PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Rogers, AEJ; Le, JP; Sather, S; Pernu, BM; Graham, DK; Pierce, AM; Keating, AK				Rogers, A. E. J.; Le, J. P.; Sather, S.; Pernu, B. M.; Graham, D. K.; Pierce, A. M.; Keating, A. K.			Mer receptor tyrosine kinase inhibition impedes glioblastoma multiforme migration and alters cellular morphology	ONCOGENE			English	Article						MerTK; receptor tyrosine kinase; glioblastoma multiforme; migration; focal adhesion kinase; morphology	ACUTE LYMPHOBLASTIC-LEUKEMIA; THERAPEUTIC TARGET; ADJUVANT TEMOZOLOMIDE; APOPTOTIC CELLS; TUMOR-GROWTH; AXL; CANCER; RADIOTHERAPY; METASTASIS; SURVIVAL	Glioblastoma multiforme (GBM) is an aggressive brain tumor, fatal within 1 year from diagnosis in most patients despite intensive multimodality therapy. The migratory and microscopically invasive nature of GBM as well as its resistance to chemotherapy renders conventional therapies inadequate in its treatment. Although Mer receptor tyrosine kinase (RTK) inhibition has been shown to decrease the long-term survival and improve the chemosensitivity of GBM in vitro, its role in malignant cellular migration has not been previously evaluated. In this study, we report for the first time a role for Mer RTK in brain tumor migration and show that Mer inhibition profoundly impedes GBM migration and alters cellular morphology. Our data demonstrate that Mer RTK inhibition results in altered signaling through focal adhesion kinase (FAK) and RhoA GTPase and a transformation of cytoskeletal organization, suggesting both molecular and structural mechanisms for the abrogation of migration. We also describe a novel and translational method of Mer RTK inhibition using a newly developed monoclonal antibody, providing proof of principle for future evaluation of Mer-targeted translational therapies in the treatment of GBM. Previous findings implicating Mer signaling in glioblastoma survival and chemotherapy resistance coupled with our discovery of the role of Mer RTK in GBM cellular migration support the development of novel Mer-targeted therapies for this devastating disease. Oncogene (2012) 31, 4171-4181; doi:10.1038/onc.2011.588; published online 19 December 2011	[Rogers, A. E. J.; Le, J. P.; Sather, S.; Pernu, B. M.; Graham, D. K.; Pierce, A. M.; Keating, A. K.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA; [Rogers, A. E. J.; Graham, D. K.; Keating, A. K.] Childrens Hosp Colorado, Dept Pediat, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado	Keating, AK (corresponding author), Univ Colorado, Sch Med, Dept Pediat, MS 8302,12800 E 19th Ave,Rm P18-4105, Aurora, CO 80045 USA.	amy.keating@ucdenver.edu			NIH [R01 1CA137078, K12 HD068372]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD068372] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA082086, R01CA137078, P30CA046934] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Rachel Linger, PhD for her expertise and insight into this project. We thank Jennifer Schlegel for production of the Mer add-back vector, the Advanced Light Microscopy Core Facility at the University of Colorado School of Medicine for their technical support in microscopy, and the University of Colorado Cancer Center Tissue Culture Core for their technical support in monoclonal antibody development. DKG is supported by NIH R01 1CA137078. AKK is generously supported by the St Baldrick's Foundation and the NIH K12 HD068372Child Health Research Career Development Award.	Chung H, 2011, J BIOL CHEM, V286, P13438, DOI 10.1074/jbc.M110.166751; Donson AM, 1999, J NEUROSURG, V90, P533, DOI 10.3171/jns.1999.90.3.0533; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; Goldberg L, 2006, CANCER RES, V66, P11709, DOI 10.1158/0008-5472.CAN-06-1878; Graham DK, 2006, CLIN CANCER RES, V12, P2662, DOI 10.1158/1078-0432.CCR-05-2208; HOCHBERG FH, 1980, NEUROLOGY, V30, P907, DOI 10.1212/WNL.30.9.907; Hutterer M, 2008, CLIN CANCER RES, V14, P130, DOI 10.1158/1078-0432.CCR-07-0862; Keating AK, 2006, ONCOGENE, V25, P6092, DOI 10.1038/sj.onc.1209633; Keating AK, 2010, MOL CANCER THER, V9, P1298, DOI 10.1158/1535-7163.MCT-09-0707; Koorstra JBM, 2009, CANCER BIOL THER, V8, P618, DOI 10.4161/cbt.8.7.7923; Li Y, 2009, ONCOGENE, V28, P3442, DOI 10.1038/onc.2009.212; Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X; Linger RMA, 2009, BLOOD, V114, P2678, DOI 10.1182/blood-2009-03-209247; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rochlitz C, 1999, LEUKEMIA, V13, P1352, DOI 10.1038/sj.leu.2401484; Salhia B, 2005, CANCER RES, V65, P8792, DOI 10.1158/0008-5472.CAN-05-0160; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Schwock J, 2010, EXPERT OPIN THER TAR, V14, P77, DOI 10.1517/14728220903460340; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Souhami L, 2004, INT J RADIAT ONCOL, V60, P853, DOI 10.1016/j.ijrobp.2004.04.011; Steinle M, 2011, RADIOTHER ONCOL, V101, P122, DOI 10.1016/j.radonc.2011.05.069; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Vajkoczy P, 2006, P NATL ACAD SCI USA, V103, P5799, DOI 10.1073/pnas.0510923103; Wu CW, 2002, ANTICANCER RES, V22, P1071; Wu Y, 2005, J CELL SCI, V118, P539, DOI 10.1242/jcs.01632	27	49	52	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2012	31	38					4171	4181		10.1038/onc.2011.588	http://dx.doi.org/10.1038/onc.2011.588			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	008SC	22179835	Green Accepted			2022-12-25	WOS:000308975800001
J	Roth, L; Agemy, L; Kotamraju, VR; Braun, G; Teesalu, T; Sugahara, KN; Hamzah, J; Ruoslahti, E				Roth, L.; Agemy, L.; Kotamraju, V. R.; Braun, G.; Teesalu, T.; Sugahara, K. N.; Hamzah, J.; Ruoslahti, E.			Transtumoral targeting enabled by a novel neuropilin-binding peptide	ONCOGENE			English	Article						tumor homing; tumor penetration; breast cancer; nanoparticles	ENDOTHELIAL GROWTH-FACTOR; HOMING PEPTIDE; TUMOR-CELLS; SEMAPHORIN-III; RECEPTOR; NANOPARTICLES; CANCER; PERMEABILITY; DRUGS; VEGF	We have recently described a class of peptides that improve drug delivery by increasing penetration of drugs into solid tumors. These peptides contain a C-terminal Cend Rule (CendR) sequence motif (R/K)XX(R/K), which is responsible for cell internalization and tissue-penetration activity. Tumor-specific CendR peptides contain both a tumor-homing motif and a cryptic CendR motif that is proteolytically unmasked in tumor tissue. A previously described cyclic tumor-homing peptide, LyP-1 (sequence: CGNKRTRGC), contains a CendR element and is capable of tissue penetration. We use here the truncated form of LyP-1, in which the CendR motif is exposed (CGNKRTR; tLyP-1), and show that both LyP-1 and tLyP-1 internalize into cells through the neuropilin-1-dependent CendR internalization pathway. Moreover, we show that neuropilin-2 also binds tLyP-1 and that this binding equally activates the CendR pathway. Fluorescein-labeled tLyP-1 peptide and tLyP-1-conjugated nanoparticles show robust and selective homing to tumors, penetrating from the blood vessels into the tumor parenchyma. The truncated peptide is more potent in this regard than the parent peptide LyP-1. tLyP-1 furthermore improves extravasation of a co-injected nanoparticle into the tumor tissue. These properties make tLyP-1 a promising tool for targeted delivery of therapeutic and diagnostic agents to breast cancers and perhaps other types of tumors. Oncogene (2012) 31, 3754-3763; doi:10.1038/onc.2011.537; published online 19 December 2011	[Roth, L.; Agemy, L.; Kotamraju, V. R.; Teesalu, T.; Hamzah, J.; Ruoslahti, E.] Univ Calif Santa Barbara, Sanford Burnham Med Res Inst, Vasc Mapping Lab, Ctr Nanomed, Santa Barbara, CA 93106 USA; [Roth, L.; Agemy, L.; Kotamraju, V. R.; Teesalu, T.; Sugahara, K. N.; Hamzah, J.; Ruoslahti, E.] La Jolla Canc Res Fdn, Canc Res Ctr, Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Braun, G.] Univ Calif Santa Barbara, Inst Collaborat Biotechnol, Santa Barbara, CA 93106 USA	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California Santa Barbara; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California Santa Barbara	Ruoslahti, E (corresponding author), Univ Calif Santa Barbara, Sanford Burnham Med Res Inst, Vasc Mapping Lab, Ctr Nanomed, UCSB Campus,Biol 2 Bldg,Room 3119, Santa Barbara, CA 93106 USA.	ruoslahti@sanfordburnham.org	hamzah, juliana/G-3114-2013; Teesalu, Tambet/J-1802-2015; Braun, Gary/A-4913-2009	Braun, Gary/0000-0002-6301-0228; Roth, Lise/0000-0001-7555-2916	USAMRAA for the Department of Defense [W81XWH-09-1-0698, W81XWH-08-1-0727]; Susan G Komen for the Cure post-doctoral fellowship [KG091411]; Santa Barbara Cancer Center; Cancer Center Support Grant from the NCI [CA30199]; NATIONAL CANCER INSTITUTE [P30CA030199] Funding Source: NIH RePORTER	USAMRAA for the Department of Defense; Susan G Komen for the Cure post-doctoral fellowship(Susan G. Komen Breast Cancer Foundation); Santa Barbara Cancer Center; Cancer Center Support Grant from the NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Eva Engvall for comments on the manuscript. This work was supported by grant number W81XWH-09-1-0698 and W81XWH-08-1-0727 from the USAMRAA for the Department of Defense (ER). LR was supported by Susan G Komen for the Cure post-doctoral fellowship (KG091411) and GB by a fellowship from the Santa Barbara Cancer Center. ER was supported in part by CA30199 the Cancer Center Support Grant from the NCI.	Acevedo LM, 2008, BLOOD, V111, P2674, DOI 10.1182/blood-2007-08-110205; Agemy L, 2011, P NATL ACAD SCI USA, V108, P17450, DOI 10.1073/pnas.1114518108; Agemy L, 2010, BLOOD, V116, P2847, DOI 10.1182/blood-2010-03-274258; Bagri A, 2009, CLIN CANCER RES, V15, P1860, DOI 10.1158/1078-0432.CCR-08-0563; Becker PM, 2005, CIRC RES, V96, P1257, DOI 10.1161/01.RES.0000171756.13554.49; Caunt M, 2008, CANCER CELL, V13, P331, DOI 10.1016/j.ccr.2008.01.029; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; Dallas NA, 2008, CLIN CANCER RES, V14, P8052, DOI 10.1158/1078-0432.CCR-08-1520; Ellis LM, 2006, MOL CANCER THER, V5, P1099, DOI 10.1158/1535-7163.MCT-05-0538; Fogal V, 2008, CANCER RES, V68, P7210, DOI 10.1158/0008-5472.CAN-07-6752; Gluzman-Poltorak Z, 2000, J BIOL CHEM, V275, P18040, DOI 10.1074/jbc.M909259199; Greish K, 2007, J DRUG TARGET, V15, P457, DOI 10.1080/10611860701539584; Guttmann-Raviv N, 2006, CANCER LETT, V231, P1, DOI 10.1016/j.canlet.2004.12.047; Hamzah J, 2011, P NATL ACAD SCI USA, V108, P7154, DOI 10.1073/pnas.1104540108; Haspel N, 2011, BIOCHEMISTRY-US, V50, P1755, DOI 10.1021/bi101662j; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Hoffman JA, 2003, CANCER CELL, V4, P383, DOI 10.1016/S1535-6108(03)00273-3; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jain R, 1999, IEEE MULTIMEDIA, V6, P1, DOI 10.1109/MMUL.1999.809225; Karmali PP, 2009, NANOMED-NANOTECHNOL, V5, P73, DOI 10.1016/j.nano.2008.07.007; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Laakkonen P, 2004, P NATL ACAD SCI USA, V101, P9381, DOI 10.1073/pnas.0403317101; Laakkonen P, 2002, NAT MED, V8, P751, DOI 10.1038/nm720; Liang WC, 2007, J MOL BIOL, V366, P815, DOI 10.1016/j.jmb.2006.11.021; Mamluk Roni, 2005, Angiogenesis, V8, P217, DOI 10.1007/s10456-005-9009-6; Pan Q, 2007, CANCER CELL, V11, P53, DOI 10.1016/j.ccr.2006.10.018; Park JH, 2009, SMALL, V5, P694, DOI 10.1002/smll.200801789; Ruoslahti E, 2002, NAT REV CANCER, V2, P83, DOI 10.1038/nrc724; Ruoslahti E, 2002, DRUG DISCOV TODAY, V7, P1138, DOI 10.1016/S1359-6446(02)02501-1; Ruoslahti E, 2010, J CELL BIOL, V188, P759, DOI 10.1083/jcb.200910104; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Sugahara KN, 2010, SCIENCE, V328, P1031, DOI 10.1126/science.1183057; Sugahara KN, 2009, CANCER CELL, V16, P510, DOI 10.1016/j.ccr.2009.10.013; TAKAGI S, 1987, DEV BIOL, V122, P90, DOI 10.1016/0012-1606(87)90335-6; Teesalu T, 2009, P NATL ACAD SCI USA, V106, P16157, DOI 10.1073/pnas.0908201106; Thorek DLJ, 2006, ANN BIOMED ENG, V34, P23, DOI 10.1007/s10439-005-9002-7; Uchida M, 2011, ACS NANO, V5, P2493, DOI 10.1021/nn102863y; von Maltzahn G, 2008, BIOCONJUGATE CHEM, V19, P1570, DOI 10.1021/bc800077y	39	175	191	8	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG	2012	31	33					3754	3763		10.1038/onc.2011.537	http://dx.doi.org/10.1038/onc.2011.537			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	994IU	22179825				2022-12-25	WOS:000307924900002
J	Foveau, B; Boulay, G; Pinte, S; Van Rechem, C; Rood, BR; Leprince, D				Foveau, Benedicte; Boulay, Gaylor; Pinte, Sebastien; Van Rechem, Capucine; Rood, Brian R.; Leprince, Dominique			The Receptor Tyrosine Kinase EphA2 Is a Direct Target Gene of Hypermethylated in Cancer 1 (HIC1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; HUMAN BREAST-CANCER; CLINICAL-SIGNIFICANCE; CARCINOMA-CELLS; LIGAND-BINDING; EXPRESSION; GROWTH; METHYLATION; INVASION; MICE	The tumor suppressor gene hypermethylated in cancer 1 (HIC1), which encodes a transcriptional repressor, is epigenetically silenced in many human tumors. Here, we show that ectopic expression of HIC1 in the highly malignant MDA-MB-231 breast cancer cell line severely impairs cell proliferation, migration, and invasion in vitro. In parallel, infection of breast cancer cell lines with a retrovirus expressing HIC1 also induces decreased mRNA and protein expression of the tyrosine kinase receptor EphA2. Moreover, chromatin immunoprecipitation (ChIP) and sequential ChIP experiments demonstrate that endogenous HIC1 proteins are bound, together with the MTA1 corepressor, to the EphA2 promoter in WI38 cells. Taken together, our results identify EphA2 as a new direct target gene of HIC1. Finally, we observe that inactivation of endogenous HIC1 through RNA interference in normal breast epithelial cells results in the up-regulation of EphA2 and is correlated with increased cellular migration. To conclude, our results involve the tumor suppressor HIC1 in the transcriptional regulation of the tyrosine kinase receptor EphA2, whose ligand ephrin-A1 is also a HIC1 target gene. Thus, loss of the regulation of this Eph pathway through HIC1 epigenetic silencing could be an important mechanism in the pathogenesis of epithelial cancers.	[Foveau, Benedicte; Boulay, Gaylor; Pinte, Sebastien; Van Rechem, Capucine; Leprince, Dominique] Univ Lille 2, Univ Lille 1, CNRS, UMR 8161,Inst Pasteur Lille,Inst Biol Lille, F-59021 Lille, France; [Rood, Brian R.] George Washington Univ, Childrens Natl Med Ctr, Sch Med, Washington, DC 20010 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Children's National Health System; George Washington University	Leprince, D (corresponding author), Univ Lille 2, Univ Lille 1, CNRS, UMR 8161,Inst Pasteur Lille,Inst Biol Lille, BP 447, F-59021 Lille, France.	dominique.leprince@ibl.fr		Van Rechem, Capucine/0000-0002-5408-6124; Leprince, Dominique/0000-0002-1999-0775	National Institutes of Health from NINDS [1K08NS051477]; CNRS; Association for International Cancer Research; Association pour la Recherche Contre le Cancer [ARC 3983, ARC 1081]; CNRS/Region Nord-Pas de Calais; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS051477] Funding Source: NIH RePORTER	National Institutes of Health from NINDS; CNRS(Centre National de la Recherche Scientifique (CNRS)); Association for International Cancer Research; Association pour la Recherche Contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); CNRS/Region Nord-Pas de Calais(Centre National de la Recherche Scientifique (CNRS)Region Hauts-de-France); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1K08NS051477 from NINDS (for work performed in the laboratory of B. R. R.). This work was also supported by CNRS, the Association for International Cancer Research), and the Association pour la Recherche Contre le Cancer Grants ARC 3983 and ARC 1081 (to D. L.).; Supported by fellowships from the CNRS/Region Nord-Pas de Calais and from the Association pour la Recherche Contre le Cancer. Present address: Harvard Medical School and Massachusetts General Hospital Cancer Center, Charlestown, MA 02129.	ANDRES AC, 1994, ONCOGENE, V9, P1461; Annamalai B, 2009, MOL CANCER RES, V7, P1021, DOI 10.1158/1541-7786.MCR-08-0582; BAE SN, 1993, BREAST CANCER RES TR, V24, P241, DOI 10.1007/BF01833264; Beauchamp A., 2011, SEMIN CELL IN PRESS; Bin Fang W, 2008, J BIOL CHEM, V283, P16017, DOI 10.1074/jbc.M709934200; Boulay G, 2012, J BIOL CHEM, V287, P5379, DOI 10.1074/jbc.M111.304287; Brantley-Sieders D, 2004, CURR PHARM DESIGN, V10, P3431, DOI 10.2174/1381612043383160; Brantley-Sieders DM, 2008, J CLIN INVEST, V118, P64, DOI 10.1172/JCI33154; Brantley-Sieders Dana M., 2004, Angiogenesis, V7, P17, DOI 10.1023/B:AGEN.0000037340.33788.87; Brieger J, 2010, ORAL ONCOL, V46, P678, DOI 10.1016/j.oraloncology.2010.06.016; Briggs KJ, 2008, CANCER RES, V68, P8654, DOI 10.1158/0008-5472.CAN-08-1904; Briones VR, 2006, BIOCHEM BIOPH RES CO, V345, P595, DOI 10.1016/j.bbrc.2006.04.052; Carles-Kinch K, 2002, CANCER RES, V62, P2840; Chen Jin, 2008, Cancer Res, V68, P10031, DOI 10.1158/0008-5472.CAN-08-3010; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Chen WY, 2003, NAT GENET, V33, P197, DOI 10.1038/ng1077; Dahl JA, 2007, STEM CELLS, V25, P1037, DOI 10.1634/stemcells.2006-0430; Deltour S, 1999, P NATL ACAD SCI USA, V96, P14831, DOI 10.1073/pnas.96.26.14831; Deltour S, 2002, MOL CELL BIOL, V22, P4890, DOI 10.1128/MCB.22.13.4890-4901.2002; Dohn M, 2001, ONCOGENE, V20, P6503, DOI 10.1038/sj.onc.1204816; Eguchi K, 1997, CANCER RES, V57, P4913; Fang BW, 2008, J CELL SCI, V121, P358, DOI 10.1242/jcs.017145; Fleuriel C, 2009, INT J BIOCHEM CELL B, V41, P26, DOI 10.1016/j.biocel.2008.05.028; Fox BP, 2004, BIOCHEM BIOPH RES CO, V318, P882, DOI 10.1016/j.bbrc.2004.04.102; Fujii H, 1998, ONCOGENE, V16, P2159, DOI 10.1038/sj.onc.1201976; Giunciuglio D, 1995, INT J CANCER, V63, P815, DOI 10.1002/ijc.2910630612; Han LQ, 2005, GYNECOL ONCOL, V99, P278, DOI 10.1016/j.ygyno.2005.06.036; Hayashi M, 2001, ANTICANCER RES, V21, P535; Ireton RC, 2005, CURR CANCER DRUG TAR, V5, P149, DOI 10.2174/1568009053765780; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kawabe M, 2009, CANCER RES, V69, P6995, DOI 10.1158/0008-5472.CAN-08-4511; Kinch MS, 2003, CLIN EXP METASTAS, V20, P59, DOI 10.1023/A:1022546620495; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Larsen AB, 2007, MOL CANCER RES, V5, P283, DOI 10.1158/1541-7786.MCR-06-0321; Larsen AB, 2010, CELL SIGNAL, V22, P636, DOI 10.1016/j.cellsig.2009.11.018; Lu YL, 1999, ONCOGENE, V18, P7034, DOI 10.1038/sj.onc.1203183; Macrae M, 2005, CANCER CELL, V8, P111, DOI 10.1016/j.ccr.2005.07.005; Miao H., 2011, SEMIN CELL IN PRESS; Miao H, 2009, CANCER CELL, V16, P9, DOI 10.1016/j.ccr.2009.04.009; Mohammad HP, 2011, ONCOGENE, V30, P2659, DOI 10.1038/onc.2010.633; Morton RA, 1996, J UROLOGY, V156, P512, DOI 10.1016/S0022-5347(01)65916-0; Nicoll G, 2001, BRIT J CANCER, V85, P1878, DOI 10.1054/bjoc.2001.2163; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Pinte S, 2004, J BIOL CHEM, V279, P38313, DOI 10.1074/jbc.M401610200; Pratt RL, 2003, MOL CANCER RES, V1, P1070; Ramnarain DB, 2006, CANCER RES, V66, P867, DOI 10.1158/0008-5472.CAN-05-2753; Rood BR, 2002, CANCER RES, V62, P3794; Stankovic-Valentin N, 2006, FEBS J, V273, P2879, DOI 10.1111/j.1742-4658.2006.05301.x; Taddei ML, 2009, AM J PATHOL, V174, P1492, DOI 10.2353/ajpath.2009.080473; Tandon M, 2011, EXPERT OPIN THER TAR, V15, P31, DOI 10.1517/14728222.2011.538682; Van Rechem C, 2010, MOL CELL BIOL, V30, P4045, DOI 10.1128/MCB.00582-09; Van Rechem C, 2009, J BIOL CHEM, V284, P20927, DOI 10.1074/jbc.M109.022350; Vaught D, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2207; Vilgelm A, 2008, ONCOGENE, V27, P2170, DOI 10.1038/sj.onc.1210862; Waha A, 2004, INT J CANCER, V110, P542, DOI 10.1002/ijc.20165; WALES MM, 1995, NAT MED, V1, P570, DOI 10.1038/nm0695-570; Walker-Daniels J, 2002, MOL CANCER RES, V1, P79; Wykosky J, 2008, MOL CANCER RES, V6, P1795, DOI 10.1158/1541-7786.MCR-08-0244; Zantek ND, 1999, CELL GROWTH DIFFER, V10, P629; Zantek ND, 2001, CLIN CANCER RES, V7, P3640; Zelinski DP, 2002, J CELL BIOCHEM, V85, P714, DOI 10.1002/jcb.10186; Zelinski DP, 2001, CANCER RES, V61, P2301; Zhang GQ, 2008, CANCER RES, V68, P1691, DOI 10.1158/0008-5472.CAN-07-2372; Zhang W, 2010, ONCOGENE, V29, P2467, DOI 10.1038/onc.2010.12; Zhou N, 2011, MICROVASC RES, V82, P113, DOI 10.1016/j.mvr.2011.06.005	66	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5366	5378		10.1074/jbc.M111.329466	http://dx.doi.org/10.1074/jbc.M111.329466			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22184117	Green Published, hybrid			2022-12-25	WOS:000300638000018
J	Burkart, C; Fan, JB; Zhang, DE				Burkart, Christoph; Fan, Jun-Bao; Zhang, Dong-Er			Two Independent Mechanisms Promote Expression of an N-terminal Truncated USP18 Isoform with Higher DeISGylation Activity in the Nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERNAL RIBOSOME ENTRY; INTERFERON-STIMULATED GENES; TRANS-ACTING FACTORS; UBIQUITIN-SPECIFIC PROTEASE; MESSENGER-RNA TRANSLATION; HEPATITIS-C VIRUS; UBP43 USP18; MEDIATED TRANSLATION; MAMMALIAN-CELLS; SECONDARY STRUCTURE	Expression of the ISG15 specific protease USP18 is highly induced by type I interferons. The two main functions of USP18, i.e. its enzymatic activity and down-regulation of type I interferon signaling, are well characterized. However, to date all functional studies focused on full-length USP18. Here, we report that translation of human USP18 is initiated by a rare start codon (CUG). Usage of this non-canonical initiation site with its weak translation initiation efficiency promotes expression of an N-terminal truncated isoform (USP18-sf). In addition, an internal ribosome entry site (IRES) located in the 5'-coding region of USP18 also contributes to translation of USP18-sf. Functionally, both isoforms exhibit enzymatic activity and interfere with type I interferon signaling. However, USP18-sf shows different subcellular distribution compared with the full-length protein and enhanced deISGylation activity in the nucleus. Taken together, we report the existence of an N-terminal truncated isoform of USP18, whose expression is controlled on translational level by two independent mechanisms providing translational flexibility as well as cell type-specific resistance to inhibition of cap-dependent translation.	[Zhang, Dong-Er] Univ Calif San Diego, Moores Canc Ctr, Dept Pathol, La Jolla, CA 92093 USA; [Zhang, Dong-Er] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Zhang, DE (corresponding author), Univ Calif San Diego, Moores Canc Ctr, Dept Pathol, 3855 Hlth Sci Dr, La Jolla, CA 92093 USA.	d7zhang@ucsd.edu	Fan, Jun-bao/E-7155-2012	Fan, Junbao/0000-0002-1709-3659	National Institutes of Health [HL091549]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091549] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL091549 (to D.-E. Z.).	Baird SD, 2006, RNA, V12, P1755, DOI 10.1261/rna.157806; Biron CA, 2001, IMMUNITY, V14, P661, DOI 10.1016/S1074-7613(01)00154-6; Bonnet ME, 2008, PHARM RES-DORDR, V25, P2972, DOI 10.1007/s11095-008-9693-1; Borden EC, 2011, J INTERF CYTOK RES, V31, P1, DOI 10.1089/jir.2010.0129; Calkhoven CF, 2000, GENE DEV, V14, P1920; Chawla-Sarkar M, 2003, APOPTOSIS, V8, P237, DOI 10.1023/A:1023668705040; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Dhar D, 2007, NUCLEIC ACIDS RES, V35, P5409, DOI 10.1093/nar/gkm524; Duex JE, 2009, MOL BIOL CELL, V20, P1833, DOI 10.1091/mbc.E08-08-0880; Fernandez J, 2002, J BIOL CHEM, V277, P19198, DOI 10.1074/jbc.M201052200; Fitzgerald KD, 2009, BBA-GENE REGUL MECH, V1789, P518, DOI 10.1016/j.bbagrm.2009.07.004; Gerashchenko MV, 2010, J BIOL CHEM, V285, P4595, DOI 10.1074/jbc.M109.070532; Gradi A, 1998, P NATL ACAD SCI USA, V95, P11089, DOI 10.1073/pnas.95.19.11089; HANN SR, 1994, GENE DEV, V8, P2441, DOI 10.1101/gad.8.20.2441; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Holcik M, 2005, RNA, V11, P1605, DOI 10.1261/rna.2158605; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; Kim JH, 2011, EMBO J, V30, P2454, DOI 10.1038/emboj.2011.146; Kim JH, 2008, J IMMUNOL, V181, P6467, DOI 10.4049/jimmunol.181.9.6467; Kim KI, 2004, MOL CELL BIOL, V24, P9592, DOI 10.1128/MCB.24.21.9592-9600.2004; Kim KI, 2005, METHOD ENZYMOL, V398, P491, DOI 10.1016/S0076-6879(05)98040-3; Komar AA, 2011, CELL CYCLE, V10, P229, DOI 10.4161/cc.10.2.14472; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; KOZAK M, 1986, P NATL ACAD SCI USA, V83, P2850, DOI 10.1073/pnas.83.9.2850; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; Leaman DW, 2003, J INTERF CYTOK RES, V23, P745, DOI 10.1089/107999003772084860; Lewis SM, 2008, ONCOGENE, V27, P1033, DOI 10.1038/sj.onc.1210777; Liu LQ, 1999, MOL CELL BIOL, V19, P3029; Lu G, 2006, CELL MOL BIOL, V52, P29, DOI 10.1170/T695; Malakhov MP, 2002, J BIOL CHEM, V277, P9976, DOI 10.1074/jbc.M109078200; Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149; Marissen WE, 1998, MOL CELL BIOL, V18, P7565, DOI 10.1128/MCB.18.12.7565; Mokrejs M, 2006, NUCLEIC ACIDS RES, V34, pD125, DOI 10.1093/nar/gkj081; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Oumard A, 2000, MOL CELL BIOL, V20, P2755, DOI 10.1128/MCB.20.8.2755-2759.2000; Palam LR, 2011, J BIOL CHEM, V286, P10939, DOI 10.1074/jbc.M110.216093; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; PEABODY DS, 1989, J BIOL CHEM, V264, P5031; PELLETIER J, 1985, CELL, V40, P515, DOI 10.1016/0092-8674(85)90200-4; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Platanias LC, 1999, EXP HEMATOL, V27, P1583, DOI 10.1016/S0301-472X(99)00109-5; Potu H, 2010, CANCER RES, V70, P655, DOI 10.1158/0008-5472.CAN-09-1942; Randall G, 2006, GASTROENTEROLOGY, V131, P1584, DOI 10.1053/j.gastro.2006.08.043; Ritchie KJ, 2004, NAT MED, V10, P1374, DOI 10.1038/nm1133; Robert F, 2006, MOL BIOL CELL, V17, P4632, DOI 10.1091/mbc.E06-06-0478; Roth W, 1998, J NEUROIMMUNOL, V87, P121, DOI 10.1016/S0165-5728(98)00079-4; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Sarasin-Filipowicz M, 2009, MOL CELL BIOL, V29, P4841, DOI 10.1128/MCB.00224-09; Sasaki A, 2003, J BIOL CHEM, V278, P2432, DOI 10.1074/jbc.C200608200; Schwab SR, 2004, PLOS BIOL, V2, P1774, DOI 10.1371/journal.pbio.0020366; Schwer H, 2000, GENOMICS, V65, P44, DOI 10.1006/geno.2000.6148; Semler BL, 2008, TRENDS MICROBIOL, V16, P1, DOI 10.1016/j.tim.2007.11.001; Shi HX, 2010, MOL CELL BIOL, V30, P2424, DOI 10.1128/MCB.01466-09; Spotts GD, 1997, MOL CELL BIOL, V17, P1459, DOI 10.1128/MCB.17.3.1459; Spriggs KA, 2005, CELL DEATH DIFFER, V12, P585, DOI 10.1038/sj.cdd.4401642; Stoneley M, 2000, NUCLEIC ACIDS RES, V28, P687, DOI 10.1093/nar/28.3.687; Sudhakar A, 2000, BIOCHEMISTRY-US, V39, P12929, DOI 10.1021/bi0008682; Van Eden ME, 2004, RNA, V10, P720, DOI 10.1261/rna.5225204; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Warnakulasuriyarachchi D, 2004, J BIOL CHEM, V279, P17148, DOI 10.1074/jbc.M308737200; Wegrzyn JL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-232; Zhu YA, 1997, J BIOL CHEM, V272, P51	62	25	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4883	4893		10.1074/jbc.M111.255570	http://dx.doi.org/10.1074/jbc.M111.255570			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22170061	hybrid, Green Published			2022-12-25	WOS:000300608500049
J	Gomez, IG; Tang, JJ; Wilson, CL; Yan, W; Heinecke, JW; Harlan, JM; Raines, EW				Gomez, Ivan G.; Tang, Jingjing; Wilson, Carole L.; Yan, Wei; Heinecke, Jay W.; Harlan, John M.; Raines, Elaine W.			Metalloproteinase-mediated Shedding of Integrin beta 2 Promotes Macrophage Efflux from Inflammatory Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; BLOOD-VESSELS; ROLES; MAC-1; MIGRATION; LFA-1; MICE; CD18; ALPHA(M)BETA(2); FIBRIN(OGEN)	Macrophage exiting from inflammatory sites is critical to limit the local innate immune response. With tissue insult, resident tissue macrophages rapidly efflux to lymph nodes where they modulate the adaptive immune response, and inflammatory macrophages attracted to the site of injury then exit during the resolution phase. However, the mechanisms that regulate macrophage efflux are poorly understood. This study has investigated soluble forms of integrin beta 2 whose levels are elevated in experimental peritonitis at times when macrophages are exiting the peritoneum, suggesting that its proteolytic shedding may be involved in macrophage efflux. Both constitutive and inducible metalloproteinase-dependent shedding of integrin beta 2 from mouse macrophages are demonstrated. Soluble integrin beta 2 is primarily released as a heterodimeric complex with alpha M that retains its ability to bind its ligands intracellular adhesion molecule-1, fibrin, and collagen and thus may serve as a soluble antagonist. In a model of accelerated exiting, administration of a metalloproteinase inhibitor prevents macrophage efflux by 50% and impedes loss of macrophage integrin beta 2 from the cell surface. Exiting of peritoneal macrophages in mice lacking integrin beta 2 is accelerated, and antibody disruption of integrin beta 2-substrate interactions can reverse 50% of the metalloprotease inhibitor blockade of macrophage exiting. Thus, our study demonstrates the ability of metalloproteinase-mediated shedding of integrin beta 2 to promote macrophage efflux from inflammatory sites, and the release of soluble integrin heterodimers may also limit local inflammation.	[Raines, Elaine W.] Univ Washington, Harborview Med Ctr, Dept Pathol, Seattle, WA 98104 USA; [Heinecke, Jay W.; Harlan, John M.] Univ Washington, Dept Med, Seattle, WA 98104 USA; [Yan, Wei] Inst Syst Biol, Seattle, WA 98109 USA	Harborview Medical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Institute for Systems Biology (ISB)	Raines, EW (corresponding author), Univ Washington, Harborview Med Ctr, Dept Pathol, 325 9Th Ave, Seattle, WA 98104 USA.	ewraines@u.washington.edu	Yan, Wei/AAI-9905-2020	Yan, Wei/0000-0003-0619-5876	National Institutes of Health [5P01 HL018645, R01 HL067267, HL081795, 5P01 HL030086]; Mass Spectrometry Core, Diabetes Education and Research Center, University of Washington [P30 DK017047]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018645, R01HL081795, P01HL030086, R01HL067267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mass Spectrometry Core, Diabetes Education and Research Center, University of Washington; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Identification of increased Grants 5P01 HL018645 (to E. W. R., J. M. H., and J. W. H.), R01 HL067267 and HL081795 (to E. W. R.), and 5P01 HL030086 (to J. W. H.). This work was also supported by Grant P30 DK017047 from the Mass Spectrometry Core, Diabetes Education and Research Center, University of Washington.	Alon R, 2002, SEMIN IMMUNOL, V14, P93, DOI 10.1006/smim.2001.0346; Alon R, 2007, IMMUNITY, V26, P17, DOI 10.1016/j.immuni.2007.01.002; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Bellingan GJ, 1996, J IMMUNOL, V157, P2577; Cao CZ, 2006, EMBO J, V25, P1860, DOI 10.1038/sj.emboj.7601082; Cao CZ, 2005, BLOOD, V106, P3234, DOI 10.1182/blood-2005-03-1288; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; COLVIN RB, 1975, J EXP MED, V142, P1377, DOI 10.1084/jem.142.6.1377; Cook AD, 2006, THROMB HAEMOSTASIS, V95, P659, DOI 10.1160/TH05-06-0405; Evans BJ, 2006, BLOOD, V107, P3593, DOI 10.1182/blood-2005-09-3695; Filep JG, 1999, BLOOD, V94, P4132, DOI 10.1182/blood.V94.12.4132.424k25_4132_4142; Flick MJ, 2004, J CLIN INVEST, V113, P1596, DOI 10.1172/JCI200420741; Garton KJ, 2006, J LEUKOCYTE BIOL, V79, P1105, DOI 10.1189/jlb.0106038; Gibb DR, 2010, J EXP MED, V207, P623, DOI 10.1084/jem.20091990; Gjelstrup LC, 2010, J IMMUNOL, V185, P4154, DOI 10.4049/jimmunol.1000952; Gong YQ, 2008, J CLIN INVEST, V118, P3012, DOI 10.1172/JCI32750; ISSEKUTZ TB, 1995, J IMMUNOL, V154, P6533; Iwata A, 2002, BLOOD, V100, P2077, DOI 10.1182/blood-2002-03-0752; Lefort CT, 2009, J IMMUNOL, V183, P6460, DOI 10.4049/jimmunol.0900983; Matsukawa A, 2005, J IMMUNOL, V175, P3354, DOI 10.4049/jimmunol.175.5.3354; MELNICOFF MJ, 1989, CELL IMMUNOL, V118, P178, DOI 10.1016/0008-8749(89)90367-5; MILLER LJ, 1987, J CLIN INVEST, V80, P535, DOI 10.1172/JCI113102; Murphy G, 2008, TRENDS IMMUNOL, V29, P75, DOI 10.1016/j.it.2007.10.009; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Ranganathan S, 2011, J BIOL CHEM, V286, P30535, DOI 10.1074/jbc.M111.265413; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Scharffetter-Kochanek K, 1998, J EXP MED, V188, P119, DOI 10.1084/jem.188.1.119; Schif-Zuck S, 2011, EUR J IMMUNOL, V41, P366, DOI 10.1002/eji.201040801; Semmrich M, 2005, J EXP MED, V201, P1987, DOI 10.1084/jem.20041850; Solovjov DA, 2005, J BIOL CHEM, V280, P1336, DOI 10.1074/jbc.M406968200; Szaba FM, 2002, BLOOD, V99, P1053, DOI 10.1182/blood.V99.3.1053; Tang JJ, 2011, BLOOD, V118, P786, DOI 10.1182/blood-2010-11-321406; Ulyanova T, 2007, EXP HEMATOL, V35, P1256, DOI 10.1016/j.exphem.2007.04.015; Vaisar T, 2009, MOL CELL PROTEOMICS, V8, P1044, DOI 10.1074/mcp.M800449-MCP200; Yakubenko VP, 2006, BLOOD, V107, P1643, DOI 10.1182/blood-2005-06-2509; Youker KA, 2000, J IMMUNOL, V164, P2752, DOI 10.4049/jimmunol.164.5.2752; Zen K, 2011, BLOOD, V117, P4885, DOI 10.1182/blood-2010-05-287722	37	35	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4581	4589		10.1074/jbc.M111.321182	http://dx.doi.org/10.1074/jbc.M111.321182			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22170060	Green Published, hybrid			2022-12-25	WOS:000300608500021
J	Vainio, L; Perjes, A; Ryti, N; Magga, J; Alakoski, T; Serpi, R; Kaikkonen, L; Piuhola, J; Szokodi, I; Ruskoaho, H; Kerkela, R				Vainio, Laura; Perjes, Abel; Ryti, Niilo; Magga, Johanna; Alakoski, Tarja; Serpi, Raisa; Kaikkonen, Leena; Piuhola, Jarkko; Szokodi, Istvan; Ruskoaho, Heikki; Kerkela, Risto			Neuronostatin, a Novel Peptide Encoded by Somatostatin Gene, Regulates Cardiac Contractile Function and Cardiomyocyte Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; GATA-4 TRANSCRIPTION FACTOR; IN-VIVO; VENTRICULAR CARDIOMYOCYTES; SIGNAL-TRANSDUCTION; MYOCYTE APOPTOSIS; CELL-GROWTH; EEF2 KINASE; P38; HEART	Neuronostatin, a recently discovered peptide encoded by somatostatin gene, is involved in regulation of neuronal function, blood pressure, food intake, and drinking behavior. However, the biological effects of neuronostatin on cardiac myocytes are not known, and the intracellular signaling mechanisms induced by neuronostatin remain unidentified. We analyzed the effect of neuronostatin in isolated perfused rat hearts and in cultured primary cardiomyocytes. Neuronostatin infusion alone had no effect on left ventricular (LV) contractile function or on isoprenaline-or preload-induced increase in cardiac contractility. However, infusion of neuronostatin significantly decreased the positive inotropic response to endothelin-1 (ET-1). This was associated with an increase in phosphorylation of p38 mitogen-activated protein kinase and c-Jun N-terminal kinase (JNK). Treatment of both neonatal and adult cardiomyocytes with neuronostatin resulted in reduced cardiomyocyte viability. Inhibition of JNK further increased the neuronostatin-induced cell death. We conclude that neuronostatin regulates cardiac contractile function and cardiomyocyte survival. Receptors for neuronostatin need to be identified to further characterize the biological functions of the peptide.	[Vainio, Laura; Perjes, Abel; Ryti, Niilo; Magga, Johanna; Alakoski, Tarja; Serpi, Raisa; Kaikkonen, Leena; Ruskoaho, Heikki; Kerkela, Risto] Univ Oulu, Inst Biomed, Dept Pharmacol & Toxicol, FIN-90014 Oulu, Finland; [Piuhola, Jarkko] Univ Oulu, Dept Internal Med, FIN-90014 Oulu, Finland; [Perjes, Abel; Szokodi, Istvan] Univ Pecs, Sch Med, Inst Heart, H-7624 Pecs, Hungary	University of Oulu; University of Oulu; University of Pecs	Kerkela, R (corresponding author), Univ Oulu, Inst Biomed, Dept Pharmacol & Toxicol, POB 5000, FIN-90014 Oulu, Finland.	Risto.Kerkela@oulu.fi	Szokodi, Istvan/X-3704-2019	Szokodi, Istvan/0000-0002-2162-6155; Serpi, Raisa/0000-0002-8207-4673; Magga, Johanna/0000-0003-4688-9098; Ryti, Niilo/0000-0001-5357-1251	Finnish Foundation for Cardiovascular Research; Sigrid Juselius Foundation; Academy of Finland (Center of Excellence); Emil Aaltonen Foundation; Hungarian Scientific Research Fund [K69118]	Finnish Foundation for Cardiovascular Research; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland (Center of Excellence)(Academy of Finland); Emil Aaltonen Foundation; Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported, in whole or in part, by the Finnish Foundation for Cardiovascular Research, Sigrid Juselius Foundation, Academy of Finland (Center of Excellence) and Emil Aaltonen Foundation (to R. K.) and by Hungarian Scientific Research Fund (K69118) (to I. S.).	Andreka P, 2001, CIRC RES, V88, P305, DOI 10.1161/01.RES.88.3.305; Baines CP, 2005, J MOL CELL CARDIOL, V38, P47, DOI 10.1016/j.yjmcc.2004.11.004; Bell D, 2008, CELL PHYSIOL BIOCHEM, V22, P653, DOI 10.1159/000185549; Bellahcene M, 2006, J AM COLL CARDIOL, V48, P545, DOI 10.1016/j.jacc.2006.02.072; Bogazzi F, 2005, CLIN ENDOCRINOL, V62, P590, DOI 10.1111/j.1365-2265.2005.02265.x; Braz JC, 2003, J CLIN INVEST, V111, P1475, DOI 10.1172/JCI200317295; BRAZEAU P, 1973, SCIENCE, V179, P77, DOI 10.1126/science.179.4068.77; BRUNO JF, 1993, ENDOCRINOLOGY, V133, P2561, DOI 10.1210/en.133.6.2561; Chadee DN, 2004, NAT CELL BIOL, V6, P770, DOI 10.1038/ncb1152; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; ENDOU M, 1989, J PHARMACOL EXP THER, V250, P726; Ferrandi C, 2004, BRIT J PHARMACOL, V142, P953, DOI 10.1038/sj.bjp.0705873; Hua YA, 2009, AM J PHYSIOL-REG I, V297, pR682, DOI 10.1152/ajpregu.00196.2009; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kerkela R, 2002, J BIOL CHEM, V277, P13752, DOI 10.1074/jbc.M105736200; Kerkela R, 2006, NAT MED, V12, P908, DOI 10.1038/nm1446; Kerkela R, 2006, J AM COLL CARDIOL, V48, P556, DOI 10.1016/j.jacc.2006.05.005; Kerkela R, 2009, CTS-CLIN TRANSL SCI, V2, P15, DOI 10.1111/j.1752-8062.2008.00090.x; Knebel A, 2002, BIOCHEM J, V367, P525, DOI 10.1042/BJ20020916; Knebel A, 2001, EMBO J, V20, P4360, DOI 10.1093/emboj/20.16.4360; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Liao P, 2002, CIRC RES, V90, P190, DOI 10.1161/hh0202.104220; Liao P, 2001, P NATL ACAD SCI USA, V98, P12283, DOI 10.1073/pnas.211086598; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Martini JS, 2008, P NATL ACAD SCI USA, V105, P12457, DOI 10.1073/pnas.0803153105; Matsui T, 2001, CIRCULATION, V104, P330; Matsui T, 2003, CELL CYCLE, V2, P220, DOI 10.4161/cc.2.3.381; Minamino T, 2002, P NATL ACAD SCI USA, V99, P3866, DOI 10.1073/pnas.062453699; Moller LN, 2003, BBA-BIOMEMBRANES, V1616, P1, DOI 10.1016/S0005-2736(03)00235-9; Murray F, 2001, J CARDIOVASC PHARM, V37, P324, DOI 10.1097/00005344-200103000-00011; Nishida K, 2004, MOL CELL BIOL, V24, P10611, DOI 10.1128/MCB.24.24.10611-10620.2004; Pikkarainen S, 2002, J MOL MED, V80, P51, DOI 10.1007/s001090100278; Piuhola J, 2003, HYPERTENSION, V41, P93, DOI 10.1161/01.HYP.0000050929.96979.EC; Pollari E, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-74; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Russell FD, 2001, BRIT J PHARMACOL, V132, P5, DOI 10.1038/sj.bjp.0703811; Samson WK, 2008, J BIOL CHEM, V283, P31949, DOI 10.1074/jbc.M804784200; Schwabe W, 1996, GENE, V168, P233, DOI 10.1016/0378-1119(95)00748-2; Shao ZL, 2006, CIRC RES, V98, P111, DOI 10.1161/01.RES.0000197781.20524.b9; Smith EM, 2008, EMBO J, V27, P1005, DOI 10.1038/emboj.2008.39; Szokodi I, 2002, CIRC RES, V91, P434, DOI 10.1161/01.RES.0000033522.37861.69; Szokodi I, 1996, ACTA PHYSIOL SCAND, V156, P151, DOI 10.1046/j.1365-201X.1996.454169000.x; Szokodi I, 2008, CIRCULATION, V118, P1651, DOI 10.1161/CIRCULATIONAHA.107.758623; Tenhunen O, 2004, J BIOL CHEM, V279, P24852, DOI 10.1074/jbc.M314317200; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Wang XM, 2006, PHYSIOLOGY, V21, P362, DOI 10.1152/physiol.00024.2006; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zechner D, 1997, J CELL BIOL, V139, P115, DOI 10.1083/jcb.139.1.115	48	19	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4572	4580		10.1074/jbc.M111.289215	http://dx.doi.org/10.1074/jbc.M111.289215			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22170057	Green Published, hybrid			2022-12-25	WOS:000300608500020
J	Rohde, LAH; Ahring, PK; Jensen, ML; Nielsen, EO; Peters, D; Helgstrand, C; Krintel, C; Harpsoe, K; Gajhede, M; Kastrup, JS; Balle, T				Rohde, Line Aagot Hede; Ahring, Philip Kiaer; Jensen, Marianne Lerbech; Nielsen, Elsebet Ostergaard; Peters, Dan; Helgstrand, Charlotte; Krintel, Christian; Harpsoe, Kasper; Gajhede, Michael; Kastrup, Jette Sandholm; Balle, Thomas			Intersubunit Bridge Formation Governs Agonist Efficacy at Nicotinic Acetylcholine alpha 4 beta 2 Receptors UNIQUE ROLE OF HALOGEN BONDING REVEALED	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN; STRUCTURAL DETERMINANTS; CRYSTAL-STRUCTURE; LIGAND-BINDING; SMOKING-CESSATION; POTENT AGONISTS; ACHBP; SUBTYPE; ALPHA-7; AFFINITY	The alpha 4 beta 2 subtype of the nicotinic acetylcholine receptor has been pursued as a drug target for treatment of psychiatric and neurodegenerative disorders and smoking cessation aids for decades. Still, a thorough understanding of structure-function relationships of alpha 4 beta 2 agonists is lacking. Using binding experiments, electrophysiology and x-ray crystallography we have investigated a consecutive series of five prototypical pyridine-containing agonists derived from 1-(pyridin-3-yl)-1,4-diazepane. A correlation between binding affinities at alpha 4 beta 2 and the acetylcholine-binding protein from Lymnaea stagnalis (Ls-AChBP) confirms Ls-AChBP as structural surrogate for alpha 4 beta 2 receptors. Crystal structures of five agonists with efficacies at alpha 4 beta 2 from 21-76% were determined in complex with Ls-AChBP. No variation in closure of loop C is observed despite large efficacy variations. Instead, the efficacy of a compound appears tightly coupled to its ability to form a strong intersubunit bridge linking the primary and complementary binding interfaces. For the tested agonists, a specific halogen bond was observed to play a large role in establishing such strong intersubunit anchoring.	[Helgstrand, Charlotte; Krintel, Christian; Harpsoe, Kasper; Gajhede, Michael; Kastrup, Jette Sandholm; Balle, Thomas] Univ Copenhagen, Dept Med Chem, Fac Pharmaceut Sci, DK-2100 Copenhagen, Denmark; [Rohde, Line Aagot Hede; Ahring, Philip Kiaer; Jensen, Marianne Lerbech; Nielsen, Elsebet Ostergaard; Peters, Dan] NeuroSearch AS, DK-2750 Ballerup, Denmark	University of Copenhagen	Balle, T (corresponding author), Univ Copenhagen, Dept Med Chem, Fac Pharmaceut Sci, DK-2100 Copenhagen, Denmark.	tb@farma.ku.dk	Harpsøe, Kasper/V-6870-2018	Harpsøe, Kasper/0000-0002-9326-9644; Gajhede, Michael/0000-0001-9864-2287; Ahring, Joergen Philip Kiaer/0000-0003-1807-3331; Balle, Thomas/0000-0002-0233-8350; krintel, christian/0000-0001-5925-5639; Kastrup, Jette Sandholm/0000-0003-2654-1510				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andreasen JT, 2011, J PSYCHOPHARMACOL, V25, P1347, DOI 10.1177/0269881110364271; Atack JR, 2008, CNS NEUROSCI THER, V14, P25, DOI 10.1111/j.1527-3458.2007.00034.x; Audouze K, 2006, J MED CHEM, V49, P3159, DOI 10.1021/jm058058h; Bissantz C, 2010, J MED CHEM, V53, P5061, DOI 10.1021/jm100112j; Bisson WH, 2008, J MOL MODEL, V14, P891, DOI 10.1007/s00894-008-0340-x; Blum AP, 2010, P NATL ACAD SCI USA, V107, P13206, DOI 10.1073/pnas.1007140107; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Bourne Y, 2010, P NATL ACAD SCI USA, V107, P6076, DOI 10.1073/pnas.0912372107; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Brams M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001034; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Bunnelle WH, 2007, J MED CHEM, V50, P3627, DOI 10.1021/jm070018l; Bunnelle WH, 2009, J MED CHEM, V52, P4126, DOI 10.1021/jm900249k; Burmeister WP, 2000, ACTA CRYSTALLOGR D, V56, P328, DOI 10.1107/S0907444999016261; Carroll FI, 2004, BIOORG MED CHEM LETT, V14, P1889, DOI 10.1016/j.bmcl.2004.02.007; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Cunningham CS, 2011, EUR J PHARMACOL, V654, P47, DOI 10.1016/j.ejphar.2010.12.003; Dutertre S, 2007, EMBO J, V26, P3858, DOI 10.1038/sj.emboj.7601785; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Etter JF, 2006, TOB CONTROL, V15, DOI 10.1136/tc.2005.015487; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Frost JM, 2006, J MED CHEM, V49, P7843, DOI 10.1021/jm060846z; Gay EA, 2008, J PHYSIOL-LONDON, V586, P1105, DOI 10.1113/jphysiol.2007.149492; Gay EA, 2007, MOL PHARMACOL, V72, P838, DOI 10.1124/mol.107.035527; Geitmann M, 2010, BIOCHEMISTRY-US, V49, P8143, DOI 10.1021/bi1006354; Glennon RA, 2004, BIOORG MED CHEM LETT, V14, P1841, DOI 10.1016/j.bmcl.2003.07.035; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Grottick AJ, 2000, BEHAV BRAIN RES, V117, P197, DOI 10.1016/S0166-4328(00)00305-3; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hansen SB, 2002, J BIOL CHEM, V277, P41299, DOI 10.1074/jbc.C200462200; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; Henderson BJ, 2010, J PHARMACOL EXP THER, V334, P761, DOI 10.1124/jpet.110.168211; Hibbs RE, 2009, EMBO J, V28, P3040, DOI 10.1038/emboj.2009.227; Houlihan LM, 2001, J NEUROCHEM, V78, P1029, DOI 10.1046/j.1471-4159.2001.00481.x; Ihara Makoto, 2008, Invertebrate Neuroscience, V8, P71, DOI 10.1007/s10158-008-0069-3; Jensen AA, 2003, MOL PHARMACOL, V64, P865, DOI 10.1124/mol.64.4.865; Jensen AA, 2005, J MED CHEM, V48, P4705, DOI 10.1021/jm040219e; Ji J, 2007, J MED CHEM, V50, P5493, DOI 10.1021/jm070755h; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lamb PW, 2005, J MOL NEUROSCI, V27, P13, DOI 10.1385/JMN:27:1:013; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Levin ED, 1999, COGNITIVE BRAIN RES, V7, P405, DOI 10.1016/S0926-6410(98)00044-5; Lu Yan-Hui, 2009, Acta Entomologica Sinica, V52, P52; Ludwig J, 2010, J RECEPT SIG TRANSD, V30, P469, DOI 10.3109/10799893.2010.505239; Luttmann E, 2009, CHEMMEDCHEM, V4, P1874, DOI 10.1002/cmdc.200900320; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Nielsen SF, 2000, J MED CHEM, V43, P2217, DOI 10.1021/jm990973d; Peters D., 1999, Patent No. [WO9921834, 9921834]; Ravelli RBG, 2000, STRUCTURE, V8, P315, DOI 10.1016/S0969-2126(00)00109-X; Rollema H, 2007, NEUROPHARMACOLOGY, V52, P985, DOI 10.1016/j.neuropharm.2006.10.016; Rucktooa P, 2009, BIOCHEM PHARMACOL, V78, P777, DOI 10.1016/j.bcp.2009.06.098; Sander T, 2011, PROTEINS, V79, P1458, DOI 10.1002/prot.22975; Sander T, 2010, J MOL GRAPH MODEL, V29, P415, DOI 10.1016/j.jmgm.2010.08.004; Schneider JS, 1998, ANN NEUROL, V43, P311, DOI 10.1002/ana.410430308; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; STEINLEIN OK, 1995, NAT GENET, V11, P201, DOI 10.1038/ng1095-201; Talley TT, 2008, P NATL ACAD SCI USA, V105, P7606, DOI 10.1073/pnas.0802197105; Tonstad Serena, 2010, Expert Rev Respir Med, V4, P291, DOI 10.1586/ers.10.27; Tosco P, 2009, J MED CHEM, V52, P2311, DOI 10.1021/jm801060h; Ulens C, 2006, P NATL ACAD SCI USA, V103, P3615, DOI 10.1073/pnas.0507889103; Ulens C, 2009, J MED CHEM, V52, P2372, DOI 10.1021/jm801400g; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Unwin N, 2002, J MOL BIOL, V319, P1165, DOI 10.1016/S0022-2836(02)00381-9; Weik M, 2000, P NATL ACAD SCI USA, V97, P623, DOI 10.1073/pnas.97.2.623; Williams DK, 2009, J PHARMACOL EXP THER, V330, P40, DOI 10.1124/jpet.109.151225; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yakel JL, 2010, J PHYSIOL-LONDON, V588, P597, DOI 10.1113/jphysiol.2009.182691; Zhou Y, 2003, J NEUROSCI, V23, P9004	72	40	40	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4248	4259		10.1074/jbc.M111.292243	http://dx.doi.org/10.1074/jbc.M111.292243			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22170047	Green Published, hybrid			2022-12-25	WOS:000300410900057
J	Sanchez, EJ; Lewis, KM; Munske, GR; Nissen, MS; Kang, C				Sanchez, Emiliano J.; Lewis, Kevin M.; Munske, Gerhard R.; Nissen, Mark S.; Kang, ChulHee			Glycosylation of Skeletal Calsequestrin IMPLICATIONS FOR ITS FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM; CARDIAC CALSEQUESTRIN; CA2+ RELEASE; MUSCLE CALSEQUESTRIN; LUMINAL CA2+; PROTEIN; BINDING; PHOSPHORYLATION; MECHANISM; IDENTIFICATION	Calsequestrin (CASQ) serves as a major Ca2+ storage/buffer protein in the sarcoplasmic reticulum (SR). When purified from skeletal muscle, CASQ1 is obtained in its glycosylated form. Here, we have confirmed the specific site and degree of glycosylation of native rabbit CASQ1 and have investigated its effect on critical properties of CASQ by comparison with the non-glycosylated recombinant form. Based on our comparative approach utilizing crystal structures, Ca2+ binding capacities, analytical ultracentrifugation, and light-scattering profiles of the native and recombinant rabbit CASQ1, we propose a novel and dynamic role for glycosylation in CASQ. CASQ undergoes a unique degree of mannose trimming as it is trafficked from the proximal endoplasmic reticulum to the SR. The major glycoform of CASQ (GlcNAc(2)Man(9)) found in the proximal endoplasmic reticulum can severely hinder formation of the back-to-back interface, potentially preventing premature Ca2+-dependent polymerization of CASQ and ensuring its continuous mobility to the SR. Only trimmed glycans can stabilize both front-to-front and the back-to-back interfaces of CASQ through extensive hydrogen bonding and electrostatic interactions. Therefore, the mature glycoform of CASQ (GlcNAc(2)Man(1-4)) within the SR can be retained upon establishing a functional high capacity Ca2+ binding polymer. In addition, based on the high resolution structures, we propose a molecular mechanism for the catecholaminergic polymorphic ventricular tachycardia (CPVT2) mutation, K206N.	[Sanchez, Emiliano J.; Munske, Gerhard R.; Kang, ChulHee] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Lewis, Kevin M.; Nissen, Mark S.; Kang, ChulHee] Washington State Univ, Dept Chem, Pullman, WA 99164 USA	Washington State University; Washington State University	Kang, C (corresponding author), Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.	chkang@wsu.edu		Lewis, Kevin/0000-0003-3403-9520; Kang, ChulHee/0000-0002-0693-7860	American Heart Association [0850084Z]; National Science Foundation [MCB 1021148, DBI 0959778]; M. J. Murdock Charitable Trust; National Institutes of Health [T32GM083864]; National Institutes of Health/Center for Research Resources [P20RR016454]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM083864] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); M. J. Murdock Charitable Trust; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Heart Association Grant 0850084Z, National Science Foundation Grants MCB 1021148 and DBI 0959778, and by the M. J. Murdock Charitable Trust. This work was also supported in part by National Institutes of Health Grant T32GM083864 (NIGMS; to E. J. S.).; We thank L. M. Gloss and T. Topping (Washington State University) and J. T. Oxford (Boise State University, M. J. Murdock Charitable Trust, and National Institutes of Health/Center for Research Resources Grant P20RR016454).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Beard NA, 2008, CELL CALCIUM, V44, P363, DOI 10.1016/j.ceca.2008.01.005; CALA SE, 1991, J BIOL CHEM, V266, P391; CAMPBELL KP, 1983, J BIOL CHEM, V258, P1197; Cho JH, 2007, J CELL SCI, V120, P1551, DOI 10.1242/jcs.001016; Chopra N, 2007, CIRC RES, V101, P617, DOI 10.1161/CIRCRESAHA.107.157552; Domingues MRM, 2003, J AM SOC MASS SPECTR, V14, P406, DOI 10.1016/S1044-0305(03)00127-2; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRANZINIARMSTRONG C, 1987, J CELL BIOL, V105, P49, DOI 10.1083/jcb.105.1.49; Gatti G, 2001, J CELL BIOL, V154, P525, DOI 10.1083/jcb.200103002; HE ZP, 1993, J BIOL CHEM, V268, P24635; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Herzog A, 2000, FEBS LETT, V472, P73, DOI 10.1016/S0014-5793(00)01431-9; Hidalgo C, 1996, BIOPHYS J, V71, P2130, DOI 10.1016/S0006-3495(96)79413-4; Houle TD, 2004, CARDIOVASC RES, V64, P227, DOI 10.1016/j.cardiores.2004.09.009; Houle TD, 2006, EXP CELL RES, V312, P4150, DOI 10.1016/j.yexcr.2006.09.010; HUBBARD MJ, 1993, TRENDS BIOCHEM SCI, V18, P172, DOI 10.1016/0968-0004(93)90109-Z; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; IKEMOTO N, 1974, J BIOL CHEM, V249, P2357; JAENICKE R, 1991, BIOCHEMISTRY-US, V30, P3147, DOI 10.1021/bi00227a001; Johnson LN, 2009, BIOCHEM SOC T, V37, P627, DOI 10.1042/BST0370627; Kalyanasundaram A, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.053892; Kiarash A, 2004, CARDIOVASC RES, V63, P264, DOI 10.1016/j.cardiores.2004.04.001; Kim E, 2007, J MOL BIOL, V373, P1047, DOI 10.1016/j.jmb.2007.08.055; Kirchhefer U, 2010, J MOL CELL CARDIOL, V49, P95, DOI 10.1016/j.yjmcc.2010.03.006; Larkin A, 2011, BIOCHEMISTRY-US, V50, P4411, DOI 10.1021/bi200346n; Launikonis BS, 2006, P NATL ACAD SCI USA, V103, P2982, DOI 10.1073/pnas.0511252103; MacLennan DH, 2009, J PHYSIOL-LONDON, V587, P3113, DOI 10.1113/jphysiol.2009.172155; MacLennan DH, 1998, NAT STRUCT BIOL, V5, P409, DOI 10.1038/nsb0698-409; MacLennan DH, 2002, J MOL CELL CARDIOL, V34, P897, DOI 10.1006/jmcc.2002.2031; MACLENNAN DH, 1971, P NATL ACAD SCI USA, V68, P1231, DOI 10.1073/pnas.68.6.1231; McFarland TP, 2010, J MOL CELL CARDIOL, V49, P556, DOI 10.1016/j.yjmcc.2010.05.012; MEISSNER G, 1973, BIOCHIM BIOPHYS ACTA, V298, P246, DOI 10.1016/0005-2736(73)90355-6; Milstein ML, 2009, EXP CELL RES, V315, P523, DOI 10.1016/j.yexcr.2008.11.006; MITCHELL RD, 1988, J BIOL CHEM, V263, P1376; Mitra N, 2006, TRENDS BIOCHEM SCI, V31, P156, DOI 10.1016/j.tibs.2006.01.003; Moremen KW, 2002, BBA-GEN SUBJECTS, V1573, P225, DOI 10.1016/S0304-4165(02)00388-4; Noh SM, 2008, INFECT IMMUN, V76, P2219, DOI 10.1128/IAI.00008-08; O'Brian JJ, 2002, J BIOL CHEM, V277, P37154, DOI 10.1074/jbc.M204370200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park HJ, 2003, J BIOL CHEM, V278, P16176, DOI 10.1074/jbc.M300120200; Park HJ, 2004, J BIOL CHEM, V279, P18026, DOI 10.1074/jbc.M311553200; Priori SG, 2011, CIRC RES, V108, P871, DOI 10.1161/CIRCRESAHA.110.226845; Ram ML, 2004, MOL CELL BIOCHEM, V266, P209, DOI 10.1023/B:MCBI.0000049164.28580.56; Rodriguez MM, 1999, FEBS LETT, V454, P240, DOI 10.1016/S0014-5793(99)00697-3; Royer L, 2009, J PHYSIOL-LONDON, V587, P3101, DOI 10.1113/jphysiol.2009.171934; SALVATORI S, 1994, BIOCHEM BIOPH RES CO, V198, P144, DOI 10.1006/bbrc.1994.1021; Sanchez EJ, 2011, MOL CELL BIOCHEM, V353, P195, DOI 10.1007/s11010-011-0787-4; Shental-Bechor D, 2008, P NATL ACAD SCI USA, V105, P8256, DOI 10.1073/pnas.0801340105; Shoshan-Barmatz V, 1998, INT REV CYTOL, V183, P185, DOI 10.1016/S0074-7696(08)60145-X; ShoshanBarmatz V, 1996, BBA-BIOMEMBRANES, V1283, P89, DOI 10.1016/0005-2736(96)00079-X; SLUPSKY JR, 1987, BIOCHEMISTRY-US, V26, P6539, DOI 10.1021/bi00394a038; Szegedi C, 1999, BIOCHEM J, V337, P19, DOI 10.1042/0264-6021:3370019; VARSANYI M, 1980, FEBS LETT, V122, P227, DOI 10.1016/0014-5793(80)80444-3; Wang SR, 1998, NAT STRUCT BIOL, V5, P476, DOI 10.1038/nsb0698-476	55	14	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3042	3050		10.1074/jbc.M111.326363	http://dx.doi.org/10.1074/jbc.M111.326363			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22170046	Green Published, hybrid			2022-12-25	WOS:000300295100011
J	Lanham, KA; Prasch, AL; Weina, KM; Peterson, RE; Heideman, W				Lanham, Kevin A.; Prasch, Amy L.; Weina, Kasia M.; Peterson, Richard E.; Heideman, Warren			A Dominant Negative Zebrafish Ahr2 Partially Protects Developing Zebrafish from Dioxin Toxicity	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; DEVELOPMENTAL TOXICITY; DANIO-RERIO; TRANSACTIVATION DOMAIN; DEFICIENT MICE; PAS DOMAIN; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN; IDENTIFICATION; EXPRESSION; MALFORMATION	The toxicity by 2,3,7,8 tetrachlorodibenzo-p-dioxin (TCDD) is thought to be caused by activation of the aryl hydrocarbon receptor (AHR). However, our understanding of how AHR activation by TCDD leads to toxic effects is poor. Ideally we would like to manipulate AHR activity in specific tissues and at specific times. One route to this is expressing dominant negative AHRs (dnAHRs). This work describes the construction and characterization of dominant negative forms of the zebrafish Ahr2 in which the C-terminal transactivation domain was either removed, or replaced with the inhibitory domain from the Drosophila engrailed repressor protein. One of these dnAhr2s was selected for expression from the ubiquitously active e2f alpha promoter in transgenic zebrafish. We found that these transgenic zebrafish expressing dnAhr2 had reduced TCDD induction of the Ahr2 target gene cyp1a, as measured by 7-ethoxyresorufin-O-deethylase activity. Furthermore, the cardiotoxicity produced by TCDD, pericardial edema, heart malformation, and reduced blood flow, were all mitigated in the zebrafish expressing the dnAhr2. These results provide in vivo proof-of-principle results demonstrating the effectiveness of dnAHRs in manipulating AHR activity in vivo, and demonstrating that this approach can be a means for blocking TCDD toxicity.	[Lanham, Kevin A.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Peterson, Richard E.; Heideman, Warren] Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA; [Prasch, Amy L.] NimbleGen, Madison, WI USA; [Weina, Kasia M.] Univ London, Sch Pharm, London WC1N 1AX, England	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Roche Holding; Roche NimbleGen; University of London; University College London; University of London School of Pharmacy	Lanham, KA (corresponding author), Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA.	wheidema@wisc.edu		Lanham, Kevin/0000-0001-6406-0019	National Institutes of Health (NIH) from the National Institute of Environmental Health Sciences (NIEHS) [R01 ES012716, T32 ES07015]; University of Wisconsin Sea Grant Institute, National Sea Grant College, National Oceanic and Atmospheric Administration, U.S. Department of Commerce [NA 16RG2257];  [R/BT-20];  [R/BT-22]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012716, T32ES007015] Funding Source: NIH RePORTER	National Institutes of Health (NIH) from the National Institute of Environmental Health Sciences (NIEHS); University of Wisconsin Sea Grant Institute, National Sea Grant College, National Oceanic and Atmospheric Administration, U.S. Department of Commerce; ; ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by the National Institutes of Health (NIH) grant R01 ES012716 from the National Institute of Environmental Health Sciences (NIEHS) (W. H. and R. E. P.) and the University of Wisconsin Sea Grant Institute, National Sea Grant College Program, National Oceanic and Atmospheric Administration, U.S. Department of Commerce grant number NA 16RG2257, Sea Grant Project Numbers R/BT-20 and R/BT-22 (W. H. and R. E. P.) and NIH grant T32 ES07015 from the NIEHS (K. A. L.). The contents are solely the responsibility of the authors and do not necessarily represent the official view of the NIEHS, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 1999, J BIOL CHEM, V274, P15159, DOI 10.1074/jbc.274.21.15159; Abnet CC, 1999, TOXICOL APPL PHARM, V159, P41, DOI 10.1006/taap.1999.8719; Andreasen EA, 2002, J BIOL CHEM, V277, P13210, DOI 10.1074/jbc.M200073200; Andreasen EA, 2002, MOL PHARMACOL, V62, P234, DOI 10.1124/mol.62.2.234; Andrysik Z, 2007, MUTAT RES-FUND MOL M, V615, P87, DOI 10.1016/j.mrfmmm.2006.10.004; Antkiewicz DS, 2005, TOXICOL SCI, V84, P368, DOI 10.1093/toxsci/kfi073; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20; Belair CD, 2001, DEV DYNAM, V222, P581, DOI 10.1002/dvdy.1213; Carney SA, 2006, BIRTH DEFECTS RES A, V76, P7, DOI 10.1002/bdra.20216; Carney SA, 2004, MOL PHARMACOL, V66, P512; CARVER LA, 1994, NUCLEIC ACIDS RES, V22, P3038, DOI 10.1093/nar/22.15.3038; Chang CY, 1998, MOL CELL BIOL, V18, P525, DOI 10.1128/MCB.18.1.525; FernandezSalguero PM, 1996, TOXICOL APPL PHARM, V140, P173, DOI 10.1006/taap.1996.0210; Flaveny C, 2008, ARCH BIOCHEM BIOPHYS, V471, P215, DOI 10.1016/j.abb.2008.01.014; FUKUNAGA BN, 1995, J BIOL CHEM, V270, P29270, DOI 10.1074/jbc.270.49.29270; Garrison PM, 1996, FUND APPL TOXICOL, V30, P194, DOI 10.1006/faat.1996.0056; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; HAHN ME, 1995, BIOCHEM J, V310, P383, DOI 10.1042/bj3100383; Heideman W, 2005, CARDIOVASC TOXICOL, V5, P203, DOI 10.1385/CT:5:2:203; Henry TR, 1997, TOXICOL APPL PHARM, V142, P56, DOI 10.1006/taap.1996.8024; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; JAIN S, 1994, J BIOL CHEM, V269, P31518; Jones LC, 2001, J BIOL CHEM, V276, P25037, DOI 10.1074/jbc.M102910200; Karchner SI, 2005, BIOCHEM J, V392, P153, DOI 10.1042/BJ20050713; Kumar MB, 2001, J BIOL CHEM, V276, P42302, DOI 10.1074/jbc.M104798200; Lahvis GP, 2000, P NATL ACAD SCI USA, V97, P10442, DOI 10.1073/pnas.190256997; McGuire J, 2001, J BIOL CHEM, V276, P41841, DOI 10.1074/jbc.M105607200; McMillan BJ, 2007, MOL PHARMACOL, V72, P487, DOI 10.1124/mol.107.037259; Nacci D, 1998, ENVIRON TOXICOL CHEM, V17, P2481, DOI 10.1002/etc.5620171214; Ponting CP, 1997, CURR BIOL, V7, pR674, DOI 10.1016/S0960-9822(06)00352-6; Prasch AL, 2006, MOL PHARMACOL, V69, P776, DOI 10.1124/mol.105.016873; Prasch AL, 2003, TOXICOL SCI, V76, P138, DOI 10.1093/toxsci/kfg202; Ramadoss P, 2005, BIOCHEMISTRY-US, V44, P11148, DOI 10.1021/bi050948b; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; Tanguay RL, 2000, BBA-GENE STRUCT EXPR, V1494, P117, DOI 10.1016/S0167-4781(00)00225-6; Tanguay RL, 1999, BBA-GENE STRUCT EXPR, V1444, P35, DOI 10.1016/S0167-4781(98)00252-8; Thackaberry E A, 2002, Cardiovasc Toxicol, V2, P263, DOI 10.1385/CT:2:4:263; Thummel R, 2006, THESCIENTIFICWORLDJO, V6, P65, DOI 10.1100/tsw.2006.328; Vasquez Alejandro, 2003, Cardiovasc Toxicol, V3, P153, DOI 10.1385/CT:3:2:153; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Xiong KM, 2008, MOL PHARMACOL, V74, P1544, DOI 10.1124/mol.108.050435	41	10	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e28020	10.1371/journal.pone.0028020	http://dx.doi.org/10.1371/journal.pone.0028020			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22194803	Green Submitted, gold, Green Published			2022-12-25	WOS:000298370400009
J	Schwab, C; Cristescu, B; Northrup, JM; Stenhouse, GB; Ganzle, M				Schwab, Clarissa; Cristescu, Bogdan; Northrup, Joseph M.; Stenhouse, Gordon B.; Gaenzle, Michael			Diet and Environment Shape Fecal Bacterial Microbiota Composition and Enteric Pathogen Load of Grizzly Bears	PLOS ONE			English	Article							CLOSTRIDIUM-PERFRINGENS; FECES; POPULATIONS; SORDELLII; DIVERSITY; HEALTH	Background: Diet and environment impact the composition of mammalian intestinal microbiota; dietary or health disturbances trigger alterations in intestinal microbiota composition and render the host susceptible to enteric pathogens. To date no long term monitoring data exist on the fecal microbiota and pathogen load of carnivores either in natural environments or in captivity. This study investigates fecal microbiota composition and the presence of pathogenic Escherichia coli and toxigenic clostridia in wild and captive grizzly bears (Ursus arctos) and relates these to food resources consumed by bears. Methodology/Principal Findings: Feces were obtained from animals of two wild populations and from two captive animals during an active bear season. Wild animals consumed a diverse diet composed of plant material, animal prey and insects. Captive animals were fed a regular granulated diet with a supplement of fruits and vegetables. Bacterial populations were analyzed using quantitative PCR. Fecal microbiota composition fluctuated in wild and in captive animals. The abundance of Clostridium clusters I and XI, and of C. perfringens correlated to regular diet protein intake. Enteroaggregative E. coli were consistently present in all populations. The C. sordellii phospholipase C was identified in three samples of wild animals and for the first time in Ursids. Conclusion: This is the first longitudinal study monitoring the fecal microbiota of wild carnivores and comparing it to that of captive individuals of the same species. Location and diet affected fecal bacterial populations as well as the presence of enteric pathogens.	[Schwab, Clarissa; Gaenzle, Michael] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Cristescu, Bogdan; Northrup, Joseph M.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Stenhouse, Gordon B.] Foothills Res Inst, Hinton, AB, Canada	University of Alberta; University of Alberta	Schwab, C (corresponding author), Univ Vienna, Dept Genet Ecol, Vienna, Austria.	clarissa.schwab@univie.ac.at	Northrup, Joseph/G-5427-2012; Northrup, Joseph/AAM-2874-2020; Gänzle, Michael/F-1432-2017; Schwab, Clarissa/AGL-7943-2022; schwab, clarissa/AAZ-4537-2020	Northrup, Joseph/0000-0001-6319-4138; Northrup, Joseph/0000-0001-6319-4138; Gänzle, Michael/0000-0003-0972-928X; Cristescu, Bogdan/0000-0003-2964-5040	Alberta Conservation Association; Alberta's Conservation Collaboration; Alberta Ingenuity Fund; Alberta Sport, Recreation, Parks and Wildlife Foundation; American Society of Mammalogists; Canadian Wildlife Federation; Environment Canada; International Association for Bear Research and Management; Natural Sciences and Engineering Research Council of Canada; TD - Friends of the Environment Foundation; University of Alberta; Wild Sheep Foundation - Alberta Chapter; World Wildlife Fund; Yellowstone; Mountain Equipment Co-op; Royal Dutch Shell; Safari Club International - Northern Alberta Chapter; Teck Resources Limited	Alberta Conservation Association; Alberta's Conservation Collaboration; Alberta Ingenuity Fund; Alberta Sport, Recreation, Parks and Wildlife Foundation; American Society of Mammalogists; Canadian Wildlife Federation; Environment Canada(CGIAR); International Association for Bear Research and Management; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); TD - Friends of the Environment Foundation; University of Alberta(University of Alberta); Wild Sheep Foundation - Alberta Chapter; World Wildlife Fund; Yellowstone; Mountain Equipment Co-op; Royal Dutch Shell(Royal Dutch Shell); Safari Club International - Northern Alberta Chapter; Teck Resources Limited	This work was supported by the Alberta Conservation Association; Alberta's Conservation Collaboration; Alberta Ingenuity Fund; Alberta Sport, Recreation, Parks and Wildlife Foundation; American Society of Mammalogists; Canadian Wildlife Federation; Environment Canada; International Association for Bear Research and Management; Natural Sciences and Engineering Research Council of Canada; TD - Friends of the Environment Foundation; University of Alberta; Wild Sheep Foundation - Alberta Chapter; World Wildlife Fund; and Yellowstone to Yukon Foundation. We thank Alberta Tourism Parks and Recreation, Alberta Sustainable Resource Development, and Parks Canada for in-kind support. This study was funded by Mountain Equipment Co-op, Royal Dutch Shell, Safari Club International - Northern Alberta Chapter, Teck Resources Limited. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldape MJ, 2006, CLIN INFECT DIS, V43, P1436, DOI 10.1086/508866; Armstrong DP, 2008, TRENDS ECOL EVOL, V23, P20, DOI 10.1016/j.tree.2007.10.003; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Beutin L, 1999, VET RES, V30, P285; Blaser MJ, 2009, NAT REV MICROBIOL, V7, P887, DOI 10.1038/nrmicro2245; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; de la Fe C, 2006, VET PATHOL, V43, P370, DOI 10.1354/vp.43-3-370; Deem SL, 2001, CONSERV BIOL, V15, P1224, DOI 10.1046/j.1523-1739.2001.00336.x; Fujita S, 2007, J MED PRIMATOL, V36, P25, DOI 10.1111/j.1600-0684.2006.00191.x; Glad T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-10; *GOV ALB, 2010, GRIZZL BEAR CONS ALB; Greco G, 2005, J VET DIAGN INVEST, V17, P186, DOI 10.1177/104063870501700216; Jores J, 2008, J WILDLIFE DIS, V44, P155, DOI 10.7589/0090-3558-44.1.155; Khachatryan ZA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003064; KOVACH WL, 1993, MVSP MULTIVARIATE ST, P3; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Li M, 2003, J MICROBIOL METH, V54, P13, DOI 10.1016/S0167-7012(02)00260-9; Lubbs DC, 2009, J ANIM PHYSIOL AN N, V93, P113, DOI 10.1111/j.1439-0396.2007.00788.x; Mathews F, 2006, BIOL CONSERV, V131, P338, DOI 10.1016/j.biocon.2006.04.011; McCartney AL, 1996, APPL ENVIRON MICROB, V62, P4608, DOI 10.1128/AEM.62.12.4608-4613.1996; Metzler-Zebeli BU, 2010, APPL ENVIRON MICROB, V76, P3692, DOI 10.1128/AEM.00257-10; Milligan SR, 2009, PHILOS T R SOC B, V364, P3313, DOI 10.1098/rstb.2009.0175; Mowat G, 2006, CAN J ZOOL, V84, P473, DOI 10.1139/z06-016; Munro RHM, 2006, J MAMMAL, V87, P1112, DOI 10.1644/05-MAMM-A-410R3.1; Nagy B, 1999, VET RES, V30, P259; Nielsen S.E., 2009, J CONSERVATION PLANN, V5, P38; Ochman H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000546; PRITCHARD GT, 1990, CAN J ZOOL, V68, P1645, DOI 10.1139/z90-244; Schwab C, 2011, CAN J MICROBIOL, V57, P177, DOI 10.1139/W10-113; Schwab C, 2009, CAN J MICROBIOL, V55, P1335, DOI 10.1139/W09-083; STEVENS CE, 1995, COMP PHYSL VERTEBRAT, pCH4; Suchodolski JS, 2008, FEMS MICROBIOL ECOL, V66, P567, DOI 10.1111/j.1574-6941.2008.00521.x; Wei GF, 2007, MICROB ECOL, V54, P194, DOI 10.1007/s00248-007-9225-2; Zentek J, 2003, J ANIM PHYSIOL AN N, V87, P397, DOI 10.1046/j.0931-2439.2003.00451.x	35	48	50	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e27905	10.1371/journal.pone.0027905	http://dx.doi.org/10.1371/journal.pone.0027905			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22194798	Green Published, gold, Green Submitted			2022-12-25	WOS:000298370400006
J	Gu, XC; Liu, B; Wu, XJ; Yan, Y; Zhang, Y; Wei, YQ; Pleasure, SJ; Zhao, CJ				Gu, Xiaochun; Liu, Bin; Wu, Xiaojing; Yan, Yan; Zhang, Ying; Wei, Yiquan; Pleasure, Samuel J.; Zhao, Chunjie			Inducible Genetic Lineage Tracing of Cortical Hem Derived Cajal-Retzius Cells Reveals Novel Properties	PLOS ONE			English	Article							CEREBRAL-CORTEX; MARGINAL ZONE; IN-VIVO; REELIN; EXPRESSION; MOUSE; FOXG1; FATE; CONNECTIONS; GENERATION	During cortical development, Cajal-Retzius (CR) cells are among the earliest-born subclasses of neurons. These enigmatic neurons play an important role in cortical development through their expression of the extracellular protein, reelin. CR cells arise from discrete sources within the telencephalon, including the pallial-subpallial border and the medial (cortical hem) regions of the pallium. Combined evidence suggests that CR cells derived from distinct origins may have different distributions and functions. By tracing CR cells derived from the cortical hem using the inducible Cre transgenic mouse tool, Frizzled 10-CreER (TM), we examined the specific properties of hem-derived CR cells during cortical development. Our results show that the progenitor zone for later production of CR cells from the hem can be specifically marked as early as embryonic day 6.5 (E6.5), a pre-neural period. Moreover, using our Cre line, we found that some hem-derived CR cells migrated out along the fimbrial radial glial scaffold, which was also derived from the cortical hem, and preferentially settled in the hippocampal marginal zone, which indicated specific roles for hem-derived CR cells in hippocampal development.	[Gu, Xiaochun; Liu, Bin; Wu, Xiaojing; Yan, Yan; Zhang, Ying; Wei, Yiquan; Zhao, Chunjie] Southeast Univ, Inst Life Sci, MOE, Key Lab Dev Genes & Human Dis, Nanjing, Jiangsu, Peoples R China; [Pleasure, Samuel J.] Dept Neurol, Program Neurosci, San Francisco, CA USA; [Pleasure, Samuel J.] Dept Neurol, Program Dev Biol, San Francisco, CA USA; [Pleasure, Samuel J.] Dept Neurol, Program Biomed Sci, San Francisco, CA USA	Southeast University - China	Gu, XC (corresponding author), Southeast Univ, Inst Life Sci, MOE, Key Lab Dev Genes & Human Dis, Nanjing, Jiangsu, Peoples R China.	zhaocj@seu.edu.cn			National Nature Science Foundation of China [81000485, 30525017, 30770696, 81070904]; The Ministry of Science and Technology of China [2007CB512303]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); The Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by funds 81000485 to XG and 30525017, 30770696 and 81070904 from the National Nature Science Foundation of China, and 2007CB512303 from The Ministry of Science and Technology of China to CZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abellan A, 2010, CEREB CORTEX, V20, P1788, DOI 10.1093/cercor/bhp242; Bielle F, 2005, NAT NEUROSCI, V8, P1002, DOI 10.1038/nn1511; Deller T, 1999, EXP NEUROL, V156, P239, DOI 10.1006/exnr.1999.7020; DELRIO JA, 1995, CEREB CORTEX, V5, P13, DOI 10.1093/cercor/5.1.13; DelRio JA, 1997, NATURE, V385, P70, DOI 10.1038/385070a0; Fatemi SH, 2000, MOL PSYCHIATR, V5, P571, DOI 10.1038/sj.mp.4000794; Grove EA, 1998, DEVELOPMENT, V125, P2315; Gu XC, 2009, GENESIS, V47, P210, DOI 10.1002/dvg.20472; Hanashima C, 2004, SCIENCE, V303, P56, DOI 10.1126/science.1090674; Hanashima C, 2007, J NEUROSCI, V27, P11103, DOI 10.1523/JNEUROSCI.1066-07.2007; Hevner RF, 2003, DEV BRAIN RES, V141, P39, DOI 10.1016/S0165-3806(02)00641-7; Hong YL, 2000, OBES RES, V8, P151, DOI 10.1038/oby.2000.16; Ivanova A, 2005, GENESIS, V43, P129, DOI 10.1002/gene.20162; Kemp CR, 2007, DEV DYNAM, V236, P2011, DOI 10.1002/dvdy.21198; Mallamaci A, 2000, J NEUROSCI, V20, P1109, DOI 10.1523/JNEUROSCI.20-03-01109.2000; Mangale VS, 2008, SCIENCE, V319, P304, DOI 10.1126/science.1151695; Marin-Padilla M, 1998, TRENDS NEUROSCI, V21, P64, DOI 10.1016/S0166-2236(97)01164-8; Meyer G, 2002, J NEUROSCI, V22, P4973, DOI 10.1523/JNEUROSCI.22-12-04973.2002; Miquelajauregui A, 2010, J NEUROSCI, V30, P10551, DOI 10.1523/JNEUROSCI.5563-09.2010; Muzio L, 2003, CEREB CORTEX, V13, P641, DOI 10.1093/cercor/13.6.641; Muzio L, 2005, J NEUROSCI, V25, P4435, DOI 10.1523/JNEUROSCI.4804-04.2005; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Soriano E, 2005, NEURON, V46, P389, DOI 10.1016/j.neuron.2005.04.019; Stoykova A, 2003, CEREB CORTEX, V13, P560, DOI 10.1093/cercor/13.6.560; Super H, 1998, J NEUROSCI, V18, P4616; Takiguchi-Hayashi K, 2004, J NEUROSCI, V24, P2286, DOI 10.1523/JNEUROSCI.4671-03.2004; Tissir F, 2009, P NATL ACAD SCI USA, V106, P16871, DOI 10.1073/pnas.0903191106; Yamazaki H, 2004, P NATL ACAD SCI USA, V101, P14509, DOI 10.1073/pnas.0406295101; Yoshida M, 2006, DEVELOPMENT, V133, P537, DOI 10.1242/dev.02209; Zhao CJ, 2006, BRAIN RES, V1077, P48, DOI 10.1016/j.brainres.2006.01.042	30	25	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28653	10.1371/journal.pone.0028653	http://dx.doi.org/10.1371/journal.pone.0028653			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174859	Green Published, Green Submitted, gold			2022-12-25	WOS:000298367300018
J	Pereira, AM; Tudor, C; Kanger, JS; Subramaniam, V; Martin-Blanco, E				Pereira, Andrea Maria; Tudor, Cicerone; Kanger, Johannes S.; Subramaniam, Vinod; Martin-Blanco, Enrique			Integrin-Dependent Activation of the JNK Signaling Pathway by Mechanical Stress	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; PROTEIN-KINASE; PHOSPHORYLATION NETWORKS; STRETCH; FLUORESCENCE; MATRIX; MAP; APOPTOSIS; TRANSDUCTION; EXPRESSION	Mechanical force is known to modulate the activity of the Jun N-terminal kinase (JNK) signaling cascade. However, the effect of mechanical stresses on JNK signaling activation has previously only been analyzed by in vitro detection methods. It still remains unknown how living cells activate the JNK signaling cascade in response to mechanical stress and what its functions are in stretched cells. We assessed in real-time the activity of the JNK pathway in Drosophila cells by Fluorescence Lifetime Imaging Microscopy (FLIM), using an intramolecular phosphorylation-dependent dJun-FRET (Fluorescence Resonance Energy Transfer) biosensor. We found that quantitative FRET-FLIM analysis and confocal microscopy revealed sustained dJun-FRET biosensor activation and stable morphology changes in response to mechanical stretch for Drosophila S2R+ cells. Further, these cells plated on different substrates showed distinct levels of JNK activity that associate with differences in cell morphology, integrin expression and focal adhesion organization. These data imply that alterations in the cytoskeleton and matrix attachments may act as regulators of JNK signaling, and that JNK activity might feed back to modulate the cytoskeleton and cell adhesion. We found that this dynamic system is highly plastic; at rest, integrins at focal adhesions and talin are key factors suppressing JNK activity, while multidirectional static stretch leads to integrin-dependent, and probably talin-independent, Jun sensor activation. Further, our data suggest that JNK activity has to coordinate with other signaling elements for the regulation of the cytoskeleton and cell shape remodeling associated with stretch.	[Pereira, Andrea Maria; Martin-Blanco, Enrique] CSIC, Inst Biol Mol Barcelona, Barcelona, Spain; [Tudor, Cicerone; Kanger, Johannes S.; Subramaniam, Vinod] Univ Twente, MESA Inst Nanotechnol, NL-7500 AE Enschede, Netherlands; [Tudor, Cicerone; Kanger, Johannes S.; Subramaniam, Vinod] Univ Twente, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); University of Twente; University of Twente	Pereira, AM (corresponding author), CSIC, Inst Biol Mol Barcelona, Parc Cient Barcelona, Barcelona, Spain.	v.subramaniam@utwente.nl; embbmc@ibmb.csic.es	Pereira, Andrea/AAL-2973-2020; Subramaniam, Vinod/B-4197-2010; Martin-Blanco, Enrique/ABH-1280-2020	Subramaniam, Vinod/0000-0001-6712-7266; Martin-Blanco, Enrique/0000-0002-6926-910X	Marie Curie Research Training Network IMMUNANOMAP [MRTNCT-2006-035946]; Spanish Ministry of Science (DGI and Consolider); European Union; Stichting voor Fundamenteel Onderzoek der Materie; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Spanish FPU	Marie Curie Research Training Network IMMUNANOMAP; Spanish Ministry of Science (DGI and Consolider); European Union(European Commission); Stichting voor Fundamenteel Onderzoek der Materie(FOM (The Netherlands)); Nederlandse Organisatie voor Wetenschappelijk Onderzoek(Netherlands Organization for Scientific Research (NWO)European Commission); Spanish FPU(Spanish Government)	AMP held a Spanish FPU PhD studentship and CT was supported by the Marie Curie Research Training Network IMMUNANOMAP (MRTNCT-2006-035946). Research in the EMB laboratory is funded by grants of the Spanish Ministry of Science (DGI and Consolider) and the European Union. Research in the VS laboratory is supported by "Stichting voor Fundamenteel Onderzoek der Materie'', the "Nederlandse Organisatie voor Wetenschappelijk Onderzoek'', and the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakal C, 2008, SCIENCE, V322, P453, DOI 10.1126/science.1158739; Baker EL, 2010, J BIOMECH, V43, P38, DOI 10.1016/j.jbiomech.2009.09.007; Borst JW, 2005, J FLUORESC, V15, P153, DOI 10.1007/s10895-005-2523-5; Bost F, 1999, MOL CELL BIOL, V19, P1938; Chen NY, 2001, CANCER RES, V61, P3908; Cohen TS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010385; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Elul T, 1997, DEV BIOL, V191, P243, DOI 10.1006/dbio.1997.8711; Fosbrink M, 2010, P NATL ACAD SCI USA, V107, P5459, DOI 10.1073/pnas.0909671107; Frangos J. A., 1993, PHYS FORCES MAMMALIA; Giannone G, 2003, J CELL BIOL, V163, P409, DOI 10.1083/jcb.200302001; Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011; Grecco HE, 2010, NAT METHODS, V7, P467, DOI [10.1038/NMETH.1458, 10.1038/nmeth.1458]; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Hsieh MH, 2005, INT REV CYTOL, V245, P45, DOI 10.1016/S0074-7696(05)45003-2; Ingber DE, 2002, CIRC RES, V91, P877, DOI 10.1161/01.RES.0000039537.73816.E5; Ingram AJ, 2000, KIDNEY INT, V58, P1431, DOI 10.1046/j.1523-1755.2000.00305.x; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; IRVINE KD, 1994, DEVELOPMENT, V120, P827; Katsumi A, 2005, J BIOL CHEM, V280, P16546, DOI 10.1074/jbc.C400455200; Kaunas R, 2006, CELL SIGNAL, V18, P1924, DOI 10.1016/j.cellsig.2006.02.008; Kaunas R, 2010, J THEOR BIOL, V264, P593, DOI 10.1016/j.jtbi.2010.02.020; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; Kippenberger S, 2000, J INVEST DERMATOL, V114, P408, DOI 10.1046/j.1523-1747.2000.00915.x; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Levitt JA, 2009, CURR OPIN BIOTECH, V20, P28, DOI 10.1016/j.copbio.2009.01.004; Li CH, 1999, J BIOL CHEM, V274, P25273, DOI 10.1074/jbc.274.36.25273; Li LF, 2003, AM J PHYSIOL-LUNG C, V285, pL464, DOI 10.1152/ajplung.00031.2003; Li S, 1997, J BIOL CHEM, V272, P30455, DOI 10.1074/jbc.272.48.30455; Milkiewicz M, 2007, J CELL BIOCHEM, V100, P750, DOI 10.1002/jcb.21055; Nguyen HT, 2000, AM J PHYSIOL-CELL PH, V279, pC1155, DOI 10.1152/ajpcell.2000.279.4.C1155; Oudin S, 2002, AM J RESP CELL MOL, V27, P107, DOI 10.1165/ajrcmb.27.1.4766; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Sawada Y, 2001, J CELL SCI, V114, P1221; Sawada Y, 2002, J CELL BIOL, V156, P609, DOI 10.1083/jcb.200110068; Schlachter S, 2009, OPT EXPRESS, V17, P1557, DOI 10.1364/OE.17.001557; Schreck I, 2011, BIOCHEM BIOPH RES CO, V407, P735, DOI 10.1016/j.bbrc.2011.03.092; Shimaoka M, 2003, NAT REV DRUG DISCOV, V2, P703, DOI 10.1038/nrd1174; Sotoudeh M, 2002, AM J PHYSIOL-HEART C, V282, pH1709, DOI 10.1152/ajpheart.00744.2001; Suzuma I, 2007, HYPERTENSION, V49, P347, DOI 10.1161/01.HYP.0000253535.26659.2f; Tan JL, 2009, APOPTOSIS, V14, P764, DOI 10.1007/s10495-009-0345-7; Tran-Thi TH, 2000, CHEM PHYS LETT, V329, P421, DOI 10.1016/S0009-2614(00)01037-X; Tremuth L, 2004, J BIOL CHEM, V279, P22258, DOI 10.1074/jbc.M400947200; Trepat X, 2004, AM J PHYSIOL-LUNG C, V287, pL1025, DOI 10.1152/ajplung.00077.2004; Wang BW, 2003, CARDIOVASC RES, V59, P460, DOI 10.1016/S0008-6363(03)00428-0; Wang YX, 2008, ANNU REV BIOMED ENG, V10, P1, DOI 10.1146/annurev.bioeng.010308.161731; Wessels JT, 2010, CYTOM PART A, V77A, P667, DOI 10.1002/cyto.a.20931; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Xia Y, 2004, TRENDS CELL BIOL, V14, P94, DOI 10.1016/j.tcb.2003.12.005; Yanagawa S, 1998, J BIOL CHEM, V273, P32353, DOI 10.1074/jbc.273.48.32353; Yu HM, 2011, TRENDS CELL BIOL, V21, P47, DOI 10.1016/j.tcb.2010.08.015	51	37	38	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e26182	10.1371/journal.pone.0026182	http://dx.doi.org/10.1371/journal.pone.0026182			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22180774	Green Published, gold			2022-12-25	WOS:000298367300001
J	Hammer, EC; Rillig, MC				Hammer, Edith C.; Rillig, Matthias C.			The Influence of Different Stresses on Glomalin Levels in an Arbuscular Mycorrhizal Fungus-Salinity Increases Glomalin Content	PLOS ONE			English	Article							GLOMUS-INTRARADICES; PROTEIN GLOMALIN; FOLSOMIA-CANDIDA; SOIL FUNGI; PLANTS; AVAILABILITY; PHOSPHORUS	Glomalin is a glycoprotein produced by arbuscular mycorrhizal (AM) fungi, and the soil fraction containing glomalin is correlated with soil aggregation. Thus, factors potentially influencing glomalin production could be of relevance for this ecosystem process and for understanding AM fungal physiology. Previous work indicated that glomalin production in AM fungi may be a stress response, or related to suboptimal mycelium growth. We show here that environmental stress can enhance glomalin production in the mycelium of the AM fungus Glomus intraradices. We applied NaCl and glycerol in different intensities to the medium in which the fungus was grown in vitro, causing salinity stress and osmotic stress, respectively. As a third stress type, we simulated grazing on the extraradical hyphae of the fungus by mechanically injuring the mycelium by clipping. NaCl caused a strong increase, while the clipping treatment led to a marginally significant increase in glomalin production. Even though salinity stress includes osmotic stress, we found substantially different responses in glomalin production due to the NaCl and the glycerol treatment, as glycerol addition did not cause any response. Thus, our results indicate that glomalin is involved in inducible stress responses in AM fungi for salinity, and possibly grazing stress.	[Hammer, Edith C.] Lund Univ, Dept Biol, Lund, Sweden; [Rillig, Matthias C.] Free Univ Berlin, Inst Biol, Berlin, Germany	Lund University; Free University of Berlin	Hammer, EC (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	Edith.Hammer@biol.lu.se	Rillig, Matthias C./AAE-6980-2019; Rillig, Matthias C./B-3675-2009; Hammer, Edith/K-4055-2014	Rillig, Matthias C./0000-0003-3541-7853; Rillig, Matthias C./0000-0003-3541-7853; Hammer, Edith/0000-0003-0892-2897	FORMAS [214-2007-994]	FORMAS(Swedish Research Council Formas)	Co-funding for ECH's salary was provided by FORMAS grant number 214-2007-994. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no other external funding sources for this study.	Adame MF, 2010, ESTUAR COAST SHELF S, V86, P21, DOI 10.1016/j.ecss.2009.10.013; BECARD G, 1991, NEW PHYTOL, V118, P547, DOI 10.1111/j.1469-8137.1991.tb00994.x; BECARD G, 1988, NEW PHYTOL, V108, P211, DOI 10.1111/j.1469-8137.1988.tb03698.x; Bollmann J, 2010, PEDOBIOLOGIA, V53, P107, DOI 10.1016/j.pedobi.2009.06.003; Bois G, 2006, MYCORRHIZA, V16, P99, DOI 10.1007/s00572-005-0020-y; Bolliger A, 2008, SOIL BIOL BIOCHEM, V40, P887, DOI 10.1016/j.soilbio.2007.10.019; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DONER LW, 1991, BIOTECHNOL TECH, V5, P25, DOI 10.1007/BF00152749; Driver JD, 2005, SOIL BIOL BIOCHEM, V37, P101, DOI 10.1016/j.soilbio.2004.06.011; Gadkar V, 2006, FEMS MICROBIOL LETT, V263, P93, DOI 10.1111/j.1574-6968.2006.00412.x; Hammer EC, 2011, FEMS MICROBIOL ECOL, V76, P236, DOI 10.1111/j.1574-6941.2011.01043.x; Hammer EC, 2011, MYCORRHIZA, V21, P117, DOI 10.1007/s00572-010-0316-4; Jahromi F, 2008, MICROB ECOL, V55, P45, DOI 10.1007/s00248-007-9249-7; Johnson D, 2005, SCIENCE, V309, P1047, DOI 10.1126/science.1114769; Klironomos JN, 1996, BIOL FERT SOILS, V21, P43, DOI 10.1007/BF00335992; Klironomos JN, 1999, FUNCT ECOL, V13, P756, DOI 10.1046/j.1365-2435.1999.00379.x; Larsen J, 2008, SOIL BIOL BIOCHEM, V40, P360, DOI 10.1016/j.soilbio.2007.08.016; Lovelock CE, 2004, J ECOL, V92, P278, DOI 10.1111/j.0022-0477.2004.00855.x; Maathuis FJM, 1999, ANN BOT-LONDON, V84, P123, DOI 10.1006/anbo.1999.0912; Olsson PA, 2008, APPL ENVIRON MICROB, V74, P4144, DOI 10.1128/AEM.00376-08; Pfeffer PE, 1999, PLANT PHYSIOL, V120, P587, DOI 10.1104/pp.120.2.587; Porcel R, 2006, PLANT MOL BIOL, V60, P389, DOI 10.1007/s11103-005-4210-y; Purin S, 2008, SOIL BIOL BIOCHEM, V40, P1000, DOI 10.1016/j.soilbio.2007.11.010; Purin S, 2007, PEDOBIOLOGIA, V51, P123, DOI 10.1016/j.pedobi.2007.03.002; RAVEN JA, 1985, NEW PHYTOL, V101, P25, DOI 10.1111/j.1469-8137.1985.tb02816.x; Rillig MC, 2002, SOIL BIOL BIOCHEM, V34, P1371, DOI 10.1016/S0038-0717(02)00060-3; Rillig MC, 2004, CAN J SOIL SCI, V84, P355, DOI 10.4141/S04-003; Roda JJ, 2008, ARID LAND RES MANAG, V22, P310, DOI 10.1080/15324980802388199; Schindler FV, 2007, SOIL BIOL BIOCHEM, V39, P320, DOI 10.1016/j.soilbio.2006.08.017; SCHLESINGER MJ, 1990, J BIOL CHEM, V265, P12111; Stockinger H, 2009, NEW PHYTOL, V183, P1176, DOI 10.1111/j.1469-8137.2009.02874.x; Treseder KK, 2007, SOIL SCI SOC AM J, V71, P1257, DOI 10.2136/sssaj2006.0377; Wright SF, 1996, SOIL SCI, V161, P575, DOI 10.1097/00010694-199609000-00003	33	58	64	8	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28426	10.1371/journal.pone.0028426	http://dx.doi.org/10.1371/journal.pone.0028426			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174803	gold, Green Submitted, Green Published			2022-12-25	WOS:000298366600016
J	Gilboa-Geffen, A; Wolf, Y; Hanin, G; Melamed-Book, N; Pick, M; Bennett, ER; Greenberg, DS; Lester, S; Rischmueller, M; Soreq, H				Gilboa-Geffen, Adi; Wolf, Yochai; Hanin, Geula; Melamed-Book, Naomi; Pick, Marjorie; Bennett, Estelle R.; Greenberg, David S.; Lester, Susan; Rischmueller, Maureen; Soreq, Hermona			Activation of the Alternative NFkB Pathway Improves Disease Symptoms in a Model of Sjogren's Syndrome	PLOS ONE			English	Article							KAPPA-B ACTIVATION; REGULATORY T-CELLS; AUTOIMMUNE-DISEASES; MYASTHENIA-GRAVIS; SALIVARY-GLANDS; ACINAR-CELLS; KINASE-ALPHA; ACETYLCHOLINESTERASE; TOLL-LIKE-RECEPTOR-9; INTERFERON	The purpose of our study was to understand if Toll-like receptor 9 (TLR9) activation could contribute to the control of inflammation in Sjogren's syndrome. To this end, we manipulated TLR9 signaling in non-obese diabetic (NOD) and TLR9(-/-) mice using agonistic CpG oligonucleotide aptamers, TLR9 inhibitors, and the in-house oligonucleotide BL-7040. We then measured salivation, inflammatory response markers, and expression of proteins downstream to NF-kappa B activation pathways. Finally, we labeled proteins of interest in salivary gland biopsies from Sjogren's syndrome patients, compared to Sicca syndrome controls. We show that in NOD mice BL-7040 activates TLR9 to induce an alternative NF-kappa B activation mode resulting in increased salivation, elevated anti-inflammatory response in salivary glands, and reduced peripheral AChE activity. These effects were more prominent and also suppressible by TLR9 inhibitors in NOD mice, but TLR9(-/-) mice were resistant to the salivation-promoting effects of CpG oligonucleotides and BL-7040. Last, salivary glands from Sjogren's disease patients showed increased inflammatory and decreased anti-inflammatory biomarkers, in addition to decreased levels of alternative NF-kB pathway proteins. In summary, we have demonstrated that activation of TLR9 by BL-7040 leads to non-canonical activation of NF-kB, promoting salivary functioning and down-regulating inflammation. We propose that BL-7040 could be beneficial in treating Sjogren's syndrome and may be applicable to additional autoimmune syndromes.	[Gilboa-Geffen, Adi; Wolf, Yochai; Hanin, Geula; Melamed-Book, Naomi; Pick, Marjorie; Bennett, Estelle R.; Greenberg, David S.; Soreq, Hermona] Hebrew Univ Jerusalem, Dept Biol Chem, Jerusalem, Israel; [Lester, Susan; Rischmueller, Maureen] Queen Elizabeth Hosp, Rheumatol Unit, Woodville, SA 5011, Australia; [Soreq, Hermona] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Gilboa-Geffen, A (corresponding author), Hebrew Univ Jerusalem, Dept Biol Chem, Jerusalem, Israel.	soreq@cc.huji.ac.il	Hanin, Geula/K-8973-2019; Bennett, Estelle R/A-5067-2017; gilboa-geffen, adi/E-3028-2013	gilboa-geffen, adi/0000-0001-9549-4194; Soreq, Hermona/0000-0002-0955-526X; Wolf, Yochai/0000-0003-0270-2025; Greenberg, David/0000-0001-8959-8640; Hanin, Geula/0000-0002-3198-7990	Israel Science Foundation [ISF1876/08]; European Community [LSHG-CT-2006-037277]; National Eshkol PhD fellowship	Israel Science Foundation(Israel Science Foundation); European Community(European Commission); National Eshkol PhD fellowship	This study was supported by grants from the Israel Science Foundation (ISF1876/08) and The European Community (Grant LSHG-CT-2006-037277) (to HS). AGG was an incumbent of a National Eshkol PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Argov Z, 2007, NEUROLOGY, V69, P699, DOI 10.1212/01.wnl.0000267884.39468.7a; Azuma M, 1997, LAB INVEST, V77, P269; Beinke S, 2004, BIOCHEM J, V382, P393, DOI 10.1042/BJ20040544; Ben-Zvi I, 2011, CLIN REV ALLERGY IMM; BENASSAYAG E, 2010, MOL MED IN PRESS; Berson A, 2008, BRAIN, V131, P109, DOI 10.1093/brain/awm276; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Dawson LJ, 2006, ARTHRITIS RHEUM, V54, P1165, DOI 10.1002/art.21764; Dawson LJ, 2005, RHEUMATOLOGY, V44, P449, DOI 10.1093/rheumatology/keh506; Dawson LJ, 2001, CLIN EXP IMMUNOL, V124, P480, DOI 10.1046/j.1365-2249.2001.01526.x; Dejardin E, 2006, BIOCHEM PHARMACOL, V72, P1161, DOI 10.1016/j.bcp.2006.08.007; Ehlers M, 2007, TRENDS IMMUNOL, V28, P74, DOI 10.1016/j.it.2006.12.006; Evron T, 2005, NEURODEGENER DIS, V2, P16, DOI 10.1159/000086427; Fallarino F, 2006, TRANSPL IMMUNOL, V17, P58, DOI 10.1016/j.trim.2006.09.017; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Fallarino F, 2009, J IMMUNOL, V183, P6303, DOI 10.4049/jimmunol.0901577; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; GARRETT JR, 1993, MICROSC RES TECHNIQ, V26, P75, DOI 10.1002/jemt.1070260108; Gilboa-Geffen A, 2007, BLOOD, V109, P4383, DOI 10.1182/blood-2006-07-033373; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; HOOKS JJ, 1979, NEW ENGL J MED, V301, P5, DOI 10.1056/NEJM197907053010102; Hoshino K, 2006, NATURE, V440, P949, DOI 10.1038/nature04641; Kawashima K, 2003, LIFE SCI, V74, P675, DOI 10.1016/j.lfs.2003.09.037; Kinoshita D, 2006, J IMMUNOL, V176, P3995, DOI 10.4049/jimmunol.176.7.3995; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Lenert P, 2005, CLIN EXP IMMUNOL, V140, P1, DOI 10.1111/j.1365-2249.2004.02728.x; Lu LF, 2005, J IMMUNOL, V175, P1651, DOI 10.4049/jimmunol.175.3.1651; Nordmark G, 2006, NAT CLIN PRACT RHEUM, V2, P262, DOI 10.1038/ncprheum0173; Puccetti P, 2007, NAT REV IMMUNOL, V7, P817, DOI 10.1038/nri2163; Ramos-Casals M, 2005, RHEUMATOLOGY, V44, P1354, DOI 10.1093/rheumatology/keh714; Routsias JG, 2010, EUR J CLIN INVEST, V40, P1026, DOI 10.1111/j.1365-2362.2010.02342.x; Shaked I, 2009, IMMUNITY, V31, P965, DOI 10.1016/j.immuni.2009.09.019; Sklan EH, 2004, P NATL ACAD SCI USA, V101, P5512, DOI 10.1073/pnas.0307659101; Soreq H, 2001, NAT REV NEUROSCI, V2, P294, DOI 10.1038/35067589; Soreq L, 2008, J NEUROIMMUNOL, V201, P227, DOI 10.1016/j.jneuroim.2008.06.019; Soyfool MS, 2007, ORAL DIS, V13, P366, DOI 10.1111/j.1601-0825.2007.01376.x; Sun Siquan, 2007, Inflammation & Allergy Drug Targets, V6, P223; Tang QZ, 2006, IMMUNOL REV, V212, P217, DOI 10.1111/j.0105-2896.2006.00421.x; Tang QZ, 2006, NAT IMMUNOL, V7, P551, DOI 10.1038/ni0606-551; Tishler M, 1999, ANN RHEUM DIS, V58, P253, DOI 10.1136/ard.58.4.253; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Waterman SA, 2000, ARTHRITIS RHEUM, V43, P1647; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973	48	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28727	10.1371/journal.pone.0028727	http://dx.doi.org/10.1371/journal.pone.0028727			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174879	gold, Green Submitted, Green Published			2022-12-25	WOS:000298365700067
J	Mraja, A; Unsicker, SB; Reichelt, M; Gershenzon, J; Roscher, C				Mraja, Anne; Unsicker, Sybille B.; Reichelt, Michael; Gershenzon, Jonathan; Roscher, Christiane			Plant Community Diversity Influences Allocation to Direct Chemical Defence in Plantago lanceolata	PLOS ONE			English	Article							EXPERIMENTAL GRASSLAND COMMUNITIES; CARBON NUTRIENT BALANCE; IRIDOID GLYCOSIDES; SPECIES RICHNESS; INVERTEBRATE HERBIVORY; BIODIVERSITY; COSTS; GENOTYPE; ALLELOCHEMICALS; PLANTAGINACEAE	Background: Forecasting the consequences of accelerating rates of changes in biodiversity for ecosystem functioning requires a mechanistic understanding of the relationships between the structure of biological communities and variation in plant functional characteristics. So far, experimental data of how plant species diversity influences the investment of individual plants in direct chemical defences against herbivores and pathogens is lacking. Methodology/Principal Findings: We used Plantago lanceolata as a model species in experimental grasslands differing in species richness and composition (Jena Experiment) to investigate foliar concentrations of the iridoid glycosides (IG), catalpol and its biosynthetic precursor aucubin. Total IG and aucubin concentrations decreased, while catalpol concentrations increased with increasing plant diversity in terms of species or functional group richness. Negative plant diversity effects on total IG and aucubin concentrations correlated with increasing specific leaf area of P. lanceolata, suggesting that greater allocation to light acquisition reduced the investment into these carbon-based defence components. In contrast, increasing leaf nitrogen concentrations best explained increasing concentrations of the biosynthetically more advanced IG, catalpol. Observed levels of leaf damage explained a significant proportion of variation in total IG and aucubin concentrations, but did not account for variance in catalpol concentrations. Conclusions/Significance: Our results clearly show that plants growing in communities of varying species richness and composition differ in their defensive chemistry, which may modulate plant susceptibility to enemy attack and consequently their interactions with higher trophic level organisms.	[Mraja, Anne; Unsicker, Sybille B.; Reichelt, Michael; Gershenzon, Jonathan] Max Planck Inst Chem Ecol, Jena, Germany; [Mraja, Anne; Roscher, Christiane] Max Planck Inst Biogeochem, Jena, Germany	Max Planck Society; Max Planck Society	Mraja, A (corresponding author), Max Planck Inst Chem Ecol, Jena, Germany.	sunsicker@ice.mpg.de	Gershenzon, Jonathan/K-1331-2013; Unsicker, Sybille B./AAW-6968-2021	Gershenzon, Jonathan/0000-0002-1812-1551; Unsicker, Sybille B./0000-0002-9738-0075	Max-Planck Society; German Science Foundation [FOR 456]; University of Jena	Max-Planck Society(Max Planck SocietyFoundation CELLEX); German Science Foundation(German Research Foundation (DFG)); University of Jena	This study was funded by the Max-Planck Society, the German Science Foundation (FOR 456) with additional support from the University of Jena and coordinated by W. W. Weisser. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; ANDOW DA, 1991, ANNU REV ENTOMOL, V36, P561, DOI 10.1146/annurev.en.36.010191.003021; Barton KE, 2007, AM J BOT, V94, P56, DOI 10.3732/ajb.94.1.56; Barton KE, 2006, OECOLOGIA, V150, P442, DOI 10.1007/s00442-006-0531-z; Biere A, 2004, OECOLOGIA, V140, P430, DOI 10.1007/s00442-004-1603-6; BLOOM AJ, 1985, ANNU REV ECOL SYST, V16, P363, DOI 10.1146/annurev.es.16.110185.002051; BOWERS MD, 1992, OECOLOGIA, V91, P201, DOI 10.1007/BF00317784; BOWERS MD, 1993, ECOLOGY, V74, P1778, DOI 10.2307/1939936; BOWERS MD, 1992, J CHEM ECOL, V18, P985, DOI 10.1007/BF00980057; BRYANT JP, 1983, OIKOS, V40, P357, DOI 10.2307/3544308; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cipollini DF, 2001, J CHEM ECOL, V27, P593, DOI 10.1023/A:1010384805014; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Damtoft S., 1983, BIOCHEM SOC T, V11, P594; Darrow K, 1999, J CHEM ECOL, V25, P1427, DOI 10.1023/A:1020991229072; Ellenberg H., 1988, Vegetation ecology of Central Europe.; Evans JR, 2001, PLANT CELL ENVIRON, V24, P755, DOI 10.1046/j.1365-3040.2001.00724.x; FAJER ED, 1992, AM NAT, V140, P707, DOI 10.1086/285436; GERSHENZON J, 1994, J CHEM ECOL, V20, P1281, DOI 10.1007/BF02059810; Gubsch M, 2011, PLANT CELL ENVIRON, V34, P895, DOI 10.1111/j.1365-3040.2011.02287.x; Harvey JA, 2005, J CHEM ECOL, V31, P287, DOI 10.1007/s10886-005-1341-1; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hector A, 2002, ECOL LETT, V5, P502, DOI 10.1046/j.1461-0248.2002.00337.x; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; HilleRisLambers J, 2004, ECOL LETT, V7, P661, DOI 10.1111/j.1461-0248.2004.00623.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Jarzomski CM, 2000, OIKOS, V88, P371, DOI 10.1034/j.1600-0706.2000.880216.x; Kluge G, 2000, BER DTSCH WETTERDIEN, V213, P1; Lipowsky A, 2011, BASIC APPL ECOL, V12, P360, DOI 10.1016/j.baae.2011.03.005; Lorentzen S, 2008, PERSPECT PLANT ECOL, V10, P73, DOI 10.1016/j.ppees.2007.12.001; Marak HB, 2003, EVOLUTION, V57, P2519, DOI 10.1111/j.0014-3820.2003.tb01496.x; Marak HB, 2002, J CHEM ECOL, V28, P2429, DOI 10.1023/A:1021475800765; Marak HB, 2000, J EVOLUTION BIOL, V13, P985, DOI 10.1046/j.1420-9101.2000.00233.x; McCall AC, 2010, J ECOL, V98, P985, DOI 10.1111/j.1365-2745.2010.01693.x; MCKEY D, 1974, AM NAT, V108, P305, DOI 10.1086/282909; Mwangi PN, 2007, J ECOL, V95, P65, DOI 10.1111/j.1365-2745.2006.01189.x; Oelmann Y, 2007, SOIL SCI SOC AM J, V71, P720, DOI 10.2136/sssaj2006.0205; Poorter H, 2006, J EXP BOT, V57, P355, DOI 10.1093/jxb/erj002; Roscher C, 2005, ECOL LETT, V8, P419, DOI 10.1111/j.1461-0248.2005.00736.x; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Roscher C, 2011, PLANT BIOLOGY, V13, P134, DOI 10.1111/j.1438-8677.2010.00338.x; Roscher C, 2007, OECOLOGIA, V154, P535, DOI 10.1007/s00442-007-0846-4; SAGAR GR, 1964, J ECOL, V52, P189, DOI 10.2307/2257792; Scherber C, 2006, OECOLOGIA, V147, P489, DOI 10.1007/s00442-005-0281-3; Scherber C, 2006, J ECOL, V94, P922, DOI 10.1111/j.1365-2745.2006.01144.x; SCHLICHTING CD, 1986, ANNU REV ECOL SYST, V17, P667, DOI 10.1146/annurev.es.17.110186.003315; Shipley B., 2000, CAUSE CORRELATIONS B; Spehn EM, 2000, FUNCT ECOL, V14, P326, DOI 10.1046/j.1365-2435.2000.00437.x; Stamp N, 2003, Q REV BIOL, V78, P23, DOI 10.1086/367580; Strauss SY, 2002, TRENDS ECOL EVOL, V17, P278, DOI 10.1016/S0169-5347(02)02483-7; Temperton VM, 2007, OECOLOGIA, V151, P190, DOI 10.1007/s00442-006-0576-z; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Unsicker SB, 2006, OECOLOGIA, V150, P233, DOI 10.1007/s00442-006-0511-3; Valladares F, 2008, ANNU REV ECOL EVOL S, V39, P237, DOI 10.1146/annurev.ecolsys.39.110707.173506; VANTIENDEREN PH, 1991, J ECOL, V79, P27, DOI 10.2307/2260782; Weiner J, 2004, PERSPECT PLANT ECOL, V6, P207, DOI 10.1078/1433-8319-00083; Zangerl AR, 2002, P NATL ACAD SCI USA, V99, P1088, DOI 10.1073/pnas.022647099	57	38	38	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28055	10.1371/journal.pone.0028055	http://dx.doi.org/10.1371/journal.pone.0028055			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174766	Green Published, Green Submitted, gold			2022-12-25	WOS:000298365700016
J	Dreyer, AP; Shingleton, AW				Dreyer, Austin P.; Shingleton, Alexander W.			The Effect of Genetic and Environmental Variation on Genital Size in Male Drosophila: Canalized but Developmentally Unstable	PLOS ONE			English	Article							STATIC ALLOMETRY; FLUCTUATING ASYMMETRY; SEXUAL SELECTION; BODY-SIZE; EVOLUTION; VARIABILITY; VARIANCE; HYPOTHESES; COLEOPTERA; CHARACTER	The genitalia of most male arthropods scale hypoallometrically with body size, that is they are more or less the same size across large and small individuals in a population. Such scaling is expected to arise when genital traits show less variation than somatic traits in response to factors that generate size variation among individuals in a population. Nevertheless, there have been few studies directly examining the relative sensitivity of genital and somatic traits to factors that affect their size. Such studies are key to understanding genital evolution and the evolution of morphological scaling relationships more generally. Previous studies indicate that the size of genital traits in male Drosophila melanogaster show a relatively low response to variation in environmental factors that affect trait size. Here we show that the size of genital traits in male fruit flies also exhibit a relatively low response to variation in genetic factors that affect trait size. Importantly, however, this low response is only to genetic factors that affect body and organ size systemically, not those that affect organ size autonomously. Further, we show that the genital traits do not show low levels of developmental instability, which is the response to stochastic developmental errors that also influence organ size autonomously. We discuss these results in the context of current hypotheses on the proximate and ultimate mechanisms that generate genital hypoallometry.	[Dreyer, Austin P.; Shingleton, Alexander W.] Michigan State Univ, Dept Zool, Ecol Evolutionary Biol & Behav Program, E Lansing, MI 48824 USA	Michigan State University	Dreyer, AP (corresponding author), Michigan State Univ, Dept Zool, Ecol Evolutionary Biol & Behav Program, E Lansing, MI 48824 USA.	dreyerau@msu.edu		Shingleton, Alexander/0000-0001-9862-9947	National Science Foundation [IOS-0845847, IOS-0919855]; Michigan State University; College of Natural Science ( Michigan State University)	National Science Foundation(National Science Foundation (NSF)); Michigan State University; College of Natural Science ( Michigan State University)	This research was supported by National Science Foundation grants IOS-0845847 and IOS-0919855, and fellowship support from the Ecology, Evolution Biology and Behavior program (Michigan State University) and the College of Natural Science (Michigan State University) to APD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnqvist G, 1997, BIOL J LINN SOC, V60, P365; Bernstein S, 2002, EVOLUTION, V56, P1707, DOI 10.1111/j.0014-3820.2002.tb01483.x; Bertin A, 2007, EVOLUTION, V61, P825, DOI 10.1111/j.1558-5646.2007.00074.x; Bonduriansky R, 2003, EVOLUTION, V57, P2450, DOI 10.1111/j.0014-3820.2003.tb01490.x; BULMER MG, 1976, GENET RES, V28, P101, DOI 10.1017/S0016672300016797; COOK RM, 1977, BEHAV GENET, V7, P349, DOI 10.1007/BF01077448; CRNOKRAK P, 1995, HEREDITY, V75, P530, DOI 10.1038/hdy.1995.169; Debat V, 2001, TRENDS ECOLOGY EVOLU; Dufour L, 1936, ANN SCI NATURELLE, V1, P244; Eberhard W, 2009, J EVOLUTION BIOL, V22, P435, DOI 10.1111/j.1420-9101.2008.01654.x; Eberhard WG, 1998, EVOLUTION, V52, P415, DOI 10.1111/j.1558-5646.1998.tb01642.x; Eberhard WG, 1999, EVOLUTION, V53, P1624, DOI 10.1111/j.1558-5646.1999.tb05428.x; Eberhard WG, 1985, SEXUAL SELECTION ANI; Eberhard WG, 2009, EVOLUTION, V63, P48, DOI 10.1111/j.1558-5646.2008.00528.x; Eshel I, 1998, GENETICS, V149, P2119; Falconer D. S, 1996, INTRO QUANTITAVE GEN; Funke S, 2005, J ARACHNOL, V33, P870, DOI 10.1636/S04-16.1; GAVRILETS S, 1994, EVOLUTION, V48, P1478, DOI [10.2307/2410242, 10.1111/j.1558-5646.1994.tb02190.x]; Gibson G, 2000, BIOESSAYS, V22, P372, DOI 10.1002/(SICI)1521-1878(200004)22:4<372::AID-BIES7>3.0.CO;2-J; Green AJ, 1999, EVOLUTION, V53, P1621, DOI [10.2307/2640909, 10.1111/j.1558-5646.1999.tb05427.x]; Hosken DJ, 2005, EVOL ECOL, V19, P501, DOI 10.1007/s10682-005-1023-z; Hosken DJ, 2004, TRENDS ECOL EVOL, V19, P87, DOI 10.1016/j.tree.2003.11.012; Huber BA, 2003, ORG DIVERS EVOL, V3, P63, DOI 10.1078/1439-6092-00059; Huxley J. S., 1936, Nature London, V137, P780, DOI 10.1038/137780b0; KAUFMAN PK, 1977, GENETICS, V87, P327; Kawano K, 2006, ANN ENTOMOL SOC AM, V99, P327, DOI 10.1603/0013-8746(2006)099[0327:SDATMO]2.0.CO;2; Merila J, 1999, HEREDITY, V83, P103, DOI 10.1038/sj.hdy.6885850; Ng CS, 2008, BEHAV GENET, V38, P195, DOI 10.1007/s10519-008-9190-7; Nijhout H, 2003, DEV BIOL, V261, P1, DOI 10.1016/S0012-1606(03)00276-8; Oosthuizen WH, 2000, MAR MAMMAL SCI, V16, P124, DOI 10.1111/j.1748-7692.2000.tb00908.x; Palestrini C, 2000, CAN J ZOOL, V78, P1199, DOI 10.1139/cjz-78-7-1199; Palmer A. Richard, 2003, P279; PALMER AR, 1986, ANNU REV ECOL SYST, V17, P391, DOI 10.1146/annurev.es.17.110186.002135; PARSONS PA, 1990, BIOL REV, V65, P131, DOI 10.1111/j.1469-185X.1990.tb01186.x; PATTERSON BD, 1982, J MAMMAL, V63, P1, DOI 10.2307/1380665; R Development Core Team, 2009, R FDN STAT COMP; SCHARLOO W, 1967, GENETICS, V56, P709; Shingleton AW, 2007, BIOESSAYS, V29, P536, DOI 10.1002/bies.20584; Shingleton AW, 2009, P ROY SOC B-BIOL SCI, V276, P2625, DOI 10.1098/rspb.2008.1796; Shingleton AW, 2005, PLOS BIOL, V3, P1607, DOI 10.1371/journal.pbio.0030289; Siegal ML, 2002, P NATL ACAD SCI USA, V99, P10528, DOI 10.1073/pnas.102303999; STEARNS SC, 1995, J EVOLUTION BIOL, V8, P539, DOI 10.1046/j.1420-9101.1995.8050539.x; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Tatsuta H, 2007, BIOL J LINN SOC, V90, P573, DOI 10.1111/j.1095-8312.2007.00744.x; Uhl G, 2000, J ZOOL, V251, P7, DOI 10.1111/j.1469-7998.2000.tb00587.x; VANVALEN L, 1962, EVOLUTION, V16, P125; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Waddington CH, 1961, GENETIC ASSIMILATION; Wright S, 1952, QUANITITATIVE INHERI	49	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28278	10.1371/journal.pone.0028278	http://dx.doi.org/10.1371/journal.pone.0028278			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174784	Green Published, gold, Green Submitted			2022-12-25	WOS:000298163600016
J	Taylor, WR; Sadowski, MI				Taylor, William R.; Sadowski, Michael I.			Structural Constraints on the Covariance Matrix Derived from Multiple Aligned Protein Sequences	PLOS ONE			English	Article							FOLD; IDENTIFICATION; RESIDUES	Residue contact predictions were calculated based on the mutual information observed between pairs of positions in large multiple protein sequence alignments. Where previously only the statistical properties of these data have been considered important, we introduce new measures to impose constraints that make the contact map more consistent with a three dimensional structure. These included global (bulk) properties and local secondary structure properties. The latter allowed the contact constraints to be employed at the level of filtering pairs of secondary structure contacts which led to a more efficient (lower-level) implementation in the PLATO structure prediction server. Where previously the measure of success with this method had been whether the correct fold was predicted in the top 10 ranked models, with the current implementation, our summary statistic is the number of correct folds included in the top 10 models - which is on average over 50 percent.	[Taylor, William R.; Sadowski, Michael I.] Natl Inst Med Res, MRC, Div Math Biol, London NW7 1AA, England	MRC National Institute for Medical Research	Taylor, WR (corresponding author), Natl Inst Med Res, MRC, Div Math Biol, London NW7 1AA, England.	wtaylor@nimr.mrc.ac.uk	Sadowski, Michael/F-4475-2010	Sadowski, Michael/0000-0002-4546-2159	Medical Research Council UK [U117581331]	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Medical Research Council UK, Project code: U117581331. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASZODI A, 1995, J MATH CHEM, V17, P167, DOI 10.1007/BF01164846; ASZODI A, 1994, BIOPOLYMERS, V34, P489, DOI 10.1002/bip.360340406; Bartlett GJ, 2008, PROTEINS, V71, P950, DOI 10.1002/prot.21779; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Burger L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000633; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Hollup SM, 2011, COMPUT BIOL CHEM, V35, P174, DOI 10.1016/j.compbiolchem.2011.04.008; Lapedes A.S., 1999, STAT MOL BIOL, V33, P236; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; Pollock DD, 1997, PROTEIN ENG, V10, P647, DOI 10.1093/protein/10.6.647; Pollock DD, 1999, J MOL BIOL, V287, P187, DOI 10.1006/jmbi.1998.2601; Sadowski MI, 2011, COMPUT BIOL CHEM, V35, P323, DOI 10.1016/j.compbiolchem.2011.08.002; Taylor W, 1983, J MOL GRAPHICS, V1, P30; Taylor WR, 2008, PROTEINS, V70, P1610, DOI 10.1002/prot.21913; Taylor WR, 2009, STRUCTURE, V17, P1244, DOI 10.1016/j.str.2009.07.012; Taylor WR, 2002, MOL CELL PROTEOMICS, V1, P334, DOI 10.1074/mcp.T200001-MCP200; Taylor WR, 2002, NATURE, V416, P657, DOI 10.1038/416657a; Taylor WR, 2001, J MOL BIOL, V310, P1135, DOI 10.1006/jmbi.2001.4817; TAYLOR WR, 1994, PROTEINS, V18, P281, DOI 10.1002/prot.340180309; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106	22	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28265	10.1371/journal.pone.0028265	http://dx.doi.org/10.1371/journal.pone.0028265			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22194819	gold, Green Submitted, Green Published			2022-12-25	WOS:000298172800020
J	Campbell, M; Chang, PC; Huerta, S; Izumiya, C; Davis, R; Tepper, CG; Kim, KY; Shevchenko, B; Wang, DH; Jung, JU; Luciw, PA; Kung, HJ; Izumiya, Y				Campbell, Mel; Chang, Pei-Ching; Huerta, Steve; Izumiya, Chie; Davis, Ryan; Tepper, Clifford G.; Kim, Kevin Y.; Shevchenko, Bogdan; Wang, Don-Hong; Jung, Jae U.; Luciw, Paul A.; Kung, Hsing-Jien; Izumiya, Yoshihiro			Protein Arginine Methyltransferase 1-directed Methylation of Kaposi Sarcoma-associated Herpesvirus Latency-associated Nuclear Antigen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; K-BZIP; CHROMOSOME BINDING; SIGNALING PATHWAY; DNA-REPLICATION; VIRAL GENE; J-KAPPA; LANA; TRANSCRIPTION; KINASE	The Kaposi sarcoma-associated herpesvirus (KSHV) latency-associated nuclear antigen (LANA) is a multifunctional protein with roles in gene regulation and maintenance of viral latency. Post-translational modification of LANA is important for functional diversification. Here, we report that LANA is subject to arginine methylation by protein arginine methyltransferase 1 in vitro and in vivo. The major arginine methylation site in LANA was mapped to arginine 20. This site was mutated to either phenylalanine (bulky hydrophobic, constitutive methylated mimetic) or lysine (positively charged, non-arginine methylatable) residues. The significance of the methylation in LANA function was examined in both the isolated form and in the context of the viral genome through the generation of recombinant KSHV. In addition, authentic LANA binding sites on the KSHV episome in naturally infected cells were identified using a whole genome KSHV tiling array. Although mutation of the methylation site resulted in no significant difference in KSHV LANA subcellular localization, we found that the methylation mimetic mutation resulted in augmented histone binding in vitro and increased LANA occupancy at identified LANA target promoters in vivo. Moreover, a cell line carrying the methylation mimetic mutant KSHV showed reduced viral gene expression relative to controls both in latency and in the course of reactivation. These results suggest that residue 20 is important for modulation of a subset of LANA functions and properties of this residue, including the hydrophobic character induced by arginine methylation, may contribute to the observed effects.	[Izumiya, Yoshihiro] Univ Calif Davis, Dept Dermatol, Ctr Canc, Sacramento, CA 95817 USA; [Chang, Pei-Ching; Davis, Ryan; Tepper, Clifford G.; Kung, Hsing-Jien] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Luciw, Paul A.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Jung, Jae U.] Univ So Calif, Dept Mol Med, Keck Sch Med, Los Angeles, CA 90033 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of Southern California	Izumiya, Y (corresponding author), Univ Calif Davis, Dept Dermatol, Ctr Canc, Res 3 Rm 2400,4645 2nd Ave, Sacramento, CA 95817 USA.	yizumiya@ucdavis.edu	Tepper, Clifford G/H-6527-2011; Kung, Hsing-Jien/C-7651-2013	Davis, Ryan/0000-0001-7439-6683; Izumiya, Yoshihiro/0000-0002-9184-2603	National Institutes of Health [R01-CA147791, P01-DE19085]; University of California Davis Cancer Center [P30 CA93373]; NATIONAL CANCER INSTITUTE [R01CA147791, P30CA093373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [P01DE019085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Davis Cancer Center(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-CA147791 (to Y. I.) and P01-DE19085 (to H.-J. K., J. U. J., and Y. I.). Additional funding was provided by University of California Davis Cancer Center Support Grant P30 CA93373.	An FQ, 2005, J BIOL CHEM, V280, P3862, DOI 10.1074/jbc.M407435200; Arad U, 1998, BIOTECHNIQUES, V24, P760, DOI 10.2144/98245bm14; Barbera AJ, 2006, SCIENCE, V311, P856, DOI 10.1126/science.1120541; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Boisvert FM, 2003, MOL CELL PROTEOMICS, V2, P1319, DOI 10.1074/mcp.M300088-MCP200; Buchholz F, 1998, NAT BIOTECHNOL, V16, P657, DOI 10.1038/nbt0798-657; Cesarman E, 1999, SEMIN CANCER BIOL, V9, P165, DOI 10.1006/scbi.1998.0118; Chang PC, 2011, J VIROL, V85, P3283, DOI 10.1128/JVI.02485-10; Chang PC, 2009, CANCER RES, V69, P5681, DOI 10.1158/0008-5472.CAN-08-4570; Cheng F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000324; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Fischle W, 2003, NATURE, V425, P475, DOI 10.1038/nature02017; Friborg J, 1999, NATURE, V402, P889, DOI 10.1038/47266; Ganem D, 2010, J CLIN INVEST, V120, P939, DOI 10.1172/JCI40567; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Gross H, 2010, VIROLOGY, V397, P299, DOI 10.1016/j.virol.2009.11.023; Grundhoff A, 2003, J VIROL, V77, P2779, DOI 10.1128/JVI.77.4.2779-2783.2003; Gunther T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000935; Hamza MS, 2004, J BIOL CHEM, V279, P38325, DOI 10.1074/jbc.M400964200; Han SJ, 2010, J GEN VIROL, V91, P2203, DOI 10.1099/vir.0.020958-0; HERNDIER BG, 1994, AIDS, V8, P575, DOI 10.1097/00002030-199405000-00002; HIBBARD MK, 1995, J VIROL, V69, P4656, DOI 10.1128/JVI.69.8.4656-4667.1995; Hu JH, 2002, J VIROL, V76, P11677, DOI 10.1128/JVI.76.22.11677-11687.2002; Huq MDM, 2006, EMBO J, V25, P5094, DOI 10.1038/sj.emboj.7601389; Izumiya Y, 2005, J VIROL, V79, P9912, DOI 10.1128/JVI.79.15.9912-9925.2005; Izumiya Y, 2003, J VIROL, V77, P9652, DOI 10.1128/JVI.77.17.9652-9661.2003; Izumiya Y, 2003, J VIROL, V77, P1441, DOI 10.1128/JVI.77.2.1441-1451.2003; Izumiya Y, 2009, J VIROL, V83, P4435, DOI 10.1128/JVI.01999-08; Kedes DH, 1997, J CLIN INVEST, V100, P2606, DOI 10.1172/JCI119804; Kelley-Clarke B, 2009, J VIROL, V83, P4326, DOI 10.1128/JVI.02395-08; Koyuncu OO, 2009, J VIROL, V83, P4778, DOI 10.1128/JVI.02493-08; Lacovides DC, 2007, J VIROL, V81, P13209, DOI 10.1128/JVI.01415-06; Lan K, 2005, J VIROL, V79, P3468, DOI 10.1128/JVI.79.6.3468-3478.2005; Lee J, 2005, J BIOL CHEM, V280, P32890, DOI 10.1074/jbc.M506944200; Lei NZ, 2009, NUCLEIC ACIDS RES, V37, P832, DOI 10.1093/nar/gkn941; Li QH, 2008, VIROLOGY, V379, P234, DOI 10.1016/j.virol.2008.06.043; Li YJ, 2004, J VIROL, V78, P13325, DOI 10.1128/JVI.78.23.13325-13334.2004; Lim C, 2002, J VIROL, V76, P10320, DOI 10.1128/JVI.76.20.10320-10331.2002; Lim C, 2001, J BIOL CHEM, V276, P31016, DOI 10.1074/jbc.M102431200; Lu F, 2006, J VIROL, V80, P5273, DOI 10.1128/JVI.02541-05; Mears WE, 1996, J VIROL, V70, P7445, DOI 10.1128/JVI.70.11.7445-7453.1996; Mesri EA, 2010, NAT REV CANCER, V10, P707, DOI 10.1038/nrc2888; Murakami Y, 2006, J BIOL CHEM, V281, P28113, DOI 10.1074/jbc.M602026200; Nakamura H, 2003, J VIROL, V77, P4205, DOI 10.1128/JVI.77.7.4205-4220.2003; Ohsaki E, 2004, J VIROL, V78, P9936, DOI 10.1128/JVI.78.18.9936-9946.2004; Ohsaki E, 2009, VIRUS RES, V139, P74, DOI 10.1016/j.virusres.2008.10.011; Piolot T, 2001, J VIROL, V75, P3948, DOI 10.1128/JVI.75.8.3948-3959.2001; Platt GM, 1999, J VIROL, V73, P9789, DOI 10.1128/JVI.73.12.9789-9795.1999; Radkov SA, 2000, NAT MED, V6, P1121, DOI 10.1038/80459; Renne R, 2001, J VIROL, V75, P458, DOI 10.1128/JVI.75.1.458-468.2001; Rho J, 2001, J VIROL, V75, P8031, DOI 10.1128/JVI.75.17.8031-8044.2001; Robin-Lespinasse Y, 2007, J CELL SCI, V120, P638, DOI 10.1242/jcs.03357; Rust HL, 2011, ACS CHEM BIOL, V6, P881, DOI 10.1021/cb200171d; Schulz TF, 2006, J PATHOL, V208, P187, DOI 10.1002/path.1904; Shinohara H, 2002, J VIROL, V76, P12917, DOI 10.1128/JVI.76.24.12917-12924.2002; Shire K, 2006, J VIROL, V80, P5261, DOI 10.1128/JVI.02682-05; SIEGAL B, 1990, CANCER, V65, P492, DOI 10.1002/1097-0142(19900201)65:3<492::AID-CNCR2820650320>3.0.CO;2-C; Sun R, 1998, P NATL ACAD SCI USA, V95, P10866, DOI 10.1073/pnas.95.18.10866; Swaminathan S, 2001, GENESIS, V29, P14, DOI 10.1002/1526-968X(200101)29:1<14::AID-GENE1001>3.0.CO;2-X; Toth Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001013; Varjosalo M, 2008, CELL, V133, P537, DOI 10.1016/j.cell.2008.02.047; Verma SC, 2007, CURR TOP MICROBIOL, V312, P101; Verma SC, 2004, J VIROL, V78, P10348, DOI 10.1128/JVI.78.19.10348-10359.2004; Vieira J, 2004, VIROLOGY, V325, P225, DOI 10.1016/j.virol.2004.03.049; Wong Emily L, 2005, Curr Oncol Rep, V7, P349, DOI 10.1007/s11912-005-0061-6; Xie B, 2007, J VIROL, V81, P4226, DOI 10.1128/JVI.01888-06; Yang YP, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng080; Yu J, 2010, BIOCHEM BIOPH RES CO, V391, P322, DOI 10.1016/j.bbrc.2009.11.057; Yun MY, 2011, CELL RES, V21, P564, DOI 10.1038/cr.2011.42	70	40	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5806	5818		10.1074/jbc.M111.289496	http://dx.doi.org/10.1074/jbc.M111.289496			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22179613	Green Published, hybrid			2022-12-25	WOS:000300638000056
J	Anderson, DD; Eom, JY; Stover, PJ				Anderson, Donald D.; Eom, Jae Y.; Stover, Patrick J.			Competition between Sumoylation and Ubiquitination of Serine Hydroxymethyltransferase 1 Determines Its Nuclear Localization and Its Accumulation in the Nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN THYMIDYLATE SYNTHASE; DIHYDROFOLATE-REDUCTASE; BIOSYNTHESIS; PROTEASOME; DEOXYRIBONUCLEOTIDE; CHAIN; CYCLE; POOL	Serine hydroxymethyltransferase 1 (SHMT1) expression limits rates of de novo dTMP synthesis in the nucleus. Here we report that SHMT1 is ubiquitinated at the small ubiquitin-like modifier (SUMO) consensus motif and that ubiquitination at that site is required for SHMT1 degradation. SHMT1 protein levels are cell cycle-regulated, and Ub-SHMT1 levels are lowest at S phase when SHMT1 undergoes SUMO modification and nuclear transport. Mutation of the SUMO consensus motif increases SHMT1 stability. SHMT1 interacts with components of the proteasome in both the nucleus and cytoplasm, indicating that degradation occurs in both compartments. Ubc13-mediated ubiquitination is required for SHMT1 nuclear export and increases stability of SHMT1 within the nucleus, whereas Ubc9-mediated modification with Sumo2/3 is involved in nuclear degradation. These data demonstrate that SUMO and ubiquitin modification of SHMT1 occurs on the same lysine residue and determine the localization and accumulation of SHMT1 in the nucleus.	[Anderson, Donald D.; Stover, Patrick J.] Cornell Univ, Grad Field Biochem & Mol & Cell Biol, Ithaca, NY 14853 USA; [Eom, Jae Y.; Stover, Patrick J.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University	Stover, PJ (corresponding author), Cornell Univ, Grad Field Biochem & Mol & Cell Biol, Ithaca, NY 14853 USA.	pjs13@cornell.edu			National Institutes of Health [DK58144]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058144, R37DK058144] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK58144 (to P. J. S.).	Anderson DD, 2007, CLIN CHEM LAB MED, V45, P1760, DOI 10.1515/CCLM.2007.355; Anderson DD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005839; Brooks P, 2000, BIOCHEM J, V346, P155, DOI 10.1042/0264-6021:3460155; Fox JT, 2009, J BIOL CHEM, V284, P31097, DOI 10.1074/jbc.M109.015800; Herbig K, 2002, J BIOL CHEM, V277, P38381, DOI 10.1074/jbc.M205000200; Ke PY, 2005, GENE DEV, V19, P1920, DOI 10.1101/gad.1322905; Lafarga M, 2002, MOL BIOL CELL, V13, P2771, DOI 10.1091/mbc.E02-03-0122; Laine A, 2006, MOL CELL BIOL, V26, P8901, DOI 10.1128/MCB.01156-06; MacFarlane AJ, 2008, J BIOL CHEM, V283, P25846, DOI 10.1074/jbc.M802671200; Maguire M, 2008, CANCER RES, V68, P3232, DOI 10.1158/0008-5472.CAN-07-5271; Melo SP, 2010, BIOCHEM J, V432, P217, DOI 10.1042/BJ20101027; Oppenheim EW, 2001, J BIOL CHEM, V276, P19855, DOI 10.1074/jbc.M100039200; Pena MMO, 2009, J BIOL CHEM, V284, P31597, DOI 10.1074/jbc.M109.038455; Pena MMO, 2006, BIOCHEM J, V394, P355, DOI 10.1042/BJ20051479; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; Saeki Y, 2009, EMBO J, V28, P359, DOI 10.1038/emboj.2008.305; Samsonoff WA, 1997, J BIOL CHEM, V272, P13281, DOI 10.1074/jbc.272.20.13281; Schimmel J, 2008, MOL CELL PROTEOMICS, V7, P2107, DOI 10.1074/mcp.M800025-MCP200; SPYROU G, 1988, MUTAT RES, V200, P37, DOI 10.1016/0027-5107(88)90069-3; Ulrich HD, 2009, DNA REPAIR, V8, P461, DOI 10.1016/j.dnarep.2009.01.006; Woeller CF, 2007, J BIOL CHEM, V282, P17623, DOI 10.1074/jbc.M702526200	21	48	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4790	4799		10.1074/jbc.M111.302174	http://dx.doi.org/10.1074/jbc.M111.302174			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22194612	Green Published, hybrid			2022-12-25	WOS:000300608500040
J	Feng, XL; Liu, QT; Cao, RB; Zhou, B; Ma, ZY; Deng, WL; Wei, JC; Qiu, YF; Wang, FQ; Gu, JY; Wang, FJ; Zheng, QS; Ishag, H; Chen, PY				Feng, Xiu-Li; Liu, Qing-Tao; Cao, Rui-Bing; Zhou, Bin; Ma, Zhi-Yong; Deng, Wen-Lei; Wei, Jian-Chao; Qiu, Ya-Feng; Wang, Fang-Quan; Gu, Jin-Yan; Wang, Feng-Juan; Zheng, Qi-Sheng; Ishag, Hassan; Chen, Pu-Yan			Identification and Characterization of Novel Immunomodulatory Bursal-derived Pentapeptide-II (BPP-II)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P53 TUMOR-SUPPRESSOR; B-CELL DEVELOPMENT; IN-VIVO; DIFFERENTIATING HORMONE; APOPTOTIC RESPONSE; FAMILY-MEMBERS; FABRICIUS; PROTEIN; CANCER; DEATH	The bursa of Fabricius, the acknowledged central humoral immune organ, plays a vital role in B lymphocyte differentiation. However, there are few reports of the molecular basis of the mechanism on immune induction and potential antitumor activity of bursal-derived peptides. In this paper, a novel bursal-derived pentapeptide-II (BPP-II, MTLTG) was isolated and exerted immunomodulatory functions on antibody responses in vitro. Gene microarray analyses demonstrated that BPP-II regulated expression of 2478 genes in a mouse-derived hybridoma cell line. Immune-related gene ontology functional procedures were employed for further functional analysis. Furthermore, the majority of BPP-II-regulated pathways were associated with immune responses and tumor processes. Moreover, BPP-II exhibited immunomodulatory effects on antigen-specific immune responses in vivo, including enhancement of avian influenza virus (H9N2 subtype)-specific antibody and cytokine production and modification of T cell immunophenotypes and lymphocyte proliferation. Finally, BPP-II triggered p53 expression and stabilization and selectively inhibited tumor cell proliferation. These data identified the multifunctional factor, BPP-II, as a novel biomaterial representing an important linking between the humoral central immune system and immune induction, including antitumor. Information generated in this study elucidates further the mechanisms involved in humoral immune system and represents the potential basis of effective immunotherapeutic strategies for treating human tumors and immune improvement.	[Feng, Xiu-Li; Cao, Rui-Bing; Zhou, Bin; Deng, Wen-Lei; Wang, Fang-Quan; Gu, Jin-Yan; Wang, Feng-Juan; Ishag, Hassan; Chen, Pu-Yan] Nanjing Agr Univ, Dept Agr China, Div Key Lab Anim Dis Diag & Immunol, Nanjing 210095, Jiangsu, Peoples R China; [Liu, Qing-Tao] Yangzhou Univ, Yangzhou 225009, Peoples R China; [Ma, Zhi-Yong; Wei, Jian-Chao; Qiu, Ya-Feng] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai 200241, Peoples R China; [Zheng, Qi-Sheng] Engn Res Ctr, Div Natl Vet Biol Med, Nanjing 210014, Peoples R China	Nanjing Agricultural University; Yangzhou University; Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS	Chen, PY (corresponding author), Nanjing Agr Univ, Dept Agr China, Div Key Lab Anim Dis Diag & Immunol, Nanjing 210095, Jiangsu, Peoples R China.	puyanchen@yahoo.com.cn		Ali, Hassan/0000-0003-4723-1909	Ministry of Agriculture, China [200803020]; Jiangsu Higher Education Institutions (PAPD)	Ministry of Agriculture, China(Ministry of Agriculture & Rural Affairs); Jiangsu Higher Education Institutions (PAPD)	This work was supported by Grant 200803020 from the National Agriculture Special Research Project for Nonprofit Trades, Ministry of Agriculture, China, and by a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Adam JK, 2003, PHARMACOL THERAPEUT, V99, P113, DOI 10.1016/S0163-7258(03)00056-1; Arakawa H, 2004, DEV DYNAM, V229, P458, DOI 10.1002/dvdy.10495; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; AUDHYA T, 1986, SCIENCE, V231, P997, DOI 10.1126/science.3484838; BABA T, 1977, IMMUNOLOGY, V32, P271; Beurel E, 2008, J BIOL CHEM, V283, P21934, DOI 10.1074/jbc.M802481200; BRAND A, 1976, SCIENCE, V193, P319, DOI 10.1126/science.180600; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; CHAPPEY O, 1994, J IMMUNOL METHODS, V172, P219, DOI 10.1016/0022-1759(94)90109-0; Chernov AV, 2010, J BIOL CHEM, V285, P19647, DOI 10.1074/jbc.M109.088153; Del-Val M, 2002, MOL IMMUNOL, V39, P235, DOI 10.1016/S0161-5890(02)00104-9; Deng L, 2005, J BIOL CHEM, V280, P27561, DOI 10.1074/jbc.M502660200; Dombrowicz D, 1998, IMMUNITY, V8, P517, DOI 10.1016/S1074-7613(00)80556-7; Du JA, 2006, J BIOL CHEM, V281, P37416, DOI 10.1074/jbc.M605063200; Du LH, 2004, J BIOL CHEM, V279, P11957, DOI 10.1074/jbc.M304935200; Feng XL, 2012, AMINO ACIDS, V42, P2215, DOI 10.1007/s00726-011-0961-8; Feng XL, 2011, PEPTIDES, V32, P1103, DOI 10.1016/j.peptides.2011.04.020; Feng XL, 2010, PEPTIDES, V31, P1562, DOI 10.1016/j.peptides.2010.05.007; Fred D., 2008, AVIAN IMMUNOLOGY, P1; Gorr SU, 2008, PEPTIDES, V29, P2118, DOI 10.1016/j.peptides.2008.09.019; Gromme M, 2002, MOL IMMUNOL, V39, P181, DOI 10.1016/S0161-5890(02)00101-3; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hegde AN, 2004, PROG NEUROBIOL, V73, P311, DOI 10.1016/j.pneurobio.2004.05.005; Hokibara Sho, 2000, Archivum Immunologiae et Therapiae Experimentalis, V48, P267; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Lamprecht B, 2010, NAT MED, V16, P571, DOI 10.1038/nm.2129; LANZAVECCHIA A, 1990, ANNU REV IMMUNOL, V8, P773, DOI 10.1146/annurev.immunol.8.1.773; LASSILA O, 1989, CELL IMMUNOL, V122, P319, DOI 10.1016/0008-8749(89)90080-4; Lawrence MC, 2011, J BIOL CHEM, V286, P1025, DOI 10.1074/jbc.M110.158675; Lecompte O, 2008, TRENDS BIOCHEM SCI, V33, P453, DOI 10.1016/j.tibs.2008.07.002; Lee JT, 2010, CELL DEATH DIFFER, V17, P86, DOI 10.1038/cdd.2009.77; Li DY, 2011, AMINO ACIDS, V40, P505, DOI 10.1007/s00726-010-0663-7; Mandapathil M, 2010, J BIOL CHEM, V285, P7176, DOI 10.1074/jbc.M109.047423; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Moody TW, 2004, J BIOL CHEM, V279, P23580, DOI 10.1074/jbc.M401938200; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Niiro H, 2002, NAT REV IMMUNOL, V2, P945, DOI 10.1038/nri955; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Pal S, 2007, J BIOL CHEM, V282, P8969, DOI 10.1074/jbc.M605927200; Qiu YF, 2008, BIOCHEM BIOPH RES CO, V377, P151, DOI 10.1016/j.bbrc.2008.09.117; Ranger AM, 2001, NAT GENET, V28, P113, DOI 10.1038/88815; Ratcliffe MJH, 2006, DEV COMP IMMUNOL, V30, P101, DOI 10.1016/j.dci.2005.06.018; Riese MJ, 2011, J BIOL CHEM, V286, P5254, DOI 10.1074/jbc.M110.171884; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Rosse T, 1998, NATURE, V391, P496, DOI 10.1038/35160; Saville MK, 2004, J BIOL CHEM, V279, P42169, DOI 10.1074/jbc.M403362200; SCHMID I, 1992, CYTOMETRY, V13, P204, DOI 10.1002/cyto.990130216; Thanos CD, 1999, PROTEIN SCI, V8, P1708, DOI 10.1110/ps.8.8.1708; Vikstrom I, 2010, SCIENCE, V330, P1095, DOI 10.1126/science.1191793; Walton MI, 2005, MOL CANCER THER, V4, P1369, DOI 10.1158/1535-7163.MCT-04-0341; Xu WW, 2010, IMMUNITY, V33, P340, DOI 10.1016/j.immuni.2010.08.015; Xu WF, 2005, J INTERF CYTOK RES, V25, P113, DOI 10.1089/jir.2005.25.113; Yamaguchi H, 2004, J BIOL CHEM, V279, P39431, DOI 10.1074/jbc.M401530200; Yoshida K, 2006, J BIOL CHEM, V281, P5734, DOI 10.1074/jbc.M512074200	55	15	20	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3798	3807		10.1074/jbc.M111.273854	http://dx.doi.org/10.1074/jbc.M111.273854			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22184121	hybrid, Green Published			2022-12-25	WOS:000300410900017
J	Akhtar, S; Wenborn, A; Brandner, S; Collinge, J; Lloyd, SE				Akhtar, Shaheen; Wenborn, Adam; Brandner, Sebastian; Collinge, John; Lloyd, Sarah E.			Sex Effects in Mouse Prion Disease Incubation Time	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; CREUTZFELDT-JAKOB-DISEASE; GENETIC-CONTROL; SCRAPIE; PERIOD; IDENTIFICATION; STRAINS; SINC; MICE; PRP	w Prion disease incubation time in mice is determined by many factors including PrP expression level, Prnp alleles, genetic background, prion strain and route of inoculation. Sex differences have been described in age of onset for vCJD and in disease duration for both vCJD and sporadic CJD and have also been shown in experimental models. The sex effects reported for mouse incubation times are often contradictory and detail only one strain of mice or prions, resulting in broad generalisations and a confusing picture. To clarify the effect of sex on prion disease incubation time in mice we have compared male and female transmission data from twelve different inbred lines of mice inoculated with at least two prion strains, representing both mouse-adapted scrapie and BSE. Our data show that sex can have a highly significant difference on incubation time. However, this is limited to particular mouse and prion strain combinations. No sex differences were seen in endogenous PrPC levels nor in the neuropathological markers of prion disease: PrPSc distribution, spongiosis, neuronal loss and gliosis. These data suggest that when comparing incubation times between between experimental groups, such as testing the effects of modifier genes or therapeutics, single sex groups should be used.	[Akhtar, Shaheen] UCL, Inst Neurol, Med Res Council Prion Unit, London, England; UCL, Inst Neurol, Dept Neurodegenerat Dis, London, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; University College London; University of London; University College London	Akhtar, S (corresponding author), UCL, Inst Neurol, Med Res Council Prion Unit, London, England.	s.lloyd@prion.ucl.ac.uk	Brandner, Sebastian/J-4562-2014	Brandner, Sebastian/0000-0002-9821-0342	Medical Research Council, UK; MRC [MC_U123160652, MC_U123192748] Funding Source: UKRI; Medical Research Council [MC_U123192748, MC_U123160652] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Medical Research Council, UK. The funder had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abiola OO, 2002, INTERVIROLOGY, V45, P56, DOI 10.1159/000050088; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; BRUCE ME, 1985, J NEUROPATH EXP NEUR, V44, P285, DOI 10.1097/00005072-198505000-00006; Bruce ME, 2003, BRIT MED BULL, V66, P99, DOI 10.1093/bmb/66.1.99; BRUCE ME, 1991, J GEN VIROL, V72, P595, DOI 10.1099/0022-1317-72-3-595; BRUCE ME, 1992, PRION DIS HUMAN ANIM; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; CARLSON GA, 1993, GENETICS, V133, P979; CARLSON GA, 1988, MOL CELL BIOL, V8, P5528, DOI 10.1128/MCB.8.12.5528; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; D'Castro L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015679; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Grizenkova J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015019; HUNTER N, 1992, J GEN VIROL, V73, P2751, DOI 10.1099/0022-1317-73-10-2751; KINGSBURY DT, 1983, J IMMUNOL, V131, P491; Lloyd SE, 2010, NEUROGENETICS, V11, P185, DOI 10.1007/s10048-009-0219-8; Lloyd SE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000383; Lloyd SE, 2004, J GEN VIROL, V85, P2471, DOI 10.1099/vir.0.79889-0; Lloyd SE, 2004, MAMM GENOME, V15, P383, DOI 10.1007/s00335-004-3041-5; Lloyd SE, 2002, NEUROGENETICS, V4, P77, DOI 10.1007/s10048-002-0133-9; Lloyd SE, 2001, P NATL ACAD SCI USA, V98, P6279, DOI 10.1073/pnas.101130398; Loeuillet C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013166; Manolakou K, 2001, P NATL ACAD SCI USA, V98, P7402, DOI 10.1073/pnas.121172098; McLean AR, 2000, PHILOS T ROY SOC B, V355, P1043, DOI 10.1098/rstb.2000.0641; Moore RC, 1998, NAT GENET, V18, P118, DOI 10.1038/ng0298-118; O'Shea M, 2008, GENETICS, V180, P559, DOI 10.1534/genetics.108.090894; Pocchiari M, 2004, BRAIN, V127, P2348, DOI 10.1093/brain/awh249; Stephenson DA, 2000, GENOMICS, V69, P47, DOI 10.1006/geno.2000.6320; Wadsworth JDF, 2006, BRAIN, V129, P1557, DOI 10.1093/brain/awl076; WESTAWAY D, 1987, CELL, V51, P651, DOI 10.1016/0092-8674(87)90134-6	31	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28741	10.1371/journal.pone.0028741	http://dx.doi.org/10.1371/journal.pone.0028741			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174884	Green Published, Green Submitted, gold			2022-12-25	WOS:000298367300024
J	Leys, SP; Yahel, G; Reidenbach, MA; Tunnicliffe, V; Shavit, U; Reiswig, HM				Leys, Sally P.; Yahel, Gitai; Reidenbach, Matthew A.; Tunnicliffe, Verena; Shavit, Uri; Reiswig, Henry M.			The Sponge Pump: The Role of Current Induced Flow in the Design of the Sponge Body Plan	PLOS ONE			English	Article							CANADIAN CONTINENTAL-SHELF; HEXACTINELLID SPONGE; GLASS SPONGES; ENERGY-COST; RHABDOCALYPTUS-DAWSONI; CONDUCTION SYSTEM; WATER-FLOW; PORIFERA; REEFS; SEDIMENT	Sponges are suspension feeders that use flagellated collar-cells (choanocytes) to actively filter a volume of water equivalent to many times their body volume each hour. Flow through sponges is thought to be enhanced by ambient current, which induces a pressure gradient across the sponge wall, but the underlying mechanism is still unknown. Studies of sponge filtration have estimated the energetic cost of pumping to be <1% of its total metabolism implying there is little adaptive value to reducing the cost of pumping by using "passive'' flow induced by the ambient current. We quantified the pumping activity and respiration of the glass sponge Aphrocallistes vastus at a 150 m deep reef in situ and in a flow flume; we also modeled the glass sponge filtration system from measurements of the aquiferous system. Excurrent flow from the sponge osculum measured in situ and in the flume were positively correlated (r>0.75) with the ambient current velocity. During short bursts of high ambient current the sponges filtered two-thirds of the total volume of water they processed daily. Our model indicates that the head loss across the sponge collar filter is 10 times higher than previously estimated. The difference is due to the resistance created by a fine protein mesh that lines the collar, which demosponges also have, but was so far overlooked. Applying our model to the in situ measurements indicates that even modest pumping rates require an energetic expenditure of at least 28% of the total in situ respiration. We suggest that due to the high cost of pumping, current-induced flow is highly beneficial but may occur only in thin walled sponges living in high flow environments. Our results call for a new look at the mechanisms underlying current-induced flow and for reevaluation of the cost of biological pumping and its evolutionary role, especially in sponges.	[Leys, Sally P.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Yahel, Gitai; Tunnicliffe, Verena; Reiswig, Henry M.] Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada; [Yahel, Gitai] Ruppin Acad Ctr, Sch Marine Sci, Michmoret, Israel; [Reidenbach, Matthew A.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22903 USA; [Tunnicliffe, Verena] Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC, Canada; [Shavit, Uri] Technion Israel Inst Technol, Dept Civil & Environm Engn, Haifa, Israel; [Reiswig, Henry M.] Royal British Columbia Museum, Nat Hist Sect, Victoria, BC, Canada	University of Alberta; University of Victoria; Ruppin Academic Center; University of Virginia; University of Victoria; Technion Israel Institute of Technology	Leys, SP (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	sleys@ualberta.ca	Tunnicliffe, Verena/D-1056-2014; Leys, Sally/A-2660-2014; Yahel, Gitai/A-3696-2012	Yahel, Gitai/0000-0003-2306-355X; Leys, Sally/0000-0001-9268-2181	NSERC; Rothschild fellowship	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Rothschild fellowship	Funding for this research came from NSERC Discovery Grants to SPL, VT, and HMR; NSERC Ship Time grants to SPL and VT; and a Rothschild fellowship to GY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTIN W, SPONGE GARDENS HIDDE; Bergquist P.R., 1978, SPONGES; Bidder GP, 1923, Q J MICROSC SCI, V67, P293; Chu JWF, 2010, MAR ECOL PROG SER, V417, P97, DOI 10.3354/meps08794; Conway Kim W., 2004, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V6, P335; Conway KW, 2001, GEOSCI CAN, V28, P71; CONWAY KW, 2007, MAPPING SENSITIVE HA, P1; Cowen EA, 1997, EXP FLUIDS, V22, P199, DOI 10.1007/s003480050038; Dewey R, 2005, J PHYS OCEANOGR, V35, P1911, DOI 10.1175/JPO2799.1; FJERDINGSTAD EJ, 1961, Z ZELLFORSCH MIK ANA, V53, P645, DOI 10.1007/BF00339512; GERRODETTE T, 1979, MAR BIOL, V55, P103, DOI 10.1007/BF00397305; Hadas E, 2008, J EXP BIOL, V211, P2185, DOI 10.1242/jeb.015420; Jimenez E, 2007, LIMNOL OCEANOGR, V52, P948, DOI 10.4319/lo.2007.52.3.0948; JOHNSON AS, 1990, LIMNOL OCEANOGR, V35, P1395, DOI 10.4319/lo.1990.35.6.1395; JORGENSEN CB, 1983, MAR ECOL PROG SER, V11, P89, DOI 10.3354/meps011089; KILIAN EF, 1952, Z VERGL PHYSIOL, V34, P407, DOI 10.1007/BF00297877; Knott NA, 2004, BIOL BULL-US, V207, P217, DOI 10.2307/1543210; LARSEN PS, 1994, J THEOR BIOL, V168, P53, DOI 10.1006/jtbi.1994.1087; LAWN ID, 1981, SCIENCE, V211, P1169, DOI 10.1126/science.7466387; Leys SP, 2007, ADV MAR BIOL, V52, P1, DOI 10.1016/S0065-2881(06)52001-2; Leys SP, 1997, NATURE, V387, P29, DOI 10.1038/387029b0; Leys SP, 1999, INVERTEBR BIOL, V118, P221, DOI 10.2307/3226994; Leys SP, 1999, J EXP BIOL, V202, P1139; Leys SP, 2004, MAR ECOL PROG SER, V283, P133, DOI 10.3354/meps283133; MACKIE GO, 1983, PHILOS T ROY SOC B, V301, P365, DOI 10.1098/rstb.1983.0028; Mackie GO, 1995, MAR FRESHW BEHAV PHY, V26, P197, DOI 10.1080/10236249509378939; MACKIE GO, 1974, PROC R SOC SER B-BIO, V187, P1, DOI 10.1098/rspb.1974.0058; Miller C.B., 2004, BIOL OCEANOGRAPHY; MONISMITH SG, 1990, LIMNOL OCEANOGR, V35, P680, DOI 10.4319/lo.1990.35.3.0680; MURDOCK GR, 1978, COMP BIOCHEM PHYS A, V61, P227, DOI 10.1016/0300-9629(78)90102-0; ORIORDAN CA, 1993, LIMNOL OCEANOGR, V38, P1712, DOI 10.4319/lo.1993.38.8.1712; Pile AJ, 2006, DEEP-SEA RES PT I, V53, P1148, DOI 10.1016/j.dsr.2006.03.008; Reidenbach MA, 2008, J EXP BIOL, V211, P2849, DOI 10.1242/jeb.016394; REISWIG H M, 1974, Journal of Experimental Marine Biology and Ecology, V14, P231, DOI 10.1016/0022-0981(74)90005-7; REISWIG HM, 1975, J MORPHOL, V145, P493, DOI 10.1002/jmor.1051450407; REISWIG HM, 1991, ZOOMORPHOLOGY, V110, P301, DOI 10.1007/BF01668020; REISWIG HM, 1971, MAR BIOL, V9, P38, DOI 10.1007/BF00348816; REISWIG HM, 2002, SYSTEMA PORIFERA GUI, P1282; Riisgard HU, 1996, MAR ECOL PROG SER, V141, P47, DOI 10.3354/meps141047; RIISGARD HU, 1988, MAR ECOL PROG SER, V47, P129, DOI 10.3354/meps047129; Riisgard HU, 2000, J SEA RES, V44, P169, DOI 10.1016/S1385-1101(00)00054-X; RIISGARD HU, 1993, MAR ECOL PROG SER, V96, P177, DOI 10.3354/meps096177; RIISGARD HU, 1995, BIOL REV, V70, P67, DOI 10.1111/j.1469-185X.1995.tb01440.x; Savarese M, 1997, LIMNOL OCEANOGR, V42, P171; SILVESTER NR, 1983, J THEOR BIOL, V103, P265, DOI 10.1016/0022-5193(83)90028-0; Tompkins-MacDonald GJ, 2008, MAR BIOL, V154, P973, DOI 10.1007/s00227-008-0987-y; VOGEL S, 1973, J COMP PHYSIOL, V85, P1, DOI 10.1007/BF00694136; VOGEL S, 1978, J EXP BIOL, V76, P137; VOGEL S, 1974, BIOL BULL-US, V147, P443, DOI 10.2307/1540461; VOGEL S, 1977, P NATL ACAD SCI USA, V74, P2069, DOI 10.1073/pnas.74.5.2069; von Dassow M, 2005, J EXP BIOL, V208, P2931, DOI 10.1242/jeb.01738; Weisz JB, 2008, OECOLOGIA, V155, P367, DOI 10.1007/s00442-007-0910-0; White F.J.V.F.F, 1991, FLUID MECH-SOV RES, V39, P104; Whitney F, 2005, CONT SHELF RES, V25, P211, DOI 10.1016/j.csr.2004.09.003; Wyeth RC, 1999, INVERTEBR BIOL, V118, P236, DOI 10.2307/3226995; Yahel G, 1998, LIMNOL OCEANOGR, V43, P551, DOI 10.4319/lo.1998.43.4.0551; Yahel G, 2003, LIMNOL OCEANOGR, V48, P141, DOI 10.4319/lo.2003.48.1.0141; Yahel G, 2007, LIMNOL OCEANOGR, V52, P428, DOI 10.4319/lo.2007.52.1.0428; Yahel G, 2006, AQUAT MICROB ECOL, V45, P181, DOI 10.3354/ame045181; Yahel G, 2008, MAR ECOL PROG SER, V372, P195, DOI 10.3354/meps07688	60	96	101	0	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e27787	10.1371/journal.pone.0027787	http://dx.doi.org/10.1371/journal.pone.0027787			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22180779	gold, Green Published, Green Submitted			2022-12-25	WOS:000298367300007
J	Maunoury, N; Vaucheret, H				Maunoury, Nicolas; Vaucheret, Herve			AGO1 and AGO2 Act Redundantly in miR408-Mediated Plantacyanin Regulation	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; INTERFERING RNAS; ARGONAUTE; MECHANISMS; MICRORNAS; IMMUNITY	Background: In Arabidopsis, AGO1 and AGO2 associate with small RNAs that exhibit a Uridine and an Adenosine at their 5' end, respectively. Because most plant miRNAs have a 5'U, AGO1 plays many essential roles in miRNA-mediated regulation of development and stress responses. In contrast, AGO2 has only been implicated in antibacterial defense in association with miR393*, which has a 5'A. AGO2 also participates in antiviral defense in association with viral siRNAs. Principal Findings: This study reveals that miR408, which has a 5'A, regulates its target Plantacyanin through either AGO1 or AGO2. Indeed, neither ago1 nor ago2 single mutations abolish miR408-mediated regulation of Plantacyanin. Only an ago1 ago2 double mutant appears compromised in miR408-mediated regulation of Plantacyanin, suggesting that AGO1 and AGO2 have redundant roles in this regulation. Moreover, the nature of the 5' nucleotide of miR408 does not appear essential for its regulatory role because both a wildtype 5'A-MIR408 and a mutant 5'U-MIR408 gene complement a mir408 mutant. Conclusions/Significance: These results suggest that miR408 associates with both AGO1 and AGO2 based on criteria that differ from the 5' end rule, reminiscent of miR390-AGO7 and miR165/166-AGO10 associations, which are not based on the nature of the 5' nucleotide.	[Maunoury, Nicolas; Vaucheret, Herve] INRA, Inst Jean Pierre Bourgin, F-78026 Versailles, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay	Maunoury, N (corresponding author), INRA, Inst Jean Pierre Bourgin, F-78026 Versailles, France.	herve.vaucheret@versailles.inra.fr		VAUCHERET, HERVE/0000-0002-9986-0988	INRA; Agence Nationale de la Recherche (ANR) [ANR-10-BLAN-1707-03]	INRA; Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	This work was supported by INRA (http://www.inra.fr/) (post-doctoral fellowship to NM) and the Agence Nationale de la Recherche (ANR: http://www.agence-nationale-recherche.fr/) (grant ANR-10-BLAN-1707-03 to HV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany SE, 2008, J BIOL CHEM, V283, P15932, DOI 10.1074/jbc.M801406200; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bohmert K, 1998, EMBO J, V17, P170, DOI 10.1093/emboj/17.1.170; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Dunoyer P, 2010, SCIENCE, V328, P912, DOI 10.1126/science.1185880; Ebhardt HA, 2009, NUCLEIC ACIDS RES, V37, P2461, DOI 10.1093/nar/gkp093; ESTELLE MA, 1987, MOL GEN GENET, V206, P200, DOI 10.1007/BF00333575; Harvey JJW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014639; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Jaubert M, 2011, PLANT PHYSIOL, V156, P1556, DOI 10.1104/pp.111.178012; Jauvion V, 2010, PLANT CELL, V22, P2697, DOI 10.1105/tpc.110.076638; Lobbes D, 2006, EMBO REP, V7, P1052, DOI 10.1038/sj.embor.7400806; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Scholthof HB, 2011, PLANT PHYSIOL, V156, P1548, DOI 10.1104/pp.111.178764; TAKEDA A, 2008, PLANT CELL PHYSL; Trindade I, 2010, PLANTA, V231, P705, DOI 10.1007/s00425-009-1078-0; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang H, 2011, PLANT J, V67, P292, DOI 10.1111/j.1365-313X.2011.04594.x; Wang XB, 2011, PLANT CELL, V23, P1625, DOI 10.1105/tpc.110.082305; Yamasaki H, 2009, PLANT CELL, V21, P347, DOI 10.1105/tpc.108.060137; Zhang XM, 2011, MOL CELL, V42, P356, DOI 10.1016/j.molcel.2011.04.010; Zhu HL, 2011, CELL, V145, P242, DOI 10.1016/j.cell.2011.03.024	28	45	50	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28729	10.1371/journal.pone.0028729	http://dx.doi.org/10.1371/journal.pone.0028729			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174881	Green Published, gold, Green Submitted			2022-12-25	WOS:000298367300023
J	Alba-Ferrara, L; Hausmann, M; Mitchell, RL; Weis, S				Alba-Ferrara, Lucy; Hausmann, Markus; Mitchell, Rachel L.; Weis, Susanne			The Neural Correlates of Emotional Prosody Comprehension: Disentangling Simple from Complex Emotion	PLOS ONE			English	Article							SOCIAL COGNITION; FACIAL EXPRESSIONS; PREFRONTAL CORTEX; LANGUAGE FUNCTIONS; AUDITORY EMOTIONS; RIGHT-HEMISPHERE; MIRROR SYSTEM; HUMAN BRAIN; PERCEPTION; EMPATHY	Background: Emotional prosody comprehension (EPC), the ability to interpret another person's feelings by listening to their tone of voice, is crucial for effective social communication. Previous studies assessing the neural correlates of EPC have found inconsistent results, particularly regarding the involvement of the medial prefrontal cortex (mPFC). It remained unclear whether the involvement of the mPFC is linked to an increased demand in socio-cognitive components of EPC such as mental state attribution and if basic perceptual processing of EPC can be performed without the contribution of this region. Methods: fMRI was used to delineate neural activity during the perception of prosodic stimuli conveying simple and complex emotion. Emotional trials in general, as compared to neutral ones, activated a network comprising temporal and lateral frontal brain regions, while complex emotion trials specifically showed an additional involvement of the mPFC, premotor cortex, frontal operculum and left insula. Conclusion: These results indicate that the mPFC and premotor areas might be associated, but are not crucial to EPC. However, the mPFC supports socio-cognitive skills necessary to interpret complex emotion such as inferring mental states. Additionally, the premotor cortex involvement may reflect the participation of the mirror neuron system for prosody processing particularly of complex emotion.	[Alba-Ferrara, Lucy] Univ S Florida, Dept Psychiat & Neurosci, Tampa, FL 33620 USA; [Alba-Ferrara, Lucy; Hausmann, Markus; Mitchell, Rachel L.; Weis, Susanne] Univ Durham, Dept Psychol, Durham DH1 3LE, England	State University System of Florida; University of South Florida; Durham University	Alba-Ferrara, L (corresponding author), Univ S Florida, Dept Psychiat & Neurosci, Tampa, FL 33620 USA.	lalbafer@health.usf.edu	alba-ferrara, lucy/I-4939-2012; Hausmann, Markus/F-4060-2014	Hausmann, Markus/0000-0002-2141-1154; alba-ferrara, lucy/0000-0003-1697-9535				Adolphs R, 2002, J COGNITIVE NEUROSCI, V14, P1264, DOI 10.1162/089892902760807258; Adolphs R, 1996, J NEUROSCI, V16, P7678; Adolphs R, 2010, CURR BIOL, V20, pR1071, DOI 10.1016/j.cub.2010.11.019; Adolphs R, 2002, EMOTION, V2, P23, DOI 10.1037/1528-3542.2.1.23; ALBAFERRARA L, 2011, BRAIN SIMUL IN PRESS; Aziz-Zadeh L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008759; Bach DR, 2008, NEUROIMAGE, V42, P919, DOI 10.1016/j.neuroimage.2008.05.034; Banissy MJ, 2010, J NEUROSCI, V30, P13552, DOI 10.1523/JNEUROSCI.0786-10.2010; Banse R, 1996, J PERS SOC PSYCHOL, V70, P614, DOI 10.1037/0022-3514.70.3.614; Bastiaansen JACJ, 2009, PHILOS T R SOC B, V364, P2391, DOI 10.1098/rstb.2009.0058; Baumgartner T, 2006, BRAIN RES, V1075, P151, DOI 10.1016/j.brainres.2005.12.065; Bauminger N, 2005, J LEARN DISABIL-US, V38, P45, DOI 10.1177/00222194050380010401; Beatty WW, 2003, MULT SCLER, V9, P148, DOI 10.1191/1352458503ms897oa; Beaucousin V, 2007, CEREB CORTEX, V17, P339, DOI 10.1093/cercor/bhj151; Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Brown JW, 2005, SCIENCE, V307, P1118, DOI 10.1126/science.1105783; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; CAPPS L, 1992, J CHILD PSYCHOL PSYC, V33, P1169, DOI 10.1111/j.1469-7610.1992.tb00936.x; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Chakrabarti B, 2006, PROG BRAIN RES, V156, P403, DOI 10.1016/S0079-6123(06)56022-4; CUNNINGHAM WA, 2010, SOC COGN AFFECT NEUR; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; EKMAN P, 1992, PSYCHOL REV, V99, P550, DOI 10.1037/0033-295X.99.3.550; Ethofer T, 2006, NEUROIMAGE, V30, P580, DOI 10.1016/j.neuroimage.2005.09.059; Friederici AD, 2004, BRAIN LANG, V89, P267, DOI 10.1016/S0093-934X(03)00351-1; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Golan O, 2006, SOC NEUROSCI-UK, V1, P111, DOI 10.1080/17470910600980986; Hoekert M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002244; Hooker CI, 2008, SOC COGN AFFECT NEUR, V3, P204, DOI 10.1093/scan/nsn019; Ischebeck AK, 2008, CEREB CORTEX, V18, P541, DOI 10.1093/cercor/bhm083; Jabbi M, 2007, NEUROIMAGE, V34, P1744, DOI 10.1016/j.neuroimage.2006.10.032; Johnson-Laird PhilipN., 1989, COGNITION EMOTION, V3, P81, DOI [10.1080/02699938908408075, DOI 10.1080/02699938908408075]; Keysers C, 2006, PROG BRAIN RES, V156, P379, DOI 10.1016/S0079-6123(06)56021-2; Kington JM, 2000, J PSYCHIAT RES, V34, P341, DOI 10.1016/S0022-3956(00)00029-7; Kotz SA, 2003, BRAIN LANG, V86, P366, DOI 10.1016/S0093-934X(02)00532-1; Lee L, 2005, J AFFECT DISORDERS, V86, P247, DOI 10.1016/j.jad.2005.02.007; Leitman DI, 2006, PSYCHOL MED, V36, P1075, DOI 10.1017/S0033291706007653; Leitman DI, 2011, FRONT HUM NEUROSCI, V5, DOI [10.3389/fnhum.2011.00096, 10.3389/fnhum.2010.00019]; LEITMAN DI, 2011, BIOL PSYCHIAT; Mah L, 2004, AM J PSYCHIAT, V161, P1247, DOI 10.1176/appi.ajp.161.7.1247; Mason RA, 2011, HUM BRAIN MAPP, V32, P313, DOI 10.1002/hbm.21021; Mitchell RLC, 2008, NEUROPSYCHOLOGIA, V46, P2880, DOI 10.1016/j.neuropsychologia.2008.05.024; Mitchell RLC, 2006, EUR J NEUROSCI, V24, P3611, DOI 10.1111/j.1460-9568.2006.05231.x; Mitchell RLC, 2003, NEUROPSYCHOLOGIA, V41, P1410, DOI 10.1016/S0028-3932(03)00017-4; MURPHY D, 1990, J NEUROL NEUROSUR PS, V53, P727, DOI 10.1136/jnnp.53.9.727; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; Peelen MV, 2010, J NEUROSCI, V30, P10127, DOI 10.1523/JNEUROSCI.2161-10.2010; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ramachandra V, 2009, PERCEPT MOTOR SKILL, V108, P30, DOI 10.2466/PMS.108.1.30-36; Ross ED, 1997, BRAIN LANG, V56, P27, DOI 10.1006/brln.1997.1731; Ross ED, 2001, J NEUROL NEUROSUR PS, V70, P597, DOI 10.1136/jnnp.70.5.597; Ross ED, 2008, BRAIN LANG, V104, P51, DOI 10.1016/j.bandl.2007.04.007; Ross ED, 2011, NEUROPSYCHOLOGIA, V49, P866, DOI 10.1016/j.neuropsychologia.2010.12.024; Rubinow DR, 2006, FRONT NEUROENDOCRIN, V27, P210, DOI 10.1016/j.yfrne.2006.02.003; Sander D, 2005, NEUROIMAGE, V28, P848, DOI 10.1016/j.neuroimage.2005.06.023; Sander K, 2005, J COGNITIVE NEUROSCI, V17, P1519, DOI 10.1162/089892905774597227; Schirmer A, 2006, TRENDS COGN SCI, V10, P24, DOI 10.1016/j.tics.2005.11.009; Schirmer A, 2004, NEUROIMAGE, V21, P1114, DOI 10.1016/j.neuroimage.2003.10.048; Seitz RJ, 2008, NEUROSCIENCE, V152, P713, DOI 10.1016/j.neuroscience.2007.10.066; Shaw P, 2005, J COGNITIVE NEUROSCI, V17, P1410, DOI 10.1162/0898929054985491; Slotnick SD, 2004, NAT NEUROSCI, V7, P664, DOI 10.1038/nn1252; Slotnick SD, 2003, COGNITIVE BRAIN RES, V17, P75, DOI 10.1016/S0926-6410(03)00082-X; Tamietto M, 2006, EXP BRAIN RES, V171, P389, DOI 10.1007/s00221-005-0279-4; van Hooren S, 2008, SCHIZOPHR RES, V103, P257, DOI 10.1016/j.schres.2008.02.022; Warren JE, 2006, J NEUROSCI, V26, P13067, DOI 10.1523/JNEUROSCI.3907-06.2006; Weis S, 2011, HUM BRAIN MAPP, V32, P1544, DOI 10.1002/hbm.21126; Weis S, 2010, NEUROSCIENTIST, V16, P132, DOI 10.1177/1073858409341481; Wildgruber D, 2006, PROG BRAIN RES, V156, P249, DOI 10.1016/S0079-6123(06)56013-3; Wildgruber D, 2005, NEUROIMAGE, V24, P1233, DOI 10.1016/j.neuroimage.2004.10.034; Willems RM, 2010, PSYCHOL SCI, V21, P8, DOI 10.1177/0956797609355563; Zinck A, 2008, CONSCIOUS COGN, V17, P496, DOI 10.1016/j.concog.2008.03.014; Zinck A, 2008, SYNTHESE, V161, P1, DOI 10.1007/s11229-006-9149-2	74	47	48	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28701	10.1371/journal.pone.0028701	http://dx.doi.org/10.1371/journal.pone.0028701			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	866FT	22174872	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000298366600030
J	Holm, S; Ueland, T; Dahl, TB; Michelsen, AE; Skjelland, M; Russell, D; Nymo, SH; Krohg-Sorensen, K; Clausen, OP; Atar, D; Januzzi, JL; Aukrust, P; Jensen, JK; Halvorsen, B				Holm, Sverre; Ueland, Thor; Dahl, Tuva B.; Michelsen, Annika E.; Skjelland, Mona; Russell, David; Nymo, Stale H.; Krohg-Sorensen, Kirsten; Clausen, Ole Petter; Atar, Dan; Januzzi, James L.; Aukrust, Pal; Jensen, Jesper K.; Halvorsen, Bente			Fatty Acid Binding Protein 4 Is Associated with Carotid Atherosclerosis and Outcome in Patients with Acute Ischemic Stroke	PLOS ONE			English	Article							EXPRESSION; PLAQUE; AP2; INFLAMMATION; MACROPHAGES; PLATELET; MICE	Background and Purpose: Fatty acid binding protein 4 (FABP4) has been shown to play an important role in macrophage cholesterol trafficking and associated inflammation. To further elucidate the role of FABP4 in atherogenesis in humans, we examined the regulation of FABP4 in carotid atherosclerosis and ischemic stroke. Methods: We examined plasma FABP4 levels in asymptomatic (n = 28) and symptomatic (n = 31) patients with carotid atherosclerosis, as well as in 202 subjects with acute ischemic stroke. In a subgroup of patients we also analysed the expression of FABP4 within the atherosclerotic lesion. In addition, we investigated the ability of different stimuli with relevance to atherosclerosis to regulate FABP4 expression in monocytes/macrophages. Results: FABP4 levels were higher in patients with carotid atherosclerosis, both systemically and within the atherosclerotic lesion, with particular high mRNA levels in carotid plaques from patients with the most recent symptoms. Immunostaining of carotid plaques localized FABP4 to macrophages, while activated platelets and oxidized LDL were potent stimuli for FABP4 expression in monocytes/macrophages in vitro. When measured at the time of acute ischemic stroke, high plasma levels of FABP4 were significantly associated with total and cardiovascular mortality during follow-up, although we did not find that addition of FABP4 to the fully adjusted multivariate model had an effect on the prognostic discrimination for allcause mortality as assessed by c-statistics. Conclusions: FABP4 is linked to atherogenesis, plaque instability and adverse outcome in patients with carotid atherosclerosis and acute ischemic stroke.	[Holm, Sverre; Ueland, Thor; Dahl, Tuva B.; Michelsen, Annika E.; Nymo, Stale H.; Aukrust, Pal; Halvorsen, Bente] Univ Oslo, Rikshosp, Oslo Univ Hosp, Internal Med Res Inst, N-0027 Oslo, Norway; [Skjelland, Mona; Russell, David] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Neurol, N-0027 Oslo, Norway; [Krohg-Sorensen, Kirsten] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Thorac & Cardiovasc Surg, N-0027 Oslo, Norway; [Clausen, Ole Petter] Univ Oslo, Rikshosp, Oslo Univ Hosp, Inst Pathol, N-0027 Oslo, Norway; [Aukrust, Pal] Univ Oslo, Rikshosp, Oslo Univ Hosp, Sect Clin Immunol & Infect Dis, N-0027 Oslo, Norway; [Atar, Dan] Univ Oslo, Hosp Ulleval, Div Cardiol, Oslo, Norway; [Russell, David; Clausen, Ole Petter; Atar, Dan; Aukrust, Pal; Halvorsen, Bente] Univ Oslo, Fac Med, Oslo, Norway; [Januzzi, James L.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Jensen, Jesper K.] Odense Univ Hosp, Dept Cardiol, DK-5000 Odense, Denmark	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; Harvard University; Massachusetts General Hospital; University of Southern Denmark; Odense University Hospital	Holm, S (corresponding author), Univ Oslo, Rikshosp, Oslo Univ Hosp, Internal Med Res Inst, N-0027 Oslo, Norway.	sverre.holm@rr-research.no	Januzzi, James/Y-2436-2019; jensen, jesper K/AFP-0493-2022; Skjelland, Mona/B-7362-2016; Skjelland, Mona/Q-4674-2017	Krohg-Sorensen, Kirsten/0000-0002-5713-809X; Holm, Sverre/0000-0003-1064-3926; Dahl, Tuva/0000-0001-7818-9411; Khedri Jensen, Jesper/0000-0001-7426-4437; Skjelland, Mona/0000-0001-7950-4882	Research Council of Norway; University of Oslo; Norwegian Council of Cardiovascular Research; Helse Sor-Ost; Medinnova Foundation	Research Council of Norway(Research Council of Norway); University of Oslo; Norwegian Council of Cardiovascular Research; Helse Sor-Ost; Medinnova Foundation	This work was supported by grants from the Research Council of Norway, University of Oslo, Norwegian Council of Cardiovascular Research, Helse Sor-Ost, and Medinnova Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardh HE, 2011, J INTERN MED, V269, P200, DOI 10.1111/j.1365-2796.2010.02304.x; Breland UM, 2010, CARDIOVASC RES, V86, P265, DOI 10.1093/cvr/cvq044; Dahl TB, 2007, CIRCULATION, V115, P972, DOI 10.1161/CIRCULATIONAHA.106.665893; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Furuhashi M, 2008, J CLIN INVEST, V118, P2640, DOI 10.1172/JCI34750; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Halvorsen B, 2008, PROG CARDIOVASC DIS, V51, P183, DOI 10.1016/j.pcad.2008.09.001; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; HUNT CR, 1986, P NATL ACAD SCI USA, V83, P3786, DOI 10.1073/pnas.83.11.3786; Jensen JK, 2007, AM J CARDIOL, V99, P108, DOI 10.1016/j.amjcard.2006.07.071; Makowski L, 2005, CURR OPIN LIPIDOL, V16, P543, DOI 10.1097/01.mol.0000180166.08196.07; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Otterdal K, 2006, BLOOD, V108, P928, DOI 10.1182/blood-2005-09-010629; PEETERS W, 2010, EUR HEART J IN PRESS; Skjelland M, 2007, ATHEROSCLEROSIS, V195, pE142, DOI 10.1016/j.atherosclerosis.2007.05.001; STROKE, V16, P885	18	45	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28785	10.1371/journal.pone.0028785	http://dx.doi.org/10.1371/journal.pone.0028785			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174896	Green Published, gold, Green Submitted			2022-12-25	WOS:000298365700073
J	Madden, DT; Davila-Kruger, D; Melov, S; Bredesen, DE				Madden, David T.; Davila-Kruger, Diana; Melov, Simon; Bredesen, Dale E.			Human Embryonic Stem Cells Express Elevated Levels of Multiple Pro-Apoptotic BCL-2 Family Members	PLOS ONE			English	Article							DEATH MACHINERY; INHIBITS APOPTOSIS; SIGNALING PATHWAY; BH3-ONLY PROTEIN; BAD COUPLES; PHOSPHORYLATION; SURVIVAL; P53; GENE; ACTIVATION	Two of the greatest challenges in regenerative medicine today remain (1) the ability to culture human embryonic stem cells (hESCs) at a scale sufficient to satisfy clinical demand and (2) the ability to eliminate teratoma-forming cells from preparations of cells with clinically desirable phenotypes. Understanding the pathways governing apoptosis in hESCs may provide a means to address these issues. Limiting apoptosis could aid scaling efforts, whereas triggering selective apoptosis in hESCs could eliminate unwanted teratoma-forming cells. We focus here on the BCL-2 family of proteins, which regulate mitochondrial-dependent apoptosis. We used quantitative PCR to compare the steady-state expression profile of all human BCL-2 family members in hESCs with that of human primary cells from various origins and two cancer lines. Our findings indicate that hESCs express elevated levels of the pro-apoptotic BH3-only BCL-2 family members NOXA, BIK, BIM, BMF and PUMA when compared with differentiated cells and cancer cells. However, compensatory expression of pro-survival BCL-2 family members in hESCs was not observed, suggesting a possible explanation for the elevated rates of apoptosis observed in proliferating hESC cultures, as well as a mechanism that could be exploited to limit hESC-derived neoplasms.	[Madden, David T.] Touro Univ Calif, Coll Pharm, Vallejo, CA 94592 USA; [Madden, David T.; Davila-Kruger, Diana; Melov, Simon; Bredesen, Dale E.] Buck Inst Res Aging, Novato, CA USA; [Bredesen, Dale E.] Univ Calif San Francisco, San Francisco, CA 94143 USA	Touro University California; Buck Institute for Research on Aging; University of California System; University of California San Francisco	Madden, DT (corresponding author), Touro Univ Calif, Coll Pharm, Vallejo, CA 94592 USA.	david.madden.tu@gmail.com	Melov, Simon/AAC-9469-2020	Melov, Simon/0000-0001-8554-2834	California Institute of Regenerative Medicine [RS1-00163-1]; Larry L. Hillblom Foundation	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Larry L. Hillblom Foundation	The work was supported by a SEED grant from the California Institute of Regenerative Medicine (RS1-00163-1), as well as a postdoctoral fellowship from the Larry L. Hillblom Foundation (D.T.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardehali R, 2011, P NATL ACAD SCI USA, V108, P3282, DOI 10.1073/pnas.1019047108; Bredesen DE, 2006, NATURE, V443, P796, DOI 10.1038/nature05293; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Cimadamore F, 2011, CELL STEM CELL, V8, P538, DOI 10.1016/j.stem.2011.03.011; Conradt B, 2009, ANNU REV GENET, V43, P493, DOI 10.1146/annurev.genet.42.110807.091533; Cotteret S, 2003, MOL CELL BIOL, V23, P5526, DOI 10.1128/MCB.23.16.5526-5539.2003; Danial NN, 2008, NAT MED, V14, P144, DOI 10.1038/nm1717; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Dehan E, 2009, MOL CELL, V33, P109, DOI 10.1016/j.molcel.2008.12.020; delPeso L, 1997, SCIENCE, V278, P687; Donovan N, 2002, J BIOL CHEM, V277, P40944, DOI 10.1074/jbc.M206113200; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fox CJ, 2003, GENE DEV, V17, P1841, DOI 10.1101/gad.1105003; Happo L, 2010, BLOOD, V116, P5256, DOI 10.1182/blood-2010-04-280818; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; Hasegawa K, 2010, CELL STEM CELL, V6, P521, DOI 10.1016/j.stem.2010.05.010; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Li YM, 2003, CANCER RES, V63, P7630; Lopez H, 2010, J BIOL CHEM, V285, P15016, DOI 10.1074/jbc.M109.086231; Lowman XH, 2010, MOL CELL, V40, P823, DOI 10.1016/j.molcel.2010.11.035; Madden DT, 2007, AUTOPHAGY, V3, P519; Mathai JP, 2002, ONCOGENE, V21, P2534, DOI 10.1038/sj.onc.1205340; MIYASHITA T, 1995, CELL, V80, P293; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Ohgushi M, 2010, CELL STEM CELL, V7, P225, DOI 10.1016/j.stem.2010.06.018; Peng YW, 2003, J BIOL CHEM, V278, P8385, DOI 10.1074/jbc.M213156200; Puthalakath H, 2001, SCIENCE, V293, P1829, DOI 10.1126/science.1062257; Pyle AD, 2006, NAT BIOTECHNOL, V24, P344, DOI 10.1038/nbt1189; Qin H, 2007, J BIOL CHEM, V282, P5842, DOI 10.1074/jbc.M610464200; Rex M, 1997, DEV DYNAM, V209, P323, DOI 10.1002/(SICI)1097-0177(199707)209:3<323::AID-AJA7>3.3.CO;2-B; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schurmann A, 2000, MOL CELL BIOL, V20, P453, DOI 10.1128/MCB.20.2.453-461.2000; Spurgeon SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001662; Suzuki E, 1996, GENOMICS, V38, P283, DOI 10.1006/geno.1996.0630; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Tan Y, 1999, J BIOL CHEM, V274, P34859, DOI 10.1074/jbc.274.49.34859; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Umetani M, 2001, ARTERIOSCL THROM VAS, V21, P917, DOI 10.1161/01.ATV.21.6.917; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verma S, 2001, J BIOL CHEM, V276, P4671, DOI 10.1074/jbc.M008983200; Yan B, 2003, J BIOL CHEM, V278, P45358, DOI 10.1074/jbc.M307933200; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Yuan JY, 2010, GENE DEV, V24, P2592, DOI 10.1101/gad.1984410; Zhang L, 2011, CELL DEATH DIFFER, V18, P864, DOI 10.1038/cdd.2010.152	49	32	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28530	10.1371/journal.pone.0028530	http://dx.doi.org/10.1371/journal.pone.0028530			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174832	Green Submitted, Green Published, gold			2022-12-25	WOS:000298365700045
J	Marchesini, MI; Connolly, J; Delpino, MV; Baldi, PC; Mujer, CV; DelVecchio, VG; Comerci, DJ				Ines Marchesini, Maria; Connolly, Joseph; Victoria Delpino, Maria; Baldi, Pablo C.; Mujer, Cesar V.; DelVecchio, Vito G.; Comerci, Diego J.			Brucella abortus Choloylglycine Hydrolase Affects Cell Envelope Composition and Host Cell Internalization	PLOS ONE			English	Article							BILE-SALT HYDROLASE; OMP25/OMP31 FAMILY; VIRB; IDENTIFICATION; PROTEINS; OVIS	Choloylglycine hydrolase (CGH, E.C. 3.5.1.24) is a conjugated bile salt hydrolase that catalyses the hydrolysis of the amide bond in conjugated bile acids. Bile salt hydrolases are expressed by gastrointestinal bacteria, and they presumably decrease the toxicity of host's conjugated bile salts. Brucella species are the causative agents of brucellosis, a disease affecting livestock and humans. CGH confers Brucella the ability to deconjugate and resist the antimicrobial action of bile salts, contributing to the establishment of a successful infection through the oral route in mice. Additionally, cgh-deletion mutant was also attenuated in intraperitoneally inoculated mice, which suggests that CGH may play a role during systemic infection other than hydrolyzing conjugated bile acids. To understand the role CGH plays in B. abortus virulence, we infected phagocytic and epithelial cells with a cgh-deletion mutant (Delta cgh) and found that it is defective in the internalization process. This defect along with the increased resistance of Delta cgh to the antimicrobial action of polymyxin B, prompted an analysis of the cell envelope of this mutant. Two-dimensional electrophoretic profiles of Delta cgh cell envelope-associated proteins showed an altered expression of Omp2b and different members of the Omp25/31 family. These results were confirmed by Western blot analysis with monoclonal antibodies. Altogether, the results indicate that Brucella CGH not only participates in deconjugation of bile salts but also affects overall membrane composition and host cell internalization.	[Ines Marchesini, Maria; Comerci, Diego J.] Univ Nacl San Martin, Consejo Nacl Invest Cient & Tecn, Inst Invest Biotecnol, Inst Tecnol Chascomus, Buenos Aires, DF, Argentina; [Connolly, Joseph; Mujer, Cesar V.; DelVecchio, Vito G.] Vital Probes Inc, Mayfield, PA USA; [Victoria Delpino, Maria; Baldi, Pablo C.] Univ Buenos Aires, Fac Farm & Bioquim, Consejo Nacl Invest Cient & Tecn, Inst Estudios Inmunidad Humoral, RA-1113 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Marchesini, MI (corresponding author), Univ Nacl San Martin, Consejo Nacl Invest Cient & Tecn, Inst Invest Biotecnol, Inst Tecnol Chascomus, Buenos Aires, DF, Argentina.	dcomerci@iibintech.com.ar	Baldi, Pablo/AAS-4736-2020	Marchesini, Ines/0000-0002-8540-2337; Baldi, Pablo/0000-0002-2500-6682; Comerci, Diego J./0000-0003-1949-4226; Delpino, M. Victoria/0000-0003-2077-8509	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina(ANPCyT)	This study has been supported by grant PICT 2005 and PICT 2007 from Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina, (http://www.agencia.gov.ar/) to DC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bukata L, 2008, J BACTERIOL, V190, P8197, DOI 10.1128/JB.01069-08; Comerci DJ, 2001, CELL MICROBIOL, V3, P159, DOI 10.1046/j.1462-5822.2001.00102.x; Connolly JP, 2006, PROTEOMICS, V6, P3767, DOI 10.1002/pmic.200500730; Corbel MJ, 1997, EMERG INFECT DIS, V3, P213, DOI 10.3201/eid0302.970219; Delpino MV, 2007, INFECT IMMUN, V75, P299, DOI 10.1128/IAI.00952-06; Delpino MV, 2009, ARCH MICROBIOL, V191, P571, DOI 10.1007/s00203-009-0484-9; Fugier E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000487; GAMAZO C, 1993, FEMS MICROBIOL LETT, V112, P141, DOI 10.1111/j.1574-6968.1993.tb06439.x; Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105; Martin-Martin AI, 2008, MICROBES INFECT, V10, P706, DOI 10.1016/j.micinf.2008.02.013; Nicoletti P, 1989, RELATIONSHIP ANIMAL, P41; O'Callaghan D, 1999, MOL MICROBIOL, V33, P1210, DOI 10.1046/j.1365-2958.1999.01569.x; Bonomi HR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009435; Salhi I, 2003, INFECT IMMUN, V71, P4326, DOI 10.1128/IAI.71.8.4326-4332.2003; Vizcaino N, 2004, MICROBES INFECT, V6, P821, DOI 10.1016/j.micinf.2004.04.009; Wang YF, 2010, FEMS MICROBIOL LETT, V303, P92, DOI 10.1111/j.1574-6968.2009.01866.x; Zavascki AP, 2007, J ANTIMICROB CHEMOTH, V60, P1206, DOI 10.1093/jac/dkm357	17	13	15	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28480	10.1371/journal.pone.0028480	http://dx.doi.org/10.1371/journal.pone.0028480			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174816	Green Published, Green Submitted, gold			2022-12-25	WOS:000298163600024
J	Magwere, T; Burchill, SA				Magwere, Tapiwanashe; Burchill, Susan A.			Heterogeneous Role of the Glutathione Antioxidant System in Modulating the Response of ESFT to Fenretinide in Normoxia and Hypoxia	PLOS ONE			English	Article							EWINGS-SARCOMA FAMILY; INDUCED CELL-DEATH; GAMMA-GLUTAMYL-TRANSFERASE; PHASE-I TRIAL; OXIDATIVE STRESS; ORAL FENRETINIDE; DRUG-RESISTANCE; TUMORS; CANCER; THERAPY	Glutathione (GSH) is implicated in drug resistance mechanisms of several cancers and is a key regulator of cell death pathways within cells. We studied Ewing's sarcoma family of tumours (ESFT) cell lines and three mechanistically distinct anticancer agents (fenretinide, doxorubicin, and vincristine) to investigate whether the GSH antioxidant system is involved in the reduced sensitivity to these chemotherapeutic agents in hypoxia. Cell viability and death were assessed by the trypan blue exclusion assay and annexin V-PI staining, respectively. Hypoxia significantly decreased the sensitivity of all ESFT cell lines to fenretinide-induced death, whereas the effect of doxorubicin or vincristine was marginal and cell-line-specific. The response of the GSH antioxidant system in ESFT cell lines to hypoxia was variable and also cell-line-specific, although the level of GSH appeared to be most dependent on de novo biosynthesis rather than recycling. RNAi-mediated knockdown of key GSH regulatory enzymes gamma-glutamylcysteine synthetase or glutathione disulfide reductase partially reversed the hypoxia-induced resistance to fenretinide, and increasing GSH levels using N-acetylcysteine augmented the hypoxia-induced resistance in a cell line-specific manner. These observations are consistent with the conclusion that the role of the GSH antioxidant system in modulating the sensitivity of ESFT cells to fenretinide is heterogeneous depending on environment and cell type. This is likely to limit the value of targeting GSH as a therapeutic strategy to overcome hypoxia-induced drug resistance in ESFT. Whether targeting the GSH antioxidant system in conjunction with other therapeutics may benefit some patients with ESFT remains to be seen.	[Magwere, Tapiwanashe; Burchill, Susan A.] St James Univ Hosp, LIMM, Childrens Canc Res Grp, Leeds, W Yorkshire, England	Saint James's University Hospital; University of Leeds	Magwere, T (corresponding author), St James Univ Hosp, LIMM, Childrens Canc Res Grp, Leeds, W Yorkshire, England.	t.magwere@leeds.ac.uk			University of Leeds; Candlelighter's Trust	University of Leeds; Candlelighter's Trust	The University of Leeds and the Candlelighter's Trust funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberger-Murphy V, 2009, CURR CANCER DRUG TAR, V9, P381, DOI 10.2174/156800909788166637; Anderson CP, 2002, BONE MARROW TRANSPL, V30, P135, DOI 10.1038/sj.bmt.1703605; ANDREWS PA, 1988, CHEM-BIOL INTERACT, V65, P51, DOI 10.1016/0009-2797(88)90030-0; Aryee DNT, 2010, CANCER RES, V70, P4015, DOI 10.1158/0008-5472.CAN-09-4333; Balendiran GK, 2004, CELL BIOCHEM FUNCT, V22, P343, DOI 10.1002/cbf.1149; Batra S, 2004, CANCER RES, V64, P5415, DOI 10.1158/0008-5472.CAN-04-0377; Brahimi-Horn MC, 2007, J MOL MED-JMM, V85, P1301, DOI 10.1007/s00109-007-0281-3; Burchill SA, 2008, EXPERT REV ANTICANC, V8, P1675, DOI 10.1586/14737140.8.10.1675; DeClerck K, 2010, FRONT BIOSCI-LANDMRK, V15, P213, DOI 10.2741/3616; Estrela JM, 2006, CRIT REV CL LAB SCI, V43, P143, DOI 10.1080/10408360500523878; FACCHINETTI T, 1978, CHEM-BIOL INTERACT, V20, P97, DOI 10.1016/0009-2797(78)90084-4; Fojo T, 2003, ONCOGENE, V22, P7512, DOI 10.1038/sj.onc.1206951; FORMELLI F, 1993, CANCER RES, V53, P5374; FORMELLI F, 1993, J CLIN ONCOL, V11, P2036, DOI 10.1200/JCO.1993.11.10.2036; Franco R, 2009, CELL DEATH DIFFER, V16, P1303, DOI 10.1038/cdd.2009.107; Garaventa A, 2003, CLIN CANCER RES, V9, P2032; Goto H, 2003, INT J HEMATOL, V78, P219, DOI 10.1007/BF02983798; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; Kang KW, 2005, ANTIOXID REDOX SIGN, V7, P1664, DOI 10.1089/ars.2005.7.1664; Kilic M, 2007, ONCOGENE, V26, P2027, DOI 10.1038/sj.onc.1210008; Liu XW, 2010, PHARMACOL RES, V62, P416, DOI 10.1016/j.phrs.2010.07.002; Mackintosh C, 2010, CANCER BIOL THER, V9, P655, DOI 10.4161/cbt.9.9.11511; Magwere T, 2008, EUR J CANCER, V44, P2276, DOI 10.1016/j.ejca.2008.06.008; Malone W, 2003, EXPERT OPIN INV DRUG, V12, P1829, DOI 10.1517/eoid.12.11.1829.21882; MEISTER A, 1995, METHOD ENZYMOL, V252, P26; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Myatt SS, 2008, ONCOGENE, V27, P985, DOI 10.1038/sj.onc.1210705; Myatt SS, 2005, CLIN CANCER RES, V11, P3136, DOI 10.1158/1078-0432.CCR-04-2050; Pienta KJ, 1997, AM J CLIN ONCOL-CANC, V20, P36, DOI 10.1097/00000421-199702000-00008; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Pompella A, 2006, BIOCHEM PHARMACOL, V71, P231, DOI 10.1016/j.bcp.2005.10.005; Shentu JZ, 2007, ANTI-CANCER DRUG, V18, P47, DOI 10.1097/CAD.0b013e32800feeb5; SILBER PM, 1986, ANAL BIOCHEM, V158, P68, DOI 10.1016/0003-2697(86)90590-7; Smith DG, 2011, EXPERT REV ANTICANC, V11, P229, DOI [10.1586/era.10.224, 10.1586/ERA.10.224]; Sohn EJ, 2010, CANC RES, P0008; Soltaninassab SR, 2000, J CELL PHYSIOL, V182, P163, DOI 10.1002/(SICI)1097-4652(200002)182:2<163::AID-JCP4>3.0.CO;2-1; Song JR, 2011, J CELL BIOCHEM, V112, P3406, DOI 10.1002/jcb.23274; Sullivan R, 2008, MOL CANCER THER, V7, P1961, DOI 10.1158/1535-7163.MCT-08-0198; Thacker MM, 2005, EXPERT REV ANTICANC, V5, P319, DOI 10.1586/14737140.5.2.319; Villablanca JG, 2006, J CLIN ONCOL, V24, P3423, DOI 10.1200/JCO.2005.03.9271; Wachtel M, 2010, CANCER TREAT REV, V36, P318, DOI 10.1016/j.ctrv.2010.02.007; White CC, 2003, ANAL BIOCHEM, V318, P175, DOI 10.1016/S0003-2697(03)00143-X; White DE, 2010, BRIT J CANCER, V103, P1380, DOI 10.1038/sj.bjc.6605896; Wondrak GT, 2009, ANTIOXID REDOX SIGN, V11, P3013, DOI [10.1089/ars.2009.2541, 10.1089/ARS.2009.2541]; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Wu JM, 2001, APOPTOSIS, V6, P377, DOI 10.1023/A:1011342220621; Zhou X J, 1992, Drugs, V44 Suppl 4, P1	47	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28558	10.1371/journal.pone.0028558	http://dx.doi.org/10.1371/journal.pone.0028558			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174837	Green Published, gold, Green Submitted			2022-12-25	WOS:000298163600034
J	Pippa, R; Espinosa, L; Gundem, G; Garcia-Escudero, R; Dominguez, A; Orlando, S; Gallastegui, E; Saiz, C; Besson, A; Pujol, MJ; Lopez-Bigas, N; Paramio, JM; Bigas, A; Bachs, O				Pippa, R.; Espinosa, L.; Gundem, G.; Garcia-Escudero, R.; Dominguez, A.; Orlando, S.; Gallastegui, E.; Saiz, C.; Besson, A.; Pujol, M. J.; Lopez-Bigas, N.; Paramio, J. M.; Bigas, A.; Bachs, O.			p27(Kip1) represses transcription by direct interaction with p130/E2F4 at the promoters of target genes	ONCOGENE			English	Article						p27; p130; E2F4; transcription	CELL-CYCLE KINASES; CDK INHIBITOR P27; MICE LACKING; EXPRESSION; CANCER; MIGRATION; PROTEINS; DIFFERENTIATION; LEUKEMIA; PHOSPHORYLATION	The cyclin-cdk (cyclin-dependent kinase) inhibitor p27(Kip1) (p27) has a crucial negative role on cell cycle progression. In addition to its classical role as a cyclin-cdk inhibitor, it also performs cyclin-cdk-independent functions as the regulation of cytoskeleton rearrangements and cell motility. p27 deficiency has been associated with tumor aggressiveness and poor clinical outcome, although the mechanisms underlying this participation still remain elusive. We report here a new cellular function of p27 as a transcriptional regulator in association with p130/E2F4 complexes that could be relevant for tumorigenesis. We observed that p27 associates with specific promoters of genes involved in important cellular functions as processing and splicing of RNA, mitochondrial organization and respiration, translation and cell cycle. On these promoters p27 co-localizes with p130, E2F4 and co-repressors as histone deacetylases (HDACs) and mSIN3A. p27 co-immunoprecipitates with these proteins and by affinity chromatography, we demonstrated a direct interaction of p27 with p130 and E2F4 through its carboxyl-half. We have also shown that p130 recruits p27 on the promoters, and there p27 is needed for the subsequent recruitment of HDACs and mSIN3A. Expression microarrays and luciferase assays revealed that p27 behaves as transcriptional repressor of these p27-target genes (p27-TGs). Finally, in human tumors, we established a correlation with overexpression of p27-TGs and poor survival. Thus, this new function of p27 as a transcriptional repressor could have a role in the major aggressiveness of tumors with low levels of p27. Oncogene (2012) 31, 4207-4220; doi:10.1038/onc.2011.582; published online 19 December 2011	[Espinosa, L.; Bigas, A.] Hosp Mar, Inst Municipal Invest Med, Barcelona, Spain; [Gundem, G.; Lopez-Bigas, N.] Univ Pompeu Fabra, Catalan Inst Res & Adv Studies ICREA, Dept Expt & Hlth Sci, Res Unit Biomed Informat, Barcelona, Spain; [Garcia-Escudero, R.; Saiz, C.] CIEMAT, Div Biomed, Mol Oncol Unit, E-28040 Madrid, Spain; [Besson, A.] Canc Res Ctr Toulouse, INSERM, UMR1037, Toulouse, France; [Pippa, R.; Dominguez, A.; Orlando, S.; Gallastegui, E.; Pujol, M. J.; Bachs, O.] Univ Barcelona, IDIBAPS, Dept Cell Biol Immunol & Neurosci, E-08036 Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; ICREA; Pompeu Fabra University; Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Bachs, O (corresponding author), Univ Barcelona, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Fac Med, Dept Cell Biol Immunol & Neurosci, Casanova 143, E-08036 Barcelona, Spain.	obachs@ub.edu	Paramio, Jesus M/M-8482-2014; Lopez-Bigas, Nuria/F-6193-2011; Espinosa, Lluis/ABA-4564-2020; Garcia-Escudero, Ramon/A-2735-2012; Besson, Arnaud/J-6254-2014; Orlando, Serena/AAA-7963-2019; Gasull, Martina/J-4076-2019; Bigas, Anna/A-7457-2014; Pippa, Raffaella/J-4566-2012	Paramio, Jesus M/0000-0001-7520-3177; Lopez-Bigas, Nuria/0000-0003-4925-8988; Espinosa, Lluis/0000-0002-2897-4099; Garcia-Escudero, Ramon/0000-0001-5640-6542; Besson, Arnaud/0000-0002-9599-3943; Pippa, Raffaella/0000-0002-1028-6511; Bigas, Anna/0000-0003-4801-6899; Saiz Ladera, Cristina/0000-0001-8094-5992	Ministerio de Ciencia y Tecnologia of Spain [SAF2006-05212, SAF2009-07769, SAF2009-06954]; Fondo de Investigacion Sanitaria [PI070778]; Instituto de Salud Carlos III (RETICS) [RD06/0020/0010, RD06/0020/0029, RD06/0020/0098]; Comunidad Autonoma de Madrid (Oncocycle Program) [S2006/BIO-0232]; Generalitat de Catalunya [SGR 09-1382]; AGAUR of the Catalonian Government; Association pour la recherche sur le Cancer; Ligue Nationale Contre le Cancer; Institue National du Cancer; ICREA Funding Source: Custom	Ministerio de Ciencia y Tecnologia of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Instituto de Salud Carlos III (RETICS)(Instituto de Salud Carlos III); Comunidad Autonoma de Madrid (Oncocycle Program); Generalitat de Catalunya(Generalitat de Catalunya); AGAUR of the Catalonian Government(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Association pour la recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Institue National du Cancer; ICREA(ICREA)	We thank Dr Anxo Vidal for p27<SUP>Delta 51</SUP>- MEF cells; Dr Antonio Giordano for p130 pGEX plasmids; Dr Xavier Mayol for GST-E2F4 vector; and Dr Alan Cassady for the pGL2b plasmid. This work was supported by the Ministerio de Ciencia y Tecnologia of Spain (grants SAF2006-05212 and SAF2009-07769 to OB and SAF2009-06954 to NL-B; the Fondo de Investigacion Sanitaria (grant PI070778 to LE), the Instituto de Salud Carlos III (RETICS RD06/0020/0010 to OB, RD06/0020/0029 to JP and RD06/0020/0098 to A. Bigas), the Comunidad Autonoma de Madrid (Oncocycle Program grant S2006/BIO-0232 to JP) and the Generalitat de Catalunya (grant SGR 09-1382 to OB). GG is supported by a fellowship from AGAUR of the Catalonian Government. AB is supported by grants from the Association pour la recherche sur le Cancer, Ligue Nationale Contre le Cancer and Institue National du Cancer.	Acosta JC, 2008, MOL CELL BIOL, V28, P7286, DOI 10.1128/MCB.00752-08; Aguilera C, 2004, P NATL ACAD SCI USA, V101, P16537, DOI 10.1073/pnas.0404429101; Baldassarre G, 2005, CANCER CELL, V7, P51, DOI 10.1016/j.ccr.2004.11.025; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Besson A, 2007, GENE DEV, V21, P1731, DOI 10.1101/gad.1556607; Blain SW, 2008, CELL CYCLE, V7, P892, DOI 10.4161/cc.7.7.5637; Blanco E, 2006, PLOS COMPUT BIOL, V2, P403, DOI 10.1371/journal.pcbi.0020049; Brune V, 2008, J EXP MED, V205, P2251, DOI 10.1084/jem.20080809; Carter BZ, 2006, CELL CYCLE, V5, P2223, DOI 10.4161/cc.5.19.3255; Casey T, 2009, BREAST CANCER RES TR, V114, P47, DOI 10.1007/s10549-008-9982-8; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Cobrinik D, 1996, GENE DEV, V10, P1633, DOI 10.1101/gad.10.13.1633; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; Gundem G, 2010, NAT METHODS, V7, P92, DOI 10.1038/nmeth0210-92; Gutierrez NC, 2007, LEUKEMIA, V21, P541, DOI 10.1038/sj.leu.2404520; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Huszar D, 2009, CANCER METAST REV, V28, P197, DOI 10.1007/s10555-009-9185-8; James MK, 2008, MOL CELL BIOL, V28, P498, DOI 10.1128/MCB.02171-06; Jones MH, 2004, LANCET, V363, P775, DOI 10.1016/S0140-6736(04)15693-6; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Lopez-Bigas N, 2008, MOL CELL, V31, P520, DOI 10.1016/j.molcel.2008.08.004; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Macaluso M, 2006, ONCOGENE, V25, P5263, DOI 10.1038/sj.onc.1209680; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Malumbres M, 2007, CURR OPIN GENET DEV, V17, P60, DOI 10.1016/j.gde.2006.12.008; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; McAllister SS, 2003, MOL CELL BIOL, V23, P216, DOI 10.1128/MCB.23.1.216-228.2003; Munoz-Alonso MJ, 2005, J BIOL CHEM, V280, P18120, DOI 10.1074/jbc.M500758200; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Perez-Llamas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019541; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Piccaluga PP, 2007, J CLIN INVEST, V117, P823, DOI 10.1172/JCI26833; Pyeon D, 2007, CANCER RES, V67, P4605, DOI 10.1158/0008-5472.CAN-06-3619; Rayman JB, 2002, GENE DEV, V16, P933, DOI 10.1101/gad.969202; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Saijo T, 2006, LUNG CANCER, V54, P217, DOI 10.1016/j.lungcan.2006.06.018; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shirane M, 1999, J BIOL CHEM, V274, P13886, DOI 10.1074/jbc.274.20.13886; Sicinski P, 2007, GENE DEV, V21, P1703, DOI 10.1101/gad.1583207; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Soeiro I, 2006, MOL CELL BIOL, V26, P6170, DOI 10.1128/MCB.02182-05; Vera J, 2007, PROTEOMICS, V7, P578, DOI 10.1002/pmic.200600458; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762; Yeh N, 2007, MOL CELL BIOL, V27, P5161, DOI 10.1128/MCB.02431-06	58	54	54	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2012	31	38					4207	4220		10.1038/onc.2011.582	http://dx.doi.org/10.1038/onc.2011.582			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	008SC	22179826				2022-12-25	WOS:000308975800004
J	Kasiviswanathan, R; Gustafson, MA; Copeland, WC; Meyer, JN				Kasiviswanathan, Rajesh; Gustafson, Margaret A.; Copeland, William C.; Meyer, Joel N.			Human Mitochondrial DNA Polymerase gamma Exhibits Potential for Bypass and Mutagenesis at UV-induced Cyclobutane Thymine Dimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ULTRAVIOLET-RADIATION EXPOSURE; MISMATCH-REPAIR ACTIVITY; NONMELANOMA SKIN-CANCER; ESCHERICHIA-COLI; NUCLEOTIDE INCORPORATION; MAMMALIAN MITOCHONDRIA; MALIGNANT-MELANOMA; OXIDATIVE STRESS; COMMON DELETION; LESION BYPASS	Cyclobutane thymine dimers (T-T) comprise the majority of DNA damage caused by short wavelength ultraviolet radiation. These lesions generally block replicative DNA polymerases and are repaired by nucleotide excision repair or bypassed by translesion polymerases in the nucleus. Mitochondria lack nucleotide excision repair, and therefore, it is important to understand how the sole mitochondrial DNA polymerase, pol gamma, interacts with irreparable lesions such as T-T. We performed in vitro DNA polymerization assays to measure the kinetics of incorporation opposite the lesion and bypass of the lesion by pol gamma with a dimer-containing template. Exonuclease-deficient pol gamma bypassed thymine dimers with low relative efficiency; bypass was attenuated but still detectable when using exonuclease-proficient pol gamma. When bypass did occur, pol gamma misincorporated a guanine residue opposite the 3'-thymine of the dimer only 4-fold less efficiently than it incorporated an adenine. Surprisingly, the pol gamma exonuclease-proficient enzyme excised the incorrectly incorporated guanine at similar rates irrespective of the nature of the thymines in the template. In the presence of all four dNTPs, pol gamma extended the primer after incorporation of two adenines opposite the lesion with relatively higher efficiency compared with extension past either an adenine or a guanine incorporated opposite the 3'-thymine of the T-T. Our results suggest that T-T usually stalls mitochondrial DNA replication but also suggest a mechanism for the introduction of point mutations and deletions in the mitochondrial genomes of chronically UV-exposed cells.	[Gustafson, Margaret A.; Meyer, Joel N.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Kasiviswanathan, Rajesh; Copeland, William C.] NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA	Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Meyer, JN (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	joel.meyer@duke.edu	Copeland, William/C-4242-2019; Kasiviswanathan, Rajesh/D-2744-2012; Meyer, Joel/G-9836-2017	Copeland, William/0000-0002-0359-0953; Meyer, Joel/0000-0003-1219-0983	National Institutes of Health [R21 NS065468, ES 065078]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017540, Z01ES065078, ZIAES065078] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS065468] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R21 NS065468 (to J. N. M.) and ES 065078 (to W. C. C.).	Alberts B., 2008, MOL BIOL CELL, P856; Berneburg M, 2004, J INVEST DERMATOL, V122, P1277, DOI 10.1111/j.0022-202X.2004.22502.x; Berneburg M, 1997, PHOTOCHEM PHOTOBIOL, V66, P271, DOI 10.1111/j.1751-1097.1997.tb08654.x; Birch-Machin MA, 2010, MUTAGENESIS, V25, P101, DOI 10.1093/mutage/gep061; Birket MJ, 2007, AGING CELL, V6, P557, DOI 10.1111/j.1474-9726.2007.00310.x; Bohr VA, 1999, J BIOENERG BIOMEMBR, V31, P391, DOI 10.1023/A:1005484004167; BOLLUM FJ, 1963, BIOCHIM BIOPHYS ACTA, V68, P599; BOOTSMA D, 1968, MUTAT RES, V5, P289, DOI 10.1016/0027-5107(68)90027-4; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; CLAYTON DA, 1974, P NATL ACAD SCI USA, V71, P2777, DOI 10.1073/pnas.71.7.2777; CLEAVER JE, 1967, RADIAT RES, V30, P795, DOI 10.2307/3572145; de Souza-Pinto NC, 2009, DNA REPAIR, V8, P704, DOI 10.1016/j.dnarep.2009.01.021; Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602; Durham SE, 2003, BRIT J CANCER, V88, P90, DOI 10.1038/sj.bjc.6600773; EDENBERG HJ, 1976, BIOPHYS J, V16, P849, DOI 10.1016/S0006-3495(76)85735-9; Friedberg EC, 2006, DNA REPAIR MUTAGENES, pxxix; Gandhi VV, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002078; Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d; Graziewicz MA, 2004, NUCLEIC ACIDS RES, V32, P397, DOI 10.1093/nar/gkh213; Gueranger Q, 2008, DNA REPAIR, V7, P1551, DOI 10.1016/j.dnarep.2008.05.012; Harbottle A, 2006, BRIT J CANCER, V94, P1887, DOI 10.1038/sj.bjc.6603178; HAYES FN, 1971, J AM CHEM SOC, V93, P4940, DOI 10.1021/ja00748a065; HEYDUK T, 1990, P NATL ACAD SCI USA, V87, P1744, DOI 10.1073/pnas.87.5.1744; HIXON S, 1978, BIOCHEM BIOPH RES CO, V81, P288, DOI 10.1016/0006-291X(78)91531-0; KAGUNI LS, 1989, P NATL ACAD SCI USA, V86, P6469, DOI 10.1073/pnas.86.17.6469; KALINOWSKI DP, 1992, NUCLEIC ACIDS RES, V20, P3485, DOI 10.1093/nar/20.13.3485; Kasiviswanathan R, 2010, METHODS, V51, P379, DOI 10.1016/j.ymeth.2010.02.015; Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94; Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4; Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197; LIVNEH Z, 1986, P NATL ACAD SCI USA, V83, P4599, DOI 10.1073/pnas.83.13.4599; Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303; Longley MJ, 2010, J BIOL CHEM, V285, P29690, DOI 10.1074/jbc.M110.151795; Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w; Mason PA, 2003, NUCLEIC ACIDS RES, V31, P1052, DOI 10.1093/nar/gkg167; McCulloch SD, 2006, DNA REPAIR, V5, P1373, DOI 10.1016/j.dnarep.2006.06.003; McCulloch SD, 2004, NATURE, V428, P97, DOI 10.1038/nature02352; Meyer JN, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r70; Nelson JR, 1996, SCIENCE, V272, P1646, DOI 10.1126/science.272.5268.1646; OLSON MW, 1992, J BIOL CHEM, V267, P23136; Pascucci B, 1997, J MOL BIOL, V273, P417, DOI 10.1006/jmbi.1997.1268; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; PINZ KG, 1995, J BIOL CHEM, V270, P9202, DOI 10.1074/jbc.270.16.9202; Poetsch M, 2004, MELANOMA RES, V14, P501, DOI 10.1097/00008390-200412000-00010; Poetsch M, 2004, DIAGN MOL PATHOL, V13, P26, DOI 10.1097/00019606-200403000-00005; RABKIN SD, 1983, P NATL ACAD SCI-BIOL, V80, P1541, DOI 10.1073/pnas.80.6.1541; Ray AJ, 2000, J INVEST DERMATOL, V115, P674, DOI 10.1046/j.1523-1747.2000.00092.x; Reimann V, 2008, J INVEST DERMATOL, V128, P1294, DOI 10.1038/sj.jid.5701151; Schroeder P, 2008, J INVEST DERMATOL, V128, P2297, DOI 10.1038/jid.2008.57; SETLOW RB, 1963, SCIENCE, V142, P1464, DOI 10.1126/science.142.3598.1464; Shidara Y, 2005, CANCER RES, V65, P1655, DOI 10.1158/0008-5472.CAN-04-2012; Song SW, 2005, P NATL ACAD SCI USA, V102, P4990, DOI 10.1073/pnas.0500253102; Takeuchi H, 2004, ANN NY ACAD SCI, V1022, P50, DOI 10.1196/annals.1318.009; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; Tissier A, 2000, EMBO J, V19, P5259, DOI 10.1093/emboj/19.19.5259; Vaisman A, 1999, BIOCHEMISTRY-US, V38, P11026, DOI 10.1021/bi9909187; Van Houten B, 2006, DNA REPAIR, V5, P145, DOI 10.1016/j.dnarep.2005.03.002; YOSHIDA S, 1981, BIOCHIM BIOPHYS ACTA, V652, P324, DOI 10.1016/0005-2787(81)90122-2; Zhang YB, 2002, J BIOL CHEM, V277, P44582, DOI 10.1074/jbc.M207297200	59	28	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9222	9229		10.1074/jbc.M111.306852	http://dx.doi.org/10.1074/jbc.M111.306852			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22194617	hybrid, Green Published			2022-12-25	WOS:000301797800050
J	Baglieri, J; Beck, D; Vasisht, N; Smith, CJ; Robinson, C				Baglieri, Jacopo; Beck, Daniel; Vasisht, Nishi; Smith, Corinne J.; Robinson, Colin			Structure of TatA Paralog, TatE, Suggests a Structurally Homogeneous Form of Tat Protein Translocase That Transports Folded Proteins of Differing Diameter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEC-INDEPENDENT PROTEIN; TWIN-ARGININE TRANSLOCASE; BLUE NATIVE ELECTROPHORESIS; ESCHERICHIA-COLI; MEMBRANE-PROTEIN; ELECTRON-MICROSCOPY; SIGNAL PEPTIDE; BACILLUS-SUBTILIS; SINGLE PARTICLES; OXIDE REDUCTASE	The twin-arginine translocation (Tat) system transports folded proteins across bacterial and plant thylakoid membranes. Most current models for the translocation mechanism propose the coalescence of a substrate-binding TatABC complex with a separate TatA complex. In Escherichia coli, TatA complexes are widely believed to form the translocation pore, and the size variation of TatA has been linked to the transport of differently sized substrates. Here, we show that the TatA paralog TatE can substitute for TatA and support translocation of Tat substrates including AmiA, AmiC, and TorA. However, TatE is found as much smaller, discrete complexes. Gel filtration and blue native electrophoresis suggest sizes between similar to 50 and 110 kDa, and single-particle processing of electron micrographs gives size estimates of 70-90 kDa. Three-dimensional models of the two principal TatE complexes show estimated diameters of 6-8 nm and potential clefts or channels of up to 2.5 nm diameter. The ability of TatE to support translocation of the 90-kDa TorA protein suggests alternative translocation models in which single TatA/E complexes do not contribute the bulk of the translocation channel. The homogeneity of both the TatABC and the TatE complexes further suggests that a discrete Tat translocase can translocate a variety of substrates, presumably through the use of a flexible channel. The presence and possible significance of double- or triple-ring TatE forms is discussed.	[Baglieri, Jacopo; Beck, Daniel; Vasisht, Nishi; Smith, Corinne J.; Robinson, Colin] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick	Robinson, C (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	colin.robinson@warwick.ac.uk	Baglieri, Jacopo/AAR-9696-2020; Smith, Corinne J/A-3170-2009	Smith, Corinne J/0000-0003-3364-7946; Baglieri, Jacopo/0000-0002-5760-4812	Transys ITN (Marie Curie Initial Training Network) [215524]; Wellcome Trust [055663/Z/98/Z]; Biotechnology and Biological Sciences Research Council [BB/E010245/1] Funding Source: researchfish; BBSRC [BB/E010245/1] Funding Source: UKRI	Transys ITN (Marie Curie Initial Training Network); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funded by Transys ITN (Marie Curie Initial Training Network, Project 215524).; We are grateful to Ian Portman for technical help with electron microscopy and to the Wellcome Trust for generous support (Grant 055663/Z/98/Z) to the Imaging Suite at the University of Warwick. We thank Dr. James P Barnett for advice and useful discussions and Professor Gunner Von Heijne for providing the leader peptidase expression plasmid and anti-leader peptidase antiserum.	Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Beloin C, 2004, MOL MICROBIOL, V51, P659, DOI 10.1046/j.1365-2958.2003.03865.x; Bernhardt TG, 2003, MOL MICROBIOL, V48, P1171, DOI 10.1046/j.1365-2958.2003.03511.x; Bogsch EG, 1998, J BIOL CHEM, V273, P18003, DOI 10.1074/jbc.273.29.18003; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; CASADABAN MJ, 1979, P NATL ACAD SCI USA, V76, P4530, DOI 10.1073/pnas.76.9.4530; CHADDOCK AM, 1995, EMBO J, V14, P2715, DOI 10.1002/j.1460-2075.1995.tb07272.x; DALBEY RE, 1985, J BIOL CHEM, V260, P5925; deGier JWL, 1996, FEBS LETT, V399, P307, DOI 10.1016/S0014-5793(96)01354-3; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gerard F, 2006, J BIOL CHEM, V281, P6130, DOI 10.1074/jbc.M512733200; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Heikkila MP, 2001, J BACTERIOL, V183, P1663, DOI 10.1128/JB.183.5.1663-1671.2001; Hu YF, 2010, J AM CHEM SOC, V132, P15942, DOI 10.1021/ja1053785; Ikeda M, 2003, APPL MICROBIOL BIOT, V62, P99, DOI 10.1007/s00253-003-1328-1; Ize B, 2003, MOL MICROBIOL, V48, P1183, DOI 10.1046/j.1365-2958.2003.03504.x; Jack RL, 2001, J BACTERIOL, V183, P1801, DOI 10.1128/JB.183.5.1801-1804.2001; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Muller M, 2005, MOL MEMBR BIOL, V22, P113, DOI 10.1080/09687860500041809; Oates J, 2005, J MOL BIOL, V346, P295, DOI 10.1016/j.jmb.2004.11.047; PENCZEK P, 1992, ULTRAMICROSCOPY, V40, P33, DOI 10.1016/0304-3991(92)90233-A; Porcelli I, 2002, BIOCHEMISTRY-US, V41, P13690, DOI 10.1021/bi026142i; Robinson C, 2011, BBA-BIOMEMBRANES, V1808, P876, DOI 10.1016/j.bbamem.2010.11.023; Rubinstein JL, 2007, METHODS, V41, P409, DOI 10.1016/j.ymeth.2006.07.019; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Sargent F, 1999, J BIOL CHEM, V274, P36073, DOI 10.1074/jbc.274.51.36073; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; SILVESTRO A, 1989, BIOCHIM BIOPHYS ACTA, V999, P208, DOI 10.1016/0167-4838(89)90220-3; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; Tarry MJ, 2009, P NATL ACAD SCI USA, V106, P13284, DOI 10.1073/pnas.0901566106; Walther TH, 2010, J AM CHEM SOC, V132, P15945, DOI 10.1021/ja106963s; Warren G, 2009, J MOL BIOL, V388, P122, DOI 10.1016/j.jmb.2009.02.060; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; Wexler M, 2000, J BIOL CHEM, V275, P16717, DOI 10.1074/jbc.M000800200; White HE, 2004, J MOL BIOL, V336, P453, DOI 10.1016/j.jmb.2003.12.015; Yen MR, 2002, ARCH MICROBIOL, V177, P441, DOI 10.1007/s00203-002-0408-4	40	28	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7335	7344		10.1074/jbc.M111.326355	http://dx.doi.org/10.1074/jbc.M111.326355			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22190680	Green Published, hybrid			2022-12-25	WOS:000301060200035
J	Guillot-Sestier, MV; Sunyach, C; Ferreira, ST; Marzolo, MP; Bauer, C; Thevenet, A; Checler, F				Guillot-Sestier, Marie-Victoire; Sunyach, Claire; Ferreira, Sergio T.; Marzolo, Maria-Paz; Bauer, Charlotte; Thevenet, Aurelie; Checler, Frederic			alpha-Secretase-derived Fragment of Cellular Prion, N1, Protects against Monomeric and Oligomeric Amyloid beta (A beta)-associated Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN; HEK293 HUMAN-CELLS; PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; WILD-TYPE; MUSCARINIC RECEPTORS; SYNAPTIC PLASTICITY; P53; PRESENILIN-1; CLEAVAGE	In physiological conditions, both beta-amyloid precursor protein (beta APP) and cellular prion (PrPc) undergo similar disintegrin-mediated alpha-secretase cleavage yielding N-terminal secreted products referred to as soluble amyloid precursor protein-alpha (sAPP alpha) and N1, respectively. We recently demonstrated that N1 displays neuroprotective properties by reducing p53-dependent cell death both in vitro and in vivo. In this study, we examined the potential of N1 as a neuroprotector against amyloid beta (A beta)-mediated toxicity. We first show that both recombinant sAPP alpha and N1, but not its inactive parent fragment N2, reduce staurosporine-stimulated caspase-3 activation and TUNEL-positive cell death by lowering p53 promoter transactivation and activity in human cells. We demonstrate that N1 also lowers toxicity, cell death, and p53 pathway exacerbation triggered by Swedish mutated beta APP overexpression in human cells. We designed a CHO cell line overexpressing the London mutated beta APP (APP(LDN)) that yields A beta oligomers. N1 protected primary cultured neurons against toxicity and cell death triggered by oligomer-enriched APP(LDN)-derived conditioned medium. Finally, we establish that N1 also protects neurons against oligomers extracted from Alzheimer disease-affected brain tissues. Overall, our data indicate that a cellular prion catabolite could interfere with A beta-associated toxicity and that its production could be seen as a cellular protective mechanism aimed at compensating for an sAPP alpha deficit taking place at the early asymptomatic phase of Alzheimer disease.	[Guillot-Sestier, Marie-Victoire; Sunyach, Claire; Bauer, Charlotte; Thevenet, Aurelie; Checler, Frederic] Univ Nice Sophia Antipolis UNSA, Inst Pharmacol Mol & Cellulaire, CNRS, UMR6097, F-06560 Valbonne, France; [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem, BR-21941590 Rio De Janeiro, RJ, Brazil; [Marzolo, Maria-Paz] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Lab Traf Intracelular & Senalizac, Dept Biol Celular & Mol, Santiago 6513492, Chile	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Universidade Federal do Rio de Janeiro; Pontificia Universidad Catolica de Chile	Checler, F (corresponding author), Univ Nice Sophia Antipolis UNSA, Inst Pharmacol Mol & Cellulaire, CNRS, UMR6097, 660 Route Lucioles, F-06560 Valbonne, France.	checler@ipmc.cnrs.fr	Ferreira, Sergio/AAZ-1576-2020; Neurociencia, Inct/I-1011-2013; Checler, Frederic/C-1241-2009	Ferreira, Sergio/0000-0001-7160-9866; Checler, Frederic/0000-0003-2098-1750; Guillot-Sestier, Marie-Victoire/0000-0001-9674-7114	Fondation pour la Recherche Medicale; Conseil general des Alpes Maritimes; Fondecyt [1110382]; Millennium Nucleus [P-07-011-F]	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Conseil general des Alpes Maritimes(Region Provence-Alpes-Cote d'Azur); Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Millennium Nucleus	This work was supported in part by the Fondation pour la Recherche Medicale and by the Conseil general des Alpes Maritimes.; Supported by Fondecyt Grant 1110382 and Millennium Nucleus Grant P-07-011-F.	Altmeppen HC, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-36; Andrau D, 2003, J BIOL CHEM, V278, P25859, DOI 10.1074/jbc.M302622200; Armogida M, 2001, NAT CELL BIOL, V3, P1030, DOI 10.1038/ncb1101-1030; Barelli HL, 1997, MOL MED, V3, P695, DOI 10.1007/BF03401708; Benilova I, 2010, EMBO MOL MED, V2, P289, DOI 10.1002/emmm.201000088; Brandan E, 2006, J BIOL CHEM, V281, P31562, DOI 10.1074/jbc.M602919200; Caccamo A, 2006, NEURON, V49, P671, DOI 10.1016/j.neuron.2006.01.020; Caetano FA, 2011, J NEUROCHEM, V117, P538, DOI 10.1111/j.1471-4159.2011.07225.x; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; CHECLER F, 1995, J NEUROCHEM, V65, P1431; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Cheng GJ, 2002, EXP NEUROL, V175, P407, DOI 10.1006/exnr.2002.7920; Chevallier N, 1997, BRIT J PHARMACOL, V121, P556, DOI 10.1038/sj.bjp.0701151; Cisse M, 2011, J BIOL CHEM, V286, P29192, DOI 10.1074/jbc.M110.208249; Cisse M, 2011, J NEUROSCI, V31, P10427, DOI 10.1523/JNEUROSCI.1459-11.2011; Cisse M, 2011, MOL CELL NEUROSCI, V47, P223, DOI 10.1016/j.mcn.2011.04.008; Cisse MA, 2007, J NEUROSCI, V27, P4083, DOI 10.1523/JNEUROSCI.5293-06.2007; da Costa CA, 2000, J BIOL CHEM, V275, P24065, DOI 10.1074/jbc.M002413200; da Costa CA, 2006, J NEUROSCI, V26, P6377, DOI 10.1523/JNEUROSCI.0651-06.2006; da Costa CA, 2002, P NATL ACAD SCI USA, V99, P4043, DOI 10.1073/pnas.062059899; Etcheberrigaray R, 2004, P NATL ACAD SCI USA, V101, P11141, DOI 10.1073/pnas.0403921101; Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003; Fuentealba RA, 2009, J BIOL CHEM, V284, P34045, DOI 10.1074/jbc.M109.021030; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOODMAN Y, 1994, EXP NEUROL, V128, P1, DOI 10.1006/exnr.1994.1107; Gralle M, 2002, BIOPHYS J, V83, P3513, DOI 10.1016/S0006-3495(02)75351-4; Guillot-Sestier MV, 2009, J BIOL CHEM, V284, P35973, DOI 10.1074/jbc.M109.051086; HAASS C, 1993, CELL, V75, P1039, DOI 10.1016/0092-8674(93)90312-E; Heber S, 2000, J NEUROSCI, V20, P7951; Henry A, 1997, PROTEIN EXPRES PURIF, V10, P283, DOI 10.1006/prep.1997.0748; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Huber G, 1997, NEUROSCIENCE, V80, P313, DOI 10.1016/S0306-4522(97)00120-6; Iwatsubo T, 2004, CURR OPIN NEUROBIOL, V14, P379, DOI 10.1016/j.conb.2004.05.010; Jimenez S, 2011, J BIOL CHEM, V286, P18414, DOI 10.1074/jbc.M110.209718; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; KOUNNAS MZ, 1995, CELL, V82, P331, DOI 10.1016/0092-8674(95)90320-8; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lefranc-Jullien S, 2005, BRIT J PHARMACOL, V145, P228, DOI 10.1038/sj.bjp.0706183; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Ma L, 2009, J ALZHEIMERS DIS, V16, P565, DOI 10.3233/JAD-2009-0990; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; MENSAWILMOT K, 1994, J CELL BIOL, V124, P935, DOI 10.1083/jcb.124.6.935; Morel M, 2009, NEUROBIOL DIS, V36, P151, DOI 10.1016/j.nbd.2009.07.004; Nygaard HB, 2009, ARCH NEUROL-CHICAGO, V66, P1325, DOI 10.1001/archneurol.2009.223; Ohyagi Y, 2005, FASEB J, V19, P255, DOI 10.1096/fj.04-2637fje; Paitel E, 2004, J BIOL CHEM, V279, P612, DOI 10.1074/jbc.M310453200; Parkyn CJ, 2008, J CELL SCI, V121, P773, DOI 10.1242/jcs.021816; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Sevalle J, 2009, J NEUROCHEM, V110, P275, DOI 10.1111/j.1471-4159.2009.06131.x; Sevalle J, 2009, J NEUROCHEM, V109, P248, DOI 10.1111/j.1471-4159.2009.05950.x; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2011, METHODS MOL BIOL, V670, P33, DOI 10.1007/978-1-60761-744-0_3; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Sunyach C, 2007, J BIOL CHEM, V282, P1956, DOI 10.1074/jbc.M609663200; Taylor DR, 2007, BIOCHEM J, V402, P17, DOI 10.1042/BJ20061736; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vincent B, 2000, J BIOL CHEM, V275, P35612, DOI 10.1074/jbc.M004628200; Vincent B, 2001, J BIOL CHEM, V276, P37743; Vincent B, 1996, J NEUROSCI, V16, P5049; Vincent B, 2008, CURR ALZHEIMER RES, V5, P202, DOI 10.2174/156720508783954749; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Xu X, 1999, P NATL ACAD SCI USA, V96, P7547, DOI 10.1073/pnas.96.13.7547; Zhang Y, 2002, J CELL BIOL, V156, P519, DOI 10.1083/jcb.200110119	69	74	75	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					5021	5032		10.1074/jbc.M111.323626	http://dx.doi.org/10.1074/jbc.M111.323626			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22184125	hybrid, Green Published			2022-12-25	WOS:000300608500061
J	Qian, P; Marklew, CJ; Viney, J; Davison, PA; Brindley, AA; Soderberg, C; Al-Karadaghi, S; Bullough, PA; Grossmann, JG; Hunter, CN				Qian, Pu; Marklew, Christopher J.; Viney, Joanne; Davison, Paul A.; Brindley, Amanda A.; Soderberg, Christopher; Al-Karadaghi, Salam; Bullough, Per A.; Grossmann, J. Guenter; Hunter, C. Neil			Structure of the Cyanobacterial Magnesium Chelatase H Subunit Determined by Single Particle Reconstruction and Small-angle X-ray Scattering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTOPORPHYRIN-IX METHYLTRANSFERASE; MG-CHELATASE; ATPASE ACTIVITY; ABSCISIC-ACID; CHLOROPHYLL BIOSYNTHESIS; RHODOBACTER-SPHAEROIDES; SYNECHOCYSTIS PCC6803; ESCHERICHIA-COLI; BCHH; GUN4	The biosynthesis of chlorophyll, an essential cofactor for photosynthesis, requires the ATP-dependent insertion of Mg2+ into protoporphyrin IX catalyzed by the multisubunit enzyme magnesium chelatase. This enzyme complex consists of the I subunit, an ATPase that forms a complex with the D subunit, and an H subunit that binds both the protoporphyrin substrate and the magnesium protoporphyrin product. In this study we used electron microscopy and small-angle x-ray scattering to investigate the structure of the magnesium chelatase H subunit, ChlH, from the thermophilic cyanobacterium Thermosynechococcus elongatus. Single particle reconstruction of negatively stained apo-ChlH and Chl-porphyrin proteins was used to reconstitute three-dimensional structures to a resolution of similar to 30 angstrom. ChlH is a large, 148-kDa protein of 1326 residues, forming a cage-like assembly comprising the majority of the structure, attached to a globular N-terminal domain of similar to 16 kDa by a narrow linker region. This N-terminal domain is adjacent to a 5 nm-diameter opening in the structure that allows access to a cavity. Small-angle x-ray scattering analysis of ChlH, performed on soluble, catalytically active ChlH, verifies the presence of two domains and their relative sizes. Our results provide a basis for the multiple regulatory and catalytic functions of ChlH of oxygenic photosynthetic organisms and for a chaperoning function that sequesters the enzyme-bound magnesium protoporphyrin product prior to its delivery to the next enzyme in the chlorophyll biosynthetic pathway, magnesium protoporphyrin methyltransferase.	[Qian, Pu; Marklew, Christopher J.; Viney, Joanne; Davison, Paul A.; Brindley, Amanda A.; Bullough, Per A.; Hunter, C. Neil] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Soderberg, Christopher; Al-Karadaghi, Salam] Lund Univ, Dept Mol Biophys, Ctr Mol Prot Sci, S-22100 Lund, Sweden; [Grossmann, J. Guenter] Univ Liverpool, Fac Hlth & Life Sci, Inst Integrat Biol, Mol Biophys Grp, Liverpool L69 7ZB, Merseyside, England	University of Sheffield; Lund University; University of Liverpool	Hunter, CN (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.	c.n.hunter@sheffield.ac	Al-karadaghi, Salam/F-1492-2011; Qian, Pu/GZM-2400-2022	Al-karadaghi, Salam/0000-0001-8608-0635; Bullough, Per/0000-0001-8147-1127	Biotechnology and Biological Sciences Research Council (UK); Biotechnology and Biological Sciences Research Council [BB/G021546/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a grant from the Biotechnology and Biological Sciences Research Council (UK) (to C. N. H. and P. A. B.). This work was also supported by doctoral studentships from the Biotechnology and Biological Sciences Research Council (UK) (to J. V. and C. J. M.).	Adhikari ND, 2011, PLANT CELL, V23, P1449, DOI 10.1105/tpc.110.082503; Alawady A, 2005, PLANT MOL BIOL, V57, P679, DOI 10.1007/s11103-005-1427-8; Bjorn L, 2009, PHOTOSYNTH RES, V99, P85, DOI 10.1007/s11120-008-9395-x; Chew AGM, 2009, PHOTOSYNTH RES, V101, P21, DOI 10.1007/s11120-009-9460-0; Davison PA, 2005, BIOCHEMISTRY-US, V44, P7603, DOI 10.1021/bi050240x; Davison PA, 2011, FEBS LETT, V585, P183, DOI 10.1016/j.febslet.2010.11.037; Elmlund H, 2008, J MOL BIOL, V375, P934, DOI 10.1016/j.jmb.2007.11.028; Fodje MN, 2001, J MOL BIOL, V311, P111, DOI 10.1006/jmbi.2001.4834; Gibson LCD, 1999, BIOCHEM J, V337, P243, DOI 10.1042/0264-6021:3370243; GIBSON LCD, 1995, P NATL ACAD SCI USA, V92, P1941, DOI 10.1073/pnas.92.6.1941; Gibson LCD, 1996, PLANT PHYSIOL, V111, P61, DOI 10.1104/pp.111.1.61; Grossmann J. G., 2002, SCATTERING, P1123; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hinchigeri SB, 1997, FEBS LETT, V407, P337, DOI 10.1016/S0014-5793(97)00371-2; HUDSON A, 1993, EMBO J, V12, P3711, DOI 10.1002/j.1460-2075.1993.tb06048.x; Jensen PE, 1999, BIOCHEM J, V339, P127, DOI 10.1042/0264-6021:3390127; Jensen PE, 1998, BIOCHEM J, V334, P335, DOI 10.1042/bj3340335; Jensen PE, 1996, J BIOL CHEM, V271, P16662, DOI 10.1074/jbc.271.28.16662; Johnson ET, 2008, J BIOL CHEM, V283, P27776, DOI 10.1074/jbc.M804486200; Karger GA, 2001, BIOCHEMISTRY-US, V40, P9291, DOI 10.1021/bi010562a; KNIGHT S, 1990, J MOL BIOL, V215, P113, DOI 10.1016/S0022-2836(05)80100-7; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Larkin RM, 2003, SCIENCE, V299, P902, DOI 10.1126/science.1079978; Lundqvist J, 2010, STRUCTURE, V18, P354, DOI 10.1016/j.str.2010.01.001; Maqueo Chew AG, 2007, ANNU REV MICROBIOL, V61, P113, DOI 10.1146/annurev.micro.61.080706.093242; MEISENBERGER O, 1984, J BIOL CHEM, V259, P4463; Mochizuki N, 2001, P NATL ACAD SCI USA, V98, P2053, DOI 10.1073/pnas.98.4.2053; Muller AH, 2009, PLANT PHYSIOL, V150, P157, DOI 10.1104/pp.109.135277; Osanai T, 2009, P NATL ACAD SCI USA, V106, P6860, DOI 10.1073/pnas.0810040106; Papenbrock J, 1997, PLANT J, V12, P981, DOI 10.1046/j.1365-313X.1997.12050981.x; Peter E, 2009, MOL PLANT, V2, P1198, DOI 10.1093/mp/ssp072; Petersen BL, 1998, J BACTERIOL, V180, P699, DOI 10.1128/JB.180.3.699-704.1998; Petoukhov MV, 2003, J APPL CRYSTALLOGR, V36, P540, DOI 10.1107/S0021889803000591; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reid JD, 2003, BIOCHEMISTRY-US, V42, P6912, DOI 10.1021/bi034082q; Reid JD, 2004, J BIOL CHEM, V279, P26893, DOI 10.1074/jbc.M400958200; Ruzheinikov SN, 2001, STRUCTURE, V9, P789, DOI 10.1016/S0969-2126(01)00645-1; Sawicki A, 2007, BIOCHEM J, V406, P469, DOI 10.1042/BJ20070284; Sawicki A, 2010, FEBS J, V277, P4709, DOI 10.1111/j.1742-4658.2010.07877.x; SCHATZ M, 1990, ULTRAMICROSCOPY, V32, P255, DOI 10.1016/0304-3991(90)90003-5; Shang Y, 2010, PLANT CELL, V22, P1909, DOI 10.1105/tpc.110.073874; Shen Y, 2005, CHEM-EUR J, V11, P1549, DOI 10.1002/chem.200400298; Shen YY, 2006, NATURE, V443, P823, DOI 10.1038/nature05176; Shepherd M, 2005, FEBS J, V272, P4532, DOI 10.1111/j.1742-4658.2005.04873.x; Shepherd M, 2004, BIOCHEM J, V382, P1009, DOI 10.1042/BJ20040661; Shepherd M, 2003, BIOCHEM J, V371, P351, DOI 10.1042/BJ20021394; Sirijovski N, 2008, J BIOL CHEM, V283, P11652, DOI 10.1074/jbc.M709172200; Sobotka R, 2008, J BIOL CHEM, V283, P25794, DOI 10.1074/jbc.M803787200; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2002, CURR OPIN STRUC BIOL, V12, P654, DOI 10.1016/S0959-440X(02)00363-9; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tsuzuki T, 2011, J PLANT RES, V124, P527, DOI 10.1007/s10265-011-0426-x; van Heel M, 2005, J STRUCT BIOL, V151, P250, DOI 10.1016/j.jsb.2005.05.009; VANHEEL M, 1985, EMBO J, V4, P2389, DOI 10.1002/j.1460-2075.1985.tb03944.x; VANHEEL M, 1981, ULTRAMICROSCOPY, V6, P187, DOI 10.1016/0304-3991(81)90059-0; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Verdecia MA, 2005, PLOS BIOL, V3, P777, DOI 10.1371/journal.pbio.0030151; Viney J, 2007, BIOCHEMISTRY-US, V46, P12788, DOI 10.1021/bi701515y; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wilde A, 2004, FEBS LETT, V571, P119, DOI 10.1016/j.febslet.2004.06.063; Willows RD, 2004, J STRUCT BIOL, V146, P227, DOI 10.1016/j.jsb.2003.11.019; Willows RD, 2003, J BACTERIOL, V185, P3249, DOI 10.1128/JB.185.11.3249-3258.2003; Wu FQ, 2009, PLANT PHYSIOL, V150, P1940, DOI 10.1104/pp.109.140731	64	16	16	0	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4946	4956		10.1074/jbc.M111.308239	http://dx.doi.org/10.1074/jbc.M111.308239			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22179610	Green Published, hybrid			2022-12-25	WOS:000300608500055
J	Wu, JY; Kuo, CC				Wu, Jing-Yiing; Kuo, Cheng-Chin			Pivotal Role of ADP-ribosylation Factor 6 in Toll-like Receptor 9-mediated Immune Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEOXYRIBONUCLEIC-ACID FRACTION; CPG-B OLIGODEOXYNUCLEOTIDE; MYCOBACTERIUM-BOVIS BCG; BACTERIAL-DNA; INTERFERON-GAMMA; DENDRITIC CELLS; ARF GAPS; RECOGNITION; ACTIVATION; TLR9	CpG oligodeoxynucleotide (CpG ODN) cellular uptake into endosomes, the rate-limiting step of Toll-like receptor 9 (TLR9) signaling, is critical in eliciting innate immune responses. ADP-ribosylation factor 6 (ARF6) is a member of the Ras superfamily, which is critical to a wide variety of cellular events including endocytosis. Here, we found that inhibition of ARF6 by dominant mutants and siRNA impaired CpG ODN-mediated responses, whereas cells expressing the constitutively active ARF6 mutant enhanced CpG ODN-induced cytokine production. Inhibition of ARF6 impaired TLR9 trafficking into endolysosomes, thereby inhibiting proceed functional cleavage of TLR9. Additional studies showed that CpG ODN uptake was increased in ARF6-activated cells but impaired in ARF6-defective cells. Furthermore, cells pretreated with CpG ODN but not GpC ODN had increased CpG ODN uptake due to CpG ODN-induced ARF6 activity. Further studies with ARF6-defective and ARF6-activated cells demonstrated that class III phosphatidylinositol 3-kinases (PI3K) was required for downstream ARF6 regulation of CpG ODN uptake. Together, our findings demonstrate that a novel class III PI3K-ARF6 axis pathway mediates TLR9 signaling by regulating the cellular uptake of CpG ODN.	[Wu, Jing-Yiing; Kuo, Cheng-Chin] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan 35053, Miaoli, Taiwan; [Wu, Jing-Yiing] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu 30013, Taiwan; [Kuo, Cheng-Chin] China Med Univ, Grad Inst Basic Med Sci, Taichung 40402, Taiwan	National Health Research Institutes - Taiwan; National Tsing Hua University; China Medical University Taiwan	Kuo, CC (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan 35053, Miaoli, Taiwan.	kuocc@nhri.org.tw	Kuo, Cheng-Chin/B-1064-2010		National Health Research Institutes [99A1-CSPP09-014]; National Science Council of Taiwan [98-2320-B-400-007-MY3]; National Tsing Hua University	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Tsing Hua University	This work was supported by grants from National Health Research Institutes (99A1-CSPP09-014) and the National Science Council (98-2320-B-400-007-MY3) of Taiwan.; This research was conducted under the Graduate Program of Biotechnology in Medicine sponsored by National Tsing Hua University and the National Health Research Institutes.	Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Anderson RB, 2008, J LEUKOCYTE BIOL, V83, P381, DOI 10.1189/jlb.0407236; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; Butler M, 2000, J PHARMACOL EXP THER, V292, P489; Chockalingam A, 2009, IMMUNOL CELL BIOL, V87, P209, DOI 10.1038/icb.2008.101; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Gursel M, 2006, J IMMUNOL, V177, P1575, DOI 10.4049/jimmunol.177.3.1575; Hacker H, 2000, J EXP MED, V192, P595, DOI 10.1084/jem.192.4.595; Hacker H, 1998, EMBO J, V17, P6230, DOI 10.1093/emboj/17.21.6230; Halpern MD, 1996, CELL IMMUNOL, V167, P72, DOI 10.1006/cimm.1996.0009; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Inoue H, 2007, TRAFFIC, V8, P1465, DOI 10.1111/j.1600-0854.2007.00624.x; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Kline JN, 1998, J IMMUNOL, V160, P2555; Kobayashi T, 2004, MICROBES INFECT, V6, P1333, DOI 10.1016/j.micinf.2004.09.001; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Krieg AM, 2007, J CLIN INVEST, V117, P1184, DOI 10.1172/JCI31414; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Kumagai Y, 2008, ADV DRUG DELIVER REV, V60, P795, DOI 10.1016/j.addr.2007.12.004; Kuo CC, 2005, PROTEOMICS, V5, P894, DOI 10.1002/pmic.200401144; Kuo CC, 2007, J IMMUNOL, V178, P6100, DOI 10.4049/jimmunol.178.10.6100; Kuo CC, 2006, J BIOL CHEM, V281, P38200, DOI 10.1074/jbc.M605439200; Kuo CC, 2006, J IMMUNOL, V176, P5943, DOI 10.4049/jimmunol.176.10.5943; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; MESSINA JP, 1991, J IMMUNOL, V147, P1759; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Randazzo PA, 2007, BIOL CELL, V99, P583, DOI 10.1042/BC20070034; Shirota H, 2001, J IMMUNOL, V167, P66, DOI 10.4049/jimmunol.167.1.66; Sivori S, 2010, BLOOD, V116, P1637, DOI 10.1182/blood-2009-12-256586; Stacey KJ, 1996, J IMMUNOL, V157, P2116; Stein MP, 2003, TRAFFIC, V4, P754, DOI 10.1034/j.1600-0854.2003.00133.x; Takeda K, 2001, GENES CELLS, V6, P733, DOI 10.1046/j.1365-2443.2001.00458.x; Takeshita F, 2004, SEMIN IMMUNOL, V16, P17, DOI 10.1016/j.smim.2003.10.009; TOKUNAGA T, 1984, J NATL CANCER I, V72, P955; Vilaysane A, 2009, SEMIN IMMUNOL, V21, P208, DOI 10.1016/j.smim.2009.05.006; YAMAMOTO S, 1988, JPN J CANCER RES, V79, P866, DOI 10.1111/j.1349-7006.1988.tb00049.x; Yi AK, 1998, J IMMUNOL, V160, P1240; Yi AK, 1998, J IMMUNOL, V160, P4755	44	24	25	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4323	4334		10.1074/jbc.M111.295113	http://dx.doi.org/10.1074/jbc.M111.295113			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22170068	Green Published, hybrid			2022-12-25	WOS:000300410900063
J	Kelly, FD; Nurse, P				Kelly, Felice D.; Nurse, Paul			De Novo Growth Zone Formation from Fission Yeast Spheroplasts	PLOS ONE			English	Article							CELL-WALL FORMATION; SCHIZOSACCHAROMYCES-POMBE; SYMMETRY-BREAKING; CDC42P; ACTIN; MORPHOGENESIS; LOCALIZATION; POLARIZATION; MICROTUBULES; CYTOSKELETON	Eukaryotic cells often form polarized growth zones in response to internal or external cues. To understand the establishment of growth zones with specific dimensions we used fission yeast, which grows as a rod-shaped cell of near-constant width from growth zones located at the cell tips. Removing the cell wall creates a round spheroplast with a disorganized cytoskeleton and depolarized growth proteins. As spheroplasts recover, new growth zones form that resemble normal growing cell tips in shape and width, and polarized growth resumes. Regulators of the GTPase Cdc42, which control width in exponentially growing cells, also control spheroplast growth zone width. During recovery the Cdc42 scaffold Scd2 forms a polarized patch in the rounded spheroplast, demonstrating that a growth zone protein can organize independent of cell shape. Rga4, a Cdc42 GTPase activating protein (GAP) that is excluded from cell tips, is initially distributed throughout the spheroplast membrane, but is excluded from the growth zone after a stable patch of Scd2 forms. These results provide evidence that growth zones with normal width and protein localization can form de novo through sequential organization of cellular domains, and that the size of these growth zones is genetically controlled, independent of preexisting cell shape.	[Kelly, Felice D.] Rockefeller Univ, New York, NY 10021 USA; [Nurse, Paul] Francis Crick Inst, London, England	Rockefeller University; Francis Crick Institute	Kelly, FD (corresponding author), Stanford Sch Med, Stanford, CA USA.	felice.kelly@gmail.com			Breast Cancer Research Foundation; Anderson Center for Cancer Research; Rockefeller University	Breast Cancer Research Foundation; Anderson Center for Cancer Research; Rockefeller University	This study was supported by the Breast Cancer Research Foundation, the Anderson Center for Cancer Research, and the Rockefeller University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carazo-Salas RE, 2006, NAT CELL BIOL, V8, P1102, DOI 10.1038/ncb1479; Castagnetti S, 2007, J CELL SCI, V120, P2205, DOI 10.1242/jcs.03464; Castagnetti S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000512; CHANG EC, 1994, CELL, V79, P131, DOI 10.1016/0092-8674(94)90406-5; Cortes JCG, 2005, J CELL SCI, V118, P157, DOI 10.1242/jcs.01585; Das M, 2007, MOL BIOL CELL, V18, P2090, DOI 10.1091/mbc.E06-09-0883; Endo M, 2003, J BIOL CHEM, V278, P843, DOI 10.1074/jbc.M209714200; FANTES P, 1979, NATURE, V279, P428, DOI 10.1038/279428a0; FUKUI Y, 1988, MOL GEN GENET, V215, P26, DOI 10.1007/BF00331298; Hayles J, 2001, NAT REV MOL CELL BIO, V2, P647, DOI 10.1038/35089520; Hirota K, 2003, MOL BIOL CELL, V14, P3617, DOI 10.1091/mbc.E02-10-0665; Irazoqui JE, 2003, NAT CELL BIOL, V5, P1062, DOI 10.1038/ncb1068; KELLY FD, 2011, MOL BIOL CELL; KOBORI H, 1989, J CELL SCI, V94, P635; Kozubowski L, 2008, CURR BIOL, V18, P1719, DOI 10.1016/j.cub.2008.09.060; Mata J, 1997, CELL, V89, P939, DOI 10.1016/S0092-8674(00)80279-2; Minc N, 2009, CURR BIOL, V19, P83, DOI 10.1016/j.cub.2008.12.008; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Murray JM, 2001, J BIOL CHEM, V276, P3004, DOI 10.1074/jbc.M007389200; Nakamura T, 2008, MOL BIOL CELL, V19, P3544, DOI 10.1091/mbc.E08-04-0414; OSUMI M, 1989, J ELECTRON MICROSC, V38, P457; OSUMI M, 1992, J ELECTRON MICROSC, P392; Pelham RJ, 2001, NAT CELL BIOL, V3, P235, DOI 10.1038/35060020; Sawin KE, 1998, J CELL BIOL, V142, P457, DOI 10.1083/jcb.142.2.457; Slaughter BD, 2009, DEV CELL, V17, P823, DOI 10.1016/j.devcel.2009.10.022; STYRKARSDOTTIR U, 1993, CURR GENET, V23, P184, DOI 10.1007/BF00352020; Takagi T, 2003, J ELECTRON MICROSC, V52, P161, DOI 10.1093/jmicro/52.2.161; Tatebe H, 2001, MICRON, V32, P67, DOI 10.1016/S0968-4328(00)00023-8; Tatebe H, 2008, CURR BIOL, V18, P322, DOI 10.1016/j.cub.2008.02.005; Terenna CR, 2008, CURR BIOL, V18, P1748, DOI 10.1016/j.cub.2008.09.047; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944	31	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e27977	10.1371/journal.pone.0027977	http://dx.doi.org/10.1371/journal.pone.0027977			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22194800	Green Published, gold, Green Submitted			2022-12-25	WOS:000298370400008
J	Caputo, V; Sinibaldi, L; Fiorentino, A; Parisi, C; Catalanotto, C; Pasini, A; Cogoni, C; Pizzuti, A				Caputo, Viviana; Sinibaldi, Lorenzo; Fiorentino, Alessia; Parisi, Chiara; Catalanotto, Caterina; Pasini, Augusto; Cogoni, Carlo; Pizzuti, Antonio			Brain Derived Neurotrophic Factor (BDNF) Expression Is Regulated by MicroRNAs miR-26a and miR-26b Allele-Specific Binding	PLOS ONE			English	Article							VAL66MET POLYMORPHISM; FACTOR GENE; PARKINSONS-DISEASE; MESSENGER-RNA; LINKAGE DISEQUILIBRIUM; SEQUENCE VARIANTS; BIPOLAR DISORDER; CANDIDATE GENES; ASSOCIATION; SCHIZOPHRENIA	Brain-derived neurotrophic factor (BDNF) is a neurotrophin that plays an essential role in neuronal development and plasticity. MicroRNA (miRNAs) are small non-coding RNAs of about 22-nucleotides in length regulating gene expression at post-transcriptional level. In this study we explore the role of miRNAs as post-transcriptional inhibitors of BDNF and the effect of 3'UTR sequence variations on miRNAs binding capacity. Using an in silico approach we identified a group of miRNAs putatively regulating BDNF expression and binding to BDNF 3'UTR polymorphic sequences. Luciferase assays demonstrated that these miRNAs (miR-26a1/2 and miR-26b) downregulates BDNF expression and that the presence of the variant alleles of two single nucleotide polymorphisms (rs11030100 and rs11030099) mapping in BDNF 3'UTR specifically abrogates miRNAs targeting. Furthermore we found a high linkage disequilibrium rate between rs11030100, rs11030099 and the non-synonymous coding variant rs6265 (Val66Met), which modulates BDNF mRNA localization and protein intracellular trafficking. Such observation led to hypothesize that miR-26s mediated regulation could extend to rs6265 leading to an allelic imbalance with potentially functional effects, such as peptide's localization and activity-dependent secretion. Since rs6265 has been previously implicated in various neuropsychiatric disorders, we evaluated the distribution of rs11030100, rs11030099 and rs6265 both in a control and schizophrenic group, but no significant difference in allele frequencies emerged. In conclusion, in the present study we identified two novel miRNAs regulating BDNF expression and the first BDNF 3'UTR functional variants altering miRNAs-BDNF binding.	[Caputo, Viviana; Pizzuti, Antonio] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Caputo, Viviana; Parisi, Chiara; Catalanotto, Caterina; Cogoni, Carlo] European Brain Res Inst, Rome, Italy; [Sinibaldi, Lorenzo] IRCCS Casa Sollievo Sofferenza, Mendel Lab, San Giovanni Rotondo, Italy; [Fiorentino, Alessia] Univ Roma La Sapienza, Dept Mol Med, Rome, Italy; [Parisi, Chiara; Catalanotto, Caterina; Cogoni, Carlo] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, Rome, Italy; [Pasini, Augusto] Univ Roma Tor Vergata, Dept Neurosci, Div Child Neuropsychiat, Rome, Italy	Sapienza University Rome; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; Sapienza University Rome; Sapienza University Rome; University of Rome Tor Vergata	Caputo, V (corresponding author), Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy.	caputo.viviana@gmail.com	parisi, Chiara/K-6330-2016; Sinibaldi, Lorenzo/HFZ-8860-2022; Fiorentino, Alessia/ABC-3638-2020	parisi, Chiara/0000-0003-1350-3929; Sinibaldi, Lorenzo/0000-0002-1371-936X; CATALANOTTO, Caterina/0000-0001-6583-5170; Fiorentino, Alessia/0000-0002-1403-4581; PIZZUTI, Antonio/0000-0003-3245-1925	AriSLA	AriSLA(Fondazione AriSLA)	We thank AriSLA for supporting our study.	Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Bao L, 2007, NUCLEIC ACIDS RES, V35, pD51, DOI 10.1093/nar/gkl797; Bhagavathi S, 2010, ARCH PATHOL LAB MED, V134, P1276, DOI 10.1043/2009-0178-RS.1; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Castren E, 1998, PROG BRAIN RES, V117, P57; Chandrasekar V, 2009, MOL CELL NEUROSCI, V42, P350, DOI 10.1016/j.mcn.2009.08.009; Chen K, 2006, NAT GENET, V38, P1452, DOI 10.1038/ng1910; CHEN ZY, 2004, J NEUROSCI, V5, P24; Chiaruttini C, 2009, P NATL ACAD SCI USA, V106, P16481, DOI 10.1073/pnas.0902833106; CRATACOS M, 2007, BIOL PSYCHIAT, V61, P911; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Cui QH, 2007, BIOCHEM BIOPH RES CO, V352, P733, DOI 10.1016/j.bbrc.2006.11.080; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fasanaro P, 2009, J BIOL CHEM, V284, P35134, DOI 10.1074/jbc.M109.052779; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Friedman LM, 2009, P NATL ACAD SCI USA, V106, P7915, DOI 10.1073/pnas.0812446106; Gambardella S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-48; Georgel P, 2010, TRENDS MOL MED, V16, P277, DOI 10.1016/j.molmed.2010.04.003; Georges M, 2007, CURR OPIN GENET DEV, V17, P166, DOI 10.1016/j.gde.2007.04.005; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; Hakansson A, 2003, ANN NEUROL, V53, P823, DOI 10.1002/ana.10585; Hall D, 2003, AM J HUM GENET, V73, P370, DOI 10.1086/377003; Hansen T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000873; Hawi Z, 1998, PSYCHIAT RES, V81, P111, DOI 10.1016/S0165-1781(98)00076-6; Hayes VY, 1997, MOL BRAIN RES, V45, P189, DOI 10.1016/S0169-328X(96)00254-9; Hong CJ, 2003, NEUROSCI LETT, V353, P75, DOI 10.1016/j.neulet.2003.09.009; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Itoh K, 2004, AM J MED GENET B, V124B, P61, DOI 10.1002/ajmg.b.20078; Jensen KP, 2009, MOL PSYCHIATR, V14, P381, DOI 10.1038/mp.2008.15; Kartha RV, 2010, J CARDIOVASC TRANSL, V3, P256, DOI 10.1007/s12265-010-9172-z; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kong L, 2011, ACTA DIABETOL, V48, P61, DOI 10.1007/s00592-010-0226-0; Krebs MO, 2000, MOL PSYCHIATR, V5, P558, DOI 10.1038/sj.mp.4000749; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kunugi H, 2001, MOL PSYCHIATR, V6, P83, DOI 10.1038/sj.mp.4000792; Lau AG, 2010, P NATL ACAD SCI USA, V107, P15945, DOI 10.1073/pnas.1002929107; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liu QR, 2005, AM J MED GENET B, V134B, P93, DOI 10.1002/ajmg.b.30109; Lohoff FW, 2005, AM J MED GENET B, V139B, P51, DOI 10.1002/ajmg.b.30215; Martin MM, 2007, J BIOL CHEM, V282, P24262, DOI 10.1074/jbc.M701050200; Mellios N, 2008, HUM MOL GENET, V17, P3030, DOI 10.1093/hmg/ddn201; Meza-Sosa KF, 2012, J NEUROSCI RES, V90, P1, DOI 10.1002/jnr.22701; Momose Y, 2002, ANN NEUROL, V51, P133, DOI 10.1002/ana.10079; Nakata K, 2003, NEUROSCI LETT, V337, P17, DOI 10.1016/S0304-3940(02)01292-2; Nanko S, 2003, SCHIZOPHR RES, V62, P281, DOI 10.1016/S0920-9964(02)00349; Neves-Pereira M, 2002, AM J HUM GENET, V71, P651, DOI 10.1086/342288; Perkins DO, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r27; Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004; Ribases M, 2003, MOL PSYCHIATR, V8, P745, DOI 10.1038/sj.mp.4001281; Rinaldi A, 2010, BEHAV BRAIN RES, V208, P265, DOI 10.1016/j.bbr.2009.11.012; Rosa A, 2006, AM J MED GENET B, V141B, P135, DOI 10.1002/ajmg.b.30266; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Rybakowski JK, 2003, BIPOLAR DISORD, V5, P468, DOI 10.1046/j.1399-5618.2003.00071.x; Rybakowski JK, 2006, PSYCHIAT CLIN NEUROS, V60, P70, DOI 10.1111/j.1440-1819.2006.01462.x; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Sen S, 2003, NEUROPSYCHOPHARMACOL, V28, P397, DOI 10.1038/sj.npp.1300053; Sethupathy P, 2007, AM J HUM GENET, V81, P405, DOI 10.1086/519979; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Sklar P, 2002, MOL PSYCHIATR, V7, P579, DOI 10.1038/sj.mp.4001058; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Tan Z, 2007, AM J HUM GENET, V81, P829, DOI 10.1086/521200; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; Toda T, 2003, J NEUROL, V250, P40, DOI 10.1007/s00415-003-1307-6; Tsai SJ, 2004, NEUROPSYCHOBIOLOGY, V49, P13, DOI 10.1159/000075333; Tsai SJ, 2004, NEUROPSYCHOBIOLOGY, V49, P10, DOI 10.1159/000075332; Tsai SJ, 2003, AM J MED GENET B, V123B, P19, DOI 10.1002/ajmg.b.20026; Tyler WJ, 2002, LEARN MEMORY, V9, P224, DOI 10.1101/lm.51202; Uhl GR, 2001, AM J HUM GENET, V69, P1290, DOI 10.1086/324467; Wassink TH, 1999, AM J MED GENET, V88, P724, DOI 10.1002/(SICI)1096-8628(19991215)88:6<724::AID-AJMG25>3.0.CO;2-7; Xu B, 2010, BRAIN RES, V1338, P78, DOI 10.1016/j.brainres.2010.03.109; Xu Y, 2010, SCHIZOPHR RES, V119, P219, DOI 10.1016/j.schres.2010.02.1070; Yamada K, 2002, LIFE SCI, V70, P735, DOI 10.1016/S0024-3205(01)01461-8	74	87	90	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28656	10.1371/journal.pone.0028656	http://dx.doi.org/10.1371/journal.pone.0028656			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194877	Green Published, Green Submitted, gold			2022-12-25	WOS:000298369100071
J	Inada, H; Watanabe, M; Uchida, T; Ishibashi, H; Wake, H; Nemoto, T; Yanagawa, Y; Fukuda, A; Nabekura, J				Inada, Hiroyuki; Watanabe, Miho; Uchida, Taku; Ishibashi, Hitoshi; Wake, Hiroaki; Nemoto, Tomomi; Yanagawa, Yuchio; Fukuda, Atsuo; Nabekura, Junichi			GABA Regulates the Multidirectional Tangential Migration of GABAergic Interneurons in Living Neonatal Mice	PLOS ONE			English	Article							NEURONAL MIGRATION; CORTICAL INTERNEURONS; A RECEPTORS; CHLORIDE; CELL; COTRANSPORTERS; EXPRESSION; NEOCORTEX; PROMOTES; RELEASE	Cortical GABAergic interneurons originate from ganglionic eminences and tangentially migrate into the cortical plate at early developmental stages. To elucidate the characteristics of this migration of GABAergic interneurons in living animals, we established an experimental design specialized for in vivo time-lapse imaging of the neocortex of neonate mice with two-photon laser-scanning microscopy. In vesicular GABA/glycine transporter (VGAT)-Venus transgenic mice from birth (P0) through P3, we observed multidirectional tangential migration of genetically-defined GABAergic interneurons in the neocortical marginal zone. The properties of this migration, such as the motility rate (distance/hr), the direction moved, and the proportion of migrating neurons to stationary neurons, did not change through P0 to P3, although the density of GABAergic neurons at the marginal zone decreased with age. Thus, the characteristics of the tangential motility of individual GABAergic neurons remained constant in development. Pharmacological block of GABA(A) receptors and of the Na+-K+-Cl- cotransporters, and chelating intracellular Ca2+, all significantly reduced the motility rate in vivo. The motility rate and GABA content within the cortex of neonatal VGAT-Venus transgenic mice were significantly greater than those of GAD67-GFP knock-in mice, suggesting that extracellular GABA concentration could facilitate the multidirectional tangential migration. Indeed, diazepam applied to GAD67-GFP mice increased the motility rate substantially. In an in vitro neocortical slice preparation, we confirmed that GABA induced a NKCC sensitive depolarization of GABAergic interneurons in VGAT-Venus mice at P0-P3. Thus, activation of GABA(A)R by ambient GABA depolarizes GABAergic interneurons, leading to an acceleration of their multidirectional motility in vivo.	[Inada, Hiroyuki; Watanabe, Miho; Ishibashi, Hitoshi; Wake, Hiroaki; Nabekura, Junichi] Natl Inst Physiol Sci, Dept Dev Physiol, Okazaki, Aichi 444, Japan; [Inada, Hiroyuki; Nabekura, Junichi] Grad Univ Adv Studies, Dept Physiol Sci, Okazaki, Aichi, Japan; [Uchida, Taku; Fukuda, Atsuo] Hamamatsu Univ Sch Med, Dept Physiol, Hamamatsu, Shizuoka 4313192, Japan; [Nemoto, Tomomi] Hokkaido Univ, Res Inst Elect Sci, Lab Mol & Cellular Biophys, Sapporo, Hokkaido, Japan; [Yanagawa, Yuchio] Gunma Univ, Grad Sch Med, Dept Genet & Behav Neurosci, Maebashi, Gunma 371, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan; Hamamatsu University School of Medicine; Hokkaido University; Gunma University	Inada, H (corresponding author), Natl Inst Physiol Sci, Dept Dev Physiol, Okazaki, Aichi 444, Japan.	nabekura@nips.ac.jp	Nemoto, Tomomi/B-4412-2012; Fukuda, Atsuo/ABA-6843-2020	Nemoto, Tomomi/0000-0001-6102-1495; Fukuda, Atsuo/0000-0001-7112-4834; WAKE, Hiroaki/0000-0002-8543-4590	Spectrography and Bioimaging Facility; NIBB Core Research Facilities	Spectrography and Bioimaging Facility; NIBB Core Research Facilities	We are grateful to Dr. A. Miyawaki (Laboratory for Cell Function and Dynamics, Brain Science Institute, RIKEN) for providing pCS2-Venus and to Dr. A. Moorhouse (University of South Wales, Australia) for critical discussion and grammatical corrections. This work was supported by Spectrography and Bioimaging Facility, NIBB Core Research Facilities.	Adelsberger H, 2005, NAT NEUROSCI, V8, P988, DOI 10.1038/nn1502; Andang M, 2008, NATURE, V451, P460, DOI 10.1038/nature06488; Ang ESBC, 2003, J NEUROSCI, V23, P5805; Behar TN, 1996, J NEUROSCI, V16, P1808; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Bolteus AJ, 2004, J NEUROSCI, V24, P7623, DOI 10.1523/JNEUROSCI.1999-04.2004; Bortone D, 2009, NEURON, V62, P53, DOI 10.1016/j.neuron.2009.01.034; Carlson VCC, 2011, CEREB CORTEX, V21, P1792, DOI 10.1093/cercor/bhq247; Chowdhury TG, 2010, FRONT NEUROANAT, V4, DOI 10.3389/neuro.05.010.2010; Cuzon VC, 2006, CEREB CORTEX, V16, P1377, DOI 10.1093/cercor/bhj084; DEDIEGO I, 1994, EUR J NEUROSCI, V6, P983, DOI 10.1111/j.1460-9568.1994.tb00593.x; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; EBIHARA S, 1995, J PHYSIOL-LONDON, V484, P77, DOI 10.1113/jphysiol.1995.sp020649; GHOSH A, 1992, J NEUROSCI, V12, P39; Heck N, 2007, CEREB CORTEX, V17, P138, DOI 10.1093/cercor/bhj135; Hevner RF, 2004, NEUROSCIENCE, V124, P605, DOI 10.1016/j.neuroscience.2003.11.033; Kakazu Y, 2000, J NEUROPHYSIOL, V84, P281, DOI 10.1152/jn.2000.84.1.281; Kakazu Y, 1999, J NEUROSCI, V19, P2843; Kriegstein AR, 2004, TRENDS NEUROSCI, V27, P392, DOI 10.1016/j.tins.2004.05.001; Kumada T, 2004, P NATL ACAD SCI USA, V101, P8479, DOI 10.1073/pnas.0401000101; Li GN, 2008, J NEUROSCI, V28, P1085, DOI 10.1523/JNEUROSCI.4602-07.2008; Lopez-Bendito G, 2003, CEREB CORTEX, V13, P932, DOI 10.1093/cercor/13.9.932; Lopez-Bendito G, 2008, J NEUROSCI, V28, P1613, DOI 10.1523/JNEUROSCI.4651-07.2008; LUHMANN HJ, 1991, J NEUROPHYSIOL, V65, P247, DOI 10.1152/jn.1991.65.2.247; Manent JB, 2005, J NEUROSCI, V25, P4755, DOI 10.1523/JNEUROSCI.0553-05.2005; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Marty S, 1996, NEURON, V16, P565, DOI 10.1016/S0896-6273(00)80075-6; Metin C, 2006, EUR J NEUROSCI, V23, P894, DOI 10.1111/j.1460-9568.2006.04630.x; Miyoshi G, 2011, CEREB CORTEX, V21, P845, DOI 10.1093/cercor/bhq155; Nadarajah B, 2002, NAT NEUROSCI, V5, P218, DOI 10.1038/nn813; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; PAXINOS G, ATLAS DEV MOUSE BRAI; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Tanaka D, 2003, DEVELOPMENT, V130, P5803, DOI 10.1242/dev.00825; Tanaka DH, 2006, DEVELOPMENT, V133, P2167, DOI 10.1242/dev.02382; Tanaka DH, 2009, J NEUROSCI, V29, P1300, DOI 10.1523/JNEUROSCI.5446-08.2009; Wang GY, 2000, J NEUROSCI, V20, P5358, DOI 10.1523/JNEUROSCI.20-14-05358.2000; Wang Y, 2009, NEUROSCIENCE, V164, P1031, DOI 10.1016/j.neuroscience.2009.09.010; Whiting PJ, 2006, CURR OPIN PHARMACOL, V6, P24, DOI 10.1016/j.coph.2005.08.005; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Yamada J, 2004, J PHYSIOL-LONDON, V557, P829, DOI 10.1113/jphysiol.2004.062471; Yokota Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000794	46	46	47	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e27048	10.1371/journal.pone.0027048	http://dx.doi.org/10.1371/journal.pone.0027048			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22180776	Green Published, gold, Green Submitted			2022-12-25	WOS:000298367300003
J	Halachev, MR; Loman, NJ; Pallen, MJ				Halachev, Mihail R.; Loman, Nicholas J.; Pallen, Mark J.			Calculating Orthologs in Bacteria and Archaea: A Divide and Conquer Approach	PLOS ONE			English	Article							MICROBIAL PAN-GENOME; PROTEIN FAMILIES; PHYLOGENETIC TREES; EUKARYOTIC GENOMES; EVOLUTION; GENES; DATABASE; SYSTEM; RECONSTRUCTION; INPARALOGS	Among proteins, orthologs are defined as those that are derived by vertical descent from a single progenitor in the last common ancestor of their host organisms. Our goal is to compute a complete set of protein orthologs derived from all currently available complete bacterial and archaeal genomes. Traditional approaches typically rely on all-against-all BLAST searching which is prohibitively expensive in terms of hardware requirements or computational time (requiring an estimated 18 months or more on a typical server). Here, we present xBASE-Orth, a system for ongoing ortholog annotation, which applies a "divide and conquer" approach and adopts a pragmatic scheme that trades accuracy for speed. Starting at species level, xBASE-Orth carefully constructs and uses pan-genomes as proxies for the full collections of coding sequences at each level as it progressively climbs the taxonomic tree using the previously computed data. This leads to a significant decrease in the number of alignments that need to be performed, which translates into faster computation, making ortholog computation possible on a global scale. Using xBASE-Orth, we analyzed an NCBI collection of 1,288 bacterial and 94 archaeal complete genomes with more than 4 million coding sequences in 5 weeks and predicted more than 700 million ortholog pairs, clustered in 175,531 orthologous groups. We have also identified sets of highly conserved bacterial and archaeal orthologs and in so doing have highlighted anomalies in genome annotation and in the proposed composition of the minimal bacterial genome. In summary, our approach allows for scalable and efficient computation of the bacterial and archaeal ortholog annotations. In addition, due to its hierarchical nature, it is suitable for incorporating novel complete genomes and alternative genome annotations. The computed ortholog data and a continuously evolving set of applications based on it are integrated in the xBASE database, available at http://www.xbase.ac.uk/.	[Halachev, Mihail R.; Loman, Nicholas J.; Pallen, Mark J.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England	University of Birmingham	Halachev, MR (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	m.pallen@bham.ac.uk	Loman, Nicholas/Z-1573-2019	Pallen, Mark/0000-0003-1807-3657; Loman, Nicholas/0000-0002-9843-8988	Biotechnology and Biological Sciences Research Council [BBE0111791]; BBSRC [BB/E011179/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E011179/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work is supported by the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/), grant number BBE0111791. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeyenko A, 2006, BIOINFORMATICS, V22, pE9, DOI 10.1093/bioinformatics/btl213; Altenhoff AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000262; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Berglund AC, 2008, NUCLEIC ACIDS RES, V36, pD263, DOI 10.1093/nar/gkm1020; Blom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-154; Charlebois RL, 2003, FEMS MICROBIOL LETT, V225, P213, DOI 10.1016/S0378-1097(03)00512-3; Chen F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000383; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; DeLuca TF, 2006, BIOINFORMATICS, V22, P2044, DOI 10.1093/bioinformatics/btl286; Deng XY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-500; Donati C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r107; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fischer W, 2010, NUCLEIC ACIDS RES, V38, P6089, DOI 10.1093/nar/gkq378; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Fu Z, 2007, J COMPUT BIOL, V14, P1160, DOI 10.1089/cmb.2007.0048; Fu Zheng, 2008, Journal of Bioinformatics and Computational Biology, V6, P573, DOI 10.1142/S0219720008003540; Hogg JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r103; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Jensen LJ, 2008, NUCLEIC ACIDS RES, V36, pD250, DOI 10.1093/nar/gkm796; Kislyuk AO, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-32; Koonin EV, 2008, NUCLEIC ACIDS RES, V36, P6688, DOI 10.1093/nar/gkn668; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lapierrel P, 2009, TRENDS GENET, V25, P107, DOI 10.1016/j.tig.2008.12.004; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lefebure T, 2010, GENOME BIOL EVOL, V2, P646, DOI 10.1093/gbe/evq048; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Makarova KS, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-33; Makarova KS, 1999, GENOME RES, V9, P608; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Muzzi A, 2007, DRUG DISCOV TODAY, V12, P429, DOI 10.1016/j.drudis.2007.04.008; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Penel S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S3; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Roth ACJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-518; Schoen C, 2008, P NATL ACAD SCI USA, V105, P3473, DOI 10.1073/pnas.0800151105; Shi GQ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-10; Siew N, 2003, STRUCTURE, V11, P7, DOI 10.1016/S0969-2126(02)00938-3; SIEW N, 2006, BMC EVOL BIOL, V6, P63, DOI DOI 10.1186/1471-2148-6-63; Snel B, 2002, GENOME RES, V12, P17, DOI 10.1101/gr.176501; Storm CEV, 2002, BIOINFORMATICS, V18, P92, DOI 10.1093/bioinformatics/18.1.92; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tettelin H, 2008, CURR OPIN MICROBIOL, V11, P472, DOI 10.1016/j.mib.2008.09.006; Thompson JD, 2001, J MOL BIOL, V314, P937, DOI 10.1006/jmbi.2001.5187; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wapinski I, 2007, BIOINFORMATICS, V23, pI549, DOI 10.1093/bioinformatics/btm193; Willenbrock H, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r267; Wilson GA, 2005, MICROBIOL-SGM, V151, P2499, DOI 10.1099/mic.0.28146-0; Zmasek CM, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-14	54	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28388	10.1371/journal.pone.0028388	http://dx.doi.org/10.1371/journal.pone.0028388			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174796	Green Published, gold, Green Submitted			2022-12-25	WOS:000298366600013
J	Lee, B; Mann, P; Grover, V; Treuner-Lange, A; Kahnt, J; Higgs, PI				Lee, Bongsoo; Mann, Petra; Grover, Vidhi; Treuner-Lange, Anke; Kahnt, Joerg; Higgs, Penelope I.			The Myxococcus xanthus Spore Cuticula Protein C Is a Fragment of FibA, an Extracellular Metalloprotease Produced Exclusively in Aggregated Cells	PLOS ONE			English	Article							FRUITING-BODY DEVELOPMENT; SOCIAL GLIDING MOTILITY; ZINC METALLOPROTEASE; GENE-EXPRESSION; DIF GENES; DIFFERENTIATION; DOMAINS; CHEMOTAXIS; BACTERIUM; FIBRILS	Myxococcus xanthus is a soil bacterium with a complex life cycle involving distinct cell fates, including production of environmentally resistant spores to withstand periods of nutrient limitation. Spores are surrounded by an apparently self-assembling cuticula containing at least Proteins S and C; the gene encoding Protein C is unknown. During analyses of cell heterogeneity in M. xanthus, we observed that Protein C accumulated exclusively in cells found in aggregates. Using mass spectrometry analysis of Protein C either isolated from spore cuticula or immunoprecipitated from aggregated cells, we demonstrate that Protein C is actually a proteolytic fragment of the previously identified but functionally elusive zinc metalloprotease, FibA. Subpopulation specific FibA accumulation is not due to transcriptional regulation suggesting post-transcriptional regulation mechanisms mediate its heterogeneous accumulation patterns.	[Lee, Bongsoo; Mann, Petra; Grover, Vidhi; Kahnt, Joerg; Higgs, Penelope I.] Max Planck Inst Terr Microbiol, Dept Ecophysiol, D-35043 Marburg, Germany; [Treuner-Lange, Anke] Univ Giessen, Inst Microbiol & Mol Biol, Giessen, Germany	Max Planck Society; Justus Liebig University Giessen	Lee, B (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.	higgs@mpi-marburg.mpg.de	Higgs, Penelope/Y-8862-2019; Lee, BongSoo/AAP-3262-2020; Treuner-Lange, Anke U/AFQ-5368-2022	Higgs, Penelope/0000-0003-4726-3329; Treuner-Lange, Anke U/0000-0001-6435-5642	Max Planck Society; German Research Federation [DFG Tr429/4-1]	Max Planck Society(Max Planck Society); German Research Federation	This work was supported by the Max Planck Society (http://www.mpg.de/en) to PIH and the German Research Federation (http://www.dfg.de/en/index.jsp)(DFG Tr429/4-1) to AT-L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Goodger C, 2005, NUCLEIC ACIDS RES, V33, pW690, DOI 10.1093/nar/gki445; ARNOLD JW, 1988, J BACTERIOL, V170, P5771, DOI 10.1128/jb.170.12.5771-5777.1988; BEHMLANDER RM, 1994, J BACTERIOL, V176, P6304, DOI 10.1128/jb.176.20.6304-6311.1994; BEHMLANDER RM, 1991, J BACTERIOL, V173, P7810, DOI 10.1128/jb.173.24.7810-7820.1991; Bellenger K, 2002, J BACTERIOL, V184, P5654, DOI 10.1128/JB.184.20.5654-5660.2002; Black WP, 2004, J BACTERIOL, V186, P1001, DOI 10.1128/JB.186.4.1001-1008.2004; Bonner PJ, 2006, MOL MICROBIOL, V61, P1283, DOI 10.1111/j.1365-2958.2006.05298.x; Bonner PJ, 2005, MOL MICROBIOL, V57, P1499, DOI 10.1111/j.1365-2958.2005.04785.x; Bulyha I, 2009, MOL MICROBIOL, V74, P691, DOI 10.1111/j.1365-2958.2009.06891.x; Chen JC, 2005, MOL MICROBIOL, V55, P1085, DOI 10.1111/j.1365-2958.2004.04443.x; Curtis PD, 2007, J BACTERIOL, V189, P7634, DOI 10.1128/JB.01007-07; Curtis PD, 2006, ENVIRON MICROBIOL, V8, P1935, DOI 10.1111/j.1462-2920.2006.01073.x; DOWNARD JS, 1984, J MOL BIOL, V175, P469, DOI 10.1016/0022-2836(84)90180-3; DWORKIN M, 1964, SCIENCE, V146, P243, DOI 10.1126/science.146.3641.243; Higgs PI, 2008, J BACTERIOL, V190, P4416, DOI 10.1128/JB.00265-08; INOUYE M, 1979, P NATL ACAD SCI USA, V76, P209, DOI 10.1073/pnas.76.1.209; Jing H, 2002, STRUCTURE, V10, P1453, DOI 10.1016/S0969-2126(02)00840-7; Julien B, 2000, P NATL ACAD SCI USA, V97, P9098, DOI 10.1073/pnas.97.16.9098; Kahnt J, 2010, J PROTEOME RES, V9, P5197, DOI 10.1021/pr1004983; KAISER D, 1979, P NATL ACAD SCI USA, V76, P5952, DOI 10.1073/pnas.76.11.5952; Kearns DB, 2001, P NATL ACAD SCI USA, V98, P13990, DOI 10.1073/pnas.251484598; Kearns DB, 2001, TRENDS MICROBIOL, V9, P126, DOI 10.1016/S0966-842X(01)01948-5; Kearns DB, 1998, P NATL ACAD SCI USA, V95, P11957, DOI 10.1073/pnas.95.20.11957; Kearns DB, 2002, J BACTERIOL, V184, P1678, DOI 10.1128/JB.184.6.1678-1684.2002; KOMANO T, 1984, J BACTERIOL, V158, P1195, DOI 10.1128/JB.158.3.1195-1197.1984; KOTTEL RH, 1975, J BACTERIOL, V124, P550, DOI 10.1128/JB.124.1.550-557.1975; Lancero H, 2002, J BACTERIOL, V184, P1462, DOI 10.1128/JB.184.5.1462-1465.2002; Lee B, 2010, METHOD ENZYMOL, V471, P253, DOI 10.1016/S0076-6879(10)71014-4; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; LIU YN, 1990, MOL GEN GENET, V220, P433, DOI 10.1007/BF00391750; Magrini V, 1999, J BACTERIOL, V181, P4050, DOI 10.1128/JB.181.13.4050-4061.1999; Maniatis T., 1982, MOL CLONING LAB MANU; Mauriello EMF, 2010, MICROBIOL MOL BIOL R, V74, P229, DOI 10.1128/MMBR.00043-09; MCCLEARY WR, 1991, J BACTERIOL, V173, P2141, DOI 10.1128/jb.173.6.2141-2145.1991; Miyoshi S, 1997, J BACTERIOL, V179, P7606, DOI 10.1128/jb.179.23.7606-7609.1997; Muller FD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-264; Nariya H, 2008, CELL, V132, P55, DOI 10.1016/j.cell.2007.11.044; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; SHIMKETS LJ, 1986, J BACTERIOL, V166, P842, DOI 10.1128/jb.166.3.842-848.1986; Shimkets LJ, 1999, ANNU REV MICROBIOL, V53, P525, DOI 10.1146/annurev.micro.53.1.525; Simunovic V, 2003, J BACTERIOL, V185, P5066, DOI 10.1128/JB.185.17.5066-5075.2003; Thanbichler M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm818; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tsujibo H, 1996, BIOSCI BIOTECH BIOCH, V60, P1284, DOI 10.1271/bbb.60.1284; Vlamakis H, 2008, GENE DEV, V22, P945, DOI 10.1101/gad.1645008; WISTOW G, 1985, NATURE, V315, P771, DOI 10.1038/315771a0; Wu SS, 1997, J BACTERIOL, V179, P7748, DOI 10.1128/jb.179.24.7748-7758.1997; Yan BQ, 2009, EXTREMOPHILES, V13, P725, DOI 10.1007/s00792-009-0263-1; Yang ZM, 2000, J BACTERIOL, V182, P5793, DOI 10.1128/JB.182.20.5793-5798.2000; Yeats C, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-3	53	8	8	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28968	10.1371/journal.pone.0028968	http://dx.doi.org/10.1371/journal.pone.0028968			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174937	gold, Green Published, Green Submitted			2022-12-25	WOS:000298366600053
J	O'Reilly, V; Zeng, SJG; Bricard, G; Atzberger, A; Hogan, AE; Jackson, J; Feighery, C; Porcelli, SA; Doherty, DG				O'Reilly, Vincent; Zeng, Shijuan G.; Bricard, Gabriel; Atzberger, Ann; Hogan, Andrew E.; Jackson, John; Feighery, Conleth; Porcelli, Steven A.; Doherty, Derek G.			Distinct and Overlapping Effector Functions of Expanded Human CD4(+), CD8 alpha(+) and CD4(-)CD8 alpha(-) Invariant Natural Killer T Cells	PLOS ONE			English	Article							LIGAND ALPHA-GALACTOSYLCERAMIDE; MATURE DENDRITIC CELLS; V(ALPHA)14 NKT CELLS; B-CELLS; PHASE-I; RECEPTOR EXPRESSION; CANCER-PATIENTS; CUTTING EDGE; LUNG-CANCER; T(H)2 BIAS	CD1d-restricted invariant natural killer T (iNKT) cells have diverse immune stimulatory/regulatory activities through their ability to release cytokines and to kill or transactivate other cells. Activation of iNKT cells can protect against multiple diseases in mice but clinical trials in humans have had limited impact. Clinical studies to date have targeted polyclonal mixtures of iNKT cells and we proposed that their subset compositions will influence therapeutic outcomes. We sorted and expanded iNKT cells from healthy donors and compared the phenotypes, cytotoxic activities and cytokine profiles of the CD4(+), CD8 alpha(+) and CD4(+)CD8 alpha(-) double-negative (DN) subsets. CD4(+) iNKT cells expanded more readily than CD8 alpha(+) and DN iNKT cells upon mitogen stimulation. CD8 alpha(+) and DN iNKT cells most frequently expressed CD56, CD161 and NKG2D and most potently killed CD1d(+) cell lines and primary leukemia cells. All iNKT subsets released Th1 (IFN-gamma and TNF-alpha) and Th2 (IL-4, IL-5 and IL-13) cytokines. Relative amounts followed a CD8 alpha>DN>CD4 pattern for Th1 and CD4>DN>CD8 alpha for Th2. All iNKT subsets could simultaneously produce IFN-gamma and IL-4, but single-positivity for IFN-gamma or IL-4 was strikingly rare in CD4(+) and CD8 alpha(+) fractions, respectively. Only CD4(+) iNKT cells produced IL-9 and IL-10; DN cells released IL-17; and none produced IL-22. All iNKT subsets upregulated CD40L upon glycolipid stimulation and induced IL-10 and IL-12 secretion by dendritic cells. Thus, subset composition of iNKT cells is a major determinant of function. Use of enriched CD8 alpha(+), DN or CD4(+) iNKT cells may optimally harness the immunoregulatory properties of iNKT cells for treatment of disease.	[O'Reilly, Vincent; Zeng, Shijuan G.; Atzberger, Ann; Jackson, John; Feighery, Conleth; Doherty, Derek G.] St James Hosp, Trinity Coll Dublin, Dept Immunol, Dublin, Ireland; [O'Reilly, Vincent; Zeng, Shijuan G.; Atzberger, Ann; Jackson, John; Feighery, Conleth; Doherty, Derek G.] St James Hosp, Trinity Coll Dublin, Inst Mol Med, Dublin, Ireland; [Bricard, Gabriel; Porcelli, Steven A.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Hogan, Andrew E.] St Vincents Univ Hosp, Obes Immunol Grp, Educ & Res Ctr, Dublin 4, Ireland; [Hogan, Andrew E.] Univ Coll Dublin, Dublin 2, Ireland	Trinity College Dublin; Trinity College Dublin; Yeshiva University; Albert Einstein College of Medicine; University College Dublin; Saint Vincent's University Hospital; University College Dublin	O'Reilly, V (corresponding author), St James Hosp, Trinity Coll Dublin, Dept Immunol, Dublin, Ireland.	derek.doherty@tcd.ie	Hogan, Andrew/K-1521-2013	Hogan, Andrew/0000-0001-5875-230X; Doherty, Derek/0000-0002-4394-658X	Irish Health Research Board [PHD/2004/2]; Science Foundation Ireland [05/RFP/BIC0015]; National Institute of Health [RO1 AI45889]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045889] Funding Source: NIH RePORTER	Irish Health Research Board; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the Irish Health Research Board (PHD/2004/2), Science Foundation Ireland (05/RFP/BIC0015) and the National Institute of Health (RO1 AI45889). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari O, 2006, NEW ENGL J MED, V354, P1117, DOI 10.1056/NEJMoa053614; Araki M, 2003, INT IMMUNOL, V15, P279, DOI 10.1093/intimm/dxg029; Behar SM, 2007, CURR TOP MICROBIOL, V314, P215; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Berzins SP, 2011, NAT REV IMMUNOL, V11, P131, DOI 10.1038/nri2904; Bricard G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014374; Bricard G, 2009, J IMMUNOL, V182, P5140, DOI 10.4049/jimmunol.0711086; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Chang DH, 2005, J EXP MED, V201, P1503, DOI 10.1084/jem.20042592; Chang YJ, 2007, P NATL ACAD SCI USA, V104, P10299, DOI 10.1073/pnas.0703824104; Chattopadhyay PK, 2005, NAT MED, V11, P1113, DOI 10.1038/nm1293; Crowe NY, 2005, J EXP MED, V202, P1279, DOI 10.1084/jem.20050953; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Exley M, 1997, J EXP MED, V186, P109, DOI 10.1084/jem.186.1.109; Exley MA, 2001, J IMMUNOL, V167, P5531, DOI 10.4049/jimmunol.167.10.5531; Fujii SI, 2007, IMMUNOL REV, V220, P183, DOI 10.1111/j.1600-065X.2007.00561.x; Galli G, 2003, J EXP MED, V197, P1051, DOI 10.1084/jem.20021616; Giaccone G, 2002, CLIN CANCER RES, V8, P3702; Goto M, 2009, CELL IMMUNOL, V254, P81, DOI 10.1016/j.cellimm.2008.10.002; Grubor-Bauk B, 2003, J IMMUNOL, V170, P1430, DOI 10.4049/jimmunol.170.3.1430; Gumperz JE, 2002, J EXP MED, V195, P625, DOI 10.1084/jem.20011786; Hammond KJL, 1998, J EXP MED, V187, P1047, DOI 10.1084/jem.187.7.1047; Ho LP, 2004, J IMMUNOL, V172, P7350, DOI 10.4049/jimmunol.172.12.7350; Hogan AE, 2011, CLIN IMMUNOL, V140, P196, DOI 10.1016/j.clim.2011.03.016; Hong S, 2001, NAT MED, V7, P1052, DOI 10.1038/nm0901-1052; Im JS, 2008, CLIN IMMUNOL, V127, P214, DOI 10.1016/j.clim.2007.12.005; Ishikawa A, 2005, CLIN CANCER RES, V11, P1910, DOI 10.1158/1078-0432.CCR-04-1453; Jiang X, 2007, AM J TRANSPLANT, V7, P1482, DOI 10.1111/j.1600-6143.2007.01827.x; Jones TG, 2009, J IMMUNOL, V183, P5251, DOI 10.4049/jimmunol.0901471; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kenna T, 2003, J IMMUNOL, V171, P1775, DOI 10.4049/jimmunol.171.4.1775; Kim CH, 2002, TRENDS IMMUNOL, V23, P516, DOI 10.1016/S1471-4906(02)02323-2; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kitamura H, 1999, J EXP MED, V189, P1121, DOI 10.1084/jem.189.7.1121; Kunii N, 2009, CANCER SCI, V100, P1092, DOI 10.1111/j.1349-7006.2009.01135.x; Leadbetter EA, 2008, P NATL ACAD SCI USA, V105, P8339, DOI 10.1073/pnas.0801375105; Lee PT, 2002, J EXP MED, V195, P637, DOI 10.1084/jem.20011908; Lee PT, 2002, J CLIN INVEST, V110, P793, DOI 10.1172/JCI200215832; Lin H, 2006, EXP HEMATOL, V34, P289, DOI 10.1016/j.exphem.2005.12.008; Lin H, 2004, EUR J IMMUNOL, V34, P2664, DOI 10.1002/eji.200324834; Lin H, 2006, J LEUKOCYTE BIOL, V80, P164, DOI 10.1189/jlb.0705421; Liu TY, 2008, EUR J IMMUNOL, V38, P1012, DOI 10.1002/eji.200737838; Metelitsa LS, 2001, J IMMUNOL, V167, P3114, DOI 10.4049/jimmunol.167.6.3114; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Molling JW, 2005, INT J CANCER, V116, P87, DOI 10.1002/ijc.20998; Monteiro M, 2010, J IMMUNOL, V185, P2157, DOI 10.4049/jimmunol.1000359; Montoya CJ, 2007, IMMUNOLOGY, V122, P1, DOI 10.1111/j.1365-2567.2007.02647.x; Moodycliffe AM, 2000, NAT IMMUNOL, V1, P521, DOI 10.1038/82782; Moreira-Teixeira L, 2011, J IMMUNOL, V186, P5758, DOI 10.4049/jimmunol.1003043; Motohashi S, 2006, CLIN CANCER RES, V12, P6079, DOI 10.1158/1078-0432.CCR-06-0114; Noelle RJ, 2010, NAT REV IMMUNOL, V10, P683, DOI 10.1038/nri2848; Oki S, 2004, J CLIN INVEST, V113, P1631, DOI 10.1172/JCI200420862; Osada T, 2005, INT IMMUNOL, V17, P1143, DOI 10.1093/intimm/dxh292; Rachitskaya AV, 2008, J IMMUNOL, V180, P5167, DOI 10.4049/jimmunol.180.8.5167; Sakuishi K, 2007, J IMMUNOL, V179, P3452, DOI 10.4049/jimmunol.179.6.3452; Schmieg J, 2003, J EXP MED, V198, P1631, DOI 10.1084/jem.20031192; Seino K, 2005, J EXP MED, V202, P1623, DOI 10.1084/jem.20051600; Takahashi T, 2002, J IMMUNOL, V168, P3140, DOI 10.4049/jimmunol.168.7.3140; Terabe M, 2000, NAT IMMUNOL, V1, P515, DOI 10.1038/82771; Yoshimoto T, 2003, J EXP MED, V197, P997, DOI 10.1084/jem.20021701; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440	61	74	74	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28648	10.1371/journal.pone.0028648	http://dx.doi.org/10.1371/journal.pone.0028648			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174854	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000298366600029
J	Wu, PC; Zhao, R; Ye, YF; Wu, JQ				Wu, Pengcheng; Zhao, Ran; Ye, Yanfang; Wu, Jian-Qiu			Roles of the DYRK Kinase Pom2 in Cytokinesis, Mitochondrial Morphology, and Sporulation in Fission Yeast	PLOS ONE			English	Article							FORESPORE MEMBRANE FORMATION; DYNAMIN-RELATED GTPASE; SPINDLE POLE BODIES; PROTEIN-KINASE; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; CONTRACTILE RING; CELL-CYCLE; DOWN-SYNDROME; ASCOSPORE FORMATION	Pom2 is predicted to be a dual-specificity tyrosine-phosphorylation regulated kinase (DYRK) related to Pom1 in Schizosaccharomyces pombe. DYRKs share a kinase domain capable of catalyzing autophosphorylation on tyrosine and exogenous phosphorylation on serine/threonine residues. Here we show that Pom2 is functionally different from the well-characterized Pom1, although they share 55% identity in the kinase domain and the Pom2 kinase domain functionally complements that of Pom1. Pom2 localizes to mitochondria throughout the cell cycle and to the contractile ring during late stages of cytokinesis. Overexpression but not deletion of pom2 results in severe defects in cytokinesis, indicating that Pom2 might share an overlapping function with other proteins in regulating cytokinesis. Gain and loss of function analyses reveal that Pom2 is required for maintaining mitochondrial morphology independently of microtubules. Intriguingly, most meiotic pom2 Delta cells form aberrant asci with meiotic and/or forespore membrane formation defects. Taken together, Pom2 is a novel DYRK kinase involved in regulating cytokinesis, mitochondrial morphology, meiosis, and sporulation in fission yeast.	[Wu, Pengcheng; Zhao, Ran; Ye, Yanfang; Wu, Jian-Qiu] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Ye, Yanfang; Wu, Jian-Qiu] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Wu, PC (corresponding author), Natl Inst Biol Sci, Beijing, Peoples R China.	wu.620@osu.edu	Wu, Jian-qiu/G-6835-2012		National Institutes of Health (NIH) [R01GM086546]; National BioResource Project; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086546] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National BioResource Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by the National Institutes of Health (NIH) grant R01GM086546 to J-QW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Jurg Bahler, John Pringle, Takashi Toda, and the Yeast Genetic Resource Center Japan (supported by the National BioResource Project) for strains; Valerie Coffman for critical reading of the manuscript; and members of the Wu laboratory for valuable discussion. We are extremely grateful to John Pringle's generous support when this work was initiated in his laboratory.	Almonacid M, 2011, CURR BIOL, V21, P473, DOI 10.1016/j.cub.2011.02.003; Almonacid M, 2009, CURR BIOL, V19, P961, DOI 10.1016/j.cub.2009.04.024; Aranda S, 2011, FASEB J, V25, P449, DOI 10.1096/fj.10-165837; Bahler J, 1998, GENE DEV, V12, P1356, DOI 10.1101/gad.12.9.1356; Bahler J, 2001, EMBO J, V20, P1064, DOI 10.1093/emboj/20.5.1064; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Balasubramanian MK, 2004, CURR BIOL, V14, pR806, DOI 10.1016/j.cub.2004.09.022; Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; Baryshnikova A, 2010, METHOD ENZYMOL, V470, P145, DOI 10.1016/S0076-6879(10)70007-0; Bathe M, 2010, TRENDS MICROBIOL, V18, P38, DOI 10.1016/j.tim.2009.10.002; BECKER W, 1998, PROGR NUCL ACID RES, P1; Benard G, 2009, SEMIN CELL DEV BIOL, V20, P365, DOI 10.1016/j.semcdb.2008.12.012; Bimbo A, 2005, EUKARYOT CELL, V4, P799, DOI 10.1128/EC.4.4.799-813.2005; BRESCH C, 1968, MOL GEN GENET, V102, P301, DOI 10.1007/BF00433721; Campbell LE, 2002, FEBS LETT, V510, P31, DOI 10.1016/S0014-5793(01)03221-5; Celton-Morizur S, 2006, J CELL SCI, V119, P4710, DOI 10.1242/jcs.03261; Coffman VC, 2009, MOL BIOL CELL, V20, P5195, DOI 10.1091/mbc.E09-05-0428; GARRETT S, 1989, GENE DEV, V3, P1336, DOI 10.1101/gad.3.9.1336; GARRETT S, 1991, MOL CELL BIOL, V11, P4045, DOI 10.1128/MCB.11.8.4045; Gorsich SW, 2004, MOL BIOL CELL, V15, P4369, DOI 10.1091/mbc.E03-12-0875; Guimera J, 1996, HUM MOL GENET, V5, P1305, DOI 10.1093/hmg/5.9.1305; Hachet O, 2011, CELL, V145, P1116, DOI 10.1016/j.cell.2011.05.014; Hachet O, 2008, GENE DEV, V22, P3205, DOI 10.1101/gad.1697208; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; Himpel S, 2001, BIOCHEM J, V359, P497, DOI 10.1042/0264-6021:3590497; HIRATA A, 1994, YEAST, V10, P173, DOI 10.1002/yea.320100205; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Huang YY, 2007, DEV CELL, V12, P987, DOI 10.1016/j.devcel.2007.03.015; Huang YY, 2008, J CELL BIOL, V183, P979, DOI 10.1083/jcb.200806151; Ikemoto S, 2000, J CELL SCI, V113, P545; Jambhekar A, 2008, CURR BIOL, V18, P969, DOI 10.1016/j.cub.2008.05.047; Jourdain I, 2009, CELL MOTIL CYTOSKEL, V66, P509, DOI 10.1002/cm.20351; Kentrup H, 1996, J BIOL CHEM, V271, P3488; KISHIDA M, 1986, CURR GENET, V10, P443, DOI 10.1007/BF00419871; Krapp A, 2006, J CELL SCI, V119, P2882, DOI 10.1242/jcs.03025; Krapp A, 2010, J CELL SCI, V123, P3284, DOI 10.1242/jcs.069112; Laporte D, 2011, J CELL BIOL, V192, P1005, DOI 10.1083/jcb.201008171; Laporte D, 2010, SEMIN CELL DEV BIOL, V21, P892, DOI 10.1016/j.semcdb.2010.08.004; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Leupold U., 1970, METHODS CELL PHYSL, V4, P169; Li WZ, 2010, MOL BIOL CELL, V21, P4349, DOI 10.1091/mbc.E10-01-0079; Martin SG, 2009, NATURE, V459, P852, DOI 10.1038/nature08054; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; May-Panloup P, 2005, HUM REPROD, V20, P593, DOI 10.1093/humrep/deh667; Meeusen S, 2006, CELL, V127, P383, DOI 10.1016/j.cell.2006.09.021; Moseley JB, 2010, CELL, V142, P189, DOI 10.1016/j.cell.2010.07.004; Moseley JB, 2009, NATURE, V459, P857, DOI 10.1038/nature08074; MUNDY AJ, 1995, HUM REPROD, V10, P116, DOI 10.1093/humrep/10.1.116; Nakamura T, 2001, MOL BIOL CELL, V12, P3955, DOI 10.1091/mbc.12.12.3955; Nakamura T, 2008, MOL BIOL CELL, V19, P3544, DOI 10.1091/mbc.E08-04-0414; Nakamura-Kubo M, 2003, MOL BIOL CELL, V14, P1109, DOI 10.1091/mbc.E02-08-0504; Nakase Y, 2001, MOL BIOL CELL, V12, P901, DOI 10.1091/mbc.12.4.901; Nakase Y, 2008, MOL BIOL CELL, V19, P2476, DOI 10.1091/mbc.E08-02-0118; Neiman AM, 2005, MICROBIOL MOL BIOL R, V69, P565, DOI 10.1128/MMBR.69.4.565-584.2005; Nunnari J, 1997, MOL BIOL CELL, V8, P1233, DOI 10.1091/mbc.8.7.1233; Ohtaka A, 2008, J CELL SCI, V121, P1547, DOI 10.1242/jcs.022830; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Onishi M, 2010, MOL CELL BIOL, V30, P2057, DOI 10.1128/MCB.01529-09; Padmanabhan A, 2011, CURR BIOL, V21, P467, DOI 10.1016/j.cub.2011.01.059; Padte NN, 2006, CURR BIOL, V16, P2480, DOI 10.1016/j.cub.2006.11.024; Pellettieri J, 2003, DEV CELL, V5, P451, DOI 10.1016/S1534-5807(03)00231-4; Perez-Hidalgo L, 2008, J CELL SCI, V121, P1383, DOI 10.1242/jcs.023812; Piasecka M, 2003, FOLIA HISTOCHEM CYTO, V41, P125; Piasecka Malgorzata, 2003, Folia Morphol (Warsz), V62, P479; Pollard TD, 2010, NAT REV MOL CELL BIO, V11, P149, DOI 10.1038/nrm2834; Raich WB, 2003, GENETICS, V163, P571; Roberts-Galbraith RH, 2008, GENE DEV, V22, P3082, DOI 10.1101/gad.1748908; Sato M, 2009, METHODS MOL BIOL, V545, P185, DOI 10.1007/978-1-60327-993-2_11; Sesaki H, 2003, MOL BIOL CELL, V14, P2342, DOI 10.1091/mbc.E02-12-0788; Sesaki H, 2001, J CELL BIOL, V152, P1123, DOI 10.1083/jcb.152.6.1123; Shimoda C, 2004, J CELL SCI, V117, P389, DOI 10.1242/jcs.00980; SHIMODA C, 1985, MOL GEN GENET, V200, P252, DOI 10.1007/BF00425432; Sitz JH, 2008, NEUROSCIENCE, V157, P596, DOI 10.1016/j.neuroscience.2008.09.034; Smith A, 1998, EMBO J, V17, P3556, DOI 10.1093/emboj/17.13.3556; Smith DJ, 1997, NAT GENET, V16, P28, DOI 10.1038/ng0597-28; Souza GM, 1998, DEVELOPMENT, V125, P2291; Souza GM, 1999, DEVELOPMENT, V126, P3263; Taminato A, 2002, MOL BIOL CELL, V13, P2266, DOI 10.1091/mbc.01-11-0555; TANAKA K, 1982, J CELL SCI, V56, P263; Tatebe H, 2008, CURR BIOL, V18, P322, DOI 10.1016/j.cub.2008.02.005; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; van Es S, 2001, J BIOL CHEM, V276, P30761, DOI 10.1074/jbc.M103365200; Vavylonis D, 2008, SCIENCE, V319, P97, DOI 10.1126/science.1151086; Vilela M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001036; Wu JQ, 2006, J CELL BIOL, V174, P391, DOI 10.1083/jcb.200602032; Wu JQ, 2003, DEV CELL, V5, P723, DOI 10.1016/S1534-5807(03)00324-1; Wu JQ, 2001, MOL BIOL CELL, V12, P1061, DOI 10.1091/mbc.12.4.1061; Yaffe MP, 2003, P NATL ACAD SCI USA, V100, P11424, DOI 10.1073/pnas.1534703100; Yaffe MP, 1999, SCIENCE, V283, P1493, DOI 10.1126/science.283.5407.1493; Yan HY, 2008, MOL BIOL CELL, V19, P3676, DOI 10.1091/mbc.E07-10-1060; Ye YF, 2007, MOL BIOL CELL, V18, P3568, DOI 10.1091/mbc.e07-02-0112; Yoshida K, 2008, BIOCHEM PHARMACOL, V76, P1389, DOI 10.1016/j.bcp.2008.05.021	92	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28000	10.1371/journal.pone.0028000	http://dx.doi.org/10.1371/journal.pone.0028000			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174761	Green Published, gold, Green Submitted			2022-12-25	WOS:000298366600006
J	Yanagisawa, S; Kondo, N; Miki, A; Matsumiya, W; Kusuhara, S; Tsukahara, Y; Honda, S; Negi, A				Yanagisawa, Suiho; Kondo, Naoshi; Miki, Akiko; Matsumiya, Wataru; Kusuhara, Sentaro; Tsukahara, Yasutomo; Honda, Shigeru; Negi, Akira			A Common Complement C3 Variant Is Associated with Protection against Wet Age-Related Macular Degeneration in a Japanese Population	PLOS ONE			English	Article							POLYPOIDAL CHOROIDAL VASCULOPATHY; FACTOR-H POLYMORPHISM; GENE POLYMORPHISMS; FACTOR-I; R102G POLYMORPHISM; CHINESE POPULATION; HUMAN GENOME; FACTOR-B; RISK; COMPONENT	Background: Genetic variants in the complement component 3 gene (C3) have been shown to be associated with age-related macular degeneration (AMD) in Caucasian populations of European descent. In particular, a nonsynonymous coding variant, rs2230199 (R102G), is presumed to be the most likely causal variant in the C3 locus based on strong statistical evidence for disease association and mechanistic functional evidence. However, the risk allele is absent or rare (<1%) in Japanese and Chinese populations, and the association of R102G with AMD has not been reported in Asian populations. Genetic heterogeneity of disease-associated variants among different ethnicities is common in complex diseases. Here, we sought to examine whether other common variants in C3 are associated with wet AMD, a common advanced-stage manifestation of AMD, in a Japanese population. Methodology/Principal Findings: We genotyped 13 tag single nucleotide polymorphisms (SNPs) that capture the majority of common variations in the C3 locus and tested for associations between these SNPs and wet AMD in a Japanese population comprising 420 case subjects and 197 controls. A noncoding variant in C3 (rs2241394) exhibited statistically significant evidence of association (allelic P = 8.32x10(-4); odds ratio = 0.48 [95% CI = 0.31-0.74] for the rs2241394 C allele). Multilocus logistic regression analysis confirmed that the effect of rs2241394 was independent of the previously described loci at ARMS2 and CFH, and that the model including variants in ARMS2 and CFH plus C3 rs2241394 provided a better fit than the model without rs2241394. We found no evidence of epistasis between variants in C3 and CFH, despite the fact that they are involved in the same biological pathway. Conclusions: Our study provides evidence that C3 is a common AMD-associated locus that transcends racial boundaries and provides an impetus for more detailed genetic characterization of the C3 locus in Asian populations.	[Yanagisawa, Suiho; Kondo, Naoshi; Miki, Akiko; Matsumiya, Wataru; Kusuhara, Sentaro; Tsukahara, Yasutomo; Honda, Shigeru; Negi, Akira] Kobe Univ, Grad Sch Med, Div Ophthalmol, Dept Surg, Kobe, Hyogo 657, Japan	Kobe University	Yanagisawa, S (corresponding author), Kobe Univ, Grad Sch Med, Div Ophthalmol, Dept Surg, Kobe, Hyogo 657, Japan.	nskondo@gmail.com	Honda, Shigeru/W-4761-2019	Kusuhara, Sentaro/0000-0002-6458-539X; Kondo, Naoshi/0000-0001-6025-3876	Ministry of Education, Science, and Culture, Tokyo, Japan [23592567]	Ministry of Education, Science, and Culture, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-in Aid for (C) 23592567 from the Ministry of Education, Science, and Culture, Tokyo, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; ARAKAWA S, 2011, NAT GENET IN PRESS; ARVILOMMI H, 1974, NATURE, V251, P740, DOI 10.1038/251740a0; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Blom AM, 2003, ARCH BIOCHEM BIOPHYS, V418, P108, DOI 10.1016/j.abb.2003.08.018; Bora PS, 2005, J IMMUNOL, V174, P491, DOI 10.4049/jimmunol.174.1.491; Coleman HR, 2008, LANCET, V372, P1835, DOI 10.1016/S0140-6736(08)61759-6; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Ding XY, 2009, PROG RETIN EYE RES, V28, P1, DOI 10.1016/j.preteyeres.2008.10.001; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Ennis S, 2010, EUR J HUM GENET, V18, P15, DOI 10.1038/ejhg.2009.113; Fagerness JA, 2009, EUR J HUM GENET, V17, P100, DOI 10.1038/ejhg.2008.140; Fritsche LG, 2008, NAT GENET, V40, P892, DOI 10.1038/ng.170; Gehrs KM, 2006, ANN MED, V38, P450, DOI 10.1080/07853890600946724; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Goto Asako, 2009, J Ocul Biol Dis Infor, V2, P164; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hecker LA, 2010, HUM MOL GENET, V19, P209, DOI 10.1093/hmg/ddp472; Imamura Y, 2010, SURV OPHTHALMOL, V55, P501, DOI 10.1016/j.survophthal.2010.03.004; Ioannidis JPA, 2004, NAT GENET, V36, P1312, DOI 10.1038/ng1474; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Kim NR, 2008, INVEST OPHTH VIS SCI, V49, P2071, DOI 10.1167/iovs.07-1195; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kondo N, 2007, AM J OPHTHALMOL, V144, P608, DOI 10.1016/j.ajo.2007.06.003; Kondo N, 2011, OPHTHALMOLOGY, V118, P339, DOI 10.1016/j.ophtha.2010.06.040; Kondo N, 2010, EUR J HUM GENET, V18, P634, DOI 10.1038/ejhg.2009.243; Liu XQ, 2010, RETINA-J RET VIT DIS, V30, P1177, DOI 10.1097/IAE.0b013e3181cea676; Liu Y, 2007, GRAEF ARCH CLIN EXP, V245, P1441, DOI 10.1007/s00417-007-0575-8; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; Maruko I, 2007, AM J OPHTHALMOL, V144, P15, DOI 10.1016/j.ajo.2007.03.047; Mori K, 2007, INVEST OPHTH VIS SCI, V48, P5315, DOI 10.1167/iovs.07-0426; Ng TK, 2008, INVEST OPHTH VIS SCI, V49, P3312, DOI 10.1167/iovs.07-1517; Pei XT, 2009, CURR EYE RES, V34, P615, DOI 10.1080/02713680903003484; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reynolds R, 2009, INVEST OPHTH VIS SCI, V50, P5818, DOI 10.1167/iovs.09-3928; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Scholl HPN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002593; Seddon JM, 2006, OPHTHALMOLOGY, V113, P260, DOI 10.1016/j.ophtha.2005.11.001; Spencer KL, 2008, HUM MOL GENET, V17, P1821, DOI 10.1093/hmg/ddn075; Spencer KL, 2007, HUM MOL GENET, V16, P1986, DOI 10.1093/hmg/ddm146; Sun LD, 2011, NAT GENET, V43, P690, DOI 10.1038/ng.851; Tam POS, 2008, INVEST OPHTH VIS SCI, V49, P2357, DOI 10.1167/iovs.07-1520; Thakkinstian A, 2011, AM J EPIDEMIOL, V173, P1365, DOI 10.1093/aje/kwr025; WELCH TR, 1990, J PEDIATR-US, V116, pS92, DOI 10.1016/S0022-3476(05)82709-X; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Zerbib J, 2010, MOL VIS, V16, P1324	53	19	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28847	10.1371/journal.pone.0028847	http://dx.doi.org/10.1371/journal.pone.0028847			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174912	gold, Green Published, Green Submitted			2022-12-25	WOS:000298366600043
J	Riviere, G; Fellous, A; Franco, A; Bernay, B; Favrel, P				Riviere, Guillaume; Fellous, Alexandre; Franco, Alban; Bernay, Benoit; Favrel, Pascal			A Crucial Role in Fertility for the Oyster Angiotensin-Converting Enzyme Orthologue CgACE	PLOS ONE			English	Article							2 ACTIVE-SITES; CRASSOSTREA-GIGAS; CRYSTAL-STRUCTURE; DROSOPHILA-MELANOGASTER; RECEPTOR ORTHOLOGUE; MOLECULAR-CLONING; N-DOMAIN; IN-VITRO; EXPRESSION; GENE	Angiotensin-converting enzyme (ACE) is a highly conserved metallopeptidase. In mammals, the somatic isoform governs blood pressure whereas the germinal isoform (tACE) is required for fertility. In Ecdysozoans, ACE-like enzymes are implicated in reproduction. Despite ACE orthologues being present from bacteria to humans, their function(s) remain(s) unknown in distant organisms such as Lophotrochozoans. In silico analysis of an oyster (Crassostrea gigas) EST library suggested the presence of an ACE orthologue in molluscs. Primer walking and 59-RACE revealed that the 1.9 kb cDNA encodes CgACE, a 632 amino acid protein displaying a conserved single active site and a putative C-terminal transmembrane anchor, thus resembling human tACE, as supported by molecular modelling. FRET activity assays and Maldi-TOF spectrometry indicated that CgACE is a functional dipeptidyl-carboxypeptidase which is active on Angiotensin I and sensitive to ACE inhibitors and chloride ion concentration. Immunocytochemistry revealed that, as its human counterpart, recombinant CgACE is synthesised as a transmembrane enzyme. RT-qPCR, in-situ hybridization and immunohistochemistry shed light on a tissue, and development stage, specific expression pattern for CgACE, which is increased in the gonad during spermatogenesis. The use of ACE inhibitors in vivo indicates that the dipeptidase activity of CgACE is crucial for the oyster fertilization. Our study demonstrates that a transmembrane active ACE is present in the oyster Crassostrea gigas, and for the first time ascribes a functional role for ACE in Lophotrochozoans. Its biological function in reproduction is conserved from molluscs to humans, a finding of particular evolutionary interest especially since oysters represent the most important aquaculture resource worldwide.	[Riviere, Guillaume; Fellous, Alexandre; Franco, Alban; Favrel, Pascal] Univ Caen Basse Normandie, IFREMER, UMR Physiol & Ecophysiol Mollusques Marins M100, Caen, France; [Bernay, Benoit] IFR 146 ICORE, Caen, France	Ifremer; Universite de Caen Normandie	Riviere, G (corresponding author), Univ Caen Basse Normandie, IFREMER, UMR Physiol & Ecophysiol Mollusques Marins M100, Caen, France.	guillaume.riviere@unicaen.fr		Favrel, Pascal/0000-0002-2504-9957	French National Research Agency [ANR -08-GENM-041 "Gametogenes"]; European 7th Framework Program [245119 "REPROSEED"]; Regional Council of Basse-Normandie (France)	French National Research Agency(French National Research Agency (ANR)); European 7th Framework Program; Regional Council of Basse-Normandie (France)(Region Normandie)	This work was supported by grants from the French National Research Agency (ANR -08-GENM-041 "Gametogenes"), the European 7th Framework Program (FP7 ref 245119 "REPROSEED") and the Regional Council of Basse-Normandie (France) (fifth research regional program and a doctoral grant to AF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bingham RJ, 2006, FEBS J, V273, P362, DOI 10.1111/j.1742-4658.2005.05069.x; BROOKS DR, 2003, J BIOL CHEM; Carmona AK, 2006, NAT PROTOC, V1, P1971, DOI 10.1038/nprot.2006.306; Coates D, 2000, BIOCHEMISTRY-US, V39, P8963, DOI 10.1021/bi000593q; CORNEL MJ, 1995, J BIOL CHEM, V270, P13613, DOI 10.1074/jbc.270.23.13613; Corradi HR, 2006, J MOL BIOL, V357, P964, DOI 10.1016/j.jmb.2006.01.048; CORVOL P, 2004, HDB PROTEOLYTIC ENZY, P332; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dive V, 1999, P NATL ACAD SCI USA, V96, P4330, DOI 10.1073/pnas.96.8.4330; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Ekbote U, 1999, FEBS LETT, V455, P219, DOI 10.1016/S0014-5793(99)00870-4; ERICKSON RP, 1990, TRENDS GENET, V6, P264, DOI 10.1016/0168-9525(90)90209-O; Eyries M, 2001, J BIOL CHEM, V276, P5525, DOI 10.1074/jbc.M007706200; Fabioux C, 2004, BIOCHEM BIOPH RES CO, V315, P897, DOI 10.1016/j.bbrc.2004.01.145; FELSENSTEIN, 1989, CLADISTICS, V5, P164; Fleury E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-341; Franco A, 2010, CELL TISSUE RES, V340, P201, DOI 10.1007/s00441-009-0923-6; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Houard X, 1998, EUR J BIOCHEM, V257, P599, DOI 10.1046/j.1432-1327.1998.2570599.x; Howe K, 2002, BIOINFORMATICS, V18, P1546, DOI 10.1093/bioinformatics/18.11.1546; HUBERT C, 1991, J BIOL CHEM, V266, P15377; Hurst D, 2003, DEV BIOL, V254, P238, DOI 10.1016/S0012-1606(02)00082-9; JASPARD E, 1993, J BIOL CHEM, V268, P9496; Kawano N, 2010, BIOL REPROD, V83, P359, DOI 10.1095/biolreprod.109.083089; KIERSZENBAUM AL, 1978, FED PROC, V37, P2512; Kim HM, 2003, FEBS LETT, V538, P65, DOI 10.1016/S0014-5793(03)00128-5; Komatsu T, 2002, DNA SEQUENCE, V13, P217, DOI 10.1080/1042517021000021608; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Le Quere H, 2009, GENE, V436, P101, DOI 10.1016/j.gene.2009.01.010; LOBBAN M, 1994, BIOCHEM J, V304, P399, DOI 10.1042/bj3040399; Natesh R, 2004, BIOCHEMISTRY-US, V43, P8718, DOI 10.1021/bi049480n; Natesh R, 2003, NATURE, V421, P551, DOI 10.1038/nature01370; OPPONG SY, 1993, BIOCHEM J, V292, P597, DOI 10.1042/bj2920597; Parkin ET, 2002, BIOCHEMISTRY-US, V41, P4972, DOI 10.1021/bi015936e; Parvathy S, 1997, BIOCHEM J, V327, P37, DOI 10.1042/bj3270037; Quan GX, 2001, INSECT BIOCHEM MOLEC, V31, P97, DOI 10.1016/S0965-1748(00)00112-0; Riviere G, 2005, HYPERTENSION, V46, P1169, DOI 10.1161/01.HYP.0000185148.27901.fe; Riviere G, 2004, BIOCHEM J, V382, P565, DOI 10.1042/BJ20040522; Riviere G, 2007, GENE, V399, P81, DOI 10.1016/j.gene.2007.05.010; Rodet F, 2005, BBA-GENE STRUCT EXPR, V1730, P187, DOI 10.1016/j.bbaexp.2005.05.012; Schwager SL, 2006, NAT PROTOC, V1, P1961, DOI 10.1038/nprot.2006.305; Simunic J, 2009, FEBS J, V276, P4727, DOI 10.1111/j.1742-4658.2009.07169.x; TATEI K, 1995, MECH DEVELOP, V51, P157, DOI 10.1016/0925-4773(95)00349-5; Taylor CAM, 1996, GENE, V181, P191, DOI 10.1016/S0378-1119(96)00503-3; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200; Towler P, 2004, J BIOL CHEM, V279, P17996, DOI 10.1074/jbc.M311191200; Turner AJ, 2002, TRENDS PHARMACOL SCI, V23, P177, DOI 10.1016/S0165-6147(00)01994-5; Wijffels G, 1996, EUR J BIOCHEM, V237, P414, DOI 10.1111/j.1432-1033.1996.0414k.x; Zhu W, 2001, INSECT BIOCHEM MOLEC, V31, P87, DOI 10.1016/S0965-1748(00)00111-9	51	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e27833	10.1371/journal.pone.0027833	http://dx.doi.org/10.1371/journal.pone.0027833			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174750	gold, Green Submitted, Green Published			2022-12-25	WOS:000298365700009
J	So, MT; Leon, TYY; Cheng, G; Tang, CSM; Miao, XP; Cornes, BK; Ngo, DN; Cui, L; Ngan, ESW; Lui, VCH; Wu, XZ; Wang, B; Wang, HL; Yuan, ZW; Huang, LM; Li, L; Xia, HM; Zhu, DL; Liu, JC; Nguyen, TL; Chan, IHY; Chung, PHY; Liu, XL; Zhang, RZ; Wong, KKY; Sham, PC; Cherny, SS; Tam, PKH; Garcia-Barcelo, MM				So, Man-Ting; Leon, Thomas Yuk-Yu; Cheng, Guo; Tang, Clara Sze-Man; Miao, Xiao-Ping; Cornes, Belinda K.; Diem Ngoc Ngo; Cui, Long; Ngan, Elly Sau-Wai; Lui, Vincent Chai-Hang; Wu, Xuan-Zhao; Wang, Bin; Wang, Hualong; Yuan, Zheng-Wei; Huang, Liu-Ming; Li, Long; Xia, Huimin; Zhu, Deli; Liu, Juncheng; Thanh Liem Nguyen; Chan, Ivy Hau-Yee; Chung, Patrick Ho-Yu; Liu, Xue-Lai; Zhang, Ruizhong; Wong, Kenneth Kak-Yuen; Sham, Pak-Chung; Cherny, Stacey S.; Tam, Paul Kwong-Hang; Garcia-Barcelo, Maria-Merce			RET Mutational Spectrum in Hirschsprung Disease: Evaluation of 601 Chinese Patients	PLOS ONE			English	Article							PROTOONCOGENE; DYSFUNCTION; EXPRESSION; RECEPTOR; KINASE; COMMON; RISK; GENE	Rare (RVs) and common variants of the RET gene contribute to Hirschsprung disease (HSCR; congenital aganglionosis). While RET common variants are strongly associated with the commonest manifestation of the disease (males; short-segment aganglionosis; sporadic), rare coding sequence (CDS) variants are more frequently found in the lesser common and more severe forms of the disease (females; long/total colonic aganglionosis; familial). Here we present the screening for RVs in the RET CDS and intron/exon boundaries of 601 Chinese HSCR patients, the largest number of patients ever reported. We identified 61 different heterozygous RVs (50 novel) distributed among 100 patients (16.64%). Those include 14 silent, 29 missense, 5 nonsense, 4 frame-shifts, and one in-frame amino-acid deletion in the CDS, two splice-site deletions, 4 nucleotide substitutions and a 22-bp deletion in the intron/exon boundaries and 1 single-nucleotide substitution in the 59 untranslated region. Exonic variants were mainly clustered in RET the extracellular domain. RET RVs were more frequent among patients with the most severe phenotype (24% vs. 15% in short-HSCR). Phasing RVs with the RET HSCR-associated haplotype suggests that RVs do not underlie the undisputable association of RET common variants with HSCR. None of the variants were found in 250 Chinese controls.	[So, Man-Ting; Leon, Thomas Yuk-Yu; Cheng, Guo; Cornes, Belinda K.; Cui, Long; Ngan, Elly Sau-Wai; Lui, Vincent Chai-Hang; Chan, Ivy Hau-Yee; Chung, Patrick Ho-Yu; Liu, Xue-Lai; Zhang, Ruizhong; Wong, Kenneth Kak-Yuen; Tam, Paul Kwong-Hang; Garcia-Barcelo, Maria-Merce] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Tang, Clara Sze-Man; Sham, Pak-Chung; Cherny, Stacey S.] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Ngan, Elly Sau-Wai; Lui, Vincent Chai-Hang; Sham, Pak-Chung; Tam, Paul Kwong-Hang; Garcia-Barcelo, Maria-Merce] Univ Hong Kong, Ctr Reprod Dev & Growth, Hong Kong, Hong Kong, Peoples R China; [Sham, Pak-Chung] Univ Hong Kong, Genome Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Miao, Xiao-Ping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China; [Wu, Xuan-Zhao] Affiliated Hosp, Guiyang Med Coll, Dept Surg, Guiyang, Peoples R China; [Wang, Bin] Shenzhen Childrens Hosp, Shenzhen, Peoples R China; [Wang, Hualong] Changchun Childrens Hosp, Changchun, Peoples R China; [Yuan, Zheng-Wei] China Med Univ, Shengjing Hosp, Shenyang, Peoples R China; [Huang, Liu-Ming] Beijing BAYI Childrens Hosp, Beijing, Peoples R China; [Li, Long] Capital Inst Pediat, Beijing, Peoples R China; [Xia, Huimin; Zhu, Deli] Guangzhou Women & Childrens Med Ctr, Guangzhou, Guangdong, Peoples R China; [Liu, Juncheng] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pediat Surg, Guangzhou 510275, Guangdong, Peoples R China; [Diem Ngoc Ngo; Thanh Liem Nguyen] Natl Hosp Pediat, Dept Human Genet, Hanoi, Vietnam	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; Huazhong University of Science & Technology; Guizhou Medical University; China Medical University; Capital Institute of Pediatrics (CIP); Sun Yat Sen University	So, MT (corresponding author), Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China.	mmgarcia@hku.hk	Ngan, Elly/N-1543-2019; Wong, Kenneth K. Y./B-9920-2008; Cherny, Stacey S/B-3315-2008; miao, xiaoping/C-4336-2011; Zhang, Ruizhong/GOE-6855-2022	Ngan, Elly/0000-0002-0022-7999; Cherny, Stacey S/0000-0002-0269-3352; miao, xiaoping/0000-0002-6818-9722; Zhang, Ruizhong/0000-0002-4954-7192; CHUNG, Patrick Ho Yu/0000-0003-2382-5681; Tang, Clara/0000-0003-0265-2638	Hong Kong Research Grants Council [HKU 765407M, HKU 778610M]; University of Hong Kong [200611159028]; University of Hong Kong Genomics Strategic Research Theme	Hong Kong Research Grants Council(Hong Kong Research Grants Council); University of Hong Kong(University of Hong Kong); University of Hong Kong Genomics Strategic Research Theme	This work was supported by research grants from the Hong Kong Research Grants Council HKU 765407M to M-MG-B and HKU 778610M to PK-HT; and from The University of Hong Kong Seed Funding Programme 200611159028 to M-MG-B. Support was also obtained from The University of Hong Kong Genomics Strategic Research Theme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; ATTIE T, 1995, HUM MOL GENET, V4, P1381, DOI 10.1093/hmg/4.8.1381; Bolk S, 2000, P NATL ACAD SCI USA, V97, P268, DOI 10.1073/pnas.97.1.268; Cornes BK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010918; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; EDERY P, 1994, NATURE, V367, P378, DOI 10.1038/367378a0; Emison ES, 2010, AM J HUM GENET, V87, P60, DOI 10.1016/j.ajhg.2010.06.007; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; Gabriel SB, 2002, NAT GENET, V31, P89, DOI 10.1038/ng868; Garcia-Barcelo M, 2005, HUM MOL GENET, V14, P191, DOI 10.1093/hmg/ddi015; Garcia-Barcelo M, 2004, CLIN CHEM, V50, P93, DOI 10.1373/clinchem.2003.022061; Garcia-Barcelo MM, 2009, P NATL ACAD SCI USA, V106, P2694, DOI 10.1073/pnas.0809630105; Garcia-Barcelo MM, 2003, J MED GENET, V40; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Hofstra RMW, 2000, HUM MUTAT, V15, P418, DOI 10.1002/(SICI)1098-1004(200005)15:5<418::AID-HUMU3>3.0.CO;2-2; Iwashita T, 2001, GASTROENTEROLOGY, V121, P24, DOI 10.1053/gast.2001.25515; Iwashita T, 1996, HUM MOL GENET, V5, P1577, DOI 10.1093/hmg/5.10.1577; Manie S, 2001, TRENDS GENET, V17, P580, DOI 10.1016/S0168-9525(01)02420-9; Miao XP, 2010, HUM MOL GENET, V19, P1461, DOI 10.1093/hmg/ddq020; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Pelet A, 1998, J CLIN INVEST, V101, P1415, DOI 10.1172/JCI375; Pupko T, 2002, BIOINFORMATICS, V18, P1116, DOI 10.1093/bioinformatics/18.8.1116; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Seri M, 1997, HUM MUTAT, V9, P243; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Won HH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003575	27	20	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28986	10.1371/journal.pone.0028986	http://dx.doi.org/10.1371/journal.pone.0028986			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174939	Green Submitted, Green Published, gold			2022-12-25	WOS:000298365700085
J	Zhang, Y; Hong, H; Engle, JW; Bean, J; Yang, YN; Leigh, BR; Barnhart, TE; Cai, WB				Zhang, Yin; Hong, Hao; Engle, Jonathan W.; Bean, Jero; Yang, Yunan; Leigh, Bryan R.; Barnhart, Todd E.; Cai, Weibo			Positron Emission Tomography Imaging of CD105 Expression with a Cu-64-Labeled Monoclonal Antibody: NOTA Is Superior to DOTA	PLOS ONE			English	Article							ENDOGLIN CD105; BEARING MICE; SOLID TUMORS; PET; THERAPY; CANCER; COMPLEXES; RADIOPHARMACEUTICALS; VASCULATURE; STABILITIES	Optimizing the in vivo stability of positron emission tomography (PET) tracers is of critical importance to cancer diagnosis. In the case of Cu-64-labeled monoclonal antibodies (mAb), in vivo behavior and biodistribution is critically dependent on the performance of the bifunctional chelator used to conjugate the mAb to the radiolabel. This study compared the in vivo characteristics of Cu-64-labeled TRC105 (a chimeric mAb that binds to both human and murine CD105), through two commonly used chelators: 1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA) and 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA). Flow cytometry analysis confirmed that chelator conjugation of TRC105 did not affect its CD105 binding affinity or specificity. PET imaging and biodistribution studies in 4T1 murine breast tumor-bearing mice revealed that Cu-64-NOTA-TRC105 exhibited better stability than Cu-64-DOTA-TRC105 in vivo, which resulted in significantly lower liver uptake without compromising the tumor targeting efficiency. In conclusion, this study confirmed that NOTA is a superior chelator to DOTA for PET imaging with Cu-64-labeled TRC105.	[Zhang, Yin; Engle, Jonathan W.; Barnhart, Todd E.; Cai, Weibo] Univ Wisconsin, Dept Med Phys, Madison, WI 53706 USA; [Hong, Hao; Bean, Jero; Yang, Yunan; Cai, Weibo] Univ Wisconsin, Dept Radiol, Madison, WI 53706 USA; [Leigh, Bryan R.] TRACON Pharmaceut Inc, San Diego, CA USA; [Cai, Weibo] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Zhang, Y (corresponding author), Univ Wisconsin, Dept Med Phys, 1530 Med Sci Ctr, Madison, WI 53706 USA.	wcai@uwhealth.org	Zhang, Yin/E-6547-2015; Yang, Yunan/I-3451-2014; Hong, Hao/K-6035-2012; Cai, Weibo/B-9174-2008	Cai, Weibo/0000-0003-4641-0833; Engle, Jonathan W/0000-0002-3399-7228; Barnhart, Todd/0000-0002-9981-2150	University of Wisconsin Carbone Cancer Center; Department of Defense [W81XWH-11-1-0644, W81XWH-11-1-0648]; National Center for Research Resources [1UL1RR025011]; National Institutes of Health (NIH) through the UW [5 T32 CA009206-32]; NATIONAL CANCER INSTITUTE [T32CA009206] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011] Funding Source: NIH RePORTER	University of Wisconsin Carbone Cancer Center; Department of Defense(United States Department of Defense); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health (NIH) through the UW; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work is supported, in part, by the University of Wisconsin Carbone Cancer Center, the Department of Defense (W81XWH-11-1-0644 and W81XWH-11-1-0648), National Center for Research Resources 1UL1RR025011, and the National Institutes of Health (NIH) through the UW Radiological Sciences Training Program 5 T32 CA009206-32. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ait-Mohand S, 2011, BIOCONJUGATE CHEM, V22, P1729, DOI 10.1021/bc2002665; Anderson CJ, 2001, J NUCL MED, V42, P213; Blower PJ, 1996, NUCL MED BIOL, V23, P957, DOI 10.1016/S0969-8051(96)00130-8; Boswell CA, 2004, J MED CHEM, V47, P1465, DOI 10.1021/jm030383m; Cai W, 2008, EUR J NUCL MED MOL I, V35, P186, DOI 10.1007/s00259-007-0560-9; Cai WB, 2007, EUR J NUCL MED MOL I, V34, P2024, DOI 10.1007/s00259-007-0503-5; Cai WB, 2007, EUR J NUCL MED MOL I, V34, P850, DOI 10.1007/s00259-006-0361-6; Cai WB, 2006, CANCER RES, V66, P9673, DOI 10.1158/0008-5472.CAN-06-1480; CLARKE ET, 1991, INORG CHIM ACTA, V190, P27, DOI 10.1016/S0020-1693(00)80228-5; Dallas NA, 2008, CLIN CANCER RES, V14, P1931, DOI 10.1158/1078-0432.CCR-07-4478; Dearling JLJ, 2011, NUCL MED BIOL, V38, P29, DOI 10.1016/j.nucmedbio.2010.07.003; DELGADO R, 1993, INORG CHEM, V32, P3320, DOI 10.1021/ic00067a022; Fonsatti E, 2000, CLIN CANCER RES, V6, P2037; Fonsatti E, 2010, CARDIOVASC RES, V86, P12, DOI 10.1093/cvr/cvp332; Garrison JC, 2007, J NUCL MED, V48, P1327, DOI 10.2967/jnumed.107.039487; HONG H, 2011, EUR J NUCL MED MOL I; Hong H, 2011, AM J TRANSL RES, V3, P392; Hong H, 2011, EUR J NUCL MED MOL I, V38, P1335, DOI 10.1007/s00259-011-1765-5; Huang CW, 2011, BIOCONJUGATE CHEM, V22, P256, DOI 10.1021/bc100388g; Liu ZF, 2009, J NUCL MED, V50, P1168, DOI 10.2967/jnumed.108.061739; MCCARDLE RJ, 1966, J NUCL MED, V7, P837; Mendelson DS, 2010, J CLIN ONCOL, V28, p15s; Niu G, 2009, J NUCL MED, V50, P1116, DOI 10.2967/jnumed.109.061820; Prasanphanich AF, 2007, P NATL ACAD SCI USA, V104, P12462, DOI 10.1073/pnas.0705347104; Seo JW, 2008, BIOCONJUGATE CHEM, V19, P2577, DOI 10.1021/bc8002937; Seon BK, 2011, CURR DRUG DELIV, V8, P135; Takahashi N, 2001, CANCER RES, V61, P7846; TANNOCK IF, 1989, CANCER RES, V49, P4373; Wadas TJ, 2007, CURR PHARM DESIGN, V13, P3, DOI 10.2174/138161207779313768; Wadas TJ, 2006, NAT PROTOC, V1, P3062, DOI 10.1038/nprot.2006.431; Wadas TJ, 2010, CHEM REV, V110, P2858, DOI 10.1021/cr900325h; Wang H, 2007, EUR J NUCL MED MOL I, V34, P2001, DOI 10.1007/s00259-007-0524-0; Wei L, 2009, NUCL MED BIOL, V36, P277, DOI 10.1016/j.nucmedbio.2008.12.008; Wu AM, 2005, NAT BIOTECHNOL, V23, P1137, DOI 10.1038/nbt1141; Wu AM, 2009, J NUCL MED, V50, P2, DOI 10.2967/jnumed.108.056887; Yang XQ, 2011, BIOMATERIALS, V32, P4151, DOI 10.1016/j.biomaterials.2011.02.006; Yang YA, 2011, EUR J NUCL MED MOL I, V38, P2066, DOI 10.1007/s00259-011-1886-x; Zhang Y, 2011, INT J CLIN EXP MED, V4, P32	38	88	93	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28005	10.1371/journal.pone.0028005	http://dx.doi.org/10.1371/journal.pone.0028005			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174762	Green Published, gold, Green Submitted			2022-12-25	WOS:000298365700014
J	Levett, DZ; Radford, EJ; Menassa, DA; Graber, EF; Morash, AJ; Hoppeler, H; Clarke, K; Martin, DS; Ferguson-Smith, AC; Montgomery, HE; Grocott, MPW; Murray, AJ				Levett, Denny Z.; Radford, Elizabeth J.; Menassa, David A.; Graber, E. Franziska; Morash, Andrea J.; Hoppeler, Hans; Clarke, Kieran; Martin, Daniel S.; Ferguson-Smith, Anne C.; Montgomery, Hugh E.; Grocott, Michael P. W.; Murray, Andrew J.		Caudwell Xtreme Everest Res Grp	Acclimatization of skeletal muscle mitochondria to high-altitude hypoxia during an ascent of Everest	FASEB JOURNAL			English	Article						metabolism; energetics	ACTIVATED RECEPTOR-ALPHA; UNCOUPLING PROTEIN-3; HYPOBARIC HYPOXIA; OXYGEN-TRANSPORT; GENE-EXPRESSION; MOUNT EVEREST; RAT-HEART; METABOLISM; ADAPTATION; UCP3	Ascent to high altitude is associated with a fall in the partial pressure of inspired oxygen (hypobaric hypoxia). For oxidative tissues such as skeletal muscle, resultant cellular hypoxia necessitates acclimatization to optimize energy metabolism and restrict oxidative stress, with changes in gene and protein expression that alter mitochondrial function. It is known that lowlanders returning from high altitude have decreased muscle mitochondrial densities, yet the underlying transcriptional mechanisms and time course are poorly understood. To explore these, we measured gene and protein expression plus ultrastructure in muscle biopsies of lowlanders at sea level and following exposure to hypobaric hypoxia. Subacute exposure (19 d after initiating ascent to Everest base camp, 5300 m) was not associated with mitochondrial loss. After 66 d at altitude and ascent beyond 6400 m, mitochondrial densities fell by 21%, with loss of 73% of subsarcolemmal mitochondria. Correspondingly, levels of the transcriptional coactivator PGC-1 alpha fell by 35%, suggesting down-regulation of mitochondrial biogenesis. Sustained hypoxia also decreased expression of electron transport chain complexes I and IV and UCP3 levels. We suggest that during subacute hypoxia, mitochondria might be protected from oxidative stress. However, following sustained exposure, mitochondrial biogenesis is deactivated and uncoupling down-regulated, perhaps to improve the efficiency of ATP production.-Levett, D. Z., Radford, E. J., Menassa, D. A., Graber, E. F., Morash, A. J., Hoppeler, H., Clarke, K., Martin, D. C., Ferguson-Smith, A. C., Montgomery, H. E., Grocott, M. P. W., Murray, A. J., Caudwell Xtreme Everest Research Group. Acclimatization of skeletal muscle mitochondria to high-altitude hypoxia during an ascent of Everest. FASEB J. 26, 1431-1441 (2012). www.fasebj.org	[Radford, Elizabeth J.; Menassa, David A.; Morash, Andrea J.; Ferguson-Smith, Anne C.; Murray, Andrew J.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England; [Levett, Denny Z.; Martin, Daniel S.; Grocott, Michael P. W.] UCL, Inst Child Hlth, Ctr Altitude Space & Extreme Environm Med, London, England; [Graber, E. Franziska; Hoppeler, Hans] Univ Bern, Dept Anat, Inst Anat, CH-3000 Bern, Switzerland; [Clarke, Kieran] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Montgomery, Hugh E.] UCL, Inst Human Hlth & Performance, London, England; [Montgomery, Hugh E.] Inst Sport Exercise & Hlth, London, England	University of Cambridge; University of London; University College London; University of Bern; University of Oxford; University of London; University College London	Murray, AJ (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3EG, England.	ajm267@cam.ac.uk	Menassa, David/L-8726-2019; Murray, Andrew/B-3130-2010; Morash, Andrea/F-2835-2013; Montgomery, Hugh/L-1229-2019; Grocott, Michael/C-4394-2008; Martin, Daniel S/F-7997-2010; Levett, Denny/D-2239-2017; Levett, Denny Zelda Hope/AAY-4627-2021; Levett, Denny/F-4474-2011; Montgomery, Hugh/C-2592-2008	Murray, Andrew/0000-0002-0929-9315; Morash, Andrea/0000-0001-8486-4567; Grocott, Michael/0000-0002-9484-7581; Levett, Denny/0000-0002-8418-1675; Levett, Denny Zelda Hope/0000-0002-8418-1675; Levett, Denny/0000-0002-8418-1675; Martin, Daniel/0000-0001-6220-8235; Ferguson-Smith, Anne/0000-0002-7608-5894; Menassa, David/0000-0002-5984-8407; Montgomery, Hugh/0000-0001-8797-5019; Radford, Elizabeth/0000-0002-7829-5422	entrepreneur John Caudwell (BOC Medical, now part of Linde Gas Therapeutics); Lilly Critical Care; London Clinic; Smiths Medical; Deltex Medical; Rolex Foundation; Association of Anesthetists of Great Britain; Association of Anesthetists of Ireland; UK Intensive Care Foundation; Sir Halley Stuart Trust; Research Councils UK; British Heart Foundation [PS/02/002/14893, RG/07/004/22659] Funding Source: researchfish	entrepreneur John Caudwell (BOC Medical, now part of Linde Gas Therapeutics); Lilly Critical Care; London Clinic; Smiths Medical; Deltex Medical; Rolex Foundation; Association of Anesthetists of Great Britain; Association of Anesthetists of Ireland; UK Intensive Care Foundation; Sir Halley Stuart Trust; Research Councils UK(UK Research & Innovation (UKRI)); British Heart Foundation(British Heart Foundation)	Caudwell Xtreme Everest (CXE) is a project coordinated by the UCL Centre for Altitude, Space, and Extreme Environment Medicine, with the aim of conducting research into hypoxia and human performance at high altitude to improve understanding of hypoxia in critical illness. The research was funded by unrestricted grants from a variety of sources, none of which are public, including the entrepreneur John Caudwell (BOC Medical, now part of Linde Gas Therapeutics), Lilly Critical Care, the London Clinic, Smiths Medical, Deltex Medical, and the Rolex Foundation. Specific grants were awarded by the Association of Anesthetists of Great Britain and Ireland, the UK Intensive Care Foundation, and the Sir Halley Stuart Trust. The CXE volunteers who trekked to EBC also kindly donated to support the research. The CXE Research Group contributed to the design and conduct of experiments. The members of the CXE Research Group are listed on the project's website (http://www.xtreme-everest.co.uk). In particular, the authors thank Prof. Chris Imray and Prof. David Howard for collecting muscle biopsies at EBC, Adolfo Odriozola for preparing ultrathin sections of biopsies and producing some of the EM images included in this article, and the CXE Project Manager, Kay Mitchell, for her tireless work that made the expedition possible. A.J.M. thanks the Research Councils UK for supporting his academic fellowship and the Department of Physiology, Development, and Neuroscience, University of Cambridge, for welcoming him so warmly as a new member of the academic staff.	Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62; BOYER SJ, 1984, J APPL PHYSIOL, V57, P1580, DOI 10.1152/jappl.1984.57.5.1580; Brand MD, 2002, BIOCHEM J, V368, P597, DOI 10.1042/BJ20021077; Carre JE, 2010, AM J RESP CRIT CARE, V182, P745, DOI 10.1164/rccm.201003-0326OC; Chan SY, 2009, CELL METAB, V10, P273, DOI 10.1016/j.cmet.2009.08.015; CHANDEL N, 1995, AM J PHYSIOL-LUNG C, V268, pL918, DOI 10.1152/ajplung.1995.268.6.L918; Chen Z, 2010, ONCOGENE, V29, P4362, DOI 10.1038/onc.2010.193; COGSWELL AM, 1993, AM J PHYSIOL, V264, pC383, DOI 10.1152/ajpcell.1993.264.2.C383; Edwards LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010681; Essop MF, 2004, BIOCHEM BIOPH RES CO, V314, P561, DOI 10.1016/j.bbrc.2003.12.121; Favaro E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010345; Ferretti G, 2003, EUR J APPL PHYSIOL, V90, P344, DOI 10.1007/s00421-003-0923-2; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Gilde AJ, 2003, ACTA PHYSIOL SCAND, V178, P425, DOI 10.1046/j.1365-201X.2003.01161.x; Gilde AJ, 2003, CIRC RES, V92, P518, DOI 10.1161/01.RES.0000060700.55247.7C; Gore CJ, 2007, MED SCI SPORT EXER, V39, P1600, DOI 10.1249/mss.0b013e3180de49d3; GREEN HJ, 1992, J APPL PHYSIOL, V73, P2701, DOI 10.1152/jappl.1992.73.6.2701; Grocott M, 2007, CRIT CARE, V11, DOI 10.1186/cc5142; Grocott MPW, 2009, NEW ENGL J MED, V360, P140, DOI 10.1056/NEJMoa0801581; Holloway CJ, 2011, FASEB J, V25, P792, DOI 10.1096/fj.10-172999; HOPPELER H, 1973, PFLUG ARCH EUR J PHY, V344, P217, DOI 10.1007/BF00588462; HOPPELER H, 1986, INT J SPORTS MED, V7, P187, DOI 10.1055/s-2008-1025758; Houle-Leroy P, 2000, J APPL PHYSIOL, V89, P1608, DOI 10.1152/jappl.2000.89.4.1608; Howald H, 2003, EUR J APPL PHYSIOL, V90, P360, DOI 10.1007/s00421-003-0872-9; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Khosravi Maryam, 2009, Expert Rev Respir Med, V3, P561, DOI 10.1586/ers.09.56; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Koves TR, 2005, AM J PHYSIOL-CELL PH, V288, pC1074, DOI 10.1152/ajpcell.00391.2004; Levett DZH, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-98; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Ljubicic V, 2004, J APPL PHYSIOL, V97, P976, DOI 10.1152/japplphysiol.00336.2004; Lu ZP, 2008, J BIOL CHEM, V283, P23410, DOI 10.1074/jbc.M801236200; McCarthy J, 2011, J CELL PHYSIOL, V226, P2457, DOI 10.1002/jcp.22592; McClelland GB, 2005, J EXP BIOL, V208, P515, DOI 10.1242/jeb.01423; Mogensen M, 2006, J PHYSIOL-LONDON, V571, P669, DOI 10.1113/jphysiol.2005.101691; Murray AJ, 2005, DIABETES, V54, P3496, DOI 10.2337/diabetes.54.12.3496; Murray AJ, 2008, J MOL CELL CARDIOL, V44, P694, DOI 10.1016/j.yjmcc.2008.01.008; Murray AJ, 2009, GENOME MED, V1, DOI 10.1186/gm117; Murray AJ, 2009, FASEB J, V23, P4353, DOI 10.1096/fj.09-139691; Narravula S, 2001, J IMMUNOL, V166, P7543, DOI 10.4049/jimmunol.166.12.7543; Peacock AJ, 1998, BRIT MED J, V317, P1063; Raguso CA, 2004, CURR OPIN CLIN NUTR, V7, P411, DOI 10.1097/01.mco.0000134372.78438.09; REYNAFARJE B, 1962, J APPL PHYSIOL, V17, P301, DOI 10.1152/jappl.1962.17.2.301; SEMENZA GL, 2007, SCI STKE, pCM8, DOI DOI 10.1126/STKE.4072007CM8; Shukla V, 2005, NUTR NEUROSCI, V8, P161, DOI 10.1080/10284150500132823; SUTTON JR, 1988, J APPL PHYSIOL, V64, P1309, DOI 10.1152/jappl.1988.64.4.1309; VidalPuig A, 1997, BIOCHEM BIOPH RES CO, V235, P79, DOI 10.1006/bbrc.1997.6740; Vock R, 1996, J EXP BIOL, V199, P1675; WEST JB, 1983, J APPL PHYSIOL, V54, P1188, DOI 10.1152/jappl.1983.54.5.1188; Wheaton WW, 2011, AM J PHYSIOL-CELL PH, V300, pC385, DOI 10.1152/ajpcell.00485.2010; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001	53	106	114	0	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2012	26	4					1431	1441		10.1096/fj.11-197772	http://dx.doi.org/10.1096/fj.11-197772			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	919VS	22186874	Bronze			2022-12-25	WOS:000302359700006
J	Shimozaki, K; Zhang, CL; Suh, H; Denli, AM; Evans, RM; Gage, FH				Shimozaki, Koji; Zhang, Chun-Li; Suh, Hoonkyo; Denli, Ahmet M.; Evans, Ronald M.; Gage, Fred H.			SRY-box-containing Gene 2 Regulation of Nuclear Receptor Tailless (Tlx) Transcription in Adult Neural Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-RENEWAL; SOX2 FUNCTIONS; MOUSE BRAIN; EXPRESSION; PROLIFERATION; NEUROGENESIS; TUMORIGENICITY; COACTIVATOR; MULTIPOTENT; RECRUITS	Adult neurogenesis is maintained by self-renewable neural stem cells (NSCs). Their activity is regulated by multiple signaling pathways and key transcription factors. However, it has been unclear whether these factors interplay with each other at the molecular level. Here we show that SRY-box-containing gene 2 (Sox2) and nuclear receptor tailless (TLX) form a molecular network in adult NSCs. We observed that both Sox2 and TLX proteins bind to the upstream region of Tlx gene. Sox2 positively regulates Tlx expression, whereas the binding of TLX to its own promoter suppresses its transcriptional activity in luciferase reporter assays. Such TLX-mediated suppression can be antagonized by overexpressing wild-type Sox2 but not a mutant lacking the transcriptional activation domain. Furthermore, through regions involved in DNA-binding activity, Sox2 and TLX physically interact to form a complex on DNAs that contain a consensus binding site for TLX. Finally, depletion of Sox2 revealed the potential negative feedback loop of TLX expression that is antagonized by Sox2 in adult NSCs. These data suggest that Sox2 plays an important role in Tlx transcription in cultured adult NSCs.	[Shimozaki, Koji] Nagasaki Univ, Div Funct Genom, Ctr Frontier Life Sci, Nagasaki 8528102, Japan; [Shimozaki, Koji; Suh, Hoonkyo; Denli, Ahmet M.; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Zhang, Chun-Li; Evans, Ronald M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Zhang, Chun-Li] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	Nagasaki University; Salk Institute; Salk Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Shimozaki, K (corresponding author), Nagasaki Univ, Div Funct Genom, Ctr Frontier Life Sci, Nagasaki 8528102, Japan.	shimozak@nagasaki-u.ac.jp; gage@salk.edu	Evans, Ronald/AAF-4001-2019	Evans, Ronald/0000-0002-9986-5965; Suh, Hoonkyo/0000-0002-4227-2982	National Institutes of Health [NIMH-MH090258]; McDonnell Foundation; Mothers Foundation; Lookout Foundation; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Uehara Memorial Foundation of Japan; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK057978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090258] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070981] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006484] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23700383] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McDonnell Foundation; Mothers Foundation; Lookout Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation of Japan(Uehara Memorial Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grant NIMH-MH090258. This work was also supported by the McDonnell Foundation, the Mothers Foundation, and the Lookout Foundation, a Grant-in-Aid from the Japan Society for the Promotion of Science, a Grant-in-Aid for Research Activity Start-up from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and the Uehara Memorial Foundation of Japan.	Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bergsland M, 2011, GENE DEV, V25, P2453, DOI 10.1101/gad.176008.111; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Catena R, 2004, J BIOL CHEM, V279, P41846, DOI 10.1074/jbc.M405514200; Cavallaro M, 2008, DEVELOPMENT, V135, P541, DOI 10.1242/dev.010801; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Elmi M, 2010, MOL CELL NEUROSCI, V45, P121, DOI 10.1016/j.mcn.2010.06.003; Episkopou V, 2005, TRENDS NEUROSCI, V28, P219, DOI 10.1016/j.tins.2005.03.003; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Hu QK, 2010, STEM CELLS, V28, P279, DOI 10.1002/stem.246; Josephson R, 1998, DEVELOPMENT, V125, P3087; Kondoh H, 2010, INT J BIOCHEM CELL B, V42, P391, DOI 10.1016/j.biocel.2009.09.003; Liu HK, 2008, GENE DEV, V22, P2473, DOI 10.1101/gad.479308; Liu HK, 2010, GENE DEV, V24, P683, DOI 10.1101/gad.560310; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Miyagi S, 2008, FEBS LETT, V582, P2811, DOI 10.1016/j.febslet.2008.07.011; Monaghan AP, 1997, NATURE, V390, P515, DOI 10.1038/37364; Nowling T, 2003, J BIOL CHEM, V278, P13696, DOI 10.1074/jbc.M207567200; Nowling TK, 2000, J BIOL CHEM, V275, P3810, DOI 10.1074/jbc.275.6.3810; PALMER TD, 1995, MOL CELL NEUROSCI, V6, P474, DOI 10.1006/mcne.1995.1035; Pevny LH, 2010, INT J BIOCHEM CELL B, V42, P421, DOI 10.1016/j.biocel.2009.08.018; Ray J, 2006, MOL CELL NEUROSCI, V31, P560, DOI 10.1016/j.mcn.2005.11.010; RAY J, 1993, P NATL ACAD SCI USA, V90, P3602, DOI 10.1073/pnas.90.8.3602; Shi YH, 2008, CRIT REV ONCOL HEMAT, V65, P43, DOI 10.1016/j.critrevonc.2007.06.004; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Shimozaki K, 2005, J NEUROCHEM, V93, P432, DOI 10.1111/j.1471-4159.2005.03031.x; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Sun GQ, 2007, P NATL ACAD SCI USA, V104, P15282, DOI 10.1073/pnas.0704089104; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takanaga H, 2009, STEM CELLS, V27, P165, DOI 10.1634/stemcells.2008-0580; Tanaka S, 2004, MOL CELL BIOL, V24, P8834, DOI 10.1128/MCB.24.20.8834-8846.2004; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; Yokoyama A, 2008, MOL CELL BIOL, V28, P3995, DOI 10.1128/MCB.02030-07; YU RT, 1994, NATURE, V370, P375, DOI 10.1038/370375a0; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhang CL, 2006, GENE DEV, V20, P1308, DOI 10.1101/gad.1413606	42	41	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5969	5978		10.1074/jbc.M111.290403	http://dx.doi.org/10.1074/jbc.M111.290403			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22194602	hybrid, Green Submitted, Green Published			2022-12-25	WOS:000300638000070
J	Izawa, R; Onoue, T; Furukawa, N; Mima, J				Izawa, Ryota; Onoue, Toshitaka; Furukawa, Noriko; Mima, Joji			Distinct Contributions of Vacuolar Qabc- and R-SNARE Proteins to Membrane Fusion Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; T-SNARES; SUBCELLULAR MEMBRANES; REGULATORY LIPIDS; HOMOTYPIC FUSION; V-SNARES; YEAST; COMPLEX; CHAPERONES; PHOSPHOINOSITIDES	In eukaryotic endomembrane systems, Qabc-SNAREs (soluble N-ethylmaleimide-sensitive factor attachment protein receptors) on one membrane and R-SNARE on the opposing membrane assemble into a trans-QabcR-SNARE complex to drive membrane fusion. However, it remains ambiguous whether pairing of Qabc- and R-SNAREs mediates membrane fusion specificity. Here, we explored the fusion specificity of reconstituted proteoliposomes bearing purified SNAREs in yeast vacuoles and other organelles. We found that not only vacuolar R-SNARE Nyv1p but also the non-cognate R-SNAREs, endosomal Snc2p, and endoplasmic reticulum-Golgi Sec22p caused efficient fusion with vacuolar Qabc-SNAREs. In contrast, their fusion is blocked completely by replacing vacuolar Qc-SNARE Vam7p with the non-cognate endosomal Tlg1p and Syn8p, although these endosomal Qc-SNAREs fully retained the ability to form cis-SNARE complexes with vacuolar SNAREs in solution and on membranes. Thus, our current study establishes that an appropriate assembly of Qabc-SNAREs is crucial for regulating fusion specificity, whereas R-SNARE itself has little contribution to specificity.	[Izawa, Ryota; Onoue, Toshitaka; Furukawa, Noriko; Mima, Joji] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	Osaka University	Mima, J (corresponding author), Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	Joji.Mima@protein.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology; MEXT; Naito Foundation	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation)	This work was supported by the Program to Disseminate Tenure Tracking System (Ministry of Education, Culture, Sports, Science and Technology, Ministry of Education, Culture, Sports, Science and Technology), grants-in-aid for scientific research (MEXT), and the Naito Foundation (to J. M.).	Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bowers K, 2005, BBA-MOL CELL RES, V1744, P438, DOI 10.1016/j.bbamcr.2005.04.004; Brandhorst D, 2006, P NATL ACAD SCI USA, V103, P2701, DOI 10.1073/pnas.0511138103; Burri L, 2004, TRAFFIC, V5, P45, DOI 10.1046/j.1600-0854.2003.00151.x; Carr CM, 2010, CURR OPIN CELL BIOL, V22, P488, DOI 10.1016/j.ceb.2010.04.006; Dennison SM, 2006, BIOPHYS J, V90, P1661, DOI 10.1529/biophysj.105.069617; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fasshauer D, 1999, J BIOL CHEM, V274, P15440, DOI 10.1074/jbc.274.22.15440; Fratti RA, 2004, J CELL BIOL, V167, P1087, DOI 10.1083/jcb.200409068; Fukuda R, 2000, NATURE, V407, P198, DOI 10.1038/35025084; Gerrard SR, 2000, TRAFFIC, V1, P45, DOI 10.1034/j.1600-0854.2000.010108.x; Hickey CM, 2010, MOL BIOL CELL, V21, P2297, DOI 10.1091/mbc.E10-01-0044; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Liu S, 2007, TRAFFIC, V8, P1630, DOI 10.1111/j.1600-0854.2007.00628.x; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Miaczynska M, 2002, EXP CELL RES, V272, P8, DOI 10.1006/excr.2001.5401; Mima J, 2008, EMBO J, V27, P2031, DOI 10.1038/emboj.2008.139; Mima J, 2009, J BIOL CHEM, V284, P27114, DOI 10.1074/jbc.M109.010223; Mima J, 2009, P NATL ACAD SCI USA, V106, P16191, DOI 10.1073/pnas.0908694106; Nickel W, 1999, P NATL ACAD SCI USA, V96, P12571, DOI 10.1073/pnas.96.22.12571; Ostrowicz CW, 2008, AUTOPHAGY, V4, P5, DOI 10.4161/auto.5054; Parlati F, 2002, P NATL ACAD SCI USA, V99, P5424, DOI 10.1073/pnas.082100899; Paumet F, 2005, J BIOL CHEM, V280, P21137, DOI 10.1074/jbc.M500841200; Poirier MA, 1998, NAT STRUCT BIOL, V5, P765, DOI 10.1038/1799; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; Schneiter R, 1999, J CELL BIOL, V146, P741, DOI 10.1083/jcb.146.4.741; Schuette CG, 2004, P NATL ACAD SCI USA, V101, P2858, DOI 10.1073/pnas.0400044101; Seeley ES, 2002, MOL BIOL CELL, V13, P782, DOI 10.1091/mbc.01-10-0512; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Ungermann C, 1999, J CELL BIOL, V145, P1435, DOI 10.1083/jcb.145.7.1435; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Wickner W, 2010, ANNU REV CELL DEV BI, V26, P115, DOI 10.1146/annurev-cellbio-100109-104131; Xu H, 2010, J BIOL CHEM, V285, P39359, DOI 10.1074/jbc.M110.183111; Yang B, 1999, J BIOL CHEM, V274, P5649, DOI 10.1074/jbc.274.9.5649; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602; Zwilling D, 2007, EMBO J, V26, P9, DOI 10.1038/sj.emboj.7601467	44	19	19	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3445	3453		10.1074/jbc.M111.307439	http://dx.doi.org/10.1074/jbc.M111.307439			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22174414	Green Published, hybrid			2022-12-25	WOS:000300295100049
J	Top, D; Read, JA; Dawe, SJ; Syvitski, RT; Duncan, R				Top, Deniz; Read, Jolene A.; Dawe, Sandra J.; Syvitski, Raymond T.; Duncan, Roy			Cell-Cell Membrane Fusion Induced by p15 Fusion-associated Small Transmembrane (FAST) Protein Requires a Novel Fusion Peptide Motif Containing a Myristoylated Polyproline Type II Helix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STOMATITIS-VIRUS GLYCOPROTEIN; BABOON REOVIRUS; VIRAL FUSION; CONFORMATIONS; AQUAREOVIRUS; ARRANGEMENT; PLASTICITY; VESICLES; RESIDUES; HAIRPIN	The p15 fusion-associated small transmembrane (FAST) protein is a nonstructural viral protein that induces cell-cell fusion and syncytium formation. The exceptionally small, myristoylated N-terminal ectodomain of p15 lacks any of the defining features of a typical viral fusion protein. NMR and CD spectroscopy indicate this small fusion module comprises a left-handed polyproline type II (PPII) helix flanked by small, unstructured N and C termini. Individual prolines in the 6-residue proline-rich motif are highly tolerant of alanine substitutions, but multiple substitutions that disrupt the PPII helix eliminate cell-cell fusion activity. A synthetic p15 ectodomain peptide induces lipid mixing between liposomes, but with unusual kinetics that involve a long lag phase before the onset of rapid lipid mixing, and the length of the lag phase correlates with the kinetics of peptide-induced liposome aggregation. Lipid mixing, liposome aggregation, and stable peptide-membrane interactions are all dependent on both the N-terminal myristate and the presence of the PPII helix. We present a model for the mechanism of action of this novel viral fusion peptide, whereby the N-terminal myristate mediates initial, reversible peptide-membrane binding that is stabilized by subsequent amino acid-membrane interactions. These interactions induce a biphasic membrane fusion reaction, with peptide-induced liposome aggregation representing a distinct, rate-limiting event that precedes membrane merger. Although the prolines in the proline-rich motif do not directly interact with membranes, the PPII helix may function to force solvent exposure of hydrophobic amino acid side chains in the regions flanking the helix to promote membrane binding, apposition, and fusion.	[Top, Deniz; Read, Jolene A.; Dawe, Sandra J.; Duncan, Roy] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS B3H 4R2, Canada; [Duncan, Roy] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 4R2, Canada; [Syvitski, Raymond T.] CNR, Inst Marine Biosci, Halifax, NS B3H3Z1, Canada; [Duncan, Roy] Dalhousie Univ, Dept Pediat, Halifax, NS B3H 4R2, Canada	Dalhousie University; Dalhousie University; National Research Council Canada; Dalhousie University	Duncan, R (corresponding author), Dalhousie Univ, Dept Microbiol & Immunol, 5850 Coll St,POB 15000, Halifax, NS B3H 4R2, Canada.	roy.duncan@dal.ca		Top, Deniz/0000-0002-1042-8460; Duncan, Roy/0000-0002-5162-5081	Canadian Institutes of Health Research (CIHR); Nova Scotia Health Research Foundation (NSHRF); Cancer Research Training Program with the Dalhousie Cancer Research Program; Eliza Ritchie scholarship; Natural Sciences and Engineering Research Council (NSERC) of Canada; Killam Foundation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Nova Scotia Health Research Foundation (NSHRF); Cancer Research Training Program with the Dalhousie Cancer Research Program; Eliza Ritchie scholarship; Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Killam Foundation	This work was supported in part by grants from the Canadian Institutes of Health Research (CIHR).; Supported by scholarships from the Nova Scotia Health Research Foundation (NSHRF) and the Cancer Research Training Program with funding from the Dalhousie Cancer Research Program.; Supported by scholarships from the CIHR and NSHRF and an Eliza Ritchie scholarship.; Supported by scholarships from the Natural Sciences and Engineering Research Council (NSERC) of Canada, the Killam Foundation, and the NSHRF.	Attoui H, 2002, J GEN VIROL, V83, P1941, DOI 10.1099/0022-1317-83-8-1941; Barry C, 2010, J BIOL CHEM, V285, P16424, DOI 10.1074/jbc.M110.118232; Barry C, 2009, J VIROL, V83, P12185, DOI 10.1128/JVI.01667-09; Bochicchio B, 2002, CHIRALITY, V14, P782, DOI 10.1002/chir.10153; Boutilier J, 2011, CURR TOP MEMBR, V68, P107, DOI 10.1016/B978-0-12-385891-7.00005-2; Chappell J. D., 2005, ORTHOREOVIRUS REOVIR, P455; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Clancy EK, 2011, J VIROL, V85, P4707, DOI 10.1128/JVI.02223-10; Clancy EK, 2009, J VIROL, V83, P2941, DOI 10.1128/JVI.01869-08; Corcoran JA, 2004, J BIOL CHEM, V279, P51386, DOI 10.1074/jbc.M406990200; Corcoran JA, 2004, J VIROL, V78, P4342, DOI 10.1128/JVI.78.8.4342-4351.2004; Dawe S, 2005, J VIROL, V79, P6216, DOI 10.1128/JVI.79.10.6216-6226.2005; Dawe S, 2002, J VIROL, V76, P2131, DOI 10.1128/JVI.76.5.2131-2140.2002; Epand RM, 2003, BBA-BIOMEMBRANES, V1614, P116, DOI 10.1016/S0005-2736(03)00169-X; Findlay B, 2010, ANTIMICROB AGENTS CH, V54, P4049, DOI 10.1128/AAC.00530-10; Foroutan A, 2011, J PHYS CHEM B, V115, P3622, DOI 10.1021/jp1101253; Gibbons DL, 2004, NATURE, V427, P320, DOI 10.1038/nature02239; Gregory SM, 2011, P NATL ACAD SCI USA, V108, P11211, DOI 10.1073/pnas.1104760108; Groffen AJ, 2010, SCIENCE, V327, P1614, DOI 10.1126/science.1183765; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Hui EF, 2009, CELL, V138, P709, DOI 10.1016/j.cell.2009.05.049; JOSEPH M, 1995, J BIOL CHEM, V270, P16749, DOI 10.1074/jbc.270.28.16749; Kadlec J, 2008, NAT STRUCT MOL BIOL, V15, P1024, DOI 10.1038/nsmb.1484; Kelly MA, 2001, BIOCHEMISTRY-US, V40, P14376, DOI 10.1021/bi011043a; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; Korte T, 2001, VIROLOGY, V289, P353, DOI 10.1006/viro.2001.1108; Kozlov MM, 2010, TRENDS BIOCHEM SCI, V35, P699, DOI 10.1016/j.tibs.2010.06.003; Lai AL, 2006, J BIOL CHEM, V281, P5760, DOI 10.1074/jbc.M512280200; Lev N, 2007, J MOL BIOL, V374, P220, DOI 10.1016/j.jmb.2007.09.008; Li YL, 2007, BIOPHYS J, V93, P876, DOI 10.1529/biophysj.106.102335; Lorieau JL, 2010, P NATL ACAD SCI USA, V107, P11341, DOI 10.1073/pnas.1006142107; Melikyan GB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-111; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; NILGES M, 1991, COMPUTATIONAL ASPECT; Park SH, 1997, PROTEIN SCI, V6, P1694, DOI 10.1002/pro.5560060809; Pecheur EI, 1997, BIOCHEMISTRY-US, V36, P3773, DOI 10.1021/bi9622128; Peisajovich SG, 2000, BIOCHEMISTRY-US, V39, P1826, DOI 10.1021/bi991887i; Peisajovich SG, 2002, EUR J BIOCHEM, V269, P4342, DOI 10.1046/j.1432-1033.2002.03132.x; Pereira FB, 1997, BIOPHYS J, V73, P1977, DOI 10.1016/S0006-3495(97)78228-6; Pereira FB, 1999, CHEM PHYS LIPIDS, V103, P11, DOI 10.1016/S0009-3084(99)00087-0; Racine T, 2009, J VIROL, V83, P5951, DOI 10.1128/JVI.00171-09; Rath A, 2005, BIOPOLYMERS, V80, P179, DOI 10.1002/bip.20227; Reichert J, 2007, EUR BIOPHYS J BIOPHY, V36, P405, DOI 10.1007/s00249-006-0106-2; Resh MD, 2004, P NATL ACAD SCI USA, V101, P417, DOI 10.1073/pnas.0308043101; Rey FA, 2006, EMBO REP, V7, P1000, DOI 10.1038/sj.embor.7400807; Roche S, 2008, CELL MOL LIFE SCI, V65, P1716, DOI 10.1007/s00018-008-7534-3; Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683; RONISH EW, 1974, BIOPOLYMERS, V13, P1635, DOI 10.1002/bip.1974.360130810; Shmulevitz M, 2004, J VIROL, V78, P2808, DOI 10.1128/JVI.78.6.2808-2818.2004; Shmulevitz M, 2003, J VIROL, V77, P9769, DOI 10.1128/JVI.77.18.9769-9779.2003; Shmulevitz M, 2000, EMBO J, V19, P902, DOI 10.1093/emboj/19.5.902; Stapley BJ, 1999, PROTEIN SCI, V8, P587; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Syvitski RT, 2005, BIOCHEMISTRY-US, V44, P7282, DOI 10.1021/bi0504005; Tamm LK, 2002, BIOPOLYMERS, V66, P249, DOI 10.1002/bip.10261; Tamm LK, 2003, CURR OPIN STRUC BIOL, V13, P453, DOI 10.1016/S0959-440X(03)00107-6; Thalmann CM, 2010, VIROLOGY, V402, P26, DOI 10.1016/j.virol.2009.11.048; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; Whittington SJ, 2005, BIOCHEMISTRY-US, V44, P6269, DOI 10.1021/bi050124u; Whittington SJ, 2003, BIOCHEMISTRY-US, V42, P14690, DOI 10.1021/bi035565x; Zagrovic B, 2005, P NATL ACAD SCI USA, V102, P11698, DOI 10.1073/pnas.0409693102	61	31	31	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3403	3414		10.1074/jbc.M111.305268	http://dx.doi.org/10.1074/jbc.M111.305268			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22170056	Green Published, hybrid			2022-12-25	WOS:000300295100045
J	Beck, EJ; Mandalia, S; Sangha, R; Sharott, P; Youle, M; Baily, G; Brettle, R; Gompels, M; Johnson, M; McCarron, B; Ong, E; Pozniak, A; Schwenk, A; Taylor, S; Walsh, J; Wilkins, E; Williams, I; Gazzard, B				Beck, Eduard J.; Mandalia, Sundhiya; Sangha, Roshni; Sharott, Peter; Youle, Mike; Baily, Guy; Brettle, Ray; Gompels, Mark; Johnson, Margaret; McCarron, Brendan; Ong, Ed; Pozniak, Anton; Schwenk, Achim; Taylor, Stephen; Walsh, John; Wilkins, Ed; Williams, Ian; Gazzard, Brian		NPMS-HHC Steering Grp	The Cost-Effectiveness of Early Access to HIV Services and Starting cART in the UK 1996-2008	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; LATE DIAGNOSIS; ENGLAND; WALES	Aim: To calculate use, cost and cost-effectiveness of people living with HIV (PLHIV) starting routine treatment and care before starting combination antiretroviral therapy (cART) and PLHIV starting first-line 2NRTIs+NNRTI or 2NRTIs+PIboosted, comparing PLHIV with CD4 <= 200 cells/mm(3) and CD4>200 cells/mm(3). Few studies have calculated the use, cost and cost-effectiveness of routine treatment and care before starting cART and starting cART above and below CD4 200 cells/mm(3). Methods: Use, costs and cost-effectiveness were calculated for PLHIV in routine pre-cART and starting first-line cART, comparing CD4 <= 200 cells/mm3 with CD4>200 cells/mm(3) (2008 UK prices). Results: cART naive patients CD4 <= 200 cells/mm(3) had an annual cost of 6,407 pound (95% CI 6,382 pound to 6,425) pound PPY compared with 2,758 pound (95% CI 2,752 pound to 2,761) pound PPY for those with CD4>200 cells/mm3; cost per life year gained of pre-cART treatment and care for those with CD4>200 cells/mm(3) was 1,776 pound (cost-saving to 2,752) pound. Annual cost for starting 2NRTIs+NNRTI or 2NRTIs+PIboosted with CD4 <= 200 cells/mm(3) was 12,812 pound (95% CI 12,685- pound 12,937) pound compared with 10,478 pound (95% CI 10,376- pound 10,581) pound for PLHIV with CD4>200 cells/mm(3). Cost per additional life-year gained on first-line therapy for those with CD4>200 cells/mm(3) was 4639 pound (3,967 pound to 2,960) pound. Conclusion: PLHIV starting to use HIV services before CD4 <= 200 cells/mm(3) is cost-effective and enables them to be monitored so they start cART with a CD4>200 cells/mm3, which results in better outcomes and is cost-effective. However, 25% of PLHIV accessing services continue to present with CD4 <= 200 cells/mm3. This highlights the need to investigate the cost-effectiveness of testing and early treatment programs for key populations in the UK.	[Beck, Eduard J.; Mandalia, Sundhiya; Sangha, Roshni; Youle, Mike; Gazzard, Brian] NPMS HHC CIC, Coordinating & Analyt Ctr, London, England; [Beck, Eduard J.] London Sch Hyg & Trop Med, London WC1, England; [Mandalia, Sundhiya; Gazzard, Brian] Univ London Imperial Coll Sci Technol & Med, London, England; [Sharott, Peter] London Procurement Programme, London Specialised Commissioning Grp, London, England; [Youle, Mike; Johnson, Margaret] Royal Free Hosp, London NW3 2QG, England; [Baily, Guy] Royal London Hosp, London E1 1BB, England; [Baily, Guy] Barts Hosp, London, England; [Brettle, Ray] Edinburgh Gen Hosp, Edinburgh, Midlothian, Scotland; [Gompels, Mark] Southmead Hosp, Bristol, Avon, England; [McCarron, Brendan] James Cook Univ Hosp, Middlesbrough, England; [Ong, Ed] Newcastle Gen Hosp, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; [Beck, Eduard J.; Mandalia, Sundhiya; Pozniak, Anton; Gazzard, Brian] Chelsea & Westminster Hosp, London, England; [Schwenk, Achim] N Middlesex Hosp, London N18 1QX, England; [Taylor, Stephen] Birmingham Heartland Hosp, Birmingham, W Midlands, England; [Walsh, John] St Marys Hosp, London, England; [Wilkins, Ed] N Manchester Grp Hosp, N Manchester, England; [Williams, Ian] Mortimer Market Ctr, London, England	University of London; London School of Hygiene & Tropical Medicine; Imperial College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Barts Health NHS Trust; Royal London Hospital; Southmead Hospital; James Cook University Hospital; Newcastle General Hospital; Imperial College London; Heart of England NHS Foundation Trust; Imperial College London	Beck, EJ (corresponding author), NPMS HHC CIC, Coordinating & Analyt Ctr, London, England.	becke@unaids.org		Ong, Edmund/0000-0002-6594-0509	Bristol-Myers Squibb	Bristol-Myers Squibb(Bristol-Myers Squibb)	During 2010/2011, the NPMS-HHC was financially supported through a non-restrictive grant from Bristol-Myers Squibb, with no influence on the independence of the Steering Group and its editorial policy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler A, 2009, AIDS CARE, V21, P284, DOI 10.1080/09540120802183537; [Anonymous], 2011, NIH NEWS        0512; Badri M, 2006, PLOS MED, V3, P48, DOI 10.1371/journal.pmed.0030004; BAJKO MS, 2011, HIV STUD 76 DROP CAS; Beck EJ, 2008, INT J STD AIDS, V19, P297, DOI 10.1258/ijsa.2007.007236; Beck E.J., 2001, EFFECTIVE MANAGEMENT, P113; Beck EJ, 2004, AIDS, V18, P2411; BECK EJ, 2006, HIV PANDEMIC LOCAL G, P769; BECK EJ, 2010, USE COST HIV SERVICE; Brouwer WBF, 2005, BRIT MED J, V331, P446, DOI 10.1136/bmj.331.7514.446; Chadborn TR, 2006, AIDS, V20, P2371, DOI 10.1097/QAD.0b013e32801138f7; Chadborn TR, 2005, AIDS, V19, P513, DOI 10.1097/01.aids.0000162340.43310.08; Gazzard BG, 2008, HIV MED, V9, P563, DOI 10.1111/j.1468-1293.2008.00636.x; Hankins CA, 2010, AIDS, V24, pS70, DOI 10.1097/01.aids.0000390709.04255.fd; *HLTH PROT AG, 2011, HLTH PROTECTION REPO, V4; Long EF, 2010, ANN INTERN MED, V153, P778, DOI 10.7326/0003-4819-153-12-201012210-00004; Mandalia S, 2002, HIV Med, V3, P254, DOI 10.1046/j.1468-1293.2002.00110.x; NEATON JD, 2009, STRATEGIC TIMING ANT; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2011, GUID US ANT AG HIV 1; Rawlins MD, 2004, BRIT MED J, V329, P224, DOI 10.1136/bmj.329.7459.224; Rubin DB, 2004, MULTIPLE IMPUTATION; Schafer JL, 1997, ANAL INCOMPLETE MULT, V1st, DOI 10.1201/9781439821862; THAKKAR B, 1998, 226 SUGI; WHO, 2010, ANT THER HIV INF AD	24	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e27830	10.1371/journal.pone.0027830	http://dx.doi.org/10.1371/journal.pone.0027830			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194795	Green Submitted, Green Published, gold			2022-12-25	WOS:000298369100015
J	Shabel, SJ; Schairer, W; Donahue, RJ; Powell, V; Janak, PH				Shabel, Steven J.; Schairer, Will; Donahue, Rachel J.; Powell, Victoria; Janak, Patricia H.			Similar Neural Activity during Fear and Disgust in the Rat Basolateral Amygdala	PLOS ONE			English	Article							CONDITIONED TASTE-AVERSION; PRIMATE AMYGDALA; EXTRACELLULAR RECORDINGS; ORBITOFRONTAL CORTEX; PREFRONTAL CORTEX; RESPONSES; STIMULI; EMOTION; NEURONS; REINFORCEMENT	Much research has focused on how the amygdala processes individual affects, yet little is known about how multiple types of positive and negative affects are encoded relative to one another at the single-cell level. In particular, it is unclear whether different negative affects, such as fear and disgust, are encoded more similarly than negative and positive affects, such as fear and pleasure. Here we test the hypothesis that the basolateral nucleus of the amygdala (BLA), a region known to be important for learned fear and other affects, encodes affective valence by comparing neuronal activity in the BLA during a conditioned fear stimulus (fear CS) with activity during intraoral delivery of an aversive fluid that induces a disgust response and a rewarding fluid that induces a hedonic response. Consistent with the hypothesis, neuronal activity during the fear CS and aversive fluid infusion, but not during the fear CS and rewarding fluid infusion, was more similar than expected by chance. We also found that the greater similarity in activity during the fear-and disgust-eliciting stimuli was specific to a subpopulation of cells and a limited window of time. Our results suggest that a subpopulation of BLA neurons encodes affective valence during learned fear, and furthermore, within this subpopulation, different negative affects are encoded more similarly than negative and positive affects in a time-specific manner.	[Shabel, Steven J.; Schairer, Will; Donahue, Rachel J.; Powell, Victoria; Janak, Patricia H.] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA USA; [Shabel, Steven J.; Janak, Patricia H.] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA; [Janak, Patricia H.] Univ Calif San Francisco, Wheeler Ctr Neurobiol Addict, San Francisco, CA 94143 USA; [Janak, Patricia H.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Shabel, SJ (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA USA.	sshabel@ucsd.edu; pjanak@gallo.ucsf.edu		Shabel, Steven/0000-0002-2746-5399; Janak, Patricia/0000-0002-3333-9049; Schairer, William/0000-0001-6162-9329	State of California; University of California San Francisco [DAMD17-01-1-0739]; Affective Science Predoctoral Training Program [NIMH T32MH020006]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020006] Funding Source: NIH RePORTER	State of California; University of California San Francisco(University of California System); Affective Science Predoctoral Training Program; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by funds from the State of California for medical research on alcohol and substance abuse through University of California San Francisco, by award # DAMD17-01-1-0739 awarded and administered by the U.S. Army Medical Research Acquisition Activity, 820 Chandler St., Fort Detrick, MD 21702, and by the Affective Science Predoctoral Training Program (S.J.S.; NIMH T32MH020006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barot SK, 2008, P NATL ACAD SCI USA, V105, P20959, DOI 10.1073/pnas.0808996106; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Belova MA, 2008, J NEUROSCI, V28, P10023, DOI 10.1523/JNEUROSCI.1400-08.2008; Belova MA, 2007, NEURON, V55, P970, DOI 10.1016/j.neuron.2007.08.004; Berridge KC, 2000, NEUROSCI BIOBEHAV R, V24, P173, DOI 10.1016/S0149-7634(99)00072-X; BOLLES RC, 1970, PSYCHOL REV, V77, P32, DOI 10.1037/h0028589; Bromberg-Martin ES, 2010, NEURON, V67, P144, DOI 10.1016/j.neuron.2010.06.016; BURNS LH, 1993, BEHAV BRAIN RES, V55, P167, DOI 10.1016/0166-4328(93)90113-5; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Chapman HA, 2009, SCIENCE, V323, P1222, DOI 10.1126/science.1165565; Darwin C., 1872, EXPRESS EMOT MAN, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; DAVIS M, 2000, AMYGDALA FUNCTIONAL, P287; Ekman P., 1975, UNMASKING FACE; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Gallagher M, 1996, CURR OPIN NEUROBIOL, V6, P221, DOI 10.1016/S0959-4388(96)80076-6; GRILL HJ, 1978, BRAIN RES, V143, P263, DOI 10.1016/0006-8993(78)90568-1; Grossman SE, 2008, J NEUROSCI, V28, P2864, DOI 10.1523/JNEUROSCI.4063-07.2008; Hatfield T, 1996, J NEUROSCI, V16, P5256; IWATA J, 1986, BRAIN RES, V383, P195, DOI 10.1016/0006-8993(86)90020-X; Kim MJ, 2010, NEUROBIOL LEARN MEM, V93, P406, DOI 10.1016/j.nlm.2009.12.007; Lamprecht R, 2000, AMYGDALA FUNCTIONAL, P331; LEDOUX JE, 1990, J NEUROSCI, V10, P1062; Likhtik E, 2006, J NEUROPHYSIOL, V96, P3257, DOI 10.1152/jn.00577.2006; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; MURAMOTO K, 1993, NEUROSCIENCE, V52, P621, DOI 10.1016/0306-4522(93)90411-8; NISHIJO H, 1988, J NEUROSCI, V8, P3570; Pare D, 2000, J NEUROSCI, V20, P2701; PARKER LA, 1982, LEARN MOTIV, V13, P281, DOI 10.1016/0023-9690(82)90011-X; Parkinson JA, 2001, J NEUROSCI, V21, P7770, DOI 10.1523/JNEUROSCI.21-19-07770.2001; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Roesch MR, 2010, J NEUROSCI, V30, P2464, DOI 10.1523/JNEUROSCI.5781-09.2010; Rosenkranz JA, 1999, J NEUROSCI, V19, P11027, DOI 10.1523/JNEUROSCI.19-24-11027.1999; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; Shabel SJ, 2009, P NATL ACAD SCI USA, V106, P15031, DOI 10.1073/pnas.0905580106; SPECTOR AC, 1988, BEHAV NEUROSCI, V102, P942, DOI 10.1037/0735-7044.102.6.942; St Andre J, 2007, BRAIN RES, V1135, P122, DOI 10.1016/j.brainres.2006.12.010; Tye KM, 2007, J NEUROSCI, V27, P3937, DOI 10.1523/JNEUROSCI.5281-06.2007; Wang SH, 2005, J NEUROSCI, V25, P830, DOI 10.1523/JNEUROSCI.4716-04.2005; Yasoshima Y, 1995, NEUROREPORT, V6, P2424, DOI 10.1097/00001756-199511270-00034	44	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e27797	10.1371/journal.pone.0027797	http://dx.doi.org/10.1371/journal.pone.0027797			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194792	Green Submitted, Green Published, gold			2022-12-25	WOS:000298369100012
J	Kigera, JWM; Mukwaya, S				Kigera, James W. M.; Mukwaya, Stephen			Frequency of Agenesis Palmaris Longus through Clinical Examination - An East African Study	PLOS ONE			English	Article							CHINESE POPULATION; TENDON; MUSCLE; ABSENCE; ANOMALIES; SIGN	Introduction: The Palmaris longus, one of the most variable muscles in the body both flexes the wrist and tenses the palmar fascia. It is used by surgeons as a source of tendon graft and racial differences in its variation have been documented. We sought to determine the frequency of the absence of the Palmaris longus in an East African population. Methods: A prospective study was conducted using ten common clinical tests among patients and students in a large teaching hospital in East Africa to determine the presence of a Palmaris longus. Results: The overall rate of absence was 4.4% with unilateral absence at 3.3% and bilateral absence at 1.1%. The overall difference between males and females was not statistically significant (p = 0.605). Participants were more likely to have absence in their non dominant hand. Discussion: Our findings though in contrast to many studies worldwide, it concurs with most studies done in the African setting. These differences may be due to the higher levels of manual labour and the more use of the right hand in these activities. The frequency of the absence of Palmaris longus in East Africa has been determined. Surgeons should acquaint themselves with prevalence in their areas of practice.	[Kigera, James W. M.] Makerere Univ, Coll Hlth Sci, Dept Orthopaed, Kampala, Uganda; [Kigera, James W. M.] PCEA Kikuyu Hosp, Orthopaed Rehabil Unit, Kikuyu, Kenya; [Mukwaya, Stephen] Mulago Paramed Sch, Kampala, Uganda	Makerere University	Kigera, JWM (corresponding author), Makerere Univ, Coll Hlth Sci, Dept Orthopaed, Kampala, Uganda.	jameskigera@yahoo.co.uk						Acikel C, 2007, SCAND J PLAST RECONS, V41, P45, DOI 10.1080/02844310500453708; Bhattacharya V, 2005, BRIT J PLAST SURG, V58, P419, DOI 10.1016/j.bjps.2004.09.004; Ceyhan O, 1997, Indian J Med Sci, V51, P156; ERIC M, SURG RADIOL ANAT, V32, P357; ERIC M, SURG RADIOL ANAT, V33, P481; GANGATA H, CLIN ANAT, V23, P431; Gangata H, 2009, CLIN ANAT, V22, P230, DOI 10.1002/ca.20751; Mbaka Godwin O, 2009, Ulster Med J, V78, P90; MISHRA S, 2001, INDIAN J PLAST SURG, V34, P12; NDOU R, CLIN ANAT, V23, P437; Oudit D, 2005, PLAST RECONSTR SURG, V116, P691, DOI 10.1097/01.prs.0000175967.01538.3a; Pushpakumar SB, 2004, BRIT J PLAST SURG, V57, P184, DOI 10.1016/j.bjps.2003.11.024; SANKAR KD, INDIAN J PLAST SURG, V44, P134; Schaeffer JP, 1909, ANAT REC, V3, P275; Sebastin SJ, 2006, ANN ACAD MED SINGAP, V35, P249; Sebastin SJ, 2005, J HAND SURG-BRIT EUR, V30B, P525, DOI 10.1016/j.jhsb.2005.05.003; Thompson JW, 1921, AM J PHYS ANTHROPOL, V4, P205, DOI 10.1002/ajpa.1330040207; Thompson NW, 2001, ULSTER MED J, V70, P22; TROHA F, 1990, ANN PLAS SURG, V25, P477, DOI 10.1097/00000637-199012000-00008	19	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28997	10.1371/journal.pone.0028997	http://dx.doi.org/10.1371/journal.pone.0028997			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174943	gold, Green Submitted, Green Published			2022-12-25	WOS:000298367300038
J	Gagliani, N; Gregori, S; Jofra, T; Valle, A; Stabilini, A; Rothstein, DM; Atkinson, M; Roncarolo, MG; Battaglia, M				Gagliani, Nicola; Gregori, Silvia; Jofra, Tatiana; Valle, Andrea; Stabilini, Angela; Rothstein, David M.; Atkinson, Mark; Roncarolo, Maria Grazia; Battaglia, Manuela			Rapamycin Combined with Anti-CD45RB mAb and IL-10 or with G-CSF Induces Tolerance in a Stringent Mouse Model of Islet Transplantation	PLOS ONE			English	Article							REGULATORY T-CELLS; COLONY-STIMULATING FACTOR; INDUCTION; INTERLEUKIN-10; ANTIBODY; GENERATION; SURVIVAL; FOXP3(+); MICE	Background: A large pool of preexisting alloreactive effector T cells can cause allogeneic graft rejection following transplantation. However, it is possible to induce transplant tolerance by altering the balance between effector and regulatory T (Treg) cells. Among the various Treg-cell types, Foxp3(+)Treg and IL-10-producing T regulatory type 1 (Tr1) cells have frequently been associated with tolerance following transplantation in both mice and humans. Previously, we demonstrated that rapamycin+IL-10 promotes Tr1-cell-associated tolerance in Balb/c mice transplanted with C57BL/6 pancreatic islets. However, this same treatment was unsuccessful in C57BL/6 mice transplanted with Balb/c islets (classified as a stringent transplant model). We accordingly designed a protocol that would be effective in the latter transplant model by simultaneously depleting effector T cells and fostering production of Treg cells. We additionally developed and tested a clinically translatable protocol that used no depleting agent. Methodology/Principal Findings: Diabetic C57BL/6 mice were transplanted with Balb/c pancreatic islets. Recipient mice transiently treated with anti-CD45RB mAb+rapamycin+IL-10 developed antigen-specific tolerance. During treatment, Foxp3(+)Treg cells were momentarily enriched in the blood, followed by accumulation in the graft and draining lymph node, whereas CD4(+)IL-10(+)IL-4(-) T (i.e., Tr1) cells localized in the spleen. In long-term tolerant mice, only CD4(+)IL-10(+)IL-4(-) T cells remained enriched in the spleen and IL-10 was key in the maintenance of tolerance. Alternatively, recipient mice were treated with two compounds routinely used in the clinic (namely, rapamycin and G-CSF); this drug combination promoted tolerance associated with CD4(+)IL-10(+)IL-4(-) T cells. Conclusions/Significance: The anti-CD45RB mAb+rapamycin+IL-10 combined protocol promotes a state of tolerance that is IL-10 dependent. Moreover, the combination of rapamycin+G-CSF induces tolerance and such treatment could be readily translatable into the clinic.	[Gagliani, Nicola; Jofra, Tatiana; Valle, Andrea; Stabilini, Angela; Battaglia, Manuela] Ist Sci San Raffaele, San Raffaele Diabet Res Inst, I-20132 Milan, Italy; [Gagliani, Nicola; Gregori, Silvia; Roncarolo, Maria Grazia] Ist Sci San Raffaele, San Raffaele Telethon Inst Gene Therapy, I-20132 Milan, Italy; [Gagliani, Nicola; Valle, Andrea; Roncarolo, Maria Grazia] Univ Vita Salute San Raffaele, Milan, Italy; [Rothstein, David M.] Univ Pittsburgh, Med Ctr, Starzl Transplantat Inst, Pittsburgh, PA USA; [Atkinson, Mark] Univ Florida, Dept Pathol, Gainesville, FL 32611 USA	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; State University System of Florida; University of Florida	Gagliani, N (corresponding author), Ist Sci San Raffaele, San Raffaele Diabet Res Inst, I-20132 Milan, Italy.	manuela.battaglia@hsr.it	SILVIA, GREGORI/J-7718-2016; Stabilini, Angela/AAN-2002-2020; Jofra, Tatiana/AAN-4727-2020	SILVIA, GREGORI/0000-0002-3517-9683; Jofra, Tatiana/0000-0003-2825-155X; Battaglia, Manuela/0000-0003-4535-3152; RONCAROLO, Maria Grazia/0000-0002-2193-9186; Gagliani, Nicola/0000-0001-8514-1395	Juvenile Diabetes Research Foundation [7-2006-328]; Fondazione Telethon Funding Source: Custom	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Fondazione Telethon(Fondazione Telethon)	This work has been supported by the Juvenile Diabetes Research Foundation Grant 7-2006-328. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariyan C, 2003, J IMMUNOL, V171, P5673, DOI 10.4049/jimmunol.171.11.5673; Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; Basadonna GP, 1998, P NATL ACAD SCI USA, V95, P3821, DOI 10.1073/pnas.95.7.3821; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; Battaglia M, 2006, DIABETES, V55, P40, DOI 10.2337/diabetes.55.1.40; Battaglia M, 2006, DIABETES, V55, P1571, DOI 10.2337/db05-1576; Battaglia M, 2010, TRANSPL INT, V23, P761, DOI 10.1111/j.1432-2277.2010.01127.x; Davies JD, 1999, J IMMUNOL, V163, P5353; Dijke IE, 2008, HUM IMMUNOL, V69, P389, DOI 10.1016/j.humimm.2008.05.006; Fecteau S, 2001, NAT IMMUNOL, V2, P58, DOI 10.1038/83175; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Gagliani N, 2010, DIABETES, V59, P433, DOI 10.2337/db09-1168; Grinyo JM, 2009, AM J TRANSPLANT, V9, P2447, DOI 10.1111/j.1600-6143.2009.02812.x; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Hadaya K, 2005, J AUTOIMMUN, V24, P125, DOI 10.1016/j.jaut.2005.01.001; Kared H, 2005, DIABETES, V54, P78, DOI 10.2337/diabetes.54.1.78; Lazarovits AI, 1996, NATURE, V380, P717, DOI 10.1038/380717a0; Li XC, 2010, NAT REV NEPHROL, V6, P577, DOI 10.1038/nrneph.2010.101; Luke PPW, 2006, AM J TRANSPLANT, V6, P2023, DOI 10.1111/j.1600-6143.2006.01451.x; Luo XR, 2008, P NATL ACAD SCI USA, V105, P14527, DOI 10.1073/pnas.0805204105; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; Maynard CL, 2009, J EXP MED, V206, P343, DOI 10.1084/jem.20080950; Monti P, 2008, DIABETES, V57, P2341, DOI 10.2337/db08-0138; Morris ES, 2004, BLOOD, V103, P3573, DOI 10.1182/blood-2003-08-2864; Muller YD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010352; Ponticelli C, 2004, J NEPHROL, V17, P762; Pot C, 2010, J INTERF CYTOK RES, V30, P381, DOI 10.1089/jir.2010.0047; Roncarolo MG, 2007, NAT REV IMMUNOL, V7, P585, DOI 10.1038/nri2138; Rutella S, 2002, BLOOD, V100, P2562, DOI 10.1182/blood-2001-12-0291; Rutella S, 2007, TRANSPLANTATION, V84, pS26, DOI 10.1097/01.tp.0000269611.66517.bf; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Sanchez-Fueyo A, 2011, GASTROENTEROLOGY, V140, P51, DOI 10.1053/j.gastro.2010.10.059; Turka LA, 2009, NAT REV IMMUNOL, V9, P521, DOI 10.1038/nri2568; Vieira PL, 2004, J IMMUNOL, V172, P5986, DOI 10.4049/jimmunol.172.10.5986; Walsh PT, 2004, J CLIN INVEST, V114, P1398, DOI 10.1172/JCI200423238; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Zhang N, 2009, IMMUNITY, V30, P458, DOI 10.1016/j.immuni.2008.12.022	37	32	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28434	10.1371/journal.pone.0028434	http://dx.doi.org/10.1371/journal.pone.0028434			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174806	Green Accepted, gold, Green Published			2022-12-25	WOS:000298365700036
J	Han, QJ; Zhang, C; Zhang, J; Tian, ZG				Han, Qiuju; Zhang, Cai; Zhang, Jian; Tian, Zhigang			Involvement of Activation of PKR in HBx-siRNA-Mediated Innate Immune Effects on HBV Inhibition	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; DEPENDENT PROTEIN-KINASE; SHORT INTERFERING RNA; PLASMACYTOID DENDRITIC CELLS; INDUCIBLE GENE-I; RIG-I; X PROTEIN; IFN-ALPHA; INDUCTION; INFECTION	RNA interference (RNAi) of virus-specific genes offers the possibility of developing a new anti-hepatitis B virus (anti-HBV) therapy. Recent studies have revealed that siRNAs can induce an innate immune response in vitro and in vivo. Here, HBVx (HBx) mRNA expression and HBV replication were significantly inhibited, followed by the enhancement of expression of type I interferons (IFNs), IFN-stimulated genes (ISG15 and ISG56) and proinflammatory cytokines after HepG2.2.15 cells were transfected with chemically synthesized HBx-siRNAs. Transfection with HBx-siRNAs also significantly increased expression of dsRNA-dependent protein kinase R (PKR) in HepG2.2.15 cells, followed by activation of downstream signaling events such as eukaryotic initiation factor 2 alpha (eIF2-alpha). In PKR-over-expressing HepG2.2.15 cells, HBx-siRNAs exerted more potent inhibitory effects on HBV replication and greater production of type I IFNs. By contrast, the inhibitory effect of HBx-siRNAs on HBV replication was attenuated when PKR was inhibited or silenced, demonstrating that HBx-siRNAs greatly promoted PKR activation, leading to the higher production of type I IFN. Therefore, we concluded that PKR is involved in the innate immune effects mediated by HBx-siRNAs and further contributes to HBV inhibition. The bifunctional siRNAs with both gene silencing and innate immune activation properties may represent a new potential strategy for treatment of HBV.	[Han, Qiuju; Zhang, Cai; Zhang, Jian; Tian, Zhigang] Shandong Univ, Sch Pharmaceut Sci, Inst Immunopharmacol & Immunotherapy, Jinan 250100, Peoples R China; [Tian, Zhigang] Univ Sci & Technol China, Dept Immunol, Sch Life Sci, Hefei 230026, Peoples R China	Shandong University; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Han, QJ (corresponding author), Shandong Univ, Sch Pharmaceut Sci, Inst Immunopharmacol & Immunotherapy, Jinan 250100, Peoples R China.	caizhangsd@sdu.edu.cn; tzg@ustc.edu.cn	Zhang, Jian/AAQ-3068-2021; Tian, Zhigang/J-3512-2013		National Natural Science Foundation of China [90713033, 30901307, 30772497]; National 973 Basic Research Program of China [2007CB815803]; National 115 Key Project for HBV Research [2008ZX10002-008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Basic Research Program of China(National Basic Research Program of China); National 115 Key Project for HBV Research	National Natural Science Foundation of China (90713033, 30901307, and 30772497), the National 973 Basic Research Program of China (2007CB815803) and the National 115 Key Project for HBV Research (2008ZX10002-008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong ME, 2008, J IMMUNOL, V180, P7125, DOI 10.4049/jimmunol.180.11.7125; Balachandran S, 1998, EMBO J, V17, P6888, DOI 10.1093/emboj/17.23.6888; Balachandran S, 2000, IMMUNITY, V13, P129, DOI 10.1016/S1074-7613(00)00014-5; Bourquin C, 2009, J IMMUNOL, V183, P6078, DOI 10.4049/jimmunol.0901594; Cho WG, 2009, P NATL ACAD SCI USA, V106, P7137, DOI 10.1073/pnas.0812317106; Clemens MJ, 1997, J INTERF CYTOK RES, V17, P503, DOI 10.1089/jir.1997.17.503; Davis AM, 2008, J IMMUNOL, V180, P6923, DOI 10.4049/jimmunol.180.10.6923; Donze O, 1999, VIROLOGY, V256, P322, DOI 10.1006/viro.1999.9618; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Gorina R, 2009, GLIA, V57, P93, DOI 10.1002/glia.20738; Habjan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002032; Han QJ, 2011, HEPATOLOGY, V54, P1179, DOI 10.1002/hep.24505; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hosel M, 2009, HEPATOLOGY, V50, P1773, DOI 10.1002/hep.23226; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Jiang JY, 2010, PROTEIN CELL, V1, P1106, DOI 10.1007/s13238-010-0141-8; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Kariko K, 2004, J IMMUNOL, V172, P6545, DOI 10.4049/jimmunol.172.11.6545; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Khairuddin N, 2011, IMMUNOL CELL BIOL; Konishi M, 2003, HEPATOLOGY, V38, P842, DOI 10.1053/jhep.2003.50416; Kuo TM, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-41; MANCHE L, 1992, MOL CELL BIOL, V12, P5238, DOI 10.1128/MCB.12.11.5238; McCaffrey AP, 2003, NAT BIOTECHNOL, V21, P639, DOI 10.1038/nbt824; Morrissey DV, 2005, HEPATOLOGY, V41, P1349, DOI 10.1002/hep.20702; Nanduri S, 1998, EMBO J, V17, P5458, DOI 10.1093/emboj/17.18.5458; Nayak R, 2007, J VIROL, V81, P11908, DOI 10.1128/JVI.01132-07; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Saelens X, 2001, J BIOL CHEM, V276, P41620, DOI 10.1074/jbc.M103674200; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Shlomai A, 2003, HEPATOLOGY, V37, P764, DOI 10.1053/jhep.2003.50146; Sioud M, 2005, J MOL BIOL, V348, P1079, DOI 10.1016/j.jmb.2005.03.013; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Wang XM, 2010, CELL MOL IMMUNOL, V7, P341, DOI 10.1038/cmi.2010.36; Wei CW, 2010, J IMMUNOL, V185, P1158, DOI 10.4049/jimmunol.0903874; Wu J, 2009, HEPATOLOGY, V49, P1132, DOI 10.1002/hep.22751; Xu Y, 2009, MOL IMMUNOL, V46, P2640, DOI 10.1016/j.molimm.2009.04.031; Yu SY, 2010, J GEN VIROL, V91, P2080, DOI 10.1099/vir.0.020552-0; Zhang WD, 2005, NAT MED, V11, P56, DOI 10.1038/nm1174; Zhang ZR, 2006, J CELL BIOCHEM, V97, P1217, DOI 10.1002/jcb.20716	45	43	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e27931	10.1371/journal.pone.0027931	http://dx.doi.org/10.1371/journal.pone.0027931			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174754	Green Published, gold, Green Submitted			2022-12-25	WOS:000298163600009
J	Hemsley, PA; Grierson, CS				Hemsley, Piers A.; Grierson, Claire S.			The Ankyrin Repeats and DHHC S-acyl Transferase Domain of AKR1 Act Independently to Regulate Switching from Vegetative to Mating States in Yeast	PLOS ONE			English	Article							PHEROMONE RESPONSE PATHWAY; 2-STEP REACTION-MECHANISM; CONTAINING PROTEIN AKR1P; DUAL LIPID MODIFICATION; G-BETA-GAMMA; SACCHAROMYCES-CEREVISIAE; PALMITOYL TRANSFERASE; PLASMA-MEMBRANE; KINASE; LOCALIZATION	Signal transduction from G-protein coupled receptors to MAPK cascades through heterotrimeric G-proteins has been described for many eukaryotic systems. One of the best-characterised examples is the yeast pheromone response pathway, which is negatively regulated by AKR1. AKR1-like proteins are present in all eukaryotes and contain a DHHC domain and six ankyrin repeats. Whilst the DHHC domain dependant S-acyl transferase (palmitoyl transferase) function of AKR1 is well documented it is not known whether the ankyrin repeats are also required for this activity. Here we show that the ankyrin repeats of AKR1 are required for full suppression of the yeast pheromone response pathway, by sequestration of the G beta gamma dimer, and act independently of AKR1 S-acylation function. Importantly, the functions provided by the AKR1 ankyrin repeats and DHHC domain are not required on the same molecule to fully restore WT phenotypes and function. We also show that AKR1 molecules are S-acylated at locations other than the DHHC cysteine, increasing the abundance of AKR1 in the cell. Our results have important consequences for studies of AKR1 function, including recent attempts to characterise S-acylation enzymology and kinetics. Proteins similar to AKR1 are found in all eukaryotes and our results have broad implications for future work on these proteins and the control of switching between G beta gamma regulated pathways.	[Hemsley, Piers A.; Grierson, Claire S.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England	University of Bristol	Hemsley, PA (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Durham, England.	piers.hemsley@bristol.ac.uk		Hemsley, Piers/0000-0003-2950-0634	Biotechnology and Biological Sciences Research Council UK [BB/D013585/1]; Biotechnology and Biological Sciences Research Council [BB/D013585/1] Funding Source: researchfish; BBSRC [BB/D013585/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded in the UK by grant number BB/D013585/1 from the Biotechnology and Biological Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu P, 2004, J BIOL CHEM, V279, P27138, DOI 10.1074/jbc.M403071200; Brachmann CB, 1998, YEAST, V14, P115; CADWALLADER KA, 1994, MOL CELL BIOL, V14, P4722, DOI 10.1128/MCB.14.7.4722; Christopherson KS, 2003, J CELL SCI, V116, P3213, DOI 10.1242/jcs.00617; Dietrich LEP, 2004, EMBO REP, V5, P1053, DOI 10.1038/sj.embor.7400277; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; Ducker CE, 2004, ONCOGENE, V23, P9230, DOI 10.1038/sj.onc.1208171; Feng Y, 2000, MOL CELL BIOL, V20, P5350, DOI 10.1128/MCB.20.14.5350-5359.2000; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Givan SA, 1997, MOL BIOL CELL, V8, P1317, DOI 10.1091/mbc.8.7.1317; Greaves J, 2007, J CELL BIOL, V176, P249, DOI 10.1083/jcb.200610151; Harada T, 2003, GENES CELLS, V8, P493, DOI 10.1046/j.1365-2443.2003.00650.x; Hemsley PA, 2005, PLANT CELL, V17, P2554, DOI 10.1105/tpc.105.031237; Hemsley Piers A, 2008, Plant Methods, V4, P2, DOI 10.1186/1746-4811-4-2; Hirschman JE, 1999, MOL CELL BIOL, V19, P7705; Hou HT, 2009, TRAFFIC, V10, P1061, DOI 10.1111/j.1600-0854.2009.00925.x; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Huang K, 2009, FASEB J, V23, P2605, DOI 10.1096/fj.08-127399; Kao LR, 1996, MOL CELL BIOL, V16, P168; Kihara A, 2005, MOL CELL BIOL, V25, P9189, DOI 10.1128/MCB.25.21.9189-9197.2005; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; Manahan CL, 2000, MOL BIOL CELL, V11, P957, DOI 10.1091/mbc.11.3.957; Marchal C, 2000, J BIOL CHEM, V275, P23608, DOI 10.1074/jbc.M001735200; Mitchell DA, 2010, J BIOL CHEM, V285, P38104, DOI 10.1074/jbc.M110.169102; Mukherjee A, 2003, J BIOL CHEM, V278, P40806, DOI 10.1074/jbc.M306440200; Politis EG, 2005, J BIOL CHEM, V280, P10156, DOI 10.1074/jbc.M411946200; Pryciak PM, 1996, MOL CELL BIOL, V16, P2614; Robinson LC, 1999, MOL BIOL CELL, V10, P1077, DOI 10.1091/mbc.10.4.1077; ROBINSON LC, 1992, P NATL ACAD SCI USA, V89, P28, DOI 10.1073/pnas.89.1.28; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Seo M, 2002, J BIOL CHEM, V277, P24197, DOI 10.1074/jbc.M201717200; SIKORSKI RS, 1989, GENETICS, V122, P19; Singaraja RR, 2002, HUM MOL GENET, V11, P2815, DOI 10.1093/hmg/11.23.2815; Smotrys JE, 2005, J CELL BIOL, V170, P1091, DOI 10.1083/jcb.200507048; Stahlberg A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-170; Swarthout JT, 2005, J BIOL CHEM, V280, P31141, DOI 10.1074/jbc.M504113200; Valdez-Taubas J, 2005, EMBO J, V24, P2524, DOI 10.1038/sj.emboj.7600724; Yang W, PROTEOME SCALE CHARA, P54	42	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28799	10.1371/journal.pone.0028799	http://dx.doi.org/10.1371/journal.pone.0028799			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174902	Green Published, gold, Green Submitted			2022-12-25	WOS:000298163600045
J	Casar, B; He, Y; Iconomou, M; Hooper, JD; Quigley, JP; Deryugina, EI				Casar, B.; He, Y.; Iconomou, M.; Hooper, J. D.; Quigley, J. P.; Deryugina, E. I.			Blocking of CDCP1 cleavage in vivo prevents Akt-dependent survival and inhibits metastatic colonization through PARP1-mediated apoptosis of cancer cells	ONCOGENE			English	Article						CDCP1; plasmin; cleavage; colonization; apoptosis; signaling	DOMAIN-CONTAINING PROTEIN-1; PROTEASE-ACTIVATED RECEPTORS; CUB-DOMAIN; TYROSINE PHOSPHORYLATION; PKC-DELTA; SRC; CARCINOMA; MIGRATION; ADHESION; PLASMIN	The CUB domain-containing protein-1 (CDCP1) is a transmembrane molecule that has recently been implicated in cancer progression. In this study we have established a novel mechanism for initiation of CDCP1-mediated signaling in vivo and demonstrated that specific 135 -> 70-kDa processing of cell-surface CDCP1 by extracellular serine proteases is a prerequisite for CDCP1-dependent survival of cancer cells during metastasis. The in vivo cleavage of CDCP1 triggers a survival program involving recruitment of Src and PKC delta, Src-mediated phosphorylation of cell-surface-retained 70-kDa CDCP1, activation of Akt and suppression of PARP1-induced apoptosis. We demonstrate in vivo that phosphorylated Src, PKC delta and Akt all constitute activated elements of a CDCP1-signaling axis during tissue colonization of tumor cells. Preventing in vivo cleavage of CDCP1 with unique anti-CDCP1 antibodies, serine protease inhibitors or genetic modulation of the cleavage site in the CDCP1 molecule completely abrogated survival signaling associated with the 70-kDa CDCP1, and induced PARP1 cleavage and PARP1-mediated apoptosis, ultimately resulting in substantial inhibition of tissue colonization by tumor cells. The lack of CDCP1 cleavage in the lung tissue of plasminogen-knockout mice along with a coordinated reduction in tumor cell survival in a lung retention model, and importantly rescue of both by in vivo supplied plasmin, indicated that plasmin is the crucial serine pr otease executing in vivo cleavage of cell-surface CDCP1 during early stages of lung colonization. Together, our findings indicate that in vivo blocking of CDCP1 cleavage upstream from CDCP1-induced pro-survival signaling provides a potential mechanism for therapeutic intervention into metastatic disease. Oncogene ( 2012) 31, 3924-3938; doi:10.1038/onc.2011.555; published online 19 December 2011	[Casar, B.; Quigley, J. P.; Deryugina, E. I.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [He, Y.; Iconomou, M.; Hooper, J. D.] Mater Med Res Inst, Brisbane, Qld, Australia	Scripps Research Institute; Mater Research	Deryugina, EI (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd,SP3030-3120, La Jolla, CA 92037 USA.	deryugin@scripps.edu	CASAR, BERTA/M-2291-2014; Hooper, John/C-1481-2016	CASAR, BERTA/0000-0002-3058-5631; Hooper, John/0000-0003-1054-8486; HE, Yaowu/0000-0002-7828-263X	NATIONAL CANCER INSTITUTE [R01CA129484, R01CA105412] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025774] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA 129484, R01 CA129484, R01 CA105412, R01 CA 105412] Funding Source: Medline; NCRR NIH HHS [UL1 RR025774, RR 025774] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Altomare DA, 2004, ONCOGENE, V23, P5853, DOI 10.1038/sj.onc.1207721; Alvares SM, 2008, BBA-GEN SUBJECTS, V1780, P486, DOI 10.1016/j.bbagen.2008.01.010; Awakura Y, 2008, J CANCER RES CLIN, V134, P1363, DOI 10.1007/s00432-008-0412-4; Benes CH, 2012, ONCOGENE, V31, P653, DOI 10.1038/onc.2011.262; Benes CH, 2005, CELL, V121, P271, DOI 10.1016/j.cell.2005.02.019; Bhatt AS, 2005, ONCOGENE, V24, P5333, DOI 10.1038/sj.onc.1208582; Brown TA, 2004, J BIOL CHEM, V279, P14772, DOI 10.1074/jbc.M309678200; Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31; Conn EM, 2009, AM J PATHOL, V175, P1638, DOI 10.2353/ajpath.2009.090384; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Deryugina EI, 2002, J BIOL CHEM, V277, P9749, DOI 10.1074/jbc.M110269200; Deryugina EI, 2009, MOL CANCER RES, V7, P1197, DOI 10.1158/1541-7786.MCR-09-0100; Gobeil S, 2001, CELL DEATH DIFFER, V8, P588, DOI 10.1038/sj.cdd.4400851; Gray K, 2008, FEBS LETT, V582, P907, DOI 10.1016/j.febslet.2008.02.026; He Y, 2010, J BIOL CHEM, V285, P26162, DOI 10.1074/jbc.M109.096453; Hooper JD, 2003, ONCOGENE, V22, P1783, DOI 10.1038/sj.onc.1206220; Landis RC, 2001, ANN THORAC SURG, V72, P2169, DOI 10.1016/S0003-4975(01)02821-1; Liu H, 2011, P NATL ACAD SCI USA, V108, P1379, DOI 10.1073/pnas.1017228108; Miyazawa Y, 2010, CANCER RES, V70, P5136, DOI 10.1158/0008-5472.CAN-10-0220; Nam S, 2005, CANCER RES, V65, P9185, DOI 10.1158/0008-5472.CAN-05-1731; Razorenova OV, 2011, P NATL ACAD SCI USA, V108, P1931, DOI 10.1073/pnas.1011777108; Schmidt A, 2005, J BIOL CHEM, V280, P34441, DOI 10.1074/jbc.M501903200; Shi XL, 2004, MOL CANCER RES, V2, P395; Spassov DS, 2011, CELL CYCLE, V10, P1225, DOI 10.4161/cc.10.8.15343; Spassov DS, 2011, MOL CELL BIOL, V31, P766, DOI 10.1128/MCB.00841-10; Uekita T, 2008, AM J PATHOL, V172, P1729, DOI 10.2353/ajpath.2008.070981; Uekita T, 2007, MOL CELL BIOL, V27, P7649, DOI 10.1128/MCB.01246-07; Wortmann A, 2011, J BIOL CHEM; Wortmann A, 2009, IUBMB LIFE, V61, P723, DOI 10.1002/iub.198; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017	30	51	51	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG	2012	31	35					3924	3938		10.1038/onc.2011.555	http://dx.doi.org/10.1038/onc.2011.555			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	999VJ	22179830	Green Accepted			2022-12-25	WOS:000308342800002
J	Behal, RH; Miller, MS; Qin, HM; Lucker, BF; Jones, A; Cole, DG				Behal, Robert H.; Miller, Mark S.; Qin, Hongmin; Lucker, Ben F.; Jones, Alexis; Cole, Douglas G.			Subunit Interactions and Organization of the Chlamydomonas reinhardtii Intraflagellar Transport Complex A Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINESIN-LIKE PROTEIN; DISEASE GENE TG737; CAENORHABDITIS-ELEGANS; SENSORY CILIA; C-ELEGANS; FUNCTIONAL-ANALYSIS; CYTOPLASMIC DYNEIN; IFT PARTICLE; HEAVY-CHAIN; CELL BODY	Chlamydomonas reinhardtii intraflagellar transport (IFT) particles can be biochemically resolved into two smaller assemblies, complexes A and B, that contain up to six and 15 protein subunits, respectively. We provide here the proteomic and immunological analyses that verify the identity of all six Chlamydomonas A proteins. Using sucrose density gradient centrifugation and antibody pulldowns, we show that all six A subunits are associated in a 16 S complex in both the cell bodies and flagella. A significant fraction of the cell body IFT43, however, exhibits a much slower sedimentation of similar to 2 S and is not associated with the IFT A complex. To identify interactions between the six A proteins, we combined exhaustive yeast-based two-hybrid analysis, heterologous recombinant protein expression in Escherichia coli, and analysis of the newly identified complex A mutants, ift121 and ift122. We show that IFT121 and IFT43 interact directly and provide evidence for additional interactions between IFT121 and IFT139, IFT121 and IFT122, IFT140 and IFT122, and IFT140 and IFT144. The mutant analysis further allows us to propose that a subset of complex A proteins, IFT144/140/122, can form a stable 12 S subcomplex that we refer to as the IFT A core. Based on these results, we propose a model for the spatial arrangement of the six IFT A components.	[Behal, Robert H.; Miller, Mark S.; Lucker, Ben F.; Jones, Alexis; Cole, Douglas G.] Univ Idaho, Dept Biol Sci, Moscow, ID 83844 USA; [Behal, Robert H.; Miller, Mark S.; Lucker, Ben F.; Jones, Alexis; Cole, Douglas G.] Univ Idaho, Ctr Reprod Biol, Moscow, ID 83844 USA; [Qin, Hongmin] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Idaho; University of Idaho; Idaho; University of Idaho; Texas A&M University System; Texas A&M University College Station	Cole, DG (corresponding author), Univ Idaho, Dept Biol Sci, BIOL LSS 252, Moscow, ID 83844 USA.	dcole@uidaho.edu			National Institutes of Health [R01-GM61920]; INBRE of the National Center for Research Resources [P20-RR016454]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061920] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); INBRE of the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM61920 (to D. G. C.) and INBRE Program of the National Center for Research Resources Grant P20-RR016454.	Absalon S, 2008, MOL BIOL CELL, V19, P929, DOI 10.1091/mbc.E07-08-0749; AFZELIUS BA, 1995, CELL MOTIL CYTOSKEL, V32, P95, DOI 10.1002/cm.970320204; Arts HH, 2011, J MED GENET, V48, P390, DOI 10.1136/jmg.2011.088864; Asamiziu E, 2000, DNA RES, V7, P305, DOI 10.1093/dnares/7.5.305; Asamizu E, 1999, DNA Res, V6, P369, DOI 10.1093/dnares/6.6.369; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Baker K, 2009, AM J MED GENET C, V151C, P281, DOI 10.1002/ajmg.c.30231; Baker SA, 2003, J BIOL CHEM, V278, P34211, DOI 10.1074/jbc.M300156200; Bell LR, 2006, GENETICS, V173, P1275, DOI 10.1534/genetics.106.056721; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Berthold P, 2002, PROTIST, V153, P401, DOI 10.1078/14344610260450136; Betleja E, 2010, CURR BIOL, V20, pR928, DOI 10.1016/j.cub.2010.09.058; Blacque OE, 2008, FRONT BIOSCI-LANDMRK, V13, P2633, DOI 10.2741/2871; Blacque OE, 2006, MOL BIOL CELL, V17, P5053, DOI 10.1091/mbc.E06-06-0571; Boesger J, 2009, EUKARYOT CELL, V8, P922, DOI 10.1128/EC.00067-09; Brazelton WJ, 2001, CURR BIOL, V11, P1591, DOI 10.1016/S0960-9822(01)00485-7; Bredrup C, 2011, AM J HUM GENET, V89, P634, DOI 10.1016/j.ajhg.2011.10.001; Brugmann SA, 2010, AM J MED GENET A, V152A, P2995, DOI 10.1002/ajmg.a.33727; Cardenas-Rodriguez M, 2009, AM J MED GENET C, V151C, P263, DOI 10.1002/ajmg.c.30227; COLE D, 2009, CHLAMYDOMONAS SOURCE, V3, P71; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Cole DG, 2009, CELL, V137, P784, DOI 10.1016/j.cell.2009.04.053; Collet J, 1998, GENETICS, V148, P187; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Cortellino S, 2009, DEV BIOL, V325, P225, DOI 10.1016/j.ydbio.2008.10.020; Craige B, 2010, J CELL BIOL, V190, P927, DOI 10.1083/jcb.201006105; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; Efimenko E, 2006, MOL BIOL CELL, V17, P4801, DOI 10.1091/mbc.E06-04-0260; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Fan ZC, 2010, MOL BIOL CELL, V21, P2696, DOI 10.1091/mbc.E10-03-0191; Gilissen C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/j.ajhg.2010.08.004; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Haycraft CJ, 2003, EXP CELL RES, V284, P251, DOI 10.1016/S0014-4827(02)00089-7; Haycraft CJ, 2001, DEVELOPMENT, V128, P1493; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hou YQ, 2007, J CELL BIOL, V176, P653, DOI 10.1083/jcb.200608041; Inglis PN, 2009, METHOD CELL BIOL, V93, P267, DOI 10.1016/S0091-679X(08)93014-4; Iomini C, 2001, J CELL BIOL, V153, P13, DOI 10.1083/jcb.153.1.13; Iomini C, 2009, GENETICS, V183, P885, DOI 10.1534/genetics.109.101915; Kathir P, 2003, EUKARYOT CELL, V2, P362, DOI 10.1128/EC.2.2.362-379.2003; KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; Lechtreck KF, 2009, CELL MOTIL CYTOSKEL, V66, P469, DOI 10.1002/cm.20369; Lee E, 2008, CURR BIOL, V18, P1899, DOI 10.1016/j.cub.2008.11.020; Lee L, 2011, GENE, V473, P57, DOI 10.1016/j.gene.2010.11.006; Lucker BF, 2010, J BIOL CHEM, V285, P21508, DOI 10.1074/jbc.M110.106997; Lucker BF, 2005, J BIOL CHEM, V280, P27688, DOI 10.1074/jbc.M505062200; Marshall WF, 2008, J CELL BIOL, V180, P17, DOI 10.1083/jcb.200710085; Mill P, 2011, AM J HUM GENET, V88, P508, DOI 10.1016/j.ajhg.2011.03.015; Mukhopadhyay S, 2010, GENE DEV, V24, P2180, DOI 10.1101/gad.1966210; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pazour GJ, 1999, J CELL BIOL, V144, P473, DOI 10.1083/jcb.144.3.473; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Pazour GJ, 2000, METHODS, V22, P285, DOI 10.1006/meth.2000.1081; Pedersen LB, 2005, CURR BIOL, V15, P262, DOI 10.1016/j.cub.2005.01.037; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Pigino G, 2009, J CELL BIOL, V187, P135, DOI 10.1083/jcb.200905103; Piperno G, 1998, J CELL BIOL, V143, P1591, DOI 10.1083/jcb.143.6.1591; Piperno G, 1997, P NATL ACAD SCI USA, V94, P4457, DOI 10.1073/pnas.94.9.4457; Porter ME, 1999, MOL BIOL CELL, V10, P693, DOI 10.1091/mbc.10.3.693; Qin HM, 2004, J CELL BIOL, V164, P255, DOI 10.1083/jcb.200308132; Qin HM, 2001, CURR BIOL, V11, P457, DOI 10.1016/S0960-9822(01)00122-1; Qin HM, 2007, CURR BIOL, V17, P193, DOI 10.1016/j.cub.2006.12.040; Qin JA, 2011, P NATL ACAD SCI USA, V108, P1456, DOI 10.1073/pnas.1011410108; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Sambrook J., 2002, MOL CLONING LAB MANU; Scholey JM, 2003, ANNU REV CELL DEV BI, V19, P423, DOI 10.1146/annurev.cellbio.19.111401.091318; SCHULER GD, 1991, PROTEINS, V9, P180, DOI 10.1002/prot.340090304; SHAKIR MA, 1993, NEUROREPORT, V4, P891, DOI 10.1097/00001756-199307000-00013; Signor D, 1999, MOL BIOL CELL, V10, P345, DOI 10.1091/mbc.10.2.345; Silverman MA, 2009, TRENDS CELL BIOL, V19, P306, DOI 10.1016/j.tcb.2009.04.002; Sizova I, 2001, GENE, V277, P221, DOI 10.1016/S0378-1119(01)00616-3; Taschner M, 2011, J BIOL CHEM, V286, P26344, DOI 10.1074/jbc.M111.254920; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tran PV, 2008, NAT GENET, V40, P403, DOI 10.1038/ng.105; Tsao CC, 2008, J CELL SCI, V121, P428, DOI 10.1242/jcs.015826; Vincensini L, 2011, BIOL CELL, V103, P109, DOI 10.1042/BC20100104; Walczak-Sztulpa J, 2010, AM J HUM GENET, V86, P949, DOI 10.1016/j.ajhg.2010.04.012; WALTHER Z, 1994, J CELL BIOL, V126, P175, DOI 10.1083/jcb.126.1.175; Wang ZH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005384; WILKERSON CG, 1994, J CELL SCI, V107, P497; WITMAN GB, 1972, J CELL BIOL, V54, P507, DOI 10.1083/jcb.54.3.507; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Zhao CT, 2011, EMBO J, V30, P2532, DOI 10.1038/emboj.2011.165	88	67	69	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11689	11703		10.1074/jbc.M111.287102	http://dx.doi.org/10.1074/jbc.M111.287102			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22170070	Green Published, hybrid			2022-12-25	WOS:000302782200009
J	Lee, S; Thebault, P; Freschi, L; Beaufils, S; Blundell, TL; Landry, CR; Bolanos-Garcia, VM; Elowe, S				Lee, Semin; Thebault, Philippe; Freschi, Luca; Beaufils, Sylvie; Blundell, Tom L.; Landry, Christian R.; Bolanos-Garcia, Victor M.; Elowe, Sabine			Characterization of Spindle Checkpoint Kinase Mps1 Reveals Domain with Functional and Structural Similarities to Tetratricopeptide Repeat Motifs of Bub1 and BubR1 Checkpoint Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE MEIOSIS I; MITOTIC CHECKPOINT; KINETOCHORE LOCALIZATION; CHROMOSOMAL INSTABILITY; ASSEMBLY CHECKPOINT; PROTEIN MODELS; CENP-E; MITOSIS; ACTIVATION; CELLS	Kinetochore targeting of the mitotic kinases Bub1, BubR1, and Mps1 has been implicated in efficient execution of their functions in the spindle checkpoint, the self-monitoring system of the eukaryotic cell cycle that ensures chromosome segregation occurs with high fidelity. In all three kinases, kinetochore docking is mediated by the N-terminal region of the protein. Deletions within this region result in checkpoint failure and chromosome segregation defects. Here, we use an interdisciplinary approach that includes biophysical, biochemical, cell biological, and bioinformatics methods to study the N-terminal region of human Mps1. We report the identification of a tandem repeat of the tetratricopeptide repeat (TPR) motif in the N-terminal kinetochore binding region of Mps1, with close homology to the tandem TPR motif of Bub1 and BubR1. Phylogenetic analysis indicates that TPR Mps1 was acquired after the split between deutorostomes and protostomes, as it is distinguishable in chordates and echinoderms. Overexpression of TPR Mps1 resulted in decreased efficiency of both chromosome alignment and mitotic arrest, likely through displacement of endogenous Mps1 from the kinetochore and decreased Mps1 catalytic activity. Taken together, our multidisciplinary strategy provides new insights into the evolution, structural organization, and function of Mps1 N-terminal region.	[Lee, Semin; Blundell, Tom L.; Bolanos-Garcia, Victor M.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Thebault, Philippe; Elowe, Sabine] Ctr Hosp Univ Quebec, Ctr Rech, Quebec City, PQ G1V 4G2, Canada; [Freschi, Luca; Landry, Christian R.] Univ Laval, Inst Biol Integrat & Syst, PROTEO, Dept Biol, Quebec City, PQ G1V 0A6, Canada; [Beaufils, Sylvie] Univ Rennes 1, Inst Phys Rennes, CNRS, UMR 6251, F-35042 Rennes, France; [Elowe, Sabine] Univ Laval, Fac Med, Dept Pediat, Quebec City, PQ G1V 4G2, Canada	University of Cambridge; Laval University; Laval University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Rennes; Laval University	Bolanos-Garcia, VM (corresponding author), Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England.	victor@cryst.bioc.cam.ac.uk; sabine.elowe@crchuq.ulaval.ca	Pillay, Nischalan/F-9536-2012; Landry, Christian R/F-3890-2011; Freschi, Luca/AAS-9589-2020; Bolanos-Garcia, Victor M./AAN-8575-2020; sylvie, beaufils F/N-1563-2014; Lee, Semin/S-2629-2016	Bolanos-Garcia, Victor M./0000-0003-2700-1479; sylvie, beaufils F/0000-0001-5968-8119; Lee, Semin/0000-0002-9015-6046; Landry, Christian/0000-0003-3028-6866	Fondation des Etoiles; Wellcome Trust Programme [RG44650]; Canadian Institutes [GMX-191597]	Fondation des Etoiles; Wellcome Trust Programme(Wellcome Trust); Canadian Institutes(Canadian Institutes of Health Research (CIHR))	This work was supported by a "Fondation des Etoiles" starting grant (to S. E.), Wellcome Trust Programme Grant RG44650 (Structural Biology of Cell Signalling and Regulation: Multiprotein Systems and the Achievement of High Signal-to-Noise Ratios) (to T. L. B.), and Canadian Institutes of Health Research Grant GMX-191597 (to C. R. L.).	Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; Araki Y, 2010, J CELL BIOL, V189, P41, DOI 10.1083/jcb.200910027; Azzam R. M. A., 1977, ELLIPSOMETRY POLARIZ; Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041; Beaufils S, 2008, J PHYS CHEM B, V112, P7984, DOI 10.1021/jp711222s; Beddoe T, 2004, J BIOL CHEM, V279, P46448, DOI 10.1074/jbc.M405639200; BERGE B, 1993, EUROPHYS LETT, V21, P773, DOI 10.1209/0295-5075/21/7/010; Bolanos-Garcia VM, 2011, TRENDS BIOCHEM SCI, V36, P141, DOI 10.1016/j.tibs.2010.08.004; Bolanos-Garcia VM, 2005, BIOPHYS J, V89, P2640, DOI 10.1529/biophysj.105.063511; Chan YW, 2009, J CELL BIOL, V185, P859, DOI 10.1083/jcb.200812167; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; D'Arcy S, 2010, J BIOL CHEM, V285, P14764, DOI 10.1074/jbc.M109.082016; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; de Bakker PIW, 2001, BIOINFORMATICS, V17, P748, DOI 10.1093/bioinformatics/17.8.748; DEFEIJTER JA, 1978, BIOPOLYMERS, V17, P1759, DOI 10.1002/bip.1978.360170711; Dou Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018793; Dubreil L, 2003, BIOPHYS J, V85, P2650, DOI 10.1016/S0006-3495(03)74688-8; Elowe S, 2007, GENE DEV, V21, P2205, DOI 10.1101/gad.436007; Fava LL, 2011, EMBO J, V30, P3322, DOI 10.1038/emboj.2011.239; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gromiha MM, 2004, PROG BIOPHYS MOL BIO, V86, P235, DOI 10.1016/j.pbiomolbio.2003.09.003; Hached K, 2011, DEVELOPMENT, V138, P2261, DOI 10.1242/dev.061317; He XW, 1998, J CELL SCI, V111, P1635; Hewitt L, 2010, J CELL BIOL, V190, P25, DOI 10.1083/jcb.201002133; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Hubner NC, 2010, CHROMOSOMA, V119, P149, DOI 10.1007/s00412-009-0244-2; Jelluma N, 2008, CELL, V132, P233, DOI 10.1016/j.cell.2007.11.046; Jelluma N, 2010, J CELL BIOL, V191, P281, DOI 10.1083/jcb.201003038; Jelluma N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002415; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jones MH, 2005, CURR BIOL, V15, P160, DOI 10.1016/j.cub.2005.01.010; Kang JS, 2007, P NATL ACAD SCI USA, V104, P20232, DOI 10.1073/pnas.0710519105; Kiyomitsu T, 2007, DEV CELL, V13, P663, DOI 10.1016/j.devcel.2007.09.005; Kiyomitsu T, 2011, MOL CELL BIOL, V31, P998, DOI 10.1128/MCB.00815-10; Klebig C, 2009, J CELL BIOL, V185, P841, DOI 10.1083/jcb.200902128; Laskowski RA, 1998, CURR OPIN STRUC BIOL, V8, P631, DOI 10.1016/S0959-440X(98)80156-5; Liu ST, 2003, MOL BIOL CELL, V14, P1638, DOI 10.1091/mbc.02-05-0074; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Maciejowski J, 2010, J CELL BIOL, V190, P89, DOI 10.1083/jcb.201001050; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; Mattison CP, 2007, J BIOL CHEM, V282, P30553, DOI 10.1074/jbc.M707063200; Mizuguchi K, 1998, BIOINFORMATICS, V14, P617, DOI 10.1093/bioinformatics/14.7.617; Niault T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001165; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Renault A, 1999, BIOPHYS J, V76, P1580, DOI 10.1016/S0006-3495(99)77317-0; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Saurin AT, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1319; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Stucke VM, 2004, CHROMOSOMA, V113, P1, DOI 10.1007/s00412-004-0288-2; Tanudji M, 2004, MOL BIOL CELL, V15, P3771, DOI 10.1091/mbc.E03-07-0482; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Tighe A, 2008, J CELL BIOL, V181, P893, DOI 10.1083/jcb.200712028; Tyler RK, 2009, BIOCHEM J, V417, P173, DOI 10.1042/BJ20081310; Venien-Bryan C, 1998, BIOPHYS J, V74, P2649, DOI 10.1016/S0006-3495(98)77970-6; Vie V, 2010, BBA-BIOMEMBRANES, V1798, P1503, DOI 10.1016/j.bbamem.2010.04.005; Vigneron S, 2004, MOL BIOL CELL, V15, P4584, DOI 10.1091/mbc.E04-01-0051; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; Welburn JPI, 2008, DEV CELL, V15, P645, DOI 10.1016/j.devcel.2008.10.011; Xu QB, 2009, MOL BIOL CELL, V20, P10, DOI 10.1091/mbc.E08-03-0324; Yang ZY, 2009, J CELL BIOL, V186, P675, DOI 10.1083/jcb.200906150; Zhao Y, 2006, CURR BIOL, V16, P1764, DOI 10.1016/j.cub.2006.07.058	66	25	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5988	6001		10.1074/jbc.M111.307355	http://dx.doi.org/10.1074/jbc.M111.307355			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22187426	Green Published, hybrid			2022-12-25	WOS:000300638000072
J	Neill, T; Painter, H; Buraschi, S; Owens, RT; Lisanti, MP; Schaefer, L; Iozzo, RV				Neill, Thomas; Painter, Hannah; Buraschi, Simone; Owens, Rick T.; Lisanti, Michael P.; Schaefer, Liliana; Iozzo, Renato V.			Decorin Antagonizes the Angiogenic Network CONCURRENT INHIBITION OF MET, HYPOXIA INDUCIBLE FACTOR 1 alpha, VASCULAR ENDOTHELIAL GROWTH FACTOR A, AND INDUCTION OF THROMBOSPONDIN-1 AND TIMP3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCINE-RICH PROTEOGLYCANS; HYPOXIA-INDUCIBLE FACTOR-1; CYCLIN-DEPENDENT KINASES; FACTOR RECEPTOR; IN-VIVO; SIGNAL-TRANSDUCTION; DOWN-REGULATION; DEFICIENT MICE; BREAST-CANCER; MATRIX METALLOPROTEINASES	Decorin, a small leucine-rich proteoglycan, inhibits tumor growth by antagonizing multiple receptor tyrosine kinases including EGFR and Met. Here, we investigated decorin during normoxic angiogenic signaling. An angiogenic PCR array revealed a profound decorin-evoked transcriptional inhibition of pro-angiogenic genes, such as HIF1A. Decorin evoked a reduction of hypoxia inducible factor (HIF)-1 alpha and vascular endothelial growth factor A (VEGFA) in MDA-231 breast carcinoma cells expressing constitutively-active HIF-1 alpha. Suppression of Met with decorin or siRNA evoked a similar reduction of VEGFA by attenuating downstream beta-catenin signaling. These data establish a noncanonical role for beta-catenin in regulating VEGFA expression. We found that exogenous decorin induced expression of thrombospondin-1 and TIMP3, two powerful angiostatic agents. In contrast, decorin suppressed both the expression and enzymatic activity of matrix metalloprotease (MMP)-9 and MMP-2, two pro-angiogenic proteases. Our data establish a novel duality for decorin as a suppressor of tumor angiogenesis under normoxia by simultaneously down-regulating potent pro-angiogenic factors and inducing endogenous anti-angiogenic agents.	[Neill, Thomas; Painter, Hannah; Buraschi, Simone; Iozzo, Renato V.] Thomas Jefferson Univ, Canc Cell Biol & Signaling Program, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Lisanti, Michael P.] Thomas Jefferson Univ, Kimmel Canc Ctr, Stem Cell Biol & Regenerat Med Ctr, Philadelphia, PA 19107 USA; [Schaefer, Liliana] Goethe Univ Frankfurt, D-60590 Frankfurt, Germany; [Owens, Rick T.] LifeCell Corp, Branchburg, NJ 08876 USA	Jefferson University; Jefferson University; Goethe University Frankfurt	Iozzo, RV (corresponding author), Thomas Jefferson Univ, Canc Cell Biol & Signaling Program, Dept Pathol Anat & Cell Biol, 1020 Locust St,Rm 249 JAH, Philadelphia, PA 19107 USA.	iozzo@kimmelcancercenter.org	Iozzo, Renato/AAS-1980-2020; Lisanti, Michael/B-6131-2018; Lisanti, Michael P/C-6866-2013	Lisanti, Michael/0000-0003-2034-1382; Schaefer, Liliana/0000-0002-3318-3005; Painter, Hannah/0000-0003-0445-7473	National Institutes of Health [RO1 CA39481, RO1 CA47282, RO1 CA120975, T32 AA07463]; NATIONAL CANCER INSTITUTE [R01CA047282, R01CA120975, R01CA039481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA007463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 CA39481, RO1 CA47282, and RO1 CA120975 (to R. V. I.).; Supported by National Institutes of Health Training Grant T32 AA07463. This work is in partial fulfillment of a doctoral thesis in Cell and Developmental Biology, Thomas Jefferson University.	ADANY R, 1990, J BIOL CHEM, V265, P11389; Armstrong LC, 2003, MATRIX BIOL, V22, P63, DOI 10.1016/S0945-053X(03)00005-2; Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Bachman KE, 1999, CANCER RES, V59, P798; Baghy K, 2011, LAB INVEST, V91, P439, DOI 10.1038/labinvest.2010.172; Barski D, 2010, BRAIN PATHOL, V20, P623, DOI 10.1111/j.1750-3639.2009.00340.x; Bernabeu C, 2009, BBA-MOL BASIS DIS, V1792, P954, DOI 10.1016/j.bbadis.2009.07.003; Bi XL, 2008, CARCINOGENESIS, V29, P1435, DOI 10.1093/carcin/bgn141; Bi YM, 2005, J BIOL CHEM, V280, P30481, DOI 10.1074/jbc.M500573200; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Bourboulia D, 2010, SEMIN CANCER BIOL, V20, P161, DOI 10.1016/j.semcancer.2010.05.002; Brandan E, 2008, MATRIX BIOL, V27, P700, DOI 10.1016/j.matbio.2008.07.004; Brown EL, 2001, J CLIN INVEST, V107, P845, DOI 10.1172/JCI11692; Buraschi Simone, 2010, J Biol Chem, V285, P42075, DOI 10.1074/jbc.M110.172841; Chen SJ, 2011, AM J PATHOL, V179, P2409, DOI 10.1016/j.ajpath.2011.07.026; Chiavarina B, 2010, CELL CYCLE, V9, P3534, DOI 10.4161/cc.9.17.12908; COHEN IR, 1994, CANCER RES, V54, P5771; Corsi A, 2002, J BONE MINER RES, V17, P1180, DOI 10.1359/jbmr.2002.17.7.1180; Csordas G, 2000, J BIOL CHEM, V275, P32879, DOI 10.1074/jbc.M005609200; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Daum G, 2009, ARTERIOSCL THROM VAS, V29, P1439, DOI 10.1161/ATVBAHA.108.175240; Davies CD, 2001, MICROVASC RES, V62, P26, DOI 10.1006/mvre.2001.2311; DeLuca A, 1996, J BIOL CHEM, V271, P18961, DOI 10.1074/jbc.271.31.18961; Easwaran V, 2003, CANCER RES, V63, P3145; Elliott DM, 2003, ANN BIOMED ENG, V31, P599, DOI 10.1114/1.1567282; Fata JE, 2001, J CLIN INVEST, V108, P831, DOI 10.1172/JCI13171; Ferdous Z, 2007, J BIOL CHEM, V282, P35887, DOI 10.1074/jbc.M705180200; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Fust A, 2005, AM J PHYSIOL-LUNG C, V288, pL159, DOI 10.1152/ajplung.00089.2004; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Goldberg M, 2005, CALCIFIED TISSUE INT, V77, P297, DOI 10.1007/s00223-005-0026-7; Goldoni S, 2008, INT J CANCER, V123, P2473, DOI 10.1002/ijc.23930; Goldoni S, 2008, AM J PATHOL, V173, P844, DOI 10.2353/ajpath.2008.080275; Goldoni S, 2009, J CELL BIOL, V185, P743, DOI 10.1083/jcb.200901129; Goyal A, 2011, J BIOL CHEM, V286, P25947, DOI 10.1074/jbc.M111.243626; Grant DS, 2002, ONCOGENE, V21, P4765, DOI 10.1038/sj.onc.1205595; GRANT DS, 1993, P NATL ACAD SCI USA, V90, P1937, DOI 10.1073/pnas.90.5.1937; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Haruyama N, 2009, MATRIX BIOL, V28, P129, DOI 10.1016/j.matbio.2009.01.005; Hembry Rosalind M., 2007, V135, P227; Hu YP, 2009, NEOPLASIA, V11, P1042, DOI 10.1593/neo.09760; Hynes RO, 2007, J THROMB HAEMOST, V5, P32, DOI 10.1111/j.1538-7836.2007.02569.x; Iozzo RV, 2011, J BIOL CHEM, V286, P34712, DOI 10.1074/jbc.M111.262766; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Iozzo RV, 2010, FEBS J, V277, P3864, DOI 10.1111/j.1742-4658.2010.07797.x; Iozzo RV, 1999, P NATL ACAD SCI USA, V96, P3092, DOI 10.1073/pnas.96.6.3092; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; Iozzo RV, 1999, J BIOL CHEM, V274, P4489, DOI 10.1074/jbc.274.8.4489; Iozzo RV, 1996, FASEB J, V10, P598, DOI 10.1096/fasebj.10.5.8621059; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; IOZZO RV, 1994, MATRIX BIOL, V14, P203, DOI 10.1016/0945-053X(94)90183-X; Jarvelainen H, 2006, WOUND REPAIR REGEN, V14, P443, DOI 10.1111/j.1743-6109.2006.00150.x; Kalamajski S, 2010, MATRIX BIOL, V29, P248, DOI 10.1016/j.matbio.2010.01.001; Keene DR, 2000, J BIOL CHEM, V275, P21801, DOI 10.1074/jbc.C000278200; Kermorgant S, 2005, CELL CYCLE, V4, P352, DOI 10.4161/cc.4.3.1519; Khan GA, 2011, MOL ENDOCRINOL, V25, P1431, DOI 10.1210/me.2010-0426; Kinsella MG, 2000, J BIOL CHEM, V275, P13924, DOI 10.1074/jbc.275.18.13924; Lai AZ, 2009, TRENDS CELL BIOL, V19, P542, DOI 10.1016/j.tcb.2009.07.002; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; Li X, 2008, BLOOD, V112, P159, DOI 10.1182/blood-2007-11-124164; Liang FT, 2004, AM J PATHOL, V165, P977, DOI 10.1016/S0002-9440(10)63359-7; Liau SS, 2006, CANCER RES, V66, P11613, DOI 10.1158/0008-5472.CAN-06-1460; Liu ZX, 2002, J BIOL CHEM, V277, P10452, DOI 10.1074/jbc.M107551200; Merline R, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001868; Milanini-Mongiat J, 2002, J BIOL CHEM, V277, P20631, DOI 10.1074/jbc.M201753200; Mohan R, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0026846, 10.1371/journal.pone.0026432]; Moscatello DK, 1998, J CLIN INVEST, V101, P406, DOI 10.1172/JCI846; Nath D, 2001, J CELL SCI, V114, P1213; Nelimarkka L, 1997, J BIOL CHEM, V272, P12730, DOI 10.1074/jbc.272.19.12730; Nelimarkka L, 2001, AM J PATHOL, V158, P345, DOI 10.1016/S0002-9440(10)63975-2; Ngo CV, 2000, CELL GROWTH DIFFER, V11, P201; Okawa T, 2007, GENE DEV, V21, P2788, DOI 10.1101/gad.1544507; Pages G, 2005, CARDIOVASC RES, V65, P564, DOI 10.1016/j.cardiores.2004.09.032; Patel S, 1998, J BIOL CHEM, V273, P3121, DOI 10.1074/jbc.273.6.3121; Rangel R, 2007, P NATL ACAD SCI USA, V104, P4588, DOI 10.1073/pnas.0611653104; Rasola A, 2007, ONCOGENE, V26, P1078, DOI 10.1038/sj.onc.1209859; Reed CC, 2005, ONCOGENE, V24, P1104, DOI 10.1038/sj.onc.1208329; Reed CC, 2002, GLYCOCONJUGATE J, V19, P249, DOI 10.1023/A:1025383913444; Reed CC, 2002, ONCOGENE, V21, P3688, DOI 10.1038/sj.onc.1205470; Riggins KS, 2010, EXP CELL RES, V316, P2993, DOI 10.1016/j.yexcr.2010.08.003; Robinson PS, 2005, J BIOMECH ENG-T ASME, V127, P181, DOI 10.1115/1.1835363; Robinson PS, 2004, ANN BIOMED ENG, V32, P924, DOI 10.1023/B:ABME.0000032455.78459.56; Ruehland C, 2007, FEBS J, V274, P4246, DOI 10.1111/j.1742-4658.2007.05951.x; Salomaki HH, 2008, J HISTOCHEM CYTOCHEM, V56, P639, DOI 10.1369/jhc.2008.950287; Sanches JCT, 2010, J ANAT, V216, P144, DOI 10.1111/j.1469-7580.2009.01170.x; Santra M, 1997, J CLIN INVEST, V100, P149, DOI 10.1172/JCI119507; Santra M, 2002, J BIOL CHEM, V277, P35671, DOI 10.1074/jbc.M205317200; SANTRA M, 1995, P NATL ACAD SCI USA, V92, P7016, DOI 10.1073/pnas.92.15.7016; Santra M, 2000, J BIOL CHEM, V275, P35153, DOI 10.1074/jbc.M006821200; Santra M, 2008, J NEUROCHEM, V105, P324, DOI 10.1111/j.1471-4159.2007.05134.x; Schaefer L, 2002, AM J PATHOL, V160, P1181, DOI 10.1016/S0002-9440(10)64937-1; Schaefer L, 2004, AM J PATHOL, V165, P383, DOI 10.1016/S0002-9440(10)63305-6; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; Schaefer L, 2007, AM J PATHOL, V170, P301, DOI 10.2353/ajpath.2007.060497; Schaefer L, 2011, J AM SOC NEPHROL, V22, P1200, DOI 10.1681/ASN.2010050570; Schonherr E, 2004, J VASC RES, V41, P499, DOI 10.1159/000081806; Schonherr E, 2001, J BIOL CHEM, V276, P40687, DOI 10.1074/jbc.M105426200; Seidler DG, 2006, J BIOL CHEM, V281, P26408, DOI 10.1074/jbc.M602853200; Semenza GL, 2002, BIOCHEM PHARMACOL, V64, P993, DOI 10.1016/S0006-2952(02)01168-1; Semenza GL, 2009, SEMIN CANCER BIOL, V19, P12, DOI 10.1016/j.semcancer.2008.11.009; Tikhonenko AT, 1996, J BIOL CHEM, V271, P30741, DOI 10.1074/jbc.271.48.30741; Tralhao JG, 2003, FASEB J, V17, P464, DOI 10.1096/fj.02-0534fje; VONIOZZO R, 1982, LAB INVEST, V47, P124; Watnick RS, 2003, CANCER CELL, V3, P219, DOI 10.1016/S1535-6108(03)00030-8; Weis SM, 2005, MATRIX BIOL, V24, P313, DOI 10.1016/j.matbio.2005.05.003; Whitelock JM, 1996, J BIOL CHEM, V271, P10079, DOI 10.1074/jbc.271.17.10079; Williams KJ, 2007, AM J PATHOL, V171, P1441, DOI 10.2353/ajpath.2007.070079; Woodfin A, 2007, ARTERIOSCL THROM VAS, V27, P2514, DOI 10.1161/ATVBAHA.107.151456; Wu BB, 2007, IMMUNITY, V26, P227, DOI 10.1016/j.immuni.2006.12.007; Zafiropoulos A, 2008, MOL CANCER RES, V6, P785, DOI 10.1158/1541-7786.MCR-07-0165; Zarrabi K, 2011, J BIOL CHEM, V286, P33167, DOI 10.1074/jbc.M111.256644; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776; Zhang G, 2009, J BIOL CHEM, V284, P8888, DOI 10.1074/jbc.M806590200; Zhang XF, 2007, MICROVASC RES, V74, P90, DOI 10.1016/j.mvr.2007.04.007; Zhang YW, 2003, P NATL ACAD SCI USA, V100, P12718, DOI 10.1073/pnas.2135113100; Zhu JX, 2005, J BIOL CHEM, V280, P32468, DOI 10.1074/jbc.M503833200; Zochbauer-Muller S, 2001, CANCER RES, V61, P249; Zoeller JJ, 2008, J CELL BIOL, V181, P381, DOI 10.1083/jcb.200708022; Zoeller JJ, 2009, J BIOL CHEM, V284, P11728, DOI 10.1074/jbc.M808991200	121	125	130	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5492	5506		10.1074/jbc.M111.283499	http://dx.doi.org/10.1074/jbc.M111.283499			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22194599	hybrid, Green Published			2022-12-25	WOS:000300638000029
J	Zhang, SY; Condac, E; Qiu, H; Jiang, JL; Gutierrez-Sanchez, G; Bergmann, C; Handel, T; Wang, LC				Zhang, Siyuan; Condac, Eduard; Qiu, Hong; Jiang, Junlin; Gutierrez-Sanchez, Gerardo; Bergmann, Carl; Handel, Tracy; Wang, Lianchun			Heparin-induced Leukocytosis Requires 6-O-Sulfation and Is Caused by Blockade of Selectin- and CXCL12 Protein-mediated Leukocyte Trafficking in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC PROGENITOR CELLS; COLONY-STIMULATING FACTOR; P-SELECTIN; BONE-MARROW; LYMPHOCYTE RECIRCULATION; SULFATED POLYSACCHARIDES; NEUTROPHIL HOMEOSTASIS; STROMAL CELLS; STEM-CELLS; G-CSF	Leukocytosis refers to an increase in leukocyte count above the normal range in the blood and is a common laboratory finding in patients. In many cases, the mechanisms underlying leukocytosis are not known. In this study, we examined the effects, the structural determinants, and the underlying mechanisms of heparin-induced leukocytosis, a side effect occurring in 0.44% of patients receiving heparin. We observed that heparin induced both lymphocytosis and neutrophilia, and the effects required heparin to be 6-O-sulfated but did not require its anticoagulant activity. Cell mobilization studies revealed that the lymphocytosis was attributable to a combination of blockage of lymphocyte homing and the release of thymocytes from the thymus, whereas the neutrophilia was caused primarily by neutrophil release from the bone marrow and demargination in the vasculature. Mechanistic studies revealed that heparin inhibits L-and P-selectin, as well as the chemokine CXCL12, leading to leukocytosis. Heparin is known to require 6-O-sulfate to inhibit L-and P-selectin function, and in this study we observed that 6-O-sulfate is required for its interaction with CXCL12. We conclude that heparin-induced leukocytosis requires glucosamine 6-O-sulfation and is caused by blockade of L-selectin-, P-selectin-, and CXCL12-mediated leukocyte trafficking.	[Zhang, Siyuan; Condac, Eduard; Qiu, Hong; Jiang, Junlin; Gutierrez-Sanchez, Gerardo; Bergmann, Carl; Wang, Lianchun] Univ Georgia, Complex Carbohydrate Res Ctr, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Handel, Tracy] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University System of Georgia; University of Georgia; University of California System; University of California San Diego	Wang, LC (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, Dept Biochem & Mol Biol, 315 Riverbend Rd, Athens, GA 30602 USA.	Lwang@ccrc.uga.edu	Qiu, Hong/C-5888-2011	Qiu, Hong/0000-0002-4088-7828	National Institutes of Health from NHLBI [R01HL093339]; National Institutes of Health from NIAID [RR005351]; National Institutes of Health [R01AI37113]; American Heart Association; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005351] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103390] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL093339 from NHLBI (to L. W.), RR005351 from NIAID (to L. W./James Prestegard), and R01AI37113 (to T. M. H.). This work was also supported by American Heart Association postdoctoral fellowship (to S. Y. Z.) and a scientist development grant (to L. W.).	Abramson N, 2000, AM FAM PHYSICIAN, V62, P2053; Albanese P, 2009, EXP HEMATOL, V37, P1072, DOI 10.1016/j.exphem.2009.06.005; Amara A, 1999, J BIOL CHEM, V274, P23916, DOI 10.1074/jbc.274.34.23916; Basu S, 2002, BLOOD, V100, P854, DOI 10.1182/blood.V100.3.854; Borsig L, 2001, P NATL ACAD SCI USA, V98, P3352, DOI 10.1073/pnas.061615598; BRADFIEL.JW, 1969, NATURE, V222, P1183, DOI 10.1038/2221183a0; BRADFIELD JW, 1974, CELL IMMUNOL, V14, P22, DOI 10.1016/0008-8749(74)90165-8; Christopher MJ, 2007, CURR OPIN HEMATOL, V14, P3, DOI 10.1097/00062752-200701000-00003; Dar A, 2011, LEUKEMIA, V25, P1286, DOI 10.1038/leu.2011.62; de Haan G, 2000, BRIT J HAEMATOL, V110, P638, DOI 10.1046/j.1365-2141.2000.02252.x; Eash KJ, 2010, J CLIN INVEST, V120, P2423, DOI 10.1172/JCI41649; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Fahey V A, 1995, J Vasc Nurs, V13, P112, DOI 10.1016/S1062-0303(05)80003-2; FORD WL, 1969, SEMIN HEMATOL, V6, P67; Frenette PS, 2000, BLOOD, V96, P2460, DOI 10.1182/blood.V96.7.2460.h8002460_2460_2468; Furze RC, 2008, IMMUNOLOGY, V125, P281, DOI 10.1111/j.1365-2567.2008.02950.x; GODLOWSKI ZZ, 1951, BRIT MED J, V1, P854, DOI 10.1136/bmj.1.4711.854; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Hattori K, 2001, BLOOD, V97, P3354, DOI 10.1182/blood.V97.11.3354; Horwitz BH, 2001, BLOOD, V97, P1578, DOI 10.1182/blood.V97.6.1578; JOHNSON RC, 1995, BLOOD, V86, P1106; Kim CH, 1999, J LEUKOCYTE BIOL, V65, P6, DOI 10.1002/jlb.65.1.6; Lapidot T, 2002, EXP HEMATOL, V30, P973, DOI 10.1016/S0301-472X(02)00883-4; Leppanen A, 2000, J BIOL CHEM, V275, P39569, DOI 10.1074/jbc.M005005200; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; Martin C, 2003, IMMUNITY, V19, P583, DOI 10.1016/S1074-7613(03)00263-2; Nakagawa M, 1998, CIRCULATION, V98, P2307, DOI 10.1161/01.CIR.98.21.2307; NELSON RM, 1993, BLOOD, V82, P3253; Netelenbos T, 2003, J LEUKOCYTE BIOL, V74, P1035, DOI 10.1189/jlb.1202593; Netelenbos T, 2003, LEUKEMIA, V17, P175, DOI 10.1038/sj.leu.2402738; Netelenbos T, 2002, J LEUKOCYTE BIOL, V72, P353; Opdenakker G, 1998, IMMUNOL TODAY, V19, P182, DOI 10.1016/S0167-5699(97)01243-7; Osmond RIW, 2002, ANAL BIOCHEM, V310, P199, DOI 10.1016/S0003-2697(02)00396-2; Papayannopoulou T, 2004, BLOOD, V103, P1580, DOI 10.1182/blood-2003-05-1595; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Sadir R, 2001, J BIOL CHEM, V276, P8288, DOI 10.1074/jbc.M008110200; SASAKI S, 1967, NATURE, V214, P1041, DOI 10.1038/2141041a0; SCOLLAY RG, 1980, EUR J IMMUNOL, V10, P210, DOI 10.1002/eji.1830100310; Shen HM, 2001, J IMMUNOL, V166, P5027, DOI 10.4049/jimmunol.166.8.5027; Sierra MD, 2004, BLOOD, V103, P2452; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Stekel DJ, 1997, IMMUNOL TODAY, V18, P216; Stevenson JL, 2007, THROMB RES, V120, pS107, DOI 10.1016/S0049-3848(07)70138-X; Stevenson JL, 2005, CLIN CANCER RES, V11, P7003, DOI 10.1158/1078-0432.CCR-05-1131; Suratt BT, 2004, BLOOD, V104, P565, DOI 10.1182/blood-2003-10-3638; Sweeney EA, 2002, BLOOD, V99, P44, DOI 10.1182/blood.V99.1.44; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207; Tyrrell DJ, 1999, ADV PHARMACOL, V46, P151, DOI 10.1016/S1054-3589(08)60471-8; Wang JB, 1997, J LEUKOCYTE BIOL, V62, P503, DOI 10.1002/jlb.62.4.503; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Wang LC, 2002, J CLIN INVEST, V110, P127, DOI 10.1172/JCI200214996; Weninger W, 2000, IMMUNITY, V12, P665, DOI 10.1016/S1074-7613(00)80217-4; Wijelath E, 2010, J CELL BIOCHEM, V111, P461, DOI 10.1002/jcb.22727; Zhang FM, 2011, ANAL BIOANAL CHEM, V401, P2793, DOI 10.1007/s00216-011-5367-7; Zhang P, 2005, SHOCK, V23, P344, DOI 10.1097/01.shk.0000158960.93832.de; Zhou B, 2011, J CLIN INVEST, V121, P1894, DOI 10.1172/JCI45529	56	22	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5542	5553		10.1074/jbc.M111.314716	http://dx.doi.org/10.1074/jbc.M111.314716			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22194593	hybrid, Green Published			2022-12-25	WOS:000300638000033
J	Grimaldi, S; Arias-Cartin, R; Lanciano, P; Lyubenova, S; Szenes, R; Endeward, B; Prisner, TF; Guigliarelli, B; Magalon, A				Grimaldi, Stephane; Arias-Cartin, Rodrigo; Lanciano, Pascal; Lyubenova, Sevdalina; Szenes, Rodolphe; Endeward, Burkhard; Prisner, Thomas F.; Guigliarelli, Bruno; Magalon, Axel			Determination of the Proton Environment of High Stability Menasemiquinone Intermediate in Escherichia coli Nitrate Reductase A by Pulsed EPR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR DOUBLE-RESONANCE; ELECTRON-PARAMAGNETIC-RESONANCE; BACTERIAL REACTION CENTERS; PROTEIN-COFACTOR INTERACTIONS; DENSITY-FUNCTIONAL THEORY; PHOTOSYSTEM-I; ANION-RADICALS; QUINOL OXIDASE; BINDING-SITE; RHODOPSEUDOMONAS-SPHAEROIDES	Escherichia coli nitrate reductase A (NarGHI) is a membrane-bound enzyme that couples quinol oxidation at a periplasmically oriented Q-site (Q(D)) to proton release into the periplasm during anaerobic respiration. To elucidate the molecular mechanism underlying such a coupling, endogenous menasemiquinone- 8 intermediates stabilized at the Q(D) site (MSQ(D)) of NarGHI have been studied by high-resolution pulsed EPR methods in combination with (H2O)-H-1/(H2O)-H-2 exchange experiments. One of the two non-exchangeable proton hyperfine couplings resolved in hyperfine sublevel correlation (HYSCORE) spectra of the radical displays characteristics typical from quinone methyl protons. However, its unusually small isotropic value reflects a singularly low spin density on the quinone carbon alpha carrying the methyl group, which is ascribed to a strong asymmetry of the MSQ(D) binding mode and consistent with singlesided hydrogen bonding to the quinone oxygen O1. Furthermore, a single exchangeable proton hyperfine coupling is resolved, both by comparing the HYSCORE spectra of the radical in (H2O)-H-1 and (H2O)-H-2 samples and by selective detection of the exchanged deuterons using Q-band H-2 Mims electron nuclear double resonance (ENDOR) spectroscopy. Spectral analysis reveals its peculiar characteristics, i. e. a large anisotropic hyper-fine coupling together with an almost zero isotropic contribution. It is assigned to a proton involved in a short similar to 1.6 angstrom inplane hydrogen bond between the quinone O1 oxygen and the N delta of the His-66 residue, an axial ligand of the distal heme b(D). Structural and mechanistic implications of these results for the electron-coupled proton translocation mechanism at the Q(D) site are discussed, in light of the unusually high thermodynamic stability of MSQ(D).	[Grimaldi, Stephane; Lanciano, Pascal; Szenes, Rodolphe; Guigliarelli, Bruno] CNRS, Unite Bioenerget & Ingn Prot, UPR9036, Inst Microbiol Mediterranee, F-13009 Marseille, France; [Arias-Cartin, Rodrigo; Magalon, Axel] CNRS, Inst Microbiol Mediterranee, Chim Bacterienne Lab, UPR9043, F-13009 Marseille, France; [Arias-Cartin, Rodrigo; Magalon, Axel] Aix Marseille Univ, F-13009 Marseille, France; [Lyubenova, Sevdalina; Endeward, Burkhard; Prisner, Thomas F.] Goethe Univ Frankfurt, Inst Phys & Theoret Chem, D-60438 Frankfurt, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Goethe University Frankfurt	Grimaldi, S (corresponding author), CNRS, Unite Bioenerget & Ingn Prot BIP, Inst Microbiol Mediterranee, UPR9036, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	grimaldi@ifr88.cnrs-mrs.fr	Grimaldi, Stephane/G-9884-2013; Grimaldi, Stephane/AAF-7138-2020	Grimaldi, Stephane/0000-0002-9559-6112; Magalon, Axel/0000-0002-3375-738X; Prisner, Thomas F./0000-0003-2850-9573; Arias-Cartin, Rodrigo/0000-0001-5008-6437	CNRS; Agence Nationale de la Recherche,; Aix-Marseille Universite; European Community (EU-NMR) [RII3-026145]; European Cooperation in Science and Technology Action [COST P15]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche,(French National Research Agency (ANR)); Aix-Marseille Universite; European Community (EU-NMR)(European Commission); European Cooperation in Science and Technology Action	This work was supported by the CNRS, the Agence Nationale de la Recherche, and Aix-Marseille Universite. This work was also supported by Research Infrastructures Activity in the 6th Framework Program of the European Community (Contract RII3-026145, EU-NMR) for financial support (to S. G.), as well as the European Cooperation in Science and Technology Action (COST P15) "Advanced Paramagnetic Resonance Methods in Molecular Biophysics" for Short-Term Scientific Mission funding (to S. G.).	Arias-Cartin R, 2011, P NATL ACAD SCI USA, V108, P7781, DOI 10.1073/pnas.1010427108; Arias-Cartin R, 2010, J AM CHEM SOC, V132, P5942, DOI 10.1021/ja1009234; Bertero MG, 2005, J BIOL CHEM, V280, P14836, DOI 10.1074/jbc.M410457200; Bertero MG, 2003, NAT STRUCT BIOL, V10, P681, DOI 10.1038/nsb969; Blasco F, 2001, CELL MOL LIFE SCI, V58, P179, DOI 10.1007/PL00000846; Chatterjee R, 2011, BIOCHEMISTRY-US, V50, P491, DOI 10.1021/bi101883y; DAS MR, 1970, J AM CHEM SOC, V92, P2258, DOI 10.1021/ja00711a011; DIKANOV SA, 1995, J MAGN RESON SER A, V116, P125, DOI 10.1006/jmra.1995.1199; Dikanov SA, 2004, J BIOL CHEM, V279, P15814, DOI 10.1074/jbc.M313417200; Epel B, 2006, J PHYS CHEM B, V110, P11549, DOI 10.1021/jp060548d; Feher G., 1985, ANTENNAS REACTION CT, V42, P174; Flores M, 2007, BIOPHYS J, V92, P671, DOI 10.1529/biophysj.106.092460; Flores M, 2003, CHEM PHYS, V294, P401, DOI 10.1016/S0301-0104(03)00321-5; Fritscher J, 2004, PHYS CHEM CHEM PHYS, V6, P4950, DOI 10.1039/b408764j; Gardiner AT, 1999, BIOCHEMISTRY-US, V38, P11773, DOI 10.1021/bi990661c; Grimaldi S, 2005, BIOCHEMISTRY-US, V44, P1300, DOI 10.1021/bi048009r; Grimaldi S, 2003, BIOCHEMISTRY-US, V42, P5632, DOI 10.1021/bi034010z; Grimaldi S, 2010, J BIOL CHEM, V285, P179, DOI 10.1074/jbc.M109.060251; Guigliarelli B, 1996, BIOCHEMISTRY-US, V35, P4828, DOI 10.1021/bi952459p; Hastings SF, 2000, EUR J BIOCHEM, V267, P5638, DOI 10.1046/j.1432-1327.2000.01643.x; HUNT MJ, 1974, J MAGN RESON, V15, P402, DOI 10.1016/0022-2364(74)90143-7; Kacprzak S, 2006, J AM CHEM SOC, V128, P5659, DOI 10.1021/ja053988b; Kevan L., 1976, ELECT SPIN DOUBLE RE; Lanciano P, 2007, J PHYS CHEM B, V111, P13632, DOI 10.1021/jp075243t; Lanciano P, 2007, BIOCHEMISTRY-US, V46, P5323, DOI 10.1021/bi700074y; LUBITZ W, 1985, BIOCHIM BIOPHYS ACTA, V808, P464, DOI 10.1016/0005-2728(85)90155-0; Lubitz W, 1999, APPL MAGN RESON, V17, P1, DOI 10.1007/BF03162067; MacMillan F, 1995, MAGN RESON CHEM, V33, pS81, DOI 10.1002/mrc.1260331314; MacMillan F, 2011, FARADAY DISCUSS, V148, P315, DOI 10.1039/c005149g; Martin E, 2011, J AM CHEM SOC, V133, P5525, DOI 10.1021/ja2001538; MCCONNELL HM, 1956, J CHEM PHYS, V24, P764, DOI 10.1063/1.1742605; MIMS WB, 1965, PROC R SOC LON SER-A, V283, P452, DOI 10.1098/rspa.1965.0034; Nicholls D., 2002, BIOENERGETICS; Niklas J, 2009, J PHYS CHEM B, V113, P10367, DOI 10.1021/jp901890z; O'Malley PJ, 1999, BBA-BIOENERGETICS, V1411, P101, DOI 10.1016/S0005-2728(99)00036-5; O'Malley PJ, 1998, CHEM PHYS LETT, V291, P367, DOI 10.1016/S0009-2614(98)00571-5; OMALLEY PJ, 1986, J AM CHEM SOC, V108, P3995, DOI 10.1021/ja00274a024; Potter LC, 1999, BIOCHEM J, V344, P77, DOI 10.1042/0264-6021:3440077; REIJERSE EJ, 1991, J CHEM PHYS, V95, P836, DOI 10.1063/1.461091; Rigby SEJ, 1996, BIOCHEMISTRY-US, V35, P6651, DOI 10.1021/bi952619x; Rigby SEJ, 2001, BBA-BIOENERGETICS, V1507, P247, DOI 10.1016/S0005-2728(01)00211-0; ROBERTSON DE, 1984, J BIOL CHEM, V259, P1758; Rothery RA, 2001, J MOL MICROB BIOTECH, V3, P273; RUTHERFORD AW, 1980, FEBS LETT, V110, P257, DOI 10.1016/0014-5793(80)80086-X; Schweiger A., 2001, PRINCIPLES PULSE ELE; Sinnecker S, 2004, J AM CHEM SOC, V126, P3280, DOI 10.1021/ja0392014; Sinnecker S, 2006, PHYS CHEM CHEM PHYS, V8, P5659, DOI 10.1039/b612568a; SODA G, 1969, J CHEM PHYS, V50, P439, DOI 10.1063/1.1670818; Srinivasan N, 2011, BIOCHEMISTRY-US, V50, P3495, DOI 10.1021/bi102056q; Srinivasan N, 2009, BBA-BIOENERGETICS, V1787, P1057, DOI 10.1016/j.bbabio.2009.04.010; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Stowell MHB, 1997, SCIENCE, V276, P812, DOI 10.1126/science.276.5313.812; Teutloff C, 2004, APPL MAGN RESON, V26, P5, DOI 10.1007/BF03166559; Yap LL, 2006, J BIOL CHEM, V281, P16879, DOI 10.1074/jbc.M602544200; Yi SM, 2010, J BIOL CHEM, V285, P18241, DOI 10.1074/jbc.M110.116186; Zheng M, 1996, BIOCHEMISTRY-US, V35, P8955, DOI 10.1021/bi9522209	56	17	17	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4662	4670		10.1074/jbc.M111.325100	http://dx.doi.org/10.1074/jbc.M111.325100			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22190684	Green Published, hybrid			2022-12-25	WOS:000300608500028
J	Gupta, A; Dong, A; Lowe, AW				Gupta, Aparna; Dong, Aiwen; Lowe, Anson W.			AGR2 Gene Function Requires a Unique Endoplasmic Reticulum Localization Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUMINAL ER PROTEINS; CANCER CELL-LINES; ESTROGEN-RECEPTOR; LIMB REGENERATION; XENOPUS-LAEVIS; HUMAN HOMOLOG; LUNG-CANCER; YEAST-CELLS; DIFFERENTIATION; EXPRESSION	Soluble proteins are enriched in the endoplasmic reticulum (ER) by retrograde transport from the Golgi that is mediated by the KDEL receptors. In addition to the classic carboxyl-terminal KDEL motif, a variety of sequence variants are also capable of receptor binding that result in ER localization. Although different ER localization signals that exhibit varying affinities for the KDEL receptors exist, whether there are functional implications was unknown. The present study determines whether AGR2 requires a specific ER localization signal to be functionally active. AGR2 is expressed in most human adenocarcinomas and serves a role in promoting growth and the transformed phenotype. Using two different cell lines in which AGR2 induces expression of either the EGFR ligand amphiregulin or the transcription factor CDX2, only the highly conserved wild-type carboxyl-terminal KTEL motif results in the appropriate outcome. Deletion of the KTEL motif results in AGR2 secretion and loss of AGR2 function. AGR2 function is also lost when ER residence is achieved with a carboxyl-terminal KDEL or KSEL instead of a KTEL motif. Thus variations in ER localization sequences may serve a specific functional role, and in the case of AGR2, this role is served specifically by KTEL.	[Gupta, Aparna; Dong, Aiwen; Lowe, Anson W.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Gupta, Aparna; Dong, Aiwen; Lowe, Anson W.] Stanford Univ, Stanford Digest Dis Ctr, Stanford, CA 94305 USA	Stanford University; Stanford University	Lowe, AW (corresponding author), Stanford Univ, Dept Med, Alway Bldg,Rm M211,300 Pasteur Dr, Stanford, CA 94305 USA.	lowe@stanford.edu	Dong, Aiwen/B-1258-2013	Dong, Aiwen/0000-0003-4931-3633	National Institutes of Health [DK063624, DK56339]; Stanford Cancer Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063624, P30DK056339] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Cancer Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK063624 (to A. W. L.) and DK56339 (to the Stanford University Digestive Disease Center). This work was also supported by the Stanford Cancer Center.	Aberger F, 1998, MECH DEVELOP, V72, P115, DOI 10.1016/S0925-4773(98)00021-5; Alanen HI, 2011, J MOL BIOL, V409, P291, DOI 10.1016/j.jmb.2011.03.070; Capitani M, 2009, FEBS LETT, V583, P3863, DOI 10.1016/j.febslet.2009.10.053; DEAN N, 1990, J CELL BIOL, V111, P369, DOI 10.1083/jcb.111.2.369; Dong AW, 2011, J BIOL CHEM, V286, P18301, DOI 10.1074/jbc.M110.215707; Edgell TA, 2010, CLIN SCI, V118, P717, DOI 10.1042/CS20090537; Escaffit F, 2006, BIOCHEM BIOPH RES CO, V342, P66, DOI 10.1016/j.bbrc.2006.01.128; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Fletcher GC, 2003, BRIT J CANCER, V88, P579, DOI 10.1038/sj.bjc.6600740; Fritzsche FR, 2007, HISTOL HISTOPATHOL, V22, P703, DOI 10.14670/HH-22.703; Hao Y, 2006, GASTROENTEROLOGY, V131, P925, DOI 10.1053/j.gastro.2006.04.026; HARDWICK KG, 1992, EMBO J, V11, P4187, DOI 10.1002/j.1460-2075.1992.tb05512.x; Kumar A, 2007, SCIENCE, V318, P772, DOI 10.1126/science.1147710; Kumar A, 2011, P NATL ACAD SCI USA, V108, P13588, DOI 10.1073/pnas.1108472108; LEWIS MJ, 1990, CELL, V61, P1359, DOI 10.1016/0092-8674(90)90699-F; Li CH, 1998, PATTERN RECOGN LETT, V19, P771, DOI 10.1016/S0167-8655(98)00057-9; Liu D, 2005, CANCER RES, V65, P3796, DOI 10.1158/0008-5472.CAN-04-3823; Lowe AW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000323; Miller JP, 2005, P NATL ACAD SCI USA, V102, P12123, DOI 10.1073/pnas.0505482102; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Park SW, 2009, P NATL ACAD SCI USA, V106, P6950, DOI 10.1073/pnas.0808722106; PELHAM HRB, 1990, TRENDS BIOCHEM SCI, V15, P483, DOI 10.1016/0968-0004(90)90303-S; QUARONI A, 1979, J CELL BIOL, V80, P248, DOI 10.1083/jcb.80.2.248; Ramachandran V, 2008, CANCER RES, V68, P7811, DOI 10.1158/0008-5472.CAN-08-1320; Raykhel I, 2007, J CELL BIOL, V179, P1193, DOI 10.1083/jcb.200705180; Ruan J, 2008, NUCLEIC ACIDS RES, V36, pD735, DOI 10.1093/nar/gkm1005; SEMENZA JC, 1990, CELL, V61, P1349, DOI 10.1016/0092-8674(90)90698-E; SIVE HL, 1989, CELL, V58, P171, DOI 10.1016/0092-8674(89)90413-3; Snapp EL, 2006, P NATL ACAD SCI USA, V103, P6536, DOI 10.1073/pnas.0510657103; Soubeyran P, 1999, GASTROENTEROLOGY, V117, P1326, DOI 10.1016/S0016-5085(99)70283-0; Suh E, 1996, MOL CELL BIOL, V16, P619; Thompson DA, 1998, BIOCHEM BIOPH RES CO, V251, P111, DOI 10.1006/bbrc.1998.9440; TOWNSLEY FM, 1994, J CELL BIOL, V127, P21, DOI 10.1083/jcb.127.1.21; Wang Z, 2008, CANCER RES, V68, P492, DOI 10.1158/0008-5472.CAN-07-2930; WILSON DW, 1993, J BIOL CHEM, V268, P7465; Yamamoto K, 2003, J BIOL CHEM, V278, P34525, DOI 10.1074/jbc.M304188200; Yoshida S, 2002, DIABETES, V51, P2505, DOI 10.2337/diabetes.51.8.2505; Zhang JS, 2005, GENE CHROMOSOME CANC, V43, P249, DOI 10.1002/gcc.20188; Zhao F, 2010, DEV BIOL, V338, P268, DOI 10.1016/j.ydbio.2009.12.008; Zhu H, 2007, CANCER LETT, V245, P303, DOI 10.1016/j.canlet.2006.01.020	40	35	38	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4773	4782		10.1074/jbc.M111.301531	http://dx.doi.org/10.1074/jbc.M111.301531			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22184114	Green Published, hybrid			2022-12-25	WOS:000300608500038
J	Kim, PY; Tieu, LD; Stafford, AR; Fredenburgh, JC; Weitz, JI				Kim, Paul Y.; Tieu, Long D.; Stafford, Alan R.; Fredenburgh, James C.; Weitz, Jeffrey I.			A High Affinity Interaction of Plasminogen with Fibrin Is Not Essential for Efficient Activation by Tissue-type Plasminogen Activator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYS-PLASMINOGEN; LIGAND-BINDING; INTACT FIBRIN; IN-VITRO; DOMAIN; DERIVATIVES; INHIBITION; THROMBIN; KINETICS; H-1-NMR	Fibrin (Fn) enhances plasminogen (Pg) activation by tissue-type plasminogen activator(tPA) by serving as a template onto which Pg and tPA assemble. To explore the contribution of the Pg/Fn interaction to Fn cofactor activity, Pg variants were generated and their affinities for Fn were determined using surface plasmon resonance (SPR). Glu-Pg, Lys-Pg (des(1-77)), and Mini-Pg (lacking kringles 1-4) bound Fn with K-d values of 3.1, 0.21, and 24.5 mu M, respectively, whereas Micro-Pg (lacking all kringles) did not bind. The kinetics of activation of the Pg variants by tPA were then examined in the absence or presence of Fn. Whereas Fn had no effect on Micro-Pg activation, the catalytic efficiencies of Glu-Pg, Lys-Pg, and Mini-Pg activation in the presence of Fn were 300- to 600-fold higher than in its absence. The retention of Fn cofactor activity with Mini-Pg, which has low affinity for Fn, suggests that Mini-Pg binds the tPA-Fn complex more tightly than tPA alone. To explore this possibility, SPR was used to examine the interaction of Mini-Pg with Fn in the absence or presence of tPA. There was 50% more Mini-Pg binding to Fn in the presence of tPA than in its absence, suggesting that formation of the tPA-Fn complex exposes a cryptic site that binds Mini-Pg. Thus, our data (a) indicate that high affinity binding of Pg to Fn is not essential for Fn cofactor activity, and (b) suggest that kringle 5 localizes and stabilizes Pg within the tPA-Fn complex and contributes to its efficient activation.	[Kim, Paul Y.; Tieu, Long D.; Stafford, Alan R.; Fredenburgh, James C.; Weitz, Jeffrey I.] McMaster Univ, Dept Med, Hamilton, ON L8L 2X2, Canada; [Kim, Paul Y.; Tieu, Long D.; Stafford, Alan R.; Fredenburgh, James C.; Weitz, Jeffrey I.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8L 2X2, Canada; [Kim, Paul Y.; Tieu, Long D.; Stafford, Alan R.; Fredenburgh, James C.; Weitz, Jeffrey I.] Thrombosis & Atherosclerosis Res Inst, Hamilton, ON L8L 2X2, Canada	McMaster University; McMaster University; McMaster University	Weitz, JI (corresponding author), 237 Barton St E, Hamilton, ON L8L 2X2, Canada.	weitzj@taari.ca	Weitz, Jeffrey/AAD-1929-2019; Kim, Paul/GYV-3258-2022	Weitz, Jeffrey/0000-0002-1092-7550; Kim, Paul/0000-0003-0943-4924	Canadian Institutes of Health Research [MOP3992, MOP102735, CTP 79846]; Heart and Stroke Foundation of Ontario; Ontario Research and Development Challenge Fund; Heart and Stroke Foundation of Canada; AstraZeneca Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Ontario Research and Development Challenge Fund(General Electric); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); AstraZeneca Canada(AstraZeneca)	The work was supported in part by Canadian Institutes of Health Research Grants MOP3992, MOP102735, and CTP 79846, the Heart and Stroke Foundation of Ontario, and the Ontario Research and Development Challenge Fund.; Recipient of a Research Fellowship Award from the Heart and Stroke Foundation of Canada and AstraZeneca Canada.	Bachmann F., 2001, HEMOSTASIS THROMBOSI; Bachmann F., 1994, HEMOSTASIS THROMBOSI; CASTELLINO FJ, 1981, METHOD ENZYMOL, V80, P365; CASTELLINO FJ, 1981, J BIOL CHEM, V256, P4778; COLLEN D, 1991, BLOOD, V78, P3114; Dobrovolsky AB, 2002, BIOCHEMISTRY-MOSCOW+, V67, P99, DOI 10.1023/A:1013960416302; Fredenburgh JC, 2008, J BIOL CHEM, V283, P2470, DOI 10.1074/jbc.M707710200; FREDENBURGH JC, 1992, J BIOL CHEM, V267, P26150; Horrevoets AJG, 1997, J BIOL CHEM, V272, P2183; HORREVOETS AJG, 1995, J BIOL CHEM, V270, P15770, DOI 10.1074/jbc.270.26.15770; HOYLAERTS M, 1982, J BIOL CHEM, V257, P2912; Komorowicz E, 1998, BIOCHEMISTRY-US, V37, P9112, DOI 10.1021/bi980180d; Lamba D, 1996, J MOL BIOL, V258, P117, DOI 10.1006/jmbi.1996.0238; Lijnen H. R., 1995, HEMATOLOGY BASIC PRI; LIJNEN HR, 1994, J INTERN MED, V236, P415, DOI 10.1111/j.1365-2796.1994.tb00819.x; Lijnen HR, 2001, ANN NY ACAD SCI, V936, P226; Lin X, 2006, INT J MOL MED, V17, P833; LUCAS MA, 1983, J BIOL CHEM, V258, P4249; MOTTA A, 1987, BIOCHEMISTRY-US, V26, P3827, DOI 10.1021/bi00387a014; NESHEIM M, 1990, J BIOL CHEM, V265, P21541; PETROS AM, 1989, BIOCHEMISTRY-US, V28, P1368, DOI 10.1021/bi00429a064; Renatus M, 1997, J BIOL CHEM, V272, P21713, DOI 10.1074/jbc.272.35.21713; Schneider M, 2004, J BIOL CHEM, V279, P13333, DOI 10.1074/jbc.M313164200; Senis YA, 2006, BBA-PROTEINS PROTEOM, V1764, P863, DOI 10.1016/j.bbapap.2006.03.004; SHI GY, 1988, J BIOL CHEM, V263, P17071; Sottrup-Jensen L., 1978, PROGR CHEM FIBRINOLY; Stewart RJ, 1998, J BIOL CHEM, V273, P18292, DOI 10.1074/jbc.273.29.18292; STRAUGHN W, 1966, THROMB DIATH HAEMOST, V16, P198, DOI 10.1055/s-0038-1655637; SUENSON E, 1988, BIOCHEMISTRY-US, V27, P2435, DOI 10.1021/bi00407a029; THEWES T, 1990, J BIOL CHEM, V265, P3906; Vu TT, 2011, J BIOL CHEM, V286, P30314, DOI 10.1074/jbc.M111.253831; Walker JB, 1999, J BIOL CHEM, V274, P5201, DOI 10.1074/jbc.274.8.5201; WU HL, 1990, J BIOL CHEM, V265, P19658	33	26	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4652	4661		10.1074/jbc.M111.317719	http://dx.doi.org/10.1074/jbc.M111.317719			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22187433	Green Published, hybrid			2022-12-25	WOS:000300608500027
J	Negoro, S; Shibata, N; Tanaka, Y; Yasuhira, K; Shibata, H; Hashimoto, H; Lee, YH; Oshima, S; Santa, R; Oshima, S; Mochiji, K; Goto, Y; Ikegami, T; Nagai, K; Kato, D; Takeo, M; Higuchi, Y				Negoro, Seiji; Shibata, Naoki; Tanaka, Yusuke; Yasuhira, Kengo; Shibata, Hiroshi; Hashimoto, Haruka; Lee, Young-Ho; Oshima, Shohei; Santa, Ryuji; Oshima, Shohei; Mochiji, Kozo; Goto, Yuji; Ikegami, Takahisa; Nagai, Keisuke; Kato, Dai-ichiro; Takeo, Masahiro; Higuchi, Yoshiki			Three-dimensional Structure of Nylon Hydrolase and Mechanism of Nylon-6 Hydrolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-GLUTAMYL-TRANSPEPTIDASE; RAY CRYSTALLOGRAPHIC ANALYSIS; OLIGOMER DEGRADATION GENE; CRYSTAL-STRUCTURE; ORNITHINE ACETYLTRANSFERASE; 6-AMINOHEXANOATE-DIMER HYDROLASE; CATALYTIC MECHANISM; PRECURSOR PROTEIN; ESCHERICHIA-COLI; PLASMID POAD2	We performed x-ray crystallographic analyses of the 6-aminohexanoate oligomer hydrolase (NylC) from Agromyces sp. at 2.0 angstrom-resolution. This enzyme is a member of the N-terminal nucleophile hydrolase superfamily that is responsible for the degradation of the nylon-6 industry byproduct. We observed four identical heterodimers (27 kDa + 9 kDa), which resulted from the autoprocessing of the precursor protein (36 kDa) and which constitute the doughnut-shaped quaternary structure. The catalytic residue of NylC was identified as the N-terminal Thr-267 of the 9-kDa subunit. Furthermore, each heterodimer is folded into a single domain, generating a stacked alpha beta beta alpha core structure. Amino acid mutations at subunit interfaces of the tetramer were observed to drastically alter the thermostability of the protein. In particular, four mutations (D122G/H130Y/D36A/E263Q) of wild-type NylC from Arthrobacter sp. (plasmid pOAD2-encoding enzyme), with a heat denaturation temperature of T-m = 52 degrees C, enhanced the protein thermostability by 36 degrees C (T-m = 88 degrees C), whereas a single mutation (G111S or L137A) decreased the stability by similar to 10 degrees C. We examined the enzymatic hydrolysis of nylon-6 by the thermostable NylC mutant. Argon cluster secondary ion mass spectrometry analyses of the reaction products revealed that the major peak of nylon-6 (m/z 10,000-25,000) shifted to a smaller range, producing a new peak corresponding to m/z 1500-3000 after the enzyme treatment at 60 degrees C. In addition, smaller fragments in the soluble fraction were successively hydrolyzed to dimers and monomers. Based on these data, we propose that NylC should be designated as nylon hydrolase (or nylonase). Three potential uses of NylC for industrial and environmental applications are also discussed.	[Negoro, Seiji; Tanaka, Yusuke; Yasuhira, Kengo; Shibata, Hiroshi; Hashimoto, Haruka; Santa, Ryuji; Oshima, Shohei; Nagai, Keisuke; Kato, Dai-ichiro; Takeo, Masahiro] Univ Hyogo, Dept Mat Sci & Chem, Grad Sch Engn, Himeji, Hyogo 6712280, Japan; [Shibata, Naoki; Higuchi, Yoshiki] Univ Hyogo, Dept Life Sci, Grad Sch Life Sci, Kamigori, Hyogo 6781297, Japan; [Shibata, Naoki; Higuchi, Yoshiki] RIKEN Harima Inst, SPring Ctr 8, Mikazuki, Hyogo 6795148, Japan; [Lee, Young-Ho; Goto, Yuji; Ikegami, Takahisa] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Oshima, Shohei; Mochiji, Kozo] Univ Hyogo, Dept Intelligence Mech Technol, Grad Sch Engn, Himeji, Hyogo 6712280, Japan	University of Hyogo; University of Hyogo; RIKEN; Osaka University; University of Hyogo	Negoro, S (corresponding author), Univ Hyogo, Dept Mat Sci & Chem, Grad Sch Engn, 2167 Shosha, Himeji, Hyogo 6712280, Japan.	negoro@eng.u-hyogo.ac.jp; hig@sci.u-hyogo.ac.jp	Ikegami, Takahisa/I-9626-2017; Shibata, Naoki/AFK-9971-2022; Takeo, Masahiro/GYA-3639-2022	Ikegami, Takahisa/0000-0002-1429-1844; Shibata, Naoki/0000-0002-5096-1104; Higuchi, Yoshiki/0000-0001-8284-5709	Japan Society for Promotion of Science; Global Center of Excellence Program; Japan Aerospace Exploration Agency	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global Center of Excellence Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Aerospace Exploration Agency	This work was supported in part by a grant-in-aid for scientific research (Japan Society for Promotion of Science) and grants from the Global Center of Excellence Program and the Japan Aerospace Exploration Agency project.	Bompard-Gilles C, 2000, STRUCTURE, V8, P153, DOI 10.1016/S0969-2126(00)00091-5; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheng H, 2005, PROTEIN SCI, V14, P1902, DOI 10.1110/ps.051364905; Dasgupta S, 1996, J AM CHEM SOC, V118, P12291, DOI 10.1021/ja944125d; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Elkins JM, 2005, BIOCHEM J, V385, P565, DOI 10.1042/BJ20040814; Fanuel L, 1999, BIOCHEM J, V341, P147, DOI 10.1042/0264-6021:3410147; Geueke B, 2006, FEBS J, V273, P5261, DOI 10.1111/j.1742-4658.2006.05519.x; Guan C, 1998, J BIOL CHEM, V273, P9695, DOI 10.1074/jbc.273.16.9695; Guo HC, 1998, J BIOL CHEM, V273, P20205, DOI 10.1074/jbc.273.32.20205; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; KAKUDO S, 1995, J FERMENT BIOENG, V80, P12, DOI 10.1016/0922-338X(95)98169-L; KAKUDO S, 1993, APPL ENVIRON MICROB, V59, P3978, DOI 10.1128/AEM.59.11.3978-3980.1993; KATO K, 1995, MICROBIOL-UK, V141, P2585, DOI 10.1099/13500872-141-10-2585; Kawashima Y, 2009, FEBS J, V276, P2547, DOI 10.1111/j.1742-4658.2009.06978.x; Kim Y, 2000, STRUCTURE, V8, P1059, DOI 10.1016/S0969-2126(00)00505-0; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Marc F, 2001, J BIOL CHEM, V276, P25404, DOI 10.1074/jbc.M100392200; McRee D.E., 1999, PRACTICAL PROTEIN CR, V2nd ed., P91; Michalska K, 2005, J BIOL CHEM, V280, P28484, DOI 10.1074/jbc.M504501200; Michalska K, 2008, J BIOL CHEM, V283, P13388, DOI 10.1074/jbc.M800746200; Mochiji K, 2009, RAPID COMMUN MASS SP, V23, P648, DOI 10.1002/rcm.3922; Moritani K, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.046001; NEGORO S, 1992, J BACTERIOL, V174, P7948, DOI 10.1128/JB.174.24.7948-7953.1992; Negoro S, 2000, APPL MICROBIOL BIOT, V54, P461, DOI 10.1007/s002530000434; Negoro S, 2005, J BIOL CHEM, V280, P39644, DOI 10.1074/jbc.M505946200; Negoro S, 2007, J MOL BIOL, V370, P142, DOI 10.1016/j.jmb.2007.04.043; Ohki T, 2006, FEBS LETT, V580, P5054, DOI 10.1016/j.febslet.2006.08.031; Ohki T, 2009, PROTEIN SCI, V18, P1662, DOI 10.1002/pro.185; Oinonen C, 2000, PROTEIN SCI, V9, P2329, DOI 10.1110/ps.9.12.2329; OKADA H, 1983, NATURE, V306, P203, DOI 10.1038/306203a0; Okada T, 2006, P NATL ACAD SCI USA, V103, P6471, DOI 10.1073/pnas.0511020103; Okada T, 2007, J BIOL CHEM, V282, P2433, DOI 10.1074/jbc.M607490200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Saarela J, 2004, BIOCHEM J, V378, P363, DOI 10.1042/BJ20031496; Sambrook J, 2001, MOL CLONING LAB MANU; Sankaranarayanan R, 2010, J MOL BIOL, V397, P979, DOI 10.1016/j.jmb.2010.02.018; Schmidtke G, 1996, EMBO J, V15, P6887, DOI 10.1002/j.1460-2075.1996.tb01081.x; Tikkanen R, 1996, EMBO J, V15, P2954, DOI 10.1002/j.1460-2075.1996.tb00658.x; Weeks CM, 2002, Z KRISTALLOGR, V217, P686, DOI 10.1524/zkri.217.12.686.20659; Yasuhira K, 2007, J BIOSCI BIOENG, V104, P521, DOI 10.1263/jbb.104.521; Yasuhira K, 2007, APPL ENVIRON MICROB, V73, P7099, DOI 10.1128/AEM.00777-07; Yasuhira K, 2011, ACTA CRYSTALLOGR F, V67, P892, DOI 10.1107/S1744309111022858; Yasuhira K, 2010, J BIOL CHEM, V285, P1239, DOI 10.1074/jbc.M109.041285	44	23	25	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					5079	5090		10.1074/jbc.M111.321992	http://dx.doi.org/10.1074/jbc.M111.321992			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22187439	Green Published, hybrid			2022-12-25	WOS:000300608500066
J	Rai, V; Maldonado, AY; Burz, DS; Reverdatto, S; Schmidt, AM; Shekhtman, A				Rai, Vivek; Maldonado, Andres Y.; Burz, David S.; Reverdatto, Sergey; Schmidt, Ann Marie; Shekhtman, Alexander			Signal Transduction in Receptor for Advanced Glycation End Products (RAGE) SOLUTION STRUCTURE OF C-TERMINAL RAGE (ctRAGE) AND ITS BINDING TO mDia1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE RECEPTOR; PROTEIN; ACTIVATION; DOMAIN; RECOGNITION; LIGAND; RHO; CLASSIFICATION; IDENTIFICATION; INHIBITION	The receptor for advanced glycation end products (RAGE) is a multiligand cell surface macromolecule that plays a central role in the etiology of diabetes complications, inflammation, and neurodegeneration. The cytoplasmic domain of RAGE (C-terminal RAGE; ctRAGE) is critical for RAGE-dependent signal transduction. As the most membrane-proximal event, mDia1 binds to ctRAGE, and it is essential for RAGE ligand-stimulated phosphorylation of AKT and cell proliferation/migration. We show that ctRAGE contains an unusual alpha-turn that mediates the mDia1-ctRAGE interaction and is required for RAGE-dependent signaling. The results establish a novel mechanism through which an extracellular signal initiated by RAGE ligands regulates RAGE signaling in a manner requiring mDia1.	[Maldonado, Andres Y.; Burz, David S.; Reverdatto, Sergey; Shekhtman, Alexander] SUNY Albany, Dept Chem, Albany, NY 12222 USA; [Rai, Vivek; Schmidt, Ann Marie] NYU, Med Ctr, New York, NY 10016 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; New York University	Shekhtman, A (corresponding author), SUNY Albany, Dept Chem, Albany, NY 12222 USA.	ashekhta@albany.edu		Shekhtman, Alexander/0000-0003-2649-2675	National Institutes of Health [R01 GM085006-01A2]; American Diabetes Association [1-06-CD-23]; Juvenile Diabetes Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085006] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM085006-01A2. This work was also supported by American Diabetes Association Grant 1-06-CD-23 and the Juvenile Diabetes Research Foundation.	Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Alexandrov A, 2001, BIOTECHNIQUES, V30, P1194, DOI 10.2144/01306bm01; Alvarez Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007867; Anderson JS, 2008, BIOCHEMISTRY-US, V47, P6178, DOI 10.1021/bi800284y; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Barbar E, 2001, BIOCHEMISTRY-US, V40, P9734, DOI 10.1021/bi010483z; Cavanagh J., 1996, PROTEIN NMR SPECTROS, P457; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dattilo BM, 2007, BIOCHEMISTRY-US, V46, P6957, DOI 10.1021/bi7003735; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fogh Rasmus, 2002, Nature Structural Biology, V9, P416, DOI 10.1038/nsb0602-416; Fushman D, 1997, J MOL BIOL, V266, P173, DOI 10.1006/jmbi.1996.0771; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Harja E, 2008, J CLIN INVEST, V118, P183, DOI 10.1172/JCI32703; He M, 2011, EMBO REP, V12, P358, DOI 10.1038/embor.2011.28; Higashida C, 2004, SCIENCE, V303, P2007, DOI 10.1126/science.1093923; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hori O, 1996, NEPHROL DIAL TRANSPL, V11, P13; Hudson BI, 2008, FASEB J, V22, P1572, DOI 10.1096/fj.07-9909com; Hudson BI, 2008, J BIOL CHEM, V283, P34457, DOI 10.1074/jbc.M801465200; Koch M, 2010, STRUCTURE, V18, P1342, DOI 10.1016/j.str.2010.05.017; Lammers M, 2005, EMBO J, V24, P4176, DOI 10.1038/sj.emboj.7600879; Lander HM, 1997, J BIOL CHEM, V272, P17810, DOI 10.1074/jbc.272.28.17810; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Masse JE, 2005, J MAGN RESON, V174, P133, DOI 10.1016/j.jmr.2005.01.017; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Nezami AG, 2006, STRUCTURE, V14, P257, DOI 10.1016/j.str.2005.12.003; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Otomo T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012896; Pavone V, 1996, BIOPOLYMERS, V38, P705, DOI 10.1002/(SICI)1097-0282(199606)38:6<705::AID-BIP3>3.3.CO;2-O; RODER H, 1985, BIOCHEMISTRY-US, V24, P7396, DOI 10.1021/bi00346a055; Rong LL, 2004, FASEB J, V18, P1818, DOI 10.1096/fj.04-1900com; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; ROSS R, 1977, AM J PATHOL, V86, P675; Sakaguchi T, 2003, J CLIN INVEST, V111, P959, DOI 10.1172/JCI200317115; SANDERS CR, 1990, BIOPHYS J, V58, P447, DOI 10.1016/S0006-3495(90)82390-0; Schmidt AM, 1999, CIRC RES, V84, P489, DOI 10.1161/01.RES.84.5.489; Shimada A, 2004, MOL CELL, V13, P511, DOI 10.1016/S1097-2765(04)00059-0; SKELTON NJ, 1993, J MAGN RESON SER B, V102, P253, DOI 10.1006/jmrb.1993.1095; STALEY JP, 1994, PROTEIN SCI, V3, P1822, DOI 10.1002/pro.5560031021; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; TONIOLO C, 1980, CRC CR REV BIOCH MOL, V9, P1, DOI 10.3109/10409238009105471; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Wuthrich K., 1986, NMR PROTEINS NUCL AC, P6; Xie JJ, 2008, J BIOL CHEM, V283, P27255, DOI 10.1074/jbc.M801622200; Xie J, 2007, J BIOL CHEM, V282, P4218, DOI 10.1074/jbc.M608888200; Xue J, 2011, STRUCTURE, V19, P722, DOI 10.1016/j.str.2011.02.013; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; ZANOTTI G, 1992, INT J PEPT PROT RES, V40, P551; Zanotti G, 1998, J PEPT RES, V51, P460; Zong HL, 2010, J BIOL CHEM, V285, P23135, DOI 10.1074/jbc.M110.133827; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	55	81	84	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					5133	5144		10.1074/jbc.M111.277731	http://dx.doi.org/10.1074/jbc.M111.277731			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22194616	Green Published, hybrid			2022-12-25	WOS:000300608500071
J	Hartel, T; Eylert, E; Schulz, C; Petruschka, L; Gierok, P; Grubmuller, S; Lalk, M; Eisenreich, W; Hammerschmidt, S				Haertel, Tobias; Eylert, Eva; Schulz, Christian; Petruschka, Lothar; Gierok, Philipp; Grubmueller, Stephanie; Lalk, Michael; Eisenreich, Wolfgang; Hammerschmidt, Sven			Characterization of Central Carbon Metabolism of Streptococcus pneumoniae by Isotopologue Profiling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE HYDROXYMETHYL TRANSFERASE; DEPENDENT SALMONELLA-TYPHIMURIUM; NASOPHARYNGEAL COLONIZATION; DIOXIDE FIXATION; ABC TRANSPORTER; FAECALIS VAR; IRON UPTAKE; VIRULENCE; PROTEIN; ADHERENCE	The metabolism of Streptococcus pneumoniae was studied by isotopologue profiling after bacterial cultivation in chemically defined medium supplemented with [U-C-13(6)]- or [1,2-C-13(2)] glucose. GC/MS analysis of protein-derived amino acids showed lack of C-13 label in amino acids that were also essential for pneumococcal growth. Ala, Ser, Asp, and Thr displayed high C-13 enrichments, whereas Phe, Tyr, and Gly were only slightly labeled. The analysis of the labeling patterns showed formation of triose phosphate and pyruvate via the Embden-Meyerhof-Parnas pathway. The labeling patterns of Asp and Thr suggested formation of oxaloacetate exclusively via the phosphoenolpyruvate carboxylase reaction. Apparently, alpha-ketoglutarate was generated from unlabeled glutamate via the aspartate transaminase reaction. A fraction of Phe and Tyr obtained label via the chorismate route from erythrose 4-phosphate, generated via the pentose phosphate pathway, and phosphoenolpyruvate. Strikingly, the data revealed no significant flux from phosphoglycerate to Ser and Gly but showed formation of Ser via the reverse reaction, namely by hydroxymethylation of Gly. The essential Gly was acquired from the medium, and the biosynthesis pathway was confirmed in experiments using [U-C-13(2)] glycine as a tracer. The hydroxymethyl group in Ser originated from formate, which was generated by the pyruvate formate-lyase. Highly similar isotopologue profiles were observed in corresponding experiments with pneumococcal mutants deficient in PavA, CodY, and glucose-6-phosphate dehydrogenase pointing to the robustness of the core metabolic network used by these facultative pathogenic bacteria. In conclusion, this study demonstrates the dual utilization of carbohydrates and amino acids under in vitro conditions and identifies the unconventional de novo biosynthesis of serine by pneumococci.	[Haertel, Tobias; Schulz, Christian; Petruschka, Lothar; Hammerschmidt, Sven] Ernst Moritz Arndt Univ Greifswald, Dept Genet Microorganisms, Interfac Inst Genet & Funct Genom, D-17487 Greifswald, Germany; [Eylert, Eva; Grubmueller, Stephanie; Eisenreich, Wolfgang] Tech Univ Munich, Lehrstuhl Biochem, D-85747 Garching, Germany; [Gierok, Philipp; Lalk, Michael] Ernst Moritz Arndt Univ Greifswald, Inst Pharm, D-17487 Greifswald, Germany	Ernst Moritz Arndt Universitat Greifswald; Technical University of Munich; Ernst Moritz Arndt Universitat Greifswald	Hammerschmidt, S (corresponding author), Ernst Moritz Arndt Univ Greifswald, Dept Genet Microorganisms, Interfac Inst Genet & Funct Genom, Friedrich Ludwig Jahn Str 15A, D-17487 Greifswald, Germany.	sven.hammerschmidt@uni-greifswald.de	Westhoff, Philipp/AAV-1542-2020; Eisenreich, Wolfgang/A-1258-2013; Hammerschmidt, Sven/G-2598-2010; Lalk, Michael/C-1618-2010	Westhoff, Philipp/0000-0002-3494-9420; Eisenreich, Wolfgang/0000-0002-9832-8279; Hammerschmidt, Sven/0000-0002-6382-6681; Lalk, Michael/0000-0002-9230-0267	Deutsche Forschungsgemeinschaft [DFG HA 3125/3-1, EI-384/5-1, SPP1316]; European Union [EU-CP223111]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission)	This work was supported by Deutsche Forschungsgemeinschaft Grants DFG HA 3125/3-1 and EI-384/5-1 within the SPP1316 and EU FP7 CARE-PNEUMO Grant EU-CP223111 from the European Union.	Basavanna S, 2009, INFECT IMMUN, V77, P3412, DOI 10.1128/IAI.01543-08; Bergmann S, 2006, MICROBIOL-SGM, V152, P295, DOI 10.1099/mic.0.28610-0; Beste DJV, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002091; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Brinsmade SR, 2010, J BACTERIOL, V192, P6357, DOI 10.1128/JB.00937-10; Brown JS, 2002, INFECT IMMUN, V70, P4389, DOI 10.1128/IAI.70.8.4389-4398.2002; Brown JS, 2001, MOL MICROBIOL, V40, P572, DOI 10.1046/j.1365-2958.2001.02414.x; Cartwright K, 2002, EUR J PEDIATR, V161, P188, DOI 10.1007/s00431-001-0907-3; Caymaris S, 2010, MOL MICROBIOL, V78, P344, DOI 10.1111/j.1365-2958.2010.07339.x; CHEN JD, 1988, GENE, V64, P155, DOI 10.1016/0378-1119(88)90489-1; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; Claverys JP, 2000, RES MICROBIOL, V151, P457, DOI 10.1016/S0923-2508(00)00169-8; Eisenreich W, 2006, P NATL ACAD SCI USA, V103, P2040, DOI 10.1073/pnas.0507580103; Eisenreich W, 2010, NAT REV MICROBIOL, V8, P401, DOI 10.1038/nrmicro2351; Eylert E, 2008, MOL MICROBIOL, V69, P1008, DOI 10.1111/j.1365-2958.2008.06337.x; Eylert E, 2010, J BIOL CHEM, V285, P22232, DOI 10.1074/jbc.M110.128678; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; GOFF RC, 1970, J BACTERIOL, V104, P27, DOI 10.1128/JB.104.1.27-33.1970; Gutierrez ML, 2008, CHEM-EUR J, V14, P4647, DOI 10.1002/chem.200800031; Hartel T, 2011, INFECT IMMUN, V79, P44, DOI 10.1128/IAI.00855-10; Hammerschmidt S, 2006, CURR OPIN MICROBIOL, V9, P12, DOI 10.1016/j.mib.2005.11.001; Hammerschmidt S, 2007, J IMMUNOL, V178, P5848, DOI 10.4049/jimmunol.178.9.5848; HARTMAN RE, 1970, J BACTERIOL, V102, P341, DOI 10.1128/JB.102.2.341-346.1970; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.t01-1-03106.x; Hendriksen WT, 2008, INFECT IMMUN, V76, P1230, DOI 10.1128/IAI.01004-07; Hendriksen WT, 2008, J BACTERIOL, V190, P590, DOI 10.1128/JB.00917-07; Herrmann KM, 1999, ANNU REV PLANT PHYS, V50, P473, DOI 10.1146/annurev.arplant.50.1.473; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Holmes AR, 2001, MOL MICROBIOL, V41, P1395, DOI 10.1046/j.1365-2958.2001.02610.x; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Iyer R, 2005, J BACTERIOL, V187, P8340, DOI 10.1128/JB.187.24.8340-8349.2005; Jensch I, 2010, MOL MICROBIOL, V77, P22, DOI 10.1111/j.1365-2958.2010.07189.x; Kadioglu A, 2010, MOL ORAL MICROBIOL, V25, P50, DOI 10.1111/j.2041-1014.2009.00561.x; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kerr AR, 2004, INFECT IMMUN, V72, P3902, DOI 10.1128/IAI.72.7.3902-3906.2004; Kloosterman TG, 2006, J BIOL CHEM, V281, P25097, DOI 10.1074/jbc.M601661200; LACHICA VF, 1969, CAN J MICROBIOL, V15, P57, DOI 10.1139/m69-009; Lau GW, 2001, MOL MICROBIOL, V40, P555, DOI 10.1046/j.1365-2958.2001.02335.x; LEE WNP, 1991, BIOCHEM MED METAB B, V45, P298, DOI 10.1016/0885-4505(91)90034-I; Leibig M, 2011, J BACTERIOL, V193, P952, DOI 10.1128/JB.01161-10; LEONARD CG, 1970, J BACTERIOL, V104, P674, DOI 10.1128/JB.104.2.674-683.1970; Liebeke M, 2011, MOL BIOSYST, V7, P1241, DOI 10.1039/c0mb00315h; Marra A, 2002, INFECT IMMUN, V70, P1422, DOI 10.1128/IAI.70.3.1422-1433.2002; Marra A, 2002, MICROBIOL-SGM, V148, P1483, DOI 10.1099/00221287-148-5-1483; MCFARLAND WC, 1987, MICROB PATHOGENESIS, V3, P129, DOI 10.1016/0882-4010(87)90071-4; MICKELSO MN, 1964, J BACTERIOL, V88, P158, DOI 10.1128/JB.88.1.158-164.1964; Munoz-Elias EJ, 2006, CELL MICROBIOL, V8, P10, DOI 10.1111/j.1462-5822.2005.00648.x; MUSHER DM, 1992, CLIN INFECT DIS, V14, P801, DOI 10.1093/clinids/14.4.801; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; Noske N, 2009, J IMMUNOL, V183, P1952, DOI 10.4049/jimmunol.0804383; Obert C, 2006, INFECT IMMUN, V74, P4766, DOI 10.1128/IAI.00316-06; OCALLAGHAN D, 1988, INFECT IMMUN, V56, P419, DOI 10.1128/IAI.56.2.419-423.1988; Panina EM, 2003, FEMS MICROBIOL LETT, V222, P211, DOI 10.1016/S0378-1097(03)00303-3; Paulsen IT, 2000, J MOL BIOL, V301, P75, DOI 10.1006/jmbi.2000.3961; Philips BJ, 2003, INTENS CARE MED, V29, P2204, DOI 10.1007/s00134-003-1961-2; PINE L, 1979, J CLIN MICROBIOL, V9, P615; PIZER LI, 1965, J BACTERIOL, V89, P1145, DOI 10.1128/JB.89.4.1145-1150.1965; Polissi A, 1998, INFECT IMMUN, V66, P5620, DOI 10.1128/IAI.66.12.5620-5629.1998; POOLMAN B, 1993, FEMS MICROBIOL REV, V12, P125, DOI 10.1111/j.1574-6976.1993.tb00015.x; Pracht D, 2005, INFECT IMMUN, V73, P2680, DOI 10.1128/IAI.73.5.2680-2689.2005; Rennemeier C, 2007, FASEB J, V21, P3118, DOI 10.1096/fj.06-7992com; SAMPSON JS, 1994, INFECT IMMUN, V62, P319, DOI 10.1128/IAI.62.1.319-324.1994; Shafeeq S, 2011, MOL MICROBIOL, V81, P1255, DOI 10.1111/j.1365-2958.2011.07758.x; Smith AW, 2002, MOL MICROBIOL, V44, P431, DOI 10.1046/j.1365-2958.2002.02883.x; Somerville GA, 2009, MICROBIOL MOL BIOL R, V73, P233, DOI 10.1128/MMBR.00005-09; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tseng HJ, 2002, INFECT IMMUN, V70, P1635, DOI 10.1128/IAI.70.3.1635-1639.2002; Vidal L, 2005, APPL MICROBIOL BIOT, V68, P489, DOI 10.1007/s00253-005-1934-1; Yesilkaya H, 2009, INFECT IMMUN, V77, P5418, DOI 10.1128/IAI.00178-09	69	48	48	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4260	4274		10.1074/jbc.M111.304311	http://dx.doi.org/10.1074/jbc.M111.304311			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22167202	Green Published, hybrid			2022-12-25	WOS:000300410900058
J	Dwivedi, VP; Tousif, S; Bhattacharya, D; Prasad, DVR; Van Kaer, L; Das, J; Das, G				Dwivedi, Ved Prakash; Tousif, Sultan; Bhattacharya, Debapriya; Prasad, Durbaka Vijay Raghva; Luc Van Kaer; Das, Jyoti; Das, Gobardhan			Transforming Growth Factor-beta Protein Inversely Regulates in Vivo Differentiation of Interleukin-17 (IL-17)-producing CD4(+) and CD8(+) T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; SUPPRESSION; MECHANISMS; T(H)17; PLAYS	TGF-beta is a pleiotropic cytokine that predominantly exerts inhibitory functions in the immune system. Unexpectedly, the in vitro differentiation of both Th17 and Tc17 cells requires TGF-beta. However, animals that are impaired in TGF-beta signaling (TGF-beta RIIDN mice) display multiorgan autoimmune disorders. Here we show that CD4(+) T cells from TGF-beta RIIDN mice are resistant to Th17 cell differentiation and, paradoxically, that CD8(+) T cells from these animals spontaneously acquire an IL-17-producing phenotype. Neutralization of IL-17 or depletion of CD8(+) T cells dramatically inhibited inflammation in TGF-beta RIIDN mice. Therefore, the absence of TGF-beta triggers spontaneous differentiation of IL-17-producing CD8(+) T cells, suggesting that the in vivo and in vitro conditions that promote the differentiation of IL-17-producing CD8(+) T cells are distinct.	[Dwivedi, Ved Prakash; Tousif, Sultan; Bhattacharya, Debapriya; Das, Jyoti; Das, Gobardhan] Int Ctr Genet Engn & Biotechnol, Immunol Grp, New Delhi 110067, India; [Luc Van Kaer] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Das, Jyoti] Natl Inst Malaria Res, Immunol Sect, New Delhi 110077, India; [Prasad, Durbaka Vijay Raghva] Yogi Vamana Univ, Dept Microbiol, Kadapa 516003, Andhra Pradesh, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Vanderbilt University; Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Yogi Vemana University	Das, G (corresponding author), Int Ctr Genet Engn & Biotechnol, Immunol Grp, Aruna Asaf Ali Marg, New Delhi 110067, India.	dasgo@icgeb.res.in	Van Kaer, Luc/H-1033-2015	Van Kaer, Luc/0000-0001-5275-2309; Tousif, Sultan/0000-0001-6174-6541; Dwivedi, Ved Prakash/0000-0003-4321-2567	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Das J, 2009, J EXP MED, V206, P2407, DOI 10.1084/jem.20082286; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Hatton RD, 2003, SCIENCE, V302, P993, DOI 10.1126/science.1092040; Hemdan NY, 2010, AUTOIMMUN REV, V9, P785, DOI 10.1016/j.autrev.2010.07.003; Horwitz DA, 2008, TRENDS IMMUNOL, V29, P429, DOI 10.1016/j.it.2008.06.005; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kim IY, 2005, J BIOCHEM MOL BIOL, V38, P1; Kulkarni A, 1997, DIGEST DIS SCI, V42, P1142, DOI 10.1023/A:1018825301263; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Liu SJ, 2007, J LEUKOCYTE BIOL, V82, P354, DOI 10.1189/jlb.0207111; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mantel PY, 2011, METHODS MOL BIOL, V677, P303, DOI 10.1007/978-1-60761-869-0_21; Mi S, 2011, J IMMUNOL, V187, P3003, DOI 10.4049/jimmunol.1004081; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Wahl SM, 2007, CURR OPIN IMMUNOL, V19, P55, DOI 10.1016/j.coi.2006.11.008; Wilke CM, 2011, TRENDS IMMUNOL, V32, P603, DOI 10.1016/j.it.2011.08.003; Yoshimura A, 2011, CURR TOP MICROBIOL, V350, P127, DOI 10.1007/82_2010_87; Zamiri P, 2005, INVEST OPHTH VIS SCI, V46, P908, DOI 10.1167/iovs.04-0362	21	11	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					2943	2947		10.1074/jbc.C111.327627	http://dx.doi.org/10.1074/jbc.C111.327627			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22170065	Green Published, hybrid			2022-12-25	WOS:000300295100002
J	Aguer, C; Gambarotta, D; Mailloux, RJ; Moffat, C; Dent, R; McPherson, R; Harper, ME				Aguer, Celine; Gambarotta, Daniela; Mailloux, Ryan J.; Moffat, Cynthia; Dent, Robert; McPherson, Ruth; Harper, Mary-Ellen			Galactose Enhances Oxidative Metabolism and Reveals Mitochondrial Dysfunction in Human Primary Muscle Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; HUMAN SKELETAL-MUSCLE; TYPE-2 DIABETIC SUBJECTS; MYOTUBE HYPERTROPHY; GLUCOSE-TRANSPORT; GLYCOGEN-SYNTHASE; CULTURED MYOTUBES; ACRIDINE-ORANGE; HEPG2 CELLS; PHOSPHORYLATION	Background: Human primary myotubes are highly glycolytic when cultured in high glucose medium rendering it difficult to study mitochondrial dysfunction. Galactose is known to enhance mitochondrial metabolism and could be an excellent model to study mitochondrial dysfunction in human primary myotubes. The aim of the present study was to 1) characterize the effect of differentiating healthy human myoblasts in galactose on oxidative metabolism and 2) determine whether galactose can pinpoint a mitochondrial malfunction in post-diabetic myotubes. Methodology/Principal Findings: Oxygen consumption rate (OCR), lactate levels, mitochondrial content, citrate synthase and cytochrome C oxidase activities, and AMPK phosphorylation were determined in healthy myotubes differentiated in different sources/concentrations of carbohydrates: 25 mM glucose (high glucose (HG)), 5 mM glucose (low glucose (LG)) or 10 mM galactose (GAL). Effect of carbohydrates on OCR was also determined in myotubes derived from post-diabetic patients and matched obese non-diabetic subjects. OCR was significantly increased whereas anaerobic glycolysis was significantly decreased in GAL myotubes compared to LG or HG myotubes. This increased OCR in GAL myotubes occurred in conjunction with increased cytochrome C oxidase activity and expression, as well as increased AMPK phosphorylation. OCR of post-diabetic myotubes was not different than that of obese non-diabetic myotubes when differentiated in LG or HG. However, whereas GAL increased OCR in obese non-diabetic myotubes, it did not affect OCR in post-diabetic myotubes, leading to a significant difference in OCR between groups. The lack of an increase in OCR in post-diabetic myotubes differentiated in GAL was in relation with unaltered cytochrome C oxidase activity levels or AMPK phosphorylation. Conclusions/Significance: Our results indicate that differentiating human primary myoblasts in GAL enhances aerobic metabolism. Because this cell culture model elicited an abnormal response in cells from post-diabetic patients, it may be useful in further studies of the molecular mechanisms of mitochondrial dysfunction.	[Aguer, Celine; Gambarotta, Daniela; Mailloux, Ryan J.; Moffat, Cynthia; Harper, Mary-Ellen] Univ Ottawa, Dept Biochem Microbiol & Immunol, Fac Med, Ottawa, ON K1N 6N5, Canada; [Dent, Robert] Ottawa Hosp Weight Management Clin, Ottawa, ON, Canada; [McPherson, Ruth] Univ Ottawa, Inst Heart, Div Cardiol, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa Heart Institute	Aguer, C (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Fac Med, Ottawa, ON K1N 6N5, Canada.	mharper@uottawa.ca	Aguer, Celine/U-7848-2019; Aguer, Celine/K-4444-2012	Aguer, Celine/0000-0001-8828-8472; Mailloux, Ryan/0000-0003-3986-9830; Harper, Mary-Ellen/0000-0003-3864-5886	Canadian Institutes of Health Research (Institute of Nutrition, Metabolism and Diabetes)	Canadian Institutes of Health Research (Institute of Nutrition, Metabolism and Diabetes)(Canadian Institutes of Health Research (CIHR))	This research was funded by a grant from the Canadian Institutes of Health Research (Institute of Nutrition, Metabolism and Diabetes). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguer C, 2010, DIABETOLOGIA, V53, P1151, DOI 10.1007/s00125-010-1708-x; Befroy DE, 2007, DIABETES, V56, P1376, DOI 10.2337/db06-0783; BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311; Bouzakri K, 2003, DIABETES, V52, P1319, DOI 10.2337/diabetes.52.6.1319; BUSTAMANTE E, 1977, P NATL ACAD SCI USA, V74, P3735, DOI 10.1073/pnas.74.9.3735; Corpeleijn E, 2010, AM J PHYSIOL-ENDOC M, V299, pE14, DOI 10.1152/ajpendo.00187.2010; Costford SR, 2009, DIABETOLOGIA, V52, P2405, DOI 10.1007/s00125-009-1480-y; Dykens JA, 2008, TOXICOL APPL PHARM, V233, P203, DOI 10.1016/j.taap.2008.08.013; Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331; Foretz M, 1998, J BIOL CHEM, V273, P14767, DOI 10.1074/jbc.273.24.14767; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Furling D, 1999, ENDOCRINOLOGY, V140, P4244, DOI 10.1210/en.140.9.4244; Gaster M, 2005, DIABETES, V54, P648, DOI 10.2337/diabetes.54.3.648; Gaster M, 2004, DIABETES, V53, P542, DOI 10.2337/diabetes.53.3.542; Gaster M, 2002, DIABETES, V51, P921, DOI 10.2337/diabetes.51.4.921; GUPPY M, 1993, EUR J BIOCHEM, V212, P95, DOI 10.1111/j.1432-1033.1993.tb17637.x; HEIDENREICH RA, 1993, PEDIATR RES, V34, P416, DOI 10.1203/00006450-199310000-00006; IBSEN KH, 1961, CANCER RES, V21, P829; Jackson S, 2000, DIABETES, V49, P1169, DOI 10.2337/diabetes.49.7.1169; Jacquemin V, 2004, EXP CELL RES, V299, P148, DOI 10.1016/j.yexcr.2004.05.023; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kitzmann M, 2006, J CELL PHYSIOL, V208, P538, DOI 10.1002/jcp.20688; Kitzmann M, 2011, BBA-MOL BASIS DIS, V1812, P423, DOI 10.1016/j.bbadis.2010.12.007; Koistinen HA, 2003, DIABETES, V52, P1066, DOI 10.2337/diabetes.52.5.1066; MAFTAH A, 1989, BIOCHEM BIOPH RES CO, V164, P185, DOI 10.1016/0006-291X(89)91700-2; Mailloux RJ, 2010, FASEB J, V24, P2495, DOI 10.1096/fj.09-151803; Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052; Minet AD, 2011, BIOCHEM BIOPH RES CO, V409, P591, DOI 10.1016/j.bbrc.2011.04.028; Minet AD, 2010, BIOCHEM BIOPH RES CO, V402, P70, DOI 10.1016/j.bbrc.2010.09.115; Mogensen M, 2007, DIABETES, V56, P1592, DOI 10.2337/db06-0981; Nikoulina SE, 2001, J CLIN ENDOCR METAB, V86, P4307, DOI 10.1210/jc.86.9.4307; Ortenblad N, 2005, BBA-MOL BASIS DIS, V1741, P206, DOI 10.1016/j.bbadis.2005.04.001; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; PETIT JM, 1992, EUR J BIOCHEM, V209, P267, DOI 10.1111/j.1432-1033.1992.tb17285.x; PHIELIX E, 2008, DIABETES; Rana P, 2011, TOXICOL IN VITRO, V25, P580, DOI 10.1016/j.tiv.2010.11.016; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; ROBINSON BH, 1992, BIOCHEM MED METAB B, V48, P122, DOI 10.1016/0885-4505(92)90056-5; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; SESHAGIRI PB, 1991, MOL REPROD DEV, V30, P105, DOI 10.1002/mrd.1080300206; Shulga N, 2010, J CELL SCI, V123, P894, DOI 10.1242/jcs.061846; Ukropcova B, 2005, J CLIN INVEST, V115, P1934, DOI 10.1172/JCI24332; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; ZUURVELD JGEM, 1985, BIOCHIM BIOPHYS ACTA, V844, P1, DOI 10.1016/0167-4889(85)90226-5	45	147	151	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e28536	10.1371/journal.pone.0028536	http://dx.doi.org/10.1371/journal.pone.0028536			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22194845	Green Published, gold			2022-12-25	WOS:000298370400016
J	Melo, MN; Ferre, R; Feliu, L; Bardaji, E; Planas, M; Castanho, MARB				Melo, Manuel N.; Ferre, Rafael; Feliu, Lidia; Bardaji, Eduard; Planas, Marta; Castanho, Miguel A. R. B.			Prediction of Antibacterial Activity from Physicochemical Properties of Antimicrobial Peptides	PLOS ONE			English	Article							ESCHERICHIA-COLI; BACTERICIDAL ACTIVITY; CATIONIC PEPTIDES; LIPID-BILAYERS; MEMBRANE; MELITTIN; PARTITION; PERTURBATION; DEFENSINS; MECHANISM	Consensus is gathering that antimicrobial peptides that exert their antibacterial action at the membrane level must reach a local concentration threshold to become active. Studies of peptide interaction with model membranes do identify such disruptive thresholds but demonstrations of the possible correlation of these with the in vivo onset of activity have only recently been proposed. In addition, such thresholds observed in model membranes occur at local peptide concentrations close to full membrane coverage. In this work we fully develop an interaction model of antimicrobial peptides with biological membranes; by exploring the consequences of the underlying partition formalism we arrive at a relationship that provides antibacterial activity prediction from two biophysical parameters: the affinity of the peptide to the membrane and the critical bound peptide to lipid ratio. A straightforward and robust method to implement this relationship, with potential application to high-throughput screening approaches, is presented and tested. In addition, disruptive thresholds in model membranes and the onset of antibacterial peptide activity are shown to occur over the same range of locally bound peptide concentrations (10 to 100 mM), which conciliates the two types of observations.	[Melo, Manuel N.; Castanho, Miguel A. R. B.] Univ Lisbon, Inst Mol Med, P-1699 Lisbon, Portugal; [Melo, Manuel N.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands; [Ferre, Rafael; Feliu, Lidia; Bardaji, Eduard; Planas, Marta] Univ Girona, Dept Chem, Lab Innovacio Proc & Prod Sintesi Organ, Girona, Spain	Universidade de Lisboa; University of Groningen; Universitat de Girona	Melo, MN (corresponding author), Univ Lisbon, Inst Mol Med, P-1699 Lisbon, Portugal.	m.n.melo@rug.nl; macastanho@fm.ul.pt	Feliu, Lidia/H-8285-2015; Planas, Marta/E-4145-2015; BARDAJI, EDUARD/I-1211-2015	Feliu, Lidia/0000-0001-9792-6106; Planas, Marta/0000-0003-4988-4970; BARDAJI, EDUARD/0000-0001-6281-3646; Melo, Manuel Nuno/0000-0001-6567-0513; Castanho, Miguel/0000-0001-7891-7562; FCCN, Bogus/0000-0001-6282-8004; FCCN, Bogus/0000-0003-1034-3552	Fundacao para a Ciencia e a Tecnologia [SFRH/BD/24778/2005, PTDC/QUI/69937/2006]	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	Fundacao para a Ciencia e a Tecnologia (http://alfa.fct.mctes.pt/) is acknowledged for grant SFRH/BD/24778/2005 to M.N.M. and the project PTDC/QUI/69937/2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves CS, 2010, J BIOL CHEM, V285, P27536, DOI 10.1074/jbc.M110.130955; Badosa E, 2007, PEPTIDES, V28, P2276, DOI 10.1016/j.peptides.2007.09.010; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Blazyk J, 2001, J BIOL CHEM, V276, P27899, DOI 10.1074/jbc.M102865200; BLONDELLE SE, 1991, BIOCHEMISTRY-US, V30, P4671, DOI 10.1021/bi00233a006; Bray D, 2001, CELL MOVEMENTS MOL M; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Castle M, 1999, J BIOL CHEM, V274, P32555, DOI 10.1074/jbc.274.46.32555; Chiu SW, 1999, BIOPHYS J, V77, P2462, DOI 10.1016/S0006-3495(99)77082-7; Cronan JE, 2003, ANNU REV MICROBIOL, V57, P203, DOI 10.1146/annurev.micro.57.030502.090851; Ferre R, 2006, APPL ENVIRON MICROB, V72, P3302, DOI 10.1128/AEM.72.5.3302-3308.2006; Ferre R, 2009, BIOPHYS J, V96, P1815, DOI [10.1016/j.bpj.2008.11.053, 10.1016/j.bpj.2008.11053]; Friedrich CL, 2000, ANTIMICROB AGENTS CH, V44, P2086, DOI 10.1128/AAC.44.8.2086-2092.2000; Giacometti A, 1998, ANTIMICROB AGENTS CH, V42, P3320, DOI 10.1128/AAC.42.12.3320; Giacometti A, 2000, ANTIMICROB AGENTS CH, V44, P1694, DOI 10.1128/AAC.44.6.1694-1696.2000; Huang HW, 2006, BBA-BIOMEMBRANES, V1758, P1292, DOI 10.1016/j.bbamem.2006.02.001; Jawetz E., 1984, REV MED MICROBIOLOGY; KANESHIRO T, 1962, J LIPID RES, V3, P184; Leontiadou H, 2006, J AM CHEM SOC, V128, P12156, DOI 10.1021/ja062927q; Loferer-Krossbacher M, 1998, APPL ENVIRON MICROB, V64, P688; LUGTENBERG B, 1983, BIOCHIM BIOPHYS ACTA, V737, P51, DOI 10.1016/0304-4157(83)90014-X; Matos C, 2004, BIOPHYS J, V86, P946, DOI 10.1016/S0006-3495(04)74170-3; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; Melo MN, 2009, NAT REV MICROBIOL, V7, P245, DOI 10.1038/nrmicro2095; Melo MN, 2007, BBA-BIOMEMBRANES, V1768, P1277, DOI 10.1016/j.bbamem.2007.02.005; Milo R, 2010, NUCLEIC ACIDS RES, V38, pD750, DOI 10.1093/nar/gkp889; Nernst W., 1891, PHYS THEM, V8, P110; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Pistolesi S, 2007, BIOPHYS J, V93, P1651, DOI 10.1529/biophysj.107.104034; Pott T, 1998, EUR BIOPHYS J BIOPHY, V27, P237, DOI 10.1007/s002490050130; Rosen R., 1967, OPTIMALITY PRINCIPLE; Sader HS, 2004, ANTIMICROB AGENTS CH, V48, P3112, DOI 10.1128/AAC.48.8.3112-3118.2004; SESSA G, 1969, J BIOL CHEM, V244, P3575; Stella L, 2004, BIOPHYS J, V86, P936, DOI 10.1016/S0006-3495(04)74169-7; Subbalakshmi C, 1996, FEBS LETT, V395, P48, DOI 10.1016/0014-5793(96)00996-9; Sundararaj S, 2004, NUCLEIC ACIDS RES, V32, pD293, DOI 10.1093/nar/gkh108; SZOKA JF, 1980, ANNU REV BIOPHYS BIO, V9, P467; Tossi A, 2000, BIOPOLYMERS, V55, P4; Tran D, 2002, J BIOL CHEM, V277, P3079, DOI 10.1074/jbc.M109117200; van den Bogaart G, 2008, J BIOL CHEM, V283, P33854, DOI 10.1074/jbc.M805171200; WHITE SH, 1985, P NATL ACAD SCI USA, V82, P6532, DOI 10.1073/pnas.82.19.6532; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2	43	40	42	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28549	10.1371/journal.pone.0028549	http://dx.doi.org/10.1371/journal.pone.0028549			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194847	gold, Green Published, Green Submitted			2022-12-25	WOS:000298369100048
J	Ryan, RJH; Nitta, M; Borger, D; Zukerberg, LR; Ferry, JA; Harris, NL; Iafrate, AJ; Bernstein, BE; Sohani, AR; Le, LP				Ryan, Russell J. H.; Nitta, Mai; Borger, Darrell; Zukerberg, Lawrence R.; Ferry, Judith A.; Harris, Nancy Lee; Iafrate, A. John; Bernstein, Bradley E.; Sohani, Aliyah R.; Le, Long Phi			EZH2 Codon 641 Mutations are Common in BCL2-Rearranged Germinal Center B Cell Lymphomas	PLOS ONE			English	Article							FOLLICULAR LYMPHOMA; CANCER; EXPRESSION; MELANOMA; PROSTATE; FEATURES; ENHANCER; DISTINCT; PROTEIN	Mutations at codon 641 of EZH2 are recurrent in germinal center B cell lymphomas, and the most common variants lead to altered EZH2 enzymatic activity and enhanced tri-methylation of histone H3 at lysine 27, a repressive chromatin modification. As an initial step toward screening patients for cancer genotype-directed therapy, we developed a screening assay for EZH2 codon 641 mutations amenable for testing formalin-fixed clinical specimens, based on the sensitive SNaPshot single nucleotide extension technology. We detected EZH2 mutations in 12/55 (22%) follicular lymphomas (FL), 5/35 (14%) diffuse large B cell lymphomas with a germinal center immunophenotype (GCB-DLBCL), and 2/11 (18%) high grade B cell lymphomas with concurrent rearrangements of BCL2 and MYC. No EZH2 mutations were detected in cases of Burkitt lymphoma (0/23). EZH2 mutations were frequently associated with the presence of BCL2 rearrangement (BCL2-R) in both the FL (28% of BCL-R cases versus 0% of BCL2-WT cases, p<0.05) and GCB-DLBCL groups (33% of BCL2-R cases versus 4% of BCL2-WT cases, p<0.04), and across all lymphoma types excluding BL (27% of BCL2-R cases versus 3% of BCL2-WT cases, p<0.003). We confirmed gain-of-function activity for all previously reported EZH2 codon 641 mutation variants. Our findings suggest that EZH2 mutations constitute an additional genetic "hit'' in many BCL2-rearranged germinal center B cell lymphomas. Our work may be helpful in the selection of lymphoma patients for future trials of pharmacologic agents targeting EZH2 and EZH2-regulated pathways.	[Ryan, Russell J. H.; Nitta, Mai; Borger, Darrell; Zukerberg, Lawrence R.; Ferry, Judith A.; Harris, Nancy Lee; Iafrate, A. John; Bernstein, Bradley E.; Sohani, Aliyah R.; Le, Long Phi] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Ryan, Russell J. H.; Bernstein, Bradley E.] Broad Inst Massachusetts Inst Technol & Harvard U, Cambridge, MA USA; [Bernstein, Bradley E.] Howard Hughes Med Inst, Chevy Chase, MD USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute	Ryan, RJH (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.	Ryan.Russell@mgh.harvard.edu		Ryan, Russell/0000-0001-8174-3962	Department of Pathology, Massachusetts General Hospital; Howard Hughes Medical Institute	Department of Pathology, Massachusetts General Hospital; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	Funding was provided by the Austin L. Vickery, Jr. Award Program, Department of Pathology, Massachusetts General Hospital, and the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bachmann IM, 2006, J CLIN ONCOL, V24, P268, DOI 10.1200/JCO.2005.01.5180; Bodor C, 2011, LEUKEMIA, V25, P726, DOI 10.1038/leu.2010.311; Dias-Santagata D, 2010, EMBO MOL MED, V2, P146, DOI 10.1002/emmm.201000070; ERNST T, 2010, NAT GENET, P1; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; INTERESTS CF, 2011, GENOMICS, V29, P24, DOI DOI 10.1038/NBT0111-24; Kang MH, 2009, CLIN CANCER RES, V15, P1126, DOI 10.1158/1078-0432.CCR-08-0144; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Laible G, 1997, EMBO J, V16, P3219, DOI 10.1093/emboj/16.11.3219; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107; Snuderl M, 2010, AM J SURG PATHOL, V34, P327, DOI 10.1097/PAS.0b013e3181cd3aeb; Swerdlow E., 2008, WHO CLASSIFICATION T; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Wang SA, 2005, AM J SURG PATHOL, V29, P1490, DOI 10.1097/01.pas.0000172191.87176.3b; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208	25	95	102	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28585	10.1371/journal.pone.0028585	http://dx.doi.org/10.1371/journal.pone.0028585			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194861	Green Submitted, Green Published, gold			2022-12-25	WOS:000298369100058
J	Markus, MA; Marques, FZ; Morris, BJ				Markus, M. Andrea; Marques, Francine Z.; Morris, Brian J.			Resveratrol, by Modulating RNA Processing Factor Levels, Can Influence the Alternative Splicing of Pre-mRNAs	PLOS ONE			English	Article							IN-VIVO; HUMAN-DISEASE; LIFE-SPAN; PROTEIN; RESTRICTION; RELEVANCE; CANCER; SIRT1; CONNECTION; ACTIVATORS	Alternative pre-mRNA splicing defects can contribute to, or result from, various diseases, including cancer. Aberrant mRNAs, splicing factors and other RNA processing factors have therefore become targets for new therapeutic interventions. Here we report that the natural polyphenol resveratrol can modulate alternative splicing in a target-specific manner. We transfected minigenes of several alternatively spliceable primary mRNAs into HEK293 cells in the presence or absence of 1, 5, 20 and 50 mu M resveratrol and measured exon levels by semi-quantitative PCR after separation by agarose gel electrophoresis. We found that 20 mu g/ml and 50 mu g/ml of resveratrol affected exon inclusion of SRp20 and SMN2 pre-mRNAs, but not CD44v5 or tau pre-mRNAs. By Western blotting and immunofluorescence we showed that this effect may be due to the ability of resveratrol to change the protein level but not the localization of several RNA processing factors. The processing factors that increased significantly were ASF/SF2, hnRNPA1 and HuR, but resveratrol did not change the levels of RBM4, PTBP1 and U2AF35. By means of siRNA-mediated knockdown we depleted cells of SIRT1, regarded as a major target of resveratrol, and showed that the effect on splicing was not dependent on SIRT1. Our results suggest that resveratrol might be an attractive small molecule to treat diseases in which aberrant splicing has been implicated, and justify more extensive research on the effects of resveratrol on the splicing machinery.	[Markus, M. Andrea] Univ Sydney, Sch Med Sci, Basic & Clin Genom Lab, Sydney, NSW 2006, Australia; Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Markus, MA (corresponding author), Univ Sydney, Sch Med Sci, Basic & Clin Genom Lab, Sydney, NSW 2006, Australia.	brian.morris@sydney.edu.au	Marques, Francine/AAA-5767-2020; Marques, Francine/AAH-1562-2021	Marques, Francine/0000-0003-4920-9991; Markus, Andrea/0000-0003-2305-3394	Cure Cancer Australia Foundation; Endeavour International Postgraduate Research Scholarship	Cure Cancer Australia Foundation; Endeavour International Postgraduate Research Scholarship(Australian Government)	This work was supported by a Cure Cancer Australia Foundation grant (to MAM) and an Endeavour International Postgraduate Research Scholarship (to FZM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Allard JS, 2009, MOL CELL ENDOCRINOL, V299, P58, DOI 10.1016/j.mce.2008.10.018; Anekonda TS, 2006, BRAIN RES REV, V52, P316, DOI 10.1016/j.brainresrev.2006.04.004; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Bracco L, 2003, TRENDS BIOTECHNOL, V21, P346, DOI 10.1016/S0167-7799(03)00146-X; Caceres JF, 2002, TRENDS GENET, V18, P186, DOI 10.1016/S0168-9525(01)02626-9; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Cartegni L, 2006, AM J HUM GENET, V78, P63, DOI 10.1086/498853; Chabot B, 2003, Prog Mol Subcell Biol, V31, P59; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Graveley BR, 2001, RNA, V7, P806, DOI 10.1017/S1355838201010317; Greer EL, 2009, AGING CELL, V8, P113, DOI 10.1111/j.1474-9726.2009.00459.x; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Gurusamy N, 2010, CARDIOVASC RES, V86, P103, DOI 10.1093/cvr/cvp384; Hagiwara M, 2005, BBA-PROTEINS PROTEOM, V1754, P324, DOI 10.1016/j.bbapap.2005.09.010; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Harikumar KB, 2008, CELL CYCLE, V7, P1020, DOI 10.4161/cc.7.8.5740; Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Jumaa H, 2000, BBA-GENE STRUCT EXPR, V1494, P137, DOI 10.1016/S0167-4781(00)00233-5; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Leiro JM, 2010, MOL IMMUNOL, V47, P1114, DOI 10.1016/j.molimm.2009.10.030; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Markus MA, 2006, EXP CELL RES, V312, P3379, DOI 10.1016/j.yexcr.2006.07.008; Markus MA, 2008, CLIN INTERV AGING, V3, P331; Morris BJ, 2005, J HYPERTENS, V23, P1285, DOI 10.1097/01.hjh.0000173509.45363.dd; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pozo-Guisado E, 2004, INT J CANCER, V109, P167, DOI 10.1002/ijc.11720; Sakla MS, 2008, HUM GENET, V122, P635, DOI 10.1007/s00439-007-0441-0; Sawicka K, 2008, BIOCHEM SOC T, V36, P641, DOI 10.1042/BST0360641; Schroeder R, 2000, EMBO J, V19, P1, DOI 10.1093/emboj/19.1.1; Shi J, 2008, MOL CELL BIOL, V28, P883, DOI 10.1128/MCB.01345-07; Srebrow A, 2006, J CELL SCI, V119, P2635, DOI 10.1242/jcs.03053; Stoss O, 1999, BRAIN RES PROTOC, V4, P383, DOI 10.1016/S1385-299X(99)00043-4; Sumanasekera C, 2008, BIOCHEM SOC T, V36, P483, DOI 10.1042/BST0360483; Usha S, 2005, J BIOCHEM MOL BIOL, V38, P198; van der Vos KE, 2008, ONCOGENE, V27, P2289, DOI 10.1038/onc.2008.22; Ward AJ, 2010, J PATHOL, V220, P152, DOI 10.1002/path.2649; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789	45	36	37	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28926	10.1371/journal.pone.0028926	http://dx.doi.org/10.1371/journal.pone.0028926			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174926	Green Published, gold, Green Submitted			2022-12-25	WOS:000298367300032
J	Weisenberg, SA; Schuetz, AN; Alexander, EA; Eiss, B; Behta, M; Saiman, L; Larone, DH; Jenkins, SG; Rhee, KY				Weisenberg, Scott A.; Schuetz, Audrey N.; Alexander, Elizabeth A.; Eiss, Brain; Behta, Maryam; Saiman, Lisa; Larone, Davise H.; Jenkins, Stephen G.; Rhee, Kyu Y.			Endemic Acinetobacter baumannii in a New York Hospital	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; MOLECULAR EPIDEMIOLOGY; RESISTANCE; INTEGRONS; STRAINS; MECHANISMS; CITY	Background: Acinetobacter baumannii is an increasingly multidrug-resistant (MDR) cause of hospital-acquired infections, often associated with limited therapeutic options. We investigated A. baumannii isolates at a New York hospital to characterize genetic relatedness. Methods: Thirty A. baumannii isolates from geographically-dispersed nursing units within the hospital were studied. Isolate relatedness was assessed by repetitive sequence polymerase chain reaction (rep-PCR). The presence and characteristics of integrons were assessed by PCR. Metabolomic profiles of a subset of a prevalent strain isolates and sporadic isolates were characterized and compared. Results: We detected a hospital-wide group of closely related carbapenem resistant MDR A. baumannii isolates. Compared with sporadic isolates, the prevalent strain isolates were more likely to be MDR (p = 0.001). Isolates from the prevalent strain carried a novel Class I integron sequence. Metabolomic profiles of selected prevalent strain isolates and sporadic isolates were similar. Conclusion: The A. baumannii population at our hospital represents a prevalent strain of related MDR isolates that contain a novel integron cassette. Prevalent strain and sporadic isolates did not segregate by metabolomic profiles. Further study of environmental, host, and bacterial factors associated with the persistence of prevalent endemic A. baumannii strains is needed to develop effective prevention strategies.	[Weisenberg, Scott A.; Alexander, Elizabeth A.; Eiss, Brain; Rhee, Kyu Y.] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Schuetz, Audrey N.; Larone, Davise H.; Jenkins, Stephen G.] Weill Cornell Med Coll, Dept Pathol, New York, NY USA; [Behta, Maryam] New York Presbyterian Healthcare Med Ctr, Dept Informat Serv, New York, NY USA; [Saiman, Lisa] Columbia Univ, Dept Pediat, New York, NY 10027 USA; [Saiman, Lisa] New York Presbyterian Hosp, Dept Infect Prevent & Control, New York, NY USA	Cornell University; Cornell University; Columbia University; NewYork-Presbyterian Hospital	Weisenberg, SA (corresponding author), Alta Bates Summit Med Ctr, Oakland, CA USA.	scottweisenberg@gmail.com		Weisenberg, Scott/0000-0002-4839-1296	Clinical and Translation Science Center at Weill Cornell Medical College [KL2RR024997]; Merck; Cubist; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024997] Funding Source: NIH RePORTER	Clinical and Translation Science Center at Weill Cornell Medical College; Merck(Merck & Company); Cubist; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This investigation was supported by grant KL2RR024997 of the Clinical and Translation Science Center at Weill Cornell Medical College (SAW). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.; The authors have read the journal's policy and have the following conflicts: Scott Weisenberg has received an investigator initiated grant from Merck for an unrelated study (related to international travel and importation of ESBL producing bacteria). Kyu Rhee has received support for unrelated studies on Enterococci from Cubist. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	BAANG JH, 2011, AM J INFECT CONTROL; Barlow RS, 2004, ANTIMICROB AGENTS CH, V48, P838, DOI 10.1128/AAC.48.3.838-842.2004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brauer MJ, 2006, P NATL ACAD SCI USA, V103, P19302, DOI 10.1073/pnas.0609508103; Fournier PE, 2006, PLOS GENET, V2, P62, DOI 10.1371/journal.pgen.0020007; Gaynes R, 2005, CLIN INFECT DIS, V41, P848, DOI 10.1086/432803; Gordon NC, 2010, INT J ANTIMICROB AG, V35, P219, DOI 10.1016/j.ijantimicag.2009.10.024; Higgins PG, 2010, J ANTIMICROB CHEMOTH, V65, P233, DOI 10.1093/jac/dkp428; Huang LY, 2008, CLIN MICROBIOL INFEC, V14, P1010, DOI 10.1111/j.1469-0691.2008.02077.x; Jawad A, 1998, J CLIN MICROBIOL, V36, P1938, DOI 10.1128/JCM.36.7.1938-1941.1998; Jones RN, 2004, DIAGN MICR INFEC DIS, V49, P211, DOI 10.1016/j.diagmicrobio.2004.03.016; JUNI E, 1978, ANNU REV MICROBIOL, V32, P349, DOI 10.1146/annurev.mi.32.100178.002025; Kim HU, 2010, MOL BIOSYST, V6, P339, DOI 10.1039/b916446d; Landman D, 2009, EPIDEMIOL INFECT, V137, P174, DOI 10.1017/S0950268808000824; Landman D, 2007, J ANTIMICROB CHEMOTH, V60, P78, DOI 10.1093/jac/dkm129; Lee YT, 2009, J MICROBIOL IMMUNOL, V42, P210; LEVESQUE C, 1995, ANTIMICROB AGENTS CH, V39, P185, DOI 10.1128/AAC.39.1.185; Martinez-Freijo P, 1998, J ANTIMICROB CHEMOTH, V42, P689, DOI 10.1093/jac/42.6.689; Morgan DJ, 2009, INFECT CONT HOSP EP, V30, P196, DOI 10.1086/593207; Oh JY, 2002, APMIS, V110, P247, DOI 10.1034/j.1600-0463.2002.100307.x; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Quale J, 2003, CLIN INFECT DIS, V37, P214, DOI 10.1086/375821; Rodriguez-Bano J, 2004, INFECT CONT HOSP EP, V25, P819, DOI 10.1086/502302; Runnegar N, 2010, J CLIN MICROBIOL, V48, P4051, DOI 10.1128/JCM.01208-10; Saeed S, 2006, INFECT CONT HOSP EP, V27, P981, DOI 10.1086/507286; Sana Theodore R, 2008, J Biomol Tech, V19, P258; SOARES N, 2010, J PROTEOME RES; Talbot GH, 2006, CLIN INFECT DIS, V42, P657, DOI 10.1086/499819; Tomaras AP, 2008, MICROBIOL-SGM, V154, P3398, DOI 10.1099/mic.0.2008/019471-0; Turton JF, 2006, J CLIN MICROBIOL, V44, P2974, DOI 10.1128/JCM.01021-06; Weisenberg SA, 2009, J SEP SCI, V32, P2262, DOI 10.1002/jssc.200900256	31	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28566	10.1371/journal.pone.0028566	http://dx.doi.org/10.1371/journal.pone.0028566			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22180786	gold, Green Published, Green Submitted			2022-12-25	WOS:000298367300014
J	Chatterjee, SS; Chen, L; Joo, HS; Cheung, GYC; Kreiswirth, BN; Otto, M				Chatterjee, Som S.; Chen, Liang; Joo, Hwang-Soo; Cheung, Gordon Y. C.; Kreiswirth, Barry N.; Otto, Michael			Distribution and Regulation of the Mobile Genetic Element-Encoded Phenol-Soluble Modulin PSM-mec in Methicillin-Resistant Staphylococcus aureus	PLOS ONE			English	Article							VIRULENCE; AGR; IDENTIFICATION; EVOLUTION; PEPTIDES	The phenol-soluble modulin PSM-mec is the only known staphylococcal toxin that is encoded on a mobile antibiotic resistance determinant, namely the staphylococcal cassette chromosome (SCC) element mec encoding resistance to methicillin. Here we show that the psm-mec gene is found frequently among methicillin-resistant Staphylococcus aureus (MRSA) strains of SCCmec types II, III, and VIII, and is a conserved part of the class A mec gene complex. Controlled expression of AgrA versus RNAIII in agr mutants of all 3 psm-mec-positive SCCmec types demonstrated that expression of psm-mec, which is highly variable, is controlled by AgrA in an RNAIII-independent manner. Furthermore, psm-mec isogenic deletion mutants showed only minor changes in PSM alpha peptide production and unchanged (or, as previously described, diminished) virulence compared to the corresponding wild-type strains in a mouse model of skin infection. This indicates that the recently reported regulatory impact of the psm-mec locus on MRSA virulence, which is opposite to that of the PSM-mec peptide and likely mediated by a regulatory RNA, is minor when analyzed in the original strain background. Our study gives new insight in the distribution, regulation, and role in virulence of the PSM-mec peptide and the psm-mec gene locus.	[Chatterjee, Som S.; Joo, Hwang-Soo; Cheung, Gordon Y. C.; Otto, Michael] NIAID, Lab Human Bacterial Pathogenesis, NIH, Bethesda, MD 20892 USA; [Chen, Liang; Kreiswirth, Barry N.] Univ Med & Dent New Jersey, Publ Hlth Res Inst, TB Ctr, Newark, NJ 07103 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Rutgers State University New Brunswick; Rutgers State University Medical Center	Chatterjee, SS (corresponding author), NIAID, Lab Human Bacterial Pathogenesis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	motto@niaid.nih.gov	Cheung, Yiu Chong/K-3565-2012; Chen, Liang/D-3583-2009	Otto, Michael/0000-0002-2222-4115; JOO, HWANG-SOO/0000-0003-4668-3225; Chen, Liang/0000-0001-5845-2235	National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000904] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), The National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Chen LA, 2010, ANTIMICROB AGENTS CH, V54, P3347, DOI 10.1128/AAC.00001-10; Chen L, 2009, J CLIN MICROBIOL, V47, P3692, DOI 10.1128/JCM.00766-09; Cheung GYC, 2011, INFECT IMMUN, V79, P1927, DOI 10.1128/IAI.00046-11; Cheung GYC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001133; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Hiramatsu K, 2001, TRENDS MICROBIOL, V9, P486, DOI 10.1016/S0966-842X(01)02175-8; Kaito C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001267; Kaito C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003921; Kretschmer D, 2010, CELL HOST MICROBE, V7, P463, DOI 10.1016/j.chom.2010.05.012; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Li M, 2007, MOL MICROBIOL, V66, P1136, DOI 10.1111/j.1365-2958.2007.05986.x; Lowy FD, 2003, J CLIN INVEST, V111, P1265, DOI 10.1172/JC1200318535; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; Novick RP, 2001, MICROBES INFECT, V3, P585, DOI 10.1016/S1286-4579(01)01414-9; Otto M, 2010, VIRULENCE, V1, P49, DOI 10.4161/viru.1.1.10453; PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988; Queck SY, 2008, MOL CELL, V32, P150, DOI 10.1016/j.molcel.2008.08.005; Queck SY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000533; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wang R, 2011, J CLIN INVEST, V121, P238, DOI 10.1172/JCI42520	22	55	70	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28781	10.1371/journal.pone.0028781	http://dx.doi.org/10.1371/journal.pone.0028781			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174895	Green Published, gold, Green Submitted			2022-12-25	WOS:000298366600038
J	Dellinger, MT; Brekken, RA				Dellinger, Michael T.; Brekken, Rolf A.			Phosphorylation of Akt and ERK1/2 Is Required for VEGF-A/VEGFR2-Induced Proliferation and Migration of Lymphatic Endothelium	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PROTEIN-KINASE; ACTIN REORGANIZATION; VESSEL ENLARGEMENT; VEGF RECEPTOR-2; DNA-SYNTHESIS; GROWTH; CELLS; LYMPHANGIOGENESIS; MICE	There is growing evidence that vascular endothelial growth factor-A (VEGF-A), a ligand of the receptor tyrosine kinases VEGFR1 and VEGFR2, promotes lymphangiogenesis. However, the underlying mechanisms by which VEGF-A induces the growth of lymphatic vessels remain poorly defined. Here we report that VEGFR2, not VEGFR1, is the primary receptor regulating VEGF-A-induced lymphangiogenesis. We show that specific inhibition of VEGF-A/VEGFR2 signaling with the fully human monoclonal antibody r84 significantly inhibits lymphangiogenesis in MDA-MB-231 tumors. In vitro experiments with primary human dermal lymphatic endothelial cells (LECs) demonstrate that blocking VEGF-A activation of VEGFR2, not VEGFR1, significantly inhibits VEGF-A-induced proliferation and migration of LECs. We show that VEGF-A stimulation of LECs leads to the phosphorylation of VEGFR2 (Tyr 951, 1054, 1059, 1175, and 1214) which subsequently triggers PKC dependent phosphorylation of ERK1/2 and PI3-K dependent phosphorylation of Akt. Additionally, we demonstrate that inhibitors that suppress the phosphorylation of ERK1/2 and Akt significantly block VEGF-A- induced proliferation and migration of LECs. Together, these results shed light on the mechanisms regulating VEGF-A-induced proliferation and migration of LECs, reveal that VEGFR2 is the primary signaling VEGF-A receptor on lymphatic endothelium, and suggest that therapeutic agents targeting the VEGF-A/VEGFR2 axis could be useful in blocking the pathological formation of lymphatic vessels.	[Dellinger, Michael T.; Brekken, Rolf A.] Univ Texas SW Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA; [Dellinger, Michael T.; Brekken, Rolf A.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol, Dallas, TX 75390 USA; [Brekken, Rolf A.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Dellinger, MT (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA.	rolf.brekken@utsouthwestern.edu		Dellinger, Michael/0000-0002-3315-4239	National Institutes of Health [R01CA118240]; Effie Marie Cain Scholarship; Department of Defense; Affitech AS; Peregrine Pharmaceuticals Inc.; NATIONAL CANCER INSTITUTE [R01CA118240] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Effie Marie Cain Scholarship; Department of Defense(United States Department of Defense); Affitech AS; Peregrine Pharmaceuticals Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the National Institutes of Health R01CA118240 (R. A. Brekken), Effie Marie Cain Scholarship (R. A. Brekken), and Department of Defense Postdoctoral Fellowship for Breast Cancer Research (M. T. Dellinger). Funding from Affitech AS and Peregrine Pharmaceuticals Inc. was not used to support this study. The funders did not participate in the design, execution, or interpretation of experiments.	Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Dellinger MT, 2007, DEV DYNAM, V236, P2346, DOI 10.1002/dvdy.21208; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Hirakawa S, 2005, BLOOD, V105, P2392, DOI 10.1182/blood-2004-06-2435; Hirakawa S, 2003, AM J PATHOL, V162, P575, DOI 10.1016/S0002-9440(10)63851-5; Holmqvist K, 2004, J BIOL CHEM, V279, P22267, DOI 10.1074/jbc.M312729200; Hong YK, 2004, FASEB J, V18, P1111, DOI 10.1096/fj.03-1179fje; Ichise T, 2010, DEVELOPMENT, V137, P1003, DOI 10.1242/dev.043489; Jones D, 2010, ARTERIOSCL THROM VAS, V30, P2553, DOI 10.1161/ATVBAHA.110.214999; Kajiya K, 2008, FASEB J, V22, P530, DOI 10.1096/fj.07-8873com; Kajiya K, 2006, AM J PATHOL, V169, P1496, DOI 10.2353/ajpath.2006.060197; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Karpanen T, 2008, ANNU REV PATHOL-MECH, V3, P367, DOI 10.1146/annurev.pathol.3.121806.151515; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Kriehuber E, 2001, J EXP MED, V194, P797, DOI 10.1084/jem.194.6.797; Kuchler AM, 2006, CURR BIOL, V16, P1244, DOI 10.1016/j.cub.2006.05.026; Kunstfeld R, 2004, BLOOD, V104, P1048, DOI 10.1182/blood-2003-08-2964; Lahdenranta J, 2009, CANCER RES, V69, P2801, DOI 10.1158/0008-5472.CAN-08-4051; Makinen T, 2001, EMBO J, V20, P4762, DOI 10.1093/emboj/20.17.4762; Matsumoto T, 2001, Sci STKE, V2001, pre21, DOI 10.1126/stke.2001.112.re21; Morales-Ruiz M, 2000, CIRC RES, V86, P892, DOI 10.1161/01.RES.86.8.892; Nagy JA, 2002, J EXP MED, V196, P1497, DOI 10.1084/jem.20021244; Nojiri H, 1999, MICROCIRCULATION, V6, P75, DOI 10.1080/713773929; Ny A, 2005, NAT MED, V11, P998, DOI 10.1038/nm1285; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Ran S, 2003, NEOPLASIA, V5, P297, DOI 10.1016/S1476-5586(03)80023-4; Roland CL, 2009, MOL CANCER THER, V8, P1761, DOI 10.1158/1535-7163.MCT-09-0280; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Saaristo A, 2002, FASEB J, V16, P1041, DOI 10.1096/fj.01-1042com; Sakurai Y, 2005, P NATL ACAD SCI USA, V102, P1076, DOI 10.1073/pnas.0404984102; Sullivan LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012031; Takahashi T, 1999, ONCOGENE, V18, P2221, DOI 10.1038/sj.onc.1202527; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Taniguchi K, 2007, MOL CELL BIOL, V27, P4541, DOI 10.1128/MCB.01600-06; Veikkola T, 2003, FASEB J, V17, P2006, DOI 10.1096/fj.03-0179com; Whitehurst Brandt, 2006, Lymphatic Research and Biology, V4, P119, DOI 10.1089/lrb.2006.4.119; Whitehurst B, 2007, INT J CANCER, V121, P2181, DOI 10.1002/ijc.22937; Wirzenius M, 2007, J EXP MED, V204, P1431, DOI 10.1084/jem.20062642; Witte M H, 1997, EXS, V79, P65; Yuen D, 2011, INVEST OPHTH VIS SCI, V52, P2593, DOI 10.1167/iovs.10-6408; Zhou F, 2010, AM J PATHOL, V177, P2124, DOI 10.2353/ajpath.2010.091301	43	65	69	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28947	10.1371/journal.pone.0028947	http://dx.doi.org/10.1371/journal.pone.0028947			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174934	Green Published, Green Submitted, gold			2022-12-25	WOS:000298366600051
J	Djouani-Tahri, EB; Sanchez, F; Lozano, JC; Bouget, FY				Djouani-Tahri, El Batoul; Sanchez, Frederic; Lozano, Jean-Claude; Bouget, Francois-Yves			A Phosphate-Regulated Promoter for Fine-Tuned and Reversible Overexpression in Ostreococcus: Application to Circadian Clock Functional Analysis	PLOS ONE			English	Article							TRANSCRIPTION; RHYTHMS; GENE; IDENTIFICATION; TRANSPORTER; EXPRESSION; INSIGHTS	Background: The green picoalga Ostreococcus tauri (Prasinophyceae), which has been described as the smallest free-living eukaryotic organism, has minimal cellular ultra-structure and a very small genome. In recent years, O. tauri has emerged as a novel model organism for systems biology approaches that combine functional genomics and mathematical modeling, with a strong emphasis on light regulated processes and circadian clock. These approaches were made possible through the implementation of a minimal molecular toolbox for gene functional analysis including overexpression and knockdown strategies. We have previously shown that the promoter of the High Affinity Phosphate Transporter (HAPT) gene drives the expression of a luciferase reporter at high and constitutive levels under constant light. Methodology/Principal Findings: Here we report, using a luciferase reporter construct, that the HAPT promoter can be finely and reversibly tuned by modulating the level and nature of phosphate in culture medium. This HAPT regulation was additionally used to analyze the circadian clock gene Time of Cab expression 1 (TOC1). The phenotype of a TOC1ox/CCA1:Luc line was reverted from arrhythmic to rhythmic simply by adding phosphate to the culture medium. Furthermore, since the time of phosphate injection had no effect on the phase of CCA1:Luc expression, this study suggests further that TOC1 is a central clock gene in Ostreococcus. Conclusions/Perspectives: We have developed a phosphate-regulated expression system that allows fine gene function analysis in Ostreococcus. Recently, there has been a growing interest in microalgae as cell factories. This non-toxic phosphate-regulated system may prove useful in tuning protein expression levels quantitatively and temporally for biotechnological applications.	[Djouani-Tahri, El Batoul; Sanchez, Frederic; Lozano, Jean-Claude; Bouget, Francois-Yves] Univ Paris 06, Observ Oceanol, Banyuls Sur Mer, France; [Djouani-Tahri, El Batoul; Sanchez, Frederic; Lozano, Jean-Claude; Bouget, Francois-Yves] CNRS, UMR, UMR7621, LOMIC,Lab Oceanog Microbienne, Banyuls Sur Mer, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite	Djouani-Tahri, EB (corresponding author), Univ Paris 06, Observ Oceanol, Banyuls Sur Mer, France.	fy.bouget@obs-banyuls.fr			Agence Nationale de la Recherche Miniclock [F005466]; EU [227799]; CNRS-Region Languedoc Roussillon	Agence Nationale de la Recherche Miniclock(French National Research Agency (ANR)); EU(European Commission); CNRS-Region Languedoc Roussillon(Centre National de la Recherche Scientifique (CNRS)Region Occitanie)	This work was supported by Agence Nationale de la Recherche Miniclock F005466, EU FP7 ASSEMBLE (227799) and by a CNRS-Region Languedoc Roussillon doctoral fellowship to EBD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2009, APPL ENVIRON MICROB, V75, P3528, DOI 10.1128/AEM.02913-08; ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; Chung CC, 2003, APPL ENVIRON MICROB, V69, P754, DOI 10.1128/AEM.69.2.754-759.2003; Corellou F, 2009, PLANT CELL, V21, P3436, DOI 10.1105/tpc.109.068825; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Djouani-Tahri EB, 2011, PLANT J, V65, P578, DOI 10.1111/j.1365-313X.2010.04444.x; Heijde M, 2010, PLANT CELL ENVIRON, V33, P1614, DOI 10.1111/j.1365-3040.2010.02168.x; Huang TK, 2009, BIOTECHNOL BIOENG, V102, P508, DOI 10.1002/bit.22061; Knowles SM, 2008, J BIOL RHYTHM, V23, P463, DOI 10.1177/0748730408326749; MANN BJ, 1989, GENE, V83, P281, DOI 10.1016/0378-1119(89)90114-5; Martinez P, 1998, MOL GEN GENET, V258, P628, DOI 10.1007/s004380050776; McWatters HG, 2000, NATURE, V408, P716, DOI 10.1038/35047079; Monnier A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-192; Morant PE, 2010, CHAOS, V20, DOI 10.1063/1.3530118; Moulager M, 2007, PLANT PHYSIOL, V144, P1360, DOI 10.1104/pp.107.096149; Moulager M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000957; Navarre C, 2011, TRANSGENIC RES, V20, P799, DOI 10.1007/s11248-010-9459-5; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; O'Neill JS, 2008, J BIOL RHYTHM, V23, P483, DOI 10.1177/0748730408326682; Palenik B, 2007, P NATL ACAD SCI USA, V104, P7705, DOI 10.1073/pnas.0611046104; Quinn JM, 2003, EUKARYOT CELL, V2, P995, DOI 10.1128/EC.2.5.995-1002.2003; Rubio V, 2001, GENE DEV, V15, P2122, DOI 10.1101/gad.204401; Sorokina O, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-36; Thommen Q, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000990; Troein C, 2011, PLANT J, V66, P375, DOI 10.1111/j.1365-313X.2011.04489.x; Weynberg KD, 2011, J VIROL, V85, P4520, DOI 10.1128/JVI.02131-10	26	12	12	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28471	10.1371/journal.pone.0028471	http://dx.doi.org/10.1371/journal.pone.0028471			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174815	gold, Green Submitted, Green Published			2022-12-25	WOS:000298366600020
J	Gombos, I; Crul, T; Piotto, S; Gungor, B; Torok, Z; Balogh, G; Peter, M; Slotte, JP; Campana, F; Pilbat, AM; Hunya, A; Toth, N; Literati-Nagy, Z; Vigh, L; Glatz, A; Brameshuber, M; Schutz, GJ; Hevener, A; Febbraio, MA; Horvath, I; Vigh, L				Gombos, Imre; Crul, Tim; Piotto, Stefano; Guengoer, Burcin; Toeroek, Zsolt; Balogh, Gabor; Peter, Maria; Slotte, J. Peter; Campana, Federica; Pilbat, Ana-Maria; Hunya, Akos; Toth, Noemi; Literati-Nagy, Zsuzsanna; Vigh, Laszlo, Jr.; Glatz, Attila; Brameshuber, Mario; Schueutz, Gerhard J.; Hevener, Andrea; Febbraio, Mark A.; Horvath, Ibolya; Vigh, Laszlo			Membrane-Lipid Therapy in Operation: The HSP Co-Inducer BGP-15 Activates Stress Signal Transduction Pathways by Remodeling Plasma Membrane Rafts	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; CHOLESTEROL; HYPERFLUIDIZATION; BIMOCLOMOL; MODULATION; GTPASE; STEROL; MODEL; RAC1; ACTS	Aging and pathophysiological conditions are linked to membrane changes which modulate membrane-controlled molecular switches, causing dysregulated heat shock protein (HSP) expression. HSP co-inducer hydroxylamines such as BGP-15 provide advanced therapeutic candidates for many diseases since they preferentially affect stressed cells and are unlikely have major side effects. In the present study in vitro molecular dynamic simulation, experiments with lipid monolayers and in vivo ultrasensitive fluorescence microscopy showed that BGP-15 alters the organization of cholesterol-rich membrane domains. Imaging of nanoscopic long-lived platforms using the raft marker glycosylphosphatidylinositol-anchored monomeric green fluorescent protein diffusing in the live Chinese hamster ovary (CHO) cell plasma membrane demonstrated that BGP-15 prevents the transient structural disintegration of rafts induced by fever-type heat stress. Moreover, BGP-15 was able to remodel cholesterol-enriched lipid platforms reminiscent of those observed earlier following non-lethal heat priming or membrane stress, and were shown to be obligate for the generation and transmission of stress signals. BGP-15 activation of HSP expression in B16-F10 mouse melanoma cells involves the Rac1 signaling cascade in accordance with the previous observation that cholesterol affects the targeting of Rac1 to membranes. Finally, in a human embryonic kidney cell line we demonstrate that BGP-15 is able to inhibit the rapid heat shock factor 1 (HSF1) acetylation monitored during the early phase of heat stress, thereby promoting a prolonged duration of HSF1 binding to heat shock elements. Taken together, our results indicate that BGP-15 has the potential to become a new class of pharmaceuticals for use in 'membrane-lipid therapy' to combat many various protein-misfolding diseases associated with aging.	[Gombos, Imre; Crul, Tim; Guengoer, Burcin; Toeroek, Zsolt; Balogh, Gabor; Peter, Maria; Pilbat, Ana-Maria; Toth, Noemi; Literati-Nagy, Zsuzsanna; Vigh, Laszlo, Jr.; Glatz, Attila; Horvath, Ibolya; Vigh, Laszlo] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary; [Piotto, Stefano; Campana, Federica] Univ Salerno, Dept Pharmaceut & Biomed Sci, I-84100 Salerno, Italy; [Slotte, J. Peter] Abo Akad Univ, Dept Biosci, Turku, Finland; [Hunya, Akos] LipidArt Ltd, Szeged, Hungary; [Brameshuber, Mario; Schueutz, Gerhard J.] Vienna Univ Technol, Inst Appl Phys, A-1040 Vienna, Austria; [Hevener, Andrea] Univ Calif Los Angeles, Dept Med, Div Endocrinol, Los Angeles, CA 90024 USA; [Febbraio, Mark A.] Baker Heart & Diabet Inst, Cellular & Mol Metab Lab, Prahran, Vic, Australia	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; University of Salerno; Abo Akademi University; Technische Universitat Wien; University of California System; University of California Los Angeles	Gombos, I (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary.	vigh@brc.hu	Schuetz, Gerhard/B-1243-2008; Piotto, Stefano P/A-8210-2011; Balogh, Gábor/AIC-8192-2022; Piotto, Stefano/AAZ-4641-2021; Crul, Tim/AAE-8966-2020; Febbraio, Mark/AAE-9632-2019; Güngör, Burçin/AAF-6654-2021; Güngör, Burçin/AAF-8288-2021; Piotto, Stefano/AAE-4031-2020	Schuetz, Gerhard/0000-0003-1542-1089; Balogh, Gábor/0000-0002-4565-6850; Piotto, Stefano/0000-0002-3102-1918; Crul, Tim/0000-0002-6053-7016; Güngör, Burçin/0000-0001-7725-5835; Piotto, Stefano/0000-0002-3102-1918; Febbraio, Mark/0000-0002-9296-4418; Brameshuber, Mario/0000-0001-8672-2255	European Union [HEALTH-F4-2008-202272]; Hungarian National Scientific Research Foundation (OTKA) [NN 76716, K82097, K84257]; Hungarian National Development Agency [TAMOP-4.2.2/08/1-2008-0005, TAMOP-4.2.2/08/1-2008-0002, TAMOP-4.2.2/08/1-2008-0013]; Austrian Science Fund (FWF) [Y250-B03, I301-B12]; Austrian Science Fund (FWF) [Y 250, I 301] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078760, R01DK089109] Funding Source: NIH RePORTER	European Union(European Commission); Hungarian National Scientific Research Foundation (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian National Development Agency; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the European Union Project LipidomicNet (HEALTH-F4-2008-202272), by the Hungarian National Scientific Research Foundation (OTKA NN 76716, K82097 and K84257), by the "Social Renewal Operational Programme" of the Hungarian National Development Agency (TAMOP-4.2.2/08/1-2008-0005, TAMOP-4.2.2/08/1-2008-0002 and TAMOP-4.2.2/08/1-2008-0013), and by the Austrian Science Fund (FWF project Y250-B03 and I301-B12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Akiyama H, 2011, CYTOLOGIA, V76, P19, DOI 10.1508/cytologia.76.19; Balogh G, 2005, FEBS J, V272, P6077, DOI 10.1111/j.1742-4658.2005.04999.x; Balogh G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021182; Balogh G, 2010, BBA-MOL CELL BIOL L, V1801, P1036, DOI 10.1016/j.bbalip.2010.04.011; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Brameshuber M, 2010, J BIOL CHEM, V285, P41765, DOI 10.1074/jbc.M110.182121; Calderwood S K, 2010, Sign Transduct Insights, V2, P13; Cerezo A, 2009, MOL CELL BIOL, V29, P5046, DOI 10.1128/MCB.00315-09; Chung J, 2008, P NATL ACAD SCI USA, V105, P1739, DOI 10.1073/pnas.0705799105; Csermely P, 2005, TRENDS PHARMACOL SCI, V26, P178, DOI 10.1016/j.tips.2005.02.007; de Marco A, 2005, CELL STRESS CHAPERON, V10, P329, DOI 10.1379/CSC-139R.1; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Escriba PV, 2008, J CELL MOL MED, V12, P829, DOI 10.1111/j.1582-4934.2008.00281.x; Escriba PV, 2006, TRENDS MOL MED, V12, P34, DOI 10.1016/j.molmed.2005.11.004; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Finka A, 2011, CELL STRESS CHAPERON, V16, P15, DOI 10.1007/s12192-010-0216-8; Haldimann P, 2011, J BIOL CHEM, V286, P18784, DOI 10.1074/jbc.M111.234773; Halling KK, 2008, BBA-BIOMEMBRANES, V1778, P1100, DOI 10.1016/j.bbamem.2008.01.001; Han SI, 2001, J BIOL CHEM, V276, P1889, DOI 10.1074/jbc.M006042200; Hargitai J, 2003, BIOCHEM BIOPH RES CO, V307, P689, DOI 10.1016/S0006-291X(03)01254-3; Horvath I, 2008, BBA-BIOMEMBRANES, V1778, P1653, DOI 10.1016/j.bbamem.2008.02.012; Jerabek H, 2010, J AM CHEM SOC, V132, P7990, DOI 10.1021/ja910843d; Kieran D, 2004, NAT MED, V10, P402, DOI 10.1038/nm1021; KLAMT A, 1995, J PHYS CHEM-US, V99, P2224, DOI 10.1021/j100007a062; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Kucerka N, 2005, J MEMBRANE BIOL, V208, P193, DOI 10.1007/s00232-005-7006-8; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Lancelot E, 2007, COLLOID SURFACE B, V59, P81, DOI 10.1016/j.colsurfb.2007.04.017; Moertelmaier M, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2158031; Monastyrskaya K, 2009, CELL MOL LIFE SCI, V66, P2623, DOI 10.1007/s00018-009-0027-1; Nagy E, 2007, P NATL ACAD SCI USA, V104, P7945, DOI 10.1073/pnas.0702557104; Nagy G, 2010, TOXICOL APPL PHARM, V243, P96, DOI 10.1016/j.taap.2009.11.017; Noonan EJ, 2007, J CELL PHYSIOL, V210, P201, DOI 10.1002/jcp.20875; Ohvo H, 1996, BIOCHEMISTRY-US, V35, P8018, DOI 10.1021/bi9528816; Radhakrishnan A, 2000, P NATL ACAD SCI USA, V97, P12422, DOI 10.1073/pnas.220418097; Sato SB, 2004, J BIOL CHEM, V279, P23790, DOI 10.1074/jbc.M313568200; Shibata S, 2011, J CLIN INVEST, V121, P3233, DOI 10.1172/JCI43124; Sloan LA, 2009, CURR OPIN DRUG DISC, V12, P666; Soti C, 2005, BRIT J PHARMACOL, V146, P769, DOI 10.1038/sj.bjp.0706396; STEWART JJP, 1989, J COMPUT CHEM, V10, P209, DOI 10.1002/jcc.540100208; Szabados E, 2000, BIOCHEM PHARMACOL, V59, P937, DOI 10.1016/S0006-2952(99)00418-9; Vattulainen I, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004655; Vigh L, 1997, NAT MED, V3, P1150, DOI 10.1038/nm1097-1150; Vigh L, 1998, TRENDS BIOCHEM SCI, V23, P369, DOI 10.1016/S0968-0004(98)01279-1; Vigh L, 2007, TRENDS BIOCHEM SCI, V32, P357, DOI 10.1016/j.tibs.2007.06.009; Voellmy R, 2007, ADV EXP MED BIOL, V594, P89; VOROBYOV I, 2010, BIOCHIM BIOPHYS ACTA, V1808, P1673; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Zhang DL, 2011, J MOL CELL CARDIOL, V51, P381, DOI 10.1016/j.yjmcc.2011.06.008	50	58	58	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28818	10.1371/journal.pone.0028818	http://dx.doi.org/10.1371/journal.pone.0028818			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174906	gold, Green Published, Green Submitted			2022-12-25	WOS:000298366600041
J	Matsumoto, H; Terao, Y; Yugeta, A; Fukuda, H; Emoto, M; Furubayashi, T; Okano, T; Hanajima, R; Ugawa, Y				Matsumoto, Hideyuki; Terao, Yasuo; Yugeta, Akihiro; Fukuda, Hideki; Emoto, Masaki; Furubayashi, Toshiaki; Okano, Tomoko; Hanajima, Ritsuko; Ugawa, Yoshikazu			Where Do Neurologists Look When Viewing Brain CT Images? An Eye-Tracking Study Involving Stroke Cases	PLOS ONE			English	Article							VISUAL-ATTENTION; SALIENCY; PERCEPTION; SEARCH; SHIFTS; MODEL	The aim of this study was to investigate where neurologists look when they view brain computed tomography (CT) images and to evaluate how they deploy their visual attention by comparing their gaze distribution with saliency maps. Brain CT images showing cerebrovascular accidents were presented to 12 neurologists and 12 control subjects. The subjects' ocular fixation positions were recorded using an eye-tracking device (Eyelink 1000). Heat maps were created based on the eye-fixation patterns of each group and compared between the two groups. The heat maps revealed that the areas on which control subjects frequently fixated often coincided with areas identified as outstanding in saliency maps, while the areas on which neurologists frequently fixated often did not. Dwell time in regions of interest (ROI) was likewise compared between the two groups, revealing that, although dwell time on large lesions was not different between the two groups, dwell time in clinically important areas with low salience was longer in neurologists than in controls. Therefore it appears that neurologists intentionally scan clinically important areas when reading brain CT images showing cerebrovascular accidents. Both neurologists and control subjects used the "bottom-up salience" form of visual attention, although the neurologists more effectively used the "top-down instruction" form.	[Matsumoto, Hideyuki; Terao, Yasuo; Yugeta, Akihiro; Okano, Tomoko; Hanajima, Ritsuko] Univ Tokyo, Dept Neurol, Tokyo, Japan; [Fukuda, Hideki] Segawa Neurol Clin Children, Tokyo, Japan; [Emoto, Masaki] Univ Tokyo, Interfac Initiat Informat Studies, Tokyo, Japan; [Furubayashi, Toshiaki; Ugawa, Yoshikazu] Fukushima Med Univ, Sch Med, Dept Neurol, Fukushima, Japan	University of Tokyo; University of Tokyo; Fukushima Medical University	Matsumoto, H (corresponding author), Univ Tokyo, Dept Neurol, Tokyo, Japan.	hideyukimatsumoto.jp@gmail.com	Ugawa, Yoshikazu/AAM-2052-2020	Ugawa, Yoshikazu/0000-0002-8016-152X	Ministry of Education, Culture, Sports, Science, and Technology of Japan Research; GlaxoSmithKline; Boehringer Ingelheim; Ministry of Health and Welfare of Japan; Ministry of Public Management, Home Affairs, Post and Telecommunications; Medtronic Japan Co., Ltd; Novartis Japan Co., Ltd; Dainippon Sumitomo Pharma. Co., Ltd.	Ministry of Education, Culture, Sports, Science, and Technology of Japan Research; GlaxoSmithKline(GlaxoSmithKline); Boehringer Ingelheim(Boehringer Ingelheim); Ministry of Health and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Public Management, Home Affairs, Post and Telecommunications; Medtronic Japan Co., Ltd; Novartis Japan Co., Ltd; Dainippon Sumitomo Pharma. Co., Ltd.(Dainippon Sumitomo Pharma Co., Ltd.)	Dr. Terao is supported by a Research Project Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan Research and GlaxoSmithKline and Boehringer Ingelheim, and has received speaker's honoraria from Boehringer Ingelheim. Dr. Hanajima is supported by a Research Project Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan Research and has received speaker's honoraria from Medtronic Japan Co., Ltd; Novartis Japan Co., Ltd; and Dainippon Sumitomo Pharma. Co., Ltd. Dr. Ugawa is supported by supported by a Research Project Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan Research; by grants for the Research Committee on the Best rTMS Treatment of Parkinson's Disease from the Ministry of Health and Welfare of Japan; by the Research Committee on Dystonia of the Ministry of Health and Welfare of Japan; by a grant from the Committee of the Study of Human Exposure to EMF from the Ministry of Public Management, Home Affairs, Post and Telecommunications. Dr. Matsumoto, Mr. Furubayashi, Dr. Yugeta, Mr. Fukuda, Mr. Emoto, and Ms. Okano have no disclosures. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors received funding from a commercial source (GlaxoSmithKline, Boehringer Ingelheim, Medtronic Japan Co., Ltd; Novartis Japan Co., Ltd; and Dainippon Sumitomo Pharma. Co., Ltd.). Dr. Terao is supported by a Research Project Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan Research and GlaxoSmithKline and Boehringer Ingelheim, and has received speaker's honoraria from Boehringer Ingelheim. Dr. Hanajima is supported by a Research Project Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan Research and has received speaker's honoraria from Medtronic Japan Co., Ltd; Novartis Japan Co., Ltd; and Dainippon Sumitomo Pharma. Co., Ltd. Dr. Ugawa is supported by supported by a Research Project Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan Research; by grants for the Research Committee on the Best rTMS Treatment of Parkinson's Disease from the Ministry of Health and Welfare of Japan; by the Research Committee on Dystonia of the Ministry of Health and Welfare of Japan; by a grant from the Committee of the Study of Human Exposure to EMF from the Ministry of Public Management, Home Affairs, Post and Telecommunications. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Beard D V, 1990, J Digit Imaging, V3, P230; Beard D V, 1994, J Digit Imaging, V7, P189; Ellis SM, 2006, EUR J RADIOL, V59, P257, DOI 10.1016/j.ejrad.2006.05.006; Foulsham T, 2008, J VISION, V8, DOI 10.1167/8.2.6; Foulsham T, 2009, NEUROPSYCHOLOGIA, V47, P1994, DOI 10.1016/j.neuropsychologia.2009.03.013; Harel J., 2006, GRAPH BASED VISUAL S; Harel J., SALIENCY IMPLEMENTAT; HENDERSON JM, 1997, EYE MOVEMENT RES INS, P537; Hu C H, 1994, Acad Radiol, V1, P25, DOI 10.1016/S1076-6332(05)80780-9; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Kundel HL, 2008, ACAD RADIOL, V15, P881, DOI 10.1016/j.acra.2008.01.023; Kundel HL, 2007, RADIOLOGY, V242, P396, DOI 10.1148/radiol.2422051997; Land MF, 2009, VISUAL NEUROSCI, V26, P51, DOI 10.1017/S0952523808080899; Ludwig CJH, 2002, J EXP PSYCHOL HUMAN, V28, P902, DOI 10.1037//0096-1523.28.4.902; Mahajan V, 2008, AM J NEURORADIOL, V29, P1144, DOI 10.3174/ajnr.A0995; Matsumoto H, 2011, MOVEMENT DISORD, V26, P1619, DOI 10.1002/mds.23683; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; Nodine CF, 2002, AM J ROENTGENOL, V179, P917, DOI 10.2214/ajr.179.4.1790917; Peterson M. A., 2003, PERCEPTION FACES OBJ; Suwa K, 2001, Odontology, V89, P54, DOI 10.1007/s10266-001-8186-z; van Zoest W, 2004, PERCEPTION, V33, P927, DOI 10.1068/p5158; Wallis G, 1999, TRENDS COGN SCI, V3, P22, DOI 10.1016/S1364-6613(98)01261-3	25	27	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28928	10.1371/journal.pone.0028928	http://dx.doi.org/10.1371/journal.pone.0028928			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	866FT	22174928	gold, Green Published, Green Submitted			2022-12-25	WOS:000298366600049
J	Zigmond, E; Halpern, Z; Elinav, E; Brazowski, E; Jung, S; Varol, C				Zigmond, Ehud; Halpern, Zamir; Elinav, Eran; Brazowski, Eli; Jung, Steffen; Varol, Chen			Utilization of Murine Colonoscopy for Orthotopic Implantation of Colorectal Cancer	PLOS ONE			English	Article							COLON CARCINOGENESIS; MOUSE MODELS; MICE; AZOXYMETHANE; MUTATION; SITE	Background: Colorectal-cancer (CRC) research has greatly benefited from the availability of small animal tumor models. Spontaneous and chemically-induced CRC models are widely used yet limited in their resemblance to human disease and are often prolonged, not accurately repetitive, and associated with inflammatory side effects. In-situ murine or human tumor implantation in the gastrointestinal tract of mice is extremely challenging, and limited by inter-animal variability and procedure-related complications and mortality. As a result, in frequent studies CRC is implanted in distal sites, most commonly the subcutaneous region, an approach that is greatly limited by the absence of normal gastrointestinal tumor milieu and has substantial effects on tumor development. Aims: In this study we aimed to develop a well-tolerated repetitive tool to study CRC in small animals by adapting the murine colonoscopy system to serve as a platform for colonic sub-mucosal orthotopic implantation of human and murine CRC tumor cells. Results: We report the establishment of a novel small-animal CRC model that is minimally invasive, rapid, well-tolerated, highly reproducible, and confers precise control of tumor number, location and growth rate. Moreover, we show that this model uniquely allows the side-by-side induction of distinct genetically manipulated tumors, enabling the mechanistic study of tumor interaction and cross-talk within the native intestinal microenvironment. Conclusions: Employment of this new approach may represent a major technical advance for the in-vivo study of CRC.	[Zigmond, Ehud; Halpern, Zamir; Elinav, Eran; Brazowski, Eli; Varol, Chen] Tel Aviv Univ, Res Ctr Digest Tract & Liver Dis, Sourasky Med Ctr, IL-69978 Tel Aviv, Israel; [Zigmond, Ehud; Halpern, Zamir; Elinav, Eran; Brazowski, Eli; Varol, Chen] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Zigmond, Ehud; Jung, Steffen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Weizmann Institute of Science	Zigmond, E (corresponding author), Tel Aviv Univ, Res Ctr Digest Tract & Liver Dis, Sourasky Med Ctr, IL-69978 Tel Aviv, Israel.	ehudz@tasmc.health.gov.il; chenv@tasmc.health.gov.il	Varol, Chen/ABH-6487-2020; Varol, Chen/AAW-4202-2021; Elinav, Eran/ABE-8881-2020; Jung, Steffen/K-1409-2012	Elinav, Eran/0000-0002-5775-2110; Jung, Steffen/0000-0003-4290-5716	Crohn's & Colitis Foundation of America (CCFA) [7108160101]	Crohn's & Colitis Foundation of America (CCFA)	This study was supported by the Crohn's & Colitis Foundation of America (CCFA) (to S.J., number - 7108160101; website: www.ccfa.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alencar H, 2005, INT J CANCER, V117, P335, DOI 10.1002/ijc.21185; Becker C, 2006, NAT PROTOC, V1, P2900, DOI 10.1038/nprot.2006.446; CORBETT TH, 1975, CANCER RES, V35, P2434; Edelmann L, 2004, AM J MED GENET C, V129C, P91, DOI 10.1002/ajmg.c.30021; Farre L, 2002, FASEB J, V16, P975, DOI 10.1096/fj.01-0973com; Hoffman RM, 1999, INVEST NEW DRUG, V17, P343, DOI 10.1023/A:1006326203858; Issa AY, 2007, CARCINOGENESIS, V28, P1978, DOI 10.1093/carcin/bgm161; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Nakanishi M, 2007, PROTEOM CLIN APPL, V1, P1660, DOI 10.1002/prca.200700545; Nambiar PR, 2003, INT J ONCOL, V22, P145; Neufert C, 2007, NAT PROTOC, V2, P1998, DOI 10.1038/nprot.2007.279; Neurath MF, 2010, GASTROENTEROLOGY, V139, P1837, DOI 10.1053/j.gastro.2010.10.007; Rosenberg DW, 2009, CARCINOGENESIS, V30, P183, DOI 10.1093/carcin/bgn267; Shapira Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004776; Suzui M, 2002, CANCER LETT, V183, P31, DOI 10.1016/S0304-3835(02)00114-3; Taketo MM, 2009, GASTROENTEROLOGY, V136, P780, DOI 10.1053/j.gastro.2008.12.049; Tanaka T, 2003, CANCER SCI, V94, P965, DOI 10.1111/j.1349-7006.2003.tb01386.x; Cespedes MV, 2007, AM J PATHOL, V170, P1077, DOI 10.2353/ajpath.2007.060773; WHITE AC, 1982, CANCER RES, V42, P906	20	44	48	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28858	10.1371/journal.pone.0028858	http://dx.doi.org/10.1371/journal.pone.0028858			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174916	Green Published, gold, Green Submitted			2022-12-25	WOS:000298366600046
J	Ebner, S; Lang, R; Mueller, EE; Eder, W; Oeller, M; Moser, A; Koller, J; Paulweber, B; Mayr, JA; Sperl, W; Kofler, B				Ebner, Sabine; Lang, Roland; Mueller, Edith E.; Eder, Waltraud; Oeller, Michaela; Moser, Alexandra; Koller, Josef; Paulweber, Bernhard; Mayr, Johannes A.; Sperl, Wolfgang; Kofler, Barbara			Mitochondrial Haplogroups, Control Region Polymorphisms and Malignant Melanoma: A Study in Middle European Caucasians	PLOS ONE			English	Article							DNA D-LOOP; BRESLOW THICKNESS; SOMATIC MUTATIONS; COPY NUMBER; CANCER; VARIANT; ASSOCIATION; BREAST; RISK; SUSCEPTIBILITY	Background: Because mitochondria play an essential role in energy metabolism, generation of reactive oxygen species (ROS), and apoptosis, sequence variation in the mitochondrial genome has been postulated to be a contributing factor to the etiology of multifactorial age-related diseases, including cancer. The aim of the present study was to compare the frequencies of mitochondrial DNA (mtDNA) haplogroups as well as control region (CR) polymorphisms of patients with malignant melanoma (n = 351) versus those of healthy controls (n = 1598) in Middle Europe. Methodology and Principal Findings: Using primer extension analysis and DNA sequencing, we identified all nine major European mitochondrial haplogroups and known CR polymorphisms. The frequencies of the major mitochondrial haplogroups did not differ significantly between patients and control subjects, whereas the frequencies of the one another linked CR polymorphisms A16183C, T16189C, C16192T, C16270T and T195C were significantly higher in patients with melanoma compared to the controls. Regarding clinical characteristics of the patient cohort, none of the nine major European haplogroups was associated with either Breslow thickness or distant metastasis. The CR polymorphisms A302CC-insertion and T310C-insertion were significantly associated with mean Breslow thickness, whereas the CR polymorphism T16519C was associated with metastasis. Conclusions and Significance: Our results suggest that mtDNA variations could be involved in melanoma etiology and pathogenesis, although the functional consequence of CR polymorphisms remains to be elucidated.	[Ebner, Sabine; Mueller, Edith E.; Eder, Waltraud; Oeller, Michaela; Moser, Alexandra; Mayr, Johannes A.; Sperl, Wolfgang; Kofler, Barbara] Paracelsus Med Univ, Res Program Receptor Biochem & Tumor Metab, Dept Pediat, Salzburg, Austria; [Lang, Roland; Koller, Josef] Paracelsus Med Univ, Dept Dermatol, Salzburg, Austria; [Paulweber, Bernhard] Paracelsus Med Univ, Dept Internal Med, Salzburg, Austria	Paracelsus Private Medical University; Paracelsus Private Medical University; Paracelsus Private Medical University	Ebner, S (corresponding author), Paracelsus Med Univ, Res Program Receptor Biochem & Tumor Metab, Dept Pediat, Salzburg, Austria.	b.kofler@salk.at		Mayr, Johannes/0000-0001-6970-336X; Kofler, Barbara/0000-0002-1198-4776	Paracelsus Medical University Salzburg [07/05/027]	Paracelsus Medical University Salzburg	This study was supported by a grant from the Paracelsus Medical University Salzburg (07/05/027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai RK, 2007, CANCER RES, V67, P4687, DOI 10.1158/0008-5472.CAN-06-3554; Berger C, 2011, FORENSIC SCI INT-GEN, V5, P142, DOI 10.1016/j.fsigen.2010.10.002; Birch-Machin MA, 2006, CLIN EXP DERMATOL, V31, P548, DOI 10.1111/j.1365-2230.2006.02161.x; Booker LM, 2006, J UROLOGY, V175, P468, DOI 10.1016/S0022-5347(05)00163-1; Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9; Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; Copeland WC, 2002, CANCER INVEST, V20, P557, DOI 10.1081/CNV-120002155; Czarnecka AM, 2010, ONCOL REP, V24, P1521, DOI 10.3892/or_00001014; De Vries E, 2008, ANN ONCOL, V19, P583, DOI 10.1093/annonc/mdm498; Deichmann M, 2004, INT J ONCOL, V24, P137; Fang HZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-421; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Kang DC, 1997, J BIOL CHEM, V272, P15275, DOI 10.1074/jbc.272.24.15275; Khogali SS, 2001, LANCET, V357, P1265, DOI 10.1016/S0140-6736(00)04422-6; Kofler B, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-35; Lee HC, 2004, MUTAT RES-FUND MOL M, V547, P71, DOI 10.1016/j.mrfmmm.2003.12.011; Li XY, 2011, MITOCHONDRION, V11, P27, DOI 10.1016/j.mito.2010.06.005; Liou CW, 2010, J MED GENET, V47, P723, DOI 10.1136/jmg.2010.077552; Liu VWS, 2003, HUM MUTAT, V22, P173, DOI 10.1002/humu.10244; MacKie RM, 2009, ANN ONCOL, V20, P1, DOI 10.1093/annonc/mdp252; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mithani SK, 2008, MELANOMA RES, V18, P214, DOI 10.1097/CMR.0b013e3282f88a56; Modica-Napolitano JS, 2007, CURR MOL MED, V7, P121, DOI 10.2174/156652407779940495; Mueller EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016455; Murray CS, 2005, BRIT J DERMATOL, V152, P104, DOI 10.1111/J.1365-2133.2005.06409.X; Navaglia F, 2006, AM J CLIN PATHOL, V126, P593, DOI 10.1309/GQFCCJMH5KHNVX73; Osborne JE, 2001, BRIT J DERMATOL, V144, P476, DOI 10.1046/j.1365-2133.2001.04071.x; Parsons TJ, 1997, NAT GENET, V15, P363, DOI 10.1038/ng0497-363; Penta JS, 2001, MUTAT RES-REV MUTAT, V488, P119, DOI 10.1016/S1383-5742(01)00053-9; Poetsch M, 2004, MELANOMA RES, V14, P501, DOI 10.1097/00008390-200412000-00010; Poulton J, 2002, HUM MOL GENET, V11, P1581, DOI 10.1093/hmg/11.13.1581; Raule N, 2007, MITOCHONDRION, V7, P29, DOI 10.1016/j.mito.2006.11.013; Rigel DS, 2010, CA-CANCER J CLIN, V60, P301, DOI 10.3322/caac.20074; Roberti M, 1998, BIOCHEM BIOPH RES CO, V243, P36, DOI 10.1006/bbrc.1997.8052; Singh Keshav K., 2009, V471, P291, DOI 10.1007/978-1-59745-416-2_15; Stoneking M, 2000, AM J HUM GENET, V67, P1029, DOI 10.1086/303092; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Takeuchi H, 2004, ANN NY ACAD SCI, V1022, P50, DOI 10.1196/annals.1318.009; Theodoratou E, 2010, CARCINOGENESIS, V31, P296, DOI 10.1093/carcin/bgp237; Verma M, 2007, CLIN CHIM ACTA, V383, P41, DOI 10.1016/j.cca.2007.04.018; Weitgasser R, 2004, BIOMED PHARMACOTHER, V58, P619, DOI 10.1016/j.biopha.2004.09.010; Weng SW, 2005, J CLIN ENDOCR METAB, V90, P5037, DOI 10.1210/jc.2005-0227; Wiesbauer M, 2006, ELECTROPHORESIS, V27, P3864, DOI 10.1002/elps.200600086; Xu L, 2006, INT J GYNECOL CANCER, V16, P1661, DOI 10.1111/j.1525-1438.2006.00641.x; Yoneyama H, 2005, MOL CANCER RES, V3, P14	45	36	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e27192	10.1371/journal.pone.0027192	http://dx.doi.org/10.1371/journal.pone.0027192			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174736	Green Published, Green Submitted, gold			2022-12-25	WOS:000298365700003
J	Fong, V; Osterbur, M; Capella, C; Kim, YE; Hine, C; Gorbunova, V; Seluanov, A; Dewhurst, S				Fong, Vincent; Osterbur, Marika; Capella, Cristina; Kim, Yo-El; Hine, Christopher; Gorbunova, Vera; Seluanov, Andrei; Dewhurst, Stephen			Adenoviral Vector Driven by a Minimal Rad51 Promoter Is Selective for p53-Deficient Tumor Cells	PLOS ONE			English	Article							CANCER GENE-THERAPY; DNA-REPAIR; TRANSCRIPTIONAL REGULATION; HOMOLOGOUS RECOMBINATION; BINDING PROTEIN; BREAK REPAIR; P53; EXPRESSION; OVEREXPRESSION; INSTABILITY	Background: The full length Rad51 promoter is highly active in cancer cells but not in normal cells. We therefore set out to assess whether we could confer this tumor-selectivity to an adenovirus vector. Methodology/Principal Findings: Expression of an adenovirally-vectored luciferase reporter gene from the Rad51 promoter was up to 50 fold higher in cancer cells than in normal cells. Further evaluations of a panel of truncated promoter mutants identified a 447 bp minimal core promoter element that retained the full tumor selectivity and transcriptional activity of the original promoter, in the context of an adenovirus vector. This core Rad51 promoter was highly active in cancer cells that lack functional p53, but less active in normal cells and in cancer cell lines with intact p53 function. Exogenous expression of p53 in a p53 null cell line strongly suppressed activity of the Rad51 core promoter, underscoring the selectivity of this promoter for p53-deficient cells. Follow-up experiments showed that the p53-dependent suppression of the Rad51 core promoter was mediated via an indirect, p300 coactivator dependent mechanism. Finally, transduction of target cells with an adenovirus vector encoding the thymidine kinase gene under transcriptional control of the Rad51 core promoter resulted in efficient killing of p53 defective cancer cells, but not of normal cells, upon addition of ganciclovir. Conclusions/Significance: Overall, these experiments demonstrated that a small core domain of the Rad51 promoter can be used to target selective transgene expression from adenoviral vectors to tumor cells lacking functional p53.	[Fong, Vincent; Osterbur, Marika; Capella, Cristina; Kim, Yo-El; Dewhurst, Stephen] Univ Rochester, Dept Microbiol & Immunol, Rochester, NY 14627 USA; [Hine, Christopher; Gorbunova, Vera; Seluanov, Andrei] Univ Rochester, Dept Biol, Rochester, NY 14627 USA	University of Rochester; University of Rochester	Fong, V (corresponding author), Univ Rochester, Dept Microbiol & Immunol, Rochester, NY 14627 USA.	stephen_dewhurst@urmc.rochester.edu		Hine, Christopher/0000-0003-1926-7939; Dewhurst, Stephen/0000-0001-7729-7920; Gorbunova, Vera/0000-0001-8979-0333; Seluanov, Andrei/0000-0003-3400-538X	U.S. National Institutes of Health (NIH) [T32 GM07356]; NIH [R21 CA122213, R01 AG031227, R01 AG27237, T32 GM068411]; NATIONAL CANCER INSTITUTE [R21CA122213] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM068411, T32GM007356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027237, R01AG031227] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	VF is a trainee in the Medical Scientist Training Program, funded by the U.S. National Institutes of Health (NIH) award T32 GM07356. This work was also supported by NIH awards R21 CA122213 (SD), R01 AG031227, R01 AG27237 (VG) and T32 GM068411 (VF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Lopez C, 2006, EMBO REP, V7, P219, DOI 10.1038/sj.embor.7400587; Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; Barbano R, 2010, INT J CANC; Baumann P, 1998, TRENDS BIOCHEM SCI, V23, P247, DOI 10.1016/S0968-0004(98)01232-8; BETT AJ, 1993, J VIROL, V67, P5911, DOI 10.1128/JVI.67.10.5911-5921.1993; BODNER SM, 1992, ONCOGENE, V7, P743; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Grossman SR, 2001, EUR J BIOCHEM, V268, P2773, DOI 10.1046/j.1432-1327.2001.02226.x; Hainaut P, 1997, NUCLEIC ACIDS RES, V25, P151, DOI 10.1093/nar/25.1.151; Hannay JAF, 2007, MOL CANCER THER, V6, P1650, DOI 10.1158/1535-7163.MCT-06-0636; Hasselbach L, 2005, EUR J GYNAECOL ONCOL, V26, P589; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hine CM, 2008, P NATL ACAD SCI USA, V105, P20810, DOI 10.1073/pnas.0807990106; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Iwanaga R, 2004, ONCOGENE, V23, P8581, DOI 10.1038/sj.onc.1207976; JACOBS JP, 1970, NATURE, V227, P168, DOI 10.1038/227168a0; KALTHOFF H, 1993, ONCOGENE, V8, P289; Kanaya T, 2000, CLIN CANCER RES, V6, P1239; Kauffmann A, 2008, ONCOGENE, V27, P565, DOI 10.1038/sj.onc.1210700; Klein HL, 2008, DNA REPAIR, V7, P686, DOI 10.1016/j.dnarep.2007.12.008; Kubicka S, 1999, J BIOL CHEM, V274, P32137, DOI 10.1074/jbc.274.45.32137; Lu WG, 2002, CANCER RES, V62, P1305; Maacke H, 2000, INT J CANCER, V88, P907, DOI 10.1002/1097-0215(20001215)88:6<907::AID-IJC11>3.0.CO;2-4; Maacke H, 2000, ONCOGENE, V19, P2791, DOI 10.1038/sj.onc.1203578; Maggirwar SB, 2000, J NEUROCHEM, V74, P527, DOI 10.1046/j.1471-4159.2000.740527.x; Martin RW, 2007, CANCER RES, V67, P9658, DOI 10.1158/0008-5472.CAN-07-0290; Mitra A, 2009, HISTOPATHOLOGY, V55, P696, DOI 10.1111/j.1365-2559.2009.03448.x; Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063; OConnor PM, 1997, CANCER RES, V57, P4285; Pastorcic M, 2000, J BIOL CHEM, V275, P34938, DOI 10.1074/jbc.M005411200; Pfitzner E, 1998, MOL ENDOCRINOL, V12, P1582, DOI 10.1210/mend.12.10.0180; Raderschall E, 2002, CANCER RES, V62, P219; Richardson C, 2005, CANCER LETT, V218, P127, DOI 10.1016/j.canlet.2004.08.009; Richardson C, 2004, ONCOGENE, V23, P546, DOI 10.1038/sj.onc.1207098; Sadeghi H, 2005, CURR GENE THER, V5, P411, DOI 10.2174/1566523054546189; Saukkonen K, 2004, EXPERT OPIN BIOL TH, V4, P683, DOI 10.1517/eobt.4.5.683.31060; SCHEFFNER M, 1991, P NATL ACAD SCI USA, V88, P5523, DOI 10.1073/pnas.88.13.5523; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; Shammas MA, 2009, BLOOD, V113, P2290, DOI 10.1182/blood-2007-05-089193; Shirakawa T, 2008, MOL CELLS, V25, P462; Slupianek A, 2002, MOL CELL BIOL, V22, P4189, DOI 10.1128/MCB.22.12.4189-4201.2002; Smith AC, 2009, J VIROL, V83, P2025, DOI 10.1128/JVI.01644-08; Thacker J, 2005, CANCER LETT, V219, P125, DOI 10.1016/j.canlet.2004.08.018; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Wyllie FS, 2000, NAT GENET, V24, P16, DOI 10.1038/71630; Xia SJJ, 1997, MOL CELL BIOL, V17, P7151, DOI 10.1128/MCB.17.12.7151; Yuan Ying, 2004, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V21, P248	48	14	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28714	10.1371/journal.pone.0028714	http://dx.doi.org/10.1371/journal.pone.0028714			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174876	Green Published, Green Submitted, gold			2022-12-25	WOS:000298365700065
J	Liu, YW; Dai, B; Xu, CG; Fu, LL; Hua, ZH; Mei, CL				Liu, Yawei; Dai, Bing; Xu, Chenggang; Fu, Lili; Hua, Zhenhao; Mei, Changlin			Rosiglitazone Inhibits Transforming Growth Factor-beta 1 Mediated Fibrogenesis in ADPKD Cyst-Lining Epithelial Cells	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; AUTOSOMAL-DOMINANT; TGF-BETA; MESANGIAL CELLS; GROWTH-FACTOR; CROSS-TALK; SIGNALING PATHWAYS; PPAR-GAMMA; MAP KINASE; EXPRESSION	Background: Interstitial fibrosis plays an important role in progressive renal dysfunction in autosomal dominant polycystic kidney disease (ADPKD). In our previous studies, we confirmed that PPAR-gamma agonist, rosiglitazone could protect renal function and prolong the survival of a slowly progressive ADPKD animal model by reducing renal fibrosis. However, the mechanism remains unknown. Methods: Primary culture epithelial cells pretreated with TGF-beta 1 were incubated with rosiglitazone. Extracellular matrix proteins were detected using real-time PCR and Western blotting. MAPK and Smad2 phosphorylation were measured with western blot. ERK1/2 pathway and P38 pathway were inhibited with the specific inhibitors PD98059 and SB203580. The Smad2 pathway was blocked with the siRNA. To address whether PPAR-gamma agonist-mediated inhibition of TGF-beta 1-induced collagen type I expression was mediated through a PPAR-gamma dependent mechanism, genetic and pharmaceutical approaches were used to block the activity of endogenous PPAR gamma. Results: TGF-beta 1-stimulated collagen type I and fibronectin expression of ADPKD cyst-lining epithelia were inhibited by rosiglitazone in a dosage-dependent manner. Smad2, ERK1/2 and P38 pathways were activated in response to TGF-beta 1; however, TGF-beta 1 had little effect on JNK pathway. Rosiglitazone suppressed TGF-beta 1 induced Smad2 activation, while ERK1/2 and P38MAPK signals remained unaffected. Rosiglitazone could also attenuate TGF-beta 1-stimulated collagen type I and fibronectin expression in primary renal tubular epithelial cells, but had no effect on TGF-beta 1-induced activation of Smad2, ERK1/2 and P38 pathways. There was no crosstalk between the Smad2 and MAPK pathways in ADPKD cyst-lining epithelial cells. These inhibitory effects of rosiglitazone were reversed by the PPAR gamma specific antagonist GW9662 and PPAR gamma siRNA. Conclusion: ADPKD cyst-lining epithelial cells participate in TGF-beta 1 mediated fibrogenesis. Rosiglitazone could suppress TGF-beta 1-induced collagen type I and fibronectin expression in ADPKD cyst-lining epithelia through modulation of the Smad2 pathway. Our study may provide therapeutic basis for clinical applications of rosiglitazone in retarding the progression of ADPKD.	[Liu, Yawei; Dai, Bing; Xu, Chenggang; Fu, Lili; Hua, Zhenhao; Mei, Changlin] Second Mil Med Univ, Shanghai Changzheng Hosp, Div Nephrol, Nephrol Inst PLA, Shanghai, Peoples R China	Naval Medical University	Liu, YW (corresponding author), Second Mil Med Univ, Shanghai Changzheng Hosp, Div Nephrol, Nephrol Inst PLA, Shanghai, Peoples R China.	chlmei1954@yahoo.com.cn	Xu, Cheng/GXH-4815-2022	Xu, Cheng/0000-0003-1000-733X	National Natural Science Foundation of China [30900692, 81000283]; Shanghai Leading Academic Discipline Project [B902]; National 863 Plan in High Technology Progress [2007AA02Z3 Z1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); National 863 Plan in High Technology Progress(National High Technology Research and Development Program of China)	This work was supported by grants from the National Natural Science Foundation of China (30900692, 81000283), Shanghai Leading Academic Discipline Project (B902) and National 863 Plan in High Technology Progress (2007AA02Z3 Z1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Border WA, 1997, KIDNEY INT, V51, P1388, DOI 10.1038/ki.1997.190; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Chea SW, 2009, YONSEI MED J, V50, P105, DOI 10.3349/ymj.2009.50.1.105; Chin BY, 2001, AM J PHYSIOL-RENAL, V280, pF495, DOI 10.1152/ajprenal.2001.280.3.F495; Dai B, 2010, CLIN SCI, V119, P323, DOI 10.1042/CS20100113; DETRISAC CJ, 1984, KIDNEY INT, V25, P383, DOI 10.1038/ki.1984.28; Elberg G, 2008, CELL TISSUE RES, V331, P495, DOI 10.1007/s00441-007-0521-4; Guo BL, 2004, DIABETES, V53, P200, DOI 10.2337/diabetes.53.1.200; Haraguchi Kazutaka, 2003, Clin Exp Nephrol, V7, P27, DOI 10.1007/s101570300003; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Hartsough MT, 1996, J BIOL CHEM, V271, P22368, DOI 10.1074/jbc.271.37.22368; Hassane S, 2010, J PATHOL, V222, P21, DOI 10.1002/path.2734; Hayashida T, 1999, KIDNEY INT, V56, P1710, DOI 10.1046/j.1523-1755.1999.00733.x; Hayashida T, 2003, FASEB J, V17, P1576, DOI 10.1096/fj.03-0037fje; Heeg MHJ, 2005, KIDNEY INT, V68, P96, DOI 10.1111/j.1523-1755.2005.00384.x; Hocevar BA, 1999, EMBO J, V18, P1345, DOI 10.1093/emboj/18.5.1345; Kawai T, 2009, LAB INVEST, V89, P47, DOI 10.1038/labinvest.2008.104; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Li FF, 2009, BIOCHEM BIOPH RES CO, V386, P289, DOI 10.1016/j.bbrc.2009.05.084; Li J, 2009, J RECEPT SIG TRANSD, V29, P280, DOI 10.1080/10799890903078465; Li YJ, 2006, J AM SOC NEPHROL, V17, P54, DOI 10.1681/ASN.2005030257; LIESKE JC, 1993, J AM SOC NEPHROL, V3, P1442; Loghman-Adham M, 2003, AM J PHYSIOL-RENAL, V285, pF397, DOI 10.1152/ajprenal.00310.2002; Ma LJ, 2001, KIDNEY INT, V59, P1899, DOI 10.1046/j.1523-1755.2001.0590051899.x; McCarthy KJ, 2000, KIDNEY INT, V58, P2341, DOI 10.1046/j.1523-1755.2000.00418.x; Miyazono K, 2000, CYTOKINE GROWTH F R, V11, P15, DOI 10.1016/S1359-6101(99)00025-8; Okada H, 2000, KIDNEY INT, V58, P587, DOI 10.1046/j.1523-1755.2000.00205.x; Omori S, 2006, J AM SOC NEPHROL, V17, P1604, DOI 10.1681/ASN.2004090800; Routh RE, 2002, KIDNEY INT, V61, P1365, DOI 10.1046/j.1523-1755.2002.00277.x; Schieren G, 2006, NEPHROL DIAL TRANSPL, V21, P1816, DOI 10.1093/ndt/gfl071; Schoonjans K, 1997, CURR OPIN LIPIDOL, V8, P159, DOI 10.1097/00041433-199706000-00006; Serra AL, 2010, NEW ENGL J MED, V363, P820, DOI 10.1056/NEJMoa0907419; Shibazaki S, 2008, HUM MOL GENET, V17, P1505, DOI 10.1093/hmg/ddn039; Song XW, 2009, HUM MOL GENET, V18, P2328, DOI 10.1093/hmg/ddp165; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; Torres VE, 2006, NAT CLIN PRACT NEPHR, V2, P40, DOI 10.1038/ncpneph0070; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Uchiyama-Tanaka Y, 2001, KIDNEY INT, V60, P2153, DOI 10.1046/j.1523-1755.2001.00067.x; Walz G, 2010, NEW ENGL J MED, V363, P830, DOI 10.1056/NEJMoa1003491; Wang W, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/62641; Watanabe H, 2001, J BIOL CHEM, V276, P14466, DOI 10.1074/jbc.M005724200; Watnick T, 2010, NEW ENGL J MED, V363, P879, DOI 10.1056/NEJMe1006925; WILSON PD, 1991, AM J KIDNEY DIS, V17, P634, DOI 10.1016/S0272-6386(12)80338-6; WILSON PD, 1992, J CELL PHYSIOL, V150, P360, DOI 10.1002/jcp.1041500220; Yamaguchi T, 2004, J BIOL CHEM, V279, P40419, DOI 10.1074/jbc.M405079200; Yamaguchi T, 2000, KIDNEY INT, V57, P1460, DOI 10.1046/j.1523-1755.2000.00991.x; Yoshihara D, 2011, AM J PHYSIOL-RENAL, V300, pF465, DOI 10.1152/ajprenal.00460.2010; Yue JB, 1999, ONCOGENE, V18, P2033, DOI 10.1038/sj.onc.1202521; Zafar I, 2010, KIDNEY INT, V78, P754, DOI 10.1038/ki.2010.250	50	22	24	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28915	10.1371/journal.pone.0028915	http://dx.doi.org/10.1371/journal.pone.0028915			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174924	Green Published, gold, Green Submitted			2022-12-25	WOS:000298365700082
J	Morgillo, F; Martinelli, E; Troiani, T; Orditura, M; De Vita, F; Ciardiello, F				Morgillo, Floriana; Martinelli, Erika; Troiani, Teresa; Orditura, Michele; De Vita, Ferdinando; Ciardiello, Fortunato			Antitumor Activity of Sorafenib in Human Cancer Cell Lines with Acquired Resistance to EGFR and VEGFR Tyrosine Kinase Inhibitors (Publication with Expression of Concern. See vol. 14, 2019) (Publication with Expression of Concern. See vol. 14, 2019)	PLOS ONE			English	Article; Publication with Expression of Concern							LUNG-CANCER; RAF/MEK/ERK PATHWAY; TUMOR-CELLS; COMBINATION; GEFITINIB; APOPTOSIS; TRIAL	Treatment of non small cell lung cancer (NSCLC) and colorectal cancer (CRC) have substantially changed in the last years with the introduction of epidermal growth factor receptor (EGFR) inhibitors in the clinical practice. The understanding of mechanisms which regulate cells sensitivity to these drugs is necessary for their optimal use. An in vitro model of acquired resistance to two tyrosine kinase inhibitors (TKI) targeting the EGFR, erlotinib and gefitinib, and to a TKI targeting EGFR and VEGFR, vandetanib, was developed by continuously treating the human NSCLC cell line CALU-3 and the human CRC cell line HCT116 with escalating doses of each drug. MTT, western blot analysis, migration, invasion and anchorage-independent colony forming assays were conducted in vitro and experiments with established xenografts in athymic nude mice were performed in vivo in sensitive, wild type (WT) and TKI-resistant CALU-3 and HCT116 cell lines. As compared to WT CALU-3 and HCT116 human cancer cells, TKI-resistant cell lines showed a significant increase in the levels of activated, phosphorylated AKT, MAPK, and of survivin. Considering the role of RAS and RAF as downstream signals of both the EGFR and VEGFR pathways, we treated resistant cells with sorafenib, an inhibitor of C-RAF, B-RAF, c-KIT, FLT-3, RET, VEGFR-2, VEGFR-3, and PDGFR-beta. Sorafenib reduced the activation of MEK and MAPK and caused an inhibition of cell proliferation, invasion, migration, anchorage-independent growth in vitro and of tumor growth in vivo of all TKI-resistant CALU-3 and HCT116 cell lines. These data suggest that resistance to EGFR inhibitors is predominantly driven by the RAS/RAF/MAPK pathway and can be overcame by treatment with sorafenib.	[Morgillo, Floriana; Martinelli, Erika; Troiani, Teresa; Orditura, Michele; De Vita, Ferdinando; Ciardiello, Fortunato] Univ Naples 2, Div Med Oncol, Dept Clin & Expt Med & Surg F Magrassi & A Lanzar, Naples, Italy	Universita della Campania Vanvitelli	Morgillo, F (corresponding author), Univ Naples 2, Div Med Oncol, Dept Clin & Expt Med & Surg F Magrassi & A Lanzar, Naples, Italy.	florianamorgillo@yahoo.it		MORGILLO, Floriana/0000-0002-9167-323X; Ciardiello, Fortunato/0000-0002-3369-4841; Erika, Martinelli/0000-0002-0291-475X; ORDITURA, Michele/0000-0001-9105-8563; troiani, teresa/0000-0002-0646-4901	Associazione Italiana per la Ricerca sul Cancro (AIRC), Milan, Italy; European Society of Medical Oncology (ESMO)	Associazione Italiana per la Ricerca sul Cancro (AIRC), Milan, Italy(Fondazione AIRC per la ricerca sul cancro); European Society of Medical Oncology (ESMO)	This work was supported by a grant from the Associazione Italiana per la Ricerca sul Cancro (AIRC), Milan, Italy. Floriana Morgillo is the recipient of an European Society of Medical Oncology (ESMO) translational research fellowship. the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianco R, 2003, ONCOGENE, V22, P2812, DOI 10.1038/sj.onc.1206388; Bianco R, 2008, CLIN CANCER RES, V14, P5069, DOI 10.1158/1078-0432.CCR-07-4905; Ciardiello F, 2004, CLIN CANCER RES, V10, P784, DOI 10.1158/1078-0432.CCR-1100-03; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; DEROOCK A, 2010, JAMA-J AM MED ASSOC, V304, P1812; Engelman JA, 2008, CLIN CANCER RES, V14, P2895, DOI 10.1158/1078-0432.CCR-07-2248; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Flaherty KT, 2008, CLIN CANCER RES, V14, P4836, DOI 10.1158/1078-0432.CCR-07-4123; Gandhi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004576; Herbst RS, 2005, J CLIN ONCOL, V23, P2544, DOI 10.1200/JCO.2005.02.477; HEYMACH JV, 2006, P AM SOC CLIN ONCO S, V18, P7016; Janmaat ML, 2003, CLIN CANCER RES, V9, P2316; Janmaat ML, 2006, INT J CANCER, V118, P209, DOI 10.1002/ijc.21290; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; Magne N, 2002, BRIT J CANCER, V86, P1518, DOI 10.1038/sj/bjc/6600299; Martinelli E, 2010, CLIN CANCER RES, V16, P4990, DOI 10.1158/1078-0432.CCR-10-0923; MORGILLO F, 2006, CANCER RES, P66; MORGILLO F, 2010, LUNG CANCER, P8; Morgillo F, 2007, DIFFERENTIATION, V75, P788, DOI 10.1111/j.1432-0436.2007.00200.x; Morgillo F, 2007, CLIN CANCER RES, V13, P2795, DOI 10.1158/1078-0432.CCR-06-2077; Natale RB, 2006, J CLIN ONCOL, V24, p364S; Normanno N, 2009, NAT REV CLIN ONCOL, V6, P519, DOI 10.1038/nrclinonc.2009.111; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Roberts PJ, 2010, J CLIN ONCOL, V28, P4769, DOI 10.1200/JCO.2009.27.4365; ROOCK WD, 2010, LANCET ONCOL; Schiller JH, 2006, J CLIN ONCOL, V24, P7194, DOI [DOI 10.1200/JCO.2006.24.18_SUPPL.7194, 10.1200/jco.2006.24.18_suppl.7194]; Stein RC, 2001, ENDOCR-RELAT CANCER, V8, P237, DOI 10.1677/erc.0.0080237; Weickhardt AJ, 2010, CURR CANCER DRUG TAR, V10, P824; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443	29	35	38	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28841	10.1371/journal.pone.0028841	http://dx.doi.org/10.1371/journal.pone.0028841			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174910	Green Published, Green Submitted, gold			2022-12-25	WOS:000298365700076
J	Strap, JL; Latos, A; Shim, I; Bonetta, DT				Strap, Janice L.; Latos, Andrew; Shim, Isaac; Bonetta, Dario T.			Characterization of Pellicle Inhibition in Gluconacetobacter xylinus 53582 by a Small Molecule, Pellicin, Identified by a Chemical Genetics Screen	PLOS ONE			English	Article							GMP-BINDING-PROTEIN; ACETOBACTER-XYLINUM; CELLULOSE BIOSYNTHESIS; BACTERIAL CELLULOSE; ESCHERICHIA-COLI; DI-GMP; MICROBIAL CELLULOSE; CELL-GROWTH; SYNTHASE; CRYSTALLIZATION	Pellicin ([2E]-3-phenyl-1-[ 2,3,4,5-tetrahydro-1,6-benzodioxocin-8-yl]prop-2-en-1-one) was identified in a chemical genetics screen of 10,000 small molecules for its ability to completely abolish pellicle production in Gluconacetobacter xylinus. Cells grown in the presence of pellicin grew 1.5 times faster than untreated cells. Interestingly, growth in pellicin also caused G. xylinus cells to elongate. Measurement of cellulose synthesis in vitro showed that cellulose synthase activity was not directly inhibited by pellicin. Rather, when cellulose synthase activity was measured in cells that were pre-treated with the compound, the rate of cellulose synthesis increased eight-fold over that observed for untreated cells. This phenomenon was also apparent in the rapid production of cellulose when cells grown in the presence of pellicin were washed and transferred to media lacking the inhibitor. The rate at which cellulose was produced could not be accounted for by growth of the organism. Pellicin was not detected when intracellular contents were analyzed. Furthermore, it was found that pellicin exerts its effect extracellularly by interfering with the crystallization of pre-cellulosic tactoidal aggregates. This interference of the crystallization process resulted in enhanced production of cellulose II as evidenced by the ratio of acid insoluble to acid soluble product in in vitro assays and confirmed in vivo by scanning electron microscopy and powder X-ray diffraction. The relative crystallinity index, RCI, of pellicle produced by untreated G. xylinus cultures was 70% while pellicin-grown cultures had RCI of 38%. Mercerized pellicle of untreated cells had RCI of 42%, which further confirms the mechanism of action of pellicin as an inhibitor of the cellulose I crystallization process. Pellicin is a useful tool for the study of cellulose biosynthesis in G. xylinus.	[Strap, Janice L.; Latos, Andrew; Shim, Isaac; Bonetta, Dario T.] Univ Ontario, Fac Sci, Inst Technol, Oshawa, ON, Canada	Ontario Tech University	Strap, JL (corresponding author), Univ Ontario, Fac Sci, Inst Technol, Oshawa, ON, Canada.	janice.strap@uoit.ca; dario.bonetta@uoit.ca	Strap, Janice L/H-2395-2012		University of Ontario Institute of Technology; Natural Sciences and Engineering Research Council of Canada	University of Ontario Institute of Technology; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by University of Ontario Institute of Technology start-up funds to JLS and a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada to DTB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONI Y, 1982, P NATL ACAD SCI-BIOL, V79, P6448, DOI 10.1073/pnas.79.21.6448; Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739; Ausmees N, 2001, FEMS MICROBIOL LETT, V204, P163, DOI 10.1111/j.1574-6968.2001.tb10880.x; Bae SO, 2004, APPL MICROBIOL BIOT, V65, P315, DOI 10.1007/s00253-004-1593-7; BENZIMAN M, 1980, P NATL ACAD SCI-BIOL, V77, P6678, DOI 10.1073/pnas.77.11.6678; BENZIMAN M, 1983, J APPL POLYM SCI, V37, P131; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUREAU TE, 1987, P NATL ACAD SCI USA, V84, P6985, DOI 10.1073/pnas.84.20.6985; COLVIN JR, 1983, PROTOPLASMA, V116, P34, DOI 10.1007/BF01294228; Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035; Delmer DP, 2002, METAB ENG, V4, P22, DOI 10.1006/mben.2001.0206; Fu GZ, 2003, INT J LIFE CYCLE ASS, V8, P137, DOI 10.1007/BF02978458; Galperin MY, 2004, ENVIRON MICROBIOL, V6, P552, DOI 10.1111/j.1462-2920.2004.00633.x; GLASER L, 1958, J BIOL CHEM, V232, P627; HAIGLER CH, 1980, SCIENCE, V210, P903, DOI 10.1126/science.7434003; Hesse-Ertelt S, 2008, MAGN RESON CHEM, V46, P1030, DOI 10.1002/mrc.2311; HESTRIN S, 1954, BIOCHEM J, V58, P345, DOI 10.1042/bj0580345; Hu SQ, 2008, PROTEIN PEPTIDE LETT, V15, P115; Iyer PR, 2010, J BACTERIOL, V192, P4256, DOI 10.1128/JB.00588-10; Kawano S, 2002, J BIOSCI BIOENG, V94, P275, DOI 10.1263/jbb.94.275; Kawano S, 2008, J BIOSCI BIOENG, V106, P88, DOI 10.1263/jbb.106.88; Kim MK, 2002, APPL MICROBIOL BIOT, V60, P134, DOI 10.1007/s00253-002-1102-9; KUGA S, 1993, POLYMER, V34, P3293, DOI 10.1016/0032-3861(93)90404-X; Le Quere B, 2009, MOL MICROBIOL, V72, P724, DOI 10.1111/j.1365-2958.2009.06678.x; LIN FC, 1990, J BIOL CHEM, V265, P4782; Nakai T, 2002, BIOCHEM BIOPH RES CO, V295, P458, DOI 10.1016/S0006-291X(02)00696-4; Rattee I.D., 1974, PHYS CHEM DYE ABSORP; ROSS P, 1985, FEBS LETT, V186, P191, DOI 10.1016/0014-5793(85)80706-7; ROSS P, 1991, MICROBIOL REV, V55, P35, DOI 10.1128/MMBR.55.1.35-58.1991; SAXENA IM, 1990, PLANT MOL BIOL, V15, P673, DOI 10.1007/BF00016118; SAXENA IM, 1994, J BACTERIOL, V176, P5735, DOI 10.1128/JB.176.18.5735-5752.1994; SCHRAMM M, 1954, J GEN MICROBIOL, V11, P123, DOI 10.1099/00221287-11-1-123; Segal L., 1959, TEXT RES J, V29, P786, DOI [DOI 10.1177/004051755902901003, 10.1177/004051755902901003]; Shah J, 2005, APPL MICROBIOL BIOT, V66, P352, DOI 10.1007/s00253-004-1756-6; Shibazaki H, 1997, CELLULOSE, V4, P75, DOI 10.1023/A:1024273218783; STANDAL R, 1994, J BACTERIOL, V176, P665, DOI 10.1128/jb.176.3.665-672.1994; Stockwell BR, 2000, NAT REV GENET, V1, P116, DOI 10.1038/35038557; Tahara N, 1997, J FERMENT BIOENG, V83, P389, DOI 10.1016/S0922-338X(97)80148-1; Tal R, 1998, J BACTERIOL, V180, P4416, DOI 10.1128/JB.180.17.4416-4425.1998; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; Weinhouse H, 1997, FEBS LETT, V416, P207, DOI 10.1016/S0014-5793(97)01202-7; WILLIAMS WS, 1989, APPL ENVIRON MICROB, V55, P2448, DOI 10.1128/AEM.55.10.2448-2452.1989; WONG HC, 1990, P NATL ACAD SCI USA, V87, P8130, DOI 10.1073/pnas.87.20.8130; Xu HB, 2008, J BACTERIOL, V190, P4971, DOI 10.1128/JB.01849-07; Yu XC, 1996, INT J BIOL MACROMOL, V19, P145, DOI 10.1016/0141-8130(96)01109-9; Zogaj X, 2001, MOL MICROBIOL, V39, P1452, DOI 10.1046/j.1365-2958.2001.02337.x	46	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28015	10.1371/journal.pone.0028015	http://dx.doi.org/10.1371/journal.pone.0028015			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174763	gold, Green Published, Green Submitted			2022-12-25	WOS:000298365700015
J	Claessen, JHL; Ploegh, HL				Claessen, Jasper H. L.; Ploegh, Hidde L.			BAT3 Guides Misfolded Glycoproteins Out of the Endoplasmic Reticulum	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; MEMBRANE-PROTEIN; QUALITY-CONTROL; ER; CYTOSOL; DISLOCATION; DEGRADATION; PROTEASOME; TRANSLOCATION; RECOGNITION	Secretory and membrane proteins that fail to acquire their native conformation within the lumen of the Endoplasmic Reticulum (ER) are usually targeted for ubiquitin-dependent degradation by the proteasome. How partially folded polypeptides are kept from aggregation once ejected from the ER into the cytosol is not known. We show that BAT3, a cytosolic chaperone, is recruited to the site of dislocation through its interaction with Derlin2. Furthermore, we observe cytoplasmic BAT3 in a complex with a polypeptide that originates in the ER as a glycoprotein, an interaction that depends on the cytosolic disposition of both, visualized even in the absence of proteasomal inhibition. Cells depleted of BAT3 fail to degrade an established dislocation substrate. We thus implicate a cytosolic chaperone as an active participant in the dislocation of ER glycoproteins.	[Claessen, Jasper H. L.; Ploegh, Hidde L.] MIT, Dept Biol, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Claessen, JHL (corresponding author), MIT, Dept Biol, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA.	ploegh@wi.mit.edu			National Institutes of Health; Boehringer Ingelheim Fonds	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim Fonds(Boehringer Ingelheim)	This work was supported by a research grant from the National Institutes of Health and a fellowship from the Boehringer Ingelheim Fonds to JHLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagola K, 2011, BBA-BIOMEMBRANES, V1808, P925, DOI 10.1016/j.bbamem.2010.06.025; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Claessen JHL, 2010, J BIOL CHEM, V285, P20732, DOI 10.1074/jbc.M110.120766; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; Ernst R, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000605; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Hessa T, 2011, NATURE, V475, P394, DOI 10.1038/nature10181; Huppa JB, 1997, IMMUNITY, V7, P113, DOI 10.1016/S1074-7613(00)80514-2; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Leznicki P, 2010, J CELL SCI, V123, P2170, DOI 10.1242/jcs.066738; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Manchen ST, 2001, BIOCHEM BIOPH RES CO, V287, P1075, DOI 10.1006/bbrc.2001.5701; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; Minami R, 2010, J CELL BIOL, V190, P637, DOI 10.1083/jcb.200908092; Navon A, 2001, MOL CELL, V8, P1339, DOI 10.1016/S1097-2765(01)00407-5; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; SONEOKA Y, 1995, NUCLEIC ACIDS RES, V23, P628, DOI 10.1093/nar/23.4.628; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041	30	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28542	10.1371/journal.pone.0028542	http://dx.doi.org/10.1371/journal.pone.0028542			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174835	Green Published, Green Submitted, gold			2022-12-25	WOS:000298163600032
J	Escalante, T; Ortiz, N; Rucavado, A; Sanchez, EF; Richardson, M; Fox, JW; Gutierrez, JM				Escalante, Teresa; Ortiz, Natalia; Rucavado, Alexandra; Sanchez, Eladio F.; Richardson, Michael; Fox, Jay W.; Maria Gutierrez, Jose			Role of Collagens and Perlecan in Microvascular Stability: Exploring the Mechanism of Capillary Vessel Damage by Snake Venom Metalloproteinases	PLOS ONE			English	Article							BOTHROPS-ASPER TERCIOPELO; VON-WILLEBRAND-FACTOR; CROTALUS-ATROX VENOM; CYSTEINE-RICH DOMAIN; LOCAL TISSUE-DAMAGE; WEAK HEMORRHAGIC ACTIVITY; BASEMENT-MEMBRANES; HUMAN ALPHA-2-MACROGLOBULIN; CRYSTAL-STRUCTURE; ACUTUS VENOM	Hemorrhage is a clinically important manifestation of viperid snakebite envenomings, and is induced by snake venom metalloproteinases (SVMPs). Hemorrhagic and non-hemorrhagic SVMPs hydrolyze some basement membrane (BM) and associated extracellular matrix (ECM) proteins. Nevertheless, only hemorrhagic SVMPs are able to disrupt microvessels; the mechanisms behind this functional difference remain largely unknown. We compared the proteolytic activity of the hemorrhagic P-I SVMP BaP1, from the venom of Bothrops asper, and the non-hemorrhagic P-I SVMP leucurolysin-a (leuc-a), from the venom of Bothrops leucurus, on several substrates in vitro and in vivo, focusing on BM proteins. When incubated with Matrigel, a soluble extract of BM, both enzymes hydrolyzed laminin, nidogen and perlecan, albeit BaP1 did it at a faster rate. Type IV collagen was readily digested by BaP1 while leuc-a only induced a slight hydrolysis. Degradation of BM proteins in vivo was studied in mouse gastrocnemius muscle. Western blot analysis of muscle tissue homogenates showed a similar degradation of laminin chains by both enzymes, whereas nidogen was cleaved to a higher extent by BaP1, and perlecan and type IV collagen were readily digested by BaP1 but not by leuc-a. Immunohistochemistry of muscle tissue samples showed a decrease in the immunostaining of type IV collagen after injection of BaP1, but not by leuc-a. Proteomic analysis by LC/MS/MS of exudates collected from injected muscle revealed higher amounts of perlecan, and types VI and XV collagens, in exudates from BaP1-injected tissue. The differences in the hemorrhagic activity of these SVMPs could be explained by their variable ability to degrade key BM and associated ECM substrates in vivo, particularly perlecan and several non-fibrillar collagens, which play a mechanical stabilizing role in microvessel structure. These results underscore the key role played by these ECM components in the mechanical stability of microvessels.	[Escalante, Teresa; Ortiz, Natalia; Rucavado, Alexandra; Maria Gutierrez, Jose] Univ Costa Rica, Fac Microbiol, Inst Clodomiro Picado, San Jose, Costa Rica; [Ortiz, Natalia] Univ Costa Rica, Escuela Med, Dept Bioquim, San Jose, Costa Rica; [Sanchez, Eladio F.; Richardson, Michael] Fundacao Ezequiel Dias FUNED, Ctr Pesquisa & Desenvolvimento, Belo Horizonte, MG, Brazil; [Fox, Jay W.] Univ Virginia, Sch Med, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA	Universidad Costa Rica; Universidad Costa Rica; University of Virginia	Escalante, T (corresponding author), Univ Costa Rica, Fac Microbiol, Inst Clodomiro Picado, San Jose, Costa Rica.	jose.gutierrez@ucr.ac.cr	Gutiérrez, José/GSJ-1846-2022; Sanchez, Eladio Flores/E-6942-2013; Rucavado, Alexandra/AGY-1867-2022	Flores Sanchez, Eladio Oswaldo/0000-0003-1637-9345; Escalante, Teresa/0000-0003-4140-1620; Gutierrez, Jose Maria/0000-0001-8385-3081	Vicerrectoria de Investigacion, Universidad de Costa Rica [741-A7-502, 741-B0-606]; International Foundation for Science (IFS); Organisation for the Prohibition of Chemical Weapons (OPCW) [F/4096-1, 2-N-2008, 01N-2010]; Brazilian agency CNPq; Brazilian agency FAPEMIG; University of Virginia School of Medicine	Vicerrectoria de Investigacion, Universidad de Costa Rica; International Foundation for Science (IFS)(International Foundation for Science); Organisation for the Prohibition of Chemical Weapons (OPCW); Brazilian agency CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian agency FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); University of Virginia School of Medicine	This study was supported by Vicerrectoria de Investigacion, Universidad de Costa Rica (projects 741-A7-502 and 741-B0-606), the International Foundation for Science (IFS) and the Organisation for the Prohibition of Chemical Weapons (OPCW) (projectF/4096-1), NeTropica (projects 2-N-2008 and 01N-2010), Brazilian agencies CNPq and FAPEMIG, and the University of Virginia School of Medicine (J.W.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2007, PROTEOM CLIN APPL, V1, P1004, DOI 10.1002/prca.200700217; Baldo C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000727; BARAMOVA EN, 1990, BIOCHEMISTRY-US, V29, P1069, DOI 10.1021/bi00456a032; BARAMOVA EN, 1991, BIOMED BIOCHIM ACTA, V50, P763; BARAMOVA EN, 1990, MATRIX, V10, P91, DOI 10.1016/S0934-8832(11)80175-7; BARAMOVA EN, 1989, ARCH BIOCHEM BIOPHYS, V275, P63, DOI 10.1016/0003-9861(89)90350-0; Bello CA, 2006, BIOCHIMIE, V88, P189, DOI 10.1016/j.biochi.2005.07.008; Bilguvar K, 2009, J PEDIATR-US, V155, P743, DOI 10.1016/j.jpeds.2009.04.014; BJARNASON JB, 1994, PHARMACOL THERAPEUT, V62, P325, DOI 10.1016/0163-7258(94)90049-3; BJARNASON JB, 1988, BIOL CHEM H-S, V369, P121; Bolger MB, 2001, AAPS PHARMSCI, V3; Calvete JJ, 2009, FEBS LETT, V583, P1736, DOI 10.1016/j.febslet.2009.03.029; Costell M, 1999, J CELL BIOL, V147, P1109, DOI 10.1083/jcb.147.5.1109; Escalante T, 2004, TOXICON, V43, P213, DOI 10.1016/j.toxicon.2003.11.012; Escalante T, 2003, TOXICOL APPL PHARM, V193, P17, DOI 10.1016/S0041-008X(03)00337-5; Escalante T, 2006, ARCH BIOCHEM BIOPHYS, V455, P144, DOI 10.1016/j.abb.2006.09.018; Escalante T, 2009, J PROTEOME RES, V8, P5120, DOI 10.1021/pr900489m; FOX JW, 1991, EMBO J, V10, P3137, DOI 10.1002/j.1460-2075.1991.tb04875.x; Fox JW, 2005, TOXICON, V45, P969, DOI 10.1016/j.toxicon.2005.02.012; Gould DB, 2005, SCIENCE, V308, P1167, DOI 10.1126/science.1109418; GUTIERREZ JM, 1995, TOXICON, V33, P19, DOI 10.1016/0041-0101(94)00138-X; Gutierrez JM, 2006, MICROVASC RES, V71, P55, DOI 10.1016/j.mvr.2005.10.007; Gutierrez JM, 2005, TOXICON, V45, P997, DOI 10.1016/j.toxicon.2005.02.029; GUTIERREZ JM, 1985, TOXICON, V23, P887, DOI 10.1016/0041-0101(85)90380-0; Gutierrez JM, 2000, BIOCHIMIE, V82, P841, DOI 10.1016/S0300-9084(00)01163-9; Gutierrez JM, 2010, HDB VENOMS TOXINS RE, P114; Hallmann R, 2005, PHYSIOL REV, V85, P979, DOI 10.1152/physrev.00014.2004; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; IOZZO RV, 1994, BIOCHEM J, V302, P625, DOI 10.1042/bj3020625; KAMIGUTI AS, 1994, BBA-GEN SUBJECTS, V1200, P307, DOI 10.1016/0304-4165(94)90172-4; Kamiguti AS, 2005, TOXICON, V45, P1041, DOI 10.1016/j.toxicon.2005.02.026; KEENE DR, 1988, J CELL BIOL, V107, P1995, DOI 10.1083/jcb.107.5.1995; Kuo HJ, 1997, J BIOL CHEM, V272, P26522, DOI 10.1074/jbc.272.42.26522; KURECKI T, 1985, TOXICON, V23, P855, DOI 10.1016/0041-0101(85)90016-9; Kvansakul M, 2001, EMBO J, V20, P5342, DOI 10.1093/emboj/20.19.5342; LeBleu VS, 2007, EXP BIOL MED, V232, P1121, DOI 10.3181/0703-MR-72; Lingott T, 2009, BIOCHEMISTRY-US, V48, P6166, DOI 10.1021/bi9002315; Liu A, 2009, MICROVASC RES, V77, P13, DOI 10.1016/j.mvr.2008.08.008; Mackessy SP, 2002, J TOXICOL-TOXIN REV, V21, P43, DOI 10.1081/TXR-120004741; MARUYAMA M, 1992, TOXICON, V30, P1387, DOI 10.1016/0041-0101(92)90514-6; Miyoshi S, 1998, INFECT IMMUN, V66, P4851, DOI 10.1128/IAI.66.10.4851-4855.1998; Mokkapati S, 2008, J INVEST DERMATOL, V128, P2259, DOI 10.1038/jid.2008.65; MOREIRA L, 1994, TOXICON, V32, P977, DOI 10.1016/0041-0101(94)90376-X; Moura-da-Silva AM, 2008, BIOCHIMIE, V90, P484, DOI 10.1016/j.biochi.2007.11.009; Niiyama T, 2003, ACTA NEUROPATHOL, V106, P137, DOI 10.1007/s00401-003-0714-1; OHSAKA A, 1973, BIOCHIM BIOPHYS ACTA, V323, P415, DOI 10.1016/0005-2736(73)90187-9; Oliveira AK, 2010, THROMB HAEMOSTASIS, V104, P485, DOI 10.1160/TH09-12-0855; OWNBY CL, 1978, AM J PATHOL, V93, P201; Leme AFP, 2011, J PROTEOMICS, V74, P401, DOI 10.1016/j.jprot.2010.12.002; Pinto AFM, 2007, ARCH BIOCHEM BIOPHYS, V465, P11, DOI 10.1016/j.abb.2007.04.037; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Ramos OHP, 2004, TOXICON, V44, P529, DOI 10.1016/j.toxicon.2004.07.005; Rochat H., 2009, ANIMAL TOXINS STATE, P525; Rodrigues VM, 2000, ARCH BIOCHEM BIOPHYS, V381, P213, DOI 10.1006/abbi.2000.1958; Rucavado A, 1998, INT J EXP PATHOL, V79, P245; Rucavado A, 1999, TOXICON, V37, P1297, DOI 10.1016/S0041-0101(98)00268-2; Rucavado A, 1995, EXP MOL PATHOL, V63, P186, DOI 10.1006/exmp.1995.1042; Sanchez E.F., 2009, DRUG DESIGN ZINC ENZ, P789; Sanchez EF, 2010, ARCH BIOCHEM BIOPHYS, V496, P9, DOI 10.1016/j.abb.2010.01.010; Serrano SMT, 2005, BIOCHEM J, V391, P69, DOI 10.1042/BJ20050483; Serrano SMT, 2007, FEBS J, V274, P3611, DOI 10.1111/j.1742-4658.2007.05895.x; Serrano SMT, 2006, J BIOL CHEM, V281, P39746, DOI 10.1074/jbc.M604855200; Souza CT, 2001, COMP BIOCHEM PHYS B, V130, P155, DOI 10.1016/S1096-4959(01)00421-3; Specks U, 2001, CURR OPIN RHEUMATOL, V13, P12, DOI 10.1097/00002281-200101000-00003; Tanjoni I, 2010, TOXICON, V55, P1093, DOI 10.1016/j.toxicon.2009.12.010; TILLET E, 1994, EUR J BIOCHEM, V221, P177, DOI 10.1111/j.1432-1033.1994.tb18727.x; Timpl R, 1996, CURR OPIN CELL BIOL, V8, P618, DOI 10.1016/S0955-0674(96)80102-5; Tsai IH, 2000, EUR J BIOCHEM, V267, P1359, DOI 10.1046/j.1432-1327.2000.01129.x; Wallnoefer HG, 2010, J AM CHEM SOC, V132, P10330, DOI 10.1021/ja909908y; Wang WJ, 2004, BIOCHEM BIOPH RES CO, V324, P224, DOI 10.1016/j.bbrc.2004.09.031; Watanabe L, 2003, PROTEIN SCI, V12, P2273, DOI 10.1110/ps.03102403; Yurchenco PD, 2004, MATRIX BIOL, V22, P521, DOI 10.1016/j.matbio.2003.10.006	72	60	62	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28017	10.1371/journal.pone.0028017	http://dx.doi.org/10.1371/journal.pone.0028017			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174764	Green Published, gold, Green Submitted			2022-12-25	WOS:000298163600011
J	Galeano, CH; Fernandez, AC; Franco-Herrera, N; Cichy, KA; McClean, PE; Vanderleyden, J; Blair, MW				Galeano, Carlos H.; Fernandez, Andrea C.; Franco-Herrera, Natalia; Cichy, Karen A.; McClean, Phillip E.; Vanderleyden, Jos; Blair, Matthew W.			Saturation of an Intra-Gene Pool Linkage Map: Towards a Unified Consensus Linkage Map for Fine Mapping and Synteny Analysis in Common Bean	PLOS ONE			English	Article							PHASEOLUS-VULGARIS L.; QUANTITATIVE TRAIT LOCI; ROOT ARCHITECTURE TRAITS; UNGUICULATA L WALP.; MICROSATELLITE MARKERS; CROP IMPROVEMENT; GENOME SEQUENCE; SNP; QTL; INFORMATION	Map-based cloning and fine mapping to find genes of interest and marker assisted selection (MAS) requires good genetic maps with reproducible markers. In this study, we saturated the linkage map of the intra-gene pool population of common bean DOR364xBAT477 (DB) by evaluating 2,706 molecular markers including SSR, SNP, and gene-based markers. On average the polymorphism rate was 7.7% due to the narrow genetic base between the parents. The DB linkage map consisted of 291 markers with a total map length of 1,788 cM. A consensus map was built using the core mapping populations derived from inter-gene pool crosses: DOR364xG19833 (DG) and BAT93xJALO EEP558 (BJ). The consensus map consisted of a total of 1,010 markers mapped, with a total map length of 2,041 cM across 11 linkage groups. On average, each linkage group on the consensus map contained 91 markers of which 83% were single copy markers. Finally, a synteny analysis was carried out using our highly saturated consensus maps compared with the soybean pseudo-chromosome assembly. A total of 772 marker sequences were compared with the soybean genome. A total of 44 syntenic blocks were identified. The linkage group Pv6 presented the most diverse pattern of synteny with seven syntenic blocks, and Pv9 showed the most consistent relations with soybean with just two syntenic blocks. Additionally, a co-linear analysis using common bean transcript map information against soybean coding sequences (CDS) revealed the relationship with 787 soybean genes. The common bean consensus map has allowed us to map a larger number of markers, to obtain a more complete coverage of the common bean genome. Our results, combined with synteny relationships provide tools to increase marker density in selected genomic regions to identify closely linked polymorphic markers for indirect selection, fine mapping or for positional cloning.	[Galeano, Carlos H.; Vanderleyden, Jos] Katholieke Univ Leuven, Ctr Microbial & Plant Genet, Dept Microbial & Mol Syst, Heverlee, Belgium; [Fernandez, Andrea C.; Cichy, Karen A.] ARS, Sugarbeet & Bean Res Unit, USDA, E Lansing, MI USA; [Franco-Herrera, Natalia; Blair, Matthew W.] CIAT, Bean Project, Cali, Colombia; [McClean, Phillip E.] N Dakota State Univ, Genom & Bioinformat Program, Fargo, ND 58105 USA; [McClean, Phillip E.] N Dakota State Univ, Dept Plant Sci, Fargo, ND 58105 USA	KU Leuven; United States Department of Agriculture (USDA); Alliance; International Center for Tropical Agriculture - CIAT; North Dakota State University Fargo; North Dakota State University Fargo	Galeano, CH (corresponding author), Katholieke Univ Leuven, Ctr Microbial & Plant Genet, Dept Microbial & Mol Syst, Heverlee, Belgium.	galeanomendoza@gmail.com; mwb1@cornell.edu		Cichy, Karen/0000-0002-4311-0774	Generation Challenge Program and International Center for Tropical Agriculture; IRO (Interfaculty Council for Development Co-operation of the Catholic University of Leuven)	Generation Challenge Program and International Center for Tropical Agriculture; IRO (Interfaculty Council for Development Co-operation of the Catholic University of Leuven)	This work was funded by the Generation Challenge Program and International Center for Tropical Agriculture. Carlos H. Galeano is supported by a doctoral research fellowship from IRO (Interfaculty Council for Development Co-operation of the Catholic University of Leuven). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassett MJ, 1991, THEOR APPL GENET, V74, P346; BEAVIS WD, 1991, THEOR APPL GENET, V82, P636, DOI 10.1007/BF00226803; Beebe SE, 2006, CROP SCI, V46, P413, DOI 10.2135/cropsci2005.0226; Blair M, 2010, MOL BREEDING, P1; Blair MW, 2006, THEOR APPL GENET, V113, P100, DOI 10.1007/s00122-006-0276-4; Blair M, 2009, MOL BREEDING, V23, P197, DOI 10.1007/s11032-008-9225-z; Blair M, 2008, THEOR APPL GENET, V118, P91, DOI 10.1007/s00122-008-0879-z; Blair MW, 2009, CROP SCI, V49, P237, DOI 10.2135/cropsci2008.05.0246; Blair MW, 2003, THEOR APPL GENET, V107, P1362, DOI 10.1007/s00122-003-1398-6; Buso GSC, 2006, MOL ECOL NOTES, V6, P252, DOI 10.1111/j.1471-8286.2006.01210.x; Caixeta E. T., 2005, Crop Breeding and Applied Biotechnology, V5, P125; Cannon SB, 2009, PLANT PHYSIOL, V151, P970, DOI 10.1104/pp.109.144659; Cichy KA, 2009, CROP SCI, V49, P59, DOI 10.2135/cropsci2008.03.0142; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Collard BCY, 2005, EUPHYTICA, V142, P169, DOI 10.1007/s10681-005-1681-5; Cordoba JM, 2010, PLANT GENOME-US, V3, P154, DOI 10.3835/plantgenome2010.06.0013; Cordoba JM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-436; Cuevas HE, 2009, THEOR APPL GENET, V119, P741, DOI 10.1007/s00122-009-1085-3; de Campos T, 2007, PESQUI AGROPECU BRAS, V42, P589, DOI 10.1590/S0100-204X2007000400018; Frei A, 2005, CROP SCI, V45, P379, DOI 10.2135/cropsci2005.0379; Freyre R, 1998, THEOR APPL GENET, V97, P847, DOI 10.1007/s001220050964; Gaitan-Solis E, 2002, CROP SCI, V42, P2128, DOI 10.2135/cropsci2002.2128; Galeano CH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-629; Galeano CH, 2009, CROP SCI, V49, P381, DOI 10.2135/cropsci2008.07.0413; GEPTS P, 1988, ANN REP BEAN IMPROV, V31, P20; Grisi MCM, 2007, GENET MOL RES, V6, P691; Guerra-Sanz JM, 2004, PLANT BREEDING, V123, P87, DOI 10.1046/j.0179-9541.2003.00929.x; Gustafson JP, 2009, THEOR APPL GENET, V118, P793, DOI 10.1007/s00122-008-0939-4; Hanai LR, 2010, MOL BREEDING, V25, P25, DOI 10.1007/s11032-009-9306-7; Hougaard BK, 2008, GENETICS, V179, P2299, DOI 10.1534/genetics.108.090084; Hyten DL, 2010, CROP SCI, V50, P960, DOI 10.2135/cropsci2009.06.0360; Jackson BN, 2005, 2005 IEEE Computational Systems Bioinformatics Conference, Proceedings, P35, DOI 10.1109/CSB.2005.26; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lacape JM, 2009, THEOR APPL GENET, V119, P281, DOI 10.1007/s00122-009-1037-y; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Liao H, 2004, FUNCT PLANT BIOL, V31, P959, DOI 10.1071/FP03255; Lopez-Marin HD, 2009, THEOR APPL GENET, V119, P449, DOI 10.1007/s00122-009-1051-0; Mace ES, 2011, THEOR APPL GENET, V123, P169, DOI 10.1007/s00122-011-1575-y; Mace ES, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-13; Marino CL, 1996, GENOME, V39, P359, DOI 10.1139/g96-046; McClean PE, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-184; McConnell M, 2010, THEOR APPL GENET, V121, P1103, DOI 10.1007/s00122-010-1375-9; Muchero W, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-8; Muchero W, 2009, P NATL ACAD SCI USA, V106, P18159, DOI 10.1073/pnas.0905886106; NODARI RO, 1993, GENETICS, V134, P341; Quraishi UM, 2011, PLANT J, V65, P745, DOI 10.1111/j.1365-313X.2010.04461.x; Remans R, 2008, PLANT SOIL, V302, P149, DOI 10.1007/s11104-007-9462-7; Salse J, 2009, P NATL ACAD SCI USA, V106, P14908, DOI 10.1073/pnas.0902350106; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Spiller M, 2011, THEOR APPL GENET, V122, P489, DOI 10.1007/s00122-010-1463-x; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Tohme J, 1996, CROP SCI, V36, P1375, DOI 10.2135/cropsci1996.0011183X003600050048x; VALLEJOS CE, 1992, GENETICS, V131, P733; Vezzulli S, 2008, THEOR APPL GENET, V117, P499, DOI 10.1007/s00122-008-0794-3; Caldas GV, 2009, THEOR APPL GENET, V119, P131, DOI 10.1007/s00122-009-1023-4; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-101; Wu YH, 2011, IEEE ACM T COMPUT BI, V8, P381, DOI 10.1109/TCBB.2010.35; Yaish MWF, 2003, GENET MOL BIOL, V26, P337, DOI 10.1590/S1415-47572003000300019; Yap IV, 2003, GENETICS, V165, P2235	60	45	46	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28135	10.1371/journal.pone.0028135	http://dx.doi.org/10.1371/journal.pone.0028135			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174773	gold, Green Submitted, Green Published			2022-12-25	WOS:000298163600013
J	Anastas, JN; Biechele, TL; Robitaille, M; Muster, J; Allison, KH; Angers, S; Moon, RT				Anastas, J. N.; Biechele, T. L.; Robitaille, M.; Muster, J.; Allison, K. H.; Angers, S.; Moon, R. T.			A protein complex of SCRIB, NOS1AP and VANGL1 regulates cell polarity and migration, and is associated with breast cancer progression	ONCOGENE			English	Article						SCRIB; NOS1AP; VANGL1; migration; PCP	NITRIC-OXIDE SYNTHASE; NEURAL-TUBE DEFECTS; EXTENSION MOVEMENTS; E-CADHERIN; LOCALIZATION; INTERACTS; ADHESION; PATHWAY; CAPON; DEGRADATION	By analyzing public data sets of gene expression in human breast cancers we observed that increased levels of transcripts encoding the planar cell polarity (PCP) proteins SCRIB and VANGL1 correlate with increased risk of patient relapse. Experimentally, we found that reducing expression of SCRIB by short-hairpin RNAs (shRNAs) reduces the growth of human breast cancer cells in xenograft assays. To investigate SCRIB-associated proteins that might participate in the responses of breast cancer cells to altered levels of SCRIB, we used mass spectrometry and confocal microscopy. These studies reveal that SCRIB is present in at least two unique protein complexes: (1) a complex of SCRIB, ARHGEF, GIT and PAK (p21-activated kinase), and (2) a complex of SCRIB, NOS1AP and VANGL. Focusing on NOS1AP, we observed that NOS1AP colocalizes with both SCRIB and VANGL1 along cellular protrusions in metastatic breast cancer cells, but does not colocalize with either SCRIB or VANGL1 at cell junctions in normal breast cells. We investigated the effects of shRNA-mediated knockdown of NOS1AP and SCRIB in vitro, and found that reducing NOS1AP and SCRIB slows breast cancer cell migration and prevents the establishment of leading-trailing polarity. We also find that reduction of NOS1AP enhances anchorage-independent growth. Collectively these data point to the relevance of NOS1AP and SCRIB protein complexes in breast cancer. Oncogene (2012) 31, 3696-3708; doi:10.1038/onc.2011.528; published online 19 December 2011	[Anastas, J. N.; Biechele, T. L.; Muster, J.; Moon, R. T.] Univ Washington, Sch Med, Inst Stem Cell & Regenerat Med, Seattle, WA 98109 USA; [Anastas, J. N.] Univ Washington, Sch Med, Mol & Cellular Biol Grad Program, Seattle, WA 98109 USA; [Biechele, T. L.; Muster, J.; Moon, R. T.] Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98109 USA; [Biechele, T. L.; Muster, J.; Moon, R. T.] Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98109 USA; [Robitaille, M.; Angers, S.] Univ Toronto, Dept Pharmaceut Sci, Toronto, ON, Canada; [Robitaille, M.; Angers, S.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Allison, K. H.] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Toronto; University of Toronto; University of Washington; University of Washington Seattle	Moon, RT (corresponding author), Univ Washington, Sch Med, Inst Stem Cell & Regenerat Med, Campus Box 358056,815 Mercer St,Room S524, Seattle, WA 98109 USA.	rtmoon@uw.edu	Moon, Randall T/B-1743-2014; Robitaille, Melanie/ABA-5861-2020; Angers, Stephane/E-1432-2014; Moon, Randall/M-5605-2019	Moon, Randall T/0000-0002-9352-1408; Robitaille, Melanie/0000-0001-9354-5162; Angers, Stephane/0000-0001-7241-9044; Moon, Randall/0000-0002-9352-1408; Muster, Jeanot/0000-0002-1972-6851	US Department of Defense Breast Cancer Research Award [W81XWH-070100367]; Canadian Breast Cancer Foundation-Ontario Region	US Department of Defense Breast Cancer Research Award; Canadian Breast Cancer Foundation-Ontario Region	Funding for this research was provided by the US Department of Defense Breast Cancer Research Award (Grant W81XWH-070100367). RTM is an investigator of the Howard Hughes Medical Institute. MR holds a postdoctoral fellowship from the Canadian Breast Cancer Foundation-Ontario Region. Special thanks to Allison Adams for providing the GFP viruses, and Ron Steifert and the Lynn and Mike Garvey Imaging Center for their assistance.	Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Audebert S, 2004, CURR BIOL, V14, P987, DOI 10.1016/j.cub.2004.05.051; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bilder D, 2003, NAT CELL BIOL, V5, P53, DOI 10.1038/ncb897; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Carrel D, 2009, J NEUROSCI, V29, P8248, DOI 10.1523/JNEUROSCI.5287-08.2009; Cordero JB, 2010, DEV CELL, V18, P999, DOI 10.1016/j.devcel.2010.05.014; Courbard JR, 2009, DEV BIOL, V333, P67, DOI 10.1016/j.ydbio.2009.06.024; Dow LE, 2007, ONCOGENE, V26, P2272, DOI 10.1038/sj.onc.1210016; Fang M, 2000, NEURON, V28, P183, DOI 10.1016/S0896-6273(00)00095-7; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Ivanov AI, 2010, AM J PATHOL, V176, P134, DOI 10.2353/ajpath.2010.090220; Jaffrey SR, 2002, P NATL ACAD SCI USA, V99, P3199, DOI 10.1073/pnas.261705799; Jaffrey SR, 1998, NEURON, V20, P115, DOI 10.1016/S0896-6273(00)80439-0; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Metais JY, 2005, FEBS LETT, V579, P3725, DOI 10.1016/j.febslet.2005.05.062; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Moreau MM, 2010, J NEUROSCI, V30, P9738, DOI 10.1523/JNEUROSCI.6007-09.2010; Murdoch JN, 2003, HUM MOL GENET, V12, P87, DOI 10.1093/hmg/ddg014; Murdoch JN, 2001, GENOMICS, V78, P55, DOI 10.1006/geno.2001.6638; Navarro C, 2005, ONCOGENE, V24, P4330, DOI 10.1038/sj.onc.1208632; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Nola S, 2008, HUM MOL GENET, V17, P3552, DOI 10.1093/hmg/ddn248; Osmani N, 2006, CURR BIOL, V16, P2395, DOI 10.1016/j.cub.2006.10.026; Petit MM, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-1; Petit MMR, 2005, FEBS LETT, V579, P5061, DOI 10.1016/j.febslet.2005.08.012; Phua DCY, 2009, MOL BIOL CELL, V20, P2841, DOI 10.1091/mbc.E08-02-0199; Qin Y, 2005, J CELL BIOL, V171, P1061, DOI 10.1083/jcb.200506094; Richier L, 2010, J NEUROSCI, V30, P4796, DOI 10.1523/JNEUROSCI.3726-09.2010; Vervenne HBVK, 2008, DEV BIOL, V320, P267, DOI 10.1016/j.ydbio.2008.05.529; Wada H, 2005, DEVELOPMENT, V132, P2273, DOI 10.1242/dev.01810; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Zhan LX, 2008, CELL, V135, P865, DOI 10.1016/j.cell.2008.09.045	34	84	84	2	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG	2012	31	32					3696	3708		10.1038/onc.2011.528	http://dx.doi.org/10.1038/onc.2011.528			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	990TF	22179838	Green Published, hybrid			2022-12-25	WOS:000307653800004
J	Cohen-Kaplan, V; Jrbashyan, J; Yanir, Y; Naroditsky, I; Ben-Izhak, O; Ilan, N; Doweck, I; Vlodavsky, I				Cohen-Kaplan, Victoria; Jrbashyan, Jenny; Yanir, Yoav; Naroditsky, Inna; Ben-Izhak, Ofer; Ilan, Neta; Doweck, Ilana; Vlodavsky, Israel			Heparanase Induces Signal Transducer and Activator of Transcription (STAT) Protein Phosphorylation PRECLINICAL AND CLINICAL SIGNIFICANCE IN HEAD AND NECK CANCER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSTITUTIVE ACTIVATION; TUMOR PROGRESSION; GROWTH; EXPRESSION; LOCALIZATION; SULFATE; PROTEOGLYCANS; CONTRIBUTES; METASTASIS; REGULATOR	Activity of heparanase is implicated strongly in dissemination of metastatic tumor cells and cells of the immune system. In addition, heparanase enhances the phosphorylation of selected signaling molecules, including SRC and EGFR, in a manner that requires secretion but not enzymatic activity of heparanase and is mediated by its C-terminal domain. Clinically, heparanase staining is associated with larger tumors and increased EGFR phosphorylation in head and neck carcinoma. We hypothesized that signal transducer and activator of transcription (STAT) proteins mediate the protumorigenic function of heparanase downstream of the EGFR. We provide evidence that heparanase enhances the phosphorylation of STAT3 and STAT5b but not STAT5a. Moreover, enhanced proliferation of heparanase transfected cells was attenuated by STAT3 and STAT5b siRNA, but not STAT5a or STAT1 siRNA. Clinically, STAT3 phosphorylation was associated with head and neck cancer progression, EGFR phosphorylation, and heparanase expression and cellular localization. Notably, cytoplasmic rather than nuclear phospho-STAT3 correlated with increased tumor size (T-stage; p = 0.007), number of metastatic neck lymph nodes (p = 0.05), and reduced survival of patients (p = 0.04).	[Jrbashyan, Jenny; Yanir, Yoav; Doweck, Ilana] Carmel Hosp, Dept Otolaryngol Head & Neck Surg, IL-34362 Haifa, Israel; [Vlodavsky, Israel] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Canc & Vasc Biol Res Ctr, IL-31096 Haifa, Israel; [Naroditsky, Inna; Ben-Izhak, Ofer] Rambam Hlth Care Campus, Dept Pathol, IL-31096 Haifa, Israel	Clalit Health Services; Carmel Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus	Doweck, I (corresponding author), Carmel Hosp, Dept Otolaryngol Head & Neck Surg, 7 Michal St, IL-34362 Haifa, Israel.	idoweck@netvision.net.il; vlodavsk@cc.huji.ac.il		Doweck, Ilana/0000-0002-1065-0299	NCI; National Institutes of Health [CA106456]; Israel Science Foundation [593/10]; Israel Cancer Research Fund; US-Israel Binational Science Foundation; Rappaport Family Institute Fund; NATIONAL CANCER INSTITUTE [R01CA106456] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); Israel Cancer Research Fund; US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Rappaport Family Institute Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI, National Institutes of Health Grant CA106456. This work was also supported by Israel Science Foundation Grant 593/10; the Israel Cancer Research Fund; the US-Israel Binational Science Foundation, and the Rappaport Family Institute Fund (to I.V.).	Atkinson GP, 2010, EXPERT REV NEUROTHER, V10, P575, DOI [10.1586/ern.10.21, 10.1586/ERN.10.21]; Barash U, 2010, FEBS J, V277, P3890, DOI 10.1111/j.1742-4658.2010.07799.x; Barash U, 2010, FASEB J, V24, P1239, DOI 10.1096/fj.09-147074; Ben-Zaken O, 2007, BIOCHEM BIOPH RES CO, V361, P829, DOI 10.1016/j.bbrc.2007.06.188; Casu B, 2007, PATHOPHYSIOL HAEMO T, V36, P195, DOI 10.1159/000175157; Chen Z, 2008, MED RES REV, V28, P185, DOI 10.1002/med.20101; Cohen-Kaplan V, 2008, INT J CANCER, V123, P2566, DOI 10.1002/ijc.23898; Cohen-Kaplan V, 2008, CANCER RES, V68, P10077, DOI 10.1158/0008-5472.CAN-08-2910; Dempsey LA, 2000, TRENDS BIOCHEM SCI, V25, P349, DOI 10.1016/S0968-0004(00)01619-4; Doweck I, 2006, NEOPLASIA, V8, P1055, DOI 10.1593/neo.06577; Dredge K, 2010, INVEST NEW DRUG, V28, P276, DOI 10.1007/s10637-009-9245-5; Frank DA, 2007, CANCER LETT, V251, P199, DOI 10.1016/j.canlet.2006.10.017; Fung C, 2010, EXPERT OPIN EMERG DR, V15, P355, DOI 10.1517/14728214.2010.497754; Fux L, 2009, TRENDS BIOCHEM SCI, V34, P511, DOI 10.1016/j.tibs.2009.06.005; Fux L, 2009, CANCER RES, V69, P1758, DOI 10.1158/0008-5472.CAN-08-1837; Germain D, 2007, CLIN CANCER RES, V13, P5665, DOI 10.1158/1078-0432.CCR-06-2491; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P23536, DOI 10.1074/jbc.M400554200; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Koppikar P, 2008, CLIN CANCER RES, V14, P7682, DOI 10.1158/1078-0432.CCR-08-1328; Lai SY, 2010, DRUG RESIST UPDATE, V13, P67, DOI 10.1016/j.drup.2010.04.001; Leeman RJ, 2006, EXPERT OPIN BIOL TH, V6, P231, DOI 10.1517/14712598.6.3.231; Lerner I, 2008, CLIN CANCER RES, V14, P668, DOI 10.1158/1078-0432.CCR-07-1866; Lerner I, 2011, J CLIN INVEST, V121, P1709, DOI 10.1172/JCI43792; Levy-Adam F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002319; Levy-Adam F, 2010, SEMIN CANCER BIOL, V20, P153, DOI 10.1016/j.semcancer.2010.06.005; Levy-Adam F, 2010, J BIOL CHEM, V285, P28010, DOI 10.1074/jbc.M110.116384; Li HZ, 2005, CLIN CANCER RES, V11, P5863, DOI 10.1158/1078-0432.CCR-05-0562; McKenzie EA, 2007, BRIT J PHARMACOL, V151, P1, DOI 10.1038/sj.bjp.0707182; Miao HQ, 2006, CURR MED CHEM, V13, P2101, DOI 10.2174/092986706777935230; Nadav L, 2006, CANCER RES, V66, P8608, DOI 10.1158/0008-5472.CAN-06-1301; Okawa T, 2005, CLIN CANCER RES, V11, P7995, DOI 10.1158/1078-0432.CCR-05-1103; Parish CR, 2001, BBA-REV CANCER, V1471, pM99, DOI 10.1016/S0304-419X(01)00017-8; Paukku K, 2004, CYTOKINE GROWTH F R, V15, P435, DOI 10.1016/j.cytogfr.2004.09.001; Pectasides E, 2010, CLIN CANCER RES, V16, P2427, DOI 10.1158/1078-0432.CCR-09-2658; Ramani VC, 2011, J BIOL CHEM, V286, P6490, DOI 10.1074/jbc.M110.183277; Reich NC, 2006, NAT REV IMMUNOL, V6, P602, DOI 10.1038/nri1885; Rosenthal EL, 2006, LARYNGOSCOPE, V116, P1636, DOI 10.1097/01.mlg.0000232513.19873.da; Sanderson RD, 2005, J CELL BIOCHEM, V96, P897, DOI 10.1002/jcb.20602; Schlessinger K, 2005, CANCER RES, V65, P5828, DOI 10.1158/0008-5472.CAN-05-0317; Seethala RR, 2008, CLIN CANCER RES, V14, P1303, DOI 10.1158/1078-0432.CCR-07-1543; Sehgal PB, 2008, SEMIN CELL DEV BIOL, V19, P329, DOI 10.1016/j.semcdb.2008.07.003; Shafat I, 2011, J CELL MOL MED, V15, P1857, DOI 10.1111/j.1582-4934.2010.01190.x; Silver DL, 2004, CANCER RES, V64, P3550, DOI 10.1158/0008-5472.CAN-03-3959; Song JI, 2000, ONCOGENE, V19, P2489, DOI 10.1038/sj.onc.1203483; Valgeirsdottir S, 1999, FEBS LETT, V450, P1, DOI 10.1016/S0014-5793(99)00459-7; Vlodavsky I, 2001, J CLIN INVEST, V108, P341, DOI 10.1172/JCI200113662; Vlodavsky I, 2007, CURR PHARM DESIGN, V13, P2057; Vreys V, 2007, J CELL MOL MED, V11, P427, DOI 10.1111/j.1582-4934.2007.00039.x; WEICHSELBAUM RR, 1989, HEAD NECK-J SCI SPEC, V11, P437, DOI 10.1002/hed.2880110510; Xi SC, 2003, CANCER RES, V63, P6763; Yang Y, 2010, CANCER RES, V70, P8329, DOI 10.1158/0008-5472.CAN-10-2179; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zetser A, 2006, CANCER RES, V66, P1455, DOI 10.1158/0008-5472.CAN-05-1811; Zetser A, 2004, J CELL SCI, V117, P2249, DOI 10.1242/jcs.01068	56	42	47	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6668	6678		10.1074/jbc.M111.271346	http://dx.doi.org/10.1074/jbc.M111.271346			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22194600	Green Published, hybrid			2022-12-25	WOS:000300791800053
J	Khan, SR; Kuzminov, A				Khan, Sharik R.; Kuzminov, Andrei			Replication Forks Stalled at Ultraviolet Lesions Are Rescued via RecA and RuvABC Protein-catalyzed Disintegration in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; DNA-REPLICATION; CHROMOSOMAL FRAGMENTATION; RECBCD ENZYME; RECOMBINATIONAL REPAIR; POSTREPLICATION REPAIR; MAMMALIAN-CELLS; EXCISION-REPAIR; NALIDIXIC-ACID; SKIN-CANCER	Ultraviolet (UV) irradiation is not known to induce chromosomal fragmentation in sublethal doses, and yet UV irradiation causes genetic instability and cancer, suggesting that chromosomes are fragmented. Here we show that UV irradiation induces fragmentation in sublethal doses, but the broken chromosomes are repaired or degraded by RecBCD; therefore, to observe full fragmentation, RecBCD enzyme needs to be inactivated. Using quantitative pulsed field gel electrophoresis and sensitive DNA synthesis measurements, we investigated the mechanisms of UV radiation-induced chromosomal fragmentation in recBC mutants, comparing five existing models of DNA damage-induced fragmentation. We found that fragmentation depends on active DNA synthesis before, but not after, UV irradiation. At low UV irradiation doses, fragmentation does not need excision repair or daughter strand gap repair. Fragmentation absolutely depends on both RecA-catalyzed homologous strand exchange and RuvABC-catalyzed Holliday junction resolution. Thus, chromosomes fragment when replication forks stall at UV lesions and regress, generating Holliday junctions. Remarkably, cells specifically utilize fork breakage to rescue stalled replication and avoid lethality.	[Khan, Sharik R.; Kuzminov, Andrei] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Kuzminov, A (corresponding author), Univ Illinois, Dept Microbiol, B103 C&LSL,601 S Goodwin Ave, Urbana, IL 61801 USA.	kuzminov@life.illinois.edu			National Institutes of Health [GM073115]; American Cancer Society [RSG-05-135-01-GMC]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073115] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM073115. This work was also supported by American Cancer Society Grant RSG-05-135-01-GMC.	BENDER MA, 1973, MUTAT RES, V20, P387, DOI 10.1016/0027-5107(73)90060-2; BILLEN D, 1969, J BACTERIOL, V97, P1169, DOI 10.1128/JB.97.3.1169-1175.1969; BONURA T, 1975, RADIAT RES, V63, P567, DOI 10.2307/3574108; BONURA T, 1975, J BACTERIOL, V121, P511, DOI 10.1128/JB.121.2.511-517.1975; BRADLEY MO, 1983, CARCINOGENESIS, V4, P1513, DOI 10.1093/carcin/4.12.1513; BRADLEY MO, 1981, P NATL ACAD SCI-BIOL, V78, P3619, DOI 10.1073/pnas.78.6.3619; BRCICKOSTIC K, 1991, MOL GEN GENET, V228, P136, DOI 10.1007/BF00282458; Briggs GS, 2004, PHILOS T R SOC B, V359, P49, DOI 10.1098/rstb.2003.1364; Budke B, 2010, MOL MICROBIOL, V75, P230, DOI 10.1111/j.1365-2958.2009.06994.x; CHURCHILL GA, 1990, NUCLEIC ACIDS RES, V18, P589, DOI 10.1093/nar/18.3.589; Courcelle J, 2001, GENETICS, V158, P41; Courcelle J, 2003, ANNU REV GENET, V37, P611, DOI 10.1146/annurev.genet.37.110801.142616; Courcelle J, 1997, P NATL ACAD SCI USA, V94, P3714, DOI 10.1073/pnas.94.8.3714; Courcelle J, 1999, J BACTERIOL, V181, P916, DOI 10.1128/JB.181.3.916-922.1999; D'souza DI, 2003, NUCLEIC ACIDS RES, V31, P4573, DOI 10.1093/nar/gkg493; DIANOV GL, 1991, MOL GEN GENET, V225, P448, DOI 10.1007/BF00261686; Difilippantonio MJ, 2002, J EXP MED, V196, P469, DOI 10.1084/jem.20020851; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; DOUDNEY CO, 1973, MUTAT RES, V17, P1, DOI 10.1016/0027-5107(73)90247-9; DUGLE DL, 1976, P NATL ACAD SCI USA, V73, P809, DOI 10.1073/pnas.73.3.809; Dworaczek Hanna, 2007, Critical Reviews in Oncogenesis, V13, P159; EPSTEIN JH, 1983, J AM ACAD DERMATOL, V9, P487, DOI 10.1016/S0190-9622(83)70160-X; Fasullo M, 2008, MUTAT RES-FUND MOL M, V648, P73, DOI 10.1016/j.mrfmmm.2008.09.009; Fedorova LV, 2001, RUSS J GENET+, V37, P358, DOI 10.1023/A:1016642107465; Flores MJ, 2005, MOL MICROBIOL, V57, P1664, DOI 10.1111/j.1365-2958.2005.04753.x; Flores MJ, 2001, EMBO J, V20, P619, DOI 10.1093/emboj/20.3.619; FRIEDBERG EC, 2006, DNA REPAIR MUTAGENES, P227; GOSS WA, 1965, J BACTERIOL, V89, P1068, DOI 10.1128/JB.89.4.1068-1074.1965; Hanawalt P C, 1966, Photochem Photobiol, V5, P1, DOI 10.1111/j.1751-1097.1966.tb05756.x; HIGGINS NP, 1976, J MOL BIOL, V101, P417, DOI 10.1016/0022-2836(76)90156-X; JONCZYK P, 1979, MOL GEN GENET, V171, P53, DOI 10.1007/BF00274014; KELNER A, 1953, J BACTERIOL, V65, P252, DOI 10.1128/JB.65.3.252-262.1953; KHIDHIR MA, 1985, MOL GEN GENET, V199, P133, DOI 10.1007/BF00327522; Kouzminova EA, 2006, J MOL BIOL, V355, P20, DOI 10.1016/j.jmb.2005.10.044; Kouzminova EA, 2004, P NATL ACAD SCI USA, V101, P16262, DOI 10.1073/pnas.0405943101; Kouzminova EA, 2004, MOL MICROBIOL, V51, P1279, DOI 10.1111/j.1365-2958.2003.03924.x; Kouzminova EA, 2008, MOL MICROBIOL, V68, P202, DOI 10.1111/j.1365-2958.2008.06149.x; Kuong KJ, 2009, J MOL BIOL, V390, P845, DOI 10.1016/j.jmb.2009.05.038; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; KUZMINOV A, 1995, BIOESSAYS, V17, P733, DOI 10.1002/bies.950170810; KUZMINOV A, 1995, MOL MICROBIOL, V16, P373, DOI 10.1111/j.1365-2958.1995.tb02403.x; Kuzminov A., 2011, ECOSAL ESCHERICHIA C, DOI [10.1128/ecosal.7.2.6, DOI 10.1128/ECOSAL.7.2.6]; Limoli CL, 1997, CANCER RES, V57, P4048; Long DT, 2008, P NATL ACAD SCI USA, V105, P6852, DOI 10.1073/pnas.0711999105; Long DT, 2009, EMBO REP, V10, P394, DOI 10.1038/embor.2009.13; MAGEE TR, 1990, J BACTERIOL, V172, P1834, DOI 10.1128/jb.172.4.1834-1839.1990; MARSDEN HS, 1974, J BACTERIOL, V118, P465, DOI 10.1128/JB.118.2.465-470.1974; Michel B, 1997, EMBO J, V16, P430, DOI 10.1093/emboj/16.2.430; Michel B, 2007, DNA REPAIR, V6, P967, DOI 10.1016/j.dnarep.2007.02.016; Miller J.H., 1972, EXPT MOL GENETICS; Miranda A, 2003, GENETICS, V163, P1255; MORGAN AR, 1990, J THEOR BIOL, V144, P195, DOI 10.1016/S0022-5193(05)80318-2; OTSUJI N, 1974, J BACTERIOL, V117, P337, DOI 10.1128/JB.117.2.337-344.1974; Pierce AJ, 2001, TRENDS CELL BIOL, V11, pS52, DOI 10.1016/S0962-8924(01)02149-3; Pohlhaus JR, 2008, J BACTERIOL, V190, P5239, DOI 10.1128/JB.00173-08; PRELL A, 1980, EUR J BIOCHEM, V105, P109, DOI 10.1111/j.1432-1033.1980.tb04480.x; Rass K, 2008, ADV EXP MED BIOL, V624, P162, DOI 10.1007/978-0-387-77574-6_13; RESNICK MA, 1976, J THEOR BIOL, V59, P97, DOI 10.1016/S0022-5193(76)80025-2; RINKEN R, 1992, J BACTERIOL, V174, P1172, DOI 10.1128/jb.174.4.1172-1178.1992; RINKEN R, 1992, J BACTERIOL, V174, P5424, DOI 10.1128/JB.174.16.5424-5429.1992; Rossi MJ, 2011, P NATL ACAD SCI USA, V108, P6432, DOI 10.1073/pnas.1016072108; Rothkamm K, 2002, INT J ONCOL, V21, P433; Rudolph CJ, 2007, GENE DEV, V21, P668, DOI 10.1101/gad.417607; RUPP WD, 1968, J MOL BIOL, V31, P291, DOI 10.1016/0022-2836(68)90445-2; SCHIESTL R, 1983, MOL GEN GENET, V191, P59, DOI 10.1007/BF00330890; SCHNIPPER LE, 1989, CANCER RES, V49, P6640; SEDGWICK SG, 1975, J BACTERIOL, V123, P154, DOI 10.1128/JB.123.1.154-161.1975; Seigneur M, 2000, MOL MICROBIOL, V38, P565, DOI 10.1046/j.1365-2958.2000.02152.x; Seigneur M, 1998, CELL, V95, P419, DOI 10.1016/S0092-8674(00)81772-9; Seigneur M, 1997, MOL MICROBIOL, V26, P569, DOI 10.1046/j.1365-2958.1997.6021977.x; TAYLOR AF, 1985, J MOL BIOL, V185, P431, DOI 10.1016/0022-2836(85)90414-0; Thoms B, 1998, J BACTERIOL, V180, P5639, DOI 10.1128/JB.180.21.5639-5645.1998; Vilenchik MM, 2003, P NATL ACAD SCI USA, V100, P12871, DOI 10.1073/pnas.2135498100; WANG TCV, 1983, J BACTERIOL, V156, P1093, DOI 10.1128/JB.156.3.1093-1098.1983; WANG TV, 1986, MUTAT RES, V165, P39, DOI 10.1016/0167-8817(86)90007-6; West SC, 1997, ANNU REV GENET, V31, P213, DOI 10.1146/annurev.genet.31.1.213; WILLETTS NS, 1969, J BACTERIOL, V100, P231, DOI 10.1128/JB.100.1.231-239.1969; YI TM, 1988, J BACTERIOL, V170, P2898, DOI 10.1128/jb.170.7.2898-2903.1988	78	43	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6250	6265		10.1074/jbc.M111.322990	http://dx.doi.org/10.1074/jbc.M111.322990			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22194615	hybrid, Green Published			2022-12-25	WOS:000300791800018
J	Naydenov, NG; Harris, G; Brown, B; Schaefer, KL; Das, SK; Fisher, PB; Ivanov, AI				Naydenov, Nayden G.; Harris, Gianni; Brown, Bryan; Schaefer, Katherine L.; Das, Swadesh K.; Fisher, Paul B.; Ivanov, Andrei I.			Loss of Soluble N-Ethylmaleimide-sensitive Factor Attachment Protein alpha (alpha SNAP) Induces Epithelial Cell Apoptosis via Down-regulation of Bcl-2 Expression and Disruption of the Golgi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; MEMBRANE-FUSION; SECRETORY PATHWAY; CANCER-CELLS; APICAL JUNCTIONS; COPI VESICLES; SYNTAXIN 5; DEATH; NSF; ER	Intracellular trafficking represents a key mechanism that regulates cell fate by participating in either prodeath or prosurvival signaling. Soluble N-ethylmaleimide-sensitive factor (NSF) attachment protein alpha (alpha SNAP) is a well known component of vesicle trafficking machinery that mediates intermembrane fusion. alpha SNAP increases cell resistance to cytotoxic stimuli, although mechanisms of its prosurvival function are poorly understood. In this study, we found that either siRNA-mediated knockdown of alpha SNAP or expression of its dominant negative mutant induced epithelial cell apoptosis. Apoptosis was not caused by activation of the major prodeath regulators Bax and p53 and was independent of a key alpha SNAP binding partner, NSF. Instead, death of alpha SNAP-depleted cells was accompanied by down-regulation of the antiapoptotic Bcl-2 protein; it was mimicked by inhibition and attenuated by overexpression of Bcl-2. Knockdown of alpha SNAP resulted in impairment of Golgi to endoplasmic reticulum (ER) trafficking and fragmentation of the Golgi. Moreover, pharmacological disruption of ER-Golgi transport by brefeldin A and eeyarestatin 1 or siRNA-mediated depletion of an ER/Golgi-associated p97 ATPase recapitulated the effects of alpha SNAP inhibition by decreasing Bcl-2 level and triggering apoptosis. These results reveal a novel role for alpha SNAP in promoting epithelial cell survival by unique mechanisms involving regulation of Bcl-2 expression and Golgi biogenesis.	[Ivanov, Andrei I.] Univ Rochester, Dept Med, Med Ctr, Rochester, NY 14642 USA; [Das, Swadesh K.; Fisher, Paul B.] Virginia Commonwealth Univ, Dept Human & Mol Genet, VCU Inst Mol Med, Sch Med, Richmond, VA 23298 USA; [Das, Swadesh K.; Fisher, Paul B.] Virginia Commonwealth Univ, VCU Massey Canc Ctr, Sch Med, Richmond, VA 23298 USA	University of Rochester; Virginia Commonwealth University; Virginia Commonwealth University	Ivanov, AI (corresponding author), Univ Rochester, Dept Med, Med Ctr, 601 Elmwood Ave,Box 646, Rochester, NY 14642 USA.	Andrei_Ivanov@urmc.rochester.edu	Ivanov, Andrei/V-1672-2019		National Institutes of Health [RO1 DK083968, R01 DK084953, R01 CA97318, P01 CA104177]; NATIONAL CANCER INSTITUTE [P01CA104177, R01CA097318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083968, R01DK084953] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK083968 and R01 DK084953 (to A. I. I.) and R01 CA97318 and P01 CA104177 (to P. B. F.).	Akdis CA, 2004, CURR OPIN IMMUNOL, V16, P717, DOI 10.1016/j.coi.2004.09.004; Aletrari MO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022713; Andreeva AV, 2006, EXPERT OPIN THER TAR, V10, P723, DOI 10.1517/14728222.10.5.723; Aoki T, 2008, BIOCHEM J, V410, P93, DOI 10.1042/BJ20071304; Aslan JE, 2009, TRAFFIC, V10, P1390, DOI 10.1111/j.1600-0854.2009.00951.x; Babcock M, 2004, J NEUROSCI, V24, P3964, DOI 10.1523/JNEUROSCI.5259-03.2004; Barnard RJO, 1997, J CELL BIOL, V139, P875, DOI 10.1083/jcb.139.4.875; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; BOYD JM, 1994, CELL, V79, P341, DOI 10.1016/0092-8674(94)90202-X; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Burgoyne RD, 1998, BIOESSAYS, V20, P328, DOI 10.1002/(SICI)1521-1878(199804)20:4<328::AID-BIES9>3.0.CO;2-L; Capitani M, 2009, FEBS LETT, V583, P3863, DOI 10.1016/j.febslet.2009.10.053; Chae TH, 2004, NAT GENET, V36, P264, DOI 10.1038/ng1302; Chen CL, 2011, TRAFFIC, V12, P1327, DOI 10.1111/j.1600-0854.2011.01245.x; Chen LZ, 2002, NEUROCHEM RES, V27, P891, DOI 10.1023/A:1020387414086; Citterio C, 2008, P NATL ACAD SCI USA, V105, P2877, DOI 10.1073/pnas.0712224105; Cotter TG, 2009, NAT REV CANCER, V9, P501, DOI 10.1038/nrc2663; Dalal S, 2004, MOL BIOL CELL, V15, P637, DOI 10.1091/mbc.E03-02-0097; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; Ferland RJ, 2009, HUM MOL GENET, V18, P497, DOI 10.1093/hmg/ddn377; Fernandez-Ulibarri I, 2007, MOL BIOL CELL, V18, P3250, DOI 10.1091/mbc.E07-04-0334; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Foger N, 2009, FEBS J, V276, P4256, DOI 10.1111/j.1742-4658.2009.07134.x; Fu Y, 2007, CANCER RES, V67, P3734, DOI 10.1158/0008-5472.CAN-06-4594; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; Ho YHS, 2009, BIOCHEM BIOPH RES CO, V387, P371, DOI 10.1016/j.bbrc.2009.07.028; Hong WJ, 2005, BBA-MOL CELL RES, V1744, P120, DOI 10.1016/j.bbamcr.2005.03.014; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Ivanov AI, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000658; Ivanov AI, 2010, AM J PATHOL, V176, P134, DOI 10.2353/ajpath.2010.090220; Jackson C L, 2000, Subcell Biochem, V34, P233; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Joshi A, 2011, J BIOL CHEM, V286, P29861, DOI 10.1074/jbc.M111.241521; Kano F, 2005, GENES CELLS, V10, P989, DOI 10.1111/j.1365-2443.2005.00894.x; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Landry MC, 2009, MOL BIOL CELL, V20, P4091, DOI 10.1091/mbc.E09-01-0057; Lebedeva IV, 2003, ONCOGENE, V22, P8758, DOI 10.1038/sj.onc.1206891; LEBIVIC A, 1989, P NATL ACAD SCI USA, V86, P9313; Lipschutz JH, 2003, J BIOL CHEM, V278, P20954, DOI 10.1074/jbc.M213210200; Maag RS, 2003, CURR OPIN CELL BIOL, V15, P456, DOI 10.1016/S0955-0674(03)00075-9; Malsam J, 2008, CELL MOL LIFE SCI, V65, P2814, DOI 10.1007/s00018-008-8352-3; Marash L, 2008, MOL CELL, V30, P447, DOI 10.1016/j.molcel.2008.03.018; Martin HGS, 2006, J CELL BIOCHEM, V99, P1203, DOI 10.1002/jcb.20998; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakajima K, 2004, EMBO J, V23, P3216, DOI 10.1038/sj.emboj.7600333; Naydenov NG, 2010, MOL BIOL CELL, V21, P3506, DOI 10.1091/mbc.E10-03-0259; Perrotta C, 2010, J BIOL CHEM, V285, P40240, DOI 10.1074/jbc.M110.139287; Peter F, 1998, J CELL SCI, V111, P2625; Pulvirenti T, 2008, NAT CELL BIOL, V10, P912, DOI 10.1038/ncb1751; Rabouille C, 1998, CELL, V92, P603, DOI 10.1016/S0092-8674(00)81128-9; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Reed JC, 1998, ONCOGENE, V17, P3225, DOI 10.1038/sj.onc.1202591; RIPLEY CR, 1993, J BIOL CHEM, V268, P3677; Rosales KR, 2009, MOL BIOL CELL, V20, P2831, DOI 10.1091/mbc.E08-09-0911; Roy L, 2000, MOL BIOL CELL, V11, P2529, DOI 10.1091/mbc.11.8.2529; Schutze S, 2008, NAT REV MOL CELL BIO, V9, P655, DOI 10.1038/nrm2430; Sherrill KW, 2004, J BIOL CHEM, V279, P29066, DOI 10.1074/jbc.M402727200; Stauber T, 2006, CURR BIOL, V16, P2245, DOI 10.1016/j.cub.2006.09.060; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Uemura T, 2009, MOL CELL BIOL, V29, P1869, DOI 10.1128/MCB.01089-08; Ungar D, 2003, ANNU REV CELL DEV BI, V19, P493, DOI 10.1146/annurev.cellbio.19.110701.155609; Verrier SE, 2008, EUR J CELL BIOL, V87, P863, DOI 10.1016/j.ejcb.2008.07.003; Viana RJS, 2010, CNS NEUROL DISORD-DR, V9, P679; Wang JL, 2000, P NATL ACAD SCI USA, V97, P7124, DOI 10.1073/pnas.97.13.7124; Wang QY, 2008, J BIOL CHEM, V283, P7445, DOI 10.1074/jbc.M708347200; Whiteheart SW, 2001, INT REV CYTOL, V207, P71; WHITEHEART SW, 1994, J CELL BIOL, V126, P945, DOI 10.1083/jcb.126.4.945; Winter U, 2009, J BIOL CHEM, V284, P31817, DOI 10.1074/jbc.M109.045286; Wu ZZ, 2010, BIOCHEM PHARMACOL, V80, P827, DOI 10.1016/j.bcp.2010.05.026; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989; Zhang YH, 2008, J BIOL CHEM, V283, P30689, DOI 10.1074/jbc.M801711200	74	27	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5928	5941		10.1074/jbc.M111.278358	http://dx.doi.org/10.1074/jbc.M111.278358			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22194596	Green Published, hybrid			2022-12-25	WOS:000300638000067
J	Song, HW; Wohltmann, M; Tan, M; Bao, SZ; Ladenson, JH; Turk, J				Song, Haowei; Wohltmann, Mary; Tan, Min; Bao, Shunzhong; Ladenson, Jack H.; Turk, John			Group VIA PLA(2) (iPLA(2)beta) Is Activated Upstream of p38 Mitogen-activated Protein Kinase (MAPK) in Pancreatic Islet beta-Cell Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDEPENDENT PHOSPHOLIPASE A(2); ENDOPLASMIC-RETICULUM STRESS; ARACHIDONIC-ACID RELEASE; TYPE-2 DIABETES-MELLITUS; MECHANISM-BASED DISCRIMINATION; INSULIN SECRETORY RESPONSES; GLUCOSE-INDUCED ACTIVATION; TANDEM MASS-SPECTROMETRY; SMOOTH-MUSCLE-CELLS; K+ CHANNELS	Group VIA phospholipase A(2) (iPLA(2)beta) in pancreatic islet beta-cells participates in glucose-stimulated insulin secretion and sarco(endo) plasmic reticulum ATPase (SERCA) inhibitor-induced apoptosis, and both are attenuated by pharmacologic or genetic reductions in iPLA(2)beta activity and amplified by iPLA(2)beta overexpression. While exploring signaling events that occur downstream of iPLA(2)beta activation, we found that p38 MAPK is activated by phosphorylation in INS-1 insulinoma cells and mouse pancreatic islets, that this increases with iPLA(2)beta expression level, and that it is stimulated by the iPLA(2)beta reaction product arachidonic acid. The insulin secretagogue D-glucose also stimulates beta-cell p38 MAPK phosphorylation, and this is prevented by the iPLA(2)beta inhibitor bromoenol lactone. Insulin secretion induced by D-glucose and forskolin is amplified by overexpressing iPLA(2)beta in INS-1 cells and in mouse islets, and the p38 MAPK inhibitor PD169316 prevents both responses. The SERCA inhibitor thapsigargin also stimulates phosphorylation of both beta-cell MAPK kinase isoforms and p38 MAPK, and bromoenol lactone prevents both events. Others have reported that iPLA(2)beta products activate Rho family G-proteins that promote MAPK kinase activation via a mechanism inhibited by Clostridium difficile toxin B, which we find to inhibit thapsigargin-induced beta-cell p38 MAPK phosphorylation. Thapsigargin-induced beta-cell apoptosis and ceramide generation are also prevented by the p38 MAPK inhibitor PD169316. These observations indicate that p38 MAPK is activated downstream of iPLA(2)beta in beta-cells incubated with insulin secretagogues or thapsigargin, that this requires prior iPLA(2)beta activation, and that p38 MAPK is involved in the beta-cell functional responses of insulin secretion and apoptosis in which iPLA(2)beta participates.	[Song, Haowei; Wohltmann, Mary; Tan, Min; Bao, Shunzhong; Turk, John] Washington Univ, Sch Med, Dept Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA; [Ladenson, Jack H.] Washington Univ, Sch Med, Dept Pathol & Immunol, Div Lab & Genom Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Turk, J (corresponding author), Washington Univ, Sch Med, Dept Med, Div Endocrinol Metab & Lipid Res, Campus Box 8127,660 S Euclid Ave, St Louis, MO 63110 USA.	jturk@DOM.wustl.edu			National Institutes of Health United States Public Health Service [R37-DK34388, P41-RR00954, P60-DK20579, P30-DK56341]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, R37DK034388, P60DK020579, P30DK020579] Funding Source: NIH RePORTER	National Institutes of Health United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health United States Public Health Service Grants R37-DK34388, P41-RR00954, P60-DK20579, and P30-DK56341.	Araki E, 2003, EXP BIOL MED, V228, P1213, DOI 10.1177/153537020322801018; ARKHAMMAR P, 1987, J BIOL CHEM, V262, P5448; ASHCROFT SJH, 1980, DIABETOLOGIA, V18, P5, DOI 10.1007/BF01228295; BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; Bao S, 2008, AM J PHYSIOL-ENDOC M, V294, pE217, DOI 10.1152/ajpendo.00474.2007; Bao S, 2007, J BIOL CHEM, V282, P27100, DOI 10.1074/jbc.M701316200; Bao SZ, 2006, J BIOL CHEM, V281, P20958, DOI 10.1074/jbc.M600075200; Bao SZ, 2006, J BIOL CHEM, V281, P187, DOI 10.1074/jbc.M509105200; Bordin S, 2003, J IMMUNOL, V170, P667, DOI 10.4049/jimmunol.170.2.667; BROWN LJ, 1994, J BIOL CHEM, V269, P14363; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Cheng H, 2002, J CELL PHYSIOL, V192, P234, DOI 10.1002/jcp.10134; COOK DL, 1984, NATURE, V311, P271, DOI 10.1038/311271a0; Dukes I. D., 1997, CURR OPIN ENDOCRINOL, V4, P262; DUNLOP ME, 1984, BIOCHEM BIOPH RES CO, V120, P820, DOI 10.1016/S0006-291X(84)80180-1; Easom RA, 1999, DIABETES, V48, P675, DOI 10.2337/diabetes.48.4.675; Eto K, 1999, SCIENCE, V283, P981, DOI 10.1126/science.283.5404.981; GARVEY WT, 1992, DIABETES CARE, V15, P396, DOI 10.2337/diacare.15.3.396; Gerich JE, 1998, ENDOCR REV, V19, P491, DOI 10.1210/er.19.4.491; GHOSH A, 1991, J BIOL CHEM, V266, P22887; Gilon P, 1999, J BIOL CHEM, V274, P20197, DOI 10.1074/jbc.274.29.20197; GROSS RW, 1993, BIOCHEMISTRY-US, V32, P327, DOI 10.1021/bi00052a041; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; HAZEN SL, 1991, J BIOL CHEM, V266, P7227; Hii CST, 1998, J BIOL CHEM, V273, P19277, DOI 10.1074/jbc.273.30.19277; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hsu FF, 2002, J AM SOC MASS SPECTR, V13, P558, DOI 10.1016/S1044-0305(02)00358-6; Hsu FF, 2002, J AM SOC MASS SPECTR, V13, P680, DOI 10.1016/S1044-0305(02)00362-8; Jacobson DA, 2007, CELL METAB, V6, P229, DOI 10.1016/j.cmet.2007.07.010; Jacobson DA, 2007, J BIOL CHEM, V282, P7442, DOI 10.1074/jbc.M607858200; Jenkins CM, 2002, J BIOL CHEM, V277, P32807, DOI 10.1074/jbc.M202568200; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kahn BB, 1998, CELL, V92, P593, DOI 10.1016/S0092-8674(00)81125-3; KAKEI M, 1986, FEBS LETT, V208, P63, DOI 10.1016/0014-5793(86)81533-2; Khaled AR, 2001, MOL CELL BIOL, V21, P7545, DOI 10.1128/MCB.21.22.7545-7557.2001; Kienesberger PC, 2009, J LIPID RES, V50, pS63, DOI 10.1194/jlr.R800082-JLR200; KLOPPEL G, 1985, SURV SYN PATHOL RES, V4, P110; Laing SP, 2003, DIABETOLOGIA, V46, P760, DOI 10.1007/s00125-003-1116-6; LAYCHOCK SG, 1982, CELL CALCIUM, V3, P43, DOI 10.1016/0143-4160(82)90036-7; Lei XY, 2007, BIOCHEMISTRY-US, V46, P10170, DOI 10.1021/bi700017z; Lei XY, 2010, J BIOL CHEM, V285, P6693, DOI 10.1074/jbc.M109.084293; Lei XY, 2008, J BIOL CHEM, V283, P34819, DOI 10.1074/jbc.M807409200; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Ma ZM, 2001, J BIOL CHEM, V276, P13198, DOI 10.1074/jbc.M010423200; Ma ZM, 1999, J BIOL CHEM, V274, P9607, DOI 10.1074/jbc.274.14.9607; Ma ZM, 1997, J BIOL CHEM, V272, P11118; MACDONALD MJ, 1995, J BIOL CHEM, V270, P20051; Mahler RJ, 1999, J CLIN ENDOCR METAB, V84, P1165, DOI 10.1210/jc.84.4.1165; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; MARTIN GA, 1995, EMBO J, V14, P1970, DOI 10.1002/j.1460-2075.1995.tb07189.x; MATSCHINSKY FM, 1990, DIABETES, V39, P647, DOI 10.2337/diabetes.39.6.647; McDonald P, 2007, AM J PHYSIOL-CELL PH, V292, pC1216, DOI 10.1152/ajpcell.00467.2006; MEGLASSON M D, 1986, Diabetes Metabolism Reviews, V2, P163; METZ SA, 1991, DIABETES, V40, P1565, DOI 10.2337/diabetes.40.12.1565; MISLER S, 1992, DIABETES, V41, P662, DOI 10.2337/diabetes.41.6.662; Moon SH, 2008, J BIOL CHEM, V283, P33975, DOI 10.1074/jbc.M805817200; Moran JM, 2005, J BIOL CHEM, V280, P28162, DOI 10.1074/jbc.M500013200; Nikolic DM, 2007, J BIOL CHEM, V282, P33405, DOI 10.1074/jbc.M704133200; Nowatzke W, 1998, ENDOCRINOLOGY, V139, P4073, DOI 10.1210/en.139.10.4073; Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012; Owada S, 1999, J BIOL CHEM, V274, P2000, DOI 10.1074/jbc.274.4.2000; Oyadomari S, 2002, APOPTOSIS, V7, P335, DOI 10.1023/A:1016175429877; Park KS, 2006, SCIENCE, V313, P976, DOI 10.1126/science.1124254; Poitout V, 2008, AM J PHYSIOL-ENDOC M, V294, pE214, DOI 10.1152/ajpendo.00638.2007; PRENTKI M, 1987, PHYSIOL REV, V67, P1185, DOI 10.1152/physrev.1987.67.4.1185; RAMANADHAM S, 1993, BIOCHEMISTRY-US, V32, P337, DOI 10.1021/bi00052a042; Ramanadham S, 2004, BIOCHEMISTRY-US, V43, P918, DOI 10.1021/bi035536m; Ramanadham S, 2003, BIOCHEMISTRY-US, V42, P13929, DOI 10.1021/bi034843p; Ramanadham S, 1999, J BIOL CHEM, V274, P13915, DOI 10.1074/jbc.274.20.13915; RAMANADHAM S, 1992, BIOCHEM BIOPH RES CO, V184, P647, DOI 10.1016/0006-291X(92)90638-2; Ramanadham S, 1997, BBA-LIPID LIPID MET, V1344, P153, DOI 10.1016/S0005-2760(96)00139-7; RAMANADHAM S, 1994, BIOCHEMISTRY-US, V33, P7442, DOI 10.1021/bi00189a052; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Ravier MA, 2000, J BIOL CHEM, V275, P1587, DOI 10.1074/jbc.275.3.1587; Redman PT, 2007, P NATL ACAD SCI USA, V104, P3568, DOI 10.1073/pnas.0610159104; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sato Y, 1999, ENDOCRINOLOGY, V140, P2252, DOI 10.1210/en.140.5.2252; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; Seleznev K, 2006, J BIOL CHEM, V281, P22275, DOI 10.1074/jbc.M604330200; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Simonsson E, 2000, INT J PANCREATOL, V27, P1, DOI 10.1385/IJGC:27:1:01; Song HW, 2010, J BIOL CHEM, V285, P33843, DOI 10.1074/jbc.M110.153197; Song HW, 2010, AM J PHYSIOL-ENDOC M, V298, pE1097, DOI 10.1152/ajpendo.00780.2009; Song HW, 2006, BIOCHEMISTRY-US, V45, P1061, DOI 10.1021/bi052065q; Song K, 2005, MOL ENDOCRINOL, V19, P504, DOI 10.1210/me.2004-0169; STEFAN Y, 1982, DIABETES, V31, P694, DOI 10.2337/diabetes.31.8.694; Sun B, 2010, BIOCHEM PHARMACOL, V79, P1727, DOI 10.1016/j.bcp.2010.02.005; Talukdar I, 2005, J BIOL CHEM, V280, P40660, DOI 10.1074/jbc.M505531200; Thams P, 1997, BIOCHEM PHARMACOL, V53, P1077, DOI 10.1016/S0006-2952(96)00813-1; Tibbles LA, 1996, EMBO J, V15, P7026, DOI 10.1002/j.1460-2075.1996.tb01094.x; Tiran Z, 2003, J BIOL CHEM, V278, P17509, DOI 10.1074/jbc.M212766200; Turk J, 2004, CAN J PHYSIOL PHARM, V82, P824, DOI 10.1139/Y04-064; TURK J, 1992, BIOCHIM BIOPHYS ACTA, V1125, P280, DOI 10.1016/0005-2760(92)90057-3; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; WOLF BA, 1991, BIOCHEMISTRY-US, V30, P6372, DOI 10.1021/bi00240a004; WOLF BA, 1986, J BIOL CHEM, V261, P3501; Wolf MJ, 1997, J BIOL CHEM, V272, P1522, DOI 10.1074/jbc.272.3.1522; Wollheim CB, 2000, DIABETOLOGIA, V43, P265, DOI 10.1007/s001250050044; Xie Z, 2007, J BIOL CHEM, V282, P25278, DOI 10.1074/jbc.M611206200; Xie ZW, 2010, J BIOL CHEM, V285, P8628, DOI 10.1074/jbc.M109.057711; Yajima H, 1999, DIABETES, V48, P1006, DOI 10.2337/diabetes.48.5.1006; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934; Zhao ZS, 2010, ENDOCRINOLOGY, V151, P3038, DOI 10.1210/en.2010-0016; ZUPAN LA, 1993, J MED CHEM, V36, P95, DOI 10.1021/jm00053a012	107	21	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5528	5541		10.1074/jbc.M111.285114	http://dx.doi.org/10.1074/jbc.M111.285114			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22194610	hybrid, Green Published			2022-12-25	WOS:000300638000032
J	Weise, G; Basse-Lusebrink, TC; Kleinschnitz, C; Kampf, T; Jakob, PM; Stoll, G				Weise, Gesa; Basse-Luesebrink, Thomas C.; Kleinschnitz, Christoph; Kampf, Thomas; Jakob, Peter M.; Stoll, Guido			In Vivo Imaging of Stepwise Vessel Occlusion in Cerebral Photothrombosis of Mice by F-19 MRI	PLOS ONE			English	Article							ISCHEMIC BRAIN-LESIONS; MACROPHAGE INFILTRATION; NERVOUS-SYSTEM; RAT-BRAIN; INFLAMMATION; INFARCTION; INDUCTION; RESPONSES; TRACKING; STROKE	Background: F-19 magnetic resonance imaging (MRI) was recently introduced as a promising technique for in vivo cell tracking. In the present study we compared F-19 MRI with iron-enhanced MRI in mice with photothrombosis (PT) at 7 Tesla. PT represents a model of focal cerebral ischemia exhibiting acute vessel occlusion and delayed neuroinflammation. Methods/Principal Findings: Perfluorocarbons (PFC) or superparamagnetic iron oxide particles (SPIO) were injected intravenously at different time points after photothrombotic infarction. While administration of PFC directly after PT induction led to a strong F-19 signal throughout the entire lesion, two hours delayed application resulted in a rim-like F-19 signal at the outer edge of the lesion. These findings closely resembled the distribution of signal loss on T2-weighted MRI seen after SPIO injection reflecting intravascular accumulation of iron particles trapped in vessel thrombi as confirmed histologically. By sequential administration of two chemically shifted PFC compounds 0 and 2 hours after illumination the different spatial distribution of the F-19 markers (infarct core/rim) could be visualized in the same animal. When PFC were applied at day 6 the fluorine marker was only detected after long acquisition times ex vivo. SPIO-enhanced MRI showed slight signal loss in vivo which was much more prominent ex vivo indicative for neuroinflammation at this late lesion stage. Conclusion: Our study shows that vessel occlusion can be followed in vivo by F-19 and SPIO-enhanced high-field MRI while in vivo imaging of neuroinflammation remains challenging. The timing of contrast agent application was the major determinant of the underlying processes depicted by both imaging techniques. Importantly, sequential application of different PFC compounds allowed depiction of ongoing vessel occlusion from the core to the margin of the ischemic lesions in a single MRI measurement.	[Weise, Gesa; Basse-Luesebrink, Thomas C.; Kleinschnitz, Christoph; Stoll, Guido] Univ Wurzburg, Dept Neurol, D-8700 Wurzburg, Germany; [Basse-Luesebrink, Thomas C.; Kampf, Thomas; Jakob, Peter M.] Univ Wurzburg, Dept Phys, EPV, Wurzburg, Germany; [Weise, Gesa; Basse-Luesebrink, Thomas C.; Jakob, Peter M.; Stoll, Guido] Univ Wurzburg, Interdisciplinary Ctr Clin Res Wurzburg, Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg	Weise, G (corresponding author), Univ Wurzburg, Dept Neurol, Josef Schneider Str 11, D-8700 Wurzburg, Germany.	stoll_g@klinik.uni-wuerzburg.de		Jakob, Peter/0000-0002-3481-5545; Kleinschnitz, Christoph/0000-0002-1650-8875	German Research Foundation (DFG); University of Wuerzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens ET, 2005, NAT BIOTECHNOL, V23, P983, DOI 10.1038/nbt1121; Bendszus M, 2003, J NEUROSCI, V23, P10892; Bulte JWM, 2004, NMR BIOMED, V17, P484, DOI 10.1002/nbm.924; Carmichael S Thomas, 2005, NeuroRx, V2, P396; DIETRICH WD, 1987, ACTA NEUROPATHOL, V72, P315, DOI 10.1007/BF00687262; Ebner B, 2010, CIRC-CARDIOVASC IMAG, V3, P202, DOI 10.1161/CIRCIMAGING.109.902312; EDELMAN RR, 1985, RADIOLOGY, V157, P425, DOI 10.1148/radiology.157.2.4048450; Flogel U, 2008, CIRCULATION, V118, P140, DOI 10.1161/CIRCULATIONAHA.107.737890; Hitchens TK, 2011, MAGN RESON MED, V65, P1145, DOI 10.1002/mrm.22702; Jolkkonen J, 2007, NEUROSCI LETT, V428, P99, DOI 10.1016/j.neulet.2007.09.043; Kleinschnitz C, 2005, J CEREBR BLOOD F MET, V25, P1548, DOI 10.1038/sj.jcbfm.9600151; Kleinschnitz C, 2003, J CEREBR BLOOD F MET, V23, P1356, DOI 10.1097/01.WCB.0000090505.76664.DB; Lee JK, 2007, SURG NEUROL, V67, P620, DOI 10.1016/j.surneu.2006.08.077; Partlow KC, 2007, FASEB J, V21, P1647, DOI 10.1096/fj.06-6505com; Pohmann R, 2001, MAGN RESON MED, V45, P817, DOI 10.1002/mrm.1110; Schroeter M, 2004, MAGNET RESON MED, V52, P403, DOI 10.1002/mrm.20142; Schroeter M, 2002, J NEUROSCI METH, V117, P43, DOI 10.1016/S0165-0270(02)00072-9; Schroeter M, 1997, STROKE, V28, P382, DOI 10.1161/01.STR.28.2.382; Schroeter M, 2001, ACTA NEUROPATHOL, V101, P114; Shapiro EM, 2006, MAGN RESON MED, V55, P242, DOI 10.1002/mrm.20718; Speck O, 2002, MAGNET RESON MED, V48, P633, DOI 10.1002/mrm.10279; Stoll G, 2009, NEUROSCIENCE, V158, P1151, DOI 10.1016/j.neuroscience.2008.06.045; Stoll G, 2010, CURR OPIN NEUROL, V23, P282, DOI 10.1097/WCO.0b013e328337f4b5; Stoll G, 2009, J CEREBR BLOOD F MET, V29, P331, DOI 10.1038/jcbfm.2008.129; VANBRUGGEN N, 1992, STROKE, V23, P576, DOI 10.1161/01.STR.23.4.576; WATSON BD, 1985, ANN NEUROL, V17, P497, DOI 10.1002/ana.410170513; Weber R, 2005, MAGN RESON MED, V54, P59, DOI 10.1002/mrm.20532; Weise G, 2011, EXP NEUROL, V229, P494, DOI 10.1016/j.expneurol.2011.03.020	28	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e28143	10.1371/journal.pone.0028143	http://dx.doi.org/10.1371/journal.pone.0028143			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22194810	gold, Green Published, Green Submitted			2022-12-25	WOS:000298370400010
J	Chen, H; Chen, SL; Jiang, JG				Chen, Hui; Chen, Shan-Li; Jiang, Jian-Guo			Effect of Ca2+ Channel Block on Glycerol Metabolism in Dunaliella salina under Hypoosmotic and Hyperosmotic Stresses	PLOS ONE			English	Article							CALCIUM; ARABIDOPSIS; DEHYDROGENASE; BIOSYNTHESIS; EXPRESSION; PROTEINS; CLONING; PLANT; CDNA	The effect of Ca2+ channel blockers on cytosolic Ca2+ levels and the role of Ca2+ in glycerol metabolism of Dunaliella salina under hypoosmotic or hyperosmotic stress were investigated using the confocal laser scanning microscope (CLSM). Results showed that intracellular Ca2+ concentration increased rapidly when extracellular salinity suddenly decreased or increased, but the increase could be inhibited by pretreatment of Ca2+ channel blockers LaCl3, verapamil or ruthenium red. The changes of glycerol content and G3pdh activity in D. salina to respect to hypoosmotic or hyperosmotic stress were also inhibited in different degrees by pretreatment of Ca2+ channel blockers, indicating that the influx of Ca2+ via Ca2+ channels are required for the transduction of osmotic signal to regulate osmotic responses of D. salina to the changes of salinity. Differences of the three blockers in block effect suggested that they may act on different channels or had different action sites, including influx of Ca2+ from the extracellular space via Ca2+ channels localized in the plasma membrane or from intracellular calcium store via the mitochondrial. Other Ca2+-mediated or non-Ca2+-mediated osmotic signal pathway may exist in Dunaliella in response to hypoosmotic and hyperosmotic stresses.	[Chen, Hui; Chen, Shan-Li; Jiang, Jian-Guo] S China Univ Technol, Coll Food & Bioengn, Guangzhou, Guangdong, Peoples R China; [Chen, Hui] Chinese Acad Sci, Inst Hydrobiol, Wuhan, Peoples R China	South China University of Technology; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Chen, H (corresponding author), S China Univ Technol, Coll Food & Bioengn, Guangzhou, Guangdong, Peoples R China.	jgjiang@scut.edu.cn			National Natural Foundation of China [30870025]	National Natural Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by National Natural Foundation of China (Grant 30870025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkayal F, 2010, PLANT SCI, V179, P437, DOI 10.1016/j.plantsci.2010.07.001; Avron M., 1992, P135; BENAMOTZ A, 1973, PLANT PHYSIOL, V51, P875, DOI 10.1104/pp.51.5.875; Bothwell JHF, 2006, PLANT J, V46, P327, DOI 10.1111/j.1365-313X.2006.02687.x; Bothwell JHF, 2005, NEW PHYTOL, V166, P21, DOI 10.1111/j.1469-8137.2004.01312.x; Chen H, 2011, SCI TOTAL ENVIRON, V409, P1291, DOI 10.1016/j.scitotenv.2010.12.038; Chen H, 2009, J AGR FOOD CHEM, V57, P6178, DOI 10.1021/jf900447r; Chen SX, 1998, ACTA BOT SIN, V40, P126; Fraser PD, 2004, PROG LIPID RES, V43, P228, DOI 10.1016/j.plipres.2003.10.002; Harmon AC, 2000, TRENDS PLANT SCI, V5, P154, DOI 10.1016/S1360-1385(00)01577-6; Haugland R. P., 2002, HDB FLUORESCENT PROB, P119; He QH, 2007, J PLANT PHYSIOL, V164, P214, DOI 10.1016/j.jplph.2006.04.004; Hetherington AM, 2004, ANNU REV PLANT BIOL, V55, P401, DOI 10.1146/annurev.arplant.55.031903.141624; Issa AA, 1996, PHYTON-ANN REI BOT A, V36, P295; Kadota Y, 2005, BIOCHEM BIOPH RES CO, V336, P1259, DOI 10.1016/j.bbrc.2005.09.004; Karimova FG, 2000, PROTOPLASMA, V213, P93, DOI 10.1007/BF01280509; Kim KN, 2000, PLANT PHYSIOL, V124, P1844, DOI 10.1104/pp.124.4.1844; Kudla J, 1999, P NATL ACAD SCI USA, V96, P4718, DOI 10.1073/pnas.96.8.4718; Plieth C, 2001, PROTOPLASMA, V218, P1, DOI 10.1007/BF01288356; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Sanders D, 1999, PLANT CELL, V11, P691, DOI 10.1105/tpc.11.4.691; Sun QP, 2006, J PLANT RES, V119, P343, DOI 10.1007/s10265-006-0279-x; Torrecilla I, 2001, PLANT CELL ENVIRON, V24, P641, DOI 10.1046/j.0016-8025.2001.00708.x; Tsukahara K, 1999, J BIOTECHNOL, V70, P223, DOI 10.1016/S0168-1656(99)00076-0; Wang F, 2007, BIOTECHNOL ADV, V25, P211, DOI 10.1016/j.biotechadv.2006.12.001; Wei YD, 2001, PLANT PHYSIOL BIOCH, V39, P841, DOI 10.1016/S0981-9428(01)01308-0; Yan Y, 2005, J AGR FOOD CHEM, V53, P1466, DOI 10.1021/jf048358s; Zhu YH, 2005, J AGR FOOD CHEM, V53, P5593, DOI 10.1021/jf0506838; Zhu YH, 2008, EUR FOOD RES TECHNOL, V227, P953, DOI 10.1007/s00217-007-0789-3; Zielinski RE, 1998, ANNU REV PLANT PHYS, V49, P697, DOI 10.1146/annurev.arplant.49.1.697	30	15	17	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28613	10.1371/journal.pone.0028613	http://dx.doi.org/10.1371/journal.pone.0028613			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194866	Green Published, Green Submitted, gold			2022-12-25	WOS:000298369100063
J	Leychenko, A; Konorev, E; Jijiwa, M; Matter, ML				Leychenko, Anna; Konorev, Eugene; Jijiwa, Mayumi; Matter, Michelle L.			Stretch-Induced Hypertrophy Activates NFkB-Mediated VEGF Secretion in Adult Cardiomyocytes	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; FOCAL ADHESION KINASE; RAT CARDIAC MYOCYTES; KAPPA-B; TRANSCRIPTIONAL REGULATION; MYOCARDIAL-INFARCTION; PROTEIN-KINASE; MAP KINASE; EXPRESSION; CELLS	Hypertension and myocardial infarction are associated with the onset of hypertrophy. Hypertrophy is a compensatory response mechanism to increases in mechanical load due to pressure or volume overload. It is characterized by extracellular matrix remodeling and hypertrophic growth of adult cardiomyocytes. Production of Vascular Endothelial Growth Factor (VEGF), which acts as an angiogenic factor and a modulator of cardiomyocyte function, is regulated by mechanical stretch. Mechanical stretch promotes VEGF secretion in neonatal cardiomyocytes. Whether this effect is retained in adult cells and the molecular mechanism mediating stretch-induced VEGF secretion has not been elucidated. Our objective was to investigate whether cyclic mechanical stretch induces VEGF secretion in adult cardiomyocytes and to identify the molecular mechanism mediating VEGF secretion in these cells. Isolated primary adult rat cardiomyocytes (ARCMs) were subjected to cyclic mechanical stretch at an extension level of 10% at 30 cycles/min that induces hypertrophic responses. Cyclic mechanical stretch induced a 3-fold increase in VEGF secretion in ARCMs compared to non-stretch controls. This increase in stretch-induced VEGF secretion correlated with NFkB activation. Cyclic mechanical stretch-mediated VEGF secretion was blocked by an NFkB peptide inhibitor and expression of a dominant negative mutant IkB alpha, but not by inhibitors of the MAPK/ERK1/2 or PI3K pathways. Chromatin immunoprecipitation assays demonstrated an interaction of NFkB with the VEGF promoter in stretched primary cardiomyocytes. Moreover, VEGF secretion is increased in the stretched myocardium during pressure overload-induced hypertrophy. These findings are the first to demonstrate that NFkB activation plays a role in mediating VEGF secretion upon cyclic mechanical stretch in adult cardiomyocytes. Signaling by NFkB initiated in response to cyclic mechanical stretch may therefore coordinate the hypertrophic response in adult cardiomyocytes. Elucidation of this novel mechanism may provide a target for developing future pharmacotherapy to treat hypertension and heart disease.	[Leychenko, Anna; Jijiwa, Mayumi; Matter, Michelle L.] Univ Hawaii, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96822 USA; [Leychenko, Anna; Jijiwa, Mayumi; Matter, Michelle L.] Univ Hawaii, John A Burns Sch Med, Cardiovasc Res Ctr, Honolulu, HI 96822 USA; [Leychenko, Anna] Univ Hawaii Manoa, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA; [Konorev, Eugene] Univ Hawaii, Hilo Coll Pharm, Hilo, HI 96720 USA	University of Hawaii System; University of Hawaii System; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University Hawaii Hilo	Leychenko, A (corresponding author), Univ Hawaii, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96822 USA.	matter@hawaii.edu	Matter, Michelle/GSN-9703-2022	Matter, Michelle/0000-0002-5988-9663	NCRR [P20-RR016453]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016453] Funding Source: NIH RePORTER	NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the NCRR P20-RR016453 (MLM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa R, 2002, HYPERTENSION, V39, P233, DOI 10.1161/hy0202.102699; Baker EL, 2010, J BIOMECH, V43, P38, DOI 10.1016/j.jbiomech.2009.09.007; Duquesnes N, 2009, INT J BIOCHEM CELL B, V41, P1173, DOI 10.1016/j.biocel.2008.09.032; Ferrarini M, 2006, CIRC RES, V98, P954, DOI 10.1161/01.RES.0000217342.83731.89; Gawecka JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011269; Hirotani S, 2002, CIRCULATION, V105, P509, DOI 10.1161/hc0402.102863; KATZ AM, 1994, ANN INTERN MED, V121, P363, DOI 10.7326/0003-4819-121-5-199409010-00009; Kudoh S, 1998, J BIOL CHEM, V273, P24037, DOI 10.1074/jbc.273.37.24037; Kumar R, 1999, J PHARMACOL EXP THER, V291, P967; Lal H, 2007, J MOL CELL CARDIOL, V43, P137, DOI 10.1016/j.yjmcc.2007.05.012; Lammerding J, 2004, ANN NY ACAD SCI, V1015, P53, DOI 10.1196/annals.1302.005; Li J, 1997, J CLIN INVEST, V100, P18, DOI 10.1172/JCI119510; Matter ML, 2001, J BIOL CHEM, V276, P27757, DOI 10.1074/jbc.M102014200; Novotny NM, 2008, CYTOKINE, V43, P215, DOI 10.1016/j.cyto.2008.05.015; Pages G, 2005, CARDIOVASC RES, V65, P564, DOI 10.1016/j.cardiores.2004.09.032; Pikkarainen S, 2006, AM J PHYSIOL-REG I, V290, pR1639, DOI 10.1152/ajpregu.00559.2005; Pimentel RC, 2002, CIRC RES, V90, P671, DOI 10.1161/01.RES.0000014823.75393.4D; PIPER HM, 1990, CELL CULTURE TECHNIQ; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Ramanathan M, 2007, MOL BIOL CELL, V18, P14, DOI 10.1091/mbc.E06-07-0596; Ross RS, 2002, J CARD FAIL, V8, pS326, DOI 10.1054/jcaf.2002.129263; SADOSHIMA J, 1993, EMBO J, V12, P1681, DOI 10.1002/j.1460-2075.1993.tb05813.x; SADOSHIMA J, 1993, J RECEPTOR RES, V13, P777, DOI 10.3109/10799899309073692; Sasaki H, 2000, TOXICOLOGY, V155, P27, DOI 10.1016/S0300-483X(00)00274-2; Seko Y, 1999, BIOCHEM BIOPH RES CO, V259, P8, DOI 10.1006/bbrc.1999.0720; Seko Y, 1999, BIOCHEM BIOPH RES CO, V254, P462, DOI 10.1006/bbrc.1998.9969; Seko Y, 1997, CLIN SCI, V92, P453, DOI 10.1042/cs0920453; Shyu KG, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-15; Sugden PH, 1998, J MOL MED, V76, P725, DOI 10.1007/s001090050275; TADA H, 1986, J IMMUNOL METHODS, V93, P157, DOI 10.1016/0022-1759(86)90183-3; Torsoni AS, 2003, CIRC RES, V93, P140, DOI 10.1161/01.RES.0000081595.25297.1B; van Wamel AJ, 2000, ARCH BIOCHEM BIOPHYS, V381, P67, DOI 10.1006/abbi.2000.1947; Yamada K, 2005, CIRC RES, V97, P346, DOI 10.1161/01.RES.0000178788.76568.8a; Zentilin L, 2010, FASEB J, V24, P1467, DOI 10.1096/fj.09-143180; Zheng W, 2001, AM J PHYSIOL-HEART C, V280, pH909, DOI 10.1152/ajpheart.2001.280.2.H909	35	71	73	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e29055	10.1371/journal.pone.0029055	http://dx.doi.org/10.1371/journal.pone.0029055			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174951	Green Submitted, Green Published, gold			2022-12-25	WOS:000298367300043
J	Capello, M; Soria, M; Cotel, P; Deneubourg, JL; Dagorn, L				Capello, Manuela; Soria, Marc; Cotel, Pascal; Deneubourg, Jean-Louis; Dagorn, Laurent			Quantifying the Interplay between Environmental and Social Effects on Aggregated-Fish Dynamics	PLOS ONE			English	Article							PELAGIC FISH; POINT HYPOTHESIS; DECISION-MAKING; ANIMAL GROUPS; INDIAN-OCEAN; DEVICES FADS; MODEL; BEHAVIOR; MOVEMENT; DENSITY	Demonstrating and quantifying the respective roles of social interactions and external stimuli governing fish dynamics is key to understanding fish spatial distribution. If seminal studies have contributed to our understanding of fish spatial organization in schools, little experimental information is available on fish in their natural environment, where aggregations often occur in the presence of spatial heterogeneities. Here, we applied novel modeling approaches coupled to accurate acoustic tracking for studying the dynamics of a group of gregarious fish in a heterogeneous environment. To this purpose, we acoustically tracked with submeter resolution the positions of twelve small pelagic fish (Selar crumenophthalmus) in the presence of an anchored floating object, constituting a point of attraction for several fish species. We constructed a field-based model for aggregated-fish dynamics, deriving effective interactions for both social and external stimuli from experiments. We tuned the model parameters that best fit the experimental data and quantified the importance of social interactions in the aggregation, providing an explanation for the spatial structure of fish aggregations found around floating objects. Our results can be generalized to other gregarious species and contexts as long as it is possible to observe the fine-scale movements of a subset of individuals.	[Capello, Manuela; Soria, Marc; Cotel, Pascal] IRD, UMR EME, St Denis, Reunion, France; [Deneubourg, Jean-Louis] Univ Libre Bruxelles, USE, Unit Social Ecol, Brussels, Belgium; [Dagorn, Laurent] IRD, UMR EME, Victoria, Seychelles	Institut de Recherche pour le Developpement (IRD); Universite Libre de Bruxelles; Institut de Recherche pour le Developpement (IRD)	Capello, M (corresponding author), IRD, UMR EME, St Denis, Reunion, France.	manuela.capello@ird.fr	Dagorn, Laurent/K-1002-2016; Capello, Manuela/G-7360-2016	Dagorn, Laurent/0000-0003-3896-8589; Capello, Manuela/0000-0002-9206-011X	Regional Council of Reunion Island; French Ministry of Overseas; Run Sea Science [229968]; MADE: Mitigating adverse ecological impacts of open ocean fisheries [210496]; Regional Council of Reunion Island; French Ministry of Overseas; Run Sea Science [229968]; MADE: Mitigating adverse ecological impacts of open ocean fisheries [210496]	Regional Council of Reunion Island; French Ministry of Overseas; Run Sea Science; MADE: Mitigating adverse ecological impacts of open ocean fisheries; Regional Council of Reunion Island; French Ministry of Overseas; Run Sea Science; MADE: Mitigating adverse ecological impacts of open ocean fisheries	This work was supported by the Regional Council of Reunion Island, the French Ministry of Overseas, the 'Run Sea Science' (Theme - Capacity Building, contract 229968) and the 'MADE: Mitigating adverse ecological impacts of open ocean fisheries' (Theme 2 Food, Agriculture, Fisheries and Biotechnology, contract 210496) FP7 European projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida P., 2007, P 6 C FISH TEL HELD; BREDER C, 1959, AM MUS NAT HIST, V117, P397; Cavagna A, 2008, MATH BIOSCI, V214, P32, DOI 10.1016/j.mbs.2008.05.006; Cavagna A, 2010, P NATL ACAD SCI USA, V107, P11865, DOI 10.1073/pnas.1005766107; Chandler D., 1987, INTRO MODERN STAT ME; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Dempster T, 2004, REV FISH BIOL FISHER, V14, P21, DOI 10.1007/s11160-004-3151-x; Doray M, 2006, FISH RES, V82, P162, DOI 10.1016/j.fishres.2006.06.025; DURVILLE P, 2001, SPC LIVE REEF FISH I, V9, P17; Freon P, 2000, REV FISH BIOL FISHER, V10, P183, DOI 10.1023/A:1016666108540; FreuEn P., 1999, DYNAMICS PELAGIC FIS; Gautrais J, 2009, J MATH BIOL, V58, P429, DOI 10.1007/s00285-008-0198-7; Girard C, 2007, AQUAT LIVING RESOUR, V20, P313, DOI 10.1051/alr:2008005; Grunbaum Daniel, 1994, Lecture Notes in Biomathematics, V100, P296; Hemelrijk CK, 2008, ETHOLOGY, V114, P245, DOI 10.1111/j.1439-0310.2007.01459.x; Hemelrijk CK, 2005, BEHAV ECOL, V16, P178, DOI 10.1093/beheco/arh149; Josse E, 2000, AQUAT LIVING RESOUR, V13, P183, DOI 10.1016/S0990-7440(00)00051-6; KAREIVA PM, 1983, OECOLOGIA, V56, P234, DOI 10.1007/BF00379695; KATZ Y, 2011, P NATL ACAD IN PRESS; Kirkwood JG, 1935, J CHEM PHYS, V3, P300, DOI 10.1063/1.1749657; Krause J, 2002, LIVING GROUPS; Lukeman R, 2010, P NATL ACAD SCI USA, V107, P12576, DOI 10.1073/pnas.1001763107; Lukeman R, 2009, B MATH BIOL, V71, P352, DOI 10.1007/s11538-008-9365-7; MARSAC F, 2001, ACTES COLLOQUES IFRE, V28; Martinelli TL, 1998, HYDROBIOLOGIA, V372, P79, DOI 10.1023/A:1017019006039; MCCULLOCH CE, 1989, ECOLOGY, V70, P383, DOI 10.2307/1937543; Moreno G, 2007, AQUAT LIVING RESOUR, V20, P343, DOI 10.1051/alr:2008015; NIWA HS, 1994, J THEOR BIOL, V171, P123, DOI 10.1006/jtbi.1994.1218; Parrish J., 1997, ANIMAL GROUPS 3 DIME; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Roos D, 2007, SCI MAR, V71, P137, DOI 10.3989/scimar.2007.71n1137; Schellinck J, 2011, ECOL MODEL, V222, P1897, DOI 10.1016/j.ecolmodel.2011.03.013; Soria M, 2007, J FISH BIOL, V71, P1257, DOI 10.1111/j.1095-8649.2007.01554.x; Soria M, 2009, ANIM BEHAV, V78, P1441, DOI 10.1016/j.anbehav.2009.09.025; Sumpter D. J., 2010, COLLECTIVE ANIMAL BE, DOI [10.1515/9781400837106, DOI 10.1515/9781400837106]; Sumpter DJT, 2008, CURR BIOL, V18, P1773, DOI 10.1016/j.cub.2008.09.064; Taquet M, 2007, AQUAT LIVING RESOUR, V20, P331, DOI 10.1051/alr:2008007; TYLER JA, 1994, REV FISH BIOL FISHER, V4, P91, DOI 10.1007/BF00043262	39	17	17	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28109	10.1371/journal.pone.0028109	http://dx.doi.org/10.1371/journal.pone.0028109			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174770	Green Published, Green Submitted, gold			2022-12-25	WOS:000298366600009
J	Mabragana, E; de Astarloa, JMD; Hanner, R; Zhang, JB; Castro, MG				Mabragana, Ezequiel; Martin Diaz de Astarloa, Juan; Hanner, Robert; Zhang, Junbin; Gonzalez Castro, Mariano			DNA Barcoding Identifies Argentine Fishes from Marine and Brackish Waters	PLOS ONE			English	Article							NUCLEOTIDE; TAXONOMY; BIRDS	Background: DNA barcoding has been advanced as a promising tool to aid species identification and discovery through the use of short, standardized gene targets. Despite extensive taxonomic studies, for a variety of reasons the identification of fishes can be problematic, even for experts. DNA barcoding is proving to be a useful tool in this context. However, its broad application is impeded by the need to construct a comprehensive reference sequence library for all fish species. Here, we make a regional contribution to this grand challenge by calibrating the species discrimination efficiency of barcoding among 125 Argentine fish species, representing nearly one third of the known fauna, and examine the utility of these data to address several key taxonomic uncertainties pertaining to species in this region. Methodology/Principal Findings: Specimens were collected and morphologically identified during crusies conducted between 2005 and 2008. The standard BARCODE fragment of COI was amplified and bi-directionally sequenced from 577 specimens (mean of 5 specimens/species), and all specimens and sequence data were archived and interrogated using analytical tools available on the Barcode of Life Data System (BOLD; www.barcodinglife.org). Nearly all species exhibited discrete clusters of closely related haplogroups which permitted the discrimination of 95% of the species (i.e. 119/125) examined while cases of shared haplotypes were detected among just three species-pairs. Notably, barcoding aided the identification of a new species of skate, Dipturus argentinensis, permitted the recognition of Genypterus brasiliensis as a valid species and questions the generic assignment of Paralichthys isosceles. Conclusions/Significance: This study constitutes a significant contribution to the global barcode reference sequence library for fishes and demonstrates the utility of barcoding for regional species identification. As an independent assessment of alpha taxonomy, barcodes provide robust support for most morphologically based taxon concepts and also highlight key areas of taxonomic uncertainty worthy of reappraisal.	[Mabragana, Ezequiel; Martin Diaz de Astarloa, Juan; Gonzalez Castro, Mariano] Univ Nacl Mar del Plata, Fac Ciencias Exactas & Nat, Inst Invest Marinas & Costeras, Lab Biotaxon Morfol & Mol Peces, Mar Del Plata, Buenos Aires, Argentina; [Hanner, Robert] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Hanner, Robert] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Zhang, Junbin] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Shanghai, Peoples R China	National University of Mar del Plata; University of Guelph; University of Guelph; Shanghai Ocean University	Mabragana, E (corresponding author), Univ Nacl Mar del Plata, Fac Ciencias Exactas & Nat, Inst Invest Marinas & Costeras, Lab Biotaxon Morfol & Mol Peces, Mar Del Plata, Buenos Aires, Argentina.	emabraga@mdp.edu.ar	de Astarloa, Juan Diaz/F-5395-2012; González-Castro, Mariano/AAG-8103-2019	Mabragana, Ezequiel/0000-0002-4089-9888; Gonzalez-Castro, Mariano/0000-0003-2403-3168	Argentina iBOL funds; Comision de Investigaciones Cientificas; Universidad Nacional de Mardel Plata funds (Argentina); Genome (through the Ontario Genomics Institute); Natural Sciences and Engineering Research Council of Canada	Argentina iBOL funds; Comision de Investigaciones Cientificas; Universidad Nacional de Mardel Plata funds (Argentina); Genome (through the Ontario Genomics Institute); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was supported through funding to Consejo Nacional de Investigaciones Cientificas y Tecnicas, under the Argentina iBOL funds, Comision de Investigaciones Cientificas and Universidad Nacional de Mardel Plata funds (Argentina), and through funding to the Canadian Barcode of Life Network from Genome (through the Ontario Genomics Institute) and Natural Sciences and Engineering Research Council of Canada. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral AR, 2007, MAR FRESHWATER RES, V58, P505, DOI 10.1071/MF07050; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Borisenko AV, 2008, MOL ECOL RESOUR, V8, P471, DOI 10.1111/j.1471-8286.2007.01998.x; Clare EL, 2007, MOL ECOL NOTES, V7, P184, DOI 10.1111/j.1471-8286.2006.01657.x; COMPAGNO LJ, 1999, SHARKS SKATES RAYS; COUSSEAU MB, 2007, PUBLICACIONES ESPECI; COUSSEAU MB, 2004, MAR ARGENTINO SUS RE, V4, P17; De Astarloa JMD, 2004, COPEIA, P326; DEASTARLOA JMD, 1993, U CATOLICA NORTE FAC, V2, P47; Ebach MC, 2005, NATURE, V434, P697, DOI 10.1038/434697b; Eschmeyer WN, 2010, CATALOG FISHES ELECT; Garcia ML, 2002, J APPL ICHTHYOL, V18, P216, DOI 10.1046/j.1439-0426.2002.00326.x; Golding GB, 2009, MOL ECOLOGY RESOURCE, V9, pIV; GON O, 1990, FISHES SO OCEAN; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hogg ID, 2004, CAN J ZOOL, V82, P749, DOI [10.1139/z04-041, 10.1139/Z04-041]; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Janzen DH, 2005, PHILOS T R SOC B, V360, P1835, DOI 10.1098/rstb.2005.1715; Jarnegren J, 2007, MAR BIOL, V152, P43, DOI 10.1007/s00227-007-0651-y; Kerr KCR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004379; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lukhtanov VA, 2009, MOL ECOL RESOUR, V9, P1302, DOI 10.1111/j.1755-0998.2009.02577.x; MABRAGANA E, 2007, THESIS U NACL MAR PL; De Astarloa JMD, 2008, ZOOTAXA, P35, DOI 10.11646/zootaxa.1921.1.3; McEachran JD, 2004, CRC MAR BIOL SER, P79; MCEACHRAN JD, 1983, ARCH FISCHEREIWISS, V34, P23; McEachran JD, 1998, COPEIA, P271; MENNI RC, 1984, PECES MARINOS ARGENT; MENNI RC, 2007, SERIE TECNICA DIDACT, V11, P1; Menni Roberto C., 2000, Revista del Museo Argentino de Ciencias Naturales Nueva Serie, V2, P69; Menni Roberto C., 2008, Revista del Museo Argentino de Ciencias Naturales Nueva Serie, V10, P161; Nakamura I, 1986, IMPORTANT FISHES TRA; Nelson J. S., 2006, FISHES WORLD; NIELSEN JG, 1999, FAO FISHERIES SYNOPS, V125; Norman J. R., 1938, Discovery Reports Cambridge, V18, P1; Pegg GG, 2006, SCI MAR, V70, P7, DOI 10.3989/scimar.2006.70s27; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Saunders GW, 2005, PHILOS T R SOC B, V360, P1879, DOI 10.1098/rstb.2005.1719; Smith MA, 2007, P NATL ACAD SCI USA, V104, P4967, DOI 10.1073/pnas.0700050104; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Solari A, 2010, J APPL ICHTHYOL, V26, P137, DOI 10.1111/j.1439-0426.2009.01292.x; Spies IB, 2006, J FISH BIOL, V69, P283, DOI 10.1111/j.1095-8649.2006.01286.x; Stehmann M., 1986, P261; Steinke D, 2011, MITOCHONDR DNA, V22, P10, DOI 10.3109/19401736.2010.536538; Steinke D, 2009, MAR BIOL, V156, P2641, DOI 10.1007/s00227-009-1284-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teletchea F, 2010, MITOCHONDR DNA, V21, P206, DOI 10.3109/19401736.2010.532212; Victor Benjamin C., 2007, Zootaxa, V1526, P51; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2008, MAR FRESHWATER RES, V59, P57, DOI 10.1071/MF07148; Ward RD, 2007, MOL ECOL NOTES, V7, P899, DOI 10.1111/j.1471-8286.2007.01886.x; Ward RD, 2009, MOL ECOL RESOUR, V9, P1077, DOI 10.1111/j.1755-0998.2009.02541.x; Webb KE, 2006, DEEP-SEA RES PT II, V53, P1053, DOI 10.1016/j.dsr2.2006.02.013; Wohler OC, 2006, CYBIUM, V30, P285; YEARSLEY GK, 2003, AUSTR SEAFOOD, P44; Zhang DX, 1996, TRENDS ECOL EVOL, V11, P247, DOI 10.1016/0169-5347(96)10031-8	62	75	81	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28655	10.1371/journal.pone.0028655	http://dx.doi.org/10.1371/journal.pone.0028655			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174860	gold, Green Published, Green Submitted			2022-12-25	WOS:000298365700057
J	Miyake, T; McDermott, JC; Gramolini, AO				Miyake, Tetsuaki; McDermott, John C.; Gramolini, Anthony O.			A Method for the Direct Identification of Differentiating Muscle Cells by a Fluorescent Mitochondrial Dye	PLOS ONE			English	Article							DYSFUNCTION; MYOGENESIS; MYOBLASTS; APOPTOSIS; PATHWAY; DOMAIN; MICE; MYOD	Identification of differentiating muscle cells generally requires fixation, antibodies directed against muscle specific proteins, and lengthy staining processes or, alternatively, transfection of muscle specific reporter genes driving GFP expression. In this study, we examined the possibility of using the robust mitochondrial network seen in maturing muscle cells as a marker of cellular differentiation. The mitochondrial fluorescent tracking dye, MitoTracker, which is a cell-permeable, low toxicity, fluorescent dye, allowed us to distinguish and track living differentiating muscle cells visually by epi-fluorescence microscopy. MitoTracker staining provides a robust and simple detection strategy for living differentiating cells in culture without the need for fixation or biochemical processing.	[Miyake, Tetsuaki; Gramolini, Anthony O.] Univ Toronto, Dept Physiol, Best Inst Med Res, Toronto, ON, Canada; [McDermott, John C.] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada	University of Toronto; York University - Canada	Miyake, T (corresponding author), Univ Toronto, Dept Physiol, Best Inst Med Res, Toronto, ON, Canada.	tetsuaki.miyake@rogers.com; anthony.gramolini@utoronto.ca			Heart and Stroke Foundation (HSF) of Ontario [T-6281]; Canadian Institutes of Health Research (CIHR) [MOP-84267]; Canadian Foundation for Innovation	Heart and Stroke Foundation (HSF) of Ontario(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation)	This study was supported by grants from the Heart and Stroke Foundation (HSF) of Ontario (#T-6281; to AOG), Canadian Institutes of Health Research (CIHR) (to AOG; MOP-84267), and Canadian Foundation for Innovation to AOG. AOG is a Canada Research Chair and a New Investigator of the HSF of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronheim A, 1997, MOL CELL BIOL, V17, P3094, DOI 10.1128/MCB.17.6.3094; Coletti D, 2002, EMBO J, V21, P631, DOI 10.1093/emboj/21.4.631; Davis R L, 1989, Princess Takamatsu Symp, V20, P267; DAVIS RL, 1990, CELL, V60, P733, DOI 10.1016/0092-8674(90)90088-V; DUDLEY GA, 1987, J BIOL CHEM, V262, P9109; Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270; KIRKWOOD SP, 1986, AM J PHYSIOL, V251, pC395, DOI 10.1152/ajpcell.1986.251.3.C395; Merlini L, 2008, P NATL ACAD SCI USA, V105, P5225, DOI 10.1073/pnas.0800962105; Millay DP, 2008, NAT MED, V14, P442, DOI 10.1038/nm1736; Miyake T, 2010, MOL CELL BIOL, V30, P722, DOI 10.1128/MCB.01005-09; Miyake T, 2009, J BIOL CHEM, V284, P19679, DOI 10.1074/jbc.M109.017319; Ostrovsky O, 2002, J BIOL CHEM, V277, P40043, DOI 10.1074/jbc.M205494200; Poot M, 1996, J HISTOCHEM CYTOCHEM, V44, P1363, DOI 10.1177/44.12.8985128; Romanello V, 2010, EMBO J, V29, P1774, DOI 10.1038/emboj.2010.60; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Schwarzkopf M, 2006, GENE DEV, V20, P3440, DOI 10.1101/gad.412606; SILBERSTEIN L, 1986, CELL, V46, P1075, DOI 10.1016/0092-8674(86)90707-5; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Torella D, 2004, CIRC RES, V94, P514, DOI 10.1161/01.RES.0000117306.10142.50; VANDEURSEN J, 1993, CELL, V74, P621, DOI 10.1016/0092-8674(93)90510-W; Wallace LM, 2011, ANN NEUROL, V69, P540, DOI 10.1002/ana.22275; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yoshida N, 1998, J CELL SCI, V111, P769	23	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28628	10.1371/journal.pone.0028628	http://dx.doi.org/10.1371/journal.pone.0028628			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174849	Green Submitted, Green Published, gold			2022-12-25	WOS:000298365700052
J	Rodriguez-Jato, S; Busturia, A; Herr, W				Rodriguez-Jato, Sara; Busturia, Ana; Herr, Winship			Drosophila melanogaster dHCF Interacts with both PcG and TrxG Epigenetic Regulators	PLOS ONE			English	Article							HOST-CELL FACTOR; GENE-EXPRESSION; POLYCOMB GROUP; TRANSCRIPTION FACTOR; MLL FAMILY; C-ELEGANS; FACTOR-I; COMPLEX; TRITHORAX; HCF-1	Repression and activation of gene transcription involves multiprotein complexes that modify chromatin structure. The integration of these complexes at regulatory sites can be assisted by co-factors that link them to DNA-bound transcriptional regulators. In humans, one such co-factor is the herpes simplex virus host-cell factor 1 (HCF-1), which is implicated in both activation and repression of transcription. We show here that disruption of the gene encoding the Drosophila melanogaster homolog of HCF-1, dHCF, leads to a pleiotropic phenotype involving lethality, sterility, small size, apoptosis, and morphological defects. In Drosophila, repressed and activated transcriptional states of cell fate-determining genes are maintained throughout development by Polycomb Group (PcG) and Trithorax Group (TrxG) genes, respectively. dHCF mutant flies display morphological phenotypes typical of TrxG mutants and dHCF interacts genetically with both PcG and TrxG genes. Thus, dHCF inactivation enhances the mutant phenotypes of the Pc PcG as well as brm and mor TrxG genes, suggesting that dHCF possesses Enhancer of TrxG and PcG (ETP) properties. Additionally, dHCF interacts with the previously established ETP gene skd. These pleiotropic phenotypes are consistent with broad roles for dHCF in both activation and repression of transcription during fly development.	[Rodriguez-Jato, Sara; Herr, Winship] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Busturia, Ana] Ctr Biol Mol Severo Ochoa, Madrid, Spain	University of Lausanne; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Rodriguez-Jato, S (corresponding author), Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland.	winship.herr@unil.ch	Herr, Winship/E-6491-2012	Herr, Winship/0000-0002-3606-4546	Fonds National Suisse (FNS); University of Lausanne; Fundacion Mutua Madrilena; Spanish Ministry of Science and Innovation [BFU-2008-01154, CSD-2007-0008]	Fonds National Suisse (FNS)(Swiss National Science Foundation (SNSF)); University of Lausanne; Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the Fonds National Suisse (FNS), the University of Lausanne, the Fundacion Mutua Madrilena (FMM-2006), and the Spanish Ministry of Science and Innovation (BFU-2008-01154, CSD-2007-0008 and Postdoctoral Fellowship Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellosta Paola, 2010, Genes Cancer, V1, P542; Beltran S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r67; BRIZUELA BJ, 1994, GENETICS, V137, P803; Brock HW, 2001, CURR OPIN GENET DEV, V11, P175, DOI 10.1016/S0959-437X(00)00176-3; Capotosti F, 2007, MOL CELL BIOL, V27, P7063, DOI 10.1128/MCB.00769-07; Capotosti F, 2011, CELL, V144, P376, DOI 10.1016/j.cell.2010.12.030; Croker JA, 2006, DEV BIOL, V291, P368, DOI 10.1016/j.ydbio.2005.12.020; Crosby MA, 1999, MOL CELL BIOL, V19, P1159; Cui MX, 2006, PLOS GENET, V2, P719, DOI 10.1371/journal.pgen.0020074; Dejosez M, 2010, GENE DEV, V24, P1479, DOI 10.1101/gad.1935210; DENELL RE, 1973, GENETICS, V75, P279; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; DUNCAN IM, 1982, GENETICS, V102, P49; FARKAS G, 1994, NATURE, V371, P806, DOI 10.1038/371806a0; Furrer M, 2010, J BIOL CHEM; Grimaud C, 2006, CHROMOSOME RES, V14, P363, DOI 10.1007/s10577-006-1069-y; Gunther M, 2000, MOL CELL BIOCHEM, V210, P131, DOI 10.1023/A:1007177623283; HANNAHALAVA A, 1958, GENETICS, V43, P878; INGHAM P, 1980, MOL GEN GENET, V179, P607, DOI 10.1007/BF00271751; Izeta A, 2003, GENE, V305, P175, DOI 10.1016/S0378-1119(03)00380-9; Janody F, 2003, DEVELOPMENT, V130, P3691, DOI 10.1242/dev.00607; Kim JK, 2005, SCIENCE, V308, P1164, DOI 10.1126/science.1109267; Knez J, 2006, MOL CELL BIOCHEM, V288, P79, DOI 10.1007/s11010-006-9122-x; Kristie TM, 2010, BBA-GENE REGUL MECH, V1799, P257, DOI 10.1016/j.bbagrm.2009.08.003; Layalle S, 2008, DEV CELL, V15, P568, DOI 10.1016/j.devcel.2008.08.003; Lee S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001213; Li J, 2008, PLOS BIOL, V6, P1870, DOI 10.1371/journal.pbio.0060233; Lopez A, 2001, MOL GENET GENOMICS, V266, P572, DOI 10.1007/s004380100572; Machida YJ, 2009, J BIOL CHEM, V284, P34179, DOI 10.1074/jbc.M109.046755; Mahajan SS, 2003, J CELL PHYSIOL, V194, P117, DOI 10.1002/jcp.10193; Marenda DR, 2004, DEV BIOL, V267, P279, DOI 10.1016/j.ydbio.2003.10.040; Misaghi S, 2009, MOL CELL BIOL, V29, P2181, DOI 10.1128/MCB.01517-08; Muller J, 2009, CURR OPIN GENET DEV, V19, P150, DOI 10.1016/j.gde.2009.03.001; Narayanan A, 2007, P NATL ACAD SCI USA, V104, P10835, DOI 10.1073/pnas.0704351104; Poux S, 2001, GENE DEV, V15, P2509, DOI 10.1101/gad.208901; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; SHEARN A, 1989, GENETICS, V121, P517; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Sullivan W, 2000, DROSOPHILA; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; Treisman JE, 2001, DEVELOPMENT, V128, P603; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; Tyagi S, 2009, EMBO J, V28, P3185, DOI 10.1038/emboj.2009.258; Vogel JL, 2000, EMBO J, V19, P683, DOI 10.1093/emboj/19.4.683; Wichmann A, 2010, DEV BIOL, V346, P80, DOI 10.1016/j.ydbio.2010.07.023; Wysocka J, 2003, TRENDS BIOCHEM SCI, V28, P294, DOI 10.1016/S0968-0004(03)00088-4; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Yu H, 2010, MOL CELL BIOL, V30, P5071, DOI 10.1128/MCB.00396-10	52	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e27479	10.1371/journal.pone.0027479	http://dx.doi.org/10.1371/journal.pone.0027479			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174740	Green Submitted, gold, Green Published			2022-12-25	WOS:000298163600002
J	Sanchez, CJ; Kumar, N; Lizcano, A; Shivshankar, P; Hotopp, JCD; Jorgensen, JH; Tettelin, H; Orihuela, CJ				Sanchez, Carlos J.; Kumar, Nikhil; Lizcano, Anel; Shivshankar, Pooja; Hotopp, Julie C. Dunning; Jorgensen, James H.; Tettelin, Herve; Orihuela, Carlos J.			Streptococcus pneumoniae in Biofilms Are Unable to Cause Invasive Disease Due to Altered Virulence Determinant Production	PLOS ONE			English	Article							CHOLINE-BINDING-PROTEINS; PHASE VARIATION; MIDDLE-EAR; CAPSULAR POLYSACCHARIDE; ANTIBIOTIC-RESISTANCE; BACTERIAL BIOFILMS; COLONY MORPHOLOGY; CHILDREN; RECEPTOR; NEURAMINIDASE	It is unclear whether Streptococcus pneumoniae in biofilms are virulent and contribute to development of invasive pneumococcal disease (IPD). Using electron microscopy we confirmed the development of mature pneumococcal biofilms in a continuous-flow-through line model and determined that biofilm formation occurred in discrete stages with mature biofilms composed primarily of dead pneumococci. Challenge of mice with equal colony forming units of biofilm and planktonic pneumococci determined that biofilm bacteria were highly attenuated for invasive disease but not nasopharyngeal colonization. Biofilm pneumococci of numerous serotypes were hyper-adhesive and bound to A549 type II pneumocytes and Detroit 562 pharyngeal epithelial cells at levels 2 to 11-fold greater than planktonic counterparts. Using genomic microarrays we examined the pneumococcal transcriptome and determined that during biofilm formation S. pneumoniae down-regulated genes involved in protein synthesis, energy production, metabolism, capsular polysaccharide (CPS) production, and virulence. We confirmed these changes by measuring CPS by ELISA and immunoblotting for the toxin pneumolysin and the bacterial adhesins phosphorylcholine (ChoP), choline-binding protein A (CbpA), and Pneumococcal serine-rich repeat protein (PsrP). We conclude that biofilm pneumococci were avirulent due to reduced CPS and pneumolysin production along with increased ChoP, which is known to bind C-reactive protein and is opsonizing. Likewise, biofilm pneumococci were hyper-adhesive due to selection for the transparent phase variant, reduced CPS, and enhanced production of PsrP, CbpA, and ChoP. These studies suggest that biofilms do not directly contribute to development of IPD and may instead confer a quiescent mode of growth during colonization.	[Sanchez, Carlos J.; Lizcano, Anel; Shivshankar, Pooja; Jorgensen, James H.; Orihuela, Carlos J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Kumar, Nikhil; Hotopp, Julie C. Dunning; Tettelin, Herve] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Inst Genome Sci, Baltimore, MD 21201 USA; [Jorgensen, James H.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University System of Maryland; University of Maryland Baltimore; University of Texas System; University of Texas Health San Antonio	Sanchez, CJ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA.	orihuela@uthscsa.edu	Dunning Hotopp, Julie/E-7762-2010	Dunning Hotopp, Julie/0000-0003-3862-986X	National Institutes of Health [DE14318, AI078972]; University of Maryland; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE014318] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Maryland; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health grants DE14318 to CJS and AI078972 to CJO. Work completed by NK, JCDH and HT was supported by University of Maryland internal funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegrucci M, 2008, J BACTERIOL, V190, P6330, DOI 10.1128/JB.00707-08; Allegrucci M, 2007, J BACTERIOL, V189, P2030, DOI 10.1128/JB.01369-06; Allison KR, 2011, NATURE, V473, P216, DOI 10.1038/nature10069; [Anonymous], 1999, Wkly Epidemiol Rec, V74, P177; Bensing BA, 2005, MOL MICROBIOL, V58, P1468, DOI 10.1111/j.1365-2958.2005.04919.x; Bensing BA, 2004, J BACTERIOL, V186, P638, DOI 10.1128/JB.186.3.638-645.2004; Bensing BA, 2002, MOL MICROBIOL, V44, P1081, DOI 10.1046/j.1365-2958.2002.02949.x; BRILES DE, 1992, INFECT IMMUN, V60, P111, DOI 10.1128/IAI.60.1.111-116.1992; CAMARA M, 1994, INFECT IMMUN, V62, P3688; Camilli R, 2011, EUR J CLIN MICROBIOL, V30, P97, DOI 10.1007/s10096-010-1060-6; Casey R, 2008, INFECT IMMUN, V76, P1298, DOI 10.1128/IAI.00741-07; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Crook DW, 2004, PNEUMOCCOCUS, P136; CUNDELL DR, 1995, NATURE, V377, P435, DOI 10.1038/377435a0; Cundell DR, 1996, ADV EXP MED BIOL, V416, P89; del Prado G, 2010, DIAGN MICR INFEC DIS, V67, P311, DOI 10.1016/j.diagmicrobio.2010.03.016; Garcia-Castillo M, 2007, J ANTIMICROB CHEMOTH, V59, P301, DOI 10.1093/jac/dkl482; Gilbert P, 2002, ADV MICROB PHYSIOL, V46, P203, DOI 10.1016/S0065-2911(02)46005-5; Glover DT, 2008, INFECT IMMUN, V76, P2767, DOI 10.1128/IAI.01126-07; Gosink KK, 2000, INFECT IMMUN, V68, P5690, DOI 10.1128/IAI.68.10.5690-5695.2000; Hall-Stoodley L, 2006, JAMA-J AM MED ASSOC, V296, P202, DOI 10.1001/jama.296.2.202; Hall-Stoodley L, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-173; Hammerschmidt S, 2005, INFECT IMMUN, V73, P4653, DOI 10.1128/IAI.73.8.4653-4667.2005; Harro JM, 2010, FEMS IMMUNOL MED MIC, V59, P306, DOI 10.1111/j.1574-695X.2010.00708.x; Hava DL, 2003, J BACTERIOL, V185, P413, DOI 10.1128/JB.185.2.413-421.2003; Heo SM, 2008, CLIN INFECT DIS, V47, P1562, DOI 10.1086/593193; Hoa M, 2009, INT J PEDIATR OTORHI, V73, P1242, DOI 10.1016/j.ijporl.2009.05.016; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Jiang SM, 2008, J BACTERIOL, V190, P1956, DOI 10.1128/JB.01677-07; Kim JO, 1998, J INFECT DIS, V177, P368, DOI 10.1086/514205; King SJ, 2004, MOL MICROBIOL, V54, P159, DOI 10.1111/j.1365-2958.2004.04252.x; Konto-Ghiorghi Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000422; Lexau CA, 2005, JAMA-J AM MED ASSOC, V294, P2043, DOI 10.1001/jama.294.16.2043; Li-Korotky HS, 2010, MICROB PATHOGENESIS, V49, P204, DOI 10.1016/j.micpath.2010.05.014; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lizcano A, 2010, MICROB PATHOGENESIS, V48, P124, DOI 10.1016/j.micpath.2010.01.002; Manetti AGO, 2007, MOL MICROBIOL, V64, P968, DOI 10.1111/j.1365-2958.2007.05704.x; Maruyama T, 2010, RESP MED, V104, P584, DOI 10.1016/j.rmed.2009.12.008; Moschioni M, 2010, INFECT IMMUN, V78, P5033, DOI 10.1128/IAI.00601-10; Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06; Munoz-Elias EJ, 2008, INFECT IMMUN, V76, P5049, DOI 10.1128/IAI.00425-08; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Obert C, 2006, INFECT IMMUN, V74, P4766, DOI 10.1128/IAI.00316-06; Oggioni MR, 2006, MOL MICROBIOL, V61, P1196, DOI 10.1111/j.1365-2958.2006.05310.x; Orihuela CJ, 2009, J CLIN INVEST, V119, P1638, DOI 10.1172/JCI36759; Orihuela CJ, 2004, J INFECT DIS, V190, P1661, DOI 10.1086/424596; OVERTURF G, 1980, TEX REP BIOL MED, V40, P283; Parker D, 2009, INFECT IMMUN, V77, P3722, DOI 10.1128/IAI.00228-09; Ramirez P, 2007, CURR OPIN INFECT DIS, V20, P190, DOI 10.1097/QCO.0b013e328014daac; Reid SD, 2009, J INFECT DIS, V199, P786, DOI 10.1086/597042; Ren B, 2003, INFECT IMMUN, V71, P75, DOI 10.1128/IAI.71.1.75-85.2003; Rose L, 2008, J INFECT DIS, V198, P375, DOI 10.1086/589775; Rosenow C, 1997, MOL MICROBIOL, V25, P819, DOI 10.1111/j.1365-2958.1997.mmi494.x; Roush SW, 2007, JAMA-J AM MED ASSOC, V298, P2155, DOI 10.1001/jama.298.18.2155; RUBINS JB, 1995, J CLIN INVEST, V95, P142, DOI 10.1172/JCI117631; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sanchez CJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001044; Shivshankar P, 2009, MOL MICROBIOL, V73, P663, DOI 10.1111/j.1365-2958.2009.06796.x; Spellerberg B, 1996, MOL MICROBIOL, V19, P803, DOI 10.1046/j.1365-2958.1996.425954.x; Stewart PS, 2002, INT J MED MICROBIOL, V292, P107, DOI 10.1078/1438-4221-00196; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Tapiainen T, 2010, APMIS, V118, P255, DOI 10.1111/j.1600-0463.2010.02587.x; Tong HH, 2001, MICROB PATHOGENESIS, V31, P309, DOI 10.1006/mpat.2001.0473; Trappetti C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019844; Trappetti C, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-75; Trappetti C, 2009, J INFECT DIS, V199, P1497, DOI 10.1086/598483; Weiser JN, 1996, INFECT IMMUN, V64, P2240, DOI 10.1128/IAI.64.6.2240-2245.1996; WEISER JN, 1994, INFECT IMMUN, V62, P2582, DOI 10.1128/IAI.62.6.2582-2589.1994; WONG WY, 1992, CLIN INFECT DIS, V14, P1124, DOI 10.1093/clinids/14.5.1124; Zhang JR, 2000, CELL, V102, P827, DOI 10.1016/S0092-8674(00)00071-4	70	84	89	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28738	10.1371/journal.pone.0028738	http://dx.doi.org/10.1371/journal.pone.0028738			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174882	Green Published, gold, Green Submitted			2022-12-25	WOS:000298163600041
J	Wang, Y; Zocchi, G				Wang, Yong; Zocchi, Giovanni			Viscoelastic Transition and Yield Strain of the Folded Protein	PLOS ONE			English	Article							GUANYLATE KINASE; FORCES; MOLECULES; DYNAMICS; REVEALS	For proteins, the mechanical properties of the folded state are directly related to function, which generally entails conformational motion. Through sub-Angstrom resolution measurements of the AC mechanical susceptibility of a globular protein we describe a new fundamental materials property of the folded state. For increasing amplitude of the forcing, there is a reversible transition from elastic to viscoelastic response. At fixed frequency, the amplitude of the deformation is piecewise linear in the force, with different slopes in the elastic and viscoelastic regimes. Effectively, the protein softens beyond a yield point defined by this transition. We propose that ligand induced conformational changes generally operate in this viscoelastic regime, and that this is a universal property of the folded state.	[Wang, Yong; Zocchi, Giovanni] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Wang, Y (corresponding author), Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA.	zocchi@physics.ucla.edu	Wang, Yong/B-8528-2011	Wang, Yong/0000-0002-8601-8302	UC Lab; National Science Foundation [DMR-1006162]	UC Lab; National Science Foundation(National Science Foundation (NSF))	This work was supported by the UC Lab Research Program and by National Science Foundation grant DMR-1006162. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaszczyk J, 2001, J MOL BIOL, V307, P247, DOI 10.1006/jmbi.2000.4427; Choi B, 2007, BIOPHYS J, V92, P1651, DOI 10.1529/biophysj.106.092866; Cui Y, 2000, P NATL ACAD SCI USA, V97, P127, DOI 10.1073/pnas.97.1.127; Delalande O, 2011, BIOPHYS J, V101, P1440, DOI 10.1016/j.bpj.2011.07.048; Deshpande AP, 2010, RHEOLOGY OF COMPLEX FLUIDS, P87, DOI 10.1007/978-1-4419-6494-6_4; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; FRAUENFELDER H, 1979, NATURE, V280, P558, DOI 10.1038/280558a0; GO N, 1983, P NATL ACAD SCI-BIOL, V80, P3696, DOI 10.1073/pnas.80.12.3696; HOPFIELD JJ, 1973, J MOL BIOL, V77, P207, DOI 10.1016/0022-2836(73)90332-X; Kawakami M, 2005, LANGMUIR, V21, P4765, DOI 10.1021/la0469699; Kawakami M, 2004, LANGMUIR, V20, P9299, DOI 10.1021/la0486178; Kawakami M, 2006, BIOPHYS J, V91, pL16, DOI 10.1529/biophysj.106.085019; KHOLODENKO AL, 1995, PHYS REV E, V51, P1081, DOI 10.1103/PhysRevE.51.1081; Levine AJ, 2000, PHYS REV LETT, V85, P1774, DOI 10.1103/PhysRevLett.85.1774; Levine AJ, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.041510; Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219; NUZZO RG, 1987, J AM CHEM SOC, V109, P2358, DOI 10.1021/ja00242a020; RADMACHER M, 1994, LANGMUIR, V10, P3809, DOI 10.1021/la00022a068; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rief M, 1999, J MOL BIOL, V286, P553, DOI 10.1006/jmbi.1998.2466; Russel W.B., 1889, COLLOIDAL DISPERSION, P456; Sacquin-Mora S, 2010, BIOPHYS J, V99, P3412, DOI 10.1016/j.bpj.2010.09.026; Sekulic N, 2002, J BIOL CHEM, V277, P30236, DOI 10.1074/jbc.M204668200; Singh-Zocchi M, 2003, P NATL ACAD SCI USA, V100, P7605, DOI 10.1073/pnas.1337215100; Taton TA, 2002, PREPARATION GOLD NAN, DOI 10.1002s0471142700; Tseng CY, 2010, EPL-EUROPHYS LETT, V91, DOI 10.1209/0295-5075/91/18005; Tseng CY, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.061912; Wang Y, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/18003; Wang Y, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.238104; Wang Y, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/33/335103; Weltmann RN, 1943, J APPL PHYS, V14, P569, DOI 10.1063/1.1714935; Yang GL, 2000, P NATL ACAD SCI USA, V97, P139, DOI 10.1073/pnas.97.1.139; Zaccai G, 2000, SCIENCE, V288, P1604, DOI 10.1126/science.288.5471.1604; Zocchi G, 2009, ANNU REV BIOPHYS, V38, P75, DOI 10.1146/annurev.biophys.050708.133637	34	12	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28097	10.1371/journal.pone.0028097	http://dx.doi.org/10.1371/journal.pone.0028097			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174767	Green Published, gold, Green Submitted			2022-12-25	WOS:000298163600012
J	Dart, DA; Brooke, GN; Sita-Lumsden, A; Waxman, J; Bevan, CL				Dart, D. A.; Brooke, G. N.; Sita-Lumsden, A.; Waxman, J.; Bevan, C. L.			Reducing prohibitin increases histone acetylation, and promotes androgen independence in prostate tumours by increasing androgen receptor activation by adrenal androgens	ONCOGENE			English	Article						prohibitin; androgen receptor; prostate; androgens; castrate-resistant prostate cancer; corepressor	TRANSCRIPTIONAL REPRESSION; CANCER CELLS; NUCLEUS; PROTEIN; RAT; SUPERFAMILY; RECRUITMENT; SUPPRESSION; PROGRESSION; SENESCENCE	Prostate cancers (PCs), initially responsive to anti-androgen therapies, often advance to a hormone-refractory 'castrate-resistant' PC (CRPC) stage. However, the androgen receptor (AR) pathway remains active and key for cell growth and gene expression within tumours, even in the apparent absence of hormone. Proposed mechanisms to explain progression, including AR amplification/mutation, are insufficient to completely explain CRPC and possible roles of AR cofactors such as prohibitin (PHB) are poorly understood. We investigated whether PHB loss could sensitise PC cells and tumours to adrenal gland-derived androgens, which persist even after androgen ablation, hence contribute to development of CRPC. Using a pair of PC cell lines, inducibly expressing ectopic cDNA or RNAi for PHB, responses to different androgens and hormone concentrations were studied both in vitro and in vivo. PHB was found at the promoters of several genes, both AR and non-AR-regulated, and knockdown increased histone acetylation at these promoters. Further, PHB knockdown increased the rate of AR ligand-induced chromatin binding, and binding rate and occupancy of AR upon the PSA promoter. This resulted in increased cell growth and AR activity in response to all androgens, including promoting a response to the weaker adrenal androgens previously absent at physiological concentrations. In vivo this had functional consequences such that PHB knockdown resulted in androstenedione being sufficient to promote tumour growth, under conditions mimicking those in patients undergoing androgen ablation therapy. We conclude that reduction in PHB levels is sufficient to lower the threshold of AR activity in vitro and in vivo; this may be via a general increase in histone acetylation that could potentially affect signalling by other transcription factors. PHB loss may provide a mechanism for progression to CRPC by sensitising PC cells to 'castrate' conditions-that is, low levels of testicular androgens in the continued presence of weak adrenal and dietary androgens.	[Dart, D. A.; Brooke, G. N.; Sita-Lumsden, A.; Bevan, C. L.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Androgen Signalling Lab, London W12 0NN, England; Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London W12 0NN, England	Imperial College London; Imperial College London	Bevan, CL (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Androgen Signalling Lab, Hammersmith Hosp Campus,Du Cane Rd, London W12 0NN, England.	charlotte.bevan@imperial.ac.uk	Brooke, Greg/ABF-4859-2020; Bevan, Charlotte/T-7769-2019; Brooke, Greg/C-9426-2013; Bevan, Charlotte L/K-2276-2012	Bevan, Charlotte L/0000-0002-7533-0552; Brooke, Greg/0000-0003-4501-4134	Hammersmith Hospital; Medical Research Council of the UK; Cancer Research UK; Prostate Cancer Charity; Medical Research Council [G0700915] Funding Source: researchfish; Prostate Cancer UK [PG10-25] Funding Source: researchfish; MRC [G0700915] Funding Source: UKRI	Hammersmith Hospital; Medical Research Council of the UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Prostate Cancer Charity; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Prostate Cancer UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to members of the Androgen Signalling Laboratory for advice and technical help, to Ana Costa Pereira for the kind gift of TAP1 primers and interferon, and to Malcolm Parker for advice and critical reading of the manuscript. This work was supported by grants from the Hammersmith Hospital Special Trustees, the Medical Research Council of the UK, Cancer Research UK and The Prostate Cancer Charity.	Brinkmann AO, 2000, NAT MED, V6, P628, DOI 10.1038/76194; Brinkmann AO, 2001, MOL CELL ENDOCRINOL, V179, P105, DOI 10.1016/S0303-7207(01)00466-X; Brooke GN, 2009, CURR GENOMICS, V10, P18, DOI 10.2174/138920209787581307; Chen F, 2004, J STEROID BIOCHEM, V91, P247, DOI 10.1016/j.jsbmb.2004.04.009; Choi D, 2008, ONCOGENE, V27, P1716, DOI 10.1038/sj.onc.1210806; Coates PJ, 1997, CURR BIOL, V7, P607, DOI 10.1016/S0960-9822(06)00261-2; Dai Y, 2008, CARCINOGENESIS, V29, P1725, DOI 10.1093/carcin/bgn117; Dart DA, 2009, ENDOCR-RELAT CANCER, V16, P1157, DOI 10.1677/ERC-09-0028; DELATORRE B, 1976, ACTA ENDOCRINOL-COP, V81, P170, DOI 10.1530/acta.0.0810170; Eissenberg JC, 2000, CURR OPIN GENET DEV, V10, P204, DOI 10.1016/S0959-437X(00)00058-7; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FEEK CM, 1989, J STEROID BIOCHEM, V32, P573, DOI 10.1016/0022-4731(89)90392-0; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Fusaro G, 2003, J BIOL CHEM, V278, P47853, DOI 10.1074/jbc.M305171200; Gamble SC, 2007, ONCOGENE, V26, P1757, DOI 10.1038/sj.onc.1209967; Gamble SC, 2004, ONCOGENE, V23, P2996, DOI 10.1038/sj.onc.1207444; He B, 2008, MOL ENDOCRINOL, V22, P344, DOI 10.1210/me.2007-0400; Isaacs JT, 2004, NAT MED, V10, P26, DOI 10.1038/nm0104-26; Jenster G, 1999, SEMIN ONCOL, V26, P407; Jia L, 2005, CANCER RES, V65, P8003, DOI 10.1158/0008-5472.CAN-04-3679; Joshi B, 2007, BIOCHEM J, V401, P155, DOI 10.1042/BJ20060364; Kang ZG, 2004, MOL ENDOCRINOL, V18, P2633, DOI 10.1210/me.2004-0245; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; Kokontis JM, 1999, VITAM HORM, V55, P219; MCCLUNG JK, 1995, EXP GERONTOL, V30, P99, DOI 10.1016/0531-5565(94)00069-7; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Min W, 1996, J IMMUNOL, V156, P3174; Mullins LJ, 2009, J BIOL CHEM, V284, P3925, DOI 10.1074/jbc.M805081200; Nijtmans LGJ, 2002, CELL MOL LIFE SCI, V59, P143, DOI 10.1007/s00018-002-8411-0; Pignatelli D, 2006, J ENDOCRINOL, V191, P301, DOI 10.1677/joe.1.06972; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; Rastogi S, 2006, MOL CELL BIOL, V26, P4161, DOI 10.1128/MCB.02142-05; Shi SL, 2009, J CELL BIOCHEM, V108, P926, DOI 10.1002/jcb.22324; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.biochem.63.1.451; VANWEERDEN WM, 1992, LIFE SCI, V50, P857, DOI 10.1016/0024-3205(92)90204-3; Wang S, 2004, EMBO J, V23, P2293, DOI 10.1038/sj.emboj.7600231; Wang S, 2002, ONCOGENE, V21, P8388, DOI 10.1038/sj.onc.1205944; Zhang LQ, 2003, CANCER RES, V63, P4552	38	16	18	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT	2012	31	43					4588	4598		10.1038/onc.2011.591	http://dx.doi.org/10.1038/onc.2011.591			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	029WP	22179832	Green Submitted, Green Accepted			2022-12-25	WOS:000310528200002
J	Pareja, F; Ferraro, DA; Rubin, C; Cohen-Dvashi, H; Zhang, F; Aulmann, S; Ben-Chetrit, N; Pines, G; Navon, R; Crosetto, N; Kostler, W; Carvalho, S; Lavi, S; Schmitt, F; Dikic, I; Yakhini, Z; Sinn, P; Mills, GB; Yarden, Y				Pareja, F.; Ferraro, D. A.; Rubin, C.; Cohen-Dvashi, H.; Zhang, F.; Aulmann, S.; Ben-Chetrit, N.; Pines, G.; Navon, R.; Crosetto, N.; Koestler, W.; Carvalho, S.; Lavi, S.; Schmitt, F.; Dikic, I.; Yakhini, Z.; Sinn, P.; Mills, G. B.; Yarden, Y.			Deubiquitination of EGFR by Cezanne-1 contributes to cancer progression	ONCOGENE			English	Article						gene amplification; deubiquitination; endocytosis; growth factor	EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR; UBIQUITIN RECOGNITION; BINDING DOMAINS; BREAST-CANCER; ENDOCYTOSIS; DEGRADATION; PROTEIN; AMSH; MONOUBIQUITINATION	Once stimulated, the epidermal growth factor receptor (EGFR) undergoes self-phosphorylation, which, on the one hand, instigates signaling cascades, and on the other hand, recruits CBL ubiquitin ligases, which mark EGFRs for degradation. Using RNA interference screens, we identified a deubiquitinating enzyme, Cezanne-1, that opposes receptor degradation and enhances EGFR signaling. These functions require the catalytic-and ubiquitin-binding domains of Cezanne-1, and they involve physical interactions and transphosphorylation of Cezanne-1 by EGFR. In line with the ability of Cezanne-1 to augment EGF-induced growth and migration signals, the enzyme is overexpressed in breast cancer. Congruently, the corresponding gene is amplified in approximately one third of mammary tumors, and high transcript levels predict an aggressive disease course. In conclusion, deubiquitination by Cezanne-1 curtails degradation of growth factor receptors, thereby promotes oncogenic growth signals.	[Pareja, F.; Ferraro, D. A.; Rubin, C.; Cohen-Dvashi, H.; Ben-Chetrit, N.; Pines, G.; Koestler, W.; Carvalho, S.; Lavi, S.; Yarden, Y.] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Zhang, F.; Mills, G. B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Aulmann, S.; Sinn, P.] Heidelberg Univ, Inst Pathol, D-6900 Heidelberg, Germany; [Navon, R.; Yakhini, Z.] Agilent Labs, Tel Aviv, Israel; [Crosetto, N.; Dikic, I.] Goethe Univ Frankfurt, Frankfurt Inst Mol Life Sci, Frankfurt, Germany; [Crosetto, N.; Dikic, I.] Goethe Univ Frankfurt, Inst Biochem 2, Frankfurt, Germany; [Carvalho, S.; Schmitt, F.] Univ Porto, IPATIMUP Inst Mol Pathol & Immunol, P-4100 Oporto, Portugal; [Carvalho, S.; Schmitt, F.] Univ Porto, Fac Med, P-4100 Oporto, Portugal; [Yakhini, Z.] Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel	Weizmann Institute of Science; University of Texas System; UTMD Anderson Cancer Center; Ruprecht Karls University Heidelberg; Agilent Technologies; Goethe University Frankfurt; Goethe University Frankfurt; Universidade do Porto; Universidade do Porto; Technion Israel Institute of Technology	Yarden, Y (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, Max & Lillian Candiotty Bldg,Room 312,Herzl St 1, IL-76100 Rehovot, Israel.	yosef.yarden@weizmann.ac.il	Sinn, Hans-Peter/C-5661-2008; Dikic, Ivan/O-4650-2015; Schmitt, Fernando/A-5270-2008; Pines, Gur/X-7501-2019; YARDEN, YOSEF/K-1467-2012	Sinn, Hans-Peter/0000-0003-2836-6699; Dikic, Ivan/0000-0001-8156-9511; Schmitt, Fernando/0000-0002-3711-8681; Pines, Gur/0000-0002-1757-6722; Schmitt, Fernando/0000-0003-1006-6946; Yakhini, Zohar/0000-0002-0420-5412	National Cancer Institute [5R37CA072981, CCSG, P30 CA16672]; European Commission; German-Israeli Project Cooperation; Israel Cancer Research Fund; Dr Miriam and Sheldon G Adelson Medical Research Foundation; MD Moross Institute for Cancer Research; NATIONAL CANCER INSTITUTE [R37CA072981, P50CA098258, R01CA123219, P01CA099031, P30CA016672] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); European Commission(European CommissionEuropean Commission Joint Research Centre); German-Israeli Project Cooperation; Israel Cancer Research Fund; Dr Miriam and Sheldon G Adelson Medical Research Foundation; MD Moross Institute for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the Tissue Bank of the National Center for Tumor Diseases, Heidelberg University Hospital (Heidelberg, Germany). Our research is supported by grants from the National Cancer Institute (5R37CA072981, CCSG and P30 CA16672), the European Commission, the German-Israeli Project Cooperation, the Israel Cancer Research Fund, the Dr Miriam and Sheldon G Adelson Medical Research Foundation and the MD Moross Institute for Cancer Research. YY is the incumbent of the Harold and Zelda Goldenberg Professorial Chair.	Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Bowers K, 2006, J BIOL CHEM, V281, P5094, DOI 10.1074/jbc.M508632200; Caswell PT, 2008, J CELL BIOL, V183, P143, DOI 10.1083/jcb.200804140; Cheng KW, 2004, NAT MED, V10, P1251, DOI 10.1038/nm1125; Courbard JR, 2002, J BIOL CHEM, V277, P45267, DOI 10.1074/jbc.M206460200; Courjal F, 1997, CANCER RES, V57, P4368; Crosetto N, 2008, J BIOL CHEM, V283, P35173, DOI 10.1074/jbc.M803219200; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Duex JE, 2009, MOL BIOL CELL, V20, P1833, DOI 10.1091/mbc.E08-08-0880; Enesa K, 2008, J BIOL CHEM, V283, P7036, DOI 10.1074/jbc.M708690200; Evans PC, 2003, J BIOL CHEM, V278, P23180, DOI 10.1074/jbc.M301863200; Fehrenbacher N, 2009, MOL ONCOL, V3, P297, DOI 10.1016/j.molonc.2009.06.004; Frosi Y, 2010, J CELL BIOL, V189, P557, DOI 10.1083/jcb.201002032; Goh LK, 2010, J CELL BIOL, V189, P871, DOI 10.1083/jcb.201001008; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Hawthorn L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-460; Hou QS, 2008, CANCER RES, V68, P4623, DOI 10.1158/0008-5472.CAN-07-5870; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Katz M, 2002, TRAFFIC, V3, P740, DOI 10.1034/j.1600-0854.2002.31006.x; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Lee S, 2006, NAT STRUCT MOL BIOL, V13, P264, DOI 10.1038/nsmb1064; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Ma YM, 2007, J BIOL CHEM, V282, P9805, DOI 10.1074/jbc.M611635200; Magnifico A, 2003, J BIOL CHEM, V278, P43169, DOI 10.1074/jbc.M308009200; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; Mills GB, 2009, J CLIN INVEST, V119, P2123, DOI 10.1172/JCI40256; Mosesson Y, 2003, J BIOL CHEM, V278, P21323, DOI 10.1074/jbc.C300096200; Nakamura M, 2006, GENES CELLS, V11, P593, DOI 10.1111/j.1365-2443.2006.00963.x; Orsetti B, 2006, BRIT J CANCER, V95, P1439, DOI 10.1038/sj.bjc.6603433; Palmieri D, 2006, BREAST CANCER RES TR, V100, P127, DOI 10.1007/s10549-006-9244-6; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Row PE, 2006, J BIOL CHEM, V281, P12618, DOI 10.1074/jbc.M512615200; Sacco JJ, 2010, IUBMB LIFE, V62, P140, DOI 10.1002/iub.300; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Tarcic G, 2009, CURR BIOL, V19, P1788, DOI 10.1016/j.cub.2009.09.048; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Zhang JQ, 2009, J CLIN INVEST, V119, P2171, DOI 10.1172/JCI37622	40	64	72	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2012	31	43					4599	4608		10.1038/onc.2011.587	http://dx.doi.org/10.1038/onc.2011.587			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	029WP	22179831	Bronze, Green Accepted			2022-12-25	WOS:000310528200003
J	Bedrood, S; Li, YY; Isas, JM; Hegde, BG; Baxa, U; Haworth, IS; Langen, R				Bedrood, Sahar; Li, Yiyu; Isas, J. Mario; Hegde, Balachandra G.; Baxa, Ulrich; Haworth, Ian S.; Langen, Ralf			Fibril Structure of Human Islet Amyloid Polypeptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLID-STATE NMR; EXPERIMENTAL CONSTRAINTS; INSULIN-SECRETION; HUMAN AMYLIN; PEPTIDE; PROTEIN; MODEL; MICE; CONFORMATION; AGGREGATION	Misfolding and amyloid fibril formation by human islet amyloid polypeptide (hIAPP) are thought to be important in the pathogenesis of type 2 diabetes, but the structures of the misfolded forms remain poorly understood. Here we developed an approach that combines site-directed spin labeling with continuous wave and pulsed EPR to investigate local secondary structure and to determine the relative orientation of the secondary structure elements with respect to each other. These data indicated that individual hIAPP molecules take up a hairpin fold within the fibril. This fold contains two beta-strands that are much farther apart than expected from previous models. Atomistic structural models were obtained using computational refinement with EPR data as constraints. The resulting family of structures exhibited a left-handed helical twist, in agreement with the twisted morphology observed by electron microscopy. The fibril protofilaments contain stacked hIAPP monomers that form opposing beta-sheets that twist around each other. The two beta-strands of the monomer adopt out-of-plane positions and are staggered by about three peptide layers (similar to 15 angstrom). These results provide a mechanism for hIAPP fibril formation and could explain the remarkable stability of the fibrils. Thus, the structural model serves as a starting point for understanding and preventing hIAPP misfolding.	[Langen, Ralf] Univ So Calif, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Li, Yiyu; Haworth, Ian S.] Univ So Calif, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA; [Baxa, Ulrich] NIAMS, Struct Biol Lab, NIH, Bethesda, MD 20892 USA	University of Southern California; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Langen, R (corresponding author), Univ So Calif, Zilkha Neurogenet Inst, 1501 San Pablo St, Los Angeles, CA 90033 USA.	langen@usc.edu	Hegde, Balachandra/GPS-6028-2022	Baxa, Ulrich/0000-0002-7263-5078	National Institutes of Health [AG027936]; University of Southern California Center for High-performance Computing and Communications; NATIONAL INSTITUTE ON AGING [R01AG027936] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Southern California Center for High-performance Computing and Communications; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG027936 (to R. L.).; Computation for the work described in this study was supported by the University of Southern California Center for High-performance Computing and Communications.	Ahren B, 1998, DIABETOLOGIA, V41, P1374, DOI 10.1007/s001250051079; Antzutkin ON, 2002, BIOCHEMISTRY-US, V41, P15436, DOI 10.1021/bi0204185; Butler AE, 2004, DIABETES, V53, P1509, DOI 10.2337/diabetes.53.6.1509; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chiang YW, 2005, J MAGN RESON, V172, P279, DOI 10.1016/j.jmr.2004.10.012; CLARK A, 1995, DIABETES RES CLIN PR, V28, pS39, DOI 10.1016/0168-8227(95)01075-O; CLARK A, 1987, LANCET, V2, P231; COOPER GJS, 1987, P NATL ACAD SCI USA, V84, P8628, DOI 10.1073/pnas.84.23.8628; Gebre-Medhin S, 1998, BIOCHEM BIOPH RES CO, V250, P271, DOI 10.1006/bbrc.1998.9308; Goldsbury CS, 1997, J STRUCT BIOL, V119, P17, DOI 10.1006/jsbi.1997.3858; Hatmal MM, 2012, BIOPOLYMERS, V97, P35, DOI 10.1002/bip.21699; Higham CE, 2000, FEBS LETT, V470, P55, DOI 10.1016/S0014-5793(00)01287-4; Janson J, 1996, P NATL ACAD SCI USA, V93, P7283, DOI 10.1073/pnas.93.14.7283; Jao CC, 2010, J BIOL CHEM, V285, P20164, DOI 10.1074/jbc.M110.127811; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Jayasinghe SA, 2004, J BIOL CHEM, V279, P48420, DOI 10.1074/jbc.M406853200; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; KAHN SE, 1990, DIABETES, V39, P634, DOI 10.2337/diabetes.39.5.634; Kahn SE, 1999, DIABETES, V48, P241, DOI 10.2337/diabetes.48.2.241; Kajava AV, 2005, J MOL BIOL, V348, P247, DOI 10.1016/j.jmb.2005.02.029; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Luca S, 2007, BIOCHEMISTRY-US, V46, P13505, DOI 10.1021/bi701427q; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Makin OS, 2004, J MOL BIOL, V335, P1279, DOI 10.1016/j.jmb.2003.11.048; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Radovan D, 2008, BIOCHEMISTRY-US, V47, P6352, DOI 10.1021/bi800503j; Stefani M, 2004, BBA-MOL BASIS DIS, V1739, P5, DOI 10.1016/j.bbadis.2004.08.004; Torok M, 2002, J BIOL CHEM, V277, P40810, DOI 10.1074/jbc.M205659200; WESTERMARK P, 1987, LANCET, V2, P623; WESTERMARK P, 1987, P NATL ACAD SCI USA, V84, P3881, DOI 10.1073/pnas.84.11.3881; Wiltzius JJW, 2008, PROTEIN SCI, V17, P1467, DOI 10.1110/ps.036509.108; Young Andrew, 2005, Adv Pharmacol, V52, P79, DOI 10.1016/S1054-3589(05)52005-2	34	119	119	1	53	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5235	5241		10.1074/jbc.M111.327817	http://dx.doi.org/10.1074/jbc.M111.327817			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22187437	hybrid, Green Published			2022-12-25	WOS:000300638000006
J	Ohana, E; Shcheynikov, N; Park, M; Muallem, S				Ohana, Ehud; Shcheynikov, Nikolay; Park, Meeyoung; Muallem, Shmuel			Solute Carrier Family 26 Member a2 (Slc26a2) Protein Functions as an Electroneutral SO42-/OH-/Cl- Exchanger Regulated by Extracellular Cl-	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYSPLASIA SULFATE TRANSPORTER; MULTIPLE EPIPHYSEAL DYSPLASIA; CYSTIC-FIBROSIS; DTDST GENE; CHONDRODYSPLASIA PHENOTYPE; CHLORIDE CHANNEL; PANCREATIC-DUCT; HCO3-SECRETION; MALE-FERTILITY; FINE-STRUCTURE	Slc26a2 is a ubiquitously expressed SO42- transporter with high expression levels in cartilage and several epithelia. Mutations in SLC26A2 are associated with diastrophic dysplasia. The mechanism by which Slc26a2 transports SO42- and the ion gradients that mediate SO42- uptake are poorly understood. We report here that Slc26a2 functions as an SO42-/2OH(-), SO42-/2Cl(-), andSO(4)(2-)/OH-/Cl- exchanger, depending on the Cl- and OH- gradients. At inward Cl- and outward pH gradients (high Cl-o(-) and low pH(o)) Slc26a2 functions primarily as an SO4o2-/2OH(i)(-) exchanger. At low Cl-o(-) and high pH(o) Slc26a2 functions increasingly as an SO4o2-/2Cl(i)(-) exchanger. The reverse is observed for SO4i2-/2OH(o)(-) and SO4i2-/2Cl(o)(-) exchange. Slc26a2 also exchanges Cl- for I-, Br-, and NO3- and Cl-o(-) competes with SO42- on the transport site. Interestingly, Slc26a2 is regulated by an extracellular anion site, required to activate SO4i2-/2OH(o)(-) exchange. Slc26a2 can transport oxalate in exchange for OH- and/or Cl- with properties similar to SO42- transport. Modeling of the Slc26a2 transmembrane domain (TMD) structure identified a conserved extracellular sequence (367)GFXXP(371) between TMD7 and TMD8 close to the conserved Glu(417) in the permeation pathway. Mutation of Glu(417) eliminated transport by Slc26a2, whereas mutation of Phe(368) increased the affinity for SO4o2- 8-fold while reducing the affinity for Cl-o(-) 2 fold, but without affecting regulation by Cl-o(-). These findings clarify the mechanism of net SO42- transport and describe a novel regulation of Slc26a2 by an extracellular anion binding site and should help in further understanding aberrant SLC26A2 function in diastrophic dysplasia.	[Ohana, Ehud; Shcheynikov, Nikolay; Park, Meeyoung; Muallem, Shmuel] NIDCR, Epithelial Signaling & Transport Sect, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Muallem, S (corresponding author), NIDCR, Epithelial Signaling & Transport Sect, Mol Physiol & Therapeut Branch, NIH, Bldg 10,Room 1N-113, Bethesda, MD 20892 USA.	shmuel.muallem@nih.gov	Ohana, Ehud/ABB-3060-2020	Ohana, Ehud/0000-0001-8598-4042	National Institutes of Health from NIDCR [Z1A-DE000735]; Machiah Foundation [2008-0702]; foundation of the Jewish Community Federation of San Francisco; Peninsula, Marin, and Sonoma Counties; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000735] Funding Source: NIH RePORTER	National Institutes of Health from NIDCR; Machiah Foundation; foundation of the Jewish Community Federation of San Francisco; Peninsula, Marin, and Sonoma Counties; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant Z1A-DE000735 from NIDCR.; Supported by a Machiah Fellowship (Grant 2008-0702) awarded through the Machiah Foundation, a supporting foundation of the Jewish Community Federation of San Francisco, the Peninsula, Marin, and Sonoma Counties.	Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Alnouti Y, 2009, TOXICOL SCI, V108, P225, DOI 10.1093/toxsci/kfn268; ANDERSON RJ, 1984, MINER ELECTROL METAB, V10, P92; Ballhausen D, 2003, J MED GENET, V40, P65, DOI 10.1136/jmg.40.1.65; Becker HM, 2004, BIOPHYS J, V86, P235, DOI 10.1016/S0006-3495(04)74099-0; Bergsdorf EY, 2009, J BIOL CHEM, V284, P11184, DOI 10.1074/jbc.M901170200; Catalan MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016549; Chapman JM, 2010, HISTOCHEM CELL BIOL, V133, P541, DOI 10.1007/s00418-010-0694-x; Compton ELR, 2011, J BIOL CHEM, V286, P27058, DOI 10.1074/jbc.M111.244533; Coulter-Mackie M. B., 1993, GENEREVIEWS; Dorwart MR, 2008, PHYSIOLOGY, V23, P104, DOI 10.1152/physiol.00037.2007; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; ELGAVISH A, 1991, AM J PHYSIOL, V260, pL450, DOI 10.1152/ajplung.1991.260.6.L450; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; Faraldo-Gomez JD, 2004, J MOL BIOL, V339, P981, DOI 10.1016/j.jmb.2004.04.023; Feng LA, 2010, SCIENCE, V330, P635, DOI 10.1126/science.1195230; FLORIN T, 1991, GUT, V32, P766, DOI 10.1136/gut.32.7.766; Forlino A, 2005, HUM MOL GENET, V14, P859, DOI 10.1093/hmg/ddi079; Gorsi B, 2007, TRENDS CELL BIOL, V17, P173, DOI 10.1016/j.tcb.2007.02.006; Guyton A.C., 2006, TXB MED PHYSL; Habuchi O, 2000, BBA-GEN SUBJECTS, V1474, P115, DOI 10.1016/S0304-4165(00)00016-7; Haila S, 2001, J HISTOCHEM CYTOCHEM, V49, P973, DOI 10.1177/002215540104900805; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; Heneghan JF, 2010, AM J PHYSIOL-CELL PH, V298, pC1363, DOI 10.1152/ajpcell.00004.2010; Hoglund P, 1996, NAT GENET, V14, P316, DOI 10.1038/ng1196-316; Jiang ZR, 2006, NAT GENET, V38, P474, DOI 10.1038/ng1762; Karniski LP, 2004, HUM MOL GENET, V13, P2165, DOI 10.1093/hmg/ddh242; Karniski LP, 2001, HUM MOL GENET, V10, P1485, DOI 10.1093/hmg/10.14.1485; Kato A, 2011, ANNU REV PHYSIOL, V73, P261, DOI 10.1146/annurev-physiol-012110-142244; Kerr BJ, 2011, J ANIM SCI, V89, P426, DOI 10.2527/jas.2010-3228; Ko SBH, 2002, EMBO J, V21, P5662, DOI 10.1093/emboj/cdf580; Kujala M, 2007, REPRODUCTION, V133, P775, DOI 10.1530/rep.1.00964; Liu XZ, 2003, HUM MOL GENET, V12, P1155, DOI 10.1093/hmg/ddg127; Markovich D, 2007, ANNU REV PHYSIOL, V69, P361, DOI 10.1146/annurev.physiol.69.040705.141319; Melvin JE, 2005, ANNU REV PHYSIOL, V67, P445, DOI 10.1146/annurev.physiol.67.041703.084745; Nakato H, 2002, BBA-GEN SUBJECTS, V1573, P312, DOI 10.1016/S0304-4165(02)00398-7; Neel NF, 2005, CYTOKINE GROWTH F R, V16, P637, DOI 10.1016/j.cytogfr.2005.05.008; Ohana E, 2011, J GEN PHYSIOL, V137, P239, DOI 10.1085/jgp.201010531; Ohana E, 2009, J PHYSIOL-LONDON, V587, P2179, DOI 10.1113/jphysiol.2008.164863; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Rossi A, 2001, HUM MUTAT, V17, P159, DOI 10.1002/humu.1; RUPPIN H, 1980, GASTROENTEROLOGY, V78, P1500; Sachs G, 2003, PHARMACOTHERAPY, V23, p68S, DOI 10.1592/phco.23.13.68S.31931; Satoh H, 1998, J BIOL CHEM, V273, P12307, DOI 10.1074/jbc.273.20.12307; Shcheynikov N, 2006, J GEN PHYSIOL, V127, P511, DOI 10.1085/jgp.200509392; Shcheynikov N, 2008, J PHYSIOL-LONDON, V586, P3813, DOI 10.1113/jphysiol.2008.154468; Steward MC, 2005, ANNU REV PHYSIOL, V67, P377, DOI 10.1146/annurev.physiol.67.031103.153247; Stone MJ, 2009, NEW BIOTECHNOL, V25, P299, DOI 10.1016/j.nbt.2009.03.011; Superti-Furga A, 1999, J MED GENET, V36, P621; SupertiFurga A, 1996, AM J MED GENET, V63, P144, DOI 10.1002/(SICI)1096-8628(19960503)63:1<144::AID-AJMG25>3.0.CO;2-N; SupertiFurga A, 1996, NAT GENET, V12, P100, DOI 10.1038/ng0196-100; Toure A, 2007, HUM MOL GENET, V16, P1783, DOI 10.1093/hmg/ddm117; TREUHAFT PS, 1971, ARTHRITIS RHEUM, V14, P475, DOI 10.1002/art.1780140407; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wang YX, 2006, EMBO J, V25, P5049, DOI 10.1038/sj.emboj.7601387; Xu WM, 2007, P NATL ACAD SCI USA, V104, P9816, DOI 10.1073/pnas.0609253104; Zdebik AA, 2008, J BIOL CHEM, V283, P4219, DOI 10.1074/jbc.M708368200	57	33	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					5122	5132		10.1074/jbc.M111.297192	http://dx.doi.org/10.1074/jbc.M111.297192			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22190686	hybrid, Green Published			2022-12-25	WOS:000300608500070
J	Tang, MC; Fu, CY; Tang, GL				Tang, Man-Cheng; Fu, Cheng-Yu; Tang, Gong-Li			Characterization of SfmD as a Heme Peroxidase That Catalyzes the Regioselective Hydroxylation of 3-Methyltyrosine to 3-Hydroxy-5-methyltyrosine in Saframycin A Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-TYROSINE; CONVERSION; CHEMISTRY; HISTIDINE	Saframycin A (SFM-A) is a potent antitumor antibiotic that belongs to the tetrahydroisoquinoline family. Biosynthetic studies have revealed that its unique pentacyclic core structure is derived from alanine, glycine, and non-proteinogenic amino acid 3-hydroxy-5-methyl-O-methyltyrosine (3-OH-5-Me-OMe-Tyr). SfmD, a hypothetical protein in the biosynthetic pathway of SFM-A, was hypothesized to be responsible for the generation of the 3-hydroxy group of 3-OH-5-Me-OMe-Tyr based on previously heterologous expression results. We now report the in vitro characterization of SfmD as a novel hemecontaining peroxidase that catalyzes the hydroxylation of 3-methyltyrosine to 3-hydroxy-5-methyltyrosine using hydrogen peroxide as the oxidant. In addition, we elucidated the biosynthetic pathway of 3-OH-5-Me-OMe-Tyr by kinetic studies of SfmD in combination with biochemical assays of SfmM2, a methyltransferase within the same pathway. Furthermore, SacD, a counterpart of SfmD involved in safracin B biosynthesis, was also characterized as a heme-containing peroxidase, suggesting that SfmD-like heme-containing peroxidases may be commonly involved in the biosynthesis of SFM-A and its analogs. Finally, we found that the conserved motif HXXXC is crucial for heme binding using comparative UV-Vis and Magnetic Circular Dichroism (MCD) spectra studies of SfmD wild-type and mutants. Together, these findings expand the category of heme-containing peroxidases and set the stage for further mechanistic studies. In addition, this study has critical implications for delineating the biosynthetic pathway of other related tetrahydroisoquinoline family members.	[Tang, Man-Cheng; Fu, Cheng-Yu; Tang, Gong-Li] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS	Tang, GL (corresponding author), Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, 345 Lingling Rd, Shanghai 200032, Peoples R China.	gltang@sioc.ac.cn			National Basic Research Program of China (973 Program) [2010CB833200, 2012CB721100]; National Natural Science Foundation of China [20832009, 20921091]; Chinese Academy of Science [KJCX2-YW-H08]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Science(Chinese Academy of Sciences)	This work was supported in part by grants from the National Basic Research Program of China (973 Program) (2010CB833200 and 2012CB721100), the National Natural Science Foundation of China (20832009 and 20921091), and the Chinese Academy of Science (KJCX2-YW-H08).	ALBERTA JA, 1987, J BIOL CHEM, V262, P11857; Allen JWA, 2005, BIOCHEM J, V389, P587, DOI 10.1042/BJ20041894; ARAI T, 1977, J ANTIBIOT, V30, P1015; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chowdhury G, 2010, CHEM RES TOXICOL, V23, P1018, DOI 10.1021/tx900367p; Connor KL, 2011, BIOCHEMISTRY-US, V50, P8926, DOI 10.1021/bi201148a; Cuevas C, 2009, NAT PROD REP, V26, P322, DOI 10.1039/b808331m; Deboves HJC, 2001, J CHEM SOC PERK T 1, P1876, DOI 10.1039/b103832j; Fitzpatrick PF, 1999, ANNU REV BIOCHEM, V68, P355, DOI 10.1146/annurev.biochem.68.1.355; Fu CY, 2009, J MICROBIOL BIOTECHN, V19, P439, DOI 10.4014/jmb.0808.484; Guillou H, 2004, J LIPID RES, V45, P32, DOI 10.1194/jlr.M300339-JLR200; Hannemann F, 2007, BBA-GEN SUBJECTS, V1770, P330, DOI 10.1016/j.bbagen.2006.07.017; Hofrichter M, 2006, APPL MICROBIOL BIOT, V71, P276, DOI 10.1007/s00253-006-0417-3; Hofrichter M, 2010, APPL MICROBIOL BIOT, V87, P871, DOI 10.1007/s00253-010-2633-0; HUFF AM, 1993, INORG CHEM, V32, P1460, DOI 10.1021/ic00060a023; HURLEY LH, 1983, J ANTIBIOT, V36, P383, DOI 10.7164/antibiotics.36.383; Khatri Y, 2010, CHEM BIOL, V17, P1295, DOI 10.1016/j.chembiol.2010.10.010; Khindaria A, 1996, BIOCHEMISTRY-US, V35, P13107, DOI 10.1021/bi961297+; Koketsu K, 2010, NAT CHEM BIOL, V6, P408, DOI 10.1038/nchembio.365; Li L, 2008, J BACTERIOL, V190, P251, DOI 10.1128/JB.00826-07; Lin SJ, 2008, J AM CHEM SOC, V130, P6616, DOI 10.1021/ja710601d; Mense SM, 2006, CELL RES, V16, P681, DOI 10.1038/sj.cr.7310086; MIKAMI Y, 1985, J BIOL CHEM, V260, P344; Neusser D, 1998, ARCH MICROBIOL, V169, P322, DOI 10.1007/s002030050578; PALANISWAMY VA, 1986, J AM CHEM SOC, V108, P5651, DOI 10.1021/ja00278a062; Palmer G., 1983, IRON PORPHYRINS 2; Poulos TL, 2010, ARCH BIOCHEM BIOPHYS, V500, P3, DOI 10.1016/j.abb.2010.02.008; Sambrook J, 2001, MOL CLONING LAB MANU; SANCHEZFERRER A, 1995, BBA-PROTEIN STRUCT M, V1247, P1; Scott JD, 2002, CHEM REV, V102, P1669, DOI 10.1021/cr010212u; Sheoran A, 2008, MOL BIOSYST, V4, P622, DOI 10.1039/b801391h; SMITH PI, 1976, BIOCHEM J, V153, P403, DOI 10.1042/bj1530403; SMITH WL, 1991, BIOCHIM BIOPHYS ACTA, V1083, P1, DOI 10.1016/0005-2760(91)90119-3; Sono M, 1996, CHEM REV, V96, P2841, DOI 10.1021/cr9500500; Sugano Y, 2009, CELL MOL LIFE SCI, V66, P1387, DOI 10.1007/s00018-008-8651-8; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; Trost BM, 2003, ORG LETT, V5, P4599, DOI 10.1021/ol035752n; Velasco A, 2005, MOL MICROBIOL, V56, P144, DOI 10.1111/j.1365-2958.2004.04433.x; Zamocky M, 2010, BIOCATALYSIS BASED ON HEME PEROXIDASES, P7, DOI 10.1007/978-3-642-12627-7_2	40	28	32	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					5112	5121		10.1074/jbc.M111.306316	http://dx.doi.org/10.1074/jbc.M111.306316			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22187429	hybrid, Green Published			2022-12-25	WOS:000300608500069
J	Hass, CS; Lam, K; Wold, MS				Hass, Cathy S.; Lam, Koonyee; Wold, Marc S.			Repair-specific Functions of Replication Protein A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; EXCISION-REPAIR; KDA SUBUNIT; BINDING; RPA; DOMAINS; CHECKPOINT; SSDNA; BRCA2; RECONSTITUTION	Replication protein A (RPA), the major eukaryotic single-strand DNA (ssDNA)-binding protein, is essential for replication, repair, recombination, and checkpoint activation. Defects in RPA-associated cellular activities lead to genomic instability, a major factor in the pathogenesis of cancer and other diseases. ssDNA binding activity is primarily mediated by two domains in the 70-kDa subunit of the RPA complex. These ssDNA interactions are mediated by a combination of polar residues and four conserved aromatic residues. Mutation of the aromatic residues causes a modest decrease in binding to long (30-nucleotide) ssDNA fragments but results in checkpoint activation and cell cycle arrest in cells. We have used a combination of biochemical analysis and knockdown replacement studies in cells to determine the contribution of these aromatic residues to RPA function. Cells containing the aromatic residue mutants were able to progress normally through S-phase but were defective in DNA repair. Biochemical characterization revealed that mutation of the aromatic residues severely decreased binding to short ssDNA fragments less than 20 nucleotides long. These data indicate that altered binding of RPA to short ssDNA intermediates causes a defect in DNA repair but not in DNA replication. These studies show that cells require different RPA functions in DNA replication and DNA repair.	[Hass, Cathy S.; Lam, Koonyee; Wold, Marc S.] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa	Wold, MS (corresponding author), Univ Iowa, Dept Biochem, Carver Coll Med, 3107 MERF,375 Newton Rd, Iowa City, IA 52242 USA.	marc-wold@uiowa.edu		Wold, Marc/0000-0002-4580-1624	National Institutes of Health [GM44721]; American Heart Association [09PRE2160147]; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044721] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant (GM44721) (to M. S. W.). This work was also supported by the American Heart Association Fellowship 09PRE2160147 (to C. S. H.).	Arunkumar AI, 2003, J BIOL CHEM, V278, P41077, DOI 10.1074/jbc.M305871200; Bastin-Shanower SA, 2001, J BIOL CHEM, V276, P36446, DOI 10.1074/jbc.M104386200; Binz SK, 2008, J BIOL CHEM, V283, P21559, DOI 10.1074/jbc.M802450200; Binz SK, 2006, METHOD ENZYMOL, V409, P11, DOI 10.1016/S0076-6879(05)09002-6; BLACKWELL LJ, 1994, MOL CELL BIOL, V14, P3993, DOI 10.1128/MCB.14.6.3993; Bochkarev A, 2004, CURR OPIN STRUC BIOL, V14, P36, DOI 10.1016/j.sbi.2004.01.001; Bochkareva E, 2001, EMBO J, V20, P612, DOI 10.1093/emboj/20.3.612; Bochkareva E, 2000, J BIOL CHEM, V275, P27332; Bochkareva E, 2005, P NATL ACAD SCI USA, V102, P15412, DOI 10.1073/pnas.0504614102; Braun KA, 1997, BIOCHEMISTRY-US, V36, P8443, DOI 10.1021/bi970473r; Brill SJ, 1998, MOL CELL BIOL, V18, P7225, DOI 10.1128/MCB.18.12.7225; Broderick S, 2010, SUBCELL BIOCHEM, V50, P143, DOI 10.1007/978-90-481-3471-7_8; Cai LF, 2007, BIOCHEMISTRY-US, V46, P8226, DOI 10.1021/bi7004976; CHEN LC, 1991, P NATL ACAD SCI USA, V88, P3847, DOI 10.1073/pnas.88.9.3847; Choi JH, 2010, P NATL ACAD SCI USA, V107, P13660, DOI 10.1073/pnas.1007856107; COLES C, 1990, LANCET, V336, P761, DOI 10.1016/0140-6736(90)93236-I; Daughdrill GW, 2001, NUCLEIC ACIDS RES, V29, P3270, DOI 10.1093/nar/29.15.3270; de Laat WL, 1998, GENE DEV, V12, P2598, DOI 10.1101/gad.12.16.2598; DeMott MS, 1998, J BIOL CHEM, V273, P27492, DOI 10.1074/jbc.273.42.27492; Dickey JS, 2009, CHROMOSOMA, V118, P683, DOI 10.1007/s00412-009-0234-4; Dickson AM, 2009, NUCLEIC ACIDS RES, V37, P2313, DOI 10.1093/nar/gkp090; Eggler AL, 2002, J BIOL CHEM, V277, P39280, DOI 10.1074/jbc.M204328200; ERDILE LF, 1990, J BIOL CHEM, V265, P3177; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Gao H, 2007, NAT STRUCT MOL BIOL, V14, P208, DOI 10.1038/nsmb1205; Givalos N, 2007, MODERN PATHOL, V20, P159, DOI 10.1038/modpathol.3800719; Gomes XV, 1996, BIOCHEMISTRY-US, V35, P10558, DOI 10.1021/bi9607517; Haring SJ, 2008, J BIOL CHEM, V283, P19095, DOI 10.1074/jbc.M800881200; Hass CS, 2010, MOL CANCER RES, V8, P1017, DOI 10.1158/1541-7786.MCR-10-0161; Iftode C, 1999, CRIT REV BIOCHEM MOL, V34, P141, DOI 10.1080/10409239991209255; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; KIM C, 1995, BIOCHEMISTRY-US, V34, P2058, DOI 10.1021/bi00006a028; KIM CS, 1994, BIOCHEMISTRY-US, V33, P14197, DOI 10.1021/bi00251a031; KIM CS, 1992, MOL CELL BIOL, V12, P3050, DOI 10.1128/MCB.12.7.3050; Krokan HE, 2000, FEBS LETT, V476, P73, DOI 10.1016/S0014-5793(00)01674-4; Kumaran S, 2006, BIOCHEMISTRY-US, V45, P11958, DOI 10.1021/bi060994r; Lao Y, 2000, BIOCHEMISTRY-US, V39, P850, DOI 10.1021/bi991704s; Liu J, 2010, NAT STRUCT MOL BIOL, V17, P1260, DOI 10.1038/nsmb.1904; O'Driscoll M, 2007, AM J HUM GENET, V81, P77, DOI 10.1086/518696; Oakley GG, 2010, FRONT BIOSCI-LANDMRK, V15, P883, DOI 10.2741/3652; Olson E, 2007, MOL CELL BIOL, V27, P6053, DOI 10.1128/MCB.00532-07; Philipova D, 1996, GENE DEV, V10, P2222, DOI 10.1101/gad.10.17.2222; Pommier Y, 2009, CHEM REV, V109, P2894, DOI 10.1021/cr900097c; Ramilo C, 2002, MOL CELL BIOL, V22, P2037, DOI 10.1128/MCB.22.7.2037-2046.2002; Reardon JT, 2005, PROG NUCLEIC ACID RE, V79, P183, DOI 10.1016/S0079-6603(04)79004-2; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; Salas TR, 2006, NUCLEIC ACIDS RES, V34, P4857, DOI 10.1093/nar/gkl564; Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; Tomkiel JE, 2002, CLIN CANCER RES, V8, P752; Vassin VM, 2004, MOL CELL BIOL, V24, P1930, DOI 10.1128/MCB.24.5.1930-1943.2004; Walther AP, 1999, BIOCHEMISTRY-US, V38, P3963, DOI 10.1021/bi982370u; Wang YX, 2005, NAT GENET, V37, P750, DOI 10.1038/ng1587; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Wu XM, 2005, ONCOGENE, V24, P4728, DOI 10.1038/sj.onc.1208674; Wyka IM, 2003, BIOCHEMISTRY-US, V42, P12909, DOI 10.1021/bi034930h; Xu X, 2008, MOL CELL BIOL, V28, P7345, DOI 10.1128/MCB.01079-08; Zou L, 2003, P NATL ACAD SCI USA, V100, P13827, DOI 10.1073/pnas.2336100100; Zou Y, 2006, J CELL PHYSIOL, V208, P267, DOI 10.1002/jcp.20622	59	28	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3908	3918		10.1074/jbc.M111.287441	http://dx.doi.org/10.1074/jbc.M111.287441			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22179778	Green Published, hybrid			2022-12-25	WOS:000300410900027
J	Rooman, M; Albert, J; Dehouck, Y; Haye, A				Rooman, Marianne; Albert, Jaroslav; Dehouck, Yves; Haye, Alexandre			Detection of Perturbation Phases and Developmental Stages in Organisms from DNA Microarray Time Series Data	PLOS ONE			English	Article							GENE-EXPRESSION; LIFE-CYCLE; DROSOPHILA-MELANOGASTER; ESCHERICHIA-COLI; NORMALIZATION; NETWORKS	Available DNA microarray time series that record gene expression along the developmental stages of multicellular eukaryotes, or in unicellular organisms subject to external perturbations such as stress and diauxie, are analyzed. By pairwise comparison of the gene expression profiles on the basis of a translation-invariant and scale-invariant distance measure corresponding to least-rectangle regression, it is shown that peaks in the average distance values are noticeable and are localized around specific time points. These points systematically coincide with the transition points between developmental phases or just follow the external perturbations. This approach can thus be used to identify automatically, from microarray time series alone, the presence of external perturbations or the succession of developmental stages in arbitrary cell systems. Moreover, our results show that there is a striking similarity between the gene expression responses to these a priori very different phenomena. In contrast, the cell cycle does not involve a perturbation-like phase, but rather continuous gene expression remodeling. Similar analyses were conducted using three other standard distance measures, showing that the one we introduced was superior. Based on these findings, we set up an adapted clustering method that uses this distance measure and classifies the genes on the basis of their expression profiles within each developmental stage or between perturbation phases.	[Rooman, Marianne; Albert, Jaroslav; Dehouck, Yves; Haye, Alexandre] Univ Libre Bruxelles, BioSyst BioModeling & BioProc Dept, Brussels, Belgium; [Dehouck, Yves] Fritz Haber Inst Max Planck Gesell, Complex Syst Grp, Berlin, Germany	Universite Libre de Bruxelles; Max Planck Society; Fritz Haber Institute of the Max Planck Society	Rooman, M (corresponding author), Univ Libre Bruxelles, BioSyst BioModeling & BioProc Dept, Brussels, Belgium.	mrooman@ulb.ac.be		Dehouck, Yves/0000-0002-7401-104X	Belgian State Science Policy Office	Belgian State Science Policy Office(Belgian Federal Science Policy Office)	This work was supported by the Belgian State Science Policy Office through an Interuniversity Attraction Poles Program (DYSCO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Azumi K, 2007, DEV BIOL, V308, P572, DOI 10.1016/j.ydbio.2007.05.022; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BROADIE KS, 1993, J NEUROSCI, V13, P167; CAMPOSORTEGA JA, EMBRYONIC DEV DROSOP; Chang DE, 2002, MOL MICROBIOL, V45, P289, DOI 10.1046/j.1365-2958.2002.03001.x; de la Fuente A, 2002, TRENDS GENET, V18, P395, DOI 10.1016/S0168-9525(02)02692-6; Furusawa C, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-17; Jozefczuk S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.18; Kauffman S.A., 1993, ORIGINS ORDER; Liu SP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-455; Mariani TJ, 2002, AM J RESP CELL MOL, V26, P541, DOI 10.1165/ajrcmb.26.5.2001-00080c; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stein T, 2004, BREAST CANCER RES, V6, pR75, DOI 10.1186/bcr753; Zhao WT, 2006, BIOINFORMATICS, V22, P2129, DOI 10.1093/bioinformatics/btl364	17	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e27948	10.1371/journal.pone.0027948	http://dx.doi.org/10.1371/journal.pone.0027948			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22194799	Green Published, gold, Green Submitted			2022-12-25	WOS:000298370400007
J	Deeg, CA; Eberhardt, C; Hofmaier, F; Amann, B; Hauck, SM				Deeg, Cornelia A.; Eberhardt, Christina; Hofmaier, Florian; Amann, Barbara; Hauck, Stefanie M.			Osteopontin and Fibronectin Levels Are Decreased in Vitreous of Autoimmune Uveitis and Retinal Expression of Both Proteins Indicates ECM Re-Modeling	PLOS ONE			English	Article							EQUINE RECURRENT UVEITIS; EXTRACELLULAR-MATRIX; PIGMENT EPITHELIUM; MULLER CELLS; AUTOANTIGENS; MEMBRANE; NEUROPROTECTION; ADHESION; LAMININ; TISSUE	Autoimmune uveitis is an intraocular inflammation that arises through autoreactive T-cells attacking the inner eye, eventually leading to blindness. However, the contributing molecular pathomechanisms within the affected tissues remain as yet elusive. The extracellular matrix (ECM) is a highly dynamic structure that varies tremendously and influences the encompassing tissue. In order to assess ECM re-modeling in autoimmune uveitis, we investigated the expression of ECM molecules fibronectin and osteopontin in vitreous and retina samples. This was carried out in the only spontaneous animal model for human autoimmue uveitis, namely equine recurrent uveitis (ERU) that resembles the human disease in clinical as well as in immunopathological aspects. ERU is a naturally occurring autoimmune disease in horses that develops frequently and has already proved its value to study disease-related pathomechanisms. Western blot analysis of fibronectin and osteopontin in healthy and uveitic vitreous revealed significant reduction of both proteins in uveitis. Immunohistochemical expression of fibronectin in healthy retinas was restricted to the inner limiting membrane abutting vimentin positive Muller cell endfeet, while in uveitic sections, a disintegration of the ILM was observed changing the fibronectin expression to a dispersed pattern extending toward the vitreous. Retinal expression of osteopontin in control tissue was found in a characteristic Muller cell pattern illustrated by co-localization with vimentin. In uveitic retinas, the immunoreactivity of osteopontin in gliotic Muller cells was almost absent. The ability of Muller cells to express fibronectin and osteopontin was additionally shown by immunocytochemistry of primary cultured equine Muller cells and the equine Muller cell line eqMC-7. In conclusion, severe ECM re-modeling in autoimmune uveitis reported here, might affect the adhesive function of fibronectin and thus the anchoring of Muller cell endfeet to the ILM. Furthermore, the absence of osteopontin in gliotic Muller cells might represent reduced neuroprotection, an osteopontin attribute that is intensively discussed.	[Deeg, Cornelia A.; Eberhardt, Christina; Hofmaier, Florian; Amann, Barbara] Univ Munich, Dept Vet Sci, Inst Anim Physiol, Munich, Germany; [Hauck, Stefanie M.] German Res Ctr Environm Hlth GmbH, Res Unit Prot Sci, Helmholtz Zentrum Munchen, Neuherberg, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Deeg, CA (corresponding author), Univ Munich, Dept Vet Sci, Inst Anim Physiol, Munich, Germany.	deeg@tiph.vetmed.uni-muenchen.de	Deeg, Cornelia A/G-4940-2010; Hauck, Stefanie/B-3300-2013; Deeg, Cornelia/U-4216-2019; Eberhardt, Christina/AAS-4593-2020	Deeg, Cornelia A/0000-0003-0375-3190; Hauck, Stefanie/0000-0002-1630-6827; Eberhardt, Christina/0000-0002-8133-2116	Deutsche Forschungsgemeinschaft (DFG) [SFB 571/A5 Deeg, DE 719/2-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (http://www.dfg.de) SFB 571/A5 Deeg and DFG DE 719/2-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JC, 1993, DEVELOPMENT, V117, P1183; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; Caspi RR, 2011, INVEST OPHTH VIS SCI, V52, P1873, DOI 10.1167/iovs.10-6909; Caspi RR, 2010, J CLIN INVEST, V120, P3073, DOI 10.1172/JCI42440; Chen WQ, 2011, STROKE, V42, P764, DOI 10.1161/STROKEAHA.110.599118; Chen W, 2009, CURR EYE RES, V34, P1057, DOI 10.3109/02713680903308487; Chidlow G, 2008, INVEST OPHTH VIS SCI, V49, P762, DOI 10.1167/iovs.07-0726; CHOWDHURY UR, 2011, INVEST OPHTHALMOL VI; Deeg CA, 2002, EXP EYE RES, V75, P127, DOI 10.1006/exer.2002.2011; Deeg CA, 2001, INVEST OPHTH VIS SCI, V42, P393; Deeg CA, 2008, OPHTHAL RES, V40, P151, DOI 10.1159/000119867; Deeg CA, 2007, MOL IMMUNOL, V44, P3291, DOI 10.1016/j.molimm.2007.02.027; Deeg CA, 2007, PROTEOMICS, V7, P1540, DOI 10.1002/pmic.200600795; Deeg CA, 2006, MOL CELL PROTEOMICS, V5, P1462, DOI 10.1074/mcp.M500352-MCP200; Deeg CA, 2009, VET IMMUNOL IMMUNOP, V128, P132, DOI 10.1016/j.vetimm.2008.10.302; Deeg CA, 2007, CLIN DEV IMMUNOL, DOI 10.1155/2007/39245; Del Rio P, 2011, GLIA, V59, P821, DOI 10.1002/glia.21155; Dunkle ET, 2007, EXP EYE RES, V84, P707, DOI 10.1016/j.exer.2006.12.014; Eberhardt C, 2012, J ANIM PHYSIOL AN N, V96, P260, DOI 10.1111/j.1439-0396.2011.01147.x; Eberhardt C, 2011, GLIA, V59, P697, DOI 10.1002/glia.21139; Ehrenhofer MCA, 2002, VET OPHTHALMOL, V5, P39, DOI 10.1046/j.1463-5224.2002.00210.x; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Franze K, 2007, P NATL ACAD SCI USA, V104, P8287, DOI 10.1073/pnas.0611180104; Garcia M, 2003, HISTOL HISTOPATHOL, V18, P1205, DOI 10.14670/HH-18.1205; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Hauck SM, 2007, J PROTEOME RES, V6, P2121, DOI 10.1021/pr060668y; Hauck SM, 2010, MOL CELL PROTEOMICS, V9, P2292, DOI 10.1074/mcp.M110.001073; Hikita ST, 2006, INVEST OPHTH VIS SCI, V47, P4435, DOI 10.1167/iovs.06-0064; HISCOTT P, 1992, CELL TISSUE RES, V267, P185, DOI 10.1007/BF00318703; Ho TC, 1997, INVEST OPHTH VIS SCI, V38, P1110; Hofmaier F, 2011, INVEST OPHTH VIS SCI, V52, P2314, DOI 10.1167/iovs.10-6475; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Iwata D, 2010, EXP EYE RES, V90, P41, DOI 10.1016/j.exer.2009.09.008; Kase S, 2007, OPHTHAL RES, V39, P143, DOI 10.1159/000102936; Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377; Kitamura M, 2007, J IMMUNOL, V178, P6567, DOI 10.4049/jimmunol.178.10.6567; KOHNO T, 1987, INVEST OPHTH VIS SCI, V28, P506; Kunii Y, 2009, MED MOL MORPHOL, V42, P155, DOI 10.1007/s00795-009-0459-6; Ljubimov AV, 1996, J HISTOCHEM CYTOCHEM, V44, P1469, DOI 10.1177/44.12.8985139; Meller R, 2005, J CEREBR BLOOD F MET, V25, P217, DOI 10.1038/sj.jcbfm.9600022; Newman E, 1996, TRENDS NEUROSCI, V19, P307, DOI 10.1016/0166-2236(96)10040-0; NUSSENBLATT RB, 1990, INT OPHTHALMOL, V14, P303, DOI 10.1007/BF00163549; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Roehlecke C, 2009, MOL VIS, V15, P1929; Rothova A, 1996, BRIT J OPHTHALMOL, V80, P332, DOI 10.1136/bjo.80.4.332; Schroeter M, 2006, BRAIN, V129, P1426, DOI 10.1093/brain/awl094; SEILER MJ, 1995, CURR EYE RES, V14, P199, DOI 10.3109/02713689509033515; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; Sorokin L, 2010, NAT REV IMMUNOL, V10, P712, DOI 10.1038/nri2852; Stocks SZ, 1999, AUST NZ J OPHTHALMOL, V27, P247, DOI 10.1046/j.1440-1606.1999.00199.x; Sugitani Hideki, 2003, J Atheroscler Thromb, V10, P48; Tezel TH, 2004, INVEST OPHTH VIS SCI, V45, P3337, DOI 10.1167/iovs.04-0193; Uede T, 2011, PATHOL INT, V61, P265, DOI 10.1111/j.1440-1827.2011.02649.x; UGA S, 1973, INVEST OPHTH VISUAL, V12, P295; Wang XL, 2009, CELL MOL NEUROBIOL, V29, P549, DOI 10.1007/s10571-009-9346-x; Zipplies JK, 2009, J PROTEOME RES, V8, P992, DOI 10.1021/pr800694y	56	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e27674	10.1371/journal.pone.0027674	http://dx.doi.org/10.1371/journal.pone.0027674			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194789	Green Published, gold, Green Submitted			2022-12-25	WOS:000298369100009
J	Schloss, PD; Gevers, D; Westcott, SL				Schloss, Patrick D.; Gevers, Dirk; Westcott, Sarah L.			Reducing the Effects of PCR Amplification and Sequencing Artifacts on 16S rRNA-Based Studies	PLOS ONE			English	Article							HUMAN MICROBIOME PROJECT; RARE BIOSPHERE; CLONE LIBRARIES; DIVERSITY; GENES; BIAS; IDENTIFICATION; WRINKLES; QUALITY; SAMPLE	The advent of next generation sequencing has coincided with a growth in interest in using these approaches to better understand the role of the structure and function of the microbial communities in human, animal, and environmental health. Yet, use of next generation sequencing to perform 16S rRNA gene sequence surveys has resulted in considerable controversy surrounding the effects of sequencing errors on downstream analyses. We analyzed 2.7x10(6) reads distributed among 90 identical mock community samples, which were collections of genomic DNA from 21 different species with known 16S rRNA gene sequences; we observed an average error rate of 0.0060. To improve this error rate, we evaluated numerous methods of identifying bad sequence reads, identifying regions within reads of poor quality, and correcting base calls and were able to reduce the overall error rate to 0.0002. Implementation of the PyroNoise algorithm provided the best combination of error rate, sequence length, and number of sequences. Perhaps more problematic than sequencing errors was the presence of chimeras generated during PCR. Because we knew the true sequences within the mock community and the chimeras they could form, we identified 8% of the raw sequence reads as chimeric. After quality filtering the raw sequences and using the Uchime chimera detection program, the overall chimera rate decreased to 1%. The chimeras that could not be detected were largely responsible for the identification of spurious operational taxonomic units (OTUs) and genus-level phylotypes. The number of spurious OTUs and phylotypes increased with sequencing effort indicating that comparison of communities should be made using an equal number of sequences. Finally, we applied our improved quality-filtering pipeline to several benchmarking studies and observed that even with our stringent data curation pipeline, biases in the data generation pipeline and batch effects were observed that could potentially confound the interpretation of microbial community data.	[Schloss, Patrick D.; Westcott, Sarah L.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Gevers, Dirk] Broad Inst MIT & Harvard, Genome Sequencing & Anal Program, Cambridge, MA USA	University of Michigan System; University of Michigan; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Schloss, PD (corresponding author), Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	pschloss@umich.edu	Gevers, Dirk/C-1451-2009	Schloss, Patrick/0000-0002-6935-4275	National Institutes for Health [1R01HG005975-01, NIHU54HG004969]; National Science Foundation [0743432]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004969, R01HG005975] Funding Source: NIH RePORTER	National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	PDS and SLW were supported by grants from the National Institutes for Health (1R01HG005975-01) and National Science Foundation (award #0743432), and DG was supported by a grant from the National Institutes for Health (NIHU54HG004969). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Chandler DP, 1997, MOL ECOL, V6, P475, DOI 10.1046/j.1365-294X.1997.00205.x; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Cline J, 1996, NUCLEIC ACIDS RES, V24, P3546, DOI 10.1093/nar/24.18.3546; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Fredricks DN, 1996, CLIN MICROBIOL REV, V9, P18, DOI 10.1128/CMR.9.1.18; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; HAENEL H, 1959, Z Kinderheilkd, V82, P595, DOI 10.1007/BF00444718; Hansen MC, 1998, FEMS MICROBIOL ECOL, V26, P141, DOI 10.1016/S0168-6496(98)00031-2; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Magurran A.E., 2004, MEASURING BIOL DIVER; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Miller DN, 1999, APPL ENVIRON MICROB, V65, P4715; PACE NR, 1985, ASM NEWS, V51, P4; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Prosser JI, 2010, ENVIRON MICROBIOL, V12, P1806, DOI 10.1111/j.1462-2920.2010.02201.x; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; RELMAN DA, 1992, NEW ENGL J MED, V327, P293, DOI 10.1056/NEJM199207303270501; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844; Schloss PD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008230; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Thompson JR, 2002, NUCLEIC ACIDS RES, V30, P2083, DOI 10.1093/nar/30.9.2083; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418	42	1564	1696	4	358	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e27310	10.1371/journal.pone.0027310	http://dx.doi.org/10.1371/journal.pone.0027310			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194782	Green Published, gold, Green Submitted			2022-12-25	WOS:000298369100004
J	Elbez, R; McNaughton, BH; Patel, L; Pienta, KJ; Kopelman, R				Elbez, Remy; McNaughton, Brandon H.; Patel, Lalit; Pienta, Kenneth J.; Kopelman, Raoul			Nanoparticle Induced Cell Magneto-Rotation: Monitoring Morphology, Stress and Drug Sensitivity of a Suspended Single Cancer Cell	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; MICROPARTICLE; MECHANISMS; EXPRESSION; DYNAMICS; CULTURE	Single cell analysis has allowed critical discoveries in drug testing, immunobiology and stem cell research. In addition, a change from two to three dimensional growth conditions radically affects cell behavior. This already resulted in new observations on gene expression and communication networks and in better predictions of cell responses to their environment. However, it is still difficult to study the size and shape of single cells that are freely suspended, where morphological changes are highly significant. Described here is a new method for quantitative real time monitoring of cell size and morphology, on single live suspended cancer cells, unconfined in three dimensions. The precision is comparable to that of the best optical microscopes, but, in contrast, there is no need for confining the cell to the imaging plane. The here first introduced cell magnetorotation (CM) method is made possible by nanoparticle induced cell magnetization. By using a rotating magnetic field, the magnetically labeled cell is actively rotated, and the rotational period is measured in real-time. A change in morphology induces a change in the rotational period of the suspended cell (e.g. when the cell gets bigger it rotates slower). The ability to monitor, in real time, cell swelling or death, at the single cell level, is demonstrated. This method could thus be used for multiplexed real time single cell morphology analysis, with implications for drug testing, drug discovery, genomics and three-dimensional culturing.	[Elbez, Remy; McNaughton, Brandon H.; Kopelman, Raoul] Univ Michigan, Dept Appl Phys, Ann Arbor, MI 48109 USA; [McNaughton, Brandon H.; Kopelman, Raoul] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Patel, Lalit; Pienta, Kenneth J.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Pienta, Kenneth J.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI USA; [Elbez, Remy; McNaughton, Brandon H.; Kopelman, Raoul] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Elbez, R (corresponding author), Univ Michigan, Dept Appl Phys, Ann Arbor, MI 48109 USA.	kopelman@umich.edu	McNaughton, Brandon/H-2593-2012; Pienta, Kenneth/E-7679-2015	Pienta, Kenneth/0000-0002-4138-2186; Patel, Lalit/0000-0002-9064-5560	National Institutes of Health [NIH-R01-EB007977, NIH-R33CA125297-03S1, NIH-R21EB009550]; NATIONAL CANCER INSTITUTE [R33CA125297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB009550, R01EB007977] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Institutes of Health (NIH-R01-EB007977 (RK), NIH-R33CA125297-03S1 (RK) and NIH-R21EB009550 (RK)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a; Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Arbab AS, 2003, RADIOLOGY, V229, P838, DOI 10.1148/radiol.2293021215; Bertorelle F, 2006, LANGMUIR, V22, P5385, DOI 10.1021/la052710u; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Fantner GE, 2010, NAT NANOTECHNOL, V5, P280, DOI [10.1038/NNANO.2010.29, 10.1038/nnano.2010.29]; Galanzha EI, 2009, NAT NANOTECHNOL, V4, P855, DOI [10.1038/nnano.2009.333, 10.1038/NNANO.2009.333]; Gfeller KY, 2005, APPL ENVIRON MICROB, V71, P2626, DOI 10.1128/AEM.71.5.2626-2631.2005; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Ho VHB, 2009, EXP BIOL MED, V234, P332, DOI 10.3181/0809-RM-273; Hsieh HB, 2006, BIOSENS BIOELECTRON, V21, P1893, DOI 10.1016/j.bios.2005.12.024; Janssen XJA, 2009, BIOSENS BIOELECTRON, V24, P1937, DOI 10.1016/j.bios.2008.09.024; Justice BA, 2009, DRUG DISCOV TODAY, V14, P102, DOI 10.1016/j.drudis.2008.11.006; Krutzik PO, 2008, NAT CHEM BIOL, V4, P132, DOI 10.1038/nchembio.2007.59; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Longo D, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100110; Machesky Laura M, 2010, Commun Integr Biol, V3, P263; Markx GH, 1999, ENZYME MICROB TECH, V25, P161, DOI 10.1016/S0141-0229(99)00008-3; MCMANUS M, 1993, AM J PHYSIOL, V265, pC562, DOI 10.1152/ajpcell.1993.265.2.C562; McNaughton BH, 2007, SENSOR ACTUAT B-CHEM, V121, P330, DOI 10.1016/j.snb.2006.09.043; McNaughton BH, 2006, J PHYS CHEM B, V110, P18958, DOI 10.1021/jp060139h; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; Ramser K, 2010, J BIOPHOTONICS, V3, P187, DOI 10.1002/jbio.200910050; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Souza GR, 2010, NAT NANOTECHNOL, V5, P291, DOI 10.1038/nnano.2010.23; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Valet G, 2006, DRUG DISCOV TODAY, V11, P785, DOI 10.1016/j.drudis.2006.07.003; Villanueva A, 2010, J PHYS CHEM C, V114, P1976, DOI 10.1021/jp907046f; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Wilhelm C, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.061908; Wilhelm C, 2008, BIOMATERIALS, V29, P3161, DOI 10.1016/j.biomaterials.2008.04.016; Wilhelm C, 2009, J MAGN MAGN MATER, V321, P671, DOI 10.1016/j.jmmm.2008.11.022; Yu MK, 2008, ANGEW CHEM INT EDIT, V47, P5362, DOI 10.1002/anie.200800857; Zhang H, 2008, J R SOC INTERFACE, V5, P671, DOI 10.1098/rsif.2008.0052	36	30	35	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28475	10.1371/journal.pone.0028475	http://dx.doi.org/10.1371/journal.pone.0028475			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22180784	Green Published, Green Submitted, gold			2022-12-25	WOS:000298367300012
J	Gil-Ranedo, J; Mendiburu-Elicabe, M; Garcia-Villanueva, M; Medina, D; del Alamo, M; Izquierdo, M				Gil-Ranedo, Jon; Mendiburu-Elicabe, Marina; Garcia-Villanueva, Mercedes; Medina, Diego; del Alamo, Marta; Izquierdo, Marta			An Off-Target Nucleostemin RNAi Inhibits Growth in Human Glioblastoma-Derived Cancer Stem Cells	PLOS ONE			English	Article							CYCLE ARREST; PROSPECTIVE IDENTIFICATION; GENE-EXPRESSION; PROSTATE-CANCER; KNOCKING-DOWN; BRAIN; PROLIFERATION; TRANSPLANTATION; SUBPOPULATION; MODELS	Glioblastomas (GBM) may contain a variable proportion of active cancer stem cells (CSCs) capable of self-renewal, of aggregating into CD133(+) neurospheres, and to develop intracranial tumors that phenocopy the original ones. We hypothesized that nucleostemin may contribute to cancer stem cell biology as these cells share characteristics with normal stem cells. Here we report that nucleostemin is expressed in GBM-CSCs isolated from patient samples, and that its expression, conversely to what it has been described for ordinary stem cells, does not disappear when cells are differentiated. The significance of nucleostemin expression in CSCs was addressed by targeting the corresponding mRNA using lentivirally transduced short hairpin RNA (shRNA). In doing so, we found an off-target nucleostemin RNAi (shRNA22) that abolishes proliferation and induces apoptosis in GBM-CSCs. Furthermore, in the presence of shRNA22, GBM-CSCs failed to form neurospheres in vitro or grow on soft agar. When these cells are xenotransplanted into the brains of nude rats, tumor development is significantly delayed. Attempts were made to identify the primary target/s of shRNA22, suggesting a transcription factor involved in one of the MAP-kinases signaling-pathways or multiple targets. The use of this shRNA may contribute to develop new therapeutic approaches for this incurable type of brain tumor.	[Gil-Ranedo, Jon; Mendiburu-Elicabe, Marina; Izquierdo, Marta] Univ Autonoma Madrid, Dept Biol Mol, Ctr Biol Mol Severo Ochoa, Inst Sanitario Ramon y Cajal,CSIC, Madrid, Spain; [Garcia-Villanueva, Mercedes] Hosp Univ Ramon y Cajal, Serv Anat Patol, Madrid, Spain; [Medina, Diego; del Alamo, Marta] Hosp Univ Ramon y Cajal, Serv Neurocirugia, Inst Sanitario Ramon y Cajal, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Hospital Universitario Ramon y Cajal; Hospital Universitario Ramon y Cajal	Gil-Ranedo, J (corresponding author), Univ Autonoma Madrid, Dept Biol Mol, Ctr Biol Mol Severo Ochoa, Inst Sanitario Ramon y Cajal,CSIC, Madrid, Spain.	mizquierdo@cbm.uam.es		Mendiburu-Elicabe, Marina/0000-0003-2573-8709; Gil-Ranedo, Jon/0000-0002-7365-3411	Ministerio de Ciencia e Innovacion Spain [SAF 2009-07259]; Fundacion Eugenio Rodriguez Pascual (Madrid); Ramon Areces Foundation; Gobierno Vasco, Spain	Ministerio de Ciencia e Innovacion Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Eugenio Rodriguez Pascual (Madrid); Ramon Areces Foundation; Gobierno Vasco, Spain(Basque Government)	This work was supported by funds from: Ministerio de Ciencia e Innovacion (SAF 2009-07259) Spain, and Fundacion Eugenio Rodriguez Pascual (Madrid). The Centro de Biologia Molecular S.O. is also the recipient of an institutional grant from the Ramon Areces Foundation. JG-R was the recipient of a predoctoral fellowship from the Gobierno Vasco, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Baumann M, 2008, NAT REV CANCER, V8, DOI 10.1038/nrc2419-c2; Beekman C, 2006, MOL CELL BIOL, V26, P9291, DOI 10.1128/MCB.01183-06; Charles N, 2009, EXPERT REV NEUROTHER, V9, P1447, DOI 10.1586/ERN.09.91; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Gross CG, 2000, NAT REV NEUROSCI, V1, P67, DOI 10.1038/35036235; GRUPTA PB, 2009, NAT MED, V15, P1010; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; IRVIN DK, 2010, PLOS ONE, V7, P1; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Jafarnejad SM, 2008, CELL PROLIFERAT, V41, P28, DOI 10.1111/j.1365-2184.2007.00505.x; Kafienah W, 2006, STEM CELLS, V24, P1113, DOI 10.1634/stemcells.2005-0416; Kim YW, 2011, NEURO-ONCOLOGY, V13, P367, DOI 10.1093/neuonc/nor012; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Lin T, 2010, CANCER RES, V70, P9444, DOI 10.1158/0008-5472.CAN-10-2159; Lin XY, 2005, NUCLEIC ACIDS RES, V33, P4527, DOI 10.1093/nar/gki762; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Liu RL, 2008, CHINESE MED J-PEKING, V121, P299, DOI 10.1097/00029330-200802020-00004; Ma HH, 2007, MOL BIOL CELL, V18, P2630, DOI 10.1091/mbc.E07-03-0244; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Malakootian M, 2010, MOL CARCINOGEN, V49, P818, DOI 10.1002/mc.20658; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Naito Y, 2005, NUCLEIC ACIDS RES, V33, pW589, DOI 10.1093/nar/gki419; Nikpour P, 2009, CELL PROLIFERAT, V42, P762, DOI 10.1111/j.1365-2184.2009.00635.x; Nomura J, 2009, STEM CELLS, V27, P1066, DOI 10.1002/stem.44; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Romanova L, 2009, J BIOL CHEM, V284, P26685, DOI 10.1074/jbc.M109.013342; Romanova L, 2009, J BIOL CHEM, V284, P4968, DOI 10.1074/jbc.M804594200; Schultz N., 2011, SILENCE, V2; Shu Q, 2008, STEM CELLS, V26, P1414, DOI 10.1634/stemcells.2007-1009; Sijin L, 2004, J EXP CLIN CANC RES, V23, P529; Singh SK, 2003, CANCER RES, V63, P5821; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Szotek PP, 2006, P NATL ACAD SCI USA, V103, P11154, DOI 10.1073/pnas.0603672103; Tsai RYL, 2002, GENE DEV, V16, P2991, DOI 10.1101/gad.55671; Wakimoto H, 2009, CANCER RES, V69, P3472, DOI 10.1158/0008-5472.CAN-08-3886; Werbowetski-Ogilvie TE, 2009, NAT BIOTECHNOL, V27, P91, DOI 10.1038/nbt.1516; Zhu QB, 2006, MOL CELL BIOL, V26, P9279, DOI 10.1128/MCB.00724-06	48	12	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28753	10.1371/journal.pone.0028753	http://dx.doi.org/10.1371/journal.pone.0028753			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174890	Green Published, gold			2022-12-25	WOS:000298366600036
J	Wagner, TU; Fischer, A; Thoma, EC; Schartl, M				Wagner, Toni U.; Fischer, Andreas; Thoma, Eva C.; Schartl, Manfred			CrossQuery: A Web Tool for Easy Associative Querying of Transcriptome Data	PLOS ONE			English	Article							MICROARRAY	Enormous amounts of data are being generated by modern methods such as transcriptome or exome sequencing and microarray profiling. Primary analyses such as quality control, normalization, statistics and mapping are highly complex and need to be performed by specialists. Thereafter, results are handed back to biomedical researchers, who are then confronted with complicated data lists. For rather simple tasks like data filtering, sorting and cross-association there is a need for new tools which can be used by non-specialists. Here, we describe CrossQuery, a web tool that enables straight forward, simple syntax queries to be executed on transcriptome sequencing and microarray datasets. We provide deep-sequencing data sets of stem cell lines derived from the model fish Medaka and microarray data of human endothelial cells. In the example datasets provided, mRNA expression levels, gene, transcript and sample identification numbers, GO-terms and gene descriptions can be freely correlated, filtered and sorted. Queries can be saved for later reuse and results can be exported to standard formats that allow copy-and-paste to all widespread data visualization tools such as Microsoft Excel. CrossQuery enables researchers to quickly and freely work with transcriptome and microarray data sets requiring only minimal computer skills. Furthermore, CrossQuery allows growing association of multiple datasets as long as at least one common point of correlated information, such as transcript identification numbers or GO-terms, is shared between samples. For advanced users, the object-oriented plug-in and event-driven code design of both server-side and client-side scripts allow easy addition of new features, data sources and data types.	[Wagner, Toni U.; Thoma, Eva C.; Schartl, Manfred] Univ Wurzburg, Bioctr, Wurzburg, Germany; [Fischer, Andreas] Heidelberg Univ, Med Fac Mannheim, Heidelberg, Germany; [Fischer, Andreas] German Canc Res Ctr Heidelberg DKFZ ZMBH Alliance, Heidelberg, Germany	University of Wurzburg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Wagner, TU (corresponding author), Univ Wurzburg, Bioctr, Wurzburg, Germany.	toni.wagner@biozentrum.uni-wuerzburg.de		Schartl, Manfred/0000-0001-9882-5948	Deutsche Forschungsgemeinschaft [SFB-TR23, GRK880, GRK1048]; Boehringer Ingelheim Fonds Foundation for Basic Research in Medicine (ECT); European Commision [018673]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Boehringer Ingelheim Fonds Foundation for Basic Research in Medicine (ECT); European Commision	This work was funded by the Deutsche Forschungsgemeinschaft SFB-TR23, GRK880 (AF), GRK1048, Boehringer Ingelheim Fonds Foundation for Basic Research in Medicine (ECT) and the European Commision 6th Framework Programme (Plurigenes #018673). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alajati A, 2008, NAT METHODS, V5, P439, DOI 10.1038/NMETH.1198; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Battke F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016345; Brutsch R, 2010, CIRC RES, V107, P592, DOI 10.1161/CIRCRESAHA.110.217257; Dietzsch J, 2006, BIOINFORMATICS, V22, P1010, DOI 10.1093/bioinformatics/btl070; Ding LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013287; Hoek KS, 2008, PIGM CELL MELANOMA R, V21, P588, DOI 10.1111/j.1755-148X.2008.00494.x; Hong YH, 1998, P NATL ACAD SCI USA, V95, P3679, DOI 10.1073/pnas.95.7.3679; Hong YH, 2004, P NATL ACAD SCI USA, V101, P8011, DOI 10.1073/pnas.0308668101; Kallio MA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-507; Kapushesky M, 2004, NUCLEIC ACIDS RES, V32, pW465, DOI 10.1093/nar/gkh470; Rees CA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-141; Saal LH, 2002, GENOME BIOL, V3; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schartl M, 2010, J INVEST DERMATOL, V130, P249, DOI 10.1038/jid.2009.213; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schuster SC, 2008, NAT METHODS, V5, P16, DOI 10.1038/NMETH1156; Stavrum Anne Kristin, 2008, Curr Protoc Bioinformatics, VChapter 7, DOI 10.1002/0471250953.bi0703s21; Thoma EC, 2011, STEM CELLS DEV, V20, P1425, DOI 10.1089/scd.2010.0290; Turatsinze JV, 2008, NAT PROTOC, V3, P1578, DOI 10.1038/nprot.2008.97; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wagner TU, 2009, STEM CELLS DEV, V18, P151, DOI 10.1089/scd.2007.0262; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; Wustehube J, 2010, P NATL ACAD SCI USA, V107, P12640, DOI 10.1073/pnas.1000132107	24	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28990	10.1371/journal.pone.0028990	http://dx.doi.org/10.1371/journal.pone.0028990			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174941	gold, Green Submitted, Green Published			2022-12-25	WOS:000298366600055
J	Yang, SC; Chang, SS; Chen, CYC				Yang, Shun-Chieh; Chang, Su-Sen; Chen, Calvin Yu-Chian			Identifying HER2 Inhibitors from Natural Products Database	PLOS ONE			English	Article							PROTEIN-TYROSINE KINASES; PYRROLOTRIAZINE DUAL INHIBITORS; METASTATIC BREAST-CANCER; DRUG DESIGN; RECEPTOR; EGFR; EXPRESSION; DISCOVERY; TRASTUZUMAB; LAPATINIB	The relationship between abnormal HER2 expression and cancer is important in cancer therapeutics. Formation and spread of cancer cells may be restricted by inhibiting HER2. We conducted ligand-based and structure-based studies to assess the potency of natural compounds as potential HER2 inhibitors. Multiple linear regression (MLR) and support vector machine (SVM) models were constructed to predict biological activities of natural compounds, and molecular dynamics (MD) was used to assess their stability with HER2 under a dynamic environment. Predicted bioactivities of the natural compounds ranged from 6.014-9.077 using MLR (r(2) = 0.7954) and 5.122-6.950 using SVM (r(2) = 0.8620). Both models were in agreement and suggest bioactivity based on candidate structure. Conformation changes caused by MD favored the formation of stabilizing H-bonds. All candidates had higher stability than Lapinatib, which may be due to the number and spatial distribution of additional H-bonds and hydrophobic interactions. Amino acids Lys724 and Lys736 are critical for binding in HER2, and Thr798, Cys805, and Asp808 are also important for increased stability. Candidates may block the entrance to the ATP binding site located within the inner regions and prevent downstream activation of HER2. Our multidirectional approach indicates that the natural compounds have good ligand efficacy in addition to stable binding affinities to HER2, and should be potent candidates of HER2 inhibitors. With regard to drug design, designing HER2 inhibitors with carboxyl or carbonyl groups available for H-bond formation with Lys724 and Lys736, and benzene groups for hydrophobic contact with Cys805 may improve protein-ligand stability.	[Yang, Shun-Chieh; Chang, Su-Sen; Chen, Calvin Yu-Chian] China Med Univ, Lab Computat & Syst Biol, Taichung, Taiwan; [Chen, Calvin Yu-Chian] Asia Univ, Dept Bioinformat, Taichung, Taiwan; [Chen, Calvin Yu-Chian] China Med Univ, Beigang Hosp, Yunlin, Taiwan; [Chen, Calvin Yu-Chian] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Chen, Calvin Yu-Chian] MIT, Cambridge, MA 02139 USA	China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Yang, SC (corresponding author), China Med Univ, Lab Computat & Syst Biol, Taichung, Taiwan.	ycc929@MIT.EDU	Chen, Calvin Yu-Chian/E-9402-2010	Chen, Calvin Yu-Chian/0000-0003-3306-250X; Chen, Calvin Yu-Chian/0000-0001-9213-9832	National Science Council of Taiwan [NSC 99-2221-E-039-013-]; Committee on Chinese Medicine and Pharmacy [CCMP100-RD-030]; Asia University [CMU98-TCM, CMU99-TCM, CMU99-S-02, CMU99-ASIA-25, CMU99-ASIA-26, CMU99-ASIA-27, CMU99-ASIA-28]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH100-TD-B-111-004]; Taiwan Department of Health Cancer Research Center of Excellence [DOH100-TD-C-111-005]; China Medical University	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Committee on Chinese Medicine and Pharmacy; Asia University; Taiwan Department of Health Clinical Trial and Research Center of Excellence; Taiwan Department of Health Cancer Research Center of Excellence; China Medical University(China Medical University)	The research was supported by grants from the National Science Council of Taiwan (NSC 99-2221-E-039-013-), the Committee on Chinese Medicine and Pharmacy (CCMP100-RD-030), the China Medical University and Asia University (CMU98-TCM, CMU99-TCM, CMU99-S-02, CMU99-ASIA-25, CMU99-ASIA-26 CMU99-ASIA-27 CMU99-ASIA-28). This study is also supported in part by the Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH100-TD-B-111-004) and the Taiwan Department of Health Cancer Research Center of Excellence (DOH100-TD-C-111-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai X, 2010, J MED CHEM, V53, P2000, DOI 10.1021/jm901453q; Chen CYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015939; Chen CYC, 2010, J BIOMOL STRUCT DYN, V27, P627, DOI 10.1080/07391102.2010.10508577; Chen CYC, 2009, J MOL GRAPH MODEL, V28, P261, DOI 10.1016/j.jmgm.2009.08.004; Chen CY, 2010, J MOL GRAPH MODEL, V29, P21, DOI 10.1016/j.jmgm.2010.04.002; Chen CY, 2009, ACTA PHARMACOL SIN, V30, P1186, DOI 10.1038/aps.2009.100; Cheng ZY, 2007, BIOORGAN MED CHEM, V15, P1533, DOI 10.1016/j.bmc.2006.09.041; Chiosis G, 2002, BIOORGAN MED CHEM, V10, P3555, DOI 10.1016/S0968-0896(02)00253-5; Chou YS, 2009, J ASIAN NAT PROD RES, V11, P110, DOI 10.1080/02615470802573368; Curran MP, 2010, DRUGS, V70, P1411, DOI 10.2165/11204550-000000000-00000; de Oliveira AN, 2010, EUR J MED CHEM, V45, P4339, DOI 10.1016/j.ejmech.2010.04.034; Engel RH, 2007, DRUGS, V67, P1329, DOI 10.2165/00003495-200767090-00006; Fink BE, 2005, BIOORG MED CHEM LETT, V15, P4774, DOI 10.1016/j.bmcl.2005.07.027; Huang HJ, 2010, J BIOMOL STRUCT DYN, V28, P23, DOI 10.1080/07391102.2010.10507341; Hughes TV, 2008, BIOORG MED CHEM LETT, V18, P4896, DOI 10.1016/j.bmcl.2008.07.057; Kroep JR, 2010, NETH J MED, V68, P371; Liang K, 2010, CANCER CELL, V18, P423, DOI 10.1016/j.ccr.2010.10.025; Liao PC, 2010, J AGR FOOD CHEM, V58, P10445, DOI 10.1021/jf102812t; Lippa B, 2007, BIOORG MED CHEM LETT, V17, P3081, DOI 10.1016/j.bmcl.2007.03.046; Lv PC, 2010, BIOORGAN MED CHEM, V18, P314, DOI 10.1016/j.bmc.2009.10.051; Mastalerz H, 2007, BIOORG MED CHEM LETT, V17, P4947, DOI 10.1016/j.bmcl.2007.06.019; Mastalerz H, 2007, BIOORG MED CHEM LETT, V17, P2828, DOI 10.1016/j.bmcl.2007.02.050; Mastalerz H, 2007, BIOORG MED CHEM LETT, V17, P2036, DOI 10.1016/j.bmcl.2007.01.002; Neve RM, 2001, ANN ONCOL, V12, P9, DOI 10.1023/A:1011199404516; Orman JS, 2007, DRUGS, V67, P2781, DOI 10.2165/00003495-200767180-00009; Rubin I, 2001, ANN ONCOL, V12, P3, DOI 10.1023/A:1011195320446; SAKAI K, 1986, J NATL CANCER I, V77, P1047; Signoretti S, 2000, JNCI-J NATL CANCER I, V92, P1918, DOI 10.1093/jnci/92.23.1918; Steffensen KD, 2007, INT J GYNECOL CANCER, V17, P798, DOI 10.1111/j.1525-1438.2006.00855.x; Sun L, 2002, BIOORG MED CHEM LETT, V12, P2153, DOI 10.1016/S0960-894X(02)00364-5; Sun MF, 2011, MOL SIMULAT, V37, P884, DOI 10.1080/08927022.2011.569550; Theillet C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2571; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Xu GZ, 2008, BIOORG MED CHEM LETT, V18, P4615, DOI 10.1016/j.bmcl.2008.07.020; Xu GZ, 2008, BIOORG MED CHEM LETT, V18, P3495, DOI 10.1016/j.bmcl.2008.05.024; Yang HL, 2011, FOOD CHEM TOXICOL, V49, P290, DOI 10.1016/j.fct.2010.10.031	36	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28793	10.1371/journal.pone.0028793	http://dx.doi.org/10.1371/journal.pone.0028793			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174899	Green Submitted, Green Published, gold			2022-12-25	WOS:000298366600039
J	Alam-Faruque, Y; Huntley, RP; Khodiyar, VK; Camon, EB; Dimmer, EC; Sawford, T; Martin, MJ; O'Donovan, C; Talmud, PJ; Scambler, P; Apweiler, R; Lovering, RC				Alam-Faruque, Yasmin; Huntley, Rachael P.; Khodiyar, Varsha K.; Camon, Evelyn B.; Dimmer, Emily C.; Sawford, Tony; Martin, Maria J.; O'Donovan, Claire; Talmud, Philippa J.; Scambler, Peter; Apweiler, Rolf; Lovering, Ruth C.			The Impact of Focused Gene Ontology Curation of Specific Mammalian Systems	PLOS ONE			English	Article							EXPRESSION; TOOL; NETWORK; GO	The Gene Ontology (GO) resource provides dynamic controlled vocabularies to provide an information-rich resource to aid in the consistent description of the functional attributes and subcellular locations of gene products from all taxonomic groups (www.geneontology.org). System-focused projects, such as the Renal and Cardiovascular GO Annotation Initiatives, aim to provide detailed GO data for proteins implicated in specific organ development and function. Such projects support the rapid evaluation of new experimental data and aid in the generation of novel biological insights to help alleviate human disease. This paper describes the improvement of GO data for renal and cardiovascular research communities and demonstrates that the cardiovascular-focused GO annotations, created over the past three years, have led to an evident improvement of microarray interpretation. The reanalysis of cardiovascular microarray datasets confirms the need to continue to improve the annotation of the human proteome.	[Alam-Faruque, Yasmin; Huntley, Rachael P.; Dimmer, Emily C.; Sawford, Tony; Martin, Maria J.; O'Donovan, Claire; Apweiler, Rolf] EMBL European Bioinformat Inst, Cambridge, England; [Khodiyar, Varsha K.; Camon, Evelyn B.; Talmud, Philippa J.; Lovering, Ruth C.] UCL, Ctr Cardiovasc Genet, Inst Cardiovasc Sci, London, England; [Scambler, Peter] UCL, Mol Med Unit, Inst Child Hlth, London, England	European Molecular Biology Laboratory (EMBL); University of London; University College London; University of London; University College London	Alam-Faruque, Y (corresponding author), EMBL European Bioinformat Inst, Cambridge, England.	r.lovering@ucl.ac.uk	Huntley, Rachael/J-4951-2019; Martín, María/HDL-9512-2022; Scambler, Peter/AAZ-6026-2020; Huntley, Rachael/R-1036-2016	Huntley, Rachael/0000-0001-6718-3559; Scambler, Peter/0000-0002-1487-4628; Huntley, Rachael/0000-0001-6718-3559; Lovering, Ruth/0000-0002-9791-0064; Khodiyar, Varsha/0000-0002-2743-6918; Apweiler, Rolf/0000-0001-7078-200X; O'Donovan, Claire/0000-0001-8051-7429; Talmud, Philippa/0000-0002-5560-1933; Martin, Maria-Jesus/0000-0001-5454-2815	Kidney Research UK [RP26/2008]; British Heart Foundation [SP/07/007/23671]; National Institutes of Health [R01HG02273-02]; European Molecular Biology Laboratory; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002273] Funding Source: NIH RePORTER; British Heart Foundation [RG/10/13/28570] Funding Source: researchfish	Kidney Research UK(Kidney Research UK (KRUK)); British Heart Foundation(British Heart Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Molecular Biology Laboratory; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); British Heart Foundation(British Heart Foundation)	The Renal GOA Initiative is funded by the Kidney Research UK www.kidneyresearchuk.org Project Grant RP26/2008. The Cardiovascular GOA Initiative is funded by the British Heart Foundation www.bhf.org.uk Grant SP/07/007/23671. The UniProtKB-GOA project is supported by the National Institutes of Health www.nih.gov grant number R01HG02273-02 and European Molecular Biology Laboratory www.embl.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam-Faruque Y, 2010, ORGANOGENESIS, V6, P71, DOI 10.4161/org.6.2.11294; Antonov AV, 2008, NUCLEIC ACIDS RES, V36, pW347, DOI 10.1093/nar/gkn239; Antonov AV, 2011, NUCLEIC ACIDS RES, V39, pW323, DOI 10.1093/nar/gkr372; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Ashburner M, 2001, GENOME RES, V11, P1425; Ashley EA, 2006, CIRCULATION, V114, P2644, DOI 10.1161/CIRCULATIONAHA.106.637025; Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; Berardini TZ, 2010, NUCLEIC ACIDS RES, V38, pD331, DOI 10.1093/nar/gkp1018; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Blake J. A., 2008, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0702S23; Bystrom J, 2008, BLOOD, V112, P4117, DOI 10.1182/blood-2007-12-129767; Diehl AD, 2007, BIOINFORMATICS, V23, P913, DOI 10.1093/bioinformatics/btm029; Dimmer Emily, 2007, V406, P495; Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7; Feltrin E, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-6; Gaudet P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000431; Grigoryev DN, 2008, TRANSL RES, V151, P197, DOI 10.1016/j.trsl.2007.12.010; Grossmann S, 2007, BIOINFORMATICS, V23, P3024, DOI 10.1093/bioinformatics/btm440; Hill DP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S5-S2; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Huntley RP, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap010; Khodiyar VK, 2011, DEV BIOL, V354, P9, DOI 10.1016/j.ydbio.2011.03.011; Kim MJ, 2011, NEPHRON EXP NEPHROL, V119, pE1, DOI 10.1159/000324223; Kongchanagul A, 2011, J MED VIROL, V83, P1410, DOI 10.1002/jmv.22105; Lambrecht S, 2008, OSTEOARTHR CARTILAGE, V16, P163, DOI 10.1016/j.joca.2007.06.005; Lee JA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-237; Lovering RC, 2008, PROTEOMICS, V8, P1950, DOI 10.1002/pmic.200800078; Pappa KI, 2011, TRANSL ONCOL, V4, P301, DOI 10.1593/tlo.11148; Rhee SY, 2008, NAT REV GENET, V9, P509, DOI 10.1038/nrg2363; Smith AM, 2009, J EXP MED, V206, P1883, DOI 10.1084/jem.20091233; STABLES MJ, 2011, BLOOD IN PRESS; Talmud PJ, 2009, AM J HUM GENET, V85, P628, DOI 10.1016/j.ajhg.2009.10.014; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Zuckerbraun BS, 2011, CARDIOVASC RES, V89, P542, DOI 10.1093/cvr/cvq370	37	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e27541	10.1371/journal.pone.0027541	http://dx.doi.org/10.1371/journal.pone.0027541			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174742	Green Published, Green Submitted, gold			2022-12-25	WOS:000298365700005
J	Ben-Dor, M; Gopher, A; Hershkovitz, I; Barkai, R				Ben-Dor, Miki; Gopher, Avi; Hershkovitz, Israel; Barkai, Ran			Man the Fat Hunter: The Demise of Homo erectus and the Emergence of a New Hominin Lineage in the Middle Pleistocene (ca. 400 kyr) Levant	PLOS ONE			English	Article							GESHER-BENOT-YAAQOV; QESEM CAVE; BODY-SIZE; ACID-COMPOSITION; LARGE HERBIVORE; LIFE-HISTORY; HABITUAL USE; FIRE-MAKING; EVOLUTION; DIET	The worldwide association of H. erectus with elephants is well documented and so is the preference of humans for fat as a source of energy. We show that rather than a matter of preference, H. erectus in the Levant was dependent on both elephants and fat for his survival. The disappearance of elephants from the Levant some 400 kyr ago coincides with the appearance of a new and innovative local cultural complex - the Levantine Acheulo-Yabrudian and, as is evident from teeth recently found in the Acheulo-Yabrudian 400-200 kyr site of Qesem Cave, the replacement of H. erectus by a new hominin. We employ a bio-energetic model to present a hypothesis that the disappearance of the elephants, which created a need to hunt an increased number of smaller and faster animals while maintaining an adequate fat content in the diet, was the evolutionary drive behind the emergence of the lighter, more agile, and cognitively capable hominins. Qesem Cave thus provides a rare opportunity to study the mechanisms that underlie the emergence of our post-erectus ancestors, the fat hunters.	[Ben-Dor, Miki; Gopher, Avi; Barkai, Ran] Tel Aviv Univ, Inst Archaeol, IL-69978 Tel Aviv, Israel; [Hershkovitz, Israel] Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, Dan David Lab Search & Study Modern Humans, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine	Ben-Dor, M (corresponding author), Tel Aviv Univ, Inst Archaeol, IL-69978 Tel Aviv, Israel.	barkaran@post.tau.ac.il	Hershkovitz, Israel/ABH-4511-2020; Barkai, Ran/L-6495-2019	Hershkovitz, Israel/0000-0001-5841-6090; BARKAI, RAN/0000-0002-8125-8788; Ben-Dor, Miki/0000-0001-9512-1160	Israel science Foundation [820/02, 256/05, 19/10]; Dan Daviv Foundation [04740001/2011]; Thyssen foundation [R 17386]; Wenner-Gren Foundation; Leakey foundation; CARE Archaeologucal Foundation	Israel science Foundation(Israel Science Foundation); Dan Daviv Foundation; Thyssen foundation; Wenner-Gren Foundation; Leakey foundation; CARE Archaeologucal Foundation	The Qesem Cave research project is supported by the following granting agencies: The Israel science Foundation (Grants 820/02; 256/05; 19/10) http://www.isf.org.il/; The Dan Daviv Foundation (Grant 04740001/2011) http://www.dandavidprize.org/dan-david-foundation.html; The Thyssen foundation (Grant R 17386) http://www.fritz-thyssen-stiftung.de/; The Wenner-Gren Foundation http://www.wennergren.org/; The Leakey foundation http://leakeyfoundation.org/ and the CARE Archaeologucal Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello LC, 2002, ANNU REV ANTHROPOL, V31, P323, DOI 10.1146/annurev.anthro.31.040402.085403; AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; Alperson-Afil N, 2008, QUATERNARY SCI REV, V27, P1733, DOI 10.1016/j.quascirev.2008.06.009; Alperson-Afil N, 2009, SCIENCE, V326, P1677, DOI 10.1126/science.1180695; AlpersonAfil N, 2010, VERTEBR PALEOBIOL PA, P1; Alroy J, 2001, SCIENCE, V292, P1893, DOI 10.1126/science.1059342; Anton SC, 2003, YEARB PHYS ANTHROPOL, V46, P126, DOI 10.1002/ajpa.10399; Bar-Yosef O, 2011, QUATERNARY SCI REV, V30, P1318, DOI 10.1016/j.quascirev.2010.02.016; Barkai R., 2009, HUMAN EVOL, V24, P57; Barkai R., 2010, ANTIQUITY, V84; Barkal R, 2003, NATURE, V423, P977, DOI 10.1038/nature01718; BARYOSEF O, 2008, PREHISTORY ISRAEL; Bate D. M. A., 1937, P137; Beaumont PB, 2011, CURR ANTHROPOL, V52, P585, DOI 10.1086/660919; Bello SM, 2009, J ARCHAEOL SCI, V36, P1869, DOI 10.1016/j.jas.2009.04.014; BEYENE Y, 2010, P BRIT ACAD, V158, P43; Birkett A, 1996, AM J CLIN NUTR, V63, P766, DOI 10.1093/ajcn/63.5.766; Bock J, 2002, HUM NATURE-INT BIOS, V13, P161, DOI 10.1007/s12110-002-1007-4; Brink JW, 2008, IMAGINING HEAD-SMASHED-IN: ABORIGINAL BUFFALO HUNTING ON THE NORTHERN PLAINS, P1; BUNN HT, 1993, J ARCHAEOL SCI, V20, P365, DOI 10.1006/jasc.1993.1023; Byers DA, 2005, J ARCHAEOL SCI, V32, P1624, DOI 10.1016/j.jas.2005.05.003; Caluwe E., 2010, AFRIKA FOCUS, V23, P11, DOI [10.1163/2031356X-02301005, DOI 10.1163/2031356X-02301005]; Carbonell E, 2008, NATURE, V452, P465, DOI 10.1038/nature06815; Carmody RN, 2009, J HUM EVOL, V57, P379, DOI 10.1016/j.jhevol.2009.02.011; CARTMILL M, 2009, HUMAN LINEAGE; Christiansen P, 2004, ZOOL J LINN SOC-LOND, V140, P523, DOI 10.1111/j.1096-3642.2004.00113.x; Churchill Steven E., 1993, ARCHAEOLOGICAL PAPER, V4, P11; Clark JD, 2003, NATURE, V423, P747, DOI 10.1038/nature01670; CONKLINBRITTAIN NL, 2002, HUMAN DIET ITS ORIGI, P206; Coppens Y., 1978, P336; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; Cordain L, 2001, WORLD REV NUTR DIET, V90, P144; Cordain L, 2000, AM J CLIN NUTR, V71, P682, DOI 10.1093/ajcn/71.3.682; COURSEY DG, 1973, MAN, V8, P634; CRAWFORD MA, 1970, INT J BIOCHEM, V1, P295, DOI 10.1016/0020-711X(70)90072-8; Cunnane SC, 2003, COMP BIOCHEM PHYS A, V136, P17, DOI 10.1016/S1095-6433(03)00048-5; Cyran KA, 2010, THEOR POPUL BIOL, V78, P165, DOI 10.1016/j.tpb.2010.06.001; Delagnes A, 2006, J ANTHROPOL ARCHAEOL, V25, P448, DOI 10.1016/j.jaa.2006.03.002; Dennell RW, 2010, QUATERN INT, V223, P439, DOI 10.1016/j.quaint.2009.07.010; Dennell R, 2010, NATURE, V468, P512, DOI 10.1038/468512a; EADES MR, 1996, PROTEIN POWER; Endicott P, 2010, J HUM EVOL, V59, P87, DOI 10.1016/j.jhevol.2010.04.005; FOLEY RA, 1991, PHILOS T R SOC B, V334, P223, DOI 10.1098/rstb.1991.0111; Gaman P. M., 1996, SCI FOOD INTRO FOOD; Gamble C, 2011, CAMB ARCHAEOL J, V21, P115, DOI 10.1017/S0959774311000072; Gaudzinski S, 2005, QUATERN INT, V126, P179, DOI 10.1016/j.quaint.2004.04.022; GILBERST WH, HOMO ERECTUS PLEISTO; Gopher A, 2010, QUAT GEOCHRONOL, V5, P644, DOI 10.1016/j.quageo.2010.03.003; Goren-Inbar N, 2004, SCIENCE, V304, P725, DOI 10.1126/science.1095443; Goren-Inbar N, 2000, SCIENCE, V289, P944, DOI 10.1126/science.289.5481.944; Goren-Inbar N., 1994, PALEORIENT, V20, P99, DOI DOI 10.3406/PALEO.1994.4604; GORENIBNAR N, 2011, PHILOS T R SOC B, P1038; GOWLETT JAJ, 2010, SOCIAL BRAIN DISTRIB, P341; Graves RR, 2010, J HUM EVOL, V59, P542, DOI 10.1016/j.jhevol.2010.06.007; Guthrie R. D., 2007, GUTS BRAINS INTEGRAT, P133; Halton TL, 2004, J AM COLL NUTR, V23, P373, DOI 10.1080/07315724.2004.10719381; Hancock AM, 2010, P NATL ACAD SCI USA, V107, P8924, DOI 10.1073/pnas.0914625107; HARDING R, 1997, PROGR POPULATION GEN, P15; Harding RM, 1997, AM J HUM GENET, V60, P772; HATLEY T, 1980, HUM ECOL, V8, P371, DOI 10.1007/BF01561000; Hawks JD, 2001, QUATERN INT, V75, P41, DOI 10.1016/S1040-6182(00)00076-8; Hershkovitz I, 2011, AM J PHYS ANTHROPOL, V144, P575, DOI 10.1002/ajpa.21446; HO KJ, 1971, ARCH PATHOL, V91, P387; Hou YM, 2010, QUATERN INT, V223, P10, DOI 10.1016/j.quaint.2009.09.025; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P16022, DOI 10.1073/pnas.0904119106; Ichikawa M, 1983, AFR STUDY MONOGR, V4, P55, DOI [10.14989/68001, DOI 10.14989/68001]; Johnson CR, 2010, J HUM EVOL, V58, P193, DOI 10.1016/j.jhevol.2009.10.001; Jorgensen H, 2000, J NUTR, V130, P852, DOI 10.1093/jn/130.4.852; Kaplan H, 2000, EVOL ANTHROPOL, V9, P156, DOI 10.1002/1520-6505(2000)9:4<156::AID-EVAN5>3.0.CO;2-7; Kaplan H., 2007, GUTS BRAINS INTEGRAT, P47; Karkanas P, 2007, J HUM EVOL, V53, P197, DOI 10.1016/j.jhevol.2007.04.002; Klein R. G., 1988, AFR ARCHAEOL REV, V6, P3, DOI [10.1007/BF01117110., DOI 10.1007/BF01117110]; KLEIN RG, 1983, ANNU REV ANTHROPOL, V12, P25, DOI 10.1146/annurev.an.12.100183.000325; Klein RG, 2007, J HUM EVOL, V52, P164, DOI 10.1016/j.jhevol.2006.08.006; Klein RG, 2008, EVOL ANTHROPOL, V17, P267, DOI 10.1002/evan.20181; Koch PL, 2006, ANNU REV ECOL EVOL S, V37, P215, DOI 10.1146/annurev.ecolsys.34.011802.132415; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; Lawrie R., 1991, MEAT SCI; LEDGER HP, 1968, P S HELD ZOOL SOC LO, V21, P289; Lee-Thorp J, 2006, YEARB PHYS ANTHROPOL, V49, P131, DOI 10.1002/ajpa.20519; Leonard WR, 1997, AM J PHYS ANTHROPOL, V102, P265, DOI 10.1002/(SICI)1096-8644(199702)102:2<265::AID-AJPA8>3.0.CO;2-X; LIEBERMAN DE, 2009, 1 HUM OR EARL EV GEN; LINDSTEDT SL, 1985, AM NAT, V125, P873, DOI 10.1086/284385; Liu W, 2010, P NATL ACAD SCI USA, V107, P19201, DOI 10.1073/pnas.1014386107; Loarie SR, 2009, BIOL CONSERV, V142, P3086, DOI 10.1016/j.biocon.2009.08.008; Lucas PW, 2009, VERTEBR PALEOBIOL PA, P31, DOI 10.1007/978-1-4020-9699-0_3; Lyons SK, 2004, EVOL ECOL RES, V6, P339; Machin AJ, 2007, J ARCHAEOL SCI, V34, P883, DOI 10.1016/j.jas.2006.09.008; Marder O, 2011, J HUM EVOL, V60, P508, DOI 10.1016/j.jhevol.2010.01.007; MARIN A, 2011, INT J OSTEO IN PRESS; MARKS SA, 1976, LARGE MAMMALS BRAVE; Martin P.S., 1984, P354; Martinon-Torres M, 2011, J HUM EVOL, V60, P251, DOI 10.1016/j.jhevol.2010.10.005; MCBREARTY S, 2003, J HUM EVOL, V3, P1; McClellan WS, 1930, J BIOL CHEM, V87, P651; McDougall I, 2005, NATURE, V433, P733, DOI 10.1038/nature03258; McHenry H.M., 1988, P133; McHenry Henry M., 2009, P256; MCHENRY HM, 1992, AM J PHYS ANTHROPOL, V87, P407, DOI 10.1002/ajpa.1330870404; Mellars P, 2011, SCIENCE, V333, P623, DOI 10.1126/science.1206930; Metges CC, 2000, J NUTR, V130, P886, DOI 10.1093/jn/130.4.886; MILTON K, 1987, FOOD EVOLUTION THEOR, P96; Mounier A, 2009, J HUM EVOL, V56, P219, DOI 10.1016/j.jhevol.2008.12.006; Movius HL, 1950, SOUTHWEST J ANTHROP, V6, P139, DOI 10.1086/soutjanth.6.2.3628638; NOLI D, 1988, J ARCHAEOL SCI, V15, P395, DOI 10.1016/0305-4403(88)90037-4; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Pitts G, 1968, BODY COMPOSITION ANI, P45; Popovich DG, 1997, J NUTR, V127, P2000, DOI 10.1093/jn/127.10.2000; PORAT N, 2007, AM SCH PREHISTORIC R, V50, P27; Porat N, 2010, J ARCHAEOL SCI, V37, P269, DOI 10.1016/j.jas.2009.09.038; Preece RC, 2006, J QUATERNARY SCI, V21, P485, DOI 10.1002/jqs.1043; Rabinovich R, 2011, J HUM EVOL, V60, P357, DOI 10.1016/j.jhevol.2010.12.002; Reich D, 2011, AM J HUM GENET; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Richards MP, 2009, P NATL ACAD SCI USA, V106, P16034, DOI 10.1073/pnas.0903821106; Richards MP, 2009, VERTEBR PALEOBIOL PA, P251, DOI 10.1007/978-1-4020-9699-0_20; Richter D, 2011, ARCHAEOMETRY, V53, P842, DOI 10.1111/j.1475-4754.2010.00581.x; RIGHTMIRE GP, 2008, EVOLUTIONARY ANTHR, V17, P218; Roebroeks W, 2011, P NATL ACAD SCI USA, V108, pE299, DOI 10.1073/pnas.1108129108; Roebroeks W, 2011, P NATL ACAD SCI USA, V108, P5209, DOI 10.1073/pnas.1018116108; Rolland Nicolas, 2004, Asian Perspectives, V43, P248, DOI 10.1353/asi.2004.0027; RUDMAN D, 1973, J CLIN INVEST, V52, P2241, DOI 10.1172/JCI107410; Ruxton GD, 2011, J HUM EVOL, V61, P169, DOI 10.1016/j.jhevol.2011.02.012; Sandgathe DM, 2011, P NATL ACAD SCI USA, V108, pE298, DOI 10.1073/pnas.1106759108; Schwartz JH, 2010, YEARB PHYS ANTHROPOL, V53, P94; Shannon G, 2009, DIVERS DISTRIB, V15, P776, DOI 10.1111/j.1472-4642.2009.00581.x; Sharon G, 2011, J HUM EVOL, V60, P387, DOI 10.1016/j.jhevol.2009.11.012; SHIMELMITZ R, 2011, J HUMAN EVO IN PRESS; Smil V, 2002, POPUL DEV REV, V28, P599, DOI 10.1111/j.1728-4457.2002.00599.x; Smith FH, 2005, QUATERN INT, V137, P7, DOI 10.1016/j.quaint.2004.11.016; SPETH JD, 1989, J HUM EVOL, V18, P329, DOI 10.1016/0047-2484(89)90035-3; SPETH JD, 1983, J ANTHROPOL ARCHAEOL, V2, P1, DOI 10.1016/0278-4165(83)90006-5; Speth JohnD., 2010, INTERD CONTRIB ARCH; Stanford CB, 2001, MEAT EATING HUMAN EV; Stanford Craig B., 1999, HUNTING APES MEAT EA; Steudel-Numbers KL, 2007, J HUM EVOL, V53, P191, DOI 10.1016/j.jhevol.2007.04.001; Stiner MC, 2011, J HUM EVOL, V60, P213, DOI 10.1016/j.jhevol.2010.10.006; Stiner MC, 2009, VERTEBR PALEOBIOL PA, P157, DOI 10.1007/978-1-4020-9699-0_11; Stiner MC, 2009, P NATL ACAD SCI USA, V106, P13207, DOI 10.1073/pnas.0900564106; STINER MC, 1990, J ANTHROPOL ARCHAEOL, V9, P305, DOI 10.1016/0278-4165(90)90010-B; STROHLE A, 2011, NUTRITION; Surovell T, 2005, P NATL ACAD SCI USA, V102, P6231, DOI 10.1073/pnas.0501947102; Templeton AR, 2002, NATURE, V416, P45, DOI 10.1038/416045a; Thieme H, 1997, NATURE, V385, P807, DOI 10.1038/385807a0; Ungar P, 1998, EVOL ANTHROPOL, V6, P205, DOI 10.1002/(SICI)1520-6505(1998)6:6<205::AID-EVAN3>3.3.CO;2-G; UNGAR P, 2004, HUMAN EVOLUTION, V4, P605; Ungar PS, 2006, ANNU REV ANTHROPOL, V35, P209, DOI 10.1146/annurev.anthro.35.081705.123153; UNGAR PS, 2011, J HUMAN EVO IN PRESS; White MJ, 2011, J WORLD PREHIST, V24, P25, DOI 10.1007/s10963-011-9043-9; White TD, 2003, NATURE, V423, P742, DOI 10.1038/nature01669; Wood B, 2008, J ANAT, V212, P354, DOI 10.1111/j.1469-7580.2008.00871.x; Wood B, 2010, P NATL ACAD SCI USA, V107, P8902, DOI 10.1073/pnas.1001649107; Woolnough AP, 1997, WILDLIFE RES, V24, P649, DOI 10.1071/WR97010; Wrangham R, 2010, EVOL ANTHROPOL, V19, P187, DOI 10.1002/evan.20275; Wrangham RW, 1999, CURR ANTHROPOL, V40, P567, DOI 10.1086/300083; Yravedra J, 2010, J ARCHAEOL SCI, V37, P2469, DOI 10.1016/j.jas.2010.05.007; Yu N, 2001, MOL BIOL EVOL, V18, P214, DOI 10.1093/oxfordjournals.molbev.a003795; CHAILLU B EXPLORATIO; NUTRITIONDATA	159	105	107	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28689	10.1371/journal.pone.0028689	http://dx.doi.org/10.1371/journal.pone.0028689			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	866FK	22174868	gold, Green Submitted, Green Published			2022-12-25	WOS:000298365700061
J	Carrascal, L; Nieto-Gonzalez, JL; Torres, B; Nunez-Abades, P				Carrascal, Livia; Luis Nieto-Gonzalez, Jose; Torres, Blas; Nunez-Abades, Pedro			Diminution of Voltage Threshold Plays a Key Role in Determining Recruitment of Oculomotor Nucleus Motoneurons during Postnatal Development	PLOS ONE			English	Article							MOTOR-UNIT RECRUITMENT; AXON INITIAL SEGMENT; DETERMINING INPUT RESISTANCE; RAT HYPOGLOSSAL MOTONEURONS; BRAIN-STEM MOTONEURONS; ELECTROPHYSIOLOGICAL PROPERTIES; IN-VITRO; GENIOGLOSSAL MOTONEURONS; PERSISTENT SODIUM; SYNAPTIC INPUT	The size principle dictates the orderly recruitment of motoneurons (Mns). This principle assumes that Mns of different sizes have a similar voltage threshold, cell size being the crucial property in determining neuronal recruitment. Thus, smaller neurons have higher membrane resistance and require a lower depolarizing current to reach spike threshold. However, the cell size contribution to recruitment in Mns during postnatal development remains unknown. To investigate this subject, rat oculomotor nucleus Mns were intracellularly labeled and their electrophysiological properties recorded in a brain slice preparation. Mns were divided into 2 age groups: neonatal (1-7 postnatal days, n = 14) and adult (20-30 postnatal days, n = 10). The increase in size of Mns led to a decrease in input resistance with a strong linear relationship in both age groups. A well-fitted inverse correlation was also found between input resistance and rheobase in both age groups. However, input resistance versus rheobase did not correlate when data from neonatal and adult Mns were combined in a single group. This lack of correlation is due to the fact that decrease in input resistance of developing Mns did not lead to an increase in rheobase. Indeed, a diminution in rheobase was found, and it was accompanied by an unexpected decrease in voltage threshold. Additionally, the decrease in rheobase co-varied with decrease in voltage threshold in developing Mns. These data support that the size principle governs the recruitment order in neonatal Mns and is maintained in adult Mns of the oculomotor nucleus; but during postnatal development the crucial property in determining recruitment order in these Mns was not the modifications of cell size-input resistance but of voltage threshold.	[Carrascal, Livia; Torres, Blas; Nunez-Abades, Pedro] Univ Seville, Dept Fisiol, Seville, Spain; [Luis Nieto-Gonzalez, Jose] Univ Seville, Dept Fisiol Med & Biofis, Seville, Spain	University of Sevilla; University of Sevilla	Carrascal, L (corresponding author), Univ Seville, Dept Fisiol, Seville, Spain.	pnunez@us.es	Nieto-Gonzalez, Jose L/B-7165-2013; IBIS, FISIOLOGIA/O-9485-2015; Carrascal, Livia/L-5716-2014; Torres, Blas/B-9668-2015	Nieto-Gonzalez, Jose L/0000-0003-1757-4951; Carrascal, Livia/0000-0003-4222-5550; Torres, Blas/0000-0003-4508-4546; Nunez Abades, Pedro A./0000-0003-0947-8492	Ministerio de Ciencia y Tecnologia de Espana (MYCT) [BFU 2009-07867]; Proyectos de Excelencia de la Junta de Andalucia [P08-CVI-039, P09-CVI-4617]	Ministerio de Ciencia y Tecnologia de Espana (MYCT); Proyectos de Excelencia de la Junta de Andalucia(Junta de Andalucia)	This work was supported by a grant from the Ministerio de Ciencia y Tecnologia de Espana (MYCT; BFU 2009-07867) and Proyectos de Excelencia de la Junta de Andalucia (P08-CVI-039 and P09-CVI-4617). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber MJ, 1999, J NEUROSCI, V19, P9975; BAWA P, 1984, J NEUROPHYSIOL, V52, P410, DOI 10.1152/jn.1984.52.3.410; Berger AJ, 1996, J APPL PHYSIOL, V81, P1039, DOI 10.1152/jappl.1996.81.3.1039; Binder MD, 2002, ADV EXP MED BIOL, V508, P207; BULLER AJ, 1960, J PHYSIOL-LONDON, V150, P417, DOI 10.1113/jphysiol.1960.sp006395; CAMERON WE, 1991, J NEUROPHYSIOL, V65, P671, DOI 10.1152/jn.1991.65.3.671; Cameron WE, 2000, J NEUROPHYSIOL, V84, P2330, DOI 10.1152/jn.2000.84.5.2330; Cameron WE, 2000, BRAIN RES BULL, V53, P523, DOI 10.1016/S0361-9230(00)00385-3; Carrascal L, 2006, NEUROSCIENCE, V140, P1223, DOI 10.1016/j.neuroscience.2006.03.006; Carrascal L, 2005, BRAIN RES REV, V49, P377, DOI 10.1016/j.brainresrev.2005.02.003; Carrascal L, 2010, NEUROSCIENCE, V171, P613, DOI 10.1016/j.neuroscience.2010.09.001; Carrascal L, 2009, J COMP NEUROL, V514, P189, DOI 10.1002/cne.21996; COPE TC, 1991, J NEUROPHYSIOL, V66, P1127, DOI 10.1152/jn.1991.66.4.1127; CURTHOYS IS, 1981, ACTA OTO-LARYNGOL, V92, P323, DOI 10.3109/00016488109133268; CURTHOYS IS, 1979, ACTA OTO-LARYNGOL, V87, P484, DOI 10.3109/00016487909126456; DAVIES L, 1993, BRAIN RES, V602, P104, DOI 10.1016/0006-8993(93)90248-L; de Carrizosa MADL, 2009, J NEUROSCI, V29, P575, DOI 10.1523/JNEUROSCI.5312-08.2009; Duchateau J, 2011, BRAIN RES, V1409, P42, DOI 10.1016/j.brainres.2011.06.011; ElBasiouny SM, 2010, J NEUROSCI, V30, P5544, DOI 10.1523/JNEUROSCI.0434-10.2010; Faulstich BM, 2004, VISION RES, V44, P3419, DOI 10.1016/j.visres.2004.09.006; FLESHMAN JW, 1981, J NEUROPHYSIOL, V46, P1326, DOI 10.1152/jn.1981.46.6.1326; Fox MA, 2011, J COMP NEUROL, V519, P2907, DOI 10.1002/cne.22700; Gabriel JP, 2011, NAT NEUROSCI, V14, P93, DOI 10.1038/nn.2704; Gabrielaitis M, 2011, BRAIN RES, V1373, P11, DOI 10.1016/j.brainres.2010.12.011; GRANTYN R, 1978, EXP BRAIN RES, V31, P249; Grubb MS, 2010, NATURE, V465, P1070, DOI 10.1038/nature09160; Grundemann J, 2010, NATURE, V465, P1022, DOI 10.1038/4651022a; GUERITAUD JP, 1988, NEUROSCIENCE, V24, P837, DOI 10.1016/0306-4522(88)90072-3; GUSTAFSSON B, 1984, J PHYSIOL-LONDON, V356, P401, DOI 10.1113/jphysiol.1984.sp015473; Haftel VK, 2001, J NEUROPHYSIOL, V86, P616, DOI 10.1152/jn.2001.86.2.616; HECKMAN CJ, 1993, J NEUROPHYSIOL, V70, P1827, DOI 10.1152/jn.1993.70.5.1827; HENNEMAN E, 1965, J NEUROPHYSIOL, V28, P560, DOI 10.1152/jn.1965.28.3.560; Hornby TG, 2002, J NEUROPHYSIOL, V88, P86, DOI 10.1152/jn.2002.88.1.86; Kang YN, 2010, PROG BRAIN RES, V187, P163, DOI [10.1016/B978-0-444-53613-6.00011-3, 10.1016/S0079-6123(10)87011-6]; Kuba H, 2010, NATURE, V465, P1075, DOI 10.1038/nature09087; LAURSEN AM, 1989, NEUROSCIENCE, V30, P619, DOI 10.1016/0306-4522(89)90156-5; Lee RH, 1998, J NEUROPHYSIOL, V80, P583, DOI 10.1152/jn.1998.80.2.583; Li YR, 2004, J NEUROPHYSIOL, V91, P767, DOI 10.1152/jn.00788.2003; Mantilla CB, 2011, RESP PHYSIOL NEUROBI, V179, P57, DOI 10.1016/j.resp.2011.06.028; Mendell LM, 2005, J NEUROPHYSIOL, V93, P3024, DOI 10.1152/classicessays.00025.2005; Nieto-Gonzalez JL, 2007, EUR J NEUROSCI, V25, P2682, DOI 10.1111/j.1460-9568.2007.05516.x; Nieto-Gonzalez JL, 2009, J NEUROPHYSIOL, V101, P100, DOI 10.1152/jn.90239.2008; Nunez-Abades PA, 2000, J NEUROPHYSIOL, V84, P2317, DOI 10.1152/jn.2000.84.5.2317; NunezAbades PA, 1997, NEUROSCI LETT, V223, P41, DOI 10.1016/S0304-3940(97)13398-5; NUNEZABADES PA, 1995, J COMP NEUROL, V353, P129, DOI 10.1002/cne.903530112; NUNEZABADES PA, 1993, J NEUROPHYSIOL, V70, P1401, DOI 10.1152/jn.1993.70.4.1401; Ogawa Y, 2008, CURR OPIN NEUROBIOL, V18, P307, DOI 10.1016/j.conb.2008.08.008; Powers RK, 2008, J NEUROPHYSIOL, V100, P292, DOI 10.1152/jn.90296.2008; Powers RK, 2003, J NEUROPHYSIOL, V89, P615, DOI 10.1152/jn.00241.2002; POWERS RK, 1993, J NEUROPHYSIOL, V70, P1460, DOI 10.1152/jn.1993.70.4.1460; Rusch A, 1998, J NEUROSCI, V18, P7487; Russo RE, 1999, PROG BIOPHYS MOL BIO, V72, P329, DOI 10.1016/S0079-6107(99)00011-5; Seelke AMH, 2005, EUR J NEUROSCI, V22, P911, DOI 10.1111/j.1460-9568.2005.04322.x; Spencer RF, 2006, PROG BRAIN RES, V151, P43, DOI 10.1016/S0079-6123(05)51002-1; TSUZUKI S, 1995, NEUROSCI RES, V23, P389, DOI 10.1016/0168-0102(95)00966-W; VIANA F, 1993, J NEUROPHYSIOL, V69, P2137, DOI 10.1152/jn.1993.69.6.2137	56	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28748	10.1371/journal.pone.0028748	http://dx.doi.org/10.1371/journal.pone.0028748			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174887	Green Submitted, Green Published, gold			2022-12-25	WOS:000298365700069
J	Muratoglu, SC; Belgrave, S; Lillis, AP; Migliorini, M; Robinson, S; Smith, E; Zhang, L; Strickland, DK				Muratoglu, Selen Catania; Belgrave, Shani; Lillis, Anna P.; Migliorini, Mary; Robinson, Susan; Smith, Elizabeth; Zhang, Li; Strickland, Dudley K.			Macrophage LRP1 Suppresses Neo-Intima Formation during Vascular Remodeling by Modulating the TGF-beta Signaling Pathway	PLOS ONE			English	Article							TRANSFORMING-GROWTH-FACTOR; RECEPTOR-RELATED PROTEIN; SMOOTH-MUSCLE-CELLS; ALPHA-2-MACROGLOBULIN RECEPTOR; MOLECULAR-MECHANISMS; CORECEPTOR FUNCTION; CAROTID-ARTERY; GENE; PDGF; ATHEROSCLEROSIS	Background: Vascular remodeling in response to alterations in blood flow has been shown to modulate the formation of neo-intima. This process results from a proliferative response of vascular smooth muscle cells and is influenced by macrophages, which potentiate the development of the intima. The LDL receptor-related protein 1 (LRP1) is a large endocytic and signaling receptor that recognizes a number of ligands including apoE-containing lipoproteins, proteases and protease-inhibitor complexes. Macrophage LRP1 is known to influence the development of atherosclerosis, but its role in vascular remodeling has not been investigated. Methodology/Principal Findings: To define the contribution of macrophage LRP1 to vascular remodeling, we generated macrophage specific LRP1-deficient mice (macLRP1-/-) on an LDL receptor (LDLr) knock-out background. Using a carotid ligation model, we detected a 2-fold increase in neointimal thickening and a 2-fold increase in the intima/media ratio in macLRP1-/- mice. Quantitative RT-PCR arrays of the remodeled vessel wall identified increases in mRNA levels of the TGF-beta 2 gene as well as the Pdgfa gene in macLRP1-/- mice which could account for the alterations in vascular remodeling. Immunohistochemistry analysis revealed increased activation of the TGF-beta signaling pathway in macLRP1-/- mice. Further, we observed that LRP1 binds TGF-beta 2 and macrophages lacking LRP1 accumulate twice as much TGF-beta 2 in conditioned media. Finally, TNF-alpha modulation of the TGF-beta 2 gene in macrophages is attenuated when LRP1 is expressed. Together, the data reveal that LRP1 modulates both the expression and protein levels of TGF-beta 2 in macrophages. Conclusions/Significance: Our data demonstrate that macrophage LRP1 protects the vasculature by limiting remodeling events associated with flow. This appears to occur by the ability of macrophage LRP1 to reduce TGF-beta 2 protein levels and to attenuate expression of the TGF-beta 2 gene resulting in suppression of the TGF-beta signaling pathway.	[Muratoglu, Selen Catania; Belgrave, Shani; Lillis, Anna P.; Migliorini, Mary; Robinson, Susan; Smith, Elizabeth; Zhang, Li; Strickland, Dudley K.] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Zhang, Li; Strickland, Dudley K.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Muratoglu, Selen Catania; Belgrave, Shani; Migliorini, Mary; Robinson, Susan; Strickland, Dudley K.] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA; [Lillis, Anna P.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Duke University	Muratoglu, SC (corresponding author), Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA.	dstrickland@som.umaryland.edu	Lillis, Anna/AAI-6942-2021	Lillis, Anna/0000-0003-4810-9577; Muratoglu Catania, Selen/0000-0002-1804-4875	National Health Institute [PO1 HL54710, HL50784]; Maryland Stem Cell Research Fund postdoctoral fellowship;  [T32 HL007698]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL054710, T32HL007698, R01HL050784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078365] Funding Source: NIH RePORTER	National Health Institute; Maryland Stem Cell Research Fund postdoctoral fellowship; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Health Institute grants PO1 HL54710 and HL50784 awarded to DKS. SCM was supported by a Maryland Stem Cell Research Fund postdoctoral fellowship. SB was supported by T32 HL007698. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHCOM JD, 1990, J CELL BIOL, V110, P1041, DOI 10.1083/jcb.110.4.1041; ASSOIAN RK, 1986, J CELL BIOL, V102, P1217, DOI 10.1083/jcb.102.4.1217; BATTEGAY EJ, 1990, CELL, V63, P515, DOI 10.1016/0092-8674(90)90448-N; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Boucher P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000448; Bray P, 1998, HYPERTENSION, V31, P986, DOI 10.1161/01.HYP.31.4.986; Brizzi MF, 2001, CIRCULATION, V103, P549, DOI 10.1161/01.CIR.103.4.549; Campana WM, 2006, J NEUROSCI, V26, P11197, DOI 10.1523/JNEUROSCI.2709-06.2006; Cao CZ, 2006, EMBO J, V25, P1860, DOI 10.1038/sj.emboj.7601082; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Danielpour D, 2000, METH MOL B, V142, P29; Dear AE, 1996, EUR J BIOCHEM, V241, P93, DOI 10.1111/j.1432-1033.1996.0093t.x; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Eschert H, 2009, ATHEROSCLEROSIS, V204, P96, DOI 10.1016/j.atherosclerosis.2008.08.025; Gordts PLSM, 2009, ARTERIOSCL THROM VAS, V29, P1258, DOI 10.1161/ATVBAHA.109.192211; Grainger DJ, 2004, ARTERIOSCL THROM VAS, V24, P399, DOI 10.1161/01.ATV.0000114567.76772.33; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hu L, 2006, ARTERIOSCL THROM VAS, V26, P2710, DOI 10.1161/01.ATV.0000249641.96896.e6; Hu YH, 1997, ARTERIOSCL THROM VAS, V17, P2808, DOI 10.1161/01.ATV.17.11.2808; Huang SS, 2003, FASEB J, V17, P2068, DOI 10.1096/fj.03-0256com; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; Ivan E, 2002, CIRCULATION, V105, P2686, DOI 10.1161/01.CIR.0000016825.17448.11; Kumar A, 1997, ARTERIOSCL THROM VAS, V17, P2238, DOI 10.1161/01.ATV.17.10.2238; Lillis AP, 2008, J IMMUNOL, V181, P364, DOI 10.4049/jimmunol.181.1.364; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Loukinova E, 2002, J BIOL CHEM, V277, P15499, DOI 10.1074/jbc.M200427200; MCGOWAN SE, 1990, AM J RESP CELL MOL, V3, P369, DOI 10.1165/ajrcmb/3.4.369; MOESTRUP SK, 1989, J BIOL CHEM, V264, P15574; Muratoglu SC, 2010, J BIOL CHEM, V285, P14308, DOI 10.1074/jbc.M109.046672; NABEL EG, 1993, P NATL ACAD SCI USA, V90, P10759, DOI 10.1073/pnas.90.22.10759; Newby AC, 2000, J PATHOL, V190, P300, DOI 10.1002/(SICI)1096-9896(200002)190:3<300::AID-PATH596>3.0.CO;2-I; Newton CS, 2005, J BIOL CHEM, V280, P27872, DOI 10.1074/jbc.M505410200; Nuki Y, 2009, J CEREBR BLOOD F MET, V29, P495, DOI 10.1038/jcbfm.2008.136; Orlandi A, 2010, BIOCHEM PHARMACOL, V79, P1706, DOI 10.1016/j.bcp.2010.01.027; Overton CD, 2007, CIRC RES, V100, P670, DOI 10.1161/01.RES.0000260204.40510.aa; POMPILI VJ, 1995, ARTERIOSCL THROM VAS, V15, P2254, DOI 10.1161/01.ATV.15.12.2254; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; SHARMA S, 2010, PHARMACOL THERAPEUT, V129, P260; Smith JD, 1999, CIRC RES, V84, P1212, DOI 10.1161/01.RES.84.10.1212; STOUFFER GA, 1993, J BIOL CHEM, V268, P18340; STOUFFER GA, 1994, J CLIN INVEST, V93, P2048, DOI 10.1172/JCI117199; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; Yamamoto K, 2000, CIRCULATION, V102, P1308, DOI 10.1161/01.CIR.102.11.1308; Zurhove K, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164263; 2001, J BIOL CHEM, V276, P29632	45	34	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28846	10.1371/journal.pone.0028846	http://dx.doi.org/10.1371/journal.pone.0028846			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174911	Green Submitted, Green Published, gold			2022-12-25	WOS:000298365700077
J	Arriola, CS; Guere, ME; Larsen, J; Skov, RL; Gilman, RH; Gonzaiez, AE; Silbergeld, EK				Arriola, Carmen S.; Gueere, Mariella E.; Larsen, Jesper; Skov, Robert L.; Gilman, Robert H.; Gonzaiez, Armando E.; Silbergeld, Ellen K.			Presence of Methicillin-Resistant Staphylococcus aureus in Pigs in Peru	PLOS ONE			English	Article							MEC	We report the first detection of methicillin-resistant Staphylococcus aureus isolates in pigs in Peru. The isolates belong to a livestock-associated lineage previously reported in North America and Europe, CC398, and a highly virulent USA300-like ST8-IV variant, which is the predominant community-associated lineage in Latin America.	[Arriola, Carmen S.; Gueere, Mariella E.; Gonzaiez, Armando E.] San Marcos Major Natl Univ, Sch Vet Med, Lima, Peru; [Arriola, Carmen S.; Gilman, Robert H.] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Larsen, Jesper; Skov, Robert L.] Statens Serum Inst, Dept Microbiol Surveillance & Res, DK-2300 Copenhagen, Denmark; [Silbergeld, Ellen K.] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA	Universidad Nacional Mayor de San Marcos; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Statens Serum Institut; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Arriola, CS (corresponding author), San Marcos Major Natl Univ, Sch Vet Med, Lima, Peru.	carriola@jhsph.edu	Larsen, Jesper/AAJ-3161-2021; Skov, Robert/ABB-3105-2020	Larsen, Jesper/0000-0003-0582-0457; Skov, Robert/0000-0002-6079-5381; Guere, Mariella/0000-0002-0966-2524; Gonzalez, Armando/0000-0003-1909-1873	Center for a Livable Future; Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America; International Foundation for Science, Stockholm, Sweden; Fogarty International Center/National Institutes of Health [5 D43 TW008273, 5 D43 TW006581]; FOGARTY INTERNATIONAL CENTER [D43TW008273, D43TW006581] Funding Source: NIH RePORTER	Center for a Livable Future; Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America; International Foundation for Science, Stockholm, Sweden(International Foundation for Science); Fogarty International Center/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by the Center for a Livable Future, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America, and the International Foundation for Science, Stockholm, Sweden. CA was supported in part by Fogarty International Center/National Institutes of Health training grants 5 D43 TW008273 and 5 D43 TW006581. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argudin MA, 2011, APPL ENVIRON MICROB, V77, P3052, DOI 10.1128/AEM.02260-10; Arias CA, 2008, NEW ENGL J MED, V359, P2177, DOI 10.1056/NEJMc0804021; Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; Bens CCPM, 2006, J CLIN MICROBIOL, V44, P1875, DOI 10.1128/JCM.44.5.1875-1876.2006; Bhat M, 2009, EMERG INFECT DIS, V15, P285, DOI 10.3201/eid1502.080609; Clinical and Laboratory Standard Institute, 2011, M100S21 CLSI, V31; EFSA (European Food Safety Authority), 2010, EFSA J, V8, P1597, DOI [10.2903/j.efsa.2010.1597, DOI 10.2903/J.EFSA.2010.1597]; Fitzgibbon MM, 2007, J CLIN MICROBIOL, V45, P3263, DOI 10.1128/JCM.00836-07; Food and Agriculture Organization of the United Nations/World Organisation for Animal Health/World Bank, 2010, 169 UN FAO WORLD ORG; Garcia C, J INFECT IN PRESS; Hallin M, 2011, INFECT GENET EVOL, V11, P290, DOI 10.1016/j.meegid.2010.10.021; Jimenez JN, 2011, EMERG INFECT DIS OCT; Khanna T, 2008, VET MICROBIOL, V128, P298, DOI 10.1016/j.vetmic.2007.10.006; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Li SS, 2011, ANTIMICROB AGENTS CH, V55, P3046, DOI 10.1128/AAC.01475-10; Maes N, 2002, J CLIN MICROBIOL, V40, P1514, DOI 10.1128/JCM.40.4.1514-1517.2002; Reyes J, 2009, CLIN INFECT DIS, V49, P1861, DOI 10.1086/648426; Ruimy R, 2010, J INFECT DIS, V202, P924, DOI 10.1086/655901; Smith TC, 2011, VECTOR-BORNE ZOONOT, V11, P327, DOI 10.1089/vbz.2010.0072; Smith TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004258; van Rijen MML, 2008, CLIN INFECT DIS, V46, P261, DOI 10.1086/524672; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428	22	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28529	10.1371/journal.pone.0028529	http://dx.doi.org/10.1371/journal.pone.0028529			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174831	Green Published, Green Submitted, gold			2022-12-25	WOS:000298163600031
J	Gramegna, P; Latronico, T; Brana, MT; Di Bari, G; Mengoni, F; Belvisi, V; Mascellino, MT; Lichtner, M; Vullo, V; Mastroianni, CM; Liuzzi, GM				Gramegna, Pasqua; Latronico, Tiziana; Brana, Maria Teresa; Di Bari, Gaetano; Mengoni, Fabio; Belvisi, Valeria; Mascellino, Maria T.; Lichtner, Miriam; Vullo, Vincenzo; Mastroianni, Claudio M.; Liuzzi, Grazia M.			In Vitro Downregulation of Matrix Metalloproteinase-9 in Rat Glial Cells by CCR5 Antagonist Maraviroc: Therapeutic Implication for HIV Brain Infection	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; ANTIRETROVIRAL THERAPY; GELATINASE-B; TISSUE INHIBITORS; ASTROCYTES; MICROGLIA; MACROPHAGES; BIOCHEMISTRY; MECHANISMS; MONOCYTES	Background: Matrix metalloproteinases (MMPs) released by glial cells are important mediators of neuroinflammation and neurologic damage in HIV infection. The use of antiretroviral drugs able to combat the detrimental effect of chronic inflammation and target the exaggerated MMP activity might represent an attractive therapeutic challenge. Recent studies suggest that CCR5 antagonist maraviroc (MVC) exerts immunomodulant and anti-inflammatory activity beyond its anti-HIV properties. We investigated the in vitro effect of MVC on the activity of MMPs in astrocyte and microglia cultures. Methodology/Principal Findings: Primary cultures of rat astrocytes and microglia were activated by exposure to phorbol myristate acetate (PMA) or lypopolysaccharide (LPS) and treated in vitro with MVC. Culture supernatants were subjected to gelatin zymography and quantitative determination of MMP-9 and MMP-2 was done by computerized scanning densitometry. MMP-9 levels were significantly elevated in culture supernatants from both LPS- and PMA-activated astrocytes and microglia in comparison to controls. The treatment with MVC significantly inhibited in a dose-dependent manner the levels and expression of MMP-9 in PMA-activated astrocytes (p<0,05) and, to a lesser extent, in PMA-activated microglia. By contrast, levels of MMP-2 did not significantly change, although a tendency to decrease was seen in PMA-activated astrocytes after treatment with MVC. The inhibition of levels and expression of MMP-9 in PMA-activated glial cells did not depend on cytotoxic effects of MVC. No inhibition of MMP-9 and MMP-2 were found in both LPS-activated astrocytes and microglia. Conclusions: The present in vitro study suggests that CCR5 antagonist compounds, through their ability to inhibit MMP-9 expression and levels, might have a great potential for the treatment of HIV-associated neurologic damage.	[Gramegna, Pasqua; Latronico, Tiziana; Brana, Maria Teresa; Di Bari, Gaetano; Liuzzi, Grazia M.] Univ Bari, Dept Biochem & Mol Biol, Bari, Italy; [Mengoni, Fabio; Mascellino, Maria T.; Vullo, Vincenzo] Sapienza Univ, Dept Publ Hlth & Infect Dis, Rome, Italy; [Belvisi, Valeria; Lichtner, Miriam; Mastroianni, Claudio M.] Sapienza Univ, Infect Dis Unit, Fdn Eleonora Lorillard Spencer Cenci, Latina, Italy	Universita degli Studi di Bari Aldo Moro; Sapienza University Rome; Sapienza University Rome	Gramegna, P (corresponding author), Univ Bari, Dept Biochem & Mol Biol, Bari, Italy.	claudio.mastroianni@uniroma1.it	Liuzzi, Grazia Maria/GVR-7164-2022; mascellino, maria teresa/AAB-1971-2020; MASTROIANNI, Claudio Maria/O-9741-2019; Branà, Maria Teresa/P-6874-2018	mascellino, maria teresa/0000-0001-7684-3088; MASTROIANNI, Claudio Maria/0000-0002-1286-467X; Branà, Maria Teresa/0000-0002-0878-9363; Belvisi, Valeria/0000-0002-5835-1597; Latronico, Tiziana/0000-0001-6971-5416; Liuzzi, Grazia Maria/0000-0001-5692-9335	Programma Nazionale AIDS, ISS, Italy [40H8]	Programma Nazionale AIDS, ISS, Italy	The work was supported by a grant of Programma Nazionale AIDS 2009-2010, ISS, Italy (N. 40H8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal L, 2009, J GEN VIROL, V90, P710, DOI 10.1099/vir.0.006205-0; Cardenas VA, 2009, J NEUROVIROL, V15, P324, DOI 10.1080/13550280902973960; Corbeau P, 2009, AIDS, V23, P1931, DOI 10.1097/QAD.0b013e32832e71cd; Eden A, 2010, J INFECT DIS, V202, P1819, DOI 10.1086/657342; Elkington PTG, 2005, CLIN EXP IMMUNOL, V142, P12, DOI 10.1111/j.1365-2249.2005.02840.X; GEBICKEHAERTER PJ, 1989, J NEUROSCI, V9, P183; Gilliam BL, 2010, J TRANSL MED, V9, P1; Glass WG, 2004, J IMMUNOL, V172, P4018, DOI 10.4049/jimmunol.172.7.4018; Gomez DE, 1997, EUR J CELL BIOL, V74, P111; GOTTSCHALL PE, 1995, J NEUROSCI RES, V42, P335, DOI 10.1002/jnr.490420307; GOTTSCHALL PE, 1995, J NEUROCHEM, V64, P1513; Harezlak J, 2011, AIDS, V25, P625, DOI 10.1097/QAD.0b013e3283427da7; HEUSSEN C, 1980, ANAL BIOCHEM, V102, P196, DOI 10.1016/0003-2697(80)90338-3; Hisatomi T, 2008, J CLIN INVEST, V118, P2025, DOI 10.1172/JCI34267; Hunt Peter W, 2007, Curr HIV/AIDS Rep, V4, P42, DOI 10.1007/s11904-007-0007-8; Kraft-Terry SD, 2010, NEUROBIOL DIS, V37, P542, DOI 10.1016/j.nbd.2009.12.015; Latronico T, 2007, AIDS, V21, P677, DOI 10.1097/QAD.0b013e328018751d; Lee WJ, 2003, GLIA, V41, P15, DOI 10.1002/glia.10131; Lieberman-Blum SS, 2008, CLIN THER, V30, P1228, DOI 10.1016/S0149-2918(08)80048-3; Liuzzi GM, 2004, BRAIN, V127, P398, DOI 10.1093/brain/awh049; Mastroianni CM, 2007, TRENDS MOL MED, V13, P449, DOI 10.1016/j.molmed.2007.09.001; MASURE S, 1990, BIOCHIM BIOPHYS ACTA, V1054, P317, DOI 10.1016/0167-4889(90)90103-K; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NAKAJIMA K, 1989, BIOMED RES-TOKYO, V10, P411; Rizza SA, 2008, MED CHEM, V4, P75, DOI 10.2174/157340608783331443; Rossi R, 2011, CLIN EXP IMMUNOL, V166, P184, DOI 10.1111/j.1365-2249.2011.04409.x; Rossi R, 2010, JAIDS-J ACQ IMM DEF, V54, pE13, DOI 10.1097/QAI.0b013e3181ed18f6; Shapshak P, 2011, AIDS, V25, P123, DOI 10.1097/QAD.0b013e328340fd42; Sorce S, 2011, PROG NEUROBIOL, V93, P297, DOI 10.1016/j.pneurobio.2010.12.003; Soriano V, 2008, AIDS, V22, P2231, DOI 10.1097/QAD.0b013e3283136d95; Soriano V, 2009, AIDS, V23, P2377, DOI 10.1097/QAD.0b013e328332d32d; Suryadevara R, 2003, GLIA, V44, P47, DOI 10.1002/glia.10266; Toborek M, 2005, CELL MOL NEUROBIOL, V25, P181, DOI 10.1007/s10571-004-1383-x; Valcour Victor, 2011, Curr HIV/AIDS Rep, V8, P54, DOI 10.1007/s11904-010-0070-4; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Webster NL, 2006, J LEUKOCYTE BIOL, V80, P1052, DOI 10.1189/jlb.0306152; Weeks BS, 1998, INT J MOL MED, V1, P361	39	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28499	10.1371/journal.pone.0028499	http://dx.doi.org/10.1371/journal.pone.0028499			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174822	gold, Green Published, Green Submitted			2022-12-25	WOS:000298163600027
J	Jung, H; Lyons, RE; Dinh, H; Hurwood, DA; McWilliam, S; Mather, PB				Jung, Hyungtaek; Lyons, Russell E.; Dinh, Hung; Hurwood, David A.; McWilliam, Sean; Mather, Peter B.			Transcriptomics of a Giant Freshwater Prawn (Macrobrachium rosenbergii): De Novo Assembly, Annotation and Marker Discovery	PLOS ONE			English	Article							ACID O-METHYLTRANSFERASE; JUVENILE-HORMONE BIOSYNTHESIS; MYOSIN HEAVY-CHAIN; BLACK TIGER SHRIMP; METHYL FARNESOATE; PENAEUS-MONODON; MICROSATELLITE MARKERS; ALKALOID BIOSYNTHESIS; DEVELOPMENTAL-CHANGES; INVERTEBRATE MUSCLES	Background: Giant freshwater prawn (Macrobrachium rosenbergii or GFP), is the most economically important freshwater crustacean species. However, as little is known about its genome, 454 pyrosequencing of cDNA was undertaken to characterise its transcriptome and identify genes important for growth. Methodology and Principal Findings: A collection of 787,731 sequence reads (244.37 Mb) obtained from 454 pyrosequencing analysis of cDNA prepared from muscle, ovary and testis tissues taken from 18 adult prawns was assembled into 123,534 expressed sequence tags (ESTs). Of these, 46% of the 8,411 contigs and 19% of 115,123 singletons possessed high similarity to sequences in the GenBank non-redundant database, with most significant (E value < 1e(-5)) contig (80%) and singleton (84%) matches occurring with crustacean and insect sequences. KEGG analysis of the contig open reading frames identified putative members of several biological pathways potentially important for growth. The top InterProScan domains detected included RNA recognition motifs, serine/threonine-protein kinase-like domains, actin-like families, and zinc finger domains. Transcripts derived from genes such as actin, myosin heavy and light chain, tropomyosin and troponin with fundamental roles in muscle development and construction were abundant. Amongst the contigs, 834 single nucleotide polymorphisms, 1198 indels and 658 simple sequence repeats motifs were also identified. Conclusions: The M. rosenbergii transcriptome data reported here should provide an invaluable resource for improving our understanding of this species' genome structure and biology. The data will also instruct future functional studies to manipulate or select for genes influencing growth that should find practical applications in aquaculture breeding programs.	[Jung, Hyungtaek; Dinh, Hung; Hurwood, David A.; Mather, Peter B.] Queensland Univ Technol, Brisbane, Qld 4001, Australia; [Lyons, Russell E.; McWilliam, Sean] Commonwealth Sci & Ind Res Org Livestock Ind, St Lucia, Qld, Australia	Queensland University of Technology (QUT); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Jung, H (corresponding author), Queensland Univ Technol, Brisbane, Qld 4001, Australia.	h7.jung@qut.edu.au	McWilliam, Sean M/H-8978-2013; Lyons, Russell E/AAH-4097-2020; Lyons, Russell E/A-7051-2011; Lyons, Russell/H-7942-2013; Hurwood, David/I-9923-2012	McWilliam, Sean M/0000-0002-3148-0428; Lyons, Russell E/0000-0002-0795-7994; Lyons, Russell/0000-0002-0795-7994; Jung, Hyungtaek/0000-0003-2464-1235; Hurwood, David/0000-0001-9143-360X	International Postgraduate Research Scholarship (Australia); Queensland University of Technology [N7333978]	International Postgraduate Research Scholarship (Australia)(Australian Government); Queensland University of Technology	This research forms part of H. Jung's Ph.D project, and is supported by an International Postgraduate Research Scholarship (Australia) and a Queensland University of Technology Postgraduate Award (N7333978). Additional funding for this work was provided by Queensland University of Technology awarded to P. Mather (QUT VC NPSG award). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bach I, 2002, MECH DEVELOP, V91, P5; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Barat-Houari M, 2002, DIABETES, V51, P1640, DOI 10.2337/diabetes.51.5.1640; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Baruah K, 2009, AQUACULTURE, V288, P233, DOI 10.1016/j.aquaculture.2008.11.034; Bekal S, 2008, MOL GENET GENOMICS, V279, P535, DOI 10.1007/s00438-008-0331-8; Belfiore M, 2004, DEVELOPMENT, V131, P2935, DOI 10.1242/dev.01154; Birbach A, 2008, BIOESSAYS, V30, P994, DOI 10.1002/bies.20822; BOCHKAREV A, 1995, CELL, V83, P39, DOI 10.1016/0092-8674(95)90232-5; BORST DW, 1987, INSECT BIOCHEM, V17, P1123, DOI 10.1016/0020-1790(87)90133-8; Bouhouche N, 2000, TRENDS MICROBIOL, V8, P77, DOI 10.1016/S0966-842X(99)01679-0; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V50, P111, DOI 10.1007/s12013-008-9008-5; BUSS F, 1992, CELL MOTIL CYTOSKEL, V22, P51, DOI 10.1002/cm.970220106; Cam DTV, 2009, AQUACULTURE, V294, P5; Chand V, 2005, MOL ECOL NOTES, V5, P308, DOI 10.1111/j.1471-8286.2005.00910.x; Chromczynski P., 1995, BIOTECHNIQUES, V19, P942; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Critchley DR, 1999, BIOCHEM SOC SYMP, V65, P79; de Bruyn M, 2004, MOL PHYLOGENET EVOL, V30, P251, DOI 10.1016/S1055-7903(03)00176-3; De Bruyn M, 2007, MOL ECOL, V16, P4295, DOI 10.1111/j.1365-294X.2007.03481.x; Dechklar M, 2008, BIOCHEM BIOPH RES CO, V367, P768, DOI 10.1016/j.bbrc.2008.01.031; DENARDI C, 1993, J CELL BIOL, V123, P823, DOI 10.1083/jcb.123.4.823; Divu D, 2008, AQUACULTURE, V284, P281, DOI 10.1016/j.aquaculture.2008.07.023; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; Du ZQ, 2010, ANIM GENET, V41, P286, DOI 10.1111/j.1365-2052.2009.02002.x; Ellis JR, 2007, HEREDITY, V99, P125, DOI 10.1038/sj.hdy.6801001; Emrich SJ, 2007, GENOME RES, V17, P69, DOI 10.1101/gr.5145806; Esteves A, 2006, COMP BIOCHEM PHYS C, V142, P262, DOI 10.1016/j.cbpc.2005.11.006; FAO, 2009, FISH STAT DAT GLOB A; Ferrer JL, 2008, PLANT PHYSIOL BIOCH, V46, P356, DOI 10.1016/j.plaphy.2007.12.009; FEYEREISEN R, 1981, INSECT BIOCHEM, V11, P401, DOI 10.1016/0020-1790(81)90073-1; Gnaiger E, 2000, P NATL ACAD SCI USA, V97, P11080, DOI 10.1073/pnas.97.20.11080; Gorbach DM, 2010, ANIM BIOTECHNOL, V21, P100, DOI 10.1080/10495390903323968; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gunawardene YINS, 2003, PEPTIDES, V24, P1591, DOI 10.1016/j.peptides.2003.07.022; Hagel JM, 2008, PLANT PHYSIOL, V147, P1805, DOI 10.1104/pp.108.120493; Hale MC, 2010, GENETICA, V138, P745, DOI 10.1007/s10709-010-9455-y; Hale MC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-203; Hamasaki K, 2008, REV FISH SCI, V16, P164, DOI 10.1080/10641260701681722; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; HAUGWITZ M, 1994, CELL, V79, P303, DOI 10.1016/0092-8674(94)90199-6; HAUNERLAND NH, 1993, MOL CELL BIOCHEM, V123, P153, DOI 10.1007/BF01076487; HAYASHIDA M, 1991, J BIOCHEM-TOKYO, V110, P54, DOI 10.1093/oxfordjournals.jbchem.a123543; Holford KC, 2004, INSECT BIOCHEM MOLEC, V34, P785, DOI 10.1016/j.ibmb.2004.04.003; Hooper SL, 2008, PROG NEUROBIOL, V86, P72, DOI 10.1016/j.pneurobio.2008.06.004; Hooper SL, 2005, PHYSIOL REV, V85, P1001, DOI 10.1152/physrev.00019.2004; Huber K, 2009, ENDOCRINOLOGY, V150, P4135, DOI 10.1210/en.2009-0125; Hui JHL, 2008, PEPTIDES, V29, P252, DOI 10.1016/j.peptides.2007.08.033; Dinh H, 2012, AQUAC RES, V43, P1471, DOI 10.1111/j.1365-2109.2011.02949.x; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Ibrahim RK, 1998, PLANT MOL BIOL, V36, P1, DOI 10.1023/A:1005939803300; Jung HH, 1998, AM J PHYSIOL-CELL PH, V275, pC68, DOI 10.1152/ajpcell.1998.275.1.C68; KABSCH W, 1992, ANNU REV BIOPH BIOM, V21, P49, DOI 10.1146/annurev.biophys.21.1.49; Kamimura MT, 2008, AQUAC RES, V39, P200, DOI 10.1111/j.1365-2109.2007.01885.x; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kashman Y, 2010, MAR DRUGS, V8, P2810, DOI 10.3390/md8112810; Kielkopf CL, 2004, GENE DEV, V18, P1513, DOI 10.1101/gad.1206204; Kim BK, 2009, COMP BIOCHEM PHYS B, V153, P178, DOI 10.1016/j.cbpb.2009.02.013; Kim WJ, 2011, MAR BIOTECHNOL, V13, P127, DOI 10.1007/s10126-010-9280-4; Kraemer B, 1999, CURR BIOL, V9, P1009, DOI 10.1016/S0960-9822(99)80449-7; Kuballa AV, 2007, GEN COMP ENDOCR, V150, P48, DOI 10.1016/j.ygcen.2006.07.020; LAUFER H, 1987, SCIENCE, V235, P202, DOI 10.1126/science.235.4785.202; LAUFER H, 1987, INSECT BIOCHEM, V17, P1129, DOI 10.1016/0020-1790(87)90134-X; Leekitcharoenphon Pimlapas, 2010, BMC Research Notes, V3, DOI 10.1186/1756-0500-3-295; Leelatanawit R, 2009, COMP BIOCHEM PHYS A, V152, P66, DOI 10.1016/j.cbpa.2008.09.004; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Leu JH, 2011, MAR BIOTECHNOL, V13, P608, DOI 10.1007/s10126-010-9286-y; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Liang HY, 2008, TREE GENET GENOMES, V4, P419, DOI 10.1007/s11295-007-0120-2; Lyons RE, 2007, MAR BIOTECHNOL, V9, P712, DOI 10.1007/s10126-007-9022-4; MACLEOD AR, 1987, BIOESSAYS, V6, P208, DOI 10.1002/bies.950060504; MAGDOLEN V, 1988, MOL CELL BIOL, V8, P5108, DOI 10.1128/MCB.8.12.5108; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McNeil GP, 2001, GENETICS, V159, P229; Medler S, 2005, BIOL BULL-US, V208, P127, DOI 10.2307/3593121; Medler S, 2004, J EXP BIOL, V207, P2755, DOI 10.1242/jeb.01094; Meglecz E, 2010, BIOINFORMATICS, V26, P403, DOI 10.1093/bioinformatics/btp670; Meyer-Rochow VB, 2002, MICROSC RES TECHNIQ, V58, P504, DOI 10.1002/jemt.10169; Miller AD, 2005, MAR BIOTECHNOL, V7, P339, DOI 10.1007/s10126-004-4077-8; Minet-Quinared R, 2004, AM J PHYSIOL-ENDOC M, V287, pE671, DOI 10.1152/ajpendo.00185.2003; Mittapalli O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013708; Morin PA, 2004, TRENDS ECOL EVOL, V19, P208, DOI 10.1016/j.tree.2004.01.009; Morton BR, 2006, GENETICS, V172, P569, DOI 10.1534/genetics.105.049916; Ngernsoungnern P, 2009, AQUACULTURE, V296, P143, DOI 10.1016/j.aquaculture.2009.08.011; Nguyen MT, 2010, AQUACULTURE, V301, P7, DOI 10.1016/j.aquaculture.2010.02.001; Nhan DT, 2009, AQUACULTURE, V298, P36, DOI 10.1016/j.aquaculture.2009.09.011; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Oliveros JC, 2007, VENNY INTERACTIVE TO; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Perry MJ, 2009, J EXP BIOL, V212, P673, DOI 10.1242/jeb.023481; Pollard TD, 2008, BIOCHEM SOC T, V36, P425, DOI 10.1042/BST0360425; Postel U, 2010, J EXP BIOL, V213, P1740, DOI 10.1242/jeb.033829; Potapov V, 2004, J MOL BIOL, V342, P665, DOI 10.1016/j.jmb.2004.06.072; PRINJHA RK, 1994, CELL MOTIL CYTOSKEL, V28, P243, DOI 10.1002/cm.970280307; Rahman AMA, 2010, RAPID COMMUN MASS SP, V24, P2462, DOI 10.1002/rcm.4664; Rawe VY, 2006, HUM REPROD, V21, P1143, DOI 10.1093/humrep/dei480; Robalino J, 2009, VET IMMUNOL IMMUNOP, V128, P110, DOI 10.1016/j.vetimm.2008.10.329; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruddell CJ, 2003, BIOL BULL-US, V205, P308, DOI 10.2307/1543294; Rush MG, 1996, BIOESSAYS, V18, P103, DOI 10.1002/bies.950180206; SAGI A, 1991, COMP BIOCHEM PHYS B, V99, P879, DOI 10.1016/0305-0491(91)90157-9; SCHEFFZEK K, 1995, NATURE, V374, P378, DOI 10.1038/374378a0; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; Schwantes VS, 2009, AQUACULTURE, V287, P120, DOI 10.1016/j.aquaculture.2008.10.017; See LM, 2009, BIOCHEM GENET, V47, P722, DOI 10.1007/s10528-009-9270-2; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; SOLWAY J, 1995, J BIOL CHEM, V270, P13460, DOI 10.1074/jbc.270.22.13460; Soonthornchai W, 2010, DEV COMP IMMUNOL, V34, P19, DOI 10.1016/j.dci.2009.07.007; Staelens J, 2008, GENETICS, V179, P917, DOI 10.1534/genetics.107.080150; STRASSER P, 1993, FEBS LETT, V330, P13, DOI 10.1016/0014-5793(93)80909-E; Su JS, 2008, FISH SHELLFISH IMMUN, V24, P223, DOI 10.1016/j.fsi.2007.11.006; Sung HH, 2009, FISH SHELLFISH IMMUN, V26, P256, DOI 10.1016/j.fsi.2008.11.017; Sutherland LC, 2005, J CELL BIOCHEM, V94, P5, DOI 10.1002/jcb.20204; Tamone SL, 1997, GEN COMP ENDOCR, V105, P168, DOI 10.1006/gcen.1996.6815; Tangprasittipap A, 2010, AQUACULTURE, V307, P150, DOI 10.1016/j.aquaculture.2010.07.008; Tassanakajon A, 2006, GENE, V384, P104, DOI 10.1016/j.gene.2006.07.012; Teichmann SA, 2000, J MOL BIOL, V296, P1367, DOI 10.1006/jmbi.1999.3497; Thanh NM, 2010, AQUACULTURE, V299, P30, DOI 10.1016/j.aquaculture.2009.12.011; Thanh NM, 2009, AQUACULTURE, V287, P75, DOI 10.1016/j.aquaculture.2008.10.051; Towers GJ, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-40; VANDERHORST DJ, 1990, BIOCHIM BIOPHYS ACTA, V1047, P195, DOI 10.1016/0005-2760(90)90518-3; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; VERHEYEN EM, 1994, DEVELOPMENT, V120, P717; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; Wang JPZ, 2004, BIOINFORMATICS, V20, P2973, DOI 10.1093/bioinformatics/bth342; WANG ZW, 1994, J INSECT PHYSIOL, V40, P217, DOI 10.1016/0022-1910(94)90045-0; Wheat CW, 2010, GENETICA, V138, P433, DOI 10.1007/s10709-008-9326-y; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Wolska BM, 2003, PFLUG ARCH EUR J PHY, V446, P1, DOI 10.1007/s00424-002-0900-3; Wu P, 2009, COMP BIOCHEM PHYS D, V4, P111, DOI 10.1016/j.cbd.2008.12.004; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhu XJ, 2005, COMP BIOCHEM PHYS B, V140, P599, DOI 10.1016/j.cbpc.2004.12.010; Ziegler J, 2008, ANNU REV PLANT BIOL, V59, P735, DOI 10.1146/annurev.arplant.59.032607.092730; Zimmerman AW, 2002, CELL MOL LIFE SCI, V59, P1096, DOI 10.1007/s00018-002-8490-y	141	94	99	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e27938	10.1371/journal.pone.0027938	http://dx.doi.org/10.1371/journal.pone.0027938			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174756	Green Published, gold, Green Submitted			2022-12-25	WOS:000298163600010
J	Lillo, AM; Ayriss, JE; Shou, YL; Graves, SW; Bradbury, ARM; Pavlik, P				Lillo, Antonietta M.; Ayriss, Joanne E.; Shou, Yulin; Graves, Steven W.; Bradbury, Andrew R. M.; Pavlik, Peter			Development of Phage-Based Single Chain Fv Antibody Reagents for Detection of Yersinia pestis	PLOS ONE			English	Article							IMMUNOCHEMICAL REAGENTS; DISPLAY LIBRARY; FLOW-CYTOMETRY; IN-VITRO; SELECTION; SEQUENCE; PROTEIN; PLAGUE; FRAGMENTS; BINDING	Background: Most Yersinia pestis strains are known to express a capsule-like antigen, fraction 1 (F1). F1 is encoded by the caf1 gene located on the large 100-kb pFra plasmid, which is found in Y. pestis but not in closely related species such as Yersinia enterocolytica and Yersinia pseudotuberculosis. In order to find antibodies specifically binding to Y. pestis we screened a large single chain Fv antibody fragment (scFv) phage display library using purified F1 antigen as a selection target. Different forms of the selected antibodies were used to establish assays for recombinant F1 antigen and Y. pestis detection. Methods: Phage antibody panning was performed against F1 in an automated fashion using the Kingfisher magnetic bead system. Selected scFvs were screened for F1-binding specificity by one-step alkaline phosphatase enzyme linked immunosorbant assay (ELISA), and assayed for binding to recombinant antigen and/or Y. pestis by flow cytometry and whole-cell ELISA. Results: Seven of the eight selected scFvs were shown to specifically bind both recombinant F1 and a panel of F1-positive Yersinia cells. The majority of the soluble scFvs were found to be difficult to purify, unstable and prone to cross-reactivity with F1-negative Yersinia strains, whereas phage displayed scFvs were found to be easy to purify/label and remarkably stable. Furthermore direct fluorescent labeling of phage displaying scFv allowed for an easy one-step flow cytometry assay. Slight cross-reactivity was observed when fixed cells were used in ELISA. Conclusions: Our high throughput methods of selection and screening allowed for time and cost effective discovery of seven scFvs specifically binding Y. pestis F1 antigen. We describe implementation of different methods for phage-based immunoassay. Based on the success of these methods and the proven stability of phage, we indicate that the use of phage-displayed, rather than phage-free proteins, might generally overcome the shortcomings of scFv antibodies.	[Lillo, Antonietta M.; Ayriss, Joanne E.; Shou, Yulin; Graves, Steven W.; Bradbury, Andrew R. M.; Pavlik, Peter] Los Alamos Natl Lab, Div Biosci, Los Alamos, NM 87545 USA	United States Department of Energy (DOE); Los Alamos National Laboratory	Lillo, AM (corresponding author), Los Alamos Natl Lab, Div Biosci, Los Alamos, NM 87545 USA.	amb@lanl.gov		Bradbury, Andrew/0000-0002-5567-8172	Department of Homeland Security, Los Alamos National Laboratory Directed Research and development [20070010DR]	Department of Homeland Security, Los Alamos National Laboratory Directed Research and development	This work was supported by the Department of Homeland Security, Los Alamos National Laboratory Directed Research and development funds 20070010DR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Ayriss J, 2007, J PROTEOME RES, V6, P1072, DOI 10.1021/pr0604108; BRUBAKER RR, 1991, CLIN MICROBIOL REV, V4, P309, DOI 10.1128/CMR.4.3.309-324.1991; Chao HM, 1998, J CHROMATOGR B, V715, P307, DOI 10.1016/S0378-4347(98)00172-8; Chasteen L, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl772; Cherepanov P A, 1991, Mol Gen Mikrobiol Virusol, P19; CLACKSON T, 1994, TRENDS BIOTECHNOL, V12, P173, DOI 10.1016/0167-7799(94)90079-5; De Crescenzo G, 2003, BIOCHEMISTRY-US, V42, P1754, DOI 10.1021/bi0268450; Goncharov A Iu, 1992, Mol Gen Mikrobiol Virusol, P10; Jawetz E, 1943, J INFECT DIS, V73, P124, DOI 10.1093/infdis/73.2.124; Jaye DL, 2004, J IMMUNOL METHODS, V295, P119, DOI 10.1016/j.jim.2004.09.011; Kehoe JW, 2006, MOL CELL PROTEOMICS, V5, P2350, DOI 10.1074/mcp.M600314-MCP200; Lindler LE, 1998, INFECT IMMUN, V66, P5731, DOI 10.1128/IAI.66.12.5731-5742.1998; Loset GA, 2008, BIOTECHNIQUES, V44, P551, DOI 10.2144/000112724; Lou JL, 2001, J IMMUNOL METHODS, V253, P233, DOI 10.1016/S0022-1759(01)00385-4; MARKS JD, 1991, J MOL BIOL, V222, P581, DOI 10.1016/0022-2836(91)90498-U; Marzari R, 2002, EUR J IMMUNOL, V32, P2773, DOI 10.1002/1521-4141(2002010)32:10<2773::AID-IMMU2773>3.0.CO;2-G; Neri D, 1998, METH MOL B, V80, P475; NISSIM A, 1994, EMBO J, V13, P692, DOI 10.1002/j.1460-2075.1994.tb06308.x; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Sblattero D, 2002, EUR J BIOCHEM, V269, P5175, DOI 10.1046/j.1432-1033.2002.03215.x; Sblattero D, 2000, NAT BIOTECHNOL, V18, P75, DOI 10.1038/71958; Smith GP, 1997, CHEM REV, V97, P391, DOI 10.1021/cr960065d; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Velappan N, 2007, J IMMUNOL METHODS, V321, P60, DOI 10.1016/j.jim.2007.01.011	26	27	28	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e27756	10.1371/journal.pone.0027756	http://dx.doi.org/10.1371/journal.pone.0027756			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174746	Green Submitted, Green Published, gold			2022-12-25	WOS:000298163600004
J	Subach, OM; Cranfill, PJ; Davidson, MW; Verkhusha, VV				Subach, Oksana M.; Cranfill, Paula J.; Davidson, Michael W.; Verkhusha, Vladislav V.			An Enhanced Monomeric Blue Fluorescent Protein with the High Chemical Stability of the Chromophore	PLOS ONE			English	Article							PHOTOSTABILITY	Commonly used monomeric blue fluorescent proteins suffer from moderate brightness. The brightest of them, mTagBFP, has a notably low chemical stability over time. Prolonged incubation of mTagBFP leads to its transition from a blue fluorescent state with absorbance at 401 nm to a non-fluorescent state with absorbance at 330 nm. Here, we have determined the chemical structure of the degraded product of the blue mTagBFP-like chromophore. On the basis of mTagBFP we have developed an improved variant, named mTagBFP2. mTagBFP2 exhibits 2-fold greater chemical stability and substantially higher brightness in live cells than mTagBFP. mTagBFP2 is also 1.2-fold and 1.7-fold more photostable than mTagBFP in widefield and confocal microscopy setups, respectively. mTagBFP2 maintains all other beneficial properties of the parental mTagBFP including the high pH stability and fast chromophore formation. The enhanced photostability and chromophore chemical stability of mTagBFP2 make it a superior protein tag. mTagBFP2 performs well in the numerous protein fusions and surpasses mTagBFP as a donor in Forster resonance energy transfer with several green fluorescent protein acceptors.	[Subach, Oksana M.; Verkhusha, Vladislav V.] Albert Einstein Coll Med, Dept Anat & Struct Biol, New York, NY USA; [Subach, Oksana M.; Verkhusha, Vladislav V.] Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, New York, NY USA; [Cranfill, Paula J.; Davidson, Michael W.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32306 USA; [Cranfill, Paula J.; Davidson, Michael W.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	Yeshiva University; Yeshiva University; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Subach, OM (corresponding author), Albert Einstein Coll Med, Dept Anat & Struct Biol, New York, NY USA.	vladislav.verkhusha@einstein.yu.edu	Subach, Oksana (Gritsenko)/K-7086-2014; Verkhusha, Vladislav/AAU-7784-2020	Verkhusha, Vladislav/0000-0002-2083-8121	United States National Institutes of Health [GM073913]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073913] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the grant GM073913 from the United States National Institutes of Health: http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HW, 2007, BIOCHEMISTRY-US, V46, P5904, DOI 10.1021/bi700199g; Bastiaens PIH, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 3, P136; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hsu STD, 2009, CHEM SOC REV, V38, P2951, DOI 10.1039/b908170b; Markwardt ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017896; Mena MA, 2006, NAT BIOTECHNOL, V24, P1569, DOI 10.1038/nbt1264; Piatkevich KD, 2010, CURR OPIN CHEM BIOL, V14, P23, DOI 10.1016/j.cbpa.2009.10.011; Pletnev S, 2010, J AM CHEM SOC, V132, P2243, DOI 10.1021/ja908418r; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Snedecor GW, 1980, STAT METHODS, V7th; Strack RL, 2010, J AM CHEM SOC, V132, P8496, DOI 10.1021/ja1030084; Subach OM, 2008, CHEM BIOL, V15, P1116, DOI 10.1016/j.chembiol.2008.08.006; Subach OM, 2010, CHEM BIOL, V17, P333, DOI 10.1016/j.chembiol.2010.03.005; Tomosugi W, 2009, NAT METHODS, V6, P351, DOI [10.1038/NMETH.1317, 10.1038/nmeth.1317]; Verkhusha VV, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1342, DOI 10.1023/A:1013325627378; Wu B, 2011, CURR OPIN CELL BIOL, V23, P310, DOI 10.1016/j.ceb.2010.12.004	21	166	177	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28674	10.1371/journal.pone.0028674	http://dx.doi.org/10.1371/journal.pone.0028674			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174863	Green Published, gold			2022-12-25	WOS:000298163600038
J	Pacios, S; Kang, J; Galicia, J; Gluck, K; Patel, H; Ovaydi-Mandel, A; Petrov, S; Alawi, F; Graves, DT				Pacios, Sandra; Kang, Jun; Galicia, Johnah; Gluck, Kenneth; Patel, Hemal; Ovaydi-Mandel, Amy; Petrov, Sophia; Alawi, Faizan; Graves, Dana T.			Diabetes aggravates periodontitis by limiting repair through enhanced inflammation	FASEB JOURNAL			English	Article						bone formation; cytokine; growth factor; inhibitor	TUMOR-NECROSIS-FACTOR; BONE LOSS; FACTOR-ALPHA; DESTRUCTION; INHIBITION; RESORPTION; CYTOKINES; HEALTH	Periodontitis is the most common lytic bone disease and one of the first clinical manifestations of diabetes. Diabetes increases the risk of periodontitis. The aim of the present study was to examine mechanisms by which diabetes aggravates periodontitis. Ligature-induced periodontitis was examined in Goto-Kakizaki rats with type 2 diabetes. A tumor necrosis factor (TNF)-specific-inhibitor, pegsunercept, was applied to diabetic rats after the onset of periodontal disease. Interferon-gamma (IFN-gamma), TNF-alpha, interleukin-1 beta (IL-1 beta), fibroblast growth factor-2 (FGF-2), transforming growth factor beta-1 (TGF beta-1), bone morphogenetic protein-2 (BMP-2), and BMP-6 were measured by real-time RT-PCR, and histological sections were examined for leukocyte infiltration and several parameters related to bone resorption and formation. Inflammation was prolonged in diabetic rats and was reversed by the TNF inhibitor, which reduced cytokine mRNA levels, leukocyte infiltration, and osteoclasts. In contrast, new bone and osteoid formation and osteoblast numbers were increased significantly vs. untreated diabetic animals. TNF inhibition in diabetic animals also reduced apoptosis, increased proliferation of bone-lining cells, and increased mRNA levels of FGF-2, TGF beta-1, BMP-2, and BMP-6. Thus, diabetes prolongs inflammation and osteoclastogenesis in periodontitis and through TNF limits the normal reparative process by negatively modulating factors that regulate bone.-Pacios, S., Kang, J., Galicia, J., Gluck, K., Patel, H., Ovaydi-Mandel, A., Petrov, S., Alawi, F., Graves, D. T. Diabetes aggravates periodontitis by limiting repair through enhanced inflammation. FASEB J. 26, 1423-1430 (2012). www.fasebj.org	[Pacios, Sandra; Kang, Jun; Galicia, Johnah; Patel, Hemal; Graves, Dana T.] Univ Penn, Dept Periodont, Sch Dent Med, Philadelphia, PA 19104 USA; [Alawi, Faizan] Univ Penn, Dept Pathol, Sch Dent Med, Philadelphia, PA 19104 USA; [Pacios, Sandra] Univ Int Catalunya, Dept Periodont, Sch Dent Med, Sant Cugat Del Valles, Spain; [Kang, Jun] Peking Univ, Dept Periodont, Sch Stomatol, Beijing 100871, Peoples R China; [Kang, Jun] Peking Univ, Dept Periodont, Hosp Stomatol, Beijing 100871, Peoples R China; [Gluck, Kenneth; Ovaydi-Mandel, Amy; Petrov, Sophia] Univ Med & Dent New Jersey, New Jersey Dent Sch, Dept Periodont, Newark, NJ 07103 USA	University of Pennsylvania; University of Pennsylvania; Universitat Internacional de Catalunya (UIC); Peking University; Peking University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Graves, DT (corresponding author), Univ Penn, Dept Periodont, Sch Dent Med, 240 S 40th St,Levy 122, Philadelphia, PA 19104 USA.	dtgraves@dental.upenn.edu		Galicia, Johnah/0000-0003-1908-5801	U.S. National Institute of Dental and Craniofacial Research [DE018307, DE0DE17732]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE018307] Funding Source: NIH RePORTER	U.S. National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors thank Tesfahun Desta (University of Medicine and Dentistry of New Jersey) for help in the experiments and Sunitha Batchu (University of Pennsylvania School of Dental Medicine) for help in preparing the manuscript. This work was supported by the U.S. National Institute of Dental and Craniofacial Research, grants DE018307 and DE0DE17732.	Assuma R, 1998, J IMMUNOL, V160, P403; Baker PJ, 1999, INFECT IMMUN, V67, P2804, DOI 10.1128/IAI.67.6.2804-2809.1999; Chang J, 2009, NAT MED, V15, P682, DOI 10.1038/nm.1954; Delima AJ, 2002, J INFECT DIS, V186, P511, DOI 10.1086/341778; Fantuzzi F, 2008, EXPERT OPIN THER TAR, V12, P1085, DOI 10.1517/14728222.12.9.1085 ; Garlet GP, 2007, CLIN EXP IMMUNOL, V147, P128, DOI 10.1111/j.1365-2249.2006.03260.x; Garlet GP, 2010, J DENT RES, V89, P1349, DOI 10.1177/0022034510376402; Gilbert L, 2000, ENDOCRINOLOGY, V141, P3956, DOI 10.1210/en.141.11.3956; Graves DT, 2011, J DENT RES, V90, P143, DOI 10.1177/0022034510385236; Graves DT, 2008, FRONT BIOSCI-LANDMRK, V13, P1227, DOI 10.2741/2757; Graves DT, 2005, J DENT RES, V84, P324, DOI 10.1177/154405910508400406; Graves DT, 2001, J DENT RES, V80, P1875, DOI 10.1177/00220345010800100301; Guo R, 2008, J BIOL CHEM, V283, P23084, DOI 10.1074/jbc.M709848200; Han XZ, 2006, J IMMUNOL, V176, P625, DOI 10.4049/jimmunol.176.1.625; Hasturk H, 2006, FASEB J, V20, P401, DOI 10.1096/fj.05-4724fje; Hasturk H, 2007, J IMMUNOL, V179, P7021, DOI 10.4049/jimmunol.179.10.7021; HAVELL EA, 1989, J IMMUNOL, V143, P2894; Kim EY, 2006, J IMMUNOL, V176, P1026, DOI 10.4049/jimmunol.176.2.1026; Kumar PS, 2006, J CLIN MICROBIOL, V44, P3665, DOI 10.1128/JCM.00317-06; Lalla E, 2000, J CLIN INVEST, V105, P1117, DOI 10.1172/JCI8942; Lamster IB, 2008, J AM DENT ASSOC, V139, p19S, DOI 10.14219/jada.archive.2008.0363; Lencel P, 2011, BONE, V48, P242, DOI 10.1016/j.bone.2010.09.001; Liu R, 2006, J DENT RES, V85, P510, DOI 10.1177/154405910608500606; Miheller P, 2007, INFLAMM BOWEL DIS, V13, P1379, DOI 10.1002/ibd.20234; Naguib G, 2004, J INVEST DERMATOL, V123, P87, DOI 10.1111/j.0022-202X.2004.22711.x; Pacifici R, 2010, ARCH BIOCHEM BIOPHYS, V503, P41, DOI 10.1016/j.abb.2010.05.027; ROVIN SHELDON, 1966, J PERIODONTAL RES, V1, P193, DOI 10.1111/j.1600-0765.1966.tb01860.x; Salvi GE, 1997, J CLIN PERIODONTOL, V24, P8, DOI 10.1111/j.1600-051X.1997.tb01178.x; Spite M, 2010, CIRC RES, V107, P1170, DOI 10.1161/CIRCRESAHA.110.223883; Teng YTA, 2000, J CLIN INVEST, V106, pR59, DOI 10.1172/JCI10763; WILLIAMS RC, 1985, SCIENCE, V227, P640, DOI 10.1126/science.3969553; Yu H, 2011, GENE THER, V18, P344, DOI 10.1038/gt.2010.139	32	105	109	1	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2012	26	4					1423	1430		10.1096/fj.11-196279	http://dx.doi.org/10.1096/fj.11-196279			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	919VS	22179526	Green Published, Bronze			2022-12-25	WOS:000302359700005
J	Chervin-Petinot, A; Courcon, M; Almagro, S; Nicolas, A; Grichine, A; Grunwald, D; Prandini, MH; Huber, P; Gulino-Debrac, D				Chervin-Petinot, Adeline; Courcon, Marie; Almagro, Sebastien; Nicolas, Alice; Grichine, Alexei; Grunwald, Didier; Prandini, Marie-Helene; Huber, Philippe; Gulino-Debrac, Danielle			Epithelial Protein Lost In Neoplasm (EPLIN) Interacts with alpha-Catenin and Actin Filaments in Endothelial Cells and Stabilizes Vascular Capillary Network in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHERENS JUNCTIONS; BLOOD-VESSELS; CROSS-LINKING; VE-CADHERIN; COMPLEX; VINCULIN; ADHESION; TENSION; CANCER; LOCALIZATION	Adherens junctions are required for vascular endothelium integrity. These structures are formed by the clustering of the homophilic adhesive protein VE-cadherin, which recruits intracellular partners, such as beta- and alpha-catenins, vinculin, and actin filaments. The dogma according to which alpha-catenin bridges cadherin beta-catenin complexes to the actin cytoskeleton has been challenged during the past few years, and the link between the E-cadherin.catenin complex and the actin cytoskeleton remains unclear. Recently, epithelial protein lost in neoplasm (EPLIN) has been proposed as a possible bond between the VE-cadherin.catenin complex and actin in epithelial cells. Herein, we show that EPLIN is expressed at similar levels in endothelial and epithelial cells and is located at interendothelial junctions in confluent cells. Co-immunoprecipitation and GST pulldown experiments provided evidence that EPLIN interacts directly with alpha-catenin and tethers the VE-cadherin.catenin complex to the actin cytoskeleton. In the absence of EPLIN, vinculin was delocalized from the junctions. Furthermore, suppression of actomyosin tension using blebbistatin triggered a similar vinculin delocalization from the junctions. In a Matrigel assay, EPLIN-depleted endothelial cells exhibited a reduced capacity to form pseudocapillary networks because of numerous breakage events. In conclusion, we propose a model in which EPLIN establishes a link between the cadherin.catenin complex and actin that is independent of actomyosin tension. This link acts as a mechanotransmitter, allowing vinculin binding to beta-catenin and formation of a secondary molecular bond between the adherens complex and the cytoskeleton through vinculin. In addition, we provide evidence that the EPLIN clutch is necessary for stabilization of capillary structures in an angiogenesis model.	[Chervin-Petinot, Adeline; Courcon, Marie; Almagro, Sebastien; Prandini, Marie-Helene; Huber, Philippe; Gulino-Debrac, Danielle] INSERM, U882, F-38054 Grenoble, France; [Chervin-Petinot, Adeline; Courcon, Marie; Almagro, Sebastien; Grunwald, Didier; Prandini, Marie-Helene; Huber, Philippe; Gulino-Debrac, Danielle] Commissariat Energie Atom & Energies Alternat CEA, DSV, iRTSV, F-38054 Grenoble, France; [Chervin-Petinot, Adeline; Courcon, Marie; Almagro, Sebastien; Grichine, Alexei; Prandini, Marie-Helene; Huber, Philippe; Gulino-Debrac, Danielle] Univ Grenoble 1, F-38041 Grenoble, France; [Nicolas, Alice] CNRS, Lab Technol Microelect LETI, UMR5129, F-38054 Grenoble, France; [Nicolas, Alice] CEA LETI Dept Nanotec D2NT, F-38054 Grenoble, France; [Grichine, Alexei] INSERM, U823, F-38706 La Tronche, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm)	Gulino-Debrac, D (corresponding author), CEA, iRTSV, U1036, INSERM, 17 Rue Martyrs, F-38054 Grenoble 9, France.	danielle.gulino@cea.fr	Grichine, Alexei/M-3923-2013; Huber, Philippe/C-7971-2019; Grichine, Alexei/P-8377-2019	Grichine, Alexei/0000-0002-7335-9706; Huber, Philippe/0000-0002-4153-7694; Grichine, Alexei/0000-0002-7335-9706; COURCON, Marie/0000-0001-7152-1768; Nicolas, Alice/0000-0003-1758-1174				Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Almagro S, 2010, MOL CELL BIOL, V30, P1703, DOI 10.1128/MCB.01226-09; Arnaoutova I, 2009, ANGIOGENESIS, V12, P267, DOI 10.1007/s10456-009-9146-4; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Baluk P, 2005, CURR OPIN GENET DEV, V15, P102, DOI 10.1016/j.gde.2004.12.005; BREVIARIO F, 1995, ARTERIOSCL THROM VAS, V15, P1229, DOI 10.1161/01.ATV.15.8.1229; Carisey A, 2011, EUR J CELL BIOL, V90, P157, DOI 10.1016/j.ejcb.2010.06.007; Cavey M, 2008, NATURE, V453, P751, DOI 10.1038/nature06953; Chang DD, 1998, ONCOGENE, V16, P1921, DOI 10.1038/sj.onc.1201715; Chen SX, 2000, GENE, V248, P69, DOI 10.1016/S0378-1119(00)00144-X; Chircop M, 2009, CELL CYCLE, V8, P757, DOI 10.4161/cc.8.5.7878; Comunale F, 2007, BIOL CELL, V99, P503, DOI 10.1042/BC20070011; Delanoe-Ayari H, 2004, P NATL ACAD SCI USA, V101, P2229, DOI 10.1073/pnas.0304297101; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Gavard J, 2009, FEBS LETT, V583, P1, DOI 10.1016/j.febslet.2008.11.032; Han MY, 2007, MOL CELL BIOL, V27, P8190, DOI 10.1128/MCB.00661-07; Harris ES, 2010, CURR OPIN CELL BIOL, V22, P651, DOI 10.1016/j.ceb.2010.07.006; Heyraud S, 2008, MOL CELL BIOL, V28, P1657, DOI 10.1128/MCB.00695-07; Imamura Y, 1999, J CELL BIOL, V144, P1311, DOI 10.1083/jcb.144.6.1311; Jiang WG, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-71; Kiener HP, 2006, MOL BIOL CELL, V17, P2366, DOI 10.1091/mbc.E05-08-0745; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Liao F, 2002, CANCER RES, V62, P2567; Liebner S, 2006, ARTERIOSCL THROM VAS, V26, P1431, DOI 10.1161/01.ATV.0000218510.04541.5e; Liu ZJ, 2010, P NATL ACAD SCI USA, V107, P9944, DOI 10.1073/pnas.0914547107; Marie H, 2003, J BIOL CHEM, V278, P1220, DOI 10.1074/jbc.M205391200; Maruthamuthu V, 2011, P NATL ACAD SCI USA, V108, P4708, DOI 10.1073/pnas.1011123108; Maul RS, 2003, J CELL BIOL, V160, P399, DOI 10.1083/jcb.200212057; Maul RS, 1999, ONCOGENE, V18, P7838, DOI 10.1038/sj.onc.1203206; McDonald DM, 2005, CHEST, V128, p602S, DOI 10.1378/chest.128.6_suppl.602S-a; Mierke CT, 2009, CELL BIOCHEM BIOPHYS, V53, P115, DOI 10.1007/s12013-009-9047-6; Nieset JE, 1997, J CELL SCI, V110, P1013; Sanders AJ, 2010, ANGIOGENESIS, V13, P317, DOI 10.1007/s10456-010-9188-7; Shapiro L, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003053; Smutny M, 2010, J CELL BIOL, V189, P1075, DOI 10.1083/jcb.201005151; Song YH, 2002, MOL BIOL CELL, V13, P1408, DOI 10.1091/mbc.01-08-0414; Stephanou A, 2007, MICROVASC RES, V73, P182, DOI 10.1016/j.mvr.2006.12.002; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Vestweber D, 2009, TRENDS CELL BIOL, V19, P8, DOI 10.1016/j.tcb.2008.10.001; Watabe-Uchida M, 1998, J CELL BIOL, V142, P847, DOI 10.1083/jcb.142.3.847; Weiss EE, 1998, J CELL BIOL, V141, P755, DOI 10.1083/jcb.141.3.755; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Zheng Q, 2007, BIOL CELL, V99, P489, DOI 10.1042/BC20060126	47	53	54	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7556	7572		10.1074/jbc.M111.328682	http://dx.doi.org/10.1074/jbc.M111.328682			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22194609	Green Published, hybrid			2022-12-25	WOS:000301060200056
J	Boulay, G; Malaquin, N; Loison, I; Foveau, B; Van Rechem, C; Rood, BR; Pourtier, A; Leprince, D				Boulay, Gaylor; Malaquin, Nicolas; Loison, Ingrid; Foveau, Benedicte; Van Rechem, Capucine; Rood, Brian R.; Pourtier, Albin; Leprince, Dominique			Loss of Hypermethylated in Cancer 1 (HIC1) in Breast Cancer Cells Contributes to Stress-induced Migration and Invasion through beta-2 Adrenergic Receptor (ADRB2) Misregulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; BETA(2)-ADRENERGIC RECEPTOR; TRANSCRIPTIONAL REPRESSION; CARCINOMA-CELLS; BETA-BLOCKERS; CYCLIC-AMP; EXPRESSION; MOTIF; METHYLATION; METASTASIS	The transcriptional repressor HIC1 (Hypermethylated in Cancer 1) is a tumor suppressor gene inactivated in many human cancers including breast carcinomas. In this study, we show that HIC1 is a direct transcriptional repressor of beta-2 adrenergic receptor (ADRB2). Through promoter luciferase activity, chromatin immunoprecipitation (ChIP) and sequential ChIP experiments, we demonstrate that ADRB2 is a direct target gene of HIC1, endogenously in WI-38 cells and following HIC1 re-expression in breast cancer cells. Agonist-mediated stimulation of ADRB2 increases the migration and invasion of highly malignant MDA-MB-231 breast cancer cells but these effects are abolished following HIC1 re-expression or specific down-regulation of ADRB2 by siRNA treatment. Our results suggest that early inactivation of HIC1 in breast carcinomas could predispose to stress-induced metastasis through up-regulation of the beta-2 adrenergic receptor.	[Boulay, Gaylor; Malaquin, Nicolas; Loison, Ingrid; Foveau, Benedicte; Van Rechem, Capucine; Pourtier, Albin; Leprince, Dominique] Univ Lille 2, Univ Lille 1, CNRS, UMR 8161,Inst Biol Lille,Inst Pasteur Lille, F-590213 Lille, France; [Rood, Brian R.] George Washington Univ, Childrens Natl Med Ctr, Sch Med, Washington, DC 20010 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Children's National Health System; George Washington University	Leprince, D (corresponding author), Univ Lille 2, Univ Lille 1, CNRS, UMR 8161,Inst Biol Lille,Inst Pasteur Lille, BP 447, F-590213 Lille, France.	dominique.leprince@ibl.fr	POURTIER, ALBIN/G-7401-2012	POURTIER, ALBIN/0000-0002-1576-3946; Leprince, Dominique/0000-0002-1999-0775; Malaquin, Nicolas/0000-0002-1227-6341; Van Rechem, Capucine/0000-0002-5408-6124	National Institutes of Health/NINDS [1K08NS051477]; Centre National de la Recherche Scientifique (CNRS); Pasteur Institute of Lille; Ligue Nationale contre le Cancer (Comite Interregional du Septentrion); Association for International Cancer Research (AICR); Association pour la Recherche contre le Cancer (ARC) [ARC 3983, ARC 1081]; CNRS/Region Nord-Pas de Calais; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS051477] Funding Source: NIH RePORTER	National Institutes of Health/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Pasteur Institute of Lille; Ligue Nationale contre le Cancer (Comite Interregional du Septentrion); Association for International Cancer Research (AICR); Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); CNRS/Region Nord-Pas de Calais(Region Hauts-de-FranceCentre National de la Recherche Scientifique (CNRS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health/NINDS Grant 1K08NS051477. This work was also supported by the Centre National de la Recherche Scientifique (CNRS), the Pasteur Institute of Lille, the Ligue Nationale contre le Cancer (Comite Interregional du Septentrion), the Association for International Cancer Research (AICR), and the Association pour la Recherche contre le Cancer (ARC) (Grant Numbers ARC 3983 and ARC 1081, to D. L.).; Supported by fellowships from the CNRS/Region Nord-Pas de Calais.	Briggs KJ, 2008, GENE DEV, V22, P770, DOI 10.1101/gad.1640908; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Dahl JA, 2007, STEM CELLS, V25, P1037, DOI 10.1634/stemcells.2006-0430; Deltour S, 2002, MOL CELL BIOL, V22, P4890, DOI 10.1128/MCB.22.13.4890-4901.2002; Du T, 2010, J NEUROCHEM, V115, P1007, DOI 10.1111/j.1471-4159.2010.06995.x; EDWARDS JG, 1993, J CELL SCI, V104, P399; EMORINE LJ, 1987, P NATL ACAD SCI USA, V84, P6995, DOI 10.1073/pnas.84.20.6995; Fleuriel C, 2009, INT J BIOCHEM CELL B, V41, P26, DOI 10.1016/j.biocel.2008.05.028; Foveau B, 2012, J BIOL CHEM, V287, P5366, DOI 10.1074/jbc.M111.329466; Fujii H, 1998, ONCOGENE, V16, P2159, DOI 10.1038/sj.onc.1201976; Guo K, 2009, ONCOL REP, V22, P825, DOI 10.3892/or_00000505; Lang K, 2004, INT J CANCER, V112, P231, DOI 10.1002/ijc.20410; Martin P, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-4; Masur K, 2001, CANCER RES, V61, P2866; Mohammad HP, 2011, ONCOGENE, V30, P2659, DOI 10.1038/onc.2010.633; Nicoll G, 2001, BRIT J CANCER, V85, P1878, DOI 10.1054/bjoc.2001.2163; Palm D, 2006, INT J CANCER, V118, P2744, DOI 10.1002/ijc.21723; Parrella P, 2005, CANCER LETT, V222, P75, DOI 10.1016/j.canlet.2004.08.026; Pinte S, 2004, J BIOL CHEM, V279, P38313, DOI 10.1074/jbc.M401610200; Powe DG, 2010, ONCOTARGET, V1, P628, DOI 10.18632/oncotarget.197; Rangarajan S, 2003, J CELL BIOL, V160, P487, DOI 10.1083/jcb.200209105; Shahzad MMK, 2010, J BIOL CHEM, V285, P35462, DOI 10.1074/jbc.M110.109579; Slotkin TA, 2000, BREAST CANCER RES TR, V60, P153, DOI 10.1023/A:1006338232150; Sood AK, 2006, CLIN CANCER RES, V12, P369, DOI 10.1158/1078-0432.CCR-05-1698; Stankovic-Valentin N, 2007, MOL CELL BIOL, V27, P2661, DOI 10.1128/MCB.01098-06; Thaker PH, 2007, CELL CYCLE, V6, P430, DOI 10.4161/cc.6.4.3829; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Van Rechem C, 2010, MOL CELL BIOL, V30, P4045, DOI 10.1128/MCB.00582-09; Van Rechem C, 2009, J BIOL CHEM, V284, P20927, DOI 10.1074/jbc.M109.022350; Van Rechem C, 2009, BIOCHEM BIOPH RES CO, V385, P586, DOI 10.1016/j.bbrc.2009.05.115; Vilgelm AE, 2010, ONCOGENE, V29, P5861, DOI 10.1038/onc.2010.319; Violin JD, 2008, J BIOL CHEM, V283, P2949, DOI 10.1074/jbc.M707009200; WALES MM, 1995, NAT MED, V1, P570, DOI 10.1038/nm0695-570; Zhang W, 2010, ONCOGENE, V29, P2467, DOI 10.1038/onc.2010.12	34	27	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5379	5389		10.1074/jbc.M111.304287	http://dx.doi.org/10.1074/jbc.M111.304287			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22194601	hybrid, Green Published			2022-12-25	WOS:000300638000019
J	Chang, YC; Wu, CH; Yen, TC; Ouyang, P				Chang, Yu-Chen; Wu, Chu-Hen; Yen, Tzu-Chen; Ouyang, Pin			Centrosomal Protein 55 (Cep55) Stability Is Negatively Regulated by p53 Protein through Polo-like Kinase 1 (Plk1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SQUAMOUS-CELL CARCINOMA; PLK1-DEPENDENT PHOSPHORYLATION; TUMOR SUPPRESSION; DNA-DAMAGE; CYTOKINESIS; MIDBODY; CANCER; EXPRESSION; FOXM1; ESCRT	Centrosomal protein 55 (Cep55), which is localized to the centrosome in interphase cells and recruited to the midbody during cytokinesis, is a regulator required for the completion of cell abscission. Up-regulation of Cep55 and inactivation of p53 occur in the majority of human cancers, raising the possibility of a link between these two genes. In this study we evaluated the role of p53 in Cep55 regulation. We demonstrated that Cep55 expression levels are well correlated with cancer cell growth rate and that p53 is able to negatively regulate Cep55 protein and promoter activity. Down-regulation of expression of Cep55 was accompanied by repression of polo-like kinase 1 (Plk1) levels due to p53 induction. Overexpression of Plk1 and knockdown of p53 expression both enhanced the post-translational protein stability of Cep55. BI 2356, a selective Plk1 inhibitor, however, prevented Cep55 accumulation in p53 knockdown cells while persistently keeping Plk1 levels elevated. Our results, therefore, indicate the existence of a p53-Plk1-Cep55 axis in which p53 negatively regulates expression of Cep55, through Plk1 which, in turn, is a positive regulator of Cep55 protein stability.	[Wu, Chu-Hen; Ouyang, Pin] Chang Gung Univ, Dept Anat, Tao Yuan 333, Taiwan; [Chang, Yu-Chen] Chang Gung Mem Hosp, Grad Inst Clin Med Sci, Coll Med, Tao Yuan 333, Taiwan; [Chang, Yu-Chen; Yen, Tzu-Chen] Chang Gung Mem Hosp, Dept Nucl Med, Tao Yuan 333, Taiwan; [Chang, Yu-Chen; Yen, Tzu-Chen] Chang Gung Mem Hosp, Mol Imaging Ctr, Tao Yuan 333, Taiwan; [Wu, Chu-Hen; Ouyang, Pin] Chang Gung Univ, Mol Med Res Ctr, Tao Yuan 333, Taiwan; [Ouyang, Pin] Chang Gung Univ, Transgen Mouse Core Lab, Tao Yuan 333, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Ouyang, P (corresponding author), Chang Gung Univ, Dept Anat, 259 Wen Hwa 1st Rd, Tao Yuan 333, Taiwan.	ouyang@mail.cgu.edu.tw			Chang Gung Memorial Hospital [CMRPD170073]; Ministry of Education (Tope Center) [EMRPD190481]; National Science Council, Taiwan [NSC-98-2320-B-182-019-MY3]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Ministry of Education (Tope Center); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by Chang Gung Memorial Hospital Grant CMRPD170073, the Ministry of Education (Tope Center Grant EMRPD190481), and National Science Council, Taiwan Grant NSC-98-2320-B-182-019-MY3.	Bartek J, 2001, NAT REV MOL CELL BIO, V2, P877, DOI 10.1038/35103059; Bartek J, 2001, CURR OPIN CELL BIOL, V13, P738, DOI 10.1016/S0955-0674(00)00280-5; Bastos RN, 2010, J CELL BIOL, V191, P751, DOI 10.1083/jcb.201008108; Bohlig L, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/464916; Carlton JG, 2008, P NATL ACAD SCI USA, V105, P10541, DOI 10.1073/pnas.0802008105; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Chang YC, 2010, J CELL BIOCHEM, V109, P1274, DOI 10.1002/jcb.22517; Chen CH, 2007, ONCOGENE, V26, P4272, DOI 10.1038/sj.onc.1210207; Chen CH, 2009, ONCOGENE, V28, P2723, DOI 10.1038/onc.2009.128; Chen CH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005052; Chopra P, 2010, EXPERT OPIN INV DRUG, V19, P27, DOI 10.1517/13543780903483191; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; Doxsey SJ, 2005, MOL CELL, V20, P170, DOI 10.1016/j.molcel.2005.10.010; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fabbro M, 2005, DEV CELL, V9, P477, DOI 10.1016/j.devcel.2005.09.003; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; Gemenetzidis E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004849; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Inoda S, 2011, AM J PATHOL, V178, P1805, DOI 10.1016/j.ajpath.2011.01.004; Inoda S, 2011, EXP MOL PATHOL, V90, P55, DOI 10.1016/j.yexmp.2010.10.001; Inoda S, 2009, J IMMUNOTHER, V32, P474, DOI 10.1097/CJI.0b013e3181a1d109; Kho PS, 2004, J BIOL CHEM, V279, P21183, DOI 10.1074/jbc.M311912200; Kneisel L, 2002, J CUTAN PATHOL, V29, P354, DOI 10.1034/j.1600-0560.2002.290605.x; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Martinez-Garay I, 2006, GENOMICS, V87, P243, DOI 10.1016/j.ygeno.2005.11.006; McKenzie L, 2010, CELL CYCLE, V9, P4200, DOI 10.4161/cc.9.20.13532; Montoya M, 2007, NAT STRUCT MOL BIOL, V14, P579, DOI 10.1038/nsmb0707-579; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Muller PAJ, 2011, J CELL BIOL, V192, P209, DOI 10.1083/jcb.201009059; Mundt KE, 1997, BIOCHEM BIOPH RES CO, V239, P377, DOI 10.1006/bbrc.1997.7378; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Pandit B, 2009, CELL CYCLE, V8, P3425, DOI 10.4161/cc.8.20.9628; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Plyte S, 2007, CURR BIOL, V17, pR280, DOI 10.1016/j.cub.2007.02.018; Prives C, 1999, J PATHOL, V187, P112; Rozan LM, 2007, CELL DEATH DIFFER, V14, P3, DOI 10.1038/sj.cdd.4402058; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Sakai M, 2006, ONCOGENE, V25, P480, DOI 10.1038/sj.onc.1209051; Schoffski P, 2009, ONCOLOGIST, V14, P559, DOI 10.1634/theoncologist.2009-0010; Sionov RV, 1999, ONCOGENE, V18, P6145, DOI 10.1038/sj.onc.1203130; Soussi T, 2001, NAT REV CANCER, V1, P233, DOI 10.1038/35106009; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Sur S, 2009, P NATL ACAD SCI USA, V106, P3964, DOI 10.1073/pnas.0813333106; Takaki T, 2008, CURR OPIN CELL BIOL, V20, P650, DOI 10.1016/j.ceb.2008.10.005; van de Weerdt BCM, 2006, CELL CYCLE, V5, P853, DOI 10.4161/cc.5.8.2692; van der Horst A, 2009, CELL CYCLE, V8, P3742, DOI 10.4161/cc.8.22.10047; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wasch R, 2010, RECENT RESULTS CANC, V184, P215, DOI 10.1007/978-3-642-01222-8_15; Weichert W, 2004, BRIT J CANCER, V90, P815, DOI 10.1038/sj.bjc.6601610; Weichert W, 2004, PROSTATE, V60, P240, DOI 10.1002/pros.20050; Yu J, 2003, CANCER CELL, V4, P248, DOI 10.1016/S1535-6108(03)00249-6; Zhao WM, 2006, MOL BIOL CELL, V17, P3881, DOI 10.1091/mbc.E06-01-0015	56	23	24	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4376	4385		10.1074/jbc.M111.289108	http://dx.doi.org/10.1074/jbc.M111.289108			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22184120	Green Published, hybrid			2022-12-25	WOS:000300410900068
J	Chen, M; Wang, K; Zhang, L; Li, C; Yang, YL				Chen, Min; Wang, Kai; Zhang, Liang; Li, Cheng; Yang, Yongliang			The Discovery of Putative Urine Markers for the Specific Detection of Prostate Tumor by Integrative Mining of Public Genomic Profiles	PLOS ONE			English	Article							CANCER; EXPRESSION; BIOMARKERS; NETWORKS; PROGRESSION; DATABASE	Urine has emerged as an attractive biofluid for the noninvasive detection of prostate cancer (PCa). There is a strong imperative to discover candidate urinary markers for the clinical diagnosis and prognosis of PCa. The rising flood of various omics profiles presents immense opportunities for the identification of prospective biomarkers. Here we present a simple and efficient strategy to derive candidate urine markers for prostate tumor by mining cancer genomic profiles from public databases. Prostate, bladder and kidney are three major tissues from which cellular matters could be released into urine. To identify urinary markers specific for PCa, upregulated entities that might be shed in exosomes of bladder cancer and kidney cancer are first excluded. Through the ontology-based filtering and further assessment, a reduced list of 19 entities encoding urinary proteins was derived as putative PCa markers. Among them, we have found 10 entities closely associated with the process of tumor cell growth and development by pathway enrichment analysis. Further, using the 10 entities as seeds, we have constructed a protein-protein interaction (PPI) subnetwork and suggested a few urine markers as preferred prognostic markers to monitor the invasion and progression of PCa. Our approach is amenable to discover and prioritize potential markers present in a variety of body fluids for a spectrum of human diseases.	[Chen, Min; Zhang, Liang; Yang, Yongliang] Dalian Univ Technol, Sch Life Sci & Biotechnol, Ctr Mol Med, Dalian, Peoples R China; [Wang, Kai; Li, Cheng] Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Chen, Min; Zhang, Liang] Dalian Univ Technol, Sch Software, Dalian, Peoples R China	Dalian University of Technology; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; Dalian University of Technology	Chen, M (corresponding author), Dalian Univ Technol, Sch Life Sci & Biotechnol, Ctr Mol Med, Dalian, Peoples R China.	cli@hsph.harvard.edu; everbright99@gmail.com			Fundamental Research Funds for the Central Universities [DUT11SM12]; National Science Foundation in China; Medical Board Oncology Department [81000975]; National Institute of Health [R01 GM077122]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077122] Funding Source: NIH RePORTER	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Science Foundation in China(National Natural Science Foundation of China (NSFC)); Medical Board Oncology Department; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work in the Y. Yang laboratory was supported by the Fundamental Research Funds for the Central Universities (grant: DUT11SM12) and National Science Foundation in China, Medical Board Oncology Department (grant: 81000975); K. Wang and C. Li were supported by National Institute of Health grant R01 GM077122 (to C. Li). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASPINALL JO, 1995, J UROLOGY, V154, P622, DOI 10.1016/S0022-5347(01)67123-4; Bensalah K, 2008, PROSTATE CANCER P D, V11, P112, DOI 10.1038/sj.pcan.4501026; Bredel M, 2009, JAMA-J AM MED ASSOC, V302, P261, DOI 10.1001/jama.2009.997; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Downes MR, 2007, BJU INT, V99, P263, DOI 10.1111/j.1464-410X.2006.06610.x; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gnad F, 2009, NUCLEIC ACIDS RES, V37, pD902, DOI 10.1093/nar/gkn773; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Huss WJ, 2001, CANCER RES, V61, P2736; Ilan N, 2003, CURR OPIN CELL BIOL, V15, P515, DOI 10.1016/S0955-0674(03)00100-5; Jemal A, 2003, CA-CANCER J CLIN, V53, P5, DOI 10.3322/canjclin.53.1.5; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kentsis A, 2010, ANN EMERG MED, V55, P62, DOI 10.1016/j.annemergmed.2009.04.020; Kim B, 2007, CANCER RES, V67, P7431, DOI 10.1158/0008-5472.CAN-07-0003; Li SJ, 2009, NUCLEIC ACIDS RES, V37, pD907, DOI 10.1093/nar/gkn849; Muller H, 2006, CLIN CHEM, V52, P562, DOI 10.1373/clinchem.2005.062919; Newman M., 2010, NETWORKS INTRO, P720; Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9; Parkinson H, 2007, NUCLEIC ACIDS RES, V35, pD747, DOI 10.1093/nar/gkl995; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Sardana G, 2007, CLIN CHEM, V53, P429, DOI 10.1373/clinchem.2006.077370; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang Y, 2009, AM J PATHOL, V174, P1515, DOI 10.2353/ajpath.2009.080816; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Yang YL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003661; Yang YL, 2009, DRUG DISCOV TODAY, V14, P147, DOI 10.1016/j.drudis.2008.12.005; Yongliang YS, 2010, EXPERT REV MOL DIAGN, V10, P65, DOI [10.1586/ERM.09.73, 10.1586/erm.09.73]	29	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2011	6	12							e28552	10.1371/journal.pone.0028552	http://dx.doi.org/10.1371/journal.pone.0028552			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JD	22194848	Green Submitted, Green Published, gold			2022-12-25	WOS:000298664400007
J	Malek, JA; Mery, E; Mahmoud, YA; Al-Azwani, EK; Roger, L; Huang, R; Jouve, E; Lis, R; Thiery, JP; Querleu, D; Rafii, A				Malek, Joel A.; Mery, Eliane; Mahmoud, Yasmin A.; Al-Azwani, Eman K.; Roger, Laurence; Huang, Ruby; Jouve, Eva; Lis, Raphael; Thiery, Jean-Paul; Querleu, Denis; Rafii, Arash			Copy Number Variation Analysis of Matched Ovarian Primary Tumors and Peritoneal Metastasis	PLOS ONE			English	Article							GENE-EXPRESSION; CANCER; CARCINOMAS; CHEMOKINE; PROFILES	Ovarian cancer is the most deadly gynecological cancer. The high rate of mortality is due to the large tumor burden with extensive metastatic lesion of the abdominal cavity. Despite initial chemosensitivity and improved surgical procedures, abdominal recurrence remains an issue and results in patients' poor prognosis. Transcriptomic and genetic studies have revealed significant genome pathologies in the primary tumors and yielded important information regarding carcinogenesis. There are, however, few studies on genetic alterations and their consequences in peritoneal metastatic tumors when compared to their matched ovarian primary tumors. We used high-density SNP arrays to investigate copy number variations in matched primary and metastatic ovarian cancer from 9 patients. Here we show that copy number variations acquired by ovarian tumors are significantly different between matched primary and metastatic tumors and these are likely due to different functional requirements. We show that these copy number variations clearly differentially affect specific pathways including the JAK/STAT and cytokine signaling pathways. While many have shown complex involvement of cytokines in the ovarian cancer environment we provide evidence that ovarian tumors have specific copy number variation differences in many of these genes.	[Malek, Joel A.; Lis, Raphael; Rafii, Arash] Qatar Fdn, Weill Cornell Med Coll Qatar, Stem Cell & Microenvironm Lab, Doha, Qatar; [Mery, Eliane; Roger, Laurence; Jouve, Eva; Querleu, Denis] Inst Claudius Regaud, Toulouse, France; [Huang, Ruby] Natl Univ Singapore, Dept Obstet & Gynecol, Singapore 117548, Singapore; [Huang, Ruby] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Thiery, Jean-Paul] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore; [Querleu, Denis] McGill Univ, Montreal, PQ, Canada; [Rafii, Arash] Weill Cornell Med Coll, Dept Med Genet, New York, NY USA	Qatar Foundation (QF); Weill Cornell Medical College Qatar; UNICANCER; Institut Claudius Regaud; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); McGill University; Cornell University	Malek, JA (corresponding author), Qatar Fdn, Weill Cornell Med Coll Qatar, Stem Cell & Microenvironm Lab, Doha, Qatar.	jat2021@qatar-med.cornell.edu	Huang, Ruby Yun-Ju/AAE-8854-2019; Mery-Lamarche, Eliane/P-2795-2014; Rafii, Arash/E-4106-2013; Thiery, Jean Paul/M-9387-2019; Thiery, Jean Paul/H-1550-2011	Huang, Ruby Yun-Ju/0000-0001-6376-3185; Mery-Lamarche, Eliane/0000-0002-0354-4519; Thiery, Jean Paul/0000-0003-0478-5020	National Priorities Research Program [NPRP09-1174-3-291, NPRP 4-640-1-096]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000130] Funding Source: NIH RePORTER	National Priorities Research Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This publication was made possible by a grant from the Qatar National Research Fund under its National Priorities Research Program award number NPRP09-1174-3-291 and NPRP 4-640-1-096. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Qatar National Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold JM, 2005, BRIT J CANCER, V92, P2024, DOI 10.1038/sj.bjc.6602596; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berchuck A, 2004, AM J OBSTET GYNECOL, V190, P910, DOI 10.1016/j.ajog.2004.02.005; Berchuck A, 2005, CLIN CANCER RES, V11, P3686, DOI 10.1158/1078-0432.CCR-04-2398; Bindea G, 2011, SEMIN IMMUNOPATHOL, V33, P335, DOI 10.1007/s00281-011-0264-x; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Colomiere M, 2009, BRIT J CANCER, V100, P134, DOI 10.1038/sj.bjc.6604794; Dressman HK, 2007, J CLIN ONCOL, V25, P517, DOI 10.1200/JCO.2006.06.3743; Etemadmoghadam D, 2009, CLIN CANCER RES, V15, P1417, DOI 10.1158/1078-0432.CCR-08-1564; Gorringe KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011408; Grayson BL, 2011, BIODATA MIN, V4, DOI 10.1186/1756-0381-4-8; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Khalique L, 2009, INT J CANCER, V124, P1579, DOI 10.1002/ijc.24148; Meinhold-Heerlein I, 2007, CLIN CANCER RES, V13, P458, DOI 10.1158/1078-0432.CCR-06-0691; Mlecnik B, 2011, CANCER METAST REV, V30, P5, DOI 10.1007/s10555-011-9270-7; Nakayama K, 2007, INT J CANCER, V120, P2613, DOI 10.1002/ijc.22609; Nelson BH, 2008, IMMUNOL REV, V222, P101, DOI 10.1111/j.1600-065X.2008.00614.x; Pinto D, 2011, NAT BIOTECHNOL, V29, P512, DOI 10.1038/nbt.1852; Poplawski AB, 2010, EUR J HUM GENET, V18, P560, DOI 10.1038/ejhg.2009.230; Scotton C, 2001, BRIT J CANCER, V85, P891, DOI 10.1054/bjoc.2001.2020; Scotton CJ, 2002, CANCER RES, V62, P5930; Seo JH, 2010, CANCER LETT, V288, P50, DOI 10.1016/j.canlet.2009.06.023; Seruga B, 2008, NAT REV CANCER, V8, P887, DOI 10.1038/nrc2507; Spentzos D, 2004, J CLIN ONCOL, V22, P4700, DOI 10.1200/JCO.2004.04.070; Yoshida S, 2009, INT J GYNECOL CANCER, V19, P992, DOI 10.1111/IGC.0b013e3181aaa93a	26	35	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28561	10.1371/journal.pone.0028561	http://dx.doi.org/10.1371/journal.pone.0028561			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194851	Green Published, Green Submitted, gold			2022-12-25	WOS:000298369100051
J	Augustinos, AA; Santos-Garcia, D; Dionyssopoulou, E; Moreira, M; Papapanagiotou, A; Scarvelakis, M; Doudoumis, V; Ramos, S; Aguiar, AF; Borges, PAV; Khadem, M; Latorre, A; Tsiamis, G; Bourtzis, K				Augustinos, Antonis A.; Santos-Garcia, Diego; Dionyssopoulou, Eva; Moreira, Marta; Papapanagiotou, Aristeidis; Scarvelakis, Marios; Doudoumis, Vangelis; Ramos, Silvia; Aguiar, Antonio F.; Borges, Paulo A. V.; Khadem, Manhaz; Latorre, Amparo; Tsiamis, George; Bourtzis, Kostas			Detection and Characterization of Wolbachia Infections in Natural Populations of Aphids: Is the Hidden Diversity Fully Unraveled?	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; LIFE-SHORTENING WOLBACHIA; BACTERIAL ENDOSYMBIONTS; CYTOPLASMIC INCOMPATIBILITY; FACULTATIVE SYMBIONTS; PHYLOGENETIC ANALYSIS; BUCHNERA-APHIDICOLA; CULEX-PIPIENS; TYPING SYSTEM; PEA APHID	Aphids are a serious threat to agriculture, despite being a rather small group of insects. The about 4,000 species worldwide engage in highly interesting and complex relationships with their microbial fauna. One of the key symbionts in arthropods is Wolbachia, an alpha-Proteobacterium implicated in many important biological processes and believed to be a potential tool for biological control. Aphids were thought not to harbour Wolbachia; however, current data suggest that its presence in aphids has been missed, probably due to the low titre of the infection and/or to the high divergence of the Wolbachia strains of aphids. The goal of the present study is to map the Wolbachia infection status of natural aphids populations, along with the characterization of the detected Wolbachia strains. Out of 425 samples from Spain, Portugal, Greece, Israel and Iran, 37 were found to be infected. Our results, based mainly on 16S rRNA gene sequencing, indicate the presence of two new Wolbachia supergroups prevailing in aphids, along with some strains belonging either to supergroup B or to supergroup A.	[Augustinos, Antonis A.; Dionyssopoulou, Eva; Scarvelakis, Marios; Doudoumis, Vangelis; Tsiamis, George; Bourtzis, Kostas] Univ Ioannina, Dept Environm & Nat Resources Management, Agrinion, Greece; [Santos-Garcia, Diego; Ramos, Silvia; Latorre, Amparo] Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, Valencia, Spain; [Moreira, Marta; Khadem, Manhaz] Univ Madeira, ISOPlexis Gene Bank, Funchal, Portugal; [Papapanagiotou, Aristeidis] Technol Educ Inst Messolonghi, Dept Greenhouse Crops & Floriculture, Mesolongion, Greece; [Aguiar, Antonio F.] Nucleo Fitopatol, Lab Qualidade Agr, Madeira, Portugal; [Borges, Paulo A. V.] Univ Acores, Azorean Biodivers Grp, Dept Ciencias Agr CITA A, Angra Do Heroismo, Terceira Azores, Portugal; [Latorre, Amparo] CSISP, Area Genom & Salud, Valencia, Spain; [Bourtzis, Kostas] Biomed Sci Res Ctr, Vari, Greece; [Augustinos, Antonis A.; Dionyssopoulou, Eva; Doudoumis, Vangelis; Tsiamis, George] Univ Western Greece, Dept Environm & Nat Resources Management, Agrinion, Greece	University of Ioannina; University of Valencia; Universidade da Madeira; Western Greece University of Applied Sciences (TEI of Western Greece); Universidade dos Acores	Augustinos, AA (corresponding author), Univ Ioannina, Dept Environm & Nat Resources Management, Agrinion, Greece.	kbourtz@uoi.gr	Augustinos, Antonios/C-1318-2019; Borges, Paulo/B-2780-2008; Borges, Paulo/H-5153-2019; Aguiar, Antonio/GQC-6073-2022; Latorre, Amparo/E-4997-2015; Aguiar, António/ACZ-6595-2022; Santos-Garcia, Diego/N-9032-2017	Augustinos, Antonios/0000-0003-3682-6077; Borges, Paulo/0000-0002-8448-7623; Borges, Paulo/0000-0002-8448-7623; Aguiar, Antonio/0000-0002-9572-2967; Latorre, Amparo/0000-0002-9146-7284; Aguiar, António/0000-0002-9572-2967; Santos-Garcia, Diego/0000-0002-3401-2662	European Community [203590]; Ministerio de Ciencia e Innovacion-Spain [BFU2009-12895-C02-01]; Foundation for Science and Technology-Portugal [FCT-PTDC/AGR-AAM/108312/2008]; EU [FA0701]	European Community(European Commission); Ministerio de Ciencia e Innovacion-Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Foundation for Science and Technology-Portugal(Portuguese Foundation for Science and Technology); EU(European Commission)	This research was supported in part by the European Community's Seventh Framework Programme CSA-SA_ REGPROT-2007-1 under grant agreement no 203590 (KB), Project BFU2009-12895-C02-01 from the Ministerio de Ciencia e Innovacion-Spain (AL) and Project FCT-PTDC/AGR-AAM/108312/2008 by Foundation for Science and Technology-Portugal (MK). MM and VD received a travel grant from EU COST Action FA0701 "Arthropod Symbiosis: from fundamental studies to pest and disease management''. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUIAR FM, 2001, B SANIDADE VEGETAL P, V27, P323; Apostolaki A, 2011, J APPL ENTOMOL, V135, P546, DOI 10.1111/j.1439-0418.2011.01614.x; Arthofer W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022198; Arthofer W, 2009, MOL ECOL, V18, P3816, DOI 10.1111/j.1365-294X.2009.04321.x; Baldo L, 2007, CURR MICROBIOL, V55, P367, DOI 10.1007/s00284-007-9009-4; Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Bandi C, 1998, P ROY SOC B-BIOL SCI, V265, P2407, DOI 10.1098/rspb.1998.0591; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; Blackman R.L., 1984, APHIDS WORLDS CROPS; Blackman RL, 2000, APHIDS WORLDS CROPS, V2nd, DOI 10.1016/0261-2194(96)89825-5; Bordenstein S, 2005, CURR MICROBIOL, V51, P393, DOI 10.1007/s00284-005-0084-0; Bourtzis K, 1998, NATURE, V391, P852, DOI 10.1038/36017; Bourtzis K., 2006, INSECT SYMBIOSIS VOL, V2, P225, DOI DOI 10.1201/9781420005936.CH14; Bourtzis K, 2008, ADV EXP MED BIOL, V627, P104, DOI 10.1007/978-0-387-78225-6_9; Brault V, 2010, J GEN VIROL, V91, P802, DOI 10.1099/vir.0.012856-0; Breeuwer J.A.J., 1992, Insect Molecular Biology, V1, P25, DOI 10.1111/j.1365-2583.1993.tb00074.x; Brinza L, 2009, CR BIOL, V332, P1034, DOI 10.1016/j.crvi.2009.09.007; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL; Burke GR, 2009, APPL ENVIRON MICROB, V75, P5328, DOI 10.1128/AEM.00717-09; Casiraghi M, 2005, MICROBIOL-SGM, V151, P4015, DOI 10.1099/mic.0.28313-0; Cook PE, 2010, TRENDS PARASITOL, V26, P373, DOI 10.1016/j.pt.2010.05.006; Degnan PH, 2010, ENVIRON MICROBIOL, V12, P2060, DOI 10.1111/j.1462-2920.2009.02085.x; Degnan PH, 2009, P NATL ACAD SCI USA, V106, P9063, DOI 10.1073/pnas.0900194106; DIXON AFG, 1987, AM NAT, V129, P580, DOI 10.1086/284659; Dobson SL, 2002, APPL ENVIRON MICROB, V68, P656, DOI 10.1128/AEM.68.2.656-660.2002; DOUDOUMIS V, 2011, BMC MICROBI IN PRESS; Douglas AE, 1997, FEMS MICROBIOL ECOL, V24, P1, DOI 10.1111/j.1574-6941.1997.tb00418.x; Douglas AE, 2006, J EXP BOT, V57, P747, DOI 10.1093/jxb/erj067; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Dunn AK, 2005, APPL ENVIRON MICROB, V71, P8784, DOI 10.1128/AEM.71.12.8784-8794.2005; Duron O, 2005, MOL ECOL, V14, P1561, DOI 10.1111/j.1365-294X.2005.02495.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fenn K, 2006, PLOS PATHOG, V2, P887, DOI 10.1371/journal.ppat.0020094; Ferri E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020843; Glaser RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011977; Gomez-Valero L, 2004, J BACTERIOL, V186, P6626, DOI 10.1128/JB.186.19.6626-6633.2004; Gosalbes MJ, 2008, J BACTERIOL, V190, P6026, DOI 10.1128/JB.00525-08; Haegeman A, 2009, INT J PARASITOL, V39, P1045, DOI 10.1016/j.ijpara.2009.01.006; Hancock PA, 2011, AM NAT, V177, P323, DOI 10.1086/658121; Hanner R, 1997, J CRUSTACEAN BIOL, V17, P174, DOI 10.2307/1549471; Hartley J.L., 2003, FOCUS, V25, P18; Heath L, 2006, J VIROL, V80, P11827, DOI 10.1128/JVI.01100-06; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; HEIE OE, 2004, HIST STUDIES APHID P; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Hosokawa T, 2010, P NATL ACAD SCI USA, V107, P769, DOI 10.1073/pnas.0911476107; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531; Kikuchi Y, 2003, APPL ENVIRON MICROB, V69, P6082, DOI 10.1128/AEM.69.10.6082-6090.2003; Kondo N, 2005, BIOL LETTERS, V1, P488, DOI 10.1098/rsbl.2005.0340; Kondo N, 2002, P NATL ACAD SCI USA, V99, P14280, DOI 10.1073/pnas.222228199; Lamelas A, 2011, APPL ENVIRON MICROB, V77, P4446, DOI 10.1128/AEM.00141-11; LATORRE A, 1986, P NATL ACAD SCI USA, V83, P8649, DOI 10.1073/pnas.83.22.8649; LAVEN H, 1967, NATURE, V216, P383, DOI 10.1038/216383a0; Li ZX, 2007, CURR MICROBIOL, V54, P467, DOI 10.1007/s00284-007-0011-7; Li ZX, 2005, EUR J ENTOMOL, V102, P293, DOI 10.14411/eje.2005.041; Lo N, 2007, INT J SYST EVOL MICR, V57, P654, DOI 10.1099/ijs.0.64515-0; Lo N, 2002, MOL BIOL EVOL, V19, P341, DOI 10.1093/oxfordjournals.molbev.a004087; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; McNulty SN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011029; Miller WJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001214; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Moran NA, 2005, P NATL ACAD SCI USA, V102, P16919, DOI 10.1073/pnas.0507029102; Moran NA, 2010, SCIENCE, V328, P624, DOI 10.1126/science.1187113; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Mouton L, 2003, MOL ECOL, V12, P3459, DOI 10.1046/j.1365-294X.2003.02015.x; Moya A, 2008, NAT REV GENET, V9, P218, DOI 10.1038/nrg2319; Nikoh N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000827; Nirgianaki A, 2003, CURR MICROBIOL, V47, P93, DOI 10.1007/s00284-002-3969-1; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Oliver KM, 2005, P NATL ACAD SCI USA, V102, P12795, DOI 10.1073/pnas.0506131102; ONEILL SL, 1992, P NATL ACAD SCI USA, V89, P2699, DOI 10.1073/pnas.89.7.2699; Ortiz-Rivas B, 2010, MOL PHYLOGENET EVOL, V55, P305, DOI 10.1016/j.ympev.2009.12.005; Paraskevopoulos C, 2006, CURR MICROBIOL, V53, P388, DOI 10.1007/s00284-006-0054-1; Perez-Brocal V, 2006, SCIENCE, V314, P312, DOI 10.1126/science.1130441; Reed DW, 2002, APPL ENVIRON MICROB, V68, P3759, DOI 10.1128/AEM.68.8.3759-3770.2002; Remaudiere G., 1997, CATALOGUE APHIDIDAE; Reuter M, 2003, MOL BIOL EVOL, V20, P748, DOI 10.1093/molbev/msg082; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ros VID, 2009, APPL ENVIRON MICROB, V75, P1036, DOI 10.1128/AEM.01109-08; Rowley SM, 2004, CURR MICROBIOL, V49, P208, DOI 10.1007/s00284-004-4346-z; Saridaki A, 2010, CURR OPIN MICROBIOL, V13, P67, DOI 10.1016/j.mib.2009.11.005; Schadler M, 2007, ECOLOGY, V88, P1490, DOI 10.1890/06-0647; Simoes PM, 2011, MOL ECOL RESOUR, V11, P567, DOI 10.1111/j.1755-0998.2010.02955.x; SINKINS SP, 1995, P ROY SOC B-BIOL SCI, V261, P325, DOI 10.1098/rspb.1995.0154; STOUTHAMER R, 1993, NATURE, V361, P66, DOI 10.1038/361066a0; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsuchida T, 2002, MOL ECOL, V11, P2123, DOI 10.1046/j.1365-294X.2002.01606.x; Turley AP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000516; Vaishampayan PA, 2007, MOL PHYLOGENET EVOL, V44, P1346, DOI 10.1016/j.ympev.2007.01.003; Vandekerckhove TTM, 1999, FEMS MICROBIOL LETT, V180, P279, DOI 10.1111/j.1574-6968.1999.tb08807.x; Vautrin E, 2009, TRENDS MICROBIOL, V17, P95, DOI 10.1016/j.tim.2008.12.002; Vorburger C, 2010, BIOL LETTERS, V6, P109, DOI 10.1098/rsbl.2009.0642; Wang Z, 2009, EUR J ENTOMOL, V106, P49, DOI 10.14411/eje.2009.007; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; West SA, 1998, MOL ECOL, V7, P1457, DOI 10.1046/j.1365-294x.1998.00467.x; Xi ZY, 2005, INSECT BIOCHEM MOLEC, V35, P903, DOI 10.1016/j.ibmb.2005.03.015; Zabalou S, 2004, P NATL ACAD SCI USA, V101, P15042, DOI 10.1073/pnas.0403853101; Zabalou S, 2009, ENTOMOL EXP APPL, V132, P232, DOI 10.1111/j.1570-7458.2009.00886.x; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	108	143	153	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28695	10.1371/journal.pone.0028695	http://dx.doi.org/10.1371/journal.pone.0028695			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174869	Green Published, gold			2022-12-25	WOS:000298367300022
J	Schiff, M; Benit, P; El-Khoury, R; Schlemmer, D; Benoist, JF; Rustin, P				Schiff, Manuel; Benit, Paule; El-Khoury, Riyad; Schlemmer, Dimitri; Benoist, Jean-Francois; Rustin, Pierre			Mouse Studies to Shape Clinical Trials for Mitochondrial Diseases: High Fat Diet in Harlequin Mice	PLOS ONE			English	Article							APOPTOSIS-INDUCING FACTOR; MYOPATHY; ACIDS; IDENTIFICATION; DISORDERS; PHENOTYPE; OXIDATION; INCREASE; DELETION; GENE	Background: Therapeutic options in human mitochondrial oxidative phosphorylation (OXPHOS) diseases have been poorly evaluated mostly because of the scarcity of cohorts and the inter-individual variability of disease progression. Thus, while a high fat diet (HFD) is often recommended, data regarding efficacy are limited. Our objectives were 1) to determine our ability to evaluate therapeutic options in the Harlequin OXPHOS complex I (CI)-deficient mice, in the context of a mitochondrial disease with human hallmarks and 2) to assess the effects of a HFD. Methods and Findings: Before launching long and expensive animal studies, we showed that palmitate afforded long-term death-protection in 3 CI-mutant human fibroblasts cell lines. We next demonstrated that using the Harlequin mouse, it was possible to draw solid conclusions on the efficacy of a 5-month-HFD on neurodegenerative symptoms. Moreover, we could identify a group of highly responsive animals, echoing the high variability of the disease progression in Harlequin mice. Conclusions: These results suggest that a reduced number of patients with identical genetic disease should be sufficient to reach firm conclusions as far as the potential existence of responders and non responders is recognized. They also positively prefigure HFD-trials in OXPHOS-deficient patients.	[Schiff, Manuel; Benit, Paule; El-Khoury, Riyad; Benoist, Jean-Francois; Rustin, Pierre] INSERM, U676, Paris, France; [Schiff, Manuel; Benit, Paule; El-Khoury, Riyad; Rustin, Pierre] Univ Paris 07, Fac Med Denis Diderot, IFR02, Paris, France; [Schiff, Manuel; Schlemmer, Dimitri; Benoist, Jean-Francois] Hop Robert Debre, APHP, Ctr Reference Malad Hereditaires Metab, F-75019 Paris, France; [Schlemmer, Dimitri; Benoist, Jean-Francois] Hop Robert Debre, APHP, Biochim Lab, F-75019 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Schiff, M (corresponding author), INSERM, U676, Paris, France.	pierre.rustin@inserm.fr	Schiff, Manuel/G-3596-2017	Schiff, Manuel/0000-0001-8272-232X; benoist, jean-francois/0000-0002-5389-8585	INSERM; CNRS; ANR (Agence Nationale de la Recherche, France); Leducq Transatlantic Network (CarDiaNet)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR (Agence Nationale de la Recherche, France)(French National Research Agency (ANR)); Leducq Transatlantic Network (CarDiaNet)(Leducq Foundation)	This work was supported by INSERM, CNRS, ANR (Agence Nationale de la Recherche, France, http://www.agence-nationale-recherche.fr/), and the Leducq Transatlantic Network (CarDiaNet, http://cardianet.org/). The authors are grateful to AFM (Association Francaise contre les Myopathies, http://www.afm-telethon.fr/), AMMi (Association contre les Maladies Mitochondriales, http://www.association-ammi.org/) and AFAF (Association Francaise contre l'Ataxie de Friedreich, http://www.afaf.asso.fr/) for their constant support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahola-Erkkila S, 2010, HUM MOL GENET, V19, P1974, DOI 10.1093/hmg/ddq076; Benit P, 2003, HUM GENET, V112, P563, DOI 10.1007/s00439-002-0884-2; Benit P, 2001, AM J HUM GENET, V68, P1344, DOI 10.1086/320603; Benit P, 2006, CLIN CHIM ACTA, V374, P81, DOI 10.1016/j.cca.2006.05.034; Benit P, 2010, TRENDS MOL MED, V16, P210, DOI 10.1016/j.molmed.2010.03.001; Benit P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003208; BERGER I, 2011, MOL GENETIC IN PRESS; BOUAITA A, 2011, BRAIN IN PRESS; Brooks SP, 2009, NAT REV NEUROSCI, V10, P519, DOI 10.1038/nrn2652; Ciapaite J, 2011, BBA-MOL CELL BIOL L, V1811, P441, DOI 10.1016/j.bbalip.2011.05.005; de Meer K, 2005, J INHERIT METAB DIS, V28, P95, DOI 10.1007/s10545-005-1485-8; Djouadi F, 2003, MOL GENET METAB, V78, P112, DOI 10.1016/S1096-7192(03)00017-9; Garcia-Roves P, 2007, P NATL ACAD SCI USA, V104, P10709, DOI 10.1073/pnas.0704024104; Ghezzi D, 2010, AM J HUM GENET, V86, P639, DOI 10.1016/j.ajhg.2010.03.002; Guyenet S.J., 2010, J VIS EXP; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; He M, 2007, AM J HUM GENET, V81, P87, DOI 10.1086/519219; HE M, 2011, MOL GENET METAB; HOEKS J, 2011, J CELL PHYSL; Ivanova PT, 2007, METHOD ENZYMOL, V432, P21, DOI 10.1016/S0076-6879(07)32002-8; Joza N, 2005, MOL CELL BIOL, V25, P10261, DOI 10.1128/MCB.25.23.10261-10272.2005; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Klopstock T, 2011, BRAIN, V134, P2677, DOI 10.1093/brain/awr170; McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2; Munnich A, 2001, AM J MED GENET, V106, P4, DOI 10.1002/ajmg.1391; Panetta J, 2004, J INHERIT METAB DIS, V27, P487, DOI 10.1023/B:BOLI.0000037354.66587.38; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Rafael JA, 2000, MAMM GENOME, V11, P725, DOI 10.1007/s003350010149; Roef MJ, 2002, AM J CLIN NUTR, V75, P237, DOI 10.1093/ajcn/75.2.237; Roef MJ, 2002, NEUROLOGY, V58, P1088, DOI 10.1212/WNL.58.7.1088; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; SALAHUDEEN AK, 1991, J CLIN INVEST, V88, P1886, DOI 10.1172/JCI115511; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Schiff M, 2011, NUTR REV, V69, P65, DOI 10.1111/j.1753-4887.2010.00363.x; Schonfeld P, 2007, BBA-BIOENERGETICS, V1767, P1032, DOI 10.1016/j.bbabio.2007.04.005; Suomalainen A, 2011, SEMIN FETAL NEONAT M, V16, P236, DOI 10.1016/j.siny.2011.05.003; TZAGOLOFF A, 1982, MITOCHONDRIA, P1; Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461; Valsecchi F, 2010, DEV DISABIL RES REV, V16, P175, DOI 10.1002/ddrr.107; van Empel VPM, 2005, CIRC RES, V96, pE92, DOI 10.1161/01.RES.0000172081.30327.28; von Kleist-Retzow JC, 1998, AM J HUM GENET, V63, P428, DOI 10.1086/301957; Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Zeviani M, 2007, CURR OPIN NEUROL, V20, P564, DOI 10.1097/WCO.0b013e3282ef58cd	45	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28823	10.1371/journal.pone.0028823	http://dx.doi.org/10.1371/journal.pone.0028823			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174907	Green Published, Green Submitted			2022-12-25	WOS:000298367300028
J	Brinkley, TE; Jerosch-Herold, M; Folsom, AR; Carr, JJ; Hundley, WG; Allison, MA; Bluemke, DA; Burke, GL; Szklo, M; Ding, JZ				Brinkley, Tina E.; Jerosch-Herold, Michael; Folsom, Aaron R.; Carr, J. Jeffrey; Hundley, W. Gregory; Allison, Matthew A.; Bluemke, David A.; Burke, Gregory L.; Szklo, Moyses; Ding, Jingzhong			Pericardial Fat and Myocardial Perfusion in Asymptomatic Adults from the Multi-Ethnic Study of Atherosclerosis	PLOS ONE			English	Article							PERIVASCULAR ADIPOSE-TISSUE; NORMAL CORONARY-ARTERIES; BLOOD-FLOW; COMPUTED-TOMOGRAPHY; VASCULAR FUNCTION; RISK-FACTORS; RESERVE; HEART; CALCIUM; DISEASE	Background: Pericardial fat has adverse effects on the surrounding vasculature. Previous studies suggest that pericardial fat may contribute to myocardial ischemia in symptomatic individuals. However, it is unknown if pericardial fat has similar effects in asymptomatic individuals. Methods: We determined the association between pericardial fat and myocardial blood flow (MBF) in 214 adults with no prior history of cardiovascular disease from the Minnesota field center of the Multi-Ethnic Study of Atherosclerosis (43% female, 56% Caucasian, 44% Hispanic). Pericardial fat volume was measured by computed tomography. MBF was measured by MRI at rest and during adenosine-induced hyperemia. Myocardial perfusion reserve (PR) was calculated as the ratio of hyperemic to resting MBF. Results: Gender-stratified analyses revealed significant differences between men and women including less pericardial fat (71.9 +/- 31.3 vs. 105.2 +/- 57.5 cm(3), p<0.0001) and higher resting MBF (1.12 +/- 0.23 vs. 0.93 +/- 0.19 ml/min/g, p<0.0001), hyperemic MBF (3.49 +/- 0.76 vs. 2.65 +/- 0.72 ml/min/g, p<0.0001), and PR (3.19 +/- 0.78 vs. 2.93 +/- 0.89, p = 0.03) in women. Correlations between pericardial fat and clinical and hemodynamic variables were stronger in women. In women only (p = 0.01 for gender interaction) higher pericardial fat was associated with higher resting MBF (p = 0.008). However, this association was attenuated after accounting for body mass index or rate-pressure product. There were no significant associations between pericardial fat and hyperemic MBF or PR after multivariate adjustment in either gender. In logistic regression analyses there was also no association between impaired coronary vasoreactivity, defined as having a PR <2.5, and pericardial fat in men (OR, 1.18; 95% CI, 0.82-1.70) or women (OR, 1.11; 95% CI, 0.68-1.82). Conclusions: Our data fail to support an independent association between pericardial fat and myocardial perfusion in adults without symptomatic cardiovascular disease. Nevertheless, these findings highlight potentially important differences between asymptomatic and symptomatic individuals with respect to the underlying subclinical disease burden.	[Brinkley, Tina E.; Hundley, W. Gregory; Ding, Jingzhong] Wake Forest Sch Med, Dept Internal Med, Winston Salem, NC USA; [Jerosch-Herold, Michael] Univ Minnesota, Sch Med, Dept Radiol, Minneapolis, MN 55455 USA; [Folsom, Aaron R.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Carr, J. Jeffrey] Wake Forest Sch Med, Dept Radiol, Winston Salem, NC USA; [Allison, Matthew A.] Univ Calif San Diego, Dept Family & Prevent Med, La Jolla, CA 92093 USA; [Bluemke, David A.] NIH, Ctr Clin, Bethesda, MD 20892 USA; [Bluemke, David A.] Natl Inst Biomed Imaging & Bioengn, Bethesda, MD USA; [Burke, Gregory L.] Wake Forest Sch Med, Div Publ Hlth Sci, Winston Salem, NC USA; [Szklo, Moyses] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA	Wake Forest University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Wake Forest University; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); Wake Forest University; Johns Hopkins University	Brinkley, TE (corresponding author), Wake Forest Sch Med, Dept Internal Med, Winston Salem, NC USA.	tbrinkle@wakehealth.edu	Carr, John Jeffrey/A-1938-2012; Carr, John/AAN-7531-2021; Brinkley, Tina/AAT-9256-2021; Jerosch-Herold, Michael/R-9824-2019; Bluemke, David/GYU-8169-2022	Carr, John Jeffrey/0000-0002-4398-8237; Carr, John/0000-0002-4398-8237; Allison, Matthew/0000-0003-0777-8272; Bluemke, David/0000-0002-8323-8086; Szklo, Moyses/0000-0001-9433-6266	Oristano Foundation; National Heart, Lung, and Blood Institute, National Institutes of Health [N01-HC-95159, N01-HC-95169];  [R01-HL-085323];  [R01-HL-65580];  [K01-AG-033652]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000072] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL090019] Funding Source: NIH RePORTER	Oristano Foundation; National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; ; ; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); CLINICAL CENTER	This research was supported by the Oristano Foundation, as well as grants R01-HL-085323, R01-HL-65580, and K01-AG-033652, and contracts N01-HC-95159 through N01-HC-95169 from the National Heart, Lung, and Blood Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Barandier C, 2005, AM J PHYSIOL-HEART C, V289, pH1807, DOI 10.1152/ajpheart.01259.2004; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Breen JF, 2001, J THORAC IMAG, V16, P47, DOI 10.1097/00005382-200101000-00007; Bucci M, 2011, ARTERIOSCL THROM VAS, V31, P211, DOI 10.1161/ATVBAHA.110.213827; Burke AP, 2001, HERZ, V26, P239, DOI 10.1007/PL00002026; Camici PG, 2007, NEW ENGL J MED, V356, P830, DOI 10.1056/NEJMra061889; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Chatterjee TK, 2009, CIRC RES, V104, P541, DOI 10.1161/CIRCRESAHA.108.182998; Date H, 2006, CLIN CARDIOL, V29, P211, DOI 10.1002/clc.4960290508; Ding JZ, 2008, OBESITY, V16, P1914, DOI 10.1038/oby.2008.278; Ding JZ, 2009, AM J CLIN NUTR, V90, P499, DOI 10.3945/ajcn.2008.27358; Eringa EC, 2007, MICROCIRCULATION, V14, P389, DOI 10.1080/10739680701303584; Fluchter S, 2007, OBESITY, V15, P870, DOI 10.1038/oby.2007.591; Gao YJ, 2007, BRIT J PHARMACOL, V151, P323, DOI 10.1038/sj.bjp.0707228; GELTMAN EM, 1990, J AM COLL CARDIOL, V16, P586, DOI 10.1016/0735-1097(90)90347-R; Greif M, 2009, ARTERIOSCL THROM VAS, V29, P781, DOI 10.1161/ATVBAHA.108.180653; Guerci AD, 1997, AM J CARDIOL, V79, P128, DOI 10.1016/S0002-9149(96)00698-4; Henrichot E, 2005, ARTERIOSCL THROM VAS, V25, P2594, DOI 10.1161/01.ATV.0000188508.40052.35; Janik M, 2010, J NUCL CARDIOL, V17, P841, DOI 10.1007/s12350-010-9235-1; Jerosch-Herold M, 2004, J MAGN RESON IMAGING, V19, P758, DOI 10.1002/jmri.20065; Jerosch-Herold M, 2003, J MAGN RESON IMAGING, V18, P544, DOI 10.1002/jmri.10384; Jerosch-Herold M, 2002, MED PHYS, V29, P886, DOI 10.1118/1.1473135; Jerosch-Herold M, 2008, INVEST RADIOL, V43, P155, DOI 10.1097/RLI.0b013e31815abebd; KLOCKE FJ, 1987, CIRCULATION, V76, P1183, DOI 10.1161/01.CIR.76.6.1183; Mathieu P, 2008, INT J BIOCHEM CELL B, V40, P821, DOI 10.1016/j.biocel.2007.12.001; Mazurek T, 2003, CIRCULATION, V108, P2460, DOI 10.1161/01.CIR.0000099542.57313.C5; Montani JP, 2004, INT J OBESITY, V28, pS58, DOI 10.1038/sj.ijo.0802858; Natori S, 2006, AM J ROENTGENOL, V186, pS357, DOI 10.2214/AJR.04.1868; Nelson AJ, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-15; Rosito GA, 2008, CIRCULATION, V117, P605, DOI 10.1161/CIRCULATIONAHA.107.743062; Sade LE, 2009, ATHEROSCLEROSIS, V204, P580, DOI 10.1016/j.atherosclerosis.2008.09.038; Taguchi R, 2001, ATHEROSCLEROSIS, V157, P203, DOI 10.1016/S0021-9150(00)00709-7; Tamarappoo B, 2010, JACC-CARDIOVASC IMAG, V3, P1104, DOI 10.1016/j.jcmg.2010.07.014; Thanassoulis G, 2010, CIRC-CARDIOVASC IMAG, V3, P559, DOI 10.1161/CIRCIMAGING.110.956706; Wang L, 2006, J AM COLL CARDIOL, V47, P565, DOI 10.1016/j.jacc.2005.09.036; Wang L, 2006, J AM COLL CARDIOL, V48, P1018, DOI 10.1016/j.jacc.2006.04.089; Wexler L, 1996, CIRCULATION, V94, P1175, DOI 10.1161/01.CIR.94.5.1175; Zierler K, 2000, ANN BIOMED ENG, V28, P836, DOI 10.1114/1.1308496	39	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28410	10.1371/journal.pone.0028410	http://dx.doi.org/10.1371/journal.pone.0028410			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174800	Green Published, Green Submitted, gold			2022-12-25	WOS:000298365700031
J	Sarmiento, J; Shumate, C; Suetomi, K; Ravindran, A; Villegas, L; Rajarathnam, K; Navarro, J				Sarmiento, Jose; Shumate, Christie; Suetomi, Katsutoshi; Ravindran, Aishwarya; Villegas, Leon; Rajarathnam, Krishna; Navarro, Javier			Diverging Mechanisms of Activation of Chemokine Receptors Revealed by Novel Chemokine Agonists	PLOS ONE			English	Article							HIGH-AFFINITY BINDING; INTERLEUKIN-8 RECEPTOR; N-TERMINUS; CXCR2; SELECTIVITY; NEUTROPHILS; IL-8	CXCL8/interleukin-8 is a pro-inflammatory chemokine that triggers pleiotropic responses, including inflammation, angiogenesis, wound healing and tumorigenesis. We engineered the first selective CXCR1 agonists on the basis of residue substitutions in the conserved ELR triad and CXC motif of CXCL8. Our data reveal that the molecular mechanisms of activation of CXCR1 and CXCR2 are distinct: the N-loop of CXCL8 is the major determinant for CXCR1 activation, whereas the N-terminus of CXCL8 (ELR and CXC) is essential for CXCR2 activation. We also found that activation of CXCR1 cross-desensitized CXCR2 responses in human neutrophils co-expressing both receptors, indicating that these novel CXCR1 agonists represent a new class of anti-inflammatory agents. Further, these selective CXCR1 agonists will aid at elucidating the functional significance of CXCR1 in vivo under pathophysiological conditions.	[Sarmiento, Jose; Shumate, Christie; Navarro, Javier] Univ Texas Med Branch, Dept Neurosci, Galveston, TX 77555 USA; [Sarmiento, Jose; Shumate, Christie; Navarro, Javier] Univ Texas Med Branch, Dept Cell Biol, Galveston, TX USA; [Ravindran, Aishwarya; Rajarathnam, Krishna] Univ Texas Med Branch, Dept Biochem, Galveston, TX USA; [Ravindran, Aishwarya; Rajarathnam, Krishna] Univ Texas Med Branch, Dept Mol Biol, Galveston, TX USA; [Rajarathnam, Krishna; Navarro, Javier] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX USA; [Rajarathnam, Krishna; Navarro, Javier] Univ Texas Med Branch, Sealy Ctr Mol Med, Galveston, TX USA; [Sarmiento, Jose] Univ Austral Chile, Fac Med, Inst Fisiol, Valdivia, Chile; [Suetomi, Katsutoshi] Aichi Med Univ, Ctr Multidisciplinary Pain, Nagakute, Aichi 48011, Japan; [Villegas, Leon] Univ Peruana Cayetano Heredia, Dept Pharmaceut Sci, Lima, Peru	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Universidad Austral de Chile; Aichi Medical University; Universidad Peruana Cayetano Heredia	Sarmiento, J (corresponding author), Univ Texas Med Branch, Dept Neurosci, Galveston, TX 77555 USA.	jnavarro@utmb.edu		Navarro, Javier/0000-0001-7098-4373; Villegas Vilchez, Leon Faustino/0000-0001-6030-2877	National Institutes of Health (NIH) [R01EY14218, R01GM081798]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024832] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health (NIH) grants R01EY14218 and R01GM081798 to Dr. Navarro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja SK, 1996, J BIOL CHEM, V271, P225, DOI 10.1074/jbc.271.1.225; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Catusse J, 2004, BIOCHEM PHARMACOL, V68, P1947, DOI 10.1016/j.bcp.2004.07.003; CLARKLEWIS I, 1993, P NATL ACAD SCI USA, V90, P3574, DOI 10.1073/pnas.90.8.3574; CLORE GM, 1995, FASEB J, V9, P57, DOI 10.1096/fasebj.9.1.7821760; FORREST MJ, 1986, BRIT J PHARMACOL, V89, P719, DOI 10.1111/j.1476-5381.1986.tb11176.x; Hartl D, 2007, NAT MED, V13, P1423, DOI 10.1038/nm1690; Joseph PRB, 2010, J BIOL CHEM, V285, P29262, DOI 10.1074/jbc.M110.146555; Kraemer S, 2011, FASEB J, V25, P894, DOI 10.1096/fj.10-168559; LAROSA GJ, 1992, J BIOL CHEM, V267, P25402; LEE J, 1995, J IMMUNOL, V155, P2158; Lowman HB, 1996, J BIOL CHEM, V271, P14344, DOI 10.1074/jbc.271.24.14344; LU ZH, 1995, J BIOL CHEM, V270, P26239; Milatovic S, 2003, WOUND REPAIR REGEN, V11, P213, DOI 10.1046/j.1524-475X.2003.11310.x; PRADO GN, 1994, J BIOL CHEM, V269, P12391; Ragnarsdottir B, 2008, EUR J CLIN INVEST, V38, P12, DOI 10.1111/j.1365-2362.2008.02004.x; Rajagopalan L, 2006, BIOSCIENCE REP, V26, P325, DOI 10.1007/s10540-006-9025-9; Sallusto F, 2008, NAT IMMUNOL, V9, P949, DOI 10.1038/ni.f.214; Suetomi K, 1999, J BIOL CHEM, V274, P11768, DOI 10.1074/jbc.274.17.11768; SUZUKI H, 1994, J BIOL CHEM, V269, P18263; White JR, 1998, J BIOL CHEM, V273, P10095, DOI 10.1074/jbc.273.17.10095	21	14	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e27967	10.1371/journal.pone.0027967	http://dx.doi.org/10.1371/journal.pone.0027967			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174759	gold, Green Published, Green Submitted			2022-12-25	WOS:000298365700012
J	Manavathi, B; Lo, D; Bugide, S; Dey, O; Imren, S; Weiss, MJ; Humphries, RK				Manavathi, Bramanandam; Lo, Dennis; Bugide, Suresh; Dey, Oindrilla; Imren, Suzan; Weiss, Mitchell J.; Humphries, R. Keith			Functional Regulation of Pre-B-cell Leukemia Homeobox Interacting Protein 1 (PBXIP1/HPIP) in Erythroid Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-1; ACUTE MYELOID-LEUKEMIA; HEMATOPOIETIC-CELLS; STEM-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; PROGENITOR CELLS; GENE-EXPRESSION; KINASE-B; IN-VITRO; ERYTHROPOIETIN	Pre-B-cell leukemia homeobox interacting protein 1 or human PBX1 interacting protein (PBXIP1/HPIP) is a co-repressor of pre-B-cell leukemia homeobox 1 (PBX1) and is also known to regulate estrogen receptor functions by associating with the microtubule network. Despite its initial discovery in the context of hematopoietic cells, little is yet known about the role of HPIP in hematopoiesis. Here, we show that lentivirus-mediated overexpression of HPIP in human CD34(+) cells enhances hematopoietic colony formation in vitro, whereas HPIP knockdown leads to a reduction in the number of such colonies. Interestingly, erythroid colony number was significantly higher in HPIP-overexpressing cells. In addition, forced expression of HPIP in K562 cells, a multipotent erythro-megakaryoblastic leukemia cell line, led to an induction of erythroid differentiation. HPIP overexpression in both CD34(+) and K562 cells was associated with increased activation of the PI3K/AKT pathway, and corresponding treatment with a PI3K-specific inhibitor, LY-294002, caused a reduction in clonogenic progenitor number in HPIP-expressing CD34(+) cells and decreased K562 cell differentiation. Combined, these findings point to an important role of the PI3K/AKT pathway in mediating HPIP-induced effects on the growth and differentiation of hematopoietic cells. Interestingly, HPIP gene expression was found to be induced in K562 cells in response to erythroid differentiation signals such as DMSO and erythropoietin. The erythroid lineage-specific transcription factor GATA1 binds to the HPIP promoter and activates HPIP gene transcription in a CCCTC-binding factor (CTCF)-dependent manner. Co-immunoprecipitation and co-localization experiments revealed the association of CTCF with GATA1 indicating the recruitment of CTCF/GATA1 transcription factor complex onto the HPIP promoter. Together, this study provides evidence that HPIP is a target of GATA1 and CTCF in erythroid cells and plays an important role in erythroid differentiation by modulating the PI3K/AKT pathway.	[Manavathi, Bramanandam; Bugide, Suresh; Dey, Oindrilla] Univ Hyderabad, Sch Life Sci, Dept Biochem, Mol & Cellular Oncol Lab, Hyderabad 500046, Andhra Pradesh, India; [Lo, Dennis; Imren, Suzan; Humphries, R. Keith] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Lo, Dennis; Imren, Suzan; Humphries, R. Keith] Univ British Columbia, Dept Med, Vancouver, BC V5Z 1L3, Canada; [Weiss, Mitchell J.] Childrens Hosp, Div Hematol, Philadelphia, PA 19104 USA	University of Hyderabad; British Columbia Cancer Agency; University of British Columbia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Manavathi, B (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Biochem, Mol & Cellular Oncol Lab, Hyderabad 500046, Andhra Pradesh, India.	manavathibsl@uohyd.ernet.in; khumphri@bccrc.ca	Weiss, Mitchell J/W-9814-2018; Weiss, Mitchell J/A-1245-2013; Bugide, Suresh/AAD-6053-2022	Weiss, Mitchell J/0000-0003-2460-3036; Manavathi, Bramanandam/0000-0002-1797-398X; Humphries, Richard/0000-0003-0540-7005	Department of Science and Technology; Terry Fox Foundation; British Columbia Cancer Foundation	Department of Science and Technology(Department of Science & Technology (India)); Terry Fox Foundation; British Columbia Cancer Foundation	This work was supported by Department of Science and Technology under Better Opportunities for Young Scientist in Chosen Areas of Science and Technology (to B. M.), a Terry Fox Foundation program project grant (to R. K. H.), the British Columbia Cancer Foundation, and in part by the Department of Science and Technology under the Fast-Track Program young investigator award (to B. M.).	Abramovich C, 2000, J BIOL CHEM, V275, P26172, DOI 10.1074/jbc.M001323200; Abramovich C, 2002, ONCOGENE, V21, P6766, DOI 10.1038/sj.onc.1205784; AI ZW, 1995, EXP CELL RES, V219, P454, DOI 10.1006/excr.1995.1252; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bone HK, 2007, J CELL SCI, V120, P1752, DOI 10.1242/jcs.003772; Buitenhuis M, 2009, CELL CYCLE, V8, P560, DOI 10.4161/cc.8.4.7654; BUSFIELD SJ, 1995, EUR J BIOCHEM, V230, P475; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; Cheng Y, 2009, GENOME RES, V19, P2172, DOI 10.1101/gr.098921.109; Crispino JD, 2005, SEMIN CELL DEV BIOL, V16, P137, DOI 10.1016/j.semcdb.2004.11.002; Crooks GM, 1999, BLOOD, V94, P519, DOI 10.1182/blood.V94.2.519.414k20_519_528; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; DiMartino JF, 2001, BLOOD, V98, P618, DOI 10.1182/blood.V98.3.618; Fischbach NA, 2005, BLOOD, V105, P1456, DOI 10.1182/blood-2004-04-1583; Gambone JE, 2011, BLOOD, V117, P5733, DOI 10.1182/blood-2009-09-242131; Hope KJ, 2003, ARCH MED RES, V34, P507, DOI 10.1016/j.arcmed.2003.08.007; Imren S, 2004, J CLIN INVEST, V114, P953, DOI 10.1172/JCI200421838; Kadri Z, 2005, MOL CELL BIOL, V25, P7412, DOI 10.1128/MCB.25.17.7412-7422.2005; KAMPS MP, 1990, CELL, V60, P547, DOI 10.1016/0092-8674(90)90658-2; Kappen C, 2000, AM J HEMATOL, V65, P111, DOI 10.1002/1096-8652(200010)65:2<111::AID-AJH4>3.0.CO;2-Z; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kubota Y, 2001, EMBO J, V20, P5666, DOI 10.1093/emboj/20.20.5666; Liu LH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002850; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Manavathi B, 2006, P NATL ACAD SCI USA, V103, P15981, DOI 10.1073/pnas.0607445103; Marques-Garcia F, 2009, J BIOL CHEM, V284, P21139, DOI 10.1074/jbc.M109.026849; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; Myklebust JH, 2002, EXP HEMATOL, V30, P990, DOI 10.1016/S0301-472X(02)00868-8; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; PEVNY L, 1995, DEVELOPMENT, V121, P163; Saitoh N, 2000, EMBO J, V19, P2315, DOI 10.1093/emboj/19.10.2315; Sauvageau G, 2004, ONCOGENE, V23, P7223, DOI 10.1038/sj.onc.1207942; Selleri L, 2001, DEVELOPMENT, V128, P3543; Shimamoto T, 1998, INT J HEMATOL, V67, P339; SUTHERLAND HJ, 1989, BLOOD, V74, P1563; Tanimoto K, 2003, MOL CELL BIOL, V23, P8946, DOI 10.1128/MCB.23.24.8946-8952.2003; Thorsteinsdottir U, 1997, MOL CELL BIOL, V17, P495, DOI 10.1128/MCB.17.1.495; Torrano V, 2005, J BIOL CHEM, V280, P28152, DOI 10.1074/jbc.M501481200; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Wang XH, 2008, BBA-MOL CELL RES, V1783, P1220, DOI 10.1016/j.bbamcr.2008.01.026; Weiss MJ, 1997, MOL CELL BIOL, V17, P1642, DOI 10.1128/MCB.17.3.1642; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; Zon LI, 2008, NATURE, V453, P306, DOI 10.1038/nature07038	46	28	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5600	5614		10.1074/jbc.M111.289843	http://dx.doi.org/10.1074/jbc.M111.289843			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22187427	Green Published, hybrid			2022-12-25	WOS:000300638000038
J	Lambert, E; Coissieux, MM; Laudet, V; Mehlen, P				Lambert, Elise; Coissieux, Marie-May; Laudet, Vincent; Mehlen, Patrick			Netrin-4 Acts as a Pro-angiogenic Factor during Zebrafish Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; OKADAIC ACID; VASCULAR DEVELOPMENT; NETWORK FORMATION; GUIDANCE; UNC5B; RECRUITMENT; INHIBITION; MECHANISMS; EXPRESSION	Netrins form a heterogeneous family of laminin-related molecules with multifunctional activities. Netrin-4, the most distant member of this family, is related to the laminin beta chain and has recently been proposed to play an important role in embryonic and pathological angiogenesis. However, the data reported so far lead to the apparently contradictory conclusions supporting Netrin-4 as either a pro- or an anti-angiogenic factor. To elucidate this controversy, Netrin-4 was analyzed for a vascular activity in both cell-based models (human umbilical vein endothelial cells and human umbilical artery endothelial cells) and two zebrafish models: the wild-type AB/Tu strain and the transgenic Tg(fli1a:EGFP)(y1) strain. We show that Netrin-4 is expressed in endothelial cells and in the zebrafish vascular system. We also show evidence that Netrin-4 activates various kinases and induces various biological effects directly linked to angiogenesis in vitro. Using a morpholinos strategy, we demonstrate that Netrin-4 expression is crucial for zebrafish vessel formation and that a blood vessel formation defect induced by netrin-4 morpholinos can be partially rescued through drug delivery leading to protein kinase activation. Together these data underscore the crucial role of Netrin-4 in blood vessel formation and the involvement of protein kinases activation in Netrin-4-induced biological effects related to vascular development.	[Lambert, Elise; Coissieux, Marie-May; Mehlen, Patrick] Univ Lyon, Ctr Leon Berard, Apoptosis Canc & Dev Lab,Equipe Labellisee La Lig, LabEx DEVweCAN,Ctr Cancerol Lyon,INSERM U1052,CNR, F-69008 Lyon, France; [Lambert, Elise; Laudet, Vincent] Univ Lyon, Ecole Normale Super Lyon, Inst Genom Fonct Lyon, CNRS UMR5242,BioSci Gerland Lyon Sud UMS3444, F-69364 Lyon 07, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Mehlen, P (corresponding author), Univ Lyon, Ctr Leon Berard, Apoptosis Canc & Dev Lab,Equipe Labellisee La Lig, LabEx DEVweCAN,Ctr Cancerol Lyon,INSERM U1052,CNR, 28 Rue Laennec, F-69008 Lyon, France.	patrick.mehlen@lyon.unicancer.fr		Coissieux, Marie-May/0000-0001-5017-5253; LAMBERT, Elise/0000-0003-1192-0112	Ligue Contre le Cancer; Agence Nationale de la Recherche; Institut National du Cancer	Ligue Contre le Cancer(Ligue nationale contre le cancer); Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut National du Cancer(Institut National du Cancer (INCA) France)	This work was supported by the Ligue Contre le Cancer, the Agence Nationale de la Recherche, and the Institut National du Cancer (to P. M.).	Atkinson T, 2009, BIOCHEM BIOPH RES CO, V378, P394, DOI 10.1016/j.bbrc.2008.11.036; Barallobre MJ, 2005, BRAIN RES REV, V49, P22, DOI 10.1016/j.brainresrev.2004.11.003; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Castets M, 2010, CELL CYCLE, V9, P1466, DOI 10.4161/cc.9.8.11197; Castets M, 2009, DEV CELL, V16, P614, DOI 10.1016/j.devcel.2009.02.006; Cirulli V, 2007, NAT REV MOL CELL BIO, V8, P296, DOI 10.1038/nrm2142; Covassin LD, 2006, P NATL ACAD SCI USA, V103, P6554, DOI 10.1073/pnas.0506886103; Draper BW, 2001, GENESIS, V30, P154, DOI 10.1002/gene.1053; Ekker SC, 2000, YEAST, V17, P302, DOI 10.1002/1097-0061(200012)17:4<302::AID-YEA53>3.0.CO;2-#; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; FUJIKI H, 1993, ADV CANCER RES, V61, P143, DOI 10.1016/S0065-230X(08)60958-6; Hoang S, 2009, J CEREBR BLOOD F MET, V29, P385, DOI 10.1038/jcbfm.2008.128; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; Ivy SP, 2009, NAT REV CLIN ONCOL, V6, P569, DOI 10.1038/nrclinonc.2009.130; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koch M, 2000, J CELL BIOL, V151, P221, DOI 10.1083/jcb.151.2.221; Larrieu-Lahargue F, 2011, CIRC RES, V109, P770, DOI 10.1161/CIRCRESAHA.111.247239; Larrieu-Lahargue F, 2010, BLOOD, V115, P5418, DOI 10.1182/blood-2009-11-252338; Larrivee B, 2009, CIRC RES, V104, P428, DOI 10.1161/CIRCRESAHA.108.188144; Lawson ND, 2002, NAT REV GENET, V3, P674, DOI 10.1038/nrg888; Lejmi E, 2008, P NATL ACAD SCI USA, V105, P12491, DOI 10.1073/pnas.0804008105; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; Martyn U, 2004, DEV DYNAM, V231, P33, DOI 10.1002/dvdy.20048; Milman G, 2006, P NATL ACAD SCI USA, V103, P2428, DOI 10.1073/pnas.0510676103; Nacht M, 2009, EXP CELL RES, V315, P784, DOI 10.1016/j.yexcr.2008.11.018; Navankasattusas S, 2008, DEVELOPMENT, V135, P659, DOI 10.1242/dev.013623; Nguyen A, 2006, P NATL ACAD SCI USA, V103, P6530, DOI 10.1073/pnas.0511011103; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Provis JM, 1997, EXP EYE RES, V65, P555, DOI 10.1006/exer.1997.0365; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Salameh A, 2005, BLOOD, V106, P3423, DOI 10.1182/blood-2005-04-1388; Suchting S, 2006, EXP CELL RES, V312, P668, DOI 10.1016/j.yexcr.2005.11.009; Sugiyama N, 2007, BIOCHEMISTRY-US, V46, P11410, DOI 10.1021/bi700490n; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Wilson BD, 2006, SCIENCE, V313, P640, DOI 10.1126/science.1124704; Yang Y, 2007, CANCER BIOL THER, V6, P743, DOI 10.4161/cbt.6.5.3976; Yebra M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022750; Zachary I, 2005, NEUROSIGNALS, V14, P207, DOI 10.1159/000088637; Zhang X, 2010, BRIT J PHARMACOL, V160, P1583, DOI 10.1111/j.1476-5381.2010.00841.x	41	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3987	3999		10.1074/jbc.M111.289371	http://dx.doi.org/10.1074/jbc.M111.289371			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22179604	Green Published, hybrid			2022-12-25	WOS:000300410900033
J	Singh, P; Doshi, S; Spaethling, JM; Hockenberry, AJ; Patel, TP; Geddes-Klein, DM; Lynch, DR; Meaney, DF				Singh, Pallab; Doshi, Shachee; Spaethling, Jennifer M.; Hockenberry, Adam J.; Patel, Tapan P.; Geddes-Klein, Donna M.; Lynch, David R.; Meaney, David F.			N-Methyl-D-aspartate Receptor Mechanosensitivity Is Governed by C Terminus of NR2B Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRAUMATIC BRAIN-INJURY; NR2B-CONTAINING NMDA RECEPTORS; EXCITATORY AMINO-ACIDS; IN-VITRO; DIFFERENTIAL ROLES; SIGNALING PATHWAYS; DISTINCT ROLES; NEURONAL DEATH; NR1 SUBUNIT; CELL-DEATH	N-Methyl-D-aspartate receptors (NMDARs), critical mediators of both physiologic and pathologic neurological signaling, have previously been shown to be sensitive to mechanical stretch through the loss of its native Mg2+ block. However, the regulation of this mechanosensitivity has yet to be further explored. Furthermore, as it has become apparent that NMDAR-mediated signaling is dependent on specific NMDAR subtypes, as governed by the identity of the NR2 subunit, a crucial unanswered question is the role of subunit composition in observed NMDAR mechanosensitivity. Here, we used a recombinant system to assess the mechanosensitivity of specific subtypes and demonstrate that the mechanosensitive property is uniquely governed by the NR2B subunit. NR1/NR2B NMDARs displayed significant stretch sensitivity, whereas NR1/NR2A NMDARs did not respond to stretch. Furthermore, NR2B mechanosensitivity was regulated by PKC activity, because PKC inhibition reduced stretch responses in transfected HEK 293 cells and primary cortical neurons. Finally, using NR2B point mutations, we identified a PKC phosphorylation site, Ser-1323 on NR2B, as a unique critical regulator of stretch sensitivity. These data suggest that the selective mechanosensitivity of NR2B can significantly impact neuronal response to traumatic brain injury and illustrate that the mechanical tone of the neuron can be dynamically regulated by PKC activity.	[Doshi, Shachee; Lynch, David R.] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19194 USA; [Lynch, David R.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Singh, Pallab; Spaethling, Jennifer M.; Hockenberry, Adam J.; Patel, Tapan P.; Geddes-Klein, Donna M.; Meaney, David F.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania	Meaney, DF (corresponding author), 240 Skirkanich Hall,210 S 33rd St, Philadelphia, PA 19104 USA.	dmeaney@seas.upenn.edu		Meaney, David/0000-0002-0954-4122; Hockenberry, Adam/0000-0001-9476-0104; Patel, Tapan/0000-0001-8959-6645	National Institutes of Health [HD41699, NS35712, NS015212]; U.S. Department of Defense [W911NF-10-1-0526]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD041699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015212, R01NS035712] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense(United States Department of Defense); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants HD41699, NS35712, and NS015212. This work was also supported by a U.S. Department of Defense Grant W911NF-10-1-0526.	Al-Hallaq RA, 2007, J NEUROSCI, V27, P8334, DOI 10.1523/JNEUROSCI.2155-07.2007; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; BOECKMAN FA, 1994, NEUROSCI LETT, V173, P189, DOI 10.1016/0304-3940(94)90180-5; Boeckman FA, 1996, J PHARMACOL EXP THER, V279, P515; Bullock R, 1995, ANN NY ACAD SCI, V765, P290, DOI 10.1111/j.1749-6632.1995.tb16586.x; Casado M, 1998, J PHYSIOL-LONDON, V513, P317, DOI 10.1111/j.1469-7793.1998.317bb.x; Chen BS, 2007, NEUROPHARMACOLOGY, V53, P362, DOI 10.1016/j.neuropharm.2007.05.018; CHEN L, 1992, NATURE, V356, P521, DOI 10.1038/356521a0; Chen M, 2008, STROKE, V39, P3042, DOI 10.1161/STROKEAHA.108.521898; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Dempsey RJ, 2000, NEUROSURGERY, V47, P399, DOI 10.1097/00006123-200008000-00024; DeRidder MN, 2006, NEUROBIOL DIS, V22, P165, DOI 10.1016/j.nbd.2005.10.011; Dingledine R, 1999, PHARMACOL REV, V51, P7; Ehlers MD, 1998, J NEUROSCI, V18, P720; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; Ewald RC, 2008, J NEUROSCI, V28, P850, DOI 10.1523/JNEUROSCI.5078-07.2008; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Foster KA, 2010, J NEUROSCI, V30, P2676, DOI 10.1523/JNEUROSCI.4022-09.2010; Gallagher MJ, 1996, J BIOL CHEM, V271, P9603, DOI 10.1074/jbc.271.16.9603; Geddes-Klein DM, 2006, J NEUROCHEM, V97, P462, DOI 10.1111/j.1471-4159.2006.03761.x; Gogas KR, 2006, CURR OPIN PHARMACOL, V6, P68, DOI 10.1016/j.coph.2005.11.001; Grant ER, 1998, J NEUROCHEM, V71, P1471; Guttmann RP, 2001, J NEUROCHEM, V78, P1083, DOI 10.1046/j.1471-4159.2001.00493.x; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hatton CJ, 2005, NEURON, V46, P261, DOI 10.1016/j.neuron.2005.03.005; Hetman M, 2006, CURR TOP MED CHEM, V6, P787, DOI 10.2174/156802606777057553; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Ikonomidou C, 2000, P NATL ACAD SCI USA, V97, P12885, DOI 10.1073/pnas.220412197; Jin SX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011732; Jones ML, 2005, J NEUROCHEM, V92, P1431, DOI 10.1111/j.1471-4159.2004.02985.x; Kashiwagi K, 2002, MOL PHARMACOL, V61, P533, DOI 10.1124/mol.61.3.533; Kendrick SJ, 1996, J NEUROCHEM, V67, P608; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Kinney JW, 2006, J NEUROSCI, V26, P1604, DOI 10.1523/JNEUROSCI.4722-05.2006; Kohr G, 2003, J NEUROSCI, V23, P10791; Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7; Li SM, 2006, J NEUROSCI, V26, P1721, DOI 10.1523/JNEUROSCI.3990-05.2006; Liao GY, 2001, MOL PHARMACOL, V59, P960, DOI 10.1124/mol.59.5.960; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Liu XB, 2004, J NEUROSCI, V24, P8885, DOI 10.1523/JNEUROSCI.2476-04.2004; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Lusardi TA, 2004, ANN BIOMED ENG, V32, P1546, DOI 10.1114/B:ABME.0000049038.75368.75; Lynch DR, 2001, CURR DRUG TARGETS, V2, P215, DOI 10.2174/1389450013348434; Lynch DR, 2002, J PHARMACOL EXP THER, V300, P717, DOI 10.1124/jpet.300.3.717; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; Matsuda S, 1999, NEUROSCI RES, V34, P157, DOI 10.1016/S0168-0102(99)00046-2; MCINTOSH TK, 1990, J NEUROCHEM, V55, P1170, DOI 10.1111/j.1471-4159.1990.tb03122.x; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Nelson TJ, 2008, EUR J PHARMACOL, V585, P76, DOI 10.1016/j.ejphar.2008.01.051; Neyton J, 2006, J NEUROSCI, V26, P1331, DOI 10.1523/JNEUROSCI.5242-05.2006; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; Okiyama K, 1997, J NEUROTRAUM, V14, P211, DOI 10.1089/neu.1997.14.211; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PAOLETTI P, 1994, NEURON, V13, P645, DOI 10.1016/0896-6273(94)90032-9; Rao VLR, 2001, BRAIN RES, V911, P96; Rauner C, 2011, J BIOL CHEM, V286, P7558, DOI 10.1074/jbc.M110.182600; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Santucci DM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000208; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; SHAPIRA Y, 1990, Journal of Neurotrauma, V7, P131, DOI 10.1089/neu.1990.7.131; Singh P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002106; SMITH DH, 1993, NEUROSCI LETT, V157, P211, DOI 10.1016/0304-3940(93)90739-8; Spaethling JM, 2007, PROG BRAIN RES, V161, P27, DOI 10.1016/S0079-6123(06)61003-0; Tovar KR, 1999, J NEUROSCI, V19, P4180; von Engelhardt J, 2007, NEUROPHARMACOLOGY, V53, P10, DOI 10.1016/j.neuropharm.2007.04.015; Waxman EA, 2005, NEUROSCIENTIST, V11, P37, DOI 10.1177/1073858404269012; Wechsler A, 1998, EMBO J, V17, P3931, DOI 10.1093/emboj/17.14.3931; WILLIAMS K, 1993, NEURON, V10, P267, DOI 10.1016/0896-6273(93)90317-K; Wu HY, 2007, J BIOL CHEM, V282, P20075, DOI 10.1074/jbc.M700624200; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921; Zhou M, 2006, J NEUROSCI, V26, P2956, DOI 10.1523/JNEUROSCI.4299-05.2006; Zohar O, 2011, NEUROBIOL DIS, V41, P329, DOI 10.1016/j.nbd.2010.10.001	75	46	46	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4348	4359		10.1074/jbc.M111.253740	http://dx.doi.org/10.1074/jbc.M111.253740			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22179603	Green Published, hybrid			2022-12-25	WOS:000300410900065
J	Jenkins, RKB; Keane, A; Rakotoarivelo, AR; Rakotomboavonjy, V; Randrianandrianina, FH; Razafimanahaka, HJ; Ralaiarimalala, SR; Jones, JPG				Jenkins, Richard K. B.; Keane, Aidan; Rakotoarivelo, Andrinajoro R.; Rakotomboavonjy, Victor; Randrianandrianina, Felicien H.; Razafimanahaka, H. Julie; Ralaiarimalala, Sylvain R.; Jones, Julia P. G.			Analysis of Patterns of Bushmeat Consumption Reveals Extensive Exploitation of Protected Species in Eastern Madagascar	PLOS ONE			English	Article							WILDLIFE LAWS; RECALL BIAS; RIO-MUNI; WEALTH; CONSERVATION; INCOME; POPULATION; FORESTS; DECLINE; MAMMALS	Understanding the patterns of wild meat consumption from tropical forests is important for designing approaches to address this major threat to biodiversity and mitigate potential pathways for transmission of emerging diseases. Bushmeat consumption has been particularly poorly studied in Madagascar, one of the world's hottest biodiversity hotspots. Studying bushmeat consumption is challenging as many species are protected and researchers must consider the incentives faced by informants. Using interviews with 1154 households in 12 communes in eastern Madagascar, as well as local monitoring data, we investigated the importance of socio-economic variables, taste preference and traditional taboos on consumption of 50 wild and domestic species. The majority of meals contain no animal protein. However, respondents consume a wide range of wild species and 95% of respondents have eaten at least one protected species (and nearly 45% have eaten more than 10). The rural/urban divide and wealth are important predictors of bushmeat consumption, but the magnitude and direction of the effect varies between species. Bushmeat species are not preferred and are considered inferior to fish and domestic animals. Taboos have provided protection to some species, particularly the Endangered Indri, but we present evidence that this taboo is rapidly eroding. By considering a variety of potential influences on consumption in a single study we have improved understanding of who is eating bushmeat and why. Evidence that bushmeat species are not generally preferred meats suggest that projects which increase the availability of domestic meat and fish may have success at reducing demand. We also suggest that enforcement of existing wildlife and firearm laws should be a priority, particularly in areas undergoing rapid social change. The issue of hunting as an important threat to biodiversity in Madagascar is only now being fully recognised. Urgent action is required to ensure that heavily hunted species are adequately protected.	[Jenkins, Richard K. B.; Keane, Aidan; Jones, Julia P. G.] Bangor Univ, Sch Environm Nat Resources & Geog, Bangor, Gwynedd, Wales; [Jenkins, Richard K. B.] Univ Kent, Durrell Inst Conservat & Ecol, Canterbury CT2 7NZ, Kent, England; [Jenkins, Richard K. B.; Rakotoarivelo, Andrinajoro R.; Rakotomboavonjy, Victor; Randrianandrianina, Felicien H.; Razafimanahaka, H. Julie; Ralaiarimalala, Sylvain R.] Madagasikara Voakajy, Antananarivo, Madagascar	Bangor University; University of Kent	Jenkins, RKB (corresponding author), Bangor Univ, Sch Environm Nat Resources & Geog, Bangor, Gwynedd, Wales.	julia.jones@bangor.ac.uk	Jenkins, Richard KB/A-4567-2012; Keane, Aidan/Q-5153-2019; Keane, Aidan/B-4098-2011; Jones, Julia P G/ABD-5629-2021; Jones, Julia P G/A-3031-2011	Keane, Aidan/0000-0002-9704-5576; Keane, Aidan/0000-0002-9704-5576; Jones, Julia P G/0000-0002-5199-3335; Jones, Julia P G/0000-0002-5199-3335	United Kingdom government Darwin Initiative [17-1127]; Disney Wildlife Conservation Fund; National Geographic Society; IUCN Netherlands; Rufford Foundation; SeaWorld and Busch Gardens	United Kingdom government Darwin Initiative; Disney Wildlife Conservation Fund; National Geographic Society(National Geographic Society); IUCN Netherlands; Rufford Foundation; SeaWorld and Busch Gardens	The work was funded by the United Kingdom government Darwin Initiative (grant 17-1127) (http://darwin.defra.gov.uk/), Disney Wildlife Conservation Fund (http://disney.go.com/disneyhand/environmentality/dwcf/apply.html), National Geographic Society (http://www.nationalgeographic.com/field/grants-programs/cre-application.html), IUCN Netherlands (http://www.terravivagrants.org/Home/funding-news/new-and-changed-grants-programs/iucn-netherlandssmallconservationgrantsin2011), Rufford Foundation (http://www.rufford.org/) and SeaWorld and Busch Gardens (http://www.swbg-conservationfund.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Ambatovy Minerals provided some matched funding to the authors' project on the condition that the authors included areas covered by their mine in the study. However, they did not have any involvement in the design of the survey or in selecting specific study villages (just the communes in which the authors were to work; communes are large administrative units covering many 1000s of people). Conservation International similarly had no involvement in the design of the study or selecting of study villages or households. However, they also provided funding to the project on the condition that the authors included communes within their zone of intervention around a new protected area.	Allebone-Webb SM, 2011, CONSERV BIOL, V25, P597, DOI 10.1111/j.1523-1739.2011.01681.x; ANDRIAFIDISON D, 2008, IUCN 2010 IUCN RED L; Barrett MA, 2009, NATURE, V461, P470, DOI 10.1038/461470a; Bates D. M., 2010, LME4 MIXED EFFECTS M; Bennett EL, 2000, BIOL RESOURCE MANAGE, P499; BERNARD AR, 2000, SOCIAL RES METHODS Q; Bouche P, 2010, AFR J ECOL, V48, P994, DOI 10.1111/j.1365-2028.2009.01202.x; Brashares JS, 2004, SCIENCE, V306, P1180, DOI 10.1126/science.1102425; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Burney DA, 2004, J HUM EVOL, V47, P25, DOI 10.1016/j.jhevol.2004.05.005; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Coad L, 2010, CONSERV BIOL, V24, P1510, DOI 10.1111/j.1523-1739.2010.01525.x; Colding J, 2001, ECOL APPL, V11, P584; Cowlishaw G, 2005, CONSERV BIOL, V19, P139; Crowley BE, 2010, QUATERNARY SCI REV, V29, P2591, DOI 10.1016/j.quascirev.2010.06.030; DRAPER R, 2010, NATL GEOGR, V218, P80; Duffy R, 2005, DEV CHANGE, V36, P825, DOI 10.1111/j.0012-155X.2005.00437.x; Dunham AE, 2008, BIOL CONSERV, V141, P287, DOI 10.1016/j.biocon.2007.10.006; East T, 2005, BIOL CONSERV, V126, P206, DOI 10.1016/j.biocon.2005.05.012; Ehrlich I., 1996, J EC PERSPECTIVES, V10; Ekholm O, 2004, EUR J CLIN NUTR, V58, P60, DOI 10.1038/sj.ejcn.1601746; Fa JE, 2009, ANIM CONSERV, V12, P599, DOI 10.1111/j.1469-1795.2009.00289.x; Fa JE, 2009, MAMMAL REV, V39, P231, DOI 10.1111/j.1365-2907.2009.00149.x; FAVRE JC, 1996, PRIMATE REPORT, V46, P33; Garcia G, 2003, ORYX, V37, P115, DOI 10.1017/S0030605303000206; GELMAN A, 2007, DATA ANAL USING REGR, P466; Gilland B, 2002, FOOD POLICY, V27, P47, DOI 10.1016/S0306-9192(02)00002-7; Godoy R, 2010, ANIM CONSERV, V13, P265, DOI 10.1111/j.1469-1795.2009.00330.x; Golden CD, 2009, ORYX, V43, P386, DOI 10.1017/S0030605309000131; Iehle C, 2007, EMERG INFECT DIS, V13, P159, DOI 10.3201/eid1301.060791; Jenkins RKB, 2007, ORYX, V41, P263, DOI 10.1017/S0030605307001883; Jenkins Richard K.B., 2008, Madagascar Conservation & Development, V3, P22; John FAVS, 2010, BIOL CONSERV, V143, P1025, DOI 10.1016/j.biocon.2010.01.018; Jones JPG, 2008, CONSERV BIOL, V22, P976, DOI 10.1111/j.1523-1739.2008.00970.x; Karp A, 2007, SMALL ARMS SURVEY 20; Keane A, 2011, CONSERV LETT, V4, P55, DOI 10.1111/j.1755-263X.2010.00144.x; LAMBEK M, 1992, MAN, V27, P245, DOI 10.2307/2804053; Levitt SD, 1998, ECON INQ, V36, P353, DOI 10.1111/j.1465-7295.1998.tb01720.x; Lindsey PA, 2011, ORYX, V45, P84, DOI 10.1017/S0030605310001274; Mazurkiewicz SM, 1996, WILDLIFE SOC B, V24, P140; Milner-Gulland EJ, 2003, TRENDS ECOL EVOL, V18, P351, DOI 10.1016/S0169-5347(03)00123-X; *MIN FIN, 2006, ENQ PER AUPR MEN 200; Mutschler T, 2001, ORYX, V35, P152, DOI 10.1046/j.1365-3008.2001.00167.x; Nicoll M.E., 2003, NATURAL HIST MADAGAS, P1283; O'Brien S, 2003, ORYX, V37, P338, DOI 10.1017/S0030605303000590; Osborn MF, 2010, N AM J FISH MANAGE, V30, P665, DOI 10.1577/M09-196.1; Peres CA, 2000, CONSERV BIOL, V14, P240, DOI 10.1046/j.1523-1739.2000.98485.x; Quinn Aleta, 2002, Mammalian Species, P1; R Core Development Team, 2010, R LANG ENV STAT COMP; Rabearivony Jeanneney, 2008, Madagascar Conservation & Development, V3, P7; Rakotoarivelo Andrinajoro R., 2011, Madagascar Conservation & Development, V6, P37; Randrianandrianina FH, 2010, ORYX, V44, P411, DOI 10.1017/S003060531000044X; REDFORD KH, 1992, BIOSCIENCE, V42, P412, DOI 10.2307/1311860; Rowcliffe JM, 2004, P ROY SOC B-BIOL SCI, V271, P2631, DOI 10.1098/rspb.2004.2915; Smith RJ, 2006, ORYX, V40, P400, DOI 10.1017/S0030605306001232; Takasaki Y, 2000, WORLD DEV, V28, P1961, DOI 10.1016/S0305-750X(00)00062-0; THALMANN U, 1993, INT J PRIMATOL, V14, P357, DOI 10.1007/BF02192772; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; Wilkie DS, 2005, CONSERV BIOL, V19, P268, DOI 10.1111/j.1523-1739.2005.00372.x; Wilkie DS, 2001, CONSERV BIOL, V15, P761, DOI 10.1046/j.1523-1739.2001.015003761.x; Willcox AS, 2007, BIOL CONSERV, V134, P251, DOI 10.1016/j.biocon.2006.08.016; Wolfe ND, 2005, P NATL ACAD SCI USA, V102, P7994, DOI 10.1073/pnas.0501734102; Wolfe ND, 2004, LANCET, V363, P932, DOI 10.1016/S0140-6736(04)15787-5; Yee TW, 1996, J ROY STAT SOC B MET, V58, P481	64	93	97	0	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e27570	10.1371/journal.pone.0027570	http://dx.doi.org/10.1371/journal.pone.0027570			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	866GS	22194787	Green Published, gold, Green Submitted			2022-12-25	WOS:000298369100007
J	Redanz, S; Standar, K; Podbielski, A; Kreikemeyer, B				Redanz, Sylvio; Standar, Kerstin; Podbielski, Andreas; Kreikemeyer, Bernd			A Five-Species Transcriptome Array for Oral Mixed-Biofilm Studies	PLOS ONE			English	Article							COPPER-TRANSPORT OPERON; COMMUNITIES; GINGIVALIS; EXPRESSION; GENES; SUMMARIES; PROTEINS; DISEASES; COPYAZ; HSP70	Background: Oral polymicrobial interactions and biofilm formation are associated with initiation and progression of caries, gingivitis, and periodontitis. Transcriptome studies of such interactions, allowing a first mechanistic insight, are hampered by current single-species array designs. Methodology/Principal Findings: In this study we used 385 K NimbleGene (TM) technology for design and evaluation of an array covering the full genomes of 5 important physiological-, cariogenic-, and periodontitis-associated microorganisms (Streptococcus sanguinis, Streptococcus mutans, Fusobacterium nucleatum, Aggregatibacter actinomycetemcomitans, and Porphyromonas gingivalis). Array hybridization was done with cDNA from cultures grown for 24 h anaerobically. Single species experiments identified cross-species hybridizing array probes. These probes could be neglected in a mixed-species experimental setting without the need to exclude the whole genes from the analysis. Between 69% and almost 99% of the genomes were actively transcribed under the mono-species planktonic, monolayer, and biofilm conditions. The influence of Streptococcus mitis (not represented on the array) on S. mutans gene transcription was determined as a test for a dualspecies mixed biofilm setup. Phenotypically, under the influence of S. mitis an increase in S. mutans biofilm mass and a decrease in media pH-value were noticed, thereby confirming previously published data. Employing a stringent cut-off (2fold, p, 0.05), 19 S. mutans transcripts were identified with increased abundance, and 11 with decreased abundance compared to a S. mutans mono-species biofilm. Several of these genes have previously been found differentially regulated under general and acid stress, thereby confirming the value of this array. Conclusions/Significance: This new array allows transcriptome studies on multi-species oral biofilm interactions. It may become an important asset in future oral biofilm and inhibitor/therapy studies.	[Redanz, Sylvio; Standar, Kerstin; Podbielski, Andreas; Kreikemeyer, Bernd] Univ Hosp Rostock, Inst Med Microbiol Virol & Hyg, Rostock, Germany	University of Rostock	Redanz, S (corresponding author), Univ Hosp Rostock, Inst Med Microbiol Virol & Hyg, Rostock, Germany.	bernd.kreikemeyer@med.uni-rostock.de	Redanz, Sylvio/AAH-1369-2020	Kreikemeyer, Bernd/0000-0001-9527-5098; Redanz, Sylvio/0000-0003-1541-2545	German Federal Ministry of Education and Research (BMBF) [FKZ 0313801M, FKZ 0313936B]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Federal Ministry of Education and Research (BMBF) grants in the framework of the PathoGenoMic Plus program (FKZ 0313801M) and ERANet PathoGenoMics I program (FKZ 0313936B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; Ajdic D, 2007, J BACTERIOL, V189, P5049, DOI 10.1128/JB.00338-07; Albandar JM, 2002, PERIODONTOL 2000, V29, P7, DOI 10.1034/j.1600-0757.2002.290101.x; Beikler T, 2011, PERIODONTOL 2000, V55, P87, DOI 10.1111/j.1600-0757.2010.00360.x; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; De Stoppelaar J D, 1970, Caries Res, V4, P114; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Gong YX, 2009, MICROBIOL-SGM, V155, P3322, DOI 10.1099/mic.0.031591-0; Griswold AR, 2004, J BACTERIOL, V186, P1902, DOI 10.1128/JB.186.6.1902-1904.2004; Haffajee AD, 2006, PERIODONTOL 2000, V42, P7, DOI 10.1111/j.1600-0757.2006.00190.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jayaraman GC, 1997, MOL MICROBIOL, V25, P329, DOI 10.1046/j.1365-2958.1997.4671835.x; Jenkinson HF, 2005, TRENDS MICROBIOL, V13, P589, DOI 10.1016/j.tim.2005.09.006; Kajfasz JK, 2009, J BACTERIOL, V191, P2060, DOI 10.1128/JB.01609-08; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; KOLENBRANDER PE, 1989, INFECT IMMUN, V57, P3204, DOI 10.1128/IAI.57.10.3204-3209.1989; Kolenbrander PE, 2002, MICROBIOL MOL BIOL R, V66, P486, DOI 10.1128/MMBR.66.3.486-505.2002; Koo H, 2010, J BACTERIOL, V192, P3024, DOI 10.1128/JB.01649-09; Kuramitsu HK, 2007, MICROBIOL MOL BIOL R, V71, P653, DOI 10.1128/MMBR.00024-07; Lamont RJ, 2002, MICROBIOL-SGM, V148, P1627, DOI 10.1099/00221287-148-6-1627; Leme AFP, 2006, J DENT RES, V85, P878, DOI 10.1177/154405910608501002; Lemos JAC, 2005, CURR ISSUES MOL BIOL, V7, P95; Lemos JAC, 2001, J BACTERIOL, V183, P6074, DOI 10.1128/JB.183.20.6074-6084.2001; Loo CY, 2000, J BACTERIOL, V182, P1374, DOI 10.1128/JB.182.5.1374-1382.2000; Lynch DJ, 2007, FEMS MICROBIOL LETT, V268, P158, DOI 10.1111/j.1574-6968.2006.00576.x; Maeda K, 2004, MICROBES INFECT, V6, P1163, DOI 10.1016/j.micinf.2004.06.005; Mager DL, 2003, J CLIN PERIODONTOL, V30, P644, DOI 10.1034/j.1600-051X.2003.00376.x; Marsh PD, 2011, PERIODONTOL 2000, V55, P16, DOI 10.1111/j.1600-0757.2009.00339.x; Martinez AR, 2010, MOL ORAL MICROBIOL, V25, P331, DOI 10.1111/j.2041-1014.2010.00580.x; Mitrakul K, 2004, ORAL MICROBIOL IMMUN, V19, P395, DOI 10.1111/j.1399-302x.2004.00176.x; Molin S, 2003, CURR OPIN BIOTECH, V14, P255, DOI 10.1016/S0958-1669(03)00036-3; O'Toole GA, 2000, J BACTERIOL, V182, P425, DOI 10.1128/JB.182.2.425-431.2000; Paramonova E, 2009, J DENT RES, V88, P922, DOI 10.1177/0022034509344569; Shah DSH, 2004, MICROBIOL-SGM, V150, P1947, DOI 10.1099/mic.0.26955-0; Shemesh M, 2007, MICROBIOL-SGM, V153, P1307, DOI 10.1099/mic.0.2006/002030-0; Spratt D. A., 2003, Reviews in Environmental Science and Bio/Technology, V2, P109, DOI 10.1023/B:RESB.0000040466.82937.df; Standar K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013135; Vats N, 2001, MICROBIOL-UK, V147, P653, DOI 10.1099/00221287-147-3-653; Wen ZT, 2011, MOL ORAL MICROBIOL, V26, P2, DOI 10.1111/j.2041-1014.2010.00581.x; Zanin ICJ, 2006, EUR J ORAL SCI, V114, P64, DOI 10.1111/j.1600-0722.2006.00263.x	41	20	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e27827	10.1371/journal.pone.0027827	http://dx.doi.org/10.1371/journal.pone.0027827			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194794	gold, Green Submitted, Green Published			2022-12-25	WOS:000298369100014
J	Zetterberg, H; Mortberg, E; Song, LA; Chang, L; Provuncher, GK; Patel, PP; Ferrell, E; Fournier, DR; Kan, CW; Campbell, TG; Meyer, R; Rivnak, AJ; Pink, BA; Minnehan, KA; Piech, T; Rissin, DM; Duffy, DC; Rubertsson, S; Wilson, DH; Blennow, K				Zetterberg, Henrik; Mortberg, Erik; Song, Linan; Chang, Lei; Provuncher, Gail K.; Patel, Purvish P.; Ferrell, Evan; Fournier, David R.; Kan, Cheuk W.; Campbell, Todd G.; Meyer, Ray; Rivnak, Andrew J.; Pink, Brian A.; Minnehan, Kaitlin A.; Piech, Tomasz; Rissin, David M.; Duffy, David C.; Rubertsson, Sten; Wilson, David H.; Blennow, Kaj			Hypoxia Due to Cardiac Arrest Induces a Time-Dependent Increase in Serum Amyloid beta Levels in Humans	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ALZHEIMER-DISEASE; CEREBROSPINAL-FLUID; RISK; PLASMA; OLIGOMERIZATION; PEPTIDES; DEMENTIA; PROTEINS; BRAIN	Amyloid beta (Ab) peptides are proteolytic products from amyloid precursor protein (APP) and are thought to play a role in Alzheimer disease (AD) pathogenesis. While much is known about molecular mechanisms underlying cerebral A beta accumulation in familial AD, less is known about the cause(s) of brain amyloidosis in sporadic disease. Animal and postmortem studies suggest that A beta secretion can be up-regulated in response to hypoxia. We employed a new technology (Single Molecule Arrays, SiMoA) capable of ultrasensitive protein measurements and developed a novel assay to look for changes in serum A beta 42 concentration in 25 resuscitated patients with severe hypoxia due to cardiac arrest. After a lag period of 10 or more hours, very clear serum Ab42 elevations were observed in all patients. Elevations ranged fromapproximately 80% to over 70-fold, with most elevations in the range of 3-10-fold (average approximately 7-fold). The magnitude of the increase correlated with clinical outcome. These data provide the first direct evidence in living humans that ischemia acutely increases Ab levels in blood. The results point to the possibility that hypoxia may play a role in the amyloidogenic process of AD.	[Zetterberg, Henrik; Blennow, Kaj] Univ Gothenburg, Dept Psychiat & Neurochem, Sahlgrenska Acad, Molndal, Sweden; [Mortberg, Erik; Rubertsson, Sten] Uppsala Univ, Dept Surg Sci Anaesthesia & Intens Care, Uppsala, Sweden; [Song, Linan; Chang, Lei; Provuncher, Gail K.; Patel, Purvish P.; Ferrell, Evan; Fournier, David R.; Kan, Cheuk W.; Campbell, Todd G.; Meyer, Ray; Rivnak, Andrew J.; Pink, Brian A.; Minnehan, Kaitlin A.; Piech, Tomasz; Rissin, David M.; Duffy, David C.; Wilson, David H.] Quanterix Corp, Cambridge, MA USA	University of Gothenburg; Uppsala University	Zetterberg, H (corresponding author), Univ Gothenburg, Dept Psychiat & Neurochem, Sahlgrenska Acad, Molndal, Sweden.	henrik.zetterberg@clinchem.gu.se			Swedish Research Council [K2010-63P-21562-01-4, K2011-61X-20401-05-6]; Soderberg Foundation; Alzheimer's Association; Swedish State Support for Clinical Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); Soderberg Foundation; Alzheimer's Association(Alzheimer's Association); Swedish State Support for Clinical Research	This study was supported by grants from the Swedish Research Council (K2010-63P-21562-01-4, K2011-61X-20401-05-6), the Soderberg Foundation, Alzheimer's Association and Swedish State Support for Clinical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Cummins RO, 1997, RESUSCITATION, V34, P151, DOI 10.1016/S0300-9572(97)01112-X; Guglielmotto M, 2009, J NEUROCHEM, V108, P1045, DOI 10.1111/j.1471-4159.2008.05858.x; Guo M, 2005, FEBS LETT, V579, P3574, DOI 10.1016/j.febslet.2005.05.036; Guo XX, 2009, HYPERTENSION, V54, P57, DOI 10.1161/HYPERTENSIONAHA.109.129700; Hansson O, 2010, NEUROBIOL AGING, V31, P357, DOI 10.1016/j.neurobiolaging.2008.03.027; Hooshmand B, 2010, NEUROLOGY, V75, P1408, DOI 10.1212/WNL.0b013e3181f88162; JENNETT B, 1975, LANCET, V1, P480; Kirkitadze MD, 2001, J MOL BIOL, V312, P1103, DOI 10.1006/jmbi.2001.4970; Koike MA, 2010, AM J PATHOL, V177, P300, DOI 10.2353/ajpath.2010.090750; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Li J, 2011, NEUROLOGY, V76, P1485, DOI 10.1212/WNL.0b013e318217e7a4; Mehta PD, 2000, ARCH NEUROL-CHICAGO, V57, P100, DOI 10.1001/archneur.57.1.100; Mortberg E, 2011, RESUSCITATION, V82, P26, DOI 10.1016/j.resuscitation.2010.10.011; Okereke OI, 2009, J ALZHEIMERS DIS, V16, P277, DOI 10.3233/JAD-2009-0948; Portelius E, 2010, INT J ALZHEIMERS DIS; Qi JP, 2007, J ALZHEIMERS DIS, V12, P335; Rissin DM, 2011, ANAL CHEM, V83, P2279, DOI 10.1021/ac103161b; Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641; Solomon A, 2009, DEMENT GERIATR COGN, V28, P75, DOI 10.1159/000231980; Vanderstichele H, 2000, AMYLOID, V7, P245, DOI 10.3109/13506120009146438; Wang XJ, 2010, J ALZHEIMERS DIS, V21, P813, DOI 10.3233/JAD-2010-100216; Wisniewski HM, 1996, FOLIA NEUROPATHOL, V34, P65; Yaffe K, 2011, JAMA-J AM MED ASSOC, V306, P613, DOI 10.1001/jama.2011.1115	25	126	128	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28263	10.1371/journal.pone.0028263	http://dx.doi.org/10.1371/journal.pone.0028263			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194817	Green Published, Green Submitted, gold			2022-12-25	WOS:000298369100025
J	Beauvais, G; Atwell, K; Jayanthi, S; Ladenheim, B; Cadet, JL				Beauvais, Genevieve; Atwell, Kenisha; Jayanthi, Subramaniam; Ladenheim, Bruce; Cadet, Jean Lud			Involvement of Dopamine Receptors in Binge Methamphetamine-Induced Activation of Endoplasmic Reticulum and Mitochondrial Stress Pathways	PLOS ONE			English	Article							UNFOLDED-PROTEIN RESPONSE; INDUCED NEURONAL APOPTOSIS; HEAT-SHOCK-PROTEIN; INDUCED NEUROTOXICITY; RAT-BRAIN; INDUCED HYPERTHERMIA; MESSENGER-RNA; CELL-DEATH; HYBRIDIZATION HISTOCHEMISTRY; TRANSGENIC MICE	Single large doses of methamphetamine ( METH) cause endoplasmic reticulum ( ER) stress and mitochondrial dysfunctions in rodent striata. The dopamine D(1) receptor appears to be involved in these METH-mediated stresses. The purpose of this study was to investigate if dopamine D(1) and D(2) receptors are involved in ER and mitochondrial stresses caused by single-day METH binges in the rat striatum. Male Sprague-Dawley rats received 4 injections of 10 mg/kg of METH alone or in combination with a putative D(1) or D(2) receptor antagonist, SCH23390 or raclopride, respectively, given 30 min prior to each METH injection. Rats were euthanized at various timepoints afterwards. Striatal tissues were used in quantitative RT-PCR and western blot analyses. We found that binge METH injections caused increased expression of the pro-survival genes, BiP/GRP-78 and P58(IPK), in a SCH23390-sensitive manner. METH also caused up-regulation of ER-stress genes, Atf2, Atf3, Atf4, CHOP/Gadd153 and Gadd34. The expression of heat shock proteins ( HSPs) was increased after METH injections. SCH23390 completely blocked induction in all analyzed ER stress-related proteins that included ATF3, ATF4, CHOP/Gadd153, HSPs and caspase-12. The dopamine D(2)-like antagonist, raclopride, exerted small to moderate inhibitory influence on some METH-induced changes in ER stress proteins. Importantly, METH caused decreases in the mitochondrial anti-apoptotic protein, Bcl-2, but increases in the pro-apoptotic proteins, Bax, Bad and cytochrome c, in a SCH23390-sensitive fashion. In contrast, raclopride provided only small inhibition of METH-induced changes in mitochondrial proteins. These findings indicate that METH-induced activation of striatal ER and mitochondrial stress pathways might be more related to activation of SCH23390-sensitive receptors.	[Beauvais, Genevieve; Atwell, Kenisha; Jayanthi, Subramaniam; Ladenheim, Bruce; Cadet, Jean Lud] NIDA, Mol Neuropsychiat Res Branch, Intramural Res Program, Baltimore, MD USA; [Beauvais, Genevieve] Univ Paris 05, Fac Pharm, Paris, France	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); UDICE-French Research Universities; Universite Paris Cite	Beauvais, G (corresponding author), NIDA, Mol Neuropsychiat Res Branch, Intramural Res Program, Baltimore, MD USA.	jcadet@intra.nida.nih.gov	Jayanthi, Subramaniam/ABI-4023-2020	Jayanthi, Subramaniam/0000-0002-5209-303X	National Institutes of Health/National Institute on Drug Abuse; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000551] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the Intramural Research Program of the National Institutes of Health/National Institute on Drug Abuse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Ameri K, 2008, INT J BIOCHEM CELL B, V40, P14, DOI 10.1016/j.biocel.2007.01.020; ANDERSEN PH, 1986, LIFE SCI, V38, P1507, DOI 10.1016/0024-3205(86)90564-3; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; BISCHOFF S, 1986, EUR J PHARMACOL, V129, P367, DOI 10.1016/0014-2999(86)90449-8; BISCHOFF S, 1988, J RECEPTOR RES, V8, P107, DOI 10.3109/10799898809048981; Bourne JA, 2001, CNS DRUG REV, V7, P399; BOUTHENET ML, 1991, BRAIN RES, V564, P203, DOI 10.1016/0006-8993(91)91456-B; Bowyer JF, 1999, ANN NY ACAD SCI, V890, P314, DOI 10.1111/j.1749-6632.1999.tb08009.x; Cadet JL, 2010, CNS NEUROL DISORD-DR, V9, P526; CADET JL, 1994, ANN NY ACAD SCI, V738, P388; Cadet JL, 2005, NEUROTOX RES, V8, P199, DOI 10.1007/BF03033973; Cadet JL, 1997, SYNAPSE, V25, P176; Cadet JL, 2003, FASEB J, V17, P1775, DOI 10.1096/fj.03-0073rev; Deng XL, 1999, J NEUROSCI, V19, P10107; Deng XL, 2002, NEUROPHARMACOLOGY, V42, P837, DOI 10.1016/S0028-3908(02)00034-5; Deng XL, 2001, MOL BRAIN RES, V93, P64, DOI 10.1016/S0169-328X(01)00184-X; Fawcett TW, 1999, BIOCHEM J, V339, P135, DOI 10.1042/0264-6021:3390135; GANDOLFI O, 1988, NEUROSCI LETT, V92, P192, DOI 10.1016/0304-3940(88)90059-6; Gold MS, 2009, BIOL PSYCHIAT, V66, P118, DOI 10.1016/j.biopsych.2009.02.021; GOTO S, 1993, BRAIN RES, V626, P351, DOI 10.1016/0006-8993(93)90602-J; Gregersen N, 2010, METHODS MOL BIOL, V648, P3, DOI 10.1007/978-1-60761-756-3_1; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; HALL H, 1988, PROG NEURO-PSYCHOPH, V12, P559, DOI 10.1016/0278-5846(88)90001-2; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Hayashi T, 2010, J PHARMACOL EXP THER, V332, P1054, DOI 10.1124/jpet.109.159244; HURST HC, 1991, NUCLEIC ACIDS RES, V19, P4601, DOI 10.1093/nar/19.17.4601; Jayanthi S, 1998, ANN NY ACAD SCI, V844, P92, DOI 10.1111/j.1749-6632.1998.tb08224.x; Jayanthi S, 2001, FASEB J, V15, P1745, DOI 10.1096/fj.01-0025com; Jayanthi S, 2004, FASEB J, V18, P238, DOI 10.1096/fj.03-0295com; Jayanthi S, 2005, P NATL ACAD SCI USA, V102, P868, DOI 10.1073/pnas.0404990102; Jayanthi S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006092; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; JOHNSON M, 1994, J PHARMACOL EXP THER, V270, P97; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; KIYATKIN EA, 2010, J NEURAL TRANSM; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; KOHLER C, 1985, BIOCHEM PHARMACOL, V34, P2251, DOI 10.1016/0006-2952(85)90778-6; Krasnova IN, 2009, BRAIN RES REV, V60, P379, DOI 10.1016/j.brainresrev.2009.03.002; Kuhn DM, 2008, ANN NY ACAD SCI, V1139, P118, DOI 10.1196/annals.1432.026; Kuperman DI, 1997, BRAIN RES, V771, P221, DOI 10.1016/S0006-8993(97)00710-5; Lachowicz JE, 1997, PHARMACOL TOXICOL, V81, P105, DOI 10.1111/j.1600-0773.1997.tb00039.x; Lan KC, 1998, J FORMOS MED ASSOC, V97, P528; LANDWEHRMEYER B, 1993, EUR J NEUROSCI, V5, P145, DOI 10.1111/j.1460-9568.1993.tb00480.x; LaVoie MJ, 1999, J NEUROSCI, V19, P1484, DOI 10.1523/jneurosci.19-04-01484.1999; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; McGee SM, 2004, AM J FOREN MED PATH, V25, P334, DOI 10.1097/01.paf.0000137206.16785.2f; MEADORWOODRUFF JH, 1992, NEUROSCI LETT, V145, P209, DOI 10.1016/0304-3940(92)90024-2; Melville MW, 1997, P NATL ACAD SCI USA, V94, P97, DOI 10.1073/pnas.94.1.97; Melville MW, 2000, CELL MOL LIFE SCI, V57, P311, DOI 10.1007/PL00000692; Momoi T, 2004, J CHEM NEUROANAT, V28, P101, DOI 10.1016/j.jchemneu.2004.05.008; ODELL SJ, 1993, J NEUROCHEM, V60, P1792, DOI 10.1111/j.1471-4159.1993.tb13405.x; Otero JH, 2010, SEMIN CELL DEV BIOL, V21, P472, DOI 10.1016/j.semcdb.2009.12.008; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Riddle EL, 2006, AAPS J, V8, pE413, DOI 10.1007/BF02854914; Rutkowski DT, 2007, MOL BIOL CELL, V18, P3681, DOI 10.1091/mbc.e07-03-0272; Sands WA, 2008, CELL SIGNAL, V20, P460, DOI 10.1016/j.cellsig.2007.10.005; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sekine Y, 2006, ARCH GEN PSYCHIAT, V63, P90, DOI 10.1001/archpsyc.63.1.90; Simmen T, 2010, BBA-BIOMEMBRANES, V1798, P1465, DOI 10.1016/j.bbamem.2010.04.009; Simon SL, 2000, AM J ADDICTION, V9, P222; Smith DJ, 2008, IUBMB LIFE, V60, P383, DOI 10.1002/iub.44; SOKOLOFF P, 1990, NATURE, V347, P146, DOI 10.1038/347146a0; SONSALLA PK, 1986, J PHARMACOL EXP THER, V238, P932; Thiriet N, 2005, J NEUROSCI, V25, P5273, DOI 10.1523/JNEUROSCI.4893-04.2005; Thomas DM, 2010, J NEUROCHEM, V115, P595, DOI 10.1111/j.1471-4159.2010.06950.x; Thomas M, 2010, SYNAPSE, V64, P579, DOI 10.1002/syn.20763; Valjent E, 2009, TRENDS NEUROSCI, V32, P538, DOI 10.1016/j.tins.2009.06.005; van Huizen R, 2003, J BIOL CHEM, V278, P15558, DOI 10.1074/jbc.M212074200; Volkow ND, 2001, AM J PSYCHIAT, V158, P377, DOI 10.1176/appi.ajp.158.3.377; Wilson JM, 1996, NAT MED, V2, P699, DOI 10.1038/nm0696-699; Xu WJ, 2005, SYNAPSE, V58, P110, DOI 10.1002/syn.20185; Young JC, 2010, BIOCHEM CELL BIOL, V88, P291, DOI [10.1139/o09-175, 10.1139/O09-175]; Yu XW, 1999, BRAIN RES, V823, P213, DOI 10.1016/S0006-8993(99)01154-3; Zhu JPQ, 2006, NEUROTOXICOLOGY, V27, P131, DOI 10.1016/j.neuro.2005.05.014	77	74	76	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28946	10.1371/journal.pone.0028946	http://dx.doi.org/10.1371/journal.pone.0028946			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174933	gold, Green Published, Green Submitted			2022-12-25	WOS:000298367300035
J	Nouri, J; Diaz-Martinez, I; Perez-Lorente, F				Nouri, Jaouad; Diaz-Martinez, Ignacio; Perez-Lorente, Felix			Tetradactyl Footprints of an Unknown Affinity Theropod Dinosaur from the Upper Jurassic of Morocco	PLOS ONE			English	Article							CENTRAL HIGH ATLAS; IOUARIDENE FORMATION; TRACKWAYS	Background: New tetradactyl theropod footprints from Upper Jurassic (Oxfordian-Kimmeridgian) have been found in the louaridene syncline (Morocco). The tracksites are at several layers in the intermediate lacustrine unit of louaridene Formation. The footprints were named informally in previous works "Eutynichnium atlasipodus''. We consider as nomen nudum. Methodology/Principal Findings: Boutakioutichnium atlasicus ichnogen. et ichnosp. nov. is mainly characterized by the hallux impression. It is long, strong, directed medially or forward, with two digital pads and with the proximal part of the first pad in lateral position. More than 100 footprints in 15 trackways have been studied with these features. The footprints are large, 38-48 cm in length, and 26-31 cm in width. Conclusions/Significance: Boutakioutichnium mainly differs from other ichnotaxa with hallux impression in lacking metatarsal marks and in not being a very deep footprint. The distinct morphology of the hallux of the Boutakioutichnium trackmaker -i.e. size and hallux position-are unique in the dinosaur autopodial record to date.	[Nouri, Jaouad] Univ Mohammed 5, Fac Sci, Rabat, Morocco; [Diaz-Martinez, Ignacio; Perez-Lorente, Felix] Univ La Rioja, Fac Ciencas, Logrono, La Rioja, Spain; [Diaz-Martinez, Ignacio; Perez-Lorente, Felix] Fdn Patrimonio Paleontol La Rioja, Enciso, La Rioja, Spain	Mohammed V University in Rabat; Universidad de La Rioja	Nouri, J (corresponding author), Univ Mohammed 5, Fac Sci, Rabat, Morocco.	felix.perez@unirioja.es	Martínez, Ignacio Díaz/I-2766-2015; Nouri, Professor J./B-2614-2008	Martínez, Ignacio Díaz/0000-0001-5301-8384; Nouri, Professor J./0000-0002-9982-3546; Environmental Science and Management, Global Journal of/0000-0003-0365-1696	Governement of La Rioja; Paleontological Heritage of La Rioja Foundation; University of La Rioja; Fomenta [2008/02]	Governement of La Rioja; Paleontological Heritage of La Rioja Foundation; University of La Rioja; Fomenta	This article forms part of the projects: Fomenta 2008/02 and Oficina de Transferencia de Resultados de Investigacion (Bureau Transfer Results Investigations) University of La Rioja and EMpresa (enterprise) Foundation Paleontological Heritage of La Rioja 2009. This work was subsidized by the Governement of La Rioja, the Paleontological Heritage of La Rioja Foundation and the University of La Rioja. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1976, NATURE, V261, P129, DOI 10.1038/261129a0; [Anonymous], 1889, P BOSTON SOC NATURAL; BELVEDERE M, 2008, 2 INT C ICHN ICHN 20; BELVEDERE M, 2008, THESIS U STUDI PADOV; BELVEDERE M, 2007, DINOSAUR TRACKS UPPE; Belvedere M, 2010, GEOL Q, V54, P367; Belvedere M, 2010, PALAEONTOLOGY, V53, P233, DOI 10.1111/j.1475-4983.2009.00928.x; Bogdanovich A. I., 2007, Vestnik Zoologii, V41, P283; Boutakiout Mohamed, 2009, Geogaceta, V47, P33; Boutakiout Mohamed, 2008, Geogaceta, V45, P51; Boutakiout Mohamed, 2009, Revista Espanola de Paleontologia, V24, P31; CALVO J O, 1991, Ameghiniana, V28, P241; Castanera D., 2010, 5 JORN INT PAL DIN E, P47; Charriere A, 2005, CR PALEVOL, V4, P385, DOI 10.1016/j.crpv.2005.04.009; CHOUBERT G, 1956, CR HEBD ACAD SCI, V243, P1639; COPE ED, 1887, AM NAT, V21, P367, DOI DOI 10.1086/274464; Csiki Z, 2010, P NATL ACAD SCI USA, V107, P15357, DOI 10.1073/pnas.1006970107; DEMATHIEU GR, 1986, GEOBIOS-LYON, V19, P327, DOI 10.1016/S0016-6995(86)80021-3; DUTUIT JM, 1980, MEM SOC GEOL FRANCE, V139, P95; Fornos JJ, 2002, PALAEOGEOGR PALAEOCL, V180, P277, DOI 10.1016/S0031-0182(01)00431-X; Gatesy SM, 1999, NATURE, V399, P141, DOI 10.1038/20167; Gatesy Stephen M., 2003, Ichnos, V10, P91, DOI 10.1080/10420940390255484; GOMES JP, 1915, COMUNICACOES COMISIO, V9, P132; Haddoumi H, 2010, GEOBIOS-LYON, V43, P433, DOI 10.1016/j.geobios.2010.01.001; Harris JD, 1996, CRETACEOUS RES, V17, P381, DOI 10.1006/cres.1996.0024; Harris JD, 1997, CRETACEOUS RES, V18, P139, DOI 10.1006/cres.1996.0053; Haubold H., 1971, HDB PALAOHERPETOLOGI; HEILMANN G, 1926, ORIGIN BIRDS; HITCHCOCK E, 1858, ICHNOLOGY NEW ENGALN; Ishigaki S., 1989, P83; Ishigaki S., 1988, NOTES SERVICE GEOLOG, V44, P79; Ishigaki Shinobu, 2009, Memoir of the Fukui Prefectural Dinosaur Museum, V8, P1; JENNY J, 1982, CR ACAD SCI II, V294, P223; Kuhn O., 1958, FAHRTEN VORZEITLICHE; Langer MC, 2004, DINOSAURIA, 2ND EDITION, P25; LAPPARENT AFD, 1945, B MUSEUM NATL HIST N, V17, P268; Leonardi G., 1987, GLOSARY MANUAL TETRA; Lockley M.G., 1990, Ichnos, V1, P81; Lockley Martin G., 2004, Ichnos, V11, P229, DOI 10.1080/10420940490428625; Lockley Martin G., 2000, Gaia (Lisboa), V15, P313; Lockley MG, 2009, GEOL SOC SPEC PUBL, V315, P255, DOI 10.1144/SP315.18; Lockley Martin G., 1994, Ichnos, V3, P213; LULL RS, 1953, B CONNECTICUT STATE, V81, P1; Marsh O.C., 1881, AM J SCI 3, V23, P81, DOI DOI 10.2475/AJS.S3-23.133.81; MEYER CA, 2002, 7 EUR WOKSH VERT PAL; Middleton KM, 2001, J MORPHOL, V250, P51, DOI 10.1002/jmor.1058; MOJON PO, 2009, NOUVELLES DONNEES CH; Nesbitt SJ, 2009, SCIENCE, V326, P1530, DOI 10.1126/science.1180350; Nopcsa, 1923, FORTSCHRITTE GEOLOGI, V2, P1; Nouri J., 2001, Geogaceta, V29, P83; Nouri J., 2007, THESIS U MOHAMMED 5; NOURI J, 2009, INVENTAIRE ICHNOLOGI; OSBORN H.F., 1924, AM MUS NOVIT, V144, P1; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Paul G., 1988, PREDATORY DINOSAURS; Perez-Lorente F., 2003, Ciencias de la Tierra Instituto de Estudios Riojanos, V26, P161; Perez-Lorente F., 2001, PALEOICNOLOGIA DINOS; Perez-Lorente Felix, 2007, Revista Espanola de Paleontologia, V22, P157; Pereziorente Fp, 1993, ZUBIA MONOGRAFICO, V5, p181 228; PERLE A, 1982, PROBLEMS GEOLOGY MON, V5, P94; PLATEAU H, 1937, COMPTES RENDUS SOMMA, P241; REQUETA LE, 2006, ZUBIA MONOGRAFICO, V18, P21; Romero Molina M.M., 2003, Ciencias de la Tierra Instituto de Estudios Riojanos, V26, P13; TARSITANO S, 1983, Acta Palaeontologica Polonica, V28, P251; Thulborn RA., 1990, DINOSAUR TRACKS; Thulborn Tony, 2001, Ichnos, V8, P207; Torcida F., 2003, Ciencias de la Tierra Instituto de Estudios Riojanos, V26, P109; WAGNER A, 1861, PHYSIKALISCHEN CLASS, V9, P1; Weems R.E., 1992, P 26 FORUM GEOLOGY I, V119, P113; Woodward A. S., 1907, P GEOLOGICAL SOC LON, V63, P140, DOI DOI 10.1144/GSL.JGS.1907.063.01-04.12; Xu X, 2001, J VERTEBR PALEONTOL, V21, P477, DOI 10.1671/0272-4634(2001)021[0477:ANTFTL]2.0.CO;2; Yang XL, 1987, DINOSAUR FOOTPRINTS	72	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e26882	10.1371/journal.pone.0026882	http://dx.doi.org/10.1371/journal.pone.0026882			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22180775	gold, Green Submitted, Green Published			2022-12-25	WOS:000298367300002
J	Rijkenberg, MJA; Langlois, RJ; Mills, MM; Patey, MD; Hill, PG; Nielsdottir, MC; Compton, TJ; LaRoche, J; Achterberg, EP				Rijkenberg, Micha J. A.; Langlois, Rebecca J.; Mills, Matthew M.; Patey, Matthew D.; Hill, Polly G.; Nielsdottir, Maria C.; Compton, Tanya J.; LaRoche, Julie; Achterberg, Eric P.			Environmental Forcing of Nitrogen Fixation in the Eastern Tropical and Sub-Tropical North Atlantic Ocean	PLOS ONE			English	Article							DISSOLVED ORGANIC NITROGEN; N-2 FIXATION; UNICELLULAR CYANOBACTERIA; COMMUNITY STRUCTURE; GLOBAL DISTRIBUTION; SAHARAN DUST; TRICHODESMIUM; IRON; PHOSPHORUS; CULTURES	During the winter of 2006 we measured nifH gene abundances, dinitrogen (N-2) fixation rates and carbon fixation rates in the eastern tropical and sub-tropical North Atlantic Ocean. The dominant diazotrophic phylotypes were filamentous cyanobacteria, which may include Trichodesmium and Katagnymene, with up to 10(6) L-1 nifH gene copies, unicellular group A cyanobacteria with up to 10(5) L-1 nifH gene copies and gamma A proteobacteria with up to 10(4) L-1 nifH gene copies. N-2 fixation rates were low and ranged between 0.032-1.28 nmol N L-1 d(-1) with a mean of 0.30 +/- 0.29 nmol N L-1 d(-1) (1 sigma, n = 65). CO2-fixation rates, representing primary production, appeared to be nitrogen limited as suggested by low dissolved inorganic nitrogen to phosphate ratios (DIN: DIP) of about 2 +/- 3.2 in surface waters. Nevertheless, N-2 fixation rates contributed only 0.55 +/- 0.87% (range 0.03-5.24%) of the N required for primary production. Boosted regression trees analysis (BRT) showed that the distribution of the gamma A proteobacteria and filamentous cyanobacteria nifH genes was mainly predicted by the distribution of Prochlorococcus, Synechococcus, picoeukaryotes and heterotrophic bacteria. In addition, BRT indicated that multiple a-biotic environmental variables including nutrients DIN, dissolved organic nitrogen (DON) and DIP, trace metals like dissolved aluminum (DAl), as a proxy of dust inputs, dissolved iron (DFe) and Fe-binding ligands as well as oxygen and temperature influenced N-2 fixation rates and the distribution of the dominant diazotrophic phylotypes. Our results suggest that lower predicted oxygen concentrations and higher temperatures due to climate warming may increase N-2 fixation rates. However, the balance between a decreased supply of DIP and DFe from deep waters as a result of more pronounced stratification and an enhanced supply of these nutrients with a predicted increase in deposition of Saharan dust may ultimately determine the consequences of climate warming for N-2 fixation in the North Atlantic.	[Rijkenberg, Micha J. A.; Patey, Matthew D.; Hill, Polly G.; Nielsdottir, Maria C.; Achterberg, Eric P.] Univ Southampton, Sch Ocean & Earth Sci, Natl Oceanog Ctr Southampton, Southampton, Hants, England; [Langlois, Rebecca J.; LaRoche, Julie] Leibniz Inst Marine Sci, D-24105 Kiel, Germany; [Mills, Matthew M.] Stanford Univ, Dept Geophys, Stanford, CA 94305 USA; [Compton, Tanya J.] Natl Inst Water & Atmospher Res, Hamilton, New Zealand	NERC National Oceanography Centre; University of Southampton; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Stanford University; National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Rijkenberg, MJA (corresponding author), Royal Netherlands Inst Sea Res, Den Hoorn, Texel, Netherlands.	Micha.Rijkenberg@nioz.nl	Rijkenberg, Micha/C-3245-2012; Achterberg, Eric P/C-5820-2009; Compton, Tanya/G-6230-2012; LaRoche, Julie/A-1109-2010; Patey, Matthew D/N-3001-2015	Achterberg, Eric P/0000-0002-3061-2767; Patey, Matthew D/0000-0001-8677-2818; Langlois, Rebecca/0000-0002-8382-4448; Hill, Polly/0000-0003-3122-7892; LaRoche, Julie/0000-0003-4809-6411	NERC as part of the UKSOLAS [NE/C001931/1]; NERC [noc010009] Funding Source: UKRI; Natural Environment Research Council [NE/C001931/1, noc010009, NE/C001737/1] Funding Source: researchfish	NERC as part of the UKSOLAS; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was funded by NERC as part of the UKSOLAS programme (NE/C001931/1). Website address: http://www.nerc.ac.uk/research/programmes/solas/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atallah ZK, 2007, PHYTOPATHOLOGY, V97, P865, DOI 10.1094/PHYTO-97-7-0865; Avak H., 1999, EA IRMS PRECISE ACCU; Badr ESA, 2003, TRAC-TREND ANAL CHEM, V22, P819, DOI 10.1016/S0165-9936(03)01202-0; Bartoli G, 2005, DEEP-SEA RES PT I, V52, P2005, DOI 10.1016/j.dsr.2005.06.006; Berman-Frank I, 2001, LIMNOL OCEANOGR, V46, P1249, DOI 10.4319/lo.2001.46.6.1249; Berman-Frank I, 2001, SCIENCE, V294, P1534, DOI 10.1126/science.1064082; Breitbarth E, 2007, BIOGEOSCIENCES, V4, P53, DOI 10.5194/bg-4-53-2007; Capone DG, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002331; Capone DG, 2001, CURR OPIN MICROBIOL, V4, P341, DOI 10.1016/S1369-5274(00)00215-0; CAPONE DG, 1994, APPL ENVIRON MICROB, V60, P3989, DOI 10.1128/AEM.60.11.3989-3995.1994; CHIAPELLO I, 1995, GEOPHYS RES LETT, V22, P3191, DOI 10.1029/95GL03313; de Baar HJW, 2008, MAR ECOL PROG SER, V364, P269, DOI 10.3354/meps07548; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Falcon LI, 2004, APPL ENVIRON MICROB, V70, P765, DOI 10.1128/AEM.70.2.765-770.2004; Falcon LI, 2002, APPL ENVIRON MICROB, V68, P5760, DOI 10.1128/AEM.68.11.5760-5764.2002; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Fu FX, 2003, FEMS MICROBIOL ECOL, V45, P203, DOI 10.1016/S0168-6496(03)00157-0; Hamme RC, 2004, DEEP-SEA RES PT I, V51, P1517, DOI 10.1016/j.dsr.2004.06.009; Hirata T, 2011, BIOGEOSCIENCES, V8, P311, DOI 10.5194/bg-8-311-2011; Ho TY, 2003, J PHYCOL, V39, P1145, DOI 10.1111/j.0022-3646.2003.03-090.x; Holl CM, 2007, DEEP-SEA RES PT II, V54, P1045, DOI 10.1016/j.dsr2.2007.02.002; Holl CM, 2005, J PHYCOL, V41, P1178, DOI 10.1111/j.1529-8817.2005.00146.x; Hutchins DA, 2007, LIMNOL OCEANOGR, V52, P1293, DOI 10.4319/lo.2007.52.4.1293; HYDES DJ, 1976, ANALYST, V101, P922, DOI 10.1039/an9760100922; Karl DM, 2008, MAR ECOL PROG SER, V364, P257, DOI 10.3354/meps07547; Kerouel R, 1997, MAR CHEM, V57, P265, DOI 10.1016/S0304-4203(97)00040-6; Kirkwood D, 1996, NUTR PRACTICAL NOTES, P25; Kustka A, 2002, RES MICROBIOL, V153, P255, DOI 10.1016/S0923-2508(02)01325-6; Kustka AB, 2003, LIMNOL OCEANOGR, V48, P1869, DOI 10.4319/lo.2003.48.5.1869; Langlois RJ, 2008, APPL ENVIRON MICROB, V74, P1922, DOI 10.1128/AEM.01720-07; Langlois RJ, 2005, APPL ENVIRON MICROB, V71, P7910, DOI 10.1128/AEM.71.12.7910-7919.2005; LaRoche J, 2005, J SEA RES, V53, P67, DOI 10.1016/j.seares.2004.05.005; Mahaffey C, 2005, AM J SCI, V305, P546, DOI 10.2475/ajs.305.6-8.546; Mahowald NM, 2009, ANNU REV MAR SCI, V1, P245, DOI 10.1146/annurev.marine.010908.163727; Maldonado MT, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002481; Mather RL, 2008, NAT GEOSCI, V1, P439, DOI 10.1038/ngeo232; Mills MM, 2010, NAT GEOSCI, V3, P412, DOI 10.1038/NGEO856; Mills MM, 2004, NATURE, V429, P292, DOI 10.1038/nature02550; Montoya JP, 2007, BIOGEOSCIENCES, V4, P369, DOI 10.5194/bg-4-369-2007; Montoya JP, 2004, NATURE, V430, P1027, DOI 10.1038/nature02824; Montoya JP, 1996, APPL ENVIRON MICROB, V62, P986, DOI 10.1128/AEM.62.3.986-993.1996; Moore CM, 2009, NAT GEOSCI, V2, P867, DOI 10.1038/ngeo667; Mulholland MR, 2004, AQUAT MICROB ECOL, V37, P85, DOI 10.3354/ame037085; Mulholland MR, 2001, J PHYCOL, V37, P1001, DOI 10.1046/j.1529-8817.2001.00080.x; Mulholland MR, 1999, J PHYCOL, V35, P977, DOI 10.1046/j.1529-8817.1999.3550977.x; Mulholland MR, 1999, MAR ECOL PROG SER, V188, P33, DOI 10.3354/meps188033; Mulholland MR, 2000, TRENDS PLANT SCI, V5, P148, DOI 10.1016/S1360-1385(00)01576-4; Needoba JA, 2007, LIMNOL OCEANOGR, V52, P1317, DOI 10.4319/lo.2007.52.4.1317; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Patey MD, 2008, TRAC-TREND ANAL CHEM, V27, P169, DOI 10.1016/j.trac.2007.12.006; Ridgeway G., 2004, GBM GEN BOOSTED REGR; Rijkenberg MJA, 2008, MAR CHEM, V109, P29, DOI 10.1016/j.marchem.2007.12.001; Rijkenberg MJA, 2008, MAR CHEM, V110, P56, DOI 10.1016/j.marchem.2008.02.006; Sanudo-Wilhelmy SA, 2001, NATURE, V411, P66, DOI 10.1038/35075041; Staal M, 2003, NATURE, V425, P504, DOI 10.1038/nature01999; Staal M, 2007, LIMNOL OCEANOGR, V52, P1305, DOI 10.4319/lo.2007.52.4.1305; Staal M, 2007, ENVIRON MICROBIOL, V9, P727, DOI 10.1111/j.1462-2920.2006.01195.x; Stal LJ, 2009, ENVIRON MICROBIOL, V11, P1632, DOI 10.1111/j.1758-2229.2009.00016.x; Stramma L, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2005JC002939; Suggett DJ, 2009, MAR ECOL PROG SER, V376, P1, DOI 10.3354/meps07830; Tagliabue A, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003929; Turk KA, 2011, ISME J, V5, P1201, DOI 10.1038/ismej.2010.205; Voss M, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020127; Wu JF, 2000, SCIENCE, V289, P759, DOI 10.1126/science.289.5480.759; Zehr JP, 1998, APPL ENVIRON MICROB, V64, P3444; Zehr JP, 2001, NATURE, V412, P635, DOI 10.1038/35088063; Zubkov MV, 2000, PROG OCEANOGR, V45, P369, DOI 10.1016/S0079-6611(00)00008-2; Zubkov MV, 2003, APPL ENVIRON MICROB, V69, P1299, DOI 10.1128/AEM.69.2.1299-1304.2003	68	29	30	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28989	10.1371/journal.pone.0028989	http://dx.doi.org/10.1371/journal.pone.0028989			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174940	Green Accepted, Green Submitted, gold, Green Published			2022-12-25	WOS:000298367300037
J	Philipp, U; Lupp, B; Momke, S; Stein, V; Tipold, A; Eule, JC; Rehage, J; Distl, O				Philipp, Ute; Lupp, Bettina; Moemke, Stefanie; Stein, Veronika; Tipold, Andrea; Eule, Johanna Corinna; Rehage, Juergen; Distl, Ottmar			A MITF Mutation Associated with a Dominant White Phenotype and Bilateral Deafness in German Fleckvieh Cattle	PLOS ONE			English	Article							WAARDENBURG-SYNDROME; INCOMPLETE ALBINISM; TIETZ-SYNDROME; HETEROCHROMIA IRIDES; GENE; RECOGNITION; DOMAIN; SOX10; PAX3; DNA	A dominantly inherited syndrome associated with hypopigmentation, heterochromia irides, colobomatous eyes and bilateral hearing loss has been ascertained in Fleckvieh cattle (German White Fleckvieh syndrome). This syndrome has been mapped to bovine chromosome (BTA) 22 using a genome-wide association study with the bovine high density single nucleotide polymorphism array. An R210I missense mutation has been identified within microphthalmia-associated transcription factor (MITF) as responsible for this syndrome. The mutation is located in the highly conserved basic region of the protein and causes a negative-dominant effect. SOX10 and PAX3 promoter binding site mutations in MITF could be ruled out as causative for the German White Fleckvieh syndrome. Molecular characterization of this newly detected bovine syndrome means a large animal model is now available for the Tietz syndrome in humans.	[Philipp, Ute; Lupp, Bettina; Moemke, Stefanie; Distl, Ottmar] Univ Vet Med Hannover, Inst Genet & Anim Breeding, Hannover, Germany; [Stein, Veronika; Tipold, Andrea] Univ Vet Med Hannover, Clin Small Anim, Hannover, Germany; [Eule, Johanna Corinna] Free Univ Berlin, Small Anim Clin, Berlin, Germany; [Rehage, Juergen] Univ Vet Med Hannover, Clin Cattle, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; Free University of Berlin; University of Veterinary Medicine Hannover, Foundation	Philipp, U (corresponding author), Univ Vet Med Hannover, Inst Genet & Anim Breeding, Hannover, Germany.	ottmar.distl@tiho-hannover.de						Amiel J, 1998, CLIN DYSMORPHOL, V7, P17; Bondurand N, 2000, HUM MOL GENET, V9, P1907, DOI 10.1093/hmg/9.13.1907; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; FERREDAMARE AR, 1993, NATURE, V363, P38, DOI 10.1038/363038a0; FISHER DE, 1993, CELL, V72, P467, DOI 10.1016/0092-8674(93)90122-7; Izumi K, 2008, CLIN GENET, V74, P93, DOI 10.1111/j.1399-0004.2008.01010.x; LEIPOLD HW, 1969, CORNELL VET, V59, P69; LEIPOLD HW, 1968, J HERED, V59, P3, DOI 10.1093/oxfordjournals.jhered.a107635; LEIPOLD HW, 1968, J HERED, V59, P223, DOI 10.1093/oxfordjournals.jhered.a107698; Luscher B, 1999, ONCOGENE, V18, P2955, DOI 10.1038/sj.onc.1202750; MOORE KJ, 1995, TRENDS GENET, V11, P442, DOI 10.1016/S0168-9525(00)89143-X; Potterf SB, 2000, HUM GENET, V107, P1, DOI 10.1007/s004390050001; Rak SG, 2005, VET J, V169, P188, DOI 10.1016/j.tvjl.2004.01.015; Smith SD, 2000, J MED GENET, V37, P446, DOI 10.1136/jmg.37.6.446; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; STEINGRIMSSON E, 1994, NAT GENET, V8, P256, DOI 10.1038/ng1194-256; TASSABEHJI M, 1994, NAT GENET, V8, P251, DOI 10.1038/ng1194-251; TIETZ W, 1963, AM J HUM GENET, V15, P259; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546	19	45	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28857	10.1371/journal.pone.0028857	http://dx.doi.org/10.1371/journal.pone.0028857			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174915	Green Submitted, gold, Green Published			2022-12-25	WOS:000298366600045
J	Marston, CK; Allen, CA; Beaudry, J; Price, EP; Wolken, SR; Pearson, T; Keim, P; Hoffmaster, AR				Marston, Chung K.; Allen, Christina A.; Beaudry, Jodi; Price, Erin P.; Wolken, Spenser R.; Pearson, Talima; Keim, Paul; Hoffmaster, Alex R.			Molecular Epidemiology of Anthrax Cases Associated with Recreational Use of Animal Hides and Yarn in the United States	PLOS ONE			English	Article								To determine potential links between the clinical isolate to animal products and their geographic origin, we genotyped (MLVA-8, MVLA-15, and canSNP analysis) 80 environmental and 12 clinical isolates and 2 clinical specimens from five cases of anthrax (California in 1976 [n = 1], New York in 2006 [n = 1], Connecticut in 2007 [n = 2], and New Hampshire in 2009[n = 1]) resulting from recreational handling of animal products. For the California case, four clinical isolates were identified as MLVA-8 genotype (GT) 76 and in the canSNP A.Br.Vollum lineage, which is consistent with the Pakistani origin of the yarn. Twenty eight of the California isolates were in the A.Br.Vollum canSNP lineage and one isolate was in the A.Br.003/004 canSNP sub-group. All 52 isolates and both clinical specimens related to the New York and Connecticut cases were MLVA-8 GT 1. The animal products associated with the NY and CT cases were believed to originate from West Africa, but no isolates from this region are available to be genotyped for comparison. All isolates associated with the New Hampshire case were identical and had a new genotype (GT 149). Isolates from the NY, CT and NH cases diverge from the established canSNP phylogeny near the base of the A.Br.011/009. This report illustrates the power of the current genotyping methods and the dramatically different epidemiological conditions that can lead to infections (i.e., contamination by a single genotype versus widespread contamination of numerous genotypes). These cases illustrate the need to acquire and genotype global isolates so that accurate assignments can be made about isolate origins.	[Marston, Chung K.; Hoffmaster, Alex R.] Ctr Dis Control & Prevent, Bacterial Special Pathogens Branch, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA; [Allen, Christina A.; Beaudry, Jodi; Price, Erin P.; Wolken, Spenser R.; Pearson, Talima; Keim, Paul] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA	Centers for Disease Control & Prevention - USA; Northern Arizona University	Marston, CK (corresponding author), Ctr Dis Control & Prevent, Bacterial Special Pathogens Branch, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.	cdk5@cdc.gov	Price, Erin/N-2336-2013; Pearson, Talima/O-7840-2019	Price, Erin/0000-0002-1079-4882; Pearson, Talima/0000-0003-3696-041X	U.S. Department of Homeland Security S&T CB Division Bioforensics	U.S. Department of Homeland Security S&T CB Division Bioforensics(United States Department of Homeland Security (DHS))	Portions of this work were supported by the U.S. Department of Homeland Security S&T CB Division Bioforensics R&D Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this report.	*CDC, 1976, MMWR-MORBID MORTAL W, V25, P33; *CDCP, 2007, MMWR-MORBID MORTAL W, V57, P628; *CDCP, 1974, MMWR-MORBID MORTAL W, V23, P142; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P280; *ED TEAM, 2006, EURO SURVEILL, V11; Germer S, 1999, GENOME RES, V9, P72; Germer S, 2000, GENOME RES, V10, P258, DOI 10.1101/gr.10.2.258; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; Marston CK, 2005, APPL ENVIRON MICROB, V71, P7778, DOI 10.1128/AEM.71.12.7778-7780.2005; Mayo L., 2010, Morbidity and Mortality Weekly Report, V59, P872; Opare C, 2000, ACTA TROP, V76, P49, DOI 10.1016/S0001-706X(00)00089-9; SUFFIN SC, 1978, HUM PATHOL, V9, P594, DOI 10.1016/S0046-8177(78)80140-3; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461	13	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28274	10.1371/journal.pone.0028274	http://dx.doi.org/10.1371/journal.pone.0028274			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174783	Green Published, gold			2022-12-25	WOS:000298365700026
J	Porter, SS; Stanton, ML; Rice, KJ				Porter, Stephanie S.; Stanton, Maureen L.; Rice, Kevin J.			Mutualism and Adaptive Divergence: Co-Invasion of a Heterogeneous Grassland by an Exotic Legume-Rhizobium Symbiosis	PLOS ONE			English	Article							GENERAL-PURPOSE GENOTYPES; LOCAL ADAPTATION; MEDICAGO-POLYMORPHA; PLANT INVASIONS; MYCORRHIZAL SYMBIOSES; PARASITISM CONTINUUM; SERPENTINE SOILS; PARTNER CHOICE; SUILLUS-LUTEUS; TRADE-OFFS	Species interactions play a critical role in biological invasions. For example, exotic plant and microbe mutualists can facilitate each other's spread as they co-invade novel ranges. Environmental context may influence the effect of mutualisms on invasions in heterogeneous environments, however these effects are poorly understood. We examined the mutualism between the legume, Medicago polymorpha, and the rhizobium, Ensifer medicae, which have both invaded California grasslands. Many of these invaded grasslands are composed of a patchwork of harsh serpentine and relatively benign non-serpentine soils. We grew legume genotypes collected from serpentine or non-serpentine soil in both types of soil in combination with rhizobium genotypes from serpentine or non-serpentine soils and in the absence of rhizobia. Legumes invested more strongly in the mutualism in the home soil type and trends in fitness suggested that this ecotypic divergence was adaptive. Serpentine legumes had greater allocation to symbiotic root nodules in serpentine soil than did non-serpentine legumes and non-serpentine legumes had greater allocation to nodules in non-serpentine soil than did serpentine legumes. Therefore, this invasive legume has undergone the rapid evolution of divergence for soil-specific investment in the mutualism. Contrary to theoretical expectations, the mutualism was less beneficial for legumes grown on the stressful serpentine soil than on the non-serpentine soil, possibly due to the inhibitory effects of serpentine on the benefits derived from the interaction. The soil-specific ability to allocate to a robust microbial mutualism may be a critical, and previously overlooked, adaptation for plants adapting to heterogeneous environments during invasion.	[Porter, Stephanie S.; Stanton, Maureen L.] Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA; [Porter, Stephanie S.; Stanton, Maureen L.; Rice, Kevin J.] Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA; [Rice, Kevin J.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Porter, SS (corresponding author), Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA.	ssporter@ucdavis.edu	Stanton, Maureen L/E-1204-2012		National Science Foundation [0909154]; UC Davis	National Science Foundation(National Science Foundation (NSF)); UC Davis	This material is based upon work supported by the National Science Foundation under Grant No. 0909154 and a UC Davis Mathias Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaensen K, 2005, APPL ENVIRON MICROB, V71, P7279, DOI 10.1128/AEM.71.11.7279-7284.2005; AKCAY E, AM NATURALIST; [Anonymous], 1970, MANUAL PRACTICAL STU; Bailly X, 2006, MOL ECOL, V15, P2719, DOI 10.1111/j.1365-294X.2006.02969.x; Baythavong BS, 2009, ECOLOGY, V90, P2118, DOI 10.1890/08-0307.1; Berglund ABN, 2004, NEW PHYTOL, V161, P199, DOI 10.1046/j.1469-8137.2003.00934.x; Bever JD, 2010, TRENDS ECOL EVOL, V25, P468, DOI 10.1016/j.tree.2010.05.004; Brady KU, 2005, ANNU REV ECOL EVOL S, V36, P243, DOI 10.1146/annurev.ecolsys.35.021103.105730; Callaway RM, 2011, ECOLOGY, V92, P1027, DOI 10.1890/i0012-9658-92-5-1027; Charman N, 2004, SOIL BIOL BIOCHEM, V36, P1331, DOI 10.1016/j.soilbio.2004.04.014; Chen WM, 2005, NEW PHYTOL, V168, P661, DOI 10.1111/j.1469-8137.2005.01533.x; De Haan RL, 1998, CROP SCI, V38, P1558, DOI 10.2135/cropsci1998.0011183X003800060025x; del Pozo A, 2000, ANN BOT-LONDON, V85, P809, DOI 10.1006/anbo.2000.1141; Dickie IA, 2010, NEW PHYTOL, V187, P475, DOI 10.1111/j.1469-8137.2010.03277.x; Ehrenfeld JG, 2003, ECOSYSTEMS, V6, P503, DOI 10.1007/s10021-002-0151-3; Graziano D, 2010, CROP PASTURE SCI, V61, P59, DOI 10.1071/CP09116; Gubry-Rangin C, 2010, P ROY SOC B-BIOL SCI, V277, P1947, DOI 10.1098/rspb.2009.2072; Harrison S, 1999, OECOLOGIA, V121, P99, DOI 10.1007/s004420050910; Harrison S, 2003, CONSERV BIOL, V17, P837, DOI 10.1046/j.1523-1739.2003.01633.x; Heath KD, 2007, P ROY SOC B-BIOL SCI, V274, P1905, DOI 10.1098/rspb.2007.0495; Heath KD, 2009, EVOLUTION, V63, P652, DOI 10.1111/j.1558-5646.2008.00582.x; Hereford J, 2009, AM NAT, V173, P579, DOI 10.1086/597611; Hoeksema JD, 2008, AM NAT, V171, P275, DOI 10.1086/527496; Inderjit, 2010, TRENDS ECOL EVOL, V25, P512, DOI 10.1016/j.tree.2010.06.006; Johnson NC, 2010, P NATL ACAD SCI USA, V107, P2093, DOI 10.1073/pnas.0906710107; Johnson NC, 1997, NEW PHYTOL, V135, P575, DOI 10.1046/j.1469-8137.1997.00729.x; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kiers ET, 2003, NATURE, V425, P78, DOI 10.1038/nature01931; KIESTER AR, 1984, AM NAT, V124, P220, DOI 10.1086/284265; KRUCKEBERG AR, 1951, AM J BOT, V38, P408, DOI 10.2307/2438248; KRUCKEBERG AR, 1967, BRITTONIA, V19, P133, DOI 10.2307/2805271; Krznaric E, 2009, ENVIRON POLLUT, V157, P1581, DOI 10.1016/j.envpol.2008.12.030; Kurten EL, 2008, BIOL INVASIONS, V10, P19, DOI 10.1007/s10530-007-9101-5; Lambrinos JG, 2004, ECOLOGY, V85, P2061, DOI 10.1890/03-8013; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Lesins KA, 1979, GENUS MEDICAGO LEGUM; Linhart YB, 1996, ANNU REV ECOL SYST, V27, P237, DOI 10.1146/annurev.ecolsys.27.1.237; Maron JL, 1996, OECOLOGIA, V105, P302, DOI 10.1007/BF00328732; Mitchell CE, 2006, ECOL LETT, V9, P726, DOI 10.1111/j.1461-0248.2006.00908.x; Neuhauser C, 2004, ECOL MODEL, V177, P337, DOI 10.1016/j.ecolmodel.2004.02.010; Oldroyd GED, 2009, SCIENCE, V324, P753, DOI 10.1126/science.1171644; Parker IM, 2003, CONSERV BIOL, V17, P59, DOI 10.1046/j.1523-1739.2003.02019.x; Parker MA, 2006, DIVERS DISTRIB, V12, P563, DOI 10.1111/j.1366-9516.2006.00255.x; Parker Matthew A., 2001, Diversity and Distributions, V7, P125, DOI 10.1046/j.1472-4642.2001.00103.x; Perret X, 2000, MICROBIOL MOL BIOL R, V64, P180, DOI 10.1128/MMBR.64.1.180-201.2000; Pringle A, 2009, ANNU REV ECOL EVOL S, V40, P699, DOI 10.1146/annurev.ecolsys.39.110707.173454; Reinhart KO, 2006, NEW PHYTOL, V170, P445, DOI 10.1111/j.1469-8137.2006.01715.x; Rejmanek M, 1996, ECOLOGY, V77, P1655, DOI 10.2307/2265768; Richardson DM, 2000, BIOL REV, V75, P65, DOI 10.1017/S0006323199005435; Rodriguez-Echeverria S, 2011, DIVERS DISTRIB, V17, P946, DOI 10.1111/j.1472-4642.2011.00787.x; Rodriguez-Echeverria S, 2010, J BIOGEOGR, V37, P1611, DOI 10.1111/j.1365-2699.2010.02284.x; Rodriguez-Echeverria S, 2009, BIOL INVASIONS, V11, P651, DOI 10.1007/s10530-008-9280-8; Rome S, 1996, INT J SYST BACTERIOL, V46, P972, DOI 10.1099/00207713-46-4-972; Ross CA, 2009, BIOL INVASIONS, V11, P441, DOI 10.1007/s10530-008-9261-y; Salon C, 2001, AGRONOMIE, V21, P539, DOI 10.1051/agro:2001143; *SAS I, 2006, SAS SOFTW VERS 9 1 3; Sexton JP, 2002, ECOL APPL, V12, P1652, DOI 10.1890/1051-0761(2002)012[1652:PAGDMA]2.0.CO;2; Silva C, 2007, FEMS MICROBIOL ECOL, V60, P477, DOI 10.1111/j.1574-6941.2007.00301.x; Simms EL, 2006, P ROY SOC B-BIOL SCI, V273, P77, DOI 10.1098/rspb.2005.3292; Smith S.E., 2010, MYCORRHIZAL SYMBIOSI; SPIRA TP, 1983, AM J BOT, V70, P303, DOI 10.2307/2443276; Sprent JI, 2007, NEW PHYTOL, V174, P11, DOI 10.1111/j.1469-8137.2007.02015.x; Stanton ML, 2005, NEW PHYTOL, V166, P319, DOI 10.1111/j.1469-8137.2004.01311.x; SULLIVAN JT, 1995, P NATL ACAD SCI USA, V92, P8985, DOI 10.1073/pnas.92.19.8985; Thompson JN, 2002, NATURE, V417, P735, DOI 10.1038/nature00810; Thrall PH, 2008, J ECOL, V96, P746, DOI 10.1111/j.1365-2745.2008.01381.x; Thrall PH, 2007, TRENDS ECOL EVOL, V22, P120, DOI 10.1016/j.tree.2006.11.007; Thrall PH, 2009, AUSTRAL ECOL, V34, P950, DOI 10.1111/j.1442-9993.2009.01998.x; Van Riper LC, 2010, BIOL INVASIONS, V12, P2735, DOI 10.1007/s10530-009-9678-y; VITOUSEK PM, 1989, ECOL MONOGR, V59, P247, DOI 10.2307/1942601; WAREMBOURG FR, 1982, PHYSIOL PLANTARUM, V56, P46, DOI 10.1111/j.1399-3054.1982.tb04898.x; Weir BS, 2004, APPL ENVIRON MICROB, V70, P5980, DOI 10.1128/AEM.70.10.5980-5987.2004; West SA, 2002, P ROY SOC B-BIOL SCI, V269, P685, DOI 10.1098/rspb.2001.1878; Wright JW, 2006, EVOL ECOL RES, V8, P1; WU L, 1990, NEW PHYTOL, V116, P531, DOI 10.1111/j.1469-8137.1990.tb00537.x	75	37	37	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e27935	10.1371/journal.pone.0027935	http://dx.doi.org/10.1371/journal.pone.0027935			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174755	Green Submitted, gold, Green Published			2022-12-25	WOS:000298365700010
J	Tirumurugaan, KG; Kapgate, S; Vinupriya, MK; Vijayarani, K; Kumanan, K; Elankumaran, S				Tirumurugaan, Krishnaswamy G.; Kapgate, Sunil; Vinupriya, Manavalan K.; Vijayarani, Kumanan; Kumanan, Kathaperumal; Elankumaran, Subbiah			Genotypic and Pathotypic Characterization of Newcastle Disease Viruses from India	PLOS ONE			English	Article							CLEAVAGE-ACTIVATION SITE; PROTEIN GENE SEQUENCE; HEMAGGLUTININ-NEURAMINIDASE; MONOCLONAL-ANTIBODIES; PHYLOGENETIC ANALYSIS; FUSION GLYCOPROTEIN; NUCLEOTIDE-SEQUENCE; STRAINS; VIRULENT; OUTBREAKS	Newcastle disease virus (NDV) is an avian paramyxovirus that causes significant economic losses to the poultry industry in most parts of the world. The susceptibility of a wide variety of avian species coupled with synanthropic bird reservoirs has contributed to the vast genomic diversity of this virus as well as diagnostic failures. Since the first panzootic in 1926, Newcastle disease (ND) became enzootic in India with recurrent outbreaks in multiple avian species. The genetic characteristics of circulating strains in India, however, are largely unknown. To understand the nature of NDV genotypes in India, we characterized two representative strains isolated 13 years apart from a chicken and a pigeon by complete genome sequence analysis and pathotyping. The viruses were characterized as velogenic by pathogenicity indices devised to distinguish these strains. The genome length was 15,186 nucleotides (nt) and consisted of six non-overlapping genes, with conserved and complementary 3' leader and 5' trailer regions, conserved gene starts, gene stops, and intergenic sequences similar to those in avian paramyxovirus 1 (APMV-1) strains. Matrix gene sequence analysis grouped the pigeon isolate with APMV-1 strains. Phylogeny based on the fusion (F), and hemagglutinin (HN) genes and complete genome sequence grouped these viruses into genotype IV. Genotype IV strains are considered to have "died out'' after the first panzootic (1926-1960) of ND. But, our results suggest that there is persistence of genotype IV strains in India.	[Tirumurugaan, Krishnaswamy G.; Kapgate, Sunil; Vinupriya, Manavalan K.; Vijayarani, Kumanan; Kumanan, Kathaperumal] Tamil Nadu Vet & Anim Sci Univ, Madras Vet Coll, Dept Anim Biotechnol, Madras, Tamil Nadu, India; [Elankumaran, Subbiah] Virginia Polytech Inst & State Univ, Virginia Maryland Reg Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA	Tamil Nadu Veterinary & Animal Sciences University; Virginia Polytechnic Institute & State University	Tirumurugaan, KG (corresponding author), Tamil Nadu Vet & Anim Sci Univ, Madras Vet Coll, Dept Anim Biotechnol, Madras, Tamil Nadu, India.	kumarans@vt.edu			Indian Council of Agriculture; United States-India Agricultural Knowledge Initiative	Indian Council of Agriculture; United States-India Agricultural Knowledge Initiative	This study has been supported by funds from the Indian Council of Agriculture, Niche-area of excellence awarded to KK. Partial support from United States-India Agricultural Knowledge Initiative to SE as co-investigator. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFZAL MA, 1994, J GEN VIROL, V75, P1169, DOI 10.1099/0022-1317-75-5-1169; Aldous EW, 2003, AVIAN PATHOL, V32, P239, DOI 10.1080/030794503100009783; Aldous EW, 2001, AVIAN PATHOL, V30, P117, DOI 10.1080/03079450120044515; Alexander D, 2001, BRIT POULTRY SCI, V42, P5, DOI 10.1080/713655022; Alexander D.J., 1989, LAB MANUAL ISOLATION; ALEXANDER DJ, 1984, VET REC, V114, P466, DOI 10.1136/vr.114.19.466; Alexander DJ, 2003, DIS POULTRY, P63; Allan W H, 1978, FAO ANIMAL PRODUCTIO; CHAMBERS P, 1986, J GEN VIROL, V67, P475, DOI 10.1099/0022-1317-67-3-475; COLLINS MS, 1993, ARCH VIROL, V128, P363, DOI 10.1007/BF01309446; Connaris H, 2002, J VIROL, V76, P1816, DOI 10.1128/JVI.76.4.1816-1824.2002; Czegledi A, 2003, AVIAN PATHOL, V32, P271, DOI 10.1080/0307945031000097868; Czegledi A, 2006, VIRUS RES, V120, P36, DOI 10.1016/j.virusres.2005.11.009; GLICKMAN RL, 1988, J VIROL, V62, P354, DOI 10.1128/JVI.62.1.354-356.1988; Herczeg J, 1999, ARCH VIROL, V144, P2087, DOI 10.1007/s007050050624; Hooper PT, 1999, AUST VET J, V77, P50, DOI 10.1111/j.1751-0813.1999.tb12432.x; Huang ZH, 2004, J VIROL, V78, P4176, DOI 10.1128/JVI.78.8.4176-4184.2004; IORIO RM, 1989, VIRUS RES, V13, P245, DOI 10.1016/0168-1702(89)90019-1; IORIO RM, 1991, J VIROL, V65, P4999, DOI 10.1128/JVI.65.9.4999-5006.1991; Ito T, 1999, J VET MED SCI, V61, P951, DOI 10.1292/jvms.61.951; Ito T, 1997, VIROLOGY, V227, P493, DOI 10.1006/viro.1996.8323; KALETA EF, 1985, AVIAN PATHOL, V14, P553, DOI 10.1080/03079458508436258; Kapczynski DR, 2005, VACCINE, V23, P3424, DOI 10.1016/j.vaccine.2005.01.140; Kattenbelt JA, 2006, VIRUS RES, V116, P168, DOI 10.1016/j.virusres.2005.10.001; Khattar SK, 2009, J VIROL, V83, P7779, DOI 10.1128/JVI.00536-09; Kim LM, 2007, J VIROL, V81, P12641, DOI 10.1128/JVI.00843-07; Kim LM, 2007, J CLIN MICROBIOL, V45, P1310, DOI 10.1128/JCM.02594-06; Kumanan K, 2005, ACTA VIROL, V49, P105; KUMANAN K, 1992, J VET MED B, V39, P383, DOI 10.1111/j.1439-0450.1992.tb01184.x; Li Z, 2005, J VIROL METHODS, V130, P154, DOI 10.1016/j.jviromet.2005.06.022; Liu XF, 2003, ARCH VIROL, V148, P1387, DOI 10.1007/s00705-003-0014-z; Lomniczi B, 1998, ARCH VIROL, V143, P49, DOI 10.1007/s007050050267; Maminiaina OF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013987; Mayo MA, 2002, ARCH VIROL, V147, P1655, DOI 10.1007/s007050200039; Miller PJ, 2007, VACCINE, V25, P7238, DOI 10.1016/j.vaccine.2007.07.017; Miller PJ, 2010, INFECT GENET EVOL, V10, P26, DOI 10.1016/j.meegid.2009.09.012; PRITZER E, 1990, VIRUS RES, V15, P237, DOI 10.1016/0168-1702(90)90031-6; Romer-Oberdorfer A, 2006, AVIAN DIS, V50, P259, DOI 10.1637/7471-111505R.1; ROTA PA, 1994, VIROLOGY, V198, P724, DOI 10.1006/viro.1994.1086; Rout SN, 2008, J VIROL, V82, P7828, DOI 10.1128/JVI.00578-08; Roy P, 2000, VET RES COMMUN, V24, P135, DOI 10.1023/A:1006416724050; SEAL BS, 1995, J CLIN MICROBIOL, V33, P2624, DOI 10.1128/JCM.33.10.2624-2630.1995; Seal BS, 1995, VIRUS GENES, V11, P217, DOI 10.1007/BF01728661; Snoeck CJ, 2009, ARCH VIROL, V154, P47, DOI 10.1007/s00705-008-0269-5; STEWARD M, 1993, J GEN VIROL, V74, P2539, DOI 10.1099/0022-1317-74-12-2539; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tirumurugaan KG, 2011, INDIAN J VIROL, V22, P131, DOI 10.1007/s13337-011-0044-1; TOYODA T, 1987, VIROLOGY, V158, P242, DOI 10.1016/0042-6822(87)90261-3; Ujvari D, 2003, VIRUS RES, V96, P63, DOI 10.1016/S0168-1702(03)00173-4; WINSLOW NS, 1950, P SOC EXP BIOL MED, V74, P174, DOI 10.3181/00379727-74-17845; Yu L, 2001, J CLIN MICROBIOL, V39, P3512, DOI 10.1128/JCM.39.10.3512-3519.2001; YUSOFF K, 1988, VIRUS RES, V11, P319, DOI 10.1016/0168-1702(88)90005-6; Zanetti F, 2003, VIRUS GENES, V26, P199, DOI 10.1023/A:1023495615729	53	31	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28414	10.1371/journal.pone.0028414	http://dx.doi.org/10.1371/journal.pone.0028414			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174801	gold, Green Published, Green Submitted			2022-12-25	WOS:000298365700032
J	Tashiro, K; Teissier, A; Kobayashi, N; Nakanishi, A; Sasaki, T; Yan, K; Tarabykin, V; Vigier, L; Sumiyama, K; Hirakawa, M; Nishihara, H; Pierani, A; Okada, N				Tashiro, Kensuke; Teissier, Anne; Kobayashi, Naoki; Nakanishi, Akiko; Sasaki, Takeshi; Yan, Kuo; Tarabykin, Victor; Vigier, Lisa; Sumiyama, Kenta; Hirakawa, Mika; Nishihara, Hidenori; Pierani, Alessandra; Okada, Norihiro			A Mammalian Conserved Element Derived from SINE Displays Enhancer Properties Recapitulating Satb2 Expression in Early-Born Callosal Projection Neurons	PLOS ONE			English	Article							NON-GENIC SEQUENCES; ULTRACONSERVED ELEMENTS; TRANSPOSABLE ELEMENTS; CORPUS-CALLOSUM; HUMAN GENOME; MOUSE; DNA; IDENTIFICATION; EVOLUTION; CELLS	Short interspersed repetitive elements (SINEs) are highly repeated sequences that account for a significant proportion of many eukaryotic genomes and are usually considered "junk DNA". However, we previously discovered that many AmnSINE1 loci are evolutionarily conserved across mammalian genomes, suggesting that they may have acquired significant functions involved in controlling mammalian-specific traits. Notably, we identified the AS021 SINE locus, located 390 kbp upstream of Satb2. Using transgenic mice, we showed that this SINE displays specific enhancer activity in the developing cerebral cortex. The transcription factor Satb2 is expressed by cortical neurons extending axons through the corpus callosum and is a determinant of callosal versus subcortical projection. Mouse mutants reveal a crucial function for Sabt2 in corpus callosum formation. In this study, we compared the enhancer activity of the AS021 locus with Satb2 expression during telencephalic development in the mouse. First, we showed that the AS021 enhancer is specifically activated in early-born Satb2(+) neurons. Second, we demonstrated that the activity of the AS021 enhancer recapitulates the expression of Satb2 at later embryonic and postnatal stages in deep-layer but not superficial-layer neurons, suggesting the possibility that the expression of Satb2 in these two subpopulations of cortical neurons is under genetically distinct transcriptional control. Third, we showed that the AS021 enhancer is activated in neurons projecting through the corpus callosum, as described for Satb2+ neurons. Notably, AS021 drives specific expression in axons crossing through the ventral (TAG1(-)/NPY+) portion of the corpus callosum, confirming that it is active in a subpopulation of callosal neurons. These data suggest that exaptation of the AS021 SINE locus might be involved in enhancement of Satb2 expression, leading to the establishment of interhemispheric communication via the corpus callosum, a eutherian-specific brain structure.	[Tashiro, Kensuke; Kobayashi, Naoki; Nakanishi, Akiko; Sasaki, Takeshi; Nishihara, Hidenori; Okada, Norihiro] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 227, Japan; [Teissier, Anne; Vigier, Lisa; Pierani, Alessandra] Univ Paris Diderot, Inst Jacques Monod, Ctr Natl Rech Sci, Unite Mixte Rech 7592, Paris, France; [Sumiyama, Kenta] Natl Inst Genet, Mishima, Shizuoka 411, Japan; [Hirakawa, Mika] Kyoto Univ, Bioinformat Ctr, Inst Chem Res, Uji, Kyoto, Japan; [Yan, Kuo; Tarabykin, Victor] Max Planck Inst Expt Med, Dept Mol Biol Neuronal Signals, D-37075 Gottingen, Germany	Tokyo Institute of Technology; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Kyoto University; Max Planck Society	Tashiro, K (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 227, Japan.	pierani.alessandra@ijm.univ-paris-diderot.fr; nokada@bio.titech.ac.jp	Tarabykin, Victor/F-9467-2014; Teissier, Anne/K-2075-2019; Nishihara, Hidenori/B-9324-2015; Sumiyama, Kenta/ABD-5577-2020; Pierani, Alessandra/O-6136-2017; Sumiyama, Kenta/L-5902-2013	Nishihara, Hidenori/0000-0002-5843-9994; Sumiyama, Kenta/0000-0001-8785-5439; Pierani, Alessandra/0000-0002-4872-4791; Sumiyama, Kenta/0000-0001-8785-5439; Teissier, Anne/0000-0002-5172-9489; Tarabykin, Viktor/0000-0001-8931-7263	French Ministry of Education; Agence Nationale de la Recherche [ANR-07-NEURO-046-01]; Fondation pour la Recherche Medicale [INE20060306503]; Association pour la Recherche sur le Cancer [4940]; Ville de Paris [2006 ASES 102]; Ministry of Education, Culture, Sports, Science and Technology of Japan; DFG [SFB665, TA 303/3, Exzellenzcluster 257]; Grants-in-Aid for Scientific Research [23123504] Funding Source: KAKEN	French Ministry of Education; Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ville de Paris; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); DFG(German Research Foundation (DFG)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	AT was the recipient of a fellowship from the French Ministry of Education. AP is a Centre National de la Recherche Scientifique Investigator. This work was supported by grants from the Agence Nationale de la Recherche (ANR-07-NEURO-046-01), Fondation pour la Recherche Medicale (INE20060306503), the Association pour la Recherche sur le Cancer (grant # 4940), Ville de Paris (2006 ASES 102) to AP and Grant-in-Aid for Scientific Research (S) from the Ministry of Education, Culture, Sports, Science and Technology of Japan to NO. In addition, this work was supported by Grant-in-Aid for Scientific Research on Innovative Areas "Neural Diversity and Neocortical Organization" from the Ministry of Education, Culture, Sports, Science and Technology of Japan to HN, and by SFB665, DFG Heusenberg program, DFG grant TA 303/3 and Exzellenzcluster 257 to VT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboitiz F, 2003, BRAZ J MED BIOL RES, V36, P409, DOI 10.1590/S0100-879X2003000400002; Ahituv N, 2007, PLOS BIOL, V5, P1906, DOI 10.1371/journal.pbio.0050234; Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bejerano G, 2004, BIOINFORMATICS, V20, P40, DOI 10.1093/bioinformatics/bth946; Bielle F, 2005, NAT NEUROSCI, V8, P1002, DOI 10.1038/nn1511; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; Boffelli D, 2003, SCIENCE, V299, P1391, DOI 10.1126/science.1081331; Britanova O, 2005, EUR J NEUROSCI, V21, P658, DOI 10.1111/j.1460-9568.2005.03897.x; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; Britanova O, 2006, DEV BIOL, V298, P299, DOI 10.1016/j.ydbio.2006.06.040; BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349; Britten RJ, 1996, P NATL ACAD SCI USA, V93, P9374, DOI 10.1073/pnas.93.18.9374; BROSIUS J, 1992, P NATL ACAD SCI USA, V89, P10706, DOI 10.1073/pnas.89.22.10706; Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252; Cook AL, 2008, PIGM CELL MELANOMA R, V21, P611, DOI 10.1111/j.1755-148X.2008.00510.x; DEININGER PL, 1993, EVOL BIOL, V27, P157; Dermitzakis ET, 2005, NAT REV GENET, V6, P151, DOI 10.1038/nrg1527; Dermitzakis ET, 2003, SCIENCE, V302, P1033, DOI 10.1126/science.1087047; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Donahoo ALS, 2009, SEMIN PEDIATR NEUROL, V16, P127, DOI 10.1016/j.spen.2009.07.003; Fame RM, 2011, TRENDS NEUROSCI, V34, P41, DOI 10.1016/j.tins.2010.10.002; Ferrigno O, 2001, NAT GENET, V28, P77, DOI 10.1038/ng0501-77; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Gentles AJ, 2007, GENOME RES, V17, P992, DOI 10.1101/gr.6070707; Ghiasvand NM, 2011, NAT NEUROSCI, V14, P578, DOI 10.1038/nn.2798; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; GRANGER EM, 1985, J COMP NEUROL, V241, P82, DOI 10.1002/cne.902410107; HAMBOR JE, 1993, MOL CELL BIOL, V13, P7056, DOI 10.1128/MCB.13.11.7056; Hirakawa M, 2009, GENE, V441, P100, DOI 10.1016/j.gene.2008.12.009; Hong JW, 2008, SCIENCE, V321, P1314, DOI 10.1126/science.1160631; Kamal M, 2006, P NATL ACAD SCI USA, V103, P2740, DOI 10.1073/pnas.0511238103; Kamnasaran D, 2005, CLIN INVEST MED, V28, P267; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; KOTHARY R, 1989, DEVELOPMENT, V105, P707; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leone DP, 2008, CURR OPIN NEUROBIOL, V18, P28, DOI 10.1016/j.conb.2008.05.006; Lev-Maor G, 2003, SCIENCE, V300, P1288, DOI 10.1126/science.1082588; Lowe CB, 2007, P NATL ACAD SCI USA, V104, P8005, DOI 10.1073/pnas.0611223104; Lunyak VV, 2007, SCIENCE, V317, P248, DOI 10.1126/science.1140871; Margulies EH, 2003, GENOME RES, V13, P2507, DOI 10.1101/gr.1602203; McEvilly RJ, 2002, SCIENCE, V295, P1528, DOI 10.1126/science.1067132; MERRY DE, 1994, DEVELOPMENT, V120, P301; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Niquille M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000230; Nishihara H, 2006, GENOME RES, V16, P864, DOI 10.1101/gr.5255506; NORRIS J, 1995, J BIOL CHEM, V270, P22777, DOI 10.1074/jbc.270.39.22777; OKADA N, 1991, TRENDS ECOL EVOL, V6, P358, DOI 10.1016/0169-5347(91)90226-N; Okada N, 2010, GENES CELLS, V15, P801, DOI 10.1111/j.1365-2443.2010.01429.x; Okada N, 1991, CURR OPIN GENET DEV, V1, P498, DOI 10.1016/S0959-437X(05)80198-4; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Prabhakar S, 2006, GENOME RES, V16, P855, DOI 10.1101/gr.4717506; Price DJ, 1996, J NEUROSCI, V16, P3247; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Rattenborg NC, 2009, NEUROSCI BIOBEHAV R, V33, P253, DOI 10.1016/j.neubiorev.2008.08.010; Richards LJ, 2004, CLIN GENET, V66, P276, DOI 10.1111/j.1399-0004.2004.00354.x; SAFFER JD, 1989, MOL CELL BIOL, V9, P355, DOI 10.1128/MCB.9.2.355; Santangelo AM, 2007, PLOS GENET, V3, P1813, DOI 10.1371/journal.pgen.0030166; Sasaki T, 2008, P NATL ACAD SCI USA, V105, P4220, DOI 10.1073/pnas.0709398105; Sebastiano V, 2010, DEVELOPMENT, V137, P3551, DOI 10.1242/dev.047027; Shimamura M, 1998, MOL BIOL EVOL, V15, P923, DOI 10.1093/oxfordjournals.molbev.a025997; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; SINGER MF, 1982, CELL, V28, P433, DOI 10.1016/0092-8674(82)90194-5; Sumiyama K, 2002, P NATL ACAD SCI USA, V99, P780, DOI 10.1073/pnas.012584999; Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104	73	41	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28497	10.1371/journal.pone.0028497	http://dx.doi.org/10.1371/journal.pone.0028497			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174821	Green Published, gold			2022-12-25	WOS:000298163600026
J	Wang, L; Chen, W; Feng, Y; Ren, Y; Gu, ZN; Chen, HQ; Wang, HC; Thomas, MJ; Zhang, BX; Berquin, IM; Li, Y; Wu, JS; Zhang, HX; Song, YD; Liu, X; Norris, JS; Wang, S; Du, P; Shen, JG; Wang, N; Yang, YL; Wang, W; Feng, L; Ratledge, C; Zhang, H; Chen, YQ				Wang, Lei; Chen, Wei; Feng, Yun; Ren, Yan; Gu, Zhennan; Chen, Haiqin; Wang, Hongchao; Thomas, Michael J.; Zhang, Baixi; Berquin, Isabelle M.; Li, Yang; Wu, Jiansheng; Zhang, Huanxin; Song, Yuanda; Liu, Xiang; Norris, James S.; Wang, Suriguga; Du, Peng; Shen, Junguo; Wang, Na; Yang, Yanlin; Wang, Wei; Feng, Lu; Ratledge, Colin; Zhang, Hao; Chen, Yong Q.			Genome Characterization of the Oleaginous Fungus Mortierella alpina	PLOS ONE			English	Article							FATTY-ACID SYNTHASE; TANDEM MASS-SPECTROMETRY; CELL OIL PRODUCTION; ARACHIDONIC-ACID; HETEROLOGOUS EXPRESSION; QUANTITATIVE-ANALYSIS; LIPID-ACCUMULATION; MALIC ENZYME; PHYLOGENETIC CLASSIFICATION; SACCHAROMYCES-CEREVISIAE	Mortierella alpina is an oleaginous fungus which can produce lipids accounting for up to 50% of its dry weight in the form of triacylglycerols. It is used commercially for the production of arachidonic acid. Using a combination of high throughput sequencing and lipid profiling, we have assembled the M. alpina genome, mapped its lipogenesis pathway and determined its major lipid species. The 38.38 Mb M. alpina genome shows a high degree of gene duplications. Approximately 50% of its 12,796 gene models, and 60% of genes in the predicted lipogenesis pathway, belong to multigene families. Notably, M. alpina has 18 lipase genes, of which 11 contain the class 2 lipase domain and may share a similar function. M. alpina's fatty acid synthase is a single polypeptide containing all of the catalytic domains required for fatty acid synthesis from acetyl-CoA and malonyl-CoA, whereas in many fungi this enzyme is comprised of two polypeptides. Major lipids were profiled to confirm the products predicted in the lipogenesis pathway. M. alpina produces a complex mixture of glycerolipids, glycerophospholipids and sphingolipids. In contrast, only two major sterol lipids, desmosterol and 24(28)-methylene-cholesterol, were detected. Phylogenetic analysis based on genes involved in lipid metabolism suggests that oleaginous fungi may have acquired their lipogenic capacity during evolution after the divergence of Ascomycota, Basidiomycota, Chytridiomycota and Mucoromycota. Our study provides the first draft genome and comprehensive lipid profile for M. alpina, and lays the foundation for possible genetic engineering of M. alpina to produce higher levels and diverse contents of dietary lipids.	[Wang, Lei; Feng, Yun; Ren, Yan; Li, Yang; Zhang, Huanxin; Wang, Suriguga; Wang, Wei; Feng, Lu] Nankai Univ, Tianjin Econ Technol Dev Area, TEDA Sch Biol Sci & Biotechnol, Tianjin 300071, Peoples R China; [Chen, Wei; Chen, Haiqin; Wang, Hongchao; Zhang, Baixi; Song, Yuanda; Zhang, Hao] Jiangnan Univ, Sch Food Sci & Technol, State Key Lab Food Sci & Technol, Wuxi, Peoples R China; [Wang, Lei; Feng, Yun; Feng, Lu] Tianjin Res Ctr Funct Genom & Biochip, Tianjin Econ Technol Dev Area, Tianjin, Peoples R China; [Wang, Lei; Feng, Lu] Nankai Univ, Key Lab Mol Microbiol & Technol, TEDA Sch Biol Sci & Biotechnol, Minist Educ, Tianjin 300071, Peoples R China; [Gu, Zhennan; Chen, Haiqin; Berquin, Isabelle M.; Wu, Jiansheng; Chen, Yong Q.] Wake Forest Sch Med, Dept Canc Biol, Winston Salem, NC USA; [Thomas, Michael J.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC USA; [Liu, Xiang; Norris, James S.] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Du, Peng; Shen, Junguo; Wang, Na; Yang, Yanlin] Tianjin Biochip Corp, Tianjin Econ Technol Dev Area, Tianjin, Peoples R China; [Ratledge, Colin] Univ Hull, Dept Biol Sci, Kingston Upon Hull HU6 7RX, N Humberside, England	Nankai University; Jiangnan University; Nankai University; Wake Forest University; Wake Forest University; Medical University of South Carolina; University of Hull	Wang, L (corresponding author), Nankai Univ, Tianjin Econ Technol Dev Area, TEDA Sch Biol Sci & Biotechnol, Tianjin 300071, Peoples R China.	zhanghao@jiangnan.edu.cn; yqchen@wfubmc.edu	feng, lu/M-5113-2015; Wang, Lei/C-5176-2009; Chen, Yong Q/AAI-9864-2021; Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wang, Lei/0000-0003-4427-0881; Chen, Yong Q/0000-0003-4747-4708; Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507; Wang, Wei/0000-0002-6660-8540	National Science Foundation of China (NSFC) [31030002, 30530010, 20836003, 20536040, 30670038, 30870078, 30771175, 30871952, 30900041]; Chinese National Science Fund for Distinguished Young Scholars [30788001]; National Key Programs for Infectious Diseases of China [2009ZX10004-108]; National High Technology Research and Development Program of China [2010AA1000693002, 2006AA020703, 2006AA06Z409]; State Key Laboratory of Food Science and Technology [SKLF-MB-200802]; 111 Project [B07029]; American Institute for Cancer Research [07B087]; National Institutes of Health [R21CA124511, R01CA107668, P01CA106742]; National Science Fund for Distinguished Young Scholars [31125021]; NATIONAL CANCER INSTITUTE [R01CA107668, P01CA106742, R21CA124511] Funding Source: NIH RePORTER	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Chinese National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Key Programs for Infectious Diseases of China; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); State Key Laboratory of Food Science and Technology; 111 Project(Ministry of Education, China - 111 Project); American Institute for Cancer Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by the National Science Foundation of China (NSFC) Key Program Grants 31030002, 30530010, 20836003 and 20536040, NSFC General Program Grants 30670038, 30870078, 30771175, 30871952 and 30900041, the Chinese National Science Fund for Distinguished Young Scholars (30788001), the National Key Programs for Infectious Diseases of China (2009ZX10004-108), the National High Technology Research and Development Program of China 2010AA1000693002, 2006AA020703 and 2006AA06Z409, the Research Program of State Key Laboratory of Food Science and Technology (SKLF-MB-200802), the 111 Project B07029 and Program for Changjiang Scholars, American Institute for Cancer Research grant 07B087, National Institutes of Health grants R21CA124511, R01CA107668 and P01CA106742, and the National Science Fund for Distinguished Young Scholars (31125021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Andersen MR, 2011, GENOME RES, V21, P885, DOI 10.1101/gr.112169.110; Ando A, 2009, APPL ENVIRON MICROB, V75, P5529, DOI 10.1128/AEM.00648-09; Attwood TK, 2003, NUCLEIC ACIDS RES, V31, P400, DOI 10.1093/nar/gkg030; BAJPAI PK, 1991, APPL ENVIRON MICROB, V57, P1255, DOI 10.1128/AEM.57.4.1255-1258.1991; Berquin IM, 2008, CANCER LETT, V269, P363, DOI 10.1016/j.canlet.2008.03.044; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Braun BR, 2005, PLOS GENET, V1, P36, DOI 10.1371/journal.pgen.0010001; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Burns RA, 1999, FOOD CHEM TOXICOL, V37, P23, DOI 10.1016/S0278-6915(98)00104-5; CARR TP, 1993, CLIN BIOCHEM, V26, P39, DOI 10.1016/0009-9120(93)90015-X; Chaisson MJ, 2009, GENOME RES, V19, P336, DOI 10.1101/gr.079053.108; Chang A, 2009, NUCLEIC ACIDS RES, V37, pD588, DOI 10.1093/nar/gkn820; Chen YQ, 2007, CANCER METAST REV, V26, P535, DOI 10.1007/s10555-007-9075-x; Cresnar B, 2011, BBA-PROTEINS PROTEOM, V1814, P29, DOI 10.1016/j.bbapap.2010.06.020; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Espagne E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r77; Fedorova ND, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000046; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Goldberg SMD, 2006, P NATL ACAD SCI USA, V103, P11240, DOI 10.1073/pnas.0604351103; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Haas BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r7; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; Hempenius RA, 2000, FOOD CHEM TOXICOL, V38, P127, DOI 10.1016/S0278-6915(99)00144-1; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Ho SY, 2007, J AGR FOOD CHEM, V55, P3960, DOI 10.1021/jf0700071; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Jang HD, 2005, BIORESOURCE TECHNOL, V96, P1633, DOI 10.1016/j.biortech.2004.12.027; Jeffries TW, 2007, NAT BIOTECHNOL, V25, P319, DOI 10.1038/nbt1290; Jenni S, 2006, SCIENCE, V311, P1263, DOI 10.1126/science.1123251; Jenni S, 2007, SCIENCE, V316, P254, DOI 10.1126/science.1138248; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Leibundgut M, 2008, CURR OPIN STRUC BIOL, V18, P714, DOI 10.1016/j.sbi.2008.09.008; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li YH, 2005, MYCOL RES, V109, P461, DOI 10.1017/S0953756205002480; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Lomakin IB, 2007, CELL, V129, P319, DOI 10.1016/j.cell.2007.03.013; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ma LJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000549; Machida M, 2005, NATURE, V438, P1157, DOI 10.1038/nature04300; Maier T, 2006, SCIENCE, V311, P1258, DOI 10.1126/science.1123248; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; METCALFE LD, 1966, ANAL CHEM, V38, P514, DOI 10.1021/ac60235a044; Michaelson LV, 1998, J BIOL CHEM, V273, P19055, DOI 10.1074/jbc.273.30.19055; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Pettus BJ, 2004, RAPID COMMUN MASS SP, V18, P577, DOI 10.1002/rcm.1373; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Ratledge C, 2004, BIOCHIMIE, V86, P807, DOI 10.1016/j.biochi.2004.09.017; Ratledge C, 2002, ADV APPL MICROBIOL, V51, P1, DOI 10.1016/S0065-2164(02)51000-5; Ratledge C, 2002, BIOCHEM SOC T, V30, P1047, DOI 10.1042/bst0301047; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; Sakuradani E, 2005, APPL MICROBIOL BIOT, V66, P648, DOI 10.1007/s00253-004-1760-x; Sakuradani E, 1999, GENE, V238, P445, DOI 10.1016/S0378-1119(99)00359-5; Sakuradani E, 1999, EUR J BIOCHEM, V261, P812, DOI 10.1046/j.1432-1327.1999.00333.x; Sakuradani E, 1999, EUR J BIOCHEM, V260, P208, DOI 10.1046/j.1432-1327.1999.00131.x; Sakuradani E, 2009, J BIOTECHNOL, V144, P31, DOI 10.1016/j.jbiotec.2009.04.012; Scannell DR, 2007, P NATL ACAD SCI USA, V104, P8397, DOI 10.1073/pnas.0608218104; Seif E, 2005, NUCLEIC ACIDS RES, V33, P734, DOI 10.1093/nar/gki199; Simopoulos AP, 1999, AM J CLIN NUTR, V70, p560S, DOI 10.1093/ajcn/70.3.560s; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Streekstra H, 1997, J BIOTECHNOL, V56, P153, DOI 10.1016/S0168-1656(97)00109-0; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Ter-Hovhannisyan V, 2008, GENOME RES, V18, P1979, DOI 10.1101/gr.081612.108; THATCHER LF, 2011, MOL PLANT MICROBE IN; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Van Kessel W S, 1977, Biochim Biophys Acta, V486, P524; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Xu J, 2007, P NATL ACAD SCI USA, V104, P18730, DOI 10.1073/pnas.0706756104; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang Y, 2008, MYCOL RES, V112, P725, DOI 10.1016/j.mycres.2008.01.003; Zhang Y, 2007, MICROBIOL-SGM, V153, P2013, DOI 10.1099/mic.0.2006/002683-0	94	104	125	6	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28319	10.1371/journal.pone.0028319	http://dx.doi.org/10.1371/journal.pone.0028319			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174787	Green Submitted, Green Published, gold			2022-12-25	WOS:000298163600018
J	Leskela, TT; Lackman, JJ; Vierimaa, MM; Kobayashi, H; Bouvier, M; Petaja-Repo, UE				Leskela, Tarja T.; Lackman, Jarkko J.; Vierimaa, Miia M.; Kobayashi, Hiroyuki; Bouvier, Michel; Petaja-Repo, Ulla E.			Cys-27 Variant of Human delta-Opioid Receptor Modulates Maturation and Cell Surface Delivery of Phe-27 Variant via Heteromerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUTEINIZING-HORMONE RECEPTOR; RESONANCE ENERGY-TRANSFER; PHARMACOLOGICAL CHAPERONES; ENDOPLASMIC-RETICULUM; SPLICE VARIANT; SUBCELLULAR-LOCALIZATION; QUALITY-CONTROL; LIVING CELLS; PROTEIN; HETERODIMERIZATION	The important role of G protein-coupled receptor homo/heteromerization in receptor folding, maturation, trafficking, and cell surface expression has become increasingly evident. Here we investigated whether the human delta-opioid receptor (h delta OR) Cys-27 variant that shows inherent compromised maturation has an effect on the behavior of the more common Phe-27 variant in the early secretory pathway. We demonstrate that h delta OR-Cys-27 acts in a dominant negative manner and impairs cell surface delivery of the co-expressed h delta OR-Phe-27 and impairs conversion of precursors to the mature form. This was demonstrated by metabolic labeling, Western blotting, flow cytometry, and confocal microscopy in HEK293 and human SH-SY5Y neuroblastoma cells using differentially epitope-tagged variants. The h delta OR-Phe-27 precursors that were redirected to the endoplasmic reticulum-associated degradation were, however, rescued by a pharmacological chaperone, the opioid antagonist naltrexone. Co-immunoprecipitation of metabolically labeled variants revealed that both endoplasmic reticulum-localized precursors and mature receptors exist as homo/heteromers. The existence of homo/heteromers was confirmed in living cells by bioluminescence resonance energy transfer measurements, showing that the variants have a similar propensity to form homo/heteromers. By forming both homomers and heteromers, the h delta OR-Cys-27 variant may thus regulate the levels of receptors at the cell surface, possibly leading to altered responsiveness to opioid ligands in individuals carrying the Cys-27 variant.	[Leskela, Tarja T.; Lackman, Jarkko J.; Vierimaa, Miia M.; Petaja-Repo, Ulla E.] Univ Oulu, Dept Anat & Cell Biol, Inst Biomed, FI-90014 Oulu, Finland; [Kobayashi, Hiroyuki; Bouvier, Michel] Univ Montreal, Dept Biochem, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Kobayashi, Hiroyuki; Bouvier, Michel] Univ Montreal, Grp Rech Univ Medicament, Montreal, PQ H3C 3J7, Canada	University of Oulu; Universite de Montreal; Universite de Montreal	Petaja-Repo, UE (corresponding author), Univ Oulu, Dept Anat & Cell Biol, Inst Biomed, POB 5000, FI-90014 Oulu, Finland.	Ulla.Petaja-Repo@oulu.fi	Bouvier, Michel/H-2758-2014; Kobayashi, Hiroyuki/F-6386-2013; Petäjä-Repo, Ulla/AAV-6115-2021	Bouvier, Michel/0000-0003-1128-0100; Kobayashi, Hiroyuki/0000-0003-4965-0883; Lackman, Jarkko/0000-0002-0422-5157	Sigrid Juselius Foundation; Academy of Finland [127199]; Canadian Institutes for Health Research [MOP-11215]; Finnish Cultural Foundation; Finnish Glycoscience Graduate School	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Finnish Glycoscience Graduate School	This work was supported by the Sigrid Juselius Foundation and Academy of Finland Grant 127199 (to U. E. P.-R.) and Canadian Institutes for Health Research Grant MOP-11215 (to M. B.).; A Ph.D. student of the Biocenter Oulu Doctoral Program and supported by the Finnish Cultural Foundation.; Supported by the Finnish Glycoscience Graduate School.	Apaja PM, 2006, MOL BIOL CELL, V17, P2243, DOI 10.1091/mbc.E05-09-0875; Beaumont KA, 2007, HUM MOL GENET, V16, P2249, DOI 10.1093/hmg/ddm177; Benkirane M, 1997, J BIOL CHEM, V272, P30603, DOI 10.1074/jbc.272.49.30603; Breit A, 2006, MOL PHARMACOL, V70, P686, DOI 10.1124/mol.106.022897; Brothers SP, 2004, MOL ENDOCRINOL, V18, P1787, DOI 10.1210/me.2004-0091; Bulenger S, 2005, TRENDS PHARMACOL SCI, V26, P131, DOI 10.1016/j.tips.2005.01.004; Calebiro D, 2005, HUM MOL GENET, V14, P2991, DOI 10.1093/hmg/ddi329; Canals M, 2009, BIOCHEM J, V417, P161, DOI 10.1042/BJ20081227; Cvejic S, 1997, J BIOL CHEM, V272, P26959, DOI 10.1074/jbc.272.43.26959; DO SI, 1992, GLYCOBIOLOGY, V2, P345, DOI 10.1093/glycob/2.4.345; Gelernter J, 2000, HUM GENET, V107, P86; George SR, 2000, J BIOL CHEM, V275, P26128, DOI 10.1074/jbc.M000345200; Grosse R, 1997, MOL ENDOCRINOL, V11, P1305, DOI 10.1210/me.11.9.1305; Gupta A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000807; Hague C, 2004, J BIOL CHEM, V279, P15541, DOI 10.1074/jbc.M314014200; Hasbi A, 2007, BIOCHEMISTRY-US, V46, P12997, DOI 10.1021/bi701436w; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Karpa KD, 2000, MOL PHARMACOL, V58, P677, DOI 10.1124/mol.58.4.677; Kniazeff J, 2011, PHARMACOL THERAPEUT, V130, P9, DOI 10.1016/j.pharmthera.2011.01.006; Kobayashi H, 2009, TRAFFIC, V10, P1019, DOI 10.1111/j.1600-0854.2009.00932.x; Law PY, 2005, J BIOL CHEM, V280, P11152, DOI 10.1074/jbc.M500171200; Lee SP, 2000, MOL PHARMACOL, V58, P120, DOI 10.1124/mol.58.1.120; Leskela TT, 2007, J BIOL CHEM, V282, P23171, DOI 10.1074/jbc.M610896200; Leskela TT, 2009, TRAFFIC, V10, P116, DOI 10.1111/j.1600-0854.2008.00846.x; Levitt ES, 2011, MOL PHARMACOL, V79, P461, DOI 10.1124/mol.110.064816; Markkanen PMH, 2008, J BIOL CHEM, V283, P29086, DOI 10.1074/jbc.M801880200; McVey M, 2001, J BIOL CHEM, V276, P14092, DOI 10.1074/jbc.M008902200; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Okiyoneda T, 2011, CURR OPIN CELL BIOL, V23, P483, DOI 10.1016/j.ceb.2011.04.012; Parenty G, 2008, BIOCHEM J, V412, P245, DOI 10.1042/BJ20071689; Petaja-Repo UE, 2002, EMBO J, V21, P1628, DOI 10.1093/emboj/21.7.1628; Petaja-Repo UE, 2001, J BIOL CHEM, V276, P4416, DOI 10.1074/jbc.M007151200; Petaja-Repo UE, 2006, J BIOL CHEM, V281, P15780, DOI 10.1074/jbc.M602267200; Pietila EM, 2005, J BIOL CHEM, V280, P26622, DOI 10.1074/jbc.M413815200; Rajan RS, 2005, J BIOL CHEM, V280, P1284, DOI 10.1074/jbc.M406448200; Ramsay D, 2002, BIOCHEM J, V365, P429, DOI 10.1042/BJ20020251; Rozenfeld R, 2011, BIOCHEM J, V433, P11, DOI 10.1042/BJ20100458; Salahpour A, 2004, J BIOL CHEM, V279, P33390, DOI 10.1074/jbc.M403363200; Sanchez-Laorden BL, 2006, J INVEST DERMATOL, V126, P172, DOI 10.1038/sj.jid.5700036; Sarajarvi T, 2011, MOL CELL BIOL, V31, P2326, DOI 10.1128/MCB.05015-11; Shioda T, 2001, J VIROL, V75, P3462, DOI 10.1128/JVI.75.7.3462-3468.2001; Terrillon S, 2003, MOL ENDOCRINOL, V17, P677, DOI 10.1210/me.2002-0222; Tuusa JT, 2010, FEBS J, V277, P2815, DOI 10.1111/j.1742-4658.2010.07699.x; van Rijn RM, 2010, CURR OPIN PHARMACOL, V10, P73, DOI 10.1016/j.coph.2009.09.007; Villemure JF, 2005, BIOCHEM J, V388, P47, DOI 10.1042/BJ20041435; Waldhoer M, 2005, P NATL ACAD SCI USA, V102, P9050, DOI 10.1073/pnas.0501112102; Waldhoer M, 2004, ANNU REV BIOCHEM, V73, P953, DOI 10.1146/annurev.biochem.73.011303.073940; Wang DX, 2005, MOL PHARMACOL, V67, P2173, DOI 10.1124/mol.104.010272; Xie ZH, 2005, MOL PHARMACOL, V68, P1079, DOI 10.1124/mol.105.012070; YANG B, 1993, J BIOL CHEM, V268, P7435; Zhu XY, 1998, BIOCHEMISTRY-US, V37, P15773, DOI 10.1021/bi981162z	52	17	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					5008	5020		10.1074/jbc.M111.305656	http://dx.doi.org/10.1074/jbc.M111.305656			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22184124	Green Published, hybrid			2022-12-25	WOS:000300608500060
J	Xu, FH; Flowers, S; Moran, E				Xu, Fuhua; Flowers, Stephen; Moran, Elizabeth			Essential Role of ARID2 Protein-containing SWI/SNF Complex in Tissue-specific Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-REMODELING COMPLEX; CELL-CYCLE ARREST; OSTEOBLAST DIFFERENTIATION; TRANSCRIPTIONAL ACTIVATION; FAMILY PROTEINS; STEM-CELLS; CARCINOMA; MUTATION; BAF180; BRD7	Unfolding of the gene expression program that converts precursor cells to their terminally differentiated counterparts is critically dependent on the nucleosome-remodeling activity of the mammalian SWI/SNF complex. The complex can be powered by either of two alternative ATPases, BRM or BRG1. BRG1 is critical for development and the activation of tissue specific genes and is found in two major stable configurations. The complex of BRG1-associated factors termed BAF is the originally characterized form of mammalian SWI/SNF. A more recently recognized configuration shares many of the same subunits but is termed PBAF in recognition of a unique subunit, the polybromo protein (PBRM1). Two other unique subunits, BRD7 and ARID2, are also diagnostic of PBAF. PBAF plays an essential role in development, apparent from the embryonic lethality of Pbmr1-null mice, but very little is known about the role of PBAF, or its signature subunits, in tissue-specific gene expression in individual differentiation programs. Osteoblast differentiation is an attractive model for tissue-specific gene expression because the process is highly regulated and remains tightly synchronized over a period of several weeks. This model was used here, with a stable shRNA-mediated depletion approach, to examine the role of the signature PBAF subunit, ARID2, during differentiation. This analysis identifies a critical role for ARID2-containing complexes in promoting osteoblast differentiation and supports a view that the PBAF subset of SWI/SNF contributes importantly to maintaining cellular identity and activating tissue-specific gene expression.	[Xu, Fuhua; Flowers, Stephen; Moran, Elizabeth] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Orthopaed, Univ Hosp,Canc Ctr, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Moran, E (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Orthopaed, Univ Hosp,Canc Ctr, 205 S Orange Ave, Newark, NJ 07103 USA.	moranel@umdnj.edu	Xu, Fuhua/B-8937-2014		National Institutes of Health through the United States Public Health Service [GM073257, T32-CA134268]; NATIONAL CANCER INSTITUTE [T32CA134268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073257] Funding Source: NIH RePORTER	National Institutes of Health through the United States Public Health Service; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM073257 (to E. M.) and T32-CA134268 (to S. F.) through the United States Public Health Service.	Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; Beck GR, 2001, CELL GROWTH DIFFER, V12, P61; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Burrows AE, 2010, P NATL ACAD SCI USA, V107, P14280, DOI 10.1073/pnas.1009559107; Chi TH, 2002, NATURE, V418, P195, DOI 10.1038/nature00876; Cordonnier T, 2011, TISSUE ENG PART C-ME, V17, P249, DOI [10.1089/ten.tec.2010.0387, 10.1089/ten.TEC.2010.0387]; de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882; Drost J, 2010, NAT CELL BIOL, V12, P380, DOI 10.1038/ncb2038; Easley R, 2010, VIROLOGY, V405, P322, DOI 10.1016/j.virol.2010.06.009; Feng JQ, 2002, J BONE MINER RES, V17, P1822, DOI 10.1359/jbmr.2002.17.10.1822; Flores-Alcantar A, 2011, CELL TISSUE RES, V345, P137, DOI 10.1007/s00441-011-1182-x; Flowers S, 2011, J BIOL CHEM, V286, P27867, DOI 10.1074/jbc.C111.255091; Flowers S, 2010, CANCER RES, V70, P8282, DOI 10.1158/0008-5472.CAN-10-2205; Flowers S, 2009, J BIOL CHEM, V284, P10067, DOI 10.1074/jbc.M808782200; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; GEORGE A, 1993, J BIOL CHEM, V268, P12624; Gluhak-Heinrich J, 2010, BONE, V46, P1533, DOI 10.1016/j.bone.2010.02.024; Goldman DC, 2009, BLOOD, V114, P4393, DOI 10.1182/blood-2009-02-206433; Guan B, 2011, AM J SURG PATHOL, V35, P625, DOI 10.1097/PAS.0b013e318212782a; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Huang HY, 2009, P NATL ACAD SCI USA, V106, P12670, DOI 10.1073/pnas.0906266106; Huang XL, 2008, DEV BIOL, V319, P258, DOI 10.1016/j.ydbio.2008.04.020; Inoue H, 2002, J BIOL CHEM, V277, P41674, DOI 10.1074/jbc.M205961200; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kaeser MD, 2008, J BIOL CHEM, V283, P32254, DOI 10.1074/jbc.M806061200; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Nagl NG, 2006, CANCER RES, V66, P1289, DOI 10.1158/0008-5472.CAN-05-3427; Nagl NG, 2005, CANCER RES, V65, P9236, DOI 10.1158/0008-5472.CAN-05-1225; Nagl NG, 2007, EMBO J, V26, P752, DOI 10.1038/sj.emboj.7601541; Patsialou A, 2005, NUCLEIC ACIDS RES, V33, P66, DOI 10.1093/nar/gki145; Ruchon AF, 2000, J BONE MINER RES, V15, P1440, DOI 10.1359/jbmr.2000.15.8.1440; Ryme J, 2009, J CELL BIOCHEM, V108, P565, DOI 10.1002/jcb.22288; Schroeder TM, 2004, J BIOL CHEM, V279, P41998, DOI 10.1074/jbc.M403702200; Sinha KM, 2010, EMBO J, V29, P68, DOI 10.1038/emboj.2009.332; Smith CL, 2005, CURR TOP DEV BIOL, V65, P115; Stein GS, 1996, PHYSIOL REV, V76, P593, DOI 10.1152/physrev.1996.76.2.593; Toyosawa S, 2001, J BONE MINER RES, V16, P2017, DOI 10.1359/jbmr.2001.16.11.2017; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Vicent GP, 2010, MOL ENDOCRINOL, V24, P2088, DOI 10.1210/me.2010-0027; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wang XM, 2004, INT J CANCER, V112, P636, DOI 10.1002/ijc.20450; Wang XM, 2004, BIOCHEM J, V383, P319, DOI 10.1042/BJ20040524; Wang Z, 2004, GENE DEV, V18, P3106, DOI 10.1101/gad.1238104; Westendorf JJ, 2007, J CELL BIOCHEM, V102, P332, DOI 10.1002/jcb.21486; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wilsker D, 2005, GENOMICS, V86, P242, DOI 10.1016/j.ygeno.2005.03.013; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Xia W, 2008, CANCER RES, V68, P1667, DOI 10.1158/0008-5472.CAN-07-5276; Yan ZJ, 2005, GENE DEV, V19, P1662, DOI 10.1101/gad.1323805; Young DW, 2005, J CELL BIOCHEM, V94, P720, DOI 10.1002/jcb.20332; Zhang XM, 2006, BIOCHEM BIOPH RES CO, V346, P794, DOI 10.1016/j.bbrc.2006.05.211; Zhou M, 2006, J CELL BIOCHEM, V98, P920, DOI 10.1002/jcb.20788	53	45	48	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					5033	5041		10.1074/jbc.M111.279968	http://dx.doi.org/10.1074/jbc.M111.279968			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22184115	Green Published, hybrid			2022-12-25	WOS:000300608500062
J	Croizier, S; Amiot, C; Chen, XP; Presse, F; Nahon, JL; Wu, JY; Fellmann, D; Risold, PY				Croizier, Sophie; Amiot, Clotilde; Chen, Xiaoping; Presse, Francoise; Nahon, Jean-Louis; Wu, Jane Y.; Fellmann, Dominique; Risold, Pierre-Yves			Development of Posterior Hypothalamic Neurons Enlightens a Switch in the Prosencephalic Basic Plan	PLOS ONE			English	Article							MELANIN-CONCENTRATING HORMONE; CENTRAL-NERVOUS-SYSTEM; SONIC-HEDGEHOG; EXPRESSION PATTERNS; VENTRAL MIDBRAIN; GENE-EXPRESSION; AXONAL GROWTH; SEMAPHORIN 3F; MICE LACKING; ROBO-SLIT	In rats and mice, ascending and descending axons from neurons producing melanin-concentrating hormone (MCH) reach the cerebral cortex and spinal cord. However, these ascending and descending projections originate from distinct subpopulations expressing or not "Cocaine-and-Amphetamine-Regulated-Transcript'' (CART) peptide. Using a BrdU approach, MCH cell bodies are among the very first generated in the hypothalamus, within a longitudinal cell cord made of earliest delaminating neuroblasts in the diencephalon and extending from the chiasmatic region to the ventral midbrain. This region also specifically expresses the regulatory genes Sonic hedgehog (Shh) and Nkx2.2. First MCH axons run through the tractus postopticus (tpoc) which gathers pioneer axons from the cell cord and courses parallel to the Shh/Nkx2.2 expression domain. Subsequently generated MCH neurons and ascending MCH axons differentiate while neurogenesis and mantle layer differentiation are generalized in the prosencephalon, including telencephalon. Ascending MCH axons follow dopaminergic axons of the mesotelencephalic tract, both being an initial component of the medial forebrain bundle (mfb). Netrin1 and Slit2 proteins that are involved in the establishment of the tpoc and mfb, respectively attract or repulse MCH axons. We conclude that first generated MCH neurons develop in a diencephalic segment of a longitudinal Shh/Nkx2.2 domain. This region can be seen as a prosencephalic segment of a medial neurogenic column extending from the chiasmatic region through the ventral neural tube. However, as the telencephalon expends, it exerts a trophic action and the mfb expands, inducing a switch in the longitudinal axial organization of the prosencephalon.	[Croizier, Sophie; Amiot, Clotilde; Fellmann, Dominique; Risold, Pierre-Yves] Univ Franche Comte, Fac Med & Pharm, EA3922, F-25030 Besancon, France; [Croizier, Sophie; Amiot, Clotilde; Fellmann, Dominique; Risold, Pierre-Yves] Univ Franche Comte, IFR133, F-25030 Besancon, France; [Chen, Xiaoping; Wu, Jane Y.] Northwestern Univ, Sch Med, Dept Neurol, Chicago, IL 60611 USA; [Presse, Francoise; Nahon, Jean-Louis] Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, UMR CNRS 6097, Valbonne, France	Universite de Franche-Comte; Universite de Franche-Comte; Northwestern University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Croizier, S (corresponding author), Univ Franche Comte, Fac Med & Pharm, EA3922, F-25030 Besancon, France.	pierre-yves.risold@univ-fcomte.fr	Risold, Pierre-Yves/M-7730-2018; NAHON, Jean-Louis/O-7977-2016; PRESSE, Francoise/O-8508-2016; Risold, Pierre-Yves/AAJ-9535-2021	Risold, Pierre-Yves/0000-0001-6801-591X; NAHON, Jean-Louis/0000-0001-9572-7779; Croizier, Sophie/0000-0002-0076-1008	French Ministere de la Recherche; French National Research Agency [ANR-08-MNPS-018-01]; Association France Parkinson	French Ministere de la Recherche(Ministry of Research, France); French National Research Agency(French National Research Agency (ANR)); Association France Parkinson	This work was funded by a grant from the French Ministere de la Recherche, and in part by the French National Research Agency (ANR-08-MNPS-018-01), and the Association France Parkinson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews W, 2006, DEVELOPMENT, V133, P2243, DOI 10.1242/dev.02379; [Anonymous], 1996, DEV BRAIN MAPS STRUC; Arendt D, 1999, DEVELOPMENT, V126, P2309; Arendt D, 2008, PHILOS T R SOC B, V363, P1523, DOI 10.1098/rstb.2007.2242; Bagri A, 2002, NEURON, V33, P233, DOI 10.1016/S0896-6273(02)00561-5; Barallobre MJ, 2005, BRAIN RES REV, V49, P22, DOI 10.1016/j.brainresrev.2004.11.003; Barresi MJF, 2005, DEVELOPMENT, V132, P3643, DOI 10.1242/dev.01929; Bayer S., 2004, RAT NERVOUS SYSTEM, P27; BITTENCOURT JC, 1992, J COMP NEUROL, V319, P218, DOI 10.1002/cne.903190204; Braisted JE, 2000, J NEUROSCI, V20, P5792, DOI 10.1523/JNEUROSCI.20-15-05792.2000; Brischoux F, 2002, EUR J NEUROSCI, V16, P1672, DOI 10.1046/j.1460-9568.2002.02229.x; Brischoux F, 2001, EUR J NEUROSCI, V13, P1733, DOI 10.1046/j.0953-816x.2001.01552.x; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; BUGNON C, 1991, J HISTOCHEM CYTOCHEM, V39, P859, DOI 10.1177/39.6.2033243; Chung SJ, 2009, P NATL ACAD SCI USA, V106, P6772, DOI 10.1073/pnas.0811331106; Conductier G, 2011, NEUROSCIENCE, V178, P89, DOI 10.1016/j.neuroscience.2011.01.030; Cooper MA, 2009, DEV NEUROBIOL, V69, P36, DOI 10.1002/dneu.20685; Cotta-Grand N, 2009, PEPTIDES, V30, P2014, DOI 10.1016/j.peptides.2009.06.015; Croizier S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015471; Cvetkovic V, 2004, J NEUROCHEM, V91, P911, DOI 10.1111/j.1471-4159.2004.02776.x; Dallvechia-Adams S, 2002, J COMP NEUROL, V448, P360, DOI 10.1002/cne.10268; Deiner MS, 1999, J NEUROSCI, V19, P9900; Denes AS, 2007, CELL, V129, P277, DOI 10.1016/j.cell.2007.02.040; Devine CA, 2008, DEV BIOL, V313, P371, DOI 10.1016/j.ydbio.2007.10.040; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Dugan JP, 2011, MOL CELL NEUROSCI, V46, P347, DOI 10.1016/j.mcn.2010.11.003; Elias CF, 2008, J CHEM NEUROANAT, V35, P188, DOI 10.1016/j.jchemneu.2007.10.002; Elias CF, 2001, J COMP NEUROL, V432, P1, DOI 10.1002/cne.1085; FELLMANN D, 1989, NEUROSCI LETT, V106, P23, DOI 10.1016/0304-3940(89)90196-1; FELLMANN D, 1987, NEUROSCI LETT, V74, P275, DOI 10.1016/0304-3940(87)90309-0; Fernandez AS, 1998, DEVELOPMENT, V125, P2099; Funato H, 2000, MOL CELL NEUROSCI, V16, P206, DOI 10.1006/mcne.2000.0870; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Griffond B, 2002, INT REV CYTOL, V213, P233; Griffond B, 2009, PEPTIDES, V30, P2045, DOI 10.1016/j.peptides.2009.07.008; Guijarro P, 2006, MOL CELL NEUROSCI, V33, P389, DOI 10.1016/j.mcn.2006.08.010; Guyon A, 2007, J MOL ENDOCRINOL, V38, P365, DOI 10.1677/JME-06-0013; Guyon A, 2009, PEPTIDES, V30, P2031, DOI 10.1016/j.peptides.2009.05.028; Hanriot L, 2007, J COMP NEUROL, V505, P147, DOI 10.1002/cne.21482; Hassani OK, 2009, P NATL ACAD SCI USA, V106, P2418, DOI 10.1073/pnas.0811400106; Hernandez-Montiel HL, 2008, J COMP NEUROL, V506, P387, DOI 10.1002/cne.21503; Kastenhuber E, 2009, J NEUROSCI, V29, P8914, DOI 10.1523/JNEUROSCI.0568-09.2009; Kawano H, 2003, EXP NEUROL, V182, P103, DOI 10.1016/S0014-4886(03)00030-X; Kayama Y, 1998, EUR UROL, V33, P12, DOI 10.1159/000052235; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; KEYSER A, 1972, ACTA ANAT, P1; Keyser A, 1979, HDB HYPOTHALAMUS, V1, P65; Kolk SM, 2009, J NEUROSCI, V29, P12542, DOI 10.1523/JNEUROSCI.2521-09.2009; Leinninger GM, 2009, CELL METAB, V10, P89, DOI 10.1016/j.cmet.2009.06.011; Lin L, 2005, MOL CELL NEUROSCI, V28, P547, DOI 10.1016/j.mcn.2004.11.009; Lin L, 2006, STEM CELLS, V24, P2504, DOI 10.1634/stemcells.2006-0119; Marillat V, 2002, J COMP NEUROL, V442, P130, DOI 10.1002/cne.10068; Marin O, 2002, DEVELOPMENT, V129, P761; Markakis EA, 1997, BRAIN RES REV, V24, P255, DOI 10.1016/S0165-0173(97)00006-4; Mastick GS, 1996, DEV BIOL, V173, P79, DOI 10.1006/dbio.1996.0008; Metin C, 1997, DEVELOPMENT, V124, P5063; Nieuwenhuis E, 2007, DEV BIOL, V308, P547, DOI 10.1016/j.ydbio.2007.06.016; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Peyron C, 1998, J NEUROSCI, V18, P9996; Pissios P, 2007, DIABETES, V56, P311, DOI 10.2337/db06-0708; Potter GB, 2009, MOL CELL NEUROSCI, V40, P167, DOI 10.1016/j.mcn.2008.10.003; Powell AW, 2008, PLOS BIOL, V6, P1047, DOI 10.1371/journal.pbio.0060116; PRESSE F, 1993, NEUROSCIENCE, V55, P709, DOI 10.1016/0306-4522(93)90436-J; Puelles L, 2003, TRENDS NEUROSCI, V26, P469, DOI 10.1016/S0166-2236(03)00234-0; PUELLES L, 1993, TRENDS NEUROSCI, V16, P472, DOI 10.1016/0166-2236(93)90080-6; Qu DQ, 1996, NATURE, V380, P243, DOI 10.1038/380243a0; Risold PY, 2009, PEPTIDES, V30, P1969, DOI 10.1016/j.peptides.2009.07.016; RISOLD PY, 1992, NEUROSCI LETT, V136, P145, DOI 10.1016/0304-3940(92)90035-6; SCHOOFS L, 1988, BRAIN RES, V450, P202, DOI 10.1016/0006-8993(88)91559-4; Shimamura K, 1995, DEVELOPMENT, V121, P3923; Shimogori T, 2010, NAT NEUROSCI, V13, P767, DOI 10.1038/nn.2545; Shirayama Y, 2006, CURR NEUROPHARMACOL, V4, P277, DOI 10.2174/157015906778520773; Sieber BA, 2004, MOL CELL NEUROSCI, V26, P418, DOI 10.1016/j.mcn.2004.03.009; SKOFITSCH G, 1985, BRAIN RES BULL, V15, P635, DOI 10.1016/0361-9230(85)90213-8; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; Stanley S, 2010, P NATL ACAD SCI USA, V107, P7024, DOI 10.1073/pnas.1002790107; STEINBUSCH HWM, 1986, BRAIN RES, V368, P389, DOI 10.1016/0006-8993(86)90588-3; STEINBUSCH HWM, 1991, ACTA OTO-LARYNGOL, P12; Stoykova A, 1996, DEVELOPMENT, V122, P3453; Stuhmer T, 2002, DEVELOPMENT, V129, P245; Szabo NE, 2009, J NEUROSCI, V29, P6989, DOI 10.1523/JNEUROSCI.1089-09.2009; Taupin P, 2007, BRAIN RES REV, V53, P198, DOI 10.1016/j.brainresrev.2006.08.002; Vitalis T, 2000, J NEUROSCI, V20, P6501, DOI 10.1523/JNEUROSCI.20-17-06501.2000; Vokes SA, 2007, DEVELOPMENT, V134, P1977, DOI 10.1242/dev.001966; Xu C, 2008, GENE EXPR PATTERNS, V8, P502, DOI 10.1016/j.gep.2008.06.003; Yue Y, 1999, J NEUROSCI, V19, P2090; ZAMIR N, 1986, BRAIN RES, V373, P240, DOI 10.1016/0006-8993(86)90337-9	88	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2011	6	12							e28574	10.1371/journal.pone.0028574	http://dx.doi.org/10.1371/journal.pone.0028574			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JD	22194855	gold, Green Published, Green Submitted			2022-12-25	WOS:000298664400009
J	Hummelshoj, T; Nissen, J; Munthe-Fog, L; Koch, C; Bertelsen, MF; Garred, P				Hummelshoj, Tina; Nissen, Janna; Munthe-Fog, Lea; Koch, Claus; Bertelsen, Mads Frost; Garred, Peter			Allelic Lineages of the Ficolin Genes (FCNs) Are Passed from Ancestral to Descendant Primates	PLOS ONE			English	Article							CLONING; POLYMORPHISMS; PROTEIN	The ficolins recognize carbohydrates and acetylated compounds on microorganisms and dying host cells and are able to activate the lectin pathway of the complement system. In humans, three ficolin genes have been identified: FCN1, FCN2 and FCN3, which encode ficolin-1, ficolin-2 and ficolin-3, respectively. Rodents have only two ficolins designated ficolin-A and ficolin-B that are closely related to human ficolin-1, while the rodent FCN3 orthologue is a pseudogene. Ficolin-2 and ficolin-3 have so far only been observed in humans. Thus, we performed a systematic investigation of the FCN genes in non-human primates. The exons and intron-exon boundaries of the FCN1-3 genes were sequenced in the following primate species: chimpanzee, gorilla, orangutan, rhesus macaque, cynomolgus macaque, baboon and common marmoset. We found that the exon organisation of the FCN genes was very similar between all the non-human primates and the human FCN genes. Several variations in the FCN genes were found in more than one primate specie suggesting that they were carried from one species to another including humans. The amino acid diversity of the ficolins among human and non-human primate species was estimated by calculating the Shannon entropy revealing that all three proteins are generally highly conserved. Ficolin-1 and ficolin-2 showed the highest diversity, whereas ficolin-3 was more conserved. Ficolin-2 and ficolin-3 were present in non-human primate sera with the same characteristic oligomeric structures as seen in human serum. Taken together all the FCN genes show the same characteristics in lower and higher primates. The existence of trans-species polymorphisms suggests that different FCN allelic lineages may be passed from ancestral to descendant species.	[Hummelshoj, Tina; Nissen, Janna; Munthe-Fog, Lea; Garred, Peter] Univ Copenhagen, Rigshosp, Mol Med Lab, Dept Clin Immunol,Fac Hlth Sci, DK-2100 Copenhagen, Denmark; [Koch, Claus] Univ So Denmark, Dept Canc & Inflammat, Inst Mol Med, Odense, Denmark; [Bertelsen, Mads Frost] Copenhagen Zoo, Ctr Zoo & Wild Anim Hlth, Frederiksberg, Denmark	Rigshospitalet; University of Copenhagen; University of Southern Denmark	Hummelshoj, T (corresponding author), Univ Copenhagen, Rigshosp, Mol Med Lab, Dept Clin Immunol,Fac Hlth Sci, DK-2100 Copenhagen, Denmark.	garred@post5.tele.dk	Bertelsen, Mads/AAA-5746-2022	Bertelsen, Mads/0000-0001-9201-7499; Nissen, Janna/0000-0002-8891-8451; Munthe-Fog, Lea/0000-0003-1345-176X; Garred, Peter/0000-0002-2876-8586	The Novo Nordisk Research Foundation; The Lundbeck Foundation; Rigshospitalet; Svend Andersen Fonden	The Novo Nordisk Research Foundation; The Lundbeck Foundation(Lundbeckfonden); Rigshospitalet; Svend Andersen Fonden	This work was supported by The Novo Nordisk Research Foundation, The Lundbeck Foundation, Rigshospitalet, and Svend Andersen Fonden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Endo Y, 1996, GENOMICS, V36, P515, DOI 10.1006/geno.1996.0497; Endo Y, 2004, GENOMICS, V84, P737, DOI 10.1016/j.ygeno.2004.07.006; Endo Y, 2011, INT J BIOCHEM CELL B, V43, P705, DOI 10.1016/j.biocel.2011.02.003; Garlatti V, 2007, J BIOL CHEM, V282, P35814, DOI 10.1074/jbc.M705741200; Garlatti V, 2007, EMBO J, V26, P623, DOI 10.1038/sj.emboj.7601500; Garred P, 2010, J INNATE IMMUN, V2, P3, DOI 10.1159/000242419; Gout E, 2010, J BIOL CHEM, V285, P6612, DOI 10.1074/jbc.M109.065854; Honore C, 2008, MOL IMMUNOL, V45, P2782, DOI 10.1016/j.molimm.2008.02.005; Hummelshoj T, 2005, HUM MOL GENET, V14, P1651, DOI 10.1093/hmg/ddi173; Hummelshoj T, 2008, MOL IMMUNOL, V45, P2508, DOI 10.1016/j.molimm.2008.01.003; Hummelshoj T, 2008, MOL IMMUNOL, V45, P1623, DOI 10.1016/j.molimm.2007.10.006; Kakinuma Y, 2003, IMMUNOGENETICS, V55, P29, DOI 10.1007/s00251-003-0552-2; Klein J, 2007, ANNU REV GENET, V41, P281, DOI 10.1146/annurev.genet.41.110306.130137; Liu Y, 2005, J IMMUNOL, V175, P3150, DOI 10.4049/jimmunol.175.5.3150; Lu J, 1996, IMMUNOLOGY, V89, P289, DOI 10.1046/j.1365-2567.1996.d01-732.x; Lu JH, 1996, BIOCHEM J, V313, P473, DOI 10.1042/bj3130473; Munthe-Fog L, 2007, SCAND J IMMUNOL, V65, P383, DOI 10.1111/j.1365-3083.2007.01915.x; Munthe-Fog L, 2008, MOL IMMUNOL, V45, P2660, DOI 10.1016/j.molimm.2007.12.012; Munthe-Fog L, 2009, NEW ENGL J MED, V360, P2637, DOI 10.1056/NEJMoa0900381; Rorvig S, 2009, J LEUKOCYTE BIOL, V86, P1439, DOI 10.1189/jlb.1008606; Schlapbach LJ, 2011, GUT, V60, P1438, DOI 10.1136/gut.2010.226027; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Stewart JJ, 1997, MOL IMMUNOL, V34, P1067, DOI 10.1016/S0161-5890(97)00130-2; Wittenborn T, 2010, J INNATE IMMUN, V2, P167, DOI 10.1159/000218324	24	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e28187	10.1371/journal.pone.0028187	http://dx.doi.org/10.1371/journal.pone.0028187			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22194813	gold, Green Published, Green Submitted			2022-12-25	WOS:000298370400011
J	Kovalchin, J; Krieger, J; Genova, M; Kawamoto, N; Augustyniak, M; Collins, K; Bloom, T; Masci, A; Hittinger, T; Dufour, I; Strominger, JL; Zanelli, E				Kovalchin, Joseph; Krieger, Jeffrey; Genova, Michelle; Kawamoto, Norio; Augustyniak, Michael; Collins, Kathryn; Bloom, Troy; Masci, Allyson; Hittinger, Tara; Dufour, Ingrid; Strominger, Jack L.; Zanelli, Eric			Macrophage-Specific Chemokines Induced via Innate Immunity by Amino Acid Copolymers and Their Role in EAE	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MYELIN BASIC-PROTEIN; REGULATORY T-CELLS; MULTIPLE-SCLEROSIS; GLATIRAMER ACETATE; SUPPRESSOR-CELLS; DENDRITIC CELLS; SYSTEM; MICE; ACTIVATION	The random amino acid copolymer poly(Y,E,A, K)(n) (Copaxone (R)) is widely used in multiple sclerosis treatment and a second generation copolymer poly(Y, F, A, K) n with enhanced efficacy in experimental autoimmune encephalomyelitis in mice has been described. A major mechanism through which copolymers function to ameliorate disease is the generation of immunosuppressive IL-10-secreting regulatory T cells entering the CNS. In addition, the antigen presenting cell to which these copolymers bind through MHC Class II proteins may have an important role. Here, both CCL22 (a Th2 cell chemoattractant) in large amounts and CXCL13 in much smaller amounts are shown to be secreted after administration of YFAK to mice and to a smaller extent by YEAK parallel to their serum concentrations. Moreover, bone marrow-derived macrophages secrete CCL22 in vitro in response to YFAK and to higher concentrations of YEAK. Strikingly, these chemokines are also secreted into serum of MHC Class II -/- mice, indicating that an innate immune receptor on these cells also has an important role. Thus, both the innate and the adaptive immune systems are involved in the mechanism of EAE amelioration by YFAK. The enhanced ability of YFAK to stimulate the innate immune system may account for its enhanced efficacy in EAE treatment.	[Kovalchin, Joseph; Krieger, Jeffrey; Genova, Michelle; Augustyniak, Michael; Collins, Kathryn; Bloom, Troy; Masci, Allyson; Hittinger, Tara; Dufour, Ingrid; Zanelli, Eric] Peptimmune Inc, Cambridge, MA USA; [Kawamoto, Norio; Strominger, Jack L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Harvard University	Kovalchin, J (corresponding author), Peptimmune Inc, Cambridge, MA USA.	jlstrom@fas.harvard.edu	Kawamoto, Norio/AAN-5302-2021	Kawamoto, Norio/0000-0002-3482-7781	National Institutes of Health [AI-049524]; Peptimmune, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Peptimmune, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NK and JLS were supported by a research grant from the National Institutes of Health (AI-049524). Due to the collaborative nature of this study, Peptimmune, Inc. ceded study design to the corresponding author but paid salaries and expenses associated with some of the experiments for this research. All manuscript preparation was performed by the Harvard and Peptimmune scientists on their own time and without compensation. The funders, Peptimmune, Inc. and the National Institutes of Health, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2006, E SCHERING RES FDN W, V56, P161; Chen CH, 2009, J IMMUNOL, V183, P246, DOI 10.4049/jimmunol.0900193; Fridkis-Hareli M, 1998, J IMMUNOL, V160, P4386; Fridkis-Hareli M, 2002, J CLIN INVEST, V109, P1635, DOI 10.1172/JCI200215402; FRIDKISHARELI M, 1994, P NATL ACAD SCI USA, V91, P4872, DOI 10.1073/pnas.91.11.4872; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gee Katrina, 2009, Inflammation & Allergy Drug Targets, V8, P40; Glabinski AR, 2004, AUTOIMMUNITY, V37, P465, DOI 10.1080/08916930400001859; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Hohlfeid R, 2004, P NATL ACAD SCI USA, V101, P14599, DOI 10.1073/pnas.0404874101; Hussien Y, 2001, J NEUROIMMUNOL, V121, P102, DOI 10.1016/S0165-5728(01)00432-5; Illies Z, 2004, P NATL ACAD SCI USA, V101, P11749, DOI 10.1073/pnas.0403833101; Jee Y, 2007, CLIN IMMUNOL, V125, P34, DOI 10.1016/j.clim.2007.05.020; Kala M, 2010, EXP NEUROL, V221, P136, DOI 10.1016/j.expneurol.2009.10.015; Kim HJ, 2004, J IMMUNOL, V172, P7144, DOI 10.4049/jimmunol.172.11.7144; Kovalchin J, 2010, J NEUROIMMUNOL, V225, P153, DOI 10.1016/j.jneuroim.2010.04.008; Kovalchin J, 2011, J CLIN PHARMACOL, V51, P649, DOI 10.1177/0091270010373930; Kuroda E, 2009, J IMMUNOL, V183, P3652, DOI 10.4049/jimmunol.0900864; Li QD, 1998, EUR J PHARMACOL, V342, P303, DOI 10.1016/S0014-2999(97)01509-4; Makarenkova VP, 2006, J IMMUNOL, V176, P2085, DOI 10.4049/jimmunol.176.4.2085; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mellergard J, 2010, MULT SCLER J, V16, P208, DOI 10.1177/1352458509355068; Mohamadzadeh M, 1996, J IMMUNOL, V156, P3102; Newcomb DC, 2009, J IMMUNOL, V182, P5317, DOI 10.4049/jimmunol.0803868; Racke MK, 2010, NEUROLOGY, V74, pS25, DOI 10.1212/WNL.0b013e3181c97e39; Scotton CJ, 2005, J IMMUNOL, V174, P834, DOI 10.4049/jimmunol.174.2.834; Sethi G, 2009, ADV EXP MED BIOL, V647, P37, DOI 10.1007/978-0-387-89520-8_3; Sinha P, 2005, J IMMUNOL, V174, P636, DOI 10.4049/jimmunol.174.2.636; Stern JNH, 2004, P NATL ACAD SCI USA, V101, P11743, DOI 10.1073/pnas.0403832101; Stern JNH, 2008, P NATL ACAD SCI USA, V105, P5172, DOI 10.1073/pnas.0712131105; TEITELBAUM D, 1971, European Journal of Immunology, V1, P242, DOI 10.1002/eji.1830010406; TEITELBAUM D, 2005, EUR J IMMUNOL, V1, P242; Venken K, 2008, J IMMUNOL, V180, P6411, DOI 10.4049/jimmunol.180.9.6411; Vieira PL, 2003, J IMMUNOL, V170, P4483, DOI 10.4049/jimmunol.170.9.4483; Weber MS, 2007, NAT MED, V13, P935, DOI 10.1038/nm1620; Wu CY, 2006, INT IMMUNOPHARMACOL, V6, P610, DOI 10.1016/j.intimp.2005.09.010; Yin H, 2009, J NEUROIMMUNOL, V215, P43, DOI 10.1016/j.jneuroim.2009.08.002; Zhang H, 2009, P NATL ACAD SCI USA, V106, P3336, DOI 10.1073/pnas.0813197106; Zhu B, 2007, J IMMUNOL, V179, P5228, DOI 10.4049/jimmunol.179.8.5228	40	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e26274	10.1371/journal.pone.0026274	http://dx.doi.org/10.1371/journal.pone.0026274			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22194778	Green Published, gold, Green Submitted			2022-12-25	WOS:000298370400001
J	Goh, J; Jeon, J; Kim, KS; Park, J; Park, SY; Lee, YH				Goh, Jaeduk; Jeon, Junhyun; Kim, Kyoung Su; Park, Jongsun; Park, Sook-Young; Lee, Yong-Hwan			The PEX7-Mediated Peroxisomal Import System Is Required for Fungal Development and Pathogenicity in Magnaporthe oryzae	PLOS ONE			English	Article							RICE BLAST FUNGUS; MEDIATED PLANT INFECTION; ACID BETA-OXIDATION; ASPERGILLUS-NIDULANS; COLLETOTRICHUM-LAGENARIUM; PENICILLIUM-CHRYSOGENUM; FUNCTIONAL-ANALYSIS; METABOLIC FUNCTION; MAP KINASE; GRISEA	In eukaryotes, microbodies called peroxisomes play important roles in cellular activities during the life cycle. Previous studies indicate that peroxisomal functions are important for plant infection in many phytopathogenic fungi, but detailed relationships between fungal pathogenicity and peroxisomal function still remain unclear. Here we report the importance of peroxisomal protein import through PTS2 (Peroxisomal Targeting Signal 2) in fungal development and pathogenicity of Magnaporthe oryzae. Using an Agrobacterium tumefaciens-mediated transformation library, a pathogenicity-defective mutant was isolated from M. oryzae and identified as a T-DNA insert in the PTS2 receptor gene, MoPEX7. Gene disruption of MoPEX7 abolished peroxisomal localization of a thiolase (MoTHL1) containing PTS2, supporting its role in the peroxisomal protein import machinery. Delta Mopex7 showed significantly reduced mycelial growth on media containing short-chain fatty acids as a sole carbon source. Delta Mopex7 produced fewer conidiophores and conidia, but conidial germination was normal. Conidia of Delta Mopex7 were able to develop appressoria, but failed to cause disease in plant cells, except after wound inoculation. Appressoria formed by Delta Mopex7 showed a defect in turgor generation due to a delay in lipid degradation and increased cell wall porosity during maturation. Taken together, our results suggest that the MoPEX7-mediated peroxisomal matrix protein import system is required for fungal development and pathogenicity M. oryzae.	[Goh, Jaeduk; Jeon, Junhyun; Kim, Kyoung Su; Park, Jongsun; Park, Sook-Young; Lee, Yong-Hwan] Seoul Natl Univ, Dept Agr Biotechnol, Ctr Fungal Genet Resources,Res Inst Agr & Life Sc, Ctr Fungal Pathogenesis,Ctr Agr Biomat,Plan Genom, Seoul, South Korea	Seoul National University (SNU)	Goh, J (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Ctr Fungal Genet Resources,Res Inst Agr & Life Sc, Ctr Fungal Pathogenesis,Ctr Agr Biomat,Plan Genom, Seoul, South Korea.	yonglee@snu.ac.kr		Kim, Kyoung Su/0000-0002-0827-0844; Park, Jongsun/0000-0003-0786-4701	National Research Foundation of Korea [2009-0063340, 2009-0080161]; Technology Development Program for Agriculture and Forestry [309015-04-SB020]; Rural Development Administration in Kore [PJ00821201]; Brain Korea 21 Program	National Research Foundation of Korea(National Research Foundation of Korea); Technology Development Program for Agriculture and Forestry; Rural Development Administration in Kore; Brain Korea 21 Program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by grants from the National Research Foundation of Korea (2009-0063340 and 2009-0080161), the Technology Development Program for Agriculture and Forestry (309015-04-SB020) and the Next-Generation BioGreen 21 Program of Rural Development Administration in Korea (PJ00821201). Dr. Goh is grateful for a graduate fellowship through the Brain Korea 21 Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura M, 2006, APPL ENVIRON MICROB, V72, P6345, DOI 10.1128/AEM.00988-06; Aubourg P, 2000, GLIA, V29, P186, DOI 10.1002/(SICI)1098-1136(20000115)29:2<186::AID-GLIA13>3.0.CO;2-5; Bhambra GK, 2006, MOL MICROBIOL, V61, P46, DOI 10.1111/j.1365-2958.2006.05209.x; Bonnet C, 2006, MOL MICROBIOL, V62, P157, DOI 10.1111/j.1365-2958.2006.05353.x; Brown LA, 2008, MOL MEMBR BIOL, V25, P363, DOI 10.1080/09687680802130583; Chi MH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000401; Chi MH, 2009, PLANT PATHOLOGY J, V25, P108, DOI 10.5423/PPJ.2009.25.1.108; Choi J, 2009, FUNGAL GENET BIOL, V46, P243, DOI 10.1016/j.fgb.2008.11.010; deJong JC, 1997, NATURE, V389, P244, DOI 10.1038/38418; Ebbole DJ, 2007, ANNU REV PHYTOPATHOL, V45, P437, DOI 10.1146/annurev.phyto.45.062806.094346; ERDMANN R, 1991, CELL, V64, P499, DOI 10.1016/0092-8674(91)90234-P; HOWARD RJ, 1991, P NATL ACAD SCI USA, V88, P11281, DOI 10.1073/pnas.88.24.11281; Hynes MJ, 2008, GENETICS, V178, P1355, DOI 10.1534/genetics.107.085795; Hynes MJ, 2006, EUKARYOT CELL, V5, P794, DOI 10.1128/EC.5.5.794-805.2006; Idnurm A, 2007, EUKARYOT CELL, V6, P60, DOI 10.1128/EC.00214-06; Jeon J, 2008, MOL PLANT MICROBE IN, V21, P525, DOI 10.1094/MPMI-21-5-0525; Jeon J, 2007, NAT GENET, V39, P561, DOI 10.1038/ng2002; Kiel JAKW, 2005, FUNGAL GENET BIOL, V42, P154, DOI 10.1016/j.fgb.2004.10.010; Kiel JAKW, 2004, FUNGAL GENET BIOL, V41, P708, DOI 10.1016/j.fgb.2004.02.006; Kiel JAKW, 2006, TRAFFIC, V7, P1291, DOI 10.1111/j.1600-0854.2006.00479.x; Kiel JAKW, 2009, FUNGAL GENET BIOL, V46, pS62, DOI 10.1016/j.fgb.2008.07.009; Kim S, 2005, MOL MICROBIOL, V57, P1224, DOI 10.1111/j.1365-2958.2005.04750.x; Kimura A, 2001, PLANT CELL, V13, P1945, DOI 10.1105/tpc.13.8.1945; Koga H, 2004, PHYSIOL MOL PLANT P, V64, P67, DOI 10.1016/j.pmpp.2004.07.002; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Kwon M, 2010, PLANT PATHOLOGY J, V26, P8, DOI 10.5423/PPJ.2010.26.1.008; LEE YH, 1993, PLANT CELL, V5, P693, DOI 10.1105/tpc.5.6.693; Liu FF, 2008, J CELL BIOL, V180, P325, DOI 10.1083/jcb.200705049; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; Lockshon D, 2007, GENETICS, V175, P77, DOI 10.1534/genetics.106.064428; Maggio-Hall LA, 2004, MOL MICROBIOL, V54, P1173, DOI 10.1111/j.1365-2958.2004.04340.x; MONEY NP, 1989, PLANT PHYSIOL, V91, P766, DOI 10.1104/pp.91.2.766; OCHMAN H, 1988, GENETICS, V120, P621; Park J, 2008, NUCLEIC ACIDS RES, V36, pD562, DOI 10.1093/nar/gkm758; Park SY, 2010, PLANT PATHOLOGY J, V26, P313, DOI 10.5423/PPJ.2010.26.4.313; Piekarska K, 2006, EUKARYOT CELL, V5, P1847, DOI 10.1128/EC.00093-06; Platta HW, 2007, TRENDS CELL BIOL, V17, P474, DOI 10.1016/j.tcb.2007.06.009; Ramos-Pamplona M, 2006, MOL MICROBIOL, V61, P61, DOI 10.1111/j.1365-2958.2006.05194.x; Reumann S, 2004, PLANT PHYSIOL, V136, P2587, DOI 10.1104/pp.104.043695; Reumann S, 2004, PLANT PHYSIOL, V135, P783, DOI 10.1104/pp.103.035584; Sambrook J, 2001, MOL CLONING LAB MANU; Schluter A, 2010, NUCLEIC ACIDS RES, V38, pD800, DOI 10.1093/nar/gkp935; Shen YQ, 2009, FUNCT INTEGR GENOMIC, V9, P145, DOI 10.1007/s10142-008-0095-6; SHIMOZAWA N, 1992, SCIENCE, V255, P1132, DOI 10.1126/science.1546315; Sichting M, 2003, MOL BIOL CELL, V14, P810, DOI 10.1091/mbc.E02-08-0539; Soundararajan S, 2004, PLANT CELL, V16, P1564, DOI 10.1105/tpc.020677; SWEIGARD JA, 1992, MOL GEN GENET, V232, P183, DOI 10.1007/BF00279995; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; Thines E, 2000, PLANT CELL, V12, P1703, DOI 10.1105/tpc.12.9.1703; Titorenko VI, 2001, TRENDS CELL BIOL, V11, P22, DOI 10.1016/S0962-8924(00)01865-1; Titorenko VI, 2001, NAT REV MOL CELL BIO, V2, P357, DOI 10.1038/35073063; Wang ZY, 2007, MOL PLANT MICROBE IN, V20, P475, DOI 10.1094/MPMI-20-5-0475; Wilson RA, 2009, NAT REV MICROBIOL, V7, P185, DOI 10.1038/nrmicro2032; Xu JR, 1998, P NATL ACAD SCI USA, V95, P12713, DOI 10.1073/pnas.95.21.12713; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Yun SH, 1998, THESIS CORNELL U	57	41	46	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28220	10.1371/journal.pone.0028220	http://dx.doi.org/10.1371/journal.pone.0028220			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194815	Green Published, Green Submitted, gold			2022-12-25	WOS:000298369100024
J	Newman, LA; Korol, DL; Gold, PE				Newman, Lori A.; Korol, Donna L.; Gold, Paul E.			Lactate Produced by Glycogenolysis in Astrocytes Regulates Memory Processing	PLOS ONE			English	Article							HIPPOCAMPAL ACETYLCHOLINE-RELEASE; CEREBRAL CORTICAL ASTROCYTES; LONG-TERM POTENTIATION; ENERGY-METABOLISM; SPONTANEOUS-ALTERNATION; NEURONAL-ACTIVITY; GLUCOSE INJECTIONS; BRAIN GLUCOSE; MONOCARBOXYLATE TRANSPORTERS; PRIMARY CULTURES	When administered either systemically or centrally, glucose is a potent enhancer of memory processes. Measures of glucose levels in extracellular fluid in the rat hippocampus during memory tests reveal that these levels are dynamic, decreasing in response to memory tasks and loads; exogenous glucose blocks these decreases and enhances memory. The present experiments test the hypothesis that glucose enhancement of memory is mediated by glycogen storage and then metabolism to lactate in astrocytes, which provide lactate to neurons as an energy substrate. Sensitive bioprobes were used to measure brain glucose and lactate levels in 1-sec samples. Extracellular glucose decreased and lactate increased while rats performed a spatial working memory task. Intrahippocampal infusions of lactate enhanced memory in this task. In addition, pharmacological inhibition of astrocytic glycogenolysis impaired memory and this impairment was reversed by administration of lactate or glucose, both of which can provide lactate to neurons in the absence of glycogenolysis. Pharmacological block of the monocarboxylate transporter responsible for lactate uptake into neurons also impaired memory and this impairment was not reversed by either glucose or lactate. These findings support the view that astrocytes regulate memory formation by controlling the provision of lactate to support neuronal functions.	[Newman, Lori A.; Korol, Donna L.; Gold, Paul E.] Univ Illinois, Neurosci Program, Champaign, IL 61820 USA; [Korol, Donna L.; Gold, Paul E.] Univ Illinois, Inst Genom Biol, Champaign, IL 61820 USA; [Newman, Lori A.; Korol, Donna L.; Gold, Paul E.] Univ Illinois, Dept Psychol, Champaign, IL 61820 USA; [Korol, Donna L.; Gold, Paul E.] Univ Illinois, Dept Mol & Integrat Physiol, Champaign, IL 61820 USA; [Gold, Paul E.] Univ Illinois, Dept Psychiat, Champaign, IL 61820 USA; [Gold, Paul E.] Univ Illinois, Dept Biomed Engn, Champaign, IL 61820 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Newman, LA (corresponding author), Univ Illinois, Neurosci Program, Champaign, IL 61820 USA.	lanewman@illinois.edu	Newman, Lori/J-6974-2015	Newman, Lori/0000-0002-8368-7690	National Science Foundation (NSF) [IOS 1052464, IOS 0843175]; National Institutes of Health (NIH) [HD007333, AG07648]; Alzheimer's Association; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007333] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG007648] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [0843175] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The following supported this research: National Science Foundation (NSF) IOS 1052464, NSF IOS 0843175, National Institutes of Health (NIH) Training Grant HD007333, NIH grant AG07648, and an Alzheimer's Association Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENTON D, 1994, NEUROPSYCHOLOGIA, V32, P595, DOI 10.1016/0028-3932(94)90147-3; BENTON D, 1993, PSYCHOPHARMACOLOGY, V113, P83, DOI 10.1007/BF02244338; Benton D, 2008, BIOL PSYCHOL, V78, P242, DOI 10.1016/j.biopsycho.2008.03.007; Benton D, 2007, PHYSIOL BEHAV, V92, P717, DOI 10.1016/j.physbeh.2007.05.065; Bergersen LH, 2007, NEUROSCIENCE, V145, P11, DOI 10.1016/j.neuroscience.2006.11.062; BORKE RC, 1984, DEV BRAIN RES, V16, P277, DOI 10.1016/0165-3806(84)90032-4; Brooks GA, 2009, J PHYSIOL-LONDON, V587, P5591, DOI 10.1113/jphysiol.2009.178350; Brown AM, 2004, NEUROCHEM INT, V45, P529, DOI 10.1016/j.neuint.2003.11.005; Brown AM, 2007, GLIA, V55, P1263, DOI 10.1002/glia.20557; Brunet JF, 2010, J CEREBR BLOOD F MET, V30, P51, DOI 10.1038/jcbfm.2009.207; BRUNJES PC, 1991, DEV BRAIN RES, V62, P239, DOI 10.1016/0165-3806(91)90171-E; BULMER D, 1959, STAIN TECHNOL, V34, P95, DOI 10.3109/10520295909114656; Butz CE, 2004, J APPL PHYSIOL, V97, P1059, DOI 10.1152/japplphysiol.00009.2004; Canal CE, 2005, LEARN MEMORY, V12, P367, DOI 10.1101/lm.88205; Carmona MA, 2009, P NATL ACAD SCI USA, V106, P12524, DOI 10.1073/pnas.0903328106; Castro MA, 2009, J NEUROCHEM, V110, P423, DOI 10.1111/j.1471-4159.2009.06151.x; Chang Q, 2006, J NEUROCHEM, V97, P697, DOI 10.1111/j.1471-4159.2006.03765.x; Chang Q, 2004, HIPPOCAMPUS, V14, P170, DOI 10.1002/hipo.10160; Chiry O, 2006, BRAIN RES, V1070, P65, DOI 10.1016/j.brainres.2005.11.064; Choeiri C, 2006, BEHAV BRAIN RES, V172, P233, DOI 10.1016/j.bbr.2006.05.005; Choeiri C, 2005, NEUROSCIENCE, V130, P591, DOI 10.1016/j.neuroscience.2004.09.011; Chuquet J, 2010, J NEUROSCI, V30, P15298, DOI 10.1523/JNEUROSCI.0762-10.2010; Cruz NF, 2002, J CEREBR BLOOD F MET, V22, P1476, DOI 10.1097/01.WCB.0000034362.37277.C0; Darvesh AS, 2003, EUR J PHARMACOL, V464, P135, DOI 10.1016/S0014-2999(03)01432-8; Dash PK, 2006, J NEUROSCI, V26, P8048, DOI 10.1523/JNEUROSCI.0671-06.2006; Debernardi R, 2003, J NEUROSCI RES, V73, P141, DOI 10.1002/jnr.10660; DeRuisseau LR, 2009, P NATL ACAD SCI USA, V106, P9419, DOI 10.1073/pnas.0902534106; Donohoe RT, 2000, PHYSIOL BEHAV, V71, P395, DOI 10.1016/S0031-9384(00)00359-0; Dubouchaud H, 2000, AM J PHYSIOL-ENDOC M, V278, pE571, DOI 10.1152/ajpendo.2000.278.4.E571; Duelli R, 1998, J NEURAL TRANSM, V105, P1017, DOI 10.1007/s007020050109; DURHAM D, 1985, J COMP NEUROL, V231, P446, DOI 10.1002/cne.902310404; DWYER DS, 2002, INT REV NEUROBIOL, P159; Elekes O, 1996, NEUROSCI LETT, V208, P69, DOI 10.1016/0304-3940(96)12553-2; Erlichman JS, 2008, J NEUROSCI, V28, P4888, DOI 10.1523/JNEUROSCI.5430-07.2008; FELLOWS LK, 1992, J NEUROCHEM, V59, P2141; Fillenz M, 2005, NEUROCHEM INT, V47, P413, DOI 10.1016/j.neuint.2005.05.011; Fillenz M, 1999, ACTA PHYSIOL SCAND, V167, P275; Filosa A, 2009, NAT NEUROSCI, V12, P1285, DOI 10.1038/nn.2394; FRIEDE RL, 1962, J NEUROPATH EXP NEUR, V21, P471, DOI 10.1097/00005072-196207000-00015; Gibbs ME, 2008, NEUROSCI BIOBEHAV R, V32, P927, DOI 10.1016/j.neubiorev.2008.02.001; Gibbs ME, 2008, NEUROCHEM INT, V52, P1012, DOI 10.1016/j.neuint.2007.10.014; Gibbs ME, 2006, GLIA, V54, P214, DOI 10.1002/glia.20377; Gold PE, 2006, LEARN MEMORY, V13, P506, DOI 10.1101/lm.277406; Gold PE, 2005, NEUROBIOL AGING, V26, pS60, DOI 10.1016/j.neurobiolaging.2005.09.002; GOLD PE, 1978, BEHAV BIOL, V23, P509, DOI 10.1016/S0091-6773(78)91614-0; Haber M, 2006, J NEUROSCI, V26, P8881, DOI 10.1523/JNEUROSCI.1302-06.2006; Halassa MM, 2007, TRENDS MOL MED, V13, P54, DOI 10.1016/j.molmed.2006.12.005; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; HALESTRAP AP, 1975, BIOCHEM J, V148, P97, DOI 10.1042/bj1480097; HALL JL, 1986, BEHAV NEURAL BIOL, V46, P156, DOI 10.1016/S0163-1047(86)90640-0; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hertz L, 2010, NEUROCHEM INT, V57, P411, DOI 10.1016/j.neuint.2010.03.019; Hertz L, 2009, J NEUROCHEM, V109, P10, DOI 10.1111/j.1471-4159.2009.05939.x; HOSLI L, 1992, PROG BRAIN RES, V94, P317; Hu YB, 1997, J NEUROCHEM, V68, P1745; Hu YB, 1997, J NEUROCHEM, V69, P1484; Hughes RN, 2004, NEUROSCI BIOBEHAV R, V28, P497, DOI 10.1016/j.neubiorev.2004.06.006; Huja SS, 1999, J BIOMECH, V32, P1243, DOI 10.1016/S0021-9290(99)00047-0; Hutchinson DS, 2008, BRAIN RES BULL, V76, P224, DOI 10.1016/j.brainresbull.2008.02.019; KAGEYAMA GH, 1982, NEUROSCIENCE, V7, P2337, DOI 10.1016/0306-4522(82)90199-3; Kaplan RJ, 2000, AM J CLIN NUTR, V72, P825; KILLACKEY HP, 1979, J COMP NEUROL, V183, P285, DOI 10.1002/cne.901830206; Kong JM, 2002, J NEUROSCI, V22, P5581; Korol DL, 2008, HIPPOCAMPUS, V18, P81, DOI 10.1002/hipo.20372; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Laureys G, 2010, PROG NEUROBIOL, V91, P189, DOI 10.1016/j.pneurobio.2010.01.011; Loaiza A, 2003, J NEUROSCI, V23, P7337; Lynch CM, 2005, J HISTOCHEM CYTOCHEM, V53, P63, DOI 10.1369/jhc.4A6365.2005; Mackay P, 2003, DIABETES OBES METAB, V5, P397, DOI 10.1046/j.1463-1326.2003.00293.x; Magistretti PJ, 2009, SCIENCE, V325, P1349, DOI 10.1126/science.1180102; Magistretti PJ, 2006, J EXP BIOL, V209, P2304, DOI 10.1242/jeb.02208; MAGISTRETTI PJ, 1986, J NEUROSCI, V6, P2558; MAGISTRETTI PJ, 1981, P NATL ACAD SCI-BIOL, V78, P6535, DOI 10.1073/pnas.78.10.6535; MANNING CA, 1993, NEUROBIOL AGING, V14, P523, DOI 10.1016/0197-4580(93)90034-9; Manning CA, 1998, NEUROPSYCHOLOGY, V12, P479, DOI 10.1037/0894-4105.12.3.479; Manning CA, 1998, BEHAV BRAIN RES, V93, P71, DOI 10.1016/S0166-4328(97)00136-8; MAXWELL DS, 1965, J CELL BIOL, V25, P141, DOI 10.1083/jcb.25.2.141; McNay EC, 1999, J NEUROCHEM, V72, P785, DOI 10.1046/j.1471-4159.1999.720785.x; McNay EC, 2006, PHYSIOL BEHAV, V87, P298, DOI 10.1016/j.physbeh.2005.10.016; McNay EC, 2001, J GERONTOL A-BIOL, V56, pB66, DOI 10.1093/gerona/56.2.B66; McNay EC, 2001, NEUROBIOL LEARN MEM, V75, P325, DOI 10.1006/nlme.2000.3976; McNay EC, 2000, P NATL ACAD SCI USA, V97, P2881, DOI 10.1073/pnas.050583697; McNay Ewan C, 2002, Behav Cogn Neurosci Rev, V1, P264, DOI 10.1177/1534582302238337; Messier C, 2004, EUR J PHARMACOL, V490, P33, DOI 10.1016/j.ejphar.2004.02.043; MJAATVEDT AE, 1988, J COMP NEUROL, V277, P155, DOI 10.1002/cne.902770202; MORRIS KA, 2010, 39 ANN M SAN DIEG 20; Morris KA, 2010, NEUROBIOL AGING, V31, P2136, DOI 10.1016/j.neurobiolaging.2008.12.003; Nishida H, 2007, J NEUROSCI, V27, P331, DOI 10.1523/JNEUROSCI.4466-06.2007; Payne RS, 2007, NEUROSCI LETT, V424, P111, DOI 10.1016/j.neulet.2007.07.006; Pellerin L, 2005, J NEUROSCI RES, V79, P55, DOI 10.1002/jnr.20307; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; da Silva APP, 2009, BIOCHEM J, V417, P717, DOI 10.1042/BJ20080805; Petersen K. U., 1969, CELL TISSUE RES, V100, P616; Pfeiffer-Guglielmi B, 2003, J NEUROCHEM, V85, P73, DOI 10.1046/j.1471-4159.2003.01644.x; PHELPS CH, 1972, BRAIN RES, V39, P225, DOI 10.1016/0006-8993(72)90797-4; Pierre K, 2005, J NEUROCHEM, V94, P1, DOI 10.1111/j.1471-4159.2005.03168.x; PIHLMAN K, 1983, HISTOCHEMISTRY, V79, P157, DOI 10.1007/BF00489778; POBLETE JC, 1995, BRAIN RES, V680, P9, DOI 10.1016/0006-8993(95)00201-Z; Potter WB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008996; RAGOZZINO ME, 1995, NEUROSCIENCE, V68, P981, DOI 10.1016/0306-4522(95)00204-V; Ragozzino ME, 1998, J NEUROSCI, V18, P1595; Ragozzino ME, 1996, P NATL ACAD SCI USA, V93, P4693, DOI 10.1073/pnas.93.10.4693; REVEL JP, 1960, J BIOPHYS BIOCHEM CY, V8, P575, DOI 10.1083/jcb.8.3.575; RICHMAN C L, 1986, Current Psychological Research and Reviews, V5, P358, DOI 10.1007/BF02686603; Schousboe A, 2007, NEUROTOX RES, V12, P263, DOI 10.1007/BF03033909; Sickmann HM, 2009, J NEUROCHEM, V109, P80, DOI 10.1111/j.1471-4159.2009.05915.x; Sidman RL, 2008, J NEUROPATH EXP NEUR, V67, P803, DOI 10.1097/NEN.0b013e3181815994; Slezak M, 2006, J PHYSIOLOGY-PARIS, V99, P84, DOI 10.1016/j.jphysparis.2005.12.082; SORG O, 1991, BRAIN RES, V563, P227, DOI 10.1016/0006-8993(91)91538-C; SORG O, 1995, NEUROSCI LETT, V188, P109, DOI 10.1016/0304-3940(95)11410-X; Stefani MR, 2001, J NEUROSCI, V21, P609, DOI 10.1523/JNEUROSCI.21-02-00609.2001; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Talley CEP, 2000, NEUROBIOL LEARN MEM, V73, P79, DOI 10.1006/nlme.1999.3920; Todd KJ, 2006, J PHYSIOLOGY-PARIS, V99, P75, DOI 10.1016/j.jphysparis.2005.12.002; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; VERVERKEN D, 1982, J NEUROCHEM, V38, P1286, DOI 10.1111/j.1471-4159.1982.tb07903.x; Walls AB, 2009, NEUROSCIENCE, V158, P284, DOI 10.1016/j.neuroscience.2008.09.058; Walls AB, 2008, J NEUROCHEM, V105, P1462, DOI 10.1111/j.1471-4159.2008.05250.x; Witcher MR, 2007, GLIA, V55, P13, DOI 10.1002/glia.20415; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503	121	305	311	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28427	10.1371/journal.pone.0028427	http://dx.doi.org/10.1371/journal.pone.0028427			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22180782	Green Submitted, gold, Green Published			2022-12-25	WOS:000298367300010
J	Yun, CH; Kim, JG; Park, BS; Lee, HM; Kim, DH; Kim, EO; Park, JJ; Park, JW; Damante, G; Kim, YI; Lee, BJ				Yun, Chang Ho; Kim, Jae Geun; Park, Byong Seo; Lee, Hye Myeong; Kim, Dong Hee; Kim, Eun Ok; Park, Joong Jean; Park, Jeong Woo; Damante, Giuseppe; Kim, Young Il; Lee, Byung Ju			TTF-1 Action on the Transcriptional Regulation of Cyclooxygenase-2 Gene in the Rat Brain	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; TUMOR-NECROSIS-FACTOR; LPS-INDUCED FEVER; THYROGLOBULIN PROMOTER; PROTEIN EXPRESSION; FEBRILE RESPONSE; MESSENGER-RNA; GLIOMA-CELLS; FACTOR-I; SYNTHASE	We have recently found that thyroid transcription factor-1 (TTF-1), a homeodomain-containing transcription factor, is postnatally expressed in discrete areas of the hypothalamus and closely involved in neuroendocrine functions. We now report that transcription of cyclooxygenase-2 (COX-2), the rate limiting enzyme in prostaglandin biosynthesis, was inhibited by TTF-1. Double immunohistochemistry demonstrated that TTF-1 was expressed in the astrocytes and endothelial cells of blood vessel in the hypothalamus. Promoter assays and electrophoretic mobility shift assays showed that TTF-1 inhibited COX-2 transcription by binding to specific binding domains in the COX-2 promoter. Furthermore, blocking TTF-1 synthesis by intracerebroventricular injection of an antisense oligomer induced an increase of COX-2 synthesis in non-neuronal cells of the rat hypothalamus, and resulted in animals' hyperthermia. These results suggest that TTF-1 is physiologically involved in the control of thermogenesis by regulating COX-2 transcription in the brain.	[Yun, Chang Ho; Kim, Jae Geun; Park, Byong Seo; Lee, Hye Myeong; Kim, Dong Hee; Kim, Eun Ok; Park, Jeong Woo; Lee, Byung Ju] Univ Ulsan, Coll Nat Sci, Dept Biol Sci, Ulsan 680749, South Korea; [Park, Jeong Woo] Korea Univ, Coll Med, Dept Physiol, Seoul 136705, South Korea; [Damante, Giuseppe] Univ Udine, Dept Biomed Sci & Technol, I-33100 Udine, Italy; [Kim, Young Il] Ulsan Univ Hosp, Dept Internal Med, Ulsan, South Korea	University of Ulsan; Korea University; Korea University Medicine (KU Medicine); University of Udine; University of Ulsan; Ulsan University Hospital	Yun, CH (corresponding author), Univ Ulsan, Coll Nat Sci, Dept Biol Sci, Ulsan 680749, South Korea.	yikuls@uuh.ulsan.ac.kr; bjlee@ulsan.ac.kr	Damante, Giuseppe/AAC-5200-2022	Park, Joong-Jean/0000-0002-4534-3002; Damante, Giuseppe/0000-0003-2312-4009; Park, Byong Seo/0000-0001-6463-9645	NRF [KRF-2008-313-C00756]; MEST [2010-0009998]	NRF; MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea)	BJL was supported by Mid-career Researcher Program through NRF grant funded by the MEST (2010-0009998). JGK was supported by the Basic Science Research Program through the NRF (KRF-2008-313-C00756). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENDA P, 1968, SCIENCE, V161, P370, DOI 10.1126/science.161.3839.370; Boulant JA, 2000, CLIN INFECT DIS, V31, pS157, DOI 10.1086/317521; Cao CY, 1998, MOL BRAIN RES, V56, P45, DOI 10.1016/S0169-328X(98)00025-4; Cao CY, 1997, AM J PHYSIOL-REG I, V272, pR1712, DOI 10.1152/ajpregu.1997.272.6.R1712; CIVITAREALE D, 1989, EMBO J, V8, P2537, DOI 10.1002/j.1460-2075.1989.tb08391.x; Conti B, 2004, FRONT BIOSCI-LANDMRK, V9, P1433, DOI 10.2741/1341; Damante G, 1996, EMBO J, V15, P4992, DOI 10.1002/j.1460-2075.1996.tb00879.x; DEWITT DL, 1991, BIOCHIM BIOPHYS ACTA, V1083, P121, DOI 10.1016/0005-2760(91)90032-D; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; FUTAKI N, 1994, PROSTAGLANDINS, V47, P55, DOI 10.1016/0090-6980(94)90074-4; Inoue W, 2006, EUR J NEUROSCI, V24, P2233, DOI 10.1111/j.1460-9568.2006.05105.x; Kaufmann WE, 1996, P NATL ACAD SCI USA, V93, P2317, DOI 10.1073/pnas.93.6.2317; Kaufmann WE, 1997, PROSTAG OTH LIPID M, V54, P601, DOI 10.1016/S0090-6980(97)00128-7; Kim JG, 2007, J BIOL CHEM, V282, P14923, DOI 10.1074/jbc.M701411200; Kim JG, 2011, DIABETES, V60, P710, DOI 10.2337/db10-0183; Kim MS, 2002, J BIOL CHEM, V277, P36863, DOI 10.1074/jbc.M206443200; Kimura S, 1996, TRENDS ENDOCRIN MET, V7, P247, DOI 10.1016/S1043-2760(96)00115-4; Kramer SG, 1999, DEVELOPMENT, V126, P191; Kumbrink J, 2005, J BIOL CHEM, V280, P42785, DOI 10.1074/jbc.M511079200; Lee BJ, 2001, MOL CELL NEUROSCI, V17, P107, DOI 10.1006/mcne.2000.0933; Li S, 1999, BRAIN RES, V825, P86, DOI 10.1016/S0006-8993(99)01225-1; Lindstrom T, 2004, PROSTAG LEUKOTR ESS, V70, P115, DOI 10.1016/j.plefa.2003.04.003; Luheshi GN, 1999, P NATL ACAD SCI USA, V96, P7047, DOI 10.1073/pnas.96.12.7047; Magno L, 2009, BRAIN RES, V1304, P164, DOI 10.1016/j.brainres.2009.09.050; Matsumura K, 1998, J NEUROSCI, V18, P6279; Morrison SF, 2008, EXP PHYSIOL, V93, P773, DOI 10.1113/expphysiol.2007.041848; Nadjar A, 2005, J CEREBR BLOOD F MET, V25, P1047, DOI 10.1038/sj.jcbfm.9600106; Ohmori M, 1999, ENDOCRINOLOGY, V140, P4651, DOI 10.1210/en.140.10.4651; Otey CA, 2003, METHOD CELL BIOL, V71, P287, DOI 10.1016/S0091-679X(03)01013-6; Pellizzari L, 1999, BIOCHEM J, V337, P253, DOI 10.1042/0264-6021:3370253; Ray MK, 1996, MOL CELL BIOL, V16, P2056; ROSER K, 1991, EXP CELL RES, V197, P200, DOI 10.1016/0014-4827(91)90423-R; Scammell TE, 1998, AM J PHYSIOL-REG I, V274, pR783, DOI 10.1152/ajpregu.1998.274.3.R783; Scammell TE, 1996, J NEUROSCI, V16, P6246; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; Son YJ, 2003, J BIOL CHEM, V278, P27043, DOI 10.1074/jbc.M303157200; Steiner AA, 2005, AM J PHYSIOL-REG I, V289, pR1253, DOI 10.1152/ajpregu.00371.2005; Steiner AA, 2001, NEUROIMMUNOMODULAT, V9, P263, DOI 10.1159/000054289; Trentin AG, 1998, BRAZ J MED BIOL RES, V31, P1281, DOI 10.1590/S0100-879X1998001000008; Tzeng Shun-Fen, 2005, Current Drug Targets - Inflammation and Allergy, V4, P335, DOI 10.2174/1568010054022051; Ushikubi F, 1998, NATURE, V395, P281, DOI 10.1038/26233; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286; Wisse BE, 2004, AM J PHYSIOL-ENDOC M, V287, pE1107, DOI 10.1152/ajpendo.00038.2004; XIE WL, 1991, P NATL ACAD SCI USA, V88, P2692, DOI 10.1073/pnas.88.7.2692	44	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28959	10.1371/journal.pone.0028959	http://dx.doi.org/10.1371/journal.pone.0028959			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174936	Green Submitted, gold, Green Published			2022-12-25	WOS:000298367300036
J	Barthelson, R; McFarlin, AJ; Rounsley, SD; Young, S				Barthelson, Roger; McFarlin, Adam J.; Rounsley, Steven D.; Young, Sarah			Plantagora: Modeling Whole Genome Sequencing and Assembly of Plant Genomes	PLOS ONE			English	Article							ARABIDOPSIS GENOME; CHALLENGES	Background: Genomics studies are being revolutionized by the next generation sequencing technologies, which have made whole genome sequencing much more accessible to the average researcher. Whole genome sequencing with the new technologies is a developing art that, despite the large volumes of data that can be produced, may still fail to provide a clear and thorough map of a genome. The Plantagora project was conceived to address specifically the gap between having the technical tools for genome sequencing and knowing precisely the best way to use them. Methodology/Principal Findings: For Plantagora, a platform was created for generating simulated reads from several different plant genomes of different sizes. The resulting read files mimicked either 454 or Illumina reads, with varying paired end spacing. Thousands of datasets of reads were created, most derived from our primary model genome, rice chromosome one. All reads were assembled with different software assemblers, including Newbler, Abyss, and SOAPdenovo, and the resulting assemblies were evaluated by an extensive battery of metrics chosen for these studies. The metrics included both statistics of the assembly sequences and fidelity-related measures derived by alignment of the assemblies to the original genome source for the reads. The results were presented in a website, which includes a data graphing tool, all created to help the user compare rapidly the feasibility and effectiveness of different sequencing and assembly strategies prior to testing an approach in the lab. Some of our own conclusions regarding the different strategies were also recorded on the website. Conclusions/Significance: Plantagora provides a substantial body of information for comparing different approaches to sequencing a plant genome, and some conclusions regarding some of the specific approaches. Plantagora also provides a platform of metrics and tools for studying the process of sequencing and assembly further.	[Barthelson, Roger; Rounsley, Steven D.] Univ Arizona, Inst BiO5, Tucson, AZ 85721 USA; [McFarlin, Adam J.] Apple Inc, Cupertino, CA USA; [Rounsley, Steven D.] Univ Arizona, Sch Plant Sci, Tucson, AZ USA; [Young, Sarah] Broad Inst, Cambridge, MA USA	University of Arizona; Apple Inc; University of Arizona; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Barthelson, R (corresponding author), Univ Arizona, Inst BiO5, Tucson, AZ 85721 USA.	rogerab@email.arizona.edu			National Science Foundation (NSF) [0930455]	National Science Foundation (NSF)(National Science Foundation (NSF))	This work was supported by National Science Foundation (NSF) EAGER Grant: Plantagora: A Plant Genome Assembly Simulation Platform, 0930455, Steven Rounsley, PI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bevan M, 2001, CURR OPIN PLANT BIOL, V4, P105, DOI 10.1016/S1369-5266(00)00144-8; Devos KM, 2005, P NATL ACAD SCI USA, V102, P19243, DOI 10.1073/pnas.0509473102; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Flicek P, 2009, NAT METHODS, V6, pS6, DOI [10.1038/NMETH.1376, 10.1038/nmeth.1376]; Hossain MS, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S16; Imelfort M, 2009, BRIEF BIOINFORM, V10, P609, DOI 10.1093/bib/bbp039; Kurtz S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-517; LANDER E S, 1988, Genomics, V2, P231; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Pop M, 2009, BRIEF BIOINFORM, V10, P354, DOI 10.1093/bib/bbp026; Reinhardt JA, 2009, GENOME RES, V19, P294, DOI 10.1101/gr.083311.108; Sappl PG, 2004, PHYTOCHEMISTRY, V65, P1517, DOI 10.1016/j.phytochem.2004.04.021; Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Settles AM, 1998, GENOME RES, V8, P83, DOI 10.1101/gr.8.2.83; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wicker T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-275; Zhang WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017915	18	21	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28436	10.1371/journal.pone.0028436	http://dx.doi.org/10.1371/journal.pone.0028436			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174807	Green Submitted, gold, Green Published			2022-12-25	WOS:000298366600017
J	Coffa, S; Breitman, M; Hanson, SM; Callaway, K; Kook, S; Dalby, KN; Gurevich, VV				Coffa, Sergio; Breitman, Maya; Hanson, Susan M.; Callaway, Kari; Kook, Seunghyi; Dalby, Kevin N.; Gurevich, Vsevolod V.			The Effect of Arrestin Conformation on the Recruitment of c-Raf1, MEK1, and ERK1/2 Activation	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; SIGNAL-REGULATED KINASES; CRYSTAL-STRUCTURE; VISUAL ARRESTIN; BETA-ARRESTIN; METARHODOPSIN-II; TERNARY COMPLEX; 48-KDA PROTEIN; CONE ARRESTIN; BINDING	Arrestins are multifunctional signaling adaptors originally discovered as proteins that "arrest" G protein activation by G protein-coupled receptors (GPCRs). Recently GPCR complexes with arrestins have been proposed to activate G protein-independent signaling pathways. In particular, arrestin-dependent activation of extracellular signal-regulated kinase 1/2 (ERK1/2) has been demonstrated. Here we have performed in vitro binding assays with pure proteins to demonstrate for the first time that ERK2 directly binds free arrestin-2 and -3, as well as receptor-associated arrestins-1, -2, and -3. In addition, we showed that in COS-7 cells arrestin-2 and -3 association with beta(2)-adrenergic receptor (beta 2AR) significantly enhanced ERK2 binding, but showed little effect on arrestin interactions with the upstream kinases c-Raf1 and MEK1. Arrestins exist in three conformational states: free, receptor-bound, and microtubule-associated. Using conformationally biased arrestin mutants we found that ERK2 preferentially binds two of these: the "constitutively inactive" arrestin-Delta 7 mimicking microtubule-bound state and arrestin-3A, a mimic of the receptor-bound conformation. Both rescue arrestin-mediated ERK1/2/activation in arrestin-2/3 double knockout fibroblasts. We also found that arrestin-2-c-Raf1 interaction is enhanced by receptor binding, whereas arrestin-3-c-Raf1 interaction is not.	[Coffa, Sergio; Breitman, Maya; Hanson, Susan M.; Kook, Seunghyi; Gurevich, Vsevolod V.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37203 USA; [Callaway, Kari; Dalby, Kevin N.] Univ Texas Austin, Div Med Chem, Austin, TX 78712 USA	Vanderbilt University; University of Texas System; University of Texas Austin	Coffa, S (corresponding author), Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37203 USA.	vsevolod.gurevich@vanderbilt.edu	Gurevich, Vsevolod/A-3236-2008; Dalby, Kevin N/A-1905-2013	Gurevich, Vsevolod/0000-0002-3950-5351; Dalby, Kevin N/0000-0001-9272-5129	National Institutes of Health [GM081756, GM077561, EY011500, GM059802]; Welch Foundation [F-1390]; NATIONAL EYE INSTITUTE [R01EY011500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077561, R01GM059802, R01GM081756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by National Institutes of Health grants GM081756, GM077561, and EY011500 (VVG), and GM059802 and the Welch Foundation (F-1390) (KND). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MR, 2011, BIOCHEMISTRY-US, V50, P3749, DOI 10.1021/bi200175q; Ahn S, 2004, J BIOL CHEM, V279, P7807, DOI 10.1074/jbc.C300443200; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Bruchas MR, 2006, J BIOL CHEM, V281, P18081, DOI 10.1074/jbc.M513640200; Carter JM, 2005, J MOL BIOL, V351, P865, DOI 10.1016/j.jmb.2005.06.048; Celver J, 2002, J BIOL CHEM, V277, P9043, DOI 10.1074/jbc.M107400200; Coffa S, 2011, BIOCHEMISTRY-US, V50, P6951, DOI 10.1021/bi200745k; Dinculescu A, 2002, J BIOL CHEM, V277, P11703, DOI 10.1074/jbc.M111833200; Good M, 2009, CELL, V136, P1085, DOI 10.1016/j.cell.2009.01.049; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Gurevich V. V., 2008, V186, P15, DOI 10.1007/978-3-540-72843-6_2; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Gurevich VV, 2011, PROG RETIN EYE RES, V30, P405, DOI 10.1016/j.preteyeres.2011.07.002; Gurevich VV, 2000, METHOD ENZYMOL, V315, P422; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Gurevich VV, 1997, J BIOL CHEM, V272, P28849, DOI 10.1074/jbc.272.46.28849; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; Gurevich VV, 1998, J BIOL CHEM, V273, P15501, DOI 10.1074/jbc.273.25.15501; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hanson SM, 2006, J BIOL CHEM, V281, P9765, DOI 10.1074/jbc.M510738200; Hanson SM, 2006, J BIOL CHEM, V281, P3458, DOI 10.1074/jbc.M512148200; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Hanson SM, 2007, J MOL BIOL, V368, P375, DOI 10.1016/j.jmb.2007.02.053; Hanson SM, 2007, EMBO J, V26, P1726, DOI 10.1038/sj.emboj.7601614; Hanson SM, 2007, P NATL ACAD SCI USA, V104, P3125, DOI 10.1073/pnas.0610886104; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Kovoor A, 1999, J BIOL CHEM, V274, P6831, DOI 10.1074/jbc.274.11.6831; Krupnick JG, 1997, J BIOL CHEM, V272, P18125, DOI 10.1074/jbc.272.29.18125; Luo JS, 2008, MOL PHARMACOL, V74, P338, DOI 10.1124/mol.107.044750; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Meng D, 2009, J BIOL CHEM, V284, P11425, DOI 10.1074/jbc.M806395200; OHGURO H, 1994, PROTEIN SCI, V3, P2428, DOI 10.1002/pro.5560031226; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P18649; Pan L, 2003, J BIOL CHEM, V278, P11623, DOI 10.1074/jbc.M209532200; Pierce KL, 2001, ONCOGENE, V20, P1532, DOI 10.1038/sj.onc.1204184; Pulvermuller A, 2000, J BIOL CHEM, V275, P37679, DOI 10.1074/jbc.M006776200; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; SCHLEICHER A, 1989, BIOCHEMISTRY-US, V28, P1770, DOI 10.1021/bi00430a052; Song X, 2011, NEUROSCIENCE, V174, P37, DOI 10.1016/j.neuroscience.2010.11.009; Song XF, 2006, J BIOL CHEM, V281, P21491, DOI 10.1074/jbc.M603659200; Song X, 2007, J NEUROCHEM, V103, P1053, DOI 10.1111/j.1471-4159.2007.04842.x; Song X, 2009, CURR BIOL, V19, P700, DOI 10.1016/j.cub.2009.02.065; Song XF, 2009, J BIOL CHEM, V284, P685, DOI 10.1074/jbc.M806124200; Sutton RB, 2005, J MOL BIOL, V354, P1069, DOI 10.1016/j.jmb.2005.10.023; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Vishnivetskiy SA, 2004, J BIOL CHEM, V279, P1262, DOI 10.1074/jbc.M308834200; Vishnivetskiy SA, 2002, J BIOL CHEM, V277, P43961, DOI 10.1074/jbc.M206951200; Vishnivetskiy SA, 2007, J BIOL CHEM, V282, P32075, DOI 10.1074/jbc.M706057200; Vishnivetskiy SA, 2011, J BIOL CHEM, V286, P24288, DOI 10.1074/jbc.M110.213835; Vishnivetskiy SA, 2010, J MOL BIOL, V395, P42, DOI 10.1016/j.jmb.2009.10.058; Waas WF, 2003, BIOCHEMISTRY-US, V42, P12273, DOI 10.1021/bi0348617; WILDEN U, 1995, BIOCHEMISTRY-US, V34, P1446, DOI 10.1021/bi00004a040; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; ZHAN X, 2011, BIOCHEMISTR IN PRESS, V50; Zhan XZ, 2011, J MOL BIOL, V406, P467, DOI 10.1016/j.jmb.2010.12.034	60	60	61	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28723	10.1371/journal.pone.0028723	http://dx.doi.org/10.1371/journal.pone.0028723			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174878	Green Published, gold, Green Submitted			2022-12-25	WOS:000298366600032
J	Rajasekharan, A; Gummadi, SN				Rajasekharan, Archita; Gummadi, Sathyanarayana N.			Flip-Flop of Phospholipids in Proteoliposomes Reconstituted from Detergent Extract of Chloroplast Membranes: Kinetics and Phospholipid Specificity	PLOS ONE			English	Article							TRANSBILAYER MOVEMENT; ENDOPLASMIC-RETICULUM; LIPID TRAFFICKING; LABELED PHOSPHOLIPIDS; CHEMICAL-MODIFICATION; ERYTHROCYTE-MEMBRANE; PROTEIN; BIOSYNTHESIS; MECHANISMS	Eukaryotic cells are compartmentalized into distinct sub-cellular organelles by lipid bilayers, which are known to be involved in numerous cellular processes. The wide repertoire of lipids, synthesized in the biogenic membranes like the endoplasmic reticulum and bacterial cytoplasmic membranes are initially localized in the cytosolic leaflet and some of these lipids have to be translocated to the exoplasmic leaflet for membrane biogenesis and uniform growth. It is known that phospholipid (PL) translocation in biogenic membranes is mediated by specific membrane proteins which occur in a rapid, bi-directional fashion without metabolic energy requirement and with no specificity to PL head group. A recent study reported the existence of biogenic membrane flippases in plants and that the mechanism of plant membrane biogenesis was similar to that found in animals. In this study, we demonstrate for the first time ATP independent and ATP dependent flippase activity in chloroplast membranes of plants. For this, we generated proteoliposomes from Triton X-100 extract of intact chloroplast, envelope membrane and thylakoid isolated from spinach leaves and assayed for flippase activity using fluorescent labeled phospholipids. Half-life time of flipping was found to be 6 +/- 1 min. We also show that: (a) intact chloroplast and envelope membrane reconstituted proteoliposomes can flip fluorescent labeled analogs of phosphatidylcholine in ATP independent manner, (b) envelope membrane and thylakoid reconstituted proteoliposomes can flip phosphatidylglycerol in ATP dependent manner, (c) Biogenic membrane ATP independent PC flipping activity is protein mediated and (d) the kinetics of PC translocation gets affected differently upon treatment with protease and protein modifying reagents.	[Rajasekharan, Archita; Gummadi, Sathyanarayana N.] Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Rajasekharan, A (corresponding author), Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India.	gummadi@iitm.ac.in	Gummadi, Sathyanarayana/W-5354-2019; Gummadi, Sathyanarayana Naidu/K-2303-2019	Gummadi, Sathyanarayana Naidu/0000-0003-0707-5710	Department of Biotechnology, Government of India, New Delhi	Department of Biotechnology, Government of India, New Delhi(Department of Biotechnology (DBT) India)	This work was supported by a research grant from Department of Biotechnology, Government of India, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS J, 1983, PLANT PHYSIOL, V72, P735, DOI 10.1104/pp.72.3.735; Awai K, 2006, BIOCHEM SOC T, V34, P395, DOI 10.1042/BST0340395; BACKER JM, 1987, NATURE, V327, P341, DOI 10.1038/327341a0; Barr SC, 2003, J PARASITOL, V89, P385, DOI 10.1645/0022-3395(2003)089[0385:COASPA]2.0.CO;2; Basse F, 1996, J BIOL CHEM, V271, P17205, DOI 10.1074/jbc.271.29.17205; BELL RM, 1981, J LIPID RES, V22, P391; Benning C, 2006, CURR OPIN PLANT BIOL, V9, P241, DOI 10.1016/j.pbi.2006.03.012; Benning C, 2008, PROG LIPID RES, V47, P381, DOI 10.1016/j.plipres.2008.04.001; Benning C, 2009, ANNU REV CELL DEV BI, V25, P71, DOI 10.1146/annurev.cellbio.042308.113414; BISHOP WR, 1985, CELL, V42, P51, DOI 10.1016/S0092-8674(85)80100-8; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; Bunney TD, 2001, P NATL ACAD SCI USA, V98, P4249, DOI 10.1073/pnas.061437498; Buton X, 1996, J BIOL CHEM, V271, P6651, DOI 10.1074/jbc.271.12.6651; Chang QL, 2004, BIOCHEMISTRY-US, V43, P10710, DOI 10.1021/bi049063a; DIETRICH WE, 2003, ABLEWEB, V24, P131; DORNE AJ, 1990, P NATL ACAD SCI USA, V87, P71, DOI 10.1073/pnas.87.1.71; DORNE AM, 1985, MOL GEN GENET, V198, P521, DOI 10.1007/BF00332950; Essigmann B, 1998, P NATL ACAD SCI USA, V95, P1950, DOI 10.1073/pnas.95.4.1950; Fadeel B, 2009, CRIT REV BIOCHEM MOL, V44, P264, DOI 10.1080/10409230903193307; Follmer C, 2005, ARCH BIOCHEM BIOPHYS, V435, P15, DOI 10.1016/j.abb.2004.12.001; Gummadi SN, 2005, CELL MOL BIOL LETT, V10, P101; Gummadi SN, 2002, J BIOL CHEM, V277, P25337, DOI 10.1074/jbc.M203809200; Hartel H, 2000, P NATL ACAD SCI USA, V97, P10649, DOI 10.1073/pnas.180320497; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Hrafnsdottir S, 2000, J BACTERIOL, V182, P4198, DOI 10.1128/JB.182.15.4198-4206.2000; Hrafnsdottir S, 1997, BIOCHEMISTRY-US, V36, P4969, DOI 10.1021/bi962513h; Hunter DG, 1998, BIOPHYS J, V74, P2996, DOI 10.1016/S0006-3495(98)78006-3; KAGAWA T, 1973, PLANT PHYSIOL, V51, P61, DOI 10.1104/pp.51.1.61; KAPLAN RS, 1989, METHOD ENZYMOL, V172, P393; KENNETH K, 1982, PLANT PHYSIOL, V70, P232; Kol MA, 2004, BIOCHEMISTRY-US, V43, P2673, DOI 10.1021/bi036200f; Kubelt J, 2002, BIOCHEMISTRY-US, V41, P5605, DOI 10.1021/bi0118714; Lakowicz J.R., 2010, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; Lang EGE, 2011, PLANT CELL REP, V30, P205, DOI 10.1007/s00299-010-0935-4; LEVY D, 1990, BIOCHIM BIOPHYS ACTA, V1025, P179, DOI 10.1016/0005-2736(90)90096-7; MENON A, 1995, TRENDS CELL BIOL, V5, P355, DOI 10.1016/S0962-8924(00)89069-8; Menon AK, 2000, CURR BIOL, V10, P241, DOI 10.1016/S0960-9822(00)00356-0; Miyagishima S, 1999, PLANTA, V209, P371, DOI 10.1007/s004250050645; Moreau P, 1998, PROG LIPID RES, V37, P371, DOI 10.1016/S0163-7827(98)00016-2; MORKIN E, 1979, J BIOL CHEM, V254, P2647; Pomorski T, 2006, CELL MOL LIFE SCI, V63, P2908, DOI 10.1007/s00018-006-6167-7; RIGAUD JL, 1988, BIOCHEMISTRY-US, V27, P2677, DOI 10.1021/bi00408a007; ROCHA V, 1970, ARCH BIOCHEM BIOPHYS, V140, P398, DOI 10.1016/0003-9861(70)90081-0; ROTHMAN JE, 1977, P NATL ACAD SCI USA, V74, P1821, DOI 10.1073/pnas.74.5.1821; ROUGHAN G, 1984, TRENDS BIOCHEM SCI, V9, P383, DOI 10.1016/0968-0004(84)90220-2; Sahu SK, 2008, BIOCHEMISTRY-US, V47, P10481, DOI 10.1021/bi8014339; Sahu SK, 2007, ARCH BIOCHEM BIOPHYS, V462, P103, DOI 10.1016/j.abb.2007.04.002; SEIGNEURET M, 1984, P NATL ACAD SCI-BIOL, V81, P3751, DOI 10.1073/pnas.81.12.3751; VANDOR SL, 1968, CAN J BIOCHEM CELL B, V46, P1309, DOI 10.1139/o68-196; Vehring S, 2007, EUKARYOT CELL, V6, P1625, DOI 10.1128/EC.00198-07	51	7	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28401	10.1371/journal.pone.0028401	http://dx.doi.org/10.1371/journal.pone.0028401			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174798	gold, Green Published, Green Submitted			2022-12-25	WOS:000298366600014
J	Addis, RC; Hsu, FC; Wright, RL; Dichter, MA; Coulter, DA; Gearhart, JD				Addis, Russell C.; Hsu, Fu-Chun; Wright, Rebecca L.; Dichter, Marc A.; Coulter, Douglas A.; Gearhart, John D.			Efficient Conversion of Astrocytes to Functional Midbrain Dopaminergic Neurons Using a Single Polycistronic Vector	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; VENTRAL TEGMENTAL AREA; PARKINSONS-DISEASE; TRANSCRIPTION FACTORS; HUMAN FIBROBLASTS; SUBSTANTIA-NIGRA; FIRING PATTERN; IN-VIVO; MOUSE; TRANSPLANTATION	Direct cellular reprogramming is a powerful new tool for regenerative medicine. In efforts to understand and treat Parkinson's Disease (PD), which is marked by the degeneration of dopaminergic neurons in the midbrain, direct reprogramming provides a valuable new source of these cells. Astrocytes, the most plentiful cells in the central nervous system, are an ideal starting population for the direct generation of dopaminergic neurons. In addition to their potential utility in cell replacement therapies for PD or in modeling the disease in vitro, astrocyte-derived dopaminergic neurons offer the prospect of direct in vivo reprogramming within the brain. As a first step toward this goal, we report the reprogramming of astrocytes to dopaminergic neurons using three transcription factors - ASCL1, LMX1B, and NURR1 - delivered in a single polycistronic lentiviral vector. The process is efficient, with 18.261.5% of cells expressing markers of dopaminergic neurons after two weeks. The neurons exhibit expression profiles and electrophysiological characteristics consistent with midbrain dopaminergic neurons, notably including spontaneous pacemaking activity, stimulated release of dopamine, and calcium oscillations. The present study is the first demonstration that a single vector can mediate reprogramming to dopaminergic neurons, and indicates that astrocytes are an ideal starting population for the direct generation of dopaminergic neurons.	[Addis, Russell C.; Wright, Rebecca L.; Gearhart, John D.] Univ Penn, Sch Med, Inst Regenerat Med, Philadelphia, PA 19104 USA; [Addis, Russell C.; Wright, Rebecca L.; Gearhart, John D.] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Dichter, Marc A.; Coulter, Douglas A.] Univ Penn, Sch Med, Mahoney Inst Neurol Sci, Philadelphia, PA 19104 USA; [Dichter, Marc A.] Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Coulter, Douglas A.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Coulter, Douglas A.] Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; [Hsu, Fu-Chun; Coulter, Douglas A.] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Addis, RC (corresponding author), Univ Penn, Sch Med, Inst Regenerat Med, Philadelphia, PA 19104 USA.	raddis@mail.med.upenn.edu		Coulter, Douglas/0000-0002-1486-119X	University of Pennsylvania Institute for Regenerative Medicine; Pennsylvania Health Research Formula Fund	University of Pennsylvania Institute for Regenerative Medicine; Pennsylvania Health Research Formula Fund	This work was funded by the University of Pennsylvania Institute for Regenerative Medicine and the Pennsylvania Health Research Formula Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang SL, 2006, DEVELOPMENT, V133, P3499, DOI 10.1242/dev.02501; Arenas E, 2010, BIOCHEM BIOPH RES CO, V396, P152, DOI 10.1016/j.bbrc.2010.04.037; Berninger B, 2007, J NEUROSCI, V27, P8654, DOI 10.1523/JNEUROSCI.1615-07.2007; Berninger B, 2010, NEUROPHARMACOLOGY, V58, P894, DOI 10.1016/j.neuropharm.2009.11.004; Burbach JPH, 2003, ANN NY ACAD SCI, V991, P61; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Di Salvio M, 2010, NAT NEUROSCI, V13, P1481, DOI 10.1038/nn.2661; Di Salvio M, 2010, INT J DEV BIOL, V54, P939, DOI 10.1387/ijdb.092974ms; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; GRACE AA, 1984, J NEUROSCI, V4, P2877; GRACE AA, 1984, J NEUROSCI, V4, P2866; GRACE AA, 1980, SCIENCE, V210, P654, DOI 10.1126/science.7433992; Guzman JN, 2009, J NEUROSCI, V29, P11011, DOI 10.1523/JNEUROSCI.2519-09.2009; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; Hagell P, 2001, J NEUROPATH EXP NEUR, V60, P741, DOI 10.1093/jnen/60.8.741; Heinrich C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000373; Kim J, 2011, CELL STEM CELL, V9, P413, DOI 10.1016/j.stem.2011.09.011; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Piccini P, 1999, NAT NEUROSCI, V2, P1137, DOI 10.1038/16060; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Puopolo M, 2007, J NEUROSCI, V27, P645, DOI 10.1523/JNEUROSCI.4341-06.2007; Putzier I, 2009, J NEUROSCI, V29, P15414, DOI 10.1523/JNEUROSCI.4742-09.2009; Sasai Yoshiki, 2002, Journal of Neurology, V249, P41; Simon HH, 2003, ANN NY ACAD SCI, V991, P36; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Thompson L, 2005, J NEUROSCI, V25, P6467, DOI 10.1523/JNEUROSCI.1676-05.2005; Tian CH, 2011, PROTEIN CELL, V2, P128, DOI 10.1007/s13238-011-1012-7; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Wagner J, 1999, NAT BIOTECHNOL, V17, P653, DOI 10.1038/10862; Wakeman DR, 2011, MT SINAI J MED, V78, P126, DOI 10.1002/msj.20233; Wilson CJ, 2000, J NEUROPHYSIOL, V83, P3084, DOI 10.1152/jn.2000.83.5.3084; Yasumoto F, 2004, CELL MOL NEUROBIOL, V24, P51, DOI 10.1023/B:CEMN.0000012724.79184.b6	39	108	114	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28719	10.1371/journal.pone.0028719	http://dx.doi.org/10.1371/journal.pone.0028719			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174877	gold, Green Published, Green Submitted			2022-12-25	WOS:000298365700066
J	Han, YX; Wu, JB; Bi, LX; Xiong, SD; Gao, SM; Yin, LH; Jiang, L; Chen, CQ; Yu, K; Zhang, SH				Han, Yixiang; Wu, Jianbo; Bi, Laixi; Xiong, Shudao; Gao, Shenmeng; Yin, Lihui; Jiang, Lei; Chen, Chiqi; Yu, Kang; Zhang, Shenghui			Malignant B Cells Induce the Conversion of CD4(+)CD25(-) T Cells to Regulatory T Cells in B-Cell Non-Hodgkin Lymphoma	PLOS ONE			English	Article							FOLLICULAR LYMPHOMA; HEPATOCELLULAR-CARCINOMA; MEDIATED SUPPRESSION; FOXP3 EXPRESSION; HIGH NUMBERS; SURVIVAL; POPULATION; PROGNOSIS; LEUKEMIA; IMMUNITY	Recent evidence has demonstrated that regulatory T cells (Treg) were enriched in the tumor sites of patients with B-cell non-Hodgkin lymphoma (NHL). However, the causes of enrichment and suppressive mechanisms need to be further elucidated. Here we demonstrated that CD4(+)CD25(+)FoxP3(+)CD127(lo) Treg were markedly increased and their phenotypes were different in peripheral blood (PB) as well as bone marrow (BM) from newly diagnosed patients with B-cell NHL compared with those from healthy volunteers (HVs). Involved lymphatic tissues also showed higher frequencies of Treg than benign lymph nodes. Moreover, the frequencies of Treg were significantly higher in involved lymphatic tissues than those from PB as well as BM in the same patients. Suppression mediated by CD4(+)CD25(+) Treg co-cultured with allogeneic CFSE-labeled CD4(+)CD25(-) responder cells was also higher in involved lymphatic tissues from B-cell NHL than that mediated by Treg from HVs. In addition, we found that malignant B cells significantly induced FoxP3 expression and regulatory function in CD4(+)CD25(-) T cells in vitro. In contrast, normal B cells could not induce the conversion of CD4(+)CD25(-) T cells to Treg. We also showed that the PD-1/B7-H1 pathway might play an important role in Treg induction. Taken together, our results suggest that malignant B cells induce the conversion of CD4(+)CD25(-) T cells to Treg, which may play a role in the pathogenesis of B-cell NHL and represent a promising therapeutic target.	[Han, Yixiang; Wu, Jianbo; Gao, Shenmeng; Yin, Lihui; Jiang, Lei; Chen, Chiqi; Zhang, Shenghui] Wenzhou Med Coll, Affiliated Hosp 1, Lab Internal Med, Wenzhou, Peoples R China; [Bi, Laixi; Yu, Kang] Wenzhou Med Coll, Affiliated Hosp 1, Dept Hematol, Wenzhou, Peoples R China; [Xiong, Shudao] Anhui Med Univ, Hosp 2, Dept Hematol Oncol, Hefei, Peoples R China; [Zhang, Shenghui] Fudan Univ, Shanghai Med Coll, Minist Educ, Key Lab Mol Med, Shanghai 200433, Peoples R China; [Zhang, Shenghui] Fudan Univ, Shanghai Med Coll, Dept Biochem & Mol Biol, Shanghai 200433, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Anhui Medical University; Fudan University; Fudan University	Han, YX (corresponding author), Wenzhou Med Coll, Affiliated Hosp 1, Lab Internal Med, Wenzhou, Peoples R China.	shenghuizhang1@126.com	Zhang, Shenghui/AAI-7388-2021		National Natural Science of Foundation of China [81100355]; Administration of Traditional Chinese Medicine of Zhejiang Province, China [2010ZQ008]	National Natural Science of Foundation of China(National Natural Science Foundation of China (NSFC)); Administration of Traditional Chinese Medicine of Zhejiang Province, China	This work was supported by National Natural Science of Foundation of China (no. 81100355) and Administration of Traditional Chinese Medicine of Zhejiang Province, China (no. 2010ZQ008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadzadeh M, 2008, BLOOD, V112, P4953, DOI 10.1182/blood-2008-06-163048; Ai WZ, 2009, INT J CANCER, V124, P239, DOI 10.1002/ijc.23881; Burger JA, 2009, BLOOD, V114, P3367, DOI 10.1182/blood-2009-06-225326; Carreras J, 2006, BLOOD, V108, P2957, DOI 10.1182/blood-2006-04-018218; Coe D, 2010, CANCER IMMUNOL IMMUN, V59, P1367, DOI 10.1007/s00262-010-0866-5; Curran MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019499; de Lafaille MAC, 2002, CURR OPIN IMMUNOL, V14, P771; Finney OC, 2010, EUR J IMMUNOL, V40, P47, DOI 10.1002/eji.200939708; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Franceschini D, 2009, J CLIN INVEST, V119, P551, DOI 10.1172/JCI36604; Frimpong-Boateng K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012281; Hirano F, 2005, CANCER RES, V65, P1089; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jak M, 2009, LEUKEMIA LYMPHOMA, V50, P788, DOI 10.1080/10428190902803677; Ju SW, 2009, CELL CYCLE, V8, P2578, DOI 10.4161/cc.8.16.9302; Kelley TW, 2007, AM J CLIN PATHOL, V128, P958, DOI 10.1309/NB3947K383DJ0LQ2; Li X, 2007, CANCER LETT, V253, P144, DOI 10.1016/j.canlet.2007.01.024; Liu JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019495; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Mittal S, 2008, BLOOD, V111, P5359, DOI 10.1182/blood-2007-08-105395; Ndhlovu LC, 2008, J LEUKOCYTE BIOL, V83, P254, DOI 10.1189/jlb.0507281; Pang YL, 2009, CANCER IMMUNOL IMMUN, V58, P877, DOI 10.1007/s00262-008-0603-5; Piccirillo CA, 2004, SEMIN IMMUNOL, V16, P81, DOI 10.1016/j.smim.2003.12.003; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Suarez N, 2011, INT J CANCER, V129, P374, DOI 10.1002/ijc.25681; Takata Y, 2011, CANCER LETT, V307, P165, DOI 10.1016/j.canlet.2011.03.029; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Trzonkowski P, 2004, CLIN IMMUNOL, V112, P258, DOI 10.1016/j.clim.2004.04.003; Tzankov A, 2008, HAEMATOLOGICA, V93, P193, DOI 10.3324/haematol.11702; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Xu L, 2010, CLIN IMMUNOL, V135, P466, DOI 10.1016/j.clim.2010.01.014; Yang ZZ, 2007, BLOOD, V110, P2537, DOI 10.1182/blood-2007-03-082578; Yang ZZ, 2006, BLOOD, V107, P3639, DOI 10.1182/blood-2005-08-3376; Yu YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022450; Yuan XL, 2011, WORLD J GASTROENTERO, V17, P2019, DOI 10.3748/wjg.v17.i15.2019; Yuan XL, 2010, CLIN IMMUNOL, V134, P277, DOI 10.1016/j.clim.2009.10.005; Zhang SH, 2011, INT J CANCER, V129, P1373, DOI 10.1002/ijc.25791; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	41	2	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28649	10.1371/journal.pone.0028649	http://dx.doi.org/10.1371/journal.pone.0028649			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174855	Green Published, gold, Green Submitted			2022-12-25	WOS:000298365700055
J	Kang, MJ; Yu, H; Kim, SK; Park, SR; Yang, I				Kang, Min-Jung; Yu, Hannah; Kim, Sook-Kyung; Park, Sang-Ryoul; Yang, Inchul			Quantification of Trace-Level DNA by Real-Time Whole Genome Amplification	PLOS ONE			English	Article							HOST-CELL DNA; QUANTITATION; ASSAY; PCR; PROTEINS	Quantification of trace amounts of DNA is a challenge in analytical applications where the concentration of a target DNA is very low or only limited amounts of samples are available for analysis. PCR-based methods including real-time PCR are highly sensitive and widely used for quantification of low-level DNA samples. However, ordinary PCR methods require at least one copy of a specific gene sequence for amplification and may not work for a sub-genomic amount of DNA. We suggest a real-time whole genome amplification method adopting the degenerate oligonucleotide primed PCR (DOP-PCR) for quantification of sub-genomic amounts of DNA. This approach enabled quantification of sub-picogram amounts of DNA independently of their sequences. When the method was applied to the human placental DNA of which amount was accurately determined by inductively coupled plasma-optical emission spectroscopy (ICP-OES), an accurate and stable quantification capability for DNA samples ranging from 80 fg to 8 ng was obtained. In blind tests of laboratory-prepared DNA samples, measurement accuracies of 7.4%, -2.1%, and -13.9% with analytical precisions around 15% were achieved for 400-pg, 4-pg, and 400-fg DNA samples, respectively. A similar quantification capability was also observed for other DNA species from calf, E. coli, and lambda phage. Therefore, when provided with an appropriate standard DNA, the suggested real-time DOP-PCR method can be used as a universal method for quantification of trace amounts of DNA.	[Kang, Min-Jung; Kim, Sook-Kyung; Park, Sang-Ryoul; Yang, Inchul] Korea Res Inst Stand & Sci, Ctr Bioanal, Taejon, South Korea; [Yu, Hannah] Univ Sci & Technol, Dept Bioanalyt Sci, Taejon, South Korea	Korea Research Institute of Standards & Science (KRISS)	Kang, MJ (corresponding author), Korea Res Inst Stand & Sci, Ctr Bioanal, Taejon, South Korea.	icy@kriss.re.kr	Yu, Hannah/AAH-6002-2021		Korea Research Institute of Standards and Science	Korea Research Institute of Standards and Science	This work was supported by the Basic Research Projects of Korea Research Institute of Standards and Science, "Development of Protein Measurement Standards". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRIGGS J, 1991, ANAL CHEM, V63, P850, DOI 10.1021/ac00009a003; Cikos S, 2009, ANAL BIOCHEM, V384, P1, DOI 10.1016/j.ab.2008.08.031; Desjardins P., 2010, J VIS EXP, V45, P2565; DIPAOLO B, 1999, PHARM TECHNOLOGY HIG; DNA Advisory Board, 2000, FORENSIC SCI COMMUN, V2; *EU, 2001, CPMPBWP114300; Gallagher S. R., 2001, CURRENT PROTOCOLS MO; Holden MJ, 2009, J AGR FOOD CHEM, V57, P7221, DOI 10.1021/jf901165h; Ikeda Y, 2009, J PHARMACEUT BIOMED, V49, P997, DOI 10.1016/j.jpba.2009.01.022; KASS DH, 1995, ANAL BIOCHEM, V228, P185, DOI 10.1006/abio.1995.1338; Klein D, 2002, TRENDS MOL MED, V8, P257, DOI 10.1016/S1471-4914(02)02355-9; KUNG VT, 1990, ANAL BIOCHEM, V187, P220, DOI 10.1016/0003-2697(90)90447-H; KURKELA S, 2009, J AM SOC MASS SPECTR, V37, P535; KURODA S, 1988, BIOCHEM BIOPH RES CO, V152, P9, DOI 10.1016/S0006-291X(88)80672-7; Lovatt Archie, 2002, J Biotechnol, V82, P279; Nicklas JA, 2003, ANAL BIOANAL CHEM, V376, P1160, DOI 10.1007/s00216-003-1924-z; Nissom PM, 2007, BIOLOGICALS, V35, P211, DOI 10.1016/j.biologicals.2006.09.001; Pharmaceuticals and Medical Devices Agency, 2018, POINTS CONSIDER ENSU; Rathore AS, 2003, J PHARMACEUT BIOMED, V32, P1199, DOI 10.1016/S0731-7085(03)00157-2; Schroeder KL, 2006, PHYTOPATHOLOGY, V96, P637, DOI 10.1094/PHYTO-96-0637; Singer VL, 1997, ANAL BIOCHEM, V249, P228, DOI 10.1006/abio.1997.2177; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; Timken MD, 2005, J FORENSIC SCI, V50, P1044; Walker JA, 2003, ANAL BIOCHEM, V315, P122, DOI 10.1016/S0003-2697(03)00081-2; WOLTER T, 2005, BIO PROCESS INT, V2, P2; Yang I, 2004, ANAL BIOCHEM, V335, P150, DOI 10.1016/j.ab.2004.08.038	26	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28661	10.1371/journal.pone.0028661	http://dx.doi.org/10.1371/journal.pone.0028661			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174862	gold, Green Submitted, Green Published			2022-12-25	WOS:000298365700058
J	Kim, KS; Kim, YS; Han, I; Kim, MH; Jung, MH; Park, HK				Kim, Kyung Sook; Kim, Young-Sun; Han, Ihn; Kim, Mi-Hyun; Jung, Min Hyung; Park, Hun-Kuk			Quantitative and Qualitative Analyses of the Cell Death Process in Candida albicans Treated by Antifungal Agents	PLOS ONE			English	Article								The death process of Candida albicans was investigated after treatment with the antifungal agents flucytosine and amphotericin B by assessing morphological and biophysical properties associated with cell death. C. albicans was treated varying time periods (from 6 to 48 hours) and examined by scanning electron microscopy (SEM) and atomic force microscopy (AFM). SEM and AFM images clearly showed changes in morphology and biophysical properties. After drug treatment, the membrane of C. albicans was perforated, deformed, and shrunken. Compared to the control, C. albicans treated with flucytosine was softer and initially showed a greater adhesive force. Conversely, C. albicans treated with amphotericin B was harder and had a lower adhesive force. In both cases, the surface roughness increased as the treatment time increased. The relationships between morphological changes and the drugs were observed by AFM clearly; the surface of C. albicans treated with flucytosine underwent membrane collapse, expansion of holes, and shrinkage, while the membranes of cells treated with amphotericin B peeled off. According to these observations, the death process of C. albicans was divided into 4 phases, CDP0, CDP1, CDP2, and CDP4, which were determined based on morphological changes. Our results could be employed to further investigate the antifungal activity of compounds derived from natural sources.	[Kim, Kyung Sook; Kim, Mi-Hyun; Park, Hun-Kuk] Kyung Hee Univ, Dept Biomed Engn, Coll Med, Seoul, South Korea; [Kim, Kyung Sook; Kim, Mi-Hyun; Park, Hun-Kuk] Kyung Hee Univ, Healthcare Ind Res Inst, Seoul, South Korea; [Kim, Young-Sun; Jung, Min Hyung] Kyung Hee Univ, Dept Obstet & Gynecol, Sch Med, Kyung Hee Univ Hosp, Seoul, South Korea; [Han, Ihn] Kyung Hee Univ, Coll Oriental Med, Seoul, South Korea; [Park, Hun-Kuk] Kyung Hee Univ, Program Med Engn, Seoul, South Korea	Kyung Hee University; Kyung Hee University; Kyung Hee University; Kyung Hee University Hospital; Kyung Hee University; Kyung Hee University	Kim, KS (corresponding author), Kyung Hee Univ, Dept Biomed Engn, Coll Med, Seoul, South Korea.	webhospital@naver.com; sigmoidus@khu.ac.kr	Kim, Youngsun/AAY-5946-2021; Han, Ihn/ABH-6275-2020	Kim, Youngsun/0000-0002-1725-0968; Han, Ihn/0000-0002-1372-7319	Kyung Hee University [KHU-20110093]; Seoul Research and Business Development program [CR070054]	Kyung Hee University; Seoul Research and Business Development program(Seoul RBD program)	This study was supported by a grant from Kyung Hee University in 2011 (KHU-20110093) and the Seoul Research and Business Development program (Grant No. CR070054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIREZA K, 2009, MYCOPATHOLOGIA, V169, P287; AMIT KT, 2010, TYAGI MALIK BMC COMP, V10, P1; AMIT KT, 2010, MICRON, V41, P797; ANTONIO MV, 2001, SURF INTERFACE ANAL, V31, P1027; Brito GNB, 2011, BRAZ ORAL RES, V25, P28, DOI 10.1590/S1806-83242011005000001; Baginski M, 2009, CURR DRUG METAB, V10, P459, DOI 10.2174/138920009788898019; Bhushan B, 2000, J APPL PHYS, V87, P1201, DOI 10.1063/1.371998; Boonaert CJP, 2000, SURF INTERFACE ANAL, V30, P32, DOI 10.1002/1096-9918(200008)30:1<32::AID-SIA774>3.3.CO;2-P; ELISABETTA C, 2006, FEMS MICROBIOL LETT, V255, P308; GRUNDNER M, 1986, APPL PHYS A-MATER, V39, P73, DOI 10.1007/BF00616822; JOCHEN G, 2005, BIOPHYS J, V88, P3689; KENNEDY MJ, 1985, INFECT IMMUN, V49, P654, DOI 10.1128/IAI.49.3.654-663.1985; Laing R, 2003, LANCET, V361, P1723, DOI 10.1016/S0140-6736(03)13375-2; Lee Jeong Ah, 2010, Mycobiology, V38, P328, DOI 10.4489/MYCO.2010.38.4.328; MARUZZELLA JC, 1958, J AM PHARM ASSOC, V47, P250, DOI 10.1002/jps.3030470407; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Vermes A, 2000, J ANTIMICROB CHEMOTH, V46, P171, DOI 10.1093/jac/46.2.171; Volle CB, 2008, LANGMUIR, V24, P8102, DOI 10.1021/la8009354; WILBUR AL, 2007, BLOOD, V109, P3505; Zakaria Z, 2011, ASIAN PACIFIC J TROP, V1, P20; Zhang JD, 2006, J ETHNOPHARMACOL, V103, P76, DOI 10.1016/j.jep.2005.07.006	21	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28176	10.1371/journal.pone.0028176	http://dx.doi.org/10.1371/journal.pone.0028176			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174777	Green Published, gold, Green Submitted			2022-12-25	WOS:000298365700021
J	Li, HQ; Xu, J; Bian, YH; Rotllant, P; Shen, TS; Chu, WY; Zhang, JS; Schneider, M; Du, SJ				Li, Huiqing; Xu, Jin; Bian, Yue-Hong; Rotllant, Pep; Shen, Tiansheng; Chu, Wuying; Zhang, Jianshe; Schneider, Martin; Du, Shao Jun			Smyd1b_tv1, a Key Regulator of Sarcomere Assembly, Is Localized on the M-Line of Skeletal Muscle Fibers	PLOS ONE			English	Article							PROTEIN; GENE; BOP; HSP90A; PHOSPHORYLATION; METHYLATION; EXPRESSION; INTERACTS; SEQUENCE; ENCODES	Background: Smyd1b is a member of the Smyd family that plays a key role in sarcomere assembly during myofibrillogenesis. Smyd1b encodes two alternatively spliced isoforms, smyd1b_tv1 and smyd1b_tv2, that are expressed in skeletal and cardiac muscles and play a vital role in myofibrillogenesis in skeletal muscles of zebrafish embryos. Methodology/Principal Findings: To better understand Smyd1b function in myofibrillogenesis, we analyzed the subcellular localization of Smyd1b_tv1 and Smyd1b_tv2 in transgenic zebrafish expressing a myc-tagged Smyd1b_tv1 or Smyd1b_tv2. The results showed a dynamic change of their subcellular localization during muscle cell differentiation. Smyd1b_tv1 and Smyd1b_tv2 were primarily localized in the cytosol of myoblasts and myotubes at early stage zebrafish embryos. However, in mature myofibers, Smyd1b_tv1, and to a small degree of Smyd1b_tv2, exhibited a sarcomeric localization. Double staining with sarcomeric markers revealed that Smyd1b_tv1 was localized on the M-lines. The sarcomeric localization was confirmed in zebrafish embryos expressing the Smyd1b_tv1-GFP or Smyd1b_tv2-GFP fusion proteins. Compared with Smyd1b_tv1, Smyd1b_tv2, however, showed a weak sarcomeric localization. Smyd1b_tv1 differs from Smyd1b_tv2 by a 13 amino acid insertion encoded by exon 5, suggesting that some residues within the 13 aa insertion may be critical for the strong sarcomeric localization of Smyd1b_tv1. Sequence comparison with Smyd1b_tv1 orthologs from other vertebrates revealed several highly conserved residues (Phe223, His224 and Gln226) and two potential phosphorylation sites (Thr221 and Ser225) within the 13 aa insertion. To determine whether these residues are involved in the increased sarcomeric localization of Smyd1b_tv1, we mutated these residues into alanine. Substitution of Phe223 or Ser225 with alanine significantly reduced the sarcomeric localization of Smyd1b_tv1. In contrast, other substitutions had no effect. Moreover, replacing Ser225 with threonine (S225T) retained the strong sarcomeric localization of Smyd1b_tv1. Conclusion/Significance: Together, these data indicate that Phe223 and Ser225 are required for the M-line localization of Smyd1b_tv1.	[Li, Huiqing; Xu, Jin; Bian, Yue-Hong; Rotllant, Pep; Shen, Tiansheng; Schneider, Martin; Du, Shao Jun] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Chu, Wuying; Zhang, Jianshe] Changsha Univ, Dept Bioengn & Environm Sci, Changsha, Hunan, Peoples R China	University System of Maryland; University of Maryland Baltimore; Changsha University	Du, SJ (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA.	sdu@som.umaryland.edu	Rotllant, Josep/K-1146-2014; Xu, Jin/GRF-5111-2022	Rotllant, Josep/0000-0001-5331-807X; Xu, Jin/0000-0002-9860-7796; du, Jim/0000-0001-9227-4153	Israel Binational Agricultural Research and Development Fund, the United States (BARD) [IS-8713-08]; University of Maryland Biotechnology Institute	Israel Binational Agricultural Research and Development Fund, the United States (BARD); University of Maryland Biotechnology Institute	This research was supported by research grant No IS-8713-08 from the Israel Binational Agricultural Research and Development Fund, the United States (BARD), and an intercenter collaboration grant (Du-Fang) from University of Maryland Biotechnology Institute. (http://www.bard-isus.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; Clark KJ, 2011, NAT METHODS, V8, P506, DOI [10.1038/NMETH.1606, 10.1038/nmeth.1606]; Codina M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008416; Du SJ, 2008, P NATL ACAD SCI USA, V105, P554, DOI 10.1073/pnas.0707330105; Du SJ, 2006, DEV DYNAM, V235, P3306, DOI 10.1002/dvdy.20984; Etard C, 2008, J CELL BIOL, V180, P1163, DOI 10.1083/jcb.200709128; Etard C, 2007, DEV BIOL, V308, P133, DOI 10.1016/j.ydbio.2007.05.014; Garcia-Cozar FJ, 1998, J BIOL CHEM, V273, P23877, DOI 10.1074/jbc.273.37.23877; Gottlieb PD, 2002, NAT GENET, V31, P25, DOI 10.1038/ng866; HARDY MF, 1970, BIOCHEM J, V120, P653, DOI 10.1042/bj1200653; Hawkins TA, 2008, DEVELOPMENT, V135, P1147, DOI 10.1242/dev.018150; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; HUSZAR G, 1969, NATURE, V223, P834, DOI 10.1038/223834a0; Hwang I, 1997, J IMMUNOL, V158, P1165; HWANG I, 1995, IMMUNOGENETICS, V42, P353, DOI 10.1007/BF00179396; Iwabata H, 2005, PROTEOMICS, V5, P4653, DOI 10.1002/pmic.200500042; Just S, 2011, J CELL SCI, V124, P3127, DOI 10.1242/jcs.084772; Leger J, 1997, J BIOL CHEM, V272, P8441, DOI 10.1074/jbc.272.13.8441; Liu YW, 2001, J CELL BIOL, V155, P27, DOI 10.1083/jcb.200103020; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; PAIK WK, 1971, SCIENCE, V174, P114, DOI 10.1126/science.174.4005.114; Paik WK, 2007, TRENDS BIOCHEM SCI, V32, P146, DOI 10.1016/j.tibs.2007.01.006; Saad JS, 2007, PROTEIN SCI, V16, P1793, DOI 10.1110/ps.072987607; Sims RJ, 2002, J BIOL CHEM, V277, P26524, DOI 10.1074/jbc.M204121200; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Yang XD, 2009, EPIGENETICS-US, V4, P429, DOI 10.4161/epi.4.7.9787	27	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28524	10.1371/journal.pone.0028524	http://dx.doi.org/10.1371/journal.pone.0028524			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174829	Green Published, Green Submitted, gold			2022-12-25	WOS:000298365700043
J	Llop, P; Cabrefiga, J; Smits, THM; Dreo, T; Barbe, S; Pulawska, J; Bultreys, A; Blom, J; Duffy, B; Montesinos, E; Lopez, MM				Llop, Pablo; Cabrefiga, Jordi; Smits, Theo H. M.; Dreo, Tanja; Barbe, Silvia; Pulawska, Joanna; Bultreys, Alain; Blom, Jochen; Duffy, Brion; Montesinos, Emilio; Lopez, Maria M.			Erwinia amylovora Novel Plasmid pEI70: Complete Sequence, Biogeography, and Role in Aggressiveness in the Fire Blight Phytopathogen	PLOS ONE			English	Article							NUCLEOTIDE-SEQUENCE; GENETIC ELEMENTS; SP. NOV.; PATHOGEN; RESISTANCE; STRAINS; GENOME; PEAR; DIFFERENTIATION; ORGANIZATION	Comparative genomics of several strains of Erwinia amylovora, a plant pathogenic bacterium causal agent of fire blight disease, revealed that its diversity is primarily attributable to the flexible genome comprised of plasmids. We recently identified and sequenced in full a novel 65.8 kb plasmid, called pEI70. Annotation revealed a lack of known virulence-related genes, but found evidence for a unique integrative conjugative element related to that of other plant and human pathogens. Comparative analyses using BLASTN showed that pEI70 is almost entirely included in plasmid pEB102 from E. billingiae, an epiphytic Erwinia of pome fruits, with sequence identities superior to 98%. A duplex PCR assay was developed to survey the prevalence of plasmid pEI70 and also that of pEA29, which had previously been described in several E. amylovora strains. Plasmid pEI70 was found widely dispersed across Europe with frequencies of 5-92%, but it was absent in E. amylovora analyzed populations from outside of Europe. Restriction analysis and hybridization demonstrated that this plasmid was identical in at least 13 strains. Curing E. amylovora strains of pEI70 reduced their aggressiveness on pear, and introducing pEI70 into low-aggressiveness strains lacking this plasmid increased symptoms development in this host. Discovery of this novel plasmid offers new insights into the biogeography, evolution and virulence determinants in E. amylovora.	[Llop, Pablo; Barbe, Silvia; Lopez, Maria M.] IVIA, Moncada, Spain; [Cabrefiga, Jordi; Montesinos, Emilio] Univ Girona, CIDSAV CeRTA, INTEA, Inst Food & Agr Technol, Girona, Spain; [Smits, Theo H. M.; Duffy, Brion] Swiss Natl Competence Ctr Fire Blight, Wadenswil, Switzerland; [Dreo, Tanja] NIB, SI-1000 Ljubljana, Slovenia; [Pulawska, Joanna] Inst Hort, Skierniewice, Poland; [Bultreys, Alain] Ctr Wallon Rech Agron, Dept Sci Vivant, Gembloux, Belgium; [Blom, Jochen] Univ Bielefeld, CeBiTec, D-33615 Bielefeld, Germany	Universitat de Girona; Research Institute of Horticulture; University of Bielefeld	Llop, P (corresponding author), IVIA, Moncada, Spain.	mlopez@ivia.es	Cabrefiga, Jordi/H-3340-2015; Cabrefiga, Jordi/AAV-7844-2021; Llop, Pablo/H-3032-2017; Llop, Pablo/ABD-5403-2022; Pulawska, Joanna/S-3663-2019; López, Maria M/D-2584-2015; Puławska, Joanna/S-6091-2018; Montesinos, Emili/H-5246-2015; Bultreys, Alain/HHS-2296-2022; Lopez, Maria/HHC-3659-2022; Dreo, Tanja/X-1638-2019	Cabrefiga, Jordi/0000-0002-8913-2573; Cabrefiga, Jordi/0000-0002-8913-2573; Llop, Pablo/0000-0003-3075-8376; Pulawska, Joanna/0000-0001-5327-1056; Puławska, Joanna/0000-0001-5327-1056; Montesinos, Emili/0000-0003-4455-8332; Dreo, Tanja/0000-0002-0850-4874; Barbe, Silvia/0000-0002-2929-6410; Smits, Theo H.M./0000-0002-1237-235X	Spanish Ministry of Science [CICYT AGL2008-05723-C02-01/AGR]; EUPHRESCO ERA-Net ErwinDect; Swiss Federal Office of Agriculture; COST Action [864]	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); EUPHRESCO ERA-Net ErwinDect; Swiss Federal Office of Agriculture; COST Action(European Cooperation in Science and Technology (COST))	This work was financed by the Spanish Ministry of Science project CICYT AGL2008-05723-C02-01/AGR, EUPHRESCO ERA-Net ErwinDect Project, The Swiss Federal Office of Agriculture, and COST Action 864 (http://www.cost864.eu/). There are no current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge P, 1997, MOL GEN GENET, V256, P611, DOI 10.1007/s004380050609; Arnold DL, 2003, MOL PLANT PATHOL, V4, P407, DOI [10.1046/j.1364-3703.2003.00187.x, 10.1046/J.1364-3703.2003.00187.X]; Badger JH, 1999, MOL BIOL EVOL, V16, P512, DOI 10.1093/oxfordjournals.molbev.a026133; Beer S. V., 1991, Advances in molecular genetics of plant-microbe interactions. Vol. 1. Proceedings of the 5th international symposium on the molecular genetics of plant-microbe interactions, Interlaken, Switzerland, September 9-14, 1990., P53; Brennan JM, 2002, J PHYTOPATHOL, V150, P414, DOI 10.1046/j.1439-0434.2002.00789.x; Cabrefiga J, 2005, PHYTOPATHOLOGY, V95, P1430, DOI 10.1094/PHYTO-95-1430; CHIOU CS, 1991, PHYTOPATHOLOGY, V81, P710, DOI 10.1094/Phyto-81-710; Foster GC, 2004, APPL ENVIRON MICROB, V70, P7539, DOI 10.1128/AEM.70.12.7539-7544.2004; Gaillard M, 2006, J BACTERIOL, V188, P1999, DOI 10.1128/JB.188.5.1999-2013.2006; Hauben L., 2005, BERGEYS MANUAL SYSTE, V2, P670; Kim J.-H., 1995, Phytopathology, V85, P1148; Kim WS, 1999, INT J SYST BACTERIOL, V49, P899, DOI 10.1099/00207713-49-2-899; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kube M, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-110, 10.1186/1471-2164-11-393]; LAURENT J, 1989, Molecular Plant-Microbe Interactions, V2, P160, DOI 10.1094/MPMI-2-160; Llop P, 2008, ACTA HORTIC, V793, P145, DOI 10.17660/ActaHortic.2008.793.18; Llop P, 2006, PHYTOPATHOLOGY, V96, P900, DOI 10.1094/PHYTO-96-0900; Lopez MM, 2011, INT J SYST EVOL MICR, V61, P561, DOI 10.1099/ijs.0.020479-0; Maniatis T., 1982, MOL CLONING; Mavrodi DV, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-8; McGhee GC, 2008, ACTA HORTIC, V793, P271; McGhee GC, 2000, APPL ENVIRON MICROB, V66, P4897, DOI 10.1128/AEM.66.11.4897-4907.2000; McGhee GC, 2002, APPL ENVIRON MICROB, V68, P6182, DOI 10.1128/AEM.68.12.6182-6192.2002; MCGHEE GC, 2001, ACTA HORTIC, V590, P413; McHardy AC, 2004, BIOINFORMATICS, V20, P1622, DOI 10.1093/bioinformatics/bth137; MCMANUS PS, 1995, PHYTOPATHOLOGY, V85, P618, DOI 10.1094/Phyto-85-618; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Mohammadi M, 2010, PLANT PATHOL, V59, P252, DOI 10.1111/j.1365-3059.2009.02182.x; Mohd-Zain Z, 2004, J BACTERIOL, V186, P8114, DOI 10.1128/JB.186.23.8114-8122.2004; NORELLI JL, 1984, PHYTOPATHOLOGY, V74, P136, DOI 10.1094/Phyto-74-136; Oh CS, 2005, FEMS MICROBIOL LETT, V253, P185, DOI 10.1016/j.femsle.2005.09.051; Palmer EL, 1997, APPL ENVIRON MICROB, V63, P4604, DOI 10.1128/AEM.63.11.4604-4607.1997; PAULIN J-P, 1973, Annales de Phytopathologie, V5, P389; Powney R, 2011, J BACTERIOL, V193, P785, DOI 10.1128/JB.01352-10; Rezzonico F, 2011, APPL ENVIRON MICROB, V77, P3819, DOI 10.1128/AEM.00177-11; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Sebaihia M, 2010, J Bacteriol, V192, P2020, DOI 10.1128/JB.00022-10; Sholberg PL, 2001, CAN J PLANT PATHOL, V23, P60; Smits THM, 2011, J BIOTECHNOL, V155, P34, DOI 10.1016/j.jbiotec.2010.10.075; Smits THM, 2010, MOL PLANT MICROBE IN, V23, P384, DOI 10.1094/MPMI-23-4-0384; Stavrinides J, 2004, J BACTERIOL, V186, P5101, DOI [10.1128/JB.186.15.5101-5115.2004, 10.1128/jb.186.15.5101-5115.2004]; STEINBERGER EM, 1990, PLASMID, V24, P12, DOI 10.1016/0147-619X(90)90021-4; Sundin GW, 2007, ANNU REV PHYTOPATHOL, V45, P129, DOI 10.1146/annurev.phyto.45.062806.094317; SUNDIN GW, 2004, ACTA HORTIC, V704, P423; Toth IK, 2006, ANNU REV PHYTOPATHOL, V44, P305, DOI 10.1146/annurev.phyto.44.070505.143444; Triplett LR, 2006, APPL ENVIRON MICROB, V72, P7359, DOI 10.1128/AEM.01159-06; Van der Zwet T, 1979, USDA AGR HDB, V510; Vanneste J.L., 2000, FIRE BLIGHT DIS ITS; Weinthal DM, 2007, APPL ENVIRON MICROB, V73, P7552, DOI 10.1128/AEM.01511-07; Williams KP, 2002, NUCLEIC ACIDS RES, V30, P866, DOI 10.1093/nar/30.4.866; Zhang YX, 1997, APPL ENVIRON MICROB, V63, P4421, DOI 10.1128/AEM.63.11.4421-4426.1997; Zhao YF, 2005, J BACTERIOL, V187, P2113, DOI 10.1128/JB.187.6.2113-2126.2005; ZHOU C, 1990, BIOTECHNIQUES, V8, P172	53	34	35	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28651	10.1371/journal.pone.0028651	http://dx.doi.org/10.1371/journal.pone.0028651			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174857	Green Published, gold, Green Submitted			2022-12-25	WOS:000298365700056
J	Mammen, AL; Mahoney, JA; St Germain, A; Badders, N; Taylor, JP; Rosen, A; Spinette, S				Mammen, Andrew L.; Mahoney, James A.; St Germain, Amanda; Badders, Nisha; Taylor, J. Paul; Rosen, Antony; Spinette, Sarah			A Novel Conserved Isoform of the Ubiquitin Ligase UFD2a/UBE4B Is Expressed Exclusively in Mature Striated Muscle Cells	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; PROTEIN-DEGRADATION; PROTEASOME PATHWAY; UNC-45 CHAPERONE; U-BOX; MYOSIN; DIFFERENTIATION; MAINTENANCE; DOMAIN; HEART	Yeast Ufd2p was the first identified E4 multiubiquitin chain assembly factor. Its vertebrate homologues later referred to as UFD2a, UBE4B or E4B were also shown to have E3 ubiquitin ligase activity. UFD2a function in the brain has been well established in vivo, and in vitro studies have shown that its activity is essential for proper condensation and segregation of chromosomes during mitosis. Here we show that 2 alternative splice forms of UFD2a, UFD2a-7 and -7/7a, are expressed sequentially during myoblast differentiation of C2C12 cell cultures and during cardiotoxin-induced regeneration of skeletal muscle in mice. UFD2a-7 contains an alternate exon 7, and UFD2a-7/7a, the larger of the 2 isoforms, contains an additional novel exon 7a. Analysis of protein or mRNA expression in mice and zebrafish revealed that a similar pattern of isoform switching occurs during developmental myogenesis of cardiac and skeletal muscle. In vertebrates (humans, rodents, zebrafish), UFD2a-7/7a is expressed only in mature striated muscle. This unique tissue specificity is further validated by the conserved presence of 2 muscle-specific splicing regulatory motifs located in the 3' introns of exons 7 and 7a. UFD2a interacts with VCP/p97, an AAA-type ATPase implicated in processes whose functions appear to be regulated, in part, through their interaction with one or more of 15 previously identified cofactors. UFD2a-7/7a did not interact with VCP/p97 in yeast 2-hybrid experiments, which may allow the ATPase to bind cofactors that facilitate its muscle-specific functions. We conclude that the regulated expression of these UFD2a isoforms most likely imparts divergent functions that are important for myogenisis.	[Mammen, Andrew L.; Mahoney, James A.; Rosen, Antony] Johns Hopkins Univ, Sch Med, Dept Med, Div Rheumatol, Baltimore, MD 21205 USA; [Mammen, Andrew L.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Badders, Nisha; Taylor, J. Paul] St Jude Childrens Hosp, Dept Dev Neurobiol, Memphis, TN USA; [St Germain, Amanda; Spinette, Sarah] Rhode Isl Coll, Dept Biol, Providence, RI 02908 USA	Johns Hopkins University; Johns Hopkins University; St Jude Children's Research Hospital	Mammen, AL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Rheumatol, Baltimore, MD 21205 USA.	sspinette@ric.edu	Mammen, Andrew/AAF-2885-2021; Taylor, J. Paul/N-2482-2018	Taylor, J. Paul/0000-0002-5794-0349	National Institutes of Health [P01HL056091, R37DE012354, R01AR044684, R01 AG031587]; National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [P20RR016457]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016457] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL056091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE012354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031587] Funding Source: NIH RePORTER; Office Of The Director [1004057] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by National Institutes of Health grants P01HL056091, R37DE012354, R01AR044684, R01 AG031587 and RI-INBRE Grant # P20RR016457 from the National Center for Research Resources (NCRR http://ncrr.nih.gov/), a component of the National Institutes of Health (NIH http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Hatoum O, 1998, MOL CELL BIOL, V18, P5670, DOI 10.1128/MCB.18.10.5670; Aravind L, 2000, CURR BIOL, V10, pR132, DOI 10.1016/S0960-9822(00)00398-5; Ardley HC, 2005, ESSAYS BIOCHEM, V41, P15, DOI 10.1042/EB0410015; Barral JM, 2002, SCIENCE, V295, P669, DOI 10.1126/science.1066648; Bazzaro M, 2007, AM J PATHOL, V171, P1640, DOI 10.2353/ajpath.2007.070325; BENIRSCHKE RC, STRUCTURE, V18, P955; BERNICK EP, BMC CELL BIOL, V11, P70; Bland CS, 2010, NUCLEIC ACIDS RES, V38, P7651, DOI 10.1093/nar/gkq614; Brand-Saberi B, 2005, ANN ANAT, V187, P199, DOI 10.1016/j.aanat.2004.12.018; Campos Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009866; Cao K, 2003, CELL, V115, P355, DOI 10.1016/S0092-8674(03)00815-8; Cao PR, 2005, INT J BIOCHEM CELL B, V37, P2088, DOI 10.1016/j.biocel.2004.11.010; Castle JC, 2008, NAT GENET, V40, P1416, DOI 10.1038/ng.264; COUTEAUX R, 1988, BIOL CELL, V62, P171, DOI 10.1016/0248-4900(88)90034-2; CUSTER SK, HUM MOL GENET, V19; Etheridge L, 2002, DEV DYNAM, V224, P457, DOI 10.1002/dvdy.10123; Guinto JB, 2007, ACTA NEUROPATHOL, V114, P55, DOI 10.1007/s00401-007-0224-7; Heuze ML, 2008, BLOOD, V112, P5130, DOI 10.1182/blood-2007-12-128744; Higgins D G, 1994, Methods Mol Biol, V25, P307; Hoppe T, 2004, CELL, V118, P337, DOI 10.1016/j.cell.2004.07.014; Hutagalung AH, 2002, J CELL SCI, V115, P3983, DOI 10.1242/jcs.00107; Janiesch PC, 2007, NAT CELL BIOL, V9, P379, DOI 10.1038/ncb1554; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; JU JS, HUM MOL GENET, V19, pR38; Kachur T, 2004, J CELL SCI, V117, P5313, DOI 10.1242/jcs.01389; Kachur TM, 2008, INT J MOL SCI, V9, P1863, DOI 10.3390/ijms9091863; Kalsotra A, 2008, P NATL ACAD SCI USA, V105, P20333, DOI 10.1073/pnas.0809045105; Kaneko C, 2003, BIOCHEM BIOPH RES CO, V300, P297, DOI 10.1016/S0006-291X(02)02834-6; Kaneko-Oshikawa C, 2005, MOL CELL BIOL, V25, P10953, DOI 10.1128/MCB.25.24.10953-10964.2005; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Kuang S, 2008, TRENDS MOL MED, V14, P82, DOI 10.1016/j.molmed.2007.12.004; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Ladd AN, 2005, DEV DYNAM, V233, P783, DOI 10.1002/dvdy.20382; Landsverk ML, 2007, J CELL BIOL, V177, P205, DOI 10.1083/jcb.200607084; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Li WQ, 2007, FASEB J, V21, P3606, DOI 10.1096/fj.07-8159com; Lindon C, 1998, J CELL BIOL, V140, P111, DOI 10.1083/jcb.140.1.111; Mahoney JA, 2002, BIOCHEM J, V361, P587, DOI 10.1042/0264-6021:3610587; Matsumoto M, 2004, EMBO J, V23, P659, DOI 10.1038/sj.emboj.7600081; MCAULIFFE JJ, 1990, CIRC RES, V66, P1204, DOI 10.1161/01.RES.66.5.1204; McElhinny AS, 2004, J CELL SCI, V117, P3175, DOI 10.1242/jcs.01158; Ni WM, 2011, J CELL SCI, V124, P3164, DOI 10.1242/jcs.087320; NORDQUIST KA, BIOCHEMISTRY, V49, P347; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; Price MG, 2002, J CELL SCI, V115, P4013, DOI 10.1242/jcs.00108; Ramadan K, 2007, NATURE, V450, P1258, DOI 10.1038/nature06388; Samson T, 2007, J BIOL CHEM, V282, P15730, DOI 10.1074/jbc.M611197200; Solomon V, 1996, J BIOL CHEM, V271, P26690, DOI 10.1074/jbc.271.43.26690; Sorokin AV, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1411, DOI 10.1134/S000629790913001X; Spinette S, 2004, CELL CYCLE, V3, P1638; Spinette S, 2006, BIOCHEM BIOPH RES CO, V347, P1103, DOI 10.1016/j.bbrc.2006.06.194; Srikakulam R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002137; Sugnet CW, 2006, PLOS COMPUT BIOL, V2, P22, DOI 10.1371/journal.pcbi.0020004; Sun L, 2007, ONCOGENE, V26, P441, DOI 10.1038/sj.onc.1209793; Sun LP, 2005, J BIOL CHEM, V280, P26448, DOI 10.1074/jbc.M500373200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOWNSEND PJ, 1995, J MOL CELL CARDIOL, V27, P2223, DOI 10.1016/S0022-2828(95)91587-7; Vesa J, 2009, NEUROMUSCULAR DISORD, V19, P766, DOI 10.1016/j.nmd.2009.08.003; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Warren CM, 2004, MECH DEVELOP, V121, P1301, DOI 10.1016/j.mod.2004.07.003; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; YAFFE D, 1977, DIFFERENTIATION, V7, P159, DOI 10.1111/j.1432-0436.1977.tb01507.x	62	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28861	10.1371/journal.pone.0028861	http://dx.doi.org/10.1371/journal.pone.0028861			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174917	Green Published, Green Submitted, gold			2022-12-25	WOS:000298365700079
J	Sato, T; Aiyama, Y; Ishii-Inagaki, M; Hara, K; Tsunekawa, N; Harikae, K; Uemura-Kamata, M; Shinomura, M; Zhu, XB; Maeda, S; Kuwahara-Otani, S; Kudo, A; Kawakami, H; Kanai-Azuma, M; Fujiwara, M; Miyamae, Y; Yoshida, S; Seki, M; Kurohmaru, M; Kanai, Y				Sato, Takeshi; Aiyama, Yoshimi; Ishii-Inagaki, Mayuko; Hara, Kenshiro; Tsunekawa, Naoki; Harikae, Kyoko; Uemura-Kamata, Mami; Shinomura, Mai; Zhu, Xiao Bo; Maeda, Seishi; Kuwahara-Otani, Sachi; Kudo, Akihiko; Kawakami, Hayato; Kanai-Azuma, Masami; Fujiwara, Michio; Miyamae, Yoichi; Yoshida, Shosei; Seki, Makoto; Kurohmaru, Masamichi; Kanai, Yoshiakira			Cyclical and Patch-Like GDNF Distribution along the Basal Surface of Sertoli Cells in Mouse and Hamster Testes	PLOS ONE			English	Article							SPERMATOGONIAL STEM-CELLS; MALE GERM-LINE; LONG-TERM CULTURE; SELF-RENEWAL; JUNCTION DYNAMICS; SHORT PHOTOPERIOD; GOLDEN-HAMSTER; MESSENGER-RNA; SPERMATOGENESIS; TRANSPLANTATION	Background and Aims: In mammalian spermatogenesis, glial cell line-derived neurotrophic factor (GDNF) is one of the major Sertoli cell-derived factors which regulates the maintenance of undifferentiated spermatogonia including spermatogonial stem cells (SSCs) through GDNF family receptor alpha 1 (GFR alpha 1). It remains unclear as to when, where and how GDNF molecules are produced and exposed to the GFR alpha 1-positive spermatogonia in vivo. Methodology and Principal Findings: Here we show the cyclical and patch-like distribution of immunoreactive GDNF-positive signals and their close co-localization with a subpopulation of GFR alpha 1-positive spermatogonia along the basal surface of Sertoli cells in mice and hamsters. Anti-GDNF section immunostaining revealed that GDNF-positive signals are mainly cytoplasmic and observed specifically in the Sertoli cells in a species-specific as well as a seminiferous cycle- and spermatogenic activity-dependent manner. In contrast to the ubiquitous GDNF signals in mouse testes, high levels of its signals were cyclically observed in hamster testes prior to spermiation. Whole-mount anti-GDNF staining of the seminiferous tubules successfully visualized the cyclical and patch-like extracellular distribution of GDNF-positive granular deposits along the basal surface of Sertoli cells in both species. Double-staining of GDNF and GFR alpha 1 demonstrated the close co-localization of GDNF deposits and a subpopulation of GFR alpha 1-positive spermatogonia. In both species, GFR alpha 1-positive cells showed a slender bipolar shape as well as a tendency for increased cell numbers in the GDNF-enriched area, as compared with those in the GDNF-low/negative area of the seminiferous tubules. Conclusion/Significance: Our data provide direct evidence of regionally defined patch-like GDNF-positive signal site in which GFR alpha 1-positive spermatogonia possibly interact with GDNF in the basal compartment of the seminiferous tubules.	[Sato, Takeshi; Aiyama, Yoshimi; Ishii-Inagaki, Mayuko; Tsunekawa, Naoki; Harikae, Kyoko; Uemura-Kamata, Mami; Shinomura, Mai; Zhu, Xiao Bo; Kurohmaru, Masamichi; Kanai, Yoshiakira] Univ Tokyo, Dept Vet Anat, Tokyo, Japan; [Sato, Takeshi; Fujiwara, Michio; Miyamae, Yoichi] Astellas Pharma Inc, Drug Safety Res Labs, Osaka, Japan; [Hara, Kenshiro; Yoshida, Shosei] Grad Univ Adv Studies SOKENDAI, Div Germ Biol, Natl Inst Basic Biol, Okazaki, Aichi, Japan; [Hara, Kenshiro; Yoshida, Shosei] Grad Univ Adv Studies SOKENDAI, Dept Basic Biol, Sch Life Sci, Okazaki, Aichi, Japan; [Uemura-Kamata, Mami; Kanai-Azuma, Masami] Tokyo Med & Dent Univ, Ctr Expt Anim, Tokyo, Japan; [Maeda, Seishi; Kuwahara-Otani, Sachi; Seki, Makoto] Hyogo Coll Med, Dept Anat, Div Cell Biol, Nishinomiya, Hyogo 6638501, Japan; [Kudo, Akihiko; Kawakami, Hayato] Kyorin Univ, Sch Med, Dept Anat, Mitaka, Tokyo 181, Japan	University of Tokyo; Astellas Pharmaceuticals; Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB); Tokyo Medical & Dental University (TMDU); Hyogo College of Medicine; Kyorin University	Sato, T (corresponding author), Univ Tokyo, Dept Vet Anat, Tokyo, Japan.	aykanai@mail.ecc.u-tokyo.ac.jp	Kudo, Akihiko/ACZ-3340-2022	Kudo, Akihiko/0000-0002-2630-5991; Yoshida, Shosei/0000-0001-8861-1866; Kanai, Yoshiakira/0000-0003-2116-7806	 [21116501];  [3116702];  [20116004]; Grants-in-Aid for Scientific Research [20116004] Funding Source: KAKEN	; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (KAKENHI) on Innovative Areas (no. 21116501; 23116702; 20116004)(http://www.jsps.go.jp/english/e-grants/grants.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkoyunlu G, 2007, ACTA HISTOCHEM, V109, P130, DOI 10.1016/j.acthis.2006.11.003; Aponte PM, 2008, REPRODUCTION, V136, P543, DOI 10.1530/REP-07-0419; Aponte PM, 2005, THERIOGENOLOGY, V64, P1440, DOI 10.1016/j.theriogenology.2005.03.016; BERNDTSON WE, 1974, ENDOCRINOLOGY, V95, P195, DOI 10.1210/endo-95-1-195; Braydich-Stolle L, 2007, DEV BIOL, V304, P34, DOI 10.1016/j.ydbio.2006.12.013; Brinster RL, 2002, SCIENCE, V296, P2174, DOI 10.1126/science.1071607; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; CHANDRASHEKAR V, 1989, BIOL REPROD, V40, P300, DOI 10.1095/biolreprod40.2.300; Cheng CY, 2002, PHYSIOL REV, V82, P825, DOI 10.1152/physrev.00009.2002; Davies EL, 2008, COLD SH Q B, V73, P137, DOI 10.1101/sqb.2008.73.063; De Rooij DG, 2000, J ANDROL, V21, P776; de Rooij DG, 1998, CURR OPIN CELL BIOL, V10, P694, DOI 10.1016/S0955-0674(98)80109-9; He ZP, 2007, BIOL REPROD, V77, P723, DOI 10.1095/biolreprod.107.062513; Hiramatsu R, 2003, DEV DYNAM, V228, P247, DOI 10.1002/dvdy.10379; Hobbs RM, 2010, CELL, V142, P468, DOI 10.1016/j.cell.2010.06.041; Hofmann MC, 2008, MOL CELL ENDOCRINOL, V288, P95, DOI 10.1016/j.mce.2008.04.012; Hofmann MC, 2005, DEV BIOL, V279, P114, DOI 10.1016/j.ydbio.2004.12.006; Ishii M, 2007, DEVELOPMENT, V134, P449, DOI 10.1242/dev.02751; Kanai Y, 1996, J CELL BIOL, V133, P667, DOI 10.1083/jcb.133.3.667; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kanatsu-Shinohara M, 2005, BIOL REPROD, V72, P985, DOI 10.1095/biolreprod.104.036400; Kanatsu-Shinohara M, 2008, BIOL REPROD, V78, P611, DOI 10.1095/biolreprod.107.065615; KIRBY JD, 1993, BIOL REPROD, V49, P483, DOI 10.1095/biolreprod49.3.483; Klein AM, 2010, CELL STEM CELL, V7, P214, DOI 10.1016/j.stem.2010.05.017; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Lee J, 2007, DEVELOPMENT, V134, P1853, DOI 10.1242/dev.003004; Lui WY, 2003, BIOL REPROD, V68, P1087, DOI 10.1095/biolreprod.102.010371; Matsui T, 2006, J CELL SCI, V119, P3513, DOI 10.1242/jcs.03081; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Nakagawa T, 2010, SCIENCE, V328, P62, DOI 10.1126/science.1182868; Nakamura S, 2010, SCIENCE, V328, P1561, DOI 10.1126/science.1185473; Naughton CK, 2006, BIOL REPROD, V74, P314, DOI 10.1095/biolreprod.105.047365; Oatley JM, 2005, BIOL REPROD, V72, P358, DOI 10.1095/biolreprod.104.030783; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Oatley JM, 2007, J BIOL CHEM, V282, P25842, DOI 10.1074/jbc.M703474200; Ogawa T, 2000, NAT MED, V6, P29, DOI 10.1038/71496; Ogawa T, 1999, BIOL REPROD, V60, P515, DOI 10.1095/biolreprod60.2.515; Palasz A, 2009, ADV MED SCI-POLAND, V54, P143, DOI 10.2478/v10039-009-0032-5; Russell L. D., 1990, HISTOLOGICAL HISTOPA, P41; Ryu BY, 2005, P NATL ACAD SCI USA, V102, P14302, DOI 10.1073/pnas.0506970102; Sada A, 2009, SCIENCE, V325, P1394, DOI 10.1126/science.1172645; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; Sato T, 2005, ANAT HISTOL EMBRYOL, V34, P220, DOI 10.1111/j.1439-0264.2005.00599.x; Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129; Simon L, 2007, EXP CELL RES, V313, P3090, DOI 10.1016/j.yexcr.2007.05.002; Simoni M, 1997, ENDOCR REV, V18, P739, DOI 10.1210/er.18.6.739; Suzuki H, 2009, DEV BIOL, V336, P222, DOI 10.1016/j.ydbio.2009.10.002; Tadokoro Y, 2002, MECH DEVELOP, V113, P29, DOI 10.1016/S0925-4773(02)00004-7; TOPPARI J, 1991, J ELECTRON MICR TECH, V19, P203, DOI 10.1002/jemt.1060190207; TSUTSUI K, 1988, ENDOCRINOLOGY, V122, P1094, DOI 10.1210/endo-122-3-1094; Wong CH, 2005, CURR TOP DEV BIOL, V71, P263, DOI 10.1016/S0070-2153(05)71008-5; Yoshida S, 2010, DEV GROWTH DIFFER, V52, P311, DOI 10.1111/j.1440-169X.2010.01174.x	53	41	42	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28367	10.1371/journal.pone.0028367	http://dx.doi.org/10.1371/journal.pone.0028367			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174794	Green Submitted, gold, Green Published			2022-12-25	WOS:000298365700029
J	Yoshida, S; Yasuda, M; Miyashita, H; Ogawa, Y; Yoshida, T; Matsuzaki, Y; Tsubota, K; Okano, H; Shimmura, S				Yoshida, Satoru; Yasuda, Miyuki; Miyashita, Hideyuki; Ogawa, Yoko; Yoshida, Tetsu; Matsuzaki, Yumi; Tsubota, Kazuo; Okano, Hideyuki; Shimmura, Shigeto			Generation of Stratified Squamous Epithelial Progenitor Cells from Mouse Induced Pluripotent Stem Cells	PLOS ONE			English	Article							OCULAR SURFACE DISORDERS; DOPAMINERGIC-NEURONS; CORNEAL EPITHELIUM; AMNIOTIC MEMBRANE; ES CELLS; DIFFERENTIATION; INDUCTION; TRANSPLANTATION; FIBROBLASTS; TRANSDIFFERENTIATION	Background: Application of induced pluripotent stem (iPS) cells in regenerative medicine will bypass ethical issues associated with use of embryonic stem cells. In addition, patient-specific IPS cells can be useful to elucidate the pathophysiology of genetic disorders, drug screening, and tailor-made medicine. However, in order to apply iPS cells to mitotic tissue, induction of tissue stem cells that give rise to progeny of the target organ is required. Methodology/Principal Findings: We induced stratified epithelial cells from mouse iPS cells by co-culture with PA6 feeder cells (SDIA-method) with use of BMP4. Clusters of cells positive for the differentiation markers KRT1 or KRT12 were observed in KRT14-positive colonies. We successfully cloned KRT14 and p63 double-positive stratified epithelial progenitor cells from iPS-derived epithelial cells, which formed stratified epithelial sheets consisting of five-to six-polarized epithelial cells in vitro. When these clonal cells were cultured on denuded mouse corneas, a robust stratified epithelial layer was observed with physiological cell polarity including high levels of E-cadherin, p63 and K15 expression in the basal layer and ZO-1 in the superficial layer, recapitulating the apico-basal polarity of the epithelium in vivo. Conclusions/Significance: These results suggest that KRT14 and p63 double-positive epithelial progenitor cells can be cloned from iPS cells in order to produce polarized multilayer epithelial cell sheets.	[Yoshida, Satoru; Yasuda, Miyuki; Miyashita, Hideyuki; Ogawa, Yoko; Yoshida, Tetsu; Tsubota, Kazuo; Shimmura, Shigeto] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Matsuzaki, Yumi; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Tokyo 160, Japan	Keio University; Keio University	Yoshida, S (corresponding author), Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan.	shige@sc.itc.keio.ac.jp	Shimmura, Shigeto/J-4678-2013; Okano, Hideyuki/I-7584-2019	Matsuzaki, Yumi/0000-0002-3729-2997	Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science (JSPS) and the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), the project for realization of regenerative medicine and support for the core institutes for iPS cell research from Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) to S.S. and H.O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberdam E, 2008, STEM CELLS, V26, P440, DOI 10.1634/stemcells.2007-0588; Bilousova G, 2010, J INVEST DERMATOL; Blazejewska EA, 2009, STEM CELLS, V27, P642, DOI 10.1634/stemcells.2008-0721; Bonfanti P, 2010, NATURE, V466, P978, DOI 10.1038/nature09269; Buchholz DE, 2009, STEM CELLS, V27, P2427, DOI 10.1002/stem.189; Coraux C, 2003, CURR BIOL, V13, P849, DOI 10.1016/S0960-9822(03)00296-3; Davies SB, 2010, STEM CELLS DEV, V19, P1651, DOI 10.1089/scd.2010.0201; Davies SB, 2009, STEM CELLS, V27, P2781, DOI 10.1002/stem.209; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Green H, 2003, P NATL ACAD SCI USA, V100, P15625, DOI 10.1073/pnas.0307226100; HEFTON JM, 1983, LANCET, V2, P428; Ji L, 2006, TISSUE ENG, V12, P665, DOI 10.1089/ten.2006.12.665; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kawasaki H, 2002, P NATL ACAD SCI USA, V99, P1580, DOI 10.1073/pnas.032662199; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Lee CH, 2011, BIOMATERIALS, V32, P6683, DOI 10.1016/j.biomaterials.2011.05.070; Martinez-Morales JR, 2004, BIOESSAYS, V26, P766, DOI 10.1002/bies.20064; Metallo CM, 2008, STEM CELLS, V26, P372, DOI 10.1634/stemcells.2007-0501; Metallo CM, 2010, METHODS MOL BIOL, V585, P83, DOI 10.1007/978-1-60761-380-0_7; Mizuseki K, 2003, P NATL ACAD SCI USA, V100, P5828, DOI 10.1073/pnas.1037282100; Montserrat N, 2011, J CARDIOVASC TRANSL, V4, P121, DOI 10.1007/s12265-010-9233-3; Nakamura T, 2003, INVEST OPHTH VIS SCI, V44, P106, DOI 10.1167/iovs.02-0195; Nakamura T, 2004, BRIT J OPHTHALMOL, V88, P1280, DOI 10.1136/bjo.2003.038497; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; O'Connor N, 1981, LANCET, V317, P75; Ogawa Y, 2001, INVEST OPHTH VIS SCI, V42, P111; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Okita K, 2010, NAT PROTOC, V5, P418, DOI 10.1038/nprot.2009.231; Osakada F, 2009, NAT PROTOC, V4, P811, DOI 10.1038/nprot.2009.51; Pearton DJ, 2004, INT J DEV BIOL, V48, P197, DOI 10.1387/ijdb.15272385; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; Sakurai M, 2011, J ARTIF ORGANS, V14, P58, DOI 10.1007/s10047-010-0547-3; Shimazaki J, 2002, OPHTHALMOLOGY, V109, P1285, DOI 10.1016/S0161-6420(02)01089-8; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yoshida S, 2006, STEM CELLS, V24, P2714, DOI 10.1634/stemcells.2006-0156; Zhou WB, 2009, STEM CELLS, V27, P2667, DOI 10.1002/stem.201	37	23	30	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28856	10.1371/journal.pone.0028856	http://dx.doi.org/10.1371/journal.pone.0028856			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174914	Green Published, Green Submitted, gold			2022-12-25	WOS:000298365700078
J	Hu, CW; Chang, YL; Chen, SJ; Kuo-Huang, LL; Liao, JC; Huang, HC; Juan, HF				Hu, Chia-Wei; Chang, Ya-Ling; Chen, Shiang Jiuun; Kuo-Huang, Ling-Long; Liao, James C.; Huang, Hsuan-Cheng; Juan, Hsueh-Fen			Revealing the Functions of the Transketolase Enzyme Isoforms in Rhodopseudomonas palustris Using a Systems Biology Approach	PLOS ONE			English	Article							PENTOSE-PHOSPHATE PATHWAY; RIBULOSE-BISPHOSPHATE CARBOXYLASE; AMINO-ACID PERMEASE; ESCHERICHIA-COLI; PHOSPHOENOLPYRUVATE CARBOXYKINASE; ENHANCES PHOTOSYNTHESIS; RHIZOBIUM-LEGUMINOSARUM; BREAST-CARCINOMA; GENE-EXPRESSION; CARBON	Background: Rhodopseudomonas palustris (R. palustris) is a purple non-sulfur anoxygenic phototrophic bacterium that belongs to the class of proteobacteria. It is capable of absorbing atmospheric carbon dioxide and converting it to biomass via the process of photosynthesis and the Calvin-Benson-Bassham (CBB) cycle. Transketolase is a key enzyme involved in the CBB cycle. Here, we reveal the functions of transketolase isoforms I and II in R. palustris using a systems biology approach. Methodology/Principal Findings: By measuring growth ability, we found that transketolase could enhance the autotrophic growth and biomass production of R. palustris. Microarray and real-time quantitative PCR revealed that transketolase isoforms I and II were involved in different carbon metabolic pathways. In addition, immunogold staining demonstrated that the two transketolase isoforms had different spatial localizations: transketolase I was primarily associated with the intracytoplasmic membrane (ICM) but transketolase II was mostly distributed in the cytoplasm. Comparative proteomic analysis and network construction of transketolase over-expression and negative control (NC) strains revealed that protein folding, transcriptional regulation, amino acid transport and CBB cycle-associated carbon metabolism were enriched in the transketolase I over-expressed strain. In contrast, ATP synthesis, carbohydrate transport, glycolysis-associated carbon metabolism and CBB cycle-associated carbon metabolism were enriched in the transketolase II over-expressed strain. Furthermore, ATP synthesis assays showed a significant increase in ATP synthesis in the transketolase II over-expressed strain. A PEPCK activity assay showed that PEPCK activity was higher in transketolase over-expressed strains than in the negative control strain. Conclusions/Significance: Taken together, our results indicate that the two isoforms of transketolase in R. palustris could affect photoautotrophic growth through both common and divergent metabolic mechanisms.	[Hu, Chia-Wei; Chang, Ya-Ling; Juan, Hsueh-Fen] Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10764, Taiwan; [Chen, Shiang Jiuun; Kuo-Huang, Ling-Long; Juan, Hsueh-Fen] Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan; [Kuo-Huang, Ling-Long] Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Taipei 10764, Taiwan; [Liao, James C.] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA USA; [Huang, Hsuan-Cheng] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Huang, Hsuan-Cheng] Natl Yang Ming Univ, Ctr Syst & Synthet Biol, Taipei 112, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; University of California System; University of California Los Angeles; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Hu, CW (corresponding author), Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10764, Taiwan.	hsuangcheng@ym.edu.tw; yukijuan@ntu.edu.tw	Huang, Hsuan-Cheng/C-7266-2011	Huang, Hsuan-Cheng/0000-0002-3386-0934; Liao, James/0000-0002-4580-7276; JUAN, HSUEH-FEN/0000-0003-4876-3309	National Science Council, Taiwan [NSC 98-2627-M-010-001-, NSC 98-2627-M-002-001-, NSC 98-2627-M002-004, 99-2621-B-002-005-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council, Taiwan (NSC 98-2627-M-010-001-, NSC 98-2627-M-002-001-, NSC 98-2627-M002-004 and 99-2621-B-002-005-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badger MR, 2008, J EXP BOT, V59, P1525, DOI 10.1093/jxb/erm297; Barbosa MJ, 2001, J BIOTECHNOL, V85, P25, DOI 10.1016/S0168-1656(00)00368-0; Bowien B, 2002, ARCH MICROBIOL, V178, P85, DOI 10.1007/s00203-002-0441-3; BUBLITZ C, 1988, J BIOL CHEM, V263, P12849; Carlozzi P, 2010, BIORESOURCE TECHNOL, V101, P3115, DOI 10.1016/j.biortech.2009.12.049; Chinnasamy S, 2009, INT J MOL SCI, V10, P518, DOI 10.3390/ijms10020518; Crosby HA, 2010, MOL MICROBIOL, V76, P874, DOI 10.1111/j.1365-2958.2010.07127.x; DISPENSA M, 1992, J BACTERIOL, V174, P5803, DOI 10.1128/jb.174.18.5803-5813.1992; Dongen SM, 2000, THESIS U UTRECHT NET; Ellis RJ, 2005, CURR BIOL, V15, pR661, DOI 10.1016/j.cub.2005.08.025; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Faucher SP, 2006, P NATL ACAD SCI USA, V103, P1906, DOI 10.1073/pnas.0509183103; Garcia B, 1999, J BIOL CHEM, V274, P29228, DOI 10.1074/jbc.274.41.29228; Gibson JL, 1996, ARCH MICROBIOL, V166, P141, DOI 10.1007/s002030050369; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; GOLOUBINOFF P, 1989, NATURE, V337, P44, DOI 10.1038/337044a0; Gralnick JA, 2006, P NATL ACAD SCI USA, V103, P4669, DOI 10.1073/pnas.0505959103; Hanash SM, 2002, PROTEOMICS, V2, P69, DOI 10.1002/1615-9861(200201)2:1<69::AID-PROT69>3.3.CO;2-#; Hara KY, 2009, METAB ENG, V11, P1, DOI 10.1016/j.ymben.2008.07.003; Hara KY, 2006, J BIOMOL SCREEN, V11, P310, DOI 10.1177/1087057105285112; Henkes S, 2001, PLANT CELL, V13, P535, DOI 10.1105/tpc.13.3.535; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Hosie AHF, 2001, MOL MICROBIOL, V40, P1449, DOI 10.1046/j.1365-2958.2001.02497.x; Huang TC, 2008, J PROTEOME RES, V7, P1433, DOI 10.1021/pr700742h; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Inui M, 1997, J BACTERIOL, V179, P4942, DOI 10.1128/jb.179.15.4942-4945.1997; Jaubert M, 2004, J BIOL CHEM, V279, P44407, DOI 10.1074/jbc.M408039200; Joshi GS, 2009, J BACTERIOL, V191, P4243, DOI 10.1128/JB.01795-08; Juan HF, 2006, PROTEOMICS, V6, P2991, DOI 10.1002/pmic.200500435; Jung YM, 2004, J BIOSCI BIOENG, V98, P224, DOI 10.1263/jbb.98.224; Kamada N, 2001, APPL MICROBIOL BIOT, V56, P710, DOI 10.1007/s002530100738; Kim P, 2004, APPL ENVIRON MICROB, V70, P1238, DOI 10.1128/AEM.70.2.1238-1241.2004; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kwon YD, 2007, J APPL MICROBIOL, V103, P2340, DOI 10.1111/j.1365-2672.2007.03485.x; Laguna R, 2011, ARCH MICROBIOL, V193, P151, DOI 10.1007/s00203-010-0652-y; Laguna R, 2010, ADV EXP MED BIOL, V675, P265, DOI 10.1007/978-1-4419-1528-3_15; Larimer FW, 2004, NAT BIOTECHNOL, V22, P55, DOI 10.1038/nbt923; Le Naour F, 2001, J BIOL CHEM, V276, P17920, DOI 10.1074/jbc.M100156200; Leegood RC, 2003, ARCH BIOCHEM BIOPHYS, V414, P204, DOI 10.1016/S0003-9861(03)00093-6; Li M, 2010, CURR MICROBIOL, V61, P429, DOI 10.1007/s00284-010-9634-1; Lin Z, 2008, NAT STRUCT MOL BIOL, V15, P303, DOI 10.1038/nsmb.1394; Liu CM, 2010, NATURE, V463, P197, DOI 10.1038/nature08651; Lui Y, 2005, ACTA BIOCH BIOPH SIN, V37, P406, DOI 10.1111/j.1745-7270.2005.00060.x; Lynch HC, 1995, MICROBIOL-UK, V141, P3105, DOI 10.1099/13500872-141-12-3105; Ma WM, 2008, J APPL PHYCOL, V20, P437, DOI 10.1007/s10811-007-9286-0; Ma WM, 2005, J APPL PHYCOL, V17, P273, DOI 10.1007/s10811-005-4850-y; McKinlay JB, 2010, P NATL ACAD SCI USA, V107, P11669, DOI 10.1073/pnas.1006175107; Miyagawa Y, 2001, NAT BIOTECHNOL, V19, P965, DOI 10.1038/nbt1001-965; Mukhopadhyay B, 1999, APPL ENVIRON MICROB, V65, P301; NICOLAS MT, 1989, J HISTOCHEM CYTOCHEM, V37, P663, DOI 10.1177/37.5.2703702; Paoli GC, 1998, J BACTERIOL, V180, P4258, DOI 10.1128/JB.180.16.4258-4269.1998; Romagnoli S, 2006, J BACTERIOL, V188, P2780, DOI 10.1128/JB.188.8.2780-2791.2006; Sasikala C, 1998, ADV MICROB PHYSIOL, V39, P339; Schenk G, 1998, INT J BIOCHEM CELL B, V30, P1297, DOI 10.1016/S1357-2725(98)00095-8; Schocke L, 1997, ARCH MICROBIOL, V167, P289, DOI 10.1007/s002030050446; Seth A, 2000, J BACTERIOL, V182, P919, DOI 10.1128/JB.182.4.919-927.2000; Shruthi H, 2010, J MOL EVOL, V70, P359, DOI 10.1007/s00239-010-9334-2; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Sprenger GA, 1995, ARCH MICROBIOL, V164, P324, DOI 10.1007/BF02529978; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tabita FR, 2007, CELL, V129, P1039, DOI 10.1016/j.cell.2007.06.002; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; Tang YC, 2008, EMBO J, V27, P1458, DOI 10.1038/emboj.2008.77; Teige M, 1998, EUR J BIOCHEM, V252, P237, DOI 10.1046/j.1432-1327.1998.2520237.x; Veitch NJ, 2004, BIOCHEM J, V382, P759, DOI 10.1042/BJ20040459; Wall JD, 2004, NAT BIOTECHNOL, V22, P40, DOI 10.1038/nbt0104-40; Walshaw DL, 1997, FEMS MICROBIOL LETT, V152, P57, DOI 10.1111/j.1574-6968.1997.tb10409.x; Walshaw DL, 1996, MOL MICROBIOL, V21, P1239, DOI 10.1046/j.1365-2958.1996.00078.x; WANG X, 1992, J BACTERIOL, V174, P3607, DOI 10.1128/JB.174.11.3607-3611.1992; Westerhoff HV, 2004, NAT BIOTECHNOL, V22, P1249, DOI 10.1038/nbt1020; Yakandawala N, 2008, APPL MICROBIOL BIOT, V78, P283, DOI 10.1007/s00253-007-1307-z; Yue HB, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.8.e41; Zhang B, 2006, J PROTEOME RES, V5, P2909, DOI 10.1021/pr0600273	74	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28329	10.1371/journal.pone.0028329	http://dx.doi.org/10.1371/journal.pone.0028329			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174789	Green Published, Green Submitted, gold			2022-12-25	WOS:000298163600019
J	Abreu-Rodriguez, I; Silva, RS; Martins, AP; Soveral, G; Toledo-Aral, JJ; Lopez-Barneo, J; Echevarria, M				Abreu-Rodriguez, Irene; Sanchez Silva, Rocio; Martins, Ana Paula; Soveral, Graca; Jose Toledo-Aral, Juan; Lopez-Barneo, Jose; Echevarria, Miriam			Functional and Transcriptional Induction of Aquaporin-1 Gene by Hypoxia; Analysis of Promoter and Role of Hif-1 alpha	PLOS ONE			English	Article							INDUCIBLE FACTOR-I; WATER CHANNEL; HUMAN BRAIN; EXPRESSION; OVEREXPRESSION; ANGIOGENESIS; PERMEABILITY; MECHANISMS; COMPLEX; KINASE	Aquaporin-1 (AQP1) is a water channel that is highly expressed in tissues with rapid O-2 transport. It has been reported that this protein contributes to gas permeation (CO2, NO and O-2) through the plasma membrane. We show that hypoxia increases Aqp1 mRNA and protein levels in tissues, namely mouse brain and lung, and in cultured cells, the 9L glioma cell line. Stopped-flow light-scattering experiments confirmed an increase in the water permeability of 9L cells exposed to hypoxia, supporting the view that hypoxic Aqp1 up-regulation has a functional role. To investigate the molecular mechanisms underlying this regulatory process, transcriptional regulation was studied by transient transfections of mouse endothelial cells with a 1297 bp 5' proximal Aqp1 promoter-luciferase construct. Incubation in hypoxia produced a dose- and time-dependent induction of luciferase activity that was also obtained after treatments with hypoxia mimetics (DMOG and CoCl2) and by overexpressing stabilized mutated forms of HIF-1 alpha. Single mutations or full deletions of the three putative HIF binding domains present in the Aqp1 promoter partially reduced its responsiveness to hypoxia, and transfection with HIf-1 alpha siRNA decreased the in vitro hypoxia induction of Aqp1 mRNA and protein levels. Our results indicate that HIF-1 alpha participates in the hypoxic induction of AQP1. However, we also demonstrate that the activation of Aqp1 promoter by hypoxia is complex and multifactorial and suggest that besides HIF-1 alpha other transcription factors might contribute to this regulatory process. These data provide a conceptual framework to support future research on the involvement of AQP1 in a range of pathophysiological conditions, including edema, tumor growth, and respiratory diseases.	[Abreu-Rodriguez, Irene; Sanchez Silva, Rocio; Jose Toledo-Aral, Juan; Lopez-Barneo, Jose; Echevarria, Miriam] Univ Seville, Inst Biomed Sevilla IBiS, Hosp Univ Virgen Rocio, CSIC,Dept Fisiol Med & Biofis, Seville, Spain; [Martins, Ana Paula; Soveral, Graca] FCT UNL, Dept Quim, REQUIMTE, Caparica, Portugal; [Soveral, Graca] Univ Lisbon, Fac Farm, P-1699 Lisbon, Portugal; [Jose Toledo-Aral, Juan; Lopez-Barneo, Jose] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Universidade de Lisboa; CIBERNED	Abreu-Rodriguez, I (corresponding author), Univ Zurich, Inst Physiol, Zurich, Switzerland.	irusta@us.es	Martins, Ana Paula/A-5657-2013; Toledo-Aral, Juan J/F-2613-2015; IBIS, NEUROBIOLOGIA/O-9922-2015; Soveral, Graça/L-1550-2013; IBIS, TERAPIA CELULA/P-3297-2015; Echevarría, Miriam/E-6682-2010	Martins, Ana Paula/0000-0002-5064-6171; Toledo-Aral, Juan J/0000-0001-7512-7135; Soveral, Graça/0000-0001-8487-110X; Echevarría, Miriam/0000-0002-4758-9428	Instituto de Salud Carlos III [PI PI060511, PS09/00605]; La Junta de Andalucia; Consejeria de Salud [0144, 0192]; Consejeria de Innovacion Ciencia y Empresa [P08-CTS-03574]; Spanish Ministry of Science and Innovation	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); La Junta de Andalucia(Junta de Andalucia); Consejeria de Salud; Consejeria de Innovacion Ciencia y Empresa; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was funded by grants from the "Instituto de Salud Carlos III" PI PI060511 and PS09/00605, and by grants from "La Junta de Andalucia", Consejeria de Salud (exp. # 0144 and # 0192) and Consejeria de Innovacion Ciencia y Empresa (P08-CTS-03574). IAR was supported by a predoctoral fellowship from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badaut J, 2003, ACTA NEUROCHIR SUPPL, V86, P495; Badaut T, 2002, J CEREBR BLOOD F MET, V22, P367, DOI 10.1097/00004647-200204000-00001; Belkacemi L, 2008, LIFE SCI, V82, P1272, DOI 10.1016/j.lfs.2008.04.014; Cummins EP, 2005, PFLUG ARCH EUR J PHY, V450, P363, DOI 10.1007/s00424-005-1413-7; Damert A, 1997, BIOCHEM J, V327, P419, DOI 10.1042/bj3270419; Del Toro R, 2003, J BIOL CHEM, V278, P22316, DOI 10.1074/jbc.M212576200; del Valle-Rodriguez A, 2003, EMBO J, V22, P4337; Ding JY, 2009, NEUROSCI LETT, V453, P68, DOI 10.1016/j.neulet.2009.01.077; Ebert BL, 1998, MOL CELL BIOL, V18, P4089, DOI 10.1128/MCB.18.7.4089; Echevarria M, 2007, J BIOL CHEM, V282, P30207, DOI 10.1074/jbc.M702639200; Finkelstein A, 1987, WATER MOVEMENT LIPID, P166; Han ZQ, 2000, BIOCHEM BIOPH RES CO, V273, P328, DOI 10.1006/bbrc.2000.2944; Hayashi Y, 2007, NEOPLASIA, V9, P777, DOI 10.1593/neo.07454; Herrera M, 2006, HYPERTENSION, V48, P157, DOI 10.1161/01.HYP.0000223652.29338.77; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaneko K, 2008, MICROVASC RES, V75, P297, DOI 10.1016/j.mvr.2007.12.003; Kaur C, 2006, GLIA, V54, P826, DOI 10.1002/glia.20420; Kim JG, 2007, J BIOL CHEM, V282, P14923, DOI 10.1074/jbc.M701411200; Kvietikova I, 1997, KIDNEY INT, V51, P564, DOI 10.1038/ki.1997.80; KVIETIKOVA I, 1995, NUCLEIC ACIDS RES, V23, P4542, DOI 10.1093/nar/23.22.4542; Longatti PL, 2004, PEDIATR NEUROSURG, V40, P277, DOI 10.1159/000083740; Lopez-Barneo J, 2001, ANNU REV PHYSIOL, V63, P259, DOI 10.1146/annurev.physiol.63.1.259; Lopez-Campos JL, 2011, HISTOL HISTOPATHOL, V26, P451, DOI 10.14670/HH-26.451; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Moon C, 2003, ONCOGENE, V22, P6699, DOI 10.1038/sj.onc.1206762; Mou KJ, 2010, J NEURO-ONCOL, V100, P375, DOI 10.1007/s11060-010-0205-x; Munoz-Cabello AM, 2005, J NEUROSCI, V25, P6631, DOI 10.1523/JNEUROSCI.1139-05.2005; Munoz-Cabello AM, 2010, PFLUG ARCH EUR J PHY, V459, P775, DOI 10.1007/s00424-009-0774-8; Musa-Aziz R, 2009, P NATL ACAD SCI USA, V106, P5406, DOI 10.1073/pnas.0813231106; Nakhoul NL, 1998, AM J PHYSIOL-CELL PH, V274, pC543, DOI 10.1152/ajpcell.1998.274.2.C543; Nesic O, 2008, J NEUROCHEM, V105, P628, DOI 10.1111/j.1471-4159.2007.05177.x; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; Oshio K, 2005, NEUROSURGERY, V56, P375, DOI 10.1227/01.NEU.0000148904.57841.6B; Papadopoulos MC, 2004, NEUROSCIENCE, V129, P1011, DOI 10.1016/j.neuroscience.2004.05.044; Saadoun S, 2002, BRIT J CANCER, V87, P621, DOI 10.1038/sj.bjc.6600512; Semenza G L, 2000, Respir Res, V1, P159, DOI 10.1186/rr27; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Toledo-Aral JJ, 2003, J NEUROSCI, V23, P141; Vacca A, 2001, BRIT J HAEMATOL, V113, P415, DOI 10.1046/j.1365-2141.2001.02738.x; VANHEESWIJK MPE, 1986, J MEMBRANE BIOL, V92, P183, DOI 10.1007/BF01870707; Verkman AS, 2005, J CELL SCI, V118, P3225, DOI 10.1242/jcs.02519; Wanner RM, 2000, BLOOD, V96, P1558, DOI 10.1182/blood.V96.4.1558.h8001558_1558_1565; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Yamamoto N, 2001, MOL BRAIN RES, V90, P26, DOI 10.1016/S0169-328X(01)00064-X; Yamashita K, 2001, J BIOL CHEM, V276, P12645, DOI 10.1074/jbc.M011344200; Yatsushige H, 2007, J NEUROSCI RES, V85, P1436, DOI 10.1002/jnr.21281	48	58	64	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28385	10.1371/journal.pone.0028385	http://dx.doi.org/10.1371/journal.pone.0028385			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22174795	Green Published, gold, Green Submitted			2022-12-25	WOS:000298161900036
J	Maity, B; Stewart, A; Yang, JQ; Loo, L; Sheff, D; Shepherd, AJ; Mohapatra, DP; Fisher, RA				Maity, Biswanath; Stewart, Adele; Yang, Jianqi; Loo, Lipin; Sheff, David; Shepherd, Andrew J.; Mohapatra, Durga P.; Fisher, Rory A.			Regulator of G Protein Signaling 6 (RGS6) Protein Ensures Coordination of Motor Movement by Modulating GABA(B) Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBELLAR GRANULE CELLS; GTPASE-ACTIVATING PROTEINS; GIRK CHANNELS; MICE LACKING; BEHAVIORAL CHARACTERIZATION; GATING KINETICS; MOUSE MODEL; GGL DOMAIN; INHIBITION; EXPRESSION	gamma-Aminobutyric acid (GABA) release from inhibitory interneurons located within the cerebellar cortex limits the extent of neuronal excitation in part through activation of metabotropic GABA(B) receptors. Stimulation of these receptors triggers a number of downstream signaling events, including activation of GIRK channels by the G beta gamma dimer resulting in membrane hyperpolarization and inhibition of neurotransmitter release from presynaptic sites. Here, we identify RGS6, a member of the R7 subfamily of RGS proteins, as a key regulator of GABA(B)R signaling in cerebellum. RGS6 is enriched in the granule cell layer of the cerebellum along with neuronal GIRK channel subunits 1 and 2 where RGS6 forms a complex with known binding partners G beta(5) and R7BP. Mice lacking RGS6 exhibit abnormal gait and ataxia characterized by impaired rotarod performance improved by treatment with a GABA(B)R antagonist. RGS6(-/-) mice administered baclofen also showed exaggerated motor coordination deficits compared with their wild-type counterparts. Isolated cerebellar neurons natively expressed RGS6, GABA(B)R, and GIRK channel subunits, and cerebellar granule neurons from RGS6(-/-) mice showed a significant delay in the deactivation kinetics of baclofen-induced GIRK channel currents. These results establish RGS6 as a key component of GABABR signaling and represent the first demonstration of an essential role for modulatory actions of RGS proteins in adult cerebellum. Dysregulation of RGS6 expression in human patients could potentially contribute to loss of motor coordination and, thus, pharmacological manipulation of RGS6 levels might represent a viable means to treat patients with ataxias of cerebellar origin.	[Maity, Biswanath; Stewart, Adele; Yang, Jianqi; Loo, Lipin; Sheff, David; Shepherd, Andrew J.; Mohapatra, Durga P.; Fisher, Rory A.] Univ Iowa, Dept Pharmacol, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa	Fisher, RA (corresponding author), Univ Iowa, Dept Pharmacol, Carver Coll Med, Iowa City, IA 52242 USA.	rory-fisher@uiowa.edu	Mohapatra, Durga/M-2133-2017	Mohapatra, Durga/0000-0001-5016-1281; Fisher, Rory/0000-0003-3108-4836; Stewart, Adele/0000-0003-4968-2471; Maity, Biswanath/0000-0002-3239-3764; Loo, Lipin/0000-0002-4112-1816; Shepherd, Andrew/0000-0002-8440-6192	National Institutes of Health [GM075033-02]; American Recovery & Reinvestment Act (ARRA) [GM075033-03S1, NS069898]; University of Iowa; University of Iowa Graduate College; Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069898] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery & Reinvestment Act (ARRA); University of Iowa; University of Iowa Graduate College; Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM075033-02 and American Recovery & Reinvestment Act (ARRA) grant GM075033-03S1 (to R. A. F.) and NS069898 (to D. P. M.). This work was also supported by a University of Iowa Carver Collaborative Pilot Grant (to R. A. F. and D. P. M.).; A recipient of the Presidential Fellowship from the University of Iowa Graduate College and a Pre-Doctoral Fellowship in Pharmacology/Toxicology from the Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation.	Anderson GR, 2010, NEUROPSYCHOPHARMACOL, V35, P1040, DOI 10.1038/npp.2009.212; Anderson GR, 2009, CELL BIOCHEM BIOPHYS, V54, P33, DOI 10.1007/s12013-009-9052-9; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Blundell J, 2008, BRAIN RES, V1190, P78, DOI 10.1016/j.brainres.2007.11.017; Boy J, 2009, HUM MOL GENET, V18, P4282, DOI 10.1093/hmg/ddp381; Cendelin J, 2010, BEHAV BRAIN RES, V210, P8, DOI 10.1016/j.bbr.2010.01.035; Chatterjee TK, 2003, J BIOL CHEM, V278, P30261, DOI 10.1074/jbc.M212687200; Chen CK, 2003, P NATL ACAD SCI USA, V100, P6604, DOI 10.1073/pnas.0631825100; Chiu CS, 2005, J NEUROSCI, V25, P3234, DOI 10.1523/JNEUROSCI.3364-04.2005; Ciruela F, 2010, EUR J NEUROSCI, V32, P1265, DOI 10.1111/j.1460-9568.2010.07356.x; De Zeeuw CI, 2011, NAT REV NEUROSCI, V12, P327, DOI 10.1038/nrn3011; Doupnik CA, 1996, NEUROPHARMACOLOGY, V35, P923, DOI 10.1016/0028-3908(96)00125-6; Doupnik CA, 1997, P NATL ACAD SCI USA, V94, P10461, DOI 10.1073/pnas.94.19.10461; Drenan RM, 2005, J CELL BIOL, V169, P623, DOI 10.1083/jcb.200502007; Gold SJ, 2007, J NEUROSCI, V27, P14338, DOI 10.1523/JNEUROSCI.4223-07.2007; HOSFORD DA, 1995, J PHARMACOL EXP THER, V274, P1399; Jacobson LH, 2005, PSYCHOPHARMACOLOGY, V179, P688, DOI 10.1007/s00213-004-2086-1; Kovoor A, 2000, J BIOL CHEM, V275, P3397, DOI 10.1074/jbc.275.5.3397; Kovoor A, 2005, J NEUROSCI, V25, P2157, DOI 10.1523/JNEUROSCI.2840-04.2005; Labouebe G, 2007, NAT NEUROSCI, V10, P1559, DOI 10.1038/nn2006; Lalonde R, 2007, BRAIN RES, V1140, P51, DOI 10.1016/j.brainres.2006.01.031; Lambert NA, 2010, P NATL ACAD SCI USA, V107, P7066, DOI 10.1073/pnas.0912934107; Liao YJ, 1996, J NEUROSCI, V16, P7137; Maity B, 2011, J BIOL CHEM, V286, P1409, DOI 10.1074/jbc.M110.186700; Manto M, 2009, CURR OPIN NEUROL, V22, P419, DOI 10.1097/WCO.0b013e32832b9897; Mapelli L, 2009, J NEUROPHYSIOL, V101, P3089, DOI 10.1152/jn.91190.2008; Martemyanov KA, 2005, J BIOL CHEM, V280, P5133, DOI 10.1074/jbc.C400596200; Oliver PL, 2007, BEHAV BRAIN RES, V181, P239, DOI 10.1016/j.bbr.2007.04.012; Perkins EM, 2010, J NEUROSCI, V30, P4857, DOI 10.1523/JNEUROSCI.6065-09.2010; Pinard A, 2010, ADV PHARMACOL, V58, P231, DOI 10.1016/S1054-3589(10)58010-4; Posokhova E, 2010, CIRC RES, V107, P1350, DOI 10.1161/CIRCRESAHA.110.224212; Pravetoni M, 2008, GENES BRAIN BEHAV, V7, P523, DOI 10.1111/j.1601-183X.2008.00388.x; Rahman Z, 2003, NEURON, V38, P941, DOI 10.1016/S0896-6273(03)00321-0; Rossi DJ, 2003, J PHYSIOL-LONDON, V548, P97, DOI 10.1113/jphysiol.2002.036459; Rossi P, 2006, EUR J NEUROSCI, V24, P419, DOI 10.1111/j.1460-9568.2006.04914.x; Saitoh O, 2003, CEREBELLUM, V2, P154, DOI 10.1080/14734220309409; Saitoh O, 2003, BIOCHEM BIOPH RES CO, V309, P836, DOI 10.1016/j.bbrc.2003.08.083; Slesinger PA, 1997, P NATL ACAD SCI USA, V94, P12210, DOI 10.1073/pnas.94.22.12210; Snow BE, 1999, P NATL ACAD SCI USA, V96, P6489, DOI 10.1073/pnas.96.11.6489; Sodickson DL, 1996, J NEUROSCI, V16, P6374; Vigot R, 1997, NEUROSCI RES, V29, P151, DOI 10.1016/S0168-0102(97)00087-4; Watanabe D, 1998, CELL, V95, P17, DOI 10.1016/S0092-8674(00)81779-1; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Xie G, 2010, J BIOL CHEM, V285, P32160, DOI 10.1074/jbc.M110.153676; Xie KQ, 2012, PSYCHOPHARMACOLOGY, V219, P823, DOI 10.1007/s00213-011-2409-y; Xie KQ, 2010, NAT NEUROSCI, V13, P661, DOI 10.1038/nn.2549; Yamamoto M, 2003, J NEUROSCI, V23, P6759; Yang JQ, 2010, CIRC RES, V107, P1345, DOI 10.1161/CIRCRESAHA.110.224220; Zhang JH, 2011, J NEUROCHEM, V119, P544, DOI 10.1111/j.1471-4159.2011.07457.x	49	34	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4972	4981		10.1074/jbc.M111.297218	http://dx.doi.org/10.1074/jbc.M111.297218			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22179605	hybrid, Green Published			2022-12-25	WOS:000300608500057
J	Hwang, ES; Brodsky, B				Hwang, Eileen S.; Brodsky, Barbara			Folding Delay and Structural Perturbations Caused by Type IV Collagen Natural Interruptions and Nearby Gly Missense Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYSTROPHIC EPIDERMOLYSIS-BULLOSA; REPEATING TRIPEPTIDE PATTERN; BASEMENT-MEMBRANE COLLAGEN; TRIPLE-HELIX; HEREDITARY NEPHRITIS; MOLECULAR-STRUCTURE; ANCHORING FIBRILS; PROCOLLAGEN-IV; CHAIN; PEPTIDE	The standard collagen triple helix requires Gly as every third residue in the amino acid sequence, yet all nonfibrillar collagens contain sites where this repeating pattern is interrupted. To explore the effects of such natural interruptions on the triple helix, a 4- or 15-residue sequence from human basement membrane type IV collagen was introduced between (Gly-Xaa-Yaa)(n) domains within a recombinant bacterial collagen. The interruptions had little effect on melting temperature, consistent with the high thermal stability reported for nonfibrillar collagens. Although the 4-residue interruption cannot be accommodated within a standard triple helix, trypsin and thermolysin resistance indicated a tightly packed structure. Central residues of the 15-residue interruption were protease-susceptible, whereas residues near the (Gly-Xaa-Yaa)(n) boundary were resistant, supporting a transition from an alternate conformation to a well packed triple helix. Both interruptions led to a delay in triple-helix folding, with the 15-residue interruption causing slower folding than the 4-residue interruption. These results suggest that propagation through interruptions represents a slow folding step. To clarify the relation between natural interruptions and pathological mutations, a Gly to Ser missense mutation was placed three triplets away from the 4-residue interruption. As a result of this mutation, the 4-residue interruption and nearby triple helix became susceptible to protease digestion, and an additional folding delay was observed. Because Gly missense mutations that cause disease are often located near natural interruptions, structural and folding perturbations arising from such proximity could be a factor in collagen genetic diseases.	[Brodsky, Barbara] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Hwang, Eileen S.; Brodsky, Barbara] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Tufts University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Brodsky, B (corresponding author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.	barbara.brodsky@tufts.edu		Hwang, Eileen/0000-0003-0161-6977	National Institutes of Health [GM60048, DK089630]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK089630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060048] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM60048 (to B. B.). This work was also supported by National Institutes of Health F30 Fellowship DK089630 (to E. S. H.).	BABEL W, 1984, EUR J BIOCHEM, V143, P545, DOI 10.1111/j.1432-1033.1984.tb08404.x; BACHINGER HP, 1982, J BIOL CHEM, V257, P4590; BACHINGER HP, 1990, J BIOL CHEM, V265, P10095; BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; Bella J, 2006, J MOL BIOL, V362, P298, DOI 10.1016/j.jmb.2006.07.014; Bruckner-Tuderman L, 1999, MATRIX BIOL, V18, P43, DOI 10.1016/S0945-053X(98)00007-9; Bruckner-Tuderman L, 2010, DERMATOL CLIN, V28, P107, DOI 10.1016/j.det.2009.10.020; Byers P, 2002, CONNECTIVE TISSUE IT, P385, DOI DOI 10.1002/0471221929.CH8; Cheng HM, 2011, J BIOL CHEM, V286, P2041, DOI 10.1074/jbc.M110.153965; Crockett DK, 2010, HUM MUTAT, V31, pE1652, DOI 10.1002/humu.21312; DAVIS JM, 1989, J BIOL CHEM, V264, P8956; DEHM P, 1978, J BIOL CHEM, V253, P6680; DOLZ R, 1988, EUR J BIOCHEM, V178, P357, DOI 10.1111/j.1432-1033.1988.tb14458.x; Fahnestock S R, 2000, J Biotechnol, V74, P105, DOI 10.1016/S1389-0352(00)00008-8; Feng YB, 1996, BIOPOLYMERS, V39, P859, DOI 10.1002/(SICI)1097-0282(199612)39:6<859::AID-BIP10>3.3.CO;2-Z; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, DOI DOI 10.1385/1592598900; GRANT ME, 1972, J BIOL CHEM, V247, P3539; Grant ME, 2002, COLLAGEN FAMILY STRU, P159, DOI DOI 10.1002/0471221929.CH2; HARRINGT.WF, 1970, BIOCHEMISTRY-US, V9, P3714, DOI 10.1021/bi00821a010; HOFMANN H, 1984, J MOL BIOL, V172, P325, DOI 10.1016/S0022-2836(84)80029-7; HUDSON BG, 1993, J BIOL CHEM, V268, P26033; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Hwang ES, 2010, PROTEIN SCI, V19, P1053, DOI 10.1002/pro.383; Kobayashi T, 2010, BIOMED RES-TOKYO, V31, P371, DOI 10.2220/biomedres.31.371; Li YJ, 2007, J BIOL CHEM, V282, P22699, DOI 10.1074/jbc.M702910200; LONG CG, 1995, BIOPOLYMERS, V35, P621, DOI 10.1002/bip.360350608; LUNSTRUM GP, 1988, J BIOL CHEM, V263, P18318; MACWRIGHT RS, 1983, BIOCHEMISTRY-US, V22, P4940, DOI 10.1021/bi00290a010; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; Marutani T, 2004, J CELL SCI, V117, P5913, DOI 10.1242/jcs.01514; MCCOY RC, 1982, KIDNEY INT, V21, P642, DOI 10.1038/ki.1982.72; Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200; Mohs A, 2006, J BIOL CHEM, V281, P17197, DOI 10.1074/jbc.M601763200; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; NAKANISHI K, 1994, KIDNEY INT, V46, P1413, DOI 10.1038/ki.1994.413; Persikov AV, 2004, PROTEIN SCI, V13, P893, DOI 10.1110/ps.03501704; Ricard-Blum S, 2005, PATHOL BIOL, V53, P430, DOI 10.1016/j.patbio.2004.12.024; RICH A, 1961, J MOL BIOL, V3, P483, DOI 10.1016/S0022-2836(61)80016-8; SCHMID TM, 1984, BIOCHEMISTRY-US, V23, P553, DOI 10.1021/bi00298a024; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; SPIRO RG, 1969, J BIOL CHEM, V244, P2049; Thiagranjan G, 2008, J MOL BIOL, V376, P736, DOI 10.1016/j.jmb.2007.11.075; WELGUS HG, 1990, J BIOL CHEM, V265, P13521; Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200; Yoshizumi A, 2009, PROTEIN SCI, V18, P1241, DOI 10.1002/pro.134; Yu ZX, 2010, PROTEIN SCI, V19, P775, DOI 10.1002/pro.356; YURCHENCO PD, 1988, AM J PATHOL, V132, P278	47	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4368	4375		10.1074/jbc.M111.269084	http://dx.doi.org/10.1074/jbc.M111.269084			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22179614	hybrid, Green Published			2022-12-25	WOS:000300410900067
J	Valvezan, AJ; Zhang, F; Diehl, JA; Klein, PS				Valvezan, Alexander J.; Zhang, Fang; Diehl, J. Alan; Klein, Peter S.			Adenomatous Polyposis Coli (APC) Regulates Multiple Signaling Pathways by Enhancing Glycogen Synthase Kinase-3 (GSK-3) Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEIN; BETA-CATENIN; WNT/BETA-CATENIN; NEURONAL POLARITY; NEGATIVE REGULATOR; AXIN; WNT; PHOSPHORYLATION; CANCER; ACTIVATION	Glycogen synthase kinase-3 (GSK-3) is essential for many signaling pathways and cellular processes. As Adenomatous Polyposis Coli (APC) functions in many of the same processes, we investigated a role for APC in the regulation of GSK-3-dependent signaling. We find that APC directly enhances GSK-3 activity. Furthermore, knockdown of APC mimics inhibition of GSK-3 by reducing phosphorylation of glycogen synthase and by activating mTOR, revealing novel roles for APC in the regulation of these enzymes. Wnt signaling inhibits GSK-3 through an unknown mechanism, and this results in both stabilization of beta-catenin and activation of mTOR. We therefore hypothesized that Wnts may regulate GSK-3 by disrupting the interaction between APC and the Axin-GSK-3 complex. We find that Wnts rapidly induce APC dissociation from Axin, correlating with beta-catenin stabilization. Furthermore, Axin interaction with the Wnt co-receptor LRP6 causes APC dissociation from Axin. We propose that APC regulates multiple signaling pathways by enhancing GSK-3 activity, and that Wnts induce APC dissociation from Axin to reduce GSK-3 activity and activate downstream signaling. APC regulation of GSK-3 also provides a novel mechanism for Wnt regulation of multiple downstream effectors, including beta-catenin and mTOR.	[Valvezan, Alexander J.; Klein, Peter S.] Univ Penn, Sch Med, Cell & Mol Biol Grad Grp, Philadelphia, PA 19104 USA; [Zhang, Fang; Klein, Peter S.] Univ Penn, Sch Med, Pharmacol Grad Grp, Philadelphia, PA 19104 USA; [Zhang, Fang; Diehl, J. Alan] Univ Penn, Sch Med, Dept Canc Biol, Leonard & Madlyn Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Zhang, Fang; Diehl, J. Alan] Univ Penn, Sch Med, Ctr Canc, Philadelphia, PA 19104 USA; [Klein, Peter S.] Univ Penn, Sch Med, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania	Klein, PS (corresponding author), 364 Clin Res Bldg,415 Curie Blvd, Philadelphia, PA 19104 USA.	pklein@mail.med.upenn.edu			NIMH [1R01MH58324]; NHLBI, National Institutes of Health [1R01HL110806-01]; Training Program in Neuropsychopharmacology [T32 MH14654-33]; NATIONAL CANCER INSTITUTE [R01CA093237] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058324, T32MH014654] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Training Program in Neuropsychopharmacology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by Grant 1R01MH58324 from the NIMH and 1R01HL110806-01 from the NHLBI, National Institutes of Health.; Supported by the Training Program in Neuropsychopharmacology (T32 MH14654-33).	Ahmad I, 2011, ONCOGENE, V30, P178, DOI 10.1038/onc.2010.399; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Brady MJ, 2001, RECENT PROG HORM RES, V56, P157, DOI 10.1210/rp.56.1.157; Caldwell CM, 2009, ADV EXP MED BIOL, V656, P51, DOI 10.1007/978-1-4419-1145-2_5; Chen HJ, 2006, GENE DEV, V20, P1933, DOI 10.1101/gad.1411206; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cook D, 1996, EMBO J, V15, P4526, DOI 10.1002/j.1460-2075.1996.tb00830.x; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cselenyi CS, 2008, P NATL ACAD SCI USA, V105, P8032, DOI 10.1073/pnas.0803025105; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Forde JE, 2007, CELL MOL LIFE SCI, V64, P1930, DOI 10.1007/s00018-007-7045-7; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; Fujishita T, 2008, P NATL ACAD SCI USA, V105, P13544, DOI 10.1073/pnas.0800041105; Fukuda T, 2010, DIFFERENTIATION, V80, P46, DOI 10.1016/j.diff.2010.05.002; Gartner A, 2006, J CELL SCI, V119, P3927, DOI 10.1242/jcs.03159; GREENBERG SG, 1992, J BIOL CHEM, V267, P564; Guo X, 2008, GENE DEV, V22, P106, DOI 10.1101/gad.1590908; Hanson CA, 2005, GENE, V361, P1, DOI 10.1016/j.gene.2005.07.024; Hedgepeth CM, 1999, MOL CELL BIOL, V19, P7147; Hernandez F, 2009, BRAIN RES BULL, V80, P248, DOI 10.1016/j.brainresbull.2009.05.017; Hinoi T, 2000, J BIOL CHEM, V275, P34399, DOI 10.1074/jbc.M003997200; Huang J, 2009, J CLIN INVEST, V119, P3519, DOI 10.1172/JCI40572; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Jope RS, 2006, CURR DRUG TARGETS, V7, P1421, DOI 10.2174/1389450110607011421; Kawahara K, 2000, J BIOL CHEM, V275, P8369, DOI 10.1074/jbc.275.12.8369; Kishida S, 1998, J BIOL CHEM, V273, P10823, DOI 10.1074/jbc.273.18.10823; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kockeritz L, 2006, CURR DRUG TARGETS, V7, P1377, DOI 10.2174/1389450110607011377; Koehl GE, 2010, ONCOGENE, V29, P1553, DOI 10.1038/onc.2009.435; Kofron M, 2001, DEV BIOL, V237, P183, DOI 10.1006/dbio.2001.0371; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Luo J, 2009, CANCER LETT, V273, P194, DOI 10.1016/j.canlet.2008.05.045; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Miclea RL, 2011, EXP CELL RES, V317, P1411, DOI 10.1016/j.yexcr.2011.03.007; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; Park KS, 2006, J CELL SCI, V119, P819, DOI 10.1242/jcs.02779; Paul S, 2008, NEOPLASMA, V55, P165; Peterson-Nedry W, 2008, DEV BIOL, V320, P226, DOI 10.1016/j.ydbio.2008.05.521; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Piao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004046; Salahshor S, 2005, J CLIN PATHOL, V58, P225, DOI 10.1136/jcp.2003.009506; Schneikert J, 2006, INT J CANCER, V119, P74, DOI 10.1002/ijc.21826; Shi SH, 2004, CURR BIOL, V14, P2025, DOI 10.1016/j.cub.2004.11.009; SMITH KJ, 1994, CANCER RES, V54, P3672; Su YY, 2008, MOL CELL, V32, P652, DOI 10.1016/j.molcel.2008.10.023; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tolwinski NS, 2003, DEV CELL, V4, P407, DOI 10.1016/S1534-5807(03)00063-7; von Kries JP, 2000, NAT STRUCT BIOL, V7, P800; Wakefield JG, 2003, J CELL SCI, V116, P637, DOI 10.1242/jcs.00273; Wang Q, 2006, ONCOGENE, V25, P43, DOI 10.1038/sj.onc.1209004; Wang Y, 2008, MOL BIOL CELL, V19, P4076, DOI 10.1091/mbc.E07-12-1296; Wu G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004926; Xu LF, 2000, GENE DEV, V14, P585; Yamazaki H, 2003, BIOCHEM BIOPH RES CO, V304, P229, DOI 10.1016/S0006-291X(03)00582-5; Yang J, 2006, J BIOL CHEM, V281, P17751, DOI 10.1074/jbc.M600831200; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	66	62	64	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3823	3832		10.1074/jbc.M111.323337	http://dx.doi.org/10.1074/jbc.M111.323337			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22184111	Green Published, hybrid			2022-12-25	WOS:000300410900019
J	Lone, SR; Sharma, VK				Lone, Shahnaz Rahman; Sharma, Vijay Kumar			Circadian Consequence of Socio-Sexual Interactions in Fruit Flies Drosophila melanogaster	PLOS ONE			English	Article							LOCOMOTOR-ACTIVITY RHYTHM; MATERNAL ENTRAINMENT; COURTSHIP BEHAVIOR; SOCIAL EXPERIENCE; CLOCK MUTANTS; NEURONS; PLASTICITY; SLEEP; FLY; HOMEOSTASIS	In fruit flies Drosophila melanogaster, courtship is an elaborate ritual comprising chasing, dancing and singing by males to lure females for mating. Courtship interactions peak in the night and heterosexual couples display enhanced nighttime activity. What we do not know is if such socio-sexual interactions (SSI) leave long-lasting after-effects on circadian clock(s). Here we report the results of our study aimed at examining the after-effects of SSI (as a result of co-habitation of males and females in groups) between males and females on their circadian locomotor activity rhythm. Males undergo reduction in the evening activity peak and lengthening of circadian period, while females show a decrease in overall activity. Such aftereffects, at least in males, require functional circadian clocks during SSI as loss-of-function clock mutants and wild type flies interacting under continuous light (LL), do not display them. Interestingly, males with electrically silenced Pigment Dispersing Factor (PDF)-positive ventral lateral (LNv) clock neurons continue to show SSI mediated reduction in evening activity peak, suggesting that the LNv clock neurons are dispensable for SSI mediated after-effects on locomotor activity rhythm. Such after-effects in females may not be clock-dependent because clock manipulated females with prior exposure to males show decrease in overall activity, more or less similar to rhythmic wild type females. The expression of SSI mediated after-effects requires a functional olfactory system in males because males with compromised olfactory ability do not display them. These results suggest that SSI causes male-specific, long-lasting changes in the circadian clocks of Drosophila, which requires the presence of functional clocks and intact olfactory ability in males.	[Lone, Shahnaz Rahman; Sharma, Vijay Kumar] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Chronobiol Lab, Evolutionary & Organismal Biol Unit, Bangalore 560012, Karnataka, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	Lone, SR (corresponding author), Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Chronobiol Lab, Evolutionary & Organismal Biol Unit, Bangalore 560012, Karnataka, India.	vsharma@jncasr.ac.in	Lone, Shahnaz/AAM-5036-2021	Lone, shahnaz Rahman/0000-0003-0732-7068				Barnes AI, 2008, P ROY SOC B-BIOL SCI, V275, P1675, DOI 10.1098/rspb.2008.0139; Barth M, 1997, J NEUROSCI, V17, P1493; Bushey D, 2011, SCIENCE, V332, P1576, DOI 10.1126/science.1202839; Caldelas I, 2007, NEUROSCIENCE, V144, P395, DOI 10.1016/j.neuroscience.2006.09.020; Donlea JM, 2009, SCIENCE, V324, P105, DOI 10.1126/science.1166657; Duffield GE, 1998, J BIOL RHYTHM, V13, P315, DOI 10.1177/074873098129000156; Dunlap J.C., 2004, CHRONOBIOLOGY BIOL T; Fujii S, 2007, CURR BIOL, V17, P244, DOI 10.1016/j.cub.2006.11.049; Gilestro GF, 2009, SCIENCE, V324, P109, DOI 10.1126/science.1166673; Gillott C, 2003, ANNU REV ENTOMOL, V48, P163, DOI 10.1146/annurev.ento.48.091801.112657; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; GWINNER E, 1966, CELL MOL LIFE SCI, V22, P765; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Hamasaka Y, 2010, GENES CELLS, V15, P1240, DOI 10.1111/j.1365-2443.2010.01456.x; HARDELAND R, 1972, ANIM BEHAV, V20, P170, DOI 10.1016/S0003-3472(72)80188-X; HEISENBERG M, 1995, J NEUROSCI, V15, P1951, DOI 10.1523/JNEUROSCI.15-03-01951.1995; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; KONOPKA RJ, 1989, J NEUROGENET, V6, P1, DOI 10.3109/01677068909107096; Krishnan P, 2005, METHOD ENZYMOL, V393, P495, DOI 10.1016/S0076-6879(05)93025-5; Krupp JJ, 2008, CURR BIOL, V18, P1373, DOI 10.1016/j.cub.2008.07.089; Kubli E, 2003, CELL MOL LIFE SCI, V60, P1689, DOI 10.1007/s00018-003-3052; KYRIACOU CP, 1980, P NATL ACAD SCI-BIOL, V77, P6729, DOI 10.1073/pnas.77.11.6729; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Levine JD, 2002, SCIENCE, V298, P2010, DOI 10.1126/science.1076008; LOHER W, 1979, Z ANGEW ENTOMOL, V88, P425; Lone SR, 2011, J EXP BIOL, V214, P3742, DOI 10.1242/jeb.057554; Lone SR, 2011, CHRONOBIOL INT, V28, P497, DOI 10.3109/07420528.2011.591018; LONE SR, 2012, J BIOL RHYT IN PRESS; MARIMUTHU G, 1981, BEHAV ECOL SOCIOBIOL, V8, P147, DOI 10.1007/BF00300827; MARIMUTHU G, 1983, NATURWISSENSCHAFTEN, V70, P620, DOI 10.1007/BF00377411; MENAKER M, 1966, SCIENCE, V154, P1579, DOI 10.1126/science.154.3756.1579; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Sakai T, 2001, P NATL ACAD SCI USA, V98, P9221, DOI 10.1073/pnas.151443298; Saunders DS, 2002, INSECT CLOCKS; StatSoft, 1995, STAT, V1; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; VISWANATHAN N, 1985, NATURE, V317, P530, DOI 10.1038/317530a0; Viswanathan N, 1999, PHYSIOL BEHAV, V68, P157, DOI 10.1016/S0031-9384(99)00157-2; Yapici N, 2008, NATURE, V451, P33, DOI 10.1038/nature06483	41	10	11	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e28336	10.1371/journal.pone.0028336	http://dx.doi.org/10.1371/journal.pone.0028336			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22194827	gold, Green Published, Green Submitted			2022-12-25	WOS:000298370400013
J	Abe, T; Tokuda, Y; Cook, EF				Abe, Toshikazu; Tokuda, Yasuharu; Cook, E. Francis			Time-Based Partitioning Model for Predicting Neurologically Favorable Outcome among Adults with Witnessed Bystander Out-of-Hospital CPA	PLOS ONE			English	Article							AMERICAN-HEART-ASSOCIATION; AUSTRALIAN-RESUSCITATION-COUNCIL; EMERGENCY CARDIOVASCULAR CARE; CARDIOPULMONARY-RESUSCITATION; CARDIAC-ARREST; VENTRICULAR-FIBRILLATION; STROKE-FOUNDATION; CHEST COMPRESSION; TASK-FORCE; DEFIBRILLATION	Background: Optimal acceptable time intervals from collapse to bystander cardiopulmonary resuscitation (CPR) for neurologically favorable outcome among adults with witnessed out-of-hospital cardiopulmonary arrest (CPA) have been unclear. Our aim was to assess the optimal acceptable thresholds of the time intervals of CPR for neurologically favorable outcome and survival using a recursive partitioning model. Methods and Findings: From January 1, 2005 through December 31, 2009, we conducted a prospective population-based observational study across Japan involving consecutive out-of-hospital CPA patients (N = 69,648) who received a witnessed bystander CPR. Of 69,648 patients, 34,605 were assigned to the derivation data set and 35,043 to the validation data set. Time factors associated with better outcomes: the better outcomes were survival and neurologically favorable outcome at one month, defined as category one (good cerebral performance) or two (moderate cerebral disability) of the cerebral performance categories. Based on the recursive partitioning model from the derivation dataset (n = 34,605) to predict the neurologically favorable outcome at one month, 5 min threshold was the acceptable time interval from collapse to CPR initiation; 11 min from collapse to ambulance arrival; 18 min from collapse to return of spontaneous circulation (ROSC); and 19 min from collapse to hospital arrival. Among the validation dataset (n = 35,043), 209/2,292 (9.1%) in all patients with the acceptable time intervals and 1,388/2,706 (52.1%) in the subgroup with the acceptable time intervals and pre-hospital ROSC showed neurologically favorable outcome. Conclusions: Initiation of CPR should be within 5 min for obtaining neurologically favorable outcome among adults with witnessed out-of-hospital CPA. Patients with the acceptable time intervals of bystander CPR and pre-hospital ROSC within 18 min could have 50% chance of neurologically favorable outcome.	[Abe, Toshikazu] Univ Tsukuba, Mito Kyodo Gen Hosp, Dept Emergency Med, Mito, Ibaraki, Japan; [Tokuda, Yasuharu] Univ Tsukuba, Inst Clin Med, Grad Sch Comprehens Human Sci, Mito, Ibaraki, Japan; [Cook, E. Francis] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	University of Tsukuba; University of Tsukuba; Harvard University; Harvard T.H. Chan School of Public Health	Abe, T (corresponding author), Univ Tsukuba, Mito Kyodo Gen Hosp, Dept Emergency Med, Mito, Ibaraki, Japan.	mican-philia@sunny.ocn.ne.jp	Abe, Toshikazu/ABH-1639-2021		St. Luke's Life Science Institute, Japan	St. Luke's Life Science Institute, Japan	The authors are supported by St. Luke's Life Science Institute Research grant, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abe T, 2009, RESUSCITATION, V80, P431, DOI 10.1016/j.resuscitation.2008.12.010; Berg RA, 2003, ANN EMERG MED, V42, P458, DOI 10.1067/S0196-0644(03)00525-0; Berg RA, 2010, CIRCULATION, V122, pS685, DOI 10.1161/CIRCULATIONAHA.110.970939; Chan PS, 2010, JAMA-J AM MED ASSOC, V304, P2129, DOI 10.1001/jama.2010.1576; Cobb LA, 1999, JAMA-J AM MED ASSOC, V281, P1182, DOI 10.1001/jama.281.13.1182; CULLEY LL, 1991, ANN EMERG MED, V20, P362, DOI 10.1016/S0196-0644(05)81655-5; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; Field JM, 2010, CIRCULATION, V122, pS640, DOI 10.1161/CIRCULATIONAHA.110.970889; Jacobs I, 2004, RESUSCITATION, V63, P233, DOI 10.1016/j.resuscitation.2004.09.008; Koike S, 2011, CRIT CARE, V15, DOI 10.1186/cc10219; *MIN ED CULT S SCI, 2006, GUID EP STUD; Nagao K, 2007, LANCET, V369, P920; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Ogawa T, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7106; Shewry M. C., 1987, J APPL STAT, V14, P165, DOI DOI 10.1080/02664768700000020; van Alem AP, 2003, ANN EMERG MED, V42, P449, DOI 10.1067/S0196-0644(03)00383-4; *WHO, 1981, PLANN ORG EM MED SER; Wik L, 2003, JAMA-J AM MED ASSOC, V289, P1389, DOI 10.1001/jama.289.11.1389	18	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28581	10.1371/journal.pone.0028581	http://dx.doi.org/10.1371/journal.pone.0028581			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194860	Green Published, Green Submitted, gold			2022-12-25	WOS:000298369100057
J	Bauer, EM; Zheng, H; Comhair, S; Erzurum, S; Billiar, TR; Bauer, PM				Bauer, Eileen M.; Zheng, Han; Comhair, Suzy; Erzurum, Serpil; Billiar, Timothy R.; Bauer, Philip M.			Complement C3 Deficiency Attenuates Chronic Hypoxia-Induced Pulmonary Hypertension in Mice	PLOS ONE			English	Article							MUSCLE-CELL-PROLIFERATION; TISSUE FACTOR; SMOOTH-MUSCLE; ENDOTHELIAL-CELLS; THROMBOXANE; ACTIVATION; MURINE; FIBRIN; MODEL; INTERLEUKIN-6	Background: Evidence suggests a role of both innate and adaptive immunity in the development of pulmonary arterial hypertension. The complement system is a key sentry of the innate immune system and bridges innate and adaptive immunity. To date there are no studies addressing a role for the complement system in pulmonary arterial hypertension. Methodology/Principal Findings: Immunofluorescent staining revealed significant C3d deposition in lung sections from IPAH patients and C57Bl6/J wild-type mice exposed to three weeks of chronic hypoxia to induce pulmonary hypertension. Right ventricular systolic pressure and right ventricular hypertrophy were increased in hypoxic vs. normoxic wild-type mice, which were attenuated in C3(-/-) hypoxic mice. Likewise, pulmonary vascular remodeling was attenuated in the C3(-/-) mice compared to wild-type mice as determined by the number of muscularized peripheral arterioles and morphometric analysis of vessel wall thickness. The loss of C3 attenuated the increase in interleukin-6 and intracellular adhesion molecule1 expression in response to chronic hypoxia, but not endothelin-1 levels. In wild-type mice, but not C3(-/-) mice, chronic hypoxia led to platelet activation as assessed by bleeding time, and flow cytometry of platelets to determine cell surface P-selectin expression. In addition, tissue factor expression and fibrin deposition were increased in the lungs of WT mice in response to chronic hypoxia. These pro-thrombotic effects of hypoxia were abrogated in C3(-/-) mice. Conclusions: Herein, we provide compelling genetic evidence that the complement system plays a pathophysiologic role in the development of PAH in mice, promoting pulmonary vascular remodeling and a pro-thrombotic phenotype. In addition we demonstrate C3d deposition in IPAH patients suggesting that complement activation plays a role in the development of PAH in humans.	[Bauer, Eileen M.; Zheng, Han; Billiar, Timothy R.; Bauer, Philip M.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15260 USA; [Bauer, Philip M.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Bauer, Philip M.] Univ Pittsburgh, Sch Med, Vasc Med Inst, Pittsburgh, PA USA; [Comhair, Suzy; Erzurum, Serpil] Cleveland Clin, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44106 USA; [Comhair, Suzy; Erzurum, Serpil] Cleveland Clin, Resp Inst, Cleveland, OH 44106 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Bauer, EM (corresponding author), Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15260 USA.	bauerpm@upmc.edu			National Institutes of Health [HL085134, HL081064, HL60917]; University of Pittsburgh Vascular Medicine Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060917, R37HL060917, P01HL081064, R01HL085134] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh Vascular Medicine Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants HL085134 (PMB), HL081064 (SE), HL60917 (SE) and by a Pilot Project Program in Hemostasis and Vascular Biology grant from the University of Pittsburgh Vascular Medicine Institute (PMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Salam VB, 2006, PROTEOMICS, V6, P2286, DOI 10.1002/pmic.200500510; Aldred MA, 2010, AM J RESP CRIT CARE, V182, P1153, DOI 10.1164/rccm.201003-0491OC; Altman R, 1996, CLIN CARDIOL, V19, P549, DOI 10.1002/clc.4960190706; Amara U, 2010, J IMMUNOL, V185, P5628, DOI 10.4049/jimmunol.0903678; Aytekin M, 2008, AM J PHYSIOL-LUNG C, V295, pL789, DOI 10.1152/ajplung.90306.2008; Bakouboula B, 2008, AM J RESP CRIT CARE, V177, P536, DOI 10.1164/rccm.200706-840OC; Bauer PM, 2001, P NATL ACAD SCI USA, V98, P12802, DOI 10.1073/pnas.211443198; BJORK J, 1985, J IMMUNOL, V134, P1115; Cathcart MC, 2008, J PHARMACOL EXP THER, V326, P51, DOI 10.1124/jpet.107.134221; CHEUNG AK, 1989, CLIN EXP IMMUNOL, V78, P299; CHRISTMAN BW, 1992, NEW ENGL J MED, V327, P70, DOI 10.1056/NEJM199207093270202; Cirillo P, 2004, CIRCULATION, V109, P2911, DOI 10.1161/01.CIR.0000129312.43547.08; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Fijalkowska I, 2010, AM J PATHOL, V176, P1130, DOI 10.2353/ajpath.2010.090832; Firth AL, 2009, AM J PHYSIOL-LUNG C, V296, pL979, DOI 10.1152/ajplung.90412.2008; GANEY PE, 1988, AM J PHYSIOL, V255, pH1165, DOI 10.1152/ajpheart.1988.255.5.H1165; Gushiken FC, 2009, J THROMB HAEMOST, V7, P865, DOI 10.1111/j.1538-7836.2009.03334.x; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jacc.2004.02.029; Lawson CA, 1997, J CLIN INVEST, V99, P1729, DOI 10.1172/JCI119337; Maeda NY, 2010, THROMB RES, V125, P38, DOI 10.1016/j.thromres.2009.04.018; Markiewski MM, 2007, AM J PATHOL, V171, P715, DOI 10.2353/ajpath.2007.070166; Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006; Masri FA, 2007, AM J PHYSIOL-LUNG C, V293, pL548, DOI 10.1152/ajplung.00428.2006; Mathew R, 2010, CARDIOL REV, V18, P67, DOI 10.1097/CRD.0b013e3181cd612f; MOREL DR, 1987, ANESTHESIOLOGY, V66, P597, DOI 10.1097/00000542-198705000-00002; MORGANROTH ML, 1990, AM REV RESPIR DIS, V141, P296, DOI 10.1164/ajrccm/141.2.296; Nishimaki T, 1999, J RHEUMATOL, V26, P2357; Pangburn MK, 2002, BIOCHEM SOC T, V30, P1006, DOI 10.1042/bst0301006; Pendergrass SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012106; Phillippi JA, 2009, CIRCULATION, V119, P2498, DOI 10.1161/CIRCULATIONAHA.108.770776; ROSTAGNO C, 1991, CHEST, V99, P1303, DOI 10.1378/chest.99.5.1303; ROTHLEIN R, 1986, J EXP MED, V163, P1132, DOI 10.1084/jem.163.5.1132; Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212; Sakuma M, 2010, ARTERIOSCL THROM VAS, V30, P1196, DOI 10.1161/ATVBAHA.110.205559; Sato Y, 1996, THROMB HAEMOSTASIS, V75, P389; Savale L, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-6; Soon E, 2010, CIRCULATION, V122, P921, DOI 10.1161/CIRCULATIONAHA.109.933762; Steiner MK, 2009, CIRC RES, V104, P236, DOI 10.1161/CIRCRESAHA.108.182014; Verdeguer F, 2007, CARDIOVASC RES, V76, P340, DOI 10.1016/j.cardiores.2007.06.028; White RJ, 2007, AM J PHYSIOL-LUNG C, V293, pL583, DOI 10.1152/ajplung.00321.2006; White RJ, 2005, CHEST, V128, p612S, DOI 10.1378/chest.128.6_suppl.612S-a; WHITE TA, 2009, AM J RESP CELL MOL B; Xu WL, 2004, FASEB J, V18, P1746, DOI 10.1096/fj.04-2317fje; Yan SF, 2000, SEMIN THROMB HEMOST, V26, P479, DOI 10.1055/s-2000-13203; Yan SF, 1998, P NATL ACAD SCI USA, V95, P8298, DOI 10.1073/pnas.95.14.8298; Yan SF, 1999, ARTERIOSCL THROM VAS, V19, P2029, DOI 10.1161/01.ATV.19.9.2029; Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942; Zhang JQ, 2009, RESP MED, V103, P1801, DOI 10.1016/j.rmed.2009.07.017; Zuckerbraun BS, 2010, CIRCULATION, V121, P98, DOI 10.1161/CIRCULATIONAHA.109.891077	50	60	63	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28578	10.1371/journal.pone.0028578	http://dx.doi.org/10.1371/journal.pone.0028578			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194859	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000298369100056
J	Garza, MC; Fernandez-Borges, N; Bolea, R; Badiola, JJ; Castilla, J; Monleon, E				Carmen Garza, Maria; Fernandez-Borges, Natalia; Bolea, Rosa; Jose Badiola, Juan; Castilla, Joaquin; Monleon, Eva			Detection of PrPres in Genetically Susceptible Fetuses from Sheep with Natural Scrapie	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; PRPSC ACCUMULATION; PRION PROTEIN; LYMPHOID-TISSUES; TRANSMISSION; AMPLIFICATION; FERRITIN; PLACENTA; ANIMALS; BRAIN	Scrapie is a transmissible spongiform encephalopathy with a wide PrPres dissemination in many non-neural tissues and with high levels of transmissibility within susceptible populations. Mechanisms of transmission are incompletely understood. It is generally assumed that it is horizontally transmitted by direct contact between animals or indirectly through the environment, where scrapie can remain infectious for years. In contrast, in utero vertical transmission has never been demonstrated and has rarely been studied. Recently, the use of the protein misfolding cyclic amplification technique (PMCA) has allowed prion detection in various tissues and excretions in which PrPres levels have been undetectable by traditional assays. The main goal of this study was to detect PrPres in fetal tissues and the amniotic fluid from natural scrapie infected ewes using the PMCA technique. Six fetuses from three infected pregnant ewes in an advanced clinical stage of the disease were included in the study. From each fetus, amniotic fluid, brain, spleen, ileo-cecal valve and retropharyngeal lymph node samples were collected and analyzed using Western blotting and PMCA. Although all samples were negative using Western blotting, PrPres was detected after in vitro amplification. Our results represent the first time the biochemical detection of prions in fetal tissues, suggesting that the in utero transmission of scrapie in natural infected sheep might be possible.	[Carmen Garza, Maria; Bolea, Rosa; Jose Badiola, Juan; Monleon, Eva] Univ Zaragoza, Ctr Invest Encefalopatias Espongiformes Transmisi, Zaragoza, Spain; [Fernandez-Borges, Natalia; Castilla, Joaquin] CIC BioGUNE, Derio, Spain; [Castilla, Joaquin] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain; [Monleon, Eva] Univ Lleida, Lleida, Spain	University of Zaragoza; CIC bioGUNE; Basque Foundation for Science; Universitat de Lleida	Garza, MC (corresponding author), Univ Zaragoza, Ctr Invest Encefalopatias Espongiformes Transmisi, Zaragoza, Spain.	emonleon@unizar.es	Garza, M Carmen/ABI-8266-2020; Fernández-Borges, Natalia/H-1875-2012; Castilla, Joaquín/J-8414-2019; Castilla, Joaquin/D-5261-2011; Castilla, Joaquin/E-6952-2012; MONZÓN, MARTA/R-6162-2017	Garza, M Carmen/0000-0001-7098-2327; Castilla, Joaquín/0000-0002-2216-1361; Castilla, Joaquin/0000-0002-2216-1361; MONZÓN, MARTA/0000-0002-2787-9671; Fernandez-Borges, Natalia/0000-0001-6274-0096	Spain [AGL2009-11553-C02-01]; Basque government [PI2010-18]; Department of Industry, Tourism and Trade of the Government of the Autonomous Community of the Basque Country; Innovation Technology Department of the Bizkaia County; FPU, Spanish Ministry of Education [AP2007-03842]	Spain; Basque government(Basque Government); Department of Industry, Tourism and Trade of the Government of the Autonomous Community of the Basque Country; Innovation Technology Department of the Bizkaia County; FPU, Spanish Ministry of Education(Spanish Government)	This study was supported by a national grant from Spain (AGL2009-11553-C02-01), a Basque government grant (PI2010-18) and the Department of Industry, Tourism and Trade of the Government of the Autonomous Community of the Basque Country (Etortek Research Programs 2011/2013), from the Innovation Technology Department of the Bizkaia County. Dr. Garza was supported by a FPU doctoral grant from the Spanish Ministry of Education (AP2007-03842). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alverson J, 2006, J GEN VIROL, V87, P1035, DOI 10.1099/vir.0.81418-0; Andreoletti O, 2002, J GEN VIROL, V83, P2607, DOI 10.1099/0022-1317-83-10-2607; Barria MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000421; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Caplazi P, 2004, J VET DIAGN INVEST, V16, P489, DOI 10.1177/104063870401600601; Castilla J, 2005, NAT MED, V11, P982, DOI 10.1038/nm1286; Castilla J, 2005, J VIROL, V79, P8665, DOI 10.1128/JVI.79.13.8665-8668.2005; Castilla J, 2006, METHOD ENZYMOL, V412, P3, DOI 10.1016/s0076-6879(06)12001-7; DICKINSON AG, 1974, J COMP PATHOL, V84, P19, DOI 10.1016/0021-9975(74)90023-1; Ersdal C, 2005, VET PATHOL, V42, P258, DOI 10.1354/vp.42-3-258; Gough KC, 2010, PRION, V4, P275, DOI 10.4161/pri.4.4.13678; HADLOW WJ, 1982, J INFECT DIS, V146, P657, DOI 10.1093/infdis/146.5.657; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004848; Hoinville LJ, 2010, PREV VET MED, V93, P121, DOI 10.1016/j.prevetmed.2009.10.013; Hoinville LJ, 1996, REV SCI TECH OIE, V15, P827, DOI 10.20506/rst.15.3.959; HOURRIGAN JL, 1990, J AM VET MED ASSOC, V196, P1678; Jeffrey M, 2007, NEUROPATH APPL NEURO, V33, P373, DOI 10.1111/j.1365-2990.2007.00868.x; Konold T, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-14; Kruger D, 2009, VET RES, V40, DOI 10.1051/vetres:2008042; Lacroux C, 2007, J GEN VIROL, V88, P1056, DOI 10.1099/vir.0.82218-0; Lacroux C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000238; Leiser R, 1997, J ANAT, V191, P517, DOI 10.1046/j.1469-7580.1997.19140517.x; Maddison BC, 2010, J INFECT DIS, V201, P1672, DOI 10.1086/652457; Miller MW, 2003, NATURE, V425, P35, DOI 10.1038/425035a; Mishra RS, 2004, J NEUROSCI, V24, P11280, DOI 10.1523/JNEUROSCI.2864-04.2004; Monleon E, 2004, J HISTOCHEM CYTOCHEM, V52, P145, DOI 10.1177/002215540405200201; Monleon E, 2011, VET MICROBIOL, V147, P237, DOI 10.1016/j.vetmic.2010.06.028; MYAGKAYA G, 1981, CELL TISSUE RES, V214, P501, DOI 10.1007/BF00233491; ONODERA T, 1993, MICROBIOL IMMUNOL, V37, P311, DOI 10.1111/j.1348-0421.1993.tb03215.x; Peralta OA, 2011, DIFFERENTIATION, V81, P68, DOI 10.1016/j.diff.2010.09.181; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Race R, 1998, J INFECT DIS, V178, P949, DOI 10.1086/515669; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Sigurdson CJ, 2008, VET RES, V39, DOI 10.1051/vetres:2008018; Spraker TR, 2006, J VET DIAGN INVEST, V18, P553, DOI 10.1177/104063870601800605; Sunkesula SRB, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-14; Thorne L, 2008, J GEN VIROL, V89, P3177, DOI 10.1099/vir.0.2008/004226-0; Tuo WB, 2002, P NATL ACAD SCI USA, V99, P6310, DOI 10.1073/pnas.072071199; Vargas F, 2005, VET REC, V156, P318, DOI 10.1136/vr.156.10.318; Vilotte JL, 2001, J VIROL, V75, P5977, DOI 10.1128/JVI.75.13.5977-5984.2001; WOODING P, 2008, COMP PLACENTATION ST, P17; Wrathall AE, 2008, THERIOGENOLOGY, V70, P725, DOI 10.1016/j.theriogenology.2008.05.049	42	20	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e27525	10.1371/journal.pone.0027525	http://dx.doi.org/10.1371/journal.pone.0027525			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194786	Green Published, Green Submitted, gold			2022-12-25	WOS:000298369100006
J	Lillywhite, HB; Tu, MC				Lillywhite, Harvey B.; Tu, Ming-Chung			Abundance of Sea Kraits Correlates with Precipitation	PLOS ONE			English	Article							SEASONAL INCIDENCE; SNAKES	Recent studies have shown that sea kraits (Laticauda spp.) - amphibious sea snakes - dehydrate without a source of fresh water, drink only fresh water or very dilute brackish water, and have a spatial distribution of abundance that correlates with freshwater sites in Taiwan. The spatial distribution correlates with sites where there is a source of fresh water in addition to local precipitation. Here we report six years of longitudinal data on the abundance of sea kraits related to precipitation at sites where these snakes are normally abundant in the coastal waters of Lanyu (Orchid Island), Taiwan. The number of observed sea kraits varies from year-to-year and correlates positively with previous 6-mo cumulative rainfall, which serves as an inverse index of drought. Grouped data for snake counts indicate thatmean abundance in wet years is nearly 3-fold greater than in dry years, and this difference is significant. These data corroborate previous findings and suggest that freshwater dependence influences the abundance or activity of sea kraits on both spatial and temporal scales. The increasing evidence for freshwater dependence in these and othermarine species have important implications for the possible impact of climate change on sea snake distributions.	[Lillywhite, Harvey B.] Univ Florida, Dept Biol, Gainesville, FL 32610 USA; [Tu, Ming-Chung] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan	State University System of Florida; University of Florida; National Taiwan Normal University	Lillywhite, HB (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32610 USA.	hblill@ufl.edu			National Geographic Society (Committee for Research and Exploration) [8058-06]; United States National Science Foundation [IOS-0926802]; Taiwan National Science Council [97-2621-B-003-004-MY3]; University of Florida; Division Of Integrative Organismal Systems [0926802] Funding Source: National Science Foundation	National Geographic Society (Committee for Research and Exploration)(National Geographic Society); United States National Science Foundation(National Science Foundation (NSF)); Taiwan National Science Council(Ministry of Science and Technology, Taiwan); University of Florida(University of Florida); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by the National Geographic Society (Committee for Research and Exploration grant #8058-06 to HL; URL http://www.nationalgeographic.com), the United States National Science Foundation grant IOS-0926802 to HL (URL http://www.nsf.gov/), and Taiwan National Science Council grant 97-2621-B-003-004-MY3 to M-CT (URL http://web1.nsc.gov.tw/). Publication of this article was funded in part by the University of Florida Open-Access Publishing Fund. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnet X, 2008, AUSTRAL ECOL, V33, P911, DOI 10.1111/j.1442-9993.2008.01917.x; Brischoux F, 2009, BIODIVERS CONSERV, V18, P2473, DOI 10.1007/s10531-009-9602-x; DUNSON WA, 1971, LIMNOL OCEANOGR, V16, P845, DOI 10.4319/lo.1971.16.6.0845; GANS C, 1979, EVOLUTION, V33, P227, DOI 10.1111/j.1558-5646.1979.tb04677.x; Guinea M.L., 1991, Herpetofauna (Sydney), V21, P13; Hartmann Paulo A., 2009, Pap. Avulsos Zool. (São Paulo), V49, P343, DOI 10.1590/S0031-10492009002700001; HEATWOLE H, 2009, SEA SNAKES; HENDERSON RW, 1977, COPEIA, P349; Hulme M, 1998, GEOPHYS RES LETT, V25, P3379, DOI 10.1029/98GL02562; Lillywhite HB, 2008, PHYSIOL BIOCHEM ZOOL, V81, P785, DOI 10.1086/588306; Liu YL, 2010, MAR BIOL, V157, P2369, DOI 10.1007/s00227-010-1501-x; Neelin JD, 2006, P NATL ACAD SCI USA, V103, P6110, DOI 10.1073/pnas.0601798103; Oliver James A., 1947, AMER MUS NOVITATES, V1363, P1; REYNOLDS RP, 1982, SOUTHWEST NAT, V27, P161, DOI 10.2307/3671140	14	17	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28556	10.1371/journal.pone.0028556	http://dx.doi.org/10.1371/journal.pone.0028556			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194849	gold, Green Published			2022-12-25	WOS:000298369100049
J	Scholz, NL; Myers, MS; McCarthy, SG; Labenia, JS; McIntyre, JK; Ylitalo, GM; Rhodes, LD; Laetz, CA; Stehr, CM; French, BL; McMillan, B; Wilson, D; Reed, L; Lynch, KD; Damm, S; Davis, JW; Collier, TK				Scholz, Nathaniel L.; Myers, Mark S.; McCarthy, Sarah G.; Labenia, Jana S.; McIntyre, Jenifer K.; Ylitalo, Gina M.; Rhodes, Linda D.; Laetz, Cathy A.; Stehr, Carla M.; French, Barbara L.; McMillan, Bill; Wilson, Dean; Reed, Laura; Lynch, Katherine D.; Damm, Steve; Davis, Jay W.; Collier, Tracy K.			Recurrent Die-Offs of Adult Coho Salmon Returning to Spawn in Puget Sound Lowland Urban Streams	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; SOCKEYE-SALMON; PACIFIC-NORTHWEST; FRASER-RIVER; TOXICITY; EXPOSURE; ASSAY; HYDROCARBONS; THRESHOLDS; MORTALITY	Several Seattle-area streams in Puget Sound were the focus of habitat restoration projects in the 1990s. Post-project effectiveness monitoring surveys revealed anomalous behaviors among adult coho salmon returning to spawn in restored reaches. These included erratic surface swimming, gaping, fin splaying, and loss of orientation and equilibrium. Affected fish died within hours, and female carcasses generally showed high rates (>90%) of egg retention. Beginning in the fall of 2002, systematic spawner surveys were conducted to 1) assess the severity of the adult die-offs, 2) compare spawner mortality in urban vs. non-urban streams, and 3) identify water quality and spawner condition factors that might be associated with the recurrent fish kills. The forensic investigation focused on conventional water quality parameters (e. g., dissolved oxygen, temperature, ammonia), fish condition, pathogen exposure and disease status, and exposures to metals, polycyclic aromatic hydrocarbons, and current use pesticides. Daily surveys of a representative urban stream (Longfellow Creek) from 2002-2009 revealed premature spawner mortality rates that ranged from 60-100% of each fall run. The comparable rate in a non-urban stream was,1% (Fortson Creek, surveyed in 2002). Conventional water quality, pesticide exposure, disease, and spawner condition showed no relationship to the syndrome. Coho salmon did show evidence of exposure to metals and petroleum hydrocarbons, both of which commonly originate from motor vehicles in urban landscapes. The weight of evidence suggests that freshwater-transitional coho are particularly vulnerable to an as-yet unidentified toxic contaminant (or contaminant mixture) in urban runoff. Stormwater may therefore place important constraints on efforts to conserve and recover coho populations in urban and urbanizing watersheds throughout the western United States.	[Scholz, Nathaniel L.; Myers, Mark S.; Labenia, Jana S.; McIntyre, Jenifer K.; Ylitalo, Gina M.; Rhodes, Linda D.; Laetz, Cathy A.; Stehr, Carla M.; French, Barbara L.; Collier, Tracy K.] NOAA Fisheries, NW Fisheries Sci Ctr, Seattle, WA USA; [McCarthy, Sarah G.; Wilson, Dean] King Cty, Dept Nat Resources & Pk, Seattle, WA USA; [McMillan, Bill] Wild Fish Conservancy, Duvall, WA USA; [Reed, Laura; Lynch, Katherine D.] City Seattle, Seattle Publ Util, Seattle, WA USA; [Damm, Steve; Davis, Jay W.] US Fish & Wildlife Serv, Washington Fish & Wildlife Off, Lacey, WA USA	National Oceanic Atmospheric Admin (NOAA) - USA; United States Department of the Interior; US Fish & Wildlife Service	Scholz, NL (corresponding author), NOAA Fisheries, NW Fisheries Sci Ctr, Seattle, WA USA.	Nathaniel.Scholz@noaa.gov	, Jenifer/AAA-2614-2022; McCarthy, Sarah/HCI-8963-2022; Scholz, Nathaniel L/L-1642-2013	, Jenifer/0000-0003-3480-7083; Scholz, Nathaniel L/0000-0001-6207-0272; Rhodes, Linda/0000-0003-4995-9426	National Oceanic and Atmospheric Administration; U.S. Fish and Wildlife Service National Contaminants Program; U.S. Environmental Protection Agency Region; King Conservation District	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); U.S. Fish and Wildlife Service National Contaminants Program; U.S. Environmental Protection Agency Region(United States Environmental Protection Agency); King Conservation District	This project received agency funding from the National Oceanic and Atmospheric Administration (Coastal Storms Program), the U.S. Fish and Wildlife Service National Contaminants Program, the U.S. Environmental Protection Agency Region 10, and the King Conservation District. Funds were delivered via interagency agreements, so grant numbers are not applicable. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Richard O., 1996, P447; Arkoosh MR, 2004, J AQUAT ANIM HEALTH, V16, P186, DOI 10.1577/H03-071.1; Booth DB, 1997, J AM WATER RESOUR AS, V33, P1077, DOI 10.1111/j.1752-1688.1997.tb04126.x; *CA DEP FISH GAM, 2004, SEPT 2002 KLAM RIV F; Carr RL, 1997, ENVIRON TOXICOL CHEM, V16, P2369, DOI [10.1002/etc.5620161124, 10.1897/1551-5028(1997)016&lt;2369:STOCTS&gt;2.3.CO;2]; Chase DM, 1998, DIS AQUAT ORGAN, V34, P223, DOI 10.3354/dao034223; Claireaux G, 2010, AQUAT TOXICOL, V98, P113, DOI 10.1016/j.aquatox.2010.02.006; Cooke SJ, 2004, FISHERIES, V29, P22, DOI 10.1577/1548-8446(2004)29[22:AMTAHE]2.0.CO;2; Crossin GT, 2008, CAN J ZOOL, V86, P127, DOI 10.1139/Z07-122; Docker MF, 1997, DIS AQUAT ORGAN, V29, P41, DOI 10.3354/dao029041; Fairgrieve WT, 2005, DIS AQUAT ORGAN, V64, P99, DOI 10.3354/dao064099; Feist BE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023424; Fournie John W., 2000, P569, DOI 10.1016/B978-012529650-2/50043-3; Gilhousen P, 1990, B INT PACIFIC SALMON, V26; Hoffman RS, 2000, ENVIRON TOXICOL CHEM, V19, P2249, DOI [10.1002/etc.5620190915, 10.1897/1551-5028(2000)019&lt;2249:COPIEU&gt;2.3.CO;2]; Incardona JP, 2009, ENVIRON SCI TECHNOL, V43, P201, DOI 10.1021/es802270t; Jackson CR, 2010, BIOSCIENCE, V60, P37, DOI 10.1525/bio.2010.60.1.8; KENT ML, 1985, J PROTOZOOL, V32, P254; KRAHN MM, 1984, XENOBIOTICA, V14, P633, DOI 10.3109/00498258409151461; Laetz CA, 2009, ENVIRON HEALTH PERSP, V117, P348, DOI 10.1289/ehp.0800096; Lavado R, 2011, ENVIRON SCI TECHNOL, V45, P4623, DOI 10.1021/es200451j; Lough GC, 2005, ENVIRON SCI TECHNOL, V39, P826, DOI 10.1021/es048715f; Luna L, 1992, HISTOPATHOLOGIC METH; MCMILLAN B, 2007, SPAWNING SURVEY FIND; Niyogi S, 2004, ENVIRON SCI TECHNOL, V38, P6177, DOI 10.1021/es0496524; Palenzuela O, 1999, DIS AQUAT ORGAN, V36, P45, DOI 10.3354/dao036045; Quinn TP, 2007, CAN J FISH AQUAT SCI, V64, P574, DOI 10.1139/F07-035; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; Sandahl JF, 2005, ENVIRON TOXICOL CHEM, V24, P136, DOI 10.1897/04-195R.1; Sloan C. A, 2006, NMFSNWFSC77 NOAA US; Sokal R. R, 1981, BIOMETRY; Spromberg Julann A., 2011, Integrated Environmental Assessment and Management, V7, P648, DOI 10.1002/ieam.219; St-Hilaire S, 2002, J FISH DIS, V25, P107, DOI 10.1046/j.1365-2761.2002.00344.x; Stein ED, 2006, ENVIRON TOXICOL CHEM, V25, P373, DOI 10.1897/05-285R.1; Tiefenthaler LL, 2008, ENVIRON TOXICOL CHEM, V27, P277, DOI 10.1897/07-126R.1; Uchida K, 1997, MAR BIOL, V129, P247, DOI 10.1007/s002270050165; Van Genderen EJ, 2005, ENVIRON TOXICOL CHEM, V24, P408, DOI 10.1897/03-494.1; *WA TROUT, 2004, LAND US COL PRESP MO; Wagner RJ, 2000, GUIDELINES STANDARD; Walsh CJ, 2005, J N AM BENTHOL SOC, V24, P706, DOI [10.1899/04-020.1, 10.1899/04-028.1]; Williamson CE, 2008, FRONT ECOL ENVIRON, V6, P247, DOI 10.1890/070140; 2007, STATE WATERS 2007, V1	43	65	65	10	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28013	10.1371/journal.pone.0028013	http://dx.doi.org/10.1371/journal.pone.0028013			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194802	Green Submitted, gold, Green Published			2022-12-25	WOS:000298369100018
J	Liu, DF; Lian, B; Wang, B; Jiang, GF				Liu, Dianfeng; Lian, Bin; Wang, Bin; Jiang, Guofang			Degradation of Potassium Rock by Earthworms and Responses of Bacterial Communities in Its Gut and Surrounding Substrates after Being Fed with Mineral	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; DIVERSITY MEASURES; SOIL INGESTION; AVAILABILITY; METALS	Background: Earthworms are an ecosystem's engineers, contributing to a wide range of nutrient cycling and geochemical processes in the ecosystem. Their activities can increase rates of silicate mineral weathering. Their intestinal microbes usually are thought to be one of the key drivers of mineral degradation mediated by earthworms, but the diversities of the intestinal microorganisms which were relevant with mineral weathering are unclear. Methodology/Principal Findings: In this report, we show earthworms' effect on silicate mineral weathering and the responses of bacterial communities in their gut and surrounding substrates after being fed with potassium-bearing rock powder (PBRP). Determination of water-soluble and HNO3-extractable elements indicated some elements such as Al, Fe and Ca were significantly released from mineral upon the digestion of earthworms. The microbial communities in earthworms' gut and the surrounding substrates were investigated by amplified ribosomal DNA restriction analysis (ARDRA) and the results showed a higher bacterial diversity in the guts of the earthworms fed with PBRP and the PBRP after being fed to earthworms. UPGMA dendrogram with unweighted UniFrac analysis, considering only taxa that are present, revealed that earthworms' gut and their surrounding substrate shared similar microbiota. UPGMA dendrogram with weighted UniFrac, considering the relative abundance of microbial lineages, showed the two samples from surrounding substrate and the two samples from earthworms' gut had similarity in microbial community, respectively. Conclusions/Significance: Our results indicated earthworms can accelerate degradation of silicate mineral. Earthworms play an important role in ecosystem processe since they not only have some positive effects on soil structure, but also promote nutrient cycling of ecosystem by enhancing the weathering of minerals.	[Liu, Dianfeng; Lian, Bin; Jiang, Guofang] Nanjing Normal Univ, Coll Life Sci, Jiangsu Engn & Technol Res Ctr Microbiol, Jiangsu Key Lab Microbes & Funct Genom, Nanjing, Peoples R China; [Lian, Bin] Chinese Acad Sci, Inst Geochem, State Key Lab Environm Geochem, Guiyang, Peoples R China; [Wang, Bin] Henan Inst Sci & Technol, Dept Bioengn, Xinxiang, Peoples R China	Nanjing Normal University; Chinese Academy of Sciences; Guiyang Institute of Geochemistry, CAS; Henan Institute of Science & Technology	Liu, DF (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Engn & Technol Res Ctr Microbiol, Jiangsu Key Lab Microbes & Funct Genom, Nanjing, Peoples R China.	bin2368@vip.163.com	Jiang, Guo-Fang/I-5236-2019	Jiang, Guo-Fang/0000-0003-0164-0950	Jiangsu Higher Education Institutions; National High Technology Research and Development Program of China [2008AA06Z108]; National Science Fund for Creative Research Groups [40721002]	Jiangsu Higher Education Institutions; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Science Fund for Creative Research Groups(Science Fund for Creative Research Groups)	The work was supported by the Priority Academic Program Development of Jiangsu Higher Education Institutions, the National High Technology Research and Development Program of China (2008AA06Z108), and the National Science Fund for Creative Research Groups (40721002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aira M, 2003, PEDOBIOLOGIA, V47, P877, DOI 10.1016/S0031-4056(04)70283-8; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amtmann A, 2007, CELL RES, V17, P483, DOI 10.1038/cr.2007.49; Banfield JF, 1999, P NATL ACAD SCI USA, V96, P3404, DOI 10.1073/pnas.96.7.3404; Basak BB, 2009, PLANT SOIL, V317, P235, DOI 10.1007/s11104-008-9805-z; Basak BB, 2010, BIOL FERT SOILS, V46, P641, DOI 10.1007/s00374-010-0456-x; BASKER A, 1992, BIOL FERT SOILS, V14, P300, DOI 10.1007/BF00395467; BASKER A, 1994, BIOL FERT SOILS, V17, P154, DOI 10.1007/BF00337748; Burford EP, 2003, MINERAL MAG, V67, P1127, DOI 10.1180/0026461036760154; Carpenter D, 2008, MINERAL MAG, V72, P33, DOI 10.1180/minmag.2008.072.1.33; Carpenter D, 2007, EUR J SOIL BIOL, V43, pS176, DOI 10.1016/j.ejsobi.2007.08.053; CHEN J., 2000, GEOLOGY CHEM MINERAL, V22, P58; [谌书 CHEN Shu], 2008, [矿物学报, Acta Mineralogica Sinica], V28, P77; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; EDWARDS CA, 1996, BIOL ECOLOGY EARTHWO, P151; Gadd GM, 2007, MYCOL RES, V111, P3, DOI 10.1016/j.mycres.2006.12.001; Goudie AS, 1996, J ARID ENVIRON, V32, P103, DOI 10.1006/jare.1996.0010; Hill TCJ, 2003, FEMS MICROBIOL ECOL, V43, P1, DOI 10.1111/j.1574-6941.2003.tb01040.x; Hosseinifard SJ, 2010, GEODERMA, V155, P289, DOI 10.1016/j.geoderma.2009.12.013; Knapp BA, 2008, B ENTOMOL RES, V98, P271, DOI 10.1017/S0007485308006056; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li S, 2006, MINERAL RESOURCES GE, V20, P577; Liu Weiqi, 2008, Weishengwu Xuebao, V48, P1344; Liu WX, 2006, ENVIRON GEOCHEM HLTH, V28, P133, DOI 10.1007/s10653-005-9022-0; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Mathur J, 2007, APPL ENVIRON MICROB, V73, P2612, DOI 10.1128/AEM.02567-06; Needham SJ, 2004, BIOGEOSCIENCES, V1, P113, DOI 10.5194/bg-1-113-2004; Price GW, 2008, APPL SOIL ECOL, V38, P230, DOI 10.1016/j.apsoil.2007.10.014; Sanz-Montero ME, 2009, GEOL MAG, V146, P527, DOI 10.1017/S0016756808005906; Sugumaran P., 2007, World Journal of Agricultural Sciences, V3, P350; [孙爱文 SUN Ai-wen], 2009, [现代化工, Modern Chemical Industry], V29, P10; SUN AW, 2009, MOD CHEM IND, V29, P16; Suzuki Y, 2003, GEODERMA, V112, P131, DOI 10.1016/S0016-7061(02)00300-2; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Tian G, 2000, SOIL SCI SOC AM J, V64, P222, DOI 10.2136/sssaj2000.641222x; Udovic M, 2007, ENVIRON POLLUT, V148, P663, DOI 10.1016/j.envpol.2006.11.010; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wust PK, 2009, APPL ENVIRON MICROB, V75, P1852, DOI 10.1128/AEM.02745-08; XU JY, 2010, ACTA MICROBIOL SIN, V50, P438; Yin HQ, 2008, ARCH MICROBIOL, V189, P101, DOI 10.1007/s00203-007-0298-6; Zhang B G, 2000, ACTA ECOLOGICA SINIC, V20, P168; Zhang SK, 2001, J AGR U HEBEI, V24, P16; Zhang Weixin, 2007, Shengwu Duoyangxing, V15, P142, DOI 10.1360/biodiv.060294; Zhao Fei, 2010, Weishengwu Xuebao, V50, P647	45	24	29	2	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28803	10.1371/journal.pone.0028803	http://dx.doi.org/10.1371/journal.pone.0028803			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174903	gold, Green Submitted, Green Published			2022-12-25	WOS:000298367300026
J	Zheng, B; Liang, L; Huang, S; Zha, R; Liu, L; Jia, D; Tian, Q; Wang, Q; Wang, C; Long, Z; Zhou, Y; Cao, X; Du, C; Shi, Y; He, X				Zheng, B.; Liang, L.; Huang, S.; Zha, R.; Liu, L.; Jia, D.; Tian, Q.; Wang, Q.; Wang, C.; Long, Z.; Zhou, Y.; Cao, X.; Du, C.; Shi, Y.; He, X.			MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers	ONCOGENE			English	Article						gastric cancer; metastasis; microRNA-409; radixin	PANCREATIC-CANCER; IDENTIFICATION; SPECIFICITY; EXPRESSION; CARCINOMA; MIGRATION; PROTEINS; MIR-31; GENES	Emerging evidence has shown that aberrantly expressed microRNAs (miRNAs) are highly associated with tumour development and progression. However, little is known about the potential role of miRNAs in gastric cancer (GC) metastasis. In this study, miR-409-3p was found to be downregulated frequently in human GCs, and its expression was significantly associated with tumor-node-metastasis (TNM) stage and lymph node metastasis. Enforced expression of miR-409 in GC cells significantly reduced their migration and invasion in vitro and their capacity to develop distal pulmonary metastases and peritoneal dissemination in vivo. Moreover, we found that miR-409 exerted its function predominantly through the mature miR-409-3p, but not miR-409-5p. Microarray and bioinformatics analysis identified the pro-metastatic gene radixin (RDX) as a potential miR-409-3p target. Further studies confirmed that miR-409-3p suppressed the expression of RDX by directly binding to its 3'-untranslated region. Silencing of RDX by small interfering RNAs phenocopied the effects of miR-409 overexpression, whereas restoration of RDX in miR-409-overexpressed GC cells reversed the suppressive effects of miR-409. Taken together, these results demonstrate that miR-409 suppresses GC cell invasion and metastasis by directly targeting RDX and that patients with downregulated miR-409-3p are prone to lymph node metastasis.	[Zheng, B.; Wang, Q.; Wang, C.; Long, Z.; Zhou, Y.; Cao, X.; Du, C.; Shi, Y.; He, X.] Fudan Univ, Shanghai Canc Ctr, Dept Gastr Canc & Soft Tissue Sarcomas, Shanghai 200032, Peoples R China; [Zheng, B.; Wang, Q.; Wang, C.; Long, Z.; Zhou, Y.; Cao, X.; Du, C.; Shi, Y.; He, X.] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China; [Liang, L.; Huang, S.; Zha, R.; Liu, L.; Jia, D.; Tian, Q.; He, X.] Shanghai Jiao Tong Univ, Sch Med, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes, Shanghai 200030, Peoples R China	Fudan University; Fudan University; Shanghai Jiao Tong University	Shi, Y (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Gastr Canc & Soft Tissue Sarcomas, Shanghai 200032, Peoples R China.	yingqiangshi@126.com; xhhe@shsci.org	Huang, Shenglin/N-9472-2018; Jia, Deshui/U-9732-2019; He, Xianghuo/I-1497-2014; liang, linhui/AAW-4176-2021	Huang, Shenglin/0000-0003-1279-0794; He, Xianghuo/0000-0001-8872-668X; Guo, Weijie/0000-0001-7167-9899				Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Arpin M, 2011, CELL ADHES MIGR, V5, P199, DOI 10.4161/cam.5.2.15081; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cappetta A, 2012, CRIT REV ONCOL HEMAT, V81, P38, DOI 10.1016/j.critrevonc.2010.12.006; Chen ZL, 2011, J BIOL CHEM, V286, P10725, DOI 10.1074/jbc.M110.165654; Cui YZ, 2009, INT J CANCER, V124, P1614, DOI 10.1002/ijc.24163; Deng JY, 2010, J SURG RES, V161, P47, DOI 10.1016/j.jss.2008.12.019; Ding J, 2010, NAT CELL BIOL, V12, P390, DOI 10.1038/ncb2039; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hoeflich KP, 2004, INT J BIOCHEM CELL B, V36, P2131, DOI 10.1016/j.biocel.2003.11.018; Hohenberger P, 2003, LANCET, V362, P305, DOI 10.1016/S0140-6736(03)13975-X; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kanaan Z, 2010, GENET TEST MOL BIOMA, V14, P347, DOI 10.1089/gtmb.2009.0197; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Li XH, 2011, J CELL MOL MED, V15, P1887, DOI 10.1111/j.1582-4934.2010.01194.x; Li YW, 2010, CANCER RES, V70, P1486, DOI 10.1158/0008-5472.CAN-09-2792; Liang SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018409; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Liu GQ, 2005, J BIOL CHEM, V280, P39042, DOI 10.1074/jbc.M504341200; Ming OY, 2011, BIOCHIMIE, V93, P954, DOI 10.1016/j.biochi.2011.01.017; Oue N, 2004, CANCER RES, V64, P2397, DOI 10.1158/0008-5472.CAN-03-3514; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Song YX, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-1; Stacker SA, 2002, NAT REV CANCER, V2, P573, DOI 10.1038/nrc863; Stock M, 2005, GENE, V360, P1, DOI 10.1016/j.gene.2005.06.026; Takei Y, 2011, CANCER RES, V71, P1442, DOI 10.1158/0008-5472.CAN-10-2530; Tie J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000879; Tsai KW, 2011, INT J CANCER, V129, P2600, DOI 10.1002/ijc.25919; Tsukamoto Y, 2010, CANCER RES, V70, P2339, DOI 10.1158/0008-5472.CAN-09-2777; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Valastyan S, 2010, CANCER RES, V70, P5147, DOI 10.1158/0008-5472.CAN-10-0410; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Wang JB, 2010, CANCER LETT, V297, P137, DOI 10.1016/j.canlet.2010.07.018; Wu WKK, 2010, ONCOGENE, V29, P5761, DOI 10.1038/onc.2010.352; Yu HF, 2011, FRONT BIOSCI-LANDMRK, V16, P1536, DOI 10.2741/3803	40	102	110	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2012	31	42					4509	4516		10.1038/onc.2011.581	http://dx.doi.org/10.1038/onc.2011.581			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	022SH	22179828				2022-12-25	WOS:000309982100002
J	Martin, L; Rainey, M; Santocanale, C; Gardner, LB				Martin, L.; Rainey, M.; Santocanale, C.; Gardner, L. B.			Hypoxic activation of ATR and the suppression of the initiation of DNA replication through cdc6 degradation	ONCOGENE			English	Article						hypoxia; ATR; cdc6; DNA replication; APC/C-Cdh1	MINICHROMOSOME MAINTENANCE PROTEINS; INHIBITS REPLICON INITIATION; CELL-CYCLE; S-PHASE; PREREPLICATION COMPLEXES; CDC25A PHOSPHATASE; DAMAGE RESPONSE; INDUCED ARREST; CHECKPOINT; PHOSPHORYLATION	Many severely hypoxic cells fail to initiate DNA replication, but the mechanism underlying this observation is unknown. Specifically, although the ataxia-telangiectasia-rad3 related (ATR) kinase has been shown to be activated in hypoxic cells, several studies have not been able to document down-stream consequences of ATR activation in these cells. By clearly defining the DNA replication initiation checkpoint in hypoxic cells, we now demonstrate that ATR is responsible for activating this checkpoint. We show that the hypoxic activation of ATR leads to the phosphorylation-dependent degradation of the cdc25a phosphatase. Downregulation of cdc25a protein by ATR in hypoxic cells decreases CDK2 phosphorylation and activity, which results in the degradation of cdc6 by APC/C-Cdh1. These events do not occur in hypoxic cells when ATR is depleted, and the initiation of DNA replication is maintained. We therefore present a novel mechanism of cdc6 regulation in which ATR can have a central role in inhibiting the initiation of DNA replication by the regulation of cdc6 by APC/C-Cdh1. This model provides insight into the biology and therapy of hypoxic tumors. Oncogene (2012) 31, 4076-4084; doi: 10.1038/onc.2011.585; published online 19 December 2011	[Gardner, L. B.] NYU, Sch Med, NYU Canc Inst, Div Hematol & Med Oncol,Dept Pharmacol, New York, NY 10016 USA; [Martin, L.; Gardner, L. B.] NYU, Sch Med, Dept Med, New York, NY 10016 USA; [Rainey, M.; Santocanale, C.] NUI Galway, Ctr Chromosome Biol, Galway, Ireland	New York University; New York University; Ollscoil na Gaillimhe-University of Galway	Gardner, LB (corresponding author), NYU, Sch Med, NYU Canc Inst, Div Hematol & Med Oncol,Dept Pharmacol, 550 1st Ave, New York, NY 10016 USA.	Lawrence.gardner@nyumc.org		Santocanale, Corrado/0000-0003-1337-5656; Gardner, Lawrence/0000-0003-0191-0172; Rainey, Michael/0000-0001-9777-873X	Feldstein Foundation;  [DK08164]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081641] Funding Source: NIH RePORTER	Feldstein Foundation; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We appreciate the kind gifts of reagents from John Dillfey and Stephen Elledge. Luca Busino, Michele Pagano, Vincenzo D'Angiolella provided reagents and helpful advice. This work was supported in part by DK08164 and the Feldstein Foundation. LBG is the Saul J Farber Assistant Professor of Medicine.	Benmaamar R, 2005, CELL CYCLE, V4, P1230, DOI 10.4161/cc.4.9.2048; Borlado LR, 2008, CARCINOGENESIS, V29, P237, DOI 10.1093/carcin/bgm268; Brown EJ, 2000, GENE DEV, V14, P397; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Cook JG, 2002, P NATL ACAD SCI USA, V99, P1347, DOI 10.1073/pnas.032677499; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; Costanzo V, 2003, MOL CELL, V11, P203, DOI 10.1016/S1097-2765(02)00799-2; de Oliveira PEQ, 2009, CELL CYCLE, V8, P3157; Gardner LB, 2008, CELL CYCLE, V7, P1916, DOI 10.4161/cc.7.13.6203; Gardner LB, 2003, MOL CELL BIOL, V23, P9032, DOI 10.1128/MCB.23.24.9032-9045.2003; Gardner LB, 2001, J BIOL CHEM, V276, P7919, DOI 10.1074/jbc.M010189200; GRAEBER TG, 1994, MOL CELL BIOL, V14, P6264, DOI 10.1128/MCB.14.9.6264; Green SL, 2001, MOL CELL BIOL, V21, P1196, DOI 10.1128/MCB.21.4.1196-1206.2001; Green SL, 1998, CANCER J SCI AM, V4, P218; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; Hall JR, 2007, MOL BIOL CELL, V18, P3340, DOI 10.1091/mbc.E07-02-0173; Hammer S, 2007, CELL CYCLE, V6, P1919, DOI 10.4161/cc.6.15.4515; Hammond EM, 2004, DNA REPAIR, V3, P1117, DOI 10.1016/j.dnarep.2004.03.035; Hammond EM, 2004, CANCER RES, V64, P6556, DOI 10.1158/0008-5472.CAN-04-1520; Hammond EM, 2003, MUTAT RES-FUND MOL M, V532, P205, DOI 10.1016/j.mrfmmm.2003.08.017; Hammond EM, 2003, J BIOL CHEM, V278, P12207, DOI 10.1074/jbc.M212360200; Hammond EM, 2002, MOL CELL BIOL, V22, P1834, DOI 10.1128/MCB.22.6.1834-1843.2002; Hateboer G, 1998, MOL CELL BIOL, V18, P6679, DOI 10.1128/MCB.18.11.6679; Heffernan TP, 2007, J BIOL CHEM, V282, P9458, DOI 10.1074/jbc.M611292200; Heffernan TP, 2002, MOL CELL BIOL, V22, P8552, DOI 10.1128/MCB.22.24.8552-8561.2002; Jiang W, 1999, EMBO J, V18, P5703, DOI 10.1093/emboj/18.20.5703; KAUFMANN WK, 1980, BIOCHIM BIOPHYS ACTA, V608, P191, DOI 10.1016/0005-2787(80)90147-1; Koshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196; Lau E, 2006, EMBO REP, V7, P425, DOI 10.1038/sj.embor.7400624; Machida YJ, 2007, GENE DEV, V21, P184, DOI 10.1101/gad.1495007; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Martin L, 2010, J BIOL CHEM, V285, P31944, DOI 10.1074/jbc.M110.153148; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Montagnoli A, 2006, J BIOL CHEM, V281, P10281, DOI 10.1074/jbc.M512921200; Olcina M, 2010, CLIN CANCER RES, V16, P5624, DOI 10.1158/1078-0432.CCR-10-0286; Olive PL, 2002, RADIAT RES, V158, P159, DOI 10.1667/0033-7587(2002)158[0159:TROOIS]2.0.CO;2; Reimann JDR, 2001, CELL, V105, P645, DOI 10.1016/S0092-8674(01)00361-0; Schmaltz C, 1998, MOL CELL BIOL, V18, P2845, DOI 10.1128/MCB.18.5.2845; Sivaprasad U, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-8; Sotillo E, 2009, J BIOL CHEM, V284, P14126, DOI 10.1074/jbc.M900687200; Stoeber K, 1998, EMBO J, V17, P7219, DOI 10.1093/emboj/17.24.7219; Vassin VM, 2004, MOL CELL BIOL, V24, P1930, DOI 10.1128/MCB.24.5.1930-1943.2004; VAUPEL P, 1991, CANCER RES, V51, P3316; Vigo E, 1999, MOL CELL BIOL, V19, P6379; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	47	11	12	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2012	31	36					4076	4084		10.1038/onc.2011.585	http://dx.doi.org/10.1038/onc.2011.585			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	004NQ	22179839	Green Accepted			2022-12-25	WOS:000308688800008
J	Higuchi, M; Iwata, N; Matsuba, Y; Takano, J; Suemoto, T; Maeda, J; Ji, B; Ono, M; Staufenbiel, M; Suhara, T; Saido, TC				Higuchi, Makoto; Iwata, Nobuhisa; Matsuba, Yukio; Takano, Jiro; Suemoto, Takahiro; Maeda, Jun; Ji, Bin; Ono, Maiko; Staufenbiel, Matthias; Suhara, Tetsuya; Saido, Takaomi C.			Mechanistic involvement of the calpain-calpastatin system in Alzheimer neuropathology	FASEB JOURNAL			English	Article						amyloid precursor protein; APP; amyloid beta peptide; A beta; humans; mice	AMYLOID PRECURSOR PROTEIN; TRANSGENIC MOUSE MODEL; BETA-PEPTIDE; SYNAPTIC ACTIVITY; A-BETA; MEDIATED DEGRADATION; CELL-DEATH; ACTIVATION; TAU; PLAQUES	The mechanism by which amyloid-beta peptide (A beta) accumulation causes neurodegeneration in Alzheimer's disease (AD) remains unresolved. Given that A beta perturbs calcium homeostasis in neurons, we investigated the possible involvement of calpain, a calcium-activated neutral protease. We first demonstrated close postsynaptic association of calpain activation with A beta plaque formation in brains from both patients with AD and transgenic (Tg) mice overexpressing amyloid precursor protein (APP). Using a viral vector-based tracer, we then showed that axonal termini were dynamically misdirected to calpain activation-positive A beta plaques. Consistently, cerebrospinal fluid from patients with AD contained a higher level of calpain-cleaved spectrin than that of controls. Genetic deficiency of calpastatin (CS), a calpain-specific inhibitor protein, augmented A beta amyloidosis, tau phosphorylation, microgliosis, and somatodendritic dystrophy, and increased mortality in APP-Tg mice. In contrast, brain-specific CS overexpression had the opposite effect. These findings implicate that calpain activation plays a pivotal role in the A beta-triggered pathological cascade, highlighting a target for pharmacological intervention in the treatment of AD.-Higuchi, M., Iwata, N., Matsuba, Y., Takano, J., Suemoto, T., Maeda, J., Ji, B., Ono, M., Staufenbiel, M., Suhara, T., Saido, T. C. Mechanistic involvement of the calpain-calpastatin system in Alzheimer neuropathology. FASEB J. 26, 1204-1217 (2012). www.fasebj.org	[Higuchi, Makoto; Iwata, Nobuhisa; Matsuba, Yukio; Takano, Jiro; Suemoto, Takahiro; Saido, Takaomi C.] Rikagaku Kenkyujo RIKEN Brain Sci Inst, Lab Proteolyt Neurosci, Wako, Saitama, Japan; [Higuchi, Makoto; Maeda, Jun; Ji, Bin; Suhara, Tetsuya] Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 260, Japan; [Ono, Maiko; Staufenbiel, Matthias] Novartis Inst Biomed Res Basel, Basel, Switzerland	RIKEN; National Institutes for Quantum Science & Technology; Novartis	Saido, TC (corresponding author), RIKEN Brain Sci Inst, Lab Proteolyt Neurosci, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	saido@brain.riken.jp	Sado, Takaomi/AAN-2759-2021; Saido, Takaomi C/N-5472-2015	Sado, Takaomi/0000-0003-1970-6903; Saido, Takaomi C/0000-0003-1970-6903	RIKEN BSI; Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labor, and Welfare of Japan	RIKEN BSI; Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	The authors thank Misaki Sekiguchi, Ryo Fujioka, and Takashi Okauchi for technical assistance. The authors also thank Sangram Sisodia for critical reading of the manuscript. This work was supported by research grants from RIKEN BSI, grants-in-aid for the Molecular Imaging Program, Scientific Research (B) from the Ministry of Education, Culture, Sports, Science, and Technology, and grants from the Ministry of Health, Labor, and Welfare of Japan.	Amadoro G, 2006, P NATL ACAD SCI USA, V103, P2892, DOI 10.1073/pnas.0511065103; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Crews FT, 1996, INT REV NEUROBIOL, V39, P283, DOI 10.1016/S0074-7742(08)60670-4; Cruz JC, 2004, TRENDS MOL MED, V10, P452, DOI 10.1016/j.molmed.2004.07.001; DeMattos RB, 2002, J NEUROCHEM, V81, P229, DOI 10.1046/j.1471-4159.2002.00889.x; Diaz-Villasenor A, 2008, TOXICOL APPL PHARM, V231, P291, DOI 10.1016/j.taap.2008.05.018; Dong YZ, 2006, FASEB J, V20, P331, DOI 10.1096/fj.05-4524fje; Evans JS, 2007, J NEUROCHEM, V103, P849, DOI 10.1111/j.1471-4159.2007.04815.x; Fifre A, 2006, J BIOL CHEM, V281, P229, DOI 10.1074/jbc.M507378200; Fukura H, 1996, J NEUROCHEM, V67, P1426; GEDDES JW, 1986, EXP NEUROL, V94, P767, DOI 10.1016/0014-4886(86)90254-2; Glabe CG, 2006, NEUROLOGY, V66, pS74, DOI 10.1212/01.wnl.0000192103.24796.42; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gomez-Ramos A, 2006, FEBS LETT, V580, P4842, DOI 10.1016/j.febslet.2006.07.078; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hayashi T, 2004, NEUROL RES, V26, P827, DOI 10.1179/016164104X3770; Higuchi M, 2005, J BIOL CHEM, V280, P15229, DOI 10.1074/jbc.M500939200; Higuchi M, 2005, NAT NEUROSCI, V8, P527, DOI 10.1038/nn1422; Higuchi M, 2002, NEURON, V35, P433, DOI 10.1016/S0896-6273(02)00789-4; Higuchi M, 2002, NEUROMOL MED, V2, P131, DOI 10.1385/NMM:2:2:131; Huang SM, 2006, J BIOL CHEM, V281, P17941, DOI 10.1074/jbc.M601372200; Iwata N, 2004, J NEUROSCI, V24, P991, DOI 10.1523/JNEUROSCI.4792-03.2004; Kelly BL, 2006, J BIOL CHEM, V281, P28079, DOI 10.1074/jbc.M605081200; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Kuchibhotla KV, 2008, NEURON, V59, P214, DOI 10.1016/j.neuron.2008.06.008; Liang B, 2010, J BIOL CHEM, V285, P27737, DOI 10.1074/jbc.M110.117960; Liu J, 2008, SCI SIGNAL, V1, DOI [10.1126/stke.114re1, 10.1126/scisignal.123tr3]; Lu XY, 2000, NEUROSCI LETT, V286, P149, DOI 10.1016/S0304-3940(00)01101-0; Maeda J, 2007, J NEUROSCI, V27, P10957, DOI 10.1523/JNEUROSCI.0673-07.2007; Marshall C, 2005, MOL ENDOCRINOL, V19, P213, DOI 10.1210/me.2004-0064; MASLIAH E, 1991, NEURON, V6, P729, DOI 10.1016/0896-6273(91)90170-5; Mathews PM, 2002, J BIOL CHEM, V277, P36415, DOI 10.1074/jbc.M205208200; Mattson MP, 2003, CELL CALCIUM, V34, P385, DOI 10.1016/S0143-4160(03)00128-3; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; NILSSON E, 1990, NEUROBIOL AGING, V11, P425, DOI 10.1016/0197-4580(90)90009-O; NIXON RA, 1994, ANN NY ACAD SCI, V747, P77; Noble W, 2003, NEURON, V38, P555, DOI 10.1016/S0896-6273(03)00259-9; O'Donovan CN, 2001, J BIOL CHEM, V276, P43516, DOI 10.1074/jbc.M103894200; Ohbayashi K, 1998, J NEUROSCI RES, V51, P682, DOI 10.1002/(SICI)1097-4547(19980315)51:6<682::AID-JNR3>3.0.CO;2-7; Park SY, 2005, J NEUROSCI, V25, P5365, DOI 10.1523/JNEUROSCI.1125-05.2005; Phinney AL, 1999, J NEUROSCI, V19, P8552; Porn-Ares MI, 1998, CELL DEATH DIFFER, V5, P1028, DOI 10.1038/sj.cdd.4400424; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; Saido TC, 2006, NEUROSCI RES, V54, P235, DOI 10.1016/j.neures.2005.12.015; SAIDO TC, 1993, J BIOL CHEM, V268, P25239; SAIDO TC, 1994, FEBS LETT, V346, P263, DOI 10.1016/0014-5793(94)00487-0; SAIDO TC, 1992, J BIOCHEM, V111, P81, DOI 10.1093/oxfordjournals.jbchem.a123723; SAIDO TC, 1995, NEURON, V14, P457, DOI 10.1016/0896-6273(95)90301-1; SAITO KI, 1993, P NATL ACAD SCI USA, V90, P2628, DOI 10.1073/pnas.90.7.2628; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Takano J, 2005, J BIOL CHEM, V280, P16175, DOI 10.1074/jbc.M414552200; Taniguchi S, 2001, FEBS LETT, V489, P46, DOI 10.1016/S0014-5793(00)02431-5; Tomioka M, 2002, MOL BRAIN RES, V108, P18, DOI 10.1016/S0169-328X(02)00486-2; Vanderklish PW, 2000, P NATL ACAD SCI USA, V97, P2253, DOI 10.1073/pnas.040565597; Veeranna, 2004, AM J PATHOL, V165, P795, DOI 10.1016/S0002-9440(10)63342-1; Vosler PS, 2008, MOL NEUROBIOL, V38, P78, DOI 10.1007/s12035-008-8036-x; Wang K. K. W., 1992, CALPAIN PHARM TOXICO, P77; Xu W, 2007, NEURON, V53, P399, DOI 10.1016/j.neuron.2006.12.020; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010	62	71	73	0	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2012	26	3					1204	1217		10.1096/fj.11-187740	http://dx.doi.org/10.1096/fj.11-187740			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	901FY	22173972				2022-12-25	WOS:000300949300023
J	Magzoub, M; Miranker, AD				Magzoub, Mazin; Miranker, Andrew D.			Concentration-dependent transitions govern the subcellular localization of islet amyloid polypeptide	FASEB JOURNAL			English	Article						Alzheimer's disease; amylin; Parkinson's disease	BETA-CELL APOPTOSIS; ENDOPLASMIC-RETICULUM STRESS; ALPHA-HELICAL STATES; HUMAN AMYLIN; NMR-SPECTROSCOPY; INTRACELLULAR AMYLOIDOGENESIS; MEMBRANE DISRUPTION; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; DIABETES-MELLITUS	Islet amyloid polypeptide (IAPP) is a peptide hormone cosecreted with insulin by pancreatic beta-cells. In type II diabetes, IAPP aggregates in a process that is associated with beta-cell dysfunction and loss of beta-cell mass. The relationship between IAPP's conformational landscape and its capacity to mediate cell death remains poorly understood. We have addressed these unknowns by comparing the cytotoxic effects of sequence variants with differing alpha-helical and amyloid propensities. IAPP was previously shown to oligomerize cooperatively on binding to lipid bilayers. Here, comparable transitions are evident in cell culture and are associated with a change in subcellular localization to the mitochondria under toxic conditions. Notably, we find that this toxic gain of function maps to IAPP's capacity to adopt aggregated membrane-bound alpha-helical, and not beta-sheet, states. Our findings suggest that upon alpha-helical mediated oligomerization, IAPP acquires cell-penetrating peptide (CPP) properties, facilitating access to the mitochondrial compartment, resulting in its dysfunction.-Magzoub, M. Miranker, A. D. Concentration-dependent transitions govern the subcellular localization of islet amyloid polypeptide. FASEB J. 26, 1228-1238 (2012). www.fasebj.org	[Magzoub, Mazin; Miranker, Andrew D.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Miranker, AD (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 260 Whitney Ave, New Haven, CT 06520 USA.	andrew.miranker@yale.edu			U.S. National Institutes of Health [DK079829, GM094693]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK079829] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094693] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Gary W. Cline and Rebecca Pongratz (Department of Internal Medicine, Yale University) for the gift of INS-1 cells, valuable discussions, and technical assistance with cell culture. The authors thank A. Trexler for assistance with the FCS, Dr. V. Horsley and Dr. K. Nelson for assistance with FACS, Dr. J. Wolenski for assistance with confocal imaging, and N. Last and Dr. G. W. Cline for critical reading of the manuscript. This work was supported by grants from the U.S. National Institutes of Health (DK079829 and GM094693).	Apostolidou M, 2008, J BIOL CHEM, V283, P17205, DOI 10.1074/jbc.M801383200; Bai JZ, 1999, BIOCHEM J, V343, P53, DOI 10.1042/0264-6021:3430053; Brender JR, 2008, BIOCHEMISTRY-US, V47, P12680, DOI 10.1021/bi801427c; Butler AE, 2003, DIABETES, V52, P2304, DOI 10.2337/diabetes.52.9.2304; Butler AE, 2004, DIABETES, V53, P1509, DOI 10.2337/diabetes.53.6.1509; Casas S, 2007, DIABETES, V56, P2284, DOI 10.2337/db07-0178; Clark A, 2004, DIABETOLOGIA, V47, P157, DOI 10.1007/s00125-003-1304-4; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Du DG, 2011, BIOCHEMISTRY-US, V50, P1607, DOI 10.1021/bi1013744; Efanova IB, 1998, J BIOL CHEM, V273, P33501, DOI 10.1074/jbc.273.50.33501; Gurlo T, 2010, AM J PATHOL, V176, P861, DOI 10.2353/ajpath.2010.090532; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; Hebda JA, 2009, CHEM BIOL, V16, P943, DOI 10.1016/j.chembiol.2009.08.013; Hebda JA, 2009, ANNU REV BIOPHYS, V38, P125, DOI 10.1146/annurev.biophys.050708.133622; Hiddinga HJ, 1999, AM J PATHOL, V154, P1077, DOI 10.1016/S0002-9440(10)65360-6; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hoppener JWM, 1999, DIABETOLOGIA, V42, P427, DOI 10.1007/s001250051175; Hoppener JWM, 2000, NEW ENGL J MED, V343, P411; Hull RL, 2004, J CLIN ENDOCR METAB, V89, P3629, DOI 10.1210/jc.2004-0405; Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491; Kahn SE, 1999, DIABETES, V48, P241, DOI 10.2337/diabetes.48.2.241; Kapurniotu A, 2001, BIOPOLYMERS, V60, P438, DOI 10.1002/1097-0282(2001)60:6<438::AID-BIP10182>3.0.CO;2-A; Knight JD, 2006, BIOCHEMISTRY-US, V45, P9496, DOI 10.1021/bi060579z; Konarkowska B, 2006, FEBS J, V273, P3614, DOI 10.1111/j.1742-4658.2006.05367.x; Koo BW, 2008, PROTEIN ENG DES SEL, V21, P147, DOI 10.1093/protein/gzm076; Last NB, 2011, P NATL ACAD SCI USA, V108, P9460, DOI 10.1073/pnas.1102356108; Li XL, 2011, INT J BIOCHEM CELL B, V43, P525, DOI 10.1016/j.biocel.2010.12.008; Lim YA, 2008, FEBS LETT, V582, P2188, DOI 10.1016/j.febslet.2008.05.006; Lim YA, 2010, PROTEOMICS, V10, P1621, DOI 10.1002/pmic.200900651; Lin CY, 2007, DIABETES, V56, P1324, DOI 10.2337/db06-1579; Liu ML, 2005, EXP MOL MED, V37, P559, DOI 10.1038/emm.2005.69; Luca S, 2007, BIOCHEMISTRY-US, V46, P13505, DOI 10.1021/bi701427q; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Magzoub M, 2004, Q REV BIOPHYS, V37, P147, DOI 10.1017/S0033583505004014; Matveyenko AV, 2006, DIABETES, V55, P2106, DOI 10.2337/db05-1672; Matveyenko AV, 2009, DIABETES, V58, P906, DOI 10.2337/db08-1464; McNeil PL, 2002, J CELL SCI, V115, P873; MCNEIL PL, 1984, J CELL BIOL, V98, P1556, DOI 10.1083/jcb.98.4.1556; MCNEIL PL, 1989, METHOD CELL BIOL, V29, P153; Meier JJ, 2006, AM J PHYSIOL-ENDOC M, V291, pE1317, DOI 10.1152/ajpendo.00082.2006; Middleton ER, 2010, BIOPHYS J, V99, P2279, DOI 10.1016/j.bpj.2010.07.056; Mirzabekov TA, 1996, J BIOL CHEM, V271, P1988, DOI 10.1074/jbc.271.4.1988; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Nakamura K, 2008, J NEUROSCI, V28, P12305, DOI 10.1523/JNEUROSCI.3088-08.2008; Nanga RPR, 2009, J AM CHEM SOC, V131, P8252, DOI 10.1021/ja9010095; Nanga RPR, 2008, BIOCHEMISTRY-US, V47, P12689, DOI 10.1021/bi8014357; Nath A, 2011, ANGEW CHEM INT EDIT, V50, P10859, DOI 10.1002/anie.201102887; Neve RL, 1998, TRENDS NEUROSCI, V21, P15, DOI 10.1016/S0166-2236(97)01168-5; OBRIEN T, 1995, AM J PATHOL, V147, P609; Palm-Apergi C, 2009, FASEB J, V23, P214, DOI 10.1096/fj.08-110254; Patil SM, 2009, J BIOL CHEM, V284, P11982, DOI 10.1074/jbc.M809085200; Potter KJ, 2010, P NATL ACAD SCI USA, V107, P4305, DOI 10.1073/pnas.0909024107; Riss TL, 2004, ASSAY DRUG DEV TECHN, V2, P51, DOI 10.1089/154065804322966315; Ritzel RA, 2003, DIABETES, V52, P1701, DOI 10.2337/diabetes.52.7.1701; Rumora L, 2002, BIOL CHEM, V383, P1751, DOI 10.1515/BC.2002.196; Ruschak AM, 2007, P NATL ACAD SCI USA, V104, P12341, DOI 10.1073/pnas.0703306104; SAMPATH P, 1991, BIOCHEMISTRY-US, V30, P1973, DOI 10.1021/bi00221a034; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Soong R, 2009, J AM CHEM SOC, V131, P7079, DOI 10.1021/ja900285z; Soto C, 1996, BIOCHEM J, V314, P701, DOI 10.1042/bj3140701; Terasaki M, 1997, J CELL BIOL, V139, P63, DOI 10.1083/jcb.139.1.63; Tschop M, 2001, EXP CLIN ENDOCR DIAB, V109, P307, DOI 10.1055/s-2001-17297; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P5036, DOI 10.1073/pnas.87.13.5036; Williamson JA, 2007, PROTEIN SCI, V16, P110, DOI 10.1110/ps.062486907; Williamson JA, 2009, J MOL BIOL, V393, P383, DOI 10.1016/j.jmb.2009.07.077; Wiltzius JJW, 2009, PROTEIN SCI, V18, P1521, DOI 10.1002/pro.145	71	69	70	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2012	26	3					1228	1238		10.1096/fj.11-194613	http://dx.doi.org/10.1096/fj.11-194613			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	901FY	22183778	Green Published			2022-12-25	WOS:000300949300025
J	Madan, R; Rastogi, R; Parashuraman, S; Mukhopadhyay, A				Madan, Richa; Rastogi, Ruchir; Parashuraman, Seetharaman; Mukhopadhyay, Amitabha			Salmonella Acquires Lysosome-associated Membrane Protein 1 (LAMP1) on Phagosomes from Golgi via SipC Protein-mediated Recruitment of Host Syntaxin6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOINOSITIDE PHOSPHATASE; MYCOBACTERIUM-TUBERCULOSIS; CONTAINING VACUOLE; SNARE COMPLEX; RAB PROTEINS; TRAFFICKING; EFFECTOR; TRANSPORT; MATURATION; FUSION	Several intracellular pathogens have developed diverse strategies to avoid targeting to lysosomes. However, they universally recruit lysosome-associated membrane protein 1 (LAMP1); the mechanism of LAMP1 recruitment remains unclear. Here, we report that a Salmonella effector protein, SipC, specifically binds with host Syntaxin6 through its C terminus and thereby recruits Syntaxin6 and other accessory molecules like VAMP2, Rab6, and Rab8 on Salmonella-containing phagosomes (SCP) and acquires LAMP1 by fusing with LAMP1-containing Golgi-derived vesicles. In contrast, sipC knock-out: SCP (sipC(-) : SCP) or sipC(M398K): SCP fails to obtain significant amounts of Syntaxin6 and is unable to acquire LAMP1. Moreover, phagosomes containing respective knock-out Salmonella like sipA(-), sipB(-), sipD(-), sopB(-), or sopE(-) recruit LAMP1, demonstrating the specificity of SipC in this process. In addition, depletion of Syntaxin6 by shRNA in macrophages significantly inhibits LAMP1 recruitment on SCP. Additionally, survival of sipC(-) : Salmonella in mice is found to be significantly inhibited in comparison with WT: Salmonella. Our results reveal a novel mechanism showing how Salmonella acquires LAMP1 through a SipC-Syntaxin6-mediated interaction probably to stabilize their niche in macrophages and also suggest that similar modalities might be used by other intracellular pathogens to recruit LAMP1.	[Mukhopadhyay, Amitabha] Natl Inst Immunol, Cell Biol Lab, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Mukhopadhyay, A (corresponding author), Natl Inst Immunol, Cell Biol Lab, New Delhi 110067, India.	amitabha@nii.res.in	Lomash, Richa Madan/I-1307-2019; parashuraman, seetharaman/ABE-2639-2020; Parashuraman, Seetharaman/P-3389-2014	parashuraman, seetharaman/0000-0001-5113-4592; Parashuraman, Seetharaman/0000-0001-5113-4592	National Institute of Immunology, Government of India, New Delhi, India; Council of Scientific and Industrial Research, Government of India	National Institute of Immunology, Government of India, New Delhi, India; Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by a grant from National Institute of Immunology, Government of India, New Delhi, India.; Supported by a fellowship from the Council of Scientific and Industrial Research, Government of India.	Akasaki K, 1996, J BIOCHEM-TOKYO, V120, P1088; Bakowski MA, 2010, CELL HOST MICROBE, V7, P453, DOI 10.1016/j.chom.2010.05.011; Bethani I, 2007, EMBO J, V26, P3981, DOI 10.1038/sj.emboj.7601820; Braun V, 2010, CELL MICROBIOL, V12, P1352, DOI 10.1111/j.1462-5822.2010.01476.x; Brawn LC, 2007, CELL HOST MICROBE, V1, P63, DOI 10.1016/j.chom.2007.02.001; Brurnell JH, 2007, MICROBIOL MOL BIOL R, V71, P636, DOI 10.1128/MMBR.00023-07; Carlton J, 2005, TRAFFIC, V6, P75, DOI 10.1111/j.1600-0854.2005.00260.x; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Chang JH, 2005, MOL MICROBIOL, V55, P1379, DOI 10.1111/j.1365-2958.2004.04480.x; Cook NR, 2004, TRAFFIC, V5, P685, DOI 10.1111/j.1600-0854.2004.00212.x; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Davanger S, 1997, MOL BIOL CELL, V8, P1261, DOI 10.1091/mbc.8.7.1261; del Toro D, 2009, MOL BIOL CELL, V20, P1478, DOI 10.1091/mbc.E08-07-0726; Delahay RM, 2002, MOL MICROBIOL, V45, P905, DOI 10.1046/j.1365-2958.2002.03083.x; Delevoye C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000022; Dowse T, 2004, CURR OPIN MICROBIOL, V7, P388, DOI 10.1016/j.mib.2004.06.013; Drecktrah D, 2007, TRAFFIC, V8, P212, DOI 10.1111/j.1600-0854.2006.00529.x; Dukes JD, 2006, BIOCHEM J, V395, P239, DOI 10.1042/BJ20051451; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Giacomodonato MN, 2007, MICROBIOL-SGM, V153, P1221, DOI 10.1099/mic.0.2006/002758-0; HACKSTADT T, 1995, P NATL ACAD SCI USA, V92, P4877, DOI 10.1073/pnas.92.11.4877; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hashim S, 2000, J BIOL CHEM, V275, P16281, DOI 10.1074/jbc.275.21.16281; Hayward RD, 1999, EMBO J, V18, P4926, DOI 10.1093/emboj/18.18.4926; Hubber A, 2010, ANNU REV CELL DEV BI, V26, P261, DOI 10.1146/annurev-cellbio-100109-104034; HUBER LA, 1993, J CELL BIOL, V123, P35, DOI 10.1083/jcb.123.1.35; Humphreys D, 2009, CELL HOST MICROBE, V5, P225, DOI 10.1016/j.chom.2009.01.010; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kagan JC, 2002, NAT CELL BIOL, V4, P945, DOI 10.1038/ncb883; Kreykenbohm V, 2002, EUR J CELL BIOL, V81, P273, DOI 10.1078/0171-9335-00247; Kuhle V, 2006, TRAFFIC, V7, P716, DOI 10.1111/j.1600-0854.2006.00422.x; Liewen H, 2005, EXP CELL RES, V306, P24, DOI 10.1016/j.yexcr.2005.01.022; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; Ly KT, 2007, CELL MICROBIOL, V9, P2103, DOI 10.1111/j.1462-5822.2007.00992.x; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; McGhie EJ, 2009, CURR OPIN MICROBIOL, V12, P117, DOI 10.1016/j.mib.2008.12.001; Moore ER, 2011, MICROBIOL-SGM, V157, P830, DOI 10.1099/mic.0.045856-0; Mukherjee K, 2000, J CELL BIOL, V148, P741, DOI 10.1083/jcb.148.4.741; Murray RZ, 2005, J BIOL CHEM, V280, P10478, DOI 10.1074/jbc.M414420200; Nichols CD, 2010, CURR BIOL, V20, P1316, DOI 10.1016/j.cub.2010.05.065; Parashuraman S, 2010, FEBS LETT, V584, P1251, DOI 10.1016/j.febslet.2010.02.040; Ramsden AE, 2007, TRENDS MICROBIOL, V15, P516, DOI 10.1016/j.tim.2007.10.002; Rohde K, 2007, IMMUNOL REV, V219, P37, DOI 10.1111/j.1600-065X.2007.00547.x; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Salcedo SP, 2005, CURR OPIN MICROBIOL, V8, P92, DOI 10.1016/j.mib.2004.12.007; Salcedo SP, 2003, EMBO J, V22, P5003, DOI 10.1093/emboj/cdg517; Scherer CA, 2000, MOL MICROBIOL, V37, P1133, DOI 10.1046/j.1365-2958.2000.02066.x; Simonsen A, 1999, J BIOL CHEM, V274, P28857, DOI 10.1074/jbc.274.41.28857; Smith AC, 2005, J BIOL CHEM, V280, P24634, DOI 10.1074/jbc.M500358200; Steele-Mortimer O, 2008, CURR OPIN MICROBIOL, V11, P38, DOI 10.1016/j.mib.2008.01.002; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Voos W, 1998, J CELL BIOL, V140, P577, DOI 10.1083/jcb.140.3.577; Weber SS, 2009, MOL MICROBIOL, V71, P1341, DOI 10.1111/j.1365-2958.2009.06608.x; Wendler F, 2001, MOL BIOL CELL, V12, P1699, DOI 10.1091/mbc.12.6.1699; Wendler F, 2001, TRAFFIC, V2, P606, DOI 10.1034/j.1600-0854.2001.20903.x; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Xu Y, 2001, NAT CELL BIOL, V3, P658, DOI 10.1038/35083051; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhou D, 1999, SCIENCE, V283, P2092, DOI 10.1126/science.283.5410.2092	60	23	23	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5574	5587		10.1074/jbc.M111.286120	http://dx.doi.org/10.1074/jbc.M111.286120			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22190682	hybrid, Green Published			2022-12-25	WOS:000300638000036
J	Ramakrishnan, S; Docampo, MD; MacRae, JI; Pujol, FM; Brooks, CF; van Dooren, GG; Hiltunen, JK; Kastaniotis, AJ; McConville, MJ; Striepen, B				Ramakrishnan, Srinivasan; Docampo, Melissa D.; MacRae, James I.; Pujol, Francois M.; Brooks, Carrie F.; van Dooren, Giel G.; Hiltunen, J. Kalervo; Kastaniotis, Alexander J.; McConville, Malcolm J.; Striepen, Boris			Apicoplast and Endoplasmic Reticulum Cooperate in Fatty Acid Biosynthesis in Apicomplexan Parasite Toxoplasma gondii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEAROYL-COA DESATURASE; PLASMODIUM-FALCIPARUM; CRYPTOSPORIDIUM-PARVUM; FUNCTIONAL-CHARACTERIZATION; SYNTHASE; MALARIA; GROWTH; GENE; ELONGATION; METABOLISM	Apicomplexan parasites are responsible for high impact human diseases such as malaria, toxoplasmosis, and cryptosporidiosis. These obligate intracellular pathogens are dependent on both de novo lipid biosynthesis as well as the uptake of host lipids for biogenesis of parasite membranes. Genome annotations and biochemical studies indicate that apicomplexan parasites can synthesize fatty acids via a number of different biosynthetic pathways that are differentially compartmentalized. However, the relative contribution of each of these biosynthetic pathways to total fatty acid composition of intracellular parasite stages remains poorly defined. Here, we use a combination of genetic, biochemical, and metabolomic approaches to delineate the contribution of fatty acid biosynthetic pathways in Toxoplasma gondii. Metabolic labeling studies with [C-13] glucose showed that intracellular tachyzoites synthesized a range of long and very long chain fatty acids (C14:0-26: 1). Genetic disruption of the apicoplast-localized type II fatty-acid synthase resulted in greatly reduced synthesis of saturated fatty acids up to 18 carbons long. Ablation of type II fatty-acid synthase activity resulted in reduced intracellular growth that was partially restored by addition of long chain fatty acids. In contrast, synthesis of very long chain fatty acids was primarily dependent on a fatty acid elongation system comprising three elongases, two reductases, and a dehydratase that were localized to the endoplasmic reticulum. The function of these enzymes was confirmed by heterologous expression in yeast. This elongase pathway appears to have a unique role in generating very long unsaturated fatty acids (C26:1) that cannot be salvaged from the host.	[Brooks, Carrie F.; van Dooren, Giel G.; Striepen, Boris] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Ramakrishnan, Srinivasan; Docampo, Melissa D.; Striepen, Boris] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [MacRae, James I.; McConville, Malcolm J.] Univ Melbourne, Dept Biochem & Mol Biol, Inst Mol Sci & Biotechnol Bio21, Parkville, Vic 3010, Australia; [Pujol, Francois M.; Hiltunen, J. Kalervo; Kastaniotis, Alexander J.] Univ Oulu, Dept Biochem, FIN-90014 Oulu, Finland; [Pujol, Francois M.; Hiltunen, J. Kalervo; Kastaniotis, Alexander J.] Univ Oulu, Bioctr Oulu, FIN-90014 Oulu, Finland	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Melbourne; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu	Striepen, B (corresponding author), Univ Georgia, Ctr Trop & Emerging Global Dis, 500 DW Brooks Dr, Athens, GA 30602 USA.	striepen@uga.edu	van Dooren, Giel G/A-8896-2012	van Dooren, Giel G/0000-0003-2455-9821; RAMAKRISHNAN, SRINIVASAN/0000-0001-8370-0528; Kastaniotis, Alexander/0000-0003-3624-9214; Hiltunen, Kalervo/0000-0002-3073-9602; MacRae, James/0000-0002-1464-8583; Striepen, Boris/0000-0002-7426-432X	National Institutes of Health [AI084414, AI064671]; National Health and Medical Research Council [1006024]; American Heart Association; Academy of Finland; Sigrid Juselius Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064671, R01AI084415, R56AI084414] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); American Heart Association(American Heart Association); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI084414 and AI064671 (to B. S.). This work was also supported by National Health and Medical Research Council Grant 1006024 (to M. J. M.).; Supported by a predoctoral fellowship from the American Heart Association.; Recipient of funding from the Academy of Finland and the Sigrid Juselius Foundation.	Agrawal S, 2009, J BIOL CHEM, V284, P33683, DOI 10.1074/jbc.M109.044024; Amberg D. C., 2005, METHODS YEAST GENETI, P207; Bach L, 2008, P NATL ACAD SCI USA, V105, P14727, DOI 10.1073/pnas.0805089105; Bhatt A, 2007, MOL MICROBIOL, V64, P1442, DOI 10.1111/j.1365-2958.2007.05761.x; Brooks CF, 2010, CELL HOST MICROBE, V7, P62, DOI 10.1016/j.chom.2009.12.002; Carey KL, 2000, MOL BIOCHEM PARASIT, V105, P25, DOI 10.1016/S0166-6851(99)00160-7; Charron AJ, 2002, J CELL SCI, V115, P3049; CINTI DL, 1992, PROG LIPID RES, V31, P1, DOI 10.1016/0163-7827(92)90014-A; Coppens I, 2006, CELL, V125, P261, DOI 10.1016/j.cell.2006.01.056; Coppens I, 2005, INT J PARASITOL, V35, P597, DOI 10.1016/j.ijpara.2005.01.009; Coppens I, 2006, CELL MICROBIOL, V8, P1, DOI 10.1111/j.1462-5822.2005.00647.x; Denic V, 2007, CELL, V130, P663, DOI 10.1016/j.cell.2007.06.031; GEROLD P, 1994, J BIOL CHEM, V269, P2597; Goodman CD, 2007, CURR DRUG TARGETS, V8, P15, DOI 10.2174/138945007779315579; Gratraud P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006889; Gubbels MJ, 2003, ANTIMICROB AGENTS CH, V47, P309, DOI 10.1128/AAC.47.1.309-316.2003; Gupta N, 2005, J BIOL CHEM, V280, P16345, DOI 10.1074/jbc.M501523200; Hager KM, 1999, J CELL SCI, V112, P2631; Hiltunen JK, 2010, PROG LIPID RES, V49, P27, DOI 10.1016/j.plipres.2009.08.001; Jelenska J, 2001, P NATL ACAD SCI USA, V98, P2723, DOI 10.1073/pnas.051629998; Kastaniotis AJ, 2004, MOL MICROBIOL, V53, P1407, DOI 10.1111/j.1365-2958.2004.04191.x; Koo AJK, 2004, J BIOL CHEM, V279, P16101, DOI 10.1074/jbc.M311305200; Lige B, 2009, MOL BIOL CELL, V20, P658, DOI 10.1091/mbc.E08-05-0482; Lim L, 2010, FEBS LETT, V584, P549, DOI 10.1016/j.febslet.2009.11.097; Mazumdar J, 2007, EUKARYOT CELL, V6, P1727, DOI 10.1128/EC.00255-07; Mazumdar J, 2006, P NATL ACAD SCI USA, V103, P13192, DOI 10.1073/pnas.0603391103; McLeod R, 2001, INT J PARASITOL, V31, P109, DOI 10.1016/S0020-7519(01)00111-4; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; Mikolajczak SA, 2007, INT J PARASITOL, V37, P483, DOI 10.1016/j.ijpara.2007.01.002; Misra A, 2009, MOL BIOSYST, V5, P651, DOI 10.1039/b820420a; Nair SC, 2011, J EXP MED, V208, P1547, DOI 10.1084/jem.20110039; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; Prigge ST, 2003, BIOCHEMISTRY-US, V42, P1160, DOI 10.1021/bi026847k; Qin YM, 2005, CELL RES, V15, P465, DOI 10.1038/sj.cr.7290315; Qin YM, 2007, J EXP BOT, V58, P473, DOI 10.1093/jxb/erl218; Saunders EC, 2011, J BIOL CHEM, V286, P27706, DOI 10.1074/jbc.M110.213553; Sharma A, 2008, J BIOL CHEM, V283, P24077, DOI 10.1074/jbc.M801946200; Song WQ, 2009, J EXP BOT, V60, P1839, DOI 10.1093/jxb/erp057; Striepen B., 2007, P391, DOI 10.1016/B978-012369542-0/50017-9; STUKEY JE, 1990, J BIOL CHEM, V265, P20144; Surolia N, 2001, NAT MED, V7, P167, DOI 10.1038/84612; Valdivia RH, 2008, CURR OPIN MICROBIOL, V11, P53, DOI 10.1016/j.mib.2008.01.003; Vaughan AM, 2009, CELL MICROBIOL, V11, P506, DOI 10.1111/j.1462-5822.2008.01270.x; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; Welti R, 2007, BIOCHEMISTRY-US, V46, P13882, DOI 10.1021/bi7011993; Wu GZ, 2010, PLANT CELL, V22, P3726, DOI 10.1105/tpc.110.075564; Yeh E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001138; Yu Min, 2008, Cell Host Microbe, V4, P567, DOI 10.1016/j.chom.2008.11.001; Zhu G, 2004, J EUKARYOT MICROBIOL, V51, P381, DOI 10.1111/j.1550-7408.2004.tb00384.x; Zhu G, 2004, MOL BIOCHEM PARASIT, V134, P127, DOI 10.1016/j.molbiopara.2003.11.011; Zhu G, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-46	51	97	100	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4957	4971		10.1074/jbc.M111.310144	http://dx.doi.org/10.1074/jbc.M111.310144			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22179608	Green Published, hybrid			2022-12-25	WOS:000300608500056
J	Sun, J; Lee, KJ; Davis, AJ; Chen, DJ				Sun, Jingxin; Lee, Kyung-Jong; Davis, Anthony J.; Chen, David J.			Human Ku70/80 Protein Blocks Exonuclease 1-mediated DNA Resection in the Presence of Human Mre11 or Mre11/Rad50 Protein Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; SACCHAROMYCES-CEREVISIAE; MAMMALIAN-CELLS; GENOMIC INTEGRITY; DAMAGE SITES; REPAIR; KU; END; RAD50	DNA double strand breaks (DSB) are repaired by nonhomologous end-joining (NHEJ) or homologous recombination (HR). Recent genetic data in yeast shows that the choice between these two pathways for the repair of DSBs is via competition between the NHEJ protein, Ku, and the HR protein, Mre11/Rad50/Xrs2 (MRX) complex. To study the interrelationship between human Ku and Mre11 or Mre11/Rad50 (MR), we established an in vitro DNA end resection system using a forked model dsDNA substrate and purified human Ku70/80, Mre11, Mre11/Rad50, and exonuclease 1 (Exo1). Our study shows that the addition of Ku70/80 blocks Exo1-mediated DNA end resection of the forked dsDNA substrate. Although human Mre11 and MR bind to the forked double strand DNA, they could not compete with Ku for DNA ends or actively mediate the displacement of Ku from the DNA end either physically or via its exonuclease or endonuclease activity. Our in vitro studies show that Ku can block DNA resection and suggest that Ku must be actively displaced for DNA end processing to occur and is more complicated than the competition model established in yeast.	[Sun, Jingxin; Lee, Kyung-Jong; Davis, Anthony J.; Chen, David J.] Univ Texas SW Med Ctr Dallas, Div Mol Radiat Biol, Dept Radiat Oncol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Chen, DJ (corresponding author), 2201 Inwood Rd, Dallas, TX 75390 USA.	david.chen@utsouthwestern.edu	Classen, Scott/AAY-8176-2020	Davis, Anthony/0000-0003-0184-3651	National Institutes of Health [CA50519, CA134991, CA92584]; Cancer Research Institute of Texas [RP110465]; NATIONAL CANCER INSTITUTE [R01CA162804, R01CA050519, R01CA134991, R37CA050519, P01CA092584] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA50519, CA134991, and CA92584 and Cancer Research Institute of Texas Grant RP110465.	Allen C, 2002, P NATL ACAD SCI USA, V99, P3758, DOI 10.1073/pnas.052545899; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Buis J, 2008, CELL, V135, P85, DOI 10.1016/j.cell.2008.08.015; Burma S, 2006, DNA REPAIR, V5, P1042, DOI 10.1016/j.dnarep.2006.05.026; Couedel C, 2004, GENE DEV, V18, P1293, DOI 10.1101/gad.1209204; FALZON M, 1993, J BIOL CHEM, V268, P10546; Feldmann H, 1996, J BIOL CHEM, V271, P27765, DOI 10.1074/jbc.271.44.27765; Fiorentini P, 1997, MOL CELL BIOL, V17, P2764, DOI 10.1128/MCB.17.5.2764; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; Kass EM, 2010, FEBS LETT, V584, P3703, DOI 10.1016/j.febslet.2010.07.057; Kim JS, 2005, J CELL BIOL, V170, P341, DOI 10.1083/jcb.200411083; Langerak P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002271; Lim HS, 2011, GENE DEV, V25, P1091, DOI 10.1101/gad.2037811; LINDAHL T, 1993, COLD SPRING HARB SYM, V58, P619, DOI 10.1101/SQB.1993.058.01.068; Llorente B, 2004, MOL CELL BIOL, V24, P9682, DOI 10.1128/MCB.24.21.9682-9694.2004; Mimitou EP, 2010, EMBO J, V29, P3358, DOI 10.1038/emboj.2010.193; Pastink A, 2001, MUTAT RES-FUND MOL M, V480, P37, DOI 10.1016/S0027-5107(01)00167-1; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Shao ZP, 2012, DNA REPAIR, V11, P310, DOI 10.1016/j.dnarep.2011.12.007; Shim EY, 2010, EMBO J, V29, P3370, DOI 10.1038/emboj.2010.219; Siede W, 1996, GENETICS, V142, P91; So SR, 2009, J CELL BIOL, V187, P977, DOI 10.1083/jcb.200906064; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; SUN H, 1991, CELL, V64, P1155, DOI 10.1016/0092-8674(91)90270-9; Tomita K, 2003, MOL CELL BIOL, V23, P5186, DOI 10.1128/MCB.23.15.5186-5197.2003; Uematsu N, 2007, J CELL BIOL, V177, P219, DOI 10.1083/jcb.200608077; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; WHITE MB, 1990, MOL CELL BIOL, V10, P3690, DOI 10.1128/MCB.10.7.3690; Williams GJ, 2011, NAT STRUCT MOL BIOL, V18, P423, DOI 10.1038/nsmb.2038; Wu DL, 2008, GENETICS, V178, P1237, DOI 10.1534/genetics.107.083535; Yoo S, 1999, J BIOL CHEM, V274, P20034, DOI 10.1074/jbc.274.28.20034	34	54	58	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4936	4945		10.1074/jbc.M111.306167	http://dx.doi.org/10.1074/jbc.M111.306167			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22179609	Green Published, hybrid			2022-12-25	WOS:000300608500054
J	Xie, YP; He, YP; Gehring, A; Hu, Y; Li, QQ; Tu, SI; Shi, XM				Xie, Yanping; He, Yiping; Gehring, Andrew; Hu, Yu; Li, Qiongqiong; Tu, Shu-I; Shi, Xianming			Genotypes and Toxin Gene Profiles of Staphylococcus aureus Clinical Isolates from China	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; MULTIPLEX PCR; METHICILLIN-RESISTANT; EXFOLIATIVE TOXINS; RIBOSOMAL-RNA; STRAINS; AGR; SUPERANTIGEN; ENTEROTOXIN; INFECTIONS	A total of 108 S. aureus isolates from 16 major hospitals located in 14 different provinces in China were characterized for the profiles of 18 staphylococcal enterotoxin (SE) genes, 3 exfoliatin genes (eta, etb and etd), and the toxic shock syndrome toxin gene (tsst) by PCR. The genomic diversity of each isolate was also evaluated by pulsed-field gel electrophoresis (PFGE), multilocus sequence typing (MLST), and accessory gene regulator (agr) typing. Of these strains, 90.7% (98/108) harbored toxin genes, in which tsst was the most prevalent toxin gene (48.1%), followed by sea (44.4%), sek (42.6%) and seq (40.7%). The see and etb genes were not found in any of the isolates tested. Because of high-frequency transfer of toxin gene-containing mobile genetic elements between S. aureus strains, a total of 47 different toxin gene combinations were detected, including a complete egc cluster in 19 isolates, co-occurrence of sea, sek and seq in 38 strains, and sec and sel together in 11 strains. Genetic typing by PFGE grouped all the strains into 25 clusters based on 80% similarity. MLST revealed 25 sequence types (ST) which were assigned into 16 clonal complexes (CCs) including 2 new singletons. Among these, 11 new and 6 known STs were first reported in the S. aureus strains from China. Overall, the genotyping results showed high genetic diversity of the strains regardless of their geographical distributions, and no strong correlation between genetic background and toxin genotypes of the strains. For genotyping S. aureus, PFGE appears to be more discriminatory than MLST. However, toxin gene typing combined with PFGE or MLST could increase the discriminatory power of genotyping S. aureus strains.	[Xie, Yanping; Hu, Yu; Li, Qiongqiong; Shi, Xianming] Shanghai Jiao Tong Univ, Sch Agr & Biol, Bor Luh Food Safety Ctr, Shanghai 200030, Peoples R China; [He, Yiping; Gehring, Andrew; Tu, Shu-I] ARS, Mol Characterizat Foodborne Pathogens Res Unit, USDA, Eastern Reg Res Ctr, Wyndmoor, PA USA	Shanghai Jiao Tong University; United States Department of Agriculture (USDA)	Xie, YP (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Bor Luh Food Safety Ctr, Shanghai 200030, Peoples R China.	yiping.he@ars.usda.gov; xmshi@sjtu.edu.cn	Xie, Yanping/C-7950-2016; Xu, Huanyu/C-7860-2016		Ministry of Science and Technology of China [2011DFA31220]; National Natural Science Foundation of China [30972485, 31171690]; Agriculture Research Service, U.S. Department of Agriculture	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agriculture Research Service, U.S. Department of Agriculture(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was jointly supported by the Ministry of Science and Technology of China (grant no. 2011DFA31220), National Natural Science Foundation of China (grant nos. 30972485 and 31171690), and the Agriculture Research Service, U.S. Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argudin MA, 2010, TOXINS, V2, P1751, DOI 10.3390/toxins2071751; Argudin MA, 2009, J CLIN MICROBIOL, V47, P2097, DOI 10.1128/JCM.01486-08; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; BANNERMAN TL, 1995, J CLIN MICROBIOL, V33, P551, DOI 10.1128/JCM.33.3.551-555.1995; Becker K, 2003, J CLIN MICROBIOL, V41, P1434, DOI 10.1128/JCM.41.4.1434-1439.2003; BROSIUS J, 1981, J MOL BIOL, V148, P107, DOI 10.1016/0022-2836(81)90508-8; Campbell SJ, 2008, J CLIN MICROBIOL, V46, P678, DOI 10.1128/JCM.01822-07; Chen Chih-Jung, 2005, Journal of Microbiology Immunology and Infection, V38, P376; Cremonesi P, 2005, MOL CELL PROBE, V19, P299, DOI 10.1016/j.mcp.2005.03.002; Fan YL, 2008, J RAPID METH AUT MIC, V16, P394, DOI 10.1111/j.1745-4581.2008.00144.x; Gilot P, 2002, J CLIN MICROBIOL, V40, P4060, DOI 10.1128/JCM.40.11.4060-4067.2002; Hallin M, 2007, J CLIN MICROBIOL, V45, P127, DOI 10.1128/JCM.01866-06; Harbottle H, 2006, J CLIN MICROBIOL, V44, P2449, DOI 10.1128/JCM.00019-06; Holtfreter S, 2007, J CLIN MICROBIOL, V45, P2669, DOI 10.1128/JCM.00204-07; Hwang SY, 2007, INT J FOOD MICROBIOL, V117, P99, DOI 10.1016/j.ijfoodmicro.2007.02.013; Irwin P, 2008, ANAL BIOANAL CHEM, V391, P525, DOI 10.1007/s00216-008-1959-2; Jarraud S, 2000, J BACTERIOL, V182, P6517, DOI 10.1128/JB.182.22.6517-6522.2000; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; Ji GY, 1997, SCIENCE, V276, P2027, DOI 10.1126/science.276.5321.2027; JOHNSON WM, 1991, J CLIN MICROBIOL, V29, P426, DOI 10.1128/JCM.29.3.426-430.1991; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Lindsay Jodi A., 2006, Functional & Integrative Genomics, V6, P186, DOI 10.1007/s10142-005-0019-7; Lowy FD, 2007, J INFECT DIS, V196, P911, DOI 10.1086/520933; Nakaminami H, 2008, J MED MICROBIOL, V57, P1251, DOI 10.1099/jmm.0.2008/002824-0; Noto MJ, 2006, ANTIMICROB AGENTS CH, V50, P2782, DOI 10.1128/AAC.00032-06; Novick RP, 2010, NAT REV MICROBIOL, V8, P541, DOI 10.1038/nrmicro2393; Omoe K, 2003, INFECT IMMUN, V71, P6088, DOI 10.1128/IAI.71.10.6088-6094.2003; Peacock SJ, 2002, J CLIN MICROBIOL, V40, P3764, DOI 10.1128/JCM.40.10.3764-3770.2002; Peerayeh SN, 2009, LABMEDICINE, V40, P27, DOI 10.1309/LMGB9GB82WKDANWF; Rosec JP, 2002, INT J FOOD MICROBIOL, V77, P61, DOI 10.1016/S0168-1605(02)00044-2; Sharma NK, 2000, APPL ENVIRON MICROB, V66, P1347, DOI 10.1128/AEM.66.4.1347-1353.2000; Srinivasan V, 2006, FOODBORNE PATHOG DIS, V3, P274, DOI 10.1089/fpd.2006.3.274; Takano T, 2008, ANTIMICROB AGENTS CH, V52, P837, DOI 10.1128/AAC.01001-07; Tang JN, 2006, J RAPID METH AUT MIC, V14, P201, DOI 10.1111/j.1745-4581.2006.00047.x; Varshney AK, 2009, APPL ENVIRON MICROB, V75, P6839, DOI 10.1128/AEM.00272-09; Waters AE, 2011, CLIN INFECT DIS, V52, P1227, DOI 10.1093/cid/cir181; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wu DJ, 2011, J MED MICROBIOL, V60, P35, DOI 10.1099/jmm.0.023465-0	38	70	81	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e28276	10.1371/journal.pone.0028276	http://dx.doi.org/10.1371/journal.pone.0028276			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22194821	Green Submitted, gold, Green Published			2022-12-25	WOS:000298370400012
J	Chen, Q; Prior, M; Dargusch, R; Roberts, A; Riek, R; Eichmann, C; Chiruta, C; Akaishi, T; Abe, K; Maher, P; Schubert, D				Chen, Qi; Prior, Marguerite; Dargusch, Richard; Roberts, Amanda; Riek, Roland; Eichmann, Cedric; Chiruta, Chandramouli; Akaishi, Tatsuhiro; Abe, Kazuho; Maher, Pamela; Schubert, David			A Novel Neurotrophic Drug for Cognitive Enhancement and Alzheimer's Disease	PLOS ONE			English	Article							LONG-TERM POTENTIATION; AMYLOID-BETA-PROTEIN; MOUSE MODEL; HIPPOCAMPAL-LESIONS; LEARNING-DEFICITS; TRANSGENIC MOUSE; MEMORY DEFICITS; STRESS-RESPONSE; CNS DISORDERS; MICE LACKING	Currently, the major drug discovery paradigm for neurodegenerative diseases is based upon high affinity ligands for single disease-specific targets. For Alzheimer's disease (AD), the focus is the amyloid beta peptide (A beta) that mediates familial Alzheimer's disease pathology. However, given that age is the greatest risk factor for AD, we explored an alternative drug discovery scheme that is based upon efficacy in multiple cell culture models of age-associated pathologies rather than exclusively amyloid metabolism. Using this approach, we identified an exceptionally potent, orally active, neurotrophic molecule that facilitates memory in normal rodents, and prevents the loss of synaptic proteins and cognitive decline in a transgenic AD mouse model.	[Chen, Qi; Prior, Marguerite; Dargusch, Richard; Chiruta, Chandramouli; Maher, Pamela; Schubert, David] Salk Inst Biol Studies, Cellular Neurobiol Lab, La Jolla, CA 92037 USA; [Riek, Roland] Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA; [Akaishi, Tatsuhiro; Abe, Kazuho] Musashino Univ, Pharmacol Lab, Pharmaceut Sci Res Inst, Nishitokyo, Tokyo, Japan; [Roberts, Amanda] Scripps Res Inst, La Jolla, CA 92037 USA; [Riek, Roland; Eichmann, Cedric] ETH, Phys Chem Lab, Zurich, Switzerland	Salk Institute; Salk Institute; Scripps Research Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Chen, Q (corresponding author), Salk Inst Biol Studies, Cellular Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	Schubert@salk.edu	Eichmann, Cédric/U-1360-2018; Chiruta, Chandramouli/D-9155-2013	Eichmann, Cédric/0000-0002-8476-1936; Akaishi, Tatsuhiro/0000-0003-4169-4398	National Institutes of Health [R21NS064334, R01AG035055]; Fritz B. Burns Foundation; Bundy Foundation; Alzheimer's Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS064334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG035055] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fritz B. Burns Foundation; Bundy Foundation; Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from The National Institutes of Health (R21NS064334, R01AG035055) (DS), the Fritz B. Burns Foundation (DS and PM), the Bundy Foundation, (MP and QC), and The Alzheimer's Association (www.alz.org) (PM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE K, 1990, JPN J PHARMACOL, V53, P221, DOI 10.1254/jjp.53.221; Abe K, 1996, J NEUROSCI, V16, P1066; AGGLETON JP, 1986, BEHAV BRAIN RES, V19, P133, DOI 10.1016/0166-4328(86)90011-2; Aisen PS, 2011, NEUROLOGY, V76, P280, DOI 10.1212/WNL.0b013e318207b1b9; Allen GL, 2004, PERCEPT PSYCHOPHYS, V66, P170, DOI 10.3758/BF03194870; Bach ME, 1999, P NATL ACAD SCI USA, V96, P5280, DOI 10.1073/pnas.96.9.5280; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; BEACH ME, 1995, CELL, V81, P905, DOI 10.1016/0092-8674(95)90010-1; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Berchtold NC, 2010, NEUROSCIENCE, V167, P588, DOI 10.1016/j.neuroscience.2010.02.050; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Bonda DJ, 2010, NEUROPHARMACOLOGY, V59, P290, DOI 10.1016/j.neuropharm.2010.04.005; Bourtchouladze R, 2003, P NATL ACAD SCI USA, V100, P10518, DOI 10.1073/pnas.1834280100; Broadbent NJ, 2010, LEARN MEMORY, V17, P794, DOI 10.1101/lm.1650110; Calhoun ME, 1996, J NEUROCYTOL, V25, P821, DOI 10.1007/BF02284844; Cameron B, 2010, NEUROBIOL DIS, V37, P503, DOI 10.1016/j.nbd.2009.10.006; Chen JL, 2005, J NEUROSCI, V25, P2366, DOI 10.1523/JNEUROSCI.5071-04.2005; Cole GM, 2007, ADV EXP MED BIOL, V595, P197; Coma M, 2010, NEUROBIOL DIS, V38, P482, DOI 10.1016/j.nbd.2010.01.019; Cunha C, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/neuro.02.001.2010; Dawson GR, 1999, NEUROSCIENCE, V90, P1, DOI 10.1016/S0306-4522(98)00410-2; Di Domenico F, 2010, BRAIN RES, V1333, P72, DOI 10.1016/j.brainres.2010.03.085; Dore S, 2002, FREE RADICAL BIO MED, V32, P1276, DOI 10.1016/S0891-5849(02)00805-5; DUGICHDJORDJEVIC MM, 1995, EUR J NEUROSCI, V7, P1831, DOI 10.1111/j.1460-9568.1995.tb00703.x; Dumont M, 2009, FASEB J, V23, P2459, DOI 10.1096/fj.09-132928; Dun XP, 2010, HISTOL HISTOPATHOL, V25, P533, DOI 10.14670/HH-25.533; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Frautschy SA, 2010, MOL NEUROBIOL, V41, P392, DOI 10.1007/s12035-010-8137-1; Ganesan A, 2008, CURR OPIN CHEM BIOL, V12, P306, DOI 10.1016/j.cbpa.2008.03.016; Golde TE, 2011, NEURON, V69, P203, DOI 10.1016/j.neuron.2011.01.002; Gorski JA, 2003, NEUROSCIENCE, V121, P341, DOI 10.1016/S0306-4522(03)00426-3; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; GUERREIRO RJ, 2010, NEUROBIOL AGING 0620; Haigis MC, 2010, MOL CELL, V40, P333, DOI 10.1016/j.molcel.2010.10.002; Harrison FE, 2009, PHARMACOL BIOCHEM BE, V93, P443, DOI 10.1016/j.pbb.2009.06.006; Herrup K, 2010, J NEUROSCI, V30, P16755, DOI 10.1523/JNEUROSCI.4521-10.2010; Ikonomovic MD, 2008, J HISTOCHEM CYTOCHEM, V56, P1065, DOI 10.1369/jhc.2008.951855; Jankowsky JL, 2005, J NEUROSCI, V25, P5217, DOI 10.1523/JNEUROSCI.5080-04.2005; Jankowsky JL, 2007, J BIOL CHEM, V282, P22707, DOI 10.1074/jbc.M611050200; Krafft GA, 2010, NEUROPHARMACOLOGY, V59, P230, DOI 10.1016/j.neuropharm.2010.07.012; Lalonde R, 2005, NEUROSCI LETT, V390, P87, DOI 10.1016/j.neulet.2005.08.028; Lanni C, 2008, PHARMACOL RES, V57, P196, DOI 10.1016/j.phrs.2008.02.004; Lapchak PA, 2011, J NEUROCHEM, V116, P122, DOI 10.1111/j.1471-4159.2010.07090.x; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Liu YB, 2008, J NEUROCHEM, V105, P1336, DOI 10.1111/j.1471-4159.2008.05236.x; Maher P., 2010, MICRONUTRIENTS BRAIN, P189; Maher P, 2007, BRAIN RES, V1173, P117, DOI 10.1016/j.brainres.2007.07.061; Minichiello L, 2009, NAT REV NEUROSCI, V10, P850, DOI 10.1038/nrn2738; Monteggia LM, 2004, P NATL ACAD SCI USA, V101, P10827, DOI 10.1073/pnas.0402141101; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Olin D, 2005, NEUROSCI LETT, V381, P275, DOI 10.1016/j.neulet.2005.02.017; Oromo-Ibarra M, 2006, REV NEUROLOGIA, V43, P556, DOI 10.33588/rn.4309.2005487; Pajouhesh Hassan, 2005, NeuroRx, V2, P541, DOI 10.1602/neurorx.2.4.541; Pangalos MN, 2007, NAT REV DRUG DISCOV, V6, P521, DOI 10.1038/nrd2094; Pezet S, 2004, EXPERT OPIN THER TAR, V8, P391, DOI 10.1517/14728222.8.5.391; Phillis JW, 2006, BRAIN RES REV, V52, P201, DOI 10.1016/j.brainresrev.2006.02.002; Radak Z, 2010, J ALZHEIMERS DIS, V20, P777, DOI 10.3233/JAD-2010-091531; Radmark O, 2007, TRENDS BIOCHEM SCI, V32, P332, DOI 10.1016/j.tibs.2007.06.002; Reddy PH, 2005, J ALZHEIMERS DIS, V7, P103, DOI 10.3233/jad-2005-7203; Rossler OG, 2004, J NEUROCHEM, V88, P1240, DOI 10.1046/j.1471-4159.2003.02255.x; Sarnyai Z, 2000, P NATL ACAD SCI USA, V97, P14731, DOI 10.1073/pnas.97.26.14731; Sato M, 2001, J NEUROSCI, V21, P3797, DOI 10.1523/JNEUROSCI.21-11-03797.2001; Savonenko A, 2005, NEUROBIOL DIS, V18, P602, DOI 10.1016/j.nbd.2004.10.022; Schipper HM, 2009, J NEUROCHEM, V110, P469, DOI 10.1111/j.1471-4159.2009.06160.x; SCHUBERT D, 2002, Patent No. 6472436; Shia CS, 2009, J AGR FOOD CHEM, V57, P83, DOI 10.1021/jf802378q; Tan Shirlee, 2001, Current Topics in Medicinal Chemistry, V1, P497, DOI 10.2174/1568026013394741; Tapia-Arancibia L, 2008, BRAIN RES REV, V59, P201, DOI 10.1016/j.brainresrev.2008.07.007; van Groen T, 2006, NEUROBIOL DIS, V23, P653, DOI 10.1016/j.nbd.2006.05.010; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang F, 2009, NEUROSCI LETT, V454, P212, DOI 10.1016/j.neulet.2009.03.030; Winkler BS, 2003, EXP EYE RES, V76, P715, DOI 10.1016/S0014-4835(03)00052-6; Wollen KA, 2010, ALTERN MED REV, V15, P223; Woodruff-Pak DS, 2001, P NATL ACAD SCI USA, V98, P2089, DOI 10.1073/pnas.031584398; Yamagata Y, 2003, J PHARMACOL SCI, V93, P22, DOI 10.1254/jphs.93.22; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; Yao YM, 2005, ANN NEUROL, V58, P623, DOI 10.1002/ana.20558; Yoshimura Y, 2002, BIOCHEM BIOPH RES CO, V290, P948, DOI 10.1006/bbrc.2001.6320; Young JW, 2009, PHARMACOL THERAPEUT, V122, P150, DOI 10.1016/j.pharmthera.2009.02.004; Zahs KR, 2010, TRENDS NEUROSCI, V33, P381, DOI 10.1016/j.tins.2010.05.004; Zhang HT, 2005, PSYCHOPHARMACOLOGY, V179, P613, DOI 10.1007/s00213-004-2085-2; Zhao LX, 2006, NAT NEUROSCI, V9, P234, DOI 10.1038/nn1630	84	87	92	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e27865	10.1371/journal.pone.0027865	http://dx.doi.org/10.1371/journal.pone.0027865			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194796	Green Published, gold, Green Submitted			2022-12-25	WOS:000298369100016
J	Kareva, I				Kareva, Irina			Prisoner's Dilemma in Cancer Metabolism	PLOS ONE			English	Article								As tumors outgrow their blood supply and become oxygen deprived, they switch to less energetically efficient but oxygen-independent anaerobic glucose metabolism. However, cancer cells maintain glycolytic phenotype even in the areas of ample oxygen supply (Warburg effect). It has been hypothesized that the competitive advantage that glycolytic cells get over aerobic cells is achieved through secretion of lactic acid, which is a by-product of glycolysis. It creates acidic microenvironment around the tumor that can be toxic to normal somatic cells. This interaction can be seen as a prisoner's dilemma: from the point of view of metabolic payoffs, it is better for cells to cooperate and become better competitors but neither cell has an incentive to unilaterally change its metabolic strategy. In this paper a novel mathematical technique, which allows reducing an otherwise infinitely dimensional system to low dimensionality, is used to demonstrate that changing the environment can take the cells out of this equilibrium and that it is cooperation that can in fact lead to the cell population committing evolutionary suicide.	[Kareva, Irina] Arizona State Univ, Computat Modeling Sci Ctr, Tempe, AZ 85069 USA; [Kareva, Irina] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Kareva, I (corresponding author), Arizona State Univ, Computat Modeling Sci Ctr, Tempe, AZ 85069 USA.	ikareva@asu.edu			National Science Foundation (NSF) [0502349]; National Security Agency (NSA) [H98230-06-1-0097]; Alfred T. Sloan Foundation; Office of the Provost of Arizona State University	National Science Foundation (NSF)(National Science Foundation (NSF)); National Security Agency (NSA)(National Security Agency); Alfred T. Sloan Foundation(Alfred P. Sloan Foundation); Office of the Provost of Arizona State University	This research has been supported by grants from the National Science Foundation (NSF - Grant DMS - 0502349), the National Security Agency (NSA Grant H98230-06-1-0097), the Alfred T. Sloan Foundation and the Office of the Provost of Arizona State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Elser JJ, 2003, BIOSCIENCE, V53, P1112, DOI 10.1641/0006-3568(2003)053[1112:BSAEPO]2.0.CO;2; Ganapathy V, 2009, PHARMACOL THERAPEUT, V121, P29, DOI 10.1016/j.pharmthera.2008.09.005; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gatenby RA, 2008, NAT REV CANCER, V8, P56, DOI 10.1038/nrc2255; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HU F, 2005, OBSTET GYNECOLOGICAL, V60; Kaelin WG, 2010, NATURE, V465, P562, DOI 10.1038/465562a; Karev GP, 2010, J MATH BIOL, V60, P107, DOI 10.1007/s00285-009-0252-0; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; LANGE K, 1992, MATH BIOSCI, V111, P261, DOI 10.1016/0025-5564(92)90074-7; Miller JH, 2007, PRINC STUD COMPLEX, P1, DOI 10.1007/1-4020-5602-8_1; NASH JF, 1950, P NATL ACAD SCI USA, V36, P48, DOI 10.1073/pnas.36.1.48; Pepper JW, 2008, EVOLUTION, V62, P3185, DOI 10.1111/j.1558-5646.2008.00525.x; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; Rankin DJ, 2005, OIKOS, V111, P616; Robey IF, 2009, CANCER RES, V69, P2260, DOI 10.1158/0008-5472.CAN-07-5575; Schelling ThomasC., 1968, STRATEGY CONFLICT; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weinberg F, 2009, ANN NY ACAD SCI, V1177, P66, DOI 10.1111/j.1749-6632.2009.05039.x; Wright ME, 2007, CANCER-AM CANCER SOC, V109, P675, DOI 10.1002/cncr.22443; 2007, PLOS ONE, V2, pE1028	25	30	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28576	10.1371/journal.pone.0028576	http://dx.doi.org/10.1371/journal.pone.0028576			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194857	Green Submitted, Green Published, gold			2022-12-25	WOS:000298369100055
J	Mockford, EJ; Marshall, RC; Dabelsteen, T				Mockford, Emily J.; Marshall, Rupert C.; Dabelsteen, Torben			Degradation of Rural and Urban Great Tit Song: Testing Transmission Efficiency	PLOS ONE			English	Article							PARUS-MAJOR SONG; SOUND-TRANSMISSION; ACOUSTIC-SIGNALS; NOISE; COMMUNICATION; HABITAT; WREN; DIVERGENCE; FOREST; BIRDS	Acoustic signals play a fundamental role in avian territory defence and mate attraction. Several studies have now shown that spectral properties of bird song differ between urban and rural environments. Previously this has been attributed to competition for acoustic space as a result of low-frequency noise present in cities. However, the physical structure of urban areas may have a contributory effect. Here we investigate the sound degradation properties of woodland and city environments using both urban and rural great tit song. We show that although urban surroundings caused significantly less degradation to both songs, the transmission efficiency of rural song compared to urban song was significantly lower in the city. While differences between the two songs in woodland were generally minimal, some measures of the transmission efficiency of rural song were significantly lower than those of urban song, suggesting additional benefits to singing rural songs in this setting. In an attempt to create artificial urban song, we mimicked the increase in minimum frequency found several times previously in urban song. However, this did not replicate the same transmission properties as true urban song, suggesting changes in other song characteristics, such as temporal adjustments, are needed to further increase transmission of an avian signal in the city. We suggest that the structure of the acoustic environment, in addition to the background noise, plays an important role in signal adaptation.	[Mockford, Emily J.; Marshall, Rupert C.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales; [Dabelsteen, Torben] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Mockford, Emily J.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); University of Copenhagen; University of Sheffield	Marshall, RC (corresponding author), Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales.	rmm@aber.ac.uk	Dabelsteen, Torben/D-9854-2015; Marshall, Rupert/C-7093-2008	Dabelsteen, Torben/0000-0001-7162-3924; Marshall, Rupert/0000-0002-1019-465X	NERC [NE/F012756/1]; URF from Aberystwyth University; Danish Council for Independent Research [272-07-0477]	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); URF from Aberystwyth University; Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	E.J.M. was supported by NERC studentship NE/F012756/1 (http://www.nerc.ac.uk/). Additional financial support was provided by a URF grant from Aberystwyth University to R. C. M. (http://www.aber.ac.uk/en/). T. D. was supported by Framework Grant No. 272-07-0477 from the Danish Council for Independent Research (http://en.fi.dk/councils-commissions/the-danish-council-for-independent-research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER MC, 1986, AM NAT, V128, P491, DOI 10.1086/284582; Balsby TJS, 2003, BEHAVIOUR, V140, P695, DOI 10.1163/156853903322370634; Barker NKS, 2009, BEHAVIOUR, V146, P1093, DOI 10.1163/156853909X406446; Bermudez-Cuamatzin E, 2009, BEHAVIOUR, V146, P1269, DOI 10.1163/156853909X423104; Blumenrath SH, 2004, BEHAVIOUR, V141, P935, DOI 10.1163/1568539042360152; DABELSTEEN T, 1993, J ACOUST SOC AM, V93, P2206, DOI 10.1121/1.406682; Dabelsteen Torben, 2002, Acta Ethologica, V4, P65; Dingle C, 2008, J EVOLUTION BIOL, V21, P1079, DOI 10.1111/j.1420-9101.2008.01536.x; Fernandez-Juricic Esteban, 2005, Urban Habitats, V3, P49; Garamszegi LZ, 2005, OECOLOGIA, V143, P167, DOI 10.1007/s00442-004-1784-z; Gil D, 2002, TRENDS ECOL EVOL, V17, P133, DOI 10.1016/S0169-5347(02)02410-2; Halfwerk W, 2009, ANIM BEHAV, V78, P1301, DOI 10.1016/j.anbehav.2009.09.015; Hamao S, 2011, ETHOL ECOL EVOL, V23, P111, DOI 10.1080/03949370.2011.554881; Holland J, 1998, J ACOUST SOC AM, V103, P2154, DOI 10.1121/1.421361; Holland J, 2001, BEHAVIOUR, V138, P189, DOI 10.1163/15685390151074375; Holland Jo, 2001, Bioacoustics, V12, P3; HUNTER ML, 1979, J ANIM ECOL, V48, P759, DOI 10.2307/4194; KREBS J, 1978, NATURE, V271, P539, DOI 10.1038/271539a0; Krebs J.R., 1977, P47; Kroodsma D.E., 1996, ECOLOGY EVOLUTION AC; LARSEN ON, 1997, BIOACOUSTICS, V8, P323; MCGREGOR PK, 1984, BEHAV ECOL SOCIOBIOL, V16, P49, DOI 10.1007/BF00293103; MCGREGOR PK, 1983, AUK, V100, P898, DOI 10.1093/auk/100.4.898; Mockford EJ, 2009, P ROY SOC B-BIOL SCI, V276, P2979, DOI 10.1098/rspb.2009.0586; Moller AP, 2006, BEHAV ECOL, V17, P155, DOI 10.1093/beheco/arj010; MORTON ES, 1975, AM NAT, V109, P17, DOI 10.1086/282971; Mougeot F, 2000, ANIM BEHAV, V60, P647, DOI 10.1006/anbe.2000.1491; Nemeth E, 2006, J ACOUST SOC AM, V119, P620, DOI 10.1121/1.2139072; Nemeth E, 2010, AM NAT, V176, P465, DOI 10.1086/656275; Nemeth E, 2009, ANIM BEHAV, V78, P637, DOI 10.1016/j.anbehav.2009.06.016; Patricelli GL, 2006, AUK, V123, P639, DOI 10.1642/0004-8038(2006)123[639:ACIUNC]2.0.CO;2; Patten MA, 2004, EVOLUTION, V58, P2144; PEDERSEN SB, 1998, SIGPRO 3 23; RICHARDS DG, 1981, AUK, V98, P127; Ripmeester EAP, 2010, BEHAV ECOL, V21, P876, DOI 10.1093/beheco/arq075; Salaberria C, 2010, ARDEOLA, V57, P3; Slabbekoorn H, 2003, NATURE, V424, P267, DOI 10.1038/424267a; Slabbekoorn H, 2002, CONDOR, V104, P564, DOI 10.1650/0010-5422(2002)104[0564:BASTTB]2.0.CO;2; Slabbekoorn H, 2002, EVOLUTION, V56, P1849; Slabbekoorn H, 2007, CONDOR, V109, P67, DOI 10.1650/0010-5422(2007)109[67:STASDA]2.0.CO;2; Slabbekoorn H, 2006, CURR BIOL, V16, P2326, DOI 10.1016/j.cub.2006.10.008; Thomas RJ, 2003, BEHAVIOUR, V140, P387, DOI 10.1163/156853903321826693; Tratalos J, 2007, GLOBAL CHANGE BIOL, V13, P1685, DOI 10.1111/j.1365-2486.2007.01390.x; Verzijden MN, 2010, J EXP BIOL, V213, P2575, DOI 10.1242/jeb.038299; Warren PS, 2006, ANIM BEHAV, V71, P491, DOI 10.1016/j.anbehav.2005.07.014; WILEY RH, 1978, BEHAV ECOL SOCIOBIOL, V3, P69, DOI 10.1007/BF00300047; Wood WE, 2006, AUK, V123, P650, DOI 10.1642/0004-8038(2006)123[650:SSMMSV]2.0.CO;2	47	29	29	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28242	10.1371/journal.pone.0028242	http://dx.doi.org/10.1371/journal.pone.0028242			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174781	Green Published, Green Submitted, gold			2022-12-25	WOS:000298366600010
J	Cremers, H; van Tol, MJ; Roelofs, K; Aleman, A; Zitman, FG; van Buchem, MA; Veltman, DJ; van der Wee, NJA				Cremers, Henk; van Tol, Marie-Jose; Roelofs, Karin; Aleman, Andre; Zitman, Frans G.; van Buchem, Mark A.; Veltman, Dick J.; van der Wee, Nic J. A.			Extraversion Is Linked to Volume of the Orbitofrontal Cortex and Amygdala	PLOS ONE			English	Article							ANXIETY DISORDERS; INDIVIDUAL-DIFFERENCES; PERSONALITY-TRAITS; BRAIN; NEUROTICISM; DEPRESSION; METAANALYSIS; ACTIVATION; LATERALIZATION; NEUROANATOMY	Neuroticism and extraversion are personality factors associated with the vulnerability for developing depression and anxiety disorders, and are possibly differentially related to brain structures implicated in the processing of emotional information and the generation of mood states. To date, studies on brain morphology mainly focused on neuroticism, a dimension primarily related to negative affect, yielding conflicting findings concerning the association with personality, partially due to methodological issues and variable population samples under study. Recently, extraversion, a dimension primarily related to positive affect, has been repeatedly inversely related to with symptoms of depression and anxiety disorders. In the present study, high resolution structural T1-weighted MR images of 65 healthy adults were processed using an optimized Voxel Based Morphometry (VBM) approach. Multiple regression analyses were performed to test for associations of neuroticism and extraversion with prefrontal and subcortical volumes. Orbitofrontal and right amygdala volume were both positively related to extraversion. Extraversion was differentially related to volume of the anterior cingulate cortex in males (positive) and females (negative). Neuroticism scores did not significantly correlate with these brain regions. As extraversion is regarded a protective factor for developing anxiety disorders and depression and has been related to the generation of positive affect, the present results indicate that the reduced likelihood of developing affective disorders in individuals high on extraversion is related to modulation of emotion processing through the orbitofrontal cortex and the amygdala.	[Cremers, Henk; Roelofs, Karin] Leiden Univ, Clin Hlth & Neuropsychol Unit, Inst Psychol Res, Leiden, Netherlands; [Cremers, Henk; van Tol, Marie-Jose; Roelofs, Karin; van Buchem, Mark A.; van der Wee, Nic J. A.] Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands; [van Tol, Marie-Jose; Zitman, Frans G.; van der Wee, Nic J. A.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands; [van Tol, Marie-Jose; Aleman, Andre] Univ Groningen, Univ Med Ctr Groningen, BCN Neuroimaging Ctr, Groningen, Netherlands; [van Buchem, Mark A.] Leiden Univ, Dept Radiol, Med Ctr, Leiden, Netherlands; [Veltman, Dick J.] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, Amsterdam, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam	Cremers, H (corresponding author), Leiden Univ, Clin Hlth & Neuropsychol Unit, Inst Psychol Res, Leiden, Netherlands.	cremershr@fsw.leidenuniv.nl	Roelofs, Karin/D-6780-2012; Aleman, Andre/E-1341-2012; van Buchem, Mark/AAC-9843-2022	van Buchem, Mark/0000-0003-1881-1998; Roelofs, Karin/0000-0002-8863-8978	Netherlands Organization of Scientific Research (NWO) [452-07-008]; Netherlands Organisation for Health Research and Development (Zon-Mw) [10-000-1002]; VU University Medical Center; GGZ inGeest; Arkin; Leiden University Medical Center; GGZ Rivierduinen; University Medical Center Groningen; Lentis; GGZ Friesland; GGZ Drenthe; Scientific Institute for Quality of Healthcare (IQ healthcare); Netherlands Institute for Health Services Research (NIVEL); Netherlands Institute of Mental Health and Addiction (Trimbos Institute)	Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for Health Research and Development (Zon-Mw)(Netherlands Organization for Health Research and Development); VU University Medical Center; GGZ inGeest; Arkin; Leiden University Medical Center; GGZ Rivierduinen; University Medical Center Groningen; Lentis; GGZ Friesland; GGZ Drenthe; Scientific Institute for Quality of Healthcare (IQ healthcare); Netherlands Institute for Health Services Research (NIVEL); Netherlands Institute of Mental Health and Addiction (Trimbos Institute)	Henk Cremers and Karin Roelofs are supported by the Netherlands Organization of Scientific Research (NWO), VIDI grant #452-07-008. The infrastructure for the NESDA study (www.nesda.nl) is funded through the Geestkracht program of the Netherlands Organisation for Health Research and Development (Zon-Mw, grant number 10-000-1002) and is supported by participating universities and mental health care organizations (VU University Medical Center, GGZ inGeest, Arkin, Leiden University Medical Center, GGZ Rivierduinen, University Medical Center Groningen, Lentis, GGZ Friesland, GGZ Drenthe, Scientific Institute for Quality of Healthcare (IQ healthcare), Netherlands Institute for Health Services Research (NIVEL) and Netherlands Institute of Mental Health and Addiction (Trimbos Institute). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Baas D, 2004, BRAIN RES REV, V45, P96, DOI 10.1016/j.brainresrev.2004.02.004; Bienvenu OJ, 2004, DEPRESS ANXIETY, V20, P92, DOI 10.1002/da.20026; Blankstein U, 2009, NEUROPSYCHOLOGIA, V47, P599, DOI 10.1016/j.neuropsychologia.2008.10.014; Canli T, 2004, J PERS, V72, P1105, DOI 10.1111/j.1467-6494.2004.00292.x; Canli T, 2002, SCIENCE, V296, P2191, DOI 10.1126/science.1068749; CLARK LA, 1994, J ABNORM PSYCHOL, V103, P103, DOI 10.1037/0021-843X.103.1.103; Costa P.T., 1992, NEO FFI PERSONALITY; Costafreda SG, 2008, BRAIN RES REV, V58, P57, DOI 10.1016/j.brainresrev.2007.10.012; Cremers HR, 2010, NEUROIMAGE, V49, P963, DOI 10.1016/j.neuroimage.2009.08.023; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; DeYoung CG, 2010, PSYCHOL SCI, V21, P820, DOI 10.1177/0956797610370159; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Gardini S, 2009, BRAIN RES BULL, V79, P265, DOI 10.1016/j.brainresbull.2009.03.005; Haas BW, 2007, BEHAV NEUROSCI, V121, P249, DOI 10.1037/0735-7044.121.2.249; Hastings RS, 2004, NEUROPSYCHOPHARMACOL, V29, P952, DOI 10.1038/sj.npp.1300371; JACKSON J, 2009, NEUROBIOL AGING; Jylha P, 2006, DEPRESS ANXIETY, V23, P281, DOI 10.1002/da.20167; Kotov R, 2010, PSYCHOL BULL, V136, P768, DOI 10.1037/a0020327; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; LARSEN RJ, 1991, J PERS SOC PSYCHOL, V61, P132, DOI 10.1037/0022-3514.61.1.132; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Milad MR, 2007, ANN NY ACAD SCI, V1121, P546, DOI 10.1196/annals.1401.006; Omura K, 2005, NEUROREPORT, V16, P1905, DOI 10.1097/01.wnr.0000186596.64458.76; Penninx BWJH, 2008, INT J METH PSYCH RES, V17, P121, DOI 10.1002/mpr.256; Piccinelli M, 2000, BRIT J PSYCHIAT, V177, P486, DOI 10.1192/bjp.177.6.486; Price JL, 2003, ANN NY ACAD SCI, V985, P50; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Rauch SL, 2005, NEUROREPORT, V16, P1909, DOI 10.1097/01.wnr.0000186599.66243.50; Rolls ET, 2008, PROG NEUROBIOL, V86, P216, DOI 10.1016/j.pneurobio.2008.09.001; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Sergerie K, 2008, NEUROSCI BIOBEHAV R, V32, P811, DOI 10.1016/j.neubiorev.2007.12.002; Spinhoven P, 2011, J NERV MENT DIS, V199, P684, DOI 10.1097/NMD.0b013e318229d21f; van Tol MJ, 2010, ARCH GEN PSYCHIAT, V67, P1002, DOI 10.1001/archgenpsychiatry.2010.121; Wager TD, 2003, NEUROIMAGE, V19, P513, DOI 10.1016/S1053-8119(03)00078-8; Wright CI, 2007, NEUROIMAGE, V35, P263, DOI 10.1016/j.neuroimage.2006.11.039; Wright CI, 2006, CEREB CORTEX, V16, P1809, DOI 10.1093/cercor/bhj118	37	65	66	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28421	10.1371/journal.pone.0028421	http://dx.doi.org/10.1371/journal.pone.0028421			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	866FK	22174802	Green Published, Green Submitted, gold			2022-12-25	WOS:000298365700033
J	Fallas, JA; Dong, JH; Tao, YZJ; Hartgerink, JD				Fallas, Jorge A.; Dong, Jinhui; Tao, Yizhi J.; Hartgerink, Jeffrey D.			Structural Insights into Charge Pair Interactions in Triple Helical Collagen-like Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTROSTATIC INTERACTIONS; CRYSTAL-STRUCTURE; HIGH-STABILITY; IX COLLAGEN; PEPTIDE; HETEROTRIMERS; RECOGNITION; REFINEMENT; ENSEMBLES	The collagen triple helix is the most abundant protein fold in humans. Despite its deceptively simple structure, very little is understood about its folding and fibrillization energy landscape. In this work, using a combination of x-ray crystallography and nuclear magnetic resonance spectroscopy, we carry out a detailed study of stabilizing pair-wise interactions between the positively charged lysine and the negatively charged amino acids aspartate and glutamate. We find important differences in the side chain conformation of amino acids in the crystalline and solution state. Structures from x-ray crystallography may have similarities to the densely packed triple helices of collagen fibers whereas solution NMR structures reveal the simpler interactions of isolated triple helices. In solution, two distinct types of contacts are observed: axial and lateral. Such register-specific interactions are crucial for the understanding of the registration process of collagens and the overall stability of proteins in this family. However, in the crystalline state, there is a significant rearrangement of the side chain conformation allowing for packing interactions between adjacent helices, which suggests that charged amino acids may play a dual role in collagen stabilization and folding, first at the level of triple helical assembly and second during fibril formation.	[Fallas, Jorge A.; Hartgerink, Jeffrey D.] Rice Univ, Dept Chem, Houston, TX 77005 USA; [Dong, Jinhui; Tao, Yizhi J.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA; [Hartgerink, Jeffrey D.] Rice Univ, Dept Bioengn, Houston, TX 77005 USA	Rice University; Rice University; Rice University	Hartgerink, JD (corresponding author), 6100 Main St,MS 602, Houston, TX 77005 USA.	jdh@rice.edu	Hartgerink, Jeffrey D/G-4275-2016	Hartgerink, Jeffrey D/0000-0002-3186-5395; Dong, Jinhui/0000-0003-4542-7756	National Science Foundation [DMR-0645474, EIA-0216467]; Robert A. Welch Foundation [C1557, C1565]; Norman Hackerman Advanced Research Program of Texas; Shared University Grid at Rice	National Science Foundation(National Science Foundation (NSF)); Robert A. Welch Foundation(The Welch Foundation); Norman Hackerman Advanced Research Program of Texas; Shared University Grid at Rice	This work was supported in part by National Science Foundation Career Award DMR-0645474, Robert A. Welch Foundation Grants C1557 and C1565, the Norman Hackerman Advanced Research Program of Texas, the Shared University Grid at Rice funded by National Science Foundation Grant EIA-0216467, and a partnership among Rice University, Sun Microsystems, and Sigma Solutions, Inc.	Abseher R, 1998, PROTEINS, V31, P370; Antipova O, 2010, J BIOL CHEM, V285, P7087, DOI 10.1074/jbc.M109.060400; Boudko SP, 2008, J BIOL CHEM, V283, P32580, DOI 10.1074/jbc.M805394200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buevich AV, 2000, BIOCHEMISTRY-US, V39, P4299, DOI 10.1021/bi992584r; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley J, 2004, J MOL BIOL, V335, P1019, DOI 10.1016/j.jmb.2003.11.030; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fallas JA, 2009, J BIOL CHEM, V284, P26851, DOI 10.1074/jbc.M109.014753; Gauba V, 2008, J AM CHEM SOC, V130, P7509, DOI 10.1021/ja801670v; Gauba V, 2007, J AM CHEM SOC, V129, P15034, DOI 10.1021/ja075854z; Gauba V, 2007, J AM CHEM SOC, V129, P2683, DOI 10.1021/ja0683640; Gurry T, 2010, BIOPHYS J, V98, P2634, DOI 10.1016/j.bpj.2010.01.065; JELINSKI LW, 1980, J MOL BIOL, V138, P255, DOI 10.1016/0022-2836(80)90286-7; Khoshnoodi J, 2006, J BIOL CHEM, V281, P38117, DOI 10.1074/jbc.R600025200; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Kramer RZ, 2000, J MOL BIOL, V301, P1191, DOI 10.1006/jmbi.2000.4017; Kumar S, 2002, BIOPHYS J, V83, P1595, DOI 10.1016/S0006-3495(02)73929-5; Morozov AV, 2003, J PHYS CHEM B, V107, P2075, DOI 10.1021/jp0267555; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Leary LER, 2011, J AM CHEM SOC, V133, P5432, DOI 10.1021/ja111239r; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Persikov AV, 2005, J BIOL CHEM, V280, P19343, DOI 10.1074/jbc.M501657200; Persikov AV, 2005, BIOCHEMISTRY-US, V44, P1414, DOI 10.1021/bi048216r; Persikov AV, 2002, J MOL BIOL, V316, P385, DOI 10.1006/jmbi.2001.5342; Pihlajamaa T, 1999, J BIOL CHEM, V274, P22464, DOI 10.1074/jbc.274.32.22464; RAMACHANDRAN GN, 1955, NATURE, V176, P593, DOI 10.1038/176593a0; Russell LE, 2010, J AM CHEM SOC, V132, P3242, DOI 10.1021/ja909720g; Schumacher MA, 2006, J BIOL CHEM, V281, P27566, DOI 10.1074/jbc.M602797200; Schwieters CD, 2002, J BIOMOL NMR, V23, P221, DOI 10.1023/A:1019875223132; Schwieters CD, 2001, J MAGN RESON, V149, P239, DOI 10.1006/jmre.2001.2300; WU JJ, 1992, J BIOL CHEM, V267, P23007	34	64	67	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8039	8047		10.1074/jbc.M111.296574	http://dx.doi.org/10.1074/jbc.M111.296574			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22179819	Green Published, hybrid			2022-12-25	WOS:000301349400020
J	Zhou, ZC; Du, XL; Cai, Z; Song, XM; Zhang, HT; Mizuno, T; Suzuki, E; Yee, MR; Berezov, A; Murali, R; Wu, SL; Karger, BL; Greene, MI; Wang, Q				Zhou, Zhaocai; Du, Xiulian; Cai, Zheng; Song, Xiaomin; Zhang, Hongtao; Mizuno, Takako; Suzuki, Emi; Yee, Marla Rosanne; Berezov, Alan; Murali, Ramachandran; Wu, Shiaw-Lin; Karger, Barry L.; Greene, Mark I.; Wang, Qiang			Structure of Sad1-UNC84 Homology (SUN) Domain Defines Features of Molecular Bridge in Nuclear Envelope.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE POLE BODY; MEMBRANE-PROTEINS; LOCALIZATION; MIGRATION; RECEPTOR; INTERACTS; NESPRINS; BOUQUET; LAMIN; MATEFIN/SUN-1	The SUN (Sad1-UNC-84 homology) domain is conserved in a number of nuclear envelope proteins involved in nuclear migration, meiotic telomere tethering, and antiviral responses. The LINC (linker of nucleoskeleton and cytoskeleton) complex, formed by the SUN and the nesprin proteins at the nuclear envelope, serves as a mechanical linkage across the nuclear envelope. Here we report the crystal structure of the SUN2 protein SUN domain, which reveals a homotrimer. The SUN domain is sufficient to mediate binding to the KASH (Klarsicht, ANC-1, and Syne homology) domain of nesprin 2, and the regions involved in the interaction have been identified. Binding of the SUN domain to the KASH domain is abolished by deletion of a region important for trimerization or by point mutations associated with nuclear migration failure. We propose a model of the LINC complex, where the SUN and the KASH domains form a higher ordered oligomeric network in the nuclear envelope. These findings provide the structural basis for understanding the function and the regulation of the LINC complex.	[Zhou, Zhaocai; Du, Xiulian; Cai, Zheng; Song, Xiaomin; Zhang, Hongtao; Yee, Marla Rosanne; Berezov, Alan; Murali, Ramachandran; Greene, Mark I.; Wang, Qiang] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Zhou, Zhaocai] Chinese Acad Sci, State Key Lab Cell Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Wang, Qiang] Cedars Sinai Med Ctr, Womens Canc Program, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Mizuno, Takako; Suzuki, Emi; Berezov, Alan; Murali, Ramachandran; Greene, Mark I.; Wang, Qiang] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Wu, Shiaw-Lin; Karger, Barry L.] Northeastern Univ, Barnett Inst, Boston, MA 02115 USA	University of Pennsylvania; Pennsylvania Medicine; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Northeastern University	Greene, MI (corresponding author), Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, 252 John Morgan Bldg,36th St & Hamilton Walk, Philadelphia, PA 19104 USA.	greene@reo.med.upenn.edu; qiang.wang@cshs.org	Murali, Ramachandran/D-1132-2009; Wang, Qiang/N-7310-2015	Wang, Qiang/0000-0001-9409-0251; Murali, Ramachandran/0000-0002-8384-2793; Zhang, Hongtao/0000-0001-9173-0049	National Cancer Institute; Abramson Family Cancer Research Institute at the University of Pennsylvania; Samuel Oschin Comprehensive Cancer Institute; Women's Guild Lung Institute of the Cedars-Sinai Medical Center; National Natural Science Foundation of China [30970566, 10979005]; National Institutes of Health [GM15847]; Barnett Institute [992]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM015847, R37GM015847] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Abramson Family Cancer Research Institute at the University of Pennsylvania; Samuel Oschin Comprehensive Cancer Institute; Women's Guild Lung Institute of the Cedars-Sinai Medical Center; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barnett Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Cancer Institute, the Abramson Family Cancer Research Institute at the University of Pennsylvania, the Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, the Women's Guild Lung Institute of the Cedars-Sinai Medical Center, and Grants 30970566 and 10979005 from the National Natural Science Foundation of China.; Supported by National Institutes of Health Grant GM15847 and contribution number 992 from the Barnett Institute.	Burke B, 2002, NAT REV MOL CELL BIO, V3, P575, DOI 10.1038/nrm879; Burke B, 2002, NAT REV MOL CELL BIO, V3, P487, DOI 10.1038/nrm860; Burke B, 2006, ANNU REV GENOM HUM G, V7, P369, DOI 10.1146/annurev.genom.7.080505.115732; Cerhan JR, 2007, BLOOD, V110, P4455, DOI 10.1182/blood-2007-05-088682; Chikashige Y, 2006, CELL, V125, P59, DOI 10.1016/j.cell.2006.01.048; Conrad MN, 2007, P NATL ACAD SCI USA, V104, P8863, DOI 10.1073/pnas.0606165104; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Ding X, 2007, DEV CELL, V12, P863, DOI 10.1016/j.devcel.2007.03.018; Dreger M, 2001, P NATL ACAD SCI USA, V98, P11943, DOI 10.1073/pnas.211201898; Fridkin A, 2004, P NATL ACAD SCI USA, V101, P6987, DOI 10.1073/pnas.0307880101; Fridkin A, 2009, CELL MOL LIFE SCI, V66, P1518, DOI 10.1007/s00018-008-8713-y; HAGAN I, 1995, J CELL BIOL, V129, P1033, DOI 10.1083/jcb.129.4.1033; Haque F, 2006, MOL CELL BIOL, V26, P3738, DOI 10.1128/MCB.26.10.3738-3751.2006; Hodzic DM, 2004, J BIOL CHEM, V279, P25805, DOI 10.1074/jbc.M313157200; Hoffenberg S, 2000, J BIOL CHEM, V275, P24661, DOI 10.1074/jbc.M909600199; HORVITZ HR, 1980, GENETICS, V96, P435; Hung LY, 2008, NUCLEIC ACIDS RES, V36, P4337, DOI 10.1093/nar/gkn417; Jaspersen SL, 2006, J CELL BIOL, V174, P665, DOI 10.1083/jcb.200601062; Kennedy C, 2004, CELL TISSUE RES, V315, P279, DOI 10.1007/s00441-003-0821-2; Ketema M, 2007, J CELL SCI, V120, P3384, DOI 10.1242/jcs.014191; King MC, 2008, CELL, V134, P427, DOI 10.1016/j.cell.2008.06.022; Lee KK, 2002, MOL BIOL CELL, V13, P892, DOI 10.1091/mbc.01-06-0294; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Liu Q, 2007, J CELL BIOL, V178, P785, DOI 10.1083/jcb.200704108; Lombardi ML, 2011, J BIOL CHEM, V286, P26743, DOI 10.1074/jbc.M111.233700; Lu WS, 2008, BBA-MOL CELL RES, V1783, P2415, DOI 10.1016/j.bbamcr.2008.09.001; Luxton GWG, 2010, SCIENCE, V329, P956, DOI 10.1126/science.1189072; Malone CJ, 1999, DEVELOPMENT, V126, P3171; McGee MD, 2006, MOL BIOL CELL, V17, P1790, DOI 10.1091/mbc.E05-09-0894; Oksvold M, 2002, NAT CELL BIOL, V4, pE22, DOI 10.1038/ncb0202-e22a; Padmakumar VC, 2005, J CELL SCI, V118, P3419, DOI 10.1242/jcs.02471; Padmakumar VC, 2004, EXP CELL RES, V295, P330, DOI 10.1016/j.yexcr.2004.01.014; Penkner A, 2007, DEV CELL, V12, P873, DOI 10.1016/j.devcel.2007.05.004; Puckelwartz MJ, 2009, HUM MOL GENET, V18, P607, DOI 10.1093/hmg/ddn386; Roux KJ, 2007, BBA-MOL BASIS DIS, V1772, P118, DOI 10.1016/j.bbadis.2006.06.001; Schmitt J, 2007, P NATL ACAD SCI USA, V104, P7426, DOI 10.1073/pnas.0609198104; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Starr DA, 2005, BIOESSAYS, V27, P1136, DOI 10.1002/bies.20312; Starr DA, 2003, J CELL SCI, V116, P211, DOI 10.1242/jcs.00248; Starr DA, 2002, SCIENCE, V298, P406, DOI 10.1126/science.1075119; Starr DA, 2001, DEVELOPMENT, V128, P5039; Stewart CL, 2007, SCIENCE, V318, P1408, DOI 10.1126/science.1142034; Stewart-Hutchinson PJ, 2008, EXP CELL RES, V314, P1892, DOI 10.1016/j.yexcr.2008.02.022; SULSTON JE, 1981, DEV BIOL, V82, P41, DOI 10.1016/0012-1606(81)90427-9; Tomita K, 2006, CELL, V125, P19, DOI 10.1016/j.cell.2006.03.020; Turgay Y, 2010, EMBO J, V29, P2262, DOI 10.1038/emboj.2010.119; Tzur YB, 2006, NAT REV MOL CELL BIO, V7, P782, DOI 10.1038/nrm2003; Tzur YB, 2006, P NATL ACAD SCI USA, V103, P13397, DOI 10.1073/pnas.0604224103; Wajant H, 2001, INT J BIOCHEM CELL B, V33, P19, DOI 10.1016/S1357-2725(00)00064-9; Wang Q, 2006, DNA CELL BIOL, V25, P554, DOI 10.1089/dna.2006.25.554; Wilhelmsen K, 2006, J CELL SCI, V119, P5021, DOI 10.1242/jcs.03295; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; XIE YM, 1994, BIOCHEM BIOPH RES CO, V203, P1589, DOI 10.1006/bbrc.1994.2368; Xiong HJ, 2008, TRAFFIC, V9, P708, DOI 10.1111/j.1600-0854.2008.00721.x; Ye H, 1999, MOL CELL, V4, P321, DOI 10.1016/S1097-2765(00)80334-2; Yu JH, 2011, HUM MOL GENET, V20, P1061, DOI 10.1093/hmg/ddq549; Zhang QP, 2005, J CELL SCI, V118, P673, DOI 10.1242/jcs.01642; Zhang QP, 2001, J CELL SCI, V114, P4485	58	94	95	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5317	5326		10.1074/jbc.M111.304543	http://dx.doi.org/10.1074/jbc.M111.304543			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22170055	hybrid, Green Published			2022-12-25	WOS:000300638000014
J	Baudouin-Cornu, P; Lagniel, G; Kumar, C; Huang, ME; Labarre, J				Baudouin-Cornu, Peggy; Lagniel, Gilles; Kumar, Chitranshu; Huang, Meng-Er; Labarre, Jean			Glutathione Degradation Is a Key Determinant of Glutathione Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; GAMMA-GLUTAMYL-TRANSPEPTIDASE; SCHIZOSACCHAROMYCES-POMBE; CYSTEINE LIGASE; SULFUR SOURCE; INHIBITION; SYNTHETASE; PROTEOME; CADMIUM; PATHWAY	Glutathione (GSH) has several important functions in eukaryotic cells, and its intracellular concentration is tightly controlled. Combining mathematical models and S-35 labeling, we analyzed Saccharomyces cerevisiae sulfur metabolism. This led us to the observation that GSH recycling is markedly faster than previously estimated. We set up additional in vivo assays and concluded that under standard conditions, GSH half-life is around 90 min. Sulfur starvation and growth with GSH as the sole sulfur source strongly increase GSH degradation, whereas cadmium (Cd2+) treatment inhibits GSH degradation. Whatever the condition tested, GSH is degraded by the cytosolic Dug complex (composed of the three subunits Dug1, Dug2, and Dug3) but not by the gamma-glutamyl-transpeptidase, raising the question of the role of this enzyme. In vivo, both DUG2/3 mRNA levels and Dug activity are quickly induced by sulfur deprivation in a Met4-dependent manner. This suggests that Dug activity is mainly regulated at the transcriptional level. Finally, analysis of dug2 Delta and dug3 Delta mutant cells shows that GSH degradation activity strongly impacts on GSH intracellular concentration and that GSH intracellular concentration does not affect GSH synthesis rate. Altogether, our data led us to reconsider important aspects of GSH metabolism, challenging notions on GSH synthesis and GSH degradation that were considered as established.	[Baudouin-Cornu, Peggy; Lagniel, Gilles; Labarre, Jean] CEA, iBiTecS, SBIGeM, F-91191 Gif Sur Yvette, France; [Kumar, Chitranshu; Huang, Meng-Er] Univ Paris Sud 11, Inst Curie, CNRS, UMR3348 Genotox Stress & Canc, F-91405 Orsay, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay	Labarre, J (corresponding author), CEA, iBiTecS, SBIGeM, F-91191 Gif Sur Yvette, France.	Jean.Labarre@cea.fr		Baudouin-Cornu, Peggy/0000-0001-7296-099X	Agence Nationale de la Recherche	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the Agence Nationale de la Recherche.	Ausubel F. M., 2002, SHORT PROTOCOLS MOL, P13; Ballatori N, 2009, BIOL CHEM, V390, P191, DOI 10.1515/BC.2009.033; Barbey R, 2005, EMBO J, V24, P521, DOI 10.1038/sj.emboj.7600556; Baudouin-Cornu P, 2006, BIOCHIMIE, V88, P1673, DOI 10.1016/j.biochi.2006.03.001; Baudouin-Cornu P, 2009, PROTEOMICS, V9, P4606, DOI 10.1002/pmic.200800975; Biterova EI, 2010, J BIOL CHEM, V285, P14459, DOI 10.1074/jbc.M110.104802; Bourbouloux A, 2000, J BIOL CHEM, V275, P13259, DOI 10.1074/jbc.275.18.13259; Brachmann CB, 1998, YEAST, V14, P115; Cuozzo JW, 1999, NAT CELL BIOL, V1, P130, DOI 10.1038/11047; DENNDA G, 1986, Biotechnology and Applied Biochemistry, V8, P459; ELSKENS MT, 1991, J GEN MICROBIOL, V137, P637, DOI 10.1099/00221287-137-3-637; Fauchon M, 2002, MOL CELL, V9, P713, DOI 10.1016/S1097-2765(02)00500-2; Fell DA, 2005, J EXP BOT, V56, P267, DOI 10.1093/jxb/eri011; Fendt SM, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.11; Ganguli D, 2007, GENETICS, V175, P1137, DOI 10.1534/genetics.106.066944; Godat E, 2010, METHOD ENZYMOL, V473, P41, DOI 10.1016/S0076-6879(10)73002-0; Grant CM, 1997, MOL BIOL CELL, V8, P1699, DOI 10.1091/mbc.8.9.1699; HUANG CS, 1988, P NATL ACAD SCI USA, V85, P2464, DOI 10.1073/pnas.85.8.2464; JASPERS CJ, 1985, PHYTOCHEMISTRY, V24, P703; Jez JM, 2004, J BIOL CHEM, V279, P33463, DOI 10.1074/jbc.M405127200; KACSER H, 1995, BIOCHEM SOC T, V23, P341, DOI 10.1042/bst0230341; Kaur H, 2009, J BIOL CHEM, V284, P14493, DOI 10.1074/jbc.M808952200; Kumar C, 2003, FEMS MICROBIOL LETT, V219, P187, DOI 10.1016/S0378-1097(03)00059-4; Lafaye A, 2005, J BIOL CHEM, V280, P24723, DOI 10.1074/JBC.M502285200; Lee TA, 2010, MOL BIOL CELL, V21, P456, DOI 10.1091/mbc.E09-05-0420; Lu SC, 1999, FASEB J, V13, P1169, DOI 10.1096/fasebj.13.10.1169; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Mehdi K, 1997, MICROBIOL-UK, V143, P1885, DOI 10.1099/00221287-143-6-1885; MESSENGUY F, 1980, EUR J BIOCHEM, V108, P439, DOI 10.1111/j.1432-1033.1980.tb04740.x; MORTIMER RK, 1986, GENETICS, V113, P35; Paolicchi A, 1997, FREE RADICAL BIO MED, V22, P853, DOI 10.1016/S0891-5849(96)00422-4; Paolicchi A, 2002, BIOCHEM PHARMACOL, V64, P1027, DOI 10.1016/S0006-2952(02)01173-5; PENNINCKX MJ, 1985, PHYTOCHEMISTRY, V24, P1913, DOI 10.1016/S0031-9422(00)83091-5; Pereira Y, 2008, TOXICOL SCI, V106, P400, DOI 10.1093/toxsci/kfn193; Perrone GG, 2005, MOL BIOL CELL, V16, P218, DOI 10.1091/mbc.E04-07-0560; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Rebbeor JF, 1998, J BIOL CHEM, V273, P33449, DOI 10.1074/jbc.273.50.33449; RICHMAN PG, 1975, J BIOL CHEM, V250, P1422; Russell JB, 2007, J MOL MICROB BIOTECH, V13, P1, DOI 10.1159/000103591; Song SH, 2008, J MICROBIOL, V46, P70, DOI 10.1007/s12275-007-0244-y; Spector D, 2001, J BIOL CHEM, V276, P7011, DOI 10.1074/jbc.M009814200; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; Thomas D, 2000, J BIOL CHEM, V275, P40718, DOI 10.1074/jbc.M005967200; Ubiyvovk VM, 2006, CELL BIOL INT, V30, P665, DOI 10.1016/j.cellbi.2006.04.006; Vido K, 2001, J BIOL CHEM, V276, P8469, DOI 10.1074/jbc.M008708200; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6; Wunschmann J, 2010, PHYTOCHEMISTRY, V71, P54, DOI 10.1016/j.phytochem.2009.09.034	47	38	39	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4552	4561		10.1074/jbc.M111.315705	http://dx.doi.org/10.1074/jbc.M111.315705			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22170048	Green Published, hybrid			2022-12-25	WOS:000300608500018
J	Gareau, JR; Reverter, D; Lima, CD				Gareau, Jaclyn R.; Reverter, David; Lima, Christopher D.			Determinants of Small Ubiquitin-like Modifier 1 (SUMO1) Protein Specificity, E3 Ligase, and SUMO-RanGAP1 Binding Activities of Nucleoporin RanBP2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; STRUCTURAL BASIS; MECHANISTIC INSIGHTS; CONJUGATION; RANGAP1; SUMOYLATION; COMPLEX; SYSTEM; UBC9P; E2	The RanBP2 nucleoporin contains an internal repeat domain (IR1-M-IR2) that catalyzes E3 ligase activity and forms a stable complex with SUMO-modified RanGAP1 and UBC9 at the nuclear pore complex. RanBP2 exhibits specificity for SUMO1 as RanGAP1-SUMO1/UBC9 forms a more stable complex with RanBP2 compared with RanGAP1-SUMO2 that results in greater protection of RanGAP-SUMO1 from proteases. The IR1-M-IR2 SUMO E3 ligase activity also shows a similar preference for SUMO1. We utilized deletions and domain swap constructs in protease protection assays and automodification assays to define RanBP2 domains responsible for RanGAP1-SUMO1 protection and SUMO1-specific E3 ligase activity. Our data suggest that elements in both IR1 and IR2 exhibit specificity for SUMO1. IR1 protects RanGAP1-SUMO1/UBC9 and functions as the primary E3 ligase of RanBP2, whereas IR2 retains the ability to interact with SUMO1 to promote SUMO1-specific E3 ligase activity. To determine the structural basis for SUMO1 specificity, a hybrid IR1 construct and IR1 were used to determine three new structures for complexes containing UBC9 with RanGAP1-SUMO1/2. These structures show more extensive contacts among SUMO, UBC9, and RanBP2 in complexes containing SUMO1 compared with SUMO2 and suggest that differences in SUMO specificity may be achieved through these subtle conformational differences.	[Gareau, Jaclyn R.; Reverter, David; Lima, Christopher D.] Sloan Kettering Inst, Struct Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Lima, CD (corresponding author), Sloan Kettering Inst, Struct Biol Program, 1275 York Ave, New York, NY 10065 USA.	limac@mskcc.org	Reverter, David/H-5360-2015	Reverter, David/0000-0002-5347-0992; Lima, Christopher/0000-0002-9163-6092	National Institutes of Health [GM065872]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; National Center for Research Resources at the National Institute of Health [RR-15301]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065872] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Center for Research Resources at the National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM065872 (to C. D. L.). Use of the Advanced Photon Source was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38. Use of the NE-CAT beamline at Sector 24 is based upon research conducted at the Northeastern Collaborative Access Team beamlines of the Advanced Photon Source, which is supported by Award RR-15301 from the National Center for Research Resources at the National Institute of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Capili AD, 2007, CURR OPIN STRUC BIOL, V17, P726, DOI 10.1016/j.sbi.2007.08.018; Chang CC, 2011, MOL CELL, V42, P62, DOI 10.1016/j.molcel.2011.02.022; Chang PC, 2010, J BIOL CHEM, V285, P5266, DOI 10.1074/jbc.M109.088088; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Jian OY, 2009, MOL CELL, V34, P145, DOI 10.1016/j.molcel.2009.03.013; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Matunis MJ, 1998, J CELL BIOL, V140, P499, DOI 10.1083/jcb.140.3.499; Meulmeester E, 2008, MOL CELL, V30, P610, DOI 10.1016/j.molcel.2008.03.021; Olsen SK, 2010, NATURE, V463, P906, DOI 10.1038/nature08765; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pichler A, 2004, NAT STRUCT MOL BIOL, V11, P984, DOI 10.1038/nsmb834; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Reindle A, 2006, J CELL SCI, V119, P4749, DOI 10.1242/jcs.03243; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Reverter D, 2006, NAT STRUCT MOL BIOL, V13, P1060, DOI 10.1038/nsmb1168; Rodrigo-Brenni MC, 2010, MOL CELL, V39, P548, DOI 10.1016/j.molcel.2010.07.027; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; Saitoh H, 1998, CURR BIOL, V8, P121, DOI 10.1016/S0960-9822(98)70044-2; Saitoh H, 1997, P NATL ACAD SCI USA, V94, P3736, DOI 10.1073/pnas.94.8.3736; Sekiyama N, 2008, J BIOL CHEM, V283, P35966, DOI 10.1074/jbc.M802528200; Shen LN, 2006, BIOCHEM J, V397, P279, DOI 10.1042/BJ20052030; Tatham MH, 2005, NAT STRUCT MOL BIOL, V12, P67, DOI 10.1038/nsmb878; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104; Yunus AA, 2009, MOL CELL, V35, P669, DOI 10.1016/j.molcel.2009.07.013; Zhang H, 2002, MOL CELL BIOL, V22, P6498, DOI 10.1128/MCB.22.18.6498-6508.2002; Zhu SS, 2009, MOL CELL, V33, P570, DOI 10.1016/j.molcel.2009.02.008	40	51	54	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4740	4751		10.1074/jbc.M111.321141	http://dx.doi.org/10.1074/jbc.M111.321141			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22194619	hybrid, Green Published			2022-12-25	WOS:000300608500035
J	Tribouillard-Tanvier, D; Carroll, JA; Moore, RA; Striebel, JF; Chesebro, B				Tribouillard-Tanvier, Deborah; Carroll, James A.; Moore, Roger A.; Striebel, James F.; Chesebro, Bruce			Role of Cyclophilin A from Brains of Prion-infected Mice in Stimulation of Cytokine Release by Microglia and Astroglia in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; SIGNALING PATHWAY; CREUTZFELDT-JAKOB; PROTEIN; SCRAPIE; ACTIVATION; DISEASE; CELLS; IDENTIFICATION; INFLAMMATION	Prion diseases or transmissible spongiform encephalopathy diseases are typically characterized by deposition of abnormally folded partially protease-resistant host-derived prion protein (PrPres), which is associated with activated glia and increased release of cytokines. This neuroinflammatory response may play a role in transmissible spongiform encephalopathy pathogenesis. We previously reported that brain homogenates from prion-infected mice induced cytokine protein release in primary astroglial and microglial cell cultures. Here we measured cytokine release by cultured glial cells to determine what factors in infected brain contributed to activation of microglia and astroglia. In assays analyzing IL-12p40 and CCL2 (MCP-1), glial cells were not stimulated in vitro by either PrPres purified from infected mouse brains or prion protein amyloid fibrils produced in vitro. However, significant glial stimulation was induced by clarified scrapie brain homogenates lacking PrPres. This stimulation was greatly reduced both by antibody to cyclophilin A (CyPA), a known mediator of inflammation in peripheral tissues, and by cyclosporine A, a CyPA inhibitor. In biochemical studies, purified truncated CyPA fragments stimulated a pattern of cytokine release by microglia and astroglia similar to that induced by scrapie-infected brain homogenates, whereas purified full-length CyPA was a poor stimulator. This requirement for CyPA truncation was not reported in previous studies of stimulation of peripheral macrophages, endothelial cell cardiomyocytes, and vascular smooth muscle cells. Therefore, truncated CyPA detected in brain following prion infection may have an important role in the activation of brain-derived primary astroglia and microglia in prion disease and perhaps other neurodegenerative or neuroinflammatory diseases.	[Tribouillard-Tanvier, Deborah; Carroll, James A.; Moore, Roger A.; Striebel, James F.; Chesebro, Bruce] NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Chesebro, B (corresponding author), NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, 903 S 4th St, Hamilton, MT 59840 USA.	bchesebro@nih.gov		Tribouillard-Tanvier, Deborah/0000-0002-2290-5375; Carroll, James/0000-0003-4329-1488	National Institutes of Health through the Division of Intramural Research, NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000937] Funding Source: NIH RePORTER	National Institutes of Health through the Division of Intramural Research, NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the National Institutes of Health through the Division of Intramural Research, NIAID.	Arora K, 2005, J IMMUNOL, V175, P517, DOI 10.4049/jimmunol.175.1.517; BOLTON DC, 1987, ARCH BIOCHEM BIOPHYS, V258, P579, DOI 10.1016/0003-9861(87)90380-8; Boulos S, 2007, NEUROBIOL DIS, V25, P54, DOI 10.1016/j.nbd.2006.08.012; Brown AR, 2003, J GEN VIROL, V84, P2605, DOI 10.1099/vir.0.19137-0; Brown DR, 1996, NATURE, V380, P345, DOI 10.1038/380345a0; Brown GC, 2010, MOL NEUROBIOL, V41, P242, DOI 10.1007/s12035-010-8105-9; BUDKA H, 1995, BRAIN PATHOL, V5, P459, DOI 10.1111/j.1750-3639.1995.tb00625.x; Burwinkel M, 2004, INT J DEV NEUROSCI, V22, P497, DOI 10.1016/j.ijdevneu.2004.07.017; Cohen E, 2003, EMBO J, V22, P404, DOI 10.1093/emboj/cdg045; Dheen ST, 2007, CURR MED CHEM, V14, P1189, DOI 10.2174/092986707780597961; Fischer G, 2004, REV PHYSIOL BIOCH P, V148, P105, DOI 10.1007/s10254-003-0011-3; Fitting S, 2010, J PROTEOME RES, V9, P1795, DOI 10.1021/pr900926n; Giese A, 1998, BRAIN PATHOL, V8, P449; Griffin DE, 2010, IMMUNOL RES, V47, P123, DOI 10.1007/s12026-009-8143-4; Jin ZG, 2000, CIRC RES, V87, P789, DOI 10.1161/01.RES.87.9.789; Jin ZG, 2004, ARTERIOSCL THROM VAS, V24, P1186, DOI 10.1161/01.ATV.0000130664.51010.28; Kielian T, 2004, FRONT BIOSCI-LANDMRK, V9, P732, DOI 10.2741/1266; Kim JY, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/821940; Kim SH, 2004, AM J PATHOL, V164, P1567, DOI 10.1016/S0002-9440(10)63715-7; Kovacs GG, 2005, AM J PATHOL, V166, P287, DOI 10.1016/S0002-9440(10)62252-3; KRUSE M, 1995, J BIOL CHEM, V270, P2588, DOI 10.1074/jbc.270.6.2588; Lim JK, 2011, EXP CELL RES, V317, P569, DOI 10.1016/j.yexcr.2011.01.009; MALLAT M, 1994, J LEUKOCYTE BIOL, V56, P416, DOI 10.1002/jlb.56.3.416; Matsunaga Y, 2001, PROTEINS, V44, P110, DOI 10.1002/prot.1077; Meade-White K, 2007, J VIROL, V81, P4533, DOI 10.1128/JVI.02762-06; Minton Kirsty, 2001, Trends in Immunology, V22, P655, DOI 10.1016/S1471-4906(01)02116-0; Moore RA, 2010, PROTEOMICS, V10, P2858, DOI 10.1002/pmic.201000104; Na YJ, 2007, J NEUROCHEM, V103, P637, DOI 10.1111/j.1471-4159.2007.04769.x; Nakamura Y, 2002, BIOL PHARM BULL, V25, P945, DOI 10.1248/bpb.25.945; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Payeli SK, 2008, ATHEROSCLEROSIS, V197, P564, DOI 10.1016/j.atherosclerosis.2007.08.025; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Perry VH, 2002, CURR OPIN NEUROL, V15, P349, DOI 10.1097/00019052-200206000-00020; Peyrin JM, 1999, NEUROREPORT, V10, P723, DOI 10.1097/00001756-199903170-00012; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Race B, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000232; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Rezaie P, 2001, BRAIN RES REV, V35, P55, DOI 10.1016/S0165-0173(01)00042-X; Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004; Schmidt R, 2008, CIRC RES, V102, P302, DOI 10.1161/CIRCRESAHA.107.157990; Seko Y, 2004, BIOCHEM BIOPH RES CO, V317, P162, DOI 10.1016/j.bbrc.2004.03.021; SHERRY B, 1992, P NATL ACAD SCI USA, V89, P3511, DOI 10.1073/pnas.89.8.3511; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154; Takamiya M, 2007, J NEUROTRAUM, V24, P1833, DOI 10.1089/neu.2007.0336; Thellung S, 2007, ANN NY ACAD SCI, V1096, P258, DOI 10.1196/annals.1397.092; Tribouillard-Tanvier D, 2009, J VIROL, V83, P11244, DOI 10.1128/JVI.01413-09; Trifilo MJ, 2008, J VIROL, V82, P9890, DOI 10.1128/JVI.00486-08; Van Everbroeck B, 2004, ACTA NEUROPATHOL, V108, P194, DOI 10.1007/s00401-004-0879-2; Veerhuis R, 2002, BRAIN RES, V925, P195, DOI 10.1016/S0006-8993(01)03273-5; Wei YA, 2010, ATHEROSCLEROSIS, V213, P415, DOI 10.1016/j.atherosclerosis.2010.09.033; WELLS GAH, 1993, DEV BIOL STAND, V80, P61; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Williams A, 1997, EXP NEUROL, V144, P433, DOI 10.1006/exnr.1997.6424; Yang Y, 2008, RHEUMATOLOGY, V47, P1299, DOI 10.1093/rheumatology/ken225; Yurchenko V, 2002, J BIOL CHEM, V277, P22959, DOI 10.1074/jbc.M201593200	55	24	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4628	4639		10.1074/jbc.M111.269480	http://dx.doi.org/10.1074/jbc.M111.269480			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22179611	Green Published, hybrid			2022-12-25	WOS:000300608500025
J	Chen, XP; Guo, ZM; Okoro, EU; Zhang, HF; Zhou, LC; Lin, XH; Rollins, AT; Yang, H				Chen, Xinping; Guo, Zhongmao; Okoro, Emmanuel U.; Zhang, Hongfeng; Zhou, LiChun; Lin, Xinhua; Rollins, Allman T.; Yang, Hong			Up-regulation of ATP Binding Cassette Transporter A1 Expression by Very Low Density Lipoprotein Receptor and Apolipoprotein E Receptor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOAM CELL-FORMATION; KINASE-C-ZETA; CHOLESTEROL EFFLUX; TANGIER-DISEASE; VLDL RECEPTOR; LDL RECEPTOR; PROTEIN; ABCA1; INDUCTION; LIVER	Activation of very low density lipoprotein receptor (VLDLR) and apolipoprotein E receptor 2 (apoER2) results in either pro- or anti-atherogenic effects depending on the ligand. Using reelin and apoE as ligands, we studied the impact of VLDLR- and apoER2-mediated signaling on the expression of ATP binding cassette transporter A1 (ABCA1) and cholesterol efflux using RAW264.7 cells. Treatment of these mouse macrophages with reelin or human apoE3 significantly increased ABCA1 mRNA and protein levels, and apoAI-mediated cholesterol efflux. In addition, both reelin and apoE3 significantly increased phosphorylated disabled-1 (Dab1), phosphatidylinositol 3-kinase (PI3K), protein kinase C zeta (PKC zeta), and specificity protein 1 (Sp1). This reelin-or apoER2-mediated up-regulation of ABCA1 expression was suppressed by 1) knockdown of Dab1, VLDLR, and apoER2 with small interfering RNAs (siRNAs), 2) inhibition of PI3K and PKC with kinase inhibitors, 3) overexpression of kinase-dead PKC zeta, and 4) inhibition of Sp1 DNA binding with mithramycin A. Activation of the Dab1-PI3K signaling pathway has been implicated in VLDLR- and apoER2-mediated cellular functions, whereas the PI3K-PKC zeta-Sp1 signaling cascade has been implicated in the regulation of ABCA1 expression induced by apoE/apoB-carrying lipoproteins. Taken together, these data support a model in which activation of VLDLR and apoER2 by reelin and apoE induces ABCA1 expression and cholesterol efflux via a Dab1-PI3K-PKC zeta-Sp1 signaling cascade.	[Chen, Xinping; Guo, Zhongmao; Okoro, Emmanuel U.; Zhang, Hongfeng; Zhou, LiChun; Lin, Xinhua; Rollins, Allman T.; Yang, Hong] Meharry Med Coll, Dept Physiol, Nashville, TN 37208 USA	Meharry Medical College	Yang, H (corresponding author), Meharry Med Coll, Dept Physiol, Nashville, TN 37208 USA.	hyang@mmc.edu			National Institutes of Health [SC1HL101431, U54RR026140, R01ES014471, R01HL089382]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR026140] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [SC1HL101431, R01HL089382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014472] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants SC1HL101431 and U54RR026140 (to H. Y.) and R01ES014471 and R01HL089382 (to Z. G.).	Baitsch D, 2011, ARTERIOSCL THROM VAS, V31, P1160, DOI 10.1161/ATVBAHA.111.222745; Blacklow SC, 2007, CURR OPIN STRUC BIOL, V17, P419, DOI 10.1016/j.sbi.2007.08.017; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Chen W, 2001, J BIOL CHEM, V276, P43564, DOI 10.1074/jbc.M107938200; Chen XP, 2011, J BIOL CHEM, V286, P8917, DOI 10.1074/jbc.M110.214429; Choi HY, 2009, CIRCULATION, V119, P3223, DOI 10.1161/CIRCULATIONAHA.108.841130; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Costet P, 2000, J BIOL CHEM, V275, P28240; Dove DE, 2005, ARTERIOSCL THROM VAS, V25, P128, DOI 10.1161/01.ATV.0000148323.94021.e5; Guo M, 2000, BIOCHEM PHARMACOL, V60, P635, DOI 10.1016/S0006-2952(00)00379-8; Hara M, 2003, ARTERIOSCL THROM VAS, V23, P269, DOI 10.1161/01.ATV.0000054199.78458.4B; Herz J, 2009, J LIPID RES, V50, pS287, DOI 10.1194/jlr.R800077-JLR200; Hiltunen TP, 1998, CIRCULATION, V97, P1079, DOI 10.1161/01.CIR.97.11.1079; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Krimbou L, 2004, J LIPID RES, V45, P839, DOI 10.1194/jlr.M300418-JLR200; Lin XH, 2011, FREE RADICAL BIO MED, V51, P97, DOI 10.1016/j.freeradbiomed.2011.04.020; Myant NB, 2010, P R SOC B, V277, P345, DOI 10.1098/rspb.2009.1412; Onumah OE, 2009, FREE RADICAL BIO MED, V46, P1658, DOI 10.1016/j.freeradbiomed.2009.03.018; Orso E, 2000, NAT GENET, V24, P192, DOI 10.1038/72869; Samama B, 2005, ANAT REC PART A, V285A, P595, DOI 10.1002/ar.a.20202; Shen GQ, 2007, AM J HUM GENET, V81, P780, DOI 10.1086/521581; Shenoy NG, 2003, J IMMUNOL, V171, P3734, DOI 10.4049/jimmunol.171.7.3734; Singaraja RR, 2002, J CLIN INVEST, V110, P35, DOI 10.1172/JCI200215748; SUZUKI J, 1995, BIOCHEM BIOPH RES CO, V206, P835, DOI 10.1006/bbrc.1995.1119; Tacken PJ, 2002, ATHEROSCLEROSIS, V162, P103, DOI 10.1016/S0021-9150(01)00697-9; Thymiakou E, 2007, BIOCHEMISTRY-US, V46, P11473, DOI 10.1021/bi700994m; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Vaisman BL, 2012, J LIPID RES, V53, P158, DOI 10.1194/jlr.M018713; Van Eck M, 2005, ATHEROSCLEROSIS, V183, P230, DOI 10.1016/j.atherosclerosis.2005.03.045; Van Eck M, 2006, ARTERIOSCL THROM VAS, V26, P929, DOI 10.1161/01.ATV.0000208364.22732.16; Van Eck M, 2002, P NATL ACAD SCI USA, V99, P6298, DOI 10.1073/pnas.092327399; Von Eckardstein A, 2001, FASEB J, V15, P1555, DOI 10.1096/fj.00-0798com; Wang N, 2003, ARTERIOSCL THROM VAS, V23, P1178, DOI 10.1161/01.ATV.0000075912.83860.26; Wang ZF, 2009, FREE RADICAL BIO MED, V47, P1221, DOI 10.1016/j.freeradbiomed.2009.08.001; Wu DF, 2007, J LIPID RES, V48, P2571, DOI 10.1194/jlr.M700217-JLR200; Yang XV, 2009, P NATL ACAD SCI USA, V106, P274, DOI 10.1073/pnas.0807594106; Yu JH, 1999, J BIOL CHEM, V274, P34327, DOI 10.1074/jbc.274.48.34327; Zhao YF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021453	39	27	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3751	3759		10.1074/jbc.M111.310888	http://dx.doi.org/10.1074/jbc.M111.310888			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22170052	hybrid, Green Published			2022-12-25	WOS:000300410900012
J	Ianculescu, I; Wu, DY; Siegmund, KD; Stallcup, MR				Ianculescu, Irina; Wu, Dai-Ying; Siegmund, Kimberly D.; Stallcup, Michael R.			Selective Roles for cAMP Response Element-binding Protein Binding Protein and p300 Protein as Coregulators for Androgen-regulated Gene Expression in Advanced Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR COACTIVATOR; DIFFERENTIAL ROLES; DISTINCT ROLES; CBP; TRANSCRIPTION; DNA; ACTIVATION; PROLIFERATION; RECRUITMENT; ENHANCERS	The protein acetyltransferases p300 and cAMP response element-binding protein binding protein (CBP) are homologous, ubiquitously expressed proteins that interact with hundreds of proteins involved in transcriptional regulation and are involved globally as transcriptional coregulators. Although these two proteins acetylate and interact with overlapping sets of proteins, we found that p300 and CBP contribute to androgen-induced regulation of distinct sets of genes in C4-2B prostate cancer cells, a model of advanced prostate cancer. CBP cannot compensate for the loss of p300 to support androgen-induced expression of many genes, such as TMPRSS2 and PSA. Global gene expression analysis indicated that 47% of androgen-regulated genes are p300-dependent in these cells, whereas, surprisingly, only 0.3% of them are CBP-dependent. Chromatin immunoprecipitation analysis after depletion of cellular p300 indicated that p300 is required for androgen-induced acetylation of histones H3 and H4, methylation of histone H3 at Lys-4, and recruitment of TATA box binding protein (TBP) and RNA polymerase II, but not recruitment of the androgen receptor, on the TMPRSS2 gene in response to androgen. Thus, p300 is the dominant coregulator of the CBP/p300 pair for androgen-regulated gene expression in C4-2B cells. p300 is required at an early stage of chromatin remodeling and transcription complex assembly after binding of androgen receptor to the gene but before many critical histone modifications occur.	[Ianculescu, Irina; Wu, Dai-Ying; Stallcup, Michael R.] Univ So Calif, Norris Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA; [Siegmund, Kimberly D.] Univ So Calif, Norris Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Stallcup, MR (corresponding author), Univ So Calif, Norris Comprehens Canc Ctr, Dept Biochem & Mol Biol, NOR 6316,1441 Eastlake Ave, Los Angeles, CA 90089 USA.	stallcup@usc.edu		Wu, Dai-Ying/0000-0002-6485-1635	National Institutes of Health [R01DK043093, R01DK055274, T32GM067587]; National Cancer Institute [P30CA014089]; NATIONAL CANCER INSTITUTE [P30CA014089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055274, R01DK043093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067587] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK043093 and R01DK055274 (to M. R. S.) and Training Grant T32GM067587 (for D. Y. W.). This work was also supported by Cancer Center award number P30CA014089 from the National Cancer Institute (for K. S.).	ABRAHAM SE, 1993, ONCOGENE, V8, P1639; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; Claessens Frank, 2008, Nucl Recept Signal, V6, pe008, DOI 10.1621/nrs.06008; Culig Z, 2006, J CELL BIOCHEM, V99, P373, DOI 10.1002/jcb.20898; Dallas PB, 1997, J VIROL, V71, P1726, DOI 10.1128/JVI.71.2.1726-1731.1997; Debes JD, 2003, CANCER RES, V63, P7638; Dutt SS, 2009, FUTURE ONCOL, V5, P1403, DOI 10.2217/FON.09.117; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glass CK, 2000, GENE DEV, V14, P121; Hall JM, 2002, MOL ENDOCRINOL, V16, P469, DOI 10.1210/me.16.3.469; Heemers HV, 2005, CURR CANCER THER REV, V1, P175, DOI 10.2174/1573394054021745; Heemers HV, 2007, CANCER RES, V67, P3422, DOI 10.1158/0008-5472.CAN-06-2836; Heinlein CA, 2002, ENDOCR REV, V23, P175, DOI 10.1210/er.23.2.175; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Jeong KW, 2011, NAT STRUCT MOL BIOL, V18, P1358, DOI 10.1038/nsmb.2153; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kawasaki H, 1998, NATURE, V393, P284, DOI 10.1038/30538; Kim JH, 2003, MOL CELL, V12, P1537, DOI 10.1016/S1097-2765(03)00450-7; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lamont KR, 2010, ADV CANCER RES, V107, P137, DOI 10.1016/S0065-230X(10)07005-3; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; Lin BY, 1999, CANCER RES, V59, P4180; Lucas J, 2008, J PATHOL, V215, P118, DOI 10.1002/path.2330; Ma H, 2005, ONCOGENE, V24, P3619, DOI 10.1038/sj.onc.1208433; Makkonen H, 2009, NUCLEIC ACIDS RES, V37, P4135, DOI 10.1093/nar/gkp352; McManus KJ, 2001, BIOCHEM CELL BIOL, V79, P253, DOI 10.1139/bcb-79-3-253; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Miyabayashi T, 2007, P NATL ACAD SCI USA, V104, P5668, DOI 10.1073/pnas.0701331104; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Ramos YFM, 2010, NUCLEIC ACIDS RES, V38, P5396, DOI 10.1093/nar/gkq184; Rebel VI, 2002, P NATL ACAD SCI USA, V99, P14789, DOI 10.1073/pnas.232568499; Schultz JR, 2002, J BIOL CHEM, V277, P8702, DOI 10.1074/jbc.M108491200; Shi W, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq871; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Tanaka Y, 1997, P NATL ACAD SCI USA, V94, P10215, DOI 10.1073/pnas.94.19.10215; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Yuan ZM, 1999, ONCOGENE, V18, P5714, DOI 10.1038/sj.onc.1202930	48	83	83	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4000	4013		10.1074/jbc.M111.300194	http://dx.doi.org/10.1074/jbc.M111.300194			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22174411	Green Published, hybrid			2022-12-25	WOS:000300410900034
J	Zhang, L; Conway, JF; Thibodeau, PH				Zhang, Liang; Conway, James F.; Thibodeau, Patrick H.			Calcium-induced Folding and Stabilization of the Pseudomonas aeruginosa Alkaline Protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI ALPHA-HEMOLYSIN; GRAM-NEGATIVE BACTERIA; I SECRETION SYSTEM; ESCHERICHIA-COLI; ERWINIA-CHRYSANTHEMI; CRYSTAL-STRUCTURE; SERRATIA-MARCESCENS; ABC-TRANSPORTER; CYSTIC-FIBROSIS; PROTEINS	Pseudomonas aeruginosa is an opportunistic pathogen that contributes to the mortality of immunocompromised individuals and patients with cystic fibrosis. Pseudomonas infection presents clinical challenges due to its ability to form biofilms and modulate host-pathogen interactions through the secretion of virulence factors. The calcium-regulated alkaline protease (AP), a member of the repeats in toxin (RTX) family of proteins, is implicated in multiple modes of infection. A series of full-length and truncation mutants were purified for structural and functional studies to evaluate the role of Ca2+ in AP folding and activation. We find that Ca2+ binding induces RTX folding, which serves to chaperone the folding of the protease domain. Subsequent association of the RTX domain with an N-terminal alpha-helix stabilizes AP. These results provide a basis for the Ca2+-mediated regulation of AP and suggest mechanisms by which Ca2+ regulates the RTX family of virulence factors.	[Zhang, Liang; Thibodeau, Patrick H.] Univ Pittsburgh, Dept Cell Biol & Physiol, Sch Med, Pittsburgh, PA 15261 USA; [Conway, James F.] Univ Pittsburgh, Dept Biol Struct, Sch Med, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Thibodeau, PH (corresponding author), Univ Pittsburgh, Dept Cell Biol & Physiol, Sch Med, 3500 Terrace St,S327 BST, Pittsburgh, PA 15261 USA.	thibodea@pitt.edu	Conway, James F/A-2296-2010; Zhang, Liang/D-9446-2015	Conway, James F/0000-0002-6581-4748; Zhang, Liang/0000-0003-4268-6939; Thibodeau, Patrick/0000-0002-6790-144X	National Institutes of Health, NIDDK [DK083284, DK072506]; University of Pittsburgh School of Medicine, Department of Cell Biology and Physiology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072506, R01DK083284, R56DK083284] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Pittsburgh School of Medicine, Department of Cell Biology and Physiology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health, NIDDK, Grants DK083284 and DK072506 (to P. H. T.). This work was also supported by faculty development funding from the University of Pittsburgh School of Medicine, Department of Cell Biology and Physiology.	Bakas L, 1998, BBA-BIOMEMBRANES, V1368, P225, DOI 10.1016/S0005-2736(97)00181-8; BAUMANN U, 1993, EMBO J, V12, P3357, DOI 10.1002/j.1460-2075.1993.tb06009.x; BAUMANN U, 1994, J MOL BIOL, V242, P244, DOI 10.1006/jmbi.1994.1576; BAUMANN U, 1995, J MOL BIOL, V248, P653, DOI 10.1006/jmbi.1995.0249; Benabdelhak H, 2003, J MOL BIOL, V327, P1169, DOI 10.1016/S0022-2836(03)00204-3; Bertini I, 2008, J AM CHEM SOC, V130, P7011, DOI 10.1021/ja710491y; Binet R, 1997, GENE, V192, P7, DOI 10.1016/S0378-1119(96)00829-3; BLIGHT MA, 1994, MOL GEN GENET, V245, P431, DOI 10.1007/BF00302255; Chenal A, 2009, J BIOL CHEM, V284, P1781, DOI 10.1074/jbc.M807312200; DELEPELAIRE P, 1990, J BIOL CHEM, V265, P17118; Delepelaire P, 2004, BBA-MOL CELL RES, V1694, P149, DOI 10.1016/j.bbamcr.2004.05.001; DELEPELAIRE P, 1991, MOL MICROBIOL, V5, P2427, DOI 10.1111/j.1365-2958.1991.tb02088.x; DUONG F, 1992, GENE, V121, P47, DOI 10.1016/0378-1119(92)90160-Q; Duong F, 2001, GENE, V262, P147, DOI 10.1016/S0378-1119(00)00541-2; GANGOLA P, 1987, J BIOL CHEM, V262, P12570; Guyot N, 2010, BIOL CHEM, V391, P705, DOI 10.1515/BC.2010.066; GUZZO J, 1990, J BACTERIOL, V172, P942, DOI 10.1128/jb.172.2.942-948.1990; Hege T, 2001, J BIOL CHEM, V276, P35087, DOI 10.1074/jbc.M104020200; Hobden JA, 2002, DNA CELL BIOL, V21, P391, DOI 10.1089/10445490260099674; Huang SH, 1999, NAT STRUCT BIOL, V6, P1132; JAFFARBANDJEE MC, 1995, J CLIN MICROBIOL, V33, P924, DOI 10.1128/JCM.33.4.924-929.1995; Junker M, 2009, MOL MICROBIOL, V71, P1323, DOI 10.1111/j.1365-2958.2009.06607.x; KHARAZMI A, 1984, INFECT IMMUN, V44, P587, DOI 10.1128/IAI.44.3.587-591.1984; KHARAZMI A, 1984, INFECT IMMUN, V43, P161, DOI 10.1128/IAI.43.1.161-165.1984; Lang R, 2001, J MOL BIOL, V312, P731, DOI 10.1006/jmbi.2001.4954; Leidal KG, 2003, J INTERF CYTOK RES, V23, P307, DOI 10.1089/107999003766628151; LETOFFE S, 1992, J BACTERIOL, V174, P4920; LETOFFE S, 1994, J BACTERIOL, V176, P5372; Lilie H, 2000, FEBS LETT, V470, P173, DOI 10.1016/S0014-5793(00)01308-9; Linhartova I, 2010, FEMS MICROBIOL REV, V34, P1076, DOI 10.1111/j.1574-6976.2010.00231.x; Louis D, 1999, INT J BIOCHEM CELL B, V31, P1435, DOI 10.1016/S1357-2725(99)00100-4; Louis D, 1998, BBA-PROTEIN STRUCT M, V1387, P378, DOI 10.1016/S0167-4838(98)00144-7; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Ma QH, 2003, BBA-BIOMEMBRANES, V1611, P223, DOI 10.1016/S0005-2736(03)00059-2; Omori K, 2003, J BIOSCI BIOENG, V95, P1; Pace CN, 2000, PROTEINS, P1; Palacios JL, 2001, J BACTERIOL, V183, P1346, DOI 10.1128/JB.183.4.1346-1358.2001; Ravaud S, 2003, J BACTERIOL, V185, P4195, DOI 10.1128/JB.185.14.4195-4203.2003; Sarkisova S, 2005, J BACTERIOL, V187, P4327, DOI 10.1128/JB.187.13.4327-4337.2005; Soloaga A, 1999, MOL MICROBIOL, V31, P1013, DOI 10.1046/j.1365-2958.1999.01225.x; Sotomayor Perez AC, 2010, J MOL BIOL, V397, P534, DOI 10.1016/j.jmb.2010.01.031	42	39	39	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4311	4322		10.1074/jbc.M111.310300	http://dx.doi.org/10.1074/jbc.M111.310300			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22170064	Green Published, hybrid			2022-12-25	WOS:000300410900062
J	Lee, JT; Netuveli, G; Majeed, A; Millett, C				Lee, John Tayu; Netuveli, Gopalakrishnan; Majeed, Azeem; Millett, Christopher			The Effects of Pay for Performance on Disparities in Stroke, Hypertension, and Coronary Heart Disease Management: Interrupted Time Series Study	PLOS ONE			English	Article							INCENTIVE-BASED CONTRACT; PRIMARY-CARE; FOR-PERFORMANCE; HEALTH-CARE; FINANCIAL INCENTIVES; DIABETES MANAGEMENT; ETHNIC DISPARITIES; OUTCOMES FRAMEWORK; QUALITY; UK	Background: The Quality and Outcomes Framework (QOF), a major pay-for-performance programme, was introduced into United Kingdom primary care in April 2004. The impact of this programme on disparities in health care remains unclear. This study examines the following questions: has this pay for performance programme improved the quality of care for coronary heart disease, stroke and hypertension in white, black and south Asian patients? Has this programme reduced disparities in the quality of care between these ethnic groups? Did general practices with different baseline performance respond differently to this programme? Methodology/Principal Findings: Retrospective cohort study of patients registered with family practices in Wandsworth, London during 2007. Segmented regression analysis of interrupted time series was used to take into account the previous time trend. Primary outcome measures were mean systolic and diastolic blood pressure, and cholesterol levels. Our findings suggest that the implementation of QOF resulted in significant short term improvements in blood pressure control. The magnitude of benefit varied between ethnic groups with a statistically significant short term reduction in systolic BP in white and black but not in south Asian patients with hypertension. Disparities in risk factor control were attenuated only on few measures and largely remained intact at the end of the study period. Conclusions/Significance: Pay for performance programmes such as the QOF in the UK should set challenging but achievable targets. Specific targets aimed at reducing ethnic disparities in health care may also be needed.	[Lee, John Tayu; Netuveli, Gopalakrishnan; Majeed, Azeem; Millett, Christopher] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Primary Care & Publ Hlth, Sch Publ Hlth, London SW7 2AZ, England	Imperial College London	Lee, JT (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Primary Care & Publ Hlth, Sch Publ Hlth, London SW7 2AZ, England.	t.lee@imperial.ac.uk		Millett, Christopher/0000-0002-0793-9884; Lee, John Tayu/0000-0002-1551-4923; Majeed, Azeem/0000-0002-2357-9858	National Institute for Health Research Service [08/1716/209]; National Institute for Health Research Biomedical Research Centre; National Institute for Health Research; Imperial Centre for Patient Safety and Service Quality; Department of Health	National Institute for Health Research Service; National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR)); Imperial Centre for Patient Safety and Service Quality; Department of Health	This study was funded by the National Institute for Health Research Service Delivery & Organisation programme (Grant Number 08/1716/209). The Department of Primary Care & Public Health at Imperial College is grateful for support from the National Institute for Health Research Biomedical Research Centre Funding scheme, the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care scheme, and the Imperial Centre for Patient Safety and Service Quality. The Wandsworth Primary Care Research Centre has received funding from the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No potential conflicts of interest relevant to this article were reported.	Alshamsan R, 2010, J HEALTH SERV RES PO, V15, P178, DOI 10.1258/jhsrp.2010.009113; ASHWORTH M, 2008, BRIT MED J, V337, pA20; Calvert M, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1870; CAMPBELL SM, 2005, BRIT MED J, V331, P11; Campbell S, 2007, NEW ENGL J MED, V357, P181, DOI 10.1056/NEJMsr065990; Campbell SM, 2009, NEW ENGL J MED, V361, P368, DOI 10.1056/NEJMsa0807651; Casalino LP, 2007, HEALTH AFFAIR, V26, pW405, DOI 10.1377/hlthaff.26.3.w405; Chien AT, 2007, MED CARE RES REV, V64, p283S, DOI 10.1177/1077558707305426; Conrad DA, 2009, ANNU REV PUBL HEALTH, V30, P357, DOI 10.1146/annurev.publhealth.031308.100243; Crawley D, 2009, J ROY SOC MED, V102, P103, DOI 10.1258/jrsm.2009.080389; Cumberlege J., 2010, FAIR SOC HEARLY LIVE; Doran T, 2008, LANCET, V372, P728, DOI 10.1016/S0140-6736(08)61123-X; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Doran T, 2010, HEALTH AFFAIR, V29, P1023, DOI 10.1377/hlthaff.2010.0069; EMMERICH M, 2011, ENZYKLOPADIE ERZIEHU, P1; Gray J, 2003, BRIT MED J, V326, P1130, DOI 10.1136/bmj.326.7399.1130; Guthrie B, 2006, BRIT J GEN PRACT, V56, P836; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Kontopantelis E, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-61; LeGrand J, 1997, J SOC POLICY, V26, P149, DOI 10.1017/S0047279497004984; Marshall M, 2003, QUAL SAF HEALTH CARE, V12, P397, DOI 10.1136/qhc.12.6.397; McGovern MP, 2008, FAM PRACT, V25, P33, DOI 10.1093/fampra/cmm073; MCGUIRE T, 2000, HDB HLTH EC A, V1, P461; McLean G, 2006, J EPIDEMIOL COMMUN H, V60, P917, DOI 10.1136/jech.2005.044628; MILLETT C, 2011, BMJ, V342; Millett C, 2008, ANN FAM MED, V6, P490, DOI 10.1370/afm.907; Millett C, 2007, PLOS MED, V4, P1087, DOI 10.1371/journal.pmed.0040191; Millett C, 2009, J ROY SOC MED, V102, P369, DOI 10.1258/jrsm.2009.090171; Millett C, 2009, DIABETES CARE, V32, P404, DOI 10.2337/dc08-0912; Rosenthal MB, 2005, JAMA-J AM MED ASSOC, V294, P1788, DOI 10.1001/jama.294.14.1788; Saxena S, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-96; Simpson CR, 2006, STROKE, V37, P2354, DOI 10.1161/01.STR.0000236067.37267.88; Sutton M, 2006, BRIT MED J, V332, P389, DOI 10.1136/bmj.38742.554468.55; Sutton M, 2010, HEALTH ECON, V19, P1, DOI 10.1002/hec.1440; Tahrani AA, 2007, BRIT J GEN PRACT, V57, P483; Victora CG, 2000, LANCET, V356, P1093, DOI 10.1016/S0140-6736(00)02741-0; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Walker S, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X501859; Zhang F, 2009, J CLIN EPIDEMIOL, V62, P143, DOI 10.1016/j.jclinepi.2008.08.007	39	23	24	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e27236	10.1371/journal.pone.0027236	http://dx.doi.org/10.1371/journal.pone.0027236			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	866HE	22194781	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000298370400002
J	Baluch, A; Humar, A; Egli, A; Gubbay, J; Lisboa, L; Wilson, L; Kumar, D				Baluch, Aliyah; Humar, Atul; Egli, Adrian; Gubbay, Jonathan; Lisboa, Luiz; Wilson, Leticia; Kumar, Deepali			Long Term Immune Responses to Pandemic Influenza A/H1N1 Infection in Solid Organ Transplant Recipients	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; VACCINATION	In solid organ transplant (SOT) recipients it is unknown if natural infection with influenza confers protection from reinfection with the same strain during the next influenza season. The purpose of this study was to determine if infection with pandemic influenza A/H1N1 (pH1N1) resulted in a long-term immunologic response. Transplant recipients with microbiologically proven pH1N1 infection in 2009/2010 underwent humoral and cell-mediated immunity (CMI) testing for pH1N1 just prior to the next influenza season. Concurrent testing for A/Brisbane/59/2007 was done to rule-out crossreacting antibody. We enrolled 22 adult transplant patients after pH1N1 infection. Follow up testing was done at a median of 7.4 months (range 5.8-15.4) after infection. After excluding those with cross-reactive antibody, 7/19 (36.8%) patients were seroprotected. Detectable pH1N1-specific CD4+ and CD8+ interferon-c producing T-cells were found in 11/22 (50%) and 8/22 (36.4%) patients respectively. Humoral immunity had a significant correlation with a CD4 response. This is the first study in transplant patients to evaluate long-term humoral and cellular response after natural influenza infection. We show that a substantial proportion of SOT recipients with previous pH1N1 infection lack long-term humoral and cellular immune responses to pH1N1. These patients most likely are at risk for re-infection.	[Baluch, Aliyah; Humar, Atul; Egli, Adrian; Lisboa, Luiz; Wilson, Leticia; Kumar, Deepali] Univ Alberta, Alberta Inst Transplant Sci, Edmonton, AB, Canada; [Baluch, Aliyah; Humar, Atul; Egli, Adrian; Lisboa, Luiz; Wilson, Leticia; Kumar, Deepali] Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB, Canada; [Gubbay, Jonathan] Ontario Agcy Hlth Protect & Promot, Toronto, ON, Canada; [Gubbay, Jonathan] Univ Toronto, Toronto, ON, Canada	University of Alberta; University of Alberta; University of Toronto	Baluch, A (corresponding author), Univ Alberta, Alberta Inst Transplant Sci, Edmonton, AB, Canada.	deepali.kumar@ualberta.ca	Lisboa, Luiz/L-4186-2014; Gubbay, Jonathan/Q-8580-2019	Lisboa, Luiz/0000-0002-9065-6630; Gubbay, Jonathan/0000-0003-0026-3786	Hoffmann-LaRoche; Sanofi-Pasteur; HoffmanLaRoche; Swiss National Fund [PBBSP3-130963]	Hoffmann-LaRoche(Hoffmann-La Roche); Sanofi-Pasteur; HoffmanLaRoche; Swiss National Fund(Swiss National Science Foundation (SNSF))	The authors have read the journal's policy and have the following conflicts: D.K. has received research support paid to the institution from Hoffmann-LaRoche and Sanofi-Pasteur. A.H. has received research support paid to the institution from Hoffmann-LaRoche and speaker honoraria from HoffmanLaRoche. A.E. is supported by the Swiss National Fund Grant PBBSP3-130963. This does not alter the author's adherence to all the PLoS ONE policies on sharing data and materials. The remaining authors have no conflict of interest.	Bermejo-Martin JF, 2009, CRIT CARE, V13, DOI 10.1186/cc8208; Blumberg EA, 1996, CLIN INFECT DIS, V22, P295, DOI 10.1093/clinids/22.2.295; Candon S, 2009, AM J TRANSPLANT, V9, P2346, DOI 10.1111/j.1600-6143.2009.02787.x; Garland P, 2011, BIOL BLOOD MARROW TR, V17, P632, DOI 10.1016/j.bbmt.2010.08.002; Khanna N, 2009, TRANSPL INFECT DIS, V11, P100, DOI 10.1111/j.1399-3062.2008.00362.x; Kumar D, 2010, LANCET INFECT DIS, V10, P521, DOI 10.1016/S1473-3099(10)70133-X; Low CY, 2010, TRANSPLANTATION, V90, P1016, DOI 10.1097/TP.0b013e3181f546cf; Maecker HT, 2004, HUM IMMUNOL, V65, P493, DOI 10.1016/j.humimm.2004.02.004; Manuel O, 2011, J HEART LUNG TRANSPL, V30, P679, DOI 10.1016/j.healun.2011.01.705; Manuel O, 2011, CLIN INFECT DIS, V52, P248, DOI 10.1093/cid/ciq104; Mazzone PJ, 2004, J HEART LUNG TRANSPL, V23, P1175, DOI 10.1016/j.healun.2003.08.033; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; MCMICHAEL AJ, 1983, LANCET, V2, P762; Scharpe J, 2008, AM J TRANSPLANT, V8, P332, DOI 10.1111/j.1600-6143.2007.02066.x; Smud A, 2010, TRANSPLANTATION, V90, P1458, DOI 10.1097/TP.0b013e3181fc09fe; Stanekova Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-351; Wang M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016809; *WHO ESP COMM BIOL, 2007, REG PREP HUM PAND IN; World Health Organization Department of Communicable Disease Surveillance and Response, 2002, WHO MAN AN INFL DIAG	19	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28627	10.1371/journal.pone.0028627	http://dx.doi.org/10.1371/journal.pone.0028627			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194870	Green Submitted, Green Published, gold			2022-12-25	WOS:000298369100067
J	Cassagne, C; Ranque, S; Normand, AC; Fourquet, P; Thiebault, S; Planard, C; Hendrickx, M; Piarroux, R				Cassagne, Carole; Ranque, Stephane; Normand, Anne-Cecile; Fourquet, Patrick; Thiebault, Sandrine; Planard, Chantal; Hendrickx, Marijke; Piarroux, Renaud			Mould Routine Identification in the Clinical Laboratory by Matrix-Assisted Laser Desorption Ionization Time-Of-Flight Mass Spectrometry	PLOS ONE			English	Article							MEDICALLY IMPORTANT MOLDS; ASPERGILLUS; SPORES; DISCRIMINATION	Background: MALDI-TOF MS recently emerged as a valuable identification tool for bacteria and yeasts and revolutionized the daily clinical laboratory routine. But it has not been established for routine mould identification. This study aimed to validate a standardized procedure for MALDI-TOF MS-based mould identification in clinical laboratory. Materials and Methods: First, pre-extraction and extraction procedures were optimized. With this standardized procedure, a 143 mould strains reference spectra library was built. Then, the mould isolates cultured from sequential clinical samples were prospectively subjected to this MALDI-TOF MS based-identification assay. MALDI-TOF MS-based identification was considered correct if it was concordant with the phenotypic identification; otherwise, the gold standard was DNA sequence comparison-based identification. Results: The optimized procedure comprised a culture on sabouraud-gentamicin-chloramphenicol agar followed by a chemical extraction of the fungal colonies with formic acid and acetonitril. The identification was done using a reference database built with references from at least four culture replicates. For five months, 197 clinical isolates were analyzed; 20 were excluded because they were not identified at the species level. MALDI-TOF MS-based approach correctly identified 87% (154/177) of the isolates analyzed in a routine clinical laboratory activity. It failed in 12% (21/177), whose species were not represented in the reference library. MALDI-TOF MS-based identification was correct in 154 out of the remaining 156 isolates. One Beauveria bassiana was not identified and one Rhizopus oryzae was misidentified as Mucor circinelloides. Conclusions: This work's seminal finding is that a standardized procedure can also be used for MALDI-TOF MS-based identification of a wide array of clinically relevant mould species. It thus makes it possible to identify moulds in the routine clinical laboratory setting and opens new avenues for the development of an integrated MALDI-TOF MS-based solution for the identification of any clinically relevant microorganism.	[Cassagne, Carole; Ranque, Stephane; Normand, Anne-Cecile; Thiebault, Sandrine; Piarroux, Renaud] Univ Mediterranee, CHU Timone, Lab Parasitol Mycol, Marseille, France; [Fourquet, Patrick] Ctr Immunol Marseille Luminy, Serv Prote, Marseille, France; [Planard, Chantal; Hendrickx, Marijke] IHEM Sci Inst Publ Hlth, Mycol & Aerobiol Sect, Brussels, Belgium	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Cassagne, C (corresponding author), Univ Mediterranee, CHU Timone, Lab Parasitol Mycol, Marseille, France.	carole.cassagne@ap-hm.fr	Normand, Anne-Cécile/V-4271-2018; Ranque, Stéphane/K-2317-2015; cassagne, carole/P-5716-2016	Normand, Anne-Cécile/0000-0002-9589-4603; Ranque, Stéphane/0000-0003-3293-5276; Hendrickx, Marijke/0000-0001-8646-6546; cassagne, carole/0000-0001-6034-6423; piarroux, renaud/0000-0002-4151-4134				ALEXANDER BD, 2002, TRANSPL INFECT DIS S, V3, P32; Balajee SA, 2007, MED MYCOL, V45, P475, DOI 10.1080/13693780701449425; Bennett JW, 2003, CLIN MICROBIOL REV, V16, P497, DOI 10.1128/CMR.16.3.497-516.2003; CHABASSE B, 2009, REV FRANCOPHONE LAB, V416, P71; Chen HY, 2005, RAPID COMMUN MASS SP, V19, P3564, DOI 10.1002/rcm.2229; Coulibaly O, 2011, MED MYCOL, V49, P621, DOI 10.3109/13693786.2011.555424; de Hoog G S, 2007, Stud Mycol, V58, P219, DOI 10.3114/sim.2007.58.08; De Hoog G. S., 2000, ATLAS CLIN FUNGI; DERESPINIS S, 2009, MYCOLOGICAL PROGR, V109, P1209; EGE MJ, 2010, NEW ENGL J MED, V24, P701; Erhard M, 2008, EXP DERMATOL, V17, P356, DOI 10.1111/j.1600-0625.2007.00649.x; Giebel R, 2010, ADV APPL MICROBIOL, V71, P149, DOI 10.1016/S0065-2164(10)71006-6; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Hettick JM, 2008, RAPID COMMUN MASS SP, V22, P2555, DOI 10.1002/rcm.3649; Hettick JM, 2008, ANAL BIOCHEM, V380, P276, DOI 10.1016/j.ab.2008.05.051; Hsiao CR, 2005, J CLIN MICROBIOL, V43, P3760, DOI 10.1128/JCM.43.8.3760-3768.2005; Li TY, 2000, RAPID COMMUN MASS SP, V14, P2393, DOI 10.1002/1097-0231(20001230)14:24<2393::AID-RCM178>3.0.CO;2-9; Marinach-Patrice C, 2009, CLIN MICROBIOL INFEC, V15, P634, DOI 10.1111/j.1469-0691.2009.02758.x; Marvin LF, 2003, CLIN CHIM ACTA, V337, P11, DOI 10.1016/j.cccn.2003.08.008; Niemeier RT, 2006, J OCCUP ENVIRON HYG, V3, P262, DOI 10.1080/15459620600637333; Qian J, 2008, ANAL BIOANAL CHEM, V392, P439, DOI 10.1007/s00216-008-2288-1; Santos C, 2010, J APPL MICROBIOL, V108, P375, DOI 10.1111/j.1365-2672.2009.04448.x; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; TANG CM, 1993, AM REV RESPIR DIS, V148, P1313, DOI 10.1164/ajrccm/148.5.1313; Tao J, 2009, RAPID COMMUN MASS SP, V23, P3647, DOI 10.1002/rcm.4296; Valentine NB, 2002, RAPID COMMUN MASS SP, V16, P1352, DOI 10.1002/rcm.721; Welham KJ, 2000, RAPID COMMUN MASS SP, V14, P307, DOI 10.1002/(SICI)1097-0231(20000315)14:5&lt;307::AID-RCM823&gt;3.0.CO;2-3; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1	28	181	194	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28425	10.1371/journal.pone.0028425	http://dx.doi.org/10.1371/journal.pone.0028425			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194834	Green Published, gold, Green Submitted			2022-12-25	WOS:000298369100037
J	Li, Y; Yang, HJ; Xia, JY; Zhang, WH; Wan, SQ; Li, LH				Li, Yang; Yang, Haijun; Xia, Jianyang; Zhang, Wenhao; Wan, Shiqiang; Li, Linghao			Effects of Increased Nitrogen Deposition and Precipitation on Seed and Seedling Production of Potentilla tanacetifolia in a Temperate Steppe Ecosystem	PLOS ONE			English	Article							CLIMATE-CHANGE; ELEVATED CO2; POPULATION-DENSITY; FRUIT ABORTION; N DEPOSITION; SIZE; GROWTH; WATER; GERMINATION; RESPONSES	Background: The responses of plant seeds and seedlings to changing atmospheric nitrogen (N) deposition and precipitation regimes determine plant population dynamics and community composition under global change. Methodology/Principal Findings: In a temperate steppe in northern China, seeds of P. tanacetifolia were collected from a field-based experiment with N addition and increased precipitation to measure changes in their traits (production, mass, germination). Seedlings germinated from those seeds were grown in a greenhouse to examine the effects of improved N and water availability in maternal and offspring environments on seedling growth. Maternal N-addition stimulated seed production, but it suppressed seed mass, germination rate and seedling biomass of P. tanacetifolia. Maternal N-addition also enhanced responses of seedlings to N and water addition in the offspring environment. Maternal increased-precipitation stimulated seed production, but it had no effect on seed mass and germination rate. Maternal increased-precipitation enhanced seedling growth when grown under similar conditions, whereas seedling responses to offspring N- and water-addition were suppressed by maternal increased-precipitation. Both offspring N-addition and increased-precipitation stimulated growth of seedlings germinated from seeds collected from the maternal control environment without either N or water addition. Our observations indicate that both maternal and offspring environments can influence seedling growth of P. tanacetifolia with consequent impacts on the future population dynamics of this species in the study area. Conclusion/Significance: The findings highlight the importance of the maternal effects on seed and seedling production as well as responses of offspring to changing environmental drivers in mechanistic understanding and projecting of plant population dynamics under global change.	[Li, Yang; Yang, Haijun; Xia, Jianyang; Zhang, Wenhao; Li, Linghao] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Li, Yang; Yang, Haijun; Xia, Jianyang] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Wan, Shiqiang] Henan Univ, Coll Life Sci, Key Lab Plant Stress Biol, Kaifeng, Henan, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Henan University	Li, Y (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	llinghao@ibcas.ac.cn	Yang, Haijun/E-7186-2012; Wan, Shiqiang/B-5799-2009; Xia, Jianyang/A-7886-2008; Wan, Shiqiang/L-9166-2019; Xia, Jianyang/S-9499-2019; Zhang, Wen-Hao/B-5805-2009	Yang, Haijun/0000-0002-9596-4907; Wan, Shiqiang/0000-0003-0631-1232; Wan, Shiqiang/0000-0003-0631-1232; Zhang, Wen-Hao/0000-0003-2708-2221	National Natural Science Foundation of China [31130008, 30925009]; State Key Basic Research Development Program of China [2010CB833502]; Beijing Academy of Life Science of CAS	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Basic Research Development Program of China; Beijing Academy of Life Science of CAS	This research was financially supported by the projects from the National Natural Science Foundation of China (31130008 and 30925009), the State Key Basic Research Development Program of China (2010CB833502), and a grant from Beijing Academy of Life Science of CAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison VJ, 2002, FUNCT ECOL, V16, P742, DOI 10.1046/j.1365-2435.2002.00675.x; Anderson MT, 2003, J RANGE MANAGE, V56, P501, DOI 10.2307/4003843; AR6 Climate Change, 2021, SUMMARY POLICYMAKERS; Baraloto C, 2005, J ECOL, V93, P1156, DOI 10.1111/j.1365-2745.2005.01041.x; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; Breen AN, 2008, OECOLOGIA, V157, P13, DOI 10.1007/s00442-008-1049-3; Cheplick GP, 1998, INT J PLANT SCI, V159, P338, DOI 10.1086/297555; Cholaw B, 2003, ADV ATMOS SCI, V20, P755, DOI 10.1007/BF02915400; Drenovsky RE, 2005, OECOLOGIA, V143, P349, DOI 10.1007/s00442-004-1821-y; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Engel EC, 2009, J PLANT ECOL, V2, P1, DOI 10.1093/jpe/rtn026; Eriksson O, 1998, J ECOL, V86, P922, DOI 10.1046/j.1365-2745.1998.00309.x; Fenner M., 2005, ECOLOGY SEEDS; Frink CR, 1999, P NATL ACAD SCI USA, V96, P1175, DOI 10.1073/pnas.96.4.1175; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Green PT, 2004, J ECOL, V92, P397, DOI 10.1111/j.0022-0477.2004.00889.x; Hanley ME, 2007, NEW PHYTOL, V174, P381, DOI 10.1111/j.1469-8137.2007.02003.x; He CE, 2007, AGR ECOSYST ENVIRON, V121, P395, DOI 10.1016/j.agee.2006.12.016; He JS, 2005, FUNCT ECOL, V19, P437, DOI 10.1111/j.1365-2435.2005.00981.x; HilleRisLambers J, 2009, ECOLOGY, V90, P1810, DOI 10.1890/07-1351.1; Hooper DU, 1999, BIOGEOCHEMISTRY, V46, P247, DOI 10.1007/BF01007582; Hou JQ, 1998, J RANGE MANAGE, V51, P699, DOI 10.2307/4003615; Huxman TE, 1998, OECOLOGIA, V114, P202, DOI 10.1007/s004420050437; Huxman TE, 2004, OECOLOGIA, V141, P295, DOI 10.1007/s00442-003-1389-y; Jablonski LM, 2002, NEW PHYTOL, V156, P9, DOI 10.1046/j.1469-8137.2002.00494.x; Jose S, 2003, FOREST ECOL MANAG, V180, P335, DOI 10.1016/S0378-1127(02)00583-2; Jump AS, 2003, NEW PHYTOL, V160, P349, DOI 10.1046/j.1469-8137.2003.00873.x; JURADO E, 1992, J ECOL, V80, P407, DOI 10.2307/2260686; KRANNITZ PG, 1991, AM J BOT, V78, P446, DOI 10.2307/2444967; Lau JA, 2008, OECOLOGIA, V158, P141, DOI 10.1007/s00442-008-1127-6; Levin DA, 1996, CONSERV BIOL, V10, P10, DOI 10.1046/j.1523-1739.1996.10010010.x; Liu WX, 2009, GLOBAL CHANGE BIOL, V15, P184, DOI 10.1111/j.1365-2486.2008.01728.x; Marcelis LFM, 2004, J EXP BOT, V55, P2261, DOI 10.1093/jxb/erh245; McGinley MA, 1988, EVOL ECOL, V2, P77, DOI 10.1007/BF02071590; Milberg P, 1997, NEW PHYTOL, V137, P665, DOI 10.1046/j.1469-8137.1997.00870.x; Moles AT, 2004, J ECOL, V92, P372, DOI 10.1111/j.0022-0477.2004.00884.x; Monaco TA, 2003, J RANGE MANAGE, V56, P646, DOI 10.2307/4003941; Navas ML, 2002, ACTA OECOL, V23, P375, DOI 10.1016/S1146-609X(02)01168-2; Ngugi MR, 2003, NEW FOREST, V26, P187, DOI 10.1023/A:1024493917483; Ni J, 2000, J ARID ENVIRON, V46, P313, DOI 10.1006/jare.2000.0667; Niu SL, 2008, NEW PHYTOL, V177, P209, DOI 10.1111/j.1469-8137.2007.02237.x; Niu SL, 2011, GLOBAL CHANGE BIOL, V17, P1073, DOI 10.1111/j.1365-2486.2010.02280.x; Niu SL, 2010, GLOBAL CHANGE BIOL, V16, P144, DOI 10.1111/j.1365-2486.2009.01894.x; Norby RJ, 2000, PLANT SOIL, V224, P15, DOI 10.1023/A:1004629231766; Patrick L, 2007, OECOLOGIA, V151, P704, DOI 10.1007/s00442-006-0621-y; Portsmuth A, 2006, FOREST ECOL MANAG, V227, P122, DOI 10.1016/j.foreco.2006.02.020; Ren HY, 2011, ANN BOT-LONDON, V107, P145, DOI 10.1093/aob/mcq219; SAKAI S, 1995, AM NAT, V145, P918, DOI 10.1086/285776; Sakai S, 1996, AM J BOT, V83, P1454, DOI 10.2307/2446100; Schlesinger WH, 2009, P NATL ACAD SCI USA, V106, P203, DOI 10.1073/pnas.0810193105; Snyder KA, 2004, OECOLOGIA, V141, P325, DOI 10.1007/s00442-003-1403-4; Steinger T, 2000, OECOLOGIA, V123, P475, DOI 10.1007/s004420000342; STEPHENSON AG, 1981, ANNU REV ECOL SYST, V12, P253, DOI 10.1146/annurev.es.12.110181.001345; Valencia-Diaz S, 2005, J ARID ENVIRON, V63, P686, DOI 10.1016/j.jaridenv.2005.03.024; Vourlitis GL, 2009, ECOLOGY, V90, P2183, DOI 10.1890/08-1121.1; Weiner J, 1997, J ECOL, V85, P133, DOI 10.2307/2960645; Willis SG, 2004, FUNCT ECOL, V18, P887, DOI 10.1111/j.0269-8463.2004.00907.x; Xia JY, 2008, NEW PHYTOL, V179, P428, DOI 10.1111/j.1469-8137.2008.02488.x; Xia JY, 2009, GLOBAL CHANGE BIOL, V15, P1544, DOI 10.1111/j.1365-2486.2008.01807.x; Yang HJ, 2011, GLOBAL CHANGE BIOL, V17, P2936, DOI 10.1111/j.1365-2486.2011.02423.x; Yang HJ, 2011, GLOBAL CHANGE BIOL, V17, P452, DOI 10.1111/j.1365-2486.2010.02253.x; Zhang Y, 2008, ATMOS ENVIRON, V42, P1035, DOI 10.1016/j.atmosenv.2007.12.015	62	22	26	6	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28601	10.1371/journal.pone.0028601	http://dx.doi.org/10.1371/journal.pone.0028601			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194863	gold, Green Published			2022-12-25	WOS:000298369100060
J	Overman, AR; Scholtz, RV				Overman, Allen R.; Scholtz, Richard V., III			Accumulation of Biomass and Mineral Elements with Calendar Time by Corn: Application of the Expanded Growth Model	PLOS ONE			English	Article							DRY-MATTER; RATES	The expanded growth model is developed to describe accumulation of plant biomass (Mg ha(-1)) and mineral elements (kg ha(-1)) in with calendar time (wk). Accumulation of plant biomass with calendar time occurs as a result of photosynthesis for green land-based plants. A corresponding accumulation of mineral elements such as nitrogen, phosphorus, and potassium occurs from the soil through plant roots. In this analysis, the expanded growth model is tested against high quality, published data on corn (Zea mays L.) growth. Data from a field study in South Carolina was used to evaluate the application of the model, where the planting time of April 2 in the field study maximized the capture of solar energy for biomass production. The growth model predicts a simple linear relationship between biomass yield and the growth quantifier, which is confirmed with the data. The growth quantifier incorporates the unit processes of distribution of solar energy which drives biomass accumulation by photosynthesis, partitioning of biomass between light-gathering and structural components of the plants, and an aging function. A hyperbolic relationship between plant nutrient uptake and biomass yield is assumed, and is confirmed for the mineral elements nitrogen (N), phosphorus (P), and potassium (K). It is concluded that the rate limiting process in the system is biomass accumulation by photosynthesis and that nutrient accumulation occurs in virtual equilibrium with biomass accumulation.	[Overman, Allen R.; Scholtz, Richard V., III] Univ Florida, Dept Agr & Biol Engn, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Overman, AR (corresponding author), Univ Florida, Dept Agr & Biol Engn, Gainesville, FL 32610 USA.	rscholtz@ufl.edu	Scholtz, Richard/F-9513-2011	Scholtz, Richard/0000-0001-8989-0131	Florida Agricultural Experiment Station	Florida Agricultural Experiment Station	This analysis was funded by the Florida Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz M., 1965, HDB MATH FUNCTIONS; BARYOSEF B, 1972, SOIL SCI SOC AM J, V36, P931, DOI 10.2136/sssaj1972.03615995003600060028x; KARLEN DL, 1987, AGRON J, V79, P649, DOI 10.2134/agronj1987.00021962007900040014x; Laughlin R.A., 2005, DIFFERENT UNIVERSE R; Moore Jason, 2014, EATING SUN PLANTS PO; MUTTI LSM, 1984, THESIS U FLORIDA GAI; Overman A.R., 2002, MATH MODELS CROP GRO; Overman A. R., 2010, MEMOIR SIMPLIFIED TH; Overman AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016117; Overman AR, 1999, COMMUN SOIL SCI PLAN, V30, P2059, DOI 10.1080/00103629909370355; SAYRE JD, 1948, PLANT PHYSIOL, V23, P267, DOI 10.1104/pp.23.3.267; Tolk JA, 1998, AGRON J, V90, P447, DOI 10.2134/agronj1998.00021962009000040001x	12	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28515	10.1371/journal.pone.0028515	http://dx.doi.org/10.1371/journal.pone.0028515			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194842	Green Published, gold			2022-12-25	WOS:000298369100044
J	Tsukahara, Y; Tanaka, M; Miyajima, A				Tsukahara, Yuko; Tanaka, Minoru; Miyajima, Atsushi			TROP2 Expressed in the Trunk of the Ureteric Duct Regulates Branching Morphogenesis during Kidney Development	PLOS ONE			English	Article							CELL ADHESION MOLECULE; HEPATOCYTE GROWTH-FACTOR; TEMPORAL EXPRESSION; RET PROTOONCOGENE; ANTIGEN EPCAM; MURINE; MOUSE; BUD; INTEGRINS; ORGANOGENESIS	TROP2, a cell surface protein structurally related to EpCAM, is expressed in various carcinomas, though its function remains largely unknown. We examined the expression of TROP2 and EpCAM in fetal mouse tissues, and found distinct patterns in the ureteric bud of the fetal kidney, which forms a tree-like structure. The tip cells in the ureteric bud proliferate to form branches, whereas the trunk cells differentiate to form a polarized ductal structure. EpCAM was expressed throughout the ureteric bud, whereas TROP2 expression was strongest at the trunk but diminished towards the tips, indicating the distinct cell populations in the ureteric bud. The cells highly expressing TROP2 (TROP2(high)) were negative for Ki67, a proliferating cell marker, and TROP2 and collagen-I were co-localized to the basal membrane of the trunk cells. TROP2(high) cells isolated from the fetal kidney failed to attach and spread on collagen-coated plates. Using MDCK cells, a well-established model for studying the branching morphogenesis of the ureteric bud, TROP2 was shown to inhibit cell spreading and motility on collagen-coated plates, and also branching in collagen-gel cultures, which mimic the ureteric bud's microenvironment. These results together suggest that TROP2 modulates the interaction between the cells and matrix and regulates the formation of the ureteric duct by suppressing branching from the trunk during kidney development.	[Tsukahara, Yuko; Tanaka, Minoru; Miyajima, Atsushi] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan	University of Tokyo	Tsukahara, Y (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan.	tanaka@iam.u-tokyo.ac.jp; miyajima@iam.u-tokyo.ac.jp			Ministry of Health, Labour and Welfare of Japan; Takeda Science Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan; Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST))	This work was supported by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Ministry of Health, Labour and Welfare of Japan, the Core Research for Evolutional Science and Technology (CREST) program from the Japan Science and Technology Agency and Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JC, 1993, DEVELOPMENT, V117, P1183; Balzar M, 1998, MOL CELL BIOL, V18, P4833, DOI 10.1128/MCB.18.8.4833; Chen D, 2004, AM J PHYSIOL-RENAL, V287, pF602, DOI 10.1152/ajprenal.00015.2004; Chen JC, 2002, AM J PATHOL, V161, P337, DOI 10.1016/S0002-9440(10)64185-5; Chi X, 2009, DEV CELL, V17, P199, DOI 10.1016/j.devcel.2009.07.013; Costantini F, 2006, BIOESSAYS, V28, P117, DOI 10.1002/bies.20357; Costantini F, 2010, DEV CELL, V18, P698, DOI 10.1016/j.devcel.2010.04.008; Cubas R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-253; Cubas R, 2009, BBA-REV CANCER, V1796, P309, DOI 10.1016/j.bbcan.2009.08.001; De Arcangelis A, 1999, DEVELOPMENT, V126, P3957; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; El Sewedy T, 1998, INT J CANCER, V75, P324, DOI 10.1002/(SICI)1097-0215(19980119)75:2<324::AID-IJC24>3.3.CO;2-5; Enomoto H, 1998, NEURON, V21, P317, DOI 10.1016/S0896-6273(00)80541-3; Gardner H, 1996, DEV BIOL, V175, P301, DOI 10.1006/dbio.1996.0116; Goldstein AS, 2008, P NATL ACAD SCI USA, V105, P20882, DOI 10.1073/pnas.0811411106; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Karner CM, 2009, NAT GENET, V41, P793, DOI 10.1038/ng.400; Kispert A, 1996, DEVELOPMENT, V122, P3627; KORHONEN M, 1990, J CELL BIOL, V111, P1245, DOI 10.1083/jcb.111.3.1245; Kreidberg JA, 1996, DEVELOPMENT, V122, P3537; Lin YF, 2003, INT J DEV BIOL, V47, P3; Litvinov SV, 1997, J CELL BIOL, V139, P1337, DOI 10.1083/jcb.139.5.1337; Liu YJ, 2009, DEVELOPMENT, V136, P843, DOI 10.1242/dev.027805; MADIN SH, 1958, P SOC EXP BIOL MED, V98, P574, DOI 10.3181/00379727-98-24111; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Maghzal N, 2010, J CELL BIOL, V191, P645, DOI 10.1083/jcb.201004074; Michael L, 2004, J ANAT, V204, P241, DOI 10.1111/j.0021-8782.2004.00285.x; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Miyazaki Y, 2000, J CLIN INVEST, V105, P863, DOI 10.1172/JCI8256; MONTESANO R, 1991, CELL, V67, P901, DOI 10.1016/0092-8674(91)90363-4; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Munz M, 2004, ONCOGENE, V23, P5748, DOI 10.1038/sj.onc.1207610; Nakatsukasa M, 2010, AM J PATHOL, V177, P1344, DOI 10.2353/ajpath.2010.100149; Nishinakamura R, 2001, DEVELOPMENT, V128, P3105; Nubel T, 2009, MOL CANCER RES, V7, P285, DOI 10.1158/1541-7786.MCR-08-0200; Okabe M, 2009, DEVELOPMENT, V136, P1951, DOI 10.1242/dev.031369; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; Quaggin SE, 2008, DEVELOPMENT, V135, P609, DOI 10.1242/dev.001081; SAELMAN EUM, 1995, J CELL SCI, V108, P3531; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; STEFANINI M, 1967, NATURE, V216, P173, DOI 10.1038/216173a0; THESLEFF I, 1995, INT J DEV BIOL, V39, P35; Trzpis M, 2007, NEPHRON EXP NEPHROL, V107, pE119, DOI 10.1159/000111039; TSUZUKI T, 1995, ONCOGENE, V10, P191; Wang JB, 2008, MOL CANCER THER, V7, P280, DOI 10.1158/1535-7163.MCT-07-2003; YAGEL S, 1994, HUM REPROD, V9, P1184, DOI 10.1093/oxfordjournals.humrep.a138656; Zhang Z, 2010, J AM SOC NEPHROL, V21, P573, DOI 10.1681/ASN.2009070719	47	14	28	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28607	10.1371/journal.pone.0028607	http://dx.doi.org/10.1371/journal.pone.0028607			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194864	gold, Green Published, Green Submitted			2022-12-25	WOS:000298369100061
J	Jin, SH; Lin, P; Hallett, M				Jin, Seung-Hyun; Lin, Peter; Hallett, Mark			Abnormal Reorganization of Functional Cortical Small-World Networks in Focal Hand Dystonia	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; MUTUAL INFORMATION ANALYSIS; MOTOR AREAS; SENSORIMOTOR INTEGRATION; OSCILLATORY SYNCHRONY; WRITERS CRAMP; CONNECTIVITY; ACTIVATION; CORTEX; MOVEMENTS	We investigated the large-scale functional cortical connectivity network in focal hand dystonia (FHD) patients using graph theoretic measures to assess efficiency. High-resolution EEGs were recorded in 15 FHD patients and 15 healthy volunteers at rest and during a simple sequential finger tapping task. Mutual information (MI) values of wavelet coefficients were estimated to create an association matrix between EEG electrodes, and to produce a series of adjacency matrices or graphs, G, by thresholding with network cost. Efficiency measures of small-world networks were assessed. As a result, we found that FHD patients have economical small-world properties in their brain functional networks in the alpha and beta bands. During a motor task, in the beta band network, FHD patients have decreased efficiency of small-world networks, whereas healthy volunteers increase efficiency. Reduced efficient beta band network in FHD patients during the task was consistently observed in global efficiency, cost-efficiency, and maximum cost-efficiency. This suggests that the beta band functional cortical network of FHD patients is reorganized even during a task that does not induce dystonic symptoms, representing a loss of long-range communication and abnormal functional integration in large-scale brain functional cortical networks. Moreover, negative correlations between efficiency measures and duration of disease were found, indicating that the longer duration of disease, the less efficient the beta band network in FHD patients. In regional efficiency analysis, FHD patients at rest have high regional efficiency at supplementary motor cortex (SMA) compared with healthy volunteers; however, it is diminished during the motor task, possibly reflecting abnormal inhibition in FHD patients. The present study provides the first evidence with graph theory for abnormal reconfiguration of brain functional networks in FHD during motor task.	[Jin, Seung-Hyun; Lin, Peter; Hallett, Mark] NINDS, Human Motor Control Sect, NIH, Bethesda, MD 20892 USA; [Jin, Seung-Hyun] Seoul Natl Univ Hosp, Dept Neurosurg, Seoul 110744, South Korea	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Seoul National University (SNU); Seoul National University Hospital	Jin, SH (corresponding author), NINDS, Human Motor Control Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	hallettm@mail.nih.gov		Lin, Peter/0000-0003-1198-7763	National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH)	National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the Intramural Research program of the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abbruzzese G, 2001, BRAIN, V124, P537, DOI 10.1093/brain/124.3.537; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Bai O, 2005, CLIN NEUROPHYSIOL, V116, P1213, DOI 10.1016/j.clinph.2005.01.006; Ball T, 1999, NEUROIMAGE, V10, P682, DOI 10.1006/nimg.1999.0507; Bartolomei F, 2006, CLIN NEUROPHYSIOL, V117, P2039, DOI 10.1016/j.clinph.2006.05.018; Bassett DS, 2009, P NATL ACAD SCI USA, V106, P11747, DOI 10.1073/pnas.0903641106; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Boecker H, 1998, J NEUROPHYSIOL, V79, P1070, DOI 10.1152/jn.1998.79.2.1070; Breakefield XO, 2008, NAT REV NEUROSCI, V9, P222, DOI 10.1038/nrn2337; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Carbonnell L, 2004, CLIN NEUROPHYSIOL, V115, P2164, DOI 10.1016/j.clinph.2004.04.012; CERUTTI S, 1988, IEEE T BIO-MED ENG, V35, P701, DOI 10.1109/10.7271; Connolly JD, 2000, J NEUROPHYSIOL, V84, P1645, DOI 10.1152/jn.2000.84.3.1645; Defazio G, 2007, BRAIN, V130, P1183, DOI 10.1093/brain/awl355; Delorme A, 2007, J NEUROSCI, V27, P11949, DOI 10.1523/JNEUROSCI.3477-07.2007; Fallani FDV, 2007, HUM BRAIN MAPP, V28, P1334, DOI 10.1002/hbm.20353; Frasch MG, 2007, CLIN NEUROPHYSIOL, V118, P1969, DOI 10.1016/j.clinph.2007.05.071; Gail A, 2004, CEREB CORTEX, V14, P300, DOI 10.1093/cercor/bhg129; Gerloff C, 1998, BRAIN, V121, P1513, DOI 10.1093/brain/121.8.1513; Gerloff C, 2002, ACTA PSYCHOL, V110, P161, DOI 10.1016/S0001-6918(02)00032-X; Gordon AM, 1998, EXP BRAIN RES, V121, P153, DOI 10.1007/s002210050447; Gross J, 2005, NEUROIMAGE, V26, P91, DOI 10.1016/j.neuroimage.2005.01.025; Honda M, 1998, BRAIN, V121, P2159, DOI 10.1093/brain/121.11.2159; Hummel F, 2003, CLIN NEUROPHYSIOL, V114, P605, DOI 10.1016/S1388-2457(02)00417-0; Humphries MD, 2006, P ROY SOC B-BIOL SCI, V273, P503, DOI 10.1098/rspb.2005.3354; Jin SH, 2006, INT J PSYCHOPHYSIOL, V62, P337, DOI 10.1016/j.ijpsycho.2006.06.003; Jin SH, 2006, BRAIN COGNITION, V62, P191, DOI 10.1016/j.bandc.2006.05.001; Jin SH, 2011, MOVEMENT DISORD, V26, P1274, DOI 10.1002/mds.23675; Jin SH, 2010, CLIN NEUROPHYSIOL, V121, P392, DOI 10.1016/j.clinph.2009.09.033; JIN SH, 2011, HUM BRAIN MAPP; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lerner A, 2004, NEUROIMAGE, V21, P904, DOI 10.1016/j.neuroimage.2003.10.019; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; MacDonald PA, 2003, CEREB CORTEX, V13, P962, DOI 10.1093/cercor/13.9.962; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Mima T, 1999, CLIN NEUROPHYSIOL, V110, P1892, DOI 10.1016/S1388-2457(99)00238-2; Mima T, 2000, NEUROSCI LETT, V287, P93, DOI 10.1016/S0304-3940(00)01165-4; Mostofsky SH, 2003, COGNITIVE BRAIN RES, V17, P419, DOI 10.1016/S0926-6410(03)00144-7; Oga T, 2002, BRAIN, V125, P895, DOI 10.1093/brain/awf083; Pollok B, 2005, NEUROIMAGE, V24, P646, DOI 10.1016/j.neuroimage.2004.10.009; Ponten SC, 2007, CLIN NEUROPHYSIOL, V118, P918, DOI 10.1016/j.clinph.2006.12.002; Reijneveld JC, 2007, CLIN NEUROPHYSIOL, V118, P2317, DOI 10.1016/j.clinph.2007.08.010; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sadato N, 1996, J NEUROSCI, V16, P2693; Sakai K, 1998, J NEUROSCI, V18, P1827; Saramaki J, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.027105; Schnitzler A, 2005, NAT REV NEUROSCI, V6, P285, DOI 10.1038/nrn1650; Serrien DJ, 2003, HUM BRAIN MAPP, V18, P296, DOI 10.1002/hbm.10086; Serrien DJ, 2002, EXP BRAIN RES, V147, P268, DOI 10.1007/s00221-002-1253-z; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Sporns O, 2006, P NATL ACAD SCI USA, V103, P19219, DOI 10.1073/pnas.0609523103; Stam CJ, 2010, INT J PSYCHOPHYSIOL, V77, P186, DOI 10.1016/j.ijpsycho.2010.06.024; Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P708, DOI 10.1016/j.clinph.2004.09.022; Tallon-Baudry C, 2004, CEREB CORTEX, V14, P713, DOI 10.1093/cercor/bhh031; Tallon-Baudry C, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0008.2001; Tamburin S, 2002, BRAIN, V125, P2719, DOI 10.1093/brain/awf279; Tamura Y, 2009, BRAIN, V132, P749, DOI 10.1093/brain/awn348; Tinazzi M, 1999, NEUROREPORT, V10, P1547, DOI 10.1097/00001756-199905140-00028; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Wang L, 2010, BRAIN, V133, P1224, DOI 10.1093/brain/awq043; Wang L, 2009, HUM BRAIN MAPP, V30, P638, DOI 10.1002/hbm.20530; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Witt ST, 2008, NEUROIMAGE, V42, P343, DOI 10.1016/j.neuroimage.2008.04.025; Wu CC, 2010, J NEUROL NEUROSUR PS, V81, P659, DOI 10.1136/jnnp.2009.185637; Wu T, 2007, NEUROSCI LETT, V422, P164, DOI 10.1016/j.neulet.2007.06.011	66	30	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28682	10.1371/journal.pone.0028682	http://dx.doi.org/10.1371/journal.pone.0028682			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174867	Green Submitted, gold, Green Published			2022-12-25	WOS:000298367300021
J	Lo, YH; Liu, SW; Sun, YJ; Lizz, HW; Hsiao, CD				Lo, Yu-Hua; Liu, Shih-Wei; Sun, Yuh-Ju; Lizz, Hung-Wen; Hsiao, Chwan-Deng			Mutations Altering the Interplay between GkDnaC Helicase and DNA Reveal an Insight into Helicase Unwinding	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; REPLICATIVE HEXAMERIC HELICASE; TETHERED PARTICLE MOTION; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; PROTEIN HEXAMER; NUCLEIC-ACID; MECHANISM; TRANSLOCATION; MOLECULE	Replicative helicases are essential molecular machines that utilize energy derived from NTP hydrolysis to move along nucleic acids and to unwind double-stranded DNA (dsDNA). Our earlier crystal structure of the hexameric helicase from Geobacillus kaustophilus HTA426 (GkDnaC) in complex with single-stranded DNA (ssDNA) suggested several key residues responsible for DNA binding that likely play a role in DNA translocation during the unwinding process. Here, we demonstrated that the unwinding activities of mutants with substitutions at these key residues in GkDnaC are 2-4-fold higher than that of wildtype protein. We also observed the faster unwinding velocities in these mutants using single-molecule experiments. A partial loss in the interaction of helicase with ssDNA leads to an enhancement in helicase efficiency, while their ATPase activities remain unchanged. In strong contrast, adding accessory proteins (DnaG or DnaI) to GkDnaC helicase alters the ATPase, unwinding efficiency and the unwinding velocity of the helicase. It suggests that the unwinding velocity of helicase could be modulated by two different pathways, the efficiency of ATP hydrolysis or protein-DNA interaction.	[Lo, Yu-Hua; Hsiao, Chwan-Deng] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Lo, Yu-Hua; Sun, Yuh-Ju] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Liu, Shih-Wei; Lizz, Hung-Wen] Natl Taiwan Univ, Dept Chem, Taipei 10764, Taiwan	Academia Sinica - Taiwan; National Tsing Hua University; National Taiwan University	Lo, YH (corresponding author), Acad Sinica, Inst Mol Biol, Taipei, Taiwan.	hsiao@gate.sinica.edu.tw	Hsiao, Chwan-Deng/AAZ-8869-2021	Hsiao, Chwan-Deng/0000-0002-7012-1532; LI, HUNG-WEN/0000-0002-5614-3727	Academia Sinica; National Science Council, Taiwan, Republic of China [NSC98-2311-B-001-009-MY3, NSC98-2113-M-002-013-MY2]	Academia Sinica(Academia Sinica - Taiwan); National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by research grants from Academia Sinica to C.-D.H. and the National Science Council (NSC98-2311-B-001-009-MY3 to C.-D.H., and NSC98-2113-M-002-013-MY2 to H.-W.L.), Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey S, 2007, SCIENCE, V318, P459, DOI 10.1126/science.1147353; Berger JM, 2008, CELL, V134, DOI 10.1016/j.cell.2008.08.027; Bird LE, 2000, BIOCHEMISTRY-US, V39, P171, DOI 10.1021/bi9918801; BUJALOWSKI W, 1995, BIOCHEMISTRY-US, V34, P8513, DOI 10.1021/bi00027a001; Chu JF, 2010, BIOPHYS J, V98, P1608, DOI 10.1016/j.bpj.2009.12.4328; Datta K, 2003, ANAL BIOCHEM, V317, P284, DOI 10.1016/S0003-2697(03)00168-4; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Fan HF, 2009, BIOPHYS J, V96, P1875, DOI [10.1016/j.bpj.2008.11.048, 10.1016/j.bpj.2()08.11.048]; Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; Jezewska MJ, 1998, J BIOL CHEM, V273, P9058, DOI 10.1074/jbc.273.15.9058; Jezewska MJ, 1996, BIOCHEMISTRY-US, V35, P2129, DOI 10.1021/bi952345d; Johnson DS, 2007, CELL, V129, P1299, DOI 10.1016/j.cell.2007.04.038; Lionnet T, 2007, P NATL ACAD SCI USA, V104, P19790, DOI 10.1073/pnas.0709793104; Lo YH, 2009, NUCLEIC ACIDS RES, V37, P804, DOI 10.1093/nar/gkn999; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Manosas M, 2010, NUCLEIC ACIDS RES, V38, P5518, DOI 10.1093/nar/gkq273; Manosas M, 2009, NAT CHEM BIOL, V5, P904, DOI 10.1038/nchembio.236; MARRIONE PE, 1995, BIOCHEMISTRY-US, V34, P9809, DOI 10.1021/bi00030a019; MATSON SW, 1990, ANNU REV BIOCHEM, V59, P289, DOI 10.1146/annurev.bi.59.070190.001445; Nelson PC, 2006, J PHYS CHEM B, V110, P17260, DOI 10.1021/jp0630673; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Pouget N, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh073; Ribeck N, 2010, BIOPHYS J, V99, P2170, DOI 10.1016/j.bpj.2010.07.039; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Soultanas P, 2002, NUCLEIC ACIDS RES, V30, P966, DOI 10.1093/nar/30.4.966; Spies M, 2005, J BIOL CHEM, V280, P37078, DOI 10.1074/jbc.M505521200; Thomsen ND, 2009, CELL, V139, P523, DOI 10.1016/j.cell.2009.08.043; Tsai KL, 2009, J MOL BIOL, V393, P1056, DOI 10.1016/j.jmb.2009.09.002; van Oijen AM, 2010, ANNU REV BIOPHYS, V39, P429, DOI 10.1146/annurev.biophys.093008.131327; WAHLE E, 1989, J BIOL CHEM, V264, P2469; Yodh JG, 2010, Q REV BIOPHYS, V43, P185, DOI 10.1017/S0033583510000107	33	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e29016	10.1371/journal.pone.0029016	http://dx.doi.org/10.1371/journal.pone.0029016			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174946	Green Submitted, Green Published, gold			2022-12-25	WOS:000298367300040
J	Bharti, SK; Rex, K; Sreedhar, P; Krishnan, N; Varshney, U				Bharti, Sanjay Kumar; Rex, Kervin; Sreedhar, Pujari; Krishnan, Neeraja; Varshney, Umesh			Chimeras of Escherichia coli and Mycobacterium tuberculosis Single-Stranded DNA Binding Proteins: Characterization and Function in Escherichia coli	PLOS ONE			English	Article							DEINOCOCCUS-RADIODURANS; CRYSTAL-STRUCTURE; SSB GENE; X-RAY; REPLICATION; DOMAIN; COMPLEXES; SSDNA; MODES; GLYCOSYLASES	Single stranded DNA binding proteins (SSBs) are vital for the survival of organisms. Studies on SSBs from the prototype, Escherichia coli (EcoSSB) and, an important human pathogen, Mycobacterium tuberculosis (MtuSSB) had shown that despite significant variations in their quaternary structures, the DNA binding and oligomerization properties of the two are similar. Here, we used the X-ray crystal structure data of the two SSBs to design a series of chimeric proteins (m beta 1, m beta 1'beta 2, m beta 1-beta 5, m beta 1-beta 6 and m beta 4-beta 5) by transplanting beta 1, beta 1'beta 2, beta 1-beta 5, beta 1-beta 6 and beta 4-beta 5 regions, respectively of the N-terminal (DNA binding) domain of MtuSSB for the corresponding sequences in EcoSSB. In addition, m beta 1'beta 2(ESWR) SSB was generated by mutating the MtuSSB specific 'PRIY' sequence in the beta 2 strand of m beta 1'beta 2 SSB to EcoSSB specific 'ESWR' sequence. Biochemical characterization revealed that except for m beta 1 SSB, all chimeras and a control construct lacking the C-terminal domain (Delta C SSB) bound DNA in modes corresponding to limited and unlimited modes of binding. However, the DNA on MtuSSB may follow a different path than the EcoSSB. Structural probing by protease digestion revealed that unlike other SSBs used, m beta 1 SSB was also hypersensitive to chymotrypsin treatment. Further, to check for their biological activities, we developed a sensitive assay, and observed that m beta 1-beta 6, MtuSSB, m beta 1'beta 2 and m beta 1-beta 5 SSBs complemented E. coli Delta ssb in a dose dependent manner. Complementation by the m beta 1-beta 5 SSB was poor. In contrast, m beta 1'beta 2(ESWR) SSB complemented E. coli as well as EcoSSB. The inefficiently functioning SSBs resulted in an elongated cell/filamentation phenotype of E. coli. Taken together, our observations suggest that specific interactions within the DNA binding domain of the homotetrameric SSBs are crucial for their biological function.	[Bharti, Sanjay Kumar; Rex, Kervin; Sreedhar, Pujari; Krishnan, Neeraja; Varshney, Umesh] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Varshney, Umesh] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	Bharti, SK (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	varshney@mcbl.iisc.ernet.in	Varshney, Umesh/Q-6914-2019	Krishnan, Neeraja/0000-0003-0982-4367	Department of Biotechnology, New Delhi; Indian Institute of Science, Bangalore	Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India); Indian Institute of Science, Bangalore	Work was funded by the Department of Biotechnology, New Delhi. NK was supported by the centenary post-doctoral fellowship from Indian Institute of Science, Bangalore. UV is a J. C. Bose fellow of the Department of Science and Technology (DST), New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREONI F, 2008, THESIS U EDINBURGH U; Bernstein DA, 2004, P NATL ACAD SCI USA, V101, P8575, DOI 10.1073/pnas.0401331101; Bevington PR., 2002, DATA REDUCTION ERROR; Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; BUJALOWSKI W, 1988, J BIOL CHEM, V263, P4629; BUJALOWSKI W, 1986, BIOCHEMISTRY-US, V25, P7799, DOI 10.1021/bi00372a003; Buss JA, 2008, NUCLEIC ACIDS RES, V36, P7029, DOI 10.1093/nar/gkn795; Cadman CJ, 2004, NUCLEIC ACIDS RES, V32, P6378, DOI 10.1093/nar/gkh980; CARLINI LE, 1993, MOL MICROBIOL, V10, P1067, DOI 10.1111/j.1365-2958.1993.tb00977.x; Chan KW, 2009, J MOL BIOL, V388, P508, DOI 10.1016/j.jmb.2009.03.022; Chedin F, 1998, TRENDS BIOCHEM SCI, V23, P273, DOI 10.1016/S0968-0004(98)01243-2; Curth U, 1996, NUCLEIC ACIDS RES, V24, P2706, DOI 10.1093/nar/24.14.2706; CURTH U, 1994, EUR J BIOCHEM, V221, P435, DOI 10.1111/j.1432-1033.1994.tb18756.x; Eggington JM, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-2; Handa P, 2001, J BIOL CHEM, V276, P16992, DOI 10.1074/jbc.M100393200; Handa P, 2000, NUCLEIC ACIDS RES, V28, P3823, DOI 10.1093/nar/28.19.3823; Kaushal PS, 2010, ACTA CRYSTALLOGR D, V66, P1048, DOI 10.1107/S0907444910032208; Kemmer G, 2010, NAT PROTOC, V5, P267, DOI 10.1038/nprot.2009.182; Kozlov AG, 2010, BIOCHEMISTRY-US, V49, P8266, DOI 10.1021/bi100920w; Kumar NV, 1997, NUCLEIC ACIDS RES, V25, P2336, DOI 10.1093/nar/25.12.2336; LAVERY PE, 1992, J BIOL CHEM, V267, P9315; LIEBERMAN HB, 1981, MOL GEN GENET, V183, P348, DOI 10.1007/BF00270639; LOHMAN TM, 1986, J MOL BIOL, V187, P603, DOI 10.1016/0022-2836(86)90338-4; LOHMAN TM, 1992, METHOD ENZYMOL, V212, P424; LOHMAN TM, 1985, J BIOL CHEM, V260, P3594; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; Lu D, 2008, P NATL ACAD SCI USA, V105, P9169, DOI 10.1073/pnas.0800741105; McAfee JG, 1996, BIOCHEMISTRY-US, V35, P4034, DOI 10.1021/bi952555q; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; MEYER RR, 1979, P NATL ACAD SCI USA, V76, P1702, DOI 10.1073/pnas.76.4.1702; MOREAU PL, 1987, J MOL BIOL, V194, P621, DOI 10.1016/0022-2836(87)90239-7; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; PORTER RD, 1990, BIO-TECHNOL, V8, P47, DOI 10.1038/nbt0190-47; Purnapatre K, 1999, NUCLEIC ACIDS RES, V27, P3487, DOI 10.1093/nar/27.17.3487; Purnapatre K, 1999, EUR J BIOCHEM, V264, P591, DOI 10.1046/j.1432-1327.1999.00684.x; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Raghunathan S, 1997, P NATL ACAD SCI USA, V94, P6652, DOI 10.1073/pnas.94.13.6652; Roy R, 2007, J MOL BIOL, V369, P1244, DOI 10.1016/j.jmb.2007.03.079; Saikrishnan K, 2005, ACTA CRYSTALLOGR D, V61, P1140, DOI 10.1107/S0907444905016896; Saikrishnan K, 2003, J MOL BIOL, V331, P385, DOI 10.1016/S0022-2836(03)00729-0; Sambrook J., 2002, MOL CLONING LAB MANU; SANCAR A, 1981, P NATL ACAD SCI-BIOL, V78, P4274, DOI 10.1073/pnas.78.7.4274; SHAMOO Y, 1995, NATURE, V376, P362, DOI 10.1038/376362a0; Sharma A, 2009, FEBS J, V276, P519, DOI 10.1111/j.1742-4658.2008.06799.x; Suck D, 1997, NAT STRUCT BIOL, V4, P161, DOI 10.1038/nsb0397-161; WILLIAMS KR, 1983, J BIOL CHEM, V258, P3346; Witte G, 2005, NUCLEIC ACIDS RES, V33, P1662, DOI 10.1093/nar/gki310; Witte G, 2008, BIOPHYS J, V94, P2269, DOI 10.1529/biophysj.107.121533; Yang C, 1997, NAT STRUCT BIOL, V4, P153, DOI 10.1038/nsb0297-153	49	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e27216	10.1371/journal.pone.0027216	http://dx.doi.org/10.1371/journal.pone.0027216			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174737	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000298366600002
J	Druce, HC; Mackey, RL; Slotow, R				Druce, Heleen C.; Mackey, Robin L.; Slotow, Rob			How Immunocontraception Can Contribute to Elephant Management in Small, Enclosed Reserves: Munyawana Population as a Case Study	PLOS ONE			English	Article							LONG-TERM CONSERVATION; KRUGER-NATIONAL-PARK; PRIVATE GAME RESERVE; SOUTH-AFRICA; LOXODONTA-AFRICANA; MAKALALI CONSERVANCY; UNGULATE POPULATIONS; WILDLIFE MANAGEMENT; DENSITY; HORSES	Immunocontraception has been widely used as a management tool to reduce population growth in captive as well as wild populations of various fauna. We model the use of an individual-based rotational immunocontraception plan on a wild elephant, Loxodonta africana, population and quantify the social and reproductive advantages of this method of implementation using adaptive management. The use of immunocontraception on an individual, rotational basis stretches the inter-calving interval for each individual female elephant to a management-determined interval, preventing exposing females to unlimited long-term immunocontraception use (which may have as yet undocumented negative effects). Such rotational immunocontraception can effectively lower population growth rates, age the population, and alter the age structure. Furthermore, such structured intervention can simulate natural process such as predation or episodic catastrophic events (e. g., drought), which regulates calf recruitment within an abnormally structured population. A rotational immunocontraception plan is a feasible and useful elephant population management tool, especially in a small, enclosed conservation area. Such approaches should be considered for other long-lived, social species in enclosed areas where the long-term consequences of consistent contraception may be unknown.	[Druce, Heleen C.; Mackey, Robin L.; Slotow, Rob] Univ KwaZulu Natal, Amarula Elephant Res Programme, Sch Biol & Conservat Sci, Durban, South Africa	University of Kwazulu Natal	Druce, HC (corresponding author), Univ KwaZulu Natal, Amarula Elephant Res Programme, Sch Biol & Conservat Sci, Westville Campus, Durban, South Africa.	slotow@ukzn.ac.za	Slotow, Rob/AAM-9053-2020	Slotow, Rob/0000-0001-9469-1508	Distell (Pty) Ltd; University of KwaZulu-Natal; National Research Foundation; Wildlands Conservation Trust	Distell (Pty) Ltd; University of KwaZulu-Natal; National Research Foundation; Wildlands Conservation Trust	Funding received from Distell (Pty) Ltd to the Amarula Elephant Research Programme, University of KwaZulu-Natal, National Research Foundation and by the Conservation Internship Programme of the Wildlands Conservation Trust. The authors are grateful to &Beyond Africa, Phinda Private Game Reserve for providing accommodation and logistical support. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balme GA, 2009, BIOL CONSERV, V142, P2681, DOI 10.1016/j.biocon.2009.06.020; Bertschinger Henk, 2008, P257; BERTSCHINGER HJ, 2005, ROLE IMMUNOCONTRACEP, P13; BERTSCHINGER HJ, 2011, IMMUNOCONTRACEPTION; Biggs Harry C., 2008, P537; Bradshaw GA, 2005, NATURE, V433, P807, DOI 10.1038/433807a; CAUGHLEY G, 1976, E AFR WILDL J, V14, P265; CAUGHLEY G, 1970, ECOLOGY, V51, P53, DOI 10.2307/1933599; Cooper DW, 2001, REPROD FERT DEVELOP, V13, P451, DOI 10.1071/RD01072; Cumming DHM, 1997, S AFR J SCI, V93, P231; DELSINK A, 2005, ROLE IMMUNOCONTRACEP, P69; Delsink AK, 2007, J S AFR VET ASSOC, V78, P25; Delsink AK, 2006, S AFR J SCI, V102, P403; Druce Heleen, 2006, Koedoe, V49, P77; Druce HC, 2008, BIOL CONSERV, V141, P3127, DOI 10.1016/j.biocon.2008.09.024; ESTES RD, 1991, BEHAV GUIDE AFRICAN; Fayrer-Hosken RA, 1999, THERIOGENOLOGY, V52, P835, DOI 10.1016/S0093-691X(99)00176-4; Fayrer-Hosken RA, 2000, NATURE, V407, P149, DOI 10.1038/35025136; Foley C, 2008, BIOL LETTERS, V4, P541, DOI 10.1098/rsbl.2008.0370; Garai Marion E., 2004, Pachyderm, V37, P28; Gobush KS, 2008, CONSERV BIOL, V22, P1590, DOI 10.1111/j.1523-1739.2008.01035.x; Gough KF, 2006, ORYX, V40, P434, DOI 10.1017/S0030605306001189; Hayward MW, 2010, ACTA THERIOL, V55, P289, DOI 10.4098/j.at.0001-7051.076.2009; Hayward MW, 2009, BIODIVERS CONSERV, V18, P887, DOI 10.1007/s10531-008-9452-y; Hunter LTB, 2007, ORYX, V41, P196, DOI 10.1017/S003060530700172X; Kerley GIH, 2007, S AFR J SCI, V103, P181; Kerley Graham I.H., 2008, P146; Kettles R, 2009, S AFR J WILDL RES, V39, P23, DOI 10.3957/056.039.0103; KIRKPATRICK JF, 1995, ZOO BIOL, V14, P403, DOI 10.1002/zoo.1430140503; KIRKPATRICK JF, 1992, J REPROD FERTIL, V94, P437, DOI 10.1530/jrf.0.0940437; KIRKPATRICK JF, 2005, ROLE IMMUNOCONTRACEP, P43; KREBS E, 2006, VASECTOMY BIRTH CONT; Laws RM., 1975, ELEPHANT THEIR HABIT; LEE PC, 1987, ANIM BEHAV, V35, P278, DOI 10.1016/S0003-3472(87)80234-8; Lombard AT, 2001, BIOL CONSERV, V102, P191, DOI 10.1016/S0006-3207(01)00056-8; Low A.B., 1996, VEGETATION S AFRICA; Mackey RL, 2006, S AFR J WILDL RES, V36, P33; Mackey RL, 2009, AFR J ECOL, V47, P747, DOI 10.1111/j.1365-2028.2009.01075.x; McShea WJ, 1997, J WILDLIFE MANAGE, V61, P560, DOI 10.2307/3802615; Merrill JA, 2003, J WILDLIFE MANAGE, V67, P267, DOI 10.2307/3802768; Moss C, 1988, ELEPHANT MEMORIES 13; Moss CJ, 2001, J ZOOL, V255, P145, DOI 10.1017/S0952836901001212; MOSS CJ, 2000, ELEPHANTS MAJESTIC C, P106; Naugle RE, 2002, REPRODUCTION, P143; Owen-Smith N, 2006, S AFR J SCI, V102, P389; Owen-Smith N, 2005, J ANIM ECOL, V74, P774, DOI 10.1111/j.1365-2656.2005.00974.x; Owen-Smith N., 1988, MEGAHERBIVORES INFLU; Perdok AA, 2007, PACHYDERM, P97; Poole JH, 1993, PACHYDERM, V16, P62; Poole Joyce H., 1994, P331; Powell D. M., 2001, Journal of Applied Animal Welfare Science, V4, P271, DOI 10.1207/S15327604JAWS0404_04; RIJKSEN HD, 1981, BEHAVIOUR, V78, P138, DOI 10.1163/156853981X00293; Shi DZ, 2002, J APPL ECOL, V39, P337, DOI 10.1046/j.1365-2664.2002.00716.x; Shideler SE, 2000, US FOR SERV RMRS-P, V3, P137; Sikes S.K, 1971, NATURAL HIST AFRICAN; Singh M, 2005, CURR SCI INDIA, V89, P1230; Slotow R, 2000, NATURE, V408, P425, DOI 10.1038/35044191; Slotow R, 2005, S AFR J WILDL RES, V35, P23; Slotow Rob, 2004, CCA Ecological Journal, V6, P56; STOUT TAE, 2005, ROLE IMMUNOCONTRACEP, P7; Trinkel M, 2010, ANIM CONSERV, V13, P374, DOI 10.1111/j.1469-1795.2009.00344.x; Turner A, 2002, REPRODUCTION, P187; Turner JW, 2007, J WILDLIFE MANAGE, V71, P662, DOI 10.2193/2005-779; Walker B, 1998, WILDLIFE RES, V25, P1, DOI 10.1071/WR97030; Whitehouse AM, 2002, ORYX, V36, P243, DOI 10.1017/S0030605302000455; Whyte I, 1998, ANIM CONSERV, V1, P77, DOI 10.1111/j.1469-1795.1998.tb00014.x; Whyte Ian J., 1998, Pachyderm, V25, P45; Wiseman R, 2004, S AFR J WILDL RES, V34, P25; Wittemyer G, 2007, ECOGRAPHY, V30, P42, DOI 10.1111/j.2006.0906-7590.04900.x; Woolley LA, 2008, ORYX, V42, P49, DOI 10.1017/S0030605308000495; Woolley LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003233	71	21	22	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e27952	10.1371/journal.pone.0027952	http://dx.doi.org/10.1371/journal.pone.0027952			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174758	Green Published, Green Submitted, gold			2022-12-25	WOS:000298365700011
J	Liew, YX; Krishnan, P; Yeo, CL; Tan, TY; Lee, SY; Lim, WP; Lee, W; Hsu, LY				Liew, Yi-Xin; Krishnan, Prabha; Yeo, Chay-Leng; Tan, Thean-Yen; Lee, Siok-Ying; Lim, Wan-Peng; Lee, Winnie; Hsu, Li-Yang		Network Antimicrobial Resistance S	Surveillance of Broad-Spectrum Antibiotic Prescription in Singaporean Hospitals: A 5-Year Longitudinal Study	PLOS ONE			English	Article							EUROPEAN COUNTRIES; RESISTANCE; CONSUMPTION	Background: Inappropriate prescription of antibiotics may contribute towards higher levels antimicrobial resistance. A key intervention for improving appropriate antibiotic prescription is surveillance of prescription. This paper presents the results of a longitudinal surveillance of broad-spectrum antibiotic prescription in 5 public-sector hospitals in Singapore from 2006 to 2010. Methodology/Principal Findings: Quarterly antibiotic prescription data were obtained and converted to defined daily doses (DDDs) per 1,000 inpatient-days. The presence of significant trends in antibiotic prescription over time for both individual and combined hospitals was tested by regression analysis and corrected for autocorrelation between time-points. Excluding fluoroquinolones, there was a significant increase in prescription of all monitored antibiotics from an average of 233.12 defined daily doses (DDD)/1,000 inpatient-days in 2006 to 254.38 DDD/1,000 inpatient-days in 2010 (Coefficient = 1.13, 95% CI: 0.16-2.09, p = 0.025). Increasing utilization of carbapenems, piperacillin/tazobactam, and Gram-positive agents were seen in the majority of the hospitals, while cephalosporins were less prescribed over time. The combined expenditure for 5 hospitals increased from USD9.9 million in 2006 to USD16.7 million in 2010. Conclusions/Significance: The rate of prescription of broad-spectrum antibiotics in Singaporean hospitals is much higher compared to those of European hospitals. This may be due to high rates of antimicrobial resistance. The increase in expenditure on monitored antibiotics over the past 5 years outstripped the actual increase in DDD/1,000 inpatient-days of antibiotics prescribed. Longitudinal surveillance of antibiotic prescription on a hospital and countrywide level is important for detecting trends for formulating interventions or policies. Further research is needed to understand the causes for the various prescription trends and to act on these where necessary.	[Liew, Yi-Xin; Lee, Winnie] Singapore Gen Hosp, Dept Pharm, Singapore 0316, Singapore; [Krishnan, Prabha] Tan Tock Seng Hosp, Dept Lab Med, Singapore, Singapore; [Yeo, Chay-Leng] Natl Univ Hlth Syst, Dept Pharm, Singapore, Singapore; [Tan, Thean-Yen] Changi Gen Hosp, Dept Lab Med, Singapore, Singapore; [Lee, Siok-Ying] Khoo Teck Puat Hosp, Dept Pharm, Singapore, Singapore; [Lim, Wan-Peng] Tan Tock Seng Hosp, Dept Pharm, Singapore, Singapore; [Hsu, Li-Yang] Natl Univ Hlth Syst, Dept Med, Singapore, Singapore	Singapore General Hospital; Tan Tock Seng Hospital; National University of Singapore; Changi General Hospital; Tan Tock Seng Hospital; National University of Singapore	Liew, YX (corresponding author), Singapore Gen Hosp, Dept Pharm, Singapore 0316, Singapore.	liyang_hsu@yahoo.com		Hsu, Li Yang/0000-0002-0396-066X; Tan, Thean Yen/0000-0003-4358-1098	SingHealth Foundation; Ministry of Health; Pfizer Singapore; Janssen-Cilag; Merck; Sharpe; Dohme; AstraZenea; Pfizer; AstraZeneca; Janssen Cilag; Sharpe Dohme	SingHealth Foundation(SingHealth); Ministry of Health; Pfizer Singapore(Pfizer); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck(Merck & Company); Sharpe; Dohme; AstraZenea; Pfizer(Pfizer); AstraZeneca(AstraZeneca); Janssen Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Sharpe Dohme	This work was supported by the following grants: SingHealth Foundation Grant 2006, Ministry of Health Healthcare Quality Improvement Fund 2006, and education grants from Pfizer Singapore, Janssen-Cilag, Merck, Sharpe and Dohme, AstraZenea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; L-YH has received research funding and speaker's honoraria from Pfizer, AstraZeneca, Janssen & Cilag, and Merck, Sharpe & Dohme. PK has received speaker's honorarium from Merck, Sharpe & Dohme. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Ansari F, 2010, J ANTIMICROB CHEMOTH, V65, P2685, DOI 10.1093/jac/dkq378; Bergman M, 2009, ANTIMICROB AGENTS CH, V53, P912, DOI 10.1128/AAC.00856-08; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Dumartin C, 2010, J ANTIMICROB CHEMOTH, V65, P2028, DOI 10.1093/jac/dkq228; EAGYE KJ, 2011, J ANTIMICRO IN PRESS; Fridkin SK, 2002, EMERG INFECT DIS, V8, P702, DOI 10.3201/eid0807.010465; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Hirakata Y, 2005, DIAGN MICR INFEC DIS, V52, P323, DOI 10.1016/j.diagmicrobio.2005.04.004; Hsu LY, 2007, EMERG INFECT DIS, V13, P1944, DOI 10.3201/eid1312.070299; Hsu LY, 2010, ANTIMICROB AGENTS CH, V54, P1173, DOI 10.1128/AAC.01076-09; LAI CC, 2011, J ANTIMICRO IN PRESS; Liew YX, 2011, INT J ANTIMICROB AG, V37, P87, DOI 10.1016/j.ijantimicag.2010.09.008; Muller A, 2006, BRIT J CLIN PHARMACO, V61, P585, DOI 10.1111/j.1365-2125.2006.02605.x; TEO J, 2011, EUR J CLIN IN PRESS; VanderStichele RH, 2006, J ANTIMICROB CHEMOTH, V58, P159, DOI 10.1093/jac/dkl147; WHO International Working Group for Drug Statistics Methodology, 2011, WHO COLL CTR DRUG ST; World Health Organization, 2001, WHO GLOB STRAT CONT	17	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28751	10.1371/journal.pone.0028751	http://dx.doi.org/10.1371/journal.pone.0028751			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174889	gold, Green Published, Green Submitted			2022-12-25	WOS:000298365700070
J	Wu, HQ; Ma, HM; Ye, CT; Ramirez, D; Chen, SP; Montoya, J; Shankar, P; Wang, XZA; Manjunath, N				Wu, Haoquan; Ma, Hongming; Ye, Chunting; Ramirez, Danielle; Chen, Shuiping; Montoya, Jessica; Shankar, Premlata; Wang, Xiaozhong A.; Manjunath, N.			Improved siRNA/shRNA Functionality by Mismatched Duplex	PLOS ONE			English	Article							MEDIATE RNA INTERFERENCE; RATIONAL SIRNA DESIGN; CHEMICAL-MODIFICATIONS; ARGONAUTE PROTEINS; PRIMARY MICRORNAS; PASSENGER-STRAND; GUIDE STRAND; STABILITY; EFFICACY; DETERMINANTS	siRNA (small interfering RNA) and shRNA (small hairpin RNA) are powerful and commonly used tools in biomedical research. Currently, siRNAs are generally designed as two 21 nt strands of RNA that include a 19 nt completely complementary part and a 2 nt overhang. However, since the si/shRNAs use the endogenous miRNA machinery for gene silencing and the miRNAs are generally 22 nt in length and contain multiple internal mismatches, we tested if the functionality can be increased by designing the si/shRNAs to mimic a miRNA structure. We systematically investigated the effect of single or multiple mismatches introduced in the passenger strand at different positions on siRNA functionality. Mismatches at certain positions could significantly increase the functionality of siRNAs and also, in some cases decreased the unwanted passenger strand functionality. The same strategy could also be used to design shRNAs. Finally, we showed that both si and miRNA structured oligos (siRNA with or without mismatches in the passenger strand) can repress targets in all individual Ago containing cells, suggesting that the Ago proteins do not differentiate between si/miRNA-based structure for silencing activity.	[Wu, Haoquan; Ma, Hongming; Ye, Chunting; Ramirez, Danielle; Chen, Shuiping; Montoya, Jessica; Shankar, Premlata; Manjunath, N.] Texas Tech Univ, Hlth Sci Ctr, Ctr Excellence Infect Dis Res, Dept Biomed Sci,Paul L Foster Sch Med, El Paso, TX 79905 USA; [Wang, Xiaozhong A.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL USA	Texas Tech University System; Texas Tech University; Northwestern University	Wu, HQ (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Ctr Excellence Infect Dis Res, Dept Biomed Sci,Paul L Foster Sch Med, El Paso, TX 79905 USA.	haoquan.wu@ttuhsc.edu; manjunath.swamy@ttuhsc.edu	ma, hongming/N-6099-2014	ma, hongming/0000-0001-5105-1332; Wu, Haoquan/0000-0001-9386-3187	National Institutes of Health [AI075419]; Paul L. Foster School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI075419] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul L. Foster School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health [grant number AI075419] to NM; and the Paul L. Foster School of Medicine seed grant to HW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addepalli H, 2010, NUCLEIC ACIDS RES, V38, P7320, DOI 10.1093/nar/gkq568; Amarzguioui M, 2003, NUCLEIC ACIDS RES, V31, P589, DOI 10.1093/nar/gkg147; Birmingham A, 2007, NAT PROTOC, V2, P2068, DOI 10.1038/nprot.2007.278; Bramsen JB, 2007, NUCLEIC ACIDS RES, V35, P5886, DOI 10.1093/nar/gkm548; Bramsen JB, 2010, NUCLEIC ACIDS RES, V38, P5761, DOI 10.1093/nar/gkq341; Bramsen JB, 2009, NUCLEIC ACIDS RES, V37, P2867, DOI 10.1093/nar/gkp106; Chen PY, 2008, RNA, V14, P263, DOI 10.1261/rna.789808; Chiu YL, 2003, RNA, V9, P1034, DOI 10.1261/rna.5103703; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Grimm D, 2010, J CLIN INVEST, V120, P3106, DOI 10.1172/JCI43565; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Gu S, 2011, P NATL ACAD SCI USA, V108, P9208, DOI 10.1073/pnas.1018023108; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Henschel A, 2004, NUCLEIC ACIDS RES, V32, pW113, DOI 10.1093/nar/gkh408; Hock J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-210; Hong J, 2008, BIOCHEM BIOPH RES CO, V368, P703, DOI 10.1016/j.bbrc.2008.01.116; Huesken D, 2005, NAT BIOTECHNOL, V23, P995, DOI 10.1038/nbt1118; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jagla B, 2005, RNA, V11, P864, DOI 10.1261/rna.7275905; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Kawamata T, 2011, EMBO REP, V12, P944, DOI 10.1038/embor.2011.128; Kawamata T, 2009, NAT STRUCT MOL BIOL, V16, P953, DOI 10.1038/nsmb.1630; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kumar P, 2006, PLOS MED, V3, P505, DOI 10.1371/journal.pmed.0030096; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Laursen MB, 2010, MOL BIOSYST, V6, P862, DOI 10.1039/b918869j; Layzer JM, 2004, RNA, V10, P766, DOI 10.1261/rna.5239604; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Li LM, 2007, RNA, V13, P1765, DOI 10.1261/rna.599107; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Matveeva O, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm088; Matveeva OV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010180; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; Mittal V, 2004, NAT REV GENET, V5, P355, DOI 10.1038/nrg1323; Naito Y, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-80; Ohnishi Y, 2005, BIOCHEM BIOPH RES CO, V329, P516, DOI 10.1016/j.bbrc.2005.02.012; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Patzel V, 2005, NAT BIOTECHNOL, V23, P1440, DOI 10.1038/nbt1151; Pei Y, 2006, NAT METHODS, V3, P670, DOI 10.1038/NMETH911; Petrova NS, 2010, OLIGONUCLEOTIDES, V20, P297, DOI 10.1089/oli.2010.0246; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Saetrom P, 2004, BIOINFORMATICS, V20, P3055, DOI 10.1093/bioinformatics/bth364; Sano M, 2008, NUCLEIC ACIDS RES, V36, P5812, DOI 10.1093/nar/gkn584; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Shabalina SA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-65; Snyder LL, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp657; Su H, 2009, GENE DEV, V23, P304, DOI 10.1101/gad.1749809; Sun XG, 2008, NAT BIOTECHNOL, V26, P1379, DOI 10.1038/nbt.1512; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; Vert JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-520; Wang BB, 2009, NAT STRUCT MOL BIOL, V16, P1259, DOI 10.1038/nsmb.1712; Wei JX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005382; Wu HQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007566; Ye CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017889; Yoda M, 2010, NAT STRUCT MOL BIOL, V17, P17, DOI 10.1038/nsmb.1733; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5	66	24	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28580	10.1371/journal.pone.0028580	http://dx.doi.org/10.1371/journal.pone.0028580			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174840	Green Submitted, Green Published, gold			2022-12-25	WOS:000298365700048
J	Taccioli, C; Chen, H; Jiang, Y; Liu, XP; Huang, K; Smalley, KJ; Farber, JL; Croce, CM; Fong, LY				Taccioli, C.; Chen, H.; Jiang, Y.; Liu, X. P.; Huang, K.; Smalley, K. J.; Farber, J. L.; Croce, C. M.; Fong, L. Y.			Dietary zinc deficiency fuels esophageal cancer development by inducing a distinct inflammatory signature	ONCOGENE			English	Article						inflammation; esophageal squamous cell carcinoma; zinc deficiency; transcriptome profiling	NF-KAPPA-B; SQUAMOUS-CELL CARCINOMA; EXPRESSION; PROGRESSION; S100A8; GENES; NITROSOMETHYLBENZYLAMINE; SUPPLEMENTATION; OVEREXPRESSION; CARCINOGENESIS	Chronic inflammation is implicated in the pathogenesis of esophageal squamous cell carcinoma (ESCC). The causes of inflammation in ESCC, however, are undefined. Dietary zinc (Zn)-deficiency (ZD) increases the risk of ESCC. We have previously shown that short-term ZD (6 weeks) in rats induces overexpression of the proinflammatory mediators S100a8 and S100a9 in the esophageal mucosa with accompanying esophageal epithelial hyperplasia. Here we report that prolonged ZD (21 weeks) in rats amplified this inflammation that when combined with non-carcinogenic low doses of the environmental carcinogen, N-nitrosomethylbenzylamine (NMBA) elicited a 66.7% (16/24) incidence of ESCC. With Zn-sufficiency, NMBA produced no cancers (0/21) (P<0.001). At tumor endpoint, the neoplastic ZD esophagus, as compared with Zn-sufficient esophagus, had an inflammatory gene signature with upregulation of numerous cancer-related inflammation genes (CXC and CC chemokines, chemokine receptors, cytokines and Cox-2) in addition to S100a8 and S100a9. This signature was already activated in the earlier dysplastic stage. Additionally, time-course bioinformatics analysis of expression profiles at tumor endpoint and before NMBA exposure revealed that this sustained inflammation was due to ZD rather than carcinogen exposure. Importantly, Zn replenishment reversed this inflammatory signature at both the dysplastic and neoplastic stages of ESCC development, and prevented cancer formation. Thus, the molecular definition of ZD-induced inflammation as a critical factor in ESCC development has important clinical implications with regard to development and prevention of this deadly disease.	[Chen, H.; Jiang, Y.; Fong, L. Y.] Thomas Jefferson Univ, Dept Pharmacol & Expt Therapeut, Philadelphia, PA 19107 USA; [Taccioli, C.; Liu, X. P.; Croce, C. M.] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Smalley, K. J.; Fong, L. Y.] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Farber, J. L.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA	Jefferson University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Jefferson University; Jefferson University	Fong, LY (corresponding author), Thomas Jefferson Univ, Dept Pharmacol & Expt Therapeut, Room 420,Jefferson Alumni Hall,1020 Locust St, Philadelphia, PA 19107 USA.	louise.fong@jefferson.edu	Huang, Kun/E-3272-2011; Young, Richard A/F-6495-2012; Taccioli, Cristian/F-8801-2010; Smalley, Karl/AGF-1390-2022; Taccioli, Cristian/ABC-3379-2020	Young, Richard A/0000-0001-8855-8647; Taccioli, Cristian/0000-0003-2995-5612; Taccioli, Cristian/0000-0003-2995-5612; Chen, Hongping/0000-0002-1670-5449; Fong, Louise/0000-0001-7654-7035; Smalley, Karl J./0000-0003-1502-6759	NIH [R01CA118560, R01CA115965]; NATIONAL CANCER INSTITUTE [R01CA118560, R01CA115965] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Kay Huebner (The Ohio State University) for reading and critical discussion of the manuscript. We thank Shao-gui Wan's assistance with animal care and validation of the array data. The microarray data were submitted to ArrayExpress (Accession number: E-MTAB-428). This work was supported by NIH grants R01CA118560 (LYYF) and R01CA115965 (CMC).	Abnet CC, 2005, JNCI-J NATL CANCER I, V97, P301, DOI 10.1093/jnci/dji042; Allavena P, 2011, EXP CELL RES, V317, P664, DOI 10.1016/j.yexcr.2010.11.013; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cintorino M, 2001, ANTICANCER RES, V21, P4195; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fong LYY, 2011, CARCINOGENESIS, V32, P554, DOI 10.1093/carcin/bgr004; Fong LYY, 2005, J NATL CANCER I, V97, P40, DOI 10.1093/jnci/dji006; Fong LYY, 2001, JNCI-J NATL CANCER I, V93, P1525, DOI 10.1093/jnci/93.20.1525; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; HISCOTT J, 1993, MOL CELL BIOL, V13, P6231, DOI 10.1128/MCB.13.10.6231; Ho E, 2002, P NATL ACAD SCI USA, V99, P16770, DOI 10.1073/pnas.222679399; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kaifi JT, 2005, J NATL CANCER I, V97, P1840, DOI 10.1093/jnci/dji431; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; KMET J, 1972, SCIENCE, V175, P846, DOI 10.1126/science.175.4024.846; Kumar A, 2007, INT J CANCER, V120, P230, DOI 10.1002/ijc.22246; LOZANO JC, 1994, MOL CARCINOGEN, V9, P33, DOI 10.1002/mc.2940090107; MAGEE PN, 1989, CANCER SURV, V8, P207; Mandard AM, 2000, MUTAT RES-REV MUTAT, V462, P335, DOI 10.1016/S1383-5742(00)00019-3; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Miyazaki H, 2006, CANCER RES, V66, P4279, DOI 10.1158/0008-5472.CAN-05-4398; Nemeth J, 2009, HEPATOLOGY, V50, P1251, DOI 10.1002/hep.23099; PEGG AE, 1984, CANCER INVEST, V2, P223, DOI 10.3109/07357908409104376; Poschl G, 2004, ALCOHOL ALCOHOLISM, V39, P155, DOI 10.1093/alcalc/agh057; Prasad AS, 2002, CANCER METAST REV, V21, P291, DOI 10.1023/A:1021215111729; Richmond A, 2002, NAT REV IMMUNOL, V2, P664, DOI 10.1038/nri887; Rink L, 2007, TRENDS IMMUNOL, V28, P1, DOI 10.1016/j.it.2006.11.005; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566; STINSON SF, 1978, JNCI-J NATL CANCER I, V61, P1471; Stoner GD, 2001, CARCINOGENESIS, V22, P1737, DOI 10.1093/carcin/22.11.1737; Sun J, 2011, CARCINOGENESIS, V32, P351, DOI 10.1093/carcin/bgq251; Taccioli C, 2009, GASTROENTEROLOGY, V136, P953, DOI 10.1053/j.gastro.2008.11.039; Tu S, 2008, CANCER CELL, V14, P408, DOI 10.1016/j.ccr.2008.10.011; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; Wang B, 2006, CANCER RES, V66, P3071, DOI 10.1158/0008-5472.CAN-05-2871; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286; Yamamoto K, 2004, EXP TOXICOL PATHOL, V56, P145, DOI 10.1016/j.etp.2004.07.001; YANG CS, 1980, CANCER RES, V40, P2633; Zimmermann KC, 1999, CANCER RES, V59, P198	47	55	59	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2012	31	42					4550	4558		10.1038/onc.2011.592	http://dx.doi.org/10.1038/onc.2011.592			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	022SH	22179833	Green Submitted, Green Accepted			2022-12-25	WOS:000309982100006
J	Klimacek, M; Brunsteiner, M; Nidetzky, B				Klimacek, Mario; Brunsteiner, Michael; Nidetzky, Bernd			Dynamic Mechanism of Proton Transfer in Mannitol 2-Dehydrogenase from Pseudomonas fluorescens MOBILE GLU(292) CONTROLS PROTON RELAY THROUGH A WATER CHANNEL THAT CONNECTS THE ACTIVE SITE WITH BULK SOLVENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED ELECTRON-TRANSFER; CYTOCHROME-C-OXIDASE; P-HYDROXYBENZOATE HYDROXYLASE; LIVER ALCOHOL-DEHYDROGENASE; CARBONIC-ANHYDRASE II; CATALYTIC MECHANISM; MEMBRANE-PROTEIN; CHAIN DEHYDROGENASES/REDUCTASES; CONFORMATIONAL-CHANGES; MOLECULAR SIMULATION	The active site of mannitol 2-dehydrogenase from Pseudomonas fluorescens (PfM2DH) is connected with bulk solvent through a narrow protein channel that shows structural resemblance to proton channels utilized by redox-driven proton pumps. A key element of the PfM2DH channel is the "mobile" Glu(292), which was seen crystallographically to adopt distinct positions up and down the channel. It was suggested that the "down -> up" conformational change of Glu(292) could play a proton relay function in enzymatic catalysis, through direct proton shuttling by the Glu or because the channel is opened for water molecules forming a chain along which the protons flow. We report evidence from site-directed mutagenesis (Glu(292) -> Ala) substantiated by data from molecular dynamics simulations that support a role for Glu(292) as a gate in a water chain (von Grotthuss-type) mechanism of proton translocation. Occupancy of the up and down position of Glu(292) is influenced by the bonding and charge state of the catalytic acid base Lys(295), suggesting that channel opening/closing motions of the Glu are synchronized to the reaction progress. Removal of gatekeeper control in the E292A mutant resulted in a selective, up to 120-fold slowing down of microscopic steps immediately preceding catalytic oxidation of mannitol, consistent with the notion that formation of the productive enzyme-NAD(+) -mannitol complex is promoted by a corresponding position change of Glu(292), which at physiological pH is associated with obligatory deprotonation of Lys(295) to solvent. These results underscore the important role of conformational dynamics in the proton transfer steps of alcohol dehydrogenase catalysis.	[Klimacek, Mario; Brunsteiner, Michael; Nidetzky, Bernd] Graz Univ Technol, Inst Biotechnol & Biochem Engn, A-8010 Graz, Austria; [Brunsteiner, Michael; Nidetzky, Bernd] Res Ctr Pharmaceut Engn, A-8010 Graz, Austria	Graz University of Technology; Research Center for Pharmaceutical Engineering (RCPE)	Nidetzky, B (corresponding author), Graz Univ Technol, Inst Biotechnol & Biochem Engn, Petersgasse 12-1, A-8010 Graz, Austria.	bernd.nidetzky@tugraz.at		Nidetzky, Bernd/0000-0002-5030-2643; Brunsteiner, Michael/0000-0002-1149-7847	Austrian Science Fund FWF [P18275-B09]	Austrian Science Fund FWF(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund FWF, Grant P18275-B09 (to B.N.).	AGMON N, 1995, CHEM PHYS LETT, V244, P456, DOI 10.1016/0009-2614(95)00905-J; Basran J., 2007, HYDROGEN TRANSFER RE, P1341; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Belevich I, 2010, P NATL ACAD SCI USA, V107, P18469, DOI 10.1073/pnas.1010974107; Braun-Sand S, 2004, BIOPHYS J, V87, P2221, DOI 10.1529/biophysj.104.043257; de Smidt O, 2008, FEMS YEAST RES, V8, P967, DOI 10.1111/j.1567-1364.2008.00387.x; Dementin S, 2004, J BIOL CHEM, V279, P10508, DOI 10.1074/jbc.M312716200; DePaul AJ, 2010, NUCLEIC ACIDS RES, V38, P4856, DOI 10.1093/nar/gkq134; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; Faber K., 2018, BIOTRANSFORMATIONS O; Ferrer S, 2005, CHEM COMMUN, P5873, DOI 10.1039/b510735k; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Fisher SZ, 2010, BIOCHEMISTRY-US, V49, P415, DOI 10.1021/bi901995n; Fitch CA, 2002, BIOPHYS J, V82, P3289, DOI 10.1016/S0006-3495(02)75670-1; Frederick KK, 2005, BIOCHEMISTRY-US, V44, P13304, DOI 10.1021/bi051119t; Frederick KK, 2001, BIOCHEMISTRY-US, V40, P3891, DOI 10.1021/bi001851m; Freier E, 2011, P NATL ACAD SCI USA, V108, P11435, DOI 10.1073/pnas.1104735108; Furuichi M, 2008, J MOL BIOL, V378, P436, DOI 10.1016/j.jmb.2008.02.062; Garczarek F, 2005, P NATL ACAD SCI USA, V102, P3633, DOI 10.1073/pnas.0500421102; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Hall M, 2011, CHEM REV, V111, P4088, DOI 10.1021/cr200013n; Hammes-Schiffer S, 2002, CHEMPHYSCHEM, V3, P33, DOI 10.1002/1439-7641(20020118)3:1<33::AID-CPHC33>3.0.CO;2-6; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Heyes DJ, 2011, J BIOL CHEM, V286, P11849, DOI 10.1074/jbc.M111.219626; Hoog JO, 2011, CHEM-BIOL INTERACT, V191, P2, DOI 10.1016/j.cbi.2011.01.028; Hummel W, 1997, Adv Biochem Eng Biotechnol, V58, P145; Hyndman D, 2003, CHEM-BIOL INTERACT, V143, P621, DOI 10.1016/S0009-2797(02)00193-X; Inoue J, 1998, BIOCHEMISTRY-US, V37, P3305, DOI 10.1021/bi970726g; Kavanagh KL, 2002, J BIOL CHEM, V277, P43433, DOI 10.1074/jbc.M206914200; Klimacek M, 2003, CHEM-BIOL INTERACT, V143, P559, DOI 10.1016/S0009-2797(02)00219-3; Klimacek M, 2003, BIOCHEM J, V375, P141, DOI 10.1042/BJ20030733; Klimacek M, 2002, BIOCHEM J, V367, P13, DOI 10.1042/BJ20020932; Klimacek M, 2002, BIOCHEMISTRY-US, V41, P10158, DOI 10.1021/bi025517x; Klimacek M, 2007, BIOCHEM J, V404, P421, DOI 10.1042/BJ20061384; Klimacek M, 2010, BIOCHEM J, V425, P455, DOI 10.1042/BJ20091441; Klimacek M, 2010, J BIOL CHEM, V285, P30644, DOI 10.1074/jbc.M110.108993; Koumanov A, 2003, PROTEINS, V51, P289, DOI 10.1002/prot.10354; Kovaleva EG, 2005, BIOCHEMISTRY-US, V44, P12797, DOI 10.1021/bi050865v; Ladenstein R, 2008, CELL MOL LIFE SCI, V65, P3918, DOI 10.1007/s00018-008-8590-4; Lanyi JK, 2003, J MOL BIOL, V328, P439, DOI 10.1016/S0022-2836(03)00263-8; Leferink NGH, 2011, BIOCHEMISTRY-US, V50, P4121, DOI 10.1021/bi200246f; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Luo J, 2001, J AM CHEM SOC, V123, P11952, DOI 10.1021/ja0109747; Marx D, 2006, CHEMPHYSCHEM, V7, P1848, DOI 10.1002/cphc.200600128; Maupin CM, 2010, BBA-PROTEINS PROTEOM, V1804, P332, DOI 10.1016/j.bbapap.2009.09.006; MEIBOOM S, 1961, J CHEM PHYS, V34, P375, DOI 10.1063/1.1700960; Meijers R., 2004, HDB METALLOPROTEINS, P5; Metzler D. E, 2001, BIOCHEMISTRY-US, P765; Milburn CC, 2006, J BIOL CHEM, V281, P14796, DOI 10.1074/jbc.M601334200; Nagel ZD, 2006, CHEM REV, V106, P3095, DOI 10.1021/cr050301x; Namslauer A, 2004, FEBS LETT, V567, P103, DOI 10.1016/j.febslet.2004.04.027; Neutze R, 2002, BBA-BIOMEMBRANES, V1565, P144, DOI 10.1016/S0005-2736(02)00566-7; Northrop D. B., 1977, ISOTOPE EFFECTS ENZY, P122; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PETTERSSON G, 1987, CRIT REV BIOCHEM MOL, V21, P349, DOI 10.3109/10409238609113616; Plapp B. V., 2006, ISOTOPE EFFECTS CHEM, P811; Plapp BV, 2010, ARCH BIOCHEM BIOPHYS, V493, P3, DOI 10.1016/j.abb.2009.07.001; QUINN DM, 1991, ENZYME MECH ISOTOPE, P73; Reece SY, 2009, ANNU REV BIOCHEM, V78, P673, DOI 10.1146/annurev.biochem.78.080207.092132; ROBERTS SM, 1989, PHILOS T ROY SOC B, V324, P577, DOI 10.1098/rstb.1989.0069; Rostkowski M, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-6; Schwartz S. D., 2007, HYDROGEN TRANSFER RE, P1209; Siegbahn PEM, 2010, CHEM REV, V110, P7040, DOI 10.1021/cr100070p; Silverman D. N., 2006, ISOTOPE EFFECTS CHEM, P847; Slatner M, 1999, BIOCHEMISTRY-US, V38, P10489, DOI 10.1021/bi990327g; Sorin EJ, 2005, BIOPHYS J, V88, P2472, DOI 10.1529/biophysj.104.051938; Toba S, 1999, J AM CHEM SOC, V121, P2290, DOI 10.1021/ja983579y; Tripp BC, 2000, BIOCHEMISTRY-US, V39, P9232, DOI 10.1021/bi0001877; Wikstrom M, 2003, BBA-BIOENERGETICS, V1604, P61, DOI 10.1016/S0005-2728(03)00041-0; Wolf S, 2010, ANGEW CHEM INT EDIT, V49, P6889, DOI 10.1002/anie.201001243; Wolf S, 2008, CHEMPHYSCHEM, V9, P2772, DOI 10.1002/cphc.200800703; Wraight CA, 2006, BBA-BIOENERGETICS, V1757, P886, DOI 10.1016/j.bbabio.2006.06.017	73	6	6	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6655	6667		10.1074/jbc.M111.289223	http://dx.doi.org/10.1074/jbc.M111.289223			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22194597	Green Published, hybrid			2022-12-25	WOS:000300791800052
J	Kashif, M; Hellwig, A; Hashemolhosseini, S; Kumar, V; Bock, F; Wang, HJ; Shahzad, K; Ranjan, S; Wolter, J; Madhusudhan, T; Bierhaus, A; Nawroth, P; Isermann, B				Kashif, Muhammed; Hellwig, Andrea; Hashemolhosseini, Said; Kumar, Varun; Bock, Fabian; Wang, Hongjie; Shahzad, Khurrum; Ranjan, Satish; Wolter, Juliane; Madhusudhan, Thati; Bierhaus, Angelika; Nawroth, Peter; Isermann, Berend			Nuclear Factor Erythroid-derived 2 (Nfe2) Regulates JunD DNA-binding Activity via Acetylation A NOVEL MECHANISM REGULATING TROPHOBLAST DIFFERENTIATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE ACTIVITY; PLACENTAL VASCULARIZATION; ERYTHROLEUKEMIA-CELLS; TRANSCRIPTION FACTORS; CROSS-TALK; KAPPA-B; C-JUN; PROTEIN; CREB; EXPRESSION	We recently demonstrated that the bZip transcription factor nuclear factor erythroid-derived 2 (Nfe2) represses protein acetylation and expression of the transcription factor glial cell missing 1 (Gcm1) in trophoblast cells, preventing excess syncytiotrophoblast formation and permitting normal placental vascularization and embryonic growth. However, the Gcm1 promoter lacks a Nfe2-binding site and hence the mechanisms linking Nfe2 and Gcm1 expression remained unknown. Here we show that Nfe2 represses JunD DNA-binding activity to the Gcm1 promoter during syncytiotrophoblast differentiation. Interventional studies using knockdown and knockin approaches show that enhanced JunD DNA-binding activity is required for increased expression of Gcm1 and syncytiotrophoblast formation as well as impaired placental vascularization and reduced growth of Nfe2(-/-) embryos. Induction of Gcm1 expression requires binding of JunD to the -1441 site within the Gcm1 promoter, which is distinct from the -1314 site previously shown to induce Gcm1 expression by other bZip transcription factors. Nfe2 modulates JunD binding to the Gcm1 promoter via acetylation, as reducing JunD acetylation using the histone acetyltransferase inhibitor curcumin reverses the increased JunD DNA-binding activity observed in the absence of Nfe2. This identifies a novel mechanism through which bZip transcription factors interact. Within the placenta this interaction regulates Gcm1 expression, syncytiotrophoblast formation, placental vascularization, and embryonic growth.	[Wang, Hongjie; Shahzad, Khurrum; Ranjan, Satish; Wolter, Juliane; Madhusudhan, Thati; Isermann, Berend] Otto von Guericke Univ, D-39120 Magdeburg, Germany; [Bierhaus, Angelika; Nawroth, Peter] Univ Heidelberg, Dept Internal Med & Clin Chem, D-69120 Heidelberg, Germany; [Hellwig, Andrea] Univ Heidelberg, Dept Neurobiol, Interdisciplinary Ctr Neurosci IZN, D-69120 Heidelberg, Germany; [Hashemolhosseini, Said] Univ Erlangen Nurnberg, Inst Biochem, Emil Fischer Ctr, D-91054 Erlangen, Germany; [Wang, Hongjie] Huazhong Univ Sci Technol, Dept Cardiol, Tongji Hosp, Tongji Med Coll, Wuhan 430030, Peoples R China	Otto von Guericke University; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Erlangen Nuremberg; Huazhong University of Science & Technology	Isermann, B (corresponding author), Otto von Guericke Univ, Leipziger Str 44, D-39120 Magdeburg, Germany.	ikcp@med.ovgu.de; berend.isermann@med.ovgu.de	Bock, Fabian/K-3366-2019; Hashemolhosseini, Said/N-2464-2013	Hashemolhosseini, Said/0000-0002-6564-5649; Ranjan, Dr. Satish/0000-0003-0200-5385	Deutsche Forschungsgemeinschaft [IS 67/4-1, IS 67/4-2]; German Israeli Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Israeli Foundation(German-Israeli Foundation for Scientific Research and Development)	This work was supported by Deutsche Forschungsgemeinschaft Grants IS 67/4-1 and IS 67/4-2 (to B. I.) and a grant of the German Israeli Foundation (to B. I. and P. P. N.).	Aguilera C, 2011, NATURE, V469, P231, DOI 10.1038/nature09607; Anson-Cartwright L, 2000, NAT GENET, V25, P311, DOI 10.1038/77076; Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; Bamberger AM, 2004, MOL HUM REPROD, V10, P223, DOI 10.1093/molehr/gah011; Bierhaus A, 2001, DIABETES, V50, P2792, DOI 10.2337/diabetes.50.12.2792; Chen Z, 2007, BLOOD, V109, P1451, DOI 10.1182/blood-2006-08-038901; Cheng XB, 1997, MOL CELL BIOL, V17, P1407, DOI 10.1128/MCB.17.3.1407; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dhanasekaran N, 1998, ONCOGENE, V17, P1447, DOI 10.1038/sj.onc.1202251; Follenzi A, 2000, ONCOGENE, V19, P3041, DOI 10.1038/sj.onc.1203620; Francastel C, 1997, ONCOGENE, V14, P873, DOI 10.1038/sj.onc.1200902; Giunta B, 2006, BRAIN RES, V1123, P216, DOI 10.1016/j.brainres.2006.09.057; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Hashemolhosseini S, 2004, J MOL BIOL, V336, P441, DOI 10.1016/j.jmb.2003.12.029; Himeno Emi, 2008, Curr Protoc Stem Cell Biol, VChapter 1, DOI 10.1002/9780470151808.sc01e04s7; Hung HL, 2001, J BIOL CHEM, V276, P10715, DOI 10.1074/jbc.M007846200; Isermann B, 2003, NAT MED, V9, P331, DOI 10.1038/nm825; Johnson KD, 2002, NUCLEIC ACIDS RES, V30, P1522, DOI 10.1093/nar/30.7.1522; Johnson KD, 2002, P NATL ACAD SCI USA, V99, P11760, DOI 10.1073/pnas.192285999; Kallunki T, 1996, CELL, V87, P929, DOI 10.1016/S0092-8674(00)81999-6; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kashif M, 2011, DEVELOPMENT, V138, P2235, DOI 10.1242/dev.059105; Lee TL, 2010, P NATL ACAD SCI USA, V107, P52, DOI 10.1073/pnas.0909153107; Maltepe E, 2005, DEVELOPMENT, V132, P3393, DOI 10.1242/dev.01923; McIntire DD, 1999, NEW ENGL J MED, V340, P1234, DOI 10.1056/NEJM199904223401603; Nandiwada SL, 2006, J IMMUNOL, V177, P401, DOI 10.4049/jimmunol.177.1.401; Nervi C, 2001, CANCER RES, V61, P1247; Okada Y, 2007, NAT BIOTECHNOL, V25, P233, DOI 10.1038/nbt1280; Pan Y, 2008, MOL CELLS, V25, P531; Reddy SPM, 2002, AM J PHYSIOL-LUNG C, V283, pL1161, DOI 10.1152/ajplung.00140.2002; Rudofsky G, 2007, HORM METAB RES, V39, P665, DOI 10.1055/s-2007-985395; Schorpp-Kistner M, 1999, EMBO J, V18, P934, DOI 10.1093/emboj/18.4.934; Schreiber M, 2000, DEVELOPMENT, V127, P4937; Schubert SW, 2008, NUCLEIC ACIDS RES, V36, P3834, DOI 10.1093/nar/gkn306; Tachibana H, 2004, BIOFACTORS, V21, P383, DOI 10.1002/biof.552210174; Tachibana H, 2004, NAT STRUCT MOL BIOL, V11, P380, DOI 10.1038/nsmb743; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Thepot D, 2000, DEVELOPMENT, V127, P143	39	13	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5400	5411		10.1074/jbc.M111.289801	http://dx.doi.org/10.1074/jbc.M111.289801			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22174410	Green Published, hybrid			2022-12-25	WOS:000300638000021
J	George, A; Panda, S; Kudmulwar, D; Chhatbar, SP; Nayak, SC; Krishnan, HH				George, Anju; Panda, Swarupa; Kudmulwar, Devika; Chhatbar, Salma Pathan; Nayak, Sanjeev Chavan; Krishnan, Harinivas Harshan			Hepatitis C Virus NS5A Binds to the mRNA Cap-binding Eukaryotic Translation Initiation 4F (eIF4F) Complex and Up-regulates Host Translation Initiation Machinery through eIF4E-binding Protein 1 Inactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR 4E EIF4E; NONSTRUCTURAL PROTEIN; 4E-BINDING PROTEIN-1; DEPENDENT TRANSLATION; MOLECULAR-MECHANISMS; INCREASED EXPRESSION; VIRAL REPLICATION; CELL-SURVIVAL; PHOSPHORYLATION; ACTIVATION	Initiation, a major rate-limiting step of host protein translation, is a critical target in many viral infections. Chronic hepatitis C virus (HCV) infection results in hepatocellular carcinoma. Translation initiation, up-regulated in many cancers, plays a critical role in tumorigenesis. mTOR is a major regulator of host protein translation. Even though activation of PI3K-AKT-mTOR by HCV non-structural protein 5A (NS5A) is known, not much is understood about the regulation of host translation initiation by this virus. Here for the first time we show that HCV up-regulates host cap-dependent translation machinery in Huh7.5 cells through simultaneous activation of mTORC1 and eukaryotic translation initiation factor 4E (eIF4E) by NS5A. NS5A, interestingly, overexpressed and subsequently hyperphosphorylated 4EBP1. NS5A phosphorylated eIF4E through the p38 MAPK-MNK pathway. Both HCV infection and NS5A expression augmented eIF4F complex assembly, an indicator of cap-dependent translation efficiency. Global translation, however, was not altered by HCV NS5A. 4EBP1 phosphorylation, but not that of S6K1, was uniquely resistant to rapamycin in NS5A-Huh7.5 cells, indicative of an alternate phosphorylation mechanism of 4EBP1. Resistance of Ser-473, but not Thr-308, phosphorylation of AKT to PI3K inhibitors suggested an activation of mTORC2 by NS5A. NS5A associated with eIF4F complex and polysomes, suggesting its active involvement in host translation. This is the first report that implicates an HCV protein in the up-regulation of host translation initiation apparatus through concomitant regulation of multiple pathways. Because both mTORC1 activation and eIF4E phosphorylation are involved in tumorigenesis, we propose that their simultaneous activation by NS5A might contribute significantly to the development of hepatocellular carcinoma.	[George, Anju; Panda, Swarupa; Kudmulwar, Devika; Chhatbar, Salma Pathan; Nayak, Sanjeev Chavan; Krishnan, Harinivas Harshan] Ctr Cellular & Mol Biol, Council Sci & Ind Res, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Krishnan, HH (corresponding author), Ctr Cellular & Mol Biol, Council Sci & Ind Res, Hyderabad 500007, Andhra Pradesh, India.	hkrishnan@ccmb.res.in			Department of Biotechnology, Government of India [BT/PR11339/MED/29/103/2008]; Council of Scientific and Industrial Research, Government of India; Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by the Department of Biotechnology, Government of India (BT/PR11339/MED/29/103/2008 (to H. H. K.)) and the Council of Scientific and Industrial Research, Government of India.; Supported by a Department of Biotechnology Fellowship, Department of Biotechnology, Government of India.	Aoyagi M, 2010, P NATL ACAD SCI USA, V107, P2640, DOI 10.1073/pnas.0914856107; Arima N, 2001, J BIOL CHEM, V276, P12675, DOI 10.1074/jbc.M008329200; Armengol G, 2007, CANCER RES, V67, P7551, DOI 10.1158/0008-5472.CAN-07-0881; Avdulov S, 2004, CANCER CELL, V5, P553, DOI 10.1016/j.ccr.2004.05.024; Balakumaran BS, 2009, CANCER RES, V69, P7803, DOI 10.1158/0008-5472.CAN-09-0910; Bianchini A, 2008, CARCINOGENESIS, V29, P2279, DOI 10.1093/carcin/bgn221; Bradrick SS, 2006, NUCLEIC ACIDS RES, V34, P1293, DOI 10.1093/nar/gkl019; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Chuluunbaatar U, 2010, GENE DEV, V24, P2627, DOI 10.1101/gad.1978310; Clemens MJ, 1999, INT J BIOCHEM CELL B, V31, P1, DOI 10.1016/S1357-2725(98)00127-7; Cohen AM, 2004, LEUKEMIA LYMPHOMA, V45, P951, DOI 10.1080/10428190310001641251; Cuesta R, 2000, EMBO J, V19, P3465, DOI 10.1093/emboj/19.13.3465; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Edgil D, 2006, J VIROL, V80, P2976, DOI 10.1128/JVI.80.6.2976-2986.2006; ETCHISON D, 1982, J BIOL CHEM, V257, P4806; Everly DN, 2002, J VIROL, V76, P8560, DOI 10.1128/JVI.76.17.8560-8571.2002; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gimenez-Barcons M, 2005, J INTERF CYTOK RES, V25, P152, DOI 10.1089/jir.2005.25.152; Gingras AC, 1996, P NATL ACAD SCI USA, V93, P5578, DOI 10.1073/pnas.93.11.5578; Gong JP, 2009, J SURG RES, V153, P17, DOI 10.1016/j.jss.2008.03.033; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; HAGHIGHAT A, 1995, EMBO J, V14, P5701, DOI 10.1002/j.1460-2075.1995.tb00257.x; He YP, 2001, J VIROL, V75, P5090, DOI 10.1128/JVI.75.11.5090-5098.2001; Hershey J. W. B., 2000, TRANSLATIONAL REGULA, P87; Hirota M, 1999, VIROLOGY, V257, P130, DOI 10.1006/viro.1999.9658; Huang LY, 2005, J BIOL CHEM, V280, P36417, DOI 10.1074/jbc.M508175200; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; KANEKO T, 1994, BIOCHEM BIOPH RES CO, V205, P320, DOI 10.1006/bbrc.1994.2667; KEREKATTE V, 1995, INT J CANCER, V64, P27, DOI 10.1002/ijc.2910640107; Kevil CG, 1996, INT J CANCER, V65, P785, DOI 10.1002/(SICI)1097-0215(19960315)65:6<785::AID-IJC14>3.0.CO;2-3; Khaleghpour K, 1999, MOL CELL BIOL, V19, P4302; Li BDL, 1997, CANCER-AM CANCER SOC, V79, P2385; Lin CJ, 2009, CANCER RES, V69, P7491, DOI 10.1158/0008-5472.CAN-09-0813; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; LODISH HF, 1976, ANNU REV BIOCHEM, V45, P39, DOI 10.1146/annurev.bi.45.070176.000351; Macdonald A, 2004, J GEN VIROL, V85, P2485, DOI 10.1099/vir.0.80204-0; MADER S, 1995, MOL CELL BIOL, V15, P4990; Majumder M, 2002, VIROLOGY, V294, P94, DOI 10.1006/viro.2001.1309; Majumder M, 2001, J VIROL, V75, P1401, DOI 10.1128/JVI.75.3.1401-1407.2001; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; MANILOFF J, 1995, ARCH VIROL, V140, P1515, DOI 10.1007/BF01322679; Mannova P, 2005, J VIROL, V79, P8742, DOI 10.1128/JVI.79.14.8742-8749.2005; Marzec M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024849; Moorman NJ, 2010, J VIROL, V84, P5260, DOI 10.1128/JVI.02733-09; MORLEY SJ, 1995, J CELL SCI, V108, P1751; MORLEY SJ, 1995, BIOCHEM J, V312, P627, DOI 10.1042/bj3120627; Nathan CAO, 1999, LARYNGOSCOPE, V109, P1253, DOI 10.1097/00005537-199908000-00013; Ohlmann T, 1996, EMBO J, V15, P1371, DOI 10.1002/j.1460-2075.1996.tb00479.x; Otto GA, 2004, CELL, V119, P369, DOI 10.1016/j.cell.2004.09.038; Pardo OE, 2002, J BIOL CHEM, V277, P12040, DOI 10.1074/jbc.M109006200; Peng L, 2010, J BIOL CHEM, V285, P20870, DOI 10.1074/jbc.M110.112045; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Preiss T, 2003, BIOESSAYS, V25, P1201, DOI 10.1002/bies.10362; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Raught B, 2000, EMBO J, V19, P434, DOI 10.1093/emboj/19.3.434; Roberts LO, 2009, PROG MOL BIOL TRANSL, V90, P313, DOI 10.1016/S1877-1173(09)90009-6; ROSENWALD IB, 1993, MOL CELL BIOL, V13, P7358, DOI 10.1128/MCB.13.12.7358; Rosenwald IB, 2001, CANCER-AM CANCER SOC, V92, P2164, DOI 10.1002/1097-0142(20011015)92:8<2164::AID-CNCR1559>3.0.CO;2-A; SAITO H, 1983, P NATL ACAD SCI-BIOL, V80, P7476, DOI 10.1073/pnas.80.24.7476; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Scheper GC, 2002, EUR J BIOCHEM, V269, P5350, DOI 10.1046/j.1432-1033.2002.03291.x; Scheper GC, 2002, J BIOL CHEM, V277, P3303, DOI 10.1074/jbc.M103607200; Schlaepfer DD, 1998, MOL CELL BIOL, V18, P2571, DOI 10.1128/MCB.18.5.2571; Seki N, 2002, CLIN CANCER RES, V8, P3046; Shveygert M, 2010, MOL CELL BIOL, V30, P5160, DOI 10.1128/MCB.00448-10; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Street A, 2004, J BIOL CHEM, V279, P12232, DOI 10.1074/jbc.M312245200; Tan SL, 2001, VIROLOGY, V284, P1, DOI 10.1006/viro.2001.0885; TANJI Y, 1995, J VIROL, V69, P3980, DOI 10.1128/JVI.69.7.3980-3986.1995; Vary TC, 2007, AM J PHYSIOL-ENDOC M, V293, pE188, DOI 10.1152/ajpendo.00037.2007; Walsh D, 2005, J VIROL, V79, P8057, DOI 10.1128/JVI.79.13.8057-8064.2005; Walsh D, 2004, GENE DEV, V18, P660, DOI 10.1101/gad.1185304; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zindy P, 2011, CANCER RES, V71, P4068, DOI 10.1158/0008-5472.CAN-11-0420	76	36	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					5042	5058		10.1074/jbc.M111.308916	http://dx.doi.org/10.1074/jbc.M111.308916			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22184107	hybrid, Green Published			2022-12-25	WOS:000300608500063
J	Robertson, IM; Holmes, PC; Li, MX; Pineda-Sanabria, SE; Baryshnikova, OK; Sykes, BD				Robertson, Ian M.; Holmes, Peter C.; Li, Monica X.; Pineda-Sanabria, Sandra E.; Baryshnikova, Olga K.; Sykes, Brian D.			Elucidation of Isoform-dependent pH Sensitivity of Troponin I by NMR Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CARDIAC TROPONIN; NUCLEAR MAGNETIC-RESONANCE; CARBON-13 CHEMICAL SHIFTS; CALCIUM-BINDING; ACIDIC PH; CONTRACTILE FUNCTION; REGULATORY DOMAIN; ESCHERICHIA-COLI; STRIATED-MUSCLE; SKELETAL	Myocardial ischemia is characterized by reduced blood flow to cardiomyocytes, which can lead to acidosis. Acidosis decreases the calcium sensitivity and contractile efficiency of cardiac muscle. By contrast, skeletal and neonatal muscles are much less sensitive to changes in pH. The pH sensitivity of cardiac muscle can be reduced by replacing cardiac troponin I with its skeletal or neonatal counterparts. The isoform-specific response of troponin I is dictated by a single histidine, which is replaced by an alanine in cardiac troponin I. The decreased pH sensitivity may stem from the protonation of this histidine at low pH, which would promote the formation of electrostatic interactions with negatively charged residues on troponin C. In this study, we measured acid dissociation constants of glutamate residues on troponin C and of histidine on skeletal troponin I (His-130). The results indicate that Glu-19 comes in close contact with an ionizable group that has a pK(a) of similar to 6.7 when it is in complex with skeletal troponin I but not when it is bound to cardiac troponin I. The pK(a) of Glu-19 is decreased when troponin C is bound to skeletal troponin I and the pK(a) of His-130 is shifted upward. These results strongly suggest that these residues form an electrostatic interaction. Furthermore, we found that skeletal troponin I bound to troponin C tighter at pH 6.1 than at pH 7.5. The data presented here provide insights into the molecular mechanism for the pH sensitivity of different muscle types.	[Robertson, Ian M.; Holmes, Peter C.; Li, Monica X.; Pineda-Sanabria, Sandra E.; Baryshnikova, Olga K.; Sykes, Brian D.] Univ Alberta, Dept Biochem, Fac Med & Dent, Edmonton, AB T6G 2H7, Canada	University of Alberta	Sykes, BD (corresponding author), Univ Alberta, Dept Biochem, Fac Med & Dent, 4-19 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	brian.sykes@ualberta.ca	Robertson, Ian/D-8266-2013	Robertson, Ian/0000-0001-9561-1418	Canadian Institute of Health Research; Heart and Stroke Foundation of Canada; Alberta Innovates Health Solutions	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Alberta Innovates Health Solutions	This work was supported by the Canadian Institute of Health Research and the Heart and Stroke Foundation of Canada.; Supported by Alberta Innovates Health Solutions studentships.	ALLEN DG, 1987, CIRC RES, V60, P153, DOI 10.1161/01.RES.60.2.153; Baryshnikova OK, 2008, J BIOMOL NMR, V41, P5, DOI 10.1007/s10858-008-9234-6; BJORNSON ME, 1985, J INORG BIOCHEM, V25, P141, DOI 10.1016/0162-0134(85)80022-2; BLANCHARD EM, 1984, CIRC RES, V55, P382, DOI 10.1161/01.RES.55.3.382; BUNDI A, 1979, BIOPOLYMERS, V18, P285, DOI 10.1002/bip.1979.360180206; CEDERHOLM MT, 1991, P NATL ACAD SCI USA, V88, P8116, DOI 10.1073/pnas.88.18.8116; COHEN P, 1972, FEBS LETT, V25, P282, DOI 10.1016/0014-5793(72)80504-0; Dargis R, 2002, J BIOL CHEM, V277, P34662, DOI 10.1074/jbc.C200419200; Day SM, 2006, NAT MED, V12, P181, DOI 10.1038/nm1346; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DONALDSON SKB, 1978, PFLUG ARCH EUR J PHY, V376, P55; ELSALEH SC, 1988, J BIOL CHEM, V263, P3274; FABIATO A, 1978, J PHYSIOL-LONDON, V276, P233, DOI 10.1113/jphysiol.1978.sp012231; Farrell D, 2010, PROTEINS, V78, P843, DOI 10.1002/prot.22611; Forsyth WR, 2002, PROTEINS, V48, P388, DOI 10.1002/prot.10174; GEMMECKER G, 1992, J MAGN RESON, V96, P199, DOI 10.1016/0022-2364(92)90304-P; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; HAGEN R, 1969, J AM CHEM SOC, V91, P4504, DOI 10.1021/ja01044a032; Hoffman RMB, 2005, BIOCHEMISTRY-US, V44, P15750, DOI 10.1021/bi051583y; HORSLEY WJ, 1968, J AM CHEM SOC, V90, P3738, DOI 10.1021/ja01016a025; IKURA M, 1992, J AM CHEM SOC, V114, P2433, DOI 10.1021/ja00033a019; JACKSON SE, 1993, BIOCHEMISTRY-US, V32, P13909, DOI 10.1021/bi00213a021; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Julien O, 2011, PROTEINS, V79, P1240, DOI 10.1002/prot.22959; Kobayashi T, 2008, PFLUG ARCH EUR J PHY, V457, P37, DOI 10.1007/s00424-008-0511-8; LEE JA, 1991, J CLIN INVEST, V88, P361, DOI 10.1172/JCI115311; Li G, 2001, J MOL CELL CARDIOL, V33, P1309, DOI 10.1006/jmcc.2000.1392; Li MX, 2004, J MUSCLE RES CELL M, V25, P559, DOI 10.1007/s10974-004-5879-2; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; Li MX, 2002, EUR BIOPHYS J BIOPHY, V31, P245, DOI 10.1007/s00249-002-0227-1; Liou YM, 2004, J BIOCHEM, V136, P683, DOI 10.1093/jb/mvh175; MACIEL GE, 1965, J CHEM PHYS, V42, P2752, DOI 10.1063/1.1703232; MACIEL GE, 1966, J AM CHEM SOC, V88, P220, DOI 10.1021/ja00954a006; MARKLEY JL, 1970, P NATL ACAD SCI USA, V65, P645, DOI 10.1073/pnas.65.3.645; MARKLEY JL, 1975, ACCOUNTS CHEM RES, V8, P70, DOI 10.1021/ar50086a004; Martin SR, 2004, FEBS LETT, V577, P284, DOI 10.1016/j.febslet.2004.10.023; McKay RT, 1999, BIOCHEMISTRY-US, V38, P5478; NELSON DJ, 1979, INT J QUANTUM CHEM, V16, P159, DOI 10.1002/qua.560160118; ODA Y, 1994, BIOCHEMISTRY-US, V33, P5275, DOI 10.1021/bi00183a034; Ogura K, 1996, J BIOMOL NMR, V8, P492, DOI 10.1007/BF00228150; Palpant NJ, 2010, PHYSIOL GENOMICS, V42, P287, DOI 10.1152/physiolgenomics.00033.2010; Parsons B, 1997, J MUSCLE RES CELL M, V18, P599, DOI 10.1023/A:1018623604365; REES DC, 1980, J MOL BIOL, V141, P323, DOI 10.1016/0022-2836(80)90184-9; Robertson IM, 2009, NATO SCI PEACE SEC B, P101, DOI 10.1007/978-90-481-2368-1_7; RUSSELL AJ, 1987, J MOL BIOL, V193, P803, DOI 10.1016/0022-2836(87)90360-3; RUSSELL ST, 1985, J MOL BIOL, V185, P389, DOI 10.1016/0022-2836(85)90411-5; Sheehan KA, 2011, J MOL CELL CARDIOL, V50, P442, DOI 10.1016/j.yjmcc.2010.10.032; Sia SK, 1997, J BIOL CHEM, V272, P18216, DOI 10.1074/jbc.272.29.18216; Slupsky CM, 2003, J BIOMOL NMR, V27, P313, DOI 10.1023/A:1025870122182; SOLARO RJ, 1988, CIRC RES, V63, P779, DOI 10.1161/01.RES.63.4.779; Spyracopoulos L, 1997, BIOCHEMISTRY-US, V36, P12138, DOI 10.1021/bi971223d; STERNBERG MJE, 1987, NATURE, V330, P86, DOI 10.1038/330086a0; Szakacs Z, 2004, ANAL BIOANAL CHEM, V378, P1428, DOI 10.1007/s00216-003-2390-3; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Tran K, 2010, BIOPHYS J, V98, P267, DOI 10.1016/j.bpj.2009.10.011; Vinogradova MV, 2005, P NATL ACAD SCI USA, V102, P5038, DOI 10.1073/pnas.0408882102; Westfall MV, 1997, P NATL ACAD SCI USA, V94, P5444, DOI 10.1073/pnas.94.10.5444; Westfall MV, 2000, CIRC RES, V86, P470, DOI 10.1161/01.RES.86.4.470; Wuthrich K., 1986, NMR PROTEINS NUCL AC, P1; YAMAZAKI T, 1993, BIOCHEMISTRY-US, V32, P5656, DOI 10.1021/bi00072a023	60	12	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4996	5007		10.1074/jbc.M111.301499	http://dx.doi.org/10.1074/jbc.M111.301499			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22179777	Green Published, hybrid			2022-12-25	WOS:000300608500059
J	Timme-Laragy, AR; Karchner, SI; Franks, DG; Jenny, MJ; Harbeitner, RC; Goldstone, JV; McArthur, AG; Hahn, ME				Timme-Laragy, Alicia R.; Karchner, Sibel I.; Franks, Diana G.; Jenny, Matthew J.; Harbeitner, Rachel C.; Goldstone, Jared V.; McArthur, Andrew G.; Hahn, Mark E.			Nrf2b, Novel Zebrafish Paralog of Oxidant-responsive Transcription Factor NF-E2-related Factor 2 (NRF2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARYL-HYDROCARBON RECEPTOR; MULTIPLE SEQUENCE ALIGNMENT; ELEMENT SIGNALING PATHWAY; OXIDATIVE STRESS-RESPONSE; AH GENE BATTERY; DNA-BINDING; CHEMOPREVENTIVE AGENTS; DEVELOPMENTAL TOXICITY; KEAP1-NRF2 SYSTEM; EXPRESSION	NF-E2-related factor 2 (NRF2; also called NFE2L2) and related NRF family members regulate antioxidant defenses by activating gene expression via antioxidant response elements (AREs), but their roles in embryonic development are not well understood. We report here that zebrafish (Danio rerio), an important developmental model species, possesses six nrf genes, including duplicated nrf1 and nrf2 genes. We cloned a novel zebrafish nrf2 paralog, nrf2b. The predicted Nrf2b protein sequence shares several domains with the original Nrf2 (now Nrf2a) but lacks the Neh4 transactivation domain. Zebrafish-human comparisons demonstrate conserved synteny involving nrf2 and hox genes, indicating that nrf2a and nrf2b are co-orthologs of human NRF2. nrf2a and nrf2b displayed distinct patterns of expression during embryonic development; nrf2b was more highly expressed at all stages. Embryos in which Nrf2a expression had been knocked down with morpholino oligo-nucleotides were more sensitive to tert-butylhydroperoxide but not tert-butylhydroquinone, whereas knockdown of Nrf2b did not affect sensitivity of embryos to either chemical. Gene expression profiling by microarray identified a specific role for Nrf2b as a negative regulator of several genes, including p53, cyclin G1, and heme oxygenase 1, in embryos. Nrf2a and Nrf2b exhibited different mechanisms of cross-talk with the Ahr2 signaling pathway. Together, these results demonstrate distinct roles for nrf2a and nrf2b, consistent with sub-function partitioning, and identify a novel negative regulatory role for Nrf2b during development. The identification of zebrafish nrf2 co-orthologs will facilitate new understanding of the multiple roles of NRF2 in protecting vertebrate embryos from oxidative damage.	[Timme-Laragy, Alicia R.; Karchner, Sibel I.; Franks, Diana G.; Jenny, Matthew J.; Harbeitner, Rachel C.; Goldstone, Jared V.; Hahn, Mark E.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Jenny, Matthew J.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA; [McArthur, Andrew G.] Andrew McArthur Consulting, Hamilton, ON L8S 3P6, Canada	Woods Hole Oceanographic Institution; University of Alabama System; University of Alabama Tuscaloosa	Timme-Laragy, AR (corresponding author), Woods Hole Oceanog Inst, Dept Biol, 266 Woods Hole Rd,MS 32, Woods Hole, MA 02543 USA.	atimmelaragy@whoi.edu	Hahn, Mark/AAV-7516-2020	Hahn, Mark/0000-0003-4358-2082; McArthur, Andrew/0000-0002-1142-3063; Timme-Laragy, Alicia/0000-0002-8835-5038; Goldstone, Jared/0000-0002-9618-4961; Jenny, Matthew/0000-0002-1834-2629	National Institutes of Health [F32ES017585, R00ES017044, R01ES015912, R01ES016366, R01ES006272]; Woods Hole Oceanographic Institution; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES017044, F32ES017585, R01ES006272, R01ES016366, R01ES015912] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Woods Hole Oceanographic Institution; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants F32ES017585 (to A. R. T.-L.), R00ES017044 (to M. J. J.), R01ES015912 (to J. V. G.), and R01ES016366 and R01ES006272 (to M. E. H.). This work was also supported by a Woods Hole Oceanographic Institution postdoctoral scholar award and by Walter A. and Hope Noyes Smith.	Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Anwar-Mohamed A, 2011, TOXICOL IN VITRO, V25, P785, DOI 10.1016/j.tiv.2011.01.014; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Bloom D, 2002, ONCOGENE, V21, P2191, DOI 10.1038/sj.onc.1205288; Boutten A, 2010, EXPERT OPIN THER TAR, V14, P329, DOI 10.1517/14728221003629750; Breitling R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-34; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Calabrese V, 2010, ANTIOXID REDOX SIGN, V13, P1763, DOI 10.1089/ars.2009.3074; Carvan MJ, 2000, ARCH BIOCHEM BIOPHYS, V376, P320, DOI 10.1006/abbi.2000.1727; Carvan MJ, 2001, SCI TOTAL ENVIRON, V274, P183, DOI 10.1016/S0048-9697(01)00742-2; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Cho HY, 2005, FREE RADICAL BIO MED, V38, P325, DOI 10.1016/j.freeradbiomed.2004.10.013; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Jong Mark, 2010, BMC Res Notes, V3, P73, DOI 10.1186/1756-0500-3-73; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evans BR, 2008, MOL PHARMACOL, V73, P387, DOI 10.1124/mol.107.040204; Goldstone JV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-643; Hahn ME, 2007, TOXICOL SCI TOXICO S, V96, P326; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jain AK, 2007, J BIOL CHEM, V282, P16502, DOI 10.1074/jbc.M611336200; Jain AK, 2005, J BIOL CHEM, V280, P29158, DOI 10.1074/jbc.M502083200; Jenny MJ, 2009, TOXICOL SCI, V110, P426, DOI 10.1093/toxsci/kfp116; Jonsson ME, 2007, TOXICOL APPL PHARM, V221, P29, DOI 10.1016/j.taap.2007.02.017; Kalthoff S, 2010, GASTROENTEROLOGY, V139, P1699, DOI 10.1053/j.gastro.2010.06.048; Kalthoff S, 2010, J BIOL CHEM, V285, P5993, DOI 10.1074/jbc.M109.075770; Katoh Y, 2005, ARCH BIOCHEM BIOPHYS, V433, P342, DOI 10.1016/j.abb.2004.10.012; Katoh Y, 2001, GENES CELLS, V6, P857, DOI 10.1046/j.1365-2443.2001.00469.x; Kawai Y, 2011, J BIOL CHEM, V286, P7629, DOI 10.1074/jbc.M110.208173; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kobayashi M, 2002, GENES CELLS, V7, P807, DOI 10.1046/j.1365-2443.2002.00561.x; Kobayashi M, 2009, MOL CELL BIOL, V29, P493, DOI 10.1128/MCB.01080-08; Kusik BW, 2008, MAR BIOTECHNOL, V10, P750, DOI 10.1007/s10126-008-9113-x; Kwak MK, 2002, MOL CELL BIOL, V22, P2883, DOI 10.1128/MCB.22.9.2883-2892.2002; Lee JM, 2003, J BIOL CHEM, V278, P12029, DOI 10.1074/jbc.M211558200; Lee JM, 2003, J BIOL CHEM, V278, P37948, DOI 10.1074/jbc.M305204200; Lewis KN, 2010, INTEGR COMP BIOL, V50, P829, DOI 10.1093/icb/icq034; Li JQ, 2009, EXPERT OPIN THER TAR, V13, P785, DOI 10.1517/14728220903025762; Li L, 2008, J BIOL CHEM, V283, P3248, DOI 10.1074/jbc.M708702200; Li ZB, 2007, PLOS BIOL, V5, P212, DOI 10.1371/journal.pbio.0050035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCurley AT, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-102; McMahon M, 2004, J BIOL CHEM, V279, P31556, DOI 10.1074/jbc.M403061200; McMahon M, 2006, J BIOL CHEM, V281, P24756, DOI 10.1074/jbc.M601119200; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Miao WM, 2005, J BIOL CHEM, V280, P20340, DOI 10.1074/jbc.M412081200; Nebert DW, 2000, BIOCHEM PHARMACOL, V59, P65, DOI 10.1016/S0006-2952(99)00310-X; NEBERT DW, 1993, ANN NY ACAD SCI, V685, P624, DOI 10.1111/j.1749-6632.1993.tb35928.x; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Nioi P, 2005, MOL CELL BIOL, V25, P10895, DOI 10.1128/MCB.25.24.10895-10906.2005; Numazawa S, 2003, AM J PHYSIOL-CELL PH, V285, pC334, DOI 10.1152/ajpcell.00043.2003; Osburn WO, 2006, ARCH BIOCHEM BIOPHYS, V454, P7, DOI 10.1016/j.abb.2006.08.005; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Postlethwait JH, 2006, GENOME DYN, V2, P183, DOI 10.1159/000095104; Postlethwait JH, 2007, J EXP ZOOL PART B, V308B, P563, DOI 10.1002/jez.b.21137; Prasch AL, 2003, TOXICOL SCI, V76, P138, DOI 10.1093/toxsci/kfg202; Pratt SJ, 2002, PHYSIOL GENOMICS, V11, P91, DOI 10.1152/physiolgenomics.00112.2001; Rada P, 2011, MOL CELL BIOL, V31, P1121, DOI 10.1128/MCB.01204-10; Reichard JF, 2008, J BIOL CHEM, V283, P22363, DOI 10.1074/jbc.M801784200; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Shenvi SV, 2009, PHARMACOL RES, V60, P229, DOI 10.1016/j.phrs.2009.06.003; Shimamoto K, 2011, TOXICOLOGY, V283, P109, DOI 10.1016/j.tox.2011.03.003; Song HD, 2004, P NATL ACAD SCI USA, V101, P16240, DOI 10.1073/pnas.0407241101; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stegeman JJ, 2010, FISH PHYSIOL, V29, P367, DOI 10.1016/S1546-5098(10)02910-9; Storer NY, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001123; Sun Z, 2009, MOL CELL BIOL, V29, P2658, DOI 10.1128/MCB.01639-08; Sundstrom G, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-254; Suzuki T, 2005, BIOCHEM J, V388, P65, DOI 10.1042/BJ20041860; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Tanaka Y, 2008, J PHARMACOL EXP THER, V325, P655, DOI 10.1124/jpet.107.135822; Thangasamy A, 2011, J BIOL CHEM, V286, P32115, DOI 10.1074/jbc.M111.245746; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Timme-Laragy AR, 2009, TOXICOL SCI, V109, P217, DOI 10.1093/toxsci/kfp038; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; Tong KI, 2006, BIOL CHEM, V387, P1311, DOI 10.1515/BC.2006.164; Tsujita T, 2011, GENES CELLS, V16, P46, DOI 10.1111/j.1365-2443.2010.01466.x; Warnatz HJ, 2011, J BIOL CHEM, V286, P23521, DOI 10.1074/jbc.M111.220178; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Woltering JM, 2006, NAT GENET, V38, P601, DOI 10.1038/ng0606-601; Yeager RL, 2009, TOXICOL SCI, V111, P238, DOI 10.1093/toxsci/kfp115; You A, 2011, ARCH BIOCHEM BIOPHYS, V507, P356, DOI 10.1016/j.abb.2010.12.034; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang J, 2007, BIOCHEM J, V404, P459, DOI 10.1042/BJ20061611; Zhao L, 2003, MOL CANCER RES, V1, P195	89	70	75	2	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4609	4627		10.1074/jbc.M111.260125	http://dx.doi.org/10.1074/jbc.M111.260125			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22174413	Green Published, hybrid			2022-12-25	WOS:000300608500024
J	Lin, D; Lavender, H; Soilleux, EJ; O'Callaghan, CA				Lin, Da; Lavender, Hayley; Soilleux, Elizabeth J.; O'Callaghan, Christopher A.			NF-kappa B Regulates MICA Gene Transcription in Endothelial Cell through a Genetically Inhibitable Control Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; CORONARY-HEART-DISEASE; NATURAL-KILLER-CELLS; FACTOR-ALPHA; TNF-ALPHA; T-CELLS; ATHEROMATOUS PLAQUES; ATHEROSCLEROSIS RISK; MESSENGER-RNA; ACTIVATION	Endothelial cells form a barrier between blood and the underlying vessel wall, which characteristically demonstrates inflammatory damage in atherosclerotic disease. MICA is a highly polymorphic ligand for the activating immune receptor NKG2D and can be expressed on endothelial cells. We hypothesized that damaged vessel walls, such as those involved in atherosclerosis, might express MICA, which could contribute to the vascular immunopathology. Immune activation resulting from MICA expression could play a significant role in the development of vascular damage. We have demonstrated that TNF alpha up-regulates MICA on human endothelial cells. The up-regulation is mediated by NF-kappa B, and we have defined the regulatory control site responsible for this at -130 bp upstream of the MICA transcription start site. This site overlaps with a heat shock response element and integrates input from the two pathways. We have shown that in atherosclerotic lesions there is expression of MICA on endothelial cells. Using lentivirus-mediated gene delivery in primary human endothelial cells, we were able to inhibit the MICA response to TNF alpha with a truncated HSF1 that lacked a transactivation domain. This highlights the potential for transcription-based therapeutic approaches in atherosclerotic vascular disease to reduce immune-mediated endothelial and vessel wall damage.	[Lin, Da; O'Callaghan, Christopher A.] Univ Oxford, Oxford OX3 7BN, England; [Lavender, Hayley] Univ Oxford, Nuffield Dept Clin Lab Sci, John Radcliffe Hosp, Oxford OX3 9DU, England; [Soilleux, Elizabeth J.] Univ Oxford, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England; [Soilleux, Elizabeth J.] John Radcliffe Hosp, Dept Cellular Pathol, Oxford OX3 9DU, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford	O'Callaghan, CA (corresponding author), Univ Oxford, Henry Wellcome Bldg Mol Physiol,Roosevelt Dr, Oxford OX3 7BN, England.	chris.ocallaghan@ndm.ox.ac.uk		Lavender, Hayley/0000-0001-9996-8107; Soilleux, Elizabeth Jane/0000-0002-4032-7249	Medical Research Council; National Institute for Health Research Oxford Comprehensive Biomedical Research Centre; MRC [G116/165] Funding Source: UKRI; British Heart Foundation [PG/11/4/28645] Funding Source: researchfish; Medical Research Council [G116/165] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Oxford Comprehensive Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council and the National Institute for Health Research Oxford Comprehensive Biomedical Research Centre Programme.	ABRAVAYA K, 1991, MOL CELL BIOL, V11, P586, DOI 10.1128/MCB.11.1.586; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Beauparlant P, 1996, J VIROL, V70, P5777, DOI 10.1128/JVI.70.9.5777-5785.1996; Bobryshev YV, 2005, ATHEROSCLEROSIS, V180, P423, DOI 10.1016/j.atherosclerosis.2005.01.046; Bruunsgaard H, 2003, AM J MED, V115, P278, DOI 10.1016/S0002-9343(03)00329-2; Champsaur M, 2010, IMMUNOL REV, V235, P267, DOI 10.1111/j.0105-2896.2010.00893.x; Chen DLN, 2008, J IMMUNOL METHODS, V330, P57, DOI 10.1016/j.jim.2007.10.018; Chiu JJ, 2004, ARTERIOSCL THROM VAS, V24, P73, DOI 10.1161/01.ATV.0000106321.63667.24; Cicha I, 2009, ATHEROSCLEROSIS, V207, P93, DOI 10.1016/j.atherosclerosis.2009.04.034; Cines DB, 1998, BLOOD, V91, P3527; Csiszar A, 2008, J APPL PHYSIOL, V105, P1333, DOI 10.1152/japplphysiol.90470.2008; Ehrlich LIR, 2005, J IMMUNOL, V174, P1922, DOI 10.4049/jimmunol.174.4.1922; Espinola-Klein C, 2002, CIRCULATION, V105, P15, DOI 10.1161/hc0102.101362; Feletou M, 2006, AM J PHYSIOL-HEART C, V291, pH985, DOI 10.1152/ajpheart.00292.2006; FRANGOS JA, 1985, SCIENCE, V227, P1477, DOI 10.1126/science.3883488; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; GERRITSEN ME, 1993, FASEB J, V7, P523, DOI 10.1096/fasebj.7.6.8472891; Gourin CG, 1997, J TRAUMA, V42, P1101, DOI 10.1097/00005373-199706000-00020; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Haddy N, 2003, ATHEROSCLEROSIS, V170, P277, DOI 10.1016/S0021-9150(03)00287-9; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Hilgendorff A, 2003, INT J CLIN PHARM TH, V41, P397; Holmen C, 2005, J AM SOC NEPHROL, V16, P3110, DOI 10.1681/ASN.2005040347; Holschermann H, 2006, ATHEROSCLEROSIS, V185, P240, DOI 10.1016/j.atherosclerosis.2005.06.019; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; Jamison DT, 2006, PRIORITIES HLTH; Jovinge S, 1996, ARTERIOSCL THROM VAS, V16, P1573, DOI 10.1161/01.ATV.16.12.1573; Jovinge S, 1998, METABOLISM, V47, P113, DOI 10.1016/S0026-0495(98)90203-7; Madge LA, 2001, EXP MOL PATHOL, V70, P317, DOI 10.1006/exmp.2001.2368; Mantovani A, 1997, ANN NY ACAD SCI, V832, P93, DOI 10.1111/j.1749-6632.1997.tb46240.x; Maurus CF, 2006, TRANSPLANTATION, V81, P1204, DOI 10.1097/01.tp.0000205175.53938.bd; McGuire TR, 2005, INFLAMM RES, V54, P375, DOI 10.1007/s00011-005-1370-9; Mistry AR, 2007, IMMUNOLOGY, V121, P439, DOI 10.1111/j.1365-2567.2007.02652.x; Molinero LL, 2004, J IMMUNOL, V173, P5583, DOI 10.4049/jimmunol.173.9.5583; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Rayment NB, 1996, CARDIOVASC RES, V32, P1123, DOI 10.1016/S0008-6363(96)00145-9; Ridker PM, 2000, CIRCULATION, V101, P2149, DOI 10.1161/01.CIR.101.18.2149; Robinson J, 2011, NUCLEIC ACIDS RES, V39, pD1171, DOI 10.1093/nar/gkq998; RYAN US, 1987, ANN NY ACAD SCI, V516, P22, DOI 10.1111/j.1749-6632.1987.tb33027.x; Sorlie PD, 2000, ARCH INTERN MED, V160, P2027, DOI 10.1001/archinte.160.13.2027; Sumitran-Holgersson S, 2002, TRANSPLANTATION, V74, P268, DOI 10.1097/00007890-200207270-00019; TIPPING PG, 1993, AM J PATHOL, V142, P1721; Tonetti MS, 2007, NEW ENGL J MED, V356, P911, DOI 10.1056/NEJMoa063186; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; WHITESIDE TL, 1994, CLIN DIAGN LAB IMMUN, V1, P125, DOI 10.1128/CDLI.1.2.125-133.1994; Woollard KJ, 2010, NAT REV CARDIOL, V7, P77, DOI 10.1038/nrcardio.2009.228; YAMASHIROYA HM, 1988, AM J PATHOL, V130, P71; Zhang LS, 2010, HUM MOL GENET, V19, P2754, DOI 10.1093/hmg/ddq172; Zou YZ, 2007, NEW ENGL J MED, V357, P1293, DOI 10.1056/NEJMoa067160	50	46	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4299	4310		10.1074/jbc.M111.282152	http://dx.doi.org/10.1074/jbc.M111.282152			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22170063	Green Published, hybrid			2022-12-25	WOS:000300410900061
J	Soifer, HS; Souleimanian, N; Wu, SJ; Voskresenskiy, AM; Collak, FK; Cinar, B; Stein, CA				Soifer, Harris S.; Souleimanian, Naira; Wu, Sijian; Voskresenskiy, Anatoliy M.; Collak, Filiz Kisaayak; Cinar, Bekir; Stein, Cy A.			Direct Regulation of Androgen Receptor Activity by Potent CYP17 Inhibitors in Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I CLINICAL-TRIAL; ABIRATERONE ACETATE; ANTITUMOR-ACTIVITY; DOWN-REGULATION; EXPRESSION; GROWTH; GENE; PROGRESSION; INDUCTION; DOCETAXEL	TOK-001 and abiraterone are potent 17-heteroarylsteroid (17-HAS) inhibitors of Cyp17, one of the rate-limiting enzymes in the biosynthesis of testosterone from cholesterol in prostate cancer cells. Nevertheless, the molecular mechanism underlying the prevention of prostate cell growth by 17-HASs still remains elusive. Here, we assess the effects of 17-HASs on androgen receptor (AR) activity in LNCaP and LAPC-4 cells. We demonstrate that both TOK-001 and abiraterone reduced AR protein and mRNA expression, and antagonized AR-dependent promoter activation induced by androgen. TOK-001, but not abiraterone, is an effective apparent competitor of the radioligand [H-3]R1881 for binding to the wild type and various mutant AR (W741C, W741L) proteins. In agreement with these data, TOK-001 is a consistently superior inhibitor than abiraterone of R1881-induced transcriptional activity of both wild type and mutant AR. However, neither agent was able to trans-activate the AR in the absence of R1881. Our data demonstrate that phospho-4EBP1 levels are significantly reduced by TOK-001 and to a lesser extent by abiraterone alcohol, and suggest a mechanism by which cap-dependent translation is suppressed by blocking assembly of the eIF4F and eIF4G complex to the mRNA 5' cap. Thus, the effects of these 17-HASs on AR signaling are complex, ranging from a decrease in testosterone production through the inhibition of Cyp17 as previously described, to directly reducing both AR protein expression and R1881-induced AR trans-activation.	[Soifer, Harris S.; Souleimanian, Naira; Wu, Sijian; Voskresenskiy, Anatoliy M.; Stein, Cy A.] Montefiore Med Ctr, Albert Einstein Montefiore Canc Ctr, Bronx, NY 10467 USA; [Collak, Filiz Kisaayak; Cinar, Bekir] Univ Calif Los Angeles, Cedars Sinai Med Ctr,David Geffen Sch Med, Samuel Oschin Comprehens Canc Inst, Dept Med Hematol Oncol & Biomed Sci,Dept Med, Los Angeles, CA 90048 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Stein, CA (corresponding author), 111 E 210th St, Bronx, NY 10463 USA.	cstein@montefiore.org	CİNAR, BEKIR MURAT/AAL-4474-2021	CİNAR, BEKIR MURAT/0000-0002-7906-5039; Cinar, Bekir/0000-0003-4028-7600	Tokai Pharmaceuticals, Cambridge, MA; David and Rose Himelberg Foundation; New York Academy of Medicine [R24D00]; Garber Foundation from Cedars-Sinai Medical Center	Tokai Pharmaceuticals, Cambridge, MA; David and Rose Himelberg Foundation; New York Academy of Medicine; Garber Foundation from Cedars-Sinai Medical Center	This work was generously funded by Tokai Pharmaceuticals, Cambridge, MA, the David and Rose Himelberg Foundation (to C. A. S.), the Edwin Beer Fellowship Grant R24D00 from the New York Academy of Medicine, and the Garber Foundation from Cedars-Sinai Medical Center (to B. C.).	Attard G, 2008, J CLIN ONCOL, V26, P4563, DOI 10.1200/JCO.2007.15.9749; Attard G, 2009, J CLIN ONCOL, V27, P3742, DOI 10.1200/JCO.2008.20.0642; Balk SP, 2002, UROLOGY, V60, P132, DOI 10.1016/S0090-4295(02)01593-5; Balk SP, 2008, NUCL RECEPT SIGNAL, V6, pe001, DOI DOI 10.1621/NRS.06001; Bruno RD, 2008, MOL CANCER THER, V7, P2828, DOI 10.1158/1535-7163.MCT-08-0336; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chiu FL, 2008, PROSTATE, V68, P61, DOI 10.1002/pros.20690; Cinar B, 2005, CANCER RES, V65, P2547, DOI 10.1158/0008-5472.CAN-04-3411; Danila DC, 2010, J CLIN ONCOL, V28, P1496, DOI 10.1200/JCO.2009.25.9259; Eder IE, 2000, CANCER GENE THER, V7, P997, DOI 10.1038/sj.cgt.7700202; Farla P, 2005, J CELL SCI, V118, P4187, DOI 10.1242/jcs.02546; Ferrari N, 2006, ANN NY ACAD SCI, V1082, P91, DOI 10.1196/annals.1348.032; GELLER J, 1979, J STEROID BIOCHEM, V11, P631, DOI 10.1016/0022-4731(79)90092-X; GELLER J, 1978, J CLIN ENDOCR METAB, V46, P440; HALL PF, 1991, J STEROID BIOCHEM, V40, P527, DOI 10.1016/0960-0760(91)90272-7; Handratta VD, 2005, J MED CHEM, V48, P2972, DOI 10.1021/jm040202w; Hara T, 2003, CANCER RES, V63, P149; Holcik M, 1999, NAT CELL BIOL, V1, P190, DOI 10.1038/11109; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Huang ZQ, 2002, MOL ENDOCRINOL, V16, P924, DOI 10.1210/me.16.5.924; Ikezoe T, 2004, CANCER SCI, V95, P271, DOI 10.1111/j.1349-7006.2004.tb02215.x; Kampa M, 2002, FASEB J, V16, P1429, DOI 10.1096/fj.02-0131fje; Ko YJ, 2004, J UROLOGY, V172, P1140, DOI 10.1097/01.ju.0000134698.87862.e6; Koch T., 2008, ANTISENSE DRUG DISCO, P519; Koivisto P, 1997, CANCER RES, V57, P314; Kuroda K, 2009, PROSTATE, V69, P1579, DOI 10.1002/pros.21004; Li TH, 2007, NUCLEIC ACIDS RES, V35, P2767, DOI 10.1093/nar/gkm198; Liao XB, 2005, MOL CANCER THER, V4, P505, DOI 10.1158/1535-7163.MCT-04-0313; Lin FM, 2007, CARCINOGENESIS, V28, P2521, DOI 10.1093/carcin/bgm137; Lin HK, 2002, J BIOL CHEM, V277, P36570, DOI 10.1074/jbc.M204751200; Masiello D, 2002, J BIOL CHEM, V277, P26321, DOI 10.1074/jbc.M203310200; Mitchell SH, 1999, CANCER RES, V59, P5892; MIZOKAMI A, 1994, J BIOL CHEM, V269, P25655; Mohler JL, 2004, CLIN CANCER RES, V10, P440, DOI 10.1158/1078-0432.CCR-1146-03; Mostaghel Elahe A, 2007, Curr Urol Rep, V8, P224, DOI 10.1007/s11934-007-0010-z; Mukhopadhyay NK, 2009, CANCER RES, V69, P2210, DOI 10.1158/0008-5472.CAN-08-2308; Pajonk F, 2005, CANCER RES, V65, P4836, DOI 10.1158/0008-5472.CAN-03-2749; Reddy GPV, 2006, J CELL BIOCHEM, V98, P1408, DOI 10.1002/jcb.20927; Reid AHM, 2010, J CLIN ONCOL, V28, P1489, DOI 10.1200/JCO.2009.24.6819; Ryan CJ, 2010, J CLIN ONCOL, V28, P1481, DOI 10.1200/JCO.2009.24.1281; Schayowitz A, 2008, MOL CANCER THER, V7, P121, DOI 10.1158/1535-7163.MCT-07-0581; Seligson DB, 2007, CLIN CANCER RES, V13, P6056, DOI 10.1158/1078-0432.CCR-07-0960; Shamji AF, 2003, MOL CELL, V12, P271, DOI 10.1016/j.molcel.2003.08.016; She QB, 2010, CANCER CELL, V18, P39, DOI 10.1016/j.ccr.2010.05.023; Singh P, 2006, ENDOCR-RELAT CANCER, V13, P653, DOI 10.1677/erc.1.00797; Snoek R, 2009, CLIN CANCER RES, V15, P39, DOI 10.1158/1078-0432.CCR-08-1726; Stein CA, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp841; TAPLIN ME, 1995, NEW ENGL J MED, V332, P1393, DOI 10.1056/NEJM199505253322101; Thomson AA, 2001, REPRODUCTION, V121, P187, DOI 10.1530/rep.0.1210187; Tilley WD, 1996, CLIN CANCER RES, V2, P277; Vasaitis T, 2008, MOL CANCER THER, V7, P2348, DOI 10.1158/1535-7163.MCT-08-0230; VELDSCHOLTE J, 1992, J STEROID BIOCHEM, V41, P665, DOI 10.1016/0960-0760(92)90401-4; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Xing NZ, 2001, CARCINOGENESIS, V22, P409, DOI 10.1093/carcin/22.3.409; Yong EL, 2000, ANN MED, V32, P15, DOI 10.3109/07853890008995905; Zegarra-Moro OL, 2002, CANCER RES, V62, P1008; Zhu W, 1999, ENDOCRINOLOGY, V140, P5451, DOI 10.1210/en.140.11.5451	58	60	69	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3777	3787		10.1074/jbc.M111.261933	http://dx.doi.org/10.1074/jbc.M111.261933			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22174412	hybrid, Green Published			2022-12-25	WOS:000300410900015
J	Lee, TC; Glynn, RJ; Pena, JM; Paynter, NP; Conen, D; Ridker, PM; Pradhan, AD; Buring, JE; Albert, MA				Lee, Timothy C.; Glynn, Robert J.; Pena, Jessica M.; Paynter, Nina P.; Conen, David; Ridker, Paul M.; Pradhan, Aruna D.; Buring, Julie E.; Albert, Michelle A.			Socioeconomic Status and Incident Type 2 Diabetes Mellitus: Data from the Women's Health Study	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; CARDIOVASCULAR-DISEASE; RISK-FACTORS; LIFE; ASSOCIATION	Objectives: We prospectively examined whether socioeconomic status (SES) predicts incident type II diabetes (diabetes), a cardiovascular risk equivalent and burgeoning public health epidemic among women. Methods: Participants include 23,992 women with Hb(A1c) levels <6% and no CVD or diabetes at baseline followed from February 1993 to March 2007. SES was measured by education and income while diabetes was self-reported. Results: Over 12.3 years of follow-up, 1,262 women developed diabetes. In age and race adjusted models, the relative risk of diabetes decreased with increasing education (<2 years of nursing, 2 to <4 years of nursing, bachelor's degree, master's degree, and doctorate: 1.0, 0.7 [95% Confidence Interval (CI), 0.6-0.8], 0.6 (95% CI, 0.5-0.7), 0.5 (95% CI, 0.4-0.6), 0.4 (95% CI, 0.3-0.5); p(trend)<0.001). Adjustment for traditional and non-traditional cardiovascular risk factors attenuated this relationship (education: p(trend)=0.96). Similar associations were observed between income categories and diabetes. Conclusion: Advanced education and increasing income were both inversely associated with incident diabetes even in this relatively well-educated cohort. This relationship was largely explained by behavioral factors, particularly body mass index.	[Lee, Timothy C.; Glynn, Robert J.; Pena, Jessica M.; Paynter, Nina P.; Conen, David; Ridker, Paul M.; Pradhan, Aruna D.; Buring, Julie E.; Albert, Michelle A.] Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA; [Pena, Jessica M.; Ridker, Paul M.; Pradhan, Aruna D.; Albert, Michelle A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc Med,Dept Med, Boston, MA 02115 USA; [Conen, David] Univ Basel Hosp, Dept Med, CH-4031 Basel, Switzerland	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Basel	Albert, MA (corresponding author), Brigham & Womens Hosp, Dept Med, Div Prevent Med, 75 Francis St, Boston, MA 02115 USA.	maalbert@partners.org		Venkatasubramanian, Siddharth/0000-0002-5860-0768	National Heart Lung and Blood Institute [HL-080467, HL-043851, CA-047988]; National Cancer Institute; NATIONAL CANCER INSTITUTE [R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080467, T32HL007575, R01HL043851] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The Women's Health study is supported by grants HL-080467, HL-043851 and CA-047988 from the National Heart Lung and Blood Institute and the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardh EE, 2007, INT J EPIDEMIOL, V36, P84, DOI 10.1093/ije/dyl269; Albert MA, 2006, CIRCULATION, V114, P2619, DOI 10.1161/CIRCULATIONAHA.106.660043; Boden G, 2003, EXP CLIN ENDOCR DIAB, V111, P121, DOI 10.1055/s-2003-39781; COX DR, 1972, J R STAT SOC B, V34, P187; Gavin JR, 1997, DIABETES CARE, V20, P1183; Greenland, 1998, MODERN EPIDEMIOLOGY, P47; HOUSE JS, 1996, C SOC STAT CARD HLTH; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973; Krishnan S, 2010, AM J EPIDEMIOL, V171, P564, DOI 10.1093/aje/kwp443; Kumari M, 2004, ARCH INTERN MED, V164, P1873, DOI 10.1001/archinte.164.17.1873; Lee IM, 1999, J NATL CANCER I, V91, P2102, DOI 10.1093/jnci/91.24.2102; Lidfeldt J, 2007, AM J EPIDEMIOL, V165, P882, DOI 10.1093/aje/kwk078; Liu SM, 2006, DIABETES, V55, P2856, DOI 10.2337/db06-0456; Maty SC, 2005, INT J EPIDEMIOL, V34, P1274, DOI 10.1093/ije/dyi167; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Mora S, 2007, CIRCULATION, V116, P2110, DOI 10.1161/CIRCULATIONAHA.107.729939; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Pradhan AD, 2009, DIABETES CARE, V32, P3, DOI 10.2337/dc08-1206; Rana JS, 2007, DIABETES CARE, V30, P53, DOI 10.2337/dc06-1456; Rathmann W, 2006, EUR J EPIDEMIOL, V21, P55, DOI 10.1007/s10654-005-5085-6; Rathmann W, 2005, EUR J PUBLIC HEALTH, V15, P627, DOI 10.1093/eurpub/cki037; Rhodes ET, 2007, DIABETES CARE, V30, P141, DOI 10.2337/dc06-1142; Robbins JM, 2005, DIABETES RES CLIN PR, V68, P230, DOI 10.1016/j.diabres.2004.09.007; Shishehbor MH, 2006, JAMA-J AM MED ASSOC, V295, P784, DOI 10.1001/jama.295.7.784; WANG Y, 2007, EPIDEMIOL REV, P296; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068; Wong MD, 2002, NEW ENGL J MED, V347, P1585, DOI 10.1056/NEJMsa012979	28	68	70	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e27670	10.1371/journal.pone.0027670	http://dx.doi.org/10.1371/journal.pone.0027670			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194788	Green Submitted, Green Published, gold			2022-12-25	WOS:000298369100008
J	Piralla, A; Pariani, E; Rovida, F; Campanini, G; Muzzi, A; Emmi, V; Iotti, GA; Pesenti, A; Conaldi, PG; Zanetti, A; Baldanti, F				Piralla, Antonio; Pariani, Elena; Rovida, Francesca; Campanini, Giulia; Muzzi, Alba; Emmi, Vincenzo; Iotti, Giorgio A.; Pesenti, Antonio; Conaldi, Pier Giulio; Zanetti, Alessandro; Baldanti, Fausto		Severe Influenza A Task Force	Segregation of Virulent Influenza A(H1N1) Variants in the Lower Respiratory Tract of Critically Ill Patients during the 2010-2011 Seasonal Epidemic	PLOS ONE			English	Article							HEMAGGLUTININ; VIRUS; D222G	Background: Since its appearance in 2009, the pandemic influenza A(H1N1) virus circulated worldwide causing several severe infections. Methods: Respiratory samples from patients with 2009 influenza A(H1N1) and acute respiratory distress attending 24 intensive care units (ICUs) as well as from patients with lower respiratory tract infections not requiring ICU admission and community upper respiratory tract infections in the Lombardy region (10 million inhabitants) of Italy during the 2010-2011 winter-spring season, were analyzed. Results: In patients with severe ILI, the viral load was higher in bronchoalveolar lavage (BAL) with respect to nasal swab (NS), (p < 0.001) suggesting a higher virus replication in the lower respiratory tract. Four distinct virus clusters (referred to as cluster A to D) circulated simultaneously. Most (72.7%, n = 48) of the 66 patients infected with viruses belonging to cluster A had a severe (n = 26) or moderate ILI (n = 22). Amino acid mutations (V26I, I116M, A186T, D187Y, D222G/N, M257I, S263F, I286L/M, and N473D) were observed only in patients with severe ILI. D222G/N variants were detected exclusively in BAL samples. Conclusions: Multiple virus clusters co-circulated during the 2010-2011 winter-spring season. Severe or moderate ILI were associated with specific 2009 influenza A(H1N1) variants, which replicated preferentially in the lower respiratory tract.	[Piralla, Antonio; Muzzi, Alba] Policlin San Matteo, Fdn Ist Ricovero & Cura Carattere Sci, Struttura Complessa Direz Med Presidio, I-27100 Pavia, Italy; [Pariani, Elena; Zanetti, Alessandro] Univ Milan, Dipartimento Sanita Pubbl Microbiol Virol, Milan, Italy; [Pesenti, Antonio] Azienda Osped San Gerardo, Monza, Italy; [Conaldi, Pier Giulio] Ist Mediterraneo Trapianti & Terapie Ad Alta Spec, Lab Patol Clin Microbiol & Virol, Palermo, Italy	IRCCS Fondazione San Matteo; University of Milan; IRCCS Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione (ISMETT)	Piralla, A (corresponding author), Policlin San Matteo, Fdn Ist Ricovero & Cura Carattere Sci, Struttura Complessa Direz Med Presidio, I-27100 Pavia, Italy.	f.baldanti@smatteo.pv.it	Rovida, Francesca/K-7984-2016; Ranghiero, Alberto/AAR-8131-2020; Campanini, Giulia/J-4889-2018; Baldanti, Fausto/J-4924-2018; Pariani, Elena/M-3491-2016; Muzzi, Alessandro/J-6200-2012; Piralla, Antonio/K-4756-2018; Pesenti, Antonio/H-7483-2012; Conaldi, Pier Giulio/AAC-1573-2019	Rovida, Francesca/0000-0003-2345-2790; Campanini, Giulia/0000-0002-3536-2437; Baldanti, Fausto/0000-0002-3358-8969; Pariani, Elena/0000-0001-5681-3455; Piralla, Antonio/0000-0002-6062-2579; Pesenti, Antonio/0000-0003-2593-729X; Conaldi, Pier Giulio/0000-0003-1994-8005; IOTTI, GIORGIO ANTONIO/0000-0003-0305-8921	Regione Lombardia, Milano; Ministero della Salute; Fondazione IRCCS Policlinico San Matteo; Ricerca Corrente [80622]; Istituto Superiore di Sanita, Roma [CCM 2009-ISS]	Regione Lombardia, Milano; Ministero della Salute(Ministry of Health, Italy); Fondazione IRCCS Policlinico San Matteo; Ricerca Corrente(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Corrente (MOH-RC)); Istituto Superiore di Sanita, Roma	This study was supported by grants from the Regione Lombardia, Milano (FB and AZ), Ministero della Salute, Fondazione IRCCS Policlinico San Matteo, Ricerca Corrente (grant no. 80622) and the Istituto Superiore di Sanita, Roma (grant no. CCM 2009-ISS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldanti F, 2011, CLIN MICROBIOL INFEC, V17, P1166, DOI 10.1111/j.1469-0691.2010.03403.x; Baldanti F, 2011, EURO SURVEILL, V16; Barr IG, 2010, EURO SURVEILL, V15; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Chen HL, 2010, J INFECT DIS, V201, P1517, DOI 10.1086/652661; Ellis J, 2011, EUROSURVEILLANCE, V16, P2; Giannella M, 2011, CLIN MICROBIOL INFEC, V17, P1160, DOI 10.1111/j.1469-0691.2010.03399.x; Graham M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016087; Ikonen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013329; Kilander A, 2010, EUROSURVEILLANCE, V15, P6; Liu Y, 2010, J VIROL, V84, P12069, DOI 10.1128/JVI.01639-10; Maurer-Stroh Sebastian, 2010, PLoS Curr, V2, pRRN1162; Nunthaboot N, 2010, J CHEM INF MODEL, V50, P1410, DOI 10.1021/ci100038g; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Zarychanski Ryan, 2010, CMAJ, V182, P257, DOI 10.1503/cmaj.091884	15	31	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28332	10.1371/journal.pone.0028332	http://dx.doi.org/10.1371/journal.pone.0028332			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194826	Green Published, gold			2022-12-25	WOS:000298369100031
J	Fernandez-Jimenez, N; Castellanos-Rubio, A; Plaza-Izurieta, L; Gutierrez, G; Irastorza, I; Castano, L; Vitoria, JC; Bilbao, JR				Fernandez-Jimenez, Nora; Castellanos-Rubio, Ainara; Plaza-Izurieta, Leticia; Gutierrez, Galder; Irastorza, Inaki; Castano, Luis; Carlos Vitoria, Juan; Ramon Bilbao, Jose			Accuracy in Copy Number Calling by qPCR and PRT: A Matter of DNA	PLOS ONE			English	Article							BETA-DEFENSIN	The possible implication of copy number variation (CNV) in the genetic susceptibility to human disease needs to be assessed using robust methods that can be applied at a population scale. In this report, we analyze the performance of the two major techniques, quantitative PCR (qPCR) and paralog ratio test (PRT), and investigate the influence of input DNA amount and template integrity on the reliability of both methods. Analysis of three genes (PRELID1, SYNPO and DEFB4) in a large sample set showed that both methods are prone to false copy number assignments if sufficient attention is not paid to DNA concentration and quality. Accurate normalization of samples is essential for reproducible qPCR because it avoids the effect of differential amplification efficiencies between target and control assays, whereas PRT is generally more sensitive to template degradation due to the fact that longer amplicons are usually needed to optimize sensitivity and specificity of paralog sequence PCR. The use of normalized, high quality genomic DNA yields comparable results with both methods.	[Fernandez-Jimenez, Nora; Castellanos-Rubio, Ainara; Plaza-Izurieta, Leticia; Gutierrez, Galder; Irastorza, Inaki; Castano, Luis; Carlos Vitoria, Juan; Ramon Bilbao, Jose] Cruces Univ Hosp, Immunogenet Res Lab, Baracaldo, Basque Country, Spain; [Fernandez-Jimenez, Nora; Castellanos-Rubio, Ainara; Plaza-Izurieta, Leticia; Ramon Bilbao, Jose] Univ Basque Country, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Basque Country, Spain; [Irastorza, Inaki; Castano, Luis; Carlos Vitoria, Juan] Univ Basque Country, Dept Pediat, Bilbao, Basque Country, Spain	Hospital Universitario Cruces; University of Basque Country; University of Basque Country	Fernandez-Jimenez, N (corresponding author), Cruces Univ Hosp, Immunogenet Res Lab, Baracaldo, Basque Country, Spain.	joseramon.bilbaocatala@osakidetza.net	Vitoria, Juan Carlos/B-8914-2009; Fernandez-Jimenez, Nora/T-1535-2019; Irastorza, Inaki/AAN-7054-2021; Castellanos-Rubio, Ainara/AAB-9700-2022; Bilbao, Jose Ramon/A-9177-2008; Gutierrez, Galder/D-1286-2012	Vitoria, Juan Carlos/0000-0002-8741-8666; Irastorza, Inaki/0000-0002-1460-031X; Bilbao, Jose Ramon/0000-0002-3176-501X; Gutierrez, Galder/0000-0002-4877-3489; Castellanos Rubio, Ainara/0000-0003-3192-9544; Castano, Luis/0000-0003-0437-9401; Fernandez-Jimenez, Nora/0000-0001-6307-0880	Instituto de Salud Carlos III of the Spanish Ministry of Science and Innovation [PI10/0310]; Basque Departments of Health [2006/111030, SAIO-PE08BF03]; Basque Department of Education, Universities and Research [BIF-2009-099, BIF-2010-189]; Spanish Ministry of Health [CES05/036]	Instituto de Salud Carlos III of the Spanish Ministry of Science and Innovation(Spanish Government); Basque Departments of Health; Basque Department of Education, Universities and Research; Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government)	This work was partially funded by research project grants from the Instituto de Salud Carlos III of the Spanish Ministry of Science and Innovation (PI10/0310) and from the Basque Departments of Health (2006/111030) and of Industry (SAIO-PE08BF03). NF-J and LP-I are predoctoral fellows supported by FPI grants from the Basque Department of Education, Universities and Research (BIF-2009-099 and BIF-2010-189, respectively). JRB is co-funded by the I3SNS Program of the Spanish Ministry of Health (CES05/036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldhous MC, 2010, HUM MOL GENET, V19, P4930, DOI 10.1093/hmg/ddq411; Armour JAL, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1089; Asanuma K, 2005, J CLIN INVEST, V115, P1188, DOI 10.1172/JCI200523371; Bentley RW, 2010, AM J GASTROENTEROL, V105, P354, DOI 10.1038/ajg.2009.582; Castellanos-Rubio A, 2008, GASTROENTEROLOGY, V134, P738, DOI 10.1053/j.gastro.2007.11.041; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Fernandez-Jimenez N, 2010, HUM IMMUNOL, V71, P833, DOI 10.1016/j.humimm.2010.05.012; Fode P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016768; Guescini M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-326; Hollox EJ, 2008, CYTOGENET GENOME RES, V123, P148, DOI 10.1159/000184702; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Karlen Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-131; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Putkonen Mikko T, 2010, Investig Genet, V1, P9, DOI 10.1186/2041-2223-1-9; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Schrider DR, 2010, MOL BIOL EVOL, V27, P103, DOI 10.1093/molbev/msp210; Tahvanainen J, 2009, BLOOD, V113, P1268, DOI 10.1182/blood-2008-07-166553; Urban TJ, 2009, NAT MED, V15, P1110, DOI 10.1038/nm1009-1110	19	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28910	10.1371/journal.pone.0028910	http://dx.doi.org/10.1371/journal.pone.0028910			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174923	gold, Green Published, Green Submitted			2022-12-25	WOS:000298367300031
J	Brites, D; Encinas-Viso, F; Ebert, D; Du Pasquier, L; Haag, CR				Brites, Daniela; Encinas-Viso, Francisco; Ebert, Dieter; Du Pasquier, Louis; Haag, Christoph R.			Population Genetics of Duplicated Alternatively Spliced Exons of the Dscam Gene in Daphnia and Drosophila	PLOS ONE			English	Article							DETECTING POSITIVE SELECTION; CODON-SUBSTITUTION MODELS; NUCLEOTIDE SUBSTITUTION; MOLECULAR EVOLUTION; BALANCING SELECTION; POLYMORPHISM; OVERDOMINANT; LOCUS; SOFTWARE; TESTS	In insects and crustaceans, the Down syndrome cell adhesion molecule (Dscam) occurs in many different isoforms. These are produced by mutually exclusive alternative splicing of dozens of tandem duplicated exons coding for parts or whole immunoglobulin (Ig) domains of the Dscam protein. This diversity plays a role in the development of the nervous system and also in the immune system. Structural analysis of the protein suggested candidate epitopes where binding to pathogens could occur. These epitopes are coded by regions of the duplicated exons and are therefore diverse within individuals. Here we apply molecular population genetics and molecular evolution analyses using Daphnia magna and several Drosophila species to investigate the potential role of natural selection in the divergence between orthologs of these duplicated exons among species, as well as between paralogous exons within species. We found no evidence for a role of positive selection in the divergence of these paralogous exons. However, the power of this test was low, and the fact that no signs of gene conversion between paralogous exons were found suggests that paralog diversity may nonetheless be maintained by selection. The analysis of orthologous exons in Drosophila and in Daphnia revealed an excess of non-synonymous polymorphisms in the epitopes putatively involved in pathogen binding. This may be a sign of balancing selection. Indeed, in Dr. melanogaster the same derived non-synonymous alleles segregate in several populations around the world. Yet other hallmarks of balancing selection were not found. Hence, we cannot rule out that the excess of non-synonymous polymorphisms is caused by segregating slightly deleterious alleles, thus potentially indicating reduced selective constraints in the putative pathogen binding epitopes of Dscam.	[Brites, Daniela; Ebert, Dieter; Du Pasquier, Louis] Univ Basel, Inst Zool, CH-4051 Basel, Switzerland; [Encinas-Viso, Francisco] Univ Groningen, Community & Conservat Ecol Grp, Haren, Netherlands; [Haag, Christoph R.] Univ Fribourg, Dept Biol Ecol & Evolut, CH-1700 Fribourg, Switzerland	University of Basel; University of Groningen; University of Fribourg	Brites, D (corresponding author), Univ Basel, Inst Zool, Rheinsprung 9, CH-4051 Basel, Switzerland.	d.brites@unibas.ch	Ebert, Dieter/P-6134-2019; Haag, Christoph/B-6488-2009; Ebert, Dieter/B-5502-2009; Encinas-Viso, Francisco/M-8408-2013; Brites, Daniela/AGL-8378-2022	Ebert, Dieter/0000-0003-2653-3772; Haag, Christoph/0000-0002-8817-1431; Ebert, Dieter/0000-0003-2653-3772; Brites, Daniela/0000-0002-8090-2287	Portuguese Science Foundation; Roche Research Foundation; Swiss National Foundation	Portuguese Science Foundation(Portuguese Foundation for Science and Technology); Roche Research Foundation; Swiss National Foundation(Swiss National Science Foundation (SNSF))	DB was supported by the Portuguese Science Foundation and by the Roche Research Foundation. DE and CRH were supported by the Swiss National Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; Bielawski JP, 2003, J STRUCT FUNCT GENOM, V3, P201, DOI DOI 10.1007/978-94-010-0263-9_20; Brites D, 2008, MOL BIOL EVOL, V25, P1429, DOI 10.1093/molbev/msn087; Charlesworth D, 2006, PLOS GENET, V2, P379, DOI 10.1371/journal.pgen.0020064; CHARLESWORTH J, 2008, EVOLUTION, V25, P1007; Chen BE, 2006, CELL, V125, P607, DOI 10.1016/j.cell.2006.03.034; Chou PH, 2009, DEV COMP IMMUNOL, V33, P1258, DOI 10.1016/j.dci.2009.07.006; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Ding KY, 2005, MOL BIOL EVOL, V22, P148, DOI 10.1093/molbev/msh266; Dong YM, 2006, PLOS BIOL, V4, P1137, DOI 10.1371/journal.pbio.0040229; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Haag CR, 2009, GENETICS, V182, P313, DOI 10.1534/genetics.109.101147; Hattori D, 2008, ANNU REV CELL DEV BI, V24, P597, DOI 10.1146/annurev.cellbio.24.110707.175250; HUDSON RR, 1987, GENETICS, V116, P153; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; HUGHES AL, 1989, P NATL ACAD SCI USA, V86, P958, DOI 10.1073/pnas.86.3.958; Innan H, 2009, GENETICA, V137, P19, DOI 10.1007/s10709-009-9355-1; Kreitman M, 2004, TRENDS GENET, V20, P300, DOI 10.1016/j.tig.2004.05.002; Lee C, 2010, RNA, V16, P91, DOI 10.1261/rna.1812710; Lefranc M-P., 2001, IMMUNOGLOBULIN FACTS; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Little TJ, 2004, J MOL EVOL, V59, P498, DOI 10.1007/s00239-004-2641-8; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Meijers R, 2007, NATURE, V449, P487, DOI 10.1038/nature06147; Millard SS, 2007, NATURE, V447, P720, DOI 10.1038/nature05855; Miller M. A., 2010, CIPRES PORTALS; Muse SV, 1997, J MOL EVOL, V44, P492, DOI 10.1007/PL00006173; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Obbard DJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000698; Obbard DJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-274; Pond SK, 2005, MOL BIOL EVOL, V22, P2375, DOI 10.1093/molbev/msi232; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Rottschaefer SM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000600; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Stahl EA, 1999, NATURE, V400, P667, DOI 10.1038/23260; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stephens M, 2001, AM J HUM GENET, V69, P912, DOI 10.1086/323623; Su XD, 1998, SCIENCE, V281, P991, DOI 10.1126/science.281.5379.991; Swanson WJ, 2001, P NATL ACAD SCI USA, V98, P2509, DOI 10.1073/pnas.051605998; TAKAHATA N, 1990, GENETICS, V124, P967; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tennessen JA, 2008, MOL BIOL EVOL, V25, P2669, DOI 10.1093/molbev/msn208; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vlisidou I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000518; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Watthanasurorot A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002062; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2002, MOL BIOL EVOL, V19, P49, DOI 10.1093/oxfordjournals.molbev.a003981; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; YANG ZH, 2002, EVOLUTION, V19, P908	53	17	17	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e27947	10.1371/journal.pone.0027947	http://dx.doi.org/10.1371/journal.pone.0027947			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174757	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000298366600005
J	Miyamura, T; Kanda, T; Nakamoto, S; Wu, S; Fujiwara, K; Imazeki, F; Yokosuka, O				Miyamura, Tatsuo; Kanda, Tatsuo; Nakamoto, Shingo; Wu, Shuang; Fujiwara, Keiichi; Imazeki, Fumio; Yokosuka, Osamu			Hepatic STAT1-Nuclear Translocation and Interleukin 28B Polymorphisms Predict Treatment Outcomes in Hepatitis C Virus Genotype 1-Infected Patients	PLOS ONE			English	Article							SIGNALING PATHWAY; GENETIC-VARIATION; IL28B GENOTYPE; CORE PROTEIN; EXPRESSION; INFECTION; RIBAVIRIN; THERAPY; CELLS; IFN	Background: We investigated associations between signal transducer and activator of transcription (STAT) 1 in pretreated liver tissues, interleukin (IL) 28B polymorphism and treatment response in hepatitis C virus (HCV)-infected patients treated with peginterferon and ribavirin. Methods and Findings: We performed immunostaining analysis of STAT1 in liver tissues and determined IL28B polymorphism at rs8099917. We then compared the results with treatment outcomes in HCV genotype 1 patients with high viral load who were receiving peginterferon plus ribavirin. In univariate analysis, younger age, white blood cell counts, virological responder, early virological responder (EVR), mild activity (A1) of liver inflammation grading, and lower STAT1 nuclear-stain of hepatocytes in zone 1, zone 2 and total zones of liver were associated with sustained virological responder (SVR). Multivariate analysis showed that EVR, age and hepatic STAT1 nuclear-stain in zone 2 of liver were independent predictors of SVR. It was also revealed that IL28B and STAT1-nuclear translocation in hepatocytes are independent predictors of response to treatment with peginterferon and ribavirin in chronic hepatitis C patients. Conclusions: Concomitant assessment of lower STAT1 nuclear-stain of hepatocytes and IL28B polymorphism is useful for prediction of SVR in HCV genotype 1 patients.	[Miyamura, Tatsuo; Kanda, Tatsuo; Nakamoto, Shingo; Wu, Shuang; Fujiwara, Keiichi; Imazeki, Fumio; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Med & Clin Oncol, Chiba, Japan	Chiba University	Miyamura, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Med & Clin Oncol, Chiba, Japan.	kandat-cib@umin.ac.jp		Kanda, Tatsuo/0000-0002-1654-5385	Ministry of Education, Culture, Sports, Science, and Technology, Japan [21590829, 21590828, 21390225]; Japan Society of Hepatology; Chiba University	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society of Hepatology; Chiba University	This work was supported by grants for Scientific Research 21590829, 21590828, and 21390225 from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (TK, FI, and OY), a grant from the Japan Society of Hepatology (TK) and a grant from Chiba University Young Research-Oriented Faculty Member Development Program in Bioscience Areas (TK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2011, J MED VIROL, V83, P1597, DOI 10.1002/jmv.22158; Abe H, 2011, J HEPATOL, V54, P1094, DOI 10.1016/j.jhep.2010.09.019; Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Bacon Bruce R, 2011, Mo Med, V108, P255; Basu A, 2001, VIROLOGY, V288, P379, DOI 10.1006/viro.2001.1100; Basu A, 2006, VIROLOGY, V349, P347, DOI 10.1016/j.virol.2006.02.023; Brand S, 2005, AM J PHYSIOL-GASTR L, V289, pG960, DOI 10.1152/ajpgi.00126.2005; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; Di Bisceglie AM, 2007, J VIRAL HEPATITIS, V14, P721, DOI 10.1111/j.1365-2893.2007.00862.x; Di Bisceglie AM, 2011, HEPATOLOGY, V53, P1100, DOI 10.1002/hep.24169; Di Bisceglie AM, 2002, HEPATOLOGY, V36, pS121, DOI 10.1053/jhep.2002.36228; Dill MT, 2011, GASTROENTEROLOGY, V140, P1021, DOI 10.1053/j.gastro.2010.11.039; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Honda M, 2010, J HEPATOL, V53, P817, DOI 10.1016/j.jhep.2010.04.036; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Kanda T, 2011, J VIRAL HEPATITIS, V18, pE292, DOI 10.1111/j.1365-2893.2010.01409.x; Kanda T, 2010, HEPATOL INT, V4, P548, DOI 10.1007/s12072-010-9193-3; Lagging M, 2008, HEPATOLOGY, V47, P1837, DOI 10.1002/hep.22253; Lagging M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017232; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Ma DL, 2009, ANTIVIR RES, V83, P53, DOI 10.1016/j.antiviral.2009.03.006; Mowen K, 1998, J BIOL CHEM, V273, P30073, DOI 10.1074/jbc.273.46.30073; Nakamoto S, 2011, SCAND J GASTROENTERO, V46, P955, DOI 10.3109/00365521.2011.574731; RAPPAPORT AM, 1976, BEITR PATHOL, V157, P215, DOI 10.1016/S0005-8165(76)80083-2; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; SIMMONDS P, 1993, J GEN VIROL, V74, P2391, DOI 10.1099/0022-1317-74-11-2391; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; TSUKIYAMAKOHARA K, 1993, VIROLOGY, V192, P430, DOI 10.1006/viro.1993.1058; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; VOLPES R, 1991, J HEPATOL, V12, P195, DOI 10.1016/0168-8278(91)90938-8; Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06	32	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28617	10.1371/journal.pone.0028617	http://dx.doi.org/10.1371/journal.pone.0028617			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174846	Green Submitted, gold, Green Published			2022-12-25	WOS:000298366600026
J	Pendse, GV; Borsook, D; Becerra, L				Pendse, Gautam V.; Borsook, David; Becerra, Lino			A Simple and Objective Method for Reproducible Resting State Network (RSN) Detection in fMRI	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; BLIND SEPARATION; IDENTIFIABILITY; SEPARABILITY; UNIQUENESS	Spatial Independent Component Analysis (ICA) decomposes the time by space functional MRI (fMRI) matrix into a set of 1-D basis time courses and their associated 3-D spatial maps that are optimized for mutual independence. When applied to resting state fMRI (rsfMRI), ICA produces several spatial independent components (ICs) that seem to have biological relevance - the so-called resting state networks (RSNs). The ICA problem is well posed when the true data generating process follows a linear mixture of ICs model in terms of the identifiability of the mixing matrix. However, the contrast function used for promoting mutual independence in ICA is dependent on the finite amount of observed data and is potentially non-convex with multiple local minima. Hence, each run of ICA could produce potentially different IC estimates even for the same data. One technique to deal with this run-to-run variability of ICA was proposed by [1] in their algorithm RAICAR which allows for the selection of only those ICs that have a high run-to-run reproducibility. We propose an enhancement to the original RAICAR algorithm that enables us to assign reproducibility p-values to each IC and allows for an objective assessment of both within subject and across subjects reproducibility. We call the resulting algorithm RAICAR-N (N stands for null hypothesis test), and we have applied it to publicly available human rsfMRI data (http://www.nitrc.org). Our reproducibility analyses indicated that many of the published RSNs in rsfMRI literature are highly reproducible. However, we found several other RSNs that are highly reproducible but not frequently listed in the literature.	[Pendse, Gautam V.; Borsook, David; Becerra, Lino] Harvard Univ, McLean Hosp, Sch Med, PAIN Grp,Imaging & Anal Grp IMAG, Belmont, MA USA; [Borsook, David; Becerra, Lino] Massachusetts Gen Hosp, AA Martinos Ctr Biomed Imaging, Charlestown, MA USA	Harvard University; McLean Hospital; Harvard University; Massachusetts General Hospital	Pendse, GV (corresponding author), Harvard Univ, McLean Hosp, Sch Med, PAIN Grp,Imaging & Anal Grp IMAG, Belmont, MA USA.	gpendse@mclean.harvard.edu			National Institutes of Health (NIH) [K24NS064050, R01NS065051]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065051, K24NS064050] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (NIH) under the grants K24NS064050 (to DB) and R01NS065051 (to DB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attias H, 1999, NEURAL COMPUT, V11, P803, DOI 10.1162/089976699300016458; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Cardoso JF, 1998, P IEEE, V86, P2009, DOI 10.1109/5.720250; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; COMON P, 1994, SIGNAL PROCESS, V36, P287, DOI 10.1016/0165-1684(94)90029-9; Davies M, 2004, IEEE SIGNAL PROC LET, V11, P470, DOI 10.1109/LSP.2004.826508; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Eriksson J, 2006, IEEE T INFORM THEORY, V52, P1017, DOI 10.1109/TIT.2005.864440; Eriksson J, 2004, IEEE SIGNAL PROC LET, V11, P601, DOI 10.1109/LSP.2004.830118; Esposito F, 2005, NEUROIMAGE, V25, P193, DOI 10.1016/j.neuroimage.2004.10.042; Feller W., 1966, INTRO PROBABILITY TH, VII; Harrison BJ, 2008, P NATL ACAD SCI USA, V105, P9781, DOI 10.1073/pnas.0711791105; Hastie T., 2009, UNSUPERVISED LEARNIN; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Hyvarinen A, 1998, ADV NEUR IN, V10, P273; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; JUTTEN C, 1991, SIGNAL PROCESS, V24, P1, DOI 10.1016/0165-1684(91)90079-X; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Kritchman S, 2009, IEEE T SIGNAL PROCES, V57, P3930, DOI 10.1109/TSP.2009.2022897; MA S, 2011, IEEE T BIOMEDIC 0906; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P160, DOI 10.1002/(SICI)1097-0193(1998)6:3<160::AID-HBM5>3.0.CO;2-1; Minka T., 2000, 514 MIT MED LAB VIS; RAO CR, 1969, STATISTICS, V40, P1845; RATLIFF D, 1981, VEGETATIO, V48, P83, DOI 10.1007/BF00117364; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Theis FJ, 2004, NEURAL COMPUT, V16, P1827, DOI 10.1162/0899766041336404; Tipping ME, 1999, J R STAT SOC B, V61, P611, DOI 10.1111/1467-9868.00196; Tohka J, 2008, NEUROIMAGE, V39, P1227, DOI 10.1016/j.neuroimage.2007.10.013; van Albada SJ, 2007, J NEUROSCI METH, V161, P205, DOI 10.1016/j.jneumeth.2006.11.004; Vul E., 2010, FDN ISSUES HUMAN BRA, P71; Wlodzimierz  B., 1995, NORMAL DISTRIBUTION; Yang Z, 2008, HUM BRAIN MAPP, V29, P711, DOI 10.1002/hbm.20432; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080; [No title captured]	38	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e27594	10.1371/journal.pone.0027594	http://dx.doi.org/10.1371/journal.pone.0027594			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174743	gold, Green Published, Green Submitted			2022-12-25	WOS:000298366600003
J	Wang, KY; Liu, YF; Li, YD; Guo, YM; Song, PP; Zhang, XH; Zeng, SQ; Wang, ZR				Wang, Kaiyu; Liu, Yafeng; Li, Yiding; Guo, Yanmeng; Song, Peipei; Zhang, Xiaohui; Zeng, Shaoqun; Wang, Zuoren			Precise Spatiotemporal Control of Optogenetic Activation Using an Acousto-Optic Device	PLOS ONE			English	Article							OPTICAL INTERROGATION; 2-PHOTON EXCITATION; NEURONAL NETWORK; CHANNELRHODOPSIN-2; MANIPULATION; BEHAVIOR; REVEALS	Light activation and inactivation of neurons by optogenetic techniques has emerged as an important tool for studying neural circuit function. To achieve a high resolution, new methods are being developed to selectively manipulate the activity of individual neurons. Here, we report that the combination of an acousto-optic device (AOD) and single-photon laser was used to achieve rapid and precise spatiotemporal control of light stimulation at multiple points in a neural circuit with millisecond time resolution. The performance of this system in activating ChIEF expressed on HEK 293 cells as well as cultured neurons was first evaluated, and the laser stimulation patterns were optimized. Next, the spatiotemporally selective manipulation of multiple neurons was achieved in a precise manner. Finally, we demonstrated the versatility of this high-resolution method in dissecting neural circuits both in the mouse cortical slice and the Drosophila brain in vivo. Taken together, our results show that the combination of AOD-assisted laser stimulation and optogenetic tools provides a flexible solution for manipulating neuronal activity at high efficiency and with high temporal precision.	[Wang, Kaiyu; Li, Yiding; Guo, Yanmeng; Song, Peipei; Zhang, Xiaohui; Wang, Zuoren] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Inst Neurosci, Shanghai, Peoples R China; [Wang, Kaiyu; Li, Yiding; Guo, Yanmeng] Chinese Acad Sci, Grad Sch, Shanghai, Peoples R China; [Liu, Yafeng; Zeng, Shaoqun] Huazhong Univ Sci & Technol, Britton Chance Ctr Biomed Photon, Wuhan Natl Lab Optoelect, Wuhan 430074, Peoples R China; [Liu, Yafeng; Zeng, Shaoqun] Huazhong Univ Sci & Technol, Minist Educ, Key Lab Biomed Photon, Wuhan 430074, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Wang, KY (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Inst Neurosci, Shanghai, Peoples R China.	xhzhang@ion.ac.cn; sqzeng@mail.hust.edu.cn; zuorenwang@ion.ac.cn	Zhang, Xiaohui/ABD-7056-2021; Li, Yiding/HII-3453-2022		China 973 [2011CBA00404, 2011CBA00403]; NSFC [30927001, 30925013]	China 973(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by China 973 project 2011CBA00404 to ZW, 2011CBA00403 to XZ and NSFC 30927001 & 30925013 to SZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrasfalvy BK, 2010, P NATL ACAD SCI USA, V107, P11981, DOI 10.1073/pnas.1006620107; Arrenberg AB, 2010, SCIENCE, V330, P971, DOI 10.1126/science.1195929; Bamann C, 2008, J MOL BIOL, V375, P686, DOI 10.1016/j.jmb.2007.10.072; Brown AEX, 2011, NAT METHODS, V8, P129, DOI 10.1038/nmeth0211-129; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Cetin A, 2006, NAT PROTOC, V1, P3166, DOI 10.1038/nprot.2006.450; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; CRICK FHC, 1979, SCI AM, V241, P219, DOI 10.1038/scientificamerican0979-219; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Davison IG, 2011, NEURON, V70, P82, DOI 10.1016/j.neuron.2011.02.047; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Gouwens NW, 2009, J NEUROSCI, V29, P6239, DOI 10.1523/JNEUROSCI.0764-09.2009; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Grewe BF, 2010, NAT METHODS, V7, P399, DOI 10.1038/nmeth.1453; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Guo ZV, 2009, NAT METHODS, V6, P891, DOI 10.1038/nmeth.1397; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Iyer V, 2006, J NEUROPHYSIOL, V95, P535, DOI 10.1152/jn.00865.2005; Kantevari S, 2010, NAT METHODS, V7, P123, DOI [10.1038/NMETH.1413, 10.1038/nmeth.1413]; Kuhlman SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002005; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Leifer AM, 2011, NAT METHODS, V8, P147, DOI 10.1038/NMETH.1554; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Losavio BE, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/045002; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Lv XH, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2190047; Miesenbock G, 2009, SCIENCE, V326, P395, DOI 10.1126/science.1174520; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; O'Connor DH, 2009, NATURE, V461, P923, DOI 10.1038/nature08539; Papagiakoumou E, 2010, NAT METHODS, V7, P848, DOI [10.1038/NMETH.1505, 10.1038/nmeth.1505]; Peron S, 2011, NAT METHODS, V8, P30, DOI 10.1038/NMETH.F.325; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Reddy GD, 2008, NAT NEUROSCI, V11, P713, DOI 10.1038/nn.2116; Rickgauer JP, 2009, P NATL ACAD SCI USA, V106, P15025, DOI 10.1073/pnas.0907084106; Schoonheim PJ, 2010, J NEUROSCI, V30, P7111, DOI 10.1523/JNEUROSCI.5193-09.2010; Shoham S, 2005, NAT METHODS, V2, P837, DOI 10.1038/nmeth793; Shoham S, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/040201; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Stirman JN, 2011, NAT METHODS, V8, P153, DOI 10.1038/NMETH.1555; Weissenberger S, 2011, J NEUROCHEM, V116, P616, DOI 10.1111/j.1471-4159.2010.07148.x; Wyart C, 2009, NATURE, V461, P407, DOI 10.1038/nature08323; Xie QW, 1996, P NATL ACAD SCI USA, V93, P4891, DOI 10.1073/pnas.93.10.4891; Zeng SQ, 2006, OPT LETT, V31, P1091, DOI 10.1364/OL.31.001091; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	47	17	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28468	10.1371/journal.pone.0028468	http://dx.doi.org/10.1371/journal.pone.0028468			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174813	Green Submitted, Green Published, gold			2022-12-25	WOS:000298365700038
J	Kolundzic, N; Bojic-Trbojevic, Z; Kovacevic, T; Stefanoska, I; Kadoya, T; Vicovac, L				Kolundzic, Nikola; Bojic-Trbojevic, Zanka; Kovacevic, Tamara; Stefanoska, Ivana; Kadoya, Toshihiko; Vicovac, Ljiljana			Galectin-1 Is Part of Human Trophoblast Invasion Machinery - A Functional Study In Vitro	PLOS ONE			English	Article							GALACTOSIDE-BINDING LECTIN; MATERNAL-FETAL INTERFACE; FRIEDENREICH TF ANTIGEN; HUMAN-PLACENTA; CELL-PROLIFERATION; EXTRACELLULAR-MATRIX; CANCER CELLS; EXPRESSION; ADHESION; DIFFERENTIATION	Background: Interactions of glycoconjugates with endogenous galectins, have been long proposed to participate in several reproductive processes including implantation. In human placenta gal-1, gal-3, gal-8, and gal-13 proteins are known to be present. Each of them has been proposed to play multiple functions, but so far no clear picture has emerged. We hypothesized that gal-1 participates in trophoblast invasion, and conducted Matrigel invasion assay using isolated cytotrophoblast from first trimester placenta and HTR-8/SVneo cell line to test it. Methods and Findings: Function blocking anti-gal-1 antibody was employed to assess participation of endogenous gal-1 in cell adhesion, cell invasion of HTR-8/SVneo cells. When gal-1 was blocked in isolated trophoblast cell invasion was reduced to 75% of control (SEM +/- 6.3, P<0.001) and to 66% of control (SEM +/- 1.7, P<0.001) in HTR-8/SVneo cell line. Increased availability of gal-1, as two molecular forms of recombinant human gal-1 (CS-gal-1 and Ox-gal-1), resulted in increased cell invasion by cytotrophoblast to 151% (SEM +/- 16, P<0.01) with 1 ng/ml of CS-gal-1, and to 192% (SEM +/- 51, P<0.05) with 1 mu g/ml of Ox-gal-1. Stimulation was also observed in HTR-8/SVneo cells, to 317% (SEM +/- 58, P<0.001) by CS-gal-1, and to 200% (SEM +/- 24, P<0.001) by Ox-gal-1 at 1 mu g/ml. Both sets of results confirmed involvement of gal-1 in trophoblast invasion. Galectin profile of isolated cytotrophoblast and HTR-8/SVneo cells was established using RT-PCR and real-time PCR and found to consist of gal-1, gal-3 and gal-8 for both cell types. Only gal-1 was located at the trophoblast cell membrane, as determined by FACS analysis, which is consistent with the results of the functional tests. Conclusion and Significance: These findings qualify gal-1 as a member of human trophoblast cell invasion machinery.	[Kolundzic, Nikola; Bojic-Trbojevic, Zanka; Kovacevic, Tamara; Stefanoska, Ivana; Vicovac, Ljiljana] Univ Belgrade, Inst INEP, Reprod Biol Lab, Belgrade, Serbia; [Kadoya, Toshihiko] Maebashi Inst Technol, Dept Biotechnol, Maebashi, Gunma, Japan	University of Belgrade	Kolundzic, N (corresponding author), Univ Belgrade, Inst INEP, Reprod Biol Lab, Belgrade, Serbia.	vicovac@inep.co.rs	Vicovac, Ljiljana/I-1973-2019	Vicovac, Ljiljana/0000-0002-2744-415X; Bojic-Trbojevic, Zanka/0000-0001-5619-1027	Ministry of Education and Science of the Government of Serbia [173004]	Ministry of Education and Science of the Government of Serbia	Research was funded by grant 173004 of Ministry of Education and Science of the Government of Serbia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplin JD, 1999, BIOL REPROD, V60, P828, DOI 10.1095/biolreprod60.4.828; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; BEVAN BH, 1994, HISTOCHEM J, V26, P582, DOI 10.1007/BF00158592; Blois SM, 2007, NAT MED, V13, P1450, DOI 10.1038/nm1680; Bojic-Trbojevic Z, 2008, ARCH BIOL SCI, V60, P11, DOI 10.2298/ABS0801011B; Bozic M, 2004, PLACENTA, V25, P797, DOI 10.1016/j.placenta.2004.03.006; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; Caniggia I, 2000, J CLIN INVEST, V105, P577, DOI 10.1172/JCI8316; Chakraborty C, 2002, CAN J PHYSIOL PHARM, V80, P116, DOI 10.1139/Y02-016; Colnot C, 1998, DEV DYNAM, V211, P306, DOI 10.1002/(SICI)1097-0177(199804)211:4<306::AID-AJA2>3.0.CO;2-L; COOPER DNW, 1990, J CELL BIOL, V110, P1681, DOI 10.1083/jcb.110.5.1681; DAMSKY CH, 1994, DEVELOPMENT, V120, P3657; DAMSKY CH, 1992, J CLIN INVEST, V89, P210, DOI 10.1172/JCI115565; Endharti AT, 2005, EUR J IMMUNOL, V35, P86, DOI 10.1002/eji.200425340; Fischer I, 2009, PLACENTA, V30, P1078, DOI 10.1016/j.placenta.2009.10.003; FUJIWARA S, 1988, BIOCHEM J, V252, P453, DOI 10.1042/bj2520453; Genbacev OD, 2003, SCIENCE, V299, P405, DOI 10.1126/science.1079546; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Hadari YR, 2000, J CELL SCI, V113, P2385; Hanisch FG, 1993, LECTINS GLYCOBIOLOGY, P411; He J, 2006, LAB INVEST, V86, P578, DOI 10.1038/labinvest.3700420; HIRABAYASHI J, 1984, BIOCHEM BIOPH RES CO, V122, P938, DOI 10.1016/0006-291X(84)91181-1; Horie H, 1999, J NEUROSCI, V19, P9964; Hsu DK, 2002, GLYCOCONJUGATE J, V19, P507, DOI 10.1023/B:GLYC.0000014080.95829.52; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; Inagaki Y, 2000, EUR J BIOCHEM, V267, P2955, DOI 10.1046/j.1432-1033.2000.01311.x; IRVING JA, 1995, PLACENTA, V16, P413, DOI 10.1016/0143-4004(95)90100-0; Jeschke U, 2007, PLACENTA, V28, P1165, DOI 10.1016/j.placenta.2007.06.006; Jeschke U, 2006, HISTOCHEM CELL BIOL, V126, P437, DOI 10.1007/s00418-006-0178-1; Jones CJP, 2009, GLYCOCONJUGATE J, V26, P359, DOI 10.1007/s10719-008-9152-6; Jovanovic M, 2010, REPRODUCTION, V139, P789, DOI 10.1530/REP-09-0341; Kadoya T, 2005, CURR DRUG TARGETS, V6, P375, DOI 10.2174/1389450054022007; Kolundzic N, 2011, PLACENTA, V32, P909, DOI 10.1016/j.placenta.2011.07.087; Korhonen M, 1997, J HISTOCHEM CYTOCHEM, V45, P569, DOI 10.1177/002215549704500409; Lajoie P, 2009, J CELL BIOL, V185, P381, DOI 10.1083/jcb.200811059; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Lei CX, 2009, HUM REPROD, V24, P2879, DOI 10.1093/humrep/dep250; LIBRACH CL, 1991, J CELL BIOL, V113, P437, DOI 10.1083/jcb.113.2.437; Liu AX, 2006, BIOL REPROD, V75, P414, DOI 10.1095/biolreprod.105.049379; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohr M, 2008, HISTOCHEM CELL BIOL, V130, P567, DOI 10.1007/s00418-008-0465-0; Maquoi E, 1997, PLACENTA, V18, P433, DOI 10.1016/S0143-4004(97)80044-6; Masamune A, 2006, AM J PHYSIOL-GASTR L, V290, pG729, DOI 10.1152/ajpgi.00511.2005; Moiseeva EP, 2003, BBA-GEN SUBJECTS, V1619, P125, DOI 10.1016/S0304-4165(02)00447-6; Moiseeva EP, 2003, BIOCHEM BIOPH RES CO, V310, P1010, DOI 10.1016/j.bbrc.2003.09.112; Moiseeva EP, 2000, CARDIOVASC RES, V45, P493, DOI 10.1016/S0008-6363(99)00276-X; MOSS L, 1994, GLYCOBIOLOGY, V4, P567, DOI 10.1093/glycob/4.5.567; OZEKI Y, 1995, GLYCOBIOLOGY, V5, P255, DOI 10.1093/glycob/5.2.255; Park JW, 2001, NUCLEIC ACIDS RES, V29, P3595, DOI 10.1093/nar/29.17.3595; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; POIRIER F, 1993, DEVELOPMENT, V119, P1229; POIRIER F, 1992, DEVELOPMENT, V115, P143; Poirier F, 2002, BIOCHEM SOC SYMP, V69, P95; Poirier F, 1997, MOL HUM REPROD, V3, P907, DOI 10.1093/molehr/3.10.907; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; Roda O, 2009, GASTROENTEROLOGY, V136, P1379, DOI 10.1053/j.gastro.2008.12.039; Satelli A, 2008, ONCOL REP, V19, P587; Spano D, 2010, MOL MED, V16, P102, DOI 10.2119/molmed.2009.00119; Takamoto M, 1987, J BIOCH, V106, P228; Than NG, 2004, EUR J BIOCHEM, V6, P1068; Thijssen VL, 2008, AM J PATHOL, V172, P545, DOI 10.2353/ajpath.2008.070938; van den Brule F, 2003, LAB INVEST, V83, P377, DOI 10.1097/01.LAB.0000059949.01480.40; VANDENBRULE FA, 1995, BIOCHEM BIOPH RES CO, V209, P760, DOI 10.1006/bbrc.1995.1564; VANDENBRULE FA, 1994, BIOCHEM BIOPH RES CO, V201, P388, DOI 10.1006/bbrc.1994.1713; Vicovac L, 1998, HUM REPROD, V13, P730, DOI 10.1093/humrep/13.3.730; Vicovac L, 2007, PLACENTA, V28, P85, DOI 10.1016/j.placenta.2006.02.002; Tribulatti MV, 2009, J LEUKOCYTE BIOL, V86, P371, DOI 10.1189/jlb.0908529; von Wolff M, 2005, MOL HUM REPROD, V11, P189, DOI 10.1093/molehr/gah144; Wu MH, 2009, MOL CANCER RES, V7, P311, DOI 10.1158/1541-7786.MCR-08-0297; Zhao XY, 2010, CARCINOGENESIS, V31, P1367, DOI 10.1093/carcin/bgq116; Zhou Y, 2003, ANN NY ACAD SCI, V995, P73, DOI 10.1111/j.1749-6632.2003.tb03211.x	71	55	57	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28514	10.1371/journal.pone.0028514	http://dx.doi.org/10.1371/journal.pone.0028514			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174828	gold, Green Submitted, Green Published			2022-12-25	WOS:000298163600030
J	Wrzeszczynski, KO; Varadan, V; Byrnes, J; Lum, E; Kamalakaran, S; Levine, DA; Dimitrova, N; Zhang, MQ; Lucito, R				Wrzeszczynski, Kazimierz O.; Varadan, Vinay; Byrnes, James; Lum, Elena; Kamalakaran, Sitharthan; Levine, Douglas A.; Dimitrova, Nevenka; Zhang, Michael Q.; Lucito, Robert			Identification of Tumor Suppressors and Oncogenes from Genomic and Epigenetic Features in Ovarian Cancer	PLOS ONE			English	Article							OLIGONUCLEOTIDE MICROARRAY ANALYSIS; CIRCULAR BINARY SEGMENTATION; HIGH-RESOLUTION METHOD; COPY-NUMBER; BREAST-CANCER; DNA METHYLATION; GENE-EXPRESSION; HYPERMETHYLATION; HYBRIDIZATION; CARCINOMAS	The identification of genetic and epigenetic alterations from primary tumor cells has become a common method to identify genes critical to the development and progression of cancer. We seek to identify those genetic and epigenetic aberrations that have the most impact on gene function within the tumor. First, we perform a bioinformatic analysis of copy number variation (CNV) and DNA methylation covering the genetic landscape of ovarian cancer tumor cells. We separately examined CNV and DNA methylation for 42 primary serous ovarian cancer samples using MOMA-ROMA assays and 379 tumor samples analyzed by The Cancer Genome Atlas. We have identified 346 genes with significant deletions or amplifications among the tumor samples. Utilizing associated gene expression data we predict 156 genes with altered copy number and correlated changes in expression. Among these genes CCNE1, POP4, UQCRB, PHF20L1 and C19orf2 were identified within both data sets. We were specifically interested in copy number variation as our base genomic property in the prediction of tumor suppressors and oncogenes in the altered ovarian tumor. We therefore identify changes in DNA methylation and expression for all amplified and deleted genes. We statistically define tumor suppressor and oncogenic features for these modalities and perform a correlation analysis with expression. We predicted 611 potential oncogenes and tumor suppressors candidates by integrating these data types. Genes with a strong correlation for methylation dependent expression changes exhibited at varying copy number aberrations include CDCA8, ATAD2, CDKN2A, RAB25, AURKA, BOP1 and EIF2C3. We provide copy number variation and DNA methylation analysis for over 11,500 individual genes covering the genetic landscape of ovarian cancer tumors. We show the extent of genomic and epigenetic alterations for known tumor suppressors and oncogenes and also use these defined features to identify potential ovarian cancer gene candidates.	[Wrzeszczynski, Kazimierz O.; Byrnes, James; Lum, Elena; Zhang, Michael Q.; Lucito, Robert] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Varadan, Vinay; Kamalakaran, Sitharthan; Dimitrova, Nevenka] Philips Res N Amer, Briarcliff Manor, NY USA; [Levine, Douglas A.] Mem Sloan Kettering Canc Ctr, Dept Surg, Gynecol Serv, New York, NY 10021 USA; [Zhang, Michael Q.] Univ Texas Dallas, Dept Mol & Cell Biol, Richardson, TX 75083 USA	Cold Spring Harbor Laboratory; Philips; Philips Research; Memorial Sloan Kettering Cancer Center; University of Texas System; University of Texas Dallas	Wrzeszczynski, KO (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	kwrzesz@cshl.edu	Varadan, Vinay/AAC-2520-2020; Lucito, Robert/AID-7159-2022	Levine, Douglas/0000-0003-1038-8232	Department of Defense [W81XWH-05-1-0068]; Starr Foundation; Philips Research North America	Department of Defense(United States Department of Defense); Starr Foundation; Philips Research North America	This work was supported by Department of Defense W81XWH-05-1-0068, The Starr Foundation (http://www.starrcancer.org) and Philips Research North America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2009, TRAFFIC, V10, P1561, DOI 10.1111/j.1600-0854.2009.00969.x; Andrews J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008665; Bapat SA, 2010, CANCER RES, V70, P4809, DOI 10.1158/0008-5472.CAN-10-0447; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bohnert KA, 2009, MOL BIOL CELL, V20, P3646, DOI 10.1091/mbc.E09-04-0289; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bowtell DD, NAT REV CANC, V10, P803; Burrows JF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-250; Carden CP, 2010, DRUG DISCOV TODAY, V15, P88, DOI 10.1016/j.drudis.2009.11.006; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; Chari R, 2010, CANCER METAST REV, V29, P73, DOI 10.1007/s10555-010-9199-2; CHEN S, 2008, CANC BIOL THER, V7; Cheng KW, 2004, NAT MED, V10, P1251, DOI 10.1038/nm1125; Ciro M, 2009, CANCER RES, V69, P8491, DOI 10.1158/0008-5472.CAN-09-2131; de Pontual L, 2007, EUR J CANCER, V43, P2366, DOI 10.1016/j.ejca.2007.07.016; Degenhardt YY, 2008, CURR OPIN GENET DEV, V18, P68, DOI 10.1016/j.gde.2008.01.005; Delcuve GP, 2009, J CELL PHYSIOL, V219, P243, DOI 10.1002/jcp.21678; Despierre E, 2010, GYNECOL ONCOL, V117, P358, DOI 10.1016/j.ygyno.2010.02.012; Ehrlich M, 2006, CURR TOP MICROBIOL, V310, P251; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Fang F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001875; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Haller F, 2005, CLIN CANCER RES, V11, P6589, DOI 10.1158/1078-0432.CCR-05-0329; Hansen KD, 2011, NAT GENET; Hao M, 2009, J OBSTET GYNAECOL RE, V35, P918, DOI 10.1111/j.1447-0756.2009.01045.x; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hicks J, 2006, GENOME RES, V16, P1465, DOI 10.1101/gr.5460106; Iacobuzio-Donahue CA, 2009, ANNU REV PATHOL-MECH, V4, P229, DOI 10.1146/annurev.pathol.3.121806.151442; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kamalakaran S, 2011, MOL ONCOL, V5, P77, DOI 10.1016/j.molonc.2010.11.002; Kamalakaran S, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp413; Kiechle M, 2001, CANCER, V91, P534, DOI 10.1002/1097-0142(20010201)91:3<534::AID-CNCR1031>3.3.CO;2-K; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Leary RJ, 2008, P NATL ACAD SCI USA, V105, P16224, DOI 10.1073/pnas.0808041105; Li ZY, 2010, INT J GYNECOL CANCER, V20, P9, DOI 10.1111/IGC.0b013e3181a9026d; Lucito R, 2003, GENOME RES, V13, P2291, DOI 10.1101/gr.1349003; Lucito R, 1998, P NATL ACAD SCI USA, V95, P4487, DOI 10.1073/pnas.95.8.4487; Lucito R, 2009, METHODS MOL BIOL, V556, P33, DOI 10.1007/978-1-60327-192-9_4; McDermott U, 2011, NEW ENGL J MED, V364, P340, DOI 10.1056/NEJMra0907178; Meinhold-Heerlein I, 2005, ONCOGENE, V24, P1053, DOI 10.1038/sj.onc.1208298; Nakayama K, 2007, INT J CANCER, V120, P2613, DOI 10.1002/ijc.22609; Narayan G, 2009, GENE CHROMOSOME CANC, V48, P983, DOI 10.1002/gcc.20703; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pereg Y, 2010, NAT CELL BIOL, V12, P400, DOI 10.1038/ncb2041; Pinkel D, 2005, NAT GENET, V37, pS11, DOI 10.1038/ng1569; Ramakrishna M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009983; Reitman ZJ, 2010, J NATL CANC I; Sadikovic B, 2008, CURR GENOMICS, V9, P394, DOI 10.2174/138920208785699580; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Sawyers CL, 2008, NATURE, V452, P548, DOI 10.1038/nature06913; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Taylor BS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003179; Ting AH, 2006, GENE DEV, V20, P3215, DOI 10.1101/gad.1464906; Ushijima T, 2005, NAT REV CANCER, V5, P223, DOI 10.1038/nrc1571; Vang R, 2009, ADV ANAT PATHOL, V16, P267, DOI 10.1097/PAP.0b013e3181b4fffa; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Veeck J, 2010, J MAMMARY GLAND BIOL, V15, P5, DOI 10.1007/s10911-010-9165-1; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Wimmer K, 2002, GENE CHROMOSOME CANC, V33, P285, DOI 10.1002/gcc.10030; Yap TA, 2009, NAT REV CANCER, V9, P167, DOI 10.1038/nrc2583; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu JS, 2008, ONCOGENE, V27, P4657, DOI 10.1038/onc.2008.101	70	74	78	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28503	10.1371/journal.pone.0028503	http://dx.doi.org/10.1371/journal.pone.0028503			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174824	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000298163600029
J	Zapater, JL; Colley, KJ				Zapater, Joseph L.; Colley, Karen J.			Sequences Prior to Conserved Catalytic Motifs of Polysialyltransferase ST8Sia IV Are Required for Substrate Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE; CENTRAL-NERVOUS-SYSTEM; AMINO-ACID-RESIDUES; POLYSIALIC-ACID; III REPEAT; DIFFERENTIAL BIOSYNTHESIS; INTERNEURON PRECURSORS; GLYCAN POLYSIALYLATION; NCAM POLYSIALYLATION; PROTEIN SECONDARY	Polysialic acid on the neural cell adhesion molecule (NCAM) modulates cell-cell adhesion and signaling, is required for proper brain development, and plays roles in neuronal regeneration and the growth and invasiveness of tumor cells. Evidence indicates that NCAM polysialylation is highly protein-specific, requiring an initial polysialyltransferase-NCAM protein-protein interaction. Previous work suggested that a polybasic region located prior to the conserved polysialyltransferase catalytic motifs may be involved in NCAM recognition, but not overall enzyme activity (Foley, D. A., Swartzentruber, K. G., and Colley, K. J. (2009) J. Biol. Chem. 284, 15505-15516). Here, we employ a competition assay to evaluate the role of this region in substrate recognition. We find that truncated, catalytically inactive ST8SiaIV/PST proteins that include the polybasic region, but not those that lack this region, compete with endogenous ST8SiaIV/PST and reduce NCAM polysialylation in SW2 small cell lung carcinoma cells. Replacing two polybasic region residues, Arg(82) and Arg(93), eliminates the ability of a full-length, catalytically inactive enzyme (PST H331K) to compete with SW2 cell ST8SiaIV/PST and block NCAM polysialylation. Replacing these residues singly or together in ST8SiaIV/PST substantially reduces or eliminates NCAM polysialylation, respectively. In contrast, replacing Arg(82), but not Arg(93), substantially reduces the ability of ST8SiaIV/PST to polysialylate neuropilin-2 and SynCAM 1, suggesting that Arg(82) plays a general role in substrate recognition, whereas Arg(93) specifically functions in NCAM recognition. Taken together, our results indicate that the ST8SiaIV/PST polybasic region plays a critical role in substrate recognition and suggest that different combinations of basic residues may mediate the recognition of distinct substrates.	[Zapater, Joseph L.; Colley, Karen J.] Univ Illinois, Coll Med, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Colley, KJ (corresponding author), 900 S Ashland Ave,M-C 669, Chicago, IL 60607 USA.	karenc@uic.edu			National Institutes of Health [RO1 GM063843]; NIGMS [F31 GM096739]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063843, F31GM096739] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM063843 (to K.J.C.) and Fellowship F31 GM096739 from the NIGMS (to J.L.Z.).	Angata K, 2003, BIOCHIMIE, V85, P195, DOI 10.1016/S0300-9084(03)00051-8; Angata K, 2000, J BIOL CHEM, V275, P18594, DOI 10.1074/jbc.M910204199; Angata K, 2004, J BIOL CHEM, V279, P25883, DOI 10.1074/jbc.M401562200; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; Bruses JL, 2001, BIOCHIMIE, V83, P635, DOI 10.1016/S0300-9084(01)01293-7; Burgess A, 2008, DEV NEUROBIOL, V68, P1580, DOI 10.1002/dneu.20681; Chiu CPC, 2004, NAT STRUCT MOL BIOL, V11, P163, DOI 10.1038/nsmb720; Close BE, 2003, J BIOL CHEM, V278, P30796, DOI 10.1074/jbc.M305390200; Close BE, 1998, J BIOL CHEM, V273, P34586, DOI 10.1074/jbc.273.51.34586; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; Curreli S, 2007, J BIOL CHEM, V282, P30346, DOI 10.1074/jbc.M702965200; DATTA AK, 1995, J BIOL CHEM, V270, P1497, DOI 10.1074/jbc.270.4.1497; Datta AK, 1998, J BIOL CHEM, V273, P9608, DOI 10.1074/jbc.273.16.9608; Ditlevsen DK, 2008, J NEUROSCI RES, V86, P727, DOI 10.1002/jnr.21551; Durbec P, 2001, MOL NEUROBIOL, V24, P53; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; Foley DA, 2010, J BIOL CHEM, V285, P35056, DOI 10.1074/jbc.M110.170209; Foley DA, 2010, J BIOL CHEM, V285, P27360, DOI 10.1074/jbc.M110.140038; Foley DA, 2009, J BIOL CHEM, V284, P15505, DOI 10.1074/jbc.M809696200; Forsee WT, 2006, J BIOL CHEM, V281, P6283, DOI 10.1074/jbc.M511124200; Fujimoto I, 2001, J BIOL CHEM, V276, P31745, DOI 10.1074/jbc.M104525200; Galuska SP, 2006, J BIOL CHEM, V281, P31605, DOI 10.1074/jbc.M606516200; Galuska SP, 2010, P NATL ACAD SCI USA, V107, P10250, DOI 10.1073/pnas.0912103107; Geremia RA, 1997, GLYCOBIOLOGY, V7, pR5; Geyer H, 2001, EUR J BIOCHEM, V268, P6587, DOI 10.1046/j.0014-2956.2001.02613.x; Hildebrandt H, 1998, CANCER RES, V58, P779; Hildebrandt H, 2007, J NEUROCHEM, V103, P56, DOI 10.1111/j.1471-4159.2007.04716.x; Horstkorte R, 1999, EXP CELL RES, V246, P122, DOI 10.1006/excr.1998.4255; Hu HY, 2000, J NEUROSCI RES, V61, P480, DOI 10.1002/1097-4547(20000901)61:5<480::AID-JNR2>3.0.CO;2-M; Hu HY, 1996, NEURON, V16, P735, DOI 10.1016/S0896-6273(00)80094-X; Isomura R, 2011, J BIOL CHEM, V286, P21535, DOI 10.1074/jbc.M111.221143; JAMES WM, 1987, BIOCHEM BIOPH RES CO, V148, P817, DOI 10.1016/0006-291X(87)90949-1; Jeanneau C, 2004, J BIOL CHEM, V279, P13461, DOI 10.1074/jbc.M311764200; Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jungnickel J, 2009, MOL CELL NEUROSCI, V40, P374, DOI 10.1016/j.mcn.2008.12.003; Kanato Y, 2008, GLYCOBIOLOGY, V18, P1044, DOI 10.1093/glycob/cwn084; KISS JZ, 1993, NEUROSCIENCE, V53, P213, DOI 10.1016/0306-4522(93)90299-U; Kitazume-Kawaguchi S, 2001, J BIOL CHEM, V276, P15696, DOI 10.1074/jbc.M010371200; KOJIMA N, 1995, FEBS LETT, V360, P1, DOI 10.1016/0014-5793(95)00059-I; Kojima N, 1996, J BIOL CHEM, V271, P19457, DOI 10.1074/jbc.271.32.19457; Kudo M, 1996, J BIOL CHEM, V271, P32667, DOI 10.1074/jbc.271.51.32667; Laha KT, 2011, MOL PHARMACOL, V79, P662, DOI 10.1124/mol.110.068619; LIVINGSTON BD, 1988, J BIOL CHEM, V263, P9443; Meiler J, 2003, P NATL ACAD SCI USA, V100, P12105, DOI 10.1073/pnas.1831973100; Mendiratta SS, 2006, J BIOL CHEM, V281, P36052, DOI 10.1074/jbc.M608073200; Mendiratta SS, 2005, J BIOL CHEM, V280, P32340, DOI 10.1074/jbc.M506217200; Miyahara R, 2001, J SURG ONCOL, V77, P49, DOI 10.1002/jso.1065; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; Muhlenhoff M, 1996, EMBO J, V15, P6943, DOI 10.1002/j.1460-2075.1996.tb01086.x; Nakata D, 2006, GLYCOCONJUGATE J, V23, P423, DOI 10.1007/s10719-006-6356-5; NAKAYAMA J, 1995, P NATL ACAD SCI USA, V92, P7031, DOI 10.1073/pnas.92.15.7031; Nakayama J, 1998, PATHOL INT, V48, P665, DOI 10.1111/j.1440-1827.1998.tb03967.x; NELSON RW, 1995, J BIOL CHEM, V270, P17171, DOI 10.1074/jbc.270.29.17171; Pellet-Many C, 2008, BIOCHEM J, V411, P211, DOI 10.1042/BJ20071639; PERERA AD, 1993, ENDOCRINOLOGY, V133, P2729, DOI 10.1210/en.133.6.2729; Petridis AK, 2009, ACTA NEUROCHIR, V151, P601, DOI 10.1007/s00701-009-0324-3; Rao FV, 2009, NAT STRUCT MOL BIOL, V16, P1186, DOI 10.1038/nsmb.1685; Rey-Gallardo A, 2010, GLYCOBIOLOGY, V20, P1139, DOI 10.1093/glycob/cwq078; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; SCHEIDEGGER EP, 1995, J BIOL CHEM, V270, P22685, DOI 10.1074/jbc.270.39.22685; SCHEIDEGGER EP, 1994, LAB INVEST, V70, P95; Seidenfaden R, 2000, EUR J CELL BIOL, V79, P680, DOI 10.1078/0171-9335-00093; SEKI T, 1993, NEUROSCI RES, V17, P265, DOI 10.1016/0168-0102(93)90111-3; Soroka V, 2003, STRUCTURE, V11, P1291, DOI 10.1016/j.str.2003.09.006; STANLEY P, 1984, ANNU REV GENET, V18, P525, DOI 10.1146/annurev.ge.18.120184.002521; Stoenica L, 2006, EUR J NEUROSCI, V23, P2255, DOI 10.1111/j.1460-9568.2006.04771.x; Suzuki M, 2005, GLYCOBIOLOGY, V15, P887, DOI 10.1093/glycob/cwi071; Thomas LA, 2008, J COMP NEUROL, V510, P47, DOI 10.1002/cne.21773; Thompson MG, 2011, J BIOL CHEM, V286, P4525, DOI 10.1074/jbc.M110.200386; von der Ohe M, 2002, GLYCOBIOLOGY, V12, P47, DOI 10.1093/glycob/12.1.47; Walmod PS, 2004, NEUROCHEM RES, V29, P2015, DOI 10.1007/s11064-004-6875-z; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Yabe U, 2003, J BIOL CHEM, V278, P13875, DOI 10.1074/jbc.M300458200	75	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6441	6453		10.1074/jbc.M111.322024	http://dx.doi.org/10.1074/jbc.M111.322024			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22184126	Green Published, hybrid			2022-12-25	WOS:000300791800034
J	Page, TH; D'Souza, Z; Nakanishi, S; Serikawa, T; Pusey, CD; Aitman, TJ; Cook, HT; Behmoaras, J				Page, Theresa H.; D'Souza, Zelpha; Nakanishi, Satoshi; Serikawa, Tadao; Pusey, Charles D.; Aitman, Timothy J.; Cook, H. Terence; Behmoaras, Jacques			Role of Novel Rat-specific Fc Receptor in Macrophage Activation Associated with Crescentic Glomerulonephritis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-RIII CD16; MEDIATED PHAGOCYTOSIS; FUNCTIONAL ASSOCIATION; SIGNAL-TRANSDUCTION; TYROSINE KINASES; IMMUNOGLOBULIN-G; DEFICIENT MICE; CHAIN; POLYMORPHISM; EXPRESSION	Crescentic glomerulonephritis (Crgn) is a complex disease where the initial insult is often the glomerular deposition of antibodies against intrinsic or deposited antigens in the glomerulus. The role of Fc receptors in the induction and progression of Crgn is increasingly recognized, and our previous studies have shown that copy number variation in Fcgr3 partially explains the genetic susceptibility of the Wistar-Kyoto (WKY) rat to nephrotoxic nephritis, a rat model of Crgn. The Fcgr3-related sequence (Fcgr3-rs) is a novel rat-specific Fc receptor with a cytoplasmic domain 6 amino acids longer than its paralogue, Fcgr3. The Fcgr3-rs gene is deleted from the WKY rat genome, and this deletion is associated with enhanced macrophage activity in this strain. Here, we investigated the mechanism by which the deletion of Fcgr3-rs in the WKY strain leads to increased macrophage activation. By lentivirus-mediated gene delivery, we generated stably transduced U937 cells expressing either Fcgr3-rs or Fcgr3. In these cells, which lack endogenous Fcgr3 receptors, we show that Fcgr3-rs interacts with the common Fc-gamma chain but that Fc receptor-mediated phagocytosis and signaling are defective. Furthermore, in primary macrophages, expression of Fcgr3-rs inhibits Fc receptor-mediated functions, because WKY bone marrow-derived macrophages transduced with Fcgr3-rs had significantly reduced phagocytic activity. This inhibitory effect on phagocytosis was mediated by the novel cytoplasmic domain of Fcgr3-rs. These results suggest that Fcgr3-rs may act to inhibit Fcgr3-mediated signaling and phagocytosis and could be considered as a novel mechanism in the modulation of Fc receptor-mediated cell activation in autoimmune diseases.	[Cook, H. Terence; Behmoaras, Jacques] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Ctr Complement & Inflammat Res, London W12 0NN, England; [Page, Theresa H.] Univ London Imperial Coll Sci Technol & Med, Div Rheumatol, Kennedy Inst, London W6 8LH, England; [Pusey, Charles D.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Renal Dept, London W12 0NN, England; [D'Souza, Zelpha; Aitman, Timothy J.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Med Res Council Clin Sci Ctr, London W12 0NN, England; [Nakanishi, Satoshi; Serikawa, Tadao] Kyoto Univ, Grad Sch Med, Inst Lab Anim, Sakyo Ku, Kyoto 6068501, Japan	Imperial College London; Imperial College London; University of Oxford; Imperial College London; Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Kyoto University	Behmoaras, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Ctr Complement & Inflammat Res, Du Cane Rd, London W12 0NN, England.	Jacquesb@imperial.ac.uk		Page, Theresa/0000-0002-2664-4256; Aitman, Timothy/0000-0002-7875-4502	Wellcome Trust; Clinical Sciences Centre; United Kingdom Medical Research Council; Imperial College; MRC [MC_U120061454, G0400116] Funding Source: UKRI; Medical Research Council [G0400116, MC_U120061454] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Clinical Sciences Centre; United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Imperial College; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by intramural funding from the Wellcome Trust, Clinical Sciences Centre, and the United Kingdom Medical Research Council. Recipient of an Imperial College Junior Research Fellowship.	Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Bainbridge JWB, 2001, GENE THER, V8, P1665, DOI 10.1038/sj.gt.3301574; Behmoaras J, 2008, NAT GENET, V40, P553, DOI 10.1038/ng.137; Behmoaras J, 2010, J AM SOC NEPHROL, V21, P1136, DOI 10.1681/ASN.2009090968; Brown EE, 2007, AUTOIMMUNITY, V40, P567, DOI 10.1080/08916930701763710; Crowley MT, 1997, J EXP MED, V186, P1027, DOI 10.1084/jem.186.7.1027; DAVIS W, 1995, EMBO J, V14, P432, DOI 10.1002/j.1460-2075.1995.tb07019.x; Floto RA, 2005, NAT MED, V11, P1056, DOI 10.1038/nm1288; GHAZIZADEH S, 1994, J BIOL CHEM, V269, P8878; Hou XH, 1996, J BIOL CHEM, V271, P22815, DOI 10.1074/jbc.271.37.22815; Huang ZY, 2004, J LEUKOCYTE BIOL, V76, P491, DOI 10.1189/jlb.1103562; INDIK ZK, 1995, BLOOD, V86, P4389, DOI 10.1182/blood.V86.12.4389.bloodjournal86124389; Kim MK, 2003, BLOOD, V101, P4479, DOI 10.1182/blood.V101.11.4479; Kuramoto T, 2008, PHYSIOL GENOMICS, V33, P205, DOI 10.1152/physiolgenomics.00222.2007; LANIER LL, 1991, J IMMUNOL, V146, P1571; Lowry MB, 1998, J EXP MED, V187, P161, DOI 10.1084/jem.187.2.161; Maratou K, 2011, GENES IMMUN, V12, P78, DOI 10.1038/gene.2010.61; Mason JC, 2008, HANDB SYST AUTOIMMUN, V7, pV; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Nimmerjahn F, 2007, ADV IMMUNOL, V96, P179, DOI 10.1016/S0065-2776(07)96005-8; PARK JG, 1993, J CLIN INVEST, V92, P1967, DOI 10.1172/JCI116790; Park SY, 1998, J CLIN INVEST, V102, P1229, DOI 10.1172/JCI3256; Sharif O, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-1; Strzelecka A, 1997, FEBS LETT, V400, P11, DOI 10.1016/S0014-5793(96)01359-2; Suzuki Y, 1998, KIDNEY INT, V54, P1166, DOI 10.1046/j.1523-1755.1998.00108.x; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Tarzi RM, 2002, KIDNEY INT, V62, P2087, DOI 10.1046/j.1523-1755.2002.00687.x; Wakayama H, 2000, EUR J IMMUNOL, V30, P1182, DOI 10.1002/(SICI)1521-4141(200004)30:4<1182::AID-IMMU1182>3.0.CO;2-H; WANG AVT, 1994, J EXP MED, V180, P1165, DOI 10.1084/jem.180.3.1165; WIRTHMUELLER U, 1992, J EXP MED, V175, P1381, DOI 10.1084/jem.175.5.1381	30	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5710	5719		10.1074/jbc.M111.260695	http://dx.doi.org/10.1074/jbc.M111.260695			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22184119	hybrid, Green Published			2022-12-25	WOS:000300638000047
J	Sun, HG; Ruszczycky, MW; Chang, WC; Thibodeaux, CJ; Liu, HW				Sun, He G.; Ruszczycky, Mark W.; Chang, Wei-Chen; Thibodeaux, Christopher J.; Liu, Hung-Wen			Nucleophilic Participation of Reduced Flavin Coenzyme in Mechanism of UDP-galactopyranose Mutase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSITIONAL ISOTOPE-EXCHANGE; STEREOSELECTIVE-SYNTHESIS; CATALYTIC MECHANISM; ESCHERICHIA-COLI; INHIBITORS; OXIDASE; GALACTOFURANOSE; RESONANCE; BINDING; ROLES	UDP-galactopyranose mutase (UGM) requires reduced FAD (FAD(red)) to catalyze the reversible interconversion of UDP-galactopyranose (UDP-Galp) and UDP-galactofuranose (UDP-Galf). Recent structural and mechanistic studies of UGM have provided evidence for the existence of an FAD-Galf/p adduct as an intermediate in the catalytic cycle. These findings are consistent with Lewis acid/base chemistry involving nucleophilic attack by N5 of FAD(red) at C1 of UDP-Galf/p. In this study, we employed a variety of FAD analogues to characterize the role of FAD(red) in the UGM catalytic cycle using positional isotope exchange (PIX) and linear free energy relationship studies. PIX studies indicated that UGM reconstituted with 5-deaza-FAD(red) is unable to catalyze PIX of the bridging C1-OP beta oxygen of UDP-Galp, suggesting a direct role for the FAD(red) N5 atom in this process. In addition, analysis of kinetic linear free energy relationships of k(cat) versus the nucleophilicity of N5 of FAD(red) gave a slope of rho = -2.4 +/- 0.4. Together, these findings are most consistent with a chemical mechanism for UGM involving an S(N)2-type displacement of UDP from UDP-Galf/p by N5 of FAD(red).	[Sun, He G.; Ruszczycky, Mark W.; Chang, Wei-Chen; Thibodeaux, Christopher J.; Liu, Hung-Wen] Univ Texas Austin, Coll Pharm, Dept Chem & Biochem, Div Med Chem, Austin, TX 78712 USA; [Sun, He G.; Ruszczycky, Mark W.; Chang, Wei-Chen; Thibodeaux, Christopher J.; Liu, Hung-Wen] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Liu, HW (corresponding author), Univ Texas Austin, Coll Pharm, Dept Chem & Biochem, Div Med Chem, 2409 Univ Ave,PHR 3-206B, Austin, TX 78712 USA.	h.w.liu@mail.utexas.edu		CHANG, WEI-CHEN/0000-0002-2341-9846	National Institutes of Health [GM035906, GM054346]; NIAID [F32AI082906]; Welch Foundation [F-1511]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI082906] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035906, R37GM035906, R01GM054346] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM035906 and GM054346 and Fellowship Award F32AI082906 from NIAID (to M. W. R.). This work was also supported by Welch Foundation Grant F-1511.	Barlow JN, 1999, J AM CHEM SOC, V121, P6968, DOI 10.1021/ja991582r; Caravano A, 2006, CHEM-EUR J, V12, P3114, DOI 10.1002/chem.200500991; Caravano A, 2004, CHEM COMMUN, P1216, DOI 10.1039/b402469a; Desvergnes S, 2007, BIOORGAN MED CHEM, V15, P6443, DOI 10.1016/j.bmc.2007.06.059; Edmondson D.E., 1999, FLAVINS FLAVOPROTEIN, P71; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Gruber TD, 2009, BIOCHEMISTRY-US, V48, P9171, DOI 10.1021/bi901437v; HANSCH C, 1991, CHEM REV, V91, P165, DOI 10.1021/cr00002a004; Huang ZH, 2003, BIOORG CHEM, V31, P494, DOI 10.1016/j.bioorg.2003.08.002; Itoh K, 2007, ORG LETT, V9, P879, DOI 10.1021/ol0631408; Kommoju PR, 2009, BIOCHEMISTRY-US, V48, P6951, DOI 10.1021/bi9006918; Legrand YM, 2003, J AM CHEM SOC, V125, P15789, DOI 10.1021/ja036940b; Liautard V, 2008, J ORG CHEM, V73, P3103, DOI 10.1021/jo8001134; Mansoorabadi SO, 2007, J ORG CHEM, V72, P6329, DOI 10.1021/jo0703092; MIDELFORT CF, 1976, J BIOL CHEM, V251, P5881; MULLINS LS, 1995, METHOD ENZYMOL, V249, P398; Pan F, 2001, J BACTERIOL, V183, P3991, DOI 10.1128/JB.183.13.3991-3998.2001; Peltier P, 2008, CARBOHYD RES, V343, P1897, DOI 10.1016/j.carres.2008.02.010; Peltier P, 2010, CHEM BIOL, V17, P1356, DOI 10.1016/j.chembiol.2010.10.014; Rauch G, 2007, BIOCHEMISTRY-US, V46, P3768, DOI 10.1021/bi602420u; Richards MR, 2009, CHEMBIOCHEM, V10, P1920, DOI 10.1002/cbic.200900208; Roth JP, 2004, J AM CHEM SOC, V126, P15120, DOI 10.1021/ja047050e; Soltero-Higgin M, 2004, NAT STRUCT MOL BIOL, V11, P539, DOI 10.1038/nsmb772; Taft RW, 1960, J PHYS CHEM-US, V64, P1805, DOI 10.1021/j100841a003; TAFT RW, 1959, J AM CHEM SOC, V81, P5352, DOI 10.1021/ja01529a026; Thibodeaux CJ, 2010, J AM CHEM SOC, V132, P9994, DOI 10.1021/ja104090m; WALSH C, 1986, ACCOUNTS CHEM RES, V19, P216, DOI 10.1021/ar00127a004; Yorita K, 2000, P NATL ACAD SCI USA, V97, P2480, DOI 10.1073/pnas.040559797; Yu QJ, 2010, J BIOL CHEM, V285, P12109, DOI 10.1074/jbc.M109.091843; Yuan Y, 2008, J AM CHEM SOC, V130, P3157, DOI 10.1021/ja7104152; Zhang QB, 2001, J AM CHEM SOC, V123, P6756, DOI 10.1021/ja010473l; Zhang QB, 2000, J AM CHEM SOC, V122, P9065, DOI 10.1021/ja001333z	32	32	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4602	4608		10.1074/jbc.M111.312538	http://dx.doi.org/10.1074/jbc.M111.312538			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22187430	Green Published, hybrid			2022-12-25	WOS:000300608500023
J	Zhi, XY; Zhou, XE; Melcher, K; Motola, DL; Gelmedin, V; Hawdon, J; Kliewer, SA; Mangelsdorf, DJ; Xu, HE				Zhi, Xiaoyong; Zhou, X. Edward; Melcher, Karsten; Motola, Daniel L.; Gelmedin, Verena; Hawdon, John; Kliewer, Steven A.; Mangelsdorf, David J.; Xu, H. Eric			Structural Conservation of Ligand Binding Reveals a Bile Acid-like Signaling Pathway in Nematodes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEGANS DAUER FORMATION; NUCLEAR RECEPTOR; CRYSTAL-STRUCTURE; DAF-12; IDENTIFICATION; ACTIVATION; BETA	Bile acid-like molecules named dafachronic acids (DAs) control the dauer formation program in Caenorhabditis elegans through the nuclear receptor DAF-12. This mechanism is conserved in parasitic nematodes to regulate their dauer-like infective larval stage, and as such, the DAF-12 ligand binding domain has been identified as an important therapeutic target in human parasitic hookworm species that infect more than 600 million people worldwide. Here, we report two x-ray crystal structures of the hookworm Ancylostoma ceylanicum DAF-12 ligand binding domain in complex with DA and cholestenoic acid (a bile acid-like metabolite), respectively. Structure analysis and functional studies reveal key residues responsible for species-specific ligand responses of DAF-12. Furthermore, DA binds to DAF-12 mechanistically and is structurally similar to bile acids binding to the mammalian bile acid receptor farnesoid X receptor. Activation of DAF-12 by cholestenoic acid and the cholestenoic acid complex structure suggest that bile acid-like signaling pathways have been conserved in nematodes and mammals. Together, these results reveal the molecular mechanism for the interplay between parasite and host, provide a structural framework for DAF-12 as a promising target in treating nematode parasitism, and provide insight into the evolution of gut parasite hormone-signaling pathways.	[Zhi, Xiaoyong; Zhou, X. Edward; Melcher, Karsten; Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA; [Melcher, Karsten] Van Andel Res Inst, Lab Struct Biol & Biochem, Grand Rapids, MI 49503 USA; [Motola, Daniel L.; Kliewer, Steven A.; Mangelsdorf, David J.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Gelmedin, Verena; Hawdon, John] George Washington Univ, Med Ctr, Dept Microbiol Immunol & Trop Med, Washington, DC 20037 USA; [Xu, H. Eric] Chinese Acad Sci, Shanghai Inst Mat Med, Ctr Struct & Funct Drug Targets, VARI SIMM Ctr,State Key Lab Drug Res, Shanghai 201203, Peoples R China; [Kliewer, Steven A.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Mangelsdorf, David J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	Van Andel Institute; Van Andel Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; George Washington University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Xu, HE (corresponding author), Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA.	eric.xu@vai.org	Melcher, Karsten/AAZ-3861-2020; Xu, H. Eric/ABD-7487-2021; Hawdon, John/I-1201-2019	Melcher, Karsten/0000-0002-9125-4027; Hawdon, John/0000-0002-6164-1413; Mangelsdorf, David/0000-0002-4355-0796; Xu, H. Eric/0000-0002-6829-8144	National Institutes of Health [DK071662, DK066202, HL089301, DK62434]; Jay and Betty Van Andel Foundation; Howard Hughes Medical Institute; Robert A. Welch Foundation [I-1275, I-1558]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK062434, R01DK071662, R01DK066202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jay and Betty Van Andel Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Robert A. Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK071662, DK066202, and HL089301 (to H. E. X.) and DK62434 (to D. J. M.). This work was also supported by the Jay and Betty Van Andel Foundation, Howard Hughes Medical Institute (to D. J. M.), and the Robert A. Welch Foundation Grants I-1275 (to D. J. M.) and I-1558 (to S. A. K.).	Antebi A, 2000, GENE DEV, V14, P1512; Dieterich C, 2009, TRENDS GENET, V25, P203, DOI 10.1016/j.tig.2009.03.006; Fielenbach N, 2008, GENE DEV, V22, P2149, DOI 10.1101/gad.1701508; HAWDON JM, 1993, PARASITOLOGY, V106, P163, DOI 10.1017/S0031182000074953; Held JM, 2006, AGING CELL, V5, P283, DOI 10.1111/j.1474-9726.2006.00218.x; Hotez PJ, 2006, TRENDS PARASITOL, V22, P327, DOI 10.1016/j.pt.2006.05.004; Hu Patrick J, 2007, WormBook, P1; Jasmer DP, 2003, ANNU REV PHYTOPATHOL, V41, P245, DOI 10.1146/annurev.phyto.41.052102.104023; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaplan RM, 2004, TRENDS PARASITOL, V20, P477, DOI 10.1016/j.pt.2004.08.001; Krylova IN, 2005, CELL, V120, P343, DOI 10.1016/j.cell.2005.01.024; Li Y, 2005, P NATL ACAD SCI USA, V102, P9505, DOI 10.1073/pnas.0501204102; Li Y, 2005, MOL CELL, V17, P491, DOI 10.1016/j.molcel.2005.02.002; Ludewig AH, 2004, GENE DEV, V18, P2120, DOI 10.1101/gad.312604; Martinez-Augustin O, 2008, WORLD J GASTROENTERO, V14, P5630, DOI 10.3748/wjg.14.5630; Mi LZ, 2003, MOL CELL, V11, P1093, DOI 10.1016/S1097-2765(03)00112-6; Modica Salvatore, 2010, Nucl Recept Signal, V8, pe005, DOI 10.1621/nrs.08005; Mooijaart SP, 2005, AGEING RES REV, V4, P351, DOI 10.1016/j.arr.2005.03.006; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Motola DL, 2006, CELL, V124, P1209, DOI 10.1016/j.cell.2006.01.037; Ogawa A, 2009, CURR BIOL, V19, P67, DOI 10.1016/j.cub.2008.11.063; Rochel N, 2000, MOL CELL, V5, P173, DOI 10.1016/S1097-2765(00)80413-X; Rottiers V, 2006, DEV CELL, V10, P473, DOI 10.1016/j.devcel.2006.02.008; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Setchell KDR, 1998, J CLIN INVEST, V102, P1690, DOI 10.1172/JCI2962; Sharma KK, 2009, MOL ENDOCRINOL, V23, P640, DOI 10.1210/me.2008-0415; Shulman AI, 2004, CELL, V116, P417, DOI 10.1016/S0092-8674(04)00119-9; Viney ME, 2009, BIOESSAYS, V31, P496, DOI 10.1002/bies.200900010; Viney ME, 2005, INT J PARASITOL, V35, P1473, DOI 10.1016/j.ijpara.2005.07.006; Wang Z, 2009, P NATL ACAD SCI USA, V106, P9138, DOI 10.1073/pnas.0904064106; Williams S, 2003, J BIOL CHEM, V278, P27138, DOI 10.1074/jbc.M302260200; Wollam J, 2011, AGING CELL, V10, P879, DOI 10.1111/j.1474-9726.2011.00733.x	32	24	24	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4894	4903		10.1074/jbc.M111.315242	http://dx.doi.org/10.1074/jbc.M111.315242			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22170062	Green Published, hybrid			2022-12-25	WOS:000300608500050
J	Kirkwood, JS; Lebold, KM; Miranda, CL; Wright, CL; Miller, GW; Tanguay, RL; Barton, CL; Traber, MG; Stevens, JF				Kirkwood, Jay S.; Lebold, Katie M.; Miranda, Cristobal L.; Wright, Charlotte L.; Miller, Galen W.; Tanguay, Robert L.; Barton, Carrie L.; Traber, Maret G.; Stevens, Jan F.			Vitamin C Deficiency Activates the Purine Nucleotide Cycle in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; ASCORBIC-ACID; AMP-DEAMINASE; ANTIOXIDANT DEFENSE; OXIDATIVE STRESS; PROTEIN-KINASE; FREE-RADICALS; DANIO-RERIO; PLASMA; MUSCLE	Vitamin C (ascorbic acid, AA) is a cofactor for many important enzymatic reactions and a powerful antioxidant. AA provides protection against oxidative stress by acting as a scavenger of reactive oxygen species, either directly or indirectly by recycling of the lipid-soluble antioxidant, alpha-tocopherol (vitamin E). Only a few species, including humans, guinea pigs, and zebrafish, cannot synthesize AA. Using an untargeted metabolomics approach, we examined the effects of alpha-tocopherol and AA deficiency on the metabolic profiles of adult zebrafish. We found that AA deficiency, compared with subsequent AA repletion, led to oxidative stress (using malondialdehyde production as an index) and to major increases in the metabolites of the purine nucleotide cycle (PNC): IMP, adenylosuccinate, and AMP. The PNC acts as a temporary purine nucleotide reservoir to keep AMP levels low during times of high ATP utilization or impaired oxidative phosphorylation. The PNC promotes ATP regeneration by converting excess AMP into IMP, thereby driving forward the myokinase reaction (2ADP3AMP -> ATP). On the basis of this finding, we investigated the activity of AMP deaminase, the enzyme that irreversibly deaminates AMP to form IMP. We found a 47% increase in AMP deaminase activity in the AA-deficient zebrafish, complementary to the 44-fold increase in IMP concentration. These results suggest that vitamin C is crucial for the maintenance of cellular energy metabolism.	[Stevens, Jan F.] Oregon State Univ, Linus Pauling Inst, Linus Pauling Sci Ctr 307, Corvallis, OR 97331 USA; [Kirkwood, Jay S.; Miranda, Cristobal L.; Stevens, Jan F.] Oregon State Univ, Coll Pharm, Corvallis, OR 97331 USA; [Lebold, Katie M.; Traber, Maret G.] Oregon State Univ, Sch Biol & Populat Hlth Sci, Corvallis, OR 97331 USA; [Tanguay, Robert L.; Barton, Carrie L.] Oregon State Univ, Dept Environm & Mol Toxicol, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; Oregon State University; Oregon State University	Stevens, JF (corresponding author), Oregon State Univ, Linus Pauling Inst, Linus Pauling Sci Ctr 307, Corvallis, OR 97331 USA.	fred.stevens@oregonstate.edu	Traber, Maret G./ABI-2511-2020; Miller, Galen/J-4386-2012	Traber, Maret G./0000-0002-2892-4024; Stevens, Jan Frederik/0000-0002-6348-9347	National Institutes of Health [S10RR027878, R01HL081721, R01HD062109, P30ES000210]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD062109] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027878] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grants S10RR027878, R01HL081721, R01HD062109, and P30ES000210.	AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Bohensky J, 2010, PEDIATR NEPHROL, V25, P633, DOI 10.1007/s00467-009-1310-y; Boulahbel H, 2009, BIOCHEM SOC T, V37, P291, DOI 10.1042/BST0370291; Bruno RS, 2006, FREE RADICAL BIO MED, V40, P689, DOI 10.1016/j.freeradbiomed.2005.10.051; BUETTNER GR, 1993, ARCH BIOCHEM BIOPHYS, V300, P535, DOI 10.1006/abbi.1993.1074; Buettner GR, 2000, TERATOLOGY, V62, P234, DOI 10.1002/1096-9926(200010)62:4<234::AID-TERA10>3.0.CO;2-9; Dodd A, 2000, HUM MOL GENET, V9, P2443, DOI 10.1093/hmg/9.16.2443; Duggan GE, 2011, J BIOMOL NMR, V49, P165, DOI 10.1007/s10858-011-9485-5; FREI B, 1989, P NATL ACAD SCI USA, V86, P6377, DOI 10.1073/pnas.86.16.6377; Halliwell B, 1999, FREE RADICAL RES, V31, P261, DOI 10.1080/10715769900300841; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Harrison FE, 2010, BRAIN RES, V1349, P143, DOI 10.1016/j.brainres.2010.06.037; Hong YL, 2000, CLIN BIOCHEM, V33, P619, DOI 10.1016/S0009-9120(00)00177-6; ISHERWOOD FA, 1954, BIOCHEM J, V56, P15, DOI 10.1042/bj0560015; Ji H, 2010, FISH PHYSIOL BIOCHEM, V36, P749, DOI 10.1007/s10695-009-9349-z; KALYANARAMAN B, 1992, J BIOL CHEM, V267, P6789; KREBS H, 1964, PROC R SOC SER B-BIO, V159, P545, DOI 10.1098/rspb.1964.0019; Lebold KM, 2011, J NUTR, V141, P2113, DOI 10.3945/jn.111.144279; LOWENSTEIN JM, 1972, PHYSIOL REV, V52, P382, DOI 10.1152/physrev.1972.52.2.382; Lushchak V. I., 1995, Biokhimiya, V60, P270; Lushchak VI, 2009, FISH PHYSIOL BIOCHEM, V35, P443, DOI 10.1007/s10695-008-9270-x; May JM, 2000, FREE RADICAL BIO MED, V28, P1421, DOI 10.1016/S0891-5849(00)00269-0; Miller GW, 2011, J NUTR BIOC IN PRESS; MOMMSEN TP, 1988, METABOLISM, V37, P552, DOI 10.1016/0026-0495(88)90170-9; Moreau R, 2001, ASCORBIC ACID IN AQUATIC ORGANISMS, P13; NISHIKIMI M, 1994, J BIOL CHEM, V269, P13685; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; PADH H, 1990, BIOCHEM CELL BIOL, V68, P1166, DOI 10.1139/o90-173; Page EL, 2008, MOL BIOL CELL, V19, P86, DOI 10.1091/mbc.E07-06-0612; Podda M, 1996, J LIPID RES, V37, P893; RUNDELL KW, 1993, J APPL PHYSIOL, V74, P2004, DOI 10.1152/jappl.1993.74.4.2004; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; SHAPIRO IM, 1991, AM J CLIN NUTR, V54, pS1209, DOI 10.1093/ajcn/54.6.1209s; Sims B, 1998, NEUROBIOL AGING, V19, P385, DOI 10.1016/S0197-4580(98)00083-9; Sok DE, 1998, J NEUROCHEM, V70, P1167; Tavazzi B, 2001, J BIOL CHEM, V276, P48083, DOI 10.1074/jbc.M101715200; Telang S, 2007, NEOPLASIA, V9, P47, DOI 10.1593/neo.06664; Traber MG, 2011, FREE RADICAL BIO MED, V51, P1000, DOI 10.1016/j.freeradbiomed.2011.05.017; Udvadia AJ, 2003, DEV BIOL, V256, P1, DOI 10.1016/S0012-1606(02)00083-0; VANWAARDE A, 1988, BIOL REV, V63, P259; Wixon J, 2000, YEAST, V17, P225, DOI 10.1002/1097-0061(20000930)17:3&lt;225::AID-YEA34&gt;3.0.CO;2-5; YOUNG IS, 1991, ANN CLIN BIOCHEM, V28, P504, DOI 10.1177/000456329102800514	42	48	49	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3833	3841		10.1074/jbc.M111.316018	http://dx.doi.org/10.1074/jbc.M111.316018			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22170049	Green Published, hybrid			2022-12-25	WOS:000300410900020
J	Bian, SM; Bai, JP; Chapin, H; Le Moellic, C; Dong, HP; Caplan, M; Sigworth, FJ; Navaratnam, DS				Bian, Shumin; Bai, Jun-Ping; Chapin, Hannah; Le Moellic, Cathy; Dong, Huiping; Caplan, Michael; Sigworth, Fred J.; Navaratnam, Dhasakumar S.			Interactions between beta-Catenin and the HSlo Potassium Channel Regulates HSlo Surface Expression	PLOS ONE			English	Article							LARGE-CONDUCTANCE; BK CHANNELS; K+ CHANNELS; FUNCTIONAL-CHARACTERIZATION; BINDING MOTIF; RAT-BRAIN; CELL-LINE; PROTEIN; WNT; IDENTIFICATION	Background: The large conductance calcium-activated potassium channel alpha-subunit (Slo) is widely distributed throughout the body and plays an important role in a number of diseases. Prior work has shown that Slo, through its S10 region, interacts with beta-catenin, a key component of the cytoskeleton framework and the Wnt signaling pathway. However, the physiological significance of this interaction was not clear. Methodology/Principal Findings: Using a combination of proteomic and cell biology tools we show the existence of additional multiple binding sites in Slo, and explore in detail beta-catenin interactions with the S10 region. We demonstrate that deletion of this region reduces Slo surface expression in HEK cells, which indicates that interaction with beta-catenin is important for Slo surface expression. This is confirmed by reduced expression of Slo in HEK cells and chicken (Gallus gallus domesticus leghorn white) hair cells treated with siRNA to beta-catenin. HSlo reciprocally co-immunoprecipitates with beta-catenin, indicating a stable binding between these two proteins, with the S10 deletion mutant having reduced binding with beta-catenin. We also observed that mutations of the two putative GSK phosphorylation sites within the S10 region affect both the surface expression of Slo and the channel's voltage and calcium sensitivities. Interestingly, expression of exogenous Slo in HEK cells inhibits beta-catenin-dependent canonical Wnt signaling. Conclusions and Significance: These studies identify for the first time a central role for beta-catenin in mediating Slo surface expression. Additionally we show that Slo overexpression can lead to downregulation of Wnt signaling.	[Bian, Shumin; Bai, Jun-Ping; Navaratnam, Dhasakumar S.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Chapin, Hannah; Le Moellic, Cathy; Dong, Huiping; Caplan, Michael; Sigworth, Fred J.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA	Yale University; Yale University	Bian, SM (corresponding author), Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA.	Dhasakumar.Navaratnam@Yale.Edu			National Institutes of Health [NS21501, R01 DC007894]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007894] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health grants NS21501 to FJS and R01 DC007894 to DSN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alioua A, 2008, J BIOL CHEM, V283, P4808, DOI 10.1074/jbc.M709802200; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; Bingham JP, 2006, BIOCONJUGATE CHEM, V17, P689, DOI 10.1021/bc060002u; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Chairoungdua A, 2010, J CELL BIOL, V190, P1079, DOI 10.1083/jcb.201002049; Cox EA, 2003, MOL BIOL CELL, V14, P658, DOI 10.1091/mbc.E02-03-0142; Cui JM, 2001, BIOCHEMISTRY-US, V40, P6190, DOI 10.1021/bi015134j; Cui JM, 2000, BIOCHEMISTRY-US, V39, P15612, DOI 10.1021/bi001509+; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; Frucht CS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011502; Grimm PR, 2007, CURR OPIN NEPHROL HY, V16, P430, DOI 10.1097/MNH.0b013e32826fbc7d; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Jin TR, 2008, CELL SIGNAL, V20, P1697, DOI 10.1016/j.cellsig.2008.04.014; Jo S, 2005, J NEUROCHEM, V94, P1212, DOI 10.1111/j.1471-4159.2005.03344.x; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; LAL M, 2008, HUMAN MOL GENETICS, V17; Latorre R, 2006, BIOL RES, V39, P385, DOI 10.4067/S0716-97602006000300003; Ledoux J, 2006, PHYSIOLOGY, V21, P69, DOI 10.1152/physiol.00040.2005; Lesage F, 2004, P NATL ACAD SCI USA, V101, P671, DOI 10.1073/pnas.0307681100; Lim HH, 2005, MOL BIOL CELL, V16, P1013, DOI 10.1091/mbc.E04-06-0537; Ling SZ, 2003, J PHYSIOL-LONDON, V553, P65, DOI 10.1113/jphysiol.2003.051631; Lu R, 2006, J PHYSIOL-LONDON, V570, P65, DOI 10.1113/jphysiol.2005.098913; Maeda O, 2004, ONCOGENE, V23, P964, DOI 10.1038/sj.onc.1207254; Maximov A, 1999, J BIOL CHEM, V274, P24453, DOI 10.1074/jbc.274.35.24453; Navaratnam D, 2005, BIOPHYS J, V89, P3345, DOI 10.1529/biophysj.105.068759; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Perego C, 2000, EMBO J, V19, P3978, DOI 10.1093/emboj/19.15.3978; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Samaranayake H, 2004, J PHYSIOL-LONDON, V560, P13, DOI 10.1113/jphysiol.2004.069856; Shigemitsu K, 2001, ONCOGENE, V20, P4249, DOI 10.1038/sj.onc.1204557; Sun XX, 2004, J BIOL CHEM, V279, P10206, DOI 10.1074/jbc.M310728200; Tian LJ, 2006, FASEB J, V20, P2588, DOI 10.1096/fj.06-6152fje; Torres YP, 2007, J BIOL CHEM, V282, P24485, DOI 10.1074/jbc.R700022200; Usami N, 2003, ONCOGENE, V22, P7922, DOI 10.1038/sj.onc.1206533; Wallner M, 1995, RECEPTOR CHANNEL, V3, P185; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; YAN J, 2008, MOL CELL PROTEOMICS; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414	42	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28264	10.1371/journal.pone.0028264	http://dx.doi.org/10.1371/journal.pone.0028264			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194818	Green Published, Green Submitted, gold			2022-12-25	WOS:000298369100026
J	Jambunathan, S; Yin, J; Khan, W; Tamori, Y; Puri, V				Jambunathan, Srikarthika; Yin, Jun; Khan, Waheed; Tamori, Yoshikazu; Puri, Vishwajeet			FSP27 Promotes Lipid Droplet Clustering and Then Fusion to Regulate Triglyceride Accumulation	PLOS ONE			English	Article							FAT-SPECIFIC PROTEIN-27; ACTIVATED-RECEPTOR-GAMMA; INSULIN SENSITIVITY; PPAR-GAMMA; CELL-DEATH; DEFICIENT MICE; STORAGE; ADIPOCYTE; PERILIPIN; LIPOLYSIS	Fat Specific Protein 27 (FSP27), a lipid droplet (LD) associated protein in adipocytes, regulates triglyceride (TG) storage. In the present study we demonstrate that FSP27 plays a key role in LD morphology to accumulate TGs. We show here that FSP27 promotes clustering of the LDs which is followed by their fusion into fewer and enlarged droplets. To map the domains of FSP27 responsible for these events, we generated GFP-fusion constructs of deletion mutants of FSP27. Microscopic analysis revealed that amino acids 173-220 of FSP27 are necessary and sufficient for both the targeting of FSP27 to LDs and the initial clustering of the droplets. Amino acids 120-140 are essential but not sufficient for LD enlargement, whereas amino acids 120-210 are necessary and sufficient for both clustering and fusion of LDs to form enlarged droplets. In addition, we found that FSP27-mediated enlargement of LDs, but not their clustering, is associated with triglyceride accumulation. These results suggest a model in which FSP27 facilitates LD clustering and then promotes their fusion to form enlarged droplets in two discrete, sequential steps, and a subsequent triglyceride accumulation.	[Jambunathan, Srikarthika; Yin, Jun; Khan, Waheed; Puri, Vishwajeet] Boston Univ, Sch Med, Dept Med, Sect Endocrinol Diabet & Nutr, Boston, MA 02118 USA; [Tamori, Yoshikazu] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Diabet Metab & Endocrinol, Kobe, Hyogo 657, Japan	Boston University; Kobe University	Jambunathan, S (corresponding author), Boston Univ, Sch Med, Dept Med, Sect Endocrinol Diabet & Nutr, Boston, MA 02118 USA.	vpuri@bu.edu		Puri, Vishwajeet/0000-0002-0757-6067	National Institutes of Health-National Institute of Diabetes and Digestive and Kidney Diseases [P30DK046200]; Evans Medical Foundation, Boston University School of Medicine, Boston; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK046200] Funding Source: NIH RePORTER	National Institutes of Health-National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Evans Medical Foundation, Boston University School of Medicine, Boston; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding provided by National Institutes of Health-National Institute of Diabetes and Digestive and Kidney Diseases grant P30DK046200 and a pilot grant from the Evans Medical Foundation, Boston University School of Medicine, Boston. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bays H, 2004, J CLIN ENDOCR METAB, V89, P463, DOI 10.1210/jc.2003-030723; Beckman M, 2006, SCIENCE, V311, P1232, DOI 10.1126/science.311.5765.1232; Berger J, 1996, ENDOCRINOLOGY, V137, P4189, DOI 10.1210/en.137.10.4189; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Bostrom P, 2009, BIOCHEM SOC T, V37, P981, DOI 10.1042/BST0370981; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Castillo G, 1999, EMBO J, V18, P3676, DOI 10.1093/emboj/18.13.3676; Christianson JL, 2010, J LIPID RES, V51, P3455, DOI 10.1194/jlr.M009498; DiDonato D, 2003, J HISTOCHEM CYTOCHEM, V51, P773, DOI 10.1177/002215540305100608; Ducharme NA, 2008, ENDOCRINOLOGY, V149, P942, DOI 10.1210/en.2007-1713; Fang X, 2007, PROSTAG OTH LIPID M, V82, P175, DOI 10.1016/j.prostaglandins.2006.05.002; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Fujimoto T., 2011, COLD SPRING HARB PER, V3; Granneman JG, 2011, J BIOL CHEM, V286, P5126, DOI 10.1074/jbc.M110.180711; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hasegawa T, 2007, HISTOCHEM CELL BIOL, V127, P233, DOI 10.1007/s00418-006-0264-4; Inohara N, 1998, EMBO J, V17, P2526, DOI 10.1093/emboj/17.9.2526; Kashyap S, 2003, DIABETES, V52, P2461, DOI 10.2337/diabetes.52.10.2461; Keller P, 2008, J BIOL CHEM, V283, P14355, DOI 10.1074/jbc.M708323200; Kim JY, 2008, AM J PHYSIOL-ENDOC M, V294, pE654, DOI 10.1152/ajpendo.00104.2007; Kimmel AR, 2010, J LIPID RES, V51, P468, DOI 10.1194/jlr.R000034; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Li FF, 2010, FEBS J, V277, P4173, DOI 10.1111/j.1742-4658.2010.07806.x; Liu K, 2009, AM J PHYSIOL-ENDOC M, V297, pE1395, DOI 10.1152/ajpendo.00188.2009; Lu XH, 2010, AM J PHYSIOL-LUNG C, V299, pL559, DOI 10.1152/ajplung.00090.2010; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Martinez-Arca S, 2000, J CELL SCI, V113, P1705; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; Murphy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015030; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; PAOLISSO G, 1995, DIABETOLOGIA, V38, P1295; Puri V, 2008, J CLIN INVEST, V118, P2693, DOI 10.1172/JCI36554; Puri V, 2008, P NATL ACAD SCI USA, V105, P7833, DOI 10.1073/pnas.0802063105; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Ranjit S, 2011, J LIPID RES, V52, P221, DOI 10.1194/jlr.M008771; Rubio-Cabezas O, 2009, EMBO MOL MED, V1, P280, DOI 10.1002/emmm.200900037; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wang YX, 2003, OBES RES, V11, P930, DOI 10.1038/oby.2003.128; Wolins NE, 2006, DIABETES, V55, P3418, DOI 10.2337/db06-0399; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040; Yamazaki T, 2002, J CELL SCI, V115, P1791; Zhang DE, 1996, MOL CELL BIOL, V16, P1231	48	99	106	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28614	10.1371/journal.pone.0028614	http://dx.doi.org/10.1371/journal.pone.0028614			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194867	Green Submitted, Green Published, gold			2022-12-25	WOS:000298369100064
J	Rodriguez-Martinez, RE; Jordan-Garza, AG; Maldonado, MA; Blanchon, P				Rodriguez-Martinez, Rosa E.; Jordan-Garza, Adan G.; Maldonado, Miguel A.; Blanchon, Paul			Controls on Coral-Ground Development along the Northern Mesoamerican Reef Tract	PLOS ONE			English	Article							GREAT-BARRIER-REEF; SEA-LEVEL RISE; CARIBBEAN REEF; COMMUNITY STRUCTURE; PUERTO-MORELOS; GRAND-CAYMAN; ST-CROIX; SEDIMENTATION; SCLERACTINIA; MORTALITY	Coral-grounds are reef communities that colonize rocky substratum but do not form framework or three-dimensional reef structures. To investigate why, we used video transects and underwater photography to determine the composition, structure and status of a coral-ground community located on the edge of a rocky terrace in front of a tourist park, Xcaret, in the northern Mesoamerican Reef tract, Mexico. The community has a relatively low coral, gorgonian and sponge cover (<10%) and high algal cover (>40%). We recorded 23 species of Scleractinia, 14 species of Gorgonacea and 30 species of Porifera. The coral community is diverse but lacks large coral colonies, being dominated instead by small, sediment-tolerant, and brooding species. In these small colonies, the abundance of potentially lethal interactions and partial mortality is high but decreases when colonies are larger than 40 cm. Such characteristics are consistent with an environment control whereby storm waves periodically remove larger colonies and elevate sediment flux. The community only survives these storm conditions due to its slope-break location, which ensures lack of burial and continued local recruitment. A comparison with similar coral-ground communities in adjacent areas suggests that the narrow width of the rock terrace hinders sediment stabilization, thereby ensuring that communities cannot escape bottom effects and develop into three-dimensional reef structures on geological time scales.	[Rodriguez-Martinez, Rosa E.; Jordan-Garza, Adan G.; Blanchon, Paul] Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Unidad Sistemas Arrecifales, Cancun, Quintana Roo, Mexico; [Maldonado, Miguel A.] Ctr Ecol Akumal AC Akumal, Quintana Roo, Mexico	Universidad Nacional Autonoma de Mexico	Rodriguez-Martinez, RE (corresponding author), Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Unidad Sistemas Arrecifales, Cancun, Quintana Roo, Mexico.	blanchons@gmail.com	Rodríguez-Martínez, Rosa Elisa/AAV-5363-2021; Blanchon, Paul/B-7720-2009	Rodríguez-Martínez, Rosa Elisa/0000-0002-1383-1108; Blanchon, Paul/0000-0002-7792-5808				[Anonymous], 1961, SHALLOW WATER OCTOCO; BAK RPM, 1979, MAR BIOL, V54, P341, DOI 10.1007/BF00395440; Benzoni F, 2003, CORAL REEFS, V22, P475, DOI 10.1007/s00338-003-0342-1; BLANCHON P, 1995, J COASTAL RES, V11, P1; Blanchon P, 1997, J SEDIMENT RES, V67, P1; BLANCHON P, 2011, SPRINGER VERLAG EART, P469, DOI DOI 10.1007/978-90-481-2639-2; Blanchon P, 2010, CORAL REEFS, V29, P481, DOI 10.1007/s00338-010-0599-0; Blanchon P, 2009, NATURE, V458, P881, DOI 10.1038/nature07933; Box SJ, 2007, MAR ECOL PROG SER, V342, P139, DOI 10.3354/meps342139; Buddemeier RW, 1999, AM ZOOL, V39, P1; CORTES J, 1984, REV BIOL TROP, V32, P109; GARCIASALGADO MA, 2008, P 11 INT COR REEF S, P888; Geister J, 1977, P 3 INT COR REEF S, V1, P23; GLYNN P W, 1988, Galaxea, V7, P129; Grigg RW, 1998, CORAL REEFS, V17, P263, DOI 10.1007/s003380050127; Harriott VJ, 2002, CORAL REEFS, V21, P83, DOI 10.1007/s00338-001-0201-x; HUBBARD DK, 1986, CORAL REEFS, V5, P117, DOI 10.1007/BF00298179; HUBBARD DK, 1985, P 5 INT COR REEF C, P433; HUGHES TP, 1989, ECOLOGY, V70, P275, DOI 10.2307/1938434; HUMANN P, 1992, REEF CREATURES IDENT, P328; HUTCHINGS PA, 1986, CORAL REEFS, V4, P239, DOI 10.1007/BF00298083; Jordan Dahlgren Eric, 1990, Anales del Instituto de Ciencias del Mar y Limnologia Universidad Nacional Autonoma de Mexico, V16, P105; Jordan-Dahlgren E, 2003, LATIN AMERICAN CORAL REEFS, P131, DOI 10.1016/B978-044451388-5/50007-2; JORDAN-DAHLGREN E., 1979, AN CTR CIENC MAR LIM, V6, P69; JORDANDAHLGREN E, 1998, ECOLOGIA AMBIENTE MA; Kleypas JA, 1999, AM ZOOL, V39, P146; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; LOYA Y, 1976, B MAR SCI, V26, P450; MASSEL SR, 1993, CORAL REEFS, V12, P153, DOI 10.1007/BF00334475; Meesters EH, 1996, B MAR SCI, V58, P838; Perry CT, 2003, CORAL REEFS, V22, P427, DOI 10.1007/s00338-003-0330-5; PORTER JW, 1972, ECOLOGY, V53, P745, DOI 10.2307/1934796; Quan-Young LI, 2006, LIMNOL OCEANOGR, V51, P1159, DOI 10.4319/lo.2006.51.2.1159; Riegl B, 1999, CORAL REEFS, V18, P241, DOI 10.1007/s003380050188; Rodriguez S, 2009, HYDROBIOLOGIA, V624, P1, DOI 10.1007/s10750-008-9662-z; Rodriguez-Martinez RE, 2010, REV BIOL TROP, V58, P23; ROGERS CS, 1990, MAR ECOL PROG SER, V62, P185, DOI 10.3354/meps062185; ROGERS CS, 1984, CORAL REEFS, V3, P69, DOI 10.1007/BF00263756; Roy RE, 2004, REV BIOL TROP, V52, P869; SAMMARCO PW, 1980, J EXP MAR BIOL ECOL, V45, P245, DOI 10.1016/0022-0981(80)90061-1; SCOFFIN JP, 1980, B MAR SCI, V30, P475; *SEMARNAT, 1998, PROGR MAN PARQ MAR N; Silva-Casarin R, 2009, ING HIDRAUL MEX, V24, P93; SMITH SR, 1992, AM ZOOL, V32, P663; SZMANT AM, 1986, CORAL REEFS, V5, P43, DOI 10.1007/BF00302170; UYCHIAOCO AJ, 1992, 3 ASEAN SCI TECHNOLO, V6, P35; VANMOORSEL GWNM, 1988, MAR ECOL PROG SER, V50, P127, DOI 10.3354/meps050127; vanWoesik R, 1997, CORAL REEFS, V16, P103, DOI 10.1007/s003380050064; QUEENSLAND MUSEUM WE	49	7	7	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28461	10.1371/journal.pone.0028461	http://dx.doi.org/10.1371/journal.pone.0028461			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194839	Green Published, gold, Green Submitted			2022-12-25	WOS:000298369100042
J	Du, WG; Ye, H; Zhao, B; Pizzatto, L; Ji, X; Shine, R				Du, Wei-Guo; Ye, Hua; Zhao, Bo; Pizzatto, Ligia; Ji, Xiang; Shine, Richard			Patterns of Interspecific Variation in the Heart Rates of Embryonic Reptiles	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; OXYGEN-CONSUMPTION; SQUAMATE REPTILES; MITOCHONDRIAL; LIZARDS; DNA; NUCLEAR; SIZE; METABOLISM; LACERTIDAE	New non-invasive technologies allow direct measurement of heart rates (and thus, developmental rates) of embryos. We applied these methods to a diverse array of oviparous reptiles (24 species of lizards, 18 snakes, 11 turtles, 1 crocodilian), to identify general influences on cardiac rates during embryogenesis. Heart rates increased with ambient temperature in all lineages, but (at the same temperature) were faster in lizards and turtles than in snakes and crocodilians. We analysed these data within a phylogenetic framework. Embryonic heart rates were faster in species with smaller adult sizes, smaller egg sizes, and shorter incubation periods. Phylogenetic changes in heart rates were negatively correlated with concurrent changes in adult body mass and residual incubation period among the lizards, snakes (especially within pythons) and crocodilians. The total number of embryonic heart beats between oviposition and hatching was lower in squamates than in turtles or the crocodilian. Within squamates, embryonic iguanians and gekkonids required more heartbeats to complete development than did embryos of the other squamate families that we tested. These differences plausibly reflect phylogenetic divergence in the proportion of embryogenesis completed before versus after laying.	[Du, Wei-Guo] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Du, Wei-Guo; Pizzatto, Ligia; Shine, Richard] Univ Sydney, Sch Biol Sci A08, Sydney, NSW 2006, Australia; [Du, Wei-Guo; Ye, Hua; Zhao, Bo] Hangzhou Normal Univ, Coll Biol & Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Ji, Xiang] Nanjing Normal Univ, Coll Life Sci, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; University of Sydney; Hangzhou Normal University; Nanjing Normal University	Du, WG (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China.	duweiguo@ioz.ac.cn	Du, Wei-Guo/K-1071-2014		Chinese Academy of Sciences; Program for New Century Excellent Talents in University; University of Sydney; Australian Research Council; Natural Science Foundation of China	Chinese Academy of Sciences(Chinese Academy of Sciences); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); University of Sydney(University of Sydney); Australian Research Council(Australian Research Council); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the "One Hundred Talents Programme" of the Chinese Academy of Sciences, Program for New Century Excellent Talents in University, the University of Sydney (to W.-G. Du), the Australian Research Council (to R. Shine and L. Pizzatto), and the Natural Science Foundation of China (to X. Ji). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews R.M., 2004, P75; ANDREWS RM, 1985, PHYSIOL ZOOL, V58, P214, DOI 10.1086/physzool.58.2.30158569; Ar A, 1999, COMP BIOCHEM PHYS A, V124, P491, DOI 10.1016/S1095-6433(99)00142-7; Austin JJ, 2006, MOL PHYLOGENET EVOL, V39, P503, DOI 10.1016/j.ympev.2005.12.011; Birchard GF, 1996, J COMP PHYSIOL B, V166, P461, DOI 10.1007/s003600050033; Booth D.T., 1991, P325, DOI 10.1017/CBO9780511585739.021; Brandley MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011375; Brandley MC, 2005, SYST BIOL, V54, P373, DOI 10.1080/10635150590946808; BURGGREN WW, 1997, DEV CARDIOVASCULAR S; CALDER WA, 1968, CONDOR, V70, P358, DOI 10.2307/1365930; Colbert PL, 2010, FUNCT ECOL, V24, P112, DOI 10.1111/j.1365-2435.2009.01602.x; CONGDON JD, 1987, P NATL ACAD SCI USA, V84, P4145, DOI 10.1073/pnas.84.12.4145; COWLEY AW, 1971, AM J CARDIOL, V28, P321, DOI 10.1016/0002-9149(71)90121-4; Crossley DA, 2005, J EXP BIOL, V208, P31, DOI 10.1242/jeb.01355; Du WG, 2008, COMP BIOCHEM PHYS A, V151, P102, DOI 10.1016/j.cbpa.2008.06.005; Du WG, 2011, P NATL ACAD SCI USA, V108, P9513, DOI 10.1073/pnas.1102965108; Du WG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015308; Du WG, 2010, AM NAT, V176, P522, DOI 10.1086/656270; Du WG, 2010, COMP BIOCHEM PHYS A, V156, P491, DOI 10.1016/j.cbpa.2010.04.005; Du WG, 2009, J EXP BIOL, V212, P1302, DOI 10.1242/jeb.027425; Engstrom TN, 2004, SYST BIOL, V53, P693, DOI 10.1080/10635150490503053; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Feng J, 2007, ZOOL SCI, V24, P656, DOI 10.2108/zsj.24.656; Frost Darrel R., 2001, American Museum Novitates, V3343, P1, DOI 10.1206/0003-0082(2001)343<0001:TESAEO>2.0.CO;2; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; GRUBB BR, 1983, AM J PHYSIOL, V245, pH567, DOI 10.1152/ajpheart.1983.245.4.H567; Han D, 2004, BIOL J LINN SOC, V83, P353, DOI 10.1111/j.1095-8312.2004.00393.x; Honda M, 2002, J ZOOL SYST EVOL RES, V40, P195, DOI 10.1046/j.1439-0469.2002.00176.x; Honda M, 2000, ZOOL SCI, V17, P527; Hugall AF, 2008, BIOL J LINN SOC, V93, P343, DOI 10.1111/j.1095-8312.2007.00911.x; Iwabe N, 2005, MOL BIOL EVOL, V22, P810, DOI 10.1093/molbev/msi075; Kelly CMR, 2009, CLADISTICS, V25, P38, DOI 10.1111/j.1096-0031.2008.00237.x; Kluge Arnold G., 1993, Records of the Australian Museum Supplement, V19, P1; Krenz JG, 2005, MOL PHYLOGENET EVOL, V37, P178, DOI 10.1016/j.ympev.2005.04.027; Lee MSY, 2005, ORG DIVERS EVOL, V5, P25, DOI 10.1016/j.ode.2004.05.003; Maddison WP, 2010, MESQUITE MODULAR SYS; McMahon BR, 1999, COMP BIOCHEM PHYS A, V124, P539, DOI 10.1016/S1095-6433(99)00147-6; Midford PE, 2010, PDAP PACKAGE MESQUIT; Moussalli A, 2005, MOL PHYLOGENET EVOL, V34, P190, DOI 10.1016/j.ympev.2004.08.022; Nechaeva MV, 2007, COMP BIOCHEM PHYS A, V148, P599, DOI 10.1016/j.cbpa.2007.08.005; PAGEL MD, 1992, J THEOR BIOL, V156, P431, DOI 10.1016/S0022-5193(05)80637-X; PARADIS E, 2009, PACKAGE APE R VERSIO; Pavlicev M, 2009, MOL PHYLOGENET EVOL, V52, P727, DOI 10.1016/j.ympev.2009.04.020; Pearson JT, 2000, J COMP PHYSIOL B, V170, P429, DOI 10.1007/s003600000120; Radder R, 2006, BIOL LETTERS, V2, P415, DOI 10.1098/rsbl.2006.0495; Rawlings LH, 2008, BIOL J LINN SOC, V93, P603, DOI 10.1111/j.1095-8312.2007.00904.x; Reinhold K, 1999, FUNCT ECOL, V13, P217, DOI 10.1046/j.1365-2435.1999.00300.x; Rui JL, 2009, AMPHIBIA-REPTILIA, V30, P25, DOI 10.1163/156853809787392793; Scanlon JD, 2004, ZOOL SCR, V33, P335, DOI 10.1111/j.0300-3256.2004.00151.x; Shaffer HB, 1997, SYST BIOL, V46, P235, DOI 10.1093/sysbio/46.2.235; SHINE R, 1990, HERPETOLOGICA, V46, P283; Shine R, 2003, J EVOLUTION BIOL, V16, P823, DOI 10.1046/j.1420-9101.2003.00600.x; SHINE R, 1983, HERPETOLOGICA, V39, P1; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Speakman JR, 2005, J EXP BIOL, V208, P1717, DOI 10.1242/jeb.01556; STAHL WR, 1967, J APPL PHYSIOL, V22, P453, DOI 10.1152/jappl.1967.22.3.453; Stamps JA, 1998, ANIM BEHAV, V55, P461, DOI 10.1006/anbe.1997.0612; Stephens PR, 2003, BIOL J LINN SOC, V79, P577, DOI 10.1046/j.1095-8312.2003.00211.x; SWAN M, 2007, KEEPING BREEDING AUS; Tazawa H, 2001, J EXP BIOL, V204, P165; THOMPSON MB, 1989, RESP PHYSIOL, V76, P243, DOI 10.1016/0034-5687(89)90101-1; Utiger Urs, 2002, Russian Journal of Herpetology, V9, P105; Vidal N, 2005, CR BIOL, V328, P1000, DOI 10.1016/j.crvi.2005.10.001; Vidal Nicolas, 2009, P390; Vladimirova IG, 2005, BIOL BULL+, V32, P484, DOI 10.1007/s10525-005-0129-8; Wan LX, 2007, AMPHIBIA-REPTILIA, V28, P33; Warner DA, 2007, OECOLOGIA, V154, P65, DOI 10.1007/s00442-007-0809-9; Zardoya R, 2001, NATURWISSENSCHAFTEN, V88, P193, DOI 10.1007/s001140100228; Zbinden JA, 2006, J EXP MAR BIOL ECOL, V334, P151, DOI 10.1016/j.jembe.2006.01.021; ZHANG MW, 1998, FAUNA SINICA REPTILI, V1	72	23	26	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e29027	10.1371/journal.pone.0029027	http://dx.doi.org/10.1371/journal.pone.0029027			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174948	Green Submitted, Green Published			2022-12-25	WOS:000298367300041
J	Lussier, YA; Xing, HR; Salama, JK; Khodarev, NN; Huang, Y; Zhang, QB; Khan, SA; Yang, XN; Hasselle, MD; Darga, TE; Malik, R; Fan, HL; Perakis, S; Filippo, M; Corbin, K; Lee, Y; Posner, MC; Chmura, SJ; Hellman, S; Weichselbaum, RR				Lussier, Yves A.; Xing, H. Rosie; Salama, Joseph K.; Khodarev, Nikolai N.; Huang, Yong; Zhang, Qingbei; Khan, Sajid A.; Yang, Xinan; Hasselle, Michael D.; Darga, Thomas E.; Malik, Renuka; Fan, Hanli; Perakis, Samantha; Filippo, Matthew; Corbin, Kimberly; Lee, Younghee; Posner, Mitchell C.; Chmura, Steven J.; Hellman, Samuel; Weichselbaum, Ralph R.			MicroRNA Expression Characterizes Oligometastasis(es)	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; STEREOTACTIC BODY RADIATION; METASTATIC BREAST-CANCER; MIR-200 FAMILY; COLORECTAL METASTASES; PANCREATIC-CANCER; LIVER METASTASES; TUMOR-METASTASIS; PROSTATE-CANCER; THERAPY	Background: Cancer staging and treatment presumes a division into localized or metastatic disease. We proposed an intermediate state defined by <= 5 cumulative metastasis(es), termed oligometastases. In contrast to widespread polymetastases, oligometastatic patients may benefit from metastasis-directed local treatments. However, many patients who initially present with oligometastases progress to polymetastases. Predictors of progression could improve patient selection for metastasis-directed therapy. Methods: Here, we identified patterns of microRNA expression of tumor samples from oligometastatic patients treated with high-dose radiotherapy. Results: Patients who failed to develop polymetastases are characterized by unique prioritized features of a microRNA classifier that includes the microRNA-200 family. We created an oligometastatic-polymetastatic xenograft model in which the patient-derived microRNAs discriminated between the two metastatic outcomes. MicroRNA-200c enhancement in an oligometastatic cell line resulted in polymetastatic progression. Conclusions: These results demonstrate a biological basis for oligometastases and a potential for using microRNA expression to identify patients most likely to remain oligometastatic after metastasis-directed treatment.	[Lussier, Yves A.; Xing, H. Rosie; Khodarev, Nikolai N.; Huang, Yong; Weichselbaum, Ralph R.] Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA; [Lussier, Yves A.; Xing, H. Rosie; Hellman, Samuel; Weichselbaum, Ralph R.] Univ Chicago, Ludwig Ctr Metastasis Res, Chicago, IL 60637 USA; [Lussier, Yves A.; Huang, Yong; Zhang, Qingbei; Yang, Xinan; Lee, Younghee] Univ Chicago, Dept Med, Ctr Biomed Informat, Chicago, IL 60637 USA; [Lussier, Yves A.] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Xing, H. Rosie; Khodarev, Nikolai N.; Hasselle, Michael D.; Darga, Thomas E.; Malik, Renuka; Perakis, Samantha; Filippo, Matthew; Corbin, Kimberly; Chmura, Steven J.; Hellman, Samuel; Weichselbaum, Ralph R.] Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA; [Xing, H. Rosie; Zhang, Qingbei; Fan, Hanli] Univ Chicago, Dept Pathol, Comm Canc Biol, Chicago, IL 60637 USA; [Khan, Sajid A.; Posner, Mitchell C.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Salama, Joseph K.] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC USA	Robert H. Lurie Comprehensive Cancer Center; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; Duke University	Lussier, YA (corresponding author), Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA.	ylussier@uic.edu; rrw@radonc.uchicago.edu	khan, sajid/HGE-2406-2022; Lussier, Yves/N-4891-2017; Xie, Huangming/B-2260-2012; Chmura, Steven Joseph/ACU-8438-2022; Di Filippo, Mathilde/C-2234-2016	Lussier, Yves/0000-0001-9854-1005; Di Filippo, Mathilde/0000-0001-6206-5908; Darga, Thomas/0000-0002-8968-6701; Hasenleithner, Samantha O./0000-0002-9401-5224	Ludwig Center for Metastasis Research; Center for Radiation Therapy; Chicago Tumor Institute; Dr. Lloyd Old, Mr. and Mrs. Vincent Foglia and the Foglia foundation; Lung Cancer Research Foundation; Cancer Research Foundation; NIH [K22 LM008308-04, 5UL1RR024999-04]; University of Chicago Comprehensive Cancer Center [5P30CA014599-35]; National Center for the Multi Scale Analysis of Genomic and Cellular Networks (MAGNeT) [5U54CA121852-5]; NATIONAL CANCER INSTITUTE [P30CA014599, U54CA121852] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [K22LM008308] Funding Source: NIH RePORTER	Ludwig Center for Metastasis Research; Center for Radiation Therapy; Chicago Tumor Institute; Dr. Lloyd Old, Mr. and Mrs. Vincent Foglia and the Foglia foundation; Lung Cancer Research Foundation; Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago Comprehensive Cancer Center; National Center for the Multi Scale Analysis of Genomic and Cellular Networks (MAGNeT); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the Ludwig Center for Metastasis Research Grant, the Center for Radiation Therapy, the Chicago Tumor Institute, Dr. Lloyd Old, Mr. and Mrs. Vincent Foglia and the Foglia foundation, Lung Cancer Research Foundation, the Cancer Research Foundation and the following NIH Grants: K22 LM008308-04, 5UL1RR024999-04, University of Chicago Comprehensive Cancer Center (5P30CA014599-35), National Center for the Multi Scale Analysis of Genomic and Cellular Networks (MAGNeT; 5U54CA121852-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama H, 2006, JAMA-J AM MED ASSOC, V295, P2483, DOI 10.1001/jama.295.21.2483; Bandyopadhyay A, 2006, CANCER RES, V66, P6714, DOI 10.1158/0008-5472.CAN-05-3565; Bendoraite A, 2010, GYNECOL ONCOL, V116, P117, DOI 10.1016/j.ygyno.2009.08.009; Bonnomet A, 2010, J MAMMARY GLAND BIOL, V15, P261, DOI 10.1007/s10911-010-9174-0; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Buck MB, 2004, CLIN CANCER RES, V10, P491, DOI 10.1158/1078-0432.CCR-0320-03; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Dvinge H, 2009, BIOINFORMATICS, V25, P3325, DOI 10.1093/bioinformatics/btp578; Dykxhoorn DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007181; Elson-Schwab I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013176; Fong YM, 1997, J CLIN ONCOL, V15, P938, DOI 10.1200/JCO.1997.15.3.938; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Giavazzi R, 2001, Methods Mol Med, V58, P223, DOI 10.1385/1-59259-137-X:223; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gregory PA, 2011, MOL BIOL CELL, V22, P1686, DOI 10.1091/mbc.E11-02-0103; HAND DJT, 2001, MACHINE LEARNING, V45; HELLMAN S, 1995, J CLIN ONCOL, V13, P8, DOI 10.1200/JCO.1995.13.1.8; Hoyer M, 2006, ACTA ONCOL, V45, P823, DOI 10.1080/02841860600904854; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Klein CA, 2002, LANCET, V360, P683, DOI 10.1016/S0140-6736(02)09838-0; KORPAL M, 2011, NAT MED; Korpal M, 2008, RNA BIOL, V5, P115, DOI 10.4161/rna.5.3.6558; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Lee Y, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000730; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li XM, 2002, CLIN EXP METASTAS, V19, P347, DOI 10.1023/A:1015510207431; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Metha N, 2004, INT J ONCOL, V25, P1677; Milano MT, 2008, CANCER-AM CANCER SOC, V112, P650, DOI 10.1002/cncr.23209; Milano MT, 2008, RADIAT ONCOL, V3, DOI 10.1186/1748-717X-3-36; Nohata N, 2011, ONCOTARGET, V2, P29; Noonan EJ, 2010, ONCOTARGET, V1, P349, DOI 10.18632/oncotarget.167; Ory B, 2011, ONCOTARGET, V2, P259; Parmigiani G, 2003, ANAL GENE EXPRESSION, P120; Roth C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2766; Rusthoven KE, 2009, J CLIN ONCOL, V27, P1579, DOI 10.1200/JCO.2008.19.6386; Salama JK, 2008, CLIN CANCER RES, V14, P5255, DOI 10.1158/1078-0432.CCR-08-0358; Schefter TE, 2005, INT J RADIAT ONCOL, V62, P1371, DOI 10.1016/j.ijrobp.2005.01.002; Schmidt-Kittler O, 2010, ONCOTARGET, V1, P339; Siegel PM, 2003, P NATL ACAD SCI USA, V100, P8430, DOI 10.1073/pnas.0932636100; Smits M, 2010, ONCOTARGET, V1, P710, DOI 10.18632/oncotarget.205; SOOND SM, 2011, ONCOGENE; STAREN ED, 1992, ARCH SURG-CHICAGO, V127, P1282; Tanvetyanon T, 2008, J CLIN ONCOL, V26, P1142, DOI 10.1200/JCO.2007.14.2091; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Thioulouse J, 1997, STAT COMPUT, V7, P75, DOI 10.1023/A:1018513530268; Tomlinson JS, 2007, J CLIN ONCOL, V25, P4575, DOI 10.1200/JCO.2007.11.0833; Torres L, 2007, BREAST CANCER RES TR, V102, P143, DOI 10.1007/s10549-006-9317-6; Tryndyak VP, 2010, INT J CANCER, V126, P2575, DOI 10.1002/ijc.24972; Valastyan S, 2010, CELL CYCLE, V9, P2124, DOI 10.4161/cc.9.11.11843; Valastyan S, 2009, CELL CYCLE, V8, P3506, DOI 10.4161/cc.8.21.9802; Vrba L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008697; Weichselbaum R. R., 2011, NAT REV CLIN ONCOL; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Zhang QB, 2011, MOL CANCER THER, V10, P1173, DOI 10.1158/1535-7163.MCT-11-0008; Zheng Y, 1996, J BIOL CHEM, V271, P33169, DOI 10.1074/jbc.271.52.33169	56	202	214	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28650	10.1371/journal.pone.0028650	http://dx.doi.org/10.1371/journal.pone.0028650			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174856	Green Submitted, Green Published, gold			2022-12-25	WOS:000298367300017
J	Xu, HB; Wu, Q; Dang, SP; Jin, M; Xu, JW; Cheng, YJ; Pan, ML; Wu, YG; Zhang, CH; Zhang, YY				Xu, Huanbai; Wu, Qiong; Dang, Shipeng; Jin, Min; Xu, Jingwei; Cheng, Yiji; Pan, Minglin; Wu, Yugang; Zhang, Chunhui; Zhang, Yanyun			Alteration of CXCR7 Expression Mediated by TLR4 Promotes Tumor Cell Proliferation and Migration in Human Colorectal Carcinoma	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; TOLL-LIKE RECEPTOR-4; GENE-EXPRESSION; CANCER; PROTEIN; BREAST; LIPOPOLYSACCHARIDE; INVOLVEMENT; METASTASIS; ACTIVATION	The link between inflammation and colorectal carcinoma has been acknowledged. However, the impact of bacterial lipopolysaccharide (LPS) binding to Toll-like receptor 4 (TLR4) on chemokine receptors in human colorectal carcinoma cells still remains to be elucidated. The present study shows that exposure to LPS elevated CXC chemokine receptor 7 (CXCR7) expression in colorectal carcinoma SW480 and Colo 205 cell lines expressing TLR4/myeloid differential protein (MD-2). CXCR7 is associated with SW480 cell proliferation and migration. However, exposure of SW480 and Colo 205 cells to LPS had no effect on CXCR4 expression. To further support the above results, the expression of TLR4, MD-2, and CXCR7 was analyzed in human colorectal carcinoma tissues. Higher rates of TLR4 (53%), MD-2 (70%), and CXCR7 (29%) expression were found in colorectal carcinoma tissues than in normal tissues. We demonstrated that the recombination of TLR4, MD-2 and CXCR7 strongly correlated with tumor size, lymph node metastasis and distant metastasis in colorectal carcinoma tissue samples (p = 0.037, p = 0.002, p = 0.042, resp.). Accordingly, simultaneous examination of the expression of TLR4, MD-2 and CXCR7 in cancer tissues of colorectal carcinoma may provide valuable prognostic diagnosis of carcinoma growth and metastasis. Interplay of TLR4, MD-2 and CXCR7 may be of interest in the context of novel immunomodulatory therapies for colorectal carcinoma.	[Xu, Huanbai; Wu, Qiong; Dang, Shipeng; Jin, Min; Xu, Jingwei; Cheng, Yiji; Wu, Yugang; Zhang, Chunhui; Zhang, Yanyun] SJTUSM, Inst Med Sci, Shanghai Inst Immunol, Shanghai, Peoples R China; [Xu, Huanbai; Wu, Qiong; Dang, Shipeng; Jin, Min; Xu, Jingwei; Cheng, Yiji; Wu, Yugang; Zhang, Chunhui; Zhang, Yanyun] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China; [Xu, Huanbai] Bengbu Med Coll, Affiliated Hosp 1, Dept Endocrinol, Bengbu, Peoples R China; [Pan, Minglin] Nanjing Med Univ, Affiliated Hosp 2, Dept Endocrinol, Nanjing, Peoples R China; [Wu, Yugang] Soochow Univ, Affiliated Hosp 3, Changzhou, Peoples R China; [Wu, Yugang] First Peoples Hosp Changzhou, Dept Surg, Changzhou, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Bengbu Medical College; Nanjing Medical University; Soochow University - China	Xu, HB (corresponding author), SJTUSM, Inst Med Sci, Shanghai Inst Immunol, Shanghai, Peoples R China.	yyzhang@sibs.ac.cn			Ministry of Science and Technology of China [2011CB966200, 2010CB945600]; National Natural Science Foundation of China [30873045, 81071748, 30901317]; Chinese Academy of Sciences [XDA01040000, KSCX1-YW-22]; Shanghai Municipal Education Commission [J50207]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	This work was supported by the Ministry of Science and Technology of China (2011CB966200, 2010CB945600), National Natural Science Foundation of China (30873045, 81071748 and 30901317), Strategic Priority Research Program of the Chinese Academy of Sciences (XDA01040000), Knowledge Innovation Project of the Chinese Academy of Sciences (KSCX1-YW-22), and Leading Academic Discipline Project of Shanghai Municipal Education Commission (J50207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2001, J IMMUNOL, V167, P1609, DOI 10.4049/jimmunol.167.3.1609; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Cario E, 2004, GASTROENTEROLOGY, V127, P224, DOI 10.1053/j.gastro.2004.04.015; Doan HQ, 2009, ANTICANCER RES, V29, P2473; Dong Cheng, 2005, Molecular & Cellular Biomechanics, V2, P145; Franchimont D, 2004, GUT, V53, P987, DOI 10.1136/gut.2003.030205; Fukata M, 2007, GASTROENTEROLOGY, V133, P1869, DOI 10.1053/j.gastro.2007.09.008; Gonzalez-Reyes S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-665; Gunter MJ, 2006, CANCER RES, V66, P2483, DOI 10.1158/0008-5472.CAN-05-3631; Hausmann M, 2002, GASTROENTEROLOGY, V122, P1987, DOI 10.1053/gast.2002.33662; Hoshino K, 1999, J IMMUNOL, V162, P3749; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kim TW, 2007, J EXP MED, V204, P1025, DOI 10.1084/jem.20061825; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; O'Hayre M, 2008, BIOCHEM J, V409, P635, DOI 10.1042/BJ20071493; Otte JM, 2004, GASTROENTEROLOGY, V126, P1054, DOI 10.1053/j.gastro.2004.01.007; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Rao VP, 2006, CANCER RES, V66, P7395, DOI 10.1158/0008-5472.CAN-06-0558; Santin I, 2007, TISSUE ANTIGENS, V70, P495, DOI 10.1111/j.1399-0039.2007.00945.x; Strus M, 2009, J PHYSIOL PHARMACOL, V60, P49; Tarnowski M, 2010, MOL CANCER RES, V8, P1, DOI 10.1158/1541-7786.MCR-09-0259; Thuringer D, 2011, J BIOL CHEM, V286, P3418, DOI 10.1074/jbc.M110.154823; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Zhao CH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-419	28	44	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e27399	10.1371/journal.pone.0027399	http://dx.doi.org/10.1371/journal.pone.0027399			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22180778	Green Published, Green Submitted, gold			2022-12-25	WOS:000298367300006
J	Daily, JL; Nash, K; Jinwal, U; Golde, T; Rogers, J; Peters, MM; Burdine, RD; Dickey, C; Banko, JL; Weeber, EJ				Daily, Jennifer L.; Nash, Kevin; Jinwal, Umesh; Golde, Todd; Rogers, Justin; Peters, Melinda M.; Burdine, Rebecca D.; Dickey, Chad; Banko, Jessica L.; Weeber, Edwin J.			Adeno-Associated Virus-Mediated Rescue of the Cognitive Defects in a Mouse Model for Angelman Syndrome	PLOS ONE			English	Article							FRAGILE-X-SYNDROME; CONTROLLED-TRIAL; RETT-SYNDROME; PRADER-WILLI; UBIQUITIN LIGASE; KINASE-II; EXPRESSION; MICE; CHROMOSOME-15; SUBSTRATE	Angelman syndrome (AS), a genetic disorder occurring in approximately one in every 15,000 births, is characterized by severe mental retardation, seizures, difficulty speaking and ataxia. The gene responsible for AS was discovered to be UBE3A and encodes for E6-AP, an ubiquitin ligase. A unique feature of this gene is that it undergoes maternal imprinting in a neuron-specific manner. In the majority of AS cases, there is a mutation or deletion in the maternally inherited UBE3A gene, although other cases are the result of uniparental disomy or mismethylation of the maternal gene. While most human disorders characterized by severe mental retardation involve abnormalities in brain structure, no gross anatomical changes are associated with AS. However, we have determined that abnormal calcium/calmodulin-dependent protein kinase II (CaMKII) regulation is seen in the maternal UBE3A deletion AS mouse model and is responsible for the major phenotypes. Specifically, there is an increased alpha CaMKII phosphorylation at the autophosphorylation sites Thr(286) and Thr(305/306), resulting in an overall decrease in CaMKII activity. CaMKII is not produced until after birth, indicating that the deficits associated with AS are not the result of developmental abnormalities. The present studies are focused on exploring the potential to rescue the learning and memory deficits in the adult AS mouse model through the use of an adeno-associated virus (AAV) vector to increase neuronal UBE3A expression. These studies show that increasing the levels of E6-AP in the brain using an exogenous vector can improve the cognitive deficits associated with AS. Specifically, the associative learning deficit was ameliorated in the treated AS mice compared to the control AS mice, indicating that therapeutic intervention may be possible in older AS patients.	[Daily, Jennifer L.; Nash, Kevin; Rogers, Justin; Peters, Melinda M.; Weeber, Edwin J.] Univ S Florida, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA; [Jinwal, Umesh] Univ S Florida, Dept Pharm, Tampa, FL USA; [Burdine, Rebecca D.] Princeton Univ, Dept Neurosci, Princeton, NJ 08544 USA; [Daily, Jennifer L.; Nash, Kevin; Jinwal, Umesh; Rogers, Justin; Peters, Melinda M.; Dickey, Chad; Banko, Jessica L.; Weeber, Edwin J.] Univ S Florida, Hlth Byrd Alzheimers Inst, Tampa, FL USA; [Golde, Todd] Univ Florida, McKnight Brain Inst, Gainesville, FL USA; [Golde, Todd] Univ Florida, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL USA; [Dickey, Chad; Banko, Jessica L.] Univ S Florida, Dept Mol Med, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Princeton University; State University System of Florida; University of South Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of South Florida	Daily, JL (corresponding author), Univ S Florida, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA.	eweeber@health.usf.edu	Weeber, Edwin J/A-5396-2012; Nash, Kevin R/B-4567-2009; Banko, Jessica L/I-9354-2012	Nash, Kevin R/0000-0002-8607-1832; Burdine, Rebecca/0000-0001-6620-5015	National Institutes of Health (NIH) [R21NS0727851-02, R21HD062749-01]; Jerome Lejeune Foundation; Angelman Syndrome Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD062749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG031291] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jerome Lejeune Foundation; Angelman Syndrome Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding was received from National Institutes of Health (NIH) Grant R21NS0727851-02, NIH Grant R21HD062749-01, The Jerome Lejeune Foundation, and the Angelman Syndrome Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer KU, 1999, MOL BRAIN RES, V70, P147, DOI 10.1016/S0169-328X(99)00131-X; Berry-Kravis E, 2009, J MED GENET, V46, P266, DOI 10.1136/jmg.2008.063701; Berry-Kravis E, 2006, J CHILD ADOL PSYCHOP, V16, P525, DOI 10.1089/cap.2006.16.525; BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; CLAYTONSMITH J, 1993, AM J MED GENET, V46, P12, DOI 10.1002/ajmg.1320460105; Curia G, 2009, CEREB CORTEX, V19, P1515, DOI 10.1093/cercor/bhn159; Davies W, 2005, NEUROSCI BIOBEHAV R, V29, P421, DOI 10.1016/j.neubiorev.2004.11.007; Dindot SV, 2008, HUM MOL GENET, V17, P111, DOI 10.1093/hmg/ddm288; Ellaway C, 1999, J CHILD NEUROL, V14, P162, DOI 10.1177/088307389901400306; Ellaway C, 1998, J CHILD NEUROL, V13, P448, DOI 10.1177/088307389801300907; Freilinger M, 2011, J DEV BEHAV PEDIATR, V32, P454, DOI 10.1097/DBP.0b013e31822177a8; Gabriel JM, 1999, P NATL ACAD SCI USA, V96, P9258, DOI 10.1073/pnas.96.16.9258; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; HAGEBEUK EEO, 2011, J CHILD NEU IN PRESS; Heck DH, 2008, HUM MOL GENET, V17, P2181, DOI 10.1093/hmg/ddn117; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; KAPLAN LC, 1987, AM J MED GENET, V28, P45, DOI 10.1002/ajmg.1320280107; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; Kumar S, 1999, J BIOL CHEM, V274, P18785, DOI 10.1074/jbc.274.26.18785; Mah C, 2003, HUM GENE THER, V14, P143, DOI 10.1089/104303403321070838; MALCOLM S, 1991, LANCET, V337, P694, DOI 10.1016/0140-6736(91)90278-W; NICHOLLS RD, 1994, AM J HUM GENET, V54, P733; Nuber U, 1998, EUR J BIOCHEM, V254, P643, DOI 10.1046/j.1432-1327.1998.2540643.x; van Woerden GM, 2007, NAT NEUROSCI, V10, P280, DOI 10.1038/nn1845; Weeber EJ, 2003, J NEUROSCI, V23, P2634; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200; Xue J, 2002, DEV BRAIN RES, V138, P61, DOI 10.1016/S0165-3806(02)00460-1; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	29	71	76	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e27221	10.1371/journal.pone.0027221	http://dx.doi.org/10.1371/journal.pone.0027221			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174738	Green Published, gold, Green Submitted			2022-12-25	WOS:000298365700004
J	McDonnell, SRP; Hwang, SR; Basrur, V; Conlon, KP; Fermin, D; Wey, E; Murga-Zamalloa, C; Zeng, Z; Zu, Y; Elenitoba-Johnson, KSJ; Lim, MS				McDonnell, S. R. P.; Hwang, S. R.; Basrur, V.; Conlon, K. P.; Fermin, D.; Wey, E.; Murga-Zamalloa, C.; Zeng, Z.; Zu, Y.; Elenitoba-Johnson, K. S. J.; Lim, M. S.			NPM-ALK signals through glycogen synthase kinase 3 beta to promote oncogenesis	ONCOGENE			English	Article						NPM-ALK; GSK3; ALCL; oncogenesis	ANAPLASTIC LYMPHOMA KINASE; TYROSINE KINASE; APOPTOSIS; CELLS; PHOSPHORYLATION; INHIBITION; PROTEIN; CDC25A; INACTIVATION; CAL-101	Anaplastic large cell lymphoma (ALCL) is the most common type of pediatric peripheral T-cell lymphoma. In 70-80% of cases, the chromosomal aberration t(2;5)(p23;q35) results in the juxtaposition of anaplastic lymphoma kinase (ALK) with nucleophosmin (NPM) and the subsequent expression of the NPM-ALK fusion protein. NPM-ALK is a chimeric tyrosine kinase, which induces numerous signaling pathways that drive proliferation and abrogate apoptosis. However, the mechanisms that lead to activation of downstream growth regulatory molecules have not been completely elucidated. Using a mass spectrometry-based phosphoproteomic screen, we identified GSK3 beta as a signaling mediator of NPM-ALK. Using a selective inhibitor of ALK, we demonstrated that the tyrosine kinase activity of ALK regulates the serine-9 phosphorylation of GSK3 beta. Expression of NPM-ALK in 293T cells led to an increase of pS(9)-GSK3 beta (glycogen synthase kinase 3 beta) compared with kinase-defective K210R mutant NPM-ALK, but did not affect total GSK3 beta levels. Phosphorylation of pS(9)-GSK3 beta by NPM-ALK was mediated by the PI3K/AKT signaling pathway. ALK inhibition resulted in degradation of GSK3 beta substrates Mcl-1 and CDC25A, which was recovered upon chemical inhibition of the proteasome (MG132). Furthermore, the degradation of Mcl-1 was recoverable with inhibition of GSK3 beta. ALK inhibition also resulted in decreased cell viability, which was rescued by GSK3 beta inhibition. Furthermore, stable knockdown of GSK3 beta conferred resistance to the growth inhibitory effects of ALK inhibition using viability and colony formation assays. pS(9)-GSK3 beta and CDC25A were selectively expressed in neoplastic cells of ALK + ALCL tissue biopsies, and showed a significant correlation (P<0.001). Conversely, ALK-ALCL tissue biopsies did not show significant correlation of pS(9)-GSK3 beta and CDC25A expression (P<0.2). Our results demonstrate that NPM-ALK regulates the phosphorylation of S-9-GSK3 beta by PI3K/AKT. The subsequent inhibition of GSK3 beta activity results in accumulation of CDC25A and Mcl-1, which confers the advantage of growth and protection from apoptosis. These findings provide support for the role of GSK3 beta as a mediator of NPM-ALK oncogenesis. Oncogene (2012) 31, 3733-3740; doi:10.1038/onc.2011.542; published online 19 December 2011	[McDonnell, S. R. P.; Hwang, S. R.; Basrur, V.; Conlon, K. P.; Fermin, D.; Wey, E.; Murga-Zamalloa, C.; Elenitoba-Johnson, K. S. J.; Lim, M. S.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Zeng, Z.; Zu, Y.] Methodist Hosp, Dept Pathol, Houston, TX 77030 USA	University of Michigan System; University of Michigan; The Methodist Hospital System; The Methodist Hospital - Houston	Lim, MS (corresponding author), Biomed Sci Res Bldg,Room 2039,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	meganlim@med.umich.edu	Murga-Zamalloa, Carlos/AAX-9387-2021	Murga-Zamalloa, Carlos/0000-0002-2238-5066; Hwang, Steven/0000-0002-6536-1291; Elenitoba-Johnson, Kojo/0000-0002-1082-1545; Lim, Megan/0000-0002-0415-2867	NIH [5R01CA140806-02, R01DE119249, R01CA136905]; NATIONAL CANCER INSTITUTE [R01CA136905, R01CA140806] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by funding from the NIH (5R01CA140806-02) awarded to MS Lim, MD/PhD and (R01DE119249 and R01CA136905) KSJ Elenitoba-Johnson, MD. Mangeng Cheng, PhD of Cephalon, Inc provided the small molecule ALK inhibitor.	Amin HM, 2007, BLOOD, V110, P2259, DOI 10.1182/blood-2007-04-060715; Bai RY, 1998, MOL CELL BIOL, V18, P6951, DOI 10.1128/MCB.18.12.6951; Bischof D, 1997, MOL CELL BIOL, V17, P2312, DOI 10.1128/MCB.17.4.2312; Boccalatte FE, 2009, BLOOD, V113, P2776, DOI 10.1182/blood-2008-06-161018; BOSTOCK CJ, 1971, EXP CELL RES, V68, P163, DOI 10.1016/0014-4827(71)90599-4; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Fernandez-Vidal A, 2009, CELL CYCLE, V8, P1373, DOI 10.4161/cc.8.9.8302; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Herman SEM, 2010, BLOOD, V116, P2078, DOI 10.1182/blood-2010-02-271171; Ito M, 2010, CANCER GENE THER, V17, P633, DOI 10.1038/cgt.2010.20; Iwahara T, 1997, ONCOGENE, V14, P439, DOI 10.1038/sj.onc.1200849; JINNO S, 1994, EMBO J, V13, P1549, DOI 10.1002/j.1460-2075.1994.tb06417.x; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kang T, 2008, CANCER CELL, V13, P36, DOI 10.1016/j.ccr.2007.12.002; Lannutti BJ, 2011, BLOOD, V117, P591, DOI 10.1182/blood-2010-03-275305; Lim MS, 2009, BLOOD, V114, P1585, DOI 10.1182/blood-2009-02-204735; Marzec M, 2007, ONCOGENE, V26, P813, DOI 10.1038/sj.onc.1209843; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Ott GR, 2010, ACS MED CHEM LETT, V1, P493, DOI 10.1021/ml100158s; Palmer RH, 2009, BIOCHEM J, V420, P345, DOI 10.1042/BJ20090387; Ruchatz H, 2003, EXP HEMATOL, V31, P309, DOI 10.1016/S0301-472X(03)00007-9; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Slupianek A, 2001, CANCER RES, V61, P2194; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Zamo A, 2002, ONCOGENE, V21, P1038, DOI 10.1038/sj.onc.1205152; Zhao Y, 2007, MOL CELL BIOL, V27, P4328, DOI 10.1128/MCB.00153-07	32	26	27	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2012	31	32					3733	3740		10.1038/onc.2011.542	http://dx.doi.org/10.1038/onc.2011.542			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	990TF	22179823	Green Accepted			2022-12-25	WOS:000307653800007
J	Huttemann, M; Lee, I; Malek, MH				Huettemann, Maik; Lee, Icksoo; Malek, Moh H.			(-)-Epicatechin maintains endurance training adaptation in mice after 14 days of detraining	FASEB JOURNAL			English	Article						angiogenesis; exercise; flavanol; muscle physiology	CYTOCHROME-C-OXIDASE; SKELETAL-MUSCLE; MITOCHONDRIAL BIOGENESIS; EXERCISE CAPACITY; OXIDATIVE STRESS; FIBER-TYPE; PGC-1-ALPHA; EXPRESSION; PHOSPHORYLATION; CAPILLARIZATION	The purpose of this study was to determine whether (-)-epicatechin (mainly found in cocoa) could attenuate detraining effects in the hindlimb muscles of mice. Thirty-two male mice were randomized into 4 groups: control, trained, trained with 14 d of detraining and vehicle (DT-14-W), and trained with 14 d of detraining and (-)-epicatechin [DT-14-(-)-Epi]. DT-14-(-)-Epi received (-)-epicatechin (1.0 mg/kg2X/d), whereas water was given to the DT-14-W group. The latter 3 groups performed 5 wk of endurance training 5X/wk. Hindlimb muscles were harvested, and Western blots, as well as enzyme analyses, were performed. Training significantly increased capillary-to-fiber ratio (approximate to 78.8%), cytochrome-c oxidase (approximate to 35%), and activity (approximate to 144%) compared to controls. These adaptations returned to control levels for the DT-14-W group, whereas the DT-14-(-)-Epi group was able to maintain capillary-to-fiber ratio (approximate to 44%), CcO protein expression (approximate to 45%), and activity (approximate to 108%) above control levels. In addition, the increase in capillarity was related to decreased protein expression of thrombospondin-1, an antiangiogenic regulator. Furthermore, there were no significant differences in endurance capacity between the trained and DT-14-(-)-Epi groups. Our data suggest that (-)-epicatechin may be a suitable compound to maintain exercise-induced improved capillarity and mitochondrial capacity, even when exercise regimens are discontinued.-Huttemann, M., Lee, I., Malek, M. H. (-)-Epicatechin maintains endurance training adaptation in mice after 14 d of detraining. FASEB J. 26, 1413-1422 (2012). www.fasebj.org	[Malek, Moh H.] Wayne State Univ, Eugene Applebaum Coll Pharm & Hlth Sci, Integrat Physiol Exercise Lab, Detroit, MI 48201 USA; [Huettemann, Maik; Lee, Icksoo] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA	Wayne State University; Wayne State University	Malek, MH (corresponding author), Wayne State Univ, Eugene Applebaum Coll Pharm & Hlth Sci, Integrat Physiol Exercise Lab, 259 Mack Ave,Rm 2248, Detroit, MI 48201 USA.	en7488@wayne.edu	Malek, Moh/E-2321-2013	Huttemann, Maik/0000-0001-6310-7081	U.S. National Institutes of Health [GM089900]; Wayne State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089900] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wayne State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the U.S. National Institutes of Health (GM089900, M. H.) and startup funds from Wayne State University (M.H.M.).	Al-Gayyar MMH, 2011, DIABETOLOGIA, V54, P669, DOI 10.1007/s00125-010-1994-3; Augusto V, 2004, BRAZ J MORPHOL SCIS, V21, P89; Baltes-Breitwisch MM, 2010, REPRODUCTION, V140, P319, DOI 10.1530/REP-09-0456; Bengtsson J, 2001, PFLUG ARCH EUR J PHY, V443, P61, DOI 10.1007/s004240100628; Betik AC, 2008, EXP PHYSIOL, V93, P863, DOI 10.1113/expphysiol.2008.042069; Chabi B, 2009, J APPL PHYSIOL, V107, P1730, DOI 10.1152/japplphysiol.91451.2008; COYLE EF, 1984, J APPL PHYSIOL, V57, P1857, DOI 10.1152/jappl.1984.57.6.1857; DUDLEY GA, 1982, J APPL PHYSIOL, V53, P844, DOI 10.1152/jappl.1982.53.4.844; El-Remessy AB, 2007, FASEB J, V21, P2528, DOI 10.1096/fj.06-7854com; El-Remessy AB, 2005, J CELL SCI, V118, P243, DOI 10.1242/jcs.01612; Geng TY, 2010, AM J PHYSIOL-CELL PH, V298, pC572, DOI 10.1152/ajpcell.00481.2009; GOLLNICK PD, 1969, AM J PHYSIOL, V216, P1502, DOI 10.1152/ajplegacy.1969.216.6.1502; GUTH L, 1970, EXP NEUROL, V28, P365, DOI 10.1016/0014-4886(70)90244-X; Hepple RT, 1997, CAN J APPL PHYSIOL, V22, P11, DOI 10.1139/h97-002; Hepple RT, 1997, J APPL PHYSIOL, V82, P1305, DOI 10.1152/jappl.1997.82.4.1305; Hepple RT, 2001, J APPL PHYSIOL, V91, P2150, DOI 10.1152/jappl.2001.91.5.2150; HOUSTON ME, 1979, ACTA PHYSIOL SCAND, V105, P163, DOI 10.1111/j.1748-1716.1979.tb06328.x; Huttemann M, 2000, BBA-GENE STRUCT EXPR, V1492, P252, DOI 10.1016/S0167-4781(00)00087-7; Huttemann M, 2007, BBA-MOL CELL RES, V1773, P1701, DOI 10.1016/j.bbamcr.2007.10.001; Ishihara A, 1998, J APPL PHYSIOL, V84, P2183, DOI 10.1152/jappl.1998.84.6.2183; Keppel G., 2004, DESIGN ANAL RES HDB; Kleiner S, 2009, J BIOL CHEM, V284, P18624, DOI 10.1074/jbc.M109.008797; Kressler J, 2011, MED SCI SPORT EXER, V43, P2396, DOI 10.1249/MSS.0b013e31822495a7; Lee I, 2005, J BIOL CHEM, V280, P6094, DOI 10.1074/jbc.M411335200; Lehnen AM, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-67; Li L, 2011, DIABETES, V60, P157, DOI 10.2337/db10-0331; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Malek MH, 2010, EXP PHYSIOL, V95, P359, DOI 10.1113/expphysiol.2009.050369; Malek MH, 2009, EXP PHYSIOL, V94, P749, DOI 10.1113/expphysiol.2008.045989; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Nogueira L, 2011, J PHYSIOL-LONDON, V589, P4615, DOI 10.1113/jphysiol.2011.209924; Olfert IM, 2011, MICROCIRCULATION, V18, P316, DOI 10.1111/j.1549-8719.2011.00092.x; Olfert IM, 2009, J PHYSIOL-LONDON, V587, P1755, DOI 10.1113/jphysiol.2008.164384; Pae MY, 2012, J NUTR BIOCHEM, V23, P526, DOI 10.1016/j.jnutbio.2011.02.006; Pinho R. A., 2011, EUR J APPL PHYSL; ROSENBLATT JD, 1987, STAIN TECHNOL, V62, P85, DOI 10.3109/10520298709107973; Roudier E, 2010, J PHYSIOL-LONDON, V588, P4579, DOI 10.1113/jphysiol.2010.193243; Ryan MJ, 2010, J GERONTOL A-BIOL, V65, P815, DOI 10.1093/gerona/glq080; Safdar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010778; SOUSSI B, 1989, ACTA PHYSIOL SCAND, V135, P373, DOI 10.1111/j.1748-1716.1989.tb08590.x; van Praag H, 2007, J NEUROSCI, V27, P5869, DOI 10.1523/JNEUROSCI.0914-07.2007; Wagner PD, 1996, ANNU REV PHYSIOL, V58, P21, DOI 10.1146/annurev.physiol.58.1.21; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; Wong LE, 2009, J APPL PHYSIOL, V106, P1660, DOI 10.1152/japplphysiol.91233.2008; Wong YT, 2009, FREE RADICAL BIO MED, V46, P799, DOI 10.1016/j.freeradbiomed.2008.12.016; 류경렬, 2006, Endocrinology and Metabolism, V21, P302	46	32	32	0	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2012	26	4					1413	1422		10.1096/fj.11-196154	http://dx.doi.org/10.1096/fj.11-196154			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	919VS	22179525	Green Published			2022-12-25	WOS:000302359700004
J	Kim, W; Chakraborty, G; Kim, S; Shin, J; Park, CH; Jeong, MW; Bharatham, N; Yoon, HS; Kim, KT				Kim, Wanil; Chakraborty, Goutam; Kim, Sangjune; Shin, Joon; Park, Choon-Ho; Jeong, Min-Woo; Bharatham, Nagakumar; Yoon, Ho Sup; Kim, Kyong-Tai			Macro Histone H2A1.2 (MacroH2A1) Protein Suppresses Mitotic Kinase VRK1 during Interphase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACCINIA-RELATED KINASE-1; INACTIVE X-CHROMOSOME; VARIANT MACROH2A; PHOSPHORYLATION; MITOSIS; VACCINIA-RELATED-KINASE-1; ACCUMULATION; PROGRESSION; EXPRESSION; NUCLEUS	VRK1-mediated phosphorylation of histone H3 should be restricted in mitosis for consistent cell cycling, and defects in this process trigger cellular catastrophe. However, an interphasic regulator against VRK1 has not been actually investigated so far. Here, we show that the histone variant macrodomain-containing histone H2A1.2 functions as a suppressor against VRK1 during interphase. The level of macroH2A1.2 was markedly reduced in the mitotic phase, and the macroH2A1.2-mediated inhibition of histone H3 phosphorylation occurred mainly during interphase. We also found direct interaction and binding features between VRK1 and macroH2A1.2 by NMR spectroscopy. Hence, our findings might provide valuable insight into the underlying molecular mechanism regarding an epigenetic regulation of histone H3 during the cell cycle.	[Kim, Wanil; Kim, Sangjune; Park, Choon-Ho; Jeong, Min-Woo; Kim, Kyong-Tai] Pohang Univ Sci & Technol, Dept Life Sci, Div Mol & Life Sci, Pohang 790784, South Korea; [Kim, Kyong-Tai] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang 790784, South Korea; [Chakraborty, Goutam; Shin, Joon; Bharatham, Nagakumar; Yoon, Ho Sup] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Kim, KT (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Div Mol & Life Sci, Pohang 790784, South Korea.	ktk@postech.ac.kr	Yoon, Ho Sup/A-2193-2011	Yoon, Ho Sup/0000-0002-8243-3904; Kim, Sangjune/0000-0003-3052-3163; KIM, KYONG-TAI/0000-0001-7292-2627	National Research Foundation of Korea [20100030089, 20100002146, 20100019706]; Brain Korea 21 Program; World Class University [R31-10105]; Anti-aging and Well Being Research Center; Korean Ministry of Education, Science, and Technology	National Research Foundation of Korea(National Research Foundation of Korea); Brain Korea 21 Program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); World Class University; Anti-aging and Well Being Research Center; Korean Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by National Research Foundation of Korea Grants 20100030089, 20100002146, and 20100019706, the Brain Korea 21 Program, the World Class University Program Grant R31-10105, and the Regional Core Research Program/Anti-aging and Well Being Research Center funded by the Korean Ministry of Education, Science, and Technology.	Agelopoulos M, 2006, EMBO J, V25, P4843, DOI 10.1038/sj.emboj.7601364; Angelov D, 2003, MOL CELL, V11, P1033, DOI 10.1016/S1097-2765(03)00100-X; Barcia R, 2002, ARCH BIOCHEM BIOPHYS, V399, P1, DOI 10.1006/abbi.2001.2746; Bernstein E, 2008, P NATL ACAD SCI USA, V105, P1533, DOI 10.1073/pnas.0711632105; Chadwick BP, 2002, J CELL BIOL, V157, P1113, DOI 10.1083/jcb.200112074; Choi YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015254; Costanzi C, 1998, NATURE, V393, P599, DOI 10.1038/31275; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Dai J, 2005, GENE DEV, V19, P472, DOI 10.1101/gad.1267105; Gorjanacz M, 2007, EMBO J, V26, P132, DOI 10.1038/sj.emboj.7601470; Kang TH, 2008, J CELL SCI, V121, P3035, DOI 10.1242/jcs.026757; Kang TH, 2007, MOL CELL BIOL, V27, P8533, DOI 10.1128/MCB.00018-07; Kohn EA, 2002, J BIOL CHEM, V277, P26553, DOI 10.1074/jbc.M202040200; Lancaster OM, 2007, J CELL BIOL, V179, P817, DOI 10.1083/jcb.200706067; Lopez-Borges S, 2000, ONCOGENE, V19, P3656, DOI 10.1038/sj.onc.1203709; Nichols RJ, 2006, MOL BIOL CELL, V17, P2451, DOI 10.1091/mbc.E05-12-1179; Nichols RJ, 2004, J BIOL CHEM, V279, P7934, DOI 10.1074/jbc.M310813200; Park CH, 2011, MOL BIOL CELL, V22, P1398, DOI 10.1091/mbc.E10-08-0717; PEHRSON JR, 1992, SCIENCE, V257, P1398; Santos CR, 2006, MOL CANCER RES, V4, P177, DOI 10.1158/1541-7786.MCR-05-0212; Schober CS, 2011, MECH DEVELOP, V128, P178, DOI 10.1016/j.mod.2011.01.004; Sevilla A, 2004, ONCOGENE, V23, P8950, DOI 10.1038/sj.onc.1208015; Sevilla A, 2004, J BIOL CHEM, V279, P27458, DOI 10.1074/jbc.M401009200; Shin J, 2011, J BIOL CHEM, V286, P22131, DOI 10.1074/jbc.M110.200162; Vader G, 2008, BBA-REV CANCER, V1786, P60, DOI 10.1016/j.bbcan.2008.07.003; Valbuena A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001642; Valbuena A, 2006, MOL CELL BIOL, V26, P4782, DOI 10.1128/MCB.00069-06; Valbuena A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017320; Vega FM, 2004, MOL CELL BIOL, V24, P10366, DOI 10.1128/MCB.24.23.10366-10380.2004; Wang FW, 2011, CURR BIOL, V21, P1061, DOI 10.1016/j.cub.2011.05.016; Wiebe MS, 2010, BIOL REPROD, V82, P182, DOI 10.1095/biolreprod.109.079095	31	34	34	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5278	5289		10.1074/jbc.M111.281709	http://dx.doi.org/10.1074/jbc.M111.281709			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22194607	hybrid, Green Published			2022-12-25	WOS:000300638000010
J	Mogilenko, DA; Kudriavtsev, IV; Trulioff, AS; Shavva, VS; Dizhe, EB; Missyul, BV; Zhakhov, AV; Ischenko, AM; Perevozchikov, AP; Orlov, SV				Mogilenko, Denis A.; Kudriavtsev, Igor V.; Trulioff, Andrey S.; Shavva, Vladimir S.; Dizhe, Ella B.; Missyul, Boris V.; Zhakhov, Alexander V.; Ischenko, Alexander M.; Perevozchikov, Andrej P.; Orlov, Sergey V.			Modified Low Density Lipoprotein Stimulates Complement C3 Expression and Secretion via Liver X Receptor and Toll-like Receptor 4 Activation in Human Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-ENDOTHELIAL CELLS; NECROSIS-FACTOR-ALPHA; FACTOR-KAPPA-B; 3RD COMPONENT; SIGNALING PATHWAYS; GENE-EXPRESSION; DENDRITIC CELLS; HUMAN MONOCYTES; ATHEROSCLEROSIS; LIPOPOLYSACCHARIDE	Complement C3 is a pivotal component of three cascades of complement activation. C3 is expressed in human atherosclerotic lesions and is involved in atherogenesis. However, the mechanism of C3 accumulation in atherosclerotic lesions is not well elucidated. We show that acetylated low density lipoprotein and oxidized low density lipoprotein (oxLDL) increase C3 gene expression and protein secretion by human macrophages. Modified LDL (mLDL)-mediated activation of C3 expression mainly depends on liver X receptor (LXR) and partly on Toll-like receptor 4 (TLR4), whereas C3 secretion is increased due to TLR4 activation by mLDL. LXR agonist TO901317 stimulates C3 gene expression in human monocyte-macrophage cells but not in human hepatoma (HepG2) cells. We find LXR-responsive element inside of the promoter region of the human C3 gene, which binds to LXR beta in macrophages but not in HepG2 cells. We show that C3 expression and secretion is decreased in IL-4-treated (M2) and increased in IFN gamma/LPS-stimulated (M1) human macrophages as compared with resting macrophages. LXR agonist TO901317 potentiates LPS-induced C3 gene expression and protein secretion in macrophages, whereas oxLDL differently modulates LPS-mediated regulation of C3 in M1 or M2 macrophages. Treatment of human macrophages with anaphylatoxin C3a results in stimulation of C3 transcription and secretion as well as increased oxLDL accumulation and augmented oxLDL-mediated up-regulation of the C3 gene. These data provide a novel mechanism of C3 gene regulation in macrophages and suggest new aspects of cross-talk between mLDL, C3, C3a, and TLR4 during development of atherosclerotic lesions.	[Mogilenko, Denis A.; Shavva, Vladimir S.; Dizhe, Ella B.; Missyul, Boris V.; Perevozchikov, Andrej P.; Orlov, Sergey V.] Russian Acad Med Sci, Dept Biochem, Inst Expt Med, St Petersburg 197376, Russia; [Kudriavtsev, Igor V.; Trulioff, Andrey S.] Russian Acad Med Sci, Dept Immunol, Inst Expt Med, St Petersburg 197376, Russia; [Mogilenko, Denis A.; Shavva, Vladimir S.; Perevozchikov, Andrej P.; Orlov, Sergey V.] St Petersburg State Univ, Dept Embryol, St Petersburg 199034, Russia; [Kudriavtsev, Igor V.] St Petersburg State Univ, Dept Cytol & Histol, St Petersburg 199034, Russia; [Zhakhov, Alexander V.; Ischenko, Alexander M.] Res Inst Highly Pure Biopreparat, St Petersburg 197110, Russia	Institute of Experimental Medicine; Russian Academy of Medical Sciences; Institute of Experimental Medicine; Russian Academy of Medical Sciences; Saint Petersburg State University; Saint Petersburg State University	Mogilenko, DA (corresponding author), Russian Acad Med Sci, Dept Biochem, Inst Expt Med, Acad Pavlov Str 12, St Petersburg 197376, Russia.	denis@iem.sp.ru; serge@iem.sp.ru	Orlov, Sergey V./N-6823-2014; Mogilenko, Denis/H-4436-2013; Mogilenko, Denis/ABE-9454-2021; Dizhe, Ella B./N-6842-2014; Kudryavtsev, Igor/D-2124-2013; Perevozchikov, Andrej/M-9744-2015; Trulioff, Andrey/AAF-5844-2021	Orlov, Sergey V./0000-0002-3134-1989; Mogilenko, Denis/0000-0001-5427-5243; Kudryavtsev, Igor/0000-0001-7204-7850; Perevozchikov, Andrej/0000-0001-7049-3224; Trulioff, Andrey/0000-0002-7495-446X; Dizhe, Ella/0000-0001-5147-4749; Shavva, Vladimir S./0000-0002-5080-8636	Russian Fund of Basic Research [11-04-02012]	Russian Fund of Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by Russian Fund of Basic Research Grant 11-04-02012.	Ajjan R, 2005, THROMB HAEMOSTASIS, V94, P1048, DOI 10.1160/TH05-06-0384; ALPER CA, 1969, SCIENCE, V163, P286, DOI 10.1126/science.163.3864.286; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; BENNETT S, 1994, J LEUKOCYTE BIOL, V56, P236; Bosisio D, 2002, BLOOD, V99, P3427, DOI 10.1182/blood.V99.9.3427; Buono C, 2002, CIRCULATION, V105, P3025, DOI 10.1161/01.CIR.0000019584.04929.83; Calkin AC, 2010, ARTERIOSCL THROM VAS, V30, P1513, DOI 10.1161/ATVBAHA.109.191197; Chinetti-Gbaguidi G, 2011, CIRC RES, V108, P985, DOI 10.1161/CIRCRESAHA.110.233775; CHOY LN, 1992, J BIOL CHEM, V267, P12736; Dardik BN, 2000, J LIPID RES, V41, P1013; EINSTEIN LP, 1977, J CLIN INVEST, V60, P963, DOI 10.1172/JCI108876; Fischer WH, 1999, J IMMUNOL, V162, P453; Fontaine C, 2007, CIRC RES, V101, P40, DOI 10.1161/CIRCRESAHA.106.135814; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Getz GS, 2005, J LIPID RES, V46, P1, DOI 10.1194/jlr.R400013-JLR200; Groeneweg M, 2006, J LIPID RES, V47, P2259, DOI 10.1194/jlr.M600181-JLR200; Hansson GK, 2002, CIRC RES, V91, P281, DOI 10.1161/01.RES.0000029784.15893.10; HANSSON GK, 1984, ACTA PATH MICRO IM A, V92, P429; Hong C, 2008, CURR OPIN GENET DEV, V18, P461, DOI 10.1016/j.gde.2008.07.016; [Institute of Laboratory Animal Research Commission on Life Sciences National Research Council], 1996, GUID CAR US LAB AN; Ischenko A, 1998, J NEUROCHEM, V71, P2487; JIALAL I, 1989, J LIPID RES, V30, P1561; KATZ Y, 1988, ARTHRITIS RHEUM, V31, P1365, DOI 10.1002/art.1780311104; KHAN BV, 1995, J CLIN INVEST, V95, P1262, DOI 10.1172/JCI117776; Klos A, 2009, MOL IMMUNOL, V46, P2753, DOI 10.1016/j.molimm.2009.04.027; Landis MS, 2002, J BIOL CHEM, V277, P4713, DOI 10.1074/jbc.M108807200; LEVISTRAUSS M, 1987, J IMMUNOL, V139, P2361; Li K, 2008, BLOOD, V112, P5084, DOI 10.1182/blood-2008-05-156646; Maess M.B., 2011, COLD SPRING HARB PRO, V2011; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Mevorach D, 1998, J EXP MED, V188, P2313, DOI 10.1084/jem.188.12.2313; Miller YI, 2005, ARTERIOSCL THROM VAS, V25, P1213, DOI 10.1161/01.ATV.0000159891.73193.31; Miller YI, 2003, CURR OPIN LIPIDOL, V14, P437, DOI 10.1097/00041433-200310000-00004; Mogilenko DA, 2010, BIOCHEM BIOPH RES CO, V402, P477, DOI 10.1016/j.bbrc.2010.10.053; Mogilenko DA, 2009, BIOCHEMISTRY-US, V48, P11950, DOI 10.1021/bi9015742; Muscari A, 2000, EUR HEART J, V21, P1081, DOI 10.1053/euhj.1999.2013; NICHOLS W K, 1984, Complement, V1, P108; Niculescu F, 1999, MOL IMMUNOL, V36, P949, DOI 10.1016/S0161-5890(99)00117-0; Ohlsson BG, 1996, J CLIN INVEST, V98, P78, DOI 10.1172/JCI118780; Oksjoki R, 2003, CURR OPIN LIPIDOL, V14, P477, DOI 10.1097/00041433-200310000-00008; Oksjoki R, 2007, ATHEROSCLEROSIS, V195, P90, DOI 10.1016/j.atherosclerosis.2006.12.016; Onat A, 2011, CLIN CHIM ACTA, V412, P1171, DOI 10.1016/j.cca.2011.03.005; Orlov SV, 2007, FEBS J, V274, P4848, DOI 10.1111/j.1742-4658.2007.06006.x; Patel S, 2001, BIOCHEM BIOPH RES CO, V286, P164, DOI 10.1006/bbrc.2001.5276; Peng Q, 2008, BLOOD, V111, P2452, DOI 10.1182/blood-2007-06-095018; Persson L, 2004, ARTERIOSCL THROM VAS, V24, P1062, DOI 10.1161/01.ATV.0000127302.24266.40; Purwar R, 2006, J IMMUNOL, V177, P4444, DOI 10.4049/jimmunol.177.7.4444; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rodgers JT, 2000, ANAL BIOCHEM, V277, P254, DOI 10.1006/abio.1999.4394; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sahu A, 2001, IMMUNOL REV, V180, P35, DOI 10.1034/j.1600-065X.2001.1800103.x; Sandelin A, 2005, MOL ENDOCRINOL, V19, P595, DOI 10.1210/me.2004-0101; Schmiedt W, 1998, ARTERIOSCL THROM VAS, V18, P1790, DOI 10.1161/01.ATV.18.11.1790; Schmitz G, 2005, BBA-MOL CELL BIOL L, V1735, P1, DOI 10.1016/j.bbalip.2005.04.004; SUTTON MBS, 1986, J IMMUNOL, V136, P1366; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; WARREN HB, 1987, AM J PATHOL, V129, P9; Wiesner P, 2010, CIRC RES, V107, P56, DOI 10.1161/CIRCRESAHA.110.218420; Yasojima K, 2001, ARTERIOSCL THROM VAS, V21, P1214, DOI 10.1161/hq0701.092160	62	39	41	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5954	5968		10.1074/jbc.M111.289322	http://dx.doi.org/10.1074/jbc.M111.289322			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22194611	Green Published, hybrid			2022-12-25	WOS:000300638000069
J	Lambeck, IC; Fischer-Schrader, K; Niks, D; Roeper, J; Chi, JC; Hille, R; Schwarz, G				Lambeck, Iris C.; Fischer-Schrader, Katrin; Niks, Dimitri; Roeper, Juliane; Chi, Jen-Chih; Hille, Russ; Schwarz, Guenter			Molecular Mechanism of 14-3-3 Protein-mediated Inhibition of Plant Nitrate Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; KINETIC-ANALYSIS; BINDING; PHOSPHORYLATION; 14-3-3-PROTEINS; ISOFORM; NITRITE; DOMAIN; DEAMINATION; METABOLISM	14-3-3 proteins regulate key processes in eukaryotic cells including nitrogen assimilation in plants by tuning the activity of nitrate reductase (NR), the first and rate-limiting enzyme in this pathway. The homodimeric NR harbors three cofactors, each of which is bound to separate domains, thus forming an electron transfer chain. 14-3-3 proteins inhibit NR by binding to a conserved phosphorylation site localized in the linker between the heme and molybdenum cofactor-containing domains. Here, we have investigated the molecular mechanism of 14-3-3-mediated NR inhibition using a fragment of the enzyme lacking the third domain, allowing us to analyze electron transfer from the heme cofactor via the molybdenum center to nitrate. The kinetic behavior of the inhibited Mo-heme fragment indicates that the principal point at which 14-3-3 acts is the electron transfer from the heme to the molybdenum cofactor. We demonstrate that this is not due to a perturbation of the reduction potentials of either the heme or the molybdenum center and conclude that 14-3-3 most likely inhibits nitrate reductase by inducing a conformational change that significantly increases the distance between the two redox-active sites.	[Lambeck, Iris C.; Fischer-Schrader, Katrin; Roeper, Juliane; Chi, Jen-Chih; Schwarz, Guenter] Univ Cologne, Inst Biochem, Dept Chem, D-50674 Cologne, Germany; [Lambeck, Iris C.; Fischer-Schrader, Katrin; Roeper, Juliane; Chi, Jen-Chih; Schwarz, Guenter] Univ Cologne, Ctr Mol Med, D-50674 Cologne, Germany; [Niks, Dimitri; Hille, Russ] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	University of Cologne; University of Cologne; University of California System; University of California Riverside	Schwarz, G (corresponding author), Zuelpicher Str 47, D-50674 Cologne, Germany.	gschwarz@uni-koeln.de	Schwarz, Guenter/F-2217-2013; Schwarz, Guenter/ABE-9643-2021; Schrader, Katrin/GWM-7389-2022	Schwarz, Guenter/0000-0002-2118-9338; Schrader, Katrin/0000-0003-4532-8918	German Science Foundation [Schw 759/6-1, SFB 635 TP-A5]; National Institutes of Health [GM075036, ES012658]; Fonds der Chemischen Industrie; Alexander von Humboldt Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075036] Funding Source: NIH RePORTER	German Science Foundation(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the German Science Foundation (Grants Schw 759/6-1 and SFB 635 TP-A5 to G. S.), the National Institutes of Health (Grants GM075036 and ES012658 to R. H.), and the Fonds der Chemischen Industrie (to G. S.).; Supported by a grant from the Alexander von Humboldt Foundation.	Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Bachmann M, 1996, FEBS LETT, V398, P26, DOI 10.1016/S0014-5793(96)01188-X; Barbier GG, 2005, J BIOL CHEM, V280, P26049, DOI 10.1074/jbc.M409694200; Campbell WH, 1999, ANNU REV PLANT PHYS, V50, P277, DOI 10.1146/annurev.arplant.50.1.277; CANNONS AC, 1993, J BIOL CHEM, V268, P3268; Chevalier D, 2009, ANNU REV PLANT BIOL, V60, P67, DOI 10.1146/annurev.arplant.59.032607.092844; DeLille JM, 2001, PLANT PHYSIOL, V126, P35, DOI 10.1104/pp.126.1.35; Deng HT, 2006, RAPID COMMUN MASS SP, V20, P3634, DOI 10.1002/rcm.2776; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Gokirmak T, 2010, CURR OPIN PLANT BIOL, V13, P527, DOI 10.1016/j.pbi.2010.06.001; HUBER JL, 1992, ARCH BIOCHEM BIOPHYS, V296, P58, DOI 10.1016/0003-9861(92)90544-7; Huber SC, 2002, PLANT MOL BIOL, V50, P1053, DOI 10.1023/A:1021284002779; KAISER WM, 1991, PLANT PHYSIOL, V96, P363, DOI 10.1104/pp.96.2.363; Kanamaru K, 1999, J BIOL CHEM, V274, P4160, DOI 10.1074/jbc.274.7.4160; Kuper J, 2004, NATURE, V430, P803, DOI 10.1038/nature02681; Lambeck I, 2010, BIOCHEMISTRY-US, V49, P8177, DOI 10.1021/bi1003487; Lillo C, 2008, BIOCHEM J, V415, P11, DOI 10.1042/BJ20081115; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; LU GH, 1994, PLANT CELL, V6, P501, DOI 10.1105/tpc.6.4.501; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; MACKINTOSH C, 1992, BIOCHIM BIOPHYS ACTA, V1137, P121, DOI 10.1016/0167-4889(92)90109-O; MACKINTOSH C, 1995, PLANT PHYSIOL, V107, P451, DOI 10.1104/pp.107.2.451; Marzinzig M, 1997, NITRIC OXIDE-BIOL CH, V1, P177, DOI 10.1006/niox.1997.0116; Moore BE, 1967, PHYSL BIOCH ASPECTS, P343; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Obsil T, 2011, SEMIN CELL DEV BIOL, V22, P663, DOI 10.1016/j.semcdb.2011.09.001; Obsilova V, 2008, BIOCHEMISTRY-US, V47, P1768, DOI 10.1021/bi7019468; Ottmann C, 2007, MOL CELL, V25, P427, DOI 10.1016/j.molcel.2006.12.017; Ottmann C, 2007, EMBO J, V26, P902, DOI 10.1038/sj.emboj.7601530; Paul AL, 2005, MOL BIOL CELL, V16, P1735, DOI 10.1091/mbc.E04-09-0839; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Sehnke PC, 2002, PLANT CELL, V14, pS339, DOI 10.1105/tpc.010430; Shen W, 2003, PLANT J, V34, P473, DOI 10.1046/j.1365-313X.2003.01739.x; Skipper L, 2001, J BIOL CHEM, V276, P26995, DOI 10.1074/jbc.M100356200; Spencer JPE, 2000, FREE RADICAL BIO MED, V28, P1039, DOI 10.1016/S0891-5849(00)00190-8; Wang BC, 1999, BIOCHEMISTRY-US, V38, P12499, DOI 10.1021/bi991353h; Wurtele M, 2003, EMBO J, V22, P987, DOI 10.1093/emboj/cdg104; Yaffe MB, 2001, STRUCTURE, V9, pR33, DOI 10.1016/S0969-2126(01)00580-9; Yao Y, 2007, J BIOCHEM MOL BIOL, V40, P349	39	51	53	3	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4562	4571		10.1074/jbc.M111.323113	http://dx.doi.org/10.1074/jbc.M111.323113			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22170050	hybrid, Green Published			2022-12-25	WOS:000300608500019
J	Rudashevskaya, EL; Ye, JY; Jensen, ON; Fuglsang, AT; Palmgren, MG				Rudashevskaya, Elena L.; Ye, Juanying; Jensen, Ole N.; Fuglsang, Anja T.; Palmgren, Michael G.			Phosphosite Mapping of P-type Plasma Membrane H+-ATPase in Homologous and Heterologous Environments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE-SCALE ANALYSIS; C-TERMINAL END; PROTEIN-KINASE; QUANTITATIVE PHOSPHOPROTEOMICS; PROTEOMIC ANALYSIS; PROTON PUMP; IN-VIVO; PHOSPHORYLATION NETWORKS; REVEALS EVOLUTIONARY; ARABIDOPSIS-THALIANA	Phosphorylation is an important posttranslational modification of proteins in living cells and primarily serves regulatory purposes. Several methods were employed for isolating phosphopeptides from proteolytically digested plasma membranes of Arabidopsis thaliana. After a mass spectrometric analysis of the resulting peptides we could identify 10 different phosphorylation sites in plasma membrane H+-ATPases AHA1, AHA2, AHA3, and AHA4/11, five of which have not been reported before, bringing the total number of phosphosites up to 11, which is substantially higher than reported so far for any other P-type ATPase. Phosphosites were almost exclusively (9 of 10) in the terminal regulatory domains of the pumps. The AHA2 isoform was subsequently expressed in the yeast Saccharomyces cerevisiae. The plant protein was phosphorylated at multiple sites in yeast, and surprisingly, seven of nine of the phosphosites identified in AHA2 were identical in the plant and fungal systems even though none of the target sequences in AHA2 show homology to proteins of the fungal host. These findings suggest an unexpected accessibility of the terminal regulatory domain of plasma membrane H+-ATPase to protein kinase action.	[Rudashevskaya, Elena L.; Fuglsang, Anja T.; Palmgren, Michael G.] Univ Copenhagen, Dept Plant Biol & Biotechnol, Ctr Membrane Pumps Cells & Dis PUMPkin, DK-1871 Frederiksberg C, Denmark; [Ye, Juanying; Jensen, Ole N.] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark	University of Copenhagen; University of Southern Denmark	Palmgren, MG (corresponding author), Univ Copenhagen, Dept Plant Biol & Biotechnol, Ctr Membrane Pumps Cells & Dis PUMPkin, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Denmark.	palmgren@life.ku.dk	Jensen, Ole N/J-1763-2012; Fuglsang, Anja Thoe/A-6733-2015; Palmgren, Michael/A-9808-2013; fuglsang, anja thoe t/E-1683-2012	Jensen, Ole N/0000-0003-1862-8528; Fuglsang, Anja Thoe/0000-0003-1153-8394; Palmgren, Michael/0000-0002-9982-6114; fuglsang, anja thoe t/0000-0003-1153-8394	Danish Research Council; Danish Basic Research Foundation	Danish Research Council(Det Frie Forskningsrad (DFF)); Danish Basic Research Foundation	This work was supported by a Danish Research Council for Technology and Production grant (to M. G. P. and O. N. J.) and a Danish Basic Research Foundation grant (to M. G. P.).	Axelsen KB, 2001, PLANT PHYSIOL, V126, P696, DOI 10.1104/pp.126.2.696; Axelsen KB, 1999, BIOCHEMISTRY-US, V38, P7227, DOI 10.1021/bi982482l; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Benschop JJ, 2007, MOL CELL PROTEOMICS, V6, P1198, DOI 10.1074/mcp.M600429-MCP200; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Biondi RM, 2003, BIOCHEM J, V372, P1, DOI 10.1042/BJ20021641; Bodenmiller B, 2007, MOL BIOSYST, V3, P275, DOI 10.1039/b617545g; Bodenmiller B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001182; Boekhorst J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r144; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buch-Pedersen MJ, 2003, J BIOL CHEM, V278, P17845, DOI 10.1074/jbc.M212729200; CID A, 1987, CURR GENET, V12, P105, DOI 10.1007/BF00434664; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Collins MO, 2005, J BIOL CHEM, V280, P5972, DOI 10.1074/jbc.M411220200; de Lichtenberg U, 2005, SCIENCE, V307, P724, DOI 10.1126/science.1105103; Duby G, 2009, J BIOL CHEM, V284, P4213, DOI 10.1074/jbc.M807311200; Ekberg K, 2010, J BIOL CHEM, V285, P7344, DOI 10.1074/jbc.M109.096123; Fuglsang AT, 2007, PLANT CELL, V19, P1617, DOI 10.1105/tpc.105.035626; Fuglsang AT, 1999, J BIOL CHEM, V274, P36774, DOI 10.1074/jbc.274.51.36774; Fuglsang AT, 2003, J BIOL CHEM, V278, P42266, DOI 10.1074/jbc.M306707200; Glover JNM, 2004, TRENDS BIOCHEM SCI, V29, P579, DOI 10.1016/j.tibs.2004.09.010; Gobom J, 1999, J MASS SPECTROM, V34, P105, DOI 10.1002/(SICI)1096-9888(199902)34:2<105::AID-JMS768>3.0.CO;2-4; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; Haruta M, 2010, J BIOL CHEM, V285, P17918, DOI 10.1074/jbc.M110.101733; Holland PM, 1999, CURR BIOL, V9, pR329, DOI 10.1016/S0960-9822(99)80205-X; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Jahn TP, 2002, J BIOL CHEM, V277, P6353, DOI 10.1074/jbc.M109637200; Jelich-Ottmann C, 2001, J BIOL CHEM, V276, P39852, DOI 10.1074/jbc.M106746200; Jensen LJ, 2006, NATURE, V443, P594, DOI 10.1038/nature05186; Jimenez JL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r90; Jones AME, 2009, J PROTEOMICS, V72, P439, DOI 10.1016/j.jprot.2009.02.004; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; Kornev AP, 2010, BBA-PROTEINS PROTEOM, V1804, P440, DOI 10.1016/j.bbapap.2009.10.017; Krupa A, 2006, GENE, V380, P1, DOI 10.1016/j.gene.2006.05.016; Landry CR, 2009, TRENDS GENET, V25, P193, DOI 10.1016/j.tig.2009.03.003; LARSSON C, 1994, METHOD ENZYMOL, V228, P451; Lecchi S, 2007, J BIOL CHEM, V282, P35471, DOI 10.1074/jbc.M706094200; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Macek B, 2008, MOL CELL PROTEOMICS, V7, P299, DOI 10.1074/mcp.M700311-MCP200; Malik R, 2008, BIOINFORMATICS, V24, P1426, DOI 10.1093/bioinformatics/btn197; Malmstrom J, 2007, CURR OPIN BIOTECH, V18, P378, DOI 10.1016/j.copbio.2007.07.005; Mann M, 2003, NAT BIOTECHNOL, V21, P255, DOI 10.1038/nbt0303-255; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Mok J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000482; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Moses AM, 2007, P NATL ACAD SCI USA, V104, P17713, DOI 10.1073/pnas.0700997104; Nakagami H, 2010, PLANT PHYSIOL, V153, P1161, DOI 10.1104/pp.110.157347; Neduva V, 2005, FEBS LETT, V579, P3342, DOI 10.1016/j.febslet.2005.04.005; Niittylae T, 2007, MOL CELL PROTEOMICS, V6, P1711, DOI 10.1074/mcp.M700164-MCP200; Nuhse TS, 2007, PLANT J, V51, P931, DOI 10.1111/j.1365-313X.2007.03192.x; Nuhse TS, 2004, PLANT CELL, V16, P2394, DOI 10.1105/tpc.104.023150; Nuhse TS, 2003, MOL CELL PROTEOMICS, V2, P1234, DOI 10.1074/mcp.T300006-MCP200; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsson A, 1998, PLANT PHYSIOL, V118, P551, DOI 10.1104/pp.118.2.551; Ozlu N, 2010, WIRES SYST BIOL MED, V2, P255, DOI 10.1002/wsbm.41; Palmgren MG, 2001, ANNU REV PLANT PHYS, V52, P817, DOI 10.1146/annurev.arplant.52.1.817; Pawson T, 2000, GENE DEV, V14, P1027; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; Ptacek J, 2006, TRENDS GENET, V22, P545, DOI 10.1016/j.tig.2006.08.005; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; REGENBERG B, 1995, PLANT CELL, V7, P1655, DOI 10.1105/tpc.7.10.1655; Reiland S, 2009, PLANT PHYSIOL, V150, P889, DOI 10.1104/pp.109.138677; Remenyi A, 2005, MOL CELL, V20, P951, DOI 10.1016/j.molcel.2005.10.030; Remenyi A, 2006, CURR OPIN STRUC BIOL, V16, P676, DOI 10.1016/j.sbi.2006.10.008; Rigbolt KTG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001570; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Tan CSH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000316; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Thingholm TE, 2006, NAT PROTOC, V1, P1929, DOI 10.1038/nprot.2006.185; VENEMA K, 1995, J BIOL CHEM, V270, P19659, DOI 10.1074/jbc.270.33.19659; Wilson-Grady JT, 2008, J PROTEOME RES, V7, P1088, DOI 10.1021/pr7006335; Wolf-Yadlin A, 2007, P NATL ACAD SCI USA, V104, P5860, DOI 10.1073/pnas.0608638104; Won AP, 2011, P NATL ACAD SCI USA, V108, P9809, DOI 10.1073/pnas.1016337108; Ye JY, 2010, J PROTEOME RES, V9, P3561, DOI 10.1021/pr100075x; Zhang X, 2007, MOL CELL PROTEOMICS, V6, P2032, DOI 10.1074/mcp.M700278-MCP200	81	50	51	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4904	4913		10.1074/jbc.M111.307264	http://dx.doi.org/10.1074/jbc.M111.307264			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22174420	Green Published, hybrid			2022-12-25	WOS:000300608500051
J	Cichon, J; Sun, CC; Chen, B; Jiang, M; Chen, XA; Sun, YJ; Wang, Y; Chen, G				Cichon, Joseph; Sun, Chicheng; Chen, Ben; Jiang, Min; Chen, Xiangyun Amy; Sun, Yajie; Wang, Yun; Chen, Gong			Cofilin Aggregation Blocks Intracellular Trafficking and Induces Synaptic Loss in Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN DEPOLYMERIZING FACTOR; GROWTH CONE MOTILITY; DENDRITIC SPINES; LIM-KINASE; ALZHEIMERS-DISEASE; MYOTONIC-DYSTROPHY; REGULATES COFILIN; FILAMENT TURNOVER; CULTURED-CELLS; ROD FORMATION	Cofilin is an actin-binding protein and a major actin depolymerization factor in the central nervous system (CNS). Cofilin-actin aggregates are associated with neurodegenerative disorders, but how cofilin-actin aggregation induces pathological effects in the CNS remains unclear. Here, we demonstrated that cofilin rods disrupted dendritic microtubule integrity in rat hippocampal cultures. Long term time-lapse imaging revealed that cofilin rods block intracellular trafficking of both mitochondria and early endosomes. Importantly, cofilin rod formation induced a significant loss of SV2 and PSD-95 puncta as well as dendritic spines. Cofilin rods also impaired local glutamate receptor responses. We discovered an inverse relationship between the number of synaptic events and the accumulation of cofilin rods in dendrites. We also detected cofilin rods in aging rat brains in vivo. These results suggest that cofilin aggregation may contribute to neurodegeneration and brain aging by blocking intracellular trafficking and inducing synaptic loss.	[Chen, Ben; Jiang, Min; Chen, Xiangyun Amy; Sun, Yajie; Wang, Yun] Fudan Univ, Inst Brain Sci, Shanghai 200032, Peoples R China; [Chen, Ben; Jiang, Min; Chen, Xiangyun Amy; Sun, Yajie; Wang, Yun] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200032, Peoples R China; [Cichon, Joseph; Sun, Chicheng; Chen, Xiangyun Amy; Chen, Gong] Penn State Univ, Huck Inst Life Sci, Dept Biol, University Pk, PA 16802 USA	Fudan University; Fudan University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Wang, Y (corresponding author), Fudan Univ, Inst Brain Sci, Shanghai 200032, Peoples R China.	yunwang@fudan.edu.cn; gongchen@psu.edu	Sun, Chicheng/C-9980-2016	Sun, Chicheng/0000-0003-3837-2267; Chen JNU, Gong/0000-0002-1857-3670	National Institutes of Health [NS054858, MH083911]; National Science Foundation [0821955]; American Heart Association [0765258U]; Natural Science Foundation of China [30828014, 31129003, 81171224]; Ministry of Science and Technology of China [2009CB522000]; Science and Technology Commission of Shanghai Municipality [09JC1401900]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083911] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS054858] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS054858 and MH083911. This work was also supported by National Science Foundation Grant 0821955 and American Heart Association Grant 0765258U (to G. C.), Natural Science Foundation of China Grants 30828014 (to G. C. and Y. W.) and 31129003 and 81171224 (to Y. W.), and Ministry of Science and Technology of China Grant 2009CB522000 and Science and Technology Commission of Shanghai Municipality Grant 09JC1401900 (to Y. W.).	Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bernard O, 2007, INT J BIOCHEM CELL B, V39, P1071, DOI 10.1016/j.biocel.2006.11.011; Bernstein BW, 2006, AM J PHYSIOL-CELL PH, V291, pC828, DOI 10.1152/ajpcell.00066.2006; BUCCI C, 1995, FEBS LETT, V366, P65, DOI 10.1016/0014-5793(95)00477-Q; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Chan C, 2009, CURR BIOL, V19, P537, DOI 10.1016/j.cub.2009.02.060; Chen LY, 2007, J NEUROSCI, V27, P5363, DOI 10.1523/JNEUROSCI.0164-07.2007; Chua BT, 2003, NAT CELL BIOL, V5, P1083, DOI 10.1038/ncb1070; CULEBRAS A, 1973, J NEUROL SCI, V19, P319, DOI 10.1016/0022-510X(73)90095-6; Davis RC, 2009, J ALZHEIMERS DIS, V18, DOI 10.3233/JAD-2009-1122; Davis RC, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-10; Deng L, 2007, J NEUROSCI, V27, P10860, DOI 10.1523/JNEUROSCI.2744-07.2007; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Endo M, 2007, J BIOL CHEM, V282, P13692, DOI 10.1074/jbc.M610873200; Fulga TA, 2007, NAT CELL BIOL, V9, P139, DOI 10.1038/ncb1528; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; Garvalov BK, 2007, J NEUROSCI, V27, P13117, DOI 10.1523/JNEUROSCI.3322-07.2007; Gearing M, 2002, ANN NEUROL, V52, P465, DOI 10.1002/ana.10319; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; Gu JP, 2010, NAT NEUROSCI, V13, P1208, DOI 10.1038/nn.2634; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Hotulainen P, 2009, J CELL BIOL, V185, P323, DOI 10.1083/jcb.200809046; Huang TY, 2008, DEV CELL, V15, P691, DOI 10.1016/j.devcel.2008.09.017; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Jang DH, 2005, P NATL ACAD SCI USA, V102, P16072, DOI 10.1073/pnas.0507675102; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Kim JS, 2009, MOL BIOL CELL, V20, P2650, DOI 10.1091/mbc.E09-02-0131; Klamt F, 2009, NAT CELL BIOL, V11, P1241, DOI 10.1038/ncb1968; Kuhn TB, 2000, J NEUROBIOL, V44, P126, DOI 10.1002/1097-4695(200008)44:2<126::AID-NEU4>3.0.CO;2-Z; Lee CW, 2009, NAT NEUROSCI, V12, P848, DOI 10.1038/nn.2322; Maloney MT, 2005, J NEUROSCI, V25, P11313, DOI 10.1523/JNEUROSCI.3711-05.2005; MASLIAH E, 1993, NEUROLOGY, V43, P192, DOI 10.1212/WNL.43.1_Part_1.192; Mattson MP, 2003, NEUROMOL MED, V3, P65, DOI 10.1385/NMM:3:2:65; Matus A, 2005, CURR OPIN NEUROBIOL, V15, P67, DOI 10.1016/j.conb.2005.01.015; Meberg PJ, 2000, J NEUROSCI, V20, P2459; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Minamide LS, 2000, NAT CELL BIOL, V2, P628, DOI 10.1038/35023579; Montani L, 2009, J BIOL CHEM, V284, P10793, DOI 10.1074/jbc.M808297200; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; Muller WE, 2010, MOL NEUROBIOL, V41, P159, DOI 10.1007/s12035-010-8141-5; Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, pC670, DOI 10.1152/ajpcell.00213.2006; NISHIDA E, 1987, P NATL ACAD SCI USA, V84, P5262, DOI 10.1073/pnas.84.15.5262; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; ONO S, 1987, J NEUROL SCI, V81, P301, DOI 10.1016/0022-510X(87)90105-5; Racz B, 2006, NEUROSCIENCE, V138, P447, DOI 10.1016/j.neuroscience.2005.11.025; RATHKE PC, 1977, EXP CELL RES, V105, P253, DOI 10.1016/0014-4827(77)90123-9; Rex CS, 2007, J NEUROSCI, V27, P3017, DOI 10.1523/JNEUROSCI.4037-06.2007; Rosso S, 2004, MOL BIOL CELL, V15, P3433, DOI 10.1091/mbc.E03-05-0328; Rust MB, 2010, EMBO J, V29, P1889, DOI 10.1038/emboj.2010.72; Sarmiere PD, 2004, J NEUROBIOL, V58, P103, DOI 10.1002/neu.10267; Schon EA, 2011, NEURON, V70, P1033, DOI 10.1016/j.neuron.2011.06.003; Shi Y, 2009, J NEUROSCI, V29, P8129, DOI 10.1523/JNEUROSCI.4681-08.2009; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; von Blume J, 2011, DEV CELL, V20, P652, DOI 10.1016/j.devcel.2011.03.014; von Blume J, 2009, J CELL BIOL, V187, P1055, DOI 10.1083/jcb.200908040; Wen ZX, 2007, J CELL BIOL, V178, P107, DOI 10.1083/jcb.200703055; Whiteman IT, 2009, J NEUROSCI, V29, P12994, DOI 10.1523/JNEUROSCI.3531-09.2009; Wilson JM, 2000, MOL BIOL CELL, V11, P2657, DOI 10.1091/mbc.11.8.2657; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yao JQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015546; Yao J, 2006, J NEUROSCI, V26, P8137, DOI 10.1523/JNEUROSCI.1183-06.2006; Yuen EY, 2010, J PHYSIOL-LONDON, V588, P2361, DOI 10.1113/jphysiol.2009.186353; Zhao LX, 2006, NAT NEUROSCI, V9, P234, DOI 10.1038/nn1630; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	67	63	68	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3919	3929		10.1074/jbc.M111.301911	http://dx.doi.org/10.1074/jbc.M111.301911			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22184127	hybrid, Green Published			2022-12-25	WOS:000300410900028
J	Miller, A; Phillips, A; Gor, J; Wallis, R; Perkins, SJ				Miller, Ami; Phillips, Anna; Gor, Jayesh; Wallis, Russell; Perkins, Stephen J.			Near-planar Solution Structures of Mannose-binding Lectin Oligomers Provide Insight on Activation of Lectin Pathway of Complement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGEN-LIKE DOMAIN; NATURALLY-OCCURRING MUTATIONS; NEUTRON-SCATTERING; X-RAY; FACTOR-H; ANALYTICAL ULTRACENTRIFUGATION; CRYSTAL-STRUCTURE; HYDRODYNAMIC PROPERTIES; SEDIMENTATION-VELOCITY; MOLECULAR-STRUCTURE	The complement system is a fundamental component of innate immunity that orchestrates complex immunological and inflammatory processes. Complement comprises over 30 proteins that eliminate invading microorganisms while maintaining host cell integrity. Protein-carbohydrate interactions play critical roles in both the activation and regulation of complement. Mannose-binding lectin (MBL) activates the lectin pathway of complement via the recognition of sugar arrays on pathogenic surfaces. To determine the solution structure of MBL, synchrotron x-ray scattering and analytical ultracentrifugation experiments showed that the carbohydrate-recognition domains in the MBL dimer, trimer, and tetramer are positioned close to each other in near-planar fan-like structures. These data were subjected to constrained modeling fits. A bent structure for the MBL monomer was identified starting from two crystal structures for its carbohydrate-recognition domain and its triple helical region. The MBL monomer structure was used to identify 10-12 near-planar solution structures for each of the MBL dimers, trimers, and tetramers starting from 900 to 6,859 randomized structures for each. These near-planar fan-like solution structures joined at an N-terminal hub clarified how the carbohydrate-recognition domain of MBL binds to pathogenic surfaces. They also provided insight on how MBL presents a structural template for the binding and auto-activation of the MBL-associated serine proteases to initiate the lectin pathway of complement activation.	[Miller, Ami; Gor, Jayesh; Perkins, Stephen J.] UCL, Dept Struct & Mol Biol, London WC1E 6BT, England; [Phillips, Anna; Wallis, Russell] Univ Leicester, Dept Infect Immun & Inflammat, Leicester LE1 9HN, Leics, England	University of London; University College London; University of Leicester	Perkins, SJ (corresponding author), UCL, Dept Struct & Mol Biol, Darwin Bldg,Gower St, London WC1E 6BT, England.	s.perkins@ucl.ac.uk		Wallis, Russell/0000-0002-8705-5295	Biotechnology and Biological Sciences Research Council; Fight for Sight Charity; Wellcome Trust [077400]; BBSRC [BB/E013104/1] Funding Source: UKRI; MRC [G1000191, G0501425] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E013104/1] Funding Source: researchfish; Medical Research Council [G0501425, G1000191] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Fight for Sight Charity; Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by the Biotechnology and Biological Sciences Research Council and the Fight for Sight Charity.; Supported by Wellcome Trust Grant 077400.	Ashton AW, 1997, J MOL BIOL, V272, P408, DOI 10.1006/jmbi.1997.1271; Aslam M, 2003, J MOL BIOL, V329, P525, DOI 10.1016/S0022-2836(03)00492-3; Aslam M, 2001, J MOL BIOL, V309, P1117, DOI 10.1006/jmbi.2001.4720; BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; Bella J, 2006, J MOL BIOL, V362, P298, DOI 10.1016/j.jmb.2006.07.014; Boehm MK, 1999, J MOL BIOL, V286, P1421, DOI 10.1006/jmbi.1998.2556; Bonner A, 2008, J IMMUNOL, V180, P1008, DOI 10.4049/jimmunol.180.2.1008; Chamberlain D, 1998, BIOCHEMISTRY-US, V37, P13918, DOI 10.1021/bi9805184; Chen CB, 2001, J BIOL CHEM, V276, P25894, DOI 10.1074/jbc.M103539200; Chong WP, 2005, HEPATOLOGY, V42, P1037, DOI 10.1002/hep.20891; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Dong MD, 2007, J IMMUNOL, V178, P3016, DOI 10.4049/jimmunol.178.5.3016; DRICKAMER K, 1986, J BIOL CHEM, V261, P6878; DRICKAMER K, 1993, ANNU REV CELL BIOL, V9, P237, DOI 10.1146/annurev.cb.09.110193.001321; Feinberg H, 2003, EMBO J, V22, P2348, DOI 10.1093/emboj/cdg236; Fernando AN, 2007, J MOL BIOL, V368, P564, DOI 10.1016/j.jmb.2007.02.038; Fidler KJ, 2009, THORAX, V64, P150, DOI 10.1136/thx.2008.100073; FRASER RDB, 1979, J MOL BIOL, V129, P463, DOI 10.1016/0022-2836(79)90507-2; Gal P, 2005, J BIOL CHEM, V280, P33435, DOI 10.1074/jbc.M506051200; Garred P, 2002, PEDIATR PULM, V33, P201, DOI 10.1002/ppul.10064; Gilbert HE, 2005, J MOL BIOL, V346, P859, DOI 10.1016/j.jmb.2004.12.006; Glatter O., 1982, SMALL ANGLE X RAY SC; HAURUM JS, 1993, AIDS, V7, P1307, DOI 10.1097/00002030-199310000-00002; JENCKS WP, 1981, P NATL ACAD SCI-BIOL, V78, P4046, DOI 10.1073/pnas.78.7.4046; Jensen PH, 2005, J BIOL CHEM, V280, P11043, DOI 10.1074/jbc.M412472200; Jensenius H, 2009, J MOL BIOL, V391, P246, DOI 10.1016/j.jmb.2009.05.083; KURATA H, 1993, BIOCHEM BIOPH RES CO, V191, P1204, DOI 10.1006/bbrc.1993.1345; LIPSCOMBE RJ, 1995, IMMUNOLOGY, V85, P660; LU J, 1990, J IMMUNOL, V144, P2287; Mohs A, 2006, J BIOL CHEM, V281, P17197, DOI 10.1074/jbc.M601763200; Narayanan T, 2001, NUCL INSTRUM METH A, V467, P1005, DOI 10.1016/S0168-9002(01)00553-8; Okemefuna AI, 2008, J MOL BIOL, V375, P80, DOI 10.1016/j.jmb.2007.09.026; Okemefuna AI, 2010, J BIOL CHEM, V285, P1041, DOI 10.1074/jbc.M109.044495; Okemefuna AI, 2009, J MOL BIOL, V391, P98, DOI 10.1016/j.jmb.2009.06.010; Okuyama K, 2006, BIOPOLYMERS, V84, P181, DOI 10.1002/bip.20381; PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x; Perkins SJ, 2001, BIOPHYS CHEM, V93, P129, DOI 10.1016/S0301-4622(01)00216-2; PERKINS SJ, 1985, BIOCHEM J, V228, P13, DOI 10.1042/bj2280013; Perkins SJ, 2008, METHOD CELL BIOL, V84, P375, DOI 10.1016/S0091-679X(07)84013-1; Perkins SJ, 2009, J R SOC INTERFACE, V6, pS679, DOI 10.1098/rsif.2009.0164.focus; Prosser BE, 2007, J EXP MED, V204, P2277, DOI 10.1084/jem.20071069; Roversi P, 2011, P NATL ACAD SCI USA, V108, P12839, DOI 10.1073/pnas.1102167108; Roversi P, 2011, ACTA CRYSTALLOGR F, V67, P739, DOI 10.1107/S1744309111016551; Schuck P, 1998, BIOPHYS J, V75, P1503, DOI 10.1016/S0006-3495(98)74069-X; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; SHERIFF S, 1994, NAT STRUCT BIOL, V1, P789, DOI 10.1038/nsb1194-789; Teillet F, 2008, J BIOL CHEM, V283, P25715, DOI 10.1074/jbc.M803551200; Thiel S, 1997, NATURE, V386, P506, DOI 10.1038/386506a0; Thielens NM, 2001, J IMMUNOL, V166, P5068, DOI 10.4049/jimmunol.166.8.5068; Wallis R, 1999, J BIOL CHEM, V274, P3580, DOI 10.1074/jbc.274.6.3580; Wallis R, 2004, J BIOL CHEM, V279, P14065, DOI 10.1074/jbc.M400171200; Wallis R, 1997, BIOCHEM J, V325, P391, DOI 10.1042/bj3250391; Wallis R, 2000, J BIOL CHEM, V275, P30962, DOI 10.1074/jbc.M004030200; Wallis R, 2007, IMMUNOBIOLOGY, V212, P289, DOI 10.1016/j.imbio.2006.11.004; WEIS WI, 1994, STRUCTURE, V2, P1227, DOI 10.1016/S0969-2126(94)00124-3; Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755	58	19	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3930	3945		10.1074/jbc.M111.320341	http://dx.doi.org/10.1074/jbc.M111.320341			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22167201	Green Published, hybrid			2022-12-25	WOS:000300410900029
J	Li, AL; Zhang, RZ; Pan, L; Tang, LC; Zhao, GY; Zhu, MZ; Chu, JF; Sun, XH; Wei, B; Zhang, XQ; Jia, JZ; Mao, L				Li, Aili; Zhang, Rongzhi; Pan, Lei; Tang, Lichuan; Zhao, Guangyao; Zhu, Mingzhu; Chu, Jinfang; Sun, Xiaohong; Wei, Bo; Zhang, Xiangqi; Jia, Jizeng; Mao, Long			Transcriptome Analysis of H2O2-Treated Wheat Seedlings Reveals a H2O2-Responsive Fatty Acid Desaturase Gene Participating in Powdery Mildew Resistance	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; EARLY H2O2 ACCUMULATION; PROGRAMMED CELL-DEATH; NEAR-ISOGENIC LINES; HYDROGEN-PEROXIDE; DISEASE RESISTANCE; SIGNALING PATHWAYS; JASMONIC-ACID; ARABIDOPSIS-THALIANA; SALICYLIC-ACID	Hydrogen peroxide (H2O2) plays important roles in plant biotic and abiotic stress responses. However, the effect of H2O2 stress on the bread wheat transcriptome is still lacking. To investigate the cellular and metabolic responses triggered by H2O2, we performed an mRNA tag analysis of wheat seedlings under 10 mM H2O2 treatment for 6 hour in one powdery mildew (PM) resistant (PmA) and two susceptible (Cha and Han) lines. In total, 6,156, 6,875 and 3,276 transcripts were found to be differentially expressed in PmA, Han and Cha respectively. Among them, 260 genes exhibited consistent expression patterns in all three wheat lines and may represent a subset of basal H2O2 responsive genes that were associated with cell defense, signal transduction, photosynthesis, carbohydrate metabolism, lipid metabolism, redox homeostasis, and transport. Among genes specific to PmA, 'transport' activity was significantly enriched in Gene Ontology analysis. MapMan classification showed that, while both up-and down-regulations were observed for auxin, abscisic acid, and brassinolides signaling genes, the jasmonic acid and ethylene signaling pathway genes were all up-regulated, suggesting H2O2-enhanced JA/Et functions in PmA. To further study whether any of these genes were involved in wheat PM response, 19 H2O2-responsive putative defense related genes were assayed in wheat seedlings infected with Blumeria graminis f. sp. tritici (Bgt). Eight of these genes were found to be co-regulated by H2O2 and Bgt, among which a fatty acid desaturase gene TaFAD was then confirmed by virus induced gene silencing (VIGS) to be required for the PM resistance. Together, our data presents the first global picture of the wheat transcriptome under H2O2 stress and uncovers potential links between H2O2 and Bgt responses, hence providing important candidate genes for the PM resistance in wheat.	[Li, Aili; Zhang, Rongzhi; Pan, Lei; Tang, Lichuan; Zhao, Guangyao; Zhu, Mingzhu; Jia, Jizeng; Mao, Long] Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, MOA Key Lab Germplasm & Biotechnol, Beijing, Peoples R China; [Chu, Jinfang; Sun, Xiaohong] Chinese Acad Sci, State Key Lab Plant Genom, Natl Ctr Plant Gene Res, Inst Genet & Dev Biol, Beijing, Peoples R China; [Wei, Bo; Zhang, Xiangqi] Chinese Acad Sci, State Key Lab Plant Cell & Chromosome Engn, Inst Genet & Dev Biol, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Li, AL (corresponding author), Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, MOA Key Lab Germplasm & Biotechnol, Beijing, Peoples R China.	maolong@caas.net.cn			Ministry of Science and Technology [2009AA02Z307]; National Transgenic Key Project [2009ZX08009-009B, 2011ZX08009-001]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Transgenic Key Project	This work is supported in part by the National "863" program of Ministry of Science and Technology (#2009AA02Z307), and the National Transgenic Key Project (#2009ZX08009-009B and #2011ZX08009-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An QL, 2006, NEW PHYTOL, V172, P563, DOI 10.1111/j.1469-8137.2006.01844.x; Torres MA, 2010, PHYSIOL PLANTARUM, V138, P414, DOI 10.1111/j.1399-3054.2009.01326.x; Anthony RG, 2004, EMBO J, V23, P572, DOI 10.1038/sj.emboj.7600068; Aprile A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-279; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Blee E, 2002, TRENDS PLANT SCI, V7, P315, DOI 10.1016/S1360-1385(02)02290-2; Bouchez O, 2007, PLANT PHYSIOL, V145, P465, DOI 10.1104/pp.107.106302; BOYD L, 2009, NEW PHYTOL, V184, P473; Cao AH, 2011, P NATL ACAD SCI USA, V108, P7727, DOI 10.1073/pnas.1016981108; Chain F, 2009, MOL PLANT MICROBE IN, V22, P1323, DOI 10.1094/MPMI-22-11-1323; Chang CCC, 2004, PLANT J, V38, P499, DOI 10.1111/j.1365-313X.2004.02066.x; Chaturvedi R, 2008, PLANT J, V54, P106, DOI 10.1111/j.1365-313X.2007.03400.x; Collins NC, 2003, NATURE, V425, P973, DOI 10.1038/nature02076; Coram TE, 2008, MOL PLANT PATHOL, V9, P479, DOI [10.1111/j.1364-3703.2008.00476.x, 10.1111/J.1364-3703.2008.00476.X]; Costa A, 2010, PLANT J, V62, P760, DOI 10.1111/j.1365-313X.2010.04190.x; Desikan R, 2001, PLANT PHYSIOL, V127, P159, DOI 10.1104/pp.127.1.159; Desmond OJ, 2008, PHYSIOL MOL PLANT P, V73, P40, DOI 10.1016/j.pmpp.2008.12.001; Despres C, 2003, PLANT CELL, V15, P2181, DOI 10.1105/tpc.012849; Fryer MJ, 2003, PLANT J, V33, P691, DOI 10.1046/j.1365-313X.2003.01656.x; Hein I, 2005, PLANT PHYSIOL, V138, P2155, DOI 10.1104/pp.105.062810; HOEN P, 2008, NUCLEIC ACIDS RES, P1; Holzberg S, 2002, PLANT J, V30, P315, DOI 10.1046/j.1365-313X.2002.01291.x; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Hulbert SH, 2007, PHYTOPATHOLOGY, V97, P1083, DOI 10.1094/PHYTO-97-9-1083; Jiang CJ, 2009, MOL PLANT MICROBE IN, V22, P820, DOI 10.1094/MPMI-22-7-0820; Kachroo A, 2003, PLANT CELL, V15, P2952, DOI 10.1105/tpc.017301; Kachroo A, 2008, MOL PLANT MICROBE IN, V21, P564, DOI 10.1094/MPMI-21-5-0564; Kachroo P, 2005, PLANT PHYSIOL, V139, P1717, DOI 10.1104/pp.105.071662; Kachroo P, 2003, MOL PLANT MICROBE IN, V16, P1022, DOI 10.1094/MPMI.2003.16.11.1022; Kachroo P, 2001, P NATL ACAD SCI USA, V98, P9448, DOI 10.1073/pnas.151258398; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; Laudert D, 1998, PLANT J, V15, P675, DOI 10.1046/j.1365-313x.1998.00245.x; Lenucci MS, 2009, PLANT SIGNAL BEHAV, V4, P228, DOI 10.4161/psb.4.3.7883; Leshem Y, 2006, P NATL ACAD SCI USA, V103, P18008, DOI 10.1073/pnas.0604421103; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; Li AL, 2005, PLANT PATHOL, V54, P308, DOI 10.1111/j.1365-3059.2005.01173.x; Liu Y, 2005, SCI CHINA SER C, V48, P202, DOI 10.1360/04yc0088; Loggini B, 1999, PLANT PHYSIOL, V119, P1091, DOI 10.1104/pp.119.3.1091; Lu R, 2003, EMBO J, V22, P5690, DOI 10.1093/emboj/cdg546; Mackerness SAH, 1999, PLANT CELL ENVIRON, V22, P1413, DOI 10.1046/j.1365-3040.1999.00499.x; Mateo A, 2004, PLANT PHYSIOL, V136, P2818, DOI 10.1104/pp.104.043646; Mateo A, 2006, J EXP BOT, V57, P1795, DOI 10.1093/jxb/erj196; MATSUDA Y, 1994, BIOSCI BIOTECH BIOCH, V58, P906, DOI 10.1271/bbb.58.906; McConn M, 1997, P NATL ACAD SCI USA, V94, P5473, DOI 10.1073/pnas.94.10.5473; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Montillet JL, 2005, PLANT PHYSIOL, V138, P1516, DOI 10.1104/pp.105.059907; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; Muhlenbock P, 2007, PLANT CELL, V19, P3819, DOI 10.1105/tpc.106.048843; Mur LAJ, 2008, J EXP BOT, V59, P501, DOI 10.1093/jxb/erm239; Overmyer K, 2005, PLANT PHYSIOL, V137, P1092, DOI 10.1104/pp.104.055681; Overmyer K, 2003, TRENDS PLANT SCI, V8, P335, DOI 10.1016/S1360-1385(03)00135-3; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Pellinen R, 1999, PLANT J, V20, P349, DOI 10.1046/j.1365-313X.1999.00613.x; PRASAD TK, 1994, PLANT CELL, V6, P65, DOI 10.1105/tpc.6.1.65; Qin DD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-432; Qiu DY, 2007, MOL PLANT MICROBE IN, V20, P492, DOI 10.1094/MPMI-20-5-0492; Romeis T, 2001, CURR OPIN PLANT BIOL, V4, P407, DOI 10.1016/S1369-5266(00)00193-X; Schreiber AW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-285; Schutzendubel A, 2002, J EXP BOT, V53, P1351, DOI 10.1093/jexbot/53.372.1351; Scofield SR, 2005, PLANT PHYSIOL, V138, P2165, DOI 10.1104/pp.105.061861; Stone JR, 2004, ARCH BIOCHEM BIOPHYS, V422, P119, DOI 10.1016/j.abb.2003.12.029; Tao Z, 2009, PLANT PHYSIOL, V151, P936, DOI 10.1104/pp.109.145623; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Thoma I, 2003, PLANT J, V34, P363, DOI 10.1046/j.1365-313X.2003.01730.x; Thomma BPHJ, 2000, PLANT PHYSIOL BIOCH, V38, P421, DOI 10.1016/S0981-9428(00)00756-7; Tiwari BS, 2002, PLANT PHYSIOL, V128, P1271, DOI 10.1104/pp.010999; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; Valderrama R, 2006, PLANT CELL ENVIRON, V29, P1449, DOI 10.1111/j.1365-3040.2006.01530.x; Vanacker H, 2000, PLANT PHYSIOL, V123, P1289, DOI 10.1104/pp.123.4.1289; Vanderauwera S, 2005, PLANT PHYSIOL, V139, P806, DOI 10.1104/pp.105.065896; Vijayan P, 1998, P NATL ACAD SCI USA, V95, P7209, DOI 10.1073/pnas.95.12.7209; Wan XY, 2008, MOL CELL PROTEOMICS, V7, P1469, DOI 10.1074/mcp.M700488-MCP200; Wang GF, 2011, NEW PHYTOL, V191, P418, DOI 10.1111/j.1469-8137.2011.03715.x; Zeng LR, 2006, CELL RES, V16, P413, DOI 10.1038/sj.cr.7310053; Zhou HB, 2007, PLANT J, V52, P420, DOI 10.1111/j.1365-313X.2007.03246.x; Zhou RH, 2005, THEOR APPL GENET, V110, P640, DOI 10.1007/s00122-004-1889-0	78	26	27	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28810	10.1371/journal.pone.0028810	http://dx.doi.org/10.1371/journal.pone.0028810			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174904	Green Submitted, gold, Green Published			2022-12-25	WOS:000298366600040
J	Li, ZK; Musich, PR; Serrano, MA; Dong, ZP; Zou, Y				Li, Zhengke; Musich, Phillip R.; Serrano, Moises A.; Dong, Zhiping; Zou, Yue			XPA-Mediated Regulation of Global Nucleotide Excision Repair by ATR Is p53-Dependent and Occurs Primarily in S-Phase	PLOS ONE			English	Article							INDUCED DNA-DAMAGE; CYCLOBUTANE PYRIMIDINE DIMERS; XERODERMA-PIGMENTOSUM; INDUCED PHOSPHORYLATION; P53; CHECKPOINTS; EFFICIENT; STRAND; RECOGNITION; RECRUITMENT	Cell cycle checkpoints play an important role in regulation of DNA repair pathways. However, how the regulation occurs throughout the cell cycle remains largely unknown. Here we demonstrate that nucleotide excision repair (NER) is regulated by the ATR/p53 checkpoint via modulation of XPA nuclear import and that this regulation occurs in a cell cycle-dependent manner. We show that depletion of p53 abrogated the UV-induced nuclear translocation of XPA, while silencing of Chk1 or MAPKAP Kinase-2 (MK2) had no effect. Inhibition of p53 transcriptional activities and silencing of p53-Ser15 phosphorylation also reduced the damage-induced XPA nuclear import. Furthermore, in G1-phase cells the majority of XPA remained in the cytoplasm even after UV treatment. By contrast, while most of the XPA in S-phase cells was initially located in the cytoplasm before DNA damage, UV irradiation stimulated bulk import of XPA into the nucleus. Interestingly, the majority of XPA molecules always were located in the nucleus in G2-phase cells no matter whether the DNA was damaged or not. Consistently, the UV-induced Ser15 phosphorylation of p53 occurred mainly in S-phase cells, and removal of cyclobutane pyrimidine dimers (CPDs) was much more efficient in S-phase cells than in G1-phase cells. Our results suggest that upon DNA damage in S phase, NER could be regulated by the ATR/p53-dependent checkpoint via modulation of the XPA nuclear import process. In contrast, the nuclear import of XPA in G(1) or G(2) phase appears to be largely independent of DNA damage and p53.	[Li, Zhengke; Musich, Phillip R.; Serrano, Moises A.; Dong, Zhiping; Zou, Yue] E Tennessee State Univ, Dept Biochem & Mol Biol, JH Quillen Coll Med, Johnson City, TN 37614 USA	East Tennessee State University	Li, ZK (corresponding author), E Tennessee State Univ, Dept Biochem & Mol Biol, JH Quillen Coll Med, Johnson City, TN 37614 USA.	zouy@etsu.edu	Zou, Yue/ABA-8429-2020; Li, Zhengke/J-8527-2016	Li, Zhengke/0000-0001-5560-343X; Musich, Phillip/0000-0001-8816-4242; Serrano, Moises/0000-0002-1037-9304	National Institutes of Health [CA86927, GM083307]; NATIONAL CANCER INSTITUTE [R56CA086927, R01CA086927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM083307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health grants: CA86927 and GM083307. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimoolam S, 2002, P NATL ACAD SCI USA, V99, P12985, DOI 10.1073/pnas.202485699; Auclair Y, 2008, P NATL ACAD SCI USA, V105, P17896, DOI 10.1073/pnas.0801585105; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Batty DP, 2000, GENE, V241, P193, DOI 10.1016/S0378-1119(99)00489-8; Besaratinia A, 2011, FASEB J, V25, P3079, DOI 10.1096/fj.11-187336; BOHR VA, 1985, CELL, V40, P359, DOI 10.1016/0092-8674(85)90150-3; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Chen J, 2011, CELL CYCLE, V10, P1287, DOI 10.4161/cc.10.8.15341; de Lima-Bessa KM, 2008, DNA REPAIR, V7, P303, DOI 10.1016/j.dnarep.2007.11.003; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; Fan W, 2010, MOL CELL, V39, P247, DOI 10.1016/j.molcel.2010.07.006; Ford JM, 1997, J BIOL CHEM, V272, P28073, DOI 10.1074/jbc.272.44.28073; FORD JM, 1995, P NATL ACAD SCI USA, V92, P8876, DOI 10.1073/pnas.92.19.8876; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Guo RF, 2010, J BIOL CHEM, V285, P19308, DOI 10.1074/jbc.M110.121939; Helt CE, 2005, J BIOL CHEM, V280, P1186, DOI 10.1074/jbc.M410873200; Kang TH, 2011, NUCLEIC ACIDS RES, V39, P3176, DOI 10.1093/nar/gkq1318; Kang TH, 2010, P NATL ACAD SCI USA, V107, P4890, DOI 10.1073/pnas.0915085107; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Knudsen NO, 2009, DNA REPAIR, V8, P682, DOI 10.1016/j.dnarep.2009.03.005; KRAEMER KH, 1994, ARCH DERMATOL, V130, P1018, DOI 10.1001/archderm.130.8.1018; KRAEMER KH, 1987, ARCH DERMATOL, V123, P241, DOI 10.1001/archderm.123.2.241; Lambert PF, 1998, J BIOL CHEM, V273, P33048, DOI 10.1074/jbc.273.49.33048; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; Mer G, 2000, CELL, V103, P449, DOI 10.1016/S0092-8674(00)00136-7; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Niida H, 2006, MUTAGENESIS, V21, P3, DOI 10.1093/mutage/gei063; Nitta M, 2000, NUCLEIC ACIDS RES, V28, P4212, DOI 10.1093/nar/28.21.4212; Park CJ, 2006, FEBS J, V273, P1600, DOI 10.1111/j.1742-4658.2006.05189.x; Rasey JS, 2002, J NUCL MED, V43, P1210; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Schorl C, 2007, METHODS, V41, P143, DOI 10.1016/j.ymeth.2006.07.022; Shell SM, 2009, J BIOL CHEM, V284, P24213, DOI 10.1074/jbc.M109.000745; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Tan T, 2002, MOL CELL BIOL, V22, P3247, DOI 10.1128/MCB.22.10.3247-3254.2002; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; VREESWIJK MPG, 1994, J BIOL CHEM, V269, P31858; Wang QE, 2003, DNA REPAIR, V2, P483, DOI 10.1016/S1568-7864(03)00002-8; WANG XW, 1995, NAT GENET, V10, P188, DOI 10.1038/ng0695-188; Wu X, 2007, ONCOGENE, V26, P757, DOI 10.1038/sj.onc.1209828; Yang ZG, 2006, BIOCHEMISTRY-US, V45, P15921, DOI 10.1021/bi061626q; Zhang YP, 2001, SCIENCE, V292, P1910, DOI 10.1126/science.1058637; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	46	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28326	10.1371/journal.pone.0028326	http://dx.doi.org/10.1371/journal.pone.0028326			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174788	Green Published, gold, Green Submitted			2022-12-25	WOS:000298366600011
J	Shi, DS; Li, YD; Cabrera-Luque, J; Jin, ZM; Yu, XL; Zhao, GX; Haskins, N; Allewell, NM; Tuchman, M				Shi, Dashuang; Li, Yongdong; Cabrera-Luque, Juan; Jin, Zhongmin; Yu, Xiaolin; Zhao, Gengxiang; Haskins, Nantaporn; Allewell, Norma M.; Tuchman, Mendel			A Novel N-Acetylglutamate Synthase Architecture Revealed by the Crystal Structure of the Bifunctional Enzyme from Maricaulis maris	PLOS ONE			English	Article							L-GLUTAMATE KINASE; ARGININE-BIOSYNTHESIS; ESCHERICHIA-COLI; SWISS-MODEL; MOLECULAR REPLACEMENT; THERMOTOGA-MARITIMA; PROTEIN-STRUCTURE; GNAT SUPERFAMILY; WEB SERVER; HOMOLOGY	Novel bifunctional N-acetylglutamate synthase/kinases (NAGS/K) that catalyze the first two steps of arginine biosynthesis and are homologous to vertebrate N-acetylglutamate synthase (NAGS), an essential cofactor-producing enzyme in the urea cycle, were identified in Maricaulis maris and several other bacteria. Arginine is an allosteric inhibitor of NAGS but not NAGK activity. The crystal structure of M. maris NAGS/K (mmNAGS/K) at 2.7 angstrom resolution indicates that it is a tetramer, in contrast to the hexameric structure of Neisseria gonorrhoeae NAGS. The quaternary structure of crystalline NAGS/K from Xanthomonas campestris (xcNAGS/K) is similar, and cross-linking experiments indicate that both mmNAGS/K and xcNAGS are tetramers in solution. Each subunit has an amino acid kinase (AAK) domain, which is likely responsible for N-acetylglutamate kinase (NAGK) activity and has a putative arginine binding site, and an N-acetyltransferase (NAT) domain that contains the putative NAGS active site. These structures and sequence comparisons suggest that the linker residue 291 may determine whether arginine acts as an allosteric inhibitor or activator in homologous enzymes in microorganisms and vertebrates. In addition, the angle of rotation between AAK and NAT domains varies among crystal forms and subunits within the tetramer. A rotation of 26 degrees is sufficient to close the predicted AcCoA binding site, thus reducing enzymatic activity. Since mmNAGS/K has the highest degree of sequence homology to vertebrate NAGS of NAGS and NAGK enzymes whose structures have been determined, the mmNAGS/K structure was used to develop a structural model of human NAGS that is fully consistent with the functional effects of the 14 missense mutations that were identified in NAGS-deficient patients.	[Shi, Dashuang; Li, Yongdong; Cabrera-Luque, Juan; Yu, Xiaolin; Zhao, Gengxiang; Haskins, Nantaporn; Tuchman, Mendel] George Washington Univ, Med Genet Res Ctr, Washington, DC USA; [Shi, Dashuang; Li, Yongdong; Cabrera-Luque, Juan; Yu, Xiaolin; Zhao, Gengxiang; Haskins, Nantaporn; Tuchman, Mendel] George Washington Univ, Childrens Natl Med Ctr, Dept Integrat Syst Biol, Washington, DC USA; [Li, Yongdong] Gannan Normal Univ, Key Lab Organopharmaceut Chem, Ganzhou, Jiangxi, Peoples R China; [Jin, Zhongmin] Argonne Natl Lab, Adv Photon Source, SE Reg Collaborat Access Team, Argonne, IL 60439 USA; [Allewell, Norma M.] Univ Maryland, Coll Comp Math & Nat Sci, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA; [Allewell, Norma M.] Univ Maryland, Dept Chem & Biochem, Coll Comp Math & Nat Sci, College Pk, MD 20742 USA	George Washington University; Children's National Health System; George Washington University; Gannan Normal University; United States Department of Energy (DOE); Argonne National Laboratory; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Shi, DS (corresponding author), George Washington Univ, Med Genet Res Ctr, Washington, DC USA.	dshi@cnmcresearch.org		Shi, Dashuang/0000-0002-5491-1104	Public Health Service; National Institute of Diabetes, Digestive and Kidney Diseases [DK-DK064913, DK-067935]; National Institute of Child Health and Human Development [HD32652]; U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD032652] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064913, K01DK067935] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institute of Diabetes, Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Public Health Service grants DK-DK064913 (MT) and DK-067935 (DS) from the National Institute of Diabetes, Digestive and Kidney Diseases and HD32652 from the National Institute of Child Health and Human Development. Use of the Advanced Photon Source was supported by the U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. W-31-109-Eng-38. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burk DL, 2003, PROTEIN SCI, V12, P426, DOI 10.1110/ps.0233503; Caldovic L, 2004, J PEDIATR-US, V145, P552, DOI 10.1016/j.jpeds.2004.06.047; Caldovic L, 2007, HUM MUTAT, V28, P754, DOI 10.1002/humu.20518; Claude JB, 2004, NUCLEIC ACIDS RES, V32, pW606, DOI 10.1093/nar/gkh400; CUNIN R, 1986, MICROBIOL REV, V50, P314, DOI 10.1128/MMBR.50.3.314-352.1986; DAVIES GE, 1970, P NATL ACAD SCI USA, V66, P651, DOI 10.1073/pnas.66.3.651; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Errey JC, 2005, J BACTERIOL, V187, P3039, DOI 10.1128/JB.187.9.3039-3044.2005; Fernandez-Murga ML, 2004, J BACTERIOL, V186, P6142, DOI 10.1128/JB.186.18.6142-6149.2004; Gil F, 1999, ACTA CRYSTALLOGR D, V55, P1350, DOI 10.1107/S0907444999005351; Gil-Ortiz F, 2002, ACTA CRYSTALLOGR D, V58, P1892, DOI 10.1107/S0907444902013689; Gil-Ortiz F, 2010, J MOL BIOL, V399, P476, DOI 10.1016/j.jmb.2010.04.025; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hao Q, 2004, J APPL CRYSTALLOGR, V37, P498, DOI 10.1107/S0021889804008696; Haskins Nantaporn, 2008, BMC Biochemistry, V9, P24, DOI 10.1186/1471-2091-9-24; He HZ, 2003, J MOL BIOL, V325, P1019, DOI 10.1016/S0022-2836(02)01284-6; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Llacer JL, 2007, P NATL ACAD SCI USA, V104, P17644, DOI 10.1073/pnas.0705987104; Marco-Marin C, 2005, J MOL BIOL, V352, P438, DOI 10.1016/j.jmb.2005.07.045; Marco-Marin C, 2007, J MOL BIOL, V367, P1431, DOI 10.1016/j.jmb.2007.01.073; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Meyer PA, 2009, J BIOL CHEM, V284, P12933, DOI 10.1074/jbc.M809199200; Min L, 2009, J BIOL CHEM, V284, P4873, DOI 10.1074/jbc.M805348200; Mizuno Y, 2007, J BIOL CHEM, V282, P35733, DOI 10.1074/jbc.M707127200; Morris RJ, 2004, J SYNCHROTRON RADIAT, V11, P56, DOI 10.1107/S090904950302394X; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P154, DOI 10.1016/S0968-0004(97)01034-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Qu Qiuhao, 2007, BMC Biochemistry, V8, DOI 10.1186/1471-2091-8-4; Ramon-Maique S, 2010, J MOL BIOL, V397, P1261, DOI 10.1016/j.jmb.2010.02.038; Ramon-Maiques S, 2006, J MOL BIOL, V356, P695, DOI 10.1016/j.jmb.2005.11.079; Ramon-Maiques S, 2002, STRUCTURE, V10, P329, DOI 10.1016/S0969-2126(02)00721-9; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Sancho-Vaello E, 2008, FEBS LETT, V582, P1081, DOI 10.1016/j.febslet.2008.02.060; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schrodinger L., 2020, PYMOL; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shi D, 2008, J BIOL CHEM, V283, P7176, DOI 10.1074/jbc.M707678200; Shi DS, 2006, ACTA CRYSTALLOGR F, V62, P1218, DOI 10.1107/S1744309106044101; Shi DS, 2005, ACTA CRYSTALLOGR F, V61, P676, DOI 10.1107/S1744309105018051; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tuchman M, 2008, PEDIATR RES, V64, P213, DOI 10.1203/PDR.0b013e318179454b; Vetting MW, 2008, PROTEIN SCI, V17, P1781, DOI 10.1110/ps.035899.108; Vetting MW, 2005, J BIOL CHEM, V280, P22108, DOI 10.1074/jbc.M502401200; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Vetting MW, 2003, PROTEIN SCI, V12, P1954, DOI 10.1110/ps.03153703	60	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28825	10.1371/journal.pone.0028825	http://dx.doi.org/10.1371/journal.pone.0028825			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174908	Green Submitted, gold, Green Published			2022-12-25	WOS:000298366600042
J	Tate, MLK; Chang, H; Moore, SR; Knothe, UR				Tate, Melissa L. Knothe; Chang, Hana; Moore, Shannon R.; Knothe, Ulf R.			Surgical Membranes as Directional Delivery Devices to Generate Tissue: Testing in an Ovine Critical Sized Defect Model	PLOS ONE			English	Article							BONE-TRANSPORT; ILIZAROV METHOD; CELL FATE; TIBIAL DEFECTS; PERIOSTEUM; LIMB; RECONSTRUCTION; FRACTURES; OSTEOINDUCTION; COMPLICATIONS	Purpose: Pluripotent cells residing in the periosteum, a bi-layered membrane enveloping all bones, exhibit a remarkable regenerative capacity to fill in critical sized defects of the ovine femur within two weeks of treatment. Harnessing the regenerative power of the periosteum appears to be limited only by the amount of healthy periosteum available. Here we use a substitute periosteum, a delivery device cum implant, to test the hypothesis that directional delivery of endogenous periosteal factors enhances bone defect healing. Methods: Newly adapted surgical protocols were used to create critical sized, middiaphyseal femur defects in four groups of five skeletally mature Swiss alpine sheep. Each group was treated using a periosteum substitute for the controlled addition of periosteal factors including the presence of collagen in the periosteum (Group 1), periosteum derived cells (Group 2), and autogenic periosteal strips (Group 3). Control group animals were treated with an isotropic elastomer membrane alone. We hypothesized that periosteal substitute membranes incorporating the most periosteal factors would show superior defect infilling compared to substitute membranes integrating fewer factors (i.e. Group 3>Group 2>Group 1>Control). Results: Based on micro-computed tomography data, bone defects enveloped by substitute periosteum enabling directional delivery of periosteal factors exhibit superior bony bridging compared to those sheathed with isotropic membrane controls (Group 3>Group 2>Group 1, Control). Quantitative histological analysis shows significantly increased de novo tissue generation with delivery of periosteal factors, compared to the substitute periosteum containing a collagen membrane alone (Group 1) as well as compared to the isotropic control membrane. Greatest tissue generation and maximal defect bridging was observed when autologous periosteal transplant strips were included in the periosteum substitute. Conclusion: Periosteum-derived cells as well as other factors intrinsic to periosteum play a key role for infilling of critical sized defects.	[Tate, Melissa L. Knothe; Chang, Hana; Moore, Shannon R.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Tate, Melissa L. Knothe] Case Western Reserve Univ, Dept Mech & Aerosp Engn, Cleveland, OH 44106 USA; [Knothe, Ulf R.] Cleveland Clin, Dept Orthopaed Surg, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation	Tate, MLK (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.	knothetate@case.edu	Knothe, Ulf/N-6545-2014; Knothe Tate, Melissa L./O-2086-2015	Knothe, Ulf/0000-0002-1406-6014; Knothe Tate, Melissa L./0000-0002-3552-2525	Case-Coulter Translational Research Partnership; Medtronic Fellowship; AO Foundation [F-07-99K]; Whitaker International Fellows and Scholars Program; Alexander von Humboldt Foundation	Case-Coulter Translational Research Partnership; Medtronic Fellowship; AO Foundation; Whitaker International Fellows and Scholars Program; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	The surgical study was supported by the Case-Coulter Translational Research Partnership. Hana Chang was supported through a Medtronic Fellowship. Shannon Moore was supported in part through a grant from the AO Foundation (F-07-99K) and the Whitaker International Fellows and Scholars Program. Melissa Knothe Tate was supported in part through the Alexander von Humboldt Foundation's Fellowship for Senior Researchers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282; Allen MR, 2004, BONE, V35, P1003, DOI 10.1016/j.bone.2004.07.014; ALONSO J, 1997, CLIN PLAST SURG, V18, P497; Arnsdorf EJ, 2009, TISSUE ENG PT A, V15, P2637, DOI [10.1089/ten.tea.2008.0244, 10.1089/ten.TEA.2008.0244]; Aronson J, 1997, J BONE JOINT SURG AM, V79A, P1243, DOI 10.2106/00004623-199708000-00019; Atesalp AS, 1998, INT ORTHOP, V22, P343, DOI 10.1007/s002640050274; Colnot C, 2009, J BONE MINER RES, V24, P274, DOI 10.1359/JBMR.081003; DAGHER F, 1991, J BONE JOINT SURG BR, V73, P316, DOI 10.1302/0301-620X.73B2.2005164; DeCoster TA, 2004, J AM ACAD ORTHOP SUR, V12, P28, DOI 10.5435/00124635-200401000-00005; DECOSTER TA, 1992, CLIN ORTHOP RELAT R, V283, P116; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; GLOWACKI J, 1985, CLIN PLAST SURG, V12, P233; Gugenheim JJ, 1998, CLIN PLAST SURG, V25, P567; Knothe Tate ML, 2011, U.S. Patent No. US, Patent No. [US7879107 B2, 7879107, 7,879,107 B2]; KNOTHE U, 2005, WORLD J SURG ONCOL, V3, P5; Knothe UR, 2010, J BIOMECH, V43, P2728, DOI 10.1016/j.jbiomech.2010.06.026; Marsh DR, 1997, J BONE JOINT SURG BR, V79B, P273, DOI 10.1302/0301-620X.79B2.6636; McBride SH, 2011, J BIOMECH, V44, P1954, DOI 10.1016/j.jbiomech.2011.04.036; Meganck JA, 2009, BONE, V45, P1104, DOI 10.1016/j.bone.2009.07.078; Miller RM, 2011, T ORTHOP RES SOC, V36, P2213; NIELSEN FF, 1992, ACTA ORTHOP SCAND, V63, P66, DOI 10.3109/17453679209154853; Ozaki A, 2000, J Orthop Sci, V5, P64, DOI 10.1007/s007760050010; PALEY D, 1990, CLIN ORTHOP RELAT R, P81; Paley D, 2000, J ORTHOP TRAUMA, V14, P76, DOI 10.1097/00005131-200002000-00002; Pavolini B, 2000, J Orthop Sci, V5, P108, DOI 10.1007/s007760050137; Polak WG, 2001, VASA-J VASCULAR DIS, V30, P138, DOI 10.1024/0301-1526.30.2.138; POLYZOIS D, 1997, ACTA ORHTOP SCAND  S, V275, P84; PROKUSKI LJ, 1994, ORTHOP CLIN N AM, V25, P753; Saleh M, 1999, BRIT MED BULL, V55, P870, DOI 10.1258/0007142991902682; SLOMKA R, CLIN ORTHOPAEDICS RE, V391, P115; Smrke D, 2000, INJURY, V31, P153, DOI 10.1016/S0020-1383(99)00253-3; Tate MLK, 2008, INT J BIOCHEM CELL B, V40, P2720, DOI 10.1016/j.biocel.2008.05.011; Tate MLK, 2007, J BONE JOINT SURG AM, V89A, P307, DOI 10.2106/JBJS.E.00512; TATE MLK, 2011, Patent No. 2011109817; TATE MLK, 2009, Patent No. 20090053109; Taylor J, 1992, BONE, V4, P21; TUCKER HL, 1990, ORTHOP CLIN N AM, V21, P629; URIST MR, 1972, CLIN ORTHOP RELAT R, P132; WATSON JT, 1995, CLIN ORTHOP RELAT R, P138; Yamamiya K, 2008, J PERIODONTOL, V79, P811, DOI [10.1902/jop.2008.070518, 10.1902/jop.2008.070518 ]; Yiannakopoulos CK, 2008, ARCH ORTHOP TRAUM SU, V128, P117, DOI 10.1007/s00402-007-0433-5; ZHANG X, 2008, CLIN ORTHOP RELAT R, V466, P17777; Zhang XP, 2005, J BONE MINER RES, V20, P2124, DOI 10.1359/JBMR.050806; Zhao L, 2008, STRATEG TRAUMA LIMB, V3, P57, DOI 10.1007/s11751-008-0034-z	44	23	25	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28702	10.1371/journal.pone.0028702	http://dx.doi.org/10.1371/journal.pone.0028702			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174873	Green Submitted, Green Published, gold			2022-12-25	WOS:000298366600031
J	Wang, C; Hu, YM; He, JW; Gu, JM; Zhang, H; Hu, WW; Yue, H; Gao, G; Xiao, WJ; Yu, JB; Ke, YH; Hu, YQ; Li, M; Liu, YJ; Fu, WZ; Ren, Y; Zhang, ZL				Wang, Chun; Hu, Yi-Ming; He, Jin-Wei; Gu, Jie-Mei; Zhang, Hao; Hu, Wei-Wei; Yue, Hua; Gao, Gao; Xiao, Wen-Jin; Yu, Jin-Bo; Ke, Yao-Hua; Hu, Yun-Qiu; Li, Miao; Liu, Yu-Juan; Fu, Wen-Zhen; Ren, Ying; Zhang, Zhen-Lin			Association between Low Density Lipoprotein Receptor-Related Protein 2 Gene Polymorphisms and Bone Mineral Density Variation in Chinese Population	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; NUCLEAR FAMILIES; PEAK BMD; OSTEOPOROSIS; WOMEN; MEN; SUNSHINE; FRACTURE; MASS	Low density lipoprotein receptor-related protein 2 gene (LRP2) is located next to the genomic region showing suggestive linkage with both hip and wrist bone mineral density (BMD) phenotypes. LRP2 knockout mice showed severe vitamin D deficiency and bone disease, indicating the involvement of LRP2 in the preservation of vitamin D metabolites and delivery of the precursor to the kidney for the generation of 1 alpha,25(OH)(2)D(3). In order to investigate the contribution of LRP2 gene polymorphisms to the variation of BMD in Chinese population, a total of 330 Chinese female-offspring nuclear families with 1088 individuals and 400 Chinese male-offspring nuclear families with 1215 individuals were genotyped at six tagSNPs of the LRP2 gene (rs2389557, rs2544381, rs7600336, rs10210408, rs2075252 and rs4667591). BMD values at the lumbar spine 1-4 (L1-4) and hip sites were measured by DXA. The association between LRP2 polymorphisms and BMD phenotypes was assessed by quantitative transmission disequilibrium tests (QTDTs) in female- and male-offspring nuclear families separately. In the female-offspring nuclear families, rs2075252 and haplotype GA of rs4667591 and rs2075252 were identified in the nominally significant total association with peak BMD at L1-4; however, no significant within-family association was found between peak BMD at the L1-4 and hip sites and six tagSNPs or haplotypes. In male-offspring nuclear families, neither the six tagSNPs nor the haplotypes was in total association or within-family association with the peak BMD variation at the L1-4 and hip sites by QTDT analysis. Our findings suggested that the polymorphisms of LRP2 gene is not a major factor that contributes to the peak BMD variation in Chinese population.	[Wang, Chun; He, Jin-Wei; Gu, Jie-Mei; Zhang, Hao; Hu, Wei-Wei; Yue, Hua; Gao, Gao; Xiao, Wen-Jin; Yu, Jin-Bo; Ke, Yao-Hua; Hu, Yun-Qiu; Li, Miao; Liu, Yu-Juan; Fu, Wen-Zhen; Zhang, Zhen-Lin] Shanghai Jiao Tong Univ, Dept Osteoporosis & Bone Dis, Metab Bone Dis & Genet Res Unit, Shanghai Peoples Hosp 6, Shanghai 200030, Peoples R China; [Hu, Yi-Ming; Ren, Ying] Shanghai Jiao Tong Univ, Dept Special Med Serv, Shanghai Peoples Hosp 6, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, C (corresponding author), Shanghai Jiao Tong Univ, Dept Osteoporosis & Bone Dis, Metab Bone Dis & Genet Res Unit, Shanghai Peoples Hosp 6, Shanghai 200030, Peoples R China.	zzl2002@medmail.com.cn			National Natural Science Foundation of China (NSFC) [30570891, 30771019, 30800387]; Science and Technology commission of Shanghai municipality [08XD1403000, STCSM10DZ1950100, 08411963100, 11ZR1427300]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Science and Technology commission of Shanghai municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the National Natural Science Foundation of China (NSFC) (No. 30570891, 30771019, and 30800387), Science and Technology commission of Shanghai municipality (Project No. 08XD1403000, STCSM10DZ1950100, 08411963100, and 11ZR1427300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Bodine PVN, 2008, CELL RES, V18, P248, DOI 10.1038/cr.2008.13; Choi YM, 2000, J HUM GENET, V45, P280, DOI 10.1007/s100380070016; Dundar U, 2009, CLIN RHEUMATOL, V28, P1187, DOI 10.1007/s10067-009-1220-1; FARQUHAR MG, 1995, J CLIN INVEST, V96, P1184, DOI 10.1172/JCI118149; Ferrari S, 2008, BEST PRACT RES CL EN, V22, P723, DOI 10.1016/j.beem.2008.08.007; Funakoshi Yayoi, 2009, Environmental Health and Preventive Medicine, V14, P328, DOI 10.1007/s12199-009-0104-y; Gao G, 2008, J CLIN DENSITOM, V11, P360, DOI 10.1016/j.jocd.2008.04.005; Gao G, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-1; Gu JM, 2009, ACTA PHARMACOL SIN, V30, P1634, DOI 10.1038/aps.2009.169; Hsu YH, 2007, J BONE MINER RES, V22, P184, DOI 10.1359/JBMR.061015; Koller DL, 2005, J BONE MINER RES, V20, P75, DOI 10.1359/JBMR.041019; Kung Annie W. C., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P26; Laaksonen MML, 2009, J NUTRIGENET NUTRIGE, V2, P55, DOI 10.1159/000204960; Lau EMC, 2002, OSTEOPOROSIS INT, V13, P218, DOI 10.1007/s001980200017; Lopes JB, 2009, MATURITAS, V64, P218, DOI 10.1016/j.maturitas.2009.09.020; Lou YR, 2010, J STEROID BIOCHEM, V118, P162, DOI 10.1016/j.jsbmb.2009.11.011; Molgaard C, 2010, BONE, V46, P432, DOI 10.1016/j.bone.2009.08.056; Nykjaer A, 1999, CELL, V96, P507, DOI 10.1016/S0092-8674(00)80655-8; Pekkarinen T, 2010, EUR J ENDOCRINOL, V162, P183, DOI 10.1530/EJE-09-0739; Qin YJ, 2004, ACTA PHARMACOL SIN, V25, P462; Qin YJ, 2003, J BONE MINER RES, V18, P1028, DOI 10.1359/jbmr.2003.18.6.1028; Ralston SH, 2006, GENE DEV, V20, P2492, DOI 10.1101/gad.1449506; RAYCHOWDHURY R, 1989, SCIENCE, V244, P1163, DOI 10.1126/science.2786251; Remes T, 2005, ANN MED, V37, P383, DOI 10.1080/07853890510011958; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Richards JB, 2009, ANN INTERN MED, V151, P528, DOI 10.7326/0003-4819-151-8-200910200-00006; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; SILVER J, 1986, J CLIN INVEST, V78, P1296, DOI 10.1172/JCI112714; Stechschulte SA, 2009, AM J MED, V122, P793, DOI 10.1016/j.amjmed.2009.02.029; Tavera LE, 2007, SCI AM, V297, P62, DOI 10.1038/scientificamerican1107-62; Tavera-Mendoza L. E., 2007, SCI AM, V297, P72; Tavera-Mendoza LE, 2007, SCI AM, P68; Xiao P, 2006, J BONE MINER RES, V21, P1536, DOI 10.1359/JBMR.060717; Zhang ZL, 2008, OSTEOPOROSIS INT, V19, P39, DOI 10.1007/s00198-007-0435-8; Zhang ZL, 2006, ASIAN J ANDROL, V8, P419, DOI 10.1111/j.1745-7262.2006.00170.x; Zhang Zhen-lin, 2003, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V20, P5	37	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28874	10.1371/journal.pone.0028874	http://dx.doi.org/10.1371/journal.pone.0028874			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174918	gold, Green Published, Green Submitted			2022-12-25	WOS:000298365700080
J	Barjaktarovic, Z; Schmaltz, D; Shyla, A; Azimzadeh, O; Schulz, S; Haagen, J; Dorr, W; Sarioglu, H; Schafer, A; Atkinson, MJ; Zischka, H; Tapio, S				Barjaktarovic, Zarko; Schmaltz, Dominik; Shyla, Alena; Azimzadeh, Omid; Schulz, Sabine; Haagen, Julia; Doerr, Wolfgang; Sarioglu, Hakan; Schaefer, Alexander; Atkinson, Michael J.; Zischka, Hans; Tapio, Soile			Radiation-Induced Signaling Results in Mitochondrial Impairment in Mouse Heart at 4 Weeks after Exposure to X-Rays	PLOS ONE			English	Article							OXIDATIVE STRESS; LONG-TERM; BREAST-CANCER; FOLLOW-UP; QUANTITATIVE-ANALYSIS; MORTALITY EXPERIENCE; DESMIN CYTOSKELETON; POLYACRYLAMIDE GELS; IONIZING-RADIATION; STATISTICAL-MODEL	Backround: Radiation therapy treatment of breast cancer, Hodgkin's disease or childhood cancers expose the heart to high local radiation doses, causing an increased risk of cardiovascular disease in the survivors decades after the treatment. The mechanisms that underlie the radiation damage remain poorly understood so far. Previous data show that impairment of mitochondrial oxidative metabolism is directly linked to the development of cardiovascular disease. Methodology/Principal findings: In this study, the radiation-induced in vivo effects on cardiac mitochondrial proteome and function were investigated. C57BL/6N mice were exposed to local irradiation of the heart with doses of 0.2 Gy or 2 Gy (Xray, 200 kV) at the age of eight weeks, the control mice were sham-irradiated. After four weeks the cardiac mitochondria were isolated and tested for proteomic and functional alterations. Two complementary proteomics approaches using both peptide and protein quantification strategies showed radiation-induced deregulation of 25 proteins in total. Three main biological categories were affected: the oxidative phophorylation, the pyruvate metabolism, and the cytoskeletal structure. The mitochondria exposed to high-dose irradiation showed functional impairment reflected as partial deactivation of Complex I (32%) and Complex III (11%), decreased succinate-driven respiratory capacity (13%), increased level of reactive oxygen species and enhanced oxidation of mitochondrial proteins. The changes in the pyruvate metabolism and structural proteins were seen with both low and high radiation doses. Conclusion/Significance: This is the first study showing the biological alterations in the murine heart mitochondria several weeks after the exposure to low-and high-dose of ionizing radiation. Our results show that doses, equivalent to a single dose in radiotherapy, cause long-lasting changes in mitochondrial oxidative metabolism and mitochondria-associated cytoskeleton. This prompts us to propose that these first pathological changes lead to an increased risk of cardiovascular disease after radiation exposure.	[Barjaktarovic, Zarko; Schmaltz, Dominik; Shyla, Alena; Azimzadeh, Omid; Atkinson, Michael J.; Tapio, Soile] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Radiat Biol, Neuherberg, Germany; [Schulz, Sabine; Zischka, Hans] German Res Ctr Environm Hlth, Inst Toxicol, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Haagen, Julia; Doerr, Wolfgang] Tech Univ Dresden, Dept Radiotherapy & Radiooncol, Med Fac Carl Gustav Carus, D-01062 Dresden, Germany; [Sarioglu, Hakan; Schaefer, Alexander] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Dept Prot Sci, Prote Core Facil, Neuherberg, Germany; [Atkinson, Michael J.] Tech Univ Munich, Klinikum Rechts Isar, Dept Radiat Oncol, D-8000 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Barjaktarovic, Z (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Radiat Biol, Neuherberg, Germany.	zarko.barjaktarovic@helmholtz-muenchen.de	Zischka, Hans/M-1490-2017; Atkinson, Michael J/E-5537-2011; Atkinson, Michael/AAU-5127-2020; Tapio, Soile/CAJ-5871-2022; Tapio, Soile/M-7358-2014; Doerr, Wolfgang/J-9344-2014	Zischka, Hans/0000-0002-4047-1566; Atkinson, Michael J/0000-0003-3358-2089; Atkinson, Michael/0000-0003-3358-2089; Tapio, Soile/0000-0001-9860-3683; Azimzadeh, Omid/0000-0001-8984-0388; Doerr, Wolfgang/0000-0003-1477-6849	European Community [211403]	European Community(European Commission)	The research leading to these results is supported by a grant from the European Community's Seventh Framework Programme (EURATOM) contract no 211403 (CARDIORISK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V366, P2087; ALLAN IM, 1988, BRIT J CANCER, V58, P34, DOI 10.1038/bjc.1988.156; Azimzadeh O, 2011, PROTEOMICS, V11, P3299, DOI 10.1002/pmic.201100178; Azizova TV, 2010, RADIAT RES, V174; Ballinger SW, 2005, FREE RADICAL BIO MED, V38, P1278, DOI 10.1016/j.freeradbiomed.2005.02.014; Bayeva M, 2010, CURR HYPERTENS REP, V12, P426, DOI 10.1007/s11906-010-0149-8; Bindoff L, 2003, EUR HEART J, V24, P221, DOI 10.1016/S0195-668X(02)00694-2; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Boja ES, 2009, J PROTEOME RES, V8, P4665, DOI 10.1021/pr900387b; Boldogh IR, 2007, TRENDS CELL BIOL, V17, P502, DOI 10.1016/j.tcb.2007.07.008; Boldogh IR, 2006, BBA-MOL CELL RES, V1763, P450, DOI 10.1016/j.bbamcr.2006.02.014; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Capetanaki Y, 2002, TRENDS CARDIOVAS MED, V12, P339, DOI 10.1016/S1050-1738(02)00184-6; Carr ZA, 2005, INT J RADIAT ONCOL, V61, P842, DOI 10.1016/j.ijrobp.2004.07.708; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Chevallet M, 2006, NAT PROTOC, V1, P1852, DOI 10.1038/nprot.2006.288; Coyle CH, 2007, ASAIO J, V53, P17, DOI 10.1097/01.mat.0000247157.84350.e8; Darby S, 2005, BMJ-BRIT MED J, V330, P223, DOI 10.1136/bmj.38308.477650.63; Darby S, 2003, BRIT MED J, V326, P256, DOI 10.1136/bmj.326.7383.256; DARBY SC, 1987, BRIT J CANCER, V55, P179, DOI 10.1038/bjc.1987.35; Davidson SM, 2010, CARDIOVASC RES, V88, P58, DOI 10.1093/cvr/cvq195; DAVIS FG, 1989, CANCER RES, V49, P6130; Demirci S, 2009, INT J RADIAT ONCOL, V73, P980, DOI 10.1016/j.ijrobp.2008.11.016; Dhalla NS, 2000, J HYPERTENS, V18, P655, DOI 10.1097/00004872-200018060-00002; Drose S, 2008, J BIOL CHEM, V283, P21649, DOI 10.1074/jbc.M803236200; EMERIT I, 1994, J CANCER RES CLIN, V120, P558, DOI 10.1007/BF01221035; Eny KM, 2005, LUPUS, V14, P351, DOI 10.1191/0961203305lu2091oa; Eriksson P, 2010, NEUROTOXICOLOGY, V31, P223, DOI 10.1016/j.neuro.2010.01.002; Fedorova M, 2009, BBA-MOL BASIS DIS, V1792, P1185, DOI 10.1016/j.bbadis.2009.09.011; Forner F, 2006, MOL CELL PROTEOMICS, V5, P608, DOI 10.1074/mcp.M500298-MCP200; Fu CX, 2008, J PROTEOME RES, V7, P3789, DOI 10.1021/pr800233r; Garlid KD, 2009, J MOL CELL CARDIOL, V46, P858, DOI 10.1016/j.yjmcc.2008.11.019; Geiger T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001090; GOH KO, 1968, RADIAT RES, V35, P171, DOI 10.2307/3572443; Hauptmann M, 2003, AM J EPIDEMIOL, V157, P239, DOI 10.1093/aje/kwf189; Hausenloy DJ, 2008, DIABETES OBES METAB, V10, P451, DOI 10.1111/j.1463-1326.2007.00762.x; Hayashi T, 2005, AM J MED, V118, P83, DOI 10.1016/j.amjmed.2004.06.045; Heather LC, 2010, CARDIOVASC RES, V85, P127, DOI 10.1093/cvr/cvp276; HEUKESHOVEN J, 1985, ELECTROPHORESIS, V6, P103, DOI 10.1002/elps.1150060302; HOLLOWELL JG, 1968, P SOC EXP BIOL MED, V129, P240; Hu QS, 2009, AM J PHYSIOL-HEART C, V297, pH223, DOI 10.1152/ajpheart.00992.2008; Ivanov VK, 2007, HEALTH PHYS, V93, P470, DOI 10.1097/01.HP.0000282195.34508.b0; Kaczmarek A, 2004, STRUCT CHEM, V15, P517, DOI 10.1023/B:STUC.0000037910.26456.59; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; KENNEDY CH, 1992, FREE RADICAL BIO MED, V12, P381, DOI 10.1016/0891-5849(92)90087-W; Kiebish MA, 2008, J NEUROCHEM, V106, P299, DOI 10.1111/j.1471-4159.2008.05383.x; Korotchkina LG, 2001, J BIOL CHEM, V276, P5731, DOI 10.1074/jbc.M007558200; Kreuzer M, 2006, RADIAT ENVIRON BIOPH, V45, P159, DOI 10.1007/s00411-006-0056-1; Kreuzer M, 2010, RADIAT ENVIRON BIOPH, V49, P177, DOI 10.1007/s00411-009-0249-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leach JK, 2001, CANCER RES, V61, P3894; Linden M, 2001, J BIOENERG BIOMEMBR, V33, P333, DOI 10.1023/A:1010611408007; Little MP, 2010, RADIAT ENVIRON BIOPH, V49, P139, DOI 10.1007/s00411-009-0250-z; Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027; Mayburd AL, 2006, CLIN CANCER RES, V12, P1820, DOI 10.1158/1078-0432.CCR-05-2149; McGeoghegan D, 2008, INT J EPIDEMIOL, V37, P506, DOI 10.1093/ije/dyn018; Milner DJ, 2000, J CELL BIOL, V150, P1283, DOI 10.1083/jcb.150.6.1283; Misra MK, 2009, MED SCI MONITOR, V15, pRA209; Muirhead CR, 2009, BRIT J CANCER, V100, P206, DOI 10.1038/sj.bjc.6604825; Murray AJ, 2008, J MOL CELL CARDIOL, V44, P694, DOI 10.1016/j.yjmcc.2008.01.008; Nakachi K, 2008, MUTAT RES-REV MUTAT, V659, P109, DOI 10.1016/j.mrrev.2008.02.001; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Orrenius S, 2007, DRUG METAB REV, V39, P443, DOI 10.1080/03602530701468516; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Page B, 2008, CIRC RES, V102, P103, DOI 10.1161/CIRCRESAHA.107.155895; Preston DL, 2003, RADIAT RES, V160, P381, DOI 10.1667/RR3049; Rappaport L, 1998, MOL CELL BIOCHEM, V184, P101, DOI 10.1023/A:1006843113166; Richardson DB, 1999, ENVIRON HEALTH PERSP, V107, P649, DOI 10.2307/3434457; Sarioglu H, 2006, PROTEOMICS, V6, P2407, DOI 10.1002/pmic.200500680; Schlattner U, 2006, BBA-MOL BASIS DIS, V1762, P164, DOI 10.1016/j.bbadis.2005.09.004; Schmidt Alexander, 2009, V492, P21, DOI 10.1007/978-1-59745-493-3_2; Shenker BJ, 2000, ENVIRON RES, V84, P89, DOI 10.1006/enrs.2000.4078; Shimizu Y, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5349; Spitz DR, 2004, CANCER METAST REV, V23, P311, DOI 10.1023/B:CANC.0000031769.14728.bc; Susin SA, 2000, METHOD ENZYMOL, V322, P205; Swerdlow AJ, 2007, J NATL CANCER I, V99, P206, DOI 10.1093/jnci/djk029; Tahara EB, 2009, FREE RADICAL BIO MED, V46, P1283, DOI 10.1016/j.freeradbiomed.2009.02.008; Takano H, 2003, ANTIOXID REDOX SIGN, V5, P789, DOI 10.1089/152308603770380098; Talbott EO, 2003, ENVIRON HEALTH PERSP, V111, P341, DOI 10.1289/ehp.5662; Tang HL, 2008, BIOCHEM J, V410, P141, DOI 10.1042/BJ20071072; Tolstonog GV, 2001, DNA CELL BIOL, V20, P509, DOI 10.1089/104454901317094945; Tukenova M, 2010, J CLIN ONCOL, V28, P1308, DOI 10.1200/JCO.2008.20.2267; White MY, 2008, PROTEOM CLIN APPL, V2, P845, DOI 10.1002/prca.200780135; Wolf G, 2000, Curr Hypertens Rep, V2, P167, DOI 10.1007/s11906-000-0078-z; Wu J, 2007, ARTHRITIS RHEUM-US, V56, P3675, DOI 10.1002/art.22876	85	120	125	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e27811	10.1371/journal.pone.0027811	http://dx.doi.org/10.1371/journal.pone.0027811			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174747	Green Published, gold, Green Submitted			2022-12-25	WOS:000298163600005
J	Huang, S; Gulzar, ZG; Salari, K; Lapointe, J; Brooks, JD; Pollack, JR				Huang, S.; Gulzar, Z. G.; Salari, K.; Lapointe, J.; Brooks, J. D.; Pollack, J. R.			Recurrent deletion of CHD1 in prostate cancer with relevance to cell invasiveness	ONCOGENE			English	Article						prostate cancer; genomic profiling; tumor suppressor; chromatin remodeling; cell invasion	MOLECULAR ASPECTS; COPY NUMBER; MUTATIONS; CHROMATIN; ABERRATIONS; REVEALS; ARID1A; FAMILY	Though prostate cancer is often indolent, it is nonetheless a leading cause of cancer death. Defining the underlying molecular genetic alterations may lead to new strategies for prevention or treatment. Towards this goal, we performed array-based comparative genomic hybridization (CGH) on 86 primary prostate tumors. Among the most frequent alterations not associated with a known cancer gene, we identified focal deletions within 5q21 in 15 out of 86 (17%) cases. By high-resolution tiling array CGH, the smallest common deletion targeted just one gene, the chromatin remodeler chromodomain helicase DNA-binding protein 1 (CHD1). Expression of CHD1 was significantly reduced in tumors with deletion (P = 0.03), and compared with normal prostate (P = 0.04). Exon sequencing analysis also uncovered nonsynonymous mutations in 1 out of 7 (14%) cell lines (LAPC4) and in 1 out of 24 (4%) prostate tumors surveyed. RNA interference-mediated knockdown of CHD1 in two nontumorigenic prostate epithelial cell lines, OPCN2 and RWPE-1, did not alter cell growth, but promoted cell invasiveness, and in OPCN2-enhanced cell clonogenicity. Taken together, our findings suggest that CHD1 deletion may underlie cell invasiveness in a subset of prostate cancers, and indicate a possible novel role of altered chromatin remodeling in prostate tumorigenesis. Oncogene (2012) 31, 4164-4170; doi:10.1038/onc.2011.590; published online 19 December 2011	[Huang, S.; Salari, K.; Pollack, J. R.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Gulzar, Z. G.; Brooks, J. D.] Stanford Univ, Dept Urol, Stanford, CA 94305 USA; [Lapointe, J.] McGill Univ, Dept Surg, Div Urol, Montreal, PQ H3A 2T5, Canada	Stanford University; Stanford University; McGill University	Pollack, JR (corresponding author), Stanford Univ, Sch Med, Dept Pathol, 269 Campus Dr,CCSR 3245A, Stanford, CA 94305 USA.	pollack1@stanford.edu			NIH [CA122246, CA111782, CA130472]; Burroughs Wellcome Fund [1007519]; American Cancer Society [PF-08-078-01-MGO]; Prostate Cancer Canada; Stanford Cancer Center; NATIONAL CANCER INSTITUTE [P30CA124435, F32CA130472, R01CA111782, R01CA122246] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); American Cancer Society(American Cancer Society); Prostate Cancer Canada; Stanford Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We wish to thank the members of the Pollack lab for helpful discussion. Supported by grants from the NIH (CA122246 to JRP; CA111782 to JDB; CA130472 to SH), the Burroughs Wellcome Fund (1007519 to JRP), the American Cancer Society (PF-08-078-01-MGO to SH), Prostate Cancer Canada (to JL) and the Stanford Cancer Center (to JRP).	Bagchi A, 2008, CANCER RES, V68, P2551, DOI 10.1158/0008-5472.CAN-07-2095; Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Binkley J, 2010, GENOME RES, V20, P142, DOI 10.1101/gr.097121.109; Damber JE, 2008, LANCET, V371, P1710, DOI 10.1016/S0140-6736(08)60729-1; DeMarzo AM, 2003, LANCET, V361, P955, DOI 10.1016/S0140-6736(03)12779-1; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Hall JA, 2007, BIOCHEM CELL BIOL, V85, P463, DOI 10.1139/O07-063; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim JH, 2007, CANCER RES, V67, P8229, DOI 10.1158/0008-5472.CAN-07-1297; Kwei KA, 2008, ONCOGENE, V27, P3635, DOI 10.1038/sj.onc.1211012; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lapointe J, 2007, CANCER RES, V67, P8504, DOI 10.1158/0008-5472.CAN-07-0673; Mareel M, 2003, PHYSIOL REV, V83, P337, DOI 10.1152/physrev.00024.2002; Marfella CGA, 2007, MUTAT RES-FUND MOL M, V618, P30, DOI 10.1016/j.mrfmmm.2006.07.012; Mason SD, 2011, TRENDS CELL BIOL, V21, P228, DOI 10.1016/j.tcb.2010.12.002; Menon T, 2010, MOL ENDOCRINOL, V24, P1165, DOI 10.1210/me.2009-0421; Nagarajan P, 2009, ONCOGENE, V28, P1053, DOI 10.1038/onc.2008.440; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Robbins CM, 2011, GENOME RES, V21, P47, DOI 10.1101/gr.107961.110; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433	28	80	82	0	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2012	31	37					4164	4170		10.1038/onc.2011.590	http://dx.doi.org/10.1038/onc.2011.590			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	004NR	22179824	Green Accepted			2022-12-25	WOS:000308688900008
J	Kim, W; Kim, R; Park, G; Park, JW; Kim, JE				Kim, Wootae; Kim, Ranah; Park, Geunyeong; Park, Jong-Wan; Kim, Ja-Eun			Deficiency of H3K79 Histone Methyltransferase Dot1-like Protein (DOT1L) Inhibits Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ELONGATION; LYSINE-79 METHYLTRANSFERASE; HETEROCHROMATIN FORMATION; SACCHAROMYCES-CEREVISIAE; MAMMALIAN-CELLS; H3 METHYLATION; SET DOMAIN; S-PHASE; TRIMETHYLATION; H4	Dot1-like protein (DOT1L) is an evolutionarily conserved histone methyltransferase that methylates lysine 79 of histone H3 (H3K79). Mammalian DOT1L participates in the regulation of transcription, development, erythropoiesis, differentiation, and proliferation of normal cells. However, the role of DOT1L in cancer cell proliferation has not been fully elucidated. DOT1L siRNA-transfected A549 or NCI-H1299 lung cancer cells displayed a nonproliferating multinucleated phenotype. DOT1L-deficient cells also showed abnormal mitotic spindle formation and centrosome number, suggesting that DOT1L deficiency leads to chromosomal missegregation. This chromosomal instability in DOT1L-deficient cells led to cell cycle arrest at the G1 phase and induced senescence as determined by enhanced activity of senescence-associated beta-galactosidase activity. Meanwhile, overexpression of a catalytically active DOT1L, not an inactive mutant, restored DOT1L siRNA-induced phenotypes. Overall, these data imply that down-regulation of DOT1L-mediated H3K79 methylation disturbs proliferation of human cells. In addition, although H3K79 methylation is down-regulated in aged tissues, it is up-regulated in lung cancer cell lines and tumor tissues of lung cancer patients. Therefore, H3K79 methylation is a critical histone modification that regulates cell proliferation and would be a novel histone mark for aging and cancer.	[Kim, Wootae; Kim, Ranah; Park, Geunyeong; Kim, Ja-Eun] Kyung Hee Univ, Sch Med, Dept Pharmacol, Seoul 130701, South Korea; [Kim, Wootae; Kim, Ranah; Park, Geunyeong; Kim, Ja-Eun] Kyung Hee Univ, Sch Med, Dept Biomed Sci, Seoul 130701, South Korea; [Park, Jong-Wan] Seoul Natl Univ, Coll Med, Dept Pharmacol, Seoul 110799, South Korea	Kyung Hee University; Kyung Hee University; Seoul National University (SNU)	Park, JW (corresponding author), 28 Yongon Dong, Seoul 110799, South Korea.	parkjw@snu.ac.kr; jekim@khu.ac.kr	Kim, Ja-Eun/AAI-1896-2020; Kim, Wootae/AAV-9894-2020	Kim, Ja-Eun/0000-0002-9132-1277; Kim, Wootae/0000-0003-4364-3260	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology (MEST) [2010-0009414, 2008-314-E00054]; NRF; Korea government (MEST) [2010-0001754, 2011-0030722]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); NRF; Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This research was in part supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MEST) (2010-0009414 and 2008-314-E00054). This work was also supported by the NRF Grant funded by the Korea government (MEST) (2010-0001754 and 2011-0030722).	Altaf M, 2007, MOL CELL, V28, P1002, DOI 10.1016/j.molcel.2007.12.002; Nguyen AT, 2011, BLOOD, V117, P6912, DOI 10.1182/blood-2011-02-334359; Barry ER, 2009, STEM CELLS, V27, P1538, DOI 10.1002/stem.86; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Bitoun E, 2007, HUM MOL GENET, V16, P92, DOI 10.1093/hmg/ddl444; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Bringold F, 2000, EXP GERONTOL, V35, P317, DOI 10.1016/S0531-5565(00)00083-8; Calvanese V, 2009, AGEING RES REV, V8, P268, DOI 10.1016/j.arr.2009.03.004; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Fingerman IM, 2007, GENE DEV, V21, P2018, DOI 10.1101/gad.1560607; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Giannattasio M, 2005, J BIOL CHEM, V280, P9879, DOI 10.1074/jbc.M414453200; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Jacinto FV, 2009, ONCOGENE, V28, P4212, DOI 10.1038/onc.2009.267; Janzen CJ, 2006, MOL CELL, V23, P497, DOI 10.1016/j.molcel.2006.06.027; Jones B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000190; Kim JE, 2005, MOL CELL BIOL, V25, P10907, DOI 10.1128/MCB.25.24.10907-10915.2005; Krivtsov AV, 2008, CANCER CELL, V14, P355, DOI 10.1016/j.ccr.2008.10.001; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Mathon NE, 2001, NAT REV CANCER, V1, P203, DOI 10.1038/35106045; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; Min JR, 2003, CELL, V112, P711, DOI 10.1016/S0092-8674(03)00114-4; Mohan M, 2010, GENE DEV, V24, P574, DOI 10.1101/gad.1898410; Mueller D, 2007, BLOOD, V110, P4445, DOI 10.1182/blood-2007-05-090514; Nakanishi S, 2009, J CELL BIOL, V186, P371, DOI 10.1083/jcb.200906005; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Ng HH, 2003, P NATL ACAD SCI USA, V100, P1820, DOI 10.1073/pnas.0437846100; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Ooga M, 2008, BIOL REPROD, V78, P413, DOI 10.1095/biolreprod.107.063453; Park G, 2010, PROTEIN J, V29, P213, DOI 10.1007/s10930-010-9242-8; Reisenauer MR, 2010, AM J PHYSIOL-RENAL, V299, pF63, DOI 10.1152/ajprenal.00105.2010; San-Segundo PA, 2000, MOL BIOL CELL, V11, P3601, DOI 10.1091/mbc.11.10.3601; Sarg B, 2002, J BIOL CHEM, V277, P39195, DOI 10.1074/jbc.M205166200; Sawada K, 2004, J BIOL CHEM, V279, P43296, DOI 10.1074/jbc.M405902200; Sawado T, 2008, BLOOD, V112, P406, DOI 10.1182/blood-2007-12-128983; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Schulze JM, 2009, MOL CELL, V35, P626, DOI 10.1016/j.molcel.2009.07.017; Shanower GA, 2005, GENETICS, V169, P173, DOI 10.1534/genetics.104.033191; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Singer MS, 1998, GENETICS, V150, P613; Solomon DA, 2008, CANCER RES, V68, P2564, DOI 10.1158/0008-5472.CAN-07-6388; Steger DJ, 2008, MOL CELL BIOL, V28, P2825, DOI 10.1128/MCB.02076-07; Tzatsos A, 2009, P NATL ACAD SCI USA, V106, P2641, DOI 10.1073/pnas.0813139106; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Verzijlbergen KF, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-76; Wang CM, 2010, BIOGERONTOLOGY, V11, P87, DOI 10.1007/s10522-009-9231-5; Wu LP, 2011, MOL CELL, V43, P132, DOI 10.1016/j.molcel.2011.05.015; Wysocki R, 2005, MOL CELL BIOL, V25, P8430, DOI 10.1128/MCB.25.19.8430-8443.2005; Xiao PF, 2005, COLLOID SURFACE B, V40, P165, DOI 10.1016/j.colsurfb.2004.10.018; Zhang WZ, 2006, J BIOL CHEM, V281, P18059, DOI 10.1074/jbc.M601903200	58	90	97	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5588	5599		10.1074/jbc.M111.328138	http://dx.doi.org/10.1074/jbc.M111.328138			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	242WW	22190683	hybrid, Green Published			2022-12-25	WOS:000326277000001
J	Chang, YW; Lin, TW; Li, YC; Huang, YS; Sun, YJ; Hsiao, CD				Chang, Yi-Wei; Lin, Tai-Wen; Li, Yi-Chuan; Huang, Yu-Shan; Sun, Yuh-Ju; Hsiao, Chwan-Deng			Interaction Surface and Topology of Get3-Get4-Get5 Protein Complex, Involved in Targeting Tail-anchored Proteins to Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY SOLUTION SCATTERING; SMALL-ANGLE SCATTERING; MEMBRANE INSERTION; GET4/GET5 COMPLEX; STRUCTURAL BASIS; ER MEMBRANE; GET3; SGT2; MECHANISM; CLUSPRO	Recent work has uncovered the "GET system," which is responsible for endoplasmic reticulum targeting of tail-anchored proteins. Although structural information and the individual roles of most components of this system have been defined, the interactions and interplay between them remain to be elucidated. Here, we investigated the interactions between Get3 and the Get4-Get5 complex from Saccharomyces cerevisiae. We show that Get3 interacts with Get4-Get5 via an interface dominated by electrostatic forces. Using isothermal titration calorimetry and small-angle x-ray scattering, we further demonstrate that the Get3 homodimer interacts with two copies of the Get4-Get5 complex to form an extended conformation in solution.	[Chang, Yi-Wei; Lin, Tai-Wen; Li, Yi-Chuan; Hsiao, Chwan-Deng] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan; [Li, Yi-Chuan; Sun, Yuh-Ju] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu 300, Taiwan; [Huang, Yu-Shan] Natl Synchrotron Radiat Res Ctr, Hsinchu 300, Taiwan	Academia Sinica - Taiwan; National Tsing Hua University; National Synchrotron Radiation Research Center	Hsiao, CD (corresponding author), Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan.	hsiao@gate.sinica.edu.tw	Chang, Yi-Wei/ABH-1418-2020; Hsiao, Chwan-Deng/AAZ-8869-2021	Chang, Yi-Wei/0000-0003-2391-473X; Hsiao, Chwan-Deng/0000-0002-7012-1532; Li, Yi-Chuan/0000-0002-1795-1051	National Science Council [NSC-95-2311-B-001-064]; Academia Sinica (Taiwan)	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica (Taiwan)(Academia Sinica - Taiwan)	This work was supported by National Science Council Grant NSC-95-2311-B-001-064 (to C.-D.H.) and Academia Sinica (Taiwan).	Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Bozkurt G, 2009, P NATL ACAD SCI USA, V106, P21131, DOI 10.1073/pnas.0910223106; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chang YW, 2010, J BIOL CHEM, V285, P9962, DOI 10.1074/jbc.M109.087098; Chartron JW, 2011, J BIOL CHEM, V286, P34325, DOI 10.1074/jbc.M111.277798; Chartron JW, 2010, P NATL ACAD SCI USA, V107, P12127, DOI 10.1073/pnas.1006036107; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Dietmeier K, 1997, NATURE, V388, P195, DOI 10.1038/40663; Egan B, 1999, FEBS LETT, V451, P243, DOI 10.1016/S0014-5793(99)00581-5; Hu JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008061; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kohl C, 2011, BIOL CHEM, V392, P601, DOI 10.1515/BC.2011.066; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Liou ST, 2007, CELL STRESS CHAPERON, V12, P59, DOI 10.1379/CSC-220R.1; Mariappan M, 2011, NATURE, V477, P61, DOI 10.1038/nature10362; Mateja A, 2009, NATURE, V461, P361, DOI 10.1038/nature08319; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Stefer S, 2011, SCIENCE, V333, P758, DOI 10.1126/science.1207125; Suloway CJM, 2009, P NATL ACAD SCI USA, V106, P14849, DOI 10.1073/pnas.0907522106; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Walensky LD, 2006, CELL DEATH DIFFER, V13, P1339, DOI 10.1038/sj.cdd.4401992; Wang F, 2011, MOL CELL, V43, P738, DOI 10.1016/j.molcel.2011.07.020; Wang F, 2010, MOL CELL, V40, P159, DOI 10.1016/j.molcel.2010.08.038; Wattenberg B, 2001, TRAFFIC, V2, P66, DOI 10.1034/j.1600-0854.2001.20108.x; Yamagata A, 2010, GENES CELLS, V15, P29, DOI 10.1111/j.1365-2443.2009.01362.x	32	14	14	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4783	4789		10.1074/jbc.M111.318329	http://dx.doi.org/10.1074/jbc.M111.318329			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22190685	Green Published, hybrid			2022-12-25	WOS:000300608500039
J	Kim, JG; Moon, MY; Kim, HJ; Li, Y; Song, DK; Kim, JS; Lee, JY; Kim, J; Kim, SC; Park, JB				Kim, Jae-Gyu; Moon, Mi-Young; Kim, Hee-Jun; Li, Yi; Song, Dong-Keun; Kim, Jun-Sub; Lee, Jae-Yong; Kim, Jaebong; Kim, Sung-Chan; Park, Jae-Bong			Ras-related GTPases Rap1 and RhoA Collectively Induce the Phagocytosis of Serum-opsonized Zymosan Particles in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; FC-GAMMA-R; BINDING PARTNER; ACTIVATION; MOTILITY; DISTINCT; IDENTIFICATION; MECHANISMS; COMPLEX; LIGAND	Phagocytosis occurs primarily through two main processes in macrophages: the Fc gamma receptor-and the integrin alpha M beta 2-mediated processes. Complement C3bi-opsonized particles are known to be engulfed through integrin alpha M beta 2-mediated process, which is regulated by RhoA GTPase. C3 toxin fused with Tat-peptide (Tat-C3 toxin), an inhibitor of the Rho GTPases, was shown to markedly inhibit the phagocytosis of serum (C3bi)-opsonized zymosans (SOZs). However, 8CPT-2Me-cAMP, an activator of exchange protein directly activated by cAMP (Epac, Rap1 guanine nucleotide exchange factor), restored the phagocytosis of the SOZs that was previously inhibited by the Tat-C3 toxin. In addition, a constitutively active form of Rap1 GTPase (CA-Rap1) also restored the phagocytosis that was previously reduced by a dominant negative form of RhoA GTPase (DN-RhoA). This suggests that Rap1 can replace the function of RhoA in the phagocytosis. Inversely, CA-RhoA rescued the phagocytosis that was suppressed by DN-Rap1. These findings suggest that both RhoA and Rap1 GTPases collectively regulate the phagocytosis of SOZs. In addition, filamentous actin was reduced by the Tat-C3 toxin, which was again restored by 8CPT-2MecAMP. Small interfering profilin suppressed the phagocytosis, suggesting that profilin is essential for the phagocytosis of SOZs. Furthermore, 8CPT-2Me-cAMP increased the co-immunoprecipitation of profilin with Rap1, whereas Tat-C3 toxin decreased that of profilin with RhoA. Co-immunoprecipitations of profilin with actin, Rap1, and RhoA GTPases were augmented in the presence of GTP gamma S rather than GDP. Therefore, we propose that both Rap1 and RhoA GTPases regulate the formation of filamentous actin through the interaction between actin and profilin, thereby collectively inducing the phagocytosis of SOZs in macrophages.	[Kim, Jae-Gyu; Moon, Mi-Young; Kim, Hee-Jun; Li, Yi; Lee, Jae-Yong; Kim, Jaebong; Kim, Sung-Chan; Park, Jae-Bong] Hallym Univ, Coll Med, Dept Biochem, Chunchon 200702, Kangwon Do, South Korea; [Song, Dong-Keun] Hallym Univ, Coll Med, Dept Pharmacol, Chunchon 200702, Kangwon Do, South Korea; [Kim, Jun-Sub] Hangang Sacred Heart Hosp, Specialized Res Ctr, Seoul 150719, South Korea	Hallym University; Hallym University	Park, JB (corresponding author), Hallym Univ, Coll Med, Dept Biochem, Chunchon 200702, Kangwon Do, South Korea.	jbpark@hallym.ac.kr	Kim, Jaebong/AAV-1986-2021	Kim, Jaebong/0000-0003-1609-338X; LI, YI/0000-0002-7059-9317	National Research Foundation of Korea; Ministry of Education, Science, and Technology [MRC-2011-0006211, 2010-0007865]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by Ministry of Education, Science, and Technology Grants MRC-2011-0006211 and 2010-0007865.	Adachi R, 2002, J BIOL CHEM, V277, P45566, DOI 10.1074/jbc.M207419200; Arthur WT, 2004, J CELL BIOL, V167, P111, DOI 10.1083/jcb.200404068; Birukova AA, 2008, J CELL PHYSIOL, V215, P715, DOI 10.1002/jcp.21354; Boettner B, 2000, P NATL ACAD SCI USA, V97, P9064, DOI 10.1073/pnas.97.16.9064; Bos JL, 2003, BIOCHEM SOC T, V31, P83, DOI 10.1042/bst0310083; Brandt DT, 2007, J CELL BIOL, V178, P193, DOI 10.1083/jcb.200612071; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Caron E, 2000, CURR BIOL, V10, P974, DOI 10.1016/S0960-9822(00)00641-2; Chimini G, 2000, NAT CELL BIOL, V2, pE191, DOI 10.1038/35036454; Chung J, 2008, J IMMUNOL, V181, P5501, DOI 10.4049/jimmunol.181.8.5501; Colucci-Guyon E, 2005, CURR BIOL, V15, P2007, DOI 10.1016/j.cub.2005.09.051; Cox D, 1997, J EXP MED, V186, P1487, DOI 10.1084/jem.186.9.1487; CURNUTTE JT, 1994, J BIOL CHEM, V269, P10813; Da Silva JS, 2003, J CELL BIOL, V162, P1267, DOI 10.1083/jcb.200304021; Dupuy AG, 2008, J CELL SCI, V121, P1773, DOI 10.1242/jcs.018036; El Benna J, 1999, J LEUKOCYTE BIOL, V66, P1014; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Geese M, 2000, J CELL SCI, V113, P1415; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Herrmann C, 1996, J BIOL CHEM, V271, P6794, DOI 10.1074/jbc.271.12.6794; Jenei V, 2006, J BIOL CHEM, V281, P35008, DOI 10.1074/jbc.M601335200; Jeong HW, 2007, J BIOL CHEM, V282, P20752, DOI 10.1074/jbc.M700487200; Katagiri K, 2000, MOL CELL BIOL, V20, P1956, DOI 10.1128/MCB.20.6.1956-1969.2000; Kim JS, 2004, J BIOL CHEM, V279, P21589, DOI 10.1074/jbc.M308386200; Krugmann S, 2004, CURR BIOL, V14, P1380, DOI 10.1016/j.cub.2004.07.058; Lafuente EM, 2004, DEV CELL, V7, P585, DOI 10.1016/j.devcel.2004.07.021; Lim J, 2007, MOL BIOL CELL, V18, P976, DOI 10.1091/mbc.E06-09-0813; Massol P, 1998, EMBO J, V17, P6219, DOI 10.1093/emboj/17.21.6219; May RC, 2000, NAT CELL BIOL, V2, P246, DOI 10.1038/35008673; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Olazabal IM, 2002, CURR BIOL, V12, P1413, DOI 10.1016/S0960-9822(02)01069-2; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Radha V, 2007, EXP CELL RES, V313, P2476, DOI 10.1016/j.yexcr.2007.03.019; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Wiedemann AS, 2006, J CELL BIOL, V172, P1069, DOI 10.1083/jcb.200508075; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Xu JG, 2007, CELL SIGNAL, V19, P1575, DOI 10.1016/j.cellsig.2007.02.004	41	32	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					5145	5155		10.1074/jbc.M111.257634	http://dx.doi.org/10.1074/jbc.M111.257634			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22194606	Green Published, hybrid			2022-12-25	WOS:000300608500072
J	Downey, MJ; Jeziorska, DM; Ott, S; Tamai, TK; Koentges, G; Vance, KW; Bretschneider, T				Downey, Mike J.; Jeziorska, Danuta M.; Ott, Sascha; Tamai, T. Katherine; Koentges, Georgy; Vance, Keith W.; Bretschneider, Till			Extracting Fluorescent Reporter Time Courses of Cell Lineages from High-Throughput Microscopy at Low Temporal Resolution	PLOS ONE			English	Article							SUBCELLULAR LOCATION; DYNAMIC PROTEOMICS; TRACKING; IDENTIFICATION; CONSTRUCTION; IMAGES; MODEL	The extraction of fluorescence time course data is a major bottleneck in high-throughput live-cell microscopy. Here we present an extendible framework based on the open-source image analysis software ImageJ, which aims in particular at analyzing the expression of fluorescent reporters through cell divisions. The ability to track individual cell lineages is essential for the analysis of gene regulatory factors involved in the control of cell fate and identity decisions. In our approach, cell nuclei are identified using Hoechst, and a characteristic drop in Hoechst fluorescence helps to detect dividing cells. We first compare the efficiency and accuracy of different segmentation methods and then present a statistical scoring algorithm for cell tracking, which draws on the combination of various features, such as nuclear intensity, area or shape, and importantly, dynamic changes thereof. Principal component analysis is used to determine the most significant features, and a global parameter search is performed to determine the weighting of individual features. Our algorithm has been optimized to cope with large cell movements, and we were able to semi-automatically extract cell trajectories across three cell generations. Based on the MTrackJ plugin for ImageJ, we have developed tools to efficiently validate tracks and manually correct them by connecting broken trajectories and reassigning falsely connected cell positions. A gold standard consisting of two time-series with 15,000 validated positions will be released as a valuable resource for benchmarking. We demonstrate how our method can be applied to analyze fluorescence distributions generated from mouse stem cells transfected with reporter constructs containing transcriptional control elements of the Msx1 gene, a regulator of pluripotency, in mother and daughter cells. Furthermore, we show by tracking zebrafish PAC2 cells expressing FUCCI cell cycle markers, our framework can be easily adapted to different cell types and fluorescent markers.	[Downey, Mike J.] Univ Warwick, Mol Org & Assembly Cells, Coventry CV4 7AL, W Midlands, England; [Jeziorska, Danuta M.; Koentges, Georgy] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Ott, Sascha; Vance, Keith W.; Bretschneider, Till] Univ Warwick, Warwick Syst Biol Ctr, Coventry CV4 7AL, W Midlands, England; [Tamai, T. Katherine] UCL, Dept Cell & Dev Biol, London, England	University of Warwick; University of Warwick; University of Warwick; University of London; University College London	Downey, MJ (corresponding author), Univ Warwick, Mol Org & Assembly Cells, Coventry CV4 7AL, W Midlands, England.	T.Bretschneider@warwick.ac.uk	Bretschneider, Till/D-4667-2011; Ott, Sascha/A-1180-2011; Vance, Keith/AAK-5410-2021	Bretschneider, Till/0000-0002-5317-603X; Vance, Keith/0000-0002-3411-8213	EPSRC through the MOAC Doctoral Training Centre, University of Warwick; University of Warwick; WellcomeTrust [WT 066790/E/02/Z, 066745/Z/01/Z]; HFSP [RGP0029/2007 C]; BBSRC/ERASysBio+ [BB/I004823/1]; BBSRC [BB/I004823/1, BB/F005938/2, BB/F005938/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F005938/2, BB/F005938/1, BB/I004823/1] Funding Source: researchfish	EPSRC through the MOAC Doctoral Training Centre, University of Warwick; University of Warwick; WellcomeTrust(Wellcome Trust); HFSP(Human Frontier Science Program); BBSRC/ERASysBio+; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	MJD was funded by the EPSRC (www.epsrc.ac.uk) through the MOAC Doctoral Training Centre, University of Warwick. KWV was funded by a Senior Research Fellowship from the University of Warwick. The experimental work was funded by WellcomeTrust (WT 066790/E/02/Z and 066745/Z/01/Z, www.wellcome.ac.uk) and HFSP (RGP0029/2007 C, www.hfsp.org) programme grants awarded to GK. Fucci data provided by TKT was obtained through funding by BBSRC/ERASysBio+ (BB/I004823/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Kofahi O, 2006, CELL CYCLE, V5, P327, DOI 10.4161/cc.5.3.2426; ALTINOK A, 2006, IEEE CVPR, V2, P1662; Bendall AJ, 2000, GENE, V247, P17, DOI 10.1016/S0378-1119(00)00081-0; BISE R, 2011, P ISBI 2011, P1004; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; CHALFOUN J, 2010, 7663 NISTIR; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Cohen AR, 2010, NAT METHODS, V7, P213, DOI [10.1038/NMETH.1424, 10.1038/nmeth.1424]; Debeir O, 2005, Eurocon 2005: The International Conference on Computer as a Tool, Vol 1 and 2 , Proceedings, P951; Downey M, 2011, I S BIOMED IMAGING, P1913, DOI 10.1109/ISBI.2011.5872783; Finkenstadt B, 2008, BIOINFORMATICS, V24, P2901, DOI 10.1093/bioinformatics/btn562; Giuliano KA, 2005, ASSAY DRUG DEV TECHN, V3, P501, DOI 10.1089/adt.2005.3.501; Gordon A, 2007, NAT METHODS, V4, P175, DOI 10.1038/nmeth1008; Haney SA, 2006, DRUG DISCOV TODAY, V11, P889, DOI 10.1016/j.drudis.2006.08.015; Harder N, 2009, GENOME RES, V19, P2113, DOI 10.1101/gr.092494.109; Hu Y, 2010, BIOINFORMATICS, V26, P1630, DOI 10.1093/bioinformatics/btq239; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; JONKER R, 1986, OPER RES LETT, V5, P171, DOI 10.1016/0167-6377(86)90073-8; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Lehmussola A, 2008, P IEEE, V96, P1348, DOI 10.1109/JPROC.2008.925490; Li K, 2008, MED IMAGE ANAL, V12, P546, DOI 10.1016/j.media.2008.06.001; Lidral AC, 2002, J DENT RES, V81, P274, DOI 10.1177/154405910208100410; Longo D, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100110; Loo LH, 2009, NAT METHODS, V6, P759, DOI [10.1038/NMETH.1375, 10.1038/nmeth.1375]; Meijering E, 2009, SEMIN CELL DEV BIOL, V20, P894, DOI 10.1016/j.semcdb.2009.07.004; Meijering E, 2008, MICROSCOPE IMAGE PROCESSING, P401, DOI 10.1016/B978-0-12-372578-3.00015-5; Murphy RF, 2003, J VLSI SIG PROC SYST, V35, P311, DOI 10.1023/B:VLSI.0000003028.71666.44; Olariu V, 2009, BIOINFORMATICS, V25, P2824, DOI 10.1093/bioinformatics/btp456; PADFIELD D, 2010, MED IMAGE ANAL, V21, P374; Pepperkok R, 2006, NAT REV MOL CELL BIO, V7, P690, DOI 10.1038/nrm1979; Reyes-Aldasoro CC, 2008, J MICROSC-OXFORD, V229, P162, DOI 10.1111/j.1365-2818.2007.01877.x; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Schrijver A., 2003, COMBINATORIAL OPTIMI; Shen H, 2006, J R SOC INTERFACE, V3, P787, DOI 10.1098/rsif.2006.0137; Sigal A, 2006, NAT METHODS, V3, P525, DOI 10.1038/NMETH892; Smal I, 2008, IEEE T MED IMAGING, V27, P789, DOI 10.1109/TMI.2008.916964; Spiller DG, 2010, NATURE, V465, P736, DOI 10.1038/nature09232; Sugiyama M, 2009, P NATL ACAD SCI USA, V106, P20812, DOI 10.1073/pnas.0906464106; Tamai TK, 2007, P NATL ACAD SCI USA, V104, P14712, DOI 10.1073/pnas.0704588104; Thomas N, 2010, J BIOMOL SCREEN, V15, P1, DOI 10.1177/1087057109353790; Tyson RA, 2010, MATH MODEL NAT PHENO, V5, P34, DOI 10.1051/mmnp/20105102; Walter T, 2010, J STRUCT BIOL, V170, P1, DOI 10.1016/j.jsb.2009.10.004; Wang M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-32; Wang QL, 2010, CYTOM PART A, V77A, P101, DOI 10.1002/cyto.a.20812; WRIGHT MB, 1990, COMPUT OPER RES, V17, P95, DOI 10.1016/0305-0548(90)90031-2	47	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e27886	10.1371/journal.pone.0027886	http://dx.doi.org/10.1371/journal.pone.0027886			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22194797	Green Published, gold, Green Submitted			2022-12-25	WOS:000298370400005
J	Dickerman, BK; White, CL; Chevalier, C; Nalesso, V; Charles, C; Fouchecourt, S; Guillou, F; Viriot, L; Sen, GC; Herault, Y				Dickerman, Benjamin K.; White, Christine L.; Chevalier, Claire; Nalesso, Valerie; Charles, Cyril; Fouchecourt, Sophie; Guillou, Florian; Viriot, Laurent; Sen, Ganes C.; Herault, Yann			Missense Mutation in the Second RNA Binding Domain Reveals a Role for Prkra (PACT/RAX) during Skull Development	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; PKR ACTIVATION; CELLULAR ACTIVATOR; RAX; PHOSPHORYLATION; MOUSE; TRBP; MICE; DICER; INHIBITION	Random chemical mutagenesis of the mouse genome can causally connect genes to specific phenotypes. Using this approach, reduced pinna (rep) or microtia, a defect in ear development, was mapped to a small region of mouse chromosome 2. Sequencing of this region established co-segregation of the phenotype (rep) with a mutation in the Prkra gene, which encodes the protein PACT/RAX. Mice homozygous for the mutant Prkra allele had defects not only in ear development but also growth, craniofacial development and ovarian structure. The rep mutation was identified as a missense mutation (Serine 130 to Proline) that did not affect mRNA expression, however the steady state level of RAX protein was significantly lower in the brains of rep mice. The mutant protein, while normal in most biochemical functions, was unable to bind dsRNA. In addition, rep mice displayed altered morphology of the skull that was consistent with a targeted deletion of Prkra showing a contribution of the gene to craniofacial development. These observations identified a specific mutation that reduces steady-state levels of RAX protein and disrupts the dsRNA binding function of the protein, demonstrating the importance of the Prkra gene in various aspects of mouse development.	[Dickerman, Benjamin K.; White, Christine L.; Sen, Ganes C.] Cleveland Clin, Dept Mol Genet, Lerner Res Inst, Cleveland, OH 44106 USA; [Dickerman, Benjamin K.; Sen, Ganes C.] Case Western Reserve Univ, Grad Program Mol Virol, Cleveland, OH 44106 USA; [Chevalier, Claire; Nalesso, Valerie; Herault, Yann] Univ Strasbourg, INSERM, CNRS,Inst Genet Biol Mol & Cellulaire, IGBMC ICS,UMR7104,UMR964, Illkirch Graffenstaden, France; [Chevalier, Claire; Nalesso, Valerie; Herault, Yann] Univ Strasbourg, INSERM, CNRS, IGBMC ICS,UMR7104,UMR964,Inst Clin Souris, Illkirch Graffenstaden, France; [Charles, Cyril; Viriot, Laurent] Univ Lyon, CNRS, Ecole Normale Super Lyon, Inst Genom Fonct Lyon,Team Evo Devo Vertebrate De, Lyon, France; [Fouchecourt, Sophie; Guillou, Florian] Univ Tours Haras Nationaux, CNRS, UMR 6175, Physiol Reprod & Comportements INRA,Ctr Rech Tour, Nouzilly, France	Cleveland Clinic Foundation; Case Western Reserve University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE	Dickerman, BK (corresponding author), Cleveland Clin, Dept Mol Genet, Lerner Res Inst, Cleveland, OH 44106 USA.	seng@ccf.org	White, Christine/AAQ-4546-2021; Herault, Yann/B-5500-2012; White, Christine/D-7788-2014; Charles, Cyril/E-7606-2011	White, Christine/0000-0002-5920-0029; Herault, Yann/0000-0001-7049-6900; White, Christine/0000-0002-5920-0029; Charles, Cyril/0000-0002-6930-039X; Viriot, Laurent/0000-0003-2092-588X; Fouchecourt, Sophie/0000-0001-6923-6220	Le Centre National de la Recherche Scientifique; National Institutes of Health [5P01CA062220]; NATIONAL CANCER INSTITUTE [P01CA062220] Funding Source: NIH RePORTER	Le Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was received from Le Centre National de la Recherche Scientifique (to YH) and the National Institutes of Health (to GCS) 5P01CA062220. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett RL, 2008, MECH DEVELOP, V125, P777, DOI 10.1016/j.mod.2008.06.009; Bennett RL, 2006, BLOOD, V108, P821, DOI 10.1182/blood-2005-11-006817; Bennett RL, 2004, J BIOL CHEM, V279, P42687, DOI 10.1074/jbc.M403321200; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Besson V, 2005, BIOL CELL, V97, P787, DOI 10.1042/BC20040525; Camargos S, 2008, LANCET NEUROL, V7, P207, DOI 10.1016/S1474-4422(08)70022-X; Chen G, 2006, J BIOL CHEM, V281, P15909, DOI 10.1074/jbc.M600612200; CHONG KL, 1992, EMBO J, V11, P1553, DOI 10.1002/j.1460-2075.1992.tb05200.x; Daher A, 2009, MOL CELL BIOL, V29, P254, DOI 10.1128/MCB.01030-08; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; Gilbert SJ, 2002, BIOCHEM SOC T, V30, P886, DOI 10.1042/BST0300886; Gupta V, 2003, VIROLOGY, V315, P283, DOI 10.1016/S0042-6822(03)00589-0; Hallgrimsson B, 2004, J ANAT, V205, P501, DOI 10.1111/j.0021-8782.2004.00356.x; HERSHEY JWB, 1989, J BIOL CHEM, V264, P20823; Huang X, 2002, BIOCHEM J, V366, P175, DOI 10.1042/BJ20020204; Ito T, 1999, J BIOL CHEM, V274, P15427, DOI 10.1074/jbc.274.22.15427; Kok KH, 2007, J BIOL CHEM, V282, P17649, DOI 10.1074/jbc.M611768200; KOZAK CA, 1995, GENOMICS, V25, P66, DOI 10.1016/0888-7543(95)80110-8; Laraki G, 2008, RNA BIOL, V5, P92, DOI 10.4161/rna.5.2.6069; Lee ES, 2007, FEBS LETT, V581, P4325, DOI 10.1016/j.febslet.2007.08.001; Lee K, 1996, MOL CELL BIOL, V16, P3023; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Li SD, 2006, P NATL ACAD SCI USA, V103, P10005, DOI 10.1073/pnas.0602317103; Magnol L, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-81; Otsuka M, 2008, J CLIN INVEST, V118, P1944, DOI 10.1172/JCI33680; Papaioannou MD, 2009, DEV BIOL, V326, P250, DOI 10.1016/j.ydbio.2008.11.011; PARK HS, 1994, P NATL ACAD SCI USA, V91, P4713, DOI 10.1073/pnas.91.11.4713; Patel CV, 2000, J BIOL CHEM, V275, P37993, DOI 10.1074/jbc.M004762200; Patel RC, 1998, EMBO J, V17, P4379, DOI 10.1093/emboj/17.15.4379; Peters GA, 2002, J VIROL, V76, P11054, DOI 10.1128/JVI.76.21.11054-11064.2002; Peters GA, 2001, MOL CELL BIOL, V21, P1908, DOI 10.1128/MCB.21.6.1908-1920.2001; Peters GA, 2006, J BIOL CHEM, V281, P35129, DOI 10.1074/jbc.M607714200; Peters GA, 2009, P NATL ACAD SCI USA, V106, P10696, DOI 10.1073/pnas.0900735106; Rowe TM, 2006, P NATL ACAD SCI USA, V103, P5823, DOI 10.1073/pnas.0601287103; Ruvolo PP, 2001, J BIOL CHEM, V276, P11754, DOI 10.1074/jbc.M011400200; Seibler P, 2008, LANCET NEUROL, V7, P380, DOI 10.1016/S1474-4422(08)70075-9; Singh M, 2011, BIOCHEMISTRY-US, V50, P4550, DOI 10.1021/bi200104h; Singh M, 2009, J MOL BIOL, V385, P457, DOI 10.1016/j.jmb.2008.10.068; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; Zehir A, 2010, DEV BIOL, V340, P459, DOI 10.1016/j.ydbio.2010.01.039	40	8	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28537	10.1371/journal.pone.0028537	http://dx.doi.org/10.1371/journal.pone.0028537			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194846	Green Published, Green Submitted, gold			2022-12-25	WOS:000298369100047
J	Perk, S; Izamis, ML; Tolboom, H; Uygun, B; Berthiaume, F; Yarmush, ML; Uygun, K				Perk, Sinem; Izamis, Maria-Louisa; Tolboom, Herman; Uygun, Basak; Berthiaume, Francois; Yarmush, Martin L.; Uygun, Korkut			A Metabolic Index of Ischemic Injury for Perfusion-Recovery of Cadaveric Rat Livers	PLOS ONE			English	Article							MONITORING BATCH PROCESSES; HYPOTHERMIC MACHINE PERFUSION; PRINCIPAL COMPONENT ANALYSIS; COLD-STORAGE; NITRIC-OXIDE; REPERFUSION INJURY; CARDIAC DEATH; TRANSPLANTATION; PRESERVATION; SURVIVAL	With over 110,000 patients waiting for organ transplantation, the current crisis in organ transplantation is based on a lack of donors after brain-death (DBD). A very large alternative pool of donor organs that remain untapped are the donors after cardiac death (DCD), recovered after cardiac activity has ceased and therefore sustained some ischemic injury. Machine perfusion has been proposed as a novel modality of organ preservation and treatment to render such cadaveric organs, and in particular livers, transplantable. Two key issues that remain unaddressed are how to assess whether a DCD liver is damaged beyond repair, and whether machine perfusion has rendered an injured organ sufficiently viable for transplantation. In this work, we present a metabolic analysis of the transient responses of cadaveric rat livers during normothermic machine perfusion (NMP), and develop an index of ischemia that enables evaluation of the organ ischemic injury level. Further, we perform a discriminant analysis to construct a classification algorithm with >0.98 specificity to identify whether a given perfused liver is ischemic or fresh, in effect a precursor for an index of transplantability and a basis for the use of statistical process control measures for automated feedback control of treatment of ischemic injury in DCD livers. The analyses yield an index based on squared prediction error (SPE) as log(SPE) >1.35 indicating ischemia. The differences between metabolic functions of fresh and ischemic livers during perfusion are outlined and the metabolites that varied significantly for ischemic livers are identified as ornithine, arginine, albumin and tyrosine.	[Perk, Sinem; Izamis, Maria-Louisa; Uygun, Basak; Yarmush, Martin L.; Uygun, Korkut] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Engn Med, Boston, MA 02114 USA; [Perk, Sinem; Izamis, Maria-Louisa; Uygun, Basak; Yarmush, Martin L.; Uygun, Korkut] Shriners Hosp Children, Boston, MA USA; [Tolboom, Herman] Univ Zurich Hosp, Div Cardiac & Vasc Surg, CH-8091 Zurich, Switzerland; [Berthiaume, Francois; Yarmush, Martin L.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Zurich; University Zurich Hospital; Rutgers State University New Brunswick	Perk, S (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Engn Med, Boston, MA 02114 USA.	uygun.korkut@mgh.harvard.edu	Berthiaume, Francois/ABD-2139-2020; Uygun, Korkut/AAH-3950-2020; Uygun, Basak/I-1792-2012	Uygun, Korkut/0000-0003-2088-7860; Uygun, Basak/0000-0002-2600-7900; Yarmush, Martin/0000-0003-4986-8444	National Institutes of Health [R01DK59766, R01EB008678, R00DK080942, K99DK088962]; Shriners Hospitals for Children; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK080942, K99DK088962, R00DK088962, R01DK096075, R01DK059766] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospitals for Children; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding from the National Institutes of Health (R01DK59766, R01EB008678, R00DK080942, K99DK088962), and the Shriners Hospitals for Children are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abt PL, 2006, J AM COLL SURGEONS, V203, P208, DOI 10.1016/j.jamcollsurg.2006.03.014; Abt PL, 2004, ANN SURG, V239, P87, DOI 10.1097/01.sla.0000103063.82181.2c; Berendsen TA, 2011, TRANSPL P, V43, P1484, DOI 10.1016/j.transproceed.2010.12.066; Bessems M, 2005, LIVER TRANSPLANT, V11, P539, DOI 10.1002/lt.20388; Bessems M, 2007, LIVER TRANSPLANT, V13, P497, DOI 10.1002/lt.21039; BOX GEP, 1954, ANN MATH STAT, V25, P290, DOI 10.1214/aoms/1177728786; CINAR A, BATCH FERMENTATION M; CURRAN RD, 1991, FASEB J, V5, P2085, DOI 10.1096/fasebj.5.7.1707021; de Rougemont O, 2009, ANN SURG, V250, P674, DOI 10.1097/SLA.0b013e3181bcb1ee; Delriviere L, 1998, MICROSURG, V18, P12, DOI 10.1002/(SICI)1098-2752(1998)18:1<12::AID-MICR4>3.0.CO;2-W; Delriviere Luc, 1996, Microsurgery, V17, P690, DOI 10.1002/(SICI)1098-2752(1996)17:12<690::AID-MICR6>3.0.CO;2-R; DUNN JCY, 1991, BIOTECHNOL PROGR, V7, P237, DOI 10.1021/bp00009a007; Durante W, 2006, CLIN EXPT PHARM PHYS, V34, P906; Dutkowski P, 2006, ANN SURG, V244, P968, DOI 10.1097/01.sla.0000247056.85590.6b; Dutkowski R, 2006, AM J TRANSPLANT, V6, P903, DOI 10.1111/j.1600-6143.2006.01264.x; Efron B., 1994, INTRO BOOTSTRAP; Efron B., 1982, JACKKNIFE BOOTSTRAP; Eriksson L., 2006, MULTI MEGAVARIATE 1; Heijnen BHM, 2001, J APPL PHYSIOL, V91, P265, DOI 10.1152/jappl.2001.91.1.265; HEMS R, 1966, BIOCHEM J, V101, P284, DOI 10.1042/bj1010284; JACKSON JE, 1980, J QUAL TECHNOL, V12, P201, DOI 10.1080/00224065.1980.11980967; KAMADA N, 1979, TRANSPLANTATION, V28, P47, DOI 10.1097/00007890-197907000-00011; Lee CY, 2003, TRANSPLANTATION, V76, P1432, DOI 10.1097/01.TP.0000088674.23805.0F; Lee K, 2000, METAB ENG, V2, P312, DOI 10.1006/mben.2000.0160; Mateo R, 2006, AM J TRANSPLANT, V6, P791, DOI 10.1111/j.1600-6143.2006.01243.x; Miller P., 1998, Applied Mathematics and Computer Science, V8, P775; Nomikos P, 1995, CHEMOMETR INTELL LAB, V30, P97, DOI 10.1016/0169-7439(95)00043-7; NOMIKOS P, 1994, AICHE J, V40, P1361, DOI 10.1002/aic.690400809; NOMIKOS P, 1995, TECHNOMETRICS, V37, P41, DOI 10.2307/1269152; Palacios-Calender M, 2007, PNAS, V104, P508; Sariyar B, 2006, J THEOR BIOL, V242, P389, DOI 10.1016/j.jtbi.2006.03.007; Tolboom H, 2008, TRANSPL P, V40, P1306, DOI 10.1016/j.transproceed.2008.03.100; Tolboom H, 2011, J SURG RES; Tolboom H, 2007, TISSUE ENG, V13, P2143, DOI 10.1089/ten.2007.0101; Tolboom H, 2009, TRANSPLANTATION, V87, P170, DOI 10.1097/TP.0b013e318192df6b; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; TRACY ND, 1992, J QUAL TECHNOL, V24, P88, DOI 10.1080/00224065.1992.12015232; Undey C, 2002, IEEE CONTR SYST MAG, V22, P40, DOI 10.1109/MCS.2002.1035216; UYGUN K, 2010, TRANSPLANTA IN PRESS; Uygun K, 2007, BIOTECHNOL BIOENG, V97, P622, DOI 10.1002/bit.21237; Uygun K, 2010, BIOTECHNOL PROGR, V26, P1567, DOI 10.1002/btpr.482; Varadarajan R, 2004, TRANSPLANTATION, V78, P250, DOI 10.1097/01.tp.0000128188.45553.8c; Wise B., 1990, PROCESS CONTR QUAL, V1, P41; Wold S, 1998, CHEMOMETR INTELL LAB, V44, P331, DOI 10.1016/S0169-7439(98)00162-2; Wold S., 1987, J CHEMOMETR, V1, P41, DOI DOI 10.1002/CEM.1180010107; Xu HZ, 2004, TRANSPLANTATION, V77, P1676, DOI 10.1097/01.TP.0000129644.23075.71; Yang L, 2006, J AM COLL SURGEONS, V203, P817, DOI 10.1016/j.jamcollsurg.2006.08.023	47	31	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28518	10.1371/journal.pone.0028518	http://dx.doi.org/10.1371/journal.pone.0028518			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194843	Green Published, Green Submitted, gold			2022-12-25	WOS:000298369100045
J	Schweighofer, CD; Coombes, KR; Barron, LL; Diao, LX; Newman, RJ; Ferrajoli, A; O'Brien, S; Wierda, WG; Luthra, R; Medeiros, LJ; Keating, MJ; Abruzzo, LV				Schweighofer, Carmen D.; Coombes, Kevin R.; Barron, Lynn L.; Diao, Lixia; Newman, Rachel J.; Ferrajoli, Alessandra; O'Brien, Susan; Wierda, William G.; Luthra, Rajyalakshmi; Medeiros, L. Jeffrey; Keating, Michael J.; Abruzzo, Lynne V.			A Two- Gene Signature, SKI and SLAMF1, Predicts Time-to-Treatment in Previously Untreated Patients with Chronic Lymphocytic Leukemia	PLOS ONE			English	Article							MEMORY B-CELLS; ZAP-70 EXPRESSION; MUTATION STATUS; NEGATIVE REGULATORS; POOR-PROGNOSIS; ENCODING GENE; DNA-DAMAGE; MICROARRAY; DISEASE; PROGRESSION	We developed and validated a two-gene signature that predicts prognosis in previously-untreated chronic lymphocytic leukemia (CLL) patients. Using a 65 sample training set, from a cohort of 131 patients, we identified the best clinical models to predict time-to-treatment (TTT) and overall survival (OS). To identify individual genes or combinations in the training set with expression related to prognosis, we cross-validated univariate and multivariate models to predict TTT. We identified four gene sets (5, 6, 12, or 13 genes) to construct multivariate prognostic models. By optimizing each gene set on the training set, we constructed 11 models to predict the time from diagnosis to treatment. Each model also predicted OS and added value to the best clinical models. To determine which contributed the most value when added to clinical variables, we applied the Akaike Information Criterion. Two genes were consistently retained in the models with clinical variables: SKI (v-SKI avian sarcoma viral oncogene homolog) and SLAMF1 (signaling lymphocytic activation molecule family member 1; CD150). We optimized a two-gene model and validated it on an independent test set of 66 samples. This two-gene model predicted prognosis better on the test set than any of the known predictors, including ZAP70 and serum beta 2-microglobulin.	[Schweighofer, Carmen D.; Barron, Lynn L.; Luthra, Rajyalakshmi; Medeiros, L. Jeffrey; Abruzzo, Lynne V.] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Coombes, Kevin R.; Diao, Lixia; Newman, Rachel J.] Univ Texas MD Anderson Canc Ctr, Dept Biostat & Appl Math, Houston, TX 77030 USA; [Ferrajoli, Alessandra; O'Brien, Susan; Wierda, William G.; Keating, Michael J.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Schweighofer, CD (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA.	labruzzo@mdanderson.org		Coombes, Kevin/0000-0002-7630-2123	European Hematology Association-American Society of Hematology; CLL Global Research Foundation; Commonwealth Foundation for Cancer Research; National Cancer Institute [R01CA123252]; NATIONAL CANCER INSTITUTE [R01CA123252] Funding Source: NIH RePORTER	European Hematology Association-American Society of Hematology; CLL Global Research Foundation; Commonwealth Foundation for Cancer Research; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the European Hematology Association-American Society of Hematology (C.D.S.), the CLL Global Research Foundation (C.D.S. and L.V.A.; http://www.cllglobal.org/), the Commonwealth Foundation for Cancer Research and Mr. and Mrs. William H. Goodwin, Jr., (L.V.A.), and the National Cancer Institute (L.V.A., R01CA123252). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aalto Y, 2001, LEUKEMIA, V15, P1721, DOI 10.1038/sj.leu.2402282; Abruzzo LV, 2005, BIOTECHNIQUES, V38, P785, DOI 10.2144/05385MT01; Abruzzo LV, 2005, J MOL DIAGN, V7, P337, DOI 10.1016/S1525-1578(10)60562-4; Abruzzo LV, 2007, J MOL DIAGN, V9, P546, DOI 10.2353/jmoldx.2007.070001; Admirand JH, 2004, MODERN PATHOL, V17, P954, DOI 10.1038/modpathol.3800145; ADMIRAND JH, MOD PATHOL; Baggerly K, 2010, NATURE, V467, P401, DOI 10.1038/467401b; Bhattacharya D, 2007, J IMMUNOL, V179, P6808, DOI 10.4049/jimmunol.179.10.6808; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; CANNONS JL, IMMUNITY, V32, P253; COCKS BG, 1995, NATURE, V376, P260, DOI 10.1038/376260a0; Coffey AJ, 1998, NAT GENET, V20, P129, DOI 10.1038/2424; Crespo M, 2003, NEW ENGL J MED, V348, P1764, DOI 10.1056/NEJMoa023143; Dahl R, 1998, P NATL ACAD SCI USA, V95, P11187, DOI 10.1073/pnas.95.19.11187; De Salort J, 2011, IMMUNOL LETT, V134, P129, DOI 10.1016/j.imlet.2010.09.021; Deheuninck J, 2009, CELL RES, V19, P47, DOI 10.1038/cr.2008.324; Durig J, 2003, BLOOD, V101, P2748, DOI 10.1182/blood-2002-09-2683; Fais F, 1998, J CLIN INVEST, V102, P1515, DOI 10.1172/JCI3009; Fukuchi M, 2004, INT J CANCER, V108, P818, DOI 10.1002/ijc.11651; GEISLER CH, 1991, BLOOD, V78, P1795; Good KL, 2009, J IMMUNOL, V182, P890, DOI 10.4049/jimmunol.182.2.890; Jelinek DF, 2003, MOL CANCER RES, V1, P346; Klein U, 2001, J EXP MED, V194, P1625, DOI 10.1084/jem.194.11.1625; LINDEMALM C, 1988, MED ONCOL TUMOR PHAR, V5, P243; Luo KX, 2004, CURR OPIN GENET DEV, V14, P65, DOI 10.1016/j.gde.2003.11.003; Ma CS, 2007, ANNU REV IMMUNOL, V25, P337, DOI 10.1146/annurev.immunol.25.022106.141651; Matthews C, 2007, LEUKEMIA RES, V31, P231, DOI 10.1016/j.leukres.2006.03.028; McCarthy H, 2003, BLOOD, V101, P4903, DOI 10.1182/blood-2002-09-2906; Mittal AK, 2007, INT J MOL MED, V20, P461; Moreau EJ, 1997, AM J CLIN PATHOL, V108, P378; Nichols KE, 1998, P NATL ACAD SCI USA, V95, P13765, DOI 10.1073/pnas.95.23.13765; NOMURA N, 1989, NUCLEIC ACIDS RES, V17, P5489, DOI 10.1093/nar/17.14.5489; Orchard JA, 2004, LANCET, V363, P105, DOI 10.1016/S0140-6736(03)15260-9; Punnonen J, 1997, J EXP MED, V185, P993, DOI 10.1084/jem.185.6.993; Rassenti LZ, 2004, NEW ENGL J MED, V351, P893, DOI 10.1056/NEJMoa040857; Reed JA, 2005, CANCER METAST REV, V24, P265, DOI 10.1007/s10555-005-1576-x; Retter I, 2005, NUCLEIC ACIDS RES, V33, pD671, DOI 10.1093/nar/gki088; Ritter M, 2006, LEUKEMIA, V20, P437, DOI 10.1038/sj.leu.2404093; Rosenwald A, 2001, J EXP MED, V194, P1639, DOI 10.1084/jem.194.11.1639; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; Shinagawa T, 2001, ONCOGENE, V20, P8100, DOI 10.1038/sj.onc.1204987; Stankovic T, 2004, BLOOD, V103, P291, DOI 10.1182/blood-2003-04-1161; Stratowa C, 2001, INT J CANCER, V91, P474, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1078>3.0.CO;2-C; Tobin G, 2003, BLOOD, V101, P4952, DOI 10.1182/blood-2002-11-3485; Vallat L, 2003, BLOOD, V101, P4598, DOI 10.1182/blood-2002-06-1743; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vilpo J, 2003, EUR J HAEMATOL, V70, P53, DOI 10.1034/j.1600-0609.2003.02838.x; Wang J, 2004, BIOINFORMATICS, V20, P3166, DOI 10.1093/bioinformatics/bth381; Wiestner A, 2003, BLOOD, V101, P4944, DOI 10.1182/blood-2002-10-3306; Zheng Z, 2002, LEUKEMIA, V16, P2429, DOI 10.1038/sj.leu.2402711	50	17	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28277	10.1371/journal.pone.0028277	http://dx.doi.org/10.1371/journal.pone.0028277			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194822	Green Published, gold, Green Submitted			2022-12-25	WOS:000298369100028
J	Shuryak, I; Brenner, DJ; Ullrich, RL				Shuryak, Igor; Brenner, David J.; Ullrich, Robert L.			Radiation-Induced Carcinogenesis: Mechanistically Based Differences between Gamma-Rays and Neutrons, and Interactions with DMBA	PLOS ONE			English	Article							CLONAL EXPANSION MODEL; DOMESTIC RADON RISKS; LOW-DOSE RADIATION; STEM-CELLS; IONIZING-RADIATION; ALPHA-PARTICLES; X-RAYS; BIOLOGICAL RESPONSES; MAMMARY OUTGROWTHS; HUMAN FIBROBLASTS	Different types of ionizing radiation produce different dependences of cancer risk on radiation dose/dose rate. Sparsely ionizing radiation (e.g. gamma-rays) generally produces linear or upwardly curving dose responses at low doses, and the risk decreases when the dose rate is reduced (direct dose rate effect). Densely ionizing radiation (e.g. neutrons) often produces downwardly curving dose responses, where the risk initially grows with dose, but eventually stabilizes or decreases. When the dose rate is reduced, the risk increases (inverse dose rate effect). These qualitative differences suggest qualitative differences in carcinogenesis mechanisms. We hypothesize that the dominant mechanism for induction of many solid cancers by sparsely ionizing radiation is initiation of stem cells to a pre-malignant state, but for densely ionizing radiation the dominant mechanism is radiation-bystander-effect mediated promotion of already pre-malignant cell clone growth. Here we present a mathematical model based on these assumptions and test it using data on the incidence of dysplastic growths and tumors in the mammary glands of mice exposed to high or low dose rates of gamma-rays and neutrons, either with or without pre-treatment with the chemical carcinogen 7,12-dimethylbenz-alpha-anthracene (DMBA). The model provides a mechanistic and quantitative explanation which is consistent with the data and may provide useful insight into human carcinogenesis.	[Shuryak, Igor; Brenner, David J.] Columbia Univ, Ctr Radiol Res, Med Ctr, New York, NY 10032 USA; [Ullrich, Robert L.] Univ Texas Med Branch, Dept Radiat Oncol, Galveston, TX USA	Columbia University; University of Texas System; University of Texas Medical Branch Galveston	Shuryak, I (corresponding author), Columbia Univ, Ctr Radiol Res, Med Ctr, New York, NY 10032 USA.	is144@columbia.edu			National Institutes of Health [U19-AI67773]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067773] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (U19-AI67773), www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzam EI, 2003, ONCOGENE, V22, P7050, DOI 10.1038/sj.onc.1206961; Ballarini F, 2002, MUTAT RES-FUND MOL M, V501, P1, DOI 10.1016/S0027-5107(02)00010-6; Belloni F, 2002, RADIAT PROT DOSIM, V99, P199, DOI 10.1093/oxfordjournals.rpd.a006761; Belyakov OV, 2006, MUTAT RES-FUND MOL M, V597, P43, DOI 10.1016/j.mrfmmm.2005.08.012; Bennett WR, 2003, DEVELOPMENT, V130, P1079, DOI 10.1242/dev.00333; Borthwick DW, 2001, AM J RESP CELL MOL, V24, P662, DOI 10.1165/ajrcmb.24.6.4217; Brash DE, 2005, SEMIN CANCER BIOL, V15, P97, DOI 10.1016/j.semcancer.2004.08.006; Brenner DJ, 2003, HEALTH PHYS, V85, P103, DOI 10.1097/00004032-200307000-00018; Brenner DJ, 2002, INT J RADIAT BIOL, V78, P593, DOI 10.1080/09553000210121740; Brenner DJ, 1998, RADIAT RES, V150, P83, DOI 10.2307/3579648; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Brunet A, 2007, NATURE, V449, P288, DOI 10.1038/449288a; Carlson ME, 2007, AGING CELL, V6, P371, DOI 10.1111/j.1474-9726.2007.00286.x; Cornforth MN, 2002, RADIAT RES, V158, P43, DOI 10.1667/0033-7587(2002)158[0043:DRFCAP]2.0.CO;2; Curtis SB, 2004, ADV SPACE RES, V34, P1404, DOI 10.1016/j.asr.2004.03.011; Curtis SB, 2002, ADV SPACE RES, V30, P937, DOI 10.1016/S0273-1177(02)00158-8; Curtis SB, 2001, PHYS MEDICA, V17, P157; Edwards CM, 2007, B MATH BIOL, V69, P1927, DOI 10.1007/s11538-007-9199-8; ETHIER SP, 1984, CANCER RES, V44, P4523; ETHIER SP, 1982, CANCER RES, V42, P1753; Fortier JM, 2010, CANCER TREAT RES, V145, P183, DOI 10.1007/978-0-387-69259-3_11; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gao J, 2007, TOXICOL SCI, V98, P137, DOI 10.1093/toxsci/kfm089; George KA, 2009, RADIAT RES, V171, P752, DOI 10.1667/RR1680.1; Ghazizadeh S, 2005, J INVEST DERMATOL, V124, P367, DOI 10.1111/j.0022-202X.2004.23599.x; Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103; Hall EJ, 2003, HEALTH PHYS, V85, P31, DOI 10.1097/00004032-200307000-00008; Hazelton WD, 2006, J TOXICOL ENV HEAL A, V69, P1013, DOI 10.1080/00397910500360202; Hei TK, 2006, MOL CARCINOGEN, V45, P455, DOI 10.1002/mc.20219; Heidenreich WF, 2004, RADIAT PROT DOSIM, V112, P501, DOI 10.1093/rpd/nch093; Heidenreich WF, 2001, RADIAT RES, V156, P678, DOI 10.1667/0033-7587(2001)156[0678:TTSCEM]2.0.CO;2; Hu BR, 2006, CARCINOGENESIS, V27, P245, DOI 10.1093/carcin/bgi224; Imaoka T, 2009, J RADIAT RES, V50, P281, DOI 10.1269/jrr.09027; Johnston MD, 2007, P NATL ACAD SCI USA, V104, P4008, DOI 10.1073/pnas.0611179104; Kleiner HE, 2002, CHEM RES TOXICOL, V15, P226, DOI 10.1021/tx010151v; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Little JB, 2006, HEALTH PHYS, V91, P416, DOI 10.1097/01.HP.0000232847.23192.3e; LUBIN JH, 1995, HEALTH PHYS, V69, P494, DOI 10.1097/00004032-199510000-00007; Lubin JH, 1994, RADON LUNG CANC RISK; Luebeck EG, 2000, RADIAT RES, V154, P730; Lyng FM, 2000, BRIT J CANCER, V83, P1223, DOI 10.1054/bjoc.2000.1433; Magae J, 2003, RADIAT RES, V160, P543, DOI 10.1667/RR3071; Miyata M, 1999, J BIOL CHEM, V274, P23963, DOI 10.1074/jbc.274.34.23963; MOOLGAVKAR S, 1980, J NATL CANCER I, V65, P215; MOOLGAVKAR SH, 1978, J NATL CANCER I, V61, P49, DOI 10.1093/jnci/61.1.49; Mothersill C, 2000, Radiats Biol Radioecol, V40, P615; Mothersill C, 2002, RADIAT RES, V157, P526, DOI 10.1667/0033-7587(2002)157[0526:RBRILD]2.0.CO;2; NAGASAWA H, 1992, CANCER RES, V52, P6394; Peng Y, 2009, RADIAT RES, V171, P474, DOI 10.1667/RR1547.1; Pinto M, 2005, RADIAT RES, V164, P73, DOI 10.1667/RR3394; Pinto M, 2002, RADIAT PROT DOSIM, V99, P133, DOI 10.1093/oxfordjournals.rpd.a006743; Pompei F, 2002, TOXICOL IND HEALTH, V18, P365, DOI 10.1191/0748233702th164oa; Pompei F, 2001, TOXICOL IND HEALTH, V17, P7, DOI 10.1191/0748233701th091oa; Ponnaiya B, 2004, RADIAT RES, V162, P426, DOI 10.1667/RR3236; Potten CS, 2002, J INVEST DERMATOL, V119, P888, DOI 10.1046/j.1523-1747.2002.00020.x; Sachs RK, 1997, INT J RADIAT BIOL, V72, P351, DOI 10.1080/095530097143149; Sachs RK, 1998, MED PHYS, V25, P2071, DOI 10.1118/1.598431; Saleh Ekram M Y, 2005, J Egypt Natl Canc Inst, V17, P93; Schettino G, 2003, RADIAT RES, V160, P505, DOI 10.1667/RR3060; Sedelnikova OA, 2007, CANCER RES, V67, P4295, DOI 10.1158/0008-5472.CAN-06-4442; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Shuryak I, 2007, RADIAT RES, V168, P741, DOI 10.1667/RR1117.1; Shuryak I, 2010, RADIAT RES, V174, P357, DOI 10.1667/RR2143.1; Shuryak I, 2009, RADIAT ENVIRON BIOPH, V48, P263, DOI 10.1007/s00411-009-0230-3; Shuryak I, 2009, RADIAT ENVIRON BIOPH, V48, P275, DOI 10.1007/s00411-009-0231-2; Slack JMW, 2000, SCIENCE, V287, P1431, DOI 10.1126/science.287.5457.1431; Spencer SL, 2006, PLOS COMPUT BIOL, V2, P939, DOI 10.1371/journal.pcbi.0020108; Suit H, 2007, RADIAT RES, V167, P12, DOI 10.1667/RR0527.1; Zhang WG, 2001, P NATL ACAD SCI USA, V98, P13948, DOI 10.1073/pnas.241353198	69	25	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28559	10.1371/journal.pone.0028559	http://dx.doi.org/10.1371/journal.pone.0028559			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194850	Green Submitted, Green Published, gold			2022-12-25	WOS:000298369100050
J	Kuhn, T; Garcia-Marquez, J; Klimpel, S				Kuhn, Thomas; Garcia-Marquez, Jaime; Klimpel, Sven			Adaptive Radiation within Marine Anisakid Nematodes: A Zoogeographical Modeling of Cosmopolitan, Zoonotic Parasites	PLOS ONE			English	Article							SIMPLEX-SENSU-STRICTO; MOLECULAR-IDENTIFICATION; GENETIC-RELATIONSHIPS; MORPHOLOGICAL DESCRIPTION; COMPLEX ASCARIDIDA; METAZOAN PARASITES; SPECIES NEMATODA; FISH PARASITES; BEAKED-WHALES; LIFE-CYCLE	Parasites of the nematode genus Anisakis are associated with aquatic organisms. They can be found in a variety of marine hosts including whales, crustaceans, fish and cephalopods and are known to be the cause of the zoonotic disease anisakiasis, a painful inflammation of the gastro-intestinal tract caused by the accidental consumptions of infectious larvae raw or semi-raw fishery products. Since the demand on fish as dietary protein source and the export rates of seafood products in general is rapidly increasing worldwide, the knowledge about the distribution of potential foodborne human pathogens in seafood is of major significance for human health. Studies have provided evidence that a few Anisakis species can cause clinical symptoms in humans. The aim of our study was to interpolate the species range for every described Anisakis species on the basis of the existing occurrence data. We used sequence data of 373 Anisakis larvae from 30 different hosts worldwide and previously published molecular data (n = 584) from 53 field-specific publications to model the species range of Anisakis spp., using a interpolation method that combines aspects of the alpha hull interpolation algorithm as well as the conditional interpolation approach. The results of our approach strongly indicate the existence of species-specific distribution patterns of Anisakis spp. within different climate zones and oceans that are in principle congruent with those of their respective final hosts. Our results support preceding studies that propose anisakid nematodes as useful biological indicators for their final host distribution and abundance as they closely follow the trophic relationships among their successive hosts. The modeling might although be helpful for predicting the likelihood of infection in order to reduce the risk of anisakiasis cases in a given area.	[Kuhn, Thomas; Klimpel, Sven] Goethe Univ Frankfurt, Biodivers & Climate Res Ctr, BiK F, Inst Ecol Evolut & Div,LOEWE, Frankfurt, Germany; [Garcia-Marquez, Jaime] Carbones Cerrejon Ltd, Dept Gest Ambiental, Bogota, Colombia	Goethe University Frankfurt	Kuhn, T (corresponding author), Goethe Univ Frankfurt, Biodivers & Climate Res Ctr, BiK F, Inst Ecol Evolut & Div,LOEWE, Frankfurt, Germany.	sven.klimpel@senckenberg.de			Biodiversity and Climate Research Centre, Frankfurt/Main; Hesse's Ministry of Higher Education, Research, and the Arts; German Research Council [DFG KL 2087/1-1, 1-2]	Biodiversity and Climate Research Centre, Frankfurt/Main; Hesse's Ministry of Higher Education, Research, and the Arts; German Research Council(German Research Foundation (DFG))	This work was supported by the Biodiversity and Climate Research Centre (BiK-F, www.bik-f.de), Frankfurt/Main, the research funding programme "LOEWE - Landes-Offensive zur Entwicklung Wissenschaftlich-Okonomischer Exzellenz'' of Hesse's Ministry of Higher Education, Research, and the Arts as well as the German Research Council (grant no. DFG KL 2087/1-1, 1-2, www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2005, J HELMINTHOL, V79, P303, DOI 10.1079/JOH2005290; Abollo E, 2001, PARASITOL RES, V87, P492, DOI 10.1007/s004360100389; Allison EH, 2009, FISH FISH, V10, P173, DOI 10.1111/j.1467-2979.2008.00310.x; Anderson R. C., 2000, Nematode parasites of vertebrates: their development and transmission., DOI 10.1079/9780851994215.0000; Anderson TJC, 1998, ADV PARASIT, V41, P219, DOI 10.1016/S0065-308X(08)60425-X; Audicana MT, 2008, CLIN MICROBIOL REV, V21, P360, DOI 10.1128/CMR.00012-07; Baylis H.A., 1923, Annals & Magazine of Natural History Series 9, V11, P211; Burgman MA, 2003, ANIM CONSERV, V6, P19, DOI 10.1017/S1367943003003044; CAMPANA-ROUGET Y., 1955, ANN PARASITOL HUMAINE ET COMP, V30, P477; Chai JY, 2005, INT J PARASITOL, V35, P1233, DOI 10.1016/j.ijpara.2005.07.013; Colon-Llavina MM, 2009, PARASITOL RES, V105, P1239, DOI 10.1007/s00436-009-1544-4; Cross MA, 2007, MAR BIOL, V151, P695, DOI 10.1007/s00227-006-0509-8; Diesing K.M., 1861, SITZUNGSBER KAISERL, V28, P595; Dollfus R. Ph., 1966, Annales de la Societe des Sciences Naturelles de la Charente-Maritime, V4, P3; Du CX, 2010, ELECTROPHORESIS, V31, P654, DOI 10.1002/elps.200900531; Dzido J, 2009, POLAR SCI, V3, P207, DOI 10.1016/j.polar.2009.08.003; EDELSBRUNNER H, 1983, IEEE T INFORM THEORY, V29, P551, DOI 10.1109/TIT.1983.1056714; Fang WZ, 2010, EXP PARASITOL, V124, P197, DOI 10.1016/j.exppara.2009.09.011; Farjallah S, 2008, PARASITOL INT, V57, P430, DOI 10.1016/j.parint.2008.05.002; Farjallah S, 2008, PARASITOL RES, V102, P371, DOI 10.1007/s00436-007-0771-9; Garcia A, 2008, J FISH BIOL, V73, P2274, DOI 10.1111/j.1095-8649.2008.02072.x; Garcia A, 2011, ICES J MAR SCI, V68, P175, DOI 10.1093/icesjms/fsq147; GASTON KJ, 1991, OIKOS, V61, P434, DOI 10.2307/3545251; GON O, FISHES SO OCEAN; Hochberg NS, 2010, CLIN INFECT DIS, V51, P806, DOI 10.1086/656238; Iniguez AM, 2011, VET PARASITOL, V178, P293, DOI 10.1016/j.vetpar.2011.01.001; Iniguez AM, 2009, VET PARASITOL, V165, P350, DOI 10.1016/j.vetpar.2009.07.012; *IUCN, IUCN RED LIST CAT CR; *IUCN, 2001, IUCN RED LIST CAT CR, P13; Kadmon R, 2004, ECOL APPL, V14, P401, DOI 10.1890/02-5364; Karl H, 2011, DIS AQUAT ORGAN, V94, P201, DOI 10.3354/dao02317; Kijewska A, 2009, J PARASITOL, V95, P1364, DOI 10.1645/GE-1950.1; Kijewska A, 2009, J PARASITOL, V95, P639, DOI 10.1645/GE-1796.1; Klimpel S, 2008, DEEP-SEA RES PT II, V55, P229, DOI 10.1016/j.dsr2.2007.09.006; Klimpel S, 2004, PARASITOL RES, V94, P1, DOI 10.1007/s00436-004-1154-0; Klimpel S, 2008, PARASITOL RES, V104, P43, DOI 10.1007/s00436-008-1157-3; Klimpel S, 2007, MAR BIOL, V152, P725, DOI 10.1007/s00227-007-0727-8; Klimpel S, 2011, POLAR BIOL, V34, P899, DOI 10.1007/s00300-010-0946-1; Klimpel S, 2010, DEEP-SEA RES PT I, V57, P596, DOI 10.1016/j.dsr.2010.01.002; Klimpel S, 2010, MAR ECOL PROG SER, V403, P1, DOI 10.3354/meps08501; Krabbe H, 1878, OVERSIGT KONGELIGE D, V1, P43; Marques JF, 2006, J HELMINTHOL, V80, P47, DOI 10.1079/JOH2005325; Mattiucci S, 2008, FISH RES, V89, P146, DOI 10.1016/j.fishres.2007.09.032; Mattiucci S, 2005, SYST PARASITOL, V61, P157, DOI 10.1007/s11230-005-3158-2; Mattiucci S, 2004, J FISH BIOL, V65, P495, DOI 10.1111/j.0022-1112.2004.00465.x; Mattiucci S, 1998, SYST PARASITOL, V40, P81, DOI 10.1023/A:1005914926720; Mattiucci S, 1997, J PARASITOL, V83, P401, DOI 10.2307/3284402; Mattiucci S, 2002, SYST PARASITOL, V51, P159, DOI 10.1023/A:1014554900808; MATTIUCCI S, 1986, PARASITOLOGY, V93, P383, DOI 10.1017/S0031182000051544; Mattiucci S, 2005, COLLECTIVE VOLUME SC, V58, P1470; MATTIUCCI S, 2001, INT J PARASITOL, V16, P633; Mattiucci S, 2008, ADV PARASIT, V66, P47, DOI 10.1016/S0065-308X(08)00202-9; Mattiucci S, 2007, VET PARASITOL, V148, P43, DOI 10.1016/j.vetpar.2007.05.009; Mattiucci S, 2009, SYST PARASITOL, V74, P199, DOI 10.1007/s11230-009-9212-8; Moravec F., 1994, Parasitic nematodes of freshwater fishes of Europe.; Murphy TM, 2010, J PARASITOL, V96, P77, DOI 10.1645/GE-2194.1; Nadler SA, 2005, J PARASITOL, V91, P1413, DOI 10.1645/GE-522R.1; NASCETTI G, 1986, INT J PARASITOL, V16, P633, DOI 10.1016/0020-7519(86)90032-9; Noguera P, 2009, DIS AQUAT ORGAN, V87, P199, DOI 10.3354/dao02141; Paggi L, 1998, SYST PARASITOL, V40, P161, DOI 10.1023/A:1006093201920; Palm HW, 2008, HELMINTHOLOGIA, V45, P3, DOI 10.2478/s11687-008-0001-8; Pateiro-Lopez B, 2010, J STAT SOFTW, V34, P1; Pontes T, 2005, J PARASITOL, V91, P1430, DOI 10.1645/GE-565R1.1; Quantum GIS Development Team, 2011, QUANT GIS GEOGR INF; Quiazon KMA, 2009, J PARASITOL, V95, P1227, DOI 10.1645/GE-1751.1; Quiazon KMA, 2008, PARASITOL INT, V57, P483, DOI 10.1016/j.parint.2008.06.003; R Development Core Team, 2009, R FDN STAT COMP; Raedig C, 2010, BIODIVERS CONSERV, V19, P1523, DOI 10.1007/s10531-010-9785-1; Reddy S, 2003, J BIOGEOGR, V30, P1719, DOI 10.1046/j.1365-2699.2003.00946.x; Rudolphi C. A., 1819, ENTOZOORUM SYNOPSIS; Skov J, 2009, AQUACULTURE, V298, P24, DOI 10.1016/j.aquaculture.2009.09.024; Suzuki J, 2010, INT J FOOD MICROBIOL, V137, P88, DOI 10.1016/j.ijfoodmicro.2009.10.001; Umehara A., 2008, SE ASIAN J TROP MED, V39, P26; Umehara A, 2008, PARASITOL INT, V57, P49, DOI 10.1016/j.parint.2007.08.003; Umehara A, 2007, PARASITOL INT, V56, P211, DOI 10.1016/j.parint.2007.02.005; Umehara A, 2006, PARASITOL INT, V55, P267, DOI 10.1016/j.parint.2006.07.001; Umehara A, 2010, INT J FOOD MICROBIOL, V143, P161, DOI 10.1016/j.ijfoodmicro.2010.08.011; Valentini A, 2006, J PARASITOL, V92, P156, DOI 10.1645/GE-3504.1; West KL, 2009, MAR MAMMAL SCI, V25, P931, DOI 10.1111/j.1748-7692.2009.00295.x; Zhang LP, 2007, MOL CELL PROBE, V21, P386, DOI 10.1016/j.mcp.2007.05.004; Zhu XQ, 2007, PARASITOL RES, V101, P1703, DOI 10.1007/s00436-007-0699-0; Zhu XQ, 1998, INT J PARASITOL, V28, P1911, DOI 10.1016/S0020-7519(98)00150-7; Zhu XQ, 2000, PARASITOL RES, V86, P738, DOI 10.1007/PL00008561	83	55	58	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28642	10.1371/journal.pone.0028642	http://dx.doi.org/10.1371/journal.pone.0028642			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22180787	Green Published, gold, Green Submitted			2022-12-25	WOS:000298367300016
J	Song, YX; Gao, P; Wang, ZN; Tong, LL; Xu, YY; Sun, Z; Xing, CZ; Xu, HM				Song, Yong-Xi; Gao, Peng; Wang, Zhen-Ning; Tong, Lin-Lin; Xu, Ying-Ying; Sun, Zhe; Xing, Cheng-Zhong; Xu, Hui-Mian			Which Is the Most Suitable Classification for Colorectal Cancer, Log Odds, the Number or the Ratio of Positive Lymph Nodes?	PLOS ONE			English	Article							GASTRIC-CANCER; PROGNOSTIC-FACTOR; BREAST-CANCER; COLON-CANCER; SURVIVAL; IMPACT	Objective: The aim of the current study was to investigate which is the most suitable classification for colorectal cancer, log odds of positive lymph nodes (LODDS) classification or the classifications based on the number of positive lymph nodes (pN) and positive lymph node ratio(LNR) in a Chinese single institutional population. Design: Clinicopathologic and prognostic data of 1297 patients with colorectal cancer were retrospectively studied. The log-rank statistics, Cox's proportional hazards model, the Nagelkerke R-2 index and a Harrell's C statistic were used. Results: Univariate and three-step multivariate analyses identified that LNR was a significant prognostic factor and LNR classification was superior to both the pN and LODDS classifications. Moreover, the results of the Nagelkerke R-2 index (0.130) and a Harrell's C statistic (0.707) of LNR showed that LNR and LODDS classifications were similar and LNR was a little better than the other two classifications. Furthermore, for patients in each LNR classification, prognosis was homologous between those in different pN or LODDS classifications. However, for patients in pN1a, pN1b, LODDS2 and LODDS3 classifications, significant differences in survival were observed among patients in different LNR classifications. Conclusions: For patients with colorectal cancer, the LNR classification is more suitable than pN and LODDS classifications for prognostic assessment in a Chinese single institutional population.	[Song, Yong-Xi; Gao, Peng; Wang, Zhen-Ning; Tong, Lin-Lin; Xu, Ying-Ying; Sun, Zhe; Xing, Cheng-Zhong; Xu, Hui-Mian] China Med Univ, Hosp 1, Dept Surg Oncol & Gen Surg, Shenyang, Peoples R China	China Medical University	Wang, ZN (corresponding author), China Med Univ, Hosp 1, Dept Surg Oncol & Gen Surg, Shenyang, Peoples R China.	josieon826@yahoo.com.cn	wang, zhen ning/E-1878-2011; Xu, Yingying/E-3884-2018; Gao, Peng/B-8031-2013	wang, zhen ning/0000-0003-0557-3097; Xu, Yingying/0000-0003-4924-9379; 	National Science Foundation of China [30972879, 81172370]; Specialized Research Fund for the Doctoral Program of Higher Education [200801590006]; Natural Science Foundation of Liaoning Province [20092129]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Liaoning Province(Natural Science Foundation of Liaoning Province)	This work was supported by National Science Foundation of China (No. 30972879 and No. 81172370), Specialized Research Fund for the Doctoral Program of Higher Education (No. 200801590006) and Natural Science Foundation of Liaoning Province (No. 20092129). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, AJCC CANC STAGING MA; Bhatti I, 2010, WORLD J SURG, V34, P768, DOI 10.1007/s00268-009-0336-4; Ceelen W, 2010, ANN SURG ONCOL, V17, P2847, DOI 10.1245/s10434-010-1158-1; Chok KSH, 2007, WORLD J SURG, V31, P1485, DOI 10.1007/s00268-007-9089-0; CROWLEY J, 1997, LECT NOTES STAT, P199; Downing SR, 2010, J SURG RES, V163, P264, DOI 10.1016/j.jss.2010.03.017; Edge SB, 2010, AJCC CANC STAGING MA; Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Harrell FE, 2015, SPRINGER SER STAT, P453, DOI 10.1007/978-3-319-19425-7_19; Huh JW, 2010, ANN SURG ONCOL, V17, P2640, DOI 10.1245/s10434-010-1015-2; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Landau S., 2004, HDB STAT ANAL USING; Moug SJ, 2009, BRIT J CANCER, V100, P1530, DOI 10.1038/sj.bjc.6605049; Ng M, 2009, AM SURGEON, V75, P873; Ostadi MA, 2007, SURG ENDOSC, V21, P2142, DOI 10.1007/s00464-007-9414-6; Persiani R, 2008, EJSO-EUR J SURG ONC, V34, P519, DOI 10.1016/j.ejso.2007.05.009; Qiu HB, 2011, ANN SURG ONCOL, V18, P1568, DOI 10.1245/s10434-010-1528-8; Rosenberg R, 2010, ANN SURG, V251, P1070, DOI 10.1097/SLA.0b013e3181d7789d; Royston P, 2004, STAT MED, V23, P723, DOI 10.1002/sim.1621; Sun Z, 2009, ANN ONCOL, V20, P897, DOI 10.1093/annonc/mdn707; Sun Z, 2010, CANCER-AM CANCER SOC, V116, P2571, DOI 10.1002/cncr.24989; Tong LL, 2011, ANN SURG ONCOL, V18, P2453, DOI 10.1245/s10434-011-1687-2; Vinh-Hung V, 2004, BREAST CANCER RES, V6, pR680, DOI 10.1186/bcr934; Vinh-Hung V, 2009, J CLIN ONCOL, V27, P1062, DOI 10.1200/JCO.2008.18.6965; Voordeckers M, 2004, RADIOTHER ONCOL, V70, P225, DOI 10.1016/j.radonc.2003.10.015; Wang JP, 2008, J GASTROINTEST SURG, V12, P1790, DOI 10.1007/s11605-008-0651-3; Xu An-gao, 2006, Zhonghua Nei Ke Za Zhi, V45, P9	28	44	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28937	10.1371/journal.pone.0028937	http://dx.doi.org/10.1371/journal.pone.0028937			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174929	Green Submitted, Green Published, gold			2022-12-25	WOS:000298367300033
J	Armstrong, GAB; Xiao, CF; Krill, JL; Seroude, L; Dawson-Scully, K; Robertson, RM				Armstrong, Gary A. B.; Xiao, Chengfeng; Krill, Jennifer L.; Seroude, Laurent; Dawson-Scully, Ken; Robertson, R. Meldrum			Glial Hsp70 Protects K+ Homeostasis in the Drosophila Brain during Repetitive Anoxic Depolarization	PLOS ONE			English	Article							CORTICAL SPREADING DEPRESSION; CEREBRAL-ARTERY OCCLUSION; OXYGEN REPERFUSION; NEURONAL DAMAGE; GENETIC-BASIS; TOLERANCE; MELANOGASTER; MECHANISMS; ISCHEMIA; HEAT-SHOCK-PROTEIN-70	Neural tissue is particularly vulnerable to metabolic stress and loss of ion homeostasis. Repetitive stress generally leads to more permanent dysfunction but the mechanisms underlying this progression are poorly understood. We investigated the effects of energetic compromise in Drosophila by targeting the Na+/.K+-ATPase. Acute ouabain treatment of intact flies resulted in subsequent repetitive comas that led to death and were associated with transient loss of K+ homeostasis in the brain. Heat shock pre-conditioned flies were resistant to ouabain treatment. To control the timing of repeated loss of ion homeostasis we subjected flies to repetitive anoxia while recording extracellular [K+] in the brain. We show that targeted expression of the chaperone protein Hsp70 in glial cells delays a permanent loss of ion homeostasis associated with repetitive anoxic stress and suggest that this is a useful model for investigating molecular mechanisms of neuroprotection.	[Armstrong, Gary A. B.; Xiao, Chengfeng; Seroude, Laurent; Robertson, R. Meldrum] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Krill, Jennifer L.; Dawson-Scully, Ken] Florida Atlantic Univ, Dept Biol Sci, Boca Raton, FL 33431 USA	Queens University - Canada; State University System of Florida; Florida Atlantic University	Armstrong, GAB (corresponding author), Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada.	gary.ab.armstrong@gmail.com	Robertson, Robert M/B-2482-2009; Xiao, Chengfeng/B-1432-2014	Robertson, Robert M/0000-0002-2666-7861; Armstrong, Gary/0000-0003-4613-8817; Xiao, Chengfeng/0000-0002-2301-1365; Seroude, Laurent/0000-0002-4785-3890	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	The study was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC)(http://www.nserc-crsng.gc.ca/Index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW RD, 1994, NEUROSCIENCE, V62, P371, DOI 10.1016/0306-4522(94)90372-7; Armstrong GAB, 2010, BRAIN RES, V1311, P64, DOI 10.1016/j.brainres.2009.11.038; Armstrong GAB, 2009, J NEUROSCI, V29, P8225, DOI 10.1523/JNEUROSCI.1652-09.2009; Azad P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005371; Back T, 1996, J CEREBR BLOOD F MET, V16, P202, DOI 10.1097/00004647-199603000-00004; Balestrino M, 1999, BRAIN RES, V838, P37, DOI 10.1016/S0006-8993(99)01674-1; Bellen HJ, 2010, NAT REV NEUROSCI, V11, P514, DOI 10.1038/nrn2839; BRANSTON NM, 1977, J NEUROL SCI, V32, P305, DOI 10.1016/0022-510X(77)90014-4; Brown CE, 2008, STROKE, V39, P1286, DOI 10.1161/STROKEAHA.107.498238; Busch E, 1996, J CEREBR BLOOD F MET, V16, P1090, DOI 10.1097/00004647-199611000-00002; Church AJ, 2005, J NEUROTRAUM, V22, P277, DOI 10.1089/neu.2005.22.277; Dawson-Scully K, 2010, J EXP BIOL, V213, P2410, DOI 10.1242/jeb.041319; Dawson-Scully K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000773; Ekimova IV, 2010, J NEUROCHEM, V115, P1035, DOI 10.1111/j.1471-4159.2010.06989.x; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Giffard RG, 2004, J EXP BIOL, V207, P3213, DOI 10.1242/jeb.01034; Gong WJ, 2004, GENETICS, V168, P1467, DOI 10.1534/genetics.104.030874; Haddad GG, 1997, P NATL ACAD SCI USA, V94, P10809, DOI 10.1073/pnas.94.20.10809; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; Hartings JA, 2003, J NEUROSCI, V23, P11602; Krishnan SN, 1997, J INSECT PHYSIOL, V43, P203, DOI 10.1016/S0022-1910(96)00084-4; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Lighton JRB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001267; MIES G, 1993, NEUROREPORT, V4, P709, DOI 10.1097/00001756-199306000-00027; Neal SJ, 2006, PHYSIOL GENOMICS, V25, P493, DOI 10.1152/physiolgenomics.00195.2005; Obeidat AS, 2000, J CEREBR BLOOD F MET, V20, P412, DOI 10.1097/00004647-200002000-00024; Peters O, 1998, J CEREBR BLOOD F MET, V18, P196, DOI 10.1097/00004647-199802000-00011; Plumier JCL, 1997, CELL STRESS CHAPERON, V2, P162, DOI 10.1379/1466-1268(1997)002<0162:TMETHI>2.3.CO;2; Rajdev S, 2000, ANN NEUROL, V47, P782, DOI 10.1002/1531-8249(200006)47:6<782::AID-ANA11>3.0.CO;2-3; Ransom CB, 2000, J PHYSIOL-LONDON, V522, P427, DOI 10.1111/j.1469-7793.2000.00427.x; Risher WC, 2010, J NEUROSCI, V30, P9859, DOI 10.1523/JNEUROSCI.1917-10.2010; Robertson RM, 2004, J THERM BIOL, V29, P351, DOI 10.1016/j.jtherbio.2004.08.073; Rodgers CI, 2010, J INSECT PHYSIOL, V56, P980, DOI 10.1016/j.jinsphys.2010.03.030; Rodgers CI, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001366; Rodgers CI, 2009, J INSECT PHYSIOL, V55, P599, DOI 10.1016/j.jinsphys.2009.03.004; Rodgers-Garlick CI, 2011, J NEUROSCI, V31, P3207, DOI 10.1523/JNEUROSCI.5215-10.2011; Sanchez-del-Rio M, 2006, CURR OPIN NEUROL, V19, P294, DOI 10.1097/01.wco.0000227041.23694.5c; Schilman PE, 2011, J EXP BIOL, V214, P1271, DOI 10.1242/jeb.052357; SHINOHARA M, 1979, SCIENCE, V203, P188, DOI 10.1126/science.758688; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; STRONG AJ, 2005, ADV TECHNICAL STANDA, P3; Takano T, 2007, NAT NEUROSCI, V10, P754, DOI 10.1038/nn1902; Van Voorhies WA, 2009, J EXP BIOL, V212, P3132, DOI 10.1242/jeb.031179; Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336; Xiao CF, 2007, DEV NEUROBIOL, V67, P438, DOI 10.1002/dneu.20344; Yenari MA, 1998, ANN NEUROL, V44, P584, DOI 10.1002/ana.410440403; Zhou D, 2009, PEDIATR RES, V66, P239, DOI 10.1203/PDR.0b013e3181b27275	49	29	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28994	10.1371/journal.pone.0028994	http://dx.doi.org/10.1371/journal.pone.0028994			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174942	gold, Green Published			2022-12-25	WOS:000298366600056
J	Plissonnier, ML; Fauconnet, S; Bittard, H; Lascombe, I				Plissonnier, Marie-Laure; Fauconnet, Sylvie; Bittard, Hugues; Lascombe, Isabelle			The Antidiabetic Drug Ciglitazone Induces High Grade Bladder Cancer Cells Apoptosis through the Up-Regulation of TRAIL	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; SENSITIZES TUMOR-CELLS; HUMAN UROTHELIAL CELLS; DOWN-REGULATION; C-FLIP; LIGAND; SURVIVIN; DEATH; PPAR; PROGRESSION	Background: Ciglitazone belongs to the thiazolidinediones class of antidiabetic drug family and is a high-affinity ligand for the Peroxisome Proliferator-Activated Receptor gamma (PPAR gamma). Apart from its antidiabetic activity, this molecule shows antineoplastic effectiveness in numerous cancer cell lines. Methodology/Principal Findings: Using RT4 (derived from a well differentiated grade I papillary tumor) and T24 (derived from an undifferentiated grade III carcinoma) bladder cancer cells, we investigated the potential of ciglitazone to induce apoptotic cell death and characterized the molecular mechanisms involved. In RT4 cells, the drug induced G2/M cell cycle arrest characterized by an overexpression of p53, p21(waf1/CIP1) and p27(Kip1) in concomitance with a decrease of cyclin B1. On the contrary, in T24 cells, it triggered apoptosis via extrinsic and intrinsic pathways. Cell cycle arrest and induction of apoptosis occurred at high concentrations through PPAR gamma activation-independent pathways. We show that in vivo treatment of nude mice by ciglitazone inhibits high grade bladder cancer xenograft development. We identified a novel mechanism by which ciglitazone kills cancer cells. Ciglitazone up-regulated soluble and membrane-bound TRAIL and let TRAIL-resistant T24 cells to respond to TRAIL through caspase activation, death receptor signalling pathway and Bid cleavage. We provided evidence that TRAIL-induced apoptosis is partially driven by ciglitazone-mediated down-regulation of c-FLIP and survivin protein levels through a proteasome-dependent degradation mechanism. Conclusions/Significance: Therefore, ciglitazone could be clinically relevant as chemopreventive or therapeutic agent for the treatment of TRAIL-refractory high grade urothelial cancers.	[Plissonnier, Marie-Laure; Fauconnet, Sylvie; Lascombe, Isabelle] Univ Franche Comte, Fac Sci Med & Pharmaceut, Inst Fed Rech 133, Lab Biol Cellulaire & Mol,Equipe Accueil 3181, F-25030 Besancon, France; [Fauconnet, Sylvie; Bittard, Hugues] CHRU Besancon, Serv Urol & Androl, Besancon, France	Universite de Franche-Comte; Universite de Franche-Comte; CHU Besancon	Plissonnier, ML (corresponding author), Univ Franche Comte, Fac Sci Med & Pharmaceut, Inst Fed Rech 133, Lab Biol Cellulaire & Mol,Equipe Accueil 3181, F-25030 Besancon, France.	isabelle.lascombe@univ-fcomte.fr	Plissonnier, Marie-Laure/Y-9491-2019	Plissonnier, Marie-Laure/0000-0003-4879-4586	Ligue Nationale Contre le Cancer (Comite du Doubs); Canceropole du Grand-Est	Ligue Nationale Contre le Cancer (Comite du Doubs); Canceropole du Grand-Est(Region Grand-Est)	This work was supported by research grants from Ligue Nationale Contre le Cancer (Comite du Doubs). M. L. Plissonnier was supported by a fellowship from the Canceropole du Grand-Est. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogazzi F, 2004, EUR J ENDOCRINOL, V150, P863, DOI 10.1530/eje.0.1500863; Boiteux G, 2009, INT J CANCER, V124, P1820, DOI 10.1002/ijc.24112; Bonavida B, 1999, INT J ONCOL, V15, P793; Chaffer CL, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-53; Chen F, 2005, CELL SIGNAL, V17, P1572, DOI 10.1016/j.cellsig.2005.03.012; Chinnaiyan AM, 2000, P NATL ACAD SCI USA, V97, P1754, DOI 10.1073/pnas.030545097; Chintharlapalli S, 2005, MOL PHARMACOL, V68, P1782, DOI 10.1124/mol.105.017046; Day C, 1999, DIABETIC MED, V16, P179, DOI 10.1046/j.1464-5491.1999.00023.x; Doonan F, 2009, J NEUROCHEM, V109, P631, DOI 10.1111/j.1471-4159.2009.05995.x; Epstein JI, 1998, AM J SURG PATHOL, V22, P1435, DOI 10.1097/00000478-199812000-00001; Guan YF, 1997, AM J PHYSIOL-RENAL, V273, pF1013, DOI 10.1152/ajprenal.1997.273.6.F1013; Guan You-Fei, 1999, Neoplasia (New York), V1, P330, DOI 10.1038/sj.neo.7900050; Inoue T, 1999, J BIOL CHEM, V274, P32309, DOI 10.1074/jbc.274.45.32309; Jesenberger V, 2002, NAT REV MOL CELL BIO, V3, P112, DOI 10.1038/nrm731; Kamat A M, 2001, Curr Urol Rep, V2, P62, DOI 10.1007/s11934-001-0027-7; Keane MM, 1999, CANCER RES, V59, P734; Kim DJ, 2005, J BIOL CHEM, V280, P9519, DOI 10.1074/jbc.M413808200; Kim Y, 2002, J BIOL CHEM, V277, P22320, DOI 10.1074/jbc.M202458200; Kim YH, 2008, FREE RADICAL BIO MED, V44, P1055, DOI 10.1016/j.freeradbiomed.2007.12.001; Ku JH, 2010, BJU INT, V106, P1812, DOI 10.1111/j.1464-410X.2010.09259.x; Lascombe I, 2006, CLIN CANCER RES, V12, P2780, DOI 10.1158/1078-0432.CCR-05-2387; Lavrik IN, 2005, J CLIN INVEST, V115, P2665, DOI 10.1172/JCI26252; Lee R, 2000, UROL CLIN N AM, V27, P1, DOI 10.1016/S0094-0143(05)70229-9; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lu ML, 2005, J BIOL CHEM, V280, P6742, DOI 10.1074/jbc.M411519200; Ludwig AT, 2004, CANCER RES, V64, P3386, DOI 10.1158/0008-5472.CAN-04-0374; MICHALOVITZ D, 1990, CELL, V62, P671, DOI 10.1016/0092-8674(90)90113-S; Mita AC, 2008, CLIN CANCER RES, V14, P5000, DOI 10.1158/1078-0432.CCR-08-0746; Nakashiro K, 2001, AM J PATHOL, V159, P591, DOI 10.1016/S0002-9440(10)61730-0; Ning S, 2004, INT J ONCOL, V25, P1065; O'Connor DS, 2000, P NATL ACAD SCI USA, V97, P13103, DOI 10.1073/pnas.240390697; Oka N, 2006, CANCER SCI, V97, P1093, DOI 10.1111/j.1349-7006.2006.00294.x; Perez-Ortiz JM, 2004, J BIOL CHEM, V279, P8976, DOI 10.1074/jbc.M308518200; Poukkula M, 2005, J BIOL CHEM, V280, P27345, DOI 10.1074/jbc.M504019200; Rumi M. A. K., 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P465, DOI 10.2174/1568011043352678; Schultze K, 2006, APOPTOSIS, V11, P1503, DOI 10.1007/s10495-006-8896-3; Senthivinayagam S, 2009, J BIOL CHEM, V284, P13577, DOI 10.1074/jbc.M900248200; Shariat SF, 2007, UROL ONCOL-SEMIN ORI, V25, P468, DOI 10.1016/j.urolonc.2006.09.011; Smits VAJ, 2000, J BIOL CHEM, V275, P30638, DOI 10.1074/jbc.M005437200; Steele LP, 2006, CELL DEATH DIFFER, V13, P1564, DOI 10.1038/sj.cdd.4401846; STEWART N, 1995, ONCOGENE, V10, P109; Suzuki S, 2010, TOXICOL SCI, V113, P349, DOI 10.1093/toxsci/kfp256; Turturro F, 2004, CLIN CANCER RES, V10, P7022, DOI 10.1158/1078-0432.CCR-04-0879; VIKHANSKAYA F, 1994, NUCLEIC ACIDS RES, V22, P1012, DOI 10.1093/nar/22.6.1012; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wei S, 2009, CANCER LETT, V276, P119, DOI 10.1016/j.canlet.2008.08.008; Wolf BB, 1999, J BIOL CHEM, V274, P30651, DOI 10.1074/jbc.274.43.30651; Yoshimura R, 2003, INT J MOL MED, V12, P861; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu JW, 2008, ONCOGENE, V27, P6216, DOI 10.1038/onc.2008.299	50	24	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28354	10.1371/journal.pone.0028354	http://dx.doi.org/10.1371/journal.pone.0028354			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174792	Green Published, gold, Green Submitted			2022-12-25	WOS:000298366600012
J	Roy, A; Chowdhury, S; Sengupta, S; Mandal, M; Jaisankar, P; D'Annessa, I; Desideri, A; Majumder, HK				Roy, Amit; Chowdhury, Sayan; Sengupta, Souvik; Mandal, Madhumita; Jaisankar, Parasuraman; D'Annessa, Ilda; Desideri, Alessandro; Majumder, Hemanta K.			Development of Derivatives of 3, 3 '-Diindolylmethane as Potent Leishmania donovani Bi-Subunit Topoisomerase IB Poisons	PLOS ONE			English	Article							BREAST-CANCER CELLS; 3,3'-DIINDOLYLMETHANE DIM; DNA TOPOISOMERASES; MECHANISM; CAMPTOTHECIN; INHIBITION; CLEAVAGE; COMPLEX	Background: The development of 3, 3'-diindolyl methane (DIM) resistant parasite Leishmania donovani (LdDR50) by adaptation with increasing concentrations of the drug generates random mutations in the large and small subunits of heterodimeric DNA topoisomerase I of Leishmania (LdTOP1LS). Mutation of large subunit of LdTOP1LS at F270L is responsible for resistance to DIM up to 50 mu M concentration. Methodology/Principal Findings: In search of compounds that inhibit the growth of the DIM resistant parasite and inhibit the catalytic activity of mutated topoisomerase I (F270L), we have prepared three derivatives of DIM namely DPDIM (2,2'-diphenyl 3,3'-diindolyl methane), DMDIM (2,2'-dimethyl 3,3'-diindolyl methane) and DMODIM (5,5'-dimethoxy 3,3'-diindolyl methane) from parent compound DIM. All the compounds inhibit the growth of DIM resistant parasites, induce DNA fragmentation and stabilize topo1-DNA cleavable complex with the wild type and mutant enzyme. Conclusion: The results suggest that the three derivatives of DIM can act as promising lead molecules for the generation of new anti-leishmanial agents.	[Roy, Amit; Chowdhury, Sayan; Sengupta, Souvik; Majumder, Hemanta K.] Indian Inst Chem Biol, Mol Parasitol Lab, Kolkata, India; [Mandal, Madhumita; Jaisankar, Parasuraman] Indian Inst Chem Biol, Dept Med Chem, Kolkata, India; [D'Annessa, Ilda; Desideri, Alessandro] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); University of Rome Tor Vergata	Roy, A (corresponding author), Indian Inst Chem Biol, Mol Parasitol Lab, Kolkata, India.	hkmajumder@iicb.res.in	Jaisankar, Parasuraman/C-1553-2009; Gupta, Souvik Sen/X-9547-2019	Jaisankar, Parasuraman/0000-0003-0583-4920; Gupta, Souvik Sen/0000-0001-7452-979X; D'Annessa, Ilda/0000-0002-6174-6899; desideri, alessandro/0000-0003-1541-4217	Council of Scientific and Industrial Research (CSIR), Government of India [NWP-38]	Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the grants from Network Project NWP-38 of Council of Scientific and Industrial Research (CSIR), Government of India, CSIR fellowship (to Dr. Roy, Dr. Chowdhury, Dr. Sengupta). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; COMPTON MM, 1992, CANCER METAST REV, V11, P105, DOI 10.1007/BF00048058; Das A, 2004, TRENDS PARASITOL, V20, P381, DOI 10.1016/j.pt.2004.06.005; Das BB, 2006, NUCLEIC ACIDS RES, V34, P1121, DOI 10.1093/nar/gkj502; DAS BB, 2004, LEISHMANIA, V565, P81; Davies DR, 2006, J MOL BIOL, V357, P1202, DOI 10.1016/j.jmb.2006.01.022; Gong YX, 2006, MOL PHARMACOL, V69, P1320, DOI 10.1124/mol.105.018978; Guex N, 1999, TRENDS BIOCHEM SCI, V24, P364, DOI 10.1016/S0968-0004(99)01427-9; Guharay J, 2001, PROTEINS, V43, P75, DOI 10.1002/1097-0134(20010501)43:2<75::AID-PROT1019>3.3.CO;2-Z; Hong C, 2002, BIOCHEM PHARMACOL, V63, P1085, DOI 10.1016/S0006-2952(02)00856-0; Hong CB, 2002, CARCINOGENESIS, V23, P1297, DOI 10.1093/carcin/23.8.1297; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; HUMPHREY W, 1996, J MOL GRAPHICS, V14, P27, DOI DOI 10.1016/0263-7855(96)00018-5; LIU LF, 1989, ANNU REV BIOCHEM, V58, P351, DOI 10.1146/annurev.bi.58.070189.002031; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Pal C, 2007, BIOORG MED CHEM LETT, V17, P4924, DOI 10.1016/j.bmcl.2007.06.025; Roy A, 2008, MOL PHARMACOL, V74, P1292, DOI 10.1124/mol.108.050161; Roy A, 2008, BIOCHEM J, V409, P611, DOI 10.1042/BJ20071286; Roy A, 2009, ANTIMICROB AGENTS CH, V53, P2589, DOI 10.1128/AAC.01648-08; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Tesauro C, 2010, BIOCHEM J, V425, P531, DOI 10.1042/BJ20091127; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223	23	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28493	10.1371/journal.pone.0028493	http://dx.doi.org/10.1371/journal.pone.0028493			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174820	Green Submitted, gold, Green Published			2022-12-25	WOS:000298366600022
J	Hayes, NVL; Josse, L; Smales, CM; Carden, MJ				Hayes, Nandini V. L.; Josse, Lyne; Smales, C. Mark; Carden, Martin J.			Modulation of Phosducin-Like Protein 3 (PhLP3) Levels Promotes Cytoskeletal Remodelling in a MAPK and RhoA-Dependent Manner	PLOS ONE			English	Article							CYTOSOLIC CHAPERONIN COMPLEX; CULTURED-MAMMALIAN-CELLS; SACCHAROMYCES-CEREVISIAE; CYCLE PROGRESSION; GENE-EXPRESSION; COLD-SHOCK; IN-VITRO; CCT; KINASE; LINKING	Background: Phosducin-like protein 3 (PhLP3) forms a ternary complex with the ATP-dependent molecular chaperone CCT and its folding client tubulin. In vitro studies suggest PhLP3 plays an inhibitory role in beta-tubulin folding while conversely in vivo genetic studies suggest PhLP3 is required for the correct folding of beta-tubulin. We have a particular interest in the cytoskeleton, its chaperones and their role in determining cellular phenotypes associated with high level recombinant protein expression from mammalian cell expression systems. Methodology/Principal Findings: As studies into PhLP3 function have been largely carried out in non mammalian systems, we examined the effect of human PhLP3 over-expression and siRNA silencing using a single murine siRNA on both tubulin and actin systems in mammalian Chinese hamster ovary (CHO) cell lines. We show that over-expression of PhLP3 promotes an imbalance of alpha and beta tubulin subunits, microtubule disassembly and cell death. In contrast, beta-actin levels are not obviously perturbed. On-the-other-hand, RNA silencing of PhLP3 increases RhoA-dependent actin filament formation and focal adhesion formation and promotes a dramatic elongated fibroblast-like change in morphology. This was accompanied by an increase in phosphorylated MAPK which has been associated with promoting focal adhesion assembly and maturation. Transient overexpression of PhLP3 in knockdown experiments rescues cells from the morphological change observed during PhLP3 silencing but mitosis is perturbed, probably reflecting a tipping back of the balance of PhLP3 levels towards the overexpression state. Conclusions: Our results support the hypothesis that PhLP3 is important for the maintenance of beta-tubulin levels in mammalian cells but also that its modulation can promote actin-based cytoskeletal remodelling by a mechanism linked with MAPK phosphorylation and RhoA-dependent changes. PhLP3 levels in mammalian cells are thus finely poised and represents a novel target for engineering industrially relevant cell lines to evolve lines more suited to suspension or adherent cell growth.	[Hayes, Nandini V. L.] Univ Kent, Ctr Mol Proc, Canterbury, Kent, England; Univ Kent, Sch Biosci, Canterbury, Kent, England	University of Kent; University of Kent	Hayes, NVL (corresponding author), Univ Kent, Ctr Mol Proc, Canterbury, Kent, England.	c.m.smales@kent.ac.uk; m.j.carden@kent.ac.uk	Carden, Martin/D-4135-2019	Carden, Martin/0000-0002-0609-4605; Smales, Christopher Mark/0000-0002-2762-4724; JOSSE, Lyne/0000-0002-7856-7651	BBSRC [BB/E005969/1]; EPSRC; industrial club members via the Bioprocessing Research Industry Club (BRIC) initiative; Biotechnology and Biological Sciences Research Council [BB/E005969/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); industrial club members via the Bioprocessing Research Industry Club (BRIC) initiative; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by project grant BB/E005969/1 from the BBSRC, EPSRC and industrial club members via the Bioprocessing Research Industry Club (BRIC) initiative (www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Fageeh MB, 2006, BIOTECHNOL BIOENG, V93, P829, DOI 10.1002/bit.20789; Albanese V, 2006, CELL, V124, P75, DOI 10.1016/j.cell.2005.11.039; Blaauw M, 2003, EMBO J, V22, P5047, DOI 10.1093/emboj/cdg508; Brackley KI, 2010, EXP CELL RES, V316, P543, DOI 10.1016/j.yexcr.2009.11.003; Brackley KI, 2009, CELL STRESS CHAPERON, V14, P23, DOI 10.1007/s12192-008-0057-x; BURKE D, 1989, MOL CELL BIOL, V9, P1049, DOI 10.1128/MCB.9.3.1049; Camasses A, 2003, MOL CELL, V12, P87, DOI 10.1016/S1097-2765(03)00244-2; Castellano MM, 2008, PLANT CELL, V20, P969, DOI 10.1105/tpc.107.057737; Dinnis DM, 2006, BIOTECHNOL BIOENG, V94, P830, DOI 10.1002/bit.20899; Etchells SA, 2005, J BIOL CHEM, V280, P28118, DOI 10.1074/jbc.M504110200; Flanary PL, 2000, J BIOL CHEM, V275, P18462, DOI 10.1074/jbc.M002163200; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gourbatsi E, 2006, MOL BIOTECHNOL, V33, P1; Grantham J, 2002, CELL STRESS CHAPERON, V7, P235, DOI 10.1379/1466-1268(2002)007<0235:ECCTCP>2.0.CO;2; Hayes NVL, 2010, BIOTECHNOL BIOENG, V105, P770, DOI 10.1002/bit.22587; Josse L, 2010, BIOTECHNOL BIOENG, V105, P556, DOI 10.1002/bit.22572; Kabir MA, 2008, FEMS YEAST RES, V8, P1236, DOI 10.1111/j.1567-1364.2008.00425.x; Kunisawa J, 2003, MOL CELL, V12, P565, DOI 10.1016/j.molcel.2003.08.009; Lacefield S, 2003, GENETICS, V165, P531; Liu XQ, 2005, MOL CELL BIOL, V25, P4993, DOI 10.1128/MCB.25.12.4993-5010.2005; Lopez P, 2003, J BIOL CHEM, V278, P1751, DOI 10.1074/jbc.M207434200; Lukov GL, 2006, J BIOL CHEM, V281, P22261, DOI 10.1074/jbc.M601590200; Marchant RJ, 2008, MOL BIOTECHNOL, V39, P69, DOI 10.1007/s12033-008-9032-0; Martin-Benito J, 2004, P NATL ACAD SCI USA, V101, P17410, DOI 10.1073/pnas.0405070101; Masterton RJ, 2010, BIOTECHNOL BIOENG, V105, P215, DOI 10.1002/bit.22533; McCormack EA, 2009, J MOL BIOL, V391, P192, DOI 10.1016/j.jmb.2009.06.003; McLaughlin JN, 2002, P NATL ACAD SCI USA, V99, P7962, DOI 10.1073/pnas.112075699; McLaughlin JN, 2002, J BIOL CHEM, V277, P34885, DOI 10.1074/jbc.M205583200; Mead EJ, 2009, BIOTECHNOL BIOENG, V102, P1593, DOI 10.1002/bit.22201; Ogawa S, 2004, GENES CELLS, V9, P83, DOI 10.1111/j.1356-9597.2004.00708.x; Ohsaka Y, 2002, CELL PHYSIOL BIOCHEM, V12, P111, DOI 10.1159/000063787; Pullikuth AK, 2007, CELL SIGNAL, V19, P1621, DOI 10.1016/j.cellsig.2007.04.012; Pullikuth AK, 2010, MOL CELL BIOL, V30, P3233, DOI 10.1128/MCB.01178-09; Ridley AJ, 2001, TRAFFIC, V2, P303, DOI 10.1034/j.1600-0854.2001.002005303.x; Riento K, 2003, MOL CELL BIOL, V23, P4219, DOI 10.1128/MCB.23.12.4219-4229.2003; ROOBOL A, 1995, J CELL SCI, V108, P1477; Roobol A, 2011, BIOCHEM J, V435, P499, DOI 10.1042/BJ20101303; Roobol A, 2009, FEBS J, V276, P286, DOI 10.1111/j.1742-4658.2008.06781.x; Sha Z, 2009, MOL CELL, V36, P141, DOI 10.1016/j.molcel.2009.09.026; Stirling PC, 2006, J BIOL CHEM, V281, P7012, DOI 10.1074/jbc.M513235200; Stirling PC, 2007, MOL BIOL CELL, V18, P2336, DOI 10.1091/mbc.E07-01-0069; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Underhill MF, 2005, BIOTECHNOL BIOENG, V89, P805, DOI 10.1002/bit.20403; Underhill MF, 2006, MOL BIOTECHNOL, V34, P141, DOI 10.1385/MB:34:2:141; Wilkinson JC, 2004, J BIOL CHEM, V279, P51091, DOI 10.1074/jbc.M409623200; Willardson BM, 2007, CELL SIGNAL, V19, P2417, DOI 10.1016/j.cellsig.2007.06.013	46	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28271	10.1371/journal.pone.0028271	http://dx.doi.org/10.1371/journal.pone.0028271			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174782	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000298365700025
J	Henriksen, SB; Mortensen, RJ; Geertz-Hansen, HM; Neves-Petersen, MT; Arnason, O; Soring, J; Petersen, SB				Henriksen, Svend B.; Mortensen, Rasmus J.; Geertz-Hansen, Henrik M.; Neves-Petersen, Maria Teresa; Arnason, Omar; Soring, Jon; Petersen, Steffen B.			Hyperdimensional Analysis of Amino Acid Pair Distributions in Proteins	PLOS ONE			English	Article							COMPLEX SALT BRIDGES; CORRELATED MUTATIONS; ENERGETIC APPROACH; GLOBULAR-PROTEINS; DISULFIDE BRIDGES; RESIDUE CONTACTS; ALPHA-HELICES; BETA-PACKING; PREDICTION; CLASSIFICATION	Our manuscript presents a novel approach to protein structure analyses. We have organized an 8-dimensional data cube with protein 3D-structural information from 8706 high-resolution non-redundant protein-chains with the aim of identifying packing rules at the amino acid pair level. The cube contains information about amino acid type, solvent accessibility, spatial and sequence distance, secondary structure and sequence length. We are able to pose structural queries to the data cube using program ProPack. The response is a 1, 2 or 3D graph. Whereas the response is of a statistical nature, the user can obtain an instant list of all PDB-structures where such pair is found. The user may select a particular structure, which is displayed highlighting the pair in question. The user may pose millions of different queries and for each one he will receive the answer in a few seconds. In order to demonstrate the capabilities of the data cube as well as the programs, we have selected well known structural features, disulphide bridges and salt bridges, where we illustrate how the queries are posed, and how answers are given. Motifs involving cysteines such as disulphide bridges, zinc-fingers and iron-sulfur clusters are clearly identified and differentiated. ProPack also reveals that whereas pairs of Lys residues virtually never appear in close spatial proximity, pairs of Arg are abundant and appear at close spatial distance, contrasting the belief that electrostatic repulsion would prevent this juxtaposition and that Arg-Lys is perceived as a conservative mutation. The presented programs can find and visualize novel packing preferences in proteins structures allowing the user to unravel correlations between pairs of amino acids. The new tools allow the user to view statistical information and visualize instantly the structures that underpin the statistical information, which is far from trivial with most other SW tools for protein structure analysis.	[Henriksen, Svend B.; Mortensen, Rasmus J.; Geertz-Hansen, Henrik M.; Arnason, Omar; Soring, Jon] Univ Aalborg, Dept Phys & Nanotechnol, NanoBiotechnol Grp, Aalborg, Denmark; [Neves-Petersen, Maria Teresa] Int Iberian Nanotechnol Lab INL, Braga, Portugal; [Neves-Petersen, Maria Teresa] Univ Aalborg, Nanobiotechnol Grp, Dept Biotechnol Chem & Environm Sci, Aalborg, Denmark; [Petersen, Steffen B.] Univ Aalborg, Nanobiotechnol Grp, Dept Hlth Sci & Technol, Aalborg, Denmark; [Petersen, Steffen B.] SUNY Buffalo, Inst Lasers Photon & Biophoton, Buffalo, NY 14260 USA	Aalborg University; International Iberian Nanotechnology Laboratory; Aalborg University; Aalborg University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Henriksen, SB (corresponding author), Univ Aalborg, Dept Phys & Nanotechnol, NanoBiotechnol Grp, Aalborg, Denmark.	teresa.petersen@inl.int	Petersen, Steffen b/E-8727-2015	Petersen, Steffen b/0000-0002-0739-2751; Neves-Petersen, Maria Teresa/0000-0003-3178-3709; Geertz-Hansen, Henrik Marcus/0000-0003-0425-7551				Afonnikov DA, 2004, NUCLEIC ACIDS RES, V32, pW64, DOI 10.1093/nar/gkh451; ALTSCHUH D, 1987, J MOL BIOL, V193, P693, DOI 10.1016/0022-2836(87)90352-4; [Anonymous], 2010, MATLAB VERS 7 10 0 4; BAGLEY SC, 1995, PROTEIN SCI, V4, P622; BARLOW DJ, 1983, J MOL BIOL, V168, P867, DOI 10.1016/S0022-2836(83)80079-5; BENHAM CJ, 1993, PROTEIN SCI, V2, P41; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhattacharyya R, 2004, PROTEIN ENG DES SEL, V17, P795, DOI 10.1093/protein/gzh093; BOEL E, 1990, BIOCHEMISTRY-US, V29, P6244, DOI 10.1021/bi00478a019; CARLACCI L, 1991, J COMPUT CHEM, V12, P410, DOI 10.1002/jcc.540120315; CATH, PROT STRUCT CLASS DA; CHOU KC, 1988, P NATL ACAD SCI USA, V85, P4295, DOI 10.1073/pnas.85.12.4295; CHOU KC, 1984, J AM CHEM SOC, V106, P3161, DOI 10.1021/ja00323a017; CHOU KC, 1992, P NATL ACAD SCI USA, V89, P7315, DOI 10.1073/pnas.89.16.7315; CHOU KC, 1990, ACCOUNTS CHEM RES, V23, P134, DOI 10.1021/ar00173a003; CHOU KC, 1992, PROTEIN SCI, V1, P810, DOI 10.1002/pro.5560010613; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; CHOU KC, 1986, J MOL BIOL, V188, P641, DOI 10.1016/S0022-2836(86)80012-2; CHOU KC, 1985, J MOL BIOL, V186, P591, DOI 10.1016/0022-2836(85)90133-0; CHOU KC, 1983, J PHYS CHEM-US, V87, P2869, DOI 10.1021/j100238a033; CHOU KC, 2009, NAT SCI, V2, P63, DOI DOI 10.4236/NS.2009.12011; Chou KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018258; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Costantini S, 2008, BIOINFORMATION, V3, P137, DOI 10.6026/97320630003137; Creighton T.E., 1993, PROTEINS; FISER A, 1992, FEBS LETT, V302, P117, DOI 10.1016/0014-5793(92)80419-H; Fleishman SJ, 2004, J MOL BIOL, V340, P307, DOI 10.1016/j.jmb.2004.04.064; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Govindarajan S, 1999, PROTEINS, V35, P408, DOI 10.1002/(SICI)1097-0134(19990601)35:4<408::AID-PROT4>3.0.CO;2-A; Gvritishvili AG, 2008, PROTEIN SCI, V17, P1285, DOI 10.1110/ps.034975.108; Halperin I, 2006, PROTEINS, V63, P832, DOI 10.1002/prot.20933; HARRISON PM, 1994, J MOL BIOL, V244, P448, DOI 10.1006/jmbi.1994.1742; Harrison PM, 1996, J MOL BIOL, V264, P603, DOI 10.1006/jmbi.1996.0664; Hayat M, 2011, J THEOR BIOL, V271, P10, DOI 10.1016/j.jtbi.2010.11.017; Jaenicke R, 2000, J BIOTECHNOL, V79, P193, DOI 10.1016/S0168-1656(00)00236-4; Kandaswamy KK, 2011, J THEOR BIOL, V270, P56, DOI 10.1016/j.jtbi.2010.10.037; KARLIN S, 1994, J MOL BIOL, V239, P227, DOI 10.1006/jmbi.1994.1365; Kass I, 2002, PROTEINS, V48, P611, DOI 10.1002/prot.10180; Kumar S, 1999, J MOL BIOL, V293, P1241, DOI 10.1006/jmbi.1999.3218; Kumar S, 2002, CHEMBIOCHEM, V3, P604, DOI 10.1002/1439-7633(20020703)3:7<604::AID-CBIC604>3.0.CO;2-X; Kundrotas PJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-503; Lenffer J, 2004, NUCLEIC ACIDS RES, V32, pW350, DOI 10.1093/nar/gkh475; Lin H, 2011, J THEOR BIOL, V269, P64, DOI 10.1016/j.jtbi.2010.10.019; MAO B, 1989, J AM CHEM SOC, V111, P6132, DOI 10.1021/ja00198a022; Masso M, 2010, J THEOR BIOL, V266, P560, DOI 10.1016/j.jtbi.2010.07.026; MUSAFIA B, 1995, J MOL BIOL, V254, P761, DOI 10.1006/jmbi.1995.0653; MUSKAL SM, 1990, PROTEIN ENG, V3, P667, DOI 10.1093/protein/3.8.667; NEHER E, 1994, P NATL ACAD SCI USA, V91, P98, DOI 10.1073/pnas.91.1.98; Pal D, 1998, J BIOMOL STRUCT DYN, V15, P1059, DOI 10.1080/07391102.1998.10509001; Pazos F, 1997, COMPUT APPL BIOSCI, V13, P319; PERAHIA D, 1971, BIOCHEM BIOPH RES CO, V43, P65, DOI 10.1016/S0006-291X(71)80086-4; Petersen MTN, 1999, PROTEIN ENG, V12, P535, DOI 10.1093/protein/12.7.535; REID KSC, 1985, FEBS LETT, V190, P209, DOI 10.1016/0014-5793(85)81285-0; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; RICHARDSON JS, 1998, PREDICTION PROTEIN S, P1; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; Sarakatsannis JN, 2005, PROTEINS, V60, P732, DOI 10.1002/prot.20549; Sinha N, 2002, CURR PROTEIN PEPT SC, V3, P601, DOI 10.2174/1389203023380431; SRINIVASAN N, 1990, INT J PEPT PROT RES, V36, P147; THORNTON JM, 1981, J MOL BIOL, V151, P261, DOI 10.1016/0022-2836(81)90515-5; van Vlijmen HWT, 2004, J MOL BIOL, V335, P1083, DOI 10.1016/j.jmb.2003.10.077; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Zakeri P, 2011, J THEOR BIOL, V269, P208, DOI 10.1016/j.jtbi.2010.10.026	63	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e25638	10.1371/journal.pone.0025638	http://dx.doi.org/10.1371/journal.pone.0025638			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174733	Green Submitted, Green Published, gold			2022-12-25	WOS:000298365700001
J	Miteva, K; Haag, M; Peng, J; Savvatis, K; Becher, PM; Seifert, M; Warstat, K; Westermann, D; Ringe, J; Sittinger, M; Schultheiss, HP; Tschope, C; Van Linthout, S				Miteva, Kapka; Haag, Marion; Peng, Jun; Savvatis, Kostas; Becher, Peter Moritz; Seifert, Martina; Warstat, Katrin; Westermann, Dirk; Ringe, Jochen; Sittinger, Michael; Schultheiss, Heinz-Peter; Tschoepe, Carsten; Van Linthout, Sophie			Human Cardiac-Derived Adherent Proliferating Cells Reduce Murine Acute Coxsackievirus B3-Induced Myocarditis	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; INTERFERON-GAMMA; NITRIC-OXIDE; INDUCE APOPTOSIS; GENE-TRANSFER; RAT MODEL; MICE; RECEPTOR; ACTIVATION; INFARCTION	Background: Under conventional heart failure therapy, inflammatory cardiomyopathy typically has a progressive course, indicating a need for alternative therapeutic strategies to improve long-term outcomes. We recently isolated and identified novel cardiac-derived cells from human cardiac biopsies: cardiac-derived adherent proliferating cells (CAPs). They have similarities with mesenchymal stromal cells, which are known for their anti-apoptotic and immunomodulatory properties. We explored whether CAPs application could be a novel strategy to improve acute Coxsackievirus B3 (CVB3)-induced myocarditis. Methodology/Principal Findings: To evaluate the safety of our approach, we first analyzed the expression of the coxsackie- and adenovirus receptor (CAR) and the co-receptor CD55 on CAPs, which are both required for effective CVB3 infectivity. We could demonstrate that CAPs only minimally express both receptors, which translates to minimal CVB3 copy numbers, and without viral particle release after CVB3 infection. Co-culture of CAPs with CVB3-infected HL-1 cardiomyocytes resulted in a reduction of CVB3-induced HL-1 apoptosis and viral progeny release. In addition, CAPs reduced CD4 and CD8 T cell proliferation. All CAPs-mediated protective effects were nitric oxide- and interleukin-10-dependent and required interferon-gamma. In an acute murine model of CVB3-induced myocarditis, application of CAPs led to a decrease of cardiac apoptosis, cardiac CVB3 viral load and improved left ventricular contractility parameters. This was associated with a decline in cardiac mononuclear cell activity, an increase in T regulatory cells and T cell apoptosis, and an increase in left ventricular interleukin-10 and interferon-gamma mRNA expression. Conclusions: We conclude that CAPs are a unique type of cardiac-derived cells and promising tools to improve acute CVB3-induced myocarditis.	[Miteva, Kapka; Haag, Marion; Seifert, Martina; Warstat, Katrin; Ringe, Jochen; Sittinger, Michael; Tschoepe, Carsten; Van Linthout, Sophie] Charite, Berlin Brandenburg Ctr Regenerat Therapies, D-13353 Berlin, Germany; [Haag, Marion; Ringe, Jochen; Sittinger, Michael] Charite, Lab Tissue Engn, D-13353 Berlin, Germany; [Peng, Jun; Savvatis, Kostas; Becher, Peter Moritz; Westermann, Dirk; Schultheiss, Heinz-Peter; Tschoepe, Carsten; Van Linthout, Sophie] Charite, Dept Cardiol & Pneumol, D-13353 Berlin, Germany; [Seifert, Martina] Charite, Inst Med Immunol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Miteva, K (corresponding author), Charite, Berlin Brandenburg Ctr Regenerat Therapies, Campus Virchow, D-13353 Berlin, Germany.	carsten.tschoepe@charite.de	Westermann, Dirk/D-1344-2011	Tschope, Carsten/0000-0001-5243-8985; Westermann, Dirk/0000-0002-7542-1956; , Martina/0000-0002-6372-9769; Haag, Marion/0000-0002-9162-5131	Berlin-Brandenburg Center for Regenerative Therapies - BCRT (Bundesministerium fur Bildung und Forschung) [0313911]; DFG (Deutsche Forschungsgemeinschaft) through the Berlin-Brandenburg School for Regenerative Therapies; DFG [Sonderforschungsbereich Transregio-19 Z3, B5]	Berlin-Brandenburg Center for Regenerative Therapies - BCRT (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF)); DFG (Deutsche Forschungsgemeinschaft) through the Berlin-Brandenburg School for Regenerative Therapies(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	This study was supported by the Berlin-Brandenburg Center for Regenerative Therapies - BCRT (Bundesministerium fur Bildung und Forschung 0313911) to MH, MiS, CT, and SVL, by DFG (Deutsche Forschungsgemeinschaft) funding through the Berlin-Brandenburg School for Regenerative Therapies, and by the DFG Sonderforschungsbereich Transregio-19 Z3 and B5 to CT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bergelson JM, 1999, BIOCHEM PHARMACOL, V57, P975, DOI 10.1016/S0006-2952(98)00332-3; Carthy CM, 2003, VIROLOGY, V313, P147, DOI 10.1016/S0042-6822(03)00242-3; Choi YH, 2011, CARDIOVASC THER, V29, P2, DOI 10.1111/j.1755-5922.2010.00191.x; CHOW LH, 1992, LAB INVEST, V66, P24; De Geest BR, 2003, BLOOD, V101, P2551, DOI 10.1182/blood-2002-07-2146; Dhingra S, 2009, CARDIOVASC RES, V82, P59, DOI 10.1093/cvr/cvp040; Di Lanni M, 2008, EXP HEMATOL, V36, P309, DOI 10.1016/j.exphem.2007.11.007; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; HAAG M, J TISSUE EN IN PRESS; Haag M, 2010, J CELL BIOCHEM, V109, P564, DOI 10.1002/jcb.22433; Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055; Henke A, 2003, VIROLOGY, V315, P335, DOI 10.1016/S0042-6822(03)00538-5; Hidaka C, 1999, J CLIN INVEST, V103, P579, DOI 10.1172/JCI5309; Huber SA, 2000, CARDIOVASC RES, V45, P579, DOI 10.1016/S0008-6363(99)00267-9; Iso Y, 2007, BIOCHEM BIOPH RES CO, V354, P700, DOI 10.1016/j.bbrc.2007.01.045; Jarasch N, 2005, VIRAL IMMUNOL, V18, P355, DOI 10.1089/vim.2005.18.355; KISHIMOTO C, 1989, CIRCULATION, V79, P1300, DOI 10.1161/01.CIR.79.6.1300; Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Leuschner F, 2010, CIRC RES, V107, P1364, DOI 10.1161/CIRCRESAHA.110.227454; Levings MK, 2002, INT ARCH ALLERGY IMM, V129, P263, DOI 10.1159/000067596; Li JH, 2008, J ENDOCRINOL INVEST, V31, P103, DOI 10.1007/BF03345575; Martino TA, 1998, VIROLOGY, V244, P302, DOI 10.1006/viro.1998.9122; MASON JW, 1995, NEW ENGL J MED, V333, P269, DOI 10.1056/NEJM199508033330501; McBride C, 2003, CYTOTHERAPY, V5, P7, DOI 10.1080/14653240310000038; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Nagaya N, 2004, AM J PHYSIOL-HEART C, V287, pH2670, DOI 10.1152/ajpheart.01071.2003; Nagaya N, 2005, CIRCULATION, V112, P1128, DOI 10.1161/CIRCULATIONAHA.104.500447; Nishio R, 1999, CIRCULATION, V100, P1102, DOI 10.1161/01.CIR.100.10.1102; Oh I, 2007, BIOCHEM BIOPH RES CO, V355, P956, DOI 10.1016/j.bbrc.2007.02.054; Ohnishi S, 2007, J MOL CELL CARDIOL, V42, P88, DOI 10.1016/j.yjmcc.2006.10.003; Pinkert S, 2009, CIRCULATION, V120, P2358, DOI 10.1161/CIRCULATIONAHA.108.845339; Plumas J, 2005, LEUKEMIA, V19, P1597, DOI 10.1038/sj.leu.2403871; Razavi HM, 2005, PHARMACOL THERAPEUT, V106, P147, DOI 10.1016/j.pharmthera.2004.11.006; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Santis G, 1999, J GEN VIROL, V80, P1519, DOI 10.1099/0022-1317-80-6-1519; Shi Y, 2010, CIRCULATION, V121, P2624, DOI 10.1161/CIRCULATIONAHA.109.893248; Szelid Z, 2010, BASIC RES CARDIOL, V105, P169, DOI 10.1007/s00395-009-0077-4; Tschope C, 2005, CIRCULATION, V111, P879, DOI 10.1161/01.CIR.0000155615.68924.B3; Van Linthout S, 2011, EUR HEART J, V32, P2168, DOI 10.1093/eurheartj/ehq467; Van Linthout S, 2002, GENE THER, V9, P1520, DOI 10.1038/sj.gt.3301824; van Ramshorst J, 2009, JAMA-J AM MED ASSOC, V301, P1997, DOI 10.1001/jama.2009.685; Wood KJ, 2006, TRENDS IMMUNOL, V27, P183, DOI 10.1016/j.it.2006.02.008; Yang SH, 2009, EXP MOL MED, V41, P315, DOI 10.3858/emm.2009.41.5.035; Yerebakan C, 2007, CELL TRANSPLANT, V16, P935, DOI 10.3727/096368907783338280; Yuan JP, 2003, CELL RES, V13, P203, DOI 10.1038/sj.cr.7290165; Zell R, 2004, MED MICROBIOL IMMUN, V193, P91, DOI 10.1007/s00430-003-0198-6	49	31	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28513	10.1371/journal.pone.0028513	http://dx.doi.org/10.1371/journal.pone.0028513			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174827	Green Published, Green Submitted, gold			2022-12-25	WOS:000298365700042
J	Sabbaj, S; Hel, Z; Richter, HE; Mestecky, J; Goepfert, PA				Sabbaj, Steffanie; Hel, Zdenek; Richter, Holly E.; Mestecky, Jiri; Goepfert, Paul A.			Menstrual Blood as a Potential Source of Endometrial Derived CD3+T Cells	PLOS ONE			English	Article							CD8(+) T-CELLS; FEMALE REPRODUCTIVE-TRACT; CHEMOKINE RECEPTOR EXPRESSION; BREAST-MILK; EARLY-PREGNANCY; STEM-CELLS; NK CELLS; LYMPHOCYTES; INFECTION; WOMEN	Studies of T cell-mediated immunity in the human female genital tract have been problematic due to difficulties associated with the collection of mucosal samples. Consequently, most studies rely on biopsies from the lower female genital tract or remnant tissue from hysterectomies. Availability of samples from healthy women is limited, as most studies are carried out in women with underlying pathologies. Menstruation is the cyclical sloughing off of endometrial tissue, and thus it should be a source of endometrial cells without the need for a biopsy. We isolated and phenotyped T cells from menstrual and peripheral blood and from endometrial biopsy-derived tissue from healthy women to determine the types of T cells present in this compartment. Our data demonstrated that T cells isolated from menstrual blood are a heterogeneous population of cells with markers reminiscent of blood and mucosal cells as well as unique phenotypes not represented in either compartment. T cells isolated from menstrual blood expressed increased levels of HLA-DR, alpha Eb7 and CXCR4 and reduced levels of CD62L relative to peripheral blood. Menstrual blood CD4+ T cells were enriched for cells expressing both CCR7 and CD45RA, markers identifying naive T cells and were functional as determined by antigen-specific intracellular cytokine production assays. These data may open new avenues of investigation for cell mediated immune studies involving the female reproductive tract without the need for biopsies.	[Sabbaj, Steffanie; Goepfert, Paul A.] Univ Alabama, Dept Med, Birmingham, AL 35294 USA; [Hel, Zdenek] Univ Alabama, Dept Mol & Cellular Pathol, Birmingham, AL USA; [Richter, Holly E.] Univ Alabama, Dept Obstet & Gynecol, Birmingham, AL 35294 USA; [Hel, Zdenek; Mestecky, Jiri; Goepfert, Paul A.] Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Sabbaj, S (corresponding author), Univ Alabama, Dept Med, Birmingham, AL 35294 USA.	sabbaj@uab.edu		Richter, Holly E/0000-0001-7741-5771; Hel, Zdenek/0000-0002-4923-4794; Sabbaj, Steffanie/0000-0003-4052-6819	National Institutes of Health [AI074438]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074438] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant AI074438. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; BULMER JN, 1986, EUR J OBSTET GYN R B, V23, P31, DOI 10.1016/0028-2243(86)90102-4; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; CHEN CK, 1995, HUM IMMUNOL, V42, P227, DOI 10.1016/0198-8859(94)00105-Y; Eriksson M, 2004, J LEUKOCYTE BIOL, V76, P667, DOI 10.1189/jlb.0204090; Gargett CE, 2010, MOL HUM REPROD, V16, P818, DOI 10.1093/molehr/gaq061; Givan AL, 1997, AM J REPROD IMMUNOL, V38, P350; Ho HN, 1996, HUM IMMUNOL, V49, P130, DOI 10.1016/0198-8859(96)00120-6; JALANTI R, 1977, INT ARCH ALLER A IMM, V53, P402, DOI 10.1159/000231778; KAMAT BR, 1987, AM J PATHOL, V127, P66; KELLY JK, 1979, J REPROD IMMUNOL, V1, P39, DOI 10.1016/0165-0378(79)90028-7; Lapidot T, 2002, LEUKEMIA, V16, P1992, DOI 10.1038/sj.leu.2402684; LOHMAN BL, 1995, J IMMUNOL, V155, P5855; Lohman BL, 2003, J INFECT DIS, V188, P1666, DOI 10.1086/379374; Lynch L, 2007, HUM REPROD, V22, P919, DOI 10.1093/humrep/del456; Masuda H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010387; Meyer-Olson Dirk, 2010, HIV Therapy, V4, P413, DOI 10.2217/HIV.10.30; MORRIS H, 1985, J CLIN PATHOL, V38, P644, DOI 10.1136/jcp.38.6.644; Mulayim N, 2003, BIOL REPROD, V68, P1491, DOI 10.1095/biolreprod.102.009639; Musey L, 1997, J EXP MED, V185, P293, DOI 10.1084/jem.185.2.293; PARR EL, 1990, J REPROD FERTIL, V89, P619; Patel AN, 2008, CELL TRANSPLANT, V17, P303, DOI 10.3727/096368908784153922; Prakash M, 2002, J REPROD IMMUNOL, V54, P117, DOI 10.1016/S0165-0378(01)00125-5; Romero P, 2007, J IMMUNOL, V178, P4112, DOI 10.4049/jimmunol.178.7.4112; Rosu-Myles M, 2000, P NATL ACAD SCI USA, V97, P14626, DOI 10.1073/pnas.97.26.14626; Russell MW, 2010, IMMUNOL INVEST, V39, P500, DOI 10.3109/08820131003674834; Sabbaj S, 2005, J IMMUNOL, V174, P2951, DOI 10.4049/jimmunol.174.5.2951; Sabbaj S, 2002, J VIROL, V76, P7365, DOI 10.1128/JVI.76.15.7365-7373.2002; Sabbaj S, 2007, J INFECT DIS, V195, P108, DOI 10.1086/509510; Stevceva L, 2002, J VIROL, V76, P11659, DOI 10.1128/JVI.76.22.11659-11676.2002; Vassiliadou N, 1998, HUM REPROD, V13, P44, DOI 10.1093/humrep/13.1.44; White HD, 1997, J IMMUNOL, V158, P3017; White HD, 2001, J INFECT DIS, V183, P977, DOI 10.1086/319253; Yeaman GR, 1997, J LEUKOCYTE BIOL, V61, P427, DOI 10.1002/jlb.61.4.427; Yeaman GR, 2004, IMMUNOLOGY, V113, P524, DOI 10.1111/j.1365-2567.2004.01990.x; Yeaman GR, 2003, IMMUNOLOGY, V109, P137, DOI 10.1046/j.1365-2567.2003.01623.x; Yeaman GR, 2001, IMMUNOLOGY, V102, P434, DOI 10.1046/j.1365-2567.2001.01199.x	37	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28894	10.1371/journal.pone.0028894	http://dx.doi.org/10.1371/journal.pone.0028894			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174921	Green Published, gold, Green Submitted			2022-12-25	WOS:000298365700081
J	Wilke, S; Groebe, L; Maffenbeier, V; Jager, V; Gossen, M; Josewski, J; Duda, A; Polle, L; Owens, RJ; Wirth, D; Heinz, DW; van den Heuvel, J; Bussow, K				Wilke, Sonja; Groebe, Lothar; Maffenbeier, Vitali; Jaeger, Volker; Gossen, Manfred; Josewski, Joern; Duda, Agathe; Polle, Lilia; Owens, Raymond J.; Wirth, Dagmar; Heinz, Dirk W.; van den Heuvel, Joop; Buessow, Konrad			Streamlining Homogeneous Glycoprotein Production for Biophysical and Structural Applications by Targeted Cell Line Development	PLOS ONE			English	Article							DEFINED CHROMOSOMAL LOCI; TRANSGENE EXPRESSION; FLP; GLYCOSYLATION; INTEGRATION; EXCHANGE; RMCE; MET	Studying the biophysical characteristics of glycosylated proteins and solving their three-dimensional structures requires homogeneous recombinant protein of high quality. We introduce here a new approach to produce glycoproteins in homogenous form with the well-established, glycosylation mutant CHO Lec3.2.8.1 cells. Using preparative cell sorting, stable, high-expressing GFP 'master' cell lines were generated that can be converted fast and reliably by targeted integration via Flp recombinase-mediated cassette exchange (RMCE) to produce any glycoprotein. Small-scale transient transfection of HEK293 cells was used to identify genetically engineered constructs suitable for constructing stable cell lines. Stable cell lines expressing 10 different proteins were established. The system was validated by expression, purification, deglycosylation and crystallization of the heavily glycosylated luminal domains of lysosome-associated membrane proteins (LAMP).	[Wilke, Sonja; Maffenbeier, Vitali; Jaeger, Volker; Josewski, Joern; Duda, Agathe; Polle, Lilia; Heinz, Dirk W.; van den Heuvel, Joop; Buessow, Konrad] Helmholtz Ctr Infect Res, Dept Mol Struct Biol, Braunschweig, Germany; [Groebe, Lothar] Helmholtz Ctr Infect Res, Dept Expt Immunol, Braunschweig, Germany; [Gossen, Manfred] Max Delbruck Ctr Mol Med MDC, Berlin, Germany; [Gossen, Manfred] Berlin Brandenburg Ctr Regenerat Therapies BCRT, Berlin, Germany; [Owens, Raymond J.] Univ Oxford, Div Struct Biol, Oxford, England; [Wirth, Dagmar] Helmholtz Ctr Infect Res, Dept Gene Regulat & Differentiat, Braunschweig, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Oxford; Helmholtz Association; Helmholtz-Center for Infection Research	Wilke, S (corresponding author), Helmholtz Ctr Infect Res, Dept Mol Struct Biol, Braunschweig, Germany.	konrad.buessow@helmholtz-hzi.de	Gossen, Manfred/K-9602-2013	Gossen, Manfred/0000-0002-1761-4063; Bussow, Konrad/0000-0003-2031-5942	Helmholtz Association of German Research Centres; MRC [G0701506] Funding Source: UKRI; Medical Research Council [G0701506, G1100525] Funding Source: researchfish	Helmholtz Association of German Research Centres(Helmholtz Association); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Helmholtz Association of German Research Centres through the Protein Sample Production Facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1114, DOI 10.1107/S0907444906029805; Aricescu AR, 2007, SCIENCE, V317, P1217, DOI 10.1126/science.1144646; Baer A, 2001, CURR OPIN BIOTECH, V12, P473, DOI 10.1016/S0958-1669(00)00248-2; Butters TD, 1999, PROTEIN SCI, V8, P1696, DOI 10.1110/ps.8.8.1696; Chang VT, 2007, STRUCTURE, V15, P267, DOI 10.1016/j.str.2007.01.011; Gherardi E, 2006, P NATL ACAD SCI USA, V103, P4046, DOI 10.1073/pnas.0509040103; Kaufman WL, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn508; Kranz A, 2010, GENESIS, V48, P512, DOI 10.1002/dvg.20641; Mattanovich D, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-12; Nehlsen K, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-100; Niemann HH, 2007, CELL, V130, P235, DOI 10.1016/j.cell.2007.05.037; Nov D, 2007, CURR OPIN BIOTECH, V18, P411, DOI 10.1016/j.copbio.2007.07.013; Qiao JH, 2009, J MOL BIOL, V390, P579, DOI 10.1016/j.jmb.2009.05.012; Raymond CS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000162; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Schirrmann T, 2010, ANTIBODY ENGINEERING, VOL 2, SECOND EDITION, P387, DOI 10.1007/978-3-642-01147-4_30; SCHLAKE T, 1994, BIOCHEMISTRY-US, V33, P12746, DOI 10.1021/bi00209a003; Schucht R, 2006, MOL THER, V14, P285, DOI 10.1016/j.ymthe.2005.12.003; STANLEY P, 1989, MOL CELL BIOL, V9, P377, DOI 10.1128/MCB.9.2.377; TURAN S, 2011, J MOL BIOL IN PRESS; Turan S, 2010, J MOL BIOL, V402, P52, DOI 10.1016/j.jmb.2010.07.015; Verhoeyen E, 2001, HUM GENE THER, V12, P933, DOI 10.1089/104303401750195890; Wilke S, 2010, PROTEIN SCI, V19, P1264, DOI 10.1002/pro.390	23	20	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e27829	10.1371/journal.pone.0027829	http://dx.doi.org/10.1371/journal.pone.0027829			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174749	Green Published, Green Submitted, gold			2022-12-25	WOS:000298365700008
J	Inderbitzin, P; Bostock, RM; Davis, RM; Usami, T; Platt, HW; Subbarao, KV				Inderbitzin, Patrik; Bostock, Richard M.; Davis, R. Michael; Usami, Toshiyuki; Platt, Harold W.; Subbarao, Krishna V.			Phylogenetics and Taxonomy of the Fungal Vascular Wilt Pathogen Verticillium, with the Descriptions of Five New Species	PLOS ONE			English	Article							ALBO-ATRUM; V-TRICORPUS; VEGETATIVE COMPATIBILITY; SECTION PROSTRATA; PHENOTYPIC DESCRIPTION; MATING-TYPE; SP NOV.; DAHLIAE; REVISION; GENUS	Knowledge of pathogen biology and genetic diversity is a cornerstone of effective disease management, and accurate identification of the pathogen is a foundation of pathogen biology. Species names provide an ideal framework for storage and retrieval of relevant information, a system that is contingent on a clear understanding of species boundaries and consistent species identification. Verticillium, a genus of ascomycete fungi, contains important plant pathogens whose species boundaries have been ill defined. Using phylogenetic analyses, morphological investigations and comparisons to herbarium material and the literature, we established a taxonomic framework for Verticillium comprising ten species, five of which are new to science. We used a collection of 74 isolates representing much of the diversity of Verticillium, and phylogenetic analyses based on the ribosomal internal transcribed spacer region (ITS), partial sequences of the protein coding genes actin (ACT), elongation factor 1-alpha (EF), glyceraldehyde-3-phosphate dehydrogenase (GPD) and tryptophan synthase (TS). Combined analyses of the ACT, EF, GPD and TS datasets recognized two major groups within Verticillium, Clade Flavexudans and Clade Flavnonexudans, reflecting the respective production and absence of yellow hyphal pigments. Clade Flavexudans comprised V. albo-atrum and V. tricorpus as well as the new species V. zaregamsianum, V. isaacii and V. klebahnii, of which the latter two were morphologically indistinguishable from V. tricorpus but may differ in pathogenicity. Clade Flavnonexudans comprised V. nubilum, V. dahliae and V. longisporum, as well as the two new species V. alfalfae and V. nonalfalfae, which resembled the distantly related V. albo-atrum in morphology. Apart from the diploid hybrid V. longisporum, each of the ten species corresponded to a single clade in the phylogenetic tree comprising just one ex-type strain, thereby establishing a direct link to a name tied to a herbarium specimen. A morphology-based key is provided for identification to species or species groups.	[Inderbitzin, Patrik; Bostock, Richard M.; Davis, R. Michael; Subbarao, Krishna V.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Usami, Toshiyuki] Chiba Univ, Grad Sch Hort, Chiba, Japan; [Platt, Harold W.] Agr & Agri Food Canada, Charlottetown Res Ctr, Charlottetown, PE, Canada	University of California System; University of California Davis; Chiba University; Agriculture & Agri Food Canada	Inderbitzin, P (corresponding author), Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA.	kvsubbarao@ucdavis.edu	Subbarao, Krishna/X-3870-2019; Usami, Toshiyuki/AAK-6550-2020	Subbarao, Krishna/0000-0002-2075-1835; Usami, Toshiyuki/0000-0001-8071-8167	California Leafy Greens Board; United States Department of Agriculture - National Institute of Food and Agriculture (USDA-NIFA)	California Leafy Greens Board; United States Department of Agriculture - National Institute of Food and Agriculture (USDA-NIFA)(United States Department of Agriculture (USDA))	Financial support for this research was provided by the California Leafy Greens Board (www.caleafygreens.ca.gov/) and the United States Department of Agriculture - National Institute of Food and Agriculture (USDA-NIFA) (www.csrees.usda.gov/fo/specialtycropresearchinitiative.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbara DJ, 2003, MOL PLANT PATHOL, V4, P297, DOI 10.1046/J.1364-3703.2003.00172.X; BERKELEY G. H., 1926, Scientific Agriculture, V6, P261; Bischoff JF, 2009, MYCOLOGIA, V101, P512, DOI 10.3852/07-202; BULL JJ, 1993, SYST BIOL, V42, P384, DOI 10.2307/2992473; CARDER JH, 1991, MYCOL RES, V95, P935, DOI 10.1016/S0953-7562(09)80090-7; CORRELL JC, 1988, PHYTOPATHOLOGY, V78, P1017, DOI 10.1094/Phyto-78-1017; Couch BC, 2002, MYCOLOGIA, V94, P683, DOI 10.2307/3761719; Crouch JA, 2009, MYCOLOGIA, V101, P717, DOI 10.3852/08-230; Domsch K.H., 1980, COMPENDIUM SOIL FUNG; DOWN G, 2007, B OEPP, V37, P528; Drummond A.J., 2010, GENEIOUS V4 8 5; Fisher MC, 2002, MYCOLOGIA, V94, P73, DOI 10.2307/3761847; FORDYCE C, 1964, PHYTOPATHOLOGY, V54, P795; Gams W, 2002, MYCOL RES, V106, P130, DOI 10.1017/S0953756202225824; Gams W, 2001, NOVA HEDWIGIA, V72, P329; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Goud JKC, 2003, MYCOL RES, V107, P822, DOI 10.1017/S0953756203008050; Grunig CR, 2005, MYCOLOGIA, V97, P628, DOI 10.3852/mycologia.97.3.628; HAWKSWORTH DL, 1970, CMI DESCRIPTIONS PAT, V256; HEALE JB, 1965, BR MYCOL SOC TRANS, V48, P39; HEALE JB, 1963, ANN APPL BIOL, V52, P439, DOI 10.1111/j.1744-7348.1963.tb03768.x; Heale JB, 2000, ADVANCES IN VERTICILLIUM: RESEARCH AND DISEASE MANAGEMENT, P1; Hodge KT, 2005, TAXON, V54, P485, DOI 10.2307/25065318; Inderbitzin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018260; Inderbitzin P, 2010, MYCOLOGIA, V102, P1350, DOI 10.3852/10-006; ISAAC IVOR, 1953, TRANS BRIT MYCOL SOC, V36, P180; ISAAC IVOR, 1949, TRANS BRIT MYCOL SOC, V32, P137; Karapapa VK, 1997, MYCOL RES, V101, P1281, DOI 10.1017/S0953756297003985; KEYWORTH W. G., 1952, PLANT DIS REPORTER, V36, P16; KIRK PM, 2001, DICT FUNGI; KLEBAHN H., 1937, Phytopathologische Zeitschrift, V10, P121; Klebahn H, 1913, MYCOLOGISCHES CENTRA, V3, P49; Klosterman SJ, 2009, ANNU REV PHYTOPATHOL, V47, P39, DOI 10.1146/annurev-phyto-080508-081748; Korolev N, 1999, MYCOL RES, V103, P65, DOI 10.1017/S0953756298006844; Lumbsch H. Thorsten, 2010, Fieldiana-Life and Earth Sciences, V1, P1, DOI 10.3158/1557.1; Mahuku GS, 2002, MOL PLANT PATHOL, V3, P71, DOI 10.1046/j.1464-6722.2001.00096.x; Mandelc S, 2009, EUR J PLANT PATHOL, V125, P159, DOI 10.1007/s10658-009-9467-6; McKeen Colin D., 1943, CANADIAN JOUR RES SECT C BOT SCI, V21, P95; McNeill J., 2005, INT CODE BOT NOMENCL; METZENBERG RL, 1990, BIOESSAYS, V12, P53, DOI 10.1002/bies.950120202; MORTON A, 1995, PLANT PATHOL, V44, P183, DOI 10.1111/j.1365-3059.1995.tb02727.x; Nees von Esenbeck C. G., 1816, SYSTEM PILZE SCHWAMM; NOEL B, 1903, CR HEBD ACAD SCI, V137, P483; O'Donnell K, 2004, FUNGAL GENET BIOL, V41, P600, DOI 10.1016/j.fgb.2004.03.003; O'Donnell K, 2008, FUNGAL GENET BIOL, V45, P1514, DOI 10.1016/j.fgb.2008.09.002; O'Donnell K, 2008, J CLIN MICROBIOL, V46, P2477, DOI 10.1128/JCM.02371-07; Pantou MP, 2005, FEMS MICROBIOL LETT, V245, P213, DOI 10.1016/j.femsle.2005.03.011; Pegg GF, 2002, VERTICILLUM WILTS, DOI [DOI 10.1079/9780851995298.0000, 10.1079/9780851995298.0000]; Pethybridge GH., 1919, T BRIT MYCOL SOC, V6, P104; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Presley JT, 1941, PHYTOPATHOLOGY, V31, P1135; Qin QM, 2008, PLANT DIS, V92, P69, DOI 10.1094/PDIS-92-1-0069; Radisek S, 2004, PLANT DIS, V88, P1115, DOI 10.1094/PDIS.2004.88.10.1115; Radisek S, 2003, PLANT DIS, V87, P633, DOI 10.1094/PDIS.2003.87.6.633; Radisek S, 2006, EUR J PLANT PATHOL, V116, P301, DOI 10.1007/s10658-006-9061-0; Rasmussen H.N., 1995, TERRESTRIAL ORCHIDS, P444, DOI DOI 10.1017/CBO9780511525452; Reeb V, 2004, MOL PHYLOGENET EVOL, V32, P1036, DOI 10.1016/j.ympev.2004.04.012; REHNER SA, 1995, CAN J BOT, V73, pS816, DOI 10.1139/b95-327; Reinke J., 1879, UNTERSUCHUNGEN BOT L, V1, P67; ROBB J, 1993, PHYSIOL MOL PLANT P, V43, P423, DOI 10.1006/pmpp.1993.1070; Rojas EI, 2010, MYCOLOGIA, V102, P1318, DOI 10.3852/09-244; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rossman AY, 2008, PLANT DIS, V92, P1376, DOI 10.1094/PDIS-92-10-1376; Soltis DE, 1999, TRENDS ECOL EVOL, V14, P348, DOI 10.1016/S0169-5347(99)01638-9; STARK C., 1961, Gartenbauwissenschaft, V26, P493; Subbarao KV, 2007, PLANT DIS, V91, P964, DOI 10.1094/PDIS-91-8-0964; Subbarao K. V., 1997, COMPENDIUM LETTUCE D, P26; Sung GH, 2007, STUD MYCOL, P5, DOI 10.3114/sim.2007.57.01; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; TALBOYS P. W., 1960, PLANT PATHOL, V9, P57, DOI 10.1111/j.1365-3059.1960.tb01147.x; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; TROTTER A, 1972, SYLLOGE FUNGORUM, V26, P1299; USAMI T, 2010, J GEN PLANT PATHOL, P1, DOI DOI 10.1007/S10327-10010-10282-X; Usami T, 2009, J GEN PLANT PATHOL, V75, P422, DOI 10.1007/s10327-009-0197-6; Vallad GE, 2006, PHYTOPATHOLOGY, V96, P1380, DOI 10.1094/PHYTO-96-1380; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; WILHELM S, 1955, PHYTOPATHOLOGY, V45, P180; WILHELM S, 1948, PHYTOPATHOLOGY, V38, P919; Zare R, 2007, NOVA HEDWIGIA, V85, P463, DOI 10.1127/0029-5035/2007/0085-0463; Zare R, 2004, MYCOL RES, V108, P576, DOI 10.1017/S0953756204009839; Zare R, 2001, NOVA HEDWIGIA, V73, P271; Zare R, 2001, NOVA HEDWIGIA, V73, P1; Zare R, 2001, NOVA HEDWIGIA, V73, P51; Zare R, 2008, MYCOL RES, V112, P811, DOI 10.1016/j.mycres.2008.01.019; Zeise K, 2002, J PHYTOPATHOL, V150, P112, DOI 10.1046/j.1439-0434.2002.00730.x; Zhang N, 2006, MYCOLOGIA, V98, P1076, DOI 10.3852/mycologia.98.6.1076	86	202	221	2	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28341	10.1371/journal.pone.0028341	http://dx.doi.org/10.1371/journal.pone.0028341			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22174791	Green Published, gold			2022-12-25	WOS:000298161900030
J	Qin, W; Dong, P; Ma, C; Mitchelson, K; Deng, T; Zhang, L; Sun, Y; Feng, X; Ding, Y; Lu, X; He, J; Wen, H; Cheng, J				Qin, W.; Dong, P.; Ma, C.; Mitchelson, K.; Deng, T.; Zhang, L.; Sun, Y.; Feng, X.; Ding, Y.; Lu, X.; He, J.; Wen, H.; Cheng, J.			MicroRNA-133b is a key promoter of cervical carcinoma development through the activation of the ERK and AKT1 pathways	ONCOGENE			English	Article						miR-133b; tumorigenesis and metastasis; signal pathways; cervical carcinoma	SQUAMOUS-CELL CARCINOMA; IONIZING-RADIATION; TUMOR-SUPPRESSOR; IN-VIVO; CANCER; EXPRESSION; GROWTH; NEOPLASIA; SURVIVAL; TARGETS	We report that elevated microRNA-133b (miR-133b) acts as an oncogene in human cervical carcinoma to promote tumorigenesis and metastasis. In situ hybridization confirmed that miR-133b is localized in proliferating human cervical carcinoma cells with levels progressively elevating throughout advancing stages. Cellular studies showed that miR-133b enhances cell proliferation and colony formation by targeting mammalian sterile 20-like kinase 2 (MST2), cell division control protein 42 homolog (CDC42) and ras homolog gene family member A (RHOA), which subsequently results in activation of the tumorigenic protein kinase B alpha (AKT1) and mitogen-activated protein kinase (ERK1 and ERK2, here abbreviated as ERK) signaling pathways. Mouse experiments revealed that upregulation of miR-133b in cervical carcinoma cells strongly promotes both in vivo tumorigenesis and independent metastasis to the mouse lung. The data indicates that upregulation of miR-133b shortens the latency of cervical carcinoma. Together, these findings suggest that miR-133b could be a potent marker for the early onset of cervical carcinoma. Oncogene (2012) 31, 4067-4075; doi: 10.1038/onc.2011.561; published online 19 December 2011	[Wen, H.] Xinjiang Med Univ, Affiliated Hosp 1, State Key Lab Incubat Base Xinjiang Major Dis Res, Urumqi 830054, Peoples R China; [Qin, W.; Dong, P.; Mitchelson, K.; Deng, T.; Cheng, J.] Tsinghua Univ, Sch Med, Med Syst Biol Res Ctr, Beijing 100084, Peoples R China; [Mitchelson, K.; Deng, T.; Zhang, L.; Sun, Y.; Cheng, J.] Natl Engn Res Ctr Beijing Biochip Technol, Beijing, Peoples R China; [Feng, X.] Peking Union Med Coll, Canc Hosp & Inst, Dept Pathol, Beijing 100021, Peoples R China; [He, J.] Peking Union Med Coll, Canc Hosp & Inst, Dept Thorac Surg, Beijing 100021, Peoples R China; [Feng, X.; He, J.] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Cheng, J.] Tsinghua Univ, Sch Med, Dept Biomed Engn, Beijing 100084, Peoples R China	Xinjiang Medical University; Tsinghua University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Tsinghua University	Wen, H (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, State Key Lab Incubat Base Xinjiang Major Dis Res, Urumqi 830054, Peoples R China.	dr.wenhao@163.com; jcheng@mail.tsinghua.edu.cn	DONG, PENG/H-8016-2018	DONG, PENG/0000-0003-4946-1409	National High-tech Program of China [2006AA020701, 2009AA022701]	National High-tech Program of China	We thank Drs Youyong Lu and Yun Zhang for discussions and comments on the manuscript; Suqiong Wang, Zhaoli Chen and Dapeng Ding for help with mouse experiments; Jiantao Cui and Dr Bing Dong for help with IHC and ISH experiments. This study was supported by the National High-tech Program of China (grant no. 2006AA020701 and grant no. 2009AA022701).	Aguirre-Ghiso JA, 2003, CANCER RES, V63, P1684; Bertelsen BI, 2006, INT J CANCER, V118, P1877, DOI 10.1002/ijc.21461; Burk RD, 1999, NEW ENGL J MED, V341, P1687, DOI 10.1056/NEJM199911253412209; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; CIFONE MA, 1980, P NATL ACAD SCI-BIOL, V77, P1039, DOI 10.1073/pnas.77.2.1039; Cinar B, 2007, EMBO J, V26, P4523, DOI 10.1038/sj.emboj.7601872; Crawford M, 2009, BIOCHEM BIOPH RES CO, V388, P483, DOI 10.1016/j.bbrc.2009.07.143; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; GOOD M, 1978, CANCER RES, V38, P4671; Guo HY, 2011, HEPATOLOGY, V54, P808, DOI 10.1002/hep.24441; Guo Y, 2008, CANCER RES, V68, P26, DOI 10.1158/0008-5472.CAN-06-4418; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hu G, 2010, CANCER BIOL THER, V10, P190, DOI 10.4161/cbt.10.2.12186; Kahn JA, 2009, NEW ENGL J MED, V361, P271, DOI 10.1056/NEJMct0806938; Kohrenhagen N, 2008, J OBSTET GYNAECOL RE, V34, P293, DOI 10.1111/j.1447-0756.2008.00749.x; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lee JW, 2008, CLIN CANCER RES, V14, P2535, DOI 10.1158/1078-0432.CCR-07-1231; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Liu XQ, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/837514; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Mumby M, 2007, CELL, V130, P21, DOI 10.1016/j.cell.2007.06.034; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Schiffman M, 2005, NEW ENGL J MED, V353, P2101, DOI 10.1056/NEJMp058171; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Tan XG, 2011, CLIN CANCER RES, V17, P6802, DOI 10.1158/1078-0432.CCR-11-0419; Testa JR, 2001, P NATL ACAD SCI USA, V98, P10983, DOI 10.1073/pnas.211430998; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Varnholt H, 2008, HEPATOLOGY, V47, P1223, DOI 10.1002/hep.22158; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; Watanabe T, 2005, FEBS LETT, V579, P318, DOI 10.1016/j.febslet.2004.11.067; Wong TS, 2008, INT J CANCER, V123, P251, DOI 10.1002/ijc.23583; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	40	93	96	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2012	31	36					4067	4075		10.1038/onc.2011.561	http://dx.doi.org/10.1038/onc.2011.561			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	004NQ	22179829				2022-12-25	WOS:000308688800007
J	Quezada, LAL; Sajid, M; Lim, KC; McKerrow, JH				Quezada, Landys A. Lopez; Sajid, Mohammed; Lim, Kee C.; McKerrow, James H.			A Blood Fluke Serine Protease Inhibitor Regulates an Endogenous Larval Elastase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHISTOSOMA-MANSONI; PROTEOMIC ANALYSIS; SKIN INVASION; CERCARIAE; SEQUENCE; HOST; PRAZIQUANTEL; INFLAMMATION; SENSITIVITY; SECRETIONS	The larvae of Schistosoma mansoni invade their mammalian host by utilizing a serine protease, cercarial elastase (SmCE), to degrade macromolecular proteins in host skin. The catalytic activity of serine and cysteine proteases can be regulated after activation by serpins. SmSrpQ, one of two S. mansoni serpins found in larval secretions, is only expressed during larval development and in the early stages of mammalian infection. In vitro, S-35-SmSrpQ was able to form an SDS-stable complex with a component of the larval lysate, but no complex was detected when S-35-SmSrpQ was incubated with several mammalian host proteases. Formation of a complex was sensitive to the protease active site inhibitors PMSF, Z-AAPF-CMK, and Z-AAPL-CMK. Western blot analysis of parasite lysates from different life stages detected a complex of comparable size to SmCE bound to SmSrpQ using anti-SmSrpQ or anti-SmCE antibodies. SmSrpQ and SmCE are located in adjacent but discrete compartments in the secretion glands of the parasite. Fluorescence immunohistochemical analysis of simulated infection showed co-localization of SmCE and SmSrpQ in host tissue suggesting a post release regulation of parasite protease activity during skin transversal. The results of this study suggest that cercarial elastase degradation of skin tissue is carefully regulated by SmSrpQ.	[Quezada, Landys A. Lopez] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94158 USA; [Sajid, Mohammed] Leiden Univ, Med Ctr, NL-2333 ZA Leiden, Netherlands; [Lim, Kee C.; McKerrow, James H.] Univ Calif San Francisco, Dept Pathol, Sandler Ctr Drug Discovery, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of California System; University of California San Francisco	McKerrow, JH (corresponding author), 1700 4th St,Box 2550,UCSF QB3, San Francisco, CA 94158 USA.	James.McKerrow@ucsf.edu		Lopez Quezada, Landys/0000-0002-8789-4283	National Institutes of Health from NIGMS [R25 GM56847]; UCSF Microbial Pathogenesis Host Defense [T32AI060537]; Sandler Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007334, T32AI060537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056847] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); UCSF Microbial Pathogenesis Host Defense; Sandler Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health training grant R25 GM56847 from NIGMS. This work was also supported by the UCSF Microbial Pathogenesis Host Defense (training grant T32AI060537) and the Sandler Foundation.	ANDREWS P, 1981, ARZNEIMITTEL-FORSCH, V31-1, P538; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWNE HG, 1963, J PARASITOL, V49, P371, DOI 10.2307/3275800; CAMPBELL EJ, 1982, J CLIN INVEST, V70, P845, DOI 10.1172/JCI110681; CAMPBELL EJ, 1987, CHEST, V92, P161, DOI 10.1378/chest.92.1.161; Chen L, 2002, J BIOL CHEM, V277, P34329, DOI 10.1074/jbc.M201344200; COOK GC, 1988, LANCET, V1, P127; Cooley J, 2001, BIOCHEMISTRY-US, V40, P15762, DOI 10.1021/bi0113925; Curwen RS, 2006, MOL CELL PROTEOMICS, V5, P835, DOI 10.1074/mcp.M500313-MCP200; Dorsey CH, 2002, MICRON, V33, P279, DOI 10.1016/S0968-4328(01)00019-1; Duvoisin R., 2011, TRANSG IN PRESS 0928; Dvorak J, 2008, BIOCHIMIE, V90, P345, DOI 10.1016/j.biochi.2007.08.013; Ekeowa UI, 2009, CLIN SCI, V116, P837, DOI 10.1042/CS20080484; FISHELSON Z, 1992, EXP PARASITOL, V75, P87, DOI 10.1016/0014-4894(92)90124-S; GHENDLER Y, 1994, EXP PARASITOL, V78, P121, DOI 10.1006/expr.1994.1013; GONNERT R, 1977, Z PARASITENKD, V52, P129, DOI 10.1007/BF00389899; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hansell E, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000262; Harrop R, 2000, PARASITOLOGY, V121, P385, DOI 10.1017/S003118209900640X; He YX, 2002, EXP PARASITOL, V102, P99, DOI 10.1016/S0014-4894(03)00024-9; INCANI RN, 1984, INT J PARASITOL, V14, P259, DOI 10.1016/0020-7519(84)90077-8; Kang JM, 2010, ACTA TROP, V116, P134, DOI 10.1016/j.actatropica.2010.06.007; Knight M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001212; Knudsen GM, 2005, MOL CELL PROTEOMICS, V4, P1862, DOI 10.1074/mcp.M500097-MCP200; Kourilova P, 2004, J IMMUNOL, V172, P3766, DOI 10.4049/jimmunol.172.6.3766; LACLETTE JP, 1992, J IMMUNOL, V148, P124; Lim KC, 1999, AM J TROP MED HYG, V60, P487, DOI 10.4269/ajtmh.1999.60.487; Luke CJ, 2007, CELL, V130, P1108, DOI 10.1016/j.cell.2007.07.013; MCKERROW JH, 1985, J BIOL CHEM, V260, P3703; Quezada LAL, 2011, AN ACAD BRAS CIENC, V83, P663, DOI 10.1590/S0001-37652011000200025; RAY CA, 1992, CELL, V69, P597, DOI 10.1016/0092-8674(92)90223-Y; REMOLDODONNELL E, 1992, P NATL ACAD SCI USA, V89, P5635, DOI 10.1073/pnas.89.12.5635; Ross AG, 2007, LANCET INFECT DIS, V7, P218, DOI 10.1016/S1473-3099(07)70053-1; Salter JP, 2000, J BIOL CHEM, V275, P38667, DOI 10.1074/jbc.M006997200; Salter JP, 2002, J BIOL CHEM, V277, P24618, DOI 10.1074/jbc.M202364200; Skelly PJ, 2001, J PARASITOL, V87, P1218, DOI 10.1645/0022-3395(2001)087[1218:SMPSCB]2.0.CO;2; Stefanic S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000850; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WHO, 2004, WORLD MED SITUATION, P93; WHO, 2010, SCHIST FACT SHEET 11; Yang YB, 2009, PARASITOL RES, V106, P221, DOI 10.1007/s00436-009-1654-z	41	20	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7074	7083		10.1074/jbc.M111.313304	http://dx.doi.org/10.1074/jbc.M111.313304			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22174417	Green Published, hybrid			2022-12-25	WOS:000301060200012
J	Kaliappan, K; Choudhury, NR; Suyal, G; Mukherjee, SK				Kaliappan, Kosalai; Choudhury, Nirupam Roy; Suyal, Geetika; Mukherjee, Sunil Kumar			A novel role for RAD54: this host protein modulates geminiviral DNA replication	FASEB JOURNAL			English	Article						electron microscopy; RAD54; rolling circle; yeast nuclear extract	YELLOW MOSAIC-VIRUS; MODEL SYSTEM; SACCHAROMYCES-CEREVISIAE; ROLLING-CIRCLE; REP PROTEIN; HOMOLOGOUS RECOMBINATION; PLANT-CELLS; ARABIDOPSIS-THALIANA; VIRAL-DNA; YEAST	Geminiviruses primarily encode only few factors, such as replication initiator protein (Rep), and need various host cellular machineries for rolling-circle replication (RCR) and/or recombination-dependent replication (RDR). We have identified a host factor, RAD54, in a screen for Repinteracting partners and observed its role in DNA replication of the geminivirus mungbean yellow mosaic India virus (MYMIV). We identified the interacting domains ScRAD54 and MYMIV-Rep and observed that ScRAD54 enhanced MYMIV-Rep nicking, ATPase, and helicase activities. An in vitro replication assay demonstrated that the geminiviral DNA replication reaction depends on the viral Rep protein, viral origin of replication sequences, and host cellcycle proteins. Rad54-deficient yeast nuclear extract did not support in vitro viral DNA replication, while exogenous addition of the purified ScRAD54 protein enhanced replication. The role of RAD54 in in planta replication was confirmed by the transient replication assay; i.e., agroinoculation studies. RAD54 is a well-known recombination/repair protein that uses its DNA-dependent ATPase activity in conjunction with several other host factors. However, this study demonstrates for the first time that the eukaryotic rolling-circle replicon depends on the RAD54 protein.-Kaliappan, K., Choudhury, N. R., Suyal, G., Mukherjee, S. K. A novel role for RAD54: this host protein modulates geminiviral DNA replication. FASEB J. 26, 1142-1160 (2012). www.fasebj.org	[Kaliappan, Kosalai; Choudhury, Nirupam Roy; Suyal, Geetika; Mukherjee, Sunil Kumar] Int Ctr Genet Engn & Biotechnol, Plant Mol Biol Grp, New Delhi 110067, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Mukherjee, SK (corresponding author), Int Ctr Genet Engn & Biotechnol, Plant Mol Biol Grp, Aruna Asaf Ali Marg, New Delhi 110067, India.	sunilm@icgeb.res.in			Council of Scientific and Industrial Research (New Delhi, India); Department of Biotechnology (Ministry of Science and Technology, New Delhi, India); UMDNJ	Council of Scientific and Industrial Research (New Delhi, India)(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (Ministry of Science and Technology, New Delhi, India)(Department of Biotechnology (DBT) India); UMDNJ	The authors thank Dr. Tom Ellenberger (Harvard Medical School, Boston, MA, USA) and Dr. Patrick Sung (Yale University, New Haven, CT, USA) for the Rad54 constructs. The assistance of Dr. Ashish Nandi and Mr. Swadhin Swain (Jawaharlal Nehru University, New Delhi, India) in the Arabidopsis work is greatly appreciated. The authors thank Dr. Subhasis Biswas [University of Medicine and Dentistry of New Jersey (UMDNJ), Stratford, NJ, USA] for his help and the space he provided for the in vitro replication experiments. The authors thank Mr. Rajeev Mishra (Banaras Hindu University, Varanasi, India), Mr. Somyadeep Nandi (Jawaharlal Nehru University) and Dr. Esther E. Biswas (Thomas Jefferson University, Philadelphia, PA, USA) for their assistance and help. This work was partly supported by the Council of Scientific and Industrial Research (New Delhi, India), the Department of Biotechnology (Ministry of Science and Technology, New Delhi, India), and UMDNJ, through research fellowships to K. K.	Ach RA, 1997, MOL CELL BIOL, V17, P5077, DOI 10.1128/MCB.17.9.5077; Ahlquist P, 2006, NAT REV MICROBIOL, V4, P371, DOI 10.1038/nrmicro1389; Alexeev A, 2003, NAT STRUCT BIOL, V10, P182, DOI 10.1038/nsb901; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Alves-Rodrigues I, 2006, VIRUS RES, V120, P49, DOI 10.1016/j.virusres.2005.11.018; Amitani I, 2006, MOL CELL, V23, P143, DOI 10.1016/j.molcel.2006.05.009; Arguello-Astorga G, 2004, J VIROL, V78, P4817, DOI 10.1128/JVI.78.9.4817-4826.2004; Ascencio-Ibanez JT, 2008, PLANT PHYSIOL, V148, P436, DOI 10.1104/pp.108.121038; Bagewadi B, 2004, J VIROL, V78, P11890, DOI 10.1128/JVI.78.21.11890-11903.2004; Bass HW, 2000, J CELL SCI, V113, P1149; Bisaro D. M., 1994, Homologous recombination and gene silencing in plants., P39; Castillo AG, 2004, J VIROL, V78, P2758, DOI 10.1128/JVI.78.6.2758-2769.2004; Choudhury NR, 2006, NUCLEIC ACIDS RES, V34, P6362, DOI 10.1093/nar/gkl903; COELLO P, 1992, PLANT MOL BIOL, V20, P1159, DOI 10.1007/BF00028902; Davis R.W., 1971, METHODS ENZYMOL, V21, P413; Egelkrout EM, 2001, PLANT CELL, V13, P1437, DOI 10.1105/tpc.13.6.1437; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Foury F, 2002, CURR OPIN CHEM BIOL, V6, P106, DOI 10.1016/S1367-5931(01)00276-9; GAME JC, 1974, MUTAT RES, V24, P281, DOI 10.1016/0027-5107(74)90176-6; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Gutierrez C, 2000, EMBO J, V19, P792, DOI 10.1093/emboj/19.5.792; Hanley-Bowdoin L, 2000, CRIT REV BIOCHEM MOL, V35, P105; Heyer WD, 2006, NUCLEIC ACIDS RES, V34, P4115, DOI 10.1093/nar/gkl481; Interthal H, 2000, MOL GEN GENET, V263, P812, DOI 10.1007/s004380000241; James P, 1996, GENETICS, V144, P1425; Jeske H, 2001, EMBO J, V20, P6158, DOI 10.1093/emboj/20.21.6158; Klutstein M, 2008, GENETICS, V178, P2389, DOI 10.1534/genetics.108.086777; Kong LJ, 2000, EMBO J, V19, P3485, DOI 10.1093/emboj/19.13.3485; Kong LJ, 2002, PLANT CELL, V14, P1817, DOI 10.1105/tpc.003681; Longo VD, 2002, CELL MOL LIFE SCI, V59, P903, DOI 10.1007/s00018-002-8477-8; Luque A, 2002, VIROLOGY, V302, P83, DOI 10.1006/viro.2002.1599; Mansoor S, 2003, TRENDS PLANT SCI, V8, P128, DOI 10.1016/S1360-1385(03)00007-4; Matulova P, 2009, J BIOL CHEM, V284, P7733, DOI 10.1074/jbc.M806192200; Mitkova AV, 2005, J BIOL CHEM, V280, P6285, DOI 10.1074/jbc.M410129200; NAGAR S, 1995, PLANT CELL, V7, P705, DOI 10.1105/tpc.7.6.705; Nagy PD, 2008, ANNU REV PHYTOPATHOL, V46, P217, DOI 10.1146/annurev.phyto.121407.093958; Osakabe K, 2006, PLANT J, V48, P827, DOI 10.1111/j.1365-313X.2006.02927.x; Pandey P, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-152; Pant V, 2001, J GEN VIROL, V82, P2559, DOI 10.1099/0022-1317-82-10-2559; Perego P, 2000, PHARMACOL REV, V52, P477; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; Raghavan V, 2004, J VIROL, V78, P2405, DOI 10.1128/JVI.78.5.2405-2413.2004; Ramirez-Parra E, 1999, NUCLEIC ACIDS RES, V27, P3527, DOI 10.1093/nar/27.17.3527; Raschle M, 2004, J BIOL CHEM, V279, P51973, DOI 10.1074/jbc.M410101200; Replansky T, 2008, TRENDS ECOL EVOL, V23, P494, DOI 10.1016/j.tree.2008.05.005; RUSHING AE, 1987, PHYTOPATHOLOGY, V77, P1231, DOI 10.1094/Phyto-77-1231; SAUNDERS K, 1991, NUCLEIC ACIDS RES, V19, P2325, DOI 10.1093/nar/19.9.2325; Settlage SB, 1996, J VIROL, V70, P6790, DOI 10.1128/JVI.70.10.6790-6795.1996; Shaked H, 2005, P NATL ACAD SCI USA, V102, P12265, DOI 10.1073/pnas.0502601102; Siggers KA, 2008, CELL HOST MICROBE, V4, P8, DOI 10.1016/j.chom.2008.06.004; Simon JA, 2004, NAT REV CANCER, V4, P481, DOI 10.1038/nrc1372; Singh D. K., 2007, COMMUNICATING CURREN, P155; Singh DK, 2008, VIROLOGY, V380, P75, DOI 10.1016/j.virol.2008.07.010; Singh DK, 2007, NUCLEIC ACIDS RES, V35, P755, DOI 10.1093/nar/gkl1088; STANLEY J, 1995, VIROLOGY, V206, P707, DOI 10.1016/S0042-6822(95)80093-X; STENGER DC, 1991, P NATL ACAD SCI USA, V88, P8029, DOI 10.1073/pnas.88.18.8029; Swagemakers SMA, 1998, J BIOL CHEM, V273, P28292, DOI 10.1074/jbc.273.43.28292; Tan TLR, 2003, DNA REPAIR, V2, P787, DOI 10.1016/S1568-7864(03)00070-3; Tittel-Elmer M, 2009, EMBO J, V28, P1142, DOI 10.1038/emboj.2009.60; Urena DE, 2011, J MOL BIOL, V405, P77, DOI 10.1016/j.jmb.2010.10.042; VERDIER JM, 1990, NUCLEIC ACIDS RES, V18, P7033, DOI 10.1093/nar/18.23.7033; XIE Q, 1995, EMBO J, V14, P4073, DOI 10.1002/j.1460-2075.1995.tb00079.x; Xie Q, 1996, EMBO J, V15, P4900, DOI 10.1002/j.1460-2075.1996.tb00870.x; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	64	22	27	1	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2012	26	3					1142	1160		10.1096/fj.11-188508	http://dx.doi.org/10.1096/fj.11-188508			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	901FY	22171001				2022-12-25	WOS:000300949300018
J	Kumar, V; Fahey, PG; Jong, YJI; Ramanan, N; O'Malley, KL				Kumar, Vikas; Fahey, Paul G.; Jong, Yuh-Jiin I.; Ramanan, Narendrakumar; O'Malley, Karen L.			Activation of Intracellular Metabotropic Glutamate Receptor 5 in Striatal Neurons Leads to Up-regulation of Genes Associated with Sustained Synaptic Transmission Including Arc/Arg3.1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMEDIATE-EARLY GENE; SERUM RESPONSE FACTOR; ION CHANNELS; KINASE-II; EXPRESSION; RELEASE; TRANSCRIPTION; PLASTICITY; NUCLEUS; STIM1	The G-protein coupled receptor, metabotropic glutamate receptor 5 (mGluR5), is expressed on both cell surface and intracellular membranes in striatal neurons. Using pharmacological tools to differentiate membrane responses, we previously demonstrated that cell surface mGluR5 triggers rapid, transient cytoplasmic Ca2+ rises, resulting in c-Jun N-terminal kinase, Ca2+/calmodulin-dependent protein kinase, and cyclic adenosine 3',5'-monophosphate-responsive element-binding protein (CREB) phosphorylation, whereas stimulation of intracellular mGluR5 induces long, sustained Ca2+ responses leading to the phosphorylation of extracellular signal-regulated kinase (ERK1/2) and Elk-1 (Jong, Y. J., Kumar, V., and O'Malley, K. L. (2009) J. Biol. Chem. 284, 35827-35838). Using pharmacological, genetic, and bioinformatics approaches, the current findings show that both receptor populations up-regulate many immediate early genes involved in growth and differentiation. Activation of intracellular mGluR5 also up-regulates genes involved in synaptic plasticity including activity-regulated cytoskeletal-associated protein (Arc/Arg3.1). Mechanistically, intracellular mGluR5-mediated Arc induction is dependent upon extracellular and intracellular Ca2+ and ERK1/2 as well as calmodulin-dependent kinases as known chelators, inhibitors, and a dominant negative Ca2+/calmodulin-dependent protein kinase II construct block Arc increases. Moreover, intracellular mGluR5-induced Arc expression requires the serum response transcription factor (SRF) as wild type but not SRF-deficient neurons show this response. Finally, increased Arc levels due to high K+ depolarization is significantly reduced in response to a permeable but not an impermeable mGluR5 antagonist. Taken together, these data highlight the importance of intracellular mGluR5 in the cascade of events associated with sustained synaptic transmission.	[Kumar, Vikas; Fahey, Paul G.; Jong, Yuh-Jiin I.; Ramanan, Narendrakumar; O'Malley, Karen L.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	O'Malley, KL (corresponding author), 660 S Euclid Ave,Campus Box 8108, St Louis, MO 63110 USA.	omalleyk@pcg.wustl.edu	RAMANAN, NARENDRAKUMAR/L-7487-2018		National Institutes of Health [MH57817, MH69646, NS057105]; FRAXA; Simons Foundation; Bakewell Family Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH069646, R01MH057817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FRAXA; Simons Foundation; Bakewell Family Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants MH57817 and MH69646 (to K. L. O.) and NS057105 (a Neuroscience Blueprint Core grant to Washington University). This work was also supported by a FRAXA Research Grant (to K. L. O. and V. K.), the Simons Foundation, and by the Bakewell Family Foundation, Bioinformatics Core and Chemical Genetics Screening Core facilities at Washington University School of Medicine.	ABRAHAM WC, 1991, MOL NEUROBIOL, V5, P297, DOI 10.1007/BF02935553; Alberi L, 2011, NEURON, V69, P437, DOI 10.1016/j.neuron.2011.01.004; Alvarez FJ, 2000, J COMP NEUROL, V422, P464, DOI 10.1002/1096-9861(20000703)422:3<464::AID-CNE11>3.0.CO;2-#; Bauer DC, 2011, BIOINFORMATICS, V27, pI7, DOI 10.1093/bioinformatics/btr217; Bloomer WAC, 2008, J BIOL CHEM, V283, P582, DOI 10.1074/jbc.M702451200; Bloomer WAC, 2007, BRAIN RES, V1153, P20, DOI 10.1016/j.brainres.2007.03.079; Boivin B, 2008, J RECEPT SIG TRANSD, V28, P15, DOI [10.1080/10799890801941889, 10.1080/10799890801941889 ]; Borlikova G, 2009, MOL NEUROBIOL, V40, P73, DOI 10.1007/s12035-009-8072-1; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Catania MV, 2007, MOL NEUROBIOL, V35, P298, DOI 10.1007/s12035-007-0022-1; Chai J, 2002, J PHYSIOL PHARMACOL, V53, P147; Chavis P, 1996, NATURE, V382, P719, DOI 10.1038/382719a0; Cheng KT, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001025; Choe ES, 2002, INT J MOL MED, V9, P3; Chotiner JK, 2010, LEARN MEMORY, V17, P117, DOI 10.1101/lm.1585910; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Dolen G, 2008, J PHYSIOL-LONDON, V586, P1503, DOI 10.1113/jphysiol.2008.150722; Donai H, 2003, NEUROSCI RES, V47, P399, DOI 10.1016/j.neures.2003.08.004; Fagni L, 2000, TRENDS NEUROSCI, V23, P80, DOI 10.1016/S0166-2236(99)01492-7; Feijoo CG, 2009, DEV DYNAM, V238, P2034, DOI 10.1002/dvdy.22006; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Galbraith MD, 2011, CURR OPIN GENET DEV, V21, P160, DOI 10.1016/j.gde.2011.01.011; Gasparini F, 2008, CURR OPIN DRUG DISC, V11, P655; Gomes DA, 2008, J BIOL CHEM, V283, P4344, DOI 10.1074/jbc.M706550200; Hermans E, 2001, BIOCHEM J, V359, P465, DOI 10.1042/0264-6021:3590465; Hoover PJ, 2011, P NATL ACAD SCI USA, V108, P13299, DOI 10.1073/pnas.1101664108; Huang F, 2007, J NEUROSCI, V27, P9054, DOI 10.1523/JNEUROSCI.2410-07.2007; Jones NM, 1998, NEUROCHEM INT, V32, P31, DOI 10.1016/S0197-0186(97)00050-8; Jong YJI, 2005, J BIOL CHEM, V280, P30469, DOI 10.1074/jbc.M501775200; Jong YJI, 2009, J BIOL CHEM, V284, P35827, DOI 10.1074/jbc.M109.046276; Katoh Y, 2004, EUR J BIOCHEM, V271, P4307, DOI 10.1111/j.1432-1033.2004.04372.x; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Kucharska A, 2009, CELL SIGNAL, V21, P1794, DOI 10.1016/j.cellsig.2009.07.015; Kumar V, 2008, J BIOL CHEM, V283, P14072, DOI 10.1074/jbc.M708551200; Lefebvre C, 2000, NEUROREPORT, V11, P1631, DOI 10.1097/00001756-200006050-00007; de Maturana RL, 2010, CNS NEUROL DISORD-DR, V9, P601, DOI 10.2174/187152710793361531; Lorrain DS, 2002, NEUROSCI LETT, V327, P198, DOI 10.1016/S0304-3940(02)00393-2; MENNERICK S, 1995, J NEUROPHYSIOL, V73, P320, DOI 10.1152/jn.1995.73.1.320; Murtazina DA, 2011, BIOL REPROD, V85, P315, DOI 10.1095/biolreprod.111.091082; O'Malley KL, 2003, J BIOL CHEM, V278, P28210, DOI 10.1074/jbc.M300792200; Park CY, 2010, SCIENCE, V330, P101, DOI 10.1126/science.1191027; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Perez-Cadahia B, 2011, BIOCHEM CELL BIOL, V89, P61, DOI 10.1139/O10-138; Pintchovski SA, 2009, J NEUROSCI, V29, P1525, DOI 10.1523/JNEUROSCI.5575-08.2009; Pisani A, 2000, AMINO ACIDS, V19, P119, DOI 10.1007/s007260070040; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462; Romano C, 1996, J COMP NEUROL, V367, P403, DOI 10.1002/(SICI)1096-9861(19960408)367:3<403::AID-CNE6>3.0.CO;2-9; Rozen S, 2000, Methods Mol Biol, V132, P365; Salido GM, 2011, ADV EXP MED BIOL, V704, P413, DOI 10.1007/978-94-007-0265-3_23; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Smith-Hicks C, 2010, NAT NEUROSCI, V13, P1082, DOI 10.1038/nn.2611; Stritt C, 2010, MOL CELL BIOL, V30, P1828, DOI 10.1128/MCB.01434-09; Thomas LS, 2001, NEUROPHARMACOLOGY, V41, P523, DOI 10.1016/S0028-3908(01)00091-0; Thomas LS, 2000, NEUROPHARMACOLOGY, V39, P1554, DOI 10.1016/S0028-3908(99)00223-3; Tian XY, 2010, MOL CELL NEUROSCI, V44, P94, DOI 10.1016/j.mcn.2010.01.012; Torocsik B, 2002, J NEUROSCI, V22, P8971; Tullai JW, 2004, J BIOL CHEM, V279, P20167, DOI 10.1074/jbc.M309260200; Tzingounis AV, 2006, NEURON, V52, P403, DOI 10.1016/j.neuron.2006.10.016; Vazdarjanova A, 2006, J COMP NEUROL, V498, P317, DOI 10.1002/cne.21003; Verde EMR, 2006, NEURON, V52, P461, DOI 10.1016/j.neuron.2006.09.031; Wang Y, 2009, NEUROSCI LETT, V460, P36, DOI 10.1016/j.neulet.2009.05.023; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Waung MW, 2008, NEURON, V59, P84, DOI 10.1016/j.neuron.2008.05.014; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; Zanocco-Marani T, 2010, CELL CYCLE, V9, P4771, DOI 10.4161/cc.9.24.14217; Zhao Y, 2010, ARTERIOSCL THROM VAS, V30, P1535, DOI 10.1161/ATVBAHA.109.191163	66	56	58	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5412	5425		10.1074/jbc.M111.301366	http://dx.doi.org/10.1074/jbc.M111.301366			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22179607	Green Published, hybrid			2022-12-25	WOS:000300638000022
J	Sakamoto, T; Inoue, T; Otomo, Y; Yokomori, N; Ohno, M; Arai, H; Nakagawa, Y				Sakamoto, Taro; Inoue, Takao; Otomo, Yukae; Yokomori, Nagaharu; Ohno, Motoki; Arai, Hiroyuki; Nakagawa, Yasuhito			Deficiency of Cardiolipin Synthase Causes Abnormal Mitochondrial Function and Morphology in Germ Cells of Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C REDUCTASE; SACCHAROMYCES-CEREVISIAE; YEAST MITOCHONDRIA; RESPIRATORY-CHAIN; ATP SYNTHASE; NMR-SPECTROSCOPY; MEMBRANE; PHOSPHOLIPIDS; APOPTOSIS; HEART	Cardiolipin (CL) is a major membrane phospholipid specifically localized in mitochondria. At the cellular level, CL has been shown to have a role in mitochondrial energy production, mitochondrial membrane dynamics, and the triggering of apoptosis. However, the in vivo role of CL in multicellular organisms is largely unknown. In this study, by analyzing deletion mutants of a CL synthase gene (crls-1) in Caenorhabditis elegans, we demonstrated that CL depletion selectively caused abnormal mitochondrial function and morphology in germ cells but not in somatic cell types such as muscle cells. crls-1 mutants reached adulthood but were sterile with reduced germ cell proliferation and impaired oogenesis. In the gonad of crls-1 mutants, mitochondrial membrane potential was significantly decreased, and the structure of the mitochondrial cristae was disrupted. Contrary to the abnormalities in the gonad, somatic tissues in crls-1 mutants appeared normal with respect to cell proliferation, mitochondrial function, and mitochondrial morphology. Increased susceptibility to CL depletion in germ cells was also observed in mutants of phosphatidylglycerophosphate synthase, an enzyme responsible for producing phosphatidylglycerol, a precursor phospholipid of CL. We propose that the contribution of CL to mitochondrial function and morphology is different among the cell types in C. elegans.	[Sakamoto, Taro] Kitasato Univ, Sch Pharm, Minato Ku, Tokyo 1088641, Japan; [Inoue, Takao; Arai, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan; [Inoue, Takao] Natl Inst Hlth Sci, Div Cellular & Gene Therapy Prod, Tokyo 1588501, Japan; [Inoue, Takao; Arai, Hiroyuki] Japan Sci & Technol Agcy, CREST, Tokyo 1020075, Japan	Kitasato University; University of Tokyo; National Institute of Health Sciences - Japan; Japan Science & Technology Agency (JST)	Sakamoto, T (corresponding author), Kitasato Univ, Sch Pharm, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.	sakamotot@pharm.kitasato-u.ac.jp			Japan Society for the Promotion of Science [22590072]; Kitasato University; National Institutes of Health, NCRR; Grants-in-Aid for Scientific Research [23227004] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kitasato University; National Institutes of Health, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-aid for Scientific Research (C) 22590072 from the Japan Society for the Promotion of Science (to Y. N.) and by a Kitasato University research grant for young researchers (to T. S.).; We greatly thank A. Takimoto and M. Ikuta for excellent technical assistance; Drs. K. Gengyo-Ando (Saitama University) and S. Mitani (Tokyo Women's Medical University School of Medicine) for providing alleles of crls-1 and pgs-1; Dr. A. Fire (Stanford University School of Medicine) for convenient vectors; and Dr. T. Inoue (National University of Singapore) for helpful discussions and comments on this study. Some strains were provided by the Caenorhabditis Genetics Center (University of Minnesota, Minneapolis), which is funded by the National Institutes of Health, NCRR.	Acehan D, 2011, BIOPHYS J, V100, P2184, DOI 10.1016/j.bpj.2011.03.031; Acehan D, 2011, J BIOL CHEM, V286, P899, DOI 10.1074/jbc.M110.171439; Ariz M, 2009, DEV BIOL, V326, P295, DOI 10.1016/j.ydbio.2008.11.024; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boxem M, 1999, DEVELOPMENT, V126, P2227; BRENNER S, 1974, GENETICS, V77, P71; Chang SC, 1998, J BIOL CHEM, V273, P9829, DOI 10.1074/jbc.273.16.9829; Choi SY, 2007, CELL DEATH DIFFER, V14, P597, DOI 10.1038/sj.cdd.4402020; COURTADE S, 1967, BIOCHIM BIOPHYS ACTA, V137, P121, DOI 10.1016/0005-2760(67)90015-X; Crittenden SL, 2006, MOL BIOL CELL, V17, P3051, DOI 10.1091/mbc.E06-03-0170; EBLE KS, 1990, J BIOL CHEM, V265, P19434; Fay DS, 2000, DEVELOPMENT, V127, P4049; FRY M, 1981, J BIOL CHEM, V256, P1874; Gaskova D, 2007, BIOCHEM BIOPH RES CO, V354, P814, DOI 10.1016/j.bbrc.2007.01.073; Gengyo-Ando K, 2000, BIOCHEM BIOPH RES CO, V269, P64, DOI 10.1006/bbrc.2000.2260; Gomez B, 1999, BIOCHEMISTRY-US, V38, P9031, DOI 10.1021/bi990603r; Gonzalvez F, 2007, APOPTOSIS, V12, P877, DOI 10.1007/s10495-007-0718-8; HANUKOGLU I, 1992, J STEROID BIOCHEM, V43, P779, DOI 10.1016/0960-0760(92)90307-5; HAYERHARTL M, 1992, EUR J BIOCHEM, V209, P423, DOI 10.1111/j.1432-1033.1992.tb17305.x; Houtkooper RH, 2008, CELL MOL LIFE SCI, V65, P2493, DOI 10.1007/s00018-008-8030-5; Huang ZT, 2008, FREE RADICAL BIO MED, V44, P1935, DOI 10.1016/j.freeradbiomed.2008.02.016; Hunter T, 1997, J BIOL CHEM, V272, P28652, DOI 10.1074/jbc.272.45.28652; Jiang F, 1997, MOL MICROBIOL, V26, P481, DOI 10.1046/j.1365-2958.1997.5841950.x; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Johnson DT, 2007, AM J PHYSIOL-CELL PH, V292, pC689, DOI 10.1152/ajpcell.00108.2006; Joshi AS, 2009, BBA-MOL CELL RES, V1793, P212, DOI 10.1016/j.bbamcr.2008.07.024; Kawasaki I, 2007, MECH DEVELOP, V124, P237, DOI 10.1016/j.mod.2006.11.004; Kawasaki K, 1999, J BIOL CHEM, V274, P1828, DOI 10.1074/jbc.274.3.1828; KIMBLE J, 1979, DEV BIOL, V70, P396, DOI 10.1016/0012-1606(79)90035-6; Koshkin V, 2002, BIOCHEM J, V364, P317, DOI 10.1042/bj3640317; Koshkin V, 2000, BIOCHEM J, V347, P687, DOI 10.1042/0264-6021:3470687; Kuznetsov AV, 2009, INT J BIOCHEM CELL B, V41, P1928, DOI 10.1016/j.biocel.2009.03.007; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; Maciejowski J, 2006, DEV BIOL, V292, P142, DOI 10.1016/j.ydbio.2005.12.046; Mancuso DJ, 2007, J BIOL CHEM, V282, P34611, DOI 10.1074/jbc.M707795200; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Michaelson D, 2010, DEVELOPMENT, V137, P671, DOI 10.1242/dev.042523; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Munn E. A., 1974, STRUCTURE MITOCHONDR, P1; Nomura K, 2000, BIOCHEM J, V351, P183, DOI 10.1042/0264-6021:3510183; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; ROBINSON NC, 1990, BIOCHEMISTRY-US, V29, P8962, DOI 10.1021/bi00490a012; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; SCHAGGER H, 1990, EUR J BIOCHEM, V190, P123, DOI 10.1111/j.1432-1033.1990.tb15554.x; SCHLAME M, 1993, J BIOL CHEM, V268, P74; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; Sedlak E, 1999, BIOCHEMISTRY-US, V38, P14966, DOI 10.1021/bi9914053; Shen LR, 2010, J LIPID RES, V51, P2985, DOI 10.1194/jlr.M008524; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Sumitani M, 2011, J BIOCHEM, V149, P581, DOI 10.1093/jb/mvr008; Timmons L, 2004, BIOESSAYS, V26, P715, DOI 10.1002/bies.20078; Van Gilst MR, 2005, P NATL ACAD SCI USA, V102, P13496, DOI 10.1073/pnas.0506234102; White D.A., 1973, FORM FUNCTION PHOSPH; Williams JG, 1998, J BIOL CHEM, V273, P13482, DOI 10.1074/jbc.273.22.13482; YU CA, 1980, BIOCHEMISTRY-US, V19, P5715, DOI 10.1021/bi00566a008; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200; Zhang M, 2003, J BIOL CHEM, V278, P35204, DOI 10.1074/jbc.M306729200; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200; Zhong Q, 2004, J BIOL CHEM, V279, P32294, DOI 10.1074/jbc.M403275200	62	32	44	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4590	4601		10.1074/jbc.M111.314823	http://dx.doi.org/10.1074/jbc.M111.314823			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22174409	Green Published, hybrid			2022-12-25	WOS:000300608500022
J	Christensen, B; Klaning, E; Nielsen, MS; Andersen, MH; Sorensen, ES				Christensen, Brian; Klaning, Eva; Nielsen, Mette S.; Andersen, Mikkel H.; Sorensen, Esben S.			C-terminal Modification of Osteopontin Inhibits Interaction with the alpha(V)beta(3)-Integrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSLATIONAL MODIFICATIONS; BONE SIALOPROTEIN; SIBLING PROTEINS; PHOSPHORYLATION; BINDING; IDENTIFICATION; SITES; ALPHA-V-BETA-3; SUBSTRATE; FRAGMENT	Osteopontin (OPN) is a multifunctional phosphorylated protein containing the integrin binding sequence Arg-Gly-Asp through which it interacts with several integrin receptors, such as the alpha(V)beta(3)-integrin. OPN exists in many different isoforms differing in phosphorylation status that are likely to interact differently with integrins. The C-terminal region of OPN is particularly well conserved among mammalian species, which suggests an important functional role of this region. In this study, we show that modification of the extreme C terminus of OPN plays an important regulatory role for the interaction with the alpha(V)beta(3)-integrin. It is demonstrated that highly phosphorylated OPN has a much reduced capability to promote cell adhesion via the alpha(V)beta(3)-integrin compared with lesser phosphorylated forms. The cell attachment promoted by highly phosphorylated OPN could be greatly increased by both dephosphorylation and proteolytic removal of the C terminus. Using recombinantly expressed OPN containing a tag in the N or C terminus, it is shown that a modification in the C-terminal part significantly reduces the adhesion of cells to OPN via the alpha(V)beta(3)-integrin, whereas modification of the N terminus does not influence the binding. The inhibited binding of the alpha(V)beta(3)-integrin to OPN could be restored by proteolytic removal of the C terminus by thrombin and plasmin. These data illustrate a novel mechanism regulating the interaction of OPN and the alpha(V)beta(3)-integrin by modification of the highly conserved C-terminal region of the protein.	[Christensen, Brian; Klaning, Eva; Nielsen, Mette S.; Sorensen, Esben S.] Aarhus Univ, Dept Mol Biol & Genet, Prot Chem Lab, DK-8000 Aarhus, Denmark; [Andersen, Mikkel H.] Aarhus Univ, Dept Mol Biol & Genet, Prot Core Facil, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University	Sorensen, ES (corresponding author), Univ Aarhus, Dept Mol Biol & Genet, Prot Chem Lab, Sci Pk,Gustav Wieds Vej 10C, DK-8000 Aarhus C, Denmark.	ess@mb.au.dk		Sorensen, Esben Skipper/0000-0002-7050-3354	Novo Nordisk Foundation; Danish Council for Independent Research	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	This work was supported by grants from the Novo Nordisk Foundation and the Danish Council for Independent Research.	Agnihotri R, 2001, J BIOL CHEM, V276, P28261, DOI 10.1074/jbc.M103608200; Anborgh PH, 2011, J CELL COMMUN SIGNAL, V5, P111, DOI 10.1007/s12079-011-0130-6; Bayless KJ, 2001, J BIOL CHEM, V276, P13483, DOI 10.1074/jbc.M011392200; CHEN YP, 1995, BLOOD, V86, P2606, DOI 10.1182/blood.V86.7.2606.bloodjournal8672606; Christensen B, 2005, BIOCHEM J, V390, P285, DOI 10.1042/BJ20050341; Christensen B, 2008, BIOCHEM J, V411, P53, DOI 10.1042/BJ20071021; Christensen B, 2007, J BIOL CHEM, V282, P19463, DOI 10.1074/jbc.M703055200; Christensen B, 2010, J BIOL CHEM, V285, P7929, DOI 10.1074/jbc.M109.075010; Ek-Rylander B, 2010, EXP CELL RES, V316, P443, DOI 10.1016/j.yexcr.2009.10.019; EKRYLANDER B, 1994, J BIOL CHEM, V269, P14853; Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146; Frenzel DF, 2011, EXPERT REV CLIN IMMU, V7, P93, DOI 10.1586/ECI.10.82; Gericke A, 2005, CALCIFIED TISSUE INT, V77, P45, DOI 10.1007/s00223-004-1288-1; Ito K, 2009, MATRIX BIOL, V28, P11, DOI 10.1016/j.matbio.2008.10.002; Katayama Y, 1998, J CELL PHYSIOL, V176, P179, DOI 10.1002/(SICI)1097-4652(199807)176:1<179::AID-JCP19>3.3.CO;2-M; Kazanecki CC, 2007, J CELL BIOCHEM, V102, P912, DOI 10.1002/jcb.21558; Kazanecki CC, 2007, J CELL BIOCHEM, V102, P925, DOI 10.1002/jcb.21487; Keykhosravani M, 2005, BIOCHEMISTRY-US, V44, P6990, DOI 10.1021/bi050109p; Lee JL, 2007, CANCER RES, V67, P2089, DOI 10.1158/0008-5472.CAN-06-3625; Lund SA, 2009, J CELL COMMUN SIGNAL, V3, P311, DOI 10.1007/s12079-009-0068-0; Miura Y, 2010, ANAL CHEM, V82, P10021, DOI 10.1021/ac101599p; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Platzer G, 2011, BIOCHEMISTRY-US, V50, P6113, DOI 10.1021/bi200291e; Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302; ROSS FP, 1993, J BIOL CHEM, V268, P9901; Schack L, 2009, J DAIRY SCI, V92, P5378, DOI 10.3168/jds.2009-2360; Schack L, 2009, J IMMUNOL, V182, P6943, DOI 10.4049/jimmunol.0900065; SENGER DR, 1994, MOL BIOL CELL, V5, P565, DOI 10.1091/mbc.5.5.565; SENGER DR, 1988, CANCER RES, V48, P5770; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; SORENSEN ES, 1995, PROTEIN SCI, V4, P2040, DOI 10.1002/pro.5560041009; Weber GF, 2002, J LEUKOCYTE BIOL, V72, P752; Yamaguchi Y, 2010, BIOCHEM BIOPH RES CO, V393, P487, DOI 10.1016/j.bbrc.2010.02.030; Yokosaki Y, 2005, MATRIX BIOL, V24, P418, DOI 10.1016/j.matbio.2005.05.005; Yokosaki Y, 1999, J BIOL CHEM, V274, P36328, DOI 10.1074/jbc.274.51.36328	35	43	46	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3788	3797		10.1074/jbc.M111.277996	http://dx.doi.org/10.1074/jbc.M111.277996			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22179617	hybrid, Green Published			2022-12-25	WOS:000300410900016
J	Greget, R; Pernot, F; Bouteiller, JMC; Ghaderi, V; Allam, S; Keller, AF; Ambert, N; Legendre, A; Sarmis, M; Haeberle, O; Faupel, M; Bischoff, S; Berger, TW; Baudry, M				Greget, Renaud; Pernot, Fabien; Bouteiller, Jean-Marie C.; Ghaderi, Viviane; Allam, Sushmita; Keller, Anne Florence; Ambert, Nicolas; Legendre, Arnaud; Sarmis, Merdan; Haeberle, Olivier; Faupel, Michel; Bischoff, Serge; Berger, Theodore W.; Baudry, Michel			Simulation of Postsynaptic Glutamate Receptors Reveals Critical Features of Glutamatergic Transmission	PLOS ONE			English	Article							EXCITATORY SYNAPTIC CURRENTS; LONG-TERM DEPRESSION; ENDOPLASMIC-RETICULUM; CALCIUM-RELEASE; RAT-BRAIN; ACTIVATION; MECHANISMS; CHANNEL; SINGLE; MODEL	Activation of several subtypes of glutamate receptors contributes to changes in postsynaptic calcium concentration at hippocampal synapses, resulting in various types of changes in synaptic strength. Thus, while activation of NMDA receptors has been shown to be critical for long-term potentiation (LTP) and long term depression (LTD) of synaptic transmission, activation of metabotropic glutamate receptors (mGluRs) has been linked to either LTP or LTD. While it is generally admitted that dynamic changes in postsynaptic calcium concentration represent the critical elements to determine the direction and amplitude of the changes in synaptic strength, it has been difficult to quantitatively estimate the relative contribution of the different types of glutamate receptors to these changes under different experimental conditions. Here we present a detailed model of a postsynaptic glutamatergic synapse that incorporates ionotropic and mGluR type I receptors, and we use this model to determine the role of the different receptors to the dynamics of postsynaptic calcium with different patterns of presynaptic activation. Our modeling framework includes glutamate vesicular release and diffusion in the cleft and a glutamate transporter that modulates extracellular glutamate concentration. Our results indicate that the contribution of mGluRs to changes in postsynaptic calcium concentration is minimal under basal stimulation conditions and becomes apparent only at high frequency of stimulation. Furthermore, the location of mGluRs in the postsynaptic membrane is also a critical factor, as activation of distant receptors contributes significantly less to calcium dynamics than more centrally located ones. These results confirm the important role of glutamate transporters and of the localization of mGluRs in postsynaptic sites in their signaling properties, and further strengthen the notion that mGluR activation significantly contributes to postsynaptic calcium dynamics only following high-frequency stimulation. They also provide a new tool to analyze the interactions between metabotropic and ionotropic glutamate receptors.	[Greget, Renaud; Pernot, Fabien; Bouteiller, Jean-Marie C.; Keller, Anne Florence; Ambert, Nicolas; Legendre, Arnaud; Sarmis, Merdan; Faupel, Michel; Bischoff, Serge; Berger, Theodore W.; Baudry, Michel] Rhenovia Pharma, Mulhouse, France; [Greget, Renaud; Sarmis, Merdan; Haeberle, Olivier] Univ Haute Alsace, MIPS, Mulhouse, France; [Bouteiller, Jean-Marie C.; Ghaderi, Viviane; Allam, Sushmita; Berger, Theodore W.; Baudry, Michel] Univ So Calif, Neurosci Program, Los Angeles, CA 90089 USA; [Bouteiller, Jean-Marie C.; Ghaderi, Viviane; Allam, Sushmita; Berger, Theodore W.; Baudry, Michel] Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA	Universites de Strasbourg Etablissements Associes; Universite de Haute-Alsace (UHA); University of Southern California; University of Southern California	Greget, R (corresponding author), Rhenovia Pharma, Mulhouse, France.	serge.bischoff@rhenovia.com; baudry@usc.edu	bouteiller, jean-marie/L-4298-2019; Haeberlé, Olivier/AAS-7479-2021	bouteiller, jean-marie/0000-0003-3069-0826; Haeberle, Olivier/0000-0003-0977-3256	French Ministry of Research; OSEO; Region Alsace; European Community; French National Agency of Research and Technology (ANRT); Convention Industrielle de Formation par la Recherche (Cifre); Alsace Business Angels; Societe de Diversification du bassin potassique (SODIV); National Institute of Neurological Disorders and Stroke (NINDS) [R01NS057128-01]; National Institute of Biomedical Imaging and Bioengineering (NIBIB) [P41 EB001978-24]; Rhenovia Pharma; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057128] Funding Source: NIH RePORTER	French Ministry of Research(Ministry of Research, FranceEuropean Commission); OSEO; Region Alsace(Region Grand-Est); European Community(European Commission); French National Agency of Research and Technology (ANRT)(French National Research Agency (ANR)); Convention Industrielle de Formation par la Recherche (Cifre); Alsace Business Angels; Societe de Diversification du bassin potassique (SODIV); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Biomedical Imaging and Bioengineering (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Rhenovia Pharma; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Rhenovia obtained financing from the French Ministry of Research, OSEO, the Region Alsace, the European Community, the French National Agency of Research and Technology (ANRT) with a Convention Industrielle de Formation par la Recherche (Cifre) grant (Renaud Greget), Alsace Business Angels, and Societe de Diversification du bassin potassique (SODIV). Research was also funded by grant R01NS057128-01 from the National Institute of Neurological Disorders and Stroke (NINDS) to MB and TWB, and P41 EB001978-24 from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) to TWB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; MB, TB and JMB have a conflict of interest. The University of Southern California holds an equity interest in Rhenovia Pharma, and has also received licensing income from Rhenovia Pharma. Rhenovia Pharma received funding from a commercial source (Alsace Business Angel). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. All authors except OH are employees or consultants of Rhenovia Pharma. This does not affect the authors' adherence to all the PLoS ONE policies on sharing data and materials. There are no other other relevant declarations relating to employment, consultancy, patents, products in development or marketed products, etc.	Akam EC, 1997, BRIT J PHARMACOL, V121, P1203, DOI 10.1038/sj.bjp.0701238; Albasanz JL, 2002, BBA-MOL CELL RES, V1593, P69, DOI 10.1016/S0167-4889(02)00330-0; Ambert Nicolas, 2010, Open Access Bioinformatics, V2, P113; Anwyl R, 2009, NEUROPHARMACOLOGY, V56, P735, DOI 10.1016/j.neuropharm.2009.01.002; Bellone C, 2008, CELL MOL LIFE SCI, V65, P2913, DOI 10.1007/s00018-008-8263-3; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; BOCKAERT J, 1993, FUNDAM CLIN PHARM, V7, P473, DOI 10.1111/j.1472-8206.1993.tb00252.x; Boucher J, 2010, BRAIN STRUCT FUNCT, V215, P49, DOI 10.1007/s00429-010-0273-x; Brasnjo G, 2001, NEURON, V31, P607, DOI 10.1016/S0896-6273(01)00377-4; Cartmell J, 2000, J NEUROCHEM, V75, P889, DOI 10.1046/j.1471-4159.2000.0750889.x; CATANIA MV, 1994, NEUROSCIENCE, V61, P481, DOI 10.1016/0306-4522(94)90428-6; DEYOUNG GW, 1992, P NATL ACAD SCI USA, V89, P9895, DOI 10.1073/pnas.89.20.9895; Doi T, 2005, J NEUROSCI, V25, P950, DOI 10.1523/JNEUROSCI.2727-04.2005; Dupont G, 1997, CELL CALCIUM, V22, P321, DOI 10.1016/S0143-4160(97)90017-8; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; Fujiwara A, 2001, NEUROREPORT, V12, P2647, DOI 10.1097/00001756-200108280-00012; Gladding CM, 2009, PHARMACOL REV, V61, P395, DOI 10.1124/pr.109.001735; Herman MA, 2007, J NEUROSCI, V27, P9736, DOI 10.1523/JNEUROSCI.3009-07.2007; HESTRIN S, 1990, NEURON, V5, P247, DOI 10.1016/0896-6273(90)90162-9; Holbro N, 2009, P NATL ACAD SCI USA, V106, P15055, DOI 10.1073/pnas.0905110106; ISAACSON JS, 1993, J NEUROPHYSIOL, V70, P2187, DOI 10.1152/jn.1993.70.5.2187; JONAS P, 1992, J PHYSIOL-LONDON, V455, P143, DOI 10.1113/jphysiol.1992.sp019294; Kelly L, 2009, NAT NEUROSCI, V12, P593, DOI 10.1038/nn.2309; Kinzer-Ursem TL, 2007, PLOS COMPUT BIOL, V3, P84, DOI 10.1371/journal.pcbi.0030006; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; Le Duigou C, 2011, NEUROPHARMACOLOGY, V60, P748, DOI 10.1016/j.neuropharm.2010.12.015; Leon D, 2007, NEUROCHEM INT, V50, P681, DOI 10.1016/j.neuint.2006.12.012; LESTER RAJ, 1992, J NEUROSCI, V12, P635; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Marcaggi P, 2009, P NATL ACAD SCI USA, V106, P11388, DOI 10.1073/pnas.0901290106; MURPHY SN, 1989, MOL PHARMACOL, V35, P671; Nakamura T, 2002, J PHYSIOL-LONDON, V543, P465, DOI 10.1113/jphysiol.2002.020362; Nevian T, 2006, J NEUROSCI, V26, P11001, DOI 10.1523/JNEUROSCI.1749-06.2006; Nicoletti E, 2011, NEUROPHARMACOLOGY, V60, P1017, DOI 10.1016/j.neuropharm.2010.10.022; NICOLETTI F, 1986, J NEUROCHEM, V46, P40, DOI 10.1111/j.1471-4159.1986.tb12922.x; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Purvis JE, 2008, BLOOD, V112, P4069, DOI 10.1182/blood-2008-05-157883; Raymond CR, 2002, J NEUROPHYSIOL, V88, P249, DOI 10.1152/jn.2002.88.1.249; Reichelt W, 2002, J NEUROPHYSIOL, V87, P1974, DOI 10.1152/jn.00704.2001; Ribeiro FM, 2010, CNS NEUROL DISORD-DR, V9, P574; Robert A, 2003, J NEUROSCI, V23, P847; Rusakov DA, 1998, J NEUROSCI, V18, P3158; SARANTIS M, 1993, NEURON, V11, P541, DOI 10.1016/0896-6273(93)90158-N; Scanziani M, 2002, TRENDS NEUROSCI, V25, P282, DOI 10.1016/S0166-2236(02)02155-0; Schikorski T, 1997, J NEUROSCI, V17, P5858; Schmidt H, 2009, J COMPUT NEUROSCI, V27, P229, DOI 10.1007/s10827-009-0139-5; Schorge S, 2005, J PHYSIOL-LONDON, V569, P395, DOI 10.1113/jphysiol.2005.095349; Shuai JW, 2007, BIOPHYS J, V93, P1151, DOI 10.1529/biophysj.107.108795; SLADECZEK F, 1985, NATURE, V317, P717, DOI 10.1038/317717a0; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; SOMMER B, 1992, EMBO J, V11, P1651, DOI 10.1002/j.1460-2075.1992.tb05211.x; SUGIYAMA H, 1987, NATURE, V325, P531, DOI 10.1038/325531a0; Takechi H, 1998, NATURE, V396, P757, DOI 10.1038/25547; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; WHITHAM EM, 1991, BRIT J PHARMACOL, V104, P202, DOI 10.1111/j.1476-5381.1991.tb12408.x; Wu J, 2004, NEUROSCIENCE, V123, P507, DOI 10.1016/j.neuroscience.2003.09.013; Zheng KY, 2008, BIOPHYS J, V95, P4584, DOI 10.1529/biophysj.108.129874	58	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e28380	10.1371/journal.pone.0028380	http://dx.doi.org/10.1371/journal.pone.0028380			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22194830	Green Published, gold			2022-12-25	WOS:000298370400014
J	Schinzel, RT; Ahfeldt, T; Lau, FH; Lee, YK; Cowley, A; Shen, T; Peters, D; Lum, DH; Cowan, CA				Schinzel, Robert T.; Ahfeldt, Tim; Lau, Frank H.; Lee, Youn-Kyoung; Cowley, Alicia; Shen, Tony; Peters, Derek; Lum, David H.; Cowan, Chad A.			Efficient Culturing and Genetic Manipulation of Human Pluripotent Stem Cells	PLOS ONE			English	Article							SURVIVAL; LINES	Human pluripotent stem cells (hPSC) hold great promise as models for understanding disease and as a source of cells for transplantation therapies. However, the lack of simple, robust and efficient culture methods remains a significant obstacle for realizing the utility of hPSCs. Here we describe a platform for the culture of hPSCs that 1) allows for dissociation and replating of single cells, 2) significantly increases viability and replating efficiency, 3) improves freeze/thaw viability 4) improves cloning efficiency and 5) colony size variation. When combined with standard methodologies for genetic manipulation, we found that the enhanced culture platform allowed for lentiviral transduction rates of up to 95% and electroporation efficiencies of up to 25%, with a significant increase in the total number of antibiotic-selected colonies for screening for homologous recombination. We further demonstrated the utility of the enhanced culture platform by successfully targeting the ISL1 locus. We conclude that many of the difficulties associated with culturing and genetic manipulation of hPSCs can be addressed with optimized culture conditions, and we suggest that the use of the enhanced culture platform could greatly improve the ease of handling and general utility of hPSCs.	[Schinzel, Robert T.; Ahfeldt, Tim; Lee, Youn-Kyoung; Cowley, Alicia; Shen, Tony; Peters, Derek; Cowan, Chad A.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Schinzel, Robert T.; Ahfeldt, Tim; Lau, Frank H.; Lee, Youn-Kyoung; Cowley, Alicia; Shen, Tony; Peters, Derek; Cowan, Chad A.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Schinzel, Robert T.; Ahfeldt, Tim; Lee, Youn-Kyoung; Peters, Derek; Cowan, Chad A.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Schinzel, Robert T.] Free Univ Berlin, Inst Biol Mikrobiol, Fachbereich Biol, Berlin, Germany; [Cowley, Alicia; Shen, Tony] Harvard Univ, Harvard Coll, Cambridge, MA 02138 USA; [Lum, David H.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Lum, David H.] Univ Utah, Dept Oncol Sci, Salt Lake City, UT USA	Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Free University of Berlin; Harvard University; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Schinzel, RT (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst, Cambridge, MA 02138 USA.	ccowan@fas.harvard.edu	Ahfeldt, Tim/E-2935-2017	Cowley, Alicia/0000-0001-8136-169X; Ahfeldt, Tim/0000-0001-6377-7376; Shen, Tony/0000-0002-7740-6389	Harvard Stem Cell Institute; Stowers Medical Research Institute	Harvard Stem Cell Institute; Stowers Medical Research Institute	Funding was provided by a Junior Faculty Program Award from Harvard Stem Cell Institute, and by the Stowers Medical Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Yacoub N, 2007, J GENE MED, V9, P579, DOI 10.1002/jgm.1052; Bajpai R, 2008, MOL REPROD DEV, V75, P818, DOI 10.1002/mrd.20809; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Li XY, 2009, HUM REPROD, V24, P580, DOI 10.1093/humrep/den404; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Ma Y, 2003, STEM CELLS, V21, P111, DOI 10.1634/stemcells.21-1-111; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	16	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e27495	10.1371/journal.pone.0027495	http://dx.doi.org/10.1371/journal.pone.0027495			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22194785	Green Submitted, gold, Green Published			2022-12-25	WOS:000298370400004
J	Deftereos, G; Corrie, SR; Feng, QH; Morihara, J; Stern, J; Hawes, SE; Kiviat, NB				Deftereos, Georgios; Corrie, Simon R.; Feng, Qinghua; Morihara, Janice; Stern, Joshua; Hawes, Stephen E.; Kiviat, Nancy B.			Expression of Mir-21 and Mir-143 in Cervical Specimens Ranging from Histologically Normal through to Invasive Cervical Cancer	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; ALTERED MICRORNA EXPRESSION; DEATH 4 PDCD4; BREAST-CANCER; HUMAN-PAPILLOMAVIRUS; COLORECTAL-CANCER; CARCINOMA CELLS; GASTRIC-CANCER; APOPTOSIS; TARGETS	Background: MicroRNA expression is severely disrupted in carcinogenesis, however limited evidence is available validating results from cell-line models in human clinical cancer specimens. MicroRNA-21 (mir-21) and microRNA-143 (mir-143) have previously been identified as significantly deregulated in a range of cancers including cervical cancer. Our goal was to investigate the expression patterns of several well-studied microRNA species in cervical samples and compare the results to cell line samples. Methodology/Principal Findings: We measured the expression of mir-21 and mir-143 in 142 formalin-fixed, paraffin embedded (FFPE) cervical biopsy tissue blocks, collected from Dantec Oncology Clinic, Dakar, Senegal. MicroRNA expression analysis was performed using Taqman-based real-time PCR assays. Protein immunohistochemical staining was also performed to investigate target protein expression on 72 samples. We found that mir-21 expression increased with worsening clinical diagnosis but that mir-143 was not correlated with histology. These observations were in stark contrast to previous reports involving cervical cancer cell lines in which mir-143 was consistently down-regulated but mir-21 largely unaffected. We also identified, for the first time, that cytoplasmic expression of Programmed Cell Death Protein 4 PDCD4; a known target of mir-21) was significantly lower in women with invasive cervical carcinoma (ICC) in comparison to those with cervical intraepithelial neoplasia (2-3) or carcinoma in situ (CIN2-3/CIS), although there was no significant correlation between mir-21 and PDCD4 expression, despite previous studies identifying PDCD4 transcript as a known mir-21 target. Conclusions: Whilst microRNA biomarkers have a number of promising features, more studies on expression levels in histologically defined clinical specimens are required to investigate clinical relevance of discovery-based studies. Mir-21 may be of some utility in predictive screening, given that we observed a significant correlation between mir-21 expression level and worsening histological diagnosis of cervical cancer.	[Deftereos, Georgios; Corrie, Simon R.; Feng, Qinghua; Morihara, Janice; Stern, Joshua; Hawes, Stephen E.; Kiviat, Nancy B.] Univ Washington, HPV Res Lab, UW Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Deftereos, G (corresponding author), Univ Washington, HPV Res Lab, UW Med, Seattle, WA 98195 USA.	nbk@u.washington.edu	Corrie, Simon/M-9838-2019; Corrie, Simon/D-1596-2009	Corrie, Simon/0000-0001-8029-1896	National Institutes of Health/National Cancer Institutes (NIH/NCI) [R01 CA75920, R01 CA115713]; American Australian Association (Merck Company Foundation); NATIONAL CANCER INSTITUTE [R01CA075920, R01CA115713] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institutes (NIH/NCI); American Australian Association (Merck Company Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors acknowledge funding contributions from the National Institutes of Health/National Cancer Institutes (NIH/NCI) (R01 CA75920 and R01 CA115713; Dr. Kiviat) and the American Australian Association (Merck Company Foundation Postdoctoral Fellowship; Dr. Corrie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2007, CANCER SCI, V98, P1914, DOI 10.1111/j.1349-7006.2007.00618.x; American College of Obstetricians and Gynecologist, 2008, OBSTET GYNECOL, V112, P1419, DOI DOI 10.1097/AOG.0B013E318192497C; Birchall MA, 1995, ORAL ONCOL, V31B, P380, DOI 10.1016/0964-1955(95)00048-8; Brockenbrough J Scott, 2011, J Nucl Med, V52, P1181, DOI 10.2967/jnumed.111.089482; Clape C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007542; Cowland JB, 2007, APMIS, V115, P1090, DOI 10.1111/j.1600-0463.2007.apm_775.xml.x; El-Mansi MT, 2006, INT J GYNECOL CANCER, V16, P1254, DOI 10.1111/j.1525-1438.2006.00569.x; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Feng QH, 2005, JNCI-J NATL CANCER I, V97, P273, DOI 10.1093/jnci/dji041; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grill J, 2002, MOL THER, V6, P609, DOI 10.1006/mthe.2002.0713; Guo JM, 2009, J GASTROEN HEPATOL, V24, P652, DOI 10.1111/j.1440-1746.2008.05666.x; HAWES SE, 1999, SEXUALLY TRANSMITTED, P1399; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Hernandez A, 2000, ANN SURG, V232, P576, DOI 10.1097/00000658-200010000-00013; Holowaty P, 1999, JNCI-J NATL CANCER I, V91, P252, DOI 10.1093/jnci/91.3.252; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; KAAIJK P, 1995, NEUROPATH APPL NEURO, V21, P386, DOI 10.1111/j.1365-2990.1995.tb01075.x; KAIHUNG W, 2009, CANC SCI, V9999; Lai JC, 2005, INT J CANCER, V117, P974, DOI 10.1002/ijc.21278; Lee JW, 2008, CLIN CANCER RES, V14, P2535, DOI 10.1158/1078-0432.CCR-07-1231; Lee JS, 2006, J SURG ONCOL, V93, P233, DOI 10.1002/jso.20493; Li T, 2009, BIOCHEM BIOPH RES CO, V383, P280, DOI 10.1016/j.bbrc.2009.03.077; Lind GE, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-28; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Lynam-Lennon N, 2009, BIOL REV, V84, P55, DOI 10.1111/j.1469-185X.2008.00061.x; Martinez I, 2008, ONCOGENE, V27, P2575, DOI 10.1038/sj.onc.1210919; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; Paranjape T, 2009, GUT, V58, P1546, DOI 10.1136/gut.2009.179531; Pereira PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011780; Reshmi G, 2008, FEBS LETT, V582, P4113, DOI 10.1016/j.febslet.2008.11.011; Saitoh T, 2002, INT J MOL MED, V9, P515; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Singh P, 2009, ONCOGENE, V28, P3758, DOI 10.1038/onc.2009.239; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang CJ, 2009, DIS MARKERS, V26, P27, DOI [10.3233/DMA-2009-0601, 10.1155/2009/921907]; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; Wang Y, 2009, J CELL MOL MED, V13, P12, DOI 10.1111/j.1582-4934.2008.00510.x; Wei N, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-70; Xi LF, 2003, INT J CANCER, V103, P803, DOI 10.1002/ijc.10876; Xia HHX, 2001, AM J GASTROENTEROL, V96, P16, DOI 10.1111/j.1572-0241.2001.03447.x; Yang ZZ, 2009, IUBMB LIFE, V61, P1075, DOI 10.1002/iub.252; Yao Q, 2009, BIOCHEM BIOPH RES CO, V388, P539, DOI 10.1016/j.bbrc.2009.08.044; Zhang ZM, 2007, CANCER LETT, V247, P318, DOI 10.1016/j.canlet.2006.05.013; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	52	85	94	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28423	10.1371/journal.pone.0028423	http://dx.doi.org/10.1371/journal.pone.0028423			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194833	Green Submitted, gold, Green Published			2022-12-25	WOS:000298369100036
J	Sammicheli, S; Linh, DVP; Ruffin, N; Hong, TP; Lantto, R; Vivar, N; Chiodi, F; Rethi, B				Sammicheli, Stefano; Linh Dang Vu Phuong; Ruffin, Nicolas; Thang Pham Hong; Lantto, Rebecka; Vivar, Nancy; Chiodi, Francesca; Rethi, Bence			IL-7 Promotes CD95-Induced Apoptosis in B Cells via the IFN-gamma/STAT1 Pathway	PLOS ONE			English	Article							T-CELLS; HIV-1 INFECTION; UP-REGULATION; FAS ANTIGEN; RECEPTOR EXPRESSION; POTENTIAL ROLE; SERUM-LEVELS; IFN-GAMMA; IN-VIVO; INTERLEUKIN-7	Interleukin-7 (IL-7) concentrations are increased in the blood of CD4+ T cell depleted individuals, including HIV-1 infected patients. High IL-7 levels might stimulate T cell activation and, as we have shown earlier, IL-7 can prime resting T cell to CD95 induced apoptosis as well. HIV-1 infection leads to B cell abnormalities including increased apoptosis via the CD95 (Fas) death receptor pathway and loss of memory B cells. Peripheral B cells are not sensitive for IL-7, due to the lack of IL-7Ra expression on their surface; however, here we demonstrate that high IL-7 concentration can prime resting B cells to CD95-mediated apoptosis via an indirect mechanism. T cells cultured with IL-7 induced high CD95 expression on resting B cells together with an increased sensitivity to CD95 mediated apoptosis. As the mediator molecule responsible for B cell priming to CD95 mediated apoptosis we identified the cytokine IFN-gamma that T cells secreted in high amounts in response to IL-7. These results suggest that the lymphopenia induced cytokine IL-7 can contribute to the increased B cell apoptosis observed in HIV-1 infected individuals.	[Sammicheli, Stefano; Linh Dang Vu Phuong; Ruffin, Nicolas; Thang Pham Hong; Lantto, Rebecka; Vivar, Nancy; Chiodi, Francesca; Rethi, Bence] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden	Karolinska Institutet	Sammicheli, S (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	Bence.Rethi@ki.se	Rethi, Bence/C-5770-2013	Rethi, Bence/0000-0001-8220-5015; Chiodi, Francesca/0000-0002-1385-8343; Ruffin, Nicolas/0000-0002-3698-5505	Swedish Medical Research Council; Swedish International Development Agency; European Union Europrise Network of Excellence; Marie Curie 'Early Stage Research Training' fellowship	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish International Development Agency; European Union Europrise Network of Excellence; Marie Curie 'Early Stage Research Training' fellowship(European Commission)	The study received support from the Swedish Medical Research Council, the Swedish International Development Agency and the Fp6 European Union Europrise Network of Excellence. BR is supported by the Swedish Medical Research Council and SS received a Marie Curie 'Early Stage Research Training' fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baran-Marszak F, 2004, BLOOD, V104, P2475, DOI 10.1182/blood-2003-10-3508; Baumler CB, 1996, BLOOD, V88, P1741; Bolotin E, 1999, BONE MARROW TRANSPL, V23, P783, DOI 10.1038/sj.bmt.1701655; Borger P, 1996, J IMMUNOL, V156, P1333; Borghesi LA, 1999, BLOOD, V93, P140, DOI 10.1182/blood.V93.1.140.401k40_140_148; Boudet F, 1996, J IMMUNOL, V156, P2282; Chahroudi A, 2010, EUR CYTOKINE NETW, V21, P202, DOI 10.1684/ecn.2010.0205; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; De Milito A, 2001, AIDS, V15, P957, DOI 10.1097/00002030-200105250-00003; Defrance T, 2002, ADV CANCER RES, V86, P195, DOI 10.1016/S0065-230X(02)86006-7; Dockrell DH, 1998, J CLIN INVEST, V101, P2394, DOI 10.1172/JCI1171; Fluur C, 2007, J IMMUNOL, V178, P5340, DOI 10.4049/jimmunol.178.8.5340; Fry TJ, 2001, BLOOD, V97, P2983, DOI 10.1182/blood.V97.10.2983; Fry TJ, 2001, TRENDS IMMUNOL, V22, P564, DOI 10.1016/S1471-4906(01)02028-2; Gougeon ML, 1996, J IMMUNOL, V156, P3509; Gougeon ML, 2003, NAT REV IMMUNOL, V3, P392, DOI 10.1038/nri1087; Grelli S, 2000, AIDS, V14, P939, DOI 10.1097/00002030-200005260-00005; KATSIKIS PD, 1995, J EXP MED, V181, P2029, DOI 10.1084/jem.181.6.2029; KIMURA K, 1991, J IMMUNOL, V146, P2618; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Krupica T, 2006, CLIN IMMUNOL, V120, P121, DOI 10.1016/j.clim.2006.04.569; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; Levy Y, 2009, J CLIN INVEST, V119, P997, DOI 10.1172/JCI38052; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Mackall CL, 2011, NAT REV IMMUNOL, V11, P330, DOI 10.1038/nri2970; Malaspina A, 2006, P NATL ACAD SCI USA, V103, P2262, DOI 10.1073/pnas.0511094103; Malaspina A, 2007, BLOOD, V109, P2086, DOI 10.1182/blood-2006-06-031385; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; MERTSCHING E, 1995, INT IMMUNOL, V7, P401, DOI 10.1093/intimm/7.3.401; Moir S, 2001, P NATL ACAD SCI USA, V98, P10362, DOI 10.1073/pnas.181347898; Moir S, 2004, J EXP MED, V200, P587, DOI 10.1084/jem.20032236; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Munitic I, 2004, BLOOD, V104, P4165, DOI 10.1182/blood-2004-06-2484; Napolitano LA, 2001, NAT MED, V7, P73, DOI 10.1038/83381; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; Reich NC, 2007, CYTOKINE GROWTH F R, V18, P511, DOI 10.1016/j.cytogfr.2007.06.021; Rethi B, 2008, BLOOD, V112, P1195, DOI 10.1182/blood-2007-12-126698; Rethia B, 2009, AIDS, V23, P745, DOI 10.1097/QAD.0b013e3283298572; ROECKLEIN BA, 1995, BLOOD, V85, P997, DOI 10.1182/blood.V85.4.997.bloodjournal854997; Sawa Y, 2009, IMMUNITY, V30, P447, DOI 10.1016/j.immuni.2009.01.007; Sereti I, 2009, BLOOD, V113, P6304, DOI 10.1182/blood-2008-10-186601; Silvestris F, 1996, AIDS, V10, P131, DOI 10.1097/00002030-199602000-00002; Sloand EM, 1997, BLOOD, V89, P1357, DOI 10.1182/blood.V89.4.1357; Spets H, 1998, BLOOD, V92, P2914, DOI 10.1182/blood.V92.8.2914.420k14_2914_2923; Sportes C, 2008, J EXP MED, V205, P1701, DOI 10.1084/jem.20071681; Sportes C, 2010, CLIN CANCER RES, V16, P727, DOI 10.1158/1078-0432.CCR-09-1303; Thang PH, 2010, J INTERN MED, V268, P181, DOI 10.1111/j.1365-2796.2010.02241.x; Titanji K, 2005, AIDS, V19, P1947, DOI 10.1097/01.aids.0000191231.54170.89; Titanji K, 2006, BLOOD, V108, P1580, DOI 10.1182/blood-2005-11-013383; Watanabe M, 1999, IMMUNOL RES, V20, P251, DOI 10.1007/BF02790408; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Williams IR, 1997, J IMMUNOL, V159, P3044; Xu XL, 1998, CANCER RES, V58, P2832; Zeng M, 2011, J CLIN INVEST, V121, P998, DOI 10.1172/JCI45157	54	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28629	10.1371/journal.pone.0028629	http://dx.doi.org/10.1371/journal.pone.0028629			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194871	Green Submitted, gold, Green Published			2022-12-25	WOS:000298369100068
J	Wessels, JM; Edwards, AK; Zettler, C; Tayade, C				Wessels, Jocelyn M.; Edwards, Andrew K.; Zettler, Candace; Tayade, Chandrakant			Selection and Validation of Reference Genes for miRNA Expression Studies during Porcine Pregnancy	PLOS ONE			English	Article							QUANTITATIVE RT-PCR; RELATIVE QUANTIFICATION; RNA EXPRESSION; MICRORNAS; NORMALIZATION; IDENTIFICATION; PROFILES; IDENTIFY; TARGETS; CANCER	MicroRNAs comprise a family of small non-coding RNAs that modulate several developmental and physiological processes including pregnancy. Their ubiquitous presence is confirmed in mammals, worms, flies and plants. Although rapid advances have been made in microRNA research, information on stable reference genes for validation of microRNA expression is still lacking. Real time PCR is a widely used tool to quantify gene transcripts. An appropriate reference gene must be chosen to minimize experimental error in this system. A small difference in miRNA levels between experimental samples can be biologically meaningful as these entities can affect multiple targets in a pathway. This study examined the suitability of six commercially available reference genes (RNU1A, RNU5A, RNU6B, SNORD25, SCARNA17, and SNORA73A) in maternal-fetal tissues from healthy and spontaneously arresting/dying conceptuses from sows were separately analyzed at gestation day 20. Comparisons were also made with non-pregnant endometrial tissues from sows. Spontaneous fetal loss is a prime concern to the commercial pork industry. Our laboratory has previously identified deficits in vasculature development at maternal-fetal interface as one of the major participating causes of fetal loss. Using this well-established model, we have extended our studies to identify suitable microRNA reference genes. A methodical approach to assessing suitability was adopted using standard curve and melting curve analysis, PCR product sequencing, real time PCR expression in a panel of gestational tissues, and geNorm and NormFinder analysis. Our quantitative real time PCR analysis confirmed expression of all 6 reference genes in maternal and fetal tissues. All genes were uniformly expressed in tissues from healthy and spontaneously arresting conceptus attachment sites. Comparisons between tissue types (maternal/fetal/non-pregnant) revealed significant differences for RNU5A, RNU6B, SCARNA17, and SNORA73A expression. Based on our methodical assessment of all 6 reference genes, results suggest that RNU1A is the most stable reference gene for porcine pregnancy studies.	[Wessels, Jocelyn M.; Zettler, Candace; Tayade, Chandrakant] Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada; [Edwards, Andrew K.; Tayade, Chandrakant] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada	University of Guelph; Queens University - Canada	Wessels, JM (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada.	tayadec@queensu.ca			Ontario Pork; Natural Sciences and Engineering Research Council of Canada; Agriculture and Agri-Food Canada; Ontario Ministry of Agriculture Food and Rural Affairs; Bioniche Life Sciences Inc., Belleville, Ontario, Canada	Ontario Pork; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada); Ontario Ministry of Agriculture Food and Rural Affairs; Bioniche Life Sciences Inc., Belleville, Ontario, Canada	This research was supported by funding from Ontario Pork, Natural Sciences and Engineering Research Council of Canada, Agriculture and Agri-Food Canada, Ontario Ministry of Agriculture Food and Rural Affairs, and Bioniche Life Sciences Inc., Belleville, Ontario, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaoglu FY, 2011, TUMOR BIOL, V32, P583, DOI 10.1007/s13277-011-0154-9; Alevizos I, 2011, ARTHRITIS RHEUM-US, V63, P535, DOI 10.1002/art.30131; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chang KH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-173; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Choong ML, 2007, EXP HEMATOL, V35, P551, DOI 10.1016/j.exphem.2006.12.002; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Engels BM, 2006, ONCOGENE, V25, P6163, DOI 10.1038/sj.onc.1209909; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gee HE, 2011, BRIT J CANCER, V104, P1168, DOI 10.1038/sj.bjc.6606076; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Kuijk EW, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-58; Kulcheski FR, 2010, ANAL BIOCHEM, V406, P185, DOI 10.1016/j.ab.2010.07.020; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Latham GJ, 2010, METHODS MOL BIOL, V667, P19, DOI 10.1007/978-1-60761-811-9_2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mahn R, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2011.01.020; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Nygard AB, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-67; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Pope WF, 1994, EMBRYONIC MORTALITY, P53; *QIAGEN, 2011, HIGHL SPEC PCR PROD; Tayade C, 2006, J IMMUNOL, V176, P148, DOI 10.4049/jimmunol.176.1.148; Tayade C, 2007, J LEUKOCYTE BIOL, V82, P877, DOI 10.1189/jlb.0507330; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wessels JM, 2011, IMMUNOL CELL BIOL, V89, P304, DOI 10.1038/icb.2010.95; Wotschofsky Z, 2011, ANAL BIOCHEM, V417, P233, DOI 10.1016/j.ab.2011.06.009; ZHU HT, 2011, MOL BIOTECHNOL	36	14	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28940	10.1371/journal.pone.0028940	http://dx.doi.org/10.1371/journal.pone.0028940			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174931	Green Published, Green Submitted, gold			2022-12-25	WOS:000298366600050
J	Gomez-Lopez, N; Vadillo-Ortega, F; Estrada-Gutierrez, G				Gomez-Lopez, Nardhy; Vadillo-Ortega, Felipe; Estrada-Gutierrez, Guadalupe			Combined Boyden-Flow Cytometry Assay Improves Quantification and Provides Phenotypification of Leukocyte Chemotaxis	PLOS ONE			English	Article							HUMAN POLYMORPHONUCLEAR LEUKOCYTES; HUMAN NEUTROPHIL; MIGRATION; CELL; LOCOMOTION; MONOCYTES; RESPONSIVENESS; MOTILITY; AGAROSE; CAP37	Chemotaxis has been studied by classical methods that measure chemotactic and random motility responses in vitro, but these methods do not evaluate the total number and phenotype of migrating leukocytes simultaneously. Our objective was to develop and validate a novel assay, combined Boyden-flow cytometry chemotaxis assay (CBFCA), for simultaneous quantification and phenotypification of migrating leukocytes. CBFCA exhibited several important advantages in comparison to the classic Boyden chemotaxis assay (CBCA): 1) improved precision (intra-assay coefficients of variation (CVs): CBFCA-4.7 and 4.8% vs. CBCA-30.1 and 17.3%; inter-observer CVs: CBFCA-3.6% vs. CBCA 30.1%); 2) increased recovery of cells, which increased assay to provide increased sensitivity; 3) high specificity for determining the phenotype of migrating/attracted leukocytes; and 4) reduced performance time (CBFCA 120 min vs. CBCA 265 min). Other advantages of CBFCA are: 5) robustness, 6) linearity, 7) eliminated requirement for albumin and, importantly, 8) enabled recovery of migrating leukocytes for subsequent studies. This latter feature is of great benefit in the study of migrating leukocyte subsets. We conclude that the CBFCA is a novel and improved technique for experiments focused on understanding leukocyte trafficking during the inflammatory response.	[Gomez-Lopez, Nardhy] Inst Nacl Perinatol Isidro Espinosa de los Reyes, Res Direct, Mexico City, DF, Mexico; [Gomez-Lopez, Nardhy] Univ Alberta, Dept Obstet & Gynecol, Edmonton, AB, Canada; [Gomez-Lopez, Nardhy] Univ Adelaide, Discipline Obstet & Gynaecol, Adelaide, SA, Australia; [Vadillo-Ortega, Felipe] Univ Nacl Autonoma Mexico, Fac Med, Dept Biochem, Mexico City 04510, DF, Mexico; [Estrada-Gutierrez, Guadalupe] Inst Nacl Perinatol Isidro Espinosa de los Reyes, Dept Infectol, Mexico City, DF, Mexico	University of Alberta; University of Adelaide; Universidad Nacional Autonoma de Mexico	Gomez-Lopez, N (corresponding author), Inst Nacl Perinatol Isidro Espinosa de los Reyes, Res Direct, Mexico City, DF, Mexico.	nardhy.gomez-lopez@adelaide.edu.au; gpestrad@gmail.com	Gomez-Lopez, Nardhy/R-7664-2016; Estrada, Guadalupe/AAT-3970-2021; Estrada-Gutierrez, Guadalupe/AAM-4642-2021; Vadillo-Ortega, Felipe/I-5273-2017	Gomez-Lopez, Nardhy/0000-0002-3406-5262; Estrada-Gutierrez, Guadalupe/0000-0001-9551-9021; Vadillo-Ortega, Felipe/0000-0001-7137-4200	Molly Towell Perinatal Research Foundation; CONACyT - SALUD [7036, 69353]	Molly Towell Perinatal Research Foundation; CONACyT - SALUD(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	NG-L is sponsored by the Molly Towell Perinatal Research Foundation. FV-O was supported by CONACyT - SALUD 7036 and 69353. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOXER LA, 1979, J LAB CLIN MED, V93, P506; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; Constantin G, 2010, NAT IMMUNOL, V11, P463, DOI 10.1038/ni0610-463; CUTLER JE, 1974, P SOC EXP BIOL MED, V147, P471; Dunzendorfer S, 2000, IMMUNOL LETT, V71, P5, DOI 10.1016/S0165-2478(99)00161-3; Ellingsen T, 2000, SCAND J IMMUNOL, V52, P257; FALK W, 1980, INFECT IMMUN, V29, P953; FALK W, 1980, J IMMUNOL METHODS, V33, P239, DOI 10.1016/S0022-1759(80)80014-7; GEE AP, 1984, MOL CELL BIOCHEM, V62, P5; HARVATH L, 1983, SURV IMMUNOL RES, V2, P145; KELLER H U, 1972, Journal of Immunological Methods, V1, P165, DOI 10.1016/0022-1759(72)90043-9; Koedel U, 1999, J IMMUNOL, V163, P1237; KRETSCHMER R, 1985, PARASITE IMMUNOL, V7, P527, DOI 10.1111/j.1365-3024.1985.tb00097.x; KRETSCHMER RR, 1976, J IMMUNOL, V117, P1303; Kushner EJ, 2010, J APPL PHYSIOL, V109, P1756, DOI 10.1152/japplphysiol.00601.2010; LAUFFENBURGER D, 1983, J IMMUNOL, V131, P940; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; MARTIN LS, 1988, J LEUKOCYTE BIOL, V44, P361, DOI 10.1002/jlb.44.5.361; NELSON RD, 1975, J IMMUNOL, V115, P1650; Patel MK, 2005, BRIT J PHARMACOL, V145, P811, DOI 10.1038/sj.bjp.0706237; PEREIRA HA, 1990, J CLIN INVEST, V85, P1468, DOI 10.1172/JCI114593; Pereira HA, 2004, INVEST OPHTH VIS SCI, V45, P4284, DOI 10.1167/iovs.03-1052; Rudack C, 2004, CLIN EXP IMMUNOL, V135, P511, DOI 10.1111/j.1365-2249.2003.02390.x; Sato E, 1999, AM J PHYSIOL-LUNG C, V277, pL1149, DOI 10.1152/ajplung.1999.277.6.L1149; SCHREINER A, 1978, ACTA PATH MICRO IM C, V86, P117; SHI YF, 1993, J IMMUNOL METHODS, V164, P149, DOI 10.1016/0022-1759(93)90307-S; SNYDERMAN R, 1972, J IMMUNOL, V108, P857; SORG C, 1982, IMMUNOBIOLOGY, V162, P192, DOI 10.1016/S0171-2985(11)80030-6; WIERUSZWYSOCKA B, 1983, ARTIF ORGANS, V7, P159, DOI 10.1111/j.1525-1594.1983.tb04181.x; Wilkinson P. C., 1996, Methods (Orlando), V10, P74, DOI 10.1006/meth.1996.0081; WILKINSON PC, 1988, METHOD ENZYMOL, V162, P38; ZIGMOND SH, 1973, J EXP MED, V137, P387, DOI 10.1084/jem.137.2.387	32	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28771	10.1371/journal.pone.0028771	http://dx.doi.org/10.1371/journal.pone.0028771			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174892	Green Submitted, Green Published, gold			2022-12-25	WOS:000298365700071
J	Holtz, LR; Bauer, IK; Rajendran, P; Kang, G; Wang, D				Holtz, Lori R.; Bauer, Irma K.; Rajendran, Priya; Kang, Gagandeep; Wang, David			Astrovirus MLB1 Is Not Associated with Diarrhea in a Cohort of Indian Children	PLOS ONE			English	Article							BIRTH COHORT; GASTROENTERITIS; ROTAVIRUS; DISEASE; VOLUNTEERS; INFECTION; ETIOLOGY; ILLNESS; SLUM	Astroviruses are a known cause of human diarrhea. Recently the highly divergent astrovirus MLB1 (MLB1) was identified in a stool sample from a patient with diarrhea. It has subsequently been detected in stool from individuals with and without diarrhea. To determine whether MLB1 is associated with diarrhea, we conducted a case control study of MLB1. In parallel, the prevalence of the classic human astroviruses (HAstVs) was also determined in the same case control cohort. 400 cases and 400 paired controls from a longitudinal birth cohort in Vellore, India were analyzed by RT-PCR. While HAstVs were associated with diarrhea (p = 0.029) in this cohort, MLB1 was not; 14 of the controls and 4 cases were positive for MLB1. Furthermore, MLB1 viral load did not differ significantly between the cases and controls. The role of MLB1 in human health still remains unknown and future studies are needed.	[Holtz, Lori R.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Bauer, Irma K.; Wang, David] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Bauer, Irma K.; Wang, David] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Rajendran, Priya; Kang, Gagandeep] Christian Med Coll & Hosp, Dept Gastrointestinal Sci, Vellore, Tamil Nadu, India	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Christian Medical College & Hospital (CMCH) Vellore	Holtz, LR (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.	davewang@borcim.wustl.edu	Holtz, Lori/AAA-4296-2020	Kang, Gagandeep/0000-0002-3656-564X; Holtz, Lori/0000-0002-5591-7794	National Institutes of Health (NIH)/National Center for Research Resources Washington University-ICTS [KL2 RR024994]; NIH [R21 AI090199]; Burroughs Wellcome Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI090199] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Center for Research Resources Washington University-ICTS; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health (NIH)/National Center for Research Resources Washington University-ICTS grant number KL2 RR024994 and by NIH grant R21 AI090199. DW holds an Investigators in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED S, NOVEL ASTRO IN PRESS; Ajjampur SSR, 2008, J MED MICROBIOL, V57, P1364, DOI 10.1099/jmm.0.2008/003319-0; Albert MJ, 1999, J CLIN MICROBIOL, V37, P3458, DOI 10.1128/JCM.37.11.3458-3464.1999; Atmar RL, 2008, EMERG INFECT DIS, V14, P1553, DOI 10.3201/eid1410.080117; Banyai K, 2010, EMERG INFECT DIS, V16, P169, DOI [10.3201/eid1601.091120, 10.3201/eid1601.091563]; Bodhidatta L, 2010, AM J TROP MED HYG, V83, P1106, DOI 10.4269/ajtmh.2010.10-0367; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Ken BTT, 2007, J MED MICROBIOL, V56, P1086, DOI 10.1099/jmm.0.47093-0; Chu DKW, 2010, J GEN VIROL, V91, P2457, DOI 10.1099/vir.0.022764-0; Dennehy PH, 2001, J INFECT DIS, V184, P10, DOI 10.1086/321007; DM Knipe, 2007, FIELDS VIROLOGY, P981; Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011; Finkbeiner SR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-161; Finkbeiner SR, 2009, J VIROL, V83, P10836, DOI 10.1128/JVI.00998-09; Finkbeiner SR, 2009, EMERG INFECT DIS, V15, P441, DOI 10.3201/eid1503.081213; Gladstone BP, 2008, ARCH DIS CHILD, V93, P479, DOI 10.1136/adc.2006.114546; Gladstone BP, 2011, NEW ENGL J MED, V365, P337, DOI 10.1056/NEJMoa1006261; Gladstone BP, 2010, J TROP PEDIATRICS, V56, P221, DOI 10.1093/tropej/fmp116; Glass RI, 1996, ARCH VIROL, P287; HOLTZ LR, 2011, EMERGING INFECT DIS; KAPIKIAN AZ, 1983, J INFECT DIS, V147, P95, DOI 10.1093/infdis/147.1.95; Kapoor A, 2009, J GEN VIROL, V90, P2965, DOI 10.1099/vir.0.014449-0; Klein EJ, 2006, CLIN INFECT DIS, V43, P807, DOI 10.1086/507335; MADELEY CR, 1975, LANCET, V2, P451; MIDTHUN K, 1993, J CLIN MICROBIOL, V31, P955, DOI 10.1128/JCM.31.4.955-962.1993; Nguyen TA, 2008, J MED VIROL, V80, P298, DOI 10.1002/jmv.21032; NOEL JS, 1995, J CLIN MICROBIOL, V33, P797, DOI 10.1128/JCM.33.4.797-801.1995; Phillips G, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-63; Quan PL, 2010, EMERG INFECT DIS, V16, P918, DOI 10.3201/eid1606.091536; RUUSKA T, 1990, SCAND J INFECT DIS, V22, P259, DOI 10.3109/00365549009027046; Soares CC, 2008, J MED VIROL, V80, P113, DOI 10.1002/jmv.21053; THORNHILL TS, 1975, J INFECT DIS, V132, P28, DOI 10.1093/infdis/132.1.28	32	43	44	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28647	10.1371/journal.pone.0028647	http://dx.doi.org/10.1371/journal.pone.0028647			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174853	Green Published, gold			2022-12-25	WOS:000298365700054
J	Pask, GM; Jones, PL; Rutzler, M; Rinker, DC; Zwiebel, LJ				Pask, Gregory M.; Jones, Patrick L.; Ruetzler, Michael; Rinker, David C.; Zwiebel, Laurence J.			Heteromeric Anopheline Odorant Receptors Exhibit Distinct Channel Properties	PLOS ONE			English	Article							MOLECULAR-BASIS; BEHAVIOR	Background: Insect odorant receptors (ORs) function as odorant-gated ion channels consisting of a conventional, odorant-binding OR and the Orco coreceptor. While Orco can function as a homomeric ion channel, the role(s) of the conventional OR in heteromeric OR complexes has largely focused only on odorant recognition. Results: To investigate other roles of odorant-binding ORs, we have employed patch clamp electrophysiology to investigate the properties of the channel pore of several OR complexes formed by a range of different odorant-specific Anopheles gambiae ORs (AgOrs) each paired with AgOrco. These studies reveal significant differences in cation permeability and ruthenium red susceptibility among different AgOr complexes. Conclusions: With observable differences in channel function, the data support a model in which the odorant-binding OR also affects the channel pore. The variable effect contributed by the conventional OR on the conductive properties of odorant-gated sensory channels adds additional complexity to insect olfactory signaling, with differences in odor coding beginning with ORs on the periphery of the olfactory system.	[Pask, Gregory M.; Jones, Patrick L.; Ruetzler, Michael; Zwiebel, Laurence J.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37203 USA; [Ruetzler, Michael] Univ Aarhus, Inst Anat, Water & Salt Res Ctr, Aarhus C, Denmark; [Rinker, David C.] Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Nashville, TN USA; [Zwiebel, Laurence J.] Vanderbilt Univ, Med Ctr, Inst Biol Chem, Ctr Mol Neurosci,Dept Pharmacol, Nashville, TN USA; [Zwiebel, Laurence J.] Vanderbilt Univ, Med Ctr, Inst Biol Chem, Ctr Human Genet Res,Dept Pharmacol, Nashville, TN USA; [Zwiebel, Laurence J.] Vanderbilt Univ, Med Ctr, Inst Global Hlth, Nashville, TN USA; [Zwiebel, Laurence J.] Vanderbilt Univ, Med Ctr, Program Dev Biol, Nashville, TN USA	Vanderbilt University; Aarhus University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Pask, GM (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37203 USA.	l.zwiebel@vanderbilt.edu	Rutzler, Michael/ABE-7914-2020	Rutzler, Michael/0000-0001-5597-8880; Zwiebel, Laurence/0000-0001-6686-7289	Foundation for the National Institutes of Health (NIH) through the Grand Challenges in Global Health Initiative; NIH [AI056402]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080178] Funding Source: NIH RePORTER	Foundation for the National Institutes of Health (NIH) through the Grand Challenges in Global Health Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the Foundation for the National Institutes of Health (NIH) through the Grand Challenges in Global Health Initiative and the NIH (AI056402) to LJZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bohbot JD, 2011, CHEM SENSES, V36, P149, DOI 10.1093/chemse/bjq105; Bonigk W, 1999, J NEUROSCI, V19, P5332; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Cheng W, 2007, J GEN PHYSIOL, V129, P191, DOI 10.1085/jgp.200709731; Cibulsky SM, 1999, J PHARMACOL EXP THER, V289, P1447; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; EISENMAN G, 1987, ANNU REV BIOPHYS BIO, V16, P205; EISENMAN G, 1962, Biophys J, V2, P259; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Kaissling K.-E, 1995, EXPT CELL BIOL TASTE, P361; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; LEE CO, 1974, BIOPHYS J, V14, P46, DOI 10.1016/S0006-3495(74)85902-3; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Nichols AS, 2011, CHEM SENSES, V36, P781, DOI 10.1093/chemse/bjr053; Pelletier J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010090; Pitts RJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-271; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Su CY, 2011, P NATL ACAD SCI USA, V108, P5075, DOI 10.1073/pnas.1100369108; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Voets T, 2002, J BIOL CHEM, V277, P33704, DOI 10.1074/jbc.M204828200; Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Xia YF, 2008, P NATL ACAD SCI USA, V105, P6433, DOI 10.1073/pnas.0801007105; ZUFALL F, 1991, J NEUROSCI, V11, P956	28	56	60	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28774	10.1371/journal.pone.0028774	http://dx.doi.org/10.1371/journal.pone.0028774			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174894	Green Published, gold, Green Submitted			2022-12-25	WOS:000298365700072
J	Sun, X; Chen, XJ; Feng, J; Zhao, JY; Li, YZ				Sun, Xia; Chen, Xiao-jing; Feng, Jing; Zhao, Jing-yi; Li, Yue-zhong			Characterization of the Partitioning System of Myxococcus Plasmid pMF1	PLOS ONE			English	Article							PARB PROTEIN; F-PLASMID; P1; SEGREGATION; COMPLEX; BINDING; REGION; GENE; TRANSCRIPTION; STABILITY	pMF1 is the only autonomously replicating plasmid that has been recently identified in myxobacteria. This study characterized the partitioning (par) system of this plasmid. The fragment that significantly increased the retaining stability of plasmids in Myxococcus cells in the absence of selective antibiotics contained three open reading frames (ORFs) pMF1.21-pMF1.23 (parCAB). The pMF1.22 ORF (parA) is homologous to members of the parA ATPase family, with the highest similarity (56%) to the Sphingobium japonicum ParA-like protein, while the other two ORFs had no homologs in GenBank. DNase I footprinting and electrophoretic mobility shift assays showed that the pMF1.23 (parB) product is a DNA-binding protein of iteron DNA sequences, while the product of pMF1.21 (parC) has no binding activity but is able to enhance the DNA-binding activity of ParB to iterons. The ParB protein autogenously repressed the expression of the par genes, consistent with the type Ib par pattern, while the ParC protein has less repressive activity. The ParB-binding iteron sequences are distributed not only near the partitioning gene loci but also along pMF1. These results indicate that the pMF1 par system has novel structural and functional characteristics.	[Sun, Xia; Chen, Xiao-jing; Feng, Jing; Zhao, Jing-yi; Li, Yue-zhong] Shandong Univ, Sch Life Sci, State Key Lab Microbial Technol, Jinan 250100, Peoples R China	Shandong University	Sun, X (corresponding author), Shandong Univ, Sch Life Sci, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	lilab@sdu.edu.cn	Li, Yuezhong/ACN-5179-2022	Li, Yuezhong/0000-0001-8336-6638	National Science Foundation for Distinguished Young Scholars [30825001]; National Natural Science Foundation of China [30971572]	National Science Foundation for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Science Foundation for Distinguished Young Scholars (grant 30825001) and the National Natural Science Foundation (grant 30971572) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bode HB, 2006, J BACTERIOL, V188, P6524, DOI 10.1128/JB.00825-06; Bouet JY, 1999, EMBO J, V18, P1415, DOI 10.1093/emboj/18.5.1415; DAM M, 1994, J MOL BIOL, V236, P1289, DOI 10.1016/0022-2836(94)90058-2; DAVIS MA, 1988, EMBO J, V7, P1881, DOI 10.1002/j.1460-2075.1988.tb03021.x; de la Hoz AB, 2000, P NATL ACAD SCI USA, V97, P728, DOI 10.1073/pnas.97.2.728; Dmowski M, 2006, J BACTERIOL, V188, P4362, DOI 10.1128/JB.01922-05; Dolowy P, 2005, PLASMID, V53, P239, DOI 10.1016/j.plasmid.2004.11.005; Ebersbach G, 2005, ANNU REV GENET, V39, P453, DOI 10.1146/annurev.genet.38.072902.091252; Ebersbach G, 2001, P NATL ACAD SCI USA, V98, P15078, DOI 10.1073/pnas.261569598; Edgar R, 2001, MOL MICROBIOL, V42, P1363, DOI 10.1046/j.1365-2958.2001.02717.x; FRIEDMAN SA, 1988, PLASMID, V19, P103, DOI 10.1016/0147-619X(88)90049-2; FUNNELL BE, 1993, J BIOL CHEM, V268, P3616; FUNNELL BE, 1991, J BIOL CHEM, V266, P14328; HAYES F, 1994, MOL MICROBIOL, V11, P249, DOI 10.1111/j.1365-2958.1994.tb00305.x; Hayes F, 2000, MOL MICROBIOL, V37, P528, DOI 10.1046/j.1365-2958.2000.02030.x; Jensen RB, 1997, J MOL BIOL, V269, P505, DOI 10.1006/jmbi.1997.1061; JENSEN RB, 1994, J MOL BIOL, V236, P1299, DOI 10.1016/0022-2836(94)90059-0; KAISER D, 1979, P NATL ACAD SCI USA, V76, P5952, DOI 10.1073/pnas.76.11.5952; Kalnin K, 2000, J BACTERIOL, V182, P1889, DOI 10.1128/JB.182.7.1889-1894.2000; KASHEFI K, 1995, MOL MICROBIOL, V15, P483, DOI 10.1111/j.1365-2958.1995.tb02262.x; KOONIN EV, 1993, J MOL BIOL, V229, P1165, DOI 10.1006/jmbi.1993.1115; Kwong SM, 2001, MOL MICROBIOL, V40, P621, DOI 10.1046/j.1365-2958.2001.02405.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larsen RA, 2007, GENE DEV, V21, P1340, DOI 10.1101/gad.1546107; Lukaszewicz M, 2002, NUCLEIC ACIDS RES, V30, P1046, DOI 10.1093/nar/30.4.1046; Misselwitz R, 2001, FEBS LETT, V505, P436, DOI 10.1016/S0014-5793(01)02865-4; Moller-Jensen J, 2000, TRENDS MICROBIOL, V8, P313, DOI 10.1016/S0966-842X(00)01787-X; MORI H, 1989, J BIOL CHEM, V264, P15535; MOTALLEBIVESHAREH M, 1990, MOL MICROBIOL, V4, P1455, DOI 10.1111/j.1365-2958.1990.tb02056.x; MOTALLEBIVESHAREH M, 1992, MOL MICROBIOL, V6, P907, DOI 10.1111/j.1365-2958.1992.tb01541.x; OGURA T, 1983, CELL, V32, P351, DOI 10.1016/0092-8674(83)90454-3; PANSEGRAU W, 1994, J MOL BIOL, V239, P623, DOI 10.1006/jmbi.1994.1404; Ravin N, 1999, J BACTERIOL, V181, P6898, DOI 10.1128/JB.181.22.6898-6906.1999; REICHENBACH H, 1993, BIOTECHNOL ADV, V11, P219, DOI 10.1016/0734-9750(93)90042-L; Sambrook J, 2001, MOL CLONING LAB MANU; SHIMKETS LJ, 1990, MICROBIOL REV, V54, P473, DOI 10.1128/MMBR.54.4.473-501.1990; Zhao JY, 2008, APPL ENVIRON MICROB, V74, P1980, DOI 10.1128/AEM.02143-07	37	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28122	10.1371/journal.pone.0028122	http://dx.doi.org/10.1371/journal.pone.0028122			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174771	Green Submitted, Green Published, gold			2022-12-25	WOS:000298365700018
J	Taher, L; Collette, NM; Murugesh, D; Maxwell, E; Ovcharenko, I; Loots, GG				Taher, Leila; Collette, Nicole M.; Murugesh, Deepa; Maxwell, Evan; Ovcharenko, Ivan; Loots, Gabriela G.			Global Gene Expression Analysis of Murine Limb Development	PLOS ONE			English	Article							VERTEBRATE LIMB; T-BOX; TBX4; SPECIFICATION; BIOCONDUCTOR; IDENTITY; MODELS; LMX1B	Detailed information about stage-specific changes in gene expression is crucial for understanding the gene regulatory networks underlying development and the various signal transduction pathways contributing to morphogenesis. Here we describe the global gene expression dynamics during early murine limb development, when cartilage, tendons, muscle, joints, vasculature and nerves are specified and the musculoskeletal system of limbs is established. We used whole-genome microarrays to identify genes with differential expression at 5 stages of limb development E9.5 to 13.5), during fore- and hind-limb patterning. We found that the onset of limb formation is characterized by an up-regulation of transcription factors, which is followed by a massive activation of genes during E10.5 and E11.5 which levels off at later time points. Among the 3520 genes identified as significantly up-regulated in the limb, we find similar to 30% to be novel, dramatically expanding the repertoire of candidate genes likely to function in the limb. Hierarchical and stage-specific clustering identified expression profiles that are likely to correlate with functional programs during limb development and further characterization of these transcripts will provide new insights into specific tissue patterning processes. Here, we provide for the first time a comprehensive analysis of developmentally regulated genes during murine limb development, and provide some novel insights into the expression dynamics governing limb morphogenesis.	[Taher, Leila; Ovcharenko, Ivan] Natl Lib Med, Natl Ctr Biotechnol Informat, Computat Biol Branch, Bethesda, MD 20894 USA; [Collette, Nicole M.; Murugesh, Deepa; Loots, Gabriela G.] Lawrence Livermore Natl Lab, Biol & Biotechnol Div, Livermore, CA USA; [Loots, Gabriela G.] Univ Calif Merced, Sch Nat Sci, Merced, CA USA; [Maxwell, Evan] Boston Univ, Bioinformat Program, Boston, MA 02215 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Merced; Boston University	Taher, L (corresponding author), Natl Lib Med, Natl Ctr Biotechnol Informat, Computat Biol Branch, Bethesda, MD 20894 USA.	loots1@llnl.gov	Loots, Gabriela G/AGA-4868-2022	Loots, Gabriela G/0000-0001-9546-5561; Collette, Nicole/0000-0002-9068-8712; Taher, Leila/0000-0002-2013-5426; Murugesh, Deepa/0000-0002-4232-8480	National Institutes of Health [DK075730, HG003963]; National Institutes of Health, National Library of Medicine; U.S. Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075730] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM200881] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); U.S. Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	GGL, NMC and DM were supported by National Institutes of Health grants DK075730 and HG003963. This research was supported in part by the Intramural Research Program of the National Institutes of Health, National Library of Medicine. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Carsten Jacobi and Michaela Kneissel from the Bone and Cartilage Group at Novartis Pharma and Shalini Mabery at LLNL for assistance with generating the microarray data. Special thanks to Jim Kent for giving us permission to use in situ images from Visigene; Nick Fischer for graphic design of Figure 1 and all members of the Loots group who have helped with animal husbandry, embryo isolation and engaged in insightful manuscript discussions. This work performed under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344.	Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Dai JX, 2009, DEV GROWTH DIFFER, V51, P241, DOI 10.1111/j.1440-169X.2008.01083.x; Dreyer SD, 1998, NAT GENET, V19, P47, DOI 10.1038/ng0598-47; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gibson-Brown JJ, 1998, DEVELOPMENT, V125, P2499; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Johnson RL, 1997, CELL, V90, P979, DOI 10.1016/S0092-8674(00)80364-5; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Logan M, 1999, SCIENCE, V283, P1736, DOI 10.1126/science.283.5408.1736; Logan M, 1998, DEVELOPMENT, V125, P2825; Malemud CJ, 2006, FRONT BIOSCI-LANDMRK, V11, P1696, DOI 10.2741/1915; Margulies EH, 2001, GENOME RES, V11, P1686, DOI 10.1101/gr.192601; Mariani FV, 2003, NATURE, V423, P319, DOI 10.1038/nature01655; Martin G, 2001, BIOESSAYS, V23, P865, DOI 10.1002/bies.1126; Naiche LA, 2007, DEVELOPMENT, V134, P93, DOI 10.1242/dev.02712; Ouimette JF, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1036; Phadke SR, 2010, INDIAN J PEDIATR, V77, P277, DOI 10.1007/s12098-010-0033-1; Piette D, 2008, NAT PROTOC, V3, P1194, DOI 10.1038/nprot.2008.103; Qiu Q, 2009, GENESIS, V47, P224, DOI 10.1002/dvg.20430; *R FDN STAT COMP, RDC T R LANG ENV STA; Rodriguez-Esteban C, 1999, NATURE, V398, P814, DOI 10.1038/19769; Schmahl J, 2007, NAT GENET, V39, P52, DOI 10.1038/ng1922; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Towers M, 2009, DEVELOPMENT, V136, P179, DOI 10.1242/dev.024158; Tse E, 2004, MOL CELL BIOL, V24, P2063, DOI 10.1128/MCB.24.5.2063-2073.2004; Tzchori I, 2009, DEVELOPMENT, V136, P1375, DOI 10.1242/dev.026476; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; WANEK N, 1989, J EXP ZOOL, V249, P41, DOI 10.1002/jez.1402490109; Wang Z, 2011, NATURE, V477, P583, DOI 10.1038/nature10391; White KP, 1999, SCIENCE, V286, P2179, DOI 10.1126/science.286.5447.2179; Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605; Wu Y, 2008, DEVELOPMENT, V135, P171, DOI 10.1242/dev.009225; Xu B, 2011, P NATL ACAD SCI USA, V108, P4888, DOI 10.1073/pnas.1018161108	36	56	57	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28358	10.1371/journal.pone.0028358	http://dx.doi.org/10.1371/journal.pone.0028358			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174793	gold, Green Published, Green Submitted			2022-12-25	WOS:000298365700028
J	Camus, S; Quevedo, C; Menendez, S; Paramonov, I; Stouten, PFW; Janssen, RAJ; Rueb, S; He, S; Snaar-Jagalska, BE; Laricchia-Robbio, L; Belmonte, JCI				Camus, S.; Quevedo, C.; Menendez, S.; Paramonov, I.; Stouten, P. F. W.; Janssen, R. A. J.; Rueb, S.; He, S.; Snaar-Jagalska, B. E.; Laricchia-Robbio, L.; Belmonte, J. C. Izpisua			Identification of phosphorylase kinase as a novel therapeutic target through high-throughput screening for anti-angiogenesis compounds in zebrafish	ONCOGENE			English	Article						phosphorylase kinase; PhK; angiogenesis; zebrafish; cancer	ANTIANGIOGENIC COMPOUNDS; CLINICAL RESISTANCE; GENE AMPLIFICATION; CANCER; GROWTH; METHOTREXATE	Angiogenesis is essential for development and tumor progression. With the aim of identifying new compound inhibitors of the angiogenesis process, we used an established enhanced green fluorescent protein-transgenic zebrafish line to develop an automated assay that enables high-throughput screening of compound libraries in a whole-organism setting. Using this system, we have identified novel kinase inhibitor compounds that show anti-angiogenic properties in both zebrafish in-vivo system and in human endothelial cell in-vitro angiogenesis models. Furthermore, we have determined the kinase target of these compounds and have identified and validated a previously uncharacterized involvement of phosphorylase kinase subunit G1 (PhKG1) in angiogenesis in vivo. In addition, we have found that PhKG1 is upregulated in human tumor samples and that aberrations in gene copy number of PhK subunits are a common feature of human tumors. Our results provide a novel insight into the angiogenesis process, as well as identify new potential targets for anti-angiogenic therapies. Oncogene (2012) 31, 4333-4342; doi:10.1038/onc.2011.594; published online 19 December 2011	[Belmonte, J. C. Izpisua] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Camus, S.; Menendez, S.; Paramonov, I.; Laricchia-Robbio, L.; Belmonte, J. C. Izpisua] Ctr Regenerat Med Barcelona, Barcelona, Spain; [Quevedo, C.] Biobide SL, San Sebastian, Spain; [Stouten, P. F. W.] Galapagos NV, Mechelen, Belgium; [Janssen, R. A. J.] Galapagos BV, Leiden, Netherlands; [Rueb, S.; He, S.; Snaar-Jagalska, B. E.] Leiden Univ, Inst Biol, Leiden, Netherlands	Salk Institute; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona; Galapagos NV; Galapagos NV; Leiden University; Leiden University - Excl LUMC	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu		Stouten, Pieter/0000-0002-5203-2202; Menendez, Sergio/0000-0002-7929-8641	European Community [HEALTH-F2-2008-201439]; MICINN; Fundacion Cellex	European Community(European Commission); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Fundacion Cellex(Foundation CELLEX)	We would like to thank Cornel Catana of Galapagos for molecular modeling efforts and acknowledge the support and intellectual contribution of the Scientific Director of Biobide, Carles Callol. This project was financially supported by the European Community under the FP7 ZF-Cancer project (HEALTH-F2-2008-201439), MICINN and Fundacion Cellex.	Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; CARMAN MD, 1984, J CLIN ONCOL, V2, P16, DOI 10.1200/JCO.1984.2.1.16; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Cascante M, 2010, BIOCHEM SOC T, V38, P1302, DOI 10.1042/BST0381302; Edmunds SC, 2002, INVEST OPHTH VIS SCI, V43, P2845; Eilken HM, 2010, CURR OPIN CELL BIOL, V22, P617, DOI 10.1016/j.ceb.2010.08.010; Faucherre A, 2008, ONCOGENE, V27, P1079, DOI 10.1038/sj.onc.1210730; FERGUSON PJ, 1991, J OTOLARYNGOL, V20, P130; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; GOKER E, 1995, BLOOD, V86, P677, DOI 10.1182/blood.V86.2.677.bloodjournal862677; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Graves D, 1999, PHARMACOL THERAPEUT, V82, P143, DOI 10.1016/S0163-7258(98)00049-7; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Kidd KR, 2003, BRIT J PHARMACOL, V140, P585, DOI 10.1038/sj.bjp.0705496; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Lane DP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001222; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Letamendia A, PLOS ONE UNPUB; Liang D, 2001, MECH DEVELOP, V108, P29, DOI 10.1016/S0925-4773(01)00468-3; Lyons MS, 1998, DEV DYNAM, V212, P133, DOI 10.1002/(SICI)1097-0177(199805)212:1<133::AID-AJA12>3.0.CO;2-8; Marshall KE, 2010, DEV DYNAM, V239, P3000, DOI 10.1002/dvdy.22437; Parng C, 2002, ASSAY DRUG DEV TECHN, V1, P41, DOI 10.1089/154065802761001293; Pownall ME, 1996, DEVELOPMENT, V122, P3881; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Tran TC, 2007, CANCER RES, V67, P11386, DOI 10.1158/0008-5472.CAN-07-3126; Vizan P, 2009, CARCINOGENESIS, V30, P946, DOI 10.1093/carcin/bgp083; Wang CY, 2010, EUR UROL, V58, P418, DOI 10.1016/j.eururo.2010.05.024	29	37	40	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2012	31	39					4333	4342		10.1038/onc.2011.594	http://dx.doi.org/10.1038/onc.2011.594			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	016LP	22179836				2022-12-25	WOS:000309520200007
J	van Lummel, M; van Veelen, PA; Zaldumbide, A; de Ru, A; Janssen, GMC; Moustakas, AK; Papadopoulos, GK; Drijfhout, JW; Roep, BO; Koning, F				van Lummel, Menno; van Veelen, Peter A.; Zaldumbide, Arnaud; de Ru, Arnoud; Janssen, George M. C.; Moustakas, Antonis K.; Papadopoulos, George K.; Drijfhout, Jan W.; Roep, Bart O.; Koning, Frits			Type 1 Diabetes-associated HLA-DQ8 Transdimer Accommodates a Unique Peptide Repertoire	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE-ASSOCIATED DQ(ALPHA-1-ASTERISK-0501; T-CELL RESPONSES; HLA-DQ; CELIAC-DISEASE; BINDING CHARACTERISTICS; INSULIN; SUSCEPTIBILITY; GENETICS; EPITOPES; COMPLEX	HLA-DQ2 and HLA-DQ8 are strongly predisposing haplotypes for type 1 diabetes (T1D). Yet HLA-DQ2/8 heterozygous individuals have a synergistically increased risk compared with HLA-DQ2 or HLA-DQ8 homozygote subjects that may result from the presence of a transdimer formed between the alpha-chain of HLA-DQ2 (DQA1*05:01) and the beta-chain of HLA-DQ8 (DQB1*03:02). We generated cells exclusively expressing this transdimer (HLA-DQ8trans), characterized its peptide binding repertoire, and defined a unique transdimer-specific peptide binding motif that was found to be distinct from those of HLA-DQ2 and HLA-DQ8. This motif predicts an array of peptides of islet autoantigens as candidate T cell epitopes, many of which selectively bind to the HLA transdimer, whereas others bind to both HLA-DQ8 and transdimer with similar affinity. Our findings provide a molecular basis for the association between HLA-DQ transdimers and T1D and set the stage for rational testing of potential diabetogenic peptide epitopes.	[van Lummel, Menno; van Veelen, Peter A.; de Ru, Arnoud; Janssen, George M. C.; Roep, Bart O.; Koning, Frits] Leiden Univ, Dept Immunohematol & Blood Transfus, Med Ctr, NL-2300 RC Leiden, Netherlands; [Zaldumbide, Arnaud] Leiden Univ, Dept Mol Cell Biol, Med Ctr, NL-2300 RC Leiden, Netherlands; [Moustakas, Antonis K.] Technol Educ Inst Ionian Isl, Dept Organ Farming, GR-27100 Argostoli, Greece; [Papadopoulos, George K.] Epirus Inst Technol, Biochem & Biophys Lab, Fac Agr Technol, GR-47100 Arta, Greece	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Koning, F (corresponding author), Leiden Univ, Dept Immunohematol & Blood Transfus, Med Ctr, E3-Q,POB 9600, NL-2300 RC Leiden, Netherlands.	fkoning@lumc.nl	Roep, Bart/AAD-7609-2021; Drijfhout, Jan Wouter/ABA-6318-2021	Drijfhout, Jan Wouter/0000-0003-4808-5296; Papadopoulos, George K/0000-0002-6944-6591; Koning, Frits/0000-0002-4007-5715; van Veelen, Peter/0000-0002-7898-9408	Dutch Diabetes Foundation [2007.00.038]; Celiac Disease Consortium; Dutch government [BSIK03009]; European Union [241447]; The Netherlands Organization for Scientific Research [VICI 918.86.611]	Dutch Diabetes Foundation; Celiac Disease Consortium; Dutch government; European Union(European Commission); The Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by Dutch Diabetes Foundation Grant 2007.00.038, by the Celiac Disease Consortium, an Innovative Cluster approved by The Netherlands Genomics Initiative partially funded by the Dutch government (BSIK03009), by the European Union 7th Framework Programme (FP7/2007-2013) under Grant Agreement 241447 (Natural Immunomodulators as Novel Immunotherapies for Type 1 Diabetes; NAIMIT), and by a VICI grant of The Netherlands Organization for Scientific Research (VICI 918.86.611).	ATKINSON MA, 1994, NEW ENGL J MED, V331, P1428; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Bondinas GP, 2007, IMMUNOGENETICS, V59, P539, DOI 10.1007/s00251-007-0224-8; Carlotti F, 2004, MOL THER, V9, P209, DOI 10.1016/j.ymthe.2003.11.021; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Concannon P, 2009, NEW ENGL J MED, V360, P1646, DOI 10.1056/NEJMra0808284; Di Lorenzo TP, 2007, CLIN EXP IMMUNOL, V148, P1, DOI 10.1111/j.1365-2249.2006.03244.x; Eerligh P, 2011, GENES IMMUN, V12, P415, DOI 10.1038/gene.2011.24; Erlich H, 2008, DIABETES, V57, P1084, DOI 10.2337/db07-1331; Fremont DH, 1998, IMMUNITY, V8, P305, DOI 10.1016/S1074-7613(00)80536-1; Godkin A, 1997, INT IMMUNOL, V9, P905, DOI 10.1093/intimm/9.6.905; Harfouch-Hammoud E, 1999, DIABETES, V48, P1937, DOI 10.2337/diabetes.48.10.1937; Kelemen K, 2004, J IMMUNOL, V172, P3955, DOI 10.4049/jimmunol.172.6.3955; Kent SC, 2005, NATURE, V435, P224, DOI 10.1038/nature03625; KHALIL I, 1992, DIABETES, V41, P378, DOI 10.2337/diabetes.41.3.378; Kim CY, 2004, P NATL ACAD SCI USA, V101, P4175, DOI 10.1073/pnas.0306885101; Koeleman BPC, 2004, GENES IMMUN, V5, P381, DOI 10.1038/sj.gene.6364106; Kooy-Winkelaar Y, 2011, J IMMUNOL, V187, P5123, DOI 10.4049/jimmunol.1101179; Lee KH, 2001, NAT IMMUNOL, V2, P501, DOI 10.1038/88694; MILLER GG, 1987, J IMMUNOL, V139, P3622; Moustakas AK, 2002, AM J MED GENET, V115, P37, DOI 10.1002/ajmg.10342; Moustakas AK, 2000, INT IMMUNOL, V12, P1157, DOI 10.1093/intimm/12.8.1157; Nepom GT, 1998, DIABETES, V47, P1177, DOI 10.2337/diabetes.47.8.1177; Oling V, 2010, AUTOIMMUNITY, V43, P573, DOI 10.3109/08916930903540424; Pinkse GGM, 2005, P NATL ACAD SCI USA, V102, P18425, DOI 10.1073/pnas.0508621102; Pociot F, 2002, GENES IMMUN, V3, P235, DOI 10.1038/sj.gene.6363875; Schloot NC, 1998, J AUTOIMMUN, V11, P169, DOI 10.1006/jaut.1997.0183; Stepniak D, 2008, J IMMUNOL, V180, P3268, DOI 10.4049/jimmunol.180.5.3268; Tollefsen S, 2006, J CLIN INVEST, V116, P2226, DOI 10.1172/JCI27620; Tree TIM, 2004, DIABETES, V53, P1692, DOI 10.2337/diabetes.53.7.1692; Vader W, 2002, GASTROENTEROLOGY, V122, P1729, DOI 10.1053/gast.2002.33606; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; van de Wal Y, 1998, P NATL ACAD SCI USA, V95, P10050, DOI 10.1073/pnas.95.17.10050; vandeWal Y, 1997, IMMUNOGENETICS, V46, P484, DOI 10.1007/s002510050309; vandeWal Y, 1996, IMMUNOGENETICS, V44, P246, DOI 10.1007/s002510050120; Vartdal F, 1996, EUR J IMMUNOL, V26, P2764, DOI 10.1002/eji.1830261132	36	54	54	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9514	9524		10.1074/jbc.M111.313940	http://dx.doi.org/10.1074/jbc.M111.313940			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22184118	Green Published, hybrid			2022-12-25	WOS:000301797800082
J	Davydov, DR; Rumfeldt, JAO; Sineva, EV; Fernando, H; Davydova, NY; Halpert, JR				Davydov, Dmitri R.; Rumfeldt, Jessica A. O.; Sineva, Elena V.; Fernando, Harshica; Davydova, Nadezhda Y.; Halpert, James R.			Peripheral Ligand-binding Site in Cytochrome P450 3A4 Located with Fluorescence Resonance Energy Transfer (FRET)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SUBSTRATE-BINDING; ALPHA-NAPHTHOFLAVONE; HETEROTROPIC COOPERATIVITY; TESTOSTERONE BINDING; MOLECULAR-MECHANICS; P450; TRANSITIONS; COMPLEXES; KINETICS; CYP3A4	The mechanisms of ligand binding and allostery in the major human drug-metabolizing enzyme cytochrome P450 3A4 (CYP3A4) were explored with fluorescence resonance energy transfer (FRET) using a laser dye, fluorol-7GA (F7GA), as a model substrate. Incorporation into the enzyme of a thiol-reactive FRET probe, pyrene iodoacetamide, allowed us to monitor the binding by FRET from the pyrene donor to the F7GA acceptor. Cooperativity of the interactions detected by FRET indicates that the enzyme possesses at least two F7GA-binding sites that have different FRET efficiencies and are therefore widely separated. To probe spatial localization of these sites, we studied FRET in a series of mutants bearing pyrene iodoacetamide at different positions, and we measured the distances from each of the sites to the donor. Our results demonstrate the presence of a high affinity binding site at the enzyme periphery. Analysis of the set of measured distances complemented with molecular modeling and docking allowed us to pinpoint the most probable peripheral site. It is located in the vicinity of residues 217-220, similar to the position of the progesterone molecule bound at the distal surface of the CYP3A4 in a prior x-ray crystal structure. Peripheral binding of F7GA causes a substantial spin shift and serves as a prerequisite for the binding in the active site. This is the first indication of functionally important ligand binding outside of the active site in cytochromes P450. The findings strongly suggest that the mechanisms of CYP3A4 cooperativity involve a conformational transition triggered by an allosteric ligand.	[Davydov, Dmitri R.; Rumfeldt, Jessica A. O.; Sineva, Elena V.; Davydova, Nadezhda Y.; Halpert, James R.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Fernando, Harshica] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77551 USA	University of California System; University of California San Diego; University of Texas System; University of Texas Medical Branch Galveston	Davydov, DR (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, MC 0703,9500 Gilman Dr, La Jolla, CA 92093 USA.	ddavydov@ucsd.edu	Davydov, Dmitri R/H-2736-2013; Sineva, Elena/A-5267-2008	Davydov, Dmitri R/0000-0001-8520-0033; Sineva, Elena/0000-0003-2307-0581	National Institutes of Health [GM054995]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054995, R01GM054995] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM054995 (to J. R. H.).	ALLINGER NL, 1989, J AM CHEM SOC, V111, P8551, DOI 10.1021/ja00205a001; Atkins WM, 2001, CHEM RES TOXICOL, V14, P338, DOI 10.1021/tx0002132; Baas BJ, 2004, ARCH BIOCHEM BIOPHYS, V430, P218, DOI 10.1016/j.abb.2004.07.003; Brackman U., 2000, LAMBDACHROME LASER D; Conner KP, 2011, ARCH BIOCHEM BIOPHYS, V507, P56, DOI 10.1016/j.abb.2010.10.006; Dabrowski MJ, 2002, J AM CHEM SOC, V124, P11866, DOI 10.1021/ja027552x; Davydov DR, 2008, BIOCHEMISTRY-US, V47, P11348, DOI 10.1021/bi8011803; Davydov DR, 2006, BIOPHYS CHEM, V123, P95, DOI 10.1016/j.bpc.2006.04.007; Davydov DR, 2010, BBA-BIOENERGETICS, V1797, P378, DOI 10.1016/j.bbabio.2009.12.008; Davydov DR, 2008, EXPERT OPIN DRUG MET, V4, P1523, DOI 10.1517/17425250802500028 ; Davydov DR, 2005, BIOPHYS J, V89, P418, DOI 10.1529/biophysj.104.058479; DAVYDOV DR, 1995, ARCH BIOCHEM BIOPHYS, V320, P330, DOI 10.1016/0003-9861(95)90017-9; Davydov DR, 2002, BIOCHEM BIOPH RES CO, V294, P806, DOI 10.1016/S0006-291X(02)00565-X; Denisov IG, 2007, J BIOL CHEM, V282, P7066, DOI 10.1074/jbc.M609589200; Denisov IG, 2009, PHARMACOL THERAPEUT, V124, P151, DOI 10.1016/j.pharmthera.2009.05.011; Dixon JM, 2005, PHOTOCHEM PHOTOBIOL, V81, P212, DOI 10.1562/2004-11-06-TSN-361.1; Domanski TL, 2000, J PHARMACOL EXP THER, V293, P585; Domanski TL, 1998, ARCH BIOCHEM BIOPHYS, V350, P223, DOI 10.1006/abbi.1997.0525; Domanski TL, 2001, BIOCHEMISTRY-US, V40, P10150, DOI 10.1021/bi010758a; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Fernando H, 2006, BIOCHEMISTRY-US, V45, P4199, DOI 10.1021/bi052491b; Fernando H, 2011, XENOBIOTICA, V41, P281, DOI 10.3109/00498254.2010.538748; Harlow GR, 1998, P NATL ACAD SCI USA, V95, P6636, DOI 10.1073/pnas.95.12.6636; Haugland R. P., 2007, HDB FLUORESCENT PROB; Hosea NA, 2000, BIOCHEMISTRY-US, V39, P5929, DOI 10.1021/bi992765t; Isin EM, 2006, J BIOL CHEM, V281, P9127, DOI 10.1074/jbc.M511375200; Isin EM, 2008, ANAL BIOANAL CHEM, V392, P1019, DOI 10.1007/s00216-008-2244-0; Isin EM, 2007, J BIOL CHEM, V282, P6863, DOI 10.1074/jbc.M610346200; JONES G, 1985, J PHYS CHEM-US, V89, P294, DOI 10.1021/j100248a024; Kapelyukh Y, 2008, DRUG METAB DISPOS, V36, P2136, DOI 10.1124/dmd.108.021733; Korzekwa KR, 1998, BIOCHEMISTRY-US, V37, P4137, DOI 10.1021/bi9715627; Koushik SV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008031; Lakowitz J., 1999, PRINCIPLES FLUORESCE; Lewis DFV, 2004, XENOBIOTICA, V34, P549, DOI 10.1080/00498250410001691325; Masuko M, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e34; Niwa T, 2008, CURR DRUG METAB, V9, P453, DOI 10.2174/138920008784746364; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PONDER JW, 1987, J COMPUT CHEM, V8, P1016, DOI 10.1002/jcc.540080710; Renaud JP, 1996, BIOCHEM J, V319, P675, DOI 10.1042/bj3190675; Roberts AG, 2005, BIOCHEMISTRY-US, V44, P1353, DOI 10.1021/bi0481390; Roberts AG, 2007, ARCH BIOCHEM BIOPHYS, V463, P89, DOI 10.1016/j.abb.2007.03.006; Schoch GA, 2004, J BIOL CHEM, V279, P9497, DOI 10.1074/jbc.M312516200; Segel IH, 1975, ENZYME KINETICS BEHA; Sevrioukova IF, 2010, P NATL ACAD SCI USA, V107, P18422, DOI 10.1073/pnas.1010693107; Szklarz GD, 1997, LIFE SCI, V61, P2507, DOI 10.1016/S0024-3205(97)00717-0; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tsalkova TN, 2007, BIOCHEMISTRY-US, V46, P106, DOI 10.1021/bi061944p; Ueng YF, 1997, BIOCHEMISTRY-US, V36, P370, DOI 10.1021/bi962359z; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736	50	53	54	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6797	6809		10.1074/jbc.M111.325654	http://dx.doi.org/10.1074/jbc.M111.325654			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22194603	Green Published, hybrid			2022-12-25	WOS:000300791800065
J	Li, L; Cao, XH; Chen, SR; Han, HD; Lopez-Berestein, G; Sood, AK; Pan, HL				Li, Li; Cao, Xue-Hong; Chen, Shao-Rui; Han, Hee-Dong; Lopez-Berestein, Gabriel; Sood, Anil K.; Pan, Hui-Lin			Up-regulation of Cav beta(3) Subunit in Primary Sensory Neurons Increases Voltage-activated Ca2+ Channel Activity and Nociceptive Input in Neuropathic Pain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCARINIC RECEPTOR SUBTYPES; SPINAL NERVE LIGATION; ROOT GANGLION NEURONS; BETA-SUBUNIT; MICE LACKING; INTRATHECAL ZICONOTIDE; PERIPHERAL NEUROPATHY; CALCIUM-CHANNELS; SKELETAL-MUSCLE; EXPRESSION	High voltage-activated calcium channels (HVACCs) are essential for synaptic and nociceptive transmission. Although blocking HVACCs can effectively reduce pain, this treatment strategy is associated with intolerable adverse effects. Neuronal HVACCs are typically composed of alpha(1), beta (Cav beta), and alpha(2)delta subunits. The Cav beta subunit plays a crucial role in the membrane expression and gating properties of the pore-forming alpha(1) subunit. However, little is known about how nerve injury affects the expression and function of Cav beta subunits in primary sensory neurons. In this study, we found that Cav beta(3) and Cav beta(4) are the most prominent subtypes expressed in the rat dorsal root ganglion (DRG) and dorsal spinal cord. Spinal nerve ligation (SNL) in rats significantly increased mRNA and protein levels of the Cav beta(3), but not Cav beta(4), subunit in the DRG. SNL also significantly increased HVACC currents in small DRG neurons and monosynaptic excitatory postsynaptic currents of spinal dorsal horn neurons evoked from the dorsal root. Intrathecal injection of Cav beta(3)-specific siRNA significantly reduced HVACC currents in small DRG neurons and the amplitude of monosynaptic excitatory postsynaptic currents of dorsal hornneurons in SNL rats. Furthermore, intrathecal treatment with Cav beta(3)-specific siRNA normalized mechanical hyperalgesia and tactile allodynia caused by SNL but had no significant effect on the normal nociceptive threshold. Our findings provide novel evidence that increased expression of the Cav beta(3) subunit augments HVACC activity in primary sensory neurons and nociceptive input to dorsal horn neurons in neuropathic pain. Targeting the Cav beta(3) subunit at the spinal level represents an effective strategy for treating neuropathic pain.	[Pan, Hui-Lin] Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Unit 110, Houston, TX 77030 USA; [Li, Li; Cao, Xue-Hong; Chen, Shao-Rui; Pan, Hui-Lin] Univ Texas MD Anderson Canc Ctr, Ctr Neurosci & Pain Res, Houston, TX 77030 USA; [Han, Hee-Dong; Lopez-Berestein, Gabriel] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Han, Hee-Dong; Lopez-Berestein, Gabriel; Sood, Anil K.; Pan, Hui-Lin] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNA, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Pan, HL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Unit 110, 1515 Holcombe Blvd, Houston, TX 77030 USA.	huilinpan@mdanderson.org	Li, Li/K-9630-2013	Pan, Hui-Lin/0000-0001-8444-3770	National Institutes of Health [GM064830, NS045602, NS073935, CA151668]; N. G. and Helen T. Hawkins endowment; NATIONAL CANCER INSTITUTE [U54CA151668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073935, R01NS045602] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); N. G. and Helen T. Hawkins endowment; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM064830, NS045602, and NS073935 (to H.-L. P.) and CA151668 (to A. K. S. and G. L.-B.). This work was also supported by the N. G. and Helen T. Hawkins endowment (to H.-L. P.).	Abdulla FA, 2001, J NEUROPHYSIOL, V85, P644, DOI 10.1152/jn.2001.85.2.644; Andrade A, 2009, CELL CALCIUM, V46, P282, DOI 10.1016/j.ceca.2009.08.006; Buraei Z, 2010, PHYSIOL REV, V90, P1461, DOI 10.1152/physrev.00057.2009; Burgess DL, 1997, CELL, V88, P385, DOI 10.1016/S0092-8674(00)81877-2; Cai YQ, 2009, J NEUROCHEM, V111, P1000, DOI 10.1111/j.1471-4159.2009.06396.x; Campero M, 1998, MUSCLE NERVE, V21, P1661, DOI 10.1002/(SICI)1097-4598(199812)21:12<1661::AID-MUS6>3.3.CO;2-E; CASTELLANO A, 1993, J BIOL CHEM, V268, P3450; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; CERVERO F, 1980, BRAIN, V103, P717, DOI 10.1093/brain/103.4.717; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen CC, 1998, P NATL ACAD SCI USA, V95, P10240, DOI 10.1073/pnas.95.17.10240; Chen SR, 2011, J PHARMACOL EXP THER, V337, P285, DOI 10.1124/jpet.110.176586; Chen SR, 2009, J NEUROCHEM, V110, P352, DOI 10.1111/j.1471-4159.2009.06138.x; Chen SR, 2000, ANESTHESIOLOGY, V92, P500, DOI 10.1097/00000542-200002000-00033; Chu PJ, 2004, J MOL CELL CARDIOL, V36, P423, DOI 10.1016/j.yjmcc.2003.12.012; DEWAARD M, 1994, NEURON, V13, P495, DOI 10.1016/0896-6273(94)90363-8; Dworkin RH, 2007, PAIN, V132, P237, DOI 10.1016/j.pain.2007.08.033; Fossat P, 2010, J NEUROSCI, V30, P1073, DOI 10.1523/JNEUROSCI.3145-09.2010; Frey UH, 2008, NAT PROTOC, V3, P1312, DOI 10.1038/nprot.2008.112; GRACELY RH, 1992, PAIN, V51, P175, DOI 10.1016/0304-3959(92)90259-E; Gregg RG, 1996, P NATL ACAD SCI USA, V93, P13961, DOI 10.1073/pnas.93.24.13961; HOFMANN F, 1994, ANNU REV NEUROSCI, V17, P399, DOI 10.1146/annurev.neuro.17.1.399; HULLIN R, 1992, EMBO J, V11, P885, DOI 10.1002/j.1460-2075.1992.tb05126.x; Kang MG, 2001, J BIOL CHEM, V276, P32917, DOI 10.1074/jbc.M100787200; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Kim DS, 2001, MOL BRAIN RES, V96, P151, DOI 10.1016/S0169-328X(01)00285-6; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Liu XZ, 2001, BRAIN RES, V900, P119, DOI 10.1016/S0006-8993(01)02274-0; Ludwig A, 1997, J NEUROSCI, V17, P1339; Luo ZD, 2002, J PHARMACOL EXP THER, V303, P1199, DOI 10.1124/jpet.102.041574; Luo ZD, 2001, J NEUROSCI, V21, P1868, DOI 10.1523/JNEUROSCI.21-06-01868.2001; McDavid S, 2006, J NEUROSCI, V26, P13373, DOI 10.1523/JNEUROSCI.3332-06.2006; Murakami M, 2003, J BIOL CHEM, V278, P43261, DOI 10.1074/jbc.M211380200; Murakami M, 2002, J BIOL CHEM, V277, P40342, DOI 10.1074/jbc.M203425200; Murakami M, 2007, BRAIN RES, V1160, P102, DOI 10.1016/j.brainres.2007.05.041; Namkung Y, 1998, P NATL ACAD SCI USA, V95, P12010, DOI 10.1073/pnas.95.20.12010; Newton RA, 2001, MOL BRAIN RES, V95, P1, DOI 10.1016/S0169-328X(01)00188-7; Pan HL, 2003, J NEUROSCI, V23, P2911; Pan YZ, 2004, J NEUROPHYSIOL, V91, P2413, DOI 10.1152/jn.01242.2003; PERRY MJ, 1991, J NEUROCYTOL, V20, P746, DOI 10.1007/BF01187848; POWERS PA, 1992, J BIOL CHEM, V267, P22967; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Saegusa H, 2001, EMBO J, V20, P2349, DOI 10.1093/emboj/20.10.2349; Schmidtko A, 2010, LANCET, V375, P1569, DOI 10.1016/S0140-6736(10)60354-6; Staats PS, 2004, JAMA-J AM MED ASSOC, V291, P63, DOI 10.1001/jama.291.1.63; Wallace MS, 2008, ANESTH ANALG, V106, P628, DOI 10.1213/ane.0b013e3181606fad; Wang XL, 2006, J PHYSIOL-LONDON, V571, P403, DOI 10.1113/jphysiol.2005.102905; Weissgerber P, 2006, CIRC RES, V99, P749, DOI 10.1161/01.RES.0000243978.15182.c1; Wu ZZ, 2009, J BIOL CHEM, V284, P36453, DOI 10.1074/jbc.M109.075523; Wu ZZ, 2004, NEUROSCI LETT, V368, P96, DOI 10.1016/j.neulet.2004.06.067; Yamaguchi H, 1998, J BIOL CHEM, V273, P19348, DOI 10.1074/jbc.273.30.19348; Zhou HY, 2008, J PHARMACOL EXP THER, V324, P1000, DOI 10.1124/jpet.107.133470; Zhou HY, 2011, J PHARMACOL EXP THER, V336, P254, DOI 10.1124/jpet.110.173112; Zhou HY, 2010, J NEUROSCI, V30, P4460, DOI 10.1523/JNEUROSCI.5857-09.2010	56	24	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					6002	6013		10.1074/jbc.M111.310110	http://dx.doi.org/10.1074/jbc.M111.310110			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22187436	Green Published, hybrid			2022-12-25	WOS:000300638000073
J	Chen, Y; Okano, K; Maeda, T; Chauhan, V; Golczak, M; Maeda, A; Palczewski, K				Chen, Yu; Okano, Kiichiro; Maeda, Tadao; Chauhan, Vishal; Golczak, Marcin; Maeda, Akiko; Palczewski, Krzysztof			Mechanism of All-trans-retinal Toxicity with Implications for Stargardt Disease and Age-related Macular Degeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECESSIVE RETINITIS-PIGMENTOSA; NEUTROPHIL NADPH-OXIDASE; ACTIVATED PROTEIN-KINASE; VISUAL CYCLE; PHOSPHOLIPASE-C; GENE ABCR; IN-VIVO; BINDING-PROPERTIES; 5-HT1A RECEPTORS; OXIDATIVE STRESS	Compromised clearance of all-trans-retinal (atRAL), a component of the retinoid cycle, increases the susceptibility of mouse retina to acute light-induced photoreceptor degeneration. Abca4(-/-)Rdh8(-/-) mice featuring defective atRAL clearance were used to examine the one or more underlying molecular mechanisms, because exposure to intense light causes severe photoreceptor degeneration in these animals. Here we report that bright light exposure of Abca4(-/-)Rdh8(-/-) mice increased atRAL levels in the retina that induced rapid NADPH oxidase-mediated overproduction of intracellular reactive oxygen species (ROS). Moreover, such ROS generation was inhibited by blocking phospholipase C and inositol 1,4,5-trisphosphate-induced Ca2+ release, indicating that activation occurs upstream of NADPH oxidase-mediated ROS generation. Because multiple upstream G protein-coupled receptors can activate phospholipase C, we then tested the effects of antagonists of serotonin 2A (5-HT2AR) and M-3-muscarinic (M3R) receptors and found they both protected Abca4(-/-)Rdh8(-/-) mouse retinas from light-induced degeneration. Thus, a cascade of signaling events appears to mediate the toxicity of atRAL in light-induced photoreceptor degeneration of Abca4(-/-)Rdh8(-/-) mice. A similar mechanism may be operative in human Stargardt disease and age-related macular degeneration.	[Chen, Yu; Okano, Kiichiro; Maeda, Tadao; Chauhan, Vishal; Golczak, Marcin; Maeda, Akiko; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Maeda, Tadao; Chauhan, Vishal; Maeda, Akiko] Case Western Reserve Univ, Sch Med, Dept Ophthalmol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Palczewski, K (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	kxp65@case.edu			National Institutes of Health [EY009339, EY021126, EY019031, EY019880, P30 EY11373]; Research to Prevent Blindness Foundation; Ohio Lions Eye Research Foundation; NATIONAL EYE INSTITUTE [R24EY021126, K08EY019031, R01EY009339, K08EY019880, P30EY011373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); Ohio Lions Eye Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY009339, EY021126, EY019031, EY019880, and P30 EY11373. This work was also supported by the Research to Prevent Blindness Foundation and the Ohio Lions Eye Research Foundation.	Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allikmets R, 2000, AM J HUM GENET, V67, P487, DOI 10.1086/303018; ARVIDSSON LE, 1981, J MED CHEM, V24, P921, DOI 10.1021/jm00140a002; BADWEY JA, 1989, J BIOL CHEM, V264, P14947; BADWEY JA, 1986, J CELL PHYSIOL, V127, P223, DOI 10.1002/jcp.1041270206; BLEASDALE JE, 1990, J PHARMACOL EXP THER, V255, P756; Bootman MD, 2001, SEMIN CELL DEV BIOL, V12, P3, DOI 10.1006/scdb.2000.0211; Collier RJ, 2011, INVEST OPHTH VIS SCI, V52, P2118, DOI 10.1167/iovs.10-6304; Cremers FPM, 1998, HUM MOL GENET, V7, P355, DOI 10.1093/hmg/7.3.355; Donovan M, 2001, J BIOL CHEM, V276, P23000, DOI 10.1074/jbc.M005359200; DOUSSIERE J, 1992, EUR J BIOCHEM, V208, P61, DOI 10.1111/j.1432-1033.1992.tb17159.x; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; FISHER SK, 1992, J NEUROCHEM, V58, P18, DOI 10.1111/j.1471-4159.1992.tb09273.x; Fishkin N, 2005, BIOORGAN MED CHEM, V13, P5189, DOI 10.1016/j.bmc.2005.05.001; Fleisch VC, 2008, J NEUROSCI, V28, P8208, DOI 10.1523/JNEUROSCI.2367-08.2008; Golczak M, 2005, P NATL ACAD SCI USA, V102, P8162, DOI 10.1073/pnas.0503318102; Greene EL, 2000, AM J PHYSIOL-RENAL, V278, pF650, DOI 10.1152/ajprenal.2000.278.4.F650; Haruta M, 2009, P NATL ACAD SCI USA, V106, P9397, DOI 10.1073/pnas.0808940106; Hensler JG, 1998, NEUROPSYCHOPHARMACOL, V19, P354, DOI 10.1016/S0893-133X(98)00037-2; HOYER D, 1994, PHARMACOL REV, V46, P157; Hsu YC, 2011, CELL SIGNAL, V23, P2013, DOI 10.1016/j.cellsig.2011.07.015; JONES GJ, 1989, P NATL ACAD SCI USA, V86, P9606, DOI 10.1073/pnas.86.23.9606; Kim YK, 2008, J BIOL CHEM, V283, P5611, DOI 10.1074/jbc.M708885200; Kiser P. D., 2011, BIOCHIM BIOPHYS ACTA; Kiser PD, 2010, PROG RETIN EYE RES, V29, P428, DOI 10.1016/j.preteyeres.2010.03.002; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; LEYSEN JE, 1985, MOL PHARMACOL, V27, P600; LEYSEN JE, 1982, MOL PHARMACOL, V21, P301; LOCHNER JE, 1986, P NATL ACAD SCI USA, V83, P7673, DOI 10.1073/pnas.83.20.7673; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2012, NAT CHEM BIOL, V8, P170, DOI 10.1038/nchembio.759; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Martinez-Mir A, 1998, NAT GENET, V18, P11, DOI 10.1038/ng0198-11; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; Mata NL, 2000, P NATL ACAD SCI USA, V97, P7154, DOI 10.1073/pnas.130110497; Mata NL, 2002, NEURON, V36, P69, DOI 10.1016/S0896-6273(02)00912-1; MICHEL AD, 1989, EUR J PHARMACOL, V166, P459, DOI 10.1016/0014-2999(89)90359-2; Molday RS, 2006, ADV EXP MED BIOL, V572, P465; Movitz C, 1997, INFLAMMATION, V21, P531, DOI 10.1023/A:1027363730746; Naumenko VS, 2010, GENES BRAIN BEHAV, V9, P519, DOI 10.1111/j.1601-183X.2010.00581.x; ORGANISCIAK DT, 1992, INVEST OPHTH VIS SCI, V33, P1599; Palczewska G, 2010, NAT MED, V16, P1444, DOI 10.1038/nm.2260; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; Rattner A, 2000, J BIOL CHEM, V275, P11034, DOI 10.1074/jbc.275.15.11034; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rozanowska M, 2005, PHOTOCHEM PHOTOBIOL, V81, P1305, DOI 10.1562/2004-11-13-IR-371; Shiose S, 2011, J BIOL CHEM, V286, P15543, DOI 10.1074/jbc.M111.228551; STEINBECK MJ, 1991, J BIOL CHEM, V266, P16336; STOLK J, 1994, AM J RESP CELL MOL, V11, P95, DOI 10.1165/ajrcmb.11.1.8018341; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Tsybovsky Y, 2011, BIOCHEMISTRY-US, V50, P6855, DOI 10.1021/bi200774w; Usui S, 2009, J NEUROCHEM, V110, P1028, DOI 10.1111/j.1471-4159.2009.06195.x; von Lintig J, 2010, TRENDS BIOCHEM SCI, V35, P400, DOI 10.1016/j.tibs.2010.01.005; Yannuzzi LA, 2004, AM J OPHTHALMOL, V137, P511, DOI 10.1016/j.ajo.2003.12.035; Zhang QJ, 2005, HUM GENET, V118, P356, DOI 10.1007/s00439-005-0054-4; Zhang YH, 2004, J PHARMACOL EXP THER, V310, P59, DOI 10.1124/jpet.103.062224; Zhang YH, 2001, J NEUROSCI, V21, P7919, DOI 10.1523/JNEUROSCI.21-20-07919.2001	59	142	145	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					5059	5069		10.1074/jbc.M111.315432	http://dx.doi.org/10.1074/jbc.M111.315432			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22184108	hybrid, Green Published			2022-12-25	WOS:000300608500064
J	Gautherot, J; Durand-Schneider, AM; Delautier, D; Delaunay, JL; Rada, A; Gabillet, J; Housset, C; Maurice, M; Ait-Slimane, T				Gautherot, Julien; Durand-Schneider, Anne-Marie; Delautier, Daniele; Delaunay, Jean-Louis; Rada, Alegna; Gabillet, Julie; Housset, Chantal; Maurice, Michele; Ait-Slimane, Tounsia			Effects of Cellular, Chemical, and Pharmacological Chaperones on the Rescue of a Trafficking-defective Mutant of the ATP-binding Cassette Transporter Proteins ABCB1/ABCB4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN P-GLYCOPROTEIN; TRANSMEMBRANE CONDUCTANCE REGULATOR; FIBROSIS EPITHELIAL-CELLS; QUALITY-CONTROL; CYSTIC-FIBROSIS; SODIUM 4-PHENYLBUTYRATE; ENDOPLASMIC-RETICULUM; SURFACE EXPRESSION; RECEPTOR MUTANTS; DELTA-F508 CFTR	The ATP-binding cassette transporter ABCB4 is a phosphatidylcholine translocator specifically expressed at the bile canalicular membrane in hepatocytes, highly homologous to the multidrug transporter ABCB1. Variations in the ABCB4 gene sequence cause progressive familial intrahepatic cholestasis type 3. We have shown previously that the I541F mutation, when reproduced either in ABCB1 or in ABCB4, led to retention in the endoplasmic reticulum (ER)/Golgi. Here, Madin-Darby canine kidney cells expressing ABCB1-GFP were used as a model to investigate this mutant. We show that ABCB1-I541F is not properly folded and is more susceptible to in situ protease degradation. It colocalizes and coprecipitates with the ER chaperone calnexin and coprecipitates with the cytosolic chaperone Hsc/Hsp70. Silencing of calnexin or overexpression of Hsp70 have no effect on maturation of the mutant. We also tested potential rescue by chemical and pharmacological chaperones. Thapsigargin and sodium 4-phenyl butyrate were inefficient. Glycerol improved maturation and exit of the mutant from the ER. Cyclosporin A, a competitive substrate for ABCB1, restored maturation, plasma membrane expression, and activity of ABCB1-I541F. Cyclosporin A also improved maturation of ABCB4-I541F in Madin-Darby canine kidney cells. In HepG(2) cells transfected with ABCB4-I541F cDNA, cyclosporin A allowed a significant amount of the mutant protein to reach the membrane of bile canaliculi. These results show that the best strategy to rescue conformation-defective ABCB4 mutants is provided by pharmacological chaperones that specifically target the protein. They identify cyclosporin A as a potential novel therapeutic tool for progressive familial intrahepatic cholestasis type 3 patients.	[Gautherot, Julien; Durand-Schneider, Anne-Marie; Delautier, Daniele; Delaunay, Jean-Louis; Rada, Alegna; Gabillet, Julie; Housset, Chantal; Maurice, Michele; Ait-Slimane, Tounsia] UPMC Univ Paris 06, INSERM, UMR S 938, CdR St Antoine, F-75012 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Maurice, M (corresponding author), Fac Med Pierre & Marie Curie, UMR S 938, Site St Antoine,27 Rue Chaligny, F-75571 Paris, France.	Michele.Maurice@inserm.fr		Delaunay, jean-louis/0000-0002-6512-5483; Housset, Chantal/0000-0001-6469-0651; AIT SLIMANE, Tounsia/0000-0002-7459-859X	French National Society of Gastroenterology (SNFGE); Mucoviscidose ABCF2 Association; Albi; Robert Debre; Vaincre la Mucoviscidose associations	French National Society of Gastroenterology (SNFGE); Mucoviscidose ABCF2 Association; Albi; Robert Debre; Vaincre la Mucoviscidose associations	This work was supported by grants from the French National Society of Gastroenterology (SNFGE) and by Mucoviscidose ABCF2 Association. This work was also supported by fellowships from the Albi, Robert Debre, and Vaincre la Mucoviscidose associations (to J. G.).	Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Arakawa T, 2006, BBA-PROTEINS PROTEOM, V1764, P1677, DOI 10.1016/j.bbapap.2006.08.012; Bernier V, 2004, TRENDS ENDOCRIN MET, V15, P222, DOI 10.1016/j.tem.2004.05.003; Choo-Kang LR, 2001, AM J PHYSIOL-LUNG C, V281, pL58, DOI 10.1152/ajplung.2001.281.1.L58; Delaunay JL, 2009, HEPATOLOGY, V49, P1218, DOI 10.1002/hep.22775; Delisle BP, 2003, J BIOL CHEM, V278, P35749, DOI 10.1074/jbc.M305787200; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Egan ME, 2002, NAT MED, V8, P485, DOI 10.1038/nm0502-485; Fan JQ, 1999, NAT MED, V5, P112, DOI 10.1038/4801; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hayashi H, 2007, HEPATOLOGY, V45, P1506, DOI 10.1002/hep.21630; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Jacquemin E, 2001, GASTROENTEROLOGY, V120, P1448, DOI 10.1053/gast.2001.23984; Janovick JA, 2002, J CLIN ENDOCR METAB, V87, P3255, DOI 10.1210/jc.87.7.3255; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; Liu XL, 2004, J AM SOC NEPHROL, V15, P1731, DOI 10.1097/01.ASN.0000129826.28932.FD; Loo TW, 1997, J BIOL CHEM, V272, P709, DOI 10.1074/jbc.272.2.709; Loo TW, 2003, J BIOL CHEM, V278, P13603, DOI 10.1074/jbc.C300073200; Loo TW, 2004, BIOCHEM BIOPH RES CO, V325, P580, DOI 10.1016/j.bbrc.2004.10.070; LOO TW, 1995, J BIOL CHEM, V270, P21839, DOI 10.1074/jbc.270.37.21839; LOO TW, 1994, J BIOL CHEM, V269, P28683; Maattanen P, 2010, SEMIN CELL DEV BIOL, V21, P500, DOI 10.1016/j.semcdb.2010.03.006; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Morello JP, 2000, TRENDS PHARMACOL SCI, V21, P466, DOI 10.1016/S0165-6147(00)01575-3; Morello JP, 2001, BIOCHEMISTRY-US, V40, P6766, DOI 10.1021/bi002699r; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; Norez C, 2006, TRAFFIC, V7, P562, DOI 10.1111/j.1600-0854.2006.00409.x; Okiyoneda T, 2008, BBA-MOL CELL RES, V1783, P1585, DOI 10.1016/j.bbamcr.2008.04.002; Petaja-Repo UE, 2002, EMBO J, V21, P1628, DOI 10.1093/emboj/21.7.1628; Plass JRM, 2004, J HEPATOL, V40, P24, DOI 10.1016/S0168-8278(03)00483-5; Polli JW, 2001, J PHARMACOL EXP THER, V299, P620; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Pruliere-Escabasse V, 2007, J BIOL CHEM, V282, P34048, DOI 10.1074/jbc.M702384200; Robben JH, 2006, MOL BIOL CELL, V17, P379, DOI 10.1091/mbc.E05-06-0579; Rubenstein RC, 2000, AM J PHYSIOL-CELL PH, V278, pC259, DOI 10.1152/ajpcell.2000.278.2.C259; Rubenstein RC, 1997, J CLIN INVEST, V100, P2457, DOI 10.1172/JCI119788; Singh LR, 2009, J BIOL CHEM, V284, P4238, DOI 10.1074/jbc.M806387200; Sobolewski A, 2008, HUM MOL GENET, V17, P3180, DOI 10.1093/hmg/ddn214; Swanton E, 2003, EMBO J, V22, P2948, DOI 10.1093/emboj/cdg300; TAMAI I, 1990, J BIOL CHEM, V265, P16509; Tveten K, 2007, FEBS J, V274, P1881, DOI 10.1111/j.1742-4658.2007.05735.x; Ulloa-Aguirre A, 2004, TRAFFIC, V5, P821, DOI 10.1111/j.1600-0854.2004.00232.x; van der Velden LM, 2010, HEPATOLOGY, V51, P286, DOI 10.1002/hep.23268; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Welch WJ, 2004, SEMIN CELL DEV BIOL, V15, P31, DOI 10.1016/j.semcdb.2003.12.011; Zhang F, 1998, NAT STRUCT BIOL, V5, P180, DOI 10.1038/nsb0398-180; Zhang XM, 2003, J BIOL CHEM, V278, P51232, DOI 10.1074/jbc.M309076200	48	45	46	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					5070	5078		10.1074/jbc.M111.275438	http://dx.doi.org/10.1074/jbc.M111.275438			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22184139	Green Published, hybrid			2022-12-25	WOS:000300608500065
J	Wang, T; Leyh, TS				Wang, Ting; Leyh, Thomas S.			Three-stage Assembly of the Cysteine Synthase Complex from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-ACETYLSERINE SULFHYDRYLASE; SERINE ACETYLTRANSFERASE; SALMONELLA-TYPHIMURIUM; BIENZYME COMPLEX; KINETIC MECHANISM; CYSB PROTEIN; ACTIVE-SITE; A-ISOZYME; B-ISOZYME; IN-VITRO	Control of sulfur metabolism in plants and bacteria is linked, in significant measure, to the behavior of the cysteine synthase complex (CSC). The complex is comprised of the two enzymes that catalyze the final steps in cysteine biosynthesis: serine O-acetyltransferase (SAT, EC 2.3.1.30), which produces O-acetyl-L-serine, and O-acetyl-L-serine sulfhydrylase (OASS, EC 2.5.1.47), which converts it to cysteine. SAT (a dimer of homotrimers) binds a maximum of two molecules of OASS (a dimer) in an interaction believed to involve docking of the C terminus from a protomer in an SAT trimer into an OASS active site. This interaction inactivates OASS catalysis and prevents further binding to the trimer; thus, the system exhibits a contact-induced inactivation of half of each biomolecule. To better understand the dynamics and energetics that underlie formation of the CSC, the interactions of OASS and SAT from Escherichia coli were studied at equilibrium and in the pre-steady state. Using an experimental strategy that initiates dissociation of the CSC at different points in the CSC-forming reaction, three stable forms of the complex were identified. Comparison of the binding behaviors of SAT and its C-terminal peptide supports a mechanism in which SAT interacts with OASS in a non-allosteric interaction involving its C terminus. This early docking event appears to fasten the proteins in close proximity and thus prepares the system to engage in a series of subsequent, energetically favorable isomerizations that inactivate OASS and produce the fully isomerized CSC.	[Wang, Ting; Leyh, Thomas S.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Leyh, TS (corresponding author), 1300 Morris Pk Ave, Bronx, NY 10461 USA.	tom.leyh@einstein.yu.edu	Wang, Ting/J-7577-2015		National Institutes of Health [GM54469]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054469] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM54469 (to T. S. L.).	Andreassi JL, 2004, BIOCHEMISTRY-US, V43, P14594, DOI 10.1021/bi048963o; Auger S, 2002, J BACTERIOL, V184, P5179, DOI 10.1128/JB.184.18.5179-5186.2002; Benci S, 1999, BBA-PROTEIN STRUCT M, V1429, P317, DOI 10.1016/S0167-4838(98)00229-5; Bhave Devayani P., 2007, Infectious Disorders - Drug Targets, V7, P140; Campanini B, 2005, PROTEIN SCI, V14, P2115, DOI 10.1110/ps.051492805; Chattopadhyay A, 2007, BIOCHEMISTRY-US, V46, P8315, DOI 10.1021/bi602603c; CLELAND WW, 1975, BIOCHEMISTRY-US, V14, P3220, DOI 10.1021/bi00685a029; COOK PF, 1977, ARCH BIOCHEM BIOPHYS, V178, P293, DOI 10.1016/0003-9861(77)90194-1; CORDINGLEY MG, 1990, J BIOL CHEM, V265, P9062; Droux M, 1998, EUR J BIOCHEM, V255, P235, DOI 10.1046/j.1432-1327.1998.2550235.x; Feldman-Salit A, 2009, J MOL BIOL, V386, P37, DOI 10.1016/j.jmb.2008.08.075; FLAVIN M, 1965, BIOCHEMISTRY-US, V4, P1370, DOI 10.1021/bi00883a022; Forquin MP, 2011, APPL ENVIRON MICROB, V77, P1449, DOI 10.1128/AEM.01708-10; Gyaneshwar P, 2005, P NATL ACAD SCI USA, V102, P3453, DOI 10.1073/pnas.0500141102; Gyaneshwar P, 2005, J BACTERIOL, V187, P1074, DOI 10.1128/JB.187.3.1074-1090.2005; Hatzios SK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002036; Hindson VJ, 2003, BIOCHEM J, V375, P745, DOI 10.1042/BJ20030429; Hindson VJ, 2003, BIOCHEMISTRY-US, V42, P3113, DOI 10.1021/bi0267893; Hirai MY, 2003, PLANT J, V33, P651, DOI 10.1046/j.1365-313X.2003.01658.x; Huang B, 2005, J BACTERIOL, V187, P3201, DOI 10.1128/JB.187.9.3201-3205.2005; Johnson CM, 2004, ARCH BIOCHEM BIOPHYS, V429, P115, DOI 10.1016/j.abb.2004.06.006; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Keseler IM, 2011, NUCLEIC ACIDS RES, V39, pD583, DOI 10.1093/nar/gkq1143; Kredich N.M., 1987, ESCHERICHIA COLI SAL, P419; Kredich N.M., 1967, ORG BIOSYNTHESIS, P189; KREDICH NM, 1969, J BIOL CHEM, V244, P2428; KREDICH NM, 1966, J BIOL CHEM, V241, P4955; KREDICH NM, 1992, MOL MICROBIOL, V6, P2747, DOI 10.1111/j.1365-2958.1992.tb01453.x; Kumar S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.197376; LEU LS, 1994, BIOCHEMISTRY-US, V33, P2667, DOI 10.1021/bi00175a040; Mino K, 2000, BIOSCI BIOTECH BIOCH, V64, P1628, DOI 10.1271/bbb.64.1628; Mino K, 1999, BIOSCI BIOTECH BIOCH, V63, P168, DOI 10.1271/bbb.63.168; Mino K, 2000, BIOSCI BIOTECH BIOCH, V64, P1874, DOI 10.1271/bbb.64.1874; Mino K, 2001, BIOSCI BIOTECH BIOCH, V65, P865, DOI 10.1271/bbb.65.865; Olsen LR, 2004, BIOCHEMISTRY-US, V43, P6013, DOI 10.1021/bi0358521; OSTROWSKI J, 1989, J BACTERIOL, V171, P130, DOI 10.1128/jb.171.1.130-140.1989; OSTROWSKI J, 1991, J BACTERIOL, V173, P2212, DOI 10.1128/JB.173.7.2212-2218.1991; Pye VE, 2004, J BIOL CHEM, V279, P40729, DOI 10.1074/jbc.M403751200; Rabeh WM, 2004, J BIOL CHEM, V279, P26803, DOI 10.1074/jbc.R400001200; Salsi E, 2010, J BIOL CHEM, V285, P12813, DOI 10.1074/jbc.M109.075762; Salsi E, 2010, J MED CHEM, V53, P345, DOI 10.1021/jm901325e; SCHNACKERZ KD, 1995, BIOCHEMISTRY-US, V34, P12152, DOI 10.1021/bi00038a008; Schnell R, 2007, J BIOL CHEM, V282, P23473, DOI 10.1074/jbc.M703518200; Strambini GB, 1996, BIOCHEMISTRY-US, V35, P8392, DOI 10.1021/bi952919e; TAI CH, 1993, BIOCHEMISTRY-US, V32, P6433, DOI 10.1021/bi00076a017; Zare H, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-39; Zhao CH, 2006, BIOCHEM BIOPH RES CO, V341, P911, DOI 10.1016/j.bbrc.2006.01.054	47	22	22	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4360	4367		10.1074/jbc.M111.288423	http://dx.doi.org/10.1074/jbc.M111.288423			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22179612	Green Published, hybrid			2022-12-25	WOS:000300410900066
J	Kaczocha, M; Vivieca, S; Sun, J; Glaser, ST; Deutsch, DG				Kaczocha, Martin; Vivieca, Stephanie; Sun, Jing; Glaser, Sherrye T.; Deutsch, Dale G.			Fatty Acid-binding Proteins Transport N-Acylethanolamines to Nuclear Receptors and Are Targets of Endocannabinoid Transport Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANANDAMIDE CELLULAR UPTAKE; AMIDE HYDROLASE; MONOACYLGLYCEROL LIPASE; CANNABINOID RECEPTORS; SELECTIVE-INHIBITION; MEMBRANE-TRANSPORT; NEUROPATHIC PAIN; AM404; RAT; HYDROLYSIS	N-Acylethanolamines (NAEs) are bioactive lipids that engage diverse receptor systems. Recently, we identified fatty acid-binding proteins (FABPs) as intracellular NAE carriers. Here, we provide two new functions for FABPs in NAE signaling. We demonstrate that FABPs mediate the nuclear translocation of the NAE oleoylethanolamide, an agonist of nuclear peroxisome proliferator-activated receptor alpha (PPAR alpha). Antagonism of FABP function through chemical inhibition, dominant-negative approaches, or shRNA-mediated knockdown reduced PPAR alpha activation, confirming a requisite role for FABPs in this process. In addition, we show that NAE analogs, traditionally employed as inhibitors of the putative endocannabinoid transmembrane transporter, target FABPs. Support for the existence of the putative membrane transporter stems primarily from pharmacological inhibition of endocannabinoid uptake by such transport inhibitors, which are widely employed in endocannabinoid research despite lacking a known cellular target(s). Our approach adapted FABP-mediated PPAR alpha signaling and employed in vitro binding, arachidonoyl-[1-C-14] ethanolamide ([C-14] AEA) uptake, and FABP knockdown to demonstrate that transport inhibitors exert their effects through inhibition of FABPs, thereby providing a molecular rationale for the underlying physiological effects of these compounds. Identification of FABPs as targets of transport inhibitors undermines the central pharmacological support for the existence of an endocannabinoid transmembrane transporter.	[Kaczocha, Martin; Vivieca, Stephanie; Sun, Jing; Deutsch, Dale G.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Glaser, Sherrye T.] Kingsborough Community Coll, Dept Biol Sci, Brooklyn, NY 11235 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; City University of New York (CUNY) System	Kaczocha, M (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	MKaczoch@notes.sunysb.edu		Kaczocha, Martin/0000-0002-2527-1398	National Institute on Drug Abuse [DA032232, DA021806, DA016419, DA026953]; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA021806, R01DA016419, R21DA032232, R21DA026953] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institute on Drug Abuse Grants DA032232 (to M. K.), DA021806 (to S. T. G.), and DA016419 and DA026953 (to D. G. D.).	Adermark L, 2007, P NATL ACAD SCI USA, V104, P20564, DOI 10.1073/pnas.0706873104; Adermark L, 2009, EUR J NEUROSCI, V29, P32, DOI 10.1111/j.1460-9568.2008.06551.x; Alptekin A, 2010, EUR J PHARMACOL, V634, P10, DOI 10.1016/j.ejphar.2010.02.013; Beltramo M, 1997, SCIENCE, V277, P1094, DOI 10.1126/science.277.5329.1094; Bojesen IN, 2005, J LIPID RES, V46, P1652, DOI 10.1194/jlr.M400498-JLR200; Chuang S, 2008, J MED CHEM, V51, P3755, DOI 10.1021/jm701192w; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; Day TA, 2001, MOL PHARMACOL, V59, P1369, DOI 10.1124/mol.59.6.1369; De Petrocellis L, 2000, FEBS LETT, V483, P52, DOI 10.1016/S0014-5793(00)02082-2; Deutsch DG, 2001, J BIOL CHEM, V276, P6967, DOI 10.1074/jbc.M003161200; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Fasia L, 2003, EUR J BIOCHEM, V270, P3498, DOI 10.1046/j.1432-1033.2003.03724.x; Fegley D, 2004, P NATL ACAD SCI USA, V101, P8756, DOI 10.1073/pnas.0400997101; Fezza F, 2008, J LIPID RES, V49, P1216, DOI 10.1194/jlr.M700486-JLR200; Fowler CJ, 2004, EUR J PHARMACOL, V492, P1, DOI 10.1016/j.ejphar.2004.03.048; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Fu J, 2012, NAT NEUROSCI, V15, P64, DOI 10.1038/nn.2986; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Glaser ST, 2010, J PHARMACOL EXP THER, V335, P380, DOI 10.1124/jpet.110.168831; Glaser ST, 2003, P NATL ACAD SCI USA, V100, P4269, DOI 10.1073/pnas.0730816100; Glaser ST, 2005, LIFE SCI, V77, P1584, DOI 10.1016/j.lfs.2005.05.007; Hasanein P, 2009, NEUROSCI LETT, V462, P230, DOI 10.1016/j.neulet.2009.07.026; Hogestatt ED, 2005, J BIOL CHEM, V280, P31405, DOI 10.1074/jbc.M501489200; Howlett AC, 2011, BRIT J PHARMACOL, V163, P1329, DOI 10.1111/j.1476-5381.2011.01364.x; Kaczocha M, 2006, J BIOL CHEM, V281, P9066, DOI 10.1074/jbc.M509721200; Kaczocha M, 2010, J BIOL CHEM, V285, P2796, DOI 10.1074/jbc.M109.058461; Kaczocha M, 2009, P NATL ACAD SCI USA, V106, P6375, DOI 10.1073/pnas.0901515106; Karlsson M, 2004, EUR J PHARM SCI, V22, P181, DOI 10.1016/j.ejps.2004.03.009; Kelley BG, 2004, EUR J PHARMACOL, V496, P33, DOI 10.1016/j.ejphar.2004.06.011; Kim J, 2010, NAT NEUROSCI, V13, P592, DOI 10.1038/nn.2517; La Rana G, 2008, NEUROPHARMACOLOGY, V54, P521, DOI 10.1016/j.neuropharm.2007.10.021; La Rana G, 2006, J PHARMACOL EXP THER, V317, P1365, DOI 10.1124/jpet.105.100792; Lastres-Becker I, 2003, J NEUROCHEM, V84, P1097, DOI 10.1046/j.1471-4159.2003.01595.x; Lichtman AH, 2004, PAIN, V109, P319, DOI 10.1016/j.pain.2004.01.022; Lo Verme J, 2005, MOL PHARMACOL, V67, P15, DOI 10.1124/mol.104.006353; Mallet C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012748; McFarland MJ, 2004, PHARMACOL THERAPEUT, V104, P117, DOI 10.1016/j.pharmthera.2004.07.008; Nicholson RA, 2003, BRAIN RES, V978, P194, DOI 10.1016/S0006-8993(03)02808-7; Oddi S, 2005, CELL MOL LIFE SCI, V62, P386, DOI 10.1007/s00018-004-4446-8; Oddi S, 2009, CHEM BIOL, V16, P624, DOI 10.1016/j.chembiol.2009.05.004; Ortar G, 2003, BIOCHEM PHARMACOL, V65, P1473, DOI 10.1016/S0006-2952(03)00109-6; Owada Y, 1996, J CHEM NEUROANAT, V12, P113, DOI 10.1016/S0891-0618(96)00192-5; Piomelli D, 1999, P NATL ACAD SCI USA, V96, P5802, DOI 10.1073/pnas.96.10.5802; Richieri GV, 2000, BIOCHEMISTRY-US, V39, P7197, DOI 10.1021/bi000314z; Ronesi J, 2004, J NEUROSCI, V24, P1673, DOI 10.1523/JNEUROSCI.5214-03.2004; Sagar DR, 2010, EUR J NEUROSCI, V31, P1414, DOI 10.1111/j.1460-9568.2010.07162.x; Sandberg A, 2005, CHEM PHYS LIPIDS, V134, P131, DOI 10.1016/j.chemphyslip.2004.12.010; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Spradley JM, 2010, PHARMACOL RES, V62, P249, DOI 10.1016/j.phrs.2010.03.007; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Thors L, 2006, BRIT J PHARMACOL, V149, P73, DOI 10.1038/sj.bjp.0706831; Trezza V, 2009, J PHARMACOL EXP THER, V328, P343, DOI 10.1124/jpet.108.141069; Vandevoorde S, 2005, BRIT J PHARMACOL, V145, P885, DOI 10.1038/sj.bjp.0706253; Wolfrum C, 2007, CELL MOL LIFE SCI, V64, P2465, DOI 10.1007/s00018-007-7279-4; Xu LZ, 1996, J BIOL CHEM, V271, P24711; Ziouzenkova O, 2003, P NATL ACAD SCI USA, V100, P2730, DOI 10.1073/pnas.0538015100; Zygmunt PM, 2000, EUR J PHARMACOL, V396, P39, DOI 10.1016/S0014-2999(00)00207-7	59	117	121	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3415	3424		10.1074/jbc.M111.304907	http://dx.doi.org/10.1074/jbc.M111.304907			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22170058	hybrid, Green Published			2022-12-25	WOS:000300295100046
J	Dubois, A; Remay, A; Raymond, O; Balzergue, S; Chauvet, A; Maene, M; Pecrix, Y; Yang, SH; Jeauffre, J; Thouroude, T; Boltz, V; Martin-Magniette, ML; Janczarski, S; Legeai, F; Renou, JP; Vergne, P; Le Bris, M; Foucher, F; Bendahmane, M				Dubois, Annick; Remay, Arnaud; Raymond, Olivier; Balzergue, Sandrine; Chauvet, Aurelie; Maene, Marion; Pecrix, Yann; Yang, Shu-Hua; Jeauffre, Julien; Thouroude, Tatiana; Boltz, Veronique; Martin-Magniette, Marie-Laure; Janczarski, Stephane; Legeai, Fabrice; Renou, Jean-Pierre; Vergne, Philippe; Le Bris, Manuel; Foucher, Fabrice; Bendahmane, Mohammed			Genomic Approach to Study Floral Development Genes in Rosa sp.	PLOS ONE			English	Article							MADS-BOX GENES; O-METHYLTRANSFERASES; ARABIDOPSIS; EXPRESSION; SYNTHASE; ACETYLTRANSFERASE; BIOSYNTHESIS; EVOLUTION; SCENT; PETAL	Cultivated for centuries, the varieties of rose have been selected based on a number of flower traits. Understanding the genetic and molecular basis that contributes to these traits will impact on future improvements for this economically important ornamental plant. In this study, we used scanning electron microscopy and sections of meristems and flowers to establish a precise morphological calendar from early rose flower development stages to senescing flowers. Global gene expression was investigated from floral meristem initiation up to flower senescence in three rose genotypes exhibiting contrasted floral traits including continuous versus once flowering and simple versus double flower architecture, using a newly developed Affymetrix microarray (Rosa1_Affyarray) tool containing sequences representing 4765 unigenes expressed during flower development. Data analyses permitted the identification of genes associated with floral transition, floral organs initiation up to flower senescence. Quantitative real time PCR analyses validated the mRNA accumulation changes observed in microarray hybridizations for a selection of 24 genes expressed at either high or low levels. Our data describe the early flower development stages in Rosa sp, the production of a rose microarray and demonstrate its usefulness and reliability to study gene expression during extensive development phases, from the vegetative meristem to the senescent flower.	[Dubois, Annick; Raymond, Olivier; Chauvet, Aurelie; Maene, Marion; Yang, Shu-Hua; Boltz, Veronique; Janczarski, Stephane; Vergne, Philippe; Bendahmane, Mohammed] Ecole Normale Super Lyon, CNRS, Inst Natl Rech Agron, Lab Reprod & Dev Plantes, F-69364 Lyon, France; [Balzergue, Sandrine; Martin-Magniette, Marie-Laure; Renou, Jean-Pierre] CNRS, Inst Natl Rech Agron, Unite Rech Genom Vegetale, Evry, France; [Pecrix, Yann; Le Bris, Manuel] Univ Aix Marseille 3, CNRS, Inst Mediterrane Ecol & Paleoecol, Marseille, France; [Remay, Arnaud; Jeauffre, Julien; Thouroude, Tatiana; Renou, Jean-Pierre; Foucher, Fabrice] Univ Angers, Inst Natl Rech Agron, UMR Genet & Hort, Beaucouze, France; [Legeai, Fabrice] INRA, Equipe Symbiose Campus Beaulieu, UMR Bio3P IRISA, Rennes, France	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; INRAE; Universite d'Angers; INRAE	Dubois, A (corresponding author), Ecole Normale Super Lyon, CNRS, Inst Natl Rech Agron, Lab Reprod & Dev Plantes, F-69364 Lyon, France.	mohammed.bendahmane@ens-lyon.fr	Bendahmane, Mohammed/AAX-1296-2020; Foucher, Fabrice/AAJ-5069-2021; Raymond, Olivier/AAO-5868-2020; Dubois, Annick/AAX-2219-2021	Bendahmane, Mohammed/0000-0003-1661-1060; Foucher, Fabrice/0000-0002-3693-7183; Raymond, Olivier/0000-0002-9664-5377; Dubois, Annick/0000-0002-3646-3811; Legeai, Fabrice/0000-0002-6472-4839; Pecrix, Yann/0000-0002-6537-3145	Departments of the French Institut National de la Recherche Agronomique; Region Rhones-Alpes; Region Rhone Alpes; The Region PACA; Region Pays de la Loire; French 'Institut National de la Recherche Agronomique	Departments of the French Institut National de la Recherche Agronomique; Region Rhones-Alpes(Region Auvergne-Rhone-Alpes); Region Rhone Alpes(Region Auvergne-Rhone-Alpes); The Region PACA(Region Provence-Alpes-Cote d'Azur); Region Pays de la Loire(Region Pays de la Loire); French 'Institut National de la Recherche Agronomique	This work was funded by the "Biologie Vegetale" and the "Genetique et Amelioration des Plantes" Departments of the French Institut National de la Recherche Agronomique, and by the Region Rhones-Alpes. Dr. Maene, Dr. Pecrix and Dr. Remay were supported by funds from the Region Rhone Alpes (Dr. Maene), The Region PACA (Dr. Pecrix) and by a joint grant from Region Pays de la Loire and the French 'Institut National de la Recherche Agronomique" (Dr. Remay). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amasino R, 2010, PLANT J, V61, P1001, DOI 10.1111/j.1365-313X.2010.04148.x; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; BENNETT MJ, 2007, PLANT CELL, V19, P2186; Bishopp A, 2006, DEVELOPMENT, V133, P1857, DOI 10.1242/dev.02359; Borner R, 2000, PLANT J, V24, P591, DOI 10.1046/j.1365-313x.2000.00906.x; Channeliere S, 2002, FEBS LETT, V515, P35, DOI 10.1016/S0014-5793(02)02413-4; Cheng H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000440; CHIMONIDOU D, 2003, ENCY ROSE SCI, P504; COPPACK SW, 1990, CLIN SCI, V79, P287, DOI 10.1042/cs0790287; Das P, 2009, DEVELOPMENT, V136, P1605, DOI 10.1242/dev.035436; Dubois A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009288; Fornara F, 2010, CELL, V141, DOI 10.1016/j.cell.2010.04.024; Foster T, 2003, ANN BOT-LONDON, V92, P199, DOI 10.1093/aob/mcg120; Foucher F, 2008, GENOME, V51, P827, DOI 10.1139/G08-067; Gagnot S, 2008, NUCLEIC ACIDS RES, V36, pD986, DOI 10.1093/nar/gkm757; Ge YC, 2003, TEST-SPAIN, V12, P1, DOI 10.1007/BF02595811; GENTLEMAN R, 2002, RNEWS, V2, P1116; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gudin S, 2001, ACTA HORTIC, P23, DOI 10.17660/ActaHortic.2001.547.2; Gudin S., 2000, Plant Breeding Reviews, V17, P159; Guterman I, 2006, PLANT MOL BIOL, V60, P555, DOI 10.1007/s11103-005-4924-x; Guterman I, 2002, PLANT CELL, V14, P2325, DOI 10.1105/tpc.005207; Hortensteiner S, 2009, TRENDS PLANT SCI, V14, P155, DOI 10.1016/j.tplants.2009.01.002; Irizarry RA, 2003, STAT APPL GENET MOL, V2, DOI DOI 10.2202/1544-6115.1002; Kaminaga Y, 2006, J BIOL CHEM, V281, P23357, DOI 10.1074/jbc.M602708200; KANG BG, 1971, PLANT PHYSIOL, V47, P504, DOI 10.1104/pp.47.4.504; Kaufmann K, 2010, SCIENCE, V328, P85, DOI 10.1126/science.1185244; Kitahara K, 2004, PLANT SCI, V166, P1245, DOI 10.1016/j.plantsci.2003.12.040; Kitahara K, 2001, PLANT SCI, V161, P549, DOI 10.1016/S0168-9452(01)00442-3; KOVATS ES, 1987, J CHROMATOGR, V406, P185; Kroes GMLW, 1998, EUR J PLANT PATHOL, V104, P725, DOI 10.1023/A:1008604417614; Krussmann G., 1981, BAUMSCHULE, V5th ed, P565; Lavid N, 2002, PLANT PHYSIOL, V129, P1899, DOI 10.1104/pp.005330; Liu YS, 2004, J CHROMATOGR SCI, V42, P545, DOI 10.1093/chromsci/42.10.545; Ma N, 2006, J EXP BOT, V57, P2763, DOI 10.1093/jxb/erl033; Maier AT, 2009, DEVELOPMENT, V136, P1613, DOI 10.1242/dev.033647; Martin M, 2001, THEOR APPL GENET, V102, P398, DOI 10.1007/s001220051660; Nakamura S., 1987, Perfumer & Flavorist, V12, P43; Ogata J, 2005, NATURE, V435, P757, DOI 10.1038/nature435757a; Remay A, 2009, THEOR APPL GENET, V119, P767, DOI 10.1007/s00122-009-1087-1; Reynders-Aloisi S., 1996, Acta Horticulturae, P253; Roberts AV, 1999, J PLANT GROWTH REGUL, V18, P113, DOI 10.1007/PL00007058; Sane AP, 2007, PLANT SCI, V172, P481, DOI 10.1016/j.plantsci.2006.10.005; Scalliet G, 2006, PLANT PHYSIOL, V140, P18, DOI 10.1104/pp.105.070961; Scalliet G, 2002, FEBS LETT, V523, P113, DOI 10.1016/S0014-5793(02)02956-3; Scalliet G, 2008, P NATL ACAD SCI USA, V105, P5927, DOI 10.1073/pnas.0711551105; Shalit M, 2003, PLANT PHYSIOL, V131, P1868, DOI 10.1104/pp.102.018572; SINGH AP, 2011, J EXP BOT; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Spellman PT, 2002, GENOME BIOL, V3; Spiller M, 2010, THEOR APPL GENET, V120, P1461, DOI 10.1007/s00122-010-1268-y; Stead A, 2007, COMP BIOCHEM PHYS A, V146, pS199, DOI 10.1016/j.cbpa.2007.01.439; THEOLOGIS A, 2009, GENETICS, V183, P979; Tsuchisaka A, 2004, P NATL ACAD SCI USA, V101, P2275, DOI 10.1073/pnas.0308515101; Vanneste S, 2011, EMBO J, V30, P3430, DOI 10.1038/emboj.2011.240; Vries D. P. de, 1996, Acta Horticulturae, P241; Wellmer F, 2006, PLOS GENET, V2, P1012, DOI 10.1371/journal.pgen.0020117; Yamagami T, 2003, J BIOL CHEM, V278, P49102, DOI 10.1074/jbc.M308297200	58	35	38	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28455	10.1371/journal.pone.0028455	http://dx.doi.org/10.1371/journal.pone.0028455			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194838	Green Published, Green Submitted, gold			2022-12-25	WOS:000298369100041
J	Shankar, J; Wu, TD; Clemons, KV; Monteiro, JP; Mirels, LF; Stevens, DA				Shankar, Jata; Wu, Thomas D.; Clemons, Karl V.; Monteiro, Jomar P.; Mirels, Laurence F.; Stevens, David A.			Influence of 17 beta-Estradiol on Gene Expression of Paracoccidioides during Mycelia-to-Yeast Transition	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; PATHOGENIC FUNGUS; PENICILLIUM-MARNEFFEI; DIFFERENTIAL EXPRESSION; TRANSCRIPTOME ANALYSIS; BRASILIENSIS REVEALS; MOLECULAR CHAPERONES; GROWTH-INHIBITION; CANDIDA-ALBICANS; HSP70 GENE	Background: Paracoccidioides is the causative agent of paracoccidioidomycosis, a systemic mycosis endemic to Latin America. Infection is initiated by inhalation of conidia (C) or mycelial (M) fragments, which subsequently differentiate into yeast (Y). Epidemiological studies show a striking predominance of paracoccidioidomycosis in adult men compared to premenopausal women. In vitro and in vivo studies suggest that the female hormone (17 beta-estradiol, E-2) regulates or inhibits M-or-C-to-Y transition. In this study we have profiled transcript expression to understand the molecular mechanism of how E-2 inhibits M-to-Y transition. Methodology: We assessed temporal gene expression in strain Pb01 in the presence or absence of E-2 at various time points through 9 days of the M-to-Y transition using an 11,000 element random-shear genomic DNA microarray and verified the results using quantitative real time-PCR. E-2-regulated clones were sequenced to identify genes and biological function. Principal Findings: E-2-treatment affected gene expression of 550 array elements, with 331 showing up-regulation and 219 showing down-regulation at one or more time points (p <= 0.001). Genes with low expression after 4 or 12 h exposure to E-2 belonged to pathways involved in heat shock response (hsp90 and hsp70), energy metabolism, and several retrotransposable elements. Y-related genes, alpha-1,3-glucan synthase, mannosyltransferase and Y20, demonstrated low or delayed expression in E-2-treated cultures. Genes potentially involved in signaling, such as palmitoyltransferase (erf2), small GTPase RhoA, phosphatidylinositol-4-kinase, and protein kinase (serine/threonine) showed low expression in the presence of E-2, whereas a gene encoding for an arrestin domain-containing protein showed high expression. Genes related to ubiquitin-mediated protein degradation, and oxidative stress response genes were up-regulated by E-2. Conclusion: This study characterizes the effect of E-2 at the molecular level on the inhibition of the M-to-Y transition and is indicative that the inhibitory actions of E-2 may be working through signaling genes that regulate dimorphism.	[Shankar, Jata; Clemons, Karl V.; Monteiro, Jomar P.; Mirels, Laurence F.; Stevens, David A.] Santa Clara Valley Med Ctr, Calif Inst Med Res, San Jose, CA 95128 USA; [Shankar, Jata; Clemons, Karl V.; Monteiro, Jomar P.; Mirels, Laurence F.; Stevens, David A.] Santa Clara Valley Med Ctr, Div Infect Dis, Dept Med, San Jose, CA 95128 USA; [Shankar, Jata; Clemons, Karl V.; Monteiro, Jomar P.; Mirels, Laurence F.; Stevens, David A.] Stanford Univ, Dept Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA; [Wu, Thomas D.] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA	Santa Clara Valley Medical Center; Santa Clara Valley Medical Center; Stanford University; Roche Holding; Genentech	Shankar, J (corresponding author), Santa Clara Valley Med Ctr, Calif Inst Med Res, San Jose, CA 95128 USA.	Clemons@cimr.org	shankar, jata/I-2675-2019; Monteiro, Jomar Patricio/ABF-7207-2021	shankar, jata/0000-0003-4993-9580; Monteiro, Jomar Patricio/0000-0002-5979-0305				Almeida AJ, 2007, FUNGAL GENET BIOL, V44, P25, DOI 10.1016/j.fgb.2006.06.003; Almeida AJ, 2009, FUNGAL GENET BIOL, V46, P919, DOI 10.1016/j.fgb.2009.08.004; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aristizabal BH, 2002, MED MYCOL, V40, P169, DOI 10.1080/mmy.40.2.169.178; Aristizabal BH, 1998, INFECT IMMUN, V66, P5587, DOI 10.1128/IAI.66.11.5587-5591.1998; Bailao AM, 2007, FEMS IMMUNOL MED MIC, V51, P43, DOI 10.1111/j.1574-695X.2007.00277.x; Bartels DJ, 1999, MOL CELL BIOL, V19, P6775, DOI 10.1128/mcb.19.10.6775; Bastos KP, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-29; Batista WL, 2006, EUKARYOT CELL, V5, P379, DOI 10.1128/EC.5.2.379-390.2006; Bicalho RN, 2001, ORAL DIS, V7, P56, DOI 10.1034/j.1601-0825.2001.0070111.x; Blotta MHSL, 1999, AM J TROP MED HYG, V61, P390, DOI 10.4269/ajtmh.1999.61.390; Borges-Walmsley MI, 2002, TRENDS MICROBIOL, V10, P80, DOI 10.1016/S0966-842X(01)02292-2; Boyce KJ, 2005, MOL MICROBIOL, V55, P1487, DOI 10.1111/j.1365-2958.2005.04485.x; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; BRUMMER E, 1993, CLIN MICROBIOL REV, V6, P89, DOI 10.1128/CMR.6.2.89-117.1993; Burnie JR, 2006, FEMS MICROBIOL REV, V30, P53, DOI 10.1111/j.1574-6976.2005.00001.x; Campos CBL, 2008, EUKARYOT CELL, V7, P1856, DOI 10.1128/EC.00110-08; Cano MIN, 1998, J CLIN MICROBIOL, V36, P742, DOI 10.1128/JCM.36.3.742-747.1998; CARBONELL LM, 1965, J BACTERIOL, V90, P504, DOI 10.1128/JB.90.2.504-510.1965; Carrero LL, 2008, FUNGAL GENET BIOL, V45, P605, DOI 10.1016/j.fgb.2008.02.002; Castillo J., 1994, Biomedica, V14, P230; Chandler JM, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-17; Chen DL, 2007, MOL MICROBIOL, V65, P761, DOI 10.1111/j.1365-2958.2007.05824.x; Cheng G, 2006, EUKARYOT CELL, V5, P180, DOI 10.1128/EC.5.1.180-191.2006; Clemons KV, 2010, MICROBIAL ENDOCRINOLOGY: INTERKINGDOM SIGNALING IN INFECTIOUS DISEASE AND HEALTH, P269, DOI 10.1007/978-1-4419-5576-0_15; CLEMONS KV, 1989, J BIOL CHEM, V264, P11186; CLEMONS KV, 1989, J GEN MICROBIOL, V135, P1607; Costa M, 2007, MICROBIOL-SGM, V153, P4194, DOI 10.1099/mic.0.2007/009332-0; CYR DM, 1994, TRENDS BIOCHEM SCI, V19, P176, DOI 10.1016/0968-0004(94)90281-X; da Silva SP, 1999, MOL MICROBIOL, V31, P1039, DOI 10.1046/j.1365-2958.1999.01236.x; de Carvalho MJA, 2003, FUNGAL GENET BIOL, V39, P204, DOI 10.1016/S1087-1845(03)00044-6; Dummitt B, 2005, J BIOL CHEM, V280, P14356, DOI 10.1074/jbc.M501059200; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Felipe MSS, 2005, J BIOL CHEM, V280, P24706, DOI 10.1074/jbc.M500625200; Felipe MSS, 2003, YEAST, V20, P263, DOI 10.1002/yea.964; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; Francoise S, 2010, MED MYCOL, V48, P35, DOI 10.3109/13693780802713356; Garcia AM, 2010, MED MYCOL, V48, P147, DOI 10.3109/13693780903055673; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Graham TR, 2011, TRENDS CELL BIOL, V21, P113, DOI 10.1016/j.tcb.2010.10.002; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Jeraj N, 2005, FEMS MICROBIOL LETT, V242, P147, DOI 10.1016/j.femsle.2004.10.051; Johnson JL, 2000, MOL CELL BIOL, V20, P3027, DOI 10.1128/MCB.20.9.3027-3036.2000; KANETSUNA F, 1972, J BACTERIOL, V110, P208, DOI 10.1128/JB.110.1.208-218.1972; KANETSUNA F, 1969, J BACTERIOL, V97, P1036, DOI 10.1128/JB.97.3.1036-1041.1969; Kauffmann A, 2009, BIOINFORMATICS, V25, P2092, DOI 10.1093/bioinformatics/btp354; Kelley WL, 1999, CURR BIOL, V9, pR305, DOI 10.1016/S0960-9822(99)80185-7; Klein BS, 2007, CURR OPIN MICROBIOL, V10, P314, DOI 10.1016/j.mib.2007.04.002; Knoblauch R, 1999, MOL CELL BIOL, V19, P3748; Krishnamurthy S, 1998, FEMS MICROBIOL LETT, V158, P69, DOI 10.1111/j.1574-6968.1998.tb12802.x; Kummasook A, 2007, DNA SEQUENCE, V18, P385, DOI 10.1080/10425170701309012; Lacaz CS, 2002, TRATADO MICOLOGIA ME, V9th, P639; Lee AJ, 2003, ENDOCRINOLOGY, V144, P3382, DOI 10.1210/en.2003-0192; Londero AT, 1990, JORNAL PNEU MOLOGIA, V16, P129; LOOSE DS, 1983, P NATL ACAD SCI-BIOL, V80, P7659, DOI 10.1073/pnas.80.24.7659; Luttrell LM, 2010, PHARMACOL REV, V62, P305, DOI 10.1124/pr.109.002436; Marini MM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-130; Marques ER, 2004, MOL GENET GENOMICS, V271, P667, DOI 10.1007/s00438-004-1016-6; Monteiro JP, 2009, MICROBIOL-SGM, V155, P2795, DOI 10.1099/mic.0.027441-0; Neuveglise C, 2002, GENOME RES, V12, P930, DOI 10.1101/gr.219202; Nicola AM, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-158; Nino-Vega GA, 2004, MED MYCOL, V42, P51, DOI 10.1080/1369378031000153811; Nunes LR, 2005, EUKARYOT CELL, V4, P2115, DOI 10.1128/EC.4.12.2115-2128.2005; Parente JA, 2008, MYCOPATHOLOGIA, V165, P259, DOI 10.1007/s11046-007-9078-8; PARIS S, 1985, MYCOPATHOLOGIA, V92, P115, DOI 10.1007/BF00444093; Pereira M, 2009, MEM I OSWALDO CRUZ, V104, P486, DOI 10.1590/S0074-02762009000300015; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; RESTREPO A, 1984, INFECT IMMUN, V46, P346, DOI 10.1128/IAI.46.2.346-353.1984; RESTREPO A, 1980, J CLIN MICROBIOL, V12, P279, DOI 10.1128/JCM.12.2.279-281.1980; RESTREPO A, 2010, CLIN MYCOLO IN PRESS; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rooney PJ, 2002, CELL MICROBIOL, V4, P127, DOI 10.1046/j.1462-5822.2002.00179.x; SALAZAR ME, 1988, INFECT IMMUN, V56, P711, DOI 10.1128/IAI.56.3.711-713.1988; Semighini CP, 2002, APPL ENVIRON MICROB, V68, P1351, DOI 10.1128/AEM.68.3.1351-1357.2002; Shankar J, 2011, CLIN MICROBIOL REV, V24, P296, DOI 10.1128/CMR.00062-10; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Mendes-Giannini MJS, 2008, MYCOPATHOLOGIA, V165, P237, DOI 10.1007/s11046-007-9074-z; STOVER EP, 1986, INFECT IMMUN, V51, P199, DOI 10.1128/IAI.51.1.199-203.1986; Teixeira MM, 2009, MOL PHYLOGENET EVOL, V52, P273, DOI 10.1016/j.ympev.2009.04.005; Vigh L, 1998, TRENDS BIOCHEM SCI, V23, P369, DOI 10.1016/S0968-0004(98)01279-1; VILLAR LAC, 1992, MED UIS, V16, P182	81	34	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28402	10.1371/journal.pone.0028402	http://dx.doi.org/10.1371/journal.pone.0028402			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194832	Green Published, Green Submitted, gold			2022-12-25	WOS:000298369100035
J	Tweya, H; Kanyerere, H; Ben-Smith, A; Kwanjana, J; Jahn, A; Feldacker, C; Gareta, D; Mbetewa, L; Kagoli, M; Kalulu, MT; Weigel, R; Phiri, S; Edginton, M				Tweya, Hannock; Kanyerere, Henry; Ben-Smith, Anne; Kwanjana, John; Jahn, Andreas; Feldacker, Caryl; Gareta, Dickman; Mbetewa, Limbani; Kagoli, Mathew; Kalulu, Mike Tikhalenawo; Weigel, Ralf; Phiri, Sam; Edginton, Mary			Re-Treatment Tuberculosis Cases Categorised as "Other": Are They Properly Managed?	PLOS ONE			English	Article							NEGATIVE PULMONARY TUBERCULOSIS; HUMAN-IMMUNODEFICIENCY-VIRUS; TREATMENT OUTCOMES; MALAWI; DIAGNOSIS; INDIA	Background: Although the World Health Organization (WHO) provides information on the number of TB patients categorised as "other", there is limited information on treatment regimens or treatment outcomes for "other". Such information is important, as inappropriate treatment can lead to patients remaining infectious and becoming a potential source of drug resistance. Therefore, using a cohort of TB patients from a large registration centre in Lilongwe, Malawi, our study determined the proportion of all TB re-treatment patients who were registered as "other", and described their characteristics and treatment outcomes. Methods: This retrospective observational study used routine program data to determine the proportion of all TB retreatment patients who were registered as "other" and describe their characteristics and treatment outcomes between January 2006 and December 2008. Results: 1,384 (12%) of 11,663 TB cases were registered as re-treatment cases. Of these, 898 (65%) were categorised as "other": 707 (79%) had sputum smear-negative pulmonary TB and 191 (21%) had extra pulmonary TB. Compared to the smear-positive relapse, re-treatment after default (RAD) and failure cases, smear-negative "other" cases were older than 34 years and less likely to have their HIV status ascertained. Among those with known HIV status, "other" TB cases were more likely to be HIV positive. Of TB patients categorised as "other", 462 (51%) were managed on the first-line regimen with a treatment success rate of 63%. Conclusion: A large proportion of re-treatment patients were categorised as "other". Many of these patients were HIVinfected and over half were treated with a first-line regimen, contrary to national guidelines. Treatment success was low. More attention to recording, diagnosis and management of these patients is warranted as incorrect treatment regimen and poor outcomes could lead to the development of drug resistant forms of TB.	[Tweya, Hannock; Edginton, Mary] Int Union TB & Lung Dis, Paris, France; [Tweya, Hannock; Feldacker, Caryl; Gareta, Dickman; Kalulu, Mike Tikhalenawo; Weigel, Ralf; Phiri, Sam] Lighthouse Trust, Lilongwe, Malawi; [Kanyerere, Henry; Kwanjana, John; Mbetewa, Limbani; Kagoli, Mathew] Minist Hlth, Natl TB Control Programme, Lilongwe, Malawi; [Ben-Smith, Anne] Maame Akua, Lilongwe, Malawi; [Jahn, Andreas] Minist Hlth, Dept HIV & AIDS, Ctr Monitoring & Evaluat Dept, Lilongwe, Malawi; [Jahn, Andreas; Feldacker, Caryl] Univ Washington, Int Training & Educ Ctr Hlth, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Tweya, H (corresponding author), Int Union TB & Lung Dis, Paris, France.	h_tweya@lighthouse.org.mw	Weigel, Ralf/ABD-2310-2020; Jahn, Andreas/ABB-7796-2020	Weigel, Ralf/0000-0001-9034-2634; Jahn, Andreas/0000-0003-4645-1600; Feldacker, Caryl/0000-0002-8152-6754	United States Agency for International Development (USAID) via USAID	United States Agency for International Development (USAID) via USAID(United States Agency for International Development (USAID))	This research was made possible, in part, by the generous support of the American people through the United States Agency for International Development (USAID) via the USAID-funded TREAT TB Initiative. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government. No additional external funding was received for this study.	Balasubramanian R, 2004, INT J TUBERC LUNG D, V8, P323; Basu S, 2009, P NATL ACAD SCI USA, V106, P7672, DOI 10.1073/pnas.0812472106; Hargreaves NJ, 2001, T ROY SOC TROP MED H, V95, P402, DOI 10.1016/S0035-9203(01)90197-X; Hargreaves NJ, 2001, INT J TUBERC LUNG D, V5, P113; Harries AD, 2003, TROP DOCT, V33, P7, DOI 10.1177/004947550303300106; Harries AD, 2001, INT J TUBERC LUNG D, V5, P1143; Johnson Jasmin, 2003, Indian J Chest Dis Allied Sci, V45, P105; Jones-Lopez EC, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000427; Kironde S, 2002, INT J TUBERC LUNG D, V6, P599; Korenromp EL, 2003, CLIN INFECT DIS, V37, P101, DOI 10.1086/375220; Lefebvre N, 2008, EUR RESPIR J, V31, P1256, DOI 10.1183/09031936.00131107; MacDougall D S, 1999, J Int Assoc Physicians AIDS Care, V5, P20; Mak A, 2008, AM J RESP CRIT CARE, V178, P306, DOI 10.1164/rccm.200802-240OC; *MOH, 2007, MAL NAT TUB CONTR PR; Murray J, 1999, AM J RESP CRIT CARE, V159, P733, DOI 10.1164/ajrccm.159.3.9804147; Srinath S, 2011, INT J TUBERC LUNG D, V15, P105; WHO, 2009, TREATM TUB GUID NAT; *WHO, 2006, STRENGTH TEACH TUB C; World Health Organization, 2003, TREATM TUB GUID NAT, DOI DOI 10.1016/S0035-9203(99)90185-2; World Health Organization, 2009, GLOB TUB CONTR EP ST	20	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28034	10.1371/journal.pone.0028034	http://dx.doi.org/10.1371/journal.pone.0028034			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194804	Green Published, gold, Green Submitted			2022-12-25	WOS:000298369100019
J	Sab, AB; Bouchard, MF; Beland, M; Prud'homme, B; Souchkova, O; Viger, RS; Pilon, N				Sab, Alain Boulende; Bouchard, Marie-France; Beland, Melanie; Prud'homme, Bruno; Souchkova, Ouliana; Viger, Robert S.; Pilon, Nicolas			An Ebox Element in the Proximal Gata4 Promoter Is Required for Gata4 Expression In Vivo	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; GENE-EXPRESSION; BINDING-SITES; MICE; HEART; DETERMINANTS; ENHANCER; RNA	GATA4 is an essential transcription factor required for the development and function of multiple tissues, including a major role in gonadogenesis. Despite its crucial role, the molecular mechanisms that regulate Gata4 expression in vivo remain poorly understood. We recently found that the Gata4 gene is expressed as multiple transcripts with distinct 5' origins. These co-expressed alternative transcripts are generated by different non-coding first exons with transcripts E1a and E1b being the most prominent. Moreover, we previously showed that an Ebox element, located in Gata4 5' flanking sequences upstream of exon 1a, is important for the promoter activity of these sequences in cell lines. To confirm the importance of this element in vivo, we generated and characterized Gata4 Ebox knockout mice. Quantitative PCR analyses realized on gonads, heart and liver at three developmental stages (embryonic, pre-pubertal and adult) revealed that the Ebox mutation leads to a robust and specific decrease (up to 89%) of Gata4 E1a transcript expression in all tissues and stages examined. However, a detailed characterization of the gonads revealed normal morphology and GATA4 protein levels in these mutants. Our qPCR data further indicate that this outcome is most likely due to the presence of Gata4 E1b mRNA, whose expression levels were not decreased by the Ebox mutation. In conclusion, our work clearly confirms the importance of the proximal Ebox element and suggests that adequate GATA4 protein expression is likely protected by a compensation mechanism between Gata4 E1a and E1b transcripts operating at the translational level.	[Sab, Alain Boulende; Beland, Melanie; Souchkova, Ouliana; Pilon, Nicolas] Univ Quebec Montreal, Fac Sci, Dept Biol Sci, Montreal, PQ, Canada; [Sab, Alain Boulende; Beland, Melanie; Souchkova, Ouliana; Pilon, Nicolas] Univ Quebec Montreal, Fac Sci, Biomed Res Ctr, Montreal, PQ, Canada; [Sab, Alain Boulende; Bouchard, Marie-France; Prud'homme, Bruno; Viger, Robert S.] Univ Laval, Fac Med, Dept Obstet & Gynecol, CHUQ Res Ctr, Quebec City, PQ G1K 7P4, Canada; [Sab, Alain Boulende; Bouchard, Marie-France; Prud'homme, Bruno; Viger, Robert S.] Univ Laval, Fac Med, Dept Obstet & Gynecol, CRBR, Quebec City, PQ G1K 7P4, Canada	University of Quebec; University of Quebec Montreal; University of Quebec; University of Quebec Montreal; Laval University; Laval University	Sab, AB (corresponding author), Univ Quebec Montreal, Fac Sci, Dept Biol Sci, Montreal, PQ, Canada.	robert.viger@crchul.ulaval.ca; pilon.nicolas@uqam.ca			(Universite a du Quebec a Montreal) UQAM; Canadian Institutes of Health Research (CIHR) [MOP-14796]	(Universite a du Quebec a Montreal) UQAM; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	ABS is supported by a (Universite a du Quebec a Montreal) UQAM scholarship, RSV holds the Canada Research Chair in Reproduction and Sex Development and NP is a Fonds de Recherche Sante (FRSQ) Jr1 Scholar. This work was supported by Canadian Institutes of Health Research (CIHR) grant MOP-14796 to RSV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anttonen M, 2003, BIOL REPROD, V68, P1333, DOI 10.1095/biolreprod.102.008599; Bossard P, 1998, DEVELOPMENT, V125, P4909; Burch JBE, 2005, SEMIN CELL DEV BIOL, V16, P71, DOI 10.1016/j.semcdb.2004.10.002; Gingold H, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.14; Guittot SM, 2007, BIOL REPROD, V76, P85, DOI 10.1095/biolreprod.106.055137; Guittot SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008454; Heicklen-Klein A, 2004, DEV BIOL, V267, P490, DOI 10.1016/j.ydbio.2003.09.042; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; Kwon GS, 2009, GENESIS, V47, P447, DOI 10.1002/dvg.20522; Kyronlahti A, 2011, MOL CELL ENDOCRINOL, V333, P85, DOI 10.1016/j.mce.2010.12.019; Manuylov NL, 2011, DEV BIOL, V353, P229, DOI 10.1016/j.ydbio.2011.02.032; Manuylov NL, 2008, DEVELOPMENT, V135, P3731, DOI 10.1242/dev.024653; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Nagy A., 2003, MANIPULATING MOUSE E; Narita N, 1997, DEV BIOL, V189, P270, DOI 10.1006/dbio.1997.8684; Nel-Themaat L, 2011, BIOL REPROD, V84, P342, DOI 10.1095/biolreprod.110.086900; Ohara Y, 2006, BIOL PHARM BULL, V29, P410, DOI 10.1248/bpb.29.410; Pilon N, 2008, DEV DYNAM, V237, P1133, DOI 10.1002/dvdy.21496; Pilon N, 2007, DEVELOPMENT, V134, P2315, DOI 10.1242/dev.001206; Rojas A, 2005, DEVELOPMENT, V132, P3405, DOI 10.1242/dev.01913; Rojas A, 2010, DEV BIOL, V346, P346, DOI 10.1016/j.ydbio.2010.07.032; Rojas A, 2009, DEV DYNAM, V238, P2588, DOI 10.1002/dvdy.22091; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Tevosian SG, 2002, DEVELOPMENT, V129, P4627; Thurisch B, 2009, J MOL ENDOCRINOL, V43, P157, DOI 10.1677/JME-09-0030; Viger RS, 2008, MOL ENDOCRINOL, V22, P781, DOI 10.1210/me.2007-0513; Viger RS, 1998, DEVELOPMENT, V125, P2665; Wang LJ, 2001, PLANT PHYSIOL, V125, P1380, DOI 10.1104/pp.125.3.1380	30	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e29038	10.1371/journal.pone.0029038	http://dx.doi.org/10.1371/journal.pone.0029038			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174950	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000298367300042
J	Gabriel, SI; Stevens, MI; Mathias, MD; Searle, JB				Gabriel, Sofia I.; Stevens, Mark I.; Mathias, Maria da Luz; Searle, Jeremy B.			Of Mice and 'Convicts': Origin of the Australian House Mouse, Mus musculus	PLOS ONE			English	Article							MITOCHONDRIAL-DNA VARIATION; COLONIZATION; PHYLOGEOGRAPHY; POPULATIONS; INVASIONS; EVOLUTION; PATTERNS; INSIGHTS; GENETICS	The house mouse, Mus musculus, is one of the most ubiquitous invasive species worldwide and in Australia is particularly common and widespread, but where it originally came from is still unknown. Here we investigated this origin through a phylogeographic analysis of mitochondrial DNA sequences (D-loop) comparing mouse populations from Australia with those from the likely regional source area in Western Europe. Our results agree with human historical associations, showing a strong link between Australia and the British Isles. This outcome is of intrinsic and applied interest and helps to validate the colonization history of mice as a proxy for human settlement history.	[Gabriel, Sofia I.; Searle, Jeremy B.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Gabriel, Sofia I.; Mathias, Maria da Luz] Univ Lisbon, Fac Ciencias, Dept Biol Anim, CESAM Ctr Environm & Marine Studies, Lisbon, Portugal; [Stevens, Mark I.] Univ Adelaide, S Australian Museum, Adelaide, SA, Australia; [Stevens, Mark I.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA, Australia; [Searle, Jeremy B.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA	University of York - UK; Universidade de Lisboa; University of Adelaide; University of Adelaide; Cornell University	Gabriel, SI (corresponding author), Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England.	jeremy.searle@cornell.edu	Gabriel, Sofia I/C-1770-2013; da Luz Mathias, Maria/V-9931-2018	Gabriel, Sofia I/0000-0003-3702-4631; da Luz Mathias, Maria/0000-0003-3876-958X; Searle, Jeremy/0000-0001-7710-5204	Fundacao para a Ciencia e a Tecnologia (Portugal); Microsoft Corporation	Fundacao para a Ciencia e a Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Microsoft Corporation(Microsoft)	Fundacao para a Ciencia e a Tecnologia (Portugal) provided funding. Part of this work was carried out by using the resources of the Computational Biology Service Unit from Cornell University which is partially funded by Microsoft Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begun DJ, 2007, PLOS BIOL, V5, P2534, DOI 10.1371/journal.pbio.0050310; Bonhomme F, 2011, P ROY SOC B-BIOL SCI, V278, P1034, DOI 10.1098/rspb.2010.1228; BOURSOT P, 1993, ANNU REV ECOL SYST, V24, P119, DOI 10.1146/annurev.es.24.110193.001003; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FIGUEROA F, 1986, CURR TOP MICROBIOL, V127, P229; Forster DW, 2009, MOL ECOL, V18, P4477, DOI 10.1111/j.1365-294X.2009.04344.x; Gabriel SI, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-131; Gunduz I, 2005, BIOL J LINN SOC, V84, P473, DOI 10.1111/j.1095-8312.2005.00448.x; Hardouin EA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-325; Ihle S, 2006, MOL BIOL EVOL, V23, P790, DOI 10.1093/molbev/msj096; Jones EP, 2011, J ZOOL, V283, P257, DOI 10.1111/j.1469-7998.2010.00767.x; Jones EP, 2011, BIOL J LINN SOC, V102, P471, DOI 10.1111/j.1095-8312.2010.01597.x; Jones EP, 2010, MOL ECOL, V19, P5252, DOI 10.1111/j.1365-294X.2010.04874.x; Jupp James, 2002, WHITE AUSTR WOOMERA; NACHMAN MW, 1994, GENETICS, V136, P1105; NELSON JG, 1961, CAN GEOGR-GEOGR CAN, V5, P18; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prager EM, 1996, GENETICS, V143, P427; PRAGER EM, 1993, BIOL J LINN SOC, V50, P85; Prager EM, 1998, GENETICS, V150, P835; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROSS JOC, 1987, W STEWART SEALING CA; Sax DF, 2007, TRENDS ECOL EVOL, V22, P465, DOI 10.1016/j.tree.2007.06.009; Schwarz Ernst, 1943, JOUR MAMMAL, V24, P59, DOI 10.2307/1374781; Searle JB, 2008, WILDLIFE RES, V35, P185, DOI 10.1071/WR07123; Searle JB, 2009, P ROY SOC B-BIOL SCI, V276, P209, DOI 10.1098/rspb.2008.0959; Searle JB, 2009, P ROY SOC B-BIOL SCI, V276, P201, DOI 10.1098/rspb.2008.0958; Singleton GR, 2005, BIOL J LINN SOC, V84, P617, DOI 10.1111/j.1095-8312.2005.00458.x; SINGLETON GR, 1990, BIOL J LINN SOC, V41, P285, DOI 10.1111/j.1095-8312.1990.tb00837.x; SINGLETON GR, 1995, MAMMALS AUSTR, P646; Singleton GR, 2007, J APPL ECOL, V44, P644, DOI 10.1111/j.1365-2664.2007.01296.x	31	35	37	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28622	10.1371/journal.pone.0028622	http://dx.doi.org/10.1371/journal.pone.0028622			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174847	Green Published, Green Submitted, gold			2022-12-25	WOS:000298366600027
J	Henmi, Y; Tanabe, K; Takei, K				Henmi, Yuji; Tanabe, Kenji; Takei, Kohji			Disruption of Microtubule Network Rescues Aberrant Actin Comets in Dynamin2-Depleted Cells	PLOS ONE			English	Article							CLATHRIN-COATED PITS; LISTERIA-MONOCYTOGENES; MEDIATED ENDOCYTOSIS; BINDING PROTEIN; DYNAMIN; CORTACTIN; MOTILITY; GTPASE; IDENTIFICATION; ORGANIZATION	A large GTPase dynamin, which is required for endocytic vesicle formation, regulates the actin cytoskeleton through its interaction with cortactin. Dynamin2 mutants impair the formation of actin comets, which are induced by Listeria monocytogenes or phosphatidylinositol-4-phosphate 5-kinase. However, the role of dynamin2 in the regulation of the actin comet is still unclear. Here we show that aberrant actin comets in dynamin2-depleted cells were rescued by disrupting of microtubule networks. Depletion of dynamin2, but not cortactin, significantly reduced the length and the speed of actin comets induced by Listeria. This implies that dynamin2 may regulate the actin comet in a cortactin-independent manner. As dynamin regulates microtubules, we investigated whether perturbation of microtubules would rescue actin comet formation in dynamin2-depleted cells. Treatment with taxol or colchicine created a microtubule-free space in the cytoplasm, and made no difference between control and dynamin2 siRNA cells. This suggests that the alteration of microtubules by dynamin2 depletion reduced the length and the speed of the actin comet.	[Henmi, Yuji; Tanabe, Kenji; Takei, Kohji] Okayama Univ, Grad Sch Med, Dept Neurosci, Okayama 7008530, Japan	Okayama University	Henmi, Y (corresponding author), Okayama Univ, Grad Sch Med, Dept Neurosci, Okayama 7008530, Japan.	kt0911@gmail.com; kohji@md.okayama-u.ac.jp		Tanabe, Kenji/0000-0003-2645-9429; Takei, Kohji/0000-0002-6555-9425	Ministry of Education, Culture, Sports, Science and Technology of Japan [23113721, 15079206]; Grants-in-Aid for Scientific Research [23770148] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (23113721, 15079206, http://kaken.nii.ac.jp/en/p/23113721, http://kaken.nii.ac.jp/en/p/15079206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammer AG, 2008, CELL MOTIL CYTOSKEL, V65, P687, DOI 10.1002/cm.20296; Barroso C, 2006, CELL MOTIL CYTOSKEL, V63, P231, DOI 10.1002/cm.20119; Bershadsky A, 1996, CURR BIOL, V6, P1279, DOI 10.1016/S0960-9822(02)70714-8; Cao H, 2005, NAT CELL BIOL, V7, P483, DOI 10.1038/ncb1246; Cao H, 2003, MOL CELL BIOL, V23, P2162, DOI 10.1128/MCB.23.6.2162-2170.2003; COOK TA, 1994, P NATL ACAD SCI USA, V91, P644, DOI 10.1073/pnas.91.2.644; DANOWSKI BA, 1989, J CELL SCI, V93, P255; Goldberg MB, 2001, MICROBIOL MOL BIOL R, V65, P595, DOI 10.1128/MMBR.65.4.595-626.2001; Gorvel JP, 2006, SCIENCE, V314, P931, DOI 10.1126/science.1135742; Gu C, 2010, EMBO J, V29, P3593, DOI 10.1038/emboj.2010.249; Lambrechts A, 2008, TRENDS CELL BIOL, V18, P220, DOI 10.1016/j.tcb.2008.03.001; Lee E, 2002, P NATL ACAD SCI USA, V99, P161, DOI 10.1073/pnas.012607799; Liu J, 2006, P NATL ACAD SCI USA, V103, P10277, DOI 10.1073/pnas.0601045103; MAEDA K, 1992, MOL BIOL CELL, V3, P1181, DOI 10.1091/mbc.3.10.1181; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Mesaki K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019764; Mooren OL, 2009, J BIOL CHEM, V284, P23995, DOI 10.1074/jbc.M109.024398; NAKATA T, 1993, J CELL SCI, V105, P1; Ohashi E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019942; Orth JD, 2003, CURR OPIN CELL BIOL, V15, P31, DOI 10.1016/S0955-0674(02)00010-8; Orth JD, 2002, P NATL ACAD SCI USA, V99, P167, DOI 10.1073/pnas.012607899; Pfeuffer T, 2000, CELL MICROBIOL, V2, P101, DOI 10.1046/j.1462-5822.2000.00034.x; SCAIFE R, 1990, J CELL BIOL, V111, P3023, DOI 10.1083/jcb.111.6.3023; Schafer DA, 2002, CURR BIOL, V12, P1852, DOI 10.1016/S0960-9822(02)01228-9; SHPETNER HS, 1992, NATURE, V355, P733, DOI 10.1038/355733a0; SHPETNER HS, 1989, CELL, V59, P421, DOI 10.1016/0092-8674(89)90027-5; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Tanabe K, 2009, J CELL BIOL, V185, P939, DOI 10.1083/jcb.200803153; Wittmann T, 2001, J CELL SCI, V114, P3795; Yoshida S, 2006, SCIENCE, V314, P985, DOI 10.1126/science.1133174; Zhu JW, 2005, J CELL SCI, V118, P807, DOI 10.1242/jcs.01668	32	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28603	10.1371/journal.pone.0028603	http://dx.doi.org/10.1371/journal.pone.0028603			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174845	gold, Green Published, Green Submitted			2022-12-25	WOS:000298366600025
J	Huang, TH; Uthe, JJ; Bearson, SMD; Demirkale, CY; Nettleton, D; Knetter, S; Christian, C; Ramer-Tait, AE; Wannemuehler, MJ; Tuggle, CK				Huang, Ting-Hua; Uthe, Jolita J.; Bearson, Shawn M. D.; Demirkale, Cumhur Yusuf; Nettleton, Dan; Knetter, Susan; Christian, Curtis; Ramer-Tait, Amanda E.; Wannemuehler, Michael J.; Tuggle, Christopher K.			Distinct Peripheral Blood RNA Responses to Salmonella in Pigs Differing in Salmonella Shedding Levels: Intersection of IFNG, TLR and miRNA Pathways	PLOS ONE			English	Article							ENTERICA SEROVAR CHOLERAESUIS; DIFFERENTIAL GENE-EXPRESSION; NF-KAPPA-B; QUANTITATIVE TRAIT LOCI; IMMUNE-RESPONSE; INNATE IMMUNITY; BETA-CATENIN; SR PROTEINS; TRANSCRIPTIONAL RESPONSE; CYTOKINE EXPRESSION	Transcriptomic analysis of the response to bacterial pathogens has been reported for several species, yet few studies have investigated the transcriptional differences in whole blood in subjects that differ in their disease response phenotypes. Salmonella species infect many vertebrate species, and pigs colonized with Salmonella enterica serovar Typhimurium (ST) are usually asymptomatic, making detection of these Salmonella-carrier pigs difficult. The variable fecal shedding of Salmonella is an important cause of foodborne illness and zoonotic disease. To investigate gene pathways and biomarkers associated with the variance in Salmonella shedding following experimental inoculation, we initiated the first analysis of the whole blood transcriptional response induced by Salmonella. A population of pigs (n = 40) was inoculated with ST and peripheral blood and fecal Salmonella counts were collected between 2 and 20 days post-inoculation (dpi). Two groups of pigs with either low shedding (LS) or persistent shedding (PS) phenotypes were identified. Global transcriptional changes in response to ST inoculation were identified by Affymetrix Genechip (R) analysis of peripheral blood RNA at day 0 and 2 dpi. ST inoculation triggered substantial gene expression changes in the pigs and there was differential expression of many genes between LS and PS pigs. Analysis of the differential profiles of gene expression within and between PS and LS phenotypic classes identified distinct regulatory pathways mediated by IFN-gamma, TNF, NF-kappa B, or one of several miRNAs. We confirmed the activation of two regulatory factors, SPI1 and CEBPB, and demonstrated that expression of miR-155 was decreased specifically in the PS animals. These data provide insight into specific pathways associated with extremes in Salmonella fecal shedding that can be targeted for further exploration on why some animals develop a carrier state. This knowledge can also be used to develop rational manipulations of genetics, pharmaceuticals, nutrition or husbandry methods to decrease Salmonella colonization, shedding and spread.	[Huang, Ting-Hua; Uthe, Jolita J.; Knetter, Susan; Christian, Curtis; Tuggle, Christopher K.] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA; [Bearson, Shawn M. D.] ARS, Natl Anim Dis Ctr, USDA, Ames, IA USA; [Demirkale, Cumhur Yusuf; Nettleton, Dan] Iowa State Univ, Dept Stat, Ames, IA USA; [Ramer-Tait, Amanda E.; Wannemuehler, Michael J.] Iowa State Univ, Coll Vet Med, Ames, IA USA	Iowa State University; United States Department of Agriculture (USDA); Iowa State University; Iowa State University	Huang, TH (corresponding author), Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA.	cktuggle@iastate.edu		Nettleton, Dan/0000-0002-6045-1036; Ramer-Tait, Amanda/0000-0003-0950-7548	USDA National Institute of Food and Agriculture [2009-35205-05192]; National Pork Board; USDA-CSREES; USDA [2005-38420-15810]; National Institute of Food and Agriculture	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); National Pork Board; USDA-CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); USDA(United States Department of Agriculture (USDA)); National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This project was supported by National Research Initiative Competitive Grant no. 2009-35205-05192 from the USDA National Institute of Food and Agriculture to CKT, SMDB, MJW and DN, as well as the National Pork Board in grants to both SMDB and CKT. Support is also gratefully acknowledged from the USDA-CSREES Special Grant to the Food Safety Consortium to CKT and MJW. CC gratefully acknowledges support from the USDA National Needs Graduate Fellowship Competitive Grant No. 2005-38420-15810 from the National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; Allantaz F, 2007, J EXP MED, V204, P2131, DOI 10.1084/jem.20070070; Balbin M, 2003, NAT GENET, V35, P252, DOI 10.1038/ng1249; Banerjee A, 2010, EUR J IMMUNOL, V40, P225, DOI 10.1002/eji.200939381; Becker C, 2001, J IMMUNOL, V167, P2608, DOI 10.4049/jimmunol.167.5.2608; Bedard KM, 2007, EMBO J, V26, P459, DOI 10.1038/sj.emboj.7601494; Belicha-Villanueva A, 2010, IMMUNOL RES, V46, P32, DOI 10.1007/s12026-009-8123-8; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bonadies N, 2010, ONCOGENE, V29, P1062, DOI 10.1038/onc.2009.371; Burkey TE, 2007, VET IMMUNOL IMMUNOP, V115, P309, DOI 10.1016/j.vetimm.2006.11.012; Burkey TE, 2009, VET IMMUNOL IMMUNOP, V130, P96, DOI 10.1016/j.vetimm.2008.12.027; Chaussabel D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-84; Chen HB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-64; Chen K, 2009, NAT IMMUNOL, V10, P889, DOI 10.1038/ni.1748; Clapperton M, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-54; Collado-Romero M, 2010, VET RES, V41, DOI 10.1051/vetres/2009072; Couture O, 2009, MAMM GENOME, V20, P768, DOI 10.1007/s00335-009-9234-1; Crawley AM, 2005, VET IMMUNOL IMMUNOP, V108, P71, DOI 10.1016/j.vetimm.2005.07.006; Dar A, 2008, VET IMMUNOL IMMUNOP, V123, P324, DOI 10.1016/j.vetimm.2008.02.007; Dar A, 2010, RES VET SCI, V88, P242, DOI 10.1016/j.rvsc.2009.10.003; de Koning DJ, 2005, TRENDS GENET, V21, P377, DOI 10.1016/j.tig.2005.05.004; Duan YL, 2007, LAB INVEST, V87, P613, DOI 10.1038/labinvest.3700545; Dvorak CMT, 2006, PHYSIOL GENOMICS, V28, P5, DOI 10.1152/physiolgenomics.00104.2006; Edfors-Lilja I, 2000, ANIM GENET, V31, P186, DOI 10.1046/j.1365-2052.2000.00628.x; Edfors-Lilja I, 1998, J IMMUNOL, V161, P829; EDFORSLILJA I, 1994, VET IMMUNOL IMMUNOP, V40, P1, DOI 10.1016/0165-2427(94)90011-6; Edwards RA, 2002, TRENDS MICROBIOL, V10, P94, DOI 10.1016/S0966-842X(01)02293-4; Escudero-Paunetto L, 2010, VIROLOGY, V401, P155, DOI 10.1016/j.virol.2010.02.023; FEDORKACRAY PJ, 1995, INFECT IMMUN, V63, P2658, DOI 10.1128/IAI.63.7.2658-2664.1995; Flach CF, 2007, INFECT IMMUN, V75, P2343, DOI 10.1128/IAI.01900-06; Flori L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022717; Galina-Pantoja L, 2009, ANIM GENET, V40, P795, DOI 10.1111/j.1365-2052.2009.01916.x; Gao Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-292; Gladue DP, 2010, VIRUS RES, V151, P10, DOI 10.1016/j.virusres.2010.03.007; Goncalves V, 2008, RNA, V14, P2538, DOI 10.1261/rna.1253408; GUIGNARD F, 1995, BIOCHEM J, V309, P395, DOI 10.1042/bj3090395; Hillenbrand A, 2010, BMC SURG, V10, DOI 10.1186/1471-2482-10-26; Hu XY, 2008, IMMUNITY, V29, P691, DOI 10.1016/j.immuni.2008.08.016; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hurd HS, 2001, J FOOD PROTECT, V64, P939, DOI 10.4315/0362-028X-64.7.939; Hyland KA, 2006, MOL IMMUNOL, V43, P1890, DOI 10.1016/j.molimm.2005.10.011; Jia R, 2009, J VIROL, V83, P167, DOI 10.1128/JVI.01719-08; JOHNSTON J, 1989, J BIOL CHEM, V264, P15754; Leeman JR, 2008, GENE, V423, P97, DOI 10.1016/j.gene.2008.07.015; Li J, 2010, VIRUS RES, V148, P60, DOI 10.1016/j.virusres.2009.12.004; Liu XY, 2010, FEBS LETT, V584, P911, DOI 10.1016/j.febslet.2010.01.024; Lkhagvadorj S, 2009, PHYSIOL GENOMICS, V38, P98, DOI 10.1152/physiolgenomics.90372.2008; Loynachan AT, 2004, J FOOD PROTECT, V67, P1484, DOI 10.4315/0362-028X-67.7.1484; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Lynn DJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-117; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Martinez-Nunez RT, 2009, J BIOL CHEM, V284, P16334, DOI 10.1074/jbc.M109.011601; McFarlane M, 2010, BIOCHEM SOC T, V38, P1116, DOI 10.1042/BST0381116; Mellman I, 2010, SCIENCE, V329, P767, DOI 10.1126/science.1194185; Meurens F, 2009, VET RES, V40, DOI 10.1051/vetres:2008043; Moriconi F, 2007, TRANSL RES, V150, P223, DOI 10.1016/j.trsl.2007.04.004; Moser RJ, 2008, VET IMMUNOL IMMUNOP, V121, P260, DOI 10.1016/j.vetimm.2007.10.007; Nhu QM, 2006, J ENDOTOXIN RES, V12, P285, DOI 10.1179/096805106X118834; Nishimura H, 2000, J EXP MED, V191, P157, DOI 10.1084/jem.191.1.157; Ote I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007882; Pascual V, 2010, ANNU REV IMMUNOL, V28, P535, DOI 10.1146/annurev-immunol-030409-101221; Ponsuksili S, 2008, DEV BIOLOGICALS, V132, P185, DOI 10.1159/000317159; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Renson P, 2010, VET RES, V41, DOI 10.1051/vetres/2009055; Saha B, 2010, CYTOKINE, V50, P1, DOI 10.1016/j.cyto.2009.11.021; Sahoo A, 2010, INT REV IMMUNOL, V29, P77, DOI 10.3109/08830180903349651; Schroder K, 2007, J LEUKOCYTE BIOL, V81, P1577, DOI 10.1189/jlb.0107036; Schroder K, 2006, IMMUNOBIOLOGY, V211, P511, DOI 10.1016/j.imbio.2006.05.007; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shi ZX, 2009, J GEN VIROL, V90, P1670, DOI 10.1099/vir.0.009415-0; Shimosato T, 2005, BIOCHEM BIOPH RES CO, V326, P782, DOI 10.1016/j.bbrc.2004.11.119; Skjolaas KA, 2006, VET IMMUNOL IMMUNOP, V111, P199, DOI 10.1016/j.vetimm.2006.01.002; Smith MF, 1998, J BIOL CHEM, V273, P24272, DOI 10.1074/jbc.273.37.24272; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Takaoka Akinori, 2008, Virus (Nagoya), V58, P37; Takeshita F, 2008, CURR OPIN IMMUNOL, V20, P383, DOI 10.1016/j.coi.2008.05.009; Tomas A, 2010, VET RES, V41, DOI 10.1051/vetres/2009060; Trieu A, 2009, IMMUNOL CELL BIOL, V87, P218, DOI 10.1038/icb.2008.95; Tuggle CK, 2010, VET IMMUNOL IMMUNOP, V138, P280, DOI 10.1016/j.vetimm.2010.10.006; Uthe JJ, 2009, VET MICROBIOL, V135, P384, DOI 10.1016/j.vetmic.2008.09.074; Uthe JJ, 2006, VET MICROBIOL, V114, P60, DOI 10.1016/j.vetmic.2005.10.042; Uthe JJ, 2007, MOL IMMUNOL, V44, P2900, DOI 10.1016/j.molimm.2007.01.016; Van Damme P, 2009, MOL CELL PROTEOMICS, V8, P258, DOI 10.1074/mcp.M800060-MCP200; van Diemen PM, 2002, VET IMMUNOL IMMUNOP, V88, P183, DOI 10.1016/S0165-2427(02)00165-4; Vartanian K, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-2; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Wang YF, 2007, GENOMICS, V90, P72, DOI 10.1016/j.ygeno.2007.03.018; Wang YF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-437; Wattrang E, 2005, ANIM GENET, V36, P337, DOI 10.1111/j.1365-2052.2005.01315.x; Wigley P, 2004, RES VET SCI, V76, P165, DOI 10.1016/S0034-5288(03)00117-6; Wilkie B, 1999, VET IMMUNOL IMMUNOP, V72, P231, DOI 10.1016/S0165-2427(99)00136-1; Winn ME, 2010, MAMM GENOME, V21, P268, DOI 10.1007/s00335-010-9261-y; WOOD RL, 1992, AM J VET RES, V53, P653; Wurfel MM, 2005, J IMMUNOL, V175, P2570, DOI 10.4049/jimmunol.175.4.2570; Yanai H, 2009, CURR OPIN IMMUNOL, V21, P17, DOI 10.1016/j.coi.2009.01.005; Zhao SH, 2006, MAMM GENOME, V17, P777, DOI 10.1007/s00335-005-0155-3	96	33	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28768	10.1371/journal.pone.0028768	http://dx.doi.org/10.1371/journal.pone.0028768			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174891	Green Published, gold, Green Submitted			2022-12-25	WOS:000298366600037
J	Xia, HJ; Ma, JP; Zhang, GH; Han, JB; Wang, JH; Zheng, YT				Xia, Hou-Jun; Ma, Jian-Ping; Zhang, Gao-Hong; Han, Jian-Bao; Wang, Jian-Hua; Zheng, Yong-Tang			Effect of Plasma Viremia on Apoptosis and Immunophenotype of Dendritic Cells Subsets in Acute SIVmac239 Infection of Chinese Rhesus Macaques	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; INTERFERON-PRODUCING CELLS; LYMPHOID-TISSUE; ALPHA PRODUCTION; HIV-1 INFECTION; SURFACE CCR5; IN-VITRO; BLOOD; MATURATION; NEF	Non-human primates such as Chinese rhesus macaques (Ch Rhs) provide good animal models for research on human infectious diseases. Similar to humans, there are two principal subsets of dendritic cells (DCs) in the peripheral blood of Ch Rhs: myeloid DCs (mDCs) and plasmacytoid DCs (pDCs). In this study, two-color fluorescence-activated cell sorting (FACS) analyses were used to identify the main DC subsets, namely CD1c(+) mDCs and pDCs from Ch Rhs. Then, the apoptosis and immunophenotype changes of DCs subsets were first described during the acute phase of SIVmac239 infection. Both the DCs subsets showed decreased CD4 expression and enhanced CCR5 expression; in particular, those of pDCs significantly changed at most time points. Interestingly, the plasma viral loads were negatively correlated with CD4 expression, but were positively correlated with CCR5 expression of pDCs. During this period, both CD1c(+) mDCs and pDCs were activated by enhancing expressions of co-stimulatory molecules, accompanied with increase in CCR7. Either CD80 or CD86 expressed on CD1c(+) mDCs and pDCs was positively correlated with the plasma viral loads. Our analysis demonstrates that the pDCs were more prone to apoptosis after infection during the acute phase of SIVmac239 infection, which may be due to their high expressions of CD4 and CCR5. Both DCs subsets activated through elevating the expression of co-stimulatory molecules, which was beneficial in controlling the replication of SIV. However, a mere broad immune activation initiated by activated DCs may lead to tragic AIDS progression.	[Xia, Hou-Jun; Ma, Jian-Ping; Zhang, Gao-Hong; Han, Jian-Bao; Zheng, Yong-Tang] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mechanisms, Chinese Acad Sci & Yunnan Prov, Kunming, Yunnan, Peoples R China; [Wang, Jian-Hua] Chinese Acad Sci, Inst Pasteur Shanghai, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Xia, Hou-Jun; Ma, Jian-Ping] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xia, HJ (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mechanisms, Chinese Acad Sci & Yunnan Prov, Kunming, Yunnan, Peoples R China.	zhengyt@mail.kiz.ac.cn	Zhang, Gao-Hong/AAJ-8843-2020	Zhang, Gao-Hong/0000-0003-3237-5352; Xia, Houjun/0000-0003-1045-1465	National Basic Research Program of China [2006CB504208, 2006CB504302, 2009CB522300]; National Natural Science Foundation of China [30872317, 30800113, U0832601]; CAS [KSCX1-YW-R-15, KSCX2-YW-R-128, KSCX2-YW-R-185]; Eleventh Five-Year Key Scientific and Technological Program of China [2008ZX10001-002, 2008ZX10001-015, 2008ZX10005-005, 2009ZX09501-029, 2009ZX09103-414]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS(Chinese Academy of Sciences); Eleventh Five-Year Key Scientific and Technological Program of China	This work was supported in part by grants from National Basic Research Program of China (2006CB504208, 2006CB504302, 2009CB522300), National Natural Science Foundation of China (30872317, 30800113, U0832601), the Knowledge Innovation Program of CAS (KSCX1-YW-R-15, KSCX2-YW-R-128, KSCX2-YW-R-185), and Eleventh Five-Year Key Scientific and Technological Program of China (2008ZX10001-002, 2008ZX10001-015, 2008ZX10005-005, 2009ZX09501-029, 2009ZX09103-414) and "Western Light" Projects of CAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; Almeida M, 2005, AIDS, V19, P261; Anthony DD, 2004, J IMMUNOL, V172, P4907, DOI 10.4049/jimmunol.172.8.4907; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Barron MA, 2003, J INFECT DIS, V187, P26, DOI 10.1086/345957; Brown KN, 2007, J IMMUNOL, V178, P6958, DOI 10.4049/jimmunol.178.11.6958; Brown KN, 2009, J MED PRIMATOL, V38, P272, DOI 10.1111/j.1600-0684.2009.00353.x; Brown KN, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000413; Canque B, 1999, BLOOD, V93, P3866, DOI 10.1182/blood.V93.11.3866.411k43_3866_3875; Chung E, 2005, CLIN DIAGN LAB IMMUN, V12, P426, DOI 10.1128/CDLI.12.3.426-435.2005; Coates PTH, 2003, BLOOD, V102, P2513, DOI 10.1182/blood-2002-09-2929; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Dai JH, 2004, J IMMUNOL, V173, P1535, DOI 10.4049/jimmunol.173.3.1535; Dillon SM, 2008, JAIDS-J ACQ IMM DEF, V48, P1, DOI 10.1097/QAI.0b013e3181664b60; Donaghy H, 2001, BLOOD, V98, P2574, DOI 10.1182/blood.V98.8.2574; Donaghy H, 2003, BLOOD, V101, P4505, DOI 10.1182/blood-2002-10-3189; Feldman S, 2001, CLIN IMMUNOL, V101, P201, DOI 10.1006/clim.2001.5111; Fong L, 2002, J VIROL, V76, P11033, DOI 10.1128/JVI.76.21.11033-11041.2002; Fonteneau JF, 2004, J VIROL, V78, P5223, DOI 10.1128/JVI.78.10.5223-5232.2004; Granelli-Piperno A, 2004, P NATL ACAD SCI USA, V101, P7669, DOI 10.1073/pnas.0402431101; Hsieh SM, 2003, JAIDS-J ACQ IMM DEF, V33, P413, DOI 10.1097/00126334-200308010-00001; Jacquelin B, 2009, J CLIN INVEST, V119, P3544, DOI 10.1172/JCI40093; Lindwasser OW, 2007, CURR MOL MED, V7, P171; Ling BH, 2002, AIDS, V16, P1489, DOI 10.1097/00002030-200207260-00005; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Lore K, 2002, AIDS, V16, P683, DOI 10.1097/00002030-200203290-00003; Malleret B, 2008, IMMUNOLOGY, V124, P223, DOI 10.1111/j.1365-2567.2007.02758.x; Mandl JN, 2008, NAT MED, V14, P1077, DOI 10.1038/nm.1871; Meier A, 2009, NAT MED, V15, P955, DOI 10.1038/nm.2004; Michel N, 2005, CURR BIOL, V15, P714, DOI 10.1016/j.cub.2005.02.058; Pacanowski J, 2001, BLOOD, V98, P3016, DOI 10.1182/blood.V98.10.3016; Pandrea I, 2008, TRENDS IMMUNOL, V29, P419, DOI 10.1016/j.it.2008.05.004; Patterson S, 2001, J VIROL, V75, P6710, DOI 10.1128/JVI.75.14.6710-6713.2001; Piccioli D, 2007, BLOOD, V109, P5371, DOI 10.1182/blood-2006-08-038422; Reeves RK, 2007, VIROLOGY, V365, P356, DOI 10.1016/j.virol.2007.03.055; Reynes J, 2000, J INFECT DIS, V181, P927, DOI 10.1086/315315; Smed-Sorensen A, 2004, BLOOD, V104, P2810, DOI 10.1182/blood-2003-07-2314; Smed-Sorensen A, 2005, J VIROL, V79, P8861, DOI 10.1128/JVI.79.14.8861-8869.2005; Sodora DL, 2008, AIDS, V22, P439, DOI 10.1097/QAD.0b013e3282f2dbe7; Soumelis V, 2001, BLOOD, V98, P906, DOI 10.1182/blood.V98.4.906; Xia HJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-102; Xia HJ, 2009, CELL MOL IMMUNOL, V6, P433, DOI 10.1038/cmi.2009.55; Yonezawa A, 2003, J VIROL, V77, P3777, DOI 10.1128/JVI.77.6.3777-3784.2003	44	4	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e29036	10.1371/journal.pone.0029036	http://dx.doi.org/10.1371/journal.pone.0029036			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174949	gold, Green Submitted, Green Published			2022-12-25	WOS:000298366600059
J	Field, H; de Jong, C; Melville, D; Smith, C; Smith, I; Broos, A; Kung, YH; McLaughlin, A; Zeddeman, A				Field, Hume; de Jong, Carol; Melville, Deb; Smith, Craig; Smith, Ina; Broos, Alice; Kung, Yu Hsin (Nina); McLaughlin, Amanda; Zeddeman, Anne			Hendra Virus Infection Dynamics in Australian Fruit Bats	PLOS ONE			English	Article							NIPAH VIRUS	Hendra virus is a recently emerged zoonotic agent in Australia. Since first described in 1994, the virus has spilled from its wildlife reservoir (pteropid fruit bats, or 'flying foxes') on multiple occasions causing equine and human fatalities. We undertook a three-year longitudinal study to detect virus in the urine of free-living flying foxes (a putative route of excretion) to investigate Hendra virus infection dynamics. Pooled urine samples collected off plastic sheets placed beneath roosting flying foxes were screened for Hendra virus genome by quantitative RT-PCR, using a set of primers and probe derived from the matrix protein gene. A total of 1672 pooled urine samples from 67 sampling events was collected and tested between 1 July 2008 and 30 June 2011, with 25% of sampling events and 2.5% of urine samples yielding detections. The proportion of positive samples was statistically associated with year and location. The findings indicate that Hendra virus excretion occurs periodically rather than continuously, and in geographically disparate flying fox populations in the state of Queensland. The lack of any detection in the Northern Territory suggests prevalence may vary across the range of flying foxes in Australia. Finally, our findings suggest that flying foxes can excrete virus at any time of year, and that the apparent seasonal clustering of Hendra virus incidents in horses and associated humans (70% have occurred June to October) reflects factors other than the presence of virus. Identification of these factors will strengthen risk minimization strategies for horses and ultimately humans.	[Field, Hume; de Jong, Carol; Melville, Deb; Smith, Craig; Broos, Alice; Kung, Yu Hsin (Nina); McLaughlin, Amanda; Zeddeman, Anne] Biosecur Queensland, Dept Employment Econ Dev & Innovat, Biosecur Sci Lab, Brisbane, Qld, Australia; [Smith, Ina] CSIRO Livestock Ind, Australian Anim Hlth Lab, Geelong, Vic, Australia; [Smith, Ina; Broos, Alice] Queensland Hlth, Queensland Hlth Forens & Sci Serv Lab, Brisbane, Qld, Australia; [Zeddeman, Anne] Univ Wageningen, Wageningen, Netherlands	Queensland Department of Agriculture & Fisheries; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Queensland Health; Wageningen University & Research	Field, H (corresponding author), Biosecur Queensland, Dept Employment Econ Dev & Innovat, Biosecur Sci Lab, Brisbane, Qld, Australia.	Hume.Field@deedi.qld.gov.au	Smith, Ina/H-7225-2013	Smith, Ina/0000-0001-5807-3737; Broos, Alice/0000-0001-7593-1000	Wildlife Exotic Diseases Preparedness Program [WEDPP08/09FIE, WEDPP09/10FIE WEDPP10/11FIE]	Wildlife Exotic Diseases Preparedness Program	Wildlife Exotic Diseases Preparedness Program, http://www.daff.gov.au/animal-plant-health/emergency/wedpp WEDPP08/09FIE; WEDPP09/10FIE WEDPP10/11FIE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, ECOLOGY HENDRA VIRUS; Chua KB, 2003, MICROBES INFECT, V5, P487, DOI 10.1016/S1286-4579(03)00067-4; Epstein J, 2011, ECOHEALTH, V7, pS38; Field H, 2010, EMERG INFECT DIS, V16, P338, DOI 10.3201/eid1602.090780; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Playford EG, 2010, EMERG INFECT DIS, V16, P219, DOI 10.3201/eid1602.090552; Plowright RK, 2008, P ROY SOC B-BIOL SCI, V275, P861, DOI 10.1098/rspb.2007.1260; Plowright RK, 2011, P R SOC B; Smith IL, 2001, J VIROL METHODS, V98, P33, DOI 10.1016/S0166-0934(01)00354-8; Wacharapluesadee S, 2005, EMERG INFECT DIS, V11, P1949, DOI 10.3201/eid1112.050613; Wacharapluesadee S, 2010, VECTOR-BORNE ZOONOT, V10, P183, DOI 10.1089/vbz.2008.0105; 2011, GUIDELINES VETERINAR	12	93	94	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28678	10.1371/journal.pone.0028678	http://dx.doi.org/10.1371/journal.pone.0028678			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174865	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000298365700059
J	Chakraborty, S; Minda, R; Salaye, L; Bhattacharjee, SK; Rao, BJ				Chakraborty, Sandeep; Minda, Renu; Salaye, Lipika; Bhattacharjee, Swapan K.; Rao, Basuthkar J.			Active Site Detection by Spatial Conformity and Electrostatic Analysis-Unravelling a Proteolytic Function in Shrimp Alkaline Phosphatase	PLOS ONE			English	Article							A BETA-LACTAMASES; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; PROTEIN-STRUCTURE; PK(A) VALUES; STRUCTURAL BASIS; PREDICTION; ENZYME; MECHANISM; DATABASE	Computational methods are increasingly gaining importance as an aid in identifying active sites. Mostly these methods tend to have structural information that supplement sequence conservation based analyses. Development of tools that compute electrostatic potentials has further improved our ability to better characterize the active site residues in proteins. We have described a computational methodology for detecting active sites based on structural and electrostatic conformity - CataLytic Active Site Prediction (CLASP). In our pipelined model, physical 3D signature of any particular enzymatic function as defined by its active sites is used to obtain spatially congruent matches. While previous work has revealed that catalytic residues have large pKa deviations from standard values, we show that for a given enzymatic activity, electrostatic potential difference (PD) between analogous residue pairs in an active site taken from different proteins of the same family are similar. False positives in spatially congruent matches are further pruned by PD analysis where cognate pairs with large deviations are rejected. We first present the results of active site prediction by CLASP for two enzymatic activities - beta-lactamases and serine proteases, two of the most extensively investigated enzymes. The results of CLASP analysis on motifs extracted from Catalytic Site Atlas (CSA) are also presented in order to demonstrate its ability to accurately classify any protein, putative or otherwise, with known structure. The source code and database is made available at www.sanchak.com/clasp/. Subsequently, we probed alkaline phosphatases (AP), one of the well known promiscuous enzymes, for additional activities. Such a search has led us to predict a hitherto unknown function of shrimp alkaline phosphatase (SAP), where the protein acts as a protease. Finally, we present experimental evidence of the prediction by CLASP by showing that SAP indeed has protease activity in vitro.	[Chakraborty, Sandeep; Minda, Renu; Salaye, Lipika; Bhattacharjee, Swapan K.; Rao, Basuthkar J.] Tata Inst Fundamental Res, Dept Biol Sci, Mumbai 400005, Maharashtra, India	Tata Institute of Fundamental Research (TIFR)	Chakraborty, S (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Homi Bhabha Rd, Mumbai 400005, Maharashtra, India.	bjrao@tifr.res.in	Minda, Renu/M-5476-2016	Minda, Renu/0000-0002-2359-9146	Tata Institute of Fundamental Research (Department of Atomic Energy)	Tata Institute of Fundamental Research (Department of Atomic Energy)	This work was funded by the Tata Institute of Fundamental Research (Department of Atomic Energy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alterovitz R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-197; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angaran S, 2009, NUCLEIC ACIDS RES, V37, pW565, DOI 10.1093/nar/gkp405; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; BASHFORD D, 1990, BIOCHEMISTRY-US, V29, P10219, DOI 10.1021/bi00496a010; Bate P, 2004, J MOL BIOL, V340, P263, DOI 10.1016/j.jmb.2004.04.070; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bauer RA, 2008, NUCLEIC ACIDS RES, V36, pW47, DOI 10.1093/nar/gkn285; Beadle BM, 2002, ANTIMICROB AGENTS CH, V46, P3978, DOI 10.1128/AAC.46.12.3978-3980.2002; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Broun P, 1998, SCIENCE, V282, P1315, DOI 10.1126/science.282.5392.1315; Brown G, 2008, BIOCHEMISTRY-US, V47, P5724, DOI 10.1021/bi800097h; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Capra JA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000585; Catrina I, 2007, J AM CHEM SOC, V129, P5760, DOI 10.1021/ja069111+; Chen Y, 2007, J AM CHEM SOC, V129, P5378, DOI 10.1021/ja0712064; Damblon C, 1996, P NATL ACAD SCI USA, V93, P1747, DOI 10.1073/pnas.93.5.1747; de Backer M, 2002, J MOL BIOL, V318, P1265, DOI 10.1016/S0022-2836(02)00035-9; Debret G, 2009, NUCLEIC ACIDS RES, V37, pW459, DOI 10.1093/nar/gkp304; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Elcock AH, 2001, J MOL BIOL, V312, P885, DOI 10.1006/jmbi.2001.5009; Forsyth WR, 2002, PROTEINS, V48, P388, DOI 10.1002/prot.10174; Freire P, 2009, J MOL BIOL, V385, P1345, DOI 10.1016/j.jmb.2008.12.026; Galperin MY, 1998, PROTEIN SCI, V7, P1829, DOI 10.1002/pro.5560070819; GENGE BR, 1988, J BIOL CHEM, V263, P18513; Gherardini PF, 2007, J MOL BIOL, V372, P817, DOI 10.1016/j.jmb.2007.06.017; Gijsbers R, 2001, J BIOL CHEM, V276, P1361, DOI 10.1074/jbc.M007552200; Golemi-Kotra D, 2004, J BIOL CHEM, V279, P34665, DOI 10.1074/jbc.M313143200; Gordon JC, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2956499; Goyal K, 2007, NUCLEIC ACIDS RES, V35, pW503, DOI 10.1093/nar/gkm252; Greaves R, 2005, J MOL BIOL, V349, P547, DOI 10.1016/j.jmb.2005.04.018; Grochowski P, 2008, BIOPOLYMERS, V89, P93, DOI 10.1002/bip.20877; Harris TK, 2002, IUBMB LIFE, V53, P85, DOI 10.1080/15216540211468; Helland R, 2009, BBA-PROTEINS PROTEOM, V1794, P297, DOI 10.1016/j.bbapap.2008.09.020; Hermann JC, 2007, NATURE, V448, P775, DOI 10.1038/nature05981; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; HOLM L, 1992, PROTEIN SCI, V1, P1691, DOI 10.1002/pro.5560011217; Holtz KM, 1999, FEBS LETT, V462, P7, DOI 10.1016/S0014-5793(99)01448-9; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Jackel C, 2008, ANNU REV BIOPHYS, V37, P153, DOI 10.1146/annurev.biophys.37.032807.125832; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; KIM EE, 1991, J MOL BIOL, V218, P449, DOI 10.1016/0022-2836(91)90724-K; Kleywegt GJ, 1999, J MOL BIOL, V285, P1887, DOI 10.1006/jmbi.1998.2393; Konc J, 2010, BIOINFORMATICS, V26, P1160, DOI 10.1093/bioinformatics/btq100; Koutsioulis D, 2010, PROTEIN SCI, V19, P75, DOI 10.1002/pro.284; Kurth T, 1997, BIOCHEMISTRY-US, V36, P10098, DOI 10.1021/bi970937l; Lamotte-Brasseur J, 1999, PROTEIN SCI, V8, P404; Laskowski RA, 1996, PROTEIN SCI, V5, P2438; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Le Du MH, 2001, J BIOL CHEM, V276, P9158, DOI 10.1074/jbc.M009250200; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; MADURA JD, 1995, COMPUT PHYS COMMUN, V91, P57, DOI 10.1016/0010-4655(95)00043-F; Matagne A, 1998, BIOCHEM J, V330, P581, DOI 10.1042/bj3300581; Millan Jose Luis, 2006, Purinergic Signal, V2, P335, DOI 10.1007/s11302-005-5435-6; Minasov G, 2002, J AM CHEM SOC, V124, P5333, DOI 10.1021/ja0259640; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; Nielsen JE, 2001, PROTEINS, V43, P403, DOI 10.1002/prot.1053; Nielsen JE, 2003, PROTEIN SCI, V12, P1894, DOI 10.1110/ps.03114903; Nielsen JE, 1999, EUR J BIOCHEM, V264, P816, DOI 10.1046/j.1432-1327.1999.00664.x; Nobeli I, 2009, NAT BIOTECHNOL, V27, P157, DOI 10.1038/nbt1519; NUSSINOV R, 1991, P NATL ACAD SCI USA, V88, P10495, DOI 10.1073/pnas.88.23.10495; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; O'Brien PJ, 2001, BIOCHEMISTRY-US, V40, P5691, DOI 10.1021/bi0028892; Olguin Luis F, 2008, J Am Chem Soc, V130, P16547, DOI 10.1021/ja8047943; Oliva M, 2003, PROTEINS, V53, P88, DOI 10.1002/prot.10450; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Panchenko AR, 2004, PROTEIN SCI, V13, P884, DOI 10.1110/ps.03465504; Porter CT, 2004, NUCLEIC ACIDS RES, V32, pD129, DOI 10.1093/nar/gkh028; Rapp CS, 2009, PROTEINS, V77, P52, DOI 10.1002/prot.22415; Raquet X, 1997, BIOPHYS J, V73, P2416, DOI 10.1016/S0006-3495(97)78270-5; RAWLINGS ND, 1993, BIOCHEM J, V290, P205, DOI 10.1042/bj2900205; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rocchia W, 2007, GENET MOL RES, V6, P923; Rout AK, 2010, BIOMOL NMR ASSIGN, V4, P171, DOI 10.1007/s12104-010-9239-4; Russell RB, 1998, J MOL BIOL, V279, P1211, DOI 10.1006/jmbi.1998.1844; Sankararaman S, 2010, BIOINFORMATICS, V26, P617, DOI 10.1093/bioinformatics/btq008; Sarkany Z, 2003, BIOCHEMISTRY-US, V42, P516, DOI 10.1021/bi027004w; Shatsky M, 2006, J COMPUT BIOL, V13, P407, DOI 10.1089/cmb.2006.13.407; Shulman-Peleg A, 2008, NUCLEIC ACIDS RES, V36, pW260, DOI 10.1093/nar/gkn185; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Singh Rohit, 2003, Pac Symp Biocomput, P228; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Stec B, 2000, J MOL BIOL, V299, P1303, DOI 10.1006/jmbi.2000.3799; Teotico DG, 2009, P NATL ACAD SCI USA, V106, P7455, DOI 10.1073/pnas.0813029106; Tomatis PE, 2005, P NATL ACAD SCI USA, V102, P13761, DOI 10.1073/pnas.0503495102; Tong WX, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000266; Tseng YY, 2011, P NATL ACAD SCI USA, V108, P5313, DOI 10.1073/pnas.1102210108; Tsuruta H, 2010, BIOSCI BIOTECH BIOCH, V74, P69, DOI 10.1271/bbb.90563; Wang E, 2007, J MOL BIOL, V366, P1318, DOI 10.1016/j.jmb.2006.11.079; WARSHEL A, 1981, ACCOUNTS CHEM RES, V14, P284, DOI 10.1021/ar00069a004; WARWICKER J, 1982, J MOL BIOL, V157, P671, DOI 10.1016/0022-2836(82)90505-8; Wei Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-119; Wende A, 2010, J MOL BIOL, V400, P52, DOI 10.1016/j.jmb.2010.04.057; Wixon J, 2000, YEAST, V17, P48, DOI 10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H; Yang KC, 2004, P NATL ACAD SCI USA, V101, P7919, DOI 10.1073/pnas.0400664101; Youn E, 2007, PROTEIN SCI, V16, P216, DOI 10.1110/ps.062523907; Zalatan JG, 2008, J MOL BIOL, V384, P1174, DOI 10.1016/j.jmb.2008.09.059; Zalatan JG, 2006, J AM CHEM SOC, V128, P1293, DOI 10.1021/ja056528r	104	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28470	10.1371/journal.pone.0028470	http://dx.doi.org/10.1371/journal.pone.0028470			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174814	Green Submitted, Green Published, gold			2022-12-25	WOS:000298163600023
J	Qi, P; Cheng, SQ; Wang, H; Li, N; Chen, YF; Gao, CF				Qi, Peng; Cheng, Shu-qun; Wang, Hao; Li, Nan; Chen, Yue-feng; Gao, Chun-fang			Serum MicroRNAs as Biomarkers for Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection	PLOS ONE			English	Article							NON-TUMOROUS TISSUES; CIRCULATING MICRORNAS; C VIRUS; EXPRESSION PATTERNS; PLASMA MICRORNAS; OVARIAN-CANCER; IN-VIVO; MIR-122; INJURY; CELLS	Background: MicroRNAs (miRNAs) have been shown to anticipate great cancer diagnostic potential. Recently, circulating miRNAs have been reported as promising biomarkers for various pathologic conditions. The objective of this study was to investigate the potential of serum miRNAs as novel biomarkers for hepatocellular carcinoma (HCC). Methodology/Principal Findings: This study was divided into four phases: (I) Ten candidate serum miRNAs were detected by using real-time RT-PCR, corresponding 10 HCC patients with chronic hepatitis B virus (HBV) infection and 10 age-and sex-matched healthy subjects. (II) Marker validation by real-time RT-PCR on HBV patients with (n = 48) or without HCC (n = 48), and healthy subjects (n = 24). (III) Marker detection by real-time RT-PCR in sera from another 14 HCC patients before and 1 month after surgical resection. (IV) We examined the correlation between the expressions of candidate serum miRNAs with clinical parameters of HCC patients. Although miR-222, miR-223 or miR-21 were significantly up-or down-regulated between HCC patients and healthy controls, no significant difference was observed in the levels of these miRNAs between HBV patients without and with HCC. MiR-122 in serum was significantly higher in HCC patients than healthy controls (p<0.001). More importantly, it was found that the levels of miR-122 were significantly reduced in the post-operative serum samples when compared to the pre-operative samples. Although serum miR-122 was also elevated in HBV patients with HCC comparing with those without HCC, the difference was at the border line (p = 0.043). Conclusions/Significance: Our results suggest that serum miR-122 might serve as a novel and potential noninvasive biomarker for detection of HCC in healthy subjects, moreover, it might serve as a novel biomarker for liver injury but not specifically for detection of HCC in chronic HBV infection patients.	[Qi, Peng; Chen, Yue-feng; Gao, Chun-fang] Second Mil Med Univ, Eastern Hepatobiliary Hosp, Dept Lab Med, Shanghai, Peoples R China; [Cheng, Shu-qun; Li, Nan] Second Mil Med Univ, Eastern Hepatobiliary Hosp, Dept Oncol Comprehens Treatment, Shanghai, Peoples R China; [Wang, Hao] Second Mil Med Univ, Dept Lab Med, Changzheng Hosp, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University	Qi, P (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Hosp, Dept Lab Med, Shanghai, Peoples R China.	gaocf1115@163.com	cheng, sq/GPT-4112-2022		National Natural Science Foundation of China [30971345]; Youth Research Foundation of Second Military Medical University [2010QN22]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Research Foundation of Second Military Medical University	This work was supported by the National Natural Science Foundation of China (No. 30971345) and the Youth Research Foundation of Second Military Medical University (No. 2010QN22). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chang JH, 2008, J VIROL, V82, P8215, DOI 10.1128/JVI.02575-07; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; El-Serag HB, 2004, GASTROENTEROLOGY, V127, pS27, DOI 10.1053/j.gastro.2004.09.013; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Fleischhacker M, 2007, BBA-REV CANCER, V1775, P181, DOI 10.1016/j.bbcan.2006.10.001; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244; Ho AS, 2010, TRANSL ONCOL, V3, P109, DOI 10.1593/tlo.09256; Huang YS, 2008, J GASTROEN HEPATOL, V23, P87, DOI 10.1111/j.1440-1746.2007.05223.x; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Ji X, 2009, CLIN CHEM, V55, P1944, DOI 10.1373/clinchem.2009.125310; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Jopling CL, 2008, BIOCHEM SOC T, V36, P1220, DOI 10.1042/BST0361220; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Laterza OF, 2009, CLIN CHEM, V55, P1977, DOI 10.1373/clinchem.2009.131797; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Li JH, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-36; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Markou A, 2008, CLIN CHEM, V54, P1696, DOI 10.1373/clinchem.2007.101741; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Qu KZ, 2011, J CLIN GASTROENTEROL, V45, P355, DOI 10.1097/MCG.0b013e3181f18ac2; Resnick KE, 2009, GYNECOL ONCOL, V112, P55, DOI 10.1016/j.ygyno.2008.08.036; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Srivatanakul Petcharin, 2004, Asian Pac J Cancer Prev, V5, P118; Sukata T, 2011, TOXICOL LETT, V200, P46, DOI 10.1016/j.toxlet.2010.10.013; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Varnholt H, 2008, HEPATOLOGY, V47, P1223, DOI 10.1002/hep.22158; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Wang Y, 2008, J BIOL CHEM, V283, P13205, DOI 10.1074/jbc.M707629200; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; Xu JA, 2011, MOL CARCINOGEN, V50, P136, DOI 10.1002/mc.20712; Yu CH, 2009, DIGEST DIS SCI, V54, P2362, DOI 10.1007/s10620-008-0629-8; Zinkin NT, 2008, CLIN CANCER RES, V14, P470, DOI 10.1158/1078-0432.CCR-07-0586	45	231	246	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28486	10.1371/journal.pone.0028486	http://dx.doi.org/10.1371/journal.pone.0028486			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174818	gold, Green Submitted, Green Published			2022-12-25	WOS:000298163600025
J	Hitomi, K; Arvai, AS; Yamamoto, J; Hitomi, C; Teranishi, M; Hirouchi, T; Yamamoto, K; Iwai, S; Tainer, JA; Hidema, J; Getzoff, ED				Hitomi, Kenichi; Arvai, Andrew S.; Yamamoto, Junpei; Hitomi, Chiharu; Teranishi, Mika; Hirouchi, Tokuhisa; Yamamoto, Kazuo; Iwai, Shigenori; Tainer, John A.; Hidema, Jun; Getzoff, Elizabeth D.			Eukaryotic Class II Cyclobutane Pyrimidine Dimer Photolyase Structure Reveals Basis for Improved Ultraviolet Tolerance in Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI DNA PHOTOLYASE; CRYSTAL-STRUCTURE; DAMAGE RECOGNITION; REPAIR; GENE; PHOTOREPAIR; REMOVAL; PROTEIN; CLONING; RICE	Ozone depletion increases terrestrial solar ultraviolet B (UV-B; 280-315 nm) radiation, intensifying the risks plants face from DNA damage, especially covalent cyclobutane pyrimidine dimers (CPD). Without efficient repair, UV-B destroys genetic integrity, but plant breeding creates rice cultivars with more robust photolyase (PHR) DNA repair activity as an environmental adaptation. So improved strains of Oryza sativa (rice), the staple food for Asia, have expanded rice cultivation worldwide. Efficient light-driven PHR enzymes restore normal pyrimidines to UV-damaged DNA by using blue light via flavin adenine dinucleotide to break pyrimidine dimers. Eukaryotes duplicated the photolyase gene, producing PHRs that gained functions and adopted activities that are distinct from those of prokaryotic PHRs yet are incompletely understood. Many multicellular organisms have two types of PHR: (6-4) PHR, which structurally resembles bacterial CPD PHRs but recognizes different substrates, and Class II CPD PHR, which is remarkably dissimilar in sequence from bacterial PHRs despite their common substrate. To understand the enigmatic DNA repair mechanisms of PHRs in eukaryotic cells, we determined the first crystal structure of a eukaryotic Class II CPD PHR from the rice cultivar Sasanishiki. Our 1.7 angstrom resolution PHR structure reveals structure-activity relationships in Class II PHRs and tuning for enhanced UV tolerance in plants. Structural comparisons with prokaryotic Class I CPD PHRs identified differences in the binding site for UV-damaged DNA substrate. Convergent evolution of both flavin hydrogen bonding and a Trp electron transfer pathway establish these as critical functional features for PHRs. These results provide a paradigm for light-dependent DNA repair in higher organisms.	[Hitomi, Kenichi; Yamamoto, Junpei; Iwai, Shigenori] Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan; [Hitomi, Kenichi; Arvai, Andrew S.; Hitomi, Chiharu; Tainer, John A.; Getzoff, Elizabeth D.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Hitomi, Kenichi; Arvai, Andrew S.; Hitomi, Chiharu; Tainer, John A.; Getzoff, Elizabeth D.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Hitomi, Kenichi; Tainer, John A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Hitomi, Kenichi] Natl Inst Biomed Innovat, Sect Lab Equipment, Osaka 5670085, Japan; [Teranishi, Mika; Hirouchi, Tokuhisa; Yamamoto, Kazuo; Hidema, Jun] Tohoku Univ, Grad Sch Life Sci, Aoba Ku, Sendai, Miyagi 9808577, Japan	Osaka University; Scripps Research Institute; Scripps Research Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; National Institute of Health Sciences - Japan; Tohoku University	Getzoff, ED (corresponding author), 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	edg@scripps.edu	Tainer, John/GWQ-4878-2022; Hidema, Jun/AAH-5124-2019	Tainer, John/0000-0003-1659-2429; 	National Institutes of Health [GM37684, GM046312]; Japan Society for the Promotion of Science; Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046312, R01GM037684] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [21780294, 21380205] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	* This work was supported, in whole or in part, by National Institutes of Health Grants. GM37684 (to E. D. G.) and in part by Grant GM046312 (to J. A. T.).; <SUP>1</SUP> Supported in part by Japan Society for the Promotion of Science Fellowship and The Skaggs Institute for Chemical Biology.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahmad M, 1997, PLANT CELL, V9, P199, DOI 10.1105/tpc.9.2.199; Biskup T, 2009, ANGEW CHEM INT EDIT, V48, P404, DOI 10.1002/anie.200803102; Brudler R, 2003, MOL CELL, V11, P59, DOI 10.1016/S1097-2765(03)00008-X; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Christine KS, 2002, J BIOL CHEM, V277, P38339, DOI 10.1074/jbc.M206531200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Friedberg EC, 2005, DNA REPAIR MUTAGENES; Fuss JO, 2011, DNA REPAIR, V10, P697, DOI 10.1016/j.dnarep.2011.04.028; Hidema J, 2005, PLANT J, V43, P57, DOI 10.1111/j.1365-313X.2005.02428.x; Hidema J, 2000, PLANT CELL, V12, P1569, DOI 10.1105/tpc.12.9.1569; Hidema J, 2007, PLANT J, V50, P70, DOI 10.1111/j.1365-313X.2007.03041.x; Hitomi K, 2001, J BIOL CHEM, V276, P10103, DOI 10.1074/jbc.M008828200; Hitomi K, 1997, J BIOL CHEM, V272, P32591, DOI 10.1074/jbc.272.51.32591; Hitomi K, 2007, DNA REPAIR, V6, P410, DOI 10.1016/j.dnarep.2006.10.004; Hitomi K, 2009, P NATL ACAD SCI USA, V106, P6962, DOI 10.1073/pnas.0809180106; Huffman JL, 2005, MUTAT RES-FUND MOL M, V577, P55, DOI 10.1016/j.mrfmmm.2005.03.012; Iwamatsu Y, 2008, PHOTOCH PHOTOBIO SCI, V7, P311, DOI 10.1039/b719034d; Iwata T, 2010, BIOCHEMISTRY-US, V49, P8882, DOI 10.1021/bi1009979; Jiang CZ, 1997, P NATL ACAD SCI USA, V94, P7441, DOI 10.1073/pnas.94.14.7441; Kanai S, 1997, J MOL EVOL, V45, P535, DOI 10.1007/PL00006258; KATO T, 1994, NUCLEIC ACIDS RES, V22, P4119, DOI 10.1093/nar/22.20.4119; KIM ST, 1992, P NATL ACAD SCI USA, V89, P900, DOI 10.1073/pnas.89.3.900; Kondoh M, 2011, J AM CHEM SOC, V133, P2183, DOI 10.1021/ja107691w; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Maul MJ, 2008, ANGEW CHEM INT EDIT, V47, P10076, DOI 10.1002/anie.200804268; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Miyazawa Y, 2008, BIOPHYS J, V94, P2194, DOI 10.1529/biophysj.107.119248; Nakajima S, 1998, NUCLEIC ACIDS RES, V26, P638, DOI 10.1093/nar/26.2.638; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Okafuji A, 2010, DNA REPAIR, V9, P495, DOI 10.1016/j.dnarep.2010.01.014; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARK HW, 1995, SCIENCE, V268, P1866, DOI 10.1126/science.7604260; Pellequer JL, 1998, P NATL ACAD SCI USA, V95, P5884, DOI 10.1073/pnas.95.11.5884; Roussel A., 1989, TURBO FRODO; Tamada T, 1997, NAT STRUCT BIOL, V4, P887, DOI 10.1038/nsb1197-887; Teranishi M, 2008, PLANT PHYSIOL, V146, P1941, DOI 10.1104/pp.107.110189; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tubbs JL, 2009, NATURE, V459, P808, DOI 10.1038/nature08076; Xu L, 2008, BIOCHEMISTRY-US, V47, P8736, DOI 10.1021/bi800391j; Yamamoto J, 2006, NUCLEIC ACIDS RES, V34, P4406, DOI 10.1093/nar/gkl572; YASUI A, 1994, EMBO J, V13, P6143, DOI 10.1002/j.1460-2075.1994.tb06961.x	44	26	29	0	22	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12060	12069		10.1074/jbc.M111.244020	http://dx.doi.org/10.1074/jbc.M111.244020			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22170053	Green Published, hybrid			2022-12-25	WOS:000302782200043
J	Yang, J; Wang, Q; Zheng, W; Tuli, J; Li, Q; Wu, Y; Hussein, S; Dai, XQ; Shafiei, S; Li, XG; Shen, PY; Tu, JC; Chen, XZ				Yang, Jungwoo; Wang, Qian; Zheng, Wang; Tuli, Jagdeep; Li, Qiang; Wu, Yuliang; Hussein, Shaimaa; Dai, Xiao-Qing; Shafiei, Shiva; Li, Xiao-Gai; Shen, Patrick Y.; Tu, Jian-Cheng; Chen, Xing-Zhen			Receptor for Activated C Kinase 1 (RACK1) Inhibits Function of Transient Receptor Potential (TRP)-type Channel Pkd2L1 through Physical Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYCYSTIC KIDNEY-DISEASE; TRPP3 CHANNEL; BETA-SUBUNIT; SCAFFOLDING PROTEIN; TASTE RECEPTOR; CA2+ RELEASE; ION CHANNELS; TROPONIN-I; PKD1L3; CELLS	Pkd2L1 (also called TRPP3) is a non-selective cation channel permeable to Ca2+, Na+, and K+ and is activated by Ca2+. It is also part of an acid-triggered off-response cation channel complex. We previously reported roles of the Pkd2L1 C-terminal fragments in its channel function, but the role of the N terminus remains unclear. Using a yeast two-hybrid screening, we found that the Pkd2L1 N terminus interacts with the receptor for activated C kinase 1 (RACK1), a scaffolding/anchoring protein implicated in various cellular functions. This interaction requires the last two Trp-Asp (WD) motifs of RACK1 and fragment Ala(19)-Pro(45) of Pkd2L1. The interaction was confirmed by GST pulldown, blot overlay, and co-immunoprecipitation assays. By Ca-45 tracer uptake and two-microelectrode voltage clamp electrophysiology, we found that in Xenopus oocytes with RACK1 overexpression Pkd2L1 channel activity is abolished or substantially reduced. Combining with oocyte surface biotinylation experiments, we demonstrated that RACK1 inhibits the function of Pkd2L1 channel on the plasma membrane in addition to reducing its total and plasma membrane expression. Overexpressing Pkd2L1 N- or C-terminal fragments as potential blocking peptides for the Pkd2L1-RACK1 interaction, we found that Pkd2L1 N- terminal fragment Met(1)-Pro(45), but not Ile(40)-Ile(97) or C-terminal fragments, abolishes the inhibition of Pkd2L1 channel by overexpressed and oocyte-native RACK1 likely through disrupting the Pkd2L1-RACK1 association. Taken together, our study demonstrated that RACK1 inhibits Pkd2L1 channel function through binding to domain Met(1)-Pro(45) of Pkd2L1. Thus, Pkd2L1 is a novel target channel whose function is regulated by the versatile scaffolding protein RACK1.	[Yang, Jungwoo; Wang, Qian; Zheng, Wang; Tuli, Jagdeep; Li, Qiang; Wu, Yuliang; Hussein, Shaimaa; Dai, Xiao-Qing; Shafiei, Shiva; Shen, Patrick Y.; Chen, Xing-Zhen] Univ Alberta, Dept Physiol, Edmonton, AB T6G 2H7, Canada; [Li, Xiao-Gai; Tu, Jian-Cheng] Wuhan Univ, Zhongnan Hosp, Wuhan 430071, Peoples R China	University of Alberta; Wuhan University	Chen, XZ (corresponding author), Univ Alberta, Dept Physiol, 7-29 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	xzchen@ualberta.ca	Hussein, Shaimaa/HHZ-5533-2022	Hussein, Shaimaa/0000-0003-0849-9670	Canadian Institutes of Health Research; Alberta Innovates Health Solutions; Kidney Foundation of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions; Kidney Foundation of Canada	This work was supported by the Canadian Institutes of Health Research, the Alberta Innovates Health Solutions, and the Kidney Foundation of Canada (to X.-Z.C.).	Bandyopadhyay BC, 2008, J BIOL CHEM, V283, P32821, DOI 10.1074/jbc.M805382200; Basora N, 2002, J AM SOC NEPHROL, V13, P293, DOI 10.1681/ASN.V132293; Brandon NJ, 2002, J NEUROSCI, V22, P6353; Bui-Xuan EF, 2006, AM J PHYSIOL-RENAL, V291, pF395, DOI 10.1152/ajprenal.00282.2005; Cao G, 2008, CURR OPIN NEPHROL HY, V17, P373, DOI 10.1097/MNH.0b013e328303e184; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; Chandrashekar J, 2009, SCIENCE, V326, P443, DOI 10.1126/science.1174601; Chang BY, 1998, MOL CELL BIOL, V18, P3245, DOI 10.1128/MCB.18.6.3245; Chang BY, 2002, ONCOGENE, V21, P7619, DOI 10.1038/sj.onc.1206002; Chang RB, 2010, P NATL ACAD SCI USA, V107, P22320, DOI 10.1073/pnas.1013664107; Chen XZ, 1999, NATURE, V401, P383, DOI 10.1038/43907; Dai XQ, 2007, MOL PHARMACOL, V72, P1576, DOI 10.1124/mol.107.037150; Dai XQ, 2006, BBA-BIOMEMBRANES, V1758, P197, DOI 10.1016/j.bbamem.2006.01.020; Horio N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020007; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Huque T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007347; Inada H, 2008, EMBO REP, V9, P690, DOI 10.1038/embor.2008.89; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; Ishimaru Y, 2010, FASEB J, V24, P4058, DOI 10.1096/fj.10-162925; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Li Q, 2005, HUM MOL GENET, V14, P1587, DOI 10.1093/hmg/ddi167; Li Q, 2003, BIOCHEMISTRY-US, V42, P7618, DOI 10.1021/bi034210a; Li Q, 2003, J MOL BIOL, V325, P949, DOI 10.1016/S0022-2836(02)01333-5; Li Q, 2003, BIOCHEMISTRY-US, V42, P450, DOI 10.1021/bi0267792; Li Q, 2002, FEBS LETT, V516, P270, DOI 10.1016/S0014-5793(02)02513-9; Li Q, 2007, J NEUROCHEM, V103, P2391, DOI 10.1111/j.1471-4159.2007.04940.x; Li SD, 2011, P NATL ACAD SCI USA, V108, P2264, DOI 10.1073/pnas.1013170108; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; Liu Y, 2002, FEBS LETT, V525, P71, DOI 10.1016/S0014-5793(02)03071-5; LopezJimenez ND, 2006, J NEUROCHEM, V98, P68, DOI 10.1111/j.1471-4159.2006.03842.x; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Mourton T, 2001, J BIOL CHEM, V276, P14896, DOI 10.1074/jbc.M010823200; Murakami M, 2005, J BIOL CHEM, V280, P5626, DOI 10.1074/jbc.M411496200; Nelson TM, 2010, CHEM SENSES, V35, P565, DOI 10.1093/chemse/bjq070; Nilsson J, 2004, EMBO REP, V5, P1137, DOI 10.1038/sj.embor.7400291; Nomura H, 1998, J BIOL CHEM, V273, P25967, DOI 10.1074/jbc.273.40.25967; Parent A, 2008, TRAFFIC, V9, P394, DOI 10.1111/j.1600-0854.2007.00692.x; Patterson RL, 2004, P NATL ACAD SCI USA, V101, P2328, DOI 10.1073/pnas.0308567100; Robles MS, 2010, SCIENCE, V327, P463, DOI 10.1126/science.1180067; Ron D, 2004, NEUROSCIENTIST, V10, P325, DOI 10.1177/1073858404263516; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Schechtman D, 2001, ONCOGENE, V20, P6339, DOI 10.1038/sj.onc.1204778; Shimizu T, 2009, PFLUG ARCH EUR J PHY, V457, P795, DOI 10.1007/s00424-008-0558-6; Sklan EH, 2006, PROG NEUROBIOL, V78, P117, DOI 10.1016/j.pneurobio.2005.12.002; Usacheva A, 2001, J BIOL CHEM, V276, P22948, DOI 10.1074/jbc.M100087200; Vassilev PM, 2001, BIOCHEM BIOPH RES CO, V282, P341, DOI 10.1006/bbrc.2001.4554; Yaka R, 2002, P NATL ACAD SCI USA, V99, P5710, DOI 10.1073/pnas.062046299; Yarwood SJ, 1999, J BIOL CHEM, V274, P14909, DOI 10.1074/jbc.274.21.14909	50	18	21	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6551	6561		10.1074/jbc.M111.305854	http://dx.doi.org/10.1074/jbc.M111.305854			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22174419	Green Published, hybrid			2022-12-25	WOS:000300791800043
J	Jang, Y; Jung, J; Kim, H; Oh, J; Jeon, JH; Jung, S; Kim, KT; Cho, H; Yang, DJ; Kim, SM; Kim, IB; Song, MR; Oh, U				Jang, Yongwoo; Jung, Jooyoung; Kim, Hyungsup; Oh, Jungeun; Jeon, Ji Hyun; Jung, Saewoon; Kim, Kyung-Tai; Cho, Hawon; Yang, Dong-Jin; Kim, Sung Min; Kim, In-Beom; Song, Mi-Ryoung; Oh, Uhtaek			Axonal Neuropathy-associated TRPV4 Regulates Neurotrophic Factor-derived Axonal Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MARIE-TOOTH DISEASE; CATION CHANNEL TRPV4; CYCLIC-AMP; NEURITE OUTGROWTH; NEURONS; MUTATIONS; MICE; ACTIVATION; CELLS; GENE	Spinal muscular atrophy and hereditary motor and sensory neuropathies are characterized by muscle weakness and atrophy caused by the degenerations of peripheral motor and sensory nerves. Recent advances in genetics have resulted in the identification of missense mutations in TRPV4 in patients with these hereditary neuropathies. Neurodegeneration caused by Ca2+ overload due to the gain-of-function mutation of TRPV4 was suggested as the molecular mechanism for the neuropathies. Despite the importance of TRPV4 mutations in causing neuropathies, the precise role of TRPV4 in the sensory/motor neurons is unknown. Here, we report that TRPV4 mediates neurotrophic factor-derived neuritogenesis in developing peripheral neurons. TRPV4 was found to be highly expressed in sensory and spinal motor neurons in early development as well as in the adult, and the overexpression or chemical activation of TRPV4 was found to promote neuritogenesis in sensory neurons as well as PC12 cells, whereas its knockdown and pharmacologic inhibition had the opposite effect. More importantly, nerve growth factor or cAMP treatment up-regulated the expression of phospholipase A(2) and TRPV4. Neurotrophic factor-derived neuritogenesis appears to be regulated by the phospholipase A(2)-mediated TRPV4 pathway. These findings show that TRPV4 mediates neurotrophic factor-induced neuritogenesis in developing peripheral nerves. Because neurotrophic factors are essential for the maintenance of peripheral nerves, these findings suggest that aberrant TRPV4 activity may lead to some types of pathology of sensory and motor nerves.	[Jang, Yongwoo; Jung, Jooyoung; Kim, Hyungsup; Jung, Saewoon; Cho, Hawon; Oh, Uhtaek] Seoul Natl Univ, Sensory Res Ctr, Coll Pharm, Seoul 151742, South Korea; [Oh, Jungeun; Yang, Dong-Jin; Oh, Uhtaek] Seoul Natl Univ, Dept Mol Med & Biopharmaceut Sci, Grad Sch Convergence Sci & Technol, Seoul 151742, South Korea; [Kim, Sung Min] Hanyang Univ, Coll Phys Educ, Seoul 133791, South Korea; [Jeon, Ji Hyun; Kim, In-Beom] Catholic Univ Korea, Dept Anat, Coll Med, Seoul 137701, South Korea; [Kim, Kyung-Tai; Song, Mi-Ryoung] Gwangju Inst Sci & Technol, Sch Life Sci, Bioimaging Res Ctr, Kwangju 500712, South Korea; [Kim, Kyung-Tai; Song, Mi-Ryoung] Gwangju Inst Sci & Technol, Cell Dynam Res Ctr, Kwangju 500712, South Korea	Seoul National University (SNU); Seoul National University (SNU); Hanyang University; Catholic University of Korea; Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST)	Oh, U (corresponding author), Seoul Natl Univ, Sensory Res Ctr, Coll Pharm, Seoul 151742, South Korea.	utoh@snu.ac.kr	Kim, In-Beom/A-6728-2011; Jang, Yongwoo/Y-9854-2018; KIM, SUNG MIN/U-5269-2017	Jang, Yongwoo/0000-0003-1574-9009; KIM, SUNG MIN/0000-0002-0590-9868; Kim, Kyung-Tai/0000-0001-7405-2258; Kim, Hyungsup/0000-0003-2008-198X	World Class University program; Creative Research Initiatives Program [20110018358]; Ministry of Education Science and Technology; National Research Foundation of Korea	World Class University program; Creative Research Initiatives Program; Ministry of Education Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by Grant R31-2008-000-10103-0 from the World Class University program and Creative Research Initiatives Program Grant 20110018358 of the Ministry of Education Science and Technology and the National Research Foundation of Korea.	Akiyama N, 2004, NEUROSCI LETT, V365, P218, DOI 10.1016/j.neulet.2004.05.001; Aloe L, 2000, AUTON NEUROSCI-BASIC, V86, P84, DOI 10.1016/S1566-0702(00)00247-2; Anand P, 2004, PROG BRAIN RES, V146, P477; Auer-Grumbach M, 2010, NAT GENET, V42, P160, DOI 10.1038/ng.508; AVILA MA, 1993, DEV BIOL, V159, P266, DOI 10.1006/dbio.1993.1239; Bai JZ, 2010, NEUROTOXICOLOGY, V31, P204, DOI 10.1016/j.neuro.2010.01.001; Benfenati V, 2007, NEUROSCIENCE, V148, P876, DOI 10.1016/j.neuroscience.2007.06.039; Berti C, 2006, NEUROMOL MED, V8, P191, DOI 10.1385/NMM:8:1:191; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Causing CG, 1997, NEURON, V18, P257, DOI 10.1016/S0896-6273(00)80266-4; CONNOLLY JL, 1979, J CELL BIOL, V82, P820, DOI 10.1083/jcb.82.3.820; Costantini LC, 2000, EXP NEUROL, V164, P60, DOI 10.1006/exnr.2000.7417; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; Dehmelt L, 2003, J NEUROSCI, V23, P9479; DELONG R, 1992, ARCH NEUROL-CHICAGO, V49, P905, DOI 10.1001/archneur.1992.00530330027010; Deng HX, 2010, NAT GENET, V42, P165, DOI 10.1038/ng.509; Drew AP, 2011, CURR MOL MED, V11, P650; Everaerts W, 2010, P NATL ACAD SCI USA, V107, P19084, DOI 10.1073/pnas.1005333107; Everaerts W, 2010, PROG BIOPHYS MOL BIO, V103, P2, DOI 10.1016/j.pbiomolbio.2009.10.002; Fecto F, 2011, J BIOL CHEM, V286, P17281, DOI 10.1074/jbc.M111.237685; Fernyhough P, 2010, CELL CALCIUM, V47, P130, DOI 10.1016/j.ceca.2009.11.008; Gehler S, 2004, J NEUROSCI, V24, P10741, DOI 10.1523/JNEUROSCI.2836-04.2004; Glebova NO, 2004, J NEUROSCI, V24, P743, DOI 10.1523/JNEUROSCI.4523-03.2004; Granholm ACE, 1997, J NEUROSCI, V17, P1168; GU XN, 1994, J NEUROSCI, V14, P6325; Gupton SL, 2010, DEV CELL, V18, P725, DOI [10.1016/j.devcel.2010.02.017, 10.1016/j.devce1.2010.02.017]; Hansen TVO, 2000, J NEUROCHEM, V75, P1870, DOI 10.1046/j.1471-4159.2000.0751870.x; Herring TL, 1999, J MEMBRANE BIOL, V171, P151, DOI 10.1007/s002329900567; Hiltunen PH, 2004, MOL CELL NEUROSCI, V26, P450, DOI 10.1016/j.mcn.2004.04.003; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Indo Y, 1996, NAT GENET, V13, P485, DOI 10.1038/ng0896-485; Jin M, 2005, J NEUROSCI, V25, P2338, DOI 10.1523/JNEUROSCI.4889-04.2005; Lamande SR, 2011, NAT GENET, V43, P1142, DOI 10.1038/ng.945; Landoure G, 2010, NAT GENET, V42, P170, DOI 10.1038/ng.512; LARGE TH, 1986, SCIENCE, V234, P352, DOI 10.1126/science.3764415; LEVIMONTALCINI R, 1987, EMBO J, V6, P1145, DOI 10.1002/j.1460-2075.1987.tb02347.x; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Lin CJ, 1995, J BIOMECH, V28, P1429, DOI 10.1016/0021-9290(95)00091-7; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; Pullikuth AK, 2007, CELL SIGNAL, V19, P1621, DOI 10.1016/j.cellsig.2007.04.012; Reilly MM, 2011, J PERIPHER NERV SYST, V16, P1, DOI 10.1111/j.1529-8027.2011.00324.x; Rock MJ, 2008, NAT GENET, V40, P999, DOI 10.1038/ng.166; RYDEL RE, 1988, P NATL ACAD SCI USA, V85, P1257, DOI 10.1073/pnas.85.4.1257; Shibasaki K, 2010, J NEUROSCI, V30, P4601, DOI 10.1523/JNEUROSCI.5830-09.2010; Shy ME, 2011, CURR OPIN NEUROL, V24, P475, DOI 10.1097/WCO.0b013e32834aa331; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Tang Z, 2005, PHYSIOL RES, V54, P671, DOI 10.33549/physiolres.930719; Thorneloe KS, 2008, J PHARMACOL EXP THER, V326, P432, DOI 10.1124/jpet.108.139295; Tian W, 2009, P NATL ACAD SCI USA, V106, P14034, DOI 10.1073/pnas.0904084106; Tojima T, 2003, BRAIN RES, V985, P43, DOI 10.1016/S0006-8993(03)03113-5; Tosaki T, 2008, EXP NEUROL, V213, P381, DOI 10.1016/j.expneurol.2008.06.017; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Yu WM, 2007, MOL NEUROBIOL, V35, P288, DOI 10.1007/s12035-007-0026-x; Zimon M, 2010, BRAIN, V133, P1798, DOI 10.1093/brain/awq109	58	41	43	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					6014	6024		10.1074/jbc.M111.316315	http://dx.doi.org/10.1074/jbc.M111.316315			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22187434	Green Published, hybrid			2022-12-25	WOS:000300638000074
J	Kon, N; Zhong, JY; Qiang, L; Accili, D; Gu, W				Kon, Ning; Zhong, Jiayun; Qiang, Li; Accili, Domenico; Gu, Wei			Inactivation of arf-bp1 Induces p53 Activation and Diabetic Phenotypes in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEIN LIGASE; TUMOR-SUPPRESSOR; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; IN-VIVO; PROLIFERATION; DEGRADATION; STABILITY; HUWE1; MDM2	It is well accepted that the Mdm2 ubiquitin ligase acts as a major factor in controlling p53 stability and activity in vivo. Although several E3 ligases have been reported to be involved in Mdm2-independent p53 degradation, the roles of these ligases in p53 regulation in vivo remain largely unknown. To elucidate the physiological role of the ubiquitin ligase ARF-BP1, we generated arf-bp1 mutant mice. We found that inactivation of arf-bp1 during embryonic development in mice resulted in p53 activation and embryonic lethality, but the mice with arf-bp1 deletion specifically in the pancreatic beta-cells (arf-bp1(FL/Y)/RIP-cre) were viable and displayed no obvious abnormality after birth. Interestingly, these mice showed dramatic loss of beta-cells as mice aged, and >50% of these mice died of severe diabetic symptoms before reaching 1 year of age. Notably, the diabetic phenotype of these mice was largely reversed by concomitant deletion of p53, and the life span of the mice was significantly extended (p53(LFL/FL)/arf-bp1(FL/Y)/RIP-cre). These findings underscore an important role of ARF-BP1 in maintaining beta-cell homeostasis in aging mice and reveal that the stability of p53 is critically regulated by ARF-BP1 in vivo.	[Gu, Wei] Columbia Univ, Inst Canc Genet, Dept Pathol & Cell Biol, Coll Phys & Surg, New York, NY 10032 USA; [Qiang, Li; Accili, Domenico] Columbia Univ, Naomi Berrie Diabet Ctr, Dept Med, Coll Phys & Surg, New York, NY 10032 USA	Columbia University; Columbia University	Gu, W (corresponding author), Columbia Univ, Inst Canc Genet, Dept Pathol & Cell Biol, Coll Phys & Surg, 1130 St Nicholas Ave, New York, NY 10032 USA.	wg8@columbia.edu	Qiang, Li/C-9560-2012	Qiang, Li/0000-0001-8322-1797	National Institutes of Health from the NCI; Leukemia and Lymphoma Society; Diabetes Research Center [DK63608]; NATIONAL CANCER INSTITUTE [R01CA129627, R01CA118561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063608] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Diabetes Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by a National Institutes of Health grant from the NCI. This work was also supported by a grant from the Leukemia and Lymphoma Society (to W. G.) and by Diabetes Research Center Grant DK63608 (to D. A.).	Armata HL, 2010, MOL CELL BIOL, V30, P5787, DOI 10.1128/MCB.00347-10; Bitti MLM, 2011, J PEDIATR ENDOCR MET, V24, P437, DOI 10.1515/JPEM.2011.058; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Chen HA, 2009, GENE DEV, V23, P975, DOI 10.1101/gad.1742509; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Eischen CM, 2009, CANCER CELL, V15, P161, DOI 10.1016/j.ccr.2009.02.004; Gudkov AV, 2005, BIOCHEM BIOPH RES CO, V331, P726, DOI 10.1016/j.bbrc.2005.03.153; Gurzov EN, 2010, J BIOL CHEM, V285, P19910, DOI 10.1074/jbc.M110.122374; Hall JR, 2007, MOL BIOL CELL, V18, P3340, DOI 10.1091/mbc.E07-02-0173; Herold S, 2008, EMBO J, V27, P2851, DOI 10.1038/emboj.2008.200; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Hinault C, 2011, DIABETES, V60, P1210, DOI 10.2337/db09-1379; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Liu ZQ, 2007, DEV DYNAM, V236, P2889, DOI 10.1002/dvdy.21302; LUNA RMD, 1995, NATURE, V378, P203; Marine JC, 2010, CELL DEATH DIFFER, V17, P93, DOI 10.1038/cdd.2009.68; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Migliorini D, 2011, J CLIN INVEST, V121, P1329, DOI 10.1172/JCI45784; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Qian YJ, 2010, HISTOL HISTOPATHOL, V25, P515, DOI 10.14670/HH-25.515; Ringshausen I, 2006, CANCER CELL, V10, P501, DOI 10.1016/j.ccr.2006.10.010; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Tschen SI, 2009, DIABETES, V58, P1312, DOI 10.2337/db08-1651; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vitari AC, 2011, NATURE, V474, P403, DOI 10.1038/nature10005; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Xuan SH, 2002, J CLIN INVEST, V110, P1011, DOI 10.1172/JCI200215276; Yin L, 2010, P NATL ACAD SCI USA, V107, P11614, DOI 10.1073/pnas.1000438107; Zhang XN, 2011, EMBO J, V30, P2177, DOI 10.1038/emboj.2011.125; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhang YP, 2004, CELL CYCLE, V3, P259; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727; Zhao X, 2009, DEV CELL, V17, P210, DOI 10.1016/j.devcel.2009.07.009; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	40	38	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					5102	5111		10.1074/jbc.M111.322867	http://dx.doi.org/10.1074/jbc.M111.322867			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22187431	Green Published, hybrid			2022-12-25	WOS:000300608500068
J	Yuan, XJ; Protchenko, O; Philpott, CC; Hamza, I				Yuan, Xiaojing; Protchenko, Olga; Philpott, Caroline C.; Hamza, Iqbal			Topologically Conserved Residues Direct Heme Transport in HRG-1-related Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; IRON UPTAKE; FERRIC REDUCTASE; YEAST; GENES; TRANSCRIPTION; BIOSYNTHESIS; HOMEOSTASIS; ACTIVATION; MECHANISM	Caenorhabditis elegans and human HRG-1-related proteins are conserved, membrane-bound permeases that bind and translocate heme in metazoan cells via a currently uncharacterized mechanism. Here, we show that cellular import of heme by HRG-1-related proteins from worms and humans requires strategically located amino acids that are topologically conserved across species. We exploit a heme synthesis-defective Saccharomyces cerevisiae mutant to model the heme auxotrophy of C. elegans and demonstrate that, under heme-deplete conditions, the endosomal CeHRG-1 requires both a specific histidine in the predicted second transmembrane domain (TMD2) and the FARKY motif in the C terminus tail for heme transport. By contrast, the plasma membrane CeHRG-4 transports heme by utilizing a histidine in the exoplasmic (E2) loop and the FARKY motif. Optimal activity under heme-limiting conditions, however, requires histidine in the E2 loop of CeHRG-1 and tyrosine in TMD2 of CeHRG-4. An analogous system exists in humans, because mutation of the synonymous histidine in TMD2 of hHRG-1 eliminates heme transport activity, implying an evolutionary conserved heme transport mechanism that predates vertebrate origins. Our results support a model in which heme is translocated across membranes facilitated by conserved amino acids positioned on the exoplasmic, cytoplasmic, and transmembrane regions of HRG-1-related proteins. These findings may provide a framework for understanding the structural basis of heme transport in eukaryotes and human parasites, which rely on host heme for survival.	[Yuan, Xiaojing; Hamza, Iqbal] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Yuan, Xiaojing; Hamza, Iqbal] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Protchenko, Olga; Philpott, Caroline C.] NIDDK, Genet & Metab Sect, Liver Dis Branch, NIH, Bethesda, MD 20892 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Hamza, I (corresponding author), Univ Maryland, Dept Anim & Avian Sci, 2413 Anim & Avian Sci,Bldg 142, College Pk, MD 20742 USA.	hamza@umd.edu	Yuan, Xiaojing/V-6882-2019; Protchenko, Olga/AAU-9237-2021	Yuan, Xiaojing/0000-0002-0969-5748; Protchenko, Olga/0000-0002-4688-4214; Hamza, Iqbal/0000-0003-0045-0610	National Institutes of Health [R01DK74797, R01DK85035]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK054513] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK74797 and R01DK85035 (to I. H.).	BODE HP, 1995, EUR J BIOCHEM, V228, P337; Brown JK, 2006, J VIROL, V80, P1742, DOI 10.1128/JVI.80.4.1742-1751.2006; Burke D., 2000, METHODS YEAST GENETI; Cescau S, 2007, BIOMETALS, V20, P603, DOI 10.1007/s10534-006-9050-y; Chen CY, 2011, CELL, V145, P720, DOI 10.1016/j.cell.2011.04.025; Crisp RJ, 2003, J BIOL CHEM, V278, P45499, DOI 10.1074/jbc.M307229200; DANCIS A, 1990, MOL CELL BIOL, V10, P2294, DOI 10.1128/MCB.10.5.2294; De Feo CJ, 2009, P NATL ACAD SCI USA, V106, P4237, DOI 10.1073/pnas.0810286106; Diallinas G, 2008, SCIENCE, V322, P1644, DOI 10.1126/science.1168107; Duffy SP, 2010, MOL CELL BIOL, V30, P5318, DOI 10.1128/MCB.00690-10; Frawley ER, 2009, P NATL ACAD SCI USA, V106, P10201, DOI 10.1073/pnas.0903132106; GEORGATSOU E, 1994, MOL CELL BIOL, V14, P3065, DOI 10.1128/MCB.14.5.3065; Goodwin DC, 2000, BIOCHEMISTRY-US, V39, P5422, DOI 10.1021/bi992752f; Grigg JC, 2010, J INORG BIOCHEM, V104, P341, DOI 10.1016/j.jinorgbio.2009.09.012; GUARENTE L, 1983, CELL, V32, P1279, DOI 10.1016/0092-8674(83)90309-4; Hon T, 2003, J BIOL CHEM, V278, P50771, DOI 10.1074/jbc.M303677200; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Keel SB, 2008, SCIENCE, V319, P825, DOI 10.1126/science.1151133; Layer G, 2010, PROTEIN SCI, V19, P1137, DOI 10.1002/pro.405; LI JM, 1988, J BACTERIOL, V170, P1021, DOI 10.1128/jb.170.2.1021-1025.1988; Lipovich L, 2002, GENE, V286, P203, DOI 10.1016/S0378-1119(02)00457-2; Liu Y, 1999, BIOCHEMISTRY-US, V38, P3733, DOI 10.1021/bi982707s; Maines MD, 2005, ANTIOXID REDOX SIGN, V7, P1761, DOI 10.1089/ars.2005.7.1761; Merchant SS, 2009, P NATL ACAD SCI USA, V106, P10069, DOI 10.1073/pnas.0905189106; Nass R., 2007, CURRENT PROTOCOLS TO, P191; O'Callaghan KM, 2010, J BIOL CHEM, V285, P381, DOI 10.1074/jbc.M109.063248; Protchenko O, 2008, EUKARYOT CELL, V7, P859, DOI 10.1128/EC.00414-07; Protchenko O, 2006, J BIOL CHEM, V281, P21445, DOI 10.1074/jbc.M512812200; Quigley JG, 2004, CELL, V118, P757, DOI 10.1016/j.cell.2004.08.014; RAGUZZI F, 1988, FEBS LETT, V231, P253, DOI 10.1016/0014-5793(88)80742-7; Rajagopal A, 2008, NATURE, V453, P1127, DOI 10.1038/nature06934; Rao AU, 2005, P NATL ACAD SCI USA, V102, P4270, DOI 10.1073/pnas.0500877102; Schultz IJ, 2010, J BIOL CHEM, V285, P26753, DOI 10.1074/jbc.R110.119503; Severance S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001044; Severance S, 2009, CHEM REV, V109, P4596, DOI 10.1021/cr9001116; Shatwell KP, 1996, J BIOL CHEM, V271, P14240, DOI 10.1074/jbc.271.24.14240; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Sinclair J, 2010, J BIOL CHEM, V285, P39536, DOI 10.1074/jbc.M110.167619; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Tong Y, 2009, ARCH BIOCHEM BIOPHYS, V481, P1, DOI 10.1016/j.abb.2008.10.013; Villareal VA, 2011, J AM CHEM SOC, V133, P14176, DOI 10.1021/ja203805b; West AR, 2008, WORLD J GASTROENTERO, V14, P4101, DOI 10.3748/wjg.14.4101; Wilks A, 2007, NAT PROD REP, V24, P511, DOI 10.1039/b604193k; Yadav J, 2007, MOL BIOL CELL, V18, P1480, DOI 10.1091/mbc.E06-11-1049; Yang ZT, 2010, J BIOL CHEM, V285, P28874, DOI 10.1074/jbc.M110.119131	45	40	42	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4914	4924		10.1074/jbc.M111.326785	http://dx.doi.org/10.1074/jbc.M111.326785			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22174408	Green Published, hybrid			2022-12-25	WOS:000300608500052
J	Audfray, A; Claudinon, J; Abounit, S; Ruvoen-Clouet, N; Larson, G; Smith, DF; Wimmerova, M; Le Pendu, J; Romer, W; Varrot, A; Imberty, A				Audfray, Aymeric; Claudinon, Julie; Abounit, Saida; Ruvoen-Clouet, Nathalie; Larson, Goran; Smith, David F.; Wimmerova, Michaela; Le Pendu, Jacques; Roemer, Winfried; Varrot, Annabelle; Imberty, Anne			Fucose-binding Lectin from Opportunistic Pathogen Burkholderia ambifaria Binds to Both Plant and Human Oligosaccharidic Epitopes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEPACIA COMPLEX; PSEUDOMONAS-AERUGINOSA; MOLECULAR-BASIS; SP-NOV.; INFECTION; GLYCOSYLATION; POLYMORPHISM; SPECIFICITY; RECOGNITION; DIVERSITY	Burkholderia ambifaria is generally associated with the rhizosphere of plants where it has biocontrol effects on other microorganisms. It is also a member of the Burkholderia cepacia complex, a group of closely related bacteria that cause lung infections in immunocompromised patients as well as in patients with granulomatous disease or cystic fibrosis. Our previous work indicated that fucose on human epithelia is a frequent target for lectins and adhesins of lung pathogens (Sulak, O., Cioci, G., Lameignere, E., Balloy, V., Round, A., Gutsche, I., Malinovska, L., Chignard, M., Kosma, P., Aubert, D. F., Marolda, C. L., Valvano, M. A., Wimmerova, M., and Imberty, A. (2011) PLoS Pathog. 7, e1002238). Analysis of the B. ambifaria genome identified BambL as a putative fucose-binding lectin. The 87-amino acid protein was produced recombinantly and demonstrated to bind to fucosylated oligosaccharides with a preference for alpha Fuc1-2Gal epitopes. Crystal structures revealed that it associates as a trimer with two fucose-binding sites per monomer. The overall fold is a six-bladed beta-propeller formed by oligomerization as in the Ralstonia solanacearum lectin and not by sequential domains like the fungal fucose lectin from Aleuria aurantia. The affinity of BambL for small fucosylated glycans is very high as demonstrated by microcalorimetry (K-D < 1 mu M). Plant cell wall oligosaccharides and human histo-blood group oligosaccharides H-type 2 and Lewis Y are bound with equivalent efficiency. Binding to artificial glycosphingolipid-containing vesicles, human saliva, and lung tissues confirmed that BambL could recognize a wide spectrum of fucosylated epitopes, albeit with a lower affinity for biological material from nonsecretor individuals.	[Audfray, Aymeric; Varrot, Annabelle; Imberty, Anne] Univ Grenoble 1, Ctr Rech Macromol Vegetales CERMAV CNRS, F-38041 Grenoble, France; [Audfray, Aymeric; Varrot, Annabelle; Imberty, Anne] Inst Chim Mol Grenoble, F-38041 Grenoble, France; [Claudinon, Julie; Roemer, Winfried] Univ Freiburg, Inst Biol 2, D-79104 Freiburg, Germany; [Claudinon, Julie; Roemer, Winfried] Univ Freiburg, Ctr Biol Signaling Studies BIOSS, D-79104 Freiburg, Germany; [Abounit, Saida; Roemer, Winfried] Inst Curie, Traff Signaling & Delivery Grp, Ctr Rech, CNRS UMR 144, F-75248 Paris, France; [Ruvoen-Clouet, Nathalie; Le Pendu, Jacques] Univ Nantes, INSERM U892, Inst Rech Therapeut IRT UN, F-44007 Nantes, France; [Larson, Goran] Sahlgrens Univ Hosp, Dept Clin Chem & Transfus Med, S-41345 Gothenburg, Sweden; [Smith, David F.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Wimmerova, Michaela] Masaryk Univ, Cent European Inst Technol, Brno 62500, Czech Republic	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Freiburg; University of Freiburg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Sahlgrenska University Hospital; Emory University; Masaryk University Brno	Imberty, A (corresponding author), CERMAV CNRS, 601 Rue Chim,BP53, F-38041 Grenoble 9, France.	Imberty@cermav.cnrs.fr	Ruvoen-clouet, Nathalie/K-9609-2015; Le Pendu, Jacques/F-4760-2013; Larson, Göran/AAF-3404-2019; Wimmerova, Michaela/A-4114-2010; Imberty, Anne/P-6451-2018	Le Pendu, Jacques/0000-0002-4856-0387; Wimmerova, Michaela/0000-0002-7108-4198; Varrot, Annabelle/0000-0001-6667-8162; Imberty, Anne/0000-0001-6825-9527	CNRS-INSERM; German Excellence Initiative of the Deutsche Forschungsgemeinschaft; Association Vaincre la Mucoviscidose; Agence Nationale de la Recherche [NeoLect 11-BSV5-002-01]; GlycanClust; Czech Science Foundation [GA303/09/1168]; CEITEC-Central European Institute of Technology [CZ.1.05/1.1.00/02.0068]; European Community; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	CNRS-INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)Centre National de la Recherche Scientifique (CNRS)); German Excellence Initiative of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Association Vaincre la Mucoviscidose; Agence Nationale de la Recherche(French National Research Agency (ANR)); GlycanClust; Czech Science Foundation(Grant Agency of the Czech Republic); CEITEC-Central European Institute of Technology; European Community(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by CNRS-INSERM, the German Excellence Initiative of the Deutsche Forschungsgemeinschaft, and the Association Vaincre la Mucoviscidose. This work was also supported by Agence Nationale de la Recherche Grants NeoLect 11-BSV5-002-01 (to A. I., W. R., and J. L. P.) and GlycanClust (to W. R.) and by grants from the Czech Science Foundation (GA303/09/1168) and the CEITEC-Central European Institute of Technology (CZ.1.05/1.1.00/02.0068) from the European Regional Development Fund (to M. W.).; The glycan array resources were provided by the Consortium for Functional Glycomics (GM62116). Crystal data collection was performed at the European Synchrotron Radiation Facility, and we are grateful for the assistance in using beamline BM30A. Access to the High Throughput Crystallization facility of the Partnership for Structural Biology (PSB) in Grenoble was supported by the European Community PCube program. We acknowledge the help received from the Cell and Tissue Imaging Core Facility of the Institut Curie (PICT-IBiSA) and the staff of the Life Imaging Center (LIC) Freiburg and the use of the advanced microscopy equipment of the LIC Freiburg and the Nikon Imaging Center at the Institut Curie-CNRS. We also thank the MicroPiCell core facility of IFR26, Nantes, for the preparation of tissue microarrays.	Aaron SD, 2000, AM J RESP CRIT CARE, V161, P1206, DOI 10.1164/ajrccm.161.4.9907147; Aspholm-Hurtig M, 2004, SCIENCE, V305, P519, DOI 10.1126/science.1098801; Azevedo M, 2008, J PATHOL, V215, P308, DOI 10.1002/path.2363; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Chiarini L, 2006, TRENDS MICROBIOL, V14, P277, DOI 10.1016/j.tim.2006.04.006; Coenye T, 2001, INT J SYST EVOL MICR, V51, P1481, DOI 10.1099/00207713-51-4-1481; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferrer-Admetlla A, 2009, MOL BIOL EVOL, V26, P1993, DOI 10.1093/molbev/msp108; GILBOAGARBER N, 1982, METHOD ENZYMOL, V83, P378; Glick MC, 2001, BIOCHIMIE, V83, P743, DOI 10.1016/S0300-9084(01)01323-2; Holmner A, 2010, FEBS LETT, V584, P2548, DOI 10.1016/j.febslet.2010.03.050; IMBERTY A, 1995, GLYCOCONJUGATE J, V12, P331, DOI 10.1007/BF00731336; Imberty A, 2004, MICROBES INFECT, V6, P221, DOI 10.1016/j.micinf.2003.10.016; Imberty A, 2008, CURR OPIN STRUC BIOL, V18, P567, DOI 10.1016/j.sbi.2008.08.001; KARLSSON KA, 1981, J BIOL CHEM, V256, P3512; KIARASH A, 1994, J BIOL CHEM, V269, P11138; Kostlanova N, 2005, J BIOL CHEM, V280, P27839, DOI 10.1074/jbc.M505184200; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le Pendu J, 2006, SEMIN IMMUNOL, V18, P375, DOI 10.1016/j.smim.2006.07.009; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Linden S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040002; Marionneau S, 2005, J INFECT DIS, V192, P1071, DOI 10.1086/432546; Marionneau S, 2001, BIOCHIMIE, V83, P565, DOI 10.1016/S0300-9084(01)01321-9; Mathivet L, 1996, BIOPHYS J, V70, P1112, DOI 10.1016/S0006-3495(96)79693-5; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mitchell E, 2002, NAT STRUCT BIOL, V9, P918, DOI 10.1038/nsb865; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nystrom K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002188; Parke JL, 2001, ANNU REV PHYTOPATHOL, V39, P225, DOI 10.1146/annurev.phyto.39.1.225; Pieters RJ, 2011, ADV EXP MED BIOL, V715, P227, DOI 10.1007/978-94-007-0940-9_14; Pirone L, 2005, ENVIRON MICROBIOL, V7, P1734, DOI 10.1111/j.1462-2920.2005.00897.x; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Saiman L, 2004, CLIN MICROBIOL REV, V17, P57, DOI 10.1128/CMR.17.1.57-71.2004; Scanlin TF, 2001, RESP RES, V2, P276, DOI 10.1186/rr69; Schmidt S, 2009, ENVIRON MICROBIOL, V11, P1422, DOI 10.1111/j.1462-2920.2009.01870.x; Smith DF, 2010, METHOD ENZYMOL, V480, P417, DOI 10.1016/S0076-6879(10)80033-3; Staudacher E, 1999, BBA-GEN SUBJECTS, V1473, P216, DOI 10.1016/S0304-4165(99)00181-6; Sulak O, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002238; Sulak O, 2010, STRUCTURE, V18, P59, DOI 10.1016/j.str.2009.10.021; Taylor-Cousar JL, 2009, PLOS ONE, V4, pCP5, DOI 10.1371/journal.pone.0004270; Valvano MA, 2005, CURR OPIN MICROBIOL, V8, P99, DOI 10.1016/j.mib.2004.12.002; Vanlaere E, 2008, INT J SYST EVOL MICR, V58, P1580, DOI 10.1099/ijs.0.65634-0; Vanlaere E, 2009, INT J SYST EVOL MICR, V59, P102, DOI 10.1099/ijs.0.001123-0; Vial L, 2008, J BACTERIOL, V190, P5339, DOI 10.1128/JB.00400-08; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wimmerova M, 2003, J BIOL CHEM, V278, P27059, DOI 10.1074/jbc.M302642200	48	75	75	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4335	4347		10.1074/jbc.M111.314831	http://dx.doi.org/10.1074/jbc.M111.314831			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22170069	hybrid, Green Published			2022-12-25	WOS:000300410900064
J	Svastova, E; Witarski, W; Csaderova, L; Kosik, I; Skvarkova, L; Hulikova, A; Zatovicova, M; Barathova, M; Kopacek, J; Pastorek, J; Pastorekova, S				Svastova, Eliska; Witarski, Wojciech; Csaderova, Lucia; Kosik, Ivan; Skvarkova, Lucia; Hulikova, Alzbeta; Zatovicova, Miriam; Barathova, Monika; Kopacek, Juraj; Pastorek, Jaromir; Pastorekova, Silvia			Carbonic Anhydrase IX Interacts with Bicarbonate Transporters in Lamellipodia and Increases Cell Migration via Its Catalytic Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH; CANCER; ADHESION; METASTASIS; EXPRESSION; BIOLOGY; FRONT	Carbonic anhydrase IX (CA IX) is a hypoxia-induced cell surface enzyme expressed in solid tumors, and functionally involved in acidification of extracellular pH and destabilization of intercellular contacts. Since both extracellular acidosis and reduced cell adhesion facilitate invasion and metastasis, we investigated the role of CA IX in cell migration, which promotes the metastatic cascade. As demonstrated here, ectopically expressed CA IX increases scattering, wound healing and transwell migration of MDCK cells, while an inactive CA IX variant lacking the catalytic domain (Delta CA) fails to do so. Correspondingly, hypoxic HeLa cells exhibit diminished migration upon inactivation of the endogenous CA IX either by forced expression of the dominant-negative Delta CA variant or by treatment with CA inhibitor, implying that the catalytic activity is indispensable for the CA IX function. Interestingly, CA IX improves cell migration both in the absence and presence of hepatocyte growth factor (HGF), an established inducer of epithelial-mesenchymal transition. On the other hand, HGF up-regulates CA IX transcription and triggers CA IX protein accumulation at the leading edge of lamellipodia. In these membrane regions CA IX co-localizes with sodium bicarbonate co-transporter (NBCe1) and anion exchanger 2 (AE2) that are both components of the migration apparatus and form bicarbonate transport metabolon with CA IX. Moreover, CA IX physically interacts with AE2 and NBCe1 in situ, as shown here for the first time. Thus, our findings suggest that CA IX actively contributes to cell migration via its ability to facilitate ion transport and pH control at protruding fronts of moving cells.	[Svastova, Eliska; Witarski, Wojciech; Csaderova, Lucia; Kosik, Ivan; Skvarkova, Lucia; Hulikova, Alzbeta; Zatovicova, Miriam; Barathova, Monika; Kopacek, Juraj; Pastorek, Jaromir; Pastorekova, Silvia] Slovak Acad Sci, Inst Virol, Dept Mol Med, Bratislava 84505, Slovakia; [Csaderova, Lucia] Slovak Acad Sci, Ctr Mol Med, Bratislava 84505, Slovakia	Slovak Academy of Sciences; Slovak Academy of Sciences	Pastorekova, S (corresponding author), Slovak Acad Sci, Inst Virol, Dept Mol Med, Dubravska Cesta 9, Bratislava 84505, Slovakia.	virusipa@savba.sk	Kopacek, Juraj/GRF-4984-2022; Pastorek, Jaromir/AAR-2647-2020; Pastorekova, Silvia/C-6685-2018; Zaťovičová, Miriam/ABA-3268-2021; Svastova, Eliska/AAD-9768-2019; Witarski, Wojciech/M-8692-2015	Zaťovičová, Miriam/0000-0002-8682-4232; Witarski, Wojciech/0000-0001-8957-8623; Svastova, Eliska/0000-0003-0679-1061; Csaderova, Lucia/0000-0003-4728-0305; Kopacek, Juraj/0000-0003-3069-646X; Kosik, Ivan/0000-0001-5756-5182; Barathova, Monika/0000-0002-6577-220X	Slovak Scientific Grant Agency [VEGA 2/0130/11]; ERDF [TRANSMED 2, ITMS 26240120030]; EU; Research and Development Support Agency [DO7RP-0017-09]; Research & Development Operational Program	Slovak Scientific Grant Agency(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)); ERDF(European Commission); EU(European Commission); Research and Development Support Agency(Slovak Research and Development Agency); Research & Development Operational Program	This work was supported by Grants VEGA 2/0130/11, 2/0129/11 from the Slovak Scientific Grant Agency, from the 7th Framework program of EU (Collaborative Project METOXIA), from the Research and Development Support Agency (DO7RP-0017-09), from the 6th Framework program of EU (Marie Curie RTN project CELLCHECK), and from the Research & Development Operational Program funded by the ERDF (Project TRANSMED 2, ITMS 26240120030).	Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Brahimi-Horn MC, 2011, CURR OPIN GENET DEV, V21, P67, DOI 10.1016/j.gde.2010.10.006; Chen J, 2005, GUT, V54, P920, DOI 10.1136/gut.2004.047340; Chiche J, 2009, CANCER RES, V69, P358, DOI 10.1158/0008-5472.CAN-08-2470; Cristini V, 2005, CLIN CANCER RES, V11, P6772, DOI 10.1158/1078-0432.CCR-05-0852; Ditte P, 2011, CANCER RES, V71, P7558, DOI 10.1158/0008-5472.CAN-11-2520; Dorai T, 2005, EUR J CANCER, V41, P2935, DOI 10.1016/j.ejca.2005.09.011; Dubois L, 2011, RADIOTHER ONCOL, V99, P424, DOI 10.1016/j.radonc.2011.05.045; Hulikova A, 2009, FEBS LETT, V583, P3563, DOI 10.1016/j.febslet.2009.10.060; Innocenti A, 2009, BIOORG MED CHEM LETT, V19, P5825, DOI 10.1016/j.bmcl.2009.08.088; Klein M, 2000, J GEN PHYSIOL, V115, P599, DOI 10.1085/jgp.115.5.599; Lou YM, 2011, CANCER RES, V71, P3364, DOI 10.1158/0008-5472.CAN-10-4261; Morgan P. E., 2005, INT C PHYS SCI MARCH; Morgan PE, 2007, AM J PHYSIOL-CELL PH, V293, pC738, DOI 10.1152/ajpcell.00157.2007; Opavsky R, 1996, GENOMICS, V33, P480, DOI 10.1006/geno.1996.0223; PASTOREKOVA S, 1992, VIROLOGY, V187, P620, DOI 10.1016/0042-6822(92)90464-Z; Pastorekova S., 2010, TUMOR MICROENVIRONME, P59; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sansone P, 2009, J CELL MOL MED, V13, P3876, DOI 10.1111/j.1582-4934.2008.00580.x; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Shin HJ, 2011, J CELL SCI, V124, P1077, DOI 10.1242/jcs.072207; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stock C, 2009, PFLUG ARCH EUR J PHY, V458, P981, DOI 10.1007/s00424-009-0677-8; Studebaker AW, 2008, CANCER RES, V68, P9087, DOI 10.1158/0008-5472.CAN-08-0400; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Svastova E, 2003, EXP CELL RES, V290, P332, DOI 10.1016/S0014-4827(03)00351-3; Svastova E, 2004, FEBS LETT, V577, P439, DOI 10.1016/j.febslet.2004.10.043; Swietach P, 2010, ONCOGENE, V29, P6509, DOI 10.1038/onc.2010.455; Swietach P, 2009, J BIOL CHEM, V284, P20299, DOI 10.1074/jbc.M109.006478; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Troyanovsky Sergey M, 2009, Front Biosci (Schol Ed), V1, P61, DOI 10.2741/s7; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Woelber L, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-12; Worthylake RA, 2003, J BIOL CHEM, V278, P13578, DOI 10.1074/jbc.M211584200; Wykoff CC, 2000, CANCER RES, V60, P7075; Yap AS, 2007, CURR OPIN CELL BIOL, V19, P508, DOI 10.1016/j.ceb.2007.09.008; Zat'ovicova M, 2003, J IMMUNOL METHODS, V282, P117, DOI 10.1016/j.jim.2003.08.011; Zavada J, 2000, BRIT J CANCER, V82, P1808, DOI 10.1054/bjoc.2000.1111	40	130	131	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3392	3402		10.1074/jbc.M111.286062	http://dx.doi.org/10.1074/jbc.M111.286062			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22170054	Green Published, hybrid			2022-12-25	WOS:000300295100044
J	Tasic, V; Hynes, AM; Kitamura, K; Cheong, HI; Lozanovski, VJ; Gucev, Z; Jutabha, P; Anzai, N; Sayer, JA				Tasic, Velibor; Hynes, Ann Marie; Kitamura, Kenichiro; Cheong, Hae Il; Lozanovski, Vladimir J.; Gucev, Zoran; Jutabha, Promsuk; Anzai, Naohiko; Sayer, John A.			Clinical and Functional Characterization of URAT1 Variants	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; GENOME-WIDE ASSOCIATION; URIC-ACID LEVEL; SERUM URATE; URATE-TRANSPORTER-1 URAT1; MOLECULAR ANALYSIS; ANION EXCHANGER; GENE-MUTATIONS; HYPOURICEMIA; EXERCISE	Idiopathic renal hypouricaemia is an inherited form of hypouricaemia, associated with abnormal renal handling of uric acid. There is excessive urinary wasting of uric acid resulting in hypouricaemia. Patients may be asymptomatic, but the persistent urinary abnormalities may manifest as renal stone disease, and hypouricaemia may manifest as exercise induced acute kidney injury. Here we have identified Macedonian and British patients with hypouricaemia, who presented with a variety of renal symptoms and signs including renal stone disease, hematuria, pyelonephritis and nephrocalcinosis. We have identified heterozygous missense mutations in SLC22A12 encoding the urate transporter protein URAT1 and correlate these genetic findings with functional characterization. Urate handling was determined using uptake experiments in HEK293 cells. This data highlights the importance of the URAT1 renal urate transporter in determining serum urate concentrations and the clinical phenotypes, including nephrolithiasis, that should prompt the clinician to suspect an inherited form of renal hypouricaemia.	[Tasic, Velibor; Lozanovski, Vladimir J.; Gucev, Zoran] Univ Childrens Hosp, Sch Med, Skopje, North Macedonia; [Hynes, Ann Marie; Sayer, John A.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Kitamura, Kenichiro] Kumamoto Univ, Grad Sch Life Sci, Dept Nephrol, Kumamoto, Japan; [Cheong, Hae Il] Seoul Natl Univ, Childrens Hosp, Dept Pediat, Seoul, South Korea; [Jutabha, Promsuk; Anzai, Naohiko] Dokkyo Med Univ, Sch Med, Dept Pharmacol & Toxicol, Mibu, Tochigi, Japan	Newcastle University - UK; Kumamoto University; Seoul National University (SNU); Seoul National University Hospital; Dokkyo Medical University	Tasic, V (corresponding author), Univ Childrens Hosp, Sch Med, Skopje, North Macedonia.	j.a.sayer@ncl.ac.uk	Lozanovski, Vladimir J/AAP-9781-2020; Jutabha, Promsuk/AAE-9872-2022; Tasic, Velibor/H-8714-2019; Jutabha, Promsuk/AFF-4363-2022; ANZAI, NAOHIKO/K-9492-2017; Cheong, Hae Il/J-5652-2012; Sayer, John A./AAN-2729-2020	Lozanovski, Vladimir J/0000-0002-7332-3973; Tasic, Velibor/0000-0002-3377-1245; ANZAI, NAOHIKO/0000-0003-0605-0458; Sayer, John A./0000-0003-1881-3782	Japan Society for the Promotion of Science (JSPS KAKENHI) [21390073, 21659216, 21890245]; Nakatomi Foundation; Gout Research Foundation of Japan; Ministry for Health, Welfare and Family Affairs, Republic of Korea [A080588]; Newcastle Healthcare Charities; Northern Counties Kidney Research Fund, UK	Japan Society for the Promotion of Science (JSPS KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Nakatomi Foundation; Gout Research Foundation of Japan(Gout Research Foundation of Japan); Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Newcastle Healthcare Charities; Northern Counties Kidney Research Fund, UK	This work was supported in part by grants from the Japan Society for the Promotion of Science (JSPS KAKENHI 21390073, 21659216, 21890245), the Nakatomi Foundation, and Gout Research Foundation of Japan (NA, PJ). This study was partly supported by a grant of the Korea Healthcare technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (A080588)(HIC). AMH is supported by Newcastle Healthcare Charities and the Northern Counties Kidney Research Fund, UK. JAS is a GlaxoSmithKline clinician scientist. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anzai N, 2004, J BIOL CHEM, V279, P45942, DOI 10.1074/jbc.M406724200; Anzai N, 2008, J BIOL CHEM, V283, P26834, DOI 10.1074/jbc.C800156200; Anzai N, 2007, CURR OPIN RHEUMATOL, V19, P151, DOI 10.1097/BOR.0b013e328032781a; Anzai N, 2010, CURR HYPERTENS REV, V6, P148, DOI 10.2174/157340210791936732; Bahat H, 2009, PEDIATR NEPHROL, V24, P999, DOI 10.1007/s00467-008-1093-6; Bairaktari ET, 2003, AM J KIDNEY DIS, V41, P1225, DOI 10.1016/S0272-6386(03)00355-X; Bo S, 2001, EUR J CLIN INVEST, V31, P318, DOI 10.1046/j.1365-2362.2001.00812.x; Cheong HI, 2005, PEDIATR NEPHROL, V20, P886, DOI 10.1007/s00467-005-1863-3; Dinour D, 2011, NEPHROL DIAL TRANSPL; Dinour D, 2010, J AM SOC NEPHROL, V21, P64, DOI 10.1681/ASN.2009040406; Don BR, 2001, CLIN NEPHROL, V55, P45; Enomoto A, 2002, NATURE, V417, P447, DOI 10.1038/nature742; ERLEY CMM, 1989, KLIN WOCHENSCHR, V67, P308, DOI 10.1007/BF01892900; Golembiewska E, 2005, ARCH MED RES, V36, P32, DOI 10.1016/j.arcmed.2004.09.003; Hamada T, 2008, AM J HYPERTENS, V21, P1157, DOI 10.1038/ajh.2008.245; HEDLEY JM, 1980, J CLIN PATHOL, V33, P971, DOI 10.1136/jcp.33.10.971; HISATOME I, 1989, NEPHRON, V51, P13, DOI 10.1159/000185233; Ichida K, 2004, J AM SOC NEPHROL, V15, P164, DOI 10.1097/01.ASN.0000105320.04395.D0; Inazu T, 2006, CLIN NEPHROL, V65, P370; Ito O, 2003, HYPERTENS RES, V26, P509, DOI 10.1291/hypres.26.509; Jutabha P, 2010, J BIOL CHEM, V285, P35123, DOI 10.1074/jbc.M110.121301; Kaneko K, 2009, PEDIATR NEPHROL, V24, P869, DOI 10.1007/s00467-008-1032-6; Komatsuda A, 2006, RENAL FAILURE, V28, P223, DOI 10.1080/08860220600580365; Komoda F, 2004, PEDIATR NEPHROL, V19, P728, DOI 10.1007/s00467-004-1424-1; Kurihara I, 2000, NEPHROL DIAL TRANSPL, V15, P104, DOI 10.1093/ndt/15.1.104; Kuriki S, 2011, NAGOYA J MED SCI, V73, P41; Laspa E, 2004, J CLIN ENDOCR METAB, V89, P5942, DOI 10.1210/jc.2004-0249; Lee JH, 2008, NEPHROLOGY, V13, P661, DOI 10.1111/j.1440-1797.2008.01029.x; Li S, 2007, PLOS GENET, V3, P2156, DOI 10.1371/journal.pgen.0030194; Martin Hernandez E, 2001, An Esp Pediatr, V55, P273; Matsuo H, 2008, AM J HUM GENET, V83, P744, DOI 10.1016/j.ajhg.2008.11.001; MEISEL AD, 1977, AM J MED SCI, V273, P109, DOI 10.1097/00000441-197701000-00013; Mima A, 2008, AM J MED SCI, V336, P512, DOI 10.1097/MAJ.0b013e318164717f; Nakamura A, 2006, PEDIATR NEPHROL, V21, P1898, DOI 10.1007/s00467-006-0255-7; Nakamura M, 2010, J PHARMACOL SCI, V114, P115, DOI 10.1254/jphs.10064SC; Ohta T, 2004, NEPHROL DIAL TRANSPL, V19, P1447, DOI 10.1093/ndt/gfh094; Onishi A, 2010, CLIN NEPHROL, V74, P403, DOI 10.2379/CNX06485; Ouellet G, 2009, NEPHROL THER, V5, P568, DOI 10.1016/j.nephro.2009.03.003; Sakata T, 2010, J PHARMACOL SCI, V113, P263, DOI 10.1254/jphs.09331SC; Sperling O, 2006, MOL GENET METAB, V89, P14, DOI 10.1016/j.ymgme.2006.03.015; Takahashi T, 2005, PEDIATR NEPHROL, V20, P576, DOI 10.1007/s00467-005-1830-z; Tanaka M, 2003, AM J KIDNEY DIS, V42, P1287, DOI 10.1053/j.ajkd.2003.08.032; Tasic V, 2008, PEDIATR NEPHROL, V23, P1177, DOI 10.1007/s00467-008-0796-z; Tin A, 2011, HUM MOL GENET, V20, P4056, DOI 10.1093/hmg/ddr307; Tsimihodimos V, 2001, EUR J ENDOCRINOL, V144, P83, DOI 10.1530/eje.0.1440083; Tzovaras V, 2007, SCAND J CLIN LAB INV, V67, P589, DOI 10.1080/00365510701222868; Vazquez-Mellado J, 2007, RHEUMATOLOGY, V46, P215, DOI 10.1093/rheumatology/kel205; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Watanabe T, 2000, PEDIATR NEPHROL, V14, P851, DOI 10.1007/s004679900233; Watanabe T, 2005, PEDIATR NEPHROL, V20, P86, DOI 10.1007/s00467-004-1693-8; Wright AF, 2010, KIDNEY INT, V78, P446, DOI 10.1038/ki.2010.206; Wu VC, 2005, AM J KIDNEY DIS, V45, P88, DOI 10.1053/j.ajkd.2004.09.031; Yan MT, 2010, KIDNEY INT, V77, P935, DOI 10.1038/ki.2009.563; Yim JJ, 1998, NEPHROL DIAL TRANSPL, V13, P994, DOI 10.1093/ndt/13.4.994; Yoshikawa H, 2003, BRAIN DEV-JPN, V25, P186, DOI 10.1016/S0387-7604(02)00210-3	56	41	45	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2011	6	12							e28641	10.1371/journal.pone.0028641	http://dx.doi.org/10.1371/journal.pone.0028641			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JD	22194875	Green Submitted, Green Published, gold			2022-12-25	WOS:000298664400013
J	Brown, SK; Pedersen, NC; Jafarishorijeh, S; Bannasch, DL; Ahrens, KD; Wu, JT; Okon, M; Sacks, BN				Brown, Sarah K.; Pedersen, Niels C.; Jafarishorijeh, Sardar; Bannasch, Danika L.; Ahrens, Kristen D.; Wu, Jui-Te; Okon, Michaella; Sacks, Benjamin N.			Phylogenetic Distinctiveness of Middle Eastern and Southeast Asian Village Dog Y Chromosomes Illuminates Dog Origins	PLOS ONE			English	Article							HAPLOTYPE ANALYSIS; GENOME SEQUENCE; DNA; DOMESTICATION; INFERENCES; DIVERSITY; AUSTRALIA; WOLVES; BREEDS; BALI	Modern genetic samples are commonly used to trace dog origins, which entails untested assumptions that village dogs reflect indigenous ancestry or that breed origins can be reliably traced to particular regions. We used high-resolution Y chromosome markers (SNP and STR) and mitochondrial DNA to analyze 495 village dogs/dingoes from the Middle East and Southeast Asia, along with 138 dogs from >35 modern breeds to 1) assess genetic divergence between Middle Eastern and Southeast Asian village dogs and their phylogenetic affinities to Australian dingoes and gray wolves (Canis lupus) and 2) compare the genetic affinities of modern breeds to regional indigenous village dog populations. The Y chromosome markers indicated that village dogs in the two regions corresponded to reciprocally monophyletic clades, reflecting several to many thousand years divergence, predating the Neolithic ages, and indicating long-indigenous roots to those regions. As expected, breeds of the Middle East and East Asia clustered within the respective regional village dog clade. Australian dingoes also clustered in the Southeast Asian clade. However, the European and American breeds clustered almost entirely within the Southeast Asian clade, even sharing many haplotypes, suggesting a substantial and recent influence of East Asian dogs in the creation of European breeds. Comparison to 818 published breed dog Y STR haplotypes confirmed this conclusion and indicated that some African breeds reflect another distinct patrilineal origin. The lower-resolution mtDNA marker consistently supported Y-chromosome results. Both marker types confirmed previous findings of higher genetic diversity in dogs from Southeast Asia than the Middle East. Our findings demonstrate the importance of village dogs as windows into the past and provide a reference against which ancient DNA can be used to further elucidate origins and spread of the domestic dog.	[Brown, Sarah K.; Ahrens, Kristen D.; Sacks, Benjamin N.] Univ Calif Davis, Ctr Vet Genet, Canid Divers & Conservat Lab, Davis, CA 95616 USA; [Brown, Sarah K.; Pedersen, Niels C.; Bannasch, Danika L.; Sacks, Benjamin N.] Univ Calif Davis, Vet Genet Lab, Davis, CA 95616 USA; [Pedersen, Niels C.] Univ Calif Davis, Sch Vet Med, Ctr Compan Anim Hlth, Davis, CA 95616 USA; [Pedersen, Niels C.] Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA; [Jafarishorijeh, Sardar] Shiraz Univ, Sch Vet Med, Dept Clin Sci, Shiraz, Iran; [Bannasch, Danika L.; Sacks, Benjamin N.] Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA; [Ahrens, Kristen D.; Sacks, Benjamin N.] Calif State Univ Sacramento, Dept Biol Sci, Sacramento, CA 95819 USA; [Wu, Jui-Te] Natl Chiayi Univ, Dept Vet Med, Chiayi, Taiwan; [Okon, Michaella] Ruah Midbar Kennel Desert Bred Salukis, Herzliyya, Israel	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Shiraz University; University of California System; University of California Davis; California State University System; California State University Sacramento; National Chiayi University	Brown, SK (corresponding author), Univ Calif Davis, Ctr Vet Genet, Canid Divers & Conservat Lab, Davis, CA 95616 USA.	bnsacks@ucdavis.edu	Bannasch, Danika/GZL-8044-2022	Bannasch, Danika/0000-0002-7614-7207; Brown, Sarah/0000-0001-5615-6467	Center for Global, International, and Regional Studies [08-105]; Veterinary Genetics Laboratory; Center for Companion Animal Health at University of California Davis	Center for Global, International, and Regional Studies; Veterinary Genetics Laboratory; Center for Companion Animal Health at University of California Davis	This research was funded by the Pacific Rim Research Program (LSP#08-105) of the Center for Global, International, and Regional Studies, and the Veterinary Genetics Laboratory and Center for Companion Animal Health at University of California Davis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bannasch DL, 2005, MAMM GENOME, V16, P273, DOI 10.1007/s00335-004-2435-8; Bellwood P., 1997, PREHISTORY INDO MALA, VRevised ed.; BENECKE N, 1987, J ARCHAEOL SCI, V14, P31, DOI 10.1016/S0305-4403(87)80004-3; Boyko AR, 2009, P NATL ACAD SCI USA, V106, P13903, DOI 10.1073/pnas.0902129106; Brumfield RT, 2003, TRENDS ECOL EVOL, V18, P249, DOI 10.1016/S0169-5347(03)00018-1; CORBETT L, 1995, DINGO AUSTR ASIA, P216; Cox MP, 2008, HUM BIOL, V80, P335, DOI 10.3378/1534-6617-80.4.335; CRANDALL KA, 1994, SYST BIOL, V43, P222, DOI 10.2307/2413463; Cruciani F, 2010, EUR J HUM GENET, V18, P800, DOI 10.1038/ejhg.2009.231; DAVIS SJM, 1978, NATURE, V276, P608, DOI 10.1038/276608a0; Deguilloux MF, 2009, J ARCHAEOL SCI, V36, P513, DOI 10.1016/j.jas.2008.10.011; Forster P, 2000, AM J HUM GENET, V67, P182, DOI 10.1086/302953; Ginja C, 2009, J HERED, V100, P148, DOI 10.1093/jhered/esn080; Gray MM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-16; HANCOCK D, 1990, HERITAGE DOG; Irion DN, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-6; JUDAH JC, 2007, ANCIENT HIST DOGS SP; Koler-Matznick J, 2002, ANTHROZOOS, V15, P98, DOI 10.2752/089279302786992595; Leonard JA, 2002, SCIENCE, V298, P1613, DOI 10.1126/science.1076980; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Malmstrom H, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-71; Napierala H, 2012, INT J OSTEOARCHAEOL, V22, P127, DOI 10.1002/oa.1182; Natanaelsson C, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-45; Nauta MJ, 1996, GENETICS, V143, P1021; NOBIS G, 1979, UMSCHAU, V79, P610; Oberbauer AM, 2003, VET RES COMMUN, V27, P27, DOI 10.1023/A:1022006606796; Olsen S.J., 1985, ORIGINS DOMESTIC DOG; OLSEN SJ, 1977, SCIENCE, V197, P533, DOI 10.1126/science.197.4303.533; Pang JF, 2009, MOL BIOL EVOL, V26, P2849, DOI 10.1093/molbev/msp195; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Runstadler JA, 2006, TISSUE ANTIGENS, V68, P418, DOI 10.1111/j.1399-0039.2006.00696.x; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Savolainen P, 2004, P NATL ACAD SCI USA, V101, P12387, DOI 10.1073/pnas.0401814101; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Semyenova SK, 2002, RUSS J GENET+, V38, P704, DOI 10.1023/A:1016004320484; Sundqvist AK, 2006, GENETICS, V172, P1121, DOI 10.1534/genetics.105.042358; Sundqvist AK, 2001, MOL ECOL, V10, P1959, DOI 10.1046/j.1365-294X.2001.01326.x; Toonen RJ, 2001, BIOTECHNIQUES, V31, P1320; Verginelli F, 2005, MOL BIOL EVOL, V22, P2541, DOI 10.1093/molbev/msi248; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; WENTWORTH J, 2011, TOY DOGS THEIR ANCES, P716; Wilson IJ, 2003, J R STAT SOC A STAT, V166, P155, DOI 10.1111/1467-985X.00264; Woodall PF, 1996, WILDLIFE RES, V23, P581, DOI 10.1071/WR9960581	46	50	52	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28496	10.1371/journal.pone.0028496	http://dx.doi.org/10.1371/journal.pone.0028496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194840	Green Published, gold, Green Submitted			2022-12-25	WOS:000298369100043
J	Zauli, G; Monasta, L; Rimondi, E; Brumatti, LV; Radillo, O; Ronfani, L; Montico, M; D'Ottavio, G; Alberico, S; Secchiero, P				Zauli, Giorgio; Monasta, Lorenzo; Rimondi, Erika; Brumatti, Liza Vecchi; Radillo, Oriano; Ronfani, Luca; Montico, Marcella; D'Ottavio, Giuseppina; Alberico, Salvatore; Secchiero, Paola			Circulating TRAIL Shows a Significant Post-Partum Decline Associated to Stressful Conditions	PLOS ONE			English	Article							APOPTOSIS-INDUCING LIGAND; INFLAMMATORY MARKERS; ENDOTHELIAL-CELLS; SERUM-LEVELS; OSTEOPROTEGERIN; PREGNANCY; EXPRESSION; RECEPTORS	Background: Since circulating levels of TNF-related apoptosis inducing ligand (TRAIL) may be important in the physiopathology of pregnancy, we tested the hypothesis that TRAIL levels change at delivery in response to stressful conditions. Methods/Principal Findings: We conducted a longitudinal study in a cohort of 73 women examined at week 12, week 16, delivery and in the corresponding cord blood (CB). Serum TRAIL was assessed in relationship with maternal characteristics and to biochemical parameters. TRAIL did not vary between 12 (67.6 +/- 27.6 pg/ml, means +/- SD) and 16 (64.0 +/- 16.2 pg/ml) weeks' gestation, while displaying a significant decline after partum (49.3 +/- 26.4 pg/ml). Using a cut-off decline >20 pg/ml between week 12 and delivery, the subset of women with the higher decline of circulating TRAIL (41.7%) showed the following characteristics: i) nullipara, ii) higher age, iii) operational vaginal delivery or urgent CS, iv) did not receive analgesia during labor, v) induced labor. CB TRAIL was significantly higher (131.6 +/- 52 pg/ml) with respect to the corresponding maternal TRAIL, and the variables significantly associated with the first quartile of CB TRAIL (<90 pg/ml) were higher prepregnancy BMI, induction of labor and fetal distress. With respect to the biochemical parameters, maternal TRAIL at delivery showed an inverse correlation with C-reactive protein (CRP), total cortisol, glycemia and insulin at bivariate analysis, but only with CRP at multivariate analysis. Conclusions: Stressful partum conditions and elevated CRP levels are associated with a decrease of circulating TRAIL.	[Zauli, Giorgio; Monasta, Lorenzo; Brumatti, Liza Vecchi; Radillo, Oriano; Ronfani, Luca; Montico, Marcella; D'Ottavio, Giuseppina; Alberico, Salvatore] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy; [Rimondi, Erika; Secchiero, Paola] Univ Ferrara, Dept Morphol & Embryol, I-44100 Ferrara, Italy; [Rimondi, Erika; Secchiero, Paola] Univ Ferrara, LTTA Ctr, I-44100 Ferrara, Italy	IRCCS Burlo Garofolo; University of Ferrara; University of Ferrara	Zauli, G (corresponding author), IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy.	paola.secchiero@unife.it	Montico, Marcella/B-5290-2013; Rimondi, Erika/AAB-8237-2022; secchiero, paola/G-9689-2015; Monasta, Lorenzo/B-1388-2012; Zauli, Giorgio/ABE-8001-2020; Vecchi Brumatti, Liza/J-4968-2016; RIMONDI, Erika/AAB-6206-2022; Ronfani, Luca/B-6668-2013	Montico, Marcella/0000-0003-0377-8232; secchiero, paola/0000-0003-4101-7987; Monasta, Lorenzo/0000-0001-7774-548X; Vecchi Brumatti, Liza/0000-0001-8149-1873; RIMONDI, Erika/0000-0002-8241-2513; Ronfani, Luca/0000-0001-5710-3914; Zauli, Giorgio/0000-0002-3750-8698	CRTrieste foundation; Associazione Amici del Cuore	CRTrieste foundation; Associazione Amici del Cuore	This study was supported by CRTrieste foundation (to GZ) and Associazione Amici del Cuore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alladina SJ, 2005, J VASC RES, V42, P337, DOI 10.1159/000086599; Ashkenazi A, 2008, CYTOKINE GROWTH F R, V19, P325, DOI 10.1016/j.cytogfr.2008.04.001; Bai X, 2009, PLACENTA, V30, P855, DOI 10.1016/j.placenta.2009.07.006; Camozzi V, 2010, EUR J ENDOCRINOL, V162, P85, DOI 10.1530/EJE-09-0800; Chen LH, 2004, LIFE SCI, V74, P1479, DOI 10.1016/j.lfs.2003.07.044; Di Pietro R, 2004, J CELL PHYSIOL, V201, P331, DOI 10.1002/jcp.20099; Fluhr H, 2009, FERTIL STERIL, V92, P1420, DOI 10.1016/j.fertnstert.2009.04.017; Groebner AE, 2010, PLACENTA, V31, P168, DOI 10.1016/j.placenta.2009.12.017; Hofbauer LC, 2006, RHEUMATOLOGY, V45, P1218, DOI 10.1093/rheumatology/kel108; Jung C, 2011, J CLIN ENDOCR METAB, V96, P1533, DOI 10.1210/jc.2010-2395; Kawano N, 2011, DIABETES RES CLIN PR, V91, P316, DOI 10.1016/j.diabres.2010.11.034; Keogh RJ, 2007, CIRC RES, V100, P834, DOI 10.1161/01.RES.0000261352.81736.37; Klugman SD, 2008, PLACENTA, V29, P382, DOI 10.1016/j.placenta.2008.01.013; Liabeuf S, 2010, NEPHROL DIAL TRANSPL, V25, P2596, DOI 10.1093/ndt/gfq042; Liguori A, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.11.027; Lonergan M, 2003, J CLIN ENDOCR METAB, V88, P3835, DOI 10.1210/jc.2002-021905; Michowitz Y, 2005, J AM COLL CARDIOL, V45, P1018, DOI 10.1016/j.jacc.2004.12.065; Mori K, 2010, THROMB RES, V125, P322, DOI 10.1016/j.thromres.2009.11.024; Naylor KE, 2003, J CLIN ENDOCR METAB, V88, P5361, DOI 10.1210/jc.2003-030486; Niessner A, 2009, EUR HEART J, V30, P789, DOI 10.1093/eurheartj/ehp004; Nomura S, 2007, TRANSPL IMMUNOL, V18, P115, DOI 10.1016/j.trim.2007.05.012; Phillips TA, 1999, J IMMUNOL, V162, P6053; Phillips TA, 2001, PLACENTA, V22, P663, DOI 10.1053/plac.2001.0703; Secchiero P, 2005, BLOOD, V105, P3413, DOI 10.1182/blood-2004-10-4111; Secchiero P, 2008, CURR OPIN HEMATOL, V15, P42, DOI 10.1097/MOH.0b013e3282f15fa6; Secchiero P, 2006, CIRCULATION, V114, P1522, DOI 10.1161/CIRCULATIONAHA.106.643841; Secchiero P, 2010, ATHEROSCLEROSIS, V211, P333, DOI 10.1016/j.atherosclerosis.2010.02.024; Secchiero P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004442; Shaker OG, 2010, ANGIOLOGY, V61, P756, DOI 10.1177/0003319710370961; Sokolov DI, 2009, B EXP BIOL MED+, V148, P766, DOI 10.1007/s10517-010-0812-8; Swellam M, 2009, DIS MARKERS, V26, P127, DOI [10.1155/2009/658943, 10.3233/DMA-2009-0622]; Volpato S, 2011, ATHEROSCLEROSIS, V215, P452, DOI 10.1016/j.atherosclerosis.2010.11.004; von Versen-Hoeynck FM, 2009, AM J HYPERTENS, V22, P687, DOI 10.1038/ajh.2009.54; Watt V, 2011, ATHEROSCLEROSIS, V215, P348, DOI 10.1016/j.atherosclerosis.2011.01.010; Zai-Xing Y, 2008, J CLIN LAB ANAL, V22, P138, DOI 10.1002/jcla.20231; Zauli G, 2007, BLOOD, V110, P536, DOI 10.1182/blood-2007-01-068395	36	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e27011	10.1371/journal.pone.0027011	http://dx.doi.org/10.1371/journal.pone.0027011			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194780	Green Published, Green Submitted, gold			2022-12-25	WOS:000298369100003
J	Ahmad, S; Simmons, T; Varagic, J; Moniwa, N; Chappell, MC; Ferrario, CM				Ahmad, Sarfaraz; Simmons, Tony; Varagic, Jasmina; Moniwa, Norihito; Chappell, Mark C.; Ferrario, Carlos M.			Chymase-Dependent Generation of Angiotensin II from Angiotensin-(1-12) in Human Atrial Tissue	PLOS ONE			English	Article							MAST-CELL CHYMASE; CONVERTING ENZYME; HUMAN HEART; PROANGIOTENSIN-12 PA12; FORMING PATHWAYS; CARDIAC TISSUE; RENIN; SYSTEM; RAT; INHIBITION	Since angiotensin-(1-12) [Ang-(1-12)] is a non-renin dependent alternate precursor for the generation of cardiac Ang peptides in rat tissue, we investigated the metabolism of Ang-(1-12) by plasma membranes (PM) isolated from human atrial appendage tissue from nine patients undergoing cardiac surgery for primary control of atrial fibrillation (MAZE surgical procedure). PM was incubated with highly purified (125)I-Ang-(1-12) at 37 degrees C for 1 h with or without renin-angiotensin system (RAS) inhibitors [lisinopril for angiotensin converting enzyme (ACE), SCH39370 for neprilysin (NEP), MLN-4760 for ACE2 and chymostatin for chymase; 50 mu M each]. (125)I-Ang peptide fractions were identified by HPLC coupled to an inline gamma-detector. In the absence of all RAS inhibitor, (125)I-Ang-(1-12) was converted into Ang I (2 +/- 2%), Ang II (69 +/- 21%), Ang-(1-7) (5 +/- 2%), and Ang-(1-4) (2 +/- 1%). In the absence of all RAS inhibitor, only 22 +/- 10% of (125)I-Ang-(1-12) was unmetabolized, whereas, in the presence of the all RAS inhibitors, 98 +/- 7% of (125)I-Ang-(1-12) remained intact. The relative contribution of selective inhibition of ACE and chymase enzyme showed that (125)I-Ang-(1-12) was primarily converted into Ang II (65 +/- 18%) by chymase while its hydrolysis into Ang II by ACE was significantly lower or undetectable. The activity of individual enzyme was calculated based on the amount of Ang II formation. These results showed very high chymase-mediated Ang II formation (28 +/- 3.1 fmolxmin(-1) xmg(-1), n = 9) from (125)I-Ang-(1-12) and very low or undetectable Ang II formation by ACE (1.1 +/- 0.2 fmolxmin(-2) xmg(-1)). Paralleling these findings, these tissues showed significant content of chymase protein that by immunocytochemistry were primarily localized in atrial cardiac myocytes. In conclusion, we demonstrate for the first time in human cardiac tissue a dominant role of cardiac chymase in the formation of Ang II from Ang-(1-12).	[Ahmad, Sarfaraz; Varagic, Jasmina; Moniwa, Norihito; Chappell, Mark C.; Ferrario, Carlos M.] Wake Forest Univ, Bowman Gray Sch Med, Div Surg Sci, Winston Salem, NC 27106 USA; [Varagic, Jasmina; Chappell, Mark C.] Wake Forest Univ, Bowman Gray Sch Med, Hypertens & Vasc Res Ctr, Winston Salem, NC USA; [Varagic, Jasmina; Chappell, Mark C.; Ferrario, Carlos M.] Wake Forest Univ, Bowman Gray Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27103 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Ahmad, S (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Div Surg Sci, Winston Salem, NC 27106 USA.	sahmad@wakehealth.edu	Chappell, Mark/AAX-9087-2021; Ferrario, Carlos/ABB-4165-2021; Ferrario, Carlos/ABD-2791-2020	Ferrario, Carlos/0000-0003-0792-6239	National Institutes of Health [2PO1 HL-051952, R01 HL-56973]; Farley-Hudson Foundation, Jacksonville, NC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051952, R01HL056973] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Farley-Hudson Foundation, Jacksonville, NC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by the National Heart, Lung and Blood Institutes of the National Institutes of Health (2PO1 HL-051952 and R01 HL-56973). The authors also acknowledge partial support provided by the Farley-Hudson Foundation, Jacksonville, NC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ahmad S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015759; Akasu M, 1998, HYPERTENSION, V32, P514, DOI 10.1161/01.HYP.32.3.514; Arakawa H, 2011, AM J PHYSIOL-HEART C, V300, pH951, DOI 10.1152/ajpheart.01144.2010; Arnold AC, 2010, AM J PHYSIOL-HEART C, V299, pH763, DOI 10.1152/ajpheart.00345.2010; Balcells E, 1997, AM J PHYSIOL-HEART C, V273, pH1769, DOI 10.1152/ajpheart.1997.273.4.H1769; Batlle M, 2006, J HEART LUNG TRANSPL, V25, P1117, DOI 10.1016/j.healun.2006.04.012; Becari C, 2011, AM J PHYSIOL-HEART C, V301, pH565, DOI 10.1152/ajpheart.00534.2010; Bujak-Gizycka B, 2010, J PHYSIOL PHARMACOL, V61, P679; Calkins H, 2007, HEART RHYTHM, V4, P816, DOI 10.1016/j.hrthm.2007.04.005; Chen PM, 2005, CHINESE MED J-PEKING, V118, P1886; Chitravanshi VC, 2011, AM J PHYSIOL-HEART C, V300, pH230, DOI 10.1152/ajpheart.00861.2010; Cohen JA, 2010, AM J PHYSIOL-RENAL, V299, pF35, DOI 10.1152/ajprenal.00138.2010; Dell'Italia LJ, 2002, CURR PROB CARDIOLOGY, V27, P6, DOI 10.1067/mcd.2002.121580; Dell'Italia LJ, 2002, CURR OPIN CARDIOL, V17, P374, DOI 10.1097/00001573-200207000-00009; DellItalia LJ, 1995, AM J PHYSIOL-HEART C, V269, pH2065, DOI 10.1152/ajpheart.1995.269.6.H2065; DORER FE, 1975, BIOCHEM PHARMACOL, V24, P1137, DOI 10.1016/0006-2952(75)90207-5; Ferrario CM, 2010, AM J PHYSIOL-RENAL, V298, pF1297, DOI 10.1152/ajprenal.00110.2010; Ferrario CM, 2010, HYPERTENSION, V55, P445, DOI 10.1161/HYPERTENSIONAHA.109.145839; Ferrario CM, 2009, AM J PHYSIOL-HEART C, V296, pH1184, DOI 10.1152/ajpheart.01114.2008; Fleming I, 2006, CIRC RES, V98, P887, DOI 10.1161/01.RES.0000217340.40936.53; Fukami H, 1998, CURR PHARM DESIGN, V4, P439; Gwathmey TM, 2009, AM J PHYSIOL-RENAL, V296, pF1484, DOI 10.1152/ajprenal.90766.2008; Huang XR, 2003, J AM SOC NEPHROL, V14, P1738, DOI 10.1097/01.ASN.0000071512.93927.4E; Inoue N, 2009, ATHEROSCLEROSIS, V204, P359, DOI 10.1016/j.atherosclerosis.2008.09.032; Isa K, 2009, AM J PHYSIOL-REG I, V297, pR111, DOI 10.1152/ajpregu.90588.2008; Jessup JA, 2008, AM J PHYSIOL-HEART C, V294, pH2614, DOI 10.1152/ajpheart.91521.2007; Kanemitsu H, 2008, EUR J CARDIO-THORAC, V33, P25, DOI 10.1016/j.ejcts.2007.09.040; KIELTY CM, 1993, BIOCHEM BIOPH RES CO, V191, P1230, DOI 10.1006/bbrc.1993.1349; KINOSHITA A, 1991, J BIOL CHEM, V266, P19192; Komeda K, 2008, HEPATOL RES, V38, P501, DOI 10.1111/j.1872-034X.2007.00271.x; Lee M, 2002, ARTERIOSCL THROM VAS, V22, P1475, DOI 10.1161/01.ATV.0000029782.84357.68; Maeda Y, 2010, AM J PHYSIOL-RENAL, V299, pF1328, DOI 10.1152/ajprenal.00337.2010; Miyazaki M, 2006, PHARMACOL THERAPEUT, V112, P668, DOI 10.1016/j.pharmthera.2006.05.008; Miyazaki M, 2006, J PHARMACOL SCI, V100, P391, DOI 10.1254/jphs.CPJ06008X; Nagata S, 2006, BIOCHEM BIOPH RES CO, V350, P1026, DOI 10.1016/j.bbrc.2006.09.146; NAKAJIMA K, 1979, J BIOL CHEM, V254, P4027; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Prosser HC, 2010, PEPTIDES, V31, P1540, DOI 10.1016/j.peptides.2010.05.009; Prosser HCG, 2009, CARDIOVASC RES, V82, P40, DOI 10.1093/cvr/cvp003; Shaltout HA, 2007, AM J PHYSIOL-RENAL, V292, pF82, DOI 10.1152/ajprenal.00139.2006; SKEGGS LT, 1977, FED PROC, V36, P1755; Takai S, 1999, CIRCULATION, V100, P654, DOI 10.1161/01.CIR.100.6.654; Takai S, 1997, CLIN CHIM ACTA, V265, P13, DOI 10.1016/S0009-8981(97)00114-9; Takai S, 2010, J PHARMACOL SCI, V113, P301, DOI 10.1254/jphs.10R05FM; Tchougounova E, 2003, J EXP MED, V198, P423, DOI 10.1084/jem.20030671; Tchougounova E, 2001, FASEB J, V15, P2763, DOI 10.1096/fj.01-0486fje; Trask AJ, 2008, AM J PHYSIOL-HEART C, V294, pH2242, DOI 10.1152/ajpheart.00175.2008; URATA H, 1991, J BIOL CHEM, V266, P17173; URATA H, 1990, J BIOL CHEM, V265, P22348; URATA H, 1990, CIRC RES, V66, P883, DOI 10.1161/01.RES.66.4.883; URATA H, 1993, J CLIN INVEST, V91, P1269, DOI 10.1172/JCI116325; Varagic J, 2008, J MOL MED, V86, P663, DOI 10.1007/s00109-008-0340-4; Wei CC, 2010, J CLIN INVEST, V120, P1229, DOI 10.1172/JCI39345; WELCHES WR, 1993, LIFE SCI, V52, P1461, DOI 10.1016/0024-3205(93)90108-F	54	87	88	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28501	10.1371/journal.pone.0028501	http://dx.doi.org/10.1371/journal.pone.0028501			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22180785	gold, Green Published			2022-12-25	WOS:000298367300013
J	Axelsson, S; Cheramy, M; Hjorth, M; Pihl, M; Akerman, L; Martinuzzi, E; Mallone, R; Ludvigsson, J; Casas, R				Axelsson, Stina; Cheramy, Mikael; Hjorth, Maria; Pihl, Mikael; Akerman, Linda; Martinuzzi, Emanuela; Mallone, Roberto; Ludvigsson, Johnny; Casas, Rosaura			Long-Lasting Immune Responses 4 Years after GAD-Alum Treatment in Children with Type 1 Diabetes	PLOS ONE			English	Article							TRANSCRIPTIONAL REPRESSOR BLIMP-1; T-CELL HOMEOSTASIS; MEMORY; RECEPTOR; SUBSETS; CD4(+); INTERLEUKIN-4; PATHOGENESIS; LYMPHOCYTES; EXPRESSION	A phase II clinical trial with glutamic acid decarboxylase (GAD) 65 formulated with aluminium hydroxide (GAD-alum) has shown efficacy in preserving residual insulin secretion in children and adolescents with recent-onset type 1 diabetes (T1D). We have performed a 4-year follow-up study of 59 of the original 70 patients to investigate long-term cellular and humoral immune responses after GAD-alum-treatment. Peripheral blood mononuclear cells (PBMC) were stimulated in vitro with GAD(65). Frequencies of naive, central and effector memory CD4+ and CD8+ T cells were measured, together with cytokine secretion, proliferation, gene expression and serum GAD(65) autoantibody (GADA) levels. We here show that GAD-alum-treated patients display increased memory T-cell frequencies and prompt T-cell activation upon in vitro stimulation with GAD(65), but not with control antigens, compared with placebo subjects. GAD(65)-induced T-cell activation was accompanied by secretion of T helper (Th) 1, Th2 and T regulatory cytokines and by induction of T-cell inhibitory pathways. Moreover, post-treatment serum GADA titres remained persistently increased in the GAD-alum arm, but did not inhibit GAD(65) enzymatic activity. In conclusion, memory T- and B-cell responses persist 4 years after GAD-alum-treatment. In parallel to a GAD(65)-induced T-cell activation, our results show induction of T-cell inhibitory pathways important for regulating the GAD(65) immunity.	[Axelsson, Stina; Cheramy, Mikael; Hjorth, Maria; Pihl, Mikael; Akerman, Linda; Ludvigsson, Johnny; Casas, Rosaura] Linkoping Univ, Fac Hlth Sci, Div Paediat, Dept Clin & Expt Med, Linkoping, Sweden; [Martinuzzi, Emanuela; Mallone, Roberto] St Vincent de Paul Hosp, INSERM, U986, DeAR Lab Avenir, Paris, France; [Martinuzzi, Emanuela; Mallone, Roberto] Univ Paris 05, Fac Med, Paris, France; [Mallone, Roberto] Hop Cochin, AP HP, Paris, France; [Mallone, Roberto] Hop Hotel Dieu, Serv Diabetol, Paris, France	Linkoping University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	Axelsson, S (corresponding author), Linkoping Univ, Fac Hlth Sci, Div Paediat, Dept Clin & Expt Med, Linkoping, Sweden.	stina.axelsson@liu.se	Mallone, Roberto/H-4430-2013; Martinuzzi, Emanuela/S-3053-2019; Ludvigsson, Johnny/AAI-2051-2020	Mallone, Roberto/0000-0002-9846-8861; Martinuzzi, Emanuela/0000-0001-5832-951X; Ludvigsson, Johnny/0000-0003-1695-5234	Swedish Research Council [K2008-55x-20652-01-3]; Swedish Child Diabetes Foundation (Barndiabetesfonden); Medical Research Council of Southeast Sweden; Juvenile Diabetes Research Foundation (JDRF) [1-2008-106]; Ile-de-France CODDIM; Inserm Avenir Program	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Child Diabetes Foundation (Barndiabetesfonden); Medical Research Council of Southeast Sweden(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Ile-de-France CODDIM; Inserm Avenir Program(Institut National de la Sante et de la Recherche Medicale (Inserm))	This project was supported by grants from the Swedish Research Council (K2008-55x-20652-01-3), the Swedish Child Diabetes Foundation (Barndiabetesfonden) and the Medical Research Council of Southeast Sweden. R.M. has support from the Juvenile Diabetes Research Foundation (JDRF grant 1-2008-106), the Ile-de-France CODDIM and the Inserm Avenir Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardh CD, 2005, J DIABETES COMPLICAT, V19, P238, DOI 10.1016/j.jdiacomp.2004.12.003; ATKINSON MA, 1994, NEW ENGL J MED, V331, P1428; Axelsson S, 2010, DIABETES-METAB RES, V26, P559, DOI 10.1002/dmrr.1126; BAEKKESKOV S, 1990, NATURE, V347, P151, DOI 10.1038/347151a0; BRIERE F, 1994, J EXP MED, V179, P757, DOI 10.1084/jem.179.2.757; Cheramy M, 2010, CLIN IMMUNOL, V137, P31, DOI 10.1016/j.clim.2010.06.001; Cimmino L, 2008, J IMMUNOL, V181, P2338, DOI 10.4049/jimmunol.181.4.2338; Dooms H, 2007, J EXP MED, V204, P547, DOI 10.1084/jem.20062381; Dooms H, 2006, IMMUNOL REV, V211, P23, DOI 10.1111/j.0105-2896.2006.00387.x; Fourlanos S, 2011, DIABETES, V60, P1237, DOI 10.2337/db10-1360; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; GASCAN H, 1991, J EXP MED, V173, P747, DOI 10.1084/jem.173.3.747; Hedman M, 2008, CLIN EXP IMMUNOL, V153, P360, DOI 10.1111/j.1365-2249.2008.03720.x; Hjorth M, 2011, CLIN IMMUNOL, V138, P117, DOI 10.1016/j.clim.2010.10.004; Kallies A, 2006, NAT IMMUNOL, V7, P466, DOI 10.1038/ni1321; KAUFMAN DL, 1993, NATURE, V366, P69, DOI 10.1038/366069a0; Lord JD, 2000, J IMMUNOL, V164, P2533, DOI 10.4049/jimmunol.164.5.2533; Ludvigsson J, 2009, Diabetologia, V52, P175, DOI 10.1007/s00125-008-1211-9; Ludvigsson J, 2011, DIABETOLOGIA, V54, P634, DOI 10.1007/s00125-010-1988-1; Ludvigsson J, 2008, NEW ENGL J MED, V359, P1909, DOI 10.1056/NEJMoa0804328; Mallone R, 2008, CURR DIABETES REP, V8, P101, DOI 10.1007/s11892-008-0019-9; Martins GA, 2006, NAT IMMUNOL, V7, P457, DOI 10.1038/ni1320; Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241; MARTINUZZI E, 2011, BLOOD; Martinuzzi E, 2008, DIABETES, V57, P1312, DOI 10.2337/db07-1594; McHeyzer-Williams LJ, 2006, IMMUNOL REV, V211, P255, DOI 10.1111/j.0105-2896.2006.00397.x; MICHIE CA, 1992, NATURE, V360, P264, DOI 10.1038/360264a0; Passerini L, 2008, INT IMMUNOL, V20, P421, DOI 10.1093/intimm/dxn002; Raju R, 2005, J IMMUNOL, V175, P7755, DOI 10.4049/jimmunol.175.11.7755; Reijonen H, 2002, DIABETES, V51, P1375, DOI 10.2337/diabetes.51.5.1375; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Vibhakar R, 1997, EXP CELL RES, V232, P25, DOI 10.1006/excr.1997.3493; Wherrett DK, 2011, LANCET, V378, P319, DOI 10.1016/S0140-6736(11)60895-7; ZURAWSKI SM, 1995, J BIOL CHEM, V270, P13869, DOI 10.1074/jbc.270.23.13869	35	32	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e29008	10.1371/journal.pone.0029008	http://dx.doi.org/10.1371/journal.pone.0029008			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174945	Green Published, Green Submitted, gold			2022-12-25	WOS:000298366600057
J	Lingappa, JR; Petrovski, S; Kahle, E; Fellay, J; Shianna, K; McElrath, MJ; Thomas, KK; Baeten, JM; Celum, C; Wald, A; de Bruyn, G; Mullins, JI; Nakku-Joloba, E; Farquhar, C; Essex, M; Donnell, D; Kiarie, J; Haynes, B; Goldstein, D				Lingappa, Jairam R.; Petrovski, Slave; Kahle, Erin; Fellay, Jacques; Shianna, Kevin; McElrath, M. Juliana; Thomas, Katherine K.; Baeten, Jared M.; Celum, Connie; Wald, Anna; de Bruyn, Guy; Mullins, James I.; Nakku-Joloba, Edith; Farquhar, Carey; Essex, Max; Donnell, Deborah; Kiarie, James; Haynes, Bart; Goldstein, David		Partners Prevention HSV HIV Transm	Genomewide Association Study for Determinants of HIV-1 Acquisition and Viral Set Point in HIV-1 Serodiscordant Couples with Quantified Virus Exposure	PLOS ONE			English	Article							MANNOSE-BINDING LECTIN; WIDE ASSOCIATION; GENETIC ASSOCIATION; HAPLOTYPE MAP; INFECTION; SUSCEPTIBILITY; POPULATION; AIDS; POLYMORPHISMS; TRANSMISSION	Background: Host genetic factors may be important determinants of HIV-1 sexual acquisition. We performed a genomewide association study (GWAS) for host genetic variants modifying HIV-1 acquisition and viral control in the context of a cohort of African HIV-1 serodiscordant heterosexual couples. To minimize misclassification of HIV-1 risk, we quantified HIV-1 exposure, using data including plasma HIV-1 concentrations, gender, and condom use. Methods: We matched couples without HIV-1 seroconversion to those with seroconversion by quantified HIV-1 exposure risk. Logistic regression of single nucleotide polymorphisms (SNPs) for 798 samples from 496 HIV-1 infected and 302 HIV-1 exposed, uninfected individuals was performed to identify factors associated with HIV-1 acquisition. In addition, a linear regression analysis was performed using SNP data from a subset (n = 403) of HIV-1 infected individuals to identify factors predicting plasma HIV-1 concentrations. Results: After correcting for multiple comparisons, no SNPs were significantly associated with HIV-1 infection status or plasma HIV-1 concentrations. Conclusion: This GWAS controlling for HIV-1 exposure did not identify common host genotypes influencing HIV-1 acquisition. Alternative strategies, such as large-scale sequencing to identify low frequency variation, should be considered for identifying novel host genetic predictors of HIV-1 acquisition.	[Lingappa, Jairam R.; Kahle, Erin; Baeten, Jared M.; Celum, Connie; Wald, Anna; Farquhar, Carey] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Lingappa, Jairam R.; Thomas, Katherine K.; Baeten, Jared M.; Celum, Connie; Wald, Anna; Farquhar, Carey] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Lingappa, Jairam R.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Petrovski, Slave; Fellay, Jacques; Shianna, Kevin; Haynes, Bart; Goldstein, David] Duke Univ, Sch Med, Ctr Human Genome Variat, Durham, NC USA; [Petrovski, Slave] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3050, Australia; [Fellay, Jacques; Shianna, Kevin; Haynes, Bart; Goldstein, David] Duke Univ, Sch Med, Ctr HIV AIDS Vaccine Immunol, Durham, NC USA; [McElrath, M. Juliana; Wald, Anna] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Baeten, Jared M.; Celum, Connie; Wald, Anna; Farquhar, Carey] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [de Bruyn, Guy] Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa; [Mullins, James I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Nakku-Joloba, Edith] Makerere Univ, Mulago Hosp, Kampala, Uganda; [Essex, Max] Harvard Univ, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Donnell, Deborah] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS, Seattle, WA 98104 USA; [Kiarie, James] Univ Nairobi, Dept Obstet & Gynaecol, Nairobi, Kenya	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Duke University; Royal Melbourne Hospital; University of Melbourne; Duke University; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Witwatersrand; University of Washington; University of Washington Seattle; Makerere University; Mulago National Referral Hospital; Harvard University; Fred Hutchinson Cancer Center; University of Nairobi	Lingappa, JR (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	lingappa@UW.edu	Fellay, Jacques/A-6681-2009; Lingappa, Jairam/N-7760-2017; Goldstein, David/AAY-8125-2020; Wald, Anna/B-6272-2012	Fellay, Jacques/0000-0002-8240-939X; Wald, Anna/0000-0003-3486-6438; Thomas, Katherine K/0000-0002-7024-468X; Kapiga, Saidi/0000-0003-1753-4060; Donnell, Deborah/0000-0002-0587-7480; de Bruyn, Guy/0000-0002-8028-4474; , Erin/0000-0001-6060-9852; kiarie, james/0000-0003-4180-7858; Petrovski, Slave/0000-0002-1527-961X; Were, Edwin/0000-0002-4783-0795	Bill and Melinda Gates Foundation [26469]; NIH/NIAID [AI27757, AI073115]; Center for HIV-1/AIDS Vaccine Immunology [AI067854]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757, R21AI073115, P01AI057005, U19AI067854, U01AI067854] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Center for HIV-1/AIDS Vaccine Immunology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this work was through the Bill and Melinda Gates Foundation grant #26469 and NIH/NIAID grants AI27757, AI073115 and Center for HIV-1/AIDS Vaccine Immunology grant AI067854. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ball TB, 2007, AIDS, V21, P1091, DOI 10.1097/QAD.0b013e3280ef6ae1; Bhangale TR, 2008, NAT GENET, V40, P841, DOI 10.1038/ng.180; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Boniotto M, 2003, AIDS, V17, P779, DOI 10.1097/00002030-200303280-00025; Campbell MS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016986, 10.1371/journal.pone.0018283]; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Dalmasso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003907; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001033; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Garred P, 1997, LANCET, V349, P236, DOI 10.1016/S0140-6736(96)08440-1; Hughes JP, 2011, J INFECT DI IN PRESS; *ILL INC, 2010, HUM 1M DUO DNA AN BE; Limou S, 2009, J INFECT DIS, V199, P419, DOI 10.1086/596067; Limou S, 2010, J INFECT DIS, V202, P908, DOI 10.1086/655782; Lingappa JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012598; Lingappa JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005272; LINGAPPA JR, 2011, 18 C RETR OPP INF FE; LINGAPPA JR, 2010, AIDS VACC 2010 SEPT; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; MACKELPRANG R, 2011, 18 C RETR OPP INF FE; Malik S, 2003, IMMUNOGENETICS, V55, P49, DOI 10.1007/s00251-003-0550-4; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mombo LE, 2003, GENES IMMUN, V4, P362, DOI 10.1038/sj.gene.6363979; Pastinen T, 1998, AIDS RES HUM RETROV, V14, P695, DOI 10.1089/aid.1998.14.695; Pelak K, 2010, J INFECT DIS, V201, P1141, DOI 10.1086/651382; Petrovski S, 2011, AIDS, V25, P513, DOI 10.1097/QAD.0b013e328343817b; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; PURCELL AW, PLINK WHOL GEN ASS A; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Restrepo C, 2011, AIDS REV, V13, P30; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Teo YY, 2010, NAT REV GENET, V11, P149, DOI 10.1038/nrg2731; Vallinoto ACR, 2006, MOL IMMUNOL, V43, P1358, DOI 10.1016/j.molimm.2005.09.001	41	64	64	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28632	10.1371/journal.pone.0028632	http://dx.doi.org/10.1371/journal.pone.0028632			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174851	gold, Green Published			2022-12-25	WOS:000298366600028
J	Brown, A; Thatje, S				Brown, Alastair; Thatje, Sven			Respiratory Response of the Deep-Sea Amphipod Stephonyx biscayensis Indicates Bathymetric Range Limitation by Temperature and Hydrostatic Pressure	PLOS ONE			English	Article							OXYGEN-CONSUMPTION; CLIMATE-CHANGE; THERMAL TOLERANCE; BODY-SIZE; PATTERNS; ADAPTATIONS; METABOLISM; DEPTH; FISH	Depth zonation of fauna on continental margins is well documented. Whilst increasing hydrostatic pressure with depth has long been considered a factor contributing significantly to this pattern, discussion of the relative significance of decreasing temperature with depth has continued. This study investigates the physiological tolerances of fed and starved specimens of the bathyal lysianassoid amphipod Stephonyx biscayensis at varying temperature to acute pressure exposure by measuring the rate of oxygen consumption. Acclimation to atmospheric pressure is shown to have no significant interaction with temperature and/or pressure effects. Similarly, starvation is shown to have no significant effect on the interaction of temperature and pressure. Subsequently, the effect of pressure on respiration rate is revealed to be dependent on temperature: pressure equivalent to 2000 m depth was tolerated at 1 and 3 degrees C; pressure equivalent to 2500 m depth was tolerated at 5.5 degrees C; at 10 degrees C pressure equivalent to 3000 m depth was tolerated. The variation in tolerance is consistent with the natural distribution range reported for this species. There are clear implications for hypotheses relating to the observed phenomenon of a biodiversity bottleneck between 2000 and 3000 metres, and for the potential for bathymetric range shifts in response to global climate change.	[Brown, Alastair; Thatje, Sven] Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England	NERC National Oceanography Centre; University of Southampton	Brown, A (corresponding author), Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England.	alastair.brown@noc.soton.ac.uk	Brown, Alastair/I-7875-2012	Brown, Alastair/0000-0002-2126-203X	Total Foundation [Abyss2100]; Natural Environment Research Council	Total Foundation(Total SA); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was made possible through a grant (Abyss2100) from the Total Foundation to Sven Thatje. Alastair Brown was supported through a Natural Environment Research Council PhD studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIRRIESS CN, 1994, BIOL BULL, V187, P208, DOI 10.2307/1542243; Balny C, 2002, BBA-PROTEIN STRUCT M, V1595, P3, DOI 10.1016/S0167-4838(01)00331-4; BARNARD JL, 1990, SMITHSONIAN CONTRIBU, V499; Carney RS, 2005, OCEANOGR MAR BIOL, V43, P211; CHAPELLE G, 1994, J EXP MAR BIOL ECOL, V183, P63, DOI 10.1016/0022-0981(94)90157-0; Chase MR, 1998, MAR BIOL, V131, P301, DOI 10.1007/s002270050323; CHILDRESS JJ, 1990, DEEP-SEA RES, V37, P929, DOI 10.1016/0198-0149(90)90104-4; CHILDRESS JJ, 1977, MAR BIOL, V39, P19, DOI 10.1007/BF00395588; Clarke A., 1998, Society for Experimental Biology Seminar Series, V66, P3; Dulvy NK, 2008, J APPL ECOL, V45, P1029, DOI 10.1111/j.1365-2664.2008.01488.x; GEORGE RY, 1979, SARSIA, V64, P61, DOI 10.1080/00364827.1979.10411364; Hall S, 2009, J BIOGEOGR, V36, P2125, DOI 10.1111/j.1365-2699.2009.02153.x; Hargrave BT, 1995, DEEP-SEA RES PT I, V42, P1905, DOI 10.1016/0967-0637(95)00080-1; HARGRAVE BT, 1994, DEEP-SEA RES PT I, V41, P1489, DOI 10.1016/0967-0637(94)90057-4; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; HAZEL JR, 1990, PROG LIPID RES, V29, P167, DOI 10.1016/0163-7827(90)90002-3; Hochachka P. W., 2002, BIOCH ADAPTATION MEC, DOI 10.1002/bmb.2002.494030030071; Jablonski D, 2005, J EXP ZOOL PART B, V304B, P504, DOI 10.1002/jez.b.21075; Levin LA, 2001, ANNU REV ECOL SYST, V32, P51, DOI 10.1146/annurev.ecolsys.32.081501.114002; LOWRY JK, 1997, MEMOIRS HOURGLASS CR, V10; MASSON D, 2009, RRS J COOK CRUISE, V36; McMahon BR, 2001, RESP PHYSIOL, V128, P349, DOI 10.1016/S0034-5687(01)00311-5; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Mestre NC, 2009, P ROY SOC B-BIOL SCI, V276, P717, DOI 10.1098/rspb.2008.1376; MICKEL TJ, 1982, DEEP-SEA RES, V29, P1293, DOI 10.1016/0198-0149(82)90009-7; Oliphant A, 2011, J EXP BIOL, V214, P1109, DOI 10.1242/jeb.048058; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Pradillon Florence, 2007, Reviews in Environmental Science and Bio/Technology, V6, P181, DOI 10.1007/s11157-006-9111-2; Raupach MJ, 2009, P ROY SOC B-BIOL SCI, V276, P799, DOI 10.1098/rspb.2008.1063; Rex MA, 1999, EVOLUTION, V53, P1298, DOI 10.1111/j.1558-5646.1999.tb04543.x; Rex MA, 1998, DEEP-SEA RES PT II, V45, P103, DOI 10.1016/S0967-0645(97)00082-9; Samerotte AL, 2007, PHYSIOL BIOCHEM ZOOL, V80, P197, DOI 10.1086/510566; Schmidt-Nielsen K, 1997, ANIMAL PHYSL ADAPTAT; Seibel BA, 2007, PHILOS T R SOC B, V362, P2061, DOI 10.1098/rstb.2007.2101; Shillito B, 2006, J EXP BIOL, V209, P945, DOI 10.1242/jeb.02102; SMITH KL, 1982, MAR BIOL, V68, P287, DOI 10.1007/BF00409595; Sokal R. R., 2012, BIOMETRY; Somero GN, 2003, COMP BIOCHEM PHYS B, V136, P577, DOI 10.1016/S1096-4959(03)00215-X; SOMERO GN, 1992, ANNU REV PHYSIOL, V54, P557, DOI 10.1146/annurev.ph.54.030192.003013; Stouffer RJ, 2003, CLIM DYNAM, V20, P759, DOI 10.1007/s00382-002-0302-4; Thatje S, 2011, NATURWISSENSCHAFTEN, V98, P299, DOI 10.1007/s00114-011-0768-1; Thatje S, 2010, J EXP MAR BIOL ECOL, V390, P22, DOI 10.1016/j.jembe.2010.04.028; Thurston MH, 2002, J MAR BIOL ASSOC UK, V82, P205, DOI 10.1017/S0025315402005374; Treude T, 2002, DEEP-SEA RES PT I, V49, P1281, DOI 10.1016/S0967-0637(02)00023-7; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a	48	29	31	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28562	10.1371/journal.pone.0028562	http://dx.doi.org/10.1371/journal.pone.0028562			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174838	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000298365700047
J	Gerstein, AC; Otto, SP				Gerstein, Aleeza C.; Otto, Sarah P.			Cryptic Fitness Advantage: Diploids Invade Haploid Populations Despite Lacking Any Apparent Advantage as Measured by Standard Fitness Assays	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; PLOIDY; EVOLUTION; MICROORGANISMS; REJECTION	Ploidy varies tremendously within and between species, yet the factors that influence when or why ploidy variants are adaptive remains poorly understood. Our previous work found that diploid individuals repeatedly arose within ten replicate haploid populations of Saccharomyces cerevisiae, and in each case we witnessed diploid takeover within similar to 1800 asexual generations of batch culture evolution in the lab. The character that allowed diploids to rise in frequency within haploid populations remains unknown. Here we present a number of experiments conducted with the goal to determine what this trait (or traits) might have been. Experiments were conducted both by sampling a small number of colonies from the stocks frozen every two weeks (similar to 93 generations) during the original experiment, as well through sampling a larger number of colonies at the two time points where polymorphism for ploidy was most prevalent. Surprisingly, none of our fitness component measures (lag phase, growth rate, biomass production) indicated an advantage to diploidy. Similarly, competition assays against a common competitor and direct competition between haploid and diploid colonies isolated from the same time point failed to indicate a diploid advantage. Furthermore, we uncovered a tremendous amount of trait variation among colonies of the same ploidy level. Only late-appearing diploids showed a competitive advantage over haploids, indicating that the fitness advantage that allowed eventual takeover was not diploidy per se but an attribute of a subset of diploid lineages. Nevertheless, the initial rise in diploids to intermediate frequency cannot be explained by any of the fitness measures used; we suggest that the resolution to this mystery is negative frequency-dependent selection, which is ignored in the standard fitness measures used.	[Gerstein, Aleeza C.; Otto, Sarah P.] Univ British Columbia, Dept Zool, Biodivers Res Ctr, Vancouver, BC, Canada	University of British Columbia	Gerstein, AC (corresponding author), Univ British Columbia, Dept Zool, Biodivers Res Ctr, Vancouver, BC, Canada.	gerstein@zoology.ubc.ca	Gerstein, Aleeza/D-4139-2011; Otto, Sarah Perin/K-5625-2012	Gerstein, Aleeza/0000-0002-0781-9356; Otto, Sarah Perin/0000-0003-3042-0818	NSERC (Canadian National Science and Engineering Research Council); Killam Trusts	NSERC (Canadian National Science and Engineering Research Council); Killam Trusts	This research was funded by NSERC (Canadian National Science and Engineering Research Council) and the Killam Trusts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS J, 1985, GENETICS, V110, P173; ADAMS J, 1974, GENETICS, V76, P327; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; COWEN LE, 2001, J BACTERIOL; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; de Visser JAGM, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-19; DYKHUIZEN DE, 1990, ANNU REV ECOL SYST, V21, P373, DOI 10.1146/annurev.ecolsys.21.1.373; Ezov TK, 2006, GENETICS, V174, P1455, DOI 10.1534/genetics.106.062745; Galitski T, 1999, SCIENCE, V285, P251, DOI 10.1126/science.285.5425.251; GERSTEIN AC, 2011, J EVOLUTION BIOL, P531; Gerstein AC, 2008, BIOL LETTERS, V4, P91, DOI 10.1098/rsbl.2007.0476; Gerstein AC, 2006, PLOS GENET, V2, P1396, DOI 10.1371/journal.pgen.0020145; Gerstein AC, 2009, J HERED, V100, P571, DOI 10.1093/jhered/esp057; GLAZUNOV A V, 1989, Mikrobiologiya, V58, P769; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Hall DW, 2010, GENETICS, V185, P1397, DOI 10.1534/genetics.110.118307; Mable BK, 2001, J EVOLUTION BIOL, V14, P157, DOI 10.1046/j.1420-9101.2001.00245.x; Mongold JA, 1996, J BACTERIOL, V178, P5333, DOI 10.1128/jb.178.17.5333-5334.1996; Novak M, 2006, AM NAT, V168, P242, DOI 10.1086/506527; Pandit MK, 2011, J ECOL, V99, P1108, DOI 10.1111/j.1365-2745.2011.01838.x; PAQUIN CE, 1983, NATURE, V306, P368, DOI 10.1038/306368a0; Parfrey LW, 2008, MOL BIOL EVOL, V25, P787, DOI 10.1093/molbev/msn032; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; SLATER ML, 1973, J BACTERIOL, V113, P263, DOI 10.1128/JB.113.1.263-270.1973; Stahl G, 2004, EUKARYOT CELL, V3, P331, DOI 10.1128/EC.3.2.331-338.2004; TEMINA A V, 1979, Mikrobiologiya, V48, P610; WEISS RL, 1975, P NATL ACAD SCI USA, V72, P794, DOI 10.1073/pnas.72.3.794; Wu CY, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000523	28	36	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e26599	10.1371/journal.pone.0026599	http://dx.doi.org/10.1371/journal.pone.0026599			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174734	Green Submitted, Green Published, gold			2022-12-25	WOS:000298365700002
J	Jakola, AS; Gulati, S; Weber, C; Unsgard, G; Solheim, O				Jakola, Asgeir S.; Gulati, Sasha; Weber, Clemens; Unsgard, Geirmund; Solheim, Ole			Postoperative Deterioration in Health Related Quality of Life as Predictor for Survival in Patients with Glioblastoma: A Prospective Study	PLOS ONE			English	Article							HIGH-GRADE GLIOMAS; INTRAOPERATIVE 3D ULTRASOUND; RESECTION; EXTENT; OUTCOMES; MULTIFORME; EUROQOL; IMPACT; COMPLICATIONS; RADIOTHERAPY	Background: Studies indicate that acquired deficits negatively affect patients' self-reported health related quality of life (HRQOL) and survival, but the impact of HRQOL deterioration after surgery on survival has not been explored. Objective: Assess if change in HRQOL after surgery is a predictor for survival in patients with glioblastoma. Methods: Sixty-one patients with glioblastoma were included. The majority of patients (n = 56, 91.8%) were operated using a neuronavigation system which utilizes 3D preoperative MRI and updated intraoperative 3D ultrasound volumes to guide resection. HRQOL was assessed using EuroQol 5D (EQ-5D), a generic instrument. HRQOL data were collected 1-3 days preoperatively and after 6 weeks. The mean change in EQ-5D index was -0.05 (95% CI -0.15-0.05) 6 weeks after surgery (p = 0.285). There were 30 patients (49.2%) reporting deterioration 6 weeks after surgery. In a Cox multivariate survival analysis we evaluated deterioration in HRQOL after surgery together with established risk factors (age, preoperative condition, radiotherapy, temozolomide and extent of resection). Results: There were significant independent associations between survival and use of temozolomide (HR 0.30, p = 0.019), radiotherapy (HR 0.26, p = 0.030), and deterioration in HRQOL after surgery (HR 2.02, p = 0.045). Inclusion of surgically acquired deficits in the model did not alter the conclusion. Conclusion: Early deterioration in HRQOL after surgery is independently and markedly associated with impaired survival in patients with glioblastoma. Deterioration in patient reported HRQOL after surgery is a meaningful outcome in surgical neuro-oncology, as the measure reflects both the burden of symptoms and treatment hazards and is linked to overall survival.	[Jakola, Asgeir S.; Gulati, Sasha; Weber, Clemens; Unsgard, Geirmund; Solheim, Ole] St Olavs Univ Hosp, Dept Neurosurg, Trondheim, Norway; [Jakola, Asgeir S.; Solheim, Ole] Norwegian Univ Sci & Technol, Med Imaging Lab, N-7034 Trondheim, Norway; [Jakola, Asgeir S.; Solheim, Ole] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, N-7034 Trondheim, Norway; [Jakola, Asgeir S.; Unsgard, Geirmund; Solheim, Ole] Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway; [Gulati, Sasha] Norwegian Univ Sci & Technol, Dept Lab Med, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Jakola, AS (corresponding author), St Olavs Univ Hosp, Dept Neurosurg, Trondheim, Norway.	asgeir.s.jakola@ntnu.no	Jakola, Asgeir S/J-1738-2018	Jakola, Asgeir S/0000-0002-2860-9331; Solheim, Ole/0000-0002-5954-4817; Weber, Clemens/0000-0001-7007-5719				ALTMAN DG, 1994, J NATL CANCER I, V86, P829, DOI 10.1093/jnci/86.11.829; Brandsma D, 2008, LANCET ONCOL, V9, P453, DOI 10.1016/S1470-2045(08)70125-6; Brown PD, 2006, J NEURO-ONCOL, V76, P283, DOI 10.1007/s11060-005-7020-9; Brown PD, 2005, NEUROSURGERY, V57, P495, DOI 10.1227/01.NEU.0000170562.25335.C7; Burstrom K, 2001, QUAL LIFE RES, V10, P621, DOI 10.1023/A:1013171831202; Chaichana KL, 2011, J NEUROSURG, V114, P587, DOI 10.3171/2010.8.JNS1081; Chang SM, 2003, J NEUROSURG, V98, P1175, DOI 10.3171/jns.2003.98.6.1175; Cheng JX, 2009, NEURO-ONCOLOGY, V11, P41, DOI 10.1215/15228517-2008-050; DEGROOT JF, 2011, J CLIN ONCOLOGY; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Gotay CC, 2008, J CLIN ONCOL, V26, P1355, DOI 10.1200/JCO.2007.13.3439; Gulati S, 2009, MINIM INVAS NEUROSUR, V52, P17, DOI 10.1055/s-0028-1104566; GULATI S, 2011, WORLD NEURO IN PRESS; Jakola AS, 2011, J NEUROSURG, V114, P1622, DOI 10.3171/2011.1.JNS101657; Keime-Guibert F, 2007, NEW ENGL J MED, V356, P1527, DOI 10.1056/NEJMoa065901; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Ibanez FAL, 2011, WORLD NEUROSURG, V75, P709, DOI 10.1016/j.wneu.2010.11.010; Lutterbach J, 2005, CANCER, V103, P1234, DOI 10.1002/cncr.20895; LYDICK E, 1993, QUAL LIFE RES, V2, P221, DOI 10.1007/BF00435226; MARINA O, 2011, J NEUROSURG, P1; Mauer M, 2007, BRIT J CANCER, V97, P302, DOI 10.1038/sj.bjc.6603876; McGirt MJ, 2009, NEUROSURGERY, V65, P463, DOI 10.1227/01.NEU.0000349763.42238.E9; McGirt MJ, 2009, J NEUROSURG, V110, P156, DOI 10.3171/2008.4.17536; NORD E, 1991, HEALTH POLICY, V18, P25, DOI 10.1016/0168-8510(91)90141-J; Quinten C, 2009, LANCET ONCOL, V10, P865, DOI 10.1016/S1470-2045(09)70200-1; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Rasmussen IA, 2007, ACTA NEUROCHIR, V149, P365, DOI 10.1007/s00701-006-1110-0; Sanai N, 2008, NEUROSURGERY, V62, P753, DOI 10.1227/01.neu.0000318159.21731.cf; Sanai N, 2011, J NEUROSURG, V115, P3, DOI 10.3171/2011.2.JNS10998; Sawaya R, 1998, NEUROSURGERY, V42, P1044, DOI 10.1097/00006123-199805000-00054; SOLHEIM O, 2010, ACTA NEUROCHIR, P1; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Stummer W, 2008, NEUROSURGERY, V62, P564, DOI [10.1227/01.NEU.0000297118.47076.5F, 10.1227/01.NEU.0000346230.80425.3A, 10.1227/01.neu.0000317304.31579.17]; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Unsgaard G, 2006, ACTA NEUROCHIR, V148, P235, DOI 10.1007/s00701-005-0688-y; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	37	53	54	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28592	10.1371/journal.pone.0028592	http://dx.doi.org/10.1371/journal.pone.0028592			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	866FK	22174842	gold, Green Published, Green Submitted			2022-12-25	WOS:000298365700049
J	Kornblatt, MJ; Kornblatt, JA; Hancock, MA				Kornblatt, M. Judith; Kornblatt, Jack A.; Hancock, Mark A.			The Interaction of Canine Plasminogen with Streptococcus pyogenes Enolase: They Bind to One Another but What Is the Nature of the Structures Involved?	PLOS ONE			English	Article							ALPHA-ENOLASE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; CELL-SURFACE; LACTOBACILLUS-CRISPATUS; PROTEIN; PNEUMONIAE; IDENTIFICATION; PLASMIN(OGEN); ACTIVATION; CLONING	For years it has been clear that plasminogen from different sources and enolase from different sources interact strongly. What is less clear is the nature of the structures required for them to interact. This work examines the interaction between canine plasminogen (dPgn) and Streptococcus pyogenes enolase (Str enolase) using analytical ultracentrifugation (AUC), surface plasmon resonance (SPR), fluorescence polarization, dynamic light scattering (DLS), isothermal titration calorimetry (ITC), and simple pull-down reactions. Overall, our data indicate that a non-native structure of the octameric Str enolase (monomers or multimers) is an important determinant of its surface-mediated interaction with host plasminogen. Interestingly, a non-native structure of plasminogen is capable of interacting with native enolase. As far as we can tell, the native structures resist forming stable mixed complexes.	[Kornblatt, M. Judith; Kornblatt, Jack A.] Concordia Univ, Dept Biol, Montreal, PQ H3G 1M8, Canada; [Kornblatt, M. Judith; Kornblatt, Jack A.] Concordia Univ, Dept Chem & Biochem, Montreal, PQ H3G 1M8, Canada; [Kornblatt, M. Judith; Kornblatt, Jack A.] Concordia Univ, Ctr Struct & Funct Genom, Montreal, PQ H3G 1M8, Canada; [Hancock, Mark A.] McGill Univ, Sheldon Biotechnol Ctr, Montreal, PQ, Canada	Concordia University - Canada; Concordia University - Canada; Concordia University - Canada; McGill University	Kornblatt, MJ (corresponding author), Concordia Univ, Dept Biol, 1455 De Maisonneuve Blvd W, Montreal, PQ H3G 1M8, Canada.	krnbltt@alcor.concordia.ca		kornblatt, jack/0000-0002-9802-8321	Natural Sciences and Engineering Research Council, Canada [9988-6]; Canadian Institutes of Health Research (CIHR)	Natural Sciences and Engineering Research Council, Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	The research was generously supported by the Natural Sciences and Engineering Research Council, Canada (Grant Number 9988-6 to JAK). The Sheldon Biotechnology Centre is supported by a Research Resource Grant from the Canadian Institutes of Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2008, BBA-PROTEINS PROTEOM, V1784, P986, DOI 10.1016/j.bbapap.2008.03.017; Andronicos NM, 1997, BBA-PROTEIN STRUCT M, V1337, P27, DOI 10.1016/S0167-4838(96)00146-X; Antikainen J, 2007, FEMS IMMUNOL MED MIC, V51, P526, DOI 10.1111/j.1574-695X.2007.00330.x; Antikainen J, 2007, J BACTERIOL, V189, P4539, DOI 10.1128/JB.00378-07; Attali C, 2008, INFECT IMMUN, V76, P5350, DOI 10.1128/IAI.00184-08; BACHMANN F, 1994, HAEMOSTASIS THROMBOS, P525; Bergmann S, 2004, INFECT IMMUN, V72, P2416, DOI 10.1128/IAI.72.4.2416-2419.2004; Bergmann S, 2003, MOL MICROBIOL, V49, P411, DOI 10.1046/j.1365-2958.2003.03557.x; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Bernal D, 2004, FEBS LETT, V563, P203, DOI 10.1016/S0014-5793(04)00306-0; BREWER JM, 1995, PHYS ASPECTS PROTEIN, P57; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Candela M, 2009, MICROBIOL-SGM, V155, P3294, DOI 10.1099/mic.0.028795-0; Chhatwal GS, 2002, TRENDS MICROBIOL, V10, P205, DOI 10.1016/S0966-842X(02)02351-X; Chung MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018119; Cork AJ, 2009, J BIOL CHEM, V284, P17129, DOI 10.1074/jbc.M109.004317; de la Torre-Escudero E, 2010, VET PARASITOL, V173, P76, DOI 10.1016/j.vetpar.2010.06.011; Derbise A, 2004, INFECT IMMUN, V72, P94, DOI 10.1128/IAI.72.1.94-105.2004; Ehinger S, 2004, J MOL BIOL, V343, P997, DOI 10.1016/j.jmb.2004.08.088; Esgleas M, 2008, MICROBIOL-SGM, V154, P2668, DOI 10.1099/mic.0.2008/017145-0; Fox D, 2001, MED MYCOL, V39, P495, DOI 10.1080/714031070; Ge JP, 2004, INFECT IMMUN, V72, P6748, DOI 10.1128/IAI.72.11.6748-6752.2004; Hakobyan S, 2008, J BIOL CHEM, V283, P30451, DOI 10.1074/jbc.M803648200; Hurmalainen V, 2007, MICROBIOL-SGM, V153, P1112, DOI 10.1099/mic.0.2006/000901-0; Itzek A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013826; Jolodar A, 2003, BBA-GENE STRUCT EXPR, V1627, P111, DOI 10.1016/S0167-4781(03)00083-6; Jones MN, 2007, BIOCHEM BIOPH RES CO, V364, P924, DOI 10.1016/j.bbrc.2007.10.098; Jong AY, 2003, J MED MICROBIOL, V52, P615, DOI 10.1099/jmm.0.05060-0; Karbassi F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008810; Karlsson R, 2006, ANAL BIOCHEM, V349, P136, DOI 10.1016/j.ab.2005.09.034; Kinnby B, 2008, MICROBIOL-SGM, V154, P924, DOI 10.1099/mic.0.2007/013235-0; Kolberg J, 2006, MICROBIOL-SGM, V152, P1307, DOI 10.1099/mic.0.28747-0; Kornblatt JA, 1999, EUR J BIOCHEM, V265, P120, DOI 10.1046/j.1432-1327.1999.00695.x; Kornblatt JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006196; Kornblatt MJ, 1998, EUR J BIOCHEM, V251, P775, DOI 10.1046/j.1432-1327.1998.2510775.x; Lee JH, 2006, FEMS MICROBIOL LETT, V259, P240, DOI 10.1111/j.1574-6968.2006.00274.x; LEWIS JH, 1951, AM J PHYSIOL, V166, P594, DOI 10.1152/ajplegacy.1951.166.3.594; Lopez-Alemany R, 2005, FRONT BIOSCI-LANDMRK, V10, P30, DOI 10.2741/1503; Lottenberg Richard, 1994, Trends in Microbiology, V2, P20, DOI 10.1016/0966-842X(94)90340-9; Matta SK, 2010, BBA-PROTEINS PROTEOM, V1804, P2111, DOI 10.1016/j.bbapap.2010.08.004; MILES LA, 1985, J BIOL CHEM, V260, P4303; MILES LA, 1989, BIOCHEMISTRY-US, V28, P9337, DOI 10.1021/bi00450a014; MILES LA, 1991, BIOCHEMISTRY-US, V30, P1682, DOI 10.1021/bi00220a034; Molkanen T, 2002, FEBS LETT, V517, P72, DOI 10.1016/S0014-5793(02)02580-2; Mundodi V, 2008, INFECT IMMUN, V76, P523, DOI 10.1128/IAI.01352-07; Myszka DG, 1998, ANAL BIOCHEM, V265, P326, DOI 10.1006/abio.1998.2937; NAKAJIMA K, 1994, J NEUROCHEM, V63, P2048; Nogueira SV, 2010, INFECT IMMUN, V78, P4040, DOI 10.1128/IAI.00221-10; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Pancholi V, 2003, MICROB PATHOGENESIS, V35, P293, DOI 10.1016/j.micpath.2003.08.004; PLOW EF, 1991, THROMB HAEMOSTASIS, V66, P32; Ramajo-Hernandez A, 2007, EXP PARASITOL, V115, P83, DOI 10.1016/j.exppara.2006.07.003; REDLITZ A, 1995, EUR J BIOCHEM, V227, P407, DOI 10.1111/j.1432-1033.1995.tb20403.x; ROGALSKI AA, 1989, J BIOL CHEM, V264, P6438; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Seweryn Ewa, 2007, Postepy Hig Med Dosw (Online), V61, P672; Sha J, 2003, MICROB PATHOGENESIS, V34, P195, DOI 10.1016/S0882-4010(03)00028-7; Sha J, 2009, J BACTERIOL, V191, P3095, DOI 10.1128/JB.00005-09; Vanegas G, 2007, PARASITOL RES, V101, P1511, DOI 10.1007/s00436-007-0668-7; Whiting GC, 2002, J MED MICROBIOL, V51, P837, DOI 10.1099/0022-1317-51-10-837; Wygrecka M, 2009, BLOOD, V113, P5588, DOI 10.1182/blood-2008-08-170837; Yavlovich A, 2007, INFECT IMMUN, V75, P5716, DOI 10.1128/IAI.01049-07	62	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28481	10.1371/journal.pone.0028481	http://dx.doi.org/10.1371/journal.pone.0028481			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174817	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000298365700039
J	Ravenscroft, G; Jackaman, C; Sewry, CA; McNamara, E; Squire, SE; Potter, AC; Papadimitriou, J; Griffiths, LM; Bakker, AJ; Davies, KE; Laing, NG; Nowak, KJ				Ravenscroft, Gianina; Jackaman, Connie; Sewry, Caroline A.; McNamara, Elyshia; Squire, Sarah E.; Potter, Allyson C.; Papadimitriou, John; Griffiths, Lisa M.; Bakker, Anthony J.; Davies, Kay E.; Laing, Nigel G.; Nowak, Kristen J.			Actin Nemaline Myopathy Mouse Reproduces Disease, Suggests Other Actin Disease Phenotypes and Provides Cautionary Note on Muscle Transgene Expression	PLOS ONE			English	Article							DOMINANT CONGENITAL MYOPATHY; CORE-LIKE LESIONS; SKELETAL-MUSCLE; ALPHA-ACTIN; MDX MICE; MUSCULAR-DYSTROPHY; RYANODINE RECEPTOR; MAMMALIAN MUSCLE; GENE ACTA1; MUTATIONS	Mutations in the skeletal muscle alpha-actin gene (ACTA1) cause congenital myopathies including nemaline myopathy, actin aggregate myopathy and rod-core disease. The majority of patients with ACTA1 mutations have severe hypotonia and do not survive beyond the age of one. A transgenic mouse model was generated expressing an autosomal dominant mutant (D286G) of ACTA1 (identified in a severe nemaline myopathy patient) fused with EGFP. Nemaline bodies were observed in multiple skeletal muscles, with serial sections showing these correlated to aggregates of the mutant skeletal muscle alpha-actin-EGFP. Isolated extensor digitorum longus and soleus muscles were significantly weaker than wild-type (WT) muscle at 4 weeks of age, coinciding with the peak in structural lesions. These 4 week-old mice were, similar to 30% less active on voluntary running wheels than WT mice. The alpha-actin-EGFP protein clearly demonstrated that the transgene was expressed equally in all myosin heavy chain (MHC) fibre types during the early postnatal period, but subsequently became largely confined to MHCIIB fibres. Ringbinden fibres, internal nuclei and myofibrillar myopathy pathologies, not typical features in nemaline myopathy or patients with ACTA1 mutations, were frequently observed. Ringbinden were found in fast fibre predominant muscles of adult mice and were exclusively MHCIIB-positive fibres. Thus, this mouse model presents a reliable model for the investigation of the pathobiology of nemaline body formation and muscle weakness and for evaluation of potential therapeutic interventions. The occurrence of core-like regions, internal nuclei and ringbinden will allow analysis of the mechanisms underlying these lesions. The occurrence of ringbinden and features of myofibrillar myopathy in this mouse model of ACTA1 disease suggests that patients with these pathologies and no genetic explanation should be screened for ACTA1 mutations.	[Ravenscroft, Gianina; Jackaman, Connie; McNamara, Elyshia; Laing, Nigel G.; Nowak, Kristen J.] Univ Western Australia, Med Res Ctr, Western Australian Inst Med Res, Nedlands, WA 6009, Australia; [Ravenscroft, Gianina; Bakker, Anthony J.] Univ Western Australia, Sch Biomed Biomol & Chem Sci, Perth, WA 6009, Australia; [Sewry, Caroline A.] Robert Jones & Agnes Hunt Orthopaed Hosp, Wolfson Ctr Inherited Neuromuscular Dis, Oswestry SY10 7AG, Shrops, England; [Squire, Sarah E.; Potter, Allyson C.; Davies, Kay E.] Univ Oxford, Dept Physiol Anat & Genet, MRC Funct Genet Unit, Oxford, England; [Papadimitriou, John] Univ Western Australia, Sch Pathol & Lab Med, Perth, WA 6009, Australia; [Griffiths, Lisa M.] Royal Perth Hosp, Perth, WA, Australia; [Griffiths, Lisa M.] PathW Anat Pathol, Perth, WA, Australia	University of Western Australia; University of Western Australia; Keele University; University of Oxford; University of Western Australia; Royal Perth Hospital; University of Western Australia	Ravenscroft, G (corresponding author), Univ Western Australia, Med Res Ctr, Western Australian Inst Med Res, Nedlands, WA 6009, Australia.	Kristen.Nowak@uwa.edu.au	Ravenscroft, Gina/H-5695-2014; Bakker, Anthony/B-8163-2014	Ravenscroft, Gina/0000-0003-3634-211X; Bakker, Anthony/0000-0002-6889-8932; Jackaman, Connie/0000-0002-4583-7029; Laing, Nigel/0000-0001-5111-3732	National Health and Medical Research Council of Australia [212086, 403941, 403904]; Association Francaise contre les Myopathies; United States Muscular Dystrophy Association; Foundation Building Strength for Nemaline Myopathy; UK Medical Research Council; Ada Bartholomew Medical Research Trust; West Australian Government; Western Australian Institute for Medical Research; Australian Postgraduate Award; University, State and Commonwealth Governments; MRC [MC_U137761449] Funding Source: UKRI; Medical Research Council [MC_U137761449] Funding Source: researchfish	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); United States Muscular Dystrophy Association; Foundation Building Strength for Nemaline Myopathy; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ada Bartholomew Medical Research Trust; West Australian Government; Western Australian Institute for Medical Research; Australian Postgraduate Award(Australian Government); University, State and Commonwealth Governments; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the National Health and Medical Research Council of Australia [CJ Martin Fellowship #212086 to KJN, Project Grant #403941, Fellowship #403904 to NGL]; the Association Francaise contre les Myopathies; the United States Muscular Dystrophy Association; A Foundation Building Strength for Nemaline Myopathy; the UK Medical Research Council; the Ada Bartholomew Medical Research Trust; the West Australian Government's Medical and Health Research Infrastructure Fund; the Western Australian Institute for Medical Research, and an Australian Postgraduate Award [GR]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Prof Edna Hardeman for providing the plasmid containing the HSA promoter and TnI enhancer. We gratefully acknowledge the professional staff at the Animal Resources Centre. The authors acknowledge the facilities, scientific and technical assistance of the Australian Microscopy & Microanalysis Research Facility at the Centre for Microscopy, Characterisation & Analysis, The University of Western Australia, a facility funded by The University, State and Commonwealth Governments.	ABE H, 1993, EXP CELL RES, V206, P1, DOI 10.1006/excr.1993.1113; Agrawal PB, 2007, AM J HUM GENET, V80, P162, DOI 10.1086/510402; Agrawal PB, 2004, ANN NEUROL, V56, P86, DOI 10.1002/ana.20157; Banks GB, 2008, HUM MOL GENET, V17, P3975, DOI 10.1093/hmg/ddn301; BETHLEM J, 1978, ARCH NEUROL-CHICAGO, V35, P555, DOI 10.1001/archneur.1978.00500330003002; BETHLEM J, 1963, J NEUROL NEUROSUR PS, V26, P326, DOI 10.1136/jnnp.26.4.326; BRENNAN KJ, 1993, J BIOL CHEM, V268, P719; BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279; Corbett MA, 2001, HUM MOL GENET, V10, P317, DOI 10.1093/hmg/10.4.317; CORIN SJ, 1994, J BIOL CHEM, V269, P10651; Domazetovska A, 2007, BRAIN, V130, P3275, DOI 10.1093/brain/awm247; Donner K, 2002, NEUROMUSCULAR DISORD, V12, P151, DOI 10.1016/S0960-8966(01)00252-8; Dubowitz V, 2007, MUSCLE BIOPSY PRACTI, P626; Dunant P, 2003, MOL THER, V8, P80, DOI 10.1016/S1525-0016(03)00129-1; Engel A.G., 2004, MYOLOGY; Feinberg DM, 1998, NEUROLOGY, V50, P529, DOI 10.1212/WNL.50.2.529; Feng JJ, 2009, J MUSCLE RES CELL M, V30, P85, DOI 10.1007/s10974-009-9178-9; Gommans IMP, 2003, BRAIN, V126, P1545, DOI 10.1093/brain/awg162; Ilkovski B, 2004, HUM MOL GENET, V13, P1727, DOI 10.1093/hmg/ddh185; Ilkovski B, 2001, AM J HUM GENET, V68, P1333, DOI 10.1086/320605; Jackaman C, 2007, CELL MOTIL CYTOSKEL, V64, P914, DOI 10.1002/cm.20239; Jeannet PY, 2007, NEUROMUSCULAR DISORD, V17, P6, DOI 10.1016/j.nmd.2006.10.005; JOCKUSCH BM, 1980, EXP CELL RES, V127, P409, DOI 10.1016/0014-4827(80)90445-0; Jockusch H, 2003, J HISTOCHEM CYTOCHEM, V51, P401, DOI 10.1177/002215540305100315; Johnston JJ, 2000, AM J HUM GENET, V67, P814, DOI 10.1086/303089; Joya JE, 2004, HUM MOL GENET, V13, P2633, DOI 10.1093/hmg/ddh285; Jungbluth H, 2001, NEUROMUSCULAR DISORD, V11, P35, DOI 10.1016/S0960-8966(00)00167-X; Kaindl AM, 2004, J MED GENET, V41, P842, DOI 10.1136/jmg.2004.020271; KARPATI G, 1972, ARCH NEUROL-CHICAGO, V27, P237, DOI 10.1001/archneur.1972.00490150045008; Laing NG, 2004, ANN NEUROL, V56, P689, DOI 10.1002/ana.20260; LAING NG, 1995, NAT GENET, V9, P75, DOI 10.1038/ng0195-75; Laing NG, 2009, HUM MUTAT, V30, P1267, DOI 10.1002/humu.21059; Li ZB, 2004, OTOLARYNG HEAD NECK, V130, P217, DOI 10.1016/j.otohns.2003.09.009; MENDEZ J, 1960, METABOLISM, V9, P184; Mokhtarian A, 1999, J APPL PHYSIOL, V86, P924, DOI 10.1152/jappl.1999.86.3.924; Mologni L, 2005, BIOCHEM BIOPH RES CO, V329, P1001, DOI 10.1016/j.bbrc.2005.02.074; Monnier N, 2000, HUM MOL GENET, V9, P2599, DOI 10.1093/hmg/9.18.2599; MORGAN JE, 1990, J CELL BIOL, V111, P2437, DOI 10.1083/jcb.111.6.2437; MORRIS WR, 1959, ARCH PATHOL, V68, P438; Nair-Shalliker V, 2004, MUSCLE NERVE, V30, P470, DOI 10.1002/mus.20138; Neville C, 1996, DEV GENET, V19, P157, DOI 10.1002/(SICI)1520-6408(1996)19:2<157::AID-DVG7>3.0.CO;2-8; NORTH K, 2008, ADV EXPT MED BIOL LA, P15; Nowak KJ, 1999, NAT GENET, V23, P208, DOI 10.1038/13837; Nowak KJ, 2009, J CELL BIOL, V185, P903, DOI 10.1083/jcb.200812132; ONO S, 1993, J MUSCLE RES CELL M, V14, P195, DOI 10.1007/BF00115454; Pelin K, 1999, P NATL ACAD SCI USA, V96, P2305, DOI 10.1073/pnas.96.5.2305; Pena J, 2001, PATHOL RES PRACT, V197, P21, DOI 10.1078/0344-0338-00004; Plant DR, 2005, J APPL PHYSIOL, V98, P1998, DOI 10.1152/japplphysiol.01381.2004; Ravenscroft G, 2011, BRAIN, V134, P1101, DOI 10.1093/brain/awr004; Ravenscroft G, 2011, NEUROMUSCULAR DISORD, V21, P31, DOI 10.1016/j.nmd.2010.08.005; Sambuughin N, 2010, AM J HUM GENET, V87, P842, DOI 10.1016/j.ajhg.2010.10.020; Scacheri PC, 2000, NEUROLOGY, V55, P1689, DOI 10.1212/WNL.55.11.1689; Schroder R, 2003, NEUROMUSCULAR DISORD, V13, P451, DOI 10.1016/S0960-8966(03)00064-6; Selcen D, 2004, BRAIN, V127, P439, DOI 10.1093/brain/awh052; SHY GM, 1963, BRAIN, V86, P793, DOI 10.1093/brain/86.4.793; Tai PWL, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-25; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; Vandamme D, 2009, BBA-MOL CELL RES, V1793, P1259, DOI 10.1016/j.bbamcr.2009.04.004; von der Hagen M, 2008, EUR J NEUROL, V15, pE31, DOI 10.1111/j.1468-1331.2008.02094.x; Vrabie A, 2005, ACTA NEUROPATHOL, V109, P411, DOI 10.1007/s00401-005-0980-1; Wallefeld W, 2006, NEUROMUSCULAR DISORD, V16, P541, DOI 10.1016/j.nmd.2006.07.018; Wallgren-Pettersson C, 2004, NEUROMUSCULAR DISORD, V14, P461, DOI 10.1016/j.nmd.2004.03.006; Wallgren-Pettersson C, 1999, NEUROMUSCULAR DISORD, V9, P564, DOI 10.1016/S0960-8966(99)00061-9; WALLGRENPETTERSSON C, 1995, NEUROMUSCULAR DISORD, V5, P93, DOI 10.1016/0960-8966(94)00035-8; YAMAGUCHI M, 1982, J NEUROL SCI, V56, P35, DOI 10.1016/0022-510X(82)90059-4	65	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28699	10.1371/journal.pone.0028699	http://dx.doi.org/10.1371/journal.pone.0028699			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174871	Green Published, gold, Green Submitted			2022-12-25	WOS:000298365700063
J	Wang, SB; Hu, KM; Seamon, KJ; Mani, V; Chen, YD; Gronert, K				Wang, Samantha B.; Hu, Kyle M.; Seamon, Kyle J.; Mani, Vinidhra; Chen, Yangdi; Gronert, Karsten			Estrogen negatively regulates epithelial wound healing and protective lipid mediator circuits in the cornea	FASEB JOURNAL			English	Article						17 beta-estradiol; lipoxin A(4); ER beta; ER alpha; 15-LOX; sex-specific	DRY EYE; MEIBOMIAN GLAND; SJOGRENS-SYNDROME; GENE-EXPRESSION; MESSENGER-RNAS; RECEPTOR ALX; INFLAMMATION; LIPOXINS; RESOLUTION; RESPONSES	Estrogen receptors (ERs) are expressed in leukocytes and in every ocular tissue. However, sex-specific differences and the role of estradiol in ocular inflammatory-reparative responses are not well understood. We found that female mice exhibited delayed corneal epithelial wound closure and attenuated polymorphonuclear (PMN) leukocyte responses, a phenotype recapitulated by estradiol treatment both in vivo (topically in male mice) and in vitro (corneal epithelial cell wound healing). The cornea expresses 15-lipoxygenase (15-LOX) and receptors for lipoxin A(4) (LXA(4)), which have been implicated in an intrinsic lipid circuit that regulates corneal inflammation and wound healing. Delayed epithelial wound healing correlated with lower expression of 15-LOX in the regenerated epithelium of female mice. Estradiol in vitro and in vivo down-regulated epithelial 15-LOX expression and LXA(4) formation, while estradiol abrogation of epithelial wound healing was completely reversed by treatment with LXA(4). More important, ER beta and ER alpha selectively regulated epithelial wound healing, PMN cell recruitment, and activity of the intrinsic 15-LOX/LXA(4) circuit. Our results demonstrate for the first time a sex-specific difference in the corneal reparative response, which is mediated by ER beta and ER alpha selective regulation of the epithelial and PMN 15-LOX/LXA(4) circuit. These findings may provide novel insights into the etiology of sex-specific ocular inflammatory diseases.-Wang, S. B., Hu, K. M., Seamon, K. J., Mani, V., Chen, Y., Gronert, K. Estrogen negatively regulates epithelial wound healing and protective lipid mediator circuits in the cornea. FASEB J. 26, 1506-1516 (2012). www.fasebj.org	[Wang, Samantha B.; Hu, Kyle M.; Seamon, Kyle J.; Mani, Vinidhra; Chen, Yangdi; Gronert, Karsten] Univ Calif Berkeley, Sch Optometry, Vis Sci Program, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Gronert, K (corresponding author), Univ Calif Berkeley, Sch Optometry, Vis Sci Program, 594 Minor Hall,MC 2020, Berkeley, CA 94720 USA.	kgronert@berkeley.edu			U.S. National Eye Institute [EY016136, P30EY003176]; Hellman's Family Faculty; University of California, Berkeley; NATIONAL EYE INSTITUTE [R01EY016136, P30EY003176, R01EY022208] Funding Source: NIH RePORTER	U.S. National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Hellman's Family Faculty; University of California, Berkeley(University of California System); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by U.S. National Eye Institute grants EY016136 and P30EY003176 and a Hellman's Family Faculty Fund grant from the University of California, Berkeley.	Ashcroft GS, 2003, J CLIN INVEST, V111, P1309, DOI 10.1172/KCO200316288; Ashcroft GS, 1997, NAT MED, V3, P1209, DOI 10.1038/nm1197-1209; Barabino Stefano, 2007, Chem Immunol Allergy, V92, P176, DOI 10.1159/000099268; Bazan NG, 2011, ANNU REV NUTR, V31, P321, DOI 10.1146/annurev.nutr.012809.104635; Biteman B, 2007, FASEB J, V21, P2257, DOI 10.1096/fj.06-7918com; Calandria JM, 2009, J BIOL CHEM, V284, P17877, DOI 10.1074/jbc.M109.003988; Chiang N, 2005, PROSTAG LEUKOTR ESS, V73, P163, DOI 10.1016/j.plefa.2005.05.003; Chiang N, 2006, PHARMACOL REV, V58, P463, DOI 10.1124/pr.58.3.4; COLES N, 1988, Investigative Ophthalmology and Visual Science, V29, P48; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Gilliver SC, 2010, J STEROID BIOCHEM, V120, P105, DOI 10.1016/j.jsbmb.2009.12.015; Godson C, 2000, Curr Opin Investig Drugs, V1, P380; Gronert K, 2005, PROSTAG LEUKOTR ESS, V73, P221, DOI 10.1016/j.plefa.2005.05.009; Gronert K, 2005, J BIOL CHEM, V280, P15267, DOI 10.1074/jbc.M410638200; Gronert K, 2008, MOL INTERV, V8, P28, DOI 10.1124/mi.8.1.7; Gronert K, 2010, EXP EYE RES, V91, P478, DOI 10.1016/j.exer.2010.07.004; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Jin YP, 2009, INVEST OPHTH VIS SCI, V50, P4743, DOI 10.1167/iovs.08-2462; Karim MJ, 2009, J OCUL PHARMACOL TH, V25, P483, DOI [10.1089/jop.2008.0134, 10.1089/jop.2009.0134]; Kenchegowda S, 2011, INVEST OPHTH VIS SCI, V52, P2240, DOI 10.1167/iovs.10-6199; Kenchegowda S, 2010, J LIPID RES, V51, P879, DOI 10.1194/jlr.R001347; Krishnan T, 2012, BRIT J OPHTHALMOL, V96, P137, DOI 10.1136/bjophthalmol-2011-300441; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Leedom AJ, 2010, AM J PATHOL, V176, P74, DOI 10.2353/ajpath.2010.090678; Leitman DC, 2010, CURR OPIN PHARMACOL, V10, P629, DOI 10.1016/j.coph.2010.09.009; Li Z, 2007, AM J PATHOL, V171, P838, DOI 10.2353/ajpath.2007.070008; Li ZJ, 2006, INVEST OPHTH VIS SCI, V47, P4794, DOI 10.1167/iovs.06-0381; Li ZJ, 2006, INVEST OPHTH VIS SCI, V47, P1947, DOI 10.1167/iovs.05-1193; Liclican EL, 2010, INVEST OPHTH VIS SCI, V51, P6311, DOI 10.1167/iovs.10-5455; Liclican EL, 2010, THESCIENTIFICWORLDJO, V10, P1029, DOI 10.1100/tsw.2010.99; Maderna P, 2009, BRIT J PHARMACOL, V158, P947, DOI 10.1111/j.1476-5381.2009.00386.x; McMahon B, 2004, AM J PHYSIOL-RENAL, V286, pF189, DOI 10.1152/ajprenal.00224.2003; McMahon B, 2001, TRENDS PHARMACOL SCI, V22, P391, DOI 10.1016/S0165-6147(00)01771-5; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Russell R, 2011, FASEB J, V25, P4326, DOI 10.1096/fj.11-187658; Sapieha P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001571; Sator MO, 1998, BRIT J OBSTET GYNAEC, V105, P100, DOI 10.1111/j.1471-0528.1998.tb09358.x; Schaumberg DA, 2002, ADV EXP MED BIOL, V506, P989; Schaumberg DA, 2001, JAMA-J AM MED ASSOC, V286, P2114, DOI 10.1001/jama.286.17.2114; Schirra F, 2006, CORNEA, V25, P438, DOI 10.1097/01.ico.0000183664.80004.44; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Seta F, 2006, AM J PATHOL, V169, P1612, DOI 10.2353/ajpath.2006.060555; Sharma GD, 2005, J BIOL CHEM, V280, P7917, DOI 10.1074/jbc.M408852200; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Sullivan DA, 2004, DRY EYE AND OCULAR SURFACE DISORDERS, P165; Sullivan DA, 2002, LUPUS, V11, P667, DOI 10.1191/0961203302lu275oa; Sullivan David A, 2004, Ocul Surf, V2, P92; Suzuki T, 2005, CORNEA, V24, P1004, DOI 10.1097/01.ico.0000160973.04072.a5; Suzuki T, 2002, ANN NY ACAD SCI, V966, P223, DOI 10.1111/j.1749-6632.2002.tb04218.x; Suzuki T, 2001, CURR EYE RES, V22, P28, DOI 10.1076/ceyr.22.1.28.6980; Suzuki T, 2008, INVEST OPHTH VIS SCI, V49, P1797, DOI 10.1167/iovs.07-1458; Suzuki T, 2006, CORNEA, V25, P454; Tachibana M, 2000, INVEST OPHTH VIS SCI, V41, P668; Vij N, 2005, INVEST OPHTH VIS SCI, V46, P88, DOI 10.1167/iovs.04-0833; Wickham LA, 2000, ACTA OPHTHALMOL SCAN, V78, P146, DOI 10.1034/j.1600-0420.2000.078002146.x	56	68	71	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2012	26	4					1506	1516		10.1096/fj.11-198036	http://dx.doi.org/10.1096/fj.11-198036			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	919VS	22186873	Green Published			2022-12-25	WOS:000302359700013
J	Xia, W; Li, HY; Yang, XM; Wong, KB; Sun, HZ				Xia, Wei; Li, Hongyan; Yang, Xinming; Wong, Kam-Bo; Sun, Hongzhe			Metallo-GTPase HypB from Helicobacter pylori and Its Interaction with Nickel Chaperone Protein HypA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTIDINE-RICH PROTEIN; BINDING; HYDROGENASE; UREASE; MATURATION; METALLOCHAPERONE; TITRATION; INSERTION; SYNTHASE; DOMAIN	The maturation of [NiFe]-hydrogenase is highly dependent on a battery of chaperone proteins. Among these, HypA and HypB were proposed to exert nickel delivery functions in the metallocenter assembly process, although the detailed mechanism remains unclear. Herein, we have overexpressed and purified wild-type HypB as well as two mutants, K168A and M186L/F190V, from Helicobacter pylori. We demonstrated that all proteins bind Ni2+ at a stoichiometry of one Ni2+ per monomer of the proteins with dissociation constants at micromolar levels. Ni2+ elevated GTPase activity of WT HypB, which is attributable to a lower affinity of the protein toward GDP as well as Ni2+-induced dimerization. The disruption of GTP-dependent dimerization has led to GTPase activities of both mutants in apo-forms almost completely abolished, compared with the wild-type protein. The GTPase activity is partially restored for HypB(M186L/F190V) mutant but not for HypB(K168A) mutant upon Ni2+ binding. HypB forms a complex with its partner protein HypA with a low affinity (K-d of 52.2 +/- 8.8 mu M). Such interactions were also observed in vivo both in the absence and presence of nickel using a GFP-fragment reassembly technique. The putative protein-protein interfaces on H. pylori HypA and HypB proteins were identified by NMR chemical shift perturbation and mutagenesis studies, respectively. Intriguingly, the unique N terminus of H. pylori HypB was identified to participate in the interaction with H. pylori HypA. These structural and functional studies provide insight into the molecular mechanism of Ni2+ delivery during maturation of [NiFe]-hydrogenase.	[Xia, Wei; Li, Hongyan; Yang, Xinming; Sun, Hongzhe] Univ Hong Kong, Dept Chem, Hong Kong, Hong Kong, Peoples R China; [Wong, Kam-Bo] Chinese Univ Hong Kong, Sch Life Sci, Ctr Prot Sci & Crystallog, Shatin, Hong Kong, Peoples R China	University of Hong Kong; Chinese University of Hong Kong	Sun, HZ (corresponding author), Univ Hong Kong, Dept Chem, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	hsun@hku.hk	Wong, Kam-Bo/G-4258-2013; Wong, Kam-Bo/AAU-9364-2021; xia, wei/C-2628-2015; /D-3123-2009	Wong, Kam-Bo/0000-0002-6984-5373; Wong, Kam-Bo/0000-0002-6984-5373; xia, wei/0000-0001-6480-3265; /0000-0001-6697-6899; YANG, Xinming/0000-0001-6240-5212	Council of Hong Kong [HKU1/07C, HKU7042/07P, HKU7049/09P, N_HKU752/09, CUHK4610/06]; Croucher Foundation; University of Hong Kong	Council of Hong Kong(Hong Kong Research Grants Council); Croucher Foundation; University of Hong Kong(University of Hong Kong)	This work was supported by Research Grants Council of Hong Kong Grants HKU1/07C, HKU7042/07P, HKU7049/09P, N_HKU752/09, and CUHK4610/06, the Croucher Foundation, and the University of Hong Kong.	Ajees AA, 2011, BIOMETALS, V24, P391, DOI 10.1007/s10534-010-9398-x; Bai YC, 2008, ANAL CHIM ACTA, V616, P115, DOI 10.1016/j.aca.2008.04.003; Bauerfeind P, 1997, GUT, V40, P25, DOI 10.1136/gut.40.1.25; Blokesch M, 2002, BIOCHEM SOC T, V30, P674, DOI 10.1042/BST0300674; Cheng T., 2011, J BIOL INORG CHEM, DOI [10.1007/s00775-011-0855y, DOI 10.1007/S00775-011-0855Y]; Ciurli S., 2009, PROTEINS, V74, P222; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; Cun SJ, 2008, J BIOL CHEM, V283, P15142, DOI 10.1074/jbc.M800591200; Cun SJ, 2010, P NATL ACAD SCI USA, V107, P4943, DOI 10.1073/pnas.0913970107; Cunha L, 2008, PROTEINS, V71, P855, DOI 10.1002/prot.21755; Danielli A, 2010, FEMS MICROBIOL REV, V34, P738, DOI 10.1111/j.1574-6976.2010.00233.x; Forzi L, 2007, BIOMETALS, V20, P565, DOI 10.1007/s10534-006-9048-5; Freyer MW, 2008, METHOD CELL BIOL, V84, P79, DOI 10.1016/S0091-679X(07)84004-0; Gasper R, 2006, J BIOL CHEM, V281, P27492, DOI 10.1074/jbc.M600809200; Gasper R, 2009, NAT REV MOL CELL BIO, V10, P423, DOI 10.1038/nrm2689; Ge RG, 2006, BIOCHEM J, V393, P285, DOI 10.1042/BJ20051160; Ge RG, 2006, J AM CHEM SOC, V128, P11330, DOI 10.1021/ja062589t; Jeoung JH, 2009, BIOCHEMISTRY-US, V48, P11505, DOI 10.1021/bi901443z; Kaluarachchi H, 2011, BIOCHEMISTRY-US, V50, P10761, DOI 10.1021/bi201590d; Kunzelmann S, 2005, METHOD ENZYMOL, V404, P512, DOI 10.1016/S0076-6879(05)04045-0; Leach MR, 2007, CURR OPIN CHEM BIOL, V11, P159, DOI 10.1016/j.cbpa.2007.01.011; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Lin YF, 2006, P NATL ACAD SCI USA, V103, P15617, DOI 10.1073/pnas.0603974103; Ma C, 2011, NAT STRUCT MOL BIOL, V18, P542, DOI 10.1038/nsmb.2047; Macomber L, 2011, METALLOMICS, V3, P1153, DOI 10.1039/c1mt00063b; Maier RJ, 2007, BIOMETALS, V20, P655, DOI 10.1007/s10534-006-9061-8; MAIER T, 1995, EUR J BIOCHEM, V230, P133, DOI 10.1111/j.1432-1033.1995.tb20543.x; MARSHALL BJ, 1984, LANCET, V1, P1311; Mehta N, 2003, J BACTERIOL, V185, P726, DOI 10.1128/JB.185.3.726-734.2003; Morell M, 2007, PROTEOMICS, V7, P1023, DOI 10.1002/pmic.200600966; Olson JW, 2002, SCIENCE, V298, P1788, DOI 10.1126/science.1077123; Olson JW, 2001, MOL MICROBIOL, V39, P176, DOI 10.1046/j.1365-2958.2001.02244.x; PARSONNET J, 1991, JNCI-J NATL CANCER I, V83, P640, DOI 10.1093/jnci/83.9.640; Roberts G. C. K., 1993, NMR MACROMOLECULES P, P153; Rosen BP, 2002, FEBS LETT, V529, P86, DOI 10.1016/S0014-5793(02)03186-1; Stingl K, 2008, MOL CELL PROTEOMICS, V7, P2429, DOI 10.1074/mcp.M800160-MCP200; Sydor AM, 2011, J BACTERIOL, V193, P1359, DOI 10.1128/JB.01333-10; Tugarinov V, 2003, J MOL BIOL, V327, P1121, DOI 10.1016/S0022-2836(03)00238-9; Vinogradova O, 2012, TOP CURR CHEM, V326, P35, DOI 10.1007/128_2011_216; Watanabe S, 2009, J MOL BIOL, V394, P448, DOI 10.1016/j.jmb.2009.09.030; Wilson CG, 2004, NAT METHODS, V1, P255, DOI 10.1038/nmeth1204-255; Xia W, 2009, J AM CHEM SOC, V131, P10031, DOI 10.1021/ja900543y; Yang JB, 2010, BIOCHEMISTRY-US, V49, P3658, DOI 10.1021/bi100026a; Zeng YB, 2011, CHEM-EUR J, V17, P5852, DOI 10.1002/chem.201100279; Zhang JW, 2005, J BIOL CHEM, V280, P4360, DOI 10.1074/jbc.M411799200	45	44	44	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6753	6763		10.1074/jbc.M111.287581	http://dx.doi.org/10.1074/jbc.M111.287581			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22179820	Green Published, hybrid			2022-12-25	WOS:000300791800061
J	Wu, N; Rollin, J; Masse, I; Lamartine, J; Gidrol, X				Wu, Ning; Rollin, Jerome; Masse, Ingrid; Lamartine, Jerome; Gidrol, Xavier			p63 Regulates Human Keratinocyte Proliferation via MYC-regulated Gene Network and Differentiation Commitment through Cell Adhesion-related Gene Network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL STEM-CELLS; C-MYC; HAIR FOLLICLE; PROGENITOR CELLS; BETA-CATENIN; EXPRESSION; GROWTH; NOTCH; SKIN; ACTIVATION	Although p63 and MYC are important in the control of epidermal homeostasis, the underlying molecular mechanisms governing keratinocyte proliferation or differentiation downstream of these two genes are not completely understood. By analyzing the transcriptional changes and phenotypic consequences of the loss of either p63 or MYC in human developmentally mature keratinocytes, we have characterized the networks acting downstream of these two genes to control epidermal homeostasis. We show that p63 is required to maintain growth and to commit to differentiation by two distinct mechanisms. Knockdown of p63 led to down-regulation of MYC via the Wnt/beta-catenin and Notch signaling pathways and in turn reduced keratinocyte proliferation. We demonstrate that a p63-controlled keratinocyte cell fate network is essential to induce the onset of keratinocyte differentiation. This network contains several secreted proteins involved in cell migration/adhesion, including fibronectin 1 (FN1), interleukin-1 beta (IL1B), cysteine-rich protein 61 (CYR61), and jagged-1 (JAG1), that act downstream of p63 as key effectors to trigger differentiation. Our results characterized for the first time a connection between p63 and MYC and a cell adhesion-related network that controls differentiation. Furthermore, we show that the balance between the MYC-controlled cell cycle progression network and the p63-controlled cell adhesion-related network could dictate skin cell fate.	[Wu, Ning; Gidrol, Xavier] Commissariat Energie Atom, F-38054 Grenoble, France; [Wu, Ning; Gidrol, Xavier] INSERM, U1038, F-38054 Grenoble, France; [Wu, Ning; Gidrol, Xavier] Univ Grenoble 1, F-38000 Grenoble 1, France; [Rollin, Jerome] Hop Tours, Lab Hematol Hemostase, UMR6239, CNRS, F-37100 Tours, France; [Masse, Ingrid; Lamartine, Jerome] Univ Lyon 1, CNRS, UMR5534, Ctr Genet & Physiol Mol & Cellulaire, F-69622 Villeurbanne, France	CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CHU Tours; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Gidrol, X (corresponding author), Commissariat Energie Atom, F-38054 Grenoble, France.	xavier.gidrol@cea.fr	Jerome, Rollin/K-2157-2019	Lamartine, Jerome/0000-0003-2322-1618; Gidrol, Xavier/0000-0002-4233-3749; MASSE, Ingrid/0000-0003-3193-970X	Commissariat a l'Energie Atomique; Fondation pour la Recherche Medicale	Commissariat a l'Energie Atomique(French Atomic Energy Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	Supported by Commissariat a l'Energie Atomique and Fondation pour la Recherche Medicale.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Arnold I, 2001, CURR BIOL, V11, P558, DOI 10.1016/S0960-9822(01)00154-3; Barbieri CE, 2006, CANCER RES, V66, P7589, DOI 10.1158/0008-5472.CAN-06-2020; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bull JJ, 2001, J INVEST DERMATOL, V116, P617, DOI 10.1046/j.1523-1747.2001.12771234.x; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Dai X, 2004, CURR OPIN GENET DEV, V14, P485, DOI 10.1016/j.gde.2004.07.002; Devgan V, 2005, GENE DEV, V19, P1485, DOI 10.1101/gad.341405; DLUGOSZ AA, 1993, J CELL BIOL, V120, P217, DOI 10.1083/jcb.120.1.217; Estrach S, 2006, DEVELOPMENT, V133, P4427, DOI 10.1242/dev.02644; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Fuchs E, 2009, CELL STEM CELL, V4, P499, DOI 10.1016/j.stem.2009.05.001; Gandarillas A, 1997, GENE DEV, V11, P2869, DOI 10.1101/gad.11.21.2869; Gebhardt A, 2006, J CELL BIOL, V172, P139, DOI 10.1083/jcb.200506057; HASHIRO M, 1991, BIOCHEM BIOPH RES CO, V174, P287, DOI 10.1016/0006-291X(91)90518-C; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Jensen KB, 2006, P NATL ACAD SCI USA, V103, P11958, DOI 10.1073/pnas.0601886103; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Le Brigand K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl485; Maas-Szabowski N, 2003, J CELL SCI, V116, P2937, DOI 10.1242/jcs.00474; McKeon F, 2004, GENE DEV, V18, P465, DOI 10.1101/gad.1190504; Mehic D, 2005, J INVEST DERMATOL, V124, P212, DOI 10.1111/j.0022-202X.2004.23558.x; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Muller EJ, 2008, J INVEST DERMATOL, V128, P501, DOI 10.1038/sj.jid.5701248; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; Nickoloff BJ, 2002, CELL DEATH DIFFER, V9, P842, DOI 10.1038/sj.cdd.4401036; Ogawa E, 2008, J BIOL CHEM, V283, P34241, DOI 10.1074/jbc.M804101200; OSTERLAND CK, 1990, CLIN EXP RHEUMATOL, V8, P145; PIETENPOL JA, 1990, P NATL ACAD SCI USA, V87, P3758, DOI 10.1073/pnas.87.10.3758; Pozzi S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005008; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Reuter JA, 2009, CANCER CELL, V15, P477, DOI 10.1016/j.ccr.2009.04.002; Sasaki Y, 2002, J BIOL CHEM, V277, P719, DOI 10.1074/jbc.M108080200; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; Slavik MA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-9; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Su XH, 2009, EMBO J, V28, P1904, DOI 10.1038/emboj.2009.151; Testoni B, 2006, NUCLEIC ACIDS RES, V34, P928, DOI 10.1093/nar/gkj477; Truong AB, 2007, CELL CYCLE, V6, P295, DOI 10.4161/cc.6.3.3753; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Vigano MA, 2006, EMBO J, V25, P5105, DOI 10.1038/sj.emboj.7601375; Waikel RL, 2001, NAT GENET, V28, P165, DOI 10.1038/88889; Watt FM, 2008, CURR OPIN CELL BIOL, V20, P171, DOI 10.1016/j.ceb.2008.01.010; Watt FM, 2008, NAT REV CANCER, V8, P234, DOI 10.1038/nrc2328; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Westfall MD, 2003, MOL CELL BIOL, V23, P2264, DOI 10.1128/MCB.23.7.2264-2276.2003; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yano S, 2008, J CELL PHYSIOL, V214, P1, DOI 10.1002/jcp.21300; Yu XB, 2006, STEM CELLS, V24, P876, DOI 10.1634/stemcells.2005-0598	56	56	57	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5627	5638		10.1074/jbc.M111.328120	http://dx.doi.org/10.1074/jbc.M111.328120			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22184109	Green Published, hybrid			2022-12-25	WOS:000300638000040
J	Seabold, GK; Wang, PY; Petralia, RS; Chang, K; Zhou, A; McDermott, MI; Wang, YX; Milgram, SL; Wenthold, RJ				Seabold, Gail K.; Wang, Philip Y.; Petralia, Ronald S.; Chang, Kai; Zhou, Arthur; McDermott, Mark I.; Wang, Ya-Xian; Milgram, Sharon L.; Wenthold, Robert J.			Dileucine and PDZ-binding Motifs Mediate Synaptic Adhesion-like Molecule 1 (SALM1) Trafficking in Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER RETENTION SIGNAL; MENTAL-RETARDATION; DENDRITIC SPINES; PLASMA-MEMBRANE; RECEPTOR; NMDA; PROTEINS; FAMILY; EXPRESSION; RHO	Synaptic adhesion-like molecules (SALMs) are a family of cell adhesion molecules involved in neurite outgrowth and synapse formation. Of the five family members, only SALM1, -2, and -3 contain a cytoplasmic C-terminal PDZ-binding motif. We have found that SALM1 is unique among the SALMs because deletion of its PDZ-binding motif (SALM1 Delta PDZ) blocks its surface expression in heterologous cells. When expressed in hippocampal neurons, SALM1 Delta PDZ had decreased surface expression in dendrites and the cell soma but not in axons, suggesting that the PDZ-binding domain may influence cellular trafficking of SALMs to specific neuronal locations. Endoglycosidase H digestion assays indicated that SALM1 Delta PDZ is retained in the endoplasmic reticulum (ER) in heterologous cells. However, when the entire C-terminal tail of SALM1 was deleted, SALM1 was detected on the cell surface. Using serial deletions, we identified a region of SALM1 that contains a putative dileucine ER retention motif, which is not present in the other SALMs. Mutation of this DXXXLL motif allowed SALM1 to leave the ER and enhanced its surface expression in heterologous cells and neurons. An increase in the number of protrusions at the dendrites and cell body was observed when this SALM1 mutant was expressed in hippocampal neurons. With electron microscopy, these protrusions appeared to be irregular, enlarged spines and filopodia. Thus, enrichment of SALM1 on the cell surface affects dendritic arborization, and intracellular motifs regulate its dendritic versus axonal localization.	[Seabold, Gail K.; Wang, Philip Y.; Petralia, Ronald S.; Chang, Kai; Zhou, Arthur; Wang, Ya-Xian; Wenthold, Robert J.] NIDCD, Neurochem Lab, Bethesda, MD 20892 USA; [Seabold, Gail K.; McDermott, Mark I.; Milgram, Sharon L.] NHLBI, Kidney & Electrolyte Metab Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Seabold, GK (corresponding author), NIDCD, NIH, 50 S Dr,Bldg 50,Rm 4144, Bethesda, MD 20892 USA.	Gail.Seabold@nih.gov			National Institutes of Health, NIDCD; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZICDC000081, ZIADC000003] Funding Source: NIH RePORTER	National Institutes of Health, NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by the National Institutes of Health, NIDCD, Intramural Research Program.	Benson D. L., 2010, HIPPOCAMPUS IN PRESS; Betancur C, 2009, TRENDS NEUROSCI, V32, P402, DOI 10.1016/j.tins.2009.04.003; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Carrel D, 2006, J CELL SCI, V119, P4276, DOI 10.1242/jcs.03189; Chih B, 2004, HUM MOL GENET, V13, P1471, DOI 10.1093/hmg/ddh158; Comoletti D, 2004, J NEUROSCI, V24, P4889, DOI 10.1523/JNEUROSCI.0468-04.2004; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; De Angelis E, 2002, HUM MOL GENET, V11, P1, DOI 10.1093/hmg/11.1.1; de Bruijn DRH, 2010, MOL SYNDROMOL, V1, P46, DOI 10.1159/000280290; Dierssen M, 2006, GENES BRAIN BEHAV, V5, P48, DOI 10.1111/j.1601-183X.2006.00224.x; Dong CM, 2007, BBA-BIOMEMBRANES, V1768, P853, DOI 10.1016/j.bbamem.2006.09.008; Durand CM, 2012, MOL PSYCHIATR, V17, P71, DOI 10.1038/mp.2011.57; Duvernay MT, 2004, J BIOL CHEM, V279, P30741, DOI 10.1074/jbc.M313881200; Ethell IM, 1999, J CELL BIOL, V144, P575, DOI 10.1083/jcb.144.3.575; Fairless R, 2008, J NEUROSCI, V28, P12969, DOI 10.1523/JNEUROSCI.5294-07.2008; Fan YJ, 2011, J NEUROSCI, V31, P10228, DOI 10.1523/JNEUROSCI.0115-11.2011; Francesconi A, 2002, J NEUROSCI, V22, P2196, DOI 10.1523/JNEUROSCI.22-06-02196.2002; Gauthier J, 2011, HUM GENET, V130, P563, DOI 10.1007/s00439-011-0975-z; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Hering H, 2003, J NEUROSCI, V23, P11759; HINTON VJ, 1991, AM J MED GENET, V41, P289, DOI 10.1002/ajmg.1320410306; Homma S, 2009, GENE EXPR PATTERNS, V9, P1, DOI 10.1016/j.gep.2008.09.004; Ko JW, 2006, NEURON, V50, P233, DOI 10.1016/j.neuron.2006.04.005; Konakahara S, 2011, FEBS LETT, V585, P2377, DOI 10.1016/j.febslet.2011.06.011; Lasiecka ZM, 2009, INT REV CEL MOL BIO, V272, P303, DOI 10.1016/S1937-6448(08)01607-9; Lin YL, 2007, J CELL BIOL, V177, P829, DOI 10.1083/jcb.200608121; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Loo TW, 2005, J BIOL CHEM, V280, P2522, DOI 10.1074/jbc.M411483200; Ludwig T, 2008, J BIOL CHEM, V283, P35410, DOI 10.1074/jbc.M801816200; Mah W, 2010, J NEUROSCI, V30, P5559, DOI 10.1523/JNEUROSCI.4839-09.2010; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; Mikhail FM, 2011, AM J MED GENET A, V155A, P2386, DOI 10.1002/ajmg.a.34177; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Morimura N, 2006, GENE, V380, P72, DOI 10.1016/j.gene.2006.05.014; Mu YY, 2003, NEURON, V40, P581, DOI 10.1016/S0896-6273(03)00676-7; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Nakagawa T, 2004, NEUROPHARMACOLOGY, V47, P734, DOI 10.1016/j.neuropharm.2004.07.022; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Newey SE, 2005, J NEUROBIOL, V64, P58, DOI 10.1002/neu.20153; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Petralia RS, 2010, NEUROSCIENCE, V167, P68, DOI 10.1016/j.neuroscience.2010.01.022; PORTERACAILLIAU C, 2011, NEUROSCIENT IN PRESS; Poyatos I, 2000, MOL CELL NEUROSCI, V15, P99, DOI 10.1006/mcne.1999.0807; PURPURA DP, 1974, SCIENCE, V186, P1126, DOI 10.1126/science.186.4169.1126; Ramakers GJA, 2012, HUM MOL GENET, V21, P268, DOI 10.1093/hmg/ddr457; Restituito S, 2005, MOL CELL NEUROSCI, V28, P747, DOI 10.1016/j.mcn.2004.12.006; Rivera JF, 2003, NAT NEUROSCI, V6, P243, DOI 10.1038/nn1020; Robert J, 2005, J BIOL CHEM, V280, P2300, DOI 10.1074/jbc.M410655200; Rosales CR, 2005, EUR J NEUROSCI, V22, P2381, DOI 10.1111/j.1460-9568.2005.04400.x; Ruberti F, 2000, J NEUROSCI, V20, part. no.; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; Sans N, 2005, NAT CELL BIOL, V7, P1179, DOI 10.1038/ncb1325; Sans N, 2003, NAT CELL BIOL, V5, P520, DOI 10.1038/ncb990; Schafer MKE, 2010, NEUROBIOL DIS, V40, P222, DOI 10.1016/j.nbd.2010.05.029; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Schulein R, 1998, MOL PHARMACOL, V54, P525, DOI 10.1124/mol.54.3.525; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; Seabold GK, 2008, J BIOL CHEM, V283, P8395, DOI 10.1074/jbc.M709456200; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Stowell JN, 1999, NEURON, V22, P525, DOI 10.1016/S0896-6273(00)80707-2; Taniguchi H, 2007, J NEUROSCI, V27, P2815, DOI 10.1523/JNEUROSCI.0032-07.2007; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Tran TS, 2009, NATURE, V462, P1065, DOI 10.1038/nature08628; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wang CY, 2006, J NEUROSCI, V26, P2174, DOI 10.1523/JNEUROSCI.3799-05.2006; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Wang PY, 2008, MOL CELL NEUROSCI, V39, P83, DOI 10.1016/j.mcn.2008.05.019; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; Wisco D, 2003, J CELL BIOL, V162, P1317, DOI 10.1083/jcb.200307069; Xia H, 2001, NEUROPHARMACOLOGY, V41, P714, DOI 10.1016/S0028-3908(01)00103-4; Xu J, 2006, J NEUROSCI, V26, P9780, DOI 10.1523/JNEUROSCI.0840-06.2006; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8	73	11	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4470	4484		10.1074/jbc.M111.279661	http://dx.doi.org/10.1074/jbc.M111.279661			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22174418	Green Published, hybrid			2022-12-25	WOS:000300608500011
J	Yuan, FH; Qian, LY; Zhao, XL; Liu, JY; Song, LM; D'Urso, G; Jain, C; Zhang, YB				Yuan, Fenghua; Qian, Liangyue; Zhao, Xinliang; Liu, Jesse Y.; Song, Limin; D'Urso, Gennaro; Jain, Chaitanya; Zhang, Yanbin			Fanconi Anemia Complementation Group A (FANCA) Protein Has Intrinsic Affinity for Nucleic Acids with Preference for Single-stranded Forms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-LINK REPAIR; CORE COMPLEX; DNA-DAMAGE; REPLICATION FORKS; PATHWAY; CELLS; IDENTIFICATION; CHROMATIN; SLX4; LOCALIZATION	The Fanconi anemia complementation group A (FANCA) gene is one of 15 disease-causing genes and has been found to be mutated in similar to 60% of Fanconi anemia patients. Using purified protein, we report that human FANCA has intrinsic affinity for nucleic acids. FANCA binds to both single-stranded (ssDNA) and double-stranded (dsDNA) DNAs; however, its affinity for ssDNA is significantly higher than for dsDNA in an electrophoretic mobility shift assay. FANCA also binds to RNA with an intriguingly higher affinity than its DNA counterpart. FANCA requires a certain length of nucleic acids for optimal binding. Using DNA and RNA ladders, we determined that the minimum number of nucleotides required for FANCA recognition is similar to 30 for both DNA and RNA. By testing the affinity between FANCA and a variety of DNA structures, we found that a 5'-flap or 5'-tail on DNA facilitates its interaction with FANCA. A patient-derived FANCA truncation mutant (Q772X) has diminished affinity for both DNA and RNA. In contrast, the complementing C-terminal fragment of Q772X, C772-1455, retains the differentiated nucleic acid-binding activity (RNA > ssDNA > dsDNA), indicating that the nucleic acid-binding domain of FANCA is located primarily at its C terminus, where most disease-causing mutations are found.	[Yuan, Fenghua; Qian, Liangyue; Zhao, Xinliang; Liu, Jesse Y.; Song, Limin; Jain, Chaitanya; Zhang, Yanbin] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA; [D'Urso, Gennaro] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA	University of Miami; University of Miami	Zhang, YB (corresponding author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Gautier Bldg,Rm 310,1011 NW 15th St, Miami, FL 33136 USA.	yzhang4@med.miami.edu	Zhang, Yanbin/F-2998-2011; Jain, Chaitanya/ABA-4238-2021	Zhang, Yanbin/0000-0002-7263-5510; Jain, Chaitanya/0000-0003-2429-0105	National Institutes of Health [R01 HL105631]; Florida Biomedical Research Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105631] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Biomedical Research Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL105631 (to Y.Z.). This work was also supported by a new investigator research grant from the Florida Biomedical Research Program (to Y.Z.).	Alter BP, 2003, CANCER-AM CANCER SOC, V97, P425, DOI 10.1002/cncr.11046; Auerbach AD, 2009, MUTAT RES-FUND MOL M, V668, P4, DOI 10.1016/j.mrfmmm.2009.01.013; Bakker ST, 2009, HUM MOL GENET, V18, P3484, DOI 10.1093/hmg/ddp297; Christianson TA, 2000, BLOOD, V95, P725, DOI 10.1182/blood.V95.2.725; Ciccia A, 2008, ANNU REV BIOCHEM, V77, P259, DOI 10.1146/annurev.biochem.77.070306.102408; Ciccia A, 2007, MOL CELL, V25, P331, DOI 10.1016/j.molcel.2007.01.003; Collins NB, 2009, BLOOD, V113, P2181, DOI 10.1182/blood-2008-05-154294; Crossan GP, 2011, NAT GENET, V43, P147, DOI 10.1038/ng.752; Cybulski KE, 2011, CELL CYCLE, V10, P1757, DOI 10.4161/cc.10.11.15818; D'Andrea AD, 2010, NEW ENGL J MED, V362, P1909, DOI 10.1056/NEJMra0809889; de Oca RM, 2005, BLOOD, V105, P1003, DOI 10.1182/blood-2003-11-3997; de Winter JP, 2009, MUTAT RES-FUND MOL M, V668, P11, DOI 10.1016/j.mrfmmm.2008.11.004; Du W, 2010, J BIOL CHEM, V285, P37436, DOI 10.1074/jbc.M110.113209; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Garcia-Higuera I, 2000, BLOOD, V96, P3224, DOI 10.1182/blood.V96.9.3224.h8003224_3224_3230; Garcia-Higuera I, 1999, MOL CELL BIOL, V19, P4866; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Gari K, 2008, P NATL ACAD SCI USA, V105, P16107, DOI 10.1073/pnas.0804777105; Gari K, 2008, MOL CELL, V29, P141, DOI 10.1016/j.molcel.2007.11.032; Joenje H, 2001, NAT REV GENET, V2, P446, DOI 10.1038/35076590; Kee Y, 2010, GENE DEV, V24, P1680, DOI 10.1101/gad.1955310; Kim JM, 2008, BLOOD, V111, P5215, DOI 10.1182/blood-2007-09-113092; Kim Y, 2011, NAT GENET, V43, P142, DOI 10.1038/ng.750; Kruyt FAE, 1997, BLOOD, V90, P3288, DOI 10.1182/blood.V90.9.3288; Kutler DI, 2003, BLOOD, V101, P1249, DOI 10.1182/blood-2002-07-2170; Li YL, 1997, J CLIN INVEST, V100, P2873, DOI 10.1172/JCI119836; Ling C, 2007, EMBO J, V26, P2104, DOI 10.1038/sj.emboj.7601666; Mao GG, 2007, NUCLEIC ACIDS RES, V35, P2759, DOI 10.1093/nar/gkm189; Medhurst AL, 2006, BLOOD, V108, P2072, DOI 10.1182/blood-2005-11-008151; Meetei AR, 2003, MOL CELL BIOL, V23, P3417, DOI 10.1128/MCB.23.10.3417-3426.2003; Meetei AR, 2005, NAT GENET, V37, P958, DOI 10.1038/ng1626; Mirchandani KD, 2008, DNA REPAIR, V7, P902, DOI 10.1016/j.dnarep.2008.03.001; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Mosedale G, 2005, NAT STRUCT MOL BIOL, V12, P763, DOI 10.1038/nsmb981; Naf D, 1998, MOL CELL BIOL, V18, P5952; Niedernhofer LJ, 2005, CELL, V123, P1191, DOI 10.1016/j.cell.2005.12.009; Oakley GG, 2010, FRONT BIOSCI-LANDMRK, V15, P883, DOI 10.2741/3652; Otsuki T, 2001, HUM MOL GENET, V10, P2651, DOI 10.1093/hmg/10.23.2651; PAPADOPOULO D, 1990, CANCER RES, V50, P3289; Park SJ, 2004, J BIOL CHEM, V279, P30053, DOI 10.1074/jbc.M403527200; Qiao FY, 2001, J BIOL CHEM, V276, P23391, DOI 10.1074/jbc.M101855200; Reuter T, 2000, BLOOD, V95, P719, DOI 10.1182/blood.V95.2.719; Rosado IV, 2009, NUCLEIC ACIDS RES, V37, P4360, DOI 10.1093/nar/gkp365; Singh TR, 2009, BLOOD, V114, P174, DOI 10.1182/blood-2009-02-207811; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Sobeck A, 2006, MOL CELL BIOL, V26, P425, DOI 10.1128/MCB.26.2.425-437.2006; Stoepker C, 2011, NAT GENET, V43, P138, DOI 10.1038/ng.751; Thompson LH, 2009, MUTAT RES-FUND MOL M, V668, P54, DOI 10.1016/j.mrfmmm.2009.02.003; Tremblay CS, 2008, BLOOD, V112, P2062, DOI 10.1182/blood-2008-04-152710; Tremblay CS, 2009, J BIOL CHEM, V284, P13384, DOI 10.1074/jbc.M807921200; Tulpule A, 2010, BLOOD, V115, P3453, DOI 10.1182/blood-2009-10-246694; Vaz F, 2010, NAT GENET, V42, P406, DOI 10.1038/ng.570; Wang LC, 2008, DNA REPAIR, V7, P1973, DOI 10.1016/j.dnarep.2008.08.005; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Yang YG, 2005, CARCINOGENESIS, V26, P1731, DOI 10.1093/carcin/bgi134; Yuan FH, 2010, FRONT BIOSCI-LANDMRK, V15, P1131, DOI 10.2741/3666; Yuan FH, 2009, J BIOL CHEM, V284, P24443, DOI 10.1074/jbc.M109.016006; Zhang XL, 2004, J BIOL CHEM, V279, P43910, DOI 10.1074/jbc.M403884200; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027	61	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4800	4807		10.1074/jbc.M111.315366	http://dx.doi.org/10.1074/jbc.M111.315366			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22194614	Green Published, hybrid			2022-12-25	WOS:000300608500041
J	Peh, GSL; Toh, KP; Wu, FY; Tan, DT; Mehta, JS				Peh, Gary S. L.; Toh, Kah-Peng; Wu, Fei-Yi; Tan, Donald T.; Mehta, Jodhbir S.			Cultivation of Human Corneal Endothelial Cells Isolated from Paired Donor Corneas	PLOS ONE			English	Article							PUMP FUNCTION; TRANSPLANTATION; MEMBRANE	Consistent expansion of human corneal endothelial cells (hCECs) is critical in the development of tissue engineered endothelial constructs. However, a wide range of complex culture media, developed from different basal media have been reported in the propagation of hCECs, some with more success than others. These results are further confounded by donor-to-donor variability. The aim of this study is to evaluate four culture media in the isolation and propagation of hCECs isolated from a series of paired donor corneas in order to negate donor variability. Isolated primary hCECs were cultured in four previously published medium coded in this study as: M1-DMEM; M2-OptiMEM-I; M3-DMEM/F12, & M4-Ham's F12/M199. Primary hCECs established in these conditions were expanded for two passages and analyzed for (1) their propensity to adhere and proliferate; (2) their expression of characteristic corneal endothelium markers: Na+K+/ATPase and ZO-1; and (3) their cellular morphology throughout the study. We found that hCECs isolated in all four media showed rapid attachment when cultured on FNC-coated dishes. However, hCECs established in the four media exhibited different proliferation profiles with striking morphological differences. Corneal endothelial cells cultured in M1 and M3 could not be propagated beyond the first and second passage respectively. The hCECs cultured in M2 and M4 were significantly more proliferative and expressed markers characteristics of human corneal endothelium: Na+K+/ATPase and ZO-1. However, the unique morphological characteristics of cultivated hCECs were not maintained in either M2 or M4 beyond the third passage. The proliferative capacity and morphology of hCECs are vastly affected by the four culture media. For the development of tissue engineered graft materials using cultured hCECs derived from the isolation methodology described in this study, we propose the use of proliferative media M2 or M4 up to the third passage, or before the cultured hCECs lose their unique cellular morphology.	[Peh, Gary S. L.; Toh, Kah-Peng; Wu, Fei-Yi; Tan, Donald T.; Mehta, Jodhbir S.] Singapore Eye Res Inst, Singapore, Singapore; [Tan, Donald T.; Mehta, Jodhbir S.] Singapore Natl Eye Ctr, Singapore, Singapore; [Mehta, Jodhbir S.] Natl Univ Singapore, Duke Med Sch Med, Singapore 117548, Singapore; [Tan, Donald T.; Mehta, Jodhbir S.] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore	National University of Singapore; Singapore National Eye Center; Singapore National Eye Center; National University of Singapore; National University of Singapore	Peh, GSL (corresponding author), Singapore Eye Res Inst, Singapore, Singapore.	jodmehta@gmail.com	Peh, Gary/A-8327-2010	Peh, Gary/0000-0002-5387-4209	National Research Foundation [R621/42/2008]	National Research Foundation	This study is supported by the National Research Foundation Translational and Clinical Research (TCR) Programme Grant (R621/42/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourne W M, 1998, Trans Am Ophthalmol Soc, V96, P229; Bourne WM, 1997, INVEST OPHTH VIS SCI, V38, P779; Edelhauser HF, 2000, CORNEA, V19, P263, DOI 10.1097/00003226-200005000-00002; Engelmann K, 2004, EXP EYE RES, V78, P573, DOI 10.1016/S0014-4835(03)00209-4; ENGELMANN K, 1989, IN VITRO CELL DEV B, V25, P1065; ENGELMANN K, 1995, CORNEA, V14, P62; Engler C, 2009, CORNEA, V28, P1050, DOI 10.1097/ICO.0b013e3181a165a3; GEROSKI DH, 1985, OPHTHALMOLOGY, V92, P759; Ishino Y, 2004, INVEST OPHTH VIS SCI, V45, P800, DOI 10.1167/iovs.03-0016; Joyce Nancy C, 2004, Cornea, V23, pS8, DOI 10.1097/01.ico.0000136666.63870.18; Joyce NC, 2003, PROG RETIN EYE RES, V22, P359, DOI 10.1016/S1350-9462(02)00065-4; KAUFMAN HE, 1977, INVEST OPHTH VIS SCI, V16, P265; Li W, 2007, INVEST OPHTH VIS SCI, V48, P614, DOI 10.1167/iovs.06-1126; Melles GRJ, 2006, CORNEA, V25, P987, DOI 10.1097/01.ico.0000248385.16896.34; ONEAL MR, 1986, INVEST OPHTH VIS SCI, V27, P457; Peh GSL, 2011, TRANSPLANTATION, V91, P811, DOI 10.1097/TP.0b013e3182111f01; RILEY MV, 1977, EXP EYE RES, V25, P483, DOI 10.1016/0014-4835(77)90177-4; Rose L, 2009, CAN J OPHTHALMOL, V44, P401, DOI 10.3129/i09-090; Ruberti JW, 2008, PROG RETIN EYE RES, V27, P549, DOI 10.1016/j.preteyeres.2008.08.001; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Senoo T, 2000, INVEST OPHTH VIS SCI, V41, P2930; STIEMKE MM, 1991, INVEST OPHTH VIS SCI, V32, P2757; Tan DTH, 2009, ANN ACAD MED SINGAP, V38, P332; Zhu C, 2004, INVEST OPHTH VIS SCI, V45, P1743, DOI 10.1167/iovs.03-0814	24	114	117	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2011	6	12							e28310	10.1371/journal.pone.0028310	http://dx.doi.org/10.1371/journal.pone.0028310			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JD	22194824	Green Published, Green Submitted, gold			2022-12-25	WOS:000298664400006
J	Caeymaex, L; Speranza, M; Vasilescu, C; Danan, C; Bourrat, MM; Garel, M; Jousselme, C				Caeymaex, Laurence; Speranza, Mario; Vasilescu, Caroline; Danan, Claude; Bourrat, Marie-Michele; Garel, Micheline; Jousselme, Catherine			Living with a Crucial Decision: A Qualitative Study of Parental Narratives Three Years after the Loss of Their Newborn in the NICU	PLOS ONE			English	Article							NEONATAL INTENSIVE-CARE; OF-LIFE DECISIONS; ETHICAL DILEMMAS; END; DEATH; EXPERIENCES; ENCOUNTER; AUTONOMY; PATIENT; INFANTS	Background: The importance of involving parents in the end-of-life decision-making-process (EOL DMP) for their child in the neonatal intensive care unit (NICU) is recognised by ethical guidelines in numerous countries. However, studies exploring parents' opinions on the type of involvement report conflicting results. This study sought to explore parents' experience of the EOL DMP for their child in the NICU. Methods: The study used a retrospective longitudinal design with a qualitative analysis of parental experience 3 years after the death of their child in four NICUs in France. 53 face-to-face interviews and 80 telephone interviews were conducted with 164 individuals. Semi-structured interviews were conducted to explore how parents perceived their role in the decision process, what they valued about physicians' attitudes in this situation and whether their long-term emotional well being varied according to their perceived role in the EOL DMP. Findings: Qualitative analysis identified four types of perceived role in the DMP: shared, medical, informed parental decision, and no decision. Shared DM was the most appreciated by parents. Medical DM was experienced as positive only when it was associated with communication. Informed parental DM was associated with feelings of anxiousness and abandonment. The physicians' attitudes that were perceived as helpful in the long term were explicit sharing of responsibility, clear expression of staff preferences, and respectful care and language toward the child. Interpretation: Parents find it valuable to express their opinion in the EOL DMP of their child. Nonetheless, they do need continuous emotional support and an explicit share of the responsibility for the decision. As involvement preferences and associated feelings can vary, parents should be able to decide what role they want to play. However, our study suggests that fully autonomous decisions should be misadvised in these types of tragic choices.	[Caeymaex, Laurence; Danan, Claude] Studies Sci & Tech Paris S Univ, Ctr Hosp Intercommunal Creteil, Newborn Intens Care Unit, Dept Res Eth EA Etud Sci & Tech 1610, Creteil, France; [Speranza, Mario] Ctr Hosp Versailles, Serv Pedopsychiat, Le Chesnay, France; [Speranza, Mario] Univ Paris 11, INSERM, U669, Paris, France; [Speranza, Mario] Univ Paris 05, UMR S0669, Paris, France; [Vasilescu, Caroline] Ctr Hosp Univ Antoine Beclere, AP HP, Clamart, France; [Bourrat, Marie-Michele] Serv Hosp Univ Limoges, Ctr Mere & Enfant, Limoges, France; [Garel, Micheline] INSERM, UMR S953, Epidemiol Reseach Unit Perinatal Hlth & Womens &, Villejuif, France; [Jousselme, Catherine] Univ Paris 11, INSERM, U669, Ctr Hosp Univ Gentilly,Fdn Vallee, Paris, France; [Jousselme, Catherine] Univ Paris 05, UMR S0669, Gentilly, France	Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Centre Hospitalier de Versailles; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; CHU Limoges; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite	Caeymaex, L (corresponding author), Studies Sci & Tech Paris S Univ, Ctr Hosp Intercommunal Creteil, Newborn Intens Care Unit, Dept Res Eth EA Etud Sci & Tech 1610, Creteil, France.	laurencecmx@yahoo.fr	caeymaex, laurence/ABF-1423-2020	caeymaex, laurence/0000-0003-3822-5136	national Programme Hospitalier de Recherche Clinique [AOM0605]; Fondation de France	national Programme Hospitalier de Recherche Clinique; Fondation de France(Fondation de France)	This work was funded by a grant from a national Programme Hospitalier de Recherche Clinique (2006, N<SUP>o</SUP> AOM0605) and a grant from the Fondation de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlettaz R, 2005, ACTA PAEDIATR, V94, P1626, DOI 10.1080/08035250510036543; Barton L, 2005, PEDIATRICS, V116, P1487, DOI 10.1542/peds.2005-0392; BENFIELD DG, 1978, PEDIATRICS, V62, P171; Botti S, 2009, J CONSUM RES, V36, P337, DOI 10.1086/598969; Brinchmann BS, 2002, NURS ETHICS, V9, P388, DOI 10.1191/0969733002ne523oa; BRITTEN N, 1995, BRIT MED J, V311, P251, DOI 10.1136/bmj.311.6999.251; CAMPBELL AGM, 1988, ANN NY ACAD SCI, V530, P92, DOI 10.1111/j.1749-6632.1988.tb35300.x; CAPLAN G, 1990, COMMUNITY MENT HLT J, V26, P27, DOI 10.1007/BF00752675; Carnevale FA, 2007, PEDIATR CRIT CARE ME, V8, P337, DOI 10.1097/01.PCC.0000269399.47060.6D; Charles C, 1997, SOC SCI MED, V44, P681, DOI 10.1016/S0277-9536(96)00221-3; Cuttini M, 2000, LANCET, V355, P2112, DOI 10.1016/S0140-6736(00)02378-3; Dageville C, 2011, NEONATOLOGY, V100, P206, DOI 10.1159/000324119; Dehan M, 2001, ARCH PEDIATRIE, V8, P407; Einarsdottir J, 2009, MED ANTHROPOL Q, V23, P34, DOI 10.1111/j.1548-1387.2009.01036.x; Gafni A, 1998, SOC SCI MED, V47, P347, DOI 10.1016/S0277-9536(98)00091-4; Garel M, 2011, J MED ETHICS, V37, P240, DOI 10.1136/jme.2010.038356; HARRISON H, 1993, PEDIATRICS, V92, P643; Hester DM, 2007, THEOR MED BIOETH, V28, P357, DOI 10.1007/s11017-007-9048-7; Hodges BD, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a879; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kirschbaum MS, 1996, ADV NURS SCI, V19, P51, DOI 10.1097/00012272-199609000-00007; McHaffie HE, 2001, J MED ETHICS, V27, P104, DOI 10.1136/jme.27.2.104; MCHAFFIE HE, 1996, LIFE DEATH DECISIONS; Mead N, 2000, SOC SCI MED, V51, P1087, DOI 10.1016/S0277-9536(00)00098-8; NORWEGIAN CR, 1999, CONS C 24 25 NOV 199; Nuffield Council on Bioethics, 2006, CRIT CAR DEC FET NEO; Orfali K, 2004, SOC SCI MED, V58, P2009, DOI 10.1016/S0277-9536(03)00406-4; Orfali K, 2004, THEOR MED BIOETH, V25, P329, DOI 10.1007/s11017-004-3135-9; Partridge JC, 2005, PEDIATRICS, V116, pE263, DOI 10.1542/peds.2004-2274; Pector Elizabeth A, 2004, J Perinatol, V24, P4, DOI 10.1038/sj.jp.7211001; RENE RA, 1993, DECIDING WHO LIVES F; *ROYAL COLL PAED C, 2004, WITHDR WITHH LIF SAV; Stark AR, 2007, PEDIATRICS, V119, P401, DOI 10.1542/peds.2006-3180; Strauss A., BASICS QUALITATIVE R; van der Heide A, 1998, PEDIATRICS, V101, P413, DOI 10.1542/peds.101.3.413; Verhagen AAE, 2009, ARCH PEDIAT ADOL MED, V163, P895, DOI 10.1001/archpediatrics.2009.166; Verloove-Vanhorick SP, 2006, BJOG-INT J OBSTET GY, V113, P13, DOI 10.1111/j.1471-0528.2006.01119.x; Wilkinson DJ, 2006, ARCH DIS CHILD-FETAL, V91, pF268, DOI 10.1136/adc.2005.074971	38	54	54	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28633	10.1371/journal.pone.0028633	http://dx.doi.org/10.1371/journal.pone.0028633			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	866GS	22194873	Green Submitted, Green Published, gold			2022-12-25	WOS:000298369100069
J	Brown, LE; Doole, R; Malfait, N				Brown, Liana E.; Doole, Robert; Malfait, Nicole			The Role of Motor Learning in Spatial Adaptation near a Tool	PLOS ONE			English	Article							PERIPERSONAL SPACE; HAND; ARM; ATTENTION; DYNAMICS; REPRESENTATION; COMPENSATION; FACILITATION; EXTINCTION; PERCEPTION	Some visual-tactile (bimodal) cells have visual receptive fields (vRFs) that overlap and extend moderately beyond the skin of the hand. Neurophysiological evidence suggests, however, that a vRF will grow to encompass a hand-held tool following active tool use but not after passive holding. Why does active tool use, and not passive holding, lead to spatial adaptation near a tool? We asked whether spatial adaptation could be the result of motor or visual experience with the tool, and we distinguished between these alternatives by isolating motor from visual experience with the tool. Participants learned to use a novel, weighted tool. The active training group received both motor and visual experience with the tool, the passive training group received visual experience with the tool, but no motor experience, and finally, a no-training control group received neither visual nor motor experience using the tool. After training, we used a cueing paradigm to measure how quickly participants detected targets, varying whether the tool was placed near or far from the target display. Only the active training group detected targets more quickly when the tool was placed near, rather than far, from the target display. This effect of tool location was not present for either the passive-training or control groups. These results suggest that motor learning influences how visual space around the tool is represented.	[Brown, Liana E.; Doole, Robert] Trent Univ, Dept Psychol, Peterborough, ON K9J 7B8, Canada; [Malfait, Nicole] CNRS, INT, Marseille, France	Trent University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Brown, LE (corresponding author), Trent Univ, Dept Psychol, Peterborough, ON K9J 7B8, Canada.	lianabrown@trentu.ca			Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	The study was funded by Natural Sciences and Engineering Research Council of Canada (NSERC; http://www.nserc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams RA, 2008, COGNITION, V107, P1035, DOI 10.1016/j.cognition.2007.09.006; Bagesteiro LB, 2003, J NEUROPHYSIOL, V90, P1503, DOI 10.1152/jn.00189.2003; Bernstein N.A., 1967, COORDINATION REGULAT; Berti A, 2000, J COGNITIVE NEUROSCI, V12, P415, DOI 10.1162/089892900562237; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brown LE, 2008, NEUROPSYCHOLOGIA, V46, P786, DOI 10.1016/j.neuropsychologia.2007.10.006; Brown LE, 2009, NEUROPSYCHOLOGIA, V47, P1621, DOI 10.1016/j.neuropsychologia.2008.11.021; Cardinali L, 2009, BRAIN TOPOGR, V21, P252, DOI 10.1007/s10548-009-0092-7; Cardinali L, 2009, CURR BIOL, V19, pR478, DOI 10.1016/j.cub.2009.05.009; Carello C, 2004, CURR DIR PSYCHOL SCI, V13, P25, DOI 10.1111/j.0963-7214.2004.01301007.x; Carello C, 1998, PERCEPT PSYCHOPHYS, V60, P89, DOI 10.3758/BF03211920; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; d'Avella A, 2005, P NATL ACAD SCI USA, V102, P3076, DOI 10.1073/pnas.0500199102; d'Avella A, 2006, J NEUROSCI, V26, P7791, DOI 10.1523/JNEUROSCI.0830-06.2006; Debicki DB, 2005, EXP BRAIN RES, V163, P252, DOI 10.1007/s00221-005-2229-6; Debicki DB, 2004, J NEUROPHYSIOL, V92, P754, DOI 10.1152/jn.00119.2004; di Pellegrino G, 2000, CURR BIOL, V10, P1475, DOI 10.1016/S0960-9822(00)00809-5; Farne A, 2005, COGN NEUROPSYCHOL, V22, P408, DOI 10.1080/02643290442000112; Farne A, 2005, NEUROPSYCHOLOGIA, V43, P238, DOI 10.1016/j.neuropsychologia.2004.11.010; Farne A, 2007, CORTEX, V43, P436, DOI 10.1016/S0010-9452(08)70468-4; Flanagan JR, 2000, NAT NEUROSCI, V3, P737, DOI 10.1038/76701; Flanagan JR, 2003, CURR BIOL, V13, P146, DOI 10.1016/S0960-9822(03)00007-1; Fogassi L, 1996, J NEUROPHYSIOL, V76, P141, DOI 10.1152/jn.1996.76.1.141; GIELEN SCAM, 1983, PERCEPT PSYCHOPHYS, V34, P161, DOI 10.3758/BF03211343; GOZLI DG, PERCEPTION IN PRESS; GRAZIANO MSA, 1994, SCIENCE, V266, P1054, DOI 10.1126/science.7973661; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; Graziano MSA, 2000, EXP BRAIN RES, V135, P259, DOI 10.1007/s002210000518; Gribble PL, 1999, J NEUROPHYSIOL, V82, P2310, DOI 10.1152/jn.1999.82.5.2310; Haruno M, 2001, NEURAL COMPUT, V13, P2201, DOI 10.1162/089976601750541778; Holmes NP, 2007, EXP BRAIN RES, V183, P465, DOI 10.1007/s00221-007-1060-7; Holmes NP, 2007, CORTEX, V43, P469, DOI 10.1016/S0010-9452(08)70471-4; Holmes NP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003502; Iriki A, 1996, NEUROREPORT, V7, P2325; IWAMURA Y, 1993, EXP BRAIN RES, V92, P360; Kao KLC, 2009, NEUROPSYCHOLOGIA, V47, P2454, DOI 10.1016/j.neuropsychologia.2009.04.016; Ladavas E, 1998, J COGNITIVE NEUROSCI, V10, P581, DOI 10.1162/089892998562988; MACMILLAN NA, 2002, DETECTION THEORY USE; Malfait N, 2005, J NEUROPHYSIOL, V93, P3327, DOI 10.1152/jn.00883.2004; Maravita A, 2004, TRENDS COGN SCI, V8, P79, DOI 10.1016/j.tics.2003.12.008; Maravita A, 2002, NEUROCASE, V8, P411, DOI 10.1093/neucas/8.6.411; Maravita A, 2001, NEUROPSYCHOLOGIA, V39, P580, DOI 10.1016/S0028-3932(00)00150-0; Morris SB, 2002, PSYCHOL METHODS, V7, P105, DOI 10.1037//1082-989X.7.1.105; Obayashi S, 2000, NEUROREPORT, V11, P3499, DOI 10.1097/00001756-200011090-00020; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; RAAB DH, 1962, T NEW YORK ACAD SCI, V24, P574, DOI 10.1111/j.2164-0947.1962.tb01433.x; Reed CL, 2010, ATTEN PERCEPT PSYCHO, V72, P236, DOI 10.3758/APP.72.1.236; Reed CL, 2006, J EXP PSYCHOL HUMAN, V32, P166, DOI 10.1037/0096-1523.32.1.166; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P147, DOI 10.1016/0166-4328(81)90053-X; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P125, DOI 10.1016/0166-4328(81)90052-8; Sainburg RL, 1999, J NEUROPHYSIOL, V81, P1045, DOI 10.1152/jn.1999.81.3.1045; SAINBURG RL, 1995, J NEUROPHYSIOL, V73, P820, DOI 10.1152/jn.1995.73.2.820; Schendel K, 2004, J COGNITIVE NEUROSCI, V16, P935, DOI 10.1162/0898929041502698; SIMON JR, 1967, J APPL PSYCHOL, V51, P300, DOI 10.1037/h0020586; Sternberg S, 1969, ACTA PSYCHOL, V30, P276, DOI 10.1016/0001-6918(69)90055-9; VANSTRIEN JW, 2002, NED TIJDSCHR PSYCHOL, V47, P88; VONHELMHOLTZ H, 1962, HDB PHYSL OPTICS; VONHOLST E, 1950, BEHAV PHYSL ANIMALS, V1; Wang JS, 2004, J NEUROPHYSIOL, V92, P349, DOI 10.1152/jn.00960.2003; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5	61	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28999	10.1371/journal.pone.0028999	http://dx.doi.org/10.1371/journal.pone.0028999			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	866GA	22174944	Green Published, Green Submitted, gold			2022-12-25	WOS:000298367300039
J	Feng, R; Wu, YH; Jang, GH; Ordovas, JM; Arnett, D				Feng, Rui; Wu, Yinghua; Jang, Gun Ho; Ordovas, Jose M.; Arnett, Donna			A Powerful Test of Parent-of-Origin Effects for Quantitative Traits Using Haplotypes	PLOS ONE			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; LINKAGE ANALYSIS; VARIANCE-COMPONENTS; BIPOLAR DISORDER; SIB-PAIR; GENE; LOCI; ASSOCIATION; FAMILIES; MODELS	Imprinting is an epigenetic phenomenon where the same alleles have unequal transcriptions and thus contribute differently to a trait depending on their parent of origin. This mechanism has been found to affect a variety of human disorders. Although various methods for testing parent-of-origin effects have been proposed in linkage analysis settings, only a few are available for association analysis and they are usually restricted to small families and particular study designs. In this study, we develop a powerful maximum likelihood test to evaluate the parent-of-origin effects of SNPs on quantitative phenotypes in general family studies. Our method incorporates haplotype distribution to take advantage of inter-marker LD information in genome-wide association studies (GWAS). Our method also accommodates missing genotypes that often occur in genetic studies. Our simulation studies with various minor allele frequencies, LD structures, family sizes, and missing schemes have uniformly shown that using the new method significantly improves the power of detecting imprinted genes compared with the method using the SNP at the testing locus only. Our simulations suggest that the most efficient strategy to investigate parent-of-origin effects is to recruit one parent and as many offspring as possible under practical constraints. As a demonstration, we applied our method to a dataset from the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) to test the parent-of-origin effects of the SNPs within the PPARGC1A, MTP and FABP2 genes on diabetes-related phenotypes, and found that several SNPs in the MTP gene show parent-of-origin effects on insulin and glucose levels.	[Feng, Rui; Wu, Yinghua; Jang, Gun Ho] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Ordovas, Jose M.] Tufts Univ, Nutr & Genom Lab, JM USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Ordovas, Jose M.] Ctr Nacl Invest Cardiovasc, Dept Cardiovasc Epidemiol & Populat Genet, Madrid, Spain; [Arnett, Donna] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA	University of Pennsylvania; Tufts University; United States Department of Agriculture (USDA); Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of Alabama System; University of Alabama Birmingham	Feng, R (corresponding author), Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA.	ruifeng@upenn.edu	Ordovas, Jose/B-8727-2013	Ordovas, Jose/0000-0002-7581-5680	National Institutes of Health [R01GM088566]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088566] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Institutes of Health grant R01GM088566 (www.nigms.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Amos CI, 2001, HUM HERED, V51, P133, DOI 10.1159/000053334; BAIN SC, 1994, DIABETES, V43, P1462, DOI 10.2337/diabetes.43.12.1462; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chen JB, 2004, HUM HERED, V58, P18, DOI 10.1159/000081453; Clerget-Darpoux F, 2007, HUM HERED, V64, P91, DOI 10.1159/000101960; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; Cordell HJ, 2004, GENET EPIDEMIOL, V26, P167, DOI 10.1002/gepi.10307; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; Falls JG, 1999, AM J PATHOL, V154, P635, DOI 10.1016/S0002-9440(10)65309-6; Gao GM, 2004, GENETICS, V167, P2055, DOI 10.1534/genetics.103.021055; Genovese G, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-58; Gorlova OY, 2007, HUM GENET, V122, P159, DOI 10.1007/s00439-007-0387-2; Hanson RL, 2001, AM J HUM GENET, V68, P951, DOI 10.1086/319508; Karason A, 2003, AM J HUM GENET, V72, P125, DOI 10.1086/345646; Knapp M, 2004, GENET EPIDEMIOL, V26, P273, DOI 10.1002/gepi.10320; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lai CQ, 2007, ARTERIOSCL THROM VAS, V27, P1417, DOI 10.1161/ATVBAHA.107.140103; Li MY, 2006, GENETICS, V173, P2317, DOI 10.1534/genetics.105.054650; LIN MCM, 1995, J LIPID RES, V36, P1073; Liu NJ, 2009, COMMUN STAT-THEOR M, V38, P3445, DOI 10.1080/03610920802696588; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; McInnis MG, 2003, BIOL PSYCHIAT, V54, P1265, DOI 10.1016/j.biopsych.2003.08.001; Morral N, 2007, J LIPID RES, V48, P1499, DOI 10.1194/jlr.M700090-JLR200; Niu TH, 2004, GENET EPIDEMIOL, V27, P334, DOI 10.1002/gepi.20024; O'Connell JR, 2000, GENET EPIDEMIOL, V19, pS64, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI10>3.0.CO;2-G; Paterson AD, 1999, HUM HERED, V49, P197, DOI 10.1159/000022875; Pratt SC, 2000, AM J HUM GENET, V66, P1153, DOI 10.1086/302830; Pugh EW, 1997, GENET EPIDEMIOL, V14, P867, DOI 10.1002/(SICI)1098-2272(1997)14:6<867::AID-GEPI51>3.0.CO;2-K; Qian DJ, 2002, AM J HUM GENET, V70, P1434, DOI 10.1086/340610; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Shete S, 2002, AM J HUM GENET, V70, P751, DOI 10.1086/338931; Shete S, 2003, AM J HUM GENET, V73, P933, DOI 10.1086/378592; Shugart YY, 1999, EUR J HUM GENET, V7, P103, DOI 10.1038/sj.ejhg.5200280; STINE OC, 1995, AM J HUM GENET, V57, P1384; Strauch K, 2000, AM J HUM GENET, V66, P1945, DOI 10.1086/302911; Vincent Q, 2006, BIOMETRICS, V62, P1071, DOI 10.1111/j.1541-0420.2006.00610.x; Weinberg CR, 1999, AM J HUM GENET, V65, P229, DOI 10.1086/302466; WETTERAU JR, 1992, SCIENCE, V258, P999; WETTERAU JR, 1986, BIOCHIM BIOPHYS ACTA, V875, P610, DOI 10.1016/0005-2760(86)90084-6; Whittaker JC, 2003, AM J HUM GENET, V72, P1035, DOI 10.1086/374382; Williams JT, 1997, GENET EPIDEMIOL, V14, P1065, DOI 10.1002/(SICI)1098-2272(1997)14:6<1065::AID-GEPI84>3.0.CO;2-F; Williams JT, 1999, GENET EPIDEMIOL, V16, P113, DOI 10.1002/(SICI)1098-2272(1999)16:2<113::AID-GEPI1>3.0.CO;2-6; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002	45	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28909	10.1371/journal.pone.0028909	http://dx.doi.org/10.1371/journal.pone.0028909			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174922	Green Published, gold, Green Submitted			2022-12-25	WOS:000298367300030
J	Zhang, X; Yaseen, ZS; Galynker, II; Hirsch, J; Winston, A				Zhang, Xian; Yaseen, Zimri S.; Galynker, Igor I.; Hirsch, Joy; Winston, Arnold			Can Depression be Diagnosed by Response to Mother's Face? A Personalized Attachment-Based Paradigm for Diagnostic fMRI	PLOS ONE			English	Article							MAJOR DEPRESSION; NEUROBIOLOGICAL MARKERS; INDIVIDUAL-DIFFERENCES; DISORDER; BRAIN; EMOTION; CORTEX; ACTIVATION; CHILDHOOD; CONFLICT	Objective measurement of depression remains elusive. Depression has been associated with insecure attachment, and both have been associated with changes in brain reactivity in response to viewing standard emotional and neutral faces. In this study, we developed a method to calculate predicted scores for the Beck Depression Inventory II (BDI-II) using personalized stimuli: fMRI imaging of subjects viewing pictures of their own mothers. Methods: 28 female subjects ages 18-30 (14 healthy controls and 14 unipolar depressed diagnosed by MINI psychiatric interview) were scored on the Beck Depression Inventory II (BDI-II) and the Adult Attachment Interview (AAI) coherence of mind scale of global attachment security. Subjects viewed pictures of Mother (M), Friend (F) and Stranger (S), during functional magnetic resonance imaging (fMRI). Using a principal component regression method (PCR), a predicted Beck Depression Inventory II (BDI-II) score was obtained from activity patterns in the paracingulate gyrus (Brodmann area 32) and compared to clinical diagnosis and the measured BDI-II score. The same procedure was performed for AAI coherence of mind scores. Results: Activity patterns in BA-32 identified depressed subjects. The categorical agreement between the derived BDI-II score (using the standard clinical cut-score of 14 on the BDI-II) and depression diagnosis by MINI psychiatric interview was 89%, with sensitivity 85.7% and specificity 92.8%. Predicted and measured BDI-II scores had a correlation of 0.55. Prediction of attachment security was not statistically significant. Conclusions: Brain activity in response to viewing one's mother may be diagnostic of depression. Functional magnetic resonance imaging using personalized paradigms has the potential to provide objective assessments, even when behavioral measures are not informative. Further, fMRI based diagnostic algorithms may enhance our understanding of the neural mechanisms of depression by identifying distinctive neural features of the illness.	[Zhang, Xian; Hirsch, Joy] Columbia Univ, Dept Psychol, Hatch Res Ctr, Dept Radiol,Neurol Inst, New York, NY 10027 USA; [Winston, Arnold] Beth Israel Deaconess Med Ctr, Dept Psychiat & Behav Sci, Albert Einstein Sch Med, New York, NY 10003 USA	Columbia University; Harvard University; Beth Israel Deaconess Medical Center; Yeshiva University	Zhang, X (corresponding author), Columbia Univ, Dept Psychol, Hatch Res Ctr, Dept Radiol,Neurol Inst, New York, NY 10027 USA.	zsyaseen@gmail.com	Galynker, Igor/AAC-9629-2021	Hirsch, Joy/0000-0002-1418-6489; Yaseen, Zimri/0000-0003-4103-2511	Hope for Depression Research Foundation; Family Center for Bipolar Disorder; Zirinsky Mood Disorders Center at Beth Israel Medical Center, New York, NY; Empire Clinical Research Investigator Program (ECRIP)	Hope for Depression Research Foundation; Family Center for Bipolar Disorder; Zirinsky Mood Disorders Center at Beth Israel Medical Center, New York, NY; Empire Clinical Research Investigator Program (ECRIP)	This work was supported by a grant from the Hope for Depression Research Foundation and received additional funding from the Family Center for Bipolar Disorder and the Zirinsky Mood Disorders Center at Beth Israel Medical Center, New York, NY, as well as support from the Empire Clinical Research Investigator Program (ECRIP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anda RF, 2006, EUR ARCH PSY CLIN N, V256, P174, DOI 10.1007/s00406-005-0624-4; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Blair KS, 2007, NEUROIMAGE, V35, P430, DOI 10.1016/j.neuroimage.2006.11.048; Bradley B, 2011, DEV PSYCHOPATHOL, V23, P439, DOI 10.1017/S0954579411000162; Brennan KA, 1998, J PERS, V66, P835, DOI 10.1111/1467-6494.00034; Brody AL, 2001, ARCH GEN PSYCHIAT, V58, P631, DOI 10.1001/archpsyc.58.7.631; Chen AC, 2010, NEUROIMAGE, V51, P930, DOI 10.1016/j.neuroimage.2010.02.044; Craddock RC, 2009, MAGN RESON MED, V62, P1619, DOI 10.1002/mrm.22159; Desmet C, 2011, J NEUROSCI, V31, P1366, DOI 10.1523/JNEUROSCI.5371-10.2011; Ende G, 2006, PROG BRAIN RES, V156, P481, DOI 10.1016/S0079-6123(06)56027-3; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Freed PJ, 2007, AM J PSYCHIAT, V164, P28, DOI 10.1176/appi.ajp.164.1.28; Fu CHY, 2008, BIOL PSYCHIAT, V63, P656, DOI 10.1016/j.biopsych.2007.08.020; Fuchs T, 2010, J COMP PSYCHOL, V124, P166, DOI 10.1037/a0018704; George C., 1996, ADULT ATTACHME UNPUB; Giessing C, 2007, J COGNITIVE NEUROSCI, V19, P658, DOI 10.1162/jocn.2007.19.4.658; Hahn T, 2011, ARCH GEN PSYCHIAT, V68, P361, DOI 10.1001/archgenpsychiatry.2010.178; Herrington JD, 2010, PSYCHOPHYSIOLOGY, V47, P442, DOI 10.1111/j.1469-8986.2009.00958.x; Hsieh WW, 2007, NEURAL NETWORKS, V20, P434, DOI 10.1016/j.neunet.2007.04.018; Jackson PL, 2006, NEUROPSYCHOLOGIA, V44, P752, DOI 10.1016/j.neuropsychologia.2005.07.015; Kessler H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015712; Levitan RD, 2009, J CLIN PSYCHIAT, V70, P879, DOI 10.4088/JCP.07m03306; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; Mikulincer M, 2002, J PERS SOC PSYCHOL, V83, P881, DOI 10.1037//0022-3514.83.4.881; Mitchell DGV, 2007, NEUROIMAGE, V34, P1299, DOI 10.1016/j.neuroimage.2006.10.012; Monk CS, 2006, AM J PSYCHIAT, V163, P1091, DOI 10.1176/appi.ajp.163.6.1091; Monkul ES, 2007, MOL PSYCHIATR, V12, P360, DOI 10.1038/sj.mp.4001919; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Pizzagalli D, 2001, AM J PSYCHIAT, V158, P405, DOI 10.1176/appi.ajp.158.3.405; Pochon JB, 2008, J NEUROSCI, V28, P3468, DOI 10.1523/JNEUROSCI.4195-07.2008; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stensland MD, 2008, J CLIN PSYCHIAT, V69, P749, DOI 10.4088/JCP.v69n0508; Strathearn L, 2009, NEUROPSYCHOPHARMACOL, V34, P2655, DOI 10.1038/npp.2009.103; Swaab DF, 2000, PROG BRAIN RES, V126, P369; van Eijndhoven P, 2011, NEUROIMAGE, V54, P1677, DOI 10.1016/j.neuroimage.2010.08.040; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Yoshimura S, 2010, J AFFECT DISORDERS, V122, P76, DOI 10.1016/j.jad.2009.06.017; Zhou Y, 2010, J AFFECT DISORDERS, V121, P220, DOI 10.1016/j.jad.2009.05.029	42	5	7	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e27253	10.1371/journal.pone.0027253	http://dx.doi.org/10.1371/journal.pone.0027253			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22180777	Green Published, Green Submitted, gold			2022-12-25	WOS:000298367300004
J	He, P; Zhang, J; Liu, NY; Zhang, YN; Yang, K; Dong, SL				He, Peng; Zhang, Jin; Liu, Nai-Yong; Zhang, Ya-Nan; Yang, Ke; Dong, Shuang-Lin			Distinct Expression Profiles and Different Functions of Odorant Binding Proteins in Nilaparvata lugens Stal	PLOS ONE			English	Article							RICE BROWN PLANTHOPPER; PHEROMONE-SENSITIVE NEURONS; CHEMOSENSORY PROTEINS; ELECTROANTENNOGRAM RESPONSES; DROSOPHILA-MELANOGASTER; RNA INTERFERENCE; BOMBYX-MORI; PLANT; VOLATILES; DELPHACIDAE	Background: Odorant binding proteins (OBPs) play important roles in insect olfaction. The brown planthopper (BPH), Nilaparvata lugens Stal (Delphacidae, Auchenorrhyncha, Hemiptera) is one of the most important rice pests. Its monophagy (only feeding on rice), wing form (long and short wing) variation, and annual long distance migration (seeking for rice plants of high nutrition) imply that the olfaction would play a central role in BPH behavior. However, the olfaction related proteins have not been characterized in this insect. Methodology/Principal Findings: Full length cDNA of three OBPs were obtained and distinct expression profiles were revealed regarding to tissue, developmental stage, wing form and gender for the first time for the species. The results provide important clues in functional differentiation of these genes. Binding assays with 41 compounds demonstrated that NlugOBP3 had markedly higher binding ability and wider binding spectrum than the other two OBPs. Terpenes and Ketones displayed higher binding while Alkanes showed no binding to the three OBPs. Focused on NlugOBP3, RNA interference experiments showed that NlugOBP3 not only involved in nymph olfaction on rice seedlings, but also had non-olfactory functions, as it was closely related to nymph survival. Conclusions: NlugOBP3 plays important roles in both olfaction and survival of BPH. It may serve as a potential target for developing behavioral disruptant and/or lethal agent in N. lugens.	[He, Peng; Zhang, Jin; Liu, Nai-Yong; Zhang, Ya-Nan; Yang, Ke; Dong, Shuang-Lin] Nanjing Agr Univ, Educ Minist, Key Lab Integrated Management Crop Dis & Pests, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	He, P (corresponding author), Nanjing Agr Univ, Educ Minist, Key Lab Integrated Management Crop Dis & Pests, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China.	sldong@njau.edu.cn	He, Peng/ABF-9928-2020; He, Peng/H-1098-2013; Liu, Naiyong/C-1862-2012	He, Peng/0000-0003-2934-0044; Zhang, Jin/0000-0002-0077-0748	National 973 Project [2010CB126200]; National Natural Science Foundation of China [31071978]; Priority Academic Program Development of Jiangsu Higher Education Institutions, China	National 973 Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions, China	This work was in part supported by the National 973 Project (2010CB126200), National Natural Science Foundation (31071978) of China, and the Priority Academic Program Development of Jiangsu Higher Education Institutions, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biessmann H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009471; Blomquist Gary J., 2003, P3, DOI 10.1016/B978-012107151-6/50003-7; Bohbot J, 2005, INSECT BIOCHEM MOLEC, V35, P961, DOI 10.1016/j.ibmb.2005.03.010; Chen J, 2010, INSECT MOL BIOL, V19, P777, DOI 10.1111/j.1365-2583.2010.01038.x; CHENIER JVR, 1989, J CHEM ECOL, V15, P1729, DOI 10.1007/BF01012261; Cu S.H., 2011, ARCH INSECT BIOCH PH; Dani FR, 2010, J PROTEOME RES, V9, P1822, DOI 10.1021/pr900969k; Dickens JC, 1998, J EXP BIOL, V201, P33; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Forstner Maike, 2009, Int J Biol Sci, V5, P745; Fu Q, 2001, APPL ENTOMOL ZOOL, V36, P111, DOI 10.1303/aez.2001.111; Gu SH, 2011, INSECT BIOCHEM MOLEC, V41, P254, DOI 10.1016/j.ibmb.2011.01.002; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; HE XL, 2010, J CHEM ECOLOGY; HERNANDEZ HP, 1989, PHYTOCHEMISTRY, V28, P2959, DOI 10.1016/0031-9422(89)80261-4; KHAN ZR, 1986, J ECON ENTOMOL, V79, P928, DOI 10.1093/jee/79.4.928; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Leal WS, 1999, FEBS LETT, V464, P85, DOI 10.1016/S0014-5793(99)01683-X; Liu SH, 2010, INSECT BIOCHEM MOLEC, V40, P666, DOI 10.1016/j.ibmb.2010.06.007; Liu SH, 2008, J INSECT PHYSIOL, V54, P1495, DOI 10.1016/j.jinsphys.2008.08.010; Lou YG, 2003, BIOCONTROL, V48, P73, DOI 10.1023/A:1021291427256; Matsuo T, 2007, PLOS BIOL, V5, P985, DOI 10.1371/journal.pbio.0050118; Noda H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-117; OBATA T, 1981, JPN J APPL ENTOMOL Z, V25, P47, DOI 10.1303/jjaez.25.47; OBATA T, 1983, APPL ENTOMOL ZOOL, V18, P161, DOI 10.1303/aez.18.161; PELLETIER J, 2010, J CHEM ECOLOGY; Pelosi P, 1998, ANN NY ACAD SCI, V855, P281, DOI 10.1111/j.1749-6632.1998.tb10584.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qiao H.-L, 2010, CELLULAR MOL LIFE SC, P1; Qiao HL, 2009, INSECT BIOCHEM MOLEC, V39, P414, DOI 10.1016/j.ibmb.2009.03.004; SOGAWA K, 1982, ANNU REV ENTOMOL, V27, P49, DOI 10.1146/annurev.en.27.010182.000405; Swarup S, 2011, GENES BRAIN BEHAV, V10, P648, DOI 10.1111/j.1601-183X.2011.00704.x; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; Vandermoten S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023608; VANSAMBEEK JW, 1980, Z ANGEW ENTOMOL, V89, P479; VISSER JH, 1986, ANNU REV ENTOMOL, V31, P121, DOI 10.1146/annurev.en.31.010186.001005; Visser JH, 1996, ENTOMOL EXP APPL, V80, P35, DOI 10.1007/BF00194719; VISSER JH, 1995, J APPL ENTOMOL, V119, P539, DOI 10.1111/j.1439-0418.1995.tb01332.x; Vogt RG, 1999, CHEM SENSES, V24, P481, DOI 10.1093/chemse/24.5.481; VOGT RG, 1985, P NATL ACAD SCI USA, V82, P8827, DOI 10.1073/pnas.82.24.8827; Vogt RG, 2002, J EXP BIOL, V205, P719; VOGT RG, 2005, COMPREHENSIVE INSECT, V3, P753, DOI DOI 10.1016/B0-44-451924-6/00047-8; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wojtasek H, 1999, J BIOL CHEM, V274, P30950, DOI 10.1074/jbc.274.43.30950; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Xu YL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-632; YAMAMOTO R. T., 1962, NATURE, V196, P908, DOI 10.1038/196908b0; Yan Feng, 2010, Chinese Bulletin of Entomology, V47, P96; Youn YN, 2002, J ECON ENTOMOL, V95, P269, DOI 10.1603/0022-0493-95.2.269; Zhai Bao-Ping, 2005, Kunchong Zhishi, V42, P217; Zhang SA, 2009, CHEM SENSES, V34, P503, DOI 10.1093/chemse/bjp027; ZHANG ZQ, 1983, ACTA ENTOMOL SINICA, V26, P260; Zhou JJ, 2010, INSECT MOL BIOL, V19, P113, DOI 10.1111/j.1365-2583.2009.00919.x; Zhou Yao-zhen, 2009, Nanjing Nongye Daxue Xuebao, V32, P58	55	108	115	5	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28921	10.1371/journal.pone.0028921	http://dx.doi.org/10.1371/journal.pone.0028921			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174925	Green Submitted, gold, Green Published			2022-12-25	WOS:000298365700083
J	Roose, JL; Frankel, LK; Bricker, TM				Roose, Johnna L.; Frankel, Laurie K.; Bricker, Terry M.			Developmental Defects in Mutants of the PsbP Domain Protein 5 in Arabidopsis thaliana	PLOS ONE			English	Article							DEHYDROGENASE-LIKE COMPLEX; CYCLIC ELECTRON FLOW; PHOTOSYSTEM-II; CHLOROPHYLL FLUORESCENCE; SUPERCOMPLEX FORMATION; CHLOROPLAST LUMEN; STRIGOLACTONE; PHOTOSYNTHESIS; TRANSFORMATION; STABILIZATION	Plants contain an extensive family of PsbP-related proteins termed PsbP-like (PPL) and PsbP domain (PPD) proteins, which are localized to the thylakoid lumen. The founding member of this family, PsbP, is an established component of the Photosystem II (PS II) enzyme, and the PPL proteins have also been functionally linked to other photosynthetic processes. However, the functions of the remaining seven PPD proteins are unknown. To elucidate the function of the PPD5 protein (At5g11450) in Arabidopsis, we have characterized a mutant T-DNA insertion line (SALK_061118) as well as several RNAi lines designed to suppress the expression of this gene. The functions of the photosynthetic electron transfer reactions are largely unaltered in the ppd5 mutants, except for a modest though significant decrease in NADPH dehydrogenase (NDH) activity. Interestingly, these mutants show striking plant developmental and morphological defects. Relative to the wildtype Col-0 plants, the ppd5 mutants exhibit both increased lateral root branching and defects associated with axillary bud formation. These defects include the formation of additional rosettes originating from axils at the base of the plant as well as aerial rosettes formed at the axils of the first few nodes of the shoot. The root-branching phenotype is chemically complemented by treatment with the synthetic strigolactone, GR24. We propose that the developmental defects observed in the ppd5 mutants are related to a deficiency in strigolactone biosynthesis.	[Roose, Johnna L.; Frankel, Laurie K.; Bricker, Terry M.] Louisiana State Univ, Biochem & Mol Biol Sect, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Roose, JL (corresponding author), Louisiana State Univ, Biochem & Mol Biol Sect, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jroose@lsu.edu			Department of Energy, Office of Basic Energy Sciences, Chemical Sciences, Geosciences and Biosciences Division [DE-FG02-98ER20310]; USDA National Institute of Food and Agriculture [2008-35318-04605]	Department of Energy, Office of Basic Energy Sciences, Chemical Sciences, Geosciences and Biosciences Division(United States Department of Energy (DOE)); USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This research was supported by a grant to TMB and LKF from the Department of Energy, Office of Basic Energy Sciences, Chemical Sciences, Geosciences and Biosciences Division, Photosynthetic Systems Program (#DE-FG02-98ER20310) and a postdoctoral fellowship to JLR from the USDA National Institute of Food and Agriculture Grant # 2008-35318-04605. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Antal T, 2008, PHOTOSYNTH RES, V96, P217, DOI 10.1007/s11120-008-9301-6; Arite T, 2009, PLANT CELL PHYSIOL, V50, P1416, DOI 10.1093/pcp/pcp091; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Booker J, 2005, DEV CELL, V8, P443, DOI 10.1016/j.devcel.2005.01.009; Booker J, 2004, CURR BIOL, V14, P1232, DOI 10.1016/j.cub.2004.06.061; Bricker TM, 2008, J BIOL CHEM, V283, P29022, DOI 10.1074/jbc.M805122200; Bricker TM, 2005, ADV PHOTO RESPIRAT, V22, P95; BRICKER TM, EXTRINSIC P IN PRESS, V2; Cazzonelli CI, 2010, TRENDS PLANT SCI, V15, P266, DOI 10.1016/j.tplants.2010.02.003; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DEVITRY C, 1989, J CELL BIOL, V109, P991, DOI 10.1083/jcb.109.3.991; Dreuw A, 2005, BIOCHEM SOC T, V33, P858, DOI 10.1042/BST0330858; Dun EA, 2009, TRENDS PLANT SCI, V14, P364, DOI 10.1016/j.tplants.2009.04.003; Ferguson BJ, 2009, PLANT PHYSIOL, V149, P1929, DOI 10.1104/pp.109.135475; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Hashimoto M, 2003, PLANT J, V36, P541, DOI 10.1046/j.1365-313X.2003.01900.x; HOLSTERS M, 1978, MOL GEN GENET, V163, P181, DOI 10.1007/BF00267408; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Ifuku K, 2005, PLANT PHYSIOL, V139, P1175, DOI 10.1104/pp.105.068643; Ifuku K, 2010, J INTEGR PLANT BIOL, V52, P723, DOI 10.1111/j.1744-7909.2010.00976.x; Ishihara S, 2007, PLANT PHYSIOL, V145, P668, DOI 10.1104/pp.107.105866; Kapulnik Y, 2011, PLANTA, V233, P209, DOI 10.1007/s00425-010-1310-y; Kieselbach T, 2003, PHOTOSYNTH RES, V78, P249, DOI 10.1023/B:PRES.0000006913.86689.f1; Koltai H, 2010, J EXP BOT, V61, P1739, DOI 10.1093/jxb/erq041; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Lin H, 2009, PLANT CELL, V21, P1512, DOI 10.1105/tpc.109.065987; Matusova R, 2005, PLANT PHYSIOL, V139, P920, DOI 10.1104/pp.105.061382; Mayzlish-Gati E, 2010, J EXP BOT, V61, P3129, DOI 10.1093/jxb/erq138; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nashilevitz S, 2010, PLANT CELL, V22, P1977, DOI 10.1105/tpc.110.074716; Nedbal L, 1999, J PHOTOCH PHOTOBIO B, V48, P154, DOI 10.1016/S1011-1344(99)00032-9; NIEVELSTEIN V, 1995, EUR J BIOCHEM, V233, P864, DOI 10.1111/j.1432-1033.1995.864_3.x; Peltier JB, 2004, J BIOL CHEM, V279, P49367, DOI 10.1074/jbc.M406763200; Peltier JB, 2002, PLANT CELL, V14, P211, DOI 10.1105/tpc.010304; Peng LW, 2011, PLANT PHYSIOL, V155, P1629, DOI 10.1104/pp.110.171264; Peng LW, 2009, PLANT CELL, V21, P3623, DOI 10.1105/tpc.109.068791; Roose JL, 2007, PHOTOSYNTH RES, V92, P369, DOI 10.1007/s11120-006-9117-1; Rova EM, 1996, J BIOL CHEM, V271, P28918, DOI 10.1074/jbc.271.46.28918; Rumeau D, 2005, PLANT CELL, V17, P219, DOI 10.1105/tpc.104.028282; Rumeau D, 2007, PLANT CELL ENVIRON, V30, P1041, DOI 10.1111/j.1365-3040.2007.01675.x; Sato N, 2010, MOL PHYLOGENET EVOL, V56, P176, DOI 10.1016/j.ympev.2009.11.021; Schubert M, 2002, J BIOL CHEM, V277, P8354, DOI 10.1074/jbc.M108575200; Shikanai T, 1998, P NATL ACAD SCI USA, V95, P9705, DOI 10.1073/pnas.95.16.9705; Shikanai T, 2007, ANNU REV PLANT BIOL, V58, P199, DOI 10.1146/annurev.arplant.58.091406.110525; Stirbet A, 2011, J PHOTOCH PHOTOBIO B, V104, P236, DOI 10.1016/j.jphotobiol.2010.12.010; Suorsa M, 2009, MOL PLANT, V2, P1127, DOI 10.1093/mp/ssp052; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; Vogel JT, 2010, PLANT J, V61, P300, DOI 10.1111/j.1365-313X.2009.04056.x; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Yamamoto H, 2011, PLANT CELL, V23, P1480, DOI 10.1105/tpc.110.080291; YAMORI W, 2011, PLANT J; Yi XP, 2007, J BIOL CHEM, V282, P24833, DOI 10.1074/jbc.M705011200; Yi XP, 2009, FEBS LETT, V583, P2142, DOI 10.1016/j.febslet.2009.05.048; Yu QJ, 2011, J BIOL CHEM, V286, P8666, DOI 10.1074/jbc.M110.208017	57	32	34	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28624	10.1371/journal.pone.0028624	http://dx.doi.org/10.1371/journal.pone.0028624			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174848	gold, Green Submitted, Green Published			2022-12-25	WOS:000298365700051
J	Taylor, NG; McAllister, MK; Lawson, GL; Carruthers, T; Block, BA				Taylor, Nathan G.; McAllister, Murdoch K.; Lawson, Gareth L.; Carruthers, Tom; Block, Barbara A.			Atlantic Bluefin Tuna: A Novel Multistock Spatial Model for Assessing Population Biomass	PLOS ONE			English	Article							THUNNUS-THYNNUS; MEDITERRANEAN SEA; DIVING BEHAVIOR; THERMAL BIOLOGY; ARCHIVAL TAGS; AGE; FISHERIES; MOVEMENTS	Atlantic bluefin tuna (Thunnus thynnus) is considered to be overfished, but the status of its populations has been debated, partly because of uncertainties regarding the effects of mixing on fishing grounds. A better understanding of spatial structure and mixing may help fisheries managers to successfully rebuild populations to sustainable levels while maximizing catches. We formulate a new seasonally and spatially explicit fisheries model that is fitted to conventional and electronic tag data, historic catch-at-age reconstructions, and otolith microchemistry stock-composition data to improve the capacity to assess past, current, and future population sizes of Atlantic bluefin tuna. We apply the model to estimate spatial and temporal mixing of the eastern (Mediterranean) and western (Gulf of Mexico) populations, and to reconstruct abundances from 1950 to 2008. We show that western and eastern populations have been reduced to 17% and 33%, respectively, of 1950 spawning stock biomass levels. Overfishing to below the biomass that produces maximum sustainable yield occurred in the 1960s and the late 1990s for western and eastern populations, respectively. The model predicts that mixing depends on season, ontogeny, and location, and is highest in the western Atlantic. Assuming that future catches are zero, western and eastern populations are predicted to recover to levels at maximum sustainable yield by 2025 and 2015, respectively. However, the western population will not recover with catches of 1750 and 12,900 tonnes (the "rebuilding quotas") in the western and eastern Atlantic, respectively, with or without closures in the Gulf of Mexico. If future catches are double the rebuilding quotas, then rebuilding of both populations will be compromised. If fishing were to continue in the eastern Atlantic at the unregulated levels of 2007, both stocks would continue to decline. Since populations mix on North Atlantic foraging grounds, successful rebuilding policies will benefit from trans-Atlantic cooperation.	[Taylor, Nathan G.; McAllister, Murdoch K.; Carruthers, Tom] Univ British Columbia, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada; [Lawson, Gareth L.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Block, Barbara A.] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA	University of British Columbia; Woods Hole Oceanographic Institution; Stanford University	Taylor, NG (corresponding author), Univ British Columbia, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada.	nathan.taylor@dfo-mpo.gc.ca		Taylor, Nathan/0000-0002-7110-0995	TAG A Giant Foundation; Monterey Bay Aquarium Foundation; Lenfest Ocean Program, Washington, DC, USA; Canadian Fisheries and Oceans International Governance Strategies Fund; National Oceanic and Atmospheric Administration (NOAA) of the United States; Lenfest Ocean Program	TAG A Giant Foundation; Monterey Bay Aquarium Foundation; Lenfest Ocean Program, Washington, DC, USA; Canadian Fisheries and Oceans International Governance Strategies Fund; National Oceanic and Atmospheric Administration (NOAA) of the United States; Lenfest Ocean Program	This work was supported by grants from the TAG A Giant Foundation, the Monterey Bay Aquarium Foundation, the Lenfest Ocean Program, Washington, DC, USA, the Canadian Fisheries and Oceans International Governance Strategies Fund and the National Oceanic and Atmospheric Administration (NOAA) of the United States. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Drs. Robert Ahrens, Hiroyuki Kurota, Andre Boustany, Shelley Clarke, and Daniel Pauly for reviewing early drafts of the manuscript. We thank Shana Miller for considerable help on all portions of the study. Mr. James Ganong and Mike Castleton helped extract and parse out electronic tag data. Funding for this project was provided by the Tag-A-Giant Foundation, the Lenfest Ocean Program, the Canadian Fisheries and Oceans International Governance Strategies Fund, the Monterey Bay Aquarium Foundation and the U.S. National Oceanic and Atmospheric Administration. Early drafts were greatly improved by the feedback of two anonymous reviewers.	Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; Boustany AM, 2008, MAR BIOL, V156, P13, DOI 10.1007/s00227-008-1058-0; Corriero A, 2005, J APPL ICHTHYOL, V21, P483, DOI 10.1111/j.1439-0426.2005.00700.x; Cort J. L., 1991, COL VOL SCI PAP ICCA, V35, P213; De Valpine P, 2002, ECOL MONOGR, V72, P57, DOI 10.1890/0012-9615(2002)072[0057:FPMIPN]2.0.CO;2; DIAZ GA, 2006, COL VOL SCI PAP ICCA, V60, P160; Dickhut RM, 2009, ENVIRON SCI TECHNOL, V43, P8522, DOI 10.1021/es901810e; Fromentin JM, 2009, FISH FISH, V10, P197, DOI 10.1111/j.1467-2979.2008.00311.x; FROMENTIN JM, 2002, COLLECTIVE VOLUME SC, V54, P353; GAVARIS S, 1988, 882930 CAN ATL FISH; Gelman A., 2004, BAYESIAN DATA ANAL; GIBBS RH, 1967, US FISH WLD S FISH B, V66, P65; GOODYEAR CP, 1977, C ASS EFF POW PLANT, P184; *ICCAT, 2006, REC ICCAT EST MULT R; ICCAT, 2010, REP 2010 ATL BLUEF T; ICCAT (International Commission for the Conservation of Atlantic Tunas), 2009, EXT 2009 SCRS M CONS; ICCAT (International Commission for the Conservation of Atlantic Tunas), 2008, REP 2008 ATL BLUEF T; Kurota H, 2009, CAN J FISH AQUAT SCI, V66, P321, DOI 10.1139/F08-197; Maigret J., 1986, POISSONS MER MAURITA; Martell SJD, 2008, CAN J FISH AQUAT SCI, V65, P1586, DOI 10.1139/F08-055; Mather F.J., 1995, NOAA TECHNICAL MEMOR, V370, P1; Neilson JD, 2008, CAN J FISH AQUAT SCI, V65, P1523, DOI 10.1139/F08-127; PORCH CE, 2001, COLLECTIVE VOLUME SC, V52, P1022; Punt A.E., 1995, COLLECTIVE VOLUME SC, V44, P166; Riccioni G, 2010, P NATL ACAD SCI USA, V107, P2102, DOI 10.1073/pnas.0908281107; Rooker JR, 2008, SCIENCE, V322, P742, DOI 10.1126/science.1161473; Senina I, 2008, PROG OCEANOGR, V78, P319, DOI 10.1016/j.pocean.2008.06.003; Sibert JR, 2006, CAN J FISH AQUAT SCI, V63, P2154, DOI 10.1139/F06-114; Teo SLH, 2007, MAR BIOL, V151, P1, DOI 10.1007/s00227-006-0447-5; Teo SLH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010756; Walli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006151; WALTERS C, 1994, CAN J FISH AQUAT SCI, V51, P713, DOI 10.1139/f94-071; 2001, COL VOL SCI PAP ICCA, V54, P261	34	87	87	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e27693	10.1371/journal.pone.0027693	http://dx.doi.org/10.1371/journal.pone.0027693			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174745	Green Published, gold, Green Submitted			2022-12-25	WOS:000298365700007
J	Bi, M; Ittner, A; Ke, YD; Gotz, J; Ittner, LM				Bi, Mian; Ittner, Arne; Ke, Yazi D.; Goetz, Juergen; Ittner, Lars M.			Tau-Targeted Immunization Impedes Progression of Neurofibrillary Histopathology in Aged P301L Tau Transgenic Mice	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; MOUSE MODEL; PHOSPHORYLATED TAU; PATHOLOGY; IMMUNOTHERAPY; DEFICITS; NEURODEGENERATION; MUTATIONS; TAUOPATHY; TANGLES	In Alzheimer's disease (AD) brains, the microtubule-associated protein tau and amyloid-beta (A beta) deposit as intracellular neurofibrillary tangles (NFTs) and extracellular plaques, respectively. Tau deposits are furthermore found in a significant number of frontotemporal dementia cases. These diseases are characterized by progressive neurodegeneration, the loss of intellectual capabilities and behavioral changes. Unfortunately, the currently available therapies are limited to symptomatic relief. While active immunization against A beta has shown efficacy in both various AD mouse models and patients with AD, immunization against pathogenic tau has only recently been shown to prevent pathology in young tau transgenic mice. However, if translated to humans, diagnosis and treatment would be routinely done when symptoms are overt, meaning that the histopathological changes have already progressed. Therefore, we used active immunization to target pathogenic tau in 4, 8, and 18 months-old P301L tau transgenic pR5 mice that have an onset of NFT pathology at 6 months of age. In all age groups, NFT pathology was significantly reduced in treated compared to control pR5 mice. Similarly, phosphorylation of tau at pathological sites was reduced. In addition, increased astrocytosis was found in the oldest treated group. Taken together, our data suggests that tau-targeted immunization slows the progression of NFT pathology in mice, with practical implications for human patients.	[Bi, Mian; Ittner, Arne; Ke, Yazi D.; Ittner, Lars M.] Univ Sydney, Lab Translat Neurodegenerat, Brain & Mind Res Inst, Camperdown, NSW, Australia; [Ittner, Arne; Goetz, Juergen] Univ Sydney, Alzheimers & Parkinsons Dis Lab, Brain & Mind Res Inst, Camperdown, NSW, Australia	University of Sydney; University of Sydney	Bi, M (corresponding author), Univ Sydney, Lab Translat Neurodegenerat, Brain & Mind Res Inst, Camperdown, NSW, Australia.	lars.ittner@sydney.edu.au	Ittner, Arne/ABD-3072-2021; Ke, Yazi/ABC-3052-2020; Götz, Jürgen/C-2448-2014	Ittner, Arne/0000-0001-5244-6897; Ke, Yazi/0000-0002-1423-0451; Götz, Jürgen/0000-0001-8501-7896; Ittner, Lars/0000-0001-6738-3825; Bi, Mian/0000-0002-4383-3606	National Health & Medical Research Council (NHMRC) of Australia; Australian Research Council (ARC)	National Health & Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council)	This work has been funded by the National Health & Medical Research Council (NHMRC) of Australia and the Australian Research Council (ARC). L. M. I. is an NHMRC Senior Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen B, 2002, J NEUROSCI, V22, P9340; Asuni AA, 2007, J NEUROSCI, V27, P9115, DOI 10.1523/JNEUROSCI.2361-07.2007; Boimel M, 2010, EXP NEUROL, V224, P472, DOI 10.1016/j.expneurol.2010.05.010; Boutajangout A, 2010, J NEUROSCI, V30, P16559, DOI 10.1523/JNEUROSCI.4363-10.2010; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Brunden KR, 2009, NAT REV DRUG DISCOV, V8, P783, DOI 10.1038/nrd2959; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Desai BS, 2007, CELL TRANSPLANT, V16, P285, DOI 10.3727/000000007783464731; Deters N, 2008, EUR J NEUROSCI, V28, P137, DOI 10.1111/j.1460-9568.2008.06318.x; Farrall AJ, 2009, NEUROBIOL AGING, V30, P337, DOI 10.1016/j.neurobiolaging.2007.07.015; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Gotz J, 2001, J BIOL CHEM, V276, P529, DOI 10.1074/jbc.M006531200; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ittner LM, 2008, P NATL ACAD SCI USA, V105, P15997, DOI 10.1073/pnas.0808084105; Ittner LM, 2011, NAT REV NEUROSCI, V12, P67, DOI 10.1038/nrn2967; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Ittner LM, 2009, J BIOL CHEM, V284, P20909, DOI 10.1074/jbc.M109.014472; Liscic RM, 2008, EUR J NEUROL, V15, P772, DOI 10.1111/j.1468-1331.2008.02195.x; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; Morgan D, 2011, J INTERN MED, V269, P54, DOI 10.1111/j.1365-2796.2010.02315.x; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Rosenmann H, 2006, ARCH NEUROL-CHICAGO, V63, P1459, DOI 10.1001/archneur.63.10.1459; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630; Spillantini MG, 1998, AM J PATHOL, V153, P1359, DOI 10.1016/S0002-9440(10)65721-5; van Eersel J, 2010, P NATL ACAD SCI USA, V107, P13888, DOI 10.1073/pnas.1009038107	28	135	144	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e26860	10.1371/journal.pone.0026860	http://dx.doi.org/10.1371/journal.pone.0026860			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174735	Green Published, Green Submitted, gold			2022-12-25	WOS:000298163600001
J	Miao, B; Skidan, I; Yang, J; You, Z; Fu, X; Famulok, M; Schaffhausen, B; Torchilin, V; Yuan, J; Degterev, A				Miao, B.; Skidan, I.; Yang, J.; You, Z.; Fu, X.; Famulok, M.; Schaffhausen, B.; Torchilin, V.; Yuan, J.; Degterev, A.			Inhibition of cell migration by PITENINs: the role of ARF6	ONCOGENE			English	Article						ARF6 guanine nucleotide exchange factor; ARNO/GRP1 membrane translocation; lamellipodia suppression; anti-angiogenesis; anti-metastasis	GUANINE-NUCLEOTIDE-EXCHANGE; RIBOSYLATION FACTOR 6; PLECKSTRIN-HOMOLOGY DOMAINS; PLASMA-MEMBRANE; MAMMALIAN-CELLS; PATHWAY; PROTEINS; BINDING; SEC7; ARNO	We have reported previously the development of small-molecule phosphatidylinositol-3,4,5-trisphosphate (PIP3) antagonists (PITs) that block pleckstrin homology (PH) domain interaction, including activation of Akt, and show anti-tumor potential. Here we show that the same molecules inhibit growth factor-induced actin remodeling, lamellipodia formation and, ultimately, cell migration and invasion, consistent with an important role of PIP3 in these processes. In vivo, a PIT-1 analog displays significant inhibition on tumor angiogenesis and metastasis. ADP ribosylation factor 6 (ARF6) was recently identified as an important mediator of cytoskeleton and cell motility, which is regulated by PIP3-dependent membrane translocation of the guanine nucleotide exchange factors (GEFs), such as ADP-ribosylation factor nucleotide binding site opener (ARNO) and general receptor for 3-phosphoinositides (GRP1). We demonstrate that PITs inhibit PIP3/ARNO or GRP1 PH domain binding and membrane localization, resulting in the inhibition of ARF6 activation. Importantly, we show that expression of the constitutively active mutant of ARF6 attenuates inhibition of lamellipodia formation and cell migration by PITs, confirming that inhibition of ARF6 contributes to inhibition of these processes by PITs. Overall, our studies demonstrate the feasibility of developing specific small-molecule targeting PIP3 binding by PH domains as potential anticancer agents that can simultaneously interfere with cancer development at multiple points. Oncogene (2012) 31, 4317-4332; doi:10.1038/onc.2011.593; published online 19 December 2011	[Miao, B.; You, Z.; Schaffhausen, B.; Degterev, A.] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA; [Skidan, I.; Torchilin, V.] Northeastern Univ, Dept Pharmaceut Sci, Ctr Pharmaceut Biotechnol & Nanomed, Boston, MA 02115 USA; [Skidan, I.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Neurosci Ctr, Charlestown, MA USA; [Fu, X.] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Famulok, M.] Univ Bonn, Program Unit Chem Biol & Med Chem, LIMES Inst, Bonn, Germany; [Yuan, J.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA	Tufts University; Northeastern University; Harvard University; Massachusetts General Hospital; Tufts University; United States Department of Agriculture (USDA); University of Bonn; Harvard University; Harvard Medical School	Degterev, A (corresponding author), Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA.	alexei.degterev@tufts.edu	fu, xueyan/C-1126-2012		Smith Family Award for Excellence in Biomedical Research; National Institute on Aging Mentored Research Scientist Career Development Award; US Army [DAMD17-02-1-0403]; National Cancer Institute [RO1 CA34722/PO1-50661]; National Institute on Aging [R37 AG012859]; NATIONAL CANCER INSTITUTE [R01CA034722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG012859] Funding Source: NIH RePORTER	Smith Family Award for Excellence in Biomedical Research; National Institute on Aging Mentored Research Scientist Career Development Award; US Army(United States Department of DefenseUnited States Army); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Dr Joan Brugge (Harvard Medical School), Dr Tamas Balla (National Institutes of Health) and Dr Philippe Chavrier (Institut Curie) for the gifts of plasmids and cells. We thank Dr Jeff Peterson (Fox Chase Cancer Center, Philadelphia, PA, USA) for providing valuable comments. This work was supported by Smith Family Award for Excellence in Biomedical Research and National Institute on Aging Mentored Research Scientist Career Development Award (to AD), an Innovator Award from US Army (DAMD17-02-1-0403), National Cancer Institute (RO1 CA34722/PO1-50661) (to BSS) and the National Institute on Aging (R37 AG012859) (to JY).	Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Balana ME, 2005, J CELL SCI, V118, P2201, DOI 10.1242/jcs.02351; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Caumon AS, 2000, J BIOL CHEM, V275, P15637, DOI 10.1074/jbc.M908347199; Cavenagh MM, 1996, J BIOL CHEM, V271, P21767, DOI 10.1074/jbc.271.36.21767; Chardin P, 1996, NATURE, V384, P481, DOI 10.1038/384481a0; Cox R, 2004, MOL BIOL CELL, V15, P1487, DOI 10.1091/mbc.E03-06-0443; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Esteban PF, 2006, J CELL BIOL, V173, P291, DOI 10.1083/jcb.200512013; Frank S, 1998, J BIOL CHEM, V273, P23, DOI 10.1074/jbc.273.1.23; Frank SR, 1998, MOL BIOL CELL, V9, P3133, DOI 10.1091/mbc.9.11.3133; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Hashimoto S, 2004, P NATL ACAD SCI USA, V101, P6647, DOI 10.1073/pnas.0401753101; Hornstein I, 2004, CELL SIGNAL, V16, P1, DOI 10.1016/S0898-6568(03)00110-4; Hu B, 2009, CANCER RES, V69, P794, DOI 10.1158/0008-5472.CAN-08-2110; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Klarlund JK, 1998, J BIOL CHEM, V273, P1859, DOI 10.1074/jbc.273.4.1859; Klarlund JK, 1997, SCIENCE, V275, P1927, DOI 10.1126/science.275.5308.1927; Langille SE, 1999, J BIOL CHEM, V274, P27099, DOI 10.1074/jbc.274.38.27099; Macia E, 2004, J CELL SCI, V117, P2389, DOI 10.1242/jcs.01090; Macia E, 2008, J BIOL CHEM, V283, P19836, DOI 10.1074/jbc.M800781200; Miao BC, 2010, P NATL ACAD SCI USA, V107, P20126, DOI 10.1073/pnas.1004522107; Muralidharan-Chari V, 2009, CANCER RES, V69, P2201, DOI 10.1158/0008-5472.CAN-08-1301; Nie ZZ, 2003, CURR OPIN CELL BIOL, V15, P396, DOI 10.1016/S0955-0674(03)00071-1; Park WS, 2008, MOL CELL, V30, P381, DOI 10.1016/j.molcel.2008.04.008; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Simpson KJ, 2004, CANCER RES, V64, P8694, DOI 10.1158/0008-5472.CAN-04-2247; Tague SE, 2004, P NATL ACAD SCI USA, V101, P9671, DOI 10.1073/pnas.0403531101; Varnai P, 2005, J CELL SCI, V118, P4879, DOI 10.1242/jcs.02606; Venkateswarlu K, 1998, CURR BIOL, V8, P463, DOI 10.1016/S0960-9822(98)70181-2; Viaud J, 2007, P NATL ACAD SCI USA, V104, P10370, DOI 10.1073/pnas.0700773104; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Yang CZ, 1998, J BIOL CHEM, V273, P4006, DOI 10.1074/jbc.273.7.4006	38	18	19	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2012	31	39					4317	4332		10.1038/onc.2011.593	http://dx.doi.org/10.1038/onc.2011.593			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	016LP	22179837	Green Accepted, Green Submitted			2022-12-25	WOS:000309520200006
J	Deng, W; Bukiya, AN; Rodriguez-Menchaca, AA; Zhang, Z; Baumgarten, CM; Logothetis, DE; Levitan, I; Rosenhouse-Dantsker, A				Deng, Wu; Bukiya, Anna N.; Rodriguez-Menchaca, Aldo A.; Zhang, Zhe; Baumgarten, Clive M.; Logothetis, Diomedes E.; Levitan, Irena; Rosenhouse-Dantsker, Avia			Hypercholesterolemia Induces Up-regulation of K-ACh Cardiac Currents via a Mechanism Independent of Phosphatidylinositol 4,5-Bisphosphate and G beta gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATRIAL-FIBRILLATION; POTASSIUM CHANNEL; CHOLESTEROL SENSITIVITY; KIR CHANNELS; I-KACH; PROTEIN; ACTIVATION; RECEPTOR; BINDING; IDENTIFICATION	Hypercholesterolemia is a well-known risk factor for cardiovascular disease. In the heart, activation of K-ACh mediates the vagal (parasympathetic) negative chronotropic effect on heart rate. Yet, the effect of cholesterol on K-ACh is unknown. Here we show that cholesterol plays a critical role in modulating K-ACh currents (I-K,I-ACh) in atrial cardiomyocytes. Specifically, cholesterol enrichment of rabbit atrial cardiomyocytes led to enhanced channel activity while cholesterol depletion suppressed I-K,I-ACh. Moreover, a high-cholesterol diet resulted in up to 3-fold increase in I-K,I-ACh in rodents. In accordance, elevated currents were observed in Xenopus oocytes expressing the Kir3.1/Kir3.4 heteromer that underlies I-K,I-ACh. Furthermore, our data suggest that cholesterol affects I-K,I-ACh via a mechanism which is independent of both PI(4,5)P-2 and G(beta gamma). Interestingly, the effect of cholesterol on I-K,I-ACh is opposite to its effect on I-K1 in atrial myocytes. The latter are suppressed by cholesterol enrichment and by high-cholesterol diet, and facilitated following cholesterol depletion. These findings establish that cholesterol plays a critical role in modulating I-K,I-ACh in atrial cardiomyocytes via a mechanism independent of the channel's major modulators.	[Levitan, Irena; Rosenhouse-Dantsker, Avia] Univ Illinois, Dept Med, Pulm Sect, Chicago, IL 60612 USA; [Deng, Wu; Rodriguez-Menchaca, Aldo A.; Zhang, Zhe; Baumgarten, Clive M.; Logothetis, Diomedes E.] Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA 23298 USA; [Bukiya, Anna N.] Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Virginia Commonwealth University; University of Tennessee System; University of Tennessee Health Science Center	Rosenhouse-Dantsker, A (corresponding author), Univ Illinois, Dept Med, Pulm Sect, Chicago, IL 60612 USA.	dantsker@uic.edu	Zhang, Zhe/C-2685-2011; Rodríguez-Menchaca, Aldo A./AAD-4603-2019; Bukiya, Anna/N-5361-2019	Rodríguez-Menchaca, Aldo A./0000-0001-7501-8836; 	National Institutes of Health [HL-073965, HL-083298, HL-059949, 5T32HL094290]; American Heart Association [11SDG5190025]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083298, R01HL059949, R01HL073965] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-073965, HL-083298 (to I. L.), and HL-059949 (to D. E. L.) and Scientist Development Grant 11SDG5190025 from the American Heart Association (to A. R.-D.).; Supported by National Institutes of Health Training Grant 5T32HL094290.	Adam O, 2008, CIRCULATION, V118, P1285, DOI 10.1161/CIRCULATIONAHA.107.760892; Bettahi H, 2002, J BIOL CHEM, V277, P48282, DOI 10.1074/jbc.M209599200; Blednov YA, 2001, J PHARMACOL EXP THER, V298, P521; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BREITWIESER GE, 1985, NATURE, V317, P538, DOI 10.1038/317538a0; Carman CV, 2000, J BIOL CHEM, V275, P10443, DOI 10.1074/jbc.275.14.10443; Cha TJ, 2006, CIRCULATION, V113, P1730, DOI 10.1161/CIRCULATIONAHA.105.561738; Christian AE, 1997, J LIPID RES, V38, P2264; Dobrev D, 2005, CIRCULATION, V112, P3697, DOI 10.1161/circulationaha.105.575332; Ehrlich JR, 2004, J PHYSIOL-LONDON, V557, P583, DOI 10.1113/jphysiol.2004.061119; Epshtein Y, 2009, P NATL ACAD SCI USA, V106, P8055, DOI 10.1073/pnas.0809847106; Fang Y, 2006, CIRC RES, V98, P1064, DOI 10.1161/01.RES.0000218776.87842.43; Fauchier L, 2008, J AM COLL CARDIOL, V51, P828, DOI 10.1016/j.jacc.2007.09.063; Finley M, 2004, J PHYSIOL-LONDON, V555, P643, DOI 10.1113/jphysiol.2003.056101; GURDON JB, 1971, NATURE, V233, P177, DOI 10.1038/233177a0; He C, 1999, J BIOL CHEM, V274, P12517, DOI 10.1074/jbc.274.18.12517; He C, 2002, J BIOL CHEM, V277, P6088, DOI 10.1074/jbc.M104851200; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Hughes M, 2008, THROMB HAEMOSTASIS, V99, P295, DOI 10.1160/TH07-08-0508; JONES OT, 1988, BIOCHEMISTRY-US, V27, P2364, DOI 10.1021/bi00407a018; Kim D, 1997, AM J PHYSIOL-HEART C, V272, pH195, DOI 10.1152/ajpheart.1997.272.1.H195; Kitamura H, 2000, J PHARMACOL EXP THER, V293, P196; Kobayashi T, 2006, CURR PHARM DESIGN, V12, P4513, DOI 10.2174/138161206779010468; Kovoor P, 2001, J AM COLL CARDIOL, V37, P2136, DOI 10.1016/S0735-1097(01)01304-3; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; KURACHI Y, 1986, AM J PHYSIOL, V251, pH681, DOI 10.1152/ajpheart.1986.251.3.H681; Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Marius P, 2008, BIOPHYS J, V94, P1689, DOI 10.1529/biophysj.107.117507; Menke J, 2010, AM J CARDIOL, V105, P502, DOI 10.1016/j.amjcard.2009.10.018; Murata Y, 2007, J PHYSIOL-LONDON, V583, P875, DOI 10.1113/jphysiol.2007.134775; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; PFAFFINGER PJ, 1985, NATURE, V317, P536, DOI 10.1038/317536a0; Rankin SE, 1997, BIOPHYS J, V73, P2446, DOI 10.1016/S0006-3495(97)78273-0; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Rishal I, 2005, J BIOL CHEM, V280, P16685, DOI 10.1074/jbc.M412196200; Romanenko VG, 2004, BIOPHYS J, V87, P3850, DOI 10.1529/biophysj.104.043273; Romanenko VG, 2002, BIOPHYS J, V83, P3211, DOI 10.1016/S0006-3495(02)75323-X; Rosenhouse-Dantsker A, 2008, NAT CHEM BIOL, V4, P624, DOI 10.1038/nchembio.112; Rosenhouse-Dantsker A, 2011, BIOPHYS J, V100, P381, DOI 10.1016/j.bpj.2010.11.086; Rosenhouse-Dantsker A, 2010, CHANNELS, V4, P63, DOI 10.4161/chan.4.1.10366; SHOUFFANI A, 1990, J BIOL CHEM, V265, P6002; Signorini S, 1997, P NATL ACAD SCI USA, V94, P923, DOI 10.1073/pnas.94.3.923; Slesinger PA, 1997, P NATL ACAD SCI USA, V94, P12210, DOI 10.1073/pnas.94.22.12210; SOEJIMA M, 1984, PFLUG ARCH EUR J PHY, V400, P424, DOI 10.1007/BF00587544; SUNSHINE C, 1994, BBA-BIOMEMBRANES, V1191, P59, DOI 10.1016/0005-2736(94)90233-X; Vivaudou M, 1997, J BIOL CHEM, V272, P31553, DOI 10.1074/jbc.272.50.31553; Wang ZG, 1998, CIRCULATION, V98, P2422, DOI 10.1161/01.CIR.98.22.2422; Wickman K, 1998, NEURON, V20, P103, DOI 10.1016/S0896-6273(00)80438-9; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103	52	25	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4925	4935		10.1074/jbc.M111.306134	http://dx.doi.org/10.1074/jbc.M111.306134			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22174416	hybrid, Green Published			2022-12-25	WOS:000300608500053
J	Thome, R; Gust, A; Toci, R; Mendel, R; Bittner, F; Magalon, A; Walburger, A				Thome, Remi; Gust, Alexander; Toci, Rene; Mendel, Ralf; Bittner, Florian; Magalon, Axel; Walburger, Anne			A Sulfurtransferase Is Essential for Activity of Formate Dehydrogenases in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPLASMIC NITRATE REDUCTASE; MOLYBDENUM COFACTOR SULFURATION; THALIANA PROVIDES INSIGHT; FE-S CLUSTER; XANTHINE DEHYDROGENASE; CRYSTAL-STRUCTURE; CYSTEINE DESULFURASE; ARABIDOPSIS-THALIANA; 4-THIOURIDINE BIOSYNTHESIS; TRANSFER-RNA	L-Cysteine desulfurases provide sulfur to several metabolic pathways in the form of persulfides on specific cysteine residues of an acceptor protein for the eventual incorporation of sulfur into an end product. IscS is one of the three Escherichia coli L-cysteine desulfurases. It interacts with FdhD, a protein essential for the activity of formate dehydrogenases (FDHs), which are iron/molybdenum/selenium-containing enzymes. Here, we address the role played by this interaction in the activity of FDH-H (FdhF) in E. coli. The interaction of IscS with FdhD results in a sulfur transfer between IscS and FdhD in the form of persulfides. Substitution of the strictly conserved residue Cys-121 of FdhD impairs both sulfur transfer from IscS to FdhD and FdhF activity. Furthermore, inactive FdhF produced in the absence of FdhD contains both metal centers, albeit the molybdenum cofactor is at a reduced level. Finally, FdhF activity is sulfur-dependent, as it shows reversible sensitivity to cyanide treatment. Conclusively, FdhD is a sulfurtransferase between IscS and FdhF and is thereby essential to yield FDH activity.	[Thome, Remi; Toci, Rene; Magalon, Axel; Walburger, Anne] CNRS, Inst Microbiol Mediterranee, Chim Bacterienne Lab, UPR9043, F-13009 Marseille, France; [Thome, Remi; Toci, Rene; Magalon, Axel; Walburger, Anne] Aix Marseille Univ, F-13009 Marseille, France; [Gust, Alexander; Mendel, Ralf; Bittner, Florian] Tech Univ Carolo Wilhelmina Braunschweig, Inst Pflanzenbiol, D-38023 Braunschweig, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Braunschweig University of Technology	Magalon, A (corresponding author), CNRS, Inst Microbiol Mediterranee, Chim Bacterienne Lab, UPR9043, F-13009 Marseille, France.	magalon@ifr88.cnrs-mrs.fr		Magalon, Axel/0000-0002-3375-738X	Agence Nationale Recherche Jeunes Chercheurs; CNRS; Aix-Marseille University; Deutsche Forschungsgemeinschaft	Agence Nationale Recherche Jeunes Chercheurs(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille University; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Agence Nationale Recherche Jeunes Chercheurs (to A. M.), CNRS, the Aix-Marseille University (to R. T. and A. W.), and the Deutsche Forschungsgemeinschaft (to F. B. and R. M.).	ABAIBOU H, 1995, J BACTERIOL, V177, P7141, DOI 10.1128/jb.177.24.7141-7149.1995; Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; Arnoux P, 2003, NAT STRUCT BIOL, V10, P928, DOI 10.1038/nsb994; AXLEY MJ, 1990, J BIOL CHEM, V265, P18213; AXLEY MJ, 1991, P NATL ACAD SCI USA, V88, P8450, DOI 10.1073/pnas.88.19.8450; Bittner F, 2001, J BIOL CHEM, V276, P40381, DOI 10.1074/jbc.C100472200; Boyington JC, 1997, SCIENCE, V275, P1305, DOI 10.1126/science.275.5304.1305; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Coelho C, 2011, J MOL BIOL, V408, P932, DOI 10.1016/j.jmb.2011.03.016; Cupp-Vickery JR, 2003, J MOL BIOL, V330, P1049, DOI 10.1016/S0022-2836(03)00690-9; Enroth C, 2000, P NATL ACAD SCI USA, V97, P10723, DOI 10.1073/pnas.97.20.10723; Heidenreich T, 2005, J BIOL CHEM, V280, P4213, DOI 10.1074/jbc.M411195200; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; Jepson BJN, 2007, J BIOL CHEM, V282, P6425, DOI 10.1074/jbc.M607353200; JONES RW, 1977, BIOCHEM J, V164, P199, DOI 10.1042/bj1640199; Jormakka M, 2002, SCIENCE, V295, P1863, DOI 10.1126/science.1068186; Kambampati R, 2000, J BIOL CHEM, V275, P10727, DOI 10.1074/jbc.275.15.10727; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kato S, 2002, P NATL ACAD SCI USA, V99, P5948, DOI 10.1073/pnas.082123599; Kessler D, 2006, FEMS MICROBIOL REV, V30, P825, DOI 10.1111/j.1574-6976.2006.00036.x; Lehrke M., 2011, BIOCH J IN PRESS; Leimkuhler S, 2003, J BIOL CHEM, V278, P20802, DOI 10.1074/jbc.M303091200; Loiseau L, 2005, J BIOL CHEM, V280, P26760, DOI 10.1074/jbc.M504067200; Loiseau L, 2003, J BIOL CHEM, V278, P38352, DOI 10.1074/jbc.M305953200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Magalon A, 2002, J BIOL CHEM, V277, P48199, DOI 10.1074/jbc.M205806200; Magalon A, 2011, COORDIN CHEM REV, V255, P1159, DOI 10.1016/j.ccr.2010.12.031; MANDRANDBERTHELOT MA, 1988, J GEN MICROBIOL, V134, P3129; Mihara H, 2002, APPL MICROBIOL BIOT, V60, P12, DOI 10.1007/s00253-002-1107-4; Najmudin S, 2008, J BIOL INORG CHEM, V13, P737, DOI 10.1007/s00775-008-0359-6; Neumann M, 2007, BIOCHEMISTRY-US, V46, P9586, DOI 10.1021/bi700630p; Neumann M, 2006, J BIOL CHEM, V281, P15701, DOI 10.1074/jbc.M601617200; Raaijmakers H, 2002, STRUCTURE, V10, P1261, DOI 10.1016/S0969-2126(02)00826-2; Raaijmakers HCA, 2006, J BIOL INORG CHEM, V11, P849, DOI 10.1007/s00775-006-0129-2; SCHLINDWEIN C, 1990, J BACTERIOL, V172, P6112, DOI 10.1128/jb.172.10.6112-6121.1990; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; Stanley NR, 2002, MOL MICROBIOL, V43, P1005, DOI 10.1046/j.1365-2958.2002.02797.x; STEWART V, 1991, J BACTERIOL, V173, P4417, DOI 10.1128/JB.173.14.4417-4423.1991; WAHL RC, 1982, J BIOL CHEM, V257, P3958; Wollers S, 2008, J BIOL CHEM, V283, P9642, DOI 10.1074/jbc.M708549200; Wright CM, 2006, CHEM COMMUN, P3104, DOI 10.1039/b604040c; Wright CM, 2002, CHEM COMMUN, P2708, DOI 10.1039/b208626c; WU LF, 1986, BIOCHIMIE, V68, P167, DOI 10.1016/S0300-9084(86)81081-1; Zhang WJ, 2010, J BIOL CHEM, V285, P2302, DOI 10.1074/jbc.M109.082172; ZHENG LM, 1994, J BIOL CHEM, V269, P18723; ZHENG LM, 1994, BIOCHEMISTRY-US, V33, P4714, DOI 10.1021/bi00181a031	46	55	57	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4671	4678		10.1074/jbc.M111.327122	http://dx.doi.org/10.1074/jbc.M111.327122			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22194618	hybrid, Green Published			2022-12-25	WOS:000300608500029
J	Orsi, M; Essex, JW				Orsi, Mario; Essex, Jonathan W.			The ELBA Force Field for Coarse-Grain Modeling of Lipid Membranes	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; SIMPLE POINT-CHARGE; LIQUID WATER; SPONTANEOUS CURVATURE; COMPUTER-SIMULATION; LATERAL PRESSURE; CHAIN-LENGTH; ELECTROSTATIC PROPERTIES; DIELECTRIC-PROPERTIES; DIPOLE POTENTIALS	A new coarse-grain model for molecular dynamics simulation of lipid membranes is presented. Following a simple and conventional approach, lipid molecules are modeled by spherical sites, each representing a group of several atoms. In contrast to common coarse-grain methods, two original (interdependent) features are here adopted. First, the main electrostatics are modeled explicitly by charges and dipoles, which interact realistically through a relative dielectric constant of unity (is an element of(r) = 1). Second, water molecules are represented individually through a new parametrization of the simple Stockmayer potential for polar fluids; each water molecule is therefore described by a single spherical site embedded with a point dipole. The force field is shown to accurately reproduce the main physical properties of single-species phospholipid bilayers comprising dioleoylphosphatidylcholine (DOPC) and dioleoylphosphatidylethanolamine (DOPE) in the liquid crystal phase, as well as distearoylphosphatidylcholine (DSPC) in the liquid crystal and gel phases. Insights are presented into fundamental properties and phenomena that can be difficult or impossible to study with alternative computational or experimental methods. For example, we investigate the internal pressure distribution, dipole potential, lipid diffusion, and spontaneous self-assembly. Simulations lasting up to 1.5 microseconds were conducted for systems of different sizes (128, 512 and 1058 lipids); this also allowed us to identify size-dependent artifacts that are expected to affect membrane simulations in general. Future extensions and applications are discussed, particularly in relation to the methodology's inherent multiscale capabilities.	[Orsi, Mario; Essex, Jonathan W.] Univ Southampton, Sch Chem, Southampton, Hants, England	University of Southampton	Orsi, M (corresponding author), Univ Southampton, Sch Chem, Southampton, Hants, England.	orsi@soton.ac.uk			United Kingdom Engineering and Physical Sciences Research Council (EPSRC) [EP/G050708/1]; Biotechnology and Biological Sciences Research Council [BB/D01414X/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/G050708/1] Funding Source: researchfish; BBSRC [BB/D01414X/1] Funding Source: UKRI; EPSRC [EP/G050708/1] Funding Source: UKRI	United Kingdom Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the United Kingdom Engineering and Physical Sciences Research Council (EPSRC) under grant number EP/G050708/1 (http://www.epsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKUTSU H, 1991, BIOCHEMISTRY-US, V30, P4510, DOI 10.1021/bi00232a020; Alemani D, 2010, J CHEM THEORY COMPUT, V6, P315, DOI 10.1021/ct900457z; All-Jamal WT, 2009, MOL PHARMACEUT, V6, P520, DOI 10.1021/mp800187d; Allen MP., 1989, COMPUTER SIMULATION; ALPER HE, 1989, J CHEM PHYS, V91, P1242, DOI 10.1063/1.457198; Atkins PW, 1982, PHYS CHEM; Attard GS, 2000, P NATL ACAD SCI USA, V97, P9032, DOI 10.1073/pnas.160260697; Balgavy P, 2001, BBA-BIOMEMBRANES, V1512, P40, DOI 10.1016/S0005-2736(01)00298-X; Bartke J, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.061503; Beck DAC, 2005, BIOCHEMISTRY-US, V44, P609, DOI 10.1021/bi0486381; Ben-Shaul A., 1995, STRUCTURE DYNAMICS M, P359; Berendsen H., 1981, INTERMOLECULAR FORCE, DOI DOI 10.1007/978-94-015-7658-1_21; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bezrukov SM, 2000, CURR OPIN COLLOID IN, V5, P237, DOI 10.1016/S1359-0294(00)00061-3; Bhide SY, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2132277; Bond PJ, 2007, J STRUCT BIOL, V157, P593, DOI 10.1016/j.jsb.2006.10.004; Botelho AV, 2006, BIOPHYS J, V91, P4464, DOI 10.1529/biophysj.106.082776; Braun AR, 2011, BIOPHYS J, V100, P2112, DOI 10.1016/j.bpj.2011.03.009; Brink-van der Laan EV, 2004, BBA-BIOMEMBRANES, V1666, P275, DOI 10.1016/j.bbamem.2004.06.010; Cafiso DS, 1998, TOXICOL LETT, V101, P431, DOI 10.1016/S0378-4274(98)00217-3; Cantor RS, 1997, J PHYS CHEM B, V101, P1723, DOI 10.1021/jp963911x; Cevc G., 1987, PHOSPHOLIPID BILAYER; Chen Z, 1997, BIOPHYS J, V73, P267, DOI 10.1016/S0006-3495(97)78067-6; Cladera J, 2003, J PHARM SCI, V92, P1018, DOI 10.1002/jps.10344; Clarke RJ, 2001, ADV COLLOID INTERFAC, V89, P263, DOI 10.1016/S0001-8686(00)00061-0; Cleaver DJ, 1996, PHYS REV E, V54, P559, DOI 10.1103/PhysRevE.54.559; Cordomi A, 2008, J PHYS CHEM B, V112, P1397, DOI 10.1021/jp073897w; Creighton T. E., 1993, PROTEINS STRUCTURES; DAMODARAN KV, 1994, BIOPHYS J, V66, P1076, DOI 10.1016/S0006-3495(94)80889-6; DELEEUW SW, 1986, ANNU REV PHYS CHEM, V37, P245, DOI 10.1146/annurev.pc.37.100186.001333; Demchenko AP, 2009, CHEM PHYS LIPIDS, V160, P63, DOI 10.1016/j.chemphyslip.2009.05.002; Dullweber A, 1997, J CHEM PHYS, V107, P5840, DOI 10.1063/1.474310; Essex JW, 1998, MOL SIMULAT, V20, P159, DOI 10.1080/08927029808024175; ESSEX JW, 1994, PHILOS T ROY SOC B, V344, P239, DOI 10.1098/rstb.1994.0064; Feenstra KA, 1999, J COMPUT CHEM, V20, P786, DOI 10.1002/(SICI)1096-987X(199906)20:8<786::AID-JCC5>3.0.CO;2-B; Fennell CJ, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2206581; FERNANDEZPUENTE L, 1994, EUROPHYS LETT, V28, P181, DOI 10.1209/0295-5075/28/3/005; Filippov A, 2003, LANGMUIR, V19, P6397, DOI 10.1021/la034222x; Filippov A, 2003, BIOPHYS J, V84, P3079, DOI 10.1016/S0006-3495(03)70033-2; GAWRISCH K, 1992, BIOPHYS J, V61, P1213, DOI 10.1016/S0006-3495(92)81931-8; GAWRISCH K, 1992, BIOCHEMISTRY-US, V31, P2856, DOI 10.1021/bi00126a003; GAY JG, 1981, J CHEM PHYS, V74, P3316, DOI 10.1063/1.441483; HARASIMA A, 1958, ADV CHEM PHYS, V1, P203; Harvey SC, 1998, J COMPUT CHEM, V19, P726, DOI 10.1002/(SICI)1096-987X(199805)19:7<726::AID-JCC4>3.0.CO;2-S; Hayasaka T, 2009, LIPIDS, V44, P837, DOI 10.1007/s11745-009-3331-5; Hogberg CJ, 2006, J PHYS CHEM B, V110, P14326, DOI 10.1021/jp0614796; Hogberg CJ, 2008, BIOPHYS J, V94, P525, DOI 10.1529/biophysj.107.104208; Holdbrook DA, 2010, BIOCHEMISTRY-US, V49, P10796, DOI 10.1021/bi101743w; Holz M, 2000, PHYS CHEM CHEM PHYS, V2, P4740, DOI 10.1039/b005319h; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunt AN, 2004, BBA-MOL CELL BIOL L, V1686, P50, DOI 10.1016/j.bbalip.2004.08.003; Hunt AN, 2001, J BIOL CHEM, V276, P8492, DOI 10.1074/jbc.M009878200; Huster D, 1997, BIOPHYS J, V73, P855, DOI 10.1016/S0006-3495(97)78118-9; Izvekov S, 2005, J PHYS CHEM B, V109, P2469, DOI 10.1021/jp044629q; Izvekov S, 2006, J CHEM THEORY COMPUT, V2, P637, DOI 10.1021/ct050300c; JANSEN M, 1995, BIOPHYS J, V68, P997, DOI 10.1016/S0006-3495(95)80275-4; Johnson LE, 2010, J PHYS CHEM B, V114, P8431, DOI 10.1021/jp1010605; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; JORGENSEN WL, 1985, MOL PHYS, V56, P1381, DOI 10.1080/00268978500103111; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P2097, DOI 10.1021/bi0478502; Kranenburg M, 2005, J PHYS CHEM B, V109, P6553, DOI 10.1021/jp0457646; Kucerka N, 2008, BIOPHYS J, V95, P2356, DOI 10.1529/biophysj.108.132662; Lairion F, 2004, LANGMUIR, V20, P9151, DOI 10.1021/la049515k; Leach A. R., 2001, MOL MODELLING PRINCI; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Lee CH, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.020901; Leekumjorn S, 2006, BIOPHYS J, V90, P3951, DOI 10.1529/biophysj.105.076596; Liu Y, 1996, J PHYS CHEM-US, V100, P2723, DOI 10.1021/jp952324t; Liu YF, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.040901; Lopez CF, 2002, COMPUT PHYS COMMUN, V147, P1, DOI 10.1016/S0010-4655(02)00195-9; LUCKHURST GR, 1990, LIQ CRYST, V8, P451, DOI 10.1080/02678299008047361; Lundbaek JA, 2010, J R SOC INTERFACE, V7, P373, DOI 10.1098/rsif.2009.0443; Lyubartsev AP, 2011, SOFT MATTER, V7, P25, DOI 10.1039/c0sm00457j; Mackerell AD, 2004, J COMPUT CHEM, V25, P1584, DOI 10.1002/jcc.20082; Mahoney MW, 2000, J CHEM PHYS, V112, P8910, DOI 10.1063/1.481505; Mark P, 2002, J COMPUT CHEM, V23, P1211, DOI 10.1002/jcc.10117; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marrink SJ, 2001, J AM CHEM SOC, V123, P8638, DOI 10.1021/ja0159618; Marsh D, 2008, BBA-BIOMEMBRANES, V1778, P1545, DOI 10.1016/j.bbamem.2008.01.015; Marsh D, 2007, BIOPHYS J, V93, P3884, DOI 10.1529/biophysj.107.107938; Mathai JC, 2008, J GEN PHYSIOL, V131, P69, DOI 10.1085/jgp.200709848; Mathias G, 2003, J CHEM PHYS, V118, P10847, DOI 10.1063/1.1574774; Michel J, 2008, J PHYS CHEM B, V112, P657, DOI 10.1021/jp076142y; Mitchell TW, 2007, J EXP BIOL, V210, P3440, DOI 10.1242/jeb.007286; Mouritsen OG, 2005, LIFEAS MATTER FAT EM; Muller M, 2006, PHYS REP, V434, P113, DOI 10.1016/j.physrep.2006.08.003; Mukhin SI, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.061918; Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2; NAGLE JF, 1978, BIOPHYS J, V23, P159, DOI 10.1016/S0006-3495(78)85441-1; NEEDHAM D, 1988, BIOCHEMISTRY-US, V27, P4668, DOI 10.1021/bi00413a013; NEUMANN M, 1983, MOL PHYS, V50, P841, DOI 10.1080/00268978300102721; O'Shea P, 2005, PHILOS T R SOC A, V363, P575, DOI 10.1098/rsta.2004.1509; O'Shea P, 2004, BIOELECTROCHEM P & P, V6, P23; O'Shea P, 2003, BIOCHEM SOC T, V31, P990; Ollila OHS, 2007, J STRUCT BIOL, V159, P311, DOI 10.1016/j.jsb.2007.01.012; Ollila OHS, 2010, RSC BIOMOL SCI, P26, DOI 10.1039/9781849732154-00026; Ollila OHS, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.078101; Orsi M, 2007, MOL INTERACTIONS BRI, P185; Orsi M, 2008, J PHYS CHEM B, V112, P802, DOI 10.1021/jp076139e; Orsi M, 2011, J R SOC INTERFACE, V8, P826, DOI 10.1098/rsif.2010.0541; Orsi M, 2010, SOFT MATTER, V6, P3797, DOI 10.1039/c0sm00136h; Orsi M, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/15/155106; Orsi M, 2009, J PHYS CHEM B, V113, P12019, DOI 10.1021/jp903248s; Pan J, 2008, BIOPHYS J, V94, P117, DOI 10.1529/biophysj.107.115691; Pandit SA, 2009, BBA-BIOMEMBRANES, V1788, P136, DOI 10.1016/j.bbamem.2008.09.004; Parton DL, 2011, BIOPHYS J, V101, P691, DOI 10.1016/j.bpj.2011.06.048; PasenkiewiczGierula M, 1997, J PHYS CHEM A, V101, P3677, DOI 10.1021/jp962099v; Patra M, 2004, J PHYS CHEM B, V108, P4485, DOI 10.1021/jp031281a; Petrache HI, 2000, BIOPHYS J, V79, P3172, DOI 10.1016/S0006-3495(00)76551-9; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Poger D, 2010, J COMPUT CHEM, V31, P1117, DOI 10.1002/jcc.21396; Postle AD, 2006, J LIPID RES, V47, P1322, DOI 10.1194/jlr.M600054-JLR200; PRICE SL, 1984, MOL PHYS, V52, P987, DOI 10.1080/00268978400101721; Puri A, 2009, CRIT REV THER DRUG, V26, P523, DOI 10.1615/CritRevTherDrugCarrierSyst.v26.i6.10; RAND RP, 1994, BIOPHYS J, V66, P2127, DOI 10.1016/S0006-3495(94)81008-2; Rapaport D.C., 2004, ART MOL DYNAMICS SIM, DOI 10.1017/CBO9780511816581; Rawicz W, 2008, BIOPHYS J, V94, P4725, DOI 10.1529/biophysj.107.121731; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; Roark M, 2009, J PHYS CHEM B, V113, P13229, DOI 10.1021/jp902186f; Rokitskaya TI, 2002, BIOPHYS J, V82, P865, DOI 10.1016/S0006-3495(02)75448-9; Schamberger J, 2002, BIOPHYS J, V82, P3081, DOI 10.1016/S0006-3495(02)75649-X; Scott HL, 2002, CURR OPIN STRUC BIOL, V12, P495, DOI 10.1016/S0959-440X(02)00353-6; Seddon JM, 1995, STRUCTURE DYNAMICS M, V1, P97, DOI DOI 10.1016/S1383-8121(06)80020-5; Shalaev EY, 1999, BBA-BIOMEMBRANES, V1419, P229, DOI 10.1016/S0005-2736(99)00068-1; Shearman GC, 2006, J PHYS-CONDENS MAT, V18, pS1105, DOI 10.1088/0953-8984/18/28/S01; SHEPHERD JCW, 1978, BIOCHIM BIOPHYS ACTA, V514, P83, DOI 10.1016/0005-2736(78)90078-0; Shinoda K, 2004, J CHEM PHYS, V121, P9648, DOI 10.1063/1.1806791; Shinoda W, 1998, J PHYS CHEM B, V102, P6647, DOI 10.1021/jp9814808; Shinoda W, 2010, J PHYS CHEM B, V114, P6836, DOI 10.1021/jp9107206; SMITH PE, 1994, J CHEM PHYS, V100, P3169, DOI 10.1063/1.466407; Sokhan VP, 1997, MOL PHYS, V92, P625, DOI 10.1080/002689797169916; Starke-Peterkovic T, 2005, AM J PHYSIOL-REG I, V288, pR663, DOI 10.1152/ajpregu.00434.2004; Stepniewski M, 2010, J PHYS CHEM B, V114, P11784, DOI 10.1021/jp104739a; Stockmayer WH, 1941, J CHEM PHYS, V9, P398, DOI 10.1063/1.1750922; STODDARD SD, 1973, PHYS REV A, V8, P1504, DOI 10.1103/PhysRevA.8.1504; Szule JA, 2002, BIOPHYS J, V83, P977, DOI 10.1016/S0006-3495(02)75223-5; Tanaka M, 2001, METROLOGIA, V38, P301, DOI 10.1088/0026-1394/38/4/3; Templer RH, 1998, FARADAY DISCUSS, V111, P41; Templer RH, 1998, LANGMUIR, V14, P7427, DOI 10.1021/la980701y; Tobias DJ, 2001, CURR OPIN STRUC BIOL, V11, P253, DOI 10.1016/S0959-440X(00)00198-6; Tristram-Nagle S, 1998, BIOPHYS J, V75, P917, DOI 10.1016/S0006-3495(98)77580-0; TRISTRAMNAGLE S, 1993, BIOPHYS J, V64, P1097, DOI 10.1016/S0006-3495(93)81475-9; UENO M, 1990, J COLLOID INTERF SCI, V134, P589, DOI 10.1016/0021-9797(90)90167-M; van der Spoel D, 2006, J CHEM THEORY COMPUT, V2, P1, DOI 10.1021/ct0502256; van der Spoel D, 1998, J CHEM PHYS, V108, P10220, DOI 10.1063/1.476482; VANLEEUWEN ME, 1994, FLUID PHASE EQUILIBR, V99, P1, DOI 10.1016/0378-3812(94)80018-9; Wang LCH, 2006, J ETHNOPHARMACOL, V103, P103, DOI 10.1016/j.jep.2005.07.010; WARSHEL A, 1979, J PHYS CHEM-US, V83, P1640, DOI 10.1021/j100475a014; Whitehead L, 2001, J COMPUT CHEM, V22, P1622, DOI 10.1002/jcc.1118; Wu YJ, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2136877; Yang Y, 2008, BIOPHYS J, V95, P5193, DOI 10.1529/biophysj.108.136507; Yesylevskyy SO, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000810; Yonetani Y, 2005, CHEM PHYS LETT, V406, P49, DOI 10.1016/j.cplett.2005.02.073	154	133	133	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2011	6	12							e28637	10.1371/journal.pone.0028637	http://dx.doi.org/10.1371/journal.pone.0028637			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JD	22194874	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000298664400012
J	Graham, K; Moran-Jones, K; Sansom, OJ; Brunton, VG; Frame, MC				Graham, Kathryn; Moran-Jones, Kim; Sansom, Owen J.; Brunton, Valerie G.; Frame, Margaret C.			FAK Deletion Promotes p53-Mediated Induction of p21, DNA-Damage Responses and Radio-Resistance in Advanced Squamous Cancer Cells	PLOS ONE			English	Article							FOCAL-ADHESION KINASE; EPITHELIAL-SPECIFIC DISRUPTION; HUMAN BREAST-CANCER; IONIZING-RADIATION; GROWTH-FACTOR; OVARIAN-CARCINOMA; TUMOR-FORMATION; INHIBITOR; EXPRESSION; ADENOCARCINOMA	Focal adhesion kinase (FAK) is a cytoplasmic tyrosine kinase that is elevated in a variety of human cancers. While FAK is implicated in many cellular processes that are perturbed in cancer, including proliferation, actin and adhesion dynamics, polarisation and invasion, there is only some limited information regarding the role of FAK in radiation survival. We have evaluated whether FAK is a general radio-sensitising target, as has been suggested by previous reports. We used a clean genetic system in which FAK was deleted from mouse squamous cell carcinoma (SCC) cells (FAK -/-), and reconstituted with exogenous FAK wild type (wt). Surprisingly, the absence of FAK was associated with increased radio-resistance in advanced SCC cells. FAK re-expression inhibited p53-mediated transcriptional up-regulation of p21, and a sub-set of other p53 target genes involved in DNA repair, after treatment with ionizing radiation. Moreover, p21 depletion promoted radio-sensitisation, implying that FAK-mediated inhibition of p21 induction is responsible for the relative radio-sensitivity of FAK-proficient SCC cells. Our work adds to a growing body of evidence that there is a close functional relationship between integrin/FAK signalling and the p53/p21 pathway, but demonstrates that FAK's role in survival after stress is context-dependent, at least in cancer cells. We suggest that there should be caution when considering inhibiting FAK in combination with radiation, as this may not always be clinically advantageous.	[Graham, Kathryn; Moran-Jones, Kim; Sansom, Owen J.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Brunton, Valerie G.; Frame, Margaret C.] Univ Edinburgh, Edinburgh Canc Res Ctr, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland	Beatson Institute; University of Edinburgh	Graham, K (corresponding author), Beatson Inst Canc Res, Garscube Estate, Glasgow G61 1BD, Lanark, Scotland.	m.frame@ed.ac.uk		Frame, Margaret/0000-0001-5882-1942; Sansom, Owen J./0000-0001-9540-3010	Cancer Research UK [C157/A9148]; Cancer Research UK [12481] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This work was funded by Cancer Research UK Program Grant (C157/A9148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton GH, 2010, DEV CELL, V19, P259, DOI 10.1016/j.devcel.2010.07.015; Beinke C, 2003, INT J RADIAT BIOL, V79, P721, DOI 10.1080/09553000310001610231; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Bonner JA, 2010, LANCET ONCOL, V11, P21, DOI 10.1016/S1470-2045(09)70311-0; Ceballos E, 2005, ONCOGENE, V24, P4559, DOI 10.1038/sj.onc.1208652; Chen YY, 2009, CANCER SCI, V100, P1708, DOI 10.1111/j.1349-7006.2009.01217.x; Cordes N, 2007, ONCOGENE, V26, P6851, DOI 10.1038/sj.onc.1210498; Cosaceanu D, 2007, ONCOGENE, V26, P2423, DOI 10.1038/sj.onc.1210037; Cuneo KC, 2006, INT J RADIAT ONCOL, V64, P1197, DOI 10.1016/j.ijrobp.2005.11.014; Dittmann K, 2009, RADIOTHER ONCOL, V92, P379, DOI 10.1016/j.radonc.2009.06.003; Dittmann K, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-69; Duxbury MS, 2004, SURGERY, V135, P555, DOI 10.1016/j.surg.2003.10.017; Duxbury MS, 2003, BIOCHEM BIOPH RES CO, V311, P786, DOI 10.1016/j.bbrc.2003.10.060; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Gabarra-Niecko V, 2003, CANCER METAST REV, V22, P359, DOI 10.1023/A:1023725029589; Golubovskaya V, 2004, BBA-GENE STRUCT EXPR, V1678, P111, DOI 10.1016/j.bbaexp.2004.03.002; Golubovskaya VM, 2008, MOL CARCINOGEN, V47, P373, DOI 10.1002/mc.20395; Golubovskaya VM, 2009, INT J CANCER, V125, P1735, DOI 10.1002/ijc.24486; Halder J, 2005, CLIN CANCER RES, V11, P8829, DOI 10.1158/1078-0432.CCR-05-1728; Halder J, 2007, CANCER RES, V67, P10976, DOI 10.1158/0008-5472.CAN-07-2667; Halder J, 2006, CLIN CANCER RES, V12, P4916, DOI 10.1158/1078-0432.CCR-06-0021; Hauck CR, 2001, CANCER RES, V61, P7079; Hochwald SN, 2009, CELL CYCLE, V8, P2435, DOI 10.4161/cc.8.15.9145; Hungerford JE, 1996, J CELL BIOL, V135, P1383, DOI 10.1083/jcb.135.5.1383; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Kasahara T, 2002, ANTIOXID REDOX SIGN, V4, P491, DOI 10.1089/15230860260196290; Lahlou H, 2007, P NATL ACAD SCI USA, V104, P20302, DOI 10.1073/pnas.0710091104; Li ZP, 2006, BIOCHEM BIOPH RES CO, V341, P363, DOI 10.1016/j.bbrc.2005.12.193; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Luo M, 2009, CANCER RES, V69, P466, DOI 10.1158/0008-5472.CAN-08-3078; McLean GW, 2004, GENE DEV, V18, P2998, DOI 10.1101/gad.316304; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Meyn RE, 2009, RADIOTHER ONCOL, V92, P316, DOI 10.1016/j.radonc.2009.06.031; Park CM, 2006, CANCER RES, V66, P8511, DOI 10.1158/0008-5472.CAN-05-4340; Provenzano PP, 2008, AM J PATHOL, V173, P1551, DOI 10.2353/ajpath.2008.080308; Pylayeva Y, 2009, J CLIN INVEST, V119, P252, DOI 10.1172/JCI37160; Roberts WG, 2008, CANCER RES, V68, P1935, DOI 10.1158/0008-5472.CAN-07-5155; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; SERRELS A, 2011, INT J CANC IN PRESS; Serrels B, 2010, CURR BIOL, V20, P1086, DOI 10.1016/j.cub.2010.04.042; Sieg DJ, 1999, J CELL SCI, V112, P2677; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Siesser PMF, 2006, CLIN CANCER RES, V12, P3233, DOI 10.1158/1078-0432.CCR-06-0456; Slack-Davis JK, 2009, MOL CANCER THER, V8, P2470, DOI 10.1158/1535-7163.MCT-09-0262; Smith CS, 2005, MELANOMA RES, V15, P357, DOI 10.1097/00008390-200510000-00003; van Nimwegen MJ, 2007, BIOCHEM PHARMACOL, V73, P597, DOI 10.1016/j.bcp.2006.08.011; Zhang Y, 2004, J BIOL CHEM, V279, P48342, DOI 10.1074/jbc.M407953200	48	22	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e27806	10.1371/journal.pone.0027806	http://dx.doi.org/10.1371/journal.pone.0027806			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194793	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000298369100013
J	Zwielehner, J; Lassl, C; Hippe, B; Pointner, A; Switzeny, OJ; Remely, M; Kitzweger, E; Ruckser, R; Haslberger, AG				Zwielehner, Jutta; Lassl, Cornelia; Hippe, Berit; Pointner, Angelika; Switzeny, Olivier J.; Remely, Marlene; Kitzweger, Elvira; Ruckser, Reinhard; Haslberger, Alexander G.			Changes in Human Fecal Microbiota Due to Chemotherapy Analyzed by TaqMan-PCR, 454 Sequencing and PCR-DGGE Fingerprinting	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; INTESTINAL MICROBIOTA; ULCERATIVE-COLITIS; INDUCED DIARRHEA; GUT MICROBIOTA; SP-NOV.; BACTERIA; TIME; MICROFLORA; MUCOSA	Background: We investigated whether chemotherapy with the presence or absence of antibiotics against different kinds of cancer changed the gastrointestinal microbiota. Methodology/Principal Findings: Feces of 17 ambulant patients receiving chemotherapy with or without concomitant antibiotics were analyzed before and after the chemotherapy cycle at four time points in comparison to 17 gender-, age- and lifestyle-matched healthy controls. We targeted 16S rRNA genes of all bacteria, Bacteroides, bifidobacteria, Clostridium cluster IV and XIVa as well as C. difficile with TaqMan qPCR, denaturing gradient gel electrophoresis (DGGE) fingerprinting and high-throughput sequencing. After a significant drop in the abundance of microbiota (p = 0.037) following a single treatment the microbiota recovered within a few days. The chemotherapeutical treatment marginally affected the Bacteroides while the Clostridium cluster IV and XIVa were significantly more sensitive to chemotherapy and antibiotic treatment. DGGE fingerprinting showed decreased diversity of Clostridium cluster IV and XIVa in response to chemotherapy with cluster IV diversity being particularly affected by antibiotics. The occurrence of C. difficile in three out of seventeen subjects was accompanied by a decrease in the genera Bifidobacterium, Lactobacillus, Veillonella and Faecalibacterium prausnitzii. Enterococcus faecium increased following chemotherapy. Conclusions/Significance: Despite high individual variations, these results suggest that the observed changes in the human gut microbiota may favor colonization with C. difficile and Enterococcus faecium. Perturbed microbiota may be a target for specific mitigation with safe pre- and probiotics.	[Zwielehner, Jutta; Lassl, Cornelia; Hippe, Berit; Pointner, Angelika; Switzeny, Olivier J.; Remely, Marlene; Haslberger, Alexander G.] Dept Nutr Sci, Vienna, Austria; [Kitzweger, Elvira; Ruckser, Reinhard] Sozialmed Zentrum Ost, Vienna, Austria	Donauspital	Zwielehner, J (corresponding author), Dept Nutr Sci, Vienna, Austria.	alexander.haslberger@univie.ac.at	Haslberger, Alexander G/B-9120-2013	Switzeny, Olivier/0000-0001-6279-2558; Haslberger, Alexander/0000-0001-9699-537X; Hippe, Berit/0000-0001-7830-8812	Austrian Science Fund (FWF	Austrian Science Fund (FWF(Austrian Science Fund (FWF))	The work was supported by the Austrian Science Fund (FWF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; BENUS RF, 2010, BR J NUTR, P1; Bergmans DCJJ, 1997, J ANTIMICROB CHEMOTH, V39, P527, DOI 10.1093/jac/39.4.527; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Chung HC, 2010, CURR OPIN IMMUNOL, V22, P455, DOI 10.1016/j.coi.2010.06.008; Collado MC, 2007, APPL ENVIRON MICROB, V73, P7767, DOI 10.1128/AEM.01477-07; Croswell A, 2009, INFECT IMMUN, V77, P2741, DOI 10.1128/IAI.00006-09; Cucchiara S, 2009, DIGEST DIS, V27, P252, DOI 10.1159/000228558; da Silva MF, 2006, FEMS MICROBIOL ECOL, V55, P322, DOI 10.1111/j.1574-6941.2005.00032.x; De La Cochetiere MF, 2005, J CLIN MICROBIOL, V43, P5588, DOI 10.1128/JCM.43.11.5588-5592.2005; de Regt MJA, 2010, ANTIMICROB AGENTS CH, V54, P2801, DOI 10.1128/AAC.01765-09; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; El-Atti SA, 2009, JPEN-PARENTER ENTER, V33, P569, DOI 10.1177/0148607109332004; Falk A, 2007, SCAND J GASTROENTERO, V42, P973, DOI 10.1080/00365520701204238; Fanci R, 2010, CASE REP MED, V2010, DOI 10.1155/2010/313514; Flythe MD, 2010, J APPL MICROBIOL, V109, P1169, DOI 10.1111/j.1365-2672.2010.04739.x; Gibson RJ, 2006, SUPPORT CARE CANCER, V14, P890, DOI 10.1007/s00520-006-0040-y; GOODMAN MJ, 1977, GUT, V18, P229, DOI 10.1136/gut.18.3.229; Grobner S, 2010, CELL MOL LIFE SCI, V67, P3331, DOI 10.1007/s00018-010-0384-9; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Guilmeau S, 2008, GASTROENTEROLOGY, V135, P849, DOI 10.1053/j.gastro.2008.05.050; Heuer H, 1999, APPL ENVIRON MICROB, V65, P1045; Koning CJM, 2008, AM J GASTROENTEROL, V103, P178, DOI 10.1111/j.1572-0241.2007.01547.x; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Liu CX, 2008, INT J SYST EVOL MICR, V58, P1896, DOI 10.1099/ijs.0.65208-0; Louis P, 2007, J APPL MICROBIOL, V102, P1197, DOI 10.1111/j.1365-2672.2007.03322.x; Marquet P, 2009, FEMS MICROBIOL LETT, V299, P128, DOI 10.1111/j.1574-6968.2009.01750.x; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P7220, DOI 10.1128/AEM.70.12.7220-7228.2004; Maukonen J, 2008, J MED MICROBIOL, V57, P1560, DOI 10.1099/jmm.0.47352-0; Meier H, 1999, SYST APPL MICROBIOL, V22, P186, DOI 10.1016/S0723-2020(99)80065-4; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; NEEFS JM, 1991, NUCLEIC ACIDS RES, V19, P1987, DOI 10.1093/nar/19.suppl.1987; Nomura T, 2005, ALIMENT PHARM THER, V21, P1017, DOI 10.1111/j.1365-2036.2005.02428.x; Nyhlen A, 2002, SCAND J INFECT DIS, V34, P17, DOI 10.1080/00365540110076994; Penders J, 2005, FEMS MICROBIOL LETT, V243, P141, DOI 10.1016/j.femsle.2004.11.052; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rettedal E, 2009, APPL ENVIRON MICROB, V75, P5489, DOI 10.1128/AEM.02220-08; Schalk E, 2010, ANN HEMATOL, V89, P9, DOI 10.1007/s00277-009-0772-0; Schiffrin EJ, 2002, EUR J CLIN NUTR, V56, pS60, DOI 10.1038/sj.ejcn.1601489; Shen J, 2006, APPL ENVIRON MICROB, V72, P5232, DOI 10.1128/AEM.00151-06; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Sonis ST, 1998, ORAL ONCOL, V34, P39, DOI 10.1016/S1368-8375(97)00053-5; Stringer AM, 2007, EXP BIOL MED, V232, P96; Stringer AM, 2009, CANCER CHEMOTH PHARM, V64, P123, DOI 10.1007/s00280-008-0855-y; Symons S, 2010, J INTEGR BIOINFORMAT, V7, DOI 10.2390/biecoll-jib-2010-115; Taras D, 2002, INT J SYST EVOL MICR, V52, P423, DOI 10.1099/00207713-52-2-423; Turroni F, 2008, ANTON LEEUW INT J G, V94, P35, DOI 10.1007/s10482-008-9232-4; van Vliet MJ, 2009, CLIN INFECT DIS, V49, P262, DOI 10.1086/599346; Vrieze A, 2010, DIABETOLOGIA, V53, P606, DOI 10.1007/s00125-010-1662-7; Willing B, 2009, INFLAMM BOWEL DIS, V15, P653, DOI 10.1002/ibd.20783; Woting A, 2010, FEMS MICROBIOL ECOL, V72, P507, DOI 10.1111/j.1574-6941.2010.00863.x; Yu Y, 2005, BIOTECHNOL BIOENG, V89, P670, DOI 10.1002/bit.20347; Zwielehner J, 2009, EXP GERONTOL, V44, P440, DOI 10.1016/j.exger.2009.04.002	56	139	152	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28654	10.1371/journal.pone.0028654	http://dx.doi.org/10.1371/journal.pone.0028654			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194876	gold, Green Submitted, Green Published			2022-12-25	WOS:000298369100070
J	Baiden, F; Owusu-Agyei, S; Bawah, J; Bruce, J; Tivura, M; Delmini, R; Gyaase, S; Amenga-Etego, S; Chandramohan, D; Webster, J				Baiden, Frank; Owusu-Agyei, Seth; Bawah, Justina; Bruce, Jane; Tivura, Mathilda; Delmini, Rupert; Gyaase, Stephaney; Amenga-Etego, Seeba; Chandramohan, Daniel; Webster, Jayne			An Evaluation of the Clinical Assessments of Under-Five Febrile Children Presenting to Primary Health Facilities in Rural Ghana	PLOS ONE			English	Article							CHILDHOOD ILLNESS IMCI; INTEGRATED MANAGEMENT; MALARIA; QUALITY; WORKERS; PNEUMONIA; COUNTRIES; DIARRHEA; SIGNS; COST	Background: The shift to test-based management of malaria represents an important departure from established practice under the Integrated Management of Childhood Illnesses (IMCI). The possibility of false results of tests for malaria and co-morbidity, however, make it important that guidelines in IMCI case assessment are still followed. Methods and Findings: We conducted a cross-sectional observational study to evaluate current practices in IMCI-based assessment of febrile children in 10 health centres and 5 district hospitals, with follow up of a subset of children to determine day 7-10 post-treatment clinical outcome. Clinical consultation, examination and prescribing practices were recorded using a checklist by trained non-medical observers. The facility case management of 1,983 under-five years old febrile children was observed and 593 followed up at home on days 5-10. The mean number of tasks performed from the 11 tasks expected to be done by the IMCI guidelines was 6 (SD 1.6). More than 6 tasks were performed in only 35% of children and this varied substantially between health facilities (range 3-85%). All 11 tasks were performed in only 1% of children. The most commonly performed tasks were temperature measurement (91%) and weighing (88%). Respiratory rate was checked in only 4% of children presenting with cough or difficulty in breathing. The likelihood of performing "better than average number of tasks" (> 6) was higher when the consultation was done by medical assistants than doctors (O.R. = 3.16, 1.02-9.20). The number of tasks performed during assessment did not, however, influence clinical outcome (O.R. = 1.02, 0.83-1.24). Conclusion: Facility-tailored interventions are needed to improve adherence to IMCI guidelines incorporating test-based management of malaria. Studies are needed to re-evaluate the continued validity of tasks defined in IMCI case assessment guidelines.	[Baiden, Frank; Owusu-Agyei, Seth; Bawah, Justina; Tivura, Mathilda; Delmini, Rupert; Gyaase, Stephaney; Amenga-Etego, Seeba] Kintampo Hlth Res Ctr, Malaria Grp, Kintampo, Ghana; [Owusu-Agyei, Seth; Bruce, Jane; Chandramohan, Daniel; Webster, Jayne] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England	Kintampo Health Research Centre; University of London; London School of Hygiene & Tropical Medicine	Baiden, F (corresponding author), Kintampo Hlth Res Ctr, Malaria Grp, Kintampo, Ghana.	baidenf@yahoo.co.uk	Baiden, Frank/Q-2018-2019; Baiden, Frank/AAF-7309-2020	Baiden, Frank/0000-0003-0141-6561; Webster, Jayne/0000-0002-0498-8883; Owusu-Agyei, Seth/0000-0002-0807-1781	ACT Consortium through Bill and Melinda Gates Foundation	ACT Consortium through Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This research was funded by the ACT Consortium (www.actconsortium.org) through a grant from the Bill and Melinda Gates Foundation to the London School of Hygiene and Tropical Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arifeen SE, 2005, B WORLD HEALTH ORGAN, V83, P260; Bishai D, 2008, HEALTH ECON, V17, P5, DOI 10.1002/hec.1231; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Chandler CIR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-53; Chisti MJ, 2009, TROP MED INT HEALTH, V14, P1173, DOI 10.1111/j.1365-3156.2009.02364.x; d'Acremont V, 2010, CLIN INFECT DIS, V51, P506, DOI 10.1086/655688; D'Acremont V, 2009, PLOS MED, V6, P4, DOI 10.1371/journal.pmed.0050252; Dery DB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-314; English M, 2009, PLOS MED, V6, P7, DOI 10.1371/journal.pmed.1000015; FALADE AG, 1995, B WORLD HEALTH ORGAN, V73, P299; Gove S, 1997, B WORLD HEALTH ORGAN, V75, P7; Huicho L, 2008, LANCET, V372, P910, DOI 10.1016/S0140-6736(08)61401-4; JONES SRG, 1992, AM J SOCIOL, V98, P451, DOI 10.1086/230046; Kaiser R, 2006, DISASTERS, V30, P199, DOI 10.1111/j.0361-3666.2006.00315.x; KATZ J, 1993, AM J EPIDEMIOL, V138, P994, DOI 10.1093/oxfordjournals.aje.a116820; Kolstad PR, 1997, B WORLD HEALTH ORGAN, V75, P77; Laurant M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001271.pub2; [Anonymous], 2006, Bull World Health Organ, V84, P595; McCarney R, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-30; *MIN HLTH, 2005, INT MAN CHILDH ILLN; Moti M., 2008, Papua New Guinea Medical Journal, V51, P138; Mullan F, 2007, LANCET, V370, P2158, DOI 10.1016/S0140-6736(07)60785-5; Nicoll A, 2000, T ROY SOC TROP MED H, V94, P9, DOI 10.1016/S0035-9203(00)90418-8; ODEMPSEY TJD, 1993, T ROY SOC TROP MED H, V87, P662, DOI 10.1016/0035-9203(93)90279-Y; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Rowe AK, 2001, AM J PUBLIC HEALTH, V91, P1625, DOI 10.2105/AJPH.91.10.1625; Rowe AK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-275; Rowe SY, 2006, INT J QUAL HEALTH C, V18, P299, DOI 10.1093/intqhc/mzl009; Sanne I, 2010, LANCET, V376, P33, DOI 10.1016/S0140-6736(10)60894-X; Schellenberg JRMA, 2004, LANCET, V364, P1583, DOI 10.1016/S0140-6736(04)17311-X; TULLOCH J, 1993, MED J AUSTRALIA, V159, P46, DOI 10.5694/j.1326-5377.1993.tb137705.x; Tulloch J, 1999, LANCET, V354, pS16; *UNICEF, 2010, STAT WORLDS CHILDR R; Wasunna B, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-261; Weber MW, 1997, B WORLD HEALTH ORGAN, V75, P25; *WHO, 1997, IMCI IN SERV TRAIN G; WHO, 2010, GUID TREATM MAL, V2nd; *WHO, 1999, WHOCHSCAH981AREV1; WHO, 2005, HDB IMCI INT MAN CHI; WHO, 2003, HLTH FAC SURV TOOL E; *WHO GHAN, 2004, IMCI DOCUMENTATION E	41	34	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28944	10.1371/journal.pone.0028944	http://dx.doi.org/10.1371/journal.pone.0028944			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	866GA	22174932	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000298367300034
J	Bessen, RA; Robinson, CJ; Seelig, DM; Watschke, CP; Lowe, D; Shearin, H; Martinka, S; Babcock, AM				Bessen, Richard A.; Robinson, Cameron J.; Seelig, Davis M.; Watschke, Christopher P.; Lowe, Diana; Shearin, Harold; Martinka, Scott; Babcock, Alex M.			Transmission of Chronic Wasting Disease Identifies a Prion Strain Causing Cachexia and Heart Infection in Hamsters	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; DEER ODOCOILEUS-HEMIONUS; EARLY BEHAVIORAL-CHANGES; CERVUS-ELAPHUS-NELSONI; RANGING MULE DEER; TRANSGENIC MICE; SPONGIFORM ENCEPHALOPATHY; MINK ENCEPHALOPATHY; INTERSPECIES TRANSMISSION; ORAL-TRANSMISSION	Chronic wasting disease (CWD) is an emerging prion disease of free-ranging and captive cervids in North America. In this study we established a rodent model for CWD in Syrian golden hamsters that resemble key features of the disease in cervids including cachexia and infection of cardiac muscle. Following one to three serial passages of CWD from white-tailed deer into transgenic mice expressing the hamster prion protein gene, CWD was subsequently passaged into Syrian golden hamsters. In one passage line there were preclinical changes in locomotor activity and a loss of body mass prior to onset of subtle neurological symptoms around 340 days. The clinical symptoms included a prominent wasting disease, similar to cachexia, with a prolonged duration. Other features of CWD in hamsters that were similar to cervid CWD included the brain distribution of the disease-specific isoform of the prion protein, PrPSc, prion infection of the central and peripheral neuroendocrine system, and PrPSc deposition in cardiac muscle. There was also prominent PrPSc deposition in the nasal mucosa on the edge of the olfactory sensory epithelium with the lumen of the nasal airway that could have implications for CWD shedding into nasal secretions and disease transmission. Since the mechanism of wasting disease in prion diseases is unknown this hamster CWD model could provide a means to investigate the physiological basis of cachexia, which we propose is due to a prion-induced endocrinopathy. This prion disease phenotype has not been described in hamsters and we designate it as the 'wasting' or WST strain of hamster CWD.	[Bessen, Richard A.; Watschke, Christopher P.; Lowe, Diana; Shearin, Harold; Martinka, Scott] Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA; [Robinson, Cameron J.; Babcock, Alex M.] Montana State Univ, Dept Psychol, Bozeman, MT 59717 USA; [Seelig, Davis M.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; Colorado State University	Bessen, RA (corresponding author), Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA.	rbessen@montana.edu			Public Health Service from the National Institutes of Health [R01 AI055043, P20 RR020185]; National Research Initiative of the United States Department of Agriculture [2006-35201-16626]; Murphy Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055043] Funding Source: NIH RePORTER	Public Health Service from the National Institutes of Health; National Research Initiative of the United States Department of Agriculture; Murphy Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grants R01 AI055043 and P20 RR020185 from the National Institutes of Health, by the National Research Initiative of the United States Department of Agriculture grant 2006-35201-16626, and The Murphy Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers RC, 2010, SCIENCE, V328, P1154, DOI 10.1126/science.1187107; Angers RC, 2006, SCIENCE, V311, P1117, DOI 10.1126/science.1122864; Baeten LA, 2007, J WILDLIFE DIS, V43, P309, DOI 10.7589/0090-3558-43.2.309; Bailey JD, 2008, J ENDOCRINOL, V197, P251, DOI 10.1677/JOE-07-0516; Balachandran A, 2010, CAN VET J, V51, P169; Bartz JC, 2003, J VIROL, V77, P583, DOI 10.1128/JVI.77.1.583-591.2003; Bartz JC, 2002, J VIROL, V76, P5759, DOI 10.1128/JVI.76.11.5759-5768.2002; Bartz JC, 1998, VIROLOGY, V251, P297, DOI 10.1006/viro.1998.9427; Belay ED, 2004, EMERG INFECT DIS, V10, P977, DOI 10.3201/eid1006.031082; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BESSEN RA, 1992, J GEN VIROL, V73, P329, DOI 10.1099/0022-1317-73-2-329; BESSEN RA, 1995, NATURE, V375, P698, DOI 10.1038/375698a0; Bessen RA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000837; Bessen RA, 2009, J VIROL, V83, P6435, DOI 10.1128/JVI.00018-09; Bondiolotti G, 2010, NEUROBIOL DIS, V37, P114, DOI 10.1016/j.nbd.2009.09.014; Browning SR, 2004, J VIROL, V78, P13345, DOI 10.1128/JVI.78.23.13345-13350.2004; Capucchio MT, 2001, J VET MED A, V48, P23, DOI 10.1046/j.1439-0442.2001.00312.x; CARP RI, 1990, J INFECT DIS, V161, P462, DOI 10.1093/infdis/161.3.462; Chiti Z, 2006, NEUROBIOL DIS, V22, P363, DOI 10.1016/j.nbd.2005.12.002; Choleris E, 2001, NEUROSCI BIOBEHAV R, V25, P235, DOI 10.1016/S0149-7634(01)00011-2; Corona C, 2009, J VIROL, V83, P3657, DOI 10.1128/JVI.01966-08; DeJoia C, 2006, J VIROL, V80, P4546, DOI 10.1128/JVI.80.9.4546-4556.2006; Dell'Omo G, 2002, EUR J NEUROSCI, V16, P735, DOI 10.1046/j.1460-9568.2002.02128.x; Fox KA, 2006, J GEN VIROL, V87, P3451, DOI 10.1099/vir.0.81999-0; Georgsson G, 2008, ARCH VIROL, V153, P637, DOI 10.1007/s00705-008-0035-8; Guenther K, 2001, EUR J NEUROSCI, V14, P401, DOI 10.1046/j.0953-816x.2001.01645.x; GUIROY DC, 1991, ACTA NEUROPATHOL, V81, P475, DOI 10.1007/BF00310125; HADLOW WJ, 1982, J INFECT DIS, V146, P657, DOI 10.1093/infdis/146.5.657; HADLOW WJ, 1974, J INFECT DIS, V129, P559, DOI 10.1093/infdis/129.5.559; Hamir AN, 2006, J VET DIAGN INVEST, V18, P558, DOI 10.1177/104063870601800606; Hamir AN, 2005, J VET DIAGN INVEST, V17, P276, DOI 10.1177/104063870501700313; Hamir AN, 2001, J VET DIAGN INVEST, V13, P91, DOI 10.1177/104063870101300121; Harrington RD, 2008, J GEN VIROL, V89, P1086, DOI 10.1099/vir.0.83422-0; Heisey DM, 2010, J VIROL, V84, P210, DOI 10.1128/JVI.00560-09; Jewell JE, 2006, J GEN VIROL, V87, P3443, DOI 10.1099/vir.0.81777-0; Keane DP, 2008, J VET DIAGN INVEST, V20, P698, DOI 10.1177/104063870802000534; Kercher L, 2004, AM J PATHOL, V165, P2055, DOI 10.1016/S0002-9440(10)63256-7; KIMBERLIN RH, 1987, J GEN VIROL, V68, P1875, DOI 10.1099/0022-1317-68-7-1875; KIMBERLIN RH, 1977, J GEN VIROL, V34, P295, DOI 10.1099/0022-1317-34-2-295; KIMBERLIN RH, 1989, J GEN VIROL, V70, P2017, DOI 10.1099/0022-1317-70-8-2017; KIMBERLIN RH, 1975, J INFECT DIS, V131, P97, DOI 10.1093/infdis/131.2.97; Kong QZ, 2005, J NEUROSCI, V25, P7944, DOI 10.1523/JNEUROSCI.2467-05.2005; LaFauci G, 2006, J GEN VIROL, V87, P3773, DOI 10.1099/vir.0.82137-0; MANUELIDIS EE, 1978, P NATL ACAD SCI USA, V75, P3432, DOI 10.1073/pnas.75.7.3432; Marsh RF, 2005, J VIROL, V79, P13794, DOI 10.1128/JVI.79.21.13794-13796.2005; Masujin K, 2007, J GEN VIROL, V88, P1850, DOI 10.1099/vir.0.82779-0; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Miller MW, 2000, J WILDLIFE DIS, V36, P676, DOI 10.7589/0090-3558-36.4.676; Miller MW, 2004, CURR TOP MICROBIOL, V284, P193; Notari S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008765; Peden AH, 2007, J GEN VIROL, V88, P1068, DOI 10.1099/vir.0.81913-0; Pollera C, 2007, VET RES COMMUN, V31, P249, DOI 10.1007/s11259-007-0089-1; PORTALUPPI F, 1994, HYPERTENSION, V23, P569, DOI 10.1161/01.HYP.23.5.569; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Race B, 2009, EMERG INFECT DIS, V15, P1366, DOI 10.3201/eid1509.090253; Race R, 2000, J VIROL, V74, P828, DOI 10.1128/JVI.74.2.828-833.2000; RACE RE, 1995, NEURON, V15, P1183, DOI 10.1016/0896-6273(95)90105-1; Raymond GJ, 2007, J VIROL, V81, P4305, DOI 10.1128/JVI.02474-06; Sandberg MK, 2010, J GEN VIROL, V91, P2651, DOI 10.1099/vir.0.024380-0; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; Seelig DM, 2010, AM J PATHOL, V176, P2785, DOI 10.2353/ajpath.2010.090710; Shu YJ, 2011, PRION, V5, P103, DOI 10.4161/pri.5.2.15847; Sigurdson CJ, 2008, J COMP PATHOL, V138, P189, DOI 10.1016/j.jcpa.2008.01.004; Sigurdson CJ, 1999, J GEN VIROL, V80, P2757, DOI 10.1099/0022-1317-80-10-2757; Sigurdson CJ, 2002, J GEN VIROL, V83, P2617, DOI 10.1099/0022-1317-83-10-2617; Sigurdson CJ, 2001, J GEN VIROL, V82, P2327, DOI 10.1099/0022-1317-82-10-2327; Spraker TR, 2010, VET PATHOL, V47, P536, DOI 10.1177/0300985810363702; Spraker TR, 2002, VET PATHOL, V39, P546, DOI 10.1354/vp.39-5-546; Spraker TR, 2002, VET PATHOL, V39, P110, DOI 10.1354/vp.39-1-110; SRINIVASAPPA J, 1989, MICROB PATHOGENESIS, V7, P189, DOI 10.1016/0882-4010(89)90054-5; Tabaton M, 2004, ANN NEUROL, V55, P294, DOI 10.1002/ana.20038; Tamguney G, 2006, J VIROL, V80, P9104, DOI 10.1128/JVI.00098-06; Thomzig A, 2006, J GEN VIROL, V87, P251, DOI 10.1099/vir.0.81277-0; Thomzig A, 2004, J CLIN INVEST, V113, P1465, DOI 10.1172/JCI200421083; Thomzig A, 2003, EMBO REP, V4, P530, DOI 10.1038/sj.embor.embor827; Tomzig A, 2004, J BIOL CHEM, V279, P33847, DOI 10.1074/jbc.M403730200; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; *WI DEP NAT RES, 2009, CHRON WAST DIS TEST; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217; Williams ES, 2005, VET PATHOL, V42, P530, DOI 10.1354/vp.42-5-530; YE X, 1995, HISTOL HISTOPATHOL, V10, P995; Zanusso G, 2003, NEW ENGL J MED, V348, P711, DOI 10.1056/NEJMoa022043	82	15	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28026	10.1371/journal.pone.0028026	http://dx.doi.org/10.1371/journal.pone.0028026			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174765	Green Published, Green Submitted, gold			2022-12-25	WOS:000298366600007
J	Kariyat, RR; Scanlon, SR; Mescher, MC; De Moraes, CM; Stephenson, AG				Kariyat, Rupesh R.; Scanlon, Sarah R.; Mescher, Mark C.; De Moraes, Consuelo M.; Stephenson, Andrew G.			Inbreeding Depression in Solanum carolinense (Solanaceae) under Field Conditions and Implications for Mating System Evolution	PLOS ONE			English	Article							GAMETOPHYTIC SELF-INCOMPATIBILITY; PLANT VOLATILES; POLLEN PERFORMANCE; SPATIAL-PATTERN; GENETIC LOAD; LEAF DAMAGE; HERBIVORY; REPRODUCTION; RESISTANCE; DEFENSE	The clonal weed Solanum carolinense exhibits plasticity in the strength of its self-incompatibility (SI) system and suffers low levels of inbreeding depression (delta) in the greenhouse. We planted one inbred and one outbred plant from each of eight maternal plants in a ring (replicated twice) and monitored clonal growth, herbivory, and reproduction over two years. Per ramet delta was estimated to be 0.63 in year one and 0.79 in year two, and outbred plants produced 2.5 times more ramets than inbred plants in the spring of year two. Inbred plants also suffered more herbivore damage than outbred plants in both fields, suggesting that inbreeding compromises herbivore resistance. Total per genet delta was 0.85 over the two years, indicating that S. carolinense is unlikely to become completely self-compatible, and suggesting that plasticity in the SI system is part of a stable mixed-mating system permitting self-fertilization when cross pollen limits seed production.	[Kariyat, Rupesh R.; Scanlon, Sarah R.; Stephenson, Andrew G.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Mescher, Mark C.; De Moraes, Consuelo M.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Kariyat, RR (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	as4@psu.edu	kariyat, rupesh/AAN-2347-2020		National Science Foundation [DEB1050998]; USDA National Institute of Food and Agriculture [2008-35302-04577, 2009-33120-20093]; Division Of Environmental Biology [1050998] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation (http://www.nsf.gov/) grant DEB1050998 and by grants 2008-35302-04577 and 2009-33120-20093 from USDA National Institute of Food and Agriculture (http://www.csrees.usda.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila-Sakar G, 2003, J ECOL, V91, P867, DOI 10.1046/j.1365-2745.2003.00819.x; Avila-Sakar G, 2006, INT J PLANT SCI, V167, P1021, DOI 10.1086/505609; BAKER H. G., 1965, The genetics of colonizing species: Proc. 1st Internat, Union biol Sci., Asilomar, California., P147; Barrett S.C.H., 1990, BIOL APPROACHES EVOL, P229, DOI DOI 10.1016/B978-0-12-402960-6.50019-6; BASSETT IJ, 1986, CAN J PLANT SCI, V66, P977, DOI 10.4141/cjps86-120; Bello-Bedoy R, 2011, J EVOLUTION BIOL, V24, P518, DOI 10.1111/j.1420-9101.2010.02185.x; Bello-Bedoy R, 2010, ANN BOT-LONDON, V105, P747, DOI 10.1093/aob/mcq038; Boege K, 2005, TRENDS ECOL EVOL, V20, P441, DOI 10.1016/j.tree.2005.05.001; BYERS DL, 1992, HEREDITY, V68, P353, DOI 10.1038/hdy.1992.50; Carr DE, 2002, EVOLUTION, V56, P22, DOI 10.1111/j.0014-3820.2002.tb00846.x; Carr DE, 1997, EVOLUTION, V51, P1797, DOI 10.1111/j.1558-5646.1997.tb05103.x; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.ecolsys.18.1.237; CHARLESWORTH D, 1990, EVOLUTION, V44, P870, DOI 10.1111/j.1558-5646.1990.tb03811.x; Cheptou PO, 2000, J EVOLUTION BIOL, V13, P522, DOI 10.1046/j.1420-9101.2000.00175.x; Cipollini ML, 1997, ECOLOGY, V78, P782; Cipollini ML, 2002, J CHEM ECOL, V28, P2377, DOI 10.1023/A:1021494315786; Crnokrak P, 2002, EVOLUTION, V56, P2347, DOI 10.1111/j.0014-3820.2002.tb00160.x; De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; Delph LF, 1997, ECOLOGY, V78, P1632, DOI 10.1890/0012-9658(1997)078[1632:HEFAPP]2.0.CO;2; Delphia CM, 2009, ECOL ENTOMOL, V34, P513, DOI 10.1111/j.1365-2311.2009.01097.x; Delphia CM, 2009, INT J PLANT SCI, V170, P12, DOI 10.1086/593039; Dicke M, 2000, ENTOMOL EXP APPL, V97, P237, DOI 10.1023/A:1004111624780; DOLE J, 1993, EVOLUTION, V47, P361, DOI 10.1111/j.1558-5646.1993.tb02099.x; Du DL, 2008, AM J BOT, V95, P84, DOI 10.3732/ajb.95.1.84; Dudareva N, 2006, CRIT REV PLANT SCI, V25, P417, DOI 10.1080/07352680600899973; DUDASH MR, 1990, EVOLUTION, V44, P1129, DOI 10.1111/j.1558-5646.1990.tb05220.x; Ferrari MJ, 2007, INT J PLANT SCI, V168, P603, DOI 10.1086/513487; Good-Avila S. V., 2008, P33, DOI 10.1007/978-3-540-68486-2_2; HARDIN J W, 1972, Southwestern Naturalist, V16, P403, DOI 10.2307/3670071; Hauser TP, 1996, EVOLUTION, V50, P1119, DOI 10.2307/2410652; Hayes CN, 2005, J EVOLUTION BIOL, V18, P147, DOI 10.1111/j.1420-9101.2004.00785.x; Helenurm K, 1996, AM J BOT, V83, P1585, DOI 10.2307/2445835; Hull-Sanders HM, 2005, ECOLOGY, V86, P897, DOI 10.1890/04-0935; Husband BC, 1996, EVOLUTION, V50, P54, DOI [10.2307/2410780, 10.1111/j.1558-5646.1996.tb04472.x]; ILNICKI RD, 1962, B U RHODE ISLAND, V368; Imura O, 2003, APPL ENTOMOL ZOOL, V38, P293, DOI 10.1303/aez.2003.293; Ivey CT, 2005, AM J BOT, V92, P1641, DOI 10.3732/ajb.92.10.1641; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Koelewijn HP, 1998, EVOLUTION, V52, P692, DOI 10.1111/j.1558-5646.1998.tb03694.x; LANDE R, 1985, EVOLUTION, V39, P24, DOI [10.2307/2408514, 10.1111/j.1558-5646.1985.tb04077.x]; Levin DA, 1996, AM NAT, V148, P321, DOI 10.1086/285927; LLOYD DG, 1992, INT J PLANT SCI, V153, P358, DOI 10.1086/297040; LLOYD DG, 1979, AM NAT, V113, P67, DOI 10.1086/283365; Lu Y, 2006, HEREDITY, V96, P22, DOI 10.1038/sj.hdy.6800740; Marquis R. J., 1992, Plant resistance to herbivores and pathogens: ecology, evolution, and genetics., P301; MCNAUGHTON SJ, 1989, NATURE, V341, P142, DOI 10.1038/341142a0; Mena-Ali JI, 2007, GENETICS, V177, P501, DOI 10.1534/genetics.107.073775; Mena-Ali JI, 2009, SEX PLANT REPROD, V22, P63, DOI 10.1007/s00497-008-0092-x; Mena-Ali JI, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-10; Mutikainen P, 1996, OIKOS, V75, P353, DOI 10.2307/3545874; Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325; Porcher E, 2005, EVOLUTION, V59, P46, DOI 10.1111/j.0014-3820.2005.tb00893.x; Ramsey M, 1998, INT J PLANT SCI, V159, P98, DOI 10.1086/297525; RICHMAN AD, 1995, HEREDITY, V75, P405, DOI 10.1038/hdy.1995.153; SCHMITT J, 1990, EVOLUTION, V44, P269, DOI [10.2307/2409406, 10.1111/j.1558-5646.1990.tb05197.x]; SOLOMON BP, 1985, ECOLOGY, V66, P1321, DOI 10.2307/1939185; SOLOMON BP, 1980, ENVIRON ENTOMOL, V9, P821, DOI 10.1093/ee/9.6.821; SOLOMON BP, 1983, J ECOL, V71, P681, DOI 10.2307/2259585; SOLOMON BP, 1981, ECOLOGY, V62, P1205, DOI 10.2307/1937285; Stebbins G.L., 1974, FLOWERING PLANTS EVO, DOI 10.4159/harvard.9780674864856; Steets JA, 2007, EVOLUTION, V61, P2043, DOI 10.1111/j.1558-5646.2007.00184.x; Stephenson AG, 2004, ECOLOGY, V85, P3023, DOI 10.1890/04-0005; Stephenson AG, 2003, PHILOS T R SOC B, V358, P1009, DOI 10.1098/rstb.2003.1290; Strauss SY, 2001, AM NAT, V158, P496, DOI 10.1086/323116; Travers SE, 2004, PLANT SPEC BIOL, V19, P127, DOI 10.1111/j.1442-1984.2004.00109.x; Uyenoyama M.K., 1993, OXFORD SURVEYS EVOLU, V9, P327, DOI [DOI 10.1016/0040-5809(91)90046-I, 10.1016/0040-5809(91)90046-I]; Uyenoyama MK, 2003, THEOR POPUL BIOL, V63, P281, DOI 10.1016/S0040-5809(03)00020-0; Vallejo-Marin M, 2004, EVOLUTION, V58, P1924, DOI 10.1111/j.0014-3820.2004.tb00480.x; Wise MJ, 2007, SOUTHEAST NAT, V6, P505, DOI 10.1656/1528-7092(2007)6[505:THOSCH]2.0.CO;2; Wise MJ, 2007, NEW PHYTOL, V175, P773, DOI 10.1111/j.1469-8137.2007.02143.x; Wise MJ, 2002, ECOL ENTOMOL, V27, P115, DOI 10.1046/j.0307-6946.2001.00383.x; Wise MJ, 1996, OECOLOGIA, V108, P328, DOI 10.1007/BF00334658; WOLFE LM, 1993, EVOLUTION, V47, P374, DOI 10.1111/j.1558-5646.1993.tb02100.x; Yuan JS, 2008, PLANT J, V55, P491, DOI 10.1111/j.1365-313X.2008.03524.x	75	33	33	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28459	10.1371/journal.pone.0028459	http://dx.doi.org/10.1371/journal.pone.0028459			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174810	Green Published, gold, Green Submitted			2022-12-25	WOS:000298366600018
J	Paukner, A; Ferrari, PF; Suomi, SJ				Paukner, Annika; Ferrari, Pier F.; Suomi, Stephen J.			Delayed Imitation of Lipsmacking Gestures by Infant Rhesus Macaques (Macaca mulatta)	PLOS ONE			English	Article							NEONATAL IMITATION; TONGUE PROTRUSION; FACIAL GESTURES; MANUAL GESTURES; NEURONS	Human infants are capable of accurately matching facial gestures of an experimenter within a few hours after birth, a phenomenon called neonatal imitation. Recent studies have suggested that rather than being a simple reflexive-like behavior, infants exert active control over imitative responses and 'provoke' previously imitated gestures even after a delay of up to 24 h. Delayed imitation is regarded as the hallmark of a sophisticated capacity to control and flexibly engage in affective communication and has been described as an indicator of innate protoconversational readiness. However, we are not the only primates to exhibit neonatal imitation, and delayed imitation abilities may not be uniquely human. Here we report that 1-week-old infant rhesus macaques (Macaca mulatta) who show immediate imitation of a lipsmacking gesture also show delayed imitation of lipsmacking, facilitated by a tendency to refrain from lipsmacking toward a still face during baseline measurements. Individual differences in delayed imitation suggest that differentially matured cortical mechanisms may be involved, allowing some newborns macaques to actively participate in communicative exchanges from birth. Macaque infants are endowed with basic social competencies of intersubjective communication that indicate cognitive and emotional commonality between humans and macaques, which may have evolved to nurture an affective mother-infant relationship in primates.	[Paukner, Annika; Suomi, Stephen J.] NIH, Comparat Ethol Lab, Anim Ctr, Poolesville, MD USA; [Ferrari, Pier F.] Univ Parma, Dipartimento Neurosci, I-43100 Parma, Italy; [Ferrari, Pier F.] Univ Parma, Dipartimento Biol Evolut & Funz, I-43100 Parma, Italy	National Institutes of Health (NIH) - USA; University of Parma; University of Parma	Paukner, A (corresponding author), NIH, Comparat Ethol Lab, Anim Ctr, Poolesville, MD USA.	pauknera@mail.nih.gov	Ferrari, Pier Francesco/G-5547-2017; Paukner, Annika/ABA-3275-2020	Paukner, Annika/0000-0002-3421-1864	Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development; Eunice Kennedy Shriver National Institute of Child Health and Human Development [P01 HD064653]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001107, P01HD064653] Funding Source: NIH RePORTER	Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by the Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development. PFF was supported by Eunice Kennedy Shriver National Institute of Child Health and Human Development P01 HD064653. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAVANEL E, 1984, CHILD DEV, V55, P381, DOI 10.2307/1129950; Anisfeld M, 1996, DEV REV, V16, P149, DOI 10.1006/drev.1996.0006; Anisfeld M., 2005, PERSPECTIVES IMITATI, P107; Bard KA, 2007, ANIM COGN, V10, P233, DOI 10.1007/s10071-006-0062-3; Barr R, 1996, INFANT BEHAV DEV, V19, P159, DOI 10.1016/S0163-6383(96)90015-6; Ferrari PF, 2009, PHILOS T R SOC B, V364, P2311, DOI 10.1098/rstb.2009.0062; Ferrari PF, 2006, PLOS BIOL, V4, P1501, DOI 10.1371/journal.pbio.0040302; Ferrari PF, 2009, CURR BIOL, V19, P1768, DOI 10.1016/j.cub.2009.08.055; Ferrari PF, 2009, CHILD DEV, V80, P1057, DOI 10.1111/j.1467-8624.2009.01316.x; HAYES L, 1981, DEV PSYCHOL, V177, P660; HEIMANN M, 1989, SCAND J PSYCHOL, V30, P90, DOI 10.1111/j.1467-9450.1989.tb01072.x; Heimann M., 2002, IMITATIVE MIND DEV E, P74, DOI DOI 10.1017/CB09780511489969.005; Heyes C, 2001, TRENDS COGN SCI, V5, P253, DOI 10.1016/S1364-6613(00)01661-2; JACOBSON SW, 1979, CHILD DEV, V50, P425, DOI 10.2307/1129418; Jones SS, 2006, INFANT BEHAV DEV, V29, P126, DOI 10.1016/j.infbeh.2005.08.004; Jones SS, 2009, PHILOS T R SOC B, V364, P2325, DOI 10.1098/rstb.2009.0045; Kraskov A, 2009, NEURON, V64, P922, DOI 10.1016/j.neuron.2009.12.010; Kugiumutzakis G., 1999, IMITATION INFANCY, P22; Maestripieri D, 1997, EVOL COMMUN, V1, P193, DOI [10.1075/eoc.1.2.03mae, DOI 10.1075/E0C.1.2.03MAE]; MCKENZIE B, 1983, INFANT BEHAV DEV, V6, P85, DOI 10.1016/S0163-6383(83)80011-3; MELTZOFF AN, 1994, INFANT BEHAV DEV, V17, P83, DOI 10.1016/0163-6383(94)90024-8; MELTZOFF AN, 1977, SCIENCE, V198, P75, DOI 10.1126/science.198.4312.75; MELTZOFF AN, 1983, CHILD DEV, V54, P702, DOI 10.2307/1130058; Myowa M, 1996, PRIMATES, V37, P207, DOI 10.1007/BF02381408; Nagy E, 2005, PEDIATR RES, V58, P749, DOI 10.1203/01.PDR.0000180570.28111.D9; Nagy E, 2004, INFANT BEHAV DEV, V27, P54, DOI 10.1016/j.infbeh.2003.06.004; Ray E, 2011, DEVELOPMENTAL SCI, V14, P92, DOI 10.1111/j.1467-7687.2010.00961.x; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rogers SJ, 2008, J CHILD PSYCHOL PSYC, V49, P449, DOI 10.1111/j.1469-7610.2007.01866.x; Ross MD, 2008, BIOL LETTERS, V4, P27, DOI 10.1098/rsbl.2007.0535; Shannon C, 1998, AM J PRIMATOL, V46, P311, DOI 10.1002/(SICI)1098-2345(1998)46:4<311::AID-AJP3>3.0.CO;2-L; STERN DN, 1985, INTERPERSONAL WORLD, P352; Trevarthen C, 2001, J CHILD PSYCHOL PSYC, V42, P3, DOI 10.1111/1469-7610.00701; Ullstadius E, 1998, EARLY DEV PARENTING, V7, P1, DOI 10.1002/(SICI)1099-0917(199803)7:1<1::AID-EDP158>3.0.CO;2-J	34	23	24	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28848	10.1371/journal.pone.0028848	http://dx.doi.org/10.1371/journal.pone.0028848			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174913	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000298366600044
J	Kumar, A; Swanwick, CC; Johnson, N; Menashe, I; Basu, SN; Bales, ME; Banerjee-Basu, S				Kumar, Ajay; Swanwick, Catherine Croft; Johnson, Nicole; Menashe, Idan; Basu, Saumyendra N.; Bales, Michael E.; Banerjee-Basu, Sharmila			A Brain Region-Specific Predictive Gene Map for Autism Derived by Profiling a Reference Gene Set	PLOS ONE			English	Article							PERVASIVE DEVELOPMENTAL DISORDERS; RECEPTOR SUBUNIT GENES; SPECTRUM DISORDERS; ASSOCIATION ANALYSIS; HEAD CIRCUMFERENCE; LINKAGE; CHILDREN; MODEL; IDENTIFICATION; EXPRESSION	Molecular underpinnings of complex psychiatric disorders such as autism spectrum disorders (ASD) remain largely unresolved. Increasingly, structural variations in discrete chromosomal loci are implicated in ASD, expanding the search space for its disease etiology. We exploited the high genetic heterogeneity of ASD to derive a predictive map of candidate genes by an integrated bioinformatics approach. Using a reference set of 84 Rare and Syndromic candidate ASD genes (AutRef84), we built a composite reference profile based on both functional and expression analyses. First, we created a functional profile of AutRef84 by performing Gene Ontology (GO) enrichment analysis which encompassed three main areas: 1) neurogenesis/projection, 2) cell adhesion, and 3) ion channel activity. Second, we constructed an expression profile of AutRef84 by conducting DAVID analysis which found enrichment in brain regions critical for sensory information processing (olfactory bulb, occipital lobe), executive function (prefrontal cortex), and hormone secretion (pituitary). Disease specificity of this dual AutRef84 profile was demonstrated by comparative analysis with control, diabetes, and non-specific gene sets. We then screened the human genome with the dual AutRef84 profile to derive a set of 460 potential ASD candidate genes. Importantly, the power of our predictive gene map was demonstrated by capturing 18 existing ASD-associated genes which were not part of the AutRef84 input dataset. The remaining 442 genes are entirely novel putative ASD risk genes. Together, we used a composite ASD reference profile to generate a predictive map of novel ASD candidate genes which should be prioritized for future research.	[Kumar, Ajay; Swanwick, Catherine Croft; Johnson, Nicole; Menashe, Idan; Basu, Saumyendra N.; Banerjee-Basu, Sharmila] MindSpec, Mclean, VA USA; [Bales, Michael E.] NMBI Syst, New York, NY USA		Kumar, A (corresponding author), MindSpec, Mclean, VA USA.	sharmila@mindspec.org	Menashe, Idan/W-6214-2019; Menashe, Idan/AAC-8670-2020; Bales, Michael/B-4731-2008	Menashe, Idan/0000-0003-1961-1461; Kumar, Ajay/0000-0003-3904-592X; Bales, Michael/0000-0001-7988-5195	Simons Foundation	Simons Foundation	AutDB is currently funded by the Simons Foundation, which licenses it as SFARI Gene (http://gene.sfari.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashley-Koch AE, 2006, ANN HUM GENET, V70, P281, DOI 10.1111/j.1469-1809.2006.00253.x; Aylward EH, 2002, NEUROLOGY, V59, P175, DOI 10.1212/WNL.59.2.175; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; BALES ME, 2009, AM MED INF ASS ANN S; Banerjee-Basu S, 2010, DIS MODEL MECH, V3, P133, DOI 10.1242/dmm.005439; Baron-Cohen S, 2000, NEUROSCI BIOBEHAV R, V24, P355, DOI 10.1016/S0149-7634(00)00011-7; Basu SN, 2009, NUCLEIC ACIDS RES, V37, pD832, DOI 10.1093/nar/gkn835; Bennetto L, 2007, BIOL PSYCHIAT, V62, P1015, DOI 10.1016/j.biopsych.2007.04.019; Bernier PJ, 2002, P NATL ACAD SCI USA, V99, P11464, DOI 10.1073/pnas.172403999; BOUCHER J, 1992, J CHILD PSYCHOL PSYC, V33, P843, DOI 10.1111/j.1469-7610.1992.tb01960.x; Braun Kim Van Naarden, 2007, Morbidity and Mortality Weekly Report, V56, P29; Buxbaum JD, 2002, MOL PSYCHIATR, V7, P311, DOI 10.1038/sj.mp.4001011; Chakrabarti S, 2001, JAMA-J AM MED ASSOC, V285, P3093, DOI 10.1001/jama.285.24.3093; CHAMBERLAIN RS, 1990, BIOL PSYCHIAT, V28, P773, DOI 10.1016/0006-3223(90)90513-2; Cohen D, 2005, J AUTISM DEV DISORD, V35, P103, DOI 10.1007/s10803-004-1038-2; Cook EH, 1998, AM J HUM GENET, V62, P1077, DOI 10.1086/301832; Crawley JN, 2007, BRAIN PATHOL, V17, P448, DOI 10.1111/j.1750-3639.2007.00096.x; CRESPI B, 2010, NATURE, V455, P919; Curran S, 2005, AM J MED GENET B, V137B, P25, DOI 10.1002/ajmg.b.30126; Davidovitch M, 1996, J CHILD NEUROL, V11, P389, DOI 10.1177/088307389601100509; Delahanty RJ, 2011, MOL PSYCHIATR, V16, P86, DOI 10.1038/mp.2009.118; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; El-Fishawy P, 2010, PSYCHIAT CLIN N AM, V33, P83, DOI 10.1016/j.psc.2009.12.002; Elia J, 2010, MOL PSYCHIATR, V15, P637, DOI 10.1038/mp.2009.57; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Folstein SE, 2001, NAT REV GENET, V2, P943, DOI 10.1038/35103559; Fombonne E, 2005, J CLIN PSYCHIAT, V66, P3; Freitag CM, 2007, MOL PSYCHIATR, V12, P2, DOI 10.1038/sj.mp.4001896; Garber K, 2007, SCIENCE, V317, P190, DOI 10.1126/science.317.5835.190; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gillis J, 2010, NAT PROTOC, V5, P1148, DOI 10.1038/nprot.2010.78; Insel TR, 2010, NEURON, V65, P768, DOI 10.1016/j.neuron.2010.03.005; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Khatri P, 2002, GENOMICS, V79, P266, DOI 10.1006/geno.2002.6698; Kumar A, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-15; LeCouteur A, 1996, J CHILD PSYCHOL PSYC, V37, P785; Li H, 2008, AM J MED GENET B, V147B, P194, DOI 10.1002/ajmg.b.30584; Lord C, 2000, NEURON, V28, P355, DOI 10.1016/S0896-6273(00)00115-X; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McCauley JL, 2004, AM J MED GENET B, V131B, P51, DOI 10.1002/ajmg.b.30038; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Melin M, 2006, NEUROPSYCHOBIOLOGY, V54, P64, DOI 10.1159/000096040; Menold MM, 2001, J NEUROGENET, V15, P245, DOI 10.3109/01677060109167380; Mercadante MT, 2008, MED HYPOTHESES, V70, P352, DOI 10.1016/j.mehy.2007.05.018; MOURIDSEN SE, 2010, BRAIN DEV; Nass R, 1998, DEV MED CHILD NEUROL, V40, P453; Nicholas B, 2007, MOL PSYCHIATR, V12, P581, DOI 10.1038/sj.mp.4001953; Nurmi EL, 2003, J AM ACAD CHILD PSY, V42, P856, DOI 10.1097/01.CHI.0000046868.56865.0F; Persico AM, 2001, MOL PSYCHIATR, V6, P150, DOI 10.1038/sj.mp.4000850; Persico AM, 2006, TRENDS NEUROSCI, V29, P349, DOI 10.1016/j.tins.2006.05.010; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Rogers SJ, 2001, J DEV BEHAV PEDIATR, V22, P409, DOI 10.1097/00004703-200112000-00008; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Scott-Van Zeeland AA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001344; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Serajee FJ, 2006, GENOMICS, V87, P75, DOI 10.1016/j.ygeno.2005.09.008; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Silk TJ, 2006, AM J PSYCHIAT, V163, P1440, DOI 10.1176/appi.ajp.163.8.1440; Skaar DA, 2005, MOL PSYCHIATR, V10, P563, DOI 10.1038/sj.mp.4001614; Suzuki Y, 2003, J NEUROPSYCH CLIN N, V15, P105, DOI 10.1176/appi.neuropsych.15.1.105; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Tan GCY, 2010, NEUROIMAGE, V53, P1030, DOI 10.1016/j.neuroimage.2010.02.018; Toro R, 2010, TRENDS GENET, V26, P363, DOI 10.1016/j.tig.2010.05.007; VOLKMAR FR, 1990, J AM ACAD CHILD PSY, V29, P127, DOI 10.1097/00004583-199001000-00020; Vorstman JAS, 2006, MOL PSYCHIATR, V11, P18, DOI 10.1038/sj.mp.4001757; Yang MS, 2007, INT J DEV NEUROSCI, V25, P69, DOI 10.1016/j.ijdevneu.2006.12.002; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	72	4	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28431	10.1371/journal.pone.0028431	http://dx.doi.org/10.1371/journal.pone.0028431			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174805	gold, Green Published, Green Submitted			2022-12-25	WOS:000298365700035
J	Molavian, HR; Kohandel, M; Milosevic, M; Sivaloganathan, S				Molavian, Hamid R.; Kohandel, Mohammad; Milosevic, Michael; Sivaloganathan, Sivabal			Deriving Mechanisms Responsible for the Lack of Correlation between Hypoxia and Acidity in Solid Tumors	PLOS ONE			English	Article							PH; METASTASES; GROWTH; ANGIOGENESIS; MANIPULATION; VASCULATURE; THERAPY	Hypoxia and acidity are two main microenvironmental factors intimately associated with solid tumors and play critical roles in tumor growth and metastasis. The experimental results of Helmlinger and colleagues ( Nature Medicine 3, 177, 1997) provide evidence of a lack of correlation between these factors on the micrometer scale in vivo and further show that the distribution of pH and pO(2) are heterogeneous. Here, using computational simulations, grounded in these experimental results, we show that the lack of correlation between pH and pO(2) and the heterogeneity in their shapes are related to the heterogeneous concentration of buffers and oxygen in the blood vessels, further amplified by the network of blood vessels and the cell metabolism. We also demonstrate that, although the judicious administration of anti-angiogenesis agents ( normalization process) in tumors may lead to recovery of the correlation between hypoxia and acidity, it may not normalize the pH throughout the whole tumor. However, an increase in the buffering capacity inside the blood vessels does appear to increase the extracellular pH throughout the whole tumor. Based on these results, we propose that the application of anti-angiogenic agents and at the same time increasing the buffering capacity of the tumor extracellular environment may be the most efficient way of normalizing the tumor microenvironment. As a by-product of our simulation we show that the recently observed lack of correlation between glucose consumption and hypoxia in cells which rely on respiration is related to the inhomogeneous consumption of glucose to oxygen concentration. We also demonstrate that this lack of correlation in cells which rely on glycolysis could be related to the heterogeneous concentration of oxygen inside the blood vessels.	[Molavian, Hamid R.; Kohandel, Mohammad; Sivaloganathan, Sivabal] Univ Waterloo, Dept Appl Math, Waterloo, ON N2L 3G1, Canada; [Kohandel, Mohammad; Sivaloganathan, Sivabal] Fields Inst Res Math Sci, Ctr Math Med, Toronto, ON, Canada; [Milosevic, Michael] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada; [Milosevic, Michael] Univ Toronto, Radiat Med Program, Princess Margaret Hosp, Toronto, ON, Canada	University of Waterloo; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Molavian, HR (corresponding author), Univ Waterloo, Dept Appl Math, Waterloo, ON N2L 3G1, Canada.	kohandel@math.uwaterloo.ca		Milosevic, Michael/0000-0002-9620-6876	Natural Sciences and Engineering Research Council; Canadian Institutes of Health Research	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funding was provided by the Natural Sciences and Engineering Research Council and the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brizel DM, 1996, CANCER RES, V56, P941; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; CASCIARI JJ, 1992, J CELL PHYSIOL, V151, P386, DOI 10.1002/jcp.1041510220; Fatt I, 1998, BIOPHYS J, V74, P475, DOI 10.1016/S0006-3495(98)77805-1; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; Hockel M, 1996, CANCER RES, V56, P4509; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; MOLAVIAN HR, 2009, CANCER RES, V9141, P47; Raghunand N, 1999, BRIT J CANCER, V80, P1005, DOI 10.1038/sj.bjc.6690455; Rasey JS, 1996, INT J RADIAT ONCOL, V36, P417, DOI 10.1016/S0360-3016(96)00325-2; Robey IF, 2009, CANCER RES, V69, P2260, DOI 10.1158/0008-5472.CAN-07-5575; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; SILVA AS, 2009, CANCER RES, V69, P4484; TANNOCK IF, 1989, CANCER RES, V49, P4373; Zhong H, 1999, CANCER RES, V59, P5830	18	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28101	10.1371/journal.pone.0028101	http://dx.doi.org/10.1371/journal.pone.0028101			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174768	Green Published, gold, Green Submitted			2022-12-25	WOS:000298365700017
J	Rivadulla, C; de Labra, C; Grieve, KL; Cudeiro, J				Rivadulla, Casto; de Labra, Carmen; Grieve, Kenneth L.; Cudeiro, Javier			Vasomotion and Neurovascular Coupling in the Visual Thalamus In Vivo	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; RAT SOMATOSENSORY CORTEX; SMOOTH-MUSCLE-CELLS; BLOOD-FLOW; NEURAL ACTIVITY; CEREBRAL VASOMOTION; SYNTHASE INHIBITION; NEURONAL-ACTIVITY; BASILAR ARTERY; OXYGENATION	Spontaneous contraction and relaxation of arteries (and in some instances venules) has been termed vasomotion and has been observed in an extensive variety of tissues and species. However, its functions and underlying mechanisms are still under discussion. We demonstrate that in vivo spectrophotometry, measured simultaneously with extracellular recordings at the same locations in the visual thalamus of the cat, reveals vasomotion, measured as an oscillation (0.14hz) in the recorded oxyhemoglobin (OxyHb) signal, which appears spontaneously in the microcirculation and can last for periods of hours. During some non-oscillatory periods, maintained sensory stimulation evokes vasomotion lasting, similar to 30s, resembling an adaptive vascular phenomenon. This oscillation in the oxyhaemoblobin signal is sensitive to pharmacological manipulation: it is inducible by chloralose anaesthesia and it can be temporarily blocked by systemic administration of adrenaline or acetylcholine (ACh). During these oscillatory periods, neurovascular coupling (i.e. the relationship between local neural activity and the rate of blood supply to that location) appears significantly altered. This raises important questions with regard to the interpretation of results from studies currently dependent upon a linear relationship between neural activity and blood flow, such as neuroimaging.	[Rivadulla, Casto; de Labra, Carmen; Cudeiro, Javier] Univ A Coruna, Dept Med INEF Galicia, Lab Neurosci & Motor Control Neurocom, Coruna, Spain; [Rivadulla, Casto; de Labra, Carmen; Cudeiro, Javier] Inst Biomed Res Coruna INIBIC, Coruna, Spain; [Grieve, Kenneth L.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	Universidade da Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); University of Manchester	Rivadulla, C (corresponding author), Univ A Coruna, Dept Med INEF Galicia, Lab Neurosci & Motor Control Neurocom, Coruna, Spain.	casto@udc.es	RIVADULLA, CASTO/K-8425-2012; de Labra, Carmen/C-9992-2017	RIVADULLA, CASTO/0000-0001-5580-3917; de Labra, Carmen/0000-0002-5306-0475; , Gerontology Research Group/0000-0001-7207-9481; Cudeiro, Javier/0000-0002-6597-6077	Ministerio de Educacion y Ciencia (MEC) [BFU2009-08169]; Xunta de Galicia, Spain [Conselleria de Educacion-2007/000140-0]	Ministerio de Educacion y Ciencia (MEC)(Spanish Government); Xunta de Galicia, Spain(Xunta de Galicia)	This work was supported by Ministerio de Educacion y Ciencia (MEC) (BFU2009-08169) and Xunta de Galicia (Conselleria de Educacion-2007/000140-0), Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalkjaer C, 2005, BRIT J PHARMACOL, V144, P605, DOI 10.1038/sj.bjp.0706084; Auer DP, 2008, MAGN RESON IMAGING, V26, P1055, DOI 10.1016/j.mri.2008.05.008; AUER LM, 1981, EUR NEUROL, V20, P448, DOI 10.1159/000115278; Biswal BB, 1996, MICROVASC RES, V52, P1, DOI 10.1006/mvre.1996.0039; Boorman L, 2010, J NEUROSCI, V30, P4285, DOI 10.1523/JNEUROSCI.6063-09.2010; BOUSKELA E, 1992, AM J PHYSIOL, V262, pH478, DOI 10.1152/ajpheart.1992.262.2.H478; Brown LA, 2002, AUTON NEUROSCI-BASIC, V95, P137, DOI 10.1016/S1566-0702(01)00395-2; CLELAND BG, 1971, J PHYSIOL-LONDON, V217, P473, DOI 10.1113/jphysiol.1971.sp009581; COLANTUONI A, 1984, MICROVASC RES, V28, P143, DOI 10.1016/0026-2862(84)90014-1; Colantuoni A, 2001, AUTON NEUROSCI-BASIC, V90, P148, DOI 10.1016/S1566-0702(01)00281-8; de Labra C, 2007, CEREB CORTEX, V17, P1376, DOI 10.1093/cercor/bhl048; de Labra C, 2009, FRONT SYST NEUROSCI, V3, DOI 10.3389/neuro.06.009.2009; De Luca M, 2005, EXP BRAIN RES, V167, P587, DOI 10.1007/s00221-005-0059-1; DERRINGTON AM, 1979, J PHYSIOL-LONDON, V293, P347, DOI 10.1113/jphysiol.1979.sp012893; Devor A, 2003, NEURON, V39, P353, DOI 10.1016/S0896-6273(03)00403-3; DIRNAGL U, 1989, J CEREBR BLOOD F MET, V9, P589, DOI 10.1038/jcbfm.1989.84; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; FUJII K, 1990, AM J PHYSIOL, V258, pH1829, DOI 10.1152/ajpheart.1990.258.6.H1829; GOLANOV EV, 1995, AM J PHYSIOL-REG I, V268, pR454, DOI 10.1152/ajpregu.1995.268.2.R454; GUSTAFSSON H, 1993, ACTA PHYSIOL SCAND, V148, P153, DOI 10.1111/j.1748-1716.1993.tb09545.x; Haddock RE, 2005, J PHYSIOL-LONDON, V566, P645, DOI 10.1113/jphysiol.2005.086405; Haddock RE, 2002, J PHYSIOL-LONDON, V545, P615, DOI 10.1113/jphysiol.2002.027904; Haddock RE, 2006, AM J PHYSIOL-HEART C, V291, pH2047, DOI 10.1152/ajpheart.00484.2006; Hempelmann RG, 1998, NEUROL RES, V20, P63; Hill CE, 1999, J PHYSIOL-LONDON, V521, P507, DOI 10.1111/j.1469-7793.1999.00507.x; HUNDLEY WG, 1988, AM J PHYSIOL, V254, pH67, DOI 10.1152/ajpheart.1988.254.1.H67; JACKSON WF, 1991, AM J PHYSIOL, V260, pH248, DOI 10.1152/ajpheart.1991.260.1.H248; JOHNSON PC, 1967, AM J PHYSIOL, V212, P1405, DOI 10.1152/ajplegacy.1967.212.6.1405; Jones T.W., 1852, PHILOS T R SOC LOND, V142, P131; Lauritzen M, 2001, J CEREBR BLOOD F MET, V21, P1367, DOI 10.1097/00004647-200112000-00001; Lecrux C, 2011, ACTA PHYSIOL, V203, P47, DOI 10.1111/j.1748-1716.2011.02256.x; Leithner C, 2010, J CEREBR BLOOD F MET, V30, P311, DOI 10.1038/jcbfm.2009.211; Li B, 2007, J NEUROSCI, V27, P10223, DOI 10.1523/JNEUROSCI.1505-07.2007; Lindauer Ute, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00025; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 2002, PHILOS T R SOC B, V357, P1003, DOI 10.1098/rstb.2002.1114; Matchkov VV, 2004, J GEN PHYSIOL, V123, P121, DOI 10.1085/jgp.200308972; Mayhew JEW, 1996, NEUROIMAGE, V4, P183, DOI 10.1006/nimg.1996.0069; Nielsen AN, 2001, J PHYSIOL-LONDON, V533, P773, DOI 10.1111/j.1469-7793.2001.00773.x; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; Nilsson Holger, 2003, Mol Interv, V3, P79, DOI 10.1124/mi.3.2.79; Paulson OB, 2010, J CEREBR BLOOD F MET, V30, P2, DOI 10.1038/jcbfm.2009.188; Peng HL, 2001, CIRC RES, V88, P810, DOI 10.1161/hh0801.089603; Rasmussen T, 2009, NEUROIMAGE, V45, P96, DOI 10.1016/j.neuroimage.2008.10.023; Razavi M, 2008, J MAGN RESON IMAGING, V27, P891, DOI 10.1002/jmri.21283; Roy C S, 1890, J Physiol, V11, P85; Schuster A, 2001, AM J PHYSIOL-HEART C, V280, pH1088, DOI 10.1152/ajpheart.2001.280.3.H1088; Sheth SA, 2004, J NEUROSCI, V24, P634, DOI 10.1523/JNEUROSCI.4526-03.2004; Thompson JK, 2005, J NEUROSCI, V25, P9046, DOI 10.1523/JNEUROSCI.2127-05.2005; Toga A.W., 2002, BRAIN MAPPING METHOD; Ursino M, 1996, MICROVASC RES, V51, P229, DOI 10.1006/mvre.1996.0023; Vetri F, 2007, NEUROIMAGE, V38, P25, DOI 10.1016/j.neuroimage.2007.07.017	52	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28746	10.1371/journal.pone.0028746	http://dx.doi.org/10.1371/journal.pone.0028746			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174886	Green Published, gold			2022-12-25	WOS:000298365700068
J	Schloss, CA; Lawler, JJ; Larson, ER; Papendick, HL; Case, MJ; Evans, DM; Delap, JH; Langdon, JGR; Hall, SA; Mcrae, BH				Schloss, Carrie A.; Lawler, Joshua J.; Larson, Eric R.; Papendick, Hilary L.; Case, Michael J.; Evans, Daniel M.; Delap, Jack H.; Langdon, Jesse G. R.; Hall, Sonia A.; Mcrae, Brad H.			Systematic Conservation Planning in the Face of Climate Change: Bet-Hedging on the Columbia Plateau	PLOS ONE			English	Article							CHANGE ADAPTATION STRATEGIES; ECOLOGICAL RESTORATION; SPECIES DISTRIBUTIONS; RESOURCE-MANAGEMENT; PLANT-COMMUNITIES; RESERVE-SELECTION; PROTECTED AREAS; LAND FACETS; BIODIVERSITY; FOREST	Systematic conservation planning efforts typically focus on protecting current patterns of biodiversity. Climate change is poised to shift species distributions, reshuffle communities, and alter ecosystem functioning. In such a dynamic environment, lands selected to protect today's biodiversity may fail to do so in the future. One proposed approach to designing reserve networks that are robust to climate change involves protecting the diversity of abiotic conditions that in part determine species distributions and ecological processes. A set of abiotically diverse areas will likely support a diversity of ecological systems both today and into the future, although those two sets of systems might be dramatically different. Here, we demonstrate a conservation planning approach based on representing unique combinations of abiotic factors. We prioritize sites that represent the diversity of soils, topographies, and current climates of the Columbia Plateau. We then compare these sites to sites prioritized to protect current biodiversity. This comparison highlights places that are important for protecting both today's biodiversity and the diversity of abiotic factors that will likely determine biodiversity patterns in the future. It also highlights places where a reserve network designed solely to protect today's biodiversity would fail to capture the diversity of abiotic conditions and where such a network could be augmented to be more robust to climate-change impacts.	[Schloss, Carrie A.; Lawler, Joshua J.; Papendick, Hilary L.; Case, Michael J.; Delap, Jack H.; Langdon, Jesse G. R.] Univ Washington, Sch Forest Resources, Seattle, WA 98195 USA; [Larson, Eric R.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Evans, Daniel M.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Hall, Sonia A.] Nature Conservancy, Wenatchee, WA USA; [Mcrae, Brad H.] Nature Conservancy, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Nature Conservancy	Schloss, CA (corresponding author), Univ Washington, Sch Forest Resources, Seattle, WA 98195 USA.	cschloss@u.washington.edu	Larson, Eric/H-3528-2012; Larson, Eric R/P-8253-2016	Larson, Eric R/0000-0002-9232-5907; Case, Michael/0000-0003-4111-2298; Hall, Sonia A/0000-0002-3442-814X	Bullitt Foundation	Bullitt Foundation	This work was produced as part of the Conservation of Living Systems Graduate Program at the University of Washington and was funded in part by the Bullitt Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Anderson M, 1998, INT CLASSIFICATION E; Anderson MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011554; Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; Ardron JA, MARXAN GOOD PRACTICE; Ball I.R., 2000, MARXAN 1 8 2 MARINE; Beier P., 2007, CONCEPTUAL STEPS DES; Beier P, 2008, CONSERV BIOL, V22, P836, DOI 10.1111/j.1523-1739.2008.00942.x; Beier P, 2010, CONSERV BIOL, V24, P701, DOI 10.1111/j.1523-1739.2009.01422.x; BELBIN L, 1993, BIOL CONSERV, V66, P223, DOI 10.1016/0006-3207(93)90007-N; Brost B, 2011, ECOLOGICAL IN PRESS; Carlson Brian, 2004, Journal for Nature Conservation (Jena), V12, P15, DOI 10.1016/j.jnc.2003.07.001; Carroll C, 2007, CONSERV BIOL, V21, P1092, DOI 10.1111/j.1523-1739.2007.00719.x; Carvalho SB, 2011, BIOL CONSERV, V144, P2020, DOI 10.1016/j.biocon.2011.04.024; Comer P., 2003, ECOLOGICAL SYSTEMS U; Cowling RM, 2003, BIOL CONSERV, V112, P191, DOI 10.1016/S0006-3207(02)00425-1; Davis F.W., 1999, PARKS, V9, P31; Eeley HAC, 1999, J BIOGEOGR, V26, P595, DOI 10.1046/j.1365-2699.1999.00307.x; Fairbanks DHK, 2000, LANDSCAPE URBAN PLAN, V50, P237, DOI 10.1016/S0169-2046(00)00068-2; Game ET, 2008, MARXAN USER MANUAL M; Groves C.R., 2003, DRAFTING CONSERVATIO; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; Hannah L, 2005, BIOSCIENCE, V55, P231, DOI 10.1641/0006-3568(2005)055[0231:TVFTCE]2.0.CO;2; Hannah L, 2008, ANN NY ACAD SCI, V1134, P201, DOI 10.1196/annals.1439.009; Harris JA, 2006, RESTOR ECOL, V14, P170, DOI 10.1111/j.1526-100X.2006.00136.x; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hobbs RJ, 2009, TRENDS ECOL EVOL, V24, P599, DOI 10.1016/j.tree.2009.05.012; Hobbs RJ, 2008, ANNU REV ENV RESOUR, V33, P39, DOI 10.1146/annurev.environ.33.020107.113631; HUNTER ML, 1988, CONSERV BIOL, V2, P375, DOI 10.1111/j.1523-1739.1988.tb00202.x; Iwamura T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015103; Jackson ST, 2009, SCIENCE, V325, P567, DOI 10.1126/science.1172977; KIRKPATRICK JB, 1994, CONSERV BIOL, V8, P217, DOI 10.1046/j.1523-1739.1994.08010217.x; Lawler JJ, 2010, FRONT ECOL ENVIRON, V8, P35, DOI 10.1890/070146; Lawler JJ, 2009, ANN NY ACAD SCI, V1162, P79, DOI 10.1111/j.1749-6632.2009.04147.x; Lawler JJ, 2009, ECOLOGY, V90, P588, DOI 10.1890/08-0823.1; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; MacKenzie DI, 2005, J WILDLIFE MANAGE, V69, P849, DOI 10.2193/0022-541X(2005)069[0849:WATIWP]2.0.CO;2; MACKEY BG, 1988, ENVIRON MANAGE, V12, P502; Margules CR, 2002, J BIOSCIENCES, V27, P309, DOI 10.1007/BF02704962; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Mawdsley JR, 2009, CONSERV BIOL, V23, P1080, DOI 10.1111/j.1523-1739.2009.01264.x; Meir E, 2004, ECOL LETT, V7, P615, DOI 10.1111/j.1461-0248.2004.00624.x; Noss RF, 2001, CONSERV BIOL, V15, P578, DOI 10.1046/j.1523-1739.2001.015003578.x; NOSS RF, 1987, BIOL CONSERV, V41, P11, DOI 10.1016/0006-3207(87)90045-0; Olson LT, 2009, J GEOGRAPHY REGIONAL, V2, P20; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; PETERS RL, 1985, BIOSCIENCE, V35, P707, DOI 10.2307/1310052; Possingham H, 1998, QUANTITATIVE METHODS FOR CONSERVATION BIOLOGY, P291; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; Pyke CR, 2005, BIOL CONSERV, V121, P429, DOI 10.1016/j.biocon.2004.05.019; Saxon E, 2005, ECOL LETT, V8, P53, DOI 10.1111/j.1461-0248.2004.00694.x; Scott JM, 2001, ECOL APPL, V11, P999, DOI 10.1890/1051-0761(2001)011[0999:NRDTCT]2.0.CO;2; Seaber P.R., 1987, US GEOLOGICAL SURVEY; Team RDC, 2010, R LANG ENV STAT COMP; Tear TH, 2005, BIOSCIENCE, V55, P835, DOI 10.1641/0006-3568(2005)055[0835:HMIETR]2.0.CO;2; Theobald DM, 2010, LANDSCAPE ECOL, V25, P999, DOI 10.1007/s10980-010-9484-z; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Warman LD, 2004, ECOL LETT, V7, P374, DOI 10.1111/j.1461-0248.2004.00590.x; Washington Biodiversity Project, 2011, COL PLAT EC BIOD; Wessels KJ, 1999, BIOL CONSERV, V89, P21, DOI 10.1016/S0006-3207(98)00133-5; Wiens JA, 2010, CONSERV BIOL, V24, P51, DOI 10.1111/j.1523-1739.2009.01409.x; [No title captured]	67	37	37	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28788	10.1371/journal.pone.0028788	http://dx.doi.org/10.1371/journal.pone.0028788			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174897	Green Published, gold, Green Submitted			2022-12-25	WOS:000298163600042
J	Tian, L; Meng, C; Yan, H; Zhao, Q; Liu, Q; Yan, J; Han, YH; Yuan, HS; Wang, LF; Yue, WH; Zhang, YB; Li, XM; Zhu, CZ; He, Y; Zhang, D				Tian, Lin; Meng, Chun; Yan, Hao; Zhao, Qiang; Liu, Qi; Yan, Jun; Han, Yonghua; Yuan, Huishu; Wang, Lifang; Yue, Weihua; Zhang, Yanbo; Li, Xinmin; Zhu, Chaozhe; He, Yong; Zhang, Dai			Convergent Evidence from Multimodal Imaging Reveals Amygdala Abnormalities in Schizophrenic Patients and Their First-Degree Relatives	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; VOXEL-BASED MORPHOMETRY; HIGH-RISK; HIPPOCAMPAL VOLUME; PSYCHIATRIC-DISORDERS; NONPSYCHOTIC SIBLINGS; SYNAPTIC PLASTICITY; EMOTION PERCEPTION; BRAIN VOLUMES; FMRI	Background: Shared neuropathological features between schizophrenic patients and their first-degree relatives have potential as indicators of genetic vulnerability to schizophrenia. We sought to explore genetic influences on brain morphology and function in schizophrenic patients and their relatives. Methods: Using a multimodal imaging strategy, we studied 33 schizophrenic patients, 55 of their unaffected parents, 30 healthy controls for patients, and 29 healthy controls for parents with voxel-based morphometry of structural MRI scans and functional connectivity analysis of resting-state functional MRI data. Results: Schizophrenic patients showed widespread gray matter reductions in the bilateral frontal cortices, bilateral insulae, bilateral occipital cortices, left amygdala and right thalamus, whereas their parents showed more localized reductions in the left amygdala, left thalamus and right orbitofrontal cortex. Patients and their parents shared gray matter loss in the left amygdala. Further investigation of the resting-state functional connectivity of the amygdala in the patients showed abnormal functional connectivity with the bilateral orbitofrontal cortices, bilateral precunei, bilateral dorsolateral frontal cortices and right insula. Their parents showed slightly less, but similar changes in the pattern in the amygdala connectivity. Co-occurrences of abnormal connectivity of the left amygdala with the left orbitofrontal cortex, right dorsolateral frontal cortex and right precuneus were observed in schizophrenic patients and their parents. Conclusions: Our findings suggest a potential genetic influence on structural and functional abnormalities of the amygdala in schizophrenia. Such information could help future efforts to identify the endophenotypes that characterize the complex disorder of schizophrenia.	[Tian, Lin; Yan, Hao; Liu, Qi; Yan, Jun; Han, Yonghua; Wang, Lifang; Yue, Weihua; Zhang, Dai] Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China; [Tian, Lin; Yan, Hao; Liu, Qi; Yan, Jun; Han, Yonghua; Wang, Lifang; Yue, Weihua; Zhang, Dai] Minist Hlth, Key Lab Mental Hlth, Beijing, Peoples R China; [Meng, Chun; Zhu, Chaozhe; He, Yong] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Zhao, Qiang; Yuan, Huishu] Peking Univ, Dept Radiol, Hosp 3, Beijing 100871, Peoples R China; [Zhang, Yanbo; Li, Xinmin] Univ Manitoba, Dept Psychiat, Fac Med, Winnipeg, MB R3T 2N2, Canada	Peking University; Beijing Normal University; Peking University; University of Manitoba	Tian, L (corresponding author), Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China.	hao_y@hsc.pku.edu.cn; daizhang@hsc.pku.edu.cn	He, Yong/C-2161-2009; Chaozhe, Zhu/AAK-7737-2020; He, Yong/Q-5756-2018; Yan, Hao/U-1330-2017	Chaozhe, Zhu/0000-0002-9247-9607; Yan, Hao/0000-0003-0376-9037; Zhang, Yanbo/0000-0002-2421-157X	National Basic Research Program of China [2011CB707805, 2007CB512301]; National Natural Science Foundation of China [81071088, 81000580]; International Science & Technology Cooperation Program of China [2010DFB30820]; Capital Foundation of Medical Developments [2007-1001]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science & Technology Cooperation Program of China; Capital Foundation of Medical Developments	This work was supported by grants from the National Basic Research Program of China (2011CB707805, 2007CB512301), National Natural Science Foundation of China (81071088, 81000580), International Science & Technology Cooperation Program of China (2010DFB30820), and Capital Foundation of Medical Developments (2007-1001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 1997, AM J HUM GENET, V60, P676; Alstott J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000408; Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Bai YM, 2007, J CLIN PSYCHIAT, V68, P1218, DOI 10.4088/JCP.v68n0808; BOGERTS B, 1993, BIOL PSYCHIAT, V33, P236, DOI 10.1016/0006-3223(93)90289-P; Boos H.B., 2011, SCHIZOPHR B; Boos HBM, 2007, ARCH GEN PSYCHIAT, V64, P297, DOI 10.1001/archpsyc.64.3.297; Bora E, 2011, SCHIZOPHR RES, V127, P46, DOI 10.1016/j.schres.2010.12.020; BRACHA HS, 1991, SCHIZOPHRENIA BULL, V17, P551, DOI 10.1093/schbul/17.4.551; Calhoun VD, 2006, HUM BRAIN MAPP, V27, P47, DOI 10.1002/hbm.20166; Calhoun VD, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.017.2009; Chan RCK, 2011, SCHIZOPHRENIA BULL, V37, P177, DOI 10.1093/schbul/sbp073; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Exner C, 2004, SCHIZOPHR RES, V71, P493, DOI 10.1016/j.schres.2004.02.023; Fornito A, 2009, SCHIZOPHR RES, V108, P104, DOI 10.1016/j.schres.2008.12.011; Friston KJ, 1999, ACTA PSYCHIAT SCAND, V99, P68, DOI 10.1111/j.1600-0447.1999.tb05985.x; Gilmore JH, 2007, J NEUROSCI, V27, P1255, DOI 10.1523/JNEUROSCI.3339-06.2007; Glahn DC, 2010, P NATL ACAD SCI USA, V107, P1223, DOI 10.1073/pnas.0909969107; Glahn DC, 2008, BIOL PSYCHIAT, V64, P774, DOI 10.1016/j.biopsych.2008.03.031; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Gur RE, 2002, AM J PSYCHIAT, V159, P1992, DOI 10.1176/appi.ajp.159.12.1992; Habel U, 2004, AM J PSYCHIAT, V161, P1806, DOI 10.1176/appi.ajp.161.10.1806; Harms MP, 2007, J NEUROSCI, V27, P13835, DOI 10.1523/JNEUROSCI.2571-07.2007; Honea RA, 2008, BIOL PSYCHIAT, V63, P465, DOI 10.1016/j.biopsych.2007.05.027; Hoptman MJ, 2010, SCHIZOPHRENIA BULL, V36, P1020, DOI 10.1093/schbul/sbp012; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Jang JH, 2011, SCHIZOPHR RES, V127, P58, DOI 10.1016/j.schres.2010.12.022; Jiang AP, 1995, HUM BRAIN MAPP, V3, P224, DOI 10.1002/hbm.460030306; Job DE, 2003, SCHIZOPHR RES, V64, P1, DOI 10.1016/S0920-9964(03)00158-0; Job DE, 2005, NEUROIMAGE, V25, P1023, DOI 10.1016/j.neuroimage.2005.01.006; Joyal CC, 2003, BIOL PSYCHIAT, V54, P1302, DOI 10.1016/S0006-3223(03)00597-3; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Ke M, 2008, LECT NOTES ARTIF INT, V5009, P628; Keshavan MS, 2002, SCHIZOPHR RES, V58, P173, DOI 10.1016/S0920-9964(01)00404-2; Lawrie SM, 2003, ANN NY ACAD SCI, V985, P445; Lawrie SM, 1998, BRIT J PSYCHIAT, V172, P110, DOI 10.1192/bjp.172.2.110; Lehman AF, 1998, SCHIZOPHRENIA BULL, V24, P1; Liu H., 2010, SCHIZOPHR B; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Lui S, 2009, PSYCHIAT RES-NEUROIM, V171, P71, DOI 10.1016/j.pscychresns.2008.02.004; Lui S, 2009, AM J PSYCHIAT, V166, P196, DOI 10.1176/appi.ajp.2008.08020183; MacDonald AW, 2009, SCHIZOPHRENIA BULL, V35, P1142, DOI 10.1093/schbul/sbn053; MCGUFFIN P, 1995, LANCET, V346, P678, DOI 10.1016/S0140-6736(95)92285-7; McIntosh AM, 2004, BIOL PSYCHIAT, V56, P544, DOI 10.1016/j.biopsych.2004.07.020; Mitchell RLC, 2001, TRENDS COGN SCI, V5, P71, DOI 10.1016/S1364-6613(00)01599-0; Moorhead TWJ, 2009, PSYCHIAT RES-NEUROIM, V174, P105, DOI 10.1016/j.pscychresns.2009.04.003; Mueser KT, 2004, LANCET, V363, P2063, DOI 10.1016/S0140-6736(04)16458-1; Niu L, 2004, PSYCHIAT RES-NEUROIM, V132, P41, DOI 10.1016/j.pscychresns.2004.06.002; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Driscoll GA, 2001, PSYCHIAT RES-NEUROIM, V107, P75, DOI 10.1016/S0925-4927(01)00095-6; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paradiso S, 2003, AM J PSYCHIAT, V160, P1775, DOI 10.1176/appi.ajp.160.10.1775; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; Pearlson GD, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.037.2009; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Pol HEH, 2001, ARCH GEN PSYCHIAT, V58, P1118; Pomarol-Clotet E, 2010, MOL PSYCHIATR, V15, P823, DOI 10.1038/mp.2009.146; Potkin SG, 2009, SCHIZOPHRENIA BULL, V35, P15, DOI 10.1093/schbul/sbn159; Prasad KM, 2008, SCHIZOPHRENIA BULL, V34, P774, DOI 10.1093/schbul/sbn017; Qiu AQ, 2009, NEUROIMAGE, V47, P1221, DOI 10.1016/j.neuroimage.2009.05.054; Qiu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025805; REYNOLDS GP, 1983, NATURE, V305, P527, DOI 10.1038/305527a0; Salvadore G, 2011, NEUROIMAGE, V54, P2643, DOI 10.1016/j.neuroimage.2010.11.011; Sawa A, 2002, SCIENCE, V296, P692, DOI 10.1126/science.1070532; Schlosser RGM, 2007, SCHIZOPHR RES, V89, P1, DOI 10.1016/j.schres.2006.09.007; Seidman LJ, 1999, BIOL PSYCHIAT, V46, P941, DOI 10.1016/S0006-3223(99)00075-X; Seidman LJ, 2002, ARCH GEN PSYCHIAT, V59, P839, DOI 10.1001/archpsyc.59.9.839; Seshadri S, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S15; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Steel RM, 2002, J NEUROL NEUROSUR PS, V72, P455; Stephan KE, 2009, SCHIZOPHRENIA BULL, V35, P509, DOI 10.1093/schbul/sbn176; Stephan KE, 2006, BIOL PSYCHIAT, V59, P929, DOI 10.1016/j.biopsych.2005.10.005; Takahashi H, 2004, NEUROIMAGE, V22, P1247, DOI 10.1016/j.neuroimage.2004.03.028; Tregellas J, 2009, AM J PSYCHIAT, V166, P134, DOI 10.1176/appi.ajp.2008.08111685; Tsuang M, 2000, BIOL PSYCHIAT, V47, P210, DOI 10.1016/S0006-3223(99)00289-9; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; van Haren NE, 2008, CURR OPIN PSYCHIATR, V21, P161, DOI 10.1097/YCO.0b013e3282f4f25b; van Rijn S, 2005, NEUROSCI BIOBEHAV R, V29, P385, DOI 10.1016/j.neubiorev.2004.11.005; Velakoulis D, 2006, ARCH GEN PSYCHIAT, V63, P139, DOI 10.1001/archpsyc.63.2.139; Venables NC, 2009, SCHIZOPHRENIA BULL, V35, P826, DOI 10.1093/schbul/sbn021; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; Williams LM, 2007, PSYCHIAT RES-NEUROIM, V155, P29, DOI 10.1016/j.pscychresns.2006.12.018; Williams LM, 2004, AM J PSYCHIAT, V161, P480, DOI 10.1176/appi.ajp.161.3.480; Wolf DH, 2007, PSYCHIAT RES-NEUROIM, V154, P221, DOI 10.1016/j.pscychresns.2006.11.008; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607; World Health Organization, 1993, ICD 10 CLASS MENT BE, Vxiii; Wright IC, 2000, AM J PSYCHIAT, V157, P16, DOI 10.1176/ajp.157.1.16; Yan H, 2009, NEUROIMAGE, V47, P1579, DOI 10.1016/j.neuroimage.2009.05.080; Zhou YA, 2008, SCHIZOPHR RES, V100, P120, DOI 10.1016/j.schres.2007.11.039	93	28	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28794	10.1371/journal.pone.0028794	http://dx.doi.org/10.1371/journal.pone.0028794			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174900	Green Published, gold, Green Submitted			2022-12-25	WOS:000298163600043
J	Zuniga, J; Cancino, M; Medina, F; Varela, P; Vargas, R; Tapia, G; Videla, LA; Fernandez, V				Zuniga, Jessica; Cancino, Milena; Medina, Fernando; Varela, Patricia; Vargas, Romina; Tapia, Gladys; Videla, Luis A.; Fernandez, Virginia			N-3 PUFA Supplementation Triggers PPAR-alpha Activation and PPAR-alpha/NF-kappa B Interaction: Anti-Inflammatory Implications in Liver Ischemia-Reperfusion Injury	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; OMEGA-3-FATTY-ACIDS; EXPRESSION; PROTEINS; INFLAMMATION; MECHANISMS; PROTECTION; RESOLVINS; DEFENSE; CELLS	Dietary supplementation with the n-3 polyunsaturated fatty acids (n-3 PUFA) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) to rats preconditions the liver against ischemia-reperfusion (IR) injury, with reduction of the enhanced nuclear factor-kappa B (NF-kappa B) functionality occurring in the early phase of IR injury, and recovery of IR-induced proinflammatory cytokine response. The aim of the present study was to test the hypothesis that liver preconditioning by n-3 PUFA is exerted through peroxisone proliferator-activated receptor alpha (PPAR-alpha) activation and interference with NF-kappa B activation. For this purpose we evaluated the formation of PPAR-alpha/NF-kappa Bp65 complexes in relation to changes in PPAR-alpha activation, I kappa B-alpha phosphorylation and serum levels and expression of interleukin (IL)-1 beta and tumor necrosis factor (TNF)-alpha in a model of hepatic IR-injury (1 h of ischemia and 20 h of reperfusion) or sham laparotomy (controls) in male Sprague Dawley rats. Animals were previously supplemented for 7 days with encapsulated fish oil (General Nutrition Corp., Pittsburg, PA) or isovolumetric amounts of saline (controls). Normalization of IR-altered parameters of liver injury (serum transaminases and liver morphology) was achieved by dietary n-3 PUFA supplementation. EPA and DHA suppression of the early IR-induced NF-kappa B activation was paralleled by generation of PPAR-alpha/NF-kappa Bp65 complexes, in concomitance with normalization of the IR-induced IkB-alpha phosphorylation. PPAR-alpha activation by n-3 PUFA was evidenced by enhancement in the expression of the PPAR-alpha-regulated Acyl-CoA oxidase (Acox) and Carnitine-Palmitoyl-CoA transferase I (CPT-I) genes. Consistent with these findings, normalization of IR-induced expression and serum levels of NF-kappa B-controlled cytokines IL-I beta and TNF-alpha was observed at 20 h of reperfusion. Taken together, these findings point to an antagonistic effect of PPAR-alpha on NF-kappa B-controlled transcription of pro-inflammatory mediators. This effect is associated with the formation of PPAR-alpha/NF-kappa Bp65 complexes and enhanced cytosolic I kappa B-alpha stability, as major preconditioning mechanisms induced by n-3 PUFA supplementation against IR liver injury.	[Zuniga, Jessica; Cancino, Milena; Medina, Fernando; Varela, Patricia; Vargas, Romina; Tapia, Gladys; Videla, Luis A.; Fernandez, Virginia] Univ Chile, Fac Med, Inst Biomed Sci, Mol & Clin Pharmacol Program, Santiago 7, Chile	Universidad de Chile	Zuniga, J (corresponding author), Univ Chile, Fac Med, Inst Biomed Sci, Mol & Clin Pharmacol Program, Santiago 7, Chile.	vfernand@med.uchile.cl	Medina Ferrer, Fernando/F-1931-2017; Zuñiga-Hernandez, Jessica/AGC-4271-2022	Medina Ferrer, Fernando/0000-0001-9864-7627; Zuniga, Jessica/0000-0003-2930-991X	FONDECYT (Fondo Nacional de Desarrollo Cientifico y Tecnologico), Chile [1080039, 1110006]	FONDECYT (Fondo Nacional de Desarrollo Cientifico y Tecnologico), Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	These studies were supported by grants 1080039 and 1110006 (to VF) from FONDECYT (Fondo Nacional de Desarrollo Cientifico y Tecnologico), Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins Y, 2010, J NUTR BIOCHEM, V21, P781, DOI 10.1016/j.jnutbio.2009.12.004; Araki Y, 2011, J NUTR METAB, V2011, DOI 10.1155/2011/374542; Ariel A, 2007, TRENDS IMMUNOL, V28, P176, DOI 10.1016/j.it.2007.02.007; Arita M, 2007, J IMMUNOL, V178, P3912, DOI 10.4049/jimmunol.178.6.3912; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Bilzer M, 2006, LIVER INT, V26, P1175, DOI 10.1111/j.1478-3231.2006.01342.x; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Casillas-Ramirez A, 2006, LIFE SCI, V79, P1881, DOI 10.1016/j.lfs.2006.06.024; Chen HH, 2009, AM J PHYSIOL-RENAL, V297, pF1109, DOI 10.1152/ajprenal.00057.2009; Chen WY, 2012, J NUTR BIOCHEM, V23, P252, DOI 10.1016/j.jnutbio.2010.11.022; De Caterina R, 2005, J MEMBRANE BIOL, V206, P103, DOI 10.1007/s00232-005-0783-2; de Roos B, 2009, BRIT J PHARMACOL, V158, P413, DOI 10.1111/j.1476-5381.2009.00189.x; de Rougemont O, 2009, LIVER TRANSPLANT, V15, P1172, DOI 10.1002/lt.21876; Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048; Delerive P, 2001, J ENDOCRINOL, V169, P453, DOI 10.1677/joe.0.1690453; Delerive P, 2000, J BIOL CHEM, V275, P36703, DOI 10.1074/jbc.M004045200; DEMOZ A, 1992, LIPIDS, V27, P968, DOI 10.1007/BF02535573; DERYCKERE F, 1994, BIOTECHNIQUES, V16, P405; DINARELLO CA, 1986, J EXP MED, V163, P1433, DOI 10.1084/jem.163.6.1433; El-Badry AM, 2007, HEPATOLOGY, V45, P855, DOI 10.1002/hep.21625; Fernandez V, 2007, HEPATOLOGY, V45, P170, DOI 10.1002/hep.21476; Gao L, 2007, J BIOL CHEM, V282, P2529, DOI 10.1074/jbc.M607622200; Giakoustidis D, 2006, SURG TODAY, V36, P450, DOI 10.1007/s00595-005-3162-9; Gonzalez-Periz A, 2006, FASEB J, V20, P2537, DOI 10.1096/fj.06-6250fje; Gonzalez-Periz A, 2009, FASEB J, V23, P1946, DOI 10.1096/fj.08-125674; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Iwasaki W, 2010, SHOCK, V33, P306, DOI 10.1097/SHK.0b013e3181b2ffd2; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mishra A, 2004, ARTERIOSCL THROM VAS, V24, P1621, DOI 10.1161/01.ATV.0000137191.02577.86; Okayasu T, 2008, LIFE SCI, V82, P884, DOI 10.1016/j.lfs.2008.02.002; Schmocker C, 2007, HEPATOLOGY, V45, P864, DOI 10.1002/hep.21626; Sethi S, 2002, BLOOD, V100, P1340, DOI 10.1182/blood-2002-01-0316; SEVANIAN A, 1985, ANNU REV NUTR, V5, P365, DOI 10.1146/annurev.nu.05.070185.002053; Sierra S., 2004, Nutr. Hosp., V19, P376; Takahashi Y, 2002, AM J PHYSIOL-GASTR L, V283, pG1175, DOI 10.1152/ajpgi.00515.2001; Tapia G, 2003, FREE RADICAL BIO MED, V35, P257, DOI 10.1016/S0891-5849(03)00209-0; Tapia G, 2010, MOL CELL ENDOCRINOL, V323, P292, DOI 10.1016/j.mce.2010.03.014; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tsukamoto H, 1997, CELLS OF THE HEPATIC SINUSOID, VOL 6, P244; Wanner GA, 1996, SHOCK, V5, P34, DOI 10.1097/00024382-199601000-00008; Ye D, 2002, J PHARMACOL EXP THER, V303, P768, DOI 10.1124/jpet.303.2.768; ZHONG Z, 1995, HEPATOLOGY, V22, P929, DOI 10.1016/0270-9139(95)90317-8; Zuniga J, 2010, FREE RADICAL RES, V44, P854, DOI 10.3109/10715762.2010.485995	44	145	147	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28502	10.1371/journal.pone.0028502	http://dx.doi.org/10.1371/journal.pone.0028502			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174823	Green Published, gold, Green Submitted			2022-12-25	WOS:000298163600028
J	Haynes, LM; Dubief, YC; Mann, KG				Haynes, Laura M.; Dubief, Yves C.; Mann, Kenneth G.			Membrane Binding Events in the Initiation and Propagation Phases of Tissue Factor-initiated Zymogen Activation under Flow	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE FACTOR-V; COAGULATION FACTOR-X; BLOOD-COAGULATION; FACTOR-VIIA; PROTHROMBIN ACTIVATION; SHEAR RATE; PHOSPHOLIPID-VESICLES; CATALYZED ACTIVATION; PLATELET DEPOSITION; THROMBIN GENERATION	This study investigates the dynamics of zymogen activation when both extrinsic tenase and prothrombinase are assembled on an appropriate membrane. Although the activation of prothrombin by surface-localized prothrombinase is clearly mediated by flow-induced dilutional effects, we find that when factor X is activated in isolation by surface-localized extrinsic tenase, it exhibits characteristics of diffusion-mediated activation in which diffusion of substrate to the catalytically active region is rate-limiting. When prothrombin and factor X are activated coincident with each other, competition for available membrane binding sites masks the diffusion-limiting effects of factor X activation. To verify the role of membrane binding in the activation of factor X by extrinsic tenase under flow conditions, we demonstrate that bovine lactadherin competes for both factor X and Xa binding sites, limiting factor X activation and forcing the release of bound factor Xa from the membrane at a venous shear rate (100 s(-1)). Finally, we present steady-state models of prothrombin and factor X activation under flow showing that zymogen and enzyme membrane binding events further regulate the coagulation process in an open system representative of the vasculature geometry.	[Haynes, Laura M.; Mann, Kenneth G.] Univ Vermont, Dept Biochem, Coll Med, Colchester, VT 05446 USA; [Dubief, Yves C.] Univ Vermont, Dept Mech Engn, Coll Engn & Math Sci, Burlington, VT 05405 USA	University of Vermont; University of Vermont	Mann, KG (corresponding author), Univ Vermont, Dept Biochem, Coll Med, S Pk Dr, Colchester, VT 05446 USA.	kenneth.mann@uvm.edu	Dubief, Yves/B-5714-2011	Dubief, Yves/0000-0001-8181-7597	National Institutes of Health [P01 HL46703, 5T32HL007594]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL046703, T32HL007594] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 HL46703 (project 1) (to K. G. M.). This work was presented in part at the XXIII Congress of the International Society of Thrombosis and Haemostasis, Kyoto, Japan, July 25-29, 2011 (58).; Supported by National Institutes of Health Thrombosis and Hemostasis Training Grant 5T32HL007594 (to K. G. M.).	Andersen MH, 2000, BIOCHEMISTRY-US, V39, P6200, DOI 10.1021/bi992221r; BAJAJ SP, 1973, J BIOL CHEM, V248, P7729; BILLY D, 1995, J BIOL CHEM, V270, P1029, DOI 10.1074/jbc.270.3.1029; BLOOM JW, 1979, BIOCHEMISTRY-US, V18, P4419, DOI 10.1021/bi00587a023; BROZE GJ, 1990, BIOCHEMISTRY-US, V29, P7539, DOI 10.1021/bi00485a001; Brummel KE, 2002, BLOOD, V100, P148, DOI 10.1182/blood.V100.1.148; BUNTING PS, 1974, BIOTECHNOL BIOENG, V16, P119, DOI 10.1002/bit.260160109; Butenas S, 2003, J THROMB HAEMOST, V1, P2103, DOI 10.1046/j.1538-7836.2003.00431.x; Butenas S, 2003, J THROMB HAEMOST, V1, P1158, DOI 10.1046/j.1538-7836.2003.00181.x; Butenas S, 2003, ARTERIOSCL THROM VAS, V23, P123, DOI 10.1161/01.ATV.0000042081.57854.A2; Contino P B, 1994, J Physiol Pharmacol, V45, P81; Diamond SL, 2010, THROMB RES, V125, pS29, DOI 10.1016/j.thromres.2010.01.029; ESMON CT, 1981, P NATL ACAD SCI-BIOL, V78, P2249, DOI 10.1073/pnas.78.4.2249; Fogelson AL, 2005, PATHOPHYSIOL HAEMO T, V34, P91, DOI 10.1159/000089930; GEMMELL CH, 1990, MICROVASC RES, V40, P327, DOI 10.1016/0026-2862(90)90031-L; GEMMELL CH, 1988, BLOOD, V72, P1404; Hathcock J, 2007, BIOCHEMISTRY-US, V46, P6134, DOI 10.1021/bi700136a; Hathcock JJ, 2006, ARTERIOSCL THROM VAS, V26, P1729, DOI 10.1161/01.ATV.0000229658.76797.30; Hathcock JJ, 2005, BIOCHEMISTRY-US, V44, P8187, DOI 10.1021/bi050338b; Haynes LM, 2011, J THROMB HAEMOST, V9, P346; Haynes LM, 2011, BIOPHYS J, V100, P765, DOI 10.1016/j.bpj.2010.12.3720; HIGGINS DL, 1983, J BIOL CHEM, V258, P6503; JACKSON CM, 1968, BIOCHEMISTRY-US, V7, P4506, DOI 10.1021/bi00852a047; Jordan SW, 2011, BIOPHYS J, V101, P276, DOI 10.1016/j.bpj.2011.05.056; KALB E, 1992, BIOCHIM BIOPHYS ACTA, V1103, P307, DOI 10.1016/0005-2736(92)90101-Q; Kastrup CJ, 2007, BIOPHYS J, V93, P2969, DOI 10.1529/biophysj.107.109009; KATZMANN JA, 1981, P NATL ACAD SCI-BIOL, V78, P162, DOI 10.1073/pnas.78.1.162; KOBAYASHI T, 1974, BIOTECHNOL BIOENG, V16, P77, DOI 10.1002/bit.260160107; KOYAYASHI T, 1974, BIOTECHNOL BIOENG, V16, P99, DOI 10.1002/bit.260160108; KRISHNASWAMY S, 1992, J BIOL CHEM, V267, P26110; KRISHNASWAMY S, 1992, J BIOL CHEM, V267, P23696; KRISHNASWAMY S, 1988, J BIOL CHEM, V263, P3823; Krudysz-Amblo J, 2010, J BIOL CHEM, V285, P3371, DOI 10.1074/jbc.M109.055178; Kuharsky AL, 2001, BIOPHYS J, V80, P1050, DOI 10.1016/S0006-3495(01)76085-7; KUNG C, 1994, J BIOL CHEM, V269, P25838; Laidler K J, 1980, Methods Enzymol, V64, P227; LANCHANTIN GF, 1963, J BIOL CHEM, V238, P238; Leiderman K, 2011, MATH MED BIOL, V28, P47, DOI 10.1093/imammb/dqq005; Lundblad R L, 1976, Methods Enzymol, V45, P156; MANN KG, 1990, BLOOD, V76, P1; Marsh D, 1996, BIOPHYS J, V70, P2248, DOI 10.1016/S0006-3495(96)79790-4; MCGEE MP, 1992, J BIOL CHEM, V267, P24333; NESHEIM ME, 1984, J BIOL CHEM, V259, P1447; NESHEIM ME, 1981, J BIOL CHEM, V256, P9874; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; Okorie UM, 2008, BLOOD, V111, P3507, DOI 10.1182/blood-2007-08-106229; Orfeo T, 2004, J BIOL CHEM, V279, P19580, DOI 10.1074/jbc.M400727200; Parhami-Seren B, 2006, J THROMB HAEMOST, V4, P1747, DOI 10.1111/j.1538-7836.2006.02000.x; RADCLIFFE RD, 1972, J BIOL CHEM, V247, P7735; ROSING J, 1980, J BIOL CHEM, V255, P274; Runyon MK, 2008, J AM CHEM SOC, V130, P3458, DOI 10.1021/ja076301r; SCHOEN P, 1991, BLOOD, V78, P118; SCHOEN P, 1990, THROMB HAEMOSTASIS, V64, P542; Shaw AW, 2007, J BIOL CHEM, V282, P6556, DOI 10.1074/jbc.M607973200; Shen F, 2008, ARTERIOSCL THROM VAS, V28, P2035, DOI 10.1161/ATVBAHA.108.173930; Shi JL, 2003, BLOOD, V101, P2628, DOI 10.1182/blood-2002-07-1951; SILVERBERG SA, 1977, J BIOL CHEM, V252, P8481; TAMM LK, 1985, BIOPHYS J, V47, P105, DOI 10.1016/S0006-3495(85)83882-0	58	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5225	5234		10.1074/jbc.M111.302075	http://dx.doi.org/10.1074/jbc.M111.302075			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22187432	Green Published, hybrid			2022-12-25	WOS:000300638000005
J	Cheung, PFY; Cheng, CKC; Wong, NCL; Ho, JCY; Yip, CW; Lui, VCH; Cheung, ANY; Fan, ST; Cheung, ST				Cheung, Phyllis Fung Yi; Cheng, Christine Kei Chin; Wong, Nicholas Chun Lim; Ho, Jenny Chung Yee; Yip, Chi Wai; Lui, Vincent Chi Hang; Cheung, Annie Nga Yin; Fan, Sheung Tat; Cheung, Siu Tim			Granulin-Epithelin Precursor Is an Oncofetal Protein Defining Hepatic Cancer Stem Cells	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; SELF-RENEWAL; IDENTIFICATION; DIFFERENTIATION; CHEMORESISTANCE; PROGRANULIN; PATHWAYS; MELANOMA; GROWTH; BRAIN	Background and Aims: Increasing evidence has suggested that hepatocellular carcinoma (HCC) might originate from a distinct subpopulation called cancer stem cells (CSCs), which are responsible for the limited efficacy of conventional therapies. We have previously demonstrated that granulin-epithelin precursor (GEP), a pluripotent growth factor, is upregulated in HCC but not in the adjacent non-tumor, and that GEP is a potential therapeutic target for HCC. Here, we characterized its expression pattern and stem cell properties in fetal and cancerous livers. Methods: Protein expression of GEP in fetal and adult livers was examined in human and mouse models by immunohistochemical staining and flow cytometry. Liver cancer cell lines, isolated based on their GEP and/or ATP-dependent binding cassette (ABC) drug transporter ABCB5 expression, were evaluated for hepatic CSC properties in terms of colony formation, chemoresistance and tumorigenicity. Results: We demonstrated that GEP was a hepatic oncofetal protein that expressed in the fetal livers, but not in the normal adult livers. Importantly, GEP+ fetal liver cells co-expressed the embryonic stem (ES) cell-related signaling molecules including beta-catenin, Oct4, Nanog, Sox2 and DLK1, and also hepatic CSC-markers CD133, EpCAM and ABCB5. Phenotypic characterization in HCC clinical specimens and cell lines revealed that GEP+ cancer cells co-expressed these stem cell markers similarly as the GEP+ fetal liver cells. Furthermore, GEP was shown to regulate the expression of ES cell-related signaling molecules beta-catenin, Oct4, Nanog, and Sox2. Isolated GEP(high) cancer cells showed enhanced colony formation ability and chemoresistance when compared with the GEP(low) counterparts. Co-expression of GEP and ABCB5 better defined the CSC populations with enhanced tumorigenic ability in immunocompromised mice. Conclusions: Our findings demonstrate that GEP is a hepatic oncofetal protein regulating ES cell-related signaling molecules. Co-expression of GEP and ABCB5 further enriches a subpopulation with enhanced CSC properties. The current data provide new insight into the therapeutic strategy.	[Cheung, Phyllis Fung Yi; Cheng, Christine Kei Chin; Wong, Nicholas Chun Lim; Ho, Jenny Chung Yee; Yip, Chi Wai; Lui, Vincent Chi Hang; Fan, Sheung Tat; Cheung, Siu Tim] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Cheung, Phyllis Fung Yi; Fan, Sheung Tat; Cheung, Siu Tim] Univ Hong Kong, Ctr Canc Res, Hong Kong, Hong Kong, Peoples R China; [Cheung, Annie Nga Yin] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Fan, Sheung Tat; Cheung, Siu Tim] Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Cheung, PFY (corresponding author), Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China.	stcheung@hku.hk	Cheung, Siu-Tim/C-4238-2009; /C-4359-2009; Cheung, Annie Nga Yin/C-4231-2009	Cheung, Siu-Tim/0000-0003-2147-315X; /0000-0002-1758-8854; Cheung, Annie Nga Yin/0000-0002-1584-7568	Sun C.Y. Research Foundation for Hepatobiliary and Pancreatic Surgery; National Natural Science Foundation of China; Hong Kong Research Grants Council [N_HKU 709/07, HKU7/CRG/09]; University of Hong Kong	Sun C.Y. Research Foundation for Hepatobiliary and Pancreatic Surgery; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hong Kong Research Grants Council(Hong Kong Research Grants Council); University of Hong Kong(University of Hong Kong)	This study was supported in part by Sun C.Y. Research Foundation for Hepatobiliary and Pancreatic Surgery, National Natural Science Foundation of China and the Hong Kong Research Grants Council (N_HKU 709/07, HKU7/CRG/09), the Seed Funding Program and Small Project Funding Program of the University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Bateman A, 2009, BIOESSAYS, V31, P1245, DOI 10.1002/bies.200900086; Cheung ST, 2011, GASTROENTEROLOGY, V140, P344, DOI 10.1053/j.gastro.2010.07.049; Cheung ST, 2006, ONCOL REP, V15, P1507; Cheung ST, 2004, CLIN CANCER RES, V10, P7629, DOI 10.1158/1078-0432.CCR-04-0960; Daniel R, 2003, DEV DYNAM, V227, P593, DOI 10.1002/dvdy.10341; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Diaz-Cueto L, 2000, DEV BIOL, V217, P406, DOI 10.1006/dbio.1999.9564; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Frank NY, 2005, CANCER RES, V65, P4320, DOI 10.1158/0008-5472.CAN-04-3327; He ZH, 2003, NAT MED, V9, P225, DOI 10.1038/nm816; Ho JC, 2008, HEPATOLOGY, V47, P1524, DOI 10.1002/hep.22191; Kakinuma S, 2009, J HEPATOL, V51, P127, DOI 10.1016/j.jhep.2009.02.033; Kern SE, 2007, CANCER RES, V67, P8985, DOI 10.1158/0008-5472.CAN-07-1971; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; Lade AG, 2011, DEV DYNAM, V240, P486, DOI 10.1002/dvdy.22522; Lee MY, 2009, STEM CELLS, V27, P1858, DOI 10.1002/stem.124; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; O'Brien CA, 2010, CLIN CANCER RES, V16, P3113, DOI 10.1158/1078-0432.CCR-09-2824; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Pei DQ, 2009, J BIOL CHEM, V284, P3365, DOI 10.1074/jbc.R800063200; Postovit LM, 2007, J CELL BIOCHEM, V101, P908, DOI 10.1002/jcb.21227; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Sell S, 2004, CRIT REV ONCOL HEMAT, V51, P1, DOI 10.1016/j.critrevonc.2004.04.007; Suzuki M, 2002, MOL GENET METAB, V75, P31, DOI 10.1006/mgme.2001.3274; Takahashi K, 2005, BIOCHEM SOC T, V33, P1522, DOI 10.1042/BST0331522; Tanaka M, 2009, MECH DEVELOP, V126, P665, DOI 10.1016/j.mod.2009.06.939; Tanimizu N, 2003, J CELL SCI, V116, P1775, DOI 10.1242/jcs.00388; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Topczewska JM, 2006, NAT MED, V12, P925, DOI 10.1038/nm1448; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004	38	39	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2011	6	12							e28246	10.1371/journal.pone.0028246	http://dx.doi.org/10.1371/journal.pone.0028246			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JD	22194816	Green Submitted, Green Published, gold			2022-12-25	WOS:000298664400005
J	Lim, YJ; Choi, JA; Choi, HH; Cho, SN; Kim, HJ; Jo, EK; Park, JK; Song, CH				Lim, Yun-Ji; Choi, Ji-Ae; Choi, Hong-Hee; Cho, Soo-Na; Kim, Hwa-Jung; Jo, Eun-Kyeong; Park, Jeong-Kyu; Song, Chang-Hwa			Endoplasmic Reticulum Stress Pathway-Mediated Apoptosis in Macrophages Contributes to the Survival of Mycobacterium tuberculosis	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; INNATE IMMUNE-RESPONSES; TOLL-LIKE RECEPTORS; NITRIC-OXIDE; CELL-DEATH; INFLAMMATORY RESPONSE; GENE-EXPRESSION; ALPHA-SUBUNIT; ER STRESS; ACTIVATION	Background: Apoptosis is thought to play a role in host defenses against intracellular pathogens, including Mycobacterium tuberculosis (Mtb), by preventing the release of intracellular components and the spread of mycobacterial infection. This study aims to investigate the role of endoplasmic reticulum (ER) stress mediated apoptosis in mycobacteria infected macrophages. Methodology/Principal Findings: Here, we demonstrate that ER stress-induced apoptosis is associated with Mtb H37Rv-induced cell death of Raw264.7 murine macrophages. We have shown that Mtb H37Rv induced apoptosis are involved in activation of caspase-12, which resides on the cytoplasmic district of the ER. Mtb infection increase levels of other ER stress indicators in a time-dependent manner. Phosphorylation of eIF2 alpha was decreased gradually after Mtb H37Rv infection signifying that Mtb H37Rv infection may affect eIF2 alpha phosphorylation in an attempt to survive within macrophages. Interestingly, the survival of mycobacteria in macrophages was enhanced by silencing CHOP expression. In contrast, survival rate of mycobacteria was reduced by phosphorylation of the eIF2 alpha. Futhermore, the levels of ROS, NO or CHOP expression were significantly increased by live Mtb H37Rv compared to heat-killed Mtb H37Rv indicating that live Mtb H37Rv could induce ER stress response. Conclusion/Significance: These findings indicate that eIF2 alpha/CHOP pathway may influence intracellular survival of Mtb H37Rv in macrophages and only live Mtb H37Rv can induce ER stress response. The data support the ER stress pathway plays an important role in the pathogenesis and persistence of mycobacteria.	[Lim, Yun-Ji; Choi, Ji-Ae; Choi, Hong-Hee; Cho, Soo-Na; Kim, Hwa-Jung; Jo, Eun-Kyeong; Park, Jeong-Kyu; Song, Chang-Hwa] Chungnam Natl Univ, Coll Med, Dept Microbiol, Taejon, South Korea; [Choi, Hong-Hee; Jo, Eun-Kyeong] Chungnam Natl Univ, Coll Med, Infect Signaling Network Res Ctr, Taejon, South Korea; [Kim, Hwa-Jung; Jo, Eun-Kyeong; Park, Jeong-Kyu; Song, Chang-Hwa] Chungnam Natl Univ, Coll Med, Res Inst Med Sci, Taejon, South Korea	Chungnam National University; Chungnam National University; Chungnam National University	Lim, YJ (corresponding author), Chungnam Natl Univ, Coll Med, Dept Microbiol, Taejon, South Korea.	songch@cnu.ac.kr	Song, Chang-Hwa/AAD-7917-2022	Song, Chang-Hwa/0000-0002-9490-0573; Eun-Kyeong, Jo/0000-0001-7191-0587; Kim, Hwa-Jung/0000-0002-1127-0909; park, jeong-kyu/0000-0003-4203-3604	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0025985]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0025985). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; Briken V, 2008, FUTURE MICROBIOL, V3, P415, DOI 10.2217/17460913.3.4.415; Chiang CY, 2010, RESPIROLOGY, V15, P413, DOI 10.1111/j.1440-1843.2010.01738.x; Choi HH, 2010, FEBS LETT, V584, P2445, DOI 10.1016/j.febslet.2010.04.050; Divangahi M, 2009, NAT IMMUNOL, V10, P899, DOI 10.1038/ni.1758; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Fairbairn IP, 2004, BIOCHEM SOC T, V32, P496, DOI 10.1042/BST0320496; Ferwerda B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006870; Fratazzi C, 1999, J LEUKOCYTE BIOL, V66, P763, DOI 10.1002/jlb.66.5.763; Giacomini E, 2001, J IMMUNOL, V166, P7033, DOI 10.4049/jimmunol.166.12.7033; Gotoh T, 2002, J BIOL CHEM, V277, P12343, DOI 10.1074/jbc.M107988200; Groskreutz DJ, 2010, J BIOL CHEM, V285, P24023, DOI 10.1074/jbc.M109.077321; He SK, 2008, GRAEF ARCH CLIN EXP, V246, P677, DOI 10.1007/s00417-008-0770-2; Jo EK, 2007, CELL MICROBIOL, V9, P1087, DOI 10.1111/j.1462-5822.2007.00914.x; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kawahara K, 2001, FEBS LETT, V506, P135, DOI 10.1016/S0014-5793(01)02898-8; Kazemi S, 2004, MOL CELL BIOL, V24, P3415, DOI 10.1128/MCB.24.8.3415-3429.2004; Labbe K, 2010, J IMMUNOL, V185, P5495, DOI 10.4049/jimmunol.1002517; Lee J, 2006, J IMMUNOL, V176, P4267, DOI 10.4049/jimmunol.176.7.4267; Lee J, 2009, YONSEI MED J, V50, P1, DOI 10.3349/ymj.2009.50.1.1; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Means TK, 1999, J IMMUNOL, V163, P3920; Miller KA, 2010, EUKARYOT CELL, V9, P1669, DOI 10.1128/EC.00191-10; Momoi T, 2004, J CHEM NEUROANAT, V28, P101, DOI 10.1016/j.jchemneu.2004.05.008; Morishima N, 2002, J BIOL CHEM, V277, P34287, DOI 10.1074/jbc.M204973200; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Perskvist N, 2002, J IMMUNOL, V168, P6358, DOI 10.4049/jimmunol.168.12.6358; Pieters J, 2001, CURR OPIN IMMUNOL, V13, P37, DOI 10.1016/S0952-7915(00)00179-5; Rachman H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000029; Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5; Richardson CE, 2010, NATURE, V463, P1092, DOI 10.1038/nature08762; Rojas M, 1997, J IMMUNOL, V159, P1352; Saleh M, 2006, NATURE, V440, P1064, DOI 10.1038/nature04656; Seimon TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012772; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Torres M, 2006, INFECT IMMUN, V74, P1621, DOI 10.1128/IAI.74.3.1621-1630.2006; Wang HQ, 2007, ENDOCRINOLOGY, V148, P3258, DOI 10.1210/en.2006-1564; Wati S, 2009, J VIROL, V83, P12871, DOI 10.1128/JVI.01419-09; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200	44	72	74	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28531	10.1371/journal.pone.0028531	http://dx.doi.org/10.1371/journal.pone.0028531			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194844	gold, Green Submitted, Green Published			2022-12-25	WOS:000298369100046
J	Taylor, AH; Elliffe, DM; Hunt, GR; Emery, NJ; Clayton, NS; Gray, RD				Taylor, Alex H.; Elliffe, Douglas M.; Hunt, Gavin R.; Emery, Nathan J.; Clayton, Nicola S.; Gray, Russell D.			New Caledonian Crows Learn the Functional Properties of Novel Tool Types	PLOS ONE			English	Article							CORVUS-MONEDULOIDES; HOOK-TOOLS; MANUFACTURE; COGNITION	New Caledonian crows were presented with Bird and Emery's (2009a) Aesop's fable paradigm, which requires stones to be dropped into a water-filled tube to bring floating food within reach. The crows did not spontaneously use stones as tools, but quickly learned to do so, and to choose objects and materials with functional properties. Some crows discarded both inefficient and non-functional objects before observing their effects on the water level. Interestingly, the crows did not learn to discriminate between functional and non-functional objects and materials when there was an arbitrary, rather than causal, link between object and reward. This finding suggests that the crows' performances were not based on associative learning alone. That is, learning was not guided solely by the covariation rate between stimuli and outcomes or the conditioned reinforcement properties acquired by functional objects. Our results, therefore, show that New Caledonian crows can process causal information not only when it is linked to sticks and stick-like tools but also when it concerns the functional properties of novel types of tool.	[Taylor, Alex H.; Elliffe, Douglas M.; Hunt, Gavin R.; Gray, Russell D.] Univ Auckland, Dept Psychol, Auckland, New Zealand; [Emery, Nathan J.] Queen Mary Univ, Sch Biol & Chem Sci, London, England; [Taylor, Alex H.; Clayton, Nicola S.] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England	University of Auckland; University of London; Queen Mary University London; University of Cambridge	Taylor, AH (corresponding author), Univ Auckland, Dept Psychol, Auckland, New Zealand.	at564@cam.ac.uk	Taylor, Alex H/D-6428-2012; Gray, Russell/H-2078-2015	Gray, Russell/0000-0002-9858-0191; Clayton, Nicola/0000-0003-1835-423X; Elliffe, Douglas/0000-0001-9449-9540; Taylor, Alex/0000-0003-3492-7667	Cogito Foundation; Corpus Christi College, Cambridge; New Zealand Marsden Fund; Royal Society University	Cogito Foundation; Corpus Christi College, Cambridge; New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Royal Society University(Royal Society of London)	This work was supported by the Cogito Foundation and a Junior Research Fellowship from Corpus Christi College, Cambridge (Dr. Taylor). Additional support was provided by a grant from the New Zealand Marsden Fund (Dr. Hunt, Dr. Taylor and Dr. Gray). Dr. Elliffe was supported by a Royal Society University Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bird CD, 2009, P NATL ACAD SCI USA, V106, P10370, DOI 10.1073/pnas.0901008106; Bird CD, 2009, CURR BIOL, V19, P1410, DOI 10.1016/j.cub.2009.07.033; Cheke LG, 2011, ANIM COGN, V14, P441, DOI 10.1007/s10071-011-0379-4; Hunt GR, 2000, P ROY SOC B-BIOL SCI, V267, P403, DOI 10.1098/rspb.2000.1015; Hunt GR, 2002, EMU, V102, P283, DOI 10.1071/MU01037; Hunt GR, 2004, P ROY SOC B-BIOL SCI, V271, pS88, DOI 10.1098/rsbl.2003.0085; Hunt GR, 2004, ANIM COGN, V7, P114, DOI 10.1007/s10071-003-0200-0; Hunt GR, 1996, NATURE, V379, P249, DOI 10.1038/379249a0; Kenward B, 2004, IBIS, V146, P652, DOI 10.1111/j.1474-919x.2004.00299.x; McGrew WC, 2010, SCIENCE, V328, P579, DOI 10.1126/science.1187921; Sterelny K, 2003, THOUGHT HOSTILE WORL; Taylor AH, 2009, P R SOC B, V276, P247, DOI 10.1098/rspb.2008.1107; TAYLOR AH, 2011, BIOL LETT IN PRESS; Taylor Alex, 2009, Communicative & Integrative Biology, V2, P311; Taylor AH, 2007, CURR BIOL, V17, P1504, DOI 10.1016/j.cub.2007.07.057; Taylor AH, 2010, P ROY SOC B-BIOL SCI, V277, P2637, DOI 10.1098/rspb.2010.0285; Taylor AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009345; VANLAWIC.J, 1966, NATURE, V212, P1468, DOI 10.1038/2121468a0; von Bayern AMP, 2009, CURR BIOL, V19, P1965, DOI 10.1016/j.cub.2009.10.037; Weir AAS, 2002, SCIENCE, V297, P981, DOI 10.1126/science.1073433; Weir AAS, 2006, ANIM COGN, V9, P317, DOI 10.1007/s10071-006-0052-5	21	50	50	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e26887	10.1371/journal.pone.0026887	http://dx.doi.org/10.1371/journal.pone.0026887			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194779	Green Published, Green Submitted, gold			2022-12-25	WOS:000298369100002
J	Guerra, S; Abaitua, F; Martinez-Sobrido, L; Esteban, M; Garcia-Sastre, A; Rodriguez, D				Guerra, Susana; Abaitua, Fernando; Martinez-Sobrido, Luis; Esteban, Mariano; Garcia-Sastre, Adolfo; Rodriguez, Dolores			Host-Range Restriction of Vaccinia Virus E3L Deletion Mutant Can Be Overcome In Vitro, but Not In Vivo, by Expression of the Influenza Virus NS1 Protein	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; INTERFERON REGULATORY FACTOR-3; HUMAN HELA-CELLS; Z-DNA-BINDING; NF-KAPPA-B; KINASE PKR; IMMUNE-RESPONSE; GENE-EXPRESSION; INFECTED-CELLS; SIGNALING PATHWAY	During the last decades, research focused on vaccinia virus (VACV) pathogenesis has been intensified prompted by its potential beneficial application as a vector for vaccine development and anti-cancer therapies, but also due to the fear of its potential use as a bio-terrorism threat. Recombinant viruses lacking a type I interferon (IFN) antagonist are attenuated and hence good vaccine candidates. However, vaccine virus growth requires production in IFN-deficient systems, and thus viral IFN antagonists that are active in vitro, yet not in vivo, are of great value. The VACV E3 and influenza virus NS1 proteins are distinct double-stranded RNA-binding proteins that play an important role in pathogenesis by inhibiting the mammalian IFN-regulated innate antiviral response. Based on the functional similarities between E3 and NS1, we investigated the ability of NS1 to replace the biological functions of E3 of VACV in both in vitro and in vivo systems. For this, we generated a VACV recombinant virus lacking the E3L gene, yet expressing NS1 (VV Delta E3L/NS1). Our study revealed that NS1 can functionally replace E3 in cultured cells, rescuing the protein synthesis blockade, and preventing apoptosis and RNA breakdown. In contrast, in vivo the VV Delta E3L/NS1 virus was highly attenuated after intranasal inoculation, as it was unable to spread to the lungs and other organs. These results indicate that there are commonalities but also functional differences in the roles of NS1 and E3 as inhibitors of the innate antiviral response, which could potentially be utilized for vaccine production purposes in the future.	[Guerra, Susana; Abaitua, Fernando; Esteban, Mariano; Rodriguez, Dolores] CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain; [Guerra, Susana] Univ Autonoma Madrid, Dept Prevent Med & Publ Hlth, Madrid, Spain; [Martinez-Sobrido, Luis] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Dept Microbiol, New York, NY USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Dept Med, Div Infect Dis, New York, NY USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Global Hlth & Emerging Pathogens Inst, New York, NY USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Autonomous University of Madrid; University of Rochester; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Guerra, S (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain.	susana.guerra@uam.es; drodrig@cnb.csic.es	guerra, susana/K-5972-2014; Martinez-Sobrido, Luis/ACJ-7853-2022; Esteban, Mariano/ABG-5375-2020; Rodriguez, Dolores/ABF-9855-2020	guerra, susana/0000-0001-9067-2991; Martinez-Sobrido, Luis/0000-0001-7084-0804; Esteban, Mariano/0000-0003-0846-2827; Garcia-Sastre, Adolfo/0000-0002-6551-1827; Rodriguez, Dolores/0000-0001-6365-4501	Ramon y Cajal of Spain; Spanish Ministry of Health [FIS 2009-80145]; Comunidad de Madrid [UAM-CM-CCG10-4911]; UAM-Banco de Santander; Spanish Ministry of Science and Technology [CSD2006-00007, AGL2010-15495]; NIAID [R01AI046954, U19AI083025, HHSN266200700010C]; CRIP; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046954, U19AI083025] Funding Source: NIH RePORTER	Ramon y Cajal of Spain; Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Comunidad de Madrid(Comunidad de Madrid); UAM-Banco de Santander; Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CRIP; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	SG holds a research contract from the program Ramon y Cajal of Spain. This work was supported by grants from the Spanish Ministry of Health FIS 2009-80145, Comunidad de Madrid UAM-CM-CCG10-4911 and UAM-Banco de Santander to S. Guerra and from the Spanish Ministry of Science and Technology CONSOLIDER-PORCIVIR CSD2006-00007 and AGL2010-15495 to D. Rodriguez. This work is also partly supported by NIAID grants R01AI046954, U19AI083025, and by CRIP, an NIAID-funded Center of Excellence for Influenza Research and Surveillance (HHSN266200700010C) to AG-S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcami A, 2002, J GEN VIROL, V83, P545, DOI 10.1099/0022-1317-83-3-545; BEATTIE E, 1995, J VIROL, V69, P499, DOI 10.1128/JVI.69.1.499-505.1995; Beattie E, 1996, VIRUS GENES, V12, P89, DOI 10.1007/BF00370005; Brandt T, 2005, VIROLOGY, V333, P263, DOI 10.1016/j.virol.2005.01.006; Brandt TA, 2001, J VIROL, V75, P850, DOI 10.1128/JVI.75.2.850-856.2001; Chakrabarti S, 1997, BIOTECHNIQUES, V23, P1094, DOI 10.2144/97236st07; CHANG HW, 1993, VIROLOGY, V194, P537, DOI 10.1006/viro.1993.1292; CHANG HW, 1992, P NATL ACAD SCI USA, V89, P4825, DOI 10.1073/pnas.89.11.4825; CHANG HW, 1995, J VIROL, V69, P6605, DOI 10.1128/JVI.69.10.6605-6608.1995; COLAMONICI OR, 1995, J BIOL CHEM, V270, P15974, DOI 10.1074/jbc.270.27.15974; DAVIES MV, 1993, J VIROL, V67, P1688, DOI 10.1128/JVI.67.3.1688-1692.1993; Deng L, 2006, J VIROL, V80, P9977, DOI 10.1128/JVI.00354-06; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Gherardi MM, 1999, J IMMUNOL, V162, P6724; Gomez CE, 2011, CURR GENE THER, V11, P189; Guerra S, 2003, J VIROL, V77, P6493, DOI 10.1128/JVI.77.11.6493-6506.2003; Guerra S, 2006, J BIOL CHEM, V281, P18734, DOI 10.1074/jbc.M511983200; Guerra S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000096; Hrincius ER, 2010, CELL MICROBIOL, V12, P831, DOI 10.1111/j.1462-5822.2010.01436.x; Iwai A, 2010, J BIOL CHEM, V285, P32064, DOI 10.1074/jbc.M110.112458; Kim YG, 2003, P NATL ACAD SCI USA, V100, P6974, DOI 10.1073/pnas.0431131100; Kwon JA, 2005, P NATL ACAD SCI USA, V102, P12759, DOI 10.1073/pnas.0506011102; Langland JO, 2006, J VIROL, V80, P10083, DOI 10.1128/JVI.00607-06; Langland JO, 2004, VIROLOGY, V324, P419, DOI 10.1016/j.virol.2004.03.012; Langland JO, 2002, VIROLOGY, V299, P133, DOI 10.1006/viro.2002.1479; LANGLAND JO, 1994, J VIROL, V68, P3821, DOI 10.1128/JVI.68.6.3821-3829.1994; Li SD, 2006, VIROLOGY, V349, P13, DOI 10.1016/j.virol.2006.01.005; LU Y, 1995, VIROLOGY, V214, P222, DOI 10.1006/viro.1995.9937; Malathi K, 2005, P NATL ACAD SCI USA, V102, P14533, DOI 10.1073/pnas.0507551102; Min JY, 2007, VIROLOGY, V363, P236, DOI 10.1016/j.virol.2007.01.038; Min JY, 2006, P NATL ACAD SCI USA, V103, P7100, DOI 10.1073/pnas.0602184103; Moss B, 2001, SEMIN IMMUNOL, V13, P59, DOI 10.1006/smim.2000.0296; MOSS B, 2007, FIELDS VIROLOGY, V2; Myskiw C, 2009, J VIROL, V83, P6757, DOI 10.1128/JVI.02570-08; Osiak A, 2005, MOL CELL BIOL, V25, P6338, DOI 10.1128/MCB.25.15.6338-6345.2005; Pang QS, 2002, J BIOL CHEM, V277, P49638, DOI 10.1074/jbc.M209386200; Perdiguero B, 2009, J INTERF CYTOK RES, V29, P581, DOI 10.1089/jir.2009.0073; Rice AD, 2011, J VIROL, V85, P550, DOI 10.1128/JVI.00254-10; Rivas C, 1998, VIROLOGY, V243, P406, DOI 10.1006/viro.1998.9072; RODRIGUEZ JR, 1992, J VIROL, V66, P183, DOI 10.1128/JVI.66.1.183-189.1992; Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049; SEN, 1992, J BIOL CHEM, V267, P5017; Shors ST, 1998, J INTERF CYTOK RES, V18, P721, DOI 10.1089/jir.1998.18.721; SIMPSONHOLLEY M, 2010, J VIROL; Smith CA, 1997, VIROLOGY, V236, P316, DOI 10.1006/viro.1997.8730; Smith EJ, 2001, J BIOL CHEM, V276, P8951, DOI 10.1074/jbc.M008717200; Smith GL, 1997, IMMUNOL REV, V159, P137, DOI 10.1111/j.1600-065X.1997.tb01012.x; Sroller V, 2001, ARCH VIROL, V146, P239, DOI 10.1007/s007050170172; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Talon J, 2000, J VIROL, V74, P7989, DOI 10.1128/JVI.74.17.7989-7996.2000; Tan SL, 1998, J INTERF CYTOK RES, V18, P757, DOI 10.1089/jir.1998.18.757; Valentine R, 2010, J GEN VIROL, V91, P2221, DOI 10.1099/vir.0.021998-0; Varga ZT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002067; Vijaysri S, 2003, VIROLOGY, V314, P305, DOI 10.1016/S0042-6822(03)00433-1; Vijaysri S, 2008, VACCINE, V26, P664, DOI 10.1016/j.vaccine.2007.11.045; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; Xiang Y, 2002, J VIROL, V76, P5251, DOI 10.1128/JVI.76.10.5251-5259.2002; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; Zhang P, 2008, J VIROL, V82, P840, DOI 10.1128/JVI.01891-07; Zhang P, 2008, J BIOL CHEM, V283, P34580, DOI 10.1074/jbc.M807029200	60	11	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28677	10.1371/journal.pone.0028677	http://dx.doi.org/10.1371/journal.pone.0028677			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174864	Green Published, gold			2022-12-25	WOS:000298367300020
J	Mourad, R; Sinoquet, C; Dina, C; Leray, P				Mourad, Raphael; Sinoquet, Christine; Dina, Christian; Leray, Philippe			Visualization of Pairwise and Multilocus Linkage Disequilibrium Structure Using Latent Forests	PLOS ONE			English	Article							GRAPHICAL MODELS; HUMAN GENOME; HAPLOTYPE; MAP; INFERENCE; SNPS; LOCI	Linkage disequilibrium study represents a major issue in statistical genetics as it plays a fundamental role in gene mapping and helps us to learn more about human history. The linkage disequilibrium complex structure makes its exploratory data analysis essential yet challenging. Visualization methods, such as the triangular heat map implemented in Haploview, provide simple and useful tools to help understand complex genetic patterns, but remain insufficient to fully describe them. Probabilistic graphical models have been widely recognized as a powerful formalism allowing a concise and accurate modeling of dependences between variables. In this paper, we propose a method for short-range, long-range and chromosome-wide linkage disequilibrium visualization using forests of hierarchical latent class models. Thanks to its hierarchical nature, our method is shown to provide a compact view of both pairwise and multilocus linkage disequilibrium spatial structures for the geneticist. Besides, a multilocus linkage disequilibrium measure has been designed to evaluate linkage disequilibrium in hierarchy clusters. To learn the proposed model, a new scalable algorithm is presented. It constrains the dependence scope, relying on physical positions, and is able to deal with more than one hundred thousand single nucleotide polymorphisms. The proposed algorithm is fast and does not require phase genotypic data.	[Mourad, Raphael; Leray, Philippe] Univ Nantes, Ecole Polytech, UMR CNRS 6241, LINA, Nantes, France; [Dina, Christian] INSERM, UMR 915, Inst Thorax, Nantes, France	Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes	Mourad, R (corresponding author), Univ Nantes, Ecole Polytech, UMR CNRS 6241, LINA, BP 50609, Nantes, France.	raphael.mourad@univ-nantes.fr; christine.sinoquet@nantes.fr	Dina, Christian R/D-3535-2015; Leray, Philippe/AAR-5500-2020	Dina, Christian R/0000-0002-7722-7348; Leray, Philippe/0000-0002-0207-9280	Pays de la Loire Region, France	Pays de la Loire Region, France(Region Pays de la Loire)	This work was supported by the BIL Bioinformatics Research Project of Pays de la Loire Region, France. The funder supported the PhD grant of the first author, Raphael Mourad. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anderson EC, 2003, AM J HUM GENET, V73, P336, DOI 10.1086/377106; Azuaje F, 2005, DATA ANALYSIS AND VISUALIZATION IN GENOMICS AND PROTEOMICS, P1, DOI 10.1002/0470094419; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Ben-Dor A, 1999, P 3 ANN INT C COMP M, P33; Cannings C, 2007, HDB STAT GENETICS, P878; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; DAVID J, 2001, PRINCIPLES DATA MINI; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; FRY B, 2004, THESIS MIT; Koller D., 2009, PROBABILISTIC GRAPHI; Kullback S., 1968, INFORM THEORY STAT; Kumasaka N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010207; MCVEAN G, 2007, HDB STAT GENETICS, V2, P909; Miretti MM, 2005, AM J HUM GENET, V76, P634, DOI 10.1086/429393; MORRIS AP, 2007, HDB STAT GENETICS, V2, P1238; MOURAD R, 2010, 19 INT C COMP STAT C, P549; Mourad R, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-16; Pemberton TJ, 2010, AM J HUM GENET, V87, P457, DOI 10.1016/j.ajhg.2010.08.014; Phillips MS, 2003, NAT GENET, V33, P382, DOI 10.1038/ng1100; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Robbins MD, 2011, J EXP BOT, V62, P1831, DOI 10.1093/jxb/erq367; Simoff SJ, 2008, LECT NOTES COMPUT SC, V4404, P1, DOI 10.1007/978-3-540-71080-6; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Thomas A, 2004, AM J HUM GENET, V74, P1088, DOI 10.1086/421249; Thomas A, 2009, COMPUT STAT DATA AN, V53, P1818, DOI 10.1016/j.csda.2008.02.003; Thomas A, 2009, BIOINFORMATICS, V25, P1287, DOI 10.1093/bioinformatics/btp146; Verzilli CJ, 2006, AM J HUM GENET, V79, P100, DOI 10.1086/505313; WATANABE S, 1960, IBM J RES DEV, V4, P6682	30	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e27320	10.1371/journal.pone.0027320	http://dx.doi.org/10.1371/journal.pone.0027320			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174739	gold, Green Published			2022-12-25	WOS:000298367300005
J	Li, WL; Wang, W; Sun, SP; Sun, Y; Pan, Y; Wang, LN; Zhang, R; Zhang, K; Li, JM				Li, Wenli; Wang, Wei; Sun, Shipeng; Sun, Yu; Pan, Yang; Wang, Lunan; Zhang, Rui; Zhang, Kuo; Li, Jinming			Autoantibodies against the Catalytic Domain of BRAF Are Not Specific Serum Markers for Rheumatoid Arthritis	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; GENE-EXPRESSION; INTERLEUKIN-6; RESPONSES; LUPUS; MAPKS	Background: Autoantibodies to the catalytic domain of v-raf murine sarcoma viral oncogene homologue B1 (BRAF) have been recently identified as a new family of autoantibodies involved in rheumatoid arthritis (RA). The objective of this study was to determine antibody responses to the catalytic domain of BRAF in RA and other autoimmune diseases. The association between RA-related clinical indices and these antibodies was also assessed. Methodology/Principal Findings: The presence of autoantibodies to the catalytic domain of BRAF (anti-BRAF) or to peptide P25 (amino acids 656-675 of the catalytic domain of BRAF; anti-P25) was determined in serum samples from patients with RA, primary Sjogren's syndrome (pSS), systemic lupus erythematosus (SLE), and healthy controls by using indirect enzyme-linked immunosorbent assays (ELISAs) based on the recombinant catalytic domain of BRAF or a synthesized peptide, respectively. Associations of anti-BRAF or anti-P25 with disease variables of RA patients were also evaluated. Our results show that the BRAF-specific antibodies anti-BRAF and anti-P25 are equally present in RA, pSS, and SLE patients. However, the erythrocyte sedimentation rate (ESR) used to detect inflammation was significantly different between patients with and without BRAF-specific antibodies. The anti-BRAF-positive patients were found to have prolonged disease, and active disease occurred more frequently in anti-P25-positive patients than in anti-P25-negative patients. A weak but significant correlation between anti-P25 levels and ESRs was observed (r = 0.319, p = 0.004). Conclusions/Significance: The antibody response against the catalytic domain of BRAF is not specific for RA, but the higher titers of BRAF-specific antibodies may be associated with increased inflammation in RA.	[Li, Wenli; Wang, Wei; Sun, Shipeng; Sun, Yu; Pan, Yang; Wang, Lunan; Zhang, Rui; Zhang, Kuo; Li, Jinming] Beijing Hosp, Natl Ctr Clin Labs, Beijing, Peoples R China; [Li, Wenli; Wang, Wei; Sun, Shipeng; Sun, Yu; Pan, Yang] Chinese Acad Med Sci, Grad Sch, Peking Union Med Coll, Beijing 100730, Peoples R China	Beijing Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Li, WL (corresponding author), Beijing Hosp, Natl Ctr Clin Labs, Beijing, Peoples R China.	ljm63hn@yahoo.com.cn	Wang, Lunan/AAS-9785-2021	Wang, Lunan/0000-0003-3163-7891	National High Technology Reseach and Development Program of China (863 Program) [2011AA02A116]	National High Technology Reseach and Development Program of China (863 Program)	This work was supported by a grant from the National High Technology Reseach and Development Program of China (863 Program) (No. 2011AA02A116). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Auger I, 2009, ANN RHEUM DIS, V68, P591, DOI 10.1136/ard.2008.096917; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Charpin C, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3165; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Di Bonito Paola, 2006, Infect Agent Cancer, V1, P6, DOI 10.1186/1750-9378-1-6; Fensterle J, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-62; Johansson AG, 1996, HEPATOLOGY, V24, P169, DOI 10.1053/jhep.1996.v24.pm0008707258; Lacki JK, 1997, CLIN RHEUMATOL, V16, P275, DOI 10.1007/BF02238963; Luo SF, 2010, ARTHRITIS RHEUM-US, V62, P105, DOI 10.1002/art.25060; Miyazawa K, 1998, J BIOL CHEM, V273, P24832, DOI 10.1074/jbc.273.38.24832; Raptopoulou A, 2007, CRIT REV CL LAB SCI, V44, P339, DOI 10.1080/10408360701295623; Richards HB, 1998, J EXP MED, V188, P985, DOI 10.1084/jem.188.5.985; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Schett G, 2008, ANN RHEUM DIS, V67, P909, DOI 10.1136/ard.2007.074278; Strumberg D, 2002, Int J Clin Pharmacol Ther, V40, P580; Sweeney SE, 2004, CURR OPIN RHEUMATOL, V16, P231, DOI 10.1097/00002281-200405000-00011; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Thalhamer T, 2008, RHEUMATOLOGY, V47, P409, DOI 10.1093/rheumatology/kem297; Wang W, 2011, CLIN RHEUMATOL, V30, P563, DOI 10.1007/s10067-010-1671-4; Westermarck J, 2001, MOL CELL BIOL, V21, P2373, DOI 10.1128/MCB.21.7.2373-2383.2001; Yang JC, 1996, INFECT IMMUN, V64, P3584, DOI 10.1128/IAI.64.9.3584-3591.1996	22	0	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28975	10.1371/journal.pone.0028975	http://dx.doi.org/10.1371/journal.pone.0028975			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174938	Green Submitted, Green Published, gold			2022-12-25	WOS:000298366600054
J	Liao, HH; Irvine, AD; MacEwen, CJ; Weed, KH; Porter, L; Corden, LD; Gibson, AB; Moore, JE; Smith, FJD; McLean, WHI; Moore, CBT				Liao, Haihui; Irvine, Alan D.; MacEwen, Caroline J.; Weed, Kathryn H.; Porter, Louise; Corden, Laura D.; Gibson, A. Bethany; Moore, Jonathan E.; Smith, Frances J. D.; McLean, W. H. Irwin; Moore, C. B. Tara			Development of Allele-Specific Therapeutic siRNA in Meesmann Epithelial Corneal Dystrophy	PLOS ONE			English	Article							KANGAROO PTK2 CELLS; MUTATIONS; GENE; DISORDERS; DISEASE; EXPRESSION; SPECTRUM; CLONING; RNAI; K12	Background: Meesmann epithelial corneal dystrophy (MECD) is an inherited eye disorder caused by dominant-negative mutations in either keratins K3 or K12, leading to mechanical fragility of the anterior corneal epithelium, the outermost covering of the eye. Typically, patients suffer from lifelong irritation of the eye and/or photophobia but rarely lose visual acuity; however, some individuals are severely affected, with corneal scarring requiring transplant surgery. At present no treatment exists which addresses the underlying pathology of corneal dystrophy. The aim of this study was to design and assess the efficacy and potency of an allele-specific siRNA approach as a future treatment for MECD. Methods and Findings: We studied a family with a consistently severe phenotype where all affected persons were shown to carry heterozygous missense mutation Leu132Pro in the KRT12 gene. Using a cell-culture assay of keratin filament formation, mutation Leu132Pro was shown to be significantly more disruptive than the most common mutation, Arg135Thr, which is associated with typical, mild MECD. A siRNA sequence walk identified a number of potent inhibitors for the mutant allele, which had no appreciable effect on wild-type K12. The most specific and potent inhibitors were shown to completely block mutant K12 protein expression with negligible effect on wild-type K12 or other closely related keratins. Cells transfected with wild-type K12-EGFP construct show a predominantly normal keratin filament formation with only 5% aggregate formation, while transfection with mutant K12-EGFP construct resulted in a significantly higher percentage of keratin aggregates (41.75%; p<0.001 with 95% confidence limits). The lead siRNA inhibitor significantly rescued the ability to form keratin filaments (74.75% of the cells contained normal keratin filaments; p<0.001 with 95% confidence limits). Conclusions: This study demonstrates that it is feasible to design highly potent siRNA against mutant alleles with single-nucleotide specificity for future treatment of MECD.	[Liao, Haihui; Porter, Louise; Corden, Laura D.; Gibson, A. Bethany; Smith, Frances J. D.; McLean, W. H. Irwin; Moore, C. B. Tara] Univ Dundee, Coll Life Sci & Med, Div Mol Med, Dundee, Scotland; [Liao, Haihui; Porter, Louise; Corden, Laura D.; Gibson, A. Bethany; Smith, Frances J. D.; McLean, W. H. Irwin; Moore, C. B. Tara] Univ Dundee, Coll Dent, Div Mol Med, Dundee, Scotland; [Liao, Haihui; Porter, Louise; Corden, Laura D.; Gibson, A. Bethany; Smith, Frances J. D.; McLean, W. H. Irwin; Moore, C. B. Tara] Univ Dundee, Coll Nursing, Div Mol Med, Dundee, Scotland; [Irvine, Alan D.] Our Ladys Hosp Sick Children, Dept Paediat Dermatol, Dublin 12, Ireland; [Irvine, Alan D.] Trinity Coll Dublin, Inst Mol Med, Dublin, Ireland; [MacEwen, Caroline J.; Weed, Kathryn H.] Univ Dundee, Ninewells Hosp & Med Sch, Dept Ophthalmol, Dundee DD1 9SY, Scotland; [Moore, Jonathan E.; Moore, C. B. Tara] Univ Ulster, Sch Biomed Sci, Coleraine, Londonderry, North Ireland	University of Dundee; University of Dundee; University of Dundee; Our Ladys Children Hospital Crumlin; Trinity College Dublin; University of Dundee; Ulster University	Liao, HH (corresponding author), Univ Dundee, Coll Life Sci & Med, Div Mol Med, Dundee, Scotland.	w.h.i.mclean@dundee.ac.uk	Irvine, Alan D/A-3982-2008; Porter, Louise/GQP-6108-2022	Irvine, Alan D/0000-0002-9048-2044; Moore, Johnny/0000-0001-8451-9421; Moore, Tara/0000-0002-7659-9326; Porter, Louise/0000-0002-7406-0319; McLean, William Henry Irwin/0000-0001-5539-5757	Medical Research Council [G0801742, G0802780]; Fight for Sight; MRC [G0801742, G0802780] Funding Source: UKRI; National Institute for Health Research [ACF-2007-06-011] Funding Source: researchfish; Fight for Sight [1879/80] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fight for Sight; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Fight for Sight	This work was funded by grants from The Medical Research Council (grant numbers G0801742 and G0802780, to WHIM and FJDS) and Fight for Sight (to WHIM and CBTM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASEHOAR G, 1973, SCIENCE, V179, P1333, DOI 10.1126/science.179.4080.1333; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Boutboul S, 2006, HUM MUTAT, V27, P553, DOI 10.1002/humu.20331; Bumcrot D, 2006, NAT CHEM BIOL, V2, P711, DOI 10.1038/nchembio839; Chiou AGY, 1998, CORNEA, V17, P566; Corden LD, 2000, EXP EYE RES, V70, P41, DOI 10.1006/exer.1999.0769; COULOMBE PA, 1991, CELL, V66, P1301, DOI 10.1016/0092-8674(91)90051-Y; Dykxhoorn DM, 2006, CELL, V126, P231, DOI 10.1016/j.cell.2006.07.007; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; FRANKE WW, 1978, CYTOBIOLOGIE, V17, P392; Goldberg A, 1997, INT OPHTHALMOL, V21, P117, DOI 10.1023/A:1026456232212; HANNA C, 1960, ARCH OPHTHALMOL-CHIC, V64, P536; Hao J, 2010, BRAIN RES BULL, V81, P256, DOI 10.1016/j.brainresbull.2009.06.011; Hickerson RP, 2008, J INVEST DERMATOL, V128, P594, DOI 10.1038/sj.jid.5701060; Irvine AD, 2002, BRIT J OPHTHALMOL, V86, P729, DOI 10.1136/bjo.86.7.729; Irvine AD, 1997, NAT GENET, V16, P184, DOI 10.1038/ng0697-184; Irvine AD, 1999, BRIT J DERMATOL, V140, P815, DOI 10.1046/j.1365-2133.1999.02810.x; Kao WWY, 1996, INVEST OPHTH VIS SCI, V37, P2572; Kaspar RL, 2005, J INVEST DERM SYMP P, V10, P62, DOI 10.1111/j.1087-0024.2005.10208.x; Kawamata T, 2010, TRENDS BIOCHEM SCI, V35, P368, DOI 10.1016/j.tibs.2010.03.009; Korvatska E, 2000, J BIOL CHEM, V275, P11465, DOI 10.1074/jbc.275.15.11465; LANE EB, 2008, DRUG DISCOV TODAY, V5, pE93; Leachman SA, 2008, J DERMATOL SCI, V51, P151, DOI 10.1016/j.jdermsci.2008.04.003; Lewin AS, 2005, J INVEST DERM SYMP P, V10, P47, DOI 10.1111/j.1087-0024.2005.10207.x; McLean WHI, 2011, HUM MOL GENET, V20, pR189, DOI 10.1093/hmg/ddr379; Meesmann A, 1938, BER ZUSAMMENKUNFT DT, V52, P154; Munier FL, 2002, INVEST OPHTH VIS SCI, V43, P949; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; RUGG EL, 1994, GENE DEV, V8, P2563, DOI 10.1101/gad.8.21.2563; Rugg EL, 1994, KERATINOCYTE METHODS, P127; Smith FJD, 2000, EXP DERMATOL, V9, P170, DOI 10.1034/j.1600-0625.2000.009003170.x; Smith FJD, 2002, BIOCHEM BIOPH RES CO, V297, P818, DOI 10.1016/S0006-291X(02)02288-X; Smith FJD, 2008, J INVEST DERMATOL, V128, P50, DOI 10.1038/sj.jid.5701040; Szeverenyi I, 2008, HUM MUTAT, V29, P351, DOI 10.1002/humu.20652; Yokota T, 2004, BIOCHEM BIOPH RES CO, V314, P283, DOI 10.1016/j.bbrc.2003.12.098	35	36	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28582	10.1371/journal.pone.0028582	http://dx.doi.org/10.1371/journal.pone.0028582			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174841	Green Published, Green Submitted, gold			2022-12-25	WOS:000298366600024
J	Romero-Granados, R; Fontan-Lozano, A; Aguilar-Montilla, FJ; Carrion, AM				Romero-Granados, Rocio; Fontan-Lozano, Angela; Javier Aguilar-Montilla, Francisco; Manuel Carrion, Angel			Postnatal Proteasome Inhibition Induces Neurodegeneration and Cognitive Deficiencies in Adult Mice: A New Model of Neurodevelopment Syndrome	PLOS ONE			English	Article							LONG-TERM POTENTIATION; DOMOIC ACID EXPOSURE; PROTEIN-DEGRADATION; HIPPOCAMPAL NEUROGENESIS; STATUS EPILEPTICUS; OXIDATIVE STRESS; DEVELOPING BRAIN; UBIQUITIN; NEURONS; ROLES	Defects in the ubiquitin-proteasome system have been related to aging and the development of neurodegenerative disease, although the effects of deficient proteasome activity during early postnatal development are poorly understood. Accordingly, we have assessed how proteasome dysfunction during early postnatal development, induced by administering proteasome inhibitors daily during the first 10 days of life, affects the behaviour of adult mice. We found that this regime of exposure to the proteasome inhibitors MG132 or lactacystin did not produce significant behavioural or morphological changes in the first 15 days of life. However, towards the end of the treatment with proteasome inhibitors, there was a loss of mitochondrial markers and activity, and an increase in DNA oxidation. On reaching adulthood, the memory of mice that were injected with proteasome inhibitors postnatally was impaired in hippocampal and amygdala-dependent tasks, and they suffered motor dysfunction and imbalance. These behavioural deficiencies were correlated with neuronal loss in the hippocampus, amygdala and brainstem, and with diminished adult neurogenesis. Accordingly, impairing proteasome activity at early postnatal ages appears to cause morphological and behavioural alterations in adult mice that resemble those associated with certain neurodegenerative diseases and/or syndromes of mental retardation.	[Romero-Granados, Rocio; Fontan-Lozano, Angela; Javier Aguilar-Montilla, Francisco; Manuel Carrion, Angel] Univ Pablo Olavide, Dept Fisiol Anat & Biol Celular, Seville, Spain	Universidad Pablo de Olavide	Romero-Granados, R (corresponding author), Andalusian Ctr Mol Biol & Regenerat Med CABIMER, Dept Cell Therapy & Regenerat Med, Seville, Spain.	amancar@upo.es	Romero-Granados, Rocío/AAD-6360-2019; FONTÁN-LOZANO, ÁNGELA/R-9081-2019; Carrion, Angel Manuel/K-5875-2014	FONTÁN-LOZANO, ÁNGELA/0000-0003-1646-0952; Carrion, Angel Manuel/0000-0001-8158-9512	Junta de Andalucia [BIO-122]; Fundacion Ramon Areces; DGICYT (Departmento Governmental de Investigaciones Cientificas y Tecnologicas) [BFU2008-01552]; Juan de la Cierva; Spanish Science Ministry	Junta de Andalucia(Junta de Andalucia); Fundacion Ramon Areces; DGICYT (Departmento Governmental de Investigaciones Cientificas y Tecnologicas); Juan de la Cierva(Instituto de Salud Carlos III); Spanish Science Ministry(Spanish Government)	This work was supported by grants from the Junta de Andalucia (BIO-122), Fundacion Ramon Areces and DGICYT (Departmento Governmental de Investigaciones Cientificas y Tecnologicas) (BFU2008-01552). AFL and RRG were supported by a Juan de la Cierva and FPU programs from Spanish Science Ministry respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedford L, 2008, J NEUROSCI, V28, P8189, DOI 10.1523/JNEUROSCI.2218-08.2008; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Bingol B, 2005, CURR OPIN NEUROBIOL, V15, P536, DOI 10.1016/j.conb.2005.08.016; BURGARD EC, 1993, J NEUROPHYSIOL, V69, P230, DOI 10.1152/jn.1993.69.1.230; Crusio WE, 1996, PHYSIOL BEHAV, V59, P1171, DOI 10.1016/0031-9384(95)02251-1; de Kloet ER, 2005, NEUROSCI BIOBEHAV R, V29, P271, DOI 10.1016/j.neubiorev.2004.10.008; de los Santos-Arteaga M, 2003, J NEUROSCI, V23, P11120; DiAntonio A, 2004, ANNU REV NEUROSCI, V27, P223, DOI 10.1146/annurev.neuro.27.070203.144317; Dityatev AE, 2005, NEUROSCIENTIST, V11, P75, DOI 10.1177/1073858404270857; DOBBING J, 1974, BRIT MED BULL, V30, P164, DOI 10.1093/oxfordjournals.bmb.a071188; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; FOX WM, 1965, ANIM BEHAV, V13, P234, DOI 10.1016/0003-3472(65)90041-2; Galvan CD, 2000, J NEUROSCI, V20, P2904; Germain D, 2008, MOL MICROBIOL, V70, P1334, DOI 10.1111/j.1365-2958.2008.06502.x; Gill DA, 2010, BRAIN RES, V1331, P114, DOI 10.1016/j.brainres.2010.03.054; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Goldberg AL, 1997, BIOL CHEM, V378, P131; Groenewegen Henk J., 2003, Neural Plasticity, V10, P107, DOI 10.1155/NP.2003.107; Gruart A, 2007, GENES BRAIN BEHAV, V6, P24, DOI 10.1111/j.1601-183X.2007.00319.x; Grune T, 2004, INT J BIOCHEM CELL B, V36, P2519, DOI 10.1016/j.biocel.2004.04.020; Havekes R, 2007, HIPPOCAMPUS, V17, P338, DOI 10.1002/hipo.20272; Hegde AN, 2011, BBA-GENE REGUL MECH, V1809, P128, DOI 10.1016/j.bbagrm.2010.07.006; Heo JM, 2011, INT J BIOCHEM CELL B, V43, P1422, DOI 10.1016/j.biocel.2011.06.002; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hougaard KS, 2005, DEV BRAIN RES, V159, P55, DOI 10.1016/j.devbrainres.2005.06.014; Kaffman A, 2007, J CHILD PSYCHOL PSYC, V48, P224, DOI 10.1111/j.1469-7610.2007.01730.x; Keller JN, 2000, MECH AGEING DEV, V113, P61, DOI 10.1016/S0047-6374(99)00101-3; Levin ED, 2005, NEUROTOXICOL TERATOL, V27, P719, DOI 10.1016/j.ntt.2005.06.017; Levin ED, 2006, NEUROTOXICOL TERATOL, V28, P673, DOI 10.1016/j.ntt.2006.08.005; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Matilla-Duenas A, 2010, CEREBELLUM, V9, P148, DOI 10.1007/s12311-009-0144-2; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Murphey RK, 2002, NEURON, V36, P5, DOI 10.1016/S0896-6273(02)00943-1; Nakano K, 2000, J NEUROL, V247, P1; NOUWS JFM, 1992, J ANIM SCI, V70, P3627, DOI 10.2527/1992.70113627x; Patrick GN, 2006, CURR OPIN NEUROBIOL, V16, P90, DOI 10.1016/j.conb.2006.01.007; Pines J, 2005, NAT CELL BIOL, V7, P731, DOI 10.1038/ncb0805-731; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Ross CA, 2004, TRENDS CELL BIOL, V14, P703, DOI 10.1016/j.tcb.2004.10.006; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Santos NF, 2000, EPILEPSIA, V41, pS57, DOI 10.1111/j.1528-1157.2000.tb01558.x; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Stafstrom CE, 2005, EPILEPSY BEHAV, V7, pS18, DOI 10.1016/j.yebeh.2005.08.005; STAFSTROM CE, 1992, DEV BRAIN RES, V65, P227, DOI 10.1016/0165-3806(92)90184-X; Sullivan PG, 2004, J BIOL CHEM, V279, P20699, DOI 10.1074/jbc.M313579200; Surget A, 2008, BIOL PSYCHIAT, V64, P293, DOI 10.1016/j.biopsych.2008.02.022; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Taylor EB, 2011, BIOCHEM SOC T, V39, P1509, DOI 10.1042/BST0391509; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Tyzio R, 1999, J NEUROSCI, V19, P10372; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4; Zhao MR, 2007, BIOL PSYCHIAT, V62, P381, DOI 10.1016/j.biopsych.2006.10.019	57	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28927	10.1371/journal.pone.0028927	http://dx.doi.org/10.1371/journal.pone.0028927			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174927	Green Submitted, Green Published, gold			2022-12-25	WOS:000298366600048
J	Lucio, KA; Rocha, GD; Moncao-Ribeiro, LC; Fernandes, J; Takiya, CM; Gattass, CR				Lucio, Kelly Araujo; Rocha, Gleice da Graca; Moncao-Ribeiro, Leonardo Campos; Fernandes, Janaina; Takiya, Christina Maeda; Gattass, Cerli Rocha			Oleanolic Acid Initiates Apoptosis in Non-Small Cell Lung Cancer Cell Lines and Reduces Metastasis of a B16F10 Melanoma Model In Vivo	PLOS ONE			English	Article							RESISTANCE-ASSOCIATED PROTEIN; MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; URSOLIC ACID; TUMOR-GROWTH; EXPRESSION; SURVIVIN; MRP1; TRITERPENES; GLUTATHIONE	Background: Drug resistance, a process mediated by multiple mechanisms, is a critical determinant for treating lung cancer. The aim of this study is to determine if oleanolic acid (OA), a pentacyclic triterpene present in several plants, is able to circumvent the mechanisms of drug resistance present in non-small cell lung cancer (NSCLC) cell lines and to induce their death. Principal Findings: OA decreased the cell viability of the NSCLC cell lines A459 and H460 despite the presence of active, multidrug-resistant (MDR) MRP1/ABCC1 proteins and the anti-apoptotic proteins Bcl-2 and survivin. These effects are due to apoptosis, as evidenced by the capacity of OA to induce fragmentation of DNA and activate caspase 3. Induction of NSCLC cell death by OA cannot be explained by inhibition of the MDR proteins, since treatment with triterpene had little or no effect on the activity or expression of MRP1. Moreover, treatment with OA had no effect on the expression of the antiapoptotic protein Bcl-2, but increased the expression of the pro-apoptotic protein Bax, altering the Bcl-2/Bax balance towards a pro-apoptotic profile. OA also decreased the expression of the anti-apoptotic protein survivin. Furthermore, OA decreased the expression of the angiogenic vascular endothelial growth factor (VEGF) and decreased the development of melanoma-induced lung metastasis. Conclusion: Our data provide a significant insight into the antitumoral and antimetastatic activity of OA in NSCLC and suggest that including OA in the NSCLC regimens may help to decrease the number of relapses and reduce the development of metastases.	[Lucio, Kelly Araujo; Rocha, Gleice da Graca; Fernandes, Janaina; Gattass, Cerli Rocha] Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Biofis Carlos Chagas Filho, Lab Imunol Celular, Rio De Janeiro, Brazil; [Moncao-Ribeiro, Leonardo Campos; Takiya, Christina Maeda] Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Ciencias Biomed, Lab Patol Celular, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Lucio, KA (corresponding author), Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Biofis Carlos Chagas Filho, Lab Imunol Celular, Rio De Janeiro, Brazil.	cerli@chagas.biof.ufrj.br	Takiya, Christina/AAU-5959-2021; Fernandes, Janaina/AAY-3331-2020; Fernandes, Janaina/E-8888-2015; Monção-Ribeiro, Leonardo/F-8633-2012	Takiya, Christina/0000-0002-8019-628X; Fernandes, Janaina/0000-0002-3442-6101; Fernandes, Janaina/0000-0002-3442-6101; Fernandes, Jennifer/0000-0002-9491-916X	Financiadora de Estudos e Projetos [FINEP/FNDCT/NQTN Conv.01.06.0390.00]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E-26/110.135/2009]; Instituto Nacional para Pesquisa Translacional em Saude e Ambiente na Regiao Amazonica (INCT-INPeTAm/CNPq/MCT) [57.3695/2008-3]; Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES)	Financiadora de Estudos e Projetos(Financiadora de Inovacao e Pesquisa (Finep)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Instituto Nacional para Pesquisa Translacional em Saude e Ambiente na Regiao Amazonica (INCT-INPeTAm/CNPq/MCT)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from Financiadora de Estudos e Projetos (FINEP/FNDCT/NQTN Conv.01.06.0390.00), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, grant number E-26/110.135/2009), Instituto Nacional para Pesquisa Translacional em Saude e Ambiente na Regiao Amazonica (INCT-INPeTAm/CNPq/MCT Conv. # 57.3695/2008-3) and Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES, PhD fellowship to KAL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Zaher AO, 2007, TOXICOLOGY, V234, P124, DOI 10.1016/j.tox.2007.02.014; Berger W, 2005, J CANCER RES CLIN, V131, P355, DOI 10.1007/s00432-004-0653-9; Braga F, 2007, CANCER LETT, V248, P147, DOI 10.1016/j.canlet.2006.06.008; Cheng YJ, 2010, EUR J PHARMACOL, V627, P75, DOI 10.1016/j.ejphar.2009.11.003; Dean EJ, 2010, BRIT J CANCER, V102, P97, DOI 10.1038/sj.bjc.6605418; Fernandes J, 2003, CANCER LETT, V190, P165, DOI 10.1016/S0304-3835(02)00593-1; Fernandes J, 2009, J MED CHEM, V52, P1214, DOI 10.1021/jm801389m; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Gao GH, 2009, LUNG CANCER, V65, P339, DOI 10.1016/j.lungcan.2008.11.019; GEKELER V, 1995, BIOCHEM BIOPH RES CO, V208, P345, DOI 10.1006/bbrc.1995.1344; Giaccone G, 1996, INT J CANCER, V66, P760, DOI 10.1002/(SICI)1097-0215(19960611)66:6<760::AID-IJC9>3.3.CO;2-F; Giner-Larza EM, 2001, EUR J PHARMACOL, V428, P137, DOI 10.1016/S0014-2999(01)01290-0; Haura Eric B, 2004, Clin Lung Cancer, V6, P113, DOI 10.3816/CLC.2004.n.025; Hsu HY, 1997, CANCER LETT, V111, P7, DOI 10.1016/S0304-3835(96)04481-3; Ikuta K, 2005, ONCOL REP, V13, P1229; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kim YK, 2000, PLANTA MED, V66, P485, DOI 10.1055/s-2000-8585; Krepela E, 2009, INT J ONCOL, V35, P1449, DOI 10.3892/ijo_00000464; Krysan K, 2004, CANCER RES, V64, P6359, DOI 10.1158/0008-5472.CAN-04-1681; Laupeze B, 1999, INT J ONCOL, V15, P571; Li J, 2002, WORLD J GASTROENTERO, V8, P493, DOI 10.3748/wjg.v8.i3.493; Li J, 2008, CANCER CHEMOTH PHARM, V61, P525, DOI 10.1007/s00280-007-0499-3; Li XQ, 2009, INT J BIOL MARKER, V24, P230, DOI 10.1177/172460080902400403; Liu J, 1995, J ETHNOPHARMACOL, V49, P57, DOI 10.1016/0378-8741(95)90032-2; Luzzi KJ, 1998, AM J PATHOL, V153, P865, DOI 10.1016/S0002-9440(10)65628-3; Mehrotra S, 2010, CANCER CELL, V17, P53, DOI 10.1016/j.ccr.2009.11.021; Mena S, 2007, CLIN CANCER RES, V13, P2658, DOI 10.1158/1078-0432.CCR-06-2642; MICKLEY LA, 1989, J BIOL CHEM, V264, P18031; Mita AC, 2008, CLIN CANCER RES, V14, P5000, DOI 10.1158/1078-0432.CCR-08-0746; Olie RA, 2000, CANCER RES, V60, P2805; Oshika Y, 1998, MODERN PATHOL, V11, P1059; Patil CR, 2010, PHYTOTHER RES, V24, P33, DOI 10.1002/ptr.2861; Pesic M, 2009, INVEST NEW DRUG, V27, P99, DOI 10.1007/s10637-008-9140-5; Reck M, 2008, TARGET ONCOL, V3, P135, DOI 10.1007/s11523-008-0082-9; Rocha GD, 2012, INVEST NEW DRUG, V30, P105, DOI 10.1007/s10637-010-9524-1; Sawada N, 2004, BRIT J CANCER, V90, P1672, DOI 10.1038/sj.bjc.6601746; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; SINGH GB, 1992, J PHARM PHARMACOL, V44, P456, DOI 10.1111/j.2042-7158.1992.tb03646.x; Torky ARW, 2005, TOXICOLOGY, V207, P437, DOI 10.1016/j.tox.2004.10.014; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Young LC, 2001, CLIN CANCER RES, V7, P1798; Young LC, 1999, CLIN CANCER RES, V5, P673; Zhang PX, 2007, ACTA BIOCH BIOPH SIN, V39, P803, DOI 10.1111/j.1745-7270.2007.00335.x	43	83	86	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28596	10.1371/journal.pone.0028596	http://dx.doi.org/10.1371/journal.pone.0028596			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174843	Green Published, gold, Green Submitted			2022-12-25	WOS:000298365700050
J	Rochira, V; Zirilli, L; Orlando, G; Santi, D; Brigante, G; Diazzi, C; Carli, F; Carani, C; Guaraldi, G				Rochira, Vincenzo; Zirilli, Lucia; Orlando, Gabriella; Santi, Daniele; Brigante, Giulia; Diazzi, Chiara; Carli, Federica; Carani, Cesare; Guaraldi, Giovanni			Premature Decline of Serum Total Testosterone in HIV-Infected Men in the HAART-Era	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; ERECTILE DYSFUNCTION; ANDROGEN DEFICIENCY; ANTIRETROVIRAL THERAPY; INTERNATIONAL INDEX; BINDING GLOBULIN; GONADAL-FUNCTION; ELDERLY-MEN; WEIGHT-LOSS; AGING MEN	Background: Testosterone (T) deficiency remains a poorly understood issue in men with Human Immunodeficiency Virus (HIV). We investigated the gonadal status in HIV-infected men in order to characterize T deficiency and to identify predictive factors for low serum T. Methodology/Principal Findings: We performed a cross-sectional, observational study on 1325 consecutive HIV male outpatients, most of them having lipodystrophy. Serum total T<300 ng/dL was used as the threshold for biochemical T deficiency. Morning serum total T, luteinizing hormone (LH), estradiol, HIV parameters, and body composition parameters by CT-scan and Dual-Energy-X-ray-Absorptiometry were measured in each case. Sexual behavior was evaluated in a subset of 247 patients. T deficiency was found in 212 subjects, especially in the age range 40-59, but was frequent even in younger patients. T deficiency occurred mainly in association with low/normal serum LH. Adiposity was higher in subjects with T deficiency (p<0.0001) and both visceral adipose tissue and body mass index were the main negative predictors of serum total T. Osteoporosis and erectile dysfunction were present in a similar percentage in men with or without T deficiency. Conclusions/Significance: Premature decline of serum T is common (16%) among young/middle-aged HIV-infected men and is associated with inappropriately low/normal LH and increased visceral fat. T deficiency occurs at a young age and may be considered an element of the process of premature or accelerated aging known to be associated with HIV infection. The role of HIV and/or HIV infection treatments, as well as the role of the general health state on the gonadal axis, remains, in fact, to be elucidated. Due to the low specificity of signs and symptoms of hypogonadism in the context of HIV, caution is needed in the diagnosis of hypogonadism in HIV-infected men with biochemical low serum T levels.	[Rochira, Vincenzo; Zirilli, Lucia; Santi, Daniele; Brigante, Giulia; Diazzi, Chiara; Carani, Cesare] Univ Modena & Reggio Emilia, Azienda AUSL NOCSAE Baggiovara, Chair & Unit Endocrinol & Metab, Dept Med Endocrinol & Metab Geriatr, Modena, Italy; [Orlando, Gabriella; Carli, Federica; Guaraldi, Giovanni] Univ Modena & Reggio Emilia, Dept Med & Med Specialties, Metab Clin, Infect & Trop Dis Unit, Modena, Italy	Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia	Rochira, V (corresponding author), Univ Modena & Reggio Emilia, Azienda AUSL NOCSAE Baggiovara, Chair & Unit Endocrinol & Metab, Dept Med Endocrinol & Metab Geriatr, Modena, Italy.	vincenzo.rochira@unimore.it	Guaraldi, Giovanni/J-9467-2018; Rochira, Vincenzo/F-4225-2015; Santi, Daniele/J-7005-2018; Brigante, Giulia/J-8775-2018; Orlando, Gabriella/K-3954-2018; Rochira, Vincenzo/S-7340-2019; Diazzi, Chiara/J-8708-2018	Rochira, Vincenzo/0000-0001-8169-0696; Santi, Daniele/0000-0001-6607-7105; Brigante, Giulia/0000-0001-8426-4502; Orlando, Gabriella/0000-0002-4590-9045; Rochira, Vincenzo/0000-0001-8169-0696; Diazzi, Chiara/0000-0002-6259-2481; Guaraldi, Giovanni/0000-0002-5724-3914	Department of Medicine, Endocrinology & Metabolism, University of Modena	Department of Medicine, Endocrinology & Metabolism, University of Modena	The authors wish to thank Prof. Manuela Simoni, Department of Medicine, Endocrinology & Metabolism, University of Modena, and Reggio Emilia for proofreading the manuscript, careful copyediting, thoughtful assistance in the preparation of this paper, and continuous support and trust.	Araujo AB, 2004, J CLIN ENDOCR METAB, V89, P5920, DOI 10.1210/jc.2003-031719; Araujo AB, 2007, J CLIN ENDOCR METAB, V92, P4241, DOI 10.1210/jc.2007-1245; Arver S, 1999, J ANDROL, V20, P611; Bhasin S, 2010, J CLIN ENDOCR METAB, V95, P2536, DOI 10.1210/jc.2009-2354; BORKAN GA, 1982, AM J CLIN NUTR, V36, P172, DOI 10.1093/ajcn/36.1.172; Brambilla DJ, 2007, CLIN ENDOCRINOL, V67, P853, DOI 10.1111/j.1365-2265.2007.02976.x; Brambilla DJ, 2009, J CLIN ENDOCR METAB, V94, P907, DOI 10.1210/jc.2008-1902; Cappelleri JC, 1999, UROLOGY, V54, P346, DOI 10.1016/S0090-4295(99)00099-0; Collazos Julio, 2009, J Int Assoc Physicians AIDS Care (Chic), V8, P43, DOI 10.1177/1545109708330908; Cotter AG, 2011, BEST PRACT RES CL EN, V25, P501, DOI 10.1016/j.beem.2010.11.003; Crum NF, 2005, AIDS PATIENT CARE ST, V19, P655, DOI 10.1089/apc.2005.19.655; Crum-Cianflone NF, 2007, AIDS PATIENT CARE ST, V21, P9, DOI 10.1089/apc.2006.0071; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Dobs AS, 1996, J CLIN ENDOCR METAB, V81, P4108, DOI 10.1210/jc.81.11.4108; Dube MP, 2007, CLIN INFECT DIS, V45, P120, DOI 10.1086/518620; Gorman AA, 2009, NEUROPSYCHOL REV, V19, P186, DOI 10.1007/s11065-009-9095-0; Grinspoon S, 1996, J CLIN ENDOCR METAB, V81, P4051, DOI 10.1210/jc.81.11.4051; Guaraldi G, 2007, ANTIVIR THER, V12, pL58; Handelsman DJ, 2011, ASIAN J ANDROL, V13, P125, DOI 10.1038/aja.2010.154; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Kalyani Rita R, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P226, DOI 10.1097/MED.0b013e32814db856; Kalyani RR, 2007, ENDOCRIN METAB CLIN, V36, P333, DOI 10.1016/j.ecl.2007.03.014; Kaufman JM, 1997, BAILLIERE CLIN ENDOC, V11, P289, DOI 10.1016/S0950-351X(97)80302-3; Klein RS, 2005, CLIN INFECT DIS, V41, P1794, DOI 10.1086/498311; Ly LP, 2010, CLIN ENDOCRINOL, V73, P382, DOI 10.1111/j.1365-2265.2010.03804.x; Martin J, 2010, ANN INTERN MED, V153, P477, DOI 10.7326/0003-4819-153-7-201010050-00013; MARTIN ME, 1992, J ENDOCRINOL INVEST, V15, P597, DOI 10.1007/BF03344932; McLachlan RI, 2010, J CLIN ENDOCR METAB, V95, P2610, DOI 10.1210/jc.2010-0838; Moreno-Perez O, 2010, J SEX MED, V7, P2873, DOI 10.1111/j.1743-6109.2010.01886.x; Mulligan T, 2006, INT J CLIN PRACT, V60, P762, DOI 10.1111/j.1742-1241.2006.00992.x; Mylonakis E, 2001, CLIN INFECT DIS, V33, P857, DOI 10.1086/322695; Ofotokun I, 2010, CURR OPIN ENDOCRINOL, V17, P523, DOI 10.1097/MED.0b013e32833f48d6; Onen Nur F, 2011, Curr Aging Sci, V4, P33; Palella FJ, 2004, CLIN INFECT DIS, V38, P903, DOI 10.1086/381684; Park YW, 2002, INT J OBESITY, V26, P978, DOI 10.1038/sj.ijo.0801982; Rietschel P, 2000, CLIN INFECT DIS, V31, P1240, DOI 10.1086/317457; Rochira V, 2006, EUR J ENDOCRINOL, V155, P513, DOI 10.1530/eje.1.02254; Rosen RC, 1997, UROLOGY, V49, P822, DOI 10.1016/S0090-4295(97)00238-0; Rosner W, 2007, J CLIN ENDOCR METAB, V92, P405, DOI 10.1210/jc.2006-1864; Sartorius G, 2009, ANN CLIN BIOCHEM, V46, P137, DOI 10.1258/acb.2008.008171; Sartorius GA, 2010, ANDROLOGY: MALE REPRODUCTIVE HEALTH AND DYSFUNCTION, THIRD EDITION, P339, DOI 10.1007/978-3-540-78355-8_18; Schneider HJ, 2009, CLIN ENDOCRINOL, V70, P446, DOI 10.1111/j.1365-2265.2008.03370.x; Shiels MS, 2010, ANN INTERN MED, V153, P452, DOI 10.7326/0003-4819-153-7-201010050-00008; Tajar A, 2010, J CLIN ENDOCR METAB, V95, P1810, DOI 10.1210/jc.2009-1796; Travison TG, 2007, J CLIN ENDOCR METAB, V92, P549, DOI 10.1210/jc.2006-1859; Travison TG, 2006, J CLIN ENDOCR METAB, V91, P2509, DOI 10.1210/jc.2005-2508; VERMEULEN A, 1992, J CLIN ENDOCR METAB, V74, P939, DOI 10.1210/jc.74.4.939; Wasserman P, 2008, J SEX MED, V5, P241, DOI 10.1111/j.1743-6109.2007.00634.x; Wu FCW, 2010, NEW ENGL J MED, V363, P123, DOI 10.1056/NEJMoa0911101; Wunder DM, 2008, HIV MED, V9, P427, DOI 10.1111/j.1468-1293.2008.00578.x; Zirilli L, 2008, J Endocrinol Invest, V31, P33	51	87	89	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28512	10.1371/journal.pone.0028512	http://dx.doi.org/10.1371/journal.pone.0028512			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174826	Green Submitted, Green Published, gold			2022-12-25	WOS:000298365700041
J	Tadaishi, M; Miura, S; Kai, Y; Kano, Y; Oishi, Y; Ezaki, O				Tadaishi, Miki; Miura, Shinji; Kai, Yuko; Kano, Yutaka; Oishi, Yuichi; Ezaki, Osamu			Skeletal Muscle-Specific Expression of PGC-1 alpha-b, an Exercise-Responsive Isoform, Increases Exercise Capacity and Peak Oxygen Uptake	PLOS ONE			English	Article							TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; FATTY-ACID OXIDATION; ALL-CAUSE MORTALITY; INTENSITY EXERCISE; CARDIORESPIRATORY FITNESS; INDUCED ANGIOGENESIS; RECEPTOR ACTIVATION; UNTRAINED MEN; MESSENGER-RNA; TRAINED MEN	Background: Maximal oxygen uptake (VO2max) predicts mortality and is associated with endurance performance. Trained subjects have a high VO2max due to a high cardiac output and high metabolic capacity of skeletal muscles. Peroxisome proliferator-activated receptor c coactivator 1 alpha (PGC-1 alpha), a nuclear receptor coactivator, promotes mitochondrial biogenesis, a fiber-type switch to oxidative fibers, and angiogenesis in skeletal muscle. Because exercise training increases PGC-1 alpha in skeletal muscle, PGC-1 alpha-mediated changes may contribute to the improvement of exercise capacity and VO2max. There are three isoforms of PGC-1 alpha mRNA. PGC-1 alpha-b protein, whose amino terminus is different from PGC-1 alpha-a protein, is a predominant PGC-1a isoform in response to exercise. We investigated whether alterations of skeletal muscle metabolism by overexpression of PGC-1 alpha-b in skeletal muscle, but not heart, would increase VO(2ma)x and exercise capacity. Methodology/Principal Findings: Transgenic mice showed overexpression of PGC-1 alpha-b protein in skeletal muscle but not in heart. Overexpression of PGC-1 alpha-b promoted mitochondrial biogenesis 4-fold, increased the expression of fatty acid transporters, enhanced angiogenesis in skeletal muscle 1.4 to 2.7-fold, and promoted exercise capacity (expressed by maximum speed) by 35% and peak oxygen uptake by 20%. Across a broad range of either the absolute exercise intensity, or the same relative exercise intensities, lipid oxidation was always higher in the transgenic mice than wild-type littermates, suggesting that lipid is the predominant fuel source for exercise in the transgenic mice. However, muscle glycogen usage during exercise was absent in the transgenic mice. Conclusions/Significance: Increased mitochondrial biogenesis, capillaries, and fatty acid transporters in skeletal muscles may contribute to improved exercise capacity via an increase in fatty acid utilization. Increases in PGC-1 alpha-b protein or function might be a useful strategy for sedentary subjects to perform exercise efficiently, which would lead to prevention of life-style related diseases and increased lifespan.	[Tadaishi, Miki; Miura, Shinji; Kai, Yuko; Ezaki, Osamu] Natl Inst Hlth & Nutr, Dept Nutr Sci, Tokyo 162, Japan; [Tadaishi, Miki; Oishi, Yuichi] Tokyo Univ Agr, Fac Appl Biosci, Dept Nutr Sci, Tokyo, Japan; [Kano, Yutaka] Univ Electrocommun, Dept Engn Sci, Tokyo, Japan	National Institute of Health & Nutrition - Japan; Tokyo University of Agriculture; University of Electro-Communications - Japan	Tadaishi, M (corresponding author), Natl Inst Hlth & Nutr, Dept Nutr Sci, Tokyo 162, Japan.	shinjim@nih.go.jp; ezaki@nih.go.jp	Miura, Shinji/K-6516-2013; Kano, Yutaka/I-9003-2014	Miura, Shinji/0000-0001-8806-9763; Kano, Yutaka/0000-0003-0913-9714	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT, Tokyo) [21300240]; Nakatomi Foundation (Tokyo, Japan); Takeda Science Foundation (Osaka, Japan)	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT, Tokyo)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nakatomi Foundation (Tokyo, Japan); Takeda Science Foundation (Osaka, Japan)(Takeda Science Foundation (TSF))	This work was supported in part by grants-in-aid for scientific research (KAKENHI, 21300240) from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT, Tokyo), The Nakatomi Foundation (Tokyo, Japan) and The Takeda Science Foundation (Osaka, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achten J, 2004, NUTRITION, V20, P716, DOI 10.1016/j.nut.2004.04.005; Aquilano K, 2010, J BIOL CHEM, V285, P21590, DOI 10.1074/jbc.M109.070169; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Benton CR, 2006, J PHYSIOL-LONDON, V573, P199, DOI 10.1113/jphysiol.2006.106013; Bloor Colin M., 2005, Angiogenesis, V8, P263, DOI 10.1007/s10456-005-9013-x; Bouchard C, 1998, MED SCI SPORT EXER, V30, P252, DOI 10.1097/00005768-199802000-00013; Bouchard C, 2011, J APPL PHYSIOL, V110, P1160, DOI 10.1152/japplphysiol.00973.2010; Brand M, 1995, MITOCHONDRIA PRACTIC; Brey EM, 2002, MICROVASC RES, V63, P279, DOI 10.1006/mvre.2002.2395; Bruce CR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1231, DOI 10.1152/ajpendo.00561.2006; Bruce CR, 2006, AM J PHYSIOL-ENDOC M, V291, pE99, DOI 10.1152/ajpendo.00587.2005; Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007; Chao LC, 2007, MOL ENDOCRINOL, V21, P2152, DOI 10.1210/me.2007-0169; Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106; Coggan AR, 2000, METABOLISM, V49, P122, DOI 10.1016/S0026-0495(00)90963-6; COGSWELL AM, 1993, AM J PHYSIOL, V264, pC383, DOI 10.1152/ajpcell.1993.264.2.C383; Davis JM, 1997, J APPL PHYSIOL, V83, P1461, DOI 10.1152/jappl.1997.83.5.1461; Davis JM, 1998, MED SCI SPORT EXER, V30, P863, DOI 10.1097/00005768-199806000-00014; Egginton S, 2009, PFLUG ARCH EUR J PHY, V457, P963, DOI 10.1007/s00424-008-0563-9; FERRANNINI E, 1988, METABOLISM, V37, P287, DOI 10.1016/0026-0495(88)90110-2; Friedlander AL, 1998, AM J PHYSIOL-ENDOC M, V275, pE853, DOI 10.1152/ajpendo.1998.275.5.E853; Frohnert BI, 1999, J BIOL CHEM, V274, P3970, DOI 10.1074/jbc.274.7.3970; Hagberg CE, 2010, NATURE, V464, P917, DOI 10.1038/nature08945; Hakimi P, 2007, J BIOL CHEM, V282, P32844, DOI 10.1074/jbc.M706127200; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hawley JA, 1998, SPORTS MED, V25, P241, DOI 10.2165/00007256-199825040-00003; HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278; HORAK ER, 1992, LANCET, V340, P1120, DOI 10.1016/0140-6736(92)93150-L; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; JANSSON E, 1987, J APPL PHYSIOL, V62, P999, DOI 10.1152/jappl.1987.62.3.999; Jiang LQ, 2010, AM J PHYSIOL-ENDOC M, V298, pE8, DOI 10.1152/ajpendo.00403.2009; KLEIN S, 1994, AM J PHYSIOL-ENDOC M, V267, pE934, DOI 10.1152/ajpendo.1994.267.6.E934; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Lee DC, 2011, BRIT J SPORT MED, V45, P504, DOI 10.1136/bjsm.2009.066209; Lee DC, 2010, J PSYCHOPHARMACOL, V24, P27, DOI 10.1177/1359786810382057; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; MacArthur DG, 2007, NAT GENET, V39, P1261, DOI 10.1038/ng2122; Miura S, 2008, ENDOCRINOLOGY, V149, P4527, DOI 10.1210/en.2008-0466; Miura S, 2006, AM J PATHOL, V169, P1129, DOI 10.2353/ajpath.2006.060034; Muoio DM, 2010, NEW ENGL J MED, V363, P291, DOI 10.1056/NEJMcibr1005397; Nagy TR, 2000, OBES RES, V8, P392, DOI 10.1038/oby.2000.47; Passonneau J.V., 1972, FLEXIBLE SYSTEM ENZY; Prior BM, 2004, J APPL PHYSIOL, V97, P1119, DOI 10.1152/japplphysiol.00035.2004; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Quinlan KGR, 2010, HUM MOL GENET, V19, P1335, DOI 10.1093/hmg/ddq010; Saltin B, 2006, J APPL PHYSIOL, V100, P744, DOI 10.1152/japplphysiol.01395.2005; Scarpulla RC, 1996, TRENDS CARDIOVAS MED, V6, P39, DOI 10.1016/1050-1738(95)00129-8; Sidossis LS, 1998, AM J PHYSIOL-ENDOC M, V274, pE510, DOI 10.1152/ajpendo.1998.274.3.E510; SUTER E, 1995, INT J SPORTS MED, V16, P160, DOI 10.1055/s-2007-972985; Tadaishi M, 2011, AM J PHYSIOL-ENDOC M, V300, pE341, DOI 10.1152/ajpendo.00400.2010; Tjonna AE, 2008, CIRCULATION, V118, P346, DOI 10.1161/CIRCULATIONAHA.108.772822; Tonkonogi M, 1997, ACTA PHYSIOL SCAND, V161, P345, DOI 10.1046/j.1365-201X.1997.00222.x; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; TURCOTTE LP, 1992, AM J PHYSIOL, V262, pE791; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200; Wisloff U, 2007, CIRCULATION, V115, P3086, DOI 10.1161/CIRCULATIONAHA.106.675041; Yoshioka T, 2009, BIOCHEM BIOPH RES CO, V381, P537, DOI 10.1016/j.bbrc.2009.02.077	62	112	124	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28290	10.1371/journal.pone.0028290	http://dx.doi.org/10.1371/journal.pone.0028290			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174785	Green Submitted, Green Published, gold			2022-12-25	WOS:000298163600017
J	Ma, WB; Xie, SS; Ni, MJ; Huang, XX; Hu, SG; Liu, Q; Liu, AH; Zhang, JS; Zhang, YL				Ma, Wubin; Xie, Shengsong; Ni, Minjie; Huang, Xingxu; Hu, Shuanggang; Liu, Qiang; Liu, Aihua; Zhang, Jinsong; Zhang, Yonglian			MicroRNA-29a Inhibited Epididymal Epithelial Cell Proliferation by Targeting Nuclear Autoantigenic Sperm Protein (NASP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; HISTONE CHAPERONE; SELF-RENEWAL; MIR-29; TUMORIGENICITY; EXPRESSION; REGULATORS; GROWTH; CANCER; MOUSE	Cell proliferation often decreases gradually during postnatal development of some organs. However, the underlying molecular mechanisms remain unclear. Epididymis, playing important roles in sperm maturation, is a typical organ of this type, which displays a decreased proliferation during postnatal development and even ceased at the adult stage. Here, epididymis was employed as a model to explore the underlying mechanisms. We profiled the microRNA and mRNA expression of newborn (1 day) and adult (90 day) rat epididymis by microarray analysis, and found that the level of miR-29a was dramatically up-regulated during postnatal development of rat epididymis. Subsequent investigations demonstrated that overexpression of miR-29a inhibited the proliferation of epididymal epithelial cells in vitro. The nuclear autoantigenic sperm protein (NASP), a novel target of miR-29a, was significantly down-regulated during postnatal development of rat epididymis. Further analysis showed that silence of NASP mimicked the anti-proliferation effect of miR-29a, whereas overexpression of this protein attenuated the effect of miR-29a. As in rat epididymis, miR-29a was up-regulated and Nasp was down-regulated during postnatal development of mouse epididymis, heart, liver, and lung. Moreover, miR-29a can also inhibit the proliferation of cancer cells by targeting Nasp. Thus, an increase of miR-29a, and hence decrease of Nasp, may contribute to inhibit cell proliferation during postnatal organ development.	[Ma, Wubin; Xie, Shengsong; Ni, Minjie; Hu, Shuanggang; Liu, Qiang; Liu, Aihua; Zhang, Jinsong; Zhang, Yonglian] Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Labs Shanghai Key Lab Mol Androl, Shanghai 200031, Peoples R China; [Ma, Wubin; Xie, Shengsong; Hu, Shuanggang] Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China; [Huang, Xingxu] Nanjing Univ, Model Anim Res Ctr, Nanjing 210061, Peoples R China; [Zhang, Yonglian] Shanghai Inst Planned Parenthood Res, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Nanjing University	Zhang, YL (corresponding author), Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Labs Shanghai Key Lab Mol Androl, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	ylzhang@sibs.ac.cn	Ma, Wubin/P-3045-2017; Liu, Qiang/HHZ-3181-2022	huang, xingxu/0000-0001-8934-1247; Zhang, Jinsong/0000-0002-6457-0235	National Basic Science Research and Development Project of China [30930053, 31101069]; Chinese Academy of Sciences (CAS) [KSCX2-EW-R-07]	National Basic Science Research and Development Project of China; Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences)	This work was supported by National Basic Science Research and Development Project of China Grants 30930053 and 31101069 and Chinese Academy of Sciences (CAS) Knowledge Innovation Program Grant KSCX2-EW-R-07.	Akao Y, 2007, CANCER SCI, V98, P1914, DOI 10.1111/j.1349-7006.2007.00618.x; Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903; Alekseev OM, 2003, J BIOL CHEM, V278, P8846, DOI 10.1074/jbc.M210352200; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Araki Y, 2002, J ANDROL, V23, P854; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Cornwall GA, 2009, HUM REPROD UPDATE, V15, P213, DOI 10.1093/humupd/dmn055; CROCKER TT, 1970, CANCER RES, V30, P357; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gupta A, 2011, METHODS MOL BIOL, V676, P73, DOI 10.1007/978-1-60761-863-8_6; Han YC, 2010, J EXP MED, V207, P475, DOI 10.1084/jem.20090831; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Ivey KN, 2010, CELL STEM CELL, V7, P36, DOI 10.1016/j.stem.2010.06.012; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Li XQ, 2010, BRIT J HAEMATOL, V148, P69, DOI 10.1111/j.1365-2141.2009.07920.x; Li Y, 2009, DEV DYNAM, V238, P2388, DOI 10.1002/dvdy.22056; Lin TX, 2009, J UROLOGY, V181, P1372, DOI 10.1016/j.juro.2008.10.149; Liu SJ, 2010, CANCER CELL, V17, P333, DOI 10.1016/j.ccr.2010.03.008; Liu Y, 2010, HYPERTENSION, V55, P974, DOI 10.1161/HYPERTENSIONAHA.109.144428; Machida N, 1997, J MOL CELL CARDIOL, V29, P1895, DOI 10.1006/jmcc.1997.0427; Marquez MG, 2002, ANAT EMBRYOL, V205, P431, DOI 10.1007/s00429-002-0262-9; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Muniyappa MK, 2009, EUR J CANCER, V45, P3104, DOI 10.1016/j.ejca.2009.09.014; Nuovo GJ, 2008, METHODS, V44, P39, DOI 10.1016/j.ymeth.2007.10.008; Ott CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016250; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Pekarsky Y, 2006, CANCER RES, V66, P11590, DOI 10.1158/0008-5472.CAN-06-3613; Podolska A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014494; Richardson RT, 2006, J BIOL CHEM, V281, P21526, DOI 10.1074/jbc.M603816200; Richardson RT, 2000, J BIOL CHEM, V275, P30378, DOI 10.1074/jbc.M003781200; Robaire B., 1988, P999; Rodriguez C. M., 2001, EPIDIDYMIS MOL CLIN, P251; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Santanam U, 2010, P NATL ACAD SCI USA, V107, P12210, DOI 10.1073/pnas.1007186107; Shenouda SK, 2009, CANCER METAST REV, V28, P369, DOI 10.1007/s10555-009-9188-5; Wang HY, 2008, NUCLEIC ACIDS RES, V36, P5763, DOI 10.1093/nar/gkn574; Wang JF, 2010, BIOCHEM BIOPH RES CO, V402, P222, DOI 10.1016/j.bbrc.2010.10.002; Williams AE, 2007, DEV DYNAM, V236, P572, DOI 10.1002/dvdy.21047; Winbanks CE, 2011, J BIOL CHEM, V286, P13805, DOI 10.1074/jbc.M110.192625; Wu HL, 2009, CELL RES, V19, P439, DOI 10.1038/cr.2009.18; Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380; Xu JA, 2011, NUCLEIC ACIDS RES, V39, P825, DOI 10.1093/nar/gkq832; Xu T, 2009, HEPATOLOGY, V50, P113, DOI 10.1002/hep.22919; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhang JS, 2010, ACTA BIOCH BIOPH SIN, V42, P145, DOI 10.1093/abbs/gmp116; Zhao JJ, 2010, BLOOD, V115, P2630, DOI 10.1182/blood-2009-09-243147; Zhu CF, 2007, BIOL REPROD, V76, P63, DOI 10.1095/biolreprod.106.054635	51	29	31	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10189	10199		10.1074/jbc.M111.303636	http://dx.doi.org/10.1074/jbc.M111.303636			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22194605	hybrid, Green Published			2022-12-25	WOS:000302167200050
J	Cheng, W; Yang, F; Liu, S; Colton, CK; Wang, CB; Cui, YY; Cao, X; Zhu, MX; Sun, CS; Wang, KW; Zheng, J				Cheng, Wei; Yang, Fan; Liu, Shuang; Colton, Craig K.; Wang, Chunbo; Cui, Yuanyuan; Cao, Xu; Zhu, Michael X.; Sun, Changsen; Wang, KeWei; Zheng, Jie			Heteromeric Heat-sensitive Transient Receptor Potential Channels Exhibit Distinct Temperature and Chemical Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROOT GANGLION NEURONS; CAPSAICIN RECEPTOR; TRP CHANNELS; ION CHANNELS; ANKYRIN REPEAT; MICE LACKING; THERMOSENSATION; ACTIVATION; PAIN; EXPRESSION	TRPV1 and TRPV3 are two heat-sensitive ion channels activated at distinct temperature ranges perceived by human as hot and warm, respectively. Compounds eliciting human sensations of heat or warmth can also potently activate these channels. In rodents, TRPV3 is expressed predominantly in skin keratinocytes, whereas in humans TRPV1 and TRPV3 are co-expressed in sensory neurons of dorsal root ganglia and trigeminal ganglion and are known to form heteromeric channels with distinct single channel conductances as well as sensitivities to TRPV1 activator capsaicin and inhibitor capsazepine. However, how heteromeric TRPV1/TRPV3 channels respond to heat and other stimuli remains unknown. In this study, we examined the behavior of heteromeric TRPV1/TRPV3 channels activated by heat, capsaicin, and voltage. Our results demonstrate that the heteromeric channels exhibit distinct temperature sensitivity, activation threshold, and heat-induced sensitization. Changes in gating properties apparently originate from interactions between TRPV1 and TRPV3 subunits. Our results suggest that heteromeric TRPV1/TRPV3 channels are unique heat sensors that may contribute to the fine-tuning of sensitivity to sensory inputs.	[Liu, Shuang; Cui, Yuanyuan; Cao, Xu; Wang, KeWei] Peking Univ, Hlth Sci Ctr, Dept Neurobiol, Neurosci Res Inst, Beijing 100083, Peoples R China; [Cheng, Wei; Sun, Changsen] Dalian Univ Technol, Coll Phys & Optoelect Engn, Lab Biomed Opt, Dalian 116023, Peoples R China; [Cheng, Wei; Yang, Fan; Cui, Yuanyuan; Cao, Xu; Zheng, Jie] Univ Calif Davis, Dept Physiol & Membrane Biol, Davis, CA 95616 USA; [Yang, Fan] Univ Calif Davis, Mol Cellular & Integrat Physiol Grad Grp, Davis, CA 95616 USA; [Colton, Craig K.; Wang, Chunbo] Ohio State Univ, Ctr Mol Neurobiol, Columbus, OH 43210 USA; [Zhu, Michael X.] Univ Texas Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	Peking University; Dalian University of Technology; University of California System; University of California Davis; University of California System; University of California Davis; University System of Ohio; Ohio State University; University of Texas System; University of Texas Health Science Center Houston	Wang, KW (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Neurobiol, Neurosci Res Inst, Beijing 100083, Peoples R China.	wangkw@bjmu.edu; jzheng@ucdavis.edu	Yang, Fan/C-6586-2012; Cao, Xu/G-6209-2015; Cui, Yuanyuan/G-1787-2017; Yang, Fan/AAA-6904-2022; Yang, Fan/GYU-4249-2022; Cui, Yuanyuan/G-1899-2015; Yang, Fan/J-4562-2015; chegn, maizy/GVU-3127-2022; Zhu, Ren-Yuan/V-8966-2019	Yang, Fan/0000-0002-9406-7710; Cao, Xu/0000-0003-1796-2735; Cui, Yuanyuan/0000-0002-1455-5643; Yang, Fan/0000-0002-0520-5254; Yang, Fan/0000-0002-9406-7710; Zhu, Ren-Yuan/0000-0003-3091-7461	National Institutes of Health [NS072377, GM081658]; University of California Davis Health System; National Science Foundation of China [30970919, 3092800]; Ministry of Education of China [B07001]; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072377] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Davis Health System; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS072377 (to J. Z.) and GM081658 (to M. X. Z.). This work was also supported by the University of California Davis Health System (to J. Z.), National Science Foundation of China Grants 30970919 (to K. W. W.) and 3092800 (to J. Z.), Ministry of Education of China 111 Project B07001 (to K. W. W.), and an American Heart Association predoctoral fellowship (to F. Y.).	Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bandell M, 2007, CURR OPIN NEUROBIOL, V17, P490, DOI 10.1016/j.conb.2007.07.014; Baumann TK, 1996, PAIN, V65, P31, DOI 10.1016/0304-3959(95)00145-X; Benham CD, 2003, CELL CALCIUM, V33, P479, DOI 10.1016/S0143-4160(03)00063-0; Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cheng W, 2007, J GEN PHYSIOL, V129, P191, DOI 10.1085/jgp.200709731; Cheng W, 2010, PROTEIN CELL, V1, P802, DOI 10.1007/s13238-010-0108-9; Chung MK, 2005, J BIOL CHEM, V280, P15928, DOI 10.1074/jbc.M500596200; Clapham DE, 2002, SCIENCE, V295, P2228, DOI 10.1126/science.1070766; Colton C. K., 2006, THESIS OHIO STATE U; Facer P, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-11; Garcia-Sanz N, 2007, J NEUROSCI, V27, P11641, DOI 10.1523/JNEUROSCI.2457-07.2007; Gopinath Preethi, 2005, BMC Womens Health, V5, P2, DOI 10.1186/1472-6874-5-2; Greffrath W, 2003, NEUROREPORT, V14, P2251, DOI 10.1097/00001756-200312020-00023; Gunthorpe MJ, 2002, TRENDS PHARMACOL SCI, V23, P183, DOI 10.1016/S0165-6147(02)01999-5; Hjerling-Leffler J, 2007, J NEUROSCI, V27, P2435, DOI 10.1523/JNEUROSCI.5614-06.2007; Huang SM, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-37; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; Jordt SE, 2003, CURR OPIN NEUROBIOL, V13, P487, DOI 10.1016/S0959-4388(03)00101-6; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Latorre R, 2007, CELL CALCIUM, V42, P427, DOI 10.1016/j.ceca.2007.04.004; Latorre R, 2009, Q REV BIOPHYS, V42, P201, DOI 10.1017/S0033583509990072; Liang SS, 2009, CELL BIOCHEM BIOPHYS, V53, P33, DOI 10.1007/s12013-008-9035-2; Macpherson LJ, 2006, MOL CELL NEUROSCI, V32, P335, DOI 10.1016/j.mcn.2006.05.005; Moiseenkova-Bell VY, 2008, P NATL ACAD SCI USA, V105, P7451, DOI 10.1073/pnas.0711835105; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Puntambekar P, 2005, J NEUROCHEM, V95, P1689, DOI 10.1111/j.1471-4159.2005.03518.x; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Siemens J, 2006, NATURE, V444, P208, DOI 10.1038/nature05285; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Szallasi A, 1995, Acta Physiol Scand Suppl, V629, P1; Valente P, 2008, FASEB J, V22, P3298, DOI 10.1096/fj.08-107425; Vetter I, 2008, J BIOL CHEM, V283, P19540, DOI 10.1074/jbc.M707865200; Vlachova V, 2003, J NEUROSCI, V23, P1340, DOI 10.1523/JNEUROSCI.23-04-01340.2003; Wang CB, 2004, J BIOL CHEM, V279, P37423, DOI 10.1074/jbc.M407205200; Xiao R, 2008, J BIOL CHEM, V283, P6162, DOI 10.1074/jbc.M706535200; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Yan T, 2007, ANESTH ANALG, V104, P1246, DOI 10.1213/01.ane.0000263270.39480.a2; Yang F, 2010, P NATL ACAD SCI USA, V107, P7083, DOI 10.1073/pnas.1000357107; Zhang F, 2011, J BIOL CHEM, V286, P15308, DOI 10.1074/jbc.M111.223941	48	57	57	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7279	7288		10.1074/jbc.M111.305045	http://dx.doi.org/10.1074/jbc.M111.305045			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22184123	Green Published, hybrid			2022-12-25	WOS:000301060200030
J	Cardarelli, F; Tosti, L; Serresi, M; Beltram, F; Bizzarri, R				Cardarelli, Francesco; Tosti, Luca; Serresi, Michela; Beltram, Fabio; Bizzarri, Ranieri			Fluorescent Recovery after Photobleaching (FRAP) Analysis of Nuclear Export Rates Identifies Intrinsic Features of Nucleocytoplasmic Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE COMPLEX; FACILITATED TRANSPORT; CYTOPLASM; DOMAIN; SIGNAL; CELLS; CRM1; REV	A quantitative description of carrier-mediated nuclear export in live cells is presented. To this end, we fused a prototypical leucine-rich nuclear export signal (NES) to GFP as a cargo model and expressed the fluorescent chimera in live CHO-K1 cells. By modeling FRAP data, we calculate the NES affinity for the export machinery and the maximum rate of nuclear export achievable at saturation of endogenous carriers. The measured active-export time through the Nuclear Pore Complex (NPC) is 18 ms, remarkably similar to the previously determined active-import rate. Also, our results reveal that active export/import and active export/passive diffusion fluxes are uncoupled, thus complementing previous reports on active import/passive diffusion uncoupling. These findings suggest differential gating at the NPC level.	[Cardarelli, Francesco; Serresi, Michela; Beltram, Fabio; Bizzarri, Ranieri] Ist Italiano Tecnol, Ctr Nanotechnol Innovat NEST, I-56124 Pisa, Italy; [Tosti, Luca; Beltram, Fabio; Bizzarri, Ranieri] Scuola Normale Super Pisa, NEST, I-56124 Pisa, Italy; [Tosti, Luca; Beltram, Fabio; Bizzarri, Ranieri] Ist Nanosci CNR, I-56124 Pisa, Italy	Istituto Italiano di Tecnologia - IIT; Scuola Normale Superiore di Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR)	Bizzarri, R (corresponding author), Ist Biofis CNR, Via Moruzzi 1, I-56124 Pisa, Italy.	r.bizzarri@sns.it	Beltram, Fabio/L-9486-2019; Beltram, Fabio/F-2920-2013; Bizzarri, Ranieri/H-1779-2011; Bizzarri, Ranieri/ABH-8343-2020	Beltram, Fabio/0000-0002-6081-436X; Beltram, Fabio/0000-0002-6081-436X; Bizzarri, Ranieri/0000-0002-8222-2672; Tosti, Luca/0000-0003-2941-965X	Italian Ministry for University and Research (MIUR) [RBLA03ER38, RBPR05JH2P, 2008JZ4MLB]	Italian Ministry for University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was supported in part by the Italian Ministry for University and Research (MIUR) under the framework of the FIRB Projects RBLA03ER38 and RBPR05JH2P, and PRIN 2008JZ4MLB.	Cardarelli F, 2008, TRAFFIC, V9, P528, DOI 10.1111/j.1600-0854.2007.00696.x; Cardarelli F, 2011, BIOPHYS J, V101, pL27, DOI 10.1016/j.bpj.2011.04.057; Cardarelli F, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.203083; Cardarelli F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010475; Cardarelli F, 2009, J BIOL CHEM, V284, P36638, DOI 10.1074/jbc.M109.036699; Conti E, 2006, CURR OPIN STRUC BIOL, V16, P237, DOI 10.1016/j.sbi.2006.03.010; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Daelemans D, 2005, MOL CELL BIOL, V25, P728, DOI 10.1128/MCB.25.2.728-739.2005; DINGWALL C, 1982, CELL, V30, P449, DOI 10.1016/0092-8674(82)90242-2; Dong XH, 2009, NATURE, V458, P1136, DOI 10.1038/nature07975; Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Fiserova J, 2010, J CELL SCI, V123, P2773, DOI 10.1242/jcs.070730; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Lim RYH, 2007, SCIENCE, V318, P640, DOI 10.1126/science.1145980; Lindsay ME, 2001, J CELL BIOL, V153, P1391, DOI 10.1083/jcb.153.7.1391; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Naim B, 2007, J BIOL CHEM, V282, P3881, DOI 10.1074/jbc.M608329200; Neville M, 1997, CURR BIOL, V7, P767, DOI 10.1016/S0960-9822(06)00335-6; PAINE PL, 1975, J CELL BIOL, V66, P652, DOI 10.1083/jcb.66.3.652; Paraskeva E, 1999, J CELL BIOL, V145, P255, DOI 10.1083/jcb.145.2.255; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Walde S, 2010, TRENDS CELL BIOL, V20, P461, DOI 10.1016/j.tcb.2010.05.001; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Wente SR, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000562	29	16	16	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5554	5561		10.1074/jbc.M111.304899	http://dx.doi.org/10.1074/jbc.M111.304899			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22190681	Green Published, hybrid			2022-12-25	WOS:000300638000034
J	Zhao, ZS; Choi, JW; Zhao, CY; Ma, ZA				Zhao, Zhengshan; Choi, Jinwoo; Zhao, Chunying; Ma, Zhongmin Alex			FTY720 Normalizes Hyperglycemia by Stimulating beta-Cell in Vivo Regeneration in db/db Mice through Regulation of Cyclin D3 and p57(KIP2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPHINGOSINE 1-PHOSPHATE; MULTIPLE-SCLEROSIS; INSULIN-SECRETION; DIABETES-MELLITUS; SPHINGOSINE-1-PHOSPHATE RECEPTOR; PHOSPHATIDYLINOSITOL-3 KINASE; PHOSPHOINOSITIDE 3-KINASE; IMMUNOMODULATOR FTY720; FINGOLIMOD FTY720; MODULATOR FTY720	Loss of insulin-producing beta-cell mass is a hallmark of type 2 diabetes in humans and diabetic db/db mice. Pancreatic beta-cells can modulate their mass in response to a variety of physiological and pathophysiological cues. There are currently few effective therapeutic approaches targeting beta-cell regeneration although some anti-diabetic drugs may positively affect beta-cell mass. Here we show that oral administration of FTY720, a sphingosine 1-phosphate (S1P) receptor modulator, to db/db mice normalizes fasting blood glucose by increasing beta-cell mass and blood insulin levels without affecting insulin sensitivity. Fasting blood glucose remained normal in the mice even after the drug was withdrawn after 23 weeks of treatment. The islet area in the pancreases of the FTY720-treated db/db mice was more than 2-fold larger than that of the untreated mice after 6 weeks of treatment. Furthermore, BrdU incorporation assays and Ki67 staining demonstrated cell proliferation in the islets and pancreatic duct areas. Finally, islets from the treated mice exhibited a significant decrease in the level of cyclin-dependent kinase inhibitor p57(KIP2) and an increase in the level of cyclin D3 as compared with those of untreated mice, which could be reversed by the inhibition of phosphatidylinositol 3-kinase (PI3K). Our findings reveal a novel network that controls beta-cell regeneration in the obesity-diabetes setting by regulating cyclin D3 and p57(KIP2) expression through the S1P signaling pathway. Therapeutic strategies targeting this network may promote in vivo regeneration of beta-cells in patients and prevent and/or cure type 2 diabetes.	[Zhao, Zhengshan; Choi, Jinwoo; Zhao, Chunying; Ma, Zhongmin Alex] Mt Sinai Sch Med, Dept Geriatr & Palliat Med, Div Expt Diabet & Aging, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Ma, ZA (corresponding author), Mt Sinai Sch Med, Dept Geriatr & Palliat Med, Div Expt Diabet & Aging, 1 Gustave L Levy Pl, New York, NY 10029 USA.	Zhongmin.ma@mssm.edu			National Institutes of Health from the NINDS [R01 NS063962]; Iacocca Family foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK074805, R01DK063076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063962] Funding Source: NIH RePORTER	National Institutes of Health from the NINDS; Iacocca Family foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS063962 from the NINDS and the Iacocca Family foundation.	Albert R, 2005, J MED CHEM, V48, P5373, DOI 10.1021/jm050242f; Ashizawa S, 2004, PANCREAS, V28, P109, DOI 10.1097/00006676-200403000-00001; Assmann A, 2009, PEDIATR DIABETES, V10, P14, DOI 10.1111/j.1399-5448.2008.00468.x; Bonner-Weir S, 2010, DIABETES, V59, P2340, DOI 10.2337/db10-0084; Bouwens L, 2005, PHYSIOL REV, V85, P1255, DOI 10.1152/physrev.00025.2004; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Butler PC, 2007, NAT CLIN PRACT ENDOC, V3, P758, DOI 10.1038/ncpendmet0647; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Desai BM, 2007, J CLIN INVEST, V117, P971, DOI 10.1172/JCI29988; Dhawan S, 2009, GENE DEV, V23, P906, DOI 10.1101/gad.1742609; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Fiaschi-Taesch NM, 2010, DIABETES, V59, P1926, DOI 10.2337/db09-1776; Gardell SE, 2006, TRENDS MOL MED, V12, P65, DOI 10.1016/j.molmed.2005.12.001; Georgia S, 2004, J CLIN INVEST, V114, P963, DOI 10.1172/JCI200422098; Georgia S, 2006, DEV BIOL, V298, P22, DOI 10.1016/j.ydbio.2006.05.036; Guillermet-Guibert J, 2008, P NATL ACAD SCI USA, V105, P8292, DOI 10.1073/pnas.0707761105; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Huwiler A, 2008, BIOCHEM PHARMACOL, V75, P1893, DOI 10.1016/j.bcp.2007.12.018; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Jongsma M, 2006, BRIT J PHARMACOL, V149, P277, DOI 10.1038/sj.bjp.0706872; Kassem SA, 2001, DIABETES, V50, P2763, DOI 10.2337/diabetes.50.12.2763; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Laychock SG, 2006, ENDOCRINOLOGY, V147, P4705, DOI 10.1210/en.2006-0456; Leahy JL, 2010, J CLIN ENDOCR METAB, V95, P4206, DOI 10.1210/jc.2010-0668; LEITER EH, 1989, ENDOCRINOLOGY, V124, P912, DOI 10.1210/endo-124-2-912; Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200; Li WC, 2010, J CELL SCI, V123, P2792, DOI 10.1242/jcs.065268; Lipsett M, 2002, DIABETES, V51, P1834, DOI 10.2337/diabetes.51.6.1834; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Menge BA, 2008, DIABETES, V57, P142, DOI 10.2337/db07-1294; Minami K, 2005, P NATL ACAD SCI USA, V102, P15116, DOI 10.1073/pnas.0507567102; Pateras IS, 2009, MOL CANCER RES, V7, P1902, DOI 10.1158/1541-7786.MCR-09-0317; PORTE D, 1991, DIABETES, V40, P166, DOI 10.2337/diabetes.40.2.166; Potteck H, 2010, CELL PHYSIOL BIOCHEM, V26, P67, DOI 10.1159/000315107; Radeff-Huang J, 2004, J CELL BIOCHEM, V92, P949, DOI 10.1002/jcb.20094; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Rieck S, 2010, TRENDS ENDOCRIN MET, V21, P151, DOI 10.1016/j.tem.2009.11.001; Rothschild G, 2006, MOL CELL BIOL, V26, P4351, DOI 10.1128/MCB.01743-05; Samad F, 2006, DIABETES, V55, P2579, DOI 10.2337/db06-0330; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Seleznev K, 2006, J BIOL CHEM, V281, P22275, DOI 10.1074/jbc.M604330200; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Shen Y, 2007, CANCER LETT, V254, P288, DOI 10.1016/j.canlet.2007.03.013; Sicinska E, 2003, CANCER CELL, V4, P451, DOI 10.1016/S1535-6108(03)00301-5; Song K, 2005, MOL ENDOCRINOL, V19, P504, DOI 10.1210/me.2004-0169; Sorenson RL, 1997, HORM METAB RES, V29, P301, DOI 10.1055/s-2007-979040; Strader CR, 2011, J NAT PROD, V74, P900, DOI 10.1021/np2000528; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Tokumura A, 2002, BIOL REPROD, V67, P1386, DOI 10.1095/biolreprod.102.004051; Truong W, 2007, AM J TRANSPLANT, V7, P2031, DOI 10.1111/j.1600-6143.2007.01880.x; VANASSCHE FA, 1978, BRIT J OBSTET GYNAEC, V85, P818; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Verzijl D, 2010, MOL CELLS, V29, P99, DOI 10.1007/s10059-010-0041-z; Watanabe H, 2008, BIOCHEM BIOPH RES CO, V370, P33, DOI 10.1016/j.bbrc.2008.03.012; Watanabe H, 2008, PANCREAS, V36, P153, DOI 10.1097/MPA.0b013e318157753e; Wymann MP, 1996, MOL CELL BIOL, V16, P1722; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Zhang XH, 2006, J CELL SCI, V119, P1005, DOI 10.1242/jcs.02821; Zhang XH, 2007, J CELL SCI, V120, P4134, DOI 10.1242/jcs.015834; Zhao ZS, 2010, ENDOCRINOLOGY, V151, P3038, DOI 10.1210/en.2010-0016; Zhao ZS, 2009, ENDOCRINOLOGY, V150, P2569, DOI 10.1210/en.2008-1342	64	43	46	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5562	5573		10.1074/jbc.M111.305359	http://dx.doi.org/10.1074/jbc.M111.305359			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22194608	hybrid, Green Published			2022-12-25	WOS:000300638000035
J	Zanini, C; Bruno, S; Mandili, G; Baci, D; Cerutti, F; Cenacchi, G; Izzi, L; Camussi, G; Forni, M				Zanini, Cristina; Bruno, Stefania; Mandili, Giorgia; Baci, Denisa; Cerutti, Francesco; Cenacchi, Giovanna; Izzi, Leo; Camussi, Giovanni; Forni, Marco			Differentiation of Mesenchymal Stem Cells Derived from Pancreatic Islets and Bone Marrow into Islet-Like Cell Phenotype	PLOS ONE			English	Article							2-DIMENSIONAL GEL-ELECTROPHORESIS; BETA-CELLS; STROMAL CELLS; PROTEOMICS; PLURIPOTENCY; TECHNOLOGY; GENERATION	Background: Regarding regenerative medicine for diabetes, accessible sources of Mesenchymal Stem Cells (MSCs) for induction of insular beta cell differentiation may be as important as mastering the differentiation process itself. Methodology/Principal Findings: In the present work, stem cells from pancreatic islets (human islet-mesenchymal stem cells, HI-MSCs) and from human bone marrow (bone marrow mesenchymal stem cells, BM-MSCs) were cultured in custom-made serum-free medium, using suitable conditions in order to induce differentiation into Islet-like Cells (ILCs). HI-MSCs and BM-MSCs were positive for the MSC markers CD105, CD73, CD90, CD29. Following this induction, HI-MSC and BM-MSC formed evident islet-like structures in the culture flasks. To investigate functional modifications after induction to ILCs, ultrastructural analysis and immunofluorescence were performed. PDX1 (pancreatic duodenal homeobox gene-1), insulin, C peptide and Glut-2 were detected in HI-ILCs whereas BM-ILCs only expressed Glut-2 and insulin. Insulin was also detected in the culture medium following glucose stimulation, confirming an initial differentiation that resulted in glucose-sensitive endocrine secretion. In order to identify proteins that were modified following differentiation from basal MSC (HI-MSCs and BM-MSCs) to their HI-ILCs and BM-ILCs counterparts, proteomic analysis was performed. Three new proteins (APOA1, ATL2 and SODM) were present in both ILC types, while other detected proteins were verified to be unique to the single individual differentiated cells lines. Hierarchical analysis underscored the limited similarities between HI-MSCs and BM-MSCs after induction of differentiation, and the persistence of relevant differences related to cells of different origin. Conclusions/Significance: Proteomic analysis highlighted differences in the MSCs according to site of origin, reflecting spontaneous differentiation and commitment. A more detailed understanding of protein assets may provide insights required to master the differentiation process of HI-MSCs to functional beta cells based only upon culture conditioning. These findings may open new strategies for the clinical use of BM-MSCs in diabetes.	[Zanini, Cristina; Bruno, Stefania; Baci, Denisa; Cerutti, Francesco; Forni, Marco] Univ Turin, Ctr Mol Biotechnol, Turin, Italy; [Zanini, Cristina; Izzi, Leo] EuroClone SpA, Milan, Italy; [Mandili, Giorgia] Univ Turin, Res Ctr Expt Med CeRMS, Turin, Italy; [Cerutti, Francesco] Univ Turin, Dept Anim Prod Epidemiol & Ecol, Turin, Italy; [Cenacchi, Giovanna] Alma Mater Studiorum Univ Bologna, Clin Dept Radiol & Histopathol Sci, Bologna, Italy; [Camussi, Giovanni] Univ Turin, Dept Internal Med, Turin, Italy	University of Turin; University of Turin; University of Turin; University of Bologna; University of Turin	Zanini, C (corresponding author), Univ Turin, Ctr Mol Biotechnol, Turin, Italy.	cristina.zanini@unito.it	Baci, Denisa/J-2929-2018; Cerutti, Francesco/J-5920-2016; Baci, Denisa/AAE-4344-2022; Camussi, Giovanni/J-7624-2016	Baci, Denisa/0000-0001-6474-0970; Cerutti, Francesco/0000-0003-0480-8296; Baci, Denisa/0000-0001-6474-0970; Camussi, Giovanni/0000-0003-2795-232X; Zanini, Cristina/0000-0002-6554-2113; CENACCHI, GIOVANNA/0000-0001-5824-3118; BRUNO, Stefania/0000-0002-8879-9536	Ricerca Finanziata Regione Piemonte; Comitato Interministeriale per la programmazione Economica (CIPE); Piattaforma Piemontese per la Ricerca sulle Cellule staminali (PISTEM)	Ricerca Finanziata Regione Piemonte; Comitato Interministeriale per la programmazione Economica (CIPE); Piattaforma Piemontese per la Ricerca sulle Cellule staminali (PISTEM)	This work was supported by Ricerca Finanziata Regione Piemonte and Comitato Interministeriale per la programmazione Economica (CIPE), and by Piattaforma Piemontese per la Ricerca sulle Cellule staminali (PISTEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2005, J PROTEOME RES, V4, P931, DOI 10.1021/pr050024a; Barbero G, 2006, ANAL BIOCHEM, V349, P62, DOI 10.1016/j.ab.2005.10.020; Bolker B, 2010, GPLOTS VARIOUS R PRO; Borowiak Malgorzata, 2010, Rev Diabet Stud, V7, P93, DOI 10.1900/RDS.2010.7.93; Bruno S, 2009, STEM CELLS DEV, V18, P867, DOI 10.1089/scd.2008.0320; Bruno S, 2009, J AM SOC NEPHROL, V20, P1053, DOI 10.1681/ASN.2008070798; Coute Y, 2010, PROTEOMICS, V10, P59, DOI 10.1002/pmic.200900080; D'Hertog W, 2007, MOL CELL PROTEOMICS, V6, P2180, DOI 10.1074/mcp.M700085-MCP200; Davani B, 2007, STEM CELLS, V25, P3215, DOI 10.1634/stemcells.2007-0323; Development Core Team R, 2009, R LANG ENV STAT COMP; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Duinsbegen D, 2008, EXP CELL RES, V314, P3255, DOI 10.1016/j.yexcr.2008.06.024; Gehrmann W, 2010, DIABETES OBES METAB, V12, P149, DOI 10.1111/j.1463-1326.2010.01265.x; Han D, 2011, J PROTEOME RES, V10, P564, DOI 10.1021/pr100759a; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Karnieli O, 2007, STEM CELLS, V25, P2837, DOI 10.1634/stemcells.2007-0164; Lu HF, 2008, MOL CELL PROTEOMICS, V7, P1434, DOI 10.1074/mcp.M700478-MCP200; Mandili G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018254; Martens GA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014214; Mathews CE, 1999, FREE RADICAL BIO MED, V27, P449, DOI 10.1016/S0891-5849(99)00084-2; Mineo D, 2009, DIABETES CARE, V32, P1563, DOI 10.2337/dc09-0490; Mrozik KM, 2010, STEM CELLS DEV, V19, P1485, DOI 10.1089/scd.2009.0446; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pei DQ, 2010, ADV BIOCHEM ENG BIOT, V123, P127, DOI 10.1007/10_2010_72; RICORDI C, 1989, DIABETES, V38, P140, DOI 10.2337/diab.38.1.S140; Sanchez JC, 2001, PROTEOMICS, V1, P136; Scarano V, 2005, J NEUROL, V252, P901, DOI 10.1007/s00415-005-0768-1; Schugar RC, 2008, GENE THER, V15, P126, DOI 10.1038/sj.gt.3303062; Suss C, 2008, EXP CLIN ENDOCR DIAB, V116, pS13, DOI 10.1055/s-2008-1080898; Tsai SY, 2011, STEM CELLS, V29, P964, DOI 10.1002/stem.649; Zanini C, 2011, CHILDS NERV SYS 0630; Zhou HY, 2010, CURR OPIN HEMATOL, V17, P276, DOI 10.1097/MOH.0b013e328339f2ee	32	41	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2011	6	12							e28175	10.1371/journal.pone.0028175	http://dx.doi.org/10.1371/journal.pone.0028175			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JD	22194812	gold, Green Submitted, Green Published			2022-12-25	WOS:000298664400003
J	Noberini, R; Mitra, S; Salvucci, O; Valencia, F; Duggineni, S; Prigozhina, N; Wei, K; Tosato, G; Huang, ZW; Pasquale, EB				Noberini, Roberta; Mitra, Sayantan; Salvucci, Ombretta; Valencia, Fatima; Duggineni, Srinivas; Prigozhina, Natalie; Wei, Ke; Tosato, Giovanna; Huang, Ziwei; Pasquale, Elena B.			PEGylation Potentiates the Effectiveness of an Antagonistic Peptide That Targets the EphB4 Receptor with Nanomolar Affinity	PLOS ONE			English	Article							COLORECTAL-CANCER PROGRESSION; GROWTH-FACTOR WITHDRAWAL; TUMOR-GROWTH; TYROSINE KINASE; MELANOMA-CELLS; BLOOD-VESSELS; IN-VIVO; VASCULAR MORPHOGENESIS; DRUG-DELIVERY; ANGIOGENESIS	The EphB4 receptor tyrosine kinase together with its preferred ligand, ephrin-B2, regulates a variety of physiological and pathological processes, including tumor progression, pathological forms of angiogenesis, cardiomyocyte differentiation and bone remodeling. We previously reported the identification of TNYL-RAW, a 15 amino acid-long peptide that binds to the ephrin-binding pocked of EphB4 with low nanomolar affinity and inhibits ephrin-B2 binding. Although ephrin-B2 interacts promiscuously with all the EphB receptors, the TNYL-RAW peptide is remarkably selective and only binds to EphB4. Therefore, this peptide is a useful tool for studying the biological functions of EphB4 and for imaging EphB4-expressing tumors. Furthermore, TNYL-RAW could be useful for treating pathologies involving EphB4-ephrin-B2 interaction. However, the peptide has a very short half-life in cell culture and in the mouse blood circulation due to proteolytic degradation and clearance by the kidneys and reticuloendothelial system. To overcome these limitations, we have modified TNYL-RAW by fusion with the Fc portion of human IgG1, complexation with streptavidin or covalent coupling to a 40 KDa branched polyethylene glycol (PEG) polymer. These modified forms of TNYL-RAW all have greatly increased stability in cell culture, while retaining high binding affinity for EphB4. Furthermore, PEGylation most effectively increases peptide half-life in vivo. Consistent with increased stability, submicromolar concentrations of PEGylated TNYL-RAW effectively impair EphB4 activation by ephrin-B2 in cultured B16 melanoma cells as well as capillary-like tube formation and capillary sprouting in co-cultures of endothelial and epicardial mesothelial cells. Therefore, PEGylated TNYL-RAW may be useful for inhibiting pathological forms of angiogenesis through a novel mechanism involving disruption of EphB4-ephrin-B2 interactions between endothelial cells and supporting perivascular mesenchymal cells. Furthermore, the PEGylated peptide is suitable for other cell culture and in vivo applications requiring prolonged EphB4 receptor targeting.	[Noberini, Roberta; Mitra, Sayantan; Valencia, Fatima; Prigozhina, Natalie; Wei, Ke; Pasquale, Elena B.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Salvucci, Ombretta; Tosato, Giovanna] NCI, Cellular Oncol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Duggineni, Srinivas; Huang, Ziwei] SUNY Syracuse, Dept Pharmacol, State Univ New York Upstate Canc Res Inst, Syracuse, NY USA; [Prigozhina, Natalie] Univ San Diego, Dept Biol, San Diego, CA 92110 USA; [Pasquale, Elena B.] Univ San Diego, Dept Pathol, San Diego, CA 92110 USA	Sanford Burnham Prebys Medical Discovery Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); State University of New York (SUNY) System; University of San Diego; University of San Diego	Noberini, R (corresponding author), Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA.	elenap@sanfordburnham.org	duggineni, srinivas/J-3691-2012; Noberini, Roberta/AAP-4527-2020	Noberini, Roberta/0000-0002-7267-1079; Tosato, Giovanna/0000-0003-1663-3227	National Institutes of Health [CA116099, CA138390]; Department of Defense [W81XWH-07-1-0462]; MedImmune/AstraZeneca; NATIONAL CANCER INSTITUTE [R01CA116099, ZIASC010355, P01CA138390] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); MedImmune/AstraZeneca(AstraZeneca); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding provided by the National Institutes of Health grants CA116099 and CA138390 (EP) and Department of Defense grant W81XWH-07-1-0462 (ZH and EP). Funding was also received from a commercial source: MedImmune/AstraZeneca (EP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitch R, 1999, CANCER RES, V59, P5012; Adams RH, 2001, CELL, V104, P57, DOI 10.1016/S0092-8674(01)00191-X; Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Benjamin LE, 1999, J CLIN INVEST, V103, P159, DOI 10.1172/JCI5028; Bochenek ML, 2010, J CELL SCI, V123, P1235, DOI 10.1242/jcs.061903; Chen K, 2010, J CELL BIOCHEM, V111, P29, DOI 10.1002/jcb.22680; Chrencik JE, 2006, STRUCTURE, V14, P321, DOI 10.1016/j.str.2005.11.011; Djokovic D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-641; Dopeso H, 2009, CANCER RES, V69, P7430, DOI 10.1158/0008-5472.CAN-09-0706; Ehlken C, 2011, ACTA OPHTHALMOL, V89, P82, DOI 10.1111/j.1755-3768.2009.01609.x; EID H, 1992, CIRC RES, V71, P40, DOI 10.1161/01.RES.71.1.40; Erber R, 2006, EMBO J, V25, P628, DOI 10.1038/sj.emboj.7600949; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Fuller T, 2003, J CELL SCI, V116, P2461, DOI 10.1242/jcs.00426; Galati R, 2003, Z NATURFORSCH C, V58, P558; Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033; Heroult M, 2006, EXP CELL RES, V312, P642, DOI 10.1016/j.yexcr.2005.10.028; Heroult M, 2010, MOL CANCER RES, V8, P1297, DOI 10.1158/1541-7786.MCR-09-0453; Huang JZ, 2004, MOL CANCER RES, V2, P36; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jazayeri JA, 2008, BIODRUGS, V22, P11, DOI 10.2165/00063030-200822010-00002; Jevsevar S, 2010, BIOTECHNOL J, V5, P113, DOI 10.1002/biot.200900218; Joralemon MJ, 2010, CHEM COMMUN, V46, P1377, DOI 10.1039/b920570p; Kang JS, 2009, EXPERT OPIN EMERG DR, V14, P363, DOI 10.1517/14728210902907847; Kertesz N, 2006, BLOOD, V107, P2330, DOI 10.1182/blood-2005-04-1655; Koolpe M, 2005, J BIOL CHEM, V280, P17301, DOI 10.1074/jbc.M500363200; Korff T, 1999, J CELL SCI, V112, P3249; Krasnoperov V, 2010, AM J PATHOL, V176, P2029, DOI 10.2353/ajpath.2010.090755; Kuijper S, 2007, TRENDS CARDIOVAS MED, V17, P145, DOI 10.1016/j.tcm.2007.03.003; Kumar SR, 2007, BRIT J CANCER, V96, P1083, DOI 10.1038/sj.bjc.6603642; Kumar SR, 2009, CANCER RES, V69, P3736, DOI 10.1158/0008-5472.CAN-08-3232; Ladner RC, 2004, DRUG DISCOV TODAY, V9, P525, DOI 10.1016/S1359-6446(04)03104-6; Lee HJ, 2001, BIOCONJUGATE CHEM, V12, P995, DOI 10.1021/bc0155061; Martiny-Baron G, 2004, NEOPLASIA, V6, P248, DOI 10.1593/neo.03457; Martiny-Baron G, 2010, ANGIOGENESIS, V13, P259, DOI 10.1007/s10456-010-9183-z; McGregor DP, 2008, CURR OPIN PHARMACOL, V8, P616, DOI 10.1016/j.coph.2008.06.002; Menzel P, 2001, DEV BIOL, V230, P74, DOI 10.1006/dbio.2000.0109; Meyer DL, 2001, PROTEIN SCI, V10, P491, DOI 10.1110/ps.19901; Meyer S, 2005, INT J ONCOL, V27, P1197; Mitra S, 2010, BIOCHEMISTRY-US, V49, P6687, DOI 10.1021/bi1006223; Morikawa S, 2002, AM J PATHOL, V160, P985, DOI 10.1016/S0002-9440(10)64920-6; Noren NK, 2007, CANCER RES, V67, P3994, DOI 10.1158/0008-5472.CAN-07-0525; Noren NK, 2009, BIOCHEM J, V422, P433, DOI 10.1042/BJ20090014; Noren NK, 2004, P NATL ACAD SCI USA, V101, P5583, DOI 10.1073/pnas.0401381101; Ogawa K, 2000, ONCOGENE, V19, P6043, DOI 10.1038/sj.onc.1204004; Oliner J, 2004, CANCER CELL, V6, P507, DOI 10.1016/j.ccr.2004.09.030; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Pasut G, 2009, ADV DRUG DELIVER REV, V61, P1177, DOI 10.1016/j.addr.2009.02.010; Prigozhina NL, 2011, BIOL CELL, V103, P467, DOI 10.1042/BC20100146; Ribatti D, 2011, INT J DEV BIOL, V55, P261, DOI 10.1387/ijdb.103167dr; Salvucci O, 2006, BLOOD, V108, P2914, DOI 10.1182/blood-2006-05-023341; Salvucci O, 2009, BLOOD, V114, P1707, DOI 10.1182/blood-2008-12-192294; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; Scehnet JS, 2009, BLOOD, V113, P254, DOI 10.1182/blood-2008-02-140020; Steinle JJ, 2003, CELL SIGNAL, V15, P1011, DOI 10.1016/S0898-6568(03)00072-X; Tigges U, 2008, DEVELOPMENT, V135, P523, DOI 10.1242/dev.002071; Torchilin VP, 2003, DRUG DISCOV TODAY, V8, P259, DOI 10.1016/S1359-6446(03)02623-0; Veronese FM, 2005, DRUG DISCOV TODAY, V10, P1451, DOI 10.1016/S1359-6446(05)03575-0; Veronese FM, 2008, BIODRUGS, V22, P315, DOI 10.2165/00063030-200822050-00004; Wada AM, 2003, CIRC RES, V92, P525, DOI 10.1161/01.RES.0000060484.11032.0B; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Wang ZY, 2004, BLOOD, V103, P100, DOI 10.1182/blood-2003-04-1063; Werle M, 2006, AMINO ACIDS, V30, P351, DOI 10.1007/s00726-005-0289-3; Xia G, 2006, ONCOGENE, V25, P769, DOI 10.1038/sj.onc.1209108; Xia GB, 2005, CLIN CANCER RES, V11, P4305, DOI 10.1158/1078-0432.CCR-04-2109; Xiong CY, 2011, J NUCL MED, V52, P241, DOI 10.2967/jnumed.110.081943; Yang NY, 2006, J BIOL CHEM, V281, P32574, DOI 10.1074/jbc.M604338200; Yang NY, 2010, PIGM CELL MELANOMA R, V23, P684, DOI 10.1111/j.1755-148X.2010.00745.x; Zhang R, 2011, BIOMATERIALS, V32, P5872, DOI 10.1016/j.biomaterials.2011.04.070; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012	72	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28611	10.1371/journal.pone.0028611	http://dx.doi.org/10.1371/journal.pone.0028611			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194865	Green Published, gold, Green Submitted			2022-12-25	WOS:000298369100062
J	Rifflet, A; Tene, N; Orivel, J; Treilhou, M; Dejean, A; Vetillard, A				Rifflet, Aline; Tene, Nathan; Orivel, Jerome; Treilhou, Michel; Dejean, Alain; Vetillard, Angelique			Paralyzing Action from a Distance in an Arboreal African Ant Species	PLOS ONE			English	Article							CREMATOGASTER-SCUTELLARIS HYMENOPTERA; TROPICAL RAIN-FOREST; VENOM ALKALOIDS; DUFOUR GLAND; POISON APPARATUS; CONTACT POISONS; FIRE ANTS; FORMICIDAE; BEHAVIOR; MYRMICINAE	Due to their prowess in interspecific competition and ability to catch a wide range of arthropod prey (mostly termites with which they are engaged in an evolutionary arms race), ants are recognized as a good model for studying the chemicals involved in defensive and predatory behaviors. Ants' wide diversity of nesting habits and relationships with plants and prey types implies that these chemicals are also very diverse. Using the African myrmicine ant Crematogaster striatula as our focal species, we adopted a three-pronged research approach. We studied the aggressive and predatory behaviors of the ant workers, conducted bioassays on the effect of their Dufour gland contents on termites, and analyzed these contents. (1) The workers defend themselves or eliminate termites by orienting their abdominal tip toward the opponent, stinger protruded. The chemicals emitted, apparently volatile, trigger the recruitment of nestmates situated in the vicinity and act without the stinger having to come into direct contact with the opponent. Whereas alien ants competing with C. striatula for sugary food sources are repelled by this behavior and retreat further and further away, termites defend their nest whatever the danger. They face down C. striatula workers and end up by rolling onto their backs, their legs batting the air. (2) The bioassays showed that the toxicity of the Dufour gland contents acts in a time-dependent manner, leading to the irreversible paralysis, and, ultimately, death of the termites. (3) Gas chromatography-mass spectrometry analyses showed that the Dufour gland contains a mixture of mono-or polyunsaturated long-chain derivatives, bearing functional groups like oxo-alcohols or oxo-acetates. Electrospray ionization-mass spectrometry showed the presence of a molecule of 1584 Da that might be a large, acetylated alkaloid capable of splitting into smaller molecules that could be responsible for the final degree of venom toxicity.	[Rifflet, Aline; Tene, Nathan; Treilhou, Michel; Vetillard, Angelique] PRES Univ Toulouse, Jean Francois Champoll Univ Ctr, EA 4357, Venoms & Biol Act Lab, Albi, France; [Orivel, Jerome; Dejean, Alain] CNRS, UMR 8172, Kourou, France; [Dejean, Alain] Univ Toulouse 3, Univ Toulouse, F-31062 Toulouse, France	Universite Federale Toulouse Midi-Pyrenees (ComUE); AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Rifflet, A (corresponding author), PRES Univ Toulouse, Jean Francois Champoll Univ Ctr, EA 4357, Venoms & Biol Act Lab, Albi, France.	avetilla@univ-jfc.fr		Treilhou, Michel/0000-0002-3364-1950; Dejean, Alain/0000-0002-3561-2248; Orivel, Jerome/0000-0002-5636-3228	CUFR JFC; UPS; CNRS; Communaute d'Agglomeration de l'Albigeois; Region Midi-Pyrenees	CUFR JFC; UPS; CNRS(Centre National de la Recherche Scientifique (CNRS)); Communaute d'Agglomeration de l'Albigeois; Region Midi-Pyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie)	Financial support for this study was provided by CUFR JFC, UPS, CNRS and the Communaute d'Agglomeration de l'Albigeois. A.R was supported by a grant from Region Midi-Pyrenees. No additonal external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS R, 2000, CHEM ECOLOGY MEGALOM; ANDERSEN AN, 1991, OECOLOGIA, V88, P157, DOI 10.1007/BF00320805; Berger RG, 2009, BIOTECHNOL LETT, V31, P1651, DOI 10.1007/s10529-009-0083-5; Berthe RA, 2009, J COMP PHYSIOL A, V195, P753, DOI 10.1007/s00359-009-0451-6; Bluthgen N, 2007, AUSTRAL ECOL, V32, P93, DOI 10.1111/j.1442-9993.2007.01744.x; Blum M. S., 1978, Arthropod venoms., P801; Bluthgen N, 2004, OIKOS, V106, P344, DOI 10.1111/j.0030-1299.2004.12687.x; BOEVE JL, 1994, J ZOOL, V234, P165, DOI 10.1111/j.1469-7998.1994.tb06063.x; BRAND JM, 1972, TOXICON, V10, P259, DOI 10.1016/0041-0101(72)90011-6; BUREN WILLIAM F., 1958, JOUR NEW YORK ENT SOC, V66, P119; Buschinger A., 1984, P95; Carlet G, 1884, CR HEBD ACAD SCI, V98, P1550; Cerda X., 2011, PREDATION HYMENOPTER; Chen J, 2009, J AGR FOOD CHEM, V57, P3128, DOI 10.1021/jf803561y; Conover WJ, 1980, PRACTICAL NONPARAMET, P493; DALOZE D, 1991, EXPERIENTIA, V47, P1082, DOI 10.1007/BF01923348; DALOZE D, 1987, CAN J CHEM, V65, P432, DOI 10.1139/v87-073; Daloze D, 1998, TETRAHEDRON LETT, V39, P4671, DOI 10.1016/S0040-4039(98)00875-2; Davidson DW, 2003, SCIENCE, V300, P969, DOI 10.1126/science.1082074; Deblauwe I, 2007, INSECT SOC, V54, P334, DOI 10.1007/s00040-007-0951-8; Dejean A, 1996, BIOTROPICA, V28, P701, DOI 10.2307/2389056; Dejean A, 2000, SOCIOBIOLOGY, V35, P385; Dejean A., 2007, FUNCT ECOSYST COMMUN, V1, P105, DOI DOI 10.1515/CCLM.2008.220; Dejean A, 2009, NATURWISSENSCHAFTEN, V96, P57, DOI 10.1007/s00114-008-0448-y; Dejean A, 2008, BASIC APPL ECOL, V9, P316, DOI 10.1016/j.baae.2007.03.001; Dejean A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019837; Dejean A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011331; Deslippe RJ, 2000, TOXICON, V38, P223, DOI 10.1016/S0041-0101(99)00147-6; Dossey AT, 2009, J CHEM ECOL, V35, P861, DOI 10.1007/s10886-009-9666-9; DUMPERT K, 1981, SOCIAL BIOL ANTS; Graham JH, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.30; Greenberg L, 2008, ANN ENTOMOL SOC AM, V101, P1162, DOI 10.1603/0013-8746-101.6.1162; Heredia A, 2005, CHEMOECOLOGY, V15, P235, DOI 10.1007/s00049-005-0317-5; Hermann H.R., 1981, P77; HERMANN HR, 1967, ANN ENTOMOL SOC AM, V60, P1282, DOI 10.1093/aesa/60.6.1282; HERMANN HR, 1967, ANN ENTOMOL SOC AM, V60, P661, DOI 10.1093/aesa/60.3.661; Hermann HR, 1969, GEORGIA ENTOMOL SOC, V4, P123; Holldobler B., 1990, pi; Hunt JH, 2003, SCIENCE, V300, P916, DOI 10.1126/science.1085065; JONES TH, 1991, J CHEM ECOL, V17, P2507, DOI 10.1007/BF00994598; JONES TH, 1982, TETRAHEDRON, V38, P1949, DOI 10.1016/0040-4020(82)80044-6; Kenne M, 2000, ENTOMOL EXP APPL, V94, P31, DOI 10.1023/A:1003900925341; Kenne M, 2009, MYRMECOL NEWS, V12, P109; KUGLER C, 1978, Studia Entomologica, V20, P413; Laurent P, 2005, TOP CURR CHEM, V240, P167; Laurent P, 2003, TETRAHEDRON LETT, V44, P1383, DOI 10.1016/S0040-4039(02)02870-8; Leclercq S, 1997, J NAT PROD, V60, P1143, DOI 10.1021/np970202h; Leclercq S, 2000, TETRAHEDRON LETT, V41, P633, DOI 10.1016/S0040-4039(99)02127-9; Leclercq S, 1996, NATURWISSENSCHAFTEN, V83, P222, DOI 10.1007/BF01143328; Leclercq S, 2000, TETRAHEDRON, V56, P2037, DOI 10.1016/S0040-4020(00)00113-7; LESTON D, 1973, PANS (PEST ARTIC NEWS SUMM), V19, P311; LEUTHOLD RH, 1973, INSECT SOC, V20, P205, DOI 10.1007/BF02223190; MAJER JD, 1976, J APPL ECOL, V13, P145, DOI 10.2307/2401934; Majer Jonathan D., 1993, P115; Marlier JF, 2004, BEHAV PROCESS, V67, P427, DOI 10.1016/j.beproc.2004.07.003; Maschwitz U., 1975, P47; MASCHWITZ UWJ, 1971, VENOMOUS ANIMALS THE, V3, P1; Morgan E. David, 2008, Myrmecological News, V11, P79; Morgan ED, 2003, J CHEM ECOL, V29, P95, DOI 10.1023/A:1021928630441; Nikbakhtzadeh MR, 2009, TOXICON, V54, P80, DOI 10.1016/j.toxicon.2009.03.005; OBIN MS, 1985, J CHEM ECOL, V11, P1757, DOI 10.1007/BF01012125; PASTEELS JM, 1989, J CHEM ECOL, V15, P1501, DOI 10.1007/BF01012379; PRESTWICH GD, 1984, ANNU REV ENTOMOL, V29, P201, DOI 10.1146/annurev.en.29.010184.001221; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Richard FJ, 2001, J INSECT BEHAV, V14, P271, DOI 10.1023/A:1007845929801; Schatz B, 2003, ECOL ENTOMOL, V28, P359, DOI 10.1046/j.1365-2311.2003.00519.x; SCHEFFRAHN RH, 1984, ENVIRON ENTOMOL, V13, P1502, DOI 10.1093/ee/13.6.1502; Will KW, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.1201; 2010, POSTHOC ANAL FRIEDMA	69	8	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28571	10.1371/journal.pone.0028571	http://dx.doi.org/10.1371/journal.pone.0028571			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194854	Green Published, gold, Green Submitted			2022-12-25	WOS:000298369100053
J	Siman, R; Giovannone, N; Toraskar, N; Frangos, S; Stein, SC; Levine, JM; Kumar, MA				Siman, Robert; Giovannone, Nicholas; Toraskar, Nikhil; Frangos, Suzanne; Stein, Sherman C.; Levine, Joshua M.; Kumar, Monisha A.			Evidence that a Panel of Neurodegeneration Biomarkers Predicts Vasospasm, Infarction, and Outcome in Aneurysmal Subarachnoid Hemorrhage	PLOS ONE			English	Article							SPECTRIN BREAKDOWN PRODUCTS; TRAUMATIC BRAIN-INJURY; ALPHA-II-SPECTRIN; CEREBROSPINAL-FLUID; CEREBRAL VASOSPASM; SURROGATE MARKERS; CALPAIN-I; DAMAGE; ISCHEMIA; CASPASE	Biomarkers for neurodegeneration could be early prognostic measures of brain damage and dysfunction in aneurysmal subarachnoid hemorrhage (aSAH) with clinical and medical applications. Recently, we developed a new panel of neurodegeneration biomarkers, and report here on their relationships with pathophysiological complications and outcomes following severe aSAH. Fourteen patients provided serial cerebrospinal fluid samples for up to 10 days and were evaluated by ultrasonography, angiography, magnetic resonance imaging, and clinical examination. Functional outcomes were assessed at hospital discharge and 6-9 months thereafter. Eight biomarkers for acute brain damage were quantified: calpain-derived alpha-spectrin N- and C-terminal fragments (CCSntf and CCSctf), hypophosphorylated neurofilament H, 14-3-3 beta and zeta, ubiquitin C-terminal hydrolase L1, neuron-specific enolase, and S100 beta. All 8 biomarkers rose up to 100-fold in a subset of patients. Better than any single biomarker, a set of 6 correlated significantly with cerebral vasospasm, brain infarction, and poor outcome. Furthermore, CSF levels of 14-3-3 beta, CCSntf, and NSE were early predictors of subsequent moderate-to-severe vasospasm. These data provide evidence that a panel of neurodegeneration biomarkers may predict lasting brain dysfunction and the pathophysiological processes that lead to it following aSAH. The panel may be valuable as surrogate endpoints for controlled clinical evaluation of treatment interventions and for guiding aSAH patient care.	[Siman, Robert; Giovannone, Nicholas; Toraskar, Nikhil; Frangos, Suzanne; Stein, Sherman C.; Levine, Joshua M.; Kumar, Monisha A.] Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; [Levine, Joshua M.; Kumar, Monisha A.] Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Siman, R (corresponding author), Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA.	siman@mail.med.upenn.edu		Giovannone, Nicholas/0000-0001-5391-8729	National Institute of Health [NS048234]; Groff Foundation; Sharps Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048234] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Groff Foundation; Sharps Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants to RS from the National Institute of Health (NS048234) and to JML from the Groff Foundation and Sharps Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Chen HI, 2011, NEUROSURGERY, V69, P53, DOI 10.1227/NEU.0b013e3182191451; Frontera JA, 2006, NEUROSURGERY, V59, P21, DOI 10.1227/01.NEU.0000218821.34014.1B; Hoh BL, 2004, NEUROSURGERY, V55, P779, DOI 10.1227/01.NEU.0000137628.51839.D5; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; KASSELL NF, 1985, STROKE, V16, P562, DOI 10.1161/01.STR.16.4.562; Kramer A, 2009, STROKE, V40, P3403, DOI 10.1161/STROKEAHA.109.560243; LAD SP, 2011, J STROKE CE IN PRESS; Lewis SB, 2008, J CEREBR BLOOD F MET, V28, P1261, DOI 10.1038/jcbfm.2008.12; Lewis SB, 2007, J NEUROSURG, V107, P792, DOI 10.3171/JNS-07/10/0792; Lewis SB, 2010, J NEUROSCI RES, V88, P1475, DOI 10.1002/jnr.22323; Liu MC, 2010, EUR J NEUROSCI, V31, P722, DOI 10.1111/j.1460-9568.2010.07097.x; Nylen K, 2006, NEUROSCI LETT, V404, P132, DOI 10.1016/j.neulet.2006.05.029; Nylen K, 2007, STROKE, V38, P1489, DOI 10.1161/STROKEAHA.106.478362; Petzold A, 2006, J NEUROL NEUROSUR PS, V77, P753, DOI 10.1136/jnnp.2005.085175; Petzold A, 2005, J NEUROL SCI, V233, P183, DOI 10.1016/j.jns.2005.03.015; Pike BR, 2004, J CEREBR BLOOD F MET, V24, P98, DOI 10.1097/01.WCB.0000098520.11962.37; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; ROBERTSLEWIS JM, 1994, J NEUROSCI, V14, P3934; ROBERTSLEWIS JM, 1993, ANN NY ACAD SCI, V679, P78; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Sehba FA, 2011, MOL NEUROBIOL, V43, P27, DOI 10.1007/s12035-010-8155-z; Shirao S, 2010, CEREBROVASC DIS, V30, P105, DOI 10.1159/000314713; Siman R, 2005, J CEREBR BLOOD F MET, V25, P1433, DOI 10.1038/sj.jcbfm.9600138; SIMAN R, 1988, NEURON, V1, P279, DOI 10.1016/0896-6273(88)90076-1; Siman R, 2004, NEUROBIOL DIS, V16, P311, DOI 10.1016/j.nbd.2004.03.016; SIMAN R, 1989, J NEUROSCI, V9, P1579; Siman R, 2008, BRAIN RES, V1213, P1, DOI 10.1016/j.brainres.2008.03.034; Siman R, 2009, J NEUROTRAUM, V26, P1867, DOI 10.1089/neu.2009.0882; Smith ML, 2005, SURG NEUROL, V63, P229, DOI 10.1016/j.surneu.2004.06.017; Vergouwen MDI, 2011, J CEREBR BLOOD F MET, V31, P1545, DOI 10.1038/jcbfm.2011.56; Vergouwen MDI, 2010, STROKE, V41, P2391, DOI 10.1161/STROKEAHA.110.589275; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Yamashima T, 2004, CELL CALCIUM, V36, P285, DOI 10.1016/j.ceca.2004.03.001; Zhang C, 2002, NEUROBIOL DIS, V10, P289, DOI 10.1006/nbdi.2002.0526	35	34	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28938	10.1371/journal.pone.0028938	http://dx.doi.org/10.1371/journal.pone.0028938			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174930	Green Published, Green Submitted, gold			2022-12-25	WOS:000298365700084
J	Sokolowski, B; Orchard, S; Harvey, M; Sridhar, S; Sakai, Y				Sokolowski, Bernd; Orchard, Sandra; Harvey, Margaret; Sridhar, Settu; Sakai, Yoshihisa			Conserved BK Channel-Protein Interactions Reveal Signals Relevant to Cell Death and Survival	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNEL; POTASSIUM CHANNELS; SMOOTH-MUSCLE; CA CHANNELS; KINASE-C; CALCIUM; ACTIVATION; EXPRESSION; PHOSPHORYLATION; APOPTOSIS	The large-conductance Ca2+-activated K+ (BK) channel and its beta-subunit underlie tuning in non-mammalian sensory or hair cells, whereas in mammals its function is less clear. To gain insights into species differences and to reveal putative BK functions, we undertook a systems analysis of BK and BK-Associated Proteins (BKAPS) in the chicken cochlea and compared these results to other species. We identified 110 putative partners from cytoplasmic and membrane/cytoskeletal fractions, using a combination of coimmunoprecipitation, 2-D gel, and LC-MS/MS. Partners included 14-3-3 gamma, valosin-containing protein (VCP), stathmin (STMN), cortactin (CTTN), and prohibitin (PHB), of which 16 partners were verified by reciprocal coimmunoprecipitation. Bioinformatics revealed binary partners, the resultant interactome, subcellular localization, and cellular processes. The interactome contained 193 proteins involved in 190 binary interactions in subcellular compartments such as the ER, mitochondria, and nucleus. Comparisons with mice showed shared hub proteins that included N-methyl-D-aspartate receptor (NMDAR) and ATP-synthase. Ortholog analyses across six species revealed conserved interactions involving apoptosis, Ca2+ binding, and trafficking, in chicks, mice, and humans. Functional studies using recombinant BK and RNAi in a heterologous expression system revealed that proteins important to cell death/survival, such as annexinA5, gamma-actin, lamin, superoxide dismutase, and VCP, caused a decrease in BK expression. This revelation led to an examination of specific kinases and their effectors relevant to cell viability. Sequence analyses of the BK C-terminus across 10 species showed putative binding sites for 14-3-3, RAC-alpha serine/threonine-protein kinase 1 (Akt), glycogen synthase kinase-3 beta (GSK3 beta) and phosphoinositide-dependent kinase-1 (PDK1). Knockdown of 14-3-3 and Akt caused an increase in BK expression, whereas silencing of GSK3b and PDK1 had the opposite effect. This comparative systems approach suggests conservation in BK function across different species in addition to novel functions that may include the initiation of signals relevant to cell death/survival.	[Sokolowski, Bernd; Harvey, Margaret; Sakai, Yoshihisa] Univ S Florida, Coll Med, Dept Otolaryngol Head & Neck Surg, Otol Lab, Tampa, FL 33620 USA; [Orchard, Sandra] Wellcome Trust Genome Campus, European Bioinformat Inst, European Mol Biol Lab, Cambridge, England; [Sridhar, Settu] Univ Bergen, Dept Informat, N-5008 Bergen, Norway	State University System of Florida; University of South Florida; European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; University of Bergen	Sokolowski, B (corresponding author), Univ S Florida, Coll Med, Dept Otolaryngol Head & Neck Surg, Otol Lab, Tampa, FL 33620 USA.	bsokolow@health.usf.edu	Orchard, Sandra/ABC-1609-2020	Orchard, Sandra/0000-0002-8878-3972	National Institutes of Health/National Institute on Deafness and Other Communication Disorders [R01DC004295]; European Commission under PSIMEx [FP7-HEALTH-2007-223411]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004295] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); European Commission under PSIMEx; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by the National Institutes of Health/National Institute on Deafness and Other Communication Disorders Grant R01DC004295 to BS (http://www.nidcd.nih.gov/Pages/default.aspx). SO is supported by the European Commission under PSIMEx, contract number FP7-HEALTH-2007-223411 http://www.psimex.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brownawell AM, 1996, BIOCHEMISTRY-US, V35, P6839, DOI 10.1021/bi952585t; Case RM, 2007, CELL CALCIUM, V42, P345, DOI 10.1016/j.ceca.2007.05.001; Cenni V, 2008, J PROTEOME RES, V7, P4727, DOI 10.1021/pr800262g; Chae KS, 2005, J NEUROPHYSIOL, V93, P1174, DOI 10.1152/jn.00796.2004; Chowdhury D, 2006, MOL CELL, V23, P133, DOI 10.1016/j.molcel.2006.06.005; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Denson DD, 2001, J BIOL CHEM, V276, P7136, DOI 10.1074/jbc.M009566200; Fan ZS, 2003, CELL, V112, P659, DOI 10.1016/S0092-8674(03)00150-8; Fettiplace R, 1999, ANNU REV PHYSIOL, V61, P809, DOI 10.1146/annurev.physiol.61.1.809; Franklin-Tong VE, 2008, BIOCHEM J, V413, P389, DOI 10.1042/BJ20080320; Hafidi A, 2005, NEUROSCIENCE, V130, P475, DOI 10.1016/j.neuroscience.2004.09.038; Han GC, 2007, AM J PHYSIOL-HEART C, V293, pH314, DOI 10.1152/ajpheart.01342.2006; Harvey Margaret C., 2009, V493, P299, DOI 10.1007/978-1-59745-523-7_18; Higashiyama H, 2002, CELL DEATH DIFFER, V9, P264, DOI 10.1038/sj.cdd.4400955; Isaacson JS, 2001, NEURON, V31, P1027, DOI 10.1016/S0896-6273(01)00428-7; Jin J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000546; Kathiresan T, 2009, MOL CELL PROTEOMICS, V8, P1972, DOI 10.1074/mcp.M800495-MCP200; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Kim MJ, 2002, P NATL ACAD SCI USA, V99, P9870, DOI 10.1073/pnas.152336999; Latorre R, 2006, BIOL RES, V39, P385, DOI 10.4067/S0716-97602006000300003; LAZEBNIK YA, 1995, P NATL ACAD SCI USA, V92, P9042, DOI 10.1073/pnas.92.20.9042; Lhuillier L, 2002, J NEUROPHYSIOL, V88, P954, DOI 10.1152/jn.2002.88.2.954; Lu R, 2006, J PHYSIOL-LONDON, V570, P65, DOI 10.1113/jphysiol.2005.098913; Madeira A, 2005, FASEB J, V19, P1905, DOI 10.1096/fj.05-3839fje; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mwangi S, 2006, NEUROSCIENCE, V143, P241, DOI 10.1016/j.neuroscience.2006.07.050; Nakano T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000670; Nordang L, 2000, ACTA OTO-LARYNGOL, V120, P359, DOI 10.1080/000164800750000568; O'Malley D, 2005, FASEB J, V19, P1917, DOI 10.1096/fj.05-4166fje; O'Rourke B, 2005, PHYSIOLOGY, V20, P303, DOI 10.1152/physiol.00020.2005; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pyott SJ, 2007, J BIOL CHEM, V282, P3312, DOI 10.1074/jbc.M608726200; Rajan S, 2002, J PHYSIOL-LONDON, V545, P13, DOI 10.1113/jphysiol.2002.027052; Rao RV, 2006, CELL DEATH DIFFER, V13, P415, DOI 10.1038/sj.cdd.4401761; Ruel J, 2008, J NEUROSCI, V28, P7313, DOI 10.1523/JNEUROSCI.5335-07.2008; Sakai Y, 2011, J NEUROSCI RES, V89, P1747, DOI 10.1002/jnr.22713; Salwinski L, 2009, NAT METHODS, V6, P860, DOI 10.1038/nmeth1209-860; Shipston MJ, 2001, TRENDS CELL BIOL, V11, P353, DOI 10.1016/S0962-8924(01)02068-2; Sokolowski B, 2009, BIOCHEM BIOPH RES CO, V387, P671, DOI 10.1016/j.bbrc.2009.07.074; Srivastava S, 2006, MOL CELL, V24, P665, DOI 10.1016/j.molcel.2006.11.012; Stoop MP, 2008, J PROTEOME RES, V7, P4841, DOI 10.1021/pr800489a; Sunesson L, 2008, J BIOL CHEM, V283, P16653, DOI 10.1074/jbc.M710436200; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Turnay J, 2002, BIOPHYS J, V83, P2280, DOI 10.1016/S0006-3495(02)73988-X; Vandermoere F, 2006, J BIOL CHEM, V281, P14307, DOI 10.1074/jbc.M510003200; Veitonmaki N, 2004, CANCER RES, V64, P3679, DOI 10.1158/0008-5472.CAN-03-1754; WALLACE RW, 1981, COLD SPRING HARB SYM, V46, P893; Weatherly DB, 2005, MOL CELL PROTEOMICS, V4, P762, DOI 10.1074/mcp.M400215-MCP200; White RE, 2000, CIRC RES, V86, P897, DOI 10.1161/01.RES.86.8.897; Xu H, 2005, HYPERTENSION, V46, P1154, DOI 10.1161/01.HYP.0000186278.50275.fa; Yamashita M, 2006, FEBS J, V273, P3585, DOI 10.1111/j.1742-4658.2006.05365.x; Yan JS, 2008, MOL CELL PROTEOMICS, V7, P2188, DOI 10.1074/mcp.M800063-MCP200; Yu HY, 2004, GENOME RES, V14, P1107, DOI 10.1101/gr.1774904; Yu SP, 2003, PROG NEUROBIOL, V70, P363, DOI 10.1016/S0301-0082(03)00090-X; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414; Zhang CL, 2010, J NEUROSCI, V30, P3555, DOI 10.1523/JNEUROSCI.4551-09.2010; Zhou XB, 2010, P NATL ACAD SCI USA, V107, P8005, DOI 10.1073/pnas.0912029107; Zhou Y, 2007, NUCLEIC ACIDS RES, V35, pW678, DOI 10.1093/nar/gkm278; Zou SW, 2008, MOL PHARMACOL, V73, P359, DOI 10.1124/mol.107.039743	59	35	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28532	10.1371/journal.pone.0028532	http://dx.doi.org/10.1371/journal.pone.0028532			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174833	gold, Green Published			2022-12-25	WOS:000298365700046
J	Zheng, LL; Niu, S; Hao, P; Feng, K; Cai, YD; Li, YX				Zheng, Lu-Lu; Niu, Shen; Hao, Pei; Feng, KaiYan; Cai, Yu-Dong; Li, Yixue			Prediction of Protein Modification Sites of Pyrrolidone Carboxylic Acid Using mRMR Feature Selection and Analysis	PLOS ONE			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; THYROTROPIN-RELEASING HORMONE; GENE-EXPRESSION PROFILES; POSTTRANSLATIONAL MODIFICATIONS; PYROGLUTAMIC ACID; QUALITY ASSESSMENT; PEPTIDES; PHOSPHORYLATION; DATABASE; IDENTIFICATION	Pyrrolidone carboxylic acid (PCA) is formed during a common post-translational modification (PTM) of extracellular and multi-pass membrane proteins. In this study, we developed a new predictor to predict the modification sites of PCA based on maximum relevance minimum redundancy (mRMR) and incremental feature selection (IFS). We incorporated 727 features that belonged to 7 kinds of protein properties to predict the modification sites, including sequence conservation, residual disorder, amino acid factor, secondary structure and solvent accessibility, gain/loss of amino acid during evolution, propensity of amino acid to be conserved at protein-protein interface and protein surface, and deviation of side chain carbon atom number. Among these 727 features, 244 features were selected by mRMR and IFS as the optimized features for the prediction, with which the prediction model achieved a maximum of MCC of 0.7812. Feature analysis showed that all feature types contributed to the modification process. Further site-specific feature analysis showed that the features derived from PCA's surrounding sites contributed more to the determination of PCA sites than other sites. The detailed feature analysis in this paper might provide important clues for understanding the mechanism of the PCA formation and guide relevant experimental validations.	[Zheng, Lu-Lu; Li, Yixue] Huazhong Univ Sci & Technol, Hubei Bioinformat & Mol Imaging Key Lab, Wuhan 430074, Peoples R China; [Zheng, Lu-Lu; Hao, Pei; Feng, KaiYan; Li, Yixue] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Niu, Shen; Hao, Pei; Li, Yixue] Chinese Acad Sci, Key Lab Syst Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China	Huazhong University of Science & Technology; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai University	Zheng, LL (corresponding author), Huazhong Univ Sci & Technol, Hubei Bioinformat & Mol Imaging Key Lab, Wuhan 430074, Peoples R China.	cai_yud@yahoo.com.cn; yxli@sibs.ac.cn	zheng, lu/GXH-7035-2022	cai, yudong/0000-0001-5664-7979; Hao, Pei/0000-0002-1498-7059	National Basic Research Program of China [2011CB510102, 2011CB510101, 2012CB517905]; National High-Tech Research and Development Program of China [2009AA02Z308]; Shanghai Municipal Education Commission [12ZZ087]; SA-SIBS	National Basic Research Program of China(National Basic Research Program of China); National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); SA-SIBS	This work was supporeted by the National Basic Research Program of China (2011CB510102, 2011CB510101, and 2012CB517905), National High-Tech Research and Development Program of China (863) (grant 2009AA02Z308) and Innovation Program of Shanghai Municipal Education Commission (12ZZ087). PH gratefully acknowledges the support of the SA-SIBS Scholarship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM GN, 1981, MOL CELL BIOCHEM, V38, P181, DOI 10.1007/BF00235695; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Atchley WR, 2005, P NATL ACAD SCI USA, V102, P6395, DOI 10.1073/pnas.0408677102; AWADE AC, 1994, PROTEINS, V20, P34, DOI 10.1002/prot.340200106; Cai YD, 2009, J PROTEOME RES, V8, P999, DOI 10.1021/pr800717y; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cummins PM, 1998, BBA-PROTEIN STRUCT M, V1429, P1, DOI 10.1016/S0167-4838(98)00248-9; DANNIES PS, 1973, J BIOL CHEM, V248, P6174; DIMARCHI RD, 1982, INT J PEPT PROT RES, V19, P88; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; ELEMANS CPH, 2011, SUPERFAST MUSCLES SE, P1885; Fenves AZ, 2006, CLIN J AM SOC NEPHRO, V1, P441, DOI 10.2215/CJN.01411005; FernandezGarcia A, 2003, J AGR FOOD CHEM, V51, P8093, DOI 10.1021/jf0348471; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Gray VE, 2011, MOL BIOL EVOL, V28, P1565, DOI 10.1093/molbev/msr013; HINKLE PM, 1973, J BIOL CHEM, V248, P6180; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pW226, DOI 10.1093/nar/gki471; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008126; Huang T, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-44; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Jordan IK, 2005, NATURE, V433, P633, DOI 10.1038/nature03306; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; Koenig T, 2008, J PROTEOME RES, V7, P3708, DOI 10.1021/pr700859x; Lee TY, 2006, NUCLEIC ACIDS RES, V34, pD622, DOI 10.1093/nar/gkj083; Liu JF, 2002, J MOL BIOL, V322, P53, DOI 10.1016/S0022-2836(02)00736-2; Liu MC, 2007, IUBMB LIFE, V59, P622, DOI 10.1080/15216540701589320; Ma BY, 2003, P NATL ACAD SCI USA, V100, P5772, DOI 10.1073/pnas.1030237100; Mandal AK, 2007, ANAL BIOCHEM, V370, P118, DOI 10.1016/j.ab.2007.06.027; Mann M, 2003, NAT BIOTECHNOL, V21, P255, DOI 10.1038/nbt0303-255; Marsella L, 2009, BIOINFORMATICS, V25, pI289, DOI 10.1093/bioinformatics/btp232; Nesvizhskii AI, 2006, MOL CELL PROTEOMICS, V5, P652, DOI 10.1074/mcp.M500319-MCP200; Pang CNI, 2007, J PROTEOME RES, V6, P1833, DOI 10.1021/pr060674u; Pellegrini-Giampietro D E, 1989, Recenti Prog Med, V80, P160; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Popelier PLA, 2003, J AM CHEM SOC, V125, P1284, DOI 10.1021/ja0284198; Qian ZL, 2006, BIOCHEM BIOPH RES CO, V348, P1034, DOI 10.1016/j.bbrc.2006.07.149; Rubinstein ND, 2009, MOL IMMUNOL, V46, P840, DOI 10.1016/j.molimm.2008.09.009; Silva AR, 2001, NEUROCHEM RES, V26, P1277, DOI 10.1023/A:1014289232039; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Torkamani A, 2007, BIOINFORMATICS, V23, P2918, DOI 10.1093/bioinformatics/btm437; Wilkins MR, 1999, J MOL BIOL, V289, P645, DOI 10.1006/jmbi.1999.2794; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Xie HB, 2007, J PROTEOME RES, V6, P1917, DOI 10.1021/pr060394e	49	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28221	10.1371/journal.pone.0028221	http://dx.doi.org/10.1371/journal.pone.0028221			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174779	gold, Green Published, Green Submitted			2022-12-25	WOS:000298365700023
J	Xiong, Y; Xia, JF; Zhang, W; Liu, J				Xiong, Yi; Xia, Junfeng; Zhang, Wen; Liu, Juan			Exploiting a Reduced Set of Weighted Average Features to Improve Prediction of DNA-Binding Residues from 3D Structures	PLOS ONE			English	Article							SEQUENCE-BASED PREDICTION; ACCURATE PREDICTION; SECONDARY STRUCTURE; WEB SERVER; SITES; PROTEINS; EVOLUTIONARY; INFORMATION; RECOGNITION; NETWORK	Predicting DNA-binding residues from a protein three-dimensional structure is a key task of computational structural proteomics. In the present study, based on machine learning technology, we aim to explore a reduced set of weighted average features for improving prediction of DNA-binding residues on protein surfaces. Via constructing the spatial environment around a DNA-binding residue, a novel weighting factor is first proposed to quantify the distance-dependent contribution of each neighboring residue in determining the location of a binding residue. Then, a weighted average scheme is introduced to represent the surface patch of the considering residue. Finally, the classifier is trained on the reduced set of these weighted average features, consisting of evolutionary profile, interface propensity, betweenness centrality and solvent surface area of side chain. Experimental results on 5-fold cross validation and independent tests indicate that the new feature set are effective to describe DNA-binding residues and our approach has significantly better performance than two previous methods. Furthermore, a brief case study suggests that the weighted average features are powerful for identifying DNA-binding residues and are promising for further study of protein structure-function relationship. The source code and datasets are available upon request.	[Xiong, Yi; Zhang, Wen; Liu, Juan] Wuhan Univ, Sch Comp, Wuhan 430072, Peoples R China; [Xia, Junfeng] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA	Wuhan University; Vanderbilt University	Xiong, Y (corresponding author), Wuhan Univ, Sch Comp, Wuhan 430072, Peoples R China.	liujuan@whu.edu.cn	Xia, Junfeng/S-2456-2019; Zhang, Wen/W-7471-2019; Xiong, Yi/F-7377-2012	Xia, Junfeng/0000-0003-3024-1705; Zhang, Wen/0000-0001-5221-2628; Xiong, Yi/0000-0003-2910-6725	National Science Foundation of China [60970063, 61103126]; program for New Century Excellent Talents in Universities [NCET-10-0644]; Foundation of Ministry of Education of China [20090141110026, 20100141120049]; Fundamental Research Funds for the Central Universities [6081007, 3101054]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); program for New Century Excellent Talents in Universities(Program for New Century Excellent Talents in University (NCET)); Foundation of Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work is supported by the grants from the National Science Foundation of China (60970063, 61103126), the program for New Century Excellent Talents in Universities (NCET-10-0644), the Ph.D. Programs Foundation of Ministry of Education of China (20090141110026, 20100141120049) and the Fundamental Research Funds for the Central Universities (6081007, 3101054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-33; Ahmad S, 2004, BIOINFORMATICS, V20, P477, DOI 10.1093/bioinformatics/btg432; Ahmad S, 2008, NUCLEIC ACIDS RES, V36, P5922, DOI 10.1093/nar/gkn573; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrabi M, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-30; Bhardwaj N, 2007, FEBS LETT, V581, P1058, DOI 10.1016/j.febslet.2007.01.086; Carson MB, 2010, NUCLEIC ACIDS RES, V38, pW431, DOI 10.1093/nar/gkq361; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chea E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-153; Chen YC, 2007, PROTEINS, V67, P671, DOI 10.1002/prot.21366; Chiu TK, 2002, EMBO J, V21, P801, DOI 10.1093/emboj/21.4.801; Davis J, 2006, P 23 INT C MACH LEAR, P233, DOI [DOI 10.1145/1143844.1143874, 10.1145/1143844.1143874]; del Sol A, 2005, PROTEINS, V58, P672, DOI 10.1002/prot.20348; del Sol A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100063; del Sol A, 2006, PROTEIN SCI, V15, P2120, DOI 10.1110/ps.062249106; Gao M, 2008, NUCLEIC ACIDS RES, V36, P3978, DOI 10.1093/nar/gkn332; Gao M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000341; Gromiha MM, 2011, J CHEM INF MODEL, V51, P721, DOI 10.1021/ci1003703; Gromiha MM, 2010, CURR PROTEIN PEPT SC, V11, P629; Hubbard S. J., 1993, NACCESS; Hwang S, 2007, BIOINFORMATICS, V23, P634, DOI 10.1093/bioinformatics/btl672; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jones S, 2003, NUCLEIC ACIDS RES, V31, P7189, DOI 10.1093/nar/gkg922; Koike A, 2004, PROTEIN ENG DES SEL, V17, P165, DOI 10.1093/protein/gzh020; Kuznetsov IB, 2006, PROTEINS, V64, P19, DOI 10.1002/prot.20977; Li J, 2008, PROTEINS, V71, P1899, DOI 10.1002/prot.21891; Li YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016932; Liu ZJ, 2008, PROTEINS, V72, P1114, DOI 10.1002/prot.22002; Luscombe NM, 2000, GENOME BIOL, V1; Maetschke SR, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-341; Nadassy K, 1999, BIOCHEMISTRY-US, V38, P1999, DOI 10.1021/bi982362d; Nimrod G, 2009, J MOL BIOL, V387, P1040, DOI 10.1016/j.jmb.2009.02.023; Ofran Y, 2007, BIOINFORMATICS, V23, pI347, DOI 10.1093/bioinformatics/btm174; Ozbek P, 2010, NUCLEIC ACIDS RES, V38, pW417, DOI 10.1093/nar/gkq396; Sathyapriya R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000170; Shazman S, 2007, NUCLEIC ACIDS RES, V35, pW526, DOI 10.1093/nar/gkm401; Si JN, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S1-S7; Stawiski EW, 2003, J MOL BIOL, V326, P1065, DOI 10.1016/S0022-2836(03)00031-7; Tjong H, 2007, NUCLEIC ACIDS RES, V35, P1465, DOI 10.1093/nar/gkm008; Tsuchiya Y, 2004, PROTEINS, V55, P885, DOI 10.1002/prot.20111; van Dijk M, 2006, NUCLEIC ACIDS RES, V34, P3317, DOI 10.1093/nar/gkl412; Wang L, 2009, BMC GENOMICS, V10, DOI [10.1186/1471-2164-10-220, 10.1186/1471-2164-10-S1-S1]; Wang LJ, 2006, NUCLEIC ACIDS RES, V34, pW243, DOI 10.1093/nar/gkl298; Wang LJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S1-S3; Wu JS, 2009, BIOINFORMATICS, V25, P30, DOI 10.1093/bioinformatics/btn583; Xia JF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-174; Xiong Y, 2011, PROTEINS, V79, P509, DOI 10.1002/prot.22898; Yan CH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-262; Zen A, 2009, BIOINFORMATICS, V25, P1876, DOI 10.1093/bioinformatics/btp339; Zeng T, 2011, PROTEINS, V79, P598, DOI 10.1002/prot.22908; Zhang T, 2008, BIOINFORMATICS, V24, P2329, DOI 10.1093/bioinformatics/btn433; Zhang T, 2010, CURR PROTEIN PEPT SC, V11, P609, DOI 10.2174/138920310794109193; Zhang W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-341; Zhao HY, 2010, BIOINFORMATICS, V26, P1857, DOI 10.1093/bioinformatics/btq295	54	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28440	10.1371/journal.pone.0028440	http://dx.doi.org/10.1371/journal.pone.0028440			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174808	Green Published, Green Submitted, gold			2022-12-25	WOS:000298163600021
J	Gupta, S; Jie, S; Colby, DW				Gupta, Sharad; Jie, Shy'Ann; Colby, David W.			Protein Misfolding Detected Early in Pathogenesis of Transgenic Mouse Model of Huntington Disease Using Amyloid Seeding Assay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; MUTANT HUNTINGTIN; IN-VITRO; NEUROPATHOLOGICAL ABNORMALITIES; NUCLEAR-LOCALIZATION; PRION DETECTION; MOTOR; AGGREGATION; FORM; HD	Huntington disease (HD) is one of several fatal neurodegenerative disorders associated with misfolded proteins. Here, we report a novel method for the sensitive detection of misfolded huntingtin (HTT) isolated from the brains of transgenic (Tg) mouse models of HD and humans with HD using an amyloid seeding assay (ASA), which is based on the propensity of misfolded proteins to act as a seed and shorten the nucleation-associated lag phase in the kinetics of amyloid formation in vitro. Using synthetic polyglutamine peptides as the substrate for amyloid formation, we found that partially purified misfolded HTT obtained from end-stage brain tissue of two Tg HD mouse models and brain tissue of post-mortem human HD patients was capable of specifically accelerating polyglutamine amyloid formation compared with unseeded reactions and controls. Alzheimer and prion disease brain tissues did not do so, demonstrating the specificity of the ASA. It is unclear whether early intermediates or later conformational species in the protein misfolding process act as seeds in the ASA for HD. However, we were able to detect misfolded protein in the brains of YAC128 mice early in disease pathogenesis (11 weeks of age), whereas large inclusion bodies have not been observed in the brains of these mice by histology until 78 weeks of age, much later in the pathogenic process. The sensitive detection of misfolded HTT protein early in the disease pathogenesis in the YAC128 Tg mouse model strengthens the argument for a causative role of protein misfolding in HD.	[Gupta, Sharad; Jie, Shy'Ann; Colby, David W.] Univ Delaware, Dept Chem Engn, Newark, DE 19716 USA	University of Delaware	Colby, DW (corresponding author), Univ Delaware, Dept Chem Engn, 150 Acad St, Newark, DE 19716 USA.	colby@udel.edu	colby, david/E-5821-2011	Colby, David/0000-0002-4856-6295	National Institutes of Health from NINDS [R00 NS064173]; National Center for Research Resources [P30 RR031160]; United States Public Health Service from the National Institutes of Health [R24 MH068855]; NINDS/National Institute of Mental Health; NATIONAL CENTER FOR RESEARCH RESOURCES [P30RR031160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R24MH068855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS064173] Funding Source: NIH RePORTER	National Institutes of Health from NINDS; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); United States Public Health Service from the National Institutes of Health; NINDS/National Institute of Mental Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R00 NS064173 from NINDS and Grant P30 RR031160 from the National Center for Research Resources.; We thank Natalie Barnes for help with breeding mouse colonies and harvesting tissue samples, Zachary March for purification of AD and control brain tissue samples, and Kyle Doolan for purification of PrPSc from brain tissue sample. We thank the patients and families who donated tissue samples and the Harvard Brain Tissue Resource Center (supported in part by United States Public Health Service Grant R24 MH068855 from the National Institutes of Health) and the Human Brain and Spinal Fluid Resource Center at UCLA (supported in part by NINDS/National Institute of Mental Health) for providing tissues.	Andreassen OA, 2001, NEUROBIOL DIS, V8, P479, DOI 10.1006/nbdi.2001.0406; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Atarashi R, 2011, NAT MED, V17, P175, DOI 10.1038/nm.2294; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Chen S, 2001, J MOL BIOL, V311, P173, DOI 10.1006/jmbi.2001.4850; Chen SM, 2002, P NATL ACAD SCI USA, V99, P11884, DOI 10.1073/pnas.182276099; Colby DW, 2007, P NATL ACAD SCI USA, V104, P20914, DOI 10.1073/pnas.0710152105; Colby DW, 2006, NAT CHEM BIOL, V2, P319, DOI 10.1038/nchembio792; Colby DW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000736; Colby DW, 2004, P NATL ACAD SCI USA, V101, P17616, DOI 10.1073/pnas.0408134101; Crook ZR, 2011, NEURON, V69, P423, DOI 10.1016/j.neuron.2010.12.035; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Dedeoglu A, 2002, J NEUROSCI, V22, P8942; DeMarch Z, 2008, NEUROBIOL DIS, V30, P375, DOI 10.1016/j.nbd.2008.02.010; Diaz-Hernandez M, 2004, J NEUROSCI, V24, P9361, DOI 10.1523/JNEUROSCI.2365-04.2004; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Du DG, 2011, BIOCHEMISTRY-US, V50, P1607, DOI 10.1021/bi1013744; Ferrante RJ, 2000, J NEUROSCI, V20, P4389, DOI 10.1523/JNEUROSCI.20-12-04389.2000; Gourfinkel-An I, 1998, NEUROREPORT, V9, P1823, DOI 10.1097/00001756-199806010-00028; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Herndon ES, 2009, J NEUROPATH EXP NEUR, V68, P250, DOI 10.1097/NEN.0b013e318198d320; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; Huntington G., 1872, MED SURG REP, V26, P320; Legleiter J, 2010, J BIOL CHEM, V285, P14777, DOI 10.1074/jbc.M109.093708; Li H, 1999, HUM MOL GENET, V8, P1227, DOI 10.1093/hmg/8.7.1227; Maat-Schieman M, 2007, BRAIN PATHOL, V17, P31, DOI 10.1111/j.1750-3639.2006.00040.x; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Masuda N, 2008, NEUROBIOL DIS, V30, P293, DOI 10.1016/j.nbd.2008.01.014; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Nekooki-Machida Y, 2009, P NATL ACAD SCI USA, V106, P9679, DOI 10.1073/pnas.0812083106; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; O'Nuallain B, 2006, METHOD ENZYMOL, V413, P34, DOI 10.1016/S0076-6879(06)13003-7; SAEED SM, 1967, AM J CLIN PATHOL, V47, P588, DOI 10.1093/ajcp/47.5.588; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Schilling G, 2001, NEUROBIOL DIS, V8, P405, DOI 10.1006/nbdi.2001.0385; Sieradzan KA, 1999, EXP NEUROL, V156, P92, DOI 10.1006/exnr.1998.7005; Simmons DA, 2011, NEUROBIOL DIS, V41, P436, DOI 10.1016/j.nbd.2010.10.015; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Van Raamsdonk JM, 2007, NEUROBIOL DIS, V26, P189, DOI 10.1016/j.nbd.2006.12.010; Van Raamsdonk JM, 2005, HUM MOL GENET, V14, P3823, DOI 10.1093/hmg/ddi407; Van Raamsdonk JM, 2005, J NEUROSCI, V25, P4169, DOI 10.1523/JNEUROSCI.0590-05.2005; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217; Yang W, 2002, HUM MOL GENET, V11, P2905, DOI 10.1093/hmg/11.23.2905; Zadori D, 2011, J NEURAL TRANSM, V118, P865, DOI 10.1007/s00702-010-0573-6	48	25	26	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9982	9989		10.1074/jbc.M111.305417	http://dx.doi.org/10.1074/jbc.M111.305417			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22187438	hybrid, Green Published			2022-12-25	WOS:000302167200030
J	Berezniuk, I; Vu, HT; Lyons, PJ; Sironi, JJ; Xiao, H; Burd, B; Setou, M; Angeletti, RH; Ikegami, K; Fricker, LD				Berezniuk, Iryna; Vu, Hang T.; Lyons, Peter J.; Sironi, Juan J.; Xiao, Hui; Burd, Berta; Setou, Mitsutoshi; Angeletti, Ruth H.; Ikegami, Koji; Fricker, Lloyd D.			Cytosolic Carboxypeptidase 1 Is Involved in Processing alpha- and beta-Tubulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PURKINJE-CELL-DEGENERATION; MOUSE-BRAIN; POSTTRANSLATIONAL MODIFICATIONS; TETRAHYMENA-THERMOPHILA; MICE REVEALS; PCD MICE; NNA1; POLYGLUTAMYLATION; MICROTUBULES; NEURODEGENERATION	The Purkinje cell degeneration (pcd) mouse has a disruption in the gene encoding cytosolic carboxypeptidase 1 (CCP1). This study tested two proposed functions of CCP1: degradation of intracellular peptides and processing of tubulin. Overexpression (2-3-fold) or knockdown (80-90%) of CCP1 in human embryonic kidney 293T cells (HEK293T) did not affect the levels of most intracellular peptides but altered the levels of alpha-tubulin lacking two C-terminal amino acids (delta2-tubulin) >= 5-fold, suggesting that tubulin processing is the primary function of CCP1, not peptide degradation. Purified CCP1 produced delta2-tubulin from purified porcine brain alpha-tubulin or polymerized HEK293T microtubules. In addition, CCP1 removed Glu residues from the polyglutamyl side chains of porcine brain alpha- and beta-tubulin and also generated a form of alpha-tubulin with two C-terminal Glu residues removed (delta3-tubulin). Consistent with this, pcd mouse brain showed hyperglutamylation of both alpha- and beta-tubulin. The hyperglutamylation of alpha- and beta-tubulin and subsequent death of Purkinje cells in pcd mice was counteracted by the knock-out of the gene encoding tubulin tyrosine ligase-like-1, indicating that this enzyme hyperglutamylates alpha- and beta-tubulin. Taken together, these results demonstrate a role for CCP1 in the processing of Glu residues from beta- as well as alpha- tubulin in vitro and in vivo.	[Vu, Hang T.; Setou, Mitsutoshi; Ikegami, Koji] Hamamatsu Univ Sch Med, Dept Cell Biol & Anat, Hamamatsu, Shizuoka 4313192, Japan; [Sironi, Juan J.] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; [Berezniuk, Iryna; Fricker, Lloyd D.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; [Xiao, Hui; Burd, Berta; Angeletti, Ruth H.] Albert Einstein Coll Med, Lab Macromol Anal & Prote, Bronx, NY 10461 USA; [Lyons, Peter J.; Sironi, Juan J.; Fricker, Lloyd D.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	Hamamatsu University School of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Ikegami, K (corresponding author), Hamamatsu Univ Sch Med, Dept Cell Biol & Anat, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	kikegami@hama-med.ac.jp; lloyd.fricker@einstein.yu.edu		Lyons, Peter/0000-0001-5214-5445	National Institutes of Health [DA-004494, 1P20 DA026149, 1R01 CA124898]; Uehara Memorial Foundation; Japan Society for the Promotion of Science [23570209, 23117517]; Sao Paulo State Research Foundation; Financiadora de Estudos e Projetos; Brazilian National Research Council; NATIONAL CANCER INSTITUTE [R01CA124898] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019352, S10RR019891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004494, P20DA026149] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23570209] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Sao Paulo State Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Financiadora de Estudos e Projetos(Financiadora de Inovacao e Pesquisa (Finep)); Brazilian National Research Council(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grants DA-004494 (to L.D.F.), 1P20 DA026149 (to R.H.A.), and 1R01 CA124898 (to S.B. Horwitz). This work was also supported by the Uehara Memorial Foundation and Japan Society for the Promotion of Science Grants 23570209 and 23117517 (to K.I.).; Mass spectrometry for the analysis of peptides in HEK293T cells was performed in the laboratory of Prof. Fabio Gozzo, Universidade de Campinas, Brazil, by Leandro M. Castro and was supported by grants from Sao Paulo State Research Foundation, Financiadora de Estudos e Projetos, and Brazilian National Research Council. Antibodies to tubulin were provided by Prof. Martin Gorovsky (University of Rochester, Rochester, NY) and by Prof. Carsten Janke (Universite Montpellier, France).	ARGARANA CE, 1978, MOL CELL BIOCHEM, V19, P17; Baltanas FC, 2011, J BIOL CHEM, V286, P28287, DOI 10.1074/jbc.M111.246041; BAURLE J, 1994, ACTA NEUROPATHOL, V88, P237; Berezniuk I, 2010, AUTOPHAGY, V6, P558, DOI 10.4161/auto.6.4.11813; Berezniuk I, 2010, FASEB J, V24, P1813, DOI 10.1096/fj.09-147942; Berti DA, 2009, J BIOL CHEM, V284, P14105, DOI 10.1074/jbc.M807916200; Cartelli D, 2010, J NEUROCHEM, V115, P247, DOI 10.1111/j.1471-4159.2010.06924.x; Chakrabarti L, 2008, VISION RES, V48, P1999, DOI 10.1016/j.visres.2008.05.026; Chakrabarti L, 2010, NEURON, V66, P835, DOI 10.1016/j.neuron.2010.05.024; de la Vega MR, 2007, FASEB J, V21, P851, DOI 10.1096/fj.06-7330com; Dunn S, 2008, J CELL SCI, V121, P1085, DOI 10.1242/jcs.026492; EDDE B, 1990, SCIENCE, V247, P83, DOI 10.1126/science.1967194; Fernandez D., 2011, ENZYME RES, V2011; Fernandez-Gonzalez A, 2002, SCIENCE, V295, P1904, DOI 10.1126/science.1068912; FRICKER LD, 1982, P NATL ACAD SCI-BIOL, V79, P3886, DOI 10.1073/pnas.79.12.3886; Gelman JS, 2010, J NEUROCHEM, V113, P871, DOI 10.1111/j.1471-4159.2010.06653.x; Harris A, 2000, MOL CELL NEUROSCI, V16, P578, DOI 10.1006/mcne.2000.0900; Ikegami K, 2007, P NATL ACAD SCI USA, V104, P3213, DOI 10.1073/pnas.0611547104; Ikegami K, 2006, J BIOL CHEM, V281, P30707, DOI 10.1074/jbc.M603984200; Ikegami K, 2010, P NATL ACAD SCI USA, V107, P10490, DOI 10.1073/pnas.1002128107; Ikegami K, 2010, CELL STRUCT FUNCT, V35, P15, DOI 10.1247/csf.09027; Janke C, 2005, SCIENCE, V308, P1758, DOI 10.1126/science.1113010; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Kalinina E, 2007, FASEB J, V21, P836, DOI 10.1096/fj.06-7329com; Kimura Y, 2010, J BIOL CHEM, V285, P22934, DOI 10.1074/jbc.C110.128280; Kreitzer G, 1999, MOL BIOL CELL, V10, P1105, DOI 10.1091/mbc.10.4.1105; Kyuhou S, 2006, NEUROSCI LETT, V396, P91, DOI 10.1016/j.neulet.2005.11.023; LANDIS SC, 1978, J COMP NEUROL, V177, P125, DOI 10.1002/cne.901770109; Li JX, 2010, NEURON, V68, P45, DOI 10.1016/j.neuron.2010.08.013; Lyons PJ, 2011, J BIOL CHEM, V286, P39023, DOI 10.1074/jbc.M111.265819; Million K, 1999, J CELL SCI, V112, P4357; Morano C, 2008, ANAL CHEM, V80, P9298, DOI 10.1021/ac801654h; MULLEN RJ, 1976, P NATL ACAD SCI USA, V73, P208, DOI 10.1073/pnas.73.1.208; NALAMACHU SR, 1994, J BIOL CHEM, V269, P11192; O'Hagan R, 2011, CURR BIOL, V21, P1685, DOI 10.1016/j.cub.2011.08.049; PATURLELAFANECHERE L, 1994, J CELL SCI, V107, P1529; PATURLELAFANECHERE L, 1991, BIOCHEMISTRY-US, V30, P10523, DOI 10.1021/bi00107a022; RAYBIN D, 1977, BIOCHEMISTRY-US, V16, P2189, DOI 10.1021/bi00629a023; Rogowski K, 2010, CELL, V143, P564, DOI 10.1016/j.cell.2010.10.014; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; SCHULZE E, 1987, J CELL BIOL, V105, P2167, DOI 10.1083/jcb.105.5.2167; Shang YH, 2002, J CELL BIOL, V158, P1195, DOI 10.1083/jcb.200205101; SONG LX, 1995, J BIOL CHEM, V270, P25007, DOI 10.1074/jbc.270.42.25007; Valero J, 2006, MOL CELL NEUROSCI, V33, P283, DOI 10.1016/j.mcn.2006.08.002; Van Dijk J, 2008, J BIOL CHEM, V283, P3915, DOI 10.1074/jbc.M705813200; van Dijk J, 2007, MOL CELL, V26, P437, DOI 10.1016/j.molcel.2007.04.012; Vassal E, 2006, J BIOMOL SCREEN, V11, P377, DOI 10.1177/1087057106286210; Wang TY, 2007, BRAIN RES, V1140, P26, DOI 10.1016/j.brainres.2006.07.065; Wang TY, 2006, MOL CELL NEUROSCI, V33, P200, DOI 10.1016/j.mcn.2006.07.009; Wardman J, 2011, METHODS MOL BIOL, V768, P307, DOI 10.1007/978-1-61779-204-5_17; Wei SW, 2002, J BIOL CHEM, V277, P14954, DOI 10.1074/jbc.M112254200; Wloga D, 2008, EUKARYOT CELL, V7, P1362, DOI 10.1128/EC.00084-08; Wloga D, 2010, J CELL SCI, V123, P3447, DOI 10.1242/jcs.063727; WOLFF A, 1992, EUR J CELL BIOL, V59, P425	54	58	60	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6503	6517		10.1074/jbc.M111.309138	http://dx.doi.org/10.1074/jbc.M111.309138			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22170066	Green Published, hybrid			2022-12-25	WOS:000300791800039
J	Elhassan, MO; Christie, J; Duxbury, MS				Elhassan, Mohamed O.; Christie, Jennifer; Duxbury, Mark S.			Homo sapiens Systemic RNA Interference-defective-1 Transmembrane Family Member 1 (SIDT1) Protein Mediates Contact-dependent Small RNA Transfer and MicroRNA-21-driven Chemoresistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP JUNCTIONAL COMMUNICATION; SHORT INTERFERING RNA; TUMOR-NECROSIS-FACTOR; PHASE-I; CARCINOMA CELLS; DOWN-REGULATION; GEMCITABINE; MICRORNA; MECHANISMS; EXPRESSION	Locally initiated RNA interference (RNAi) has the potential for spatial propagation, inducing posttranscriptional gene silencing in distant cells. In Caenorhabditis elegans, systemic RNAi requires a phylogenetically conserved transmembrane channel, SID-1. Here, we show that a human SID-1 orthologue, SIDT1, facilitates rapid, contact-dependent, bidirectional small RNA transfer between human cells, resulting in target-specific non-cell-autonomous RNAi. Intercellular small RNA transfer can be both homotypic and heterotypic. We show SIDT1-mediated intercellular transfer of microRNA-21 to be a driver of resistance to the nucleoside analog gemcitabine in human adenocarcinoma cells. Documentation of a SIDT1-dependent small RNA transfer mechanism and the associated phenotypic effects on chemoresistance in human cancer cells raises the possibility that conserved systemic RNAi pathways contribute to the acquisition of drug resistance. Mediators of non-cell-autonomous RNAi may be tractable targets for novel therapies aimed at improving the efficacy of current cytotoxic agents.	[Elhassan, Mohamed O.; Duxbury, Mark S.] Univ Edinburgh, Royal Infirm, Edinburgh EH16 4SA, Midlothian, Scotland; [Elhassan, Mohamed O.; Christie, Jennifer; Duxbury, Mark S.] Western Gen Hosp, Pancreat Canc Biol Grp, Edinburgh Canc Res UK Ctr, Inst Genet & Mol Med, Edinburgh EH4 2XR, Midlothian, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh; University of Edinburgh	Duxbury, MS (corresponding author), Western Gen Hosp, Pancreat Canc Biol Grp, Edinburgh Canc Res Ctr, Crewe Rd S, Edinburgh EH4 2XR, Midlothian, Scotland.	mark.duxbury@ed.ac.uk			Chief Scientist Office Project Grant [CZB/4/693]; Melville Trust for the Care and Cure of Cancer; National Health Service Education Scotland Clinician Scientist Fellowship; Chief Scientist Office [CZB/4/693] Funding Source: researchfish	Chief Scientist Office Project Grant; Melville Trust for the Care and Cure of Cancer; National Health Service Education Scotland Clinician Scientist Fellowship; Chief Scientist Office	This work was supported by Chief Scientist Office Project Grant CZB/4/693 and by the Melville Trust for the Care and Cure of Cancer.; Supported by a National Health Service Education Scotland Clinician Scientist Fellowship. To whom correspondence should be addressed: Pancreatic Cancer Biology Group, Edinburgh Cancer Research Centre, Western General Hospital, Crewe Rd. S., Edinburgh EH4 2XR, Scotland, United Kingdom. Tel.: 44-131-7773500; E-mail: mark.duxbury@ed.ac.uk.	ABBRUZZESE JL, 1991, J CLIN ONCOL, V9, P491, DOI 10.1200/JCO.1991.9.3.491; Ammerpohl O, 2007, BRIT J CANCER, V96, P73, DOI 10.1038/sj.bjc.6603511; Bachem MG, 2005, GASTROENTEROLOGY, V128, P907, DOI 10.1053/j.gastro.2004.12.036; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Bai HT, 2011, FEBS LETT, V585, P402, DOI 10.1016/j.febslet.2010.12.027; Bantly Andrew D, 2007, Immunol Invest, V36, P581, DOI 10.1080/08820130701712461; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bhargava P, 2001, CANCER CHEMOTH PHARM, V48, P95, DOI 10.1007/s002800100317; Chitwood DH, 2010, NATURE, V467, P415, DOI 10.1038/nature09351; Cottin S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-141; Dalton WS, 1999, DRUG RESIST UPDATE, V2, P285, DOI 10.1054/drup.1999.0097; Dinger ME, 2008, J MOL ENDOCRINOL, V40, P151, DOI 10.1677/JME-07-0160; Duxbury MS, 2007, BIOCHEM BIOPH RES CO, V354, P190, DOI 10.1016/j.bbrc.2006.12.177; Duxbury MS, 2005, BIOCHEM BIOPH RES CO, V331, P459, DOI 10.1016/j.bbrc.2005.03.199; Duxbury MS, 2004, CANCER RES, V64, P3987, DOI 10.1158/0008-5472.CAN-04-0424; Duxbury MS, 2004, J BIOL CHEM, V279, P23176, DOI 10.1074/jbc.M402051200; ELFOULY MH, 1987, EXP CELL RES, V168, P422, DOI 10.1016/0014-4827(87)90014-0; Feinberg EH, 2003, SCIENCE, V301, P1545, DOI 10.1126/science.1087117; Fujita H, 2009, CANCER SCI, V100, P2309, DOI 10.1111/j.1349-7006.2009.01317.x; Garcia-Rodriguez L, 2011, MOL CANCER THER, V10, P505, DOI 10.1158/1535-7163.MCT-10-0693; Giovannetti E, 2010, CANCER RES, V70, P4528, DOI 10.1158/0008-5472.CAN-09-4467; Goldberg GS, 1996, EXP CELL RES, V222, P48, DOI 10.1006/excr.1996.0006; Green SK, 1999, ANTI-CANCER DRUG DES, V14, P153; GRUNEWALD R, 1991, CANCER CHEMOTH PHARM, V27, P258, DOI 10.1007/BF00685109; Herr AJ, 2004, COLD SPRING HARB SYM, V69, P363, DOI 10.1101/sqb.2004.69.363; HORAN PK, 1989, NATURE, V340, P167, DOI 10.1038/340167a0; Hunter CP, 2006, COLD SPRING HARB SYM, V71, P95, DOI 10.1101/sqb.2006.71.060; Hwang HW, 2009, P NATL ACAD SCI USA, V106, P7016, DOI 10.1073/pnas.0811523106; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; John SA, 1999, J BIOL CHEM, V274, P236, DOI 10.1074/jbc.274.1.236; Jose AM, 2007, ANNU REV GENET, V41, P305, DOI 10.1146/annurev.genet.41.110306.130216; Katakowski M, 2010, CANCER RES, V70, P8259, DOI 10.1158/0008-5472.CAN-10-0604; KIANG DT, 1994, IN VITRO CELL DEV-AN, V30A, P796; KOBAYASHI H, 1993, P NATL ACAD SCI USA, V90, P3294, DOI 10.1073/pnas.90.8.3294; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Lahlou H, 2005, MOL CELL BIOL, V25, P4034, DOI 10.1128/MCB.25.10.4034-4045.2005; Li H, 2006, NUCLEIC ACIDS RES, V34, pD572, DOI 10.1093/nar/gkj118; Lin J, 2011, LEUKEMIA, V25, P145, DOI 10.1038/leu.2010.230; Lwin T, 2010, BLOOD, V116, P5228, DOI 10.1182/blood-2010-03-275925; MacFarlane LA, 2010, CURR GENOMICS, V11, P537, DOI 10.2174/138920210793175895; McSpadden LC, 2009, AM J PHYSIOL-CELL PH, V297, pC339, DOI 10.1152/ajpcell.00024.2009; Misawa A, 2010, ONCOL RES, V19, P23, DOI 10.3727/096504010X12828372551759; Pan XA, 2010, CANCER BIOL THER, V10, P1224, DOI 10.4161/cbt.10.12.14252; PATEK PQ, 1989, P SOC EXP BIOL MED, V190, P234; RAITANO AB, 1990, PANCREAS, V5, P267, DOI 10.1097/00006676-199005000-00005; Rechavi O, 2009, GENE DEV, V23, P1971, DOI 10.1101/gad.1789609; Rocha JJE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019087; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shih JD, 2011, RNA, V17, P1057, DOI 10.1261/rna.2596511; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Toyofuku T, 1998, J BIOL CHEM, V273, P1519, DOI 10.1074/jbc.273.3.1519; Tsang SY, 2007, BIOCHEM BIOPH RES CO, V357, P480, DOI 10.1016/j.bbrc.2007.03.187; Valiunas V, 2005, J PHYSIOL-LONDON, V568, P459, DOI 10.1113/jphysiol.2005.090985; van Riel JM, 2009, EUR J CANCER, V45, P2519, DOI 10.1016/j.ejca.2009.05.025; Veltkamp SA, 2008, ONCOLOGIST, V13, P261, DOI 10.1634/theoncologist.2007-0215; WALLACE PK, 1993, CANCER RES, V53, P2358; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Wolfrum C, 2007, NAT BIOTECHNOL, V25, P1149, DOI 10.1038/nbt1339; Wolvetang EJ, 2007, BIOCHEM BIOPH RES CO, V363, P610, DOI 10.1016/j.bbrc.2007.09.035; Zhang ZQ, 1998, CARCINOGENESIS, V19, P1889, DOI 10.1093/carcin/19.11.1889; Zhao TY, 2006, J NEUROCHEM, V98, P1541, DOI 10.1111/j.1471-4159.2006.03974.x	62	42	43	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5267	5277		10.1074/jbc.M111.318865	http://dx.doi.org/10.1074/jbc.M111.318865			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22174421	hybrid, Green Published			2022-12-25	WOS:000300638000009
J	Jiang, ZH; Yu, N; Kuang, PP; Chen, M; Shao, FZ; Martin, G; Chui, DHK; Cardoso, WV; Ai, XB; Lu, JN				Jiang, Zhihua; Yu, Nan; Kuang, Pingping; Chen, Melody; Shao, Fengzhi; Martin, Gregory; Chui, David H. K.; Cardoso, Wellington V.; Ai, Xingbin; Lu, Jining			Trinucleotide Repeat Containing 6a (Tnrc6a)-mediated MicroRNA Function Is Required for Development of Yolk Sac Endoderm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GW BODIES; GW182; FAMILY; COMPONENT; DEADENYLASE; BIOGENESIS; REGULATOR; PROTEINS; CCR4-NOT; DOMAINS	Tnrc6 family members (Tnrc6a/b/c) are key components of the RNA-induced silencing complex in microRNA (miRNA)mediated gene suppression. Here, we show that Tnrc6a, also known as GW182, is selectively expressed in the yolk sac endoderm and that gene trap disruption of GW182 leads to growth arrest and apoptosis. We found that targets of miRNAs highly expressed in the yolk sac are significantly derepressed in GW182(gt/gt) mutant mice, although levels of miRNAs are not altered. Specifically, growth arrest and apoptosis phenotype are associated with significant derepression of Cdkn1a (p21), Cdkn1c (P27), Lats1, Lats2, Rb1, Rbl, Bim, and Pten, known targets of miRNAs from miR-17/20/93/106 clusters highly expressed in yolk sac endoderm. Together, these data strongly suggest that GW182 is an essential functional component in the RNA-induced silencing complex for miRNA-mediated gene silencing in vivo, and selectively regulation of miRNA activity plays an important role in the proper development of yolk sac.	[Jiang, Zhihua; Yu, Nan; Kuang, Pingping; Chen, Melody; Shao, Fengzhi; Cardoso, Wellington V.; Ai, Xingbin; Lu, Jining] Boston Univ, Ctr Pulm, Sch Med, Boston, MA 02118 USA; [Martin, Gregory] Boston Univ, Transgen Core Facil, Sch Med, Boston, MA 02118 USA; [Chui, David H. K.] Boston Univ, Dept Med, Sch Med, Boston, MA 02118 USA	Boston University; Boston University; Boston University	Lu, JN (corresponding author), 715 Albany St,R304, Boston, MA 02118 USA.	jining@bu.edu	jiang, zhihua/I-6998-2012	Cardoso, Wellington/0000-0002-2550-3697; Ai, Xingbin/0000-0002-2178-0080	National Institutes of Health [P01 HL47049, R01 HL081800]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081800, R01HL105971, P01HL047049] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL47049 and R01 HL081800.	Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Astorga J, 2007, DEVELOPMENT, V134, P3753, DOI 10.1242/dev.004432; Baillat D, 2009, MOL CELL BIOL, V29, P4144, DOI 10.1128/MCB.00380-09; Baron MH, 2003, EXP HEMATOL, V31, P1160, DOI 10.1016/j.exphem.2003.08.019; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Behm-Ansmant I, 2006, COLD SPRING HARB SYM, V71, P523, DOI 10.1101/sqb.2006.71.013; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Braun JE, 2011, MOL CELL, V44, P120, DOI 10.1016/j.molcel.2011.09.007; Chekulaeva M, 2011, NAT STRUCT MOL BIOL, V18, P1218, DOI 10.1038/nsmb.2166; Cushing L, 2011, AM J RESP CELL MOL, V45, P287, DOI 10.1165/rcmb.2010-0323OC; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Damert A, 2002, DEVELOPMENT, V129, P1881; Ding L, 2005, MOL CELL, V19, P437, DOI 10.1016/j.molcel.2005.07.013; Ding L, 2007, TRENDS CELL BIOL, V17, P411, DOI 10.1016/j.tcb.2007.06.003; Eulalio A, 2009, RNA, V15, P1433, DOI 10.1261/rna.1703809; Eulalio A, 2009, RNA, V15, P1067, DOI 10.1261/rna.1605509; Eystathioy T, 2002, MOL BIOL CELL, V13, P1338, DOI 10.1091/mbc.01-11-0544; Fabian MR, 2011, NAT STRUCT MOL BIOL, V18, P1211, DOI 10.1038/nsmb.2149; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Jakymiw A, 2005, NAT CELL BIOL, V7, P1267, DOI 10.1038/ncb1334; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Lazzaretti D, 2009, RNA, V15, P1059, DOI 10.1261/rna.1606309; Lian SL, 2006, CELL CYCLE, V5, P242, DOI 10.4161/cc.5.3.2410; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Malpel S, 2000, DEVELOPMENT, V127, P3057; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Olive V, 2010, INT J BIOCHEM CELL B, V42, P1348, DOI 10.1016/j.biocel.2010.03.004; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Schneider MD, 2006, J CELL BIOL, V174, P349, DOI 10.1083/jcb.200512103; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; Spruce T, 2010, DEV CELL, V19, P207, DOI 10.1016/j.devcel.2010.07.014; Tsao PN, 2009, DEVELOPMENT, V136, P2297, DOI 10.1242/dev.034884; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Zipprich JT, 2009, RNA, V15, P781, DOI 10.1261/rna.1448009	38	4	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5979	5987		10.1074/jbc.M111.297937	http://dx.doi.org/10.1074/jbc.M111.297937			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22187428	Green Published, hybrid			2022-12-25	WOS:000300638000071
J	Jimenez, B; Ugwu, F; Zhao, RM; Orti, L; Makhnevych, T; Pineda-Lucena, A; Houry, WA				Jimenez, Beatriz; Ugwu, Francisca; Zhao, Rongmin; Orti, Leticia; Makhnevych, Taras; Pineda-Lucena, Antonio; Houry, Walid A.			Structure of Minimal Tetratricopeptide Repeat Domain Protein Tah1 Reveals Mechanism of Its Interaction with Pih1 and Hsp90	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TPR-DOMAIN; SACCHAROMYCES-CEREVISIAE; R2TP COMPLEX; SNAP HELIX; CHAPERONE; MOTIF; MACHINERY; BINDING; NMR; TRANSCRIPTION	Tah1 and Pih1 are novel Hsp90 interactors. Tah1 acts as a cofactor of Hsp90 to stabilize Pih1. In yeast, Hsp90, Tah1, and Pih1 were found to form a complex that is required for ribosomal RNA processing through their effect on box C/D small nucleolar ribonucleoprotein assembly. Tah1 is a minimal tetratricopeptide repeat protein of 111 amino acid residues that binds to the C terminus of the Hsp90 molecular chaperone, whereas Pih1 consists of 344 residues of unknown fold. The NMR structure of Tah1 has been solved, and this structure shows the presence of two tetratricopeptide repeat motifs followed by a C helix and an unstructured region. The binding of Tah1 to Hsp90 is mediated by the EEVD C-terminal residues of Hsp90, which bind to a positively charged channel formed by Tah1. Five highly conserved residues, which form a two-carboxylate clamp that tightly interacts with the ultimate Asp-0 residue of the bound peptide, are also present in Tah1. Tah1 was found to bind to the C terminus of Pih1 through the C helix and the unstructured region. The C terminus of Pih1 destabilizes the protein in vitro and in vivo, whereas the binding of Tah1 to Pih1 allows for the formation of a stable complex. Based on our data, a model for an Hsp90-Tah1-Pih1 ternary complex is proposed.	[Jimenez, Beatriz; Orti, Leticia; Pineda-Lucena, Antonio] Ctr Invest Principe Felipe, Dept Med Chem, Struct Biochem Lab, E-46012 Valencia, Spain; [Ugwu, Francisca; Makhnevych, Taras; Houry, Walid A.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Zhao, Rongmin] Univ Toronto, Dept Biol Sci, Scarborough, ON M1C 1A4, Canada	Prince Felipe Research Center; University of Toronto; University of Toronto; University Toronto Scarborough	Pineda-Lucena, A (corresponding author), Ctr Invest Principe Felipe, Dept Med Chem, Struct Biochem Lab, E-46012 Valencia, Spain.	apineda@cipf.es; walid.houry@utoronto.ca	Pineda-Lucena, Antonio/B-1320-2014	Pineda-Lucena, Antonio/0000-0002-3532-8781; Zhao, Rongmin/0000-0003-1300-5882	Canadian Institutes of Health Research [MOP-93778]; Spanish Ministerio de Ciencia e Innovacion (MICINN) [SAF2008-01845]; EC [RII3-026145]; Ontario Institute for Cancer Research; Faculty of Medicine at the University of Toronto; European FP7 e-Infrastructure grant [261572]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); EC(European CommissionEuropean Commission Joint Research Centre); Ontario Institute for Cancer Research; Faculty of Medicine at the University of Toronto(University of Toronto); European FP7 e-Infrastructure grant	This work was supported by a grant from the Canadian Institutes of Health Research (MOP-93778) to WAH, Spanish Ministerio de Ciencia e Innovacion (MICINN, SAF2008-01845) to AP-L.; Supported by the Access to Research Infrastructures activity in the 6th FP of the EC (Contract RII3-026145, EU-NMR).; Supported in part by the Ontario Institute for Cancer Research and by the Grant Miller Cancer Research Grant from the Faculty of Medicine at the University of Toronto.; We thank Dr. Francesca Cantini and Prof. Antonio Rosato for help with the structure calculations and software usage. We thank Dr. Hermann Torsten for help with UNIO. We thank Elisa Leung and Usheer Kanjee for help with the ITC experiments and Dr. Majida El Bakkouri for help with the structure figures. A.P.-L. and B. J. acknowledge the We NMR project (European FP7 e-Infrastructure grant, Contract 261572) for use of Web portals, computing, and storage facilities and CERM (University of Florence) for technical support.	Abe Y, 2000, CELL, V100, P551, DOI 10.1016/S0092-8674(00)80691-1; Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Bertini I, 2011, BIOINFORMATICS, V27, P2384, DOI 10.1093/bioinformatics/btr415; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Boulon S, 2008, J CELL BIOL, V180, P579, DOI 10.1083/jcb.200708110; Boulon S, 2010, MOL CELL, V39, P912, DOI 10.1016/j.molcel.2010.08.023; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cliff MJ, 2005, J MOL BIOL, V346, P717, DOI 10.1016/j.jmb.2004.12.017; Cliff MJ, 2006, STRUCTURE, V14, P415, DOI 10.1016/j.str.2005.12.009; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cortajarena AL, 2010, FEBS J, V277, P1058, DOI 10.1111/j.1742-4658.2009.07549.x; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Eckert K, 2010, J BIOL CHEM, V285, P31304, DOI 10.1074/jbc.M110.138263; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feldman DE, 1999, MOL CELL, V4, P1051, DOI 10.1016/S1097-2765(00)80233-6; GOEBL M, 1991, TRENDS BIOCHEM SCI, V16, P173, DOI 10.1016/0968-0004(91)90070-C; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; HIRANO T, 1990, CELL, V60, P319, DOI 10.1016/0092-8674(90)90746-2; Horejsi Z, 2010, MOL CELL, V39, P839, DOI 10.1016/j.molcel.2010.08.037; Hu YH, 2007, GENOME RES, V17, P536, DOI 10.1101/gr.6037607; Huen J, 2010, BIOCHEM CELL BIOL, V88, P29, DOI [10.1139/o09-122, 10.1139/O09-122]; Inoue M, 2010, BIOCHEM BIOPH RES CO, V403, P340, DOI 10.1016/j.bbrc.2010.11.031; Jeronimo C, 2007, MOL CELL, V27, P262, DOI 10.1016/j.molcel.2007.06.027; Jha S, 2009, MOL CELL, V34, P521, DOI 10.1016/j.molcel.2009.05.016; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li JX, 2009, J BIOL CHEM, V284, P23852, DOI 10.1074/jbc.M109.023986; Magliery TJ, 2004, J MOL BIOL, V343, P731, DOI 10.1016/j.jmb.2004.08.026; Millson SH, 2008, BIOCHEM J, V413, P261, DOI 10.1042/BJ20080105; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Ni L, 2009, J CELL BIOCHEM, V106, P920, DOI 10.1002/jcb.22073; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161; Savchenko A, 2003, PROTEINS, V50, P392, DOI 10.1002/prot.10282; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; SIKORSKI RS, 1990, CELL, V60, P307, DOI 10.1016/0092-8674(90)90745-Z; Smith DF, 2004, CELL STRESS CHAPERON, V9, P109, DOI 10.1379/CSC-31.1; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Yang J, 2005, EMBO J, V24, P1, DOI 10.1038/sj.emboj.7600496; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Zhao RM, 2008, J CELL BIOL, V180, P563, DOI 10.1083/jcb.200709061	46	37	38	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5698	5709		10.1074/jbc.M111.287458	http://dx.doi.org/10.1074/jbc.M111.287458			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22179618	Green Published, hybrid			2022-12-25	WOS:000300638000046
J	Wang, Y; Kallgren, SP; Reddy, BD; Kuntz, K; Lopez-Maury, L; Thompson, J; Watt, S; Ma, C; Hou, HT; Shi, Y; Yates, JR; Bahler, J; O'Connell, MJ; Jia, ST				Wang, Yu; Kallgren, Scott P.; Reddy, Bharat D.; Kuntz, Karen; Lopez-Maury, Luis; Thompson, James; Watt, Stephen; Ma, Chun; Hou, Haitong; Shi, Yang; Yates, John R., III; Baehler, Juerg; O'Connell, Matthew J.; Jia, Songtao			Histone H3 Lysine 14 Acetylation Is Required for Activation of a DNA Damage Checkpoint in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHIZOSACCHAROMYCES-POMBE; ACETYLTRANSFERASE COMPLEXES; PROTEIN COMPLEXES; CHROMATIN; GENOME; H4; TRANSCRIPTION; METHYLATION; MUTANTS; BIOLOGY	Histone lysine acetylation has emerged as a key regulator of genome organization. However, with a few exceptions, the contribution of each acetylated lysine to cellular functions is not well understood because of the limited specificity of most histone acetyltransferases and histone deacetylases. Here we show that the Mst2 complex in Schizosaccharomyces pombe is a highly specific H3 lysine 14 (H3K14) acetyltransferase that functions together with Gcn5 to regulate global levels of H3K14 acetylation (H3K14ac). By analyzing the effect of H3K14ac loss through both enzymatic inactivation and histone mutations, we found that H3K14ac is critical for DNA damage checkpoint activation by directly regulating the compaction of chromatin and by recruiting chromatin remodeling protein complex RSC.	[Jia, Songtao] Columbia Univ, Fairchild Ctr 1114, Dept Biol Sci, New York, NY 10027 USA; [Kuntz, Karen; O'Connell, Matthew J.] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Lopez-Maury, Luis; Watt, Stephen; Baehler, Juerg] UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England; [Lopez-Maury, Luis; Watt, Stephen; Baehler, Juerg] UCL, Inst Canc, London WC1E 6BT, England; [Thompson, James; Yates, John R., III] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Ma, Chun; Shi, Yang] Fudan Univ, Lab Epigenet, Inst Biomed Sci, Sch Med, Shanghai 20032, Peoples R China; [Ma, Chun; Shi, Yang] Fudan Univ, Dept Biochem, Sch Med, Shanghai 20032, Peoples R China; [Shi, Yang] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Shi, Yang] Childrens Hosp, Div Newborn Med, Dept Med, Boston, MA 02115 USA	Columbia University; Icahn School of Medicine at Mount Sinai; University of London; University College London; University of London; University College London; Scripps Research Institute; Fudan University; Fudan University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Jia, ST (corresponding author), Columbia Univ, Fairchild Ctr 1114, Dept Biol Sci, MC2458, New York, NY 10027 USA.	jia@biology.columbia.edu	Hou, Haitong/E-8416-2013; Lopez-Maury, Luis/B-3715-2015; Bahler, Jurg/B-4572-2009; hou, haitong/D-5188-2019	Lopez-Maury, Luis/0000-0002-3510-0621; Bahler, Jurg/0000-0003-4036-1532; Kallgren, Scott/0000-0002-6318-3268; hou, haitong/0000-0003-4493-9645; Jia, Songtao/0000-0002-7927-0227	National Institutes of Health [R01-GM085145, R01-GM087326, T32-GM008798]; National Institutes of Health NCI [T32-CA78207]; Cancer Research UK; National Center for Research Resources [P41 RR11823]; Chinese Ministry of Education [2009CB825602]; "973" State Key Development Program of Basic Research of China [2009CB825603]; NATIONAL CANCER INSTITUTE [T32CA078207] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008798, R01GM087326, R01GM085145] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Chinese Ministry of Education(Ministry of Education, China); "973" State Key Development Program of Basic Research of China(National Basic Research Program of China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported, in whole or in part, by National Institutes of Health Grants R01-GM085145 (to S. J.) and R01-GM087326 (to M. J. O), by National Institutes of Health Training Grant T32-GM008798 (to S. P. K. and B. D. R.), and by National Institutes of Health NCI Training Grant T32-CA78207 (to K. K.). This work was also supported by a Cancer Research UK grant (to J. B.), by National Center for Research Resources Grant P41 RR11823 (to T. N.D.), by "985" Program Grant 2009CB825602 from the Chinese Ministry of Education, and by "973" State Key Development Program of Basic Research of China Grant 2009CB825603.	Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Dai J, 2008, CELL, V134, P1066, DOI 10.1016/j.cell.2008.07.019; Dion MF, 2005, P NATL ACAD SCI USA, V102, P5501, DOI 10.1073/pnas.0500136102; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Du LL, 2006, GENE DEV, V20, P1583, DOI 10.1101/gad.1422606; DURRIN LK, 1991, CELL, V65, P1023, DOI 10.1016/0092-8674(91)90554-C; Eberharter A, 1998, METHODS, V15, P315, DOI 10.1006/meth.1998.0635; Ferreira H, 2007, J MOL BIOL, V374, P563, DOI 10.1016/j.jmb.2007.09.059; Gomez EB, 2005, MOL CELL BIOL, V25, P8887, DOI 10.1128/MCB.25.20.8887-8903.2005; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Helmlinger D, 2008, GENE DEV, V22, P3184, DOI 10.1101/gad.1719908; Howe L, 2002, MOL CELL BIOL, V22, P5047, DOI 10.1128/MCB.22.14.5047-5053.2002; Howe L, 2001, GENE DEV, V15, P3144, DOI 10.1101/gad.931401; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; John S, 2000, GENE DEV, V14, P1196; Kasten M, 2004, EMBO J, V23, P1348, DOI 10.1038/sj.emboj.7600143; Kim YC, 2009, NAT CELL BIOL, V11, P92, DOI 10.1038/ncb1817; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kuntz K, 2009, CANCER BIOL THER, V8, P1433, DOI 10.4161/cbt.8.15.9081; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Liang B, 2007, CURR BIOL, V17, P1432, DOI 10.1016/j.cub.2007.07.035; Lopez-Girona A, 2001, P NATL ACAD SCI USA, V98, P11289, DOI 10.1073/pnas.191557598; Martin DGE, 2006, MOL CELL BIOL, V26, P7871, DOI 10.1128/MCB.00573-06; MEGEE PC, 1990, SCIENCE, V247, P841, DOI 10.1126/science.2106160; MEGEE PC, 1995, GENE DEV, V9, P1716, DOI 10.1101/gad.9.14.1716; Mellone BG, 2003, CURR BIOL, V13, P1748, DOI 10.1016/j.cub.2003.09.031; Monahan BJ, 2008, NAT STRUCT MOL BIOL, V15, P873, DOI 10.1038/nsmb.1452; Nakanishi S, 2008, NAT STRUCT MOL BIOL, V15, P881, DOI 10.1038/nsmb.1454; Nugent RL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-59; PARK EC, 1990, MOL CELL BIOL, V10, P4932, DOI 10.1128/MCB.10.9.4932; Pidoux A, 2004, METHODS, V33, P252, DOI 10.1016/j.ymeth.2003.11.021; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Reddy BD, 2011, GENE DEV, V25, P214, DOI 10.1101/gad.1993611; Sanchez R, 2009, CURR OPIN DRUG DISC, V12, P659; Schneider J, 2006, J BIOL CHEM, V281, P37270, DOI 10.1074/jbc.C600265200; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shim EY, 2007, MOL CELL BIOL, V27, P1602, DOI 10.1128/MCB.01956-06; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Taverna SD, 2006, MOL CELL, V24, P785, DOI 10.1016/j.molcel.2006.10.026; Tsutsui Y, 2001, GENETICS, V159, P91; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Wang Y, 2009, MOL CELL, V33, P428, DOI 10.1016/j.molcel.2009.02.002; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wiren M, 2005, EMBO J, V24, P2906, DOI 10.1038/sj.emboj.7600758	47	50	58	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4386	4393		10.1074/jbc.M111.329417	http://dx.doi.org/10.1074/jbc.M111.329417			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22184112	hybrid, Green Published			2022-12-25	WOS:000300410900069
J	Alvarez-Vasquez, F; Riezman, H; Hannun, YA; Voit, EO				Alvarez-Vasquez, Fernando; Riezman, Howard; Hannun, Yusuf A.; Voit, Eberhard O.			Mathematical Modeling and Validation of the Ergosterol Pathway in Saccharomyces cerevisiae	PLOS ONE			English	Article							YEAST SPHINGOLIPID METABOLISM; STERYL ESTER HYDROLASE; PLASMA-MEMBRANE ATPASE; COENZYME-A REDUCTASE; CELL-SURFACE; LIPID RAFTS; ENDOPLASMIC-RETICULUM; BIOLOGICAL-MEMBRANES; TRANSBILAYER MOVEMENT; BIOSYNTHETIC-PATHWAY	The de novo biosynthetic machinery for both sphingolipid and ergosterol production in yeast is localized in the endoplasmic reticulum (ER) and Golgi. The interconnections between the two pathways are still poorly understood, but they may be connected in specialized membrane domains, and specific knockouts strongly suggest that both routes have different layers of mutual control and are co-affected by drugs. With the goal of shedding light on the functional integration of the yeast sphingolipid-ergosterol (SL-E) pathway, we constructed a dynamic model of the ergosterol pathway using the guidelines of Biochemical Systems Theory (BST) (Savageau., J. theor. Biol., 25, 365-9, 1969). The resulting model was merged with a previous mathematical model of sphingolipid metabolism in yeast (Alvarez-Vasquez et al., J. theor. Biol., 226, 265-91, 2004; Alvarez-Vasquez et al., Nature 433, 425-30, 2005). The S-system format within BST was used for analyses of consistency, stability, and sensitivity of the SL-E model, while the GMA format was used for dynamic simulations and predictions. Model validation was accomplished by comparing predictions from the model with published results on sterol and sterol-ester dynamics in yeast. The validated model was used to predict the metabolomic dynamics of the SL-E pathway after drug treatment. Specifically, we simulated the action of drugs affecting sphingolipids in the endoplasmic reticulum and studied changes in ergosterol associated with microdomains of the plasma membrane (PM).	[Alvarez-Vasquez, Fernando; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Riezman, Howard] Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland; [Voit, Eberhard O.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Alvarez-Vasquez, Fernando] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX USA	Medical University of South Carolina; University of Geneva; University System of Georgia; Georgia Institute of Technology; Texas A&M University System; Texas A&M University College Station	Alvarez-Vasquez, F (corresponding author), Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Programa Genom Computac, Cuernavaca 62191, Morelos, Mexico.	alvarezf@ccg.unam.mx		Alvarez-Vasquez, Fernando/0000-0003-4008-9858; Riezman, Howard/0000-0003-4680-9422	NIH [GM63265]; Human Frontiers in Science Program; SystemsX.ch; National Science Foundation [MCB-0946595]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063265] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers in Science Program(Human Frontier Science Program); SystemsX.ch; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIH grant GM63265 (Dr. Hannun), by a grant from the Human Frontiers in Science Program (Dr. Riezman and Dr. Hannun), by a grant from SystemsX.ch (Dr. Riezman, evaluated by the Swiss National Science Foundation), and in part by the National Science Foundation (Project MCB-0946595; PI: Dr. Voit). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez FJ, 2007, EUKARYOT CELL, V6, P755, DOI 10.1128/EC.00008-07; Alvarez-Vasquez F, 2005, NATURE, V433, P425, DOI 10.1038/nature03232; Alvarez-Vasquez F, 2004, J THEOR BIOL, V226, P265, DOI 10.1016/j.jtbi.2003.08.010; Alvarez-Vasquez F, 2008, BIOCHEM ENG J, V40, P157, DOI 10.1016/j.bej.2007.12.003; Alvarez-Vasquez F, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-42; [Anonymous], 2010, MATLAB 7 10 0 499; Bagnat M, 2000, P NATL ACAD SCI USA, V97, P3254, DOI 10.1073/pnas.060034697; BAILEY RB, 1975, J BACTERIOL, V124, P606, DOI 10.1128/JB.124.2.606-612.1975; Bajzer Z, 2008, MATH BIOSCI, V215, P35, DOI 10.1016/j.mbs.2008.05.003; BARD M, 1981, J GEN MICROBIOL, V125, P415; Baumann NA, 2005, BIOCHEMISTRY-US, V44, P5816, DOI 10.1021/bi048296z; Berchtold D, 2009, MOL BIOL CELL, V20, P1565, DOI 10.1091/mbc.E08-10-1001; Breinig F, 2006, APPL ENVIRON MICROB, V72, P7140, DOI 10.1128/AEM.00503-06; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Burrage K, 2007, BRIEF BIOINFORM, V8, P234, DOI 10.1093/bib/bbm033; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; Casal M, 1996, MICROBIOL-UK, V142, P1385, DOI 10.1099/13500872-142-6-1385; CERBON J, 1995, BBA-BIOMEMBRANES, V1235, P100, DOI 10.1016/0005-2736(94)00311-C; CERBON J, 1991, BIOCHIM BIOPHYS ACTA, V1067, P139, DOI 10.1016/0005-2736(91)90035-7; Czabany T, 2008, J BIOL CHEM, V283, P17065, DOI 10.1074/jbc.M800401200; Czabany T, 2007, BBA-MOL CELL BIOL L, V1771, P299, DOI 10.1016/j.bbalip.2006.07.001; Daum G, 2007, NOVART FDN SYMP, V286, P196; Daum Gunther, 2007, Novartis Found Symp, V286, P142; Delaunay JL, 2008, BBA-BIOMEMBRANES, V1778, P105, DOI 10.1016/j.bbamem.2007.09.017; Devaux PF, 2004, TRAFFIC, V5, P241, DOI 10.1111/j.1600-0854.2004.0170.x; Devaux PF, 2006, CHEM PHYS LIPIDS, V141, P119, DOI 10.1016/j.chemphyslip.2006.02.007; Dimster-Denk D, 1999, J LIPID RES, V40, P850; DIMSTERDENK D, 1994, MOL BIOL CELL, V5, P655, DOI 10.1091/mbc.5.6.655; DimsterDenk D, 1996, MOL CELL BIOL, V16, P3981; Eisenkolb M, 2002, MOL BIOL CELL, V13, P4414, DOI 10.1091/mbc.E02-02-0116; Emter R, 2002, FEBS LETT, V521, P57, DOI 10.1016/S0014-5793(02)02818-1; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; Fantini Jacques, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402005392; FERREIRA AEN, 2005, PLAS 1 2 0 120; Gaigg B, 2006, J BIOL CHEM, V281, P34135, DOI 10.1074/jbc.M603791200; Goel Gautam, 2006, J Biomol Tech, V17, P252; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Gomez-Lopez A, 2008, EXPERT OPIN PHARMACO, V9, P2801, DOI 10.1517/14656566.9.16.2801 ; Griac P, 2007, BBA-MOL CELL BIOL L, V1771, P737, DOI 10.1016/j.bbalip.2007.02.008; Grilley MM, 1998, J BIOL CHEM, V273, P11062, DOI 10.1074/jbc.273.18.11062; Grossmann G, 2006, EUKARYOT CELL, V5, P945, DOI 10.1128/EC.00206-05; Guan XL, 2009, MOL BIOL CELL, V20, P2083, DOI 10.1091/mbc.E08-11-1126; Hampton R, 1996, TRENDS BIOCHEM SCI, V21, P140, DOI 10.1016/S0968-0004(96)80168-X; Harder T, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-21; Hearn JD, 2003, J BIOL CHEM, V278, P3679, DOI 10.1074/jbc.M209170200; Heino S, 2000, P NATL ACAD SCI USA, V97, P8375, DOI 10.1073/pnas.140218797; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Holthuis JCM, 2003, MOL MEMBR BIOL, V20, P231, DOI 10.1080/0988768031000100768; HORVATH A, 1994, EMBO J, V13, P3687, DOI 10.1002/j.1460-2075.1994.tb06678.x; Hu B, 2009, BIOINFORMATICS, V25, P1457, DOI 10.1093/bioinformatics/btp173; Jazwinski SM, 2001, MECH AGEING DEV, V122, P865, DOI 10.1016/S0047-6374(01)00244-5; Jenkins GM, 2001, J BIOL CHEM, V276, P8574, DOI 10.1074/jbc.M007425200; Jin H, 2008, J CELL BIOL, V180, P813, DOI 10.1083/jcb.200705076; John K, 2002, BIOPHYS J, V83, P1525, DOI 10.1016/S0006-3495(02)73922-2; John K, 2002, BIOPHYS J, V83, P3315, DOI 10.1016/S0006-3495(02)75332-0; Kajiwara K, 2008, MOL BIOL CELL, V19, P2069, DOI 10.1091/mbc.E07-08-0740; Klose C, 2010, J BIOL CHEM, V285, P30224, DOI 10.1074/jbc.M110.123554; Koffel R, 2006, EUKARYOT CELL, V5, P1018, DOI 10.1128/EC.00002-06; Koffel R, 2005, MOL CELL BIOL, V25, P1655, DOI 10.1128/MCB.25.5.1655-1668.2005; Leber R, 1998, MOL BIOL CELL, V9, P375, DOI 10.1091/mbc.9.2.375; LEBER R, 1994, YEAST, V10, P1421, DOI 10.1002/yea.320101105; Lees ND, 1999, CRIT REV BIOCHEM MOL, V34, P33; LEWIS TA, 1987, BIOCHIM BIOPHYS ACTA, V921, P205, DOI 10.1016/0005-2760(87)90020-8; LORENZ RT, 1991, LIPIDS, V26, P598, DOI 10.1007/BF02536423; Maczek J, 2006, BIOPROC BIOSYST ENG, V29, P241, DOI 10.1007/s00449-006-0072-1; Malinska K, 2003, MOL BIOL CELL, V14, P4427, DOI 10.1091/mbc.E03-04-0221; Maxfield FR, 2006, BIOCHEM SOC T, V34, P335, DOI 10.1042/BST0340335; Meier KD, 2006, MOL BIOL CELL, V17, P1164, DOI 10.1091/mbc.E05-11-1039; Miller JP, 2005, P NATL ACAD SCI USA, V102, P12123, DOI 10.1073/pnas.0505482102; Mondal M, 2009, MOL BIOL CELL, V20, P581, DOI 10.1091/mbc.E08-07-0785; Monk BC, 2008, SCIENCE, V321, P367, DOI 10.1126/science.1159746; Mukhopadhyay K, 2004, ANTIMICROB AGENTS CH, V48, P1778, DOI 10.1128/AAC.48.5.1778-1787.2004; Mullner H, 2005, J BIOL CHEM, V280, P13321, DOI 10.1074/jbc.M409914200; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Nagiec MM, 2003, BIOCHEM BIOPH RES CO, V307, P369, DOI 10.1016/S0006-291X(03)01164-1; O'Shea P, 2003, BIOCHEM SOC T, V31, P990; Okamoto M, 2006, J BIOL CHEM, V281, P4013, DOI 10.1074/jbc.M504684200; Ott RG, 2005, BBA-MOL CELL BIOL L, V1735, P111, DOI 10.1016/j.bbalip.2005.05.003; Paiva S, 2004, YEAST, V21, P201, DOI 10.1002/yea.1056; Pampulha ME, 2000, FEMS MICROBIOL LETT, V184, P69, DOI 10.1016/S0378-1097(00)00022-7; PARKS LW, 1995, LIPIDS, V30, P227, DOI 10.1007/BF02537825; PARKS LW, 1995, ANNU REV MICROBIOL, V49, P95, DOI 10.1146/annurev.mi.49.100195.000523; Pichler H, 2001, EUR J BIOCHEM, V268, P2351, DOI 10.1046/j.1432-1327.2001.02116.x; Pike LJ, 2005, J BIOL CHEM, V280, P26796, DOI 10.1074/jbc.M503805200; Proszynski TJ, 2005, P NATL ACAD SCI USA, V102, P17981, DOI 10.1073/pnas.0509107102; Radin NS, 2006, MICROBES INFECT, V8, P938, DOI 10.1016/j.micinf.2005.09.005; Ridgway ND, 2000, BBA-MOL CELL BIOL L, V1484, P129, DOI 10.1016/S1388-1981(00)00006-8; Sano T, 2005, J BIOL CHEM, V280, P36674, DOI 10.1074/jbc.M503147200; SAVAGEAU MA, 1993, J MOL RECOGNIT, V6, P149, DOI 10.1002/jmr.300060403; SAVAGEAU MA, 1995, J THEOR BIOL, V176, P115, DOI 10.1006/jtbi.1995.0181; SAVAGEAU MA, 1969, J THEOR BIOL, V25, P365, DOI 10.1016/S0022-5193(69)80026-3; SAVAGEAU MA, 1976, ADV BOOK PROGRAM, V17, P379; Schnabl M, 2005, BBA-MOL CELL BIOL L, V1687, P130, DOI 10.1016/j.bbalip.2004.11.016; Schulz TA, 2007, BBA-MOL CELL BIOL L, V1771, P769, DOI 10.1016/j.bbalip.2007.03.003; Seker T, 2005, APPL MICROBIOL BIOT, V67, P119, DOI 10.1007/s00253-004-1697-0; Sims KJ, 2007, METHOD ENZYMOL, V432, P319, DOI 10.1016/S0076-6879(07)32013-2; Sorger D, 2004, J BIOL CHEM, V279, P31190, DOI 10.1074/jbc.M403251200; Sturley SL, 2000, BBA-MOL CELL BIOL L, V1529, P155, DOI 10.1016/S1388-1981(00)00145-1; Sturley SL, 2009, P NATL ACAD SCI USA, V106, P2093, DOI 10.1073/pnas.0812934106; Sullivan DP, 2006, BIOCHEM SOC T, V34, P356, DOI 10.1042/BST0340356; Swain E, 2002, J BIOL CHEM, V277, P26177, DOI 10.1074/jbc.M204115200; Tani M, 2006, BIOCHEM J, V394, P237, DOI 10.1042/BJ20051354; TAYLOR FR, 1978, J BACTERIOL, V136, P531, DOI 10.1128/JB.136.2.531-537.1978; Thomas KC, 2002, APPL ENVIRON MICROB, V68, P1616, DOI 10.1128/AEM.68.4.1616-1623.2002; TORRES NV, 2002, PATHWAY ANAL OPTIMIZ, V14, P305; Valachovic M, 2006, GENETICS, V173, P1893, DOI 10.1534/genetics.105.053025; Vallee B, 2005, EMBO J, V24, P730, DOI 10.1038/sj.emboj.7600562; Veen M, 2005, BIOCHEM SOC T, V33, P1178, DOI 10.1042/BST0331178; Veen M, 2004, APPL MICROBIOL BIOT, V63, P635, DOI 10.1007/s00253-003-1456-7; Veen M, 2003, FEMS YEAST RES, V4, P87, DOI 10.1016/S1567-1356(03)00126-0; Vereb G, 2003, P NATL ACAD SCI USA, V100, P8053, DOI 10.1073/pnas.1332550100; Voit EO, 2004, MATH BIOSCI, V191, P83, DOI 10.1016/j.mbs.2004.04.004; Voit EO, 2000, COMPUTATIONAL ANAL B, V12, P531; WANG CH, 1952, J BIOL CHEM, V197, P645; Wang QQ, 2002, P NATL ACAD SCI USA, V99, P12853, DOI 10.1073/pnas.202115499; Wang TY, 2003, BIOPHYS J, V84, P367, DOI 10.1016/S0006-3495(03)74857-7; WIEMKEN A, 1970, Archiv fuer Mikrobiologie, V70, P89, DOI 10.1007/BF00412200; WU WI, 1995, J BIOL CHEM, V270, P13171, DOI 10.1074/jbc.270.22.13171; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991; ZINSER E, 1993, J BACTERIOL, V175, P2853, DOI 10.1128/JB.175.10.2853-2858.1993; Zweytick D, 2000, EUR J BIOCHEM, V267, P1075, DOI 10.1046/j.1432-1327.2000.01103.x	122	14	16	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28344	10.1371/journal.pone.0028344	http://dx.doi.org/10.1371/journal.pone.0028344			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194828	gold, Green Published, Green Submitted			2022-12-25	WOS:000298369100032
J	Wang, D; Li, LB; Hou, ZW; Kang, XJ; Xie, QD; Yu, XJ; Ma, MF; Ma, BL; Wang, ZS; Lei, Y; Huang, TH				Wang, Dian; Li, Lian-Bing; Hou, Zhi-Wei; Kang, Xiang-Jin; Xie, Qing-Dong; Yu, Xiao-Jun; Ma, Ming-Fu; Ma, Bo-Lu; Wang, Zheng-Song; Lei, Yong; Huang, Tian-Hua			The Integrated HIV-1 Provirus in Patient Sperm Chromosome and Its Transfer into the Early Embryo by Fertilization	PLOS ONE			English	Article							FOREIGN DNA-SEQUENCES; HUMAN SPERMATOZOA; SEROPOSITIVE SUBJECTS; HAMSTER OVA; GENOME; TRANSMISSION; MOUSE; CELLS; HYBRIDIZATION; INFECTION	Complete understanding of the route of HIV-1 transmission is an important prerequisite for curbing the HIV/AIDS pandemic. So far, the known routes of HIV-1 transmission include sexual contact, needle sharing, puncture, transfusion and mother-to-child transmission. Whether HIV can be vertically transmitted from human sperm to embryo by fertilization is largely undetermined. Direct research on embryo derived from infected human sperm and healthy human ova have been difficult because of ethical issues and problems in the collection of ova. However, the use of inter-specific in vitro fertilization (IVF) between human sperm and hamster ova can avoid both of these problems. Combined with molecular, cytogenetical and immunological techniques such as the preparation of human sperm chromosomes, fluorescent in situ hybridization (FISH), and immunofluorescence assay (IFA), this study mainly explored whether any integrated HIV provirus were present in the chromosomes of infected patients' sperm, and whether that provirus could be transferred into early embryos by fertilization and maintain its function of replication and expression. Evidence showed that HIV-1 nucleic acid was present in the spermatozoa of HIV/AIDS patients, that HIV-1 provirus is present on the patient sperm chromosome, that the integrated provirus could be transferred into early embryo chromosomally integrated by fertilization, and that it could replicate alongside the embryonic genome and subsequently express its protein in the embryo. These findings indicate the possibility of vertical transmission of HIV-1 from the sperm genome to the embryonic genome by fertilization. This study also offers a platform for the research into this new mode of transmission for other viruses, especially sexually transmitted viruses.	[Wang, Dian; Kang, Xiang-Jin; Xie, Qing-Dong; Huang, Tian-Hua] Shantou Univ Med Coll, Res Ctr Reprod Med, Shantou, Peoples R China; [Li, Lian-Bing; Hou, Zhi-Wei; Ma, Ming-Fu] Chongqing Key Lab Birth Defects & Reprod Hlth, Chongqing, Peoples R China; [Ma, Bo-Lu; Wang, Zheng-Song; Lei, Yong] Jiangbei Dist Ctr Dis Control & Prevent, Chongqing, Peoples R China; [Wang, Dian; Yu, Xiao-Jun] Shantou Univ Med Coll, Dept Forens Med, Shantou, Peoples R China		Wang, D (corresponding author), Shantou Univ Med Coll, Res Ctr Reprod Med, Shantou, Peoples R China.	thhuang@stu.edu.cn			National Nature Science Foundation of China [30800940]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grant of National Nature Science Foundation of China (Grant No. 30800940). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali BA, 2006, ASIAN J ANDROL, V8, P273, DOI 10.1111/j.1745-7262.2006.00141.x; BACCETTI B, 1994, J CELL BIOL, V127, P903, DOI 10.1083/jcb.127.4.903; BAGASRA O, 1994, AIDS, V8, P1669, DOI 10.1097/00002030-199412000-00005; Barbonetti A, 2009, HUM REPROD, V24, P2979, DOI 10.1093/humrep/dep304; Cardona-Maya W, 2006, AM J REPROD IMMUNOL, V55, P241, DOI 10.1111/j.1600-0897.2005.00340.x; Ceballos A, 2009, J EXP MED, V206, P2717, DOI 10.1084/jem.20091579; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Giordano R, 2000, J CELL BIOL, V148, P1107, DOI 10.1083/jcb.148.6.1107; Huang JM, 2002, ASIAN J ANDROL, V4, P209; KAMIGUCHI Y, 1986, AM J HUM GENET, V38, P724; LAVITRANO M, 1989, CELL, V57, P717, DOI 10.1016/0092-8674(89)90787-3; Le Tortorec A, 2010, INT J ANDROL, V33, pE98, DOI 10.1111/j.1365-2605.2009.00973.x; Magnano AR, 1998, J REPROD IMMUNOL, V41, P187, DOI 10.1016/S0165-0378(98)00058-8; Muciaccia B, 2007, HUM REPROD, V22, P2868, DOI 10.1093/humrep/dem288; Muciaccia B, 2005, FASEB J, V19, P2048, DOI 10.1096/fj.05-3962fje; Muciaccia B, 2005, AIDS, V19, P1424, DOI 10.1097/01.aids.0000180809.04427.04; Muciaccia B, 1998, FASEB J, V12, P151, DOI 10.1096/fasebj.12.2.151; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; NUOVO GJ, 1994, AM J PATHOL, V144, P1142; Pinney JW, 2009, AIDS, V23, P549, DOI 10.1097/QAD.0b013e328325a495; Piomboni P, 2000, MOL REPROD DEV, V56, P238, DOI 10.1002/(SICI)1098-2795(200006)56:2+&lt;238::AID-MRD5&gt;3.0.CO;2-1; RUDAK E, 1978, NATURE, V274, P911, DOI 10.1038/274911a0; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Spadafora C, 1998, BIOESSAYS, V20, P955, DOI 10.1002/(SICI)1521-1878(199811)20:11&lt;955::AID-BIES11&gt;3.0.CO;2-8; Trkola A, 2004, CURR OPIN MICROBIOL, V7, P555, DOI 10.1016/j.mib.2004.08.001; Wang DA, 2011, J MED VIROL, V83, P16, DOI 10.1002/jmv.21767; Zoraqi G, 1997, DNA CELL BIOL, V16, P291, DOI 10.1089/dna.1997.16.291	27	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28586	10.1371/journal.pone.0028586	http://dx.doi.org/10.1371/journal.pone.0028586			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194862	gold, Green Published, Green Submitted			2022-12-25	WOS:000298369100059
J	Dyer, GA; Gonzalez, C; Lopera, DC				Dyer, George A.; Gonzalez, Carolina; Lopera, Diana Carolina			Informal "Seed'' Systems and the Management of Gene Flow in Traditional Agroecosystems: The Case of Cassava in Cauca, Colombia	PLOS ONE			English	Article							MANIHOT-ESCULENTA CRANTZ; MAIZE LANDRACES; DIVERSITY; CROP; CONSERVATION; PERSPECTIVE; TRANSGENES; ECOLOGY; OAXACA	Our ability to manage gene flow within traditional agroecosystems and their repercussions requires understanding the biology of crops, including farming practices' role in crop ecology. That these practices' effects on crop population genetics have not been quantified bespeaks lack of an appropriate analytical framework. We use a model that construes seed-management practices as part of a crop's demography to describe the dynamics of cassava (Manihot esculenta Crantz) in Cauca, Colombia. We quantify several management practices for cassava-the first estimates of their kind for a vegetatively-propagated crop-describe their demographic repercussions, and compare them to those of maize, a sexually-reproduced grain crop. We discuss the implications for gene flow, the conservation of cassava diversity, and the biosafety of vegetatively-propagated crops in centers of diversity. Cassava populations are surprisingly open and dynamic: farmers exchange germplasm across localities, particularly improved varieties, and distribute it among neighbors at extremely high rates vis-a-vis maize. This implies that a large portion of cassava populations consists of non-local germplasm, often grown in mixed stands with local varieties. Gene flow from this germplasm into local seed banks and gene pools via pollen has been documented, but its extent remains uncertain. In sum, cassava's biology and vegetative propagation might facilitate pre-release confinement of genetically-modified varieties, as expected, but simultaneously contribute to their diffusion across traditional agroecosystems if released. Genetically-modified cassava is unlikely to displace landraces or compromise their diversity; but rapid diffusion of improved germplasm and subsequent incorporation into cassava landraces, seed banks or wild populations could obstruct the tracking and eradication of deleterious transgenes. Attempts to regulate traditional farming practices to reduce the risks could compromise cassava populations' adaptive potential and ultimately prove ineffectual.	[Dyer, George A.] James Hutton Inst, Aberdeen, Scotland; [Gonzalez, Carolina] Ctr Int Agr Trop, LACBiosafety Project, Cali, Colombia; [Gonzalez, Carolina] Int Food Policy Res Inst, Washington, DC 20036 USA; [Lopera, Diana Carolina] Ctr Int Agr Trop, LACBiosafety Project, Cali, Colombia	James Hutton Institute; Alliance; International Center for Tropical Agriculture - CIAT; CGIAR; International Food Policy Research Institute (IFPRI); Alliance; International Center for Tropical Agriculture - CIAT	Dyer, GA (corresponding author), James Hutton Inst, Aberdeen, Scotland.	georgie.dyer@gmail.com		Gonzalez, Carolina/0000-0003-3613-1769	LACBiosafety Project	LACBiosafety Project	This work was supported by the LACBiosafety Project (http://www.lacbiosafety.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andow DA, 2006, ECOL LETT, V9, P196, DOI 10.1111/j.1461-0248.2005.00846.x; Ceballos H, 2004, PLANT MOL BIOL, V56, P503, DOI 10.1007/s11103-004-5010-5; Celis C, 2004, NATURE, V432, P222, DOI 10.1038/nature03048; Duputie A, 2007, MOL ECOL, V16, P3025, DOI 10.1111/j.1365-294X.2007.03340.x; Dyer GA, 2008, P NATL ACAD SCI USA, V105, P470, DOI 10.1073/pnas.0706321105; Dyer GA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005734; Elias M, 2001, EUPHYTICA, V120, P143, DOI 10.1023/A:1017501017031; Elias Marianne, 2000, Journal of Ethnobiology, V20, P239; ELSHARKAWY MA, 1993, BIOSCIENCE, V43, P441, DOI 10.2307/1311903; Gepts Paul, 2003, Environmental Biosafety Research, V2, P89, DOI 10.1051/ebr:2003009; Halsey ME, 2008, CROP SCI, V48, P49, DOI 10.2135/cropsci2007.05.0279; HERSHEY CH, 1987, CASSAVA BREEDING MUL, P1; JARAMILLO G, 2008, DIAGNOSTICO CULTIVO; Jarvis DI, 2008, P NATL ACAD SCI USA, V105, P5326, DOI 10.1073/pnas.0800607105; Lavigne C, 2008, J APPL ECOL, V45, P1104, DOI 10.1111/j.1365-2664.2008.01504.x; Louette D, 1997, ECON BOT, V51, P20, DOI 10.1007/BF02910401; Ma JKC, 2005, TRENDS PLANT SCI, V10, P580, DOI 10.1016/j.tplants.2005.10.009; McKey D, 2010, NEW PHYTOL, V186, P318, DOI 10.1111/j.1469-8137.2010.03210.x; Morris M.L., 1999, 9907 CIMMYT; PALACIOS JD, 2007, DESARROLLO CAPACIDAD, P85; Parzies HK, 2004, GENET RESOUR CROP EV, V51, P471, DOI 10.1023/B:GRES.0000024157.67531.88; Perales H, 2003, ECON BOT, V57, P21, DOI 10.1663/0013-0001(2003)057[0007:LOMICM]2.0.CO;2; Pressoir G, 2004, HEREDITY, V92, P88, DOI 10.1038/sj.hdy.6800387; Pujol B, 2002, ECON BOT, V56, P366, DOI [10.1663/0013-0001(2002)056[0366:GEOCME]2.0.CO;2, 10.1111/j.1461-0248.2004.00708.x]; Pujol B, 2007, BIOL CONSERV, V136, P541, DOI 10.1016/j.biocon.2006.12.025; Quist D, 2001, NATURE, V414, P541, DOI 10.1038/35107068; Raven PH, 2005, P NATL ACAD SCI USA, V102, P13003, DOI 10.1073/pnas.0506082102; Rival L, 2008, CURR ANTHROPOL, V49, P1116, DOI 10.1086/593119; Serratos J. Antonio, 1997, GENE FLOW MAIZE LAND; Smale M, 1997, WORLD DEV, V25, P1257, DOI 10.1016/S0305-750X(97)00038-7; Sokal R. R., 2012, BIOMETRY; Spok A, 2007, TRENDS BIOTECHNOL, V25, P74, DOI 10.1016/j.tibtech.2006.12.003; Taylor N, 2004, PLANT MOL BIOL, V56, P671, DOI 10.1007/s11103-004-4872-x; Thomas M, 2011, GENET RESOUR CROP EV, V58, P321, DOI 10.1007/s10722-011-9662-0; Twyman RM, 2003, TRENDS BIOTECHNOL, V21, P570, DOI 10.1016/j.tibtech.2003.10.002; van Heerwaarden J, 2010, HEREDITY, V104, P28, DOI 10.1038/hdy.2009.110; Zeven AC, 1999, EUPHYTICA, V110, P181, DOI 10.1023/A:1003701529155; Zeven AC, 1998, EUPHYTICA, V104, P127, DOI 10.1023/A:1018683119237	38	17	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e29067	10.1371/journal.pone.0029067	http://dx.doi.org/10.1371/journal.pone.0029067			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174952	gold, Green Published, Green Submitted			2022-12-25	WOS:000298366600060
J	Lim, YA; Grimm, A; Giese, M; Mensah-Nyagan, AG; Villafranca, JE; Ittner, LM; Eckert, A; Gotz, J				Lim, Yun-An; Grimm, Amandine; Giese, Maria; Mensah-Nyagan, Ayikoe Guy; Villafranca, J. Ernest; Ittner, Lars M.; Eckert, Anne; Goetz, Juergen			Inhibition of the Mitochondrial Enzyme ABAD Restores the Amyloid-beta-Mediated Deregulation of Estradiol	PLOS ONE			English	Article							TAU TRANSGENIC MICE; ALCOHOL-DEHYDROGENASE ABAD; COENZYME-A DEHYDROGENASE; DISEASE MOUSE MODEL; ALZHEIMERS-DISEASE; METABOLIC DYSFUNCTION; DIABETES-MELLITUS; BINDING; TOXICITY; 17-BETA-HYDROXYSTEROID-DEHYDROGENASE	Alzheimer's disease (AD) is a conformational disease that is characterized by amyloid-beta (A beta) deposition in the brain. A beta exerts its toxicity in part by receptor-mediated interactions that cause down-stream protein misfolding and aggregation, as well as mitochondrial dysfunction. Recent reports indicate that A beta may also interact directly with intracellular proteins such as the mitochondrial enzyme ABAD (A beta binding alcohol dehydrogenase) in executing its toxic effects. Mitochondrial dysfunction occurs early in AD, and A beta's toxicity is in part mediated by inhibition of ABAD as shown previously with an ABAD decoy peptide. Here, we employed AG18051, a novel small ABAD-specific compound inhibitor, to investigate the role of ABAD in A beta toxicity. Using SH-SY5Y neuroblastoma cells, we found that AG18051 partially blocked the A beta-ABAD interaction in a pull-down assay while it also prevented the A beta 42-induced down-regulation of ABAD activity, as measured by levels of estradiol, a known hormone and product of ABAD activity. Furthermore, AG18051 is protective against A beta 42 toxicity, as measured by LDH release and MTT absorbance. Specifically, AG18051 reduced A beta 42-induced impairment of mitochondrial respiration and oxidative stress as shown by reduced ROS (reactive oxygen species) levels. Guided by our previous finding of shared aspects of the toxicity of A beta and human amylin (HA), with the latter forming aggregates in Type 2 diabetes mellitus (T2DM) pancreas, we determined whether AG18051 would also confer protection from HA toxicity. We found that the inhibitor conferred only partial protection from HA toxicity indicating distinct pathomechanisms of the two amyloidogenic agents. Taken together, our results present the inhibition of ABAD by compounds such as AG18051 as a promising therapeutic strategy for the prevention and treatment of AD, and suggest levels of estradiol as a suitable readout.	[Lim, Yun-An; Ittner, Lars M.; Goetz, Juergen] Univ Sydney, Alzheimers & Parkinsons Dis Lab, Brain & Mind Res Inst, Camperdown, NSW, Australia; [Grimm, Amandine; Giese, Maria; Eckert, Anne] Univ Basel, Neurobiol Lab, Psychiat Univ Clin Basel, Basel, Switzerland; [Mensah-Nyagan, Ayikoe Guy] Univ Strasbourg, Equipe Steroides Neuromodulateurs & Neuropathol, Strasbourg, France; [Villafranca, J. Ernest] Villafranca Consulting, San Diego, CA USA	University of Sydney; University of Basel; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Lim, YA (corresponding author), Univ Sydney, Alzheimers & Parkinsons Dis Lab, Brain & Mind Res Inst, Camperdown, NSW, Australia.	Anne.Eckert@upkbs.ch; juergen.goetz@sydney.edu.au	Götz, Jürgen/C-2448-2014; Grimm, Amandine/ABE-5634-2020; Mensah-Nyagan, Ayikoe G/D-5951-2011	Götz, Jürgen/0000-0001-8501-7896; Grimm, Amandine/0000-0003-3323-1756; Mensah-Nyagan, Ayikoe G/0000-0003-4454-511X; Ittner, Lars/0000-0001-6738-3825; Eckert, Anne/0000-0002-9341-3669	Australian Research Council (ARC); NHMRC (National Health and Medical Research Council); Judith Jane Mason & Harold Stannett Williams Memorial Foundation; Swiss National Science Foundation [310000-108223]	Australian Research Council (ARC)(Australian Research Council); NHMRC (National Health and Medical Research Council)(National Health and Medical Research Council (NHMRC) of Australia); Judith Jane Mason & Harold Stannett Williams Memorial Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This research was supported by grants to JG from the Australian Research Council (ARC), the NHMRC (National Health and Medical Research Council), and the Judith Jane Mason & Harold Stannett Williams Memorial Foundation, to LMI from the NHMRC and ARC, and to AE from the Swiss National Science Foundation (SNF #310000-108223). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanas'ev I, 2010, OXID MED CELL LONGEV, V3, P361, DOI 10.4161/oxim.3.6.14415; Bernas T, 2002, CYTOMETRY, V47, P236, DOI 10.1002/cyto.10080; Borger E, 2011, BIOCHEM SOC T, V39, P868, DOI 10.1042/BST0390868; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Budd SL, 1997, FEBS LETT, V415, P21, DOI 10.1016/S0014-5793(97)01088-0; Cappai R, 2008, NEUROCHEM RES, V33, P526, DOI 10.1007/s11064-007-9469-8; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Chen X, 2006, IUBMB LIFE, V58, P686, DOI 10.1080/15216540601047767; Crouch PJ, 2005, J NEUROSCI, V25, P672, DOI 10.1523/JNEUROSCI.4276-04.2005; D'Amelio M, 2011, NAT NEUROSCI, V14, P69, DOI 10.1038/nn.2709; David DC, 2005, J BIOL CHEM, V280, P23802, DOI 10.1074/jbc.M500356200; David DC, 2006, PROTEOMICS, V6, P6566, DOI 10.1002/pmic.200600634; Du Yan S, 1999, J BIOL CHEM, V274, P2145, DOI 10.1074/jbc.274.4.2145; DUMONT M, 2010, FREE RADIC BIOL MED; Eckert A, 2008, J MOL MED, V86, P1255, DOI 10.1007/s00109-008-0391-6; Eckert A, 2008, NEURODEGENER DIS, V5, P157, DOI 10.1159/000113689; Eckert A, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt74; Ferrari A, 2003, J BIOL CHEM, V278, P40162, DOI 10.1074/jbc.M308243200; Garcia-Segura LM, 2001, PROG NEUROBIOL, V63, P29, DOI 10.1016/S0301-0082(00)00025-3; Gotz J, 2009, CELL MOL LIFE SCI, V66, P1321, DOI 10.1007/s00018-009-9070-1; Gotz J, 2011, CELL MOL LIFE SCI, V68, P3359, DOI 10.1007/s00018-011-0750-2; Gotz Jurgen, 2008, Neuropsychiatr Dis Treat, V4, P1033; HALLIWELL B, 1994, ENVIRON HEALTH PERSP, V102, P5, DOI 10.2307/3432205; He XY, 1999, J BIOL CHEM, V274, P15014, DOI 10.1074/jbc.274.21.15014; He XY, 2002, MOL BRAIN RES, V99, P46, DOI 10.1016/S0169-328X(02)00102-X; He XY, 2001, EUR J BIOCHEM, V268, P4899, DOI 10.1046/j.0014-2956.2001.02421.2421.x; He XY, 2000, BBA-MOL CELL BIOL L, V1484, P267, DOI 10.1016/S1388-1981(00)00014-7; Henderson VW, 2010, PROG BRAIN RES, V182, P77, DOI 10.1016/S0079-6123(10)82003-5; Hoerndli F, 2005, PROG NEUROBIOL, V76, P169, DOI 10.1016/j.pneurobio.2005.07.002; Hoerndli FJ, 2004, ANAL BIOCHEM, V335, P30, DOI 10.1016/j.ab.2004.08.028; Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013; Holzmann J, 2009, MITOCHONDRION, V9, P284, DOI 10.1016/j.mito.2009.03.008; Ittner LM, 2011, NAT REV NEUROSCI, V12, P67, DOI 10.1038/nrn2967; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Ivell R, 2003, ENDOCRINOLOGY, V144, P3130, DOI 10.1210/en.2002-0082; Keil U, 2004, J BIOL CHEM, V279, P50310, DOI 10.1074/jbc.M405600200; Kenney AM, 1998, J NEUROSCI, V18, P1318; Kissinger CR, 2004, J MOL BIOL, V342, P943, DOI 10.1016/j.jmb.2004.07.071; Lim YA, 2008, FEBS LETT, V582, P2188, DOI 10.1016/j.febslet.2008.05.006; Lim YA, 2010, PROTEOMICS, V10, P1621, DOI 10.1002/pmic.200900651; Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com; Lobner D, 2000, J NEUROSCI METH, V96, P147, DOI 10.1016/S0165-0270(99)00193-4; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Marques AT, 2008, BIOORGAN MED CHEM, V16, P9511, DOI 10.1016/j.bmc.2008.09.043; Marques AT, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-202; Moeller G, 2006, MOL CELL ENDOCRINOL, V248, P47, DOI 10.1016/j.mce.2005.11.031; Moreira PI, 2009, J ALZHEIMERS DIS, V16, P741, DOI 10.3233/JAD-2009-0972; Muirhead KEA, 2010, ACS CHEM BIOL, V5, P1105, DOI 10.1021/cb100199m; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Oppermann UCT, 1999, FEBS LETT, V451, P238, DOI 10.1016/S0014-5793(99)00586-4; Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027; Powell AJ, 2000, J MOL BIOL, V303, P311, DOI 10.1006/jmbi.2000.4139; Rauschenberger K, 2010, EMBO MOL MED, V2, P51, DOI 10.1002/emmm.200900055; RHEIN V, 2009, CELL MOL NEUROBIOL; Rhein V, 2009, P NATL ACAD SCI USA, V106, P20057, DOI 10.1073/pnas.0905529106; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Seo JS, 2011, FREE RADICAL BIO MED, V50, P1526, DOI 10.1016/j.freeradbiomed.2011.02.035; Small DH, 2001, NAT REV NEUROSCI, V2, P595, DOI 10.1038/35086072; Takuma K, 2005, FASEB J, V19, P597, DOI 10.1096/fj.04-2582fje; TILLEMENT L, 2011, NEURODEGENER DIS; Winton MJ, 2011, J NEUROSCI, V31, P7691, DOI 10.1523/JNEUROSCI.6637-10.2011; Yan SD, 1997, NATURE, V389, P689; Yan YL, 2007, BIOCHEMISTRY-US, V46, P1724, DOI 10.1021/bi061314n; Yang SY, 2007, MOL GENET METAB, V92, P36, DOI 10.1016/j.ymgme.2007.06.001; Yao J., 2011, NEUROBIOL AGING; Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106; Yao J, 2007, MOL CELL NEUROSCI, V35, P377, DOI 10.1016/j.mcn.2007.03.013; Yao J, 2011, J NEUROSCI, V31, P2313, DOI 10.1523/JNEUROSCI.4717-10.2011	68	39	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28887	10.1371/journal.pone.0028887	http://dx.doi.org/10.1371/journal.pone.0028887			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174920	Green Published, gold, Green Submitted			2022-12-25	WOS:000298366600047
J	Delyfer, MN; Raffelsberger, W; Mercier, D; Korobelnik, JF; Gaudric, A; Charteris, DG; Tadayoni, R; Metge, F; Caputo, G; Barale, PO; Ripp, R; Muller, JD; Poch, O; Sahel, JA; Leveillard, T				Delyfer, Marie-Noelle; Raffelsberger, Wolfgang; Mercier, David; Korobelnik, Jean-Francois; Gaudric, Alain; Charteris, David G.; Tadayoni, Ramin; Metge, Florence; Caputo, Georges; Barale, Pierre-Olivier; Ripp, Raymond; Muller, Jean-Denis; Poch, Olivier; Sahel, Jose-Alain; Leveillard, Thierry			Transcriptomic Analysis of Human Retinal Detachment Reveals Both Inflammatory Response and Photoreceptor Death	PLOS ONE			English	Article							PIGMENT EPITHELIAL-CELLS; INTERCELLULAR-ADHESION MOLECULE-1; CONE VIABILITY FACTOR; PROLIFERATIVE VITREORETINOPATHY; MATRIX METALLOPROTEINASES; EPIRETINAL MEMBRANES; MUTUAL INFORMATION; GENE-EXPRESSION; PROTEIN; MOUSE	Background: Retinal detachment often leads to a severe and permanent loss of vision and its therapeutic management remains to this day exclusively surgical. We have used surgical specimens to perform a differential analysis of the transcriptome of human retinal tissues following detachment in order to identify new potential pharmacological targets that could be used in combination with surgery to further improve final outcome. Methodology/Principal Findings: Statistical analysis reveals major involvement of the immune response in the disease. Interestingly, using a novel approach relying on coordinated expression, the interindividual variation was monitored to unravel a second crucial aspect of the pathological process: the death of photoreceptor cells. Within the genes identified, the expression of the major histocompatibility complex I gene HLA-C enables diagnosis of the disease, while PKD2L1 and SLCO4A1 - which are both down-regulated-act synergistically to provide an estimate of the duration of the retinal detachment process. Our analysis thus reveals the two complementary cellular and molecular aspects linked to retinal detachment: an immune response and the degeneration of photoreceptor cells. We also reveal that the human specimens have a higher clinical value as compared to artificial models that point to IL6 and oxidative stress, not implicated in the surgical specimens studied here. Conclusions/Significance: This systematic analysis confirmed the occurrence of both neurodegeneration and inflammation during retinal detachment, and further identifies precisely the modification of expression of the different genes implicated in these two phenomena. Our data henceforth give a new insight into the disease process and provide a rationale for therapeutic strategies aimed at limiting inflammation and photoreceptor damage associated with retinal detachment and, in turn, improving visual prognosis after retinal surgery.	[Delyfer, Marie-Noelle; Poch, Olivier; Sahel, Jose-Alain; Leveillard, Thierry] INSERM, U968, Paris, France; [Delyfer, Marie-Noelle; Poch, Olivier; Sahel, Jose-Alain; Leveillard, Thierry] Univ Paris 06, UMR S 968, Inst Vis, Paris, France; [Delyfer, Marie-Noelle; Poch, Olivier; Sahel, Jose-Alain; Leveillard, Thierry] CNRS, UMR 7210, Paris, France; [Delyfer, Marie-Noelle; Korobelnik, Jean-Francois] Ctr Hosp Univ Bordeaux, Dept Ophtalmol, Unite Retine Uveite & Neuroophtalmol, Bordeaux, France; [Raffelsberger, Wolfgang; Ripp, Raymond; Poch, Olivier] CNRS, UMR 7104, Inst Genet & Biol Mol & Cellulaire, Lab BioInformat & Genom Integrat, Strasbourg, France; [Mercier, David; Muller, Jean-Denis] CEA, LIST, Informat Models & Learning Lab, Gif Sur Yvette, France; [Gaudric, Alain; Tadayoni, Ramin] Hop Lariboisiere, Dept Ophtalmol, F-75475 Paris, France; [Charteris, David G.] Moorfields Eye Hosp, Vitreoretinal Unit, London, England; [Metge, Florence; Caputo, Georges; Sahel, Jose-Alain] Fdn Ophtalmol Adolphe de Rothschild, Paris, France; [Barale, Pierre-Olivier; Sahel, Jose-Alain] Ctr Ophtalmol Quinze Vingts, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CEA; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Delyfer, MN (corresponding author), INSERM, U968, Paris, France.	thierry.leveillard@inserm.fr	Delyfer, Marie-Noelle/T-3304-2019; Sahel, Jose-Alain/F-3172-2017; Léveillard, Thierry/AAR-1804-2020; KOROBELNIK, Jean-Francois/A-5448-2016	Sahel, Jose-Alain/0000-0002-4831-1153; Léveillard, Thierry/0000-0001-5692-8770; Gaudric, Alain/0000-0002-2486-4722	Institut National de la Sante et de la Recherche Medicale, CNRS, University of Strasbourg; network Reseaux National de Genopoles [RNG 209]	Institut National de la Sante et de la Recherche Medicale, CNRS, University of Strasbourg; network Reseaux National de Genopoles	The work was supported by the Institut National de la Sante et de la Recherche Medicale, CNRS, University of Strasbourg and the network Reseaux National de Genopoles (RNG 209). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando A, 2000, BRIT J OPHTHALMOL, V84, P1306, DOI 10.1136/bjo.84.11.1306; Arroyo JG, 2005, AM J OPHTHALMOL, V139, P605, DOI 10.1016/j.ajo.2004.11.046; Audo I, 2009, AM J HUM GENET, V85, P720, DOI 10.1016/j.ajhg.2009.10.013; BONNLANDER BV, 1994, P INT S ART NEUR NET, P42; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Burgi S, 2009, MOL VIS, V15, P1631; CARTERDAWSON LD, 1978, INVEST OPHTH VIS SCI, V17, P489; Casaroli-Marano RP, 1999, INVEST OPHTH VIS SCI, V40, P2062; CHARTERIS DG, 1992, OPHTHALMOLOGY, V99, P1364; Charteris DG, 2002, EYE, V16, P369, DOI 10.1038/sj.eye.6700194; Cheema RA, 2007, OPHTHAL SURG LAS IM, V38, P365, DOI 10.3928/15428877-20070901-02; Cox RA., 1968, METHODS ENZYMOL, V12, P120, DOI 10.1016/0076-6879(67)12123-X; El Ghrably I, 2004, INVEST OPHTH VIS SCI, V45, P1473, DOI 10.1167/iovs.03-0060; ELNER SG, 1992, LAB INVEST, V66, P200; ELNER SG, 1992, EXP EYE RES, V55, P21, DOI 10.1016/0014-4835(92)90087-9; Farjo R, 2008, INVEST OPHTH VIS SCI, V49, P511, DOI 10.1167/iovs.07-1013; Fisher SK, 2005, PROG RETIN EYE RES, V24, P395, DOI 10.1016/j.preteyeres.2004.10.004; Fridlich R, 2009, MOL CELL PROTEOMICS, V8, P1206, DOI 10.1074/mcp.M800406-MCP200; Ganti R, 2007, INVEST OPHTH VIS SCI, V48, P1853, DOI 10.1167/iovs.06-0198; GLISIN V, 1974, BIOCHEMISTRY-US, V13, P2633, DOI 10.1021/bi00709a025; HEIDENKUMMER HP, 1992, GRAEF ARCH CLIN EXP, V230, P483, DOI 10.1007/BF00175938; Hollborn M, 2008, INVEST OPHTH VIS SCI, V49, P1262, DOI 10.1167/iovs.07-0879; Isernhagen R D, 1988, Trans Am Ophthalmol Soc, V86, P291; Jackson CR, 2009, J NEUROCHEM, V109, P148, DOI 10.1111/j.1471-4159.2009.05920.x; Kalathur RKR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-208; Kawaguchi H, 2010, J BIOL CHEM, V285, P17277, DOI 10.1074/jbc.C110.132944; Klitten LL, 2008, EXP EYE RES, V87, P471, DOI 10.1016/j.exer.2008.08.004; Kon CH, 1998, INVEST OPHTH VIS SCI, V39, P1524; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Kubay OV, 2005, SURV OPHTHALMOL, V50, P463, DOI 10.1016/j.survophthal.2005.06.004; Kullback S., 1968, INFORM THEORY STAT; LENDASSE A, 2004, SELECTION VARIABLES, P44; Leveillard T, 2004, NAT GENET, V36, P755, DOI 10.1038/ng1386; Leveillard T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000866; LEWIS GP, 1994, AM J OPHTHALMOL, V118, P368, DOI 10.1016/S0002-9394(14)72962-9; Lewis GP, 2003, INT REV CYTOL, V230, P263, DOI 10.1016/S0074-7696(03)30005-1; Limb GA, 1997, INVEST OPHTH VIS SCI, V38, P1043; LIMB GA, 1993, GRAEF ARCH CLIN EXP, V231, P331, DOI 10.1007/BF00919029; Liu LL, 2005, MOL BIOL REP, V32, P41, DOI 10.1007/s11033-004-4250-4; MACHEMER R, 1991, AM J OPHTHALMOL, V112, P159, DOI 10.1016/S0002-9394(14)76695-4; MICHELS RG, 1996, MICHELS RETINAL DETA, P935; Mitry D, 2010, BRIT J OPHTHALMOL, V94, P678, DOI 10.1136/bjo.2009.157727; NORK TM, 1995, ARCH OPHTHALMOL-CHIC, V113, P1066, DOI 10.1001/archopht.1995.01100080118039; OWARIBE K, 1988, CELL TISSUE RES, V254, P301; Padgett LC, 1997, EXP EYE RES, V64, P927, DOI 10.1006/exer.1997.0287; PASANTESMORALES H, 1985, BRAIN RES, V330, P154, DOI 10.1016/0006-8993(85)90018-6; Pastor JC, 1998, SURV OPHTHALMOL, V43, P3, DOI 10.1016/S0039-6257(98)00023-X; Ploner A, 2006, BIOINFORMATICS, V22, P556, DOI 10.1093/bioinformatics/btk013; Rahman A, 2006, J NEURAL TRANSM, V113, P219, DOI 10.1007/s00702-005-0313-5; Reichman S, 2010, HUM MOL GENET, V19, P250, DOI 10.1093/hmg/ddp484; Rossi F, 2006, CHEMOMETR INTELL LAB, V80, P215, DOI 10.1016/j.chemolab.2005.06.010; Sethi CS, 2005, INVEST OPHTH VIS SCI, V46, P329, DOI 10.1167/iovs.03-0518; Sherman BT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-426; Sherman PM, 1997, P NATL ACAD SCI USA, V94, P11639, DOI 10.1073/pnas.94.21.11639; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sodhi A, 2008, SURV OPHTHALMOL, V53, P50, DOI 10.1016/j.survophthal.2007.10.007; Steuer R, 2002, BIOINFORMATICS, V18, pS231, DOI 10.1093/bioinformatics/18.suppl_2.S231; Sumbayev VV, 2005, ARCH BIOCHEM BIOPHYS, V436, P406, DOI 10.1016/j.abb.2005.02.021; Symeonidis C, 2007, RETINA-J RET VIT DIS, V27, P1279, DOI 10.1097/IAE.0b013e3180592c00; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Warskulat U, 2007, ARCH BIOCHEM BIOPHYS, V462, P202, DOI 10.1016/j.abb.2007.03.022; Webster L, 1999, EXP EYE RES, V68, P91, DOI 10.1006/exer.1998.0585; Wickham L, 2007, OPHTHALMOLOGY, V114, P698, DOI 10.1016/j.ophtha.2006.08.042; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yang Y, 2009, MOL THER, V17, P787, DOI 10.1038/mt.2009.28; Zacks DN, 2006, INVEST OPHTH VIS SCI, V47, P1691, DOI 10.1167/iovs.05-1209	67	37	40	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28791	10.1371/journal.pone.0028791	http://dx.doi.org/10.1371/journal.pone.0028791			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174898	Green Published, gold, Green Submitted			2022-12-25	WOS:000298365700074
J	Lu, B; Asara, JM; Sanda, MG; Arredouani, MS				Lu, Bin; Asara, John M.; Sanda, Martin G.; Arredouani, Mohamed S.			The Role of the Transcription Factor SIM2 in Prostate Cancer	PLOS ONE			English	Article							DRUG-THERAPY TARGET; SINGLE-MINDED GENE; DOWNS-SYNDROME; EXPRESSION; CELLS; IDENTIFICATION; REPRESSION; SINGLEMINDED-2S; OLIGONUCLEOTIDE; INHIBITION	Background: Recent reports have suggested a possible involvement of Single-minded homolog 2 (SIM2) in human solid cancers, including prostate cancer. However, the exact role of SIM2 in cancer in general, and in prostate cancer in particular, remains largely unknown. This study was designed to elucidate the role of SIM2 in prostate cancer using a shRNA-based approach in the PC3 prostate cancer cell line. Methods: Lentiviral shRNAs were used to inhibit SIM2 gene and protein levels in PC3 cells. Quantitative RT-PCR and branched DNA were performed to evaluate transcript expression. SIM2 protein expression level was measured by western blot. Profiling of gene expression spanning the whole genome, as well as polar metabolomics of several major metabolic pathways was performed to identify major pathway dysregulations. Results: SIM2 gene and protein products were significantly downregulated by lenti-shRNA in PC3 cell line. This low expression of SIM2 affected gene expression profile, revealing significant changes in major signaling pathways, networks and functions. In addition, major metabolic pathways were affected. Conclusion: Taken together, our results suggest an involvement of SIM2 in key traits of prostate tumor cell biology and might underlie a contribution of this transcription factor to prostate cancer onset and progression.	[Lu, Bin; Sanda, Martin G.; Arredouani, Mohamed S.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg, Boston, MA 02215 USA; [Asara, John M.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Lu, B (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg, Boston, MA 02215 USA.	msanda@bidmc.harvard.edu; marredou@bidmc.harvard.edu	Sanda, Martin G/B-2023-2015; Sanda, Martin G/A-6202-2013		NIH-NCI Early Detection Research Network [UO1-CA11391]; Department of Defense [W81XWH-09-1-0626]; Prostate Cancer Foundation	NIH-NCI Early Detection Research Network; Department of Defense(United States Department of Defense); Prostate Cancer Foundation	This work is supported by NIH-NCI Early Detection Research Network grant UO1-CA11391 (M. Sanda), Department of Defense Prostate Cancer Training Award W81XWH-09-1-0626 (B. Lu), and Prostate Cancer Foundation Young Investigator Award (M.S. Arredouani). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman MJ, 2005, P NATL ACAD SCI USA, V102, P12765, DOI 10.1073/pnas.0505484102; Arredouani MS, 2009, CLIN CANCER RES, V15, P5794, DOI 10.1158/1078-0432.CCR-09-0911; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Chrast R, 1997, GENOME RES, V7, P615, DOI 10.1101/gr.7.6.615; Colombatti M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004608; DeYoung MP, 2003, CANCER LETT, V200, P25, DOI 10.1016/S0304-3835(03)00409-9; DeYoung MP, 2003, P NATL ACAD SCI USA, V100, P4760, DOI 10.1073/pnas.0831000100; Deyoung MP, 2002, ANTICANCER RES, V22, P3149; Ema M, 1999, HUM MOL GENET, V8, P1409, DOI 10.1093/hmg/8.8.1409; Farrall AL, 2009, ONCOGENE, V28, P3671, DOI 10.1038/onc.2009.228; Gustafson TL, 2009, ONCOGENE, V28, P1561, DOI 10.1038/onc.2008.497; Halvorsen OJ, 2007, CLIN CANCER RES, V13, P892, DOI 10.1158/1078-0432.CCR-06-1207; Haram KM, 2008, PROSTATE, V68, P1517, DOI 10.1002/pros.20803; HE Q, CANC BIOL THER, V9, P430; Jones J, 2005, CLIN CANCER RES, V11, P5730, DOI 10.1158/1078-0432.CCR-04-2225; Kwak HI, 2007, CARCINOGENESIS, V28, P259, DOI 10.1093/carcin/bgl122; Laffin B, 2008, MOL CELL BIOL, V28, P1936, DOI 10.1128/MCB.01701-07; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; LI X, CYTOKINE, V49, P1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Metz RP, 2006, J BIOL CHEM, V281, P10839, DOI 10.1074/jbc.M508858200; Moffett P, 1997, MOL CELL BIOL, V17, P4933, DOI 10.1128/MCB.17.9.4933; Moffett P, 2000, FEBS LETT, V466, P80, DOI 10.1016/S0014-5793(99)01750-0; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Shimada K, 2008, CANCER SCI, V99, P39, DOI 10.1111/j.1349-7006.2007.00655.x; Vaday GG, 2006, PROSTATE, V66, P124, DOI 10.1002/pros.20306; WELLBERG E, DEVELOPMENT, V137, P945; XIA J, NAT PROTOC, V6, P743; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Yamaki A, 2001, GENE, V270, P265, DOI 10.1016/S0378-1119(01)00450-4; Yamanaka R, 2006, ONCOGENE, V25, P5994, DOI 10.1038/sj.onc.1209585; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Yuen T, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e48	33	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28837	10.1371/journal.pone.0028837	http://dx.doi.org/10.1371/journal.pone.0028837			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174909	Green Submitted, gold, Green Published			2022-12-25	WOS:000298365700075
J	Hirst, MB; Kita, KN; Dawson, SC				Hirst, Marissa B.; Kita, Kelley N.; Dawson, Scott C.			Uncultivated Microbial Eukaryotic Diversity: A Method to Link ssu rRNA Gene Sequences with Morphology	PLOS ONE			English	Article							SITU HYBRIDIZATION FISH; IDENTIFICATION; PROTISTS; ECOLOGY; COMMUNITIES; PERSPECTIVE; ATLANTIC; PROTOZOA; AMEBAS	Protists have traditionally been identified by cultivation and classified taxonomically based on their cellular morphologies and behavior. In the past decade, however, many novel protist taxa have been identified using cultivation independent ssu rRNA sequence surveys. New rRNA "phylotypes" from uncultivated eukaryotes have no connection to the wealth of prior morphological descriptions of protists. To link phylogenetically informative sequences with taxonomically informative morphological descriptions, we demonstrate several methods for combining whole cell rRNA-targeted fluorescent in situ hybridization (FISH) with cytoskeletal or organellar immunostaining. Either eukaryote or ciliate-specific ssu rRNA probes were combined with an anti-a-tubulin antibody or phalloidin, a common actin stain, to define cytoskeletal features of uncultivated protists in several environmental samples. The eukaryote ssu rRNA probe was also combined with Mitotracker (R) or a hydrogenosomal-specific anti-Hsp70 antibody to localize mitochondria and hydrogenosomes, respectively, in uncultivated protists from different environments. Using rRNA probes in combination with immunostaining, we linked ssu rRNA phylotypes with microtubule structure to describe flagellate and ciliate morphology in three diverse environments, and linked Naegleria spp. to their amoeboid morphology using actin staining in hay infusion samples. We also linked uncultivated ciliates to morphologically similar Colpoda-like ciliates using tubulin immunostaining with a ciliate-specific rRNA probe. Combining rRNA-targeted FISH with cytoskeletal immunostaining or stains targeting specific organelles provides a fast, efficient, high throughput method for linking genetic sequences with morphological features in uncultivated protists. When linked to phylotype, morphological descriptions of protists can both complement and vet the increasing number of sequences from uncultivated protists, including those of novel lineages, identified in diverse environments.	[Hirst, Marissa B.; Kita, Kelley N.; Dawson, Scott C.] Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA	University of California System; University of California Davis	Hirst, MB (corresponding author), Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA.	scdawson@ucdavis.edu		Dawson, Scott/0000-0002-0843-1759	National Institutes of Health National Institute of Allergy and Infectious Diseases [3R01AI077571-01A1S1]; University of California Davis; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077571] Funding Source: NIH RePORTER	National Institutes of Health National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of California Davis(University of California System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health National Institute of Allergy and Infectious Diseases 3R01AI077571-01A1S1 (http://www.niaid.nih.gov/) to SD. This study was also additionally supported by the University of California Davis Marjorie and Charles Elliot pre-doctoral Fellowship to MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM RD, 1991, MICROBIOL REV, V55, P706, DOI 10.1128/MMBR.55.4.706-732.1991; AMANN RI, 1990, J BACTERIOL, V172, P762, DOI 10.1128/jb.172.2.762-770.1990; Baker BJ, 2004, APPL ENVIRON MICROB, V70, P6264, DOI 10.1128/AEM.70.10.6264-6271.2004; Bass D, 2009, PROTIST, V160, P483, DOI 10.1016/j.protis.2009.01.004; Caron DA, 2009, APPL ENVIRON MICROB, V75, P5797, DOI 10.1128/AEM.00298-09; Caron DA, 2009, ISME J, V3, P4, DOI 10.1038/ismej.2008.101; Cavalier-Smith T, 2004, P ROY SOC B-BIOL SCI, V271, P1251, DOI 10.1098/rspb.2004.2705; Countway PD, 2005, J EUKARYOT MICROBIOL, V52, P95, DOI 10.1111/j.1550-7408.2005.05202006.x; Dawson SC, 2002, P NATL ACAD SCI USA, V99, P8324, DOI 10.1073/pnas.062169599; Dawson Scott C, 2009, J Biol, V8, P105, DOI 10.1186/jbiol201; Dawson SC, 2009, ENVIRON MICROBIOL, V11, P1627, DOI 10.1111/j.1462-2920.2009.01965.x; DEHORITY BA, 1994, J EUKARYOT MICROBIOL, V41, P103, DOI 10.1111/j.1550-7408.1994.tb01481.x; Duff RJ, 2008, J EUKARYOT MICROBIOL, V55, P306, DOI 10.1111/j.1550-7408.2008.00328.x; Finlay BJ, 2004, PHILOS T R SOC B, V359, P599, DOI 10.1098/rstb.2003.1450; Foissner W, 1999, PROTIST, V150, P363, DOI 10.1016/S1434-4610(99)70037-4; Fried J, 2002, SYST APPL MICROBIOL, V25, P555, DOI 10.1078/07232020260517706; HONIGBERG BM, 1972, J PROTOZOOL, V19, P446, DOI 10.1111/j.1550-7408.1972.tb03499.x; Hugenholtz P, 1998, J BACTERIOL, V180, P366, DOI 10.1128/JB.180.2.366-376.1998; KEMP PF, 1993, APPL ENVIRON MICROB, V59, P2594, DOI 10.1128/AEM.59.8.2594-2601.1993; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; Lopez-Garcia P, 2003, P NATL ACAD SCI USA, V100, P697, DOI 10.1073/pnas.0235779100; Lopez-Garcia P, 2007, ENVIRON MICROBIOL, V9, P546, DOI 10.1111/j.1462-2920.2006.01158.x; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Moreira D, 2002, TRENDS MICROBIOL, V10, P31, DOI 10.1016/S0966-842X(01)02257-0; Moter A, 2000, J MICROBIOL METH, V41, P85, DOI 10.1016/S0167-7012(00)00152-4; MULLER M, 1988, ANNU REV MICROBIOL, V42, P465, DOI 10.1146/annurev.mi.42.100188.002341; Regensbogenova M, 2004, FEMS MICROBIOL LETT, V238, P307, DOI [10.1111/j.1574-6968.2004.tb09771.x, 10.1016/j.femsle.2004.07.049]; RODRIGUEZZARAGOZA S, 1994, CRIT REV MICROBIOL, V20, P225, DOI 10.3109/10408419409114556; Saldarriaga JF, 2004, EUR J PROTISTOL, V40, P85, DOI 10.1016/j.ejop.2003.11.003; Sims GP, 2002, J EUKARYOT MICROBIOL, V49, P478, DOI 10.1111/j.1550-7408.2002.tb00232.x; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stoeck T, 2003, APPL ENVIRON MICROB, V69, P6856, DOI 10.1128/AEM.69.11.6856-6863.2003; Stoeck T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-72; van der Giezen M, 2003, MOL BIOL EVOL, V20, P1051, DOI 10.1093/molbev/msg103; WOODS A, 1989, J CELL SCI, V93, P491	35	6	6	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28158	10.1371/journal.pone.0028158	http://dx.doi.org/10.1371/journal.pone.0028158			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174774	Green Published, Green Submitted, gold			2022-12-25	WOS:000298163600014
J	Ma, SL; Pastorino, L; Zhou, XZ; Lu, KP				Ma, Suk Ling; Pastorino, Lucia; Zhou, Xiao Zhen; Lu, Kun Ping			Prolyl Isomerase Pin1 Promotes Amyloid Precursor Protein (APP) Turnover by Inhibiting Glycogen Synthase Kinase-3 beta (GSK3 beta) Activity NOVEL MECHANISM FOR Pin1 TO PROTECT AGAINST ALZHEIMER DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; DOWNS-SYNDROME; TAU-PROTEIN; PHOSPHORYLATION; BETA; DEMENTIA	Alzheimer disease (AD) is characterized by the presence of senile plaques of amyloid-beta (A beta) peptides derived from amyloid precursor protein (APP) and neurofibrillary tangles made of hyperphosphorylated Tau. Increasing APP gene dosage or expression has been shown to cause familial early-onset AD. However, whether and how protein stability of APP is regulated is unclear. The prolyl isomerase Pin1 and glycogen synthase kinase-3 beta (GSK3 beta) have been shown to have the opposite effects on APP processing and Tau hyperphosphorylation, relevant to the pathogenesis of AD. However, nothing is known about their relationship. In this study, we found that Pin1 binds to the pT330-P motif in GSK3 beta to inhibit its kinase activity. Furthermore, Pin1 promotes protein turnover of APP by inhibiting GSK3 beta activity. A point mutation either at Thr-330, the Pin1-binding site in GSK3 beta, or at Thr-668, the GSK3 beta phosphorylation site in APP, abolished the regulation of GSK3 beta activity, Thr-668 phosphorylation, and APP stability by Pin1, resulting in reduced non-amyloidogenic APP processing and increased APP levels. These results uncover a novel role of Pin1 in inhibiting GSK3 beta kinase activity to reduce APP protein levels, providing a previously unrecognized mechanism by which Pin1 protects against Alzheimer disease.	[Pastorino, Lucia] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Ctr Life Sci, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Pastorino, L (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Ctr Life Sci, Rm 0408, Boston, MA 02115 USA.	lpastori@bidmc.harvard.edu; klu@bidmc.harvard.edu	Ma, Suk Ling/AAF-2859-2019	Ma, Suk Ling/0000-0001-6175-5691	National Institutes of Health [R01AG017870, R01AG039405, K01AG030007]; NATIONAL INSTITUTE ON AGING [R01AG039405, K01AG030007, R01AG017870] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AG017870 and R01AG039405 (to K. P. L).; Recipient of a National Institutes of Health Mentored Research Scientist Development Award (K01AG030007).	Aplin AE, 1996, J NEUROCHEM, V67, P699; Castano Z, 2010, J NEUROCHEM, V113, P117, DOI 10.1111/j.1471-4159.2010.06581.x; Engel T, 2006, J NEUROSCI, V26, P5083, DOI 10.1523/JNEUROSCI.0604-06.2006; Flaherty DB, 2000, J NEUROSCI RES, V62, P463, DOI 10.1002/1097-4547(20001101)62:3<463::AID-JNR16>3.0.CO;2-7; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Lim J, 2008, J CLIN INVEST, V118, P1877, DOI 10.1172/JCI34308; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu PJ, 1999, NATURE, V399, P784; Ma S. L., 2012, NEUROBIOL A IN PRESS; MANN DMA, 1988, HISTOPATHOLOGY, V13, P125, DOI 10.1111/j.1365-2559.1988.tb02018.x; Nakamura K., 2012, CELL IN PRESS; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Pei JJ, 1997, J NEUROPATH EXP NEUR, V56, P70, DOI 10.1097/00005072-199701000-00007; Prasher VP, 1998, ANN NEUROL, V43, P380, DOI 10.1002/ana.410430316; Rayasam GV, 2009, BRIT J PHARMACOL, V156, P885, DOI 10.1111/j.1476-5381.2008.00085.x; Sleegers K, 2006, BRAIN, V129, P2977, DOI 10.1093/brain/awl203; Theuns J, 2006, AM J HUM GENET, V78, P936, DOI 10.1086/504044; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037	20	65	70	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					6969	6973		10.1074/jbc.C111.298596	http://dx.doi.org/10.1074/jbc.C111.298596			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22184106	Green Published, hybrid			2022-12-25	WOS:000301060200002
J	Tsukatani, Y; Romberger, SP; Golbeck, JH; Bryant, DA				Tsukatani, Yusuke; Romberger, Steven P.; Golbeck, John H.; Bryant, Donald A.			Isolation and Characterization of Homodimeric Type-I Reaction Center Complex from Candidatus Chloracidobacterium thermophilum, an Aerobic Chlorophototroph	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN SULFUR BACTERIUM; PHOTOSYNTHETIC REACTION-CENTER; FMO ANTENNA PROTEIN; CHLOROPHYLL-PROTEIN; CHLOROBIUM-TEPIDUM; ELECTRON-TRANSFER; PIGMENT COMPOSITION; CYTOCHROME-C; BACTERIOCHLOROPHYLL; CHLOROSOMES	The recently discovered thermophilic acidobacterium Candidatus Chloracidobacterium thermophilum is the first aerobic chlorophototroph that has a type-I, homodimeric reaction center (RC). This organism and its type-I RCs were initially detected by the occurrence of pscA gene sequences, which encode the core subunit of the RC complex, in metagenomic sequence data derived from hot spring microbial mats. Here, we report the isolation and initial biochemical characterization of the type-I RC from Ca. C. thermophilum. After removal of chlorosomes, crude membranes were solubilized with 0.1% (w/v) n-dodecyl beta-D-maltoside, and the RC complex was purified by ion-exchange chromatography. The RC complex comprised only two polypeptides: the reaction center core protein PscA and a 22-kDa carotenoid-binding protein denoted CbpC. The absorption spectrum showed a large, broad absorbance band centered at similar to 483 nm from carotenoids as well as smaller Q(y) absorption bands at 672 and 812 nm from chlorophyll a and bacteriochlorophyll a, respectively. The light-induced difference spectra of whole cells, membranes, and the isolated RC showed maximal bleaching at 840 nm, which is attributed to the special pair and which we denote as P840. Making it unique among homodimeric type-I RCs, the isolated RC was photoactive in the presence of oxygen. Analyses by optical spectroscopy, chromatography, and mass spectrometry revealed that the RC complex contained 10.3 bacteriochlorophyll a(P), 6.4 chlorophyll a(PD), and 1.6 Zn-bacteriochlorophyll a(P)' molecules per P840 (12.8:8.0:2.0). The possible functions of the Zn-bacteriochlorophyll a(P)' molecules and the carotenoid-binding protein are discussed.	[Bryant, Donald A.] Penn State Univ, Dept Biochem & Mol Biol, Althouse Lab 108, University Pk, PA 16802 USA; [Golbeck, John H.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Bryant, Donald A.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Montana State University System; Montana State University Bozeman	Bryant, DA (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Althouse Lab 108, University Pk, PA 16802 USA.	dab14@psu.edu	Tsukatani, Yusuke/A-6448-2014	Tsukatani, Yusuke/0000-0003-2831-8996	United States Department of Energy [DE-FG02-94ER20137]; National Science Foundation [MCB-0519743, MCB-1021725]; Uehara Memorial Foundation	United States Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported in part by United States Department of Energy Grant DE-FG02-94ER20137 (to D. A. B.) and National Science Foundation Grants MCB-0519743 and MCB-1021725 (to J. H. G. and D. A. B.).; Supported by a postdoctoral fellowship from The Uehara Memorial Foundation.	ALLEN KD, 1991, ANAL BIOCHEM, V194, P214, DOI 10.1016/0003-2697(91)90170-X; Azai C, 2010, PHOTOSYNTH RES, V104, P189, DOI 10.1007/s11120-009-9521-4; BRITTON G, 1985, METHOD ENZYMOL, V111, P113, DOI 10.1016/S0076-6879(85)11007-4; Bryant DA, 2007, SCIENCE, V317, P523, DOI 10.1126/science.1143236; Costas AMG, 2012, ENVIRON MICROBIOL, V14, P177, DOI 10.1111/j.1462-2920.2011.02592.x; Costas AMG, 2011, J BACTERIOL, V193, P6701, DOI 10.1128/JB.06124-11; FOWLER CF, 1971, P NATL ACAD SCI USA, V68, P2278, DOI 10.1073/pnas.68.9.2278; Frank HA, 2004, BIOCHEMISTRY-US, V43, P8607, DOI 10.1021/bi0492096; Frigaard N-U., 2006, COMPLEX INTRACELLULA, V2, P79, DOI [10.1007/7171_021, DOI 10.1007/7171_021]; Frigaard NU, 1997, ARCH MICROBIOL, V167, P343, DOI 10.1007/s002030050453; Ganapathy S, 2009, P NATL ACAD SCI USA, V106, P8525, DOI 10.1073/pnas.0903534106; Garcia Costas A. M., 2008, PHOTOSYNTHESIS ENERG, V1, P1161; Garcia Costas A. M., 2010, THESIS PENNSYLVANIA; Garcia Costas A. M., 2011, J BACTERIOL IN PRESS; Garrity GM, 2007, TAXONOMIC OUTLINE BA; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; GOLBECK JH, 1993, P NATL ACAD SCI USA, V90, P1642, DOI 10.1073/pnas.90.5.1642; Griesbeck C, 1998, BBA-BIOENERGETICS, V1365, P285, DOI 10.1016/S0005-2728(98)00081-4; Hauska G, 2001, BBA-BIOENERGETICS, V1507, P260, DOI 10.1016/S0005-2728(01)00200-6; Heinnickel M, 2007, PHOTOSYNTH RES, V92, P35, DOI 10.1007/s11120-007-9162-4; Hofmann E, 1996, SCIENCE, V272, P1788, DOI 10.1126/science.272.5269.1788; HOLO H, 1985, ARCH MICROBIOL, V143, P94, DOI 10.1007/BF00414775; Jagannathan B, 2008, BBA-BIOENERGETICS, V1777, P1535, DOI 10.1016/j.bbabio.2008.09.001; Jaschke PR, 2011, J BIOL CHEM, V286, P20313, DOI 10.1074/jbc.M110.212605; Kirilovsky D, 2010, ADV EXP MED BIOL, V675, P139, DOI 10.1007/978-1-4419-1528-3_9; Klatt CG, 2011, ISME J, V5, P1262, DOI 10.1038/ismej.2011.73; Kobayashi M, 1996, J PLANT RES, V109, P223, DOI 10.1007/BF02344549; Kobayashi M, 2000, PHOTOSYNTH RES, V63, P269, DOI 10.1023/A:1006480629059; Larson CR, 2011, PHOTOSYNTH RES, V107, P139, DOI 10.1007/s11120-010-9604-2; Li H, 2009, ARCH MICROBIOL, V191, P853, DOI 10.1007/s00203-009-0514-7; Liu ZF, 2011, ISME J, V5, P1279, DOI 10.1038/ismej.2011.37; Madigan MT, 2001, BERGEYS MANUAL SYSTE, P625, DOI [DOI 10.1021/JP809094Y, 10.1021/jp809094y]; Maresca JA, 2008, J BACTERIOL, V190, P6384, DOI 10.1128/JB.00758-08; Maresca JA, 2008, PHOTOSYNTH RES, V97, P121, DOI 10.1007/s11120-008-9312-3; Maresca JA, 2007, P NATL ACAD SCI USA, V104, P11784, DOI 10.1073/pnas.0702984104; Mattick JS, 1996, GENE, V179, P147, DOI 10.1016/S0378-1119(96)00441-6; Noy D, 1998, J AM CHEM SOC, V120, P3684, DOI 10.1021/ja970875m; Oh-oka H, 2007, PHOTOCHEM PHOTOBIOL, V83, P177, DOI 10.1562/2006-03-29-IR-860; OhOka H, 1997, BIOCHEMISTRY-US, V36, P9267, DOI 10.1021/bi9701787; OHOKA H, 1995, FEBS LETT, V365, P30, DOI 10.1016/0014-5793(95)00433-A; OHOKA H, 1995, BIOCHEMISTRY-US, V34, P13091, DOI 10.1021/bi00040a021; Olson J M, 1976, Brookhaven Symp Biol, P238; Olson JM, 2004, PHOTOSYNTH RES, V80, P181, DOI 10.1023/B:PRES.0000030428.36950.43; OLSON JM, 1973, BIOCHIM BIOPHYS ACTA, V292, P206, DOI 10.1016/0005-2728(73)90265-X; Overmann J, 2001, BERGEYS MANUAL SYSTE, V1, P601; Pedersen MO, 2010, PHOTOSYNTH RES, V104, P233, DOI 10.1007/s11120-009-9519-y; Permentier HP, 2000, PHOTOSYNTH RES, V64, P27, DOI 10.1023/A:1026515027824; Polivka T, 2007, ARCH BIOCHEM BIOPHYS, V458, P111, DOI 10.1016/j.abb.2006.10.006; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Romberger SP, 2010, PHOTOSYNTH RES, V104, P293, DOI 10.1007/s11120-010-9558-4; Sakurai H, 1996, PHOTOCHEM PHOTOBIOL, V64, P5, DOI 10.1111/j.1751-1097.1996.tb02414.x; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Takaichi S, 1999, PLANT CELL PHYSIOL, V40, P691, DOI 10.1093/oxfordjournals.pcp.a029594; Tsukatani Y, 2006, FEBS LETT, V580, P2191, DOI 10.1016/j.febslet.2006.03.016; Tsukatani Y, 2004, J BIOL CHEM, V279, P51122, DOI 10.1074/jbc.M410432200; Tsukatani Y, 2010, PHOTOSYNTH RES, V104, P201, DOI 10.1007/s11120-009-9517-0; Vassilieva EV, 2001, BIOCHEMISTRY-US, V40, P464, DOI 10.1021/bi001917d; Wakao N, 1996, PLANT CELL PHYSIOL, V37, P889, DOI 10.1093/oxfordjournals.pcp.a029029; Wen JZ, 2011, BBA-BIOENERGETICS, V1807, P157, DOI 10.1016/j.bbabio.2010.09.008; Wen JZ, 2009, P NATL ACAD SCI USA, V106, P6134, DOI 10.1073/pnas.0901691106	60	31	31	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5720	5732		10.1074/jbc.M111.323329	http://dx.doi.org/10.1074/jbc.M111.323329			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22184116	Green Published, hybrid			2022-12-25	WOS:000300638000048
J	Hou, ZJ; Desmoulin, SK; Etnyre, E; Olive, M; Hsiung, B; Cherian, C; Wloszczynski, PA; Moin, K; Matherly, LH				Hou, Zhanjun; Desmoulin, Sita Kugel; Etnyre, Erika; Olive, Mary; Hsiung, Benjamin; Cherian, Christina; Wloszczynski, Patrick A.; Moin, Kamiar; Matherly, Larry H.			Identification and Functional Impact of Homo-oligomers of the Human Proton-coupled Folate Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-BINDING DOMAIN; OF-FUNCTION MUTATION; HUMAN SOLID TUMORS; THIENOYL ANTIFOLATE; PURINE BIOSYNTHESIS; ANTITUMOR-ACTIVITY; GENE PCFT-SLC46A1; PHASE-III; CARRIER; MEMBRANE	The proton-coupled folate transporter (PCFT; SLC46A1) is a proton-folate symporter that is abundantly expressed in solid tumors and normal tissues, such as duodenum. The acidic pH optimum for PCFT is relevant to intestinal absorption of folates and could afford a means of selectively targeting tumors with novel cytotoxic antifolates. PCFT is a member of the major facilitator superfamily of transporters. Because major facilitator superfamily members exist as homo-oligomers, we tested this for PCFT because such structures could be significant to PCFT mechanism and regulation. By transiently expressing PCFT in reduced folate carrier-and PCFT-null HeLa (R1-11) cells and chemical cross-linking with 1,1-methanediyl bismethanethiosulfonate and Western blotting, PCFT species with molecular masses approximating those of the PCFT dimer and higher order oligomers were detected. Blue native polyacrylamide gel electrophoresis identified PCFT dimer, trimer, and tetramer forms. PCFT monomers with hemagglutinin and His(10) epitope tags were co-expressed in R1-11 cells, solubilized, and bound to nickel affinity columns, establishing their physical associations. Co-expressing YPet and ECFP*-tagged PCFT monomers enabled transport and fluorescence resonance energy transfer in plasma membranes of R1-11 cells. Combined wild-type (WT) and inactive mutant P425R PCFTs were targeted to the cell surface by surface biotinylation/Western blots and confocal microscopy and functionally exhibited a "dominant-positive" phenotype, implying positive cooperativity between PCFT monomers and functional rescue of mutant by WT PCFT. Our results demonstrate the existence of PCFT homo-oligomers and imply their functional and regulatory impact. Better understanding of these higher order PCFT structures may lead to therapeutic applications related to folate uptake in hereditary folate malabsorption, and delivery of PCFT-targeted chemotherapy drugs for cancer.	[Hou, Zhanjun; Etnyre, Erika; Hsiung, Benjamin; Cherian, Christina; Wloszczynski, Patrick A.; Matherly, Larry H.] Wayne State Univ, Sch Med, Dev Therapeut Program, Barbara Ann Karmanos Canc Inst, Detroit, MI 48201 USA; [Desmoulin, Sita Kugel; Matherly, Larry H.] Wayne State Univ, Sch Med, Canc Biol Grad Program, Dept Oncol, Detroit, MI 48201 USA; [Moin, Kamiar; Matherly, Larry H.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Wayne State University	Hou, ZJ (corresponding author), 110 E Warren Ave, Detroit, MI 48201 USA.	houz@karmanos.org; matherly@karmanos.org	/S-1117-2019		National Institutes of Health (NIH), NCI [R01 CA53535]; NIH Center [P30CA22453]; Perinatology Research Branch of NICHD, NIH, Wayne State University; Canadian Institutes of Health Research; NATIONAL CANCER INSTITUTE [R01CA053535, P30CA022453] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Perinatology Research Branch of NICHD, NIH, Wayne State University; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health (NIH), NCI, Grant R01 CA53535. The Microscopy, Imaging and Cytometry Resources Core is supported, in part, by NIH Center Grant P30CA22453 (to the Barbara Ann Karmanos Cancer Institute) and the Perinatology Research Branch of NICHD, NIH, Wayne State University.; Supported by a Doctoral Research Award from the Canadian Institutes of Health Research.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Atabay B, 2010, PEDIATR HEMAT ONCOL, V27, P614, DOI 10.3109/08880018.2010.481705; Bamber L, 2007, P NATL ACAD SCI USA, V104, P10830, DOI 10.1073/pnas.0703969104; Bisetto Elena, 2007, Ital J Biochem, V56, P254; Borzutzky A, 2009, CLIN IMMUNOL, V133, P287, DOI 10.1016/j.clim.2009.08.006; Ciuleanu T, 2009, LANCET, V374, P1432, DOI 10.1016/S0140-6736(09)61497-5; Dahl NK, 2003, J BIOL CHEM, V278, P44949, DOI 10.1074/jbc.M308660200; Desmoulin SK, 2011, MOL PHARMACOL, V80, P1096, DOI 10.1124/mol.111.073833; Desmoulin SK, 2010, MOL PHARMACOL, V78, P577, DOI 10.1124/mol.110.065896; Duan Peng, 2011, Int J Biochem Mol Biol, V2, P1; Fleming JC, 1999, NAT GENET, V22, P305, DOI 10.1038/10379; Hanna N, 2004, J CLIN ONCOL, V22, P1589, DOI 10.1200/JCO.2004.08.163; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; Heuberger EHML, 2002, J MOL BIOL, V317, P591, DOI 10.1006/jmbi.2002.5416; HICKMAN RK, 1988, J BACTERIOL, V170, P1715, DOI 10.1128/jb.170.4.1715-1720.1988; Hou ZJ, 2010, J BIOL CHEM, V285, P4732, DOI 10.1074/jbc.M109.086033; Hou ZJ, 2009, J BIOL CHEM, V284, P3285, DOI 10.1074/jbc.M807206200; Hou ZJ, 2005, J BIOL CHEM, V280, P36206, DOI 10.1074/jbc.M507295200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lasry I, 2008, BLOOD, V112, P2055, DOI 10.1182/blood-2008-04-150276; Lasry I, 2009, BIOCHEM BIOPH RES CO, V386, P426, DOI 10.1016/j.bbrc.2009.06.007; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; Mahadeo K, 2010, AM J PHYSIOL-CELL PH, V299, pC1153, DOI 10.1152/ajpcell.00113.2010; Mahadeo KM, 2011, J PEDIATR-US, V159, P623, DOI 10.1016/j.jpeds.2011.03.005; Matherly LH, 2007, CANCER METAST REV, V26, P111, DOI 10.1007/s10555-007-9046-2; MATHERLY LH, 1991, CANCER RES, V51, P3420; Meyer E, 2010, MOL GENET METAB, V99, P325, DOI 10.1016/j.ymgme.2009.11.004; Min SH, 2008, J PEDIATR-US, V153, P435, DOI 10.1016/j.jpeds.2008.04.009; Nakai Y, 2007, J PHARMACOL EXP THER, V322, P469, DOI 10.1124/jpet.107.122606; Ohashi T, 2007, PROTEIN SCI, V16, P1429, DOI 10.1110/ps.072845607; Payton SG, 2007, BBA-GENE STRUCT EXPR, V1769, P131, DOI 10.1016/j.bbaexp.2006.12.006; Polgar O, 2010, BIOCHEMISTRY-US, V49, P2235, DOI 10.1021/bi902085q; Qiu A, 2007, AM J PHYSIOL-CELL PH, V293, pC1669, DOI 10.1152/ajpcell.00202.2007; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Raghunand N, 1999, BIOCHEM PHARMACOL, V57, P309, DOI 10.1016/S0006-2952(98)00306-2; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shin DS, 2011, MOL GENET METAB, V103, P33, DOI 10.1016/j.ymgme.2011.01.008; Shin DS, 2010, BLOOD, V116, P5162, DOI 10.1182/blood-2010-06-291237; Stokstad E. L. R., 1990, HIST PERSPECTIVE KEY, P1; Subramanian VS, 2008, AM J PHYSIOL-CELL PH, V294, pC233, DOI 10.1152/ajpcell.00468.2007; SWAMY M, 2006, SCI STKE; Taylor AM, 2001, BIOCHEM J, V359, P661, DOI 10.1042/0264-6021:3590661; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Unal ES, 2009, AM J PHYSIOL-CELL PH, V297, pC66, DOI 10.1152/ajpcell.00096.2009; Unal ES, 2009, J BIOL CHEM, V284, P17846, DOI 10.1074/jbc.M109.008060; Unal ES, 2008, BBA-BIOMEMBRANES, V1778, P1407, DOI 10.1016/j.bbamem.2008.03.009; Veenhoff LM, 2001, EMBO J, V20, P3056, DOI 10.1093/emboj/20.12.3056; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Wang L, 2011, J MED CHEM, V54, P7150, DOI 10.1021/jm200739e; Wang L, 2010, J MED CHEM, V53, P1306, DOI 10.1021/jm9015729; Witt TL, 2004, J BIOL CHEM, V279, P46755, DOI 10.1074/jbc.M408696200; Wouters FS, 2001, TRENDS CELL BIOL, V11, P203, DOI 10.1016/S0962-8924(01)01982-1; Yerushalmi H, 1996, J BIOL CHEM, V271, P31044, DOI 10.1074/jbc.271.49.31044; Yin CC, 2000, MOL MICROBIOL, V38, P482, DOI 10.1046/j.1365-2958.2000.02149.x; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhao RB, 2004, CLIN CANCER RES, V10, P718, DOI 10.1158/1078-0432.CCR-1066-03; Zhao RB, 2008, MOL PHARMACOL, V74, P854, DOI 10.1124/mol.108.045443; Zhao R, 2007, BLOOD, V110, P1147, DOI 10.1182/blood-2007-02-077099; Zhao RB, 2007, CANCER METAST REV, V26, P129, DOI 10.1007/s10555-007-9047-1; Zhao RB, 2010, BIOCHEMISTRY-US, V49, P2925, DOI 10.1021/bi9021439; Zhao RB, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000969; ZOTTOLA RJ, 1995, BIOCHEMISTRY-US, V34, P9734, DOI 10.1021/bi00030a011	63	29	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4982	4995		10.1074/jbc.M111.306860	http://dx.doi.org/10.1074/jbc.M111.306860			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22179615	hybrid, Green Published			2022-12-25	WOS:000300608500058
J	Min, J; Choi, ES; Hwang, K; Kim, J; Sampath, S; Venkitaraman, AR; Lee, H				Min, Jaewon; Choi, Eun Shik; Hwang, Kwangwoo; Kim, Jimi; Sampath, Srihari; Venkitaraman, Ashok R.; Lee, Hyunsook			The Breast Cancer Susceptibility Gene BRCA2 Is Required for the Maintenance of Telomere Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; QUADRUPLEX DNA; HOMOLOGOUS RECOMBINATION; SACCHAROMYCES-CEREVISIAE; DYSFUNCTIONAL TELOMERES; MAMMALIAN TELOMERES; REPLICATION FORKS; GENOMIC STABILITY; FRAGILE SITES; HUMAN-CELLS	Inactivating mutations in the breast cancer susceptibility gene BRCA2 cause gross chromosomal rearrangements. Chromosome structural instability in the absence of BRCA2 is thought to result from defective homology-directed DNA repair. Here, we show that BRCA2 links the fidelity of telomere maintenance with genetic integrity. Absence of BRCA2 resulted in signs of dysfunctional telomeres, such as telomere shortening, erosions, and end fusions in proliferating mouse fibroblasts. BRCA2 localized to the telomeres in S phase in an ATR-dependent manner, and its absence resulted in the accumulation of common fragile sites, particularly at the G-rich lagging strand, and increased the telomere sister chromatid exchange in unchallenged cells. The incidence of common fragile sites and telomere sister chromatid exchange increased markedly after treatment with replication inhibitors. Congruently, telomere-induced foci were frequently observed in the absence of Brca2, denoting activation of the DNA damage response and abnormal chromosome end joining. These telomere end fusions constituted a significant portion of chromosome aberrations in Brca2-deficient cells. Our results suggest that BRCA2 is required for telomere homeostasis and may be particularly important for the replication of G-rich telomeric lagging strands.	[Min, Jaewon; Choi, Eun Shik; Hwang, Kwangwoo; Kim, Jimi; Lee, Hyunsook] Seoul Natl Univ, Dept Biol Sci, Seoul 151742, South Korea; [Min, Jaewon; Choi, Eun Shik; Hwang, Kwangwoo; Kim, Jimi; Lee, Hyunsook] Seoul Natl Univ, Inst Mol Biol & Genet, Seoul 151742, South Korea; [Sampath, Srihari; Venkitaraman, Ashok R.] Univ Cambridge, Hutchison Med Res Council, Med Res Council, Canc Cell Unit,Res Ctr, Cambridge CB2 0XZ, England	Seoul National University (SNU); Seoul National University (SNU); UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge	Lee, H (corresponding author), Seoul Natl Univ, Dept Biol Sci, 599 Gwanak Ro, Seoul 151742, South Korea.	HL212@snu.ac.kr	Kim, Jimi/AAL-8563-2021	Lee, Hyunsook/0000-0002-2251-5019; Kim, Jimi/0000-0002-6764-9934; Choi, Eun Shik/0000-0002-2306-2103	Basic Science Research Program [2011-0018630]; National Research Foundation of Korea [2009-0093927, 2010-0026104]; Research Center for Functional Cellulomics, Seoul National University (Seoul, Korea) [2005-0048590]; MRC [G0600332, G0700651, MC_U105359877, G1001521] Funding Source: UKRI; Medical Research Council [MC_U105359877, G1001521, G0600332, G0700651] Funding Source: researchfish	Basic Science Research Program; National Research Foundation of Korea(National Research Foundation of Korea); Research Center for Functional Cellulomics, Seoul National University (Seoul, Korea); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Basic Science Research Program Grant 2011-0018630 and National Research Foundation of Korea Grants 2009-0093927 and 2010-0026104.; HeLa_CFLAP_BRCA2 was a gift from M. Petronczki (Claire Hall Laboratories, London, United Kingdom). We are grateful to Dr. Titia de Lange (The Rockefeller University, New York) for providing telomere DNA constructs. Imaging and flow cytometric analyses were supported by Grant 2005-0048590 from the Research Center for Functional Cellulomics, Seoul National University (Seoul, Korea).	Alao JP, 2009, RADIAT ONCOL, V4, DOI 10.1186/1748-717X-4-51; Badie S, 2010, NAT STRUCT MOL BIOL, V17, P1461, DOI 10.1038/nsmb.1943; Baur JA, 2001, SCIENCE, V292, P2075, DOI 10.1126/science.1062329; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Cesare AJ, 2010, NAT REV GENET, V11, P319, DOI 10.1038/nrg2763; Choi E, 2009, EMBO J, V28, P2077, DOI 10.1038/emboj.2009.123; Cimino-Reale G, 2003, J BIOL CHEM, V278, P2136, DOI 10.1074/jbc.M208939200; Cimino-Reale G, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.7.e35; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [10.1038/nature02118, DOI 10.1038/NATURE02118]; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dimitrova DS, 2000, NAT CELL BIOL, V2, P686, DOI 10.1038/35036309; Durkin SG, 2008, P NATL ACAD SCI USA, V105, P246, DOI 10.1073/pnas.0708097105; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; Gohler T, 2011, J CELL BIOL, V192, P219, DOI 10.1083/jcb.201008076; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Hackett JA, 2002, ONCOGENE, V21, P619, DOI 10.1038/sj.onc.1205061; Hashimoto Y, 2010, NAT STRUCT MOL BIOL, V17, P1305, DOI 10.1038/nsmb.1927; Hemann MT, 1999, NUCLEIC ACIDS RES, V27, P3964, DOI 10.1093/nar/27.20.3964; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Ijpma AS, 2003, MOL BIOL CELL, V14, P987, DOI 10.1091/mbc.02-04-0057; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Lekomtsev S, 2010, J CELL SCI, V123, P1395, DOI 10.1242/jcs.068015; Liu QH, 2000, GENE DEV, V14, P1448; Lomonosov M, 2003, GENE DEV, V17, P3017, DOI 10.1101/gad.279003; Londono-Vallejo JA, 2004, CANCER RES, V64, P2324, DOI 10.1158/0008-5472.CAN-03-4035; Longhese MP, 2008, GENE DEV, V22, P125, DOI 10.1101/gad.1626908; Maizels N, 2008, CURR BIOL, V18, pR613, DOI 10.1016/j.cub.2008.06.011; McGowan CH, 2004, CURR OPIN CELL BIOL, V16, P629, DOI 10.1016/j.ceb.2004.09.005; Melchionna R, 2000, NAT CELL BIOL, V2, P762, DOI 10.1038/35036406; Morrish TA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000357; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Opresko PL, 2005, J BIOL CHEM, V280, P32069, DOI 10.1074/jbc.M505211200; Paeschke K, 2011, CELL, V145, P678, DOI 10.1016/j.cell.2011.04.015; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; Pellegrini L, 2004, TRENDS BIOCHEM SCI, V29, P310, DOI 10.1016/j.tibs.2004.04.009; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Poon Steven S S, 2001, Curr Protoc Cell Biol, VChapter 18, DOI 10.1002/0471143030.cb1804s12; Rizzo A, 2009, NUCLEIC ACIDS RES, V37, P5353, DOI 10.1093/nar/gkp582; ROSCHE WA, 1995, J BACTERIOL, V177, P4385, DOI 10.1128/jb.177.15.4385-4391.1995; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Schwartz M, 2005, GENE DEV, V19, P2715, DOI 10.1101/gad.340905; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Shiloh Y, 2001, BIOCHEM SOC T, V29, P661, DOI 10.1042/0300-5127:0290661; Skoulidis F, 2010, CANCER CELL, V18, P499, DOI 10.1016/j.ccr.2010.10.015; SMITH FW, 1992, NATURE, V356, P164, DOI 10.1038/356164a0; Stewart SA, 2003, NAT GENET, V33, P492, DOI 10.1038/ng1127; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; TRINH TQ, 1991, NATURE, V352, P544, DOI 10.1038/352544a0; Venkitaraman AR, 2004, NAT REV CANCER, V4, P266, DOI 10.1038/nrc1321; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Venkitaraman AR, 2009, ANNU REV PATHOL-MECH, V4, P461, DOI 10.1146/annurev.pathol.3.121806.151422; Verdun RE, 2007, NATURE, V447, P924, DOI 10.1038/nature05976; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Wang YS, 2005, P NATL ACAD SCI USA, V102, P10256, DOI 10.1073/pnas.0504635102; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Williams E. S., 2009, COLD SPRING HARB PRO; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Wu X, 2001, NUCLEIC ACIDS RES, V29, P1765, DOI 10.1093/nar/29.8.1765; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07; Yang Q, 2005, MOL CELL BIOL, V25, P1070, DOI 10.1128/MCB.25.3.1070-1080.2005; Yang XH, 2008, GENE DEV, V22, P1147, DOI 10.1101/gad.1632808; Yu VPCC, 2000, GENE DEV, V14, P1400; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001	71	32	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					5091	5101		10.1074/jbc.M111.278994	http://dx.doi.org/10.1074/jbc.M111.278994			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22187435	hybrid, Green Published			2022-12-25	WOS:000300608500067
J	Uchida, H; Maruyama, T; Nishikawa-Uchida, S; Oda, H; Miyazaki, K; Yamasaki, A; Yoshimura, Y				Uchida, Hiroshi; Maruyama, Tetsuo; Nishikawa-Uchida, Sayaka; Oda, Hideyuki; Miyazaki, Kaoru; Yamasaki, Akiko; Yoshimura, Yasunori			Studies Using an in Vitro Model Show Evidence of Involvement of Epithelial-Mesenchymal Transition of Human Endometrial Epithelial Cells in Human Embryo Implantation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOCARCINOMA CELLS; UP-REGULATION; GLYCODELIN; APOPTOSIS; ADHESION; DIFFERENTIATION; TROPHOBLAST; EXPRESSION; MIGRATION; CADHERINS	Human embryo implantation is a critical multistep process consisting of embryo apposition/adhesion, followed by penetration and invasion. Through embryo penetration, the endometrial epithelial cell barrier is disrupted and remodeled by an unknown mechanism. We have previously developed an in vitro model for human embryo implantation employing the human choriocarcinoma cell line JAR and the human endometrial adenocarcinoma cell line Ishikawa. Using this model we have shown that stimulation with ovarian steroid hormones (17 beta-estradiol and progesterone, E2P4) and suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, enhances the attachment and adhesion of JAR spheroids to Ishikawa. In the present study we showed that the attachment and adhesion of JAR spheroids and treatment with E2P4 or SAHA individually induce the epithelial-mesenchymal transition (EMT) in Ishikawa cells. This was evident by up-regulation of N-cadherin and vimentin, a mesenchymal cell marker, and concomitant down-regulation of E-cadherin in Ishikawa cells. Stimulation with E2P4 or SAHA accelerated Ishikawa cell motility, increased JAR spheroid outgrowth, and enhanced the unique redistribution of N-cadherin, which was most prominent in proximity to the adhered spheroids. Moreover, an N-cadherin functional blocking antibody attenuated all events but not JAR spheroid adhesion. These results collectively provide evidence suggesting that E2P4- and implanting embryo-induced EMT of endometrial epithelial cells may play a pivotal role in the subsequent processes of human embryo implantation with functional control of N-cadherin.	[Uchida, Hiroshi; Maruyama, Tetsuo; Nishikawa-Uchida, Sayaka; Oda, Hideyuki; Miyazaki, Kaoru; Yamasaki, Akiko; Yoshimura, Yasunori] Keio Univ, Sch Med, Dept Obstet & Gynecol, Shinjuku Ku, Tokyo 1608582, Japan	Keio University	Uchida, H (corresponding author), Keio Univ, Sch Med, Dept Obstet & Gynecol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	uchida@a5.keio.jp			Japan Society for the Promotion of Science [21592108]; Kanzawa Medical Research Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kanzawa Medical Research Foundation(Kanzawa Medical Research Foundation)	This work was supported in part by Grant-in-aid for Scientific Research C 21592108 (to H. U.) from the Japan Society for the Promotion of Science and by grants from the Kanzawa Medical Research Foundation (to H. U.).	Achache H, 2006, HUM REPROD UPDATE, V12, P731, DOI 10.1093/humupd/dml004; Anastasiadis PZ, 2001, CURR OPIN CELL BIOL, V13, P604, DOI 10.1016/S0955-0674(00)00258-1; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Galan A, 2000, BIOL REPROD, V63, P430, DOI 10.1093/biolreprod/63.2.430; Grewal S, 2008, P NATL ACAD SCI USA, V105, P16189, DOI 10.1073/pnas.0806219105; Hannan NJ, 2010, BIOL REPROD, V82, P235, DOI 10.1095/biolreprod.109.077800; Hay ED, 1995, ACTA ANAT, V154, P8; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; Hohn HP, 2000, MOL REPROD DEV, V57, P135; Kamijo T, 1998, MOL HUM REPROD, V4, P990, DOI 10.1093/molehr/4.10.990; Kao LC, 2002, ENDOCRINOLOGY, V143, P2119, DOI 10.1210/en.143.6.2119; Li HY, 2003, BIOL REPROD, V69, P1515, DOI 10.1095/biolreprod.103.015669; Nishida Masato, 2002, Hum Cell, V15, P104, DOI 10.1111/j.1749-0774.2002.tb00105.x; Norwitz ER, 2001, NEW ENGL J MED, V345, P1400, DOI 10.1056/NEJMra000763; Simon C, 2001, ANN NY ACAD SCI, V943, P1; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Uchida H, 2005, ENDOCRINOLOGY, V146, P5365, DOI 10.1210/en.2005-0359; Uchida H, 2007, HUM REPROD, V22, P2615, DOI 10.1093/humrep/dem263; Uchida H, 2007, ENDOCRINOLOGY, V148, P896, DOI 10.1210/en.2006-0896; VANDERLINDEN PJQ, 1995, FERTIL STERIL, V63, P1210, DOI 10.1016/S0015-0282(16)57599-2; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; Wheelock MJ, 2003, CURR OPIN CELL BIOL, V15, P509, DOI 10.1016/S0955-0674(03)00101-7	23	60	64	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4441	4450		10.1074/jbc.M111.286138	http://dx.doi.org/10.1074/jbc.M111.286138			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22174415	Green Published, hybrid			2022-12-25	WOS:000300608500008
J	Hendriksma, HP; Hartel, S; Steffan-Dewenter, I				Hendriksma, Harmen P.; Haertel, Stephan; Steffan-Dewenter, Ingolf			Testing Pollen of Single and Stacked Insect-Resistant Bt-Maize on In vitro Reared Honey Bee Larvae	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS; APIS-MELLIFERA; RISK-ASSESSMENT; TRANSGENE PRODUCTS; WORKER LARVAE; CRY1AB; CORN; INGESTION; TOXINS; IMPACT	The ecologically and economic important honey bee (Apis mellifera) is a key non-target arthropod species in environmental risk assessment (ERA) of genetically modified (GM) crops. Honey bee larvae are directly exposed to transgenic products by the consumption of GM pollen. But most ERA studies only consider responses of adult bees, although Bt-proteins primarily affect the larval phases of target organisms. We adopted an in vitro larvae rearing system, to assess lethal and sublethal effects of Bt-pollen consumption in a standardized eco-toxicological bioassay. The effects of pollen from two Bt-maize cultivars, one expressing a single and the other a total of three Bt-proteins, on the survival and prepupae weight of honey bee larvae were analyzed. The control treatments included pollen from three non-transgenic maize varieties and of Heliconia rostrata. Three days old larvae were fed the realistic exposure dose of 2 mg pollen within the semi-artificial diet. The larvae were monitored over 120 h, until the prepupal stage, where larvae terminate feeding and growing. Neither single nor stacked Bt-maize pollen showed an adverse effect on larval survival and the prepupal weight. In contrast, feeding of H. rostrata pollen caused significant toxic effects. The results of this study indicate that pollen of the tested Bt-varieties does not harm the development of in vitro reared A. mellifera larvae. To sustain the ecosystem service of pollination, Bt-impact on A. mellifera should always be a crucial part of regulatory biosafety assessments. We suggest that our approach of feeding GM pollen on in vitro reared honey bee larvae is well suited of becoming a standard bioassay in regulatory risk assessments schemes of GM crops.	[Hendriksma, Harmen P.; Haertel, Stephan; Steffan-Dewenter, Ingolf] Univ Wurzburg, Bioctr, Dept Anim Ecol & Trop Biol, Wurzburg, Germany	University of Wurzburg	Hendriksma, HP (corresponding author), Univ Wurzburg, Bioctr, Dept Anim Ecol & Trop Biol, Wurzburg, Germany.	harmen-pieter.hendriksma@uni-wuerzburg.de	Hendriksma, Harmen/AAB-9020-2019	Hendriksma, Harmen/0000-0002-3153-0392; Steffan-Dewenter, Ingolf/0000-0003-1359-3944	The Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung (BMBF) [0315215E]; German Research Foundation (DFG); University of Wuerzburg	The Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This work was funded by The Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung (BMBF), project 0315215E). The German Research Foundation (DFG) and the University of Wuerzburg funded the Open Access publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen ME, 2004, ENVIRON TOXICOL PHAR, V16, P1, DOI 10.1016/j.etap.2003.10.004; [Anonymous], BIOGEOGRAPHY TAXONOM, DOI DOI 10.1007/978-3-642-72649-1; Arpaia S., 1996, Journal of Genetics and Breeding, V50, P315; AUERBACH MJ, 1981, ECOL MONOGR, V51, P63, DOI 10.2307/2937307; Aupinel P, 2007, PEST MANAG SCI, V63, P1090, DOI 10.1002/ps.1446; Babendreier D, 2005, APIDOLOGIE, V36, P585, DOI 10.1051/apido:2005049; Babendreier D, 2004, APIDOLOGIE, V35, P293, DOI 10.1051/apido:2004016; Babendreier D, 2008, ENTOMOL EXP APPL, V126, P148, DOI 10.1111/j.1570-7458.2007.00652.x; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; Brodschneider R, 2009, APIDOLOGIE, V40, P441, DOI 10.1051/apido/2009006; Brodsgaard HF, 2003, APIDOLOGIE, V34, P139, DOI 10.1051/apido:2003003; Clark PL, 2006, J ECON ENTOMOL, V99, P722, DOI 10.1603/0022-0493-99.3.722; de Maagd RA, 2001, TRENDS GENET, V17, P193, DOI 10.1016/S0168-9525(01)02237-5; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Dively GP, 2005, ENVIRON ENTOMOL, V34, P1267, DOI 10.1603/0046-225X(2005)034[1267:IOTVCL]2.0.CO;2; Duan JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001415; Felke M, 2005, BFN SKRIPTEN, V157, p[1, 4, 5, 8, 9, 10]; Fox J., 2002, R S PLUS COMPANION A; FREE J. B., 1955, INSECTES SOCIAUX, V2, P195, DOI 10.1007/BF02224381; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Glare T.R., 2000, BACILLUS THURINGIENS; Han P, 2010, ECOTOXICOLOGY, V19, P1452, DOI 10.1007/s10646-010-0530-z; Hanley AV, 2003, J APICULT RES, V42, P77, DOI 10.1080/00218839.2003.11101097; HAYDAK MH, 1970, ANNU REV ENTOMOL, V15, P143, DOI 10.1146/annurev.en.15.010170.001043; Hendriksma HP, 2011, METHODS ECOL EVOL, V2, P509, DOI 10.1111/j.2041-210X.2011.00099.x; Hendriksma HP, 2010, J APICULT RES, V49, P215, DOI 10.3896/IBRA.1.49.2.13; HOLM S, 1979, SCAND J STAT, V6, P65; Jung-Hoffmann I., 1966, BIENENFORSCH, V8, P296; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Lee MK, 1996, APPL ENVIRON MICROB, V62, P583, DOI 10.1128/AEM.62.2.583-586.1996; Lima MAP, 2011, J APPL ENTOMOL, V135, P415, DOI 10.1111/j.1439-0418.2010.01573.x; Malone LA, 2009, ENVIRONMENTAL IMPACT OF GENETICALLY MODIFIED CROPS, P199, DOI 10.1079/9781845934095.0199; Malone LA, 2002, APIDOLOGIE, V33, P447, DOI 10.1051/apido:2002030; Malone LA, 2001, APIDOLOGIE, V32, P287, DOI 10.1051/apido:2001130; Malone LA, 2001, APIDOLOGIE, V32, P57, DOI 10.1051/apido:2001111; Meissle M, 2011, PEST MANAG SCI, V67, P807, DOI 10.1002/ps.2117; Miranda M, 2008, GENE DNA SEQUENCE CR; Nguyen HT, 2007, J PLANT DIS PROTECT, V114, P82, DOI 10.1007/BF03356208; PINHEIRO J., 2009, NLME LINEAR NONLINEA; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Ramirez-Romero R, 2005, APIDOLOGIE, V36, P601, DOI 10.1051/apido:2005039; Ramirez-Romero R, 2008, ECOTOX ENVIRON SAFE, V70, P327, DOI 10.1016/j.ecoenv.2007.12.002; Rauschen S, 2009, TRANSGENIC RES, V18, P203, DOI 10.1007/s11248-008-9207-2; Ripley RM, 2004, STAT MED, V23, P825, DOI 10.1002/sim.1655; Romeis J, 2008, NAT BIOTECHNOL, V26, P203, DOI 10.1038/nbt1381; Romeis J, 2011, TRANSGENIC RES, V20, P1, DOI 10.1007/s11248-010-9446-x; Sagili RR, 1995, J INSECT PHYSL, V51, P953; Seeley T.D., 1985, HONEY BEE ECOLOGY; Sharma P, 2010, LETT APPL MICROBIOL, V51, P42, DOI 10.1111/j.1472-765X.2010.02856.x; SIMPSON J, 1955, Q J MICROSC SCI, V96, P117; Therneau T, 2009, SURVIVAL SURVIVAL AN, V2.35.8; Vaughn T, 2005, CROP SCI, V45, P931, DOI 10.2135/cropsci2004.0304; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	53	41	45	0	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2011	6	12							e28174	10.1371/journal.pone.0028174	http://dx.doi.org/10.1371/journal.pone.0028174			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	870JD	22194811	gold, Green Published, Green Submitted			2022-12-25	WOS:000298664400002
J	Sero, JE; Thodeti, CK; Mammoto, A; Bakal, C; Thomas, S; Ingber, DE				Sero, Julia E.; Thodeti, Charles K.; Mammoto, Akiko; Bakal, Chris; Thomas, Sheila; Ingber, Donald E.			Paxillin Mediates Sensing of Physical Cues and Regulates Directional Cell Motility by Controlling Lamellipodia Positioning	PLOS ONE			English	Article							FOCAL ADHESION KINASE; PROTEIN PAXILLIN; TYROSINE PHOSPHORYLATION; CONTACT GUIDANCE; RAC ACTIVATION; MELANOMA-CELLS; LEADING-EDGE; LUNG-CANCER; LD4 MOTIF; MIGRATION	Physical interactions between cells and the extracellular matrix (ECM) guide directional migration by spatially controlling where cells form focal adhesions (FAs), which in turn regulate the extension of motile processes. Here we show that physical control of directional migration requires the FA scaffold protein paxillin. Using single-cell sized ECM islands to constrain cell shape, we found that fibroblasts cultured on square islands preferentially activated Rac and extended lamellipodia from corner, rather than side regions after 30 min stimulation with PDGF, but that cells lacking paxillin failed to restrict Rac activity to corners and formed small lamellipodia along their entire peripheries. This spatial preference was preceded by non-spatially constrained formation of both dorsal and lateral membrane ruffles from 5-10 min. Expression of paxillin N-terminal (paxN) or C-terminal (paxC) truncation mutants produced opposite, but complementary, effects on lamellipodia formation. Surprisingly, pax-/- and paxN cells also formed more circular dorsal ruffles (CDRs) than pax+ cells, while paxC cells formed fewer CDRs and extended larger lamellipodia even in the absence of PDGF. In a two-dimensional (2D) wound assay, pax-/- cells migrated at similar speeds to controls but lost directional persistence. Directional motility was rescued by expressing full-length paxillin or the N-terminus alone, but paxN cells migrated more slowly. In contrast, pax-/- and paxN cells exhibited increased migration in a three-dimensional (3D) invasion assay, with paxN cells invading Matrigel even in the absence of PDGF. These studies indicate that paxillin integrates physical and chemical motility signals by spatially constraining where cells will form motile processes, and thereby regulates directional migration both in 2D and 3D. These findings also suggest that CDRs may correspond to invasive protrusions that drive cell migration through 3D extracellular matrices.	[Sero, Julia E.; Bakal, Chris] Inst Canc Res, Dynam Cell Syst Team, Div Canc Biol, London SW3 6JB, England; [Sero, Julia E.; Thodeti, Charles K.; Mammoto, Akiko; Ingber, Donald E.] Childrens Hosp, Dept Pathol, Vasc Biol Program, Boston, MA 02115 USA; [Sero, Julia E.; Thodeti, Charles K.; Mammoto, Akiko; Ingber, Donald E.] Childrens Hosp, Dept Surg, Vasc Biol Program, Boston, MA 02115 USA; [Sero, Julia E.; Thodeti, Charles K.; Mammoto, Akiko; Thomas, Sheila; Ingber, Donald E.] Harvard Univ, Sch Med, Boston, MA USA; [Thomas, Sheila] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Ingber, Donald E.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Ingber, Donald E.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard University	Sero, JE (corresponding author), Inst Canc Res, Dynam Cell Syst Team, Div Canc Biol, London SW3 6JB, England.	don.ingber@wyss.harvard.edu	Ingber, Donald E/AAC-5894-2019; Julia, Sero/J-5476-2016	Julia, Sero/0000-0002-0299-9212; Bakal, Chris/0000-0002-0413-6744	National Institutes of Health (NIH) [CA45548]; National Science Foundation; American Cancer Society; American Heart Association; NATIONAL CANCER INSTITUTE [P01CA045548] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); American Cancer Society(American Cancer Society); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	These studies were supported by National Institutes of Health (NIH) Program Project Grant CA45548 (to D. E. I.), a National Science Foundation Graduate Student Research Fellowship (to J.E.S.), American Cancer Society (to S.T.), and American Heart Association (to A.M. and C.K.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; Banyard J, 2000, ONCOGENE, V19, P580, DOI 10.1038/sj.onc.1203338; BIRGE RB, 1993, MOL CELL BIOL, V13, P4648, DOI 10.1128/MCB.13.8.4648; Brock A. L., 2005, Molecular & Cellular Biomechanics, V2, P135; Brown MC, 1996, J CELL BIOL, V135, P1109, DOI 10.1083/jcb.135.4.1109; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Brown MC, 2002, INT J BIOCHEM CELL B, V34, P855, DOI 10.1016/S1357-2725(01)00154-6; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m; Cote JF, 1999, J BIOL CHEM, V274, P20550, DOI 10.1074/jbc.274.29.20550; Eskandarpour M, 2009, INT J CANCER, V124, P16, DOI 10.1002/ijc.23876; Ezzell RM, 1997, EXP CELL RES, V231, P14, DOI 10.1006/excr.1996.3451; Fischer RS, 2009, CURR BIOL, V19, P260, DOI 10.1016/j.cub.2008.12.045; Franco S, 2004, EXP CELL RES, V299, P179, DOI 10.1016/j.yexcr.2004.05.021; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Frank SR, 2006, EMBO J, V25, P1848, DOI 10.1038/sj.emboj.7601092; Friedl P, 1997, CANCER RES, V57, P2061; Galbraith CG, 1998, CURR OPIN CELL BIOL, V10, P566, DOI 10.1016/S0955-0674(98)80030-6; Gray DS, 2003, J BIOMED MATER RES A, V66A, P605, DOI 10.1002/jbm.a.10585; Hagel M, 2002, MOL CELL BIOL, V22, P901, DOI 10.1128/MCB.22.3.901-915.2002; Hartmann A, 2006, BLOOD CELL MOL DIS, V36, P191, DOI 10.1016/j.bcmd.2005.12.033; Herreros L, 2000, J BIOL CHEM, V275, P26436, DOI 10.1074/jbc.M003970200; HILDEBRAND JD, 1995, MOL BIOL CELL, V6, P637, DOI 10.1091/mbc.6.6.637; Ingber D E, 1997, Gravit Space Biol Bull, V10, P49; Jagadeeswaran R, 2008, CANCER RES, V68, P132, DOI 10.1158/0008-5472.CAN-07-1998; Jamieson JS, 2005, J CELL SCI, V118, P5835, DOI 10.1242/jcs.02693; Jiang GY, 2006, BIOPHYS J, V90, P1804, DOI 10.1529/biophysj.105.072462; Jiang XY, 2005, P NATL ACAD SCI USA, V102, P975, DOI 10.1073/pnas.0408954102; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Madan R, 2006, HUM PATHOL, V37, P9, DOI 10.1016/j.humpath.2005.09.024; Mammoto A, 2008, METHOD ENZYMOL, V443, P227, DOI 10.1016/S0076-6879(08)02012-0; Mudera VC, 2000, CELL MOTIL CYTOSKEL, V45, P1, DOI 10.1002/(SICI)1097-0169(200001)45:1<1::AID-CM1>3.0.CO;2-J; Nayal A, 2006, J CELL BIOL, V173, P587, DOI 10.1083/jcb.200509075; Nishiya N, 2005, NAT CELL BIOL, V7, P343, DOI 10.1038/ncb1234; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Novak IL, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.268109; Orth JD, 2006, CANCER RES, V66, P3603, DOI 10.1158/0008-5472.CAN-05-2916; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Parker KK, 2002, FASEB J, V16, DOI 10.1096/fj.02-0038com; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Petroll WM, 2008, DEV DYNAM, V237, P2726, DOI 10.1002/dvdy.21629; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Salgia R, 1999, ONCOGENE, V18, P67, DOI 10.1038/sj.onc.1202273; Sanders MA, 2005, J BIOL CHEM, V280, P23516, DOI 10.1074/jbc.M413165200; Schaller MD, 2001, BIOCHEM J, V360, P57, DOI 10.1042/0264-6021:3600057; Schwartz MA, 2006, CELL, V125, P1223, DOI 10.1016/j.cell.2006.06.015; Short SM, 2007, BREAST J, V13, P130, DOI 10.1111/j.1524-4741.2007.00389.x; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; TACHIBANA K, 1995, J EXP MED, V182, P1089, DOI 10.1084/jem.182.4.1089; Tan JL, 2004, TISSUE ENG, V10, P865, DOI 10.1089/1076327041348365; Tumbarello DA, 2002, FEBS LETT, V513, P114, DOI 10.1016/S0014-5793(01)03244-6; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059; TURNER DC, 1983, DEV BIOL, V95, P497, DOI 10.1016/0012-1606(83)90052-0; Velasco-Velazquez MA, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-8; Wade R, 2002, ONCOGENE, V21, P96, DOI 10.1038/sj.onc.1205013; Wang N, 2001, P NATL ACAD SCI USA, V98, P7765, DOI 10.1073/pnas.141199598; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; West KA, 2001, J CELL BIOL, V154, P161, DOI 10.1083/jcb.200101039; Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335; WojciakStothard B, 1996, EXP CELL RES, V223, P426, DOI 10.1006/excr.1996.0098; Wolf K, 2003, BLOOD, V102, P3262, DOI 10.1182/blood-2002-12-3791; Wolf K, 2006, BRIT J DERMATOL, V154, P11, DOI 10.1111/j.1365-2133.2006.07231.x; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Xia N, 2008, FASEB J, V22, P1649, DOI 10.1096/fj.07-090571; Zamir E, 2001, J CELL SCI, V114, P3583; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000	74	35	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28303	10.1371/journal.pone.0028303	http://dx.doi.org/10.1371/journal.pone.0028303			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194823	Green Published, Green Submitted, gold			2022-12-25	WOS:000298369100029
J	Colles, FM; McCarthy, ND; Layton, R; Maiden, MCJ				Colles, Frances M.; McCarthy, Noel D.; Layton, Ruth; Maiden, Martin C. J.			The Prevalence of Campylobacter amongst a Free-Range Broiler Breeder Flock Was Primarily Affected by Flock Age	PLOS ONE			English	Article							SEQUENCE TYPING SYSTEM; THERMOPHILIC CAMPYLOBACTER; JEJUNI; COLONIZATION; CHICKENS; INFECTION; COLI; SEASONALITY; POPULATIONS; POULTRY	Campylobacter successfully colonizes broiler chickens, but little is known about the longer term natural history of colonization, since most flocks are slaughtered at an immature age. In this study, the prevalence and genetic diversity of Campylobacter colonizing a single free-range broiler breeder flock was investigated over the course of a year. The age of the flock was the most important factor in determining both the prevalence and diversity of Campylobacter over time. There was no correlation with season, temperature, the amount of rain and sunshine, or the dynamics of colonization amongst geographically and temporally matched broiler flocks. The higher prevalence rates coincided with the age at which broiler chickens are typically slaughtered, but then in the absence of bio-security or other intervention methods, and despite changes in flock management, the prevalence fell to significantly lower levels for the remainder of the study. The genetic diversity of Campylobacter increased as the flock aged, implying that genotypes were accumulated within the flock and may persist for a long time. A better understanding of the ecology of Campylobacter within commercial chicken flocks will allow the design of more effective farm-based interventions.	[Colles, Frances M.; McCarthy, Noel D.; Maiden, Martin C. J.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Layton, Ruth] Wytham, Food Anim Initiat, Oxford, England	University of Oxford	Colles, FM (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	frances.colles@zoo.ox.ac.uk	Maiden, Martin C J/C-5055-2014; Maiden, Martin/N-6805-2019; McCarthy, Noel D/K-3314-2012	Maiden, Martin C J/0000-0001-6321-5138; Maiden, Martin/0000-0001-6321-5138; McCarthy, Noel/0000-0003-1113-1017; Colles, Frances/0000-0002-3322-2991	UK Department for Environment, Food and Rural Affairs (DEFRA) [OZ0604]	UK Department for Environment, Food and Rural Affairs (DEFRA)(Department for Environment, Food & Rural Affairs (DEFRA))	This work and the maintenance of the Campylobacter MLST database (http://pubmlst.org/campylobacter/) was funded by the UK Department for Environment, Food and Rural Affairs (DEFRA), Contract Number OZ0604. MCJM is a Welcome Trust Senior Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achen M, 1998, AVIAN DIS, V42, P732, DOI 10.2307/1592708; Allos BM, 2001, CLIN INFECT DIS, V32, P1201, DOI 10.1086/319760; Baker Michael, 2006, N Z Med J, V119, pU2264; Berndtson E, 1996, INT J FOOD MICROBIOL, V32, P35, DOI 10.1016/0168-1605(96)01102-6; Bi P, 2008, J INFECTION, V57, P317, DOI 10.1016/j.jinf.2008.08.004; Cogan TA, 2007, GUT, V56, P1060, DOI 10.1136/gut.2006.114926; Colles FM, 2008, APPL ENVIRON MICROB, V74, P3583, DOI 10.1128/AEM.02491-07; Colles FM, 2009, ENVIRON MICROBIOL, V11, P258, DOI 10.1111/j.1462-2920.2008.01773.x; COLLES FM, 2008, APPL ENV MICROBIOLOG; Colles FM, 2008, ENVIRON MICROBIOL, V10, P2042, DOI 10.1111/j.1462-2920.2008.01623.x; Corry JEL, 2001, J APPL MICROBIOL, V90, p96S, DOI 10.1046/j.1365-2672.2001.01358.x; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Dingle KE, 2002, EMERG INFECT DIS, V8, P949; Frost JA, 2001, J APPL MICROBIOL, V90, p85S, DOI 10.1046/j.1365-2672.2001.01357.x; Gillespie IA, 2002, EMERG INFECT DIS, V8, P937, DOI 10.3201/eid0809.010817; Hald B, 2008, POULTRY SCI, V87, P1428, DOI 10.3382/ps.2007-00301; Heuer OE, 2001, LETT APPL MICROBIOL, V33, P269, DOI 10.1046/j.1472-765X.2001.00994.x; Humphrey T, 2006, BRIT POULTRY SCI, V47, P379, DOI 10.1080/00071660600829084; HUNTER PR, 1990, J CLIN MICROBIOL, V28, P1903, DOI 10.1128/JCM.28.9.1903-1905.1990; Johnsen G, 2006, POULTRY SCI, V85, P2278, DOI 10.1093/ps/85.12.2278; Ketley JM, 1997, MICROBIOL-UK, V143, P5, DOI 10.1099/00221287-143-1-5; Louis VR, 2005, APPL ENVIRON MICROB, V71, P85, DOI 10.1128/AEM.71.1.85-92.2005; Meinersmann RJ, 1997, J CLIN MICROBIOL, V35, P2810, DOI 10.1128/JCM.35.11.2810-2814.1997; Miller WG, 2005, J CLIN MICROBIOL, V43, P2315, DOI 10.1128/JCM.43.5.2315-2329.2005; Newell DG, 2003, APPL ENVIRON MICROB, V69, P4343, DOI 10.1128/AEM.69.8.4343-4351.2003; Ridley AM, 2008, J APPL MICROBIOL, V105, P95, DOI 10.1111/j.1365-2672.2008.03759.x; Sheppard SK, 2010, APPL ENVIRON MICROB, V76, P5269, DOI 10.1128/AEM.00124-10; Van Overbeke I, 2006, AVIAN DIS, V50, P196, DOI 10.1637/7448-093005R.1; Wallace JS, 1997, J APPL MICROBIOL, V82, P219, DOI 10.1111/j.1365-2672.1997.tb03576.x; Whyte P, 2001, POULTRY SCI, V80, P817, DOI 10.1093/ps/80.6.817; Wilson DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000203; Wilson DL, 2010, MICROBIOL-SGM, V156, P2046, DOI 10.1099/mic.0.035717-0	32	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e22825	10.1371/journal.pone.0022825	http://dx.doi.org/10.1371/journal.pone.0022825			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174732	Green Published, Green Submitted, gold			2022-12-25	WOS:000298366600001
J	Guo, W; Wu, SH; Wang, L; Wei, XL; Liu, XY; Wang, J; Lu, ZM; Hollingshead, M; Fang, BL				Guo, Wei; Wu, Shuhong; Wang, Li; Wei, Xiaoli; Liu, Xiaoying; Wang, Ji; Lu, Zhimin; Hollingshead, Melinda; Fang, Bingliang			Antitumor Activity of a Novel Oncrasin Analogue Is Mediated by JNK Activation and STAT3 Inhibition	PLOS ONE			English	Article							RNA-POLYMERASE-II; HUMAN CANCER-CELLS; INDUCED APOPTOSIS; SELICICLIB CYC202; MULTIPLE-MYELOMA; DOWN-REGULATION; SMALL-MOLECULE; R-ROSCOVITINE; P-TEFB; FLAVOPIRIDOL	Background: To optimize the antitumor activity of oncrasin-1, a small molecule identified through synthetic lethality screening on isogenic K-Ras mutant tumor cells, we developed several analogues and determined their antitumor activities. Here we investigated in vitro and in vivo antitumor activity of NSC-743380 (1-[(3-chlorophenyl) methyl]-1H-indole-3-methanol, oncrasin-72), one of most potent analogues of oncrasin-1. Methodology and Principal Findings: In vitro antitumor activity was determined in NCI-60 cancer cell line panel using cell viability assay. In vivo antitumor activity was determined in parallel with NSC-741909 (oncrasin-60) in xenograft tumors established in nude mice from A498, a human renal cancer cell line. Changes in gene expression levels and signaling pathway activities upon treatment with NSC-743380 were analyzed in breast and renal cancer cells by Western blot analysis. Apoptosis was demonstrated by Western blot analysis and flow cytometric analysis. NSC-743380 is highly active against a subset of cancer cell lines derived from human lung, colon, ovary, kidney, and breast cancers. The 50% growth-inhibitory concentration (GI(50)) for eight of the most sensitive cell lines was <= 10 nM. In vivo study showed that NSC-743380 has a better safety profile and greater antitumor activity than NSC-741909. Treatment with NSC-743380 caused complete regression of A498 xenograft tumors in nude mice at the tested doses ranging from 67 mg/kg to 150 mg/kg. Mechanistic characterization revealed that NSC-743380 suppressed the phosphorylation of C-terminal domain of RNA polymerase II, induced JNK activation, inhibited JAK2/STAT3 phosphorylation and suppressed cyclin D1 expression in sensitive human cancer cells. Blocking JNK activation or overexpression of constitutively active STAT3 partially blocked NSC-743380-induced antitumor activity. Conclusions: NSC-743380 induces antitumor activity through modulation of functions in multiple cancer related pathways and could be a potential anticancer agent for some solid tumors.	[Guo, Wei; Wu, Shuhong; Wang, Li; Wei, Xiaoli; Liu, Xiaoying; Wang, Ji; Fang, Bingliang] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA; [Lu, Zhimin] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Hollingshead, Melinda] NCI, Biol Testing Branch, Frederick, MD 21701 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Guo, W (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA.	Bfang@mdanderson.org			National Institutes of Health (NIH) [R01 CA 092481, R01 CA 124951]; Rapid Access to Interventional Development (RAID) Program; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), NIH; University of Texas MD Anderson Cancer Center [CA-016672]; National Cancer Institute, National Institutes of Health [NO1-CO-12400]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA124951] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rapid Access to Interventional Development (RAID) Program; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), NIH; University of Texas MD Anderson Cancer Center; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the National Institutes of Health (NIH) through R01 CA 092481 and R01 CA 124951 to B. Fang, the Rapid Access to Interventional Development (RAID) Program, the Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), NIH, The University of Texas MD Anderson Cancer Center Support Grant CA-016672, Lung Program, Nuclear Magnetic Resonance, DNA Analysis and Flow Cytometry, and Cellular Imaging Core Facility. Additional support was provided with federal funds from the National Cancer Institute, National Institutes of Health, under contract NO1-CO-12400. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumli S, 2008, EMBO J, V27, P1907, DOI 10.1038/emboj.2008.121; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Blaskovich MA, 2003, CANCER RES, V63, P1270; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Chen R, 2005, BLOOD, V106, P2513, DOI 10.1182/blood-2005-04-1678; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Dolma S, 2003, CANCER CELL, V3, P285, DOI 10.1016/S1535-6108(03)00050-3; Fan MY, 2000, J BIOL CHEM, V275, P29980, DOI 10.1074/jbc.M003776200; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Guo W, 2008, CANCER RES, V68, P7403, DOI 10.1158/0008-5472.CAN-08-1449; Guo W, 2009, MOL CANCER THER, V8, P441, DOI 10.1158/1535-7163.MCT-08-0839; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; HOPERT A, 1993, J IMMUNOL METHODS, V164, P91, DOI 10.1016/0022-1759(93)90279-G; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kennedy NJ, 2003, GENE DEV, V17, P629, DOI 10.1101/gad.1062903; Koppikar P, 2010, BLOOD, V115, P2919, DOI 10.1182/blood-2009-04-218842; Koumenis C, 1997, MOL CELL BIOL, V17, P7306, DOI 10.1128/MCB.17.12.7306; Lim CP, 1999, J BIOL CHEM, V274, P31055, DOI 10.1074/jbc.274.43.31055; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; MacCallum DE, 2005, CANCER RES, V65, P5399, DOI 10.1158/0008-5472.CAN-05-0233; MIGONE TS, 1995, SCIENCE, V269, P79, DOI 10.1126/science.7604283; PLOWMAN J, 1988, INVEST NEW DRUG, V6, P147; Raje N, 2005, BLOOD, V106, P1042, DOI 10.1182/blood-2005-01-0320; Sanchez-Perez I, 1998, ONCOGENE, V16, P533, DOI 10.1038/sj.onc.1201578; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Toji LH, 1998, IN VITRO CELL DEV-AN, V34, P356; Torrance CJ, 2001, NAT BIOTECHNOL, V19, P940, DOI 10.1038/nbt1001-940; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Wei XL, 2009, J BIOL CHEM, V284, P16948, DOI 10.1074/jbc.M109.010256; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697; Wittmann S, 2003, CANCER RES, V63, P93; Wu SH, 2011, J MED CHEM, V54, P2668, DOI 10.1021/jm101417n	34	27	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28487	10.1371/journal.pone.0028487	http://dx.doi.org/10.1371/journal.pone.0028487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174819	Green Published, gold, Green Submitted			2022-12-25	WOS:000298366600021
J	Van der Velden, J; Barker, D; Barcham, G; Koumoundouros, E; Snibson, K				Van der Velden, Joanne; Barker, Donna; Barcham, Garry; Koumoundouros, Emmanuel; Snibson, Kenneth			Assessment of Peripheral Airway Function following Chronic Allergen Challenge in a Sheep Model of Asthma	PLOS ONE			English	Article							HOUSE-DUST MITE; COLLATERAL VENTILATION; DISEASE; INFLAMMATION; RESISTANCE; LUNGS; ANTIGEN	Background: There is increasing evidence that the small airways contribute significantly to the pathophysiology of asthma. However, due to the difficulty in accessing distal lung regions in clinical settings, functional changes in the peripheral airways are often overlooked in studies of asthmatic patients. The aim of the current study was to characterize progressive changes in small airway function in sheep repeatedly challenged with house dust mite (HDM) allergen. Methodology/Principal Findings: Four spatially separate lung segments were utilized for HDM challenges. The right apical, right medial, right caudal and left caudal lung segments received 0, 8, 16 and 24 weekly challenges with HDM respectively. A wedged-bronchoscope technique was used to assess changes in peripheral resistance (R(p)) at rest, and in response to specific and non-specific stimuli throughout the trial. Allergen induced inflammatory cell infiltration into bronchoalveolar lavage and increases in R(p) in response to HDM and methacholine were localized to treated lung segments, with no changes observed in adjacent lung segments. The acute response to HDM was variable between sheep, and was significantly correlated to airway responsiveness to methacholine (r(s) = 0.095, P<0.01). There was no correlation between resting Rp and the number of weeks of HDM exposure. Nor was there a correlation between the magnitude of early-phase airway response and the number of HDM-challenges. Conclusions: Our findings indicate that airway responses to allergic and non-allergic stimuli are localized to specific treated areas of the lung. Furthermore, while there was a decline in peripheral airway function with HDM exposure, this decrease was not correlated with the length of allergen challenge.	[Van der Velden, Joanne; Barker, Donna; Barcham, Garry; Koumoundouros, Emmanuel; Snibson, Kenneth] Univ Melbourne, Ctr Anim Biotechnol, Melbourne, Vic, Australia; [Koumoundouros, Emmanuel] Univ Melbourne, Sch Engn, Melbourne, Vic, Australia	University of Melbourne; University of Melbourne	Van der Velden, J (corresponding author), Univ Melbourne, Ctr Anim Biotechnol, Melbourne, Vic, Australia.	ksnibson@unimelb.edu.au	KOUMOUNDOUROS, EMMANUEL/H-5766-2016	KOUMOUNDOUROS, EMMANUEL/0000-0002-6419-329X; Barker, Donna/0000-0003-2005-5239; Snibson, Kenneth/0000-0003-4772-9408	National Health and Medical Research Council (NHMRC) of Australia [566904]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the National Health and Medical Research Council (NHMRC) of Australia (Project no. 566904; http://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM WM, 1983, AM REV RESPIR DIS, V128, P839; Bischof RJ, 2003, CLIN EXP ALLERGY, V33, P367, DOI 10.1046/j.1365-2222.2003.01534.x; BOSSE J, 1987, J ALLERGY CLIN IMMUN, V79, P339, DOI 10.1016/0091-6749(87)90152-7; Corren J, 2008, CURR ALLERGY ASTHM R, V8, P533, DOI 10.1007/s11882-008-0097-4; Goldman MD, 2005, RESP PHYSIOL NEUROBI, V148, P179, DOI 10.1016/j.resp.2005.05.026; Hamid Q, 1997, J ALLERGY CLIN IMMUN, V100, P44, DOI 10.1016/S0091-6749(97)70193-3; HOGG JC, 1969, J CLIN INVEST, V48, P421, DOI 10.1172/JCI105999; KLEEBERGER SR, 1986, J APPL PHYSIOL, V61, P1309, DOI 10.1152/jappl.1986.61.4.1309; Klug B, 1997, EUR RESPIR J, V10, P1599, DOI 10.1183/09031936.97.10071599; Koumoundouros E, 2006, EXP LUNG RES, V32, P321, DOI 10.1080/01902140600916960; Palmans E, 2000, AM J RESP CRIT CARE, V161, P627, DOI 10.1164/ajrccm.161.2.9902094; Scheerlinck JPY, 2008, TRENDS BIOTECHNOL, V26, P259, DOI 10.1016/j.tibtech.2008.02.002; Shaw RJ, 1997, VET IMMUNOL IMMUNOP, V57, P253, DOI 10.1016/S0165-2427(97)00010-X; Shaw RJ, 2002, RESP MED, V96, P67, DOI 10.1053/rmed.2001.1216; Snibson KJ, 2005, CLIN EXP ALLERGY, V35, P146, DOI 10.1111/j.1365-2222.2005.02137.x; TERRY PB, 1978, NEW ENGL J MED, V298, P10, DOI 10.1056/NEJM197801052980103; Tsai LW, 2007, RESPIRATION, V74, P565, DOI 10.1159/000103514; Vanacker NJ, 2002, CLIN EXP ALLERGY, V32, P914, DOI 10.1046/j.1365-2222.2002.01394.x; Wagner EM, 1998, AM J RESP CRIT CARE, V157, P447, DOI 10.1164/ajrccm.157.2.9611043; WAGNER EM, 1990, AM REV RESPIR DIS, V141, P584, DOI 10.1164/ajrccm/141.3.584; Zosky GR, 2007, CLIN EXP ALLERGY, V37, P973, DOI 10.1111/j.1365-2222.2007.02740.x	21	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28740	10.1371/journal.pone.0028740	http://dx.doi.org/10.1371/journal.pone.0028740			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174883	Green Published, gold			2022-12-25	WOS:000298366600033
J	Kamita, SG; Samra, AI; Liu, JY; Cornel, AJ; Hammock, BD				Kamita, Shizuo G.; Samra, Aman I.; Liu, Jun-Yan; Cornel, Anthony J.; Hammock, Bruce D.			Juvenile Hormone (JH) Esterase of the Mosquito Culex quinquefasciatus Is Not a Target of the JH Analog Insecticide Methoprene	PLOS ONE			English	Article							IN-VITRO EXPRESSION; MOLECULAR-CLONING; DEVELOPMENTAL EXPRESSION; CATALYTIC MECHANISM; TENEBRIO-MOLITOR; TRICHOPLUSIA-NI; GENE; RESISTANCE; CDNA; IDENTIFICATION	Juvenile hormones (JHs) are essential sesquiterpenes that control insect development and reproduction. JH analog (JHA) insecticides such as methoprene are compounds that mimic the structure and/or biological activity of JH. In this study we obtained a full-length cDNA, cqjhe, from the southern house mosquito Culex quinquefasciatus that encodes CqJHE, an esterase that selectively metabolizes JH. Unlike other recombinant esterases that have been identified from dipteran insects, CqJHE hydrolyzed JH with specificity constant (k(cat)/K-M ratio) and V-max values that are common among JH esterases (JHEs). CqJHE showed picomolar sensitivity to OTFP, a JHE-selective inhibitor, but more than 1000-fold lower sensitivity to DFP, a general esterase inhibitor. To our surprise, CqJHE did not metabolize the isopropyl ester of methoprene even when 25 pmol of methoprene was incubated with an amount of CqJHE that was sufficient to hydrolyze 7,200 pmol of JH to JH acid under the same assay conditions. In competition assays in which both JH and methoprene were available to CqJHE, methoprene did not show any inhibitory effects on the JH hydrolysis rate even when methoprene was present in the assay at a 10-fold higher concentration relative to JH. Our findings indicated that JHE is not a molecular target of methoprene. Our findings also do not support the hypothesis that methoprene functions in part by inhibiting the action of JHE.	[Kamita, Shizuo G.; Samra, Aman I.; Liu, Jun-Yan; Cornel, Anthony J.; Hammock, Bruce D.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Kamita, Shizuo G.; Samra, Aman I.; Liu, Jun-Yan; Hammock, Bruce D.] Univ Calif Davis, Ctr Canc, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis	Kamita, SG (corresponding author), Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA.	bdhammock@ucdavis.edu	LIU, JUNYAN/B-2515-2010; liu, junyan/HGV-1505-2022	LIU, JUNYAN/0000-0002-3018-0335; 	National Institute of Environmental Health Sciences [RO1 ES002710, P42 ES004699]; National Institites of Health/National Institute of Allergy and Infectious Diseases [U01 AI068855]; U.S. Department of Agriculture [2007-35607-17830]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES002710, P42ES004699] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institites of Health/National Institute of Allergy and Infectious Diseases; U.S. Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was partially funded by grants from the National Institute of Environmental Health Sciences (RO1 ES002710 and P42 ES004699), National Institites of Health/National Institute of Allergy and Infectious Diseases (U01 AI068855), and the U.S. Department of Agriculture (2007-35607-17830). B. D. H. is a George and Judy Marcus Senior Fellow of the American Asthma Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELAAL YAI, 1986, SCIENCE, V233, P1073, DOI 10.1126/science.3738525; ABDELAAL YAI, 1985, INSECT BIOCHEM, V15, P111, DOI 10.1016/0020-1790(85)90051-4; Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864; Aronov PA, 2005, J AGR FOOD CHEM, V53, P3306, DOI 10.1021/jf0485842; Ashok M, 1998, P NATL ACAD SCI USA, V95, P2761, DOI 10.1073/pnas.95.6.2761; Bai H, 2007, INSECT BIOCHEM MOLEC, V37, P829, DOI 10.1016/j.ibmb.2007.05.010; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BROWN TM, 1979, PESTIC BIOCHEM PHYS, V12, P79, DOI 10.1016/0048-3575(79)90097-X; BROWN TM, 1974, J ECON ENTOMOL, V67, P799, DOI 10.1093/jee/67.6.799a; Campbell PM, 2001, INSECT BIOCHEM MOLEC, V31, P513, DOI 10.1016/S0965-1748(01)00035-2; Campbell PM, 1998, INSECT BIOCHEM MOLEC, V28, P501, DOI 10.1016/S0965-1748(98)00037-X; Cornel AJ, 2002, PEST MANAG SCI, V58, P791, DOI 10.1002/ps.521; COTRUVO J, 2008, METHOPRENE DRINKING, P1; Crone EJ, 2007, INSECT BIOCHEM MOLEC, V37, P540, DOI 10.1016/j.ibmb.2007.02.010; Dame DA, 1998, J AM MOSQUITO CONTR, V14, P200; Feng QL, 1999, MOL CELL ENDOCRINOL, V148, P95, DOI 10.1016/S0303-7207(98)00228-7; GOODMAN WG, 2005, COMPREHENSIVE MOL IN, V3, P319; Hammock B.D., 1985, P431; HAMMOCK BD, 1977, PESTIC BIOCHEM PHYS, V7, P517, DOI 10.1016/0048-3575(77)90046-3; HAMMOCK BD, 1984, PESTIC BIOCHEM PHYS, V22, P209, DOI 10.1016/0048-3575(84)90092-0; HAMMOCK BD, 1977, ANAL BIOCHEM, V82, P573, DOI 10.1016/0003-2697(77)90196-8; HANZLIK TN, 1989, J BIOL CHEM, V264, P12419; HARMON MA, 1995, P NATL ACAD SCI USA, V92, P6157, DOI 10.1073/pnas.92.13.6157; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Henrick CA, 2007, J AM MOSQUITO CONTR, V23, P225, DOI 10.2987/8756-971X(2007)23[225:M]2.0.CO;2; Hinton AC, 2003, INSECT BIOCHEM MOLEC, V33, P477, DOI 10.1016/S0965-1748(03)00010-9; Hinton AC, 2003, INSECT BIOCHEM MOLEC, V33, P317, DOI 10.1016/S0965-1748(02)00246-1; Hinton AC, 2001, INSECT BIOCHEM MOLEC, V32, P57, DOI 10.1016/S0965-1748(01)00079-0; Hirai M, 2002, INSECT BIOCHEM MOLEC, V32, P627, DOI 10.1016/S0965-1748(01)00141-2; Kamita SG, 2003, INSECT BIOCHEM MOLEC, V33, P1261, DOI 10.1016/j.ibmb.2003.08.004; Kamita SG, 2010, J PESTIC SCI, V35, P265, DOI 10.1584/jpestics.R10-09; Kotaki T, 2009, ORG LETT, V11, P5234, DOI 10.1021/ol902161x; Lawson D, 2007, NUCLEIC ACIDS RES, V35, pD503, DOI 10.1093/nar/gkl960; Liu SH, 2008, J INSECT PHYSIOL, V54, P1495, DOI 10.1016/j.jinsphys.2008.08.010; Mackert A, 2008, COMP BIOCHEM PHYS B, V150, P33, DOI 10.1016/j.cbpb.2008.01.004; MASTROPAOLO W, 1981, ANAL BIOCHEM, V115, P188, DOI 10.1016/0003-2697(81)90544-3; McAbee RD, 2004, PEST MANAG SCI, V60, P359, DOI 10.1002/ps.799; MCCUTCHEN BF, 1993, ARCH BIOCHEM BIOPHYS, V307, P231, DOI 10.1006/abbi.1993.1584; Merrington CL, 1999, PRACT APPROACH SER, V202, P101; Miura K, 2005, FEBS J, V272, P1169, DOI 10.1111/j.1742-4658.2005.04552.x; Morisseau C, 2002, BIOCHEM PHARMACOL, V63, P1599, DOI 10.1016/S0006-2952(02)00952-8; Munyiri FN, 2007, INSECT BIOCHEM MOLEC, V37, P497, DOI 10.1016/j.ibmb.2007.02.006; Paul A, 2005, J AM MOSQUITO CONTR, V21, P305, DOI 10.2987/8756-971X(2005)21[305:IRICPF]2.0.CO;2; Rasband W.S., 2006, IMAGE J; Riddiford LM, 2008, J INSECT PHYSIOL, V54, P895, DOI 10.1016/j.jinsphys.2008.01.014; RUSSEL RM, 1977, ESA B, V23, P209; SLADE M, 1973, SCIENCE, V181, P672, DOI 10.1126/science.181.4100.672; SPARKS TC, 1980, PESTIC BIOCHEM PHYS, V14, P290, DOI 10.1016/0048-3575(80)90037-1; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teese MG, 2010, INSECT BIOCHEM MOLEC, V40, P1, DOI 10.1016/j.ibmb.2009.12.002; Thomas BA, 1999, PROTEINS, V34, P184, DOI 10.1002/(SICI)1097-0134(19990201)34:2<184::AID-PROT4>3.3.CO;2-#; Tsubota T, 2010, INSECT BIOCHEM MOLEC, V40, P100, DOI 10.1016/j.ibmb.2009.12.015; Vinogradova EB, 2000, CULEX PIPIENS PIPIEN; WARD VK, 1992, INT J BIOCHEM, V24, P1933, DOI 10.1016/0020-711X(92)90289-D; WEIRICH G, 1973, LIFE SCI, V13, P213, DOI 10.1016/0024-3205(73)90020-9; Wilson TG, 1998, P NATL ACAD SCI USA, V95, P14040, DOI 10.1073/pnas.95.24.14040; Wilson TG, 2004, J INSECT PHYSIOL, V50, P111, DOI 10.1016/j.jinsphys.2003.12.004; Wogulis M, 2006, BIOCHEMISTRY-US, V45, P4045, DOI 10.1021/bi0521644	58	23	23	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28392	10.1371/journal.pone.0028392	http://dx.doi.org/10.1371/journal.pone.0028392			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174797	Green Submitted, Green Published, gold			2022-12-25	WOS:000298365700030
J	Miettinen, HM				Miettinen, Heini M.			Regulation of Human Formyl Peptide Receptor 1 Synthesis: Role of Single Nucleotide Polymorphisms, Transcription Factors, and Inflammatory Mediators	PLOS ONE			English	Article							NADPH OXIDASE COMPONENTS; LEUKEMIA-CELL LINE; INTERFERON-GAMMA; GENE-EXPRESSION; CHEMOATTRACTANT RECEPTORS; TRANSLATION EFFICIENCY; DIMETHYL-SULFOXIDE; PROMOTER ACTIVITY; MYELOID CELLS; BONE-MARROW	The gene encoding the human formyl peptide receptor 1 (FPR1) is heterogeneous, containing numerous single nucleotide polymorphisms (SNPs). Here, we examine the effect of these SNPs on gene transcription and protein translation. We also identify gene promoter sequences and putative FPR1 transcription factors. To test the effect of codon bias and codon pair bias on FPR1 expression, four FPR1 genetic variants were expressed in human myeloid U937 cells fused to a reporter gene encoding firefly luciferase. No significant differences in luciferase activity were detected, suggesting that the translational regulation and protein stability of FPR1 are modulated by factors other than the SNP codon bias and the variant amino acid properties. Deletion and mutagenesis analysis of the FPR1 promoter showed that a CCAAT box is not required for gene transcription. A -88/41 promoter construct resulted in the strongest transcriptional activity, whereas a -72/41 construct showed large reduction in activity. The region between -88 and -72 contains a consensus binding site for the transcription factor PU.1. Mutagenesis of this site caused significant reduction in reporter gene expression. The PU.1 binding was confirmed in vivo by chromatin immunoprecipitation, and the binding to nucleotides -84 to -76 (TTCCTATTT) was confirmed in vitro by an electrophoretic mobility shift assay. Thus, similar to many other myeloid genes, FPR1 promoter activity requires PU.1. Two single nucleotide polymorphisms at -56 and -54 did not significantly affect FPR1 gene expression, despite differences in binding of transcription factor IRF1 in vitro. Inflammatory mediators such as interferon-c, tumor necrosis factor-alpha, and lipopolysaccharide did not increase FPR1 promoter activity in myeloid cells, whereas differentiation induced by DMSO and retinoic acid enhanced the activity. This implies that the expression of FPR1 in myeloid cells is developmentally regulated, and that the differentiated cells are equipped for immediate response to microbial infections.	Montana State Univ, Dept Microbiol, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman	Miettinen, HM (corresponding author), Montana State Univ, Dept Microbiol, Bozeman, MT 59717 USA.	heini@montana.edu			National Institutes of Health(NIH)/National Institute of Allergy and Infectious Diseases (NIAID) [1R21 AI83244-02]; NIH/National Center for Research Resources INBRE (IDeA Networks of Biomedical Research Excellence) [P20 RR016455]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083244] Funding Source: NIH RePORTER	National Institutes of Health(NIH)/National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/National Center for Research Resources INBRE (IDeA Networks of Biomedical Research Excellence); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by National Institutes of Health(NIH)/National Institute of Allergy and Infectious Diseases (NIAID) 1R21 AI83244-02. The Montana State University Functional Genomics Core Facility was funded by the NIH/National Center for Research Resources INBRE (IDeA Networks of Biomedical Research Excellence) award P20 RR016455. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjerregaard MD, 2003, BLOOD, V101, P4322, DOI 10.1182/blood-2002-03-0835; Borregaard N, 2007, TRENDS IMMUNOL, V28, P340, DOI 10.1016/j.it.2007.06.002; Brugnoli F, 2010, EXP CELL RES, V316, P38, DOI 10.1016/j.yexcr.2009.09.004; Buchan JR, 2006, NUCLEIC ACIDS RES, V34, P1015, DOI 10.1093/nar/gkj488; CASSATELLA MA, 1990, J BIOL CHEM, V265, P20241; Chateau MT, 1996, ANAL CELL PATHOL, V10, P75; CHEN HM, 1995, BLOOD, V85, P2918, DOI 10.1182/blood.V85.10.2918.bloodjournal85102918; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; Eklund EA, 1998, J BIOL CHEM, V273, P13957, DOI 10.1074/jbc.273.22.13957; ERBECK K, 1993, J IMMUNOL, V150, P1913; Ermolaeva M D, 2001, Curr Issues Mol Biol, V3, P91; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Gauss KA, 2002, J LEUKOCYTE BIOL, V71, P163; GREEN SP, 1994, J LEUKOCYTE BIOL, V55, P530, DOI 10.1002/jlb.55.4.530; Gripentrog JM, 2008, IMMUNOGENETICS, V60, P83, DOI 10.1007/s00251-008-0277-3; HARRIS PE, 1985, CANCER RES, V45, P9; HAVILAND DL, 1993, BIOCHEMISTRY-US, V32, P4168, DOI 10.1021/bi00067a003; Jormsjo S, 2000, CIRC RES, V86, P998, DOI 10.1161/01.RES.86.9.998; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; LEVY R, 1991, J IMMUNOL, V147, P3066; LEWIN B, 2007, GENES, V9, P609; Li SL, 1997, J BIOL CHEM, V272, P17802, DOI 10.1074/jbc.272.28.17802; Li SL, 2002, BLOOD, V99, P4578, DOI 10.1182/blood.V99.12.4578; Mandal P, 2005, J IMMUNOL, V175, P6085, DOI 10.4049/jimmunol.175.9.6085; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; MURPHY PM, 1993, GENE, V133, P285, DOI 10.1016/0378-1119(93)90653-K; PEREZ HD, 1992, BIOCHEMISTRY-US, V31, P11595, DOI 10.1021/bi00161a044; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Rockman MV, 2003, CURR BIOL, V13, P2118, DOI 10.1016/j.cub.2003.11.025; Sahagun-Ruiz A, 2001, GENES IMMUN, V2, P335, DOI 10.1038/sj.gene.6363787; SAKANO T, 1988, CELL IMMUNOL, V111, P390, DOI 10.1016/0008-8749(88)90102-5; SHERF BA, 1996, PROMEGA NOTES MAGAZI, P2; Suzuki S, 1998, P NATL ACAD SCI USA, V95, P6085, DOI 10.1073/pnas.95.11.6085; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; Tamura T, 1996, BIOCHEM BIOPH RES CO, V229, P21, DOI 10.1006/bbrc.1996.1752; TANAKA N, 1993, MOL CELL BIOL, V13, P4531, DOI 10.1128/MCB.13.8.4531; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59; Waldman YY, 2010, NUCLEIC ACIDS RES, V38, P2964, DOI 10.1093/nar/gkq009; Ye R D, 1997, Adv Pharmacol, V39, P221, DOI 10.1016/S1054-3589(08)60073-3; Zella D, 1998, BLOOD, V91, P4444, DOI 10.1182/blood.V91.12.4444.412k46_4444_4450; Zhang FL, 2010, SCIENCE, V329, P1534, DOI 10.1126/science.1191701; Zhang Y, 2003, GENES IMMUN, V4, P22, DOI 10.1038/sj.gene.6363900	45	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28712	10.1371/journal.pone.0028712	http://dx.doi.org/10.1371/journal.pone.0028712			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174875	Green Published, gold, Green Submitted			2022-12-25	WOS:000298365700064
J	Raj, A; Dewar, M; Palacios, G; Rabadan, R; Wiggins, CH				Raj, Anil; Dewar, Michael; Palacios, Gustavo; Rabadan, Raul; Wiggins, Christopher H.			Identifying Hosts of Families of Viruses: A Machine Learning Approach	PLOS ONE			English	Article							RNA-BINDING; 2C	Identifying emerging viral pathogens and characterizing their transmission is essential to developing effective public health measures in response to an epidemic. Phylogenetics, though currently the most popular tool used to characterize the likely host of a virus, can be ambiguous when studying species very distant to known species and when there is very little reliable sequence information available in the early stages of the outbreak of disease. Motivated by an existing framework for representing biological sequence information, we learn sparse, tree-structured models, built from decision rules based on subsequences, to predict viral hosts from protein sequence data using popular discriminative machine learning tools. Furthermore, the predictive motifs robustly selected by the learning algorithm are found to show strong host-specificity and occur in highly conserved regions of the viral proteome.	[Raj, Anil; Wiggins, Christopher H.] Columbia Univ, Dept Appl Phys & Appl Math, Ctr Computat Biol & Bioinformat, New York, NY 10027 USA; [Palacios, Gustavo] Columbia Univ, Ctr Infect & Immun, Mailman Sch Publ Hlth, New York, NY USA; [Rabadan, Raul] Columbia Univ, Coll Phys & Surg, Dept Biomed Informat, Ctr Computat Biol & Bioinformat, New York, NY USA	Columbia University; Columbia University; Columbia University	Raj, A (corresponding author), Columbia Univ, Dept Appl Phys & Appl Math, Ctr Computat Biol & Bioinformat, New York, NY 10027 USA.	ar2384@columbia.edu	Rabadan, Raul/AAZ-7367-2020; Palacios, Gustavo/I-7773-2015	Palacios, Gustavo/0000-0001-5062-1938; Rabadan, Raul/0000-0001-7946-9255	National Institutes of Health [U54 CA121852-05]; Northeast Biodefence Center [U54-AI057158]; National Library of Medicine [1R01LM010140-01]; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northeast Biodefence Center; National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	RR and CW are supported by the National Institutes of Health (U54 CA121852-05). RR and GP are supported by the Northeast Biodefence Center (U54-AI057158). RR is also supported by the National Library of Medicine (1R01LM010140-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDABE R, 1995, BIOCHEM BIOPH RES CO, V206, P64, DOI 10.1006/bbrc.1995.1010; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Briese T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000455; Busa-Fekete R, 2009, J MACHINE LEARNING R, V7, P111; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Freund Y, 1999, MACHINE LEARNING, PROCEEDINGS, P124; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; GORBALENYA AE, 1989, J MOL EVOL, V28, P256, DOI 10.1007/BF02102483; HAMMING RW, 1950, BELL SYST TECH J, V29, P147, DOI 10.1002/j.1538-7305.1950.tb00463.x; Jimenez-Baranda S, 2011, J VIROL, V85, P3893, DOI 10.1128/JVI.01908-10; Kress WJ, 2008, P NATL ACAD SCI USA, V105, P2761, DOI 10.1073/pnas.0800476105; Kusov YY, 1998, ARCH VIROL, V143, P931, DOI 10.1007/s007050050343; Leslie CS, 2004, BIOINFORMATICS, V20, P467, DOI 10.1093/bioinformatics/btg431; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Pfister T, 1999, J BIOL CHEM, V274, P6992, DOI 10.1074/jbc.274.11.6992; Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583; RODRIGUEZ PL, 1995, J BIOL CHEM, V270, P10105, DOI 10.1074/jbc.270.17.10105; RODRIGUEZ PL, 1993, J BIOL CHEM, V268, P8105; Schapire RE, 1999, MACH LEARN, V37, P297, DOI 10.1023/A:1007614523901; Seberg O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004598; Touchon M, 2008, BIOCHIMIE, V90, P648, DOI 10.1016/j.biochi.2007.09.015; Trifonov V, 2010, MBIO, V1, DOI 10.1128/mBio.00156-10; Williamson SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001456	24	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e27631	10.1371/journal.pone.0027631	http://dx.doi.org/10.1371/journal.pone.0027631			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174744	gold, Green Published, Green Submitted			2022-12-25	WOS:000298365700006
J	Zheng, F; Zhou, XJ; Luo, YN; Xiao, H; Wayman, G; Wang, HB				Zheng, Fei; Zhou, Xianju; Luo, Yongneng; Xiao, Hua; Wayman, Gary; Wang, Hongbing			Regulation of Brain-Derived Neurotrophic Factor Exon IV Transcription through Calcium Responsive Elements in Cortical Neurons	PLOS ONE			English	Article							LONG-TERM POTENTIATION; CREB-BINDING PROTEIN; HIPPOCAMPAL-NEURONS; BDNF EXPRESSION; INDEPENDENT MECHANISMS; GENE-TRANSCRIPTION; SIGNALING PATHWAY; NUCLEAR-PROTEIN; FEAR MEMORY; MAP KINASE	Activity-dependent transcription of brain-derived neurotrophic factor (BDNF) has been studied as an important model to elucidate the mechanisms underlying numerous aspects of neuroplasticity. It has been extensively emphasized that Ca(2+) influx through different routes may have significantly different effects on BDNF transcription. Here, we examined the regulatory property of the major calcium responsive elements (CaRE) in BDNF promoter IV in cultured rat cortical neurons. BDNF promoter IV, as well as CaRE1 and CaRE3, was significantly activated by Ca(2+) influx through L-type voltage-gated calcium channel (L-VGCC) or NMDA receptor (NMDAR). However, the L-VGCC- and NMDAR-mediated activation of CaRE was differentially regulated by different Ca(2+)-stimulated protein kinases. Specifically, PKA, CaMKI, and CaMKIV activity were required for L-VGCC-, but not NMDAR-mediated CaRE1 activation. CaMKI activity was required for NMDAR- but not L-VGCC-mediated CaRE3 activation. Surprisingly, the activation of CaRF, a previously identified transcription factor for CaRE1, was stimulated via L-VGCC but not NMDAR, and required MEK, PI3K and CaMKII activity. These results suggest a new working model that activity-dependent BDNF IV up-regulation may be coordinately mediated by CaRE1 and CaRE3 activity, which show different responses to Ca(2+)-stimulated kinases. Our data also explain how the individual cis-element in BDNF promoter is distinctively coupled to different Ca(2+) routes.	[Zheng, Fei] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Zhou, Xianju; Luo, Yongneng; Xiao, Hua; Wang, Hongbing] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA; [Wang, Hongbing] Michigan State Univ, Cellular & Mol Biol Program, E Lansing, MI 48824 USA; [Wang, Hongbing] Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA; [Wayman, Gary] Washington State Univ, Dept Vet & Comparat Anat Pharmacol & Physiol, Pullman, WA 99164 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University; Washington State University	Zheng, F (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	wangho@msu.edu			National Institute of Health [MH076906, DK066110, MH086032]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086032, R01MH076906] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institute of Health Grants MH076906 (H.W.), DK066110 (H.X.), and MH086032 (G.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Arthur JSC, 2004, J NEUROSCI, V24, P4324, DOI 10.1523/JNEUROSCI.5227-03.2004; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Bauer EP, 2002, J NEUROSCI, V22, P5239, DOI 10.1523/JNEUROSCI.22-12-05239.2002; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Chang BH, 2001, NEUROSCIENCE, V102, P767, DOI 10.1016/S0306-4522(00)00520-0; Chen WG, 2003, J NEUROSCI, V23, P2572; Chen X, 2005, NAT NEUROSCI, V8, P925, DOI 10.1038/nn1482; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; DUGICHDJORDJEVIC MM, 1992, NEURON, V8, P1127, DOI 10.1016/0896-6273(92)90133-X; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; Gray PC, 1998, NEURON, V20, P1017, DOI 10.1016/S0896-6273(00)80482-1; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Grewal SS, 2000, J BIOL CHEM, V275, P34433, DOI 10.1074/jbc.M004728200; Hall J, 2000, NAT NEUROSCI, V3, P533, DOI 10.1038/75698; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hong EJ, 2008, NEURON, V60, P610, DOI 10.1016/j.neuron.2008.09.024; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381; Kawanishi Y, 1999, J HUM GENET, V44, P428, DOI 10.1007/s100380050196; Labasque M, 2008, MOL BIOL CELL, V19, P4640, DOI 10.1091/mbc.E08-04-0422; LESSMANN V, 1994, NEUROREPORT, V6, P21; Linnarsson S, 1997, EUR J NEUROSCI, V9, P2581, DOI 10.1111/j.1460-9568.1997.tb01687.x; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; Marshall J, 2003, NEURON, V39, P625, DOI 10.1016/S0896-6273(03)00496-3; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McDowell KA, 2010, J NEUROSCI, V30, P7453, DOI 10.1523/JNEUROSCI.3997-09.2010; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; NEEPER SA, 1995, NATURE, V373, P109, DOI 10.1038/373109a0; Newton SS, 2002, J NEUROSCI, V22, P10883; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Opazo P, 2003, J NEUROSCI, V23, P3679; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Sala C, 2000, J NEUROSCI, V20, P3529, DOI 10.1523/JNEUROSCI.20-10-03529.2000; Schinder AF, 2000, TRENDS NEUROSCI, V23, P639, DOI 10.1016/S0166-2236(00)01672-6; Schmitt JM, 2005, J NEUROSCI, V25, P1281, DOI 10.1523/JNEUROSCI.4086-04.2005; Shaywitz AJ, 2000, MOL CELL BIOL, V20, P9409, DOI 10.1128/MCB.20.24.9409-9422.2000; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Soriano FX, 2006, J NEUROSCI, V26, P4509, DOI 10.1523/JNEUROSCI.0455-06.2006; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Sun PQ, 1996, J BIOL CHEM, V271, P3066, DOI 10.1074/jbc.271.6.3066; Tabuchi A, 2000, J BIOL CHEM, V275, P17269, DOI 10.1074/jbc.M909538199; Tao X, 2002, NEURON, V33, P383, DOI 10.1016/S0896-6273(01)00561-X; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Vaidyanathan H, 2007, P NATL ACAD SCI USA, V104, P19837, DOI 10.1073/pnas.0704514104; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wayman GA, 2004, J NEUROSCI, V24, P3786, DOI 10.1523/JNEUROSCI.3294-03.2004; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Zheng F, 2009, NEUROCHEM INT, V54, P385, DOI 10.1016/j.neuint.2009.01.006; ZHOU X, 2009, J NEUROSCI RES; Zhou XJ, 2009, J NEUROSCI RES, V87, P2632, DOI 10.1002/jnr.22103	58	56	60	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28441	10.1371/journal.pone.0028441	http://dx.doi.org/10.1371/journal.pone.0028441			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174809	Green Published, gold, Green Submitted			2022-12-25	WOS:000298365700037
J	Chan, KYK; Wong, CM; Kwan, JSH; Lee, JMF; Cheung, KW; Yuen, MF; Lai, CL; Poon, RTP; Sham, PC; Ng, IOL				Chan, Kelvin Yuen-Kwong; Wong, Chun-Ming; Kwan, Johnny Sheung-Him; Lee, Joyce Man-Fong; Cheung, Ka Wai; Yuen, Man Fung; Lai, Ching Lung; Poon, Ronnie Tung-Ping; Sham, Pak Chung; Ng, Irene Oi-Lin			Genome-Wide Association Study of Hepatocellular Carcinoma in Southern Chinese Patients with Chronic Hepatitis B Virus Infection	PLOS ONE			English	Article							GENE POLYMORPHISMS; SUSCEPTIBILITY LOCUS; NONCODING RNA; RISK; CYTOKINE	One of the most relevant risk factors for hepatocellular carcinoma (HCC) development is chronic hepatitis B virus (HBV) infection, but only a fraction of chronic HBV carriers develop HCC, indicating that complex interactions among viral, environmental and genetic factors lead to HCC in HBV-infected patients. So far, host genetic factors have incompletely been characterized. Therefore, we performed a genome-wide association (GWA) study in a Southern Chinese cohort consisting of 95 HBV-infected HCC patients (cases) and 97 HBV-infected patients without HCC (controls) using the Illumina Human610-Quad BeadChips. The top single nucleotide polymorphisms (SNPs) were then validated in an independent cohort of 500 cases and 728 controls. 4 SNPs (rs12682266, rs7821974, rs2275959, rs1573266) at chromosome 8p12 showed consistent association in both the GWA and replication phases (ORcombined = 1.31-1.39; p(combined) = 2.71x10(-5)-5.19x10(-4); PAR(combined) = 26-31%). We found a 2.3-kb expressed sequence tag (EST) in the region using in-silico data mining and verified the existence of the full-length EST experimentally. The expression level of the EST was significantly reduced in human HCC tumors in comparison to the corresponding non-tumorous liver tissues (P<0.001). Results from sequence analysis and in-vitro protein translation study suggest that the transcript might function as a long non-coding RNA. In summary, our study suggests that variations at chromosome 8p12 may promote HCC in patients with HBV. Further functional studies of this region may help understand HBV-associated hepatocarcinogenesis.	[Chan, Kelvin Yuen-Kwong; Wong, Chun-Ming; Lee, Joyce Man-Fong; Cheung, Ka Wai; Yuen, Man Fung; Lai, Ching Lung; Poon, Ronnie Tung-Ping; Ng, Irene Oi-Lin] Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China; [Chan, Kelvin Yuen-Kwong; Wong, Chun-Ming; Lee, Joyce Man-Fong; Cheung, Ka Wai; Ng, Irene Oi-Lin] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Kwan, Johnny Sheung-Him; Sham, Pak Chung] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Yuen, Man Fung; Lai, Ching Lung] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Poon, Ronnie Tung-Ping] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Chan, KYK (corresponding author), Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China.	pcsham@hku.hk; iolng@hku.hk	WONG, Chun-Ming/A-6739-2009; Chan, Kelvin/HGA-3097-2022	WONG, Chun-Ming/0000-0002-2497-7858; Ng, Irene Oi-lin/0000-0001-7532-2029; Lai, Ching-Lung/0000-0002-5927-2436	Hong Kong Research Grants Council [HKU 1/06C, HKU 7/CRG/09]	Hong Kong Research Grants Council(Hong Kong Research Grants Council)	The study was supported by Hong Kong Research Grants Council Collaborative Research Fund (HKU 1/06C and HKU 7/CRG/09). I.O.L. Ng is Loke Yew Professor in Pathology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly M, 2011, EUR UROL, V60, P21, DOI 10.1016/j.eururo.2011.01.017; Arason A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2608; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chan KL, 2002, CANCER, V94, P3179, DOI 10.1002/cncr.10612; Chen CC, 2005, INT J EPIDEMIOL, V34, P1310, DOI 10.1093/ije/dyi191; Chen JM, 2009, AM J HUM GENET, V85, P775, DOI 10.1016/j.ajhg.2009.10.016; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Gibb EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025915; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Kotake Y, 2011, ONCOGENE, V30, P1956, DOI 10.1038/onc.2010.568; Kumar V, 2011, NAT GENET, V43, P455, DOI 10.1038/ng.809; Kummee P, 2007, J VIRAL HEPATITIS, V14, P841, DOI 10.1111/j.1365-2893.2007.00880.x; Lai CL, 2008, NEW ENGL J MED, V359, P2488, DOI 10.1056/NEJMe0808185; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Lee TKW, 2011, HEPATOLOGY, V53, P160, DOI 10.1002/hep.24000; Migita K, 2005, J HEPATOL, V42, P505, DOI 10.1016/j.jhep.2004.11.026; Ng IOL, 2000, CANCER RES, V60, P6581; Panzitt K, 2007, GASTROENTEROLOGY, V132, P330, DOI 10.1053/j.gastro.2006.08.026; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Su WH, 2007, NUCLEIC ACIDS RES, V35, pD727, DOI 10.1093/nar/gkl845; Tseng CS, 2005, AM J GASTROENTEROL, V100, P1758, DOI 10.1111/j.1572-0241.2005.41857.x; Yu MW, 2000, GUT, V47, P703, DOI 10.1136/gut.47.5.703; Yu MW, 2002, HEPATOLOGY, V36, P156, DOI 10.1053/jhep.2002.33897; Yu SZ, 2002, JPN J CANCER RES, V93, P1287, DOI 10.1111/j.1349-7006.2002.tb01236.x; Zhang HX, 2010, NAT GENET, V42, P755, DOI 10.1038/ng.638	29	49	52	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28798	10.1371/journal.pone.0028798	http://dx.doi.org/10.1371/journal.pone.0028798			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174901	gold, Green Published, Green Submitted			2022-12-25	WOS:000298163600044
J	LaTuga, MS; Ellis, JC; Cotton, CM; Goldberg, RN; Wynn, JL; Jackson, RB; Seed, PC				LaTuga, Mariam Susan; Ellis, Joseph Christopher; Cotton, Charles Michael; Goldberg, Ronald N.; Wynn, James L.; Jackson, Robert B.; Seed, Patrick C.			Beyond Bacteria: A Study of the Enteric Microbial Consortium in Extremely Low Birth Weight Infants	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; INTENSIVE-CARE-UNIT; NECROTIZING ENTEROCOLITIS; PRETERM INFANTS; INVASIVE CANDIDIASIS; GENOME SEQUENCE; ORAL NYSTATIN; ONSET SEPSIS; COLONIZATION; PROBIOTICS	Extremely low birth weight (ELBW) infants have high morbidity and mortality, frequently due to invasive infections from bacteria, fungi, and viruses. The microbial communities present in the gastrointestinal tracts of preterm infants may serve as a reservoir for invasive organisms and remain poorly characterized. We used deep pyrosequencing to examine the gut-associated microbiome of 11 ELBW infants in the first postnatal month, with a first time determination of the eukaryote microbiota such as fungi and nematodes, including bacteria and viruses that have not been previously described. Among the fungi observed, Candida sp. and Clavispora sp. dominated the sequences, but a range of environmental molds were also observed. Surprisingly, seventy-one percent of the infant fecal samples tested contained ribosomal sequences corresponding to the parasitic organism Trichinella. Ribosomal DNA sequences for the roundworm symbiont Xenorhabdus accompanied these sequences in the infant with the greatest proportion of Trichinella sequences. When examining ribosomal DNA sequences in aggregate, Enterobacteriales, Pseudomonas, Staphylococcus, and Enterococcus were the most abundant bacterial taxa in a low diversity bacterial community (mean Shannon-Weaver Index of 1.02 +/- 0.69), with relatively little change within individual infants through time. To supplement the ribosomal sequence data, shotgun sequencing was performed on DNA from multiple displacement amplification (MDA) of total fecal genomic DNA from two infants. In addition to the organisms mentioned previously, the metagenome also revealed sequences for gram positive and gram negative bacteriophages, as well as human adenovirus C. Together, these data reveal surprising eukaryotic and viral microbial diversity in ELBW enteric microbiota dominated bytypes of bacteria known to cause invasive disease in these infants.	[LaTuga, Mariam Susan] Albert Einstein Coll Med, Dept Pediat, New York, NY USA; [Ellis, Joseph Christopher; Jackson, Robert B.] Duke Univ, Dept Biol, Durham, NC USA; [Cotton, Charles Michael; Goldberg, Ronald N.; Wynn, James L.; Seed, Patrick C.] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Jackson, Robert B.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Jackson, Robert B.] Duke Univ, Ctr Global Change, Durham, NC USA; [Seed, Patrick C.] Duke Univ, Ctr Microbial Pathogenesis, Durham, NC USA; [Cotton, Charles Michael; Goldberg, Ronald N.; Wynn, James L.; Seed, Patrick C.] Duke Univ, Jean & George Brumley Jr Neonatal Perinatal Res I, Durham, NC USA	Yeshiva University; Duke University; Duke University; Duke University; Duke University; Duke University; Duke University	LaTuga, MS (corresponding author), Albert Einstein Coll Med, Dept Pediat, New York, NY USA.	patrick.seed@duke.edu	Ellis, Joseph/G-6335-2011	LaTuga, Mariam/0000-0001-8330-3477; Jackson, Robert/0000-0001-8846-7147; Wynn, James/0000-0001-7052-4836	Duke Institute for Genome Sciences and Policy; Duke Department of Pediatrics Division of Perinatal-Neonatal Medicine; Jean and George Brumley, Jr Neonatal-Perinatal Research Network; Center on Global Change at Duke University; Gerber Foundation; Hartwell Foundation	Duke Institute for Genome Sciences and Policy; Duke Department of Pediatrics Division of Perinatal-Neonatal Medicine; Jean and George Brumley, Jr Neonatal-Perinatal Research Network; Center on Global Change at Duke University; Gerber Foundation; Hartwell Foundation	This research was supported by a pilot grant from the Duke Institute for Genome Sciences and Policy, the Duke Department of Pediatrics Division of Perinatal-Neonatal Medicine, the Jean and George Brumley, Jr Neonatal-Perinatal Research Network, and by the Center on Global Change at Duke University. MSL received support from the Gerber Foundation. PCS received support from the Hartwell Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Maziad A, 2010, PEDIATR RES, V68, P323, DOI 10.1203/00006450-201011001-00632; Aydemir C, 2010, ARCH DIS CHILD FETAL; Ben XM, 2004, CHINESE MED J-PEKING, V117, P927; Benjamin DK, 2006, PEDIATRICS, V117, P84, DOI 10.1542/peds.2004-2292; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Blouin MS, 2002, INT J PARASITOL, V32, P527, DOI 10.1016/S0020-7519(01)00357-5; Braga TD, 2011, AM J CLIN NUTR, V93, P81, DOI 10.3945/ajcn.2010.29799; Caplan MS, 2009, J PERINATOL, V29, pS2, DOI 10.1038/jp.2009.21; Cerikcioglu N, 2004, TURKISH J PEDIATR, V46, P245; Chanchalchaovivat A, 2007, BIOL CONTROL, V42, P326, DOI 10.1016/j.biocontrol.2007.05.016; CHAO A, 1984, SCAND J STAT, V11, P265; Chavan P, 2009, FOOD MICROBIOL, V26, P801, DOI 10.1016/j.fm.2009.05.005; Clark RH, 2006, PEDIATRICS, V117, P1979, DOI 10.1542/peds.2005-1707; Coates EW, 2005, PEDIATRICS, V116, pE241, DOI 10.1542/peds.2004-2537; Cole JR, 2003, NUCLEIC ACIDS RES, V31, P442, DOI 10.1093/nar/gkg039; Cotten CM, 2006, PEDIATRICS, V118, P717, DOI 10.1542/peds.2005-2677; Cotten CM, 2009, PEDIATRICS, V123, P58, DOI 10.1542/peds.2007-3423; DAMJANOVIC V, 1993, J HOSP INFECT, V24, P245, DOI 10.1016/0195-6701(93)90057-7; Davidoff MJ, 2006, SEMIN PERINATOL, V30, P8, DOI 10.1053/j.semperi.2006.01.009; De la Cochetiere MF, 2004, PEDIATR RES, V56, P366, DOI 10.1203/01.PDR.0000134251.45878.D5; Disz T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-319; Duarte W, 2009, J IND MICROBIOL BIOT, V36, P557, DOI 10.1007/s10295-009-0526-y; Ehrenkranz RA, 2006, PEDIATRICS, V117, P1253, DOI 10.1542/peds.2005-1368; Embleton NE, 2001, PEDIATRICS, V107, P270, DOI 10.1542/peds.107.2.270; Favier CF, 2002, APPL ENVIRON MICROB, V68, P219, DOI 10.1128/AEM.68.1.219-226.2002; Fridkin SK, 2006, PEDIATRICS, V117, P1680, DOI 10.1542/peds.2005-1996; Gareau MG, 2010, NAT REV GASTRO HEPAT, V7, P503, DOI 10.1038/nrgastro.2010.117; Gewolb IH, 1999, ARCH DIS CHILD-FETAL, V80, pF167, DOI 10.1136/fn.80.3.F167; Guillet R, 2006, PEDIATRICS, V117, pE137, DOI 10.1542/peds.2005-1543; Guthmann F, 2010, KLIN PADIATR, V222, P284, DOI 10.1055/s-0030-1254113; Huys G, 2008, CURR MICROBIOL, V56, P553, DOI 10.1007/s00284-008-9122-z; Krebs C. J., 2014, ECOLOGICAL METHODOLO; Kunin V, 2010, OPEN J, V1, P1; Li SS, 2010, INT J FOOD MICROBIOL, V138, P85, DOI 10.1016/j.ijfoodmicro.2010.01.009; Lin HC, 2008, PEDIATRICS, V122, P693, DOI 10.1542/peds.2007-3007; Liu J, 2001, J INVERTEBR PATHOL, V77, P87, DOI 10.1006/jipa.2001.5007; Lutgendorff F, 2008, CURR MOL MED, V8, P282, DOI 10.2174/156652408784533779; Magne F, 2006, FEMS MICROBIOL ECOL, V57, P128, DOI 10.1111/j.1574-6941.2006.00097.x; Millar MR, 1996, J CLIN MICROBIOL, V34, P2506, DOI 10.1128/JCM.34.10.2506-2510.1996; Morowitz MJ, 2011, P NATL ACAD SCI USA, V108, P1128, DOI 10.1073/pnas.1010992108; Mshvildadze M, 2010, J PEDIATR-US, V156, P20, DOI 10.1016/j.jpeds.2009.06.063; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; Nechvatal JM, 2008, J MICROBIOL METH, V72, P124, DOI 10.1016/j.mimet.2007.11.007; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; ORMALA T, 1992, SCAND J INFECT DIS, V24, P781, DOI 10.3109/00365549209062464; Ozturk MA, 2006, MYCOSES, V49, P484, DOI 10.1111/j.1439-0507.2006.01274.x; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Pan XH, 2008, P NATL ACAD SCI USA, V105, P15499, DOI 10.1073/pnas.0808028105; Parra-Herran CE, 2010, FETAL PEDIATR PATHOL, V29, P172, DOI 10.3109/15513811003777342; Ramet M, 2011, PEDIATR PULM, V46, P101, DOI 10.1002/ppul.21348; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schwiertz A, 2003, PEDIATR RES, V54, P393, DOI 10.1203/01.PDR.0000078274.74607.7A; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; SIMS ME, 1988, AM J PERINAT, V5, P33, DOI 10.1055/s-2007-999649; Smith A, 2010, PEDIATR INFECT DIS J, V29, P831, DOI 10.1097/INF.0b013e3181e7884f; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285; Stoll BJ, 2002, NEW ENGL J MED, V347, P240, DOI 10.1056/NEJMoa012657; [US Department of Health and Human Services HRaSA Maternal and Child Health Bureau Services UDoHaH], 2010, CHILD HLTH US 2010; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37; Westerlund E, 2011, BLOOD COAGUL FIBRIN, V22, P127, DOI 10.1097/MBC.0b013e32834363ea; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Wilson-Costello D, 2005, PEDIATRICS, V115, P997, DOI 10.1542/peds.2004-0221	64	87	91	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e27858	10.1371/journal.pone.0027858	http://dx.doi.org/10.1371/journal.pone.0027858			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174751	Green Published, gold, Green Submitted			2022-12-25	WOS:000298163600007
J	Montane, F; Casals, P; Dale, MRT				Montane, Francesc; Casals, Pere; Dale, Mark R. T.			How Spatial Heterogeneity of Cover Affects Patterns of Shrub Encroachment into Mesic Grasslands	PLOS ONE			English	Article							JUNIPERUS-VIRGINIANA; PLANT ESTABLISHMENT; DISTRIBUTION MODELS; SAFE SITES; FACILITATION; CONSEQUENCES; VEGETATION; REGENERATION; COMMUNITIES; MECHANISMS	We used a multi-method approach to analyze the spatial patterns of shrubs and cover types (plant species, litter or bare soil) in grassland-shrubland ecotones. This approach allows us to assess how fine-scale spatial heterogeneity of cover types affects the patterns of Cytisus balansae shrub encroachment into mesic mountain grasslands (Catalan Pyrenees, Spain). Spatial patterns and the spatial associations between juvenile shrubs and different cover types were assessed in mesic grasslands dominated by species with different palatabilities (palatable grass Festuca nigrescens and unpalatable grass Festuca eskia). A new index, called RISES ("Relative Index of Shrub Encroachment Susceptibility"), was proposed to calculate the chances of shrub encroachment into a given grassland, combining the magnitude of the spatial associations and the surface area for each cover type. Overall, juveniles showed positive associations with palatable F. nigrescens and negative associations with unpalatable F. eskia, although these associations shifted with shrub development stage. In F. eskia grasslands, bare soil showed a low scale of pattern and positive associations with juveniles. Although the highest RISES values were found in F. nigrescens plots, the number of juvenile Cytisus was similar in both types of grasslands. However, F. nigrescens grasslands showed the greatest number of juveniles in early development stage (i.e. height<10 cm) whereas F. eskia grasslands showed the greatest number of juveniles in late development stages (i.e. height>30 cm). We concluded that in F. eskia grasslands, where establishment may be constrained by the dominant cover type, the low scale of pattern on bare soil may result in higher chances of shrub establishment and survival. In contrast, although grasslands dominated by the palatable F. nigrescens may be more susceptible to shrub establishment; current grazing rates may reduce juvenile survival.	[Montane, Francesc; Casals, Pere] Forest Sci Ctr Catalonia CTFC, Solsona, Spain; [Dale, Mark R. T.] Univ No British Columbia, Prince George, BC V2L 5P2, Canada	Centre Tecnologic Forestal de Catalunya (CTFC); University of Northern British Columbia	Montane, F (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada.	francesc.montane@gmail.com	Montane, Francesc/B-7780-2008; Casals, Pere/M-2418-2014	Montane, Francesc/0000-0001-8126-8612; Casals, Pere/0000-0002-0372-988X	Academic Mission at the University of Northern British Columbia [2008 BE-1 00493]; DURSI-Generalitat de Catalunya [2005FI 00801]; European Social Fund; Spanish Ministerio de Educacion y Ciencia (VULCA) [CGL2005-08133-CO3]; Ministerio de Medio Ambiente y Medio Rural y Marino [69/2005]; Ministerio de Ciencia e Innovacion, Spain	Academic Mission at the University of Northern British Columbia; DURSI-Generalitat de Catalunya(Generalitat de Catalunya); European Social Fund(European Social Fund (ESF)); Spanish Ministerio de Educacion y Ciencia (VULCA)(Spanish Government); Ministerio de Medio Ambiente y Medio Rural y Marino(Spanish Government); Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by a grant for an Academic Mission at the University of Northern British Columbia (2008 BE-1 00493) awarded to FM, a PhD fellowship (2005FI 00801) awarded by DURSI-Generalitat de Catalunya, and by the European Social Fund. Additional support was receive from the Spanish Ministerio de Educacion y Ciencia (VULCA, CGL2005-08133-CO3) and Ministerio de Medio Ambiente y Medio Rural y Marino (Parques Nacionales 69/2005). PC was supported by a Ramon y Cajal contract (Ministerio de Ciencia e Innovacion, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERTS R, 1991, OECOLOGIA, V87, P551, DOI 10.1007/BF00320419; ARCHER S, 1995, CLIMATIC CHANGE, V29, P91, DOI 10.1007/BF01091640; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Baraza E, 2006, OIKOS, V113, P148, DOI 10.1111/j.0030-1299.2006.14265.x; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Briggs JM, 2005, BIOSCIENCE, V55, P243, DOI 10.1641/0006-3568(2005)055[0243:AEITCA]2.0.CO;2; Briggs JM, 2002, ECOSYSTEMS, V5, P578, DOI 10.1007/s10021-002-0187-4; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; Browning DM, 2011, ECOLOGICAL APPL, DOI [10.1890/10-0542.1, DOI 10.1890/10-0542.1]; Burke IC, 1998, BIOGEOCHEMISTRY, V42, P121, DOI 10.1023/A:1005987807596; Callaway R. M., 2007, POSITIVE INTERACTION; Castro J, 2004, J ECOL, V92, P266, DOI 10.1111/j.0022-0477.2004.00870.x; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Daget P, 1972, ANN ARGON, V22, P5; Dale M.R.T., 1999, SPATIAL PATTERN ANAL; DEBUSSCHE M, 1980, VEGETATIO, V43, P73; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Gracia M, 2007, FOREST ECOL MANAG, V242, P391, DOI 10.1016/j.foreco.2007.01.056; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hovstad KA, 2008, PLANT ECOL, V196, P251, DOI 10.1007/s11258-007-9349-y; Jurena PN, 2003, ECOLOGY, V84, P907, DOI 10.1890/0012-9658(2003)084[0907:WPEASH]2.0.CO;2; LAVOREL S, 1994, OIKOS, V71, P75, DOI 10.2307/3546174; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Liu F, 2011, GLOBAL CHANGE BIOL, V17, P1119, DOI 10.1111/j.1365-2486.2010.02251.x; Maestre FT, 2001, ECOL APPL, V11, P1641, DOI 10.1890/1051-0761(2001)011[1641:PFUFBG]2.0.CO;2; McIntire EJB, 2009, ECOLOGY, V90, P46, DOI 10.1890/07-2096.1; McKinley DC, 2008, ECOSYSTEMS, V11, P454, DOI 10.1007/s10021-008-9133-4; Milbau A, 2009, BIOL INVASIONS, V11, P941, DOI 10.1007/s10530-008-9306-2; Miriti MN, 2006, J ECOL, V94, P973, DOI 10.1111/j.1365-2745.2006.01138.x; Montane F, 2010, PLANT ECOL, V211, P267, DOI 10.1007/s11258-010-9788-8; Montane F, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2009050; Nelson TA, 2008, ECOGRAPHY, V31, P556, DOI 10.1111/j.0906-7590.2008.05548.x; Olff H, 1999, PLANT BIOLOGY, V1, P127, DOI 10.1111/j.1438-8677.1999.tb00236.x; Palmer SCF, 2003, ECOLOGY, V84, P2877, DOI 10.1890/02-0245; Pasche F, 2004, BIOL CONSERV, V118, P101, DOI 10.1016/j.biocon.2003.07.012; Pornon A, 2007, AM J BOT, V94, P1778, DOI 10.3732/ajb.94.11.1778; Purves DW, 2002, J ECOL, V90, P121, DOI 10.1046/j.0022-0477.2001.00652.x; Rosenberg MS, 2009, PASSAGE PATTERN ANAL; Roura-Pascual N, 2005, MT RES DEV, V25, P252, DOI 10.1659/0276-4741(2005)025[0252:TOARLI]2.0.CO;2; RUSCH G, 1995, J VEG SCI, V6, P417, DOI 10.2307/3236241; SKARPE C, 1991, J VEG SCI, V2, P565, DOI 10.2307/3236039; Smit C, 2006, J APPL ECOL, V43, P305, DOI 10.1111/j.1365-2664.2006.01147.x; Smit C, 2005, J VEG SCI, V16, P209, DOI 10.1111/j.1654-1103.2005.tb02357.x; Soliveres S, 2010, PERSPECT PLANT ECOL, V12, P227, DOI 10.1016/j.ppees.2010.02.003; TURKINGTON R, 1979, J ECOL, V67, P201, DOI 10.2307/2259345; Van Auken OW, 2000, ANNU REV ECOL SYST, V31, P197, DOI 10.1146/annurev.ecolsys.31.1.197; Van Uytvanck J, 2008, BIOL CONSERV, V141, P78, DOI 10.1016/j.biocon.2007.09.001; WATT AS, 1947, J ECOL, V35, P1, DOI 10.2307/2256497; Xiong SJ, 1999, J ECOL, V87, P984, DOI 10.1046/j.1365-2745.1999.00414.x	50	6	6	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28652	10.1371/journal.pone.0028652	http://dx.doi.org/10.1371/journal.pone.0028652			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174858	Green Published, gold, Green Submitted			2022-12-25	WOS:000298163600037
J	Shibata, TK; Matsumura, F; Wang, P; Yu, SY; Chou, CC; Khoo, KH; Kitayama, K; Akama, TO; Sugihara, K; Kanayama, N; Kojima-Aikawa, K; Seeberger, PH; Fukuda, M; Suzuki, A; Aoki, D; Fukuda, MN				Shibata, Toshiaki K.; Matsumura, Fumiko; Wang, Ping; Yu, ShinYi; Chou, Chi-Chi; Khoo, Kay-Hooi; Kitayama, Kazuko; Akama, Tomoya O.; Sugihara, Kazuhiro; Kanayama, Naohiro; Kojima-Aikawa, Kyoko; Seeberger, Peter H.; Fukuda, Minoru; Suzuki, Atsushi; Aoki, Daisuke; Fukuda, Michiko N.			Identification of Mono- and Disulfated N-Acetyl-lactosaminyl Oligosaccharide Structures as Epitopes Specifically Recognized by Humanized Monoclonal Antibody HMOCC-1 Raised against Ovarian Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORNEAL KERATAN SULFATE; BLOOD-GROUP ANTIGEN; MOLECULAR-CLONING; L-SELECTIN; SIALYL LEWIS(X); O-GLYCANS; GLCNAC 6-O-SULFOTRANSFERASE; HEPARAN-SULFATE; EXPRESSION; GENE	A humanized monoclonal antibody raised against human ovarian cancer RMG-I cells and designated as HMOCC-1 (Suzuki, N., Aoki, D., Tamada, Y., Susumu, N., Orikawa, K., Tsukazaki, K., Sakayori, M., Suzuki, A., Fukuchi, T., Mukai, M., Kojima-Aikawa, K., Ishida, I., and Nozawa, S. (2004) Gynecol. Oncol. 95, 290-298) was characterized for its carbohydrate epitope structure. Specifically, a series of co-transfections was performed using mammalian expression vectors encoding specific glycosyltransferases and sulfotransferases. These experiments identified one sulfotransferase, GAL3ST3, and one glycosyltransferase, B3GNT7, as required for HMOCC-1 antigen formation. They also suggested that the sulfotransferase CHST1 regulates the abundance and intensity of HMOCC-1 antigen. When HEK293T cells were co-transfected with GAL3ST3 and B3GNT7 expression vectors, transfected cells weakly expressed HMOCC-1 antigen. When cells were first co-transfected with GAL3ST3 and B3GNT7 and then with CHST1, the resulting cells strongly expressed HMOCC-1 antigen. However, when cells were transfected with a mixture of GAL3ST3 and CHST1 before or after transfection with B3GNT7, the number of anti-gen-positive cells decreased relative to the number seen with only GAL3ST3 and B3GNT7, suggesting that CHST1 plays a regulatory role in HMOCC-1 antigen formation. Because these results predicted that HMOCC-1 antigens are SO3 -> 3Gal beta 1 -> 4GlcNAc beta 1 -> 3(+/- SO3 -> 6)Gal beta 1 -> 4GlcNAc, we chemically synthesized mono- and disulfated and unsulfated oligosaccharides. Immunoassays using these oligosaccharides as inhibitors showed the strongest activity by disulfated tetrasaccharide, weak but positive activity by monosulfated tetrasaccharide at the terminal galactose, and no activity by nonsulfated tetrasaccharides. These results establish the HMOCC-1 epitope, which should serve as a useful reagent to further characterize ovarian cancer.	[Shibata, Toshiaki K.; Matsumura, Fumiko; Wang, Ping; Kitayama, Kazuko; Akama, Tomoya O.; Seeberger, Peter H.; Fukuda, Minoru; Fukuda, Michiko N.] Sanford Burnham Med Res Inst, Tumor Microenvironm Program, Ctr Canc, La Jolla, CA 92037 USA; [Yu, ShinYi; Chou, Chi-Chi; Khoo, Kay-Hooi] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan; [Sugihara, Kazuhiro; Kanayama, Naohiro] Hamamatsu Univ Sch Med, Dept Gynecol & Obstet, Hamamatsu, Shizuoka 4313192, Japan; [Kojima-Aikawa, Kyoko] Ochanomizu Univ, Grad Sch Humanities & Sci, Tokyo 1128610, Japan; [Seeberger, Peter H.] Max Planck Inst Colloids & Interfaces, Dept Biomol Syst, D-14476 Potsdam, Germany; [Suzuki, Atsushi; Aoki, Daisuke] Keio Univ, Sch Med, Dept Obstet & Gynecol, Shinjuku Ku, Tokyo 1600016, Japan	Sanford Burnham Prebys Medical Discovery Institute; Academia Sinica - Taiwan; Hamamatsu University School of Medicine; Ochanomizu University; Max Planck Society; Keio University	Fukuda, MN (corresponding author), Sanford Burnham Med Res Inst, Tumor Microenvironm Program, Ctr Canc, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	michiko@sanfordburnham.org	Chou, Chi-Chi/X-6053-2019; Khoo, Kay-Hooi/E-1989-2019; Wang, Ping/I-6183-2013; Aoki, Daisuke/E-6650-2014	Chou, Chi-Chi/0000-0002-7862-7757; Khoo, Kay-Hooi/0000-0003-2906-406X; Kitayama, Kazuko/0000-0003-2829-762X; KAWASAKI, FUMIKO/0000-0002-6641-2599; YU, Shin-Yi/0000-0003-0197-9575; Wang, Ping/0000-0002-8640-1483	National Institutes of Health [CA33895, EY014620]; NSC [100-2325-B-001-029]; NATIONAL CANCER INSTITUTE [R01CA033895] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014620] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23792096] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSC(Ministry of Science and Technology, Taiwan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA33895 (to M.N.F.) and EY014620 (to T.O.A.).; The MS data were acquired at the Core Facilities for Protein Structural Analysis at Academia Sinica, supported under the Taiwan National Core Facility Program for Biotechnology, NSC Grant 100-2325-B-001-029. We thank Dr. Elise Lamar for editing of the manuscript.	Aguilan JT, 2009, GLYCOBIOLOGY, V19, P971, DOI 10.1093/glycob/cwp074; Akama TO, 2000, NAT GENET, V26, P237, DOI 10.1038/79987; Akama TO, 2002, J BIOL CHEM, V277, P42505, DOI 10.1074/jbc.M207412200; Akama TO, 2001, J BIOL CHEM, V276, P16271, DOI 10.1074/jbc.M009995200; ALBANO RM, 1986, J BIOL CHEM, V261, P758; BIERHUIZEN MFA, 1993, GENE DEV, V7, P468, DOI 10.1101/gad.7.3.468; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Clark RA, 1998, J CELL BIOL, V140, P721, DOI 10.1083/jcb.140.3.721; FEIZI T, 1994, METHOD ENZYMOL, V230, P484; Fukuda M, 1996, CANCER RES, V56, P2237; Fukuda MN, 2008, J OBSTET GYNAECOL RE, V34, P129, DOI 10.1111/j.1447-0756.2008.00776.x; Fukui S, 2002, NAT BIOTECHNOL, V20, P1011, DOI 10.1038/nbt735; Fukuta M, 1997, J BIOL CHEM, V272, P32321, DOI 10.1074/jbc.272.51.32321; Genbacev OD, 2003, SCIENCE, V299, P405, DOI 10.1126/science.1079546; HAKOMORI S, 1983, B CANCER, V70, P118; HAKOMORI SI, 1989, ADV CANCER RES, V52, P257; Hirakawa J, 2010, J BIOL CHEM, V285, P40864, DOI 10.1074/jbc.M110.167296; Hiraoka N, 1999, IMMUNITY, V11, P79, DOI 10.1016/S1074-7613(00)80083-7; Isshiki S, 1999, J BIOL CHEM, V274, P12499, DOI 10.1074/jbc.274.18.12499; Iwai T, 2002, J BIOL CHEM, V277, P12802, DOI 10.1074/jbc.M112457200; Izawa M, 2000, CANCER RES, V60, P1410; Jain RK, 1997, CHEM COMMUN, P23, DOI 10.1039/a605439k; KANNAGI R, 1986, CANCER RES, V46, P2619; Kannagi R, 2000, METHOD ENZYMOL, V312, P160; Khoo KH, 2010, METHOD ENZYMOL, V478, P3, DOI 10.1016/S0076-6879(10)78001-0; Kitayama K, 2007, J BIOL CHEM, V282, P30085, DOI 10.1074/jbc.M703695200; KUKOWSKALATALLO JF, 1990, GENE DEV, V4, P1288, DOI 10.1101/gad.4.8.1288; Kumamoto K, 1998, BIOCHEM BIOPH RES CO, V247, P514, DOI 10.1006/bbrc.1998.8824; LARSEN RD, 1990, P NATL ACAD SCI USA, V87, P6674, DOI 10.1073/pnas.87.17.6674; MAGNANI JL, 1984, ARCH BIOCHEM BIOPHYS, V233, P501, DOI 10.1016/0003-9861(84)90473-9; MCEVER RP, 1995, J BIOL CHEM, V270, P11025, DOI 10.1074/jbc.270.19.11025; MIYAKE M, 1992, NEW ENGL J MED, V327, P14, DOI 10.1056/NEJM199207023270103; NAKAMORI S, 1993, CANCER RES, V53, P3632; Noti C, 2006, CHEM-EUR J, V12, P8664, DOI 10.1002/chem.200601103; Nozawa S, 2004, CLIN CANCER RES, V10, P7071, DOI 10.1158/1078-0432.CCR-04-0802; Plante OJ, 2001, SCIENCE, V291, P1523, DOI 10.1126/science.1057324; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Rosen SD, 2006, J IMMUNOL, V177, P3, DOI 10.4049/jimmunol.177.1.3; Seeberger PH, 2005, NAT REV DRUG DISCOV, V4, P751, DOI 10.1038/nrd1823; Seko A, 2004, FEBS LETT, V556, P216, DOI 10.1016/S0014-5793(03)01440-6; Seko A, 2002, GLYCOBIOLOGY, V12, P379, DOI 10.1093/glycob/12.6.379; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Stoll MS, 2000, EUR J BIOCHEM, V267, P1795, DOI 10.1046/j.1432-1327.2000.01178.x; STREETER PR, 1988, J CELL BIOL, V107, P1853, DOI 10.1083/jcb.107.5.1853; Suzuki A, 2001, J BIOL CHEM, V276, P24388, DOI 10.1074/jbc.M103135200; Suzuki N, 2004, GYNECOL ONCOL, V95, P290, DOI 10.1016/j.ygyno.2004.06.024; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; Tully SE, 2006, J AM CHEM SOC, V128, P7740, DOI 10.1021/ja061906t; Uchimura K, 1998, J BIOL CHEM, V273, P22577, DOI 10.1074/jbc.273.35.22577; vanSeeventer PB, 1997, CARBOHYD RES, V299, P181, DOI 10.1016/S0008-6215(97)00013-X; Yeh JC, 2001, CELL, V105, P957, DOI 10.1016/S0092-8674(01)00394-4; Yeh JC, 1999, J BIOL CHEM, V274, P3215, DOI 10.1074/jbc.274.5.3215; Yin BWT, 1996, INT J CANCER, V65, P406, DOI 10.1002/(SICI)1097-0215(19960208)65:4<406::AID-IJC2>3.3.CO;2-5; Yu B, 2002, J ORG CHEM, V67, P9099, DOI 10.1021/jo026103c; Yusa A, 2010, CANCER RES, V70, P4064, DOI 10.1158/0008-5472.CAN-09-2383	57	18	19	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6592	6602		10.1074/jbc.M111.305334	http://dx.doi.org/10.1074/jbc.M111.305334			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22194598	hybrid, Green Published			2022-12-25	WOS:000300791800047
J	Goh, WI; Lim, KB; Sudhaharan, T; Sem, KP; Bu, WY; Chou, AM; Ahmed, S				Goh, Wah Ing; Lim, Kim Buay; Sudhaharan, Thankiah; Sem, Kai Ping; Bu, Wenyu; Chou, Ai Mei; Ahmed, Sohail			mDia1 and WAVE2 Proteins Interact Directly with IRSp53 in Filopodia and Are Involved in Filopodium Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIAPHANOUS-RELATED FORMINS; ACTIN-BUNDLING ACTIVITY; MIGRATING CELLS; GTPASE RIF; RHO; MEMBRANE; COMPLEX; CDC42; RAC; LOCALIZATION	Filopodia are dynamic actin-rich cell surface protrusions involved in cell migration, axon guidance, and wound healing. The RhoGTPase Cdc42 generates filopodia via IRSp53, a multidomain protein that links the processes of plasma membrane deformation and actin dynamics required for their formation in mammalian cells. The Src homology 3 domain of IRSp53 binds to the actin regulators Mena, Eps8, WAVE1, WAVE2, mDia1, and mDia2. We show that mDia1 and WAVE2 synergize with IRSp53 to form filopodia. IRSp53 also interacts directly with these two proteins within filopodia, as observed in acceptor photobleaching FRET studies. Measurement of filopodium formation by time-lapse imaging of live cells also revealed that depleting neuronal cells of either mDia1 or WAVE2 protein decreases the ability of IRSp53 to induce filopodia. In contrast, IRSp53 does not appear to partner WAVE1 or mDia2 to give rise to these structures. In addition, although all three isoforms of mDia are capable of inducing filopodia, IRSp53 requires only mDia1 to do so. These findings suggest that mDia1 and WAVE2 are important Src homology 3 domain partners of IRSp53 in forming filopodia.	[Goh, Wah Ing; Lim, Kim Buay; Sudhaharan, Thankiah; Sem, Kai Ping; Bu, Wenyu; Chou, Ai Mei; Ahmed, Sohail] Inst Med Biol, Immunos 138665, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Ahmed, S (corresponding author), Inst Med Biol, 8A Biomed Grove, Immunos 138665, Singapore.	sohail.ahmed@imb.a-star.edu.sg		Chou, Amy/0000-0002-6831-0799; Goh, Wah Ing/0000-0001-6594-0640				Abou-Kheir W, 2008, J CELL SCI, V121, P379, DOI 10.1242/jcs.010272; Ahmed S, 2010, SEMIN CELL DEV BIOL, V21, P350, DOI 10.1016/j.semcdb.2009.11.008; Arakawa Y, 2003, J CELL BIOL, V161, P381, DOI 10.1083/jcb.200210149; Beli P, 2008, NAT CELL BIOL, V10, P849, DOI 10.1038/ncb1745; Berger CN, 2009, CELL MICROBIOL, V11, P309, DOI 10.1111/j.1462-5822.2008.01254.x; Block J, 2008, J MICROSC-OXFORD, V231, P506, DOI 10.1111/j.1365-2818.2008.02063.x; Bu WY, 2009, J BIOL CHEM, V284, P11622, DOI 10.1074/jbc.M805940200; Carramusa L, 2007, J CELL SCI, V120, P3870, DOI 10.1242/jcs.014365; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Dent EW, 2007, NAT CELL BIOL, V9, P1347, DOI 10.1038/ncb1654; Disanza A, 2006, NAT CELL BIOL, V8, P1337, DOI 10.1038/ncb1502; Dixit R, 2008, NEUROSCI LETT, V440, P113, DOI 10.1016/j.neulet.2008.05.031; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; Fan LF, 2010, J CELL SCI, V123, P1247, DOI 10.1242/jcs.061754; Fujiwara T, 2000, BIOCHEM BIOPH RES CO, V271, P626, DOI 10.1006/bbrc.2000.2671; Goh WI, 2011, J BIOL CHEM, V286, P13681, DOI 10.1074/jbc.M110.182683; Gomez TS, 2007, IMMUNITY, V26, P177, DOI 10.1016/j.immuni.2007.01.008; Govind S, 2001, J CELL BIOL, V152, P579, DOI 10.1083/jcb.152.3.579; Harris ES, 2006, J BIOL CHEM, V281, P14383, DOI 10.1074/jbc.M510923200; Hotulainen P, 2009, J CELL BIOL, V185, P323, DOI 10.1083/jcb.200809046; Ji P, 2008, NAT CELL BIOL, V10, P314, DOI 10.1038/ncb1693; Krugmann S, 2001, CURR BIOL, V11, P1645, DOI 10.1016/S0960-9822(01)00506-1; Kurisu S, 2010, CANCER SCI, V101, P2093, DOI 10.1111/j.1349-7006.2010.01654.x; Lanier LM, 1999, NEURON, V22, P313, DOI 10.1016/S0896-6273(00)81092-2; Lee K, 2010, SCIENCE, V329, P1341, DOI 10.1126/science.1191710; Lim KB, 2008, J BIOL CHEM, V283, P20454, DOI 10.1074/jbc.M710185200; Lin L, 2010, EXP CELL RES, V316, P2260, DOI 10.1016/j.yexcr.2010.05.006; Lizarraga F, 2009, CANCER RES, V69, P2792, DOI 10.1158/0008-5472.CAN-08-3709; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Mellor H, 2010, BBA-MOL CELL RES, V1803, P191, DOI 10.1016/j.bbamcr.2008.12.018; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Nakagawa H, 2003, J CELL SCI, V116, P2577, DOI 10.1242/jcs.00462; Nozumi M, 2003, J CELL SCI, V116, P239, DOI 10.1242/jcs.00233; Pellegrin S, 2005, CURR BIOL, V15, P129, DOI 10.1016/j.cub.2005.01.011; Peng J, 2003, CURR BIOL, V13, P534, DOI 10.1016/S0960-9822(03)00170-2; Ramalingam N, 2010, EUR J CELL BIOL, V89, P723, DOI 10.1016/j.ejcb.2010.06.001; Robens JM, 2010, MOL CELL BIOL, V30, P829, DOI 10.1128/MCB.01574-08; Roffers-Agarwal J, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-36; Sudhaharan T, 2009, J BIOL CHEM, V284, P13602, DOI 10.1074/jbc.M900894200; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tokuo H, 2004, BIOCHEM BIOPH RES CO, V319, P214, DOI 10.1016/j.bbrc.2004.04.167; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Wallar BJ, 2007, EXP CELL RES, V313, P560, DOI 10.1016/j.yexcr.2006.10.033; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Watanabe S, 2010, MOL BIOL CELL, V21, P3193, DOI 10.1091/mbc.E10-04-0324; Yamagishi A, 2004, J BIOL CHEM, V279, P14929, DOI 10.1074/jbc.M309408200; Yamana N, 2006, MOL CELL BIOL, V26, P6844, DOI 10.1128/MCB.00283-06; Yamazaki D, 2003, NATURE, V424, P452, DOI 10.1038/nature01770; Yan C, 2003, EMBO J, V22, P3602, DOI 10.1093/emboj/cdg350; Yang C, 2007, PLOS BIOL, V5, P2624, DOI 10.1371/journal.pbio.0050317; Young KG, 2010, BBA-MOL CELL RES, V1803, P183, DOI 10.1016/j.bbamcr.2008.09.017; Zaoui K, 2008, J CELL BIOL, V183, P401, DOI 10.1083/jcb.200805107	56	54	55	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4702	4714		10.1074/jbc.M111.305102	http://dx.doi.org/10.1074/jbc.M111.305102			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22179776	Green Published, hybrid			2022-12-25	WOS:000300608500032
J	Das, F; Ghosh-Choudhury, N; Dey, N; Mandal, CC; Mahimainathan, L; Kasinath, BS; Abboud, HE; Choudhury, GG				Das, Falguni; Ghosh-Choudhury, Nandini; Dey, Nirmalya; Mandal, Chandi Charan; Mahimainathan, Lenin; Kasinath, Balakuntalam S.; Abboud, Hanna E.; Choudhury, Goutam Ghosh			Unrestrained Mammalian Target of Rapamycin Complexes 1 and 2 Increase Expression of Phosphatase and Tensin Homolog Deleted on Chromosome 10 to Regulate Phosphorylation of Akt Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; TUBEROUS-SCLEROSIS; INSULIN-RESISTANCE; SIGNALING PATHWAY; BINDING PARTNER; MTOR; ACTIVATION; PTEN; TSC2; GROWTH	Tuberous sclerosis complex 2 (TSC2) and phosphatase and tensin homolog deleted on chromosome 10 (PTEN) function to block growth factor-induced mammalian target of rapamycin (mTOR) signaling and are mutated in autosomal dominant hamartoma syndromes. mTOR binds to a spectrum of common and different proteins to form TOR complex 1 (TORC1) and TORC2, which regulate cell growth, division, and metabolism. TSC2 deficiency induces constitutive activation of mTOR, leading to a state of insulin resistance due to a negative feedback regulation, resulting in reduced Akt phosphorylation. We have recently described an alternative mechanism showing that in TSC2 deficiency, enhanced PTEN expression contributes to reduced Akt phosphorylation. To explore the mechanism of PTEN regulation, we used rapamycin and constitutively active mTOR to show that TORC1 increases the expression of PTEN mRNA and protein. We found that in TSC2(-/-) mouse embryonic fibroblasts expression of a kinase-dead mutant of mTOR, which inhibits both TORC1 and TORC2, decreases the expression of PTEN via transcriptional mechanism. Furthermore, kinase-deadm TOR increased and decreased phosphorylation of Akt at catalytic loop site Thr-308 and hydrophobic motif site Ser-473, respectively. Moreover, inhibition of deregulated TORC1 in TSC2-null mouse embryonic fibroblasts or in 293 cells by down-regulation of raptor decreased the levels of the transcription factor Hif1 alpha and blocked PTEN expression, resulting in enhanced phosphorylation of Akt at Thr-308 and Ser-473. Finally, knockdown of rictor or mSin1 attenuated the expression of Hif1 alpha, which decreased transcription of PTEN. These results unravel a previously unrecognized cell-autonomous function of TORC1 and TORC2 in the up-regulation of PTEN, which prevents phosphorylation of Akt and may shield against the development of malignancy in TSC patients.	[Das, Falguni; Dey, Nirmalya; Mahimainathan, Lenin; Kasinath, Balakuntalam S.; Abboud, Hanna E.; Choudhury, Goutam Ghosh] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Ghosh-Choudhury, Nandini; Mandal, Chandi Charan] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Choudhury, Goutam Ghosh] S Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Ctr, San Antonio, TX 78229 USA; [Ghosh-Choudhury, Nandini; Choudhury, Goutam Ghosh] S Texas Vet Hlth Care Syst, Vet Affairs Res, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Choudhury, GG (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	choudhuryg@uthscsa.edu		/0000-0001-5077-3552; Mandal, Chandi/0000-0002-2292-6635	National Institutes of Health [RO1 DK50190, RO1 AR 52425, RO1 DK 077295, RC2A 036613]; Veterans Affairs Merit Review; Cancer Therapy and Research Center, San Antonio; Veterans Affairs Senior Research Career Scientist Award; Juvenile Diabetes Research Foundation [1-2008-185]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050190, R01DK077295, R01DK078971] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review(US Department of Veterans Affairs); Cancer Therapy and Research Center, San Antonio; Veterans Affairs Senior Research Career Scientist Award; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK50190 (to G. G. C.), RO1 AR 52425 (to N. G. C.). This work was also supported by Veterans Affairs Merit Review grant (to G. G. C.).; Supported by Veterans Affairs Merit Review grants and a Ronald P. Williams Orthopedic Oncology Developmental Research Award from Cancer Therapy and Research Center, San Antonio.; Supported by NIH RO1 DK 077295, RC2A 036613, and Veterans Affairs Research Service grant.; Recipient of a Veterans Affairs Senior Research Career Scientist Award and supported by Regular Research Grant 1-2008-185 from the Juvenile Diabetes Research Foundation. To whom correspondence should be addressed: Dept. of Medicine, University of Texas Health Science Center, 7703 Floyd Curl Dr., San Antonio, TX 78229. E-mail: choudhuryg@uthscsa.edu.	Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Brugarolas JB, 2003, CANCER CELL, V4, P147, DOI 10.1016/S1535-6108(03)00187-9; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Chandrasekar B, 2006, BIOCHEM BIOPH RES CO, V339, P956, DOI 10.1016/j.bbrc.2005.11.100; Cheadle JP, 2000, HUM GENET, V107, P97, DOI 10.1007/s004390000348; Choudhury GG, 2004, J BIOL CHEM, V279, P27399, DOI 10.1074/jbc.M403530200; Cloughesy TF, 2008, PLOS MED, V5, P139, DOI 10.1371/journal.pmed.0050008; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Dabora SL, 2001, AM J HUM GENET, V68, P64, DOI 10.1086/316951; Das F, 2008, CELL SIGNAL, V20, P409, DOI 10.1016/j.cellsig.2007.10.027; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; El-Hashemite N, 2003, LANCET, V361, P1348, DOI 10.1016/S0140-6736(03)13044-9; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Ghosh-Choudhury T, 2009, BREAST CANCER RES TR, V118, P213, DOI 10.1007/s10549-008-0227-7; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Ji SP, 2006, NAT MED, V12, P324, DOI 10.1038/nm1349; Kasinath BS, 2009, AM J PHYSIOL-RENAL, V297, pF1153, DOI 10.1152/ajprenal.90748.2008; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Lamborn KR, 2008, NEURO-ONCOLOGY, V10, P162, DOI 10.1215/15228517-2007-062; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li Y, 2004, TRENDS BIOCHEM SCI, V29, P32, DOI 10.1016/j.tibs.2003.11.007; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Ma L, 2007, CANCER RES, V67, P7106, DOI 10.1158/0008-5472.CAN-06-4798; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mahimainathan L, 2004, J BIOL CHEM, V279, P15258, DOI 10.1074/jbc.M314328200; Mahimainathan L, 2009, J BIOL CHEM, V284, P27790, DOI 10.1074/jbc.M109.028860; Manning BD, 2005, GENE DEV, V19, P1773, DOI 10.1101/gad.1314605; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Ohne Y, 2008, J BIOL CHEM, V283, P31861, DOI 10.1074/jbc.M801546200; Riemenschneider MJ, 2006, CANCER RES, V66, P5618, DOI 10.1158/0008-5472.CAN-06-0364; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Saal LH, 2008, NAT GENET, V40, P102, DOI 10.1038/ng.2007.39; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Scheid MP, 2003, FEBS LETT, V546, P108, DOI 10.1016/S0014-5793(03)00562-3; Shah OJ, 2006, MOL CELL BIOL, V26, P6425, DOI 10.1128/MCB.01254-05; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shah OJ, 2005, CELL CYCLE, V4, P46, DOI 10.4161/cc.4.1.1343; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Stiles BL, 2009, INT J BIOCHEM CELL B, V41, P757, DOI 10.1016/j.biocel.2008.09.022; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Thomas GV, 2006, NAT MED, V12, P122, DOI 10.1038/nm1337; Virolle T, 2001, NAT CELL BIOL, V3, P1124, DOI 10.1038/ncb1201-1124; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Wymann MP, 2005, CURR OPIN CELL BIOL, V17, P141, DOI 10.1016/j.ceb.2005.02.011; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhang HB, 2007, J CLIN INVEST, V117, P730, DOI 10.1172/JCI28984; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	65	32	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3808	3822		10.1074/jbc.M111.246397	http://dx.doi.org/10.1074/jbc.M111.246397			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22184110	Green Published, hybrid			2022-12-25	WOS:000300410900018
J	Guo, HX; Kan, YC; Liu, WQ				Guo, Hongxiang; Kan, Yunchao; Liu, Weiqun			Differential Expression of miRNAs in Response to Topping in Flue-Cured Tobacco (Nicotiana tabacum) Roots	PLOS ONE			English	Article							TERMINAL DOMAIN; TARGET GENES; BINDING-PROTEIN; PLANT MICRORNA; ARABIDOPSIS; IDENTIFICATION; ENCODES; RNA; SUPPRESSION; HOMEOSTASIS	Background: Topping is an important cultivating measure for flue-cured tobacco, and many genes had been found to be differentially expressed in response to topping. But it is still unclear how these genes are regulated. MiRNAs play a critical role in post-transcriptional gene regulation, so we sequenced two sRNA libraries from tobacco roots before and after topping, with a view to exploring transcriptional differences in miRNAs. Methodology/Principal Findings: Two sRNA libraries were generated from tobacco roots before and after topping. Solexa high-throughput sequencing of tobacco small RNAs revealed a total of 12,104,207 and 11,292,018 reads representing 3,633,398 and 3,084,102 distinct sequences before and after topping. The expressions of 136 conserved miRNAs (belonging to 32 families) and 126 new miRNAs (belonging to 77 families) were determined. There were three major conserved miRNAs families (nta-miR156, nta-miR172 and nta-miR171) and two major new miRNAs families (nta-miRn2 and nta-miRn26). All of these identified miRNAs can be folded into characteristic miRNA stem-loop secondary hairpin structures, and qRT-PCR was adopted to validate and measure the expression of miRNAs. Putative targets were identified for 133 out of 136 conserved miRNAs and 126 new miRNAs. Of these miRNAs whose targets had been identified, the miRNAs which change markedly (>2 folds) belong to 53 families and their targets have different biological functions including development, response to stress, response to hormone, N metabolism, C metabolism, signal transduction, nucleic acid metabolism and other metabolism. Some interesting targets for miRNAs had been determined. Conclusions/Significance: The differential expression profiles of miRNAs were shown in flue-cured tobacco roots before and after topping, which can be expected to regulate transcripts distinctly involved in response to topping. Further identification of these differentially expressed miRNAs and their targets would allow better understanding of the regulatory mechanisms for flue-cured tobacco response to topping.	[Guo, Hongxiang; Liu, Weiqun] Henan Agr Univ, Coll Life Sci, Key Lab Natl Tobacco Cultivat, Zhengzhou, Peoples R China; [Kan, Yunchao] Nanyang Normal Univ, China UK NYNU RRes Joint Lab Insect Biol, Nanyang, Peoples R China	Henan Agricultural University; Nanyang Normal College	Guo, HX (corresponding author), Henan Agr Univ, Coll Life Sci, Key Lab Natl Tobacco Cultivat, Zhengzhou, Peoples R China.	microrna09@126.com			National Natural Science Foundation of China [30971704]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the project of National Natural Science Foundation of China (30971704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Kamei CLA, 2008, PLANT PHYSIOL, V147, P1735, DOI 10.1104/pp.108.122226; BALDWIN IT, 1994, J CHEM ECOL, V20, P2139, DOI 10.1007/BF02066250; Bari R, 2006, PLANT PHYSIOL, V141, P988, DOI 10.1104/pp.106.079707; Bellec Y, 2002, PLANT J, V32, P713, DOI 10.1046/j.1365-313X.2002.01456.x; Chen QH, 2005, FREE RADICAL BIO MED, V38, P226, DOI 10.1016/j.freeradbiomed.2004.10.019; Chen XB, 2010, J INTEGR PLANT BIOL, V52, P946, DOI 10.1111/j.1744-7909.2010.00987.x; Chen XM, 2005, FEBS LETT, V579, P5923, DOI 10.1016/j.febslet.2005.07.071; Dutting S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-2; Frazier TP, 2011, MOL BIOTECHNOL, V49, P159, DOI 10.1007/s12033-011-9387-5; Frazier TP, 2010, PLANTA, V232, P1289, DOI 10.1007/s00425-010-1255-1; Galway ME, 2011, PLANTA, V233, P985, DOI 10.1007/s00425-011-1355-6; Gao MJ, 2004, PLANT MOL BIOL, V55, P417, DOI 10.1007/s11103-004-0892-9; Gu HD, 2003, NUCLEIC ACIDS RES, V31, P6264, DOI 10.1093/nar/gkg823; HIROSHI A, 1997, PLANT CELL, V9, P1859; HU GS, 1999, J HENAN AGR SCI, V1, P10; Kawashima CG, 2009, PLANT J, V57, P313, DOI 10.1111/j.1365-313X.2008.03690.x; Knill T, 2008, PLANT PHYSIOL, V146, P1028, DOI 10.1104/pp.107.111609; Lee S, 2003, PLANT PHYSIOL, V131, P656, DOI 10.1104/pp.014118; Li CJ, 2007, PLANT SIGNAL BEHAV, V2, P280, DOI 10.4161/psb.2.4.4008; Lin Fan-Yun, 2008, Yichuan, V30, P1608, DOI 10.3724/SP.J.1005.2008.01608; LIN GH, 2004, ACTA BOT BOREALI-OCC, V7, P1362; Liu WeiQun, 2008, Agricultural Sciences in China, V7, P1084, DOI 10.1016/S1671-2927(08)60150-9; [刘卫群 Liu Weiqun], 2005, [河南农业大学学报, JOURNAL OF HENAN AGRICULTURAL UNIVERSITY], V39, P26; [刘卫群 Liu Weiqun], 2004, [植物营养与肥料学报, Plant nutrition and fertitizer science], V10, P104; Lores P, 2010, FEBS J, V277, P1453, DOI 10.1111/j.1742-4658.2010.07575.x; Mayer U, 1999, EUR J CELL BIOL, V78, P100, DOI 10.1016/S0171-9335(99)80011-9; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; Meng YJ, 2010, BIOCHEM BIOPH RES CO, V393, P345, DOI 10.1016/j.bbrc.2010.01.129; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Morikawa T, 2006, PLANT CELL, V18, P1008, DOI 10.1105/tpc.105.036012; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Nakatsuka A, 1998, PLANT PHYSIOL, V118, P1295, DOI 10.1104/pp.118.4.1295; Ng DWK, 2011, PLANT CELL, V23, P1729, DOI 10.1105/tpc.111.083915; Oh S, 2003, J EXP BOT, V54, P2709, DOI 10.1093/jxb/erg304; Park HC, 2007, NUCLEIC ACIDS RES, V35, P3612, DOI 10.1093/nar/gkm273; Qi YuanCheng, 2011, Scientia Agricultura Sinica, V44, P1331; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; RICHARD W, 1994, EMBO J, V13, P4729; SERIZAWA H, 1994, J BIOL CHEM, V269, P20750; Shiozawa K, 2004, J BIOL CHEM, V279, P50060, DOI 10.1074/jbc.M407837200; Shoji T, 2000, PLANT CELL PHYSIOL, V41, P831, DOI 10.1093/pcp/pcd001; SISTRUNK ML, 1994, PLANT CELL, V6, P1553, DOI 10.1105/tpc.6.11.1553; Slavikova S, 2008, J EXP BOT, V59, P4029, DOI 10.1093/jxb/ern244; Sun YJ, 2007, J INTEGR PLANT BIOL, V49, P940, DOI 10.1111/j.1744-7909.2007.00498.x; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-37; Takatsuji H, 1999, PLANT MOL BIOL, V39, P1073, DOI 10.1023/A:1006184519697; Tanaka N, 2005, J PROTEOME RES, V4, P1575, DOI 10.1021/pr050114f; Tiwari S, 2008, PLANT CELL, V20, P2387, DOI 10.1105/tpc.108.061929; Turlapati PV, 2011, PLANTA, V233, P439, DOI 10.1007/s00425-010-1298-3; Wagner A, 2009, PLANT PHYSIOL, V149, P370, DOI 10.1104/pp.108.125765; Wang C, 2009, PLANT J, V57, P895, DOI 10.1111/j.1365-313X.2008.03734.x; Wang RC, 2009, PLANT PHYSIOL, V151, P472, DOI 10.1104/pp.109.140434; Weber H, 2009, FEBS J, V276, P6624, DOI 10.1111/j.1742-4658.2009.07373.x; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Wurzinger B, 2011, PLANT SIGNAL BEHAV, V6, P8, DOI 10.4161/psb.6.1.14012; Xie Q, 2000, GENE DEV, V14, P3024, DOI 10.1101/gad.852200; Yamasaki H, 2007, J BIOL CHEM, V282, P16369, DOI 10.1074/jbc.M700138200; YI JH, 2006, J ANHUI AGR SCI, V34, P2777; [易建华 YI Jianhua], 2006, [安徽农业科学, Journal of anhui agricultural sciences], V34; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; Zhang BH, 2006, FEBS LETT, V580, P3753, DOI 10.1016/j.febslet.2006.05.063; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhao BT, 2007, BIOCHEM BIOPH RES CO, V354, P585, DOI 10.1016/j.bbrc.2007.01.022; Zhao L, 2007, PLANT J, V51, P840, DOI 10.1111/j.1365-313X.2007.03181.x	66	21	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28565	10.1371/journal.pone.0028565	http://dx.doi.org/10.1371/journal.pone.0028565			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194852	gold, Green Published, Green Submitted			2022-12-25	WOS:000298369100052
J	Zhang, Y; Jiang, WK; Gao, LZ				Zhang, Yun; Jiang, Wen-kai; Gao, Li-zhi			Evolution of MicroRNA Genes in Oryza sativa and Arabidopsis thaliana: An Update of the Inverted Duplication Model	PLOS ONE			English	Article							SMALL RNAS; GENOME; MIRNA; DIVERSIFICATION; CANALIZATION; SUPPRESSION; EXPRESSION; SEQUENCES; PETUNIA; BIOLOGY	The origin and evolution of microRNA (miRNA) genes, which are of significance in tuning and buffering gene expressions in a number of critical cellular processes, have long attracted evolutionary biologists. However, genome-wide perspectives on their origins, potential mechanisms of their de novo generation and subsequent evolution remain largely unsolved in flowering plants. Here, genome-wide analyses of Oryza sativa and Arabidopsis thaliana revealed apparently divergent patterns of miRNA gene origins. A large proportion of miRNA genes in O. sativa were TE-related and MITE-related miRNAs in particular, whereas the fraction of these miRNA genes much decreased in A. thaliana. Our results show that the majority of TE-related and pseudogene-related miRNA genes have originated through inverted duplication instead of segmental or tandem duplication events. Based on the presented findings, we hypothesize and illustrate the four likely molecular mechanisms to de novo generate novel miRNA genes from TEs and pseudogenes. Our rice genome analysis demonstrates that non-MITEs and MITEs mediated inverted duplications have played different roles in de novo generating miRNA genes. It is confirmed that the previously proposed inverted duplication model may give explanations for non-MITEs mediated duplication events. However, many other miRNA genes, known from the earlier proposed model, were rather arisen from MITE transpositions into target genes to yield binding sites. We further investigated evolutionary processes spawned from de novo generated to maturely-formed miRNA genes and their regulatory systems. We found that miRNAs increase the tunability of some gene regulatory systems with low gene copy numbers. The results also suggest that gene balance effects may have largely contributed to the evolution of miRNA regulatory systems.	[Zhang, Yun; Jiang, Wen-kai; Gao, Li-zhi] Chinese Acad Sci, Plant Germplasm & Genom Ctr, Kunming Inst Bot, Kunming, Peoples R China; [Zhang, Yun] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, Y (corresponding author), Chinese Acad Sci, Plant Germplasm & Genom Ctr, Kunming Inst Bot, Kunming, Peoples R China.	Lgao@mail.kib.ac.cn	Zhang, Yun/AAG-9646-2021		Chinese Academy of Sciences (CAS) [KSCX2-YW-N-029]; Talents Program of Yunnan Province [20080A009]; Chinese Department of Science and Technology [2007CB815703]; Kunming Institute of Botany, CAS	Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences); Talents Program of Yunnan Province; Chinese Department of Science and Technology; Kunming Institute of Botany, CAS(Chinese Academy of Sciences)	This work was supported by the Hundreds Talents Program of the Chinese Academy of Sciences (CAS), Talents Program of Yunnan Province (20080A009), a grant from the Chinese Academy of Science (KSCX2-YW-N-029), a grant from Chinese Department of Science and Technology (973 Program 2007CB815703) and a startup grant from Kunming Institute of Botany, CAS to Dr. Gao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Bartel B, 2005, NAT STRUCT MOL BIOL, V12, P569, DOI 10.1038/nsmb0705-569; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; Birchler JA, 2007, PLANT CELL, V19, P395, DOI 10.1105/tpc.106.049338; Chandler VL, 2007, CELL, V128, P641, DOI 10.1016/j.cell.2007.02.007; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; De Felippes FF, 2008, RNA, V14, P2455, DOI 10.1261/rna.1149408; Devor EJ, 2006, J HERED, V97, P186, DOI 10.1093/jhered/esj022; Dewannieux M, 2005, CYTOGENET GENOME RES, V110, P35, DOI 10.1159/000084936; Fahlgren N, 2010, PLANT CELL, V22, P1074, DOI 10.1105/tpc.110.073999; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Grosshans H, 2008, NATURE, V451, P414, DOI 10.1038/451414a; Gu ZL, 2002, MOL BIOL EVOL, V19, P256, DOI 10.1093/oxfordjournals.molbev.a004079; Guo XY, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000449; Guo XY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-454; Ha M, 2009, P NATL ACAD SCI USA, V106, P17835, DOI 10.1073/pnas.0907003106; Hennig W, 2004, CELL RES, V14, P1, DOI 10.1038/sj.cr.7290196; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Kim VN, 2008, CELL, V133, P25, DOI 10.1016/j.cell.2008.03.015; Kopelman NM, 2005, NAT GENET, V37, P588, DOI 10.1038/ng1575; Leung AKL, 2007, CELL, V130, P581, DOI 10.1016/j.cell.2007.08.010; Li JJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r132; Li YY, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-18; Lu J, 2008, NAT GENET, V40, P351, DOI 10.1038/ng.73; Luo QJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000457; Ma ZR, 2010, PLANT CELL, V22, P1090, DOI 10.1105/tpc.110.073882; Maher C, 2006, GENOME RES, V16, P510, DOI 10.1101/gr.4680506; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Masel J, 2010, TRENDS GENET, V26, P406, DOI 10.1016/j.tig.2010.06.002; Mello CC, 2007, CELL DEATH DIFFER, V14, P2013, DOI 10.1038/sj.cdd.4402252; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Naito K, 2009, NATURE, V461, P1130, DOI 10.1038/nature08479; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Niu QW, 2006, NAT BIOTECHNOL, V24, P1420, DOI 10.1038/nbt1255; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Piriyapongsa J, 2008, RNA, V14, P814, DOI 10.1261/rna.916708; Piriyapongsa J, 2007, GENETICS, V176, P1323, DOI 10.1534/genetics.107.072553; Sasidharan R, 2008, NATURE, V453, P729, DOI 10.1038/453729a; Sharp PA, 2009, CELL, V136, P577, DOI 10.1016/j.cell.2009.02.007; Smalheiser NR, 2006, TRENDS GENET, V22, P532, DOI 10.1016/j.tig.2006.08.007; Smalheiser NR, 2005, TRENDS GENET, V21, P322, DOI 10.1016/j.tig.2005.04.008; Smith SA, 2008, SCIENCE, V322, P86, DOI 10.1126/science.1163197; Takuno S, 2008, TRENDS GENET, V24, P56, DOI 10.1016/j.tig.2007.11.002; VANDERKROL AR, 1990, PLANT CELL, V2, P291, DOI 10.1105/tpc.2.4.291; Vazquez F, 2008, NUCLEIC ACIDS RES, V36, P6429, DOI 10.1093/nar/gkn670; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wu CI, 2009, GENOME RES, V19, P734, DOI 10.1101/gr.084640.108; Wu L, 2009, PLANT CELL, V21, P3421, DOI 10.1105/tpc.109.070938; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zeller G, 2008, GENOME RES, V18, P918, DOI 10.1101/gr.070169.107; Zhang WX, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r81	58	21	23	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28073	10.1371/journal.pone.0028073	http://dx.doi.org/10.1371/journal.pone.0028073			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194805	gold, Green Submitted, Green Published			2022-12-25	WOS:000298369100020
J	Yasar, S; Ko, JY; Nothelle, S; Mielke, MM; Carlson, MC				Yasar, Sevil; Ko, Jean Y.; Nothelle, Stephanie; Mielke, Michelle M.; Carlson, Michelle C.			Evaluation of the Effect of Systolic Blood Pressure and Pulse Pressure on Cognitive Function: The Women's Health and Aging Study II	PLOS ONE			English	Article							VASCULAR RISK-FACTORS; MINI-MENTAL-STATE; HYPERTENSION; DECLINE; ASSOCIATION; OLDER; AGE; DEMENTIA; DISEASE; PREVALENCE	Background: Evidence suggests that elevated systolic blood pressure (SBP) and pulse pressure (PP) in midlife is associated with increased risk for cognitive impairment later in life. There is mixed evidence regarding the effects of late life elevated SBP or PP on cognitive function, and limited information on the role of female gender. Methods/Principal Findings: Effects of SBPand PPon cognitive abilities at baseline and over a 9-year period were evaluated in 337 non-demented community-dwelling female participants over age 70 in the Women's Health and Aging Study II using logistic and Cox proportional hazards regression analyses. Participants aged 76-80 years with SBP >= 160 mmHg or PP >= 84 mmHg showed increased incidence of impairment on Trail Making Test-Part B (TMT, Part B), a measure of executive function, over time when compared to the control group that included participants with normal and pre-hypertensive SBP (<120 and 120-139 mmHg) or participants with low PP (<68 mmHg) (HR = 5.05 [95%CI = 1.42, 18.04], [HR = 5.12 [95%CI = 1.11; 23.62], respectively). Participants aged 70-75 years with PP >= 71 mmHg had at least a two-fold higher incidence of impairment on HVLT-I, a measure of verbal learning, over time when compared to participants with low PP (< 68 mmHg) (HR = 2.44 [95%CI = 1.11, 5.39]). Conclusions/Significance: Our data suggest that elevated SBP or PP in older non-demented women increases risk for late-life cognitive impairment and that PP could be used when assessing the risk for impairment in cognitive abilities. These results warrant further, larger studies to evaluate possible effects of elevated blood pressure in normal cognitive aging.	[Yasar, Sevil] Johns Hopkins Sch Med, Dept Med, Div Geriatr Med & Gerontol, Baltimore, MD USA; [Yasar, Sevil; Mielke, Michelle M.; Carlson, Michelle C.] Johns Hopkins Sch Med, Ctr Aging & Hlth, Baltimore, MD USA; [Ko, Jean Y.; Carlson, Michelle C.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA; [Nothelle, Stephanie] Indiana Univ Sch Med, Indianapolis, IN USA; [Mielke, Michelle M.] Mayo Clin, Div Epidemiol, Rochester, MN USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Indiana University System; Indiana University Bloomington; Mayo Clinic	Yasar, S (corresponding author), Johns Hopkins Sch Med, Dept Med, Div Geriatr Med & Gerontol, Baltimore, MD USA.	syasar1@jhmi.edu		Yasar, Sevil/0000-0002-5080-6534; Mielke, Michelle/0000-0001-7177-1185	NIH from the National Institute on Aging, National Institutes of Health [RO1 AG19825-02, RO1 AG11703-10]; National Institute of Aging [NIA: 1F31AG030908-01-A1]; Medical Student Training in Aging Research (MSTAR); NATIONAL INSTITUTE ON AGING [F31AG030908, R01AG019825, R01AG011703] Funding Source: NIH RePORTER	NIH from the National Institute on Aging, National Institutes of Health; National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Student Training in Aging Research (MSTAR); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported in part by NIH grants RO1 AG19825-02 and RO1 AG11703-10 from the National Institute on Aging, National Institutes of Health. Jean Y. Ko was supported by the National Institute of Aging (NIA: 1F31AG030908-01-A1) and Stephanie Nothelle was supported by the 2008 Medical Student Training in Aging Research (MSTAR) Program by The American Federation for Aging Research (AFAR) and the National Institute on Aging (NIA). The funders had no role in the study design, data collection, and analysis, decision to publish or preparation of the manuscript.	ABBOTT RD, 1988, JAMA-J AM MED ASSOC, V260, P3456, DOI 10.1001/jama.260.23.3456; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Birns J, 2009, J HUM HYPERTENS, V23, P86, DOI 10.1038/jhh.2008.80; Bohannon AD, 2002, J AM GERIATR SOC, V50, P424, DOI 10.1046/j.1532-5415.2002.50104.x; Brandt J., 1991, CLIN NEUROPSYCHOL, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]; Brookmeyer R, 2011, ALZHEIMERS DEMENT, V7, P61, DOI 10.1016/j.jalz.2010.11.007; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; de Simone G, 2005, HYPERTENSION, V45, P575, DOI 10.1161/01.HYP.0000158268.95012.08; Elias MF, 2003, INT J OBESITY, V27, P260, DOI 10.1038/sj.ijo.802225; ELIAS MF, 1993, AM J EPIDEMIOL, V138, P353, DOI 10.1093/oxfordjournals.aje.a116868; Elias PK, 2004, HYPERTENSION, V44, P631, DOI 10.1161/01.HYP.0000145858.07252.99; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fried LP, 1999, J CLIN EPIDEMIOL, V52, P27, DOI 10.1016/S0895-4356(98)00124-3; Froehlich TE, 2001, J AM GERIATR SOC, V49, P477, DOI 10.1046/j.1532-5415.2001.49096.x; Glynn RJ, 1999, JAMA-J AM MED ASSOC, V281, P438, DOI 10.1001/jama.281.5.438; Guo ZC, 1997, AM J EPIDEMIOL, V145, P1106; Hebert LE, 2004, NEUROLOGY, V62, P2021, DOI 10.1212/01.WNL.0000129258.93137.4B; Ivnik RJ, 1996, CLIN NEUROPSYCHOL, V10, P262, DOI 10.1080/13854049608406689; Kannel WB, 1998, AM HEART J, V136, P205, DOI 10.1053/hj.1998.v136.90226; Kearney PM, 2004, J HYPERTENS, V22, P11, DOI 10.1097/00004872-200401000-00003; Kilander L, 2000, AGE AGEING, V29, P243, DOI 10.1093/ageing/29.3.243; Kivipelto M, 2001, NEUROLOGY, V56, P1683, DOI 10.1212/WNL.56.12.1683; Knopman D, 2001, NEUROLOGY, V56, P42, DOI 10.1212/WNL.56.1.42; Kuller LH, 2010, J CLIN HYPERTENS, V12, P203, DOI 10.1111/j.1751-7176.2009.00234.x; LAUNER LJ, 1995, JAMA-J AM MED ASSOC, V274, P1846, DOI 10.1001/jama.274.23.1846; Legato MJ, 1998, J WOMENS HEALTH, V7, P199, DOI 10.1089/jwh.1998.7.199; Martins D, 2001, J Gend Specif Med, V4, P10; Obisesan TO, 2008, J AM GERIATR SOC, V56, P501, DOI 10.1111/j.1532-5415.2007.01592.x; Peters R, 2008, LANCET NEUROL, V7, P683, DOI 10.1016/S1474-4422(08)70143-1; Piguet O, 2003, NEUROEPIDEMIOLOGY, V22, P165, DOI 10.1159/000069886; PRENTICE RL, 1978, BIOMETRICS, V34, P57, DOI 10.2307/2529588; Qiu CX, 2003, STROKE, V34, P594, DOI 10.1161/01.STR.0000060127.96986.F4; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; SHARP ES, 2011, ALZHEIMER D IN PRESS; Swan GE, 1998, NEUROLOGY, V51, P986, DOI 10.1212/WNL.51.4.986; Tzourio C, 1999, NEUROLOGY, V53, P1948, DOI 10.1212/WNL.53.9.1948; Waldstein SR, 2008, HYPERTENSION, V51, P99, DOI 10.1161/HYPERTENSIONAHA.107.093674; Waldstein SR, 2005, HYPERTENSION, V45, P374, DOI 10.1161/01.HYP.0000156744.44218.74; WILKIE F, 1971, SCIENCE, V172, P959, DOI 10.1126/science.172.3986.959; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	42	12	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e27976	10.1371/journal.pone.0027976	http://dx.doi.org/10.1371/journal.pone.0027976			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174760	Green Published, gold, Green Submitted			2022-12-25	WOS:000298365700013
J	Ge, XM; Luo, D; Xu, JF				Ge, Xumeng; Luo, Dan; Xu, Jianfeng			Cell-Free Protein Expression under Macromolecular Crowding Conditions	PLOS ONE			English	Article							IN-VITRO; SYNTHESIS SYSTEM; BIOCHEMICAL REACTIONS; HIGHLY EFFICIENT; DNA-POLYMERASE; CONFINEMENT; ENVIRONMENT; STABILITY; INCREASES	Background: Cell-free protein expression (CFPE) comprised of in vitro transcription and translation is currently manipulated in relatively dilute solutions, in which the macromolecular crowding effects present in living cells are largely ignored. This may not only affect the efficiency of protein synthesis in vitro, but also limit our understanding of the functions and interactions of biomolecules involved in this fundamental biological process. Methodology/Principal Findings: Using cell-free synthesis of Renilla luciferase in wheat germ extract as a model system, we investigated the CFPE under macromolecular crowding environments emulated with three different crowding agents: PEG-8000, Ficoll-70 and Ficoll-400, which vary in chemical properties and molecular size. We found that transcription was substantially enhanced in the macromolecular crowding solutions; up to 4-fold increase in the mRNA production was detected in the presence of 20% (w/v) of Ficoll-70. In contrast, translation was generally inhibited by the addition of each of the three crowding agents. This might be due to PEG-induced protein precipitation and non-specific binding of translation factors to Ficoll molecules. We further explored a two-stage CFPE in which transcription and translation was carried out under high then low macromolecular crowding conditions, respectively. It produced 2.2-fold higher protein yield than the coupled CFPE control. The macromolecular crowding effects on CFPE were subsequently confirmed by cell-free synthesis of an approximately two-fold larger protein, Firefly luciferase, under macromolecular crowding environments. Conclusions/Significance: Three macromolecular crowding agents used in this research had opposite effects on transcription and translation. The results of this study should aid researchers in their choice of macromolecular crowding agents and shows that two-stage CFPE is more efficient than coupled CFPE.	[Ge, Xumeng; Xu, Jianfeng] Arkansas State Univ, Arkansas Biosci Inst, Jonesboro, AR USA; [Ge, Xumeng; Xu, Jianfeng] Arkansas State Univ, Coll Agr & Technol, Jonesboro, AR USA; [Luo, Dan] Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY USA	Arkansas State University; Arkansas State University; Cornell University	Ge, XM (corresponding author), Arkansas State Univ, Arkansas Biosci Inst, Jonesboro, AR USA.	jxu@astate.edu			Plant Powered Production (P3) Center; NSF RII Arkansas ASSET Initiative; Arkansas Biosciences Institute	Plant Powered Production (P3) Center; NSF RII Arkansas ASSET Initiative; Arkansas Biosciences Institute	This work was supported by the Plant Powered Production (P3) Center funds provided through an NSF RII Arkansas ASSET Initiative (AR EPSCoR) grant and the Arkansas Biosciences Institute, the major research component of the Arkansas Tobacco Settlement Proceeds Act of 2000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakke CK, 2006, PROTEIN EXPRES PURIF, V45, P381, DOI 10.1016/j.pep.2005.08.001; Ballantyne KN, 2006, ANAL BIOCHEM, V355, P298, DOI 10.1016/j.ab.2006.04.039; Bundy BC, 2010, BIOCONJUGATE CHEM, V21, P255, DOI 10.1021/bc9002844; Chattopadhaya S, 2006, NAT PROTOC, V1, P2386, DOI 10.1038/nprot.2006.338; Du F, 2006, J MOL BIOL, V364, P469, DOI 10.1016/j.jmb.2006.09.018; Elcock AH, 2010, CURR OPIN STRUC BIOL, V20, P196, DOI 10.1016/j.sbi.2010.01.008; Elcock AH, CURR OPIN STRUCT BIO, V20, P196; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Ellis RJ, 2003, NATURE, V425, P27, DOI 10.1038/425027a; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; Fedorov AN, 1998, METHOD ENZYMOL, V290, P1, DOI 10.1016/S0076-6879(98)90003-9; Foley PL, 2010, BIOTECHNOL BIOENG, V105, P26, DOI 10.1002/bit.22575; Forster AC, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100090; Harve KS, 2008, P NATL ACAD SCI USA, V105, pE119, DOI 10.1073/pnas.0810077106; He MY, 2008, NEW BIOTECHNOL, V25, P126, DOI 10.1016/j.nbt.2008.08.004; Iskakova MB, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl462; Jewett MC, 2004, BIOTECHNOL BIOENG, V86, P19, DOI 10.1002/bit.20026; Jewett MC, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.57; Katzen F, 2005, TRENDS BIOTECHNOL, V23, P150, DOI 10.1016/j.tibtech.2005.01.003; Kern JA, 1997, BIOTECHNOL PROGR, V13, P747, DOI 10.1021/bp970094p; Khnouf R, 2010, ANAL CHEM, V82, P7021, DOI 10.1021/ac1015479; Kim DM, 1996, EUR J BIOCHEM, V239, P881, DOI 10.1111/j.1432-1033.1996.0881u.x; Kim JS, 2009, BIOPHYS J, V96, P1333, DOI 10.1016/j.bpj.2008.11.030; Kim KO, 2009, BIOTECHNOL BIOENG, V102, P303, DOI 10.1002/bit.22022; Kim TW, 2008, BIOTECHNOL BIOPROC E, V13, P464, DOI 10.1007/s12257-008-0139-8; Kinjo AR, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.051902; Klammt C, 2006, FEBS J, V273, P4141, DOI 10.1111/j.1742-4658.2006.05432.x; Kurotani A, 2010, FASEB J, V24, P1095, DOI 10.1096/fj.09-139527; Li GW, 2009, NAT PHYS, V5, P294, DOI 10.1038/NPHYS1222; Madin K, 2005, MOL CELL PROTEOMICS, V4, pS371; Madono M, 2011, NEW BIOTECHNOL, V28, P211, DOI 10.1016/j.nbt.2010.08.009; McGuffee SR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000694; Minton AP, 2006, J CELL SCI, V119, P2863, DOI 10.1242/jcs.03063; Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; Muhuri S, 2009, J AM CHEM SOC, V131, P9268, DOI 10.1021/ja900744e; Mukherjee S, 2009, J MOL BIOL, V393, P227, DOI 10.1016/j.jmb.2009.08.016; Nakano H, 1996, J BIOTECHNOL, V46, P275, DOI 10.1016/0168-1656(96)00022-3; NAKANO H, 1994, BIOSCI BIOTECH BIOCH, V58, P631, DOI 10.1271/bbb.58.631; Nakano S, 2009, J AM CHEM SOC, V131, P16881, DOI 10.1021/ja9066628; Noireaux V, 2005, PHYS BIOL, V2, pP1, DOI 10.1088/1478-3975/2/3/P01; Noireaux V, 2003, P NATL ACAD SCI USA, V100, P12672, DOI 10.1073/pnas.2135496100; Park N, 2009, NAT PROTOC, V4, P1759, DOI 10.1038/nprot.2009.174; Park N, 2009, NAT MATER, V8, P432, DOI [10.1038/NMAT2419, 10.1038/nmat2419]; Richter K, 2008, BBA-MOL CELL RES, V1783, P2100, DOI 10.1016/j.bbamcr.2008.07.017; Samiotakis A, 2009, INT J MOL SCI, V10, P572, DOI 10.3390/ijms10020572; SANDERS GM, 1994, P NATL ACAD SCI USA, V91, P7703, DOI 10.1073/pnas.91.16.7703; Sasahara K, 2003, J MOL BIOL, V326, P1227, DOI 10.1016/S0022-2836(02)01443-2; Sasaki Yoshiharu, 2006, Biotechnology Journal, V1, P440, DOI 10.1002/biot.200500032; Sasaki Y, 2007, NUCLEIC ACIDS RES, V35, P4086, DOI 10.1093/nar/gkm445; Sawasaki T, 2002, P NATL ACAD SCI USA, V99, P14652, DOI 10.1073/pnas.232580399; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Spirin AS, 2004, TRENDS BIOTECHNOL, V22, P538, DOI 10.1016/j.tibtech.2004.08.012; Stapleton JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010554; Takai K, 2010, CURR PHARM BIOTECHNO, V11, P272, DOI 10.2174/138920110791111933; Tokuriki N, 2004, PROTEIN SCI, V13, P125, DOI 10.1110/ps.03288104; Totani K, 2008, J AM CHEM SOC, V130, P2101, DOI 10.1021/ja077570k; Underwood KA, 2005, BIOTECHNOL BIOENG, V91, P425, DOI 10.1002/bit.20529; van den Berg B, 1999, EMBO J, V18, P6927, DOI 10.1093/emboj/18.24.6927; Vinarov DA, 2004, NAT METHODS, V1, P149, DOI 10.1038/NMETH716; Wenner JR, 1999, BIOPHYS J, V77, P3234, DOI 10.1016/S0006-3495(99)77154-7; Xu ZN, 2005, APPL BIOCHEM BIOTECH, V127, P53, DOI 10.1385/ABAB:127:1:053; Zhang C, 2009, P NATL ACAD SCI USA, V106, P16651, DOI 10.1073/pnas.0904741106; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817; ZIMMERMAN SB, 1983, P NATL ACAD SCI-BIOL, V80, P5852, DOI 10.1073/pnas.80.19.5852; ZIMMERMAN SB, 1988, NUCLEIC ACIDS RES, V16, P6309, DOI 10.1093/nar/16.14.6309; ZIMMERMAN SB, 1987, P NATL ACAD SCI USA, V84, P1871, DOI 10.1073/pnas.84.7.1871	67	70	73	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28707	10.1371/journal.pone.0028707	http://dx.doi.org/10.1371/journal.pone.0028707			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174874	gold, Green Published, Green Submitted			2022-12-25	WOS:000298163600039
J	Guler, GD; Liu, HJ; Vaithiyalingam, S; Arnett, DR; Kremmer, E; Chazin, WJ; Fanning, E				Guler, Gulfem Dilek; Liu, Hanjian; Vaithiyalingam, Sivaraja; Arnett, Diana R.; Kremmer, Elisabeth; Chazin, Walter J.; Fanning, Ellen			Human DNA Helicase B (HDHB) Binds to Replication Protein A and Facilitates Cellular Recovery from Replication Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; DEPENDENT ADENOSINE-TRIPHOSPHATASE; POLYMERASE ALPHA-PRIMASE; MOUSE FM3A CELLS; HOMOLOGOUS RECOMBINATION; SACCHAROMYCES-CEREVISIAE; GENOME INTEGRITY; DAMAGE RESPONSE; TERMINAL DOMAIN; T-ANTIGEN	Maintenance of genomic stability in proliferating cells depends on a network of proteins that coordinate chromosomal replication with DNA damage responses. Human DNA helicase B (HELB or HDHB) has been implicated in chromosomal replication, but its role in this coordinated network remains undefined. Here we report that cellular exposure to UV irradiation, camptothecin, or hydroxyurea induces accumulation of HDHB on chromatin in a dose- and time-dependent manner, preferentially in S phase cells. Replication stress-induced recruitment of HDHB to chromatin is independent of checkpoint signaling but correlates with the level of replication protein A (RPA) recruited to chromatin. We show using purified proteins that HDHB physically interacts with the N-terminal domain of the RPA 70-kDa subunit (RPA70N). NMR spectroscopy and site-directed mutagenesis reveal that HDHB docks on the same RPA70N surface that recruits S phase checkpoint signaling proteins to chromatin. Consistent with this pattern of recruitment, cells depleted of HDHB display reduced recovery from replication stress.	[Guler, Gulfem Dilek; Liu, Hanjian; Arnett, Diana R.; Fanning, Ellen] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Vaithiyalingam, Sivaraja; Chazin, Walter J.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Vaithiyalingam, Sivaraja; Chazin, Walter J.] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA; [Vaithiyalingam, Sivaraja; Chazin, Walter J.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA; [Kremmer, Elisabeth] Helmholtz Ctr Munich, D-81377 Munich, Germany	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Fanning, E (corresponding author), Vanderbilt Univ, Dept Biol Sci, 2325 Stevenson Ctr,1161 21st Ave S, Nashville, TN 37232 USA.	ellen.fanning@vanderbilt.edu			National Institutes of Health [GM52948, GM65484, P30 CA068485, P30 ES00267]; Vanderbilt University; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052948, R01GM065484] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM52948 (to E.F.), GM65484 (to W.J.C.), P30 CA068485 (to the Vanderbilt-Ingram Cancer Center), and P30 ES00267 (to the Center for Molecular Toxicology) and Vanderbilt University.	Arunkumar AI, 2005, NAT STRUCT MOL BIOL, V12, P332, DOI 10.1038/nsmb916; Atkinson J, 2011, NUCLEIC ACIDS RES, V39, P1351, DOI 10.1093/nar/gkq975; Azvolinsky A, 2006, GENE DEV, V20, P3104, DOI 10.1101/gad.1478906; Azvolinsky A, 2009, MOL CELL, V34, P722, DOI 10.1016/j.molcel.2009.05.022; Ball HL, 2007, MOL CELL BIOL, V27, P3367, DOI 10.1128/MCB.02238-06; Bochkareva E, 1998, J BIOL CHEM, V273, P3932, DOI 10.1074/jbc.273.7.3932; Bochkareva E, 2005, P NATL ACAD SCI USA, V102, P15412, DOI 10.1073/pnas.0504614102; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; BRATTAIN MG, 1981, CANCER RES, V41, P1751; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Cannavo E, 2007, J BIOL CHEM, V282, P2976, DOI 10.1074/jbc.M609989200; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; COLLINS KL, 1991, MOL CELL BIOL, V11, P2108, DOI 10.1128/MCB.11.4.2108; Cordeiro-Stone M, 1999, J MOL BIOL, V289, P1207, DOI 10.1006/jmbi.1999.2847; Davies AA, 2008, MOL CELL, V29, P625, DOI 10.1016/j.molcel.2007.12.016; DILLER L, 1990, MOL CELL BIOL, V10, P5772, DOI 10.1128/MCB.10.11.5772; Doherty KM, 2005, J BIOL CHEM, V280, P29494, DOI 10.1074/jbc.M500653200; Driscoll R, 2009, GENE DEV, V23, P2359, DOI 10.1101/gad.1860609; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; Elvers I, 2011, NUCLEIC ACIDS RES, V39, P7049, DOI 10.1093/nar/gkr420; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; GOMES XV, 1995, J BIOL CHEM, V270, P4534, DOI 10.1074/jbc.270.9.4534; Goodwin EC, 2000, P NATL ACAD SCI USA, V97, P12513, DOI 10.1073/pnas.97.23.12513; Gu JM, 2004, MOL BIOL CELL, V15, P3320, DOI 10.1091/mbc.E04-03-0227; Guy CP, 2009, MOL CELL, V36, P654, DOI 10.1016/j.molcel.2009.11.009; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Huang H, 2010, J BIOL CHEM, V285, P33475, DOI 10.1074/jbc.M110.156240; Huang H, 2010, J BIOL CHEM, V285, P17112, DOI 10.1074/jbc.M110.116830; Iftode C, 1999, CRIT REV BIOCHEM MOL, V34, P141, DOI 10.1080/10409239991209255; Inagaki A, 2009, DNA REPAIR, V8, P190, DOI 10.1016/j.dnarep.2008.10.008; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kadyrov FA, 2004, J BIOL CHEM, V279, P35735, DOI 10.1074/jbc.M403942200; KENNY M K, 1990, Journal of Biological Chemistry, V265, P7693; KREMMER E, 1995, VIROLOGY, V208, P336, DOI 10.1006/viro.1995.1157; Lecointe F, 2007, EMBO J, V26, P4239, DOI 10.1038/sj.emboj.7601848; Letessier A, 2011, NATURE, V470, P120, DOI 10.1038/nature09745; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Liu J, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-357; Lopes M, 2006, MOL CELL, V21, P15, DOI 10.1016/j.molcel.2005.11.015; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Machwe A, 2011, J BIOL CHEM, V286, P3497, DOI 10.1074/jbc.M110.105411; Mackintosh SG, 2006, NUCLEIC ACIDS RES, V34, P4154, DOI 10.1093/nar/gkl501; MATSUMOTO K, 1995, BIOCHEMISTRY-US, V34, P7913, DOI 10.1021/bi00024a016; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; MELENDY T, 1993, J BIOL CHEM, V268, P3389; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Mer G, 2000, CELL, V103, P449, DOI 10.1016/S0092-8674(00)00136-7; Michael WM, 2000, SCIENCE, V289, P2133, DOI 10.1126/science.289.5487.2133; Mimitou EP, 2009, TRENDS BIOCHEM SCI, V34, P264, DOI 10.1016/j.tibs.2009.01.010; Motegi A, 2008, P NATL ACAD SCI USA, V105, P12411, DOI 10.1073/pnas.0805685105; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Olson E, 2007, MOL CELL BIOL, V27, P6053, DOI 10.1128/MCB.00532-07; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; Petermann E, 2010, NAT REV MOL CELL BIO, V11, P683, DOI 10.1038/nrm2974; Pfuetzner RA, 1997, J BIOL CHEM, V272, P430; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Rost B, 2003, NUCLEIC ACIDS RES, V31, P3300, DOI 10.1093/nar/gkg508; SAITOH A, 1995, NUCLEIC ACIDS RES, V23, P2014, DOI 10.1093/nar/23.11.2014; Saleh-Gohari N, 2005, MOL CELL BIOL, V25, P7158, DOI 10.1128/MCB.25.16.7158-7169.2005; Sarkaria JN, 1998, CANCER RES, V58, P4375; Schmidt KH, 2004, MOL CELL BIOL, V24, P3213, DOI 10.1128/MCB.24.8.3213-3226.2004; SEKI M, 1986, BIOCHEMISTRY-US, V25, P3239, DOI 10.1021/bi00359a024; SEKI M, 1995, MOL CELL BIOL, V15, P165, DOI 10.1128/MCB.15.1.165; SEKI M, 1987, BIOCHEMISTRY-US, V26, P2924, DOI 10.1021/bi00384a038; SEKI M, 1988, BIOCHEMISTRY-US, V27, P1766, DOI 10.1021/bi00405a057; Shen JC, 2003, MECH AGEING DEV, V124, P921, DOI 10.1016/S0047-6374(03)00164-7; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Stauffer ME, 2004, J BIOL CHEM, V279, P30915, DOI 10.1074/jbc.R400015200; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Tada S, 2001, NUCLEIC ACIDS RES, V29, P3835, DOI 10.1093/nar/29.18.3835; Taneja P, 2002, J BIOL CHEM, V277, P40853, DOI 10.1074/jbc.M208067200; Vanoli F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001205; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Xu X, 2008, MOL CELL BIOL, V28, P7345, DOI 10.1128/MCB.01079-08; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430; Zou Y, 2006, J CELL PHYSIOL, V208, P267, DOI 10.1002/jcp.20622	81	33	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6469	6481		10.1074/jbc.M111.324582	http://dx.doi.org/10.1074/jbc.M111.324582			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22194613	Green Published, hybrid			2022-12-25	WOS:000300791800036
J	Hassan, IH; Zhang, MS; Powers, LS; Shao, JQ; Baltrusaitis, J; Rutkowski, DT; Legge, K; Monick, MM				Hassan, Ihab H.; Zhang, Michael S.; Powers, Linda S.; Shao, Jian Q.; Baltrusaitis, Jonas; Rutkowski, D. Thomas; Legge, Kevin; Monick, Martha M.			Influenza A Viral Replication Is Blocked by Inhibition of the Inositol-requiring Enzyme 1 (IRE1) Stress Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; HEPATITIS-C VIRUS; NF-KAPPA-B; ER STRESS; EPITHELIAL-CELLS; CHEMICAL CHAPERONES; INFECTION; INDUCTION; DISEASE	Known therapies for influenza A virus infection are complicated by the frequent emergence of resistance. A therapeutic strategy that may escape viral resistance is targeting host cellular mechanisms involved in viral replication and pathogenesis. The endoplasmic reticulum (ER) stress response, also known as the unfolded protein response (UPR), is a primitive, evolutionary conserved molecular signaling cascade that has been implicated in multiple biological phenomena including innate immunity and the pathogenesis of certain viral infections. We investigated the effect of influenza A viral infection on ER stress pathways in lung epithelial cells. Influenza A virus induced ER stress in a pathway-specific manner. We showed that the virus activates the IRE1 pathway with little or no concomitant activation of the PERK and the ATF6 pathways. When we examined the effects of modulating the ER stress response on the virus, we found that the molecular chaperone tauroursodeoxycholic acid (TUDCA) significantly inhibits influenza A viral replication. In addition, a specific inhibitor of the IRE1 pathway also blocked viral replication. Our findings constitute the first evidence that ER stress plays a role in the pathogenesis of influenza A viral infection. Decreasing viral replication by modulating the host ER stress response is a novel strategy that has important therapeutic implications.	[Hassan, Ihab H.; Zhang, Michael S.; Powers, Linda S.; Monick, Martha M.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Shao, Jian Q.; Baltrusaitis, Jonas] Univ Iowa, Cent Microscopy Res Facil, Iowa City, IA 52242 USA; [Rutkowski, D. Thomas] Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; [Legge, Kevin] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa	Hassan, IH (corresponding author), Rm 100 EMRB, Iowa City, IA 52242 USA.	ihab-hassan@uiowa.edu	Baltrusaitis, Jonas/AAW-6072-2021; Baltrusaitis, Jonas/F-9367-2013; Baltrusaitis, Jonas/AAT-3166-2020	Baltrusaitis, Jonas/0000-0001-5634-955X; Zhang, Michael/0000-0003-1992-2550; Rutkowski, Thomas/0000-0001-6586-4449; Legge, Kevin/0000-0001-9800-6854	National Institutes of Health [R01 HL079901, R01 HL 096625, R21 HL109589]; NIDDK [R01 DK 084058]; National Center for Research Resources (NCRR), part of the National Institutes of Health [NCRR1 UL1 RR024979]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024979] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL109589, R01HL096625, R01HL079901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084058] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Research Resources (NCRR), part of the National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL079901, R01 HL 096625, and R21 HL109589 (to M. M. M.) and NIDDK Grants R01 DK 084058 (to D. T. R.) and NCRR1 UL1 RR024979 from the National Center for Research Resources (NCRR), part of the National Institutes of Health.	Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Bermejo-Martin JF, 2009, CRIT CARE, V13, DOI 10.1186/cc8208; Cheng GF, 2005, J VIROL, V79, P1379, DOI 10.1128/JVI.79.3.1379-1388.2005; Dolan BP, 2011, CELL MOL LIFE SCI, V68, P1481, DOI 10.1007/s00018-011-0656-z; Dolan BP, 2010, J IMMUNOL, V184, P1419, DOI 10.4049/jimmunol.0901907; Fiore Anthony E., 2008, Morbidity and Mortality Weekly Report, V57, P1; GUPTA S, 2010, INT J CELL BIOL; He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833; He B, 1997, P NATL ACAD SCI USA, V94, P843, DOI 10.1073/pnas.94.3.843; Hirota Morihiko, 2006, Journal of Toxicological Sciences, V31, P149, DOI 10.2131/jts.31.149; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; HUNTER JA, 1985, P NATL ACAD SCI USA, V82, P4633, DOI 10.1073/pnas.82.14.4633; Jheng JR, 2010, CELL MICROBIOL, V12, P796, DOI 10.1111/j.1462-5822.2010.01434.x; Ji C, 2011, HEPATOLOGY, V54, P229, DOI 10.1002/hep.24368; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Ketterer MR, 1999, INFECT IMMUN, V67, P4161, DOI 10.1128/IAI.67.8.4161-4170.1999; Kim HT, 2004, LAB INVEST, V84, P816, DOI 10.1038/labinvest.3700104; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; Langlois RA, 2010, ALCOHOL CLIN EXP RES, V34, P1425, DOI 10.1111/j.1530-0277.2010.01226.x; Li BZ, 2007, VIRUS RES, V124, P44, DOI 10.1016/j.virusres.2006.09.011; Li XD, 2005, VIROLOGY, V333, P180, DOI 10.1016/j.virol.2005.01.002; LOOK DC, 1992, AM J PHYSIOL, V263, pL79, DOI 10.1152/ajplung.1992.263.1.L79; Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07; Meyerholz DK, 2008, J IMMUNOL, V181, P641, DOI 10.4049/jimmunol.181.1.641; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Naidoo N, 2009, AGEING RES REV, V8, P150, DOI 10.1016/j.arr.2009.03.001; Nakajima S, 2011, MOL CELL BIOL, V31, P1710, DOI 10.1128/MCB.00939-10; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Pahl HL, 1996, FEBS LETT, V392, P129, DOI 10.1016/0014-5793(96)00800-9; PAHL HL, 1995, J VIROL, V69, P1480, DOI 10.1128/JVI.69.3.1480-1484.1995; Post DMB, 2002, INFECT IMMUN, V70, P909, DOI 10.1128/IAI.70.2.909-920.2002; Rajagopal S, 2007, SEMIN RESP CRIT CARE, V28, P159, DOI 10.1055/s-2007-976488; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Su HL, 2002, J VIROL, V76, P4162, DOI 10.1128/JVI.76.9.4162-4171.2002; Tardif KD, 2005, TRENDS MICROBIOL, V13, P159, DOI 10.1016/j.tim.2005.02.004; Tardif KD, 2004, J BIOL CHEM, V279, P17158, DOI 10.1074/jbc.M312144200; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Ulianich L, 2011, BBA-MOL BASIS DIS, V1812, P431, DOI 10.1016/j.bbadis.2010.12.013; Volkmann K, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.199737; Welch WJ, 1996, CELL STRESS CHAPERON, V1, P109, DOI 10.1379/1466-1268(1996)001<0109:IOMACC>2.3.CO;2; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Ye ZD, 2008, BBA-GEN SUBJECTS, V1780, P1383, DOI 10.1016/j.bbagen.2008.07.009; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	45	101	111	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4679	4689		10.1074/jbc.M111.284695	http://dx.doi.org/10.1074/jbc.M111.284695			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22194594	hybrid, Green Published			2022-12-25	WOS:000300608500030
J	Imamura, K; Averill, A; Wallace, SS; Doublie, S				Imamura, Kayo; Averill, April; Wallace, Susan S.; Doublie, Sylvie			Structural Characterization of Viral Ortholog of Human DNA Glycosylase NEIL1 Bound to Thymine Glycol or 5-Hydroxyuracil-containing DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI ENDONUCLEASE-VIII; BASE-EXCISION-REPAIR; OXIDATIVELY DAMAGED DNA; ESCHERICHIA-COLI; DEOXYRIBONUCLEIC-ACID; SUBSTRATE-SPECIFICITY; LESION RECOGNITION; CRYSTAL-STRUCTURE; OXIDIZED BASES; ENZYME	Thymine glycol (Tg) and 5-hydroxyuracil (5-OHU) are common oxidized products of pyrimidines, which are recognized and cleaved by two DNA glycosylases of the base excision repair pathway, endonuclease III (Nth) and endonuclease VIII (Nei). Although there are several structures of Nei enzymes unliganded or bound to an abasic (apurinic or apyrimidinic) site, until now there was no structure of an Nei bound to a DNA lesion. Mimivirus Nei1 (MvNei1) is an ortholog of human NEIL1, which was previously crystallized bound to DNA containing an apurinic site (Imamura, K., Wallace, S. S., and Doublie, S. (2009) J. Biol. Chem. 284, 26174-26183). Here, we present two crystal structures of MvNei1 bound to two oxidized pyrimidines, Tg and 5-OHU. Both lesions are flipped out from the DNA helix. Tg is in the anti conformation, whereas 5-OHU adopts both anti and syn conformations in the glycosylase active site. Only two protein side chains (Glu-6 and Tyr-253) are within hydrogen-bonding contact with either damaged base, and mutating these residues did not markedly affect the glycosylase activity. This finding suggests that lesion recognition by Nei occurs before the damaged base flips into the glycosylase active site.	[Wallace, Susan S.; Doublie, Sylvie] Univ Vermont, Dept Microbiol & Mol Genet, Markey Ctr Mol Genet, Burlington, VT 05405 USA	University of Vermont	Wallace, SS (corresponding author), Univ Vermont, Dept Microbiol & Mol Genet, Markey Ctr Mol Genet, Stafford Hall,95 Carrigan Dr, Burlington, VT 05405 USA.	Susan.Wallace@uvm.edu; Sylvie.Doublie@uvm.edu		Imamura, Kayo/0000-0002-2141-8495; Wallace, Susan S./0000-0002-3906-0321; Doublie, Sylvie/0000-0002-6294-5304	National Institutes of Health from NCI [P01CA098993, Y1-CO-1020]; NIGMS [Y1-GM-1104]; United States Department of Energy, Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [P01CA098993] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Energy, Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01CA098993 from NCI.; We thank Dr. Pierre Aller and Karl Zahn for data collection of the MvNei1.Tg complex at beamline 23-ID-B at the Advanced Photon Source; Minmin Liu for helpful discussions regarding the kinetics experiments; Dr. Matthew Hogg for technical assistance with the rapid quench instrument; and Drs. Peter Orth, Terukazu Nogi, and Mark Rould for helpful crystallographic suggestions. The beamline GM/CA CAT has been funded in whole or in part by National Institutes of Health Grant Y1-CO-1020 from NCI and Grant Y1-GM-1104 from NIGMS. Use of the Advanced Photon Source was supported by United States Department of Energy, Basic Energy Sciences, Contract DE-AC02-06CH11357.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Aller P, 2007, P NATL ACAD SCI USA, V104, P814, DOI 10.1073/pnas.0606648104; Aller P, 2011, J MOL BIOL, V412, P22, DOI 10.1016/j.jmb.2011.07.007; Bandaru V, 2002, DNA REPAIR, V1, P517, DOI 10.1016/S1568-7864(02)00036-8; Bandaru V, 2007, DNA REPAIR, V6, P1629, DOI 10.1016/j.dnarep.2007.05.011; Brown KL, 2010, NUCLEIC ACIDS RES, V38, P428, DOI 10.1093/nar/gkp844; Brown KL, 2009, BIOCHEMISTRY-US, V48, P9722, DOI 10.1021/bi900695e; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; CHETSANGA CJ, 1981, BIOCHEMISTRY-US, V20, P5201, DOI 10.1021/bi00521a016; CHUNG MH, 1991, MUTAT RES, V254, P1, DOI 10.1016/0921-8777(91)90035-N; Coste F, 2004, J BIOL CHEM, V279, P44074, DOI 10.1074/jbc.M405928200; Coste F, 2008, CHEM BIOL, V15, P706, DOI 10.1016/j.chembiol.2008.05.014; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dizdaroglu M, 2001, BIOCHEMISTRY-US, V40, P12150, DOI 10.1021/bi015552o; Dou H, 2003, J BIOL CHEM, V278, P49679, DOI 10.1074/jbc.M308658200; Doublie S, 2004, P NATL ACAD SCI USA, V101, P10284, DOI 10.1073/pnas.0402051101; FRENKEL K, 1981, BIOCHEMISTRY-US, V20, P7566, DOI 10.1021/bi00529a035; Fromme JC, 2003, J BIOL CHEM, V278, P51543, DOI 10.1074/jbc.M307768200; Fromme JC, 2002, NAT STRUCT BIOL, V9, P544, DOI 10.1038/nsb809; Gilboa R, 2002, J BIOL CHEM, V277, P19811, DOI 10.1074/jbc.M202058200; Hailer MK, 2005, DNA REPAIR, V4, P41, DOI 10.1016/j.dnarep.2004.07.006; Harris TK, 2002, IUBMB LIFE, V53, P85, DOI 10.1080/15216540211468; Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799; Hazra TK, 2001, NUCLEIC ACIDS RES, V29, P1967, DOI 10.1093/nar/29.9.1967; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Hickerson RP, 1999, J AM CHEM SOC, V121, P9901, DOI 10.1021/ja9923484; Imamura K, 2009, J BIOL CHEM, V284, P26174, DOI 10.1074/jbc.M109.021907; Iwai S, 2001, CHEM-EUR J, V7, P4343, DOI 10.1002/1521-3765(20011015)7:20<4343::AID-CHEM4343>3.0.CO;2-H; Jia L, 2007, BIOCHEMISTRY-US, V46, P5305, DOI 10.1021/bi062269m; Jiang DY, 1997, J BIOL CHEM, V272, P32230, DOI 10.1074/jbc.272.51.32230; Kathe SD, 2009, DNA REPAIR, V8, P643, DOI 10.1016/j.dnarep.2008.12.013; Krishnamurthy N, 2008, BIOCHEMISTRY-US, V47, P7137, DOI 10.1021/bi800160s; Kropachev KY, 2006, BIOCHEMISTRY-US, V45, P12039, DOI 10.1021/bi060663e; Laskowski R., 1993, J APPL CRYSTALLOGR, DOI [10.1107/S002188982009944, DOI 10.1107/S002188982009944]; Le Bihan YV, 2011, NUCLEIC ACIDS RES, V39, P6277, DOI 10.1093/nar/gkr215; Liu MM, 2010, P NATL ACAD SCI USA, V107, P4925, DOI 10.1073/pnas.0908307107; LUSTIG MJ, 1992, NUCLEIC ACIDS RES, V20, P4839, DOI 10.1093/nar/20.18.4839; MELAMEDE RJ, 1994, BIOCHEMISTRY-US, V33, P1255, DOI 10.1021/bi00171a028; Morland I, 2002, NUCLEIC ACIDS RES, V30, P4926, DOI 10.1093/nar/gkf618; Ocampo-Hafalla MT, 2006, DNA REPAIR, V5, P444, DOI 10.1016/j.dnarep.2005.12.004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parsons JL, 2007, BIOCHEMISTRY-US, V46, P4158, DOI 10.1021/bi0622569; Parsons JL, 2005, NUCLEIC ACIDS RES, V33, P4849, DOI 10.1093/nar/gki816; Perry JJP, 2010, CURR OPIN STRUC BIOL, V20, P283, DOI 10.1016/j.sbi.2010.03.012; Purmal AA, 1998, J BIOL CHEM, V273, P10026, DOI 10.1074/jbc.273.16.10026; Qi Y, 2009, NATURE, V462, P762, DOI 10.1038/nature08561; Sugahara M, 2000, EMBO J, V19, P3857, DOI 10.1093/emboj/19.15.3857; Sugden KD, 2002, ENVIRON HEALTH PERSP, V110, P725, DOI 10.1289/ehp.02110s5725; Takao M, 2002, J BIOL CHEM, V277, P42205, DOI 10.1074/jbc.M206884200; TCHOU J, 1991, P NATL ACAD SCI USA, V88, P4690, DOI 10.1073/pnas.88.11.4690; TEOULE R, 1974, RADIAT RES, V57, P46, DOI 10.2307/3573754; Thiviyanathan V, 2008, BIOCHEM BIOPH RES CO, V366, P752, DOI 10.1016/j.bbrc.2007.12.010; VONSONNTAG C, 1986, INT J RADIAT BIOL, V49, P1; WAGNER JR, 1992, P NATL ACAD SCI USA, V89, P3380, DOI 10.1073/pnas.89.8.3380; Wallace SS, 2002, FREE RADICAL BIO MED, V33, P1, DOI 10.1016/S0891-5849(02)00827-4; Wallace SS, 2003, DNA REPAIR, V2, P441, DOI 10.1016/S1568-7864(02)00182-9; Wallace SS, 1998, RADIAT RES, V150, pS60, DOI 10.2307/3579809; Wilson DM, 2003, FRONT BIOSCI-LANDMRK, V8, pD963, DOI 10.2741/1109; Zharkov DO, 2005, MUTAT RES-FUND MOL M, V577, P24, DOI 10.1016/j.mrfmmm.2005.03.011; Zharkov DO, 2003, DNA REPAIR, V2, P839, DOI 10.1016/S1568-7864(03)00084-3; Zharkov DO, 2002, EMBO J, V21, P789, DOI 10.1093/emboj/21.4.789	62	44	44	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4288	4298		10.1074/jbc.M111.315309	http://dx.doi.org/10.1074/jbc.M111.315309			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22170059	Green Published, hybrid			2022-12-25	WOS:000300410900060
J	Klenner, C; Kuhn, A				Klenner, Christian; Kuhn, Andreas			Dynamic Disulfide Scanning of the Membrane-inserting Pf3 Coat Protein Reveals Multiple YidC Substrate Contacts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI YIDC; F1F0 ATP SYNTHASE; PERIPLASMIC DOMAIN; INNER-MEMBRANE; CRYSTAL-STRUCTURE; SUBUNIT-C; BIOGENESIS; BACTERIAL; REGIONS; REQUIREMENTS	The membrane insertase YidC inserts newly synthesized proteins into the plasma membrane. While defects in YidC homologs in animals and plants cause diseases, YidC in bacteria is essential for life. Membrane insertion and assembly of ATP synthase and respiratory complexes is catalyzed by YidC. To investigate how YidC interacts with membrane-inserting proteins, we generated single cysteine mutants in YidC and in the model substrate Pf3 coat protein. The single cysteine mutants were expressed and analyzed for disulfide formation during 30 s of synthesis. The results show that the substrate contacts different YidC residues in four of the six transmembrane regions. The residues are located either in the region of the inner leaflet, in the center, as well as in the periplasmic leaflet, consistent with the hypothesis that YidC presents a hydrophobic platform for inserting membrane proteins. In a YidC mutant where most of the contacting residues were mutated to serines, YidC function was severely disturbed and no longer active in a complementation test, suggesting that the residues are important for function. In addition, a Pf3 mutant with a defect in membrane insertion was deficient to contact the periplasmic residues of YidC.	[Klenner, Christian; Kuhn, Andreas] Univ Hohenheim, Inst Microbiol & Mol Biol, D-70599 Stuttgart, Germany	University Hohenheim	Kuhn, A (corresponding author), Univ Hohenheim, Inst Microbiol & Mol Biol, D-70599 Stuttgart, Germany.	Andreas.Kuhn@uni-hohenheim.de			Deutsche Forschungsgemeinschaft [Ku749/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft grant Ku749/6-1 (to A. K.).	Celebi N, 2006, J MOL BIOL, V357, P1428, DOI 10.1016/j.jmb.2006.01.030; Dalbey RE, 2004, J CELL BIOL, V166, P769, DOI 10.1083/jcb.200405161; Facey SJ, 2007, J MOL BIOL, V365, P995, DOI 10.1016/j.jmb.2006.10.083; Facey SJ, 2010, CELL MOL LIFE SCI, V67, P2343, DOI 10.1007/s00018-010-0303-0; Gerken U, 2008, BIOCHEMISTRY-US, V47, P6052, DOI 10.1021/bi800116t; Imhof N, 2011, BIOCHEMISTRY-US, V50, P3229, DOI 10.1021/bi1020293; Jiang FL, 2003, J BIOL CHEM, V278, P48965, DOI 10.1074/jbc.M307362200; Jiang FL, 2002, J BIOL CHEM, V277, P19281, DOI 10.1074/jbc.M110857200; Kiefer D, 1999, EMBO J, V18, P6299, DOI 10.1093/emboj/18.22.6299; Kiefer D, 1997, EMBO J, V16, P2197, DOI 10.1093/emboj/16.9.2197; Kiefer D, 2007, INT REV CYTOL, V259, P113, DOI 10.1016/S0074-7969(06)59003-5; Klenner C, 2008, FEBS LETT, V582, P3967, DOI 10.1016/j.febslet.2008.10.044; Kuhn A, 2003, TRENDS CELL BIOL, V13, P510, DOI 10.1016/j.tcb.2003.08.005; KUHN A, 1985, J BIOL CHEM, V260, P5907; Nagler C, 2007, J BACTERIOL, V189, P2897, DOI 10.1128/JB.01551-06; Oliver DC, 2008, J BIOL CHEM, V283, P5208, DOI 10.1074/jbc.M708936200; Price CE, 2010, BBA-MOL CELL RES, V1803, P748, DOI 10.1016/j.bbamcr.2010.01.019; Ravaud S, 2008, J BIOL CHEM, V283, P9350, DOI 10.1074/jbc.M710493200; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Serek J, 2004, EMBO J, V23, P294, DOI 10.1038/sj.emboj.7600063; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; van der Laan M, 2004, J CELL BIOL, V165, P213, DOI 10.1083/jcb.200402100; Wang P, 2010, J BACTERIOL, V192, P2193, DOI 10.1128/JB.00484-09; Winterfeld S, 2009, BIOCHEMISTRY-US, V48, P6684, DOI 10.1021/bi9003809; Xie K, 2006, BIOCHEMISTRY-US, V45, P13401, DOI 10.1021/bi060826z; Yi L, 2004, J BIOL CHEM, V279, P39260, DOI 10.1074/jbc.M405490200; Yu Z, 2008, J BIOL CHEM, V283, P34635, DOI 10.1074/jbc.M804344200; Yuan J, 2007, J BACTERIOL, V189, P8961, DOI 10.1128/JB.01365-07	29	34	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3769	3776		10.1074/jbc.M111.307223	http://dx.doi.org/10.1074/jbc.M111.307223			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22179606	hybrid, Green Published			2022-12-25	WOS:000300410900014
J	Yu, TX; Chen, X; Zhang, W; Colon, D; Shi, JD; Napier, D; Rychahou, P; Lu, WG; Lee, EY; Weiss, HL; Evers, BM; Liu, CM				Yu, Tianxin; Chen, Xi; Zhang, Wen; Colon, Deannon; Shi, Jiandang; Napier, Dana; Rychahou, Piotr; Lu, Wange; Lee, Eun Y.; Weiss, Heidi L.; Evers, B. Mark; Liu, Chunming			Regulation of the Potential Marker for Intestinal Cells, Bmi1, by beta-Catenin and the Zinc Finger Protein KLF4 IMPLICATIONS FOR COLON CANCER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; TUMOR-SUPPRESSOR; C-MYC; H2A UBIQUITYLATION; INDUCED APOPTOSIS; SELF-RENEWAL; GENE; DIFFERENTIATION; IDENTIFICATION; SENESCENCE	B lymphoma Mo-MLV insertion region 1 (Bmi1) is a Polycomb Group (PcG) protein important in gene silencing. It is a component of Polycomb Repressive Complex 1 (PRC1), which is required to maintain the transcriptionally repressive state of many genes. Bmi1 was initially identified as an oncogene that regulates cell proliferation and transformation, and is important in hematopoiesis and the development of nervous systems. Recently, it was reported that Bmi1 is a potential marker for intestinal stem cells. Because Wnt signaling plays a key role in intestinal stem cells, we analyzed the effects of Wnt signaling on Bmi1 expression. We found that Wnt signaling indeed regulates the expression of Bmi1 in colon cancer cells. In addition, the expression of Bmi1 in human colon cancers is significantly associated with nuclear beta-catenin, a hallmark for the activated Wnt signaling. Kruppel-like factor 4 (KLF4) is a zinc finger protein highly expressed in the gut and skin. We recently found that KLF4 cross-talks with Wnt/beta-catenin in regulating intestinal homeostasis. We demonstrated that KLF4 directly inhibits the expression of Bmi1 in colon cancer cells. We also found that Bmi1 regulates histone ubiquitination and is required for colon cancer proliferation in vitro and in vivo. Our findings further suggest that Bmi1 is an attractive target for cancer therapeutics.	[Yu, Tianxin; Chen, Xi; Zhang, Wen; Shi, Jiandang; Napier, Dana; Rychahou, Piotr; Lee, Eun Y.; Weiss, Heidi L.; Evers, B. Mark; Liu, Chunming] Univ Kentucky, Markey Canc Ctr, Lexington, KY 40506 USA; [Napier, Dana; Lee, Eun Y.] Univ Kentucky, Dept Pathol, Lexington, KY 40506 USA; [Rychahou, Piotr; Evers, B. Mark] Univ Kentucky, Dept Surg, Lexington, KY 40506 USA; [Yu, Tianxin; Colon, Deannon] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Lu, Wange] Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA; [Liu, Chunming] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40506 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Texas System; University of Texas Medical Branch Galveston; University of Southern California; University of Kentucky	Liu, CM (corresponding author), Univ Kentucky, Markey Canc Ctr, Lexington, KY 40506 USA.	chunming.liu@uky.edu		Rychahou, Piotr/0000-0001-7352-9122	National Institutes of Health [R01 DK071976]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071976] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK071976 (to C. L.).	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Brown JL, 2005, NUCLEIC ACIDS RES, V33, P5181, DOI 10.1093/nar/gki827; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Evans PM, 2007, J BIOL CHEM, V282, P33994, DOI 10.1074/jbc.M701847200; Evans PM, 2010, MOL CELL BIOL, V30, P372, DOI 10.1128/MCB.00063-09; EVERS BM, 1991, GASTROENTEROLOGY, V101, P303, DOI 10.1016/0016-5085(91)90004-5; Ghaleb AM, 2011, DEV BIOL, V349, P310, DOI 10.1016/j.ydbio.2010.11.001; Ghaleb AM, 2008, MOL CANCER RES, V6, P1920, DOI 10.1158/1541-7786.MCR-08-0224; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Guo WJ, 2007, MOL BIOL CELL, V18, P536, DOI 10.1091/mbc.E06-05-0447; HAUPT Y, 1991, CELL, V65, P753, DOI 10.1016/0092-8674(91)90383-A; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kang MK, 2007, BRIT J CANCER, V96, P126, DOI 10.1038/sj.bjc.6603529; Katz JP, 2002, DEVELOPMENT, V129, P2619; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Qin H, 2007, J BIOL CHEM, V282, P5842, DOI 10.1074/jbc.M610464200; Rajasekhar VK, 2007, STEM CELLS, V25, P2498, DOI 10.1634/stemcells.2006-0608; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Scoville DH, 2008, GASTROENTEROLOGY, V134, P849, DOI 10.1053/j.gastro.2008.01.079; Shields JM, 1998, NUCLEIC ACIDS RES, V26, P796, DOI 10.1093/nar/26.3.796; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; VANDEWETERING M, 1992, EMBO J, V11, P3039, DOI 10.1002/j.1460-2075.1992.tb05374.x; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang QD, 2002, CLIN CANCER RES, V8, P1940; Wei JH, 2006, J BIOL CHEM, V281, P22537, DOI 10.1074/jbc.M600826200; Yamamoto Y, 2003, HEPATOLOGY, V37, P528, DOI 10.1053/jhep.2003.50029; Zhang W, 2006, MOL CELL BIOL, V26, P2055, DOI 10.1128/MCB.26.6.2055-2064.2006; Zhao WD, 2004, ONCOGENE, V23, P395, DOI 10.1038/sj.onc.1207067; Zheng H, 2009, AM J PHYSIOL-GASTR L, V296, pG490, DOI 10.1152/ajpgi.90393.2008	43	73	80	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3760	3768		10.1074/jbc.M111.316349	http://dx.doi.org/10.1074/jbc.M111.316349			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22170051	Green Published, hybrid			2022-12-25	WOS:000300410900013
J	Beuving, J; Verbon, A; Gronthoud, FA; Stobberingh, EE; Wolffs, PFG				Beuving, Judith; Verbon, Annelies; Gronthoud, Firza A.; Stobberingh, Ellen E.; Wolffs, Petra F. G.			Antibiotic Susceptibility Testing of Grown Blood Cultures by Combining Culture and Real-Time Polymerase Chain Reaction Is Rapid and Effective	PLOS ONE			English	Article							GRAM-POSITIVE COCCI; DIRECT INOCULATION; ANTIMICROBIAL THERAPY; MICROBIOLOGY SYSTEM; STREAM INFECTIONS; CLINICAL IMPACT; PHOENIX SYSTEM; UNITED-STATES; SEVERE SEPSIS; IDENTIFICATION	Background: Early administration of appropriate antibiotic therapy in bacteraemia patients dramatically reduces mortality. A new method for RApid Molecular Antibiotic Susceptibility Testing (RAMAST) that can be applied directly to positive blood cultures was developed and evaluated. Methodology/Principal Findings: Growth curves and antibiotic susceptibility of blood culture isolates (Staphylococcus aureus, enterococci and (facultative) aerobic Gram-negative rods) were determined by incubating diluted blood cultures with and without antibiotics, followed by a quantitative universal 16S PCR to detect the presence or absence of growth. Testing 114 positive blood cultures, RAMAST showed an agreement with microbroth dilution of 96.7% for Gram-negative rods, with a minor error (false-susceptibility with a intermediate resistant strain) rate of 1.9%, a major error (false resistance) rate of 0.8% and a very major error (false susceptibility) rate of 0.6%. Agreement for S. aureus was 97.9%, with a very major error rate of 2.1%. Enterococcus species showed 95.0% agreement, with a major error rate of 5.0%. These agreements are comparable with those of the Phoenix system. Starting from a positive blood culture, the test was completed within 9 hours. Conclusions/Significance: This new rapid method for antibiotic susceptibility testing can potentially provide accurate results for most relevant bacteria commonly isolated from positive blood cultures in less time than routine methods.	[Beuving, Judith; Verbon, Annelies; Gronthoud, Firza A.; Stobberingh, Ellen E.; Wolffs, Petra F. G.] Maastricht Univ, Dept Med Microbiol, CAPHRI, Med Ctr, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC)	Beuving, J (corresponding author), Maastricht Univ, Dept Med Microbiol, CAPHRI, Med Ctr, Maastricht, Netherlands.	p.wolffs@mumc.nl		Wolffs, Petra/0000-0002-5326-3985	Profileringsfonds azM [PF245]	Profileringsfonds azM	This work was supported by Profileringsfonds azM (PF245). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Barenfanger J, 1999, J CLIN MICROBIOL, V37, P1415, DOI 10.1128/JCM.37.5.1415-1418.1999; Bearman GML, 2005, ARCH MED RES, V36, P646, DOI 10.1016/j.arcmed.2005.02.005; Beuving J, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-156; Bouza E, 2004, CLIN INFECT DIS, V39, P1161, DOI 10.1086/424520; Bruins M, 2005, EUR J CLIN MICROBIOL, V24, P305, DOI 10.1007/s10096-005-1309-7; Bruins MJ, 2004, J CLIN MICROBIOL, V42, P7, DOI 10.1128/JCM.42.1.7-11.2004; Byl B, 1999, CLIN INFECT DIS, V29, P60, DOI 10.1086/520182; Chapin KC, 2003, J CLIN MICROBIOL, V41, P4751, DOI 10.1128/JCM.41.10.4751-4754.2003; Chapin KC, 2003, J CLIN MICROBIOL, V41, P1951, DOI 10.1128/JCM.41.5.1951-1956.2003; CLSI (Clinical and Laboratory Standards Institute), 2007, M10017 CLSI; DOERN GV, 1994, J CLIN MICROBIOL, V32, P1757, DOI 10.1128/JCM.32.7.1757-1762.1994; Dombrovskiy VY, 2005, CRIT CARE MED, V33, P2555, DOI 10.1097/01.CCM.0000186748.64438.7B; Donay JL, 2004, J CLIN MICROBIOL, V42, P1542, DOI 10.1128/JCM.42.4.1542-1546.2004; Edelmann A, 2007, J MED MICROBIOL, V56, P202, DOI 10.1099/jmm.0.46937-0; Fraser A, 2006, AM J MED, V119, P970, DOI 10.1016/j.amjmed.2006.03.034; Funke G, 2004, J CLIN MICROBIOL, V42, P1466, DOI 10.1128/JCM.42.4.1466-1470.2004; Hansen WLJ, 2010, J CLIN MICROBIOL, V48, P4432, DOI 10.1128/JCM.00562-10; Ibrahim EH, 2000, CHEST, V118, P146, DOI 10.1378/chest.118.1.146; JORGENSEN JH, 1993, J CLIN MICROBIOL, V31, P2841, DOI 10.1128/JCM.31.11.2841-2844.1993; Kerremans JJ, 2008, J ANTIMICROB CHEMOTH, V61, P428, DOI 10.1093/jac/dkm497; Kerremans JJ, 2004, EUR J CLIN MICROBIOL, V23, P892, DOI 10.1007/s10096-004-1247-9; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Kung Hsiang-Ching, 2008, Natl Vital Stat Rep, V56, P1; La Scola B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008041; Livermore DM, 2005, LANCET INFECT DIS, V5, P450, DOI 10.1016/S1473-3099(05)70166-3; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Menozzi MG, 2006, J CLIN MICROBIOL, V44, P4085, DOI 10.1128/JCM.00614-06; Rolain JM, 2004, J ANTIMICROB CHEMOTH, V54, P538, DOI 10.1093/jac/dkh324; Swinnen IAM, 2004, INT J FOOD MICROBIOL, V94, P137, DOI 10.1016/j.ijfoodmicro.2004.01.006; TRENHOLME GM, 1989, J CLIN MICROBIOL, V27, P1342, DOI 10.1128/JCM.27.6.1342-1345.1989; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Vliegen I, 2006, J MICROBIOL METH, V66, P156, DOI 10.1016/j.mimet.2005.11.005; Waites KB, 1998, J CLIN MICROBIOL, V36, P2052, DOI 10.1128/JCM.36.7.2052-2056.1998; Wellinghausen N, 2007, J CLIN MICROBIOL, V45, P789, DOI 10.1128/JCM.01856-06	35	25	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e27689	10.1371/journal.pone.0027689	http://dx.doi.org/10.1371/journal.pone.0027689			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194790	gold, Green Published, Green Submitted			2022-12-25	WOS:000298369100010
J	Guttal, V; Bartumeus, F; Hartvigsen, G; Nevai, AL				Guttal, Vishwesha; Bartumeus, Frederic; Hartvigsen, Gregg; Nevai, Andrew L.			Retention Time Variability as a Mechanism for Animal Mediated Long-Distance Dispersal	PLOS ONE			English	Article							SEED DISPERSAL; PLANT MIGRATION; PATTERNS; BEHAVIOR; MODELS; MOVEMENT; TAIL; DETERMINANTS; CONSERVATION; WIND	Long-distance dispersal (LDD) events, although rare for most plant species, can strongly influence population and community dynamics. Animals function as a key biotic vector of seeds and thus, a mechanistic and quantitative understanding of how individual animal behaviors scale to dispersal patterns at different spatial scales is a question of critical importance from both basic and applied perspectives. Using a diffusion-theory based analytical approach for a wide range of animal movement and seed transportation patterns, we show that the scale (a measure of local dispersal) of the seed dispersal kernel increases with the organisms' rate of movement and mean seed retention time. We reveal that variations in seed retention time is a key determinant of various measures of LDD such as kurtosis (or shape) of the kernel, thinkness of tails and the absolute number of seeds falling beyond a threshold distance. Using empirical data sets of frugivores, we illustrate the importance of variability in retention times for predicting the key disperser species that influence LDD. Our study makes testable predictions linking animal movement behaviors and gut retention times to dispersal patterns and, more generally, highlights the potential importance of animal behavioral variability for the LDD of seeds.	[Guttal, Vishwesha] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Guttal, Vishwesha] Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India; [Bartumeus, Frederic] CEAB CSIC, Ctr Adv Studies Blanes, Blanes, Spain; [Hartvigsen, Gregg] SUNY Coll Geneseo, Dept Biol, Coll Circle, Geneseo, NY 14454 USA; [Nevai, Andrew L.] Univ Cent Florida, Dept Math, Orlando, FL 32816 USA	Princeton University; Indian Institute of Science (IISC) - Bangalore; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); State University of New York (SUNY) System; SUNY Geneseo; State University System of Florida; University of Central Florida	Guttal, V (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	guttal@ces.iisc.ernet.in	Bartumeus, Frederic/D-1911-2010; Guttal, Vishwesha/A-3007-2008	Bartumeus, Frederic/0000-0001-6908-3797; Guttal, Vishwesha/0000-0002-2677-857X	National Science Foundation [0112050]; Spanish Ministry of Science and Innovation	National Science Foundation(National Science Foundation (NSF)); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The authors thank Mathematical Biosciences Institute (supported by National Science Foundation under Agreement No. 0112050) at the Ohio State University where the project was initiated. FB was supported by a Juan de la Cierva contract from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz M., 1964, HDB MATH FUNCTIONS F; Anderson JT, 2011, P ROY SOC B-BIOL SCI, V278, P3329, DOI 10.1098/rspb.2011.0155; Bartumeus F, 2005, ECOLOGY, V86, P3078, DOI 10.1890/04-1806; Bolker B, 2008, ECOLOGICAL MODELS DA; Bullock JM, 2000, OECOLOGIA, V124, P506, DOI 10.1007/PL00008876; Clark JS, 1998, BIOSCIENCE, V48, P13, DOI 10.2307/1313224; Clark JS, 1999, ECOLOGY, V80, P1475, DOI 10.2307/176541; DeCarlo LT, 1997, PSYCHOL METHODS, V2, P292, DOI 10.1037/1082-989X.2.3.292; Dennis A. J., 2007, Seed dispersal: theory and its application in a changing world, P201, DOI 10.1079/9781845931650.0201; Fragoso JMV, 2003, ECOLOGY, V84, P1998, DOI 10.1890/01-0621; Hawkes C, 2009, J ANIM ECOL, V78, P894, DOI 10.1111/j.1365-2656.2009.01534.x; HERRERA CM, 1985, OIKOS, V44, P132, DOI 10.2307/3544054; Higgins SI, 1999, AM NAT, V153, P464, DOI 10.1086/303193; Holbrook KM, 2000, OECOLOGIA, V125, P249, DOI 10.1007/s004420000445; Janzen D.H., 1983, P232; Jordano P, 2007, P NATL ACAD SCI USA, V104, P3278, DOI 10.1073/pnas.0606793104; Katul GG, 2005, AM NAT, V166, P368, DOI 10.1086/432589; Keeling MJ., 2008, MODELING INFECT DIS, DOI [DOI 10.1515/9781400841035, 10.1515/9781400841035]; Kot M, 1996, ECOLOGY, V77, P2027, DOI 10.2307/2265698; LEVEY DJ, 1987, AM NAT, V129, P471, DOI 10.1086/284652; Levin SA, 2003, ANNU REV ECOL EVOL S, V34, P575, DOI 10.1146/annurev.ecolsys.34.011802.132428; Lindstrom T, 2008, ECOLOGY, V89, P1784, DOI 10.1890/07-1363.1; Lowe WH, 2009, ECOLOGY, V90, P1456, DOI 10.1890/08-1903.1; MOLLISON D, 1977, J ROY STAT SOC B MET, V39, P283; Moorcroft P.R., 2006, MECHANISTIC HOME RAN; Morales JM, 2006, ECOLOGY, V87, P1489, DOI 10.1890/0012-9658(2006)87[1489:TEOPDA]2.0.CO;2; MURRAY KG, 1988, ECOL MONOGR, V58, P271, DOI 10.2307/1942541; Nathan R, 2002, NATURE, V418, P409, DOI 10.1038/nature00844; Nathan R, 2003, OIKOS, V103, P261, DOI 10.1034/j.1600-0706.2003.12146.x; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Nathan R, 2008, TRENDS ECOL EVOL, V23, P638, DOI 10.1016/j.tree.2008.08.003; NEUBERT MG, 1995, THEOR POPUL BIOL, V48, P7, DOI 10.1006/tpbi.1995.1020; OKUBO A, 2001, DIFFUSION ECOLOGICAL; Pearson RG, 2005, BIOL CONSERV, V123, P389, DOI 10.1016/j.biocon.2004.12.006; Petrovskii S, 2009, AM NAT, V173, P278, DOI 10.1086/595755; PORTNOY S, 1993, EVOL ECOL, V7, P25, DOI 10.1007/BF01237733; Russo SE, 2006, ECOLOGY, V87, P3160, DOI 10.1890/0012-9658(2006)87[3160:IABISD]2.0.CO;2; SCHUPP EW, 1993, VEGETATIO, V108, P15; Skalski GT, 2003, AM NAT, V161, P441, DOI 10.1086/367592; Soons MB, 2008, J ECOL, V96, P581, DOI 10.1111/j.1365-2745.2008.01370.x; STRONG AM, 1994, CONSERV BIOL, V8, P770, DOI 10.1046/j.1523-1739.1994.08030770.x; Sun C, 1997, OECOLOGIA, V112, P94, DOI 10.1007/s004420050288; Turchin Peter, 1998; Westcott DA, 2005, OECOLOGIA, V146, P57, DOI 10.1007/s00442-005-0178-1; Westcott DA, 2000, OECOLOGIA, V122, P249, DOI 10.1007/PL00008853; WILLIAMS EJ, 1971, AUSTRA J BIOL SCI, V14, P598	46	24	24	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28447	10.1371/journal.pone.0028447	http://dx.doi.org/10.1371/journal.pone.0028447			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194837	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000298369100040
J	Zhang, J; Tan, KL; Wu, XF; Chen, GF; Sun, JJ; Reck-Peterson, SL; Hammer, JA; Xiang, X				Zhang, Jun; Tan, Kaeling; Wu, Xufeng; Chen, Guifang; Sun, Jinjin; Reck-Peterson, Samara L.; Hammer, John A., III; Xiang, Xin			Aspergillus Myosin-V Supports Polarized Growth in the Absence of Microtubule-Based Transport	PLOS ONE			English	Article							FUNGUS USTILAGO-MAYDIS; HYPHAL TIP GROWTH; MOTOR-LIKE DOMAIN; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; FISSION YEAST; PLUS-ENDS; NIDULANS; KINESIN; PROTEIN	In the filamentous fungus Aspergillus nidulans, both microtubules and actin filaments are important for polarized growth at the hyphal tip. Less clear is how different microtubule-based and actin-based motors work together to support this growth. Here we examined the role of myosin-V (MYOV) in hyphal growth. MYOV-depleted cells form elongated hyphae, but the rate of hyphal elongation is significantly reduced. In addition, although wild type cells without microtubules still undergo polarized growth, microtubule disassembly abolishes polarized growth in MYOV-depleted cells. Thus, MYOV is essential for polarized growth in the absence of microtubules. Moreover, while a triple kinesin null mutant lacking kinesin-1 (KINA) and two kinesin-3s (UNCA and UNCB) undergoes hyphal elongation and forms a colony, depleting MYOV in this triple mutant results in lethality due to a severe defect in polarized growth. These results argue that MYOV, through its ability to transport secretory cargo, can support a significant amount of polarized hyphal tip growth in the absence of any microtubule-based transport. Finally, our genetic analyses also indicate that KINA (kinesin-1) rather than UNCA (kinesin-3) is the major kinesin motor that supports polarized growth in the absence of MYOV.	[Zhang, Jun; Chen, Guifang; Xiang, Xin] Uniformed Serv Univ Hlth Sci, Dept Biochem & Mol Biol, F Edward Hebert Sch Med, Bethesda, MD 20814 USA; [Tan, Kaeling; Reck-Peterson, Samara L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; [Wu, Xufeng; Sun, Jinjin; Hammer, John A., III] NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; [Sun, Jinjin] River Hill High Sch, Clarksville, MD USA	Uniformed Services University of the Health Sciences - USA; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Zhang, J (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Biochem & Mol Biol, F Edward Hebert Sch Med, Bethesda, MD 20814 USA.	hammerj@nhlbi.nih.gov; xxiang@usuhs.mil		Reck-Peterson, Samara/0000-0002-1553-465X; Tan, Kaeling/0000-0002-3347-7628	National Institutes of the Health [5RO1GM069527, 1RO1GM097580-01, 1 DP2 OD004268-01]; Uniformed Services University of the Health Sciences [R071JD]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000514] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097580, R01GM069527] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004268] Funding Source: NIH RePORTER	National Institutes of the Health; Uniformed Services University of the Health Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of the Health grants (5RO1GM069527 and 1RO1GM097580-01 to X. X. and 1 DP2 OD004268-01 to S. R. -P.) and a Uniformed Services University of the Health Sciences intramural grant (R071JD to X. X.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2010, CURR OPIN CELL BIOL, V22, P479, DOI 10.1016/j.ceb.2010.04.008; Ali MY, 2008, P NATL ACAD SCI USA, V105, P4691, DOI 10.1073/pnas.0711531105; Altmann K, 2008, J CELL BIOL, V181, P119, DOI 10.1083/jcb.200709099; Penalva MA, 2010, CURR OPIN MICROBIOL, V13, P684, DOI 10.1016/j.mib.2010.09.005; Araujo-Bazan L, 2008, MOL MICROBIOL, V67, P891, DOI 10.1111/j.1365-2958.2007.06102.x; Chang W, 2008, RNA, V14, P491, DOI 10.1261/rna.665008; Estrada P, 2003, J CELL BIOL, V163, P1255, DOI 10.1083/jcb.200304030; Fagarasanu A, 2009, J CELL BIOL, V186, P541, DOI 10.1083/jcb.200904050; Fischer R, 2008, MOL MICROBIOL, V68, P813, DOI 10.1111/j.1365-2958.2008.06193.x; Fuchs U, 2005, MOL BIOL CELL, V16, P2746, DOI 10.1091/mbc.E05-03-0176; Fujiwara M, 1997, BIOCHEM BIOPH RES CO, V236, P75, DOI 10.1006/bbrc.1997.6907; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Goldman G. H., 2008, ASPERGILLI GENOMICS; GOVINDAN B, 1995, J CELL BIOL, V128, P1055, DOI 10.1083/jcb.128.6.1055; Harris SD, 2005, EUKARYOT CELL, V4, P225, DOI 10.1128/EC.4.2.225-229.2005; Harris SD, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P238; Hayakawa Y, 2011, MOL MICROBIOL, V81, P40, DOI 10.1111/j.1365-2958.2011.07700.x; Hervas-Aguilar A, 2010, EUKARYOT CELL, V9, P1504, DOI 10.1128/EC.00119-10; Horio T, 2005, MOL BIOL CELL, V16, P918, DOI 10.1091/mbc.E04-09-0798; Huang JD, 1999, NATURE, V397, P267, DOI 10.1038/16722; Jedd G, 2011, TRENDS CELL BIOL, V21, P12, DOI 10.1016/j.tcb.2010.09.001; Jung G, 2009, J CELL BIOL, V186, P555, DOI 10.1083/jcb.200810147; Konzack S, 2005, MOL BIOL CELL, V16, P497, DOI 10.1091/mbc.E04-02-0083; Langford GM, 2002, TRAFFIC, V3, P859, DOI 10.1034/j.1600-0854.2002.31202.x; Lawrence CJ, 2004, J CELL BIOL, V167, P19, DOI 10.1083/jcb.200408113; Lenz JH, 2006, EMBO J, V25, P2275, DOI 10.1038/sj.emboj.7601119; Lipatova Z, 2008, MOL BIOL CELL, V19, P4177, DOI 10.1091/mbc.E08-02-0220; Liu B, 2000, MOL GEN GENET, V263, P375, DOI 10.1007/s004380051181; Loubery S, 2008, CELL MOL LIFE SCI, V65, P2790, DOI 10.1007/s00018-008-8350-5; MCGOLDRICK CA, 1995, J CELL BIOL, V128, P577, DOI 10.1083/jcb.128.4.577; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; Momany M, 2002, MYCOLOGIA, V94, P260, DOI 10.2307/3761802; Motegi F, 2001, MOL BIOL CELL, V12, P1367, DOI 10.1091/mbc.12.5.1367; Mulvihill DP, 2006, CELL MOTIL CYTOSKEL, V63, P149, DOI 10.1002/cm.20113; Nayak T, 2006, GENETICS, V172, P1557, DOI 10.1534/genetics.105.052563; OAKLEY BR, 1980, CELL, V19, P255, DOI 10.1016/0092-8674(80)90407-9; Pashkova N, 2006, EMBO J, V25, P693, DOI 10.1038/sj.emboj.7600965; Peraza-Reyes L, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P191; Read ND, 2011, MOL MICROBIOL, V81, P4, DOI 10.1111/j.1365-2958.2011.07702.x; Reck-Peterson SL, 1999, MOL BIOL CELL, V10, P1001, DOI 10.1091/mbc.10.4.1001; Requena N, 2001, MOL MICROBIOL, V42, P121, DOI 10.1046/j.1365-2958.2001.02609.x; Riquelme M, 1998, FUNGAL GENET BIOL, V24, P101, DOI 10.1006/fgbi.1998.1074; Rischitor PE, 2004, EUKARYOT CELL, V3, P632, DOI 10.1128/EC.3.3.632-645.2004; Schoch CL, 2003, FUNGAL GENET BIOL, V39, P1, DOI 10.1016/S1087-1845(03)00022-7; Schuchardt I, 2005, MOL BIOL CELL, V16, P5191, DOI 10.1091/mbc.E05-04-0272; SCHUSTER M, 2011, EMBO J IN PRESS; Soldati T, 2006, NAT REV MOL CELL BIO, V7, P897, DOI 10.1038/nrm2060; STEINBERG G, 2011, CURR OPIN M IN PRESS; Steinberg G, 2007, EUKARYOT CELL, V6, P351, DOI 10.1128/EC.00381-06; Stiess M, 2011, NAT CELL BIOL, V13, P10, DOI 10.1038/ncb2147; Straubinger B., 1992, FUNGAL GENET NEWSLET, V39, P82; Taheri-Talesh N, 2008, MOL BIOL CELL, V19, P1439, DOI 10.1091/mbc.E07-05-0464; Takeshita N, 2006, MOL MICROBIOL, V59, P1380, DOI 10.1111/j.1365-2958.2006.05030.x; Upadhyay S, 2008, MOL MICROBIOL, V68, P690, DOI 10.1111/j.1365-2958.2008.06178.x; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Virag A, 2007, MOL MICROBIOL, V66, P1579, DOI 10.1111/j.1365-2958.2007.06021.x; Wagner W, 2011, NAT CELL BIOL, V13, P40, DOI 10.1038/ncb2132; Weber I, 2003, PLANT CELL, V15, P2826, DOI 10.1105/tpc.016246; Wedlich-Soldner R, 2002, EMBO J, V21, P2946, DOI 10.1093/emboj/cdf296; Win TZ, 2001, J CELL SCI, V114, P69; Wu XF, 2006, TRENDS CELL BIOL, V16, P135, DOI 10.1016/j.tcb.2006.01.004; Wu XF, 1998, J CELL BIOL, V143, P1899, DOI 10.1083/jcb.143.7.1899; Wu XS, 2005, J CELL BIOL, V171, P201, DOI 10.1083/jcb.200503028; XIANG X, 1995, MOL BIOL CELL, V6, P297, DOI 10.1091/mbc.6.3.297; Yamashita RA, 1998, J BIOL CHEM, V273, P14644, DOI 10.1074/jbc.273.23.14644; Zekert N, 2010, EUKARYOT CELL, V9, P795, DOI 10.1128/EC.00058-10; Zekert N, 2009, MOL BIOL CELL, V20, P673, DOI 10.1091/mbc.E08-07-0685; Zhang J, 2003, MOL BIOL CELL, V14, P1479, DOI 10.1091/mbc.E02-08-0516	68	26	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28575	10.1371/journal.pone.0028575	http://dx.doi.org/10.1371/journal.pone.0028575			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194856	Green Published, Green Submitted, gold			2022-12-25	WOS:000298369100054
J	Wolf, AI; Mozdzanowska, K; Williams, KL; Singer, D; Richter, M; Hoffmann, R; Caton, AJ; Otvos, L; Erikson, J				Wolf, Amaya I.; Mozdzanowska, Krystyna; Williams, Katie L.; Singer, David; Richter, Monique; Hoffmann, Ralf; Caton, Andrew J.; Otvos, Laszlo; Erikson, Jan			Vaccination with M2e-Based Multiple Antigenic Peptides: Characterization of the B Cell Response and Protection Efficacy in Inbred and Outbred Mice	PLOS ONE			English	Article							INFLUENZA-A-VIRUS; INTEGRAL MEMBRANE-PROTEIN; MATRIX PROTEIN-2; M2 PROTEIN; T-CELL; EXTRACELLULAR DOMAIN; CONJUGATE VACCINES; ANTIBODY-RESPONSE; MONOCLONAL-ANTIBODY; RESPIRATORY-TRACT	Background: The extracellular domain of the influenza A virus protein matrix protein 2 (M2e) is remarkably conserved between various human isolates and thus is a viable target antigen for a universal influenza vaccine. With the goal of inducing protection in multiple mouse haplotypes, M2e-based multiple antigenic peptides (M2e-MAP) were synthesized to contain promiscuous T helper determinants from the Plasmodium falciparum circumsporozoite protein, the hepatitis B virus antigen and the influenza virus hemagglutinin. Here, we investigated the nature of the M2e-MAP-induced B cell response in terms of the distribution of antibody (Ab) secreting cells (ASCs) and Ab isotypes, and tested the protective efficacy in various mouse strains. Methodology/Principal Findings: Immunization of BALB/c mice with M2e-MAPs together with potent adjuvants, CpG 1826 oligonucleotides (ODN) and cholera toxin (CT) elicited high M2e-specific serum Ab titers that protected mice against viral challenge. Subcutaneous (s.c.) and intranasal (i.n.) delivery of M2e-MAPs resulted in the induction of IgG in serum and airway secretions, however only i.n. immunization induced anti-M2e IgA ASCs locally in the lungs, correlating with M2-specific IgA in the bronchio-alveolar lavage (BAL). Interestingly, both routes of vaccination resulted in equal protection against viral challenge. Moreover, M2e-MAPs induced cross-reactive and protective responses to diverse M2e peptides and variant influenza viruses. However, in contrast to BALB/c mice, immunization of other inbred and outbred mouse strains did not induce protective Abs. This correlated with a defect in T cell but not B cell responsiveness to the M2e-MAPs. Conclusion/Significance: Anti-M2e Abs induced by M2e-MAPs are highly cross-reactive and can mediate protection to variant viruses. Although synthetic MAPs are promising designs for vaccines, future constructs will need to be optimized for use in the genetically heterogeneous human population.	[Wolf, Amaya I.; Mozdzanowska, Krystyna; Williams, Katie L.; Caton, Andrew J.; Erikson, Jan] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Singer, David; Richter, Monique; Hoffmann, Ralf] Univ Leipzig, Inst Bioanalyt Chem, Ctr Biotechnol & Biomed, Leipzig, Germany; [Otvos, Laszlo] Temple Univ, Dept Biol, Philadelphia, PA 19122 USA	The Wistar Institute; Leipzig University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Wolf, AI (corresponding author), Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA.	jan@wistar.org	Hoffmann, Ralf/ABD-8779-2020		National Institutes of Health [U19 AI083022]; Commonwealth of Pennsylvania; Wistar Cancer Center [P30 CA10815, CA09171-32]; NATIONAL CANCER INSTITUTE [T32CA009171, P30CA010815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083022] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Pennsylvania; Wistar Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by the National Institutes of Health grant U19 AI083022 to J.E. and A.J.C., a grant from the Commonwealth of Pennsylvania to J.E., A.J.C. and L.O., the Wistar Cancer Center Core Grant P30 CA10815, and a T32 Training grant CA09171-32 to A.I.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahi Y, 2002, J IMMUNOL, V168, P2930, DOI 10.4049/jimmunol.168.6.2930; Beerli RR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-224; Bessa J, 2008, EUR J IMMUNOL, V38, P114, DOI 10.1002/eji.200636959; BLACK RA, 1993, J GEN VIROL, V74, P143, DOI 10.1099/0022-1317-74-1-143; Calvo-Calle JM, 2006, INFECT IMMUN, V74, P6929, DOI 10.1128/IAI.01151-06; Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x; De Filette M, 2006, VACCINE, V24, P544, DOI 10.1016/j.vaccine.2005.08.061; De Filette M, 2005, VIROLOGY, V337, P149, DOI 10.1016/j.virol.2005.04.004; De Filette M, 2008, J BIOL CHEM, V283, P11382, DOI 10.1074/jbc.M800650200; De Filette M, 2006, VACCINE, V24, P6597, DOI 10.1016/j.vaccine.2006.05.082; DEFILETTE M, 2008, VACCINE; Ebrahimi SM, 2011, VIRUS GENES, V42, P1, DOI 10.1007/s11262-010-0547-7; Falugi F, 2001, EUR J IMMUNOL, V31, P3816, DOI 10.1002/1521-4141(200112)31:12<3816::AID-IMMU3816>3.0.CO;2-K; Fan JA, 2004, VACCINE, V22, P2993, DOI 10.1016/j.vaccine.2004.02.021; Feng JQ, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-102; Fiers W, 2004, VIRUS RES, V103, P173, DOI 10.1016/j.virusres.2004.02.030; Fiers W, 2009, VACCINE, V27, P6280, DOI 10.1016/j.vaccine.2009.07.007; Fu TM, 2009, VACCINE, V27, P1440, DOI 10.1016/j.vaccine.2008.12.034; GREENSTEIN JL, 1992, J IMMUNOL, V148, P3970; Hagenaars N, 2008, VACCINE, V26, P6555, DOI 10.1016/j.vaccine.2008.09.057; HAMMER J, 1993, CELL, V74, P197, DOI 10.1016/0092-8674(93)90306-B; HIRABAYASHI Y, 1991, IMMUNOLOGY, V72, P329; HOLSINGER LJ, 1991, VIROLOGY, V183, P32, DOI 10.1016/0042-6822(91)90115-R; Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062; Jegerlehner A, 2004, J IMMUNOL, V172, P5598, DOI 10.4049/jimmunol.172.9.5598; Joo HM, 2010, VACCINE, V28, P2186, DOI 10.1016/j.vaccine.2009.12.058; Kitikoon P, 2009, VACCINE, V28, P523, DOI 10.1016/j.vaccine.2009.09.130; Klinman DM, 2004, IMMUNOL REV, V199, P201, DOI 10.1111/j.0105-2896.2004.00148.x; LAMB RA, 1985, CELL, V40, P627, DOI 10.1016/0092-8674(85)90211-9; LIANG SH, 1994, J IMMUNOL, V152, P1653; Liu WL, 2005, MICROBES INFECT, V7, P171, DOI 10.1016/j.micinf.2004.10.006; Liu WL, 2004, IMMUNOL LETT, V93, P131, DOI 10.1016/j.imlet.2004.03.003; Milich DR, 2003, AUTOIMMUN REV, V2, P248, DOI 10.1016/S1568-9972(03)00031-4; Misplon JA, 2010, VACCINE, V28, P5817, DOI 10.1016/j.vaccine.2010.06.069; Mozdzanowska K, 2003, VACCINE, V21, P2616, DOI 10.1016/S0264-410X(03)00040-9; Mozdzanowska K, 1999, VIROLOGY, V254, P138, DOI 10.1006/viro.1998.9534; Mozdzanowska K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-118; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; Otvos Laszlo Jr., 2008, V494, P263, DOI 10.1007/978-1-59745-419-3_15; PEJOSKI D, 2010, IMMUNOL CELL BIOL; Price GE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013162; Rao SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009812; Renegar KB, 2004, J IMMUNOL, V173, P1978, DOI 10.4049/jimmunol.173.3.1978; RENEGAR KB, 1991, J VIROL, V65, P2146, DOI 10.1128/JVI.65.4.2146-2148.1991; SCHERLE PA, 1992, J IMMUNOL, V148, P212; SINIGAGLIA F, 1988, NATURE, V336, P778, DOI 10.1038/336778a0; Soboleski MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021937; SUGRUE RJ, 1991, VIROLOGY, V180, P617, DOI 10.1016/0042-6822(91)90075-M; Talbot HK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014442; TAMURA S, 1991, EUR J IMMUNOL, V21, P1337, DOI 10.1002/eji.1830210602; Tamura SI, 2005, JPN J INFECT DIS, V58, P195; Tompkins SM, 2007, EMERG INFECT DIS, V13, P426, DOI 10.3201/eid1303.061125; TREANOR JJ, 1990, J VIROL, V64, P1375, DOI 10.1128/JVI.64.3.1375-1377.1990; Wolf AI, 2009, J IMMUNOL, V182, P871, DOI 10.4049/jimmunol.182.2.871; WU F, 2009, VACCINE; WU F, 2008, VACCINE; Wu F, 2007, VACCINE, V25, P8868, DOI 10.1016/j.vaccine.2007.09.056; ZEBEDEE SL, 1988, J VIROL, V62, P2762, DOI 10.1128/JVI.62.8.2762-2772.1988; Zhang MX, 2006, MOL IMMUNOL, V43, P2195, DOI 10.1016/j.molimm.2005.12.015; Zhao GY, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-151; Zhao GY, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-9; Zharikova D, 2005, J VIROL, V79, P6644, DOI 10.1128/JVI.79.11.6644-6654.2005; Zhou DM, 2010, MOL THER, V18, P2182, DOI 10.1038/mt.2010.202	63	31	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28445	10.1371/journal.pone.0028445	http://dx.doi.org/10.1371/journal.pone.0028445			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22180783	gold, Green Submitted, Green Published			2022-12-25	WOS:000298367300011
J	Bazzini, AA; Manacorda, CA; Tohge, T; Conti, G; Rodriguez, MC; Nunes-Nesi, A; Villanueva, S; Fernie, AR; Carrari, F; Asurmendi, S				Bazzini, Ariel A.; Manacorda, Carlos A.; Tohge, Takayuki; Conti, Gabriela; Rodriguez, Maria C.; Nunes-Nesi, Adriano; Villanueva, Sofia; Fernie, Alisdair R.; Carrari, Fernando; Asurmendi, Sebastian			Metabolic and miRNA Profiling of TMV Infected Plants Reveals Biphasic Temporal Changes	PLOS ONE			English	Article							TOBACCO-MOSAIC-VIRUS; SYSTEMIC ACQUIRED-RESISTANCE; PROTEIN-MEDIATED RESISTANCE; RNA SILENCING SUPPRESSORS; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; TRANSGENIC TOBACCO; DISEASE RESISTANCE; GAS-CHROMATOGRAPHY; NICOTIANA-TABACUM	Plant viral infections induce changes including gene expression and metabolic components. Identification of metabolites and microRNAs (miRNAs) differing in abundance along infection may provide a broad view of the pathways involved in signaling and defense that orchestrate and execute the response in plant-pathogen interactions. We used a systemic approach by applying both liquid and gas chromatography coupled to mass spectrometry to determine the relative level of metabolites across the viral infection, together with a miRs profiling using a micro-array based procedure. Systemic changes in metabolites were characterized by a biphasic response after infection. The first phase, detected at one dpi, evidenced the action of a systemic signal since no virus was detected systemically. Several of the metabolites increased at this stage were hormone-related. miRs profiling after infection also revealed a biphasic alteration, showing miRs alteration at 5 dpi where no virus was detected systemically and a late phase correlating with virus accumulation. Correlation analyses revealed a massive increase in the density of correlation networks after infection indicating a complex reprogramming of the regulatory pathways, either in response to the plant defense mechanism or to the virus infection itself. Our data propose the involvement of a systemic signaling on early miRs alteration.	[Bazzini, Ariel A.; Manacorda, Carlos A.; Conti, Gabriela; Rodriguez, Maria C.; Villanueva, Sofia; Carrari, Fernando; Asurmendi, Sebastian] CICVyA INTA, Inst Biotecnol, Buenos Aires, DF, Argentina; [Rodriguez, Maria C.; Carrari, Fernando; Asurmendi, Sebastian] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Tohge, Takayuki; Nunes-Nesi, Adriano; Fernie, Alisdair R.] Max Planck Inst Mol Plant Physiol, Potsdam, Germany	Instituto Nacional de Tecnologia Agropecuaria (INTA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Max Planck Society	Bazzini, AA (corresponding author), Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA.	sasurmendi@cnia.inta.gov.ar	Tohge, Takayuki/G-7924-2017; Nunes-Nesi, Adriano/D-6430-2013; Asurmendi, Sebastian/AAJ-1400-2021	Tohge, Takayuki/0000-0001-5555-5650; Asurmendi, Sebastian/0000-0001-9516-5948; Conti, Gabriela/0000-0003-4221-3760; Nunes-Nesi, Adriano/0000-0002-9581-9355	Instituto Nacional de Tecnologia Agropecuaria (INTA) (Argentina) [PE243532]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) (Argentina) Proyecto de Investigacion Cientifica y Tecnologica (PICT) [2005 32598]; Max Planck Society (Germany); European Molecular Biology Organization (EMBO); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); INTA; ANPCyT; Alexander von Humdoldt foundation	Instituto Nacional de Tecnologia Agropecuaria (INTA) (Argentina); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) (Argentina) Proyecto de Investigacion Cientifica y Tecnologica (PICT); Max Planck Society (Germany)(Max Planck Society); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); INTA; ANPCyT(ANPCyT); Alexander von Humdoldt foundation	This work was supported by grants from Instituto Nacional de Tecnologia Agropecuaria (INTA) PE243532 (Argentina), Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) (Argentina) Proyecto de Investigacion Cientifica y Tecnologica (PICT) 2005 32598, and Max Planck Society (Germany). A. B. is INTA research assistant and held a fellowship from European Molecular Biology Organization (EMBO) and Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET). C. A. M. holds a fellowship from INTA and G. C. holds an ANPCyT fellowship. T. T. is a recipient of a fellowship from the Alexander von Humdoldt foundation. M. C. R. hold a CONICET Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany SE, 2008, J BIOL CHEM, V283, P15932, DOI 10.1074/jbc.M801406200; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Asurmendi S, 2007, VIROLOGY, V366, P98, DOI 10.1016/j.virol.2007.03.014; Asurmendi S, 2004, P NATL ACAD SCI USA, V101, P1415, DOI 10.1073/pnas.0307778101; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bazzini AA, 2007, P NATL ACAD SCI USA, V104, P12157, DOI 10.1073/pnas.0705114104; Bazzini AA, 2006, PHYTOPATHOLOGY, V96, P1175, DOI 10.1094/PHYTO-96-1175; Bazzini AA, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-152; Blevins T, 2006, NUCLEIC ACIDS RES, V34, P6233, DOI 10.1093/nar/gkl886; Bouche N, 2004, TRENDS PLANT SCI, V9, P110, DOI 10.1016/j.tplants.2004.01.006; Browse J, 2009, ANNU REV PLANT BIOL, V60, P183, DOI 10.1146/annurev.arplant.043008.092007; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chapman EJ, 2004, GENE DEV, V18, P1179, DOI 10.1101/gad.1201204; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen J, 2004, PLANT CELL, V16, P1302, DOI 10.1105/tpc.018986; Choi YH, 2006, J NAT PROD, V69, P742, DOI 10.1021/np050535b; Cillo F, 2009, MOL PLANT MICROBE IN, V22, P1239, DOI 10.1094/MPMI-22-10-1239; Csorba T, 2007, J VIROL, V81, P11768, DOI 10.1128/JVI.01230-07; Culver JN, 2007, ANNU REV PHYTOPATHOL, V45, P221, DOI 10.1146/annurev.phyto.45.062806.094422; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Dunoyer P, 2005, CURR OPIN PLANT BIOL, V8, P415, DOI 10.1016/j.pbi.2005.05.012; Dunoyer P, 2004, PLANT CELL, V16, P1235, DOI 10.1105/tpc.020719; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Fait A, 2008, TRENDS PLANT SCI, V13, P14, DOI 10.1016/j.tplants.2007.10.005; FARMER EE, 1992, PLANT CELL, V4, P129, DOI 10.1105/tpc.4.2.129; Fernie AR, 2007, PHYTOCHEMISTRY, V68, P2861, DOI 10.1016/j.phytochem.2007.07.010; Foyer CH, 2009, ANNU REV PLANT BIOL, V60, P455, DOI 10.1146/annurev.arplant.043008.091948; Frazier TP, 2010, PLANTA, V232, P1289, DOI 10.1007/s00425-010-1255-1; Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002; Grant MR, 2009, SCIENCE, V324, P750, DOI 10.1126/science.1173771; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; He XF, 2008, FEBS LETT, V582, P2445, DOI 10.1016/j.febslet.2008.06.011; Heiling S, 2010, PLANT CELL, V22, P273, DOI 10.1105/tpc.109.071449; HORAI H, 2008, P INT C BIOMEDICAL E, P853; Hu QA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019549; Hull R., 2002, MATTHEWS PLANT VIROL; Jahangir M, 2008, J PLANT PHYSIOL, V165, P1429, DOI 10.1016/j.jplph.2008.04.011; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Junker BH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-109; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; KHRAIWESH B, 2011, BIOCH BIOPHYS ACTA; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Kurihara Y, 2007, J GEN VIROL, V88, P2347, DOI 10.1099/vir.0.82994-0; Lilly ST, 2011, MOL PLANT MICROBE IN, V24, P294, DOI 10.1094/MPMI-10-10-0236; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Liu YJ, 2009, PLANT PHYSIOL, V150, P1248, DOI 10.1104/pp.109.136242; Luedemann A, 2008, BIOINFORMATICS, V24, P732, DOI 10.1093/bioinformatics/btn023; Luo J, 2008, PLANT J, V56, P316, DOI 10.1111/j.1365-313X.2008.03597.x; MAHER EA, 1994, P NATL ACAD SCI USA, V91, P7802, DOI 10.1073/pnas.91.16.7802; Mallory AC, 2005, PLANT CELL, V17, P1360, DOI 10.1105/tpc.105.031716; Martin RC, 2010, J EXP BOT, V61, P2229, DOI 10.1093/jxb/erq063; Metraux JP, 2002, TRENDS PLANT SCI, V7, P332, DOI 10.1016/S1360-1385(02)02313-0; Mishina TE, 2006, PLANT PHYSIOL, V141, P1666, DOI 10.1104/pp.106.081257; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Navarro L, 2008, SCIENCE, V321, P964, DOI 10.1126/science.1159505; Niggeweg R, 2004, NAT BIOTECHNOL, V22, P746, DOI 10.1038/nbt966; Padmanabhan C, 2009, CURR OPIN PLANT BIOL, V12, P465, DOI 10.1016/j.pbi.2009.06.005; Park SW, 2007, SCIENCE, V318, P113, DOI 10.1126/science.1147113; Pavet V, 2005, PLANT PHYSIOL, V139, P1291, DOI 10.1104/pp.105.067686; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Lopez-Gresa MP, 2010, PHYTOCHEM ANALYSIS, V21, P89, DOI 10.1002/pca.1179; Reichel C, 1998, P NATL ACAD SCI USA, V95, P11169, DOI 10.1073/pnas.95.19.11169; Roessner U, 2001, PLANT CELL, V13, P11, DOI 10.1105/tpc.13.1.11; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Ruiz-Ferrer V, 2009, ANNU REV PLANT BIOL, V60, P485, DOI 10.1146/annurev.arplant.043008.092111; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Shadle GL, 2003, PHYTOCHEMISTRY, V64, P153, DOI 10.1016/S0031-9422(03)00151-1; Shinbo Y, 2006, BIOTECH AGR FOREST, V57, P165; Silhavy D, 2004, TRENDS PLANT SCI, V9, P76, DOI 10.1016/j.tplants.2003.12.010; SUNKAR R, 2010, SEMIN CELL DEV BIOL; Tagami Y, 2007, DNA RES, V14, P227, DOI 10.1093/dnares/dsm022; Trindade I, 2010, PLANTA, V231, P705, DOI 10.1007/s00425-009-1078-0; Truman W, 2007, P NATL ACAD SCI USA, V104, P1075, DOI 10.1073/pnas.0605423104; Varallyay E, 2010, EMBO J, V29, P3507, DOI 10.1038/emboj.2010.215; Vazquez F, 2004, CURR BIOL, V14, P346, DOI 10.1016/j.cub.2004.01.035; Vlot AC, 2008, CURR OPIN PLANT BIOL, V11, P436, DOI 10.1016/j.pbi.2008.05.003; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Vogler H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000038; Voinnet O, 2005, NAT REV GENET, V6, P206, DOI 10.1038/nrg1555; Whitham SA, 2006, MOL PLANT MICROBE IN, V19, P1207, DOI 10.1094/MPMI-19-1207; Xin MM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-123; Yang CL, 2007, MOL PLANT MICROBE IN, V20, P358, DOI 10.1094/MPMI-20-4-0358; Yonekura-Sakakibara K, 2009, NAT PROD REP, V26, P1466, DOI 10.1039/b817077k; ZAITLIN M, 1987, ANNU REV PLANT PHYS, V38, P291, DOI 10.1146/annurev.pp.38.060187.001451	86	51	52	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28466	10.1371/journal.pone.0028466	http://dx.doi.org/10.1371/journal.pone.0028466			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174812	Green Published, Green Submitted, gold			2022-12-25	WOS:000298366600019
J	Cantalapiedra, JL; Fernandez, MH; Morales, J				Cantalapiedra, Juan L.; Hernandez Fernandez, Manuel; Morales, Jorge			Biomic Specialization and Speciation Rates in Ruminants (Cetartiodactyla, Mammalia): A Test of the Resource-Use Hypothesis at the Global Scale	PLOS ONE			English	Article							EXTINCTION RATES; RED QUEEN; EVOLUTION; PATTERNS	The resource-use hypothesis proposed by E.S. Vrba predicts that specialist species have higher speciation and extinction rates than generalists because they are more susceptible to environmental changes and vicariance. In this work, we test some of the predictions derived from this hypothesis on the 197 extant and recently extinct species of Ruminantia (Cetartiodactyla, Mammalia) using the biomic specialization index (BSI) of each species, which is based on its distribution within different biomes. We ran 10000 Monte Carlo simulations of our data in order to get a null distribution of BSI values against which to contrast the observed data. Additionally, we drew on a supertree of the ruminants and a phylogenetic likelihood-based method (QuaSSE) for testing whether the degree of biomic specialization affects speciation rates in ruminant lineages. Our results are consistent with the predictions of the resource-use hypothesis, which foretells a higher speciation rate of lineages restricted to a single biome (BSI = 1) and higher frequency of specialist species in biomes that underwent high degree of contraction and fragmentation during climatic cycles. Bovids and deer present differential specialization across biomes; cervids show higher specialization in biomes with a marked hydric seasonality (tropical deciduous woodlands and schlerophyllous woodlands), while bovids present higher specialization in a greater variety of biomes. This might be the result of divergent physiological constraints as well as a different biogeographic and evolutionary history.	[Cantalapiedra, Juan L.; Morales, Jorge] CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, E-28006 Madrid, Spain; [Hernandez Fernandez, Manuel] Univ Complutense Madrid, Dept Paleontol, Fac Ciencias Geol, Madrid, Spain; [Hernandez Fernandez, Manuel] CSIC, UCM, Inst Geociencias, Dept Cambio Ambiental, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Complutense University of Madrid; Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UCM - Instituto de Geociencias (IGEO)	Cantalapiedra, JL (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, E-28006 Madrid, Spain.	jlopezcant@gmail.com	Fernández, Manuel Hernández/I-5012-2013; Morales, Jorge/L-1476-2014; Cantalapiedra, Juan L/L-2135-2014	Fernández, Manuel Hernández/0000-0001-5640-9647; Morales, Jorge/0000-0001-5170-5754; Cantalapiedra, Juan L/0000-0003-0913-7735	Spanish Ministry of Science and Innovation [CGL2006-01773/BTE, CGL2008-05813-C02-01/BTE, CGL2010-19116/BOS]; Complutensian University of Madrid [PR1/06-14470-B]; UCM [UCM 910607]; Ministerio de Educacion y Ciencia of Spain	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Complutensian University of Madrid; UCM; Ministerio de Educacion y Ciencia of Spain(Spanish Government)	This research was made possible by grants from the Spanish Ministry of Science and Innovation (CGL2006-01773/BTE, CGL2008-05813-C02-01/BTE and CGL2010-19116/BOS) and from the Complutensian University of Madrid (PR1/06-14470-B). The authors acknowledge additional financial support from the UCM through a grant to the Research Group UCM 910607 on Evolution of Cenozoic Mammals and Continental Palaeoenvironments. During the development of this research, MHF had a UCM contract from the Program "Ramon y Cajal" of the Ministerio de Educacion y Ciencia of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alroy J, 2011, PALEOBIOLOGY DATABAS; Ansell W. F. H., 1971, P1; Beerling DJ, 2006, GLOBAL CHANGE BIOL, V12, P2023, DOI 10.1111/j.1365-2486.2006.01239.x; Benton MJ, 2009, SCIENCE, V323, P728, DOI 10.1126/science.1157719; Bibi F, 2009, PALAEONTOL ELECTRON, V12; Bigelow NH, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002558; Bobe R, 2001, PALEOBIOLOGY, V27, P1, DOI 10.1666/0094-8373(2001)027<0001:ROABTP>2.0.CO;2; Bofarull AM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-97; Bruch AA, 2007, PALAEOGEOGR PALAEOCL, V253, P1, DOI 10.1016/j.palaeo.2007.03.030; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; CERLING TE, 1993, NATURE, V361, P344, DOI 10.1038/361344a0; Corbet G.B, 1978, MAMMALS PALAEARCTIC; Corbet GB, 1992, MAMMALS INDO MALAYAN; DeMiguel D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-13; Doherty DA, 2004, J BIOGEOGR, V31, P57, DOI 10.1111/j.1365-2699.2004.00943.x; Eeley HAC, 1999, BIODIVERS CONSERV, V8, P1033, DOI 10.1023/A:1008831320469; Eisenberg H. J. F., 1989, MAMMALS NEOTROPICS, V1; Eisenberg H. J. F., 2000, MAMMALS NEOTROPICS, V3; Eronen JT, 2010, EVOL ECOL RES, V12, P235; Eronen JT, 2010, EVOLUTION, V64, P398, DOI 10.1111/j.1558-5646.2009.00830.x; European Commission, 2020, GUID GEOGR IND GIS S; Fernandez MH, 2005, EVOL ECOL, V19, P199, DOI 10.1007/s10682-004-8152-7; Fernandez MH, 2005, BIOL REV, V80, P269, DOI 10.1017/S1464793104006670; Fernandez MH, 2001, GLOBAL ECOL BIOGEOGR, V10, P189, DOI 10.1046/j.1466-822x.2001.00218.x; FitzJohn R. G., 2011, DIVERSITREE COMP PHY; FitzJohn RG, 2010, SYST BIOL, V59, P619, DOI 10.1093/sysbio/syq053; Fortelius M., 2011, NEOGENE OLD WORLD DA; Geist V., 1998, DEER WORLD THEIR EVO, P1; Gentry Alan W., 2000, P11; GILINSKY NL, 1994, PALEOBIOLOGY, V20, P445, DOI 10.1017/S0094837300012926; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Grubb Peter, 1993, P377; Hall E. R., 1981, MAMMALS N AM; Harcourt AH, 2002, J BIOGEOGR, V29, P445, DOI 10.1046/j.1365-2699.2002.00685.x; Harcourt AH, 2000, J BIOGEOGR, V27, P1169, DOI 10.1046/j.1365-2699.2000.00482.x; Hassanin A, 1999, MOL PHYLOGENET EVOL, V13, P227, DOI 10.1006/mpev.1999.0619; IUCN, 2008, DIG DISTR MAPS MAMM; JANIS CM, 1993, ANNU REV ECOL SYST, V24, P467, DOI 10.1146/annurev.es.24.110193.002343; Kingdon J, 1997, KINGDON FIELD GUIDE; Kuhn TS, 2011, METHODS ECOL EVOL, V2, P427, DOI 10.1111/j.2041-210X.2011.00103.x; Liow LH, 2008, P NATL ACAD SCI USA, V105, P6097, DOI 10.1073/pnas.0709763105; Maddison WP, 2007, SYST BIOL, V56, P701, DOI 10.1080/10635150701607033; McKenna M.C., 1997, CLASSIFICATION MAMMA, P640; MitchellJones A.J., 1999, ATLAS EUROPEAN MAMMA; MORALES J, 1993, GEOBIOS-LYON, V26, P207, DOI 10.1016/S0016-6995(93)80016-K; PICKFORD M, 1994, PALAEOGEOGR PALAEOCL, V112, P297, DOI 10.1016/0031-0182(94)90078-7; R Core Team, 2022, R LANG ENV STAT COMP; Rabosky DL, 2010, EVOLUTION, V64, P1816, DOI 10.1111/j.1558-5646.2009.00926.x; Redford KH, 1992, MAMMALS NEOTROPICS, V2; SCHALLER GB, 1977, MOUNTAIN MONARCHS WI, P45; Scopoli J.A., 1777, INTRODVCTIO AD HIST; van Dam JA, 2006, NATURE, V443, P687, DOI 10.1038/nature05163; Vrba E.S., 1980, P247; Vrba E. S., 1997, Palaeontologia Africana, V34, P127; Vrba ES, 1987, EVOL ECOL, V1, P283, DOI 10.1007/BF02071554; Vrba Elizabeth S., 1995, PALEOCLIMATE EVOLUTI; Vrba ES, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P24; Vrba ES, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P385; VRBA ES, 1980, S AFR J SCI, V76, P61; VRBA ES, 1992, J MAMMAL, V73, P1, DOI 10.2307/1381862; Vrba ES, 1999, HUMAN EVOLUT SER, P19; VRBA ES, 1993, AM J SCI, V293A, P418, DOI 10.2475/ajs.293.A.418; Walter H., 1970, VEGETATION CLIMA; WILSON DE, 1993, MAMMAL SPECIES WORLD, P377	64	24	26	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28749	10.1371/journal.pone.0028749	http://dx.doi.org/10.1371/journal.pone.0028749			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174888	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000298366600035
J	Papayannopoulos, V; Staab, D; Zychlinsky, A				Papayannopoulos, Venizelos; Staab, Doris; Zychlinsky, Arturo			Neutrophil Elastase Enhances Sputum Solubilization in Cystic Fibrosis Patients Receiving DNase Therapy	PLOS ONE			English	Article							EXTRACELLULAR TRAPS; DISEASE; PATHOGENESIS; INFLAMMATION; INHIBITOR; PROTEASES	Cystic fibrosis patients suffer from chronic lung infection and inflammation due to the secretion of viscous sputum. Sputum viscosity is caused by extracellular DNA, some of which originates from the release of neutrophil extracellular traps (NETs). During NET formation neutrophil elastase (NE) partially processes histones to decondense chromatin. NE is abundant in CF sputum and is thought to contribute to tissue damage. Exogenous nucleases are a palliative treatment in CF as they promote sputum solubilization. We show that in a process reminiscent of NET formation, NE enhances sputum solubilization by cleaving histones to enhance the access of exogenous nucleases to DNA. In addition, we find that in Cf sputum NE is predominantly bound to DNA, which is known to downregulate its proteolytic activity and may restrict host tissue damage. The beneficial role of NE in CF sputum solubilization may have important implications for the development of CF therapies targeting NE.	[Papayannopoulos, Venizelos; Zychlinsky, Arturo] Max Planck Inst Infect Biol, Dept Cellular Microbiol, Berlin, Germany; [Staab, Doris] Charite, Christiane Herzog Cyst Fibrosis Ctr, Clin Pediat Pneumol & Immunol, Berlin, Germany	Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Papayannopoulos, V (corresponding author), Max Planck Inst Infect Biol, Dept Cellular Microbiol, Berlin, Germany.	veni@mpiib-berlin.mpg.de		Papayannopoulos, Venizelos/0000-0002-3741-8190	May Planck Society; European Molecular Biology Organization (EMBO)	May Planck Society; European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO))	This study was funded by the May Planck Society. Dr. Papayannopoulos was also funded by and by Postdoctoral Fellowship from the European Molecular Biology Organization (EMBO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beiter K, 2006, CURR BIOL, V16, P401, DOI 10.1016/j.cub.2006.01.056; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Cantin AM, 1998, AM J RESP CRIT CARE, V157, P464, DOI 10.1164/ajrccm.157.2.9608033; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Fujie K, 1999, EUR J PHARMACOL, V374, P117, DOI 10.1016/S0014-2999(99)00268-X; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Greene CM, 2009, BRIT J PHARMACOL, V158, P1048, DOI 10.1111/j.1476-5381.2009.00448.x; Henke MO, 2011, INFECT IMMUN, V79, P3438, DOI 10.1128/IAI.01252-10; LETHEM MI, 1990, EUR RESPIR J, V3, P19; LIEBERMAN J, 1967, J LAB CLIN MED, V70, P595; Marcos V, 2010, NAT MED, V16, P1018, DOI 10.1038/nm.2209; MCINTOSH I, 1992, FASEB J, V6, P2775, DOI 10.1096/fasebj.6.10.1378801; Oermann C M, 2001, Curr Opin Investig Drugs, V2, P900; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Papayannopoulos V, 2009, TRENDS IMMUNOL, V30, P513, DOI 10.1016/j.it.2009.07.011; Ratjen F, 2008, PAEDIATR RESPIR REV, V9, P144, DOI 10.1016/j.prrv.2008.01.004; Roghanian A, 2008, J AEROSOL MED PULM D, V21, P125, DOI 10.1089/jamp.2007.0653; Shah PL, 2001, RESPIRATION, V68, P160, DOI 10.1159/000050486; Taggart CC, 2001, J BIOL CHEM, V276, P33345, DOI 10.1074/jbc.M103220200; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; Vogelmeier C, 1996, EUR RESPIR J, V9, P2193, DOI 10.1183/09031936.96.09112193; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; Wartha F, 2007, CURR OPIN MICROBIOL, V10, P52, DOI 10.1016/j.mib.2006.12.005	24	158	164	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28526	10.1371/journal.pone.0028526	http://dx.doi.org/10.1371/journal.pone.0028526			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174830	Green Submitted, Green Published, gold			2022-12-25	WOS:000298365700044
J	Tibbetts, EA; Skaldina, O; Zhao, V; Toth, AL; Skaldin, M; Beani, L; Dale, J				Tibbetts, Elizabeth A.; Skaldina, Oksana; Zhao, Vera; Toth, Amy L.; Skaldin, Maksim; Beani, Laura; Dale, James			Geographic Variation in the Status Signals of Polistes dominulus Paper Wasps	PLOS ONE			English	Article							BODY-SIZE; SEXUAL SELECTION; CHARACTER DISPLACEMENT; QUALITY SIGNALS; COLOR PATTERNS; XENOS-VESPARUM; BIRD-SONG; SPECIATION; HYMENOPTERA; EVOLUTION	Understanding intraspecific geographic variation in animal signals poses a challenging evolutionary problem. Studies addressing geographic variation typically focus on signals used in mate-choice, however, geographic variation in intrasexual signals involved in competition is also known to occur. In Polistes dominulus paper wasps, females have black facial spots that signal dominance: individuals wasps with more complex 'broken' facial patterns are better fighters and are avoided by rivals. Recent work suggests there is dramatic geographic variation in these visual signals of quality, though this variation has not been explicitly described or quantified. Here, we analyze variation in P. dominulus signals across six populations and explore how environmental conditions may account for this variation. Overall, we found substantial variation in facial pattern brokenness across populations and castes. Workers have less broken facial patterns than gynes and queens, which have similar facial patterns. Strepsipteran parasitism, body size and temperature are all correlated with the facial pattern variation, suggesting that developmental plasticity likely plays a key role in this variation. First, the extent of parasitism varies across populations and parasitized individuals have lower facial pattern brokenness than unparasitized individuals. Second, there is substantial variation in body size across populations and a weak but significant relationship between facial pattern brokenness and body size. Wasps from populations with smaller body size (e. g. Italy) tend to have less broken facial patterns than wasps from populations with larger body size (e. g. New York, USA). Third, there is an apparent association between facial patterns and climate, with wasp from cooler locations tending to have higher facial pattern brokenness than wasps from warmer locations. Additional experimental work testing the causes and consequences of facial pattern variation will be important, as geographic variation in signals has important consequences for the evolution of communication systems and social behavior.	[Tibbetts, Elizabeth A.] Univ Michigan, Ann Arbor, MI 48109 USA; [Skaldina, Oksana] Natl Sci Ctr Nikita, Dept Nat Protect Nikitsky Bot Garden, Yalta, Crimea, Ukraine; [Zhao, Vera; Toth, Amy L.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA USA; [Zhao, Vera; Toth, Amy L.] Iowa State Univ, Dept Entomol, Ames, IA USA; [Skaldin, Maksim] Univ Turku, Dept Chem, Joint Biotechnol Lab, Math & Nat Sci Fac, Turku, Finland; [Beani, Laura] Univ Florence, Dept Evolutionary Biol Leo Pardi, Florence, Italy; [Dale, James] Massey Univ, Inst Nat Sci, Auckland, New Zealand	University of Michigan System; University of Michigan; Iowa State University; Iowa State University; University of Turku; University of Florence; Massey University	Tibbetts, EA (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.	tibbetts@umich.edu		Tibbetts, Elizabeth/0000-0002-5625-892X	University of Michigan	University of Michigan(University of Michigan System)	Funding was provided by the University of Michigan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CN, 2010, P ROY SOC B-BIOL SCI, V277, P3669, DOI 10.1098/rspb.2010.0935; Arnett AE, 2003, ECOL ENTOMOL, V28, P645, DOI 10.1111/j.1365-2311.2003.00554.x; BAKER MC, 1985, BEHAV BRAIN SCI, V8, P85, DOI 10.1017/S0140525X00019750; BEANI L, ANIMAL BEHAV; Campbell P, 2010, EVOLUTION, V64, P1955, DOI 10.1111/j.1558-5646.2010.00962.x; Cervo R, 2008, P ROY SOC B-BIOL SCI, V275, P1189, DOI 10.1098/rspb.2007.1779; Cervo R, 2006, ANN ZOOL FENN, V43, P531; Chown SL, 2010, BIOL REV, V85, P139, DOI 10.1111/j.1469-185X.2009.00097.x; CUSHMAN JH, 1993, OECOLOGIA, V95, P30, DOI 10.1007/BF00649503; Dapporto L, 2007, PARASITOLOGY, V134, P545, DOI 10.1017/S0031182006001739; ENDLER JA, 1995, TRENDS ECOL EVOL, V10, P22, DOI 10.1016/S0169-5347(00)88956-9; Foster SA, 1999, TRENDS ECOL EVOL, V14, P190, DOI 10.1016/S0169-5347(98)01577-8; Fucini S, 2009, INSECT SOC, V56, P347, DOI 10.1007/s00040-009-0030-4; GERHARDT HC, 1994, ANNU REV ECOL SYST, V25, P293, DOI 10.1146/annurev.es.25.110194.001453; Giusti F, 2007, ARTHROPOD STRUCT DEV, V36, P183, DOI 10.1016/j.asd.2007.01.001; Green JP, 2011, ANIM BEHAV, V81, P205, DOI 10.1016/j.anbehav.2010.10.002; Hochberg ME, 2003, EVOLUTION, V57, P154, DOI 10.1554/0014-3820(2003)057[0154:SMS]2.0.CO;2; Hughes DP, 2005, OIKOS, V110, P428, DOI 10.1111/j.0030-1299.2005.13791.x; MANFREDINI F, 2010, ETHOL ECOL EVOL, V22, P1; NONACS P, 1995, ECOLOGY, V76, P953, DOI 10.2307/1939359; Ortolani I, 2010, ANIM BEHAV, V80, P683, DOI 10.1016/j.anbehav.2010.07.003; Panhuis TM, 2001, TRENDS ECOL EVOL, V16, P364, DOI 10.1016/S0169-5347(01)02160-7; Pfennig KS, 2009, Q REV BIOL, V84, P253, DOI 10.1086/605079; Pickett KM, 2004, J KANSAS ENTOMOL SOC, V77, P742, DOI 10.2317/E-18.1; Podos J, 2007, ADV STUD BEHAV, V37, P403, DOI 10.1016/S0065-3454(07)37009-5; Price T, 1998, PHILOS T R SOC B, V353, P251, DOI 10.1098/rstb.1998.0207; Price TD, 2006, J EXP BIOL, V209, P2368, DOI 10.1242/jeb.02183; Reeve H.K., 1991, P99; Rusina LYu, 2007, ENTOMOL REV, V87, P1155, DOI DOI 10.1134/S0013873807090060; Slabbekoorn H, 2002, PHILOS T R SOC B, V357, P493, DOI 10.1098/rstb.2001.1056; Stillwell RC, 2010, OIKOS, V119, P1387, DOI 10.1111/j.1600-0706.2010.18670.x; Tibbetts EA, 2004, NATURE, V432, P218, DOI 10.1038/nature02949; Tibbetts EA, 2008, BIOL LETTERS, V4, P237, DOI 10.1098/rsbl.2008.0048; Tibbetts EA, 2006, ANN ZOOL FENN, V43, P575; Tibbetts EA, 2007, BEHAV ECOL, V18, P602, DOI 10.1093/beheco/arm013; Tibbetts EA, 2011, BEHAV ECOL SOCIOBIOL, V65, P1123, DOI 10.1007/s00265-010-1126-6; Tibbetts EA, 2010, P ROY SOC B-BIOL SCI, V277, P3461, DOI 10.1098/rspb.2010.1003; Tibbetts EA, 2010, AM NAT, V175, P495, DOI 10.1086/651596; Tibbetts EA, 2010, BIOL LETTERS, V6, P10, DOI 10.1098/rsbl.2009.0420; Tibbetts EA, 2009, BEHAV ECOL SOCIOBIOL, V63, P1377, DOI 10.1007/s00265-009-0764-z; Toth AL, 2009, INSECT SOC, V56, P77, DOI 10.1007/s00040-008-1041-2; TURILLAZZI S, 1980, MONIT ZOOL ITAL, V14, P63; TURILLAZZI S, 1981, MONIT ZOOL ITAL, V15, P275; Wilczynski W, 1999, GEOGRAPHIC VARIATION IN BEHAVIOR, P234; Zanette L, 2009, BEHAV ECOL, V20, P773, DOI 10.1093/beheco/arp060	45	24	24	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28173	10.1371/journal.pone.0028173	http://dx.doi.org/10.1371/journal.pone.0028173			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174776	Green Submitted, gold, Green Published			2022-12-25	WOS:000298365700020
J	Yee, J; White, RE; Anderton, E; Allday, MJ				Yee, Jade; White, Robert E.; Anderton, Emma; Allday, Martin J.			Latent Epstein-Barr Virus Can Inhibit Apoptosis in B Cells by Blocking the Induction of NOXA Expression	PLOS ONE			English	Article							BURKITTS-LYMPHOMA CELLS; DEATH; PROTEIN; BCL-2; P53; EBNA2; LINES; DNA; PERSISTENCE; ACTIVATION	Latent Epstein-Barr virus (EBV) has been shown to protect Burkitt's lymphoma-derived B cells from apoptosis induced by agents that cause damage to DNA, in the context of mutant p53. This protection requires expression of the latency-associated nuclear proteins EBNA3A and EBNA3C and correlates with their ability to cooperate in the repression of the gene encoding the pro-apoptotic, BH3-only protein BIM. Here we confirm that latent EBV in B cells also inhibits apoptosis induced by two other agents - ionomycin and staurosporine - and show that these act by a distinct pathway that involves a p53-independent increase in expression of another pro-apoptotic, BH3-only protein, NOXA. Analyses employing a variety of B cells infected with naturally occurring EBV or B95.8 EBV-BAC recombinant mutants indicated that the block to NOXA induction does not depend on the well-characterized viral latency-associated genes (EBNAs 1, 2, 3A, 3B, 3C, the LMPs or the EBERs) or expression of BIM. Regulation of NOXA was shown to be at least partly at the level of mRNA and the requirement for NOXA to induce cell death in this context was demonstrated by NOXA-specific shRNA-mediated depletion experiments. Although recombinant EBV with a deletion removing the BHRF1 locus - that encodes the BCL2-homologue BHRF1 and three microRNAs - partially abrogates protection against ionomycin and staurosporine, the deletion has no effect on the EBV-mediated block to NOXA accumulation.	[Yee, Jade; White, Robert E.; Anderton, Emma; Allday, Martin J.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Infect Dis, Virol Sect, London, England	Imperial College London	Yee, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Infect Dis, Virol Sect, London, England.	m.allday@imperial.ac.uk		White, Robert/0000-0002-5115-2173	Wellcome Trust [077489]	Wellcome Trust(Wellcome TrustEuropean Commission)	This research was supported by a Wellcome Trust programme grant (077489). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allday MJ, 2009, SEMIN CANCER BIOL, V19, P366, DOI 10.1016/j.semcancer.2009.07.007; ALLDAY MJ, 1995, EMBO J, V14, P1382, DOI 10.1002/j.1460-2075.1995.tb07124.x; Altmann M, 2005, PLOS BIOL, V3, P2148, DOI 10.1371/journal.pbio.0030404; Anderton E, 2008, ONCOGENE, V27, P421, DOI 10.1038/sj.onc.1210668; Babcock GJ, 1999, J EXP MED, V190, P567, DOI 10.1084/jem.190.4.567; Bornkamm GW, 2001, PHILOS T R SOC B, V356, P437, DOI 10.1098/rstb.2000.0781; CasciolaRosen L, 1996, J EXP MED, V183, P1957, DOI 10.1084/jem.183.5.1957; Crawford DH, 2001, PHILOS T R SOC B, V356, P461, DOI 10.1098/rstb.2000.0783; Defrance T, 2002, ADV CANCER RES, V86, P195, DOI 10.1016/S0065-230X(02)86006-7; Delecluse HJ, 1998, P NATL ACAD SCI USA, V95, P8245, DOI 10.1073/pnas.95.14.8245; FARRELL PJ, 1991, EMBO J, V10, P2879, DOI 10.1002/j.1460-2075.1991.tb07837.x; Feederle R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001294; FINKE J, 1987, J VIROL, V61, P3870, DOI 10.1128/JVI.61.12.3870-3878.1987; Garibal J, 2007, J VIROL, V81, P7598, DOI 10.1128/JVI.02435-06; GREGORY CD, 1991, NATURE, V349, P612, DOI 10.1038/349612a0; HENDERSON S, 1993, P NATL ACAD SCI USA, V90, P8479, DOI 10.1073/pnas.90.18.8479; HENDERSON S, 1991, CELL, V65, P1107, DOI 10.1016/0092-8674(91)90007-L; Inman GJ, 2001, J VIROL, V75, P2400, DOI 10.1128/JVI.75.5.2400-2410.2001; Karpinich NO, 2002, J BIOL CHEM, V277, P16547, DOI 10.1074/jbc.M110629200; Kelly G, 2002, NAT MED, V8, P1098, DOI 10.1038/nm758; Kelly Gemma L, 2007, Hematology Am Soc Hematol Educ Program, P277; Kelly GL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000341; Kelly GL, 2005, J VIROL, V79, P10709, DOI 10.1128/JVI.79.16.10709-10717.2005; Kennedy G, 2003, P NATL ACAD SCI USA, V100, P14269, DOI 10.1073/pnas.2336099100; LAHERTY CD, 1992, J BIOL CHEM, V267, P24157; Leao M, 2007, J VIROL, V81, P248, DOI 10.1128/JVI.01096-06; Lee JM, 2002, P NATL ACAD SCI USA, V99, P11878, DOI 10.1073/pnas.182552499; Lindstrom MS, 2002, SEMIN CANCER BIOL, V12, P381, DOI 10.1016/S1044-579X(02)00058-5; Neuhierl B, 2002, P NATL ACAD SCI USA, V99, P15036, DOI 10.1073/pnas.232381299; O'Nions J, 2004, J GEN VIROL, V85, P881, DOI 10.1099/vir.0.19704-0; O'Nions J, 2006, J VIROL, V80, P12408, DOI 10.1128/JVI.01363-06; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; PEARSON GR, 1987, VIROLOGY, V160, P151, DOI 10.1016/0042-6822(87)90055-9; ROUGHAN JE, 2009, J VIROL; Seto E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001063; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; Speck SH, 2002, NAT MED, V8, P1086, DOI 10.1038/nm1002-1086; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Tafani M, 2001, CANCER RES, V61, P2459; TAKADA K, 1991, VIRUS GENES, V5, P147, DOI 10.1007/BF00571929; Thorley-Lawson DA, 2004, NEW ENGL J MED, V350, P1328, DOI 10.1056/NEJMra032015; Thorley-Lawson DA, 2008, NAT REV MICROBIOL, V6, P913, DOI 10.1038/nrmicro2015; Touitou R, 2001, J VIROL, V75, P7749, DOI 10.1128/JVI.75.16.7749-7755.2001; Wang S, 1996, CANCER RES, V56, P4610; White RE, 2003, J GEN VIROL, V84, P3393, DOI 10.1099/vir.0.19387-0; White RE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013979; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452	47	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28506	10.1371/journal.pone.0028506	http://dx.doi.org/10.1371/journal.pone.0028506			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174825	Green Published, Green Submitted, gold			2022-12-25	WOS:000298365700040
J	Liu, WB; Li, DF; Liu, JF; Chen, SR; Qu, LJ; Zheng, JX; Xu, GY; Yang, N				Liu, Wenbo; Li, Dongfeng; Liu, Jianfeng; Chen, Sirui; Qu, Lujiang; Zheng, Jiangxia; Xu, Guiyun; Yang, Ning			A Genome-Wide SNP Scan Reveals Novel Loci for Egg Production and Quality Traits in White Leghorn and Brown-Egg Dwarf Layers	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; QUANTITATIVE TRAITS; GENETIC-VARIATION; INSULIN-RECEPTOR; RED JUNGLEFOWL; ASSOCIATION; CHICKENS; CATTLE; POULTRY; IDENTIFICATION	Availability of the complete genome sequence as well as high-density SNP genotyping platforms allows genome-wide association studies (GWAS) in chickens. A high-density SNP array containing 57,636 markers was employed herein to identify associated variants underlying egg production and quality traits within two lines of chickens, i.e., White Leghorn and brown-egg dwarf layers. For each individual, age at first egg (AFE), first egg weight (FEW), and number of eggs (EN) from 21 to 56 weeks of age were recorded, and egg quality traits including egg weight (EW), eggshell weight (ESW), yolk weight (YW), eggshell thickness (EST), eggshell strength (ESS), albumen height(AH) and Haugh unit(HU) were measured at 40 and 60 weeks of age. A total of 385 White Leghorn females and 361 brown-egg dwarf dams were selected to be genotyped. The genome-wide scan revealed 8 SNPs showing genome-wise significant (P<1.51E-06, Bonferroni correction) association with egg production and quality traits under the Fisher's combined probability method. Some significant SNPs are located in known genes including GRB14 and GALNT1 that can impact development and function of ovary, but more are located in genes with unclear functions in layers, and need to be studied further. Many chromosome-wise significant SNPs were also detected in this study and some of them are located in previously reported QTL regions. Most of loci detected in this study are novel and the follow-up replication studies may be needed to further confirm the functional significance for these newly identified SNPs.	[Liu, Wenbo] China Agr Univ, Natl Engn Lab Anim Breeding, Beijing 100094, Peoples R China; China Agr Univ, MOA Key Lab Anim Genet & Breeding, Coll Anim Sci & Technol, Beijing 100094, Peoples R China	China Agricultural University; China Agricultural University	Liu, WB (corresponding author), China Agr Univ, Natl Engn Lab Anim Breeding, Beijing 100094, Peoples R China.	nyang@cau.edu.cn		Liu, Jian-Feng/0000-0002-5766-7864; Yang, Ning/0000-0001-5772-3320	Chinese Agricultural Research System [CARS-41]; National Scientific Supporting Projects of China [2011BAD28B03]	Chinese Agricultural Research System; National Scientific Supporting Projects of China	This work was supported by funds of the Chinese Agricultural Research System (CARS-41) and the National Scientific Supporting Projects of China (2011BAD28B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasht B, 2006, POULTRY SCI, V85, P2079, DOI 10.1093/ps/85.12.2079; Abasht B, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S2-S2; [Anonymous], 1990, POULTRY BREEDING GEN; Arnett DK, 2011, CIRC RES, V108, P279, DOI 10.1161/CIRCRESAHA.110.239210; Bereziat V, 2002, J BIOL CHEM, V277, P4845, DOI 10.1074/jbc.M106574200; Besbes B, 1999, ANIM SCI, V68, P433, DOI 10.1017/S135772980005044X; Bhattacharya TK, 2010, THERIOGENOLOGY; Bolormaa S, 2011, J ANIM SCI; CARRASQUILLO MM, 2011, J ALZHEIMERS DIS; Chen CF, 2007, THERIOGENOLOGY, V68, P1305, DOI 10.1016/j.theriogenology.2007.08.032; Daly RJ, 1996, J BIOL CHEM, V271, P12502, DOI 10.1074/jbc.271.21.12502; Dekkers J C M, 2004, J Anim Sci, V82 E-Suppl, pE313; Dunn IC, 2009, ANIM GENET, V40, P110, DOI 10.1111/j.1365-2052.2008.01794.x; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Han B, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000456; Hemming R, 2001, BIOCHEM CELL BIOL, V79, P21, DOI 10.1139/bcb-79-1-21; Hess A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-96; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Kenzelmann D, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-30; Kerje S, 2003, ANIM GENET, V34, P264, DOI 10.1046/j.1365-2052.2003.01000.x; Kim MH, 2004, POULTRY SCI, V83, P1203, DOI 10.1093/ps/83.7.1203; Kurz EU, 2004, DNA REPAIR, V3, P889, DOI 10.1016/j.dnarep.2004.03.029; Lamont SJ, 1996, ANIM GENET, V27, P1, DOI 10.1111/j.1365-2052.1996.tb01170.x; Lewis PD, 2010, POULTRY SCI, V89, P108, DOI 10.3382/ps.2009-00312; Lewis PD, 1999, POULTRY SCI, V78, P1227, DOI 10.1093/ps/78.8.1227; Ma L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-315; Mao YC, 2006, PHYSIOL GENOMICS, V28, P46, DOI 10.1152/physiolgenomics.00096.2006; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; McMurtry JP, 1997, DOMEST ANIM ENDOCRIN, V14, P199, DOI 10.1016/S0739-7240(97)00019-2; Meuwissen THE, 2001, GENETICS, V157, P1819; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rubin BP, 1999, DEV BIOL, V216, P195, DOI 10.1006/dbio.1999.9503; Sahana G, 2010, ANIM GENET, V41, P579, DOI 10.1111/j.1365-2052.2010.02064.x; Sakai T, 2003, DNA RES, V10, P155, DOI 10.1093/dnares/10.4.155; Sasaki O, 2004, ANIM GENET, V35, P188, DOI 10.1111/j.1365-2052.2004.01133.x; Sellers TA, 2008, CANCER EPIDEM BIOMAR, V17, P397, DOI 10.1158/1055-9965.EPI-07-0565; Smith TPL, 2001, GENOME RES, V11, P626, DOI 10.1101/gr.170101; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Takahashi H, 2010, ANIM GENET, V41, P541, DOI 10.1111/j.1365-2052.2010.02034.x; Tuiskula-Haavisto M, 2002, POULTRY SCI, V81, P919, DOI 10.1093/ps/81.7.919; Wardecka Barbara, 2002, Journal of Applied Genetics, V43, P319; WEI M, 1993, J ANIM SCI, V71, P57, DOI 10.2527/1993.71157x; Wong GKS, 2004, NATURE, V432, P717, DOI 10.1038/nature03156; Wright D, 2006, ANIM GENET, V37, P529, DOI 10.1111/j.1365-2052.2006.01515.x; Yang N., 1996, P 20 WORLDS POULTR C, V1, P447; Yao JF, 2010, POULTRY SCI, V89, P883, DOI 10.3382/ps.2009-00613; Zhang LC, 2005, POULTRY SCI, V84, P1209, DOI 10.1093/ps/84.8.1209	49	76	91	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28600	10.1371/journal.pone.0028600	http://dx.doi.org/10.1371/journal.pone.0028600			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174844	Green Published, Green Submitted, gold			2022-12-25	WOS:000298163600036
J	Seeliger, JC; Holsclaw, CM; Schelle, MW; Botyanszki, Z; Gilmore, SA; Tully, SE; Niederweis, M; Cravatt, BF; Leary, JA; Bertozzi, CR				Seeliger, Jessica C.; Holsclaw, Cynthia M.; Schelle, Michael W.; Botyanszki, Zsofia; Gilmore, Sarah A.; Tully, Sarah E.; Niederweis, Michael; Cravatt, Benjamin F.; Leary, Julie A.; Bertozzi, Carolyn R.			Elucidation and Chemical Modulation of Sulfolipid-1 Biosynthesis in Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHAGOSOME-LYSOSOME FUSION; CUTINASE-LIKE PROTEINS; CULTURED MACROPHAGES; MEMBRANE-PROTEIN; VIRULENCE; IDENTIFICATION; INHIBITION; SULFATIDE; LIPASE; TETRAHYDROLIPSTATIN	Mycobacterium tuberculosis possesses unique cell-surface lipids that have been implicated in virulence. One of the most abundant is sulfolipid-1 (SL-1), a tetraacyl-sulfotrehalose glycolipid. Although the early steps in SL-1 biosynthesis are known, the machinery underlying the final acylation reactions is not understood. We provide genetic and biochemical evidence for the activities of two proteins, Chp1 and Sap (corresponding to gene loci rv3822 and rv3821), that complete this pathway. The membrane-associated acyltransferase Chp1 accepts a synthetic diacyl sulfolipid and transfers an acyl group regioselectively from one donor substrate molecule to a second acceptor molecule in two successive reactions to yield a tetraacylated product. Chp1 is fully active in vitro, but in M. tuberculosis, its function is potentiated by the previously identified sulfolipid transporter MmpL8. We also show that the integral membrane protein Sap and MmpL8 are both essential for sulfolipid transport. Finally, the lipase inhibitor tetrahydrolipstatin disrupts Chp1 activity in M. tuberculosis, suggesting an avenue for perturbing SL-1 biosynthesis in vivo. These data complete the SL-1 biosynthetic pathway and corroborate a model in which lipid biosynthesis and transmembrane transport are coupled at the membrane-cytosol interface through the activity of multiple proteins, possibly as a macromolecular complex.	[Seeliger, Jessica C.; Schelle, Michael W.; Botyanszki, Zsofia; Bertozzi, Carolyn R.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Gilmore, Sarah A.; Bertozzi, Carolyn R.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Bertozzi, Carolyn R.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Holsclaw, Cynthia M.; Leary, Julie A.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Tully, Sarah E.; Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, Dept Physiol Chem, La Jolla, CA 92037 USA; [Niederweis, Michael] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Davis; Scripps Research Institute; University of Alabama System; University of Alabama Birmingham	Bertozzi, CR (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	crb@berkeley.edu	Seeliger, Jessica/J-3344-2014	Seeliger, Jessica/0000-0001-7148-1073; Niederweis, Michael/0000-0003-4068-8092	National Institutes of Health [AI51622, 1S10RR017786-01]; National Institutes of Health from NIAID [HHSN266200400091C]; NATIONAL CANCER INSTITUTE [R37CA087660] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051622] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI51622 (to C. R. B.) and by Shared Instrumentation Grant 1S10RR017786-01 (to the QB3/Chemistry Mass Spectrometry Facility).; We thank Dr. Sloan Siegrist and Kimberly Sogi for helpful discussions and critical reading of the manuscript. The QB3/Chemistry Mass Spectrometry Facility at the University of California at Berkeley acknowledges National Institutes of Health Shared Instrumentation Grant 1S10RR017786-01. gamma-Irradiated H37Rv whole cells and anti-KatG antibody were kindly provided as part of National Institutes of Health Contract HHSN266200400091C from NIAID ("Tuberculosis Vaccine Testing and Research Materials"), which was awarded to Colorado State University.	Adindla S, 2003, J BIOSCIENCES, V28, P169, DOI 10.1007/BF02706216; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; Brodin P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001100; BROZNA JP, 1991, INFECT IMMUN, V59, P2542, DOI 10.1128/IAI.59.8.2542-2548.1991; Busso D, 2005, ANAL BIOCHEM, V343, P313, DOI 10.1016/j.ab.2005.05.015; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Converse SE, 2003, P NATL ACAD SCI USA, V100, P6121, DOI 10.1073/pnas.1030024100; Cotes K, 2007, BIOCHEM J, V408, P417, DOI 10.1042/BJ20070745; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Crellin PK, 2010, J BIOL CHEM, V285, P30050, DOI 10.1074/jbc.M110.150094; Deb C, 2006, J BIOL CHEM, V281, P3866, DOI 10.1074/jbc.M505556200; Deshayes C, 2010, MOL MICROBIOL, V78, P989, DOI 10.1111/j.1365-2958.2010.07385.x; Domenech P, 2004, J BIOL CHEM, V279, P21257, DOI 10.1074/jbc.M400324200; GANGADHARAM P R, 1963, Tubercle, V44, P452, DOI 10.1016/S0041-3879(63)80087-2; Ghosh D, 2001, J BIOL CHEM, V276, P11159, DOI 10.1074/jbc.M008831200; Gilleron M, 2004, J EXP MED, V199, P649, DOI 10.1084/jem.20031097; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Gokhale RS, 2007, NAT PROD REP, V24, P267, DOI 10.1039/b616817p; GOREN MB, 1976, P NATL ACAD SCI USA, V73, P2510, DOI 10.1073/pnas.73.7.2510; GOREN MB, 1987, J LEUKOCYTE BIOL, V41, P111, DOI 10.1002/jlb.41.2.111; Guiard J, 2009, J IMMUNOL, V182, P7030, DOI 10.4049/jimmunol.0804044; Hatzios SK, 2009, J BIOL CHEM, V284, P12745, DOI 10.1074/jbc.M809088200; Heinz C, 2000, ANAL BIOCHEM, V285, P113, DOI 10.1006/abio.2000.4728; Hotsclaw CM, 2008, ACS CHEM BIOL, V3, P619, DOI 10.1021/cb800145r; Jain M, 2005, PLOS PATHOG, V1, P12, DOI 10.1371/journal.ppat.0010002; KATO M, 1974, INFECT IMMUN, V10, P733, DOI 10.1128/IAI.10.4.733-741.1974; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kremer L, 2005, MOL MICROBIOL, V57, P1113, DOI 10.1111/j.1365-2958.2005.04717.x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar P, 2007, P NATL ACAD SCI USA, V104, P11221, DOI 10.1073/pnas.0611649104; LANGSTON S, 1994, HELV CHIM ACTA, V77, P2341, DOI 10.1002/hlca.19940770821; Larsen MH, 2007, CURR PROTOC MICROBIO, V6, p10A; Layre E, 2011, J LIPID RES, V52, P1098, DOI 10.1194/jlr.M013482; Leigh CD, 2008, J ORG CHEM, V73, P1008, DOI 10.1021/jo702032c; Low KL, 2009, J BACTERIOL, V191, P5037, DOI 10.1128/JB.00530-09; MIDDLEBROOK G, 1959, P NATL ACAD SCI USA, V45, P1801, DOI 10.1073/pnas.45.12.1801; Mougous JD, 2004, NAT STRUCT MOL BIOL, V11, P721, DOI 10.1038/nsmb802; Niederweis M, 1999, MOL MICROBIOL, V33, P933, DOI 10.1046/j.1365-2958.1999.01472.x; PABST MJ, 1988, J IMMUNOL, V140, P634; Parker SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004281; Patricelli MP, 2001, PROTEOMICS, V1, P1067, DOI 10.1002/1615-9861(200109)1:9<1067::AID-PROT1067>3.0.CO;2-4; Rezwan M, 2007, J MICROBIOL METH, V68, P32, DOI 10.1016/j.mimet.2006.05.016; Rodionov DA, 2009, J BACTERIOL, V191, P42, DOI 10.1128/JB.01208-08; Rousseau C, 2003, INFECT IMMUN, V71, P4684, DOI 10.1128/IAI.71.8.4684-4690.2003; Schue M, 2010, FASEB J, V24, P1893, DOI 10.1096/fj.09-144766; Sirakova TD, 2001, J BIOL CHEM, V276, P16833, DOI 10.1074/jbc.M011468200; Sonden B, 2005, MOL MICROBIOL, V58, P426, DOI 10.1111/j.1365-2958.2005.04847.x; Sultana R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016745; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Vrljic M., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P327; West NP, 2009, FASEB J, V23, P1694, DOI 10.1096/fj.08-114421; ZHANG L, 1991, J IMMUNOL, V146, P2730; ZHANG L, 1988, INFECT IMMUN, V56, P2876, DOI 10.1128/IAI.56.11.2876-2883.1988	53	53	57	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					7990	8000		10.1074/jbc.M111.315473	http://dx.doi.org/10.1074/jbc.M111.315473			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22194604	Green Published, hybrid			2022-12-25	WOS:000301349400015
J	Fluhrer, R; Martin, L; Klier, B; Haug-Kroper, M; Grammer, G; Nuscher, B; Haass, C				Fluhrer, Regina; Martin, Lucas; Klier, Baerbel; Haug-Kroeper, Martina; Grammer, Gudula; Nuscher, Brigitte; Haass, Christian			The alpha-Helical Content of the Transmembrane Domain of the British Dementia Protein-2 (Bri2) Determines Its Processing by Signal Peptide Peptidase-like 2b (SPPL2b)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATED INTRAMEMBRANE PROTEOLYSIS; TERMINAL PAL MOTIF; GAMMA-SECRETASE; PRESENILIN; PROTEASES; SEQUENCE; CLEAVAGE; IDENTIFICATION; SPECIFICITY; MECHANISM	Regulated intramembrane proteolysis is a widely accepted concept describing the processing of various transmembrane proteins via ectodomain shedding followed by an intramembrane cleavage. The resulting cleavage products can be involved in reverse signaling. Presenilins, which constitute the active center of the gamma-secretase complex, signal peptide peptidase (SPP), and its homologues, the SPP-like (SPPL) proteases are members of the family of intramembrane-cleaving aspartyl proteases of the GXGD-type. We recently demonstrated that Bri2 (itm2b) is a substrate for regulated intramembrane proteolysis by SPPL2a and SPPL2b. Intramembrane cleavage of Bri2 is triggered by an initial shedding event catalyzed by A Disintegrin and Metalloprotease 10 (ADAM10). Additionally primary sequence determinants within the intracellular domain, the transmembrane domain and the luminal juxtamembrane domain are required for efficient cleavage of Bri2 by SPPL2b. Using mutagenesis and circular dichroism spectroscopy we now demonstrate that a high alpha-helical content of the Bri2 transmembrane domain (TMD) reduces cleavage efficiency of Bri2 by SPPL2b, while the presence of a GXXXG dimerization motif influences the intramembrane cleavage only to a minor extent. Surprisingly, only one of the four conserved intramembrane glycine residues significantly affects the secondary structure of the Bri2 TMD and thereby its intramembrane cleavage. Other glycine residues do not influence the alpha-helical content of the transmembrane domain nor its intramembrane processing.	[Fluhrer, Regina; Haass, Christian] German Ctr Neurodegenerat Dis DZNE, D-80336 Munich, Germany; [Fluhrer, Regina; Martin, Lucas; Klier, Baerbel; Haug-Kroeper, Martina; Grammer, Gudula; Nuscher, Brigitte; Haass, Christian] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich	Haass, C (corresponding author), German Ctr Neurodegenerat Dis DZNE, D-80336 Munich, Germany.	christian.haass@dzne.lmu.de			DFG [HA1737-11]; LMU<SUP>excellent</SUP>	DFG(German Research Foundation (DFG)); LMU<SUP>excellent</SUP>	This work was supported in part by DFG Grant HA1737-11 (to C. H. and R. F.).; Supported by a Research Professorship provided by the LMU<SUP>excellent</SUP> program.	Akiyama Y, 2007, MOL MICROBIOL, V64, P1028, DOI 10.1111/j.1365-2958.2007.05715.x; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Eggert S, 2009, J BIOL CHEM, V284, P28943, DOI 10.1074/jbc.M109.038646; Fluhrer R, 2002, J NEUROCHEM, V81, P1011, DOI 10.1046/j.1471-4159.2002.00908.x; Fluhrer R, 2008, J BIOL CHEM, V283, P30121, DOI 10.1074/jbc.M806092200; Fluhrer R, 2009, J BIOL CHEM, V284, P13975, DOI 10.1074/jbc.R800040200; Friedmann E, 2004, J BIOL CHEM, V279, P50790, DOI 10.1074/jbc.M407898200; Hemming ML, 2008, PLOS BIOL, V6, P2314, DOI 10.1371/journal.pbio.0060257; Hubbard SJ, 1998, BBA-PROTEIN STRUCT M, V1382, P191, DOI 10.1016/S0167-4838(97)00175-1; Kaden D, 2008, J BIOL CHEM, V283, P7271, DOI 10.1074/jbc.M708046200; Kaether C, 2004, EMBO J, V23, P4738, DOI 10.1038/sj.emboj.7600478; Kim SH, 2002, J BIOL CHEM, V277, P1872, DOI 10.1074/jbc.M108739200; Kim SH, 1999, NAT NEUROSCI, V2, P984, DOI 10.1038/14783; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Lemberg MK, 2007, MOL CELL, V28, P930, DOI 10.1016/j.molcel.2007.12.003; Lemberg MK, 2002, MOL CELL, V10, P735, DOI 10.1016/S1097-2765(02)00655-X; LI SC, 1994, NAT STRUCT BIOL, V1, P558; Madala PK, 2010, CHEM REV, V110, pPR1, DOI 10.1021/cr900368a; Martin L, 2008, J BIOL CHEM, V283, P1644, DOI 10.1074/jbc.M706661200; Martin L, 2009, J BIOL CHEM, V284, P5662, DOI 10.1074/jbc.M807485200; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Munter LM, 2010, J BIOL CHEM, V285, P21636, DOI 10.1074/jbc.M109.088005; Popot JL, 2000, ANNU REV BIOCHEM, V69, P881, DOI 10.1146/annurev.biochem.69.1.881; Ren Z, 2007, J BIOL CHEM, V282, P35350, DOI 10.1074/jbc.M702739200; Sanchez-Pulido L, 2002, TRENDS BIOCHEM SCI, V27, P329, DOI 10.1016/S0968-0004(02)02134-5; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Steiner H, 2008, J BIOL CHEM, V283, P29627, DOI 10.1074/jbc.R800010200; Strisovsky K, 2009, MOL CELL, V36, P1048, DOI 10.1016/j.molcel.2009.11.006; Tolia A, 2008, J BIOL CHEM, V283, P19793, DOI 10.1074/jbc.M802461200; Urban S, 2003, MOL CELL, V11, P1425, DOI 10.1016/S1097-2765(03)00181-3; Vidal R, 1999, NATURE, V399, P776; Wang J, 2006, J NEUROCHEM, V96, P218, DOI 10.1111/j.1471-4159.2005.03548.x; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wolfe MS, 2010, BIOL CHEM, V391, P839, DOI 10.1515/BC.2010.086; Wolfe MS, 2009, J BIOL CHEM, V284, P13969, DOI 10.1074/jbc.R800039200; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Ye J, 2000, P NATL ACAD SCI USA, V97, P5123, DOI 10.1073/pnas.97.10.5123	39	31	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					5156	5163		10.1074/jbc.M111.328104	http://dx.doi.org/10.1074/jbc.M111.328104			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22194595	Green Published, hybrid			2022-12-25	WOS:000300608500073
J	Tse, MK; Hui, SK; Yang, YH; Yin, ST; Hu, HY; Zou, B; Wong, BCY; Sze, KH				Tse, Man Kit; Hui, Sin Kam; Yang, Yinhua; Yin, Si-Tao; Hu, Hong-Yu; Zou, Bing; Wong, Benjamin Chun Yu; Sze, Kong Hung			Structural Analysis of the UBA Domain of X-linked Inhibitor of Apoptosis Protein Reveals Different Surfaces for Ubiquitin-Binding and Self-Association	PLOS ONE			English	Article							NF-KAPPA-B; LYS48-LINKED POLYUBIQUITIN CHAIN; MEDIATED DIMERIZATION; CRYSTAL-STRUCTURE; NMR-SPECTROSCOPY; BIR DOMAIN; C-CBL; RECOGNITION; COMPLEX; XIAP	Background: Inhibitor of apoptosis proteins (IAPs) belong to a pivotal antiapoptotic protein family that plays a crucial role in tumorigenesis, cancer progression, chemoresistance and poor patient-survival. X-linked inhibitor of apoptosis protein (XIAP) is a prominent member of IAPs attracting intense research because it has been demonstrated to be a physiological inhibitor of caspases and apoptosis. Recently, an evolutionarily conserved ubiquitin-associated (UBA) domain was identified in XIAP and a number of RING domain-bearing IAPs. This has placed the IAPs in the group of ubiquitin binding proteins. Here, we explore the three-dimensional structure of the XIAP UBA domain (XIAP-UBA) and how it interacts with mono-ubiquitin and diubiquitin conjugates. Principal Findings: The solution structure of the XIAP-UBA domain was determined by NMR spectroscopy. XIAP-UBA adopts a typical UBA domain fold of three tightly packed alpha-helices but with an additional N-terminal 3(10) helix. The XIAP-UBA binds mono-ubiquitin as well as Lys48-linked and linear-linked diubiquitins at low-micromolar affinities. NMR analysis of the XIAP-UBA-ubiquitin interaction reveals that it involves the classical hydrophobic patches surrounding Ile44 of ubiquitin and the conserved MGF/LV motif surfaces on XIAP-UBA. Furthermore, dimerization of XIAP-UBA was observed. Mapping of the self-association surface of XIAP-UBA reveals that the dimerization interface is formed by residues in the N-terminal 3(10) helix, helix alpha 1 and helix alpha 2, separate from the ubiquitin-binding surface. Conclusion: Our results provide the first structural information of XIAP-UBA and map its interaction with mono-ubiquitin, Lys48-linked and linear-linked diubiquitins. The notion that XIAP-UBA uses different surfaces for ubiquitin-binding and self-association provides a plausible model to explain the reported selectivity of XIAP in binding polyubiquitin chains with different linkages.	[Tse, Man Kit; Sze, Kong Hung] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Tse, Man Kit; Sze, Kong Hung] Univ Hong Kong, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Tse, Man Kit; Hui, Sin Kam; Sze, Kong Hung] Univ Hong Kong, Dept Chem, Hong Kong, Hong Kong, Peoples R China; [Tse, Man Kit; Hui, Sin Kam; Sze, Kong Hung] Univ Hong Kong, Open Lab Chem Biol, Inst Mol Technol Drug Discovery & Synth, Hong Kong, Hong Kong, Peoples R China; [Yang, Yinhua] Chinese Univ Hong Kong, Dept Biochem, Ctr Prot Sci & Crystallog, Shatin, Hong Kong, Peoples R China; [Yin, Si-Tao; Hu, Hong-Yu] Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Zou, Bing; Wong, Benjamin Chun Yu] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; Chinese University of Hong Kong; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Hong Kong	Tse, MK (corresponding author), Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.	khsze@hku.hk	Wong, Benjamin Chun Yu/ABB-1962-2020; Hu, Hong-Yu/AAQ-2633-2020; Tse, Man Kit/N-6218-2018	Tse, Man Kit/0000-0002-7882-0848; Yang, Yanqi/0000-0002-3582-1277	Research Grants Council of Hong Kong [GRF 7755/08M, GRF 7765/09M]; University Grants Committee of Hong Kong SAR [SEG/CUHK09]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); University Grants Committee of Hong Kong SAR	This work was supported by the Research Grants Council of Hong Kong (GRF 7755/08M and GRF 7765/09M) and a Special Equipment Grant (Project no. SEG/CUHK09) from the University Grants Committee of Hong Kong SAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayrer JR, 2005, J BIOL CHEM, V280, P32989, DOI 10.1074/jbc.M507990200; Bertolaet BL, 2001, J MOL BIOL, V313, P955, DOI 10.1006/jmbi.2001.5105; Blankenship JW, 2009, BIOCHEM J, V417, P149, DOI 10.1042/BJ20081885; Chang YG, 2006, PROTEIN SCI, V15, P1248, DOI 10.1110/ps.051995006; Charbonnier S, 2008, BIOTECHNOL ANN REV, V14, P1, DOI 10.1016/S1387-2656(08)00001-X; Chim N, 2004, PROTEINS, V54, P784, DOI 10.1002/prot.10636; Ciani B, 2003, J BIOL CHEM, V278, P37409, DOI 10.1074/jbc.M307416200; COOK WJ, 1992, J BIOL CHEM, V267, P15116; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; DeLano W, 2002, PYMOL 0 99; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Dey S, 2010, J MOL BIOL, V398, P146, DOI 10.1016/j.jmb.2010.02.020; Dieckmann T, 1998, NAT STRUCT BIOL, V5, P1042, DOI 10.1038/4220; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Eddins MJ, 2007, J MOL BIOL, V367, P204, DOI 10.1016/j.jmb.2006.12.065; French M, 2005, METHOD ENZYMOL, V399, P135, DOI 10.1016/S0076-6879(05)99009-5; Galban S, 2010, CELL DEATH DIFFER, V17, P54, DOI 10.1038/cdd.2009.81; GODDARD TD, 1998, SPARKY 3 0; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Gyrd-Hansen M, 2008, NAT CELL BIOL, V10, P1309, DOI 10.1038/ncb1789; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hui SK, 2010, BIOMOL NMR ASSIGN, V4, P13, DOI 10.1007/s12104-009-9197-x; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Iwai K, 2009, EMBO REP, V10, P706, DOI 10.1038/embor.2009.144; Jaravine VA, 2008, J AM CHEM SOC, V130, P3927, DOI 10.1021/ja077282o; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kozlov G, 2007, J BIOL CHEM, V282, P27547, DOI 10.1074/jbc.M703333200; Lin SC, 2007, J MOL BIOL, V372, P847, DOI 10.1016/j.jmb.2007.07.019; Long J, 2010, J MOL BIOL, V396, P178, DOI 10.1016/j.jmb.2009.11.032; Lowe ED, 2006, ACTA CRYSTALLOGR D, V62, P177, DOI 10.1107/S0907444905037777; Mace PD, 2008, J BIOL CHEM, V283, P31633, DOI 10.1074/jbc.M804753200; Matta-Camacho E, 2009, J MOL BIOL, V386, P569, DOI 10.1016/j.jmb.2008.09.086; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Mueller TD, 2004, J BIOL CHEM, V279, P11926, DOI 10.1074/jbc.M312865200; Mueller TD, 2002, J MOL BIOL, V319, P1243, DOI 10.1016/S0022-2836(02)00302-9; Ogura K, 1996, J BIOMOL NMR, V8, P492, DOI 10.1007/BF00228150; Ohno A, 2005, STRUCTURE, V13, P521, DOI 10.1016/j.str.2005.01.011; Panneerselvam S, 2006, STRUCTURE, V14, P173, DOI 10.1016/j.str.2005.09.022; Peschard P, 2007, MOL CELL, V27, P474, DOI 10.1016/j.molcel.2007.06.023; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Reyes-Turcu FE, 2008, J BIOL CHEM, V283, P19581, DOI 10.1074/jbc.M800947200; Ryabov Y, 2006, PROTEINS, V63, P787, DOI 10.1002/prot.20917; Salvesen GS, 2004, ONCOGENE, V23, P2774, DOI 10.1038/sj.onc.1207522; Sasaki T, 2005, BIOCHEM BIOPH RES CO, V336, P530, DOI 10.1016/j.bbrc.2005.08.126; Schimmer AD, 2006, CELL DEATH DIFFER, V13, P179, DOI 10.1038/sj.cdd.4401826; Sims JJ, 2009, NAT STRUCT MOL BIOL, V16, P883, DOI 10.1038/nsmb.1637; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Sun CH, 2000, J BIOL CHEM, V275, P33777, DOI 10.1074/jbc.M006226200; Swanson KA, 2006, J MOL BIOL, V358, P713, DOI 10.1016/j.jmb.2006.02.059; Takahashi R, 1998, J BIOL CHEM, V273, P7787, DOI 10.1074/jbc.273.14.7787; Trempe JF, 2005, EMBO J, V24, P3178, DOI 10.1038/sj.emboj.7600797; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Varadan R, 2005, MOL CELL, V18, P687, DOI 10.1016/j.molcel.2005.05.013; Varadan R, 2002, J MOL BIOL, V324, P637, DOI 10.1016/S0022-2836(02)01198-1; Vucic D, 2008, CURR CANCER DRUG TAR, V8, P110, DOI 10.2174/156800908783769373; Weeks SD, 2009, PROTEINS, V77, P753, DOI 10.1002/prot.22568; Winget JM, 2010, MOL CELL, V38, P627, DOI 10.1016/j.molcel.2010.05.003; Withers-Ward ES, 2000, BIOCHEMISTRY-US, V39, P14103, DOI 10.1021/bi0017071; Yuan XM, 2004, EMBO J, V23, P1463, DOI 10.1038/sj.emboj.7600152; Zhang D, 2008, J MOL BIOL, V377, P162, DOI 10.1016/j.jmb.2007.12.029; Zhou ZR, 2008, PROTEIN SCI, V17, P1805, DOI 10.1110/ps.036384.108	67	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e28511	10.1371/journal.pone.0028511	http://dx.doi.org/10.1371/journal.pone.0028511			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22194841	Green Submitted, Green Published, gold			2022-12-25	WOS:000298370400015
J	Lam, SH; Hlaing, MM; Zhang, XY; Yan, CA; Duan, ZH; Zhu, L; Ung, CY; Mathavan, S; Ong, CN; Gong, ZY				Lam, Siew Hong; Hlaing, Mya Myintzu; Zhang, Xiaoyan; Yan, Chuan; Duan, Zhenghua; Zhu, Lin; Ung, Choong Yong; Mathavan, Sinnakaruppan; Ong, Choon Nam; Gong, Zhiyuan			Toxicogenomic and Phenotypic Analyses of Bisphenol-A Early-Life Exposure Toxicity in Zebrafish	PLOS ONE			English	Article							IN-VIVO; DANIO-RERIO; SIGNALING PATHWAYS; MODEL VERTEBRATE; EXPRESSION; ESTROGEN; SUSCEPTIBILITY; BIOLOGY; BRAIN; GENE	Bisphenol-A is an important environmental contaminant due to the increased early-life exposure that may pose significant health-risks to various organisms including humans. This study aimed to use zebrafish as a toxicogenomic model to capture transcriptomic and phenotypic changes for inference of signaling pathways, biological processes, physiological systems and identify potential biomarker genes that are affected by early-life exposure to bisphenol-A. Phenotypic analysis using wildtype zebrafish larvae revealed BPA early-life exposure toxicity caused cardiac edema, cranio-facial abnormality, failure of swimbladder inflation and poor tactile response. Fluorescent imaging analysis using three transgenic lines revealed suppressed neuron branching from the spinal cord, abnormal development of neuromast cells, and suppressed vascularization in the abdominal region. Using knowledge-based data mining algorithms, transcriptome analysis suggests that several signaling pathways involving ephrin receptor, clathrin-mediated endocytosis, synaptic long-term potentiation, axonal guidance, vascular endothelial growth factor, integrin and tight junction were deregulated. Physiological systems with related disorders associated with the nervous, cardiovascular, skeletal-muscular, blood and reproductive systems were implicated, hence corroborated with the phenotypic analysis. Further analysis identified a common set of BPA-targeted genes and revealed a plausible mechanism involving disruption of endocrine-regulated genes and processes in known susceptible tissue-organs. The expression of 28 genes were validated in a separate experiment using quantitative real-time PCR and 6 genes, ncl1, apoeb, mdm1, mycl1b, sp4, U1SNRNPBP homolog, were found to be sensitive and robust biomarkers for BPA early-life exposure toxicity. The susceptibility of sp4 to BPA perturbation suggests its role in altering brain development, function and subsequently behavior observed in laboratory animals exposed to BPA during early life, which is a health-risk concern of early life exposure in humans. The present study further established zebrafish as a model for toxicogenomic inference of early-life chemical exposure toxicity.	[Lam, Siew Hong; Hlaing, Mya Myintzu; Zhang, Xiaoyan; Yan, Chuan; Duan, Zhenghua; Ung, Choong Yong; Gong, Zhiyuan] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Lam, Siew Hong; Ong, Choon Nam; Gong, Zhiyuan] Natl Univ Singapore, NERI, Singapore 117548, Singapore; [Duan, Zhenghua; Zhu, Lin] Nankai Univ, Coll Environm Sci & Engn, Tianjin 300071, Peoples R China; [Mathavan, Sinnakaruppan] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore, Singapore; [Ong, Choon Nam] Natl Univ Singapore, Dept Epidemiol & Publ Hlth, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; Nankai University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore	Lam, SH (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbslsh@nus.edu.sg; dbsgzy@nus.edu.sg	Lam, Siew Hong/H-8483-2012; Gong, Zhiyuan/H-8794-2012; Ong, Choon Nam/E-8638-2010; Hlaing, Mya/N-6774-2016; Ung, Choong Yong/D-4525-2012	Gong, Zhiyuan/0000-0002-9660-5260; Hlaing, Mya/0000-0002-7351-864X; yan, chuan/0000-0002-0449-7072; Ong, Choon Nam/0000-0002-4002-1725	Environment and Water Industry Development Council of Singapore	Environment and Water Industry Development Council of Singapore	This work is supported by Environment and Water Industry Development Council of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alestrom P, 2006, TRENDS BIOTECHNOL, V24, P15, DOI 10.1016/j.tibtech.2005.11.004; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Beronius A, 2010, REPROD TOXICOL, V29, P132, DOI 10.1016/j.reprotox.2009.11.007; Betancourt AM, 2010, ENVIRON HEALTH PERSP, V118, P1614, DOI 10.1289/ehp.1002148; Chapin RE, 2008, BIRTH DEFECTS RES B, V83, P157, DOI 10.1002/bdrb.20147; Crain DA, 2007, REPROD TOXICOL, V24, P225, DOI 10.1016/j.reprotox.2007.05.008; Dooley K, 2000, CURR OPIN GENET DEV, V10, P252, DOI 10.1016/S0959-437X(00)00074-5; Duan ZH, 2008, ECOTOX ENVIRON SAFE, V71, P774, DOI 10.1016/j.ecoenv.2008.01.021; Gahmberg CG, 2009, BBA-GEN SUBJECTS, V1790, P431, DOI 10.1016/j.bbagen.2009.03.007; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Granseth B, 2007, J PHYSIOL-LONDON, V585, P681, DOI 10.1113/jphysiol.2007.139022; Grunwald DJ, 2002, NAT REV GENET, V3, P717, DOI 10.1038/nrg892; Haigh J. J, 2008, ORGANOGENESIS, V4, P247, DOI DOI 10.4161/0RG.4.4.7415; Hill AJ, 2005, TOXICOL SCI, V86, P6, DOI 10.1093/toxsci/kfi110; Jones HS, 2010, ZEBRAFISH, V7, P23, DOI 10.1089/zeb.2009.0630; Kang JH, 2007, CRIT REV TOXICOL, V37, P607, DOI 10.1080/10408440701493103; Keri RA, 2007, REPROD TOXICOL, V24, P240, DOI 10.1016/j.reprotox.2007.06.008; Kishida M, 2001, COMP BIOCHEM PHYS B, V129, P261, DOI 10.1016/S1096-4959(01)00319-0; Kochukov MY, 2009, ENVIRON HEALTH PERSP, V117, P723, DOI 10.1289/ehp.0800182; Lam SH, 2006, NAT BIOTECHNOL, V24, P73, DOI 10.1038/nbt1169; Lam SH, 2005, GEN COMP ENDOCR, V142, P325, DOI 10.1016/j.ygcen.2005.02.004; Lam SH, 2006, PHYSIOL GENOMICS, V27, P351, DOI 10.1152/physiolgenomics.00201.2005; Lam SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000121; Liu YW, 2002, DIFFERENTIATION, V70, P36, DOI 10.1046/j.1432-0436.2002.700104.x; Muncke J, 2007, ENVIRON TOXICOL, V22, P185, DOI 10.1002/tox.20255; Nilsson S, 2002, CRIT REV BIOCHEM MOL, V37, P1, DOI 10.1080/10409230290771438; OECD, 2006, FISH EMBR TOX FET TE; Palanza P, 2008, ENVIRON RES, V108, P150, DOI 10.1016/j.envres.2008.07.023; Palmer A, 2003, GENE DEV, V17, P1429, DOI 10.1101/gad.1093703; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Paules R, 2003, ENVIRON HEALTH PERSP, V111, pA338, DOI 10.1289/ehp.111-a338; Pedram A, 2002, J BIOL CHEM, V277, P50768, DOI 10.1074/jbc.M210106200; Prins GS, 2008, BASIC CLIN PHARMACOL, V102, P134, DOI 10.1111/j.1742-7843.2007.00166.x; Ramos B, 2009, MOL CELL NEUROSCI, V42, P152, DOI 10.1016/j.mcn.2009.06.008; Richter CA, 2007, REPROD TOXICOL, V24, P199, DOI 10.1016/j.reprotox.2007.06.004; Rodriguez-Cuenca S, 2007, AM J PHYSIOL-ENDOC M, V292, pE340, DOI 10.1152/ajpendo.00175.2006; Safe S, 2008, J MOL ENDOCRINOL, V41, P263, DOI 10.1677/JME-08-0103; Salian S, 2011, REPROD TOXICOL, V31, P359, DOI 10.1016/j.reprotox.2010.10.008; Scholz S, 2008, ENVIRON SCI POLLUT R, V15, P394, DOI 10.1007/s11356-008-0018-z; Spitsbergen Jan M., 2003, Toxicologic Pathology, V31, P62, DOI 10.1080/01926230309774; Sukardi H, 2011, EXPERT OPIN DRUG MET, V7, P579, DOI 10.1517/17425255.2011.562197; Sukardi H, 2010, ZEBRAFISH, V7, P41, DOI 10.1089/zeb.2009.0636; Ung CY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-212; US EPA (US Environmental Protection Agency), 2002, SHORT TERM METH EST; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; Warner KE, 2007, ENVIRON TOXICOL CHEM, V26, P732, DOI 10.1897/06-482R.1; Wetherill YB, 2007, REPROD TOXICOL, V24, P178, DOI 10.1016/j.reprotox.2007.05.010; Willhite CC, 2008, J TOXICOL ENV HEAL B, V11, P69, DOI 10.1080/10937400701724303; Yang LX, 2009, REPROD TOXICOL, V28, P245, DOI 10.1016/j.reprotox.2009.04.013; Zhou X, 2007, GENES BRAIN BEHAV, V6, P269, DOI 10.1111/j.1601-183X.2006.00256.x; Zhou XJ, 2010, HUM MOL GENET, V19, P3797, DOI 10.1093/hmg/ddq298; Zhou XJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005196; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	53	71	78	3	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28273	10.1371/journal.pone.0028273	http://dx.doi.org/10.1371/journal.pone.0028273			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194820	Green Submitted, Green Published, gold			2022-12-25	WOS:000298369100027
J	Acharya, BK; Sanders, NJ; Vijayan, L; Chettri, B				Acharya, Bhoj Kumar; Sanders, Nathan J.; Vijayan, Lalitha; Chettri, Basundhara			Elevational Gradients in Bird Diversity in the Eastern Himalaya: An Evaluation of Distribution Patterns and Their Underlying Mechanisms	PLOS ONE			English	Article							SPECIES RICHNESS PATTERNS; SMALL MAMMAL DIVERSITY; GEOMETRIC CONSTRAINTS; RAPOPORTS RULE; RANGE-SIZE; BIOGEOGRAPHICAL PATTERNS; SCALE PATTERNS; ENERGY; AREA; EXPLAIN	Background: Understanding diversity patterns and the mechanisms underlying those patterns along elevational gradients is critically important for conservation efforts in montane ecosystems, especially those that are biodiversity hotspots. Despite recent advances, consensus on the underlying causes, or even the relative influence of a suite of factors on elevational diversity patterns has remained elusive. Methods and Principal Findings: We examined patterns of species richness, density and range size distribution of birds, and the suite of biotic and abiotic factors (primary productivity, habitat variables, climatic factors and geometric constraints) that governs diversity along a 4500-m elevational gradient in the Eastern Himalayan region, a biodiversity hotspot within the world's tallest mountains. We used point count methods for sampling birds and quadrats for estimating vegetation at 22 sites along the elevational gradient. We found that species richness increased to approximately 2000 m, then declined. We found no evidence that geometric constraints influenced this pattern, whereas actual evapotranspiration (a surrogate for primary productivity) and various habitat variables (plant species richness, shrub density and basal area of trees) accounted for most of the variation in bird species richness. We also observed that ranges of most bird species were narrow along the elevation gradient. We find little evidence to support Rapoport's rule for the birds of Sikkim region of the Himalaya. Conclusions and Significance: This study in the Eastern Himalaya indicates that species richness of birds is highest at intermediate elevations along one of the most extensive elevational gradients ever examined. Additionally, primary productivity and factors associated with habitat accounted for most of the variation in avian species richness. The diversity peak at intermediate elevations and the narrow elevational ranges of most species suggest important conservation implications: not only should mid-elevation areas be conserved, but the entire gradient requires equal conservation attention.	[Acharya, Bhoj Kumar; Vijayan, Lalitha; Chettri, Basundhara] Salim Ali Ctr Ornithol & Nat Hist, Div Conservat Ecol, Coimbatore, Tamil Nadu, India; [Sanders, Nathan J.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN USA	Salim Ali Center for Ornithology & Natural History (SACON); University of Tennessee System; University of Tennessee Knoxville	Acharya, BK (corresponding author), Sikkim Govt Coll, Dept Zool, Gangtok, Sikkim, India.	acharya2skm@gmail.com	Sanders, Nathan/ABE-4335-2020; Sanders, Nathan/A-6945-2009	Sanders, Nathan/0000-0001-6220-6731; Vijayan, Lalitha/0000-0002-4074-5002	MoEF, Government of India, through CISMHE, University of Delhi; Danish National Research Foundation [DOE-PER DE-FG02]	MoEF, Government of India, through CISMHE, University of Delhi; Danish National Research Foundation(Danmarks Grundforskningsfond)	This study was funded by MoEF, Government of India, through CISMHE, University of Delhi. NJS was supported by DOE-PER DE-FG02 a grant from the Danish National Research Foundation to the Center for Macroecology, Evolution and Climate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; Bhattarai KR, 2006, DIVERS DISTRIB, V12, P373, DOI 10.1111/j.1366-9516.2006.00244.x; Bhattarai KR, 2004, J BIOGEOGR, V31, P389, DOI 10.1046/j.0305-0270.2003.01013.x; Bibby CJ, 2000, BIRD CENSUS TECHNIQU, DOI 10.1016/b978-0-12-095830-6.50007-9; Bini LM, 2009, ECOGRAPHY, V32, P193, DOI 10.1111/j.1600-0587.2009.05717.x; Blake JG, 2000, AUK, V117, P663, DOI 10.1642/0004-8038(2000)117[0663:DOBAAE]2.0.CO;2; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; COLWELL RK, 1994, AM NAT, V144, P570, DOI 10.1086/285695; Colwell RK, 2004, AM NAT, V163, pE1, DOI 10.1086/382056; COLWELL RK, ESTIMATES DATA ANAL; CUERTO VR, 1999, J BIOGEOGR, V26, P487; Currie DJ, 2008, ECOL MONOGR, V78, P3, DOI 10.1890/06-1302.1; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; De Klerk HM, 2002, DIVERS DISTRIB, V8, P147, DOI 10.1046/j.1472-4642.2002.00142.x; Ding TS, 2006, J BIOGEOGR, V33, P683, DOI 10.1111/j.1365-2699.2006.01419.x; Ding TS, 2005, GLOBAL ECOL BIOGEOGR, V14, P299, DOI 10.1111/j.1466-822x.2005.00159.x; Diniz JAF, 2003, GLOBAL ECOL BIOGEOGR, V12, P53, DOI 10.1046/j.1466-822X.2003.00322.x; Dunn RR, 2007, GLOBAL ECOL BIOGEOGR, V16, P305, DOI 10.1111/j.1466-8238.2006.00284.x; Evans KL, 2005, BIOL REV, V80, P1, DOI 10.1017/S1464793104006517; Fjeldsa J, 1999, ECOGRAPHY, V22, P63, DOI 10.1111/j.1600-0587.1999.tb00455.x; Fleishman E, 1998, ECOLOGY, V79, P2482, DOI 10.1890/0012-9658(1998)079[2482:AETORS]2.0.CO;2; Freifeld HB, 1999, J BIOGEOGR, V26, P1191, DOI 10.1046/j.1365-2699.1999.00349.x; Fu CZ, 2007, BIODIVERS CONSERV, V16, P707, DOI 10.1007/s10531-005-4382-4; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gaston KJ, 1998, TRENDS ECOL EVOL, V13, P70, DOI 10.1016/S0169-5347(97)01236-6; Gaston KJ, 1996, TRENDS ECOL EVOL, V11, P197, DOI 10.1016/0169-5347(96)10027-6; Graham CH, 2009, P NATL ACAD SCI USA, V106, P19673, DOI 10.1073/pnas.0901649106; GRAHAM GL, 1990, J BIOGEOGR, V17, P657, DOI 10.2307/2845147; Grau O, 2007, J BIOGEOGR, V34, P1907, DOI 10.1111/j.1365-2699.2007.01745.x; Grytnes JA, 2002, AM NAT, V159, P294, DOI 10.1086/338542; Haribal M., 1992, BUTTERFLIES SIKKIM H; Harris G, 2008, CONSERV BIOL, V22, P163, DOI 10.1111/j.1523-1739.2007.00798.x; Hawkins AFA, 1999, J BIOGEOGR, V26, P447, DOI 10.1046/j.1365-2699.1999.00306.x; Hawkins BA, 2005, AM NAT, V166, pE140, DOI 10.1086/491686; Hawkins BA, 2002, GLOBAL ECOL BIOGEOGR, V11, P419, DOI 10.1046/j.1466-822x.2002.00299.x; Hawkins BA, 2007, AM NAT, V170, pS16, DOI 10.1086/519009; Heaney LR, 2001, GLOBAL ECOL BIOGEOGR, V10, P15, DOI 10.1046/j.1466-822x.2001.00227.x; Hernandez CE, 2005, ECOGRAPHY, V28, P363, DOI 10.1111/j.0906-7590.2005.04013.x; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Hofer U, 1999, ECOLOGY, V80, P976, DOI 10.2307/177031; Hortal J, 2006, J ANIM ECOL, V75, P274, DOI 10.1111/j.1365-2656.2006.01048.x; HUNTER ML, 1993, CONSERV BIOL, V7, P420, DOI 10.1046/j.1523-1739.1993.07020420.x; Jankowski JE, 2010, ECOLOGY, V91, P1877, DOI 10.1890/09-2063.1; Jetz W, 2001, P NATL ACAD SCI USA, V98, P5661, DOI 10.1073/pnas.091100998; Johansson US, 2007, EVOLUTION, V61, P324, DOI 10.1111/j.1558-5646.2007.00024.x; Kattan GH, 2004, GLOBAL ECOL BIOGEOGR, V13, P451, DOI 10.1111/j.1466-822X.2004.00117.x; Kessler Michael, 2001, Diversity and Distributions, V7, P61, DOI 10.1046/j.1472-4642.2001.00097.x; Kluge J, 2006, GLOBAL ECOL BIOGEOGR, V15, P358, DOI [10.1111/j.1466-822X.2006.00223.x, 10.1111/j.1466-822x.2006.00223.x]; Korner C, 2000, TRENDS ECOL EVOL, V15, P513, DOI 10.1016/S0169-5347(00)02004-8; Kozak KH, 2010, AM NAT, V176, P40, DOI 10.1086/653031; Li JS, 2003, GLOBAL ECOL BIOGEOGR, V12, P449, DOI 10.1046/j.1466-822X.2003.00052.x; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; MACARTHUR R, 1966, AM NAT, V100, P319, DOI 10.1086/282425; Machac A, 2011, ECOGRAPHY, V34, P364, DOI 10.1111/j.1600-0587.2010.06629.x; McCain CM, 2007, GLOBAL ECOL BIOGEOGR, V16, P1, DOI 10.1111/j.1466-8238.2006.00263.x; McCain CM, 2009, GLOBAL ECOL BIOGEOGR, V18, P346, DOI 10.1111/j.1466-8238.2008.00443.x; McCain CM, 2004, J BIOGEOGR, V31, P19, DOI 10.1046/j.0305-0270.2003.00992.x; McCain CM, 2003, J MAMMAL, V84, P967, DOI 10.1644/BJK-026; Naniwadekar R, 2007, J BIOGEOGR, V34, P842, DOI 10.1111/j.1365-2699.2006.01648.x; Nogues-Bravo D, 2008, NATURE, V453, P216, DOI 10.1038/nature06812; Nor SM, 2001, GLOBAL ECOL BIOGEOGR, V10, P41, DOI 10.1046/j.1466-822x.2001.00231.x; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; OLSON DM, 1994, J TROP ECOL, V10, P129, DOI 10.1017/S0266467400007793; Oommen MA, 2005, ECOLOGY, V86, P3039, DOI 10.1890/04-1837; Orme CDL, 2006, PLOS BIOL, V4, P1276, DOI 10.1371/journal.pbio.0040208; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Patterson BD, 1998, J BIOGEOGR, V25, P593, DOI 10.1046/j.1365-2699.1998.2530593.x; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; Rahbek C, 1997, AM NAT, V149, P875, DOI 10.1086/286028; Rahbek C, 2007, P ROY SOC B-BIOL SCI, V274, P165, DOI 10.1098/rspb.2006.3700; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Rasmussen PC., 2005, BIRDS S ASIA RIPLEY; REYNOLDS RT, 1980, CONDOR, V82, P309, DOI 10.2307/1367399; Rohde Klaus, 1996, Biodiversity Letters, V3, P10, DOI 10.2307/2999704; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; ROSENZWEIG ML, 1992, J MAMMAL, V73, P715, DOI 10.2307/1382191; Rowe RJ, 2009, GLOBAL ECOL BIOGEOGR, V18, P163, DOI 10.1111/j.1466-8238.2008.00438.x; Sanders NJ, 2007, GLOBAL ECOL BIOGEOGR, V16, P640, DOI 10.1111/j.1466-8238.2007.00316.x; Sanders NJ, 2010, DATA MINING FOR GLOBAL TRENDS IN MOUNTAIN BIODIVERSITY, P75; Sanders NJ, 2002, ECOGRAPHY, V25, P25, DOI 10.1034/j.1600-0587.2002.250104.x; Sanders NJ, 2003, GLOBAL ECOL BIOGEOGR, V12, P93, DOI 10.1046/j.1466-822X.2003.00324.x; SANDERS NJ, ECOGRAPHY IN PRESS; Smith TB, 2005, J EVOLUTION BIOL, V18, P257, DOI 10.1111/j.1420-9101.2004.00825.x; Srivastava DS, 1998, AM NAT, V152, P510, DOI 10.1086/286187; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; STEVENS GC, 1992, AM NAT, V140, P893, DOI 10.1086/285447; TERBORGH J, 1977, ECOLOGY, V58, P1007, DOI 10.2307/1936921; TURC L., 1954, Annales Agronomiques, V5, P491; Vazquez JA, 1998, J ECOL, V86, P999, DOI 10.1046/j.1365-2745.1998.00325.x; Whittaker RJ, 2010, ECOLOGY, V91, P2522, DOI 10.1890/08-0968.1; Willson MF, 1996, CONDOR, V98, P350, DOI 10.2307/1369153	91	65	78	4	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e29097	10.1371/journal.pone.0029097	http://dx.doi.org/10.1371/journal.pone.0029097			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174953	gold, Green Submitted, Green Published			2022-12-25	WOS:000298367300044
J	Caspersen, JP; Vanderwel, MC; Cole, WG; Purves, DW				Caspersen, John P.; Vanderwel, Mark C.; Cole, William G.; Purves, Drew W.			How Stand Productivity Results from Size- and Competition-Dependent Growth and Mortality	PLOS ONE			English	Article							NORTHERN HARDWOOD FORESTS; GROWING SPACE EFFICIENCY; CANOPY TREE COMPETITION; WOODY DEBRIS DYNAMICS; PLANT-POPULATIONS; MULTISPECIES MODEL; METABOLIC ECOLOGY; CENTRAL ONTARIO; DECAYING LOGS; SELECTION	Background: A better understanding of the relationship between stand structure and productivity is required for the development of: a) scalable models that can accurately predict growth and yield dynamics for the world's forests; and b) stand management regimes that maximize wood and/or timber yield, while maintaining structural and species diversity. Methods: We develop a cohort-based canopy competition model ("CAIN''), parameterized with inventory data from Ontario, Canada, to examine the relationship between stand structure and productivity. Tree growth, mortality and recruitment are quantified as functions of diameter and asymmetric competition, using a competition index (CAI(h)) defined as the total projected area of tree crowns at a given tree's mid-crown height. Stand growth, mortality, and yield are simulated for inventoried stands, and also for hypothetical stands differing in total volume and tree size distribution. Results: For a given diameter, tree growth decreases as CAI(h) increases, whereas the probability of mortality increases. For a given CAI(h), diameter growth exhibits a humped pattern with respect to diameter, whereas mortality exhibits a U-shaped pattern reflecting senescence of large trees. For a fixed size distribution, stand growth increases asymptotically with total density, whereas mortality increases monotonically. Thus, net productivity peaks at an intermediate volume of 100-150 m(3)/ha, and approaches zero at 250 m(3)/ha. However, for a fixed stand volume, mortality due to senescence decreases if the proportion of large trees decreases as overall density increases. This size-related reduction in mortality offsets the density-related increase in mortality, resulting in a 40% increase in yield. Conclusions: Size-related variation in growth and mortality exerts a profound influence on the relationship between stand structure and productivity. Dense stands dominated by small trees yield more wood than stands dominated by fewer large trees, because the relative growth rate of small trees is higher, and because they are less likely to die.	[Caspersen, John P.] Univ Toronto, Fac Forestry, Toronto, ON, Canada; [Vanderwel, Mark C.; Purves, Drew W.] Microsoft Res, Computat Ecol & Environm Sci Grp, Cambridge, England; [Cole, William G.] Ontario Forest Res Inst, Sault Ste Marie, ON, Canada	University of Toronto; Microsoft	Caspersen, JP (corresponding author), Univ Toronto, Fac Forestry, Toronto, ON, Canada.	john.caspersen@utoronto.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) [90439956]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grant to JPC (grant #90439956) (http://www.nserc-crsng.gc.ca/professors-professeurs/grants-subs/dgigp-psigp_eng.asp) NSERC had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS D M, 1974, Canadian Journal of Forest Research, V4, P274, DOI 10.1139/x74-041; Adams TP, 2007, P ROY SOC B-BIOL SCI, V274, P3039, DOI 10.1098/rspb.2007.0891; [Anonymous], 2004, TROPICAL FOREST DIVE; Assmann E., 1970, PRINCIPLES FOREST YI; BAKER F. S., 1949, JOUR FOREST, V47, P179; Bowman JC, 1997, WILDLIFE BIOL, V3, P97, DOI 10.2981/wlb.1997.012; Brunner A, 1998, FOREST ECOL MANAG, V107, P19, DOI 10.1016/S0378-1127(97)00325-3; Bugmann H, 2001, CLIMATIC CHANGE, V51, P259, DOI 10.1023/A:1012525626267; BUONGIORNO J, 1980, FOREST SCI, V26, P609; Buongiorno J, 2000, SILVA FENN, V34, P223, DOI 10.14214/sf.627; Burns R. M., 1990, AGR HDB, V2, P877, DOI DOI 10.1093/JHERED/ESP102; Canham CD, 2006, ECOL APPL, V16, P540, DOI 10.1890/1051-0761(2006)016[0540:NAOCTC]2.0.CO;2; Canham CD, 2004, CAN J FOREST RES, V34, P778, DOI [10.1139/x03-232, 10.1139/X03-232]; Caspersen JP, 2006, CAN J FOREST RES, V36, P1255, DOI 10.1139/X06-034; Coates KD, 2009, J ECOL, V97, P118, DOI 10.1111/j.1365-2745.2008.01458.x; COLE WG, 1995, HARDWOOD TREE CROWN; Coomes DA, 2003, ECOL LETT, V6, P980, DOI 10.1046/j.1461-0248.2003.00520.x; Coomes DA, 2006, TRENDS ECOL EVOL, V21, P593, DOI 10.1016/j.tree.2006.09.002; Enquist BJ, 2001, NATURE, V410, P655, DOI 10.1038/35070500; Fisher R, 2010, NEW PHYTOL, V187, P666, DOI 10.1111/j.1469-8137.2010.03340.x; Groot A, 2008, FOREST ECOL MANAG, V255, P1647, DOI 10.1016/j.foreco.2007.11.024; HAIGHT RG, 1985, FOREST SCI, V31, P451; Hanewinkel M, 2002, FORESTRY, V75, P473, DOI 10.1093/forestry/75.4.473; HANSEN GD, 1987, CAN J FOREST RES, V17, P1, DOI 10.1139/x87-001; HARA T, 1988, TRENDS ECOL EVOL, V3, P129, DOI 10.1016/0169-5347(88)90175-9; HARA T, 1992, ANN BOT-LONDON, V69, P509, DOI 10.1093/oxfordjournals.aob.a088380; Hayden J., 1995, FIELD MANUAL ESTABLI; Herault B, 2011, J ECOL, V99, P1431, DOI 10.1111/j.1365-2745.2011.01883.x; HIX DM, 1990, FOREST SCI, V36, P1032; Holloway GL, 2006, J WILDLIFE MANAGE, V70, P1735, DOI 10.2193/0022-541X(2006)70[1735:SHRIFM]2.0.CO;2; Holloway GL, 2007, FOREST ECOL MANAG, V239, P191, DOI 10.1016/j.foreco.2006.12.004; Jung TS, 1999, J WILDLIFE MANAGE, V63, P1306, DOI 10.2307/3802849; KOHYAMA T, 1992, FUNCT ECOL, V6, P206, DOI 10.2307/2389756; KOHYAMA T, 1992, ANN BOT-LONDON, V70, P451, DOI 10.1093/oxfordjournals.aob.a088502; Kraft NJB, 2010, NEW PHYTOL, V188, P1124, DOI 10.1111/j.1469-8137.2010.03444.x; LAHDE E, 1994, ANN SCI FOREST, V51, P97, DOI 10.1051/forest:19940201; Lichstein JW, 2010, ECOL APPL, V20, P684, DOI 10.1890/08-2334.1; Lines ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013212; Lopez-Gonzalez G, 2011, J VEG SCI, V22, P610, DOI 10.1111/j.1654-1103.2011.01312.x; Lorimer CG, 2001, J ECOL, V89, P960, DOI 10.1111/j.1365-2745.2001.00619.x; McGee GG, 2001, J TORREY BOT SOC, V128, P370, DOI 10.2307/3088669; McKenny HC, 2006, FOREST ECOL MANAG, V230, P186, DOI 10.1016/j.foreco.2006.04.034; *MILL EC ASS, 2005, BIOD WHAT IS IT IS I; Muller-Landau HC, 2006, ECOL LETT, V9, P589, DOI 10.1111/j.1461-0248.2006.00915.x; Muller-Landau HC, 2006, ECOL LETT, V9, P575, DOI 10.1111/j.1461-0248.2006.00904.x; Nyland RD, 1998, J FOREST, V96, P18; O'Hara KL, 2006, FOREST SCI, V52, P290; *ONT MIN NAT RES, 2000, SILV GUID TOL HARDW; Pacala SW, 1996, ECOL MONOGR, V66, P1, DOI 10.2307/2963479; Poulin JF, 2008, BIOL CONSERV, V141, P1129, DOI 10.1016/j.biocon.2008.02.012; Poulin JF, 2010, ECOSCIENCE, V17, P20, DOI 10.2980/17-1-3297; Pretzsch H, 2005, PLANT BIOLOGY, V7, P628, DOI 10.1055/s-2005-865965; Price CA, 2010, NEW PHYTOL, V188, P696, DOI 10.1111/j.1469-8137.2010.03442.x; Purves D, 2008, SCIENCE, V320, P1452, DOI 10.1126/science.1155359; Purves DW, 2008, P NATL ACAD SCI USA, V105, P17018, DOI 10.1073/pnas.0807754105; Purves DW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000870; Rowe J.S., 1972, CANADIAN FOREST SERV, V1300; *ROY SOC, 2001, GLOB CARB STOCKS SIN; Silvertown J., 2001, INTRO PLANT POPULATI; Straus MA, 2011, CAN J FOREST RES, V41, P1004, DOI [10.1139/X11-012, 10.1139/x11-012]; Strigul N, 2008, ECOL MONOGR, V78, P523, DOI 10.1890/08-0082.1; Vanderwel MC, 2011, FOREST ECOL MANAG, V261, P1362, DOI 10.1016/j.foreco.2011.01.016; Vanderwel MC, 2009, CAN J FOREST RES, V39, P1709, DOI 10.1139/X09-087; Vanderwel MC, 2008, CAN J FOREST RES, V38, P2850, DOI 10.1139/X08-130; Vanderwel MC, 2006, FOREST ECOL MANAG, V225, P190, DOI 10.1016/j.foreco.2005.12.051; Webster CR, 2003, FOREST ECOL MANAG, V177, P361, DOI 10.1016/S0378-1127(02)00394-8; WEINER J, 1990, TRENDS ECOL EVOL, V5, P360, DOI 10.1016/0169-5347(90)90095-U; WELLER DE, 1987, ECOL MONOGR, V57, P23, DOI 10.2307/1942637	68	41	42	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28660	10.1371/journal.pone.0028660	http://dx.doi.org/10.1371/journal.pone.0028660			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174861	gold, Green Published			2022-12-25	WOS:000298367300019
J	Conroy, AL; Liles, WC; Molyneux, ME; Rogerson, SJ; Kain, KC				Conroy, Andrea L.; Liles, W. Conrad; Molyneux, Malcolm E.; Rogerson, Stephen J.; Kain, Kevin C.			Performance Characteristics of Combinations of Host Biomarkers to Identify Women with Occult Placental Malaria: A Case-Control Study from Malawi	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM PARASITEMIA; PREGNANT-WOMEN; BLOOD; SERUM; HYPERTENSION; ASSOCIATION; INFECTION; SFLT1	Background: Because of its propensity to sequester in the placental intervillous space, Plasmodium falciparum can evade detection by peripheral smear in women with placental malaria (PM). We evaluated host biomarkers as potential indicators of occult PM infections. Methods and Findings: Using a case-control design, we evaluated the ability of biomarkers to identify PM in the absence of circulating peripheral parasites (n = 24) compared to placental smear-negative controls (n = 326). We measured levels of biomarkers (C3a, C5a, CRP, angiopoietin-1, angiopoietin-2, sTie-2, sEndoglin, VEGF, sFlt-1, tissue factor, and leptin) in maternal peripheral plasma at delivery. Using ROC curve analysis, we assessed the ability of clinical parameters and biomarkers to accurately detect PM infections identified by placental smear. We show that decreases in sFlt-1 and leptin and increases in CRP were associated with occult PM infections (p<0.01) and correlated with placental parasitaemia (p<0.01). Individually, all markers had moderate ability to diagnose occult PM infections with areas under the ROC between 0.62 and 0.72. In order to improve diagnostic performance, we generated simple scoring systems to identify PM infections using either a clinical score (0-2), a biomarker score (0-3) or a clinical plus biomarker score (0-5). The combinatorial model that incorporated both clinical parameters and biomarkers had an area under curve (AUC) of 0.85 (95% CI, 0.81-0.89), which was significantly better at identifying occult PM infections than the clinical score alone (p = 0.001). Conclusion: These data suggest that host biomarkers in the maternal peripheral blood may improve the detection of PM in the absence of peripheral parasitaemia.	[Conroy, Andrea L.; Liles, W. Conrad; Kain, Kevin C.] Univ Toronto, Sandra A Rotman Labs, McLaughlin Rotman Ctr Global Hlth, Univ Hlth Network Toronto Gen Hosp, Toronto, ON, Canada; [Molyneux, Malcolm E.] Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Molyneux, Malcolm E.] Univ Malawi, Coll Med, Blantyre, Malawi; [Molyneux, Malcolm E.] Univ Liverpool, Sch Trop Med, Liverpool L69 3BX, Merseyside, England; [Rogerson, Stephen J.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia; [Liles, W. Conrad; Kain, Kevin C.] Univ Toronto, Dept Med, Div Infect Dis, Trop Dis Unit, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Malawi; University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool; Royal Melbourne Hospital; University of Melbourne; University of Toronto	Conroy, AL (corresponding author), Univ Toronto, Sandra A Rotman Labs, McLaughlin Rotman Ctr Global Hlth, Univ Hlth Network Toronto Gen Hosp, Toronto, ON, Canada.	kevin.kain@uhn.on.ca	Conroy, Andrea/AAA-8356-2020; Conroy, Andrea/ABC-5715-2020	Conroy, Andrea/0000-0002-5328-6511; Conroy, Andrea/0000-0002-5328-6511; Rogerson, Stephen/0000-0003-4287-1982; Kain, Kevin/0000-0001-6068-1272	Canadian Institutes of Health Research [MOP-13721, MOP-115160]; Genome Canada through the Ontario Genomics Institute; CIHR Canada Research Chairs; Wellcome Trust	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada through the Ontario Genomics Institute(Genome Canada); CIHR Canada Research Chairs(Canada Research ChairsCanadian Institutes of Health Research (CIHR)); Wellcome Trust(Wellcome TrustEuropean Commission)	This study was supported by the Canadian Institutes of Health Research grants MOP-13721 and MOP-115160 (KCK), Genome Canada through a grant by the Ontario Genomics Institute (KCK), and CIHR Canada Research Chairs (KCK, WCL). ALC was supported by a CIHR PhD studentship. SJR was supported by a Wellcome Trust Senior Research Fellowship. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegnika AA, 2006, AM J TROP MED HYG, V75, P798, DOI 10.4269/ajtmh.2006.75.798; [Anonymous], 2004, STRATEGIC FRAMEWORK; Conroy A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004953; Conroy AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015291; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; DESOWITZ RS, 1992, ANN TROP MED PARASIT, V86, P95, DOI 10.1080/00034983.1992.11812638; Fried M, 1998, J MOL MED-JMM, V76, P162, DOI 10.1007/s001090050205; Hirokoshi K, 2007, NEPHRON CLIN PRACT, V106, pC43, DOI 10.1159/000101483; Kabyemela ER, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-26; Leke RFG, 1999, J CLIN MICROBIOL, V37, P2992, DOI 10.1128/JCM.37.9.2992-2996.1999; Levine RJ, 2006, AM J OBSTET GYNECOL, V194, P1034, DOI 10.1016/j.ajog.2005.10.192; Linnemann K, 2000, J CLIN ENDOCR METAB, V85, P4298, DOI 10.1210/jc.85.11.4298; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Mockenhaupt FP, 2000, TROP MED INT HEALTH, V5, P167, DOI 10.1046/j.1365-3156.2000.00532.x; Mockenhaupt FP, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-119; Morrow DA, 2003, CIRCULATION, V108, P250, DOI 10.1161/01.CIR.0000078080.37974.D2; Muehlenbachs A, 2008, P NATL ACAD SCI USA, V105, P14488, DOI 10.1073/pnas.0803657105; Muehlenbachs A, 2006, PLOS MED, V3, P2124, DOI 10.1371/journal.pmed.0030446; Pighetti M, 2003, OBSTET GYNECOL, V102, P535, DOI 10.1016/S0029-7844(03)00668-9; Rogerson SJ, 2003, AM J TROP MED HYG, V68, P115, DOI 10.4269/ajtmh.2003.68.1.0680115; Silver KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009481; Smith LA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-18; Tagbor H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014425; Thevenon AD, 2010, J IMMUNOL, V185, P7115, DOI 10.4049/jimmunol.1002293; van de Laar R, 2009, EUR J OBSTET GYN R B, V147, P124, DOI 10.1016/j.ejogrb.2009.09.017; Yildiz L, 2002, CLIN CHEM LAB MED, V40, P1114, DOI 10.1515/CCLM.2002.195	28	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28540	10.1371/journal.pone.0028540	http://dx.doi.org/10.1371/journal.pone.0028540			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174834	Green Published, gold			2022-12-25	WOS:000298366600023
J	Gomez, F; Stoop, R				Gomez, Florian; Stoop, Ruedi			Quantitative Assessment of the Log-Log-Step Method for Pattern Detection in Noise-Prone Environments	PLOS ONE			English	Article							CORRELATION DIMENSION	Staircase-like structures in the log-log correlation plot of a time series indicate patterns against a noisy background, even under condition of strong jitter. We analyze the method for different jitter-noise-combinations, using quantitative criteria to measure the achievement by the method. A phase diagram shows the remarkable potential of this method even under very unfavorable conditions of noise and jitter. Moreover, we provide a novel and compact analytical derivation of the upper and lower bounds on the number of steps observable in the ideal noiseless case, as a function of pattern length and embedding dimension. The quantitative measure developed combined with the ideal bounds can serve as guiding lines for determining potential periodicity in noisy data.	[Gomez, Florian] ETH, Inst Neuroinformat, Zurich, Switzerland; Univ Zurich, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Gomez, F (corresponding author), ETH, Inst Neuroinformat, Zurich, Switzerland.	ruedi@ini.phys.ethz.ch						ABELES M, 1988, J NEUROPHYSIOL, V60, P909, DOI 10.1152/jn.1988.60.3.909; Castro R, 1997, PHYS REV E, V55, P287, DOI 10.1103/PhysRevE.55.287; Christen M, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.011901; DAYHOFF JE, 1983, J NEUROPHYSIOL, V49, P1334, DOI 10.1152/jn.1983.49.6.1334; DING MZ, 1993, PHYS REV LETT, V70, P3872, DOI 10.1103/PhysRevLett.70.3872; ECKMANN JP, 1985, REV MOD PHYS, V57, P617, DOI 10.1103/RevModPhys.57.617; GRASSBERGER P, 1983, PHYSICA D, V9, P189, DOI 10.1016/0167-2789(83)90298-1; Kantz H., 2003, NONLINEAR TIME SERIE; Kern A, 1999, Z NATURFORSCH A, V54, P404, DOI 10.1515/zna-1999-6-710; Lestienne R, 1998, NEUROSCIENCE, V82, P315; LESTIENNE R, 1987, BRAIN RES, V437, P214, DOI 10.1016/0006-8993(87)91638-6; Pecora LM, 2009, UNDERST COMPLEX SYST, P3, DOI 10.1007/978-1-4020-9143-8_1; PEINKE J, 1992, ENCOUNTER CHAOS; Prut Y, 1998, J NEUROPHYSIOL, V79, P2857, DOI 10.1152/jn.1998.79.6.2857; Rieke F., 1999, SPIKES EXPLORING NEU; SAUER T, 1994, PHYS REV LETT, V72, P3811, DOI 10.1103/PhysRevLett.72.3811; Stoop R, 2000, BIOL CYBERN, V83, P481, DOI 10.1007/PL00007975; Stoop R, 2002, COGNITIVE BRAIN RES, V13, P293, DOI 10.1016/S0926-6410(01)00123-9; STOOP R, 2003, J ELECT ELECT ENG IS, V3, P693; Stoop R, 2010, UNDERST COMPLEX SYST, P271, DOI 10.1007/978-3-642-04629-2_12	20	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28107	10.1371/journal.pone.0028107	http://dx.doi.org/10.1371/journal.pone.0028107			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174769	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000298366600008
J	De Lucia, M; Constantinescu, I; Sterpenich, V; Pourtois, G; Seeck, M; Schwartz, S				De Lucia, Marzia; Constantinescu, Irina; Sterpenich, Virginie; Pourtois, Gilles; Seeck, Margitta; Schwartz, Sophie			Decoding Sequence Learning from Single-Trial Intracranial EEG in Humans	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACES; HIDDEN MARKOV-MODELS; PREFRONTAL CORTEX; MICROSTATE DURATION; MEMORY; HIPPOCAMPUS; CLASSIFICATION; SLEEP; IMPLICIT; REPLAY	We propose and validate a multivariate classification algorithm for characterizing changes in human intracranial electroencephalographic data (iEEG) after learning motor sequences. The algorithm is based on a Hidden Markov Model (HMM) that captures spatio-temporal properties of the iEEG at the level of single trials. Continuous intracranial iEEG was acquired during two sessions (one before and one after a night of sleep) in two patients with depth electrodes implanted in several brain areas. They performed a visuomotor sequence (serial reaction time task, SRTT) using the fingers of their non-dominant hand. Our results show that the decoding algorithm correctly classified single iEEG trials from the trained sequence as belonging to either the initial training phase (day 1, before sleep) or a later consolidated phase (day 2, after sleep), whereas it failed to do so for trials belonging to a control condition (pseudo-random sequence). Accurate single-trial classification was achieved by taking advantage of the distributed pattern of neural activity. However, across all the contacts the hippocampus contributed most significantly to the classification accuracy for both patients, and one fronto-striatal contact for one patient. Together, these human intracranial findings demonstrate that a multivariate decoding approach can detect learning-related changes at the level of single-trial iEEG. Because it allows an unbiased identification of brain sites contributing to a behavioral effect (or experimental condition) at the level of single subject, this approach could be usefully applied to assess the neural correlates of other complex cognitive functions in patients implanted with multiple electrodes.	[De Lucia, Marzia] Vaudois Univ Hosp Ctr, Dept Radiol, Lausanne, Switzerland; [De Lucia, Marzia] Univ Lausanne, Lausanne, Switzerland; [Constantinescu, Irina; Sterpenich, Virginie; Schwartz, Sophie] Univ Geneva, Dept Neurosci, Geneva, Switzerland; [Constantinescu, Irina; Sterpenich, Virginie; Schwartz, Sophie] Univ Geneva, Geneva Neurosci Ctr, Geneva, Switzerland; [Pourtois, Gilles] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium; [Seeck, Margitta] Univ Hosp Geneva, Dept Clin Neurol, Geneva, Switzerland; [Schwartz, Sophie] Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland; [De Lucia, Marzia] Ctr Biomed Imaging, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Geneva; University of Geneva; Ghent University; University of Geneva; University of Geneva	De Lucia, M (corresponding author), Vaudois Univ Hosp Ctr, Dept Radiol, Lausanne, Switzerland.	marzia.de-lucia@chuv.ch	De Lucia, Marzia/O-6523-2015	De Lucia, Marzia/0000-0001-8792-7885; Schwartz, Sophie/0000-0001-7718-4053; Sterpenich, Virginie/0000-0002-2125-833X; Pourtois, Gilles/0000-0002-5109-2801	Swiss National Science Foundation [K-33K1_122518/1, 310000-114008]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Grants from the Swiss National Science Foundation (K-33K1_122518/1 to M.D.L. and 310000-114008 to SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agster KL, 2002, J NEUROSCI, V22, P5760; Albouy G, 2006, BRAIN RES, V1090, P163, DOI 10.1016/j.brainres.2006.03.076; Andres FG, 1999, J CLIN NEUROPHYSIOL, V16, P520, DOI 10.1097/00004691-199911000-00004; Axmacher N, 2010, P NATL ACAD SCI USA, V107, P3228, DOI 10.1073/pnas.0911531107; BAUM LE, 1970, ANN MATH STAT, V41, P164, DOI 10.1214/aoms/1177697196; Birbaumer N, 2006, CLIN NEUROPHYSIOL, V117, P479, DOI 10.1016/j.clinph.2005.11.002; Bishop C. M., 1995, NEURAL NETWORKS PATT; Blankertz B, 2011, NEUROIMAGE, V56, P814, DOI 10.1016/j.neuroimage.2010.06.048; Britz J, 2010, NEUROIMAGE, V52, P1162, DOI 10.1016/j.neuroimage.2010.02.052; CINCOTTI F, 2003, P 1 INT IEEE EMBS C; Clemens Z, 2007, BRAIN, V130, P2868, DOI 10.1093/brain/awm146; Dastjerdi M, 2011, P NATL ACAD SCI USA, V108, P3023, DOI 10.1073/pnas.1017098108; De Lucia M, 2010, J NEUROSCI, V30, P11210, DOI 10.1523/JNEUROSCI.2239-10.2010; Degonda N, 2005, NEURON, V46, P505, DOI 10.1016/j.neuron.2005.02.030; DELUCIA M, 2007, INT J BIOELECTROMAGN, P168; DELUCIA M, 2007, P IEEE EMBS REG 8 IN, P95; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Destrebecqz A, 2005, LEARN MEMORY, V12, P480, DOI 10.1101/lm.95605; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Ergorul C, 2004, LEARN MEMORY, V11, P397, DOI 10.1101/lm.73304; Ethofer T, 2009, CURR BIOL, V19, P1028, DOI 10.1016/j.cub.2009.04.054; Euston DR, 2007, SCIENCE, V318, P1147, DOI 10.1126/science.1148979; Formisano E, 2008, SCIENCE, V322, P970, DOI 10.1126/science.1164318; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Galan F, 2008, CLIN NEUROPHYSIOL, V119, P2159, DOI 10.1016/j.clinph.2008.06.001; HALSBAND U, 1994, NEUROSCI RES, V20, P149, DOI 10.1016/0168-0102(94)90032-9; Haynes JD, 2011, NEUROIMAGE, V56, P385, DOI 10.1016/j.neuroimage.2011.03.057; Iber C., 2007, AASM MANUAL SCORING; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Kali S, 2004, NAT NEUROSCI, V7, P286, DOI 10.1038/nn1202; KINDLER J, 2010, CLIN NEUROPHYSIOL; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Lefevre J, 2009, HUM BRAIN MAPP, V30, P1887, DOI 10.1002/hbm.20781; Lehmann D, 2005, PSYCHIAT RES-NEUROIM, V138, P141, DOI 10.1016/j.pscychresns.2004.05.007; Lehmann D., 1987, HDB ELECTROENCEPHALO, V1, P309; Lemm S, 2011, NEUROIMAGE, V56, P387, DOI 10.1016/j.neuroimage.2010.11.004; Lotte F, 2007, J NEURAL ENG, V4, pR1, DOI 10.1088/1741-2560/4/2/R01; Maquet P, 2000, NAT NEUROSCI, V3, P831, DOI 10.1038/77744; Maquet P, 2003, J NEUROSCI, V23, P1432, DOI 10.1523/JNEUROSCI.23-04-01432.2003; Michel CM, 2001, BRAIN RES REV, V36, P108, DOI 10.1016/S0165-0173(01)00086-8; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Moscovitch M, 2006, CURR OPIN NEUROBIOL, V16, P179, DOI 10.1016/j.conb.2006.03.013; Murray MM, 2009, BRAIN SIGNAL ANALYSIS: ADVANCES IN NEUROELECTRIC AND NEUROMAGNETIC METHODS, P21; Murray MM, 2006, J NEUROSCI, V26, P1293, DOI 10.1523/JNEUROSCI.4511-05.2006; Nadel L, 2000, HIPPOCAMPUS, V10, P352, DOI 10.1002/1098-1063(2000)10:4<352::AID-HIPO2>3.3.CO;2-4; Nahum L, 2011, HIPPOCAMPUS, V21, P689, DOI 10.1002/hipo.20819; Nestor A, 2011, P NATL ACAD SCI USA, V108, P9998, DOI 10.1073/pnas.1102433108; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; O'Toole AJ, 2007, J COGNITIVE NEUROSCI, V19, P1735, DOI 10.1162/jocn.2007.19.11.1735; Obermaier B, 2001, PATTERN RECOGN LETT, V22, P1299, DOI 10.1016/S0167-8655(01)00075-7; Obermaier B, 2001, IEEE T NEUR SYS REH, V9, P283, DOI 10.1109/7333.948456; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Peyrache A, 2009, NAT NEUROSCI, V12, P919, DOI 10.1038/nn.2337; Pourtois G, 2010, J COGNITIVE NEUROSCI, V22, P2086, DOI 10.1162/jocn.2009.21404; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Rasch B, 2007, CURR OPIN NEUROBIOL, V17, P698, DOI 10.1016/j.conb.2007.11.007; Ratcliff R, 2009, P NATL ACAD SCI USA, V106, P6539, DOI 10.1073/pnas.0812589106; Rieger JW, 2008, NEUROIMAGE, V42, P1056, DOI 10.1016/j.neuroimage.2008.06.014; Robertson EM, 2001, CEREB CORTEX, V11, P628, DOI 10.1093/cercor/11.7.628; Ryan L, 2010, HIPPOCAMPUS, V20, P11, DOI 10.1002/hipo.20607; Shima K, 2007, NATURE, V445, P315, DOI 10.1038/nature05470; Simanova I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014465; Staeren N, 2009, CURR BIOL, V19, P498, DOI 10.1016/j.cub.2009.01.066; Strik WK, 1997, PSYCHIAT RES-NEUROIM, V75, P183, DOI 10.1016/S0925-4927(97)00054-1; SWETS JA, 1979, SCIENCE, V205, P753, DOI 10.1126/science.462188; Tzovara A, 2012, PATTERN RECOGN, V45, P2109, DOI 10.1016/j.patcog.2011.04.007; Van de Ville D, 2010, P NATL ACAD SCI USA, V107, P18179, DOI 10.1073/pnas.1007841107; VANDEVILLE D, 2011, PATTERN RECOGN, DOI DOI 10.1016/J.PAT-COG.2011.06.001; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Wallenstein GV, 1998, TRENDS NEUROSCI, V21, P317, DOI 10.1016/S0166-2236(97)01220-4; Wolpaw JR, 2007, J PHYSIOL-LONDON, V579, P613, DOI 10.1113/jphysiol.2006.125948; Yamashita O, 2008, NEUROIMAGE, V42, P1414, DOI 10.1016/j.neuroimage.2008.05.050	75	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28630	10.1371/journal.pone.0028630	http://dx.doi.org/10.1371/journal.pone.0028630			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174850	Green Published, Green Submitted, gold			2022-12-25	WOS:000298365700053
J	Goatman, K; Charnley, A; Webster, L; Nussey, S				Goatman, Keith; Charnley, Amanda; Webster, Laura; Nussey, Stephen			Assessment of Automated Disease Detection in Diabetic Retinopathy Screening Using Two-Field Photography	PLOS ONE			English	Article							VISUAL-LOSS; OPHTHALMOSCOPY	Aim: To assess the performance of automated disease detection in diabetic retinopathy screening using two field mydriatic photography. Methods Images from 8,271 sequential patient screening episodes from a South London diabetic retinopathy screening service were processed by the Medalytix iGrading (TM) automated grading system. For each screening episode macular-centred and disc-centred images of both eyes were acquired and independently graded according to the English national grading scheme. Where discrepancies were found between the automated result and original manual grade, internal and external arbitration was used to determine the final study grades. Two versions of the software were used: one that detected microaneurysms alone, and one that detected blot haemorrhages and exudates in addition to microaneurysms. Results for each version were calculated once using both fields and once using the macula-centred field alone. Results: Of the 8,271 episodes, 346 (4.2%) were considered unassessable. Referable disease was detected in 587 episodes (7.1%). The sensitivity of the automated system for detecting unassessable images ranged from 97.4% to 99.1% depending on configuration. The sensitivity of the automated system for referable episodes ranged from 98.3% to 99.3%. All the episodes that included proliferative or pre-proliferative retinopathy were detected by the automated system regardless of configuration (192/192, 95% confidence interval 98.0% to 100%). If implemented as the first step in grading, the automated system would have reduced the manual grading effort by between 2,183 and 3,147 patient episodes (26.4% to 38.1%). Conclusion: Automated grading can safely reduce the workload of manual grading using two field, mydriatic photography in a routine screening service.	[Goatman, Keith] Univ Aberdeen, Sch Med & Dent, Aberdeen, Scotland; [Charnley, Amanda; Webster, Laura; Nussey, Stephen] St George Hosp, London, England	University of Aberdeen; St Georges University London	Goatman, K (corresponding author), Univ Aberdeen, Sch Med & Dent, Aberdeen, Scotland.	Stephen.Nussey@stgeorges.nhs.uk			NIHR [HTA 06/402/49]	NIHR(National Institute for Health Research (NIHR))	KAG was supported by NIHR grant HTA 06/402/49 and the remaining authors were personally salaried by their institutions during the period of writing (though no specific salary was set aside or given for the writing of this paper). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham P, 2006, OPHTHALMOLOGY, V113, P2221, DOI 10.1016/j.ophtha.2006.07.032; Arun CS, 2009, DIABETIC MED, V26, P489, DOI 10.1111/j.1464-5491.2009.02718.x; Fleming AD, 2010, BRIT J OPHTHALMOL, P1; Fleming AD, 2010, BRIT J OPHTHALMOL, V94, P706, DOI 10.1136/bjo.2008.149807; Gardner TW, 2009, ACTA OPHTHALMOL, V87, P709, DOI 10.1111/j.1755-3768.2009.01545.x; Goatman KA, DIABETIC ME IN PRESS; HARDING SP, 1995, BMJ-BRIT MED J, V311, P1131, DOI 10.1136/bmj.311.7013.1131; Olson JA, 2003, DIABETIC MED, V20, P528, DOI 10.1046/j.1464-5491.2003.00969.x; Philip S, 2007, BRIT J OPHTHALMOL, V91, P1512, DOI 10.1136/bjo.2007.119453; Ruamviboonsuk P, 2006, OPHTHALMOLOGY, V113, P826, DOI 10.1016/j.ophtha.2005.11.021; Sanchez CI, 2011, INVEST OPHTH VIS SCI, V52, P4866, DOI 10.1167/iovs.10-6633; Scanlon PH, 2003, DIABETIC MED, V20, P467, DOI 10.1046/j.1464-5491.2003.00954.x; Stellingwerf C, 2004, DOC OPHTHALMOL, V108, P203, DOI 10.1007/s10633-004-5733-2; UK National Screening Committee, 2009, ESS EL DEV DIAB RET; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	15	37	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e27524	10.1371/journal.pone.0027524	http://dx.doi.org/10.1371/journal.pone.0027524			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174741	Green Submitted, Green Published, gold			2022-12-25	WOS:000298163600003
J	Konopova, B; Smykal, V; Jindra, M				Konopova, Barbora; Smykal, Vlastimil; Jindra, Marek			Common and Distinct Roles of Juvenile Hormone Signaling Genes in Metamorphosis of Holometabolous and Hemimetabolous Insects	PLOS ONE			English	Article							BEETLE TRIBOLIUM-CASTANEUM; RED FLOUR BEETLE; RHODNIUS-PROLIXUS HEMIPTERA; LARVAL-PUPAL METAMORPHOSIS; BHLH-PAS FAMILY; DROSOPHILA-MELANOGASTER; METHOPRENE-TOLERANT; BROAD-COMPLEX; ADULT STRUCTURES; KRUPPEL-HOMOLOG-1	Insect larvae metamorphose to winged and reproductive adults either directly (hemimetaboly) or through an intermediary pupal stage (holometaboly). In either case juvenile hormone (JH) prevents metamorphosis until a larva has attained an appropriate phase of development. In holometabolous insects, JH acts through its putative receptor Methoprene-tolerant (Met) to regulate Kruppel-homolog 1 (Kr-h1) and Broad-Complex (BR-C) genes. While Met and Kr-h1 prevent precocious metamorphosis in pre-final larval instars, BR-C specifies the pupal stage. How JH signaling operates in hemimetabolous insects is poorly understood. Here, we compare the function of Met, Kr-h1 and BR-C genes in the two types of insects. Using systemic RNAi in the hemimetabolous true bug, Pyrrhocoris apterus, we show that Met conveys the JH signal to prevent premature metamorphosis by maintaining high expression of Kr-h1. Knockdown of either Met or Kr-h1 (but not of BR-C) in penultimate-instar Pyrrhocoris larvae causes precocious development of adult color pattern, wings and genitalia. A natural fall of Kr-h1 expression in the last larval instar normally permits adult development, and treatment with an exogenous JH mimic methoprene at this time requires both Met and Kr-h1 to block the adult program and induce an extra larval instar. Met and Kr-h1 therefore serve as JH-dependent repressors of deleterious precocious metamorphic changes in both hemimetabolous and holometabolous juveniles, whereas BR-C has been recruited for a new role in specifying the holometabolous pupa. These results show that despite considerable evolutionary distance, insects with diverse developmental strategies employ a common-core JH signaling pathway to commit to adult morphogenesis.	[Konopova, Barbora; Jindra, Marek] Acad Sci Czech Republic, Ctr Biol, Ceske Budejovice, Czech Republic; [Smykal, Vlastimil] Univ S Bohemia, Dept Mol Biol, Ceske Budejovice, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Konopova, B (corresponding author), Acad Sci Czech Republic, Ctr Biol, Ceske Budejovice, Czech Republic.	jindra@entu.cas.cz	Jindra, Marek/H-2082-2014; Konopova, Barbora/AAI-9163-2020; Smýkal, Vlastimil/Q-7706-2018	Jindra, Marek/0000-0002-2196-9924; Konopova, Barbora/0000-0002-8456-9530; Smýkal, Vlastimil/0000-0002-7383-5506	Academy of Sciences [500960906]; Ministry of Education of the Czech Republic [6007665801]; Czech Science Foundation [204/07/1032, 204/09/H058]	Academy of Sciences(Egyptian Academy of Scientific Research & Technology (ASRT)); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic)	This work was supported by grants 500960906 from the Academy of Sciences and 6007665801 from the Ministry of Education of the Czech Republic, and by projects 204/07/1032 and 204/09/H058 from the Czech Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashok M, 1998, P NATL ACAD SCI USA, V95, P2761, DOI 10.1073/pnas.95.6.2761; Belles X, 2011, ORIGIN EVOLUTION INS, DOI [10.1002/9780470015902.a0022854, DOI 10.1002/9780470015902.A0022854, 10.1002/9780470015902]; Dolezel D, 2008, CELL MOL LIFE SCI, V65, P964, DOI 10.1007/s00018-008-7506-7; Erezyilmaz DF, 2009, DEV GENES EVOL, V219, P535, DOI 10.1007/s00427-009-0315-7; Erezyilmaz DF, 2006, P NATL ACAD SCI USA, V103, P6925, DOI 10.1073/pnas.0509983103; FUKUDA SOICHI, 1944, JOUR FAC SCI IMP UNIV TOKYO SECT IV, V6, P477; Gilbert LI, 2000, INSECT BIOCHEM MOLEC, V30, P617, DOI 10.1016/S0965-1748(00)00034-5; Hinton H, 1963, P R ENTOMOL SOC LOND, V38, P77; KISS I, 1988, GENETICS, V118, P247; Konopova B, 2008, DEVELOPMENT, V135, P559, DOI 10.1242/dev.016097; Konopova B, 2007, P NATL ACAD SCI USA, V104, P10488, DOI 10.1073/pnas.0703719104; Kristensen NP, 1999, EUR J ENTOMOL, V96, P237; Minakuchi C, 2009, DEV BIOL, V325, P341, DOI 10.1016/j.ydbio.2008.10.016; Minakuchi C, 2008, FEBS J, V275, P2919, DOI 10.1111/j.1742-4658.2008.06428.x; Minakuchi C, 2008, MECH DEVELOP, V125, P91, DOI 10.1016/j.mod.2007.10.002; Nijhout H.F., 1994, INSECT HORMONES; NIJHOUT HF, 1983, J INSECT PHYSIOL, V29, P669, DOI 10.1016/0022-1910(83)90041-0; Novak V, 1966, INSECT HORMONES; Parthasarathy R, 2008, MECH DEVELOP, V125, P601, DOI 10.1016/j.mod.2008.03.004; Parthasarathy R, 2008, MECH DEVELOP, V125, P299, DOI 10.1016/j.mod.2007.11.001; Piulachs MD, 2010, INSECT BIOCHEM MOLEC, V40, P468, DOI 10.1016/j.ibmb.2010.04.006; RIDDIFORD LM, 1994, ADV INSECT PHYSIOL, V24, P213, DOI 10.1016/S0065-2806(08)60084-3; Sehnal Frantisek, 1996, P3, DOI 10.1016/B978-012283245-1/50003-8; SLAMA K, 1965, P NATL ACAD SCI USA, V54, P411, DOI 10.1073/pnas.54.2.411; SLAMA K., 1965, J INSECT PHYSIOL, V11, P113, DOI 10.1016/0022-1910(65)90098-3; Suzuki Y, 2008, DEVELOPMENT, V135, P569, DOI 10.1242/dev.015263; Truman JW, 1999, NATURE, V401, P447, DOI 10.1038/46737; Truman JW, 2002, ANNU REV ENTOMOL, V47, P467, DOI 10.1146/annurev.ento.47.091201.145230; Uhlirova M, 2003, P NATL ACAD SCI USA, V100, P15607, DOI 10.1073/pnas.2136837100; Wigglesworth V.B.S., 1954, PHYSL INSECT METAMOR; Wigglesworth VB, 1936, Q J MICROSC SCI, V79, P91; Wigglesworth VB, 1934, Q J MICROSC SCI, V77, P191; Williams C, 1961, BIOL BULL, V116, P323; WILLIS JH, 1982, J EMBRYOL EXP MORPH, V71, P25; WILSON TG, 1986, DEV BIOL, V118, P190, DOI 10.1016/0012-1606(86)90087-4; Zhou XF, 2002, DEVELOPMENT, V129, P2259	36	168	176	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28728	10.1371/journal.pone.0028728	http://dx.doi.org/10.1371/journal.pone.0028728			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174880	Green Published, gold, Green Submitted			2022-12-25	WOS:000298163600040
J	Zhang, ZC; Wlodarczyk, BJ; Niederreither, K; Venugopalan, S; Florez, S; Finnell, RH; Amendt, BA				Zhang, Zichao; Wlodarczyk, Bogdan J.; Niederreither, Karen; Venugopalan, Shankar; Florez, Sergio; Finnell, Richard H.; Amendt, Brad A.			Fuz Regulates Craniofacial Development through Tissue Specific Responses to Signaling Factors	PLOS ONE			English	Article							PLANAR CELL POLARITY; PRIMARY CILIA FORMATION; AUTOSOMAL SEX REVERSAL; CRANIAL NEURAL CREST; SONIC-HEDGEHOG; MECKELS CARTILAGE; CONVERGENT EXTENSION; CAMPOMELIC DYSPLASIA; NEGATIVE REGULATOR; GENE	The planar cell polarity effector gene Fuz regulates ciliogenesis and Fuz loss of function studies reveal an array of embryonic phenotypes. However, cilia defects can affect many signaling pathways and, in humans, cilia defects underlie several craniofacial anomalies. To address this, we analyzed the craniofacial phenotype and signaling responses of the Fuz(-/-) mice. We demonstrate a unique role for Fuz in regulating both Hedgehog (Hh) and Wnt/beta-catenin signaling during craniofacial development. Fuz expression first appears in the dorsal tissues and later in ventral tissues and craniofacial regions during embryonic development coincident with cilia development. The Fuz(-/-) mice exhibit severe craniofacial deformities including anophthalmia, agenesis of the tongue and incisors, a hypoplastic mandible, cleft palate, ossification/skeletal defects and hyperplastic malformed Meckel's cartilage. Hh signaling is down-regulated in the Fuz null mice, while canonical Wnt signaling is up-regulated revealing the antagonistic relationship of these two pathways. Meckel's cartilage is expanded in the Fuz(-/-) mice due to increased cell proliferation associated with the up-regulation of Wnt canonical target genes and decreased non-canonical pathway genes. Interestingly, cilia development was decreased in the mandible mesenchyme of Fuz null mice, suggesting that cilia may antagonize Wnt signaling in this tissue. Furthermore, expression of Fuz decreased expression of Wnt pathway genes as well as a Wnt-dependent reporter. Finally, chromatin IP experiments demonstrate that beta-catenin/TCF-binding directly regulates Fuz expression. These data demonstrate a new model for coordination of Hh and Wnt signaling and reveal a Fuz-dependent negative feedback loop controlling Wnt/beta-catenin signaling.	[Zhang, Zichao; Venugopalan, Shankar; Florez, Sergio; Amendt, Brad A.] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA; [Wlodarczyk, Bogdan J.; Niederreither, Karen; Finnell, Richard H.] Univ Texas Austin, Dell Pediat Res Inst, Austin, TX 78712 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Austin	Amendt, BA (corresponding author), Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA.	bamendt@ibt.tamhsc.edu	Rengasamy Venugopalan, Shankar/GPX-7671-2022; Zuo, Xi-Nian/A-7273-2009; Finnell, Richard/D-8174-2018	Wlodarczyk, Bogdan J./0000-0001-5249-5832; Amendt, Brad A./0000-0001-6524-1006; Zuo, Xi-Nian/0000-0001-9110-585X; Finnell, Richard/0000-0002-5962-8754	National Institutes of Health [DE016315, DE13941, DE18885]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013941, R01DE018885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016315] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the National Institutes of Health grants DE016315 to RHF, DE13941 and DE18885 to BAA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PN, 2001, CURR OPIN CELL BIOL, V13, P635, DOI 10.1016/S0955-0674(00)00263-5; Amen M, 2008, NUCLEIC ACIDS RES, V36, P462, DOI 10.1093/nar/gkm1047; Amendt BA, 1999, MOL CELL BIOL, V19, P7001; Aoto K, 2009, DEV BIOL, V327, P106, DOI 10.1016/j.ydbio.2008.11.022; Baek SH, 2003, P NATL ACAD SCI USA, V100, P3245, DOI 10.1073/pnas.0330217100; Baker K, 2009, AM J MED GENET C, V151C, P281, DOI 10.1002/ajmg.c.30231; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Bi WM, 2001, P NATL ACAD SCI USA, V98, P6698, DOI 10.1073/pnas.111092198; Bisgrove BW, 2006, DEVELOPMENT, V133, P4131, DOI 10.1242/dev.02595; Brugmann SA, 2010, AM J MED GENET A, V152A, P2995, DOI 10.1002/ajmg.a.33727; Brugmann SA, 2010, HUM MOL GENET, V19, P1577, DOI 10.1093/hmg/ddq030; Carda C, 2005, TISSUE CELL, V37, P247, DOI 10.1016/j.tice.2005.03.002; Cardenas-Rodriguez M, 2009, AM J MED GENET C, V151C, P263, DOI 10.1002/ajmg.c.30227; Chai Y, 2000, DEVELOPMENT, V127, P1671; Chai Y, 1998, INT J DEV BIOL, V42, P87; Chai Y, 2006, DEV DYNAM, V235, P2353, DOI 10.1002/dvdy.20833; CHEN LS, 1992, ARCH ORAL BIOL, V37, P771, DOI 10.1016/0003-9969(92)90110-T; Cobourne MT, 2001, J DENT RES, V80, P1974, DOI 10.1177/00220345010800110501; Coene KLM, 2009, AM J HUM GENET, V85, P465, DOI 10.1016/j.ajhg.2009.09.002; Collier S, 1997, DEVELOPMENT, V124, P4029; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Dabdoub A, 2003, DEVELOPMENT, V130, P2375, DOI 10.1242/dev.00448; Dai D, 2010, J INVEST DERMATOL, V130, pS103; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Ferrante MI, 2006, NAT GENET, V38, P112, DOI 10.1038/ng1684; Ferrante MI, 2003, GENOMICS, V81, P560, DOI 10.1016/S0888-7543(03)00091-0; Ferrante MI, 2001, AM J HUM GENET, V68, P569, DOI 10.1086/318802; Finetti F, 2009, NAT CELL BIOL, V11, P1332, DOI 10.1038/ncb1977; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; FRANCO B, 2008, INBORN ERRORS DEV, P1379; FROMMER J, 1971, J DENT RES, V50, P1260, DOI 10.1177/00220345710500052801; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Giorgio G, 2007, MOL BIOL CELL, V18, P4397, DOI 10.1091/mbc.E07-03-0198; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Gray RS, 2009, NAT CELL BIOL, V11, P1225, DOI 10.1038/ncb1966; HALL BK, 1980, J EMBRYOL EXP MORPH, V56, P71; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Haycraft CJ, 2008, CURR TOP DEV BIOL, V85, P303, DOI 10.1016/S0070-2153(08)00811-9; Heydeck W, 2009, DEV DYNAM, V238, P3035, DOI 10.1002/dvdy.22130; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Iwatsuki K, 2007, P NATL ACAD SCI USA, V104, P2253, DOI 10.1073/pnas.0607399104; Jenny A, 2005, NAT CELL BIOL, V7, P691, DOI 10.1038/ncb1271; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; Kolpakova-Hart E, 2007, DEV BIOL, V309, P273, DOI 10.1016/j.ydbio.2007.07.018; Lee H, 2002, GENETICS, V160, P1535; Lee J, 1997, DEVELOPMENT, V124, P2537; Lee YH, 2011, GENESIS, V49, P200, DOI 10.1002/dvg.20717; Lefebvre V, 1998, MATRIX BIOL, V16, P529; Lefebvre Veronique, 2005, Birth Defects Research, V75, P200, DOI 10.1002/bdrc.20048; Lopes SS, 2010, DEVELOPMENT, V137, P3625, DOI 10.1242/dev.054452; Lou Y, 2009, HUM MOL GENET, V18, P556, DOI 10.1093/hmg/ddn383; Macca M, 2009, AM J MED GENET C, V151C, P318, DOI 10.1002/ajmg.c.30224; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; McDermott KM, 2010, CURR BIOL, V20, P731, DOI 10.1016/j.cub.2010.02.048; Melnick M, 2005, CELLS TISSUES ORGANS, V179, P146, DOI 10.1159/000085950; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Minoux M, 2010, DEVELOPMENT, V137, P2605, DOI 10.1242/dev.040048; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Mori-Akiyama Y, 2003, P NATL ACAD SCI USA, V100, P9360, DOI 10.1073/pnas.1631288100; Morleo M, 2008, J MED GENET, V45, P401, DOI 10.1136/jmg.2008.058305; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Ohazama A, 2009, DEVELOPMENT, V136, P897, DOI 10.1242/dev.027979; Oishi I, 2006, NAT GENET, V38, P1316, DOI 10.1038/ng1892; Oka K, 2007, DEV BIOL, V303, P391, DOI 10.1016/j.ydbio.2006.11.025; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; Qian D, 2007, DEV BIOL, V306, P121, DOI 10.1016/j.ydbio.2007.03.011; Ramaesh T, 2003, J ANAT, V203, P213, DOI 10.1046/j.1469-7580.2003.00210.x; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Saegusa M, 2005, LAB INVEST, V85, P768, DOI 10.1038/labinvest.3700273; SAVOSTIN.I, 1973, ANAT RECORD, V176, P345, DOI 10.1002/ar.1091760310; Schneider FT, 2010, AM J PATHOL, V177, P404, DOI 10.2353/ajpath.2010.091079; Strutt D, 2008, CURR BIOL, V18, pR898, DOI 10.1016/j.cub.2008.07.055; Tamakoshi T, 2006, BIOCHEM BIOPH RES CO, V339, P932, DOI 10.1016/j.bbrc.2005.11.097; Tang MZ, 2010, J NEUROSCI, V30, P9280, DOI 10.1523/JNEUROSCI.0860-10.2010; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Wallingford JB, 2002, DEVELOPMENT, V129, P5815, DOI 10.1242/dev.00123; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wallingford JB, 2011, GENE DEV, V25, P201, DOI 10.1101/gad.2008011; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Wang JB, 2005, NAT GENET, V37, P980, DOI 10.1038/ng1622; Weinmann AS, 2002, GENE DEV, V16, P235, DOI 10.1101/gad.943102; Zhang QH, 2003, DEV DYNAM, V227, P78, DOI 10.1002/dvdy.10289; Zhang ZC, 2010, J BIOL CHEM, V285, P34718, DOI 10.1074/jbc.M110.126441; Zhao H, 2008, DEV BIOL, V320, P19, DOI 10.1016/j.ydbio.2008.03.045	95	113	114	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24608	10.1371/journal.pone.0024608	http://dx.doi.org/10.1371/journal.pone.0024608			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	22174905	Green Submitted, Green Published, gold			2022-12-25	WOS:000295039700030
J	Zhao, K; Blacker, K; Luo, YH; Bryant, B; Jiang, JB				Zhao, Kai; Blacker, Kara; Luo, Yuehao; Bryant, Bruce; Jiang, Jianbo			Perceiving Nasal Patency through Mucosal Cooling Rather than Air Temperature or Nasal Resistance	PLOS ONE			English	Article							TOPOGRAPHICAL DIFFERENCES; TRIGEMINAL SENSITIVITY; SUBJECTIVE MEASURES; FLOW	Adequate perception of nasal airflow (i.e., nasal patency) is an important consideration for patients with nasal sinus diseases. The perception of a lack of nasal patency becomes the primary symptom that drives these patients to seek medical treatment. However, clinical assessment of nasal patency remains a challenge because we lack objective measurements that correlate well with what patients perceive. The current study examined factors that may influence perceived patency, including air temperature, humidity, mucosal cooling, nasal resistance, and trigeminal sensitivity. Forty-four healthy subjects rated nasal patency while sampling air from three facial exposure boxes that were ventilated with untreated room air, cold air, and dry air, respectively. In all conditions, air temperature and relative humidity inside each box were recorded with sensors connected to a computer. Nasal resistance and minimum airway cross-sectional area (MCA) were measured using rhinomanometry and acoustic rhinometry, respectively. General trigeminal sensitivity was assessed through lateralization thresholds to butanol. No significant correlation was found between perceived patency and nasal resistance or MCA. In contrast, air temperature, humidity, and butanol threshold combined significantly contributed to the ratings of patency, with mucosal cooling (heat loss) being the most heavily weighted predictor. Air humidity significantly influences perceived patency, suggesting that mucosal cooling rather than air temperature alone provides the trigeminal sensation that results in perception of patency. The dynamic cooling between the airstream and the mucosal wall may be quantified experimentally or computationally and could potentially lead to a new clinical evaluation tool.	[Zhao, Kai; Blacker, Kara; Luo, Yuehao; Bryant, Bruce; Jiang, Jianbo] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA	Monell Chemical Senses Center	Zhao, K (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	kzhao@monell.org	Bianconi, Ginestra/I-5742-2018	Bianconi, Ginestra/0000-0002-3380-887X; Karsai, Marton/0000-0001-5382-8950	 [NIH P50 DC00006760];  [NIH 5R03DC008187]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC008187, P50DC006760] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study is supported in part by a grant to PD (NIH P50 DC00006760) and a grant to KZ (NIH 5R03DC008187). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre RF, 2009, CLIN OTOLARYNGOL, V34, P518, DOI 10.1111/j.1749-4486.2009.02042.x; Cahusac PMB, 2007, NEUROSCIENCE, V148, P489, DOI 10.1016/j.neuroscience.2007.06.018; Clarke JD, 2005, CLIN OTOLARYNGOL, V30, P35, DOI 10.1111/j.1365-2273.2004.00915.x; CLARKE RW, 1994, J LARYNGOL OTOL, V108, P1045, DOI 10.1017/S0022215100128853; CLARKE RW, 1992, CLIN OTOLARYNGOL, V17, P388, DOI 10.1111/j.1365-2273.1992.tb01680.x; Clement P A, 1984, Rhinology, V22, P151; ECCLES R, 1983, J LARYNGOL OTOL, V97, P705, DOI 10.1017/S002221510009486X; Fontanari P, 1996, J APPL PHYSIOL, V81, P1739, DOI 10.1152/jappl.1996.81.4.1739; Inoue T, 2005, PAIN, V117, P193, DOI 10.1016/j.pain.2005.06.012; JONES AS, 1987, CLIN OTOLARYNGOL, V12, P461, DOI 10.1111/j.1365-2273.1987.tb00233.x; Lam DJ, 2006, AM J RHINOL, V20, P463, DOI 10.2500/ajr.2006.20.2940; Lindemann J, 2002, CLIN OTOLARYNGOL, V27, P135, DOI 10.1046/j.1365-2273.2002.00544.x; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Meusel T, 2010, PAIN, V151, P516, DOI 10.1016/j.pain.2010.08.013; Naftali S, 2005, ANN BIOMED ENG, V33, P545, DOI 10.1007/s10439-005-2513-4; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Rouadi P, 1999, J APPL PHYSIOL, V87, P400, DOI 10.1152/jappl.1999.87.1.400; Scheibe M, 2006, NEUROREPORT, V17, P1417, DOI 10.1097/01.wnr.0000224764.61959.e8; Voets T., 2007, V179, P329; Wrobel BB, 2006, AM J RHINOL, V20, P364, DOI 10.2500/ajr.2006.20.2862; Wysocki CJ, 2003, PERCEPT PSYCHOPHYS, V65, P115, DOI 10.3758/BF03194788; Yogeetha R., 2007, SMJ Singapore Medical Journal, V48, P304; Zhao K, 2004, CHEM SENSES, V29, P365, DOI 10.1093/chemse/bjh033	24	86	89	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e24618	10.1371/journal.pone.0024618	http://dx.doi.org/10.1371/journal.pone.0024618			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22194809	Green Submitted, gold, Green Published			2022-12-25	WOS:000295978600005
J	da Silva, JM; dos Santos, A; Cunha, MR; Costa, FO; Creer, S; Carvalho, GR				da Silva, Joana Matzen; dos Santos, Antonina; Cunha, Marina R.; Costa, Filipe O.; Creer, Simon; Carvalho, Gary R.			Multigene Molecular Systematics Confirm Species Status of Morphologically Convergent Pagurus Hermit Crabs	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; MITOCHONDRIAL 16S; DNA-SEQUENCES; DECAPODA; CRUSTACEA; PHYLOGENY; ANOMURA; POPULATIONS; BRACHYURA; EVOLUTION	Introduction: In spite of contemporary morphological taxonomy appraisals, apparent high morphological similarity raises uncertainty about the species status of certain Pagurus hermit crabs. This is exemplified between two European species, Pagurus excavatus (Herbst, 1791) and Pagurus alatus (Fabricius 1775), whose species status is still difficult to resolve using morphological criteria alone. Methodology/Principal Findings: To address such ambiguities, we used combinations of Maximum Likelihood (ML) and Bayesian Inference (BI) methods to delineate species boundaries of P. alatus and P. excavatus and formulate an intermediate Pagurus phylogenetic hypothesis, based upon single and concatenated mitochondrial (cytochrome oxidase I [COI]) and nuclear (16S and 28s ribosomal RNA) gene partitions. The molecular data supported the species status of P. excavatus and P. alatus and also clearly resolved two divergent clades within hermit crabs from the Northeast Atlantic Ocean and the Mediterranean Sea. Conclusions/Significance: Despite the abundance and prominent ecological role of hermit crabs, Pagurus, in North East Atlantic Ocean and Mediterranean Sea ecosystems, many important aspects of their taxonomy, biology, systematics and evolution remain poorly explored. The topologies presented here should be regarded as hypotheses that can be incorporated into the robust and integrated understanding of the systematic relationships within and between species of the genus Pagurus inhabiting the Northeast Atlantic Ocean and the Mediterranean Sea.	[da Silva, Joana Matzen; Creer, Simon; Carvalho, Gary R.] Bangor Univ, Mol Ecol & Fisheries Genet Lab, Sch Biol Sci, Environm Ctr Wales, Bangor, Gwynedd, Wales; [da Silva, Joana Matzen; Cunha, Marina R.] Univ Aveiro, Dept Biol, Ctr Estudos Ambiente & Mar, P-3800 Aveiro, Portugal; [dos Santos, Antonina] L IPIMAR, Inst Nacl Recursos Biol, Lisbon, Portugal; [Costa, Filipe O.] Univ Minho, Dept Biol, Ctr Biol Mol Ambiental CBMA, Braga, Portugal	Bangor University; Universidade de Aveiro; Portuguese Institute of Sea & Fisheries Research (IPIMAR); Universidade do Minho	da Silva, JM (corresponding author), Bangor Univ, Mol Ecol & Fisheries Genet Lab, Sch Biol Sci, Environm Ctr Wales, Bangor, Gwynedd, Wales.	joanamatzen@yahoo.com; g.r.carvalho@bangor.ac.uk	Costa, Filipe/M-9623-2019; Costa, Filipe/B-5890-2009; Costa, Filipe/GSD-2439-2022; Costa, Ana Cristina M R/L-8023-2013; Costa, Ana/HDL-9297-2022; Cunha, Marina R/B-7644-2008; Dos Santos, Antonina/B-9055-2011; Costa, Ana Cristina de Matos Ricardo/H-3775-2019	Costa, Filipe/0000-0001-5398-3942; Costa, Filipe/0000-0001-5398-3942; Costa, Ana Cristina M R/0000-0002-0258-3460; Cunha, Marina R/0000-0001-8833-6980; Dos Santos, Antonina/0000-0002-2238-9315; Costa, Ana Cristina de Matos Ricardo/0000-0002-0258-3460	Fundacao para a Ciencia e Tecnologia (Portugal) [SFRH/BD/25568/2006]; European Centre for Arctic Environmental Research [ARCFAC-026129-2008-21]; LusoMarBol FCT [PTDC/MAR/69892/2006]	Fundacao para a Ciencia e Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); European Centre for Arctic Environmental Research; LusoMarBol FCT	The Fundacao para a Ciencia e Tecnologia (Portugal) provided a doctoral fellowship (SFRH/BD/25568/2006) to Joana Matzen da Silva. This research was partially supported by the European Centre for Arctic Environmental Research ARCFAC-026129-2008-21 and LusoMarBol FCT research grant PTDC/MAR/69892/2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Akaike H., 1973, 2 INT S INF THEOR, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Appel M, 2009, ANIM BEHAV, V78, P1373, DOI 10.1016/j.anbehav.2009.09.008; Avise JC, 1997, P NATL ACAD SCI USA, V94, P7748, DOI 10.1073/pnas.94.15.7748; Brian JV, 2006, J EXP MAR BIOL ECOL, V329, P47, DOI 10.1016/j.jembe.2005.08.002; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; Cruickshank Robert H., 2002, Systematic and Applied Acarology, V7, P3; Cuesta JA, 1998, J NAT HIST, V32, P1499, DOI 10.1080/00222939800771031; CUNNINGHAM CW, 1992, NATURE, V355, P539, DOI 10.1038/355539a0; da Silva JM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028233, 10.1371/journal.pone.0019449]; DACOZ CD, 2001, ARQUIPELAGO A, V18, P61; DACOZ CD, 1999, INVENTAIRE DISTRIBUT; De Grave S, 2009, RAFFLES B ZOOL, P1; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Ellis JR, 2000, ESTUAR COAST SHELF S, V51, P299, DOI 10.1006/ecss.2000.0677; ELWOOD RW, 1985, ANIM BEHAV, V33, P620, DOI 10.1016/S0003-3472(85)80086-5; ELWOOD RW, 1981, ANIM BEHAV, V29, P1239, DOI 10.1016/S0003-3472(81)80075-9; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Groeneveld JC, 2007, MOL PHYLOGENET EVOL, V45, P102, DOI 10.1016/j.ympev.2007.06.002; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Harrison JS, 2004, MOL PHYLOGENET EVOL, V30, P743, DOI 10.1016/S1055-7903(03)00250-1; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hiller A, 2006, MOL PHYLOGENET EVOL, V40, P547, DOI 10.1016/j.ympev.2006.03.030; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/10635150490522629; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; INGLE RW, 1985, J NAT HIST, V19, P745, DOI 10.1080/00222938500770461; JACKSON NW, 1989, ANIM BEHAV, V37, P529, DOI 10.1016/0003-3472(89)90032-8; JACKSON NW, 1989, ANIM BEHAV, V38, P951, DOI 10.1016/S0003-3472(89)80136-8; JAGT JWM, 2003, REV MEXICANA CIENCIA, V23, P364; KELLOGG CW, 1976, J EXP MAR BIOL ECOL, V22, P101, DOI 10.1016/0022-0981(76)90112-X; Kumar S, 1996, GENETICS, V143, P537; LANCASTER I, 1988, Field Studies, V7, P189; Lefebure T, 2006, MOL PHYLOGENET EVOL, V40, P435, DOI 10.1016/j.ympev.2006.03.014; Malay MCD, 2010, EVOLUTION, V64, P634, DOI 10.1111/j.1558-5646.2009.00848.x; Mantelatto FLM, 2006, ZOOSYSTEMA, V28, P495; Mantelatto FL, 2009, ZOOTAXA, P20, DOI 10.11646/zootaxa.2133.1.2; Mathews LM, 2009, MOL PHYLOGENET EVOL, V50, P268, DOI 10.1016/j.ympev.2008.10.026; Mathews LM, 2002, MOL ECOL, V11, P1427, DOI 10.1046/j.1365-294X.2002.01539.x; MCLAUGHLIN PA, 1988, J CRUSTACEAN BIOL, V8, P262, DOI 10.2307/1548319; McLaughlin PA, 1997, CONTRIB ZOOL, V67, P79, DOI 10.1163/18759866-06702001; McLaughlin PA, 2007, J CRUSTACEAN BIOL, V27, P97, DOI 10.1651/S-2675.1; McLaughlin PA, 2010, RAFFLES B ZOOL, P5; McLaughlin Patsy A., 2003, Memoirs of Museum Victoria, V60, P111; NEIL SJ, 1985, J EXP MAR BIOL ECOL, V94, P99, DOI 10.1016/0022-0981(85)90052-8; Palumbi Stephen R., 1991, Molecular Marine Biology and Biotechnology, V1, P27; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; Radulovici AE, 2009, MOL ECOL RESOUR, V9, P181, DOI 10.1111/j.1755-0998.2009.02643.x; Rivera M Jorge, 2006, Rev. biol. mar. oceanogr., V41, P239; Scelzo MA, 2010, ZOOL STUD, V49, P421; Schubart CD, 2000, CRUSTACEAN ISS, V12, P817; SCHUBART CD, 2005, NAUPLIUS, V12, P99; Schubart Christoph D., 2009, Crustacean Issues, V18, P47; Schwentner M, 2009, MOL PHYLOGENET EVOL, V53, P716, DOI 10.1016/j.ympev.2009.07.021; Shih HT, 2007, ZOOL SCI, V24, P57, DOI 10.2108/zsj.24.57; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Spivak ED, 2003, J CRUSTACEAN BIOL, V23, P212, DOI 10.1651/0278-0372(2003)023[0212:SSIQAM]2.0.CO;2; STAMATAKIS A, 2008, RAXML; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TAYLOR PR, 1982, J EXP MAR BIOL ECOL, V57, P229, DOI 10.1016/0022-0981(82)90194-0; TAYLOR PR, 1981, J EXP MAR BIOL ECOL, V52, P205, DOI 10.1016/0022-0981(81)90037-X; von Rintelen K, 2007, MOL PHYLOGENET EVOL, V45, P1033, DOI 10.1016/j.ympev.2007.07.002; Whiting MF, 2002, ZOOL SCR, V31, P93, DOI 10.1046/j.0300-3256.2001.00095.x; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Yang ZH, 2000, GENETICS, V155, P431; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yang ZH, 1999, J MOL EVOL, V48, P274, DOI 10.1007/PL00006470; Young AM, 2002, MAR BIOL, V140, P1059, DOI 10.1007/s00227-002-0780-2; [Заславская Н.И. Zaslavskaya N.I.], 2009, [Зоология беспозвоночных, Invertebrate Zoology, Zoologiya bespozvonochnykh], V6, P147	71	147	151	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28233	10.1371/journal.pone.0028233	http://dx.doi.org/10.1371/journal.pone.0028233			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174780	Green Published, Green Submitted, gold			2022-12-25	WOS:000298365700024
J	Xia, HB; Wang, W; Xia, H; Zhao, W; Lu, BR				Xia, Han-Bing; Wang, Wei; Xia, Hui; Zhao, Wei; Lu, Bao-Rong			Conspecific Crop-Weed Introgression Influences Evolution of Weedy Rice (Oryza sativa f. spontanea) across a Geographical Range	PLOS ONE			English	Article							GENETIC DIVERSITY; RED RICE; OUTBREEDING DEPRESSION; INBREEDING DEPRESSION; POPULATION-GENETICS; CULTIVATED RICE; HYBRIDIZATION; FLOW; TRAITS; EXTENSIONS	Background: Introgression plays an important role in evolution of plant species via its influences on genetic diversity and differentiation. Outcrossing determines the level of introgression but little is known about the relationships of outcrossing rates, genetic diversity, and differentiation particularly in a weedy taxon that coexists with its conspecific crop. Methodology/Principal Findings: Eleven weedy rice (Oryza sativa f. spontanea) populations from China were analyzed using microsatellite (SSR) fingerprints to study outcrossing rate and its relationship with genetic variability and differentiation. To estimate outcrossing, six highly polymorphic SSR loci were used to analyze >5500 progeny from 216 weedy rice families, applying a mixed mating model; to estimate genetic diversity and differentiation, 22 SSR loci were analyzed based on 301 weedy individuals. Additionally, four weed-crop shared SSR loci were used to estimate the influence of introgression from rice cultivars on weedy rice differentiation. Outcrossing rates varied significantly (0.4 similar to 11.7%) among weedy rice populations showing relatively high overall Nei's genetic diversity (0.635). The observed heterozygosity was significantly correlated with outcrossing rates among populations (r(2) = 0.783; P<0.001) although no obvious correlation between outcrossing rates and genetic diversity parameters was observed. Allelic introgression from rice cultivars to their coexisting weedy rice was detected. Weedy rice populations demonstrated considerable genetic differentiation that was correlated with their spatial distribution (r(2) = 0.734; P<0.001), and possibly also influenced by the introgression from rice cultivars. Conclusions/Significance: Outcrossing rates can significantly affect heterozygosity of populations, which may shape the evolutionary potential of weedy rice. Introgression from the conspecific crop rice can influence the genetic differentiation and possibly evolution of its coexisting weedy rice populations.	[Xia, Han-Bing; Wang, Wei; Xia, Hui; Zhao, Wei; Lu, Bao-Rong] Fudan Univ, Dept Ecol & Evolutionary Biol, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Shanghai 200433, Peoples R China	Fudan University	Lu, BR (corresponding author), Fudan Univ, Dept Ecol & Evolutionary Biol, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Shanghai 200433, Peoples R China.	brlu@fudan.edu.cn	Lu, Bao-Rong/C-3130-2009; Xia, Hui/L-7129-2019	Lu, Bao-Rong/0000-0002-0214-2390; Xia, Hui/0000-0003-2446-5171	Nature Science Foundation of China [30730066, 30871503]; Chinese Ministry of Science and Technology [2006CB100205, 2007CB109202]; National Program of Development of Transgenic New Species of China [2008ZX08011-006]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Program of Development of Transgenic New Species of China	This work was supported by the Nature Science Foundation of China (grant numbers 30730066, 30871503), Chinese Ministry of Science and Technology (grant numbers 2006CB100205, 2007CB109202), and the National Program of Development of Transgenic New Species of China (2008ZX08011-006). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghani AH, 2005, CROP SCI, V45, P98, DOI 10.2135/cropsci2005.0098; ANDERSON E, 1954, EVOLUTION, V8, P378, DOI 10.2307/2405784; Andow DA, 2006, ECOL LETT, V9, P196, DOI 10.1111/j.1461-0248.2005.00846.x; Baack EJ, 2007, CURR OPIN GENET DEV, V17, P513, DOI 10.1016/j.gde.2007.09.001; Barton NH, 2001, MOL ECOL, V10, P551, DOI 10.1046/j.1365-294x.2001.01216.x; Burgos NR, 2008, WEED TECHNOL, V22, P200, DOI 10.1614/WT-07-075.1; Burgos NR., 2007, WEEDY RICE ORIGIN BI; Campbell LG, 2006, ECOL LETT, V9, P1198, DOI 10.1111/j.1461-0248.2006.00974.x; Cao QJ, 2006, ANN BOT-LONDON, V98, P1241, DOI 10.1093/aob/mcl210; CHARLESWORTH D, 1990, EVOLUTION, V44, P870, DOI 10.1111/j.1558-5646.1990.tb03811.x; Charlesworth D, 2003, PHILOS T R SOC B, V358, P1051, DOI 10.1098/rstb.2003.1296; Chen LJ, 2004, ANN BOT-LONDON, V93, P67, DOI 10.1093/aob/mch006; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Ellstrand NC, 1999, ANNU REV ECOL SYST, V30, P539, DOI 10.1146/annurev.ecolsys.30.1.539; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Felsenstein J., 1993, PHYLIP PHYLOGENETIC; Fischer M, 1997, AM J BOT, V84, P1685, DOI 10.2307/2446466; Fishman L, 2002, EVOLUTION, V56, P2138, DOI 10.1111/j.0014-3820.2002.tb00139.x; Gealy DR, 2009, WEED SCI, V57, P627, DOI 10.1614/WS-09-018.1; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hansen LB, 2001, GENET RESOUR CROP EV, V48, P621, DOI 10.1023/A:1013825816443; HARLAN JR, 1965, EUPHYTICA, V14, P173, DOI 10.1007/BF00038984; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Hiscock SJ, 2003, PHILOS T R SOC B, V358, P1037, DOI 10.1098/rstb.2003.1297; HOLTSFORD TP, 1989, THEOR APPL GENET, V78, P480, DOI 10.1007/BF00290831; Husband BC, 1996, EVOLUTION, V50, P54, DOI [10.2307/2410780, 10.1111/j.1558-5646.1996.tb04472.x]; Ishikawa R, 2005, GENET RESOUR CROP EV, V52, P395, DOI 10.1007/s10722-005-2257-x; Jarne P, 2008, HEREDITY, V100, P431, DOI 10.1038/hdy.2008.2; LANGEVIN SA, 1990, EVOLUTION, V44, P1000, DOI 10.1111/j.1558-5646.1990.tb03820.x; Lewis PO, 2001, GENETIC DATA ANAL GD; Londo JP, 2007, MOL ECOL, V16, P4523, DOI 10.1111/j.1365-294X.2007.03489.x; Lu BR, 2009, BIOTECHNOL ADV, V27, P1083, DOI 10.1016/j.biotechadv.2009.05.018; Lu BR, 2005, BIOSCIENCE, V55, P669, DOI 10.1641/0006-3568(2005)055[0669:GFFGMR]2.0.CO;2; NEI M, 1974, GENETICS, V76, P379; Oka H. I., 1988, Origin of cultivated rice.; OKA H. I. W. T. CHANG, 1959, PHYTON REV INTERNAC BOT EXPTL ARGENTINA, V13, P105; Quilichini A, 2001, HEREDITY, V87, P190, DOI 10.1046/j.1365-2540.2001.00897.x; Reagon M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-180; Rieseberg LH, 1998, NEW PHYTOL, V140, P599, DOI 10.1046/j.1469-8137.1998.00315.x; RITLAND K, 1989, EVOLUTION, V43, P848, DOI 10.1111/j.1558-5646.1989.tb05182.x; Ritland K, 2002, HEREDITY, V88, P221, DOI 10.1038/sj.hdy.6800029; Rohlf F. J., 1998, NTSYSPC NUMERICAL TA; Rong J, 2010, PLANT BIOTECHNOL J, V8, P452, DOI 10.1111/j.1467-7652.2009.00488.x; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Olguin ERS, 2009, TRANSGENIC RES, V18, P633, DOI 10.1007/s11248-009-9255-2; SHAW DV, 1981, P NATL ACAD SCI-BIOL, V78, P1298, DOI 10.1073/pnas.78.2.1298; Shivrain VK, 2008, WEED SCI, V56, P807, DOI 10.1614/WS-08-026.1; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Song ZP, 2003, THEOR APPL GENET, V107, P1492, DOI 10.1007/s00122-003-1380-3; Stebbins G. L., 1959, Proceedings of the American Philosophical Society, V103, P231; Stewart CN, 2003, NAT REV GENET, V4, P806, DOI 10.1038/nrg1179; Suh H., 2008, WEEDY RICE; Suh H. S., 1996, International Rice Research Notes, V21, P7; Thurber CS, 2010, MOL ECOL, V19, P3271, DOI 10.1111/j.1365-294X.2010.04708.x; Vaughan DA, 2002, W CROP SCI, P27; Vaughan LK, 2001, WEED SCI, V49, P468, DOI 10.1614/0043-1745(2001)049[0468:IARRFI]2.0.CO;2; Wright S, 1921, GENETICS, V6, P111; Wright S, 1978, VARIABILITY NATURAL; Yu GQ, 2005, BIOCHEM GENET, V43, P261, DOI 10.1007/s10528-005-5218-3; Zhang DL, 2009, THEOR APPL GENET, V119, P1105, DOI 10.1007/s00122-009-1112-4; Zhao R, 2009, AM J BOT, V96, P1138, DOI 10.3732/ajb.0800173	62	95	101	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16189	10.1371/journal.pone.0016189	http://dx.doi.org/10.1371/journal.pone.0016189			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	22174836	Green Published, gold, Green Submitted			2022-12-25	WOS:000286515000030
J	Yu, X; Zheng, J				Yu, Xiang; Zheng, Jie			Polymorphic Structures of Alzheimer's beta-Amyloid Globulomers	PLOS ONE			English	Article							EXPERIMENTAL CONSTRAINTS; SOLUBLE OLIGOMERS; ION CHANNELS; PROTEIN; FIBRIL; PEPTIDE; SHEET; DISEASE; BETA(2)-MICROGLOBULIN; ORGANIZATION	Background: Misfolding and self-assembly of Amyloid-beta (A beta) peptides into amyloid fibrils is pathologically linked to the development of Alzheimer's disease. Polymorphic A beta structures derived from monomers to intermediate oligomers, protofilaments, and mature fibrils have been often observed in solution. Some aggregates are on-pathway species to amyloid fibrils, while the others are off-pathway species that do not evolve into amyloid fibrils. Both on-pathway and off-pathway species could be biologically relevant species. But, the lack of atomic-level structural information for these A beta species leads to the difficulty in the understanding of their biological roles in amyloid toxicity and amyloid formation. Methods and Findings: Here, we model a series of molecular structures of A beta globulomers assembled by monomer and dimer building blocks using our peptide-packing program and explicit-solvent molecular dynamics (MD) simulations. Structural and energetic analysis shows that although A beta globulomers could adopt different energetically favorable but structurally heterogeneous conformations in a rugged energy landscape, they are still preferentially organized by dynamic dimeric subunits with a hydrophobic core formed by the C-terminal residues independence of initial peptide packing and organization. Such structural organizations offer high structural stability by maximizing peptide-peptide association and optimizing peptide-water solvation. Moreover, curved surface, compact size, and less populated beta-structure in A beta globulomers make them difficult to convert into other high-order A beta aggregates and fibrils with dominant beta-structure, suggesting that they are likely to be off-pathway species to amyloid fibrils. These A beta globulomers are compatible with experimental data in overall size, subunit organization, and molecular weight from AFM images and H/D amide exchange NMR. Conclusions: Our computationally modeled A beta globulomers provide useful insights into structure, dynamics, and polymorphic nature of A beta globulomers which are completely different from A beta fibrils, suggesting that these globulomers are likely off-pathway species and explaining the independence of the aggregation kinetics between A beta globulomers and fibrils.	[Yu, Xiang; Zheng, Jie] Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA	University System of Ohio; University of Akron	Yu, X (corresponding author), Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA.	zhengj@uakron.edu	Yu, Xiang/A-9765-2012; Zheng, Jie/B-5057-2013	Yu, Xiang/0000-0002-0486-1110; Zheng, Jie/0000-0003-1547-3612	National Science Foundation [CBET-0952624]; 3M Non-Tenured Faculty Award	National Science Foundation(National Science Foundation (NSF)); 3M Non-Tenured Faculty Award(3M)	This work is supported by a National Science Foundation CAREER Award (CBET-0952624) and a 3M Non-Tenured Faculty Award. This study utilized the high-performance Biowulf PC cluster at the Ohio Supercomputer Center and our ATOM Biowulf cluster at the University of Akron. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Bellesia G, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3216103; Blackley HKL, 1999, EXP NEUROL, V158, P437, DOI 10.1006/exnr.1999.7114; CATRIONA AM, 1999, ANN NEUROL, V46, P860; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; Chaudhary N, 2008, BIOPOLYMERS, V90, P783, DOI 10.1002/bip.21087; Cheon M, 2007, PLOS COMPUT BIOL, V3, P1727, DOI 10.1371/journal.pcbi.0030173; DICARLO M, 2009, EURO BIOPHYS J; DOMINIC M, 2007, J NEUROCHEM, V101, P1172; Gellermann GP, 2008, NEUROBIOL DIS, V30, P212, DOI 10.1016/j.nbd.2008.01.010; Goda R, 2008, BIOMED CHROMATOGR, V22, P1279, DOI 10.1002/bmc.1058; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Huang THJ, 2000, J MOL BIOL, V297, P73, DOI 10.1006/jmbi.2000.3559; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hung LW, 2008, J NEUROSCI, V28, P11950, DOI 10.1523/JNEUROSCI.3916-08.2008; Hwang W, 2004, P NATL ACAD SCI USA, V101, P12916, DOI 10.1073/pnas.0402634101; Im WP, 2003, J COMPUT CHEM, V24, P1691, DOI 10.1002/jcc.10321; Jang H, 2007, BIOPHYS J, V93, P1938, DOI 10.1529/biophysj.107.110148; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; Kim S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3447894; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Krone MG, 2008, J AM CHEM SOC, V130, P11066, DOI 10.1021/ja8017303; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lee YH, 2009, J BIOL CHEM, V284, P2169, DOI 10.1074/jbc.M806939200; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Ma BY, 2010, J BIOL CHEM, V285, P37102, DOI 10.1074/jbc.M110.133488; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Meredith SC, 2005, ANN NY ACAD SCI, V1066, P181, DOI 10.1196/annals.1363.030; Miller Y, 2011, J AM CHEM SOC, V133, P2742, DOI 10.1021/ja1100273; Miller Y, 2010, P NATL ACAD SCI USA, V107, P14128, DOI 10.1073/pnas.1004704107; Miller Y, 2010, CHEM REV, V110, P4820, DOI 10.1021/cr900377t; Mukherjee S, 2009, J PHYS CHEM B, V113, P531, DOI 10.1021/jp809817s; Nimmrich V, 2008, J NEUROSCI, V28, P788, DOI 10.1523/JNEUROSCI.4771-07.2008; Olofsson A, 2007, BIOCHEM J, V404, P63, DOI 10.1042/BJ20061561; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Ravault S, 2005, PROTEIN SCI, V14, P1181, DOI 10.1110/ps.041291405; Reddy G, 2010, P NATL ACAD SCI USA, V107, P21459, DOI 10.1073/pnas.1008616107; Reddy G, 2009, J PHYS CHEM B, V113, P1162, DOI 10.1021/jp808914c; Rezaei-Ghaleh N, 2009, BIOPOLYMERS, V91, P28, DOI 10.1002/bip.21079; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Roher AE, 1996, J BIOL CHEM, V271, P20631, DOI 10.1074/jbc.271.34.20631; Sato T, 2006, BIOCHEMISTRY-US, V45, P5503, DOI 10.1021/bi052485f; Schmechel A, 2003, J BIOL CHEM, V278, P35317, DOI 10.1074/jbc.M303547200; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Tycko R, 2006, Q REV BIOPHYS, V39, P1, DOI 10.1017/S0033583506004173; Viola KL, 2008, J NUTR HEALTH AGING, V12, p51S, DOI 10.1007/BF02982587; Wray S, 2009, J NEUROSCI, V29, P9665, DOI 10.1523/JNEUROSCI.2234-09.2009; Yu LP, 2009, BIOCHEMISTRY-US, V48, P1870, DOI 10.1021/bi802046n; Yu XA, 2010, BIOPHYS J, V99, P666, DOI 10.1016/j.bpj.2010.05.006; Zhang A, 2009, BIOPHYS J, V96, P1091, DOI 10.1016/j.bpj.2008.10.022; Zheng J, 2008, J PHYS CHEM B, V112, P6856, DOI 10.1021/jp711335b; Zheng J, 2008, FRONT BIOSCI-LANDMRK, V13, P3919, DOI 10.2741/2980; Zheng J, 2008, BIOCHEMISTRY-US, V47, P2497, DOI 10.1021/bi7019194; Zheng J, 2007, BIOPHYS J, V93, P3046, DOI 10.1529/biophysj.107.110700; Zheng J, 2010, J PHYS CHEM B, V114, P463, DOI 10.1021/jp907608s; Zhu M, 2004, J BIOL CHEM, V279, P24452, DOI 10.1074/jbc.M400004200	62	87	88	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2011	6	6							e20575	10.1371/journal.pone.0020575	http://dx.doi.org/10.1371/journal.pone.0020575			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777HR	22174866	Green Submitted, gold, Green Published			2022-12-25	WOS:000291607000013
J	da Silva, JM; Creer, S; dos Santos, A; Costa, AC; Cunha, MR; Costa, FO; Carvalho, GR				da Silva, Joana Matzen; Creer, Simon; dos Santos, Antonina; Costa, Ana C.; Cunha, Marina R.; Costa, Filipe O.; Carvalho, Gary R.			Systematic and Evolutionary Insights Derived from mtDNA COI Barcode Diversity in the Decapoda (Crustacea: Malacostraca)	PLOS ONE			English	Article							FRESH-WATER CRAYFISH; GENUS MACROBRACHIUM BATE; DNA BARCODES; MITOCHONDRIAL PSEUDOGENES; DEMERSAL FISH; BODY-SIZE; BIOLOGICAL IDENTIFICATIONS; MOLECULAR SYSTEMATICS; SPECIES COMPLEX; MUTATIONAL BIAS	Background: Decapods are the most recognizable of all crustaceans and comprise a dominant group of benthic invertebrates of the continental shelf and slope, including many species of economic importance. Of the 17635 morphologically described Decapoda species, only 5.4% are represented by COI barcode region sequences. It therefore remains a challenge to compile regional databases that identify and analyse the extent and patterns of decapod diversity throughout the world. Methodology/Principal Findings: We contributed 101 decapod species from the North East Atlantic, the Gulf of Cadiz and the Mediterranean Sea, of which 81 species represent novel COI records. Within the newly-generated dataset, 3.6% of the species barcodes conflicted with the assigned morphological taxonomic identification, highlighting both the apparent taxonomic ambiguity among certain groups, and the need for an accelerated and independent taxonomic approach. Using the combined COI barcode projects from the Barcode of Life Database, we provide the most comprehensive COI data set so far examined for the Order (1572 sequences of 528 species, 213 genera, and 67 families). Patterns within families show a general predicted molecular hierarchy, but the scale of divergence at each taxonomic level appears to vary extensively between families. The range values of mean K2P distance observed were: within species 0.285% to 1.375%, within genus 6.376% to 20.924% and within family 11.392% to 25.617%. Nucleotide composition varied greatly across decapods, ranging from 30.8 % to 49.4 % GC content. Conclusions/Significance: Decapod biological diversity was quantified by identifying putative cryptic species allowing a rapid assessment of taxon diversity in groups that have until now received limited morphological and systematic examination. We highlight taxonomic groups or species with unusual nucleotide composition or evolutionary rates. Such data are relevant to strategies for conservation of existing decapod biodiversity, as well as elucidating the mechanisms and constraints shaping the patterns observed.	[da Silva, Joana Matzen; Creer, Simon; Carvalho, Gary R.] Bangor Univ, Mol Ecol & Fisheries Genet Lab, Sch Biol Sci, Environm Ctr Wales, Bangor, Gwynedd, Wales; [da Silva, Joana Matzen; Cunha, Marina R.] Univ Aveiro, Ctr Estudos Ambiente & Mar, Dept Biol, P-3800 Aveiro, Portugal; [dos Santos, Antonina] Inst Nacl Recursos Biol L IPIMAR, Lisbon, Portugal; [Costa, Ana C.] Univ Acores, Dept Biol, Sao Miguel, Portugal; [Costa, Filipe O.] Univ Minho, CBMA, Dept Biol, Braga, Portugal	Bangor University; Universidade de Aveiro; Universidade dos Acores; Universidade do Minho	da Silva, JM (corresponding author), Bangor Univ, Mol Ecol & Fisheries Genet Lab, Sch Biol Sci, Environm Ctr Wales, Bangor, Gwynedd, Wales.	joanamatzen@yahoo.com	Costa, Filipe/M-9623-2019; Costa, Filipe/B-5890-2009; Costa, Filipe/GSD-2439-2022; Costa, Ana Cristina M R/L-8023-2013; Costa, Ana/HDL-9297-2022; Cunha, Marina R/B-7644-2008; Dos Santos, Antonina/B-9055-2011; Costa, Ana Cristina de Matos Ricardo/H-3775-2019	Costa, Filipe/0000-0001-5398-3942; Costa, Filipe/0000-0001-5398-3942; Costa, Ana Cristina M R/0000-0002-0258-3460; Cunha, Marina R/0000-0001-8833-6980; Dos Santos, Antonina/0000-0002-2238-9315; Costa, Ana Cristina de Matos Ricardo/0000-0002-0258-3460	The Fundacao para a Ciencia e Tecnologia (Portugal) [SFRH/BD/25568/2006]; HERMES; European Commission [GOCE-CT-2005-511234]; LusoMarBol FCT [PTDC/MAR/69892/2006]	The Fundacao para a Ciencia e Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); HERMES(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); LusoMarBol FCT	The Fundacao para a Ciencia e Tecnologia (Portugal) provided a doctoral fellowship (SFRH/BD/25568/2006) to Joana Matzen da Silva. This research was partially supported by the HERMES project, EC contract GOCE-CT-2005-511234, funded by the European Commission's Sixth Framework Programme under the priority Sustainable Development, Global Change and Ecosystems and LusoMarBol FCT research grant PTDC/MAR/69892/2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekhnovich AV, 2001, RUSS J ECOL+, V32, P420, DOI 10.1023/A:1012586218096; Apte S, 2007, MOL ECOL, V16, P1897, DOI 10.1111/j.1365-294X.2007.03224.x; Arif I. A., 2009, Animal Biodiversity and Conservation, V32, P9; Bachtrog D, 2006, EVOLUTION, V60, P292, DOI 10.1111/j.0014-3820.2006.tb01107.x; Baer CF, 2007, NAT REV GENET, V8, P619, DOI 10.1038/nrg2158; Balakirev ES, 2003, ANNU REV GENET, V37, P123, DOI 10.1146/annurev.genet.37.040103.103949; Banerjee T, 2005, BIOSYSTEMS, V81, P11, DOI 10.1016/j.biosystems.2005.01.002; Baratti M, 2005, J EXP MAR BIOL ECOL, V315, P225, DOI 10.1016/j.jembe.2004.09.020; Barber PH, 2006, EVOLUTION, V60, P1825; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Bernardi G, 1995, ANNU REV GENET, V29, P445, DOI 10.1146/annurev.ge.29.120195.002305; Bierne N, 2003, P ROY SOC B-BIOL SCI, V270, P1399, DOI 10.1098/rspb.2003.2404; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Blaxter M, 2003, NATURE, V421, P122, DOI 10.1038/421122a; Boero Ferdinando, 2010, Diversity, V2, P115; Bracken Heather D., 2009, Crustacean Issues, V18, P281; Brokeland W, 2008, ZOOL J LINN SOC-LOND, V152, P655, DOI 10.1111/j.1096-3642.2008.00362.x; Bucciarelli G, 2002, GENE, V295, P153, DOI 10.1016/S0378-1119(02)00733-3; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Calado R, 2006, SCI MAR, V70, P389, DOI 10.3989/scimar.2006.70n3389; Cartes JE, 2002, SCI MAR, V66, P209, DOI 10.3989/scimar.2002.66s2209; CARTES JE, 2007, DEEP-SEA RES, V1, P263; Casiraghi M, 2010, BRIEF BIOINFORM, V11, P440, DOI 10.1093/bib/bbq003; Chan TY, 2004, MEMOIR MUS NATL HIST, V191, P293; CHAN TY, 1991, P BIOL SOC WASH, V104, P545; CHAN TY, NEW DEEP SEA SHRIMP, P119; Chandor A, 2007, CR CHIM, V10, P756, DOI 10.1016/j.crci.2007.02.019; Chang CH, 2009, PEDOBIOLOGIA, V52, P171, DOI 10.1016/j.pedobi.2008.08.002; CHILDRESS JJ, 1990, DEEP-SEA RES, V37, P929, DOI 10.1016/0198-0149(90)90104-4; CHILDRESS JJ, 1995, TRENDS ECOL EVOL, V10, P30, DOI 10.1016/S0169-5347(00)88957-0; CINZIA V, 2006, ANTARCTIC SCI, V19, P271; Clare EL, 2008, J MOL EVOL, V66, P362, DOI 10.1007/s00239-008-9088-2; Company JB, 1998, DEEP-SEA RES PT I, V45, P1861, DOI 10.1016/S0967-0637(98)00034-X; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; COSTA FO, 2007, GENOMICS SOC POLICY, V3, P29, DOI DOI 10.1186/1746-5354-3-2-29; Cuesta JA, 2000, HYDROBIOLOGIA, V436, P119, DOI 10.1023/A:1026576614590; Cuesta JA, 1998, J NAT HIST, V32, P1499, DOI 10.1080/00222939800771031; CUNNINGHAM CW, 1992, NATURE, V355, P539, DOI 10.1038/355539a0; DACOZ CD, 1999, INVENTAIRE DISTRIBUT; De Grave S, 2008, HYDROBIOLOGIA, V595, P287, DOI 10.1007/s10750-007-9024-2; de Grave Sammy, 2006, Aquatic Invasions, V1, P204; De Grave S, 2009, RAFFLES B ZOOL, P1; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; Dimmock A, 2004, AQUACULT INT, V12, P435, DOI 10.1023/B:AQUI.0000042140.48340.c8; Drake JW, 2006, GENETICS, V173, P1; Drake JW, 1998, GENETICS, V148, P1667; Ebach MC, 2005, NATURE, V434, P697, DOI 10.1038/434697b; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FORTUNATO C, 1998, 4 INT CRUST C AMST; Foster PG, 1997, J MOL EVOL, V44, P282, DOI 10.1007/PL00006145; Fourment M, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-1; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; FRIEDBERG EC, 1995, TRENDS BIOCHEM SCI, V20, P381, DOI 10.1016/S0968-0004(00)89082-9; Garcia Raso J.E., 1989, Miscellania Zoologica (Barcelona), V11, P113; Garcia-Castrillo Gerardo, 1995, ICES Marine Science Symposia, V199, P151; Gerstein M, 2006, SCI AM, V295, P48, DOI 10.1038/scientificamerican0806-48; Gillooly JF, 2007, ECOLOGY, V88, P1890, DOI 10.1890/06-1935.1; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gillooly JF, 2005, P NATL ACAD SCI USA, V102, P140, DOI 10.1073/pnas.0407735101; Gomez A, 2007, P ROY SOC B-BIOL SCI, V274, P199, DOI 10.1098/rspb.2006.3718; GONZALEZGORILLO JI, 2001, INVERTEBRATE REPROD, V39, P165; Gouws G, 2006, MAR FRESHWATER RES, V57, P837, DOI 10.1071/MF05248; Grabowski Michal, 2006, Aquatic Invasions, V1, P116; Gregory TR, 2005, NATURE, V434, P1067, DOI 10.1038/4341067b; Guerao G, 1997, J CRUSTACEAN BIOL, V17, P459, DOI 10.2307/1549440; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hajibabaei M, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-24; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hall S, 2009, J BIOGEOGR, V36, P2125, DOI 10.1111/j.1365-2699.2009.02153.x; Harris DJ, 2003, TRENDS ECOL EVOL, V18, P317, DOI 10.1016/S0169-5347(03)00150-2; Harrison JS, 2004, MOL PHYLOGENET EVOL, V30, P743, DOI 10.1016/S1055-7903(03)00250-1; Hassanin A, 2006, MOL PHYLOGENET EVOL, V38, P100, DOI 10.1016/j.ympev.2005.09.012; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hebert PDN, 2002, EVOLUTION, V56, P909; Herring PJ, 1998, DEEP-SEA RES PT I, V45, P2105, DOI 10.1016/S0967-0637(98)00050-8; Hickerson MJ, 2006, SYST BIOL, V55, P729, DOI 10.1080/10635150600969898; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Holthuis L. B., 1950, Siboga Expeditie Leiden, V39a9, P1; Hultgren KM, 2008, MOL PHYLOGENET EVOL, V48, P986, DOI 10.1016/j.ympev.2008.05.004; IVANOVA NV, 2007, MOL ECOL NOTES, P1; Jones GP, 2007, OCEANOGRAPHY, V20, P100, DOI 10.5670/oceanog.2007.33; JONG G, 2004, NEW PHYTOL, V166, P101; KIRKPATRICK K, 1985, J EXP MAR BIOL ECOL, V93, P61, DOI 10.1016/0022-0981(85)90148-0; Komai T, 1999, J NAT HIST, V33, P1265, DOI 10.1080/002229399299914; Lefebure T, 2006, MOL PHYLOGENET EVOL, V40, P435, DOI 10.1016/j.ympev.2006.03.014; LEVESQUE R, 2008, SPSS PROGRAMMING DAT; Liu MY, 2007, ZOOL STUD, V46, P272; MACPHERSON E, 1991, MAR ECOL PROG SER, V71, P103, DOI 10.3354/meps071103; Maki H, 2002, ANNU REV GENET, V36, P279, DOI 10.1146/annurev.genet.36.042602.094806; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; MALLET J, 2007, TRENDS ECOL EVOL, V18, P57; Marin IN, 2005, ZOOL STUD, V44, P234; MARKLE DF, 1988, CAN J ZOOL, V66, P1952, DOI 10.1139/z88-286; MARTIN AP, 1993, P NATL ACAD SCI USA, V90, P4087, DOI 10.1073/pnas.90.9.4087; MARTIN AP, 1992, NATURE, V357, P153, DOI 10.1038/357153a0; MARTIN J. W., 2001, NATURAL HIST MUSEUM, V39, P1; Martin JW, 2009, DECAPOD CRUSTACEAN P; Mashiko K, 2000, J CRUSTACEAN BIOL, V20, P118, DOI 10.1651/0278-0372(2000)020[0118:DOPWDS]2.0.CO;2; Mathews LM, 2007, MAR BIOL, V152, P645, DOI 10.1007/s00227-007-0718-9; Mathews LM, 2009, MOL PHYLOGENET EVOL, V50, P268, DOI 10.1016/j.ympev.2008.10.026; Matz MV, 2005, PHILOS T R SOC B, V360, P1969, DOI 10.1098/rstb.2005.1728; MATZ MV, 2005, SCIENCE; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miller SE, 2007, P NATL ACAD SCI USA, V104, P4775, DOI 10.1073/pnas.0700466104; Min XJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000325; Minelli A, 2003, TRENDS ECOL EVOL, V18, P75, DOI 10.1016/S0169-5347(02)00051-4; Mooers AO, 2000, TRENDS ECOL EVOL, V15, P365, DOI 10.1016/S0169-5347(00)01934-0; Munasinghe DHN, 2003, J CRUSTACEAN BIOL, V23, P402, DOI 10.1651/0278-0372(2003)023[0402:UOMDSF]2.0.CO;2; Murphy NP, 2005, ZOOL SCR, V34, P187, DOI 10.1111/j.1463-6409.2005.00185.x; Nguyen TTT, 2002, ANIM GENET, V33, P304, DOI 10.1046/j.1365-2052.2002.00867.x; NOEL PY, 1992, CLE PRELIMINAIRE IDE, P1; OHTA T, 1992, ANNU REV ECOL SYST, V23, P263, DOI 10.1146/annurev.es.23.110192.001403; Olaso I., 1995, ICES Marine Science Symposia, V199, P209; OLIVER I, 1993, CONSERV BIOL, V7, P562, DOI 10.1046/j.1523-1739.1993.07030562.x; Ostrow D, 2007, GENETICS, V176, P1653, DOI 10.1534/genetics.107.074666; PAGE RDM, 1998, BIOL LETTERS, V1, P139; Palumbi SR, 2003, ECOL APPL, V13, pS146; Payne RW, 2009, WILEY INTERDISCIP RE, V1, P255, DOI 10.1002/wics.32; Perez-Barros P, 2008, BIOL J LINN SOC, V94, P421, DOI 10.1111/j.1095-8312.2008.00987.x; Pfeiler E, 2005, MAR BIOL, V146, P559, DOI 10.1007/s00227-004-1463-y; Polunin NVC, 2001, MAR ECOL PROG SER, V220, P13; Porter ML, 2005, MOL PHYLOGENET EVOL, V37, P355, DOI 10.1016/j.ympev.2005.06.021; Puillandre N, 2009, MOL ECOL RESOUR, V9, P1311, DOI 10.1111/j.1755-0998.2009.02576.x; Radulovici Adriana E., 2010, Diversity, V2, P450; Radulovici AE, 2009, MOL ECOL RESOUR, V9, P181, DOI 10.1111/j.1755-0998.2009.02643.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Reuschel S, 2010, MOL PHYLOGENET EVOL, V55, P765, DOI 10.1016/j.ympev.2010.03.021; Rock J, 2008, ANTARCT SCI, V20, P253, DOI 10.1017/S0954102008001120; Roe AD, 2007, MOL PHYLOGENET EVOL, V44, P325, DOI 10.1016/j.ympev.2006.12.005; Romiguier J, 2010, GENOME RES, V20, P1001, DOI 10.1101/gr.104372.109; SALMAN DS, 2006, AQUAT INVASIONS, V1, P109; Sanchez JA, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-122; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Schindel DE, 2005, NATURE, V435, P17, DOI 10.1038/435017b; SCHUBART CD, 1996, PHYLOGENY N ATLANTIC, P83; Schubart Christoph D., 2009, Crustacean Issues, V18, P47; Seibel BA, 1997, BIOL BULL, V192, P262, DOI 10.2307/1542720; Seibel BA, 2000, DEEP-SEA RES PT I, V47, P1247, DOI 10.1016/S0967-0637(99)00103-X; Semon M, 2005, HUM MOL GENET, V14, P421, DOI 10.1093/hmg/ddi038; Shih HT, 2007, ZOOL SCI, V24, P57, DOI 10.2108/zsj.24.57; Sicot FX, 2000, J MOL BIOL, V302, P811, DOI 10.1006/jmbi.2000.4505; Silliman BR, 2003, J CRUSTACEAN BIOL, V23, P876, DOI 10.1651/C-2410; Smith MA, 2008, MOL ECOL RESOUR, V8, P235, DOI 10.1111/j.1471-8286.2007.01964.x; Somero GN, 2003, COMP BIOCHEM PHYS B, V136, P577, DOI 10.1016/S1096-4959(03)00215-X; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Stevens Bradley G., 2000, Journal of Northwest Atlantic Fishery Science, V27, P77, DOI 10.2960/J.v27.a7; Summerbell RC, 2005, PHILOS T R SOC B, V360, P1897, DOI 10.1098/rstb.2005.1721; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TAYLOR AC, 1987, MAR BIOL, P521; TAYLOR WR, 1986, J THEOR BIOL, V119, P205, DOI 10.1016/S0022-5193(86)80075-3; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsang LM, 2008, MOL PHYLOGENET EVOL, V48, P359, DOI 10.1016/j.ympev.2008.04.009; TSANG LM, 2009, MOL PHYLOGENET EVOL, P1; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Williams ST, 2001, MOL BIOL EVOL, V18, P1484, DOI 10.1093/oxfordjournals.molbev.a003934; WILLIAMSON D I, 1972, Crustaceana (Leiden), V23, P282, DOI 10.1163/156854072X00174; Wilson EO, 2003, TRENDS ECOL EVOL, V18, P77, DOI 10.1016/S0169-5347(02)00040-X; Wilson EO, 2003, ISSUES SCI TECHNOL, V19, P45; Wilson EO, 2003, PALEOBIOLOGY, V29, P14, DOI 10.1666/0094-8373(2003)029<0014:OGBE>2.0.CO;2; WONG JTY, 1990, AQUACULTURE, V88, P151, DOI 10.1016/0044-8486(90)90290-4; Zaklan SD, 2002, LOW WAKE FI, V19, P751; Zaksek V, 2009, MOL ECOL, V18, P931, DOI 10.1111/j.1365-294X.2008.04061.x; ZANG AB, 2010, MOL PHYLOGENET EVOL, P1035; ZARIQUIEY-ALVAREZ R, 1968, Investigacion Pesquera (Barcelona), V32, P1	174	147	151	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19449	10.1371/journal.pone.0019449	http://dx.doi.org/10.1371/journal.pone.0019449			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	22174780	Green Submitted, Green Published, gold			2022-12-25	WOS:000290531100010
J	Zhang, LJ; Xi, J; Xu, GQ; Shu, H; Wang, XY; Li, P				Zhang, Linjun; Xi, Jie; Xu, Guoqing; Shu, Hua; Wang, Xiaoyi; Li, Ping			Cortical Dynamics of Acoustic and Phonological Processing in Speech Perception	PLOS ONE			English	Article							HUMAN AUDITORY-CORTEX; TOP-DOWN INFLUENCES; HIERARCHICAL ORGANIZATION; INTELLIGIBLE SPEECH; MECHANISMS; PITCH; NEUROANATOMY; INFORMATION; MODULATION; NETWORKS	In speech perception, a functional hierarchy has been proposed by recent functional neuroimaging studies: Core auditory areas on the dorsal plane of superior temporal gyrus (STG) are sensitive to basic acoustic characteristics, whereas downstream regions, specifically the left superior temporal sulcus (STS) and middle temporal gyrus (MTG) ventral to Heschl's gyrus (HG) are responsive to abstract phonological features. What is unclear so far is the relationship between the dorsal and ventral processes, especially with regard to whether low-level acoustic processing is modulated by high-level phonological processing. To address the issue, we assessed sensitivity of core auditory and downstream regions to acoustic and phonological variations by using within-and across-category lexical tonal continua with equal physical intervals. We found that relative to within-category variation, across-category variation elicited stronger activation in the left middle MTG (mMTG), apparently reflecting the abstract phonological representations. At the same time, activation in the core auditory region decreased, resulting from the top-down influences of phonological processing. These results support a hierarchical organization of the ventral acoustic-phonological processing stream, which originates in the right HG/STG and projects to the left mMTG. Furthermore, our study provides direct evidence that low-level acoustic analysis is modulated by high-level phonological representations, revealing the cortical dynamics of acoustic and phonological processing in speech perception. Our findings confirm the existence of reciprocal progression projections in the auditory pathways and the roles of both feed-forward and feedback mechanisms in speech perception.	[Zhang, Linjun; Xi, Jie; Shu, Hua] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Zhang, Linjun] Beijing Language & Culture Univ, Coll Chinese Studies, Beijing, Peoples R China; [Xi, Jie] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China; [Xu, Guoqing] Dalian Med Univ, Dept Psychol, Dalian, Peoples R China; [Wang, Xiaoyi] Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing, Peoples R China; [Li, Ping] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Li, Ping] Penn State Univ, Ctr Language Sci, University Pk, PA 16802 USA	Beijing Normal University; Beijing Language & Culture University; Chinese Academy of Sciences; Institute of Psychology, CAS; Dalian Medical University; Capital Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Zhang, LJ (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	shuh@bnu.edu.cn; pul8@psu.edu	; Speicher, Andreas/B-3134-2014	Lin, Jinxing/0000-0001-9338-1356; Speicher, Andreas/0000-0001-6608-3994; Li, Ping/0000-0002-3314-943X	Program for Changjiang Scholars and Innovative Research Team in University [IRT0710]; Natural Science Foundation of China [30870758]; Natural Science Foundation of Beijing [7092051]; Fund for Foreign Scholars in University Research and Teaching Programs [B07008]	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation); Fund for Foreign Scholars in University Research and Teaching Programs	The research was supported by the Program for Changjiang Scholars and Innovative Research Team in University (IRT0710, http://www.cksp.edu.cn/index.php), by grants from the Natural Science Foundation of China (30870758, http://www.nsfc.gov.cn/Portal0/default124.htm), by grants from the Natural Science Foundation of Beijing (7092051, http://www.bjnsf.org/) to HS, and the Fund for Foreign Scholars in University Research and Teaching Programs (B07008, http://www.bjnsf.org/) to PL and HS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendor D, 2006, CURR OPIN NEUROBIOL, V16, P391, DOI 10.1016/j.conb.2006.07.001; Binder J, 2000, BRAIN, V123, P2371, DOI 10.1093/brain/123.12.2371; Brechmann A, 2005, CEREB CORTEX, V15, P578, DOI 10.1093/cercor/bhh159; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dehaene-Lambertz G, 2005, NEUROIMAGE, V24, P21, DOI 10.1016/j.neuroimage.2004.09.039; Gandour J, 2004, NEUROIMAGE, V23, P344, DOI 10.1016/j.neuroimage.2004.06.004; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; Hesling I, 2005, NEUROIMAGE, V24, P937, DOI 10.1016/j.neuroimage.2004.11.003; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Humphries C, 2005, HUM BRAIN MAPP, V26, P128, DOI 10.1002/hbm.20148; Joanisse MF, 2007, CEREB CORTEX, V17, P2084, DOI 10.1093/cercor/bhl124; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; Liebenthal E, 2005, CEREB CORTEX, V15, P1621, DOI 10.1093/cercor/bhi040; Liebenthal E, 2010, CEREB CORTEX, V20, P2958, DOI 10.1093/cercor/bhq045; Meyer M, 2004, BRAIN LANG, V89, P277, DOI 10.1016/S0093-934X(03)00350-X; Naatanen R, 1997, NATURE, V385, P432, DOI 10.1038/385432a0; Narain C, 2003, CEREB CORTEX, V13, P1362, DOI 10.1093/cercor/bhg083; Obleser J, 2007, CEREB CORTEX, V17, P2251, DOI 10.1093/cercor/bhl133; Okada K, 2010, CEREB CORTEX, V20, P2486, DOI 10.1093/cercor/bhp318; Patterson RD, 2002, NEURON, V36, P767, DOI 10.1016/S0896-6273(02)01060-7; Rinne T, 2009, J NEUROSCI, V29, P13338, DOI 10.1523/JNEUROSCI.3012-09.2009; Rogalsky C, 2009, CEREB CORTEX, V19, P786, DOI 10.1093/cercor/bhn126; Schofield TM, 2009, P NATL ACAD SCI USA, V106, P11765, DOI 10.1073/pnas.0811402106; Scott SK, 2004, COGNITION, V92, P13, DOI 10.1016/j.cognition.2002.12.002; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; Scott SK, 2006, J ACOUST SOC AM, V120, P1075, DOI 10.1121/1.2216725; Shulman GL, 1997, CEREB CORTEX, V7, P193, DOI 10.1093/cercor/7.3.193; Sussman E, 2002, COGNITIVE BRAIN RES, V13, P393, DOI 10.1016/S0926-6410(01)00131-8; Talairach J., 1988, COPLANAR STEREOTAXIC; Tervaniemi M, 2000, HUM BRAIN MAPP, V10, P74, DOI 10.1002/(SICI)1097-0193(200006)10:2<74::AID-HBM30>3.0.CO;2-2; Tervaniemi M, 2006, J NEUROSCI, V26, P8647, DOI 10.1523/JNEUROSCI.0995-06.2006; Wessinger CM, 2001, J COGNITIVE NEUROSCI, V13, P1, DOI 10.1162/089892901564108; Xi J, 2010, NEUROSCIENCE, V170, P223, DOI 10.1016/j.neuroscience.2010.06.077; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994; Zhang LJ, 2010, HUM BRAIN MAPP, V31, P1106, DOI 10.1002/hbm.20922	36	344	349	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2011	6	6							e20963	10.1371/journal.pone.0020963	http://dx.doi.org/10.1371/journal.pone.0020963			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777ZG	22022536	gold, Green Published, Green Submitted			2022-12-25	WOS:000291663300033
